FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Moretti, D
   Wegmuller, R
   Speich, C
   Zeder, C
   Cichucka, M
   Cercamondi, CI
   Prentice, A
   Brittenham, G
   Zimmermann, MB
AF Moretti, Diego
   Wegmueller, Rita
   Speich, Cornelia
   Zeder, Christophe
   Cichucka, Magdalena
   Cercamondi, Colin Ivano
   Prentice, Andrew
   Brittenham, Gary
   Zimmermann, Michael Bruce
TI EVALUATING IRON METABOLISM AND SUPPLEMENTATION IN GAMBIAN TODDLERS USING
   A NOVEL, HIGH-PRECISION METHOD BASED ON THE DILUTION OF LABELLED BODY
   IRON
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Meeting Abstract
C1 [Moretti, Diego; Speich, Cornelia; Zeder, Christophe; Cichucka, Magdalena; Cercamondi, Colin Ivano; Brittenham, Gary; Zimmermann, Michael Bruce] Swiss Fed Inst Technol, Zurich, Switzerland.
   [Wegmueller, Rita; Prentice, Andrew] MRC Unit, Serekunda, Gambia.
   [Wegmueller, Rita; Prentice, Andrew] LSHTM, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
EI 1096-8652
J9 AM J HEMATOL
JI Am. J. Hematol.
PD AUG
PY 2017
VL 92
IS 8
MA 48
BP E290
EP E290
PG 1
WC Hematology
SC Hematology
GA FA4MJ
UT WOS:000405417100126
OA No
DA 2017-08-15
ER

PT J
AU Pereira, D
   Wegmuller, R
   Cerami, C
   Prentice, A
AF Pereira, Dora
   Wegmuller, Rita
   Cerami, Carla
   Prentice, Andrew
TI PREDICTORS OF IRON ABSORPTION FROM A NOVEL NANO IRON SUPPLEMENT (IHAT)
   IN GAMBIAN WOMEN IN THE ABSENCE OF INFLAMMATION
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Meeting Abstract
C1 [Pereira, Dora] Univ Cambridge, Cambridge, England.
   [Wegmuller, Rita; Cerami, Carla; Prentice, Andrew] MRC Unit, Serekunda, Gambia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
EI 1096-8652
J9 AM J HEMATOL
JI Am. J. Hematol.
PD AUG
PY 2017
VL 92
IS 8
MA 149
BP E392
EP E392
PG 1
WC Hematology
SC Hematology
GA FA4MJ
UT WOS:000405417100227
OA No
DA 2017-08-15
ER

PT J
AU Harding-Esch, EM
   Kadimpeul, J
   Sarr, B
   Sane, A
   Badji, S
   Laye, M
   Sillah, A
   Burr, SE
   MacLeod, D
   Last, AR
   Holland, MJ
   Mabey, DC
   Bailey, RL
AF Harding-Esch, Emma M.
   Kadimpeul, Julbert
   Sarr, Boubacar
   Sane, Awa
   Badji, Souleymane
   Laye, Mass
   Sillah, Ansumana
   Burr, Sarah E.
   MacLeod, David
   Last, Anna R.
   Holland, Martin J.
   Mabey, David C.
   Bailey, Robin L.
TI Population-based prevalence survey of follicular trachoma and
   trachomatous trichiasis in the Casamance region of Senegal
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Chlamydia trachomatis; Active trachoma; Trachomatous trichiasis; Survey;
   Senegal; Control
ID RANDOMIZED CONTROLLED-TRIAL; ACTIVE TRACHOMA; RISK-FACTORS; BIJAGOS
   ARCHIPELAGO; GUINEA-BISSAU; GAMBIA; INFECTION; COMMUNITIES; TANZANIA;
   AFRICA
AB Background: Trachoma, caused by ocular infection with Chlamydia trachomatis, is the leading infectious cause of blindness worldwide. We conducted the first population-based trachoma prevalence survey in the Casamance region of Senegal to enable the Senegalese National Eye Care Programme (NECP) to plan its trachoma control activities. The World Health Organization (WHO) guidelines state that any individual with trachomatous trichiasis (TT) should be offered surgery, but that surgery should be prioritised where the prevalence is >0.1%, and that districts and communities with a trachomatous inflammation, follicular(TF) prevalence of >= 10% in 1-9 year-olds should receive mass antibiotic treatment annually for a minimum of three years, along with hygiene promotion and environmental improvement, before re-assessing the prevalence to determine whether treatment can be discontinued (when TF prevalence in 1-9 year-olds falls <5%).
   Methods: Local healthcare workers conducted a population-based household survey in four districts of the Bignona Department of Casamance region to estimate the prevalence of TF in 1-9 year-olds, and TT in >= 15 year-olds. Children's facial cleanliness (ocular and/or nasal discharge, dirt on the face, flies on the face) was measured at time of examination. Risk factor questionnaires were completed at the household level.
   Results: Sixty communities participated with a total censused population of 5580 individuals. The cluster-, age-and sex-adjusted estimated prevalence of TF in 1-9 year-olds was 2.5% (95% Confidence Interval (CI) 1.8-3.6) (38/ 1425) at the regional level and < 5% in all districts, although the upper 95% CI exceeded 5% in all but one district. The prevalence of TT in those aged >= 15 years was estimated to be 1.4% (95% CI 1.0-1.9) (40/2744) at the regional level and >1% in all districts.
   Conclusion: With a prevalence < 5%, TF does not appear to be a significant public health problem in this region. However, TF monitoring and surveillance at sub-district level will be required to ensure that elimination targets are sustained and that TF does not re-emerge as a public health problem. TT surgery remains the priority for trachoma elimination efforts in the region, with an estimated 1819 TT surgeries to conduct.
C1 [Harding-Esch, Emma M.; Burr, Sarah E.; Last, Anna R.; Holland, Martin J.; Mabey, David C.; Bailey, Robin L.] London Sch Hyg & Trop Med, Dept Clin Res, London, England.
   [Kadimpeul, Julbert; Sarr, Boubacar; Sane, Awa; Badji, Souleymane] Minist Sante, Programme Natl Lutte Cecite, Dakar, Senegal.
   [Laye, Mass; Sillah, Ansumana] Minist Hlth & Social Welf, Natl Eye Hlth Programme, Kanifing, Gambia.
   [Burr, Sarah E.] MRC Unit, Dis Control & Eliminat Theme, Banjul, Gambia.
   [MacLeod, David] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Harding-Esch, EM (reprint author), London Sch Hyg & Trop Med, Dept Clin Res, London, England.
EM eharding@sgul.ac.uk
FU Bill and Melinda Gates Foundation [48027]
FX This work was supported by the Bill and Melinda Gates Foundation, grant
   number 48027. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Brockerhoff M, 2000, B WORLD HEALTH ORGAN, V78, P30
   Brooks P, CASES GLOBAL HLTH DE
   Burr SE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004906
   Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X
   Cahill KV, 2012, SMITH NESIS OPHTHALM, P317
   Courtright P, 2004, EMERG INFECT DIS, V10, P2012
   Cromwell EA, 2009, T ROY SOC TROP MED H, V103, P985, DOI 10.1016/j.trstmh.2009.03.012
   Dolin PJ, 1998, BRIT J OPHTHALMOL, V82, P930, DOI 10.1136/bjo.82.8.930
   Dolin PJ, 1997, LANCET, V349, P1511, DOI 10.1016/S0140-6736(97)01355-X
   Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1
   Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x
   FAAL H, 1989, BRIT J OPHTHALMOL, V73, P82, DOI 10.1136/bjo.73.2.82
   Faye M, 2006, T ROY SOC TROP MED H, V100, P149, DOI 10.1016/j.trstmh.2005.06.029
   Harding-Esch EM, 2008, T ROY SOC TROP MED H, V102, P1255, DOI 10.1016/j.trstmh.2008.04.022
   Harding-Esch EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002115
   Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861
   Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573
   Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298
   Last AR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002900
   Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1
   Ngondi J, 2009, B WORLD HEALTH ORGAN, V87, P143, DOI 10.2471/BLT.07.046326
   PNLC HKI CC, 2013, COMMUNITY EYE HLTH, V26, P58
   Saal M B, 2003, Med Trop (Mars), V63, P53
   Smith JL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002359
   Solomon Anthony W, 2014, Community Eye Health, V27, P18
   Solomon AW, 2004, CLIN MICROBIOL REV, V17, P982, DOI 10.1128/CMR.17.4.982-1011.2004
   Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605
   Thompson K, 2015, OPHTHAL EPIDEMIOL, V22, P190, DOI 10.3109/09286586.2015.1036889
   THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477
   UNDP, HUM DEV REP 2015 WOR
   UNDP, MILL DEV GOALS REP
   WEST SK, 1991, INT J EPIDEMIOL, V20, P1088, DOI 10.1093/ije/20.4.1088
   WHO, 2015, TECHN CONS TRACH SUR
   WHO, REP 3 GLOB SCI M TRA
   WHO, 2014, WKLY EPIDEMIOL REC, V89, P421
   WHO, 2006, TRACH CONTR GUID PRO
   WHO, REP M POST SURV BLIN
NR 37
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUL 26
PY 2017
VL 18
AR 62
DI 10.1186/s12889-017-4605-0
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FB8VZ
UT WOS:000406418900003
OA gold
DA 2017-08-15
ER

PT J
AU Barber, RM
   Fullman, N
   Sorensen, RJD
   Bollyky, T
   McKee, M
   Nolte, E
   Abajobir, AA
   Abate, KH
   Abbafati, C
   Abbas, KM
   Abd-Allah, F
   Abdulle, AM
   Abdurahman, AA
   Abera, SF
   Abraham, B
   Abreha, GF
   Adane, K
   Adelekan, AL
   Adetifa, IMO
   Afshin, A
   Agarwal, A
   Agarwal, SK
   Agarwal, S
   Agrawal, A
   Kiadaliri, AA
   Ahmadi, A
   Ahmed, KY
   Ahmed, MB
   Akinyemi, RO
   Akinyemiju, TF
   Akseer, N
   Al-Aly, Z
   Alam, K
   Alam, N
   Alam, SS
   Alemu, ZA
   Alene, KA
   Alexander, L
   Ali, R
   Ali, SD
   Alizadeh-Navaei, R
   Alkerwi, A
   Alla, F
   Allebeck, P
   Allen, C
   Al-Raddadi, R
   Alsharif, U
   Altirkawi, KA
   Martin, EA
   Alvis-Guzman, N
   Amare, AT
   Amini, E
   Ammar, W
   Amo-Adjei, J
   Amoako, YA
   Anderson, BO
   Androudi, S
   Ansari, H
   Ansha, MG
   Antonio, CAT
   Arnlov, J
   Al Artaman,
   Asayesh, H
   Assadi, R
   Astatkie, A
   Atey, TM
   Atique, S
   Atnafu, NT
   Atre, SR
   Avila-Burgos, L
   Avokpaho, EFGA
   Quintanilla, BPA
   Awasthi, A
   Ayele, NN
   Azzopardi, P
   Saleem, HOB
   Baernighausen, T
   Bacha, U
   Badawi, A
   Banerjee, A
   Barac, A
   Barboza, MA
   Barker-Collo, SL
   Barrero, LH
   Basu, S
   Baune, BT
   Baye, K
   Bayou, YT
   Bazargan-Hejazi, S
   Bedi, N
   Beghi, E
   Bejot, Y
   Bello, AK
   Bennett, DA
   Bensenor, IM
   Berhane, A
   Bernabe, E
   Bernal, OA
   Beyene, AS
   Beyene, TJ
   Bhutta, ZA
   Biadgilign, S
   Bikbov, B
   Birlik, SM
   Birungi, C
   Biryukov, S
   Bisanzio, D
   Bizuayehu, HM
   Bose, D
   Brainin, M
   Brauer, M
   Brazinova, A
   Breitborde, NJK
   Brenner, H
   Butt, ZA
   Cardenas, R
   Cahuana-Hurtado, L
   Campos-Nonato, IR
   Car, J
   Carrero, JJ
   Casey, D
   Caso, V
   Castaneda-Orjuela, CA
   Rivas, JC
   Catala-Lopez, F
   Cecilio, P
   Cercy, K
   Charlson, FJ
   Chen, AZ
   Chew, A
   Chibalabala, M
   Chibueze, CE
   Chisumpa, VH
   Chitheer, AA
   Chowdhury, R
   Christensen, H
   Christopher, DJ
   Ciobanu, LG
   Cirillo, M
   Coggeshall, MS
   Cooper, LT
   Cortinovis, M
   Crump, JA
   Dalal, K
   Dandona, L
   Dandona, R
   Dargan, PI
   das Neves, J
   Davey, G
   Davitoiu, DV
   Davletov, K
   De Leo, D
   Del Gobbo, LC
   del Pozo-Cruz, B
   Dellavalle, RP
   Deribe, K
   Deribew, A
   Jarlais, DCD
   Dey, S
   Dharmaratne, SD
   Dicker, D
   Ding, EL
   Dokova, K
   Dorsey, ER
   Doyle, KE
   Dubey, M
   Ehrenkranz, R
   Ehrenkranz, R
   Ellingsen, CL
   Elyazar, I
   Enayati, A
   Ermakov, SP
   Eshrati, B
   Esteghamati, A
   Estep, K
   Fuerst, T
   Faghmous, IDA
   Fanuel, FBB
   Faraon, EJA
   Farid, TA
   Farinha, CSES
   Faro, A
   Farvid, MS
   Farzadfar, F
   Feigin, VL
   Feigl, AB
   Fereshtehnejad, SM
   Fernandes, JG
   Fernandes, JC
   Feyissa, TR
   Fischer, F
   Fitzmaurice, C
   Fleming, TD
   Foigt, N
   Foreman, KJ
   Forouzanfar, MH
   Franklin, RC
   Frostad, J
   Hiwot, TTG
   Gakidou, E
   Gambashidze, K
   Gamkrelidze, A
   Gao, W
   Garcia-Basteiro, AL
   Gebre, T
   Gebremedhin, AT
   Gebremichael, MW
   Gebru, AA
   Gelaye, AA
   Geleijnse, JM
   Genova-Maleras, R
   Gibney, KB
   Giref, AZ
   Gishu, MD
   Giussani, G
   Godwin, WW
   Gold, A
   Goldberg, EM
   Gona, PN
   Goodridge, A
   Gopalani, SV
   Goto, A
   Graetz, N
   Greaves, F
   Griswold, M
   Guban, PI
   Gugnani, HC
   Gupta, PC
   Gupta, R
   Gupta, R
   Gupta, T
   Gupta, V
   Habtewold, TD
   Hafezi-Nejad, N
   Haile, D
   Hailu, AD
   Hailu, GB
   Hakuzimana, A
   Hamadeh, RR
   Hambisa, MT
   Hamidi, S
   Hammami, M
   Hankey, GJ
   Hao, Y
   Harb, HL
   Hareri, HA
   Haro, JM
   Hassanvand, MS
   Havmoeller, R
   Hay, RJ
   Hay, SI
   Hendrie, D
   Heredia-Pi, IB
   Hoek, HW
   Horino, M
   Horita, N
   Hosgood, HD
   Htet, AS
   Hu, G
   Huang, H
   Huang, JJ
   Huntley, BM
   Huynh, C
   Iburg, KM
   Ileanu, BV
   Innos, K
   Irenso, AA
   Jahanmehr, N
   Jakovljevic, MB
   James, P
   James, SL
   Javanbakht, M
   Jayaraman, SP
   Jayatilleke, AU
   Jeemon, P
   Jha, V
   John, D
   Johnson, C
   Johnson, SC
   Jonas, JB
   Juel, K
   Kabir, Z
   Kalkonde, Y
   Kamal, R
   Kan, H
   Karch, A
   Karema, CK
   Karimi, SM
   Kasaeian, A
   Kassebaum, NJ
   Kastor, A
   Katikireddi, SV
   Kazanjan, K
   Keiyoro, PN
   Kemmer, L
   Kemp, AH
   Kengne, AP
   Kerbo, AA
   Kereselidze, M
   Kesavachandran, CN
   Khader, YS
   Khalil, I
   Khan, AR
   Khan, EA
   Khan, G
   Khang, YH
   Khoja, ATA
   Khonelidze, I
   Khubchandani, J
   Kibret, GD
   Kim, D
   Kim, P
   Kim, YJ
   Kimokoti, RW
   Kinfu, Y
   Kissoon, N
   Kivipelto, M
   Kokubo, Y
   Kolk, A
   Kolte, D
   Kopec, JA
   Kosen, S
   Koul, PA
   Koyanagi, A
   Kravchenko, M
   Krishnaswami, S
   Krohn, KJ
   Defo, BK
   Bicer, BK
   Kuipers, EJ
   Kulkarni, VS
   Kumar, GA
   Kumsa, FA
   Kutz, M
   Kyu, HH
   Lager, ACJ
   Lal, A
   Lal, DK
   Lalloo, R
   Lallukka, T
   Lan, Q
   Langan, SM
   Lansingh, VC
   Larson, HJ
   Larsson, A
   Laryea, DO
   Latif, AA
   Lawrynowicz, AEB
   Leasher, JL
   Leigh, J
   Leinsalu, M
   Leshargie, CT
   Leung, J
   Leung, R
   Levi, M
   Liang, X
   Lim, SS
   Lind, M
   Linn, S
   Lipshultz, SE
   Liu, P
   Liu, Y
   Lo, LT
   Logroscino, G
   Lopez, AD
   Lorch, SA
   Lotufo, PA
   Lozano, R
   Lunevicius, R
   Lyons, RA
   Macarayan, ERK
   Mackay, MT
   El Razek, HMA
   El Razek, MMA
   Mahdavi, M
   Majeed, A
   Malekzadeh, R
   Malta, DC
   Mantovani, LG
   Manyazewal, T
   Mapoma, CC
   Marcenes, W
   Marks, GB
   Marquez, N
   Martinez-Raga, J
   Marzan, MB
   Massano, J
   Mathur, MR
   Maulik, PK
   Mazidi, M
   McAlinden, C
   McGrath, JJ
   McNellan, C
   Meaney, PA
   Mehari, A
   Mehndiratta, MM
   Meier, T
   Mekonnen, AB
   Meles, KG
   Memish, ZA
   Mengesha, MM
   Mengiste, DT
   Mengistie, MA
   Menota, BG
   Mensah, GA
   Mereta, ST
   Meretoja, A
   Meretoja, TJ
   Mezgebe, HB
   Micha, R
   Millear, A
   Mills, EJ
   Minnig, S
   Mirarefin, M
   Mirrakhimov, EM
   Mock, CN
   Mohammad, KA
   Mohammed, S
   Mohanty, SK
   Mokdad, AH
   Mola, GLD
   Molokhia, M
   Monasta, L
   Montico, M
   Moradi-Lakeh, M
   Moraga, P
   Morawska, L
   Mori, R
   Moses, M
   Mueller, UO
   Murthy, S
   Musa, KI
   Nachega, JB
   Nagata, C
   Nagel, G
   Naghavi, M
   Naheed, A
   Naldi, L
   Nangia, V
   Nascimento, BR
   Negoi, I
   Neupane, SP
   Newton, CR
   Ng, M
   Ngalesoni, FN
   Ngunjiri, JW
   Nguyen, G
   Ningrum, DNA
   Nolte, S
   Nomura, M
   Norheim, OF
   Norrving, B
   Noubiap, JJN
   Obermeyer, CM
   Ogbo, FA
   Oh, IH
   Okoro, A
   Oladimeji, O
   Olagunju, AT
   Olivares, PR
   Olsen, HE
   Olusanya, BO
   Olusanya, JO
   Opio, JN
   Oren, E
   Ortiz, A
   Osborne, RH
   Osman, M
   Owolabi, MO
   Mahesh, PA
   Pain, AW
   Pakhale, S
   Castillo, EP
   Pana, A
   Papachristou, C
   Parsaeian, M
   Patel, T
   Patton, GC
   Paudel, D
   Paul, VK
   Pearce, N
   Pereira, DM
   Perez-Padilla, R
   Perez-Ruiz, F
   Perico, N
   Pesudovs, K
   Petzold, M
   Phillips, MR
   Pigott, DM
   Pillay, JD
   Pinho, C
   Polinder, S
   Pond, CD
   Prakash, V
   Purwar, M
   Qorbani, M
   Quistberg, DA
   Radfar, A
   Rafay, A
   Rahimi, K
   Rahimi-Movaghar, V
   Rahman, M
   Rahman, MHU
   Rai, RK
   Ram, U
   Rana, SM
   Rankin, Z
   Rao, PV
   Rao, PC
   Rawaf, S
   Rego, MAS
   Reitsma, M
   Remuzzi, G
   Renzaho, AMNN
   Resnikoff, S
   Rezaei, S
   Rezai, MS
   Ribeiro, AL
   Roba, HS
   Rokni, MB
   Ronfani, L
   Roshandel, G
   Roth, GA
   Rothenbacher, D
   Roy, NK
   Sachdev, PS
   Sackey, BB
   Saeedi, MY
   Safiri, S
   Sagar, R
   Sahraian, MA
   Saleh, MM
   Salomon, JA
   Samy, AM
   Sanabria, JR
   Sanchez-Nino, MD
   Sandar, L
   Santos, IS
   Santos, JV
   Milicevic, MMS
   Sarmiento-Suarez, R
   Sartorius, B
   Satpathy, M
   Savic, M
   Sawhney, M
   Saylan, MI
   Schottker, B
   Schutte, AE
   Schwebel, DC
   Seedat, S
   Seid, AM
   Seifu, CN
   Sepanlou, SG
   Serdar, B
   Servan-Mori, EE
   Setegn, T
   Shackelford, KA
   Shaheen, A
   Shahraz, S
   Shaikh, MA
   Shakh-Nazarova, M
   Shamsipour, M
   Islam, SMS
   Sharma, J
   Sharma, R
   She, J
   Sheikhbahaei, S
   Shen, JB
   Shi, P
   Shigematsu, M
   Shin, MJ
   Shiri, R
   Shoman, H
   Shrime, MG
   Sibamo, ELS
   Sigfusdottir, ID
   Silva, DAS
   Silveira, DGA
   Sindi, S
   Singh, A
   Singh, JA
   Singh, OP
   Singh, PK
   Singh, V
   Sinke, AH
   Sinshaw, AE
   Skirbekk, V
   Sliwa, K
   Smith, A
   Sobngwi, E
   Soneji, S
   Soriano, JB
   Sousa, TCM
   Sposato, LA
   Sreeramareddy, CT
   Stathopoulou, V
   Steel, N
   Steiner, C
   Steinke, S
   Stokes, MA
   Stranges, S
   Strong, M
   Stroumpoulis, K
   Sturua, L
   Sufiyan, MB
   Suliankatchi, RA
   Sun, JD
   Sur, P
   Swaminathan, S
   Sykes, BL
   Tabares-Seisdedos, R
   Tabb, KM
   Taffere, GR
   Talongwa, RT
   Tarajia, M
   Tavakkoli, M
   Taveira, N
   Teeple, S
   Tegegne, TK
   Tehrani-Banihashemi, A
   Tekelab, T
   Tekle, DY
   Shifa, GT
   Terkawi, AS
   Tesema, AG
   Thakur, JS
   Thomson, AJ
   Tillmann, T
   Tiruye, TY
   Tobe-Gai, R
   Tonelli, M
   Topor-Madry, R
   Tortajada, M
   Troeger, C
   Truelsen, T
   Tura, AK
   Uchendu, US
   Ukwaja, KN
   Undurraga, EA
   Uneke, CJ
   Uthman, OA
   van Boven, JFM
   Van Dingenen, R
   Varughese, S
   Vasankari, T
   Venketasubramanian, N
   Violante, FS
   Vladimirov, SK
   Vlassov, VV
   Vollset, SE
   Vos, T
   Wagner, JA
   Wakayo, T
   Waller, SG
   Walson, JL
   Wang, H
   Wang, YP
   Watkins, DA
   Weiderpass, E
   Weintraub, RG
   Wen, CP
   Werdecker, A
   Wesana, J
   Westerman, R
   Whiteford, HA
   Wilkinson, JD
   Wiysonge, CS
   Woldeyes, BG
   Wolfe, CDA
   Won, S
   Workicho, A
   Workie, SB
   Wubshet, M
   Xavier, D
   Xu, GL
   Yadav, AK
   Yaghoubi, M
   Yakob, B
   Yan, LL
   Yano, Y
   Yaseri, M
   Yimam, HH
   Yip, P
   Yonemoto, N
   Yoon, SJ
   Younis, MZ
   Yu, CH
   Zaidi, Z
   Zaki, MES
   Zambrana-Torrelio, C
   Zapata, T
   Zenebe, ZM
   Zodpey, S
   Zoeckler, L
   Zuhlke, LJ
   Murray, CJL
AF Barber, Ryan M.
   Fullman, Nancy
   Sorensen, Reed J. D.
   Bollyky, Thomas
   McKee, Martin
   Nolte, Ellen
   Abajobir, Amanuel Alemu
   Abate, Kalkidan Hassen
   Abbafati, Cristiana
   Abbas, Kaja M.
   Abd-Allah, Foad
   Abdulle, Abdishakur M.
   Abdurahman, Ahmed Abdulahi
   Abera, Semaw Ferede
   Abraham, Biju
   Abreha, Girmatsion Fisseha
   Adane, Kelemework
   Adelekan, Ademola Lukman
   Adetifa, Ifedayo Morayo O.
   Afshin, Ashkan
   Agarwal, Arnav
   Agarwal, Sanjay Kumar
   Agarwal, Sunilkumar
   Agrawal, Anurag
   Kiadaliri, Aliasghar Ahmad
   Ahmadi, Alireza
   Ahmed, Kedir Yimam
   Ahmed, Muktar Beshir
   Akinyemi, Rufus Olusola
   Akinyemiju, Tomi F.
   Akseer, Nadia
   Al-Aly, Ziyad
   Alam, Khurshid
   Alam, Noore
   Alam, Sayed Saidul
   Alemu, Zewdie Aderaw
   Alene, Kefyalew Addis
   Alexander, Lily
   Ali, Raghib
   Ali, Syed Danish
   Alizadeh-Navaei, Reza
   Alkerwi, Ala'a
   Alla, Francois
   Allebeck, Peter
   Allen, Christine
   Al-Raddadi, Rajaa
   Alsharif, Ubai
   Altirkawi, Khalid A.
   Martin, Elena Alvarez
   Alvis-Guzman, Nelson
   Amare, Azmeraw T.
   Amini, Erfan
   Ammar, Walid
   Amo-Adjei, Joshu
   Amoako, Yaw Ampem
   Anderson, Benjamin O.
   Androudi, Sofia
   Ansari, Hossein
   Ansha, Mustafa Geleto
   Antonio, Carl Abelardo T.
   Aernloev, Johan
   Artaman, Al
   Asayesh, Hamid
   Assadi, Reza
   Astatkie, Ayalew
   Atey, Tesfay Mehari
   Atique, Suleman
   Atnafu, Niguse Tadele
   Atre, Sachin R.
   Avila-Burgos, Leticia
   Avokpaho, Euripide Frinel G. Arthur
   Quintanilla, Beatriz Paulina Ayala
   Awasthi, Ashish
   Ayele, Nebiyu Negussu
   Azzopardi, Peter
   Saleem, Huda Omer Ba
   Baernighausen, Till
   Bacha, Umar
   Badawi, Alaa
   Banerjee, Amitava
   Barac, Aleksandra
   Barboza, Miguel A.
   Barker-Collo, Suzanne L.
   Barrero, Lope H.
   Basu, Sanjay
   Baune, Bernhard T.
   Baye, Kaleab
   Bayou, Yibeltal Tebekaw
   Bazargan-Hejazi, Shahrzad
   Bedi, Neeraj
   Beghi, Ettore
   Bejot, Yannick
   Bello, Aminu K.
   Bennett, Derrick A.
   Bensenor, Isabela M.
   Berhane, Adugnaw
   Bernabe, Eduardo
   Bernal, Oscar Alberto
   Beyene, Addisu Shunu
   Beyene, Tariku Jibat
   Bhutta, Zulfiqar A.
   Biadgilign, Sibhatu
   Bikbov, Boris
   Birlik, Sait Mentes
   Birungi, Charles
   Biryukov, Stan
   Bisanzio, Donal
   Bizuayehu, Habtamu Mellie
   Bose, Dipan
   Brainin, Michael
   Brauer, Michael
   Brazinova, Alexandra
   Breitborde, Nicholas J. K.
   Brenner, Hermann
   Butt, Zahid A.
   Cardenas, Rosario
   Cahuana-Hurtado, Lucero
   Campos-Nonato, Ismael Ricardo
   Car, Josip
   Carrero, Juan Jesus
   Casey, Daniel
   Caso, Valeria
   Castaneda-Orjuela, Carlos A.
   Rivas, Jacqueline Castillo
   Catala-Lopez, Ferran
   Cecilio, Pedro
   Cercy, Kelly
   Charlson, Fiona J.
   Chen, Alan Z.
   Chew, Adrienne
   Chibalabala, Mirriam
   Chibueze, Chioma Ezinne
   Chisumpa, Vesper Hichilombwe
   Chitheer, Abdulaal A.
   Chowdhury, Rajiv
   Christensen, Hanne
   Christopher, Devasahayam Jesudas
   Ciobanu, Liliana G.
   Cirillo, Massimo
   Coggeshall, Megan S.
   Cooper, Leslie Trumbull
   Cortinovis, Monica
   Crump, John A.
   Dalal, Koustuv
   Dandona, Lalit
   Dandona, Rakhi
   Dargan, Paul I.
   das Neves, Jose
   Davey, Gail
   Davitoiu, Dragos V.
   Davletov, Kairat
   De Leo, Diego
   Del Gobbo, Liana C.
   del Pozo-Cruz, Borja
   Dellavalle, Robert P.
   Deribe, Kebede
   Deribew, Amare
   Jarlais, Don C. Des
   Dey, Subhojit
   Dharmaratne, Samath D.
   Dicker, Daniel
   Ding, Eric L.
   Dokova, Klara
   Dorsey, E. Ray
   Doyle, Kerrie E.
   Dubey, Manisha
   Ehrenkranz, Rebecca
   Ehrenkranz, Rebecca
   Ellingsen, Christian Lycke
   Elyazar, Iqbal
   Enayati, Ahmadali
   Ermakov, Sergey Petrovich
   Eshrati, Babak
   Esteghamati, Alireza
   Estep, Kara
   Fuerst, Thomas
   Faghmous, Imad D. A.
   Fanuel, Fanuel Belayneh Bekele
   Faraon, Emerito Jose Aquino
   Farid, Talha A.
   Farinha, Carla Sofia e Sa
   Faro, Andre
   Farvid, Maryam S.
   Farzadfar, Farshad
   Feigin, Valery L.
   Feigl, Andrea B.
   Fereshtehnejad, Seyed-Mohammad
   Fernandes, Jefferson G.
   Fernandes, Joao C.
   Feyissa, Tesfaye Regassa
   Fischer, Florian
   Fitzmaurice, Christina
   Fleming, Thomas D.
   Foigt, Nataliya
   Foreman, Kyle J.
   Forouzanfar, Mohammad H.
   Franklin, Richard C.
   Frostad, Joseph
   hiwot, Tsegaye Tewelde G.
   Gakidou, Emmanuela
   Gambashidze, Ketevan
   Gamkrelidze, Amiran
   Gao, Wayne
   Garcia-Basteiro, Alberto L.
   Gebre, Teshome
   Gebremedhin, Amanuel Tesfay
   Gebremichael, Mengistu Welday
   Gebru, Alemseged Aregay
   Gelaye, Amha Admasie
   Geleijnse, Johanna M.
   Genova-Maleras, Ricard
   Gibney, Katherine B.
   Giref, Ababi Zergaw
   Gishu, Melkamu Dedefo
   Giussani, Giorgia
   Godwin, William W.
   Gold, Audra
   Goldberg, Ellen M.
   Gona, Philimon N.
   Goodridge, Amador
   Gopalani, Sameer Vali
   Goto, Atsushi
   Graetz, Nicholas
   Greaves, Felix
   Griswold, Max
   Guban, Peter Imre
   Gugnani, Harish Chander
   Gupta, Prakash C.
   Gupta, Rahul
   Gupta, Rajeev
   Gupta, Tanush
   Gupta, Vipin
   Habtewold, Tesfa Dejenie
   Hafezi-Nejad, Nima
   Haile, Demewoz
   Hailu, Alemayehu Desalegne
   Hailu, Gessessew Bugssa
   Hakuzimana, Alex
   Hamadeh, Randah Ribhi
   Hambisa, Mitiku Teshome
   Hamidi, Samer
   Hammami, Mouhanad
   Hankey, Graeme J.
   Hao, Yuantao
   Harb, Hilda L.
   Hareri, Habtamu Abera
   Haro, Josep Maria
   Hassanvand, Mohammad Sadegh
   Havmoeller, Rasmus
   Hay, Roderick J.
   Hay, Simon I.
   Hendrie, Delia
   Heredia-Pi, Ileana Beatriz
   Hoek, Hans W.
   Horino, Masako
   Horita, Nobuyuki
   Hosgood, H. Dean
   Htet, Aung Soe
   Hu, Guoqing
   Huang, Hsiang
   Huang, John J.
   Huntley, Bethany M.
   Huynh, Chantal
   Iburg, Kim Moesgaard
   Ileanu, Bogdan Vasile
   Innos, Kaire
   Irenso, Asnake Ararsa
   Jahanmehr, Nader
   Jakovljevic, Mihajlo B.
   James, Peter
   James, Spencer Lewis
   Javanbakht, Mehdi
   Jayaraman, Sudha P.
   Jayatilleke, Achala Upendra
   Jeemon, Panniyammakal
   Jha, Vivekanand
   John, Denny
   Johnson, Catherine
   Johnson, Sarah C.
   Jonas, Jost B.
   Juel, Knud
   Kabir, Zubair
   Kalkonde, Yogeshwar
   Kamal, Ritul
   Kan, Haidong
   Karch, Andre
   Karema, Corine Kakizi
   Karimi, Seyed M.
   Kasaeian, Amir
   Kassebaum, Nicholas J.
   Kastor, Anshul
   Katikireddi, Srinivasa Vittal
   Kazanjan, Konstantin
   Keiyoro, Peter Njenga
   Kemmer, Laura
   Kemp, Andrew Haddon
   Kengne, Andre Pascal
   Kerbo, Amene Abebe
   Kereselidze, Maia
   Kesavachandran, Chandrasekharan Nair
   Khader, Yousef Saleh
   Khalil, Ibrahim
   Khan, Abdur Rahman
   Khan, Ejaz Ahmad
   Khan, Gulfaraz
   Khang, Young-Ho
   Khoja, Abdullah Tawfih Abdullah
   Khonelidze, Irma
   Khubchandani, Jagdish
   Kibret, Getiye Dejenu
   Kim, Daniel
   Kim, Pauline
   Kim, Yun Jin
   Kimokoti, Ruth W.
   Kinfu, Yohannes
   Kissoon, Niranjan
   Kivipelto, Miia
   Kokubo, Yoshihiro
   Kolk, Anneli
   Kolte, Dhaval
   Kopec, Jacek A.
   Kosen, Soewarta
   Koul, Parvaiz A.
   Koyanagi, Ai
   Kravchenko, Michael
   Krishnaswami, Sanjay
   Krohn, Kristopher J.
   Defo, Barthelemy Kuate
   Bicer, Burcu Kucuk
   Kuipers, Ernst J.
   Kulkarni, Veena S.
   Kumar, G. Anil
   Kumsa, Fekede Asefa
   Kutz, Michael
   Kyu, Hmwe H.
   Lager, Anton Carl Jonas
   Lal, Aparna
   Lal, Dharmesh Kumar
   Lalloo, Ratilal
   Lallukka, Tea
   Lan, Qing
   Langan, Sinead M.
   Lansingh, Van C.
   Larson, Heidi J.
   Larsson, Anders
   Laryea, Dennis Odai
   Latif, Asma Abdul
   Lawrynowicz, Alicia Elena Beatriz
   Leasher, Janet L.
   Leigh, James
   Leinsalu, Mall
   Leshargie, Cheru Tesema
   Leung, Janni
   Leung, Ricky
   Levi, Miriam
   Liang, Xiaofeng
   Lim, Stephen S.
   Lind, Margaret
   Linn, Shai
   Lipshultz, Steven E.
   Liu, Patrick
   Liu, Yang
   Lo, Loon-Tzian
   Logroscino, Giancarlo
   Lopez, Alan D.
   Lorch, Scott A.
   Lotufo, Paulo A.
   Lozano, Rafael
   Lunevicius, Raimundas
   Lyons, Ronan A.
   Macarayan, Erlyn Rachelle King
   Mackay, Mark T.
   El Razek, Hassan Magdy Abd
   El Razek, Mohammed Magdy Abd
   Mahdavi, Mahdi
   Majeed, Azeem
   Malekzadeh, Reza
   Malta, Deborah Carvalho
   Mantovani, Lorenzo G.
   Manyazewal, Tsegahun
   Mapoma, Chabila C.
   Marcenes, Wagner
   Marks, Guy B.
   Marquez, Neal
   Martinez-Raga, Jose
   Marzan, Melvin Barrientos
   Massano, Joao
   Mathur, Manu Raj
   Maulik, Pallab K.
   Mazidi, Mohsen
   McAlinden, Colm
   McGrath, John J.
   McNellan, Claire
   Meaney, Peter A.
   Mehari, Alem
   Mehndiratta, Man Mohan
   Meier, Toni
   Mekonnen, Alemayehu B.
   Meles, Kidanu Gebremariam
   Memish, Ziad A.
   Mengesha, Melkamu Merid
   Mengiste, Desalegn Tadese
   Mengistie, Mubarek Abera
   Menota, Bereket Gebremichael
   Mensah, George A.
   Mereta, Seid Tiku
   Meretoja, Atte
   Meretoja, Tuomo J.
   Mezgebe, Haftay Berhane
   Micha, Renata
   Millear, Anoushka
   Mills, Edward J.
   Minnig, Shawn
   Mirarefin, Mojde
   Mirrakhimov, Erkin M.
   Mock, Charles N.
   Mohammad, Karzan Abdulmuhsin
   Mohammed, Shafiu
   Mohanty, Sanjay K.
   Mokdad, Ali H.
   Mola, Glen Liddell D.
   Molokhia, Mariam
   Monasta, Lorenzo
   Montico, Marcella
   Moradi-Lakeh, Maziar
   Moraga, Paula
   Morawska, Lidia
   Mori, Rintaro
   Moses, Mark
   Mueller, Ulrich O.
   Murthy, Srinivas
   Musa, Kamarul Imran
   Nachega, Jean B.
   Nagata, Chie
   Nagel, Gabriele
   Naghavi, Mohsen
   Naheed, Aliya
   Naldi, Luigi
   Nangia, Vinay
   Nascimento, Bruno Ramos
   Negoi, Ionut
   Neupane, Sudan Prasad
   Newton, Charles R.
   Ng, Marie
   Ngalesoni, Frida Namnyak
   Ngunjiri, Josephine Wanjiku
   Nguyen, Grant
   Ningrum, Dina Nur Anggraini
   Nolte, Sandra
   Nomura, Marika
   Norheim, Ole F.
   Norrving, Bo
   Noubiap, Jean Jacques N.
   Obermeyer, Carla Makhlouf
   Ogbo, Felix Akpojene
   Oh, In-Hwan
   Okoro, Anselm
   Oladimeji, Olanrewaju
   Olagunju, Andrew Toyin
   Olivares, Pedro R.
   Olsen, Helen E.
   Olusanya, Bolajoko Olubukunola
   Olusanya, Jacob Olusegun
   Opio, John Nelson
   Oren, Eyal
   Ortiz, Alberto
   Osborne, Richard H.
   Osman, Majdi
   Owolabi, Mayowa O.
   Mahesh, P. A.
   Pain, Amanda W.
   Pakhale, Smita
   Castillo, Elizabeth Palomares
   Pana, Adrian
   Papachristou, Christina
   Parsaeian, Mahboubeh
   Patel, Tejas
   Patton, George C.
   Paudel, Deepak
   Paul, Vinod K.
   Pearce, Neil
   Pereira, David M.
   Perez-Padilla, Rogelio
   Perez-Ruiz, Fernando
   Perico, Norberto
   Pesudovs, Konrad
   Petzold, Max
   Phillips, Michael Robert
   Pigott, David M.
   Pillay, Julian David
   Pinho, Christine
   Polinder, Suzanne
   Pond, Constance D.
   Prakash, V.
   Purwar, Manorama
   Qorbani, Mostafa
   Quistberg, D. Alex
   Radfar, Amir
   Rafay, Anwar
   Rahimi, Kazem
   Rahimi-Movaghar, Vafa
   Rahman, Mahfuzar
   Rahman, Mohammad Hifz Ur
   Rai, Rajesh Kumar
   Ram, Usha
   Rana, Saleem M.
   Rankin, Zane
   Rao, Paturi Vishnupriya
   Rao, Puja C.
   Rawaf, Salman
   Rego, Maria Albertina Santiago
   Reitsma, Marissa
   Remuzzi, Giuseppe
   Renzaho, Andre M. N. N.
   Resnikoff, Serge
   Rezaei, Satar
   Rezai, Mohammad Sadegh
   Ribeiro, Antonio L.
   Roba, Hirbo Shore
   Rokni, Mohammad Bagher
   Ronfani, Luca
   Roshandel, Gholamreza
   Roth, Gregory A.
   Rothenbacher, Dietrich
   Roy, Nawal K.
   Sachdev, Perminder S.
   Sackey, Ben Benasco
   Saeedi, Mohammad Yahya
   Safiri, Saeid
   Sagar, Rajesh
   Sahraian, Mohammad Ali
   Saleh, Muhammad Muhammad
   Salomon, Joshua A.
   Samy, Abdallah M.
   Sanabria, Juan Ramon
   Sanchez-Nino, Maria Dolores
   Sandar, Logan
   Santos, Itamar S.
   Santos, Joao Vasco
   Milicevic, Milena M. Santric
   Sarmiento-Suarez, Rodrigo
   Sartorius, Benn
   Satpathy, Maheswar
   Savic, Miloje
   Sawhney, Monika
   Saylan, Mete I.
   Schoettker, Ben
   Schutte, Aletta E.
   Schwebel, David C.
   Seedat, Soraya
   Seid, Abdulbasit Musa
   Seifu, Canaan Negash
   Sepanlou, Sadaf G.
   Serdar, Berrin
   Servan-Mori, Edson E.
   Setegn, Tesfaye
   Shackelford, Katya Anne
   Shaheen, Amira
   Shahraz, Saeid
   Shaikh, Masood Ali
   Shakh-Nazarova, Marina
   Shamsipour, Mansour
   Islam, Sheikh Mohammed Shariful
   Sharma, Jayendra
   Sharma, Rajesh
   She, Jun
   Sheikhbahaei, Sara
   Shen, Jiabin
   Shi, Peilin
   Shigematsu, Mika
   Shin, Min-Jeong
   Shiri, Rahman
   Shoman, Haitham
   Shrime, Mark G.
   Sibamo, Ephrem Lejore Sibamo
   Sigfusdottir, Inga Dora
   Silva, Diego Augusto Santos
   Silveira, Dayane Gabriele Alves
   Sindi, Shireen
   Singh, Abhishek
   Singh, Jasvinder A.
   Singh, Om Prakash
   Singh, Prashant Kumar
   Singh, Virendra
   Sinke, Abiy Hiruye
   Sinshaw, Aklilu Endalamaw
   Skirbekk, Vegard
   Sliwa, Karen
   Smith, Alison
   Sobngwi, Eugene
   Soneji, Samir
   Soriano, Joan B.
   Sousa, Tatiane Cristina Moraes
   Sposato, Luciano A.
   Sreeramareddy, Chandrashekhar T.
   Stathopoulou, Vasiliki
   Steel, Nicholas
   Steiner, Caitlyn
   Steinke, Sabine
   Stokes, Mark Andrew
   Stranges, Saverio
   Strong, Mark
   Stroumpoulis, Konstantinos
   Sturua, Lela
   Sufiyan, Muawiyyah Babale
   Suliankatchi, Rizwan Abdulkader
   Sun, Jiandong
   Sur, Patrick
   Swaminathan, Soumya
   Sykes, Bryan L.
   Tabares-Seisdedos, Rafael
   Tabb, Karen M.
   Taffere, Getachew Redae
   Talongwa, Roberto Tchio
   Tarajia, Musharaf
   Tavakkoli, Mohammad
   Taveira, Nuno
   Teeple, Stephanie
   Tegegne, Teketo Kassaw
   Tehrani-Banihashemi, Arash
   Tekelab, Tesfalidet
   Tekle, Dejen Yemane
   Shifa, Girma Temam
   Terkawi, Abdullah Sulieman
   Tesema, Azeb Gebresilassie
   Thakur, J. S.
   Thomson, Alan J.
   Tillmann, Taavi
   Tiruye, Tenaw Yimer
   Tobe-Gai, Ruoyan
   Tonelli, Marcello
   Topor-Madry, Roman
   Tortajada, Miguel
   Troeger, Christopher
   Truelsen, Thomas
   Tura, Abera Kenay
   Uchendu, Uche S.
   Ukwaja, Kingsley N.
   Undurraga, Eduardo A.
   Uneke, Chigozie Jesse
   Uthman, Olalekan A.
   van Boven, Job F. M.
   Van Dingenen, Rita
   Varughese, Santosh
   Vasankari, Tommi
   Venketasubramanian, Narayanaswamy
   Violante, Francesco S.
   Vladimirov, Sergey K.
   Vlassov, Vasiliy Victorovich
   Vollset, Stein Emil
   Vos, Theo
   Wagner, Joseph A.
   Wakayo, Tolassa
   Waller, Stephen G.
   Walson, Judd L.
   Wang, Haidong
   Wang, Yuan-Pang
   Watkins, David A.
   Weiderpass, Elisabete
   Weintraub, Robert G.
   Wen, Chi-Pang
   Werdecker, Andrea
   Wesana, Joshua
   Westerman, Ronny
   Whiteford, Harvey A.
   Wilkinson, James D.
   Wiysonge, Charles Shey
   Woldeyes, Belete Getahun
   Wolfe, Charles D. A.
   Won, Sungho
   Workicho, Abdulhalik
   Workie, Shimelash Bitew
   Wubshet, Mamo
   Xavier, Denis
   Xu, Gelin
   Yadav, Ajit Kumar
   Yaghoubi, Mohsen
   Yakob, Bereket
   Yan, Lijing L.
   Yano, Yuichiro
   Yaseri, Mehdi
   Yimam, Hassen Hamid
   Yip, Paul
   Yonemoto, Naohiro
   Yoon, Seok-Jun
   Younis, Mustafa Z.
   Yu, Chuanhua
   Zaidi, Zoubida
   Zaki, Maysaa El Sayed
   Zambrana-Torrelio, Carlos
   Zapata, Tomas
   Zenebe, Zerihun Menlkalew
   Zodpey, Sanjay
   Zoeckler, Leo
   Zuhlke, Liesl Joanna
   Murray, Christopher J. L.
CA GBD 2015 Healthcare Access Quality
TI Healthcare Access and Quality Index based on mortality from causes
   amenable to personal health care in 195 countries and territories,
   1990-2015: a novel analysis from the Global Burden of Disease Study 2015
SO LANCET
LA English
DT Article
ID COMPARATIVE RISK-ASSESSMENT; SYSTEMATIC ANALYSIS; MEDICAL-CARE; LIFE
   EXPECTANCY; AVOIDABLE MORTALITY; EUROPEAN COUNTRIES; DEVELOPMENT GOALS;
   UNITED-STATES; TRENDS; DEATH
AB Background National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor estimates generated through the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to improve and expand the quantification of personal health-care access and quality for 195 countries and territories from 1990 to 2015.
   Methods We mapped the most widely used list of causes amenable to personal health care developed by Nolte and McKee to 32 GBD causes. We accounted for variations in cause of death certification and misclassifications through the extensive data standardisation processes and redistribution algorithms developed for GBD. To isolate the effects of personal health-care access and quality, we risk-standardised cause-specific mortality rates for each geography-year by removing the joint effects of local environmental and behavioural risks, and adding back the global levels of risk exposure as estimated for GBD 2015. We employed principal component analysis to create a single, interpretable summary measure-the Healthcare Quality and Access (HAQ) Index-on a scale of 0 to 100. The HAQ Index showed strong convergence validity as compared with other health-system indicators, including health expenditure per capita (r= 0.88), an index of 11 universal health coverage interventions (r= 0.83), and human resources for health per 1000 (r= 0.77). We used free disposal hull analysis with bootstrapping to produce a frontier based on the relationship between the HAQ Index and the Socio-demographic Index (SDI), a measure of overall development consisting of income per capita, average years of education, and total fertility rates. This frontier allowed us to better quantify the maximum levels of personal health-care access and quality achieved across the development spectrum, and pinpoint geographies where gaps between observed and potential levels have narrowed or widened over time.
   Findings Between 1990 and 2015, nearly all countries and territories saw their HAQ Index values improve; nonetheless, the difference between the highest and lowest observed HAQ Index was larger in 2015 than in 1990, ranging from 28.6 to 94.6. Of 195 geographies, 167 had statistically significant increases in HAQ Index levels since 1990, with South Korea, Turkey, Peru, China, and the Maldives recording among the largest gains by 2015. Performance on the HAQ Index and individual causes showed distinct patterns by region and level of development, yet substantial heterogeneities emerged for several causes, including cancers in highest-SDI countries; chronic kidney disease, diabetes, diarrhoeal diseases, and lower respiratory infections among middle-SDI countries; and measles and tetanus among lowest-SDI countries. While the global HAQ Index average rose from 40.7 (95% uncertainty interval, 39.0-42.8) in 1990 to 53.7 (52.2-55.4) in 2015, far less progress occurred in narrowing the gap between observed HAQ Index values and maximum levels achieved; at the global level, the difference between the observed and frontier HAQ Index only decreased from 21.2 in 1990 to 20.1 in 2015. If every country and territory had achieved the highest observed HAQ Index by their corresponding level of SDI, the global average would have been 73.8 in 2015. Several countries, particularly in eastern and western sub-Saharan Africa, reached HAQ Index values similar to or beyond their development levels, whereas others, namely in southern sub-Saharan Africa, the Middle East, and south Asia, lagged behind what geographies of similar development attained between 1990 and 2015.
   Interpretation This novel extension of the GBD Study shows the untapped potential for personal health-care access and quality improvement across the development spectrum. Amid substantive advances in personal health care at the national level, heterogeneous patterns for individual causes in given countries or territories suggest that few places have consistently achieved optimal health-care access and quality across health-system functions and therapeutic areas. This is especially evident in middle-SDI countries, many of which have recently undergone or are currently experiencing epidemiological transitions. The HAQ Index, if paired with other measures of health-systemcharacteristics such as intervention coverage, could provide a robust avenue for tracking progress on universal health coverage and identifying local priorities for strengthening personal health-care quality and access throughout the world. Copyright (C) The Author(s). Published by Elsevier Ltd.
C1 [Barber, Ryan M.; Fullman, Nancy; Sorensen, Reed J. D.; Afshin, Ashkan; Alexander, Lily; Allen, Christine; Biryukov, Stan; Brauer, Michael; Casey, Daniel; Cercy, Kelly; Charlson, Fiona J.; Chen, Alan Z.; Chew, Adrienne; Coggeshall, Megan S.; Dandona, Lalit; Dandona, Rakhi; Dicker, Daniel; Ehrenkranz, Rebecca; Estep, Kara; Fitzmaurice, Christina; Fleming, Thomas D.; Foreman, Kyle J.; Frostad, Joseph; Gakidou, Emmanuela; Godwin, William W.; Gold, Audra; Goldberg, Ellen M.; Graetz, Nicholas; Griswold, Max; Hay, Simon I.; Huntley, Bethany M.; Huynh, Chantal; Johnson, Sarah C.; Kassebaum, Nicholas J.; Kemmer, Laura; Khalil, Ibrahim; Kim, Pauline; Krohn, Kristopher J.; Kutz, Michael; Kyu, Hmwe H.; Larson, Heidi J.; Lim, Stephen S.; Liu, Patrick; Marquez, Neal; McAlinden, Colm; McNellan, Claire; Millear, Anoushka; Minnig, Shawn; Mirarefin, Mojde; Mokdad, Ali H.; Moradi-Lakeh, Maziar; Moses, Mark; Naghavi, Mohsen; Ng, Marie; Nguyen, Grant; Olsen, Helen E.; Pain, Amanda W.; Pigott, David M.; Pinho, Christine; Rankin, Zane; Rao, Puja C.; Reitsma, Marissa; Roth, Gregory A.; Sandar, Logan; Shackelford, Katya Anne; Smith, Alison; Steiner, Caitlyn; Sur, Patrick; Teeple, Stephanie; Troeger, Christopher; Vollset, Stein Emil; Vos, Theo; Wagner, Joseph A.; Wang, Haidong; Whiteford, Harvey A.; Zoeckler, Leo; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98195 USA.
   [Fitzmaurice, Christina] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA.
   [Mock, Charles N.; Quistberg, D. Alex] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.
   [Quistberg, D. Alex] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.
   [Anderson, Benjamin O.; Leung, Janni; Walson, Judd L.; Watkins, David A.] Univ Washington, Seattle, WA 98195 USA.
   [Bollyky, Thomas] Council Foreign Relat, Washington, DC USA.
   [Nolte, Ellen] London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London, England.
   [Larson, Heidi J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [McKee, Martin; Adetifa, Ifedayo Morayo O.; Faghmous, Imad D. A.; Langan, Sinead M.; Pearce, Neil] London Sch Hyg & Trop Med, London, England.
   [Abajobir, Amanuel Alemu; Charlson, Fiona J.; Leung, Janni; Whiteford, Harvey A.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
   [Lalloo, Ratilal] Univ Queensland, Sch Dent, Brisbane, Qld, Australia.
   [McGrath, John J.] Univ Queensland, Brisbane, Qld, Australia.
   [Ahmed, Muktar Beshir] Jimma Univ, Coll Hlth Sci, Dept Epidemiol, ICT & E Learning, Jimma, Ethiopia.
   [Abate, Kalkidan Hassen; Gebremedhin, Amanuel Tesfay; Mengistie, Mubarek Abera; Mereta, Seid Tiku; Wakayo, Tolassa; Workicho, Abdulhalik] Jimma Univ, Jimma, Ethiopia.
   [Abbafati, Cristiana] Univ Roma La Sapienza, Rome, Italy.
   [Abbas, Kaja M.] Virginia Tech, Blacksburg, VA USA.
   [Abd-Allah, Foad] Cairo Univ, Dept Neurol, Cairo, Egypt.
   [Abdulle, Abdishakur M.] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates.
   [Amini, Erfan] Univ Tehran Med Sci, Urooncol Res Ctr, Tehran, Iran.
   [Amini, Erfan; Esteghamati, Alireza; Hafezi-Nejad, Nima; Kasaeian, Amir; Sheikhbahaei, Sara] Univ Tehran Med Sci, Res Inst, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.
   [Farzadfar, Farshad; Parsaeian, Mahboubeh] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   [Parsaeian, Mahboubeh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.
   [Hassanvand, Mohammad Sadegh] Univ Tehran Med Sci, Ctr Air Pollut Res, Tehran, Iran.
   [Shamsipour, Mansour] Univ Tehran Med Sci, Inst Environm Res, Tehran, Iran.
   [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran.
   [Malekzadeh, Reza; Roshandel, Gholamreza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Sahraian, Mohammad Ali] Univ Tehran Med Sci, MS Res Ctr, Neurosci Inst, Tehran, Iran.
   [Abdurahman, Ahmed Abdulahi; Rokni, Mohammad Bagher] Univ Tehran Med Sci, Tehran, Iran.
   [Abera, Semaw Ferede; Abreha, Girmatsion Fisseha; Meles, Kidanu Gebremariam; Taffere, Getachew Redae] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia.
   [Mengiste, Desalegn Tadese] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia.
   [Adane, Kelemework] Mekelle Univ, Dept Med Microbiol & Immunol, Mekelle, Ethiopia.
   [Atey, Tesfay Mehari; Gebremichael, Mengistu Welday; Gebru, Alemseged Aregay; Hailu, Gessessew Bugssa; Mezgebe, Haftay Berhane; Tekle, Dejen Yemane; Tesema, Azeb Gebresilassie; Zenebe, Zerihun Menlkalew] Mekelle Univ, Mekelle, Ethiopia.
   [Abera, Semaw Ferede] Univ Hohenheim, Food Secur, Stuttgart, Germany.
   [Abera, Semaw Ferede] Univ Hohenheim, Inst Biol Chem & Nutr, Stuttgart, Germany.
   [Abraham, Biju] NMSM Govt Coll Kalpetta, Kalpetta, Kerala, India.
   [Adelekan, Ademola Lukman] Publ Hlth Promot Alliance, Osogbo, Nigeria.
   [Adelekan, Ademola Lukman; Akinyemi, Rufus Olusola] Univ Ibadan, Ibadan, Nigeria.
   [Adetifa, Ifedayo Morayo O.; Deribew, Amare] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.
   [Akseer, Nadia] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Badawi, Alaa] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
   [Agarwal, Arnav] Univ Toronto, Toronto, ON, Canada.
   [Agarwal, Arnav] McMaster Univ, Hamilton, ON, Canada.
   [Agarwal, Sanjay Kumar; Paul, Vinod K.; Sagar, Rajesh; Satpathy, Maheswar] All India Inst Med Sci, New Delhi, India.
   [Agarwal, Sunilkumar] Natl Inst Occupat Hlth ICMR, Ahmadabad, Gujarat, India.
   [Agarwal, Arnav] CSIR, Inst Genom & Integrat Biol, Delhi, India.
   [Agarwal, Arnav] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA.
   [Kiadaliri, Aliasghar Ahmad] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Orthoped Clin Epidemiol Unit, Lund, Sweden.
   [Norrving, Bo] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurol, Lund, Sweden.
   [Rezaei, Satar] Kermanshah Univ Med Sci, Sch Publ Hlth, Kermanshah, Iran.
   [Ahmadi, Alireza] Kermanshah Univ Med Sci, Kermanshah, Iran.
   [Ahmed, Kedir Yimam; Alemu, Zewdie Aderaw; Kibret, Getiye Dejenu; Leshargie, Cheru Tesema; Tegegne, Teketo Kassaw; Tiruye, Tenaw Yimer] Debre Markos Univ, Debre Markos, Ethiopia.
   [Akinyemi, Rufus Olusola] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England.
   [Akinyemiju, Tomi F.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.
   [Schwebel, David C.] Univ Alabama Birmingham, Birmingham, AL USA.
   [Akseer, Nadia; Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada.
   [Al-Aly, Ziyad] Washington Univ, St Louis, MO USA.
   [Alam, Khurshid] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Alam, Khurshid] Univ Melbourne, Melbourne, Vic, Australia.
   [Alam, Khurshid] Univ Sydney, Sydney, NSW, Australia.
   [Alam, Noore] Dept Hlth, Brisbane, Qld, Australia.
   [Alam, Sayed Saidul; Naheed, Aliya; Islam, Sheikh Mohammed Shariful] Int Ctr Diarrhoeal Dis Res ICDDR, Dhaka, Bangladesh.
   [Alene, Kefyalew Addis] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.
   [Mekonnen, Alemayehu B.] Univ Gondar, Gondar, Ethiopia.
   [Bisanzio, Donal; Deribew, Amare] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Hay, Roderick J.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England.
   [Ali, Raghib; Bennett, Derrick A.; Jha, Vivekanand; Rahimi, Kazem] Univ Oxford, Oxford, England.
   [Ali, Syed Danish] Univ London, London, England.
   [Ali, Syed Danish] SIR Management Consultants, Oxford, England.
   [Ali, Syed Danish] Inst & Fac Actuaries, Oxford, England.
   [Alizadeh-Navaei, Reza] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Sari, Iran.
   [Rezaei, Satar] Mazandaran Univ Med Sci, Sari, Iran.
   [Alkerwi, Ala'a; Stranges, Saverio] Luxembourg Inst Hlth, Strassen, Luxembourg.
   [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France.
   [Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Aernloev, Johan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Care, Stockholm, Sweden.
   [Carrero, Juan Jesus] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
   [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.
   [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.
   [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden.
   [Al-Raddadi, Rajaa] Minist Hlth, Jeddah, Saudi Arabia.
   [Alsharif, Ubai; Papachristou, Christina] Charite, Ctr Internal Med & Dermatol, Dept Psychosomat Med, Berlin, Germany.
   [Altirkawi, Khalid A.] King Saud Univ, Riyadh, Saudi Arabia.
   [Martin, Elena Alvarez] Spanish Observ Drugs, Govt Delegat Natl Plan Drugs, Minist Hlth Social Policy & Equal, Madrid, Spain.
   [Alvis-Guzman, Nelson] Univ Cartagena, Cartagena De Indias, Colombia.
   [Amare, Azmeraw T.; Baune, Bernhard T.] Univ Adelaide, Sch Med, Adealaide, SA, Australia.
   [Ciobanu, Liliana G.; Olagunju, Andrew Toyin] Univ Adelaide, Adealaide, SA, Australia.
   [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.
   [Setegn, Tesfaye] Bahir Dar Univ, Bahir Dar, Ethiopia.
   [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon.
   [Amo-Adjei, Joshu] African Populat & Hlth Res Ctr, Nairobi, Kenya.
   [Amo-Adjei, Joshu] Univ Cape Coast, Cape Coast, Ghana.
   [Amoako, Yaw Ampem] Komfo Anokye Teaching Hosp, Dept Med, Kumasi, Ghana.
   [Laryea, Dennis Odai] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Androudi, Sofia] Univ Thessaly, Larisa, Greece.
   [Ansari, Hossein] Zahedan Univ Med Sci, Hlth Promot Res Ctr, Dept Epidemiol & Biostat, Zahedan, Iran.
   [Ansha, Mustafa Geleto] West Hararghe Zonal Hlth Dept, Chiro, Ethiopia.
   [Antonio, Carl Abelardo T.] Univ Philippines, Coll Publ Hlth, Dept Hlth Policy & Adm, Manila, Philippines.
   [Faraon, Emerito Jose Aquino] Univ Philippines, Coll Publ Hlth, Manila, Philippines.
   [Aernloev, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden.
   [Artaman, Al] Univ Manitoba, Winnipeg, MB, Canada.
   [Asayesh, Hamid] Qom Univ Med Sci, Sch Paramed, Dept Emergency Med, Qom, Iran.
   [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran.
   [Astatkie, Ayalew; Fanuel, Fanuel Belayneh Bekele] Hawassa Univ, Hawassa, Ethiopia.
   [Atique, Suleman] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan.
   [Ningrum, Dina Nur Anggraini] Taipei Med Univ, Coll Med Sci & Technol, Taipei, Taiwan.
   [Atnafu, Niguse Tadele; Yimam, Hassen Hamid] Tepi Univ, Mizan Teferi, Ethiopia.
   [Atre, Sachin R.] Johns Hopkins Univ, BJ Med Coll, Clin Trials Unit, Pune, Maharashtra, India.
   [Avila-Burgos, Leticia] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Avokpaho, Euripide Frinel G. Arthur] Inst Rech Clin Benin IRCB, Cotonou, Benin.
   [Avokpaho, Euripide Frinel G. Arthur] LERAS Afr, Parakou, Benin.
   [Quintanilla, Beatriz Paulina Ayala] La Trobe Univ, Judith Lumley Ctr Mother Infant & Family Hlth Res, Melbourne, Vic, Australia.
   [Quintanilla, Beatriz Paulina Ayala] Peruvian Natl Inst Hlth, Lima, Peru.
   [Awasthi, Ashish] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India.
   [Ayele, Nebiyu Negussu] Minist Hlth, Addis Ababa, Ethiopia.
   [Azzopardi, Peter] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Alam, Khurshid; Azzopardi, Peter; Patton, George C.; Weintraub, Robert G.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Azzopardi, Peter] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Dept Paediat, Melbourne, Vic, Australia.
   [Lopez, Alan D.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.
   [Meretoja, Atte] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Alam, Khurshid] Univ Melbourne, Melbourne, Vic, Australia.
   [Azzopardi, Peter] South Australian Hlth & Med Res Inst, Wardliparingga Aboriginal Res Unit, Adelaide, SA, Australia.
   [Azzopardi, Peter] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia.
   [Saleem, Huda Omer Ba] Aden Univ, Fac Med & Hlth Sci, Aden, Yemen.
   [Baernighausen, Till; Feigl, Andrea B.; Salomon, Joshua A.] Harvard Univ, Harvard Med Sch, Dept Global Hlth & Populat, Boston, MA USA.
   [James, Peter] Harvard Univ, Harvard Med Sch, Dept Epidemiol, Boston, MA USA.
   [Farvid, Maryam S.] Harvard Univ, Harvard Med Sch, Dept Nutr, Boston, MA USA.
   [Campos-Nonato, Ismael Ricardo; Ding, Eric L.] Harvard Univ, Harvard Med Sch, Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Osman, Majdi; Shrime, Mark G.] Harvard Univ, Harvard Med Sch, Boston, MA USA.
   [Baernighausen, Till] Africa Hlth Res Inst, Mtubatuba, South Africa.
   [Baernighausen, Till; Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Bacha, Umar] Univ Management & Technol, Sch Hlth Sci, Lahore, Pakistan.
   [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada.
   [Banerjee, Amitava; Giref, Ababi Zergaw] UCL, Farr Inst Hlth Informat Res, London, England.
   [Tillmann, Taavi] UCL, Inst Epidemiol & Hlth, London, England.
   [Birungi, Charles] UCL, London, England.
   [Barac, Aleksandra] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Milicevic, Milena M. Santric] Univ Belgrade, Inst Social Med, Belgrade, Serbia.
   [Milicevic, Milena M. Santric] Univ Belgrade, Fac Med, Ctr Sch Publ Hlth & Hlth Management, Belgrade, Serbia.
   [Barboza, Miguel A.] CCSS, Hosp Dr Rafael Calderon Guardia, San Jose, Costa Rica.
   [Barboza, Miguel A.] Univ Costa Rica, San Pedro, Costa Rica.
   [Barker-Collo, Suzanne L.] Univ Auckland, Sch Psychol, Auckland, New Zealand.
   [del Pozo-Cruz, Borja] Univ Auckland, Auckland, New Zealand.
   [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia.
   [Basu, Sanjay; Del Gobbo, Liana C.] Stanford Univ, Stanford, CA 94305 USA.
   [Deribe, Kebede; Hailu, Alemayehu Desalegne] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia.
   [Baye, Kaleab; Beyene, Tariku Jibat; Giref, Ababi Zergaw; Haile, Demewoz; Hareri, Habtamu Abera; Menota, Bereket Gebremichael; Shifa, Girma Temam; Woldeyes, Belete Getahun] Univ Addis Ababa, Addis Ababa, Ethiopia.
   [Bayou, Yibeltal Tebekaw] Jhpiego Ethiopia, Addis Ababa, Ethiopia.
   [Bazargan-Hejazi, Shahrzad] Charles R Drew Univ Med & Sci, Coll Med, Los Angeles, CA 90059 USA.
   [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia.
   [Beghi, Ettore; Giussani, Giorgia] IRCCS, Ist Ric Farmacol Mario Negri, Milan, Italy.
   [Bejot, Yannick] Univ Burgundy, Univ Hosp & Med Sch Dijon, Dijon, France.
   [Bello, Aminu K.] Univ Alberta, Edmonton, AB, Canada.
   [Santos, Itamar S.] Univ Sao Paulo, Internal Med Dept, Sao Paulo, Brazil.
   [Bensenor, Isabela M.; Lotufo, Paulo A.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Berhane, Adugnaw] Debre Berhan Univ, Coll Hlth Sci, Debre Berhan, Ethiopia.
   [Habtewold, Tesfa Dejenie] Debre Berhan Univ, Debre Berhan, Ethiopia.
   [Wolfe, Charles D. A.] Kings Coll London, Div Hlth & Social Care Res, London, England.
   [Bernabe, Eduardo; Hay, Roderick J.; Molokhia, Mariam] Kings Coll London, London, England.
   [Bernal, Oscar Alberto] Univ Andes, Bogota, Colombia.
   [Beyene, Addisu Shunu; Hambisa, Mitiku Teshome; Mengesha, Melkamu Merid; Roba, Hirbo Shore; Seid, Abdulbasit Musa] Haramaya Univ, Coll Hlth & Med Sci, Dire Dawa, Ethiopia.
   [Gishu, Melkamu Dedefo; Irenso, Asnake Ararsa; Kumsa, Fekede Asefa; Tura, Abera Kenay] Haramaya Univ, Dire Dawa, Ethiopia.
   [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.
   [Beyene, Tariku Jibat] Wageningen Univ, Wageningen, Netherlands.
   [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.
   [Biadgilign, Sibhatu] Independent Publ Hlth Consultants, Addis Ababa, Ethiopia.
   [Bikbov, Boris; Cortinovis, Monica; Remuzzi, Giuseppe] IRCCS, Ist Ric Farmacol Mario Negri, Bergamo, Italy.
   [Birlik, Sait Mentes] GBS CIDP Int Fdn, Menemen, Turkey.
   [Bizuayehu, Habtamu Mellie] Debre Markos Univ, Debre Markos Town, Ethiopia.
   [Bose, Dipan] World Bank, Washington, DC 20433 USA.
   [Brainin, Michael] Danube Univ Krems, Krems, Austria.
   [Brauer, Michael; Giref, Ababi Zergaw; Kissoon, Niranjan; Kopec, Jacek A.; Murthy, Srinivas] Univ British Columbia, Vancouver, BC, Canada.
   [Brazinova, Alexandra] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia.
   [Brazinova, Alexandra] Int Neurotrauma Res Org, Vienna, Austria.
   [Shen, Jiabin] Ohio State Univ, Coll Med, Columbus, OH 43210 USA.
   [Breitborde, Nicholas J. K.] Ohio State Univ, Columbus, OH 43210 USA.
   [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Ageing Res, Heidelberg, Germany.
   [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany.
   [Butt, Zahid A.] Al Shifa Trust Eye Hosp, Rawalpindi, Pakistan.
   [Cardenas, Rosario] Metropolitan Autonomous Univ, Mexico City, DF, Mexico.
   [Cahuana-Hurtado, Lucero; Campos-Nonato, Ismael Ricardo; Heredia-Pi, Ileana Beatriz; Lozano, Rafael; Servan-Mori, Edson E.] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Car, Josip] Nanyang Technol Univ, Singapore, Singapore.
   [Caso, Valeria] Univ Perugia, Stroke Unit, Perugia, Italy.
   [Castaneda-Orjuela, Carlos A.] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia.
   [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Dept Publ Hlth, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia.
   [Rivas, Jacqueline Castillo] Caja Costarricense Seguro Social, San Jose, Costa Rica.
   [Rivas, Jacqueline Castillo] Univ Costa Rica, San Pedro, Montes De Oca, Costa Rica.
   [Catala-Lopez, Ferran] Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain.
   [Catala-Lopez, Ferran] CIBERSAM, Valencia, Spain.
   [Catala-Lopez, Ferran] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   [Charlson, Fiona J.; Whiteford, Harvey A.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.
   [Chibalabala, Mirriam] Crowd Watch Africa, Lusaka, Zambia.
   [Chibueze, Chioma Ezinne] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan.
   [Chisumpa, Vesper Hichilombwe; Mapoma, Chabila C.] Univ Zambia, Lusaka, Zambia.
   [Chisumpa, Vesper Hichilombwe] Univ Witwatersrand, Johannesburg, South Africa.
   [Chitheer, Abdulaal A.] Minist Hlth, Baghdad, Iraq.
   [Chowdhury, Rajiv] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Christensen, Hanne] Bispebjerg Hosp, Copenhagen, Denmark.
   [Christopher, Devasahayam Jesudas; Varughese, Santosh] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India.
   [Amare, Azmeraw T.; Baune, Bernhard T.] Univ Salerno, Sch Med, Baronissi, Italy.
   [Cirillo, Massimo] Univ Salerno, Baronissi, Italy.
   [Cooper, Leslie Trumbull] Mayo Clin, Jacksonville, FL 32224 USA.
   [Crump, John A.] Univ Otago, Dunedin Sch Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Dalal, Koustuv] Univ Orebro, Sch Hlth & Med Sci, Ctr Injury Prevent & Safety Promot, Orebro, Sweden.
   Walden Univ, Minneapolis, MN USA.
   [Jeemon, Panniyammakal] Publ Hlth Fdn India, Ctr Control Chron Condit, New Delhi, India.
   [Dandona, Lalit; Dandona, Rakhi] Publ Hlth Fdn India, New Delhi, India.
   [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England.
   [das Neves, Jose] Univ Porto, Fac Med, I3S Inst Invest Inovacao Saude, Oporto, Portugal.
   [das Neves, Jose] Univ Porto, Fac Med, INEB Inst Engn Biomed, Oporto, Portugal.
   [Massano, Joao; Santos, Joao Vasco] Univ Porto, Fac Med, Oporto, Portugal.
   [Davey, Gail] Wellcome Trust Brighton & Sussex Ctr Global Hlth, Brighton, E Sussex, England.
   [Davitoiu, Dragos V.] Univ Med & Pharm Bucharest, Bucharest, Romania.
   [Davletov, Kairat] Republican Inst Cardiol & Internal Dis, Alma Ata, Kazakhstan.
   [Davletov, Kairat] Kazakh Natl Med Univ, Sch Publ Hlth, Alma Ata, Kazakhstan.
   [De Leo, Diego] Griffith Univ, Brisbane, Qld, Australia.
   [Dellavalle, Robert P.] Univ Colorado, Sch Med, Aurora, CO USA.
   [Dellavalle, Robert P.] Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA.
   [Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England.
   [Jarlais, Don C. Des] Mt Sinai Beth Israel, New York, NY USA.
   [Jarlais, Don C. Des] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
   [Dey, Subhojit; Zodpey, Sanjay] Publ Hlth Fdn India, Indian Inst Publ Hlth Delhi, Gurgaon, India.
   [Dharmaratne, Samath D.] Univ Peradeniya, Fac Med, Dept Community Med, Peradeniya, Sri Lanka.
   [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria.
   [Dorsey, E. Ray] Univ Rochester, Med Ctr, Rochester, NY 14642 USA.
   [Doyle, Kerrie E.] RMIT Univ, Bundoora, Vic, Australia.
   [Doyle, Kerrie E.] Australian Natl Univ, Canberra, ACT, Australia.
   [Dubey, Manisha; Kastor, Anshul; Mohanty, Sanjay K.; Rahman, Mahfuzar; Ram, Usha; Singh, Abhishek; Yadav, Ajit Kumar] Int Inst Populat Sci, Mumbai, Maharashtra, India.
   [Vollset, Stein Emil] Norwegian Inst Publ Hlth, Ctr Dis Burden, Oslo, Norway.
   [Ellingsen, Christian Lycke; Savic, Miloje; Skirbekk, Vegard] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Elyazar, Iqbal] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [Enayati, Ahmadali] Sch Publ Hlth & Hlth Sci Res Ctr, Sari, Iran.
   [Ermakov, Sergey Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia.
   [Ermakov, Sergey Petrovich] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia.
   [Eshrati, Babak] Minist Hlth & Med Educ, Tehran, Iran.
   [Eshrati, Babak] Arak Univ Med Sci, Arak, Iran.
   [Fuerst, Thomas] Imperial Coll London, Dept Infect Dis Epidemiol, London, England.
   [Foreman, Kyle J.; Greaves, Felix; Majeed, Azeem; Rawaf, Salman] Imperial Coll London, London, England.
   [Fuerst, Thomas] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Karema, Corine Kakizi] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Fuerst, Thomas] Univ Basel, Basel, Switzerland.
   [Fanuel, Fanuel Belayneh Bekele; Kerbo, Amene Abebe; Seifu, Canaan Negash; Sibamo, Ephrem Lejore Sibamo] Wolaita Sodo Univ, Wolaita Sodo, Ethiopia.
   [Faraon, Emerito Jose Aquino] Dept Hlth, Manila, Philippines.
   [Farid, Talha A.; Khan, Abdur Rahman] Univ Louisville, Louisville, KY 40292 USA.
   [Farinha, Carla Sofia e Sa] DGS Directorate Gen Hlth, Lisbon, Portugal.
   [Farinha, Carla Sofia e Sa] Univ Aberta, Lisbon, Portugal.
   [Faro, Andre] Univ Fed Sergipe, Aracaju, Brazil.
   [Farvid, Maryam S.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Harvard MGH Ctr Gen Vulnerable Populat & Hlth Dis, Boston, MA 02114 USA.
   [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.
   [Fernandes, Jefferson G.] German Hosp Oswaldo Cruz, Inst Educ & Sci, Sao Paulo, Brazil.
   [Fernandes, Jefferson G.] Catholic Univ Portugal, Fac Biotechnol, CBQF Ctr Biotechnol & Fine Chem, Associate Lab, Oporto, Portugal.
   [Feyissa, Tesfaye Regassa; Tekelab, Tesfalidet] Wollega Univ, Nekemte, Ethiopia.
   [Fischer, Florian] Univ Bielefeld, Sch Publ Hlth, Bielefeld, Germany.
   [Fitzmaurice, Christina] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA.
   [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine.
   [Forouzanfar, Mohammad H.] Seattle Genet, Seattle, WA USA.
   [Franklin, Richard C.] James Cook Univ, Townsville, Qld, Australia.
   [Gambashidze, Ketevan; Kazanjan, Konstantin; Kereselidze, Maia; Khonelidze, Irma; Shakh-Nazarova, Marina; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Rep of Georgia.
   [Gambashidze, Ketevan] Natl Ctr Dis Control Publ Hlth, Tbilisi, Rep of Georgia.
   [Wen, Chi-Pang] Natl Hlth Res Inst, Hlth Policy, Taipei, Taiwan.
   [Gao, Wayne] Natl Hlth Res Inst, Taipei, Taiwan.
   [Garcia-Basteiro, Alberto L.] Manhica Hlth Res Ctr, Manhica, Mozambique.
   [Garcia-Basteiro, Alberto L.] Barcelona Inst Global Hlth, Barcelona, Spain.
   [Gebre, Teshome] Task Force Global Hlth, Decatur, GA USA.
   [Gebremedhin, Amanuel Tesfay] Ludwig Maximilians Univ Munchen, Munich, Germany.
   [Gebru, Alemseged Aregay; Hailu, Gessessew Bugssa] Kilte Awlaelo Hlth & Demog Surveillance Syst, Mekelle, Ethiopia.
   [Gelaye, Amha Admasie] Wolaita Sodo Univ, Sodo, Ethiopia.
   [Genova-Maleras, Ricard] Reg Hlth Council, Directorate Gen Publ Hlth, Madrid, Spain.
   [Genova-Maleras, Ricard] Natl Sch Publ Hlth, Madrid, Spain.
   [Gibney, Katherine B.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.
   [Gibney, Katherine B.] Royal Melbourne Hosp, Melbourne, Vic, Australia.
   [Gishu, Melkamu Dedefo] Kersa Hlth & Demog Surveillance Syst, Harar, Ethiopia.
   [Gona, Philimon N.] Univ Massachusetts Boston, Boston, MA 02125 USA.
   [Goodridge, Amador] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Cuidad Del Saber, Panama.
   [Gopalani, Sameer Vali] Govt Federated States Micronesia, Dept Hlth & Social Affairs, Palikir, Micronesia.
   [Goto, Atsushi] Natl Canc Ctr, Ctr Publ Hlth Sci, Div Epidemiol, Tokyo, Japan.
   [Greaves, Felix; Steel, Nicholas] Publ Hlth England, London, England.
   [Guban, Peter Imre] Stockholm Cty Council Surveillance & Anal Ctr Epi, Solna, Sweden.
   [Gugnani, Harish Chander] St James Sch Med, Dept Microbiol, Quarter, Anguilla.
   [Gugnani, Harish Chander] St James Sch Med, Dept Epidemiol & Biostat, Quarter, Anguilla.
   [Gupta, Prakash C.] Sekhsaria Inst Publ Hlth, Navi Mumbai, India.
   [Gupta, Rahul] West Virginia Bur Publ Hlth, Charleston, WV USA.
   [Gupta, Rahul] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India.
   [Gupta, Tanush] Montefiore Med Ctr, Bronx, NY 10467 USA.
   [Gupta, Vipin] Univ Delhi, Dept Anthropol, Delhi, India.
   [Hoek, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.
   [Habtewold, Tesfa Dejenie; Tura, Abera Kenay; van Boven, Job F. M.] Univ Groningen, Groningen, Netherlands.
   [Vollset, Stein Emil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Hailu, Alemayehu Desalegne; Norheim, Ole F.] Univ Bergen, Bergen, Norway.
   [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa.
   [Hakuzimana, Alex; Kengne, Andre Pascal; Noubiap, Jean Jacques N.; Watkins, David A.] Univ Cape Town, Cape Town, South Africa.
   [Hakuzimana, Alex] Euclid Univ, Banjul, Gambia.
   [Hamadeh, Randah Ribhi] Arabian Gulf Univ, Manama, Bahrain.
   [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Dubai, U Arab Emirates.
   [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA.
   [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia.
   [Hankey, Graeme J.] Harry Perkins Inst Med Res, Nedlands, WA, Australia.
   [Hankey, Graeme J.] Western Australian Neurosci Res Inst, Nedlands, WA, Australia.
   [Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Beyene, Addisu Shunu] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.
   [Irenso, Asnake Ararsa; Kumsa, Fekede Asefa] Haramaya Univ, Harar, Ethiopia.
   [Hay, Roderick J.] Int Fdn Dermatol, London, England.
   [Hendrie, Delia] Curtin Univ, Ctr Populat Hlth Res, Bentley, WA, Australia.
   [Hoek, Hans W.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [Skirbekk, Vegard] Columbia Univ, New York, NY USA.
   [Horino, Masako] Nevada Div Publ & Behav Hlth, Dept Hlth & Human Serv, Carson City, NV USA.
   [Horita, Nobuyuki] Yokohama City Univ, Grad Sch Med, Dept Pulmonol, Yokohama, Kanagawa, Japan.
   [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA.
   [Htet, Aung Soe] Minist Hlth, Int Relat Div, Nay Pyi Taw, Myanmar.
   [Htet, Aung Soe; Neupane, Sudan Prasad] Univ Oslo, Oslo, Norway.
   [Hu, Guoqing] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.
   [Huang, Hsiang] Cambridge Hlth Alliance, Cambridge, MA USA.
   [Huang, John J.; Macarayan, Erlyn Rachelle King] Yale Univ, New Haven, CT USA.
   [Iburg, Kim Moesgaard] Aarhus Univ, Aarhus, Denmark.
   [Ileanu, Bogdan Vasile; Pana, Adrian] Bucharest Univ Econ Studies, Bucharest, Romania.
   [Innos, Kaire; Leinsalu, Mall] Natl Inst Hlth Dev, Tallinn, Estonia.
   [Jahanmehr, Nader] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Tehran, Iran.
   [Yaseri, Mehdi] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran.
   [Jakovljevic, Mihajlo B.] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia.
   [James, Spencer Lewis] Univ Colorado, Denver Hlth, Denver, CO 80202 USA.
   [Javanbakht, Mehdi] Univ Aberdeen, Aberdeen, Scotland.
   [Jayaraman, Sudha P.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA.
   [Jayatilleke, Achala Upendra] Postgrad Inst Med, Colombo 07, Sri Lanka.
   [Jayatilleke, Achala Upendra] Inst Violence & Injury Prevent, Colombo 08, Sri Lanka.
   [Jeemon, Panniyammakal] Ctr Chron Dis Control, New Delhi, India.
   [Jeemon, Panniyammakal] Publ Hlth Fdn India, Ctr Control Chron Condit, Guragon, India.
   [Kumar, G. Anil] Publ Hlth Fdn India, Guragon, India.
   [Jha, Vivekanand] George Inst Global Hlth, New Delhi, India.
   [John, Denny] Int Ctr Res Women, New Delhi, India.
   [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.
   [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark.
   [Kabir, Zubair] Univ Coll Cork, Cork, Ireland.
   [Kalkonde, Yogeshwar] Soc Educ Act & Res Community Hlth, Gadchiroli, India.
   [Kamal, Ritul; Kesavachandran, Chandrasekharan Nair] CSIR, Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India.
   [She, Jun] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China.
   [Kan, Haidong] Fudan Univ, Shanghai, Peoples R China.
   [Karch, Andre] Helmholtz Ctr Infect Res, Epidemiol & Stat Methods Res Grp, Braunschweig, Germany.
   [Karch, Andre] German Ctr Infect Res, Hannover Braunschweig Site, Braunschweig, Germany.
   [Karema, Corine Kakizi] Qual & Equity Hlth Care, Kigali, Rwanda.
   [Karimi, Seyed M.] Univ Washington Tacoma, Tacoma, WA USA.
   [Kassebaum, Nicholas J.] Seattle Childrens Hosp, Dept Anesthesiol & Pain Med, Seattle, WA USA.
   [Katikireddi, Srinivasa Vittal] Univ Glasgow, Glasgow, Lanark, Scotland.
   [Keiyoro, Peter Njenga] Inst Trop & Infect Dis, Nairobi, Kenya.
   [Keiyoro, Peter Njenga] Sch Continuing & Distance Educ, Nairobi, Kenya.
   [Lyons, Ronan A.] Swansea Univ, Farr Inst, Swansea, W Glam, Wales.
   [Kemp, Andrew Haddon] Swansea Univ, Swansea, W Glam, Wales.
   [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Camperdown, NSW, Australia.
   [Kemp, Andrew Haddon] Univ Sydney, Camperdown, NSW, Australia.
   [Kengne, Andre Pascal] South African Med Res Council, Cape Town, South Africa.
   [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Irbid, Jordan.
   [Khan, Ejaz Ahmad] Hlth Serv Acad, Islamabad, Pakistan.
   [Khan, Gulfaraz] United Arab Emirates Univ, Coll Med Hlth Sci, Dept Microbiol & Immunol, Al Ain, U Arab Emirates.
   [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea.
   [Won, Sungho] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.
   [Khoja, Abdullah Tawfih Abdullah] Mohammed Ibn Saudi Univ, Riyadh, Saudi Arabia.
   [Khubchandani, Jagdish] Ball State Univ, Muncie, IN 47306 USA.
   [Kim, Daniel] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA.
   [Kim, Yun Jin] Southern Univ Coll, Skudai, Malaysia.
   [Kimokoti, Ruth W.] Simmons Coll, Boston, MA 02115 USA.
   [Kinfu, Yohannes] Univ Canberra, Fac Hlth, Ctr Res & Act Publ Hlth, Canberra, ACT, Australia.
   [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan.
   [Kolk, Anneli] Univ Tartu, Fac Med, Dept Pediat, Tartu, Estonia.
   [Kolte, Dhaval] Brown Univ, Div Cardiol, Providence, RI 02912 USA.
   [Kosen, Soewarta] NIHRD, Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia.
   [Koul, Parvaiz A.] Sher Kashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India.
   [Haro, Josep Maria; Koyanagi, Ai] CIBERSAM, Res & Dev Unit, Parc Sanitari Sant Joan de Deu, Barcelona, Spain.
   [Kravchenko, Michael] Res Ctr Neurol, Moscow, Russia.
   [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Defo, Barthelemy Kuate] Univ Montreal, Dept Demog, Montreal, PQ, Canada.
   [Defo, Barthelemy Kuate] Univ Montreal, Publ Hlth Res Inst, Montreal, PQ, Canada.
   [Defo, Barthelemy Kuate] Univ Montreal, Sch Publ Hlth, Dept Social & Prevent Med, Montreal, PQ, Canada.
   [Bicer, Burcu Kucuk] Hacettepe Univ, Inst Publ Hlth, Ankara, Turkey.
   [Polinder, Suzanne] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.
   [Giref, Ababi Zergaw; Khoja, Abdullah Tawfih Abdullah; Kuipers, Ernst J.; Samy, Abdallah M.] Erasmus MC, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.
   [Kulkarni, Veena S.] Arkansas State Univ, State Univ, AR USA.
   [Lager, Anton Carl Jonas] Stockholm Cty Council, Ctr Epidemiol & Community Med, Solna, Sweden.
   [Lal, Aparna] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.
   [Jeemon, Panniyammakal] Publ Hlth Fdn India, Ctr Control Chron Condit, Gurgaon, India.
   [Lal, Aparna; Mathur, Manu Raj] Publ Hlth Fdn India, Gurgaon, India.
   [Lallukka, Tea; Shiri, Rahman] Univ Helsinki, Fac Med, Finnish Inst Occupat Hlth Work Org, Dept Publ Hlth,Work Disabil Program, Helsinki, Finland.
   [Meretoja, Tuomo J.] Univ Helsinki, Helsinki, Finland.
   [Lan, Qing] NCI, Rockville, MD USA.
   [Lansingh, Van C.] Help Me See Inc, New York, NY USA.
   [Lansingh, Van C.] Inst Mexicano Oftalmol, Queretaro, Mexico.
   [Larsson, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden.
   [Latif, Asma Abdul] Lahore Coll Women Univ, Dept Zool, Lahore, Pakistan.
   [Lawrynowicz, Alicia Elena Beatriz] Inst Nacl Epidemiol Dr Juan H Jara, Mar Del Plata, Buenos Aires, Argentina.
   [Leasher, Janet L.] Nova Southeastern Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA.
   [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia.
   [Leigh, James; Mekonnen, Alemayehu B.] Univ Sydney, Sydney, NSW, Australia.
   [Leinsalu, Mall] Sodertorn Univ, Stockholm Ctr Hlth & Social Change, Stockholm, Sweden.
   [Leung, Ricky] SUNY Albany, Albany, NY 12222 USA.
   [Levi, Miriam] Tuscany Reg Ctr Occupat Injuries & Dis, Florence, Italy.
   [Liang, Xiaofeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.
   [Linn, Shai] Univ Haifa, Haifa, Israel.
   [Lipshultz, Steven E.; Wilkinson, James D.] Wayne State Univ, Sch Med, Detroit, MI USA.
   [Lipshultz, Steven E.] Childrens Hosp Michigan, Detroit, MI 48201 USA.
   [Liu, Yang; Phillips, Michael Robert] Emory Univ, Atlanta, GA 30322 USA.
   [Lo, Loon-Tzian] UnionHealth Associates LLC, St Louis, MO USA.
   [Lo, Loon-Tzian] Alton Mental Hlth Ctr, Alton, IL USA.
   [Logroscino, Giancarlo] Univ Bari, Bari, Italy.
   [Lorch, Scott A.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA.
   [Lunevicius, Raimundas] Aintree Univ Hosp Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England.
   [Lunevicius, Raimundas] Univ Liverpool, Sch Med, Liverpool, Merseyside, England.
   [Mackay, Mark T.; Weintraub, Robert G.] Royal Childrens Hosp, Melbourne, Vic, Australia.
   [El Razek, Hassan Magdy Abd] Mansoura Fac Med, Mansoura, Egypt.
   [El Razek, Mohammed Magdy Abd] Aswan Univ Hosp, Aswan Fac Med, Aswan, Egypt.
   [Mahdavi, Mahdi] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands.
   [Mahdavi, Mahdi] Social Secur Org Res Inst, Tehran, Iran.
   [Rego, Maria Albertina Santiago] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Mantovani, Lorenzo G.] Univ Milano Bicocca, Monza, Italy.
   [Manyazewal, Tsegahun] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia.
   [Marcenes, Wagner] Kings Coll London, Dent Inst, Div Populat & Patient Hlth, London, England.
   [Martinez-Raga, Jose] Hosp Univ Doctor Peset, Valencia, Spain.
   [Martinez-Raga, Jose] CEU Cardinal Herrera Univ, Moncada, Spain.
   [Marzan, Melvin Barrientos] Univ East Ramon, Magsaysay Mem Med Ctr, Quezon City, Philippines.
   [Massano, Joao] ULS Matosinhos, Hosp Pedro Hispano, Matosinhos, Portugal.
   [Maulik, Pallab K.] George Inst Global Hlth India, New Delhi, India.
   [Mazidi, Mohsen] Chinese Acad Sci, Inst Genet & Dev Biol, Key State Lab Mol Dev Biol, Beijing, Peoples R China.
   [McAlinden, Colm] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England.
   [McAlinden, Colm] Publ Hlth Wales, Swansea, W Glam, Wales.
   [Meaney, Peter A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Meaney, Peter A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.
   [Mehari, Alem] Howard Univ, Coll Med, Washington, DC USA.
   [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, New Delhi, India.
   [Meier, Toni] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany.
   [Memish, Ziad A.] Saudi Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   [Mensah, George A.] NHLBI, NIH, Ctr Translat Res & Implementat Sci, Bethesda, MD 20892 USA.
   [Meretoja, Tuomo J.] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
   [Meretoja, Tuomo J.] Helsinki Univ Hosp, Ctr Comprehens Canc, Breast Surg Unit, Helsinki, Finland.
   [Micha, Renata] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
   [Shi, Peilin] Tufts Univ, Boston, MA 02111 USA.
   [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada.
   [Mirarefin, Mojde] Hunger Act Los Angeles, Los Angeles, CA USA.
   [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan.
   [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Bishkek, Kyrgyzstan.
   [Mohammad, Karzan Abdulmuhsin] Univ Salahaddin, Erbil, Iraq.
   [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria.
   [Mola, Glen Liddell D.] Univ Papua New Guinea, Sch Med & Hlth Sci, Reprod Hlth & ObGyn, Boroko, Papua N Guinea.
   [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Preventat Med & Publ Hlth Res Ctr, Gastrointestinal & Liver Dis Res Ctr GILDRC, Dept Community Med, Tehran, Iran.
   [Tehrani-Banihashemi, Arash] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, Iran.
   [Morawska, Lidia] Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld, Australia.
   [Sun, Jiandong] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.
   [Moraga, Paula] Queensland Univ Technol, Brisbane, Qld, Australia.
   [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan.
   [Werdecker, Andrea] Fed Inst Populat Res, Competence Ctr Mortality Follow Up German Natl Co, Wiesbaden, Germany.
   [Mueller, Ulrich O.; Westerman, Ronny] Fed Inst Populat Res, Wiesbaden, Germany.
   [Musa, Kamarul Imran] Univ Sci Malaysia, Sch Med Sci, Kubang Kerian, Malaysia.
   [Nachega, Jean B.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
   [Nachega, Jean B.; Seedat, Soraya; Wiysonge, Charles Shey] Univ Stellenbosch, Cape Town, South Africa.
   [Nachega, Jean B.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Nagata, Chie] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan.
   [Rothenbacher, Dietrich] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany.
   [Nagel, Gabriele] Ulm Univ, Ulm, Germany.
   [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy.
   [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India.
   [Nascimento, Bruno Ramos; Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Nascimento, Bruno Ramos] Hosp Univ Ciencias Med, Belo Horizonte, MG, Brazil.
   [Negoi, Ionut] Carol Davila Univ Med & Pharm Bucharest, Bucharest, Romania.
   [Newton, Charles R.] KEMRI Wellcome Trust, Kilifi, Kenya.
   [Ngalesoni, Frida Namnyak] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania.
   [Ngunjiri, Josephine Wanjiku] Univ Nairobi, Nairobi, Kenya.
   [Ningrum, Dina Nur Anggraini] Semarang State Univ, Dept Publ Hlth, Semarang City, Indonesia.
   [Nolte, Sandra] Deakin Univ, Sch Hlth & Social Dev, Populat Hlth Strateg Res Ctr, Burwood, Vic, Australia.
   [Stokes, Mark Andrew] Deakin Univ, Burwood, Vic, Australia.
   [Nomura, Marika] Natl Inst Publ Hlth, Saitama, Japan.
   [Noubiap, Jean Jacques N.] Med Diagnost Ctr, Yaounde, Cameroon.
   [Obermeyer, Carla Makhlouf] Amer Univ Beirut, Fac Hlth Sci, Ctr Res Populat & Hlth, Beirut, Lebanon.
   [Ogbo, Felix Akpojene] Univ Western Sydney, Ctr Hlth Res, Penrith, NSW, Australia.
   [Renzaho, Andre M. N. N.] Univ Western Sydney, Penrith, NSW, Australia.
   [Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea.
   [Okoro, Anselm] Soc Family Hlth, Abuja, Nigeria.
   [Oladimeji, Olanrewaju] HSRC, Durban, South Africa.
   [Oladimeji, Olanrewaju] Univ KwaZulu Natal, Durban, South Africa.
   [Olivares, Pedro R.] Univ Autonoma Chile, Talca, Chile.
   [Olusanya, Bolajoko Olubukunola; Olusanya, Jacob Olusegun] Ctr Healthy Start Initiat, Lagos, Nigeria.
   [Opio, John Nelson] Lira Dist Local Govt, Lira Municipal Council, Lira, Uganda.
   [Oren, Eyal] Univ Arizona, Tucson, AZ USA.
   [Ortiz, Alberto] IIS Fdn Jimenez Diaz UAM, Madrid, Spain.
   [Nolte, Sandra] Deakin Univ, Populat Hlth Strateg Res Ctr, Sch Hlth & Social Dev, Geelong, Vic, Australia.
   [Osborne, Richard H.] Deakin Univ, Geelong, Vic, Australia.
   [Osman, Majdi] YBank, Cambridge, MA USA.
   [Owolabi, Mayowa O.] Dept Med, Ibadan, Nigeria.
   [Owolabi, Mayowa O.] Blossom Specialist Med Ctr, Ibadan, Nigeria.
   JSS Univ, JSS Med Coll, Mysore, Karnataka, India.
   [Pakhale, Smita] Ottawa Hosp, Res Inst, Ottawa, ON, Canada.
   [Castillo, Elizabeth Palomares] Minist Hlth, Mexico City, DF, Mexico.
   [Castillo, Elizabeth Palomares] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico.
   [Patel, Tejas] Mt Sinai Hlth Syst, New York, NY USA.
   [Paudel, Deepak] UK Dept Int Dev, Lalitpur, Nepal.
   [Pereira, David M.] Univ Porto, Fac Farm, REQUIMTE LAQV, Lab Farmacognosia, Oporto, Portugal.
   [Perez-Padilla, Rogelio] Natl Inst Resp Dis, Mexico City, DF, Mexico.
   [Perez-Ruiz, Fernando] Hop Univ Cruces, OSI EE Cruces, Baracaldo, Spain.
   [Perez-Ruiz, Fernando] Biocruces Hlth Res Inst, Baracaldo, Spain.
   [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA, Australia.
   [Petzold, Max] Univ Gothenburg, Hlth Metr Unit, Gothenburg, Sweden.
   [Petzold, Max] Univ Witwatersrand, Johannesburg, South Africa.
   [Phillips, Michael Robert] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China.
   [Pillay, Julian David] Durban Univ Technol, Durban, South Africa.
   [Pond, Constance D.] Univ Newcastle, Callaghan, NSW, Australia.
   [Prakash, V.] Charotar Univ Sci & Technol, Anand, Gujarat, India.
   [Purwar, Manorama] Intergrowth 21st Study Res Ctr, Nagpur, Maharashtra, India.
   [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran.
   [Radfar, Amir] AT Still Univ, Kirksville, MO USA.
   [Rafay, Anwar; Rana, Saleem M.] Contech Int Hlth Consultants, Lahore, Pakistan.
   [Rafay, Anwar; Rana, Saleem M.] Contech Sch Publ Hlth, Lahore, Pakistan.
   [Rahman, Mahfuzar] BRAC, Res & Evaluat Div, Dhaka, Bangladesh.
   [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India.
   [Rao, Paturi Vishnupriya] Diabet Res Soc, Hyderabad, Andhra Pradesh, India.
   [Rao, Paturi Vishnupriya] Diabet Res Ctr, Hyderabad, Andhra Pradesh, India.
   [Remuzzi, Giuseppe] Papa Giovanni XXIII, Bergamo, Italy.
   [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.
   [Resnikoff, Serge] Univ New South Wales, Brien Holden Vision Inst, Randwick, NSW, Australia.
   [Resnikoff, Serge] Univ New South Wales, Sch Optometry & Vis Sci, Randwick, NSW, Australia.
   [Sachdev, Perminder S.] Univ New South Wales, Randwick, NSW, Australia.
   [Roshandel, Gholamreza] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran.
   [Roy, Nawal K.] Holmusk, Singapore, Singapore.
   [Roy, Nawal K.] Duke NUS Med Sch, Singapore, Singapore.
   [Sachdev, Perminder S.] Prince Wales Hosp, Randwick, NSW, Australia.
   [Sackey, Ben Benasco] World Hlth Org, Accra, Ghana.
   [Saeedi, Mohammad Yahya] Minist Hlth, Riyadh, Saudi Arabia.
   [Safiri, Saeid] Maragheh Univ Med Sci, Managerial Epidemiol Res Ctr, Maragheh, Iran.
   [Saleh, Muhammad Muhammad] Dev Res & Projects Ctr, Abuja, Nigeria.
   [Samy, Abdallah M.] Ain Shams Univ, Cairo, Egypt.
   [Sanabria, Juan Ramon] Marshall Univ, J Edwards Sch Med, Huntington, WV USA.
   [Sanabria, Juan Ramon] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Sanchez-Nino, Maria Dolores] IIS Fdn Jimenez Diaz, Madrid, Spain.
   [Sarmiento-Suarez, Rodrigo] Univ Ciencias Aplicadas & Ambient, Bogota, Colombia.
   [Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Publ Hlth Med, Durban, South Africa.
   [Yakob, Bereket] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.
   [Sartorius, Benn] SAMRC, UKZN Gastrointestinal Canc Res Ctr, Cape Town, South Africa.
   [Sawhney, Monika] Marshall Univ, Huntington, WV USA.
   [Saylan, Mete I.] Bayer Turkey, Istanbul, Turkey.
   [Schoettker, Ben] FOM Univ, Inst Hlth Care & Social Sci, Essen, Germany.
   [Schutte, Aletta E.] North West Univ, Hypertens Africa Res Team HART, Potchefstroom, South Africa.
   [Schutte, Aletta E.] South African Med Res Council, Potchefstroom, South Africa.
   [Serdar, Berrin] Univ Colorado, Aurora, CO USA.
   [Shaheen, Amira] Najah Univ, Dept Publ Hlth, Nablus, Palestine.
   [Shahraz, Saeid] Tufts Med Ctr, Boston, MA USA.
   [Sharma, Jayendra] Minist Hlth, Thimphu, Bhutan.
   [Sharma, Rajesh] Indian Inst Technol Ropar, Rupnagar, India.
   [Shen, Jiabin] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.
   [Shigematsu, Mika] Natl Inst Infect Dis, Tokyo, Japan.
   [Shigematsu, Mika] Sandia Natl Labs, Albuquerque, NM 87185 USA.
   [Shin, Min-Jeong] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul, South Korea.
   [Yoon, Seok-Jun] Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   [Shoman, Haitham] Imperial Coll London, London, England.
   [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland.
   [Silva, Diego Augusto Santos] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Silveira, Dayane Gabriele Alves] Brasilia Univ, Brasilia, DF, Brazil.
   [Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA.
   [Singh, Jasvinder A.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA.
   [Singh, Om Prakash] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India.
   [Singh, Prashant Kumar] Inst Human Dev, New Delhi, India.
   [Singh, Virendra] Asthma Bhawan, Jaipur, Rajasthan, India.
   [Sinke, Abiy Hiruye] Ethiopian Med Assoc, Addis Ababa, Ethiopia.
   [Sinshaw, Aklilu Endalamaw] Univ Gondar, Gondar, Ethiopia.
   [Sobngwi, Eugene] Univ Yaounde, Yaounde, Cameroon.
   [Sobngwi, Eugene] Yaounde Cent Hosp, Yaounde, Cameroon.
   [Soneji, Samir] Dartmouth Coll, Hanover, NH 03755 USA.
   [Soriano, Joan B.] Univ Autonoma Madrid, Inst Invest Hosp Univ Princesa, Madrid, Spain.
   [Sousa, Tatiane Cristina Moraes] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Sposato, Luciano A.] Western Univ, Dept Clin Neurol Sci, London, ON, Canada.
   [Sreeramareddy, Chandrashekhar T.] Int Med Univ, Dept Community Med, Kuala Lumpur, Malaysia.
   [Stathopoulou, Vasiliki] Attikon Univ Hosp, Athens, Greece.
   [Steel, Nicholas] Univ East Anglia, Norwich, Norfolk, England.
   [Steinke, Sabine] Univ Hosp Muenster, Dept Dermatol, Munster, Germany.
   [Strong, Mark] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.
   [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, Athens, Greece.
   [Stroumpoulis, Konstantinos] Ctr Hosp Publ Cotentin, Cherbourg, France.
   [Sufiyan, Muawiyyah Babale] Ahmadu Bello Univ, Zaria, Nigeria.
   [Suliankatchi, Rizwan Abdulkader] Minist Hlth, Riyadh, Saudi Arabia.
   [Sun, Jiandong] Univ Southern Queensland, Inst Resilient Regions, Springfield, Qld, Australia.
   [Swaminathan, Soumya] Indian Council Med Res, Chennai, Tamil Nadu, India.
   [Sykes, Bryan L.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA.
   [Sykes, Bryan L.] Univ Calif Irvine, Dept Publ Hlth, Irvine, CA USA.
   [Tabares-Seisdedos, Rafael] Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain.
   [Tabares-Seisdedos, Rafael] CIBERSAM, Valencia, Spain.
   [Tabb, Karen M.] Univ Illinois, Sch Social Work, Champaign, IL USA.
   [Talongwa, Roberto Tchio] Minist Hlth, MINSANTE, Yaounde, Cameroon.
   [Tarajia, Musharaf] Inst Conmemorativo Gorgas Estudios Salud, Panama City, Panama.
   [Tavakkoli, Mohammad] New York Med Ctr, Valhalla, NY USA.
   [Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, Almada, Portugal.
   [Taveira, Nuno] Univ Lisbon, Faulty Pharm, Lisbon, Portugal.
   [Tekelab, Tesfalidet] Univ Newcastle, Newcastle, NSW, Australia.
   [Shifa, Girma Temam] Arba Minch Univ, Arba Minch, Ethiopia.
   [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA.
   [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia.
   [Terkawi, Abdullah Sulieman] Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA.
   [Thakur, J. S.] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.
   [Thomson, Alan J.] Adapt Knowledge Management, Victoria, BC, Canada.
   [Tobe-Gai, Ruoyan] Natl Ctr Child Hlth & Dev, Tokyo, Japan.
   [Tonelli, Marcello] Univ Calgary, Calgary, AB, Canada.
   [Topor-Madry, Roman] Jagiellonian Univ, Fac Hlth Sci, Med Coll, Inst Publ Hlth, Krakow, Poland.
   [Tortajada, Miguel] Hosp Univ Dr Peset, Valencia, Spain.
   [Truelsen, Thomas] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen, Denmark.
   [Uchendu, Uche S.] Washington DC, Dept Vet Affairs, Washington, DC USA.
   [Ukwaja, Kingsley N.] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria.
   [Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA.
   [Uneke, Chigozie Jesse] Ebonyi State Univ, Abakaliki, Nigeria.
   [Uthman, Olalekan A.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England.
   [Van Dingenen, Rita] Joint Res Ctr, European Commiss, Ispra, Italy.
   [Vasankari, Tommi] UKK Inst Hlth Promot Res, Tampere, Finland.
   [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore.
   [Violante, Francesco S.] Univ Bologna, Bologna, Italy.
   [Vladimirov, Sergey K.] Fed Res Inst Hlth Org & Informat, Moscow, Russia.
   [Vlassov, Vasiliy Victorovich] Natl Res Univ Higher Sch Econ, Moscow, Russia.
   [Waller, Stephen G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Walson, Judd L.] Nat Hist Museum, London, England.
   [Wang, Yuan-Pang] Univ Sao Paulo, Med Sch, Sao Paulo, Brazil.
   [Weiderpass, Elisabete] Canc Registry Norway, Inst Populat Based Canc Res, Dept Res, Oslo, Norway.
   [Weiderpass, Elisabete] Univ Tromso, Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
   [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland.
   [Wesana, Joshua] Univ Ghent, Ghent, Belgium.
   [Wesana, Joshua] Mt Moon Univ, Ft Portal, Uganda.
   [Westerman, Ronny] German Natl Cohort Consortium, Heidelberg, Germany.
   [Wiysonge, Charles Shey] Cochrane South Africa, South African Med Res Council, Cape Town, South Africa.
   [Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Comprehens Biomed Res Ctr, Natl Inst Hlth Res, London, England.
   [Wolfe, Charles D. A.] Kings Coll London, London, England.
   [Workicho, Abdulhalik] Univ Ghent, Ghent, Belgium.
   [Workie, Shimelash Bitew] Wolaita Sodo Univ, Wolaita Sodo, Ethiopia.
   St Pauls Hosp, Millenium Med Coll, Addis Ababa, Ethiopia.
   Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia.
   [Xavier, Denis] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India.
   [Xu, Gelin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.
   [Yaghoubi, Mohsen] Univ Saskatchewan, Saskatoon, SK, Canada.
   [Yan, Lijing L.] Duke Kunshan Univ, Global Hlth Res Ctr, Kunshan, Peoples R China.
   [Yano, Yuichiro] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA.
   [Amini, Erfan] Univ Tehran Med Sci, Urooncol Res Ctr, Tehran, Iran.
   [Esteghamati, Alireza; Sheikhbahaei, Sara] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.
   [Farzadfar, Farshad; Parsaeian, Mahboubeh] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   [Hafezi-Nejad, Nima] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran.
   [Hassanvand, Mohammad Sadegh] Univ Tehran Med Sci, Ctr Air Pollut Res Inst Environm Res, Tehran, Iran.
   [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran.
   [Malekzadeh, Reza; Roshandel, Gholamreza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Sahraian, Mohammad Ali] Univ Tehran Med Sci, MS Res Ctr, Neurosci Inst, Tehran, Iran.
   [Shamsipour, Mansour] Univ Tehran Med Sci, Inst Environm Res, Tehran, Iran.
   [Yaseri, Mehdi] Univ Tehran Med Sci, Tehran, Iran.
   [Yip, Paul] Univ Hong Kong, Social Work & Social Adm Dept, Hong Kong, Hong Kong, Peoples R China.
   [Yip, Paul] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.
   [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan.
   [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA.
   [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Peoples R China.
   [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan, Peoples R China.
   [Zaidi, Zoubida] Univ Hosp, Setif, Algeria.
   [Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt.
   [Zambrana-Torrelio, Carlos] EcoHlth Alliance, New York, NY USA.
   [Zambrana-Torrelio, Carlos] Inst Ecol Bolivia, La Paz, Bolivia.
   [Zapata, Tomas] World Hlth Org, Windhoek, Namibia.
   [Zuhlke, Liesl Joanna] Red Cross War Mem Childrens Hosp, Cape Town, South Africa.
RP Murray, CJL (reprint author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98195 USA.
EM cjlm@uw.edu
RI Qorbani, Mostafa/M-8171-2017
FU Bill & Melinda Gates Foundation
FX Bill & Melinda Gates Foundation.
CR Adam T, 2005, BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107
   Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207
   Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006
   Bogetoft P, 2013, BENCHMARKING DATA EN
   Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217
   Burki TK, 2016, LANCET ONCOL, V17, pE185, DOI 10.1016/S1470-2045(16)30059-6
   CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016
   Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1
   Carmines E., 1979, RELIABILITY VALIDITY
   CHARLTON JRH, 1986, BRIT MED J, V292, P295
   Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558
   Ebrahim S, 1999, STROKE EPIDEMIOLOGY
   Endreseth BH, 2006, COLORECTAL DIS, V8, P471, DOI 10.1111/j.1463-1318.2005.00921.x
   Forouzanfar MH, 2016, LANCET, V388, P1659
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Gay JG, 2011, MORTALITY AMENABLE H
   Group I. A. S., 2004, LANCET, V363, P9
   Halstead S, 1985, GOOD HLTH LOW COST
   Harris A. R., 2002, HOMICIDE STUDIES, V6, P128, DOI 10.1177/1088767902006002003
   Holland W., 1990, INT J QUAL HEALTH C, V2, P227
   HOLLAND WW, 1986, HEALTH POLICY, V6, P115, DOI 10.1016/0168-8510(86)90001-1
   Hwang S-N, 2016, HDB OPERATIONS ANAL
   IAEG-SDGs, 2016, EC SOC COUNC
   Illich I., 1975, MED NEMESIS APPROPRI
   International Labour Organization, 2010, WORLD SOC SEC REP 20
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4
   Kassebaum NJ, 2016, LANCET, V388, P1603
   KELSON M, 1987, INT J EPIDEMIOL, V16, P411, DOI 10.1093/ije/16.3.411
   KOENIG MA, 1990, B WORLD HEALTH ORGAN, V68, P441
   Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9
   Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mackenbach JP, 2013, EUR J PUBLIC HEALTH, V23, P195, DOI 10.1093/eurpub/cks192
   Mackenbach JP, 1996, J CLIN EPIDEMIOL, V49, P1207, DOI 10.1016/S0895-4356(96)00200-4
   MACKENBACH JP, 1988, SOC SCI MED, V27, P889, DOI 10.1016/0277-9536(88)90278-X
   MACKENBACH JP, 1991, HEALTH POLICY, V19, P245, DOI 10.1016/0168-8510(91)90011-L
   MACKENBACH JP, 1988, J EPIDEMIOL COMMUN H, V42, P325, DOI 10.1136/jech.42.4.325
   Manuel DG, 2002, AM J PUBLIC HEALTH, V92, P1481, DOI 10.2105/AJPH.92.9.1481
   McCarthy D, 2015, AIMING HIGHER RESULT
   McKee M, 2011, HLTH SYSTEMS LOW MID
   McKee M, 2010, HEALTH POLICY PLANN, V25, P346, DOI 10.1093/heapol/czq032
   McKeown T., 1979, ROLE MED DREAM MIRAG
   MCKINLAY JB, 1977, MILBANK FUND Q, V55, P405, DOI 10.2307/3349539
   Merali HS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-280
   Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928
   Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757
   Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9
   Niti M, 2001, INT J EPIDEMIOL, V30, P966, DOI 10.1093/ije/30.5.966
   Nolte E, 2006, DIABETES CARE, V29, P1007, DOI 10.2337/dc05-1550
   Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129
   Nolte E, 2002, SOC SCI MED, V55, P1905, DOI 10.1016/S0277-9536(01)00320-3
   Nolte E., 2004, DOES HEALTHCARE SAVE
   Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58
   Nolte E, 2012, HEALTH AFFAIR, V31, P2114, DOI 10.1377/hlthaff.2011.0851
   Nolte E, 2011, HEALTH POLICY, V103, P47, DOI 10.1016/j.healthpol.2011.08.002
   OECD, 2016, HLTH GLANC EUR 2016
   PAMPALON R, 1993, SOC SCI MED, V37, P823, DOI 10.1016/0277-9536(93)90376-F
   Petrie D, 2014, B WORLD HEALTH ORGAN, V92, P396, DOI 10.2471/BLT.13.132480
   The Primary Health Care Performance Initiative (PHCPI), 2015, COV IND         0917
   POIKOLAINEN K, 1988, INT J EPIDEMIOL, V17, P86, DOI 10.1093/ije/17.1.86
   Richards MA, 2000, BRIT MED J, V320, P895, DOI 10.1136/bmj.320.7239.895
   Risso-Gill I, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0916-y
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104
   RUTSTEIN DD, 1980, NEW ENGL J MED, V302, P1146
   Schoen C, 2004, HEALTH AFFAIR, V23, pW4487, DOI 10.1377/hlthaff.W4.487
   Smith OK, 2015, GOING UNIVERSAL 24 D
   Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
   Stockton D, 1997, BRIT MED J, V314, P472
   Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119
   Tobias M, 2009, AUST NZ J PUBL HEAL, V33, P70, DOI 10.1111/j.1753-6405.2009.00342.x
   Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085
   Treurniet HF, 2004, J EPIDEMIOL COMMUN H, V58, P290, DOI 10.1136/jech.2002.006452
   UN, 2015, TRANSF OUR WORLD 203
   Vos T, 2016, LANCET, V388, P1545
   Wang HD, 2016, LANCET, V388, P1459
   World Health Organization (WHO), 2000, HLTH SYST IMPR PERF
NR 78
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 15
PY 2017
VL 390
IS 10091
BP 231
EP 266
DI 10.1016/S0140-6736(17)30818-8
PG 36
WC Medicine, General & Internal
SC General & Internal Medicine
GA FA5IZ
UT WOS:000405477900026
OA No
DA 2017-08-15
ER

PT J
AU Jaiteh, LES
   Helwig, SA
   Jagne, A
   Ragoschke-Schumm, A
   Sarr, C
   Walter, S
   Lesmeister, M
   Manitz, M
   Blass, S
   Weis, S
   Schlund, V
   Bah, N
   Kauffmann, J
   Fousse, M
   Kangankan, S
   Cabrera, AR
   Kronfeld, K
   Ruckes, C
   Liu, Y
   Nyan, O
   Fassbender, K
AF Jaiteh, Lamin E. S.
   Helwig, Stefan A.
   Jagne, Abubacarr
   Ragoschke-Schumm, Andreas
   Sarr, Catherine
   Walter, Silke
   Lesmeister, Martin
   Manitz, Matthias
   Blass, Sebastian
   Weis, Sarah
   Schlund, Verena
   Bah, Neneh
   Kauffmann, Jil
   Fousse, Mathias
   Kangankan, Sabina
   Cabrera, Asmell Ramos
   Kronfeld, Kai
   Ruckes, Christian
   Liu, Yang
   Nyan, Ousman
   Fassbender, Klaus
TI Standard operating procedures improve acute neurologic care in a
   sub-Saharan African setting
SO NEUROLOGY
LA English
DT Article
ID CONVULSIVE STATUS EPILEPTICUS; RISK-FACTORS; STROKE; EPILEPSY; DISEASE;
   ADULTS; BURDEN; PREVALENCE; MANAGEMENT; GUIDELINE
AB Objective: Quality of neurologic emergency management in an under-resourced country may be improved by standard operating procedures (SOPs).
   Methods: Neurologic SOPs were implemented in a large urban (Banjul) and a small rural (Brikama) hospital in the Gambia. As quality indicators of neurologic emergency management, performance of key procedures was assessed at baseline and in the first and second implementation years.
   Results: At Banjul, 100 patients of the first-year intervention group exhibited higher rates of general procedures of emergency management than 105 control patients, such as neurologic examination (99.0% vs 91.4%; p < 0.05) and assessments of respiratory rate (98.0% vs 81.9%, p < 0.001), temperature (60.0% vs 36.2%; p < 0.001), and glucose levels (73.0% vs 58.1%; p < 0.05), in addition to written directives by physicians (96.0% vs 88.6%, p < 0.05), whereas assessments of other vital signs remained unchanged. In stroke patients, rates of stroke-related procedures increased: early CT scanning (24.3% vs 9.9%; p < 0.05), blood count (73.0% vs 49.3%; p < 0.01), renal and liver function tests (50.0% vs 5.6%, p < 0.001), aspirin prophylaxis (47.3% vs 9.9%; p < 0.001), and physiotherapy (41.9% vs 4.2%; p < 0.001). Most effects persisted until the second-year evaluation. SOP implementation was similarly feasible and beneficial at the Brikama hospital. However, outcomes did not significantly differ in the hospitals.
   Conclusions: Implementing SOPs is a realistic, low-cost option for improving process quality of neurologic emergency management in under-resourced settings. Classification of evidence: This study provides Class IV evidence that, for patients with suspected neurologic emergencies in sub-Saharan Africa, neurologic SOPs increase the rate of performance of guideline-recommended procedures.
C1 [Jaiteh, Lamin E. S.; Jagne, Abubacarr; Sarr, Catherine; Bah, Neneh; Kangankan, Sabina; Cabrera, Asmell Ramos; Nyan, Ousman] Edward Francis Small Teaching Hosp, Dept Med, Banjul, Gambia.
   [Jaiteh, Lamin E. S.; Jagne, Abubacarr; Sarr, Catherine; Bah, Neneh; Kangankan, Sabina; Cabrera, Asmell Ramos; Nyan, Ousman] Edward Francis Small Teaching Hosp, Dept Surg, Banjul, Gambia.
   [Helwig, Stefan A.; Ragoschke-Schumm, Andreas; Walter, Silke; Lesmeister, Martin; Manitz, Matthias; Blass, Sebastian; Weis, Sarah; Schlund, Verena; Kauffmann, Jil; Fousse, Mathias; Liu, Yang; Fassbender, Klaus] Saarland Univ, Med Ctr, Dept Neurol, Homburg, Germany.
   [Kronfeld, Kai; Ruckes, Christian] Interdisciplinary Ctr Clin Trials IZKS, Mainz, Germany.
RP Fassbender, K (reprint author), Saarland Univ, Med Ctr, Dept Neurol, Homburg, Germany.
EM Klaus.Fassbender@uks.eu
FU Else Kroner-Fresenius-Stiftung; University of the Saarland, Germany
FX Supported by the Else Kroner-Fresenius-Stiftung. The Article Processing
   Charge was funded by the University of the Saarland, Germany.
CR Aarli JA, 2007, NEUROLOGY, V69, P1715, DOI 10.1212/01.wnl.0000285102.47543.02
   Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486
   Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0
   Berkowitz AL, 2014, NEUROLOGY, V83, P787, DOI 10.1212/WNL.0000000000000730
   Bower JH, 2007, NEUROLOGY, V68, P338, DOI 10.1212/01.wnl.0000252801.61190.e8
   Bower JH, 2005, NEUROLOGY, V64, P412
   Boyles T. H., 2013, Southern African Journal of Epidemiology & Infection, V28, P5
   Bryer A, 2010, SAMJ S AFR MED J, V100, P750
   Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9
   Craven R, 2009, LANCET NEUROL, V8, P32, DOI 10.1016/S1474-4422(08)70284-9
   Dua T, 2004, ATLAS COUNTRY RESOUR
   Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7
   Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2
   Etyang AO, 2014, LANCET GLOB HEALTH, V2, pE216, DOI 10.1016/S2214-109X(14)70023-3
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Garbusinski JM, 2005, STROKE, V36, P1388, DOI 10.1161/01.STR.0000170717.91591.7d
   Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48
   Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083
   Kariuki SM, 2015, NEUROLOGY, V84, P1838, DOI 10.1212/WNL.0000000000001542
   Koutangni T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116725
   Mathers CD, 2005, UPDATED PROJECTIONS
   Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x
   Nakibuuka J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154333
   Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6
   National Institute for Health and Care Excellence (NICE), 2010, MEN BACT MEN SEPT UN
   Nunes VD, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e281
   O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3
   Ogungbo B, 2013, NEUROLOGY, V81, P2134, DOI 10.1212/01.wnl.0000437293.13194.12
   Philip-Ephraim EE, 2013, J NEUROL SCI-TURK, V30, P72
   Silberberg D, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P351
   van der Meyden CH, 2000, S AFR MED J, V90, P403
   Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7
   Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6
   Walker RW, 2003, STROKE, V34, P1604, DOI 10.1161/01.STR.0000077943.63718.67
   Wang HD, 2016, LANCET, V388, P1459
   World Health Organization. Regional Office for Africa, 2006, HLTH PEOPL AFR REG H
   Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4
NR 37
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JUL 11
PY 2017
VL 89
IS 2
BP 144
EP 152
DI 10.1212/WNL.0000000000004080
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA EZ9UC
UT WOS:000405074400011
PM 28600460
OA No
DA 2017-08-15
ER

PT J
AU Turkova, A
   Tebruegge, M
   Brinkmann, F
   Tsolia, M
   Mouchet, F
   Kampmann, B
   Seddon, JA
AF Turkova, A.
   Tebruegge, M.
   Brinkmann, F.
   Tsolia, M.
   Mouchet, F.
   Kampmann, B.
   Seddon, J. A.
TI Management of child MDR-TB contacts across countries in the WHO European
   Region: a survey of current practice
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE MDR-TB; paediatric; chemoprophylaxis; preventive treatment
ID TUBERCULOSIS
AB The World Health Organization European Region has one of the highest rates of multidrug-resistant tuberculosis (MDR-TB) in the world, resulting in many vulnerable children being exposed each year. Evidence for preventive therapy following MDR-TB exposure is limited and current guidance is conflicting. An internet-based survey was performed to determine clinical practice in this region. Seventy-two clinicians from 25 countries participated. Practices related to screening and decision-making were highly variable. Just over half provided preventive therapy for children exposed to MDR-TB; the only characteristic associated with provision was practice within the European Union (adjusted OR 4.07, 95%CI 1.33-12.5).
C1 [Turkova, A.] UCL, MRC, Clin Trials Unit, Aviat House,125 Kingsway, London WC2B 6NH, England.
   [Turkova, A.] Great Ormond St Hosp Sick Children, Dept Paediat Infect Dis, London, England.
   [Tebruegge, M.] Univ Southampton, Acad Unit Clin & Expt Sci, Fac Med, Southampton, Hants, England.
   [Tebruegge, M.] Southampton Univ Hosp NHS Fdn Trust, Southampton Resp Biomed Res Unit, Southampton, Hants, England.
   [Tebruegge, M.] Guys & St Thomas NHS Fdn Trust, Dept Paediat Infect Dis & Immunol, Evelina London Childrens Hosp, London, England.
   [Brinkmann, F.] Ruhr Univ Bochum, Childrens Hosp, Dept Paediat Pulmonol, Bochum, Germany.
   [Tsolia, M.] Univ Athens, Univ Dept Paediat 2, Sch Med, P&A Kyriakou Childrens Hosp, Athens, Greece.
   [Mouchet, F.] Univ Libre Bruxelles, Ctr Hosp Univ St Pierre, Dept Paediat, Brussels, Belgium.
   [Kampmann, B.] MRC Unit, Banjul, Gambia.
   [Kampmann, B.; Seddon, J. A.] Imperial Coll London, Dept Paediat, Ctr Int Child Hlth, London, England.
RP Turkova, A (reprint author), UCL, MRC, Clin Trials Unit, Aviat House,125 Kingsway, London WC2B 6NH, England.
EM a.turkova@ucl.ac.uk
CR Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91
   Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392
   Parr JB, 2014, CLIN INFECT DIS, V58, P392, DOI 10.1093/cid/cit709
   Tebruegge M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099129
   WHO, 2016, GLOB TUB REP
   World Health Organization, 2008, WHOHTMTB2008402
   World Health Organization, 2015, THE END TB STRAT
   World Health Organization European Region, 2017, COUNTR INCL EUR REG
NR 9
TC 0
Z9 0
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD JUL
PY 2017
VL 21
IS 7
BP 774
EP 777
DI 10.5588/ijtld.16.0949
PG 4
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA FB6LQ
UT WOS:000406254900011
PM 28633701
OA No
DA 2017-08-15
ER

PT J
AU Egere, U
   Togun, T
   Hill, PC
   Kampmanns, B
AF Egere, Uzochukwu
   Togun, Toyin
   Hill, Philip C.
   Kampmanns, Beate
TI Untitled reply
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Letter
ID TUBERCULOSIS; CHILDREN; HOUSEHOLD; CONTACTS
C1 [Egere, Uzochukwu; Kampmanns, Beate] Vaccines & Immun Theme Med Res Council MRC Unit G, Banjul, Gambia.
   [Togun, Toyin] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.
   [Hill, Philip C.] Univ Otago, Dept Prevent & Social Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Kampmanns, Beate] Imperial Coll London, Ctr Int Child Hlth, Acad Dept Paediat, St Marys Campus, London, England.
RP Egere, U (reprint author), Vaccines & Immun Theme Med Res Council MRC Unit G, Banjul, Gambia.
EM uegere@mrc.gm; bkampmann@mrc.gm
CR Beyers N, 1997, INT J TUBERC LUNG D, V1, P38
   Egere U, 2017, INT J TUBERC LUNG D, V21, P46, DOI 10.5588/ijtld.16.0289
   Triasih R, 2015, CLIN INFECT DIS, V60, P12, DOI 10.1093/cid/ciu748
   World Health Organization, 2014, WHOHTMTB201403
NR 4
TC 0
Z9 0
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD JUL
PY 2017
VL 21
IS 7
BP 833
EP 833
DI 10.5588/ijt1d.17.0155-2
PG 1
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA FB6LQ
UT WOS:000406254900021
PM 28633711
OA No
DA 2017-08-15
ER

PT J
AU Sanyang, E
   Peek-Asa, C
   Bass, P
   Young, TL
   Jagne, A
   Njie, B
AF Sanyang, Edrisa
   Peek-Asa, Corinne
   Bass, Paul
   Young, Tracy L.
   Jagne, Abubacarr
   Njie, Baba
TI Injury factors associated with discharge status from emergency room at
   two major trauma hospitals in The Gambia, Africa
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Review
DE Traumatic injury; Hospital registry; Disability; Road traffic injury
AB Introduction: Injuries are the leading cause of disability across all ages and gender. In this study, we identified predictors of discharge status and disability at discharge among patients who seek emergency room treatment.
   Materials and methods: The study was conducted in two major trauma hospitals in urban Gambia. 1905 patients participated in the study. 74.9% were males, and 25.1% were females. The study includes injured patients from all mechanisms. However, patients' records without age, gender, injury mechanism, and deposition from the emergency room were considered incomplete and excluded. We examined distributions of injury by age, gender, mechanism, place of occurrence, intent, primary body part injured, and primary nature of injury. We identified demographic and injury characteristics associated with hospital admission (compared to emergency department discharge) and discharge disability (any level of disability compared with none).
   Results: The leading mechanisms of injury were road traffic (26.1%), struck by objects (22.1%), cut/pierce (19.2%), falls (19.2%), and burns (5.4%). Injuries most commonly occurred in the home (36.7%) and on the road (33.2%). For those aged 19-44, the proportion of injuries due to assault was higher for females (35.9%) than males (29.7%). Males had increased odds for admission (aOR = 1.48 95% CI = 1.15-1.91) and for disability (aOR = 1.45; 95% CI = 1.06-1.99). Increased odds for admission were found for brain injuries, fractures, large system injuries, and musculoskeletal injuries when compared with soft tissue injuries. The highest odds for any level of discharge disability were found for brain injuries, fractures, injuries from falls, burns, and road traffic.
   Conclusions: Epidemiology of injuries in The Gambia is similar to other low-income countries. However, the magnitude of cases and issues uncovered highlights the need for a formal registry. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Sanyang, Edrisa; Bass, Paul] Univ Gambia, Sch Med & Allied Hlth Sci, Dept Publ & Environm Hlth, Brikama, Gambia.
   [Sanyang, Edrisa; Peek-Asa, Corinne; Young, Tracy L.] Univ Iowa, Coll Publ Hlth, Injury Prevent & Res Ctr, Iowa City, IA USA.
   [Jagne, Abubacarr] Edward Francis Small Teaching Hosp, Emergency Dept, Banjul, Gambia.
   [Njie, Baba] Serrekunda Gen Hosp, Emergency Dept, Kanifing, Gambia.
RP Sanyang, E (reprint author), Univ Gambia, Sch Med & Allied Hlth Sci, Dept Publ & Environm Hlth, Brikama, Gambia.
EM edrisasanyang@gmail.com
FU World Bank Global Road Safety Facility grant; CDC/NCIPC-Injury
   Prevention Research Center [NCIPC R49CE002108]; NIH/Fogarty [NIH
   5D43TW007261]
FX This work was supported by World Bank Global Road Safety Facility grant
   to the Road Traffic Injury Research Network (RTIRN), the
   CDC/NCIPC-funded Injury Prevention Research Center (NCIPC R49CE002108)
   and the NIH/Fogarty-funded International Trauma and Injury Prevention
   Training Program (NIH 5D43TW007261). None of the sponsors were involved
   in the study design; collection, analysis and interpretation of data;
   writing of the manuscript; and the decision to submit the manuscript for
   publication.
CR Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007
   Center for Disease Control and Prevention, LINK PLUS VERS 2 0 S
   Edirisinghe PAS, 2014, J FORENSIC LEG MED, V27, P9, DOI 10.1016/j.jflm.2014.07.002
   Edward Francis Small Teaching Hospital, 2015, ANN REPORT
   Gal M, 2012, EUR J EMERG MED, V19, P146, DOI 10.1097/MEJ.0b013e32834ada2e
   Gambia Bureau of Statistics, GAMB 2013 POP HOUS C
   Government of The Gambia, SERV STAT REP 2014
   Iddriss A, 2011, EMERGENCY ANAESTHETI
   Juillard CJ, 2014, WORLD J SURG, V38, P2534, DOI 10.1007/s00268-014-2604-1
   Krug E., ROAD TRAFFIC INJURIE
   Mock CN, 2003, DISABIL REHABIL, V25, P732, DOI 10.1080/0963828031000090524
   Rani Manju, 2004, Afr J Reprod Health, V8, P116, DOI 10.2307/3583398
   Ribeiro WS, PLOS ONE
   Saidi Hassan, 2014, J Trauma Manag Outcomes, V8, P4, DOI 10.1186/1752-2897-8-4
   Serrekunda General Hospital, 2015, ANN REPORT
   WHO, 2013, GLOB STAT REP ROAD S
   World Health Organization, GLOB STAT REP ROAD S
NR 17
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUL
PY 2017
VL 48
IS 7
BP 1451
EP 1458
DI 10.1016/j.injury.2017.03.048
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA FB2TW
UT WOS:000405997100027
PM 28408082
OA No
DA 2017-08-15
ER

PT J
AU Natamba, BK
   Meta, S
   Achan, J
   Stoltzfus, RJ
   Griffiths, JK
   Young, SL
AF Natamba, Barnabas K.
   Meta, Saurabh
   Achan, Jane
   Stoltzfus, Rebecca J.
   Griffiths, Jeffrey K.
   Young, Sera L.
TI "Breastfeeding" without baby: A longitudinal, qualitative investigation
   of how mothers perceive, feel about, and practice human milk expression
   Response
SO MATERNAL AND CHILD NUTRITION
LA English
DT Letter
ID POSTPARTUM DEPRESSION; FOOD INSECURITY; SOCIAL SUPPORT; WOMEN
C1 [Natamba, Barnabas K.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA.
   [Natamba, Barnabas K.] Gulu Univ, Fac Med, Dept Publ Hlth, Gulu, Uganda.
   [Meta, Saurabh; Stoltzfus, Rebecca J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Achan, Jane] MRC, Dis Control & Eliminat Theme, Banjul, Gambia.
   [Griffiths, Jeffrey K.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Feed Future Innovat Lab Nutr, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Dept Publ Hlth & Community Med, Sch Med, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Dept Publ Hlth & Community Med, Sch Vet Med, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Sch Nutr, Dept Publ Hlth & Community Med, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Sch Engn, Dept Publ Hlth & Community Med, Medford, MA 02155 USA.
   [Young, Sera L.] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA.
RP Natamba, BK (reprint author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA.; Natamba, BK (reprint author), Gulu Univ, Fac Med, Dept Publ Hlth, Gulu, Uganda.
EM natamba@hsph.harvard.edu
CR BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006
   Chatzi L, 2011, PUBLIC HEALTH NUTR, V14, P1663, DOI 10.1017/S1368980010003629
   FAO, 2008, INTR BAS CONC FOOD S
   Food and Agriculture Organization (FAO), 2012, STATE FOOD INWORLD
   HELLAND IS, 1987, BIOMETRICS, V43, P61, DOI 10.2307/2531949
   Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617
   KENDLER KS, 1993, AM J PSYCHIAT, V150, P1139
   Kollannoor-Samuel G, 2011, J IMMIGR MINOR HEALT, V13, P982, DOI 10.1007/s10903-011-9499-9
   Natamba BK, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12351
   Natamba BK, 2015, PUBLIC HEALTH NUTR, V18, P2895, DOI 10.1017/S1368980014001669
   Natamba BK, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0303-y
   OHARA MW, 1984, J ABNORM PSYCHOL, V93, P158, DOI 10.1037/0021-843X.93.2.158
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033
   VanderWeele T., 2015, EXPLANATION CAUSAL I, DOI [10.4324/9780203470855_chapter_3, DOI 10.4324/9780203470855_CHAPTER_3]
NR 16
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1740-8695
EI 1740-8709
J9 MATERN CHILD NUTR
JI Matern. Child Nutr.
PD JUL
PY 2017
VL 13
IS 3
AR e12427
DI 10.1111/mcn.12427
PG 2
WC Nutrition & Dietetics; Pediatrics
SC Nutrition & Dietetics; Pediatrics
GA EZ2GX
UT WOS:000404528900037
OA No
DA 2017-08-15
ER

PT J
AU Natamba, BK
   Mehta, S
   Achan, J
   Stoltzfus, RJ
   Griffiths, JK
   Young, SL
AF Natamba, Barnabas K.
   Mehta, Saurabh
   Achan, Jane
   Stoltzfus, Rebecca J.
   Griffiths, Jeffrey K.
   Young, Sera L.
TI The association between food insecurity and depressive symptoms severity
   among pregnant women differs by social support category: a
   cross-sectional study
SO MATERNAL AND CHILD NUTRITION
LA English
DT Article
DE food insecurity; depressive symptoms; social support; CES-D; IFIAS;
   pregnant women; Uganda; Africa
ID COMMON MENTAL-DISORDERS; LOW-BIRTH-WEIGHT; POSTNATAL DEPRESSION;
   MATERNAL DEPRESSION; NEONATAL OUTCOMES; HIV; ANXIETY; STRESS; HEALTH;
   IMPACT
AB Common mental disorders, such as depression and anxiety, affect approximately 16% of pregnant women in low- and middle-income countries. Food insecurity (FI) has been shown to be associated with depressive symptoms. It has also been suggested that the association between FI and depressive symptoms is moderated by social support (SS); however, there is limited evidence of these associations among pregnant women living in low-income and middle-income countries. We studied the association between FI and depressive symptoms severity and assessed whether such an association varied among Ugandan pregnant women with low vs. high SS. Cross-sectional data were collected among 403 pregnant women in northern Uganda. SS was assessed using an eight-item version of the Duke-UNC functional SS scale. FI and depressive symptoms were assessed by, respectively, the individually focused FI scale and the Center for Epidemiologic Studies-Depression scale. Women were categorized into two SS groups, based on scoring < or to the median SS value. Multivariate linear regression models indicated an independent association between FI and depressive symptoms severity. The association between FI and depressive symptoms severity was moderated by SS i.e. was stronger among women in the low SS category (adjusted beta (95%CI): 0.91 (0.55; 1.27)) than for women belonging to the high SS group (0.53 (0.28; 0.78)) (adjusted p value for interaction=0.026). There is need for longitudinal or interventional studies among pregnant women living in northern Uganda or similar contexts to examine the temporal sequence of the associations among food insecurity, depressive symptoms severity and social support. (c) 2016 John Wiley & Sons Ltd
C1 [Natamba, Barnabas K.] Harvard Univ, Dept Epidemiol, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.
   [Natamba, Barnabas K.] Gulu Univ, Dept Publ Hlth, Fac Med, Gulu, Uganda.
   [Mehta, Saurabh; Stoltzfus, Rebecca J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Achan, Jane] MRC, Dis Control & Eliminat Theme, Banjul, Gambia.
   [Griffiths, Jeffrey K.] Tufts Univ, Feed Future Innovat Lab Nutr, Friedman Sch Nutr Sci & Policy, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Dept Publ Hlth & Community Med, Sch Med, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Dept Publ Hlth & Community Med, Sch Vet Med, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Sch Nutr, Dept Publ Hlth & Community Med, Medford, MA 02155 USA.
   [Griffiths, Jeffrey K.] Tufts Univ, Sch Engn, Dept Publ Hlth & Community Med, Medford, MA 02155 USA.
   [Young, Sera L.] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA.
RP Natamba, BK (reprint author), Harvard Univ, Dept Epidemiol, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.
EM natamba@hsph.harvard.edu
FU USAID Feed the Future Innovations Laboratory for Collaborative Research
   in Nutrition for Africa [AID-OAA-L-10-00006]; National Institute of
   Mental Health (NIMH) [K01 MH098902]
FX USAID Feed the Future Innovations Laboratory for Collaborative Research
   in Nutrition for Africa funded this study (Award Number
   AID-OAA-L-10-00006). SLY was supported by K01 MH098902 from the National
   Institute of Mental Health (NIMH). The content in this paper is solely
   the responsibility of the authors and does not necessarily represent the
   official views of USAID, or NIMH.
CR Anema A, 2014, AIDS BEHAV, V18, pS476, DOI 10.1007/s10461-013-0659-x
   Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318
   Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001
   Avan B, 2010, ARCH DIS CHILD, V95, P690, DOI 10.1136/adc.2009.164848
   Bolak Boratav H., 2015, POSTPARTUM DEPRESSIO, P1
   BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006
   Coates J, 2007, HOUSEHOLD FOOD INSEC
   COBB S, 1976, PSYCHOSOM MED, V38, P300
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310
   Cook JT, 2004, J NUTR, V134, P1432
   DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x
   FAO WFP IFAD, 2012, STAT FOOD INS WORLD
   Ferri CP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-209
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292
   Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850
   Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x
   Hromi-Fiedler A, 2011, MATERN CHILD NUTR, V7, P421, DOI 10.1111/j.1740-8709.2010.00266.x
   Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617
   Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573
   Kapulsky L., 2014, J IMMIGR MINOR HEALT, V17, P408
   Kollannoor-Samuel G, 2011, J IMMIGR MINOR HEALT, V13, P982, DOI 10.1007/s10903-011-9499-9
   Langford CPH, 1997, J ADV NURS, V25, P95, DOI 10.1046/j.1365-2648.1997.1997025095.x
   Laraia BA, 2010, J AM DIET ASSOC, V110, P692, DOI 10.1016/j.jada.2010.02.014
   MoH, 2012, INT NAT GUID ANT THE
   Nasreen HE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-515
   Natamba BK, 2015, PUBLIC HEALTH NUTR, V18, P2895, DOI 10.1017/S1368980014001669
   Natamba BK, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0303-y
   Olson C. M., 2005, Topics in Clinical Nutrition, V20, P321
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946
   Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Siu BWM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-22
   Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x
   Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157
   Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033
   Tsai AC, 2010, ARCH GEN PSYCHIAT, V67, P1282, DOI 10.1001/archgenpsychiatry.2010.160
   UBOS, 2010, UG NAT PAN SURV 2009
   Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070
   Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239
   World Health Orgnization, 2012, PROGR UPD US ANT DRU
   Yazici E, 2015, NEUROPSYCH DIS TREAT, V11, P405, DOI 10.2147/NDT.S77194
NR 42
TC 3
Z9 3
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1740-8695
EI 1740-8709
J9 MATERN CHILD NUTR
JI Matern. Child Nutr.
PD JUL
PY 2017
VL 13
IS 3
AR e12351
DI 10.1111/mcn.12351
PG 11
WC Nutrition & Dietetics; Pediatrics
SC Nutrition & Dietetics; Pediatrics
GA EZ2GX
UT WOS:000404528900016
OA No
DA 2017-08-15
ER

PT J
AU Heath, PT
   Culley, FJ
   Jones, CE
   Kampmann, B
   Le Doare, K
   Nunes, MC
   Sadarangani, M
   Chaudhry, Z
   Baker, CJ
   Openshaw, PJM
AF Heath, Paul T.
   Culley, Fiona J.
   Jones, Christine E.
   Kampmann, Beate
   Le Doare, Kirsty
   Nunes, Marta C.
   Sadarangani, Manish
   Chaudhry, Zain
   Baker, Carol J.
   Openshaw, Peter J. M.
TI Group B streptococcus and respiratory syncytial virus immunisation
   during pregnancy: a landscape analysis
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID TRANSPLACENTAL ANTIBODY TRANSFER; TOXOID CONJUGATE VACCINE; MATERNAL
   ANTIBODIES; IMMUNE-RESPONSE; NEUTRALIZING ANTIBODIES; NEONATAL
   IMMUNIZATION; INVASIVE DISEASE; YOUNG-CHILDREN; HEALTHY WOMEN;
   RISK-FACTORS
AB Group B streptococcus and respiratory syncytial virus are leading causes of infant morbidity and mortality worldwide. No licensed vaccines are available for either disease, but vaccines for both are under development. Severe respiratory syncytial virus disease can be prevented by passively administered antibody. The presence of maternal IgG antibody specific to respiratory syncytial virus is associated with reduced prevalence and severity of respiratory syncytial virus disease in the first few weeks of life, whereas maternal serotype-specific anticapsular antibody is associated with protection against both early-onset and late-onset group B streptococcus disease. Therefore, vaccination in pregnancy might protect infants against both diseases. This report describes what is known about immune protection against group B streptococcus and respiratory syncytial virus, identifies knowledge gaps regarding the immunobiology of both diseases, and aims to prioritise research directions in maternal immunisation.
C1 [Heath, Paul T.; Le Doare, Kirsty] St Georges Univ London, Vaccine Inst, Inst Infect & Immun, London SW17 0RE, England.
   [Heath, Paul T.; Le Doare, Kirsty] St Georges Univ Hosp NHS Fdn Trust, London, England.
   [Culley, Fiona J.; Chaudhry, Zain; Openshaw, Peter J. M.] Imperial Coll London, Resp Med, Natl Heart & Lung Inst, London, England.
   [Jones, Christine E.] Univ Southampton, Fac Med, Southampton, Hants, England.
   [Jones, Christine E.] Univ Southampton, Inst Life Sci, Southampton, Hants, England.
   [Jones, Christine E.] Univ Hosp Southampton NHS Fdn Trust, Inst Life Sci, Southampton, Hants, England.
   [Kampmann, Beate; Le Doare, Kirsty] Imperial Coll London, Ctr Int Child Hlth, Dept Paediat, London, England.
   [Kampmann, Beate] MRC Unit, Serrekunda, Gambia.
   [Nunes, Marta C.] Univ Witwatersrand, Fac Hlth Sci, Dept Sci & Technol, Johannesburg, South Africa.
   [Nunes, Marta C.] Univ Witwatersrand, Fac Hlth Sci, Natl Res Fdn, Vaccine Preventable Dis, Johannesburg, South Africa.
   [Nunes, Marta C.] Univ Witwatersrand, Fac Hlth Sci, MRC, Johannesburg, South Africa.
   [Nunes, Marta C.] Univ Witwatersrand, Fac Hlth Sci, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Sadarangani, Manish] Univ Oxford, Dept Paediat, Oxford, England.
   [Sadarangani, Manish] Univ British Columbia, Vaccine Evaluat Ctr, BC Childrens Hosp, Res Inst, Vancouver, BC, Canada.
   [Baker, Carol J.] Baylor Coll Med, Dept Pediat Mol Virol & Microbiol, Houston, TX 77030 USA.
RP Heath, PT (reprint author), St Georges Univ London, Vaccine Inst, Inst Infect & Immun, London SW17 0RE, England.
EM pheath@sgul.ac.uk
FU Wellcome Trust; Rosetrees Trust; Stoneygate Trust; Medical Research
   Council; Comprehensive Local Research Network (CLRN); National Institute
   for Health Research (NIHR); Biomedical Research Centre (BRC) at Imperial
   College London
FX We thank Denise Gardner for assistance in compiling our literature
   survey; The Wellcome Trust, The Rosetrees Trust, The Stoneygate Trust,
   The Medical Research Council, the Comprehensive Local Research Network
   (CLRN), the National Institute for Health Research (NIHR), and
   Biomedical Research Centre (BRC) at Imperial College London for
   financial support; and Charles Sande, Janet Englund, Max Habibi, Chris
   Chiu, Trevor Hansel, Laura Lambert, and Tony Piedra for discussions and
   helpful suggestions.
CR Abu Raya B, 2017, LANCET INFECT DIS
   Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3
   ANDERSON DC, 1983, PEDIATR RES, V17, P496, DOI 10.1203/00006450-198306000-00015
   Baker CJ, 2014, J INFECT DIS, V209, P781, DOI 10.1093/infdis/jit549
   Baker CJ, 1999, J INFECT DIS, V179, P142, DOI 10.1086/314574
   Baker CJ, 2004, J INFECT DIS, V189, P1103, DOI 10.1086/382193
   Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0
   Baker CJ, 2003, J INFECT DIS, V188, P66, DOI 10.1086/375536
   BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404
   Baker CJ, 2000, J INFECT DIS, V182, P1129, DOI 10.1086/315839
   BANGHAM CRM, 1986, IMMUNOLOGY, V59, P37
   BEACHLER CW, 1979, AM J OBSTET GYNECOL, V133, P171
   Bedford H, 2001, BRIT MED J, V323, P533, DOI 10.1136/bmj.323.7312.533
   Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3
   Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605
   Bergeron MG, 2000, NEW ENGL J MED, V343, P175, DOI 10.1056/NEJM200007203430303
   Blanchard-Rohner G, 2013, PEDIATR INFECT DIS J, V32, P768, DOI 10.1097/INF.0b013e318292f425
   Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917
   Blanken MO, 2013, NEW ENGL J MED, V369, P782, DOI [10.1056/NEJMc1307429, 10.1056/NEJMc1307429#SA1]
   Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1<97::AID-JMV16>3.0.CO;2-Y
   Brandt C, 1997, J INFECT DIS, V176, P884
   Brigtsen AK, 2002, J INFECT DIS, V185, P1277, DOI 10.1086/340324
   Bulkow LR, 2002, PEDIATRICS, V109, P210, DOI 10.1542/peds.109.2.210
   Buraphacheep W, 1997, J INFECT DIS, V175, P935, DOI 10.1086/513994
   Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316
   Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3<234::AID-JMV9>3.0.CO;2-2
   Crowe JE, 2001, CLIN INFECT DIS, V33, P1720, DOI 10.1086/322971
   Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943
   Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562
   Dagnew AF, 2012, CLIN INFECT DIS, V55, P91, DOI 10.1093/cid/cis395
   Daly KA, 2014, VACCINE, V32, P6948, DOI 10.1016/j.vaccine.2014.10.060
   Dangor Z, 2015, J INFECT DIS, V212, P453, DOI 10.1093/infdis/jiv064
   Dangor Z, 2015, EXPERT REV VACCINES, V14, P135, DOI 10.1586/14760584.2014.953939
   DESIERRA TM, 1993, J PEDIATR-US, V122, P787, DOI 10.1016/S0022-3476(06)80027-2
   Dhariwal J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135363
   Dixon DL, 2010, PEDIAT ALLERG IMM-UK, V21, pE691, DOI 10.1111/j.1399-3038.2010.01011.x
   Donders GGG, 2016, OBSTET GYNECOL, V127, P213, DOI 10.1097/AOG.0000000000001190
   Dunn SR, 2013, CLIN VACCINE IMMUNOL, V20, P1654, DOI 10.1128/CVI.00750-12
   Eberhardt CS, 2016, CLIN INFECT DIS, V62, P829, DOI 10.1093/cid/ciw027
   Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6
   Edwards KM, 2015, VACCINE, V33, P6469, DOI 10.1016/j.vaccine.2015.07.085
   Edwards MS, 2012, VACCINE, V30, P4123, DOI 10.1016/j.vaccine.2012.04.048
   Edwards MS, 2004, PEDIATR INFECT DIS J, V23, P961, DOI 10.1097/01.inf.0000142333.72511.8c
   Eick A, 2008, PEDIATR INFECT DIS J, V27, P207, DOI 10.1097/INF.0b013e31815ac585
   Feldman AS, 2015, AM J RESP CRIT CARE, V191, P34, DOI 10.1164/rccm.201405-0901PP
   Ferrieri P, 2013, EMERG INFECT DIS, V19, P551, DOI 10.3201/eid1904.121572
   FISHAUT M, 1981, J PEDIATR-US, V99, P186, DOI 10.1016/S0022-3476(81)80447-7
   Freitas GRO, 2011, J MED VIROL, V83, P1826, DOI 10.1002/jmv.22134
   Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346
   GLEZEN WP, 1981, J PEDIATR-US, V98, P708
   Gray KJ, 2007, EMERG INFECT DIS, V13, P223
   Gray KJ, 2011, EMERG INFECT DIS, V17, P1932, DOI 10.3201/eid1710.102008
   GRIFFITHS PD, 1982, J HYG-CAMBRIDGE, V89, P303
   Guvenel AK, 2014, EXPERT REV VACCINES, V13, P333, DOI 10.1586/14760584.2014.878653
   Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC
   Hagglund S, 2004, VACCINE, V23, P646, DOI 10.1016/j.vaccine.2004.07.006
   Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877
   Heath PT, 2009, ARCH DIS CHILD, V94, P674, DOI 10.1136/adc.2008.148874
   Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5
   HEIJTINK RA, 1977, J HYG-CAMBRIDGE, V78, P411
   HEIMAN HS, 1989, PEDIATR RES, V26, P629, DOI 10.1203/00006450-198912000-00023
   Heyderman RS, 2016, LANCET INFECT DIS, V16, P546, DOI 10.1016/S1473-3099(15)00484-3
   Hillier S, 2009, ANN M INF DIS SOC AM, P186
   HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135
   Houben ML, 2011, PEDIATRICS, V127, P35, DOI 10.1542/peds.2010-0581
   Jans J, 2014, REV MED VIROL, V24, P55, DOI 10.1002/rmv.1773
   Jones BG, 2014, VACCINE, V32, P3264, DOI 10.1016/j.vaccine.2014.03.088
   Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003
   Jones N, 2006, J CLIN PATHOL, V59, P363, DOI 10.1136/jcp.2005.029058
   Jordan HT, 2008, PEDIATR INFECT DIS J, V27, P1057, DOI 10.1097/INF.0b013e318180b3b9
   Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224
   KASEL J A, 1987, Viral Immunology, V1, P199, DOI 10.1089/vim.1987.1.199
   Kaspar DL, 1996, J CLIN INVEST, V98, P2308, DOI 10.1172/JCI119042
   Kasper DL, 1999, INFECT IMMUN, V67, P4303
   Kim SY, 2014, VACCINE, V32, P1954, DOI 10.1016/j.vaccine.2014.01.062
   KIMMAN TG, 1989, VET IMMUNOL IMMUNOP, V22, P145, DOI 10.1016/0165-2427(89)90057-3
   KIMMAN TG, 1987, J CLIN MICROBIOL, V25, P1097
   Kinyanjui TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138018
   Kwatra G, 2015, CLIN MICROBIOL INFEC, V21, pe13, DOI DOI 10.1016/J.CMI.2015.01.030
   Kwon YM, 2014, ANTIVIR RES, V104, P1, DOI 10.1016/j.antiviral.2014.01.008
   Ladhani SN, 2015, CLIN INFECT DIS, V61, P1637, DOI 10.1093/cid/civ695
   Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466
   Lancefield RC, 1934, J EXP MED, V59, P441, DOI 10.1084/jem.59.4.441
   Larsson C, 1999, VACCINE, V17, P454, DOI 10.1016/S0264-410X(98)00218-7
   Le Doare K, 2015, VACCINE, V33, P621, DOI 10.1016/j.vaccine.2014.12.025
   Le Saux N, 2003, PEDIATR INFECT DIS J, V22, P563, DOI 10.1097/00006454-200306000-00015
   Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453
   Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756
   Lin FYC, 2001, J INFECT DIS, V184, P1022, DOI 10.1086/323350
   Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814
   Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Madhi SA, 2013, VACCINE, V31, pD52, DOI 10.1016/j.vaccine.2013.02.029
   Marchant A, 2017, LANCET INFECT DIS
   Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564
   McGill A, 2004, J CLIN VIROL, V30, P73, DOI 10.1016/j.jcv.2003.09.013
   McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4
   McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914
   Meehan M, 2014, EUR J CLIN MICROBIOL, V33, P1155, DOI 10.1007/s10096-014-2055-5
   Meijboom MJ, 2012, VACCINE, V30, P4691, DOI 10.1016/j.vaccine.2012.04.072
   Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456
   Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9
   MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Nan C, 2015, BJOG-INT J OBSTET GY, V122, P1437, DOI 10.1111/1471-0528.13527
   NANDAPALAN N, 1987, J MED VIROL, V22, P277, DOI 10.1002/jmv.1890220312
   NANDAPALAN N, 1986, J MED VIROL, V20, P79, DOI 10.1002/jmv.1890200110
   Noh Y, 2013, VIRAL IMMUNOL, V26, P268, DOI 10.1089/vim.2012.0087
   Nolan T, 2015, CLIN INFECT DIS, V60, pE80, DOI 10.1093/cid/civ065
   Nyiro JU, 2015, VACCINE, V33, P1797, DOI 10.1016/j.vaccine.2015.02.039
   O'Brien KL, 2015, LANCET INFECT DIS, V15, P1398, DOI 10.1016/S1473-3099(15)00247-9
   Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088
   OGILVIE MM, 1981, J MED VIROL, V7, P263, DOI 10.1002/jmv.1890070403
   OGRA PL, 1983, ANN NY ACAD SCI, V409, P82, DOI 10.1111/j.1749-6632.1983.tb26861.x
   OKAMOTO Y, 1989, J IMMUNOL, V142, P2507
   Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808
   Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x
   OPENSHAW P, 1984, THORAX, V39, P624, DOI 10.1136/thx.39.8.624
   Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005
   Openshaw PJM, 2017, ANNU REV IMMUNOL, V35, P501, DOI 10.1146/annurev-immunol-051116-052206
   Oster G, 2014, VACCINE, V32, P4778, DOI 10.1016/j.vaccine.2014.06.003
   O'Sullivan C, 2016, ARCH DIS CHILD, V101, pA2
   [Anonymous], 1998, PEDIATRICS, V102, P531
   Paoletti LC, 2001, INFECT IMMUN, V69, P6696, DOI 10.1128/IAI.69.11.6696-6701.2001
   PARROTT RH, 1973, AM J EPIDEMIOL, V98, P289
   PERI BA, 1982, CLIN EXP IMMUNOL, V48, P91
   Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056
   Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4
   Pouwels KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163567
   PRINCE GA, 1979, INFECT IMMUN, V23, P723
   PRINCE GA, 1983, INFECT IMMUN, V42, P81
   Randis TM, 2014, J INFECT DIS, V210, P265, DOI 10.1093/infdis/jiu067
   Regnier SA, 2013, VACCINE, V31, P4347, DOI 10.1016/j.vaccine.2013.07.024
   Roberts JN, 2015, VACCINE, V33, P966, DOI 10.1016/j.vaccine.2014.12.068
   Roca A, 2002, J MED VIROL, V67, P616, DOI 10.1002/jmv.10148
   Salisbury D, 2001, J Paediatr Child Health, V37, pS34
   Sandbulte MR, 2002, VET IMMUNOL IMMUNOP, V84, P111, DOI 10.1016/S0165-2427(01)00393-2
   Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103
   Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205
   Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207
   Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460
   Siegrist CA, 1999, J INFECT DIS, V179, P1326, DOI 10.1086/314778
   Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6
   Simoes EAF, 2011, PEDIATR INFECT DIS J, V30, P778, DOI 10.1097/INF.0b013e318218ab9e
   Sommer Constanze, 2011, Open Microbiol J, V5, P144, DOI 10.2174/1874285801105010144
   Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P398, DOI 10.1016/j.jaci.2008.10.043
   Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053
   Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217
   SUFFIN SC, 1979, J IMMUNOL, V123, P10
   Surve MV, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005816
   Taylor G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5757
   Taylor G, 2013, CURR TOP MICROBIOL, V372, P327, DOI 10.1007/978-3-642-38919-1_16
   Thwaites CL, 2015, LANCET, V385, P362, DOI 10.1016/S0140-6736(14)60236-1
   Tien N, 2011, J MICROBIOL IMMUNOL, V44, P430, DOI 10.1016/j.jmii.2011.04.013
   TOMS GL, 1980, J MED VIROL, V5, P351, DOI 10.1002/1096-9071(1980)5:4<351::AID-JMV1890050412>3.0.CO;2-S
   TSUTSUMI H, 1989, J CLIN MICROBIOL, V27, P1949
   Uttenthal A, 2000, VET MICROBIOL, V76, P329, DOI 10.1016/S0378-1135(00)00261-3
   Valkenburg-van den Berg AW, 2009, ACTA OBSTET GYN SCAN, V88, P958, DOI 10.1080/00016340903176800
   van den Berg JP, 2010, PEDIATR INFECT DIS J, V29, P801, DOI 10.1097/INF.0b013e3181dc4f77
   van der Sluijs MTW, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-2
   Vangeel I, 2007, VET J, V174, P627, DOI 10.1016/j.tvjl.2006.10.013
   Vergnano S, 2010, ARCH DIS CHILD-FETAL, V95, pF72, DOI 10.1136/adc.2009.160333
   Vieira SE, 2007, CLINICS, V62, P709, DOI 10.1590/S1807-59322007000600009
   Vissers M, 2016, CLIN VACCINE IMMUNOL, V23, P243, DOI 10.1128/CVI.00590-15
   Vornhagen J, 2016, MBIO, V7, DOI 10.1128/mBio.00781-16
   Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x
   Weisner AM, 2004, CLIN INFECT DIS, V38, P1203, DOI 10.1086/382881
   Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753
   Wilczynski Jan, 1994, Acta Microbiologica Polonica, V43, P347
   WONG DT, 1986, J VIROL, V57, P1203
   YAMAZAKI H, 1994, J GEN VIROL, V75, P2115, DOI 10.1099/0022-1317-75-8-2115
   [Anonymous], 1996, MMWR RECOMM REP, V45, P1
NR 172
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2017
VL 17
IS 7
BP E223
EP E234
DI 10.1016/S1473-3099(17)30232-3
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA EY2TW
UT WOS:000403825500003
PM 28433702
OA No
DA 2017-08-15
ER

PT J
AU Marchant, A
   Sadarangani, M
   Garand, M
   Dauby, N
   Verhasselt, V
   Pereira, L
   Bjornson, G
   Jones, CE
   Halperin, SA
   Edwards, KM
   Heath, P
   Openshaw, PJ
   Scheifele, DW
   Kollmann, TR
AF Marchant, Arnaud
   Sadarangani, Manish
   Garand, Mathieu
   Dauby, Nicolas
   Verhasselt, Valerie
   Pereira, Lenore
   Bjornson, Gordean
   Jones, Christine E.
   Halperin, Scott A.
   Edwards, Kathryn M.
   Heath, Paul
   Openshaw, Peter J.
   Scheifele, David W.
   Kollmann, Tobias R.
TI Maternal immunisation: collaborating with mother nature
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID INFLUENZAE TYPE-B; TRANSPLACENTAL ANTIBODY TRANSFER; NEONATAL
   FC-RECEPTOR; PERTUSSIS TDAP IMMUNIZATION; TOXOID CONJUGATE VACCINE;
   MENINGITIDIS SEROGROUP C; FULL-TERM NEWBORNS; PREGNANT-WOMEN;
   BREAST-MILK; IMMUNE-RESPONSES
AB Maternal immunisation has the potential to substantially reduce morbidity and mortality from infectious diseases after birth. The success of tetanus, influenza, and pertussis immunisation during pregnancy has led to consideration of additional maternal immunisation strategies to prevent group B streptococcus and respiratory syncytial virus infections, among others. However, many gaps in knowledge regarding the immunobiology of maternal immunisation prevent the optimal design and application of this successful public health intervention. Therefore, we did an innovative landscape analysis to identify research priorities. Key topics were delineated through review of the published literature, consultation with vaccine developers and regulatory agencies, and a collaborative workshop that gathered experts across several maternal immunisation initiatives-group B streptococcus, respiratory syncytial virus, pertussis, and influenza. Finally, a global online survey prioritised the identified knowledge gaps on the basis of expert opinion about their importance and relevance. Here we present the results of this worldwide landscape analysis and discuss the identified research gaps.
C1 [Marchant, Arnaud; Dauby, Nicolas] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Brussels, Belgium.
   [Sadarangani, Manish] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.
   [Sadarangani, Manish; Scheifele, David W.; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Div Infect Dis, Vancouver, BC V5Z 4H4, Canada.
   [Sadarangani, Manish; Garand, Mathieu; Bjornson, Gordean; Scheifele, David W.; Kollmann, Tobias R.] Univ British Columbia, Vaccine Evaluat Ctr, Vancouver, BC, Canada.
   [Kollmann, Tobias R.] BC Childrens Hosp, Vancouver, BC, Canada.
   [Garand, Mathieu] MRC Unit, Vaccine & Immun Theme, Fajara, Gambia.
   [Dauby, Nicolas] Ctr Hosp Univ St Pierre, Dept Infect Dis, Brussels, Belgium.
   [Verhasselt, Valerie] Univ Western Australia, Fac Mol Sci, Perth, WA, Australia.
   [Pereira, Lenore] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Jones, Christine E.] St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England.
   [Heath, Paul] St Georges Univ London, Inst Infect & Immun, St Georges Vaccine Inst, London, England.
   [Halperin, Scott A.] Dalhousie Univ, Izaak Walton Killam Hlth Ctr, Canadian Ctr Vaccinol, Halifax, NS, Canada.
   [Halperin, Scott A.] Nova Scotia Hlth Author, Halifax, NS, Canada.
   [Edwards, Kathryn M.] Vanderbilt Univ, Sch Med, Dept Pediat, Vanderbilt Vaccine Res Program, Nashville, TN 37212 USA.
   [Openshaw, Peter J.] Imperial Coll London, Resp Med, Natl Heart & Lung Inst, London, England.
RP Marchant, A (reprint author), Univ Libre Bruxelles, Inst Med Immunol, B-6041 Brussels, Belgium.; Kollmann, TR (reprint author), Univ British Columbia, Dept Pediat, Div Infect Dis, Vancouver, BC V5Z 4H4, Canada.; Kollmann, TR (reprint author), BC Childrens Hosp, Vancouver, BC, Canada.
EM arnaud.marchant@ulb.ac.be; tkollm@mac.com
FU Bill & Melinda Gates Foundation; University of Sophia-Antipolis;
   Institut National de la Sante et de la Recherche Sante, France; Career
   Award in the Biomedical Sciences from the Burroughs Wellcome Fund;
   Michael Smith Foundation for Health Research Career Investigator Award
FX AM, DWS, and TRK received funding from the Bill & Melinda Gates
   Foundation to support this project. AM is a Research Director of the
   Fonds de la Recherche Scientifque, Belgium. MS was a co-investigator on
   investigator-initiated research grants from Pfizer outside of the
   submitted work. VV received funding from the University of
   Sophia-Antipolis and the Institut National de la Sante et de la
   Recherche Sante, France. SAH served on ad-hoc advisory boards for Sanofi
   Pasteur, GlaxoSmithKline, the Bill & Melinda Gates Foundation, and PATH.
   TRK is supported in part by a Career Award in the Biomedical Sciences
   from the Burroughs Wellcome Fund, and a Michael Smith Foundation for
   Health Research Career Investigator Award. All other authors declare no
   competing interests. The funders had no role in determining content of
   the manuscript, writing of the report, or the decision to submit for
   publication.
CR Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961
   Abu Raya B, 2015, VACCINE, V33, P1948, DOI 10.1016/j.vaccine.2015.02.059
   Abu-Raya B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00338
   Abu Raya B, 2017, LANCET INFECT DIS
   Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708
   Alain S, 2012, VACCINE, V30, P4921, DOI 10.1016/j.vaccine.2012.05.047
   AMINO N, 1978, OBSTET GYNECOL, V52, P415
   Ampomah P, 2014, J IMMUNOL, V192, P5236, DOI 10.4049/jimmunol.1400325
   Atwell JE, 2016, J INFECT DIS, V213, P423, DOI 10.1093/infdis/jiv401
   Avanzini MA, 1998, ACTA PAEDIATR, V87, P180, DOI 10.1080/08035259850157633
   Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418
   Baker CJ, 2014, J INFECT DIS, V209, P781, DOI 10.1093/infdis/jit549
   Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0
   Baker K, 2009, SEMIN IMMUNOPATHOL, V31, P223, DOI 10.1007/s00281-009-0160-9
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   BARINGTON T, 1994, INFECT IMMUN, V62, P9
   Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708
   Bischoff AL, 2015, PEDIATR INFECT DIS J, V34, P84, DOI 10.1097/INF.0000000000000529
   Bischoff AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056700
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Bondt A, 2014, MOL CELL PROTEOMICS, V13, P3029, DOI 10.1074/mcp.M114.039537
   Bondt A, 2013, J PROTEOME RES, V12, P4522, DOI 10.1021/pr400589m
   BRABIN BJ, 1984, B WORLD HEALTH ORGAN, V62, P919
   Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4
   Brussow H, 1996, CLIN DIAGN LAB IMMUN, V3, P37
   Bundhoo A, 2015, CLIN EXP ALLERGY, V45, P1085, DOI 10.1111/cea.12508
   Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926
   Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652
   Cavalcante RS, 2008, BRAZ J INFECT DIS, V12, P47, DOI 10.1590/S1413-86702008000100011
   Christian LM, 2013, AM J REPROD IMMUNOL, V70, P45, DOI 10.1111/aji.12117
   Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316
   Correale J, 2014, J NEUROIMMUNOL, V269, P76, DOI 10.1016/j.jneuroim.2014.02.007
   Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185
   Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845
   Dabrera G, 2015, CLIN INFECT DIS, V60, P333, DOI 10.1093/cid/ciu821
   Dangor Z, 2015, J INFECT DIS, V212, P453, DOI 10.1093/infdis/jiv064
   Dauby N, 2014, J INFECT DIS, V210, P1275, DOI 10.1093/infdis/jiu255
   de Voer RM, 2009, CLIN INFECT DIS, V49, P58, DOI 10.1086/599347
   Della Bella S, 2011, CLIN EXP IMMUNOL, V164, P180, DOI 10.1111/j.1365-2249.2011.04330.x
   Eberhardt CS, 2016, CLIN INFECT DIS, V62, P829, DOI 10.1093/cid/ciw027
   Edwards KM, 2003, VACCINE, V21, P3483, DOI 10.1016/S0264-410X(03)00356-6
   Edwards MS, 2004, PEDIATR INFECT DIS J, V23, P961, DOI 10.1097/01.inf.0000142333.72511.8c
   Ehlinger EP, 2011, J INFECT DIS, V204, P1672, DOI 10.1093/infdis/jir632
   Einarsdottir HK, 2013, GLYCOCONJUGATE J, V30, P147, DOI 10.1007/s10719-012-9381-6
   ENGLUND JA, 1995, PEDIATRICS, V96, P580
   ENGLUND JA, 1995, J INFECT DIS, V171, P99
   Faucette AN, 2015, HUM REPROD UPDATE, V21, P119, DOI 10.1093/humupd/dmu041
   Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993
   Fouda GGA, 2013, J VIROL, V87, P6986, DOI 10.1128/JVI.00528-13
   Gandhi M, 2015, J REPROD IMMUNOL, V112, P34, DOI 10.1016/j.jri.2015.06.003
   Gao XL, 2012, J PROTEOME RES, V11, P3897, DOI 10.1021/pr3004002
   GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667
   Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097
   GILL TJ, 1983, J CLIN INVEST, V72, P987, DOI 10.1172/JCI111071
   Gupta I, 2003, J OBSTET GYNAECOL RE, V29, P84
   Gutierrez G, 2005, CHEM IMMUNOL ALLERGY, V89, P158
   Hoang HTT, 2016, VACCINE, V34, P151, DOI 10.1016/j.vaccine.2015.10.098
   HARDEGREE M C, 1970, Bulletin of the World Health Organization, V43, P439
   Harris NL, 2006, J IMMUNOL, V177, P6256
   Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010
   Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242
   Healy CM, 2013, CLIN INFECT DIS, V56, P539, DOI 10.1093/cid/cis923
   Healy CM, 2004, J INFECT DIS, V190, P335, DOI 10.1086/421033
   Heath PT, 2017, LANCET INFECT DIS
   Heininger U, 2009, PEDIATR INFECT DIS J, V28, P443, DOI 10.1097/INF.0b013e318193ead7
   Heyderman RS, 2016, LANCET INFECT DIS, V16, P546, DOI 10.1016/S1473-3099(15)00484-3
   HULKA JF, 1964, OBSTET GYNECOL, V23, P830
   Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442
   Huygen K, 2015, VACCINE, V33, P4117, DOI 10.1016/j.vaccine.2015.06.108
   Islam SKN, 2006, PEDIATR INT, V48, P543, DOI 10.1111/j.1442-200X.2006.02291.x
   John-Stewart GC, 2009, J INFECT DIS, V199, P889, DOI 10.1086/597120
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Kanda N, 1999, J ALLERGY CLIN IMMUN, V103, P282, DOI 10.1016/S0091-6749(99)70503-8
   Kay AW, 2015, J INFECT DIS, V212, P861, DOI 10.1093/infdis/jiv138
   Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Kurikka S, 1996, PEDIATR INFECT DIS J, V15, P530, DOI 10.1097/00006454-199606000-00011
   Ladhani SN, 2015, CLIN INFECT DIS, V61, P1637, DOI 10.1093/cid/civ695
   Laenen J, 2015, VACCINE, V33, P2125, DOI 10.1016/j.vaccine.2015.03.020
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7
   Lawrence RM, 2004, CLIN PERINATOL, V31, P501, DOI 10.1016/j.clp.2004.03.019
   Le Doare K, 2016, AIDS, V30, P471, DOI 10.1097/QAD.0000000000000923
   Leineweber B, 2004, PEDIATR INFECT DIS J, V23, P361, DOI 10.1097/00006454-200404000-00019
   Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756
   Mabuka J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002739
   Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Maertens K, 2016, VACCINE, V34, P142, DOI 10.1016/j.vaccine.2015.10.100
   Maertens K, 2015, VACCINE, V33, P5489, DOI 10.1016/j.vaccine.2015.05.075
   Maertens K, 2014, VACCINE, V32, P1786, DOI 10.1016/j.vaccine.2014.01.083
   Mahan AE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005456
   Mahlokozera T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023735
   Mahmoud F, 2001, GYNECOL OBSTET INVES, V52, P232, DOI 10.1159/000052981
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Matthiesen L, 1999, AM J REPROD IMMUNOL, V41, P192
   MCGREGOR IA, 1970, CLIN EXP IMMUNOL, V7, P51
   McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11
   MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382
   MOHR JA, 1973, J PEDIATR-US, V82, P1062, DOI 10.1016/S0022-3476(73)80448-2
   Mooi FR, 2007, LANCET INFECT DIS, V7, P614, DOI 10.1016/s1473-3099(07)70113-5
   Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea
   MORRIS D, 1957, ARCH DIS CHILD, V32, P236
   Moussa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063408
   Mulholland K, 1996, JAMA-J AM MED ASSOC, V275, P1182
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Munoz FM, 2001, VACCINE, V20, P826, DOI 10.1016/S0264-410X(01)00397-8
   MURRAY DL, 1979, J CLIN MICROBIOL, V10, P184
   Nair N, 2007, J INFECT DIS, V196, P1339, DOI 10.1086/522519
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Nunes MC, 2015, J INFECT DIS, V212, P1976, DOI 10.1093/infdis/jiv339
   Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088
   OGRA SS, 1977, J IMMUNOL, V119, P245
   Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026
   Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521
   Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939
   Pollara J, 2015, J VIROL, V89, P9952, DOI 10.1128/JVI.01560-15
   Qureshi K, 2006, PEDIATR INFECT DIS J, V25, P1163, DOI 10.1097/01.inf.0000246977.58697.a5
   Rastogi D, 2007, J CLIN INVEST, V117, P1637, DOI 10.1172/JCI29466
   Regan AK, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0495-2
   Requena P, 2014, J IMMUNOL, V193, P2971, DOI 10.4049/jimmunol.1401037
   Rongsen-Chandola T, 2014, VACCINE, V32, pA134, DOI 10.1016/j.vaccine.2014.04.078
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   SARVAS H, 1993, J CLIN IMMUNOL, V13, P145, DOI 10.1007/BF00919271
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Schlaudecker EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070867
   Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592
   SCHLESINGER JJ, 1977, LANCET, V2, P529
   SENNHAUSER FH, 1990, PEDIATR RES, V27, P365, DOI 10.1203/00006450-199004000-00009
   Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847
   Siddiqua TJ, 2016, EUR J NUTR, V55, P281, DOI 10.1007/s00394-015-0845-x
   Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6
   Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
   Sperling RS, 2012, OBSTET GYNECOL, V119, P631, DOI 10.1097/AOG.0b013e318244ed20
   Stapleton NM, 2015, IMMUNOL REV, V268, P253, DOI 10.1111/imr.12331
   Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599
   Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107
   Ueda Y, 2003, HUM IMMUNOL, V64, P1144, DOI 10.1016/j.humimm.2003.08.342
   van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003
   van den Berg JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094714
   van den Berg JP, 2010, PEDIATR INFECT DIS J, V29, P801, DOI 10.1097/INF.0b013e3181dc4f77
   VANDERBEEKEN Y, 1985, AM J REPROD IM MIC, V8, P39
   VANSAVAGE J, 1990, J INFECT DIS, V161, P487
   Verhasselt V, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0139
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520
   VUKAVIC T, 1983, J PEDIATR GASTR NUTR, V2, P248, DOI 10.1097/00005176-198305000-00006
   Wan AKL, 2003, ORAL MICROBIOL IMMUN, V18, P72, DOI 10.1034/j.1399-302X.2003.00044.x
   Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110
   Wilks AB, 2010, J IMMUNOL, V185, P7097, DOI 10.4049/jimmunol.1002751
   Williams PJ, 1995, PLACENTA, V16, P749, DOI 10.1016/0143-4004(95)90018-7
   WIRT DP, 1992, CYTOMETRY, V13, P282, DOI 10.1002/cyto.990130310
   Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007
   Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821
   Yoshimura T, 2003, AM J REPROD IMMUNOL, V50, P137, DOI 10.1034/j.1600-0897.2003.00063.x
   Young BC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.037
   Zimmer JP, 1998, AM J REPROD IMMUNOL, V40, P57
   Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493
NR 159
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2017
VL 17
IS 7
BP E197
EP E208
DI 10.1016/S1473-3099(17)30229-3
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA EY2TW
UT WOS:000403825500001
PM 28433705
OA No
DA 2017-08-15
ER

PT J
AU Ruiz, L
   Espinosa-Martos, I
   Garcia-Carral, C
   Manzano, S
   McGuire, MK
   Meehan, CL
   McGuire, MA
   Williams, JE
   Foster, J
   Sellen, DW
   Kamau-Mbuthia, EW
   Kamundia, EW
   Mbugua, S
   Moore, SE
   Kvist, LJ
   Otoo, GE
   Lackey, KA
   Flores, K
   Pareja, RG
   Bode, L
   Rodriguez, JM
AF Ruiz, Lorena
   Espinosa-Martos, Irene
   Garcia-Carral, Cristina
   Manzano, Susana
   McGuire, Michelle K.
   Meehan, Courtney L.
   McGuire, Mark A.
   Williams, Janet E.
   Foster, James
   Sellen, Daniel W.
   Kamau-Mbuthia, Elizabeth W.
   Kamundia, Egidioh W.
   Mbugua, Samwel
   Moore, Sophie E.
   Kvist, Linda J.
   Otoo, Gloria E.
   Lackey, Kimberly A.
   Flores, Katherine
   Pareja, Rossina G.
   Bode, Lars
   Rodriguez, Juan M.
TI What's Normal? Immune Profiling of Human Milk from Healthy Women Living
   in Different Geographical and Socioeconomic Settings
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE breastfeeding; human milk; lactation; immunoglobulins; cytokines;
   chemokines; growth factors
ID GROWTH-FACTOR-BETA; HUMAN BREAST-MILK; FATTY-ACID-COMPOSITION; TGF-BETA;
   IMMUNOMODULATORY CONSTITUENTS; NECROTIZING ENTEROCOLITIS; NEONATAL
   TOLERANCE; FEEDING INFLUENCE; CYTOKINE PROFILE; ORAL TOLERANCE
AB Human milk provides a very wide range of nutrients and bioactive components, including immune factors, human milk oligosaccharides, and a commensal microbiota. These factors are essential for interconnected processes including immunity programming and the development of a normal infant gastrointestinal microbiome. Newborn immune protection mostly relies on maternal immune factors provided through milk. However, studies dealing with an in-depth profiling of the different immune compounds present in human milk and with the assessment of their natural variation in healthy women from different populations are scarce. In this context, the objective of this work was the detection and quantification of a wide array of immune compounds, including innate immunity factors (IL1 beta, IL6, IL12, INF gamma, TNF alpha), acquired immunity factors (IL2, IL4, IL10, IL13, IL17), chemokines (IL8, Groa, MCP1, MIP1 beta), growth factors [IL5, IL7, epidermal growth factor (EGF), granulocyte colony-stimulating factor, granulocyte-macrophage colony- stimulating factor, TGF beta 2], and immunoglobulins (IgA, IgG, IgM), in milk produced by healthy women of different ethnicities living in different geographic, dietary, socioeconomic, and environmental settings. Among the analyzed factors, IgA, IgG, IgM, EGF, TGF beta 2, IL7, IL8, Groa, and MIP1 beta were detected in all or most of the samples collected in each population and, therefore, this specific set of compounds might be considered as the "core" soluble immune factors in milk produced by healthy women worldwide. This approach may help define which immune factors are (or are not) common in milk produced by women living in various conditions, and to identify host, lifestyle, and environmental factors that affect the immunological composition of this complex biological fluid.
C1 [Ruiz, Lorena; Espinosa-Martos, Irene; Garcia-Carral, Cristina; Manzano, Susana; Rodriguez, Juan M.] Univ Complutense Madrid, Dept Nutr Food Sci & Food Technol, Madrid, Spain.
   [Espinosa-Martos, Irene] Probisearch SL, Tres Cantos, Spain.
   [McGuire, Mark A.; Lackey, Kimberly A.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.
   [McGuire, Michelle K.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
   [Meehan, Courtney L.; Flores, Katherine] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA.
   [McGuire, Mark A.; Williams, Janet E.] Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA.
   [Foster, James] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.
   [Sellen, Daniel W.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Kamau-Mbuthia, Elizabeth W.; Kamundia, Egidioh W.; Mbugua, Samwel] Egerton Univ, Dept Human Nutr, Nakuru, Kenya.
   [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England.
   [Moore, Sophie E.] MRC Unit, Serekunda, Gambia.
   [Kvist, Linda J.] Lund Univ, Fac Med, Lund, Sweden.
   [Otoo, Gloria E.] Univ Ghana, Dept Nutr & Food Sci, Accra, Ghana.
   [Pareja, Rossina G.] Inst Invest Nutr, Lima, Peru.
   [Bode, Lars] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
   [Bode, Lars] Univ Calif San Diego, Mother Milk Infant Ctr Res Excellence MoMICoRE, La Jolla, CA 92093 USA.
RP Ruiz, L; Espinosa-Martos, I; Rodriguez, JM (reprint author), Univ Complutense Madrid, Dept Nutr Food Sci & Food Technol, Madrid, Spain.; Espinosa-Martos, I (reprint author), Probisearch SL, Tres Cantos, Spain.
EM lorena.ruiz@ipla.csic.es; irenee70@gmail.com; jmrodrig@vet.ucm.es
FU National Science Foundation [1344288]; FP-7-PEOPLE-IEF, European
   Commission [624773]; Ministry of Economy and Competitiveness, Spain
   [AGL2013-4190-P]
FX This project was primarily funded by the National Science Foundation
   (award #1344288); in addition, sterile, single-use milk collection kits
   were kindly provided by Medela, Inc. (McHenry, IL, USA). LR (Spain) was
   funded by grant 624773 (FP-7-PEOPLE-2013-IEF, European Commission) and
   by project AGL2013-4190-P (Ministry of Economy and Competitiveness,
   Spain).
CR Andersen CJ, 2016, ADV NUTR, V7, P66, DOI 10.3945/an.115.010207
   Baldassarre ME, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110677
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Binns C, 2016, ASIA-PAC J PUBLIC HE, V28, P7, DOI 10.1177/1010539515624964
   Bloomfield SF, 2006, CLIN EXP ALLERGY, V36, P402, DOI 10.1111/j.1365-2222.2006.02463.x
   Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074
   Bottcher MF, 2000, PEDIATR RES, V47, P592
   Bourges D, 2008, MOL IMMUNOL, V45, P3354, DOI 10.1016/j.molimm.2008.04.017
   Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4
   Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014
   Brandtzaeg Per, 2007, P221, DOI 10.1007/978-0-387-72232-0_10
   Bryan DL, 2007, PEDIATR ALLERGY IMMU, V18, P495, DOI 10.1111/j.1399-3038.2007.00565.x
   Collado MC, 2015, NUTRIENTS, V7, P8577, DOI 10.3390/nu7105415
   Chollet-Hinton LS, 2014, BREASTFEED MED, V9, P530, DOI 10.1089/bfm.2014.0043
   Ciardelli L, 2007, INT J IMMUNOPATH PH, V20, P335
   Clark JA, 2005, AM J PHYSIOL-GASTR L, V288, pG755, DOI 10.1152/ajpgi.00172.2004
   Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006
   CONNOLLY JM, 1988, LIFE SCI, V42, P1751, DOI 10.1016/0024-3205(88)90041-0
   Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x
   Dill R, 2017, J MAMMARY GLAND BIOL, V22, P13, DOI 10.1007/s10911-016-9369-0
   Nguyen DN, 2014, AM J PHYSIOL-GASTR L, V307, pG689, DOI 10.1152/ajpgi.00193.2014
   Dunstan JA, 2004, CLIN EXP ALLERGY, V34, P1237, DOI 10.1111/j.1365-2222.2004.02028.x
   Dvorak B, 2010, J PEDIATR-US, V156, pS31, DOI 10.1016/j.jpeds.2009.11.018
   EBERT EC, 1995, GASTROENTEROLOGY, V109, P1154, DOI 10.1016/0016-5085(95)90573-1
   Espinosa-Martos I, 2016, BENEF MICROBES, V7, P305, DOI 10.3920/BM2015.0134
   Faria Ana M. C., 2006, Inflammation & Allergy Drug Targets, V5, P179
   Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001
   Garofalo R, 2010, J PEDIATR-US, V156, pS36, DOI 10.1016/j.jpeds.2009.11.019
   Garofalo RP, 1998, BIOL NEONATE, V74, P134, DOI 10.1159/000014019
   Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491
   Global Database BMI WHO, 2006, INT CLASS AD UND OV
   GOLDMAN AS, 1993, PEDIATR INFECT DIS J, V12, P664, DOI 10.1097/00006454-199308000-00008
   Gregory KE, 2013, CURR PEDIAT REP, V1, P1, DOI DOI 10.1007/S40124-013-0028-2
   Groer M, 2004, J HUM LACT, V20, P153, DOI 10.1177/0890334404264104
   Groer M, 2016, JOGNN-J OBST GYN NEO, V45, P639, DOI 10.1016/j.jogn.2016.04.009
   Hasselbalch H, 1999, EUR J PEDIATR, V158, P964, DOI 10.1007/s004310051258
   Hassiotou Foteini, 2013, Clin Transl Immunology, V2, pe3, DOI 10.1038/cti.2013.1
   Holmlund U, 2010, CLIN EXP IMMUNOL, V162, P500, DOI 10.1111/j.1365-2249.2010.04275.x
   Hoppu U, 2012, EUR J NUTR, V51, P211, DOI 10.1007/s00394-011-0209-0
   Ip S, 2009, BREASTFEED MED, V4, pS17, DOI 10.1089/bfm.2009.0050
   Ismail IH, 2013, PEDIAT ALLERG IMM-UK, V24, P352, DOI 10.1111/pai.12075
   Jakaitis BM, 2014, CLIN PERINATOL, V41, P423, DOI 10.1016/j.clp.2014.02.011
   Jarvinen KM, 2000, PEDIATR RES, V48, P457
   Jones M. K., 1999, Frontiers in Bioscience, V4, pD303
   Kainonen E, 2013, BRIT J NUTR, V109, P1962, DOI 10.1017/S0007114512004229
   Kalliomaki M, 1999, J ALLERGY CLIN IMMUN, V104, P1251, DOI 10.1016/S0091-6749(99)70021-7
   Kondo N, 2011, PEDIAT ALLERG IMM-UK, V22, P853, DOI 10.1111/j.1399-3038.2011.01194.x
   Kverka M, 2007, CLIN CHEM, V53, P955, DOI 10.1373/clinchem.2006.077107
   Labbok MH, 2004, NAT REV IMMUNOL, V4, P565, DOI 10.1038/nri1393
   Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002
   Linnamaa P, 2013, PEDIAT ALLERG IMM-UK, V24, P562, DOI 10.1111/pai.12110
   Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132
   Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41
   McGuire MK, 2017, AM J CLIN NUTR, V105, P1086, DOI 10.3945/ajcn.116.139980
   Mizuno K, 2012, J HUM LACT, V28, P529, DOI 10.1177/0890334412455946
   MORAN JR, 1983, J PEDIATR-US, V103, P402, DOI 10.1016/S0022-3476(83)80412-0
   Munblit D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110695
   Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18
   Ngom PT, 2004, AM J CLIN NUTR, V80, P722
   Nikniaz L, 2013, J HUM LACT, V29, P591, DOI 10.1177/0890334413490833
   Oddy WH, 2003, J ALLERGY CLIN IMMUN, V112, P723, DOI 10.1067/mai.2003.1747
   Olivares M, 2015, EUR J NUTR, V54, P119, DOI 10.1007/s00394-014-0692-1
   Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350
   Ortiz-Andrellucchi A, 2008, BRIT J NUTR, V100, P834, DOI 10.1017/S0007114508959183
   Penttila I, 2006, PEDIATR RES, V59, P650, DOI 10.1203/01.pdr.0000203149.75465.74
   Penttila IA, 2003, GUT, V52, P1579, DOI 10.1136/gut.52.11.1579
   Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010
   Penttila IA, 2010, J PEDIATR-US, V156, pS21, DOI 10.1016/j.jpeds.2009.11.016
   Polat A, 2016, BREASTFEED MED, V11, P247, DOI 10.1089/bfm.2015.0186
   Prescott SL, 2008, CLIN EXP ALLERGY, V38, P1606, DOI 10.1111/j.1365-2222.2008.03061.x
   Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024
   Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109
   Riskin A, 2012, PEDIATR RES, V71, P220, DOI 10.1038/pr.2011.34
   Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111
   U. S. Department of Health and Human Services, 2011, SURG GEN CALL ACT SU
   Savilahti E, 2005, PEDIATR RES, V58, P1300, DOI 10.1203/01.pdr.0000183784.87452.c6
   Smith KM, 2000, AM J RESP CRIT CARE, V162, pS175
   Srivastava MD, 1996, RES COMMUN MOL PATH, V93, P263
   SULLIVAN PB, 1991, LANCET, V338, P53, DOI 10.1016/0140-6736(91)90042-N
   Tomicic S, 2010, PEDIATR RES, V68, P330, DOI 10.1203/00006450-201011001-00646
   Trend S, 2016, BRIT J NUTR, V115, P1178, DOI 10.1017/S0007114516000234
   Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3
   Tsurumi Amy, 2016, Front Public Health, V4, P216
   Tuaillon E, 2017, PEDIATR RES, V81, P556, DOI 10.1038/pr.2016.220
   United Nations Development Program, 2015, WORK HUM DEV
   Urwin HJ, 2013, BRIT J NUTR, V109, P1949, DOI 10.1017/S0007114512004084
   Ustundag B, 2005, MEDIAT INFLAMM, P331, DOI 10.1155/MI.2005.331
   Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001
   Verhasselt V, 2010, CURR OPIN IMMUNOL, V22, P623, DOI 10.1016/j.coi.2010.08.008
   Verhasselt V, 2010, J PEDIATR-US, V156, pS16, DOI 10.1016/j.jpeds.2009.11.015
   Vries MHM, 2015, ANGIOGENESIS, V18, P163, DOI 10.1007/s10456-014-9454-1
   Warner Brad W, 2005, Semin Pediatr Surg, V14, P175, DOI 10.1053/j.sempedsurg.2005.05.006
   Yung SC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00276
NR 93
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUN 30
PY 2017
VL 8
AR 696
DI 10.3389/fimmu.2017.00696
PG 17
WC Immunology
SC Immunology
GA EZ3BC
UT WOS:000404583800001
OA gold
DA 2017-08-15
ER

PT J
AU Oyebola, KM
   Idowu, ET
   Olukosi, YA
   Awolola, TS
   Amambua-Ngwa, A
AF Oyebola, Kolapo M.
   Idowu, Emmanuel T.
   Olukosi, Yetunde A.
   Awolola, Taiwo S.
   Amambua-Ngwa, Alfred
TI Pooled-DNA sequencing identifies genomic regions of selection in
   Nigerian isolates of Plasmodium falciparum
SO PARASITES & VECTORS
LA English
DT Article
ID DRUG-RESISTANT MALARIA; POPULATION; ENDEMICITY; PARASITES
AB Background: The burden of falciparum malaria is especially high in sub-Saharan Africa. Differences in pressure from host immunity and antimalarial drugs lead to adaptive changes responsible for high level of genetic variations within and between the parasite populations. Population-specific genetic studies to survey for genes under positive or balancing selection resulting from drug pressure or host immunity will allow for refinement of interventions.
   Methods: We performed a pooled sequencing (pool-seq) of the genomes of 100 Plasmodium falciparum isolates from Nigeria. We explored allele-frequency based neutrality test (Tajima's D) and integrated haplotype score (iHS) to identify genes under selection.
   Results: Fourteen shared iHS regions that had at least 2 SNPs with a score > 2.5 were identified. These regions code for genes that were likely to have been under strong directional selection. Two of these genes were the chloroquine resistance transporter (CRT) on chromosome 7 and the multidrug resistance 1 (MDR1) on chromosome 5. There was a weak signature of selection in the dihydrofolate reductase (DHFR) gene on chromosome 4 and MDR5 genes on chromosome 13, with only 2 and 3 SNPs respectively identified within the iHS window. We observed strong selection pressure attributable to continued chloroquine and sulfadoxine-pyrimethamine use despite their official proscription for the treatment of uncomplicated malaria. There was also a major selective sweep on chromosome 6 which had 32 SNPs within the shared iHS region. Tajima's D of circumsporozoite protein (CSP), erythrocyte-binding antigen (EBA-175), merozoite surface proteins - MSP3 and MSP7, merozoite surface protein duffy binding-like (MSPDBL2) and serine repeat antigen (SERA-5) were 1.38, 1.29, 0.73, 0.84 and 0.21, respectively.
   Conclusion: We have demonstrated the use of pool-seq to understand genomic patterns of selection and variability in P. falciparum from Nigeria, which bears the highest burden of infections. This investigation identified known genomic signatures of selection from drug pressure and host immunity. This is evidence that P. falciparum populations explore common adaptive strategies that can be targeted for the development of new interventions.
C1 [Oyebola, Kolapo M.; Amambua-Ngwa, Alfred] Med Res Council Unit Gambia, Atlantic Rd, Fajara, Gambia.
   [Oyebola, Kolapo M.; Idowu, Emmanuel T.] Univ Lagos, Parasitol & Bioinformat, Dept Zool, Fac Sci, Lagos, Nigeria.
   [Oyebola, Kolapo M.; Olukosi, Yetunde A.; Awolola, Taiwo S.] Nigerian Inst Med Res, Lagos, Nigeria.
RP Amambua-Ngwa, A (reprint author), Med Res Council Unit Gambia, Atlantic Rd, Fajara, Gambia.
EM angwa@mrc.gm
FU MDR/DFID Career Development Fellowship from MRC Centre for Genomics and
   Global Health (CGGH) [1103-PF-PDN-GMSN]; Plasmodium Diversity Network in
   Africa Centenary Award from MRC Centre for Genomics and Global Health
   (CGGH) [1103-PF-PDN-GMSN]
FX This work was supported by the MDR/DFID Career Development Fellowship
   and Plasmodium Diversity Network in Africa Centenary Award
   (1103-PF-PDN-GMSN) from MRC Centre for Genomics and Global Health (CGGH)
   to AA-N.
CR Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992
   Chang HH, 2012, MOL BIOL EVOL, V29, P3427, DOI 10.1093/molbev/mss161
   Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Federal Ministry of Health. National Malaria Control Programme in Nigeria, 2005, ARG CITR IND, P1
   Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522
   Kublin JG, 2009, NATURE, V462, P315
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514
   Mackinnon MJ, 2004, PLOS BIOL, V2, P1286, DOI 10.1371/journal.pbio.0020230
   Mobegi VA, 2014, MOL BIOL EVOL, V31, P1490, DOI 10.1093/molbev/msu106
   Mobegi VA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-223
   Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924
   Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Omole M. K., 2010, African Journal of Biomedical Research, V13, P1
   Oyebola MK, 2012, MALARIA J, V13, P493
   Park DJ, 2012, P NATL ACAD SCI USA, V109, P13052, DOI 10.1073/pnas.1210585109
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   TAJIMA F, 1989, GENETICS, V123, P585
   Temu M J, 2006, Afr Health Sci, V6, P43
   Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41
   Veron V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-40
   Voight BF, 2006, PLOS BIOL, V10, pe72
   Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930
   Walliker D, 2005, ACTA TROP, V94, P251, DOI 10.1016/j.actatropica.2005.04.005
   Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001
   World Health Organization, 2015, WORLD MAL REP 2015
   Zhong DB, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-105
NR 29
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 29
PY 2017
VL 10
AR 320
DI 10.1186/s13071-017-2260-z
PG 7
WC Parasitology
SC Parasitology
GA FB1JS
UT WOS:000405900300004
PM 28662682
OA gold
DA 2017-08-15
ER

PT J
AU Soothill, G
   Darboe, S
   Bah, G
   Bolarinde, L
   Cunnington, A
   Anderson, S
AF Soothill, G.
   Darboe, S.
   Bah, G.
   Bolarinde, L.
   Cunnington, A.
   Anderson, S.
TI INVASIVE BACTERIAL INFECTIONS IN GAMBIAN PATIENTS WITH SICKLE CELL
   ANEMIA IN AN ERA OF WIDESPREAD PNEUMOCOCCAL AND HAEMOPHILUS INFLUENZA
   TYPE B VACCINATION
SO HAEMATOLOGICA
LA English
DT Meeting Abstract
CT 22nd Congress of the European-Hematology-Association
CY JUN 22-25, 2017
CL Madrid, SPAIN
SP European Hematol Assoc
C1 [Soothill, G.] Royal Free Hosp, London, England.
   [Darboe, S.; Bah, G.; Bolarinde, L.; Anderson, S.] MRC, Unit Gambia, Fajara, Gambia.
   [Cunnington, A.] Imperial Coll London, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FERRATA STORTI FOUNDATION
PI PAVIA
PA VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
SN 0390-6078
J9 HAEMATOLOGICA
JI Haematologica
PD JUN 26
PY 2017
VL 102
SU 2
MA E1487
BP 606
EP 606
PG 1
WC Hematology
SC Hematology
GA EY6XF
UT WOS:000404127004302
OA gold
DA 2017-08-15
ER

PT J
AU Zwang, J
   D'Alessandro, U
   Ndiaye, JL
   Djimde, AA
   Dorsey, G
   Martensson, AA
   Karema, C
   Olliaro, PL
AF Zwang, Julien
   D'Alessandro, Umberto
   Ndiaye, Jean-Louis
   Djimde, Abdoulaye A.
   Dorsey, Grant
   Martensson, Andreas A.
   Karema, Corine
   Olliaro, Piero L.
TI Haemoglobin changes and risk of anaemia following treatment for
   uncomplicated falciparum malaria in sub-Saharan Africa
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE P. Falciparum; Malaria; Artemisinin; Anaemia; Haemolysis; Artesunate;
   Amodiaquine; Sub-Saharan Africa
ID ARTESUNATE PLUS AMODIAQUINE; RANDOMIZED NON-INFERIORITY; FIXED-DOSE
   COMBINATIONS; PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE;
   ARTEMISININ DERIVATIVES; HEMATOLOGIC PARAMETERS; NIMBA COUNTY;
   OPEN-LABEL; CHILDREN
AB Background: Anaemia is common in malaria. It is important to quantitate the risk of anaemia and to distinguish factors related to the natural history of disease from potential drug toxicity.
   Methods: Individual-patient data analysis based on nine randomized controlled trials of treatments of uncomplicated falciparum malaria from 13 sub-Saharan African countries. Risk factors for reduced haemoglobin (Hb) concentrations and anaemia on presentation and after treatment were analysed using mixed effect models.
   Results: Eight thousand eight hundred ninety-seven patients (77.0% < 5 years-old) followed-up through 28 days treated with artemisinin combination therapy (ACT, 90%, n = 7968) or non-ACT. At baseline, under 5' s had the highest risk of anaemia (77.6% vs. 32.8%) and higher parasitaemia (43,938 mu l) than older subjects (2784 mu l). Baseline anaemia increased the risk of parasitological recurrence. Hb began to fall after treatment start. In under 5' s the estimated nadir was similar to 35 h (range 29-48), with a drop of -12.8% from baseline (from 9.8 g/dl to 8.7 g/dl, p = 0.001); in under 15's, the mean Hb decline between day 0-3 was -4.7% (from 9.4 to 9.0 g/dl, p = 0.001). The degree of Hb loss was greater in patients with high pre-treatment Hb and parasitaemia and with slower parasite reduction rates, and was unrelated to age. Subsequently, Hb increased linearly (+0.6%/day) until day 28, to reach + 13.8% compared to baseline. Severe anaemia (< 5 g/dl, 2 per 1000 patients) was transient and all patients recovered after day 14, except one case of very severe anaemia associated with parasite recurrence at day 28. There was no systematic difference in Hb concentrations between treatments and no case of delayed anaemia.
   Conclusion: On presentation with acute malaria young children with high parasitaemia have the highest risk of anaemia. The majority of patients experience a drop in Hb while on treatment as early as day 1-2, followed by a linear increase through follow-up. The degree of the early Hb dip is determined by pre-treatment parasitaemia and parasite clearance rates. Hb trends and rick of anaemia are independent of treatment.
C1 [D'Alessandro, Umberto] MRC Unit, Banjul, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [Ndiaye, Jean-Louis] Cheikh Anta Diop Univ, Dept Parasitol, Fac Med, Dakar, Senegal.
   [Djimde, Abdoulaye A.] Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali.
   [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Martensson, Andreas A.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
   [Martensson, Andreas A.] Uppsala Univ, IMCH, Dept Womens & Childrens Hlth, Uppsala, Sweden.
   [Karema, Corine] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Karema, Corine; Olliaro, Piero L.] Univ Basel, Basel, Switzerland.
   [Olliaro, Piero L.] Special Programme Res & Training Trop Dis WHO TDR, 20 Ave Appia, CH-1211 Geneva, Switzerland.
   [Olliaro, Piero L.] Univ Oxford, Churchill Hosp, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7LJ, England.
RP Olliaro, PL (reprint author), Univ Basel, Basel, Switzerland.; Olliaro, PL (reprint author), Special Programme Res & Training Trop Dis WHO TDR, 20 Ave Appia, CH-1211 Geneva, Switzerland.
EM olliarop@who.int
FU TDR (UNICEF/UNDP/WB/WHO Special Programme for Research & Training in
   Tropical Diseases); DNDi (Drugs for Neglected Diseases initiative);
   European and Developing Countries Clinical Trial Partnership (EDCTP)
   fellowship [2004.2.C.f1]; Sanofi Aventis [ARTEN-L-00848]
FX JZ received a grant from TDR (UNICEF/UNDP/WB/WHO Special Programme for
   Research & Training in Tropical Diseases) and DNDi (Drugs for Neglected
   Diseases initiative) to do this analysis. DNDi is an independent,
   not-for-profit product development partnership working to research and
   develop new and improved treatments for neglected diseases. DNDi
   sponsored two of the trials but had no role in the design and conduct of
   the analysis, interpretation of results of the manuscript.; The Mali
   study was supported by European and Developing Countries Clinical Trial
   Partnership (EDCTP) fellowship [Grant to AAD # 2004.2.C.f1] and by
   Sanofi Aventis [ARTEN-L-00848] who provided the monitoring services, the
   study insurance, the study drugs and the biological parameters
   assessment machines.
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4
   Bethell D, 2010, CLIN INFECT DIS, V51, pE105, DOI 10.1086/657402
   Bouyou-Akotet MK, 2013, J INFECT DEV COUNTR, V7, P983, DOI [10.3855/jidc.3347, 10.3855/jidc.3447]
   BROOKS MH, 1967, AM J MED, V43, P735, DOI 10.1016/0002-9343(67)90115-5
   Djimde AA, 2008, AM J TROP MED HYG, V78, P455
   Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210
   Finaurini S, 2010, TOXICOLOGY, V276, P128, DOI 10.1016/j.tox.2010.07.016
   Gasasira AF, 2008, CLIN INFECT DIS, V46, P985, DOI 10.1086/529192
   Jaureguiberry S, 2015, EMERG INFECT DIS, V21, P804, DOI 10.3201/eid2105.141171
   Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001
   Krystal JE, 2006, BLOOD, V107, P1192
   Maiga H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0557-y
   Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460
   Nambozi M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-220
   Ndiaye JL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-125
   Nji AM, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0521-2
   Oguche S, 2014, AM J TROP MED HYG, V91, P925, DOI 10.4269/ajtmh.13-0248
   Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4
   Olliaro P, 2011, AM J TROP MED HYG, V85, P619, DOI 10.4269/ajtmh.2011.11-0154
   Perkins DJ, 2011, INT J BIOL SCI, V7, P1427
   Rehman K, 2014, INT J INFECT DIS, V29, P268, DOI 10.1016/j.ijid.2014.09.007
   Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x
   Sagara I, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-358
   Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-250
   Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-251
   Sinclair D, 2009, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD007483.PUB2
   Sirima SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-48
   WHO, 2011, WHONMHNHDMNM111
   WHO, 2015, GUID TREATM MAL
   Zwang J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-114
   Zwang J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-25
NR 32
TC 0
Z9 0
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUN 23
PY 2017
VL 17
AR 443
DI 10.1186/s12879-017-2530-6
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA EY9SE
UT WOS:000404337500001
PM 28645255
OA gold
DA 2017-08-15
ER

PT J
AU Leffler, EM
   Band, G
   Busby, GBJ
   Kivinen, K
   Le, QS
   Clarke, GM
   Bojang, KA
   Conway, DJ
   Jallow, M
   Sisay-Joof, F
   Bougouma, EC
   Mangano, VD
   Modiano, D
   Sirima, SB
   Achidi, E
   Apinjoh, TO
   Marsh, K
   Ndila, CM
   Peshu, N
   Williams, TN
   Drakeley, C
   Manjurano, A
   Reyburn, H
   Riley, E
   Kachala, D
   Molyneux, M
   Nyirongo, V
   Taylor, T
   Thornton, N
   Tilley, L
   Grimsley, S
   Drury, E
   Stalker, J
   Cornelius, V
   Hubbart, C
   Jeffreys, AE
   Rowlands, K
   Rockett, KA
   Spencer, CCA
   Kwiatkowski, DP
AF Leffler, Ellen M.
   Band, Gavin
   Busby, George B. J.
   Kivinen, Katja
   Le, Quang Si
   Clarke, Geraldine M.
   Bojang, Kalifa A.
   Conway, David J.
   Jallow, Muminatou
   Sisay-Joof, Fatoumatta
   Bougouma, Edith C.
   Mangano, Valentina D.
   Modiano, David
   Sirima, Sodiomon B.
   Achidi, Eric
   Apinjoh, Tobias O.
   Marsh, Kevin
   Ndila, Carolyne M.
   Peshu, Norbert
   Williams, Thomas N.
   Drakeley, Chris
   Manjurano, Alphaxard
   Reyburn, Hugh
   Riley, Eleanor
   Kachala, David
   Molyneux, Malcolm
   Nyirongo, Vysaul
   Taylor, Terrie
   Thornton, Nicole
   Tilley, Louise
   Grimsley, Shane
   Drury, Eleanor
   Stalker, Jim
   Cornelius, Victoria
   Hubbart, Christina
   Jeffreys, Anna E.
   Rowlands, Kate
   Rockett, Kirk A.
   Spencer, Chris C. A.
   Kwiatkowski, Dominic P.
CA Malaria Genomic Epidemiology Netwo
TI Resistance to malaria through structural variation of red blood cell
   invasion receptors
SO SCIENCE
LA English
DT Article
C1 [Leffler, Ellen M.; Band, Gavin; Busby, George B. J.; Le, Quang Si; Clarke, Geraldine M.; Cornelius, Victoria; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Rockett, Kirk A.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.
   [Leffler, Ellen M.; Band, Gavin; Kivinen, Katja; Drury, Eleanor; Stalker, Jim; Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Bojang, Kalifa A.; Conway, David J.; Jallow, Muminatou; Sisay-Joof, Fatoumatta] MRC Unit, Atlant Blvd,Post Off Box 273, Fajara, Gambia.
   [Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England.
   [Jallow, Muminatou] Royal Victoria Teaching Hosp, Independence Dr, Post Off Box 1515, Banjul, Gambia.
   [Bougouma, Edith C.; Sirima, Sodiomon B.] CNRFP, 01 BP 2208 Ouagadougou 01, Ouagadougou, Burkina Faso.
   [Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Achidi, Eric] Univ Buea, Dept Med Lab Sci, Post Off Box 63, Buea, SW Region, Cameroon.
   [Apinjoh, Tobias O.] Univ Buea, Dept Biochem & Mol Biol, Post Off Box 63, Buea, SW Region, Cameroon.
   [Marsh, Kevin; Ndila, Carolyne M.; Peshu, Norbert; Williams, Thomas N.] KEMRI, Wellcome Trust Res Programme, Post Off Box 230-80108, Kilifi, Kenya.
   [Marsh, Kevin] Nuffield Dept Med, NDM Res Bldg,Roosevelt Dr, Oxford OX3 7FZ, England.
   [Williams, Thomas N.] Imperial Coll, Dept Med, Fac Med, Exhibit Road, London SW7 2AZ, England.
   [Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Post Off Box 2228, Moshi, Tanzania.
   [Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh; Riley, Eleanor] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.
   [Manjurano, Alphaxard] Mwanza Res Ctr, Natl Inst Med Res, Mwanza, Tanzania.
   [Kachala, David; Molyneux, Malcolm; Nyirongo, Vysaul] Queen Elizabeth Cent Hosp, Coll Med, Malawi Liverpool Wellcome Trust Clin Res, Post Off Box 30096, Blantyre 3, Malawi.
   [Molyneux, Malcolm] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Taylor, Terrie] Queen Elizabeth Cent Hosp, Blantyre Malaria Project, Coll Med, Post Off Box 30096, Blantyre 3, Malawi.
   [Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA.
   [Thornton, Nicole; Tilley, Louise; Grimsley, Shane] Int Blood Grp Reference Lab, Natl Hlth Serv NHS Blood & Transplant, 500 North Bristol Pk, Bristol BS34 7QH, Avon, England.
RP Spencer, CCA; Kwiatkowski, DP (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.; Kwiatkowski, DP (reprint author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
EM chris.spencer@well.ox.ac.uk; dominic.kwiatkowski@sanger.ac.uk
OI Busby, George/0000-0003-4148-6222; Band, Gavin/0000-0002-1710-9024;
   Conway, David/0000-0002-8711-3037
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 16
PY 2017
VL 356
IS 6343
AR eaam6393
DI 10.1126/science.aam6393
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX6BO
UT WOS:000403327400027
OA No
DA 2017-08-15
ER

PT J
AU Leffler, EM
   Band, G
   Busby, GBJ
   Kivinen, K
   Le, QS
   Clarke, GM
   Bojang, KA
   Conway, DJ
   Jallow, M
   Sisay-Joof, F
   Bougouma, EC
   Mangano, VD
   Modiano, D
   Sirima, SB
   Achidi, E
   Apinjoh, TO
   Marsh, K
   Ndila, CM
   Peshu, N
   Williams, TN
   Drakeley, C
   Manjurano, A
   Reyburn, H
   Riley, E
   Kachala, D
   Molyneux, M
   Nyirongo, V
   Taylor, T
   Thornton, N
   Tilley, L
   Grimsley, S
   Drury, E
   Stalker, J
   Cornelius, V
   Hubbart, C
   Jeffreys, AE
   Rowlands, K
   Rockett, KA
   Spencer, CCA
   Kwiatkowski, DP
AF Leffler, Ellen M.
   Band, Gavin
   Busby, George B. J.
   Kivinen, Katja
   Le, Quang Si
   Clarke, Geraldine M.
   Bojang, Kalifa A.
   Conway, David J.
   Jallow, Muminatou
   Sisay-Joof, Fatoumatta
   Bougouma, Edith C.
   Mangano, Valentina D.
   Modiano, David
   Sirima, Sodiomon B.
   Achidi, Eric
   Apinjoh, Tobias O.
   Marsh, Kevin
   Ndila, Carolyne M.
   Peshu, Norbert
   Williams, Thomas N.
   Drakeley, Chris
   Manjurano, Alphaxard
   Reyburn, Hugh
   Riley, Eleanor
   Kachala, David
   Molyneux, Malcolm
   Nyirongo, Vysaul
   Taylor, Terrie
   Thornton, Nicole
   Tilley, Louise
   Grimsley, Shane
   Drury, Eleanor
   Stalker, Jim
   Cornelius, Victoria
   Hubbart, Christina
   Jeffreys, Anna E.
   Rowlands, Kate
   Rockett, Kirk A.
   Spencer, Chris C. A.
   Kwiatkowski, Dominic P.
CA Malaria Genomic Epidemiology Netwo
TI Resistance to malaria through structural variation of red blood cell
   invasion receptors
SO SCIENCE
LA English
DT Article
ID ERYTHROCYTE BINDING ANTIGEN; ANCIENT BALANCING SELECTION; DNA-SEQUENCING
   DATA; PLASMODIUM-FALCIPARUM; GLYCOPHORIN-A; NE VARIETY;
   NATURAL-SELECTION; GENOME-WIDE; DANTU; GENE
AB The malaria parasite Plasmodium falciparum invades human red blood cells by a series of interactions between host and parasite surface proteins. By analyzing genome sequence data from human populations, including 1269 individuals from sub-Saharan Africa, we identify a diverse array of large copy-number variants affecting the host invasion receptor genes GYPA and GYPB. We find that a nearby association with severe malaria is explained by a complex structural rearrangement involving the loss of GYPB and gain of two GYPB-A hybrid genes, which encode a serologically distinct blood group antigen known as Dantu. This variant reduces the risk of severe malaria by 40% and has recently increased in frequency in parts of Kenya, yet it appears to be absent from west Africa. These findings link structural variation of red blood cell invasion receptors with natural resistance to severe malaria.
C1 [Leffler, Ellen M.; Band, Gavin; Busby, George B. J.; Le, Quang Si; Clarke, Geraldine M.; Cornelius, Victoria; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Rockett, Kirk A.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.
   [Leffler, Ellen M.; Band, Gavin; Kivinen, Katja; Drury, Eleanor; Stalker, Jim; Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Bojang, Kalifa A.; Conway, David J.; Jallow, Muminatou; Sisay-Joof, Fatoumatta] MRC Unit, Atlantic Blvd,Post Off Box 273, Fajara, Gambia.
   [Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.
   [Jallow, Muminatou] Royal Victoria Teaching Hosp, Independence Dr,Post Off Box 1515, Banjul, Gambia.
   [Bougouma, Edith C.; Sirima, Sodiomon B.] CNRFP, 01 BP 2208, Nantes 01, France.
   [Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Achidi, Eric] Univ Buea, Dept Med Lab Sci, Post Off Box 63, Buea, S W Region, Cameroon.
   [Apinjoh, Tobias O.] Univ Buea, Dept Biochem & Mol Biol, Post Off Box 63, Buea, S W Region, Cameroon.
   [Marsh, Kevin; Ndila, Carolyne M.; Peshu, Norbert; Williams, Thomas N.] Kenyan Med Res Inst KEMRI, Wellcome Trust Res Programme, Post Off Box 230-80108, Kilifi, Kenya.
   [Marsh, Kevin] Nuffield Dept Med, NDM Res Bldg,Roosevelt Dr, Oxford OX3 7FZ, England.
   [Williams, Thomas N.] Imperial Coll, Dept Med, Fac Med, Exhibition Rd, London SW7 2AZ, England.
   [Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Post Off Box 2228, Moshi, Tanzania.
   [Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh; Riley, Eleanor] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
   [Manjurano, Alphaxard] Mwanza Res Ctr, Natl Inst Med Res, Mwanza, Tanzania.
   [Kachala, David; Molyneux, Malcolm; Nyirongo, Vysaul] Queen Elizabeth Cent Hosp, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Post Off Box 30096, Blantyre 3, Malawi.
   [Molyneux, Malcolm] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Taylor, Terrie] Blantyre Malaria Project, Queen Elizabeth Cent Hosp, Coll Med, Post Off Box 30096, Blantyre 3, Malawi.
   [Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA.
   [Thornton, Nicole; Tilley, Louise; Grimsley, Shane] Natl Hlth Serv NHS Blood & Transplant, Int Blood Grp Reference Lab, 500 North Bristol Pk, Bristol BS34 7QH, Avon, England.
RP Spencer, CCA; Kwiatkowski, DP (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.; Kwiatkowski, DP (reprint author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
EM chris.spencer@well.ox.ac.uk; dominic.kwiatkowski@sanger.ac.uk
FU Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 090532/Z/09/Z, 098051,
   076934/Z/05/Z, 091758/Z/10/Z, 084538]; Bill & Melinda Gates Foundation
   through the Foundations of the National Institutes of Health as part of
   the Grand Challenges in Global Health Initiative [566]; Medical Research
   Council (MRC) [G0600718, G0600230, MR/M006212/1]; Wellcome Trust Career
   Development Fellowship [097364/Z/11/Z]; European Community's Seventh
   Framework Programme (FP7) [242095-EVIMalaR]; Central African Network for
   Tuberculosis, HIV/AIDS, and Malaria (CANTAM) - European and Developing
   Countries Clinical Trials Partnership (EDCTP); MRC [G9901439]; Wellcome
   Trust Research Leave Fellowship; MLW core grant; Istituto
   Pasteur-Fondazione Cenci Bolognetti, BioMalPar, and Evimalar (European
   Community FP6, FP7)
FX We thank all the study participants and the members of the MalariaGEN
   Consortial Projects 1 and 3 (www.malariagen.net/projects). These
   MalariaGEN Consortial Projects were supported by the Wellcome Trust
   (WT077383/Z/05/Z) and the Bill & Melinda Gates Foundation through the
   Foundations of the National Institutes of Health (566) as part of the
   Grand Challenges in Global Health Initiative. The Resource Centre for
   Genomic Epidemiology of Malaria is supported by the Wellcome Trust
   (090770/Z/09/Z). This research was supported by the Medical Research
   Council (MRC) (G0600718; G0600230; MR/M006212/1). C.C.A.S. was supported
   by a Wellcome Trust Career Development Fellowship (097364/Z/11/Z). The
   Wellcome Trust also provides core awards to the Wellcome Trust Centre
   for Human Genetics (WTCHG) (090532/Z/09/Z) and the Wellcome Trust Sanger
   Institute (WTSI) (098051). E.A. received partial funding from the
   European Community's Seventh Framework Programme (FP7/2007-2013) under
   grant agreement No 242095-EVIMalaR and the Central African Network for
   Tuberculosis, HIV/AIDS, and Malaria (CANTAM) funded by the European and
   Developing Countries Clinical Trials Partnership (EDCTP). T.N.W. is
   funded by Senior Fellowships from the Wellcome Trust (076934/Z/05/Z and
   091758/Z/10/Z) and through the European Community's Seventh Framework
   Programme (FP7/2007-2013) under grant agreement No 242095-EVIMalaR. The
   KEMRI-Wellcome Trust Programme is funded through core support from the
   Wellcome Trust. C.M.N. is supported through a strategic award to the
   KEMRI-Wellcome Trust Programme by the Wellcome Trust (084538). The Joint
   Malaria Programme at the Kilimanjaro Christian Medical Centre in Moshi,
   Tanzania, received funding from MRC grant number G9901439. The
   Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW) is a
   Major Overseas Programme of the Wellcome Trust. M.M. was funded by a
   Wellcome Trust Research Leave Fellowship. V.N. was supported on the MLW
   core grant. V.D.M. was funded by Istituto Pasteur-Fondazione Cenci
   Bolognetti, BioMalPar, and Evimalar (European Community FP6, FP7). We
   thank the staff of the WTSI Sample Logistics, Genotyping, Sequencing,
   and Informatics facilities and the WTCHG High-Throughput Genomics core
   for their contributions to sample handling and generation and processing
   of sequence data. Author contributions: Writing group: E.M.L., G.B.,
   G.B.J.B., K.A.R., C.C.A.S., and D.P.K.; Data analysis: E.M.L., G.B.,
   G.B.J.B., Q.S.L., D.P.K., G.M.C., K.A.R., and C.C.A.S.; Study site lead
   investigators: K.A.B., D.J.C., D.M., S.B.S., E.A., K.M., T.N.W., C.D.,
   H.R., E.R., M.M., and T.T.; Sample collection and curation: K.A.B.,
   D.J.C., M.J., F.S-J., E.C.B., V.D.M., D.M., S.B.S., E.A., T.O.A., K.M.,
   C.M.N., N.P., T.N.W., C.D., A.M., H.R., E.R., D.K., M.M., V.N., and
   T.T.; Serotyped sample curation and handling: N.T., L.T., and S.G.;
   Sample processing, sequencing, data management, and project
   coordination: G.B., K.K., E.D., J.S., V.C., C.H., A.E.J., K.R., K.A.R.;
   Experimental design and targeted assay development: E.M.L., G.B., C.H.,
   A.E.J., K.R., K.A.R., C.C.A.S., and D.P.K. The regional combined
   reference panel and association summary statistics, multiple sequence
   alignment of the glycophorin segmental duplication, and Sanger sequences
   are available at www.malariagen.net/resource/23. The sequence data
   generated for HG02554 and the Dantu+ (NE type) individual have been
   deposited in the European Nucleotide Archive under study accession
   number PRJEB20081. Accompanying scripts are available at
   https://github.com/malariagen/glycophorin_cnvs.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 16
PY 2017
VL 356
IS 6343
AR aam6393
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX6BO
UT WOS:000403327400028
OA No
DA 2017-08-15
ER

PT J
AU Baggett, HC
   Watson, NL
   Knoll, MD
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Murdoch, DR
   Scott, JAG
   Thea, DM
   Antonio, M
   Awori, JO
   Baillie, VL
   DeLuca, AN
   Driscoll, AJ
   Duncan, J
   Ebruke, BE
   Goswami, D
   Higdon, MM
   Karron, RA
   Moore, DP
   Morpeth, SC
   Mulindwa, JM
   Park, DE
   Paveenkittiporn, W
   Piralam, B
   Prosperi, C
   Sow, SO
   Tapia, MD
   Zaman, K
   Zeger, SL
   O'Brien, KL
AF Baggett, Henry C.
   Watson, Nora L.
   Knoll, Maria Deloria
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Murdoch, David R.
   Scott, J. Anthony G.
   Thea, Donald M.
   Antonio, Martin
   Awori, Juliet O.
   Baillie, Vicky L.
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Duncan, Julie
   Ebruke, Bernard E.
   Goswami, Doli
   Higdon, Melissa M.
   Karron, Ruth A.
   Moore, David P.
   Morpeth, Susan C.
   Mulindwa, Justin M.
   Park, Daniel E.
   Paveenkittiporn, Wantana
   Piralam, Barameht
   Prosperi, Christine
   Sow, Samba O.
   Tapia, Milagritos D.
   Zaman, Khalequ
   Zeger, Scott L.
   O'Brien, Katherine L.
CA Perch Study Grp
TI Density of Upper Respiratory Colonization With Streptococcus pneumoniae
   and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children
   Aged < 5 Years in the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumococcus; colonization; pneumonia; children; etiology
ID COMMUNITY-ACQUIRED PNEUMONIA; CONJUGATE VACCINE; ETIOLOGY RESEARCH;
   INFLUENZA-VIRUS; HEALTH PROJECT; DISEASE; IDENTIFICATION; INFECTION;
   CARRIAGE; LOAD
AB Background. Previous studies suggested an association between upper airway pneumococcal colonization density and pneumococcal pneumonia, but data in children are limited. Using data from the Pneumonia Etiology Research for Child Health (PERCH) study, we assessed this potential association.
   Methods. PERCH is a case-control study in 7 countries: Bangladesh, The Gambia, Kenya, Mali, South Africa, Thailand, and Zambia. Cases were children aged 1-59 months hospitalized with World Health Organization-defined severe or very severe pneumonia. Controls were randomly selected from the community. Microbiologically confirmed pneumococcal pneumonia (MCPP) was confirmed by detection of pneumococcus in a relevant normally sterile body fluid. Colonization density was calculated with quantitative polymerase chain reaction analysis of nasopharyngeal/oropharyngeal specimens.
   Results. Median colonization density among 56 cases with MCPP (MCPP cases; 17.28 x 10(6) copies/mL) exceeded that of cases without MCPP (non-MCPP cases; 0.75 x 10(6)) and controls (0.60 x 10(6)) (each P < .001). The optimal density for discriminating MCPP cases from controls using the Youden index was >6.9 log(10) copies/mL; overall, the sensitivity was 64% and the specificity 92%, with variable performance by site. The threshold was lower (>= 4.4 log(10) copies/mL) when MCPP cases were distinguished from controls who received antibiotics before specimen collection. Among the 4035 non-MCPP cases, 500 (12%) had pneumococcal colonization density >6.9 log(10) copies/mL; above this cutoff was associated with alveolar consolidation at chest radiography, very severe pneumonia, oxygen saturation < 92%, C-reactive protein >= 40 mg/L, and lack of antibiotic pretreatment (all P < .001).
   Conclusions. Pneumococcal colonization density >6.9 log(10) copies/mL was strongly associated with MCPP and could be used to improve estimates of pneumococcal pneumonia prevalence in childhood pneumonia studies. Our findings do not support its use for individual diagnosis in a clinical setting.
C1 [Baggett, Henry C.] Thailand Minist Publ Health, US Centers Dis Control & Prevent Collaborat, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Global Hlth, Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA.
   [Watson, Nora L.] Emmes Corp, Rockville, MD USA.
   [Knoll, Maria Deloria; Feikin, Daniel R.; Hammitt, Laura L.; Levine, Orin S.; DeLuca, Andrea N.; Driscoll, Amanda J.; Higdon, Melissa M.; Park, Daniel E.; Prosperi, Christine; O'Brien, Katherine L.] Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD USA.
   [Brooks, W. Abdullah] Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah] Int Ctr Diarrhoeal Dis Res Icddr B, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Hammitt, Laura L.; Goswami, Doli; Zaman, Khalequ] Natl Ctr Immunizat & Resp Dis, Centers Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
   [Feikin, Daniel R.] Natl Ctr Immunizat & Resp Dis, Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.; Awori, Juliet O.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Howie, Stephen R. C.; Antonio, Martin; Ebruke, Bernard E.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Pediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.; Tapia, Milagritos D.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Natl Res Fdn, Vaccine Preventable Dis Unit, Dept Sci & Technol, Johannesburg, South Africa.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Lab, Christchurch, New Zealand.
   [Scott, J. Anthony G.; Morpeth, Susan C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [Antonio, Martin] London Sch Hyg Trop Med, Dept Pathogen Mol Biol, London, England.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Duncan, Julie; Mulindwa, Justin M.] Univ Teaching Hosp, Lusaka, Zambia.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Soweto, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Morpeth, Susan C.] Middlemore Hosp, Counties Manukau Dist Hlth Board, Microbiol Lab, Auckland, New Zealand.
   [Park, Daniel E.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA.
   [Paveenkittiporn, Wantana] Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand.
   [Piralam, Barameht] Nakhon Phanom Prov Hlth Off, Nakhon Phanom, Thailand.
   [Sow, Samba O.] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
RP Baggett, HC (reprint author), 1825 Century Blvd NE,MS E98, Atlanta, GA 30329 USA.
EM hfb8@cdc.gov
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX This work was supported by the Bill & Melinda Gates Foundation (grant
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health,
   for the PERCH study) and the Wellcome Trust of Great Britain (clinical
   fellowship 098532 to J. A. G. S.).
CR Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859
   Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953
   Alpkvist H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140112
   Anh DD, 2007, TOHOKU J EXP MED, V213, P167, DOI 10.1620/tjem.213.167
   Arifeen SE, 2009, CLIN INFECT DIS, V48, pS103, DOI 10.1086/596543
   Baggett HC, 2009, CLIN INFECT DIS, V48, pS65, DOI 10.1086/596484
   Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/01.inf.0000027926.99356.4c
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS368, DOI 10.1093/cid/cix101
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Esposito S, 2013, PEDIATR INFECT DIS J, V32, P1199, DOI 10.1097/INF.0b013e31829ec274
   Falade AG, 1997, ANN TROP PAEDIATR, V17, P315
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   GRAY BM, 1980, J INFECT DIS, V142, P923
   Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405
   Knoll MD, 2017, CLIN INFECT DIS, V64, pS357, DOI 10.1093/cid/cix149
   le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828
   McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462
   McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05
   Morpeth SC, 2017, CLIN INFECT DIS, V64, pS347, DOI 10.1093/cid/cix145
   Rhodes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066038
   Saha SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032134
   Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]
   Stralin K, 2014, J CLIN MICROBIOL, V52, P83, DOI 10.1128/JCM.01742-13
   Talbot TR, 2005, AM J MED, V118, P285, DOI 10.1016/j.ajm.2004.09.016
   Vu Huong Thi Thu, 2011, Pediatr Infect Dis J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2
   Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208
   Werno AM, 2012, J MED MICROBIOL, V61, P1129, DOI 10.1099/jmm.0.044107-0
   World Health Organization, 2005, POCK BOOK HOSP CAR C
   Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 37
TC 7
Z9 7
U1 5
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S317
EP S327
DI 10.1093/cid/cix100
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300017
PM 28575365
OA No
DA 2017-08-15
ER

PT J
AU Crawley, J
   Prosperi, C
   Baggett, HC
   Brooks, WA
   Knoll, MD
   Hammitt, LL
   Howie, SRC
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Murdoch, DR
   O'Brien, KL
   Thea, DM
   Awori, JO
   Bunthi, C
   DeLuca, AN
   Driscoll, AJ
   Ebruke, BE
   Goswami, D
   Hidgon, MM
   Karron, RA
   Kazungu, S
   Kourouma, N
   Mackenzie, G
   Moore, DP
   Mudau, A
   Mwale, M
   Nahar, K
   Park, DE
   Piralam, B
   Seidenberg, P
   Sylla, M
   Feikin, DR
   Scott, JAG
AF Crawley, Jane
   Prosperi, Christine
   Baggett, Henry C.
   Brooks, W. Abdullah
   Knoll, Maria Deloria
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Murdoch, David R.
   O'Brien, Katherine L.
   Thea, Donald M.
   Awori, Juliet O.
   Bunthi, Charatdao
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Ebruke, Bernard E.
   Goswami, Doli
   Hidgon, Melissa M.
   Karron, Ruth A.
   Kazungu, Sidi
   Kourouma, Nana
   Mackenzie, Grant
   Moore, David P.
   Mudau, Azwifari
   Mwale, Magdalene
   Nahar, Kamrun
   Park, Daniel E.
   Piralam, Barameht
   Seidenberg, Phil
   Sylla, Mamadou
   Feikin, Daniel R.
   Scott, J. Anthony G.
CA PERCH Study Grp
TI Standardization of Clinical Assessment and Sample Collection Across All
   PERCH Study Sites
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; childhood; hospital; training; standardization
ID INTEROBSERVER VARIATION; PNEUMONIA ETIOLOGY; CHILDREN; EPIDEMIOLOGY;
   AGREEMENT; KAPPA; SIGNS
AB Background. Variable adherence to standardized case definitions, clinical procedures, specimen collection techniques, and laboratory methods has complicated the interpretation of previous multicenter pneumonia etiology studies. To circumvent these problems, a program of clinical standardization was embedded in the Pneumonia Etiology Research for Child Health (PERCH) study.
   Methods. Between March 2011 and August 2013, standardized training on the PERCH case definition, clinical procedures, and collection of laboratory specimens was delivered to 331 clinical staff at 9 study sites in 7 countries (The Gambia, Kenya, Mali, South Africa, Zambia, Thailand, and Bangladesh), through 32 on-site courses and a training website. Staff competency was assessed throughout 24 months of enrollment with multiple-choice question (MCQ) examinations, a video quiz, and checklist evaluations of practical skills.
   Results. MCQ evaluation was confined to 158 clinical staff members who enrolled PERCH cases and controls, with scores obtained for >86% of eligible staff at each time-point. Median scores after baseline training were >= 80%, and improved by 10 percentage points with refresher training, with no significant intersite differences. Percentage agreement with the clinical trainer on the presence or absence of clinical signs on video clips was high (>= 89%), with interobserver concordance being substantial to high (AC1 statistic, 0.62-0.82) for 5 of 6 signs assessed. Staff attained median scores of >90% in checklist evaluations of practical skills.
   Conclusions. Satisfactory clinical standardization was achieved within and across all PERCH sites, providing reassurance that any etiological or clinical differences observed across the study sites are true differences, and not attributable to differences in application of the clinical case definition, interpretation of clinical signs, or in techniques used for clinical measurements or specimen collection.
C1 [Crawley, Jane] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Prosperi, Christine; Knoll, Maria Deloria; Hammitt, Laura L.; Levine, Orin S.; O'Brien, Katherine L.; DeLuca, Andrea N.; Driscoll, Amanda J.; Hidgon, Melissa M.; Park, Daniel E.; Feikin, Daniel R.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Baggett, Henry C.; Bunthi, Charatdao] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Health, Global Dis Detect Ctr, Nonthaburi, Bangladesh.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Brooks, W. Abdullah; Goswami, Doli; Nahar, Kamrun] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Goswami, Doli; Nahar, Kamrun] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Hammitt, Laura L.; Awori, Juliet O.; Kazungu, Sidi; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Howie, Stephen R. C.; Ebruke, Bernard E.; Mackenzie, Grant] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Pediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth,Div Infect Dis & Trop Pediat, Dept Pediat,Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Moore, David P.; Mudau, Azwifari] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.; Moore, David P.; Mudau, Azwifari] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Vaccine Preventable Dis Unit, Johannesburg, South Africa.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Thea, Donald M.; Seidenberg, Phil] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Immunizat Res, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Kourouma, Nana; Sylla, Mamadou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Mackenzie, Grant] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Mackenzie, Grant] London Sch Hyg & Trop Med, London, England.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Soweto, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwale, Magdalene] Univ Teaching Hosp, Lusaka, Zambia.
   [Park, Daniel E.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA.
   [Piralam, Barameht] Nakhon Phanom Prov Hlth Off, Nakhon Phanom, Thailand.
   [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA.
   [Scott, J. Anthony G.] London Sch Hyg Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Crawley, J (reprint author), Univ Oxford, Ctr Trop Med & Global Hlth, Old Rd, Oxford OX3 7LE, England.
EM jane.crawley@gmail.com
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from The Wellcome
   Trust of Great Britain (award number 098532).
CR Bekhof J, 2015, ARCH DIS CHILD, V100, P649, DOI 10.1136/archdischild-2014-307143
   ENGLISH M, 1995, ARCH DIS CHILD, V72, P334
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   Gilani Z, 2012, CLIN INFECT DIS, V54, pS102, DOI 10.1093/cid/cir1053
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Gwet K., 2002, STAT METHODS INTERRA, V1, P1
   Ideh RC, 2011, INT J TUBERC LUNG D, V15, P729, DOI 10.5588/ijtld.10.0468
   Kahigwa E, 2002, T ROY SOC TROP MED H, V96, P162, DOI 10.1016/S0035-9203(02)90290-7
   Scott JAG, 2008, B WORLD HEALTH ORGAN, V86, P494, DOI 10.2471/BLT.08.052753
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   SELWYN BJ, 1990, REV INFECT DIS, V12, pS870
   Viera AJ, 2005, FAM MED, V37, P360
   Wagai J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004626
   Wall Stephen N, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS39, DOI 10.1097/INF.0b013e31829ff801
   Watson NL, 2017, CLIN INFECT DIS, V64, pS238, DOI 10.1093/cid/cix080
   WHO, 2013, POCK BOOK HOSP CAR C
   Wongpakaran N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-61
NR 17
TC 9
Z9 9
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S228
EP S237
DI 10.1093/cid/cix077
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300007
PM 28575355
OA No
DA 2017-08-15
ER

PT J
AU DeLuca, AN
   Hammitt, LL
   Kim, J
   Higdon, MM
   Baggett, HC
   Brooks, WA
   Howie, SRC
   Knoll, MD
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Murdoch, DR
   Scott, JAG
   Thea, DM
   Amornintapichet, T
   Awori, JO
   Chuananon, S
   Driscoll, AJ
   Ebruke, BE
   Hossain, L
   Jahan, Y
   Kagucia, EW
   Kazungu, S
   Moore, DP
   Mudau, A
   Mwananyanda, L
   Park, DE
   Prosperi, C
   Seidenberg, P
   Sylla, M
   Tapia, MD
   Zaman, SMA
   O'Brien, KL
AF DeLuca, Andrea N.
   Hammitt, Laura L.
   Kim, Julia
   Higdon, Melissa M.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Howie, Stephen R. C.
   Knoll, Maria Deloria
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Murdoch, David R.
   Scott, J. Anthony G.
   Thea, Donald M.
   Amornintapichet, Tussanee
   Awori, Juliet O.
   Chuananon, Somchai
   Driscoll, Amanda J.
   Ebruke, Bernard E.
   Hossain, Lokman
   Jahan, Yasmin
   Kagucia, E. Wangeci
   Kazungu, Sidi
   Moore, David P.
   Mudau, Azwifarwi
   Mwananyanda, Lawrence
   Park, Daniel E.
   Prosperi, Christine
   Seidenberg, Phil
   Sylla, Mamadou
   Tapia, Milagritos D.
   Zaman, Syed M. A.
   O'Brien, Katherine L.
CA Perch Study Grp
TI Safety of Induced Sputum Collection in Children Hospitalized With Severe
   or Very Severe Pneumonia
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE PERCH; induced sputum; very severe pneumonia; severe pneumonia; safety
ID ETIOLOGY RESEARCH; PULMONARY TUBERCULOSIS; YOUNG-CHILDREN; HEALTH
   PROJECT; DIAGNOSIS; INDUCTION; INFANTS
AB Background. Induced sputum (IS) may provide diagnostic information about the etiology of pneumonia. The safety of this procedure across a heterogeneous population with severe pneumonia in low-and middle-income countries has not been described.
   Methods. IS specimens were obtained as part a 7-country study of the etiology of severe and very severe pneumonia in hospitalized children <5 years of age. Rigorous clinical monitoring was done before, during, and after the procedure to record oxygen requirement, oxygen saturation, respiratory rate, consciousness level, and other evidence of clinical deterioration. Criteria for IS contraindications were predefined and serious adverse events (SAEs) were reported to ethics committees and a central safety monitor.
   Results. A total of 4653 IS procedures were done among 3802 children. Thirteen SAEs were reported in relation to collection of IS, or 0.34% of children with at least 1 IS specimen collected (95% confidence interval, 0.15%-0.53%). A drop in oxygen saturation that required supplemental oxygen was the most common SAE. One child died after feeding was reinitiated 2 hours after undergoing sputum induction; this death was categorized as "possibly related" to the procedure.
   Conclusions. The overall frequency of SAEs was very low, and the nature of most SAEs was manageable, demonstrating a low-risk safety profile for IS collection even among severely ill children in low-income-country settings. Healthcare providers should monitor oxygen saturation and requirements during and after IS collection, and assess patients prior to reinitiating feeding after the IS procedure, to ensure patient safety.
C1 [DeLuca, Andrea N.; Hammitt, Laura L.; Higdon, Melissa M.; Knoll, Maria Deloria; Levine, Orin S.; Driscoll, Amanda J.; Kagucia, E. Wangeci; Park, Daniel E.; Prosperi, Christine; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Wolfe St,Ste 563, Baltimore, MD 21231 USA.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.; Awori, Juliet O.; Kazungu, Sidi] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Kim, Julia] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Pediat Safety, Baltimore, MD USA.
   [Baggett, Henry C.] Thailand Minist Publ Health, US Centers Dis Control & Prevent Collaborat, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Hossain, Lokman; Jahan, Yasmin] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Hossain, Lokman; Jahan, Yasmin] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Matlab, Bangladesh.
   [Howie, Stephen R. C.; Ebruke, Bernard E.; Zaman, Syed M. A.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Pediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.; Tapia, Milagritos D.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Moore, David P.; Mudau, Azwifarwi] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.; Moore, David P.; Mudau, Azwifarwi] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.; Mwananyanda, Lawrence; Seidenberg, Phil] Boston Univ, Sch Publ, Ctr Global Hlth & Dev, Boston, MA USA.
   [Amornintapichet, Tussanee] Thailand Minist Health, Sa Kaeo Prov Hosp, Nakhon Phanom, Thailand.
   [Chuananon, Somchai] Nakhon Phanom Prov Hosp, Nakhon Phanom, Thailand.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwananyanda, Lawrence] Univ Teaching Hosp, Lusaka, Zambia.
   [Park, Daniel E.] George Washington Univ, Milken Inst, Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA.
   [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA.
   [Sylla, Mamadou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Zaman, Syed M. A.] London Sch Hyg & Trop Med, London, England.
RP O'Brien, KL (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Wolfe St,Ste 563, Baltimore, MD 21231 USA.
EM kobrien2@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   Das CK, 2014, J TROP PEDIATRICS, V60, P216, DOI 10.1093/tropej/fmt112
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071
   Ho J, 2015, INT J TUBERC LUNG D, V19, P537, DOI 10.5588/ijtld.14.0798
   Joel DR, 2014, INT J TUBERC LUNG D, V18, P328, DOI 10.5588/ijtld.13.0243
   Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051
   Lex C, 2005, PEDIATR PULM, V39, P318, DOI 10.1002/ppul.20159
   Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070
   Morrow BM, 2010, PEDIATR INFECT DIS J, V29, P535, DOI 10.1097/INF.0b013e3181ce871e
   Murdoch DR, 2017, CLIN INFECT DIS, V64, pS271, DOI 10.1093/cid/cix083
   Murdoch DR, 2017, CLIN INFECT DIS S3, V64, pS288
   PERCH Study Group, 2011, SOP CE SOP 11 IND SP
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   Thea DM, 2017, CLIN INFECT DIS, V64, pS289, DOI 10.1093/cid/cix098
   Wonodi CB, 2012, CLIN INFECT DIS, V54, pS124, DOI 10.1093/cid/cir1067
   Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2
   Zar HJ, 2000, ARCH DIS CHILD, V82, P305, DOI 10.1136/adc.82.4.305
NR 19
TC 5
Z9 5
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S301
EP S308
DI 10.1093/cid/cix078
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300015
PM 28575356
OA No
DA 2017-08-15
ER

PT J
AU Driscoll, AJ
   Knoll, MD
   Hammitt, LL
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Kotloff, KL
   Levine, OS
   Madhi, SA
   O'Brien, KL
   Scott, JAG
   Thea, DM
   Howie, SRC
   Adrian, PV
   Ahmed, D
   DeLuca, AN
   Ebruke, BE
   Gitahi, C
   Higdon, MM
   Kaewpan, A
   Karani, A
   Karron, RA
   Mazumder, R
   McLellan, J
   Moore, DP
   Mwananyanda, L
   Park, DE
   Prosperi, C
   Rhodes, J
   Saifullah, M
   Seidenberg, P
   Sow, SO
   Tamboura, B
   Zeger, SL
   Murdoch, DR
AF Driscoll, Amanda J.
   Knoll, Maria Deloria
   Hammitt, Laura L.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   O'Brien, Katherine L.
   Scott, J. Anthony G.
   Thea, Donald M.
   Howie, Stephen R. C.
   Adrian, Peter V.
   Ahmed, Dilruba
   DeLuca, Andrea N.
   Ebruke, Bernard E.
   Gitahi, Caroline
   Higdon, Melissa M.
   Kaewpan, Anek
   Karani, Angela
   Karron, Ruth A.
   Mazumder, Razib
   McLellan, Jessica
   Moore, David P.
   Mwananyanda, Lawrence
   Park, Daniel E.
   Prosperi, Christine
   Rhodes, Julia
   Saifullah, Md.
   Seidenberg, Phil
   Sow, Samba O.
   Tamboura, Boubou
   Zeger, Scott L.
   Murdoch, David R.
CA PERCH Study Grp
TI The Effect of Antibiotic Exposure and Specimen Volume on the Detection
   of Bacterial Pathogens in Children With Pneumonia
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; blood culture; antibiotic exposure; children
ID BLOOD-STREAM INFECTIONS; ETIOLOGY RESEARCH; ANTIMICROBIAL USE; HEALTH
   PROJECT; BACTEREMIA; CULTURE; COMMUNITY; DIAGNOSIS; KENYA; YIELD
AB Background. Antibiotic exposure and specimen volume are known to affect pathogen detection by culture. Here we assess their effects on bacterial pathogen detection by both culture and polymerase chain reaction (PCR) in children.
   Methods. PERCH (Pneumonia Etiology Research for Child Health) is a case-control study of pneumonia in children aged 1-59 months investigating pathogens in blood, nasopharyngeal/oropharyngeal (NP/OP) swabs, and induced sputum by culture and PCR. Antibiotic exposure was ascertained by serum bioassay, and for cases, by a record of antibiotic treatment prior to specimen collection. Inoculated blood culture bottles were weighed to estimate volume.
   Results. Antibiotic exposure ranged by specimen type from 43.5% to 81.7% in 4223 cases and was detected in 2.3% of 4863 controls. Antibiotics were associated with a 45% reduction in blood culture yield and approximately 20% reduction in yield from induced sputum culture. Reduction in yield of Streptococcus pneumoniae from NP culture was approximately 30% in cases and approximately 32% in controls. Several bacteria had significant but marginal reductions (by 5%-7%) in detection by PCR in NP/OP swabs from both cases and controls, with the exception of S. pneumoniae in exposed controls, which was detected 25% less frequently compared to nonexposed controls. Bacterial detection in induced sputum by PCR decreased 7% for exposed compared to nonexposed cases. For every additional 1 mL of blood culture specimen collected, microbial yield increased 0.51% (95% confidence interval, 0.47%-0.54%), from 2% when volume was <= 1 mL to approximately 6% for >= 3 mL.
   Conclusions. Antibiotic exposure and blood culture volume affect detection of bacterial pathogens in children with pneumonia and should be accounted for in studies of etiology and in clinical management.
C1 [Driscoll, Amanda J.; Knoll, Maria Deloria; Hammitt, Laura L.; Feikin, Daniel R.; Levine, Orin S.; O'Brien, Katherine L.; DeLuca, Andrea N.; Higdon, Melissa M.; Park, Daniel E.; Prosperi, Christine] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Washington St,Rm 563, Baltimore, MD 21205 USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.; Gitahi, Caroline; Karani, Angela] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Baggett, Henry C.; Kaewpan, Anek; Rhodes, Julia] Thailand Minist Publ Health US Ctr Dis Control &, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Mazumder, Razib; Saifullah, Md.] Icddr B, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Mazumder, Razib; Saifullah, Md.] Icddr B, Matlab, Bangladesh.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Dept Pediat, Div Infect Dis & Trop Pediat,Ctr Vaccine Dev,Inst, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Adrian, Peter V.; Moore, David P.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa.
   [Madhi, Shabir A.; Adrian, Peter V.; Moore, David P.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.; Mwananyanda, Lawrence; Seidenberg, Phil] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Howie, Stephen R. C.; Ebruke, Bernard E.; McLellan, Jessica] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Immunizat Res, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Internat Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [McLellan, Jessica] Univ Calgary, Cummings Sch Med, Calgary, AB, Canada.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Soweto, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwananyanda, Lawrence] Univ Teaching Hosp, Lusaka, Zambia.
   [Park, Daniel E.] George Washington Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Milken Inst, Washington, DC USA.
   [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA.
   [Sow, Samba O.; Tamboura, Boubou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
RP Driscoll, AJ (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Washington St,Rm 563, Baltimore, MD 21205 USA.
EM adrisco1@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100
   Bard JD, 2016, J CLIN MICROBIOL, V54, P1418, DOI 10.1128/JCM.02919-15
   Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275
   Bouza E, 2007, J CLIN MICROBIOL, V45, P2765, DOI 10.1128/JCM.00140-07
   Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4
   Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440
   Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   DOERN GV, 1983, J CLIN MICROBIOL, V18, P43
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089
   Gonsalves WI, 2009, J CLIN MICROBIOL, V47, P3482, DOI 10.1128/JCM.02107-08
   Gratten Mike, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P123
   Isaacman D, 1996, J PEDIATR-US, V128, P190, DOI 10.1016/S0022-3476(96)70388-8
   Kaditis AG, 1996, PEDIATR INFECT DIS J, V15, P615, DOI 10.1097/00006454-199607000-00011
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Liu YC, 1999, J CLIN EPIDEMIOL, V52, P539, DOI 10.1016/S0895-4356(99)00027-X
   MERMEL LA, 1993, ANN INTERN MED, V119, P270
   Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8
   Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09
   Resti M, 2009, CLIN THER, V31, P1266, DOI 10.1016/j.clinthera.2009.06.010
   Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584
   Saukkoriipi A, 2015, EUR J CLIN MICROBIOL, V34, P697, DOI 10.1007/s10096-014-2278-5
   Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0
   TRUDNOWSKI RJ, 1974, CLIN CHEM, V20, P615
   TUPASI TE, 1990, REV INFECT DIS, V12, pS940
NR 26
TC 6
Z9 6
U1 3
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S368
EP S377
DI 10.1093/cid/cix101
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300022
PM 28575366
OA No
DA 2017-08-15
ER

PT J
AU Driscoll, AJ
   Karron, RA
   Morpeth, SC
   Bhat, N
   Levine, OS
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Knoll, MD
   Kotloff, KL
   Madhi, SA
   Scott, JAG
   Thea, DM
   Adrian, PV
   Ahmed, D
   Alam, M
   Anderson, TP
   Antonio, M
   Baillie, VL
   Dione, M
   Endtz, HP
   Gitahi, C
   Karani, A
   Kwenda, G
   Maiga, AA
   McClellan, J
   Mitchell, JL
   Morailane, P
   Mugo, D
   Mwaba, J
   Mwansa, J
   Mwarumba, S
   Nyongesa, S
   Panchalingam, S
   Rahman, M
   Sawatwong, P
   Tamboura, B
   Toure, A
   Whistler, T
   O'Brien, KL
   Murdoch, DR
AF Driscoll, Amanda J.
   Karron, Ruth A.
   Morpeth, Susan C.
   Bhat, Niranjan
   Levine, Orin S.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Knoll, Maria Deloria
   Kotloff, Karen L.
   Madhi, Shabir A.
   Scott, J. Anthony G.
   Thea, Donald M.
   Adrian, Peter V.
   Ahmed, Dilruba
   Alam, Muntasir
   Anderson, Trevor P.
   Antonio, Martin
   Baillie, Vicky L.
   Dione, Michel
   Endtz, Hubert P.
   Gitahi, Caroline
   Karani, Angela
   Kwenda, Geoffrey
   Maiga, Abdoul Aziz
   McClellan, Jessica
   Mitchell, Joanne L.
   Morailane, Palesa
   Mugo, Daisy
   Mwaba, John
   Mwansa, James
   Mwarumba, Salim
   Nyongesa, Sammy
   Panchalingam, Sandra
   Rahman, Mustafizur
   Sawatwong, Pongpun
   Tamboura, Boubou
   Toure, Aliou
   Whistler, Toni
   O'Brien, Katherine L.
   Murdoch, David R.
TI Standardization of Laboratory Methods for the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; PERCH; laboratory; respiratory infection
ID REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE;
   CLINICAL SPECIMENS; IDENTIFICATION; MYCOBACTERIA; ASSAYS; DIAGNOSTICS;
   ETIOLOGY
AB The Pneumonia Etiology Research for Child Health study was conducted across 7 diverse research sites and relied on standardized clinical and laboratory methods for the accurate and meaningful interpretation of pneumonia etiology data. Blood, respiratory specimens, and urine were collected from children aged 1-59 months hospitalized with severe or very severe pneumonia and community controls of the same age without severe pneumonia and were tested with an extensive array of laboratory diagnostic tests. A standardized testing algorithm and standard operating procedures were applied across all study sites. Site laboratories received uniform training, equipment, and reagents for core testing methods. Standardization was further assured by routine teleconferences, in-person meetings, site monitoring visits, and internal and external quality assurance testing. Targeted confirmatory testing and testing by specialized assays were done at a central reference laboratory.
C1 [Driscoll, Amanda J.; Bhat, Niranjan; Levine, Orin S.; Feikin, Daniel R.; Hammitt, Laura L.; Knoll, Maria Deloria; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Morpeth, Susan C.; Hammitt, Laura L.; Scott, J. Anthony G.; Gitahi, Caroline; Karani, Angela; Mugo, Daisy; Mwarumba, Salim; Nyongesa, Sammy] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Morpeth, Susan C.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Morpeth, Susan C.] Middlemore Hosp, Counties Manukau Dist Hlth Board, Microbiol Lab, Auckland, New Zealand.
   [Bhat, Niranjan] PATH, Ctr Vaccine Innovat & Access, San Francisco, CA USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Baggett, Henry C.; Sawatwong, Pongpun; Whistler, Toni] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.; Whistler, Toni] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Alam, Muntasir; Endtz, Hubert P.; Rahman, Mustafizur] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Endtz, Hubert P.] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA.
   [Howie, Stephen R. C.; Antonio, Martin; Dione, Michel; McClellan, Jessica] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Dept Pediat,Inst Global Hlth, Div Infect Dis & Trop Pediat,Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Madhi, Shabir A.; Adrian, Peter V.; Baillie, Vicky L.; Morailane, Palesa] MRC, Resp & Meningeal Pathogens Res Unit, London, England.
   [Madhi, Shabir A.; Adrian, Peter V.; Baillie, Vicky L.; Morailane, Palesa] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Anderson, Trevor P.; Mitchell, Joanne L.; Murdoch, David R.] Canterbury Hlth Labs, Microbiol Dept, Christchurch, New Zealand.
   [Antonio, Martin] London Sch Hyg & Trop Med, Dept Pathogen Biol, London, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [Dione, Michel] Int Livestock Res Inst, Kampala, Uganda.
   [Endtz, Hubert P.] Erasmus MC, Dept Clin Microbiol & Infect Dis, Rotterdam, Netherlands.
   [Endtz, Hubert P.] Fdn Merieux, Lyon, France.
   [Kwenda, Geoffrey] Univ Med, Sch Med, Dept Biomed Sci, Lusaka, Zambia.
   [Kwenda, Geoffrey; Mwaba, John; Mwansa, James] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia.
   [Maiga, Abdoul Aziz; Tamboura, Boubou; Toure, Aliou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [McClellan, Jessica] Univ Calgary, Cummings Sch Med, Calgary, AB, Canada.
   [Mwaba, John; Mwansa, James] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Panchalingam, Sandra] Univ Maryland, Sch Med, Dept Med, Ctr Vaccine Dev,Inst Global Hlth, Baltimore, MD 21201 USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
RP Driscoll, AJ (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD 21231 USA.
EM adri-sco1@jhu.edu
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003
   Azzari C, 2008, J MED MICROBIOL, V57, P1205, DOI 10.1099/jmm.0.2008/000935-0
   Barger-Kamate B, 2016, CLIN INFECT DIS, V63, pS187, DOI 10.1093/cid/ciw546
   Bhat N, 2012, CLIN INFECT DIS, V54, pS153, DOI 10.1093/cid/cir1060
   BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751
   Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06
   CLSI, 2011, M100S21 CLSI
   Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   da Gloria Carvalho M, 2010, J CLIN MICROBIOL, V48, P1611, DOI DOI 10.1128/JCM.02243-09
   DeLuca AN, 2012, CLIN INFECT DIS, V54, pS172, DOI 10.1093/cid/cir1063
   Driscoll AJ, 2014, J MICROBIOL METH, V107, P222, DOI 10.1016/j.mimet.2014.10.009
   Driscoll AJ, 2012, CLIN INFECT DIS, V54, pS159, DOI 10.1093/cid/cir1061
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Higdon MM, 2017, CLIN INFECT DIS, V64, pS378, DOI 10.1093/cid/cix150
   Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006
   KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882
   Levine OS, 2012, CLIN INFECT DIS, V54, pS87, DOI 10.1093/cid/cir1050
   Maaroufi Y, 2007, J CLIN MICROBIOL, V45, P2305, DOI 10.1128/JCM.00102-07
   Marty A, 2004, J CLIN MICROBIOL, V42, P3813, DOI 10.1128/JCM.42.8.3813-3815.2004
   Murdoch DR, 2017, CLIN INFECT DIS, V64, pS271, DOI 10.1093/cid/cix083
   O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001
   Reischl U, 2002, J CLIN MICROBIOL, V40, P3814, DOI 10.1128/JCM.40.10.3814-3817.2002
   Watson NL, 2017, CLIN INFECT DIS, V64, pS238, DOI 10.1093/cid/cix080
   Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5
NR 24
TC 11
Z9 11
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S245
EP S252
DI 10.1093/cid/cix081
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300009
PM 28575358
OA No
DA 2017-08-15
ER

PT J
AU Fancourt, N
   Knoll, MD
   Barger-Kamate, B
   de Campo, J
   de Campo, M
   Diallo, M
   Ebruke, BE
   Feikin, DR
   Gleeson, F
   Gong, WF
   Hammitt, LL
   Izadnegahdar, R
   Kruatrachue, A
   Madhi, SA
   Manduku, V
   Matin, FB
   Mahomed, N
   Moore, DP
   Mwenechanya, M
   Nahar, K
   Oluwalana, C
   Ominde, MS
   Prosperi, C
   Sande, J
   Suntarattiwong, P
   O'Brien, KL
AF Fancourt, Nicholas
   Knoll, Maria Deloria
   Barger-Kamate, Breanna
   de Campo, John
   de Campo, Margaret
   Diallo, Mahamadou
   Ebruke, Bernard E.
   Feikin, Daniel R.
   Gleeson, Fergus
   Gong, Wenfeng
   Hammitt, Laura L.
   Izadnegahdar, Rasa
   Kruatrachue, Anchalee
   Madhi, Shabir A.
   Manduku, Veronica
   Matin, Fariha Bushra
   Mahomed, Nasreen
   Moore, David P.
   Mwenechanya, Musaku
   Nahar, Kamrun
   Oluwalana, Claire
   Ominde, Micah Silaba
   Prosperi, Christine
   Sande, Joyce
   Suntarattiwong, Piyarat
   O'Brien, Katherine L.
TI Standardized Interpretation of Chest Radiographs in Cases of Pediatric
   Pneumonia From the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE observer variation; chest radiograph; pneumonia; pediatrics; diagnosis
ID PNEUMOCOCCAL CONJUGATE VACCINE; RADIOLOGICALLY-CONFIRMED PNEUMONIA;
   PLACEBO-CONTROLLED-TRIAL; INTEROBSERVER VARIATION; DOUBLE-BLIND;
   CHILDREN; AGE; BURDEN; DIAGNOSIS; DISEASE
AB Background. Chest radiographs (CXRs) are a valuable diagnostic tool in epidemiologic studies of pneumonia. The World Health Organization (WHO) methodology for the interpretation of pediatric CXRs has not been evaluated beyond its intended application as an endpoint measure for bacterial vaccine trials.
   Methods. The Pneumonia Etiology Research for Child Health (PERCH) study enrolled children aged 1-59 months hospitalized with WHO-defined severe and very severe pneumonia from 7 low-and middle-income countries. An interpretation process categorized each CXR into 1 of 5 conclusions: consolidation, other infiltrate, both consolidation and other infiltrate, normal, or uninterpretable. Two members of a 14-person reading panel, who had undertaken training and standardization in CXR interpretation, interpreted each CXR. Two members of an arbitration panel provided additional independent reviews of CXRs with discordant interpretations at the primary reading, blinded to previous reports. Further discordance was resolved with consensus discussion.
   Results. A total of 4172 CXRs were obtained from 4232 cases. Observed agreement for detecting consolidation (with or without other infiltrate) between primary readers was 78% (kappa = 0.50) and between arbitrators was 84% (kappa = 0.61); agreement for primary readers and arbitrators across 5 conclusion categories was 43.5% (kappa = 0.25) and 48.5% (kappa = 0.32), respectively. Disagreement was most frequent between conclusions of other infiltrate and normal for both the reading panel and the arbitration panel (32% and 30% of discordant CXRs, respectively).
   Conclusions. Agreement was similar to that of previous evaluations using the WHO methodology for detecting consolidation, but poor for other infiltrates despite attempts at a rigorous standardization process.
C1 [Fancourt, Nicholas; Knoll, Maria Deloria; Feikin, Daniel R.; Gong, Wenfeng; Hammitt, Laura L.; Prosperi, Christine; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD USA.
   [Fancourt, Nicholas] Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia.
   [Fancourt, Nicholas] Royal Childrens Hosp, Melbourne, Vic, Australia.
   [Barger-Kamate, Breanna] Johns Hopkins Sch Med, Div Emergency Med, Dept Pediat, Baltimore, MD USA.
   [Barger-Kamate, Breanna] Spokane Emergency Phys, Washington, DC USA.
   [de Campo, John; de Campo, Margaret] Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia.
   [Diallo, Mahamadou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Ebruke, Bernard E.] MRC Unit, Basse, Gambia.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA.
   [Gleeson, Fergus] Oxford Univ Hosp Trust, Oxford, England.
   [Hammitt, Laura L.; Manduku, Veronica; Ominde, Micah Silaba] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Izadnegahdar, Rasa] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.
   [Kruatrachue, Anchalee; Suntarattiwong, Piyarat] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand.
   [Madhi, Shabir A.; Mahomed, Nasreen; Moore, David P.] MRC, Resp & Meningeal Pathogens Res Unit, Swindon, Wilts, England.
   [Madhi, Shabir A.; Moore, David P.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Vaccine Preventable Dis Unit, Johannesburg, South Africa.
   [Matin, Fariha Bushra; Nahar, Kamrun] Bangladesh Icddr B, Internat Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Matin, Fariha Bushra; Nahar, Kamrun] Bangladesh Icddr B, Internat Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Mahomed, Nasreen] Chris Hani Baragwanath Acad Hosp, Dept Diagnost Radiol, Johannesburg, South Africa.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwenechanya, Musaku] Univ Teaching Hosp, Dept Pediat, Lusaka, Zambia.
   [Sande, Joyce] Aga Khan Univ Hosp, Nairobi, Kenya.
RP Fancourt, N (reprint author), Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia.; Fancourt, N (reprint author), Royal Childrens Hosp, Melbourne, Vic, Australia.
EM nfancourt@jhu.edu
FU Bill & Melinda Gates Foundation [48968]; International Fulbright Science
   & Technology Fellowship from the U.S. Department of State
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   N. F. was supported by an International Fulbright Science & Technology
   Fellowship from the U.S. Department of State.
CR Anderson CE, 2004, CYTOPATHOLOGY, V15, P256, DOI 10.1111/j.1365-2303.2004.00161.x
   Ben Shimol S, 2012, EUR J PEDIATR, V171, P369, DOI 10.1007/s00431-011-1543-1
   Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI 10.1093/cid/cir531
   Bruce N, 2007, B WORLD HEALTH ORGAN, V85, P535, DOI 10.2471/BLT.06.035832
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089
   FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L
   Fleiss JL, 2003, STAT METHODS RATES P
   Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2
   Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f
   Hazir T, 2006, BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80
   Hortal M, 2007, INT J INFECT DIS, V11, P273, DOI 10.1016/j.ijid.2006.05.006
   International Vaccine Access Center, PERCH STUD DOC
   Key NK, 2011, INDIAN PEDIATR, V48, P873, DOI 10.1007/s13312-011-0142-6
   Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Levinsky Y, 2013, ACTA PAEDIATR, V102, pe310, DOI 10.1111/apa.12249
   Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af
   Lucero MG, 2005, LANCET, V365, P1113, DOI 10.1016/S0140-6736(05)71853-5
   Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828
   Madhi SA, 2007, VACCINE, V25, P2413, DOI 10.1016/j.vaccine.2006.09.010
   Magree HC, 2005, B WORLD HEALTH ORGAN, V83, P427
   Melia J, 2006, HISTOPATHOLOGY, V48, P644, DOI 10.1111/j.1365-2559.2006.02393.x
   Neuman MI, 2012, J HOSP MED, V7, P294, DOI 10.1002/jhm.955
   Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060
   Verani JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083600
   World Health Organization, 2001, STAND INT CHEST RAD
   Williams GJ, 2013, PEDIATR PULM, V48, P1195, DOI 10.1002/ppul.22806
   Xavier-Souza G, 2013, PEDIATR PULM, V48, P464, DOI 10.1002/ppul.22644
NR 32
TC 9
Z9 9
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S253
EP S261
DI 10.1093/cid/cix082
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300010
PM 28575359
OA No
DA 2017-08-15
ER

PT J
AU Fancourt, N
   Knoll, MD
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Murdoch, DR
   Scott, JAG
   Thea, DM
   Awori, JO
   Barger-Kamate, B
   Chipeta, J
   DeLuca, AN
   Diallo, M
   Driscoll, AJ
   Ebruke, BE
   Higdon, MM
   Jahan, Y
   Karron, RA
   Mahomed, N
   Moore, DP
   Nahar, K
   Naorat, S
   Ominde, MS
   Park, DE
   Prosperi, C
   Somwe, SW
   Thamthitiwat, S
   Zaman, SMA
   Zeger, SL
   O'Brien, KL
AF Fancourt, Nicholas
   Knoll, Maria Deloria
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R. )
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Murdoch, David R.
   Scott, J. Anthony G.
   Thea, Donald M.
   Awori, Juliet O.
   Barger-Kamate, Breanna
   Chipeta, James
   DeLuca, Andrea N.
   Diallo, Mahamadou
   Driscoll, Amanda J.
   Ebruke, Bernard E.
   Higdon, Melissa M.
   Jahan, Yasmin
   Karron, Ruth A.
   Mahomed, Nasreen
   Moore, David P.
   Nahar, Kamrun
   Naorat, Sathapana
   Ominde, Micah Silaba
   Park, Daniel E.
   Prosperi, Christine
   Somwe, Wa Somwe
   Thamthitiwat, Somsak
   Zaman, Syed M. A.
   Zeger, Scott L.
   O'Brien, Katherine L.
CA PERCH Study Grp
TI Chest Radiograph Findings in Childhood Pneumonia Cases From the
   Multisite PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE chest radiograph; pneumonia; pediatrics; signs and symptoms; mortality
ID ETIOLOGY RESEARCH; CONFIRMED PNEUMONIA; CLINICAL-FEATURES; CONJUGATE
   VACCINE; HEALTH PROJECT; CHILDREN; DIAGNOSIS; CRITERIA; DEFINITION
AB Background. Chest radiographs (CXRs) are frequently used to assess pneumonia cases. Variations in CXR appearances between epidemiological settings and their correlation with clinical signs are not well documented.
   Methods. The Pneumonia Etiology Research for Child Health project enrolled 4232 cases of hospitalized World Health Organization (WHO)-defined severe and very severe pneumonia from 9 sites in 7 countries (Bangladesh, the Gambia, Kenya, Mali, South Africa, Thailand, and Zambia). At admission, each case underwent a standardized assessment of clinical signs and pneumonia risk factors by trained health personnel, and a CXR was taken that was interpreted using the standardized WHO methodology. CXRs were categorized as abnormal (consolidation and/or other infiltrate), normal, or uninterpretable.
   Results. CXRs were interpretable in 3587 (85%) cases, of which 1935 (54%) were abnormal (site range, 35%-64%). Cases with abnormal CXRs were more likely than those with normal CXRs to have hypoxemia (45% vs 26%), crackles (69% vs 62%), tachypnea (85% vs 80%), or fever (20% vs 16%) and less likely to have wheeze (30% vs 38%; all P < .05). CXR consolidation was associated with a higher case fatality ratio at 30-day follow-up (13.5%) compared to other infiltrate (4.7%) or normal (4.9%) CXRs.
   Conclusions. Clinically diagnosed pneumonia cases with abnormal CXRs were more likely to have signs typically associated with pneumonia. However, CXR-normal cases were common, and clinical signs considered indicative of pneumonia were present in substantial proportions of these cases. CXR-consolidation cases represent a group with an increased likelihood of death at 30 days post-discharge.
C1 [Fancourt, Nicholas; Knoll, Maria Deloria; Feikin, Daniel R. ); Hammitt, Laura L.; Levine, Orin S.; DeLuca, Andrea N.; Driscoll, Amanda J.; Higdon, Melissa M.; Park, Daniel E.; Prosperi, Christine; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Fancourt, Nicholas] Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia.
   [Fancourt, Nicholas] Royal Childrens Hosp, Melbourne, Vic, Australia.
   [Baggett, Henry C.; Naorat, Sathapana; Thamthitiwat, Somsak] Thailand Minist Publ Health US Centers Dis Contro, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Jahan, Yasmin; Nahar, Kamrun] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Jahan, Yasmin; Nahar, Kamrun] Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Feikin, Daniel R. )] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.; Awori, Juliet O.; Ominde, Micah Silaba] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Howie, Stephen R. C.; Ebruke, Bernard E.; Zaman, Syed M. A.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Mahomed, Nasreen; Moore, David P.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa.
   [Madhi, Shabir A.; Moore, David P.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Barger-Kamate, Breanna] Johns Hopkins Sch Med, Div Emergency Med, Dept Paediat, Baltimore, MD USA.
   [Barger-Kamate, Breanna] Spokane Emergency Phys, Washington, DC USA.
   [Chipeta, James; Somwe, Wa Somwe] Univ Zambia, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia.
   [Chipeta, James] Univ Teaching Hosp, Lusaka, Zambia.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Diallo, Mahamadou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Mahomed, Nasreen] Univ Witwatersrand, Dept Diagnost Radiol, Johannesburg, South Africa.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
   [Zaman, Syed M. A.] London Sch Hyg & Trop Med, London, England.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
RP Fancourt, N (reprint author), Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia.
EM nfancourt@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]; International Fulbright Science and Technology Fellowship from
   the US Department of State
FX PERCH was supported by a grant from the Bill & Melinda Gates Foundation
   to the International Vaccine Access Center, Department of International
   Health, Johns Hopkins Bloomberg School of Public Health (grant 48968).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (098532). N. F. was supported by an International
   Fulbright Science and Technology Fellowship from the US Department of
   State.
CR Baqui AH, 2007, PEDIATR INFECT DIS J, V26, P565, DOI 10.1097/INF.0b013e31806166a0
   Cardoso MRA, 2011, ARCH DIS CHILD, V96, P58, DOI 10.1136/adc.2010.189894
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x
   Erdman LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137592
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   Fontoura MS, 2012, INDIAN PEDIATR, V49, P363
   Hazir T, 2006, INT J TUBERC LUNG D, V10, P924
   Hazir T, 2006, BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Lupisan SP, 2007, TROP MED INT HEALTH, V12, P962, DOI 10.1111/j.1365-3156.2007.01872.x
   Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989
   Madhi SA, 2007, VACCINE, V25, P2413, DOI 10.1016/j.vaccine.2006.09.010
   Magree HC, 2005, B WORLD HEALTH ORGAN, V83, P427
   Mahabee-Gittens EM, 2005, CLIN PEDIATR, V44, P427, DOI 10.1177/000992280504400508
   Modi P, 2013, J EMERG MED, V45, P752, DOI 10.1016/j.jemermed.2013.04.041
   Muangchana C, 2009, SE ASIAN J TROP MED, V40, P563
   Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030
   SWISCHUK LE, 1986, PEDIATR RADIOL, V16, P278, DOI 10.1007/BF02386862
   World Health Organization, 2001, STAND INT CHEST RAD
NR 25
TC 5
Z9 5
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S262
EP S270
DI 10.1093/cid/cix089
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300011
PM 28575361
OA No
DA 2017-08-15
ER

PT J
AU Feikin, DR
   Fu, W
   Park, DE
   Shi, QY
   Higdon, MM
   Baggett, HC
   Brooks, WA
   Knoll, MD
   Hammitt, LL
   Howie, SRC
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Scott, JAG
   Thea, DM
   Adrian, PV
   Antonio, M
   Awori, JO
   Baillie, VL
   DeLuca, AN
   Driscoll, AJ
   Ebruke, BE
   Goswami, D
   Karron, RA
   Li, MY
   Morpeth, SC
   Mwaba, J
   Mwansa, J
   Prosperi, C
   Sawatwong, P
   Sow, SO
   Tapia, MD
   Whistler, T
   Zaman, K
   Zeger, SL
   Brien, KLO
   Murdoch, DR
AF Feikin, Daniel R.
   Fu, Wei
   Park, Daniel E.
   Shi, Qiyuan
   Higdon, Melissa M.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Knoll, Maria Deloria
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Scott, J. Anthony G.
   Thea, Donald M.
   Adrian, Peter V.
   Antonio, Martin
   Awori, Juliet O.
   Baillie, Vicky L.
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Ebruke, Bernard E.
   Goswami, Doli
   Karron, Ruth A.
   Li, Mengying
   Morpeth, Susan C.
   Mwaba, John
   Mwansa, James
   Prosperi, Christine
   Sawatwong, Pongpun
   Sow, Samba O.
   Tapia, Milagritos D.
   Whistler, Toni
   Zaman, Khalequ
   Zeger, Scott L.
   Brien, Katherine L. O'
   Murdoch, David R.
CA Perch Study Grp
TI Is Higher Viral Load in the Upper Respiratory Tract Associated With
   Severe Pneumonia? Findings From the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; viral load; viral density; RSV; PERCH
ID HUMAN METAPNEUMOVIRUS INFECTION; SYNCYTIAL VIRUS; DISEASE SEVERITY;
   HOSPITALIZED INFANTS; ETIOLOGY RESEARCH; PANDEMIC H1N1; CUTOFF VALUES;
   CHILD HEALTH; DIAGNOSIS; QUANTIFICATION
AB Background. The etiologic inference of identifying a pathogen in the upper respiratory tract (URT) of children with pneumonia is unclear. To determine if viral load could provide evidence of causality of pneumonia, we compared viral load in the URT of children with World Health Organization-defined severe and very severe pneumonia and age-matched community controls.
   Methods. In the 9 developing country sites, nasopharyngeal/oropharyngeal swabs from children with and without pneumonia were tested using quantitative real-time polymerase chain reaction for 17 viruses. The association of viral load with case status was evaluated using logistic regression. Receiver operating characteristic (ROC) curves were constructed to determine optimal discriminatory viral load cutoffs. Viral load density distributions were plotted.
   Results. The mean viral load was higher in cases than controls for 7 viruses. However, there was substantial overlap in viral load distribution of cases and controls for all viruses. ROC curves to determine the optimal viral load cutoff produced an area under the curve of <0.80 for all viruses, suggesting poor to fair discrimination between cases and controls. Fatal and very severe pneumonia cases did not have higher viral load than less severe cases for most viruses.
   Conclusions. Although we found higher viral loads among pneumonia cases than controls for some viruses, the utility in using viral load of URT specimens to define viral pneumonia was equivocal. Our analysis was limited by lack of a gold standard for viral pneumonia.
C1 [Feikin, Daniel R.; Fu, Wei; Park, Daniel E.; Shi, Qiyuan; Higdon, Melissa M.; Knoll, Maria Deloria; Hammitt, Laura L.; Levine, Orin S.; DeLuca, Andrea N.; Driscoll, Amanda J.; Li, Mengying; Prosperi, Christine; Brien, Katherine L. O'] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Fu, Wei] Johns Hopkins Sch Med, Dept Rheumatol, Baltimore, MD USA.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA.
   [Baggett, Henry C.; Sawatwong, Pongpun; Whistler, Toni] Thailand Minist Publ Health US Centers Dis Contro, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.; Whistler, Toni] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Brooks, W. Abdullah; Goswami, Doli; Zaman, Khalequ] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Goswami, Doli; Zaman, Khalequ] Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Hammitt, Laura L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Scott, J. Anthony G.; Awori, Juliet O.] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Howie, Stephen R. C.; Antonio, Martin; Ebruke, Bernard E.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.; Tapia, Milagritos D.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Adrian, Peter V.; Baillie, Vicky L.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa.
   [Adrian, Peter V.; Baillie, Vicky L.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Scott, J. Anthony G.; Morpeth, Susan C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Antonio, Martin] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Coventry, W Midlands, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Li, Mengying] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
   [Morpeth, Susan C.] Cty Manukau Dist Hlth Board, Middlemore Hosp, Microbiol Lab, Auckland, New Zealand.
   [Mwaba, John; Mwansa, James] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Mwaba, John; Mwansa, James] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia.
   [Sow, Samba O.] Ctr Dev Vaccins, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
RP Feikin, DR (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, 415 N Washington St,Room 563, Baltimore, MD 21231 USA.
EM drf3217@gmail.com
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859
   Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100
   Bosis S, 2008, J CLIN VIROL, V42, P286, DOI 10.1016/j.jcv.2008.03.029
   Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI [10.1164/rccm.201002-0221OC, 10.1164/rccm.201002.0221OC]
   DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x
   Falade AG, 1997, ANN TROP PAEDIATR, V17, P315
   Feikin DR, 2015, EMERG INFECT DIS, V21, P2029, DOI 10.3201/eid2111.150764
   Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026
   Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007
   Fuller JA, 2013, J MED VIROL, V85, P924, DOI 10.1002/jmv.23455
   Gerna G, 2007, J CLIN VIROL, V40, P236, DOI 10.1016/j.jcv.2007.08.001
   HALL CB, 1979, J INFECT DIS, V140, P610
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068
   Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771
   Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10
   Jansen RR, 2010, PEDIATR INFECT DIS J, V29, P82, DOI 10.1097/INF.0b013e3181b6de8a
   Knoll MD, 2017, CLIN INFECT DIS, V64, pS213, DOI 10.1093/cid/cix144
   Lee CK, 2011, EMERG INFECT DIS, V17, P287, DOI 10.3201/eid1702.100282
   Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032
   Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918
   Lu PX, 2010, NATL CENT BIOTECHNOL, V33, P746
   Martin ET, 2008, DIAGN MICR INFEC DIS, V62, P382, DOI 10.1016/j.diagmicrobio.2008.08.002
   Meschi S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-140
   Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09
   Park DE, 2017, CLIN INFECT DIS, V64, pS328, DOI 10.1093/cid/cix104
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581
   Utokaparch S, 2011, PEDIATR INFECT DIS J, V30, pE18, DOI 10.1097/INF.0b013e3181ff2fac
   Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   Zhao BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062318
NR 38
TC 4
Z9 4
U1 3
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S337
EP S346
DI 10.1093/cid/cix148
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300019
PM 28575373
OA No
DA 2017-08-15
ER

PT J
AU Higdon, MM
   Le, T
   O'Brien, KL
   Murdoch, DR
   Prosperi, C
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Kotloff, KL
   Levine, OS
   Scott, JAG
   Thea, DM
   Awori, JO
   Baillie, VL
   Cascio, S
   Chuananon, S
   DeLuca, AN
   Driscoll, AJ
   Ebruke, BE
   Endtz, HP
   Kaewpan, A
   Kahn, G
   Karani, A
   Karron, RA
   Moore, DP
   Park, DE
   Rahman, MZ
   Salaudeen, R
   Seidenberg, P
   Somwe, SW
   Sylla, M
   Tapia, MD
   Zeger, SL
   Knoll, MD
   Madhi, SA
AF Higdon, Melissa M.
   Tham Le
   O'Brien, Katherine L.
   Murdoch, David R.
   Prosperi, Christine
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   Scott, J. Anthony G.
   Thea, Donald M.
   Awori, Juliet O.
   Baillie, Vicky L.
   Cascio, Stephanie
   Chuananon, Somchai
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Ebruke, Bernard E.
   Endtz, Hubert P.
   Kaewpan, Anek
   Kahn, Geoff
   Karani, Angela
   Karron, Ruth A.
   Moore, David P.
   Park, Daniel E.
   Rahman, Mohammed Ziaur
   Salaudeen, Rasheed
   Seidenberg, Phil
   Somwe, Wa Somwe
   Sylla, Mamadou
   Tapia, Milagritos D.
   Zeger, Scott L.
   Knoll, Maria Deloria
   Madhi, Shabir A.
CA PERCH Study Grp
TI Association of C-Reactive Protein With Bacterial and Respiratory
   Syncytial Virus-Associated Pneumonia Among Children Aged < 5 Years in
   the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE C-reactive protein; bacteria; RSV; biomarker; pneumonia
ID COMMUNITY-ACQUIRED PNEUMONIA; ERYTHROCYTE SEDIMENTATION-RATE; SERUM
   PROCALCITONIN; TRACT INFECTIONS; HOSPITALIZED CHILDREN; HUMAN
   METAPNEUMOVIRUS; ETIOLOGY RESEARCH; LOBAR PNEUMONIA; VIRAL PNEUMONIA;
   HEALTH PROJECT
AB Background. Lack of a gold standard for identifying bacterial and viral etiologies of pneumonia has limited evaluation of C-reactive protein (CRP) for identifying bacterial pneumonia. We evaluated the sensitivity and specificity of CRP for identifying bacterial vs respiratory syncytial virus (RSV) pneumonia in the Pneumonia Etiology Research for Child Health (PERCH) multicenter case-control study.
   Methods. We measured serum CRP levels in cases with World Health Organization-defined severe or very severe pneumonia and a subset of community controls. We evaluated the sensitivity and specificity of elevated CRP for "confirmed" bacterial pneumonia (positive blood culture or positive lung aspirate or pleural fluid culture or polymerase chain reaction [PCR]) compared to "RSV pneumonia" (nasopharyngeal/oropharyngeal or induced sputum PCR-positive without confirmed/suspected bacterial pneumonia). Receiver operating characteristic (ROC) curves were constructed to assess the performance of elevated CRP in distinguishing these cases.
   Results. Among 601 human immunodeficiency virus (HIV)-negative tested controls, 3% had CRP >= 40 mg/L. Among 119 HIV-negative cases with confirmed bacterial pneumonia, 77% had CRP >= 40 mg/L compared with 17% of 556 RSV pneumonia cases. The ROC analysis produced an area under the curve of 0.87, indicating very good discrimination; a cut-point of 37.1 mg/L best discriminated confirmed bacterial pneumonia (sensitivity 77%) from RSV pneumonia (specificity 82%). CRP >= 100 mg/L substantially improved specificity over CRP >= 40 mg/L, though at a loss to sensitivity.
   Conclusions. Elevated CRP was positively associated with confirmed bacterial pneumonia and negatively associated with RSV pneumonia in PERCH. CRP may be useful for distinguishing bacterial from RSV-associated pneumonia, although its role in discriminating against other respiratory viral-associated pneumonia needs further study.
C1 [Higdon, Melissa M.; Tham Le; O'Brien, Katherine L.; Prosperi, Christine; Feikin, Daniel R.; Hammitt, Laura L.; Levine, Orin S.; Cascio, Stephanie; DeLuca, Andrea N.; Driscoll, Amanda J.; Ebruke, Bernard E.; Kahn, Geoff; Park, Daniel E.; Knoll, Maria Deloria] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Washington St,Rm 561, Baltimore, MD 21231 USA.
   [Tham Le] Univ Maryland, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Baggett, Henry C.; Kaewpan, Anek] Thailand Minist Publ Health US Ctr Dis Control &, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah; Endtz, Hubert P.; Rahman, Mohammed Ziaur] Icddr B, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Driscoll, Amanda J.; Endtz, Hubert P.] Icddr B, Matlab, Bangladesh.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.; Awori, Juliet O.; Karani, Angela] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Howie, Stephen R. C.; Ebruke, Bernard E.; Salaudeen, Rasheed] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.; Ebruke, Bernard E.; Salaudeen, Rasheed] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.; Tapia, Milagritos D.] Univ Maryland, Sch Med, Div Infect Dis & Trop Pediat, Dept Pediat,Ctr Vaccine Dev,Inst Global Hlth, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.; Seidenberg, Phil] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Baillie, Vicky L.; Moore, David P.; Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Baillie, Vicky L.; Moore, David P.; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Vaccine Preventable Dis Unit, Johannesburg, South Africa.
   [Chuananon, Somchai] Nakhon Phanom Prov Hosp, Nai Mueang, Thailand.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Endtz, Hubert P.] Erasmus MC, Dept Clin Microbiol & Infect Dis, Rotterdam, Netherlands.
   [Endtz, Hubert P.] Fdn Merieux, Lyon, France.
   [Kahn, Geoff] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Mental Hlth, Baltimore, MD USA.
   [Kahn, Geoff; Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Int Hlth, Baltimore, MD USA.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
   [Salaudeen, Rasheed] Lagos Univ, Med Microbiol Dept, Teaching Hosp, Lagos, Nigeria.
   [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA.
   [Somwe, Wa Somwe] Univ Zambia Lusaka, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia.
   [Sylla, Mamadou] Ctr Dev Vaccins CVD Mali Bamako, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
RP Higdon, MM (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Washington St,Rm 561, Baltimore, MD 21231 USA.
EM mhigdon@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100
   Celik Tanju, 2015, Turkiye Parazitoloji Dergisi, V39, P205, DOI 10.5152/tpd.2015.3963
   Chan PC, 2007, J FORMOS MED ASSOC, V106, P16
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Elemraid MA, 2014, DIAGN MICR INFEC DIS, V79, P458, DOI 10.1016/j.diagmicrobio.2014.04.006
   Falade AG, 1997, ANN TROP PAEDIATR, V17, P315
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   Gabay C, 1999, NEW ENGL J MED, V340, P448
   HANLEY JA, 1982, RADIOLOGY, V143, P29
   Heiskanen-Kosma T, 2000, SCAND J INFECT DIS, V32, P399
   Ip M, 2007, DIAGN MICR INFEC DIS, V59, P131, DOI 10.1016/j.diagmicrobio.2007.04.019
   Kawasaki Y, 2002, J CLIN VIROL, V21, P370
   Knoll MD, 2017, CLIN INFECT DIS, V64, pS357, DOI 10.1093/cid/cix149
   KORPPI M, 1993, SCAND J INFECT DIS, V25, P207, DOI 10.3109/00365549309008486
   Korppi M, 1997, EUR RESPIR J, V10, P1125, DOI 10.1183/09031936.97.10051125
   KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512
   Kruger S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-65
   Lala SG, 2002, ANN TROP PAEDIATR, V22, P271, DOI 10.1179/027249302125001570
   Lee JY, 2010, KOREAN J LAB MED, V30, P406, DOI 10.3343/kjlm.2010.30.4.406
   Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   MORLEY JJ, 1982, ANN NY ACAD SCI, V389, P406, DOI 10.1111/j.1749-6632.1982.tb22153.x
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Ning JJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005452
   NOHYNEK H, 1995, PEDIATR INFECT DIS J, V14, P484, DOI 10.1097/00006454-199506000-00004
   Nunes AA, 2004, PEDIATR PULM, V38, P135, DOI 10.1002/ppul.20044
   Park DE, 2017, CLIN INFECT DIS, V64, pS328, DOI 10.1093/cid/cix104
   Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921
   Pfister R, 2014, CRIT CARE, V18, DOI 10.1186/cc13760
   Rainer TH, 2009, J INFECTION, V58, P123, DOI 10.1016/j.jinf.2008.11.007
   Ribeiro M, 1997, BRAZ J MED BIOL RES, V30, P1055, DOI 10.1590/S0100-879X1997000900002
   RUUSKANEN O, 1985, J PEDIATR-US, V107, P97, DOI 10.1016/S0022-3476(85)80624-7
   Shimizu Y, 2015, PEDIATR INFECT DIS J, V34, P1273, DOI 10.1097/INF.0000000000000863
   ten Oever J, 2012, J INFECTION, V65, P490, DOI 10.1016/j.jinf.2012.08.004
   Tillett W S, 1930, J Exp Med, V52, P561
   Toikka P, 2000, PEDIATR INFECT DIS J, V19, P598, DOI 10.1097/00006454-200007000-00003
   TURNER RB, 1987, J PEDIATR-US, V111, P194
   Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438
   World Health Organization, 2005, POCK BOOK HOSP CAR C
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 42
TC 2
Z9 2
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S378
EP S386
DI 10.1093/cid/cix150
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300023
PM 28575375
OA No
DA 2017-08-15
ER

PT J
AU Higdon, MM
   Hammitt, LL
   Knoll, MD
   Baggett, HC
   Brooks, WA
   Howie, SRC
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Murdoch, DR
   Scott, JAG
   Thea, DM
   Driscoll, AJ
   Karron, RA
   Park, DE
   Prosperi, C
   Zeger, SL
   O'Brien, KL
   Feikin, DR
AF Higdon, Melissa M.
   Hammitt, Laura L.
   Knoll, Maria Deloria
   Baggett, Henry C.
   Brooks, W. Abdullah
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Murdoch, David R.
   Scott, J. Anthony G.
   Thea, Donald M.
   Driscoll, Amanda J.
   Karron, Ruth A.
   Park, Daniel E.
   Prosperi, Christine
   Zeger, Scott L.
   O'Brien, Katherine L.
   Feikin, Daniel R.
CA PERCH Study Grp
TI Should Controls With Respiratory Symptoms Be Excluded From Case-Control
   Studies of Pneumonia Etiology? Reflections From the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE PERCH; control selection; respiratory symptoms; pneumonia etiology;
   selection bias
ID PNEUMOCOCCAL CONJUGATE VACCINE; COMMUNITY-ACQUIRED PNEUMONIA; CHILDHOOD
   PNEUMONIA; BACTERIAL PNEUMONIA; CHILDREN; HEALTH; HOSPITALIZATION;
   COUNTRIES; PROTOCOL; VIRUSES
AB Many pneumonia etiology case-control studies exclude controls with respiratory illness from enrollment or analyses. Herein we argue that selecting controls regardless of respiratory symptoms provides the least biased estimates of pneumonia etiology. We review 3 reasons investigators may choose to exclude controls with respiratory symptoms in light of epidemiologic principles of control selection and present data from the Pneumonia Etiology Research for Child Health (PERCH) study where relevant to assess their validity. We conclude that exclusion of controls with respiratory symptoms will result in biased estimates of etiology. Randomly selected community controls, with or without respiratory symptoms, as long as they do not meet the criteria for case-defining pneumonia, are most representative of the general population from which cases arose and the least subject to selection bias.
C1 [Higdon, Melissa M.; Hammitt, Laura L.; Knoll, Maria Deloria; Levine, Orin S.; Driscoll, Amanda J.; Park, Daniel E.; Prosperi, Christine; O'Brien, Katherine L.; Feikin, Daniel R.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Washington St,Rm 561, Baltimore, MD 21231 USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Baggett, Henry C.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Health, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Brooks, W. Abdullah] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Howie, Stephen R. C.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.; Karron, Ruth A.] Univ Maryland, Sch Med, Inst Global Hlth,Dep Pediat, Ctr Vaccine Dev,Div Infect Dis & Trop Pediat, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Park, Daniel E.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA.
RP Higdon, MM (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, 415 N Washington St,Rm 561, Baltimore, MD 21231 USA.
EM mhigdon@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Ayieko P, 2007, PEDIATR INFECT DIS J, V26, P432, DOI 10.1097/01.inf.0000260107.79355.7d
   Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675
   Cesar JA, 1999, BRIT MED J, V318, P1316
   Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   de la Hoz F, 2004, VACCINE, V23, P36, DOI 10.1016/j.vaccine.2004.05.017
   Deceuninck G, 2010, PEDIATR INFECT DIS J, V29, P546, DOI 10.1097/INF.0b013e3181cffa2a
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Feikin DR, 2012, PEDIATR INFECT DIS J, V32, P1
   Grant CC, 2012, J PAEDIATR CHILD H, V48, P402, DOI 10.1111/j.1440-1754.2011.02244.x
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071
   Howie SRC, 2016, INT J TUBERC LUNG D, V20, P1405, DOI 10.5588/ijtld.15.0993
   Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870
   Jary H, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0090-3
   Karki S, 2014, Kathmandu Univ Med J (KUMJ), V12, P247
   Madhi SA, 2015, THORAX, V70, P1149, DOI 10.1136/thoraxjnl-2014-206593
   Mathisen M, 2010, PEDIATR INFECT DIS J, V29, P731, DOI 10.1097/INF.0b013e3181d9bcce
   Picot VS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0635-8
   Pilishvili T, 2013, J PEDIATR-US, V163, pS12, DOI 10.1016/j.jpeds.2013.03.025
   Poole C, 1999, AM J EPIDEMIOL, V150, P547
   Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769
   Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323
   Shi T, 2015, J GLOB HEALTH, V5, P122, DOI 10.7189/jogh.05.010408
   WHO, 2013, POCK BOOK HOSP CAR C
   Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5
NR 26
TC 2
Z9 2
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S205
EP S212
DI 10.1093/cid/cix076
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300005
PM 28575354
OA No
DA 2017-08-15
ER

PT J
AU Knoll, MD
   Morpeth, SC
   Scott, JAG
   Watson, NL
   Park, DE
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Kotloff, KL
   Levine, OS
   O'Brien, KL
   Thea, DM
   Ahmed, D
   Antonio, M
   Awori, JO
   Baillie, VL
   Chipeta, J
   Deluca, AN
   Dione, M
   Driscoll, AJ
   Higdon, MM
   Jatapai, A
   Karron, RA
   Mazumder, R
   Moore, DP
   Mwansa, J
   Nyongesa, S
   Prosperi, C
   Seidenberg, P
   Siludjai, D
   Sow, SO
   Tamboura, B
   Zeger, SL
   Murdoch, DR
   Madhi, SA
AF Knoll, Maria Deloria
   Morpeth, Susan C.
   Scott, J. Anthony G.
   Watson, Nora L.
   Park, Daniel E.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   O'Brien, Katherine L.
   Thea, Donald M.
   Ahmed, Dilruba
   Antonio, Martin
   Awori, Juliet O.
   Baillie, Vicky L.
   Chipeta, James
   Deluca, Andrea N.
   Dione, Michel
   Driscoll, Amanda J.
   Higdon, Melissa M.
   Jatapai, Anchalee
   Karron, Ruth A.
   Mazumder, Razib
   Moore, David P.
   Mwansa, James
   Nyongesa, Sammy
   Prosperi, Christine
   Seidenberg, Phil
   Siludjai, Duangkamon
   Sow, Samba O.
   Tamboura, Boubou
   Zeger, Scott L.
   Murdoch, David R.
   Madhi, Shabir A.
CA PERCH Study Grp
TI Evaluation of Pneumococcal Load in Blood by Polymerase Chain Reaction
   for the Diagnosis of Pneumococcal Pneumonia in Young Children in the
   PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; pneumococcus; PCR; blood; diagnosis
ID STREPTOCOCCUS-PNEUMONIAE; ETIOLOGY RESEARCH; HEALTH PROJECT; BACTEREMIA;
   DISEASE; TIME; MAGNITUDE; SELECTION; SEVERITY; CULTURES
AB Background. Detection of pneumococcus by lytA polymerase chain reaction (PCR) in blood had poor diagnostic accuracy for diagnosing pneumococcal pneumonia in children in 9 African and Asian sites. We assessed the value of blood lytA quantification in diagnosing pneumococcal pneumonia.
   Methods. The Pneumonia Etiology Research for Child Health (PERCH) case-control study tested whole blood by PCR for pneumococcus in children aged 1-59 months hospitalized with signs of pneumonia and in age-frequency matched community controls. The distribution of load among PCR-positive participants was compared between microbiologically confirmed pneumococcal pneumonia (MCPP) cases, cases confirmed for nonpneumococcal pathogens, nonconfirmed cases, and controls. Receiver operating characteristic analyses determined the "optimal threshold" that distinguished MCPP cases from controls.
   Results. Load was available for 290 of 291 cases with pneumococcal PCR detected in blood and 273 of 273 controls. Load was higher in MCPP cases than controls (median, 4.0 x 10(3) vs 0.19 x 10(3) copies/mL), but overlapped substantially (range, 0.16-989.9 x 10(3) copies/mL and 0.01-551.9 x 10(3) copies/mL, respectively). The proportion with high load (>= 2.2 log(10) copies/mL) was 62.5% among MCPP cases, 4.3% among nonconfirmed cases, 9.3% among cases confirmed for a nonpneumococcal pathogen, and 3.1% among controls. Pneumococcal load in blood was not associated with respiratory tract illness in controls (P = .32). High blood pneumococcal load was associated with alveolar consolidation on chest radiograph in nonconfirmed cases, and with high (>6.9 log(10) copies/mL) nasopharyngeal/oropharyngeal load and C-reactive protein >= 40 mg/L (both P < .01) in nonconfirmed cases but not controls.
   Conclusions. Quantitative pneumococcal PCR in blood has limited diagnostic utility for identifying pneumococcal pneumonia in individual children, but may be informative in epidemiological studies.
C1 [Knoll, Maria Deloria; Park, Daniel E.; Feikin, Daniel R.; Hammitt, Laura L.; Levine, Orin S.; O'Brien, Katherine L.; Driscoll, Amanda J.; Higdon, Melissa M.; Prosperi, Christine] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Morpeth, Susan C.; Scott, J. Anthony G.; Hammitt, Laura L.; Awori, Juliet O.; Nyongesa, Sammy] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Morpeth, Susan C.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Morpeth, Susan C.] Middlemore Hosp, Counties Manukau Dist Hlth Board, Microbiol Lab, Auckland, New Zealand.
   [Watson, Nora L.] Emmes Corp, Rockville, MD USA.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst, Sch Publ Hlth, Washington, DC 20052 USA.
   [Baggett, Henry C.; Jatapai, Anchalee; Siludjai, Duangkamon] Thailand Minist Publ Health US Ctr Dis Control &, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Mazumder, Razib] Icddr B, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Mazumder, Razib] Icddr B, Matlab, Bangladesh.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Howie, Stephen R. C.; Antonio, Martin; Dione, Michel] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Div Infect Dis & Trop Pediat,Dept Pediat,Inst Glo, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Thea, Donald M.; Seidenberg, Phil] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Antonio, Martin] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [Baillie, Vicky L.; Moore, David P.; Madhi, Shabir A.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa.
   [Baillie, Vicky L.; Moore, David P.; Madhi, Shabir A.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Chipeta, James] Univ Zambia, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia.
   [Chipeta, James] Univ Teaching Hosp, Lusaka, Zambia.
   [Deluca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Dione, Michel] Int Livestock Res Inst, Kampala, Uganda.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwansa, James] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Mwansa, James] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia.
   [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA.
   [Sow, Samba O.; Tamboura, Boubou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
RP Knoll, MD (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, 415 N Washington St,Rm 549, Baltimore, MD 21231 USA.
EM mknoll2@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Azzari C, 2011, J MED MICROBIOL, V60, P710, DOI 10.1099/jmm.0.028357-0
   Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100
   BELL LM, 1985, PEDIATRICS, V76, P901
   Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61
   Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS368, DOI 10.1093/cid/cix101
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089
   Ideh RC, 2011, INT J TUBERC LUNG D, V15, P729, DOI 10.5588/ijtld.10.0468
   Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Morpeth SC, 2017, CLIN INFECT DIS, V64, pS347, DOI 10.1093/cid/cix145
   Peralta G, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-79
   Peters RPH, 2009, J CLIN MICROBIOL, V47, P3308, DOI 10.1128/JCM.01071-09
   Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258
   Rouphael N, 2011, DIAGN MICR INFEC DIS, V70, P452, DOI 10.1016/j.diagmicrobio.2010.09.006
   Song Joon Young, 2013, Infect Chemother, V45, P351, DOI 10.3947/ic.2013.45.4.351
   SULLIVAN TD, 1982, PEDIATRICS, V69, P699
   Werno AM, 2012, J MED MICROBIOL, V61, P1129, DOI 10.1099/jmm.0.044107-0
   Wolter N, 2014, J INFECT DIS, V209, P56, DOI 10.1093/infdis/jit427
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 23
TC 4
Z9 4
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S357
EP S367
DI 10.1093/cid/cix149
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300021
OA No
DA 2017-08-15
ER

PT J
AU Knoll, MD
   Fu, W
   Shi, QY
   Prosperi, C
   Wu, ZK
   Hammitt, LL
   Feikin, DR
   Baggett, HC
   Howie, SRC
   Scott, JAG
   Murdoch, DR
   Madhi, SA
   Thea, DM
   Brooks, WA
   Kotloff, KL
   Li, MY
   Park, DE
   Lin, WY
   Levine, OS
   O'Brien, KL
   Zeger, SL
AF Knoll, Maria Deloria
   Fu, Wei
   Shi, Qiyuan
   Prosperi, Christine
   Wu, Zhenke
   Hammitt, Laura L.
   Feikin, Daniel R.
   Baggett, Henry C.
   Howie, Stephen R. C.
   Scott, J. Anthony G.
   Murdoch, David R.
   Madhi, Shabir A.
   Thea, Donald M.
   Brooks, W. Abdullah
   Kotloff, Karen L.
   Li, Mengying
   Park, Daniel E.
   Lin, Wenyi
   Levine, Orin S.
   O'Brien, Katherine L.
   Zeger, Scott L.
TI Bayesian Estimation of Pneumonia Etiology: Epidemiologic Considerations
   and Applications to the Pneumonia Etiology Research for Child Health
   Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Bayes theorem; etiologic estimations; pneumonia; epidemiologic methods;
   statistical models
ID PROJECT
AB In pneumonia, specimens are rarely obtained directly from the infection site, the lung, so the pathogen causing infection is determined indirectly from multiple tests on peripheral clinical specimens, which may have imperfect and uncertain sensitivity and specificity, so inference about the cause is complex. Analytic approaches have included expert review of case-only results, case-control logistic regression, latent class analysis, and attributable fraction, but each has serious limitations and none naturally integrate multiple test results. The Pneumonia Etiology Research for Child Health (PERCH) study required an analytic solution appropriate for a case-control design that could incorporate evidence from multiple specimens from cases and controls and that accounted for measurement error. We describe a Bayesian integrated approach we developed that combined and extended elements of attributable fraction and latent class analyses to meet some of these challenges and illustrate the advantage it confers regarding the challenges identified for other methods.
C1 [Knoll, Maria Deloria; Fu, Wei; Shi, Qiyuan; Prosperi, Christine; Hammitt, Laura L.; Feikin, Daniel R.; Li, Mengying; Park, Daniel E.; Levine, Orin S.; O'Brien, Katherine L.] Johns Hopkins Sch Med, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD USA.
   [Wu, Zhenke; Lin, Wenyi; Zeger, Scott L.] Johns Hopkins Sch Med, Dept Biostat, Baltimore, MD USA.
   [Brooks, W. Abdullah] Johns Hopkins Sch Med, Dept Int Hlth, Baltimore, MD USA.
   [Li, Mengying] Johns Hopkins Sch Med, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
   [Fu, Wei] Johns Hopkins Sch Med, Dept Rheumatol, Baltimore, MD USA.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Ctr Vaccine Dev,Inst Global Hlth, Div Infect Dis & Trop Pediat,Dept Pediat, Baltimore, MD 21201 USA.
   [Wu, Zhenke] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Feikin, Daniel R.] Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Baggett, Henry C.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Howie, Stephen R. C.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Madhi, Shabir A.] MRC, Resp & Meningeal Pathogens Res Unit, London, England.
   [Madhi, Shabir A.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Brooks, W. Abdullah] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
RP Knoll, MD (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, 415 N Washington St,Room 549, Baltimore, MD 21231 USA.
EM mknoll2@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by grant 48968 from the Bill & Melinda Gates
   Foundation to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health.
   J. A. G. S. was supported by a clinical fellowship from The Wellcome
   Trust of Great Britain (098532).
CR Brooks S, 2011, CH CRC HANDB MOD STA, pXIX
   BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904
   Gelman A., 2014, BAYESIAN DATA ANAL
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Hammitt LL, 2017, CLIN INFECT DIS, V64, pS197, DOI 10.1093/cid/cix147
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Mcgrayne SB, 2011, THEORY WOULD NOT DIE
   Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070
   Plummer M., 2003, P 3 INT WORKSH DISTR
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Saha SK, 2016, PEDIATR INFECT DIS J, V35, pS16, DOI 10.1097/INF.0000000000001101
   Wu Z, 2016, BIOSTATISTICS
   Wu ZK, 2016, J R STAT SOC C-APPL, V65, P97, DOI 10.1111/rssc.12101
NR 15
TC 4
Z9 4
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S213
EP S227
DI 10.1093/cid/cix144
PG 15
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300006
OA No
DA 2017-08-15
ER

PT J
AU Morpeth, SC
   Knoll, MD
   Scott, JAG
   Park, DE
   Watson, NL
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Kotloff, KL
   Levine, OS
   Madhi, SA
   O'Brien, KL
   Thea, DM
   Adrian, PV
   Ahmed, D
   Antonio, M
   Bunthi, C
   DeLuca, AN
   Driscoll, AJ
   Githua, LP
   Higdon, MM
   Kahn, G
   Karani, A
   Karron, RA
   Kwenda, G
   Makprasert, S
   Mazumder, R
   Moore, DP
   Mwansa, J
   Nyongesa, S
   Prosperi, C
   Sow, SO
   Tamboura, B
   Whistler, T
   Zeger, SL
   Murdoch, DR
AF Morpeth, Susan C.
   Knoll, Maria Deloria
   Scott, J. Anthony G.
   Park, Daniel E.
   Watson, Nora L.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   O'Brien, Katherine L.
   Thea, Donald M.
   Adrian, Peter V.
   Ahmed, Dilruba
   Antonio, Martin
   Bunthi, Charatdao
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Githua, Louis Peter
   Higdon, Melissa M.
   Kahn, Geoff
   Karani, Angela
   Karron, Ruth A.
   Kwenda, Geoffrey
   Makprasert, Sirirat
   Mazumder, Razib
   Moore, David P.
   Mwansa, James
   Nyongesa, Sammy
   Prosperi, Christine
   Sow, Samba O.
   Tamboura, Boubou
   Whistler, Toni
   Zeger, Scott L.
   Murdoch, David R.
CA Perch Study Grp
TI Detection of Pneumococcal DNA in Blood by Polymerase Chain Reaction for
   Diagnosing Pneumococcal Pneumonia in Young Children From Low- and
   Middle-Income Countries
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; pneumococcus; PCR; blood; diagnosis
ID REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; LYTA GENE; IDENTIFICATION;
   DISEASE; INFECTIONS; SAMPLES; ASSAYS; PLY
AB Background. We investigated the performance of polymerase chain reaction (PCR) on blood in the diagnosis of pneumococcal pneumonia among children from 7 low-and middle-income countries.
   Methods. We tested blood by PCR for the pneumococcal autolysin gene in children aged 1-59 months in the Pneumonia Etiology Research for Child Health (PERCH) study. Children had World Health Organization-defined severe or very severe pneumonia or were age-frequency-matched community controls. Additionally, we tested blood from general pediatric admissions in Kilifi, Kenya, a PERCH site. The proportion PCR-positive was compared among cases with microbiologically confirmed pneumococcal pneumonia (MCPP), cases without a confirmed bacterial infection (nonconfirmed), cases confirmed for nonpneumococcal bacteria, and controls.
   Results. In PERCH, 7.3% (n = 291/3995) of cases and 5.5% (n = 273/4987) of controls were blood pneumococcal PCR-positive (P < .001), compared with 64.3% (n = 36/56) of MCPP cases and 6.3% (n = 243/3832) of nonconfirmed cases (P < .001). Blood pneumococcal PCR positivity was higher in children from the 5 African countries (5.5%-11.5% among cases and 5.3%-10.2% among controls) than from the 2 Asian countries (1.3% and 1.0% among cases and 0.8% and 0.8% among controls). Among Kilifi general pediatric admissions, 3.9% (n = 274/6968) were PCR-positive, including 61.7% (n = 37/60) of those with positive blood cultures for pneumococcus.
   Discussion. The utility of pneumococcal PCR on blood for diagnosing childhood pneumococcal pneumonia in the 7 low-and middle-income countries studied is limited by poor specificity and by poor sensitivity among MCPP cases.
C1 [Morpeth, Susan C.; Scott, J. Anthony G.; Hammitt, Laura L.; Karani, Angela; Nyongesa, Sammy] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Morpeth, Susan C.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Morpeth, Susan C.] Cty Manukau Dist Hlth Board, Middlemore Hosp, Microbiol Lab, Private Bag 93311, Auckland 1640, New Zealand.
   [Knoll, Maria Deloria; Park, Daniel E.; Feikin, Daniel R.; Levine, Orin S.; O'Brien, Katherine L.; DeLuca, Andrea N.; Driscoll, Amanda J.; Higdon, Melissa M.; Kahn, Geoff; Prosperi, Christine] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Feikin, Daniel R.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst, Sch Publ Hlth, Washington, DC 20052 USA.
   [Watson, Nora L.] Emmes Corp, Rockville, MD USA.
   [Baggett, Henry C.; Bunthi, Charatdao; Makprasert, Sirirat; Whistler, Toni] Thailand Minist Publ Health US Centers Dis Contro, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.; Whistler, Toni] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Mazumder, Razib] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Mazumder, Razib] Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Howie, Stephen R. C.; Antonio, Martin; Githua, Louis Peter] MRC Unit, Basse, Gambia.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Adrian, Peter V.; Moore, David P.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa.
   [Madhi, Shabir A.; Adrian, Peter V.; Moore, David P.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Antonio, Martin] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Coventry, W Midlands, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Kahn, Geoff] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Kwenda, Geoffrey] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.
   [Kwenda, Geoffrey; Mwansa, James] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwansa, James] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Sow, Samba O.; Tamboura, Boubou] Ctr Dev Vaccins, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
RP Morpeth, SC (reprint author), Cty Manukau Dist Hlth Board, Middlemore Hosp, Microbiol Lab, Private Bag 93311, Auckland 1640, New Zealand.
EM Susan.Morpeth@middlemore.co.nz
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by grant 48968 from the Bill & Melinda Gates
   Foundation to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health.
   J. A. G. S. was supported by a clinical fellowship from The Wellcome
   Trust of Great Britain (098532).
CR Abdeldaim G, 2010, CLIN MICROBIOL INFEC, V16, P1135, DOI 10.1111/j.1469-0691.2009.03069.x
   Avni T, 2010, J CLIN MICROBIOL, V48, P489, DOI 10.1128/JCM.01636-09
   Azzari C, 2011, J MED MICROBIOL, V60, P710, DOI 10.1099/jmm.0.028357-0
   Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100
   Benet T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145447
   Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06
   Charkaluk ML, 2006, DIAGN MICR INFEC DIS, V55, P89, DOI 10.1016/j.diagmicrobio.2005.10.013
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Cvitkovic Spik. V., 2013, SCAND J INFECT DIS, V45, P731, DOI DOI 10.3109/00365548.2013.804631
   Dagan R, 1998, J CLIN MICROBIOL, V36, P669
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089
   FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27
   Greve T, 2012, J MED MICROBIOL, V61, P478, DOI 10.1099/jmm.0.036574-0
   Knoll MD, 2017, CLIN INFECT DIS, V64, pS357, DOI 10.1093/cid/cix149
   Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006
   Messmer TO, 2004, DIAGN MICR INFEC DIS, V49, P249, DOI 10.1016/j.diagmicrobio.2004.04.013
   Park HK, 2010, J MED MICROBIOL, V59, P1146, DOI [10.1099/jmm.0.017798-0, 10.1099/jmm.0017798-0]
   Rouphael N, 2011, DIAGN MICR INFEC DIS, V70, P452, DOI 10.1016/j.diagmicrobio.2010.09.006
   Scott JAG, 2005, CLIN DIAGN LAB IMMUN, V12, P1195, DOI 10.1128/CDLI.12.10.1195-1201.2005
   Sheppard CL, 2004, J MED MICROBIOL, V53, P189, DOI 10.1099/jmm.0.05460-0
   Verhelst R, 2003, J CLIN MICROBIOL, V41, P3521, DOI 10.1128/JCM.41.8.3521-3525.2003
   Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000
   Wolter N, 2014, J INFECT DIS, V209, P56, DOI 10.1093/infdis/jit427
NR 26
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S347
EP S356
DI 10.1093/cid/cix145
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300020
PM 28575371
OA No
DA 2017-08-15
ER

PT J
AU Murdoch, DR
   Morpeth, SC
   Hammitt, LL
   Driscoll, AJ
   Watson, NL
   Baggett, HC
   Brooks, WA
   Knoll, MD
   Feikin, DR
   Kotloff, KL
   Levine, OS
   Madhi, SA
   O'Brien, KL
   Scott, JAG
   Thea, DM
   Ahmed, D
   Awori, JO
   DeLuca, AN
   Ebruke, BE
   Higdon, MM
   Jorakate, P
   Karron, RA
   Kazungu, S
   Kwenda, G
   Hossain, L
   Makprasert, S
   Moore, DP
   Mudau, A
   Mwaba, J
   Panchalingam, S
   Park, DE
   Prosperi, C
   Salaudeen, R
   Toure, A
   Zeger, SL
   Howie, SRC
AF Murdoch, David R.
   Morpeth, Susan C.
   Hammitt, Laura L.
   Driscoll, Amanda J.
   Watson, Nora L.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Knoll, Maria Deloria
   Feikin, Daniel R.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   O'Brien, Katherine L.
   Scott, J. Anthony G.
   Thea, Donald M.
   Ahmed, Dilruba
   Awori, Juliet O.
   DeLuca, Andrea N.
   Ebruke, Bernard E.
   Higdon, Melissa M.
   Jorakate, Possawat
   Karron, Ruth A.
   Kazungu, Sidi
   Kwenda, Geoffrey
   Hossain, Lokman
   Makprasert, Sirirat
   Moore, David P.
   Mudau, Azwifarwi
   Mwaba, John
   Panchalingam, Sandra
   Park, Daniel E.
   Prosperi, Christine
   Salaudeen, Rasheed
   Toure, Aliou
   Zeger, Scott L.
   Howie, Stephen R. C.
CA PERCH Study Grp
TI Microscopic Analysis and Quality Assessment of Induced Sputum From
   Children With Pneumonia in the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; induced sputum; quality; children
ID COMMUNITY-ACQUIRED PNEUMONIA; ETIOLOGY RESEARCH; YOUNG-CHILDREN; HEALTH
   PROJECT; DIAGNOSIS; INDUCTION; CULTURE; INFANTS
AB Background. It is standard practice for laboratories to assess the cellular quality of expectorated sputum specimens to check that they originated from the lower respiratory tract. The presence of low numbers of squamous epithelial cells (SECs) and high numbers of polymorphonuclear (PMN) cells are regarded as indicative of a lower respiratory tract specimen. However, these quality ratings have never been evaluated for induced sputum specimens from children with suspected pneumonia.
   Methods. We evaluated induced sputum Gram stain smears and cultures from hospitalized children aged 1-59 months enrolled in a large study of community-acquired pneumonia. We hypothesized that a specimen representative of the lower respiratory tract will contain smaller quantities of oropharyngeal flora and be more likely to have a predominance of potential pathogens compared to a specimen containing mainly saliva. The prevalence of potential pathogens cultured from induced sputum specimens and quantity of oropharyngeal flora were compared for different quantities of SECs and PMNs.
   Results. Of 3772 induced sputum specimens, 2608 (69%) had <10 SECs per low-power field (LPF) and 2350 (62%) had >25 PMNs per LPF, measures traditionally associated with specimens from the lower respiratory tract in adults. Using isolation of low quantities of oropharyngeal flora and higher prevalence of potential pathogens as markers of higher quality, <10 SECs per LPF (but not >25 PMNs per LPF) was the microscopic variable most associated with high quality of induced sputum.
   Conclusions. Quantity of SECs may be a useful quality measure of induced sputum from young children with pneumonia.
C1 [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Morpeth, Susan C.; Hammitt, Laura L.; Scott, J. Anthony G.; Awori, Juliet O.; Kazungu, Sidi] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, England.
   [Morpeth, Susan C.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Morpeth, Susan C.] Cty Manukau Dist Hlth Board, Middlemore Hosp, Microbiol Lab, Auckland, New Zealand.
   [Hammitt, Laura L.; Driscoll, Amanda J.; Knoll, Maria Deloria; Feikin, Daniel R.; Levine, Orin S.; O'Brien, Katherine L.; DeLuca, Andrea N.; Higdon, Melissa M.; Park, Daniel E.; Prosperi, Christine] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Watson, Nora L.] Emmes Corp, Rockville, MD USA.
   [Baggett, Henry C.; Jorakate, Possawat; Makprasert, Sirirat] Thailand Minist Publ Health US Centers Dis Contro, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Hossain, Lokman] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Hossain, Lokman] Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Mudau, Azwifarwi] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.; Moore, David P.; Mudau, Azwifarwi] Univ Witwatersrand, Vaccine Preventable Dis Unit, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Ebruke, Bernard E.; Salaudeen, Rasheed; Howie, Stephen R. C.] MRC Unit, Basse, Gambia.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Kwenda, Geoffrey] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.
   [Kwenda, Geoffrey; Mwaba, John] Univ Witwatersrand, Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwaba, John] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Panchalingam, Sandra] Univ Maryland, Sch Med, Ctr Vaccine Dev, Inst Global Hlth,Dept Med, Baltimore, MD 21201 USA.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst, Sch Publ Hlth, Washington, DC 20052 USA.
   [Salaudeen, Rasheed] Lagos Univ Teaching Hosp, Med Microbiol Dept, Lagos, Nigeria.
   [Toure, Aliou] Ctr Dev Vaccins, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
RP Murdoch, DR (reprint author), Univ Otago, POB 4345, Christchurch 8140, New Zealand.
EM david.murdoch@otago.ac.nz
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from The Wellcome
   Trust of Great Britain (award number 098532).
CR Barger-Kamate B, 2016, CLIN INFECT DIS, V63, pS187, DOI 10.1093/cid/ciw546
   Baron EJ, 2015, MANUAL CLIN MICROBIO
   Bartlett RC., 1974, MED MICROBIOLOGY QUA
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   DeLuca AN, 2017, CLIN INFECT DIS, V64, pS301, DOI 10.1093/cid/cix078
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS368, DOI 10.1093/cid/cix101
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   GECKLER RW, 1977, J CLIN MICROBIOL, V6, P396
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068
   INGRAM JG, 1994, J CLIN MICROBIOL, V32, P209
   Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051
   LENTINO JR, 1987, J CLIN MICROBIOL, V25, P758
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Moore DP, 2017, CLIN INFECT DIS, V64, pS309, DOI 10.1093/cid/cix099
   Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09
   Murdoch DR, 2017, CLIN INFECT DIS S3, V64, pS288
   MURRAY PR, 1975, MAYO CLIN PROC, V50, P339
   Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497
   Thea DM, 2017, CLIN INFECT DIS, V64, pS289, DOI 10.1093/cid/cix098
   Zar HJ, 2000, ARCH DIS CHILD, V82, P305, DOI 10.1136/adc.82.4.305
   Zar HJ, 2003, PEDIATR PULM, V36, P58, DOI 10.1002/ppul.10302
NR 23
TC 6
Z9 6
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S271
EP S279
DI 10.1093/cid/cix083
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300012
PM 28575360
OA No
DA 2017-08-15
ER

PT J
AU Murdoch, DR
   Morpeth, SC
   Hammitt, LL
   Driscoll, AJ
   Watson, NL
   Baggett, HC
   Brooks, WA
   Knoll, MD
   Feikin, DR
   Kotloff, KL
   Levine, OS
   Madhi, SA
   O'Brien, KL
   Scott, JAG
   Thea, DM
   Adrian, PV
   Ahmed, D
   Alam, M
   Awori, JO
   DeLuca, AN
   Higdon, MM
   Karron, RA
   Kwenda, G
   Machuka, EM
   Makprasert, S
   McLellan, J
   Moore, DP
   Mwaba, J
   Mwarumba, S
   Park, DE
   Prosperi, C
   Sangwichian, O
   Sissoko, S
   Tapia, MD
   Zeger, SL
   Howie, SRC
AF Murdoch, David R.
   Morpeth, Susan C.
   Hammitt, Laura L.
   Driscoll, Amanda J.
   Watson, Nora L.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Knoll, Maria Deloria
   Feikin, Daniel R.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   O'Brien, Katherine L.
   Scott, J. Anthony G.
   Thea, Donald M.
   Adrian, Peter V.
   Ahmed, Dilruba
   Alam, Muntasir
   Awori, Juliet O.
   DeLuca, Andrea N.
   Higdon, Melissa M.
   Karron, Ruth A.
   Kwenda, Geoffrey
   Machuka, Eunice M.
   Makprasert, Sirirat
   McLellan, Jessica
   Moore, David P.
   Mwaba, John
   Mwarumba, Salim
   Park, Daniel E.
   Prosperi, Christine
   Sangwichian, Ornuma
   Sissoko, Seydou
   Tapia, Milagritos D.
   Zeger, Scott L.
   Howie, Stephen R. C.
CA PERCH Study Grp
TI The Diagnostic Utility of Induced Sputum Microscopy and Culture in
   Childhood Pneumonia
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; induced sputum; culture; microscopy; children
ID COMMUNITY-ACQUIRED PNEUMONIA; ETIOLOGY RESEARCH; HEALTH PROJECT;
   CHILDREN; INFECTIONS; COLLECTION
AB Background. Sputum microscopy and culture are commonly used for diagnosing the cause of pneumonia in adults but are rarely performed in children due to difficulties in obtaining specimens. Induced sputum is occasionally used to investigate lower respiratory infections in children but has not been widely used in pneumonia etiology studies.
   Methods. We evaluated the diagnostic utility of induced sputum microscopy and culture in patients enrolled in the Pneumonia Etiology Research for Child Health (PERCH) study, a large study of community-acquired pneumonia in children aged 1-59 months. Comparisons were made between induced sputum samples from hospitalized children with radiographically confirmed pneumonia and children categorized as nonpneumonia (due to the absence of prespecified clinical and laboratory signs and absence of infiltrate on chest radiograph).
   Results. One induced sputum sample was available for analysis from 3772 (89.1%) of 4232 suspected pneumonia cases enrolled in PERCH. Of these, sputum from 2608 (69.1%) met the quality criterion of <10 squamous epithelial cells per low-power field, and 1162 (44.6%) had radiographic pneumonia. Induced sputum microscopy and culture results were not associated with radiographic pneumonia, regardless of prior antibiotic use, stratification by specific bacteria, or interpretative criteria used.
   Conclusions. The findings of this study do not support the culture of induced sputum specimens as a diagnostic tool for pneumonia in young children as part of routine clinical practice.
C1 [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Morpeth, Susan C.; Hammitt, Laura L.; Scott, J. Anthony G.; Awori, Juliet O.; Mwarumba, Salim] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, England.
   [Morpeth, Susan C.; Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Morpeth, Susan C.] Cty Manukau Dist Hlth Board, Middlemore Hosp, Microbiol Lab, Auckland, New Zealand.
   [Hammitt, Laura L.; Driscoll, Amanda J.; Knoll, Maria Deloria; Feikin, Daniel R.; Levine, Orin S.; O'Brien, Katherine L.; DeLuca, Andrea N.; Higdon, Melissa M.; Park, Daniel E.; Prosperi, Christine] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Watson, Nora L.] Emmes Corp, Rockville, MD USA.
   [Baggett, Henry C.; Makprasert, Sirirat; Sangwichian, Ornuma] Thailand Minist Publ Health US Centers Dis Contro, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Alam, Muntasir] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Ahmed, Dilruba; Alam, Muntasir] Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Adrian, Peter V.; Moore, David P.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.; Adrian, Peter V.; Moore, David P.] Univ Witwatersrand, Vaccine Preventable Dis Unit, Natl Res Fdn, Dept Sci & Technol, Johannesburg, South Africa.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Immunizat Res, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Kwenda, Geoffrey] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.
   [Kwenda, Geoffrey; Mwaba, John] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia.
   [Machuka, Eunice M.; McLellan, Jessica; Howie, Stephen R. C.] MRC Unit, Basse, Gambia.
   [McLellan, Jessica] Univ Calgary, Cummings Sch Med, Calgary, AB, Canada.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mwaba, John] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst, Sch Publ Hlth, Washington, DC 20052 USA.
   [Sissoko, Seydou] Ctr Dev Vaccins, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
RP Murdoch, DR (reprint author), Univ Otago, POB 4345, Christchurch 4345, New Zealand.
EM david.murdoch@otago.ac.nz
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by a grant from the Bill & Melinda Gates Foundation
   to the International Vaccine Access Center, Department of International
   Health, Johns Hopkins Bloomberg School of Public Health (grant 48968).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (098532).
CR Barger-Kamate B, 2016, CLIN INFECT DIS, V63, pS187, DOI 10.1093/cid/ciw546
   Baron EJ, 2015, MANUAL CLIN MICROBIO
   British Thoracic Society and the Public Health Laboratory Service, 1987, Q J MED, V62, P195
   Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   DeLuca AN, 2017, CLIN INFECT DIS, V64, pS301, DOI 10.1093/cid/cix078
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS368, DOI 10.1093/cid/cix101
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Garcia-Vazquez E, 2004, ARCH INTERN MED, V164, P1807, DOI 10.1001/archinte.164.16.1807
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068
   Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x
   Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051
   LENTINO JR, 1987, J CLIN MICROBIOL, V25, P758
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070
   Miyashita N, 2008, MED SCI MONITOR, V14, pCR171
   Moore DP, 2017, CLIN INFECT DIS, V64, pS309, DOI 10.1093/cid/cix099
   Murdoch DR, 2017, CLIN INFECT DIS, V64, pS271, DOI 10.1093/cid/cix083
   Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09
   Musher DM, 2005, ARCH INTERN MED, V165, P470, DOI 10.1001/archinte.165.4.470-b
   Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497
   Sanyal S, 1999, AM J RESP CRIT CARE, V160, P346
   Seligman SJ, 1973, SPUTUM FUNDAMENTALS
   Sloan CE, 2015, DIAGN MICR INFEC DIS, V83, P74, DOI 10.1016/j.diagmicrobio.2015.05.009
   Tasaka Sadatomo, 2013, Expert Opin Med Diagn, V7, P85, DOI 10.1517/17530059.2012.722080
   Thea DM, 2017, CLIN INFECT DIS, V64, pS289, DOI 10.1093/cid/cix098
   Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2
NR 29
TC 1
Z9 1
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S280
EP S288
DI 10.1093/cid/cix090
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300013
PM 28575362
OA No
DA 2017-08-15
ER

PT J
AU O'Brien, KL
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Knoll, MD
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Murdoch, DR
   Scott, JAG
   Thea, DM
   Zeger, SL
AF O'Brien, Katherine L.
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Knoll, Maria Deloria
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Murdoch, David R.
   Scott, J. Anthony G.
   Thea, Donald M.
   Zeger, Scott L.
TI Introduction to the Epidemiologic Considerations, Analytic Methods, and
   Foundational Results From the Pneumonia Etiology Research for Child
   Health Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; etiology; children; case-control analysis; PERCH
ID SYSTEMATIC ANALYSIS; MORTALITY
C1 [O'Brien, Katherine L.; Brooks, W. Abdullah; Feikin, Daniel R.; Hammitt, Laura L.; Knoll, Maria Deloria; Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Baggett, Henry C.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Health, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Feikin, Daniel R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA.
   [Hammitt, Laura L.] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Howie, Stephen R. C.; Scott, J. Anthony G.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth,Ctr Vaccine Dev, Dept Pediat,Div Infect Dis & Trop Pediat, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn, Vaccine Preventable Dis Unit, Dept Sci & Technol, Johannesburg, South Africa.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
RP O'Brien, KL (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, 415 N Washington St,Room 563, Baltimore, MD 21231 USA.
EM klobrien@jhu.edu
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by grant 48968 from The Bill & Melinda Gates
   Foundation to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health.
   J. A. G. S. was supported by a clinical fellowship from The Wellcome
   Trust of Great Britain (098532).
CR Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100
   Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   DeLuca AN, 2017, CLIN INFECT DIS, V64, pS301, DOI 10.1093/cid/cix078
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS368, DOI 10.1093/cid/cix101
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089
   Feikin DR, 2017, CLIN INFECT DIS, V64, pS337, DOI 10.1093/cid/cix148
   Feikin DR, 2017, CLIN INFECT DIS, V64, pS188, DOI 10.1093/cid/cix143
   Hammitt LL, 2017, CLIN INFECT DIS, V64, pS197, DOI 10.1093/cid/cix147
   Higdon MM, 2017, CLIN INFECT DIS, V64, pS378, DOI 10.1093/cid/cix150
   Higdon MM, 2017, CLIN INFECT DIS, V64, pS205, DOI 10.1093/cid/cix076
   Knoll MD, 2017, CLIN INFECT DIS, V64, pS357, DOI 10.1093/cid/cix149
   Knoll MD, 2017, CLIN INFECT DIS, V64, pS213, DOI 10.1093/cid/cix144
   Levine OS, 2012, CLIN INFECT DIS, V54, pS87, DOI 10.1093/cid/cir1050
   Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Moore DP, 2017, CLIN INFECT DIS, V64, pS309, DOI 10.1093/cid/cix099
   Morpeth SC, 2017, CLIN INFECT DIS, V64, pS347, DOI 10.1093/cid/cix145
   Murdoch DR, 2017, CLIN INFECT DIS, V64, pS271, DOI 10.1093/cid/cix083
   Murdoch DR, 2017, CLIN INFECT DIS, V64, pS280, DOI 10.1093/cid/cix090
   Park DE, 2017, CLIN INFECT DIS, V64, pS328, DOI 10.1093/cid/cix104
   Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947
   Thea DM, 2017, CLIN INFECT DIS, V64, pS289, DOI 10.1093/cid/cix098
   United Nations Department of Economic and Social Affairs Population Division, 2015, WORLD POP PROSP 2015
   United Nations General Assembly, 2015, TRANSF OUR WORLD 203
   Watson NL, 2017, CLIN INFECT DIS, V64, pS238, DOI 10.1093/cid/cix080
   Wu Z, 2016, BIOSTATISTICS UNPUB
   Wu ZK, 2016, J R STAT SOC C-APPL, V65, P97, DOI 10.1111/rssc.12101
   You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8
NR 30
TC 1
Z9 1
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S179
EP S184
DI 10.1093/cid/cix142
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300001
PM 28575368
OA No
DA 2017-08-15
ER

PT J
AU Park, DE
   Baggett, HC
   Howie, SRC
   Shi, QY
   Watson, NL
   Brooks, WA
   Knoll, MD
   Hammitt, LL
   Kotloff, KL
   Levine, OS
   Madhi, SA
   Murdoch, DR
   O'Brien, KL
   Scott, JAG
   Thea, DM
   Ahmed, D
   Antonio, M
   Baillie, VL
   DeLuca, AN
   Driscoll, AJ
   Fu, W
   Gitahi, CW
   Olutunde, E
   Higdon, MM
   Hossain, L
   Karron, RA
   Maiga, AA
   Maloney, SA
   Moore, DP
   Morpeth, SC
   Mwaba, J
   Mwenechanya, M
   Prosperi, C
   Sylla, M
   Thamthitiwat, S
   Zeger, SL
   Feikin, DR
AF Park, Daniel E.
   Baggett, Henry C.
   Howie, Stephen R. C.
   Shi, Qiyuan
   Watson, Nora L.
   Brooks, W. Abdullah
   Knoll, Maria Deloria
   Hammitt, Laura L.
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   Murdoch, David R.
   O'Brien, Katherine L.
   Scott, J. Anthony G.
   Thea, Donald M.
   Ahmed, Dilruba
   Antonio, Martin
   Baillie, Vicky L.
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Fu, Wei
   Gitahi, Caroline W.
   Olutunde, Emmanuel
   Higdon, Melissa M.
   Hossain, Lokman
   Karron, Ruth A.
   Maiga, Abdoul Aziz
   Maloney, Susan A.
   Moore, David P.
   Morpeth, Susan C.
   Mwaba, John
   Mwenechanya, Musaku
   Prosperi, Christine
   Sylla, Mamadou
   Thamthitiwat, Somsak
   Zeger, Scott L.
   Feikin, Daniel R.
CA Perch Study Grp
TI Colonization Density of the Upper Respiratory Tract as a Predictor of
   Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus
   aureus, and Pneumocystis jirovecii
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pneumonia; colonization density; PERCH
ID REAL-TIME PCR; CHILD HEALTH PROJECT; STREPTOCOCCUS-PNEUMONIAE; ETIOLOGY
   RESEARCH; QUANTITATIVE PCR; IMMUNOCOMPROMISED PATIENTS;
   BACTERIAL-COLONIZATION; DIAGNOSIS; INFECTIONS; CARRIAGE
AB Background. There is limited information on the association between colonization density of upper respiratory tract colonizers and pathogen-specific pneumonia. We assessed this association for Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii.
   Methods. In 7 low-and middle-income countries, nasopharyngeal/oropharyngeal swabs from children with severe pneumonia and age-frequency matched community controls were tested using quantitative polymerase chain reaction (PCR). Differences in median colonization density were evaluated using the Wilcoxon rank-sum test. Density cutoffs were determined using receiver operating characteristic curves. Cases with a pathogen identified from lung aspirate culture or PCR, pleural fluid culture or PCR, blood culture, and immunofluorescence for P. jirovecii defined microbiologically confirmed cases for the given pathogens.
   Results. Higher densities of H. influenzae were observed in both microbiologically confirmed cases and chest radiograph (CXR)-positive cases compared to controls. Staphylococcus aureus and P. jirovecii had higher densities in CXR-positive cases vs controls. A 5.9 log(10) copies/mL density cutoff for H. influenzae yielded 86% sensitivity and 77% specificity for detecting microbiologically confirmed cases; however, densities overlapped between cases and controls and positive predictive values were poor (<3%). Informative density cutoffs were not found for S. aureus and M. catarrhalis, and a lack of confirmed case data limited the cutoff identification for P. jirovecii.
   Conclusions. There is evidence for an association between H. influenzae colonization density and H. influenzae-confirmed pneumonia in children; the association may be particularly informative in epidemiologic studies. Colonization densities of M. catarrhalis, S. aureus, and P. jirovecii are unlikely to be of diagnostic value in clinical settings.
C1 [Park, Daniel E.; Shi, Qiyuan; Knoll, Maria Deloria; Hammitt, Laura L.; Levine, Orin S.; O'Brien, Katherine L.; DeLuca, Andrea N.; Driscoll, Amanda J.; Fu, Wei; Higdon, Melissa M.; Prosperi, Christine; Feikin, Daniel R.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Park, Daniel E.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC 20052 USA.
   [Baggett, Henry C.; Thamthitiwat, Somsak] Thailand Minist Publ Health, US Centers Dis Control & Prevent Collaborat, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Global Hlth, Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA.
   [Howie, Stephen R. C.; Antonio, Martin] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Pediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Watson, Nora L.] Emmes Corp, Rockville, MD USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Ahmed, Dilruba] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Ahmed, Dilruba] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Matlab, Bangladesh.
   [Hammitt, Laura L.; Scott, J. Anthony G.; Gitahi, Caroline W.; Morpeth, Susan C.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Natl Res Fdn, Dept Sci & Technology, Vaccine Preventable Dis Unit, Johannesburg, South Africa.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Lab, Christchurch, New Zealand.
   [Scott, J. Anthony G.; Morpeth, Susan C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.
   [Antonio, Martin] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Fu, Wei] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Rheumatol, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Maiga, Abdoul Aziz] Ctr Deve Vaccins CVD Mali, Bamako, Mali.
   [Maloney, Susan A.] Ctr Global Hlth, Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Morpeth, Susan C.] Middlemore Hosp, Counties Manukau Dist Hlth Board, Microbiol Lab, Auckland, New Zealand.
   [Mwaba, John] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Mwaba, John] Univ Teaching Hosp, Zambia Ctr Appl Hlth Res, Lusaka, Zambia.
   [Mwenechanya, Musaku] Univ Teaching Hosp, Dept Pediat, Lusaka, Zambia.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Feikin, Daniel R.] Natl Ctr Immunizat & Resp Dis, Centers Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
RP Park, DE (reprint author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC 20052 USA.
EM danpark@gwu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX PERCH was supported by the Bill & Melinda Gates Foundation (grant number
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
   J. A. G. S. was supported by a clinical fellowship from the Wellcome
   Trust of Great Britain (award number 098532).
CR Abdeldaim GMK, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-310
   Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c
   Anh DD, 2007, TOHOKU J EXP MED, V213, P167, DOI 10.1620/tjem.213.167
   Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100
   Bhat N, 2012, CLIN INFECT DIS, V54, pS153, DOI 10.1093/cid/cir1060
   Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC
   Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5
   Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS368, DOI 10.1093/cid/cix101
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Esposito S, 2013, PEDIATR INFECT DIS J, V32, P1199, DOI 10.1097/INF.0b013e31829ec274
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068
   Knoll MD, 2017, CLIN INFECT DIS, V64, pS213, DOI 10.1093/cid/cix144
   Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Maillet M, 2014, EUR J CLIN MICROBIOL, V33, P331, DOI 10.1007/s10096-013-1960-3
   Maurin M, 2010, CLIN MICROBIOL INFEC, V16, P379, DOI 10.1111/j.1469-0691.2009.02812.x
   Medrano FJ, 2005, EMERG INFECT DIS, V11, P245
   Miyashita Naoyuki, 2007, Journal of Infection and Chemotherapy, V13, P183, DOI 10.1007/s10156-007-0509-8
   Montesinos I, 2015, DIAGN MICR INFEC DIS, V82, P143, DOI 10.1016/j.diagmicrobio.2015.03.006
   Morrow Brenda M, 2014, BMC Res Notes, V7, P26, DOI 10.1186/1756-0500-7-26
   Muhlethaler K, 2012, EUR RESPIR J, V39, P971, DOI 10.1183/09031936.00095811
   Piters WAAD, 2016, MBIO, V7, DOI 10.1128/mBio.00009-16
   Piters WAAD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0294
   Samuel CM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-329
   Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   Shteinberg M, 2014, LUNG, V192, P875, DOI 10.1007/s00408-014-9644-z
   Spuesens EBM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001444
   Tenenbaum T, 2012, EUR J CLIN MICROBIOL, V31, P3173, DOI 10.1007/s10096-012-1682-y
   Thea DM, 2017, CLIN INFECT DIS, V64, pS289, DOI 10.1093/cid/cix098
   van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711
   Vayssier-Taussat M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00029
   Vissers M, 2014, MUCOSAL IMMUNOL, V7, P227, DOI 10.1038/mi.2013.93
   Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC
   Vu Huong Thi Thu, 2011, Pediatr Infect Dis J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2
   Vuori-Holopainen E, 2002, CLIN INFECT DIS, V34, P583, DOI 10.1086/338642
   Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 44
TC 5
Z9 5
U1 3
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S328
EP S336
DI 10.1093/cid/cix104
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300018
PM 28575367
OA No
DA 2017-08-15
ER

PT J
AU Thea, DM
   Seidenberg, P
   Park, DE
   Mwananyanda, L
   Fu, W
   Shi, QY
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Howie, SRC
   Knoll, MD
   Kotloff, KL
   Levine, OS
   Madhi, SA
   O'Brien, KL
   Scott, JAG
   Antonio, M
   Awori, JO
   Baillie, VL
   DeLuca, AN
   Driscoll, AJ
   Higdon, MM
   Hossain, L
   Jahan, Y
   Karron, RA
   Kazungu, S
   Li, MY
   Moore, DP
   Morpeth, SC
   Ofordile, O
   Prosperi, C
   Sangwichian, O
   Sawatwong, P
   Sylla, M
   Tapia, MD
   Zeger, SL
   Murdoch, DR
   Hammitt, LL
AF Thea, Donald M.
   Seidenberg, Phil
   Park, Daniel E.
   Mwananyanda, Lawrence
   Fu, Wei
   Shi, Qiyuan
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Howie, Stephen R. C.
   Knoll, Maria Deloria
   Kotloff, Karen L.
   Levine, Orin S.
   Madhi, Shabir A.
   O'Brien, Katherine L.
   Scott, J. Anthony G.
   Antonio, Martin
   Awori, Juliet O.
   Baillie, Vicky L.
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Higdon, Melissa M.
   Hossain, Lokman
   Jahan, Yasmin
   Karron, Ruth A.
   Kazungu, Sidi
   Li, Mengying
   Moore, David P.
   Morpeth, Susan C.
   Ofordile, Ogochukwu
   Prosperi, Christine
   Sangwichian, Ornuma
   Sawatwong, Pongpun
   Sylla, Mamadou
   Tapia, Milagritos D.
   Zeger, Scott L.
   Murdoch, David R.
   Hammitt, Laura L.
CA Perch Study Grp
TI Limited Utility of Polymerase Chain Reaction in Induced Sputum Specimens
   for Determining the Causes of Childhood Pneumonia in Resource-Poor
   Settings: Findings From the Pneumonia Etiology Research for Child Health
   (PERCH) Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE induced sputum; PCR; pneumonia etiology; nasopharyngeal swab;
   community-acquired pneumonia
ID COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCYSTIS PNEUMONIA; CLINICAL
   MANAGEMENT; RAPID INFLUENZA; YOUNG-CHILDREN; DIAGNOSIS; INFECTION;
   PROJECT; INFANTS; CULTURES
AB Background. Sputum examination can be useful in diagnosing the cause of pneumonia in adults but is less well established in children. We sought to assess the diagnostic utility of polymerase chain reaction (PCR) for detection of respiratory viruses and bacteria in induced sputum (IS) specimens from children hospitalized with severe or very severe pneumonia.
   Methods. Among children aged 1-59 months, we compared organism detection by multiplex PCR in IS and nasopharyngeal/oropharyngeal (NP/OP) specimens. To assess whether organism presence or density in IS specimens was associated with chest radiographic evidence of pneumonia (radiographic pneumonia), we compared prevalence and density in IS specimens from children with radiographic pneumonia and children with suspected pneumonia but without chest radiographic changes or clinical or laboratory findings suggestive of pneumonia (nonpneumonia group).
   Results. Among 4232 cases with World Health Organization-defined severe or very severe pneumonia, we identified 1935 (45.7%) with radiographic pneumonia and 573 (13.5%) with nonpneumonia. The organism detection yield was marginally improved with IS specimens (96.2% vs 92.4% for NP/OP specimens for all viruses combined [P = .41]; 96.9% vs 93.3% for all bacteria combined [P = .01]). After accounting for presence in NP/OP specimens, no organism was detected more frequently in the IS specimens from the radiographic pneumonia compared with the nonpneumonia cases. Among high-quality IS specimens, there were no statistically significant differences in organism density, except with cytomegalovirus, for which there was a higher quantity in the IS specimens from cases with radiographic pneumonia compared with the nonpneumonia cases (median cycle threshold value, 27.9 vs 28.5, respectively; P = .01).
   Conclusions. Using advanced molecular methods with IS specimens provided little additional diagnostic information beyond that obtained with NP/OP swab specimens.
C1 [Thea, Donald M.; Seidenberg, Phil; Mwananyanda, Lawrence] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02118 USA.
   [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA.
   [Park, Daniel E.; Fu, Wei; Shi, Qiyuan; Feikin, Daniel R.; Knoll, Maria Deloria; Levine, Orin S.; O'Brien, Katherine L.; DeLuca, Andrea N.; Driscoll, Amanda J.; Higdon, Melissa M.; Li, Mengying; Prosperi, Christine; Hammitt, Laura L.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Park, Daniel E.] George Washington Univ, Milken Inst, Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA.
   [Mwananyanda, Lawrence] Univ Teaching Hosp, Lusaka, Zambia.
   [Fu, Wei] Johns Hopkins Sch Med, Dept Rheumatol, Baltimore, MD USA.
   [Baggett, Henry C.; Sangwichian, Ornuma; Sawatwong, Pongpun] Thailand Minist Publ Health, US Centers Dis Control & Prevent Collaborat, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah; Hossain, Lokman; Jahan, Yasmin] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Hossain, Lokman; Jahan, Yasmin] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Matlab, Bangladesh.
   [Feikin, Daniel R.] Natl Ctr Immunizat & Resp Dis, Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
   [Howie, Stephen R. C.; Antonio, Martin; Ofordile, Ogochukwu] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Pediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Kotloff, Karen L.; Tapia, Milagritos D.] Univ Maryland, Sch Med, Inst Global Hlth, Ctr Vaccine Dev,Dept Pediat,Div Infect Dis & Trop, Baltimore, MD 21201 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Natl Res Fdn, Dept Sci & Technol, Vaccine Preventable Dis Unit, Johannesburg, South Africa.
   [Scott, J. Anthony G.; Awori, Juliet O.; Kazungu, Sidi; Morpeth, Susan C.; Hammitt, Laura L.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Scott, J. Anthony G.; Morpeth, Susan C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Antonio, Martin] London Sch Hyg & Trop Med, London, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [DeLuca, Andrea N.] Ctr Immunizat Res, Dept Epidemiol, Baltimore, MD USA.
   [Karron, Ruth A.] Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Li, Mengying] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Pediat & Child Hlth, Soweto, South Africa.
   [Moore, David P.] Univ Witwatersrand, Johannesburg, South Africa.
   [Morpeth, Susan C.] Middlemore Hosp, Counties Manukau Dist Hlth Board, Microbiol Lab, Auckland, New Zealand.
   [Sylla, Mamadou] Ctr Deloppement Vaccins CVD Mali, Bamako, Mali.
   [Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
RP Thea, DM (reprint author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02118 USA.
EM dthea@bu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Wellcome Trust of Great Britain
   [098532]
FX This work is supported by the Bill & Melinda Gates Foundation (grant
   48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health)
   and the Wellcome Trust of Great Britain (clinical fellowship 098532 to
   J. A. G. S.).
CR Abanses JC, 2006, PEDIATR EMERG CARE, V22, P145, DOI 10.1097/01.pec.0000202454.19237.b0
   Adegbola RA, 2011, EXPERT REV RESP MED, V5, P731, DOI [10.1586/ers.11.74, 10.1586/ERS.11.74]
   Barger-Kamate B, 2016, CLIN INFECT DIS, V63, pS187, DOI 10.1093/cid/ciw546
   Bhat N, 2012, CLIN INFECT DIS, V54, pS153, DOI 10.1093/cid/cir1060
   Campbell SG, 2003, CHEST, V123, P1142, DOI 10.1378/chest.123.4.1142
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   DeLuca AN, 2017, CLIN INFECT DIS, V64, pS301, DOI 10.1093/cid/cix078
   Driscoll AJ, 2017, CLIN INFECT DIS, V64, pS245, DOI 10.1093/cid/cix081
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   Feikin DR, 2017, CLIN INFECT DIS, V64, pS337, DOI 10.1093/cid/cix148
   Fujisawa T, 2009, RESPIROLOGY, V14, P203, DOI 10.1111/j.1440-1843.2008.01457.x
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068
   Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x
   Ideh RC, 2011, INT J TUBERC LUNG D, V15, P729, DOI 10.5588/ijtld.10.0468
   Jennings LC, 2009, INFLUENZA OTHER RESP, V3, P91, DOI 10.1111/j.1750-2659.2009.00079.x
   Jourdain S, 2011, CLIN MICROBIOL INFEC, V17, P907, DOI 10.1111/j.1469-0691.2010.03410.x
   Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051
   Laing R, 2001, NEW ZEAL MED J, V114, P488
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001
   Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070
   Morrow BM, 2010, PEDIATR INFECT DIS J, V29, P535, DOI 10.1097/INF.0b013e3181ce871e
   Murdoch DR, 2017, CLIN INFECT DIS, V64, pS271, DOI 10.1093/cid/cix083
   Murdoch DR, 2017, CLIN INFECT DIS S3, V64, pS288
   Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497
   Neill AM, 1996, THORAX, V51, P1010, DOI 10.1136/thx.51.10.1010
   Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4
   [Anonymous], 2014, REV WHO CLASS TREAT
   Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5
   Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2
   Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477
NR 34
TC 6
Z9 6
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S289
EP S300
DI 10.1093/cid/cix098
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300014
PM 28575363
OA No
DA 2017-08-15
ER

PT J
AU Watson, NL
   Prosperi, C
   Driscoll, AJ
   Higdon, MM
   Park, DE
   Sanza, M
   DeLuca, AN
   Awori, JO
   Goswami, D
   Hammond, E
   Hossain, L
   Johnson, C
   Kamau, A
   Kuwanda, L
   Moore, DP
   Neyzari, O
   Onwuchekwa, U
   Parker, D
   Sapchookul, P
   Seidenberg, P
   Shamsul, A
   Siazeele, K
   Srisaengchai, P
   Sylla, M
   Levine, OS
   Murdoch, DR
   O'Brien, KL
   Wolff, M
   Knoll, MD
AF Watson, Nora L.
   Prosperi, Christine
   Driscoll, Amanda J.
   Higdon, Melissa M.
   Park, Daniel E.
   Sanza, Megan
   DeLuca, Andrea N.
   Awori, Juliet O.
   Goswami, Doli
   Hammond, Emily
   Hossain, Lokman
   Johnson, Catherine
   Kamau, Alice
   Kuwanda, Locadiah
   Moore, David P.
   Neyzari, Omid
   Onwuchekwa, Uma
   Parker, David
   Sapchookul, Patranuch
   Seidenberg, Phil
   Shamsul, Arifin
   Siazeele, Kazungu
   Srisaengchai, Prasong
   Sylla, Mamadou
   Levine, Orin S.
   Murdoch, David R.
   O'Brien, Katherine L.
   Wolff, Mark
   Knoll, Maria Deloria
TI Data Management and Data Quality in PERCH, a Large International
   Case-Control Study of Severe Childhood Pneumonia
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE data management; electronic data capture; data quality; PERCH
AB The Pneumonia Etiology Research for Child Health (PERCH) study is the largest multicountry etiology study of pediatric pneumonia undertaken in the past 3 decades. The study enrolled 4232 hospitalized cases and 5325 controls over 2 years across 9 research sites in 7 countries in Africa and Asia. The volume and complexity of data collection in PERCH presented considerable logistical and technical challenges. The project chose an internet-based data entry system to allow real-time access to the data, enabling the project to monitor and clean incoming data and perform preliminary analyses throughout the study. To ensure high-quality data, the project developed comprehensive quality indicator, data query, and monitoring reports. Among the approximately 9000 cases and controls, analyzable laboratory results were available for >= 96% of core specimens collected. Selected approaches to data management in PERCH may be extended to the planning and organization of international studies of similar scope and complexity.
C1 [Watson, Nora L.; Sanza, Megan; Johnson, Catherine; Neyzari, Omid; Wolff, Mark] Emmes Corp, Rockville, MD USA.
   [Prosperi, Christine; Driscoll, Amanda J.; Higdon, Melissa M.; Park, Daniel E.; DeLuca, Andrea N.; Levine, Orin S.; O'Brien, Katherine L.; Knoll, Maria Deloria] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, 415 N Washington St,Rm 549, Baltimore, MD 21231 USA.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Awori, Juliet O.; Kamau, Alice] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Goswami, Doli; Hossain, Lokman] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Goswami, Doli; Hossain, Lokman] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Hammond, Emily; Siazeele, Kazungu] Univ Teaching Hosp, Lusaka, Zambia.
   [Kuwanda, Locadiah; Moore, David P.] MRC, Resp & Meningeal Pathogens Res Unit, Swindon, Wilts, England.
   [Kuwanda, Locadiah; Moore, David P.] Natl Res Fdn, Vaccine Preventable Dis Unit, Dept Sci & Technol, Pretoria, South Africa.
   [Moore, David P.] Chris Hani Baragwanath Acad Hosp, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Moore, David P.] Univ Witwatersrand, Dept Paediat & Child Hlth, Johannesburg, South Africa.
   [Onwuchekwa, Uma; Sylla, Mamadou] Ctr Dev Vaccins CVD Mali, Bamako, Mali.
   [Parker, David; Shamsul, Arifin] MRC Unit, Basse, Gambia.
   [Sapchookul, Patranuch; Srisaengchai, Prasong] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Health, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Seidenberg, Phil] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA.
   [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
RP Knoll, MD (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, 415 N Washington St,Rm 549, Baltimore, MD 21231 USA.
EM mknoll2@jhu.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]
FX This work was supported by the Bill & Melinda Gates Foundation (grant
   number 48968 to the International Vaccine Access Center, Department of
   International Health, Johns Hopkins Bloomberg School of Public Health).
CR Crawley J, 2017, CLIN INFECT DIS, V64, pS228, DOI 10.1093/cid/cix077
   Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   O'Brien KL, 2017, CLIN INFECT DIS, V64, pS179, DOI 10.1093/cid/cix142
NR 5
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2017
VL 64
SU 3
BP S238
EP S244
DI 10.1093/cid/cix080
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EW2AK
UT WOS:000402298300008
PM 28575357
OA No
DA 2017-08-15
ER

PT J
AU Mbaye, A
   Gaye, A
   Dieye, B
   Ndiaye, YD
   Bei, AK
   Affara, M
   Deme, AB
   Yade, MS
   Diongue, K
   Ndiaye, IM
   Ndiaye, T
   Sy, M
   Sy, N
   Koita, O
   Krogstad, DJ
   Volkman, S
   Nwakanma, D
   Ndiaye, D
AF Mbaye, Aminata
   Gaye, Amy
   Dieye, Baba
   Ndiaye, Yaye D.
   Bei, Amy K.
   Affara, Muna
   Deme, Awa B.
   Yade, Mamadou S.
   Diongue, Khadim
   Ndiaye, Ibrahima M.
   Ndiaye, Tolla
   Sy, Mouhamed
   Sy, Ngayo
   Koita, Ousmane
   Krogstad, Donald J.
   Volkman, Sarah
   Nwakanma, Davis
   Ndiaye, Daouda
TI Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates
   from Pikine, Senegal
SO MALARIA JOURNAL
LA English
DT Article
DE Chemosensitivity; Genotyping; Plasmodium falciparum; Pikine
ID SULFADOXINE-PYRIMETHAMINE RESISTANCE; CHLOROQUINE RESISTANCE;
   DIHYDROFOLATE-REDUCTASE; ANTIMALARIAL-DRUGS; MALARIA PARASITES; DHPS
   GENES; DAKAR; POLYMORPHISMS; PREVALENCE; MUTATIONS
AB Background: The monitoring of Plasmodium falciparum sensitivity to anti-malarial drugs is a necessity for effective case management of malaria. This species is characterized by a strong resistance to anti-malarial drugs. In Senegal, the first cases of chloroquine resistance were reported in the Dakar region in 1988 with nearly 7% population prevalence, reaching 47% by 1990. It is in this context that sulfadoxine-pyrimethamine temporarily replaced chloroquine as first line treatment in 2003, pending the introduction of artemisinin-based combination therapy in 2006. The purpose of this study is to assess the ex vivo sensitivity to different anti-malarial drugs of the P. falciparum population from Pikine.
   Methods: Fifty-four samples were collected from patients with non-complicated malaria and aged between 2 and 20 years in the Deggo health centre in Pikine in 2014. An assay in which parasites are stained with 4', 6-di-amidino-2-phenylindole (DAPI), was used to study the ex vivo sensitivity of isolates to chloroquine, amodiaquine, piperaquine, pyrimethamine, and dihydroartemisinin. High resolution melting was used for genotyping of pfdhps, pfdhfr, pfmdr1, and pfcrt genes.
   Results: The mean IC(50)s of chloroquine, amodiaquine, piperaquine, dihydroartemisinin, and pyrimethamine were, respectively, 39.44, 54.02, 15.28, 2.23, and 64.70 nM. Resistance mutations in pfdhfr gene, in codon 437 of pfdhps gene, and an absence of mutation at position 540 of pfdhps were observed. Mutations in codons K76T of pfcrt and N86Y of pfmdr1 were observed at 51 and 11% population prevalence, respectively. A relationship was found between the K76T and N86Y mutations and ex vivo resistance to chloroquine.
   Conclusion: An increase in sensitivity of isolates to chloroquine was observed. A high sensitivity to dihydroartemisinin was observed; whereas, a decrease in sensitivity to pyrimethamine was observed in the parasite population from Pikine.
C1 [Mbaye, Aminata; Gaye, Amy; Dieye, Baba; Ndiaye, Yaye D.; Bei, Amy K.; Deme, Awa B.; Yade, Mamadou S.; Diongue, Khadim; Ndiaye, Ibrahima M.; Ndiaye, Tolla; Sy, Mouhamed; Sy, Ngayo; Ndiaye, Daouda] Cheikh Anta Diop Univ Dakar, Lab Parasitol Mycol HALD, POB 5005, Dakar, Senegal.
   [Bei, Amy K.; Volkman, Sarah; Ndiaye, Daouda] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Krogstad, Donald J.] Tulane Univ, New Orleans, LA 70118 USA.
   [Affara, Muna; Nwakanma, Davis] MRC Unit, Fajara, Gambia.
   [Koita, Ousmane] Univ Bamako, Bamako, Mali.
RP Mbaye, A (reprint author), Cheikh Anta Diop Univ Dakar, Lab Parasitol Mycol HALD, POB 5005, Dakar, Senegal.
EM aminatambaye155@gmail.com
FU International Centers of Excellence for Malaria Research, (ICEMR) West
   Africa [U19AI089696]
FX The work was supported by the International Centers of Excellence for
   Malaria Research, (ICEMR) West Africa (U19AI089696).
CR Abdul-Ghani R, 2013, ACTA TROP, V125, P163, DOI 10.1016/j.actatropica.2012.10.013
   Bamba Sanata, 2013, Pan Afr Med J, V14, P105, DOI 10.11604/pamj.2013.14.105.1331
   Barends M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-81
   Basco LK, 2000, AM J TROP MED HYG, V62, P271
   Basco LK, 2003, ANTIMICROB AGENTS CH, V47, P1391, DOI 10.1128/AAC.47.4.1391-1394.2003
   Bei AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090928
   Boussaroque A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1379-2
   Bricaire F, 2008, CAHIERS SANTE, V63, P289
   Daniels R, 2012, ANTIMICROB AGENTS CH, V56, P2976, DOI 10.1128/AAC.05737-11
   Dieng T, 2005, Med Trop (Mars), V65, P580
   Eyase FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064299
   Fall B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-107
   GAYE O, 1990, ANN SOC BELG MED TR, V70, P33
   Hailemeskel E, 2013, ACTA TROP, V128, P636, DOI 10.1016/j.actatropica.2013.09.010
   Happi CT, 2005, ACTA TROP, V95, P183, DOI 10.1016/j.actatropica.2005.06.015
   Lim P, 2003, ANTIMICROB AGENTS CH, V47, P87, DOI 10.1128/AAC.47.1.87-94.2002
   Ly O, 2012, PARASITOL RES, V111, P1541, DOI 10.1007/s00436-012-2994-7
   Mbaye A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1490-4
   Mouzin E, 2010, FOCUS SUR LE SENEGAL
   Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09
   Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002
   Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x
   Ndiaye D, 2013, INT J PARASITOL-DRUG, V3, P135, DOI 10.1016/j.ijpddr.2013.07.001
   Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09
   Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000
   OMS, 2013, CHIM PAL SAIS, P1
   PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5
   Penh P, 2002, AM J TROP MED HYG, V66, P474
   PNLP, 2010, PLAN STRAT NAT 2011, P129
   Pradines B, 2010, REV FRANCOPHONE LAB, V422, P51, DOI DOI 10.1016/S1773-035X(10)70510-4
   Ruperez M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001964
   Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045
   Sokhna CS, 1997, B SOC PATHOL EXOT, V90, P83
   TRAPE JF, 1989, T ROY SOC TROP MED H, V83, P761, DOI 10.1016/0035-9203(89)90320-9
   [Anonymous], 2016, WORLD MALARIA REPORT
   WHO, 2014, SUMM STAT DEV AV AV, P1
NR 36
TC 0
Z9 0
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JUN 14
PY 2017
VL 16
AR 250
DI 10.1186/s12936-017-1897-6
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EY3DO
UT WOS:000403852000001
PM 28615016
OA gold
DA 2017-08-15
ER

PT J
AU Ndow, G
   Gore, ML
   Shimakawa, Y
   Suso, P
   Jatta, A
   Tamba, S
   Sow, A
   Toure-Kane, C
   Sadiq, F
   Sabally, S
   Njie, R
   Thursz, MR
   Lemoine, M
AF Ndow, Gibril
   Gore, Mindy L.
   Shimakawa, Yusuke
   Suso, Penda
   Jatta, Abdoulie
   Tamba, Saydiba
   Sow, Amina
   Toure-Kane, Coumba
   Sadiq, Fouzia
   Sabally, Saihou
   Njie, Ramou
   Thursz, Mark R.
   Lemoine, Maud
TI Hepatitis B testing and treatment in HIV patients in The
   Gambia-Compliance with international guidelines and clinical outcomes
SO PLOS ONE
LA English
DT Article
ID PLATELET RATIO INDEX; LIVER FIBROSIS; VIRUS COINFECTION; TRANSIENT
   ELASTOGRAPHY; INFECTED ADULTS; HIGH PREVALENCE; AFRICA; CANCER;
   FEASIBILITY; TENOFOVIR
AB Background
   Compliance with WHO guidelines on HBV screening and treatment in HIV-coinfected patients is often challenging in resource limited countries and has been poorly assessed in sub-Saharan Africa.
   Methods
   Between 2015 and 2016, we assessed physician's compliance with WHO guidelines on HIV-HBV coinfection in the largest HIV clinic in The Gambia, and the hepatic outcomes in HIV-HBV coinfected patients as compared to randomly selected HIV-monoinfected controls.
   Results
   870 HIV-infected patients regularly seen in this clinic agreed to participate in our study. Only 187 (21.5%, 95% CI 18.8-24.3) had previously been screened for HBsAg, 23 (12.3%, 95% CI 8.0-17.9) were positive of whom none had liver assessment and only 6 (26.1%) had received Tenofovir. Our HBV testing intervention was accepted by all participants and found 94/870 (10.8%, 95% CI 8.8-13.1) positive, 78 of whom underwent full liver assessment along with 40 HBsAg-negative controls. At the time of liver assessment, 61/78 (78.2%) HIVHBV coinfected patients received ART with 7 (11.5%) on Tenofovir and 54 (88.5%) on Lamivudine alone. HIV-HBV coinfected patients had higher APRI score compared to controls (0.58 vs 0.42, p = 0.002). HBV DNA was detectable in 52/53 (98.1%) coinfected patients with 14/53 (26.4%) having HBV DNA > 20,000 IU/L. 10/12 (83.3%) had at least one detectable 3TC-associated HBV resistance, which tended to be associated with increase in liver fibrosis after adjusting for age and sex (p = 0.05).
   Conclusions
   Compliance with HBV testing and treatment guidelines is poor in this Gambian HIV programme putting coinfected patients at risk of liver complications. However, the excellent uptake of HBV screening and linkage to care in our study suggests feasible improvements.
C1 [Ndow, Gibril; Sadiq, Fouzia; Thursz, Mark R.; Lemoine, Maud] Imperial Coll London, Div Digest Dis, Dept Surg & Canc, St Marys Hosp Campus, London, England.
   [Ndow, Gibril; Suso, Penda; Jatta, Abdoulie; Tamba, Saydiba; Njie, Ramou] MRC Unit Gambia, Hepatitis Unit, Dis Control & Eliminat, Fajara, Gambia.
   [Gore, Mindy L.] Imperial Coll London, Virol Sect, Dept Med, London, England.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.
   [Sow, Amina; Toure-Kane, Coumba] Univ Cheikh Anta DIOP, CHU Aristide Le Dantec, Lab Bacteriol Virol, Dakar, Senegal.
   [Sabally, Saihou] Brikama Hlth Ctr, Hands Care HIV Clin, Brikama, Gambia.
   [Njie, Ramou] WHO, IARC, Lyon, France.
RP Ndow, G (reprint author), Imperial Coll London, Div Digest Dis, Dept Surg & Canc, St Marys Hosp Campus, London, England.; Ndow, G (reprint author), MRC Unit Gambia, Hepatitis Unit, Dis Control & Eliminat, Fajara, Gambia.
EM g.ndow@imperial.ac.uk
FU Wellcome Trust-Imperial College Institutional Strategic Support Fund
   (ISSF); Wellcome Trust-Imperial College Centre for Global Health
   Research; NIHR Imperial Biomedical Research Centre; EU 7th Framework
   Programme (FP7-AFRICA, Collaborative Project PROLIFICA) [265994];
   Wellcome Trust grant [104771/Z/14/Z]
FX This work was supported by a Wellcome Trust-Imperial College
   Institutional Strategic Support Fund (ISSF) fellowship awarded to GN.
   Additional funding was provided by the Wellcome Trust-Imperial College
   Centre for Global Health Research (GN), the NIHR Imperial Biomedical
   Research Centre (MRT), and the EU 7th Framework Programme
   (FP7-AFRICA-2010, Collaborative Project PROLIFICA, Grant Nr. 265994).
   MLG is supported by a Wellcome Trust grant (award number 104771/Z/14/Z
   awarded to Dr Marcus Dorner). The funders had no role in the study
   design, data collection and analysis, decision to publish or preparation
   of this manuscript.; We thank the Medical Research Council Unit The
   Gambia, the Hands on Care HIV clinic and the Wellcome Trust-Imperial
   College Centre for Global Health Research for supporting this study. We
   are grateful to Professor Simon Taylor-Robinson for his continuous
   support all through the project, and Dr Marcus Dorner and his team for
   their advice and help with the molecular virology work. We thank all
   study participants, the PROLIFICA Gambia team, and the MRC data
   management unit. Lastly, we are grateful for the administrative and
   logistical support from Dr Peter Norsworthy, Dawn Campbell, Kimberley
   Trim, Susan Farrell, Mavis Foster-Nyarko and Amie Ceesay.
CR Bota S, 2011, HEPAT MON, V11, P548
   Boyd A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21426
   Boyd A, 2015, ANTIVIR THER, V20, P643, DOI 10.3851/IMP2959
   Diop S A, 2013, Bull Soc Pathol Exot, V106, P22, DOI 10.1007/s13149-012-0272-7
   Garson JA, 2005, J VIROL METHODS, V126, P207, DOI 10.1016/j.jviromet.2005.03.001
   Ghosh S, 2016, J VIRAL HEPATITIS, V23, P897, DOI 10.1111/jvh.12561
   Gitau SN, 2016, J CLIN IMAG SCI, V6, DOI 10.4103/2156-7514.183582
   Hawkins C, 2013, CLIN INFECT DIS, V57, pE189, DOI 10.1093/cid/cit564
   Japhet MM, 2016, C RETR OPP INF CROI
   Johannessen A, 2015, LIVER INT, V35, P2059, DOI 10.1111/liv.12793
   Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027
   Kouarne MG, 2016, 21 INT AIDS C 18 22
   Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9
   Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/S0016-5085(03)01529-4
   Ministry of Health & Social Welfare Republic of The Gambia, 2015, GUID ANT THER PREV T
   Ramirez-Mena A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw162
   Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646
   Stabinski L, 2015, JAIDS-J ACQ IMM DEF, V68, pS274, DOI 10.1097/QAI.0000000000000496
   Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783
   Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7
   Stewart Balint, 2011, BMC Res Notes, V4, P561, DOI 10.1186/1756-0500-4-561
   Stockdale AJ, 2015, CLIN INFECT DIS, V61, P883, DOI 10.1093/cid/civ421
   UN, 2015, TRANSF OUR WORLD 203
   United Nations, SUST DEV GOAL 3 ENS
   Vinikoor MJ, 2016, TROP MED INT HEALTH, V21, P1435, DOI 10.1111/tmi.12764
   Vinikoor MJ, 2015, LIVER INT, V35, P1886, DOI 10.1111/liv.12780
   World Health Organization, 2013, CONGUID UANT DRU
   World Health Organization, 2016, COMB HEP B C REACH E
   World Health Organization, 2015, GLOB HLTH SECT STRAT
   World Health Organization, 2015, GUID PREV CAR TREATM
   World Health Organisation, 2014, 67 WORLD HLTH ASS
   World Health Organization, 2016, CONS GUID HIV PREV D
NR 34
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 14
PY 2017
VL 12
IS 6
AR e0179025
DI 10.1371/journal.pone.0179025
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5KN
UT WOS:000403280900030
PM 28614401
OA gold
DA 2017-08-15
ER

PT J
AU Collinson, JM
   Dufour, P
   Hamza, AA
   Lawrie, Y
   Elliott, M
   Barlow, C
   Crochet, PA
AF Collinson, J. Martin
   Dufour, Paul
   Hamza, Abdulmaula A.
   Lawrie, Yvonne
   Elliott, Michael
   Barlow, Clive
   Crochet, Pierre-Andre
TI When morphology is not reflected by molecular phylogeny: the case of
   three 'orange-billed terns' Thalasseus maximus, Thalasseus bergii and
   Thalasseus bengalensis (Charadriiformes: Laridae)
SO BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY
LA English
DT Article
DE molecular phylogeny; mtDNA; Sterna; Sterninae; The Gambia
ID TAXONOMIC RECOMMENDATIONS; BRITISH BIRDS; ROYAL TERN; CONSERVATION;
   EVOLUTION; GENETICS
AB In order to elucidate genetic structure within the royal tern Thalasseus maximus, genetic analyses and phylogenetic reconstructions were performed on royal terns Thalasseus maximus albididorsalis from the West African breeding population and compared with sequences from American populations Thalasseus maximus maximus. The analysis shows that royal tern as currently defined is a paraphyletic species: West African royal tern is genetically distinct from American breeding populations of the nominate subspecies and forms part of a genetic cluster with lesser crested terns Thalasseus bengalensis (of all subspecies) and greater crested terns Thalasseus bergii. This represents the first published analysis of the genetic relationship between the two subspecies of royal terns, suggests that the West African population should be treated as a distinct species, and provides support to previous studies suggesting that morphological and genetic similarities are poorly correlated in the genus Thalasseus. Conservation and taxonomic implications are discussed.
C1 [Collinson, J. Martin; Lawrie, Yvonne] Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen AB25 2ZD, Scotland.
   [Dufour, Paul; Crochet, Pierre-Andre] Univ Montpellier, Univ Paul Valery Montpellier, EFE UMR 5175, CNRS,EPHE, 1919 Route Mende, F-34293 Montpellier 5, France.
   [Hamza, Abdulmaula A.] Univ Malaysia Terengganu, Sch Marine & Environm Sci, Kuala Terengganu 21030, Malaysia.
   [Hamza, Abdulmaula A.; Elliott, Michael] Univ Hull, Inst Estuarine & Coastal Studies, Kingston Upon Hull HU6 7RX, N Humberside, England.
   [Barlow, Clive] Birds Gambia, Brufut, Western Region, Gambia.
RP Collinson, JM (reprint author), Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen AB25 2ZD, Scotland.
EM m.collinson@abdn.ac.uk
CR BirdLife International, 2016, SPEC FACTSH THAL MAX
   Bridge ES, 2005, MOL PHYLOGENET EVOL, V35, P459, DOI 10.1016/jympev.2004.12.010
   Buckley PA, 2002, BIRDS N AM ONLINE
   Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439
   Cosgrove Peter, 2013, Bulletin of the African Bird Club, V20, P27
   del Hoyo J, 2014, HBW BIRDLIFE INT ILL, V1
   del Hoyo J, 1996, HDB BIRDS WORLD HOAT, V3
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Dickinson E.C., 2013, HOWARD MOORE COMPLET, V1
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dufour P, 2017, J ORNITHOL, V158, P351, DOI 10.1007/s10336-016-1380-0
   Efe MA, 2009, MOL PHYLOGENET EVOL, V52, P263, DOI 10.1016/j.ympev.2009.03.030
   Hamza AA, 2014, THESIS
   Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312
   HELBIG AJ, 1995, J AVIAN BIOL, V26, P139, DOI 10.2307/3677063
   MASSEY BW, 1976, AUK, V93, P760
   Mayr E, 1970, SPECIES TAXA N AM BI
   MOON SJ, 1983, BRIT BIRDS, V76, P335
   Pons JM, 2005, MOL PHYLOGENET EVOL, V37, P686, DOI 10.1016/j.ympev.2005.05.011
   Rambaut A., 2014, TRACER V1 6
   Sangster G, 2005, IBIS, V147, P821, DOI 10.1111/j.1474-919x.2005.00483.x
   Sangster G, 2011, IBIS, V153, P883, DOI 10.1111/j.1474-919X.2011.01155.x
   Shannon TJ, 2014, BIRD STUDY, V61, P135, DOI 10.1080/00063657.2014.894493
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Taylor SA, 2012, MAR ECOL PROG SER, V451, P285, DOI 10.3354/meps09694
   Tobias JA, 2010, IBIS, V152, P724
   Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x
   Whittier JB, 2006, WATERBIRDS, V29, P176, DOI 10.1675/1524-4695(2006)29[176:GVASOL]2.0.CO;2
NR 28
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0024-4066
EI 1095-8312
J9 BIOL J LINN SOC
JI Biol. J. Linnean Soc.
PD JUN 1
PY 2017
VL 121
IS 2
BP 439
EP 445
PG 7
WC Evolutionary Biology
SC Evolutionary Biology
GA FA1NZ
UT WOS:000405207800017
OA No
DA 2017-08-15
ER

PT J
AU Mwangi, MN
   Phiri, KS
   Abkari, A
   Gbane, M
   Bourdet-Sicard, R
   Braesco, VA
   Zimmermann, MB
   Prentice, AM
AF Mwangi, Martin N.
   Phiri, Kamija S.
   Abkari, Abdelhak
   Gbane, Mory
   Bourdet-Sicard, Raphaelle
   Braesco, Veronique Azais
   Zimmermann, Michael B.
   Prentice, Andrew M.
TI Iron for Africa-Report of an Expert Workshop
SO NUTRIENTS
LA English
DT Article
DE iron deficiency; fortification; benefit-risk ratio; anemia; malaria;
   biomarkers
ID HELICOBACTER-PYLORI INFECTION; PRESCHOOL-CHILDREN; CONTROLLED-TRIAL;
   DEFICIENCY ANEMIA; RANDOMIZED-TRIAL; PREGNANT-WOMEN; YOUNG-CHILDREN;
   DOUBLE-BLIND; SUPPLEMENTATION; FORTIFICATION
AB Scientific experts from nine countries gathered to share their views and experience around iron interventions in Africa. Inappropriate eating habits, infections and parasitism are responsible for significant prevalence of iron deficiency, but reliable and country-comparable prevalence estimates are lacking: improvements in biomarkers and cut-offs values adapted to context of use are needed. Benefits of iron interventions on growth and development are indisputable and outweigh risks, which exist in populations with a high infectious burden. Indeed, pathogen growth may increase with enhanced available iron, calling for caution and preventive measures where malaria or other infections are prevalent. Most African countries programmatically fortify flour and supplement pregnant women, while iron deficiency in young children is rather addressed at individual level. Coverage and efficacy could improve through increased access for target populations, raised awareness and lower cost. More bioavailable iron forms, helping to decrease iron dose, or prebiotics, which both may lower risk of infections are attractive opportunities for Africa. Fortifying specific food products could be a relevant route, adapted to local context and needs of population groups while providing education and training. More globally, partnerships involving various stakeholders are encouraged, that could tackle all aspects of the issue.
C1 [Mwangi, Martin N.] Wageningen Univ & Res, Div Human Nutr, NL-6700 AA Wageningen, Netherlands.
   [Mwangi, Martin N.] Maseno Univ, Nutr & Hlth Dept, Sch Publ Hlth & Community Dev, Maseno, Kenya.
   [Phiri, Kamija S.] Univ Malawi, Coll Med, Dept Publ Hlth, Private Bag 360, Blantyre 8, Malawi.
   [Abkari, Abdelhak] Hassan II Univ, Fac Med, CHU Ibn Rochd, Casablanca, Morocco.
   [Gbane, Mory] Natl Publ Hlth Inst INSP, Adjame BPV 47, Abidjan 01, Cote Ivoire.
   [Gbane, Mory] Nutr Soc Cote Ivoire SIN, Adjame BPV 47, Abidjan 01, Cote Ivoire.
   [Bourdet-Sicard, Raphaelle] Danone Nutricia Res, Route Vauve, F-91120 Palaiseau, France.
   [Braesco, Veronique Azais] VAB Nutr, Rue Claude Danziger, F-63100 Clermont Ferrand, France.
   [Zimmermann, Michael B.] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schmelzbergstr, CH-78092 Zurich, Switzerland.
   [Prentice, Andrew M.] MRC Unit Gambia, Atlantic Rd, Fajara, Gambia.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
RP Braesco, VA (reprint author), VAB Nutr, Rue Claude Danziger, F-63100 Clermont Ferrand, France.
EM mart.mwangi@gmail.com; kamijaphiri@gmail.co; abkari60@gmail.com;
   morydoc@gmail.com; Raphaelle.BOURDET-SICARD@danone.com;
   veronique.braesco@vab-nutrition.com; michael.zimmermann@hest.ethz.ch;
   Andrew.Prentice@lshtm.ac.uk
FU Danone
FX The workshop "iron for Africa" has been sponsored by Danone. M.N.M.,
   K.S.P., A.A., M.G., V.A.B., M.B.Z. and A.M.P.'s travel expenses have
   been covered by Danone. A.A., M.G. and V.A.B. have received fees from
   Danone for their participation to this workshop. R.B.S. is employed by
   Danone Nutricia Research.
CR Abla K., 2016, Cahiers de Nutrition et de Dietetique, V51, P157, DOI 10.1016/j.cnd.2016.04.003
   Admou B, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/637187
   Al Ghwass Mohamed M E, 2015, Ann Afr Med, V14, P25, DOI 10.4103/1596-3519.148725
   Benjelloun S, 2002, PUBLIC HEALTH NUTR, V5, P135, DOI 10.1079/PHN2001285
   Brabin BJ, 2001, J NUTR, V131, p604S
   Brissot P, 2016, EXPERT REV GASTROENT, V10, P359, DOI 10.1586/17474124.2016.1119043
   Ciacci C, 2004, DIGEST LIVER DIS, V36, P455, DOI 10.1016/j.dld.2004.02.008
   Diouf S, 2015, ROLE IRON DEFICIENCY, V22, P1188
   El Hamdouchi A., 2010, Eastern Mediterranean Health Journal, V16, P1148
   Engmann C, 2008, INT J GYNECOL OBSTET, V101, P62, DOI 10.1016/j.ijgo.2007.09.032
   Esan MO, 2013, CLIN INFECT DIS, V57, P1626, DOI 10.1093/cid/cit528
   FAO, PROF NUTR DE PAYS
   Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467
   GBOS, GAMB DEM HLTH SURV 2
   Gera T, 2002, BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142
   GINA-WHO, EFF SELL MICR POWD S
   GSS, GHAN STAT SERV DEM H
   Hudak L, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12330
   Hussein WM, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0083-8
   Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261
   Imbert M, 1998, CURR MICROBIOL, V37, P64, DOI 10.1007/s002849900339
   IUNS, INT UN NUTR SCI MICR
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   Kisiangani I, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.62.4560
   Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968
   de Romana DL, 2011, BIOL TRACE ELEM RES, V144, P1318, DOI 10.1007/s12011-011-9143-5
   Low M, 2013, CAN MED ASSOC J, V185, pE791, DOI 10.1503/cmaj.130628
   Lumbiganon P, 2014, BJOG-INT J OBSTET GY, V121, P32, DOI 10.1111/1471-0528.12647
   Malan L, 2015, AM J CLIN NUTR, V101, P668, DOI 10.3945/ajcn.113.081208
   Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z
   Ministry of Health (MoH). Ministry of Health and Population, MIN HLTH POP EG DEM
   MSLS, ENQ DEM SANT IND MUL
   Murray-Kolb LE, 2009, AM J CLIN NUTR, V89, p946S, DOI 10.3945/ajcn.2008.26692D
   Mwangi MN, 2015, JAMA-J AM MED ASSOC, V314, P1009, DOI 10.1001/jama.2015.9496
   Mwangi MN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0229-8
   Osazuwa Favour, 2011, N Am J Med Sci, V3, P30, DOI 10.4297/najms.2011.330
   Pasricha SR, 2016, HEMATOL ONCOL CLIN N, V30, P309, DOI 10.1016/j.hoc.2015.11.003
   Pena-Rosas J.P., DAILY ORAL IRON SUPP
   Phiri KS, 2009, J CLIN PATHOL, V62, P1103, DOI 10.1136/jcp.2009.066498
   Phiri KS, 2009, J CLIN PATHOL, V62, P685, DOI 10.1136/jcp.2009.064451
   PIPAF & Consortium, 2008, EV CAR VIT A FER FOL
   Rezk M, 2015, J OBSTET GYNAECOL, V35, P663, DOI 10.3109/01443615.2014.991289
   Sarker SA, 2004, AM J CLIN NUTR, V80, P149
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Shaw J.G., 2011, ANEMIA, DOI DOI 10.1155/2011/260380]
   Shisana O., S AFRICAN NATL HLTH
   Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7
   Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9
   Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215
   Thankachan P, 2010, EUR J CLIN NUTR, V64, P1101, DOI 10.1038/ejcn.2010.126
   Thompson J, 2013, PEDIATRICS, V131, P739, DOI 10.1542/peds.2012-2256
   Troesch B, 2011, J NUTR, V141, P237, DOI 10.3945/jn.110.129247
   WHO, 2011, HAEM CONC DIAGN AN A
   World Health Organization, VIT MIN NUTR INF SYS
   WHO, DAIL IR SUPPL INF CH
   WHO, DAIL IR SUPPL AD WOM
   WHO, IR SUPPL POSTP WOM
   WHO, GLOB HLTH OBS DAT SO
   WHO, 2004, ASS IR STAT POP REP
   Zaida F, 2006, ANN NUTR METAB, V50, P237, DOI 10.1159/000091680
   Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
   Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129
NR 63
TC 0
Z9 0
U1 1
U2 1
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2017
VL 9
IS 6
AR 576
DI 10.3390/nu9060576
PG 15
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EY7NA
UT WOS:000404177100047
OA gold
DA 2017-08-15
ER

PT J
AU Mwangi, MN
   Prentice, AM
   Verhoef, H
AF Mwangi, Martin N.
   Prentice, Andrew M.
   Verhoef, Hans
TI Safety and benefits of antenatal oral iron supplementation in low-income
   countries: a review
SO BRITISH JOURNAL OF HAEMATOLOGY
LA English
DT Review
DE anaemia; iron supplementation; low-income countries; malaria; pregnancy
ID RANDOMIZED CONTROLLED-TRIAL; DEFICIENCY ANEMIA; PREGNANT-WOMEN;
   PLASMODIUM-FALCIPARUM; PRESCHOOL-CHILDREN; AFRICAN CHILDREN;
   CLINICAL-TRIAL; BIRTH-WEIGHT; MALARIA; INFLAMMATION
AB The World Health Organization recommends universal iron supplementation of 30-60 mg/day in pregnancy but coverage is low in most countries. Its efficacy is uncertain, however, and there has been a vigorous debate in the last decade about its safety, particularly in areas with a high burden of malaria and other infectious diseases. We reviewed the evidence on the safety and efficacy of antenatal iron supplementation in low-income countries. We found no evidence that daily supplementation at a dose of 60 mg leads to increased maternal Plasmodium infection risk. On the other hand, recent meta-analyses found that antenatal iron supplementation provides benefits for maternal health (severe anaemia at postpartum, blood transfusion). For neonates, there was a reduced prematurity risk, and only a small or no effect on birth weight. A recent trial showed, however, that benefits of antenatal iron supplementation on maternal and neonatal health vary by maternal iron status, with substantial benefits in iron-deficient women. The benefits of universal iron supplementation are likely to vary with the prevalence of iron deficiency. As a consequence, the balance between benefits and risks is probably more favourable in low-income countries than in high-income countries despite the higher exposure to infectious pathogens.
C1 [Mwangi, Martin N.; Verhoef, Hans] Wageningen Univ, Div Human Nutr, POB 14, NL-6700 AA Wageningen, Netherlands.
   [Mwangi, Martin N.] Maseno Univ, Sch Publ Hlth & Community Dev, Nutr & Hlth Dept, Maseno, Kenya.
   [Prentice, Andrew M.] MRC Unit Gambia, Banjul, Gambia.
   [Prentice, Andrew M.; Verhoef, Hans] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands.
RP Mwangi, MN (reprint author), Wageningen Univ, Div Human Nutr, POB 14, NL-6700 AA Wageningen, Netherlands.
EM mart.mwangi@gmail.com
CR American Academy of Family Physicians, 2015, CLIN PREV SERV REC I
   American College of Obstetricians and Gynecologists, 2008, OBSTET GYNECOLOGY, V112, P201
   Beaton GH, 2000, AM J CLIN NUTR, V72, p265S
   BEGUIN Y, 1991, BLOOD, V78, P89
   Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012
   Black R.E., 2014, INT NUTR ACHIEVING M, P21
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005
   Brittenham GM, 2014, AM J CLIN NUTR, V100, P813, DOI 10.3945/ajcn.113.081505
   Casanueva E, 2003, J NUTR, V133, p1700S
   Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V47, P1
   Clark M.A., 2014, PLASMODIUM FALCIPARU, V5, P614
   Clark M, 2013, BRIT J HAEMATOL, V161, P262, DOI 10.1111/bjh.12234
   Clark MA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00084
   Cross JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16670
   Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Etheredge AJ, 2015, JAMA PEDIATR, V169, P947, DOI 10.1001/jamapediatrics.2015.1480
   FAO/WHO, 1988, FAO FOOD NUTR SER, V23
   FLEMING AF, 1986, ANN TROP MED PARASIT, V80, P211
   Forman HJ, 2016, ARCH BIOCHEM BIOPHYS, V603, P48, DOI 10.1016/j.abb.2016.05.005
   Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502
   Gaiser R., 2014, CHESTNUTS OBSTET ANE, P15
   Gamble C.L., 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003755.PUB2
   Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863
   Gashu D, 2016, PUBLIC HEALTH NUTR, V19, P1834, DOI 10.1017/S1368980015003626
   Goheen MM, 2016, EBIOMEDICINE, V14, P123, DOI 10.1016/j.ebiom.2016.11.011
   Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443
   Hodgins Stephen, 2014, Glob Health Sci Pract, V2, P173, DOI 10.9745/GHSP-D-13-00176
   Institute of Medicine, 2011, CLIN PREV SERV WOM C
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Kavle JA, 2008, J HEALTH POPUL NUTR, V26, P232
   Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968
   Kumar Neeta, 2009, Indian J Clin Biochem, V24, P5, DOI 10.1007/s12291-009-0002-5
   Kurtoglu E, 2003, BIOL TRACE ELEM RES, V96, P109, DOI 10.1385/BTER:96:1-3:109
   MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7
   MURPHY JF, 1986, LANCET, V1, P992
   Mwangi MN, 2015, JAMA-J AM MED ASSOC, V314, P1009, DOI 10.1001/jama.2015.9496
   Mwangi MN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0229-8
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Ndyomugyenyi R, 2000, ANN TROP MED PARASIT, V94, P759, DOI 10.1080/00034980020015189
   New S, 2015, BJOG-INT J OBSTET GY, V122, P166, DOI 10.1111/1471-0528.13225
   Oppenheimer SJ, 2001, J NUTR, V131, p616S
   Paino IMM, 2009, BIOL TRACE ELEM RES, V129, P116, DOI 10.1007/s12011-008-8303-8
   Pena-Rosas JP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub5
   Pena-Rosas J, 2012, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858.CD004736.pub4, DOI 10.1002/14651858.CD004736.PUB4]
   Pena-Rosas JP, 2009, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD004736.PUB3, 10.1002/14651858.CD004736.pub3]
   Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044
   Radeva-Petrova D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub3
   Rioux FM, 2007, APPL PHYSIOL NUTR ME, V32, P282, DOI 10.1139/H07-012
   Rush D, 2000, AM J CLIN NUTR, V72, p212S
   Sangare L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087743
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537
   Siu AL, 2015, ANN INTERN MED, V163, P529, DOI 10.7326/M15-1707
   Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949
   Spottiswoode N, 2012, ADV NUTR, V3, P570, DOI 10.3945/an.111.001156
   Steer PJ, 2000, AM J CLIN NUTR, V71, p1285S
   Stoltzfus RJ, 2004, COMP QUANTIFICATION, V1, P163
   Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215
   Svanberg B., 1975, ACTA OBSTET GYN SCAN, V54, P69
   Thurnham DI, 2016, CURR OPIN CLIN NUTR, V19, P458, DOI 10.1097/MCO.0000000000000323
   Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5
   Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125
   Verhoef H, 2010, AM J CLIN NUTR, V92, P1285, DOI 10.3945/ajcn.110.006700
   Vucic V, 2013, NUTR REV, V71, P386, DOI 10.1111/nure.12037
   Wang LL, 2016, BRIT J NUTR, V115, P644, DOI 10.1017/S0007114515004870
   Weinberg ED, 2010, MED HYPOTHESES, V74, P246, DOI 10.1016/j.mehy.2009.09.029
   WEINBERG ED, 1974, SCIENCE, V184, P952, DOI 10.1126/science.184.4140.952
   Weiss G, 2002, EUR J CLIN INVEST, V32, P70, DOI 10.1046/j.1365-2362.2002.0320s1070.x
   WHO, 2014, WHO POL BRIEF IMPL I
   WHO, 2012, GUID INT IR FOL AC S
   WHO, 2011, WHONMHNHDMNM111
   WHO, 2015, GLOB PREV AN 2011
   WHO, 2007, FOOD NUTR BULL, V28, pS621
   WHO, 1968, WHO TECHN REP SER
   World Health Organization, 2012, GUID DAIL IR FOL AC
   Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508
   Zhou LM, 1998, AM J EPIDEMIOL, V148, P998
   Ziaei S, 2007, BJOG-INT J OBSTET GY, V114, P684, DOI 10.1111/j.1471-0528.2007-01325.x
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
NR 84
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1048
EI 1365-2141
J9 BRIT J HAEMATOL
JI Br. J. Haematol.
PD JUN
PY 2017
VL 177
IS 6
SI SI
BP 884
EP 895
DI 10.1111/bjh.14584
PG 12
WC Hematology
SC Hematology
GA EX4PB
UT WOS:000403215900009
PM 28272734
OA No
DA 2017-08-15
ER

PT J
AU Verhoef, H
   Veenemans, J
   Mwangi, MN
   Prentice, AM
AF Verhoef, Hans
   Veenemans, Jacobien
   Mwangi, Martin N.
   Prentice, Andrew M.
TI Safety and benefits of interventions to increase folate status in
   malaria-endemic areas
SO BRITISH JOURNAL OF HAEMATOLOGY
LA English
DT Review
DE folic acid; folic acid antagonists; malaria; neural tube defects;
   sulfadoxine-pyrimethamine
ID FOLIC-ACID SUPPLEMENTATION; METHYLENETETRAHYDROFOLATE REDUCTASE GENE;
   PLASMODIUM-FALCIPARUM MALARIA; RANDOMIZED CONTROLLED-TRIAL; NEURAL-TUBE
   DEFECTS; SICKLE-CELL-DISEASE; LOW-BIRTH-WEIGHT;
   SULFADOXINE-PYRIMETHAMINE; UNITED-STATES; CLINICAL PHARMACOKINETICS
AB For decades, folic acid has routinely been given to prevent or treat anaemia in children, pregnant women and people with sickle cell disease. However, there is no conclusive evidence that folate deficiency anaemia constitutes a public health problem in any of these groups. Industrial flour fortification is recommended and implemented in many countries to combat neural tube defects. Dietary folates or folic acid can antagonise the action of antifolate drugs that play a critical role in the prevention and treatment of malaria. Randomised trials have shown that folic acid supplementation increases the rate of treatment failures with sulfadoxine-pyrimethamine. The efficacy of antifolate drugs against Plasmodium is maximized in the absence of exogenous folic acid, suggesting that there is no safe minimum dose of ingested folic acid. We here review the safety and benefits of interventions to increase folate status in malaria-endemic countries. We conclude that formal cost-benefit analyses are required.
C1 [Verhoef, Hans; Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Verhoef, Hans; Prentice, Andrew M.] MRC Unit Gambia, Nutr Theme, Banjul, Gambia.
   [Verhoef, Hans] Cell Biol & Immunol Grp, Wageningen, Netherlands.
   [Verhoef, Hans; Mwangi, Martin N.] Wageningen Univ & Res, Div Human Nutr, Wageningen, Netherlands.
   [Veenemans, Jacobien] Admiral de Ruyter Hosp, Lab Microbiol & Immunol, Goes, Netherlands.
   [Veenemans, Jacobien] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.
RP Verhoef, H (reprint author), Wageningen Univ, Cell Biol & Immunol Grp, POB 338, NL-6700 AH Wageningen, Netherlands.
EM hans.verhoef@icloud.com
CR Adjalla CE, 2003, CLIN CHEM LAB MED, V41, P1028, DOI 10.1515/CCLM.2003.158
   Allen LH, 2012, ADV NUTR, V3, P362, DOI 10.3945/an.111.001172
   Antony AC, 2008, NEW ENGL J MED, V358, P2291
   Baggott JE, 2008, AM J CLIN NUTR, V88, P479
   Bailey LB, 2004, NUTR REV, V62, pS14, DOI 10.1301/nr.2004.jun.S14-S20
   Beaudin AE, 2009, BIRTH DEFECTS RES A, V85, P274, DOI 10.1002/bdra.20553
   Berry RJ, 2010, FOOD NUTR BULL, V31, pS22
   Calis JCJ, 2008, NEW ENGL J MED, V358, P2291
   Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727
   Carter JY, 2005, AM J TROP MED HYG, V73, P166
   Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112
   Choumenkovitch SF, 2002, J NUTR, V132, P2792
   Christianson A, 2006, MARCH DIMES GLOBAL R
   CHULAY JD, 1984, AM J TROP MED HYG, V33, P325
   Clark MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5446
   Clarke R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001177
   Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671
   DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698
   De-Regil LM, 2015, COCHRANE DB SYST REV, V12
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   DHUR A, 1991, PROG FOOD NUTR SCI, V15, P43
   Dixit R, 2016, COCHRANE DB SYST REV, V2
   Dzinjalamala FK, 2005, AM J TROP MED HYG, V72, P267
   Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6
   FERONE R, 1977, B WORLD HEALTH ORGAN, V55, P291
   Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173
   FLEMING AF, 1989, BLOOD REV, V3, P18
   FLEMING AF, 1989, T ROY SOC TROP MED H, V83, P441, DOI 10.1016/0035-9203(89)90241-1
   Fleming A.F., 2003, MANSONS TROPICAL DIS, P169
   Furness DLF, 2012, J MATERN-FETAL NEO M, V25, P1423, DOI 10.3109/14767058.2011.636463
   Galloway P, 2000, ANN CLIN BIOCHEM, V37, P289
   GEARY TG, 1985, J PROTOZOOL, V32, P608, DOI 10.1111/j.1550-7408.1985.tb03087.x
   Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4
   Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004
   Hoffbrand A.V., 2011, POSTGRADUATE HAEMATO
   Hubner R, 2007, BRIT MED J, V334, P1253, DOI 10.1136/bmj.39232.496227.47
   Kalmbach RD, 2008, AM J CLIN NUTR, V88, P763
   KAMEN BA, 1988, J BIOL CHEM, V263, P13602
   Kelly P, 1997, AM J CLIN NUTR, V65, P1790
   Khanna D, 2005, ARTHRITIS RHEUM, V52, P3030, DOI 10.1002/art.21295
   Koury MJ, 2004, ANNU REV NUTR, V24, P105, DOI 10.1146/annurev.nutr.24.012003.132306
   KRUNGKRAI J, 1990, PARASITOL TODAY, V6, P388, DOI 10.1016/0169-4758(90)90148-W
   Lassi Z. S., 2013, COCHRANE DB SYST REV, V3
   Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2
   Levene M. I., 2000, ESSENTIALS NEONATAL
   Lohner S, 2012, INT J FOOD SCI NUTR, V63, P1014, DOI 10.3109/09637486.2012.683779
   LUCOCK M, 1989, EUR J CLIN NUTR, V43, P631
   Luzzatto L, 2010, LANCET, V376, P739, DOI 10.1016/S0140-6736(10)60396-0
   Mahomed K., 1997, COCHRANE DB SYST REV, V3
   Mbaye A, 2006, AM J TROP MED HYG, V74, P960
   McLean E, 2008, FOOD NUTR BULL, V29, pS38
   Meremikwu MM, 2008, COCHRANE DB SYST REV, V2
   Metz J, 2008, FOOD NUTR BULL, V29, pS74
   Metz J, 2007, FOOD NUTR BULL, V28, pS540
   Miller ER, 2010, AM J CARDIOL, V106, P517, DOI 10.1016/j.amjcard.2010.03.064
   Mulenga M, 2006, AM J TROP MED HYG, V74, P986
   Nduati E, 2008, PARASITOL RES, V102, P1227, DOI 10.1007/s00436-008-0897-4
   Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002
   Nzila A, 2006, DRUG DISCOV TODAY, V11, P939, DOI 10.1016/j.drudis.2006.08.003
   Nzila A, 2016, FOOD NUTR BULL, V37, P153, DOI 10.1177/0379572116634511
   Nzila A, 2014, J ANTIMICROB CHEMOTH, V69, P323, DOI 10.1093/jac/dkt394
   Oniyangi O, 2006, COCHRANE DB SYST REV, V4
   Ouma P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010028
   Oyediran ABOO, 2002, B WORLD HEALTH ORGAN, V80, P817
   Pegoraro RJ, 2004, ACTA OBSTET GYN SCAN, V83, P449, DOI 10.1111/j.0001-6349.2004.0355.x
   Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X
   Pietrzik K, 2010, CLIN PHARMACOKINET, V49, P535, DOI 10.2165/11532990-000000000-00000
   Powers HJ, 2007, BRIT J NUTR, V98, P665, DOI 10.1017/S0007114507795326
   Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221
   Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395
   Rodriguez-Cortes HM, 1999, J PEDIAT HEMATOL ONC, V21, P219, DOI 10.1097/00043426-199905000-00010
   Rolschau J, 1999, EUR J OBSTET GYN R B, V87, P105, DOI 10.1016/S0301-2115(99)00084-6
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   SCHALHORN A, 1992, SEMIN ONCOL, V19, P82
   Stern LL, 2000, J NUTR, V130, P2238
   STOKSTAD ELR, 1987, J NUTR, V117, P1335
   Sweeney MR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-41
   Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994
   TONG MJ, 1970, J AMER MED ASSOC, V214, P2330, DOI 10.1001/jama.214.13.2330
   van Eijk AM, 2008, J INFECT DIS, V198, P1550, DOI 10.1086/592715
   Boele van Hensbroek M, 1995, T ROY SOC TROP MED H, V89, P672
   Verhoef H, 2002, BLOOD, V100, P3489, DOI 10.1182/blood-2001-12-0228
   Wald NJ, 2007, BRIT MED J, V334, P1252, DOI 10.1136/bmj.39232.493252.47
   Wang P, 2007, MOL BIOCHEM PARASIT, V154, P40, DOI 10.1016/j.molbiopara.2007.04.002
   Wang WC, 1999, J PEDIAT HEMATOL ONC, V21, P176, DOI 10.1097/00043426-199905000-00003
   WHO, 2015, GUID OPT SER RED BLO
   WHO, 2013, SUPPL SECT WHO CONS, P8
   World Health Organization, 2012, WHO POL REC SEAS MAL
   WHO, 2010, WHO POL REC INT PREV
   WHO, 2014, WHOHTMGMP20144
   World Health Organization, 2015, WORLD MAL REP 2015
   WHO, 2010, SICKL CELL DIS STRAT
   WHO/FAO (World Health Organization/Food and Agriculture Organization of the United Nations), 2004, VIT MIN REQ HUM NUTR
   WHO/FAO/UNICEF/GAIN/MI/FFI, 2009, REC WHEAT MAIZ FLOUR
   Wilson AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016976
   Yetley E. A., 2011, AM J CLIN NUTR S, V94, p1S
   Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274
NR 97
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1048
EI 1365-2141
J9 BRIT J HAEMATOL
JI Br. J. Haematol.
PD JUN
PY 2017
VL 177
IS 6
SI SI
BP 905
EP 918
DI 10.1111/bjh.14618
PG 14
WC Hematology
SC Hematology
GA EX4PB
UT WOS:000403215900011
PM 28369746
OA No
DA 2017-08-15
ER

PT J
AU Bah, A
   Pasricha, SR
   Jallow, MW
   Sise, EA
   Wegmuller, R
   Armitage, AE
   Drakesmith, H
   Moore, SE
   Prentice, AM
AF Bah, Amat
   Pasricha, Sant-Rayn
   Jallow, Momodou W.
   Sise, Ebrima A.
   Wegmuller, Rita
   Armitage, Andrew E.
   Drakesmith, Hal
   Moore, Sophie E.
   Prentice, Andrew M.
TI Serum Hepcidin Concentrations Decline during Pregnancy and May Identify
   Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The
   Gambia
SO JOURNAL OF NUTRITION
LA English
DT Article
DE hepcidin; anemia; iron deficiency; pregnancy; diagnostic
ID RANDOMIZED CONTROLLED-TRIAL; RURAL GAMBIA; WOMEN; SUPPLEMENTATION;
   HOMEOSTASIS; INFECTION; ANEMIA; SCREEN; IDENTIFICATION; POPULATION
AB Background: Antenatal anemia is a risk factor for adverse maternal and fetal outcomes and is prevalent in sub-Saharan Africa. Less than half of antenatal anemia is considered responsive to iron; identifying women in need of iron may help target interventions. Iron absorption is governed by the iron-regulatory hormone hepcidin.
   Objective: We sought to characterize changes in hepcidin and its associations with indexes of iron stores, erythropoiesis, and inflammation at weeks 14, 20, and 30 of gestation and to assess hepcidin's diagnostic potential as an index of iron deficiency.
   Methods: We measured hemoglobin and serum hepcidin, ferritin, soluble transferrin receptor (sTfR), and C-reactive protein (CRP) at 14, 20, and 30 wk of gestation in a cohort of 395 Gambian women recruited to a randomized controlled trial. Associations with hepcidin were measured by using linear regression, and hepcidin's diagnostic test accuracy [area under the receiver operating characteristic curve (AUC(ROC)), sensitivity, specificity, cutoffs] for iron deficiency at each time point was analyzed.
   Results: The prevalence of anemia increased from 34.6% at 14 wk of gestation to 50.0% at 20 wk. Hepcidin concentrations declined between study enrollment and 20 wk, whereas ferritin declined between 20 and 30 wk of gestation. The variations in hepcidin explained by ferritin, sTfR, and CRP declined over pregnancy. The AUC(ROC) values for hepcidin to detect iron deficiency (defined as ferritin <15 mu g/L) were 0.86, 0.83, and 0.84 at 14, 20, and 30 wk, respectively. Hepcidin was superior to hemoglobin and sTfR as an indicator of iron deficiency.
   Conclusions: In Gambian pregnant women, hepcidin appears to be a useful diagnostic test for iron deficiency and may enable the identification of cases for whom iron would be beneficial. Hepcidin suppression in the second trimester suggests a window for optimal timing for antenatal iron interventions. Hemoglobin does not effectively identify iron deficiency in pregnancy.
C1 [Bah, Amat; Jallow, Momodou W.; Sise, Ebrima A.; Wegmuller, Rita] Gambia MRC Int Nutr Grp, Med Res Council MRC Unit, Banjul, Gambia.
   [Pasricha, Sant-Rayn; Armitage, Andrew E.; Drakesmith, Hal] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.
   [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England.
   [Prentice, Andrew M.] Gambia MRC Int Nutr Grp, MRC Unit, London, England.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, London, England.
RP Bah, A (reprint author), Gambia MRC Int Nutr Grp, Med Res Council MRC Unit, Banjul, Gambia.
EM amat.bah@lshtm.ac.uk
FU Medical Research Council (MRC; United Kingdom) [MC-A760-5QX00]; UK
   Department for International Development (DFID) under the MRC/DFID
FX The ENID (Early Nutrition and Immune Development) trial was supported by
   the Medical Research Council (MRC; United Kingdom), through core funding
   to the MRC International Nutrition Group (MC-A760-5QX00) and the UK
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement. This is an open access article distributed under
   the CC-BY license (http://creativecommons.org/licenses/by/3.0/).
CR Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8
   Bah A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0934-8
   Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S
   Byg KE, 2000, HEMATOLOGY, V5, P319
   Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071
   Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   The Gambia Bureau of Statistics; ICF International, 2014, GAMB DEM HLTH SURV 2
   Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013
   Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467
   Garcia-Casal MN, 2014, LANCET HAEMATOL, V1, pE92, DOI 10.1016/S2352-3026(14)00025-8
   Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112
   Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443
   Hedengran KK, 2016, J MATERN-FETAL NEO M, V29, P1506, DOI 10.3109/14767058.2015.1052396
   Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060
   Jones E, 2015, BLOOD, V125, P873, DOI 10.1182/blood-2014-10-606491
   Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996
   Koenig MD, 2014, NUTRIENTS, V6, P3062, DOI 10.3390/nu6083062
   Li X, 2016, J CLIN INVEST, V126, P389, DOI 10.1172/JCI83831
   Mei ZG, 2005, J NUTR, V135, P1974
   Minchella PA, 2015, J NUTR, V145, P1194, DOI 10.3945/jn.114.203158
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Mwangi MN, 2015, JAMA-J AM MED ASSOC, V314, P1009, DOI 10.1001/jama.2015.9496
   National Institute for Health and Care Excellence, ANT CAR UNC PREGN
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Oduro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026305
   Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249
   Pasricha SR, 2012, PATHOLOGY, V44, P139, DOI 10.1097/PAT.0b013e32834e8291
   Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   Schulze KJ, 2008, ASIA PAC J CLIN NUTR, V17, P451
   Simavli S, 2015, J MATERN-FETAL NEO M, V28, P854, DOI 10.3109/14767058.2014.935759
   Simavli S, 2014, J MATERN-FETAL NEO M, V27, P75, DOI 10.3109/14767058.2013.804054
   van der Vorm LN, 2016, CLIN CHEM, V62, P993, DOI 10.1373/clinchem.2016.256768
   van Santen S, 2013, CLIN CHEM LAB MED, V51, P1395, DOI 10.1515/cclm-2012-0576
   Wegmuller R, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0689-4
   WHITTAKER PG, 1991, BRIT J NUTR, V65, P457, DOI 10.1079/BJN19910104
   WHO (World Health Organization), 2008, WORLDWIDE PREVALENCE
   WHO, 2012, GUID INT IR FOL AC S
   World Health Organisation, 2002, WORLD HLTH REP RED R
   WHO, 2015, GLOB PREV AN 2011
   World Health Organization, 2011, SER FERR CONC ASS IR
   WHO, 2001, WHONHD013
   WHO, DAIL IR FOL AC SUPPL
   Young ME, 2012, J NUTR, V142, P33, DOI 10.3945/jn.111.145961
NR 45
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JUN
PY 2017
VL 147
IS 6
BP 1131
EP 1137
DI 10.3945/jn.116.245373
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EX3RU
UT WOS:000403150900014
PM 28424258
OA No
DA 2017-08-15
ER

PT J
AU Johnson, W
   Elmrayed, SAA
   Sosseh, F
   Prentice, AM
   Moore, SE
AF Johnson, William
   Elmrayed, Seham A. A.
   Sosseh, Fatou
   Prentice, Andrew M.
   Moore, Sophie E.
TI Preconceptional and gestational weight trajectories and risk of
   delivering a small-for-gestational-age baby in rural Gambia (1,2)
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE age-related trajectories; gestational weight gain; maternal nutrition;
   prepregnancy weight; small for gestational age
ID BODY-MASS INDEX; MIDDLE-INCOME COUNTRIES; PERICONCEPTIONAL MULTIVITAMIN
   USE; INTRAUTERINE GROWTH RESTRICTION; RANDOMIZED CONTROLLED-TRIAL;
   INFANT BIRTH-WEIGHT; PRETERM BIRTH; SEASONAL-VARIATIONS; PREGNANCY
   OUTCOMES; MATERNAL NUTRITION
AB Background: Maternal nutritional status is a key determinant of small for gestational age (SGA), but some knowledge gaps remain, particularly regarding the role of the energy balance entering pregnancy.
   Objective: We investigated how preconceptional and gestational weight trajectories (summarized by individual-level traits) are associated with SGA risk in rural Gambia.
   Design: The sample comprised 670 women in a trial with serial weight data (7310 observations) that were available before and during pregnancy. Individual trajectories from 6 mo before conception to 30 wk of gestation were produced with the use of multilevel modeling. Summary traits were expressed as weight z scores [ weight z score at 3 mo preconception (zwt(-3) (mo)), weight z score at conception, weight z score at 3 mo postconception, weight z score at 7 mo postconception (zwt(+7) (mo)), and conditional measures that represented the change from the preceding time] and were related to SGA risk with the use of Poisson regression with confounder adjustment; linear splines were used to account for nonlinearity.
   Results: Maternal weight at each time point had a consistent nonlinear relation with SGA risk. For example, the zwt(-3) (mo) estimate was stronger in women with values <= 0.5 (RR: 0.736; 95% CI: 0.594, 0.910) than in women with values >0.5 (RR: 0.920; 95% CI: 0.682, 1.241). The former group had the highest observed SGA prevalence. Focusing on weight change, only conditional zwt(+7) (mo) was associated with SGA and only in women with values >-0.5 (RR: 0.579; 95% CI: 0.463, 0.724).
   Conclusions: Protection against delivering an SGA neonate offered by greater preconceptional or gestational weight may be most pronounced in more undernourished and vulnerable women. Independent of this possibility, greater second- and third-trimester weight gain beyond a threshold may be protective.
C1 [Johnson, William] Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.
   [Elmrayed, Seham A. A.] MRC, ElsieWiddowson Lab, Cambridge, England.
   [Sosseh, Fatou; Prentice, Andrew M.; Moore, Sophie E.] MRC, Unit Gambia, Nutr Theme, Banjul, Gambia.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, Int Nutr Grp, MRC, London, England.
   [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England.
RP Johnson, W (reprint author), Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.
EM w.o.johnson@lboro.ac.uk
FU United Kingdom Medical Research Council (MRC) [MC-A760-5QX00]; United
   Kingdom Department for International Development (DFID) under the
   MRC/DFID; United Kingdom MRC program [MC_UP_1005/1]
FX Supported by the United Kingdom Medical Research Council (MRC)
   (MC-A760-5QX00) and the United Kingdom Department for International
   Development (DFID) under the MRC/DFID Concordat agreement. WJ and SEM
   are funded by the United Kingdom MRC program MC_UP_1005/1.
CR BATES CJ, 1994, EUR J CLIN NUTR, V48, P660
   BATES CJ, 1982, T ROY SOC TROP MED H, V76, P341, DOI 10.1016/0035-9203(82)90185-7
   Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Burris HH, 2010, ANN EPIDEMIOL, V20, P233, DOI 10.1016/j.annepidem.2009.12.003
   Cameron N, 2005, AM J HUM BIOL, V17, P412, DOI 10.1002/ajhb.20408
   Catov JM, 2011, AM J CLIN NUTR, V94, P906, DOI 10.3945/ajcn.111.012393
   Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786
   CHAOUKI ML, 1994, EUR J ENDOCRINOL, V130, P547
   Christian P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-58
   Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109
   CZEIZEL AE, 1994, ARCH GYNECOL OBSTET, V255, P131
   de Weerd S, 2003, EUR J CLIN NUTR, V57, P1128, DOI 10.1038/sj.ejcn.1601654
   Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2
   Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x
   Gaillard R, 2016, BJOG-INT J OBSTET GY, V123, P207, DOI 10.1111/1471-0528.13700
   Gaillard R, 2015, INT J OBESITY, V39, P677, DOI 10.1038/ijo.2014.175
   Guellec I, 2011, PEDIATRICS, V127, pE883, DOI 10.1542/peds.2010-2442
   Han YS, 2011, INT J OBESITY, V35, P570, DOI 10.1038/ijo.2010.162
   Haugen M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-201
   Hennig BJ, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv206
   Hunt KJ, 2013, MATERN CHILD HLTH J, V17, P85, DOI 10.1007/s10995-012-0950-x
   Cheikh Ismail L, 2016, BMJ-BRIT MED J, V352, pi555
   Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4
   Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401
   Johnson W, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12367
   Johnson W, 2015, AM J HUM BIOL, V27, P69, DOI 10.1002/ajhb.22589
   Johnson W, 2013, AM J PHYS ANTHROPOL, V150, P58, DOI 10.1002/ajpa.22128
   Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9
   Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004
   LAWOYIN TO, 1991, J TROP PEDIATRICS, V37, P166
   LECHTIG A, 1975, AM J CLIN NUTR, V28, P1223
   Leckie G., 2012, JOURNAL OF STATISTIC, V52, P1, DOI DOI 10.18637/JSS.V052.I11)
   Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8
   Levy-Marchal C, 2004, PEDIATR DIABETES, V5, P147, DOI 10.1111/j.1399-543X.2004.00057.x
   Liu XM, 2011, ARCH GYNECOL OBSTET, V283, P65, DOI 10.1007/s00404-009-1288-5
   Liu YY, 2012, ARCH GYNECOL OBSTET, V286, P905, DOI 10.1007/s00404-012-2403-6
   Moore SE, 2016, J DEV ORIG HLTH DIS, V7, P123, DOI 10.1017/S2040174415007199
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Muthen LK, 2015, MPLUS USERS GUIDE
   Nohr EA, 2008, AM J CLIN NUTR, V87, P1750
   Nyaruhucha C N M, 2006, Tanzan Health Res Bull, V8, P41
   Ota E, 2011, B WORLD HEALTH ORGAN, V89, P127, DOI 10.2471/BLT.10.077982
   PAUL AA, 1979, P NUTR SOC, V38, pA28
   Potdar RD, 2014, AM J CLIN NUTR, V100, P1257, DOI 10.3945/ajcn.114.084921
   PRENTICE AM, 1987, AM J CLIN NUTR, V46, P912
   PRENTICE AM, 1981, AM J CLIN NUTR, V34, P2790
   Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x
   Rasmussen KM, 2010, J NUTR, V140, P402, DOI 10.3945/jn.109.114488
   Rayco-Solon P, 2005, AM J OBSTET GYNECOL, V192, P1133, DOI 10.1016/j.ajog.2004.10.636
   Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134
   Ronnenberg AG, 2004, J NUTR, V134, P2586
   Ronnenberg AG, 2003, J NUTR, V133, P3449
   Sayers A, 2017, STAT METHODS MED RES, V26, P437, DOI 10.1177/0962280214548822
   Starling AP, 2015, AM J CLIN NUTR, V101, P302, DOI 10.3945/ajcn.114.094946
   Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994
   Toemen L, 2016, INT J OBESITY, V40, P1070, DOI 10.1038/ijo.2016.86
   Tsai IH, 2012, ASIA PAC J CLIN NUTR, V21, P82
   Vesco KK, 2011, OBSTET GYNECOL, V117, P812, DOI 10.1097/AOG.0b013e3182113ae4
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Yekta Zahra, 2006, BMC Pregnancy Childbirth, V6, P15, DOI 10.1186/1471-2393-6-15
   Young MF, 2015, EUR J OBSTET GYN R B, V194, P223, DOI 10.1016/j.ejogrb.2015.09.018
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 63
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JUN 1
PY 2017
VL 105
IS 6
BP 1474
EP 1482
DI 10.3945/ajcn.116.144196
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EW6IC
UT WOS:000402612200027
PM 28490512
OA No
DA 2017-08-15
ER

PT J
AU Niang, A
   Becker, M
   Ewert, F
   Dieng, I
   Gaiser, T
   Tanaka, A
   Senthilkumar, K
   Rodenburg, J
   Johnson, JM
   Akakpo, C
   Segda, Z
   Gbakatchetche, H
   Jaiteh, F
   Bam, RK
   Dogbe, W
   Keita, S
   Kamissoko, N
   Mossi, IM
   Bakare, OS
   Cisse, M
   Baggie, I
   Ablede, KA
   Saito, K
AF Niang, Abibou
   Becker, Mathias
   Ewert, Frank
   Dieng, Ibnou
   Gaiser, Thomas
   Tanaka, Atsuko
   Senthilkumar, Kalimuthu
   Rodenburg, Jonne
   Johnson, Jean-Martial
   Akakpo, Cyriaque
   Segda, Zacharie
   Gbakatchetche, Henri
   Jaiteh, Famara
   Bam, Ralph K.
   Dogbe, Wilson
   Keita, Sekou
   Kamissoko, Nianankoro
   Mossi, Illiassou Maiga
   Bakare, Oladele S.
   Cisse, Madiama
   Baggie, Idriss
   Ablede, Komlan A.
   Saito, Kazuki
TI Variability and determinants of yields in rice production systems of
   West Africa
SO FIELD CROPS RESEARCH
LA English
DT Article
DE Climatic zone; Boundary function; Oryza spp.; Random forest; Yield gap
ID FED LOWLAND RICE; SUB-SAHARAN AFRICA; SENEGAL RIVER VALLEY; IRRIGATED
   RICE; SOLAR-RADIATION; SOIL PROPERTIES; INLAND VALLEYS; ORYZA-SATIVA;
   O-GLABERRIMA; COTE-DIVOIRE
AB Rice (Oryza spp.) is the major staple food for most countries in West Africa, but local production does not meet demand. Rice is grown mainly by smallholder farmers, and yields are generally low with high temporal and spatial variability. Low yields have been attributed to unfavorable climate conditions, poor soil quality, and sub-optimum agricultural practices. The objectives of this study were to assess variation in yields of three major rice production systems (irrigated lowland, rainfed lowland, and upland) across three climatic zones (semi-arid, sub-humid, and humid), and identify factors affecting that variation. We analyzed data on yield, climate, soil, and agricultural practices for 1305 farmers' fields at 22 sites in 11 West African countries between 2012 and 2014. A boundary function approach was used to determine attainable yields. Random forest algorithm was used to identify factors responsible for yield variation. Average rice yield was 4.1, 2.0, and 1.5 t ha(-1) in irrigated lowland, rainfed lowland, and rainfed upland systems, respectively, with maximum attainable yields of 8.3, 6.5, and 4.0 t ha(-1). Yield difference between attainable and average yield tended to be higher in irrigated and rainfed lowland systems. In those two systems, yields were highest in the semi-arid zone, while no difference in yields among climatic zones was apparent for upland rice. High rice yields were associated with high solar radiation, high
C1 [Niang, Abibou; Dieng, Ibnou; Tanaka, Atsuko; Johnson, Jean-Martial; Saito, Kazuki] Africa Rice Ctr AfricaRice, 01 BP 2031, Cotonou, Benin.
   [Becker, Mathias; Ewert, Frank; Gaiser, Thomas] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, D-53115 Bonn, Germany.
   [Tanaka, Atsuko] Japan Int Cooperat Agcy, Benin Off, 01 BP 7097, Cotonou, Benin.
   [Senthilkumar, Kalimuthu; Rodenburg, Jonne] Africa Rice Ctr AfricaRice, Reg Stn East & Southern Africa, POB 33581, Dar Es Salaam, Tanzania.
   [Akakpo, Cyriaque] INRAB, Programme Rech Rizicole, BP 143, Bohicon, Benin.
   [Segda, Zacharie] Inst Environm & Rech Agr INERA, Programme Riz, 04 BP 8645, Ouagadougou, Burkina Faso.
   [Gbakatchetche, Henri] CNRA, Programme Riz, BP 440, Man, Cote Ivoire.
   [Jaiteh, Famara] NARI, Cereals Programme, PMB 144, Brikama, Gambia.
   [Bam, Ralph K.] CSIR, CRI, Rice Programme, POB 3785, Fumesua Kumasi, Ghana.
   [Dogbe, Wilson] CSIR, SARI, Rice Res Dev Programme, POB 52, Tamale, Ghana.
   [Keita, Sekou] IRAG, Programme Riz, BP 1523, Kankan, Conakry, Guinea.
   [Kamissoko, Nianankoro] IER, Programme Riz Irrigue, BP 258, Bamako, Mali.
   [Mossi, Illiassou Maiga] INRAN, Cultures Irriguees, BP 429, Niamey, Niger.
   [Bakare, Oladele S.] NCRI, Informat & Documentat, PMB 8, Badeggi, Niger State, Nigeria.
   [Cisse, Madiama] ISRA, BP 240, St Louis, Senegal.
   [Baggie, Idriss] Rokupr Agr Res Ctr, Soil & Crop Resource Management, PMB 736, Freetown, Sierra Leone.
   [Ablede, Komlan A.] ITRA, Programme Riz, BP 1163, Lome, Togo.
   [Niang, Abibou] Olam Int Ltd Gabon, BP 1024, Galerie Tsika, Libreville, Gabon.
   [Ewert, Frank] Leibniz Ctr Agr Landscape Res ZALF, D-15374 Muncheberg, Germany.
   [Rodenburg, Jonne] Africa Rice Ctr AfricaRice, 01 BP 4029, Abidjan 01, Cote Ivoire.
RP Niang, A (reprint author), Africa Rice Ctr AfricaRice, 01 BP 2031, Cotonou, Benin.; Niang, A (reprint author), Olam Int Ltd Gabon, BP 1024, Galerie Tsika, Libreville, Gabon.
EM abib.niang@gmail.com
FU Global Rice Science Partnership (GRiSP); African Development Bank;
   International Fund for Agricultural Development; GRiSP
FX We are grateful to the Global Rice Science Partnership (GRiSP) for
   granting Global Rice Science Scholarship (GRiSS) for Mr. Abibou Niang,
   and we thank many organizations for providing funds for implementation
   of field surveys in the different countries: the African Development
   Bank for Benin, Cote d'Ivoire, Ghana, Niger, Nigeria, Senegal, and
   Sierra Leone; International Fund for Agricultural Development for
   Guinea, Senegal, and Sierra Leone; and GRiSP for Benin, Burkina Faso,
   Cote d'Ivoire, The Gambia, Ghana, Mali, Niger, Nigeria, Senegal, Sierra
   Leone, and Togo. Special thanks to AfricaRice staff Dr. Adda Cyrille,
   Dr. Abou Togola, Boubakary Cisse, Abdoulaye Sow, Kokou Ahouanton, and
   Mariame Mariko for conducting in-country training, and Gregoire J.
   Tounde for managing the database.
CR Adekambi S.A., 2009, INT ASS AGR EC 2009
   Affholder F, 2013, FIELD CROP RES, V143, P106, DOI 10.1016/j.fcr.2012.10.021
   Angulo C, 2012, J AGR RURAL DEV TROP, V113, P61
   Asch F, 1995, PLANT SOIL, V177, P11, DOI 10.1007/BF00010333
   Balasubramanian V., 2007, ADV AGRON, P55
   Becker M, 2005, J PLANT NUTR SOIL SC, V168, P558, DOI 10.1002/jpln.200520504
   Becker M, 2003, J PLANT NUTR SOIL SC, V166, P61, DOI 10.1002/jpln.200390013
   Becker M, 2001, NUTR CYCL AGROECOSYS, V59, P107, DOI 10.1023/A:1017551529813
   Becker M, 2001, NUTR CYCL AGROECOSYS, V59, P119, DOI 10.1023/A:1017585328904
   Becker M, 1999, FIELD CROP RES, V60, P201, DOI 10.1016/S0378-4290(98)00123-3
   Boling AA, 2007, AGR SYST, V92, P115, DOI 10.1016/j.agsy.2006.05.003
   BOUMA J, 1993, PROCEEDINGS OF SOIL SPECIFIC CROP MANAGEMENT, P3
   Bouman B A M, 2001, ORYZA2000 MODELING L
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Carranza EJM, 2015, COMPUT GEOSCI-UK, V74, P60, DOI 10.1016/j.cageo.2014.10.004
   Casanova D, 1999, GEODERMA, V91, P191, DOI 10.1016/S0016-7061(99)00005-1
   Ceuppens J, 1997, SOIL SCI SOC AM J, V61, P1122
   Climate Prediction Center, 1987, CPC GLOB SUMM DAY MO
   Daouia A, 2016, J R STAT SOC B, V78, P3, DOI 10.1111/rssb.12098
   Diagne A., 2013, Realizing Africa's rice promise, P35, DOI 10.1079/9781845938123.0035
   Diaz C., 1998, Philippine Journal of Crop Science, V23, P111
   Dingkuhn M, 1999, EUPHYTICA, V110, P109, DOI 10.1023/A:1003790611929
   Donovan C, 1999, FIELD CROP RES, V61, P147, DOI 10.1016/S0378-4290(98)00153-1
   Fischer R.A., 2009, EXP M FEED WORLD
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Fukai S., 1995, FRAGILE LIVES FRAGIL, P657
   Haefele SM, 2005, PLANT SOIL, V270, P57, DOI 10.1007/s11104-004-1131-5
   Haefele SM, 2003, FIELD CROP RES, V80, P19, DOI 10.1016/S0378-4290(02)00152-1
   HarvestChoice IFPRI University of Minesota, 2016, HARVARD DATAVERSE, DOI DOI 10.7910/DVN/G4TBLF
   Houba V.J.G., 1995, SOIL ANAL PROCEDURES
   IBM Corp, 2015, IBM SPSS STAT WIND V
   Inthavong T, 2011, PLANT PROD SCI, V14, P184, DOI 10.1626/pps.14.184
   ISLAM MS, 1992, FIELD CROP RES, V30, P13, DOI 10.1016/0378-4290(92)90053-C
   Kent R, 2001, AGR ECOSYST ENVIRON, V87, P299, DOI 10.1016/S0167-8809(01)00153-0
   Liaw A, 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516
   Masiyandima MC, 2003, HYDROL PROCESS, V17, P1213, DOI 10.1002/hyp.1191
   Mutanga O, 2012, INT J APPL EARTH OBS, V18, P399, DOI 10.1016/j.jag.2012.03.012
   NASA, 2016, PRED WORLDW EN RES
   Nordstokke D.W., 2011, PRACT ASSESS RES EVA, V16
   Ofori J, 2005, SOIL SCI PLANT NUTR, V51, P469, DOI 10.1111/j.1747-0765.2005.tb00054.x
   Ogwuike P, 2014, FOOD SECUR, V6, P327, DOI 10.1007/s12571-014-0351-7
   PEEL M. C., 2007, HYDROL EARTH SYST SC, V4, P439, DOI DOI 10.5194/HESSD-4-439-2007
   Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Rodenburg J, 2015, WEED TECHNOL, V29, P751, DOI 10.1614/WT-D-15-00016.1
   Rodenburg J, 2014, AGR SYST, V123, P1, DOI 10.1016/j.agsy.2013.09.004
   Rodenburg J, 2009, FIELD CROP RES, V114, P411, DOI 10.1016/j.fcr.2009.09.014
   Saito K., 2013, Realizing Africa's rice promise, P188, DOI 10.1079/9781845938123.0188
   Saito K, 2012, CROP SCI, V52, P484, DOI 10.2135/cropsci2010.12.0734
   Saito K, 2015, COMPUT ELECTRON AGR, V116, P36, DOI 10.1016/j.compag.2015.06.008
   Saito K, 2009, FIELD CROP RES, V111, P243, DOI 10.1016/j.fcr.2008.12.011
   SESHU DV, 1984, CROP SCI, V24, P649
   Shatar TM, 2004, J AGR SCI, V142, P553, DOI 10.1017/S0021859604004642
   Sie M., 2008, Asian Journal of Plant Sciences, V7, P130
   Tanaka A, 2017, EUR J AGRON, V85, P1, DOI 10.1016/j.eja.2016.12.010
   Tanaka A, 2015, FIELD CROP RES, V176, P99, DOI 10.1016/j.fcr.2015.02.020
   Tanaka A, 2013, EUR J AGRON, V44, P46, DOI 10.1016/j.eja.2012.08.002
   Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007
   Toure A, 2009, FIELD CROP RES, V114, P304, DOI 10.1016/j.fcr.2009.08.015
   van Ittersum MK, 2016, P NATL ACAD SCI USA, V113, P14964, DOI 10.1073/pnas.1610359113
   van Oort PAJ, 2014, FIELD CROP RES, V156, P303, DOI 10.1016/j.fcr.2013.11.007
   Van Wart J, 2015, AGR FOREST METEOROL, V209, P49, DOI 10.1016/j.agrformet.2015.02.020
   Van Dat T., 1986, PROGR UPLAND RICE RE, P51
   Cassman K, 2012, F CROP RES, V143, P4
   van Oort P.A.J., 2016, GLOB FOOD SECUR
   Vincenzi S, 2011, ECOL MODEL, V222, P1471, DOI 10.1016/j.ecolmodel.2011.02.007
   Wade LJ, 1999, FIELD CROP RES, V64, P3, DOI 10.1016/S0378-4290(99)00047-7
   Wairegi LWI, 2010, FIELD CROP RES, V117, P146, DOI 10.1016/j.fcr.2010.02.010
   Windmeijer P.N., 1993, INLAND VALLEYS W AFR
   Worou ON, 2013, AGR WATER MANAGE, V126, P119, DOI 10.1016/j.agwat.2013.04.007
   Yamano T., 2015, IMPACTS INT RICE RES
NR 71
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4290
EI 1872-6852
J9 FIELD CROP RES
JI Field Crop. Res.
PD JUN
PY 2017
VL 207
BP 1
EP 12
DI 10.1016/j.fcr.2017.02.014
PG 12
WC Agronomy
SC Agriculture
GA EV6KD
UT WOS:000401877400001
OA No
DA 2017-08-15
ER

PT J
AU Idoko, OT
   Mboizi, RB
   Okoye, M
   Laudat, F
   Ceesay, B
   Liang, JZ
   Le Dren-Narayanin, N
   Jansen, KU
   Gurtman, A
   Center, KJ
   Scott, DA
   Kampmann, B
   Roca, A
AF Idoko, Olubukola T.
   Mboizi, Robert B.
   Okoye, Michael
   Laudat, France
   Ceesay, Bubacarr
   Liang, John Z.
   Le Dren-Narayanin, Natacha
   Jansen, Kathrin U.
   Gurtman, Alejandra
   Center, Kimberly J.
   Scott, Daniel A.
   Kampmann, Beate
   Roca, Anna
TI Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine
   (PCV13) formulated with 2-phenoxyethanol in multidose vials given with
   routine vaccination in healthy infants: An open-label randomized
   controlled trial
SO VACCINE
LA English
DT Article
DE Pneumococcal conjugate vaccine; 2-Phenoxyethanol; Multidose vials;
   Safety; Immunogenicity
ID STREPTOCOCCUS-PNEUMONIAE; MENINGITIS; ANTIBODIES; SEROTYPES; COUNTRIES;
   CRITERIA; DISEASE; SINGLE; ASSAY
AB Background: This open-label randomized controlled trial in infants compared safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13) formulated with the preservative 2-phenoxyethanol (2-PE) in a multidose vial (MDV) to the current PCV13 without 2-PE in a single-dose syringe (SDS).
   Methods: Gambian infants were randomized 1:1 to receive PCV13 as either MDV or SDS at ages 2, 3, and 4 months. Serotype-specific antipneumococcal antibody responses and opsonophagocytic activity ([OPA]; subset) were measured at age 5 months. Noninferiority was declared if the lower bound of the 97.5% CI for the difference (MDV-SDS) in proportions of subjects achieving IgG concentrations >= 0.35 mu g/mL (primary endpoint) was greater than -10%. IgG geometric mean concentrations (GMCs) were noninferior if the lower limit of the two-sided 97.5% CI of the geometric mean ratio (MDV vs SDS) was greater than 0.5. Reactogenicity and other adverse events were collected.
   Results: 500 participants were randomized and vaccinated; 489 (MDV: n = 245; SDS: n = 244) completed the trial. Noninferiority of MDV was demonstrated for all serotypes as measured by percentage of subjects achieving antibody responses above >= 0.35 mu g/mL. IgG GMCs (coprimary endpoint) also demonstrated noninferiority of MDV; OPA results supported these findings. Safety and tolerability were comparable between groups.
   Conclusions: PCV13 in MDV was safe and immunogenic when administered according to the routine schedule to infants. MDV was noninferior to SDS for all 13 pneumococcal serotypes. Comparable immunogenicity and safety profiles of PCV13 MDV and SDS suggest PCV13 MDV can help optimize vaccination in resource-limited settings. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Idoko, Olubukola T.; Mboizi, Robert B.; Okoye, Michael; Ceesay, Bubacarr; Kampmann, Beate; Roca, Anna] Med Res Council Unit Gambia, Vaccines & Immun, 6 Atlantic Rd, Fajara 000273, Gambia.
   [Laudat, France] Pfizer Inc, Vaccine Res & Dev, 23 Ave Docteur Lannelongue, F-75014 Paris, France.
   [Center, Kimberly J.; Scott, Daniel A.] Pfizer Inc, Vaccine Res & Dev, 500 Arcola Rd, Collegeville, PA 19426 USA.
   [Le Dren-Narayanin, Natacha] Pfizer Ltd, Vaccine Res & Dev, Horizon Bldg,Honey Lane, Hurley SL6 6RJ, England.
   [Liang, John Z.; Jansen, Kathrin U.; Gurtman, Alejandra] Pfizer Inc, Vaccine Res & Dev, 401 North Middletown Rd, Pearl River, NY 10965 USA.
   [Kampmann, Beate] Imperial Coll London, Dept Pediat, Norfolk Pl, London W2 1PG, England.
   [Roca, Anna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.
RP Idoko, OT (reprint author), Med Res Council Unit Gambia, Vaccines & Immun, 6 Atlantic Rd, Fajara 000273, Gambia.
EM oidoko@mrc.gm; rmboizi@yahoo.ca; mokoye@mrc.gm;
   france.laudat@pfizer.com; bubiskay@yahoo.com; john.liang@pfizer.com;
   Natacha.Ledren-Narayanin@pfizer.com; Kathrin.jansen@pfizer.com;
   Alejandra.Gurtman@pfizer.com; Kimberly.Center@pfizer.com;
   Dan.Scott@pfizer.com; bkampmann@mrc.gm; aroca@mrc.gm
FU Pfizer Inc.; UK Medical Research Council
FX This study was sponsored by Pfizer Inc. Authors employed by Pfizer were
   involved in the study design, collection, interpretation, and analysis
   of data, and in the preparation of the manuscript. The MRC Unit The
   Gambia receives core funding from the UK Medical Research Council for
   generic support, including clinical trials activities.
CR Amdekar YK, 2013, PEDIATR INFECT DIS J, V32, P509, DOI 10.1097/INF.0b013e31827b478d
   Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94
   Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x
   Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056
   Egere U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049143
   Idoko OT, 2014, TUBERCULOSIS, V94, P564, DOI 10.1016/j.tube.2014.07.001
   Isaacman DJ, 2007, VACCINE, V25, P2420, DOI 10.1016/j.vaccine.2006.09.011
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5
   Khandke L, 2011, VACCINE, V29, P7144, DOI 10.1016/j.vaccine.2011.05.074
   Lee BY, 2010, VACCINE, V28, P5292, DOI 10.1016/j.vaccine.2010.05.048
   Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151
   Meyer BK, 2007, J PHARM SCI-US, V96, P3155, DOI 10.1002/jps.20976
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Paradiso P, 2009, VACCINE, V27, pC15, DOI 10.1016/j.vaccine.2009.06.008
   Parmar D, 2010, HUM VACCINES, V6, P270
   Pfizer Inc, PFIZ SIGNS NEW AGR U
   Pfizer Inc, PFIZ REC WHO PREQ MU
   Pfizer Inc, PFIZ REC EUR APPR NE
   Poehling MA, 2006, JAMA-J AM MED ASSOC, V295, P1668
   Quataert SA, 2004, CLIN DIAGN LAB IMMUN, V11, P1064, DOI 10.1128/CDLI.11.6.1064-1069.2004
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415
   Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119
   Thompson A, 2013, VACCINE, V31, P5289, DOI 10.1016/j.vaccine.2013.08.025
   Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003
   World Health Organization, REPL WHO TECHN REP S, V927
   World Health Organization, WHO PREQ VACC
   World Health Organization, WHO TECHN REP SER
   Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940
NR 30
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 31
PY 2017
VL 35
IS 24
BP 3256
EP 3263
DI 10.1016/j.vaccine.2017.04.049
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FB1CJ
UT WOS:000405881000015
PM 28479175
OA No
DA 2017-08-15
ER

PT J
AU Wallis, AB
   Sanyang, E
AF Wallis, Anne Baber
   Sanyang, Edrisa
TI New era for health in The Gambia?
SO LANCET
LA English
DT Letter
C1 [Wallis, Anne Baber] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40202 USA.
   [Wallis, Anne Baber; Sanyang, Edrisa] Univ Gambia, Sch Med & Allied Hlth Sci, Dept Publ & Environm Hlth, Banjul, Gambia.
   [Sanyang, Edrisa] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Sci, Iowa City, IA USA.
RP Wallis, AB (reprint author), Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40202 USA.; Wallis, AB (reprint author), Univ Gambia, Sch Med & Allied Hlth Sci, Dept Publ & Environm Hlth, Banjul, Gambia.
EM anne.wallis@louisville.edu
CR Gambia Bureau of Statistics ICF International, 2014, GAMB DEM HLTH SURV
   Gambia Bojang S., 2017, NEW AFRICAN
   Green A, 2017, LANCET, V389, P684, DOI 10.1016/S0140-6736(17)30395-1
   Iddriss A, 2011, B WORLD HEALTH ORGAN, V89, P565, DOI 10.2471/BLT.11.086892
   Sanyang E, 2017, J ENVIRON PUBLIC HEA, DOI 10.1155/2017/8612953
   UNICEF, 2013, LEV TRENDS CHILD MOR
NR 6
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 27
PY 2017
VL 389
IS 10084
BP 2101
EP 2102
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EV7QE
UT WOS:000401973300022
PM 28560999
OA No
DA 2017-08-15
ER

PT J
AU Le Doare, K
   Faal, A
   Jaiteh, M
   Sarfo, F
   Taylor, S
   Warburton, F
   Humphries, H
   Birt, J
   Jarju, S
   Darboe, S
   Clarke, E
   Antonio, M
   Foster-Nyarko, E
   Heath, PT
   Gorringe, A
   Kampmann, B
AF Le Doare, Kirsty
   Faal, Amadou
   Jaiteh, Mustapha
   Sarfo, Francess
   Taylor, Stephen
   Warburton, Fiona
   Humphries, Holly
   Birt, Jessica
   Jarju, Sheikh
   Darboe, Saffiatou
   Clarke, Edward
   Antonio, Martin
   Foster-Nyarko, Ebenezer
   Heath, Paul T.
   Gorringe, Andrew
   Kampmann, Beate
TI Association between functional antibody against Group B Streptococcus
   and maternal and infant colonization in a Gambian cohort
SO VACCINE
LA English
DT Article
DE Neonatal; Group B Streptococcus; Meningitis; Vaccines
ID INFLUENZAE TYPE-B; CONJUGATE VACCINE; CAPSULAR ANTIBODY; INVASIVE
   DISEASE; HUMAN-COMPLEMENT; POLYSACCHARIDE; CARRIAGE; WOMEN; ASSAY;
   IMMUNIZATION
AB Background: Vertical transmission of Group B Streptococcus (GBS) is a prerequisite for early-onset disease and a consequence of maternal GBS colonization. Disease protection is associated with maternally-derived anti-GBS antibody. Using a novel antibody-mediated C3b/iC3b deposition flow cytometry assay which correlates with opsonic killing we developed a model to assess the impact of maternally-derived functional anti-GBS antibody on infant GBS colonization from birth to day 60-89 of life.
   Methods: Rectovaginal swabs and cord blood (birth) and infant nasopharyngeal/rectal swabs (birth, day 6 and day 60-89) were obtained from 750 mother/infant pairs. Antibody-mediated C3b/iC3b deposition with cord and infant sera was measured by flow cytometry.
   Results: We established that as maternally-derived anti-GBS functional antibody increases, infant colonization decreases at birth and up to three months of life, the critical time window for the development of GBS disease. Further, we observed a serotype (ST)-dependent threshold above which no infant was colonized at birth. Functional antibody above the upper 95th confidence interval for the geometric mean concentration was associated with absence of infant GBS colonization at birth for STII (p < 0.001), STIII (p = 0.01) and SW (p < 0.001). Increased functional antibody was also associated with clearance of GBS between birth and day 60-89.
   Conclusions: Higher concentrations of maternally-derived antibody-mediated complement deposition are associated with a decreased risk of GBS colonization in infants up to day 60-89 of life. Our findings are of relevance to establish thresholds for protection following vaccination of pregnant women with future GBS vaccines. (C) 2017 The Author(s). Published by Elsevier Ltd.
C1 [Le Doare, Kirsty; Kampmann, Beate] Imperial Coll London, Ctr Int Child Hlth, Norfolk Pl, London W2 1PG, England.
   [Le Doare, Kirsty; Heath, Paul T.] St Georges Univ London, Paediat Infect Dis Res Grp, Cranmer Terrace, London SW17 0TE, England.
   [Le Doare, Kirsty; Faal, Amadou; Jaiteh, Mustapha; Sarfo, Francess; Birt, Jessica; Jarju, Sheikh; Darboe, Saffiatou; Clarke, Edward; Antonio, Martin; Foster-Nyarko, Ebenezer; Kampmann, Beate] MRC Unit Gambia, Vaccines & Immun Theme, Atlantic Rd, Fajara, Gambia.
   [Taylor, Stephen; Humphries, Holly; Gorringe, Andrew] Publ Hlth England, Salisbury SP4 0JG, Wilts, England.
   [Warburton, Fiona] Publ Hlth England, Natl Infect Serv, Stat Unit, 61 Colindale Ave, London NW9 5EQ, England.
RP Le Doare, K (reprint author), Imperial Coll London, Ctr Int Child Hlth, Norfolk Pl, London W2 1PG, England.; Le Doare, K (reprint author), St Georges Univ London, Paediat Infect Dis Res Grp, Cranmer Terrace, London SW17 0TE, England.
EM K.mehring-le-doare@ic.ac.uk
FU Wellcome Trust Clinical Research Training Fellowship; Thrasher Research
   Fund [12250]; UK MRC [MC_UP_A900/1122, MC_UP_A900/115]; UK Medical
   Research Council (MRC); Department for international development (DFID)
   under the MRC/DFID
FX This work was supported by a Wellcome Trust Clinical Research Training
   Fellowship to KLD (WT2015) and the Thrasher Research Fund (BK: 12250).
   BK is also supported by grants from the UK MRC (MC_UP_A900/1122,
   MC_UP_A900/115) and the UK Medical Research Council (MRC) and the
   Department for international development (DFID) under the MRC/DFID
   Concordat arrangement.
CR Baker CJ, 2014, J INFECT DIS, V209, P781, DOI 10.1093/infdis/jit549
   BAKER CJ, 1980, AM J OBSTET GYNECOL, V137, P39
   BARBOUR ML, 1995, J INFECT DIS, V171, P93
   Bash MC, 2014, CLIN VACCINE IMMUNOL, V21, P755, DOI 10.1128/CVI.00812-13
   Brookes C, 2013, J IMMUNOL METHODS, V391, P39, DOI 10.1016/j.jim.2013.02.007
   Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679
   Dangor Z, 2015, VACCINE, V33, P6793, DOI 10.1016/j.vaccine.2015.10.019
   Dangor Z, 2015, EXPERT REV VACCINES, V14, P135, DOI 10.1586/14760584.2014.953939
   Diaz MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066183
   Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6
   Edwards MS, 2012, VACCINE, V30, P4123, DOI 10.1016/j.vaccine.2012.04.048
   EDWARDS MS, 1979, J INFECT DIS, V140, P1004
   ESKOLA J, 1987, NEW ENGL J MED, V317, P717, DOI 10.1056/NEJM198709173171201
   Fabbrini M, 2012, J IMMUNOL METHODS, V378, P11, DOI 10.1016/j.jim.2012.01.011
   Herbert J, 2015, CLIN VACCINE IMMUNOL, V22, P319, DOI 10.1128/CVI.00803-14
   Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010
   Kwatra G, 2015, CLIN MICROBIOL INFEC
   Le Doare K, 2016, J INFECTION, V72, P283, DOI 10.1016/j.jinf.2015.12.014
   Le Doare K, 2016, AIDS, V30, P471, DOI 10.1097/QAD.0000000000000923
   Le Doare K, 2015, VACCINE, V33, P621, DOI 10.1016/j.vaccine.2014.12.025
   Lin FYC, 2001, J INFECT DIS, V184, P1022, DOI 10.1086/323350
   Madhi SA, 2013, VACCINE, V31, pD52, DOI 10.1016/j.vaccine.2013.02.029
   Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8
   Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007
   Nahm M, 2016, PROTOCOL OPSONOPHAGO
   Pannaraj PS, 2009, VACCINE, V27, P4452, DOI 10.1016/j.vaccine.2009.05.039
   SUARA RO, 1994, J INFECT DIS, V170, P1316
   UNICEF, 2015, STAT WORLDS CHILDR 2
   Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1
NR 29
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 19
PY 2017
VL 35
IS 22
BP 2970
EP 2978
DI 10.1016/j.vaccine.2017.04.013
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EV6NI
UT WOS:000401885700014
PM 28449969
OA No
DA 2017-08-15
ER

PT J
AU Nambozi, M
   Kabuya, JBB
   Hachizovu, S
   Mwakazanga, D
   Mulenga, J
   Kasongo, W
   Buyze, J
   Mulenga, M
   Van Geertruyden, JP
   D'Alessandro, U
AF Nambozi, Michael
   Kabuya, Jean-Bertin Bukasa
   Hachizovu, Sebastian
   Mwakazanga, David
   Mulenga, Joyce
   Kasongo, Webster
   Buyze, Jozefien
   Mulenga, Modest
   Van Geertruyden, Jean-Pierre
   D'Alessandro, Umberto
TI Artemisinin-based combination therapy in pregnant women in Zambia:
   efficacy, safety and risk of recurrent malaria
SO MALARIA JOURNAL
LA English
DT Article
DE Zambia; Sub-Saharan; Africa; Artemisinin-combination therapy; Treatment
   failure
ID PLASMODIUM-FALCIPARUM MALARIA; ARTEMETHER-LUMEFANTRINE; NCHELENGE
   DISTRICT; TREATMENT FAILURE; TRANSMISSION; PARASITEMIA; PIPERAQUINE;
   PREDICTORS; THAILAND; IMMUNITY
AB Background: In Zambia, malaria is one of the leading causes of morbidity and mortality, especially among under five children and pregnant women. For the latter, the World Health Organization recommends the use of artemisinin-based combination therapy (ACT) in the second and third trimester of pregnancy. In a context of limited information on ACT, the safety and efficacy of three combinations, namely artemether-lumefantrine (AL), mefloquine-artesunate (MQAS) and dihydroartemisinin-piperaquine (DHAPQ) were assessed in pregnant women with malaria.
   Methods: The trial was carried out between July 2010 and August 2013 in Nchelenge district, Luapula Province, an area of high transmission, as part of a multi-centre trial. Women in the second or third trimester of pregnancy and with malaria were recruited and randomized to one of the three study arms. Women were actively followed up for 63 days, and then at delivery and 1 year post-delivery.
   Results: Nine hundred pregnant women were included, 300 per arm. PCR-adjusted treatment failure was 4.7% (12/258) (95% CI 2.7-8.0) for AL, 1.3% (3/235) (95% CI 0.4-3.7) for MQAS and 0.8% (2/236) (95% CI 0.2-3.0) for DHAPQ, with significant risk difference between AL and DHAPQ (p = 0.01) and between AL and MQAS (p = 0.03) treatments. Re-infections during follow up were more frequent in the AL (HR: 4.71; 95% CI 3.10-7.2; p < 0.01) and MQAS (HR: 1.59; 95% CI 1.02-2.46; p = 0.04) arms compared to the DHAPQ arm. PCR-adjusted treatment failure was significantly associated with women under 20 years [Hazard Ratio (HR) 5.35 (95% CI 1.07-26.73; p = 0.04)] and higher malaria parasite density [3.23 (95% CI 1.03-10.10; p = 0.04)], and still women under 20 years [1.78, (95% CI 1.26-2.52; p < 0.01)] had a significantly higher risk of re-infection. The three treatments were generally well tolerated. Dizziness, nausea, vomiting, headache and asthenia as adverse events (AEs) were more common in MQAS than in AL or DHAPQ (p < 0.001). Birth outcomes were not significantly different between treatment arms.
   Conclusion: As new infections can be prevented by a long acting partner drug to the artemisinins, DHAPQ should be preferred in places as Nchelenge district where transmission is intense while in areas of low transmission intensity AL or MQAS may be used.
C1 [Nambozi, Michael; Kabuya, Jean-Bertin Bukasa; Hachizovu, Sebastian; Mwakazanga, David; Mulenga, Joyce; Kasongo, Webster; Mulenga, Modest] Trop Dis Res Ctr, Dept Clin Sci, POB 71769, Ndola, Zambia.
   [Van Geertruyden, Jean-Pierre] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium.
   [Buyze, Jozefien; D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Serekunda, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
RP Nambozi, M (reprint author), Trop Dis Res Ctr, Dept Clin Sci, POB 71769, Ndola, Zambia.
EM michaelnambozi@yahoo.com
FU European and Developing Countries Clinical Trials Partnership; Malaria
   in Pregnancy Consortium; Bill and Melinda Gates Foundation;
   Directorate-General for Development Cooperation (DGDC)-Belgium;
   Netherlands-African Partnership for Capacity Development and Clinical
   interventions Against Poverty-related diseases (NACCAP)-Netherlands;
   Medical Research Council (MRC)-UK
FX European and Developing Countries Clinical Trials Partnership, Email:
   infor@edctp.orgWeb:http://www.edctp.org; and by the Malaria in Pregnancy
   Consortium, which is funded through a grant from the Bill and Melinda
   Gates Foundation to the Liverpool School of Tropical Medicine
   (LSHTM)-United Kingdom; Directorate-General for Development Cooperation
   (DGDC)-Belgium, Netherlands-African Partnership for Capacity Development
   and Clinical interventions Against Poverty-related diseases
   (NACCAP)-Netherlands, and Medical Research Council (MRC)-UK.
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Adegnika AA, 2005, AM J TROP MED HYG, V73, P263
   Angus BJ, 1997, BLOOD, V90, P2037
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Butt Kimberly, 2014, J Obstet Gynaecol Can, V36, P171, DOI 10.1016/S1701-2163(15)30664-2
   Chan Y H, 2004, Singapore Med J, V45, P249
   Das S, 2016, AM J TROP MED HYG, V94, P1234, DOI 10.4269/ajtmh.15-0735
   Dorsey G, 2004, AM J TROP MED HYG, V71, P531
   Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7
   Fievet Nadine, 2002, Malar J, V1, P16, DOI 10.1186/1475-2875-1-16
   FONTANET AL, 1993, AM J TROP MED HYG, V49, P465
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Hoglund RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-398
   Ittarat W, 2003, AM J TROP MED HYG, V68, P147
   Khalil IF, 2005, ANN TROP MED PARASIT, V99, P441, DOI 10.1179/136485905X46441
   Kloprogge F, 2013, CPT Pharmacometrics Syst Pharmacol, V2, pe83, DOI 10.1038/psp.2013.59
   Laufer MK, 2007, AM J TROP MED HYG, V77, P160
   Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3
   Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141
   Manyando C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-249
   McGready R, 2008, PLOS MED, V5, P1699, DOI 10.1371/journal.pmed.0050253
   Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5
   Nambozi M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-220
   Nambozi M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-50
   National Malaria Control Center, 2014, GUID DIAGN TREAT MAL
   National Malaria Control Center, 2012, ZAMB MAL IND SURV
   Nchelenge District Office, 2016, HLTH MAN INF SYST
   Nosten F, 2007, AM J TROP MED HYG, V77, P181
   Nosten Francois, 2006, Curr Drug Saf, V1, P1, DOI 10.2174/157488606775252584
   Pekyi D, 2016, NEW ENGL J MED, V374, P913, DOI 10.1056/NEJMoa1508606
   Pinchoff J, 2015, AM J TROP MED HYG, V93, P1260, DOI 10.4269/ajtmh.15-0283
   Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4
   Poespoprodjo JR, 2011, J INFECT DIS, V204, P1613, DOI 10.1093/infdis/jir558
   Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6
   Salomon LJ, 2013, ULTRASOUND OBST GYN, V41, P233, DOI 10.1002/uog.12407
   Shekalaghe S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-69
   Steketee RW, 1996, AM J TROP MED HYG, V55, P2
   terKuile FO, 1995, T ROY SOC TROP MED H, V89, P660, DOI 10.1016/0035-9203(95)90435-2
   WHO, 2009, METH SURV ANT DRUG E
   WHO, 2008, METH TECHN CLIN TRIA
   WHO, 2015, GEN WORLD HLTH ORG
   Wilby KJ, 2011, CLIN PHARMACOKINET, V50, P705, DOI 10.2165/11594550-000000000-00000
   WWARN, 2012, CLIN MOD WWARN 2012
NR 43
TC 0
Z9 0
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD MAY 16
PY 2017
VL 16
AR 199
DI 10.1186/s12936-017-1851-7
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW0VN
UT WOS:000402209400002
PM 28511713
OA gold
DA 2017-08-15
ER

PT J
AU Orikiiriza, J
   Nakawesi, J
   Kikaire, B
   Turitwenka, D
   Schlech, W
   Kambugu, A
   Lamorde, M
   Normark, J
   Hennessy, M
   Musiime, V
   Rujumba, J
   Ndeezi, G
   Tumwesigye, NM
   Doherty, DG
   Achan, J
AF Orikiiriza, Judy
   Nakawesi, Jane
   Kikaire, Ben
   Turitwenka, Dorothy
   Schlech, Walter
   Kambugu, Andrew
   Lamorde, Mohammed
   Normark, Johan
   Hennessy, Martina
   Musiime, Victor
   Rujumba, Joseph
   Ndeezi, Grace
   Tumwesigye, Nazarius M.
   Doherty, Derek G.
   Achan, Jane
TI Unmet needs persist in pediatric HIV programs: lessons from selected
   case studies in Uganda
SO AIDS
LA English
DT Letter
C1 [Orikiiriza, Judy; Kikaire, Ben; Turitwenka, Dorothy; Kambugu, Andrew; Lamorde, Mohammed] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.
   [Nakawesi, Jane] Mildmay Uganda, Pediat Dept, Kampala, Uganda.
   [Orikiiriza, Judy; Kikaire, Ben] Trinity Coll Dublin, Sch Med, Dept Immunol, Dublin, Ireland.
   [Schlech, Walter] Dalhousie Univ, Dept Med, Div Infect Dis, Halifax, NS, Canada.
   [Normark, Johan] Umea Univ, Div Infect Dis, Dept Clin Microbiol, Umea, Sweden.
   [Hennessy, Martina] Trinity Coll Dublin, Sch Med, Dept Pharmacol & Therapeut, Dublin, Ireland.
   [Musiime, Victor; Rujumba, Joseph; Ndeezi, Grace] Makerere Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Kampala, Uganda.
   [Tumwesigye, Nazarius M.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda.
   [Achan, Jane] MRC Unit, Serekunda, Gambia.
RP Orikiiriza, J (reprint author), Trinity Coll Dublin, Sch Med, Dept Immunol, Dublin, Ireland.
EM jorikiiriza@idi.co.ug
FU Irish AID (Department of Foreign Affairs Ireland); Higher Education
   Authority of Ireland; Thrasher Foundation [12849]
FX The authors would like to acknowledge the patients on the Nutrition
   outcome Irish-Ugandan Research (NOURISH)-Pediatric study who have made
   it possible for us to write this article. We would like to thank Mildmay
   Uganda and the Kampala City council clinics for graciously allowing me
   to carry out my PhD research at their centers. Funding was obtained from
   Irish AID (Department of Foreign Affairs Ireland) and the Higher
   Education Authority of Ireland through the NOURISH program and the
   Thrasher Foundation for an early career award number 12849.
CR ANECCA, 2004, HDB PAED AIDS AFR
   Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9
   Lallemant M, 2011, NEW ENGL J MED, V365, P581, DOI 10.1056/NEJMp1107275
   Tsague L, 2014, AIDS, V28, pS119, DOI 10.1097/QAD.0000000000000234
   UNAIDS, 2014, 90 90 90 AMB TREATM
   UNICEF, 2011, TECH REP
   WHO, 2014, MARCH 2014 SUPPL 201
   World Health Organization, 2015, GUID START ANT THER
   WHO, 2010, REC PUBL HLTH APPR 2
   World Health Organization. WHO, 2013, GUID UPD MAN SEV AC
   World Health Organization, 2009, RAP ADV ANT THER HIV
NR 11
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD MAY 15
PY 2017
VL 31
IS 8
BP 1196
EP 1199
DI 10.1097/QAD.0000000000001436
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA EU7DR
UT WOS:000401195800018
PM 28441178
OA No
DA 2017-08-15
ER

PT J
AU Truck, J
   Thompson, A
   Morales-Aza, B
   Clutterbuck, EA
   Voysey, M
   Clarke, E
   Snape, MD
   Kelly, DF
   Finn, A
   Pollard, AJ
AF Trueck, Johannes
   Thompson, Amber
   Morales-Aza, Begonia
   Clutterbuck, Elizabeth A.
   Voysey, Merryn
   Clarke, Ed
   Snape, Matthew D.
   Kelly, Dominic F.
   Finn, Adam
   Pollard, Andrew J.
TI Memory B cell response to a PCV-13 booster in 3.5 year old children
   primed with either PCV-7 or PCV-13
SO VACCINE
LA English
DT Article
DE Antibodies; B cells; Children; Conjugate vaccine; Memory; Memory B
   cells; Persistence; Serotype 3; Streptococcus pneumoniae; Vaccination
ID PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE;
   ANTIBODY-RESPONSES; CONTROLLED-TRIAL; IMMUNE-RESPONSE; OTITIS-MEDIA;
   PLASMA-CELLS; POLYSACCHARIDE; INFANTS; IMMUNOGENICITY
AB Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococcus pneumoniae through the induction of persistent anti-polysaccharide antibodies, and by priming for a rapid secondary antibody response. Memory B cells (B-MEM) generated during an initial immune response are responsible for both the more rapid and quantitatively greater secondary antibody response and are also thought to contribute to the ongoing production of plasma cells providing long-term antibody persistence. We recruited 3.5-year-old children who had participated in a previous clinical trial comparing infant immunizationwith either a 7-valent (PCV-7) or a 13-valent pneumococcal conjugate vaccine (PCV-13) to investigate whether prior priming with pneumococcal antigens influences B-MEM responses. Blood was taken before and 1 month after a PCV-13 booster. B-MEM were quantified using a cultured ELISpot assay for pneumococcal serotypes 1, 3, 4, 14, 19A, 23F, and with diphtheria and tetanus toxoid as controls, and then correlated with serotype-specific IgG concentrations and opsonophagocytic activity (OPA) titers. In total, blood samples from 62 participants were available for analysis. Serotype-specific B-MEM frequencies were generally low at baseline (before boost) although for serotypes 14 and 3, they were significantly higher in children primed with PCV-13 than PCV-7 primed children. Following the PCV-13 booster, B-MEM frequencies increased and were not different between the groups for all serotypes. A strong inverse correlation was found between antibody concentrations and OPA titers at baseline and B-MEM following booster vaccination for serotype 3 but not for other serotypes suggesting that, for this serotype, pre-existing serotype-specific antibodies may inhibit B-MEM formation in response to vaccination. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Trueck, Johannes; Thompson, Amber; Clutterbuck, Elizabeth A.; Snape, Matthew D.; Kelly, Dominic F.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.
   [Trueck, Johannes; Thompson, Amber; Clutterbuck, Elizabeth A.; Snape, Matthew D.; Kelly, Dominic F.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England.
   [Morales-Aza, Begonia; Clarke, Ed; Finn, Adam] Univ Hosp Bristol, NHS Fdn Trust, Bristol Childrens Vaccine Ctr, Bristol, Avon, England.
   [Morales-Aza, Begonia; Clarke, Ed; Finn, Adam] Univ Bristol, Bristol, Avon, England.
   [Voysey, Merryn] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.
   [Clarke, Ed] Vaccines & Immun Theme, MRC Unit, Gambia, Gambia.
RP Truck, J (reprint author), Univ Childrens Hosp Zurich, Childrens Res Ctr, Paediat Immunol, Steinwiesstr 75, CH-8032 Zurich, Switzerland.; Truck, J (reprint author), Univ Zurich, Steinwiesstr 75, CH-8032 Zurich, Switzerland.
EM johannes.trueck@kispi.uzh.ch
FU University of Oxford; Pfizer Vaccine Research; National Institute for
   Health Research (NIHR) Oxford Biomedical Research Centre; National
   Institute for Health Research Clinical Research Network; ESPID
   Fellowship Award; NIHR Oxford Biomedical Research Center
FX This work was sponsored by the University of Oxford and funded by Pfizer
   Vaccine Research and the National Institute for Health Research (NIHR)
   Oxford Biomedical Research Centre. The Oxford Vaccine Group acknowledges
   the support of the National Institute for Health Research Clinical
   Research Network. J.T. was supported by an ESPID Fellowship Award. DFK
   receives salary support from the NIHR Oxford Biomedical Research Center.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9
   Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071
   Blanchard-Rohner G, 2012, VACCINE, V30, P4153, DOI 10.1016/j.vaccine.2012.04.063
   Bryant KA, 2010, PEDIATRICS, V125, P866, DOI 10.1542/peds.2009-1405
   Clutterbuck EA, 2008, CLIN VACCINE IMMUNOL, V15, P182, DOI 10.1128/CVI.00336-07
   Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524
   Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x
   Khatami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101672
   Mitchell R, 2014, HUM VACC IMMUNOTHER, V10, P1661, DOI 10.4161/hv.28350
   O'Brien Katherine L, 2003, Pediatr Infect Dis J, V22, pe1, DOI 10.1097/01.inf.0000049347.42983.77
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497
   Pace D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1554
   Poolman J, 2011, EXPERT REV VACCINES, V10, P307, DOI [10.1586/erv.11.8, 10.1586/ERV.11.8]
   Poolman J, 2009, VACCINE, V27, P3213, DOI 10.1016/j.vaccine.2009.03.017
   Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Rohner GB, 2008, J IMMUNOL, V180, P2165
   Schuerman L, 2007, VACCINE, V25, P1953, DOI 10.1016/j.vaccine.2006.12.007
   Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6
   Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710
   Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE80, DOI 10.1097/INF.0b013e3181faa6be
   Taillardet M, 2009, BLOOD, V114, P4432, DOI 10.1182/blood-2009-01-200014
   Tangye SG, 2003, J IMMUNOL, V170, P686
   Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004
   Tracy JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088852
   Truck J, 2013, IMMUNOBIOLOGY, V218, P368, DOI 10.1016/j.imbio.2012.05.008
   Truck J, 2012, CLIN INFECT DIS, V55, P1577, DOI 10.1093/cid/cis700
   Truck J, 2010, EARLY HUM DEV, V86, P695, DOI 10.1016/j.earlhumdev.2010.08.010
   Turner P, 2013, CLIN MICROBIOL INFEC, V19, pE551, DOI [10.1111/1469-0691.12431, 10.1111/1469-0691.12286]
   Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476
   World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93
   Wickham H, 2009, GGPLOT2
   Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 9
PY 2017
VL 35
IS 20
BP 2701
EP 2708
DI 10.1016/j.vaccine.2017.03.079
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EU7KQ
UT WOS:000401214100013
PM 28392142
OA No
DA 2017-08-15
ER

PT J
AU Odutola, A
   Ota, MOC
   Antonio, M
   Ogundare, EO
   Saidu, Y
   Foster-Nyarko, E
   Owiafe, PK
   Ceesay, F
   Worwui, A
   Idoko, OT
   Owolabi, O
   Bojang, A
   Jarju, S
   Drammeh, I
   Kampmann, B
   Greenwood, BM
   Alderson, M
   Traskine, M
   Devos, N
   Schoonbroodt, S
   Swinnen, K
   Verlant, V
   Dobbelaere, K
   Borys, D
AF Odutola, Aderonke
   Ota, Martin O. C.
   Antonio, Martin
   Ogundare, Ezra O.
   Saidu, Yauba
   Foster-Nyarko, Ebenezer
   Owiafe, Patrick K.
   Ceesay, Fatima
   Worwui, Archibald
   Idoko, Olubukola T.
   Owolabi, Olumuyiwa
   Bojang, Abdoulie
   Jarju, Sheikh
   Drammeh, Isatou
   Kampmann, Beate
   Greenwood, Brian M.
   Alderson, Mark
   Traskine, Magali
   Devos, Nathalie
   Schoonbroodt, Sonia
   Swinnen, Kristien
   Verlant, Vincent
   Dobbelaere, Kurt
   Borys, Dorota
TI Efficacy of a novel, protein-based pneumococcal vaccine against
   nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase
   2, randomized, controlled, observer-blind study
SO VACCINE
LA English
DT Article
DE Streptococcus pneumoniae; Nasopharyngeal carriage; Pneumolysin;
   Pneumococcal histidine triad protein D; Vaccine efficacy; Infant
ID FILIPINO PREGNANT-WOMEN; PRECLINICAL EVALUATION; TRIAD PROTEINS;
   IMMUNOGENICITY; PNEUMOLYSIN; SAFETY; ANTIBODIES; ADULTS; PHTD; PCPA
AB Background: Conserved pneumococcal proteins are potential candidates for inclusion in vaccines against pneumococcal diseases. In the first part of a two-part study, an investigational vaccine (PHiD-CV/dPly/PhtD-30) containing 10 pneumococcal serotype-specific polysaccharide conjugates (10VT) combined with pneumolysin toxoid and pneumococcal histidine triad protein D (30 mu g each) was well tolerated by Gambian children. Part two, presented here, assessed the efficacy of two PHiD-CV/dPly/PhtD formulations against pneumococcal nasopharyngeal carriage (NPC) prevalence in infants.
   Methods: In this phase 2, randomized, controlled, observer-blind trial, healthy infants aged 8-10 weeks, recruited from a peri-urban health center, were randomized (1:1:1:1:1:1) into six groups. Four groups received PHiD-CV/dPly/PhtD (10 or 304 mu g of each protein), PHiD-CV, or 13-valent pneumococcal conjugate vaccine at ages 2-3-4 months (3 + 0 infant schedule) and two groups PHiD-CV/dPly/PhtD-30 or PHiD-CV at 2-4-9 months (2 + 1 infant schedule). The primary objective was impact on non-10VT NPC at ages 5-9-12 months. Secondary objectives included confirmatory analysis of protein dose superiority and safety/reactogenicity. Impact on pneumococcal NPC acquisition, bacterial load, and ply and phtD gene sequencing were explored.
   Results: 1200 infants were enrolled between June 2011 and May 2012. Prevalences of pneumococcal (60-67%) and non-10VT (55-61%) NPC were high at baseline. Across all post-vaccination time points, efficacy of PHiD-CV/dPly/PhtD-10 and PHiD-CV/dPly/PhtD-30 against non-10VT NPC (3 + 0 schedule) was 1.1% (95% CI -21.5, 19.5) and 2.1% (-20.3, 20.3), respectively; efficacy of PHiD-CV/dPly/PhtD-30 (2 + 1 schedule) was 0.5% (-22.1, 18.9) versus PHiD-CV. No differences were observed in pneumococcal NPC acquisition, clearance, or bacterial load. Both protein-based vaccines elicited immune responses to pneumococcal proteins.
   Conclusions: In this high carriage prevalence setting, inclusion of pneumococcal proteins in the PHiD-CV/dPly/PhtD investigational vaccine had no impact on pneumococcal NPC in infants, regardless of protein dose or schedule. Future evaluations will assess its impact against pneumococcal disease endpoints. (C) 2017 The Authors. Published by Elsevier Ltd.
C1 [Odutola, Aderonke; Ota, Martin O. C.; Antonio, Martin; Ogundare, Ezra O.; Saidu, Yauba; Foster-Nyarko, Ebenezer; Owiafe, Patrick K.; Ceesay, Fatima; Worwui, Archibald; Idoko, Olubukola T.; Owolabi, Olumuyiwa; Bojang, Abdoulie; Jarju, Sheikh; Drammeh, Isatou; Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, POB 273, Banjul, Gambia.
   [Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Alderson, Mark] PATH, Seattle, WA USA.
   [Traskine, Magali; Devos, Nathalie; Schoonbroodt, Sonia; Swinnen, Kristien; Verlant, Vincent; Dobbelaere, Kurt; Borys, Dorota] GSK, Wavre, Belgium.
RP Odutola, A (reprint author), MRC Unit, Vaccines & Immun Theme, POB 273, Banjul, Gambia.
EM aaodutola@mrc.gm; otama@who.int; mantonio@mrc.gm;
   tundeyogundare@yahoo.com; ysaidu@clintonhealthaccess.org;
   efosternyarko@mrc.gm; pkowiafe@uhas.edu.gh; faceesay@mrc.gm;
   aworwui@mrc.gm; oidoko@mrc.gm; oowolabi@mrc.gm; ambojang@mrc.gm;
   shjarju@mrc.gm; idrammeh@mrc.gm; bkampmann@mrc.gm;
   Brian.Greenwood@lshtm.ac.uk; malderson@path.org;
   magali.x.traskine@gsk.com; nathalie.i.devos@gsk.com;
   sonia.j.schoonbroodt@gsk.com; kristien.m.swinnen@gsk.com;
   vincent.verlant@gsk.com; dobbelaerekurt@gmail.com;
   dorota.d.borys@gsk.com
OI Kwasi Owiafe, Patrick/0000-0002-4287-3577
FU PATH, Seattle, USA; GlaxoSmithKline Biologicals SA, Belgium
FX The study was funded by PATH, Seattle, USA, and GlaxoSmithKline
   Biologicals SA, Belgium. PATH was involved in the study design, data
   analysis, and data interpretation. GlaxoSmithKline Biologicals SA
   designed the study in collaboration with PATH, London School of Hygiene
   & Tropical Medicine (LSHTM), and the Medical Research Council (MRC)
   investigators, and coordinated collection, analysis, and interpretation
   of data.
CR Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001
   Alderson MR, 2016, VACCINE, V34, P2959, DOI 10.1016/j.vaccine.2016.03.107
   ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683
   Bologa M, 2012, VACCINE, V30, P7461, DOI 10.1016/j.vaccine.2012.10.076
   Brooks WA, 2015, VACCINE, V33, P4610, DOI 10.1016/j.vaccine.2015.06.078
   Chang L, 2014, 9 INT S PNEUM PNEUM
   Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005
   Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051
   Denoel P, 2011, VACCINE, V29, P6451, DOI 10.1016/j.vaccine.2011.01.085
   Devine VT, 2015, J IMMUNOL RES, DOI 10.1155/2015/394368
   Garcia-Suarez MD, 2004, INFECT IMMUN, V72, P4534, DOI 10.1128/IAI.72.8.4534-4540.2004
   Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10
   Hermand P, 2017, HUM VACC IMMUNOTHER, V13, P220, DOI 10.1080/21645515.2016.1234553
   Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x
   Holmlund E, 2006, VACCINE, V24, P57, DOI 10.1016/j.vaccine.2005.07.055
   Holmlund E, 2009, CLIN VACCINE IMMUNOL, V16, P916, DOI 10.1128/CVI.00050-09
   Kamtchoua T, 2013, VACCINE, V31, P327, DOI 10.1016/j.vaccine.2012.11.005
   Kaur R, 2014, INFECT IMMUN, V82, P5069, DOI 10.1128/IAI.02124-14
   Khan MN, 2014, HUM VACC IMMUNOTHER, V10, P3688, DOI 10.4161/21645515.2014.979631
   Leroux-Roels G, 2014, VACCINE, V32, P6838, DOI 10.1016/j.vaccine.2014.02.052
   Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2
   Odutola A, 2016, HUM VACC IMMUNOTHER, V12, P393, DOI 10.1080/21645515.2015.1111496
   Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558
   Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537
   Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004
   Prymula R, 2014, PNEUMONIA, V3, P92
   Prymula R, 2014, VACCINE, V32, P3025, DOI 10.1016/j.vaccine.2014.03.066
   Richard AL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004339
   Roca A, 2015, VACCINE, V33, P7144, DOI 10.1016/j.vaccine.2015.11.012
   Skoberne M, 2016, 10 INT S PHEUM PNEUM
   Van Effelterre T, 2010, VACCINE, V28, P3650, DOI 10.1016/j.vaccine.2010.03.030
   Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8
   World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P129
NR 33
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 2
PY 2017
VL 35
IS 19
BP 2531
EP 2542
DI 10.1016/j.vaccine.2017.03.071
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EU0QF
UT WOS:000400715700001
PM 28389097
OA No
DA 2017-08-15
ER

PT J
AU Dellicour, S
   Sevene, E
   McGready, R
   Tinto, H
   Mosha, D
   Manyando, C
   Rulisa, S
   Desai, M
   Ouma, P
   Oneko, M
   Vala, A
   Ruperez, M
   Macete, E
   Menendez, C
   Nakanabo-Diallo, S
   Kazienga, A
   Valea, I
   Calip, G
   Augusto, O
   Genton, B
   Njunju, EM
   Moore, KA
   d'Alessandro, U
   Nosten, F
   ter Kuile, F
   Stergachis, A
AF Dellicour, Stephanie
   Sevene, Esperanca
   McGready, Rose
   Tinto, Halidou
   Mosha, Dominic
   Manyando, Christine
   Rulisa, Stephen
   Desai, Meghna
   Ouma, Peter
   Oneko, Martina
   Vala, Anifa
   Ruperez, Maria
   Macete, Eusebio
   Menendez, Clara
   Nakanabo-Diallo, Seydou
   Kazienga, Adama
   Valea, Innocent
   Calip, Gregory
   Augusto, Orvalho
   Genton, Blaise
   Njunju, Eric M.
   Moore, Kerryn A.
   d'Alessandro, Umberto
   Nosten, Francois
   ter Kuile, Feiko
   Stergachis, Andy
TI First-trimester artemisinin derivatives and quinine treatments and the
   risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis
   of observational studies
SO PLOS MEDICINE
LA English
DT Article
ID INDIVIDUAL PARTICIPANT DATA; DEVELOPMENTAL TOXICITY; ANTIMALARIAL-DRUG;
   ARTEMETHER-LUMEFANTRINE; PROSPECTIVE COHORT; 1ST TRIMESTER; RETICULOCYTE
   COUNT; WESTERN KENYA; MALARIA; ARTESUNATE
AB Background
   Animal embryotoxicity data, and the scarcity of safety data in human pregnancies, have prevented artemisinin derivatives from being recommended for malaria treatment in the first trimester except in lifesaving circumstances. We conducted a meta-analysis of prospective observational studies comparing the risk of miscarriage, stillbirth, and major congenital anomaly (primary outcomes) among first-trimester pregnancies treated with artemisinin derivatives versus quinine or no antimalarial treatment.
   Methods and findings
   Electronic databases including Medline, Embase, and Malaria in Pregnancy Library were searched, and investigators contacted. Five studies involving 30,618 pregnancies were included; four from sub-Saharan Africa (n = 6,666 pregnancies, six sites) and one from Thailand (n = 23,952). Antimalarial exposures were ascertained by self-report or active detection and confirmed by prescriptions, clinic cards, and outpatient registers. Cox proportional hazards models, accounting for time under observation and gestational age at enrollment, were used to calculate hazard ratios. Individual participant data (IPD) meta-analysis was used to combine the African studies, and the results were then combined with those from Thailand using aggregated data meta-analysis with a random effects model.
   There was no difference in the risk of miscarriage associated with the use of artemisinins anytime during the first trimester (n = 37/671) compared with quinine (n = 96/945; adjusted hazard ratio [aHR] = 0.73 [95% CI 0.44, 1.21], I-2 = 0%, p = 0.228), in the risk of stillbirth (artemisinins, n = 10/654; quinine, n = 11/615; aHR = 0.29 [95% CI 0.08-1.02], p = 0.053), or in the risk of miscarriage and stillbirth combined (pregnancy loss) (aHR = 0.58 [95% CI 0.36-1.02], p = 0.099). The corresponding risks of miscarriage, stillbirth, and pregnancy loss in a sensitivity analysis restricted to artemisinin exposures during the embryo sensitive period (6-12 wk gestation) were as follows: aHR = 1.04 (95% CI 0.54-2.01), I-2 = 0%, p = 0.910; aHR = 0.73 (95% CI 0.26-2.06), p = 0.551; and aHR = 0.98 (95% CI 0.52-2.04), p = 0.603. The prevalence of major congenital anomalies was similar for first-trimester artemisinin (1.5% [95% CI 0.6%-3.5%]) and quinine exposures (1.2% [95% CI 0.6%-2.4%]). Key limitations of the study include the inability to control for confounding by indication in the African studies, the paucity of data on potential confounders, the limited statistical power to detect differences in congenital anomalies, and the lack of assessment of cardiovascular defects in newborns.
   Conclusions
   Compared to quinine, artemisinin treatment in the first trimester was not associated with an increased risk of miscarriage or stillbirth. While the data are limited, they indicate no difference in the prevalence of major congenital anomalies between treatment groups. The benefits of 3-d artemisinin combination therapy regimens to treat malaria in early pregnancy are likely to outweigh the adverse outcomes of partially treated malaria, which can occur with oral quinine because of the known poor adherence to 7-d regimens.
C1 [Dellicour, Stephanie; ter Kuile, Feiko] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Malaria Epidemiol Unit, Liverpool, Merseyside, England.
   [Sevene, Esperanca] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique.
   [Sevene, Esperanca; Vala, Anifa; Ruperez, Maria; Macete, Eusebio; Menendez, Clara; Augusto, Orvalho] Ctr Invest Saude Manhica, Manhica, Mozambique.
   [McGready, Rose; Nosten, Francois] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.
   [McGready, Rose; Nosten, Francois] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Tinto, Halidou; Nakanabo-Diallo, Seydou; Kazienga, Adama; Valea, Innocent] Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.
   [Mosha, Dominic] Ifakara Hlth Inst, Rufiji, Tanzania.
   [Manyando, Christine] Trop Dis Res Ctr, Ndola, Zambia.
   [Rulisa, Stephen] Univ Rwanda, Univ Teaching Hosp Kigali, Kigali, Rwanda.
   [Desai, Meghna] Ctr Dis Control & Prevent, Malaria Branch, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA USA.
   [Ouma, Peter; Oneko, Martina] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.
   [Ruperez, Maria; Menendez, Clara] Inst Salud Global Barcelona, Barcelona, Spain.
   [Calip, Gregory] Univ Illinois, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA.
   [Genton, Blaise] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland.
   [Njunju, Eric M.] Copperbelt Univ, Sch Med, Ndola, Zambia.
   [Moore, Kerryn A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.
   [Moore, Kerryn A.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.
   [d'Alessandro, Umberto] MRC, Fajara, Gambia.
   [d'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [Stergachis, Andy] Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA.
   [Stergachis, Andy] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA.
RP Dellicour, S (reprint author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Malaria Epidemiol Unit, Liverpool, Merseyside, England.; Stergachis, A (reprint author), Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA.; Stergachis, A (reprint author), Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA.
EM stephanie.dellicour@lstmed.ac.uk; stergach@uw.edu
OI McGready, Rose/0000-0003-1621-3257
FU Malaria in Pregnancy (MiP) Consortium, from the Bill & Melinda Gates
   Foundation; Wellcome Trust of Great Britain
FX Part of the work presented, the ASAP studies, was supported by the
   Malaria in Pregnancy (MiP) Consortium, which is funded through a grant
   from the Bill & Melinda Gates Foundation to the Liverpool School of
   Tropical Medicine, United Kingdom. The Shoklo Malaria Research Unit is
   part of the Mahidol Oxford University Research Unit, supported by the
   Wellcome Trust of Great Britain. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144
   Huynh BT, 2015, CLIN INFECT DIS, V60, P598, DOI 10.1093/cid/ciu848
   BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005
   Burger RJ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv170
   Clark RL, 2006, BIRTH DEFECTS RES A, V76, P329
   Clark RL, 2004, BIRTH DEFECTS RES B, V71, P380, DOI 10.1002/bdrb.20027
   Clark RL, 2008, BIRTH DEFECTS RES B, V83, P418, DOI 10.1002/bdrb.20163
   Clark RL, 2008, BIRTH DEFECTS RES B, V83, P397, DOI 10.1002/bdrb.20165
   Clark RL, 2012, BIRTH DEFECTS RES A, V94, P61, DOI 10.1002/bdra.22868
   Clark RL, 2009, REPROD TOXICOL, V28, P285, DOI 10.1016/j.reprotox.2009.05.002
   Dellicour S, 2008, PLOS MED, V5, P1310, DOI 10.1371/journal.pmed.0050187
   Dellicour S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0950-6
   Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Ejiofor JI, 2006, PHARMACOLOGY, V77, P166, DOI 10.1159/000094521
   El-Dakdoky MH, 2009, FOOD CHEM TOXICOL, V47, P1437, DOI 10.1016/j.fct.2009.03.027
   Guyatt HL, 2001, AM J TROP MED HYG, V64, P36
   Haynes B, 2006, CLIN EPIDEMIOLOGY CL
   Hill J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001688
   Holmes LB, 2011, BIRTH DEFECTS RES A, V91, P807, DOI 10.1002/bdra.20842
   Howards PP, 2007, AM J EPIDEMIOL, V165, P444, DOI 10.1093/aje/kwk027
   Kioko U, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1404-5
   Li QG, 2010, MOLECULES, V15, P40, DOI 10.3390/molecules15010040
   Longo M, 2006, REPROD TOXICOL, V22, P797, DOI 10.1016/j.reprotox.2006.08.001
   Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3
   Manyando C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-249
   Margulis AV, 2015, PHARMACOEPIDEM DR S, V24, P343, DOI 10.1002/pds.3731
   McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5
   McGready Rose, 2014, F1000Res, V3, P123, DOI 10.12688/f1000research.4190.2
   Mehta U, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-89
   Moore KA, 2016, LANCET INFECT DIS, V16, P576, DOI 10.1016/S1473-3099(15)00547-2
   Mosha D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-197
   Nosten Francois, 2006, Curr Drug Saf, V1, P1, DOI 10.2174/157488606775252584
   Obonyo CO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-2
   Poespoprodjo JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084976
   Riley RD, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c221
   Rulisa S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-225
   Sangare LR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-152
   Scheuerle A, 2002, PHARMACOEPIDEM DR S, V11, P465, DOI 10.1002/pds.726
   Sinclair D, 2012, COCHRANE DB SYST REV, V6
   Steketee RW, 2001, AM J TROP MED HYG, V64, P28
   Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656
   Tinto H, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0101-0
   Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35
   Wells G, 2014, NEWCASTLE OTTAWA SCA
   White TEK, 2008, BIRTH DEFECTS RES B, V83, P407, DOI 10.1002/bdrb.20157
   World Health Organization, 2008, PRACT HDB PHARM ANT
   World Health Organization, 2007, ASS SAF ART COMP PRE
   WHO, 2015, GUID TREATM MAL
NR 49
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD MAY
PY 2017
VL 14
IS 5
AR e1002290
DI 10.1371/journal.pmed.1002290
PG 20
WC Medicine, General & Internal
SC General & Internal Medicine
GA EW5GF
UT WOS:000402532900001
PM 28463996
OA gold
DA 2017-08-15
ER

PT J
AU McGuire, MK
   Meehan, CL
   McGuire, MA
   Williams, JE
   Foster, J
   Sellen, DW
   Kamau-Mbuthia, EW
   Kamundia, EW
   Mbugua, S
   Moore, SE
   Prentice, AM
   Kvist, LJ
   Otoo, GE
   Brooker, SL
   Price, WJ
   Shafii, B
   Placek, C
   Lackey, KA
   Robertson, B
   Manzano, S
   Ruiz, L
   Rodriguez, JM
   Pareja, RG
   Bode, L
AF McGuire, Michelle K.
   Meehan, Courtney L.
   McGuire, Mark A.
   Williams, Janet E.
   Foster, James
   Sellen, Daniel W.
   Kamau-Mbuthia, Elizabeth W.
   Kamundia, Egidioh W.
   Mbugua, Samwel
   Moore, Sophie E.
   Prentice, Andrew M.
   Kvist, Linda J.
   Otoo, Gloria E.
   Brooker, Sarah L.
   Price, William J.
   Shafii, Bahman
   Placek, Caitlyn
   Lackey, Kimberly A.
   Robertson, Bianca
   Manzano, Susana
   Ruiz, Lorena
   Rodriguez, Juan M.
   Pareja, Rossina G.
   Bode, Lars
TI What's normal? Oligosaccharide concentrations and profiles in milk
   produced by healthy women vary geographically
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE breastfeeding; carbohydrates; human milk; lactation; oligosaccharides
ID BOVINE-MILK; IN-VITRO; NECROTIZING ENTEROCOLITIS;
   CAPILLARY-ELECTROPHORESIS; MATRIX FACTORIZATION; EPITHELIAL-CELLS;
   LACTATION; HIV; COLONIZATION; CONSUMPTION
AB Background: Human milk is a complex fluid comprised of myriad substances, with one of the most abundant substances being a group of complex carbohydrates referred to as human milk oligosaccharides (HMOs). There has been some evidence that HMO profiles differ in populations, but few studies have rigorously explored this variability.
   Objectives: We tested the hypothesis that HMO profiles differ in diverse populations of healthy women. Next, we examined relations between HMO and maternal anthropometric and reproductive indexes and indirectly examined whether differences were likely related to genetic or environmental variations.
   Design: In this cross-sectional, observational study, milk was collected from a total of 410 healthy, breastfeeding women in 11 international cohorts and analyzed for HMOs by using high-performance liquid chromatography.
   Results: There was an effect of the cohort (P < 0.05) on concentrations of almost all HMOs. For instance, the mean 3-fucosyllactose concentration was >4 times higher in milk collected in Sweden than in milk collected in rural Gambia (mean +/- SEM: 473 +/- 55 compared with 103 +/- 16 nmol/mL, respectively; P < 0.05), and disialyllacto-N-tetraose (DSLNT) concentrations ranged from 216 6 14 nmol/mL (in Sweden) to 870 6 68 nmol/mL (in rural Gambia) (P, 0.05). Maternal age, time postpartum, weight, and body mass index were all correlated with several HMOs, and multiple differences in HMOs [e.g., lacto-N-neotetrose and DSLNT] were shown between ethnically similar (and likely genetically similar) populations who were living in different locations, which suggests that the environment may play a role in regulating the synthesis of HMOs.
   Conclusions: The results of this study support our hypothesis that normal HMO concentrations and profiles vary geographically, even in healthy women. Targeted genomic analyses are required to determine whether these differences are due at least in part to genetic variation. A careful examination of sociocultural, behavioral, and environmental factors is needed to determine their roles in this regard.
C1 [McGuire, Michelle K.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.
   [McGuire, Michelle K.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
   [Meehan, Courtney L.; Placek, Caitlyn] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA.
   [McGuire, Mark A.; Williams, Janet E.; Brooker, Sarah L.] Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA.
   [Williams, Janet E.; Brooker, Sarah L.] Univ Idaho, Program Bioinformat & Computat Biol, Moscow, ID 83843 USA.
   [Foster, James] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.
   [Price, William J.; Shafii, Bahman] Univ Idaho, Coll Agr & Life Sci, Stat Programs, Moscow, ID 83843 USA.
   [Sellen, Daniel W.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Kamau-Mbuthia, Elizabeth W.; Kamundia, Egidioh W.; Mbugua, Samwel] Egerton Univ, Dept Human Nutr, Nakuru, Kenya.
   [Moore, Sophie E.] Elsie Widdowson Lab, Human Nutr Res, MRC, Cambridge, England.
   [Moore, Sophie E.] MRC Unit, Banjul, Gambia.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Kvist, Linda J.] Lund Univ, Fac Med, Lund, Sweden.
   [Otoo, Gloria E.] Univ Ghana, Dept Nutr & Food Sci, Accra, Ghana.
   [Robertson, Bianca; Bode, Lars] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.
   [Robertson, Bianca; Bode, Lars] Univ Calif San Diego, Mother Milk Infant Ctr Res Excellence, San Diego, CA 92103 USA.
   [Manzano, Susana; Ruiz, Lorena; Rodriguez, Juan M.] Univ Complutense Madrid, Dept Nutr Food Sci & Food Technol, Madrid, Spain.
   [Pareja, Rossina G.] Nutr Res Inst, Lima, Peru.
   [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England.
   [Placek, Caitlyn] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol, 11200 SW 8th St,AHC5 505, Miami, FL 33199 USA.
RP McGuire, MK (reprint author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.; McGuire, MK (reprint author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Bode, L (reprint author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.; Bode, L (reprint author), Univ Calif San Diego, Mother Milk Infant Ctr Res Excellence, San Diego, CA 92103 USA.
EM smcguire@wsu.edu; lbode@ucsd.edu
OI McGuire, Michelle/0000-0001-8214-2229
FU National Science Foundation [1344288]; Ministry of Economy and
   Competitiveness, Spain [AGL2013-4190-P]; European Commission [624773]
FX Supported by the National Science Foundation (award 1344288), the
   Ministry of Economy and Competitiveness, Spain (project AGL2013-4190-P;
   to LR), and the European Commission [grant 624773
   (FP-7-PEOPLE-2013-IEF); to LR]. Sterile, single-use milk-collection kits
   were generously provided by Medela Inc.
CR Alderete TL, 2015, AM J CLIN NUTR, V102, P1381, DOI 10.3945/ajcn.115.115451
   Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138
   Bao YW, 2007, ANAL BIOCHEM, V370, P206, DOI 10.1016/j.ab.2007.07.004
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bode L, 2012, AM J CLIN NUTR, V96, P831, DOI 10.3945/ajcn.112.039503
   Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074
   Bode L, 2012, ADV NUTR, V3, p383S, DOI 10.3945/an.111.001404
   Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101
   Castillo-Courtade L, 2015, ALLERGY, V70, P1091, DOI 10.1111/all.12650
   Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024
   Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365
   Coppa GV, 1999, ACTA PAEDIATR, V88, P89, DOI 10.1080/080352599750029808
   Davidson B, 2004, ADV EXP MED BIOL, V554, P427
   de Mendiburu F, 2015, R PACK VERS 1 2 3
   Domer MC, 2015, J HUM LACT, V31, P282, DOI 10.1177/0890334414565794
   Dong X, 2016, ELECTROPHORESIS, V37, P1532, DOI 10.1002/elps.201500561
   Eiwegger T, 2004, PEDIATR RES, V56, P536, DOI 10.1203/01.PDR.0000139411.35619.B4
   Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x
   Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016
   Fernandez L, 2013, CELL MOL BIOL, V59, P31, DOI 10.1170/T945
   Gabrielli O, 2011, PEDIATRICS, V128, pE1520, DOI 10.1542/peds.2011-1206
   Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367
   Gonia S, 2015, J NUTR, V145, P1992, DOI 10.3945/jn.115.214940
   Gopal PK, 2000, BRIT J NUTR, V84, pS69
   Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313
   Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404
   Jantscher-Krenn E, 2012, BRIT J NUTR, V108, P1839, DOI 10.1017/S0007114511007392
   Jiang X, 2004, J INFECT DIS, V190, P1850, DOI 10.1086/425159
   Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731
   Kuhn L, 2015, J NUTR, V145, P66, DOI 10.3945/jn.114.199794
   KUMAZAKI T, 1984, P NATL ACAD SCI-BIOL, V81, P4193, DOI 10.1073/pnas.81.13.4193
   Kunz C, 2008, ADV EXP MED BIOL, V606, P455, DOI 10.1007/978-0-387-74087-4_18
   Kunz C, 1999, CLIN PERINATOL, V26, P307
   Lin AE, 2014, J INFECT DIS, V209, P389, DOI 10.1093/infdis/jit464
   Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480
   Manthey CF, 2014, J PEDIATR GASTR NUTR, V58, P165, DOI 10.1097/MPG.0000000000000172
   Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205
   Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054
   Newburg DS, 2000, ADV EXP MED BIOL, V478, P381
   Newburg DS, 2000, J PEDIATR GASTR NUTR, V30, pS8, DOI 10.1097/00005176-200000002-00003
   Ogle DH, 2015, R PACK VERS 0 4 4
   Oksanen J, 2016, R PACK VERS 2 3 3
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200
   Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105
   Sprenger N, 2017, EUR J NUTR, V56, P1293, DOI 10.1007/s00394-016-1180-6
   Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305
   Tao N, 2009, J DAIRY SCI, V92, P2991, DOI 10.3168/jds.2008-1642
   Urbaniak C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-015-0145-y
   Van Niekerk E, 2014, J NUTR, V144, P1227, DOI 10.3945/jn.113.187799
   Vazquez E, 2015, J NUTR BIOCHEM, V26, P455, DOI 10.1016/j.jnutbio.2014.11.016
   Warnes GR, R PACK VERS 3 0 1
   Wei T., 2013, R PACK VERS 0 73
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Xu XH, 1996, J BIOL CHEM, V271, P8818
NR 55
TC 2
Z9 2
U1 5
U2 5
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAY 1
PY 2017
VL 105
IS 5
BP 1086
EP 1100
DI 10.3945/ajcn.116.139980
PG 15
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EW3NK
UT WOS:000402404900011
PM 28356278
OA No
DA 2017-08-15
ER

PT J
AU Bah, SY
   Dickinson, P
   Forster, T
   Kampmann, B
   Ghazal, P
AF Bah, Saikou Y.
   Dickinson, Paul
   Forster, Thorsten
   Kampmann, Beate
   Ghazal, Peter
TI Immune oxysterols: Role in mycobacterial infection and inflammation
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Review
DE Oxysterols; Tuberculosis; Vitamin D; 25 hydroxycholesterol; Infection;
   Cholesterol; Immunity
ID ANTIMICROBIAL PEPTIDE GENE; VITAMIN-D-RECEPTOR; 1,25-DIHYDROXYVITAMIN
   D-3; MONOCYTIC DIFFERENTIATION; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS
   INFECTION; MILIARY TUBERCULOSIS; HUMAN MACROPHAGES; RETINOIC ACID;
   CUTTING EDGE
AB Infection remains an important cause of morbidity and mortality. Natural defenses to infection are mediated by intrinsic/innate and adaptive immune responses. While our understanding is considerable it is incomplete and emerging areas of research such as those related to the immune-metabolic axis are only beginning to be appreciated. There is increasing evidence showing a connection between immune signalling and the regulation of sterol and fatty acid metabolism. In particular, metabolic intermediates of cholesterol biosynthesis and its oxidized metabolites (oxysterols) have been shown to regulate adaptive immunity and inflammation and for innate immune signalling to regulate the dynamics of cholesterol synthesis and homeostasis. The side-chain oxidized oxysterols, 25-hydroxycholesterol (25HC) and vitamin D metabolites (vitamin D-3 and vitamin D-2), are now known to impart physiologically profound effects on immune responses. Macrophages play a frontline role in this process connecting immunity, infection and lipid biology, and collaterally are a central target for infection by a wide range of pathogens including viruses and bacteria, especially intracellular bacteria such as mycobacteria. Clinical manifestations of disease severity in the infected host are likely to pay tribute to perturbations of the metabolic-immune phenomena found in lymphocytes and myeloid cells. Historically and consistent with this notion, vitamin D based oxysterols have had a long association with promoting clinical improvements to patients infected with Mycobacterium tuberculosis. Hence understanding the role of early metabolic mediators of inflammatory responses to infection in particular oxysterols, will aid in the development of urgently needed host directed therapeutic and diagnostic design innovation to combat adverse infection outcomes and antibiotic resistance. (C) 2016 The Authors. Published by Elsevier Ltd.
C1 [Bah, Saikou Y.; Dickinson, Paul; Forster, Thorsten; Ghazal, Peter] Univ Edinburgh Med, Div Infect & Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland.
   [Ghazal, Peter] Univ Edinburgh, SynthSys, Kings Bldg, Edinburgh, Midlothian, Scotland.
   [Bah, Saikou Y.; Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Serekunda, Gambia.
   [Kampmann, Beate] Imperial Coll London, Dept Med, Ctr Int Child Hlth, London, England.
RP Bah, SY; Ghazal, P (reprint author), Univ Edinburgh Med, Div Infect & Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland.
EM sabah@mrc.gm; p.ghazal@ed.ac.uk
RI Forster, Thorsten/F-4483-2017
OI Forster, Thorsten/0000-0002-4483-3069
FU MRC Gambia-Darwin Trust Scholarship award; BBSRC [BB/K019112/1]
FX SYB is supported by joint doctoral scholarship from an MRC Gambia-Darwin
   Trust Scholarship award. This work was also supported in part by the
   BBSRC (BB/K019112/1). The authors thank Wayne Hsieh for advice on
   graphical pathway notation. We thank Widad Dantoft, Kevin Robertson and
   the reviewers for their helpful comments.
CR Adorini L, 2009, HUM IMMUNOL
   Anand PK, 2008, J MICROBIOL IMMUNOL, V41, P17
   Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289
   Bacchetta J., 2013, J AM SOC NEPHROL, P1
   Baeke F., 2010, J STEROID BIOCHEM, V121
   BARSHAVIT Z, 1983, P NATL ACAD SCI-BIOL, V80, P5907, DOI 10.1073/pnas.80.19.5907
   Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106
   Bean AGD, 1999, J IMMUNOL, V162, P3504
   Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004
   Bonecini-Almeida MG, 2004, INFECT IMMUN, V72, P2628, DOI 10.1128/IAI.72.5.2628-2634.2004
   Boonstra A, 2001, J IMMUNOL, V167, P4974
   Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462
   Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09
   Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132
   Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200
   Chalmin F, 2015, J AUTOIMMUN, V56, P45, DOI 10.1016/j.jaut.2014.10.001
   Chan TYK, 2000, CALCIFIED TISSUE INT, V66, P476, DOI 10.1007/s002230010095
   Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089
   Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101
   Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y
   Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698
   Cole ST, 1998, NATURE, V393, P537
   D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050
   Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200
   DOWLING GB, 1948, BRIT MED J, V1, P430
   Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108
   Ferrara G, 2008, SCAND J IMMUNOL, V68, P668, DOI 10.1111/j.1365-3083.2008.02182.x
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253
   Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200
   Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2
   Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202
   Gold E. S., 2014, P NATL ACAD SCI US, V6
   Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com
   Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251
   Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280
   Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321
   Honda A, 2011, J LIPID RES, V52, P1509, DOI 10.1194/jlr.M014084
   Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103
   Karlic H, 2011, CLIN EPIGENETICS, V2, P55, DOI 10.1007/s13148-011-0021-y
   Kassebaum NJ, 2014, LANCET, V6736, P1
   Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262
   Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558
   Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Lobato LS, 2014, ANTIMICROB AGENTS CH, V58, P5766, DOI 10.1128/AAC.01826-13
   Lovewell RR, 2016, CURR OPIN MICROBIOL, V29, P30, DOI 10.1016/j.mib.2015.10.002
   Lowry MB, 2014, J STEROID BIOCHEM, V143, P183, DOI 10.1016/j.jsbmb.2014.02.004
   Lu H., 2015, STEROIDS
   MACRAE DE, 1947, LANCET, V252, P135
   Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020
   Mazein A., 2011, NAT PRECED
   Mazein A, 2013, BIOCHEM PHARMACOL, V86, P56, DOI 10.1016/j.bcp.2013.03.021
   Murray C. J., 2014, LANCET
   Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09
   Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009
   OBERG F, 1993, J IMMUNOL, V150, P3487
   Cyster J. G., 2014, NAT REV IMMUNOL, V14, P731
   Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105
   Parihar SP, 2014, J INFECT DIS, V209, P754, DOI 10.1093/infdis/jit550
   Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318
   Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204
   Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005
   Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100
   Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790
   RIGBY WFC, 1984, BLOOD, V64, P1110
   RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154
   Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6
   Salamon H, 2014, J IMMUNOL, V193, P30, DOI 10.4049/jimmunol.1400736
   Sharma SK, 2005, LANCET INFECT DIS, V5, P415, DOI 10.1016/S1473-3099(05)70163-8
   Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x
   Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216
   Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681
   Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908
   Takeuchi A, 1998, J IMMUNOL, V160, P209
   Talat N, 2010, EMERG INFECT DIS, V16, P853, DOI 10.3201/eid1605.091693
   van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002
   Wang TT, 2004, J IMMUNOL, V173, P2909
   Wang T. T., 2005, MOL ENDOCRINOL, V19, P2685
   World Health Organization, 2015, GLOB TUB REP 2015
   XU H, 1993, SCAND J IMMUNOL, V38, P535, DOI 10.1111/j.1365-3083.1993.tb03237.x
   Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x
   Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644
   Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015
   York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045
NR 89
TC 2
Z9 2
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD MAY
PY 2017
VL 169
SI SI
BP 152
EP 163
DI 10.1016/j.jsbmb.2016.04.015
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EU9WV
UT WOS:000401391300018
PM 27155346
OA No
DA 2017-08-15
ER

PT J
AU Ofori-Anyinam, B
   Dolganov, G
   Van, T
   Davis, JL
   Walter, ND
   Garcia, BJ
   Voskuil, M
   Fissette, K
   Diels, M
   Driesen, ME
   Meehan, CJ
   Yeboah-Manu, D
   Coscolla, M
   Gagneux, S
   Antonio, M
   Schoolnik, G
   Gehre, F
   de Jong, BC
AF Ofori-Anyinam, Boatema
   Dolganov, Gregory
   Van, Tran
   Davis, J. Lucian
   Walter, Nicholas D.
   Garcia, Benjamin J.
   Voskuil, Marty
   Fissette, Kristina
   Diels, Maren
   Driesen, Michele
   Meehan, Conor J.
   Yeboah-Manu, Dorothy
   Coscolla, Mireia
   Gagneux, Sebastien
   Antonio, Martin
   Schoolnik, Gary
   Gehre, Florian
   de Jong, Bouke C.
TI Significant under expression of the DosR regulon in M-tuberculosis
   complex lineage 6 in sputum
SO TUBERCULOSIS
LA English
DT Article
DE Mycobacterium africanum; Mycobacterium tuberculosis; Hypoxia; Sputum;
   Gene expression; DosR
ID 2-COMPONENT REGULATORY SYSTEM; NITRATE REDUCTASE-ACTIVITY;
   GENE-EXPRESSION; FUNCTIONAL ANNOTATION; NITRIC-OXIDE; WEST-AFRICA;
   DORMANCY; VIRULENCE; DIFFERENTIATION; PERSISTENCE
AB Mycobacterium africanum lineage (L) 6 is an important pathogen in West Africa, causing up to 40% of pulmonary tuberculosis (TB). The biology underlying the clinical differences between M. africanum and M. tuberculosis sensu stricto remains poorly understood. We performed ex vivo expression of 2179 genes of the most geographically dispersed cause of human TB, M. tuberculosis L4 and the geographically restricted, M. africanum L6 directly from sputa of 11 HIV-negative TB patients from The Gambia who had not started treatment. The DosR regulon was the most significantly decreased category in L6 relative to L4. Further, we identified nonsynonymous mutations in major DosR regulon genes of 44 L6 genomes of TB patients from The Gambia and Ghana. Using Lebek's test, we assessed differences in oxygen requirements for growth. L4 grew only at the aerobic surface while L6 grew throughout the medium. In the host, the DosR regulon is critical for M. tuberculosis in adaptation to oxygen limitation. However, M. africanum L6 appears to have adapted to growth under hypoxic conditions or to different biological niches. The observed under expression of DosR in L6 fits with the genomic changes in DosR genes, microaerobic growth and the association with extrapulmonary disease. (C) 2017 The Authors. Published by Elsevier Ltd.
C1 [Ofori-Anyinam, Boatema; Fissette, Kristina; Diels, Maren; Driesen, Michele; Meehan, Conor J.; Gehre, Florian; de Jong, Bouke C.] ITM, Mycobacteriol Unit, Nationalestr 155, B-2000 Antwerp, Belgium.
   [Ofori-Anyinam, Boatema; Antonio, Martin; Gehre, Florian] Med Res Council MRC Unit, Vaccines & Immun Theme, Atlantic Blvd,POB 273, Banjul, Gambia.
   [Dolganov, Gregory; Van, Tran; Schoolnik, Gary] Stanford Univ, Dept Microbiol & Immunol, 299 Campus Dr, Stanford, CA 94305 USA.
   [Davis, J. Lucian] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06504 USA.
   [Davis, J. Lucian] Yale Sch Med, Dept Pulm Crit Care & Sleep Med, POB 208057,300 Cedar St,TAC-441 South, New Haven, CT 06520 USA.
   [Walter, Nicholas D.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Bldg 500-13001 East,17th Pl,Campus Box C290, Aurora, CO 80045 USA.
   [Walter, Nicholas D.] Denver Vet Affairs Med Ctr, Pulm Sect, 1055 Clermont St, Denver, CO 80220 USA.
   [Walter, Nicholas D.; Garcia, Benjamin J.] Natl Jewish Hlth, Integrated Ctr Genes Environm & Hlth, Smith Bldg A647,1400 Jackson St, Denver, CO 80206 USA.
   [Garcia, Benjamin J.] Univ Colorado Denver, Computat Biosci Program, Bldg 500-13001 East,17th Pl,Campus Box C290, Aurora, CO 80045 USA.
   [Voskuil, Marty] Univ Colorado, Sch Med, Dept Immunol & Microbiol, 12800 E 19th Ave,Mail Stop 8333, Aurora, CO 80045 USA.
   [Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, POB LG 581, Legon, Accra, Ghana.
   [Coscolla, Mireia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, POB 4002, Basel, Switzerland.
   [Coscolla, Mireia; Gagneux, Sebastien] Univ Basel, Peterspl 1,POB 4001, Basel, Switzerland.
RP de Jong, BC (reprint author), ITM, Mycobacteriol Unit, Nationalestr 155, B-2000 Antwerp, Belgium.
EM bdejong@itg.be
RI Coscolla, Mireia/L-5893-2017
OI Coscolla, Mireia/0000-0003-0752-0538; Gagneux,
   Sebastien/0000-0001-7783-9048
FU European Research Council-INTERRUPTB starting grant [311725]
FX The authors thank patients and colleagues at MRC for their contribution
   to the present analysis. This work was supported by the European
   Research Council-INTERRUPTB starting grant nr.311725 (to BdJ, BO, FG,
   MA, CM).
CR Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370
   Boon C, 2012, FUTURE MICROBIOL, V7, P513, DOI [10.2217/fmb.12.14, 10.2217/FMB.12.14]
   Chen T, 2013, J CELL BIOCHEM, V114, P1, DOI 10.1002/jcb.24302
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08
   de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x
   de Keijzer J, 2016, J PROTEOME RES, V15, P1194, DOI 10.1021/acs.jproteome.5b01073
   de Medeiros D, 1973, Bull Soc Med Afr Noire Lang Fr, V18, P477
   Fallow A, 2010, J BACTERIOL, V192, P2228, DOI 10.1128/JB.01597-09
   Frothingham R, 1999, J CLIN MICROBIOL, V37, P1921
   Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103
   Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316
   Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337
   Garcia B, 2014, ANAL BIOCHEM, V458, P11, DOI 10.1016/j.ab.2014.04.021
   Garcia BJ, 2016, TUBERCULOSIS, V100, P89, DOI 10.1016/j.tube.2016.07.004
   Garcia BJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2311-9
   Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075
   Gehre F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002220
   Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x
   Goh KS, 2010, J MICROBIOL METH, V81, P208, DOI 10.1016/j.mimet.2010.03.005
   Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111
   Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496
   He HJ, 2011, J BACTERIOL, V193, P5105, DOI 10.1128/JB.05562-11
   Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311
   Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Iona E, 2016, J MICROBIOL, V54, P565, DOI 10.1007/s12275-016-6150-4
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907
   Koul A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4369
   Leung AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-413
   Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC
   Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006
   Niemann S, 2000, J CLIN MICROBIOL, V38, P152
   Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002
   PATTYN S R, 1970, Annales des Societes Belges de Medecine Tropicale de Parasitologie et de Mycologie, V50, P211
   Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06
   Sharma A, 2016, EMERG INFECT DIS, V22, P396, DOI 10.3201/eid2203.151505
   Sohaskey CD, 2005, MICROBIOL-SGM, V151, P3803, DOI 10.1099/mic.0.28263-0
   Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003
   Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07
   Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003
   Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205
   Walter ND, 2015, J INFECT DIS, V212, P990, DOI 10.1093/infdis/jiv149
   Wang K, 2010, NUCLEIC ACIDS RES, V38, pe164, DOI DOI 10.1093/NAR/GKQ603
   Wang XZ, 2011, SCI CHINA LIFE SCI, V54, P300, DOI 10.1007/s11427-011-4134-5
   Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139
NR 51
TC 0
Z9 0
U1 2
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD MAY
PY 2017
VL 104
BP 58
EP 64
DI 10.1016/j.tube.2017.03.001
PG 7
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA EU6EP
UT WOS:000401127100008
PM 28454650
OA No
DA 2017-08-15
ER

PT J
AU Sisawo, EJ
   Ouedraogo, SYYA
   Huang, SL
AF Sisawo, Ebrima J.
   Ouedraogo, Saide Yacine Y. Arsene
   Huang, Song-Lih
TI Workplace violence against nurses in the Gambia: mixed methods design
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
DE Workplace violence; Secondary health care facilities; Nurses; Gambia
ID NURSING STAFF; HOSPITALS; HEALTH; CARE; DEPARTMENTS; WORKERS; TAIWAN
AB Background: The aim of this study was to assess the prevalence, perpetrators and factors associated with workplace violence against nurses in public secondary health care facilities from two health regions in the Gambia.
   Methods: Data was collected from 219 nurses using self-administered questionnaire and 35 face-to-face interviews. The data collection was conducted between July and September 2014 in 14 public secondary health care facilities.
   Results: A sizable majority of respondents (62.1%) reported exposure to violence in the 12 months prior to the survey; exposure to verbal abuse, physical violence, and sexual harassment was 59.8%, 17.2%, and 10% respectively. The perpetrators were mostly patients' escorts/relatives followed by patients themselves. Perceived reasons of workplace violence were mainly attributed to nurse-client disagreement, understaffing, shortage of drugs and supplies, security vacuum, and lack of management attention to workplace violence.
   Conclusions: Nurses in the Gambia are at a relatively high risk of violent incidents at work. Policies and strategies that are sensitive to local circumstances and needs should be developed for the prevention of workplace violence.
C1 [Sisawo, Ebrima J.] Univ Gambia, Brikama, Gambia.
   [Sisawo, Ebrima J.; Ouedraogo, Saide Yacine Y. Arsene] Natl Yang Ming Univ, Int Hlth Program, Taipei, Taiwan.
   [Huang, Song-Lih] Natl Yang Ming Univ, Inst Publ Hlth, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.
RP Huang, SL (reprint author), Natl Yang Ming Univ, Inst Publ Hlth, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.
EM slhuang@ym.edu.tw
FU International Cooperation and Development Fund (Taiwan)
FX We wish to extend sincere thanks to study participants for their
   interest and time in the study. Thanks and appreciation to the two
   Regional Health Directorates (Western I and Western II) for facilitating
   the data collection exercise. We also wish to express warm thanks to the
   International Cooperation and Development Fund (Taiwan) for supporting
   two of the authors (EJS and SYAO) with scholarships.
CR Abbas Moustafa A, 2010, J Egypt Public Health Assoc, V85, P29
   Abualrub RF, 2007, J NURS SCHOLARSHIP, V39, P281, DOI 10.1111/j.1547-5069.2007.00181.x
   Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43
   Balamurugan G., 2012, INT J NURS, V1, P1
   Bewket TT, 2016, BMC NURS, V15, P42
   Camerino D, 2008, INT J NURS STUD, V45, P35, DOI 10.1016/j.ijnurstu.2007.01.013
   Cox H C, 1987, Nurs Manage, V18, P47
   Darboe A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1347-0
   Duncan S M, 2001, Can J Nurs Res, V32, P57
   Fernandes CMB, 1999, CAN MED ASSOC J, V161, P1245
   ILO/ICN/WHO/PSI, 2003, WORKPL VIOL HLTH SEC
   Peter H., 2016, NURSING OPEN, V3, P99
   Kamchuchat C, 2008, J OCCUP HEALTH, V50, P201, DOI 10.1539/joh.O7001
   Kitaneh M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-469
   Kwok R. P. W., 2006, Hong Kong Medical Journal, V12, P6
   Lin YH, 2005, INT J NURS STUD, V42, P773, DOI 10.1016/j.ijnurstu.2004.11.010
   Martino Vd, 2002, WORKPLACE VIOLENCE H
   N. H. M. I. System, 2012, ANN SERV STAT REP
   [Anonymous], 2009, HUM RES HLTH COUNTR
   [Anonymous], 2010, EFF INC HLTH SERV PR
   Mohamad A, 2015, PLOS ONE, V10
   Mohammed A, 2015, J NURS RES, V23, P75
   Pai HC, 2011, J CLIN NURS, V20, P1405, DOI 10.1111/j.1365-2702.2010.03650.x
   Paterson M, 1999, MANAGING PHYS VIOLEN
   Pinar R, 2011, J CLIN NURS, V20, P510, DOI 10.1111/j.1365-2702.2010.03520.x
   Razee H, 2012, SOC SCI MED, V75, P828, DOI 10.1016/j.socscimed.2012.04.013
   Samir N., 2012, Eastern Mediterranean Health Journal, V18, P198
   Shoghi M, 2008, ASIAN NURS RES, V2, P184, DOI 10.1016/S1976-1317(08)60042-0
   Speroni KG, 2014, J EMERG NURS, V40, P218, DOI 10.1016/j.jen.2013.05.014
   Texas Center for Nursing Workforce Studies, 2016, WORKPL VIOL NURS TEX
NR 30
TC 0
Z9 0
U1 4
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD APR 28
PY 2017
VL 17
AR 311
DI 10.1186/s12913-017-2258-4
PG 11
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA ET6NV
UT WOS:000400409300002
PM 28454539
OA gold
DA 2017-08-15
ER

PT J
AU Teshome, EM
   Andang'o, PEA
   Osoti, V
   Terwel, SR
   Otieno, W
   Demir, AY
   Prentice, AM
   Verhoef, H
AF Teshome, Emily M.
   Andang'o, Pauline E. A.
   Osoti, Victor
   Terwel, Sofie R.
   Otieno, Walter
   Demir, Ayse Y.
   Prentice, Andrew M.
   Verhoef, Hans
TI Daily home fortification with iron as ferrous fumarate versus NaFeEDTA:
   a randomised, placebo-controlled, non-inferiority trial in Kenyan
   children
SO BMC MEDICINE
LA English
DT Article
DE Anaemia; Child; Pre-school; Ferric sodium EDTA; Home fortification;
   Iron; Non-inferiority; Meta-analysis
ID WESTERN KENYA; SULFADOXINE-PYRIMETHAMINE; YOUNG-CHILDREN; AFRICAN
   CHILDREN; CHILDHOOD ANEMIA; INFANTS; MALARIA; SUPPLEMENTATION;
   INFLAMMATION; METAANALYSES
AB Background: We aimed to show the non-inferiority of home fortification with a daily dose of 3 mg iron in the form of iron as ferric sodium ethylenediaminetetraacetate (NaFeEDTA) compared with 12.5 mg iron as encapsulated ferrous fumarate in Kenyan children aged 12-36 months. In addition, we updated a recent meta-analysis to assess the efficacy of home fortification with iron-containing powders, with a view to examining diversity in trial results.
   Methods: We gave chemoprevention by dihydroartemisinin-piperaquine, albendazole and praziquantel to 338 afebrile children with haemoglobin concentration >= 70 g/L. We randomly allocated them to daily home fortification for 30 days with either placebo, 3 mg iron as NaFeEDTA or 12.5 mg iron as encapsulated ferrous fumarate. We assessed haemoglobin concentration (primary outcome), plasma iron markers, plasma inflammation markers and Plasmodium infection in samples collected at baseline and after 30 days of intervention. We conducted a meta-analysis of randomised controlled trials in pre-school children to assess the effect of home fortification with iron-containing powders on anaemia and haemoglobin concentration at end of intervention.
   Results: A total of 315 children completed the 30-day intervention period. At baseline, 66.9% of children had inflammation (plasma C-reactive protein concentration >5 mg/L or plasma alpha(1)-acid glycoprotein concentration >1.0 g/L); in those without inflammation, 42.5% were iron deficient. There was no evidence, either in per protocol analysis or intention-to-treat analysis, that home fortification with either of the iron interventions improved haemoglobin concentration, plasma ferritin concentration, plasma transferrin receptor concentration or erythrocyte zinc protoporphyrin-haem ratio. We also found no evidence of effect modification by iron status, anaemia status and inflammation status at baseline. In the meta-analysis, the effect on haemoglobin concentration was highly heterogeneous between trials (I-2: 84.1%; p value for test of heterogeneity: <0.0001).
   Conclusions: In this population, home fortification with either 3 mg iron as NaFeEDTA or 12.5 mg iron as encapsulated ferrous fumarate was insufficiently efficacious to assess non-inferiority of 3 mg iron as NaFeEDTA compared to 12.5 mg iron as encapsulated ferrous fumarate. Our finding of heterogeneity between trial results should stimulate subgroup analysis or meta-regression to identify population-specific factors that determine efficacy.
C1 [Teshome, Emily M.; Prentice, Andrew M.; Verhoef, Hans] MRC Unit, MRCG Keneba, Banjul, Gambia.
   [Teshome, Emily M.; Prentice, Andrew M.; Verhoef, Hans] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Heath, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
   [Andang'o, Pauline E. A.] Maseno Univ, Sch Publ Hlth & Community Dev, Maseno, Kenya.
   [Osoti, Victor] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.
   [Terwel, Sofie R.; Verhoef, Hans] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.
   [Terwel, Sofie R.; Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands.
   [Otieno, Walter] Maseno Univ, Sch Med, Maseno, Kenya.
   [Demir, Ayse Y.] Meander Med Ctr, Lab Clin Chem & Haematol, Amersfoort, Netherlands.
RP Teshome, EM (reprint author), MRC Unit, MRCG Keneba, Banjul, Gambia.; Teshome, EM (reprint author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Heath, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
EM Emily.teshome@lshtm.ac.uk
FU Sight and Life; MRC-ING
FX We gratefully acknowledge support by Sight and Life
   (http://www.sightandlife.org/), a non-profit organisation established by
   Royal DSM, through a research grant and a personal grant to ET. In
   addition, DSM Nutrition Products (Johannesburg, South Africa)
   manufactured the supplements with micronutrient powders. Micronutrients
   other than iron were included in the supplements at the request of Sight
   and Life; the funder had no further role in study design, data
   collection and analysis, preparation of the manuscript or decision to
   publish. We thank the MRC-ING for supporting the study through an
   additional personal grant to ET.
CR Abraham K, 2003, INT J VITAM NUTR RES, V73, P423, DOI 10.1024//0300-9831.73.6.423
   Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080
   Aydin-Schmidt B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-349
   Ayoya MA, 2010, AM J CLIN NUTR, V91, P1784, DOI 10.3945/ajcn.2010.29353
   Barth-Jaeggi T, 2015, MATERN CHILD NUTR, V11, P151, DOI 10.1111/mcn.12163
   Bland JM, 1996, BRIT MED J, V313, P106
   Bouhouch RR, 2016, AM J CLIN NUTR, V104, P1318, DOI 10.3945/ajcn.115.129346
   CRAMER JA, 1989, JAMA-J AM MED ASSOC, V261, P3273, DOI 10.1001/jama.261.22.3273
   D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425
   de Benoist B, 2008, WORLDWIDE PREVALENCE
   De-Regil LM, 2011, COCHRANE DB SYST REV, V9
   Desai MR, 2004, J NUTR, V134, P1167
   Desai MR, 2003, J INFECT DIS, V187, P658, DOI 10.1086/367986
   [Anonymous], 2005, EMEACPMPEWP215899
   Gera T, 2002, BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142
   Gill SK, 2009, J OBSTET GYNAECOL, V29, P594, DOI 10.1080/01443610903114527
   HALLBERG L, 1987, AM J CLIN NUTR, V45, P988
   Hurrell RF, 2003, AM J CLIN NUTR, V77, P1213
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968
   Kumar Neeta, 2009, Indian J Clin Biochem, V24, P5, DOI 10.1007/s12291-009-0002-5
   LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806
   Machado Katia Maria de Melo, 2011, Rev. Bras. Saude Mater. Infant., V11, P275, DOI 10.1590/S1519-38292011000300008
   MALVY DJM, 1992, CLIN CHEM, V38, P394
   Marquart L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-74
   Ministry of Health, 2013, KENY ANN MAL REP 201
   Ministry of Public Health and Sanitation, 2009, KEN NAT MAL STRAT PL
   Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571
   Nestel P, 1996, IRON MULTIMICRONUT S
   Okebe JU, 2011, COCHRANE DB SYST REV, V10
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   RAGLAND DR, 1992, EPIDEMIOLOGY, V3, P434, DOI 10.1097/00001648-199209000-00009
   ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611
   Salam RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S22
   Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106
   Solvell L, 1970, IRON DEFICIENCY PATH, P573
   Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7
   Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215
   Tarning J, 2012, CLIN PHARMACOL THER, V91, P497, DOI 10.1038/clpt.2011.254
   Terlouw DJ, 2004, AM J CLIN NUTR, V79, P466
   [Anonymous], 2010, GUID IND NON CLIN TR
   Van der Graaf R, 2015, INT ENCY SOCIAL BEHA, V18, P164
   Verhoef H, 2002, LANCET, V360, P908, DOI 10.1016/S0140-6736(02)11027-0
   Verhoef H, BRIT J HAEM IN PRESS
   Verhoef H, 2009, AM J CLIN NUTR, V89, P1949, DOI 10.3945/ajcn.2009.27785
   VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0
   Vrijens B, 2005, J ANTIMICROB CHEMOTH, V55, P616, DOI 10.1093/jac/dki066
   White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165
   White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9
   WHO, 2010, WORLD MALARIA REPORT 2010, P1
   WHO, 2007, WHO TECH REP SER, V935, P1
   World Health Organization, 2006, PREV CHEM HUM HELM C
   [Anonymous], 2011, WHONMHNHDMNW112
   [Anonymous], 2011, WHONMHNHDMNW111
   WHO. World Health Organization, 2009, MAL RAP DIAGN TEST P
   [Anonymous], 2015, GUID TREATM MAL, P237
   [Anonymous], 2011, US MULT MICR POW HOM
   [Anonymous], 1987, ENV HLTH CRIT 70
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053
   Wreesmann CTJ, 2014, MATERN CHILD NUTR, V10, P481, DOI 10.1111/mcn.12110
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
   Zlotkin S, 2003, B WORLD HEALTH ORGAN, V81, P108
   Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129
   Zongo I, 2015, ANTIMICROB AGENTS CH, V59, P4387, DOI 10.1128/AAC.04923-14
   [Anonymous], 2000, INT C HARM TECHN REQ
   [Anonymous], 2011, PROGRAMMATIC GUIDANC
NR 66
TC 1
Z9 1
U1 4
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD APR 28
PY 2017
VL 15
AR 89
DI 10.1186/s12916-017-0839-z
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA ET2VH
UT WOS:000400131900001
PM 28449690
OA gold
DA 2017-08-15
ER

PT J
AU Ruizendaal, E
   Tahita, MC
   Geskus, RB
   Versteeg, I
   Scott, S
   d'Alessandro, U
   Lompo, P
   Derra, K
   Traore-Coulibaly, M
   de Jong, MD
   Schallig, HDFH
   Tinto, H
   Mens, PF
AF Ruizendaal, Esmee
   Tahita, Marc C.
   Geskus, Ronald B.
   Versteeg, Inge
   Scott, Susana
   d'Alessandro, Umberto
   Lompo, Palpouguini
   Derra, Karim
   Traore-Coulibaly, Maminata
   de Jong, Menno D.
   Schallig, Henk D. F. H.
   Tinto, Halidou
   Mens, Petra F.
TI Increase in the prevalence of mutations associated with
   sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates
   collected from early to late pregnancy in Nanoro, Burkina Faso
SO MALARIA JOURNAL
LA English
DT Article
DE Plasmodium falciparum; Pregnancy; Sulfadoxine-pyrimethamine; Resistance;
   Mutations
ID INTERMITTENT PREVENTIVE TREATMENT; CHONDROITIN SULFATE-A;
   LOW-BIRTH-WEIGHT; DIHYDROFOLATE-REDUCTASE; MALARIA PARASITES; IN-VIVO;
   WOMEN; INFECTION; THERAPY; ALLELES
AB Background: Pregnant women are a high-risk group for Plasmodium falciparum infections, which may result in maternal anaemia and low birth weight newborns, among other adverse birth outcomes. Intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy (IPTp-SP) is widely implemented to prevent these negative effects of malaria. However, resistance against SP by P. falciparum may decrease efficacy of IPTp-SP. Combinations of point mutations in the dhps (codons A437, K540) and dhfr genes (codons N51, C59, S108) of P. falciparum are associated with SP resistance. In this study the prevalence of SP resistance mutations was determined among P. falciparum found in pregnant women and the general population (GP) from Nanoro, Burkina Faso and the association of IPTp-SP dosing and other variables with mutations was studied.
   Methods: Blood spots on filter papers were collected from pregnant women at their first antenatal care visit (ANC booking) and at delivery, from an ongoing trial and from the GP in a cross-sectional survey. The dhps and dhfr genes were amplified by nested PCR and products were sequenced to identify mutations conferring resistance (ANC booking, n = 400; delivery, n = 223; GP, n = 400). Prevalence was estimated with generalized estimating equations and for multivariate analyses mixed effects logistic regression was used.
   Results: The prevalence of the triple dhfr mutation was high, and significantly higher in the GP and at delivery than at ANC booking, but it did not affect birth weight. Furthermore, quintuple mutations (triple dhfr and double dhps mutations) were found for the first time in Burkina Faso. IPTp-SP did not significantly affect the occurrence of any of the mutations, but high transmission season was associated with increased mutation prevalence in delivery samples. It is unclear why the prevalence of mutations was higher in the GP than in pregnant women at ANC booking.
   Conclusion: The high number of mutants and the presence of quintuple mutants in Burkina Faso confirm concerns about the efficacy of IPTp-SP in the near future. Other drug combinations to tackle malaria in pregnancy should, therefore, be explored. An increase in mutation prevalence due to IPTp-SP dosing could not be confirmed.
C1 [Ruizendaal, Esmee; de Jong, Menno D.; Schallig, Henk D. F. H.; Mens, Petra F.] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands.
   [Tahita, Marc C.; Lompo, Palpouguini; Derra, Karim; Traore-Coulibaly, Maminata; Tinto, Halidou] IRSS, URCN, Nanoro, Burkina Faso.
   [Geskus, Ronald B.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands.
   [Geskus, Ronald B.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.
   [Versteeg, Inge] Koninklijk Inst Tropen, Amsterdam, Netherlands.
   [Scott, Susana] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Scott, Susana; d'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara, Gambia.
   [d'Alessandro, Umberto] London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, London, England.
RP Ruizendaal, E (reprint author), Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands.
EM esmee.ruizendaal@gmail.com
FU European Community's Seventh Framework Programme [305662]
FX This study was funded by European Community's Seventh Framework
   Programme under grant agreement No. 305662 (Project: Community-based
   scheduled screening and treatment of malaria in pregnancy for improved
   maternal and infant health: a cluster-randomized trial 'COSMIC').
CR Adu B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1146-4
   Agomo CO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146908
   Asih PBS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-222
   Bertin G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-196
   Bouyou-Akotet MK, 2010, J ANTIMICROB CHEMOTH, V65, P438, DOI 10.1093/jac/dkp467
   Bushman M, 2016, P ROY SOC LOND B BIO, V283
   Chauvin P, 2015, J ANTIMICROB CHEMOTH, V70, P2566, DOI 10.1093/jac/dkv160
   Chico RM, 2015, TROP MED INT HEALTH, V20, P1621, DOI 10.1111/tmi.12595
   Coulibaly SO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-41
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Desai M, 2016, CLIN INFECT DIS, V62, P323, DOI 10.1093/cid/civ881
   Diallo DA, 2007, AM J TROP MED HYG, V76, P237
   Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003
   Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274
   Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502
   Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570
   Gansane A, 2009, B SOC PATHOL EXOT, V102, P31
   Geiger C, 2014, TROP MED INT HEALTH, V19, P690, DOI 10.1111/tmi.12305
   Gutman J, 2015, J INFECT DIS, V211, P1997, DOI 10.1093/infdis/jiu836
   Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004
   Happi CT, 2005, ACTA TROP, V95, P183, DOI 10.1016/j.actatropica.2005.06.015
   Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106
   Harrington WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056183
   Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6
   Iwalokun BA, 2015, MED PRIN PRACT, V24, P436, DOI 10.1159/000430987
   Karunajeewa HA, 2009, ANTIMICROB AGENTS CH, V53, P4368, DOI 10.1128/AAC.00335-09
   Kattenberg JH, 2012, TROP MED INT HEALTH, V17, P550, DOI 10.1111/j.1365-3156.2012.02975.x
   Khalil IF, 2005, AM J TROP MED HYG, V73, P174
   Maubert B, 1999, INFECT IMMUN, V67, P5367
   McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77
   Menendez C, 2011, CLIN INFECT DIS, V52, P41, DOI 10.1093/cid/ciq049
   Minja DTR, 2013, EMERG INFECT DIS, V19, P1446, DOI 10.3201/eid1909.130133
   Mockenhaupt FP, 1999, AM J TROP MED HYG, V61, P375
   Mockenhaupt FP, 2008, J INFECT DIS, V198, P1545, DOI 10.1086/592455
   Moussiliou A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-195
   Naidoo I, 2011, PARASITOLOGY, V138, P1469, DOI 10.1017/S0031182011000746
   Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160
   Raman J, 2010, AM J TROP MED HYG, V82, P788, DOI 10.4269/ajtmh.2010.09-0401
   Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1
   Ryg-Cornejo V, 2016, PARASITOLOGY, V143, P199, DOI 10.1017/S0031182015001705
   Scott S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-340
   Tahita MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137440
   Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004
   Wargo AR, 2007, P NATL ACAD SCI USA, V104, P19914, DOI 10.1073/pnas.0707766104
   World Health Organization, 2015, WORLD MAL REP 2015
   WHO, 2004, STRAT FRAM MAL PREV
   World Health Organization, 2013, POL BRIEF IMPL INT P
NR 47
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD APR 26
PY 2017
VL 16
AR 179
DI 10.1186/s12936-017-1831-y
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EW0UZ
UT WOS:000402208000006
PM 28454537
OA gold
DA 2017-08-15
ER

PT J
AU Whittaker, E
   Nicol, M
   Zar, HJ
   Kampmann, B
AF Whittaker, Elizabeth
   Nicol, Mark
   Zar, Heather J.
   Kampmann, Beate
TI Regulatory T Cells and Pro-inflammatory Responses Predominate in
   children with Tuberculosis
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE tuberculosis; extrapulmonary; pediatric; mycobacterial immunity;
   regulatory T cells
ID ACTIVE PULMONARY TUBERCULOSIS; CALMETTE-GUERIN VACCINATION;
   MYCOBACTERIUM-BOVIS BCG; EXTRAPULMONARY TUBERCULOSIS; INTERFERON-GAMMA;
   IMMUNE-RESPONSE; IFN-GAMMA; CYTOKINE; DISEASE; BLOOD
AB Background: Following infection with Mycobacterium tuberculosis (M.tb), children are more susceptible to develop disease particularly extrapulmonary disease than adults. The exact mechanisms required for containment of M.tb are not known, but would be important to identify correlates of protection.
   Objective: To comprehensively analyze key immune responses to mycobacteria between HIV-negative children with extrapulmonary TB (EPTB) compared to children with pulmonary TB (PTB) or healthy controls.
   Methods: Whole blood was stimulated in vitro with mycobacteria for 24 h or 6 days to induce effector and memory responses. CD4, CD8,gamma delta, regulatory T cells, and their related cytokines were measured. Samples of children with tuberculosis (TB) disease were analyzed both at time of diagnosis and at the end of TB treatment to determine if any differences were due to TB disease or an underlying host phenotype.
   Results: Seventy-six children with TB disease (48 with PTB and 28 with EPTB) and 83 healthy controls were recruited to the study. The frequency of CD4(+) CD25(+) CD39(+) FOXP3(+) regulatory T cells and secreted IL10 were significantly higher in children with TB compared to healthy controls. IFN gamma-, IL17-, and IL22-producing gamma delta T cells, IL22-producing CD4(+) T cells and secreted pro-inflammatory cytokines (IFN gamma, IL1 beta, and TNF alpha) were significantly lower in children with TB disease compared to healthy controls. IFN gamma- producing CD4(+) T cells and Ki67(+)-proliferating CD4(+) T cells, however, were present in equal numbers in both groups. Following treatment, these immune parameters recovered to "healthy" levels or greater in children with PTB, but not those with extrapulmonary TB.
   Conclusion: In children with TB disease, a predominantly immune regulatory state is present. These immune findings do not distinguish between children with PTB and EPTB at the time of diagnosis. Following treatment, these inflammatory responses recover in PTB, suggesting that the effect is disease specific rather than due to an underlying host defect.
C1 [Whittaker, Elizabeth; Kampmann, Beate] Imperial Coll London, Acad Dept Paediat, London, England.
   [Whittaker, Elizabeth; Nicol, Mark] Inst Infect Dis & Mol Med, UCT Fac Hlth Sci, Div Med Microbiol, Dept Clin Lab Sci, Cape Town, South Africa.
   [Zar, Heather J.] Univ Cape Town, MRC Unit Child & Adolescent Hlth, Cape Town, South Africa.
   [Zar, Heather J.] Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa.
   [Kampmann, Beate] MRC Unit Gambia, Vaccines & Immun Theme, Fajara, Gambia.
RP Whittaker, E (reprint author), Imperial Coll London, Acad Dept Paediat, London, England.; Whittaker, E (reprint author), Inst Infect Dis & Mol Med, UCT Fac Hlth Sci, Div Med Microbiol, Dept Clin Lab Sci, Cape Town, South Africa.
EM e.whittaker@imperial.ac.uk
OI Whittaker, Elizabeth/0000-0002-7944-8793
FU Wellcome Trust Research Training Fellowship Grant [090208]; NIH
   [R01HD058971]; National Health Laboratory Services Research Trust;
   Medical Research Council of South Africa; National Research Foundation,
   South Africa; MRC/DFID UK [MR/K011944/1]
FX Supported by a Wellcome Trust Research Training Fellowship Grant 090208
   (EW), NIH (R01HD058971), the National Health Laboratory Services
   Research Trust, the Medical Research Council of South Africa, and the
   National Research Foundation, South Africa (HZ/MN) and the MRC/DFID UK
   MR/K011944/1(BK).
CR Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630
   Chiacchio T, 2009, CLIN EXP IMMUNOL, V156, P463, DOI 10.1111/j.1365-2249.2009.03908.x
   Cruz A, 2006, J IMMUNOL, V177, P1416
   Cruz AT, 2007, PAEDIATR RESPIR REV, V8, P107, DOI 10.1016/j.prrv.2007.04.008
   de Almeida AS, 2012, CLIN VACCINE IMMUNOL, V19, P45, DOI 10.1128/CVI.05263-11
   de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10
   Dieli F, 2002, J INFECT DIS, V186, P1835, DOI 10.1086/345766
   Fiske CT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-16
   Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881
   Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC
   Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010
   Hanekom WA, 2005, ANN NY ACAD SCI, V1062, P69, DOI 10.1196/annals.1358.010
   Hasan Z, 2009, SCAND J IMMUNOL, V69, P259, DOI 10.1111/j.1365-3083.2008.02217.x
   Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114
   Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC
   Jones C, 2011, PAEDIATR RESPIR REV, V12, P3, DOI 10.1016/j.prrv.2010.09.006
   Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI [10.1164/rccm.201003-0334OC, 10.1164/rrcm.201003-0334OC]
   Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449
   Kumar NP, 2011, CLIN VACCINE IMMUNOL, V18, P1856, DOI 10.1128/CVI.05366-11
   Marais BJ, 2011, INDIAN J PEDIATR, V78, P321, DOI 10.1007/s12098-010-0353-1
   Matthews K, 2011, TUBERCULOSIS, V91, P587, DOI 10.1016/j.tube.2011.06.009
   Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019
   Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25
   Priya VHS, 2009, CLIN VACCINE IMMUNOL, V16, P111, DOI 10.1128/CVI.00243-08
   Roy RB, 2012, CURR OPIN INFECT DIS, V25, P250, DOI 10.1097/QCO.0b013e3283529af9
   Scriba TJ, 2008, J IMMUNOL, V180, P1962
   Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886
   Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007
   Soares AP, 2008, J IMMUNOL, V180, P3569
   Sterling TR, 2001, CLIN INFECT DIS, V33, P976, DOI 10.1086/322670
   Swaminathan S, 1999, CLIN INFECT DIS, V28, P1290, DOI 10.1086/514794
   Torres M, 1998, INFECT IMMUN, V66, P176
   Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1
   Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110
   WHO Publication, 2016, GLOBAL TUBERCULOSIS, P1
   WILSON CB, 1986, J CLIN INVEST, V77, P860, DOI 10.1172/JCI112383
   Yao SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000789
   Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1
NR 40
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 25
PY 2017
VL 8
AR 448
DI 10.3389/fimmu.2017.00448
PG 11
WC Immunology
SC Immunology
GA ET5GM
UT WOS:000400312200002
PM 28487695
OA gold
DA 2017-08-15
ER

PT J
AU Hennig, BJ
   Unger, SA
   Dondeh, BL
   Hassan, J
   Hawkesworth, S
   Jarjou, L
   Jones, KS
   Moore, SE
   Nabwera, HM
   Ngum, M
   Prentice, A
   Sonko, B
   Prentice, AM
   Fulford, AJ
AF Hennig, Branwen J.
   Unger, Stefan A.
   Dondeh, Bai Lamin
   Hassan, Jahid
   Hawkesworth, Sophie
   Jarjou, Landing
   Jones, Kerry S.
   Moore, Sophie E.
   Nabwera, Helen M.
   Ngum, Mohammed
   Prentice, Ann
   Sonko, Bakary
   Prentice, Andrew M.
   Fulford, Anthony J.
TI Cohort Profile: The Kiang West Longitudinal Population Study (KWLPS)-a
   platform for integrated research and health care provision in rural
   Gambia
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
ID CALCIUM-CARBONATE SUPPLEMENTATION; BIRTH-WEIGHT; VILLAGES; GROWTH;
   MORTALITY; CHILDREN; SEASON; INFLAMMATION; VACCINATION; NUTRITION
C1 [Hennig, Branwen J.; Unger, Stefan A.; Dondeh, Bai Lamin; Hassan, Jahid; Hawkesworth, Sophie; Jarjou, Landing; Moore, Sophie E.; Nabwera, Helen M.; Ngum, Mohammed; Prentice, Ann; Sonko, Bakary; Prentice, Andrew M.; Fulford, Anthony J.] MRC Unit Gambia, MRC Int Nutr Grp, Banjul, Gambia.
   [Hennig, Branwen J.; Hawkesworth, Sophie; Moore, Sophie E.; Prentice, Ann; Prentice, Andrew M.; Fulford, Anthony J.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Unger, Stefan A.] Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland.
   [Hawkesworth, Sophie; Jones, Kerry S.; Moore, Sophie E.; Prentice, Ann] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England.
   London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England.
RP Prentice, AM (reprint author), LSHTM, MRC Int Nutr Grp, London, England.; Prentice, AM (reprint author), MRC Unit, Keppel St, London WC1E 7HT, England.
EM Andrew.prentice@lshtm.ac.uk
FU UK Medical Research Council (MRC); UK Department for International
   Development (DFID), under the MRC/DFID [MC-A760-5QX00, U105960371,
   U123261351]
FX We thank all funders who have supported individual researchers and
   studies, as well as the infrastructure and research conducted out of MRC
   Keneba; major funding was received from the UK Medical Research Council
   (MRC) and the UK Department for International Development (DFID), under
   the MRC/DFID Concordat agreement (current grants arc MC-A760-5QX00,
   U105960371 and U123261351).
CR Alderman H, 2014, AM J CLIN NUTR, V99, P122, DOI 10.3945/ajcn.113.063404
   Atkinson SH, 2014, BLOOD, V123, P3221, DOI 10.1182/blood-2013-10-533000
   BILLEWICZ WZ, 1982, ANN HUM BIOL, V9, P309, DOI 10.1080/03014468200005811
   [Anonymous], 2009, BRIT NATL FORMULARY
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Courtiol A, 2013, CURR BIOL, V23, P884, DOI 10.1016/j.cub.2013.04.006
   Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746
   Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Jarjou LMA, 2013, AM J CLIN NUTR, V98, P723, DOI 10.3945/ajcn.113.061630
   LAMB WH, 1984, LANCET, V2, P912
   MCGREGOR IA, 1968, T ROY SOC TROP MED H, V62, P341, DOI 10.1016/0035-9203(68)90084-9
   Mendy M, 2014, PATHOBIOLOGY, V81, P252, DOI 10.1159/000362093
   Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029
   Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Moore SE, 2012, VACCINE, V30, P4842, DOI 10.1016/j.vaccine.2012.05.009
   Munro JF, 2000, MACLEODS CLIN EXAMIN
   Mwangome MK, 2012, B WORLD HEALTH ORGAN, V90, P887, DOI 10.2471/BLT.12.109009
   Poskitt EME, 1999, ARCH DIS CHILD, V80, P115
   PRENTICE AM, 1987, AM J CLIN NUTR, V46, P912
   Prentice AM, 2013, WORLD REV NUTR DIET, V106, P90, DOI 10.1159/000342563
   Prentice A, 2012, AM J CLIN NUTR, V96, P1042, DOI 10.3945/ajcn.112.037481
   Prins M, 2008, EUR J CLIN NUTR, V62, P1065, DOI 10.1038/sj.ejcn.1602830
   Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x
   Richards AA, 2013, AM J HUM BIOL, V25, P457, DOI 10.1002/ajhb.22413
   Risk R, 2013, ARCH DIS CHILD, V98, P503, DOI 10.1136/archdischild-2012-302987
   Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190
   United Nations Educational Scientific and Cultural Organization, 2011, GAMB ED COUNTR STAT
   United States Central Intelligence Agency, GAMB WORLD FACT BOOK
   Ward KA, 2014, J CLIN ENDOCR METAB, V99, P3169, DOI 10.1210/jc.2014-1150
   World Health Organization, 1990, INT CLASS DIS ICD
NR 32
TC 5
Z9 5
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD APR
PY 2017
VL 46
IS 2
AR UNSP e13
DI 10.1093/ije/dyv206
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EX1PD
UT WOS:000402996000013
PM 26559544
OA No
DA 2017-08-15
ER

PT J
AU Shah, S
   Perez, GM
AF Shah, Safieh
   Martinez Perez, Guillermo
TI On MeSH Setting Equivalences Between Female and Male Genitalia
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Article
C1 [Shah, Safieh] NGO Wassu Gambia Kafo, Banjul, Gambia.
   [Martinez Perez, Guillermo] Univ Zaragoza, Fac Hlth Sci, Dept Physiatr & Nursing, Calle Domingo Miral S-N, E-50009 Zaragoza, Spain.
RP Perez, GM (reprint author), Univ Zaragoza, Fac Hlth Sci, Dept Physiatr & Nursing, Calle Domingo Miral S-N, E-50009 Zaragoza, Spain.
EM gmartinezgabas@gmail.com
CR Heinrichs S, 2015, J CLIN ETHIC, V26, P172
   Krause E, 2011, J SEX MED, V8, P1420, DOI 10.1111/j.1743-6109.2011.02225.x
   Perez GM, 2013, J SEX MED, V10, P2605, DOI 10.1111/jsm.12264
   McDougall LJ, 2013, CULT HEALTH SEX, V15, P774, DOI 10.1080/13691058.2013.780639
   Morris K, 2006, LANCET, V368, pS64, DOI 10.1016/S0140-6736(06)69936-4
   Mowat H, 2015, WOMENS HLTH, V15, P110
   Placik OJ, 2014, AESTHET SURG J, V34, P1083, DOI 10.1177/1090820X14543514
   Vestbostad E, 2014, AFR J REPROD HEALTH, V18, P22
   Wilcher G, 2006, MED SCI LAW, V46, P349
NR 9
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD APR
PY 2017
VL 14
IS 4
BP 491
EP 492
DI 10.1016/j.jsxm.2017.02.006
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA ET8WI
UT WOS:000400583800004
PM 28284633
OA No
DA 2017-08-15
ER

PT J
AU Das, JK
   Salam, RA
   Thornburg, KL
   Prentice, AM
   Campisi, S
   Lassi, ZS
   Koletzko, B
   Bhutta, ZA
AF Das, Jai K.
   Salam, Rehana A.
   Thornburg, Kent L.
   Prentice, Andrew M.
   Campisi, Susan
   Lassi, Zohra S.
   Koletzko, Berthold
   Bhutta, Zulfiqar A.
TI Nutrition in adolescents: physiology, metabolism, and nutritional needs
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article
DE adolescent nutrition; physiology; nutritional requirements; adolescents
ID MIDDLE-INCOME COUNTRIES; LOW-BIRTH-WEIGHT; PHYSICAL-ACTIVITY; MATERNAL
   GROWTH; SYSTEMATIC ANALYSIS; CHILDHOOD OBESITY; EATING-DISORDERS;
   BODY-COMPOSITION; RISK-FACTORS; LIFE-STYLE
AB Adolescence is the period of development that begins at puberty and ends in early adulthood. Most commonly, adolescence is divided into three developmental periods: early adolescence (10-14 years of age), late adolescence (15-19 years of age), and young adulthood (20-24 years of age). Adolescence is marked by physical and sexual maturation, social and economic independence, development of identity, acquisition of skills needed to carry out adult relationships and roles, and the capacity for abstract reasoning. Adolescence is characterized by a rapid pace of growth that is second only to that of infancy. Nutrition and the adolescent transition are closely intertwined, since eating patterns and behaviors are influenced by many factors, including peer influences, parental modeling, food availability, food preferences, cost, convenience, personal and cultural beliefs, mass media, and body image. Here, we describe the physiology, metabolism, and nutritional requirements for adolescents and pregnant adolescents, as well as nutrition-related behavior and current trends in adolescent nutrition. We conclude with thoughts on the implications for nutrition interventions and priority areas that would require further investigation.
C1 [Das, Jai K.; Salam, Rehana A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan.
   [Das, Jai K.; Salam, Rehana A.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
   [Das, Jai K.; Salam, Rehana A.] Univ Adelaide, Adelaide, SA, Australia.
   [Thornburg, Kent L.] Oregon Hlth & Sci Univ, Moore Inst Nutr & Wellness, Portland, OR 97201 USA.
   [Prentice, Andrew M.] MRC Unit, Serekunda, Gambia.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Campisi, Susan; Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, 686 Bay St, Toronto, ON M6S 1S6, Canada.
   [Lassi, Zohra S.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.
   [Koletzko, Berthold] Ludwig Maximilians Univ Munchen, Munich, Germany.
   [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.
RP Bhutta, ZA (reprint author), Hosp Sick Children, Ctr Global Child Hlth, 686 Bay St, Toronto, ON M6S 1S6, Canada.
EM zulfiqar.bhutta@sickkids.ca
CR Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3
   Baker AM, 2012, ARCH GYNECOL OBSTET, V286, P1093, DOI 10.1007/s00404-012-2418-z
   BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095
   BARKER DJP, 1988, BRIT MED J, V297, P134
   Bellamy L, 2007, BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.85301.BE
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Bordini B, 2011, PEDIATR REV, V32, P281, DOI 10.1542/pir.32-7-281
   Cappa C, 2012, LANCET, V379, P2324, DOI 10.1016/S0140-6736(12)60531-5
   Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4
   Christie D, 2005, BRIT MED J, V330, P301, DOI 10.1136/bmj.330.7486.301
   Collaboration GBoDP, 2016, JAMA PEDIAT, V170, P267
   Corkins MR, 2016, MED CLIN N AM, V100, P1217, DOI 10.1016/j.mcna.2016.06.005
   Davies J, 2015, LANCET, V386, pE59, DOI 10.1016/S0140-6736(15)01119-8
   de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006
   Eckert KL, 2011, BEHAVIORAL APPROACHES TO CHRONIC DISEASE IN ADOLESCENCE: A GUIDE TO INTEGRATIVE CARE, P29, DOI 10.1007/978-0-387-87687-0_4
   Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4
   Fellmeth G. L., 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD004534.PUB3
   Fesenfeld M, 2013, VACCINE, V31, P3786, DOI 10.1016/j.vaccine.2013.06.060
   Gigante DP, 2005, J NUTR, V135, P74
   Hediger ML, 1997, ANN NY ACAD SCI, V817, P281, DOI 10.1111/j.1749-6632.1997.tb48214.x
   Heinberg L. J., 1996, ADOLESCENT NUTR ASSE, P136
   Hellerstedt W. L., 2005, GUIDELINES ADOLESCEN
   Hellerstedt W. L., 2005, GUIDELINES ADOLESCEN, P1
   Henkel D, 2011, CURRENT DRUG ABUSE R, V4, P4, DOI DOI 10.2174/1874473711104010004
   HOLLIDAY MA, 1971, PEDIATRICS, V47, P169
   Khara T., 2015, ADOLESCENT NUTR POLI
   Koplan JP, 2005, J AM DIET ASSOC, V105, P131, DOI 10.1016/j.jada.2004.11.023
   Kroke A, 2004, EUR J NUTR, V43, P45, DOI 10.1007/s00394-004-0445-7
   Lackland DT, 2000, ARCH INTERN MED, V160, P1472, DOI 10.1001/archinte.160.10.1472
   LAMPL M, 1992, SCIENCE, V258, P801, DOI 10.1126/science.1439787
   Lampl M, 2011, SLEEP, V34, P641
   Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186
   Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]
   Lundeen EA, 2014, PUBLIC HEALTH NUTR, V17, P2131, DOI 10.1017/S1368980013003017
   Mina TH, 2017, PSYCHOL MED, V47, P353, DOI 10.1017/S0033291716002452
   Mombo-Ngoma G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011783
   Moreno LA, 2008, PUBLIC HEALTH NUTR, V11, P288, DOI 10.1017/S1368980007000535
   Moreno LA, 2010, CRIT REV FOOD SCI, V50, P106, DOI 10.1080/10408390903467480
   Negrato CA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-49
   Nichols MS, 2011, INT J OBESITY, V35, P916, DOI 10.1038/ijo.2011.64
   Norgan NG, 2012, HUMAN GROWTH AND DEVELOPMENT, 2ND EDITION, P123, DOI 10.1016/B978-0-12-383882-7.00006-4
   PAHO, 2011, UND SHORT STAT OV AD
   Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019
   Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1
   Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7
   Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8
   Pigeot I, 2015, OBES REV, V16, P2, DOI 10.1111/obr.12328
   Poortvliet Eric, 2003, Forum Nutr, V56, P254
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]
   Rah JH, 2008, J NUTR, V138, P1505
   Reiches Meredith W., 2013, Evolution Medicine and Public Health, P75, DOI 10.1093/emph/eot005
   Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006
   Robeva R., 2016, PUBERTY PHYSL ABNORM, P39
   Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039
   Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x
   Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0
   Ruiz JR, 2006, AM J CLIN NUTR, V84, P299
   Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS29, DOI 10.1016/j.jadohealth.2016.06.022
   Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5
   Schneider D, 2000, SOC SCI MED, V51, P955, DOI 10.1016/S0277-9536(00)00074-5
   Schofield C, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P42
   Schofield W, 1984, HUM NUTR-CLIN NUTR, V39, P5
   SCHOLL TO, 1990, AM J CLIN NUTR, V51, P790
   SCHOLL TO, 1993, J AM COLL NUTR, V12, P101
   Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y
   Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9
   Story M., 2005, GUIDELINES ADOLESCEN, P9
   Story M., 1992, TXB ADOLESCENT MED, P75
   STROBINO DM, 1995, AM J EPIDEMIOL, V142, P504
   Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22
   Tanner JM, 1962, GROWTH ADOLESCENCE
   Teivaanmaki T, 2015, ACTA PAEDIATR, V104, P1278, DOI 10.1111/apa.13060
   Thomas RE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005188.pub2
   TIMPKA S, 2016, J AM HEART ASS, V5
   United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN DEP EC
   United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH
   Van Hecke L, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0396-4
   Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4
   Wallace JM, 2004, BIOL REPROD, V71, P1055, DOI 10.1095/biolreprod.104.030965
   Ward D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003164.pub2
   World Health Organization, 2014, WORLD HLTH STAT 2014
   World Health Organization, 2014, HLTH WORLDS AD 2 CHA
   World Health Organization, 2004, HLTH BEH SCH AG CHIL
NR 84
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0077-8923
EI 1749-6632
J9 ANN NY ACAD SCI
JI Ann. N.Y. Acad. Sci.
PD APR
PY 2017
VL 1393
IS 1
SI SI
BP 21
EP 33
DI 10.1111/nyas.13330
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET0FO
UT WOS:000399937500002
PM 28436102
OA No
DA 2017-08-15
ER

PT J
AU Bhutta, ZA
   Lassi, ZS
   Bergeron, G
   Koletzko, B
   Salam, R
   Diaz, A
   McLean, M
   Black, RE
   de Rigil, LM
   Christian, P
   Prentice, AM
   Klein, JD
   Keenan, W
   Hanson, M
AF Bhutta, Zulfiqar A.
   Lassi, Zohra S.
   Bergeron, Gilles
   Koletzko, Berthold
   Salam, Rehana
   Diaz, Angela
   McLean, Mireille
   Black, Robert E.
   de Rigil, Luz Maria
   Christian, Parul
   Prentice, Andrew M.
   Klein, Jonathan D.
   Keenan, William
   Hanson, Mark
TI Delivering an action agenda for nutrition interventions addressing
   adolescent girls and young women: priorities for implementation and
   research
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article
DE adolescents; packages; delivery platforms; nutrition
ID MIDDLE-INCOME COUNTRIES; OBESE PREGNANT-WOMEN; CHILDHOOD OBESITY;
   PHYSICAL-ACTIVITY; LIFE-STYLE; HEALTH; OUTCOMES; METAANALYSIS;
   EDUCATION; RECOMMENDATIONS
AB Adolescent nutritional behaviors are assuming considerable importance in nutrition interventions given their important relationships with medium- and long-term outcomes. This is the period when young people undergo major anatomical and physiological maturational changes in preparation for adulthood. Nutritional requirements during puberty are higher during adolescence than during the prepubertal stage and during adulthood. A significant proportion of adolescents also become parents, and hence the importance of their health and nutritional status before as well as during pregnancy has its impact on their own health, fetal well-being, and newborn health. In this paper, we describe the evidence-based nutrition recommendations and the current global guidance for nutrition actions for adolescents. Despite the limitations of available information, we believe that a range of interventions are feasible to address outcomes in this age group, although some would need to start earlier in childhood. We propose packages of preventive care and management comprising nutrition-specific and nutrition-sensitive interventions to address adolescent undernutrition, overnutrition, and micronutrient deficiencies. We discuss potential delivery platforms and strategies relevant to low-and middle-income countries. Beyond the evidence synthesis, there is a clear need to translate evidence into policy and for implementation of key recommendations and addressing knowledge gaps through prioritized research.
C1 [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada.
   [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi 74800, Pakistan.
   [Lassi, Zohra S.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.
   [Bergeron, Gilles] Sackler Inst Nutr Sci, New York, NY USA.
   [Koletzko, Berthold] Ludwig Maximilians Univ Munchen, Munich, Germany.
   [Salam, Rehana] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan.
   [Diaz, Angela] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.
   [Diaz, Angela] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.
   [McLean, Mireille] New York Acad Sci, New York, NY USA.
   [Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Global Dis Epidemiol & Control, Baltimore, MD USA.
   [de Rigil, Luz Maria] Micronutr Initiat, Ottawa, ON, Canada.
   [Christian, Parul] Bill & Melinda Gates Fdn, Womens Nutr, Seattle, WA USA.
   [Prentice, Andrew M.] MRC Unit, Serrekunda, Gambia.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Klein, Jonathan D.] Amer Acad Pediat, Global Hlth Res & Policy, Washington, DC USA.
   [Keenan, William] St Louis Univ, Div Neonatal Perinatal Med, St Louis, MO 63103 USA.
   [Hanson, Mark] Univ Southampton, Inst Dev Sci, Southampton, Hants, England.
   [Hanson, Mark] Univ Southampton, NIHR Biomed Res Ctr, Southampton, Hants, England.
   [Hanson, Mark] Southampton Univ Hosp, Southampton, Hants, England.
RP Bhutta, ZA (reprint author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi 74800, Pakistan.; Bhutta, ZA (reprint author), Hosp Sick Children, Ctr Global Child Hlth, Robert Harding Chair Global Child Hlth & Policy, Toronto, ON, Canada.
EM zulfiqar.bhutta@sickkids.ca
CR Allen L, 2006, GUIDELINES FOOD FORT
   Bay J.L., 2016, HEALTHCARE, V4, P39
   Bayer O, 2009, CLIN NUTR, V28, P122, DOI 10.1016/j.clnu.2009.01.001
   Brands B, 2014, ACTA PAEDIATR, V103, P578, DOI 10.1111/apa.12593
   Campaign A., 2016, MALNUTRITION MOST EF
   Campbell MK, 2007, ANNU REV PUBL HEALTH, V28, P213, DOI 10.1146/annurev.publhealth.28.021406
   Chattinguis S., 2016, LANCET, V387, P558
   Child Labor Public Education Project, 2016, CHILD LAB US HIST
   Colquitt J.L., 2016, COCHRANE DB SYST REV, V10
   Darnton-Hill I, 2015, NUTRIENTS, V7, P1744, DOI 10.3390/nu7031744
   de Kleijn Miriam J J, 2015, Syst Rev, V4, P109, DOI 10.1186/s13643-015-0082-7
   Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285
   Fall C, 2009, INDIAN J MED RES, V130, P593
   FAO, 2013, GUID MEAS HOUS IND D
   Flynn AC, 2016, NUTR REV, V74, P312, DOI 10.1093/nutrit/nuw005
   Forthun I., PAEDIATRICS, V138
   Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3
   Grace M, 2012, HEALTH EDUC, V112, P543, DOI 10.1108/09654281211275890
   Grant MJ, 2015, POPUL DEV REV, V41, P409, DOI 10.1111/j.1728-4457.2015.00066.x
   Guerra PH, 2016, J PEDIAT-BRAZIL, V92, P15, DOI 10.1016/j.jped.2015.06.005
   Guyon A., 2015, ESSENTIAL NUTR ACTIO
   Hanson M, 2017, LANCET DIABETES ENDO, V5, P65, DOI 10.1016/S2213-8587(16)30108-5
   Hanson MA, 2015, INT J GYNECOL OBSTET, V131, pS213, DOI 10.1016/S0020-7292(15)30023-0
   Hennegan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146985
   Hofmeyr G.J., 2014, COCHRANE DB SYST REV, V24
   Institute of Medicine, 2009, WEIGHT GAIN PREGNANC
   Ihab AN, 2013, J HEALTH POPUL NUTR, V31, P480
   Johnson W, 2016, BJOG-INT J OBSTET GY, V123, P1589, DOI 10.1111/1471-0528.13782
   Kim M, 2013, LAW SOC REV, V47, P589, DOI 10.1111/lasr.12033
   Kim SY, 2012, CURR OPIN OBSTET GYN, V24, P376, DOI 10.1097/GCO.0b013e328359f0f4
   Koletzko B, 2013, ANN NUTR METAB, V63, P311, DOI 10.1159/000358398
   KOLETZKO B, 2014, ANN NUTR METAB, V64, P141
   Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2
   Lassi ZS, 2017, ANN NY ACAD SCI, V1393, P51, DOI 10.1111/nyas.13332
   Lassi ZS, 2017, ANN NY ACAD SCI, V1393, P34, DOI 10.1111/nyas.13335
   Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S7
   Lawrence W, 2016, J HEALTH PSYCHOL, V21, P138, DOI 10.1177/1359105314523304
   Liberato SC, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20499
   Malnutrition Task Force, 2013, MALN LAT LIF PREV EA
   Martin A, 2014, COCHRANE DB SYST REV, V3
   Mavalankar D., 2016, EFFECTIVENESS NUTR I
   NHS, 2016, EV CONT COUNT
   Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1
   Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2
   Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x
   Ramos S., INTERVENTIONS PREVEN
   Robinson T, 2008, J COMMUN HEALTH, V33, P395, DOI 10.1007/s10900-008-9109-5
   Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027
   Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324
   Safdie M, 2013, SALUD PUBLICA MEXICO, V55, pS357
   Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS29, DOI 10.1016/j.jadohealth.2016.06.022
   Shackleton N, 2016, J ADOLESCENT HEALTH, V58, P382, DOI 10.1016/j.jadohealth.2015.12.017
   Levy TS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-152
   Skau JKH, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1345-x
   Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108
   Stang J, 2005, GUIDELINES ADOLESCEN, P1
   Story M., 2004, INT J BEHAV NUTR PHY, V1, P3, DOI DOI 10.1186/1479-5868-1-3
   Tarasenko Y N, 2014, Am J Health Promot, V29, pe73, DOI 10.4278/ajhp.130410-QUAN-165
   Taukobong HFG, 2016, HEALTH POLICY PLANN, V31, P1492, DOI 10.1093/heapol/czw074
   Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x
   Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012
   United Nations, 2015, SUST DEV GOALS
   United Nation Population Fund, 2013, STAT WORLD POP MOTH
   UNICEF/UNESCO, 2007, HUM RIGHTS BAS APPR
   Visram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010380
   World Health Organization, 2016, REP COMM END CHILDH
   WHO, 2016, BAL EN PROT SUPPL PR
   WHO, 1998, HLTH NUTR ESS EL HLT
   WHO, 2016, GLOB ACC ACT HLTH AD
   World Health Organization, 2012, POP BAS APPR CHILDH
   Wu GY, 2012, PAEDIATR PERINAT EP, V26, P4, DOI 10.1111/j.1365-3016.2012.01291.x
NR 71
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0077-8923
EI 1749-6632
J9 ANN NY ACAD SCI
JI Ann. N.Y. Acad. Sci.
PD APR
PY 2017
VL 1393
IS 1
SI SI
BP 61
EP 71
DI 10.1111/nyas.13352
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET0FO
UT WOS:000399937500005
PM 28436103
OA No
DA 2017-08-15
ER

PT J
AU Tanaka, A
   Johnson, JM
   Senthilkumar, K
   Akakpo, C
   Segda, Z
   Yameogo, LP
   Bassoro, I
   Lamare, DM
   Allarangaye, MD
   Gbakatchetche, H
   Bayuh, BA
   Jaiteh, F
   Bam, RK
   Dogbe, W
   Sekou, K
   Rabeson, R
   Rakotoarisoa, NM
   Kamissoko, N
   Mossi, IM
   Bakare, OS
   Mabone, FL
   Gasore, ER
   Baggie, I
   Kajiru, GJ
   Mghase, J
   Ablede, KA
   Nanfumba, D
   Saito, K
AF Tanaka, Atsuko
   Johnson, Jean-Martial
   Senthilkumar, Kalimuthu
   Akakpo, Cyriaque
   Segda, Zacharie
   Yameogo, Louis P.
   Bassoro, Ibrahim
   Lamare, Delphine Mapiemfu
   Allarangaye, Moundibaye D.
   Gbakatchetche, Henri
   Bayuh, Belay A.
   Jaiteh, Famara
   Bam, Ralph K.
   Dogbe, Wilson
   Sekou, Keita
   Rabeson, Raymond
   Rakotoarisoa, Njato M.
   Kamissoko, Nianankoro
   Mossi, Illiassou Maiga
   Bakare, Oladele S.
   Mabone, Fanny L.
   Gasore, Elie R.
   Baggie, Idriss
   Kajiru, Geophrey J.
   Mghase, Jerome
   Ablede, Komlan A.
   Nanfumba, David
   Saito, Kazuki
TI On-farm rice yield and its association with biophysical factors in
   sub-Saharan Africa
SO EUROPEAN JOURNAL OF AGRONOMY
LA English
DT Article
DE Agro-ecological zone; Oryza spp.; Production system; Sub-Saharan Africa;
   Yield variation; Water
ID IRRIGATED LOWLAND RICE; WEST-AFRICA; NORTHEAST THAILAND; INLAND VALLEY;
   SYSTEMS; MANAGEMENT; GAPS; AGRICULTURE; PROSPECTS; TANZANIA
AB Although increase in rice (Oryza spp.) production is a common objective for rice-producing countries in sub-Saharan Africa (SSA), basic information on yield and its variation at farm level is lacking. Field surveys were conducted in irrigated lowland (IL), rainfed lowland (RL), and rainfed upland (RU) rice production systems in 19 SSA countries in the 2012-2014 wet seasons. Mean yield varied widely across sites: 2.2-5.8 t/ha, 1.1-5.2 t/ha, and 1.0-2.5 t/ha in IL, RL, and RU, respectively. Rice yield levels differed between the agro-ecological zones (AEZs) with the highest yield in the semi-arid zone in IL, and in the highlands zone for RL and RU. Cluster analysis identified four groups using mean yields, coefficient of variation, and skewness of yield distribution of 42 site-production system combinations. Grouping was related to production system, AEZ, and field water condition. A high-yielding group with 5.3 t/ha mean yield and negative skewness had only four site-production system combinations. Other groups had mean yields from 1.6 to 3.5 t/ha with positive skewness. In these groups, research and development priority for lifting rice yield could be given to low-yielding IL and RL sites with large yield gaps. Raising rice yield in the humid zone irrespective of the production systems and RU across AEZs remain major challenges. Further assessment of the impact of farmers' agricultural practices on yield variation is warranted to identify potential interventions to realize further yield enhancement.(C) 2016 Elsevier B.V. All rights reserved.
C1 [Tanaka, Atsuko; Johnson, Jean-Martial; Saito, Kazuki] Africa Rice Ctr AfricaRice, 01 BP 2031, Cotonou, Benin.
   [Tanaka, Atsuko] JICA, Benin Off, Cotonou, Benin.
   [Senthilkumar, Kalimuthu] Africa Rice Ctr AfricaRice, East & Southern Africa, POB 33581, Dar Es Salaam, Tanzania.
   [Akakpo, Cyriaque] INRAB, Programme Rech Rizicole, Bohicon, Benin.
   [Segda, Zacharie] Inst Environnement & Rech Agr INERA, CNRST, Programme Riz & Riziculture, Bobo Dioulasso, Burkina Faso.
   [Yameogo, Louis P.] Univ Bonn, Bonn, Germany.
   [Bassoro, Ibrahim] IRAD, Programme Cereales, Garoua, Cameroon.
   [Lamare, Delphine Mapiemfu] IRAD, Programme Cultures Annuelles, Yaounde, Cameroon.
   [Allarangaye, Moundibaye D.] ITRAD, Programme Riz, Ndjamena, Chad.
   [Gbakatchetche, Henri] CNRA, Programme Riz, Man, Cote Ivore, Cote Ivoire.
   [Bayuh, Belay A.] EIAR, Fogera Natl Rice Res & Training Ctr, Bahir Dar, Ethiopia.
   [Jaiteh, Famara] NARI, Cereals Program, Brikama, Gambia.
   [Bam, Ralph K.] CSIR, CRI, Rice Program, Kumasi, Ghana.
   [Dogbe, Wilson] CSIR, SARI, Rice Res Dev Program, Tamale, Ghana.
   [Sekou, Keita] IRAG, Programme Riz, Kankan, Guinea.
   [Rabeson, Raymond; Rakotoarisoa, Njato M.] Ctr Natl Rech Appliquee Dev Rural FOFIFA, Dept Rech Rizicoles, Antananarivo, Madagascar.
   [Kamissoko, Nianankoro] IER, Programme Riz Irrigue, Niono, Mali.
   [Mossi, Illiassou Maiga] Univ Tillaberi, Tillaberi, Niger.
   [Bakare, Oladele S.] NCRI, Informat & Documentat, Badeggi, Nigeria.
   [Mabone, Fanny L.] INERA, Kinshasa, DEM REP CONGO.
   [Gasore, Elie R.] RAB, Kigali, Rwanda.
   [Baggie, Idriss] RARC, Soil & Crop Resource Management, Freetown, Sierra Leone.
   [Kajiru, Geophrey J.] Minist Agr Food Secur & Cooperat, Dar Es Salaam, Tanzania.
   [Mghase, Jerome] Kilombero Agr Res & Training Inst KATRIN, Private Bag, Ifakara, Tanzania.
   [Ablede, Komlan A.] ITRA, Programme Riz, Lome, Togo.
   [Nanfumba, David] NARO, Mbale, Uganda.
RP Tanaka, A (reprint author), Africa Rice Ctr AfricaRice, 01 BP 2031, Cotonou, Benin.
EM a.tanaka@cgiar.org; j.johnson@cgiar.org; k.senthilkumar@cgiar.org;
   cyriaque.akakpo@yahoo.com; zacharie.segda@yahoo.fr; ylouis5@yahoo.fr;
   ibrahimbassoro@yahoo.fr; dmapiemfulamare@yahoo.com;
   allarangaye@yahoo.fr; gdjehie@yahoo.fr; bayuhb@yahoo.com;
   famajai23@yahoo.com; ralphbam@yahoo.com; wilsondogbe@yahoo.com;
   boskoukeita@yahoo.fr; rabeson.raymond@gmail.com;
   njato.michael@gmail.com; kamissokonianankoro@yahoo.fr; imossim@yahoo.fr;
   oladelebakare@yahoo.co.uk; fanlunze@yahoo.fr; ergasore@yahoo.com;
   idribaggie@gmail.com; gjkajiru@gmail.com; jmghase@yahoo.co.uk;
   bkabled@yahoo.fr; nanfumbada@yahoo.com; k.saito@cgiar.org
FU Global Rice Science Partnership (GRiSP); International Fund for
   Agricultural Development (IFAD) under the project Strengthening Rice
   Value chains in West and Central Africa [I-R-1428-AFRICARICE]; African
   Development Bank under the project Support to Agricultural Research for
   Development of Strategic Crops in Africa [2100155022217]
FX This study was supported by Global Rice Science Partnership (GRiSP);
   International Fund for Agricultural Development (IFAD) under the project
   Strengthening Rice Value chains in West and Central Africa
   [I-R-1428-AFRICARICE]; and African Development Bank under the project
   Support to Agricultural Research for Development of Strategic Crops in
   Africa [2100155022217].
CR Affholder F, 2013, FIELD CROP RES, V143, P106, DOI 10.1016/j.fcr.2012.10.021
   AfricaRice, 2013, AFR RIC CTR AFRICARI
   ANDRIESSE W, 1994, NETH J AGR SCI, V42, P159
   Balasubramanian V, 2007, ADV AGRON, V94, P55, DOI 10.1016/S0065-2113(06)94002-4
   Becker M, 1999, NUTR CYCL AGROECOSYS, V53, P71
   Becker M, 2005, J PLANT NUTR SOIL SC, V168, P558, DOI 10.1002/jpln.200520504
   Becker M, 2003, J PLANT NUTR SOIL SC, V166, P61, DOI 10.1002/jpln.200390013
   Becker M, 2001, NUTR CYCL AGROECOSYS, V59, P107, DOI 10.1023/A:1017551529813
   Becker M, 2001, NUTR CYCL AGROECOSYS, V59, P119, DOI 10.1023/A:1017585328904
   Bruelle G., 2014, EXP AGR, P1
   Defoer T., 2004, International Rice Commission Newsletter, V53, P85
   de Rouw A., 1991, THESIS
   Diagne A., 2013, THESIS, P35
   Drame K. N., 2013, Realizing Africa's rice promise, P144, DOI 10.1079/9781845938123.0144
   FAO, 2015, FAOSTAT DAT
   Fischer RA, 2015, FIELD CROP RES, V182, P9, DOI 10.1016/j.fcr.2014.12.006
   Fischer T, 2014, ACIAR MONOGR SER, V158, P1
   Haefele SM, 2014, GEODERMA, V235, P250, DOI 10.1016/j.geoderma.2014.07.019
   Haefele S. M., 2013, Realizing Africa's rice promise, P250, DOI 10.1079/9781845938123.0250
   Haefele SM, 2009, FIELD CROP RES, V114, P374, DOI 10.1016/j.fcr.2009.09.007
   Haefele SM, 2006, FIELD CROP RES, V98, P39, DOI 10.1016/j.fcr.2005.12.003
   Haefele SM, 2005, PLANT SOIL, V270, P57, DOI 10.1007/s11104-004-1131-5
   Haefele SM, 2016, FIELD CROP RES, V190, P60, DOI 10.1016/j.fcr.2016.02.001
   HarvestChoice, 2009, AEZ TROP 5 CLASS
   Hochman Z, 2013, EUR J AGRON, V44, P109, DOI 10.1016/j.eja.2011.11.003
   Homma K, 2004, FIELD CROP RES, V88, P11, DOI 10.1016/j.fcr.2003.08.010
   Kajiru GJ, 1998, NUTR CYCL AGROECOSYS, V51, P163, DOI 10.1023/A:1009774316190
   Katsura K, 2008, FIELD CROP RES, V107, P1, DOI 10.1016/j.fcr.2007.12.007
   Laborte AG, 2012, EUR J AGRON, V36, P9, DOI 10.1016/j.eja.2011.08.005
   Livingston G., 2011, IFAD C NEW DIR SMALL
   Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740
   Meertens HCC, 1999, AGR ECOSYST ENVIRON, V76, P31, DOI 10.1016/S0167-8809(99)00073-0
   Nhamo N, 2014, AGR SYST, V131, P45, DOI 10.1016/j.agsy.2014.08.003
   Otsuka K, 2006, DEV ECON, V44, P107, DOI 10.1111/j.1746-1049.2006.00009.x
   Raboin LM, 2014, FIELD CROP RES, V169, P11, DOI 10.1016/j.fcr.2014.09.006
   Raes D, 2007, AGR WATER MANAGE, V89, P229, DOI 10.1016/j.agwat.2007.01.005
   Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989
   Rodenburg J, 2009, ADV AGRON, V103, P149, DOI 10.1016/S0065-2113(09)03004-1
   Sadras V. O., 2015, FAO WATER REPORTS
   Saito K., 2013, Realizing Africa's rice promise, P188, DOI 10.1079/9781845938123.0188
   Saito K, 2006, GEODERMA, V136, P64, DOI 10.1016/j.geoderma.2006.02.003
   Saito K, 2015, GLOB FOOD SECUR-AGR, V5, P62, DOI 10.1016/j.gfs.2014.10.006
   SAS, 2013, SAS STAT SOFTW VERS
   Seck P. A., 2013, Realizing Africa's rice promise, P24, DOI 10.1079/9781845938123.0024
   Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1
   Stuart AM, 2016, FIELD CROP RES, V194, P43, DOI 10.1016/j.fcr.2016.04.039
   Tanaka A, 2015, FIELD CROP RES, V176, P99, DOI 10.1016/j.fcr.2015.02.020
   Tanaka A, 2013, EUR J AGRON, V44, P46, DOI 10.1016/j.eja.2012.08.002
   van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009
   van Oort PAJ, 2015, GLOB FOOD SECUR-AGR, V5, P39, DOI [10.1016/j.gis.2015.01.002, 10.1016/j.gfs.2015.01.002]
   Wopereis MCS, 1999, FIELD CROP RES, V61, P125, DOI 10.1016/S0378-4290(98)00154-3
   Worou ON, 2013, AGR WATER MANAGE, V126, P119, DOI 10.1016/j.agwat.2013.04.007
   You LZ, 2009, AGR SYST, V99, P126, DOI 10.1016/j.agsy.2008.11.003
   Zandstra H.G., 1981, P NATL ACAD SCI USA, V101, P9971
NR 54
TC 1
Z9 1
U1 14
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1161-0301
EI 1873-7331
J9 EUR J AGRON
JI Eur. J. Agron.
PD APR
PY 2017
VL 85
BP 1
EP 11
DI 10.1016/j.eja.2016.12.010
PG 11
WC Agronomy
SC Agriculture
GA ER5XH
UT WOS:000398877100001
OA No
DA 2017-08-15
ER

PT J
AU Johnson, W
   Darboe, MK
   Sosseh, F
   Nshe, P
   Prentice, AM
   Moore, SE
AF Johnson, William
   Darboe, Momodou K.
   Sosseh, Fatou
   Nshe, Patrick
   Prentice, Andrew M.
   Moore, Sophie E.
TI Association of prenatal lipid-based nutritional supplementation with
   fetal growth in rural Gambia
SO MATERNAL AND CHILD NUTRITION
LA English
DT Article
DE fetal growth; gestational weight gain; lipid-based nutritional
   supplement; randomized control trial; seasonality; The Gambia
ID MIDDLE-INCOME COUNTRIES; RANDOMIZED CONTROLLED-TRIAL;
   FOR-GESTATIONAL-AGE; NUTRIENT SUPPLEMENT; MATERNAL NUTRITION;
   BIRTH-WEIGHT; INTERGROWTH-21ST PROJECT; INTERNATIONAL STANDARDS;
   PREGNANT-WOMEN; PRETERM BIRTH
AB Prenatal supplementation with protein-energy (PE) and/or multiple-micronutrients (MMNs) may improve fetal growth, but trials of lipid-based nutritional supplements (LNSs) have reported inconsistent results. We conducted a post-hoc analysis of non-primary outcomes in a trial in Gambia, with the aim to test the associations of LNS with fetal growth and explore how efficacy varies depending on nutritional status. The sample comprised 620 pregnant women in an individually randomized, partially blinded trial with four arms: (a) iron and folic acid (FeFol) tablet (usual care, referent group), (b) MMN tablet, (c) PE LNS, and (d) PE + MMN LNS. Analysis of variance examined unadjusted differences in fetal biometry z-scores at 20 and 30 weeks and neonatal anthropometry z-scores, while regression tested for modification of intervention-outcome associations by season and maternal height, body mass index, and weight gain. Despite evidence of between-arm differences in some fetal biometry, z-scores at birth were not greater in the intervention arms than the FeFol arm (e.g., birth weight z-scores: FeFol -0.71, MMN -0.63, PE -0.64, PE + MMN -0.62; group-wise p=.796). In regression analyses, intervention associations with birth weight and head circumference were modified by maternal weight gain between booking and 30 weeks gestation (e.g., PE+MMN associations with birth weight were +0.462 z-scores (95% CI [0.097, 0.826]) in the highest quartile of weight gain but -0.099 z-scores (-0.459, 0.260) in the lowest). In conclusion, we found no strong evidence that a prenatal LNS intervention was associated with better fetal growth in the whole sample.
C1 [Johnson, William; Moore, Sophie E.] MRC Human Nutr Res, Cambridge, England.
   [Darboe, Momodou K.; Sosseh, Fatou; Nshe, Patrick; Prentice, Andrew M.] MRC Int Nutr Grp, MRC Unit Gambia, Banjul, Gambia.
RP Johnson, W (reprint author), MRC Human Nutr Res, Cambridge, England.
EM w.o.johnson@lboro.ac.uk
FU UK Medical Research Council (MRC) [MC-A760-5QX00]; UK Department for
   International Development (DFID) under the MRC/DFID Concordat; UK MRC
   programme [MC_UP_1005/1]
FX This trial is supported by the UK Medical Research Council (MRC)
   (MC-A760-5QX00) and the UK Department for International Development
   (DFID) under the MRC/DFID Concordat agreement. WJ and SEM are funded by
   the UK MRC programme MC_UP_1005/1.
CR Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8
   Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412
   Adu-Afarwuah S, 2015, AM J CLIN NUTR, V101, P835, DOI 10.3945/ajcn.114.091546
   Ashorn P, 2015, AM J CLIN NUTR, V101, P387, DOI 10.3945/ajcn.114.088617
   Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Briend A, 2010, INDIAN PEDIATR, V47, P655, DOI 10.1007/s13312-010-0094-2
   Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786
   Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109
   Fall CHD, 2009, FOOD NUTR BULL, V30, pS533
   Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x
   Haider BA, 2015, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.C2004905.PUB4
   Hennig B. J., 2015, INT J EPIDEMIOLOGY
   Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253
   Imdad A, 2012, PAEDIATR PERINAT EP, V26, P178, DOI 10.1111/j.1365-3016.2012.01308.x
   Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9
   Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004
   LECHTIG A, 1975, AM J CLIN NUTR, V28, P1223
   Meire H., 1995, BASIC ULTRASOUND
   Moore SE, 2016, J DEV ORIG HLTH DIS, V7, P123, DOI 10.1017/S2040174415007199
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Mridha MK, 2016, AM J CLIN NUTR, V103, P236, DOI 10.3945/ajcn.115.111336
   Neufeld LM, 2009, ULTRASOUND OBST GYN, V34, P387, DOI 10.1002/uog.6385
   OBRIEN GD, 1981, AM J OBSTET GYNECOL, V141, P833
   Ota E, 2015, COCHRANE DB SYST REV, V6
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   POPPITT SD, 1994, AM J OBSTET GYNECOL, V171, P118
   POPPITT SD, 1993, AM J CLIN NUTR, V57, P353
   Potdar RD, 2014, AM J CLIN NUTR, V100, P1257, DOI 10.3945/ajcn.114.084921
   PRENTICE AM, 1981, AM J CLIN NUTR, V34, P2790
   Rasmussen KM, 2010, J NUTR, V140, P402, DOI 10.3945/jn.109.114488
   Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134
   Tekeste Asayehegn, 2012, Cost Eff Resour Alloc, V10, P4, DOI 10.1186/1478-7547-10-4
   Toe LC, 2015, J NUTR, V145, P634, DOI 10.3945/jn.114.203448
   UNICEF-WHO-The World Bank Group, 2015, JOINT CHILD MALN EST
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
   Young MF, 2015, EUR J OBSTET GYN R B, V194, P223, DOI 10.1016/j.ejogrb.2015.09.018
NR 38
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1740-8695
EI 1740-8709
J9 MATERN CHILD NUTR
JI Matern. Child Nutr.
PD APR
PY 2017
VL 13
IS 2
AR UNSP e12367
DI 10.1111/mcn.12367
PG 13
WC Nutrition & Dietetics; Pediatrics
SC Nutrition & Dietetics; Pediatrics
GA EQ5IV
UT WOS:000398117200038
OA No
DA 2017-08-15
ER

PT J
AU Bojang, E
   Jafali, J
   Perreten, V
   Hart, J
   Harding-Esch, EM
   Sillah, A
   Mabey, DCW
   Holland, MJ
   Bailey, RL
   Roca, A
   Burr, SE
AF Bojang, Ebrima
   Jafali, James
   Perreten, Vincent
   Hart, John
   Harding-Esch, Emma M.
   Sillah, Ansumana
   Mabey, David C. W.
   Holland, Martin J.
   Bailey, Robin L.
   Roca, Anna
   Burr, Sarah E.
TI Short-term increase in prevalence of nasopharyngeal carriage of
   macrolide-resistant Staphylococcus aureus following mass drug
   administration with azithromycin for trachoma control
SO BMC MICROBIOLOGY
LA English
DT Article
DE Trachoma; Azithromycin; Mass drug administration; Staphylococcus aureus
   carriage; Macrolide resistance; iMLS(B); The Gambia; West Africa
ID STREPTOCOCCUS-PNEUMONIAE CARRIAGE; OCULAR CHLAMYDIA-TRACHOMATIS;
   PLASMID-BORNE ERM(T); ANTIBIOTIC-RESISTANCE; GAMBIAN VILLAGERS;
   RANDOMIZED-TRIAL; GROUP-B; COLONIZATION; CHILDREN; INFECTIONS
AB Background: Mass drug administration (MDA) with azithromycin is a corner-stone of trachoma control however it may drive the emergence of antimicrobial resistance. In a cluster-randomized trial (Clinical trial gov NCT00792922), we compared the reduction in the prevalence of active trachoma in communities that received three annual rounds of MDA to that in communities that received a single treatment round. We used the framework of this trial to carry out an opportunistic study to investigate if the increased rounds of treatment resulted in increased prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus. Three cross-sectional surveys were conducted in two villages receiving three annual rounds of MDA (3 x treatment arm). Surveys were conducted immediately before the third round of MDA (CSS-1) and at one (CSS-2) and six (CSS-3) months after MDA. The final survey also included six villages that had received only one round of MDA 30 months previously (1 x treatment arm).
   Results: In the 3 x treatment arm, a short-term increase in prevalence of S. aureus carriage was seen following MDA from 24.6% at CSS-1 to 38.6% at CSS-2 (p < 0.001). Prevalence fell to 8.8% at CSS-3 (p < 0.001). A transient increase was also seen in prevalence of carriage of azithromycin resistant (Azm(R)) strains from 8.9% at CSS-1 to 34.1% (p < 0.001) in CSS-2 and down to 7.3% (p = 0.417) in CSS-3. A similar trend was observed for prevalence of carriage of macrolide-inducible-clindamycin resistant (iMLS(B)) strains. In CSS-3, prevalence of carriage of resistant strains was higher in the 3 x treatment arm than in the 1 x treatment (Azm(R) 7.3% vs. 1.6%, p = 0.010; iMLS(B) 5.8% vs. 0.8%, p < 0.001). Macrolide resistance was attributed to the presence of msr and erm genes.
   Conclusions: Three annual rounds of MDA with azithromycin were associated with a short-term increase in both the prevalence of nasopharyngeal carriage of S. aureus and prevalence of carriage of Azm(R) and iMLS(B) S. aureus.
C1 [Bojang, Ebrima; Jafali, James; Roca, Anna; Burr, Sarah E.] MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Perreten, Vincent] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, CH-3012 Bern, Switzerland.
   [Hart, John; Harding-Esch, Emma M.; Mabey, David C. W.; Holland, Martin J.; Bailey, Robin L.; Burr, Sarah E.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England.
   [Sillah, Ansumana] Natl Eye Hlth Programe, Minist Hlth & Social Welf, Kanifing, Gambia.
   [Roca, Anna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.
RP Burr, SE (reprint author), MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.; Burr, SE (reprint author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England.
EM Sarah.Burr@lshtm.ac.uk
FU Bill and Melinda Gates Foundation [48027]; Wellcome Trust [WT093368MA]
FX This work was supported by the Bill and Melinda Gates Foundation (grant
   number 48027) and by the Wellcome Trust (grant number WT093368MA). The
   funders had no role in the study design, data collection, analysis and
   interpretation of the data, decision to publish, or preparation of the
   manuscript.
CR Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319
   Batt SL, 2003, ANTIMICROB AGENTS CH, V47, P2765, DOI 10.1128/AAC.47.9.2765-2769.2003
   Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5
   Burr SE, 2014, B WORLD HEALTH ORGAN, V92, P490, DOI 10.2471/BLT.13.133462
   Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI
   Coles CL, 2013, CLIN INFECT DIS, V56, P1519, DOI 10.1093/cid/cit137
   DiPersio LP, 2007, DIAGN MICR INFEC DIS, V57, P189, DOI 10.1016/j.diagmicrobio.2006.07.013
   DiPersio LP, 2011, DIAGN MICR INFEC DIS, V71, P217, DOI 10.1016/j.diagmicrobio.2011.07.010
   Ebruke C, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0661-3
   Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500
   Fiebelkorn KR, 2003, J CLIN MICROBIOL, V41, P4740, DOI 10.1128/JCM.41.10.4740-4744.2003
   Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414
   Gaynor BD, 2003, BRIT J OPHTHALMOL, V87, P147, DOI 10.1136/bjo.87.2.147
   Harding-Esch EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002115
   Hare KM, 2011, J MICROBIOL METH, V86, P364, DOI 10.1016/j.mimet.2011.06.016
   Haug S, 2010, CLIN INFECT DIS, V51, P571, DOI 10.1086/655697
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Hong KC, 2009, EMERG INFECT DIS, V15, P1088, DOI 10.3201/eid1507.081563
   Isendahl J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0715-9
   Keenan JD, 2011, CLIN INFECT DIS, V52, P883, DOI 10.1093/cid/cir069
   Leach AJ, 1997, CLIN INFECT DIS, V24, P356
   Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x
   Levy PY, 2013, ORTHOP TRAUMATOL-SUR, V99, P645, DOI 10.1016/j.otsr.2013.03.030
   Maher MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029407
   Marshall Caroline, 2014, BMC Res Notes, V7, P428, DOI 10.1186/1756-0500-7-428
   Matheson AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096658
   Ndip RN, 2008, J HEALTH POPUL NUTR, V26, P397
   Nurjadi D, 2014, J ANTIMICROB CHEMOTH, V69, P2361, DOI 10.1093/jac/dku174
   Papenburg J, 2009, CLIN INVEST MED, V32, pE352
   Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266
   Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06
   Regev-Yochay G, 2009, CLIN INFECT DIS, V48, P760, DOI 10.1086/597040
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   Rojo P, 2010, EXPERT REV ANTI-INFE, V8, P541, DOI [10.1586/eri.10.34, 10.1586/ERI.10.34]
   Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4
   Skalet AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000377
   Smith TC, 2012, AM J INFECT CONTROL, V40, P992, DOI 10.1016/j.ajic.2011.11.017
   Solomon AW, 2005, ANTIMICROB AGENTS CH, V49, P4804, DOI 10.1128/AAC.49.11.4804-4806.2005
   Stare D, 2011, OPHTHAL EPIDEMIOL, V18, P20, DOI 10.3109/09286586.2010.545500
   Strauss C, 2015, J MICROBIOL METH, V108, P25, DOI 10.1016/j.mimet.2014.11.006
   Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030
   Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12
   van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229
   Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348
   Waters D, 2011, J GLOB HEALTH, V2, P154
   West SK, 2014, J INFECT DIS, V210, P65, DOI 10.1093/infdis/jiu046
   World Health Organization, 1998, 3 M WHO ALL GLOB EL
   [Anonymous], 1997, 1 M WHO ALL GLOB EL
   Woodbury RL, 2008, ANTIMICROB AGENTS CH, V52, P1140, DOI 10.1128/AAC.01352-07
   [Anonymous], 2001, GAMBIA STANDARD DRUG
NR 50
TC 0
Z9 0
U1 3
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD MAR 28
PY 2017
VL 17
AR 75
DI 10.1186/s12866-017-0982-x
PG 10
WC Microbiology
SC Microbiology
GA EQ0EI
UT WOS:000397744100001
PM 28351345
OA gold
DA 2017-08-15
ER

PT J
AU Kollmann, TR
   Kampmann, B
   Mazmanian, SK
   Marchant, A
   Levy, O
AF Kollmann, Tobias R.
   Kampmann, Beate
   Mazmanian, Sarkis K.
   Marchant, Arnaud
   Levy, Ofer
TI Protecting the Newborn and Young Infant from Infectious Diseases:
   Lessons from Immune Ontogeny
SO IMMUNITY
LA English
DT Review
ID BACILLUS-CALMETTE-GUERIN; BOVINE LACTOFERRIN SUPPLEMENTATION; RANDOMIZED
   CONTROLLED-TRIAL; INVASIVE FUNGAL-INFECTIONS; RECENT THYMIC EMIGRANTS;
   BIRTH-WEIGHT INFANTS; REGULATORY T-CELLS; IFN-GAMMA PROMOTER;
   EARLY-LIFE; INNATE IMMUNITY
AB Infections in the first year of life are common and often severe. The newborn host demonstrates both quantitative and qualitative differences to the adult in nearly all aspects of immunity, which at least partially explain the increased susceptibility to infection. Here we discuss how differences in susceptibility to infection result not out of a state of immaturity, but rather reflect adaptation to the particular demands placed on the immune system in early life. We review the mechanisms underlying host defense in the very young, and discuss how specific developmentaldemands increase the risk of particular infectious diseases. In this context, wediscuss how this plasticity, i. e. the capacity to adapt to demands encountered in early life, also provides the potential to leverage protection of the young against infection and disease through a number of interventions.
C1 [Kollmann, Tobias R.] Univ British Columbia, Dept Paediat, Div Infect Dis, Vancouver, BC, Canada.
   [Kollmann, Tobias R.] BC Childrens Hosp, 938 28th Ave,A5-175, Vancouver, BC V5Z 4H4, Canada.
   [Kampmann, Beate] Imperial Coll London, Dept Paediat, Ctr Int Child Hlth, London, England.
   [Kampmann, Beate] MRC Unit Gambia, Serrekunda, Gambia.
   [Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, 1200 Calif Bl,Mailcode 156-29, Pasadena, CA 91125 USA.
   [Levy, Ofer] Boston Childrens Hosp, Dept Med, Div Infect Dis, Precis Vaccines Program, Boston, MA USA.
   [Levy, Ofer] Harvard Med Sch, Boston, MA 02115 USA.
   [Marchant, Arnaud] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Gosselies, Belgium.
RP Kollmann, TR (reprint author), Univ British Columbia, Dept Paediat, Div Infect Dis, Vancouver, BC, Canada.; Kollmann, TR (reprint author), BC Childrens Hosp, 938 28th Ave,A5-175, Vancouver, BC V5Z 4H4, Canada.; Levy, O (reprint author), Boston Childrens Hosp, Dept Med, Div Infect Dis, Precis Vaccines Program, Boston, MA USA.; Levy, O (reprint author), Harvard Med Sch, Boston, MA 02115 USA.
EM tkollm@mac.com; ofer.levy@childrens.harvard.edu
CR Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961
   Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020
   AlFaleh K., 2014, COCHRANE DB SYST REV, V4
   Ardeshir A., 2014, SCI TRANSL MED, V6
   Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427
   Arrieta M. C., 2015, SCI TRANSL MED, V7
   Barnighausen T, 2014, P NATL ACAD SCI USA, V111, P12313, DOI 10.1073/pnas.1400475111
   Battersby AJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00309
   Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708
   BEISEL WR, 1992, J NUTR, V122, P591
   Bertoletti A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00441
   Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853
   Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203
   Boer MC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00217
   Buchmann K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00459
   Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159
   Buffen K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004485
   Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535
   Bullen J, 2000, MICROBES INFECT, V2, P409, DOI 10.1016/S1286-4579(00)00326-9
   Carr R, 2000, BRIT J HAEMATOL, V110, P18, DOI 10.1046/j.1365-2141.2000.01992.x
   Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335
   Chan AC, 2013, CLIN EXP IMMUNOL, V172, P129, DOI 10.1111/cei.12045
   Chan M, 2012, LANCET, V379, P2119, DOI 10.1016/S0140-6736(12)60908-8
   Chaurasia S, 2016, LANCET GLOB HEALTH, V4, pE752
   Cheng SC, 2014, CYTOKINE GROWTH F R, V25, P707, DOI 10.1016/j.cytogfr.2014.06.008
   CHIRICO G, 1985, BIOL NEONATE, V47, P125
   Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635
   Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278
   Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052
   Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001
   Curtis N, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6091
   Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760
   Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X
   Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3
   De Kleer I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00423
   Debock I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00393
   Denkel LA, 2015, ANTIMICROB RESIST S1, V4, pO39, DOI DOI 10.1186/2047-2994-4-S1-039
   Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542
   Di Bartolomeo S, 2010, TRAFFIC, V11, P1280, DOI 10.1111/j.1600-0854.2010.01103.x
   Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x
   Dimova T, 2015, P NATL ACAD SCI USA, V112, pE556, DOI 10.1073/pnas.1412058112
   Dominguez-Bello MG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2741
   Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015
   Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7
   Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007
   Elahi S, 2006, INFECT IMMUN, V74, P2338, DOI 10.1128/IAI.74.4.2338-2352.2006
   Elahi S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00376
   Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010
   Gantt S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00387
   Gantt S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/369172
   Garcia-Vidal C, 2013, CURR OPIN INFECT DIS, V26, P270, DOI 10.1097/QCO.0b013e32835fb920
   Gervassi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107816
   Ghazal P, 2013, CURR OPIN INFECT DIS, V26, P213, DOI 10.1097/QCO.0b013e32835fb8bf
   Gomez de Aguero M, 2016, SCIENCE, V351, P1296, DOI DOI 10.1126/SCIENCE.AAD2571
   Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46
   Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43
   Hackam DJ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/475415
   Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996
   HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151
   Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7
   Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085
   Hay G, 2007, AM J CLIN NUTR, V86, P64
   Hermann E, 2002, BLOOD, V100, P2153
   Hong D. K., 2015, INFECT DIS FETUS NEW, P81
   Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836
   Hornef MW, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00474
   Hostetter MK, 2012, NEW ENGL J MED, V366, P1328, DOI 10.1056/NEJMra1111421
   Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937
   Huygens A, 2015, J INFECT DIS, V212, P484, DOI 10.1093/infdis/jiv071
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001
   Jones SA, 2005, J IMMUNOL, V175, P3463
   de Castro MJ, 2015, CLIN INFECT DIS, V60, P1611, DOI 10.1093/cid/civ144
   Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006
   Kinder JM, 2015, CELL, V162, P505, DOI 10.1016/j.cell.2015.07.006
   King AE, 2007, PLACENTA, V28, P1099, DOI 10.1016/j.placenta.2007.06.002
   Kleinnijenhuis J, 2015, T ROY SOC TROP MED H, V109, P29, DOI 10.1093/trstmh/tru168
   Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628
   KOCHAN I, 1969, J BACTERIOL, V100, P64
   Koff WC, 2016, EXPERT REV VACCINES, V15, P1235, DOI 10.1586/14760584.2016.1170600
   Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014
   Krow-Lucal ER, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00314
   Landwehr-Kenzel S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00519
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7
   Legrand D, 2016, J PEDIATR-US, V173, pS10, DOI 10.1016/j.jpeds.2016.02.071
   LEMOINE S, 2015, THE JOURNAL OF ALLER, V136, P1355
   Levine MM, 2011, VACCINE, V29, pD116, DOI 10.1016/j.vaccine.2011.11.090
   Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075
   Levy O, 2006, J IMMUNOL, V177, P1956
   Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214
   Li Q, 2009, ACTA PHARMACOL SIN, V30, P125, DOI 10.1038/aps.2008.3
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Libraty Daniel H, 2014, Trials Vaccinol, V3, P1, DOI 10.1016/j.trivac.2013.11.004
   Lindsey B, 2012, PATHOG GLOB HEALTH, V106, P137, DOI 10.1179/204777312X13462106637684
   Lindsey B, 2013, CURR OPIN INFECT DIS, V26, P248, DOI 10.1097/QCO.0b013e3283607a58
   Lissner MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132061
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625
   Lund N, 2015, CLIN INFECT DIS, V61, P1504, DOI 10.1093/cid/civ617
   MacGillivray DM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00434
   Mansbach JM, 2012, J ALLERGY CLIN IMMUN, V130, P1007, DOI 10.1016/j.jaci.2012.07.044
   Manzoni P, 2014, EARLY HUM DEV, V90, pS60, DOI 10.1016/S0378-3782(14)70020-9
   Manzoni P, 2012, PEDIATRICS, V129, P116, DOI 10.1542/peds.2011-0279
   Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403
   Marchant A, 1999, J IMMUNOL, V163, P2249
   Marchant EA, 2013, CLIN DEV IMMUNOL, V2013, DOI DOI 10.1155/2013/586076
   Marchant EA, 2015, PEDIATR RES, V78, P492, DOI 10.1038/pr.2015.132
   Marchini G, 2002, BRIT J DERMATOL, V147, P1127, DOI 10.1046/j.1365-2133.2002.05014.x
   Mascart F, 2003, J IMMUNOL, V170, P1504
   Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551
   McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110
   Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
   Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509
   Muenchhoff M., 2016, SCI TRANSL MED, V8
   Muenchhoff M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00391
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152
   Nakazawa T, 1997, IMMUNOLOGY, V92, P180, DOI 10.1046/j.1365-2567.1997.00343.x
   Netea MG, 2015, NAT IMMUNOL, V16, P445, DOI 10.1038/ni.3149
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70
   Oh DY, 2016, MOL CELL PROTEOMICS, V15, P1877, DOI 10.1074/mcp.M115.055541
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Oh JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00300
   Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328
   Oncel MY, 2014, ARCH DIS CHILD-FETAL, V99, pF110, DOI 10.1136/archdischild-2013-304745
   Oppenheimer SJ, 2001, J NUTR, V131, p616S
   Oppenheimer Stephen, 2012, Paediatr Int Child Health, V32 Suppl 2, pS21, DOI 10.1179/2046904712Z.00000000075
   Ota MOC, 2002, J IMMUNOL, V168, P919
   Pammi M, 2015, COCHRANE DB SYST REV, V2
   Pandiyan P, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00060
   Panigrahi P., 2013, PAS ANN M
   Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212
   Pettengill MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00457
   Power Coombs M. R., 2013, CLIN DEV IMMUNOL, V2013
   Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028
   Rao S., 2005, J POSTGADUATE MED, V51, pS27
   Recalcati S, 2012, SEMIN IMMUNOL, V24, P393, DOI 10.1016/j.smim.2013.01.001
   Rechavi E., 2015, SCI TRANSL MED, V7
   Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112
   Richetta C, 2013, CELL MICROBIOL, V15, P368, DOI 10.1111/cmi.12043
   Rochette L, 2015, PHARMACOL THERAPEUT, V146, P35, DOI 10.1016/j.pharmthera.2014.09.004
   Rousseau MC, 2008, PEDIAT ALLERG IMM-UK, V19, P438, DOI 10.1111/j.1399-3038.2007.00669.x
   Roy Amrita, 2014, N Am J Med Sci, V6, P50, DOI 10.4103/1947-2714.125870
   Ruchala P, 2014, TRENDS PHARMACOL SCI, V35, P155, DOI 10.1016/j.tips.2014.01.004
   Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002
   Samanta M, 2009, J TROP PEDIATRICS, V55, P128, DOI 10.1093/tropej/fmn091
   Saso A, 2016, LANCET INFECT DIS, V16, pE153, DOI 10.1016/S1473-3099(16)00119-5
   Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7
   Sepulveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099
   Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006
   Sherrid AM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/917198
   Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508
   Singh VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062845
   Sorup S, 2014, JAMA-J AM MED ASSOC, V311, P826, DOI 10.1001/jama.2014.470
   SPEER CP, 1988, PEDIATR RES, V24, P213, DOI 10.1203/00006450-198808000-00015
   Starner TD, 2005, J IMMUNOL, V174, P1608
   Strunk T, 2009, ARCH DIS CHILD-FETAL, V94, pF230, DOI 10.1136/adc.2008.143438
   Strunk T, 2015, LANCET INFECT DIS, V15, P378, DOI 10.1016/S1473-3099(15)70088-5
   STURGEON P, 1954, PEDIATRICS, V13, P107
   Szabo M, 2001, ACTA PAEDIATR, V90, P1167, DOI 10.1080/080352501317061585
   Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008
   Tian YJ, 2016, IMMUNITY, V44, P1204, DOI 10.1016/j.immuni.2016.04.008
   Tollin M, 2005, CELL MOL LIFE SCI, V62, P2390, DOI 10.1007/s00018-005-5260-7
   Tourneur E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/270301
   Travis SM, 1999, AM J RESP CELL MOL, V20, P872
   Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016
   Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290
   [Anonymous], 2014, IMM SUMM STAT REF CO
   van Haren SD, 2016, J IMMUNOL, V197, P4413, DOI 10.4049/jimmunol.1600282
   van Haren SD, 2016, CYTOKINE, V83, P99, DOI 10.1016/j.cyto.2016.04.001
   Vanden Driessche K., 2013, CLIN DEV IMMUNOL, V2013
   Vergnano S., 2005, J EXP MED, V90, pF220
   Vermijlen D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00486
   Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520
   Visscher M, 2014, ADV WOUND CARE NEW R, V3, P291, DOI DOI 10.1089/W0UND.2013.0467
   WANDER K, 2009, HUM BIOL, V21, P172, DOI DOI 10.1002/AJHB.20839
   Weiner J, 2014, J INTERN MED, V275, P467, DOI 10.1111/joim.12212
   White GP, 2002, J IMMUNOL, V168, P2820
   White GP, 2006, PEDIATR ALLERGY IMMU, V17, P557, DOI 10.1111/j.1399-3038.2006.00465.x
   Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983
   Wilcox DR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004580
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Wynn JL, 2015, J IMMUNOL, V195, P1064, DOI 10.4049/jimmunol.1500771
   Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0
   Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748
NR 189
TC 1
Z9 1
U1 5
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD MAR 21
PY 2017
VL 46
IS 3
BP 350
EP 363
DI 10.1016/j.immuni.2017.03.009
PG 14
WC Immunology
SC Immunology
GA EO6QR
UT WOS:000396818100009
PM 28329702
OA No
DA 2017-08-15
ER

PT J
AU Mira-Martinez, S
   van Schuppen, E
   Amambua-Ngwa, A
   Bottieau, E
   Affara, M
   Van Esbroeck, M
   Vlieghe, E
   Guetens, P
   Rovira-Graells, N
   Gomez-Perez, GP
   Alonso, PL
   D'Alessandro, U
   Rosanas-Urgell, A
   Cortes, A
AF Mira-Martinez, Sofia
   van Schuppen, Evi
   Amambua-Ngwa, Alfred
   Bottieau, Emmanuel
   Affara, Muna
   Van Esbroeck, Marjan
   Vlieghe, Erika
   Guetens, Pieter
   Rovira-Graells, Nuria
   Gomez-Perez, Gloria P.
   Alonso, Pedro L.
   D'Alessandro, Umberto
   Rosanas-Urgell, Anna
   Cortes, Alfred
TI Expression of the Plasmodium falciparum Clonally Variant clag3 Genes in
   Human Infections
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Malaria; Plasmodium falciparum; transcription; epigenetics; adaptation;
   bet-hedging; controlled human malarian infection (CHMI); mutually
   exclusive gene expression; transcriptional variation; clag3
ID MALARIA VACCINE DEVELOPMENT; ERYTHROCYTE INVASION; ANTIGENIC VARIATION;
   MULTIGENE FAMILY; NUTRIENT-UPTAKE; PARASITES; CHILDREN; TRANSCRIPTION;
   VOLUNTEERS; RESISTANCE
AB Background. Many genes of the malaria parasite Plasmodium falciparum show clonally variant expression regulated at the epigenetic level. These genes participate in fundamental host-parasite interactions and contribute to adaptive processes. However, little is known about their expression patterns during human infections. A peculiar case of clonally variant genes are the 2 nearly identical clag3 genes, clag3.1 and clag3.2, which mediate nutrient uptake and are linked to resistance to some toxic compounds.
   Methods. We developed a procedure to characterize the expression of clag3 genes in naturally infected patients and in experimentally infected human volunteers.
   Results. We provide the first description of clag3 expression during human infections, which revealed mutually exclusive expression and identified the gene predominantly expressed. Adaptation to culture conditions or selection with a toxic compound resulted in isolate-dependent changes in clag3 expression. We also found that clag3 expression patterns were reset during transmission stages.
   Conclusions. Different environment conditions select for parasites with different clag3 expression patterns, implying functional differences between the proteins encoded. The epigenetic memory is likely erased before parasites start infection of a new human host. Altogether, our findings support the idea that clonally variant genes facilitate the adaptation of parasite populations to changing conditions through bet-hedging strategies.
C1 [Mira-Martinez, Sofia; Bottieau, Emmanuel; Van Esbroeck, Marjan; Vlieghe, Erika; Guetens, Pieter; D'Alessandro, Umberto; Rosanas-Urgell, Anna] Inst Trop Med, Antwerp, Belgium.
   [Mira-Martinez, Sofia; van Schuppen, Evi; Rovira-Graells, Nuria; Gomez-Perez, Gloria P.; Alonso, Pedro L.; Cortes, Alfred] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.
   [Cortes, Alfred] ICREA, Barcelona, Spain.
   [Amambua-Ngwa, Alfred; Affara, Muna; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [Alonso, Pedro L.] World Hlth Org, Geneva, Switzerland.
RP Cortes, A (reprint author), CEK Bldg,C Rossello 153, Barcelona 08036, Spain.
EM arosanas@itg.be; alfred.cortes@isglobal.org
RI Cortes, Alfred/I-8134-2015
OI Cortes, Alfred/0000-0003-0730-6582
FU Spanish Ministry of Economy and Competitiveness [SAF2013-43601-R];
   European Regional Development Fund, European Union; Secretary for
   Universities and Research, Department of Economy and Knowledge,
   Government of Catalonia [2014 SGR 485]; Institute of Tropical Medicine,
   Antwerp; ISGlobal is a member of the CERCA Programme, Government of
   Catalonia; National Institute of Allergy and Infectious Diseases
   [R44AI058375]; Trans Global Health-Erasmus Mundus Joint Doctorate
   Programme, European Union; ICREA
FX This work was supported by the Spanish Ministry of Economy and
   Competitiveness (SAF2013-43601-R to A. C.), cofunded by the European
   Regional Development Fund, European Union; the Secretary for
   Universities and Research, Department of Economy and Knowledge,
   Government of Catalonia (2014 SGR 485 to A. C.); the Institute of
   Tropical Medicine, Antwerp (funding to A. R. U.); ISGlobal is a member
   of the CERCA Programme, Government of Catalonia; the National Institute
   of Allergy and Infectious Diseases (R44AI058375 to Sanaria); and the
   Trans Global Health-Erasmus Mundus Joint Doctorate Programme, European
   Union (scholarship to S. M. M.).
CR Abdi AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19882
   Bachmann A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005538
   Comeaux CA, 2011, MOL MICROBIOL, V80, P378, DOI 10.1111/j.1365-2958.2011.07572.x
   Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107
   Cortes A, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025528
   Crowley VM, 2011, MOL MICROBIOL, V80, P391, DOI 10.1111/j.1365-2958.2011.07574.x
   Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311
   Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145
   Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x
   Gomez-Perez GP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0817-x
   Gupta A, 2015, DRUG RESIST UPDATE, V18, P47, DOI 10.1016/j.drup.2014.10.004
   Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004
   Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107
   Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083
   Kaestli M, 2004, J INFECT DIS, V189, P1942, DOI 10.1086/383250
   Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109
   Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325
   Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x
   Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644
   Merrick CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118865
   Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a
   Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162
   Nguitragool W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093759
   Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002
   Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899
   Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224
   Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05
   Rovira-Graells N, 2015, NUCLEIC ACIDS RES, V43, P8243, DOI 10.1093/nar/gkv730
   Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111
   Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902
   Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134
   Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250
   Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371
   Sinden RE, 2010, HUM VACCINES, V6, P3
   Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183
   Spence PJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004987
   Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x
   Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002
   Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457
   Voss TS, 2014, CURR OPIN MICROBIOL, V20, P88, DOI 10.1016/j.mib.2014.05.007
   Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316
   Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004
NR 42
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 15
PY 2017
VL 215
IS 6
BP 938
EP 945
DI 10.1093/infdis/jix053
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EV7UE
UT WOS:000401986300016
PM 28419281
OA No
DA 2017-08-15
ER

PT J
AU Pickering, H
   Burr, SE
   Derrick, T
   Makalo, P
   Joof, H
   Hayward, RD
   Holland, MJ
AF Pickering, Harry
   Burr, Sarah E.
   Derrick, Tamsyn
   Makalo, Pateh
   Joof, Hassan
   Hayward, Richard D.
   Holland, Martin J.
TI Profiling and validation of individual and patterns of Chlamydia
   trachomatis-specific antibody responses in trachomatous trichiasis
SO PARASITES & VECTORS
LA English
DT Article
DE Chlamydia trachomatis; Trachoma; Trachomatous scarring; Trachomatous
   trichiasis; Microarray; Antibodies
ID GENOME-WIDE IDENTIFICATION; HUMORAL IMMUNE-RESPONSES; TUBAL FACTOR
   INFERTILITY; HEAT-SHOCK-PROTEIN; SCARRING TRACHOMA;
   SUBCELLULAR-LOCALIZATION; DEVELOPMENTAL CYCLE; ANTIGEN DISCOVERY;
   NATURAL-HISTORY; DRY EYE
AB Background: Ocular Chlamydia trachomatis (Ct) infection causes trachoma, the leading infectious cause of blindness. A Ct D/UW3 proteome microarray and sera from Gambian adults with trachomatous trichiasis (TT) or healthy matched controls previously identified several novel antigens, which suggested differential recognition in adults with TT.
   Methods: We re-analysed this serological microarray data using more robust microarray analysis techniques accounting for typical problems associated with highly dimensional data. We examined the Ct-specific antibody profile concerning the overall diversity of responses, antigen expression stage and cellular localisation of antigens. We tested differentially recognised antigens by further serological testing of the screened sera and used larger independent sample sets for validation.
   Results: Antibody responses identified High-Performance on antigens expressed early and late in the Ct developmental cycle and those secreted or localised to the outer membrane. Eight antigens were preferentially recognised by scarred individuals and one antigen by healthy individuals. Three of these antigens, two associated with scarring (CT667 and CT706) and one healthy-associated (CT442), were not associated with the presence or absence of scarring following specific serological testing of the arrayed sera and sera from larger, independent case-control cohorts.
   Conclusions: This study identified focussed Ct-specific antibody profiles targeting proteins expressed during entry and exit from cells and localised to interact with the host. A small panel of antibody responses could discriminate between adults with and without TT in a trachoma-endemic community. Heterogenous responses in the independent validation of these antibody targets highlighted the need for large sample sizes, clearly defined clinical phenotypes and follow-up work.
C1 [Pickering, Harry; Derrick, Tamsyn; Holland, Martin J.] London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London, England.
   [Burr, Sarah E.; Makalo, Pateh; Joof, Hassan] MRC, Dis Control & Eliminat Theme, Gambia Unit, Fajara, Banjul, Gambia.
   [Hayward, Richard D.] Birkbeck & Univ Coll London, Inst Struct & Mol Biol, Malet St, London, England.
RP Pickering, H (reprint author), London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London, England.
EM harry.pickering@lshtm.ac.uk
FU Wellcome Trust [GR079246MA]; Bloomsbury Colleges Studentship Programme
FX This work was supported by a programme grant from the Wellcome Trust
   (GR079246MA). HP was funded by the Bloomsbury Colleges Studentship
   Programme.
CR Bartolini E, 2013, J EXTRACELL VESICLES, V2, P2
   Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100
   Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07
   Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326
   Burton MJ, 2007, INVEST OPHTH VIS SCI, V48, P4440, DOI 10.1167/iovs.07-0315
   Burton MJ, 2011, INFECT IMMUN, V79, P499, DOI 10.1128/IAI.00888-10
   Burton MJ, 2006, INVEST OPHTH VIS SCI, V47, P847, DOI 10.1167/iovs.05-0714
   Burton MJ, 2006, CLIN INFECT DIS, V42, P463, DOI 10.1086/499814
   Coler RN, 2009, FEMS IMMUNOL MED MIC, V55, P258, DOI 10.1111/j.1574-695X.2008.00527.x
   Conway DJ, 1997, INFECT IMMUN, V65, P1003
   Conway DJ, 1996, J INFECT DIS, V174, P643
   Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102
   Derrick T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002117
   Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194
   Finco O, 2011, P NATL ACAD SCI USA, V108, P9969, DOI 10.1073/pnas.1101756108
   Goldberg T, 2014, NUCLEIC ACIDS RES, V42, pW350, DOI 10.1093/nar/gku396
   Goodhew EB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001873
   Gotelli N. J., 2013, ENCY BIODIVERSITY, P195, DOI DOI 10.1016/B978-0-12-384719-5.00424-X
   GRAYSTON JT, 1985, REV INFECT DIS, V7, P717
   Guzey M, 2001, EYE, V15, P297
   Hessel T, 2001, INFECT IMMUN, V69, P4996, DOI 10.1128/IAI.69.8.4996-5000.2001
   HOLLAND MJ, 1993, J INFECT DIS, V168, P1528
   Hu VH, 2011, INVEST OPHTH VIS SCI, V52, P2181, DOI 10.1167/iovs.10-5829
   Kroll TC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e50
   Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107
   Liang L, 2015, CURR OPIN INFECT DIS, V28, P438, DOI 10.1097/QCO.0000000000000193
   Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09
   Lu CX, 2012, INVEST OPHTH VIS SCI, V53, P2551, DOI 10.1167/iovs.11-9212
   Lucena A, 2012, ARQ BRAS OFTALMOL, V75, P420, DOI 10.1590/S0004-27492012000600010
   Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1
   MABEY DCW, 1992, EPIDEMIOL INFECT, V108, P343
   Magurran A. E., 2004, MEASURING BIOL DIVER, P256
   Migchelsen SJ, 2016, PLOS NTDS, V11
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003
   Peeling RW, 1998, J INFECT DIS, V177, P256, DOI 10.1086/517367
   Rahman KS, 2015, CLIN VACCINE IMMUNOL, V22, P539, DOI 10.1128/CVI.00102-15
   Ramadhani AM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004859
   Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006
   Silverstein AM., 1973, INVEST OPHTHALMOL, V13, P560
   Skwor T, 2010, INVEST OPHTH VIS SCI, V51, P5128, DOI 10.1167/iovs.09-5113
   Spedding L., 2009, THESIS, P116
   Starnbach MN, 2003, J IMMUNOL, V171, P4742
   Stekel D., 2003, MICROARRAY BIOINFORM, P280
   TAYLOR HR, 1992, AM J TROP MED HYG, V46, P552
   Teng A, 2012, J PROTEOMICS, V77, P176, DOI 10.1016/j.jprot.2012.08.017
   Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.M111.007948
   Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240
   WARD M, 1990, SCAND J INFECT DIS, P137
   Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09
   Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
NR 54
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 13
PY 2017
VL 10
AR 143
DI 10.1186/s13071-017-2078-8
PG 12
WC Parasitology
SC Parasitology
GA EO7VT
UT WOS:000396898900002
PM 28288672
OA gold
DA 2017-08-15
ER

PT J
AU Jobe, M
   Agbla, SC
   Prentice, AM
   Hennig, BJ
AF Jobe, Modou
   Agbla, Schadrac C.
   Prentice, Andrew M.
   Hennig, Branwen J.
TI High blood pressure and associated risk factors as indicator of
   preclinical hypertension in rural West Africa A focus on children and
   adolescents in The Gambia
SO MEDICINE
LA English
DT Article
DE adolescents; gambia; high blood pressure; population prevalence;
   pre-clinicalhypertension; risk factors; west Africa
ID SUB-SAHARAN AFRICA; NONCOMMUNICABLE DISEASES; CENTILE CURVES;
   PREVALENCE; CHILDHOOD; COUNTRIES; TRACKING; NIGERIA; GHANA; AGE
AB Hypertension is fast becoming a major public health problem across sub-Saharan Africa. We sought to determine the prevalence of high blood pressure (BP) and associated risk factors as indicator of preclinical hypertension in a rural Gambian population.
   We analyzed data on 6160 healthy Gambians cross-sectionally. Attention was given to 5 to <18-year olds (N=3637), as data from sub-Saharan Africa on this young age group are scarce. High BP was defined as systolic blood pressure (SBP) above the 95th percentile for age-sex specific height z scores in <18-year olds employing population-specific reference values. Standard high BP categories were applied to =18-year olds.
   In <18-year olds, the multivariable analysis gave an adjusted high BP prevalence ratio of 0.95 (95% confidence interval [CI] 0.92-0.98; P=0.002) for age and 1.13 (95% CI 1.06-1.19; P<0.0001) for weight-for-height z score (zWT-HT); sex and hemoglobin were not shown to affect high BP. In adults age 1.05 (95% CI 1.04-1.05; P<0.0001), body mass index z score 1.28 (95% CI 1.16-1.40; P<0.0001), hemoglobin 0.90 (95% CI 0.85-0.96; P<0.0001) and high fasting glucose 2.60 (95% CI 2.02-3.36; P<0.0001, though the number was very low) were confirmed as risk factors for high BP prevalence; sex was not associated.
   The reported high BP prevalence and associated risk factors in adults are comparable to other studies conducted in the region. The observed high BP prevalence of 8.2% (95% CI 7.4-9.2) in our generally lean young Gambians (<18 years) is alarming, given that high BP tracks from childhood to adulthood. Hence there is an urgent need for further investigation into risk factors of pediatric high BP/hypertension even in rural African settings.
C1 [Jobe, Modou; Prentice, Andrew M.; Hennig, Branwen J.] MRC Unit Gambia, Nutr Theme, Atlantic Blvd, Banjul, Gambia.
   [Agbla, Schadrac C.] Fac Epidemiol & Populat Hlth, Trop Epidemiol Grp, London, England.
   [Prentice, Andrew M.; Hennig, Branwen J.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, Fac Epidemiol & Populat Hlth, Keppel St, London, England.
RP Hennig, BJ (reprint author), LSHTM, MRC Unit, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
EM branwen.hennig@lshtm.ac.uk
FU UK Medical Research Council (MRC); UK Department for International
   Development (DFID) under the MRC/DFID [MC-A760-5QX00]
FX Funding for this work comes from the UK Medical Research Council (MRC)
   and the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement to the MRC International Nutrition Group
   (current grant MC-A760-5QX00).
CR Addo J, 2012, Ghana Med J, V46, P4
   Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336
   Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300
   Agyemang C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-114
   Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002
   Ataei N, 2016, J HUM HYPERTENS, V30, P268, DOI 10.1038/jhh.2015.52
   Awad M, 2014, CARDIOVASC J AFR, V25, DOI 10.5830/CVJA-2014-058
   Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10
   Bonafide CP, 2013, PEDIATRICS, V131, pE1150, DOI 10.1542/peds.2012-2443
   Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227
   Bovet P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-9
   Cole TJ, 2009, STAT MED, V28, P880, DOI 10.1002/sim.3504
   COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005
   Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050
   Essouma M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008472
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Fulford aJ, 2015, J MED GENET, P1
   Giday Araya, 2011, Ethiop Med J, V49, P139
   Goon D, 2013, IRAN J PUBLIC HEALTH, V42, P489
   Hawkesworth S, 2011, AM J CLIN NUTR, V94, p1853S, DOI 10.3945/ajcn.110.000877
   Hennig BJ, 2015, INT J EPIDEMIOL
   Hennig BJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-21
   Kagura J, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0402-z
   Khatib OMN, WHO REPORT
   Kidy F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1223
   Lane DA, 2004, J HUM HYPERTENS, V18, P223, DOI 10.1038/sj.jhh.1001674
   Martin RM, 2004, CIRCULATION, V109, P1259, DOI 10.1161/01.CIR.0000118468.76447.CE
   Mbolla BF Ellenga, 2014, C INT J HYPERTENS, V2014
   Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924
   Newson R, 2006, STATA J, V6, P309
   Okoh BA, 2012, PAEDIATR INT CHILD H, V32, P208, DOI 10.1179/2046905512Y.0000000039
   Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135
   Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861
   Roccella Edward J., 2004, Pediatrics, V114, P555
   Sande M, 2000, J HUM HYPERTENS, V14, P489
   Sola AO, 2013, J MED MED SCI, V4, P149
   SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408
   Stasinopoulos DM, 2007, J STAT SOFTW, V23
   Tiffin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012989
   Ujunwa FA, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-70
   van der Sande MAB, 2001, J HUM HYPERTENS, V15, P733, DOI 10.1038/sj.jhh.1001259
   vanderSande MAB, 1997, TROP MED INT HEALTH, V2, P1039, DOI 10.1046/j.1365-3156.1997.d01-184.x
   Walraven GEL, 2001, CLIN EXP ALLERGY, V31, P1679, DOI 10.1046/j.1365-2222.2001.01094.x
   World Health Organization (WHO), HAEM CONC DIAGN AN A
   WHO, WHO REPORT
   WHO Multicentre Growth Reference Study Group, 2006, ACTA PAEDIATR, V450, P76, DOI DOI 10.1080/08035320500495548
NR 46
TC 1
Z9 1
U1 3
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD MAR
PY 2017
VL 96
IS 13
AR e6170
DI 10.1097/MD.0000000000006170
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA ER2EK
UT WOS:000398606800003
PM 28353557
OA gold
DA 2017-08-15
ER

PT J
AU Zumla, A
   Otchere, ID
   Mensah, GI
   Asante-Poku, A
   Gehre, F
   Maeurer, M
   Bates, M
   Mwaba, P
   Ntoumi, F
   Yeboah-Manu, D
AF Zumla, Alimuddin
   Otchere, Isaac Darko
   Mensah, Gloria Ivy
   Asante-Poku, Adwoa
   Gehre, Florian
   Maeurer, Markus
   Bates, Matthew
   Mwaba, Peter
   Ntoumi, Francine
   Yeboah-Manu, Dorothy
TI Learning from epidemiological, clinical, and immunological studies on
   Mycobacterium africanum for improving current understanding of
   host-pathogen interactions, and for the development and evaluation of
   diagnostics, host-directed therapies, and vaccines for tuberculosis
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE TB; Mycobacterium africanum; Mycobacterium tuberculosis complex; Host;
   Diagnostics; Vaccines; \Africa; EDCTP
ID GENETIC DIVERSITY; WEST-AFRICA; COMPLEX; GENOME; TRANSMISSION;
   POLYMORPHISM; LINEAGE; HUMANS; GAMBIA
AB Mycobacterium africanum comprises two phylogenetic lineages within the Mycobacterium tuberculosis complex (MTBC). M. africanum was first described and isolated in 1968 from the sputum of a Senegalese patient with pulmonary tuberculosis (TB) and it has been identified increasingly as an important cause of human TB, particularly prevalent in West Africa. The restricted geographical distribution of M. africanum, in contrast to the widespread global distribution of other species of MTBC, requires explanation. Available data indicate that M. africanum may also have important differences in transmission, pathogenesis, and host-pathogen interactions, which could affect the evaluation of new TB intervention tools (diagnostics and vaccines)-those currently in use and those under development. The unequal geographical distribution and spread of MTBC species means that individual research findings from one country or region cannot be generalized across the continent. Thus, generalizing data from previous and ongoing research studies on MTBC may be inaccurate and inappropriate. A major rethink is required regarding the design and structure of future clinical trials of new interventions. The West, Central, East, and Southern African EDCTP Networks of Excellence provide opportunities to take forward these pan-Africa studies. More investments intomolecular, epidemiological, clinical, diagnostic, and immunological studies across the African continent are required to enable further understanding of host-M. africanum interactions, leading to the development of more specific diagnostics, biomarkers, host-directed therapies, and vaccines for TB. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license.
C1 [Zumla, Alimuddin; Bates, Matthew] UCL, Div Infect & Immun, Ctr Clin Microbiol, London, England.
   [Zumla, Alimuddin] UCL Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England.
   [Zumla, Alimuddin; Bates, Matthew; Mwaba, Peter] Univ Teaching Hosp, UNZA UCLMS Res & Training Program, Lusaka, Zambia.
   [Otchere, Isaac Darko; Mensah, Gloria Ivy; Asante-Poku, Adwoa; Yeboah-Manu, Dorothy] Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana.
   [Gehre, Florian] Inst Trop Med, Mycobacterial Unit, Biomed Sci, Antwerp, Belgium.
   [Gehre, Florian] Med Res Council MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
   [Maeurer, Markus] Karolinska Univ Hosp Huddinge, Dept Lab Med, Therapeut Immunol TIM Div, Stockholm, Sweden.
   [Maeurer, Markus] Karolinska Univ Hosp Huddinge, Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden.
   [Ntoumi, Francine] Marien Ngouabi Univ, Fac Sci Sante, Fdn Congolaise Rech Med, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
RP Yeboah-Manu, D (reprint author), Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana.
EM dyeboah-manu@noguchi.ug.edu.gh
FU Wellcome Trust, UK; European and Developing Countries Clinical Trials
   Partnership (EDCTP), The Hague, The Netherlands; NIHR Biomedical
   Research Centre at UCL Hospitals, London, UK
FX DYM acknowledges support from the Wellcome Trust, UK. Authors AZ, MB,
   and FN acknowledge support from the European and Developing Countries
   Clinical Trials Partnership (EDCTP), The Hague, The Netherlands. AZ
   receives support from the NIHR Biomedical Research Centre at UCL
   Hospitals, London, UK.
CR Affolabi D, 2009, EMERG INFECT DIS, V15, P1123, DOI 10.3201/eid1507.080697
   Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370
   Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552
   Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299
   Brown T, 2010, EMERG INFECT DIS, P16
   Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5
   Castets M, 1968, Rev Tuberc Pneumol (Paris), V32, P179
   Cole ST, 1998, NATURE, V393, P537
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815
   Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012
   de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977
   de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   Desmond E, 2004, EMERG INFECT DIS, V10, P921
   Frota CC, 2004, MICROBIOL-SGM, V150, P1519, DOI 10.1099/mic.0.26660-0
   Frothingham R, 1999, J CLIN MICROBIOL, V37, P1921
   FROTTIER J, 1990, B ACAD NAT MED PARIS, V174, P29
   Frottier J, 1990, B ACAD NATL MED, V174, P34
   Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103
   Gehre F, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004408
   Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023
   Gehre F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002220
   Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601
   JUNGBLUTH H, 1978, PRAX KLIN PNEUMOL, V32, P306
   Kallenius G, 1999, J CLIN MICROBIOL, V37, P3872
   Leone S, 2013, PLOS ONE, V8
   Musser JM, 2000, GENETICS, V155, P7
   Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004
   Ntoumi F, 2016, INT J INFECT DIS, V46, P34, DOI 10.1016/j.ijid.2016.03.003
   Ofori-Anyinam B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004801
   Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X
   Perez-de Pedro I, 2008, ENFERM INFEC MICR CL, V26, P600
   Schroder K H, 1982, Bull Int Union Tuberc, V57, P249
   Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869
   Tientcheu LD, 2015, GENES IMMUN, V16, P347, DOI 10.1038/gene.2015.21
   Tientcheu LD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004701
   Viana-Niero C, 2001, J CLIN MICROBIOL, V39, P57, DOI 10.1128/JCM.39.1.57-65.2001
   World Health Organization, 2016, GLOB TUB REP 2016
   Winglee K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004332
   Yeboah-Manu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161892
   Zumla A, 2015, NAT REV DRUG DISCOV, V14, P511, DOI 10.1038/nrd4696
   Zumla A, 2015, INT J INFECT DIS, V32, P46, DOI 10.1016/j.ijid.2014.12.039
   Zumla A, 2015, LANCET INFECT DIS, V15, P11, DOI 10.1016/S1473-3099(14)71034-5
NR 44
TC 2
Z9 2
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2017
VL 56
SI SI
BP 126
EP 129
DI 10.1016/j.ijid.2016.12.003
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EQ3BP
UT WOS:000397946200023
PM 27979782
OA gold
DA 2017-08-15
ER

PT J
AU Washabaugh, J
   Bernstein, R
   Secka, A
   Jeng, M
   Olaniyan, O
AF Washabaugh, J.
   Bernstein, R.
   Secka, A.
   Jeng, M.
   Olaniyan, O.
TI Milking and market hygiene practices: Quality of cow's milk in the
   Gambia
SO AMERICAN JOURNAL OF HUMAN BIOLOGY
LA English
DT Meeting Abstract
C1 [Washabaugh, J.; Bernstein, R.] Univ Colorado Boulder, Dept Anthropol, Boulder, CO USA.
   [Bernstein, R.] Univ Colorado Boulder, Inst Behav Sci, Boulder, CO USA.
   [Secka, A.] Int Trypanotolerance Ctr, Serekunda, Gambia.
FU University of Colorado Boulder: Center to Advance Research and Teaching
   in the Social Sciences (CARTSS) Graduate Student Award; M. Scott Ferris
   Endowment for Biological Anthropology; Beverly Sears Graduate Student
   Grant
FX University of Colorado Boulder: Center to Advance Research and Teaching
   in the Social Sciences (CARTSS) Graduate Student Award; M. Scott Ferris
   Endowment for Biological Anthropology; Beverly Sears Graduate Student
   Grant.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-0533
EI 1520-6300
J9 AM J HUM BIOL
JI Am. J. Hum. Biol.
PD MAR-APR
PY 2017
VL 29
IS 2
SI SI
MA P35
PG 1
WC Anthropology; Biology
SC Anthropology; Life Sciences & Biomedicine - Other Topics
GA EP5GM
UT WOS:000397407000128
OA No
DA 2017-08-15
ER

PT J
AU Tientcheu, LD
   Koch, A
   Ndengane, M
   Andoseh, G
   Kampmann, B
   Wilkinson, RJ
AF Tientcheu, Leopold D.
   Koch, Anastasia
   Ndengane, Mthawelenga
   Andoseh, Genevieve
   Kampmann, Beate
   Wilkinson, Robert J.
TI Immunological consequences of strain variation within the Mycobacterium
   tuberculosis complex
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Review
DE Adaptive and innate immunity; Genetic diversity; Host response;
   Mycobacterium tuberculosis complex; Translational implications
ID MANNOSE-BINDING LECTIN; PULMONARY TUBERCULOSIS; HUMAN MACROPHAGES;
   BEIJING GENOTYPE; CLINICAL STRAINS; IMMUNE-RESPONSE; DENDRITIC CELLS;
   VACCINE EFFICACY; SOUTH-AFRICA; CAPE-TOWN
AB In 2015, there were an estimated 10.4 million new cases of tuberculosis (TB) globally, making it one of the leading causes of death due to an infectious disease. TB is caused by members of the Mycobacterium tuberculosis complex (MTBC), with human disease resulting from infection by M. tuberculosis sensu stricto and M. africanum. Recent progress in genotyping techniques, in particular the increasing availability of whole genome sequence data, has revealed previously under appreciated levels of genetic diversity within the MTBC. Several studies have shown that this genetic diversity may translate into differences in TB transmission, clinical manifestations of disease, and host immune responses. This suggests the existence of MTBC genotype-dependent host-pathogen interactions which may influence the outcome of infection and progression of disease. In this review, we highlight the studies demonstrating differences in innate and adaptive immunological outcomes consequent on MTBC genetic diversity, and discuss how these differences in immune response might influence the development of TB vaccines, diagnostics and new therapies.
C1 [Tientcheu, Leopold D.; Kampmann, Beate] Vaccines & Immun Theme, Med Res Council Unit, Banjul, Gambia.
   [Tientcheu, Leopold D.; Andoseh, Genevieve] Univ Yaounde I, Dept Biochem, Fac Sci, Yaounde, Cameroon.
   [Koch, Anastasia; Ndengane, Mthawelenga; Wilkinson, Robert J.] Univ Cape Town, Wellcome Ctr Infect Dis Res Afr, Inst Infect Dis & Mol Med, Observatory, South Africa.
   [Koch, Anastasia; Ndengane, Mthawelenga; Wilkinson, Robert J.] Univ Cape Town, Dept Med, Observatory, South Africa.
   [Kampmann, Beate; Wilkinson, Robert J.] Imperial Coll, Dept Med, London, England.
   [Wilkinson, Robert J.] Francis Crick Inst, London, England.
RP Koch, A (reprint author), Univ Cape Town, Wellcome Ctr Infect Dis Res Afr, Inst Infect Dis & Mol Med IDM, Fac Hlth Sci, Private Bag X3, ZA-7701 Cape Town, South Africa.
EM anastasia.koch@uct.ac.za
FU Francis Crick Institute from Cancer Research UK [FC00110218]; UK Medical
   Research Council [FC00110218]; Wellcome Trust [FC00110218, 203135,
   104503]; National Institutes of Health [U01AI115940, U19 AI 111276];
   Medical Research Council of South Africa; National Research Foundation
   of South Africa [96841]; Harry Crossley Foundation; Africa Research
   Excellence Fund [MRF-157-0006-F-TIENT];  [FP7-HEALTH-F3-201-305578]
FX R.J.W. is supported by the Francis Crick Institute which receives its
   core funding from Cancer Research UK (FC00110218), the UK Medical
   Research Council (FC00110218), and the Wellcome Trust (FC00110218); by
   the Wellcome Trust (203135, 104503), National Institutes of Health
   (U01AI115940, U19 AI 111276), Medical Research Council of South Africa
   via its strategic health innovations partnerships, and National Research
   Foundation of South Africa (96841). A.K. receives support from the Harry
   Crossley Foundation and FP7-HEALTH-F3-201-305578. L.T. receives support
   from the Africa Research Excellence Fund (MRF-157-0006-F-TIENT).
CR Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x
   Adekambi T, 2015, J CLIN INVEST, V125, P3723, DOI 10.1172/JCI83279
   Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314
   Anderson ST, 2006, AM J RESP CRIT CARE, V173, P1038, DOI 10.1164/rccm.200509-1526OC
   Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bonar A, 2005, ARCH IMMUNOL THER EX, V53, P437
   Brites D, 2012, INFECT GENET EVOL, V12, P678, DOI 10.1016/j.meegid.2011.08.010
   Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299
   Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5
   Canaday DH, 2001, J IMMUNOL, V167, P2734
   Carmona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067277
   Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034
   Chen R. Y., 2014, SCI TRANSL MED, V6
   Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788
   CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179
   Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590
   Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815
   Copin R, 2014, MBIO, V5, DOI 10.1128/mBio.00960-13
   Coscolla M, 2015, CELL HOST MICROBE, V18, P538, DOI 10.1016/j.chom.2015.10.008
   Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012
   Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004
   Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575
   de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977
   de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x
   Domenech P, 2014, INFECT IMMUN, V82, P2902, DOI 10.1128/IAI.01791-14
   Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324
   Eldholm V, 2016, ELIFE, V5, DOI 10.7554/eLife.16644
   Reyes-Martinez JE, 2014, IMMUNOL INVEST, V43, P436, DOI 10.3109/08820139.2014.880120
   Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903
   Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746
   Fletcher HA, 2016, T ROY SOC TROP MED H, V110, P212, DOI 10.1093/trstmh/trw016
   Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103
   Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664
   Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797
   Gillard P, 2016, TUBERCULOSIS, V100, P118, DOI 10.1016/j.tube.2016.07.005
   Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099
   Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617
   Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166
   Hebert AM, 2007, INFECT IMMUN, V75, P5798, DOI 10.1128/IAI.00335-07
   Henao-Tamayo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136500
   Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378
   Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311
   Homolka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152200
   Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988
   Intemann CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-34
   Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577
   Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08
   Jones C, 2011, PAEDIATR RESPIR REV, V12, P3, DOI 10.1016/j.prrv.2010.09.006
   Kallenius G, 2016, TUBERCULOSIS, V96, P120, DOI 10.1016/j.tube.2015.09.005
   Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12
   Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI [10.2217/fmb.10.165, 10.2217/FMB.10.165]
   Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558
   Kiers A, 2008, INT J TUBERC LUNG D, V12, P1469
   Kim WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145234
   Kisich KO, 2002, INFECT IMMUN, V70, P4591, DOI 10.1128/IAI.70.8.4591-4599.2002
   Kleinnijenhuis J., 2011, CLIN DEV IMMUNOL, V2011
   Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870
   Loman NJ, 2015, NAT REV MICROBIOL, V13, P787, DOI 10.1038/nrmicro3565
   Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x
   Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072
   Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694
   Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004
   Manca C, 1999, J IMMUNOL, V162, P6740
   Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998
   Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097
   Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489
   Romero MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-262
   Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195
   Middelkoop K, 2009, J INFECT DIS, V200, P1207, DOI 10.1086/605930
   MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0
   Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103
   Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025
   Nicol MP, 2005, J CLIN MICROBIOL, V43, P5779, DOI 10.1128/JCM.43.11.5779-5781.2005
   O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939
   Ogarkov O, 2012, INFECT GENET EVOL, V12, P732, DOI 10.1016/j.meegid.2011.10.005
   Ordway D, 2007, J IMMUNOL, V179, P522
   Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76
   Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5
   Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307
   Rajashree P, 2008, IMMUNOBIOLOGY, V213, P567, DOI 10.1016/j.imbio.2008.01.007
   Ranjbar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002620
   Ranjbar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006116
   Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837
   Rhoads Anthony, 2015, Genomics Proteomics & Bioinformatics, V13, P278, DOI 10.1016/j.gpb.2015.08.002
   Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14
   Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886
   Rocha-Ramirez LM, 2008, TUBERCULOSIS, V88, P212, DOI 10.1016/j.tube.2007.10.003
   Romero M. M., 2012, CLIN DEV IMMUNOL, V2012
   Salie M, 2014, J INFECT DIS, V209, P216, DOI 10.1093/infdis/jit443
   Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203
   Sarkar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043170
   Schlesinger LS, 1996, J IMMUNOL, V157, P4568
   Schoepf K., 2012, ISRN VET SCI, V2012
   Scriba T. J., 2016, MICROBIOL SPECTR, P4
   Singla N, 2012, INT J IMMUNOGENET, V39, P10, DOI 10.1111/j.1744-313X.2011.01047.x
   Smet M, 2016, EUR J IMMUNOL, V46, P2149, DOI 10.1002/eji.201646357
   Smith NH, 2009, J CLIN MICROBIOL, V47, P2551, DOI 10.1128/JCM.00638-09
   Stamm CE, 2015, IMMUNOL REV, V264, P204, DOI 10.1111/imr.12263
   Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189
   Stucki D, 2016, NAT GENET, V48, P1535, DOI 10.1038/ng.3704
   Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468
   Theus SA, 2006, INFECT IMMUN, V74, P6865, DOI 10.1128/IAI.00561-06
   Thuong NTT, 2016, GENES IMMUN, V17, P419, DOI 10.1038/gene.2016.43
   Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07
   Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352
   Thye T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020908
   Tientcheu LD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004701
   Tientcheu LD, 2014, EUR J IMMUNOL, V44, P1387, DOI 10.1002/eji.201343956
   Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200
   Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614
   Tsenova L, 2007, VACCINE, V25, P5126, DOI 10.1016/j.vaccine.2006.11.024
   Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001
   van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002
   van Crevel R, 2009, J INFECT DIS, V200, P1671, DOI 10.1086/648477
   Gey van Pittius N. C., 2012, EMERG INFECT DIS, V18, P1708
   Vordermeier HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040890
   Wampande EM, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0455-z
   Wang CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011396
   Warner DF, 2015, TRENDS MICROBIOL, V23, P14, DOI 10.1016/j.tim.2014.10.005
   White MJ, 2014, GENES IMMUN, V15, P370, DOI 10.1038/gene.2014.28
   Zimmermann N., 2016, EMBO MOL MED
   Zumla A, 2015, NAT REV DRUG DISCOV, V14, P511, DOI 10.1038/nrd4696
NR 123
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD MAR
PY 2017
VL 47
IS 3
BP 432
EP 445
DI 10.1002/eji.201646562
PG 14
WC Immunology
SC Immunology
GA EP7NL
UT WOS:000397564400002
PM 28150302
OA No
DA 2017-08-15
ER

PT J
AU Sanyang, E
   Butler-Dawson, J
   Mikulski, MA
   Cook, T
   Kuye, RA
   Venzke, K
   Fuortes, LJ
AF Sanyang, Edrisa
   Butler-Dawson, Jaime
   Mikulski, Marek A.
   Cook, Thomas
   Kuye, Rex A.
   Venzke, Kristina
   Fuortes, Laurence J.
TI Environmental and occupational health needs assessment in West Africa:
   opportunities for research and training
SO INTERNATIONAL JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Occupational health; Environmental health; Needs assessment; West Africa
ID HEAVY-METAL POLLUTION; INCOME COUNTRIES; EMPLOYEE HEALTH; PUBLIC-HEALTH;
   WORK STRESS
AB Objectives Data are lacking on environmental and occupational health risks and resources available for the prevention of related diseases in the West African subregion.
   Methods A needs assessment survey was conducted to identify environmental and occupational health concerns, and needs and strategies for skills training in the region. The survey was followed by a consensus-building workshop to discuss research and training priorities with representatives from countries participating in the study.
   Results Two hundred and two respondents from 12 countries participated in the survey. Vector-borne diseases, solid waste, deforestation, surface and ground water contamination together with work-related stress, occupational injury and pesticide toxicity were ranked as top environmental and occupational health priorities, respectively, in the region. Top training priorities included occupational health, environmental toxicology and analytic laboratory techniques with semester-long Africa-based courses as the preferred type of training for the majority of the courses. Major differences were found between the subregion's three official language groups, both in perceived health risks and training courses needed.
   Conclusions The study results have implications for regional policies and practice in the area of environmental and occupational health research and training.
C1 [Sanyang, Edrisa; Kuye, Rex A.] Univ Gambia, Sch Med & Allied Hlth Sci, Dept Publ & Environm Hlth, Brikama Campus,POB 5330, Serrekunda, Gambia.
   [Sanyang, Edrisa; Butler-Dawson, Jaime; Venzke, Kristina] Univ Iowa, Dept Occupat & Environm Hlth, Coll Publ Hlth, 4261 Westlawn, Iowa City, IA 52242 USA.
   [Mikulski, Marek A.] Univ Iowa, Dept Occupat & Environm Hlth, Coll Publ Hlth, 2213 Westlawn, Iowa City, IA 52242 USA.
   [Cook, Thomas] Univ Iowa Healthcare, Ponseti Int Assoc, 118 Coll Med Adm Bldg, Iowa City, IA 52242 USA.
   [Fuortes, Laurence J.] Univ Iowa, Dept Occupat & Environm Hlth, Coll Publ Hlth, 2207 Westlawn, Iowa City, IA 52242 USA.
RP Fuortes, LJ (reprint author), Univ Iowa, Dept Occupat & Environm Hlth, Coll Publ Hlth, 2207 Westlawn, Iowa City, IA 52242 USA.
EM laurence-fuortes@uiowa.edu
FU Global Environmental and Occupational Health (GEOHealth) Projects
   [R24-TW009564, R24-TW009571]; Fogarty International Center of the
   National Institutes of Health
FX This study was part of the Global Environmental and Occupational Health
   (GEOHealth) Projects R24-TW009564 and R24-TW009571 and was funded by
   Fogarty International Center of the National Institutes of Health.
CR Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1
   Alexander KA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003652
   Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002
   Bjegovic-Mikanovic V, 2013, INT J PUBLIC HEALTH, V58, P801, DOI 10.1007/s00038-012-0425-2
   Central Intelligence Agency (CIA). The World Factbook, 2014, WORLD FACTB COUNTR C
   Economic Community of West African States, HIST ECOWAS ECOWAS 2
   Fasinu PS, 2013, ASIAN PAC J CANCER P, V14, P3393, DOI 10.7314/APJCP.2013.14.6.3393
   Ganster DC, 2013, J MANAGE, V39, P1085, DOI 10.1177/0149206313475815
   GANSTER DC, 1991, J MANAGE, V17, P235, DOI 10.1177/014920639101700202
   Laitin D, 2014, WORKING PAPER
   Mboera Leonard E G, 2014, Onderstepoort J Vet Res, V81, pE1, DOI 10.4102/ojvr.v81i2.734
   Murphy MW, 2012, EPIDEMIOL RES INT, V2012, DOI [10.1155/2012/387603, DOI 10.1155/2012/387603]
   Nweke OC, 2009, ENVIRON HEALTH PERSP, V117, P863, DOI 10.1289/ehp.0800126
   Ogri O. R., 2009, Toxicological and Environmental Chemistry, V91, P209, DOI 10.1080/02772240802098230
   Paccaud F, 2013, INT J PUBLIC HEALTH, V58, P799, DOI [10.1007/s00038-013-0508-8, 10.1007/s00038-013-0481-2]
   Pruss-Ustun A., 2006, PREVENTING DIS HLTH
   Rezaie-Boroon MH, 2011, FRESEN ENVIRON BULL, V20, P1853
   Saker L., 2004, GLOBALIZATION INFECT
   Schluep M, 2012, ECG 2012 JOINT INT C
   Siron S, 2015, INT J PUBLIC HEALTH, V60, P849, DOI 10.1007/s00038-015-0716-5
   Siziya S, 2013, OCCUP MED-OXFORD, V63, P109, DOI 10.1093/occmed/kqs201
   Vukovic D, 2014, INT J PUBLIC HEALTH, V59, P15, DOI 10.1007/s00038-013-0514-x
   [Anonymous], 2010, 1 WHO
   World Health Organization Public Health and Environment in the African Region, 2010, REP WORK WHO 2008 20
   Yabe J, 2010, J VET MED SCI, V72, P1257, DOI 10.1292/jvms.10-0058
NR 25
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1661-8556
EI 1661-8564
J9 INT J PUBLIC HEALTH
JI Int. J. Public Health
PD MAR
PY 2017
VL 62
IS 2
SI SI
BP 317
EP 325
DI 10.1007/s00038-016-0881-1
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EM0AN
UT WOS:000394981300016
PM 27592360
OA No
DA 2017-08-15
ER

PT J
AU Bok, J
   Hogerwerf, L
   Germeraad, EA
   Roest, HIJ
   Faye-Joof, T
   Jeng, M
   Nwakanma, D
   Secka, A
   Stegeman, A
   Goossens, B
   Wegmuller, R
   van der Sande, MAB
   van der Hoek, W
   Secka, O
AF Bok, Jeroen
   Hogerwerf, Lenny
   Germeraad, Eveline A.
   Roest, Hendrik I. J.
   Faye-Joof, Tisbeh
   Jeng, Momodou
   Nwakanma, Davis
   Secka, Arss
   Stegeman, Arjan
   Goossens, Bart
   Wegmueller, Rita
   van der Sande, Marianne A. B.
   van der Hoek, Wim
   Secka, Ousman
TI Coxiella burnetii (Q fever) prevalence in associated populations of
   humans and small ruminants in The Gambia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Q fever; Gambia; seroepidemiologic studies; humans; goats; sheep
ID OUTBREAK; GOATS; SHEEP
AB ObjectivesTo simultaneously estimate the prevalence of antibodies against Coxiella burnetii (Q fever) among adults and small ruminants, and C. burnetii shedding prevalence among small ruminants in households in the Kiang West district of The Gambia, and to assess associated risk factors.
   MethodsSera of 599 adults and 615 small ruminants from 125 compounds within 12 villages were tested for antibodies against C. burnetii using ELISA. Vaginal swabs and milk samples of 155 small ruminants were tested using PCR to investigate shedding of C. burnetii.
   ResultsA total of 3.8-9.7% of adults, depending on ELISA test cut-off, and 24.9% of small ruminants in Kiang West were seropositive. Having at least one seropositive animal in one's compound was a risk factor for human seropositivity (OR: 3.35, 95% CI: 1.09-14.44). A grazing area within a village was a risk factor for seropositivity in small ruminants (OR: 2.07, 95% CI: 1.26-3.50); others were having lambed (OR: 2.75, 95% CI: 1.37-5.76) and older age of the animals (OR: 2.75, 95% CI: 1.37-5.76 for 1-3 years and OR 5.84, 95% CI: 3.10-11.64 for >3 years); 57.4% of sampled small ruminants were shedding C. burnetii.
   ConclusionCoxiella burnetii infection is endemic among both humans and small ruminants in this area of The Gambia. Human and animal exposure to C. burnetii were related at compound level. Further research into the clinical relevance of C. burnetii infection in West Africa is needed.
C1 [Bok, Jeroen; Hogerwerf, Lenny; Germeraad, Eveline A.; van der Sande, Marianne A. B.; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, POB 1, NL-3720 BA Bilthoven, Netherlands.
   [Roest, Hendrik I. J.] Cent Vet Inst, Dept Bacteriol & Epidemiol, Lelystad, Netherlands.
   [Faye-Joof, Tisbeh; Nwakanma, Davis; Wegmueller, Rita; Secka, Ousman] MRC Unit, Banjul, Fajara, Gambia.
   [Jeng, Momodou; Secka, Arss] Int Trypanotolerance Ctr, Banjul, Gambia.
   [Stegeman, Arjan] Univ Utrecht, Dept Farm Anim Hlth, Utrecht, Netherlands.
   [Goossens, Bart] Kombo Vet Serv, Bakau, Gambia.
   [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
RP Hogerwerf, L (reprint author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, POB 1, NL-3720 BA Bilthoven, Netherlands.
EM lenny.hogerwerf@rivm.nl
FU Dutch Centre for Infectious Disease Control
FX We thank Ismaila L. Manneh of MRCG and Marga van Setten of CVI for their
   help in performing the laboratory analyses, Maarten Schipper of RIVM for
   his assistance with the statistical analysis and Ben Bom of RIVM for
   making the map of The Gambia. We are also grateful to Umberto
   D'Alessandro of MRC, The Gambia, for his help and support in conducting
   this study. The study was financed from the regular budget of the Dutch
   Centre for Infectious Disease Control made available by the Ministry of
   Health, Welfare and Sports.
CR Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1
   Ammerdorffer A, 2016, THESIS
   Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016
   Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010
   BENSON WW, 1963, PUBLIC HEALTH REP, V78, P707, DOI 10.2307/4591908
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847
   Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501
   ECDC, 2010, RISK ASS Q FEV
   Frost J. D., 2015, Earth and Space 2014 - Engineering for Extreme Environments. 14th Biennial International Conference on Engineering, Science, Construction and Operations in Challenging Environments. Proceedings, P1
   The Gambia Bureau of Statistics, 2013, GAMB 2013 POP HOUS C
   Goossens B, 1998, VET REC, V142, P277
   Hoek W, 2013, TROP MED INT HEALTH, V18, P850
   Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908
   Klaasen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085424
   Osaer S, 1999, THESIS
   Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411
   R Development Core Team, 2008, R LANG ENV STAT COMP
   Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562
   Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949
   Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004
   Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69
   Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x
   Van den Brom R, 2015, VET MICROBIOL, V181, P119, DOI 10.1016/j.vetmic.2015.07.011
   Vanderburg S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002787
   World Health Organization, 2002, US ANT DIAGN LAB INV
NR 26
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD MAR
PY 2017
VL 22
IS 3
BP 323
EP 331
DI 10.1111/tmi.12827
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EM1NG
UT WOS:000395083700007
PM 27987380
OA No
DA 2017-08-15
ER

PT J
AU Ramakrishnan, G
   Wright, M
   Alam, M
   Naylor, C
   Kabir, M
   Zerin, A
   Ferdous, T
   Pedersen, K
   Hennig, BJ
   Donowitz, JR
   Wegmuller, R
   Haque, R
   Petri, WA
   Herbein, J
   Gilchrist, CA
AF Ramakrishnan, Girija
   Wright, Marcia
   Alam, Masud
   Naylor, Caitlin
   Kabir, Mamun
   Zerin, Ayesha
   Ferdous, Tahsin
   Pedersen, Karl
   Hennig, Branwen J.
   Donowitz, Jeffrey R.
   Wegmuller, Rita
   Haque, Rashidul
   Petri, William A., Jr.
   Herbein, Joel
   Gilchrist, Carol A.
TI Rapid assessment of tetanus vaccine-induced immunity in Bangladesh and
   the Gambia
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Vaccine; Tetanus; Dipstick; Lateral flow; Fragment C
ID ANTIBODIES; INFANTS
AB We have developed recombinant fragment C based rapid point of care dipstick devices to assess tetanus immunization status using plasma or whole blood. The devices demonstrated specificity of 0.90 and sensitivity of 0.90 (whole blood)/0.94 (plasma) at field sites in Bangladesh and The Gambia when compared to a commercial ELISA with the immune cut-off titer set as >= 0.1 IU/mL. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Ramakrishnan, Girija; Petri, William A., Jr.; Gilchrist, Carol A.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.
   [Wright, Marcia; Pedersen, Karl; Herbein, Joel] TechLab Inc, Blacksburg, VA USA.
   [Alam, Masud; Kabir, Mamun; Zerin, Ayesha; Ferdous, Tahsin; Haque, Rashidul] Icddr B, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Naylor, Caitlin; Hennig, Branwen J.] MRC Unit Gambia MRCG, Nutr Theme, Banjul, Gambia.
   [Hennig, Branwen J.; Wegmuller, Rita] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Donowitz, Jeffrey R.] Virginia Commonwealth Univ, Childrens Hosp Richmond, Div Pediat Infect Dis, Richmond, VA 23284 USA.
RP Gilchrist, CA (reprint author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.
EM cg2p@eservices.virginia.edu
FU Bill and Melinda Gates Foundation (OPP) [1066629]; NIH [5R01
   AI043596-16]; UK Medical Research Council (MRC); UK Department for
   International Development (DFID) under the MRC/DFID Concordant agreement
   [MC-A760-5QX00]
FX This work was supported by the Bill and Melinda Gates Foundation (OPP
   #1066629) and by the NIH (5R01 AI043596-16). Funding to the MRC
   International Nutrition Group comes from the UK Medical Research Council
   (MRC) and the UK Department for International Development (DFID) under
   the MRC/DFID Concordant agreement (current grant MC-A760-5QX00).
CR Blatter M, 2009, VACCINE, V27, P765, DOI 10.1016/j.vaccine.2008.11.028
   Borrow R, 2007, IMMUNOL BASIS IMMUN, V3, P2
   Hennig BJ, 2015, INT J EPIDEMIOL
   Ibinda F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122606
   Jamil K, 1999, HEALTH POLICY PLANN, V14, P49, DOI 10.1093/heapol/14.1.49
   Korpe PS, 2013, CLIN INFECT DIS, V56, P988, DOI 10.1093/cid/cis1044
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   MacNeil A, 2014, VACCINE, V32, P2315, DOI 10.1016/j.vaccine.2014.02.067
   Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807
   Ramakrishnan G, 2015, DIAGN MICR INFEC DIS, V82, P11, DOI 10.1016/j.diagmicrobio.2015.01.016
   SIMONSEN O, 1986, J BIOL STAND, V14, P231, DOI 10.1016/0092-1157(86)90008-9
   Taniuchi M, 2013, J INFECT DIS, V208, P1794, DOI 10.1093/infdis/jit507
   World Health Organization (WHO), 2015, 2015 SAGE ASS REP GL
   World Health Organization (WHO), 2006, WEEKL EP REC, P197
NR 14
TC 1
Z9 1
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD MAR
PY 2017
VL 87
IS 3
BP 272
EP 274
DI 10.1016/j.diagmicrobio.2016.11.011
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EL1UV
UT WOS:000394407700017
PM 27916543
OA No
DA 2017-08-15
ER

PT J
AU de Silva, TI
   Kampmann, B
AF de Silva, Thushan I.
   Kampmann, Beate
TI Value of immunogenicity studies of influenza vaccinein resource-limited
   settings
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; EFFICACY; CHILDREN
C1 [de Silva, Thushan I.] Imperial Coll London, Dept Med, St Marys Campus, London W2 1PG, England.
   Med Res Council Unit Gambia, Atlantic Blvd,POB 273, Banjul, Gambia.
RP de Silva, TI (reprint author), Imperial Coll London, Dept Med, St Marys Campus, London W2 1PG, England.
EM t.de-silva@imperial.ac.uk
FU Medical Research Council [MC_UP_A900_1122]
CR Bracco NH, 2009, PEDIATR INFECT DIS J, V28, P365
   Brooks WA, 2016, LANCET GLOB HEALTH, V4, pE946, DOI 10.1016/S2214-109X(16)30200-5
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Victor JC, 2016, LANCET GLOB HEALTH, V4, pE955, DOI 10.1016/S2214-109X(16)30201-7
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD MAR
PY 2017
VL 5
IS 3
BP E274
EP E274
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN9TE
UT WOS:000396341700029
PM 28193395
OA gold
DA 2017-08-15
ER

PT J
AU Hamilton, WL
   Claessens, A
   Otto, TD
   Kekre, M
   Fairhurst, RM
   Rayner, JC
   Kwiatkowski, D
AF Hamilton, William L.
   Claessens, Antoine
   Otto, Thomas D.
   Kekre, Mihir
   Fairhurst, Rick M.
   Rayner, Julian C.
   Kwiatkowski, Dominic
TI Extreme mutation bias and high AT content in plasmodium falciparum
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID LOW-COMPLEXITY REGIONS; COPY NUMBER VARIATION; GENOME-WIDE VIEW; MALARIA
   PARASITE; NUCLEOTIDE SUBSTITUTION; ESCHERICHIA-COLI; DNA-SEQUENCES; VAR
   GENES; INFECTED ERYTHROCYTES; MOLECULAR-SPECTRUM
AB For reasons that remain unknown, the Plasmodium falciparum genome has an exceptionally high AT content compared to other Plasmodium species and eukaryotes in general - nearly 80% in coding regions and approaching 90% in non-coding regions. Here, we examine how this phenomenon relates to genome-wide patterns of de novo mutation. Mutation accumulation experiments were performed by sequential cloning of six P. falciparum isolates growing in human erythrocytes in vitro for 4 years, with 279 clones sampled for whole genome sequencing at different time points. Genome sequence analysis of these samples revealed a significant excess of G:C to A:T transitions compared to other types of nucleotide substitution, which would naturally cause AT content to equilibrate close to the level seen across the P. fal-ciparum reference genome (80.6% AT). These data also uncover an extremely high rate of small indel mutation relative to other species, primarily associated with repetitive AT-rich sequences, in addition to larger-scale structural rearrangements focused in antigen-coding var genes. In conclusion, high AT content in P. falciparum is driven by a systematic mutational bias and ultimately leads to an unusual level of microstructural plasticity, raising the question of whether this contributes to adaptive evolution.
C1 [Hamilton, William L.; Claessens, Antoine; Otto, Thomas D.; Kekre, Mihir; Rayner, Julian C.; Kwiatkowski, Dominic] Wellcome Trust Sanger Inst, Malaria Programme, Hinxton CB10 1SA, England.
   [Hamilton, William L.] Univ Cambridge, Sch Clin Med, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0SP, England.
   [Claessens, Antoine] Med Res Council Unit Gambia, Atlantic Rd,POB 273, Banjul, Gambia.
   [Claessens, Antoine] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England.
   [Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.
   [Kwiatkowski, Dominic] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.
RP Hamilton, WL (reprint author), Wellcome Trust Sanger Inst, Malaria Programme, Hinxton CB10 1SA, England.; Hamilton, WL (reprint author), Univ Cambridge, Sch Clin Med, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0SP, England.
EM will.l.hamilton@gmail.com
FU Wellcome Trust [098051]; Medical Research Council [G0600718]
FX Wellcome Trust [098051]; Medical Research Council [G0600718]. Funding
   for open access charge: Wellcome Trust.
CR Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Artl D., 1999, P NATL ACAD SCI USA, V96, P1475
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109
   Bachmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049540
   Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564
   Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011
   Behringer MG, 2016, CURR GENET, V62, P507, DOI 10.1007/s00294-016-0573-7
   Bensch S, 2016, GENOME BIOL EVOL, V8, P1361, DOI [10.1093/gbe/evw081, 10.1093/gbe/ewv081]
   BLAND JM, 1995, BRIT MED J, V310, P170
   Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002
   Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293
   Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148
   Brown TS, 2015, INFECT GENET EVOL, V30, P318, DOI 10.1016/j.meegid.2014.12.010
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026
   Castellini MA, 2011, MOL BIOCHEM PARASIT, V177, P143, DOI 10.1016/j.molbiopara.2011.02.004
   Caulfield JL, 1998, J BIOL CHEM, V273, P12689, DOI 10.1074/jbc.273.21.12689
   Chang HH, 2012, MOL BIOL EVOL, V29, P3427, DOI 10.1093/molbev/mss161
   Cheeseman IH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-353
   Chen JQ, 2009, MOL BIOL EVOL, V26, P1523, DOI 10.1093/molbev/msp063
   Claessens A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004812
   Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516
   Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054
   CURTIS SE, 1984, MOL BIOL EVOL, V1, P291
   de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104
   Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106
   Fairhurst RM, 2015, CURR OPIN INFECT DIS, V28, P417, DOI 10.1097/QCO.0000000000000199
   Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6
   Frugier M, 2010, FEBS LETT, V584, P448, DOI 10.1016/j.febslet.2009.11.004
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   GHIGO D, 1995, J EXP MED, V182, P677, DOI 10.1084/jem.182.3.677
   GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904
   Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375
   Heinberg A, 2013, MOL MICROBIOL, V88, P702, DOI 10.1111/mmi.12162
   Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115
   Hershberg R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r164
   Horrocks P, 2009, MOL BIOCHEM PARASIT, V164, P9, DOI 10.1016/j.molbiopara.2008.11.010
   Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4
   Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274
   Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449
   Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109
   Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881
   Kirkman LA, 2012, CURR OPIN MICROBIOL, V15, P456, DOI 10.1016/j.mib.2012.03.003
   Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578
   Lang GI, 2013, G3-GENES GENOM GENET, V3, P1453, DOI 10.1534/g3.113.006429
   Larremore DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9368
   Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27
   Lee AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154166
   Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x
   Lind PA, 2008, P NATL ACAD SCI USA, V105, P17878, DOI 10.1073/pnas.0804445105
   Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442
   Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x
   Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105
   MalariaGEN Plasmodium falciparum Community Project, 2016, ELIFE, V5
   Manske HM, 2009, GENOME RES, V19, P2125, DOI 10.1101/gr.093443.109
   Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Miles A, 2016, GENOME RES, V26, P1288, DOI 10.1101/gr.203711.115
   Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189
   Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624
   Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112
   Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119
   Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335
   Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x
   Muralidharan V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003488
   Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185
   Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243
   Nikbakht H, 2014, GENOME, V57, P507, DOI 10.1139/gen-2014-0158
   Nosten F, 2007, AM J TROP MED HYG, V77, P181
   Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677
   Ostera G, 2008, EXP PARASITOL, V120, P29, DOI 10.1016/j.exppara.2008.04.014
   Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754
   Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436
   Pizzi E, 2001, GENOME RES, V11, P218, DOI 10.1101/gr.GR-1522R
   Ponts N, 2013, CELL HOST MICROBE, V14, P696, DOI 10.1016/j.chom.2013.11.007
   Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389
   Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378
   Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2
   SCHAAPER RM, 1991, GENETICS, V129, P317
   Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016
   Sundararaman SA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11078
   Sung W, 2016, G3-GENES GENOM GENET, V6, P2583, DOI [10.1534/g3.116.030890, 10.1534/g3.116.030890/-/DC1]
   Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491
   Taylor HM, 2000, MOL BIOCHEM PARASIT, V105, P13, DOI 10.1016/S0166-6851(99)00159-0
   TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0
   Trotta RF, 2004, BIOCHEMISTRY-US, V43, P4885, DOI 10.1021/bi0499258
   Van Leuven JT, 2012, GENOME BIOL EVOL, V4, P24, DOI 10.1093/gbe/evr125
   Verra F, 1999, MOL BIOL EVOL, V16, P627
   Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930
   WAKELEY J, 1994, MOL BIOL EVOL, V11, P436
   Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4
   Wasmuth J, 2009, GENOME RES, V19, P1202, DOI 10.1101/gr.083386.108
   WatanabeAkanuma M, 1997, MUTAT RES-FUND MOL M, V373, P61, DOI 10.1016/S0027-5107(96)00189-3
   Woodrow CJ, 2006, CELL MOL LIFE SCI, V63, P1586, DOI 10.1007/s00018-006-6071-1
   Wu H, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-2
   Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745
   Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108
NR 100
TC 0
Z9 0
U1 3
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB 28
PY 2017
VL 45
IS 4
BP 1889
EP 1901
DI 10.1093/nar/gkw1259
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EN5OO
UT WOS:000396055400035
PM 27994033
OA gold
DA 2017-08-15
ER

PT J
AU Scott, S
   Kendall, L
   Gomez, P
   Howie, SRC
   Zaman, SMA
   Ceesay, S
   D'Alessandro, U
   Jasseh, M
AF Scott, Susana
   Kendall, Lindsay
   Gomez, Pierre
   Howie, Stephen R. C.
   Zaman, Syed M. A.
   Ceesay, Samba
   D'Alessandro, Umberto
   Jasseh, Momodou
TI Effect of maternal death on child survival in rural West Africa: 25
   years of prospective surveillance data in The Gambia
SO PLOS ONE
LA English
DT Article
ID DEVELOPING-COUNTRIES; BURKINA-FASO; MORTALITY; DISEASE; MOTHERS; INFANT;
   COHORT; HEALTH; HIV; INTERVENTIONS
AB Background
   The death of a mother is a tragedy in itself but it can also have devastating effects for the survival of her children. We aim to explore the impact of a mother's death on child survival in rural Gambia, West Africa.
   Methods
   We used 25 years of prospective surveillance data from the Farafenni Health and Demographic surveillance system (FHDSS). Mortality rates per 1,000 child-years up to ten years of age were estimated and Kaplan-Meier survival curves plotted by maternal vital status. Cox proportional hazard models were used to examine factors associated with child survival.
   Findings
   Between 1 st April 1989 and 31 st December 2014, a total of 2, 221 (7.8%) deaths occurred during 152,906 child-years of follow up. Overall mortality rate was 14.53 per 1,000 childyears (95% CI: 13.93 - 15.14). Amongst those whose mother died, the rate was 25.89 (95% CI: 17.99 - 37.25) compared to 14.44 (95% CI: 13.84 - 15.06) per 1,000 child-years for those whose mother did not die. Children were 4.66 (95% CI: 3.15 - 6.89) times more likely to die if their mother died compared to those with a surviving mother. Infants whose mothers died during delivery or shortly after were up to 7 times more likely to die within the first month of life compared to those whose mothers survived. Maternal vital status was significantly associated with the risk of dying within the first 2 years of life (p-value < 0.05), while this was no longer observed for children over 2 years of age (P = 0.872). Other factors associated with an increased risk of dying were living in more rural areas, and birth spacing and year of birth.
   Conclusions
   Mother's survival is strongly associated with child survival. Our findings highlight the importance of the continuum of care for both the mother and child not only throughout pregnancy, and childbirth but beyond 6 weeks post-partum.
C1 [Scott, Susana; Kendall, Lindsay; Gomez, Pierre; Howie, Stephen R. C.; Zaman, Syed M. A.; D'Alessandro, Umberto; Jasseh, Momodou] MRC, Gambia Unit, Fajara, Gambia.
   [Scott, Susana; Zaman, Syed M. A.; D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Ceesay, Samba] Minist Hlth & Social Welf, Banjul, Gambia.
RP Scott, S (reprint author), MRC, Gambia Unit, Fajara, Gambia.; Scott, S (reprint author), London Sch Hyg & Trop Med, London, England.
EM Susana.Scott@lshtm.ac.uk
FU UK Medical Research Council (MRC)
FX This study was funded by the UK Medical Research Council (MRC). The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265
   Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441
   Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3
   Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7
   Clark SJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001409
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017
   Finlay JE, 2015, MATERN CHILD HLTH J, V19, P2393, DOI 10.1007/s10995-015-1758-2
   The Gambia Bureau of Statistics (GBOS) and ICF International, 2014, GAMB DEM HLTH SURV 2, DOI [10.3402/oha.v7.25598, DOI 10.3402/GHA.V7.25598]
   Jasseh M, 2015, INT J EPIDEMIOLOGY
   Jasseh M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25598
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Lassi ZS, 2014, REPROD HLTH S1, V11, pS5
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7
   Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9
   Moucheraud C, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S4
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7
   The Partnership for Maternal Newborn & Child Health, 2011, PARTN MAT NEWB CHILD
   Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0
   Scott S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107280
   Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010
   Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011
   Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25368
   Taha TET, 1996, AIDS, V10, P111, DOI 10.1097/00002030-199601000-00021
   World Health Organization, 2013, WHO REC POSTN CAR MO
   [Anonymous], 2011, WHO GUIDELINES PREVE
   Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43
NR 30
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2017
VL 12
IS 2
AR e0172286
DI 10.1371/journal.pone.0172286
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EL5SK
UT WOS:000394680900033
PM 28225798
OA gold
DA 2017-08-15
ER

PT J
AU Cornick, JE
   Bishop, OT
   Yalcin, F
   Kiran, AM
   Kumwenda, B
   Chaguza, C
   Govindpershad, S
   Ousmane, S
   Senghore, M
   du Plessis, M
   Pluschke, G
   Ebruke, C
   Mcgee, L
   Sigauque, B
   Collard, JM
   Bentley, SD
   Kadioglu, A
   Antonio, M
   von Gottberg, A
   French, N
   Klugman, KP
   Heyderman, RS
   Alderson, M
   Everett, DB
AF Cornick, Jennifer E.
   Bishop, Oezlem Tastan
   Yalcin, Feyruz
   Kiran, Anmol M.
   Kumwenda, Benjamin
   Chaguza, Chrispin
   Govindpershad, Shanil
   Ousmane, Sani
   Senghore, Madikay
   du Plessis, Mignon
   Pluschke, Gerd
   Ebruke, Chinelo
   McGee, Lesley
   Sigauque, Beutel
   Collard, Jean-Marc
   Bentley, Stephen D.
   Kadioglu, Aras
   Antonio, Martin
   von Gottberg, Anne
   French, Neil
   Klugman, Keith P.
   Heyderman, Robert S.
   Alderson, Mark
   Everett, Dean B.
CA PAGe Consortium
TI The global distribution and diversity of protein vaccine candidate
   antigens in the highly virulent Streptococcus pnuemoniae serotype 1
SO VACCINE
LA English
DT Article
DE Protein modelling; Structural diversity; Antigenic diversity; Antigenic
   profiling; Variant; Pneumococcal disease; Multi-valent; PCV
ID PNEUMONIAE; DISEASE; PNEUMOCOCCI; MENINGITIS; PREDICTION; OUTBREAK;
   CHILDREN; SERVER
AB Serotype 1 is one of the most common causes of pneumococcal disease worldwide. Pneumococcal protein vaccines are currently being developed as an alternate intervention strategy to pneumococcal conjugate vaccines. Pre-requisites for an efficacious pneumococcal protein vaccine are universal presence and minimal variation of the target antigen in the pneumococcal population, and the capability to induce a robust human immune response. We used in silico analysis to assess the prevalence of seven protein vaccine candidates (CbpA, PcpA, PhtD, PspA, SP0148, SP1912, SP2108) among 445 serotype 1 pneumococci from 26 different countries, across four continents. CbpA (76%), PspA (68%), PhtD (28%), PcpA (11%) were not universally encoded in the study population, and would not provide full coverage against serotype 1. PcpA was widely present in the European (82%), but not in the African (2%) population. A multi-valent vaccine incorporating CbpA, PcpA, PhtD and PspA was predicted to provide coverage against 86% of the global population. SP0148, SP1912 and SP2108 were universally encoded and we further assessed their predicted amino acid, antigenic and structural variation. Multiple allelic variants of these proteins were identified, different allelic variants dominated in different continents; the observed variation was predicted to impact the antigenicity and structure of two SP0148 variants, one SP1912 variant and four SP2108 variants, however these variants were each only present in a small fraction of the global population (<2%). The vast majority of the observed variation was predicted to have no impact on the efficaciousness of a protein vaccine incorporating a single variant of SP0148, SP1912 and/or SP2108 from S. pneumoniae TIGR4. Our findings emphasise the importance of taking geographic differences into account when designing global vaccine interventions and support the continued development of SP0148, SP1912 and SP2108 as protein vaccine candidates against this important pneumococcal serotype. (C) 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Cornick, Jennifer E.; Kiran, Anmol M.; Kumwenda, Benjamin; Chaguza, Chrispin; Heyderman, Robert S.; Everett, Dean B.] Queen Elizabeth Cent Hosp, Malawi Liverpool Wellcome Trust Clin Res Programm, POB 30096, Blantyre 3, Malawi.
   [Cornick, Jennifer E.; Kiran, Anmol M.; Chaguza, Chrispin; Kadioglu, Aras; French, Neil; Everett, Dean B.] Univ Liverpool, Inst Infect & Global Hlth, Clin Infect Microbiol & Immunol, Liverpool L69 7BE, Merseyside, England.
   [Bishop, Oezlem Tastan; Bentley, Stephen D.] Rhodes Univ, Dept Biochem & Microbiol, Res Unit Bioinformat RUBi, Grahamstown, South Africa.
   [Yalcin, Feyruz] Wellcome Trust Sanger Inst, Pathogen Genom, Wellcome Trust Genome Campus, Cambridge CB10 ISA, England.
   [Ousmane, Sani; Collard, Jean-Marc] Ctr Rech Med & Sanit, Niamey, Niger.
   [Senghore, Madikay; Ebruke, Chinelo; Antonio, Martin] MRC, Banjul, Gambia.
   [Senghore, Madikay; Antonio, Martin] Univ Warwick, Div Translat & Syst Med, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
   [Govindpershad, Shanil; du Plessis, Mignon; von Gottberg, Anne] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.
   [Govindpershad, Shanil; du Plessis, Mignon; von Gottberg, Anne] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa.
   [Pluschke, Gerd] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [McGee, Lesley] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Sigauque, Beutel] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   [Alderson, Mark] PATH, Seattle, WA USA.
RP Cornick, JE (reprint author), Queen Elizabeth Cent Hosp, Malawi Liverpool Wellcome Trust Clin Res Programm, POB 30096, Blantyre 3, Malawi.
EM j.cornick@liv.ac.uk
OI Antonio, Martin/0000-0002-4810-1308; Pluschke, Gerd/0000-0003-1957-2925;
   Tastan Bishop, Ozlem/0000-0001-6861-7849
FU Bill and Melinda Gates Foundation [OPP1023440]; Wellcome Trust
   [084679/Z/08/Z]; National Research Foundation of South Africa [93690];
   NIH Common Fund Award (H3A Bionet) [U41HG006941]
FX This work supported by the Bill and Melinda Gates Foundation (Grant No.
   OPP1023440), Wellcome Trust (Award No. 084679/Z/08/Z), National Research
   Foundation of South Africa (Grant No. 93690) and the NIH Common Fund
   Award (H3A Bionet) (Grant No. U41HG006941). The content of this
   publication is solely the responsibility of the authors and does not
   necessarily represent the official views of the funders.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Basavanna S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049638
   Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052
   Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031
   Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003
   Blumental S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133885
   Bologa M, 2012, VACCINE, V30
   Brehony C, 2015, EURO SURVEILL B EUR, V20
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Cornick JE, 2015, MICROBIAL GENOMICS, V1, P1, DOI DOI 10.1099/MGEN.0.000027
   Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09
   Feldman C, 2014, J INFECT
   Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jefferies JMC, 2011, TRENDS MICROBIOL, V19, P377, DOI 10.1016/j.tim.2011.06.001
   Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348
   Klugman KP, 2008, PNEUMOCOCCAL VACCINES: THE IMPACT OF CONJUGATE VACCINE, P317
   Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151
   Mehiri-Zghal E, 2010, DIAGN MICR INFEC DIS, V66, P225, DOI 10.1016/j.diagmicrobio.2009.05.008
   Mitchell TJ, 2006, ADV EXP MED BIOL, V582, P111
   Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Skoberne M, 2014, VACCINE
   Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8
   Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940
NR 25
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 7
PY 2017
VL 35
IS 6
BP 972
EP 980
DI 10.1016/j.vaccine.2016.12.037
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EK8SX
UT WOS:000394196000019
PM 28081968
OA No
DA 2017-08-15
ER

PT J
AU Ceesay, H
AF Ceesay, Hassoum
TI The Very Reverend JC Faye: his life and times. A biography
SO AFRICA
LA English
DT Book Review
C1 [Ceesay, Hassoum] Univ Gambia, Serekunda, Gambia.
RP Ceesay, H (reprint author), Univ Gambia, Serekunda, Gambia.
EM hceesay@gmail.com
CR SENGHOR JC, 2014, VERY REVEREND J C FA
NR 1
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0001-9720
EI 1750-0184
J9 AFRICA
JI Africa
PD FEB
PY 2017
VL 87
IS 1
BP 221
EP 223
DI 10.1017/S000197201600084X
PG 3
WC Anthropology; Area Studies
SC Anthropology; Area Studies
GA EM6QB
UT WOS:000395436100019
OA No
DA 2017-08-15
ER

PT J
AU Bliss, CM
   Drammeh, A
   Bowyer, G
   Sanou, GS
   Jagne, YJ
   Ouedraogo, O
   Edwards, NJ
   Tarama, C
   Ouedraogo, N
   Ouedraogo, M
   Njie-Jobe, J
   Diarra, A
   Afolabi, MO
   Tiono, AB
   Yaro, JB
   Adetifa, UJ
   Hodgson, SH
   Anagnostou, NA
   Roberts, R
   Duncan, CJA
   Cortese, R
   Viebig, NK
   Leroy, O
   Lawrie, AM
   Flanagan, KL
   Kampmann, B
   Imoukhuede, EB
   Sirima, SB
   Bojang, K
   Hill, AVS
   Nebie, I
   Ewer, KJ
AF Bliss, Carly M.
   Drammeh, Abdoulie
   Bowyer, Georgina
   Sanou, Guillaume S.
   Jagne, Ya Jankey
   Ouedraogo, Oumarou
   Edwards, Nick J.
   Tarama, Casimir
   Ouedraogo, Nicolas
   Ouedraogo, Mireille
   Njie-Jobe, Jainaba
   Diarra, Amidou
   Afolabi, Muhammed O.
   Tiono, Alfred B.
   Yaro, Jean Baptiste
   Adetifa, Uche J.
   Hodgson, Susanne H.
   Anagnostou, Nicholas A.
   Roberts, Rachel
   Duncan, Christopher J. A.
   Cortese, Riccardo
   Viebig, Nicola K.
   Leroy, Odile
   Lawrie, Alison M.
   Flanagan, Katie L.
   Kampmann, Beate
   Imoukhuede, Egeruan B.
   Sirima, Sodiomon B.
   Bojang, Kalifa
   Hill, Adrian V. S.
   Nebie, Issa
   Ewer, Katie J.
TI Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody
   Responses in West African Children and Infants
SO MOLECULAR THERAPY
LA English
DT Article
ID MVA ME-TRAP; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN;
   EARLY-LIFE; INFECTION; IMMUNIZATION; VACCINATION; EFFICACY; AGE; ANTIGEN
AB Heterologous prime-boosting with viral vectors encoding the pre-erythrocytic antigen thrombospondin-related adhesion protein fused to a multiple epitope string (ME-TRAP) induces CD8(+) T cell-mediated immunity to malaria sporozoite challenge in European malaria-naive and Kenyan semi-immune adults. This approach has yet to be evaluated in children and infants. We assessed this vaccine strategy among 138 Gambian and Burkinabe children in four cohorts: 2-to 6-year olds in The Gambia, 5- to 17- month-olds in Burkina Faso, and 5- to 12- month-olds and 10-week-olds in The Gambia. We assessed induction of cellular immunity, taking into account the distinctive hematological status of young infants, and characterized the antibody response to vaccination. T cell responses peaked 7 days after boosting with modified vaccinia virus Ankara (MVA), with highest responses in infants aged 10 weeks at priming. Incorporating lymphocyte count into the calculation of T cell responses facilitated a more physiologically relevant comparison of cellular immunity across different age groups. Both CD8(+) and CD4(+) T cells secreted cytokines. Induced antibodies were up to 20-fold higher in all groups compared with Gambian and United Kingdom (UK) adults, with comparable or higher avidity. This immunization regimen elicited strong immune responses, particularly in young infants, supporting future evaluation of efficacy in this key target age group for a malaria vaccine.
C1 [Bliss, Carly M.; Bowyer, Georgina; Edwards, Nick J.; Hill, Adrian V. S.; Ewer, Katie J.] Univ Oxford, Jenner Inst Labs, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England.
   [Drammeh, Abdoulie; Jagne, Ya Jankey; Njie-Jobe, Jainaba; Afolabi, Muhammed O.; Adetifa, Uche J.; Flanagan, Katie L.; Kampmann, Beate; Bojang, Kalifa] MRC Unit, Fajara, Gambia.
   [Sanou, Guillaume S.; Ouedraogo, Oumarou; Tarama, Casimir; Ouedraogo, Nicolas; Ouedraogo, Mireille; Diarra, Amidou; Tiono, Alfred B.; Yaro, Jean Baptiste; Sirima, Sodiomon B.; Nebie, Issa] Ctr Natl Rech & Format Paludisme, 01 BP 2208 Ouagadougou, Ouagadougou, Burkina Faso.
   [Hodgson, Susanne H.; Anagnostou, Nicholas A.; Roberts, Rachel; Duncan, Christopher J. A.; Lawrie, Alison M.; Imoukhuede, Egeruan B.; Hill, Adrian V. S.] Churchill Hosp, Jenner Inst, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LE, England.
   [Cortese, Riccardo] Keires AG, Baumleingasse 18, CH-4051 Basel, Switzerland.
   [Viebig, Nicola K.; Leroy, Odile] Univ Klinikum Heidelberg, European Vaccine Initiat, Vossstr 2, D-69115 Heidelberg, Germany.
   [Kampmann, Beate] Imperial Coll London, Dept Paediat, London SW7 2AZ, England.
   [Duncan, Christopher J. A.] Newcastle Univ, Inst Cellular Med, Cookson Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Flanagan, Katie L.] Monash Univ, Dept Immunol, Melbourne, Vic 3181, Australia.
RP Ewer, KJ (reprint author), Univ Oxford, Jenner Inst, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.
EM katie.ewer@ndm.ox.ac.uk
OI Bojang, Kalifa/0000-0001-7506-0938
FU European and Developing Countries Clinical Trials Partnership (EDCTP);
   European and Developing Countries Clinical Trials Partnership (EDCTP)
   [IP.2008.31100.001]; EDCTP; UK National Institute of Health Research
   through the Oxford Biomedical Research Centre [A91301]; Wellcome Trust
   [084113/Z/07/Z]; Medical Research Council; UK Medical Research Council
   (MRC); UK Department for International Development (DFID)
   [MC_UP_A900/1122]; Swedish International Development Cooperation Agency
   (Sida); Austrian Federal Ministry of Science and Research; Irish Aid;
   Wellcome Trust research training fellowship [097940/Z/11/Z]
FX For the study in The Gambia, we thank the Gambian National Malaria
   Control Programme and staff of Sukuta Health Centre for their
   collaboration; Momodou Cox, Isatou Bah, Victor Kouassi, Pa Saidou Chaw,
   Ebrima Touray, Sarjo Sanneh, Lisa Fofana, Jarrai Barrow, Christiana
   Demba, Sally Savage, Omar Badjie for laboratory support; Maimuna Sowe,
   Haddy Kanyi for data management; Prof Ousman Nyan for local safety
   monitoring; Jenny Mueller and Vivat Thomas-Njie from the Clinical Trial
   Support Office; Dembo Kanteh, Mamkumba Sanneh from the Research Support
   Office. Ceri Mckenna (Appledown) for external monitoring. We thank the
   members of the Data Safety Monitoring Board and all the study
   volunteers. This work was supported by an award from the European and
   Developing Countries Clinical Trials Partnership (EDCTP) and was
   performed by the Malaria Vectored Vaccines Consortium (MVVC), a 5-year
   integrated project funded by the European and Developing Countries
   Clinical Trials Partnership (EDCTP, grant number IP.2008.31100.001). The
   European Vaccine Initiative (EVI) is the coordinator of the EDCTP-funded
   MVVC project. O.L. is executive director of EVI. N.K.V. is an employee
   of EVI. The work was also supported by the UK National Institute of
   Health Research through the Oxford Biomedical Research Centre
   (http://oxfordbrc.nihr.ac.uk/) (A91301 Adult Vaccine), the Wellcome
   Trust (https://www.wellcome.ac.uk/) (084113/Z/07/Z), and the Medical
   Research Council. This research was supported by the UK Medical Research
   Council (MRC) and the UK Department for International Development (DFID)
   under the MRC/DFID Concordat agreement and MC_UP_A900/1122 (M.O.A.,
   A.D., Y.J., K.F., B.K., K.B.). Cofunding was also provided by the
   Swedish International Development Cooperation Agency (Sida), the
   Austrian Federal Ministry of Science and Research, and Irish Aid. S.H.H.
   holds a Wellcome Trust research training fellowship (097940/Z/11/Z). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394
   Afolabi MO, 2016, MOL THER, V24, P1470, DOI 10.1038/mt.2016.83
   Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287
   Ajua A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0605-7
   Biswas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107903
   Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Chattopadhyay R, 2011, J BIOL CHEM, V286, P26396, DOI 10.1074/jbc.M111.240879
   Cheng Q, 1997, AM J TROP MED HYG, V57, P495
   Cruz A, 2015, VACCINE, V33, P85, DOI 10.1016/j.vaccine.2014.11.013
   Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836
   Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346
   Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527
   Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745
   HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151
   Hermann E, 2002, BLOOD, V100, P2153
   Hill AVS, 2010, HUM VACCINES, V6, P78
   HO M, 1986, J INFECT DIS, V153, P763
   Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579
   Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534
   Kimani D, 2014, MOL THER, V22, P1992, DOI 10.1038/mt.2014.109
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775
   Malaria Vaccine Funders Group, 2013, MAL VACC TECHN ROADM
   Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI200317470
   Martinez X, 2003, VIROLOGY, V305, P428, DOI 10.1006/viro.2002.1775
   McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Millington OR, 2007, PLOS PATHOG, V3, P1380, DOI 10.1371/journal.ppat.0030143
   Moorthy VS, 2013, LANCET, V382, P1700, DOI 10.1016/S0140-6736(13)62238-2
   MURPHY JR, 1989, J CLIN MICROBIOL, V27, P1434
   Ndungu FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052870
   O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850
   Ogwang C, 2015, SCI TRANSL MED, V7, P286
   Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726
   Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050036
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189
   RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441
   Rowe J, 2000, INFECT IMMUN, V68, P3873, DOI 10.1128/IAI.68.7.3873-3877.2000
   RTS, 2015, LANCET, V386, P31, DOI DOI 10.1016/S0140-6736(15)60721-8
   Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1067/mai.2003.1778
   Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7
   Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508
   Tiono AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086936
   Vekemans J, 2002, CLIN EXP IMMUNOL, V127, P495, DOI 10.1046/j.1365-2249.2002.01788.x
   Welsh RM, 2001, J EXP MED, V193, pF19, DOI 10.1084/jem.193.5.F19
   White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X
   White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO-UNICEF, 2014, GLOB IMM DAT
   YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225
NR 53
TC 0
Z9 0
U1 3
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD FEB 1
PY 2017
VL 25
IS 2
BP 547
EP 559
DI 10.1016/j.ymthe.2016.11.003
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA EP3UT
UT WOS:000397307900025
PM 28153101
OA No
DA 2017-08-15
ER

PT J
AU Schupbach, R
   Wegmuller, R
   Berguerand, C
   Bui, M
   Herter-Aeberli, I
AF Schupbach, R.
   Wegmuller, R.
   Berguerand, C.
   Bui, M.
   Herter-Aeberli, I.
TI Micronutrient status and intake in omnivores, vegetarians and vegans in
   Switzerland
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Vegetarian; Vegan; Vitamins; Minerals; Dietary intake; Micronutrient
   status
ID EPIC-OXFORD; MEAT-EATERS; LIFE-STYLE; VITAMIN-B-12 STATUS; ANTIOXIDANT
   STATUS; IODINE DEFICIENCY; FISH-EATERS; HOMOCYSTEINE; COBALAMIN;
   MAGNESIUM
AB Vegetarian and vegan diets have gained popularity in Switzerland. The nutritional status of individuals who have adopted such diets, however, has not been investigated. The aim of this study was to assess the intake and status of selected vitamins and minerals among vegetarian and vegan adults living in Switzerland.
   Healthy adults [omnivores (OVs), n (OV) = 100; vegetarians (VGs), n (VG) = 53; vegans (VNs), n (VN) = 53] aged 18-50 years were recruited, and their weight and height were measured. Plasma concentrations of the vitamins A, C, E, B1, B2, B6, B12, folic acid, pantothenic acid, niacin, biotin and beta-carotene and of the minerals Fe, Mg and Zn and urinary iodine concentration were determined. Dietary intake was assessed using a three-day weighed food record, and questionnaires were issued in order to assess the physical activity and lifestyle of the subjects.
   Omnivores had the lowest intake of Mg, vitamin C, vitamin E, niacin and folic acid. Vegans reported low intakes of Ca and a marginal consumption of the vitamins D and B12. The highest prevalence for vitamin and mineral deficiencies in each group was as follows: in the omnivorous group, for folic acid (58 %); in the vegetarian group, for vitamin B6 and niacin (58 and 34 %, respectively); and in the vegan group, for Zn (47 %). Despite negligible dietary vitamin B12 intake in the vegan group, deficiency of this particular vitamin was low in all groups thanks to widespread use of supplements. Prevalence of Fe deficiency was comparable across all diet groups.
   Despite substantial differences in intake and deficiency between groups, our results indicate that by consuming a well-balanced diet including supplements or fortified products, all three types of diet can potentially fulfill requirements for vitamin and mineral consumption.
C1 [Schupbach, R.; Wegmuller, R.; Herter-Aeberli, I.] Swiss Fed Inst Technol, Human Nutr Lab, Schmelzbergstr 7,LFV D22, CH-8092 Zurich, Switzerland.
   [Wegmuller, R.] MRC Keneba, Int Grp, Keneba, Gambia.
   [Berguerand, C.; Bui, M.] Swiss Vitamin Inst, Epalinges, Switzerland.
RP Herter-Aeberli, I (reprint author), Swiss Fed Inst Technol, Human Nutr Lab, Schmelzbergstr 7,LFV D22, CH-8092 Zurich, Switzerland.
EM isabelle.herter@hest.ethz.ch
FU Swiss Foundation for Nutrition Research (SFEFS); Swiss Vitamin Institute
FX We thank all the study participants for their cooperation during the
   study. Furthermore, we would like to thank Doris Schutz from the Swiss
   Vitamin Institute for her excellent support during the study and for the
   vitamin measurements. A big thank you also goes to Stefanie B. Murer,
   Jasmin Tajeri Foman, Sara Stinca, Valeria Galetti and Christophe Zeder
   at the Human Nutrition Laboratory at ETH Zurich for their support during
   the study, for help with translations, sample organization and
   laboratory analyses. For financial support, we would like to thank the
   Swiss Foundation for Nutrition Research (SFEFS) and the Swiss Vitamin
   Institute.
CR Aggett P. J., 2012, PRESENT KNOWLEDGE NU
   Appleby PN, 1999, AM J CLIN NUTR, V70, p525S
   Appleby PN, 2002, PUBLIC HEALTH NUTR, V5, P645, DOI 10.1079/PHN2002332
   Bedford JL, 2005, INT J BEHAV NUTR PHY, V2, P4, DOI DOI 10.1186/1479-5868-2-4
   BfS. Schweizerische Gesundheitsbefragung (SGB), 2012, SCHWEIZ GES SGB
   Biesalski H, 2005, POCKET ATLAS NUTR
   Bohn T, 2003, MAGNESIUM ABSORPTION
   BUI MH, 1992, J NUTR, V122, P312
   BUI MH, 1994, J CHROMATOGR B, V654, P129, DOI 10.1016/0378-4347(93)E0441-R
   Bui MH, 1999, J VIT NUTR RES, V69, P362
   Carmel R, 2013, BIOCHIMIE, V95, P1047, DOI 10.1016/j.biochi.2013.02.008
   Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430
   Devalia V, 2014, BRIT J HAEMATOL, V166, P496, DOI 10.1111/bjh.12959
   Esmaillzadeh A, 2006, AM J CLIN NUTR, V84, P1489
   Exl-Preysch BM, 2001, NUTRI TREND STUDIE 2
   FINE KD, 1991, J CLIN INVEST, V88, P396, DOI 10.1172/JCI115317
   Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K
   FSVO, 2012, VIT D KEY FACTS
   Goldberg GR, 1991, PUBLIC HEALTH NUTR, V45, P569
   Haddad EH, 1999, AM J CLIN NUTR, V70, p586S
   Haldimann M, 2005, J FOOD COMPOS ANAL, V18, P461, DOI 10.1016/j.jfca.2004.06.003
   Herrmann W, 2003, AM J CLIN NUTR, V78, P131
   Herrmann W, 2002, CLIN CHIM ACTA, V326, P47, DOI 10.1016/S0009-8981(02)00307-8
   Herrmann W, 2001, CLIN CHEM, V47, P1094
   Holt RR, 2012, PRESENT KNOWLEDGE NU
   Huang YC, 2003, EUR J NUTR, V42, P84, DOI 10.1007/s00394-003-0387-5
   Hunt JR, 2003, AM J CLIN NUTR, V78, p633S
   Ross AC, 2011, DIET REF INT DIET RE, P1132
   IOM, 2006, DIET REF INT DRI
   JANELLE KC, 1995, J AM DIET ASSOC, V95, P180, DOI 10.1016/S0002-8223(95)00045-3
   Keller R, 2010, TABAKKONSUM SCHWEIZE
   Key TJ, 2009, BRIT J CANCER, V101, P192, DOI 10.1038/sj.bjc.6605098
   Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071
   Krajcovicova-Kudlackova M, 2003, ANN NUTR METAB, V47, P183, DOI 10.1159/000070483
   Krajcovicova-Kudlackova M, 1996, FOOD NAHRUNG, V40, P17, DOI 10.1002/food.19960400105
   KrajcovicovaKudlackova M, 1995, ANN NUTR METAB, V39, P334, DOI 10.1159/000177882
   Larsson CL, 2002, AM J CLIN NUTR, V76, P100
   Li D, 2000, ASIA PAC J CLIN NUTR, V9, P18, DOI 10.1046/j.1440-6047.2000.00129.x
   Majchrzak D, 2006, ANN NUTR METAB, V50, P485, DOI 10.1159/000095828
   Norman AW, 2012, PRESENT KNOWLEDGE NU
   Pawlak R, 2014, EUR J CLIN NUTR, V68, P541, DOI 10.1038/ejcn.2014.46
   Pino S, 1996, CLIN CHEM, V42, P239
   Rauma AL, 2000, NUTRITION, V16, P111, DOI 10.1016/S0899-9007(99)00267-1
   Remer T, 1999, BRIT J NUTR, V81, P45
   Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749
   Spencer EA, 2003, INT J OBESITY, V27, P728, DOI 10.1038/sj.ijo.0802300
   SRIKUMAR TS, 1992, NUTR RES, V12, P187, DOI 10.1016/S0271-5317(05)80725-0
   Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5
   Waldmann A, 2003, EUR J CLIN NUTR, V57, P947, DOI 10.1038/sj.ejcn.1601629
   Walter P, 2005, GESUNDHEITLICHE VOR
   Walter P, 2005, FUNFTER SCHWEIZERISC, P321
   Watanabe F, 2013, J AGR FOOD CHEM, V61, P6769, DOI 10.1021/jf401545z
   Weaver CM, 2012, PRESENT KNOWLEDGE NU
NR 53
TC 4
Z9 4
U1 37
U2 37
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD FEB
PY 2017
VL 56
IS 1
BP 283
EP 293
DI 10.1007/s00394-015-1079-7
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EK8IW
UT WOS:000394168100025
PM 26502280
OA No
DA 2017-08-15
ER

PT J
AU Nabwera, HM
   Fulford, AJ
   Moore, SE
   Prentice, AM
AF Nabwera, Helen M.
   Fulford, Anthony J.
   Moore, Sophie E.
   Prentice, Andrew M.
TI Growth faltering in rural Gambian children after four decades of
   interventions: a retrospective cohort study
SO LANCET GLOBAL HEALTH
LA English
DT Article
ID LOW-BIRTH-WEIGHT; NUTRITION; TRIAL; SUPPLEMENTATION; COUNTRIES;
   EFFICACY; VILLAGES; HEALTH
AB Background Growth faltering remains common in children in sub-Saharan Africa and is associated with substantial morbidity and mortality. Due to a very slow decline in the prevalence of stunting, the total number of children with stunting continues to rise in sub-Saharan Africa. Identifi cation of eff ective interventions remains a challenge.
   Methods We analysed the eff ect of 36 years of intensive health interventions on growth in infants and young children from three rural Gambian villages. Routine growth data from birth to age 2 years were available for 3659 children between 1976 and 2012. Z scores for weight-for-age, length-for-age, weight-for-length, mid-upper-arm circumference, and head circumference were calculated using the WHO 2006 growth standards. Seasonal patterns of mean Z scores were obtained by Fourier regression. We additionally defi ned growth faltering as fall in Z score between 3 months and 21 months of age.
   Findings We noted secular improvements in all postnatal growth parameters (except weight-for-length), accompanied by declines over time in seasonal variability. The proportion of children with underweight or stunting at 2 years of age halved during four decades of the study period, from 38.7% (95% CI 33.5-44.0) for underweight and 57.1% (51.9-62.4) for stunting. However, despite unprecedented levels of intervention, postnatal growth faltering persisted, leading to poor nutritional status at 24 months (length-for-age Z score -1.36, 95% CI -1.44 to -1.27, weight-for-age Z score -1.20, -1.28 to -1.11, and head circumference Z score -0.51, -0.59 to -0.43). The prevalence of stunting and underweight remained unacceptably high (30.0%, 95% CI 27.0-33.0, for stunting and 22.1%, 19.4 to 24.8, for underweight).
   Interpretation A combination of nutrition-sensitive and nutrition-specifi c interventions has achieved a halving of undernutrition rates, but despite these intensive interventions substantial growth faltering remains. We need to understand the missing contributors to growth faltering to guide development of new interventions.
C1 [Nabwera, Helen M.; Fulford, Anthony J.; Moore, Sophie E.; Prentice, Andrew M.] MRC Unit Gambia, POB 273, Banjul, Gambia.
   [Nabwera, Helen M.; Fulford, Anthony J.; Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England.
RP Prentice, AM (reprint author), MRC Unit Gambia, POB 273, Banjul, Gambia.
EM aprentice@mrc.gm
FU UK Medical Research Council, UK Department for International Development
FX UK Medical Research Council, UK Department for International
   Development.
CR Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002
   Arnold BF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003476
   Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2
   Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x
   The Gambia Government, NAT ED STAT GEND
   Gernand AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137269
   Herlihy JM, 2016, REPROD MATERNAL NEWB, V2
   Huicho L, 2016, LANCET GLOB HEALTH, V4, pE414, DOI 10.1016/S2214-109X(16)00085-1
   Humphrey JH, 2015, CLIN INFECT DIS, V61, pS685, DOI 10.1093/cid/civ844
   Husseini M., 2012, SOCIOECONOMIC FACTOR
   KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663
   de Mola CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092550
   Lund N, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-214
   Man WDC, 1998, TROP MED INT HEALTH, V3, P678
   Poskitt EME, 1999, ARCH DIS CHILD, V80, P115
   Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x
   Said-Mohamed R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1844-9
   Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x
   Umeta M, 2000, LANCET, V355, P2021, DOI 10.1016/S0140-6736(00)02348-5
   United Nations, 2015, SUST DEV GOALS
   UNICEF WHO & World Bank, 2015, LEV TRENDS CHILD MAL
   WHO DFID UNICEF USAID, 2003, AN REV INT MAN CHILD
   WHO, 2006, WHO GROWTH REF STAND
NR 25
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD FEB
PY 2017
VL 5
IS 2
BP E208
EP E216
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN9SW
UT WOS:000396340900026
PM 28104187
OA gold
DA 2017-08-15
ER

PT J
AU Wray, K
   Allen, A
   Evans, E
   Fisher, C
   Premawardhena, A
   Perera, L
   Rodrigo, R
   Goonathilaka, G
   Ramees, L
   Webster, C
   Armitage, AE
   Prentice, AM
   Weatherall, DJ
   Drakesmith, H
   Pasricha, SR
AF Wray, Katherine
   Allen, Angela
   Evans, Emma
   Fisher, Chris
   Premawardhena, Anuja
   Perera, Lakshman
   Rodrigo, Rexan
   Goonathilaka, Gayan
   Ramees, Lebbe
   Webster, Craig
   Armitage, Andrew E.
   Prentice, Andrew M.
   Weatherall, David J.
   Drakesmith, Hal
   Pasricha, Sant-Rayn
TI Hepcidin detects iron deficiency in Sri Lankan adolescents with a high
   burden of hemoglobinopathy: A diagnostic test accuracy study
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; BETA-THALASSEMIA; SUPPLEMENTATION;
   CHILDREN; SCREEN; ERYTHROPOIESIS; INFLAMMATION; FERROPORTIN; FERRITIN
AB Anemia affects over 800 million women and children globally. Measurement of hepcidin as an index of iron status shows promise, but its diagnostic performance where hemoglobinopathies are prevalent is unclear. We evaluated the performance of hepcidin as a diagnostic test of iron deficiency in adolescents across Sri Lanka.
   We selected 2273 samples from a nationally representative cross-sectional study of 7526 secondary schoolchildren across Sri Lanka and analyzed associations between hepcidin and participant characteristics, iron indices, inflammatory markers, and hemoglobinopathy states. We evaluated the diagnostic accuracy of hepcidin as a test for iron deficiency with estimation of the AUC(ROC), sensitivity/specificity at each hepcidin cutoff, and calculation of the Youden Index to find the optimal threshold.
   Hepcidin was associated with ferritin, sTfR, and hemoglobin. The AUC(ROC) for hepcidin as a test of iron deficiency was 0.78; hepcidin outperformed Hb and sTfR. The Youden index-predicted cutoff to detect iron deficiency (3.2 ng/mL) was similar to thresholds previously identified to predict iron utilization and identify deficiency in African populations. Neither age, sex, nor - or -thalassemia trait affected diagnostic properties of hepcidin. Hepcidin pre-screening would prevent most iron-replete thalassemia carriers from receiving iron whilst still ensuring most iron deficient children were supplemented. Our data indicate that the physiological relationship between hepcidin and iron status transcends specific populations. Measurement of hepcidin in individuals or populations could establish the need for iron interventions.
C1 [Wray, Katherine; Armitage, Andrew E.; Drakesmith, Hal; Pasricha, Sant-Rayn] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.
   [Wray, Katherine; Drakesmith, Hal] NIHR Oxford Biomed Res Ctr, BRC Blood Theme, Oxford, England.
   [Allen, Angela] Ctr Trop & Infect Dis, Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Evans, Emma; Webster, Craig] Birmingham Heartlands Hosp, Dept Biochem & Immunol, Birmingham, W Midlands, England.
   [Fisher, Chris; Weatherall, David J.] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England.
   [Premawardhena, Anuja; Perera, Lakshman; Rodrigo, Rexan; Goonathilaka, Gayan; Ramees, Lebbe] Univ Kelaniya, Dept Med, Colombo, Sri Lanka.
   [Prentice, Andrew M.] MRC Keneba, MRC Unit Gambia, Darusalam, Gambia.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
RP Drakesmith, H; Pasricha, SR (reprint author), Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.; Weatherall, DJ (reprint author), Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England.
EM Liz.rose@imm.ox.ac.uk; Alexander.drakesmith@ndm.ox.ac.uk;
   sant-rayn.pasricha@ndm.ox.ac.uk
FU Medical Research Council; NIHR Oxford Biomedical Research Centre;
   Wellcome Trust; Anthony Cerami and Ann Dunne Foundation for World
   Health; Bill and Melinda Gates Foundation
FX This study was funded by support from the Medical Research Council, NIHR
   Oxford Biomedical Research Centre, The Wellcome Trust, the Anthony
   Cerami and Ann Dunne Foundation for World Health, and the Bill and
   Melinda Gates Foundation. The funders had no role in the design or
   decision to publish the study.
CR Atkinson SH, 2014, BLOOD, V123, P3221, DOI 10.1182/blood-2013-10-533000
   Bah A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0934-8
   Choi Hyoung Soo, 2012, Korean J Hematol, V47, P286, DOI 10.5045/kjh.2012.47.4.286
   Chong SS, 2000, BLOOD, V95, P360
   de Silva S, 2000, LANCET, V355, P786, DOI 10.1016/S0140-6736(99)08246-X
   Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907
   Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013
   Garcia-Casal MN, 2014, LANCET HAEMATOL, V1, pE92, DOI 10.1016/S2352-3026(14)00025-8
   Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868
   Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112
   [Anonymous], 2013, IND MOHAFW GO
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   Jones E, 2015, BLOOD, V125, P873, DOI 10.1182/blood-2014-10-606491
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249
   Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960
   Premawardhena A, BR J HAEMAT IN PRESS
   Prentice AM, 2012, BLOOD
   Punnonen K, 1997, BLOOD, V89, P1052
   Sanad M, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-37
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Thurlow RA, 2005, AM J CLIN NUTR, V82, P380
   van der Vorm LN, 2016, CLIN CHEM, V62, P993, DOI 10.1373/clinchem.2016.256768
   Wegmuller R, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0689-4
   World Health Organization, 2011, PREV IR DEF AN AD RO
   World Health Organization, 2011, VIT MIN NUTR INF SYS
   WHO, 2015, GLOB PREV AN 2011
   Wolff F, 2016, SCAND J CLIN LAB INV, P1
   Zimmermann MB, 2008, AM J CLIN NUTR, V88, P1026
   Zimmermann MB, 2009, AM J CLIN NUTR, V90, P1280, DOI 10.3945/ajcn.2009.28129
NR 30
TC 1
Z9 1
U1 1
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
EI 1096-8652
J9 AM J HEMATOL
JI Am. J. Hematol.
PD FEB
PY 2017
VL 92
IS 2
BP 196
EP 203
DI 10.1002/ajh.24617
PG 8
WC Hematology
SC Hematology
GA EJ7TJ
UT WOS:000393425200017
PM 27883199
OA No
DA 2017-08-15
ER

PT J
AU Eriksen, KG
   Johnson, W
   Sonko, B
   Prentice, AM
   Darboe, MK
   Moore, SE
AF Eriksen, Kamilla G.
   Johnson, William
   Sonko, Bakary
   Prentice, Andrew M.
   Darboe, Momodou K.
   Moore, Sophie E.
TI Following the World Health Organization's Recommendation of Exclusive
   Breastfeeding to 6 Months of Age Does Not Impact the Growth of Rural
   Gambian Infants
SO JOURNAL OF NUTRITION
LA English
DT Article
DE exclusive breastfeeding; infant feeding practice; postnatal growth; The
   Gambia; multilevel modelling; reverse causality
ID RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; COMPLEMENTARY FOODS;
   BIRTH-WEIGHT; PROMOTION; INTERVENTION; LACTATION; COMMUNITY; HONDURAS;
   AFRICA
AB Background: The WHO recommends exclusive breastfeeding (EBF) for the first 6 mo of life.
   Objective: The objective of this study was to assess the benefit of EBF to age 6 mo on growth in a large sample of rural Gambian infants at high risk of undernutrition.
   Methods: Infants with growth monitoring from birth to 2 y of age In = 7561 from the ENID (Early Nutrition and Immune Development) trial were categorized as exclusively breastfed if only breast milk and no other liquids or foods were given. EBF status was entered into confounder-adjusted multilevel models to test associations with growth trajectories by using >11,000 weight-for-age (WAZ), length-for-age (LAZ), and weight-for-length (WLZ) z score observations.
   Results: Thirty-two percent of infants were exclusively breastfed to age 6 mo. The mean age of discontinuation of EBF was 5.2 mo, and growth faltering started at similar to 3.5 mo of age. Some evidence for a difference in WAZ and WHZ was found between infants who were exclusively breastfed to age 6 mo (EBF-6) and those who were not InEBF-6), at 6 and 12 mo of age, with EBF-6 children having a higher mean z score. The differences in z scores between the 2 groups were small in magnitude (at 6 mo of age: 0.147 WAZ; 95% Cl: -0.001, 0.293 WAZ; 0:189 WHZ; 95% CI: 0.038, 0.341 WHZ). No evidence for a difference between EBF-6 and nEBF-6 infants was observed for LAZ at any time point 16, 12, and 24 mo of age). Furthermore, a higher mean WLZ at 3 mo of age was associated with a subsequent higher mean age at discontinuation of EBF, which implied reverse causality in this setting (coefficient: 0.060; 95% Cl: 0.008, 0.1201.
   Conclusion: This study suggests that EBF to age 6 mo has limited benefit to the growth of rural Gambian infants. This trial was registered at http://www.isrctn.com as ISRCTN49285450.
C1 [Eriksen, Kamilla G.; Johnson, William] Elsie Widdowson Lab, MRC, Cambridge, England.
   [Sonko, Bakary; Prentice, Andrew M.; Darboe, Momodou K.; Moore, Sophie E.] MRC Unit Gambia, Banjul, Gambia.
   [Prentice, Andrew M.] London Sch Hyg & Trop Med, Int Nutr Grp, MRC, London, England.
   [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England.
RP Eriksen, KG (reprint author), Elsie Widdowson Lab, MRC, Cambridge, England.
EM kamilla.eriksen@mrc-ewl.cam.ac.uk
FU UK Medical Research Council (MRC) [MC-A760-5QX00, MC_UP_1005]; UK
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement
FX Supported by the UK Medical Research Council (MRC; grants MC-A760-5QX00
   and MC_UP_1005) and the UK Department for International Development
   (DFID) under the MRC/DFID Concordat agreement. This is an open access
   article distributed under the CC-BY license
   (http://creativecommons.org/licenses/by/3.0/).
CR Allen LH, 2012, ADV NUTR, V3, P362, DOI 10.3945/an.111.001172
   Agence Nationale de la Statistique et de la Demographie (ANSD) [Senegal] and ICF International, 2012, SEN DEM HLTH MULT IN
   Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0
   Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786
   COHEN RJ, 1994, LANCET, V344, P288, DOI 10.1016/S0140-6736(94)91337-4
   Dewey KG, 1999, AM J CLIN NUTR, V69, P679
   Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462
   Eckhardt CL, 2001, J NUTR, V131, P2304
   Engebretsen IMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-633
   Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x
   Giugliani ERJ, 2015, ACTA PAEDIATR, V104, P20, DOI 10.1111/apa.13160
   Hawley NL, 2014, PEDIATR OBES, V9, pE1, DOI 10.1111/j.2047-6310.2012.00137.x
   International Food Policy Research Institute, 2015, NUTR SUBR PROF
   Jakobsen MS, 2008, ACTA PAEDIATR, V97, P68, DOI 10.1111/j.1651-2227.2007.00532.x
   Johnson W, 2015, AM J HUM BIOL, V27, P69, DOI 10.1002/ajhb.22589
   Khadivzadeh T, 2004, East Mediterr Health J, V10, P289
   Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2
   Kramer MS, 2012, EPIDEMIOLOGY, V23, P790, DOI 10.1097/EDE.0b013e31826cc0e9
   Kramer MS, 2003, AM J CLIN NUTR, V78, P291
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967
   Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158
   PRENTICE AM, 1994, EUR J CLIN NUTR, V48, pS78
   PRENTICE AM, 1995, P NUTR SOC, V54, P391, DOI 10.1079/PNS19950008
   Prentice AM, 1994, EUR J CLIN NUTR, V48, pS86
   Prentice AM, 2013, WORLD REV NUTR DIET, V106, P90, DOI 10.1159/000342563
   Rees CP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157790
   Simondon KB, 1997, EUR J CLIN NUTR, V51, P703, DOI 10.1038/sj.ejcn.1600470
   Vail B, 2015, J PEDIAT, V167, pe1
   Vail B, 2015, J PEDIATR-US, V167, P317, DOI 10.1016/j.jpeds.2015.05.003
   Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519
   Victora CG, 1998, AM J CLIN NUTR, V67, P452
   WATERLOW JC, 1979, LANCET, V2, P238
   WHITEHEAD RG, 1984, EARLY HUM DEV, V9, P187, DOI 10.1016/0378-3782(84)90031-8
   World Health Organization, 2002, NUTR AD EXCL BREAST
   World Health Organization, 2003, GLOB STRAT INF YOUNG
NR 36
TC 1
Z9 1
U1 1
U2 1
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD FEB
PY 2017
VL 147
IS 2
BP 248
EP 255
DI 10.3945/jn.116.241737
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EJ6XF
UT WOS:000393363500014
PM 28003540
OA No
DA 2017-08-15
ER

PT J
AU Oluwalana, C
   Camara, B
   Bottomley, C
   Goodier, S
   Bojang, A
   Kampmann, B
   Ceesay, S
   D'Alessandro, U
   Roca, A
AF Oluwalana, Claire
   Camara, Bully
   Bottomley, Christian
   Goodier, Sean
   Bojang, Abdoulie
   Kampmann, Beate
   Ceesay, Samba
   D'Alessandro, Umberto
   Roca, Anna
TI Azithromycin in Labor Lowers Clinical Infections in Mothers and
   Newborns: A Double-Blind Trial
SO PEDIATRICS
LA English
DT Article
ID LACTATING WOMEN; SEPSIS; PREVENTION; GAMBIA; HEALTH; MORTALITY;
   PROTOCOL; DISEASE; AFRICA; MILK
AB BACKGROUND AND OBJECTIVES: We have recently completed a proof-of-concept trial showing that bacterial colonization decreased in women and newborns after the administration of azithromycin during labor. Here, we aim to assess the effect of the intervention on maternal and neonatal clinical infections.
   METHODS: This was a double-blind, placebo-controlled randomized trial. Gambian women in labor were given either an oral dose of azithromycin (2 g) or placebo. Follow-up was conducted for 8 weeks after delivery.
   RESULTS: From April 2013 to April 2014, we recruited 829 mothers and their 830 newborns. Sixteen infants died during the follow-up period (8 per arm). No maternal deaths or serious adverse events related to the intervention were reported. Maternal infections were lower in the azithromycin group (3.6% vs 9.2%; relative risk [RR], 0.40; 95% confidence interval [CI], 0.22-0.71; P = .002), as was the prevalence of mastitis (1.4% vs 5.1%; RR, 0.29; 95% CI, 0.12-0.70; P = .005) and fever (1.9% vs 5.8%; RR, 0.33; 95% CI, 0.15-0.74; P = .006). Among newborns, the overall prevalence of infections was also lower in the azithromycin group (18.1% vs 23.8%; RR, 0.76; 95% CI, 0.58-0.99; P = .052) and there was a marked difference in prevalence of skin infections (3.1% vs 6.4%; RR, 0.49; 95% CI, 0.25-0.93; P = .034).
   CONCLUSIONS: Azithromycin given to women in labor decreases infections in both women and newborns during the puerperal period. Larger studies designed to evaluate the effect of the intervention on severe morbidity and mortality are warranted.
C1 [Oluwalana, Claire; Camara, Bully; Bojang, Abdoulie; Kampmann, Beate; D'Alessandro, Umberto; Roca, Anna] MRC Unit, Banjul, Gambia.
   [Bottomley, Christian; D'Alessandro, Umberto; Roca, Anna] London Sch Hyg & Trop Med, London, England.
   [Goodier, Sean] London Sch Econ, London, England.
   [Kampmann, Beate] Imperial Coll, London, England.
   [Ceesay, Samba] Minist Hlth & Social Welf, Banjul, Gambia.
   [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
RP Roca, A (reprint author), MRC Unit, Dis Control & Eliminat, Atlantic Rd,POB 273, Banjul 273, Gambia.
EM aroca@mrc.gm
FU Medical Research Council (MRC) UK [MR/J010391/1]; Department for
   International Development (DFID) under the MRC/DFID Concordat, EDCTP2
   program - European Union [MR/J010391/1]
FX All phases of this study were supported by joint funding from the
   Medical Research Council (MRC) UK and the Department for International
   Development (DFID) under the MRC/DFID Concordat agreement as part of the
   EDCTP2 program supported by the European Union (reference MR/J010391/1).
CR Amir LH, 2004, BJOG-INT J OBSTET GY, V111, P1378, DOI 10.1111/j.1471-0528.2004.00272.x
   Amir LH, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-54
   Amir LH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-62
   Arulkumaran N, 2013, BEST PRACT RES CL OB, V27, P893, DOI 10.1016/j.bpobgyn.2013.07.004
   AVERY VM, 1991, EUR J CLIN MICROBIOL, V10, P1034, DOI 10.1007/BF01984925
   Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8
   Berardi A, 2013, ACTA PAEDIATR, V102, pe95, DOI 10.1111/apa.12127
   Bonet M, 2015, LANCET GLOB HEALTH, V3, pE667, DOI 10.1016/S2214-109X(15)00213-2
   Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8
   DREW RH, 1992, PHARMACOTHERAPY, V12, P161
   Eberly MD, 2015, PEDIATRICS, V135, P483, DOI 10.1542/peds.2014-2026
   Fernandez-Perez Evans R, 2005, Crit Care Med, V33, pS286, DOI 10.1097/01.CCM.0000182479.63108.CD
   Ghosh S, 2015, INDIAN J DERMATOL, V60, P219, DOI 10.4103/0019-5154.156310
   Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kaplan A, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-26
   Leach A, 1999, ANN TROP PAEDIATR, V19, P33, DOI 10.1080/02724939992617
   Lucas DN, 2012, INT J OBSTET ANESTH, V21, P56, DOI 10.1016/j.ijoa.2011.11.001
   Maayan-Metzger A, 2003, ARCH DIS CHILD, V88, P312
   Mallika Ps, 2008, Malays Fam Physician, V3, P77
   Mogre Dilesh Arvind, 2013, Australas Med J, V6, P532, DOI 10.4066/AMJ.2013.1834
   Mullany LC, 2003, PEDIATR INFECT DIS J, V22, P996, DOI 10.1097/01.inf.0000095429.97172.48
   OBI CL, 1995, E AFR MED J, V72, P370
   Roca A, 2016, CLIN MICROBIOL INFEC, V22
   Roca A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0737-3
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103
   Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0
   Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25369
   van den Broek NR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000191
   Waters Donald, 2011, J Glob Health, V1, P154
   Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769
NR 32
TC 0
Z9 0
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD FEB
PY 2017
VL 139
IS 2
AR e20162281
DI 10.1542/peds.2016-2281
PG 11
WC Pediatrics
SC Pediatrics
GA EJ2JC
UT WOS:000393035100010
OA No
DA 2017-08-15
ER

PT J
AU Claessens, A
   Affara, M
   Assefa, SA
   Kwiatkowski, DP
   Conway, DJ
AF Claessens, Antoine
   Affara, Muna
   Assefa, Samuel A.
   Kwiatkowski, Dominic P.
   Conway, David J.
TI Culture adaptation of malaria parasites selects for convergent
   loss-of-function mutants
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PLASMODIUM-FALCIPARUM; IN-VITRO; TRANSMISSION; POPULATIONS; EVOLUTION;
   COMMITMENT; MUTATIONS; DIVERSITY; VARIANTS; MOSQUITO
AB Cultured human pathogens may differ significantly from source populations. To investigate the genetic basis of laboratory adaptation in malaria parasites, clinical Plasmodium falciparum isolates were sampled from patients and cultured in vitro for up to three months. Genome sequence analysis was performed on multiple culture time point samples from six monoclonal isolates, and single nucleotide polymorphism (SNP) variants emerging over time were detected. Out of a total of five positively selected SNPs, four represented nonsense mutations resulting in stop codons, three of these in a single ApiAP2 transcription factor gene, and one in SRPK1. To survey further for nonsense mutants associated with culture, genome sequences of eleven long-term laboratory-adapted parasite strains were examined, revealing four independently acquired nonsense mutations in two other ApiAP2 genes, and five in Epac. No mutants of these genes exist in a large database of parasite sequences from uncultured clinical samples. This implicates putative master regulator genes in which multiple independent stop codon mutations have convergently led to culture adaptation, affecting most laboratory lines of P. falciparum. Understanding the adaptive processes should guide development of experimental models, which could include targeted gene disruption to adapt fastidious malaria parasite species to culture.
C1 [Claessens, Antoine; Assefa, Samuel A.; Conway, David J.] London Sch Hyg & Trop Med, London, England.
   [Claessens, Antoine; Affara, Muna] MRC, Unit Gambia, Atlantic Rd,POB 273, Banjul, Gambia.
   [Kwiatkowski, Dominic P.] Wellcome Trust Res Labs, Sanger Inst, Cambridge, England.
RP Claessens, A; Conway, DJ (reprint author), London Sch Hyg & Trop Med, London, England.; Claessens, A (reprint author), MRC, Unit Gambia, Atlantic Rd,POB 273, Banjul, Gambia.
EM antoineclaessens@gmail.com; david.conway@lshtm.ac.uk
OI Kwiatkowski, Dominic/0000-0002-5023-0176
FU UK Medical Research Council [G1100123, G0600718]; MRC Gambia-LSHTM
   Fellowship; European Research Council [AdG-2011-294428]; Wellcome Trust
   [090770/Z/09/Z]
FX We thank the malaria patients and their families who consented to
   provide blood samples for parasite culture analysis, and clinical staff
   at the health facilities. We are grateful to colleagues at the Medical
   Research Council Unit in The Gambia who facilitated sample processing
   and management of facilities, particularly Idrissa Sambou, Simon Correa,
   Sarah Nogaro, Michael Walther, Aubrey Cunnington, Alfred Amambua-Ngwa,
   and Davis Nwakanma. We thank Lindsay Stewart, Bronwyn MacInnis, Vikki
   Cornelius, Eleanor Drury, Daniel Mead and colleagues who helped with
   subsequent sample processing, genome sequencing and data archiving.
   David Baker and Rob Moon gave very helpful comments on the manuscript.
   This publication uses data generated by the Pf3k project
   (www.malariagen.net/pf3k). The research was supported by funding from
   the UK Medical Research Council (grants G1100123 and G0600718 and core
   support to the MRC Gambia Unit), an MRC Gambia-LSHTM Fellowship award to
   A.C., the European Research Council (AdG-2011-294428), and The Wellcome
   Trust (090770/Z/09/Z).
CR Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005
   Amir A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24623
   Bass CC, 1912, J EXP MED, V16, P567, DOI 10.1084/jem.16.4.567
   BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428
   Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165
   Claessens A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004812
   Covert AW, 2013, P NATL ACAD SCI USA, V110, pE3171, DOI 10.1073/pnas.1313424110
   Dawn A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004520
   Delves MJ, 2016, NAT PROTOC, V11, P1668, DOI 10.1038/nprot.2016.096
   Dixit A, 2010, J BIOL CHEM, V285, P38315, DOI 10.1074/jbc.M110.119255
   Epstein SS, 2013, CURR OPIN MICROBIOL, V16, P636, DOI 10.1016/j.mib.2013.08.003
   Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829
   Frenkel EM, 2015, P NATL ACAD SCI USA, V112, P11306, DOI 10.1073/pnas.1506184112
   Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303
   Gruring C, 2014, CELL MICROBIOL, V16, P612, DOI 10.1111/cmi.12275
   Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375
   Hottes AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003617
   Kafsack BFC, 2014, NATURE, V507, P248, DOI 10.1038/nature12920
   Kvitek DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003972
   Lenski RE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2292
   Manske HM, 2009, GENOME RES, V19, P2125, DOI 10.1101/gr.093443.109
   Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174
   McDonald MJ, 2016, NATURE, V531, P233, DOI 10.1038/nature17143
   Mikolajczak SA, 2008, MOL CELL BIOL, V28, P6196, DOI 10.1128/MCB.00553-08
   Miles A, 2016, GENOME RES, V26, P1288, DOI 10.1101/gr.203711.115
   Militello KT, 2004, MOL BIOCHEM PARASIT, V134, P75, DOI 10.1016/j.molbiopara.2003.11.004
   Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073
   Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624
   Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599
   Ngwa CJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-256
   Obenchain V, 2014, BIOINFORMATICS, V30, P2076, DOI 10.1093/bioinformatics/btu168
   Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014
   Qian WF, 2012, CELL REP, V2, P1399, DOI 10.1016/j.celrep.2012.09.017
   Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003
   Ribacke U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069781
   Rodriguez-Verdugo A, 2016, MOL BIOL EVOL, V33, P25, DOI 10.1093/molbev/msv228
   Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970
   Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7
   Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558
   Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12
   Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   Wu W, 2015, ANTIMICROB AGENTS CH, V59, P356, DOI 10.1128/AAC.03342-14
NR 43
TC 2
Z9 2
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 24
PY 2017
VL 7
AR 41303
DI 10.1038/srep41303
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI4SC
UT WOS:000392482600001
PM 28117431
OA gold
DA 2017-08-15
ER

PT J
AU Davis, JCC
   Lewis, ZT
   Krishnan, S
   Bernstein, RM
   Moore, SE
   Prentice, AM
   Mills, DA
   Lebrilla, CB
   Zivkovic, AM
AF Davis, Jasmine C. C.
   Lewis, Zachery T.
   Krishnan, Sridevi
   Bernstein, Robin M.
   Moore, Sophie E.
   Prentice, Andrew M.
   Mills, David A.
   Lebrilla, Carlito B.
   Zivkovic, Angela M.
TI Growth and Morbidity of Gambian Infants are Influenced by Maternal Milk
   Oligosaccharides and Infant Gut Microbiota
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INFLAMMATORY-BOWEL-DISEASE; LONGUM SUBSP INFANTIS; BREAST-FED INFANTS;
   FUCOSYLATED OLIGOSACCHARIDES; INTESTINAL INFLAMMATION; FECAL
   CALPROTECTIN; SIALIC-ACID; IN-VITRO; BIFIDOBACTERIA; LACTATION
AB Human milk oligosaccharides (HMOs) play an important role in the health of an infant as substrate for beneficial gut bacteria. Little is known about the effects of HMO composition and its changes on the morbidity and growth outcomes of infants living in areas with high infection rates. Mother's HMO composition and infant gut microbiota from 33 Gambian mother/ infant pairs at 4, 16, and 20 weeks postpartum were analyzed for relationships between HMOs, microbiota, and infant morbidity and growth. The data indicate that lacto-N-fucopentaose I was associated with decreased infant morbidity, and 3'-sialyllactose was found to be a good indicator of infant weight-for-age. Because HMOs, gut microbiota, and infant health are interrelated, the relationship between infant health and their microbiome were analyzed. While bifidobacteria were the dominant genus in the infant gut overall, Dialister and Prevotella were negatively correlated with morbidity, and Bacteroides was increased in infants with abnormal calprotectin. Mothers nursing in the wet season (July to October) produced significantly less oligosaccharides compared to those nursing in the dry season (November to June). These results suggest that specific types and structures of HMOs are sensitive to environmental conditions, protective of morbidity, predictive of growth, and correlated with specific microbiota.
C1 [Davis, Jasmine C. C.; Lebrilla, Carlito B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
   [Davis, Jasmine C. C.; Lewis, Zachery T.; Mills, David A.; Lebrilla, Carlito B.; Zivkovic, Angela M.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA.
   [Lewis, Zachery T.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.
   [Krishnan, Sridevi; Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
   [Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.
   [Bernstein, Robin M.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.
   [Bernstein, Robin M.] Univ Colorado, Inst Behav Sci, Hlth & Soc Program, Boulder, CO 80309 USA.
   [Moore, Sophie E.] Med Res Council MRC Human Nutr Res, Cambridge, England.
   [Moore, Sophie E.; Prentice, Andrew M.] MRC Unit, Serekunda, Gambia.
   [Moore, Sophie E.; Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
RP Zivkovic, AM (reprint author), Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA.; Zivkovic, AM (reprint author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
EM amzivkovic@ucdavis.edu
FU UK Medical Research Council (MRC) [MC-A760-5QX00]; UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement;
   Grand Challenges Explorations award from the Bill and Melinda Gates
   Foundation [OPP1046163]; UK MRC programme [MC_UP_1005/1]; Alfred P.
   Sloan Foundation Microbiology of the Built Environment program; National
   Institutes of Health [AT007079, HD061923, AT008759]; Peter J. Shields
   Endowed Chair in Dairy Food Science
FX We thank the women of West Kiang who patiently participated in the
   study. We acknowledge the enthusiastic work of the ENID and
   ENID-Bioactives study teams, especially the fieldworkers, clinical staff
   (research clinicians, midwives, and nurses), and laboratory technicians
   who tirelessly collected the data and samples. We would also like to
   thank L. D. Wu and S. M. Totten for their help in processing the milk
   samples, and H. Drought for calprotectin analysis. The ENID trial was
   supported by the UK Medical Research Council (MRC) (MC-A760-5QX00) and
   the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement. The ENID-Bioactives sub-study was
   supported by a Grand Challenges Explorations award (OPP1046163) from the
   Bill and Melinda Gates Foundation to R.M.B., S.E.M., and A.M.P. S.E.M.
   is funded by the UK MRC programme MC_UP_1005/1. Z.T.L. is supported by a
   postdoctoral fellowship from the Alfred P. Sloan Foundation Microbiology
   of the Built Environment program. This work was funded in part by
   National Institutes of Health Awards AT007079 (D.A.M.), HD061923
   (C.B.L.), and AT008759 (D.A.M.), and the Peter J. Shields Endowed Chair
   in Dairy Food Science (D.A.M.).
CR Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI 10.1016/j.chom.2015.04.004
   Bath-Hextall FJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005205.pub3
   BEIGHTON D, 1990, J CLIN MICROBIOL, V28, P1431
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14
   Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074
   Brooks S. A., 2002, FUNCTIONAL MOL GLYCO
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024
   Charrier C, 2006, MICROBIOL-SGM, V152, P179, DOI 10.1099/MIC.0.28412-0
   Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365
   Chichlowski M, 2012, J PEDIATR GASTR NUTR, V55, P321, DOI 10.1097/MPG.0b013e31824fb899
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Coppa GV, 2011, J PEDIATR GASTR NUTR, V53, P80, DOI 10.1097/MPG.0b013e3182073103
   COPPA GV, 1993, PEDIATRICS, V91, P637
   Coppa GV, 1999, ACTA PAEDIATR, V88, P89, DOI 10.1080/080352599750029808
   Darboe MK, 2007, LANCET, V369, P2088, DOI 10.1016/S0140-6736(07)60981-7
   De Leoz MLA, 2012, J PROTEOME RES, V11, P4662, DOI 10.1021/pr3004979
   De Vuyst L, 2011, INT J FOOD MICROBIOL, V149, P73, DOI 10.1016/j.ijfoodmicro.2011.03.003
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Fagerberg UL, 2007, J PEDIATR GASTR NUTR, V45, P414
   Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0
   Flass T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116967
   Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8
   Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646
   Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012
   Garrido D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017315
   German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322
   Gough EK, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0089-2
   HAYANO S, 1969, J BACTERIOL, V97, P1328
   Huang YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9141
   Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937
   Kettle H, 2015, ENVIRON MICROBIOL, V17, P1615, DOI 10.1111/1462-2920.12599
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z
   Lewis ZT, 2013, ANAEROBE, V19, P62, DOI 10.1016/j.anaerobe.2012.12.005
   Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480
   LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10
   Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007
   MCGREGOR IA, 1970, T ROY SOC TROP MED H, V64, P48, DOI 10.1016/0035-9203(70)90196-3
   Mezoff EA, 2016, AM J PHYSIOL-GASTR L, V310, pG427, DOI 10.1152/ajpgi.00305.2015
   Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553
   Newburg DS, 2004, GLYCOBIOLOGY, V14, P253, DOI 10.1093/glycob/cwh020
   Newburg D.S, 1995, HDB MILK COMPOSITION, P273, DOI 10.1016/B978-012384430-9/50015-9
   Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Perret A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022918
   Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6
   Preising J, 2010, APPL ENVIRON MICROB, V76, P3048, DOI 10.1128/AEM.03127-09
   PRENTICE A, 1984, ACTA PAEDIATR SCAND, V73, P803, DOI 10.1111/j.1651-2227.1984.tb17779.x
   PRENTICE A, 1981, BRIT J NUTR, V45, P495, DOI 10.1079/BJN19810128
   PRENTICE AM, 1981, AM J CLIN NUTR, V34, P2790
   Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x
   Rodriguez-Diaz J, 2011, APPL ENVIRON MICROB, V77, P703, DOI 10.1128/AEM.01906-10
   Romond MB, 2008, ANAEROBE, V14, P43, DOI 10.1016/j.anaerobe.2007.09.003
   Ruhaak LR, 2012, BMB REP, V45, P442, DOI 10.5483/BMBRep.2012.45.8.161
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105
   Sheil B, 2006, CLIN EXP IMMUNOL, V144, P273, DOI 10.1111/j.1365-2249.2006.03051.x
   Tanabe S, 2008, INT J MOL MED, V22, P181, DOI 10.3892/ijmm_00000006
   Totten SM, 2014, ANAL BIOANAL CHEM, V406, P7925, DOI 10.1007/s00216-014-8261-2
   Totten SM, 2012, J PROTEOME RES, V11, P6124, DOI 10.1021/pr300769g
   Underwood MA, 2013, J PEDIATR-US, V163, P1585, DOI 10.1016/j.jpeds.2013.07.017
   Urashima T., 2009, ADV DAIRY CHEM LACTO, P295, DOI 10.1007/978-0-387-84865-5_8
   van der Merwe LF, 2013, AM J CLIN NUTR, V97, P45, DOI 10.3945/ajcn.112.042267
   Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007
   von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x
   Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Wang Y, 2012, HDB ANTHROPOMETRY PH, P29, DOI DOI 10.1007/978-1-4419-1788-1
   Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150
   WHITEHEAD RG, 1978, LANCET, V2, P178
   Wu SA, 2011, J PROTEOME RES, V10, P856, DOI 10.1021/pr101006u
   Wu SA, 2010, J PROTEOME RES, V9, P4138, DOI 10.1021/pr100362f
   Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065
   Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107
NR 82
TC 0
Z9 0
U1 19
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 12
PY 2017
VL 7
AR 40466
DI 10.1038/srep40466
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH3LV
UT WOS:000391674100001
PM 28079170
OA gold
DA 2017-08-15
ER

PT J
AU Clarke, GM
   Rockett, K
   Kivinen, K
   Hubbart, C
   Jeffreys, AE
   Rowlands, K
   Jallow, M
   Conway, DJ
   Bojang, KA
   Pinder, M
   Usen, S
   Sisay-Joof, F
   Sirugo, G
   Toure, O
   Thera, MA
   Konate, S
   Sissoko, S
   Niangaly, A
   Poudiougou, B
   Mangano, VD
   Bougouma, EC
   Sirima, SB
   Modioano, D
   Amenga-Etego, LN
   Ghansah, A
   Koram, KA
   Wilson, MD
   Enimil, A
   Evans, J
   Amodu, OK
   Olaniyan, S
   Apinjoh, T
   Mugri, R
   Ndi, A
   Ndila, CM
   Uyoga, S
   Macharia, A
   Peshu, N
   Williams, TN
   Manjurano, A
   Sepulveda, N
   Clark, TG
   Riley, E
   Drakeley, C
   Reyburn, H
   Nyirongo, V
   Kachala, D
   Molyneux, M
   Dunstan, SJ
   Phu, NH
   Quyen, NN
   Thai, CQ
   Hien, TT
   Manning, L
   Laman, M
   Siba, P
   Karunajeewa, H
   Allen, S
   Allen, A
   Davis, TME
   Michon, P
   Mueller, I
   Molloy, SF
   Campino, S
   Kerasidou, A
   Cornelius, VJ
   Hart, L
   Shah, SS
   Band, G
   Spencer, CCA
   Agbenyega, T
   Achidi, E
   Doumbo, OK
   Farrar, J
   Marsh, K
   Taylor, T
   Kwaitkowski, DP
AF Clarke, Geraldine M.
   Rockett, Kirk
   Kivinen, Katja
   Hubbart, Christina
   Jeffreys, Anna E.
   Rowlands, Kate
   Jallow, Muminatou
   Conway, David J.
   Bojang, Kalifa A.
   Pinder, Margaret
   Usen, Stanley
   Sisay-Joof, Fatoumatta
   Sirugo, Giorgio
   Toure, Ousmane
   Thera, Mahamadou A.
   Konate, Salimata
   Sissoko, Sibiry
   Niangaly, Amadou
   Poudiougou, Belco
   Mangano, Valentina D.
   Bougouma, Edith C.
   Sirima, Sodiomon B.
   Modioano, David
   Amenga-Etego, Lucas N.
   Ghansah, Anita
   Koram, Kwadwo A.
   Wilson, Michael D.
   Enimil, Anthony
   Evans, Jennifer
   Amodu, Olukemi K.
   Olaniyan, Subulade
   Apinjoh, Tobias
   Mugri, Regina
   Ndi, Andre
   Ndila, Carolyne M.
   Uyoga, Sophie
   Macharia, Alexander
   Peshu, Norbert
   Williams, Thomas N.
   Manjurano, Alphaxard
   Sepulveda, Nuno
   Clark, Taane G.
   Riley, Eleanor
   Drakeley, Chris
   Reyburn, Hugh
   Nyirongo, Vysaul
   Kachala, David
   Molyneux, Malcolm
   Dunstan, Sarah J.
   Nguyen Hoan Phu
   Nguyen Ngoc Quyen
   Cao Quang Thai
   Tran Tinh Hien
   Manning, Laurens
   Laman, Moses
   Siba, Peter
   Karunajeewa, Harin
   Allen, Steve
   Allen, Angela
   Davis, Timothy M. E.
   Michon, Pascal
   Mueller, Ivo
   Molloy, SIle F.
   Campino, Susan
   Kerasidou, Angeliki
   Cornelius, Victoria J.
   Hart, Lee
   Shah, Shivang S.
   Band, Gavin
   Spencer, Chris C. A.
   Agbenyega, Tsiri
   Achidi, Eric
   Doumbo, Ogobara K.
   Farrar, Jeremy
   Marsh, Kevin
   Taylor, Terrie
   Kwaitkowski, Dominic P.
CA MalariaGEn Consortium
TI Characterisation of the opposing effects of G6PD deficiency on cerebral
   malaria and severe malarial anaemia
SO ELIFE
LA English
DT Article
ID PLASMODIUM-FALCIPARUM TRANSMISSION; SEX-LINKED LOCUS; NATURAL-SELECTION;
   WEST-AFRICA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY;
   DEHYDROGENASE-DEFICIENCY; LINKAGE DISEQUILIBRIUM; HETEROZYGOTE
   ADVANTAGE; 2 AREAS; CHILDREN
AB Glucose-6-phosphate dehydrogenase (G6PD) deficiency is believed to confer protection against Plasmodium falciparum malaria, but the precise nature of the protective effect has proved difficult to define as G6PD deficiency has multiple allelic variants with different effects in males and females, and it has heterogeneous effects on the clinical outcome of P. falciparum infection. Here we report an analysis of multiple allelic forms of G6PD deficiency in a large multi-centre case-control study of severe malaria, using the WHO classification of G6PD mutations to estimate each individuals level of enzyme activity from their genotype. Aggregated across all genotypes, we find that increasing levels of G6PD deficiency are associated with decreasing risk of cerebral malaria, but with increased risk of severe malarial anaemia. Models of balancing selection based on these findings indicate that an evolutionary trade-off between different clinical outcomes of P. falciparum infection could have been a major cause of the high levels of G6PD polymorphism seen in human populations.
C1 [Clarke, Geraldine M.; Rockett, Kirk; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Molloy, SIle F.; Kerasidou, Angeliki; Cornelius, Victoria J.; Hart, Lee; Shah, Shivang S.; Band, Gavin; Spencer, Chris C. A.; Kwaitkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Clarke, Geraldine M.; Rockett, Kirk; Cornelius, Victoria J.; Band, Gavin; Kwaitkowski, Dominic P.] Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England.
   [Rockett, Kirk; Kivinen, Katja; Campino, Susan; Kwaitkowski, Dominic P.; MalariaGEn Consortium] Wellcome Trust Sanger Inst, Cambridge, England.
   [Jallow, Muminatou; Conway, David J.; Bojang, Kalifa A.; Pinder, Margaret; Usen, Stanley; Sisay-Joof, Fatoumatta; Sirugo, Giorgio] Med Res Council Gambia, Fajara, Gambia.
   [Jallow, Muminatou] Edward Small Teaching Hosp, Independence Dr, Banjul, Gambia.
   [Conway, David J.; Clark, Taane G.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England.
   [Toure, Ousmane; Thera, Mahamadou A.; Konate, Salimata; Sissoko, Sibiry; Niangaly, Amadou; Poudiougou, Belco; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali.
   [Mangano, Valentina D.; Modioano, David] Univ Roma La Sapienza, Rome, Italy.
   [Bougouma, Edith C.; Sirima, Sodiomon B.] CNRFP, Ouagadougou, Burkina Faso.
   [Amenga-Etego, Lucas N.] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Ghansah, Anita; Koram, Kwadwo A.; Wilson, Michael D.] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana.
   [Enimil, Anthony; Agbenyega, Tsiri] Komfo Anoyke Teaching Hosp, Kumasi, Ghana.
   [Evans, Jennifer] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.
   [Evans, Jennifer] Kumasi Ctr Collaborat Res, Kumasi, Ghana.
   [Amodu, Olukemi K.; Olaniyan, Subulade] Univ Ibadan, Ibadan, Nigeria.
   [Apinjoh, Tobias] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon.
   [Mugri, Regina; Ndi, Andre; Achidi, Eric] Univ Buea, Dept Med Lab Sci, Buea, Cameroon.
   [Ndila, Carolyne M.; Uyoga, Sophie; Macharia, Alexander; Peshu, Norbert; Williams, Thomas N.; Marsh, Kevin] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.
   [Williams, Thomas N.] Imperial Coll, Fac Med, Dept Med, London, England.
   [Manjurano, Alphaxard; Drakeley, Chris; Reyburn, Hugh] Kilimanjaro Christian Med Coll, Joint Malaria Programme, Moshi, Tanzania.
   [Manjurano, Alphaxard; Sepulveda, Nuno; Clark, Taane G.; Riley, Eleanor; Drakeley, Chris; Reyburn, Hugh] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Nyirongo, Vysaul; Molyneux, Malcolm] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.
   [Kachala, David; Nguyen Hoan Phu; Nguyen Ngoc Quyen; Cao Quang Thai; Tran Tinh Hien; Farrar, Jeremy] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Molyneux, Malcolm] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England.
   [Dunstan, Sarah J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.
   [Nguyen Hoan Phu; Cao Quang Thai; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam.
   [Tran Tinh Hien; Manning, Laurens; Laman, Moses; Siba, Peter; Michon, Pascal; Mueller, Ivo] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea.
   [Karunajeewa, Harin; Davis, Timothy M. E.] Univ Western Australia, Perth, WA, Australia.
   [Allen, Steve] Swansea Univ, Swansea, W Glam, Wales.
   [Allen, Angela] Univ Oxford, Weatherall Inst Mol Med, Oxford, England.
   [Michon, Pascal] Divine Word Univ, Fac Med & Hlth Sci, Madang, Papua N Guinea.
   [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.
   [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain.
   [Kerasidou, Angeliki] Univ Oxford, Ethox Ctr, Nuffield Dept Populat Hlth, Oxford, England.
   [Shah, Shivang S.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana.
   [Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England.
   [Taylor, Terrie] Univ Malawi, Blantyre Malaria Project, Coll Med, Blantyre, Malawi.
RP Clarke, GM; Rockett, K; Kwaitkowski, DP (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Clarke, GM; Rockett, K; Kwaitkowski, DP (reprint author), Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England.; Rockett, K; Kwaitkowski, DP (reprint author), Wellcome Trust Sanger Inst, Cambridge, England.
EM gclarke@well.ox.ac.uk; krockett@well.ox.ac.uk; dominic@well.ox.ac.uk
RI Manning, Laurens/H-5360-2014; Riley, Eleanor/C-8960-2013
OI Manning, Laurens/0000-0003-4334-5351; Riley,
   Eleanor/0000-0003-3447-3570; Kwiatkowski, Dominic/0000-0002-5023-0176;
   Sepulveda, Nuno/0000-0002-8542-1706
FU Wellcome Trust [090770/Z/09/Z, 097364/Z/11/Z, 076934/Z/05/Z,
   091758/Z/10/Z, 084538, 089276/Z/09/Z, 077383/Z/05/Z, 090532/Z/09/Z,
   077012/Z/05/Z, 087285, 096527]; Foundation for the National Institutes
   of Health [566]; European Commission [LSHP-CT-2004-503578,
   SANTE/2004/078-607]; National Institute of Allergy and Infectious
   Diseases; European and Developing Countries Clinical Trials Partnership;
   National Health and Medical Research Council; Fogarty International
   Center; Seventh Framework Programme [242095]; Royal Australasian College
   of Physicians; Medical Research Council [G9901439, G0600718, G0600230,
   G19/9]
FX Wellcome Trust 090770/Z/09/Z Geraldine M Clarke Kirk Rockett Katja
   Kivinen Christina Hubbart Anna EJeffreys Kate Rowlands Sile F Molloy
   Angeliki Kerasidou Victoria JCornelius Lee Hart Gavin Band Chris CA
   Spencer Dominic P Kwiatkowski; Foundation for the National Institutes of
   Health Billand Melinda Gates Foundation Grand Challenges in Global
   Health 566 Geraldine M Clarke Kirk Rockett Katja Kivinen Christina
   Hubbart Anna E Jeffreys Kate Rowlands Muminatou Jallow David J Conway
   Kalifa A Bojang Margaret Pinder Stanley Usen Fatoumatta Sisay-Joof
   Giorgio Sirugo Ousmane Toure Mahamadou A Thera Salimata Konate Sibiry
   Sissoko Amadou Niangaly Belco Poudiougou Valentina D Mangano Edith C
   Bougouma Sodiomon BSirima David Modiano Lucas N Amenga-Etego Anita
   Ghansah Kwadwo A Koram Michael D Wilson Anthony Enimil Jennifer Evans
   Olukemi K Amodu Subulade Olaniyan Tobias Apinjoh Regina Mugri Andre Ndi
   Carolyne M Ndila Sophie Uyoga Alexander Macharia Norbert Peshu Thomas N
   Williams Alphaxard Manjurano Nuno Sepulveda Taane G Clark Eleanor Riley
   Chris Drakeley Hugh Reyburn Vysaul Nyirongo David Kachala Malcolm
   Molyneux Sarah J Dunstan Nguyen Hoan Phu Nguyen Ngoc Quyen Cao Quang
   Thai Tran Tinh Hien Laurens Manning Moses Laman Peter Siba Harin
   Karunajeewa Steve Allen Angela Allen Timothy ME Davis Pascal Michon Ivo
   Mueller Sile F Molloy Susana Campino Angeliki Kerasidou Victoria J
   Cornelius Lee Hart Shivang S Shah Gavin Band Chris CA Spencer Tsiri
   Agbenyega Eric Achidi Ogobara K Doumbo Jeremy Farrar Kevin Marsh Terrie
   Taylor Dominic P Kwiatkowski; Wellcome Trust 097364/Z/11/Z (Spencer)
   Chris CA Spencer; European Commission LSHP-CT-2004-503578 (Nigeria)
   Olukemi K Amodu Subulade Olaniyan; National Institute of Allergy and
   Infectious Diseases Ousmane Toure Mahamadou A Thera Salimata Konate
   Sibiry Sissoko Amadou Niangaly Belco Poudiougou; European Commission
   Europaid: SANTE/2004/078-607 Alphaxard Manjurano Nuno Sepulveda Taane G
   Clark EleanorRiley Chris Drakeley Hugh Reyburn Timothy ME Davis;
   European and Developing Countries Clinical Trials Partnership Eric
   Achidi; National Health and Medical Research Council Laurens Manning
   Timothy ME Davis; Fogarty International Center Moses Laman; Seventh
   Framework Programme 242095 Thomas N Williams Eric Achidi; Wellcome Trust
   076934/Z/05/Z and 091758/Z/10/Z Sophie Uyoga Alexander Macharia Thomas N
   Williams; Wellcome Trust 084538 Carolyne M Ndila; Wellcome Trust KEMRI
   Core Support Carolyne M Ndila Sophie Uyoga Alexander Macharia Norbert
   Peshu Thomas N Williams Kevin Marsh; Wellcome Trust WT Major Overseas
   Program in Vietnam 089276/Z/09/Z David Kachala Nguyen Hoan Phu Nguyen
   Ngoc Quyen Cao Quang Thai Tran Tinh Hien Jeremy Farrar; Royal
   Australasian College of Physicians Laurens Manning; Wellcome Trust
   MalariaGEN Project 077383/Z/05/Z Geraldine M Clarke Kirk Rockett
   Christina Hubbart Anna E Jeffreys Kate Rowlands Muminatou Jallow David J
   Conway Kalifa A Bojang Margaret Pinder Stanley Usen Fatoumatta
   Sisay-Joof Giorgio Sirugo Ousmane Toure Mahamadou A Thera Salimata
   Konate Sibiry Sissoko Amadou Niangaly Belco Poudiougou Valentina D
   Mangano Edith C Bougouma Sodiomon BSirima David Modiano Lucas N
   Amenga-Etego Anita Ghansah Kwadwo A Koram Michael DWilson Anthony Enimil
   Jennifer Evans Olukemi K Amodu Subulade Olaniyan Tobias Apinjoh Regina
   Mugri Andre Ndi Carolyne M Ndila Sophie Uyoga Alexander Macharia Norbert
   Peshu Thomas N Williams Alphaxard Manjurano Nuno Sepulveda Taane G Clark
   Eleanor Riley Chris Drakeley Hugh Reyburn Vysaul Nyirongo David Kachala
   Malcolm Molyneux Sarah J Dunstan Nguyen Hoan Phu Nguyen Ngoc Quyen Cao
   Quang Thai Tran Tinh Hien Laurens Manning Moses Laman Peter Siba Harin
   Karunajeewa Steve Allen Angela Allen Timothy ME Davis Pascal Michon Ivo
   Mueller Sile F Molloy Susana Campino Angeliki Kerasidou Victoria J
   Cornelius Lee Hart Shivang S Shah Gavin Band Chris CA Spencer Tsiri
   Agbenyega Eric Achidi Ogobara K Doumbo Jeremy Farrar Kevin Marsh Terrie
   Taylor Dominic P Kwiatkowsk; Wellcome Trust WT Centre for Human Genetic
   Core 090532/Z/09/Z Geraldine M Clarke Kirk Rockett Christina Hubbart
   Anna E Jeffreys Kate Rowlands Sile F Molloy Angeliki Kerasidou Victoria
   J Cornelius Lee Hart Shivang S Shah Gavin Band Chris CA Spencer Dominic
   P Kwiatkowski; Wellcome Trust WT SangerInstitute Core 077012/Z/05/Z
   Katja Kivinen Susana Campino Dominic P Kwiatkowski; Wellcome Trust
   087285;096527 Angeliki Kerasidou; Medical Research Council Tanzania
   Joint Collaboration G9901439 Alphaxard Manjurano Nuno Sepulveda Taane G
   Clark Eleanor Riley Chris Drakeley Hugh Reyburn Timothy ME Davis;
   Medical Research Council G0600718; G0600230 Kirk Rockett Dominic P
   Kwiatkowsk; Medical Research Council G19/9 Dominic P Kwiatkowski
CR ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0
   Band G, 2015, NATURE, V526, P253, DOI 10.1038/nature15390
   BEUTLER E, 1994, BLOOD, V84, P3613
   Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490
   Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412
   BIENZLE U, 1972, LANCET, V1, P107
   Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727
   Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2
   Chu CS, 2016, THERAPY, V14, P885, DOI [10.1080/14787210.2016.1220304, DOI 10.1080/14787210.2016.1220304]
   Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8
   Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007
   Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307
   Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/nmeth.1785, 10.1038/NMETH.1785]
   GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2
   Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066
   HALDANE JBS, 1964, J GENET, V59, P29, DOI 10.1007/BF02984134
   Hartl D. L., 1989, PRINCIPLES POPULATIO
   Hedrick P, 2004, J EVOLUTION BIOL, V17, P221, DOI 10.1046/j.1420-9101.2003.00635.x
   Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16
   Hill AVS, 1991, MOL EVOLUTION MAJOR, P403
   Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339
   Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x
   Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246
   Kaplan M, 2010, SEMIN FETAL NEONAT M, V15, P148, DOI 10.1016/j.siny.2009.10.007
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632
   Leslie T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000283
   LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792
   LIVINGSTONE FB, 1984, HUM BIOL, V56, P413
   Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849
   Luzzatto L, 2015, LANCET HAEMATOL, V2, pE400, DOI 10.1016/S2352-3026(15)00191-X
   Manjurano A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004960
   Manjurano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047463
   Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241
   Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001
   Modiano D, 1998, AM J TROP MED HYG, V59, P539
   MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28
   Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4
   Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4
   Pasvol G, 2005, BRIT MED BULL, V75-76, P29, DOI 10.1093/bmb/ldh059
   Patten MM, 2009, EVOLUTION, V63, P2888, DOI 10.1111/j.1558-5646.2009.00764.x
   Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461
   Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107
   RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0
   Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140
   Saunders MA, 2005, GENETICS, V171, P1219, DOI 10.1534/genetics.105.048140
   Saunders MA, 2002, GENETICS, V162, P1849
   Severe Malaria, 2014, TROP MED INT HLTH S1, V19, P7, DOI 10.1111/tmi.12313_2
   Shah SS, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1045-0
   Silverberg D, 2012, ANEMIA
   Sirugo G, 2014, AM J TROP MED HYG, V90, P856, DOI 10.4269/ajtmh.13-0622
   SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0
   SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4
   Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2
   Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021
   Thuma PE, 2011, J INFECT DIS, V203, P211, DOI 10.1093/infdis/jiq041
   Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573
   Toure O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043987
   Tripathy V, 2007, J POSTGRAD MED, V53, P193
   Uyoga S, 2015, LANCET HAEMATOL, V2, pE437, DOI 10.1016/S2352-3026(15)00152-0
   VALAES T, 1994, ACTA PAEDIATR, V83, P58, DOI 10.1111/j.1651-2227.1994.tb13216.x
   van Hensbroek MB, 2011, BRIT J HAEMATOL, V154, P690, DOI 10.1111/j.1365-2141.2011.08761.x
   Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345
   World Health Organization, 2010, GUID TREATM MAL
   World Health Organization, 2000, T R SOC TROP MED S1, V94, pS1, DOI DOI 10.1016/S0035-9203(00)90300-6
   YOSHIDA A, 1971, B WORLD HEALTH ORGAN, V45, P243
NR 66
TC 3
Z9 3
U1 1
U2 1
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JAN 9
PY 2017
VL 6
AR e15085
DI 10.7554/eLIFE.15085
PG 30
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EJ7FS
UT WOS:000393387700001
OA gold
DA 2017-08-15
ER

PT J
AU Anyanwu, M
   Alida, BWN
AF Anyanwu, Matthew
   Alida, Bom Wekye Ndam
TI Uptake of long-acting reversible contraceptive devices in Western region
   of The Gambia
SO AFRICAN HEALTH SCIENCES
LA English
DT Article
DE Uptake; LARC; methods
ID WOMEN; ACCEPTABILITY
AB Background: The contraceptive method has become an essential factor in the life of most women of reproductive age group; although it varies in different stages of their life course. The use of long acting reversible methods (LARC) is proposed as a strategy to reverse undesirable maternal health consequences in developing countries.
   Objective: To determine the uptake of long-acting reversible contraceptive in The Gambia.
   Methods: A community based cross-sectional study of women attending family planning clinic were studied using interviewer-administered questionnaire which included information on socio-demographic factors, reproductive health and contraceptive use of the participants.
   Results: About 89 % of study participants used long acting reversible contraceptive methods. Of the three commonly available long acting reversible contraceptive methods, Depo Provera was the most commonly used method; 78 of 141 (55.32%); followed by implants (43.3%) and intrauterine contraceptive (1.42%). Being housewives, with 3-4 living children and having secondary level education were associated with high uptake of LARC.
   Conclusion: The uptake of long acting reversible contraceptive was high; with Depo Provera as the most commonly used contraceptive method in The Gambia. There seemed to be an increase in the uptake of implants; with intrauterine contraceptive device being the least commonly used method.
C1 [Anyanwu, Matthew] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [Anyanwu, Matthew; Alida, Bom Wekye Ndam] Univ Gambia, Sch Med & Allied Hlth Sci, Banjul, Gambia.
RP Anyanwu, M (reprint author), Univ Gambia, Sch Med & Allied Sci, Dept Obstet & Gynaecol, POB 1646, Banjul, Gambia.
EM anyanwum@yahoo.com
CR Adanu Richard M K, 2009, Afr J Reprod Health, V13, P123
   Blumenthal PD, 2013, CONTRACEPTION, V87, P170, DOI 10.1016/j.contraception.2012.10.002
   Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329
   Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497
   Jammeh SSS, 2014, AFR HEALTH SCI, V14, P273, DOI 10.4314/ahs.v14i2.1
   Kavanaugh ML, 2011, OBSTET GYNECOL, V117, P1349, DOI 10.1097/AOG.0b013e31821c47c9
   Masters T, 2005, CURR OBSTET GYNAECOL, V15, P31, DOI 10.1016/j.curobgyn.2004.09.004
   Mitchel MJ, 2004, CONTRACEPTION, V70, P483, DOI 10.1016/j.contraception.2004.05.004
   Okletey M, 2007, FAMILY PLANNING METH
   The Republic of Gambia, 2014, NAT DEM HLTH SURV GA
   Saleamlak A Y, 2015, BMC RES NOTES, V8, P29
   Stover J, 2010, MATERN CHILD HLTH J, V14, P687, DOI 10.1007/s10995-009-0505-y
   UNFPA, 2011, UN HIGH LEV M REPR H, P1
   [Anonymous], 2013, NYAMB VIOL FACT INFL
   [Anonymous], 2013, SUSAN BABIRYE KAYONG
NR 15
TC 1
Z9 1
U1 0
U2 0
PU MAKERERE UNIV, FAC MED
PI KAMPALA
PA PO BOX 7072, KAMPALA, 00000, UGANDA
SN 1680-6905
EI 1729-0503
J9 AFR HEALTH SCI
JI Afr. Health Sci.
PY 2017
VL 17
IS 2
BP 409
EP 417
DI 10.4314/ahs.v17i2.15
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA FB4QK
UT WOS:000406126400015
OA No
DA 2017-08-15
ER

PT J
AU Moore, SE
AF Moore, Sophie E.
TI Early-Life Nutritional Programming of Health and Disease in The Gambia
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Review
DE Developmental origins of health and disease; Gambia; Immunology and
   inflammation; Reproduction/pregnancy/lactation; Human nutrition
ID BREAST-FED INFANTS; RURAL GAMBIA; THYMUS SIZE; ENVIRONMENTAL-INFLUENCES;
   CHILD-MORTALITY; BIRTH SEASON; GROWTH; SUPPLEMENTATION; MALNUTRITION;
   BANGLADESH
AB Background: Exposures during early life are increasingly being recognised as factors that play an important role in the aetiology of chronic non-communicable diseases (NCDs). The "Developmental Origins of Health and Disease" (DOHaD) hypothesis asserts that adverse early-life exposures - most notably unbalanced nutrition - leads to an increased risk for a range of NCDs and that disease risk is highest when there is a "mismatch" between the early- and later-life environments. Thus, the DOHaD hypothesis would predict highest risk in settings undergoing a rapid nutrition transition. Summary: We investigated the link between early-life nutritional exposures and long-term health in rural Gambia, West Africa. Using demographic data dating back to the 1940s, the follow-up of randomised controlled trials of nutritional supplementation in pregnancy, and the "experiment of nature" that seasonality in this region provides, we investigated the DOHaD hypothesis in a population with high rates of maternal and infant under-nutrition, a high burden from infectious disease, and an emerging risk of NCDs. Key Messages: Our work in rural Gambia suggests that in populations with high rates of under-nutrition in early life, the immune system may be sensitive to nutritional deficiencies early in life, resulting in a greater susceptibility to infection-related morbidity and mortality. (C) 2017 S. Karger AG, Basel
C1 [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England.
   [Moore, Sophie E.] MRC Unit Gambia, Banjul, Gambia.
RP Moore, SE (reprint author), St Thomas Hosp, Div Womens Hlth, 10th Floor North Wing,Westminster Bridge Rd, London SE1 7EH, England.
EM sophie.moore@kcl.ac.uk
FU  [MC-A760-5QX00]
FX Research from The Gambia presented in this review was largely supported
   through core funding MC-A760-5QX00 to the MRC International Nutrition
   Group and the UK Department for International Development (DFID) under
   the MRC/DFID Concordat agreement.
CR Aaby P, 2002, ACTA PAEDIATR, V91, P698, DOI 10.1080/080352502760069142
   Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786
   Collinson AC, 2003, ACTA PAEDIATR, V92, P1014, DOI 10.1080/08035250310004379
   Collinson AC, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-18
   Corvalan C, 2009, P NUTR SOC, V68, P327, DOI 10.1017/S002966510900130X
   Garly ML, 2008, J PEDIATR, V153, P683, DOI 10.1016/j.jpeds.2008.04.069
   Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013
   Hasselbalch H, 1996, EUR RADIOL, V6, P700
   Hasselbalch H, 1996, ACTA PAEDIATR, V85, P1029, DOI 10.1111/j.1651-2227.1996.tb14211.x
   Hennig BJ, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv206
   Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x
   Moore SE, 2004, AM J CLIN NUTR, V80, P453
   Moore SE, 2001, AM J CLIN NUTR, V74, P840
   Moore SE, 2001, DIABETIC MED, V18, P646, DOI 10.1046/j.1464-5491.2001.00565.x
   Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245
   Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088
   Moore SE, 2014, INT J EPIDEMIOL, V43, P216, DOI 10.1093/ije/dyt232
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Ngom PT, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-41
   Ngom PT, 2004, AM J CLIN NUTR, V80, P722
   Prentice AM, 2005, P NUTR SOC, V64, P153, DOI 10.1079/PNS2005421
   Prentice AM, 1999, BRIT J NUTR, V81, P345
   Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134
NR 23
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2017
VL 70
IS 3
BP 179
EP 183
DI 10.1159/000456555
PG 5
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA FA0AG
UT WOS:000405092000004
PM 28301842
OA No
DA 2017-08-15
ER

PT J
AU Shimakawa, Y
   Njie, R
   Vray, M
   Bonnard, P
   Nana, J
   Leroy, V
   Bottero, J
   Ingiliz, P
   Post, G
   Jeng, A
   Ndow, G
   Chemin, I
   Mendy, M
   Thursz, M
   Lemoine, M
AF Shimakawa, Y.
   Njie, R.
   Vray, M.
   Bonnard, P.
   Nana, J.
   Leroy, V.
   Bottero, J.
   Ingiliz, P.
   Post, G.
   Jeng, A.
   Ndow, G.
   Chemin, I.
   Mendy, M.
   Thursz, M.
   Lemoine, M.
TI Development and validation of a simple score to select HBV-infected
   patients for antiviral therapy in Africa
SO JOURNAL OF HEPATOLOGY
LA English
DT Meeting Abstract
CT International Liver Congress / 52nd Annual Meeting of the
   European-Association-for-the-Study-of-the-Liver
CY APR 19-23, 2017
CL Amsterdam, NETHERLANDS
SP European Assoc Study Liver
C1 [Shimakawa, Y.] Inst Pasteur, Paris, France.
   [Njie, R.] GHIS, Fajara, Gambia.
   [Vray, M.] Inst Pasteur, Dakar, Senegal.
   [Bonnard, P.] Hop Tenon, Paris, France.
   [Nana, J.; Leroy, V.] Univ Grenoble Alpes, Grenoble, France.
   [Bottero, J.] Sorbonne Univ, Paris, France.
   [Ingiliz, P.; Post, G.] Zipp Clin, Berlin, Germany.
   [Jeng, A.] MRC Unit, Fajara, Gambia.
   [Ndow, G.; Thursz, M.; Lemoine, M.] Imperial Coll, London, England.
   [Chemin, I.] INSERM, Lyon, France.
   [Mendy, M.] IARC, Lyon, France.
EM yusuke.shimakawa@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PY 2017
VL 66
IS 1
SU S
MA SAT-150
BP S686
EP S686
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EU5FI
UT WOS:000401056601685
OA No
DA 2017-08-15
ER

PT J
AU Ayorinde, A
   Togun, T
   Egere, U
   Tientcheu, L
   Darboe, O
   Ceesay, M
   Gomez-Afolabi, S
   Otu, J
   Antonio, M
   Sutherland, J
   Kampmann, B
AF Ayorinde, A.
   Togun, T.
   Egere, U.
   Tientcheu, L.
   Darboe, O.
   Ceesay, M.
   Gomez-Afolabi, S.
   Otu, J.
   Antonio, M.
   Sutherland, J.
   Kampmann, B.
TI Contribution Of The Xpert Mtb/rif Assay To The Diagnosis Of Pulmonary
   Tuberculosis In A West African Childhood Tuberculosis Clinic
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Ayorinde, A.; Egere, U.; Tientcheu, L.; Darboe, O.; Ceesay, M.; Gomez-Afolabi, S.; Otu, J.; Antonio, M.; Sutherland, J.; Kampmann, B.] Med Res Council Unit Gambia, Banjul, Gambia.
   [Togun, T.] McGill Univ, Montreal, PQ, Canada.
EM aayorinde@mrc.gm
FU UK Medical Research Council (MRC); UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement; WHO STOP
   TB/TBReach Wave 2 Grant
FX This abstract is funded by: UK Medical Research Council (MRC) and the UK
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement. WHO STOP TB/TBReach Wave 2 Grant
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A1173
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372500174
OA No
DA 2017-08-15
ER

PT J
AU Faal-Jawara, T
   Mendy, FS
   Ayorinde, A
   Otu, J
   Sutherland, J
   De Jong, B
   Gehre, F
AF Faal-Jawara, T.
   Mendy, F. S.
   Ayorinde, A.
   Otu, J.
   Sutherland, J.
   De Jong, B.
   Gehre, F.
TI Determining The Transmission Dynamics Of Tuberculosis In The Greater
   Banjul Area Of The Gambia
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Faal-Jawara, T.; Mendy, F. S.; Ayorinde, A.; Otu, J.; Gehre, F.] MRC Unit Gambia, Banjul, Gambia.
   [Sutherland, J.] Med Res Council Unit Gambia, Banjul, Gambia.
   [De Jong, B.] Inst Trop Med, Antwerp, Belgium.
EM tfaal@mrc.gm
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A3986
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372503477
OA No
DA 2017-08-15
ER

PT J
AU Faal-Jawara, T
   Ofori-Anyinam, N
   Mendy, FS
   Otu, J
   Gehre, F
   Secka, O
AF Faal-Jawara, T.
   Ofori-Anyinam, N.
   Mendy, F. S.
   Otu, J.
   Gehre, F.
   Secka, O.
TI Determinating The Predominant Tb Lineage Amongst Extrapulmonary Tb Cases
   At Mrc Unit, The Gambia Clinic
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Faal-Jawara, T.; Ofori-Anyinam, N.; Mendy, F. S.; Otu, J.; Gehre, F.; Secka, O.] MRC Unit Gambia, Banjul, Gambia.
EM tfaal@mrc.gm
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A2075
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372501245
OA No
DA 2017-08-15
ER

PT J
AU Faburay, A
   Mendy, FS
   Otu, J
   Faal-Jawara, T
   Gehre, F
   Secka, O
AF Faburay, A.
   Mendy, F. S.
   Otu, J.
   Faal-Jawara, T.
   Gehre, F.
   Secka, O.
TI Performance Comparison Of Lowenstein-Jensen (lj) Media Supplemented With
   Pyruvate, Glycerol And A Combination Of Both To Assess The Growth Of
   Mycobacterium Tuberculosis Complex
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Faburay, A.; Mendy, F. S.; Otu, J.; Faal-Jawara, T.; Gehre, F.; Secka, O.] MRC Unit Gambia, Banjul, Gambia.
EM afaburay@mrc.gm
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A2080
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372501250
OA No
DA 2017-08-15
ER

PT J
AU Gitteh, E
   Otu, JK
   Jobarteh, T
   Mendy, FS
   Faal-Jawara, T
   Ofori-Anyinam, N
   Ayorinde, A
   Secka, O
   Gehre, F
   Antonio, M
AF Gitteh, E.
   Otu, J. K.
   Jobarteh, T.
   Mendy, F. S.
   Faal-Jawara, T.
   Ofori-Anyinam, N.
   Ayorinde, A.
   Secka, O.
   Gehre, F.
   Antonio, M.
TI Sodium Hydroxide-N-Acetyl-L-Cystein (naoh-Nalc) And 0.7% Chlorhexidine
   Decontamination Method In Detection Of Mycobacterium Tuberculosis: a
   Comparative Analysis
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Gitteh, E.; Otu, J. K.; Jobarteh, T.; Mendy, F. S.; Faal-Jawara, T.; Ofori-Anyinam, N.; Ayorinde, A.; Secka, O.; Gehre, F.; Antonio, M.] Med Res Council Unit Gambia, Banjul, Gambia.
EM egitteh@mrc.gm
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A2083
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372501253
OA No
DA 2017-08-15
ER

PT J
AU Jobarteh, T
   Otu, J
   Gitteh, E
   Mendy, FS
   Faal-Jawara, T
   Ofori-Anyinam, N
   Ayorinde, A
   Secka, O
   Gehre, F
   Antonio, M
AF Jobarteh, T.
   Otu, J.
   Gitteh, E.
   Mendy, F. S.
   Faal-Jawara, T.
   Ofori-Anyinam, N.
   Ayorinde, A.
   Secka, O.
   Gehre, F.
   Antonio, M.
TI Evaluation Of The Kudoh Method For Mycobacterial Culture: The Gambia
   Experience
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Jobarteh, T.; Otu, J.; Gitteh, E.; Mendy, F. S.; Faal-Jawara, T.; Ofori-Anyinam, N.; Ayorinde, A.; Secka, O.; Gehre, F.; Antonio, M.] Med Res Council Unit Gambia, Banjul 273, Gambia.
EM tijobarteh@mrc.gm
FU TB Diagnostic Medical Research Council Unit The Gambia
FX This abstract is funded by: TB Diagnostic Medical Research Council Unit
   The Gambia
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A2081
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372501251
OA No
DA 2017-08-15
ER

PT J
AU McCollum, ED
   Park, DE
   Watson, N
   Focht, C
   Bunthi, C
   Ebruke, BE
   Elhilali, M
   Emmanouilidou, D
   Hossain, L
   Moore, DP
   Mudaua, A
   Mulindwa, J
   West, JE
   O'Brien, KL
   Feikin, DR
   Hammitt, LL
AF McCollum, E. D.
   Park, D. E.
   Watson, N.
   Focht, C.
   Bunthi, C.
   Ebruke, B. E.
   Elhilali, M.
   Emmanouilidou, D.
   Hossain, L.
   Moore, D. P.
   Mudaua, A.
   Mulindwa, J.
   West, J. E.
   O'Brien, K. L.
   Feikin, D. R.
   Hammitt, L. L.
TI Digitally Recorded Lung Sounds And Mortality Among Children 1-59 Months
   Old With Pneumonia In The Pneumonia Etiology Research For Child Health
   Study
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [McCollum, E. D.] Johns Hopkins Sch Med, Baltimore, MD USA.
   [Park, D. E.; O'Brien, K. L.; Feikin, D. R.; Hammitt, L. L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Watson, N.; Focht, C.] EMMES Corp, Rockville, MD USA.
   [Bunthi, C.] Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Nonthaburi, Thailand.
   [Ebruke, B. E.] MRC, Basse, Gambia.
   [Elhilali, M.; Emmanouilidou, D.; West, J. E.] Johns Hopkins Univ, Baltimore, MD USA.
   [Hossain, L.] Icddr B, Dhaka, Bangladesh.
   [Moore, D. P.; Mudaua, A.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mulindwa, J.] Univ Teaching Hosp, Lusaka, Zambia.
EM emccoll3@jhmi.edu
FU Bill and Melinda Gates Foundation
FX This abstract is funded by: Bill and Melinda Gates Foundation
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A1195
PG 2
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372500196
OA No
DA 2017-08-15
ER

PT J
AU Mendy, A
   Tientcheu, L
   Ayorinde, A
   Coker, E
   Egere, U
   Kampmann, B
AF Mendy, A.
   Tientcheu, L.
   Ayorinde, A.
   Coker, E.
   Egere, U.
   Kampmann, B.
TI Factors Affecting Tb Transmission From Adult To Children Within
   Households In The Gambia
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Mendy, A.; Tientcheu, L.; Ayorinde, A.; Coker, E.; Egere, U.; Kampmann, B.] MRC, Banjul, Gambia.
EM alieumendy@hotmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A3987
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372503478
OA No
DA 2017-08-15
ER

PT J
AU Mendy, F
   Faburay, A
   Secka, O
   Ayorinde, A
   Faal-Jawara, T
   Otu, J
   Secka, O
AF Mendy, F.
   Faburay, A.
   Secka, O.
   Ayorinde, A.
   Faal-Jawara, T.
   Otu, J.
   Secka, O.
TI More Than A Decade Of Tuberculosis Diagnosis In Mrc Unit, The
   gambia(mrcg)
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Mendy, F.; Faburay, A.; Secka, O.; Ayorinde, A.; Faal-Jawara, T.; Otu, J.; Secka, O.] MRC Gambia, Banjul, Gambia.
EM fmendy@mrc.gm
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A2077
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372501247
OA No
DA 2017-08-15
ER

PT J
AU Mendy, J
   Togun, T
   Donkor, S
   Ota, M
   Sutherland, J
AF Mendy, J.
   Togun, T.
   Donkor, S.
   Ota, M.
   Sutherland, J.
TI Changes In Serum Crp, beta 2 Microglobulin And Neopterin Levels With Tb
   Treatment
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Mendy, J.; Togun, T.; Donkor, S.; Ota, M.; Sutherland, J.] Med Res Council Unit Gambia, Banjul, Gambia.
EM jomendy@mrc.gm
FU EDCTP
FX This abstract is funded by: EDCTP
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A1181
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372500182
OA No
DA 2017-08-15
ER

PT J
AU Smith, EL
   Wheeler, I
   Adler, H
   Ferreira, D
   Abdullahi, O
   Adetifa, I
   Sa-Leao, R
   Becker-Dreps, S
   Esposito, S
   Farida, H
   Kandasamy, R
   Hammitt, LL
   Grant, L
   O'Brien, K
   Mackenzie, G
   Nuorti, P
   Nzenze, S
   Mandi, S
   Ortega, O
   Safari, D
   Schaumburg, F
   Sanders, E
   Van Hoek, A
   Roca, A
   Usuf, E
   Rylance, J
AF Smith, E. L.
   Wheeler, I.
   Adler, H.
   Ferreira, D.
   Abdullahi, O.
   Adetifa, I.
   Sa-Leao, R.
   Becker-Dreps, S.
   Esposito, S.
   Farida, H.
   Kandasamy, R.
   Hammitt, L. L.
   Grant, L.
   O'Brien, K.
   Mackenzie, G.
   Nuorti, P.
   Nzenze, S.
   Mandi, S.
   Ortega, O.
   Safari, D.
   Schaumburg, F.
   Sanders, E.
   Van Hoek, A.
   Roca, A.
   Usuf, E.
   Rylance, J.
TI Upper Airways Carriage Of Streptococcus Pneumoniae In Over 60 Year Olds:
   A Systematic Review Of Prevalence And Individual Participant Data
   Meta-Analysis Of Risk Factors
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 19-24, 2017
CL Washington, DC
SP Amer Thorac Soc
C1 [Smith, E. L.; Wheeler, I.; Adler, H.; Ferreira, D.; Rylance, J.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Abdullahi, O.] Pwani Univ, Kilifi, Kenya.
   [Adetifa, I.] Kemri Wellcome Trust, Kilifi, Kenya.
   [Sa-Leao, R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.
   [Becker-Dreps, S.] Univ N Carolina, Chapel Hill, NC USA.
   [Esposito, S.] Univ Milan, Milan, Italy.
   [Farida, H.] Diponegoro Univ, Semarang, Indonesia.
   [Kandasamy, R.] Univ Oxford, Oxford, England.
   [Hammitt, L. L.; Grant, L.; O'Brien, K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Mackenzie, G.; Roca, A.; Usuf, E.] MRC Unit, Banjul, Gambia.
   [Nuorti, P.] Univ Tampere, Tampere, Finland.
   [Nzenze, S.] Univ Witwatersrand, Johannesburg, South Africa.
   [Mandi, S.] Natl Inst Communicable Dis, Johannesburg, South Africa.
   [Ortega, O.] Univ Autonoma Barcelona, Mataro, Spain.
   [Safari, D.] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Schaumburg, F.] Univ Hosp Munster, Munster, Germany.
   [Sanders, E.] Univ Med Ctr Utrecht, Utrecht, Germany.
   [Van Hoek, A.] Publ Hlth England, London, England.
EM emma.smith0709@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2017
VL 195
MA A3938
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA ET6AK
UT WOS:000400372503429
OA No
DA 2017-08-15
ER

PT J
AU Garand, M
   Cai, B
   Kollmann, TR
AF Garand, Mathieu
   Cai, Bing
   Kollmann, Tobias R.
TI Environment impacts innate immune ontogeny
SO INNATE IMMUNITY
LA English
DT Article
DE Environment; innate; immunity; cytokine; ethnic; race; age; responses;
   infants
ID TOLL-LIKE RECEPTORS; RESPONSES; RECOGNITION; SYSTEM; ASSOCIATION;
   DISTINCT
AB Susceptibility to infection and response to vaccination differ between populations and as a function of age. The underlying mechanisms for this age- and population-dependent variation are not known. Specifically, it is unclear if these variations are due to differences in genetically encoded host programs or driven by environmental influences or a combination of both. To address the relationship between gene and environment regarding immune ontogeny, we determined the innate cytokine responses following PRR stimulation of blood mononuclear cells at birth, 1, and 2 yr of age in infants from Caucasian vs. Asian parents and were raised in the same city. At birth, we found that innate cytokine responses were significantly elevated in Asian compared with Caucasian infants. However, these differences waned and responses became more similar over the course of 1-2 yr of living in a similar environment. Our observations that innate response differences present at birth subsequently equalized rather than diverged suggest a key role for environmental effects common to both racial groups in shaping the innate immune responses early in life. Delineating the underlying environmental factors that modulate innate immune responses early in life could provide avenues for targeted beneficial immune modulation.
C1 [Garand, Mathieu; Cai, Bing; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Div Infect Dis, Vancouver, BC, Canada.
   [Garand, Mathieu; Cai, Bing; Kollmann, Tobias R.] BC Childrens Hosp, Vancouver, BC, Canada.
   [Kollmann, Tobias R.] Child & Family Res Inst, Vaccine Evaluat Ctr, Vancouver, BC, Canada.
RP Garand, M (reprint author), MRC Unit, Vaccine & Immun Theme, Gambia Atlantic Blvd,POB 273, Banjul, Gambia.
EM mathieu.garand@gmail.com
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health [N01 AI50023]; Career Award from the Michael Smith
   Foundation for Health Research
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported in part by a National Institute of Allergy and Infectious
   Diseases, National Institutes of Health Grant number: N01 AI50023
   (http://www.nih.gov). TRK is supported in part by a Career Award from
   the Michael Smith Foundation for Health Research (http://www.msfhr.org).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Blimkie D, 2011, J IMMUNOL METHODS, V366, P89, DOI 10.1016/j.jim.2011.01.009
   Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020
   Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371
   Cho P, 2013, GENES IMMUN, V14, P199, DOI 10.1038/gene.2013.5
   Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041
   Djuardi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014066
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Kollmann TR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00081
   Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014
   Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481
   Lisciandro JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036793
   Newport MJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00018
   Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019
   R Core Team, R LANG ENV STAT COMP
   Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0
   Sepulveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099
   Smolen KK, 2014, J ALLERGY CLIN IMMUN, V133, P818, DOI 10.1016/j.jaci.2013.09.038
   Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19
   Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1753-4259
EI 1753-4267
J9 INNATE IMMUN-LONDON
JI Innate Immun.
PD JAN
PY 2017
VL 23
IS 1
BP 3
EP 10
DI 10.1177/1753425916671018
PG 8
WC Biochemistry & Molecular Biology; Immunology; Medicine, Research &
   Experimental; Microbiology
SC Biochemistry & Molecular Biology; Immunology; Research & Experimental
   Medicine; Microbiology
GA EQ6VA
UT WOS:000398220700001
PM 27697850
OA No
DA 2017-08-15
ER

PT J
AU Egere, U
   Togun, T
   Sillah, A
   Mendy, F
   Otu, J
   Hoelscher, M
   Heinrich, N
   Hill, PC
   Kampmann, B
AF Egere, U.
   Togun, T.
   Sillah, A.
   Mendy, F.
   Otu, J.
   Hoelscher, M.
   Heinrich, N.
   Hill, P. C.
   Kampmann, B.
TI Identifying children with tuberculosis among household contacts in The
   Gambia
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE contact tracing; tuberculin skin test; prevalence
ID PULMONARY TUBERCULOSIS; DIAGNOSIS; SPUTUM; INFECTION; COUNTRIES;
   SETTINGS
AB SETTING: Greater Banjul Area of the Gambia.
   OBJECTIVES: To identify co-prevalent tuberculosis (TB) among child contacts of adults with smear-positive TB.
   DESIGN: Child contacts aged <15 years in the immediate household and compound were prospectively enrolled and evaluated for TB disease using screening questionnaires and the tuberculin skin test (TST). Symptomatic and/or TST-positive (>= 10 mm) contacts were further investigated.
   RESULTS: Of 4042 child contacts who underwent symptom screening and TST, 3339 (82.6%) were diagnosed as TB-exposed but not infected, 639 (15.8%) were latently infected and 64 (1.6%) had co prevalent TB. Of the 64 TB cases, 50 (78.1%) were from within the immediate household of the index case, and 14 (21.9%) from within the same compound. Of the 27 asymptomatic but TST-positive children diagnosed with TB, 7 were microbiologically confirmed. The median age of the TB cases was 4.4 years (interquartile range 1.9-6.9); 53.1% were aged <5 years. Of the 4042 child contacts, 206 (5%) slept in the same bed as the index case; 28.1% of all TB cases occurred in this group. Symptom screening alone would have detected only 57.8% of the co-prevalent cases.
   CONCLUSION: In our community setting, if contact tracing is restricted to symptom screening and immediate households only, nearly half of all co-prevalent TB disease in child contacts would be missed.
C1 [Egere, U.; Togun, T.; Sillah, A.; Mendy, F.; Otu, J.; Kampmann, B.] MRC, Unit Gambia, Vaccines & Immun Theme, Atlantic Rd,POB 273, Banjul, Gambia.
   [Egere, U.; Togun, T.] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.
   [Hoelscher, M.; Heinrich, N.] Univ Munich, German Ctr Infect Res, Med Ctr, Div Infect Dis & Trop Med,Ctr Int Hlth, Munich Partner Site, Munich, Germany.
   [Hill, P. C.] Univ Otago, Dept Prevent & Social Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Kampmann, B.] Imperial Coll London, Acad Dept Paediat, Ctr Int Child Hlth, St Marys Campus, London, England.
RP Egere, U; Kampmann, B (reprint author), MRC, Unit Gambia, Vaccines & Immun Theme, Atlantic Rd,POB 273, Banjul, Gambia.; Kampmann, B (reprint author), Imperial Coll London, Acad Dept Paediat, Ctr Int Child Hlth, St Marys Campus, London, England.
EM uegere@mrc.gm; bkampmann@mrc.gm
FU TB REACH; TB REACH initiative [T9-370-114GAM]; MRC Programme grant
   [MR/K011944/1]; MRC/DFID (UK Department of International Development)
   Concordat Agreement
FX The authors are grateful to the following individuals for their
   invaluable contributions to this work: I Adetifa, previously of the
   Medical Research Council (MRC), The Gambia, for providing pilot
   epidemiological data and support during the setting up of the TB
   REACH-funded component of the project; A Jallow, A Able Thomas and the
   NLTP team, The Gambia, for continued support and ongoing collaboration;
   and the 'Reach4Kids' field and clinic teams at the MRC. Our sincere
   appreciation goes to all the children in this study, their families and
   the participating communities.; The study was supported by the TB REACH
   initiative (T9-370-114GAM) and an MRC Programme grant to BK
   (MR/K011944/1). The MRC Unit, The Gambia, is supported by the MRC/DFID
   (UK Department of International Development) Concordat Agreement.
CR Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da
   Adetifa I M., 2013, GAMBIAN SURVEY TUBER
   Batra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040880
   Beyers N, 1997, INT J TUBERC LUNG D, V1, P38
   Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609
   Eurosurveillance Editorial Team, 2013, EUROSURVEILLANCE, V18, P20455
   Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X
   Home N W, 1978, TUBERCLE, V59, P245
   Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001
   Jaganath D, 2013, CLIN INFECT DIS, V57, P1685, DOI 10.1093/cid/cit645
   KHAN EA, 1995, EMERG INFECT DIS, V1, P115
   Kruk A, 2008, PEDIATRICS, V121, pE1646, DOI 10.1542/peds.2007-3138
   Marais BJ, 2011, INDIAN J PEDIATR, V78, P321, DOI 10.1007/s12098-010-0353-1
   Marais BJ, 2005, INT J TUBERC LUNG D, V9, P1305
   Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392
   Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9
   Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8
   Shata AMA, 1996, ARCH DIS CHILD, V74, P535
   Stop TB, 2006, INT J TUBERC LUNG D, V10, P1091
   Triasih R, 2015, CLIN INFECT DIS, V60, P12, DOI 10.1093/cid/ciu748
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   World Health Organization, 2012, WHOHTMTB20129
   Working Group on Tuberculosis Indian Academy of Pediatrics (IAP), 2010, INDIAN PEDIATR, V47, P41
   Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2
NR 25
TC 2
Z9 2
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD JAN
PY 2017
VL 21
IS 1
BP 46
EP 52
DI 10.5588/ijtld.16.0289
PG 7
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA EP7JH
UT WOS:000397553600010
PM 28157464
OA No
DA 2017-08-15
ER

PT J
AU Prentice, AM
   Mendoza, YA
   Pereira, D
   Cerami, C
   Wegmuller, R
   Constable, A
   Spieldenner, J
AF Prentice, Andrew M.
   Mendoza, Yenry A.
   Pereira, Dora
   Cerami, Carla
   Wegmuller, Rita
   Constable, Anne
   Spieldenner, Jorg
TI Dietary strategies for improving iron status: balancing safety and
   efficacy
SO NUTRITION REVIEWS
LA English
DT Review
DE food fortification; iron; safety; staple foods; supplementation
ID ROUTINE PROPHYLACTIC SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL;
   BIOFORTIFIED PEARL-MILLET; PLACEBO-CONTROLLED TRIAL;
   PLASMODIUM-FALCIPARUM; PRESCHOOL-CHILDREN; YOUNG-CHILDREN;
   PHASEOLUS-VULGARIS; ALZHEIMERS-DISEASE; FOOD FORTIFICATION
AB In light of evidence that high-dose iron supplements lead to a range of adverse events in low-income settings, the safety and efficacy of lower doses of iron provided through biological or industrial fortification of foodstuffs is reviewed. First, strategies for point-of-manufacture chemical fortification are compared with biofortification achieved through plant breeding. Recent insights into the mechanisms of human iron absorption and regulation, the mechanisms by which iron can promote malaria and bacterial infections, and the role of iron in modifying the gut microbiota are summarized. There is strong evidence that supplemental iron given in nonphysiological amounts can increase the risk of bacterial and protozoal infections (especially malaria), but the use of lower quantities of iron provided within a food matrix, ie, fortified food, should be safer in most cases and represents a more logical strategy for a sustained reduction of the risk of deficiency by providing the best balance of risk and benefits. Further research into iron compounds that would minimize the availability of unabsorbed iron to the gut microbiota is warranted.
C1 [Prentice, Andrew M.; Cerami, Carla; Wegmuller, Rita] MRC, Unit Gambia, Banjul, Gambia.
   [Prentice, Andrew M.; Wegmuller, Rita] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London, England.
   [Mendoza, Yenry A.; Constable, Anne; Spieldenner, Jorg] Nestle Res Ctr, Lausanne, Switzerland.
   [Pereira, Dora] Univ Cambridge, Dept Pathol, Cambridge, England.
   [Cerami, Carla] Univ N Carolina, Sch Med, Inst Global Hlth & Infect Dis, Div Infect Dis, Chapel Hill, NC USA.
RP Prentice, AM (reprint author), MRC, Unit Gambia, POB 273,Atlantic Rd, Fajara, Gambia.
EM aprentice@mrc.gm
FU Medical Research Council (MRC) International Nutrition Group by UK
   Medical Research Council (MRC) [MCA760-5QX00]; UK Department for
   International Development (DFID) under MRC/DFID
FX A.M.P., R.W., and C.C. are supported by grant MCA760-5QX00 from the
   Medical Research Council (MRC) International Nutrition Group by the UK
   Medical Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement.
CR Aaron GJ, 2015, NUTRIENTS, V7, P3847, DOI 10.3390/nu7053847
   Ashmore JH, 2016, CRIT REV FOOD SCI, V56, P1012, DOI 10.1080/10408398.2012.749208
   Atkinson SH, 2014, BLOOD, V123, P3221, DOI 10.1182/blood-2013-10-533000
   Backstrand JR, 2002, NUTR REV, V60, P15, DOI 10.1301/002966402760240390
   Bao W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-119
   Barth-Jaeggi T, 2015, MATERN CHILD NUTR, V11, P151, DOI 10.1111/mcn.12163
   Bates-Earner N, POST 2015 DEV AGENDA
   Beard J, 2007, J NUTR, V137, p524S
   Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366
   Bouvard V, 2015, LANCET ONCOL, V2045, P1
   Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003
   Brito A, 2013, FOOD NUTR BULL, V34, P378
   Brittenham GM, 2014, AM J CLIN NUTR, V100, P813, DOI 10.3945/ajcn.113.081505
   Budimir A, 2011, ACTA PHARMACEUT, V61, P1, DOI 10.2478/v10007-011-0006-6
   Bullen JJ, 2005, FEMS IMMUNOL MED MIC, V43, P325, DOI 10.1016/j.femsim.2004.11.010
   Burke RM, 2014, NUTRIENTS, V6, P4093, DOI 10.3390/nu6104093
   Bystrom LM, 2014, ANTIOXID REDOX SIGN, V20, P1917, DOI 10.1089/ars.2012.5014
   Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010
   CALVO EB, 1992, PEDIATRICS, V90, P375
   Canadian Public Health Association, FOOD FORT VIT MIN
   Carvalho SMP, 2013, FOOD RES INT, V54, P961, DOI 10.1016/j.foodres.2012.12.021
   Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010
   Cercamondi CI, 2013, J NUTR, V143, P1376, DOI 10.3945/jn.113.176826
   Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Chilenje Infant Growth Nutrition and Infection (CIGNIS) Study Team, 2010, PLOS ONE, V5
   Clark MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5446
   Codex Alimentarius Commission, 1997, 231997 CACGL FAO UN
   Codex Alimentarius Commission, 1985, 21985 CACGL FAO UN
   Cross JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16670
   Das JK, 2013, SYSTEMATIC REV, V2, P67, DOI DOI 10.1186/2046-4053-2-67
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   de Gier B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145351
   De-Regil Luz Maria, 2013, Evid Based Child Health, V8, P112, DOI 10.1002/ebch.1895
   Diapari M, 2014, GENOME, V57, P459, DOI 10.1139/gen-2014-0108
   Dias DM, 2015, NUTRIENTS, V7, P9683, DOI 10.3390/nu7115488
   Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x
   Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Eichler K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-506
   Esan MO, 2013, CLIN INFECT DIS, V57, P1626, DOI 10.1093/cid/cit528
   Finkelstein JL, 2015, J NUTR, V145, P1576, DOI 10.3945/jn.114.208009
   Fonseca-Nunes A, 2014, CANCER EPIDEM BIOMAR, V23, P12, DOI 10.1158/1055-9965.EPI-13-0733
   Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013
   Gera T, 2012, AM J CLIN NUTR, V96, P309, DOI 10.3945/ajcn.111.031500
   Glinz D, 2015, AM J CLIN NUTR, V101, P462, DOI 10.3945/ajcn.114.090175
   Gulec S, 2014, AM J PHYSIOL-GASTR L, V307, pG397, DOI 10.1152/ajpgi.00348.2013
   Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010
   Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443
   Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034
   Hoppe M, 2008, EUR J CLIN NUTR, V62, P761, DOI 10.1038/sj.ejcn.1602776
   Hoppler M, 2014, J FOOD SCI, V79, pC1629, DOI 10.1111/1750-3841.12548
   Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2
   Le HT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-32
   Hurrell R, 2002, NUTR REV, V60, pS7, DOI 10.1301/002966402320285137
   Hurrell RF, 2002, J NUTR, V132, p806S
   Hurrell RF, 2007, NUTR ANEMIA
   Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   John CC, 2013, CLIN INFECT DIS, V57, P1635, DOI 10.1093/cid/cit534
   Kalgaonkar S, 2009, J NUTR BIOCHEM, V20, P304, DOI 10.1016/j.jnutbio.2008.04.003
   Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228
   Kortman GAM, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01481
   Kortman GAM, 2014, FEMS MICROBIOL REV, V38, P1202, DOI 10.1111/1574-6976.12086
   Krebs Nancy F, 2014, Nutr Today, V49, P271
   Levi S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00099
   Liao XY, 2014, CRIT REV FOOD SCI, V54, P1342, DOI 10.1080/10408398.2011.635914
   Loef M, 2012, BRIT J NUTR, V107, P7, DOI 10.1017/S000711451100376X
   Lounis N, 2001, J CLIN VIROL, V20, P123, DOI 10.1016/S1386-6532(00)00136-0
   Lozoff B, 2007, FOOD NUTR BULL, V28, pS560
   Lozoff B, 2012, ARCH PEDIAT ADOL MED, V166, P208, DOI 10.1001/archpediatrics.2011.197
   Ma QY, 2011, J FOOD SCI, V76, pH143, DOI 10.1111/j.1750-3841.2011.02184.x
   Martin CDS, 2008, J NUTR, V138, P659
   Martinez-Navarrete N, 2002, FOOD RES INT, V35, P225, DOI 10.1016/S0963-9969(01)00189-2
   Martinez-Navarrete N, 2002, FOOD RES INT, V35, pS43
   McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48
   McGuire S, 2015, ADV NUTR, V6, P134, DOI 10.3945/an.114.007781
   Meinzen-Derr JK, 2006, J NUTR, V136, P452
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Moreira-Araujo RSR, 2008, FOOD CHEM, V107, P158, DOI 10.1016/j.foodchem.2007.07.074
   Morris J, 2014, INT J BIOTECHNOL FOO, V2, P1
   Mullen A, 2012, BRIT J NUTR, V107, P893, DOI 10.1017/S0007114511003734
   MURRAY MJ, 1978, BRIT MED J, V2, P1113
   Nestel P, 2002, INT NUTR ANEMIA CONS
   Nestle, NESTL POL MICR FORT
   Parkkinen J, 2000, NEPHROL DIAL TRANSPL, V15, P1827, DOI 10.1093/ndt/15.11.1827
   Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009997
   Pereira DIA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081250
   Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144
   Petry N, 2014, J NUTR, V144, P1681, DOI 10.3945/jn.114.192989
   Platel K, 2016, CRIT REV FOOD SCI, V56, P1608, DOI 10.1080/10408398.2013.781011
   Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368
   Powell JJ, 2013, NANOMEDICINE, V10, P1529
   Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102
   Prentice AM, 2008, J NUTR, V138, P2537, DOI 10.3945/jn.108.098806
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   Prom-U-Thai C, 2006, J SCI FOOD AGR, V86, P1209, DOI 10.1002/jsfa.2471
   Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003
   Sandberg AS, 2002, INT J FOOD SCI TECH, V37, P823, DOI 10.1046/j.1365-2621.2002.00641.x
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Schaefer B, 2014, TRANSPL INT, V27, P1109, DOI 10.1111/tri.12374
   Self JL, FORTIFICATION CONDIM
   Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007
   Singh N, 2014, ANTIOXID REDOX SIGN, V20, P1324, DOI 10.1089/ars.2012.4931
   Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7
   Spohrer R, 2013, FOOD NUTR BULL, V34, pS50
   Theil EC, 1997, EUR J CLIN NUTR, V51, pS28
   Theil EC, 2012, J NUTR, V142, P478, DOI 10.3945/jn.111.145854
   Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506
   Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4
   Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Tulchinsky TH, 2015, NUTRIENTS, V7, P2518, DOI 10.3390/nu7042518
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   United Nations Standing Committee on Nutrition, 2015, NUTTR TARG IND POST
   Unger SA, 2016, THESIS
   Vaz-Tostes MD, 2016, J SCI FOOD AGR, V96, P1326, DOI 10.1002/jsfa.7226
   Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125
   Velu G, 2014, J CEREAL SCI, V59, P365, DOI 10.1016/j.jcs.2013.09.001
   WALTER T, 1993, AM J CLIN NUTR, V57, P190
   Weinberg ED, 1997, PERSPECT BIOL MED, V40, P578
   World Health Organization, 2016, DAIL IR SUPPL AD WOM
   WHO, 2007, FOOD NUTR BULL, V28, pS621
   World Health Organisation, 2016, DAIL IR SUPPL INF CH
   Zhang W, 2012, J EPIDEMIOL, V22, P484, DOI 10.2188/jea.JE20120006
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
   Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129
NR 127
TC 3
Z9 3
U1 12
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD JAN
PY 2017
VL 75
IS 1
BP 49
EP 60
DI 10.1093/nutrit/nuw055
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EP0TR
UT WOS:000397100100005
PM 27974599
OA No
DA 2017-08-15
ER

PT J
AU O'Neill, S
   Clarke, E
   Grietens, KP
AF O'Neill, Sarah
   Clarke, Ed
   Grietens, Koen Peeters
TI How to protect your new-born from neonatal death: Infant feeding and
   medical practices in the Gambia
SO WOMENS STUDIES INTERNATIONAL FORUM
LA English
DT Article
ID GENDER; POWER
AB Since the 1990s, the reduction of under-five child-mortality has been a priority for the WHO (Millennium Development Goal 4). In the last two decades, the greatest reduction has occurred in children older than 1 month, while neonatal mortality (the first 28 days of life) has declined more slowly. Neonatal deaths, estimated at approximately 4 million annually, now account for more than 40% of deaths worldwide. Bacterial infections are the leading cause of neonatal deaths. Although risk factors for community and hospital based infections potentially leading to neonatal sepsis are well researched, local people's childcare practices in the neonatal phase are poorly understood by clinicians and biomedical researchers. This paper is based on ethnographic research on neonatal caring practices in rural Gambia. We show that many practices centre on protecting the newborn from sicknesses that are believed to be caused by spirits and other supernatural inflictions. Other caring and nourishing practices are performed to enhance the baby's physical, cognitive and moral development making him/her a full member of the community. (C) 2016 The Authors. Published by Elsevier Ltd.
C1 [O'Neill, Sarah; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium.
   [Clarke, Ed] Vaccines & Immun Theme & MRC Unit, Banjul, Gambia.
   [O'Neill, Sarah] Univ Oxford, ISCA, Oxford OX1 2JD, England.
RP O'Neill, S (reprint author), Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium.; O'Neill, S (reprint author), Univ Oxford, ISCA, Oxford OX1 2JD, England.
EM soneill@itg.be
FU MRC Gambia
FX We thank Steve Howie, Anna Roca and Umberto d'Alessandro from the MRC
   Gambia for encouraging and supporting this research. Susan Dierickx
   helped with the development of the research protocol and Fatou Jaiteh
   provided useful comments on Mandinka terminology in the manuscript. We
   also thank the 'neonate' fieldworkers Michelle Demba, Kebba Jassey and
   Fatou Y Manneh for their assistance with data collection during
   fieldwork as well as for the transcription and translation of recorded
   interviews and discussions.
CR Astuti R., 1998, BODIES PERSONS COMP
   Bloch Maurice, 1982, DEATH REGENERATION L
   BROOKS GE, 1975, J AFR HIST, V16, P29
   Butler J., 1990, GENDER TROUBLE FEMIN
   CARNEY J, 1991, SIGNS, V16, P651, DOI 10.1086/494698
   Carsten Janet, 2004, KINSHIP
   Cheung Y. B., 2006, CLIN INFECT DIS, V43, P673
   Ciekawy Diane, 1998, AFR STUD REV, V41, P1, DOI 10.2307/525351
   Conklin BA, 1996, ETHOS, V24, P657, DOI 10.1525/eth.1996.24.4.02a00040
   Diallo B., 2004, NAISSANCE MARIAGE CH
   Dilley R. M., 2005, ISLAMICAND CASTE KNO
   Evans-Pritchard E.E., 1976, WITCHCRAFT ORACLES M
   Franklin Sarah, 2003, REMAKING LIFE DEATH
   Frazer James George, 1890, GOLDEN BOUGH
   Gaffey M. F., 2015, SEMINARS FETAL NEONA, P4
   Geschiere P, 1998, DEV CHANGE, V29, P811, DOI 10.1111/1467-7660.00100
   Geschiere P, 2008, PAST PRESENT, P313
   Goody Jack, 1962, DEATH PROPERTY ANCES
   GOTTLIEB A, 1982, AFRICA, V52, P34, DOI 10.2307/1160093
   Gottlieb A., 2004, AFTERLIFE IS WE COME
   Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036954
   Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443
   Huntington R, 1979, CELEBRATIONS DEATH A
   Kea P, 2013, J ROY ANTHROPOL INST, V19, P102, DOI 10.1111/1467-9655.12005
   Knight R., 1982, AFRICAN MUSIC, V6, P37
   Lambek M., 1998, BODIES PERSONS COMP
   Leach Melissa, 2007, VACCINE ANXIETIES GL
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Malinowski B., 1922, SEXUAL LIVES SAVAGES
   Malinowski B., 1948, MAGIC SCI RELIG, P10
   Muela S H, 1998, Anthropol Med, V5, P43, DOI 10.1080/13648470.1998.9964548
   Muela SH, 2002, SOC SCI MED, V55, P403
   Hausmann Muela S., 2012, MALARIA REPORTS, V2
   Mulholland E. K., 1999, PEDIAT INFECTIOU S10, V18
   *NEOV STUD GROUP, 2016, LANCET GLOB HEALTH, V4, pE266
   O'Neill S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0687-2
   ONeill S., 2013, DEFYING THE LAW NEGO
   Qureshi Kaveri, 2016, WOMEN STUD INT FORUM, V60, P128
   Rahman E., 2016, WOMEN STUD INT FORUM, V60, P144
   Riesman P., 1992, FIND YOUR CHILD GOOD
   Riesman Paul, 1998, FREEDOM FULANI SOCIA
   Rivers W. H. R., 2001, MED MAGIC RELIG
   Sarro Ramon, 2005, JASO J ANTHR SOC OXF, V31, P167
   Strathern Marilyn, 1988, GENDER GIFT
   Tumer V., 1969, RITUAL PROCESS STRUC
   Turner V., 1967, FOREST SYMBOLS ASPEC
   United Nations, 2015, MILL DEV GOALS REP C
   UNICEF, 2014, LEV TRENDS CHILD MOR
   [UN Pop The World Bank WHO UNICEF], 2012, NEON CHILD HLTH PROF
   Van Gennep A, 1960, RITES PASSAGE
   Waters Donald, 2011, J Glob Health, V1, P154
   Whittemore RD, 1996, MED ANTHROPOL Q, V10, P45, DOI 10.1525/maq.1996.10.1.02a00060
   World Health Organization, 2016, SUST DEV GOALS
   WHO, 2002, 55 WORLD HLTH ASS PR
   [Anonymous], 2010, MILL DEV GOALS REP
NR 55
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-5395
J9 WOMEN STUD INT FORUM
JI Women Stud. Int. Forum
PD JAN-FEB
PY 2017
VL 60
BP 136
EP 143
DI 10.1016/j.wsif.2016.11.003
PG 8
WC Women's Studies
SC Women's Studies
GA EN4BZ
UT WOS:000395954000018
OA No
DA 2017-08-15
ER

PT J
AU Mavoko, HM
   Nabasumba, C
   da Luz, RI
   Tinto, H
   D'Alessandro, U
   Kambugu, A
   Baraka, V
   Rosanas-Urgell, A
   Lutumba, P
   Van Geertruyden, JP
AF Mavoko, Hypolite Muhindo
   Nabasumba, Carolyn
   da Luz, Raquel Inocencio
   Tinto, Halidou
   D'Alessandro, Umberto
   Kambugu, Andrew
   Baraka, Vito
   Rosanas-Urgell, Anna
   Lutumba, Pascal
   Van Geertruyden, Jean-Pierre
TI Efficacy and safety of re-treatment with the same artemisinin-based
   combination treatment (ACT) compared with an alternative ACT and quinine
   plus clindamycin after failure of first-line recommended ACT (QUINACT):
   a bicentre, open-label, phase 3, randomised controlled trial
SO LANCET GLOBAL HEALTH
LA English
DT Article
ID UNCOMPLICATED FALCIPARUM-MALARIA; ARTEMETHER-LUMEFANTRINE;
   ANTIMALARIAL-DRUG; CHILDREN; THERAPY
AB Background Quinine or alternative artemisinin-based combination treatment (ACT) is the recommended rescue treatment for uncomplicated malaria. However, patients are often re-treated with the same ACT though it is unclear whether this is the most suitable approach. We assessed the efficacy and safety of re-treating malaria patients with uncomplicated failures with the same ACT used for the primary episode, compared with other rescue treatments.
   Methods This was a bicentre, open-label, randomised, three-arm phase 3 trial done in Lisungi health centre in DR Congo, and Kazo health centre in Uganda in 2012-14. Children aged 12-60 months with recurrent malaria infection after treatment with the first-line ACT were randomly assigned to either re-treatment with the same first-line ACT, an alternative ACT, which were given for 3 days, or quinine-clindamycin (QnC), which was given for 5-7 days, following a 2: 2: 1 ratio. Randomisation was done by computer-generated randomisation list in a block design by country. The three treatment groups were assumed to have equivalent efficacy above 90%. Both the research team and parents or guardians were aware of treatment allocation. The primary outcome was the proportion of patients with an adequate clinical and parasitological response (ACPR) at day 28, in the per-protocol population. This trial was registered under the numbers NCT01374581 in ClinicalTrials.gov and PACTR201203000351114 in the Pan African Clinical Trials Registry.
   Findings From May 22, 2012, to Jan 31, 2014, 571 children were included in the trial. 240 children were randomly assigned to the re-treatment ACT group, 233 to the alternative ACT group, and 98 to the QnC group. 500 children were assessed for the primary outcome. 71 others were not included because they did not complete the follow-up or PCR genotyping result was not conclusive. The ACPR response was similar in the three groups: 91.4% (95% CI 87.5-95.2) for the re-treatment ACT, 91.3% (95% CI 87.4-95.1) for the alternative ACT, and 89.5% (95% CI 83.0-96.0) for QnC. The estimates for rates of malaria recrudescence in the three treatment groups were similar (log-rank test:. chi(2)=0.22, p=0.894). Artemether-lumefantrine was better tolerated than QnC (p=0.0005) and artesunate-amodiaquine (p<0.0001) in the modified intention-to-treat analysis. No serious adverse events were observed. The most common adverse events reported in the re-treatment ACT group were anorexia (31 [13%] of 240 patients), asthenia (20 [8%]), coughing (16 [7%]), abnormal behaviour (13 [5%]), and diarrhoea (12 [5%]). Anorexia (13 [6%] of 233 patients) was the most frequently reported adverse event in the alternative ACT group. The most commonly reported adverse events in the QnC group were anorexia (12 [12%] of 98 patients), abnormal behaviour (6 [6%]), asthenia (6 [6%]), and pruritus (5 [5%]).
   Interpretation Re-treatment with the same ACT shows similar efficacy as recommended rescue treatments and could be considered for rescue treatment for Plasmodium falciparum malaria. However, the effect of this approach on the selection of resistant strains should be monitored to ensure that re-treatment with the same ACT does not contribute to P falciparum resistance.
   Funding Fonds Wetenschappelijk Onderzoek, Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking, European and Developing Countries Clinical Trials Partnership, and the Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
C1 [Mavoko, Hypolite Muhindo; Lutumba, Pascal] Univ Kinshasa, Fac Med, Dept Trop Med, BP 747, Kinshasa XI, DEM REP CONGO.
   [Mavoko, Hypolite Muhindo; Nabasumba, Carolyn; da Luz, Raquel Inocencio; Baraka, Vito; Van Geertruyden, Jean-Pierre] Univ Antwerp, Epidemiol Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium.
   [Nabasumba, Carolyn; Kambugu, Andrew] Makerere Univ, Infect Dis Inst, Kampala, Uganda.
   [Nabasumba, Carolyn] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda.
   [Tinto, Halidou] Inst Rech Sci Sante, Ctr Muraz, Bobo Dioulasso, Burkina Faso.
   [D'Alessandro, Umberto; Rosanas-Urgell, Anna] Inst Trop Med, Antwerp, Belgium.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [D'Alessandro, Umberto] Gambia Unit, Med Res Council, Banjul, Gambia.
   [Baraka, Vito] Tanga Res Ctr, Natl Inst Med Res, Tanga, Tanzania.
RP Mavoko, HM (reprint author), Univ Kinshasa, Fac Med, Dept Trop Med, BP 747, Kinshasa XI, DEM REP CONGO.
EM mavoko@yahoo.com
FU Fonds Wetenschappelijk Onderzoek; Vlaamse Interuniversitaire
   Raad-Universitaire Ontwikkelings Samenwerking; European and Developing
   Countries Clinical Trials Partnership; Belgian Technical
   Cooperation-Programme d'Etudes et d'Expertises-in the Democratic
   Republic of Congo
FX Fonds Wetenschappelijk Onderzoek, Vlaamse Interuniversitaire
   Raad-Universitaire Ontwikkelings Samenwerking, European and Developing
   Countries Clinical Trials Partnership, and the Belgian Technical
   Cooperation-Programme d'Etudes et d'Expertises-in the Democratic
   Republic of Congo.
CR Achan J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2763
   Beshir KB, 2013, J INFECT DIS, V208, P2017, DOI 10.1093/infdis/jit431
   WHO, 2015, GUID TREATM MAL
   Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339
   Fungladda W, 1998, Bull World Health Organ, V76 Suppl 1, P59
   Kofoed PE, 1997, T ROY SOC TROP MED H, V91, P462, DOI 10.1016/S0035-9203(97)90286-8
   Lell B, 2002, ANTIMICROB AGENTS CH, V46, P2315, DOI 10.1128/AAC.46.8.2315-2320.2002
   Mavoko HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157074
   Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137
   Obonyo CO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-2
   Onyamboko MA, 2014, ANTIMICROB AGENTS CH, V58, P5528, DOI 10.1128/AAC.02682-14
   Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649
   Shayo A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0649-8
   Snounou G, 1998, PARASITOL TODAY, V14, P462, DOI 10.1016/S0169-4758(98)01340-4
   Tshefu AK, 2010, LANCET, V375, P1457, DOI 10.1016/S0140-6736(10)60322-4
   Wembonyama S, 2007, REPUBLIC MED TROPICA, V67, P447
   World Health Organization (WHO), 2006, GUID TREATM MAL
   WHO, 2003, ASS MON ANT DRUG EFF
   World Health Organization, 2015, WORLD MAL REP 2015
   WHO, 2004, HAEM CONC DIAGN AN A
   WHO, 2007, METH TECHN CLIN TRIA
   WWARN Parasite Clearance Study Group, 2015, MALARIA J, V14, P359
   Yavo W, 2015, MALARIA RES TREATMEN, V2015
   Yeka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113311
   Yeka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053772
   Yeka A, 2009, LANCET INFECT DIS, V9, P448, DOI 10.1016/S1473-3099(09)70109-4
   Zwang J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-203
NR 27
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JAN
PY 2017
VL 5
IS 1
BP E60
EP E68
DI 10.1016/S2214-109X(16)30236-4
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN9SQ
UT WOS:000396340300028
PM 27840069
OA gold
DA 2017-08-15
ER

PT J
AU Nayagam, S
   Conteh, L
   Sicuri, E
   Shimakawa, Y
   Lemoine, M
   Hallett, TB
   Thursz, M
AF Nayagam, Shevanthi
   Conteh, Lesong
   Sicuri, Elisa
   Shimakawa, Yusuke
   Lemoine, Maud
   Hallett, Timothy B.
   Thursz, Mark
TI Community-based screening and treatment for chronic hepatitis B in
   sub-Saharan Africa Reply
SO LANCET GLOBAL HEALTH
LA English
DT Letter
C1 [Nayagam, Shevanthi; Lemoine, Maud; Thursz, Mark] Imperial Coll, Div Digest Dis, St Marys Hosp, London W2 1NY, England.
   [Nayagam, Shevanthi; Hallett, Timothy B.] Imperial Coll, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.
   [Conteh, Lesong; Sicuri, Elisa] Imperial Coll, Hlth Econ Grp, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England.
   [Sicuri, Elisa] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, Barcelona, Spain.
   [Shimakawa, Yusuke; Lemoine, Maud] Gambia Unit, Med Res Council Labs, Fajara, Gambia.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.
RP Nayagam, S (reprint author), Imperial Coll, Div Digest Dis, St Marys Hosp, London W2 1NY, England.; Nayagam, S (reprint author), Imperial Coll, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.
EM s.nayagam01@imperial.ac.uk
FU Wellcome Trust [100693]
CR Lampertico P, 2014, DIGEST LIVER DIS, V46, pE14, DOI 10.1016/j.dld.2014.01.033
   Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1
   Nayagam S, 2016, LANCET GLOB HEALTH, V4, pE568, DOI 10.1016/S2214-109X(16)30101-2
   Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035
   Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JAN
PY 2017
VL 5
IS 1
BP E35
EP E35
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN9SQ
UT WOS:000396340300020
PM 27955781
OA gold
DA 2017-08-15
ER

PT J
AU Nikolay, B
   Salje, H
   Sturm-Ramirez, K
   Azziz-Baumgartner, E
   Homaira, N
   Ahmed, M
   Luliano, AD
   Paul, RC
   Rahman, M
   Hossain, MJ
   Luby, SP
   Cauchemez, S
   Gurley, ES
AF Nikolay, Birgit
   Salje, Henrik
   Sturm-Ramirez, Katharine
   Azziz-Baumgartner, Eduardo
   Homaira, Nusrat
   Ahmed, Makhdum
   Luliano, A. Danielle
   Paul, Repon C.
   Rahman, Mahmudur
   Hossain, M. Jahangir
   Luby, Stephen P.
   Cauchemez, Simon
   Gurley, Emily S.
TI Evaluating Hospital-Based Surveillance for Outbreak Detection in
   Bangladesh: Analysis of Healthcare Utilization Data
SO PLOS MEDICINE
LA English
DT Article
ID EMERGING INFECTIOUS-DISEASES; INFLUENZA; HUMANS; VIRUS
AB Background
   The International Health Regulations outline core requirements to ensure the detection of public health threats of international concern. Assessing the capacity of surveillance systems to detect these threats is crucial for evaluating a country's ability to meet these requirements.
   Methods and Findings
   We propose a framework to evaluate the sensitivity and representativeness of hospital-based surveillance and apply it to severe neurological infectious diseases and fatal respiratory infectious diseases in Bangladesh. We identified cases in selected communities within surveillance hospital catchment areas using key informant and house-to-house surveys and ascertained where cases had sought care. We estimated the probability of surveillance detecting different sized outbreaks by distance from the surveillance hospital and compared characteristics of cases identified in the community and cases attending surveillance hospitals.
   We estimated that surveillance detected 26% (95% CI 18%-33%) of severe neurological disease cases and 18% (95% CI 16%-21%) of fatal respiratory disease cases residing at 10 km distance from a surveillance hospital. Detection probabilities decreased markedly with distance. The probability of detecting small outbreaks (three cases) dropped below 50% at distances greater than 26 km for severe neurological disease and at distances greater than 7 km for fatal respiratory disease. Characteristics of cases attending surveillance hospitals were largely representative of all cases; however, neurological disease cases aged <5 y or from the lowest socioeconomic group and fatal respiratory disease cases aged >= 60 y were underrepresented.
   Our estimates of outbreak detection rely on suspected cases that attend a surveillance hospital receiving laboratory confirmation of disease and being reported to the surveillance system. The extent to which this occurs will depend on disease characteristics (e. g., severity and symptom specificity) and surveillance resources.
   Conclusion
   We present a new approach to evaluating the sensitivity and representativeness of hospital-based surveillance, making it possible to predict its ability to detect emerging threats.
C1 [Nikolay, Birgit; Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Nikolay, Birgit; Salje, Henrik; Cauchemez, Simon] Ctr Natl Rech Sci, URA3012, Paris, France.
   [Nikolay, Birgit; Salje, Henrik; Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
   [Salje, Henrik] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Sturm-Ramirez, Katharine; Azziz-Baumgartner, Eduardo; Luliano, A. Danielle] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.
   [Sturm-Ramirez, Katharine; Homaira, Nusrat; Paul, Repon C.; Gurley, Emily S.] Int Ctr Diarrhoeal Dis Res, Div Infect Dis, Dhaka, Bangladesh.
   [Homaira, Nusrat] Univ New South Wales, Sch Womens & Childrens Hlth, Discipline Paediat, Sydney, NSW, Australia.
   [Ahmed, Makhdum] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA.
   [Ahmed, Makhdum] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.
   [Paul, Repon C.] Univ New South Wales Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.
   [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh.
   [Hossain, M. Jahangir] Med Res Council Unit Gambia, Banjul, Gambia.
   [Luby, Stephen P.] Stanford Univ, Div Infect Dis, Stanford, CA 94305 USA.
RP Salje, H (reprint author), Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.; Salje, H (reprint author), Ctr Natl Rech Sci, URA3012, Paris, France.; Salje, H (reprint author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.; Salje, H (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
EM henrik.salje@pasteur.fr
RI Gurley, Emily/B-7903-2010
OI Gurley, Emily/0000-0002-8648-9403; Salje, Henrik/0000-0003-3626-4254;
   Luby, Stephen/0000-0001-5385-899X
FU European Union [278433-PREDEMICS]; Laboratory of Excellence Integrative
   Biology of Emerging Infectious Diseases; AXA Research Fund; National
   Institute for General Medical Sciences-The Models of Infectious Disease
   Agent Study; US Centers for Disease Control and Prevention
FX The study was funded by the European Union Seventh Framework Programme
   (FP7/2007-2013) under Grant Agreement number 278433-PREDEMICS
   (http://predemics.biomedtrain.eu/cms/), The Laboratory of Excellence
   Integrative Biology of Emerging Infectious Diseases
   (https://research.pasteur.fr/fr/program_project/integrative-biology-of-e
   merging-infectious-diseases/), AXA Research Fund
   (https://www.axa-research.org), National Institute for General Medical
   Sciences-The Models of Infectious Disease Agent Study
   (https://www.nigms.nih.gov/Research/SpecificAreas/MIDAS/Pages/default.as
   px), and US Centers for Disease Control and Prevention
   (http://www.cdc.gov/). Co-authors who work for CDC were involved in
   survey design and report writing. Other sponsors had no involvement in
   study design; collection, analysis, and interpretation of data; writing
   of the report; or the decision to publish.
CR Ahmed M, 2013, OPTIONS CONTROL INFL, VVIII
   Ahmed S, 2001, J TROP PEDIATRICS, V47, P98, DOI 10.1093/tropej/47.2.98
   Andersson T, 2014, EPIDEMIOL INFECT, V142, P303, DOI 10.1017/S0950268813001088
   Ao TT, 2016, EMERG INFECT DIS, V22, P720, DOI 10.3201/eid2204.150330
   Azziz-Baumgartner E, 2012, EMERG INFECT DIS, V18, P146, DOI 10.3201/eid1801.101996
   CDC Guidelines Working Group, 2001, UPD GUID EV PUBL HLT
   CDC Working Group, 2004, FRAM EV PUBL HLTH SU
   Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   Efron B, 1994, AN INTRODUCTION TO T
   Fefferman Nh, 2010, Emerg Health Threats J, V3, pe6, DOI 10.3134/ehtj.10.006
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017
   Garcia-Abreu A, 2002, PUBLIC HLTH SURVEILL
   Gostin LO, 2004, JAMA-J AM MED ASSOC, V291, P2623, DOI 10.1001/jama.291.21.2623
   Homaira N, 2012, B WORLD HEALTH ORGAN, V90, P272, DOI 10.2471/BLT.11.095653
   Hossain MJ, 2003, AM J TROP MED HYG, V82, P344, DOI DOI 10.4269/AJTMH.2010.09-0125
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Keeling MJ, 2011, J R SOC INTERFACE, V8, P661, DOI 10.1098/rsif.2010.0474
   Krumkamp R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080598
   Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237
   MARI S, 2015, EMBO MOL MED, V0007
   Mor SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093744
   Naumova EN, 2009, J AM GERIATR SOC, V57, P2192, DOI 10.1111/j.1532-5415.2009.02565.x
   Paul RC, 2011, AM J TROP MED HYG, V85, P379, DOI 10.4269/ajtmh.2011.10-0706
   Phiri J, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-24
   QGIS Development Team, 2015, QGIS GEOGR INF SYST
   R Core Team, 2015, R LANG ENV STAT COMP
   Scarpino SV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002472
   Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042
   Tan KX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00140
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107
   [Anonymous], 2005, INT HLTH REG
   World Health Organization, 2006, COMM DIS SURV RESP S
   World Health Organization. Department of Communicable Disease Surveillance and Response, 2000, WHO REP GLOB SURV EP
   WHO-CIDA Initiative, 2012, INT TB CAS DET UPD 2
NR 37
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2017
VL 14
IS 1
AR e1002218
DI 10.1371/journal.pmed.1002218
PG 18
WC Medicine, General & Internal
SC General & Internal Medicine
GA EN0SM
UT WOS:000395719900014
PM 28095468
OA gold
DA 2017-08-15
ER

PT J
AU Migchelsen, SJ
   Martin, DL
   Southisombath, K
   Turyaguma, P
   Heggen, A
   Rubangakene, PP
   Joof, H
   Makalo, P
   Cooley, G
   Gwyn, S
   Solomon, AW
   Holland, MJ
   Courtright, P
   Willis, R
   Alexander, NDE
   Mabey, DCW
   Roberts, CH
AF Migchelsen, Stephanie J.
   Martin, Diana L.
   Southisombath, Khamphoua
   Turyaguma, Patrick
   Heggen, Anne
   Rubangakene, Peter Paul
   Joof, Hassan
   Makalo, Pateh
   Cooley, Gretchen
   Gwyn, Sarah
   Solomon, Anthony W.
   Holland, Martin J.
   Courtright, Paul
   Willis, Rebecca
   Alexander, Neal D. E.
   Mabey, David C. W.
   Roberts, Chrissy H.
TI Defining Seropositivity Thresholds for Use in Trachoma Elimination
   Studies
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PLASMID PROTEIN PGP3; HUMORAL IMMUNE-RESPONSE; DRIED BLOOD SPOTS;
   CHLAMYDIA-TRACHOMATIS; MIXTURE-MODELS; MALARIA TRANSMISSION; ACTIVE
   TRACHOMA; ROCHE AMPLICOR; RISK-FACTORS; INFECTION
AB Background Efforts are underway to eliminate trachoma as a public health problem by 2020. Programmatic guidelines are based on clinical signs that correlate poorly with Chlamydia trachomatis (Ct) infection in post-treatment and low-endemicity settings. Age-specific seroprevalence of anti Ct Pgp3 antibodies has been proposed as an alternative indicator of the need for intervention. To standardise the use of these tools, it is necessary to develop an analytical approach that performs reproducibly both within and between studies.
   Methodology Dried blood spots were collected in 2014 from children aged 1-9 years in Laos (n = 952) and Uganda (n = 2700) and from people aged 1-90 years in The Gambia (n = 1868). Anti-Pgp3 antibodies were detected by ELISA. A number of visual and statistical analytical approaches for defining serological status were compared.
   Principal Findings Seroprevalence was estimated at 11.3% (Laos), 13.4% (Uganda) and 29.3% (The Gambia) by visual inspection of the inflection point. The expectation-maximisation algorithm estimated seroprevalence at 10.4% (Laos), 24.3% (Uganda) and 29.3% (The Gambia). Finite mixture model estimates were 15.6% (Laos), 17.1% (Uganda) and 26.2% (The Gambia). Receiver operating characteristic (ROC) curve analysis using a threshold calibrated against external reference specimens estimated the seroprevalence at 6.7% (Laos), 6.8% (Uganda) and 20.9% (The Gambia) when the threshold was set to optimise Youden's J index. The ROC curve analysis was found to estimate seroprevalence at lower levels than estimates based on thresholds established using internal reference data. Thresholds defined using internal reference threshold methods did not vary substantially between population samples.
   Conclusions Internally calibrated approaches to threshold specification are reproducible and consistent and thus have advantages over methods that require external calibrators. We propose that future serological analyses in trachoma use a finite mixture model or expectation-maximisation algorithm as a means of setting the threshold for ELISA data. This will facilitate standardisation and harmonisation between studies and eliminate the need to establish and maintain a global calibration standard.
C1 [Migchelsen, Stephanie J.; Solomon, Anthony W.; Holland, Martin J.; Mabey, David C. W.; Roberts, Chrissy H.] London Sch Hyg & Trop Med, Dept Clin Res, London, England.
   [Martin, Diana L.; Cooley, Gretchen] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.
   [Southisombath, Khamphoua] Minist Hlth, Ctr Ophthalmol, Viangchan, Laos.
   [Turyaguma, Patrick] Ugandan Minist Hlth, Trachoma Control Programme, Kampala, Uganda.
   [Heggen, Anne] NTD Support Ctr, Decatur, GA USA.
   [Rubangakene, Peter Paul] RTI Int, ENVIS PROGRAMME, Kampala, Uganda.
   [Joof, Hassan; Makalo, Pateh] Med Res Council Unit Gambia, Fajara, Gambia.
   [Gwyn, Sarah] Ctr Dis Control & Prevent, IHRC Inc, Atlanta, GA USA.
   [Solomon, Anthony W.] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland.
   [Courtright, Paul] Univ Cape Town, Kilimanjaro Ctr Community Ophthalmol, Cape Town, South Africa.
   [Willis, Rebecca] Int Trachoma Initiat, Task Force Global Hlth, Decatur, GA USA.
   [Alexander, Neal D. E.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Infect Dis Epidemiol Dept, London, England.
RP Migchelsen, SJ (reprint author), London Sch Hyg & Trop Med, Dept Clin Res, London, England.
EM stephanie.migchelsen@lshtm.ac.uk
OI Solomon, Anthony/0000-0001-7101-6649
FU Wellcome Trust [098521/B/12/Z, WT098051, GR079246MA, WT093368MA,
   105609/Z/14/Z]; United Kingdom Medical Research Council (MRC);
   Department for International Development (DFID) [MR/K012126/1]; United
   States Agency for International Development (USAID) [FHI360,
   OAA-A-10-00051]; Coalition for Operational Research on the NTDs
   (COR-NTD); Bill & Melinda Gates Foundation; United States Agency for
   International Development through its Neglected Tropical
   Diseases-Support Center Program
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. This work was
   funded by grants from the Wellcome Trust
   (https://wellcome.ac.uk/)(098521/B/12/Z, WT098051, GR079246MA and
   WT093368MA). ChR is funded by the Wellcome Trust Institutional Strategic
   Support Fund (105609/Z/14/Z). SJM is funded by the Wellcome Trust. NA
   receives support from the United Kingdom Medical Research Council (MRC)
   (http://www.mrc.ac.uk/) and Department for International Development
   (DFID)
   (https://www.gov.uk/government/organisations/department-for-internationa
   l-development) (MR/K012126/1). The fieldwork in Laos was supported by
   the United States Agency for International Development (USAID)
   (https://www.usaid.gov/) via its END in Asia project, implemented by
   FHI360 (https://www.fhi360.org/) under cooperative agreement number
   OAA-A-10-00051. The fieldwork in Uganda was supported by the Coalition
   for Operational Research on the NTDs (COR-NTD)
   (http://www.ntdsupport.org/cor-ntd) which is funded at the Task Force
   for Global Health (http://www.taskforce.org/) by the Bill & Melinda
   Gates Foundation (http://www.gatesfoundation.org/) and by the United
   States Agency for International Development through its Neglected
   Tropical Diseases-Support Center Program.
CR Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570
   BEATTY WL, 1994, MICROBIOL REV, V58, P686
   Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X
   Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21
   Burr SE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002347
   Burton MJ, 2011, INVEST OPHTH VIS SCI, V52, P6012, DOI 10.1167/iovs.11-7326
   Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X
   Burton MJ, 2003, INVEST OPHTH VIS SCI, V44, P4215, DOI 10.1167/iovs.03-0107
   Carstensen B, 2016, EPIDEMIOLOGY R PACKA
   COMANDUCCI M, 1994, INFECT IMMUN, V62, P5491
   COMANDUCCI M, 1993, J GEN MICROBIOL, V139, P1083
   Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195
   Courtright P, 2015, GLOBAL TRACHOMA MAPP
   Deb P., 2012, FMM STATA MODULE TO
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   Dize L, 2013, DIAGN MICR INFEC DIS, V77, P289, DOI 10.1016/j.diagmicrobio.2013.08.005
   Dize L, 2013, J CLIN MICROBIOL, V51, P1611, DOI 10.1128/JCM.00519-13
   Donati M, 2009, VET MICROBIOL, V135, P181, DOI 10.1016/j.vetmic.2008.09.037
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521
   Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131
   Galaleldeen A, 2013, J BIOL CHEM, V288, P22068, DOI 10.1074/jbc.M113.475012
   Gay N, 1996, STAT MED, V15, P1567, DOI 10.1002/(SICI)1097-0258(19960730)15:14<1567::AID-SIM289>3.0.CO;2-G
   Gay NJ, 2003, EPIDEMIOL INFECT, V130, P285, DOI 10.1017/S0950268802008051
   Ghaem-Maghami S, 2003, CLIN EXP IMMUNOL, V132, P436, DOI 10.1046/j.1365-2249.2003.02163.x
   Goodhew EB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001873
   Goodhew EB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-216
   Harding-Esch EM, 2008, T ROY SOC TROP MED H, V102, P1255, DOI 10.1016/j.trstmh.2008.04.022
   Harding-Esch E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003670
   Harding-Esch EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002115
   Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861
   Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573
   Horner P, 1993, TRACHOMATIS C PGP3 A
   Horner PJ, 2013, SEX TRANSM INFECT, V89, P398, DOI 10.1136/sextrans-2011-050386
   Jenson A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002265
   Kaneko A, 2014, INFECT IMMUN, V82, P243, DOI 10.1128/IAI.00931-13
   Li Z, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-90
   Lyytikainen E, 2007, SEX TRANSM INFECT, V84, P19, DOI 10.1136/sti.2007.027409
   MacDonald PL, 2000, EDUC PSYCHOL MEAS, V60, P735, DOI 10.1177/00131640021970871
   Martin DL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003555
   Pant BP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004462
   PARKER RA, 1990, J VIROL METHODS, V27, P135, DOI 10.1016/0166-0934(90)90130-8
   Parker SP, 1999, J CLIN PATHOL, V52, P633
   Pfeiffer R M, 2000, J Epidemiol Biostat, V5, P267
   Polack S, 2005, B WORLD HEALTH ORGAN, V83, P913
   R Core Team. R, 2014, R LANG ENV STAT COMP
   Roberts C h, 2013, J CLIN MICROBIOL
   Roberts CH, 2014, EXPERT REV MOL DIAGN, V14, P253, DOI 10.1586/14737159.2014.897609
   Sepulveda N, 2015, J IMMUNOL RES, V2015
   Shekhawat N, 2014, INVEST OPHTH VIS SCI, V55, P2307, DOI 10.1167/iovs.13-12701
   SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545
   Smit PW, 2014, AM J TROP MED HYG, V90, P195, DOI 10.4269/ajtmh.13-0463
   Smit PW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-102
   Solomon AW, 2015, OPHTHAL EPIDEMIOL, V22, P214, DOI 10.3109/09286586.2015.1037401
   Southisombath K, 2016, OPHTHAL EPIDEMIOL, V23, P8, DOI 10.1080/09286586.2016.1236973
   Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083
   THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477
   Trotter CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055486
   van den Hoogen LL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0939-1
   Vyse AJ, 2006, EPIDEMIOL INFECT, V134, P1303, DOI 10.1017/S0950268806006340
   Vyse AJ, 2004, EPIDEMIOL INFECT, V132, P1129, DOI 10.1017/S09502688040032140
   Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240
   West SK, 2016, PLOS NEGLECT TROP D, V10, p1 
   World Health Organisation, 2014, WKLY EPIDEMIOL REC, V96, p421 
   Wills GS, 2009, CLIN VACCINE IMMUNOL, V16, P835, DOI 10.1128/CVI.00021-09
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 66
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005230
DI 10.1371/journal.pntd.0005230
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000028
OA gold
DA 2017-08-15
ER

PT J
AU Kipper, S
   Sellar, P
   Barlow, CR
AF Kipper, Silke
   Sellar, Patrick
   Barlow, Clive R.
TI A comparison of the diurnal song of the Common Nightingale (Luscinia
   megarhynchos) between the non-breeding season in The Gambia, West Africa
   and the breeding season in Europe
SO JOURNAL OF ORNITHOLOGY
LA English
DT Article
DE Song function; Non-breeding singing; Plastic song; Song practice
ID WINTER WREN; BIRDS; DAWN; 1ST
AB Understanding the full annual song and life cycle of song birds contributes substantially to our understanding of song mechanisms and functions, as well as behavioural ecology and conservation. However, the singing and behaviour of song birds outside the breeding period have barely been studied; this is particularly true for long-distance migratory species. We analysed recordings of the song of Common Nightingales (Luscinia megarhynchos) obtained from their non-breeding grounds in The Gambia, West Africa and compared these to their song during breeding in Central Europe. With regard to song patterns and singing style, we did not find an obligatory breakdown of song organization during non-breeding, but that the birds may sing a typical and recognizable breeding song, which varied on an individual basis. The duration of songs as well as their versatility did not differ between the two samples. However, we did find a difference in song type delivery, with more songs directly repeated during breeding as compared to non-breeding. These results support a practice function of song, but leave also room for additional interpretations such as a function in territorial interactions or as a 'market place' characteristic to adjust song repertoires and song sequencing among males sharing their breeding as well as non-breeding areas.
C1 [Kipper, Silke] Tech Univ Munich, Sch Life Sci Weihenstephan, Chair Zool, Liesel Beckmann Str 4, D-85350 Freising Weihenstephan, Germany.
   [Sellar, Patrick] 89 Riddlesdown Rd, Purley CR8 1DH, Surrey, England.
   [Barlow, Clive R.] Birds Gambia, Brufut, Western Region, Gambia.
RP Kipper, S (reprint author), Tech Univ Munich, Sch Life Sci Weihenstephan, Chair Zool, Liesel Beckmann Str 4, D-85350 Freising Weihenstephan, Germany.
EM silke.kipper@tum.de
CR Amrhein V, 2002, ANIM BEHAV, V64, P939, DOI 10.1006/anbe.2002.1974
   Amrhein V, 2006, ANIM BEHAV, V71, P1075, DOI 10.1016/j.anbehav.2005.07.023
   Apfelbeck B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052009
   Ball GF, 2004, ANN NY ACAD SCI, V1016, P586, DOI 10.1196/annals.1298.043
   Bartsch C, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0390-5
   Bartsch C, 2014, BEHAV ECOL SOCIOBIOL, V68, P1163, DOI 10.1007/s00265-014-1727-6
   Brumm H, 2001, ANIM BEHAV, V61, P747, DOI 10.1006/anbe.2000.1664
   Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791
   Erne N, 2008, J ORNITHOL, V149, P479, DOI 10.1007/s10336-008-0288-8
   Geberzahn N, 2003, BEHAVIOUR, V140, P593, DOI 10.1163/156853903322149450
   Geberzahn N, 2003, P ROY SOC B-BIOL SCI, V270, P1085, DOI 10.1098/rspb.2003.2340
   Geberzahn N, 2002, ANIM BEHAV, V64, P783, DOI 10.1006/snbe.2002.3099
   Greenberg Russell, 2005, P437
   Hahn S, 2014, ECOL EVOL, V4, P4150, DOI 10.1002/ece3.1279
   Hahn S, 2013, OECOLOGIA, V173, P1217, DOI 10.1007/s00442-013-2726-4
   Hultsch H, 2001, APPROACHES BOOTSTRAP, V2, P309
   Hultsch H, 2008, NEUROSCIENCE BIRDSON, P204
   Hultsch H, 1989, NEURAL MECH BEHAV, P113
   Kiefer S, 2010, ETHOLOGY, V116, P619, DOI 10.1111/j.1439-0310.2010.01774.x
   Kiefer S, 2009, J AVIAN BIOL, V40, P231, DOI 10.1111/j.1600-048X.2009.04500.x
   Kipper S, 2004, BEHAVIOUR, V141, P371, DOI 10.1163/156853904322981914
   Kunc HP, 2007, BEHAV ECOL SOCIOBIOL, V61, P557, DOI 10.1007/s00265-006-0284-z
   Landys MM, 2010, HORM BEHAV, V58, P317, DOI 10.1016/j.yhbeh.2010.02.013
   Reudink MW, 2009, P R SOC B, V276, P1619, DOI 10.1098/rspb.2008.1452
   Sorensen MC, 2016, AM NAT, V187, pE65, DOI 10.1086/684681
   Todt D, 2003, ANIM BEHAV, V65, P971, DOI 10.1006/anbe.2003.2127
   Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7
   Vokurkova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060172
   Weiss M, 2012, THESIS
   Weiss M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0460
NR 30
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0021-8375
EI 1439-0361
J9 J ORNITHOL
JI J. Ornithol.
PD JAN
PY 2017
VL 158
IS 1
BP 223
EP 231
DI 10.1007/s10336-016-1364-0
PG 9
WC Ornithology
SC Zoology
GA EK1FG
UT WOS:000393670600021
OA No
DA 2017-08-15
ER

PT J
AU Lemoine, M
   Thursz, M
   Mallet, V
   Shimakawa, Y
AF Lemoine, Maud
   Thursz, Mark
   Mallet, Vincent
   Shimakawa, Yusuke
TI Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet
   ratio (GPR) using transient elastography as a reference
SO GUT
LA English
DT Letter
ID LIVER FIBROSIS; HBV; HIV
C1 [Lemoine, Maud; Thursz, Mark] Imperial Coll London, St Marys Hosp, Dept Hepatol, London, England.
   [Lemoine, Maud; Shimakawa, Yusuke] MRC Labs, Fajara, Gambia.
   [Mallet, Vincent] Hop Cochin, AP HP, Dept Hepatol, Paris, France.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemioly, Paris, France.
RP Lemoine, M (reprint author), Imperial Coll London, South Wharf St, London W2 1NY, England.
EM m.lemoine@imperial.ac.uk
OI Mallet, Vincent/0000-0003-2219-9201
CR Boyd A, 2016, GUT, V65, P718, DOI 10.1136/gutjnl-2015-310607
   Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561
   Lemoine M, 2016, GUT, V65, P1369, DOI 10.1136/gutjnl-2015-309260
   Stockdale AJ, 2016, GUT, V65, P882, DOI 10.1136/gutjnl-2015-311133
NR 4
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD JAN
PY 2017
VL 66
IS 1
BP 195
EP +
DI 10.1136/gutjnl-2016-311554
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EI1YN
UT WOS:000392282900023
PM 26921348
OA No
DA 2017-08-15
ER

PT J
AU Xu, Y
   Doel, A
   Watson, S
   Routledge, MN
   Elliott, CT
   Moore, SE
   Gong, YY
AF Xu, Ya
   Doel, Andrew
   Watson, Sinead
   Routledge, Michael N.
   Elliott, Christopher T.
   Moore, Sophie E.
   Gong, Yun Yun
TI Study of an Educational Hand Sorting Intervention for Reducing Aflatoxin
   B-1 in Groundnuts in Rural Gambia
SO JOURNAL OF FOOD PROTECTION
LA English
DT Article
DE Aflatoxins; Groundnuts; Hand sorting; Intervention; Postharvest; West
   Africa
ID DIETARY AFLATOXIN; HUMAN-DISEASE; HUMAN HEALTH; WEST-AFRICA; EXPOSURE;
   MYCOTOXINS; CHILDREN; GROWTH; FOOD; KNOWLEDGE
AB Aflatoxin, a human liver carcinogen, frequently contaminates groundnuts, maize, rice, and other grains, especially in Africa. The aim of this study was to evaluate the effectiveness of an educational intervention that involved training rural Gambian women on how to identify and remove moldy groundnuts to reduce aflatoxin B-1 (AFB(1)) contamination. In total, 25 women, recruited from the West Kiang region of The Gambia, were trained on how to recognize and remove moldy groundnuts. Marketpurchased groundnuts were hand sorted by the women. Groundnuts were sampled at baseline (n = 5), after hand sorting ("clean,'' n = 25 and "moldy,'' n = 25), and after roasting (n = 5). All samples were analyzed for AFB(1) by enzyme-linked immunosorbent assay. A reduction of 42.9% was achieved based on the median AFB(1) levels at baseline and after hand sorting (clean groundnuts), whereas an alternative estimate, based on the total AFB(1) in moldy and clean groundnuts, indicated a reduction of 96.7%, with a loss of only 2% of the groundnuts. By roasting the already clean sorted groundnuts, the AFB(1) reduction achieved (based on median levels) was 39.3%. This educational intervention on how to identify and remove moldy groundnuts was simple and effective in reducing AFB(1) contamination.
C1 [Xu, Ya; Watson, Sinead; Elliott, Christopher T.; Gong, Yun Yun] Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast BT7 1NN, Antrim, North Ireland.
   [Doel, Andrew] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1E 7HT, England.
   [Doel, Andrew; Moore, Sophie E.] MRC Keneba, MRC Unit, Kiang West Region, Gambia.
   [Routledge, Michael N.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.
   [Moore, Sophie E.] MRC Human Nutr Res, Cambridge CB1 9NL, England.
RP Gong, YY (reprint author), Queens Univ Belfast, Inst Global Food Secur, Sch Biol Sci, Belfast BT7 1NN, Antrim, North Ireland.
EM y.gong@qub.ac.uk
RI Gong, Yun/L-7094-2016
OI Gong, Yun/0000-0003-4927-5526
FU Bill and Melinda Gates Foundation [OPP1 066947]; United Kingdom MRC;
   United Kingdom Department for International Development (DFID) under the
   MRC/DFID Concordat agreement [MC-A760-5QX00]
FX We acknowledge the laboratory support by Dr. Michalina
   Oplatowska-Stachowiak, Dr. Gaoyun Chen, and Mr. Patrick Geary. We
   acknowledge the field assistance from FatouSey (National Nutrition
   Agency, The Gambia) and Sirimang Malang (MRC Keneba). This study was
   funded by the Bill and Melinda Gates Foundation Grand Challenge
   "Achieving Healthy Growth'' scheme (grant OPP1 066947) and by core
   funding to the MRC International Nutrition Group by the United Kingdom
   MRC and the United Kingdom Department for International Development
   (DFID) under the MRC/DFID Concordat agreement (grant MC-A760-5QX00). The
   sponsors had no involvement in the study design, data collection,
   analysis, or in the writing of the report. The authors declare no
   conflict of interest.
CR Awuah R. T., 2009, Peanut Science, V36, P68, DOI 10.3146/PS06-36.1
   Cardwell KF, 2004, J TOXICOL-TOXIN REV, V23, P217, DOI 10.1081/TXR-200027817
   Castelino JM, 2014, TROP MED INT HEALTH, V19, P348, DOI 10.1111/tmi.12250
   DICKENS J W, 1975, Peanut Science, V2, P45, DOI 10.3146/i0095-3679-2-2-4
   Fandohan P, 2005, INT J FOOD MICROBIOL, V98, P249, DOI [10.1016/j.ijfoodmicro.2004.07.007, 10.1016/j.foodchem.2004.07.007]
   Filbert M. E., 2012, Journal of Hunger & Environmental Nutrition, V7, P321, DOI 10.1080/19320248.2012.707109
   Galvez FCF, 2003, J FOOD PROTECT, V66, P1879
   Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954
   Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20
   Hudson Geoffrey J., 1992, Natural Toxins, V1, P100, DOI 10.1002/nt.2620010208
   Ilesanmi F. F., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P493, DOI 10.1016/S2221-1691(11)60108-1
   International Agency for Research on Cancer, 2002, IARC MON EV CARC RIS, V82, P171
   Jiang Y, 2005, INT IMMUNOL, V17, P807, DOI 10.1093/intimm/dxh262
   Jiang Y., 2008, CLIN DEV IMMUNOL, V2008, DOI [DOI 10.1155/2008/790309, 10.1155/2008/790309]
   Jolly P, 2006, INT J HYG ENVIR HEAL, V209, P345, DOI 10.1016/j.ijheh.2006.02.002
   Kaaya A. N., 2006, Peanut Science, V33, P68, DOI 10.3146/0095-3679(2006)33[68:PALOFA]2.0.CO;2
   Khlangwiset P, 2010, FOOD ADDIT CONTAM A, V27, P998, DOI 10.1080/19440041003677475
   LEE LS, 1969, J AGR FOOD CHEM, V17, P451, DOI 10.1021/jf60163a010
   Matumba L, 2015, FOOD CONTROL, V51, P236, DOI 10.1016/j.foodcont.2014.11.035
   Muhlemann M., 1997, Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene, V88, P474
   PELLETIER M J, 1992, Peanut Science, V19, P15, DOI 10.3146/i0095-3679-19-1-4
   Pitt JI, 2013, FOOD CONTROL, V32, P205, DOI 10.1016/j.foodcont.2012.11.023
   Pourelmi M. R., 2013, EUR J ZOOL RES, V2, P89
   Probst C, 2007, APPL ENVIRON MICROB, V73, P2762, DOI 10.1128/AEM.02370-06
   Shephard GS, 2008, FOOD ADDIT CONTAM, V25, P146, DOI 10.1080/02652030701567442
   Shirima CP, 2013, MOL NUTR FOOD RES, V57, P1874, DOI 10.1002/mnfr.201300116
   Turner PC, 2007, INT J EPIDEMIOL, V36, P1119, DOI 10.1093/ije/dym122
   Turner PC, 2005, LANCET, V365, P1950, DOI 10.1016/S0140-6736(05)66661-5
   Turner PC, 2003, ENVIRON HEALTH PERSP, V111, P217, DOI 10.1289/ehp.5753
   van Egmond HP, 2007, ANAL BIOANAL CHEM, V389, P147, DOI 10.1007/s00216-007-1317-9
   Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264
   Yazdanpanah H, 2005, FOOD CHEM TOXICOL, V43, P1135, DOI 10.1016/j.fct.2005.03.004
NR 32
TC 0
Z9 0
U1 4
U2 4
PU INT ASSOC FOOD PROTECTION
PI DES MOINES
PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA
SN 0362-028X
EI 1944-9097
J9 J FOOD PROTECT
JI J. Food Prot.
PD JAN
PY 2017
VL 80
IS 1
BP 44
EP 49
DI 10.4315/0362-028X.JFP-16-152
PG 6
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA EI4SP
UT WOS:000392483900006
PM 28198655
OA No
DA 2017-08-15
ER

PT J
AU Kwambana-Adams, BA
   Laxton, CS
   Foster-Nyarko, E
   Laxton, CS
   Weinstock, G
   Antonio, M
AF Kwambana-Adams, Brenda A.
   Laxton, Claire S.
   Foster-Nyarko, Ebenezer
   Laxton, Claire S.
   Weinstock, George
   Antonio, Martin
TI Isolation of Methicillin-resistant Staphylococcus aureus and
   Multidrug-resistant Elizabethkingia meningoseptica From Neonates Within
   Minutes of Birth
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Letter
C1 [Kwambana-Adams, Brenda A.; Laxton, Claire S.; Foster-Nyarko, Ebenezer; Antonio, Martin] Med Res Council Unit Gambia, Vaccines & Immun, Fajara, Gambia.
   [Kwambana-Adams, Brenda A.; Laxton, Claire S.; Foster-Nyarko, Ebenezer; Antonio, Martin] London Sch Hyg & Trop Med, London, England.
   [Laxton, Claire S.] Univ Manchester, Manchester, Lancs, England.
   [Weinstock, George] Jackson Lab Genom Med, Farmington, CT USA.
RP Kwambana-Adams, BA (reprint author), Med Res Council Unit Gambia, Vaccines & Immun, Fajara, Gambia.; Kwambana-Adams, BA (reprint author), London Sch Hyg & Trop Med, London, England.
EM bkwambana@mrc.gm
FU Medical Research Council [MC_UP_A900_1122, MC_U190081991]
CR Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11
   Ceyhan M, 2011, INT J PEDIAT, V2011
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Wong V, 2011, J CLIN MICROBIOL, V49, P2093, DOI 10.1128/JCM.02559-10
   Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769
NR 5
TC 0
Z9 0
U1 4
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD JAN
PY 2017
VL 36
IS 1
BP 123
EP 124
DI 10.1097/INF.0000000000001368
PG 2
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA EG7TU
UT WOS:000391259900031
PM 27941472
OA No
DA 2017-08-15
ER

PT J
AU Heslop, R
   Bojang, AL
   Jarju, S
   Mendy, J
   Mulwa, S
   Secka, O
   Mendy, FS
   Owolabi, O
   Kampmann, B
   Sutherland, JS
AF Heslop, Rhiannon
   Bojang, Adama L.
   Jarju, Sheikh
   Mendy, Joseph
   Mulwa, Sarah
   Secka, Ousman
   Mendy, Francis S.
   Owolabi, Olumuyiwa
   Kampmann, Beate
   Sutherland, Jayne S.
TI Changes in Host Cytokine Patterns of TB Patients with Different
   Bacterial Loads Detected Using S-16 rRNA Analysis
SO PLOS ONE
LA English
DT Article
ID PULMONARY TUBERCULOSIS; SPUTUM; BIOMARKERS; RESPONSES; DISEASE
AB Background
   Tuberculosis (TB) has overtaken HIV as the biggest infectious disease killer, with the majority of deaths occurring in sub-Saharan Africa. However it is unknown how differences in bacterial load alter host immune profiles in the sputum and blood of TB patients.
   Methods
   S-16 ribosomal RNA analysis was used to determine bacterial load in sputum samples obtained from 173 patients with active TB (57 pre-treatment and 116 post-treatment). Host analyte concentrations in sputum and Mycobacterium tuberculosis (Mtb) antigen stimulated whole blood assay supernatants were analysed using multiplex cytokine arrays.
   Results
   Multiple logistic regression adjusting for age, sex and HIV status showed highly significant correlation of bacterial load with IL1 beta, IL2, IL1RA, IL4, IL6, IL8, IL9, IL15, IL17, EOTAX, FGF, IFN-gamma, GCSF, MCP1, M1P1 alpha, M1P1 beta, PDGF, TNF alpha, VEGF in sputum. With increasing time on treatment, FGF levels in sputum displayed the most significant inverse correlation with reduction in bacterial load.
   Conclusions
   We show that differences in bacterial load correlates with changes in several host biomarkers. These findings have implications for development of tests for TB diagnosis and treatment response.
C1 [Heslop, Rhiannon; Bojang, Adama L.; Jarju, Sheikh; Mendy, Joseph; Mulwa, Sarah; Secka, Ousman; Mendy, Francis S.; Owolabi, Olumuyiwa; Kampmann, Beate; Sutherland, Jayne S.] Med Res Council MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
   [Heslop, Rhiannon] Univ Manchester, Manchester, Lancs, England.
RP Sutherland, JS (reprint author), Med Res Council MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
EM jsutherland@mrc.gm
OI Sutherland, Jayne/0000-0002-7083-4997
FU United Kingdom (UK) Medical Research Council (MRC); UK Department for
   International Development (DFID) under MRC/DFID
FX This work was jointly supported by the United Kingdom (UK) Medical
   Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement. The funder
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122
   El-Sony A, 2002, INT J TUBERC LUNG D, V6, P91
   Honeyborne I, 2014, J CLIN MICROBIOL, V52, P3064, DOI 10.1128/JCM.01128-14
   Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107
   Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129
   Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005
   Ota MOC, 2014, EUR RESPIR J, V44, P254, DOI 10.1183/09031936.00209913
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007
   Sutherland JS, HIGHLY ACCURATE DIAG
   Theron G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037436, 10.1371/journal.pone.0037436d]
   Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103
   Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3
   Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237
NR 14
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 16
PY 2016
VL 11
IS 12
AR e0168272
DI 10.1371/journal.pone.0168272
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI8LN
UT WOS:000392758000035
PM 27992487
OA gold
DA 2017-08-15
ER

PT J
AU Roy, RB
   Brandt, N
   Moodie, N
   Motlagh, M
   Rasanathan, K
   Seddon, JA
   Detjen, AK
   Kampmann, B
AF Roy, Robindra Basu
   Brandt, Nicola
   Moodie, Nicolette
   Motlagh, Mitra
   Rasanathan, Kumanan
   Seddon, James A.
   Detjen, Anne K.
   Kampmann, Beate
TI Why the Convention on the Rights of the Child must become a guiding
   framework for the realization of the rights of children affected by
   tuberculosis
SO BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS
LA English
DT Article
DE Human Rights; Tuberculosis; Paediatrics/Pediatrics; Human Rights-Based
   Approach; Stigma; Nondiscrimination; Autonomy; Medical ethics; Child
   health; Child survival
ID PULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; SCIENTIFIC PROGRESS;
   SOUTH-AFRICA; HEALTH; METAANALYSIS; INFECTION; ACCURACY; ADVOCACY
AB Background: Until recently, paediatric tuberculosis (TB) has been relatively neglected by the broader TB and the maternal and child health communities. Human rights-based approaches to children affected by TB could be powerful; however, awareness and application of such strategies is not widespread.
   Discussion: We summarize the current challenges faced by children affected by TB, including: consideration of their family context; the limitations of preventive, diagnostic and treatment options; paucity of paediatric-specific research; failure in implementation of interventions; and stigma. We examine the articles of the Convention on the Rights of the Child (CRC) and relate them to childhood TB. Specifically, we focus on the five core principles of the CRC: children's inherent right to life and States' duties towards their survival and development; children's right to enjoyment of the highest attainable standard of health; non-discrimination; best interests of the child; and respect for the views of the child. We highlight where children's rights are violated and how a human rights-based approach should be used as a tool to help children affected by TB, particularly in light of the Sustainable Development Goals and their focus on universality and leaving no one behind.
   Summary: The article aims to bridge the gap between those providing paediatric TB clinical care and conducting research, and those working in the fields of human rights policy and advocacy to promote a human rights-based approach for children affected by TB based upon the Convention on the Rights of the Child.
C1 [Roy, Robindra Basu; Seddon, James A.; Kampmann, Beate] Imperial Coll London, Dept Paediat Floor 2, Ctr Int Child Hlth, Med Sch Bldg,St Marys Campus, London W2 1PG, England.
   [Roy, Robindra Basu; Kampmann, Beate] Med Res Council MRC Unit Gambia, Vaccines & Immun Theme, Fajara, Gambia.
   [Brandt, Nicola; Motlagh, Mitra] United Nations Childrens Fund UNICEF, Human Rights Unit, Programme Div, 3 UN Plaza, New York, NY USA.
   [Moodie, Nicolette] UNICEF, Programme Div, Human Rights Unit, 5-7 Ave Paix, CH-1211 Geneva, Switzerland.
   [Rasanathan, Kumanan] UNICEF, Hlth Sect, 3 UN Plaza, New York, NY USA.
   [Detjen, Anne K.] UNICEF, Childhood TB, 3 UN Plaza, New York, NY USA.
RP Roy, RB (reprint author), Imperial Coll London, Dept Paediat Floor 2, Ctr Int Child Hlth, Med Sch Bldg,St Marys Campus, London W2 1PG, England.; Roy, RB (reprint author), Med Res Council MRC Unit Gambia, Vaccines & Immun Theme, Fajara, Gambia.
EM r.basu-roy@imperial.ac.uk
RI Basu Roy, Robin/L-2979-2016
OI Basu Roy, Robin/0000-0001-5648-3628; Kampmann,
   Beate/0000-0002-6546-4709; Seddon, James/0000-0002-2296-2302
FU UK Medical Research Council (MRC) under the MRC/DFID Concordat
   agreement; UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement; European Union [MR/K023446/1]; National
   Institute of Health Research (NIHR); Academy of Medical Sciences; MRC
   Program Grant [MR/K011944/1]; NIHR Senior Fellowship [SRF-2009-02-07]
FX RB's Clinical Research Training Fellowship is jointly funded by the UK
   Medical Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement and is also
   part of the EDCTP2 programme supported by the European Union
   (MR/K023446/1). NB, NM, MM, KR and AKD work for UNICEF. JAS' Academic
   Clinical Lectureship is funded by the National Institute of Health
   Research (NIHR) and he is also supported by the Academy of Medical
   Sciences. BK is supported by MRC Program Grant MR/K011944/1 and NIHR
   Senior Fellowship SRF-2009-02-07.
CR Ali M, 2014, LANCET, V383, P2195, DOI 10.1016/S0140-6736(14)61063-1
   Barnes DS, 2000, MICROBES INFECT, V2, P431, DOI 10.1016/S1286-4579(00)00323-3
   Bhaumik S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4301
   Bustreo F, 2013, WOMENS CHILDRENS HLT
   Chiang SS, 2014, LANCET INFECT DIS, V14, P947, DOI 10.1016/S1473-3099(14)70852-7
   Citro B, 2016, HEALTH HUM RIGHTS, V18, P1
   Committee on Economic Social and Cultural Rights, 2000, GC14 GEN COMM 14 RIG
   Committee on the Rights of the Child, 2012, REP 2012 DAY GEN DIS
   Committee on the Rights of the Child, 2013, GC14 GEN COMM 14 RIG
   Committee on the Rights of the Child, 2013, GCL5 GEN COMM 15 RIG
   Davis SLM, 2014, HEALTH HUM RIGHTS, V16, P134
   Detjen A, 2016, INT UNION TUBERCULOS
   Devlin Sue, 2013, N S W Public Health Bull, V24, P38, DOI 10.1071/NB12113
   Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5
   Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6
   Donald PR, 2004, INT J TUBERC LUNG D, V8, P627
   Frick M, 2016, HEALTH HUM RIGHTS, V18, P9
   Getahun H, 2012, J INFECT DIS, V205, pS216, DOI 10.1093/infdis/jis009
   Hodgkin R., 2007, IMPLEMENTATION HDB C
   International Standard Randomised Controlled Trial Number Registry, 2014, ISRCTN63579542 SHINE
   Lansdown G., 2011, EVERY CHILDS RIGHT B
   London L, 2016, HEALTH HUM RIGHTS, V18, P25
   Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369
   Machado MC, 2009, MATERNAL CHILD HLTH
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392
   Mason PH, 2015, INT J TUBERC LUNG D, V19, P1135, DOI 10.5588/ijtld.15.0066
   McBroom K, 2016, HEALTH HUM RIGHTS, V18, P69
   Medecins Sans Frontieres, 2013, TEST ME TREAT ME DRU
   Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9
   Neumann J., 2014, DOCUMENTARY RETURN P
   Nicholson T, 2016, HEALTH HUM RIGHTS, V18, P85
   Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0
   Nicolai T, 2015, NEW ENGL J MED
   Office of the United Nations High Commissioner for Human Rights, 2014, TECHN GUID APPL HUM
   Papathakis P, 2008, AFRICAS HLTH 2010 PR
   Paz-Soldan VA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-290
   Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049
   Rasanathan Kumanan, 2010, Health Hum Rights, V12, P49
   Ritz N, 2015, LANCET, V386, P2475, DOI 10.1016/S0140-6736(15)01241-6
   Sandgren A, 2012, EUR RESPIR J, V40, P294, DOI 10.1183/09031936.00187711
   Schaaf HS, 2014, CURR OPIN INFECT DIS, V27, P211, DOI 10.1097/QCO.0000000000000062
   Seddon JA, 2012, AM J RESP CRIT CARE, V186, P953, DOI 10.1164/rccm.201206-1001CI
   Soborg B, 2011, B WORLD HEALTH ORGAN, V89, P741, DOI 10.2471/BLT.10.084152
   Swedish International Development Cooperation Agency (Sida), 2015, HUM RIGHTS BAS APPR
   Swingler GH, 2005, ARCH DIS CHILD, V90, P1153, DOI 10.1136/adc.2004.062315
   TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295
   TB Alliance, 2016, CHILD FRIENDL MED
   UN Committee on Economic Social and Cultural Rights (CESCR), 2000, GEN COMM 14 RIGHT HI
   United Nations General Assembly, TREAT SER, V1577, P3
   United Nations Population Division Department of Economic and Social Affairs, 2015, INT MIGR STOCK 2015
   UNICEF, 2010, STAT WORLD CHILD
   UNICEF, 2014, STAT WORLDS CHILDR 2
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, 2005, WHOHTMTB2005352
   The World Health Organization, 2015, GEAR UP END TB INTR
   Factsheet, 2014, TUB WOM
   World Health Organization, 2015, GLOB TUB REP 2015
   World Health Organization, 2014, GUID NAT TUB PROGR M
   World Health Organization, 2010, RAP ADV TREATM TUB C
   World Health Organization, 2012, EARL CHILDH DEV DIS
   World Health Organization, 2013, WHOHTMTB201312
   The World Health Organization, 2009, RED TRANSM TB HOUS W
   The World Health Organization Stop TB Partnership, 2012, MOR CRYING MOR DYING
   Yamin AE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001546
   [Anonymous], 2003, INT WORKSH HUM RIGHT
NR 65
TC 0
Z9 0
U1 2
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-698X
J9 BMC INT HEALTH HUM R
JI BMC Int. Health Hum. Rights.
PD DEC 8
PY 2016
VL 16
AR 32
DI 10.1186/s12914-016-0105-z
PG 15
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA EG3PO
UT WOS:000390957400001
OA gold
DA 2017-08-15
ER

PT J
AU Karanjia, RN
   Crossey, MME
   Cox, IJ
   Fye, HKS
   Njie, R
   Goldin, RD
   Taylor-Robinson, SD
AF Karanjia, Rustam N.
   Crossey, Mary M. E.
   Cox, I. Jane
   Fye, Haddy K. S.
   Njie, Ramou
   Goldin, Robert D.
   Taylor-Robinson, Simon D.
TI Hepatic steatosis and fibrosis: Non-invasive assessment
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE Hepatic steatosis; Fibrosis; Non-invasive assessment; Blood biomarker;
   Ultrasound
ID FATTY LIVER-DISEASE; MAGNETIC-RESONANCE-SPECTROSCOPY; CHRONIC
   VIRAL-HEPATITIS; CONTROLLED ATTENUATION PARAMETER; PLATELET RATIO INDEX;
   P-31 MR SPECTROSCOPY; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION;
   STIFFNESS MEASUREMENT; B-VIRUS
AB Chronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and scarring, resulting in end-stage liver disease and its complications. The progression of disease is characterised by ongoing inflammation and consequent fibrosis, although hepatic steatosis is increasingly being recognised as an important pathological feature of disease, rather than being simply an innocent bystander. However, the current gold standard method of quantifying and staging liver disease, histological analysis by liver biopsy, has several limitations and can have associated morbidity and even mortality. Therefore, there is a clear need for safe and non-invasive assessment modalities to determine hepatic steatosis, inflammation and fibrosis. This review covers key mechanisms and the importance of fibrosis and steatosis in the progression of liver disease. We address non-invasive imaging and blood biomarker assessments that can be used as an alternative to information gained on liver biopsy.
C1 [Karanjia, Rustam N.; Crossey, Mary M. E.; Goldin, Robert D.; Taylor-Robinson, Simon D.] Imperial Coll London, Dept Surg & Canc, Div Digest Hlth, Liver Unit, St Marys Campus,10th Floor QEQM Wing, London W2 1NY, England.
   [Cox, I. Jane] Fdn Liver Res, Inst Hepatol London, 111 Coldharbour Lane, London SE5 9NT, England.
   [Cox, I. Jane] Kings Coll London, Fac Life Sci & Med, London SE5 9NT, England.
   [Fye, Haddy K. S.] MRC Gambia, Atlantic Rd, Fajara, Gambia.
RP Karanjia, RN (reprint author), Imperial Coll London, Dept Surg & Canc, Div Digest Hlth, Liver Unit, St Marys Campus,10th Floor QEQM Wing, London W2 1NY, England.
EM rk2311@ic.ac.uk
FU British Medical Research Council; Wellcome Trust (London, United
   Kingdom); Sir Halley Stewart Trust (Cambridge, United Kingdom); European
   Union Framework 7
FX The authors thank the United Kingdom National Institute for Health
   Research (NIHR) Biomedical Research Facility at Imperial College London
   for infrastructure support. SDT-R holds grants from the British Medical
   Research Council and the Wellcome Trust (London, United Kingdom). MMEC
   is supported by a Fellowship from the Sir Halley Stewart Trust
   (Cambridge, United Kingdom). SDT-R, MMEC, HKSF and RN have been
   participant workers in the PROLIFICA project in West Africa, funded by
   the European Union Framework 7. The authors also thank Dr Jeremy Cobbold
   for helpful contributions to this review and for ongoing discussions.
CR Aguirre DA, 2006, RADIOLOGY, V239, P425, DOI 10.1148/radiol.2392050505
   Albrecht T, 1999, LANCET, V353, P1579, DOI 10.1016/S0140-6736(98)06373-9
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775
   Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007
   Aube C, 1999, J HEPATOL, V30, P472, DOI 10.1016/S0168-8278(99)80107-X
   Aube C, 2004, J RADIOL, V85, P301
   AUTRUP H, 1987, CANCER RES, V47, P3430
   Awaya H, 2002, RADIOLOGY, V224, P769, DOI 10.1148/radiol.2243011495
   Banerjee R, 2014, J HEPATOL, V60, P69, DOI 10.1016/j.jhep.2013.09.002
   Bashir MR, 2015, AM J ROENTGENOL, V204, P297, DOI 10.2214/AJR.14.12457
   Beaussier M, 2007, LAB INVEST, V87, P292, DOI 10.1038/labinvest.3700513
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022
   BELL JD, 1993, BIOCHIM BIOPHYS ACTA, V1225, P71, DOI 10.1016/0925-4439(93)90124-J
   Bernatik T, 2002, EUR J GASTROEN HEPAT, V14, P383, DOI 10.1097/00042737-200204000-00008
   Bohte AE, 2014, EUR RADIOL, V24, P638, DOI 10.1007/s00330-013-3046-0
   Borsoi Viana MS, 2009, ANN HEPATOL, V8, P26
   Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240
   Boursier J, 2009, LIVER INT, V29, P1507, DOI 10.1111/j.1478-3231.2009.02101.x
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
   BYDDER GM, 1980, BRIT MED J, V281, P1042
   Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602
   CAMPBELL T, 1994, CANCER EPIDEM BIOMAR, V3, P519
   Cassinotto C, 2015, EUR J RADIOL, V84, P1459, DOI 10.1016/j.ejrad.2015.05.019
   Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018
   Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008
   Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008
   Catanzaro R, 2013, HEPATOB PANCREAT DIS, V12, P500, DOI 10.1016/S1499-3872(13)60079-X
   Chiang HJ, 2014, TRANSPL P, V46, P666, DOI 10.1016/j.transproceed.2013.11.050
   Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573
   Cobbold J, 2006, HEPATOLOGY, V43, P1401, DOI 10.1002/hep.21217
   Cobbold JFL, 2008, HEPATOLOGY, V47, P370, DOI 10.1002/hep.22200
   Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x
   Colli A, 2003, RADIOLOGY, V227, P89, DOI 10.1148/radiol.2272020193
   Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0
   Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151
   Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158
   Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012
   Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025
   Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128
   Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153
   Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x
   Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034
   Friedrich-Rust M, 2012, EUR J RADIOL, V81, pE325, DOI 10.1016/j.ejrad.2011.10.029
   Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420
   GILMORE IT, 1995, GUT, V36, P437, DOI 10.1136/gut.36.3.437
   Goldin RD, 1996, J HEPATOL, V25, P649, DOI 10.1016/S0168-8278(96)80234-0
   Grant A., 1999, J GASTROENTERLOGO S4, V45, pIV1, DOI DOI 10.1136/GUT.45.2008.IV1]
   Grier S, 2006, WORLD J GASTROENTERO, V12, P3461
   Guzelbulut F, 2011, TURK J GASTROENTEROL, V22, P279, DOI 10.4318/tjg.2011.0213
   Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604
   Harman DJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007516
   Heba ER, 2016, J MAGN RESON IMAGING, V43, P398, DOI 10.1002/jmri.25006
   Horng DE, 2017, J MAGN RESON IMAGING, V45, P428, DOI 10.1002/jmri.25382
   Idilman IS, 2016, ACTA RADIOL, V57, P271, DOI 10.1177/0284185115580488
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Ito K, 1999, AM J ROENTGENOL, V173, P591
   Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511
   Kweon YO, 2001, J HEPATOL, V35, P749, DOI 10.1016/S0168-8278(01)00218-5
   Langer DA, 2006, J HEPATOL, V44, P209, DOI 10.1016/j.jhep.2005.10.004
   Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564
   Lee VS, 2011, TRANSPLANTATION, V92, P581, DOI 10.1097/TP.0b013e31822805fa
   Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747
   Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016
   Lim AKP, 2007, AM J ROENTGENOL, V189, P819, DOI 10.2214/AJR.07.2418
   Lim AKP, 2005, AM J ROENTGENOL, V184, P1848
   Lim AKP, 2005, GUT, V54, P128, DOI 10.1136/gut.2003.030965
   Lim AKP, 2003, HEPATOLOGY, V37, P788, DOI 10.1053/jhep.2003.50149
   Lim JK, 2007, HEPATOLOGY, V45, P1087, DOI 10.1002/hep.21731
   Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105
   Lindor KD, 1996, HEPATOLOGY, V23, P1079
   LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311
   Loomba R, 2016, AM J GASTROENTEROL, V111, P986, DOI 10.1038/ajg.2016.65
   Low Gavin, 2016, World J Radiol, V8, P59, DOI 10.4329/wjr.v8.i1.59
   Lui G, 2016, ALIMENT PHARM THER, V44, P411, DOI 10.1111/apt.13702
   Ma JJ, 2014, J GASTROEN HEPATOL, V29, P814, DOI 10.1111/jgh.12479
   MAHARAJ B, 1986, LANCET, V1, P523
   Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001
   Mehta SR, 2008, WORLD J GASTROENTERO, V14, P3476, DOI 10.3748/wjg.14.3476
   MENON DK, 1995, HEPATOLOGY, V21, P417, DOI 10.1016/0270-9139(95)90102-7
   Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119
   Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y
   Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200
   Nassir Fatiha, 2015, Gastroenterol Hepatol (N Y), V11, P167
   Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232
   Otten J, 2016, INT J OBESITY, V40, P747, DOI 10.1038/ijo.2016.4
   Paparo F, 2015, BIOMED RES INT, DOI 10.1155/2015/758164
   Paradis V, 1997, HEPATOLOGY, V26, P135
   Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361
   Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019
   Patel JH, 2010, QJM-INT J MED, V103, P293, DOI 10.1093/qjmed/hcp192
   Pavlides M, 2016, J HEPATOL, V64, P308, DOI 10.1016/j.jhep.2015.10.009
   Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com
   PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Poniachik J, 1996, GASTROINTEST ENDOSC, V43, P568, DOI 10.1016/S0016-5107(96)70192-X
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023
   Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40
   Preaux AM, 2002, HEPATOLOGY, V36, P615, DOI 10.1053/jhep.2002.35279
   Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741
   Regev A, 2002, AM J GASTROENTEROL, V97, P2614
   Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046
   Romero-Gomez M, 2008, HEPATOLOGY, V47, P810, DOI 10.1002/bep.22112
   Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052
   Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020
   Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535
   Ryan CK, 2002, LIVER TRANSPLANT, V8, P1114, DOI 10.1053/jlts.2002.36740
   Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056
   Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001
   Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x
   Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001
   Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9
   Sebastiani G, 2012, ALIMENT PHARM THER, V35, P92, DOI 10.1111/j.1365-2036.2011.04897.x
   Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835
   Shi Y, 2016, AM J GASTROENTEROL, V111, P823, DOI 10.1038/ajg.2016.56
   Shyamala K, 2014, J Int Soc Prev Community Dent, V4, P5, DOI 10.4103/2231-0762.129446
   Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P440, DOI 10.1016/j.cgh.2014.09.046
   Sohara N, 2002, J HEPATOL, V37, P214, DOI 10.1016/S0168-8278(02)00103-4
   Sporea I, 2014, MED ULTRASON, V16, P309
   Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475
   Sterling RK, 2003, GASTROENTEROLOGY, V124, pA705, DOI 10.1016/S0016-5085(03)83563-1
   Su LN, 2014, CLIN RADIOL, V69, pE545, DOI 10.1016/j.crad.2014.09.001
   Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004
   Takamura T, 2016, J MAGN RESON IMAGING, V44, P715, DOI 10.1002/jmri.25182
   Tang A, 2015, RADIOLOGY, V274, P416, DOI 10.1148/radiol.14140754
   Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086
   Taouli B, 2016, GASTROENTEROLOGY, V150, P553, DOI 10.1053/j.gastro.2016.01.017
   TAYLORROBINSON SD, 1995, BBA-MOL BASIS DIS, V1272, P113, DOI 10.1016/0925-4439(95)00074-E
   Thomas EL, 2006, WORLD J GASTROENTERO, V12, P5813
   Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566
   Thursz M, 2010, TROP MED INT HEALTH, V15, P2, DOI 10.1111/j.1365-3156.2009.02410.x
   Trovato Francesca M, 2015, World J Hepatol, V7, P2664, DOI 10.4254/wjh.v7.i26.2664
   Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   Vilgrain V, 2001, EUR RADIOL, V11, P1563, DOI 10.1007/s003300101050
   Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1016/0270-9139(95)90043-8
   Webb M, 2009, AM J ROENTGENOL, V192, P909, DOI 10.2214/AJR.07.4016
   World Health Organisation, 2000, HEP C FACTSH
   World Health Organisation, 2008, HEP B FACTSH
   YAMANE Y, 1994, DIGEST DIS SCI, V39, P33, DOI 10.1007/BF02090057
   Yeh WC, 2002, ULTRASOUND MED BIOL, V28, P467, DOI 10.1016/S0301-5629(02)00489-1
   Yoneda M, 2007, GUT, V56, P1330, DOI 10.1136/gut.2007.126417
   Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506
NR 155
TC 2
Z9 2
U1 5
U2 6
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD DEC 7
PY 2016
VL 22
IS 45
BP 9880
EP 9897
DI 10.3748/wjg.v22.i45.9880
PG 18
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EE8BC
UT WOS:000389848200002
PM 28018096
OA No
DA 2017-08-15
ER

PT J
AU Dillon, DG
   Gurdasani, D
   Riha, J
   Ekoru, K
   Asiki, G
   Mayanja, BN
   Maher, D
   Levitt, NS
   Crowther, NJ
   Nyirenda, M
   Njelekela, M
   Ramaiya, K
   Nyan, O
   Adewole, OO
   Anastos, K
   Azzoni, L
   Boom, WH
   Compostella, C
   Dave, JA
   Dawood, H
   Erikstrup, C
   Fourie, CM
   Friis, H
   Kruger, A
   Idoko, JA
   Longenecker, CT
   Mbondi, S
   Mukaya, JE
   Mutimura, E
   Ndhlovu, CE
   Praygod, G
   Yone, EWP
   Pujades-Rodriguez, M
   Range, N
   Sani, MU
   Schutte, AE
   Sliwa, K
   Tien, PC
   Vorster, EH
   Walsh, C
   Zinyama, R
   Mashili, F
   Sobngwi, E
   Adebamowo, C
   Kamali, A
   Seeley, J
   Young, EH
   Smeeth, L
   Motala, AA
   Kaleebu, P
   Sandhu, MS
AF Dillon, David G.
   Gurdasani, Deepti
   Riha, Johanna
   Ekoru, Kenneth
   Asiki, Gershim
   Mayanja, Billy N.
   Maher, Dermot
   Levitt, Naomi S.
   Crowther, Nigel J.
   Nyirenda, Moffat
   Njelekela, Marina
   Ramaiya, Kaushik
   Nyan, Ousman
   Adewole, Olanisun O.
   Anastos, Kathryn
   Azzoni, Livio
   Boom, W. Henry
   Compostella, Caterina
   Dave, Joel A.
   Dawood, Halima
   Erikstrup, Christian
   Fourie, Carla M.
   Friis, Henrik
   Kruger, Annamarie
   Idoko, John A.
   Longenecker, Chris T.
   Mbondi, Suzanne
   Mukaya, Japheth E.
   Mutimura, Eugene
   Ndhlovu, Chiratidzo E.
   Praygod, George
   Yone, Eric W. Pefura
   Pujades-Rodriguez, Mar
   Range, Nyagosya
   Sani, Mahmoud U.
   Schutte, Aletta E.
   Sliwa, Karen
   Tien, Phyllis C.
   Vorster, Este H.
   Walsh, Corinna
   Zinyama, Rutendo
   Mashili, Fredirick
   Sobngwi, Eugene
   Adebamowo, Clement
   Kamali, Anatoli
   Seeley, Janet
   Young, Elizabeth H.
   Smeeth, Liam
   Motala, Ayesha A.
   Kaleebu, Pontiano
   Sandhu, Manjinder S.
CA APCDR
TI Association of HIV and ART with cardiometabolic traits in sub-Saharan
   Africa: a systematic review and meta-analysis (vol 42, pg 1754, 2013)
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Correction
C1 [Dillon, David G.; Gurdasani, Deepti; Riha, Johanna; Ekoru, Kenneth; Young, Elizabeth H.; Sandhu, Manjinder S.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Dillon, David G.; Gurdasani, Deepti; Riha, Johanna; Ekoru, Kenneth; Young, Elizabeth H.; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Genet Epidemiol Grp, Cambridge, England.
   [Ekoru, Kenneth; Asiki, Gershim; Mayanja, Billy N.; Maher, Dermot; Kamali, Anatoli; Seeley, Janet; Kaleebu, Pontiano] MRC, UVRI, Uganda Res Unit AIDS, Entebbe, Uganda.
   [Levitt, Naomi S.] Univ Cape Town, Dept Med, Div Diabet Med & Endocrinol, Cape Town, South Africa.
   [Levitt, Naomi S.] Chron Dis Initiat Africa, Cape Town, South Africa.
   [Crowther, Nigel J.] Univ Witwatersrand, Sch Med, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa.
   [Nyirenda, Moffat] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi.
   [Njelekela, Marina; Mashili, Fredirick] Muhimbili Univ Hlth & Allied Sci, Dept Physiol, Dar Es Salaam, Tanzania.
   [Ramaiya, Kaushik] Muhimbili Univ Hlth & Allied Sci, Dept Med, Dar Es Salaam, Tanzania.
   [Nyan, Ousman] Univ Gambia, Sch Med, Royal Victoria Teaching Hosp, Banjul, Gambia.
   [Adewole, Olanisun O.] Obafemi Awolowo Univ, Dept Med, Ife, Nigeria.
   [Anastos, Kathryn; Mutimura, Eugene] Womens Equ Access Care & Treatment, Kigali, Rwanda.
   [Azzoni, Livio] Wistar Inst Anat & Biol, HIV Immunopathogenesis Lab 1, Philadelphia, PA USA.
   [Boom, W. Henry] Case Western Reserve Univ, Dept Med, TB Res Unit, Cleveland, OH 44106 USA.
   [Compostella, Caterina] Univ Padua, Dept Med & Surg Sci, Padua, Italy.
   [Dave, Joel A.] Univ Cape Town, Dept Med, Div Diabet Med & Endocrinol, Cape Town, South Africa.
   [Dawood, Halima] Greys Hosp, Dept Med, Infect Dis Unit, Pietermaritzburg, South Africa.
   [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark.
   [Fourie, Carla M.; Schutte, Aletta E.] North West Univ, HART, Potchefstroom, South Africa.
   [Friis, Henrik] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark.
   [Kruger, Annamarie] North West Univ, Africa Unit Transdisciplinary Hlth Res AUTHeR, Potchefstroom, South Africa.
   [Idoko, John A.] Jos Univ, Teaching Hosp, Dept Med, Jos, Nigeria.
   [Longenecker, Chris T.] Univ Hosp Case Med Ctr, Cleveland, OH USA.
   [Mbondi, Suzanne] German Dev Cooperat GTZ, Yaounde, Cameroon.
   [Mukaya, Japheth E.] Makerere Univ, Dept Med, Kampala, Uganda.
   [Ndhlovu, Chiratidzo E.] Univ Zimbabwe, Coll Hlth Sci, Clin Epidemiol Resource Training Ctr, Harare, Zimbabwe.
   [Praygod, George; Range, Nyagosya] Natl Inst Med Res, Dar Es Salaam, Tanzania.
   [Yone, Eric W. Pefura] Jamot Hosp, Chest Unit, Yaounde, Cameroon.
   [Pujades-Rodriguez, Mar] Medecins Sans Frontieres, Epictr, Paris, France.
   [Pujades-Rodriguez, Mar] UCL, Dept Epidemiol & Publ Hlth, Clin Epidemiol Grp, London, England.
   [Sani, Mahmoud U.] Aminu Kano Teaching Hosp, Dept Med, Cardiol Unit, Kano, Nigeria.
   [Sliwa, Karen] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Soweto Cardiovasc Res Unit, Johannesburg, South Africa.
   [Tien, Phyllis C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Vorster, Este H.] North West Univ, Fac Hlth Sci, Potchefstroom, South Africa.
   [Walsh, Corinna] Univ Free State, Dept Nutr & Dietet, Bloemfontein, South Africa.
   [Zinyama, Rutendo] Univ Zimbabwe, Dept Med Lab Sci, Med Res Council Zimbabwe, Harare, Zimbabwe.
   [Sobngwi, Eugene] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.
   [Sobngwi, Eugene] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.
   [Adebamowo, Clement] Inst Human Virol, Abuja, Nigeria.
   [Adebamowo, Clement] Univ Maryland, Sch Med, Inst Human Virol, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
   [Adebamowo, Clement] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA.
   [Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Motala, Ayesha A.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Endocrinol & Diabet, Durban, South Africa.
RP Sandhu, MS (reprint author), Univ Cambridge, Dept Publ Hlth & Primary Care, Int Hlth Res Grp, Cambridge, England.
EM ms23@sanger.ac.uk
CR Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198
NR 1
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD DEC
PY 2016
VL 45
IS 6
BP 2210
EP +
DI 10.1093/ije/dyw312
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EQ7JU
UT WOS:000398261100072
PM 27864398
OA No
DA 2017-08-15
ER

PT J
AU Peterson, I
   Bar-Zeev, N
   Kennedy, N
   Ho, A
   Newberry, L
   SanJoaquin, MA
   Menyere, M
   Alaerts, M
   Mapurisa, G
   Chilombe, M
   Mambule, I
   Lalloo, DG
   Anderson, ST
   Katangwe, T
   Cunliffe, N
   Nagelkerke, N
   McMorrow, M
   Widdowson, MA
   French, N
   Everett, D
   Heyderman, RS
AF Peterson, Ingrid
   Bar-Zeev, Naor
   Kennedy, Neil
   Ho, Antonia
   Newberry, Laura
   SanJoaquin, Miguel A.
   Menyere, Mavis
   Alaerts, Maaike
   Mapurisa, Gugulethu
   Chilombe, Moses
   Mambule, Ivan
   Lalloo, David G.
   Anderson, Suzanne T.
   Katangwe, Thembi
   Cunliffe, Nigel
   Nagelkerke, Nico
   McMorrow, Meredith
   Widdowson, Marc-Allain
   French, Neil
   Everett, Dean
   Heyderman, Robert S.
TI Respiratory Virus-Associated Severe Acute Respiratory Illness and Viral
   Clustering in Malawian Children in a Setting With a High Prevalence of
   HIV Infection, Malaria, and Malnutrition
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE children; SARI; Africa; viral coinfection; influenza
ID PANDEMIC INFLUENZA; LESS-THAN-5 YEARS; SYNCYTIAL VIRUS; SOUTH-AFRICA;
   VACCINE; BURDEN; KENYA; PNEUMONIA; ETIOLOGY; AGE
AB Background. We used data from 4 years of pediatric severe acute respiratory illness (SARI) sentinel surveillance in Blantyre, Malawi, to identify factors associated with clinical severity and coviral clustering.
   Methods. From January 2011 to December 2014, 2363 children aged 3 months to 14 years presenting to the hospital with SARI were enrolled. Nasopharyngeal aspirates were tested for influenza virus and other respiratory viruses. We assessed risk factors for clinical severity and conducted clustering analysis to identify viral clusters in children with viral codetection.
   Results. Hospital-attended influenza virus-positive SARI incidence was 2.0 cases per 10 000 children annually; it was highest among children aged <1 year (6.3 cases per 10 000), and human immunodeficiency virus (HIV)-infected children aged 5-9 years (6.0 cases per 10 000). A total of 605 SARI cases (26.8%) had warning signs, which were positively associated with HIV infection (adjusted risk ratio [aRR], 2.4; 95% confidence interval [CI], 1.4-3.9), respiratory syncytial virus infection (aRR, 1.9; 95% CI, 1.3-3.0) and rainy season (aRR, 2.4; 95% CI, 1.6-3.8). We identified 6 coviral clusters; 1 cluster was associated with SARI with warning signs.
   Conclusions. Influenza vaccination may benefit young children and HIV-infected children in this setting. Viral clustering may be associated with SARI severity; its assessment should be included in routine SARI surveillance.
C1 [Peterson, Ingrid; Menyere, Mavis; Alaerts, Maaike; Mapurisa, Gugulethu; Chilombe, Moses; Mambule, Ivan; Nagelkerke, Nico] Malawi Liverpool Wellcome Trust, Blantyre, Malawi.
   [Kennedy, Neil; Newberry, Laura; Katangwe, Thembi] Queen Elizabeth Cent Hosp, Dept Paediat, Blantyre, Malawi.
   [Bar-Zeev, Naor; Cunliffe, Nigel; French, Neil; Everett, Dean] Univ Liverpool, Inst Infect & Global Hlth, Fac Hlth & Life Sci, Liverpool, Merseyside, England.
   [Ho, Antonia] Univ Liverpool, Inst Ageing & Chron Dis, Fac Hlth & Life Sci, Liverpool, Merseyside, England.
   [Lalloo, David G.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Heyderman, Robert S.] UCL, Div Infect & Immun, London, England.
   [SanJoaquin, Miguel A.] World Bank, Hanoi, Vietnam.
   [Anderson, Suzanne T.] Med Res Council Gambia, Banjul, Gambia.
   [McMorrow, Meredith] Ctr Dis Control & Prevent CDC South Africa, Influenza Div, Johannesburg, South Africa.
   [Widdowson, Marc-Allain] CDC, Influenza Div, Atlanta, GA 30333 USA.
RP Everett, D (reprint author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
EM deaneve@liverpool.ac.uk
FU CDC [5U01CK000146-04]
FX This work was supported by with the CDC through a cooperative agreement
   (grant 5U01CK000146-04).
CR Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675
   Bigogo GM, 2013, J INFECT DIS, V208, pS207, DOI 10.1093/infdis/jit489
   Breiman RF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0827-x
   Cohen C, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3272
   Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117716
   Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546
   Copan, 2006, COP UN TRANSP MED
   Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b
   Glennie SJ, 2012, IMMUNOLOGY, V135, P125, DOI 10.1111/j.1365-2567.2011.03523.x
   GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809
   Health GoMMo, 2010, HIV SYPH SER SURV NA
   Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056
   ICF International, 2012, HIV PREV EST DEM HLT
   Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, INQ NAC PREV RISC CO
   Katz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098615
   Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372
   Lagare A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1251-y
   Leahy TR, 2014, INFLUENZA OTHER RESP, V8, P360, DOI 10.1111/irv.12243
   Levin MJ, 2008, VACCINE, V26, P4210, DOI 10.1016/j.vaccine.2008.05.054
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350
   Madhi SA, 2013, AIDS, V27, P369, DOI 10.1097/QAD.0b013e32835ab5b2
   Mainassara HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133178
   Malawi National Statistics Office, 2008, 2008 MAL POP HOUS CE
   Manda S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0055-z
   Mihigo R, 2012, J INFECT DIS, V206, pS22, DOI 10.1093/infdis/jis535
   Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   National Statistical Office (NSO) ICF Macro, 2011, MAL DEM HLTH SURV 20
   Paranhos-Baccala Glaucia, 2008, J Clin Virol, V43, P407, DOI 10.1016/j.jcv.2008.08.010
   SanJoaquin MA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001400
   Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323
   Simusika P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0779-1
   Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   World Health Organization (WHO), 2004, RAP HIV TESTS GUID U, P48
   World Food Program, MAL CURR ISS WHAT WO
   Young PW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-96
NR 38
TC 0
Z9 0
U1 3
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 1
PY 2016
VL 214
IS 11
BP 1700
EP 1711
DI 10.1093/infdis/jiw426
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EJ3RH
UT WOS:000393128800013
PM 27630199
OA No
DA 2017-08-15
ER

PT J
AU Barger-Kamate, B
   Knoll, MD
   Kagucia, EW
   Prosperi, C
   Baggett, HC
   Brooks, WA
   Feikin, DR
   Hammitt, LL
   Howie, SRC
   Levine, OS
   Madhi, SA
   Scott, JAG
   Thea, DM
   Amornintapichet, T
   Anderson, TP
   Awori, JO
   Baillie, VL
   Chipeta, J
   DeLuca, AN
   Driscoll, AJ
   Goswami, D
   Higdon, MM
   Hossain, L
   Karron, RA
   Maloney, S
   Moore, DP
   Morpeth, SC
   Mwananyanda, L
   Ofordile, O
   Olutunde, E
   Park, DE
   Sow, SO
   Tapia, MD
   Murdoch, DR
   O'Brien, KL
   Kotloff, KL
AF Barger-Kamate, Breanna
   Knoll, Maria Deloria
   Kagucia, E. Wangeci
   Prosperi, Christine
   Baggett, Henry C.
   Brooks, W. Abdullah
   Feikin, Daniel R.
   Hammitt, Laura L.
   Howie, Stephen R. C.
   Levine, Orin S.
   Madhi, Shabir A.
   Scott, J. Anthony G.
   Thea, Donald M.
   Amornintapichet, Tussanee
   Anderson, Trevor P.
   Awori, Juliet O.
   Baillie, Vicky L.
   Chipeta, James
   DeLuca, Andrea N.
   Driscoll, Amanda J.
   Goswami, Doli
   Higdon, Melissa M.
   Hossain, Lokman
   Karron, Ruth A.
   Maloney, Susan
   Moore, David P.
   Morpeth, Susan C.
   Mwananyanda, Lawrence
   Ofordile, Ogochukwu
   Olutunde, Emmanuel
   Park, Daniel E.
   Sow, Samba O.
   Tapia, Milagritos D.
   Murdoch, David R.
   O'Brien, Katherine L.
   Kotloff, Karen L.
CA Pneumonia Etiology Res Child
TI Pertussis-Associated Pneumonia in Infants and Children From Low- and
   Middle-Income Countries Participating in the PERCH Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pertussis; infant; pneumonia; whooping cough; vaccination
ID BORDETELLA-PERTUSSIS; ETIOLOGY RESEARCH; PROSPECTIVE COHORT; HEALTH
   PROJECT; RISK-FACTORS; INFECTION; MORTALITY; DIAGNOSIS; COLLECTION
AB Background. Few data exist describing pertussis epidemiology among infants and children in low-and middle-income countries to guide preventive strategies.
   Methods. Children 1-59 months of age hospitalized with World Health Organization-defined severe or very severe pneumonia in 7 African and Asian countries and similarly aged community controls were enrolled in the Pneumonia Etiology Research for Child Health study. They underwent a standardized clinical evaluation and provided nasopharyngeal and oropharyngeal swabs and induced sputum (cases only) for Bordetella pertussis polymerase chain reaction. Risk factors and pertussis-associated clinical findings were identified.
   Results. Bordetella pertussis was detected in 53 of 4200 (1.3%) cases and 11 of 5196 (0.2%) controls. In the age stratum 1-5 months, 40 (2.3% of 1721) cases were positive, all from African sites, as were 8 (0.5% of 1617) controls. Pertussis-positive African cases 1-5 months old, compared to controls, were more often human immunodeficiency virus (HIV) uninfected-exposed (adjusted odds ratio [aOR], 2.2), unvaccinated (aOR, 3.7), underweight (aOR, 6.3), and too young to be immunized (aOR, 16.1) (all P <= .05). Compared with pertussis-negative African cases in this age group, pertussis-positive cases were younger, more likely to vomit (aOR, 2.6), to cough >= 14 days (aOR, 6.3), to have leukocyte counts >20 000 cells/mu L (aOR, 4.6), and to have lymphocyte counts >10 000 cells/mu L (aOR, 7.2) (all P <= .05). The case fatality ratio of pertussis-infected pneumonia cases 1-5 months of age was 12.5% (95% confidence interval, 4.2%-26.8%; 5/40); pertussis was identified in 3.7% of 137 in-hospital deaths among African cases in this age group.
   Conclusions. In the postneonatal period, pertussis causes a small fraction of hospitalized pneumonia cases and deaths; however, case fatality is substantial. The propensity to infect unvaccinated infants and those at risk for insufficient immunity (too young to be vaccinated, premature, HIV-infected/exposed) suggests that the role for maternal vaccination should be considered along with efforts to reduce exposure to risk factors and to optimize childhood pertussis vaccination coverage.
C1 [Barger-Kamate, Breanna] Johns Hopkins Sch Med, Div Emergency Med, Dept Pediat, Baltimore, MD USA.
   [Barger-Kamate, Breanna] Spokane Emergency Phys, Washington, DC USA.
   [Knoll, Maria Deloria; Kagucia, E. Wangeci; Prosperi, Christine; Feikin, Daniel R.; Hammitt, Laura L.; Levine, Orin S.; DeLuca, Andrea N.; Driscoll, Amanda J.; Higdon, Melissa M.; Park, Daniel E.; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA.
   [Baggett, Henry C.] Thailand Minist Publ Health US Ctr Dis Control &, Global Dis Detect Ctr, Nonthaburi, Thailand.
   [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.
   [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Brooks, W. Abdullah] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Brooks, W. Abdullah; Goswami, Doli; Hossain, Lokman] Int Ctr Diarrhoeal Dis Res, Matlab, Bangladesh.
   [Feikin, Daniel R.; Ofordile, Ogochukwu; Olutunde, Emmanuel] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Hammitt, Laura L.; Scott, J. Anthony G.; Awori, Juliet O.; Morpeth, Susan C.] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Howie, Stephen R. C.] MRC Unit, Basse, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Dunedin, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Levine, Orin S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa.
   [Madhi, Shabir A.; Baillie, Vicky L.; Moore, David P.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Johannesburg, South Africa.
   [Scott, J. Anthony G.] London Sch Hyg & Trop Med, London, England.
   [Thea, Donald M.; Mwananyanda, Lawrence] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.
   [Amornintapichet, Tussanee] Thailand Minist Hlth, Sa Kaeo Prov Hosp, Sa Kaeo, Thailand.
   [Anderson, Trevor P.; Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand.
   [Chipeta, James] Univ Zambia, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia.
   [Chipeta, James; Mwananyanda, Lawrence] Univ Teaching Hosp, Lusaka, Zambia.
   [DeLuca, Andrea N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD USA.
   [Maloney, Susan] Ctr Dis Control & Prevent, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA USA.
   [Morpeth, Susan C.] Counties Manukau Dist Hlth Board, Middlemore Hosp, Microbiol Lab, Auckland, New Zealand.
   [Park, Daniel E.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA.
   [Sow, Samba O.] Ctr Dev Vaccins, Bamako, Mali.
   [Tapia, Milagritos D.; Kotloff, Karen L.] Univ Maryland, Sch Med, Inst Global Hlth, Div Infect Dis & Trop Pediat,Dept Pediat Ctr Vacc, Baltimore, MD 21201 USA.
   [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand.
RP Kotloff, KL (reprint author), Univ Maryland, Sch Med, Inst Global Hlth, Div Infect Dis & Trop Pediat,Dept Pediat Ctr Vacc, Baltimore, MD 21201 USA.
EM kkotloff@medicine.umaryland.edu
OI Park, Daniel/0000-0001-5139-5397
FU Bill & Melinda Gates Foundation [48968]; Fogarty International Clinical
   Research Scholars and Fellows Program at Vanderbilt University [R24
   TW007988]
FX This work was supported by a grant from the Bill & Melinda Gates
   Foundation (grant number 48968) to the International Vaccine Access
   Center, Department of International Health, Johns Hopkins Bloomberg
   School of Public Health. Travel for B. B.-K. was supported by the
   Fogarty International Clinical Research Scholars and Fellows Program at
   Vanderbilt University (grant number R24 TW007988).
CR Antila M, 2006, J MED MICROBIOL, V55, P1043, DOI 10.1099/jmm.0.46331-0
   Berger JT, 2013, PEDIATR CRIT CARE ME, V14, P356, DOI 10.1097/PCC.0b013e31828a70fe
   Casano P, 2002, ARCH DIS CHILD, V86, P453, DOI 10.1136/adc.86.6.453-a
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Cherry JD, 2012, CLIN INFECT DIS, V54, P1756, DOI 10.1093/cid/cis302
   Cox HC, 2013, PATHOLOGY, V45, P202, DOI 10.1097/PAT.0b013e32835cc2d7
   Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802
   Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8
   Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066
   Eberhardt CS, 2016, CLIN INFECT DIS, V62, P829, DOI 10.1093/cid/ciw027
   Forsyth K, 2015, PEDIATRICS, V135, pE1475, DOI 10.1542/peds.2014-3925
   Fulton TR, 2016, CLIN INFECT DIS, V62, P1100, DOI 10.1093/cid/ciw051
   Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]
   Haberling DL, 2009, PEDIATR INFECT DIS J, V28, P194, DOI 10.1097/INF.0b013e31818c9032
   Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068
   Hoppe JE, 2000, PEDIATR INFECT DIS J, V19, P244, DOI 10.1097/00006454-200003000-00014
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Kline JM, 2013, AM FAM PHYSICIAN, V88, P507
   KOHN JL, 1950, PEDIATRICS, V5, P840
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Loeffelholz M, 2012, J CLIN MICROBIOL, V50, P2186, DOI 10.1128/JCM.00612-12
   Muloiwa R, 2016, PEDIATR INFECT DIS J, V35, P611, DOI 10.1097/INF.0000000000001132
   Murdoch D, 2017, CLIN INFECT IN PRESS
   NICOLL A, 1988, ARCH DIS CHILD, V63, P41
   Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753
   Pittet LF, 2016, MICROBIOL SPECTR, P4
   Sawal M, 2009, PEDIATR PULM, V44, P970, DOI 10.1002/ppul.21082
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   Sheridan SL, 2015, VACCINE, V33, P5027, DOI 10.1016/j.vaccine.2015.08.021
   Tiwari TSP, 2015, PEDIATRICS, V135, P990, DOI 10.1542/peds.2014-2291
   van den Brink G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-526
   Van Rie Annelies, 2005, Pediatr Infect Dis J, V24, pS62, DOI 10.1097/01.inf.0000160915.93979.8f
   Winter K, 2015, CLIN INFECT DIS, V61, P1099, DOI 10.1093/cid/civ472
   Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041
   Wymann MN, 2011, VACCINE, V29, P2058, DOI 10.1016/j.vaccine.2011.01.017
   Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5
NR 37
TC 7
Z9 7
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 1
PY 2016
VL 63
SU 4
BP S187
EP S196
DI 10.1093/cid/ciw546
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EI7WI
UT WOS:000392714700011
PM 27838672
OA No
DA 2017-08-15
ER

PT J
AU Kampmann, B
   Mackenzie, G
AF Kampmann, Beate
   Mackenzie, Grant
TI Morbidity and Mortality Due to Bordetella pertussis: A Significant
   Pathogen in West Africa?
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE pertussis; West Africa; surveillance; case finding
ID VACCINATION PROGRAM; INFECTION; SEROPREVALENCE; EPIDEMIOLOGY; DIAGNOSIS;
   ANTITOXIN; CHILDREN; GAMBIA
AB In the absence of specific surveillance platforms for pertussis and availability of suitable diagnostics at the hospital level, reliable data that describe morbidity and mortality from pertussis are difficult to obtain in any setting, as is the case in West Africa. Here, we summarize the available evidence of the burden of pertussis in the region, given historical data, and describe recent and ongoing epidemiological studies that offer opportunities for additional data collection. The available seroepidemiological data provide evidence of ongoing circulation of Bordetella pertussis in the region. Due to the lack of systematic and targeted surveillance with laboratory confirmation of B. pertussis infection, we cannot definitively conclude that pertussis disease is well controlled in West Africa. However, based on observations by clinicians and ongoing demographic surveillance systems that capture morbidity and mortality data in general terms, currently there is no evidence that pertussis causes a significant burden of disease in young children in West Africa.
C1 [Kampmann, Beate; Mackenzie, Grant] Med Res Council Unit Gambia, POB 273, Banjul, Gambia.
   [Kampmann, Beate] Imperial Coll London, Ctr Int Child Hlth, London, England.
   [Mackenzie, Grant] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London, England.
   [Mackenzie, Grant] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
RP Mackenzie, G (reprint author), Med Res Council Unit Gambia, POB 273, Banjul, Gambia.
EM bkampmann@mrc.gm
FU UK MRC; UK Department for International Development (DFID) under the
   MRC/DFID concordat; Bill & Melinda Gates Foundation
FX This research is jointly funded by the UK MRC and the UK Department for
   International Development (DFID) under the MRC/DFID concordat agreement.
   No specific funding was provided for this work other than reimbursement
   of travel expenses to attend the meeting at Emory University, Atlanta,
   Georgia, in April 2016 (B. K.), which served as a baseline for this
   article and was funded by the Bill & Melinda Gates Foundation.
CR Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P9595, DOI 10.1073/pnas.1220908110
   Gaayeb L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048684
   Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x
   Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x
   Jusot V, 2014, J TROP PEDIATRICS, V60, P223, DOI 10.1093/tropej/fmu001
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   Muloiwa R, 2016, PEDIATR INFECT DIS J, V35, P611, DOI 10.1097/INF.0000000000001132
   Okomo UA, 2015, PAEDIATR INT CHILD H, V35, P252, DOI 10.1179/2046905515Y.0000000036
   [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P385
   Preziosi MP, 2002, AM J EPIDEMIOL, V155, P891, DOI 10.1093/aje/155.10.891
   Quattrochi J, 2015, TROP MED INT HEALTH, V20, P941, DOI 10.1111/tmi.12490
   Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005
   Scott S, 2015, PEDIATR INFECT DIS J, V34, P333, DOI 10.1097/INF.0000000000000576
   van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018
NR 14
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 1
PY 2016
VL 63
SU 4
BP S142
EP S147
DI 10.1093/cid/ciw560
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EI7WI
UT WOS:000392714700005
PM 27838666
OA No
DA 2017-08-15
ER

PT J
AU Vergnano, S
   Buttery, J
   Cailes, B
   Chandrasekaran, R
   Chiappini, E
   Clark, E
   Cutland, C
   de Andrade, SD
   Esteves-Jaramillo, A
   Guinazu, JR
   Jones, C
   Kampmann, B
   King, J
   Kochhar, S
   Macdonald, N
   Mangili, A
   Martins, RD
   Munoz, CV
   Padula, M
   Munoz, FM
   Oleske, J
   Sanicas, M
   Schlaudecker, E
   Spiegel, H
   Subelj, M
   Sukumaran, L
   Tagbo, BN
   Top, KA
   Tran, D
   Heath, PT
AF Vergnano, Stefania
   Buttery, Jim
   Cailes, Ben
   Chandrasekaran, Ravichandran
   Chiappini, Elena
   Clark, Ebiere
   Cutland, Clare
   de Andrade, Solange Dourado
   Esteves-Jaramillo, Alejandra
   Guinazu, Javier Ruiz
   Jones, Chrissie
   Kampmann, Beate
   King, Jay
   Kochhar, Sonali
   Macdonald, Noni
   Mangili, Alexandra
   Martins, Reinaldo de Menezes
   Velasco Munoz, Cesar
   Padula, Michael
   Munoz, Flor M.
   Oleske, James
   Sanicas, Melvin
   Schlaudecker, Elizabeth
   Spiegel, Hans
   Subelj, Maja
   Sukumaran, Lakshmi
   Tagbo, Beckie N.
   Top, Karina A.
   Tran, Dat
   Heath, Paul T.
CA Brighton Collaboration Neonatal In
TI Neonatal infections: Case definition and guidelines for data collection,
   analysis, and presentation of immunisation safety data
SO VACCINE
LA English
DT Article
DE Neonatal infections; Sepsis; Meningitis; Bacteremia; Possible bacterial
   infection; Pneumonia; Bronchiolitis; Perinatal; Newborn; Adverse event;
   Immunisation; Guidelines; Case definition
ID BLOOD-CELL COUNT; LOW-BIRTH-WEIGHT; HEALTH-CARE; SEPSIS; INFANTS
AB Maternal vaccination is an important area of research and requires appropriate and internationally comparable definitions and safety standards. The GALA group, part of the Brighton Collaboration was created with the mandate of proposing standardised definitions applicable to maternal vaccine research. This study proposes international definitions for neonatal infections.
   The neonatal infections GAIA working group performed a literature review using Medline, EMBASE and the Cochrane collaboration and collected definitions in use in neonatal and public health networks. The common criteria derived from the extensive search formed the basis for a consensus process that resulted in three separate definitions for neonatal blood stream infections (BSI), meningitis and lower respiratory tract infections (LRTI). For each definition three levels of evidence are proposed to ensure the applicability of the definitions to different settings,
   Recommendations about data collection, analysis and presentation are presented and harmonized with the Brighton Collaboration and GAIA format and other existing international standards for study reporting. (C) 2016 Published by Elsevier Ltd.
C1 [Vergnano, Stefania; Cailes, Ben; Jones, Chrissie; Heath, Paul T.] St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England.
   [Buttery, Jim] Monash Med Ctr, Clayton, Vic 3168, Australia.
   [Chandrasekaran, Ravichandran] Madras Med Coll & Govt Gen Hosp, Madras, Tamil Nadu, India.
   [Chiappini, Elena] Univ Florence, Meyer Childrens Hosp, I-50121 Florence, Italy.
   [Clark, Ebiere] Enhanced Vigilance Syst, Poole, Dorset, England.
   [Cutland, Clare] Univ Witwatersrand, Wits Hlth Consortium, DST NRF Resp & Meningeal Pathogens Res Unit RMPRU, ZA-2050 Johannesburg, South Africa.
   [de Andrade, Solange Dourado] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Esteves-Jaramillo, Alejandra] Sanofi Pasteur, Global Pharmacovigilance, Swiftwater, PA USA.
   [Guinazu, Javier Ruiz] GSK Vaccines, Wavre, Belgium.
   [Kampmann, Beate] Imperial Coll, London, England.
   [Kampmann, Beate] MRC Unit, Serrekunda, Gambia.
   [Kochhar, Sonali] Global Healthcare Consulting, Delhi, India.
   [Macdonald, Noni; Top, Karina A.] Dalhousie Univ, Dept Paediat, Halifax, NS, Canada.
   [Mangili, Alexandra] Novartis Vaccine GSK Vaccines, Cambridge, MA USA.
   [Martins, Reinaldo de Menezes] Bio Manguinhos Fiocruz, Manguinho, RJ, Brazil.
   [Velasco Munoz, Cesar] Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, E-08007 Barcelona, Spain.
   [Padula, Michael] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.
   [Padula, Michael] Univ Penn, Philadelphia, PA 19104 USA.
   [Munoz, Flor M.] Baylor Coll Med, Houston, TX 77030 USA.
   [Oleske, James] Rutgers New Jersey Med Sch, Dept Pediat, Newark, NJ USA.
   [Sanicas, Melvin] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Schlaudecker, Elizabeth] Cincinnati Childrens Hosp Med Ctr, Global Hlth Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.
   [Spiegel, Hans] Henry Jackson Fdn, Bethesda, MD USA.
   [Subelj, Maja] Natl Inst Publ Hlth NIJZ, Ljubljana, Slovenia.
   [Sukumaran, Lakshmi] Emory Univ, Sch Med, Ctr Dis Control & Prevent, Div Pediat Infect Dis, Atlanta, GA 30322 USA.
   [Tagbo, Beckie N.] Univ Nigeria, Teaching Hosp, Inst Child Hlth, Enugu, Nigeria.
   [Tran, Dat] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Infect Dis, Toronto, ON M5S 1A1, Canada.
RP Heath, PT (reprint author), St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England.
EM contact@brightoncollaboration.org
OI Chiappini, Elena/0000-0002-1476-4752; Martins,
   Reinaldo/0000-0002-0667-532X; Velasco Munoz, Cesar/0000-0001-8566-1155
FU Bill and Melinda Gates Foundation
FX The authors are grateful for the support and helpful comments provided
   by the Brighton Collaboration (Jan Bonhoeffer, Jorgen Bauwens) and the
   reference group (see
   https://brightoncollaboration.org/public/what-we-do/setting-standards/ca
   se-definitions/groups.html for reviewers), as well as other experts
   consulted as part of the process. The authors are also grateful to the
   Brighton Collaboration Secretariat and to the members of the ISPE
   Special Interest Group in Vaccines (VAX SIG) for their review and
   constructive comments on this document. Finally, we would like to
   acknowledge the Global Alignment of Immunisation Safety Assessment in
   Pregnancy (GAIA) project, funded by the Bill and Melinda Gates
   Foundation.
CR Carlin JB, 2008, LANCET, V371, P135
   Garges HP, 2006, PEDIATRICS, V117, P1094, DOI 10.1542/peds.2005-1132
   Greenberg RG, 2008, PEDIATR INFECT DIS J, V27, P1047, DOI 10.1097/INF.0b013e31817e519b
   Hayles EH, 2015, VACCINE, V33, P228, DOI 10.1016/j.vaccine.2014.10.074
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Ingle G K, 2007, INDIAN J COMMUNITY M, V32, P108
   Kestenbaum LA, 2010, PEDIATRICS, V125, P257, DOI 10.1542/peds.2009-1181
   Leistner R, 2013, KLIN PADIATR, V225, P75, DOI 10.1055/s-0033-1334886
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007
   Modjarrad K, 2015, VACCINE
   Munoz FM, 2015, VACCINE, V33, P6441, DOI 10.1016/j.vaccine.2015.07.112
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Nuccitelli A, 2015, THER ADV VACCINES
   Opiyo N, 2011, ARCH DIS CHILD, V96, P1052, DOI 10.1136/adc.2010.186049
   Rao S, 2014, CURR OPIN INFECT DIS, V27, P342, DOI 10.1097/QCO.0000000000000079
   Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360
   Russell ARB, 2015, ARCH DIS CHILD-FETAL, V100, pF350, DOI 10.1136/archdischild-2014-306193
   Shah PS, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-110
   Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217
   Vergnano S, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-48
   Verstraete EH, 2015, PEDIATRICS, V135, pE1002, DOI 10.1542/peds.2014-3226
   WHO,, 2005, IMCI HDB INT MAN CHI
   Wynn JL, 2014, PEDIATR CRIT CARE ME, V15, P523, DOI 10.1097/PCC.0000000000000157
NR 24
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 1
PY 2016
VL 34
IS 49
SI SI
BP 6038
EP 6046
DI 10.1016/j.vaccine.2016.03.046
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EF7MP
UT WOS:000390514000007
PM 27491687
OA No
DA 2017-08-15
ER

PT J
AU Hegde, ST
   Sazzad, HMS
   Hossain, MJ
   Alam, MU
   Kenah, E
   Daszak, P
   Rollin, P
   Rahman, M
   Luby, SP
   Gurley, ES
AF Hegde, Sonia T.
   Sazzad, Hossain M. S.
   Hossain, M. Jahangir
   Alam, Mahbub-Ul
   Kenah, Eben
   Daszak, Peter
   Rollin, Pierre
   Rahman, Mahmudur
   Luby, Stephen P.
   Gurley, Emily S.
TI Investigating Rare Risk Factors for Nipah Virus in Bangladesh: 2001-2012
SO ECOHEALTH
LA English
DT Article
DE Nipah virus; Bangladesh; risk factors; zoonoses; rare exposures;
   prevention
ID TO-PERSON TRANSMISSION; DATE PALM SAP; ATTRIBUTABLE RISK; OUTBREAK;
   INFECTION; DISEASE; ENCEPHALITIS; HUMANS
AB Human Nipah encephalitis outbreaks have been identified almost yearly in Bangladesh since 2001. Though raw date palm sap consumption and person-to-person contact are recognized as major transmission pathways, alternative pathways of transmission are plausible and may not have been identified due to limited statistical power in each outbreak. We conducted a risk factor analysis using all 157 cases and 632 controls surveyed in previous investigations during 2004-2012 to identify exposures independently associated with Nipah, since date palm sap was first asked about as an exposure in 2004. To further explore possible rare exposures, we also conducted in-depth interviews with all cases, or proxies, since 2001 that reported no exposure to date palm sap or contact with another case. Cases were 4.9 (95% 3.2-7.7) times more likely to consume raw date palm sap and 7.3 (95% 4.0-13.4) times more likely to have contact with a Nipah case than controls. In-depth interviews revealed that 39/182 (21%) of Nipah cases reporting neither date palm sap consumption nor contact with another case were misclassified. Prevention efforts should be focused on interventions to interrupt transmission through date palm sap consumption and person-to-person contact. Furthermore, pooling outbreak investigation data is a good method for assessing rare exposures.
C1 [Hegde, Sonia T.; Rollin, Pierre; Luby, Stephen P.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Hegde, Sonia T.] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Sazzad, Hossain M. S.; Hossain, M. Jahangir; Alam, Mahbub-Ul; Gurley, Emily S.] Icddr B, Ctr Communicable Dis Icddr B 68, Dhaka 1212, Bangladesh.
   [Hossain, M. Jahangir] MRC Unit, Banjul, Gambia.
   [Kenah, Eben] Univ Florida, Gainesville, FL 32611 USA.
   [Daszak, Peter] EcoHealth Alliance, New York, NY USA.
   [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh.
   [Luby, Stephen P.] Stanford Univ, Palo Alto, CA 94304 USA.
RP Gurley, ES (reprint author), Icddr B, Ctr Communicable Dis Icddr B 68, Dhaka 1212, Bangladesh.
EM egurley@icddrb.org
RI Gurley, Emily/B-7903-2010
OI Gurley, Emily/0000-0002-8648-9403; Hegde, Sonia/0000-0001-6426-0096
FU icddr,b; CDC [5U01CI000628-01]; NIH (Bangladesh-NIH/Emerging)
   [07-015-0712- 52200]
FX Funded by icddr,b and CDC cooperative agreement (no. 5U01CI000628-01),
   NIH Grant No. 07-015-0712- 52200 (Bangladesh-NIH/Emerging). icddr,b is
   grateful to the Governments of Bangladesh, Canada, Sweden and the UK for
   providing core/unrestricted support.
CR ATHERTON JG, 1978, ARCH VIROL, V56, P195, DOI 10.1007/BF01317848
   Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157
   BERNARD HR, 1984, ANNU REV ANTHROPOL, V13, P495
   BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904
   Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084
   Chua K B, 2010, Malays J Pathol, V32, P75
   Chua K B, 2010, Malays J Pathol, V32, P69
   Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432
   Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334
   Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31
   Greenland S, 1999, STAT SCI, V14, P29
   Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008
   Gurley ES, 2007, INFECT CONT HOSP EP, V28, P740, DOI 10.1086/516665
   Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128
   Gurley ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009756
   Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567
   HOLM S, 1979, SCAND J STAT, V6, P65
   Homaira N, 2010, EPIDEMIOL INFECT, V138, P1630, DOI 10.1017/S0950268810000695
   Hsu VP, 2004, EMERG INFECT DIS, V10, P2082
   ICDDRB, 2005, HLTH SCI B, V3, P1
   ICDDRB, 2003, HLTH SCI B, V1, P1
   Islam MS, 2014, AM J INFECT CONTROL, V42, P305, DOI 10.1016/j.ajic.2013.09.012
   Islam S, 2011, HEAL SCI B, V10, P16
   Kashiwazaki Y, 2004, J VIROL METHODS, V121, P259, DOI 10.1016/j.jviromet.2004.06.015
   Khan SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042689
   Luby SP, 2006, EMERG INFECT DIS, V12, P1888
   Luby SP, 2013, ANTIVIR RES, V100, P38, DOI 10.1016/j.antiviral.2013.07.011
   Luby SP, 2012, CURR TOP MICROBIOL, V359, P25, DOI 10.1007/82_2012_207
   Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951
   Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237
   Montgomery JM, 2008, EMERG INFECT DIS, V14, P1526, DOI 10.3201/eid1410.060507
   Nahar N, 2015, PLOS ONE
   Nahar N, 2014, GLOB HEALTH PROMOT, V21, P7, DOI 10.1177/1757975914528249
   Rahman MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/vbz.2011.0656
   Ram PK, 2011, AM J TROP MED HYG, V84, P510, DOI 10.4269/ajtmh.2011.10-0299
   Ramasundram V, 2000, NEUROL J SE ASIA, V5, P23
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15
   Rothman KJ, 2012, MODERN EPIDEMIOLOGY
   Sazzad HMS, 2013, EMERG INFECT DIS, V19, P210, DOI 10.3201/eid1902.120971
   Sejvar JJ, 2007, ANN NEUROL, V62, P235, DOI 10.1002/ana.21178
   Shapshak P, 2015, GLOBAL VIROLOGY 1 ID, P125
   STECKLER A, 1992, HEALTH EDUC QUART, V19, P1, DOI 10.1177/109019819201900101
NR 42
TC 2
Z9 2
U1 7
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD DEC
PY 2016
VL 13
IS 4
BP 720
EP 728
DI 10.1007/s10393-016-1166-0
PG 9
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA EE9AQ
UT WOS:000389918400013
PM 27738775
OA No
DA 2017-08-15
ER

PT J
AU Soothill, G
   Darboe, S
   Bah, G
   Bolarinde, L
   Cunnington, A
   Anderson, ST
AF Soothill, Germander
   Darboe, Saffiatou
   Bah, Gibril
   Bolarinde, Lawal
   Cunnington, Aubrey
   Anderson, Suzanne T.
TI Invasive bacterial infections in Gambians with sickle cell anemia in an
   era of widespread pneumococcal and hemophilus influenzae type b
   vaccination
SO MEDICINE
LA English
DT Article
DE antimicrobial prophylaxis; bacteremia; sickle cell anemia; West Africa
ID DISEASE; BACTEREMIA; CHILDREN; AFRICA; PROPHYLAXIS; EXPERIENCE; MALARIA
AB There is relatively little data on the etiology of bacterial infections in patients with sickle cell anemia (SCA) in West Africa, and no data from countries that have implemented conjugate vaccines against both Streptococcus pneumoniae and Haemophilus influenzae type b (Hib).
   We conducted a retrospective analysis of SCA patients admitted to the Medical Research Council Unit, The Gambia, during a 5-year period when there was high coverage of Hib and Pneumococcal conjugate vaccination. We evaluated 161 admissions of 126 patients between April 2010 and April 2015.
   Pathogenic bacteria were identified in blood cultures from 11 of the 131 admissions that had cultures taken (8.4%, 95% CI 4.5-14.1%). The most frequent isolate was Salmonella Typhimurium (6/11; 54.5%), followed by Staphylococcus aureus (2/11; 18.2%) and other enteric Gram-negative pathogens (2/11; 18.2%) and there was 1 case of H influenzae non-type b bacteremia (1/11; 9.1%). There were no episodes of bacteremia caused by S pneumoniae or Hib.
   The low prevalence of S pneumoniae and Hib and the predominance of nontyphoidal Salmonella as a cause of bacteremia suggest the need to reconsider optimal antimicrobial prophylaxis and the empirical treatment regimens for patients with SCA.
C1 [Soothill, Germander; Darboe, Saffiatou; Bah, Gibril; Bolarinde, Lawal; Anderson, Suzanne T.] MRC Unit Gambia, Atlantic Blvd,POB 273, Fajara, Gambia.
   [Soothill, Germander] Royal Free Hosp, Pond St, London, England.
   [Cunnington, Aubrey] Imperial Coll London, Paediat Sect, Dept Med, London, England.
RP Anderson, ST (reprint author), MRC Unit Gambia, Atlantic Blvd,POB 273, Fajara, Gambia.
EM s.anderson@ic.ac.uk
FU MRC Clinician Scientist Fellowship [MR/L006529/1]
FX AC is supported by an MRC Clinician Scientist Fellowship (MR/L006529/1).
CR Akuse RM, 1996, J TROP PEDIATRICS, V42, P318, DOI 10.1093/tropej/42.6.318
   ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O
   AMMANN AJ, 1977, NEW ENGL J MED, V297, P897, DOI 10.1056/NEJM197710272971701
   BARRETTCONNOR E, 1971, MEDICINE, V50, P97
   Baskin MN, 2013, PEDIATRICS, V131, P1035, DOI 10.1542/peds.2012-2139
   Cox SE, 2008, TROP MED INT HEALTH, V13, P76, DOI 10.1111/j.1365-3156.2007.01976.x
   GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501
   Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2
   JOHN AB, 1984, BRIT MED J, V288, P1567
   Kizito ME, 2007, ARCH DIS CHILD, V92, P21, DOI 10.1136/adc.2005.088807
   Knight-Madden J, 2001, J PEDIATR-US, V138, P65, DOI 10.1067/mpd.2001.109709
   Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2
   Makani J, 2015, BRIT J HAEMATOL, V171, P273, DOI 10.1111/bjh.13553
   McGann PT, 2013, AM J HEMATOL, V88, P984, DOI 10.1002/ajh.23578
   Mtunthama N, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-137
   Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063
   Obaro S, 2009, ARCH DIS CHILD, V94, P713, DOI 10.1136/adc.2008.154815
   Obaro SK, 2016, PEDIATR BLOOD CANCER, V63, P781, DOI 10.1002/pbc.25911
   Piel FB, 2010, NAT COMMUN, V1, P1
   Scott S, 2014, PLOS, V9, P1
   Small E, 2014, CRIT CARE, V18, P42
   UNICEF Multiple Indicator Cluster Survey, 2010, UNICEF MULTIPLE INDI
   Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X
   WONG WY, 1992, AM J HEMATOL, V39, P176, DOI 10.1002/ajh.2830390305
   ZARKOWSKY HS, 1986, J PEDIATR-US, V109, P579, DOI 10.1016/S0022-3476(86)80216-5
NR 27
TC 0
Z9 0
U1 7
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD DEC
PY 2016
VL 95
IS 49
AR e5512
DI 10.1097/MD.0000000000005512
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF0TW
UT WOS:000390040000037
PM 27930540
OA gold
DA 2017-08-15
ER

PT J
AU Stucki, D
   Brites, D
   Jeljeli, L
   Coscolla, M
   Liu, QY
   Trauner, A
   Fenner, L
   Rutaihwa, L
   Borrell, S
   Luo, T
   Gao, Q
   Kato-Maeda, M
   Ballif, M
   Egger, M
   Macedo, R
   Mardassi, H
   Moreno, M
   Vilanova, GT
   Fyfe, J
   Globan, M
   Thomas, J
   Jamieson, F
   Guthrie, JL
   Asante-Poku, A
   Yeboah-Manu, D
   Wampande, E
   Ssengooba, W
   Joloba, M
   Boom, WH
   Basu, I
   Bower, J
   Saraiva, M
   Vasconcellos, SEG
   Suffys, P
   Koch, A
   Wilkinson, R
   Gail-Bekker, L
   Malla, B
   Ley, SD
   Beck, HP
   de Jong, BC
   Toit, K
   Sanchez-Padilla, E
   Bonnet, M
   Gil-Brusola, A
   Frank, M
   Beng, VNP
   Eisenach, K
   Alani, I
   Ndung'u, PW
   Revathi, G
   Gehre, F
   Akter, S
   Ntoumi, F
   Stewart-Isherwood, L
   Ntinginya, NE
   Rachow, A
   Hoelscher, M
   Cirillo, DM
   Skenders, G
   Hoffner, S
   Bakonyte, D
   Stakenas, P
   Diel, R
   Crudu, V
   Moldovan, O
   Al-Hajoj, S
   Otero, L
   Barletta, F
   Carter, EJ
   Diero, L
   Supply, P
   Comas, I
   Niemann, S
   Gagneux, S
AF Stucki, David
   Brites, Daniela
   Jeljeli, Leila
   Coscolla, Mireia
   Liu, Qingyun
   Trauner, Andrej
   Fenner, Lukas
   Rutaihwa, Liliana
   Borrell, Sonia
   Luo, Tao
   Gao, Qian
   Kato-Maeda, Midori
   Ballif, Marie
   Egger, Matthias
   Macedo, Rita
   Mardassi, Helmi
   Moreno, Milagros
   Tudo Vilanova, Griselda
   Fyfe, Janet
   Globan, Maria
   Thomas, Jackson
   Jamieson, Frances
   Guthrie, Jennifer L.
   Asante-Poku, Adwoa
   Yeboah-Manu, Dorothy
   Wampande, Eddie
   Ssengooba, Willy
   Joloba, Moses
   Boom, W. Henry
   Basu, Indira
   Bower, James
   Saraiva, Margarida
   Vasconcellos, Sidra E. G.
   Suffys, Philip
   Koch, Anastasia
   Wilkinson, Robert
   Gail-Bekker, Linda
   Malla, Bijaya
   Ley, Serej D.
   Beck, Hans-Peter
   de Jong, Bouke C.
   Toit, Kadri
   Sanchez-Padilla, Elisabeth
   Bonnet, Maryline
   Gil-Brusola, Ana
   Frank, Matthias
   Beng, Veronique N. Penlap
   Eisenach, Kathleen
   Alani, Issam
   Ndung'u, Perpetual Wangui
   Revathi, Gunturu
   Gehre, Florian
   Akter, Suriya
   Ntoumi, Francine
   Stewart-Isherwood, Lynsey
   Ntinginya, Nyanda E.
   Rachow, Andrea
   Hoelscher, Michael
   Cirillo, Daniela Maria
   Skenders, Girts
   Hoffner, Sven
   Bakonyte, Daiva
   Stakenas, Petras
   Diel, Roland
   Crudu, Valeriu
   Moldovan, Olga
   Al-Hajoj, Sahal
   Otero, Larissa
   Barletta, Francesca
   Carter, E. Jane
   Diero, Lameck
   Supply, Philip
   Comas, Inack
   Niemann, Stefan
   Gagneux, Sebastien
TI Mycobacterium tuberculosis lineage 4 comprises globally distributed and
   geographically restricted sublineages
SO NATURE GENETICS
LA English
DT Article
ID PAPUA-NEW-GUINEA; GENETIC DIVERSITY; RESISTANT TUBERCULOSIS; ANTIGENIC
   VARIATION; GENOMIC DIVERSITY; HIV-INFECTION; SOUTH-AFRICA; POPULATION;
   PATHOGENS; EVOLUTION
AB Generalist and specialist species differ in the breadth of their ecological niches. Little is known about the niche width of obligate human pathogens. Here we analyzed a global collection of Mycobacterium tuberculosis lineage 4 clinical isolates, the most geographically widespread cause of human tuberculosis. We show that lineage 4 comprises globally distributed and geographically restricted sublineages, suggesting a distinction between generalists and specialists. Population genomic analyses showed that, whereas the majority of human T cell epitopes were conserved in all sublineages, the proportion of variable epitopes was higher in generalists. Our data further support a European origin for the most common generalist sublineage. Hence, the global success of lineage 4 reflects distinct strategies adopted by different sublineages and the influence of human migration.
C1 [Stucki, David; Brites, Daniela; Coscolla, Mireia; Trauner, Andrej; Fenner, Lukas; Rutaihwa, Liliana; Borrell, Sonia; Ballif, Marie; Malla, Bijaya; Ley, Serej D.; Beck, Hans-Peter; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Stucki, David; Brites, Daniela; Coscolla, Mireia; Trauner, Andrej; Fenner, Lukas; Rutaihwa, Liliana; Borrell, Sonia; Ballif, Marie; Malla, Bijaya; Ley, Serej D.; Beck, Hans-Peter; Gagneux, Sebastien] Univ Basel, Basel, Switzerland.
   [Jeljeli, Leila; Niemann, Stefan] Forschungszentrum Borstel, Borstel, Germany.
   [Jeljeli, Leila; Mardassi, Helmi] Univ Tunis El Manar, Inst Pasteur Tunis, Tunis, Tunisia.
   [Liu, Qingyun; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Minist Educ, Shanghai, Peoples R China.
   [Liu, Qingyun; Gao, Qian] Fudan Univ, Minist Hlth, Inst Biomed Sci, Shanghai, Peoples R China.
   [Liu, Qingyun; Gao, Qian] Fudan Univ, Inst Med Microbiol, Sch Basic Med Sci, Shanghai, Peoples R China.
   [Fenner, Lukas; Ballif, Marie; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Luo, Tao] Sichuan Univ, West China Ctr Med Sci, Sch Basic Med Sci, Laborat Infect & Immun, Chengdu, Peoples R China.
   [Kato-Maeda, Midori] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
   [Macedo, Rita] Lab Saude Publ, Lisbon, Portugal.
   [Moreno, Milagros] Hosp Nossa Senhora Paz, Cubal, Angola.
   [Tudo Vilanova, Griselda] Hosp Clin ISGlobal, Microbiol Serv, Barcelona, Spain.
   [Fyfe, Janet; Globan, Maria] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.
   [Thomas, Jackson] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Jamieson, Frances; Guthrie, Jennifer L.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Asante-Poku, Adwoa; Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana.
   [Wampande, Eddie; Ssengooba, Willy; Joloba, Moses] Makerere Univ, Dept Med Microbiol, Kampala, Uganda.
   [Ssengooba, Willy] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands.
   [Boom, W. Henry] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.
   [Basu, Indira; Bower, James] Auckland City Hosp, LabPlus, Auckland, New Zealand.
   [Saraiva, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.
   [Saraiva, Margarida] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Vasconcellos, Sidra E. G.; Suffys, Philip] Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Koch, Anastasia; Wilkinson, Robert; Gail-Bekker, Linda] Univ Cape Town, Institute Infect Dis & Mol Med, Cape Town, South Africa.
   [Koch, Anastasia; Wilkinson, Robert; Gail-Bekker, Linda] Univ Cape Town, Dept Clin Lab Sci, Cape Town, South Africa.
   [Wilkinson, Robert] Imperial Coll London, Dept Med, London, England.
   [Wilkinson, Robert] Francis Crick Inst Mill Hill Lab, London, England.
   [Ley, Serej D.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea.
   [de Jong, Bouke C.; Gehre, Florian; Akter, Suriya] Inst Trop Med, Antwerp, Belgium.
   [Toit, Kadri] Tartu Univ Hosp, United Labs, Mycobacteriol, Tartu, Estonia.
   [Sanchez-Padilla, Elisabeth; Bonnet, Maryline] Epicentre, Dept Clin Res, Paris, France.
   [Gil-Brusola, Ana] Univ Hosp La Fe, Dept Microbiol, Valencia, Spain.
   [Frank, Matthias; Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Beng, Veronique N. Penlap] Univ Yaounde I, Biotechnol Ctr BTC, Inst Lab TB Res LTR, Yaounde, Cameroon.
   [Eisenach, Kathleen] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA.
   [Alani, Issam] Fac Med Technol, Dept Med Lab Technol, Baghdad, Iraq.
   [Ndung'u, Perpetual Wangui] Jomo Kenyatta Univ Agr & Technol, Inst Trop Med & Infect Dis ITROMID, Nairobi, Kenya.
   [Revathi, Gunturu] Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya.
   [Gehre, Florian] MRC, Fajara, Gambia.
   [Ntoumi, Francine] Univ Marien Gouabi, Fdn Congolaise Rech Med, Brazzaville, Congo.
   [Stewart-Isherwood, Lynsey] Univ Witwatersrand, Right Care & Clin HIV Res Unit, Johannesburg, South Africa.
   [Ntinginya, Nyanda E.] Mbeya Med Res Ctr NIMR MMRC, Natl Inst Med Res, Mbeya, Tanzania.
   [Rachow, Andrea; Hoelscher, Michael] Univ Munich, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.
   [Rachow, Andrea; Hoelscher, Michael] German Ctr Infect Res DZIF, Munich, Germany.
   [Cirillo, Daniela Maria] IRCCS, San Raffaele Sci Inst, Emerging Bacterial Pathogens Unit, Milan, Italy.
   [Skenders, Girts] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia.
   [Hoffner, Sven] Publ Hlth Agcy Sweden, Dept Microbiol, WH0 Supranatl TB Reference Lab, Solna, Sweden.
   [Bakonyte, Daiva; Stakenas, Petras] Vilnius Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Vilnius, Lithuania.
   [Diel, Roland] Schleswig Holstein Univ Hosp, Inst Epidemiol, Kiel, Germany.
   [Crudu, Valeriu] Phthysiopneumol Inst, Natl TB Reference Lab, Kishinev, Moldova.
   [Moldovan, Olga] Marius Nasta Pneumophtisiol Inst, Bucharest, Romania.
   [Al-Hajoj, Sahal] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia.
   [Barletta, Francesca] Univ Peruana Cayetano Heredia, Instituto Med Trop Alexander von Humboldt, Mol Epidemiol Unit TB, Lima, Peru.
   [Carter, E. Jane] Brown Univ, Miriam Hosp, Warren Alpert Sch Med, Providence, RI USA.
   [Carter, E. Jane; Diero, Lameck] Moi Univ, Sch Med, Eldoret, Kenya.
   [Supply, Philip] Univ Lille, CNRS, INSERM,U1019,UMR 8204, CHU Lille,Inst Pasteur Lille,Ctr Infect & Immunit, Lille, France.
   [Comas, Inack] Ilnst Biomed Valencia IBV CSIC, Valencia, Spain.
   [Comas, Inack] CIBER Epidemiol & Publ Hlth, Madrid, Spain.
   [Niemann, Stefan] German Ctr Infect Res, Borstel Site, Borstel, Germany.
RP Gagneux, S (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Gagneux, S (reprint author), Univ Basel, Basel, Switzerland.
EM sebastien.gagneux@unibas.ch
RI ; Hoelscher, Michael/D-3436-2012; Niemann, Stefan/C-9327-2011; Coscolla,
   Mireia/L-5893-2017
OI Ssengooba, Willy/0000-0002-1643-110X; Coscolla,
   Mireia/0000-0003-0752-0538; Beck, Hans-Peter/0000-0001-8326-4834; Comas,
   Inaki/0000-0001-5504-9408; Gil-Brusola, Ana/0000-0002-4418-3676;
   Trauner, Andrej/0000-0002-6260-9829; Gagneux,
   Sebastien/0000-0001-7783-9048; Liu, Qingyun/0000-0002-2284-5050;
   Guthrie, Jennifer/0000-0001-8565-203X; Ley, Serej D./0000-0002-2705-9120
FU Swiss National Science Foundation [310030_166687, 320030_153442]; Swiss
   HIV Cohort Study grant [740]; European Research Council
   [309540-EVODRTB]; German Center for Infection Research (DZIF); Novartis
   Foundation; Natural Science Foundation of China [91631301]; National
   Institute of Allergy and Infectious Diseases of the US National
   Institutes of Health [5U01-AI069924-05]; TB-PAN-NET project
   [FP7-223681]; PathoNgenTrace project [FP7-278864-2]; SystemsX.ch
FX We thank S. Lecher, S. Li and J. Zallet for technical support.
   Calculations were performed at the sciCORE scientific computing core
   facility at the University of Basel. This work was supported by the
   Swiss National Science Foundation (grants 310030_166687 (S.G.) and
   320030_153442 (M.E.) and Swiss HIV Cohort Study grant 740 to L.F.), the
   European Research Council (309540-EVODRTB to S.G.), TB-PAN-NET
   (FP7-223681 to S.N.), PathoNgenTrace projects (FP7-278864-2 to S.N.),
   SystemsX.ch (S.G.), the German Center for Infection Research (DZIF;
   S.N.), the Novartis Foundation (S.G.), the Natural Science Foundation of
   China (91631301 to Q.G.), and the National Institute of Allergy and
   Infectious Diseases (5U01-AI069924-05) of the US National Institutes of
   Health (M.E.).
CR Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006
   Araujo Leonardo Silva de, 2015, Tuberculosis (Edinb), V95, P751, DOI 10.1016/j.tube.2015.08.002
   Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370
   Baily S.L., 1993, MASS MIGRATION MODER
   Baker L, 2004, EMERG INFECT DIS, V10, P1568
   Ballif M, 2012, INT J TUBERC LUNG D, V16, P1100, DOI 10.5588/ijtld.11.0779
   BATES JH, 1993, MED CLIN N AM, V77, P1205
   Bekmurzayeva A, 2013, TUBERCULOSIS, V93, P381, DOI 10.1016/j.tube.2013.03.003
   Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456
   Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591
   Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11
   Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5
   Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110
   Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878
   Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034
   Clark TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083012
   Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812
   Comas I, 2015, CURR BIOL, V25, P3260, DOI 10.1016/j.cub.2015.10.061
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590
   Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815
   Coppola M, 2015, CLIN VACCINE IMMUNOL, V22, P1060, DOI 10.1128/CVI.00271-15
   Coscolla M, 2015, CELL HOST MICROBE, V18, P538, DOI 10.1016/j.chom.2015.10.008
   Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012
   Coscolla M, 2013, EMERG INFECT DIS, V19, P969, DOI 10.3201/eid1906.121012
   Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004
   Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145
   Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004
   ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245
   Ernst JD, 2008, TUBERCULOSIS, V88, P366, DOI 10.1016/j.tube.2007.11.002
   Esparza M, 2015, SCAND J IMMUNOL, V81, P46, DOI 10.1111/sji.12249
   Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747
   Fenner L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003318
   Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11
   Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006
   Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256
   FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.ecolsys.19.1.207
   Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103
   Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1
   Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176
   Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166
   Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574
   Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855
   Jamieson FB, 2014, J CLIN MICROBIOL, V52, P3795, DOI 10.1128/JCM.01726-14
   Juarez MD, 2001, FEMS MICROBIOL LETT, V203, P95, DOI 10.1111/j.1574-6968.2001.tb10826.x
   Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717
   Kirzinger MWB, 2012, TRENDS MICROBIOL, V20, P88, DOI 10.1016/j.tim.2011.11.006
   Lanzas F, 2013, J CLIN MICROBIOL, V51, P3277, DOI 10.1128/JCM.01122-13
   Ley SD, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0307-2
   Luo T, 2015, P NATL ACAD SCI USA, V112, P8136, DOI 10.1073/pnas.1424063112
   Malla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052297
   Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195
   Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x
   Mokrousov I, 2016, MOL PHYLOGENET EVOL, V99, P133, DOI 10.1016/j.ympev.2016.03.020
   NAGAI S, 1991, INFECT IMMUN, V59, P372
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07
   Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543
   Perdigao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-991
   Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439
   Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387
   Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869
   Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253
   Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101
   Vouga M, 2016, CLIN MICROBIOL INFEC, V22, P12, DOI 10.1016/j.cmi.2015.10.010
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3
   Wampande EM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-484
   World Health Organization, 2015, GLOB TUB CONTR SURV
   Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026
   Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569
   Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906
   Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008
   Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946
NR 79
TC 8
Z9 8
U1 11
U2 21
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD DEC
PY 2016
VL 48
IS 12
BP 1535
EP 1543
DI 10.1038/ng.3704
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA ED7BQ
UT WOS:000389011100014
PM 27798628
OA No
DA 2017-08-15
ER

PT J
AU Shimakawa, Y
   Lemoine, M
   Njai, HF
   Bottomley, C
   Ndow, G
   Goldin, RD
   Jatta, A
   Jeng-Barry, A
   Wegmuller, R
   Moore, SE
   Baldeh, I
   Taal, M
   D'Alessandro, U
   Whittle, H
   Njie, R
   Thursz, M
   Mendy, M
AF Shimakawa, Yusuke
   Lemoine, Maud
   Njai, Harr Freeya
   Bottomley, Christian
   Ndow, Gibril
   Goldin, Robert D.
   Jatta, Abdoulie
   Jeng-Barry, Adam
   Wegmuller, Rita
   Moore, Sophie E.
   Baldeh, Ignatius
   Taal, Makie
   D'Alessandro, Umberto
   Whittle, Hilton
   Njie, Ramou
   Thursz, Mark
   Mendy, Maimuna
TI Natural history of chronic HBV infection in West Africa: a longitudinal
   population-based study from The Gambia
SO GUT
LA English
DT Article
ID HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; E-ANTIGEN; INFANT
   VACCINATION; CLINICAL-OUTCOMES; CHRONIC CARRIERS; VIRAL LOAD; DNA;
   CHILDREN; EFFICACY
AB Background The natural history of chronic HBV infection in sub-Saharan Africa is unknown. Data are required to inform WHO guidelines that are currently based on studies in Europe and Asia.
   Methods Between 1974 and 2008, serosurveys were repeated in two Gambian villages, and an open cohort of treatment-naive chronic HBV carriers was recruited. Participants were followed to estimate the rates of hepatitis B e (HBeAg) and surface antigen (HBsAg) clearance and incidence of hepatocellular carcinoma (HCC). In 2012-2013, a comprehensive liver assessment was conducted to estimate the prevalence of severe liver disease.
   Results 405 chronic carriers (95% genotype E), recruited at a median age of 10.8 years, were followed for a median length of 28.4 years. Annually, 7.4% (95% CI 6.3% to 8.8%) cleared HBeAg and 1.0% (0.8% to 1.2%) cleared HBsAg. The incidence of HCC was 55.5/100 000 carrier-years (95% CI 24.9 to 123.5). In the 2012-2013 survey (n=301), 5.5% (95% CI 3.4% to 9.0%) had significant liver fibrosis. HBV genotype A (versus E), chronic aflatoxin B1 exposure and an HBsAg-positive mother, a proxy for mother-to-infant transmission, were risk factors for liver fibrosis. A small proportion (16.0%) of chronic carriers were infected via mother-to-infant transmission; however, this population represented a large proportion (63.0%) of the cases requiring antiviral therapy.
   Conclusions The incidence of HCC among chronic HBV carriers in West Africa was higher than that in Europe but lower than rates in East Asia. High risk of severe liver disease among the few who are infected by their mothers underlines the importance of interrupting perinatal transmission in sub-Saharan Africa.
C1 [Shimakawa, Yusuke; Lemoine, Maud; Njai, Harr Freeya; Ndow, Gibril; Jatta, Abdoulie; Jeng-Barry, Adam; D'Alessandro, Umberto; Njie, Ramou] Med Res Council MRC Unit, Banjul, Gambia.
   [Shimakawa, Yusuke; Bottomley, Christian; Moore, Sophie E.; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.
   [Lemoine, Maud; Goldin, Robert D.; Thursz, Mark] Imperial Coll London, Dept Hepatol, Norfolk Pl, London W2 1NY, England.
   [Ndow, Gibril; Njie, Ramou] IARC, MRC Unit, Gambia Hepatitis Intervent Study, Banjul, Gambia.
   [Wegmuller, Rita; Moore, Sophie E.] MRC Keneba, MRC Int Nutr Grp, West Kiang, Gambia.
   [Baldeh, Ignatius; Taal, Makie] Minist Hlth & Social Welf, Banjul, Gambia.
   [Whittle, Hilton] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Mendy, Maimuna] IARC, Lyon, France.
RP Thursz, M (reprint author), Imperial Coll London, Dept Hepatol, Norfolk Pl, London W2 1NY, England.
EM thursz@imperial.ac.uk
OI Ndow, Gibril/0000-0001-5837-5110
FU Gambia government; MRC; European Commission's Seventh Framework Program
   [265 994]
FX The Gambia government, MRC and European Commission's Seventh Framework
   Program (grant 265 994) supported the study.
CR Bah E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075775
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bortolotti F, 2006, HEPATOLOGY, V43, P556, DOI 10.1002/hep.21077
   Chang MH, 2008, HEPATOL INT, V2, pS28, DOI 10.1007/s12072-008-9050-9
   Chen CF, 2011, GASTROENTEROLOGY, V141, P1240, DOI 10.1053/j.gastro.2011.06.036
   Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65
   Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348
   Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x
   Cowie BC, 2013, HEPATOLOGY, V58, p218A
   Crook PD, 2003, INT J EPIDEMIOL, V32, P118, DOI 10.1093/ije/dyg039
   Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313
   Evans AA, 1998, CANCER EPIDEM BIOMAR, V7, P559
   Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030
   Howell J, 2014, J VIRAL HEPATITIS, V21, P381, DOI 10.1111/jvh.12263
   HYAMS KC, 1995, CLIN INFECT DIS, V20, P992
   KEW MC, 1982, MEDICINE, V61, P98
   Kiire CF, 1996, GUT, V38, pS5, DOI 10.1136/gut.38.Suppl_2.S5
   Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x
   Lemoine M, 2015, GUT
   Lim TH, 2015, GUT, V64, P966, DOI 10.1136/gutjnl-2013-306247
   Lin XM, 2005, J GASTROEN HEPATOL, V20, P833, DOI 10.1111/j.1400-1746.2005.03813.x
   Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010
   Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190
   MCGREGOR IA, 1976, OIKOS, V27, P180, DOI 10.2307/3543897
   McMahon BJ, 2001, ANN INTERN MED, V135, P759
   Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029
   Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23
   Mendy ME, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-49
   MRC Unit The Gambia, W KIANG DEM SURV SYS
   Njai HF, 2015, J CLIN MICROBIOL, V53, P1156, DOI 10.1128/JCM.02980-14
   Papatheodoridis G, 2012, J HEPATOL, V57, P167
   Peto TJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-7
   Rothman K, 2008, MODERN EPIDEMIOLOGY
   Sanlidag T, 2005, J VIROL METHODS, V123, P49, DOI 10.1016/j.jviromet.2004.09.006
   Schur N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001194
   Shimakawa Y, 2015, BIRTH ORDER RISK HEP, DOI [doi:10.1111/liv.12814, DOI 10.1111/LIV.12814]
   Shimakawa Yusuke, 2014, Trop Med Health, V42, P59, DOI 10.2149/tmh.2014-S08
   Shimakawa Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-532
   Shimakawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069430
   Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646
   van der Sande MAB, 2006, J INFECT DIS, V193, P1528
   Villar S, 2011, ENVIRON HEALTH PERSP, V119, P1635, DOI 10.1289/ehp.1103539
   Whittle H, 2002, BRIT MED J, V325, P569, DOI 10.1136/bmj.325.7364.569
   WHITTLE H, 1990, J INFECT DIS, V161, P1112
   WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4
   WHITTLE HC, 1995, LANCET, V345, P1089, DOI 10.1016/S0140-6736(95)90822-6
   WHITTLE HC, 1983, LANCET, V1, P1203
   WHO, 2009, WKLY EPIDEMIOL REC, V84, P405
   World Health Organization, 2015, GUID PREV CAR TREATM
   WHO, 2014, WKLY EPIDEMIOL REC, V89, P517
NR 50
TC 10
Z9 10
U1 2
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD DEC
PY 2016
VL 65
IS 12
BP 2007
EP U115
DI 10.1136/gutjnl-2015-309892
PG 10
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EC4MV
UT WOS:000388106600012
PM 26185161
OA No
DA 2017-08-15
ER

PT J
AU Achan, J
   Kakuru, A
   Ikilezi, G
   Mwangwa, F
   Plenty, A
   Charlebois, E
   Young, S
   Havlir, D
   Kamya, M
   Ruel, T
AF Achan, Jane
   Kakuru, Abel
   Ikilezi, Gloria
   Mwangwa, Florence
   Plenty, Albert
   Charlebois, Edwin
   Young, Sera
   Havlir, Diane
   Kamya, Moses
   Ruel, Theodore
TI Growth Recovery Among HIV-infected Children Randomized to
   Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE growth recovery; HIV infection; children; antiretroviral drugs
ID UGANDAN CHILDREN; VIRAL LOAD; NEVIRAPINE; MALNUTRITION; PREVENTION;
   RESPONSES; IMMUNE; TRIAL; CD4
AB Background: Diminished growth is highly prevalent among HIV-infected children and might be improved by antiretroviral therapy (ART). We examined growth recovery in a rural Ugandan cohort of HIV-infected children randomized to lopinavir/ritonavir (LPV/r) or non nucleoside reverse transcription inhibitor-based ART.
   Methods: HIV-infected children 2 months to 6 years of age were randomized to LPV/r- or non nucleoside reverse transcription inhibitor-based ART. Changes in weight-for-age (WAZ), height-for-age (HAZ) and weight-for-height Z-scores for 24 months were evaluated using generalized linear repeated measures models. Recovery from being underweight (WAZ<-2), stunted (HAZ<-2) and wasted (weight-for-height <-2) to Z-scores greater than -2 was also compared by arm using Kaplan-Meier survival and Cox proportional hazard modeling.
   Results: A total of 129 children with median age of 3 years initiated therapy; 64 received LPV/r-based and 65 non nucleoside reverse transcription inhibitor-based ART (nevirapine: 36 and efavirenz: 29). The median (interquartile range) difference in growth measures between baseline and 24 months for LPV/r (n = 45) versus non nucleoside reverse transcription inhibitor-based therapy (n = 40) were as follows: WAZ, 0.47 (0.10, 1.62) versus 0.53 (0.03, 1.14) (P = 0.59) and HAZ, median 1.55 (0.78, 1.86) versus 1.19 (0.62, 1.65) (P = 0.23), respectively. ART regimen was not predictive of change in WAZ (beta: -0.02, 95% confidence interval: -0.25, 0.20) or HAZ (beta: 0.05, 95% confidence interval: -0.10, 0.19). The presence of confirmed virologic failure was not associated with growth.
   Conclusions: Most ART-naive children experienced recovery of both WAZ and HAZ over the 24 months after ART initiation, with no significant difference between those receiving LPV/r versus non nucleoside reverse transcriptase inhibitor-based ART. However, the persistence of median Z-scores below 0 underscores the need for additional strategies to improve growth outcomes in HIV+ African children.
C1 [Achan, Jane] Med Res Council Unit Gambia, Banjul, Gambia.
   [Kakuru, Abel; Ikilezi, Gloria; Mwangwa, Florence] Infect Dis Res Collaborat, Kampala, Uganda.
   [Plenty, Albert; Charlebois, Edwin; Havlir, Diane] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Young, Sera] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Kamya, Moses] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.
   [Ruel, Theodore] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA.
RP Achan, J (reprint author), Med Res Council Unit Gambia, Banjul, Gambia.
EM achanj@yahoo.co.uk
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development [P01HD059454, K23HD60459]; AbbVie
FX The study was funded by a grant from Eunice Kennedy Shriver National
   Institute of Child Health and Human Development (P01HD059454 and
   K23HD60459) and AbbVie (formerly Abbott Laboratories) donated the
   lopinavir/ritonavir.
CR Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501
   Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3
   Fergusson P, 2009, ARCH DIS CHILD, V94, P512, DOI 10.1136/adc.2008.142646
   Ghaffari G, 2004, PEDIATRICS, V114, pE604, DOI 10.1542/peds.2004-0274
   Kabue MM, 2008, AIDS PATIENT CARE ST, V22, P245, DOI 10.1089/apc.2007.0049
   Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5
   McGrath CJ, 2015, AIDS, V29, P2009, DOI 10.1097/QAD.0000000000000783
   Musoke PM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-56
   Musoke PM, 2009, JAIDS-J ACQ IMM DEF, V52, P560, DOI 10.1097/QAI.0b013e3181b93a5a
   Mwiru RS, 2014, J TROP PEDIATRICS, V60, P179, DOI 10.1093/tropej/fmt104
   Nachman SA, 2005, PEDIATR INFECT DIS J, V24, P352, DOI 10.1097/01.inf.0000157095.75081.43
   Owor M, 2013, JAIDS-J ACQ IMM DEF, V64, P464, DOI 10.1097/QAI.0000000000000015
   Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931
   Prendergast A, 2011, AIDS, V25, P951, DOI 10.1097/QAD.0b013e328345e56b
   Rose AM, 2014, ARCH DIS CHILD, V99, P546, DOI 10.1136/archdischild-2012-303348
   Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4
   Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25
   Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519
   Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249
   World Health Organization, WHO CHILD GROWTH STA
   World Health Organization, GLOB DAT CHILD GROWT
NR 21
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD DEC
PY 2016
VL 35
IS 12
BP 1329
EP 1332
DI 10.1097/INF.0000000000001318
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA EC6AH
UT WOS:000388217900016
PM 27580060
OA No
DA 2017-08-15
ER

PT J
AU Diarra, B
   Goita, D
   Tounkara, S
   Sanogo, M
   Baya, B
   Togo, ACG
   Maiga, M
   Sarro, YS
   Kone, A
   Kone, B
   M'Baye, O
   Coulibaly, N
   Kassambara, H
   Cisse, A
   Belson, M
   Polis, MA
   Otu, J
   Gehre, F
   Antonio, M
   Dao, S
   Siddiqui, S
   Murphy, RL
   de Jong, BC
   Diallo, S
AF Diarra, B.
   Goita, D.
   Tounkara, S.
   Sanogo, M.
   Baya, B.
   Togo, A. C. G.
   Maiga, M.
   Sarro, Y. S.
   Kone, A.
   Kone, B.
   M'Baye, O.
   Coulibaly, N.
   Kassambara, H.
   Cisse, A.
   Belson, M.
   Polis, M. A.
   Otu, J.
   Gehre, F.
   Antonio, M.
   Dao, S.
   Siddiqui, S.
   Murphy, R. L.
   de Jong, B. C.
   Diallo, S.
TI Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis Drug resistance; Bamako; Mali
AB Background: Although Drug resistance tuberculosis is not a new phenomenon, Mali remains one of the "blank" countries without systematic data.
   Methods: Between 2006 and 2014, we enrolled pulmonary TB patients from local TB diagnostics centers and a university referral hospital in several observational cohort studies. These consecutive patients had first line drug susceptibility testing (DST) performed on their isolates. A subset of MDR was subsequently tested for second line drug resistance.
   Results: A total of 1186 mycobacterial cultures were performed on samples from 522 patients, including 1105 sputa and 81 blood samples, yielding one or more Mycobacterium tuberculosis complex (Mtbc) positive cultures for 343 patients. Phenotypic DST was performed on 337 (98.3%) unique Mtbc isolates, of which 127 (37.7%) were resistant to at least one drug, including 75 (22.3%) with multidrug resistance (MDR). The overall prevalence of MDRTB was 3.4% among new patients and 66.3% among retreatment patients. Second line DST was available for 38 (50. 7%) of MDR patients and seven (18.4%) had resistance to either fluoroquinolones or second-line injectable drugs.
   Conclusion: The drug resistance levels, including MDR, found in this study are relatively high, likely related to the selected referral population. While worrisome, the numbers remained stable over the study period. These findings prompt a nationwide drug resistance survey, as well as continuous surveillance of all retreatment patients, which will provide more accurate results on countrywide drug resistance rates and ensure that MDR patients access appropriate second line treatment.
C1 [Diarra, B.; Goita, D.; Tounkara, S.; Sanogo, M.; Baya, B.; Togo, A. C. G.; Maiga, M.; Sarro, Y. S.; Kone, A.; Kone, B.; M'Baye, O.; Coulibaly, N.; Kassambara, H.; Dao, S.; Diallo, S.] USTTB, SEREFO Program, Bamako, Mali.
   [Cisse, A.] INRSP, Lab Natl Reference Mycobacteries LNR, Bamako, Mali.
   [Belson, M.; Polis, M. A.; Siddiqui, S.] NIAID, CCRB, Div Clin Res, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Otu, J.; Gehre, F.; Antonio, M.] MRC, Vaccines & Immun Theme, Atlantic Blvd, Banjul, Gambia.
   [Diarra, B.; Gehre, F.; de Jong, B. C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.
   [Antonio, M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Antonio, M.] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [Murphy, R. L.] Northwestern Univ, Global Hlth, Chicago, IL 60611 USA.
RP Diarra, B (reprint author), USTTB, SEREFO Program, Bamako, Mali.; Diarra, B (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.
EM bdiarra@icermali.org
FU Northwestern University (Chicago, IL, USA) [ACTG U01AI069471];
   University of Sciences, Techniques and Technologies of Bamako (USTTB)
   through NIH/R01 [R01AI110386]; European & Developing Countries Clinical
   Trials Partnership (EDCTP); AIDS and Malaria (WANETAM) [CG_cb_07_41700,
   MSI 2010_10800-01/08/2011-31/07/14]; European Research
   Council-INTERRUPTB [311725]; TDR fellowship [B40072]; special programme
   for research and training in tropical diseases; UNICEF; UNDP; World
   Bank; WHO
FX This study was partially funded by the Northwestern University (Chicago,
   IL, USA) through ACTG U01AI069471, the University of Sciences,
   Techniques and Technologies of Bamako (USTTB) through NIH/R01 grant
   R01AI110386, the European & Developing Countries Clinical Trials
   Partnership (EDCTP) through the West African Node of Excellence for TB,
   AIDS and Malaria (WANETAM) Grants numbers CG_cb_07_41700 and MSI
   2010_10800-01/08/2011-31/07/14 and the European Research
   Council-INTERRUPTB through grant nr.311725 (to B.d.J.). B.D. was
   supported by a TDR fellowship, TIMS ID B40072, the special programme for
   research and training in tropical diseases, co-sponsored by UNICEF,
   UNDP, World Bank and WHO.
CR Affolabi D, 2007, INT J TUBERC LUNG D, V11, P1221
   Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100
   CDC, 2007, TB DRUG SUSC TEST EX
   Institut National de la Statistique-INSTAT BC-dR-B, 2009, 4 REC GEN POP HAB MA
   Kaiser Family Foundation, 2013, AD HIV PREV RAT 2013
   Kamal SMM, 2015, INT J TUBERC LUNG D, V19, P151, DOI 10.5588/ijtld.14.0200
   Kendall EA, 2015, BURDEN TRANSMITTED M, V3, P963
   Cellule de Planification et de Statistique (CPS) du Ministere de la Sante, 2014, ENQ DEM SANT MAL EDS
   Ministere de la sante DNdls, 2010, RAPP ACT PROGR NAT L
   Ministere de la sante et de l'Hygiene Publique, 2014, DIR NAT SANT RAPP AC
   Van Rie A, 2000, LANCET, V356, P22, DOI 10.1016/S0140-6736(00)02429-6
   World Health Organization, 2015, GLOB TUB REP
   World Health Organization, 2008, N04 WHO
NR 13
TC 0
Z9 0
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 28
PY 2016
VL 16
AR 714
DI 10.1186/s12879-016-2060-7
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA ED7WR
UT WOS:000389083000001
PM 27894266
OA gold
DA 2017-08-15
ER

PT J
AU Chaguza, C
   Cornick, JE
   Harris, SR
   Andam, CP
   Bricio-Moreno, L
   Yang, M
   Yalcin, F
   Ousmane, S
   Govindpersad, S
   Senghore, M
   Ebruke, C
   Du Plessis, M
   Kiran, AM
   Pluschke, G
   Sigauque, B
   McGee, L
   Klugman, KP
   Turner, P
   Corander, J
   Parkhill, J
   Collard, JM
   Antonio, M
   von Gottberg, A
   Heyderman, RS
   French, N
   Kadioglu, A
   Hanage, WP
   Everett, DB
   Bentley, SD
AF Chaguza, Chrispin
   Cornick, Jennifer E.
   Harris, Simon R.
   Andam, Cheryl P.
   Bricio-Moreno, Laura
   Yang, Marie
   Yalcin, Feyruz
   Ousmane, Sani
   Govindpersad, Shanil
   Senghore, Madikay
   Ebruke, Chinelo
   Du Plessis, Mignon
   Kiran, Anmol M.
   Pluschke, Gerd
   Sigauque, Betuel
   McGee, Lesley
   Klugman, Keith P.
   Turner, Paul
   Corander, Jukka
   Parkhill, Julian
   Collard, Jean-Marc
   Antonio, Martin
   von Gottberg, Anne
   Heyderman, Robert S.
   French, Neil
   Kadioglu, Aras
   Hanage, William P.
   Everett, Dean B.
   Bentley, Stephen D.
CA PAGe Consortium
TI Understanding pneumococcal serotype 1 biology through population genomic
   analysis
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Pneumococcal serotype 1; ST217; Phylogeography; Evolution; Antibiotic
   resistance
ID STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROLOGICAL
   CHARACTERIZATION; VIRULENCE FACTORS; INVASIVE-DISEASE; DNA-SEQUENCES;
   RECOMBINATION; GENERATION; MENINGITIS; DISCOVERY
AB Background: Pneumococcus kills over one million children annually and over 90 % of these deaths occur in low-income countries especially in Sub-Saharan Africa (SSA) where HIV exacerbates the disease burden. In SSA, serotype 1 pneumococci particularly the endemic ST217 clone, causes majority of the pneumococcal disease burden. To understand the evolution of the virulent ST217 clone, we analysed ST217 whole genomes from isolates sampled from African and Asian countries.
   Methods: We analysed 226 whole genome sequences from the ST217 lineage sampled from 9 African and 4 Asian countries. We constructed a whole genome alignment and used it for phylogenetic and coalescent analyses. We also screened the genomes to determine presence of antibiotic resistance conferring genes.
   Results: Population structure analysis grouped the ST217 isolates into five sequence clusters (SCs), which were highly associated with different geographical regions and showed limited intracontinental and intercontinental spread. The SCs showed lower than expected genomic sequence, which suggested strong purifying selection and small population sizes caused by bottlenecks. Recombination rates varied between the SCs but were lower than in other successful clones such as PMEN1. African isolates showed higher prevalence of antibiotic resistance genes than Asian isolates. Interestingly, certain West African isolates harbored a defective chloramphenicol and tetracycline resistance-conferring element (Tn5253) with a deletion in the loci encoding the chloramphenicol resistance gene (cat(pC194)), which caused lower chloramphenicol than tetracycline resistance. Furthermore, certain genes that promote colonisation were absent in the isolates, which may contribute to serotype 1's rarity in carriage and consequently its lower recombination rates.
   Conclusions: The high phylogeographic diversity of the ST217 clone shows that this clone has been in circulation globally for a long time, which allowed its diversification and adaptation in different geographical regions. Such geographic adaptation reflects local variations in selection pressures in different locales. Further studies will be required to fully understand the biological mechanisms which makes the ST217 clone highly invasive but unable to successfully colonise the human nasopharynx for long durations which results in lower recombination rates.
C1 [Chaguza, Chrispin; Cornick, Jennifer E.; Andam, Cheryl P.; Bricio-Moreno, Laura; Yang, Marie; Kiran, Anmol M.; French, Neil; Kadioglu, Aras; Everett, Dean B.; Bentley, Stephen D.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 7BE, Merseyside, England.
   [Chaguza, Chrispin; Cornick, Jennifer E.; Kiran, Anmol M.; Heyderman, Robert S.; French, Neil; Everett, Dean B.] Queen Elizabeth Cent Hosp, Malawi Liverpool Wellcome Trust Clin Res Programe, Blantyre, Malawi.
   [Harris, Simon R.; Yalcin, Feyruz; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Pathogen Genom, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.
   [Andam, Cheryl P.; Hanage, William P.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA.
   [Ousmane, Sani; Collard, Jean-Marc] CERMES, Unite Biol, Niamey, Niger.
   [Govindpersad, Shanil; von Gottberg, Anne] NICD, Johannesburg, South Africa.
   [Ebruke, Chinelo; Antonio, Martin] MRC, Bacterial Dis Programme, Banjul, Gambia.
   [Senghore, Madikay; Antonio, Martin] Univ Warwick, Warwick Med Sch, Div Translat & Syst Med, Coventry CV4 7AL, W Midlands, England.
   [Ebruke, Chinelo; Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.
   [Pluschke, Gerd] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Sigauque, Betuel] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [McGee, Lesley] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30329 USA.
   [Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   [Klugman, Keith P.] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.
   [Turner, Paul] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia.
   [Turner, Paul] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford OX3 7FZ, England.
   [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland.
   [von Gottberg, Anne] Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa.
   [Heyderman, Robert S.] UCL, Div Infect & Immun, London WC1E 6BT, England.
RP Chaguza, C; Bentley, SD (reprint author), Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 7BE, Merseyside, England.; Chaguza, C (reprint author), Queen Elizabeth Cent Hosp, Malawi Liverpool Wellcome Trust Clin Res Programe, Blantyre, Malawi.; Bentley, SD (reprint author), Wellcome Trust Sanger Inst, Pathogen Genom, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.
EM Chrispin.Chaguza@liverpool.ac.uk; sdb@sanger.ac.uk
OI du Plessis, Mignon/0000-0001-9186-0679; Pluschke,
   Gerd/0000-0003-1957-2925; Chaguza, Chrispin/0000-0002-2108-1757
FU Bill and Melinda Gates Foundation (BMGF) [OPP1023440]; Wellcome Trust
   Major Overseas programme core award [084679/Z/08/Z]; Commonwealth
   Scholarship Commission, UK
FX This work was supported by funds from the Bill and Melinda Gates
   Foundation (BMGF) (grant number: OPP1023440 awarded to DBE
   [http://www.pagegenomes.org/page/consortium]) and The Wellcome Trust
   Major Overseas programme core award (Award number: 084679/Z/08/Z). CC
   acknowledges support in form of a PhD scholarship from the Commonwealth
   Scholarship Commission, UK.
CR Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198
   AYOUBI P, 1991, J BACTERIOL, V173, P1617
   Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103
   Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17
   Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031
   Blumental S, 2015, CLIN VACCINE IMMUNOL, V22, P404, DOI 10.1128/CVI.00758-14
   Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683
   Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003
   Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624
   Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451
   Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123
   Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553
   Chaguza C, 2016, MBIO, V7, DOI 10.1128/mBio.01053-16
   Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008
   Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028
   Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895
   Chiavolini D, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-14
   Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163
   Corander J, 2003, GENETICS, V163, P367
   Cornick JE, 2015, MICROBIAL GENOMICS, V1, P1, DOI DOI 10.1099/MGEN.0.000027
   Croucher NJ, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-49
   Croucher NJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003868
   Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   Croucher NJ, 2015, DRYAD DATA REPOSITOR
   Croucher NJ, 2014, NUCLEIC ACIDS RES, V43, pe15, DOI DOI 10.1093/NAR/GKU1196
   de Silva E, 2012, J R SOC INTERFACE, V9, P1797, DOI 10.1098/rsif.2011.0850
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   du Plessis M, 2016, J CLIN MICROBIOL, V54, P1326, DOI 10.1128/JCM.00055-16
   Enright MC, 1998, MICROBIOL-UK, V144, P3049
   Everett DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044250
   Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765
   Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4
   Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026
   Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360
   Jefferies JMC, 2011, HUM VACCINES, V7, P1012, DOI 10.4161/hv.7.10.16794
   Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118
   Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348
   Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871
   Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151
   Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Ndlangisa KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107666
   Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152
   Page AJ, 2016, MICROBI GENOMICS, V2
   Page AJ, 2016, MICROBIAL GENOMICS, V2
   Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421
   Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006
   Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06
   Park IH, 2015, CLIN VACCINE IMMUNOL, V22, P313, DOI 10.1128/CVI.00647-14
   Rambaut A., 2014, TRACER V1 6
   Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x
   Ritchie ND, 2012, FUTURE MICROBIOL, V7, P33, DOI [10.2217/fmb.11.146, 10.2217/FMB.11.146]
   Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044
   Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   von Claire M, 2016, EMERG INFECT DIS J, V22, P261
   Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476
   Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 77
TC 0
Z9 0
U1 1
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 8
PY 2016
VL 16
AR 649
DI 10.1186/s12879-016-1987-z
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA EB1AT
UT WOS:000387079200001
PM 27821148
OA gold
DA 2017-08-15
ER

PT J
AU Germeraad, EA
   Hogerwerf, L
   Faye-Joof, T
   Goossens, B
   van der Hoek, W
   Jeng, M
   Lamin, M
   Manneh, IL
   Nwakanma, D
   Roest, HIJ
   Secka, A
   Stegeman, A
   Wegmuller, R
   van der Sande, MAB
   Secka, O
AF Germeraad, Eveline A.
   Hogerwerf, Lenny
   Faye-Joof, Tisbeh
   Goossens, Bart
   van der Hoek, Wim
   Jeng, Momodou
   Lamin, Modou
   Manneh, Ismaila L.
   Nwakanma, Davis
   Roest, Hendrik I. J.
   Secka, Arss
   Stegeman, Arjan
   Wegmuller, Rita
   van der Sande, Marianne A. B.
   Secka, Ousman
TI Low Seroprevalence of Brucellosis in Humans and Small Ruminants in the
   Gambia
SO PLOS ONE
LA English
DT Article
ID SUB-SAHARAN AFRICA; FEBRILE ILLNESS; EPIDEMIOLOGY; DIAGNOSIS
AB Background
   Brucellosis is a worldwide zoonosis with significant impact on rural livelihoods and a potentially underestimated contributor to febrile illnesses. The aim of this study was to estimate the seroprevalence of brucellosis in humans and small ruminants in The Gambia.
   Methods
   The study was carried out in rural and urban areas. In 12 rural villages in Kiang West district, sera were collected from humans (n = 599) and small ruminants (n = 623) from the same compounds. From lactating small ruminants, milk samples and vaginal swabs were obtained. At the urban study sites, sera were collected from small ruminants (n = 500) from slaughterhouses and livestock markets. Information on possible risk factors for seropositivity was collected through questionnaires. Sera were screened for antibodies against Brucella spp. with the Rose Bengal Test, ELISA and Micro Agglutination Test (human sera only). PCR was performed on 10 percent of the milk samples and vaginal swabs from small ruminants.
   Results
   One human and 14 sheep sera were positive by the Rose Bengal Test. The rest were negative in all serological tests used. The PCR results were all negative.
   Conclusions
   The results suggest that brucellosis is currently not a generalized problem in humans or small ruminants in The Gambia.
C1 [Germeraad, Eveline A.; Hogerwerf, Lenny; van der Hoek, Wim; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [Faye-Joof, Tisbeh; Manneh, Ismaila L.] Med Res Council Unit Gambia, Dept Vaccinol, Banjul, Fajara, Gambia.
   [Goossens, Bart] Kombo Vet Serv, Bakau, Gambia.
   [Jeng, Momodou; Secka, Arss] Int Trypanotolerance Ctr, Banjul, Gambia.
   [Lamin, Modou; Nwakanma, Davis; Secka, Ousman] MRC Unit, Dept Dis Control & Eliminat, Banjul, Fajara, Gambia.
   [Roest, Hendrik I. J.] Cent Vet Inst, Dept Bacteriol & Epidemiol, Lelystad, Netherlands.
   [Stegeman, Arjan] Univ Utrecht, Dept Farm Anim Hlth, Utrecht, Netherlands.
   [Wegmuller, Rita] MRC, Int Nutr Grp, MRC Unit Gambia, Keneba, Gambia.
   [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
RP Hogerwerf, L (reprint author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.
EM lenny.hogerwerf@rivm.nl
OI Hogerwerf, Lenny/0000-0001-6329-7831
FU Ministry of Health, Welfare and Sports, the Netherlands; Ministry of
   Economic Affairs, the Netherlands [W0T-01-002-006.01]
FX This work was supported by Ministry of Health, Welfare and Sports, the
   Netherlands and by the Ministry of Economic Affairs, the Netherlands
   (www.government.nl/ministries) via the project 'Brucellosis', grant
   number W0T-01-002-006.01. The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allan KJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003899
   Banfi GB, 2002, USE ANTICOAGULANTS D
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
   Crump JA, 2012, CLIN INFECT DIS, V54, P1107, DOI 10.1093/cid/cis024
   Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501
   de Blas I, 2006, WORKING EPIDEMIOLOGY
   Ducrotoy MJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003008
   Fosgate GT, 2002, EMERG INFECT DIS, V8, P672
   Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301
   Godfroid J, 2010, CROAT MED J, V51, P296, DOI 10.3325/cmj.2010.51.296
   Goossens B, 1998, VET REC, V142, P277
   Klaasen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085424
   Maio E, 2014, VET MICROBIOL, V173, P118, DOI 10.1016/j.vetmic.2014.07.010
   McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3
   Medical Research Council D International Nutrition Group, KIANG W DEM SURV SYS
   World Organisation for Animal Health (OIE), 2002, MANUAL DIAGNOSTIC TE, P616
   Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6
   Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570
   Regional Project on Sustainable Management of Endemic Ruminant Livestock in West Africa (PROGEBE), 2013, ANN REPORT
   [Anonymous], 2014, R LANG ENV STAT COMP
   Sanogo M, 2013, VET J, V195, P114, DOI 10.1016/j.tvjl.2012.06.007
   Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021
   Goumou A., 2003, RISK ASS BOVINE BRUC
   Vanderburg S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002787
   Vialle-Valentin Catherine E, 2015, J Pharm Policy Pract, V8, P1, DOI 10.1186/s40545-014-0024-0
   World Health Organization, 2007, ASS TUB PREV POP BAS
NR 28
TC 0
Z9 0
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2016
VL 11
IS 11
AR e0166035
DI 10.1371/journal.pone.0166035
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB8BE
UT WOS:000387615200055
PM 27824952
OA gold
DA 2017-08-15
ER

PT J
AU Gehre, F
   Otu, J
   Kendall, L
   Forson, A
   Kwara, A
   Kudzawu, S
   Kehinde, AO
   Adebiyi, O
   Salako, K
   Baldeh, I
   Jallow, A
   Jallow, M
   Dagnra, A
   Disse, K
   Kadanga, EA
   Idigbe, EO
   Onubogu, C
   Onyejepu, N
   Gaye-Diallo, A
   Ba-Diallo, A
   Rabna, P
   Mane, M
   Sanogo, M
   Diarra, B
   Dezemon, Z
   Sanou, A
   Senghore, M
   Kwambana-Adams, BA
   Demba, E
   Faal-Jawara, T
   Kumar, S
   Tientcheu, LD
   Jallow, A
   Ceesay, S
   Adetifa, I
   Jaye, A
   Pallen, MJ
   D'Alessandro, U
   Kampmann, B
   Adegbola, RA
   Mboup, S
   Corrah, T
   de Jong, BC
   Antonio, M
AF Gehre, Florian
   Otu, Jacob
   Kendall, Lindsay
   Forson, Audrey
   Kwara, Awewura
   Kudzawu, Samuel
   Kehinde, Aderemi O.
   Adebiyi, Oludele
   Salako, Kayode
   Baldeh, Ignatius
   Jallow, Aisha
   Jallow, Mamadou
   Dagnra, Anoumou
   Disse, Kodjo
   Kadanga, Essosimna A.
   Idigbe, Emmanuel Oni
   Onubogu, Catherine
   Onyejepu, Nneka
   Gaye-Diallo, Aissatou
   Ba-Diallo, Awa
   Rabna, Paulo
   Mane, Morto
   Sanogo, Moumine
   Diarra, Bassirou
   Dezemon, Zingue
   Sanou, Adama
   Senghore, Madikay
   Kwambana-Adams, Brenda A.
   Demba, Edward
   Faal-Jawara, Tutty
   Kumar, Samrat
   Tientcheu, Leopold D.
   Jallow, Adama
   Ceesay, Samba
   Adetifa, Ifedayo
   Jaye, Assan
   Pallen, Mark J.
   D'Alessandro, Umberto
   Kampmann, Beate
   Adegbola, Richard A.
   Mboup, Souleymane
   Corrah, Tumani
   de Jong, Bouke C.
   Antonio, Martin
TI The emerging threat of pre-extensively drug-resistant tuberculosis in
   West Africa: preparing for large-scale tuberculosis research and drug
   resistance surveillance
SO BMC MEDICINE
LA English
DT Article
DE Tuberculosis; Extensively drug-resistant tuberculosis; West Africa;
   Drug-resistance surveillance; Capacity building
ID MYCOBACTERIUM-TUBERCULOSIS; NIGERIA; PREVALENCE; TB
AB Background: Drug-resistant tuberculosis (TB) is a global public health problem. Adequate management requires baseline drug-resistance prevalence data. In West Africa, due to a poor laboratory infrastructure and inadequate capacity, such data are scarce. Therefore, the true extent of drug-resistant TB was hitherto undetermined. In 2008, a new research network, the West African Network of Excellence for Tuberculosis, AIDS and Malaria (WANETAM), was founded, comprising nine study sites from eight West African countries (Burkina Faso, The Gambia, Ghana, Guinea-Bissau, Mali, Nigeria, Senegal and Togo). The goal was to establish Good Clinical Laboratory Practice (GCLP) principles and build capacity in standardised smear microscopy and mycobacterial culture across partnering laboratories to generate the first comprehensive West African drug-resistance data.
   Methods: Following GCLP and laboratory training sessions, TB isolates were collected at sentinel referral sites between 2009-2013 and tested for first-and second-line drug resistance.
   Results: From the analysis of 974 isolates, an unexpectedly high prevalence of multi-drug-resistant (MDR) strains was found in new (6 %) and retreatment patients (35 %) across all sentinel sites, with the highest prevalence amongst retreatment patients in Bamako, Mali (59 %) and the two Nigerian sites in Ibadan and Lagos (39 % and 66 %). In Lagos, MDR is already spreading actively amongst 32 % of new patients. Pre-extensively drug-resistant (pre-XDR) isolates are present in all sites, with Ghana showing the highest proportion (35 % of MDR). In Ghana and Togo, pre-XDR isolates are circulating amongst new patients.
   Conclusions: West African drug-resistance prevalence poses a previously underestimated, yet serious public health threat, and our estimates obtained differ significantly from previous World Health Organisation (WHO) estimates. Therefore, our data are reshaping current concepts and are essential in informing WHO and public health strategists to implement urgently needed surveillance and control interventions in West Africa.
C1 [Gehre, Florian; Otu, Jacob; Kendall, Lindsay; Senghore, Madikay; Kwambana-Adams, Brenda A.; Demba, Edward; Faal-Jawara, Tutty; Tientcheu, Leopold D.; Jaye, Assan; Kampmann, Beate; Corrah, Tumani; Antonio, Martin] Med Res Council Unit Gambia, Vaccines & Immun Theme, Banjul, Gambia.
   [Forson, Audrey] Univ Ghana, Sch Med, Accra, Ghana.
   [Forson, Audrey; Kudzawu, Samuel] Korle Bu Teaching Hosp, Accra, Ghana.
   [Kwara, Awewura] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
   [Kwara, Awewura] Miriam Hosp, Providence, RI 02906 USA.
   [Kehinde, Aderemi O.] Univ Ibadan, Coll Med, Ibadan, Nigeria.
   [Kehinde, Aderemi O.; Adebiyi, Oludele; Salako, Kayode] Univ Coll Hosp, Ibadan 23402, Oyo, Nigeria.
   [Baldeh, Ignatius; Jallow, Aisha; Jallow, Mamadou] Natl Publ Hlth Lab Serv, Banjul, Gambia.
   [Dagnra, Anoumou; Disse, Kodjo; Kadanga, Essosimna A.] Lab Natl Reference Mycobacteria, Lome, Togo.
   [Idigbe, Emmanuel Oni; Onubogu, Catherine; Onyejepu, Nneka] Nigerian Inst Med Res, Lagos, Nigeria.
   [Gaye-Diallo, Aissatou; Ba-Diallo, Awa] Lab Bacteriol Virol Aristide Le Dantec Senegal, Dakar, Senegal.
   [Rabna, Paulo; Mane, Morto] Natl Inst Publ Hlth, Bissau, Guinea Bissau.
   [Sanogo, Moumine; Diarra, Bassirou] Univ Sci Techn & Technol Bamako, SEREFO Program, Bamako, Mali.
   [Dezemon, Zingue; Sanou, Adama] Ctr Muraz & Natl TB Program, Ouagadougou, Burkina Faso.
   [Senghore, Madikay; Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.
   [Kwambana-Adams, Brenda A.; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Adetifa, Ifedayo; Antonio, Martin] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Adetifa, Ifedayo; D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Serrekunda, Gambia.
   [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [Kampmann, Beate] Imperial Coll London, Dept Pediat, London, England.
   [Adegbola, Richard A.] GSK Vaccines, Wavre, Belgium.
   [Tientcheu, Leopold D.] Univ Yaounde I, Fac Sci, Dept Biochem, Yaounde, Cameroon.
   [Jallow, Adama] Natl TB Leprosy Control Program, Banjul, Gambia.
   [Ceesay, Samba] Minist Hlth & Social Welf, Hlth Serv, Banjul, Gambia.
RP Antonio, M (reprint author), Med Res Council Unit Gambia, Vaccines & Immun Theme, Banjul, Gambia.; Antonio, M (reprint author), Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England.; Antonio, M (reprint author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
EM mantonio@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709; Antonio, Martin/0000-0002-4810-1308
FU European & Developing Countries Clinical Trials Partnership (EDCTP)
   Grant [CB. 2007. 41700.007]
FX WANETAM and the study are supported by the European & Developing
   Countries Clinical Trials Partnership (EDCTP) Grant No. CB. 2007.
   41700.007
CR Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390
   Ani AE, 2009, T ROY SOC TROP MED H, V103, P67, DOI 10.1016/j.trstmh.2008.08.004
   Ardito F, 2001, J CLIN MICROBIOL, V39, P4440, DOI 10.1128/JCM.39.12.4440-4444.2001
   Daniel O, 2011, ASIAN PAC J TROP MED, V4, P148, DOI 10.1016/S1995-7645(11)60057-6
   International Air Transport Association, 2013, INF SUBST SHIPP GUID
   Kehinde A O, 2013, Niger J Physiol Sci, V28, P187
   Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535
   Lawson L, 2011, TROP MED INT HEALTH, V16, P974, DOI 10.1111/j.1365-3156.2011.02792.x
   Miiro GM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-258
   Otu A, 2014, CLIN RESPIR J, V8, P234, DOI 10.1111/crj.12065
   Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075
   Roca A, 2015, J ALLERGY CLIN IMMUN, V135, P856, DOI 10.1016/j.jaci.2015.02.015
   Saleri N, 2010, EMERG INFECT DIS, V16, P840, DOI 10.3201/eid1605.091262
   Sangare L, 2010, INT J TUBERC LUNG D, V14, P1424
   Sangare L, 2010, Ann Afr Med, V9, P15, DOI 10.4103/1596-3519.62619
   Sebastian V., 2014, 45 UN WORLD C LUNG H, P57
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC
   WHO, 2014, WHO REPORT
   Organization WH, 2014, MULT RES TUB MDR TB
   World Health Organization, 2008, POL GUID DRUG SUSC T
NR 20
TC 2
Z9 2
U1 2
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD NOV 3
PY 2016
VL 14
AR 160
DI 10.1186/s12916-016-0704-5
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA EA9PC
UT WOS:000386975200001
PM 27806714
OA gold
DA 2017-08-15
ER

PT J
AU Dieye, B
   Affara, M
   Sangare, L
   Joof, F
   Ndiaye, YD
   Gomis, JF
   Ndiaye, M
   Mbaye, A
   Diakite, M
   Sy, N
   Mbengue, B
   Deme, AB
   Daniels, R
   Ahouidi, AD
   Dieye, T
   Abdullahi, A
   Doumbia, S
   Ndiaye, JL
   Diarra, A
   Ismaela, A
   Coulibaly, M
   Welty, C
   Ngwa, AA
   Shaffer, J
   D'Alessandro, U
   Volkman, SK
   Wirth, DF
   Krogstad, DJ
   Koita, O
   Nwakanma, D
   Ndiayel, D
AF Dieye, Baba
   Affara, Muna
   Sangare, Lassana
   Joof, Fatou
   Ndiaye, Yaye D.
   Gomis, Jules F.
   Ndiaye, Mouhamadou
   Mbaye, Aminata
   Diakite, Mouhamadou
   Sy, Ngayo
   Mbengue, Babacar
   Deme, Awa B.
   Daniels, Rachel
   Ahouidi, Ambroise D.
   Dieye, Tandakha
   Abdullahi, Ahmad
   Doumbia, Seydou
   Ndiaye, Jean L.
   Diarra, Ayouba
   Ismaela, Abubakar
   Coulibaly, Mamadou
   Welty, Clint
   Ngwa, Alfred Amambua
   Shaffer, Jeftley
   D'Alessandro, Umberto
   Volkman, Sarah K.
   Wirth, Dyann F.
   Krogstad, Donald J.
   Koita, Ousmane
   Nwakanma, Davis
   Ndiayel, Daouda
TI West Africa International Centers of Excellence for Malaria Research:
   Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali,
   and The Gambia
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; DIHYDROARTEMISININ-PIPERAQUINE;
   CHLOROQUINE SUSCEPTIBILITY; ARTEMISININ RESISTANCE; INCREASED
   SENSITIVITY; COMBINATION THERAPY; UGANDAN CHILDREN; RANDOMIZED-TRIAL;
   PFMDR1 GENE; TRANSMISSION
AB In 2006, artemether lumefantrine (AL) became the first-line treatment of uncomplicated malaria in Senegal, Mali, and the Gambia. To monitor its efficacy, between August 2011 and November 2014, children with uncomplicated Plasmodium falciparum malaria were treated with AL and followed up for 42 days. A total of 463 subjects were enrolled in three sites (246 in Senegal, 97 in Mali, and 120 in Gambia). No early treatment failure was observed and malaria infection cleared in all patients by day 3. Polymerase chain reaction (PCR)-adjusted adequate clinical and parasitological response (ACPR) was 100% in Mali, and the Gambia, and 98.8% in Senegal. However, without PCR adjustment, ACPR was 89.4% overall; 91.5% in Mali, 98.8% in Senegal, and 64.3% in the Gambia (the lower value in the Gambia attributed to poor compliance of the full antimalarial course). However, pfmdrl mutations were prevalent in Senegal and a decrease in parasite sensitivity to artesunate and lumefantrine (as measured by ex vivo drug assay) was observed at all sites. Recrudescent parasites did not show Kelch 13 (K13) mutations and AL remains highly efficacious in these west African sites.
C1 [Dieye, Baba; Ndiaye, Yaye D.; Gomis, Jules F.; Ndiaye, Mouhamadou; Mbaye, Aminata; Sy, Ngayo; Mbengue, Babacar; Deme, Awa B.; Ahouidi, Ambroise D.; Dieye, Tandakha; Ndiaye, Jean L.; Ndiayel, Daouda] Cheikh Anta Diop Univ, Dakar, Fann, Senegal.
   [Welty, Clint; Shaffer, Jeftley; Krogstad, Donald J.] Tulane Univ, New Orleans, LA 70118 USA.
   [Sangare, Lassana; Diakite, Mouhamadou; Doumbia, Seydou; Diarra, Ayouba; Coulibaly, Mamadou; Koita, Ousmane] Univ Bamako, BP 1805, Bamako, Mali.
   [Affara, Muna; Joof, Fatou; Abdullahi, Ahmad; Ismaela, Abubakar; Ngwa, Alfred Amambua; D'Alessandro, Umberto; Nwakanma, Davis] MRC, Serekunda, Gambia.
   [Daniels, Rachel; Volkman, Sarah K.; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Volkman, Sarah K.; Wirth, Dyann F.] Broad Inst MIT & Harvard, Cambridge, MA USA.
   [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   MRC Unit, Atlantic Blvd, Banjul, Gambia.
RP Ndiayel, D (reprint author), Ave Cheikh Anta Diop Univ,POB 5005, Dakar, Senegal.
EM dieyebaba2004@yahoo.fr; maffara@mrc.gm; lansana.sangare@gmail.com;
   fajoof@mrc.gm; ydndiaye@gmail.com; jules.gomis@gmail.com;
   mouhamadou.ndiaye@ucad.edu.sn; natou5002@yahoo.fr;
   mdiakite@icermali.org; ngayosy50@hotmail.com; b.mbengue@yahoo.fr;
   deme.awa@gmail.com; rdaniels@broadinstitute.org; aahouidi@gmail.com;
   tandakha.dieye@ucad.edu.sn; angwa@mrc.gm; sdoumbi@gmail.com;
   jeanloab.ndiaye@ucad.edu.sn; adiarra@icemrwaf.org; udalessandro@mrc.gm;
   doudou@icermali.org; cwelty@icemrwaf.org; dnwakanma@mrc.gm;
   jshaffer@tulane.edu; svolkman@hsph.harvard.edu;
   dfwirth@hsph.harvard.edu; donkrogstad@gmail.com; okoita@icermali.org;
   dndiaye@hsph.harvard.edu
FU NIH/ICEMR, International Centre of Excellence for Malaria Research, west
   Africa [U19AI089696]
FX The work was supported by the NIH/ICEMR, International Centre of
   Excellence for Malaria Research, west Africa (U19AI089696).
CR Adjuik M, 2004, LANCET, V363, P9
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI 10.1111/j.1365-3165.2006.01784.x
   Bogh C, 2007, AM J TROP MED HYG, V76, P875
   Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051
   Daniels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060780
   Daniels R, 2012, ANTIMICROB AGENTS CH, V56, P2976, DOI 10.1128/AAC.05737-11
   Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Dorkenoo MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-338
   Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210
   Dunyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017371
   Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x
   Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2
   Faye B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-80
   Getnet G, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0775-3
   Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010
   Ly O, 2012, PARASITOL RES, V111, P1541, DOI 10.1007/s00436-012-2994-7
   Mens PF, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-237
   Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09
   Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6
   Faye B, 2011, MALARIA J, V10, P237
   Ndiaye M, 2012, AM J TROP MED HYG, V87, P640, DOI 10.4269/ajtmh.2012.11-0709
   Niang M, 2008, J ANTIMICROB CHEMOTH, V62, P921, DOI 10.1093/jac/dkn299
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003
   Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615
   Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649
   Sibley CH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-48
   Sogoba N, 2007, ACTA TROP, V101, P232, DOI 10.1016/j.actatropica.2007.02.005
   Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789
   Thomas SM, 2002, AM J TROP MED HYG, V66, P474
   Toure OA, 2011, TROP MED INT HEALTH, V16, P290, DOI 10.1111/j.1365-3156.2010.02701.x
   TRAPE JF, 1992, AM J TROP MED HYG, V47, P181
   Tumwebaze P, 2015, ANTIMICROB AGENTS CH, V59, P3018, DOI 10.1128/AAC.05141-14
   Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212
   Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153
   White NJ, 2004, J CLIN INVEST, V113, P1084, DOI 10.1172/JCI200421682
   WHO, 2009, METH SURV ANT DRUG E
   World Health Organization, 2009, MAL MICR QUAL ASS MA
   WHO, 2005, WORLD MAL REP
   Wilson PE, 2005, TRENDS PARASITOL, V21, P278, DOI 10.1016/j.pt.2005.04.007
   Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985
NR 45
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1054
EP 1060
DI 10.4269/ajtmh.16-0053
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600020
PM 27549635
OA No
DA 2017-08-15
ER

PT J
AU Noho-Konteh, F
   Adetifa, JU
   Cox, M
   Hossin, S
   Reynolds, J
   Le, MT
   Sanyang, LC
   Drammeh, A
   Plebanski, M
   Forster, T
   Dickinson, P
   Ghazal, P
   Whittle, H
   Rowland-Jones, SL
   Sutherland, JS
   Flanagan, KL
AF Noho-Konteh, Fatou
   Adetifa, Jane U.
   Cox, Momodou
   Hossin, Safayet
   Reynolds, John
   My Thanh Le
   Sanyang, Lady Chilel
   Drammeh, Abdoulie
   Plebanski, Magdalena
   Forster, Thorsten
   Dickinson, Paul
   Ghazal, Peter
   Whittle, Hilton
   Rowland-Jones, Sarah L.
   Sutherland, Jayne S.
   Flanagan, Katie L.
TI Sex-Differential Non-Vaccine-Specific Immunological Effects of
   Diphtheria-Tetanus-Pertussis and Measles Vaccination
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE heterologous effects; transcriptome; cytokines; innate immunity; T cells
ID MORTALITY; IMMUNITY; AGE; IMMUNOMODULATION; RESPONSES; CHILDREN;
   SURVIVAL; TRIAL; BIRTH
AB Vaccines can have nontargeted heterologous effects that manifest as increased protection against nonvaccine infections, as described for measles vaccine (MV), or increased susceptibility to infections and death, as described following diphtheria-tetanus-whole cell pertussis (DTP) vaccination. The mechanisms are unknown, and high-quality immunological studies are lacking. This study was designed to investigate the heterologous effects of MV and DTP in 302 Gambian infants. The results support a sex-differential immunosuppressive effect of DTP on innate proinflammatory responses and T-cell immunity. Males but not females receiving MV had enhanced proinflammatory innate responses. The results point to modified signaling via Toll-like receptor 4 (TLR4) as a possible mechanism for the effects on innate immunity. When both vaccines were administered together, purified protein derivative responses were enhanced in females but downregulated in males. Collectively, these data indicate immunological effects that could account for heterologous effects of MV and DTP, to take forward into prospective trials.
C1 [Noho-Konteh, Fatou; Adetifa, Jane U.; Cox, Momodou; Hossin, Safayet; My Thanh Le; Sanyang, Lady Chilel; Drammeh, Abdoulie; Whittle, Hilton; Rowland-Jones, Sarah L.; Sutherland, Jayne S.; Flanagan, Katie L.] MRC Unit, Vaccines & Immun Theme, Infant Immunol Grp, Fajara, Gambia.
   [Reynolds, John] Monash Univ, Fac Med Nursing & Hlth Sci, Biostat Consulting Platform, Prahran, Vic, Australia.
   [Plebanski, Magdalena; Flanagan, Katie L.] Monash Univ, Dept Immunol & Pathol, Commercial Rd, Prahran, Vic 3004, Australia.
   [Plebanski, Magdalena] Monash Univ, Monash Inst Med Engn, Prahran, Vic, Australia.
   [Forster, Thorsten; Dickinson, Paul; Ghazal, Peter] Univ Edinburgh, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland.
   [Whittle, Hilton] London Sch Hyg & Trop Med, London, England.
   [Rowland-Jones, Sarah L.] Univ Oxford, Nuffield Dept Med, Oxford, England.
RP Flanagan, KL (reprint author), Monash Univ, Dept Immunol & Pathol, Commercial Rd, Prahran, Vic 3004, Australia.
EM katie.flanagan@ths.tas.gov
RI Reynolds, John/D-2591-2013; Forster, Thorsten/F-4483-2017
OI Reynolds, John/0000-0002-8825-8625; Forster,
   Thorsten/0000-0002-4483-3069; Sutherland, Jayne/0000-0002-7083-4997
FU UK Medical Research Council (MRC) [G0701291]; MRC [SCC1085]
FX This study was supported by the UK Medical Research Council (MRC)
   (strategic grant number G0701291); and as part of an MRC-funded 5-year
   program grant (2007-2011) to the MRC Unit, The Gambia (grant number
   SCC1085).
CR Aaby P, 2006, VACCINE, V24, P4701, DOI 10.1016/j.vaccine.2006.03.038
   AABY P, 1995, BRIT MED J, V311, P481
   Aaby P, 2016, PEDIAT INFECT DIS J
   Aaby P, 2012, BMJ OPEN, V2
   Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae
   Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961
   Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240
   Aaby P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6495
   Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004
   Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552
   Dooms H, 2013, J AUTOIMMUN, V45, P40, DOI 10.1016/j.jaut.2013.06.007
   Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112
   Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394
   Flanagan KL, 2013, CLIN INFECT DIS, V57, P283, DOI 10.1093/cid/cit209
   Flanagan KL, 2015, T ROY SOC TROP MED H, V109, P1, DOI 10.1093/trstmh/tru188
   Flanagan KL, 2011, VACCINE, V29, P2349, DOI 10.1016/j.vaccine.2011.01.071
   Flanagan KL, 2015, SEX GENDER DIFFERENC, P273
   Gil A, 2015, T ROY SOC TROP MED H, V109, P62, DOI 10.1093/trstmh/tru198
   Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354
   Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9
   Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662
   Pinheiro I, 2011, BIOESSAYS, V33, P791, DOI 10.1002/bies.201100047
   Shann F, 2015, T ROY SOC TROP MED H, V109, P5, DOI 10.1093/trstmh/tru161
   United Nations Children's Fund (UNICEF), 2015, AT A GLANC GAMB
   van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018
   WHITTLE HC, 1990, LANCET, V336, P1046, DOI 10.1016/0140-6736(90)92501-8
   World Health Organization, 2014, WKLY EPIDEMIOL REC, V89, P221
   Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257
NR 30
TC 2
Z9 2
U1 1
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2016
VL 63
IS 9
BP 1213
EP 1226
DI 10.1093/cid/ciw492
PG 14
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC2WY
UT WOS:000387986200018
PM 27436422
OA No
DA 2017-08-15
ER

PT J
AU Oyelakin, O
   Traore, M
   Mbye, EB
   Khonte, A
   Cisse, L
   Faye, AN
   Faye, O
   Mbaye, M
   Kital, K
   Gaye-Seye, MD
   Coly, A
   Tine, A
   Delattre, F
AF Oyelakin, Oladele
   Traore, Moumouny
   Mbye, El Hadji Babacar
   Khonte, Abdourahmane
   Cisse, Lamine
   Faye, Abdoulaye N.
   Faye, Ousman
   Mbaye, Moussa
   Kital, Khemesse
   Gaye-Seye, Mame Diabou
   Coly, Atanasse
   Tine, Alphonse
   Delattre, Francois
TI Spectrofluorometric Determination of Putrescine: Optimization of the
   Putrescine-Orthophthaldehyde Complex Using Spectrofluorometry
SO JOURNAL OF AOAC INTERNATIONAL
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; BIOGENIC-AMINES; DERIVATIZATION;
   WINES
AB In alkaline medium, the complex formed between putrescine and orthophthalaldehyde was studied using spectrofluorescence. The derivative is kinetically stable 24 h after complexation. The stoichiometry of the complex is 1:1 at maximum fluorescence intensity, also 24 h after complexation.
C1 [Oyelakin, Oladele; Traore, Moumouny; Mbye, El Hadji Babacar; Khonte, Abdourahmane; Cisse, Lamine; Faye, Abdoulaye N.; Faye, Ousman; Mbaye, Moussa; Kital, Khemesse; Gaye-Seye, Mame Diabou; Coly, Atanasse; Tine, Alphonse] Univ Cheikh Anta Diop, Fac Sci & Tech, Dept Chim, Lab Photochim & Anal, Dakar, Senegal.
   [Oyelakin, Oladele] Univ Gambia, Sch Arts & Sci, Div Phys & Nat Sci, Brikama Campus, Brikama, Gambia.
   [Delattre, Francois] Univ Littorale Cote Opale, Unite Chim Environm & Interact Vivant, BP 59140, Dunkerque, France.
RP Oyelakin, O (reprint author), Univ Cheikh Anta Diop, Fac Sci & Tech, Dept Chim, Lab Photochim & Anal, Dakar, Senegal.
EM ooyelakin@utg.edu.gm
FU Laboratoire de Photochimie et d'Analyse, Departement de Chimie, Faculte
   des Sciences et Techniques, Universite Cheikh Anta Diop, Dakar, Senegal;
   University of The Gambia, Brikama Campus, Brikama, The Gambia
FX This work was financed by funds and resources from the Laboratoire de
   Photochimie et d'Analyse, Departement de Chimie, Faculte des Sciences et
   Techniques, Universite Cheikh Anta Diop, Dakar, Senegal; with little
   contribution from University of The Gambia, Brikama Campus, Brikama, The
   Gambia.
CR Antila P., 1983, FORSCHUNGSBER, V35, P373
   BARTHOLOMEW BA, 1987, EPIDEMIOL INFECT, V99, P775
   BAUZA T, 1995, J CHROMATOGR A, V707, P373, DOI 10.1016/0021-9673(95)00318-H
   Busto O, 1997, J CHROMATOGR A, V757, P311, DOI 10.1016/S0021-9673(96)00693-0
   KIM IS, 1979, J FOOD SCI, V44, P922, DOI 10.1111/j.1365-2621.1979.tb08538.x
   Kuhn D.M., 1982, NUTR TOXICOLOGY, V1
   Lasekan OO, 2000, FOOD CHEM, V69, P267, DOI 10.1016/S0308-8146(99)00261-7
   Male KB, 2001, J CHROMATOGR A, V926, P309, DOI 10.1016/S0021-9673(01)01056-1
   Nairn LM, 2000, J CELL PHYSIOL, V182, P209, DOI 10.1002/(SICI)1097-4652(200002)182:2<209::AID-JCP9>3.0.CO;2-8
   Oyelakin O, 2016, J AOAC INT, V99, P170, DOI 10.5740/jaoacint.15-0212
   Romero R, 2000, J CHROMATOGR A, V871, P75, DOI 10.1016/S0021-9673(99)00946-2
   TENBRINK B, 1990, INT J FOOD MICROBIOL, V11, P73, DOI 10.1016/0168-1605(90)90040-C
   Todd E C, 1992, Can Commun Dis Rep, V18, P17
NR 13
TC 0
Z9 0
U1 1
U2 1
PU AOAC INT
PI GAITHERSBURG
PA 481 N FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 USA
SN 1060-3271
EI 1944-7922
J9 J AOAC INT
JI J. AOAC Int.
PD NOV-DEC
PY 2016
VL 99
IS 6
BP 1642
EP 1644
DI 10.5740/jaoacint.16-0136
PG 3
WC Chemistry, Analytical; Food Science & Technology
SC Chemistry; Food Science & Technology
GA ED0SH
UT WOS:000388551700030
PM 27626942
OA No
DA 2017-08-15
ER

PT J
AU Ghosh, S
   Sow, A
   Guillot, C
   Jeng, A
   Ndow, G
   Njie, R
   Toure, S
   Diop, M
   Mboup, S
   Kane, CT
   Lemoine, M
   Thursz, M
   Zoulim, F
   Mendy, M
   Chemin, I
AF Ghosh, S.
   Sow, A.
   Guillot, C.
   Jeng, A.
   Ndow, G.
   Njie, R.
   Toure, S.
   Diop, M.
   Mboup, S.
   Kane, C. T.
   Lemoine, M.
   Thursz, M.
   Zoulim, F.
   Mendy, M.
   Chemin, I.
TI Implementation of an in-house quantitative real-time polymerase chain
   reaction method for Hepatitis B virus quantification in West African
   countries
SO JOURNAL OF VIRAL HEPATITIS
LA English
DT Article
DE HBV; real-time quantification; Syber Green; viral load; viral
   quantification
ID PCR ASSAY; DNA; LAMIVUDINE; GAMBIA
AB Hepatitis B virus (HBV) is a major cause of chronic liver disease worldwide. HBV infection is diagnosed by serological tests, while real-time polymerase chain reaction (qRT-PCR) assays are used to quantify viral load, which is a crucial parameter to determine viral replication and to monitor antiviral treatments. However, measuring viral load in resource-limited countries remains nonsystematic, due to the high cost of commercial kits. Here, we describe the development, validation and implementation of a low-cost, in-house qRT-PCR assay to monitor HBV viral load in chronic carriers enrolled in the PROLIFICA programme in the Gambia and Senegal. Over 1500 HBsAg-positive patients, including 210 chronically infected HBV patients, who were given antiviral treatment (tenofovir), were monitored by qRT-PCR using the SYBR Green- and HBV-specific primers. Twenty-four tenofovir-treated patients were followed up and their viral load was tested every 3months over the 12-month experimental time course. Compared to commercial assays, our in-house assay was shown to be (i) highly reliable, with good intra- and interassay reproducibility over a wide range (45-4.5x10(8) copies mL(-1)), (ii) very similar in the viral loads detected (R-2=.90), (iii) highly sensitive, as it detected loads as low as 30 copies mL(-1) (similar to 5 IU mL(-1)), (iv) cheaper (2- to 3-fold), (v) easier to implement and (vi) more rapid. Based on our experience, we recommend this assay as a reliable alternative to commercial assays, for monitoring HBV viraemia in resource-limited, highly endemic countries to reduce the cost and technical obstacles associated with commercial kits.
C1 [Ghosh, S.; Guillot, C.; Zoulim, F.; Chemin, I.] Univ Claude Bernard, Ctr Rech Cancerol Lyon, INSERM U1052, CNRS UMR5286, Lyon, France.
   [Sow, A.; Diop, M.; Mboup, S.; Kane, C. T.] Dantec, Dakar, Senegal.
   [Jeng, A.; Ndow, G.; Njie, R.; Toure, S.] MRC, Gambia Unit, Banjul, Gambia.
   [Ndow, G.; Lemoine, M.; Thursz, M.] Imperial Coll London, Dept Hepatol, London, England.
   [Njie, R.; Mendy, M.] IARC, Lab Serv & Biobank Grp DIR LSB, Lyon, France.
   [Zoulim, F.] Hosp Civils Lyon, Dept Hepatol, Lyon, France.
RP Chemin, I (reprint author), INSERM, U1052, 151 Cours Albert Thomas, Lyon, France.
EM Isabelle.chemin@inserm.fr
OI Ndow, Gibril/0000-0001-5837-5110; Guillot, Clement/0000-0001-6849-421X;
   Sow, Amina/0000-0001-6081-4506
FU European Commission
FX We thank all of the PROLIFICA participants, Debie Garside the project
   manager of PROLIFICA and the local ministry of health and social
   affairs. We are also grateful to our regretted colleague, Dr Harr Njai.
   We acknowledge the European Commission for funding the PROLIFICA project
   and the Gilead Company for supplying the tenofovir.
CR Abe A, 1999, J CLIN MICROBIOL, V37, P2899
   Casabianca A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111919
   Chan TM, 1998, GASTROENTEROLOGY, V115, P177, DOI 10.1016/S0016-5085(98)70380-4
   Chan TM, 2002, HEPATOLOGY, V36, P1246, DOI 10.1053/jhep.2002.36156
   Finelli L, 2012, MANUAL SURVEILLANCE
   Hanaki KI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098108
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081525
   Kania D, 2014, J VIROL METHODS, V201, P24, DOI 10.1016/j.jviromet.2014.01.015
   Kumar JS, 2014, MOL CELL PROBE, V28, P221, DOI 10.1016/j.mcp.2014.03.005
   Lemoine M, 2013, FUTURE VIROL, V8, P371, DOI 10.2217/FVL.13.11
   Liu Y, 2007, J CLIN MICROBIOL, V45, P553, DOI 10.1128/JCM.00709-06
   Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23
   Njai HF, 2015, J CLIN MICROBIOL, V53, P1156, DOI 10.1128/JCM.02980-14
   Oeb KERL, 2000, HEPATOLOGY, V32, DOI [10.1053/jhep.2000.9878., DOI 10.1053/JHEP.2000.9878]
   Olioso D, 2007, EUR J CLIN MICROBIOL, V26, P43, DOI 10.1007/s10096-006-0223-y
   Sitnik R, 2010, REV INST MED TROP SP, V52, P119, DOI [10.1590/50036-46652010000300001, 10.1590/S0036-46652010000300001]
   Thursz M, 2012, NAT REV GASTRO HEPAT, V9, P492, DOI 10.1038/nrgastro.2012.155
   Weinberger KM, 2000, J VIROL METHODS, V85, P75, DOI 10.1016/S0166-0934(99)00154-8
   WHO, 2009, WKLY EPIDEMIOL REC, V84, P405
   World Health Organization, 2015, GUID PREV CAR TREATM
   [Anonymous], 2015, WHO FACTSH N204 HEP
NR 22
TC 2
Z9 2
U1 1
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1352-0504
EI 1365-2893
J9 J VIRAL HEPATITIS
JI J. Viral Hepatitis
PD NOV
PY 2016
VL 23
IS 11
BP 897
EP 904
DI 10.1111/jvh.12561
PG 8
WC Gastroenterology & Hepatology; Infectious Diseases; Virology
SC Gastroenterology & Hepatology; Infectious Diseases; Virology
GA EB1OE
UT WOS:000387121500009
PM 27353593
OA No
DA 2017-08-15
ER

PT J
AU Manigart, O
   Okeakpu, J
   Odutola, A
   Jarju, S
   Foster-Nyarko, E
   Diallo, K
   Roca, A
   Kampmann, B
   D'Alessandro, U
   Sow, S
   Antonio, M
   Maiden, MJ
   Borrow, R
   Stuart, JM
   Trotter, CL
   Greenwood, BM
AF Manigart, Olivier
   Okeakpu, Jacinta
   Odutola, Aderonke
   Jarju, Sheikh
   Foster-Nyarko, Ebenezer
   Diallo, Kanny
   Roca, Anna
   Kampmann, Beate
   D'Alessandro, Umberto
   Sow, Samba
   Antonio, Martin
   Maiden, Martin J.
   Borrow, Ray
   Stuart, James M.
   Trotter, Caroline L.
   Greenwood, Brian M.
TI Alternative Molecular Methods for Improved Detection of Meningococcal
   Carriage and Measurement of Bacterial Density
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID DRIED BLOOD SPOTS; REAL-TIME PCR; ADOLESCENTS; TRANSPORT
AB Conventional methods for detecting pharyngeal carriage of Neisseria meningitidis are complex. There is a need for simpler methods with improved performance. We have investigated two alternative approaches. Three pharyngeal swabs were collected from 999 pupils aged 10 to 18 years in The Gambia. Carriage of N. meningitidis was investigated by using three different methods: (i) plating on Thayer-Martin selective medium and testing by conventional microbiological methods followed by PCR testing; (ii) seeding in Todd-Hewitt broth (THB) and, after culture overnight, testing by PCR; and (iii) compression of the swab on filter paper and, after DNA concentration, testing by PCR. PCR after culture in THB was more than twice as sensitive as conventional methods in detecting N. meningitidis (13.2% versus 5.7%; P < 0.0001). PCR after DNA extraction from filter paper had a sensitivity similar to that of conventional methods (4.9% versus 5.7%; P = 0.33). Capsular genogroups detected by broth culture were genogroups W(21 isolates), B (12 isolates), Y (8 isolates), E (3 isolates), and X (2 isolates), and 68 meningococci had the capsule-null intergenic region. The distributions of genogroups and of capsule-null organisms were similar with each of the three methods. The carriage density in samples extracted from filter paper ranged from 1 to 25,000 DNA copies. PCR of broth cultures grown overnight doubled the yield of N. meningitidis carriage isolates compared with conventional methods. This approach could improve the efficiency of carriage studies. Collection on filter paper followed by quantitative PCR could be useful for density measurement and for carriage studies in areas with limited resources.
C1 [Manigart, Olivier; D'Alessandro, Umberto; Stuart, James M.; Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Manigart, Olivier; Okeakpu, Jacinta; Odutola, Aderonke; Jarju, Sheikh; Foster-Nyarko, Ebenezer; Roca, Anna; Kampmann, Beate; D'Alessandro, Umberto; Antonio, Martin] MRC Unit, Fajara, Gambia.
   [Manigart, Olivier; Diallo, Kanny; Sow, Samba] Ctr Vaccine Dev, Bamako, Mali.
   [Diallo, Kanny; Maiden, Martin J.] Univ Oxford, Dept Zool, Oxford, England.
   [Roca, Anna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Kampmann, Beate] Imperial Coll, Dept Paediat, London, England.
   [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [Borrow, Ray] Publ Hlth England, Vaccine Evaluat Unit, Manchester, Lancs, England.
   [Trotter, Caroline L.] Univ Cambridge, Dept Vet Med, Cambridge, England.
RP Manigart, O (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.; Manigart, O (reprint author), MRC Unit, Fajara, Gambia.; Manigart, O (reprint author), Ctr Vaccine Dev, Bamako, Mali.
EM olivier.manigart@lshtm.ac.uk
FU Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)
   [51251]; Meningitis Research Foundation (MRF); Wellcome Trust
FX This work, including the efforts of Brian M. Greenwood, was funded by
   Wellcome Trust. This work, including the efforts of Brian M. Greenwood,
   was funded by Bill and Melinda Gates Foundation (Bill & Melinda Gates
   Foundation) (51251). This work, including the efforts of Olivier
   Manigart, was funded by Meningitis Research Foundation (MRF).
CR Ali O, 2015, J INFECT DIS, V212, P1298, DOI 10.1093/infdis/jiv211
   Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125
   AMIES CR, 1967, C J PUBLIC HEALTH, V58, P296
   Basta NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078336
   Cassol S, 1996, AIDS RES HUM RETROV, V12, P1435, DOI 10.1089/aid.1996.12.1435
   Christensen H, 2015, 33 ANN M EUR SOC PAE
   Esposito S, 2013, EUR J CLIN MICROBIOL, V32, P1129, DOI 10.1007/s10096-013-1856-2
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307
   Hwang J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-339
   Jeppesen CA, 2015, J INFECTION, V71, P43, DOI 10.1016/j.jinf.2015.02.006
   Jordens JZ, 2005, J MED MICROBIOL, V54, P463, DOI 10.1099/jmm.0.45847-0
   O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001
   Roberts J, 2009, J INFECTION, V58, P103, DOI 10.1016/j.jinf.2008.12.005
   Rodrigues F, 2015, PEDIATR INFECT DIS J, V34, P1267, DOI 10.1097/INF.0000000000000860
   Stephens DS, 1999, LANCET, V353, P941, DOI 10.1016/S0140-6736(98)00279-7
   Stuart R. D., 1946, GLASGOW MED JOUR, V27, P131
   Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11
NR 17
TC 2
Z9 2
U1 1
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2016
VL 54
IS 11
BP 2743
EP 2748
DI 10.1128/JCM.01428-16
PG 6
WC Microbiology
SC Microbiology
GA DZ8ID
UT WOS:000386113200018
PM 27582517
OA No
DA 2017-08-15
ER

PT J
AU Amambua-Ngwa, A
   Danso, B
   Worwui, A
   Ceesay, S
   Davies, N
   Jeffries, D
   D'Alessandro, U
   Conway, D
AF Amambua-Ngwa, Alfred
   Danso, Bakary
   Worwui, Archibald
   Ceesay, Sukai
   Davies, Nwakanma
   Jeffries, David
   D'Alessandro, Umberto
   Conway, David
TI Exceptionally long-range haplotypes in Plasmodium falciparum chromosome
   6 maintained in an endemic African population
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Microsatellites; Selective sweep; Haplotypes; Drug resistance
ID MALARIA PARASITE; SELECTIVE SWEEPS; POSITIVE SELECTION; DRUG-RESISTANCE;
   GENOME; DIVERSITY; SCANS; DNA; CHLOROQUINE; PROVIDE
AB Background: Previous genome-wide analyses of single nucleotide variation in Plasmodium falciparum identified evidence of an extended haplotype region on chromosome 6 in West Africa, suggesting recent positive selection. Such a pattern is not seen in samples from East Africa or South East Asia, so it could be marking a selective process specific to West Africa. Analyses of the haplotype structure in samples taken at different times could give clues to possible causes of selection.
   Methods: This study investigates chromosome 6 extended haplotypes in The Gambia by analysing alleles at multiple microsatellite loci using genome sequence data previously obtained from clinical isolates collected in 2008, followed by genotyping of 13 loci in 439 isolates from 1984, 1991, 2008 and 2014. Temporal changes in haplotype structure and frequencies were determined.
   Results: A region of high linkage disequilibrium spanning over 170 kilobases (kb) was identified with both NGS and laboratory determined microsatellite alleles. Multiple long haplotypes were found in all temporal populations from The Gambia. Two of the haplotypes were detected in samples from 1984 and 1991. The frequency of long-range haplotypes increased in 2008 and 2014 populations. There was higher Fst between older and more recent populations at loci in proximity to genes involved in drug metabolism pathways.
   Conclusions: The occurrence of several long haplotypes at intermediate frequencies suggests an unusual mode of selection in chromosome 6, possibly combined with recombination suppression on specific haplotypes. Such selection apparently occurred before the emergence of known anti-malarial drug resistance alleles, and could be due to effects of other drugs or unknown processes that have long been operating in this endemic region.
C1 [Amambua-Ngwa, Alfred; Danso, Bakary; Worwui, Archibald; Ceesay, Sukai; Davies, Nwakanma; Jeffries, David; D'Alessandro, Umberto] MRC, Gambia Unit, Atlantic Rd,POB 273, Banjul, Gambia.
   [D'Alessandro, Umberto; Conway, David] London Sch Hyg & Trop Med, Keppel St, London, England.
RP Amambua-Ngwa, A (reprint author), MRC, Gambia Unit, Atlantic Rd,POB 273, Banjul, Gambia.
EM angwa@mrc.gm
FU Career Development Award by Medical Research Council, UK under
   MRC/DFID/EDCTP scheme; MRC, UK
FX The work in this manuscript was principally funded from a Career
   Development Award by the Medical Research Council, UK, to Dr. Alfred
   Amambua Ngwa under the MRC/DFID/EDCTP scheme. Short Read sequences from
   Next Generation Sequencing were acquired in collaboration with the
   Centre for Global Health Genomics funded by MRC, UK.
CR Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992
   Amambua-Ngwa A, 2012, MOL BIOL EVOL, V29, P3249, DOI 10.1093/molbev/mss151
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Borrmann S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03318
   Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966
   Dieringer D, 2005, MOL ECOL, V14, P563, DOI 10.1111/j.1365-294X.2004.02422.x
   Dittrich S, 2008, MOL MICROBIOL, V67, P609, DOI 10.1111/j.1365-2958.2007.06073.x
   Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7
   FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R
   Highnam G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks981
   Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224
   Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387
   Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157
   Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174
   Mobegi VA, 2014, MOL BIOL EVOL, V31, P1490, DOI 10.1093/molbev/msu106
   Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924
   Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528
   Nwakanma DC, 2014, J INFECT DIS, V209, P1126, DOI 10.1093/infdis/jit618
   Ocholla H, 2014, J INFECT DIS, V210, P1991, DOI 10.1093/infdis/jiu349
   Pappa V, 2014, AM J TROP MED HYG
   Park DJ, 2012, P NATL ACAD SCI USA, V109, P13052, DOI 10.1073/pnas.1210585109
   Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140
   Samad H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005131
   Schlitzer M, 2007, CHEMMEDCHEM, V2, P944, DOI 10.1002/cmdc.200600240
   Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089
   Tae H, 2014, BIOINFORMATICS, V30, P652, DOI 10.1093/bioinformatics/btt595
   Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930
   Wendler JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096486
   Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813
   ZIDOVETZKI R, 1993, J PARASITOL, V79, P565, DOI 10.2307/3283384
NR 32
TC 0
Z9 0
U1 2
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD OCT 21
PY 2016
VL 15
AR 515
DI 10.1186/s12936-016-1560-7
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ5DC
UT WOS:000385881200001
PM 27769292
OA gold
DA 2017-08-15
ER

PT J
AU Kwambana-Adams, BA
   Asiedu-Bekoe, F
   Sarkodie, B
   Afreh, OK
   Kuma, GK
   Owusu-Okyere, G
   Foster-Nyarko, E
   Ohene, SA
   Okot, C
   Worwui, AK
   Okoi, C
   Senghore, M
   Otu, JK
   Ebruke, C
   Bannerman, R
   Amponsa-Achiano, K
   Opare, D
   Kay, G
   Letsa, T
   Kaluwa, O
   Appiah-Denkyira, E
   Bampoe, V
   Zaman, SMA
   Pallen, MJ
   D'Alessandro, U
   Mwenda, JM
   Antonio, M
AF Kwambana-Adams, Brenda Anna
   Asiedu-Bekoe, Franklin
   Sarkodie, Badu
   Afreh, Osei Kuffour
   Kuma, George Khumalo
   Owusu-Okyere, Godfred
   Foster-Nyarko, Ebenezer
   Ohene, Sally-Ann
   Okot, Charles
   Worwui, Archibald Kwame
   Okoi, Catherine
   Senghore, Madikay
   Otu, Jacob Kweku
   Ebruke, Chinelo
   Bannerman, Richard
   Amponsa-Achiano, Kwame
   Opare, David
   Kay, Gemma
   Letsa, Timothy
   Kaluwa, Owen
   Appiah-Denkyira, Ebenezer
   Bampoe, Victor
   Zaman, Syed M. A.
   Pallen, Mark J.
   D'Alessandro, Umberto
   Mwenda, Jason M.
   Antonio, Martin
TI An outbreak of pneumococcal meningitis among older children (>= 5 years)
   and adults after the implementation of an infant vaccination programme
   with the 13-valent pneumococcal conjugate vaccine in Ghana
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Pneumococcus; Outbreak; Serotype 1; Ghana; Meningitis belt; West Africa;
   Meningitis; Pneumococcal conjugate vaccine (PCV)
ID DETERMINING CAPSULAR SEROTYPES; SEQUENTIAL MULTIPLEX PCR; NURSING-HOME
   RESIDENTS; STREPTOCOCCUS-PNEUMONIAE; MENINGOCOCCAL MENINGITIS;
   NEISSERIA-MENINGITIDIS; BACTERIAL-MENINGITIS; BURKINA-FASO;
   EPIDEMIOLOGY; AFRICA
AB Background: An outbreak of pneumococcal meningitis among non-infant children and adults occurred in the Brong-Ahafo region of Ghana between December 2015 and April 2016 despite the recent nationwide implementation of a vaccination programme for infants with the 13-valent pneumococcal conjugate vaccine (PCV13).
   Methods: Cerebrospinal fluid (CSF) specimens were collected from patients with suspected meningitis in the Brong-Ahafo region. CSF specimens were subjected to Gram staining, culture and rapid antigen testing. Quantitative PCR was performed to identify pneumococcus, meningococcus and Haemophilus influenzae. Latex agglutination and molecular serotyping were performed on samples. Antibiogram and whole genome sequencing were performed on pneumococcal isolates.
   Results: Eight hundred eighty six patients were reported with suspected meningitis in the Brong-Ahafo region during the period of the outbreak. In the epicenter district, the prevalence was as high as 363 suspected cases per 100,000 people. Over 95 % of suspected cases occurred in non-infant children and adults, with a median age of 20 years. Bacterial meningitis was confirmed in just under a quarter of CSF specimens tested. Pneumococcus, meningococcus and Group B Streptococcus accounted for 77 %, 22 % and 1 % of confirmed cases respectively. The vast majority of serotyped pneumococci (80 %) belonged to serotype 1. Most of the pneumococcal isolates tested were susceptible to a broad range of antibiotics, with the exception of two pneumococcal serotype 1 strains that were resistant to both penicillin and trimethoprim-sulfamethoxazole. All sequenced pneumococcal serotype 1 strains belong to Sequence Type (ST) 303 in the hypervirulent ST217 clonal complex.
   Conclusion: The occurrence of a pneumococcal serotype 1 meningitis outbreak three years after the introduction of PCV13 is alarming and calls for strengthening of meningitis surveillance and a re-evaluation of the current vaccination programme in high risk countries.
C1 [Kwambana-Adams, Brenda Anna; Foster-Nyarko, Ebenezer; Worwui, Archibald Kwame; Okoi, Catherine; Senghore, Madikay; Otu, Jacob Kweku; Ebruke, Chinelo; Antonio, Martin] Med Res Council Unit Gambia, Vaccines & Immun Theme, POB 273, Banjul, Fajara, Gambia.
   [Asiedu-Bekoe, Franklin; Sarkodie, Badu; Amponsa-Achiano, Kwame; Appiah-Denkyira, Ebenezer] Ghana Hlth Serv, Accra, Ghana.
   [Afreh, Osei Kuffour; Bannerman, Richard; Letsa, Timothy] Brong Ahafo Reg Hlth Directorate, Sunyani, Brong Ahafo, Ghana.
   [Kuma, George Khumalo] Reg Hosp Sunyani, Sunyani, Brong Ahafo Reg, Ghana.
   [Owusu-Okyere, Godfred; Opare, David] Ghana Hlth Serv, Natl Publ Hlth Reference Lab, Accra, Ghana.
   [Ohene, Sally-Ann; Okot, Charles; Kaluwa, Owen] WHO Country Off Ghana, Accra, Ghana.
   [Kay, Gemma; Pallen, Mark J.; Antonio, Martin] Warwick Med Sch, Microbiol & Infect Unit, Warwick, England.
   [Bampoe, Victor] Minist Hlth, Accra, Ghana.
   [Zaman, Syed M. A.; D'Alessandro, Umberto] Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Zaman, Syed M. A.; D'Alessandro, Umberto; Antonio, Martin] London Sch Hyg & Trop Med, London, England.
   [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [Mwenda, Jason M.] WHO Reg Off Africa, Brazzaville, Rep Congo.
RP Antonio, M (reprint author), Med Res Council Unit Gambia, Vaccines & Immun Theme, POB 273, Banjul, Fajara, Gambia.; Antonio, M (reprint author), Warwick Med Sch, Microbiol & Infect Unit, Warwick, England.
EM mantonio@mrc.gm
FU Medical Research Council Unit The Gambia; Ministry of Health Ghana; WHO
   Country Office Ghana; WHO Africa Regional Office
FX This work was funded by the Medical Research Council Unit The Gambia,
   Ministry of Health Ghana, WHO Country Office Ghana and WHO Africa
   Regional Office.
CR AlGahtani YM, 1995, EPIDEMIOL INFECT, V115, P399
   Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198
   [Anonymous], 2015, CLIN INFECT DIS S5, V61, pS410
   Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499
   Cornick JE, 2015, MICROBIAL GENOMICS, V1, P1, DOI DOI 10.1099/MGEN.0.000027
   Dawood FS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-157
   Del Amo E, 2016, SPAIN PLOS ONE, V11
   Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513
   DEMARIA A, 1980, JAMA-J AM MED ASSOC, V244, P1446, DOI 10.1001/jama.244.13.1446
   Deng XD, 2016, CLIN INFECT DIS, V62, P1126, DOI 10.1093/cid/ciw050
   Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0
   Driscoll AJ, 2012, CLIN INFECT DIS, V54, pS159, DOI 10.1093/cid/cir1061
   Feazel LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128064
   Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6
   Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22
   Greenwood B, 2006, CLIN INFECT DIS, V43, P701, DOI 10.1086/506943
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Janoir C, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw020
   JANSON H, 1993, INFECT IMMUN, V61, P4546
   LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328
   LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062
   Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151
   Lingani C, 2015, CLIN INFECT DIS, V61, pS410, DOI 10.1093/cid/civ597
   MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147
   Messmer TO, 2004, DIAGN MICR INFEC DIS, V49, P249, DOI 10.1016/j.diagmicrobio.2004.04.013
   Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966
   Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422
   Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601
   O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1
   Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006
   Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436
   Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12
   Pletz MW, 2008, INT J ANTIMICROB AG, V32, P199, DOI 10.1016/j.ijantimicag.2008.01.021
   Tan CG, 2003, INFECT CONT HOSP EP, V24, P848, DOI 10.1086/502148
   Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498
   Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
   Vuong J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147765
   WHO, 2015, BACT MEN INCL HAEM I
   Williams TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026742
   Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940
   [Anonymous], 1929, BRIT MED J, V1, P210
   [Anonymous], 2014, PERFORMANCE STANDARD
NR 43
TC 3
Z9 3
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 18
PY 2016
VL 16
AR 575
DI 10.1186/s12879-016-1914-3
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA DZ7FD
UT WOS:000386029400003
PM 27756235
OA gold
DA 2017-08-15
ER

PT J
AU Walter, ND
   de Jong, BC
   Garcia, BJ
   Dolganov, GM
   Worodria, W
   Byanyima, P
   Musisi, E
   Huang, L
   Chan, ED
   Van, TT
   Antonio, M
   Ayorinde, A
   Kato-Maeda, M
   Nahid, P
   Leung, AM
   Yen, A
   Fingerlin, TE
   Kechris, K
   Strong, M
   Voskuil, MI
   Davis, JL
   Schoolnik, GK
AF Walter, Nicholas D.
   de Jong, Bouke C.
   Garcia, Benjamin J.
   Dolganov, Gregory M.
   Worodria, William
   Byanyima, Patrick
   Musisi, Emmanuel
   Huang, Laurence
   Chan, Edward D.
   Van, Tran T.
   Antonio, Martin
   Ayorinde, Abigail
   Kato-Maeda, Midori
   Nahid, Payam
   Leung, Ann M.
   Yen, Andrew
   Fingerlin, Tasha E.
   Kechris, Katerina
   Strong, Michael
   Voskuil, Martin I.
   Davis, J. Lucian
   Schoolnik, Gary K.
TI Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in
   HIV-Infected Patients
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Mycobacterium tuberculosis/genetics; Mycobacterium
   tuberculosis/physiology; sputum/microbiology; tuberculosis;
   pulmonary/epidemiology; acquired immunodeficiency syndrome/immunology
ID NITRIC-OXIDE; TRANSCRIPTIONAL ADAPTATION; ALTERNATIVE ACTIVATION;
   PULMONARY TUBERCULOSIS; DORMANCY REGULON; GENE-EXPRESSION; LUNG
   GRANULOMAS; DOSR REGULON; MOUSE MODEL; MACROPHAGES
AB Background. It is unknown whether immunosuppression influences the physiologic state of Mycobacterium tuberculosis in vivo. We evaluated the impact of host immunity by comparing M. tuberculosis and human gene transcription in sputum between human immunodeficiency virus (HIV)-infected and uninfected patients with tuberculosis.
   Methods. We collected sputum specimens before treatment from Gambians and Ugandans with pulmonary tuberculosis, revealed by positive results of acid-fast bacillus smears. We quantified expression of 2179 M. tuberculosis genes and 234 human immune genes via quantitative reverse transcription-polymerase chain reaction. We summarized genes from key functional categories with significantly increased or decreased expression.
   Results. A total of 24 of 65 patients with tuberculosis were HIV infected. M. tuberculosis DosR regulon genes were less highly expressed among HIV-infected patients with tuberculosis than among HIV-uninfected patients with tuberculosis (Gambia, P < .0001; Uganda, P = .037). In profiling of human genes from the same sputa, HIV-infected patients had 3.4-fold lower expression of IFNG (P = .005), 4.9-fold higher expression of ARG1 (P = .0006), and 3.4-fold higher expression of IL10 (P = .0002) than in HIV-uninfected patients with tuberculosis.
   Conclusions. M. tuberculosis in HIV-infected patients had lower expression of the DosR regulon, a critical metabolic and immunomodulatory switch induced by NO, carbon monoxide, and hypoxia. Our human data suggest that decreased DosR expression may result from alternative pathway activation of macrophages, with consequent decreased NO expression and/or by poor granuloma formation with consequent decreased hypoxic stress.
C1 [Walter, Nicholas D.; Chan, Edward D.] Denver Vet Affairs Med Ctr, Pulm Sect, Denver, CO USA.
   [Walter, Nicholas D.; Garcia, Benjamin J.; Fingerlin, Tasha E.; Strong, Michael] Integrated Ctr Genes Environm & Hlth, Denver, CO USA.
   [Chan, Edward D.] Natl Jewish Hlth, Dept Acad Affairs & Med, Denver, CO USA.
   [Walter, Nicholas D.; Chan, Edward D.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO USA.
   [Garcia, Benjamin J.; Strong, Michael] Univ Colorado Denver, Computat Biosci Program, Anschutz Med Campus, Aurora, CO USA.
   [Voskuil, Martin I.] Univ Colorado Denver, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO USA.
   [Kechris, Katerina] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA.
   [de Jong, Bouke C.] NYU, New York, NY USA.
   [Dolganov, Gregory M.; Van, Tran T.; Schoolnik, Gary K.] Stanford Univ, Med Ctr, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Leung, Ann M.] Stanford Univ, Med Ctr, Dept Radiol, Stanford, CA 94305 USA.
   [Huang, Laurence; Kato-Maeda, Midori; Nahid, Payam] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.
   [Huang, Laurence] Univ Calif San Francisco, HIV AIDS Div, San Francisco, CA 94143 USA.
   [Yen, Andrew] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA.
   [Davis, J. Lucian] Yale Sch Med, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Davis, J. Lucian] Yale Sch Med, Dept Pulm Crit Care & Sleep Med, New Haven, CT USA.
   [de Jong, Bouke C.] Inst Trop Med, Antwerp, Belgium.
   [de Jong, Bouke C.; Antonio, Martin; Ayorinde, Abigail] MRC Labs, Serrekunda, Gambia.
   [Worodria, William; Byanyima, Patrick; Musisi, Emmanuel] Makerere Univ, UCSF Res Collaborat, Kampala, Uganda.
RP Walter, ND (reprint author), Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Res 2, Anschutz Med Campus,Box C272,9th Flr, Aurora, CO 80045 USA.
EM nicholas.walter@ucdenver.edu
OI Garcia, Benjamin/0000-0001-5524-6946
FU European Research Council [INTERRUPTB 311725]; National Institutes of
   Health [UL1 RR025780, 2T15LM009451-06, R21AI101714, K23AI080147,
   K24HL087713, R01HL090335, 5R01AI104589, 2RO1 AI061505]; Veteran's
   Administration [CDA1IK2CX000914-01A1]; Boettcher Foundation Webb Waring
   Award
FX This work was supported by the European Research Council Starting (grant
   INTERRUPTB 311725 to B. C. d. J.), the National Institutes of Health
   (grants UL1 RR025780 and 2T15LM009451-06 [to B. J. G.], R21AI101714 [to
   J. L. D.], K23AI080147 [to J. L. D.], K24HL087713 [to L. H.],
   R01HL090335 [to L. H.], 5R01AI104589 [to P. N.], and 2RO1 AI061505 [to
   M. I. V.]), the Veteran's Administration (CDA1IK2CX000914-01A1 to N. D.
   W.), and a Boettcher Foundation Webb Waring Award (to M. S.).
CR Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055
   Bartek IL, 2009, TUBERCULOSIS, V89, P310, DOI 10.1016/j.tube.2009.06.001
   Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918
   Chan ED, 2001, AM J RESP CELL MOL, V25, P606
   CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3
   Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08
   Cunningham-Bussel A, 2013, P NATL ACAD SCI USA, V110, pE4256, DOI 10.1073/pnas.1316894110
   Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722
   de Noronha ALL, 2008, PATHOL RES PRACT, V204, P155, DOI 10.1016/j.prp.2007.10.008
   Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10
   DiPerri G, 1996, TUBERCLE LUNG DIS, V77, P244, DOI 10.1016/S0962-8479(96)90008-8
   Duque-Correa MA, 2014, P NATL ACAD SCI USA, V111, pE4024, DOI 10.1073/pnas.1408839111
   El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671
   FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249
   Garcia B, 2014, ANAL BIOCHEM, V458, P11, DOI 10.1016/j.ab.2014.04.021
   Garton NJ, 2009, PLOS MED, V5, pe75
   Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786
   Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10
   Honeyborne I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0609-3
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Irwin SM, 2014, ANTIMICROB AGENTS CH, V58, P4026, DOI 10.1128/AAC.02565-14
   Karakousis PC, 2008, J ANTIMICROB CHEMOTH, V61, P323, DOI 10.1093/jac/dkm485
   Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200
   Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018
   Marino S, 2015, INFECT IMMUN, V83, P324, DOI 10.1128/IAI.02494-14
   Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI [10.1146/annurev.immunol.021908.132715, 10.1146/annurev.immunol.021908.132532]
   Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113
   Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC
   MULLER H, 1994, IMMUNOBIOLOGY, V191, P354
   Murray PJ, 1999, INFECT IMMUN, V67, P3087
   Patel NR, 2009, J LEUKOCYTE BIOL, V86, P53, DOI [10.1189/jlb.0908574, 10.1189/JLB.0908574]
   Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1223-1242.2006
   Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846
   Schreiber T, 2009, J IMMUNOL, V183, P1301, DOI 10.4049/jimmunol.0803567
   SHEN J-Y, 1988, Clinical and Experimental Immunology, V72, P186
   Silva Andreia A., 2014, MedicalExpress (São Paulo, online), V1, P174, DOI 10.5935/MedicalExpress.2014.04.03
   Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403
   Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07
   Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003
   Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205
   Walter ND, 2015, J INFECT DIS, V212, P990, DOI 10.1093/infdis/jiv149
   World Health Organization, 2014, GLOB TUB CONTR
NR 42
TC 3
Z9 3
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD OCT 15
PY 2016
VL 214
IS 8
BP 1205
EP 1211
DI 10.1093/infdis/jiw364
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DZ8UL
UT WOS:000386147200016
PM 27534685
OA No
DA 2017-08-15
ER

PT J
AU Adesoro, O
   Shumba, C
   Kpamor, J
   Achan, J
   Kivumbi, H
   Dada, J
   Maxwell, K
   Tibenderana, J
   Marasciulo, M
   Hamade, P
   Oresanya, O
   Nankabirwa, J
   Baba, E
AF Adesoro, Olatunde
   Shumba, Constance
   Kpamor, John
   Achan, Jane
   Kivumbi, Harriet
   Dada, John
   Maxwell, Kolawole
   Tibenderana, James
   Marasciulo, Madeline
   Hamade, Prudence
   Oresanya, Olusola
   Nankabirwa, Joanita
   Baba, Ebenezer
TI Health worker perspectives on the possible use of intramuscular
   artesunate for the treatment of severe malaria at lower-level health
   facilities in settings with poor access to referral facilities in
   Nigeria: a qualitative study
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
DE Intramuscular artesunate; Severe malaria; Lower-level facilities; Poor
   referral systems; Qualitative study
ID TREATMENT POLICY; CASE-MANAGEMENT; UGANDA
AB Background: Innovative strategies are needed to reduce malaria mortality in high burden countries like Nigeria. Given that one of the important reasons for this high malaria mortality is delay in receiving effective treatment, improved access to such treatment is critical. Intramuscular artesunate could be used at lower-level facilities given its proven efficacy, ease of use and excellent safety profile. The objective of this study was therefore to explore health workers' perspectives on the possible use of intramuscular artesunate as definitive treatment for severe malaria at lower-level facilities, especially when access to referral facilities is challenging. The study was to provide insight as a formative step into the conduct of future experimental studies to ascertain the feasibility of the use of intramuscular artesunate for definitive treatment of severe malaria in lower level facilities where access to referral care is limited.
   Methods: This qualitative study was done across three southern States in Nigeria (Oyo, Cross River and Enugu). Key informant interviews were conducted over a period of three months between October and December 2014 among 90 purposively selected health workers with different roles in malaria case management from primary care to policy level. A thematic content analysis was used to analyse data.
   Results: Overall, most of health workers and other key informant groups thought that the use of intramuscular artesunate for definitive treatment of severe malaria at lower-level facilities was possible. They however reported human resource and infrastructure constraints as factors affecting the feasibility of intramuscular artesunate use as definitive treatment for severe malaria in lower-level facilities.. Specifically identified barriers included limited numbers of skilled health workers available to manage potential complications of severe malaria and poorly equipped facilities for supportive treatment. Intramuscular artesunate was considered easy to administer and the proximity of lower-level facilities to communities was deemed important in considering the possibility of its use at lower-level facilities. Health workers also emphasised the important role of operational research to provide additional evidence to guide the implementation of existing policy recommendations and inform future policy revisions.
   Conclusions: From the perspective of health workers, use of intramuscular artesunate for definitive treatment of severe malaria at lower-level health facilities in Nigeria is possible but dependent on availability of skilled workers, well-equipped lower-level facilities to provide supportive treatment There is need for further operational research to establish feasibility and guide the implementation of such an intervention.
C1 [Adesoro, Olatunde; Kpamor, John; Dada, John; Maxwell, Kolawole; Oresanya, Olusola] Malaria Consortium Nigeria, 3rd Floor,Abia House,Ahmadu Bello Way, Abuja, Fct, Nigeria.
   [Shumba, Constance; Kivumbi, Harriet; Tibenderana, James; Nankabirwa, Joanita; Baba, Ebenezer] Malaria Consortium Africa Reg, POB 8045, Kampala, Uganda.
   [Marasciulo, Madeline; Hamade, Prudence] Malaria Consortium, Dev House,56-64 Leonard St, London EC2A 4LT, England.
   [Dada, John] Med Res Council Unit Gambia, POB 273, Serrekunda, Gambia.
RP Adesoro, O (reprint author), Malaria Consortium Nigeria, 3rd Floor,Abia House,Ahmadu Bello Way, Abuja, Fct, Nigeria.
EM o.adesoro@malariaconsortium.org
FU UNITAID through Medicines for Malaria Venture
FX This research work was funded by UNITAID through Medicines for Malaria
   Venture.
CR Achan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017053
   Adbulraheem IS, 2012, J PUBLIC HLTH EPIDEM, V4, P5
   Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   Cao X T, 1997, Trans R Soc Trop Med Hyg, V91, P335
   Chinyere M, 2001, HLTH POLICY, V77, P182
   Federal Ministry of Health, 2016, NAT GUID DIAGN TREAT
   Gupta MD, AFRICA REGION HUMAN
   Kremsner PG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001938
   Mubiru D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134767
   Nabyonga-Orem J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-345
   Namagembe A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-44
   National Primary Health Care Development Agency, 2013, MIN STAND PRIM HLTH
   Nealon C, 2002, ANTIMICROB AGENTS CH, V46, P3933, DOI 10.1128/AAC.46.12.3933-3939.2002
   Nigeria Federal Ministry of Health, 2014, NAT MAL STRAT PLAN 2
   Ntuku HMT, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1072-x
   President's Malaria Initiative PMI, NIG MAL OP PLAN FY 2
   Ssekabira U, 2008, AM J TROP MED HYG, V79, P826
   Tozan Y, 2010, LANCET, V376, P1910, DOI 10.1016/S0140-6736(10)61460-2
   Tumwebaze M., 2011, HLTH POLICY DEV, V9, P46
   Williams HA, 2004, HEALTH POLICY PLANN, V19, P356, DOI 10.1093/heapol/czh051
NR 21
TC 0
Z9 0
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD OCT 12
PY 2016
VL 16
AR 566
DI 10.1186/s12913-016-1811-x
PG 11
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA DY2QU
UT WOS:000384937900001
PM 27729076
OA gold
DA 2017-08-15
ER

PT J
AU Wang, HD
   Naghavi, M
   Allen, C
   Barber, RM
   Bhutta, ZA
   Carter, A
   Casey, DC
   Charlson, FJ
   Chen, AZ
   Coates, MM
   Coggeshall, M
   Dandona, L
   Dicker, DJ
   Erskine, HE
   Ferrari, AJ
   Fitzmaurice, C
   Foreman, K
   Forouzanfar, MH
   Fraser, MS
   Pullman, N
   Gething, PW
   Goldberg, EM
   Graetz, N
   Haagsma, JA
   Hay, SI
   Huynh, C
   Johnson, C
   Kassebaum, NJ
   Kinfu, Y
   Kulikoff, XR
   Kutz, M
   Kyu, HH
   Larson, HJ
   Leung, J
   Liang, XF
   Lim, SS
   Lind, M
   Lozano, R
   Marquez, N
   Mensah, GA
   Mikesell, J
   Mokdad, AH
   Mooney, MD
   Nguyen, G
   Nsoesie, E
   Pigott, DM
   Pinho, C
   Roth, GA
   Salomon, JA
   Sandar, L
   Silpakit, N
   Sligar, A
   Sorensen, RJD
   Stanaway, J
   Steiner, C
   Teeple, S
   Thomas, BA
   Troeger, C
   VanderZanden, A
   Vollset, SE
   Wanga, V
   Whiteford, HA
   Wolock, T
   Zoeckler, L
   Abate, KH
   Abbafati, C
   Abbas, KM
   Abd-Allah, F
   Abera, SF
   Abreu, DMX
   Abu-Raddad, LJ
   Abyu, GY
   Achoki, T
   Adelekan, AL
   Ademi, Z
   Adou, AK
   Adsuar, JC
   Afanvi, KA
   Afshin, A
   Agardh, EE
   Agarwal, A
   Agrawal, A
   Kiadaliri, AA
   Ajala, ON
   Akanda, AS
   Akinyemi, RO
   Akinyemiju, TF
   Akseer, N
   Al Lami, FH
   Alabed, S
   Al-Aly, Z
   Alam, K
   Alam, NKM
   Alasfoor, D
   Aldhahri, SF
   Aldridge, RW
   Alegretti, MA
   Aleman, AV
   Alemu, ZA
   Alexander, LT
   Alhabib, S
   Ali, R
   Alkerwi, A
   Alla, F
   Allebeck, P
   Al-Raddadi, R
   Alsharif, U
   Altirkawi, KA
   Martin, EA
   Alvis-Guzman, N
   Amare, AT
   Amegah, AK
   Ameh, EA
   Amini, H
   Ammar, W
   Amrock, SM
   Andersen, HH
   Anderson, B
   Anderson, GM
   Antonio, CAT
   Aregay, AF
   Arnlov, J
   Arsenijevic, VSA
   Al Artaman
   Asayesh, H
   Asghar, RJ
   Atique, S
   Avokpaho, EFGA
   Awasthi, A
   Azzopardi, P
   Bacha, U
   Badawi, A
   Bahit, MC
   Balakrishnan, K
   Banerjee, A
   Barac, A
   Barker-Collo, SL
   Barnighausen, T
   Barregard, L
   Barrero, LH
   Basu, A
   Basu, S
   Bayou, YT
   Bazargan-Hejazi, S
   Beardsley, J
   Bedi, N
   Beghi, E
   Belay, HA
   Bell, B
   Bell, ML
   Bello, AK
   Bennett, DA
   Bensenor, IM
   Berhane, A
   Bernabe, E
   Betsu, BD
   Beyene, AS
   Bhala, N
   Bhalla, A
   Biadgilign, S
   Bikbov, B
   Bin Abdulhak, AA
   Biroscak, BJ
   Biryukov, S
   Bjertness, E
   Blore, JD
   Blosser, CD
   Bohensky, MA
   Borschmann, R
   Bose, D
   Bourne, RRA
   Brainin, M
   Brayne, CEG
   Brazinova, A
   Breitborde, NJK
   Brenner, H
   Brewer, JD
   Brown, A
   Brown, J
   Brugha, TS
   Buckle, GC
   Butt, ZA
   Calabria, B
   Campos-Novato, IR
   Campuzano, JC
   Carapetis, JR
   Cardenas, R
   Carpenter, D
   Carrero, JJ
   Castaneda-Oquela, CA
   Rivas, JC
   Catala-Lopez, F
   Cavalleri, F
   Cercy, K
   Cerda, J
   Chen, WQ
   Chew, A
   Chiang, PPC
   Chibalabala, M
   Chibueze, CE
   Chimed-Ochir, O
   Chisumpa, VH
   Choi, JYJ
   Chowdhury, R
   Christensen, H
   Christopher, DJ
   Ciobanu, LG
   Cirillo, M
   Cohen, AJ
   Colistro, V
   Colomar, M
   Colquhoun, SM
   Cooper, C
   Cooper, LT
   Cortinovis, M
   Cowie, BC
   Crump, JA
   Damsere-Derry, J
   Danawi, H
   Dandona, R
   Daoud, F
   Darby, SC
   Dargan, PI
   das Neves, J
   Davey, G
   Davis, AC
   Davitoiu, DV
   de Castro, EF
   de Jager, P
   De Leo, D
   Degenhardt, L
   Dellavalle, RP
   Deribe, K
   Deribew, A
   Dharmaratne, SD
   Dhillon, PK
   Diaz-Torne, C
   Ding, EL
   dos Santos, KPB
   Dossou, E
   Driscoll, TR
   Duan, LL
   Dubey, M
   Bartholow, B
   Ellenbogen, RG
   Lycke, C
   Elyazar, I
   Endries, AY
   Ermakov, SP
   Eshrati, B
   Esteghamati, A
   Estep, K
   Faghmous, IDA
   Fahimi, S
   Jose, E
   Farid, TA
   Farinha, CSES
   Faro, A
   Farvid, MS
   Farzadfar, F
   Feigin, VL
   Fereshtehnejad, SM
   Fernandes, JG
   Fernandes, JC
   Fischer, F
   Fitchett, JRA
   Flaxman, A
   Foigt, N
   Fowkes, FGR
   Franca, EB
   Franklin, RC
   Friedman, J
   Frostad, J
   Hirst, T
   Futran, ND
   Gall, SL
   Gambashidze, K
   Gamkrelidze, A
   Ganguly, P
   Gankpe, FG
   Gebre, T
   Gebrehiwot, TT
   Gebremedhin, AT
   Gebru, AA
   Geleijnse, JM
   Gessner, BD
   Ghoshal, AG
   Gibney, KB
   Gillum, RF
   Gilmour, S
   Giref, AZ
   Giroud, M
   Gishu, MD
   Giussani, G
   Glaser, E
   Godwin, WW
   Gomez-Dantes, H
   Gona, P
   Goodridge, A
   Gopalani, SV
   Gosselin, RA
   Gotay, CC
   Goto, A
   Gouda, HN
   Greaves, F
   Gugnani, HC
   Gupta, R
   Gupta, R
   Gupta, V
   Gutierrez, RA
   Hafezi-Nejad, N
   Haile, D
   Hailu, AD
   Hailu, GB
   Halasa, YA
   Hamadeh, RR
   Hamidi, S
   Hancock, J
   Handal, AJ
   Hankey, GJ
   Hao, YT
   Harb, HL
   Harikrishnan, S
   Haro, JM
   Havmoeller, R
   Heckbert, SR
   Heredia-Pi, IB
   Heydarpour, P
   Hilderink, HBM
   Hoek, HW
   Hogg, RS
   Horino, M
   Horita, N
   Hosgood, HD
   Hotez, PJ
   Hoy, DG
   Hsairi, M
   Htet, AS
   Htike, MMT
   Hu, GQ
   Huang, C
   Huang, H
   Huiart, L
   Husseini, A
   Huybrechts, I
   Huynh, G
   Iburg, KM
   Innos, K
   Inoue, M
   Iyer, VJ
   Jacobs, TA
   Jacobsen, KH
   Jahanmehr, N
   Jakovljevic, MB
   James, P
   Javanbakht, M
   Jayaraman, SP
   Jayatilleke, AU
   Jeemon, P
   Jensen, PN
   Jha, V
   Jiang, G
   Jiang, Y
   Jibat, T
   Jimenez-Corona, A
   Jonas, JB
   Joshi, TK
   Kabir, Z
   Karnak, R
   Kan, HD
   Kant, S
   Karch, A
   Karema, CK
   Karimkhani, C
   Karletsos, D
   Karthikeyan, G
   Kasaeian, A
   Katibeh, M
   Kaul, A
   Kawakami, N
   Kayibanda, JF
   Keiyoro, PN
   Kemmer, L
   Kemp, AH
   Kengne, AP
   Keren, A
   Kereselidze, M
   Kesavachandran, CN
   Khader, YS
   Khalil, IA
   Khan, AR
   Khan, EA
   Khang, YH
   Khera, S
   Khoja, TAM
   Kieling, C
   Kim, D
   Kim, YJ
   Kissela, BM
   Kissoon, N
   Knibbs, LD
   Knudsen, AK
   Kokubo, Y
   Kolte, D
   Kopec, JA
   Kosen, S
   Koul, PA
   Koyanagi, A
   Krog, NH
   Defo, BK
   Bicer, BK
   Kudom, AA
   Kuipers, EJ
   Kulkarni, VS
   Kumar, GA
   Kwan, GF
   Lal, A
   Lal, DK
   Lalloo, R
   Lam, H
   Lam, JO
   Langan, SM
   Lansingh, VC
   Larsson, A
   Laryea, DO
   Latif, AA
   Lawrynowicz, AEB
   Leigh, J
   Levi, M
   Li, Y
   Lindsay, MP
   Lipshultz, SE
   Liu, PY
   Liu, S
   Liu, Y
   Lo, LT
   Logroscino, G
   Lotufo, PA
   Lucas, RM
   Lunevicius, R
   Lyons, RA
   Ma, S
   Machado, VMP
   Mackay, MT
   MacLachlan, JH
   El Razek, HMA
   El Razek, MMA
   Majdan, M
   Majeed, A
   Malekzadeh, R
   Manamo, WAA
   Mandisarisa, J
   Mangalam, S
   Mapoma, CC
   Marcenes, W
   Margolis, DJ
   Martin, GR
   Martinez-Raga, J
   Marzan, MB
   Masiye, F
   -Jones, AJM
   Massano, J
   Matzopoulos, R
   Mayosi, BM
   McGarvey, ST
   McGrath, JJ
   Mckee, M
   McMahon, BJ
   Meaney, PA
   Mehari, A
   Mehndiratta, MM
   Mena-Rodriguez, F
   Mekonnen, AB
   Melaku, YA
   Memiah, P
   Memish, ZA
   Mendoza, W
   Meretoja, A
   Meretoja, TJ
   Mhimbira, FA
   Micha, R
   Miller, TR
   Mirarefin, M
   Misganaw, A
   Mock, CN
   Mohammad, KA
   Mohammadi, A
   Mohammed, S
   Mohan, V
   Mola, GLD
   Monasta, L
   Hernandez, JCM
   Montero, P
   Montico, M
   Montine, TJ
   Moradi-Lakeh, M
   Morawska, L
   Morgan, K
   Mori, R
   Mozaffarian, D
   Mueller, U
   Murthy, GVS
   Murthy, S
   Musa, KI
   Nachega, JB
   Nagel, G
   Naidoo, KS
   Naik, N
   Naldi, L
   Nangia, V
   Nash, D
   Nejjari, C
   Neupane, S
   Newton, CR
   Newton, JN
   Ng, M
   Ngalesoni, FN
   Ngirabega, JD
   Le Nguyen, Q
   Nisar, MI
   Pete, PMN
   Nomura, M
   Norheim, OF
   Norman, PE
   Norrving, B
   Nyakarahuka, L
   Ogbo, FA
   Ohkubo, T
   Ojelabi, FA
   Olivares, PR
   Olusanya, BO
   Olusanya, JO
   Opio, JN
   Oren, E
   Ortiz, A
   Osman, M
   Ota, E
   Ozdemir, R
   Pa, M
   Pandian, JD
   Pant, PR
   Papachristou, C
   Park, EK
   Park, JH
   Parry, CD
   Parsaeian, M
   Caicedo, AJP
   Patten, SB
   Patton, GC
   Paul, VK
   Pearce, N
   Pedro, JM
   Stokic, LP
   Pereira, DM
   Perico, N
   Pesudovs, K
   Petzold, M
   Phillips, MR
   Piel, FB
   Pillay, JD
   Plass, D
   Platts-Mills, JA
   Polinder, S
   Pope, CA
   Popova, S
   Poulton, RG
   Pourmalek, F
   Prabhakaran, D
   Qorbani, M
   Quame-Amaglo, J
   Quistberg, DA
   Rafay, A
   Rahimi, K
   Rahimi-Movaghar, V
   Rahman, M
   Rahman, MHU
   Rahman, SU
   Rai, RK
   Rajavi, Z
   Rajsic, S
   Raju, M
   Rakovac, I
   Rana, SM
   Ranabhat, CL
   Rangaswamy, T
   Rao, P
   Rao, SR
   Refaat, AH
   Rehm, J
   Reitsma, MB
   Remuzzi, G
   Resnikofff, S
   Ribeiro, AL
   Ricci, S
   Blancas, MJR
   Roberts, B
   Roca, A
   Rojas-Rueda, D
   Ronfani, L
   Roshandel, G
   Rothenbacher, D
   Roy, A
   Roy, NK
   Ruhago, GM
   Sagar, R
   Saha, S
   Sahathevan, R
   Saleh, MM
   Sanabria, JR
   Sanchez-Nino, MD
   Sanchez-Riera, L
   Santos, IS
   Sarmiento-Suarez, R
   Sartorius, B
   Satpathy, M
   Savic, M
   Sawhney, M
   Schaub, MP
   Schmidt, MI
   Schneider, IJC
   Schottker, B
   Schutte, AE
   Schwebel, DC
   Seedat, S
   Sepanlou, SG
   Servan-Mori, EE
   Shackelford, KA
   Shaddick, G
   Shaheen, A
   Shahraz, S
   Shaikh, MA
   Shakh-Nazarova, M
   Sharma, R
   She, J
   Sheikhbahaei, S
   Shen, JB
   Shen, ZY
   Shepard, DS
   Sheth, KN
   Shetty, BP
   Shi, PL
   Shibuya, K
   Shin, MJ
   Shiri, R
   Shiue, I
   Shrime, MG
   Sigfusdottir, ID
   Silberberg, DH
   Silva, DAS
   Silveira, DGA
   Silverberg, JI
   Simard, EP
   Singh, A
   Singh, GM
   Singh, JA
   Singh, OP
   Singh, PK
   Singh, V
   Soneji, S
   Soreide, K
   Soriano, JB
   Sposato, LA
   Sreeramareddy, CT
   Stathopoulou, V
   Stein, DJ
   Stein, MB
   Stranges, S
   Stroumpoulis, K
   Sunguya, BF
   Sur, P
   Swaminathan, S
   Sykes, BL
   Szoeke, CEI
   Tabares-Seisdedos, R
   Tabb, KM
   Takahashi, K
   Takala, JS
   Talongwa, RT
   Tandon, N
   Tavakkoli, M
   Taye, B
   Taylor, HR
   Ao, BJT
   Tedla, BA
   Tefera, WM
   Ten Have, M
   Terkawi, AS
   Tesfay, FH
   Tessema, GA
   Thomson, AJ
   Thorne-Lyman, AL
   Thrift, AG
   Thurston, GD
   Tillmann, T
   Tirschwell, DL
   Tonelli, M
   Topor-Madry, R
   Topouzis, F
   Nx, JAT
   Traebert, J
   Tran, BX
   Truelsen, T
   Trujillo, U
   Tura, AK
   Tuzcu, EM
   Uchendu, US
   Ukwaja, KN
   Undurraga, EA
   Uthman, OA
   Van Dingenen, R
   Van Donkelaar, A
   Vasankari, T
   Vasconcelos, AMN
   Venketasubramanian, N
   Vidavalur, R
   Vijayakumar, L
   Villalpando, S
   Violante, FS
   Vlassov, VV
   Wagner, JA
   Wagner, GR
   Wallin, MT
   Wang, LH
   Watkins, DA
   Weichenthal, S
   Weiderpass, E
   Weintraub, RG
   Werdecker, A
   Westerman, R
   White, RA
   Wijeratne, T
   Wilkinson, JD
   Williams, HC
   Wiysonge, CS
   Woldeyohannes, SM
   Wolfe, CDA
   Won, SH
   Wong, JQ
   Woolf, AD
   Xavier, D
   Xiao, QY
   Xu, GL
   Yakob, B
   Yalew, AZ
   Yan, LL
   Yano, YC
   Yaseri, M
   Ye, P
   Yebyo, HG
   Yip, P
   Yirsaw, BD
   Yonemoto, N
   Yonga, G
   Younis, MZ
   Yu, SC
   Zaidi, Z
   Zaki, MES
   Zannad, F
   Zavala, DE
   Zeeb, H
   Zeleke, BM
   Zhang, H
   Zodpey, S
   Zonies, D
   Zuhlke, LJ
   Vos, T
   Lopez, AD
   Murray, CJL
AF Wang, Haidong
   Naghavi, Mohsen
   Allen, Christine
   Barber, Ryan M.
   Bhutta, Zulfiqar A.
   Carter, Austin
   Casey, Daniel C.
   Charlson, Fiona J.
   Chen, Alan Zian
   Coates, Matthew M.
   Coggeshall, Megan
   Dandona, Lalit
   Dicker, Daniel J.
   Erskine, Holly E.
   Ferrari, Alize J.
   Fitzmaurice, Christina
   Foreman, Kyle
   Forouzanfar, Mohammad H.
   Fraser, Maya S.
   Pullman, Nancy
   Gething, Peter W.
   Goldberg, Ellen M.
   Graetz, Nicholas
   Haagsma, Juanita A.
   Hay, Simon I.
   Huynh, Chantal
   Johnson, Catherine
   Kassebaum, Nicholas J.
   Kinfu, Yohannes
   Kulikoff, Xie Rachel
   Kutz, Michael
   Kyu, Hmwe H.
   Larson, Heidi J.
   Leung, Janni
   Liang, Xiaofeng
   Lim, Stephen S.
   Lind, Margaret
   Lozano, Rafael
   Marquez, Neal
   Mensah, George A.
   Mikesell, Joe
   Mokdad, Ali H.
   Mooney, Meghan D.
   Nguyen, Grant
   Nsoesie, Elaine
   Pigott, David M.
   Pinho, Christine
   Roth, Gregory A.
   Salomon, Joshua A.
   Sandar, Logan
   Silpakit, Naris
   Sligar, Amber
   Sorensen, Reed J. D.
   Stanaway, Jeffrey
   Steiner, Caitlyn
   Teeple, Stephanie
   Thomas, Bernadette A.
   Troeger, Christopher
   VanderZanden, Amelia
   Vollset, Stein Emil
   Wanga, Valentine
   Whiteford, Harvey A.
   Wolock, Timothy
   Zoeckler, Leo
   Abate, Kalkidan Hassen
   Abbafati, Cristiana
   Abbas, Kaja M.
   Abd-Allah, Foad
   Abera, Semaw Ferede
   Abreu, Daisy M. X.
   Abu-Raddad, Laith J.
   Abyu, Gebre Yitayih
   Achoki, Tom
   Adelekan, Ademola Lukman
   Ademi, Zanfina
   Adou, Arsene Kouablan
   Adsuar, Jose C.
   Afanvi, Kossivi Agbelenko
   Afshin, Ashkan
   Agardh, Emilie Elisabet
   Agarwal, Arnav
   Agrawal, Anurag
   Kiadaliri, Aliasghar Ahmad
   Ajala, Oluremi N.
   Akanda, All Shafqat
   Akinyemi, Rufus Olusola
   Akinyemiju, Tomi F.
   Akseer, Nadia
   Al Lami, Faris Hasan
   Alabed, Samer
   Al-Aly, Ziyad
   Alam, Khurshid
   Alam, Noore K. M.
   Alasfoor, Deena
   Aldhahri, Saleh Fahed
   Aldridge, Robert William
   Alegretti, Miguel Angel
   Aleman, Alicia V.
   Alemu, Zewdie Aderaw
   Alexander, Lily T.
   Alhabib, Samia
   Ali, Raghib
   Alkerwi, Ala'a
   Alla, Francois
   Allebeck, Peter
   Al-Raddadi, Rajaa
   Alsharif, Ubai
   Altirkawi, Khalid A.
   Martin, Elena Alvarez
   Alvis-Guzman, Nelson
   Amare, Azmeraw T.
   Amegah, Adeladza Kofi
   Ameh, Emmanuel A.
   Amini, Heresh
   Ammar, Walid
   Amrock, Stephen Marc
   Andersen, Hjalte H.
   Anderson, Benjamin
   Anderson, Gregory M.
   Antonio, Carl Abelardo T.
   Aregay, Atsede Fantahun
   Arnlov, Johan
   Arsenijevic, Valentina S. Arsic
   Al Artaman
   Asayesh, Hamid
   Asghar, Rana Jawad
   Atique, Suleman
   Arthur Avokpaho, Euripide Frinel G.
   Awasthi, Ashish
   Azzopardi, Peter
   Bacha, Umar
   Badawi, Alaa
   Bahit, Maria C.
   Balakrishnan, Kalpana
   Banerjee, Amitava
   Barac, Aleksandra
   Barker-Collo, Suzanne L.
   Barnighausen, Till
   Barregard, Lars
   Barrero, Lope H.
   Basu, Arindam
   Basu, Sanjay
   Bayou, Yibeltal Tebekaw
   Bazargan-Hejazi, Shahrzad
   Beardsley, Justin
   Bedi, Neeraj
   Beghi, Ettore
   Belay, Haileeyesus Adamu
   Bell, Brent
   Bell, Michelle L.
   Bello, Aminu K.
   Bennett, Derrick A.
   Bensenor, Isabela M.
   Berhane, Adugnaw
   Bernabe, Eduardo
   Betsu, Balem Demtsu
   Beyene, Addisu Shunu
   Bhala, Neeraj
   Bhalla, Ashish
   Biadgilign, Sibhatu
   Bikbov, Boris
   Bin Abdulhak, Aref A.
   Biroscak, Brian J.
   Biryukov, Stan
   Bjertness, Espen
   Blore, Jed D.
   Blosser, Christopher D.
   Bohensky, Megan A.
   Borschmann, Rohan
   Bose, Dipan
   Bourne, Rupert R. A.
   Brainin, Michael
   Brayne, Carol E. G.
   Brazinova, Alexandra
   Breitborde, Nicholas J. K.
   Brenner, Hermann
   Brewer, Jerry D.
   Brown, Alexandria
   Brown, Jonathan
   Brugha, Traolach S.
   Buckle, Geoffrey Colin
   Butt, Zahid A.
   Calabria, Bianca
   Campos-Novato, Ismael Ricardo
   Campuzano, Julio Cesar
   Carapetis, Jonathan R.
   Cardenas, Rosario
   Carpenter, David
   Carrero, Juan Jesus
   Castaneda-Oquela, Carlos A.
   Rivas, Jacqueline Castillo
   Catala-Lopez, Ferran
   Cavalleri, Fiorella
   Cercy, Kelly
   Cerda, Jorge
   Chen, Wanqing
   Chew, Adrienne
   Chiang, Peggy Pei -Chia
   Chibalabala, Mirriam
   Chibueze, Chioma Ezinne
   Chimed-Ochir, Odgerel
   Chisumpa, Vesper Hichilombwe
   Choi, Jee-Young Jasmine
   Chowdhury, Rajiv
   Christensen, Hanne
   Christopher, Devasahayam Jesudas
   Ciobanu, Liliana G.
   Cirillo, Massimo
   Cohen, Aaron J.
   Colistro, Valentina
   Colomar, Mercedes
   Colquhoun, Samantha M.
   Cooper, Cyrus
   Cooper, Leslie Trumbull
   Cortinovis, Monica
   Cowie, Benjamin C.
   Crump, John A.
   Damsere-Derry, James
   Danawi, Hadi
   Dandona, Rakhi
   Daoud, Farah
   Darby, Sarah C.
   Dargan, Paul I.
   das Neves, Jose
   Davey, Gail
   Davis, Adrian C.
   Davitoiu, Dragos V.
   de Castro, E. Filipa
   de Jager, Pieter
   De Leo, Diego
   Degenhardt, Louisa
   Dellavalle, Robert P.
   Deribe, Kebede
   Deribew, Amare
   Dharmaratne, Samath D.
   Dhillon, Preet K.
   Diaz-Torne, Cesar
   Ding, Eric L.
   dos Santos, Kadine Priscila Bender
   Dossou, Edem
   Driscoll, Tim R.
   Duan, Leilei
   Dubey, Manisha
   Bartholow, Bruce
   Ellenbogen, Richard G.
   Lycke, Christian
   Elyazar, Iqbal
   Endries, Aman Yesuf
   Ermakov, Sergey Petrovich
   Eshrati, Babak
   Esteghamati, Alireza
   Estep, Kara
   Faghmous, Imad D. A.
   Fahimi, Saman
   Jose, Emerito
   Farid, Talha A.
   Sa Farinha, Carla Sofia e
   Faro, Andre
   Farvid, Maryam S.
   Farzadfar, Farshad
   Feigin, Valery L.
   Fereshtehnejad, Seyed-Mohammad
   Fernandes, Jefferson G.
   Fernandes, Joao C.
   Fischer, Florian
   Fitchett, Joseph R. A.
   Flaxman, Abraham
   Foigt, Nataliya
   Fowkes, F. Gerry R.
   Franca, Elisabeth Barboza
   Franklin, Richard C.
   Friedman, Joseph
   Frostad, Joseph
   Hirst, Thomas
   Futran, Neal D.
   Gall, Seana L.
   Gambashidze, Ketevan
   Gamkrelidze, Amiran
   Ganguly, Parthasarathi
   Gankpe, Fortune Gbetoho
   Gebre, Teshome
   Gebrehiwot, Tsegaye Tsewelde
   Gebremedhin, Amanuel Tesfay
   Gebru, Alemseged Aregay
   Geleijnse, Johanna M.
   Gessner, Bradford D.
   Ghoshal, Aloke Gopal
   Gibney, Katherine B.
   Gillum, Richard F.
   Gilmour, Stuart
   Giref, Ababi Zergaw
   Giroud, Maurice
   Gishu, Melkamu Dedefo
   Giussani, Giorgia
   Glaser, Elizabeth
   Godwin, William W.
   Gomez-Dantes, Hector
   Gona, Philimon
   Goodridge, Amador
   Gopalani, Sameer Vali
   Gosselin, Richard A.
   Gotay, Carolyn C.
   Goto, Atsushi
   Gouda, Hebe N.
   Greaves, Felix
   Gugnani, Harish Chander
   Gupta, Rahul
   Gupta, Rajeev
   Gupta, Vipin
   Gutierrez, Reyna A.
   Hafezi-Nejad, Nima
   Haile, Demewoz
   Hailu, Alemayehu Desalegne
   Hailu, Gessessew Bugssa
   Halasa, Yara A.
   Hamadeh, Randah Ribhi
   Hamidi, Samer
   Hancock, Jamie
   Handal, Alexis J.
   Hankey, Graeme J.
   Hao, Yuantao
   Harb, Hilda L.
   Harikrishnan, Sivadasanpillai
   Haro, Josep Maria
   Havmoeller, Rasmus
   Heckbert, Susan R.
   Heredia-Pi, Ileana Beatriz
   Heydarpour, Pouria
   Hilderink, Henk B. M.
   Hoek, Hans W.
   Hogg, Robert S.
   Horino, Masako
   Horita, Nobuyuki
   Hosgood, H. Dean
   Hotez, Peter J.
   Hoy, Damian G.
   Hsairi, Mohamed
   Htet, Aung Soe
   Than Htike, Maung Maung
   Hu, Guoqing
   Huang, Cheng
   Huang, Hsiang
   Huiart, Laetitia
   Husseini, Abdullatif
   Huybrechts, Inge
   Huynh, Grace
   Iburg, Kim Moesgaard
   Innos, Kaire
   Inoue, Manami
   Iyer, Veena J.
   Jacobs, Troy A.
   Jacobsen, Kathryn H.
   Jahanmehr, Nader
   Jakovljevic, Mihajlo B.
   James, Peter
   Javanbakht, Mehdi
   Jayaraman, Sudha P.
   Jayatilleke, Achala Upendra
   Jeemon, Panniyammakal
   Jensen, Paul N.
   Jha, Vivekanand
   Jiang, Guohong
   Jiang, Ying
   Jibat, Tariku
   Jimenez-Corona, Aida
   Jonas, Jost B.
   Joshi, Tushar Kant
   Kabir, Zubair
   Karnak, Ritul
   Kan, Haidong
   Kant, Surya
   Karch, Andre
   Karema, Corine Kakizi
   Karimkhani, Chante
   Karletsos, Dimitris
   Karthikeyan, Ganesan
   Kasaeian, Amir
   Katibeh, Marzieh
   Kaul, Anil
   Kawakami, Norito
   Kayibanda, Jeanne Francoise
   Keiyoro, Peter Njenga
   Kemmer, Laura
   Kemp, Andrew Haddon
   Kengne, Andre Pascal
   Keren, Andre
   Kereselidze, Maia
   Kesavachandran, Chandrasekharan Nair
   Khader, Yousef Saleh
   Khalil, Ibrahim A.
   Khan, Abdur Rahman
   Khan, Ejaz Ahmad
   Khang, Young-Ho
   Khera, Sahil
   Muthafer Khoja, Tawfik Ahmed
   Kieling, Christian
   Kim, Daniel
   Kim, Yun Jin
   Kissela, Brett M.
   Kissoon, Niranjan
   Knibbs, Luke D.
   Knudsen, Ann Kristin
   Kokubo, Yoshihiro
   Kolte, Dhaval
   Kopec, Jacek A.
   Kosen, Soewarta
   Koul, Parvaiz A.
   Koyanagi, Ai
   Krog, Norun Hjertager
   Defo, Barthelemy Kuate
   Bicer, Burcu Kucuk
   Kudom, Andreas A.
   Kuipers, Ernst J.
   Kulkarni, Veena S.
   Kumar, G. Anil
   Kwan, Gene F.
   Lal, Aparna
   Lal, Dharmesh Kumar
   Lalloo, Ratilal
   Lam, Hilton
   Lam, Jennifer O.
   Langan, Sinead M.
   Lansingh, Van C.
   Larsson, Anders
   Laryea, Dennis Odai
   Latif, Asma Abdul
   Lawrynowicz, Alicia Elena Beatriz
   Leigh, James
   Levi, Miriam
   Li, Yongmei
   Lindsay, M. Patrice
   Lipshultz, Steven E.
   Liu, Patrick Y.
   Liu, Shiwei
   Liu, Yang
   Lo, Loon-Tzian
   Logroscino, Giancarlo
   Lotufo, Paulo A.
   Lucas, Robyn M.
   Lunevicius, Raimundas
   Lyons, Ronan A.
   Ma, Stefan
   Pedro Machado, Vasco Manuel
   Mackay, Mark T.
   MacLachlan, Jennifer H.
   Abd El Razek, Hassan Magdy
   Abd El Razek, Mohammed Magdy
   Majdan, Marek
   Majeed, Azeem
   Malekzadeh, Reza
   Ayele Manamo, Wondimu Ayele
   Mandisarisa, John
   Mangalam, Srikanth
   Mapoma, Chabila C.
   Marcenes, Wagner
   Margolis, David Joel
   Martin, Gerard Robert
   Martinez-Raga, Jose
   Marzan, Melvin Barrientos
   Masiye, Felix
   Mason-Jones, Amanda J.
   Massano, Joao
   Matzopoulos, Richard
   Mayosi, Bongani M.
   McGarvey, Stephen Theodore
   McGrath, John J.
   Mckee, Martin
   McMahon, Brian J.
   Meaney, Peter A.
   Mehari, Alem
   Mehndiratta, Man Mohan
   Mena-Rodriguez, Fabiola
   Mekonnen, Alemayehu B.
   Melaku, Yohannes Adama
   Memiah, Peter
   Memish, Ziad A.
   Mendoza, Walter
   Meretoja, Atte
   Meretoja, Tuomo J.
   Mhimbira, Francis Apolinary
   Micha, Renata
   Miller, Ted R.
   Mirarefin, Mojde
   Misganaw, Awoke
   Mock, Charles N.
   Abdulmuhsin Mohammad, Karzan
   Mohammadi, Alireza
   Mohammed, Shafiu
   Mohan, Viswanathan
   Mola, Glen Liddell D.
   Monasta, Lorenzo
   Montanez Hernandez, Julio Cesar
   Montero, Pablo
   Montico, Marcella
   Montine, Thomas J.
   Moradi-Lakeh, Maziar
   Morawska, Lidia
   Morgan, Katherine
   Mori, Rintaro
   Mozaffarian, Dariush
   Mueller, Ulrich
   Satyanarayana Murthy, Gudlavalleti Venkata
   Murthy, Srinivas
   Musa, Kamarul Imran
   Nachega, Jean B.
   Nagel, Gabriele
   Naidoo, Kovin S.
   Naik, Nitish
   Naldi, Luigi
   Nangia, Vinay
   Nash, Denis
   Nejjari, Chakib
   Neupane, Subas
   Newton, Charles R.
   Newton, John N.
   Ng, Marie
   Ngalesoni, Frida Namnyak
   Ngirabega, Jean de Dieu
   Quyen Le Nguyen
   Nisar, Muhammad Imran
   Nkamedjie Pete, Patrick Martial
   Nomura, Marika
   Norheim, Ole F.
   Norman, Paul E.
   Norrving, Bo
   Nyakarahuka, Luke
   Ogbo, Felix Akpojene
   Ohkubo, Takayoshi
   Ojelabi, Foluke Adetola
   Olivares, Pedro R.
   Olusanya, Bolajoko Olubukunola
   Olusanya, Jacob Olusegun
   Opio, John Nelson
   Oren, Eyal
   Ortiz, Alberto
   Osman, Majdi
   Ota, Erika
   Ozdemir, Raziye
   Pa, Mahesh
   Pandian, Jeyaraj D.
   Pant, Puspa Raj
   Papachristou, Christina
   Park, Eun-Kee
   Park, Jae-Hyun
   Parry, Charles D.
   Parsaeian, Mahboubeh
   Caicedo, Angel J. Paternina
   Patten, Scott B.
   Patton, George C.
   Paul, Vinod K.
   Pearce, Neil
   Pedro, Joao Mario
   Stokic, Ljiljana Pejin
   Pereira, David M.
   Perico, Norberto
   Pesudovs, Konrad
   Petzold, Max
   Phillips, Michael Robert
   Piel, Frederic B.
   Pillay, Julian David
   Plass, Dietrich
   Platts-Mills, James A.
   Polinder, Suzanne
   Pope, C. Arden
   Popova, Svetlana
   Poulton, Richie G.
   Pourmalek, Farshad
   Prabhakaran, Dorairaj
   Qorbani, Mostafa
   Quame-Amaglo, Justice
   Quistberg, D. Alex
   Rafay, Anwar
   Rahimi, Kazem
   Rahimi-Movaghar, Vafa
   Rahman, Mahfuzar
   Rahman, Mohammad Hifz Ur
   Rahman, Sajjad Ur
   Rai, Rajesh Kumar
   Rajavi, Zhale
   Rajsic, Sasa
   Raju, Murugesan
   Rakovac, Ivo
   Rana, Saleem M.
   Ranabhat, Chhabi L.
   Rangaswamy, Thara
   Rao, Puja
   Rao, Sowmya R.
   Refaat, Amany H.
   Rehm, Jurgen
   Reitsma, Marissa B.
   Remuzzi, Giuseppe
   Resnikofff, Serge
   Ribeiro, Antonio L.
   Ricci, Stefano
   Blancas, Maria Jesus Rios
   Roberts, Bayard
   Roca, Anna
   Rojas-Rueda, David
   Ronfani, Luca
   Roshandel, Gholamreza
   Rothenbacher, Dietrich
   Roy, Ambuj
   Roy, Nawal K.
   Ruhago, George Mugambage
   Sagar, Rajesh
   Saha, Sukanta
   Sahathevan, Ramesh
   Saleh, Muhammad Muhammad
   Sanabria, Juan R.
   Sanchez-Nino, Maria Dolores
   Sanchez-Riera, Lidia
   Santos, Itamar S.
   Sarmiento-Suarez, Rodrigo
   Sartorius, Benn
   Satpathy, Maheswar
   Savic, Miloje
   Sawhney, Monika
   Schaub, Michael P.
   Schmidt, Maria Ines
   Schneider, Ione J. C.
   Schottker, Ben
   Schutte, Aletta E.
   Schwebel, David C.
   Seedat, Soraya
   Sepanlou, Sadaf G.
   Servan-Mori, Edson E.
   Shackelford, Katya A.
   Shaddick, Gavin
   Shaheen, Amira
   Shahraz, Saeid
   Shaikh, Masood Ali
   Shakh-Nazarova, Marina
   Sharma, Rajesh
   She, Jun
   Sheikhbahaei, Sara
   Shen, Jiabin
   Shen, Ziyan
   Shepard, Donald S.
   Sheth, Kevin N.
   Shetty, Balakrishna P.
   Shi, Peilin
   Shibuya, Kenji
   Shin, Min-Jeong
   Shiri, Rahman
   Shiue, Ivy
   Shrime, Mark G.
   Sigfusdottir, Inga Dora
   Silberberg, Donald H.
   Silva, Diego Augusto Santos
   Silveira, Dayane Gabriele Alves
   Silverberg, Jonathan I.
   Simard, Edgar P.
   Singh, Abhishek
   Singh, Gitanjali M.
   Singh, Jasvinder A.
   Singh, Om Prakash
   Singh, Prashant Kumar
   Singh, Virendra
   Soneji, Samir
   Soreide, Kjetil
   Soriano, Joan B.
   Sposato, Luciano A.
   Sreeramareddy, Chandrashekhar T.
   Stathopoulou, Vasiliki
   Stein, Dan J.
   Stein, Murray B.
   Stranges, Saverio
   Stroumpoulis, Konstantinos
   Sunguya, Bruno F.
   Sur, Patrick
   Swaminathan, Soumya
   Sykes, Bryan L.
   Szoeke, Cassandra E. I.
   Tabares-Seisdedos, Rafael
   Tabb, Karen M.
   Takahashi, Ken
   Takala, Jukka S.
   Talongwa, Roberto Tchio
   Tandon, Nikhil
   Tavakkoli, Mohammad
   Taye, Bineyam
   Taylor, Hugh R.
   Ao, Braden J. Te
   Tedla, Bemnet Amare
   Tefera, Worku Mekonnen
   Ten Have, Margreet
   Terkawi, Abdullah Sulieman
   Tesfay, Fisaha Haile
   Tessema, Gizachew Assefa
   Thomson, Alan J.
   Thorne-Lyman, Andrew L.
   Thrift, Amanda G.
   Thurston, George D.
   Tillmann, Taavi
   Tirschwell, David L.
   Tonelli, Marcello
   Topor-Madry, Roman
   Topouzis, Fotis
   Nx, Jeffrey Allen Towb
   Traebert, Jefferson
   Tran, Bach Xuan
   Truelsen, Thomas
   Trujillo, Ulises
   Tura, Abera Kenay
   Tuzcu, Emin Murat
   Uchendu, Uche S.
   Ukwaja, Kingsley N.
   Undurraga, Eduardo A.
   Uthman, Olalekan A.
   Van Dingenen, Rita
   Van Donkelaar, Aaron
   Vasankari, Tommi
   Vasconcelos, Ana Maria Nogales
   Venketasubramanian, Narayanaswamy
   Vidavalur, Ramesh
   Vijayakumar, Lakshmi
   Villalpando, Salvador
   Violante, Francesco S.
   Vlassov, Vasiliy Victorovich
   Wagner, Joseph A.
   Wagner, Gregory R.
   Wallin, Mitchell T.
   Wang, Linhong
   Watkins, David A.
   Weichenthal, Scott
   Weiderpass, Elisabete
   Weintraub, Robert G.
   Werdecker, Andrea
   Westerman, Ronny
   White, Richard A.
   Wijeratne, Tissa
   Wilkinson, James D.
   Williams, Hywel C.
   Wiysonge, Charles Shey
   Woldeyohannes, Solomon Meseret
   Wolfe, Charles D. A.
   Won, Sungho
   Wong, John Q.
   Woolf, Anthony D.
   Xavier, Denis
   Xiao, Qingyang
   Xu, Gelin
   Yakob, Bereket
   Yalew, Ayalnesh Zemene
   Yan, Lijing L.
   Yano, Yuichiro
   Yaseri, Mehdi
   Ye, Pengpeng
   Yebyo, Henock Gebremedhin
   Yip, Paul
   Yirsaw, Biruck Desalegn
   Yonemoto, Naohiro
   Yonga, Gerald
   Younis, Mustafa Z.
   Yu, Shicheng
   Zaidi, Zoubida
   Zaki, Maysaa El Sayed
   Zannad, Faiez
   Zavala, Diego E.
   Zeeb, Hajo
   Zeleke, Berihun M.
   Zhang, Hao
   Zodpey, Sanjay
   Zonies, David
   Zuhlke, Liesl Joanna
   Vos, Theo
   Lopez, Alan D.
   Murray, Christopher J. L.
CA GBD 015 Mortality and Causes Death
TI Global, regional, and national life expectancy, all-cause mortality, and
   cause-specific mortality for 249 causes of death, 1980-2015: a
   systematic analysis for the Global Burden of Disease Study 2015
SO LANCET
LA English
DT Article
ID ROAD TRAFFIC INJURIES; ECONOMIC-DEVELOPMENT; UNITED-STATES;
   EPIDEMIOLOGIC TRANSITION; DEVELOPMENT ASSISTANCE; INTEGRATED APPROACH;
   CIVIL REGISTRATION; ALZHEIMERS-DISEASE; VITAL-STATISTICS; VERBAL AUTOPSY
AB Background Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures.
   Methods We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010. Improvements included refinements to the estimation of child and adult mortality and corresponding uncertainty, parameter selection for under-5 mortality synthesis by spatiotemporal Gaussian process regression, and sibling history data processing. We also expanded the database of vital registration, survey, and census data to 14 294 geography-year datapoints. For GBD 2015, eight causes, including Ebola virus disease, were added to the previous GBD cause list for mortality. We used six modelling approaches to assess cause-specific mortality, with the Cause of Death Ensemble Model (CODEm) generating estimates for most causes. We used a series of novel analyses to systematically quantify the drivers of trends in mortality across geographies. First, we assessed observed and expected levels and trends of cause-specific mortality as they relate to the Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility. Second, we examined factors affecting total mortality patterns through a series of counterfactual scenarios, testing the magnitude by which population growth, population age structures, and epidemiological changes contributed to shifts in mortality. Finally, we attributed changes in life expectancy to changes in cause of death. We documented each step of the GBD 2015 estimation processes, as well as data sources, in accordance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).
   Findings Globally, life expectancy from birth increased from 61.7 years (95% uncertainty interval 61.4-61.9) in 1980 to 71.8 years (71.5-72.2) in 2015. Several countries in sub-Saharan Africa had very large gains in life expectancy from 2005 to 2015, rebounding from an era of exceedingly high loss of life due to HIV/AIDS. At the same time, many geographies saw life expectancy stagnate or decline, particularly for men and in countries with rising mortality from war or interpersonal violence. From 2005 to 2015, male life expectancy in Syria dropped by 11.3 years (3.7-17.4), to 62.6 years (56.5-70.2). Total deaths increased by 4.1% (2.6-5.6) from 2005 to 2015, rising to 55.8 million (54.9 million to 56.6 million) in 2015, but age-standardised death rates fell by 17.0% (15.8-18.1) during this time, underscoring changes in population growth and shifts in global age structures. The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14.1% (12.6-16.0) to 39.8 million (39.2 million to 40.5 million) in 2015, whereas age-standardised rates decreased by 13.1% (11.9-14.3). Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias. By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42.1%, 39.1-44.6), malaria (43.1%, 34.7-51.8), neonatal preterm birth complications (29.8%, 24.8-34.9), and maternal disorders (29.1%, 19.3-37.1). Progress was slower for several causes, such as lower respiratory infections and nutritional deficiencies, whereas deaths increased for others, including dengue and drug use disorders. Age-standardised death rates due to injuries significantly declined from 2005 to 2015, yet interpersonal violence and war claimed increasingly more lives in some regions, particularly in the Middle East. In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146 000 deaths, 118 000-183 000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393 000 deaths, 228 000-532 000), although pathogen-specific mortality varied by region. Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause. Our analyses on the expected associations between cause-specific mortality and SDI show the regular shifts in cause of death composition and population age structure with rising SDI. Country patterns of premature mortality (measured as years of life lost [YLLs]) and how they differ from the level expected on the basis of SDI alone revealed distinct but highly heterogeneous patterns by region and country or territory. Ischaemic heart disease, stroke, and diabetes were among the leading causes of YLLs in most regions, but in many cases, intraregional results sharply diverged for ratios of observed and expected YLLs based on SDI. Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death.
   Interpretation At the global scale, age-specific mortality has steadily improved over the past 35 years; this pattern of general progress continued in the past decade. Progress has been faster in most countries than expected on the basis of development measured by the SDI. Against this background of progress, some countries have seen falls in life expectancy, and age-standardised death rates for some causes are increasing. Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems. Copyright (C) The Author(s). Published by Elsevier Ltd.
C1 [Wang, Haidong; Naghavi, Mohsen; Allen, Christine; Barber, Ryan M.; Carter, Austin; Casey, Daniel C.; Charlson, Fiona J.; Chen, Alan Zian; Coates, Matthew M.; Coggeshall, Megan; Dandona, Lalit; Dicker, Daniel J.; Erskine, Holly E.; Ferrari, Alize J.; Fitzmaurice, Christina; Foreman, Kyle; Forouzanfar, Mohammad H.; Fraser, Maya S.; Goldberg, Ellen M.; Graetz, Nicholas; Huynh, Chantal; Johnson, Catherine; Kassebaum, Nicholas J.; Kulikoff, Xie Rachel; Kutz, Michael; Kyu, Hmwe H.; Larson, Heidi J.; Leung, Janni; Lim, Stephen S.; Lind, Margaret; Lozano, Rafael; Marquez, Neal; Mikesell, Joe; Mokdad, Ali H.; Mooney, Meghan D.; Nguyen, Grant; Nsoesie, Elaine; Pigott, David M.; Pinho, Christine; Roth, Gregory A.; Sandar, Logan; Silpakit, Naris; Sligar, Amber; Sorensen, Reed J. D.; Stanaway, Jeffrey; Steiner, Caitlyn; Teeple, Stephanie; Thomas, Bernadette A.; Troeger, Christopher; VanderZanden, Amelia; Vollset, Stein Emil; Wanga, Valentine; Whiteford, Harvey A.; Wolock, Timothy; Zoeckler, Leo; Achoki, Tom; Afshin, Ashkan; Alexander, Lily T.; Anderson, Gregory M.; Biryukov, Stan; Blore, Jed D.; Brown, Alexandria; Brown, Jonathan; Cercy, Kelly; Chew, Adrienne; Cohen, Aaron J.; Daoud, Farah; Dossou, Edem; Estep, Kara; Flaxman, Abraham; Friedman, Joseph; Frostad, Joseph; Futran, Neal D.; Godwin, William W.; Hancock, Jamie; Kasaeian, Amir; Kemmer, Laura; Khalil, Ibrahim A.; Lindsay, M. Patrice; Liu, Patrick Y.; Masiye, Felix; Mirarefin, Mojde; Misganaw, Awoke; Moradi-Lakeh, Maziar; Morgan, Katherine; Ng, Marie; Quame-Amaglo, Justice; Rao, Puja; Reitsma, Marissa B.; Shackelford, Katya A.; Sur, Patrick; Wagner, Joseph A.; Vos, Theo; Lopez, Alan D.; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, Seattle, WA USA.
   [Ellenbogen, Richard G.] Harborview UW Med, Seattle, WA USA.
   [Mock, Charles N.; Quistberg, D. Alex] Harborview Injury Prevent & Res Ctr, Seattle, WA USA.
   [Quistberg, D. Alex] Dept Anesthesiol & Pain Med, Seattle, WA USA.
   [Anderson, Benjamin; Blosser, Christopher D.; Futran, Neal D.; Heckbert, Susan R.; Jensen, Paul N.; Montine, Thomas J.; Tirschwell, David L.; Watkins, David A.] Univ Washington, Seattle, WA 98195 USA.
   [Bhutta, Zulfiqar A.] Ctr Excellence Women & Child Hlth, Karachi, Pakistan.
   [Nisar, Muhammad Imran] Aga Khan Univ, Karachi, Pakistan.
   [Bhutta, Zulfiqar A.; Akseer, Nadia] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada.
   [Charlson, Fiona J.; Erskine, Holly E.; Ferrari, Alize J.; Leung, Janni; Whiteford, Harvey A.; Alam, Khurshid; Knibbs, Luke D.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
   [Lalloo, Ratilal] Univ Queensland, Sch Dent, Brisbane, Qld, Australia.
   [Gouda, Hebe N.; McGrath, John J.] Univ Queensland, Brisbane, Qld, Australia.
   [Charlson, Fiona J.; Erskine, Holly E.; Leung, Janni; Whiteford, Harvey A.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.
   [Jeemon, Panniyammakal] Ctr Control Chron Condit, Gurgaon, Haryana, India.
   [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil] Publ Hlth Fdn India, New Delhi, India.
   [Gething, Peter W.] Dept Zool, Oxford, England.
   [Cooper, Cyrus] NIHR Musculoskeletal Biomed Res Ctr, Oxford, England.
   [Darby, Sarah C.] Clin Trial Serv Unit, Oxford, England.
   [Deribew, Amare] Nuffield Dept Med, Oxford, England.
   [Ali, Raghib; Bennett, Derrick A.; Jha, Vivekanand; Rahimi, Kazem; Van Donkelaar, Aaron] Univ Oxford, Oxford, England.
   [Haagsma, Juanita A.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Kinfu, Yohannes] Univ Canberra, Fac Hlth, Ctr Res & Action Publ Hlth, Canberra, ACT, Australia.
   [Larson, Heidi J.] Dept Infect Dis Epidemiol, London, England.
   [Faghmous, Imad D. A.; Langan, Sinead M.; Mckee, Martin; Satyanarayana Murthy, Gudlavalleti Venkata; Pearce, Neil; Roberts, Bayard] London Sch Hyg & Trop Med, London, England.
   [Lozano, Rafael; Campos-Novato, Ismael Ricardo; Campuzano, Julio Cesar; Gomez-Dantes, Hector; Heredia-Pi, Ileana Beatriz; Mena-Rodriguez, Fabiola; Montanez Hernandez, Julio Cesar; Montero, Pablo; Blancas, Maria Jesus Rios; Servan-Mori, Edson E.; Villalpando, Salvador] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Duan, Leilei; Liu, Shiwei; Wang, Linhong] Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China.
   [Liang, Xiaofeng; Yu, Shicheng] Chinese Ctr Dis Control, Beijing, Peoples R China.
   [Mensah, George A.] NHLBI, NIH, Ctr Translat Res & Implementat Sci, Bethesda, MD USA.
   [Salomon, Joshua A.] Dept Global Hlth & Populat, Boston, MA USA.
   [Al-Raddadi, Rajaa; Barnighausen, Till; Campos-Novato, Ismael Ricardo; Ding, Eric L.; Farvid, Maryam S.; Wagner, Gregory R.] Harvard T H Chan Sch Publ Hlth, Boston, MA USA.
   [James, Peter] Channing Div Network Med, Dept Epidemiol, Boston, MA USA.
   [James, Peter] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Osman, Majdi; Shrime, Mark G.] Harvard Med Sch, Boston, MA USA.
   [Fitchett, Joseph R. A.] Harvard Univ, Boston, MA 02115 USA.
   [Vollset, Stein Emil; Knudsen, Ann Kristin] Ctr Dis Burden, Oslo, Norway.
   [Krog, Norun Hjertager; Savic, Miloje] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Vollset, Stein Emil; Knudsen, Ann Kristin] Dept Global Publ Hlth & Primary Care, Jimma, Ethiopia.
   [Hailu, Alemayehu Desalegne; Norheim, Ole F.] Univ Bergen, Bergen, Norway.
   [Abate, Kalkidan Hassen; Gebrehiwot, Tsegaye Tsewelde; Gebremedhin, Amanuel Tesfay] Jimma Univ, Jimma, Ethiopia.
   [Abbafati, Cristiana] Univ Roma La Sapienza, Rome, Italy.
   [Abbas, Kaja M.] Virginia Tech, Blacksburg, VA USA.
   [Abd-Allah, Foad] Cairo Univ, Dept Neurol, Cairo, Egypt.
   [Abera, Semaw Ferede] Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.
   [Melaku, Yohannes Adama] Sch Publ Hlth, Mekelle, Ethiopia.
   [Tesfay, Fisaha Haile] Coll Hlth Sci, Mekelle, Ethiopia.
   [Abyu, Gebre Yitayih; Aregay, Atsede Fantahun; Betsu, Balem Demtsu; Gebru, Alemseged Aregay; Hailu, Gessessew Bugssa; Yalew, Ayalnesh Zemene; Yebyo, Henock Gebremedhin] Mekelle Univ, Mekelle, Ethiopia.
   [Abera, Semaw Ferede] Kilte AwlaeloHealth & Demog Surveillance Site, Mekelle, Ethiopia.
   [Abera, Semaw Ferede] Univ Hohenheim, Food Secur & Inst Biol Chem & Nutr, Stuttgart, Germany.
   [Abera, Semaw Ferede; Franca, Elisabeth Barboza] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Abu-Raddad, Laith J.] Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.
   [Adelekan, Ademola Lukman] Publ Hlth Promot Alliance, Osogbo, Nigeria.
   [Adelekan, Ademola Lukman; Akinyemi, Rufus Olusola; Ojelabi, Foluke Adetola] Univ Ibadan, Ibadan, Nigeria.
   [Ademi, Zanfina] Univ Basel, Basel, Switzerland.
   [Azzopardi, Peter] Dept Paediat, Melbourne, Vic, Australia.
   [Cowie, Benjamin C.; Gibney, Katherine B.; MacLachlan, Jennifer H.] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.
   [Meretoja, Atte] Dept Med, Melbourne, Vic, Australia.
   [Alam, Khurshid; Azzopardi, Peter; Borschmann, Rohan; Colquhoun, Samantha M.; Patton, George C.; Weintraub, Robert G.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Szoeke, Cassandra E. I.] Inst Hlth & Ageing, Melbourne, Vic, Australia.
   [Vijayakumar, Lakshmi] Ctr Youth Mental Hlth, Melbourne, Vic, Australia.
   [Lopez, Alan D.] Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.
   [Ademi, Zanfina; Alam, Noore K. M.; Bohensky, Megan A.; Borschmann, Rohan; Colquhoun, Samantha M.; Taylor, Hugh R.; Weintraub, Robert G.; Wijeratne, Tissa] Univ Melbourne, Melbourne, Vic, Australia.
   [Adou, Arsene Kouablan] Assoc Ivoirienne Bienetre Familial, Abidjan, Cote Ivoire.
   [Adsuar, Jose C.] Univ Extremadura, Caceres, Spain.
   [Afanvi, Kossivi Agbelenko] Direct Dist Sanitaire Haho, Notse, Togo.
   [Afanvi, Kossivi Agbelenko] Univ Lome, Fac Sci Sante, Lome, Togo.
   [Agardh, Emilie Elisabet] Inst Publ Hlth Sci, Stockholm, Sweden.
   [Akseer, Nadia; Rehm, Jurgen] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Badawi, Alaa] Fac Med, Dept Nutrit Sci, Toronto, ON, Canada.
   [Lindsay, M. Patrice] Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Popova, Svetlana] Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Agarwal, Arnav] Univ Toronto, Toronto, ON, Canada.
   [Agarwal, Arnav] McMaster Univ, Hamilton, ON, Canada.
   [Agarwal, Arnav] SIR Inst Genom & Integrat Biol, Delhi, India.
   [Agarwal, Arnav] Baylor Coll Med, Dept Internal Med, Houston, TX USA.
   [Hotez, Peter J.] Baylor Coll Med, Houston, TX USA.
   [Kiadaliri, Aliasghar Ahmad] Lund Univ, Orthoped Clin Epidemiol Unit, Dept Clin Sci Lund, Lund, Sweden.
   [Norrving, Bo] Lund Univ, Dept Clin Sci Lund, Skane Univ Hosp, Lund, Sweden.
   [Kiadaliri, Aliasghar Ahmad] Kerman Univ Med Sci, Inst Futures Studies Hlth, Hlth Serv Management Res Ctr, Kerman, Iran.
   [Ajala, Oluremi N.] Univ Pittsburgh, Med Ctr, McKeesport, PA USA.
   [Akanda, All Shafqat] Univ Rhode Isl, Kingston, RI USA.
   [Akinyemi, Rufus Olusola] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England.
   [Akinyemiju, Tomi F.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.
   [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA.
   [Al Lami, Faris Hasan] Baghdad Coll Med, Baghdad, Iraq.
   [Alabed, Samer] Univ Sheffield, Sheffield, S Yorkshire, England.
   [Al-Aly, Ziyad] Washington Univ, St Louis, MO USA.
   [Driscoll, Tim R.] Sydney Sch Publ Hlth, Sydney, NSW, Australia.
   [Alam, Khurshid; Kemp, Andrew Haddon; Leigh, James; Mekonnen, Alemayehu B.] Univ Sydney, Sydney, NSW, Australia.
   [Alam, Noore K. M.] Queensland Hlth, Herston, Qld, Australia.
   [Alasfoor, Deena] Minist Hlth, Al Khuwair, Oman.
   [Aldhahri, Saleh Fahed; Altirkawi, Khalid A.] King Saud Univ, Riyadh, Saudi Arabia.
   [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia.
   [Aldhahri, Saleh Fahed] King Fahad Med City, Riyadh, Saudi Arabia.
   [Aldridge, Robert William] UCL, Inst Hlth Informat, Ctr Publ Hlth Data Sci, London, England.
   [Aldridge, Robert William; Banerjee, Amitava] UCL, Farr Inst Hlth Informat Res, London, England.
   [Aldridge, Robert William] UCL, Inst Global Hlth, London, England.
   [Tillmann, Taavi] UCL, Dept Epidemiol & Publ Hlth, London, England.
   [Alegretti, Miguel Angel] Fac Med, Dept Prevent & Social Med, Montevideo, Uruguay.
   [Aleman, Alicia V.] Sch Med, Montevideo, Uruguay.
   [Cavalleri, Fiorella] Fac Med, Montevideo, Uruguay.
   [Colistro, Valentina] Univ Republ Montevideo, Montevideo, Uruguay.
   [Alemu, Zewdie Aderaw] Debre Markos Univ, Debre, Markos, Ethiopia.
   [Alhabib, Samia] King Abdullah Bin Abdulaziz Univ Hosp, Riyadh, Saudi Arabia.
   [Alkerwi, Ala'a] Luxembourg Inst Hlth, Luxembourg, Luxembourg.
   [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France.
   [Allebeck, Peter] Dept Publ Hlth Sci, Stockholm, Sweden.
   [Carrero, Juan Jesus] Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
   [Fereshtehnejad, Seyed-Mohammad] Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.
   [Weiderpass, Elisabete] Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Havmoeller, Rasmus] Karolinska Inst, Stockholm, Sweden.
   [Al-Raddadi, Rajaa] Minist Hlth, Jeddah, Saudi Arabia.
   [Alsharif, Ubai] Charite, Berlin, Germany.
   [Martin, Elena Alvarez] Minist Hlth Social Policy & Equal, Spanish Observ Drugs Govt Delegat Natl Plan Drugs, Madrid, Spain.
   [Alvis-Guzman, Nelson] Univ Cartagena, Cartagena Indias, Colombia.
   [Amare, Azmeraw T.; Melaku, Yohannes Adama] Sch Med, Adelaide, SA, Australia.
   [Ciobanu, Liliana G.; Tessema, Gizachew Assefa] Univ Adelaide, Adelaide, SA, Australia.
   [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.
   [Amegah, Adeladza Kofi; Kudom, Andreas A.] Univ Cape Coast, Cape Coast, Ghana.
   [Ameh, Emmanuel A.] Natl Hosp, Abuja, Nigeria.
   [Amini, Heresh] Kurdistan Univ Med Sci, Environm Hlth Res Ctr, Sanandaj, Iran.
   [Amini, Heresh] Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Karema, Corine Kakizi] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon.
   [Amrock, Stephen Marc] Oregon Hlth & Sci Univ, Portland, OR USA.
   [Andersen, Hjalte H.] Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Aalborg, Denmark.
   [Antonio, Carl Abelardo T.] Univ Philippines, Coll Publ Hlth, Dept Hlth Policy & Adm, Manila, Philippines.
   Univ Philippines, Coll Publ Hlth, Manila, Philippines.
   [Arnlov, Johan; Larsson, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden.
   [Arnlov, Johan] Dalarna Univ, Falun, Sweden.
   [Arsenijevic, Valentina S. Arsic] Univ Belgrade, Inst Microbiol & Immunol, Sch Med, Belgrade, Serbia.
   [Barac, Aleksandra] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Arsenijevic, Valentina S. Arsic] Univ Children Hosp, Belgrade, Serbia.
   [Al Artaman] Univ Manitoba, Winnipeg, MB, Canada.
   [Asayesh, Hamid] Qom Univ Med Sci, Sch Paramed, Dept Emergency Med, Qom, Iran.
   [Asghar, Rana Jawad] South Asian Publ Hlth Forum, Islamabad, Pakistan.
   [Atique, Suleman] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan.
   [Arthur Avokpaho, Euripide Frinel G.] Inst Rech Clin Benin, Cotonou, Benin.
   [Arthur Avokpaho, Euripide Frinel G.; Gankpe, Fortune Gbetoho] Lab Etud & Rech Act & Sante, Parakou, Benin.
   [Awasthi, Ashish] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India.
   [Azzopardi, Peter] South Australian Hlth & Med Res Inst, Wardliparingga Aboriginal Res Unit, Adelaide, SA, Australia.
   [Bacha, Umar] Univ Management & Technol, Sch Hlth Sci, Lahore, Pakistan.
   [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada.
   [Bahit, Maria C.] INECO Neurociencias, Rosario, Argentina.
   [Balakrishnan, Kalpana] Sri Ramachandra Univ, Dept Environm Hlth Engn, Chennai, Tamil Nadu, India.
   [Barker-Collo, Suzanne L.] Univ Auckland, Sch Psychol, Auckland, New Zealand.
   [Barnighausen, Till] Africa Hlth Res Inst, Mtubatuba, South Africa.
   [Barnighausen, Till; Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Barregard, Lars] Univ Gothenburg, Dept Occupat & Environm Hlth, Gothenburg, Sweden.
   [Petzold, Max] Univ Gothenburg, Hlth Metr Unit, Gothenburg, Sweden.
   [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia.
   [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Christchurch, New Zealand.
   [Basu, Sanjay] Stanford Univ, Stanford, CA USA.
   [Bayou, Yibeltal Tebekaw] Jhpiego Ethiopia, Addis Ababa, Ethiopia.
   [Bazargan-Hejazi, Shahrzad] Charles R Drew Univ Med & Sci, Coll Med, Los Angeles, CA USA.
   [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Bazargan-Hejazi, Shahrzad] Kermanshah Univ Med Sci, Kermanshah, Iran.
   [Beardsley, Justin] Univ Oxford, Ho Chi Minh City, Vietnam.
   [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia.
   [Beghi, Ettore] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy.
   [Deribe, Kebede; Hailu, Alemayehu Desalegne] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia.
   [Belay, Haileeyesus Adamu; Giref, Ababi Zergaw; Haile, Demewoz; Jibat, Tariku; Ayele Manamo, Wondimu Ayele; Tefera, Worku Mekonnen; Yirsaw, Biruck Desalegn] Univ Addis Ababa, Addis Ababa, Ethiopia.
   [Sheth, Kevin N.] Yale Univ, Sch Med, New Haven, CT USA.
   [Bell, Michelle L.; Biroscak, Brian J.] Yale Univ, New Haven, CT USA.
   [Bello, Aminu K.] Univ Alberta, Edmonton, AB, Canada.
   [Santos, Itamar S.] Univ Sao Paulo, Dept Internal Med, Sao Paulo, Brazil.
   [Bensenor, Isabela M.; Lotufo, Paulo A.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Berhane, Adugnaw] Debre Berhane Univ, Debre Berhan, Ethiopia.
   [Wolfe, Charles D. A.] Div Hlth & Social Care Res, London, England.
   [Bernabe, Eduardo] Kings Coll London, London, England.
   [Beyene, Addisu Shunu; Gishu, Melkamu Dedefo] Haramaya Univ, Harar, Ethiopia.
   [Bhala, Neeraj] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England.
   [Bhala, Neeraj] Univ Otago, Sch Med, Wellington, New Zealand.
   [Bhalla, Ashish] Postgrad Inst Med Educ & Res, Chandigarh, India.
   [Biadgilign, Sibhatu] Independent Publ Hlth Consultants, Addis Ababa, Ethiopia.
   [Bikbov, Boris] Acad V I Shumakov Fed Res, Ctr Transplantol & Artificial Organs, Dept Nephrol Issues Transplanted Kidney, Moscow, Russia.
   [Bin Abdulhak, Aref A.] Univ Iowa, Hosp & Clin, Iowa City, IA USA.
   [Biroscak, Brian J.] Univ S Florida, Tampa, FL USA.
   [Bjertness, Espen] Univ Oslo, Dept Community Med, Oslo, Norway.
   [Htet, Aung Soe] Univ Oslo, Oslo, Norway.
   [Bose, Dipan] World Bank, Washington, DC USA.
   [Bourne, Rupert R. A.] Anglia Ruskin Univ, Vision & Eye Res Unit, Cambridge, England.
   [Brainin, Michael] Danube Univ Krems, Krems, Austria.
   [Brayne, Carol E. G.] Cambridge Inst Publ Hlth, Cambridge, England.
   [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Dept Publ Hlth, Fac Hlth Sci & Social Work, Trnava, Slovakia.
   [Brazinova, Alexandra] Int Neurotrama Res Org, Vienna, Austria.
   [Shen, Jiabin] Ohio State Univ, Coll Med, Columbus, OH 43210 USA.
   [Breitborde, Nicholas J. K.] Ohio State Univ, Columbus, OH 43210 USA.
   [Brenner, Hermann; Schottker, Ben] German Canc Res Ctr, Heidelberg, Germany.
   [Brewer, Jerry D.] Mayo Clin, Rochester, MN USA.
   [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England.
   [Buckle, Geoffrey Colin; Gosselin, Richard A.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Butt, Zahid A.] Shifa Trust Eye Hosp, Rawalpindi, Pakistan.
   [Calabria, Bianca; Lal, Aparna; Lucas, Robyn M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.
   [Degenhardt, Louisa] Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia.
   [Resnikofff, Serge] Brien Holden Vis Inst, Sydney, NSW, Australia.
   [Resnikofff, Serge] Sch Optometry & Vis Sci, Sydney, NSW, Australia.
   [Calabria, Bianca] Univ New South Wales, Sydney, NSW, Australia.
   [Carapetis, Jonathan R.] Univ Western Australia, Princess Margaret Hosp Children, Telethon Kids Inst, Subiaco, WA, Australia.
   [Cardenas, Rosario] Metropolitan Autonomous Univ, Mexico City, DF, Mexico.
   [Carpenter, David] SUNY Albany, Rensselaer, NY 12144 USA.
   [Castaneda-Oquela, Carlos A.] Colombian Natl Hlth Observ, Inst Nacl Salud, Bogota, Colombia.
   [Castaneda-Oquela, Carlos A.] Univ Nacl Colombia, Dept Publ Hlth, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia.
   [Rivas, Jacqueline Castillo] Caja Costarricense Seguro Social, San Jose, Costa Rica.
   [Rivas, Jacqueline Castillo] Univ Costa Rica, San Pedro, Montes Oca, Costa Rica.
   [Catala-Lopez, Ferran] Univ Valencia, INCLIVA Hlth Res Inst & CIBERSAM, Dept Med, Valencia, Spain.
   [Catala-Lopez, Ferran] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   [Cerda, Jorge] Albany Med Coll, Albany, NY 12208 USA.
   [Chen, Wanqing] Chinese Acad Med Sci, Inst Canc, Beijing, Peoples R China.
   [Chiang, Peggy Pei -Chia] Gold Coast Hlth, Clin Governance Unit, Southport, Qld, Australia.
   [Chibalabala, Mirriam] Crowd Watch Afr, Lusaka, Zambia.
   [Chibueze, Chioma Ezinne; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan.
   [Chimed-Ochir, Odgerel] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan.
   [Jiang, Ying] Univ Occupat & Environm Hlth, Dept Hlth Dev, Inst Ind Ecol Sci, Kitakyushu, Fukuoka, Japan.
   [Takahashi, Ken] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka, Japan.
   [Chisumpa, Vesper Hichilombwe; Mapoma, Chabila C.; Masiye, Felix] Univ Zambia, Lusaka, Zambia.
   [Chisumpa, Vesper Hichilombwe] Univ Witwatersrand, Johannesburg, South Africa.
   [Choi, Jee-Young Jasmine] Seoul Natl Univ Med Lib, Seoul, South Korea.
   [Chowdhury, Rajiv] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Christensen, Hanne] Bispebjerg Hosp, Copenhagen, Denmark.
   [Christopher, Devasahayam Jesudas] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India.
   [Cirillo, Massimo] Univ Salerno, Baronissi, Italy.
   [Cohen, Aaron J.] Hlth Effects Inst, Boston, MA USA.
   [Colistro, Valentina] Minist Salud Publ, Montevideo, Uruguay.
   [Colomar, Mercedes] UNICEM, Montevideo, Uruguay.
   [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
   [Cooper, Cyrus] Univ Southampton, NIHR Biomed Res Ctr, Southampton, Hants, England.
   [Cooper, Cyrus] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.
   [Cooper, Leslie Trumbull] Mayo Clin, Jacksonville, FL 32224 USA.
   [Cortinovis, Monica; Giussani, Giorgia] Mario Negri Inst Pharmacol Res, Milan, Italy.
   [Cowie, Benjamin C.] WHO, Collaborating Ctr Viral Hepatitis, Victorian Infect Dis Reference Lab Melbourne, Melbourne, Vic, Australia.
   [Crump, John A.] Dunedin Sch Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Poulton, Richie G.] Univ Otago, Dunedin, New Zealand.
   [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana.
   [Danawi, Hadi; Refaat, Amany H.] Walden Univ, Minneapolis, MN USA.
   [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England.
   [das Neves, Jose] Univ Porto, Inst Invest & Inovacao Saude I3S, Oporto, Portugal.
   [das Neves, Jose] Univ Porto, INEB, Oporto, Portugal.
   [Massano, Joao] Univ Porto, Fac Med, Oporto, Portugal.
   [Pedro, Joao Mario] Univ Porto, EPIUnit, Oporto, Portugal.
   [Davey, Gail] Wellcome Trust Brighton & Sussex, Ctr Global Hlth Res, Brighton, E Sussex, England.
   [Davis, Adrian C.; Greaves, Felix; Newton, John N.] Publ Hlth England, London, England.
   [Davitoiu, Dragos V.] Univ Med Pharm Bucharest, Bucharest, Romania.
   [de Castro, E. Filipa] Natl Inst Publ Hlth, Mexico City, DF, Mexico.
   [de Jager, Pieter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   [Petzold, Max] Univ Witwatersrand, Johannesburg, South Africa.
   [de Jager, Pieter] Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Johannesburg, South Africa.
   [De Leo, Diego] Griffith Univ, Brisbane, Qld, Australia.
   [Dellavalle, Robert P.] Univ Colorado, Sch Med, Aurora, CO USA.
   [Dellavalle, Robert P.] Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA.
   [Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England.
   [Deribew, Amare] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.
   [Dharmaratne, Samath D.] Univ Peradeniya, Fac Med, Dept Community Med, Peradeniya, Sri Lanka.
   [Jeemon, Panniyammakal] Ctr Control Chron Condit, Gurgaon, India.
   [Dhillon, Preet K.; Ganguly, Parthasarathi; Zodpey, Sanjay] Publ Hlth Fdn India, Gurgaon, India.
   [Diaz-Torne, Cesar] Hosp Santa Creu i Sant Pau, Barcelona, Spain.
   [dos Santos, Kadine Priscila Bender] Univ Estado Santa Catarina, Florianopolis, SC, Brazil.
   [Dubey, Manisha; Rahman, Mohammad Hifz Ur; Singh, Abhishek] Int Inst Populat Sci, Mumbai, Maharashtra, India.
   [Kieling, Christian; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Bell, Brent] Univ N Carolina, Chapel Hill, NC USA.
   [Elyazar, Iqbal] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [Endries, Aman Yesuf] Arba Minch Univ, Arba Minch, Ethiopia.
   [Ermakov, Sergey Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia.
   [Ermakov, Sergey Petrovich] Russian Federat, Fed Res Inst Hlth Org & Informat, Minist Hlth, Moscow, Russia.
   [Eshrati, Babak] Minist Hlth & Med Educ, Tehran, Iran.
   [Eshrati, Babak] Arak Univ Med Sci, Arak, Iran.
   [Esteghamati, Alireza; Hafezi-Nejad, Nima] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran.
   [Fahimi, Saman; Malekzadeh, Reza; Roshandel, Gholamreza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   [Farzadfar, Farshad; Kasaeian, Amir; Parsaeian, Mahboubeh] Univ Tehran Med Sci, Non Communicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.
   [Heydarpour, Pouria] Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Neuroscience Inst, Tehran, Iran.
   [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran.
   [Parsaeian, Mahboubeh] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Sheikhbahaei, Sara] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran.
   [Kuipers, Ernst J.] Dept Hlth, Manila, Philippines.
   [Farid, Talha A.; Khan, Abdur Rahman] Univ Louisville, Louisville, KY 40292 USA.
   [Sa Farinha, Carla Sofia e] DGS Directorate Gen Hlth, Lisbon, Portugal.
   [Sa Farinha, Carla Sofia e] Univ Aberta, Lisbon, Portugal.
   [Faro, Andre] Univ Fed Sergipe, Aracaju, Brazil.
   [Farvid, Maryam S.] Massachusetts Gen Hosp, Harvard MGH Ctr Genom, Mongan Inst Hlth Policy, Vulnerable Populat, Boston, MA 02114 USA.
   [Feigin, Valery L.] Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.
   [Ao, Braden J. Te] Auckland Univ Technol, Auckland, New Zealand.
   [Fernandes, Jefferson G.] German Hosp Oswaldo Cruz, Inst Sci Educ, Sao Paulo, Brazil.
   [Fernandes, Joao C.] Queen Mary Univ London, Ctr Expt Med & Rheumatol, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.
   [Fischer, Florian] Univ Bielefeld, Bielefeld, Germany.
   [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine.
   [Shiue, Ivy] Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland.
   [Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland.
   [Franklin, Richard C.] James Cook Univ, Townsville, Qld, Australia.
   [Futran, Neal D.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England.
   [Piel, Frederic B.] Imperial Coll London, Dept Epidemiol & Biostat, London, England.
   [Greaves, Felix; Majeed, Azeem] Imperial Coll London, London, England.
   [Gall, Seana L.] Univ Tasmania, Hobart, Tas, Australia.
   [Gambashidze, Ketevan; Gamkrelidze, Amiran; Kereselidze, Maia; Shakh-Nazarova, Marina] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Rep of Georgia.
   [Ganguly, Parthasarathi; Iyer, Veena J.] Indian Inst Publ Hlth Gandhinagar, Ahmadabad, Gujarat, India.
   [Gankpe, Fortune Gbetoho] CHU Hassan II, Fes, Morocco.
   [Gebre, Teshome] Task Force Global Hlth, Decatur, GA USA.
   [Gebremedhin, Amanuel Tesfay] Ludwig Maximilians Univ Munchen, Munich, Germany.
   [Gebru, Alemseged Aregay; Hailu, Alemayehu Desalegne] Kilte Awlaelo Hlth & Demog Surveillance Syst, Mekelle, Ethiopia.
   [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.
   [Jibat, Tariku] Wageningen Univ, Wageningen, Netherlands.
   [Gessner, Bradford D.] Agence Med Prevent, Paris, France.
   [Ghoshal, Aloke Gopal] Natl Allergy Asthma Bronchitis Inst, Kolkata, India.
   [Gibney, Katherine B.] Royal Melbourne Hosp, Melbourne, Vic, Australia.
   [Gillum, Richard F.; Mehari, Alem] Howard Univ, Coll Med, Washington, DC 20059 USA.
   [Gilmour, Stuart; Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan.
   [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan.
   [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan.
   [Giroud, Maurice] Univ Hosp Dijon, Dijon, France.
   [Gishu, Melkamu Dedefo] Kersa Hlth & Demog Surveillance Syst, Harar, Ethiopia.
   [Glaser, Elizabeth] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA.
   [Halasa, Yara A.; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA.
   [Gona, Philimon] Univ Massachusetts, Boston, MA USA.
   [Goodridge, Amador] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ciudad Del Saber, Panama.
   [Gopalani, Sameer Vali] Govt Federated States Micronesia, Dept Hlth & Social Affairs, Palikir, Micronesia.
   [Gotay, Carolyn C.; Kissoon, Niranjan; Kopec, Jacek A.; Murthy, Srinivas; Pourmalek, Farshad] Univ British Columbia, Vancouver, BC, Canada.
   [Goto, Atsushi] Ctr Publ Hlth Sci, Div Epidemiol, Tokyo, Japan.
   [Inoue, Manami] Natl Canc Ctr, Tokyo, Japan.
   [Gugnani, Harish Chander] Dept St James Sch Med, Dept Microbiol, The Quarter, Anguilla, England.
   [Gugnani, Harish Chander] Dept St James Sch Med, Dept Epidemiol & Biostat, The Quarter, Anguilla, England.
   [Gupta, Rajeev] West Virginia Bur Publ Hlth, Charleston, WV USA.
   [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India.
   [Gupta, Vipin] Univ Delhi, Dept Anthropol, Delhi, India.
   [Gutierrez, Reyna A.] Natl Inst Psychiat Ramon Fuente, Mexico City, DF, Mexico.
   [Hamadeh, Randah Ribhi] Arabian Gulf Univ, Manama, Bahrain.
   [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Dubai, U Arab Emirates.
   [Handal, Alexis J.] Univ New Mexico, Albuquerque, NM 87131 USA.
   [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA, Australia.
   [Norman, Paul E.] Univ Western Australia, Fremantle, WA, Australia.
   [Hankey, Graeme J.] Harry Perkins Inst Med Res, Nedlands, WA, Australia.
   [Hankey, Graeme J.] Western Australian Neurosci Res Inst, Nedlands, WA, Australia.
   [Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Harikrishnan, Sivadasanpillai] Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum, Kerala, India.
   [Haro, Josep Maria] Parc Sanitari Sant Joan Deu CIBERSAM, Barcelona, Spain.
   [Haro, Josep Maria] Univ Barcelona, Barcelona, Spain.
   [Hilderink, Henk B. M.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.
   [Hoek, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.
   [Tura, Abera Kenay] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   [Hoek, Hans W.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [Hogg, Robert S.] Simon Fraser Univ, Burnaby, BC, Canada.
   [Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.
   [Horino, Masako] Nevada Div Publ & Behav Hlth, Dept Hlth & Human Serv, Carson City, NV USA.
   [Horita, Nobuyuki] Yokohama City Univ Grad Sch Med, Dept Pulmonol, Yokohama, Kanagawa, Japan.
   [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA.
   [Hoy, Damian G.] Pacific Commun, Publ Hlth Div, Noumea, New Caledonia.
   [Hsairi, Mohamed] Salah Azaiz Inst, Dept Epidemiol, Tunis, Tunisia.
   [Htet, Aung Soe] Minist Hlth, Int Relat Div, Nay Pyi Taw, Myanmar.
   [Than Htike, Maung Maung] Minist Hlth, Nay Pyi Taw, Myanmar.
   [Hu, Guoqing] Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China.
   [Huang, Cheng] George Washington Univ, Washington, DC USA.
   [Huang, Hsiang] Cambridge Hlth Alliance, Cambridge, MA USA.
   [Huiart, Laetitia] CHU Reunion, St Denis, France.
   [Husseini, Abdullatif] Birzeit Univ, Birzeit, Israel.
   [Huybrechts, Inge] IARC, Lyon, France.
   [Huybrechts, Inge] Univ Ghent, Ghent, Belgium.
   [Huynh, Grace] Inst Dis Modeling, Bellevue, WA USA.
   [Iburg, Kim Moesgaard] Aarhus Univ, Aarhus, Denmark.
   [Innos, Kaire] Natl Inst Hlth Dev, Tallinn, Estonia.
   [Jacobs, Troy A.] USAID Global Hlth Bur, MCH Div, HIDN, Washington, DC USA.
   [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA USA.
   [Jahanmehr, Nader] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Tehran, Iran.
   [Katibeh, Marzieh] Shahid Beheshti Univ Med Sci, Ophthalm Epidemiol Res Ctr, Tehran, Iran.
   [Rajavi, Zhale; Yaseri, Mehdi] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran.
   [Jakovljevic, Mihajlo B.] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia.
   [Javanbakht, Mehdi] Univ Aberdeen, Aberdeen, Scotland.
   [Jayaraman, Sudha P.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA.
   [Jayatilleke, Achala Upendra] Postgrad Inst Med, Colombo, Sri Lanka.
   [Jayatilleke, Achala Upendra] Inst Violence & Injury Prevent, Colombo, Sri Lanka.
   [Jeemon, Panniyammakal; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India.
   [Jha, Vivekanand] George Inst Global Hlth India, New Delhi, India.
   [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Tianjin, Peoples R China.
   [Jimenez-Corona, Aida] Inst Ophthalmol Conde Valencia, Dept Ocular Epidemiol & Visual Hlth, Mexico City, DF, Mexico.
   [Jimenez-Corona, Aida] Gen Directorate Epidemiol, Minist Hlth, Mexico City, DF, Mexico.
   [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.
   [Joshi, Tushar Kant] Ctr Occupat & Environm Hlth, New Delhi, India.
   [Kabir, Zubair] Natl Univ Ireland Univ Coll Cork, Cork, Ireland.
   [Karnak, Ritul; Kesavachandran, Chandrasekharan Nair] CSIR Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India.
   [She, Jun] Zhongshan Hosp, Lucknow, Uttar Pradesh, India.
   [Shen, Ziyan; Zhang, Hao] Zhongshan Hosp, Dept Nephrol, Lucknow, Uttar Pradesh, India.
   [Kan, Haidong] Fudan Univ, Shanghai, Peoples R China.
   [Kant, Surya] King Georges Med Univ, Lucknow, Uttar Pradesh, India.
   [Karch, Andre] Epidemiol & Stat Methods Res Grp, Helmholtz Ctr Infect Res, Braunschweig, Germany.
   [Karch, Andre] German Ctr Infect Res, Hannover Braunschweig Site, Braunschweig, Germany.
   [Karema, Corine Kakizi] Qual & Equity Hlth Care, Kigali, Rwanda.
   [Karimkhani, Chante] Case Western Univ Hosp, Cleveland, OH USA.
   [Karletsos, Dimitris] Univ Pompeu Fabra, Ctr Res Hlth & Econ, Barcelona, Spain.
   [Karthikeyan, Ganesan; Naik, Nitish; Paul, Vinod K.; Roy, Ambuj; Sagar, Rajesh; Satpathy, Maheswar; Tandon, Nikhil] All India Inst Med Sci, New Delhi, India.
   [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA.
   [Kayibanda, Jeanne Francoise] Inst Rech Ihopital Monttfort, Ottawa, ON, Canada.
   [Keiyoro, Peter Njenga] Inst Trop & Infect Dis, Nairobi, Kenya.
   [Keiyoro, Peter Njenga] Sch Continuing & Distance Educ, Nairobi, Kenya.
   [Lyons, Ronan A.] Farr Inst, Swansea, W Glam, Wales.
   [Kemp, Andrew Haddon] Swansea Univ, Swansea, W Glam, Wales.
   [Parry, Charles D.] Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa.
   [Kengne, Andre Pascal; Matzopoulos, Richard; Wiysonge, Charles Shey] South African Med Res Council, Cape Town, South Africa.
   [Matzopoulos, Richard] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa.
   [Stein, Dan J.] Univ Cape Town, Dept Psychiat, Cape Town, South Africa.
   [Kengne, Andre Pascal; Mayosi, Bongani M.; Watkins, David A.] Univ Cape Town, Cape Town, South Africa.
   [Keren, Andre] Assuta Hosp, Assuta Hashalom, Tel Aviv, Israel.
   [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Irbid, Jordan.
   [Khan, Ejaz Ahmad] Hlth Serv Acad, Islamabad, Pakistan.
   [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea.
   [Won, Sungho] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.
   [Khera, Sahil; Tavakkoli, Mohammad] New York Med Coll, Valhalla, NY USA.
   [Muthafer Khoja, Tawfik Ahmed] Execut Board Hlth Ministers Council Cooperat Coun, Riyadh, Saudi Arabia.
   [Kieling, Christian] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Kim, Yun Jin] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA.
   [Kim, Yun Jin] Southern Univ Coll, Skudai, Malaysia.
   [Kissela, Brett M.] Univ Cincinnati, Cincinnati, OH USA.
   [Kokubo, Yoshihiro] Natl Cerebral Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan.
   [Kolte, Dhaval] Brown Univ, Div Cardiol, Providence, RI 02912 USA.
   [McGarvey, Stephen Theodore] Brown Univ, Providence, RI 02912 USA.
   [Kosen, Soewarta] NIHRD, Ctr Community Empowerment, Hlth Policy & Human, Jakarta, Indonesia.
   [Koul, Parvaiz A.] Sher Kashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India.
   [Koyanagi, Ai] Parc Sanitari Sant Joan Deu CIBERSAM, Res & Dev Unit, Barcelona, Spain.
   [Defo, Barthelemy Kuate] Univ Montreal, Dept Demog & Publ Hlth, Res Inst, Montreal, PQ, Canada.
   [Defo, Barthelemy Kuate] Univ Montreal, Dept Social & Prevent Med, Sch Publ Hlth, Montreal, PQ, Canada.
   [Bicer, Burcu Kucuk] Hacettepe Univ, Inst Publ Hlth, Ankara, Turkey.
   [Kuipers, Ernst J.] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands.
   [Kulkarni, Veena S.] Arkansas State Univ, State Univ, AR USA.
   [Kwan, Gene F.] Boston Univ, Sch Med, Boston, MA USA.
   [Rao, Sowmya R.] Boston Univ, Dept Surg, Sch Med, Boston, MA USA.
   [Lam, Hilton] Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines.
   [Lam, Jennifer O.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Nachega, Jean B.] Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Tran, Bach Xuan] Johns Hopkins Univ, Baltimore, MD USA.
   [Lansingh, Van C.] Help Me See Inc, New York, NY USA.
   [Lansingh, Van C.] Inst Mexicano Oftalmol, Queretaro, Mexico.
   [Laryea, Dennis Odai] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Latif, Asma Abdul] WomenUniv, Lahore Coll, Dept Zool, Lahore, Pakistan.
   [Lawrynowicz, Alicia Elena Beatriz] Inst Nacl Epidemiol Dr Juan H Jara, Mar Del Plata, Argentina.
   [Levi, Miriam] Tuscany Reg Ctr Occupat Injuries & Dis, Florence, Italy.
   [Liu, Yang] San Francisco VA Med Ctr, San Francisco, CA USA.
   [Lindsay, M. Patrice] Heart & Stroke Fdn Canada, Ottawa, ON, Canada.
   [Lipshultz, Steven E.; Wilkinson, James D.] Wayne State Univ, Sch Med, Detroit, MI USA.
   [Lipshultz, Steven E.] Childrens Hosp Michigan, Detroit, MI USA.
   [Simard, Edgar P.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Liu, Yang; Phillips, Michael Robert; Xiao, Qingyang] Emory Univ, Atlanta, GA 30322 USA.
   [Lo, Loon-Tzian] UnionHlth Associates LLC, St Louis, MO USA.
   [Lo, Loon-Tzian] Alton Mental Hlth Ctr, Alton, IL USA.
   [Logroscino, Giancarlo] Univ Bari, Bari, Italy.
   [Lunevicius, Raimundas] Aintree Univ Hosp Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England.
   [Lunevicius, Raimundas] Univ Liverpool, Sch Med, Liverpool, Merseyside, England.
   [Ma, Stefan] Minist Hlth Singapore, Singapore, Singapore.
   [Ma, Stefan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Pedro Machado, Vasco Manuel] Dept Publ Hlth, No Region Hlth Adm, Oporto, Portugal.
   [Mackay, Mark T.; Weintraub, Robert G.] Royal Childrens Hosp, Melbourne, Vic, Australia.
   [Abd El Razek, Hassan Magdy] Mansoura Fac Med, Mansoura, Egypt.
   [Abd El Razek, Mohammed Magdy] Aswan Univ Hosp, Aswan Fac Med, Aswan, Egypt.
   [Mandisarisa, John] JSI Res & Training, Harare, Zimbabwe.
   [Mangalam, Srikanth] Tech Stand & Safety Author, Toronto, ON, Canada.
   [Marcenes, Wagner] Kings Coll London, Div Populat & Patient Hlth, Inst Dent, London, England.
   [Meaney, Peter A.] Univ Penn, Perelman Sch Med, Philadelphia, PA USA.
   [Margolis, David Joel; Silberberg, Donald H.] Univ Penn, Philadelphia, PA USA.
   [Martin, Gerard Robert] Childrens Natl Hlth Syst, Washington, DC USA.
   [Martinez-Raga, Jose] Univ Valencia, Univ Hosp Doctor Peset, Valencia, Spain.
   [Martinez-Raga, Jose] CEU Cardenal Herrera Univ, Valencia, Spain.
   [Marzan, Melvin Barrientos] Univ E Ramon Magsaysay Mem Med Ctr, Quezon City, Philippines.
   [Mason-Jones, Amanda J.] Univ York, Dept Hlth Sci, York, N Yorkshire, England.
   [Massano, Joao] ULS Matosinhos, Hosp Pedro Hispano, Matosinhos, Portugal.
   [McMahon, Brian J.] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA.
   [Meaney, Peter A.] Childrens Hosp Philadelphia, Philadelphia, PA USA.
   [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, New Delhi, India.
   [Woldeyohannes, Solomon Meseret] Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Gondar, Ethiopia.
   [Mekonnen, Alemayehu B.; Tedla, Bemnet Amare; Zeleke, Berihun M.] Univ Gondar, Gondar, Ethiopia.
   [Memiah, Peter] Univ Florida, Pensacola, FL USA.
   [Memish, Ziad A.] Saudi Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   [Mendoza, Walter] United Nations Populat Fund, Lima, Peru.
   [Meretoja, Atte] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
   [Meretoja, Tuomo J.] Helsinki Univ Hosp, Breast Surg Unit, Ctr Comprehens Canc, Helsinki, Finland.
   [Meretoja, Tuomo J.] Univ Helsinki, Helsinki, Finland.
   [Mhimbira, Francis Apolinary] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Micha, Renata; Mozaffarian, Dariush] Friedman Sch Nutr Sci & Policy, Boston, MA USA.
   [Shi, Peilin; Singh, Gitanjali M.] Tufts Univ, Boston, MA 02111 USA.
   [Miller, Ted R.] Pacific Inst Res Evaluat, Calverton, MD USA.
   [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth, Perth, WA, Australia.
   [Abdulmuhsin Mohammad, Karzan] Univ Salahaddin, Erbil, Iraq.
   [Mohammadi, Alireza] Baqiyatallah Univ Med Sci, Neurosci Res Ctr, Tehran, Iran.
   [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria.
   [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India.
   [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Chennai, Tamil Nadu, India.
   [Mola, Glen Liddell D.] Univ Papua New Guinea, Boroko, Papua N Guinea.
   [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
   [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Gastrointestinal & Liver Dis Res Ctr, Dept Community Med, Brisbane, Qld, Australia.
   [Morawska, Lidia] Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld, Australia.
   [Werdecker, Andrea] Competence Ctr Mortal Follow Up German Natl Cohor, Wiesbaden, Germany.
   [Mueller, Ulrich; Westerman, Ronny] Fed Inst Populat Res, Wiesbaden, Germany.
   [Satyanarayana Murthy, Gudlavalleti Venkata] Indian Inst Publ Hlth, Gurgaon, India.
   [Dhillon, Preet K.; Ganguly, Parthasarathi; Lal, Dharmesh Kumar; Zodpey, Sanjay] Publ Hlth Fdn India, Gurgaon, India.
   [Musa, Kamarul Imran] Univ Sci Malaysia, Sch Med Sci, Kubang Kerian, Malaysia.
   [Nachega, Jean B.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
   [Caicedo, Angel J. Paternina] Univ Pittsburgh, Publ Hlth Dynam Lab, Pittsburgh, PA USA.
   [Parry, Charles D.] Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa.
   [Nachega, Jean B.; Seedat, Soraya; Wiysonge, Charles Shey] Univ Stellenbosch, Cape Town, South Africa.
   [Nagel, Gabriele; Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany.
   [Naidoo, Kovin S.; Sartorius, Benn] Univ KwaZulu Natal, Durban, South Africa.
   [Naldi, Luigi; Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy.
   [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India.
   [Nash, Denis] CUNY, Inst Implementat Sci Populat Hlth, Sch Publ Hlth, New York, NY USA.
   [Nejjari, Chakib] Fac Med, Fes, Morocco.
   [Neupane, Subas] Univ Tampere, Sch Hlth Sci, Tampere, Finland.
   [Newton, Charles R.] KEMRI Wellcome Trust, Kilifi, Kenya.
   [Ngalesoni, Frida Namnyak] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania.
   [Ngirabega, Jean de Dieu] East African Community Hlth Res Commiss, Kigali, Rwanda.
   [Quyen Le Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam.
   [Nkamedjie Pete, Patrick Martial] Inst Res Socioecon Dev & Commun, Yaounde, Cameroon.
   [Nomura, Marika] Natl Inst Publ Hlth, Saitama, Japan.
   [Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda.
   [Ogbo, Felix Akpojene] Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia.
   [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo, Japan.
   [Olivares, Pedro R.] Univ Autonoma Chile, Talca, Chile.
   [Olusanya, Bolajoko Olubukunola; Olusanya, Jacob Olusegun] Ctr Healthy Start Initiat, Lagos, Nigeria.
   [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Lira, Uganda.
   [Oren, Eyal] Univ Arizona, Tucson, AZ USA.
   [Ortiz, Alberto] IIS Fdn Jimenez Diaz UAM, Madrid, Spain.
   [Osman, Majdi] YBank, Cambridge, MA USA.
   [Ota, Erika; Ozdemir, Raziye] St Lukes Int Univ, Tokyo, Japan.
   [Ozdemir, Raziye] Karabuk Univ, Karabuk, Turkey.
   [Pa, Mahesh] JSS Univ, JSS Med Coll, Mysore, Karnataka, India.
   [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India.
   [Pant, Puspa Raj] Univ W England, Bristol, Avon, England.
   [Papachristou, Christina] Charite Univ Med Berlin, Berlin, Germany.
   [Park, Eun-Kee] Kosin Univ, Dept Med Human & Social Med, Coll Med, Busan, South Korea.
   [Park, Jae-Hyun] Sungkyunkwan Univ, Samsung Biomed Res Inst, Sch Med, Dept Social & Prevent Med, Suwon, South Korea.
   [Caicedo, Angel J. Paternina] Univ Cartagena, Cartagena, Colombia.
   [Patten, Scott B.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.
   [Tonelli, Marcello] Univ Calgary, Calgary, AB, Canada.
   [Pedro, Joao Mario] Hlth Res Ctr Angola, Caxito, Angola.
   [Stokic, Ljiljana Pejin] Inst Econ, Belgrade, Serbia.
   [Pereira, David M.] Univ Porto, Fac Farm, Dept Quim, Lab Farm,REQUIMTE LAQV, Oporto, Portugal.
   [Perico, Norberto; Remuzzi, Giuseppe] IRCCS Ist Ric Farmacol Mario Negri, Bergamo, Italy.
   [Pesudovs, Konrad; Tesfay, Fisaha Haile] Flinders Univ S Australia, Adelaide, SA, Australia.
   [Phillips, Michael Robert] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China.
   [Pillay, Julian David] Durban Univ Technol, Durban, South Africa.
   [Plass, Dietrich] German Environm Agcy, Exposure Assessment & Environm Hlth Indicators, Berlin, Germany.
   [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA.
   [Platts-Mills, James A.] Univ Virginia, Charlottesville, VA USA.
   [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Pope, C. Arden] Brigham Young Univ, Provo, UT USA.
   [Qorbani, Mostafa] Alborz Univ Med Sci, Sch Med, Dept Community Med, Karaj, Iran.
   [Rafay, Anwar; Rana, Saleem M.] Sch Publ Hlth, Lahore, Pakistan.
   [Rahman, Mahfuzar] Res & Evaluat Div, BRAC, Dhaka, Bangladesh.
   [Rahman, Mahfuzar] Hamad Med Corp, Doha, Qatar.
   [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India.
   [Rajsic, Sasa] UMIT, ERAWEB Program, Hall, Tyrol, Austria.
   [Raju, Murugesan] Univ Missouri, Columbia, MO USA.
   [Rakovac, Ivo] WHO Reg Off Europe, Copenhagen, Denmark.
   [Rana, Saleem M.] Contech Int Hlth Consultants, Lahore, Pakistan.
   [Ranabhat, Chhabi L.] Yonsei Univ, Wonju Coll Med, Inst Poverty Alleviat & Int Dev, Wonju, South Korea.
   [Rangaswamy, Thara] Schizophrenia Res Fdn, Chennai, Tamil Nadu, India.
   [Refaat, Amany H.] Suez Canal Univ, Ismailia, Egypt.
   [Rehm, Jurgen] Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.
   [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Ricci, Stefano] UO Neurol USL Umbria 1, Castello, Italy.
   [Roca, Anna] The Gambia, Med Res Council Unit, Fajara, Gambia.
   [Rojas-Rueda, David] I SGlobal, Barcelona, Spain.
   Golestan Univ Med Sci, Gorgan, Iran.
   [Roshandel, Gholamreza] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran.
   [Roy, Nawal K.] Holmusk, Singapore, Singapore.
   [Roy, Nawal K.] Duke NUS Med Sch, Singapore, Singapore.
   [Ruhago, George Mugambage; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.
   [Saha, Sukanta] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Brisbane, Qld, Australia.
   [Sahathevan, Ramesh] Ballarat Hlth Serv, Ballarat, Vic, Australia.
   [Sahathevan, Ramesh] Univ Kebangsaan Malaysia, Med Ctr, Kuala Lumpur, Malaysia.
   [Saleh, Muhammad Muhammad] Dev Res & Projects Ctr, Abuja, Nigeria.
   [Sanabria, Juan R.] Marshall Univ, Edwards Sch Med J, Huntington, WV USA.
   [Sanabria, Juan R.] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Sanchez-Nino, Maria Dolores] IIS Fdn Jimenez Diaz, Madrid, Spain.
   [Sanchez-Riera, Lidia] LHosp, Inst Invest Biomed Bellvitge IDIBELL, Lhospitalet De Llobregat, Spain.
   [Sarmiento-Suarez, Rodrigo] Univ Ciencias Aplicadas & Ambient, Bogota, Colombia.
   [Sawhney, Monika] Marshall Univ, Huntington, WV USA.
   [Schaub, Michael P.] Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland.
   [Yebyo, Henock Gebremedhin] Univ Zurich, Zurich, Switzerland.
   [Schneider, Ione J. C.; Silva, Diego Augusto Santos] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Schottker, Ben] FOM Univ, Inst Hlth Care & Social Sci, Essen, Germany.
   [Schutte, Aletta E.] Northwest Univ, Hypertens Africa Res Team HART, Potchefstroom, South Africa.
   [Parry, Charles D.] Alcohol, Tobacco Other Drug Res Unit, Potchefstroom, South Africa.
   [Schutte, Aletta E.] South African Med Res Council, Potchefstroom, South Africa.
   [Shaddick, Gavin] Univ Bath, Bath, Avon, England.
   [Shaheen, Amira] Najah Univ, Dept Publ Hlth, Nablus, Israel.
   [Shahraz, Saeid] Tufts Med Ctr, Boston, MA USA.
   [Shaikh, Masood Ali] Independent Consultant, Karachi, Pakistan.
   [Sharma, Rajesh] Indian Inst Technol Ropar, Rupnagar, India.
   [Shen, Jiabin] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA.
   [Shen, Ziyan] Shanghai Kidney & Dialysis Inst, Shanghai, Peoples R China.
   [Shetty, Balakrishna P.] Sri Siddhartha Univ, Tumkur, India.
   [Shetty, Balakrishna P.] ISHA Diagnost, Bangalore, Karnataka, India.
   [Shin, Min-Jeong] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul, South Korea.
   [Shiri, Rahman] Finnish Inst Occupat Hlth, Work Org, Work Disabil Prevent, Helsinki, Finland.
   [Shiue, Ivy] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland.
   [Silveira, Dayane Gabriele Alves] Univ Brasilia, Brasilia, DF, Brazil.
   [Silverberg, Jonathan I.] Feinberg Sch Med, Chicago, IL USA.
   [Yano, Yuichiro] Northwestern Univ, Dept Prevent Med, Chicago, IL USA.
   [Singh, Om Prakash] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India.
   [Singh, Prashant Kumar] Inst Human Dev, New Delhi, India.
   [Singh, Virendra] Asthma Bhawan, Jaipur, Rajasthan, India.
   [Soneji, Samir] Dartmouth Coll, Hanover, NH USA.
   [Soreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway.
   [Soriano, Joan B.] Univ Autonoma Madrid, Inst Invest Hosp Univ Princesa, Madrid, Spain.
   [Sposato, Luciano A.] Western Univ, Dept Clin Neurol Sci, London, ON, Canada.
   [Sreeramareddy, Chandrashekhar T.] Int Med Univ, Dept Community Med, Kuala Lumpur, Malaysia.
   [Stathopoulou, Vasiliki] Attikon Univ Hosp, Athens, Greece.
   [Stein, Dan J.] South African Med Res Council, Unit Anxiety & Stress Disorders, Cape Town, South Africa.
   [Stein, Murray B.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Stranges, Saverio] Luxembourg Inst Hlth, Luxembourg, Luxembourg.
   [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, Athens, Greece.
   [Stroumpoulis, Konstantinos] Ctr Hosp Publ Cotentin, Cherbourg, France.
   [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India.
   [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol, Irvine, CA USA.
   [Sykes, Bryan L.] Univ Calif Irvine, Law & Soc Sociol & Publ Hlth, Irvine, CA USA.
   [Sykes, Bryan L.] Univ Calif Irvine, Irvine, CA USA.
   [Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, INCLIVA Hlth Res Inst & CIBERSAM, Valencia, Spain.
   [Tabb, Karen M.] Univ Illinois, Sch Social Work, Urbana, IL USA.
   [Takala, Jukka S.] WSH Inst, Minist Manpower, Singapore, Singapore.
   [Takala, Jukka S.] Tampere Univ Technol, Tampere, Finland.
   [Talongwa, Roberto Tchio] Minist Hlth, MINSANTE, Yaounde, Cameroon.
   [Taye, Bineyam] Colgate Univ, Dept Biol, Hamilton, NY USA.
   [Tedla, Bemnet Amare] James Cook Univ, Cairns, Qld, Australia.
   [Tefera, Worku Mekonnen] Addis Ababa City Govt, Addis Ababa, Ethiopia.
   [Ten Have, Margreet] Netherlands Inst Mental Hlth & Addict, Utrecht, Netherlands.
   [Terkawi, Abdullah Sulieman] Outcomes Res Consortium, Cleveland, OH USA.
   [Tuzcu, Emin Murat] Cleveland Clin, Cleveland, OH USA.
   [Tessema, Gizachew Assefa] Univ Gondar, Gondar, Ethiopia.
   [Thomson, Alan J.] Adapt Knowledge Management, Victoria, BC, Canada.
   [Thorne-Lyman, Andrew L.] WorldFish, George Town, Malaysia.
   [Thrift, Amanda G.] Monash Univ, Sch Clin Sci Monash Hlth, Dept Med, Melbourne, Vic, Australia.
   [Zeleke, Berihun M.] Monash Univ, Melbourne, Vic, Australia.
   [Thurston, George D.] New York Univ, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY USA.
   [Topor-Madry, Roman] Jagiellonian Univ Med Coll, Inst Publ Hlth, Fac Hlth Sci, Krakow, Poland.
   [Topor-Madry, Roman] Wroclaw Med Univ, Fac Hlth Sci, Wroclaw, Poland.
   [Topouzis, Fotis] Aristotle Univ Thessaloniki, Thessaloniki, Greece.
   [Nx, Jeffrey Allen Towb] Bonheur Childrens Hosp Memphis, Memphis, TN USA.
   [Nx, Jeffrey Allen Towb] Univ Tennessee Hlth Sci Ctr, Memphis, TN USA.
   [Nx, Jeffrey Allen Towb] St Jude Childrens Res Hosp, Memphis, TN USA.
   [Traebert, Jefferson] Univ Southern Santa Catarina, Palhoca, Brazil.
   [Tran, Bach Xuan] Hanoi Med Univ, Hanoi, Vietnam.
   [Truelsen, Thomas] Univ Copenhagen, Dept Neurol, Rigshosp, Copenhagen, Denmark.
   [Trujillo, Ulises] Serv Canario Salud, Santa Cruz de La Palma, CA, Spain.
   [Tura, Abera Kenay] Haramaya Univ, Dire Dawa, Ethiopia.
   [Uchendu, Uche S.] Dept Vet Affairs, Washington, DC USA.
   [Ukwaja, Kingsley N.] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria.
   [Uthman, Olalekan A.] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England.
   [Van Dingenen, Rita] Joint Res Ctr, European Commiss, Ispra, Italy.
   [Van Donkelaar, Aaron] Dalhousie Univ, Dept Phys & Atsmopher Sci, Halifax, NS, Canada.
   [Vasconcelos, Ana Maria Nogales] UKK Inst Hlth Promot Res, Tampere, Finland.
   [Vasconcelos, Ana Maria Nogales] Univ Brasilia, Brasilia, DF, Brazil.
   [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore.
   [Vidavalur, Ramesh] Weill Cornell Med Coll, New York, NY USA.
   [Vijayakumar, Lakshmi] VHS SNEHA, Chennai, Tamil Nadu, India.
   [Violante, Francesco S.] Univ Bologna, Bologna, Italy.
   [Vlassov, Vasiliy Victorovich] Natl Res Univ, Higher Sch Econ, Moscow, Russia.
   [Wagner, Gregory R.] Natl Inst Occupat Safety & Hlth, Washington, DC USA.
   [Wallin, Mitchell T.] VA Med Ctr, Washington, DC USA.
   [Wallin, Mitchell T.] Georgetown Univ, Dept Neurol, Washington, DC USA.
   [Weichenthal, Scott] McGill Univ, Montreal, PQ, Canada.
   [Weiderpass, Elisabete] Canc Registry Norway, Inst Populat Based Canc Res, Dept Res, Oslo, Norway.
   [Weiderpass, Elisabete] Univ Tromso, Arctic Univ Norway, Dept Community Med, Fac Hlth Sci, Tromso, Norway.
   [Weiderpass, Elisabete] Genet Epidemiol Grp, Folkhalsan Res Ctr, Helsinki, Finland.
   [Westerman, Ronny] German Natl Cohort Consortium, Heidelberg, Germany.
   [White, Richard A.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modelling, Oslo, Norway.
   [Kieling, Christian; Krog, Norun Hjertager; Savic, Miloje] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Wijeratne, Tissa] Western Hlth, Footscray, Vic, Australia.
   [Wilkinson, James D.] Childrens Hosp Michigan, Detroit, MI 48201 USA.
   [Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust & Kings Coll, Natl Inst Hlth Res Comprehens Biomed Res Ctr, London, England.
   [Wong, John Q.] Manila Univ, Ateneo Sch Med & Publ Hlth, Pasig, Philippines.
   [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England.
   [Xavier, Denis] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India.
   [Xu, Gelin] Nanjing Univ, Sch Med, Dept Neurol, Jinling Hosp, Nanjing, Jiangsu, Peoples R China.
   [Yakob, Bereket] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.
   [Yan, Lijing L.] Duke Kunshan Univ, Global Hlth Res Ctr, Kunshan, Peoples R China.
   [Yip, Paul] Social Work & Social Adm Dept, Hong Kong, Hong Kong, Peoples R China.
   [Yip, Paul] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.
   [Yirsaw, Biruck Desalegn] Univ South Australia, Mawson Lakes, SA, Australia.
   [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostatist, Kyoto, Japan.
   [Yonga, Gerald] Aga Khan Univ, Nairobi, Kenya.
   [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA.
   [Zaidi, Zoubida] Univ Hosp, Setif, Algeria.
   [Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt.
   [Zannad, Faiez] Univ Lorraine, Clin Invest Ctr, INSERM, Natl Inst Hlth & Med Res, Vandoeuvre Ies Nancy, France.
   [Zannad, Faiez] CHU Nancy, Vandoeuvre Les Nancy, France.
   [Zavala, Diego E.] Ponce Hlth Sci Univ, Ponce, PR USA.
   [Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol, Bremen, Germany.
   [Zhang, Hao] Shanghai Inst Kidney Dis & Dialysis, Shanghai, Peoples R China.
   [Zonies, David] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Zuhlke, Liesl Joanna] Red Cross War Mem Childrens Hosp, Cape Town, South Africa.
RP Murray, CJL (reprint author), 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
EM cjlm@uw.edu
RI ; Qorbani, Mostafa/M-8171-2017; Lotufo, Paulo/A-9843-2008; Karch,
   Andre/D-6973-2017; Patten, Scott/B-4434-2011; Franklin,
   Richard/H-1731-2012; Giussani, Giorgia/E-8057-2017; Musa, Kamarul
   Imran/N-3198-2015; Pereira, David/M-9286-2013; Abbas, Kaja/E-6590-2017;
   Jayatilleke, Achala/H-1714-2017; Satpathy, Maheswar/J-3135-2017;
   Brenner, Hermann/B-4627-2017; Santos, Itamar/K-7055-2012; eshrati,
   babak/M-1152-2017; Alsharif, Ubai/C-6527-2017; Tonelli,
   Marcello/B-3028-2009; Amini, Heresh/B-3076-2010; Ribeiro,
   Antonio/C-2707-2009; Salomon, Joshua/D-3898-2009; Monasta,
   Lorenzo/B-1388-2012; Hankey, Graeme /H-4968-2014; Nagel,
   Gabriele/C-3635-2012; Patton, George/B-5246-2013; Martinez-Raga,
   Jose/B-6251-2017; Majdan, Marek/K-5017-2012; Weiderpass,
   Elisabete/M-4029-2016; Gishu, Melkamu Dedefo/C-3747-2017
OI Kemp, Andrew/0000-0003-1146-3791; Charlson, Fiona/0000-0003-2876-5040;
   Gouda, Hebe/0000-0002-5709-4509; Biroscak, Brian/0000-0002-1323-9358;
   Atique, Suleman/0000-0002-5149-0703; Hoek, Hans/0000-0001-6353-5465;
   Agrawal, Anurag/0000-0002-0340-5252; Yakob, Bereket/0000-0002-8383-6449;
   Bernabe, Eduardo/0000-0002-1858-3713; Heydarpour,
   Pouria/0000-0001-5644-7555; Degenhardt, Louisa/0000-0002-8513-2218;
   Awasthi, Ashish/0000-0002-9308-9782; Piel, Frederic
   B./0000-0001-8131-7728; Kudom, Andreas/0000-0002-7577-9368; Farzadfar,
   Farshad/0000-0001-8288-4046; das Neves, Jose/0000-0002-2317-2759;
   Wijeratne, Tissa/0000-0002-1701-7111; Ukwaja, Kingsley
   N./0000-0002-1974-8735; Miller, Ted/0000-0002-0958-2639; Jakovljevic,
   Mihajlo/0000-0002-9160-6846; Cowie, Benjamin/0000-0002-7087-5895;
   Schutte, Aletta/0000-0001-9217-4937; Massano, Joao/0000-0002-5791-7149;
   Sreeramareddy, Chandrashekhar/0000-0002-5693-7631; Jacobsen,
   Kathryn/0000-0002-4198-6246; Kuate Defo, Barthelemy/0000-0002-6589-0564;
   Wiysonge, Charles/0000-0002-1273-4779; Altirkawi,
   Khalid/0000-0002-7331-4196; Buckle, Geoffrey/0000-0001-7721-0397; Xu,
   Gelin/0000-0002-6194-0341; Al-Aly, Ziyad/0000-0002-2600-0434; Vlassov,
   Vasiliy/0000-0001-5203-549X; Alkerwi, Ala'a/0000-0002-7448-3936; Ahmad
   Kiadaliri, Aliasghar/0000-0002-4254-9099; Kieling,
   Christian/0000-0001-7691-4149; Javanbakht, Mehdi/0000-0002-8661-8439;
   Gething, Peter/0000-0001-6759-5449; Husseini,
   Abdullatif/0000-0001-8767-5956; Taylor, Hugh/0000-0002-9437-784X;
   Lotufo, Paulo/0000-0002-4856-8450; Karch, Andre/0000-0003-3014-8543;
   Patten, Scott/0000-0001-9871-4041; Franklin,
   Richard/0000-0003-1864-4552; Musa, Kamarul Imran/0000-0002-3708-0628;
   Pereira, David/0000-0003-0384-7592; Abbas, Kaja/0000-0003-0563-1576;
   Jayatilleke, Achala/0000-0002-0855-7925; Satpathy,
   Maheswar/0000-0003-3521-4781; Brenner, Hermann/0000-0002-6129-1572;
   Santos, Itamar/0000-0003-3212-8466; Alsharif, Ubai/0000-0002-4024-3950;
   Tonelli, Marcello/0000-0002-0846-3187; Amini,
   Heresh/0000-0002-4825-1322; Ribeiro, Antonio/0000-0002-2740-0042;
   Salomon, Joshua/0000-0003-3929-5515; Monasta,
   Lorenzo/0000-0001-7774-548X; Hankey, Graeme /0000-0002-6044-7328; Nagel,
   Gabriele/0000-0001-6185-8535; Patton, George/0000-0001-5039-8326;
   Martinez-Raga, Jose/0000-0002-2856-6562; Majdan,
   Marek/0000-0001-8037-742X; Weiderpass, Elisabete/0000-0003-2237-0128;
   Gishu, Melkamu Dedefo/0000-0002-3466-1232
FU Bill AMP; Melinda Gates Foundation
FX Bill & Melinda Gates Foundation.
CR AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8
   AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2
   Abu-Zidan FM, 2012, WORLD J SURG, V36, P255, DOI 10.1007/s00268-011-1386-y
   Agua-Agum J, 2015, NEW ENGL J MED, V372, P584, DOI DOI 10.1056/NEJMC1414992
   Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323
   Bhalla K, 2015, INT J EPIDEMIOL, V44, P1648, DOI 10.1093/ije/dyv019
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bidell MR, 2016, INFECT DIS THER, DOI [10.1007/s40121-016-0118-x, DOI 10.1007/S40121-016-0118-X.]
   Birnbaum JK, 2011, B WORLD HEALTH ORGAN, V89, P278, DOI 10.2471/BLT.11.086280
   Bishai D, 2006, HEALTH ECON, V15, P65, DOI 10.1002/hec.1020
   Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207
   Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544
   Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200
   Burnham G., 2006, HUMAN COST WAR IRAQ
   Burnham G, 2006, SCIENCE, V314, P1241
   Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9
   Butchart A, 2014, GLOBAL STATUS REPORT
   CALDWELL JC, 1986, POPUL DEV REV, V12, P171, DOI 10.2307/1973108
   Coale A. J., 1966, REGIONAL MODEL LIFE
   Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975
   Cusimano MD, 2011, INJURY PREV, V17, P43, DOI 10.1136/ip.2009.025502
   Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97
   Darke S, 2010, DRUG ALCOHOL REV, V29, P202, DOI 10.1111/j.1465-3362.2009.00099.x
   Deaton A, 2003, J ECON LIT, V41, P113, DOI 10.1257/002205103321544710
   Department of Peace and Conflict Research, UPPS CONFL DAT PROGR
   Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825
   Duncan ME, 2014, EUROPACE, V16, P797, DOI 10.1093/europace/eut388
   Eaton J., READ EPP SPECTRUM
   ENSR, 2008, NAT ROAD SAF STRAT 2
   Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472
   Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7
   Fekadu A, 2015, BRIT J PSYCHIAT, V206, P289, DOI 10.1192/bjp.bp.114.149112
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Ferrari AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091936
   Flaxman AD, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0061-1
   Flaxman AD, 2015, INTEGRATIVE METAREGR
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1
   Forouzanfar MH, 2016, LANCET, V388, P1659
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Garcia-Garcia G, 2005, KIDNEY INT, V68, pS58, DOI 10.1111/j.1523-1755.2005.09710.x
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   The GATHER Working Group, 2016, LANCET
   Gomez-Dantes H, 2016, LANCET
   Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799
   Guha-Sapir D., EM DAT CRED OFDA INT
   Gupta PD, 1993, STANDARDIZATION DECO
   Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616
   Hahn RA, 2005, AM J PREV MED, V28, P40, DOI 10.1016/j.amepre.2004.10.005
   Helleringer S, 2014, DEMOGRAPHY, V51, P387, DOI 10.1007/s13524-013-0268-3
   Hill K, 2015, LANCET GLOB HEALTH, V3, pE609, DOI 10.1016/S2214-109X(15)00044-3
   Hill K, 2009, DEMOGR RES, V21, P235, DOI 10.4054/DemRes.2009.21.9
   Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1
   Hyder AA, 2014, B WORLD HEALTH ORGAN, V92, P423, DOI 10.2471/BLT.13.132613
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans International Agency for Research on Cancer, 2012, REV HUM CARC
   The International Institute for Strategic Studies, ARM CONFL DAT
   [Anonymous], HAND GLOB PROGR UN E
   JH Bloomberg School of Public Health, MAT CHILD EP EST
   Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555
   Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6
   Komenda P, 2014, AM J KIDNEY DIS, V63, P789, DOI 10.1053/j.ajkd.2013.12.012
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kuhns JB, 2013, HOMICIDE STUD
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853
   Leavy JE, 2015, J COMMUN HEALTH, V40, P725, DOI 10.1007/s10900-015-9991-6
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X
   Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4
   Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12
   Lo S, 2015, LANCET, V386, P106, DOI 10.1016/S0140-6736(15)61040-6
   Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lopez AD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0333-4
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50
   Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816
   Lunyera J, 2016, CLIN J AM SOC NEPHRO, V11, P379, DOI 10.2215/CJN.07500715
   Luoma J, 2012, ROAD SAFETY MANAGEME
   Malhotra J, 2016, EUR RESPIR J, V48, P889, DOI 10.1183/13993003.00359-2016
   Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064
   Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157
   Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Motohashi Y, 2007, SUICIDE LIFE-THREAT, V37, P593, DOI 10.1521/suli.2007.37.5.593
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6
   Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4
   Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262
   Murray CJ, 1996, GLOBAL BURDEN DIS CO
   Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Murray CJL, 2015, LANCET
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9
   Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6
   Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X
   Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260
   Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737
   OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025
   OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375
   Osby U, 2016, EUR J PUBLIC HEALTH, DOI [10.1093/eurpub/ckv245, DOI 10.1093/EURPUB/CKV245.]
   Ozyilmaz A, 2012, NEPHROL DIAL TRANSPL, V27, P4046, DOI 10.1093/ndt/gfs438
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Perez K, 2007, AM J PUBLIC HEALTH, V97, P1632, DOI 10.2105/AJPH.2006.093195
   Peterson HM, 2013, LANCET, V381, P110
   PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509
   Public Health England, 2014, EV ACT OPP PROT IMPR
   Qian MB, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-4
   Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X
   Ramsey R, 2012, PUBLIC HEALTH NUTR, V15, P227, DOI 10.1017/S1368980011001996
   [Anonymous], STRAUSS CTR INT SECU
   Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a
   Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x
   Rudan I, 2015, LANCET, V385, P92, DOI 10.1016/S0140-6736(14)62006-7
   Sahoo SK, 2012, NANOTECHNOLOGY HLTH
   Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327
   Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1
   Schneider MT, 2016, AIDS, V30, P1475, DOI 10.1097/QAD.0000000000001081
   Serina P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0528-8
   Shah A Dinesh, 2015, LANCET S1, V385, pS86
   Shallcross LJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0082
   Shi T, 2015, J GLOB HEALTH, V5, P122, DOI 10.7189/jogh.05.010408
   Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7
   Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971
   Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640
   Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25362
   Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438
   Tapp Christine, 2008, Confl Health, V2, P1, DOI 10.1186/1752-1505-2-1
   Thomas B, 2015, J AM SOC NEPHROL, V26, P2621, DOI 10.1681/ASN.2014101017
   Traffic general directorate, SPAN ROAD SAF STRAT
   United Nations Department of International Economic and Social Aff airs, 1982, MOD LIF TABL DEV COU
   United Nations Development Programme, 2016, HUM DEV REP 2015
   United Nations High Commissioner for Refugees, UNHCR TOT NUMB SYR R
   United Nations Office on Drugs and Crime, 2013, GLOB STUD HOM 2013 T
   [Anonymous], INTR UNICEFS WORK ST
   National Center for Health Statistics (US), 1991, 1993 NAT MORT FOLL S
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6
   Wallis BA, 2015, INJURY PREV, V21, P195, DOI 10.1136/injuryprev-2014-041216
   Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1
   Health Organization World, 2014, WHO METH DAT SOURC C
   World Health Organization (WHO), 2014, WHO MORT DAT VERS FE
   WHO, 2005, WHO STAT 1 M INT HLT
   WHO, 2014, GLOB REP DROWN PREV
   World Health Organization, EST 2000 2012
   World Health Organization, 2015, GLOB TUB REP 2015
   World Health Organization, NUMB DEATHS 1000S DA
   [Anonymous], DENG VACC RES
   [Anonymous], EST 2000 2015
   World Health Organization, 2014, ANT RES GLOB REP SUR
   World Health Organization, 2013, WHO METH DAT SOURC G
   Xie XF, 2016, AM J KIDNEY DIS, V67, P728, DOI 10.1053/j.ajkd.2015.10.011
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6
   [Anonymous], 2015, FIRS CALLS CONTINUED
NR 162
TC 70
Z9 86
U1 165
U2 215
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD OCT 8
PY 2016
VL 388
IS 10053
BP 1459
EP 1544
PG 86
WC Medicine, General & Internal
SC General & Internal Medicine
GA DY7BU
UT WOS:000385285000007
OA No
HC Y
HP Y
DA 2017-08-15
ER

PT J
AU Qamar, FN
   Nisar, MI
   Quadri, F
   Shakoor, S
   Sow, SO
   Nasrin, D
   Blackwelder, WC
   Wu, Y
   Farag, T
   Panchalingham, S
   Sur, D
   Qureshi, S
   Faruque, ASG
   Saha, D
   Alonso, PL
   Breiman, RF
   Bassat, Q
   Tamboura, B
   Ramamurthy, T
   Kanungo, S
   Ahmed, S
   Hossain, A
   Das, SK
   Antonio, M
   Hossain, MJ
   Mandomando, I
   Tennant, SM
   Kotloff, KL
   Levine, MM
   Zaidi, AKM
AF Qamar, Farah Naz
   Nisar, Muhammad Imran
   Quadri, Farheen
   Shakoor, Sadia
   Sow, Samba O.
   Nasrin, Dilruba
   Blackwelder, William C.
   Wu, Yukun
   Farag, Tamer
   Panchalingham, Sandra
   Sur, Dipika
   Qureshi, Shahida
   Faruque, Abu S. G.
   Saha, Debasish
   Alonso, Pedro L.
   Breiman, Robert F.
   Bassat, Quique
   Tamboura, Boubou
   Ramamurthy, Thandavarayan
   Kanungo, Suman
   Ahmed, Shahnawaz
   Hossain, Anowar
   Das, Sumon K.
   Antonio, Martin
   Hossain, M. Jahangir
   Mandomando, Inacio
   Tennant, Sharon M.
   Kotloff, Karen L.
   Levine, Myron M.
   Zaidi, Anita K. M.
TI Aeromonas-Associated Diarrhea in Children under 5 Years: The GEMS
   Experience
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID GLOBAL ENTERIC MULTICENTER; DEVELOPING-COUNTRIES; CHILDHOOD
   GASTROENTERITIS; YOUNG-CHILDREN; PREVALENCE; INFANTS; CASE/CONTROL;
   ENTEROTOXIN; INFECTIONS; HYDROPHILA
AB We report the clinical findings, epidemiology, and risk factors for moderate-to-severe diarrhea (MSD) associated with Aeromonas species in children 0-59 months of age, from the Global Enteric Multicenter Study, conducted at three sites in south Asia and four sites in sub-Saharan Africa. Children with MSD were enrolled along with controls matched for age, gender, and neighborhood. Pooled, age-stratified conditional logistic regression models were applied to evaluate the association of Aeromonas infection controlling for coinfecting pathogens and socio-demographic variables. A pooled, age-stratified, multivariate logistic regression analysis was done to identify risk factors associated with Aeromonas positivity in MSD cases. A total of 12,110 cases and 17,291 matched controls were enrolled over a period of 48 months. Aeromonas was identified as a significant pathogen in 736 cases of MSD in Pakistan and Bangladesh (22.2%). Aeromonas remained a significant pathogen even after adjustment for the presence of other pathogens and sociodemographic factors. Odds ratio (OR) for Aeromonas were higher in the presence of Shigella (matched OR: 6.2, 95% confidence interval [CI]: 1.9-20.2). Cases of Aeromonas were likely to present with dysentery, particularly in the 0-11 months (OR: 1.4, 95% CI 1.0-2.0) and 12-23 months (OR: 1.8, 95% CI: 1.3-2.5) age group. The odds of Aeromonas increased with increasing degree of stunting, being highest for severe stunting (OR: 10.1, 95% CI: 3.6-28.9). Aeromonas is a significant pathogen for MSD in Pakistan and Bangladesh. Presence of dysentery and co-occurrence with other pathogens, notably Shigella spp. are significant features of Aeromonas-associated diarrhea.
C1 [Qamar, Farah Naz; Nisar, Muhammad Imran; Quadri, Farheen; Shakoor, Sadia; Qureshi, Shahida; Tamboura, Boubou] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.
   [Sow, Samba O.] Minist Hlth, Ctr Vaccine Dev, Bamako, Mali.
   [Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun; Farag, Tamer; Panchalingham, Sandra; Tennant, Sharon M.; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Baltimore Sch Med, Dept Med, College Pk, MD 20742 USA.
   [Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun; Farag, Tamer; Tennant, Sharon M.; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Farag, Tamer; Zaidi, Anita K. M.] Bill & Melinda Gates Fdn, Vaccine Dev & Surveillance, Seattle, WA USA.
   [Sur, Dipika; Ramamurthy, Thandavarayan; Kanungo, Suman] Natl Inst Cholera & Enter Dis, Div Epidemiol, Kolkata, India.
   [Faruque, Abu S. G.] Int Ctr Diarrheal Dis Res Icddr B, Clin Sci Div, Dhaka, Bangladesh.
   [Saha, Debasish; Ahmed, Shahnawaz; Hossain, Anowar; Das, Sumon K.] Int Ctr Diarrheal Dis Res Icddr B, CNFS, Dhaka, Bangladesh.
   [Alonso, Pedro L.; Bassat, Quique; Mandomando, Inacio] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Int Hlth Res, Barcelona, Spain.
   [Alonso, Pedro L.; Mandomando, Inacio] CISM, Microbiol, Maputo, Mozambique.
   [Breiman, Robert F.] Ctr Dis Control & Prevent KEMRI CDC, Kenya Med Res Inst, Int Emerging Infect Program, Nairobi, Kenya.
   [Bassat, Quique] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Tamboura, Boubou] CVD Mali, CNAM, Bamako, Mali.
   [Antonio, Martin; Hossain, M. Jahangir] Med Res Council MRC Unit, Mol Diagnost, Child Survival Theme, Banjul, Gambia.
RP Qamar, FN (reprint author), Aga Khan Univ Hosp, Dept Pediat & Child Hlth, Stadium Rd,POB 3500, Karachi 74800, Pakistan.
EM farah.qamar@aku.edu
OI Antonio, Martin/0000-0002-4810-1308; Nisar, Muhammad
   Imran/0000-0002-2378-4720
FU BMG foundation
FX The parent study (GEMS) was funded by the BMG foundation.
CR Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785
   Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788
   BURKE V, 1983, J INFECT DIS, V148, P68
   Dallal MMS, 2004, ANN TROP PAEDIATR, V24, P45, DOI 10.1179/027249304225013231
   Dixit S, 2011, J Nepal Health Res Counc, V9, P181
   FIGURA N, 1986, J CLIN MICROBIOL, V23, P595
   Ghenghesh KS, 2008, J INFECT DEV COUNTR, V2, P81, DOI 10.3855/T2.2.81
   Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09
   Klontz EH, 2012, ISRN MICROBIOL, V2012
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   KOTLOFF KL, 1988, PEDIATR INFECT DIS J, V7, P753, DOI 10.1097/00006454-198811000-00002
   LAUTROP H, 1961, ACTA PATHOL MIC SC, V51, P299
   LAWSON MA, 1985, INFECT IMMUN, V47, P680
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   PAZZAGLIA G, 1991, J CLIN MICROBIOL, V29, P1151
   Sinha S, 2004, J MED MICROBIOL, V53, P527, DOI 10.1099/jmm.0.05269-0
   von Graevenitz A, 2007, INFECTION, V35, P59, DOI 10.1007/s15010-007-6243-4
   Xu XJ, 1998, INFECT IMMUN, V66, P3501
NR 19
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2016
VL 95
IS 4
BP 774
EP 780
DI 10.4269/ajtmh.16-0321
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VB
UT WOS:000400206500010
PM 27527635
OA No
DA 2017-08-15
ER

PT J
AU Cheng, YC
   Huang, CH
   Lin, WR
   Lu, PL
   Chang, K
   Tsai, JJ
   Bojang, KS
   Lin, CY
   Chen, YH
AF Cheng, Yu-Chen
   Huang, Chung-Hao
   Lin, Wei-Ru
   Lu, Po-Liang
   Chang, Ko
   Tsai, Jih-Jin
   Bojang, Kebba S.
   Lin, Chun-Yu
   Chen, Yen-Hsu
TI Clinical outcomes of septic patients with diabetic ketoacidosis between
   2004 and 2013 in a tertiary hospital in Taiwan
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE Acute kidney injury; Diabetic ketoacidosis; End-stage kidney disease
   (RIFLE) classification; Failure; Injury; Loss; Risk; Sepsis
ID ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; ACUTE-RENAL-FAILURE;
   INFECTIOUS-DISEASES-SOCIETY; RIFLE CRITERIA; ANTIMICROBIAL THERAPY;
   HYPERGLYCEMIC CRISES; GUIDELINES; MANAGEMENT; ADULTS
AB Background: Infection is the most common predisposing factor for diabetic ketoacidosis (DKA); however, studies are rare that have investigated the clinical outcomes of septic patients with infection-precipitated DKA.
   Methods: A retrospective cohort study was conducted at a tertiary hospital from 2004 to 2013. Patients with DKA in whom the presence of a predisposing infection was confirmed were enrolled. Characteristics at initial presentation, primary infection sources, and causative microorganisms were compared between the nonacute kidney injury (non-AKI) group and acute kidney injury (AKI) group at each stage. Risk factors for the development of failure-stage AKI and its outcomes were also analyzed.
   Results: One hundred and sixty DKA episodes were assessed. The most common infection sites were the urinary and respiratory tracts. The leading causative microorganism was Escherichia coli, followed by Klebsiella pneumoniae. A complicated/severe infection state [odds ratio (OR), 15.27; p < 0.001] and a high level of C-reactive protein (OR, 1.012; p < 0.001) were independently associated with bacteremia. Corrected sodium (Na; OR, 1.062; p = 0.039), initial plasma glucose (OR, 1.003; p Z 0.041), severe grade of DKA (OR, 13.41; p Z 0.045), and the Acute Physiology and Chronic Health Evaluation (APACHE) II score (OR, 1.08; p Z 0.033) were identified as independent risk factors for the development of failure-stage AKI among septic patients with infection-precipitated DKA. Patients with failure-stage AKI had a higher frequency of incomplete recovery of renal function (20.4% of patients in failure vs. 5.9% of patients in risk and injury, p = 0.009). Bacteremia independently predicted the absence of complete recovery of renal function (OR, 5.86; p = 0.038).
   Conclusion: For patients with infection-precipitated DKA, the clinician should aggressively monitor renal function if a patient presents with risk factors associated with failure-stage AKI. Furthermore, bacteremia predicts a poor renal prognosis. Copyright (C) 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license.
C1 [Cheng, Yu-Chen; Huang, Chung-Hao; Lin, Wei-Ru; Lu, Po-Liang; Tsai, Jih-Jin; Lin, Chun-Yu; Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, 100 Tzyou First Rd, Kaohsiung, Taiwan.
   [Lu, Po-Liang; Lin, Chun-Yu; Chen, Yen-Hsu] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.
   [Lu, Po-Liang; Tsai, Jih-Jin; Lin, Chun-Yu; Chen, Yen-Hsu] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.
   [Lu, Po-Liang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Div Clin Microbiol, Kaohsiung, Taiwan.
   [Chang, Ko] Kaohsiung Municipal Hsaio Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan.
   [Bojang, Kebba S.] Royal Victoria Teaching Hosp, Dept Emergency Med, Banjul, Gambia.
RP Lin, CY (reprint author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, 100 Tzyou First Rd, Kaohsiung, Taiwan.
EM infectionman@gmail.com
FU Kaohsiung Medical University Hospital [KMUH98-8G14]
FX This study was supported in part by a grant (number KMUH98-8G14) from
   the Kaohsiung Medical University Hospital.
CR Al-Matrafi Jamila, 2009, Saudi J Kidney Dis Transpl, V20, P831
   Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2
   Bakker J, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-12
   Barrantes F, 2008, CRIT CARE MED, V36, P1397, DOI 10.1097/CCM.0b013e318168fbe0
   Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872
   Cartin-Ceba R, 2012, CRIT CARE RES PRACT, V2012, DOI [10.1155/2012/691013, DOI 10.1155/2012/691013]
   Cruz DN, 2007, CLIN J AM SOC NEPHRO, V2, P418, DOI 10.2215/CJN.03361006
   DANDONA P, 1986, DIABETES RES CLIN EX, V3, P433
   Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/S0002-9343(03)00505-9
   Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915
   Jansen TC, 2009, CRIT CARE MED, V37, P2827, DOI 10.1097/CCM.0b013e3181a98899
   Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4
   Khan MR, 2013, INDIAN PEDIATR, V50, P697, DOI 10.1007/s13312-013-0175-0
   Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032
   Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI 10.1093/cid/cis346
   MALONE ML, 1992, J AM GERIATR SOC, V40, P1100
   Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159
   MURDOCH IA, 1993, ACTA PAEDIATR, V82, P498, DOI 10.1111/j.1651-2227.1993.tb12734.x
   Nicolle L E, 2005, Can J Infect Dis Med Microbiol, V16, P349
   Piccinni P, 2011, MINERVA ANESTESIOL, V77, P1072
   Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610
   Ranzani Otavio Tavares, 2013, Rev Bras Ter Intensiva, V25, P270, DOI 10.5935/0103-507X.20130047
   Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554
   Stentz FB, 2004, DIABETES, V53, P2079, DOI 10.2337/diabetes.53.8.2079
   Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]
   Suh SH, 2013, YONSEI MED J, V54, P965, DOI 10.3349/ymj.2013.54.4.965
   Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F
   Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5
   WOODROW G, 1994, POSTGRAD MED J, V70, P192
NR 29
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD OCT
PY 2016
VL 49
IS 5
BP 663
EP 671
DI 10.1016/j.jmii.2014.08.018
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC6SU
UT WOS:000388267800005
PM 25442866
OA gold
DA 2017-08-15
ER

PT J
AU Senghore, M
   Bayliss, SC
   Kwambana-Adams, BA
   Foster-Nyarko, E
   Manneh, J
   Dione, M
   Badji, H
   Ebruke, C
   Doughty, EL
   Thorpe, HA
   Jasinska, AJ
   Schmitt, CA
   Cramer, JD
   Turner, TR
   Weinstock, G
   Freimer, NB
   Pallen, MJ
   Feil, EJ
   Antonio, M
AF Senghore, Madikay
   Bayliss, Sion C.
   Kwambana-Adams, Brenda A.
   Foster-Nyarko, Ebenezer
   Manneh, Jainaba
   Dione, Michel
   Badji, Henry
   Ebruke, Chinelo
   Doughty, Emma L.
   Thorpe, Harry A.
   Jasinska, Anna J.
   Schmitt, Christopher A.
   Cramer, Jennifer D.
   Turner, Trudy R.
   Weinstock, George
   Freimer, Nelson B.
   Pallen, Mark J.
   Feil, Edward J.
   Antonio, Martin
TI Transmission of Staphylococcus aureus from Humans to Green Monkeys in
   The Gambia as Revealed by Whole-Genome Sequencing
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID APE POPULATIONS; INFECTIONS; STRAINS; HOST; BACTEREMIA; FRAMEWORK;
   PROTEIN; AFRICA; GENE; WILD
AB Staphylococcus aureus is an important pathogen of humans and animals. We genome sequenced 90 S. aureus isolates from The Gambia: 46 isolates from invasive disease in humans, 13 human carriage isolates, and 31 monkey carriage isolates. We inferred multiple anthroponotic transmissions of S. aureus from humans to green monkeys (Chlorocebus sabaeus) in The Gambia over different time scales. We report a novel monkey-associated clade of S. aureus that emerged from a human-to-monkey switch estimated to have occurred 2,700 years ago. Adaptation of this lineage to the monkey host is accompanied by the loss of phage-carrying genes that are known to play an important role in human colonization. We also report recent anthroponotic transmission of the well-characterized human lineages sequence type 6 (ST6) and ST15 to monkeys, probably because of steadily increasing encroachment of humans into the monkeys' habitat. Although we have found no evidence of transmission of S. aureus from monkeys to humans, as the two species come into ever-closer contact, there might be an increased risk of additional interspecies exchanges of potential pathogens.
C1 [Senghore, Madikay; Kwambana-Adams, Brenda A.; Foster-Nyarko, Ebenezer; Manneh, Jainaba; Dione, Michel; Badji, Henry; Ebruke, Chinelo; Antonio, Martin] MRC Unit, Fajara, Gambia.
   [Senghore, Madikay; Doughty, Emma L.; Pallen, Mark J.; Antonio, Martin] Univ Warwick, Coventry, W Midlands, England.
   [Bayliss, Sion C.; Thorpe, Harry A.; Feil, Edward J.] Univ Bath, Bath, Avon, England.
   [Jasinska, Anna J.; Schmitt, Christopher A.; Freimer, Nelson B.] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Cramer, Jennifer D.] Amer Mil Univ, Charles Town, WV USA.
   [Cramer, Jennifer D.] Amer Publ Univ, Charles Town, WV USA.
   [Turner, Trudy R.] Univ Wisconsin, Milwaukee, WI 53201 USA.
   [Turner, Trudy R.] Univ Free State, Bloemfontein, South Africa.
   [Weinstock, George] Washington Univ, St Louis, MO USA.
   [Antonio, Martin] London Sch Hyg & Trop Med, London, England.
   [Dione, Michel] Int Livestock Res Inst, Kampala, Uganda.
   [Schmitt, Christopher A.] Boston Univ, Boston, MA 02215 USA.
   [Weinstock, George] Jackson Lab Genom Med, Farmington, CT USA.
RP Pallen, MJ (reprint author), Univ Warwick, Coventry, W Midlands, England.
EM m.pallen@warwick.ac.uk
FU HHS \ National Institutes of Health (NIH) [R01RR016300, R01OD010980];
   Medical Research Council (MRC) [G1000803, MR/L015080/1]
FX This work, including the efforts of Nelson Freimer, was funded by HHS
   vertical bar National Institutes of Health (NIH) (R01RR016300 and
   R01OD010980). This work, including the efforts of Sion C. Bayliss, Mark
   J. Pallen, and Edward J. Feil, was funded by Medical Research Council
   (MRC) (G1000803 and MR/L015080/1).
CR Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Becker S, 2014, P NATL ACAD SCI USA, V111, P1574, DOI 10.1073/pnas.1317181111
   Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063
   Clinical and Laboratory Standards Institute, 2008, M100S17 CLSI
   Ebruke C, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0661-3
   Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307.3316.2003
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x
   Garcia A, 2009, J MED PRIMATOL, V38, P377, DOI 10.1111/j.1600-0684.2009.00363.x
   Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2
   Huber H, 2010, EURO SURVEILL, V15
   Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6
   Jarraud S, 2001, J IMMUNOL, V166, P669
   Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040
   Lee JI, 2011, J MED PRIMATOL, V40, P188, DOI 10.1111/j.1600-0684.2011.00470.x
   Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006
   Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004
   Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715
   Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106
   Ma DZ, 2014, J VIROL, V88, P5687, DOI 10.1128/JVI.03606-13
   McCarthy AJ, 2013, INFECT GENET EVOL, V19, P7, DOI 10.1016/j.meegid.2013.06.012
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Moon BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09784
   Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007
   Musiime V, 2013, PEDIATR INFECT DIS J, V32, P856, DOI 10.1097/INF.0b013e31828c3991
   Nagel M, 2013, CLIN MICROBIOL INFEC, V19, P1072, DOI 10.1111/1469-0691.12119
   Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421
   Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Schaumburg F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.001
   Schaumburg F, 2012, AM J PRIMATOL, V74, P1071, DOI 10.1002/ajp.22067
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Shepheard MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062369
   Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13
   Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0
   Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14
   Tong SYC, 2015, INT J SYST EVOL MICR, V65, P15, DOI 10.1099/ijs.0.062752-0
   Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111
   Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12
   van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006
   ZHENG W, 1995, APPL ENVIRON MICROB, V61, P4310
NR 44
TC 2
Z9 2
U1 1
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD OCT
PY 2016
VL 82
IS 19
BP 5910
EP 5917
DI 10.1128/AEM.01496-16
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA DX0JX
UT WOS:000384048700018
PM 27474712
OA No
DA 2017-08-15
ER

PT J
AU Clarke, E
   Kampmann, B
   Goldblatt, D
AF Clarke, Ed
   Kampmann, Beate
   Goldblatt, David
TI Maternal and neonatal pneumococcal vaccination - where are we now?
SO EXPERT REVIEW OF VACCINES
LA English
DT Review
DE Streptococcus pneumoniae; pneumococcus; maternal vaccination; neonatal
   vaccination; 23-valent pneumococcal polysaccharide vaccine; pneumococcal
   conjugate vaccine; safety; immunogenicity; nasopharyngeal carriage
ID CAPSULAR POLYSACCHARIDE VACCINE; VITAMIN-A SUPPLEMENTATION; CONJUGATE
   VACCINE; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE;
   HAEMOPHILUS-INFLUENZAE; SYSTEMATIC ANALYSIS; PLACENTAL-TRANSFER; DOSING
   SCHEDULES; GAMBIAN INFANTS
AB Pneumococcus is a significant pathogen in neonates and in early infancy, particularly as a cause of invasive disease in sub-Saharan Africa where nasopharyngeal carriage rates are also exceptionally high. The pneumococcal-conjugate vaccines have now been rolled out in many high income settings and an increasing number of low and middle income countries. They have been highly effective at preventing vaccine serotype disease in infants. However, a window of susceptibility remains prior to the first vaccination at around six weeks of age. This paper summarizes the data available on both maternal and neonatal vaccination to prevent disease in newborns and early infancy and considers the key challenges and next steps for research in the field.
C1 [Clarke, Ed; Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, POB 273, Banjul, Gambia.
   [Kampmann, Beate] Imperial Coll London, Acad Dept Paediat, London, England.
   [Goldblatt, David] UCL, Inst Child Hlth, London, England.
RP Clarke, E (reprint author), MRC Unit, Vaccines & Immun Theme, POB 273, Banjul, Gambia.
EM eclarke@mrc.gm
RI Goldblatt, David/C-5972-2008
OI Goldblatt, David/0000-0002-0769-5242
FU MRC (UK)/Wellcome/DFID; PATH; Meningitis Research Foundation; Bill &
   Melinda Gates Foundation; GSK; Pfizer; UK NIHR; Merck; Sanofi Pasteur;
   GOSH NIHR Biomedical Research
FX E Clarke is the principal investigator on a maternal and neonatal
   pneumococcal conjugate vaccine clinical trial funded by MRC
   (UK)/Wellcome/DFID and on a clinical trial of a 10-valent pneumococcal
   vaccine trial manufactured by the Serum Institute of India Pvt Ltd and
   sponsored and funded by PATH. He received no personal re-imbursement
   related to either of these trials. He additionally currently receives
   grant funding from the Meningitis Research Foundation and from The Bill
   & Melinda Gates Foundation. B Kampmann receives grant support from GSK,
   Pfizer, The Bill & Melinda Gates Foundation, The Medical Research
   Council (UK) and the Wellcome Trust for vaccine related studies at the
   MRC Unit in The Gambia and is funded by the UK NIHR to conduct studies
   of maternal immunization in the UK. She has also served on advisory
   boards for maternal immunization strategies for both industry and the
   Bill & Melinda Gates Foundation. D Goldblatt participates in occasional
   advisory boards for GSK, Sanofi Pasteur and Merck. His laboratory
   receives research contract support from GSK, Merck and Sanofi Pasteur. D
   Goldblatt is a NIHR Senior Investigator whose work is partly supported
   by the GOSH NIHR Biomedical Research. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Advisory Committee on Immunization Practices, 2000, MMWR RECOMM REP, V49, P1
   Almeida VD, 2009, VACCINE, V27, P3856, DOI 10.1016/j.vaccine.2009.04.018
   BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127
   Binks MJ, 2015, VACCINE, V33, P6579, DOI 10.1016/j.vaccine.2015.10.101
   Borrow R, 2012, CURR OPIN INFECT DIS, V25, P292, DOI 10.1097/QCO.0b013e3283531b0f
   Chaithongwongwatthana S, 2015, COCHRANE DB SYST REV, V1
   Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185
   Choi YH, 2014, PNEUMONIA
   Coles CL, 2011, J NUTR, V141, P1907, DOI 10.3945/jn.111.141622
   Coles CL, 2001, J NUTR, V131, P255
   Daly KA, 2014, VACCINE, V32, P6948, DOI 10.1016/j.vaccine.2014.10.060
   de Voer RM, 2009, CLIN INFECT DIS, V49, P58, DOI 10.1086/599347
   Deubzer HE, 2004, J INFECT DIS, V190, P1758, DOI 10.1086/424597
   Egere U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049143
   Englund JA, 2015, VACCINE, V33, P6372, DOI 10.1016/j.vaccine.2015.07.084
   Gabarrot GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112337
   Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4
   Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688
   Holmlund E, 2011, VACCINE, V29, P4565, DOI 10.1016/j.vaccine.2011.04.068
   Jones C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002473
   Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4
   Ladhani SN, 2013, CLIN INFECT DIS, V56, P633, DOI 10.1093/cid/cis934
   LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009
   Lehmann D, 2002, VACCINE, V20, P1837, DOI 10.1016/S0264-410X(02)00040-3
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS161, DOI 10.1097/INF.0000000000000084
   Lopes CC, 2012, J TROP PEDIATRICS, V58, P348, DOI 10.1093/tropej/fmr107
   Lopes CRC, 2009, BRAZ J INFECT DIS, V13, P104, DOI 10.1590/S1413-86702009000200006
   Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007
   Munoz FM, 2001, VACCINE, V20, P826, DOI 10.1016/S0264-410X(01)00397-8
   O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Obaro SK, 2004, PEDIATR INFECT DIS J, V23, P1023, DOI 10.1097/01.inf.0000143651.54880.09
   ODempsey TJD, 1996, VACCINE, V14, P963, DOI 10.1016/0264-410X(96)00009-6
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pichichero ME, 2013, HUM VACC IMMUNOTHER, V9, P2505, DOI 10.4161/hv.26109
   Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668
   Pomat WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056698
   Poolman J, 2011, EXPERT REV VACCINES, V10, P307, DOI [10.1586/erv.11.8, 10.1586/ERV.11.8]
   Quiambao BP, 2007, VACCINE, V25, P4470, DOI 10.1016/j.vaccine.2007.03.021
   Quiambao BP, 2003, VACCINE, V21, P3451, DOI 10.1016/S0264-410X(03)00349-9
   Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9
   Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   Schlaudecker EP, 2012, VACCINE, V30, P5063, DOI 10.1016/j.vaccine.2012.06.003
   Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444
   SHAHID NS, 1995, LANCET, V346, P1252, DOI 10.1016/S0140-6736(95)91861-2
   Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]
   Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
   Swann O, 2014, PEDIATR INFECT DIS J, V33, P560, DOI 10.1097/INF.0000000000000210
   United Nations General Assembly Seventieth Session, 2015, UN GEN ASS 17 SESS T
   von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914
   Waters Donald, 2011, J Glob Health, V1, P154
   Whitney CG, 2014, PEDIATR INFECT DIS J, V33, pS172, DOI 10.1097/INF.0000000000000076
   World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P129
   World Health Organization, 2004, CHRON SUPP OT MED BU
   Wiertsema SP, 2009, MED J AUSTRALIA, V191, pS50
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
   [Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P173
NR 59
TC 2
Z9 2
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD OCT
PY 2016
VL 15
IS 10
BP 1305
EP 1317
DI 10.1586/14760584.2016.1167602
PG 13
WC Immunology
SC Immunology
GA DX4BB
UT WOS:000384322000008
PM 26998805
OA No
DA 2017-08-15
ER

PT J
AU Howie, SRC
   Schellenberg, J
   Chimah, O
   Ideh, RC
   Ebruke, BE
   Oluwalana, C
   Mackenzie, G
   Jallow, M
   Njie, M
   Donkor, S
   Dionisio, KL
   Goldberg, G
   Fornace, K
   Bottomley, C
   Hill, PC
   Grant, CC
   Corrah, T
   Prentice, AM
   Ezzati, M
   Greenwood, BM
   Smith, PG
   Adegbola, RA
   Mulholland, K
AF Howie, S. R. C.
   Schellenberg, J.
   Chimah, O.
   Ideh, R. C.
   Ebruke, B. E.
   Oluwalana, C.
   Mackenzie, G.
   Jallow, M.
   Njie, M.
   Donkor, S.
   Dionisio, K. L.
   Goldberg, G.
   Fornace, K.
   Bottomley, C.
   Hill, P. C.
   Grant, C. C.
   Corrah, T.
   Prentice, A. M.
   Ezzati, M.
   Greenwood, B. M.
   Smith, P. G.
   Adegbola, R. A.
   Mulholland, K.
TI Childhood pneumonia and crowding, bed-sharing and nutrition: a
   case-control study from The Gambia
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE Africa; risk factors; cough; household air pollution; particulate matter
ID RISK-FACTORS; BIOMASS FUELS; CHILDREN; INTERVENTIONS; MORTALITY;
   EXPOSURE; INFANTS; AFRICA; BRAZIL; AREA
AB SETTING: Greater Banjul and Upper River Regions, The Gambia.
   OBJECTIVE: To investigate tractable social, environmental and nutritional risk factors for childhood pneumonia.
   DESIGN: A case-control study examining the association of crowding, household air pollution (HAP) and nutritional factors with pneumonia was undertaken in children aged 2-59 months: 458 children with severe pneumonia, defined according to the modified WHO criteria, were compared with 322 children with non severe pneumonia, and these groups were compared to 801 neighbourhood controls. Controls were matched by age, sex, area and season.
   RESULTS: Strong evidence was found of an association between bed-sharing with someone with a cough and SUMMARY severe pneumonia (adjusted OR [aOR] 5.1, 95%CI 3.2-8.2, P < 0.001) and non-severe pneumonia (aOR 7.3, 95%CI 4.1-13.1, P < 0.001), with 18% of severe cases estimated to be attributable to this risk factor. Malnutrition and pneumonia had clear evidence of association, which was strongest between severe malnutrition and severe pneumonia (aOR 8.7, 95%CI 4.2-17.8, P < 0.001). No association was found between pneumonia and individual carbon monoxide exposure as a measure of HAP.
   CONCLUSION: Bed-sharing with someone with a cough is an important risk factor for severe pneumonia, and potentially tractable to intervention, while malnutrition remains an important tractable determinant.
C1 [Howie, S. R. C.; Chimah, O.; Ideh, R. C.; Ebruke, B. E.; Oluwalana, C.; Mackenzie, G.; Donkor, S.; Fornace, K.; Corrah, T.; Prentice, A. M.; Adegbola, R. A.] MRC Unit, Fajara, Gambia.
   [Howie, S. R. C.; Grant, C. C.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand.
   [Howie, S. R. C.; Hill, P. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Schellenberg, J.; Fornace, K.; Bottomley, C.; Prentice, A. M.; Greenwood, B. M.; Smith, P. G.; Mulholland, K.] London Sch Hyg & Trop Med, London, England.
   [Ideh, R. C.] Univ Benin, Teaching Hosp, Dept Child Hlth, Benin, Nigeria.
   [Jallow, M.; Njie, M.] Minist Hlth & Social Welf, Banjul, Gambia.
   [Dionisio, K. L.] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
   [Dionisio, K. L.] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA.
   [Dionisio, K. L.] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA.
   [Ezzati, M.] Med Res Council MRC Human Nutr Res, Cambridge, England.
   [Goldberg, G.] Imperial Coll London, MRC Publ Hlth England Ctr Environm & Hlth, London, England.
   [Ezzati, M.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.
   [Adegbola, R. A.] GlaxoSmithKline Vaccines, Wavre, Belgium.
   [Mulholland, K.] Univ Melbourne, Parkville, NSW, Australia.
RP Howie, SRC (reprint author), MRC Unit, POB 273, Banjul, Gambia.; Howie, SRC (reprint author), Univ Auckland, Dept Paediat, Auckland, New Zealand.
EM stephen.howie@auckland.ac.nz
OI Grant, Cameron/0000-0002-4032-7230
FU Medical Research Council [MC_U123292701, MC_U190088484, MC_UP_A900_1116,
   MC_UP_A900_1124]
CR Armstrong J, 1991, INT J EPIDEMIOL, V25, P885
   Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4
   DEFRANCISCO A, 1993, INT J EPIDEMIOL, V22, P1174, DOI 10.1093/ije/22.6.1174
   Dionisio KL, 2008, INDOOR AIR, V18, P317, DOI 10.1111/j.1600-0668.2008.00533.x
   Dionisio KL, 2012, ENVIRON SCI TECHNOL, V46, P3519, DOI 10.1021/es203047e
   Dionisio KL, 2012, J EXPO SCI ENV EPID, V22, P173, DOI 10.1038/jes.2011.47
   Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496.
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292
   Fonseca W, 1997, J TROP PEDIATRICS, V43, P123, DOI 10.1093/tropej/43.2.123
   Global Alliance for Vaccines and Immunization, 2011, 2 GAVI
   GREENWOOD BM, 1987, ANN TROP PAEDIATR, V7, P91
   Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x
   Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   McCracken JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055670
   Mulholland E K, 2008, PLOS MED, V12, pe85
   Mulholland K, 2007, VACCINE, V25, P2394, DOI 10.1016/j.vaccine.2006.09.007
   Mwangome MK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-92
   Niessen L, 2009, B WORLD HEALTH ORGAN, V87, P472, DOI 10.2471/BLT.08.050872
   NIOBEY FML, 1992, REV SAUDE PUBL, V26, P229
   ODempsey TJD, 1996, INT J EPIDEMIOL, V25, P885, DOI 10.1093/ije/25.4.885
   Ojo LR, 2010, VACCINE, V28, P7117, DOI 10.1016/j.vaccine.2010.07.074
   Okiro EA, 2008, TROP MED INT HEALTH, V13, P914, DOI 10.1111/j.1365-3156.2008.02092.x
   Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769
   Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086
   Scott S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107280
   SELWYN BJ, 1990, REV INFECT DIS, V12, pS870
   SHAH N, 1994, J TROP PEDIATRICS, V40, P201
   UN Interagency Group for Child Mortality Estimation, 2014, LEV TRENDS CHILD MOR
   US Centers for Disease Control and Prevention, 2006, RESP EFF CHILDR EXP
   Office on Smoking and Health (US), 2006, HLTH CONS INV EXP TO
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Victora CG, 1999, AM J CLIN NUTR, V70, P309
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   World Health Organization, 2013, END PREV CHILD DEATH
   World Health Organization, 2000, WHOFCHCAH001
   World Health Organization, 2006, GAMB SMOK PREV TOB E
   World Health Organization, 2016, WHAT AR HLTH RISKS R
   World Bank, 2012, DAT THE GAMB
NR 39
TC 3
Z9 4
U1 1
U2 4
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD OCT
PY 2016
VL 20
IS 10
BP 1405
EP 1415
DI 10.5588/ijtld.15.0993
PG 11
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA DX5AZ
UT WOS:000384393500026
PM 27725055
OA No
DA 2017-08-15
ER

PT J
AU Seddon, JA
   Paton, J
   Nademi, Z
   Keane, D
   Williams, B
   Williams, A
   Welch, SB
   Liebeschutz, S
   Riddell, A
   Bernatoniene, J
   Patel, S
   Martinez-Alier, N
   McMaster, P
   Kampmann, B
AF Seddon, James A.
   Paton, James
   Nademi, Zohreh
   Keane, Denis
   Williams, Bhanu
   Williams, Amanda
   Welch, Steven B.
   Liebeschutz, Sue
   Riddell, Anna
   Bernatoniene, Jolanta
   Patel, Sanjay
   Martinez-Alier, Nuria
   McMaster, Paddy
   Kampmann, Beate
TI The impact of BCG vaccination on tuberculin skin test responses in
   children is age dependent: evidence to be considered when screening
   children for tuberculosis infection
SO THORAX
LA English
DT Article
ID GAMMA RELEASE ASSAYS; CHILDHOOD; METAANALYSIS; RIFAPENTINE; STRATEGIES;
   DIAGNOSIS; CONTACTS; TB
AB Background Following exposure to TB, contacts are screened to target preventive treatment at those at high risk of developing TB. The UK has recently revised its recommendations for screening and now advises a 5 mm tuberculin skin test (TST) cut-off irrespective of age or BCG status. We sought to evaluate the impact of BCG on TST responses in UK children exposed to TB and the performance of different TST cut-offs to predict interferon. release assay (IGRA) positivity.
   Methods Children <15 years old were recruited from 11 sites in the UK between January 2011 and December 2014 if exposed in their home to a source case with sputum smear or culture positive TB. Demographic details were collected and TST and IGRA undertaken. The impact of BCG vaccination on TST positivity was evaluated in IGRA-negative children, as was the performance of different TST cut-offs to predict IGRA positivity.
   Results Of 422 children recruited (median age 69 months; IQR: 32-113 months), 300 (71%) had been vaccinated with BCG. BCG vaccination affected the TST response in IGRA-negative children less than 5 years old but not in older children. A 5 mm TST cut-off demonstrated good sensitivity and specificity in BCG-unvaccinated children, and an excellent negative predictive value but was associated with low specificity (62.7%; 95% CI 56.1% to 69.0%) in BCG-vaccinated children. For BCG-vaccinated children, a 10 mm cut-off provided a high negative predictive value (97.7%; 95% CI 94.2% to 99.4%) with the positive predictive value increasing with increasing age of the child.
   Discussion BCG vaccination had little impact on TST size in children over 5 years of age. The revised TST cut-off recommended in the recent revision to the UK TB guidelines demonstrates good sensitivity but is associated with impaired specificity in BCG-vaccinated children.
C1 [Seddon, James A.; Keane, Denis; Kampmann, Beate] Imperial Coll London, Acad Dept Paediat, Ctr Int Child Hlth, London, England.
   [Paton, James] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland.
   [Nademi, Zohreh] Great North Childrens Hosp, Dept Paediat, Newcastle Upon Tyne, Tyne & Wear, England.
   [Nademi, Zohreh] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.
   [Williams, Bhanu; Williams, Amanda] London North West Healthcare NHS Trust, Dept Paediat, Harrow, Middx, England.
   [Welch, Steven B.] Heart England NHS Fdn Trust, Birmingham Chest Clin, Birmingham, W Midlands, England.
   [Liebeschutz, Sue] Barts Hlth NHS Trust, Newham Univ Hosp, Dept Paediat, London, England.
   [Riddell, Anna] Barts Hlth NHS Trust, Royal London Hosp, Childrens Hosp, London, England.
   [Bernatoniene, Jolanta] Bristol Royal Hosp Children, Dept Paediat Infect Dis, Bristol, Avon, England.
   [Patel, Sanjay] Southampton Childrens Hosp, Dept Paediat Infect Dis & Immunol, Southampton, Hants, England.
   [McMaster, Paddy] Evelina Childrens Hosp, Dept Paediat Infect Dis, London, England.
   [McMaster, Paddy] North Manchester Gen Hosp, Dept Paediat Infect Dis, Manchester, Lancs, England.
   [Kampmann, Beate] Vaccines & Immun Theme, Med Res Council Unit, Atlantic Blvd, Fajara, Gambia.
RP Kampmann, B (reprint author), Imperial Coll London, Ctr Int Child Hlth, Dept Paediat, Norfolk Pl, London W2 1PG, England.
EM b.kampmann@imperial.ac.uk
OI Kampmann, Beate/0000-0002-6546-4709; Seddon, James/0000-0002-2296-2302
FU NIHR Senior Research Fellowship [NIHR/SRF-2009-02-07]; NIHR Academic
   Clinical Lectureship; Academy of Medical Sciences; BRC; National
   Institute for Health Research (NIHR) Biomedical Research Centre based at
   Imperial College Healthcare NHS Trust and Imperial College London
FX This work was funded by a NIHR Senior Research Fellowship to BK
   (NIHR/SRF-2009-02-07). JAS was supported by an NIHR Academic Clinical
   Lectureship and also through grants from the Academy of Medical Sciences
   and the BRC. The research and DK were supported by the National
   Institute for Health Research (NIHR) Biomedical Research Centre based at
   Imperial College Healthcare NHS Trust and Imperial College London.
CR Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3
   Bamford ARJ, 2010, ARCH DIS CHILD, V95, P180, DOI 10.1136/adc.2009.169805
   Berti E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S3
   Bright-Thomas R, 2010, ARCH DIS CHILD, V95, P600, DOI 10.1136/adc.2010.182600
   Chiappini E, 2012, INT J IMMUNOPATH PH, V25, P557
   Enarson Donald A, 2004, Paediatr Respir Rev, V5 Suppl A, pS135, DOI 10.1016/S1526-0542(04)90025-5
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
   FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28
   Frydenberg AR, 2009, TROP MED INT HEALTH, V14, P1329, DOI 10.1111/j.1365-3156.2009.02375.x
   Gray DM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006418.pub2
   Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012
   Jones C, 2011, PAEDIATR RESPIR REV, V12, P3, DOI 10.1016/j.prrv.2010.09.006
   Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915
   Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631
   Mandalakas AM, 2013, THORAX, V68, P247, DOI 10.1136/thoraxjnl-2011-200933
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392
   Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9
   National Institute for Health and Care Excellence, 2006, TUB CLIN DIAGN MAN T
   National Institute for Health and Care Excellence, 2016, TUBERCULOSIS
   Pineiro R, 2012, EUR J PEDIATR, V171, P1625, DOI 10.1007/s00431-012-1783-8
   Public Health England, 2013, GREEN BOOK IMM INF D
   Reid JK, 2007, CHEST, V131, P1806, DOI 10.1378/chest.06-1133
   Roy RB, 2012, CURR OPIN INFECT DIS, V25, P250, DOI 10.1097/QCO.0b013e3283529af9
   Smieja MJ, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363
   Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875
   Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158
   Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895
   World Health Organization, 2012, WHOHTMTB20129
   World Health Organization, 2014, GUID NAT TUB PROGR M
NR 29
TC 3
Z9 3
U1 2
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0040-6376
EI 1468-3296
J9 THORAX
JI Thorax
PD OCT
PY 2016
VL 71
IS 10
BP 932
EP 939
DI 10.1136/thoraxjnl-2015-207687
PG 8
WC Respiratory System
SC Respiratory System
GA DX0DH
UT WOS:000384031200010
PM 27335104
OA No
DA 2017-08-15
ER

PT J
AU Fitchett, EJA
   Seale, AC
   Vergnano, S
   Sharland, M
   Heath, PT
   Saha, SK
   Agarwal, R
   Ayede, AI
   Bhutta, ZA
   Black, R
   Bojang, K
   Campbell, H
   Cousens, S
   Darmstadt, GL
   Madhi, SA
   Sobanjo-ter Meulen, A
   Modi, N
   Patterson, J
   Qazi, S
   Schrag, SJ
   Stoll, BJ
   Wall, SN
   Wammanda, RD
   Lawn, JE
AF Fitchett, Elizabeth J. A.
   Seale, Anna C.
   Vergnano, Stefania
   Sharland, Michael
   Heath, Paul T.
   Saha, Samir K.
   Agarwal, Ramesh
   Ayede, Adejumoke I.
   Bhutta, Zulfiqar A.
   Black, Robert
   Bojang, Kalifa
   Campbell, Harry
   Cousens, Simon
   Darmstadt, Gary L.
   Madhi, Shabir A.
   Sobanjo-ter Meulen, Ajoke
   Modi, Neena
   Patterson, Janna
   Qazi, Shamim
   Schrag, Stephanie J.
   Stoll, Barbara J.
   Wall, Stephen N.
   Wammanda, Robinson D.
   Lawn, Joy E.
CA SPRING Strengthening Publications
TI Strengthening the Reporting of Observational Studies in Epidemiology for
   Newborn Infection (STROBE-NI): an extension of the STROBE statement for
   neonatal infection research
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID INJECTABLE PROCAINE BENZYLPENICILLIN; SUB-SAHARAN AFRICA; SEVERE
   BACTERIAL-INFECTION; B STREPTOCOCCAL DISEASE; EQUIVALENCE TRIAL;
   CLINICAL SIGNS; YOUNG INFANTS; OPEN-LABEL; SYSTEMATIC ANALYSIS; RURAL
   BANGLADESH
AB Neonatal infections are estimated to account for a quarter of the 2.8 million annual neonatal deaths, as well as approximately 3% of all disability-adjusted life-years. Despite this burden, few data are available on incidence, aetiology, and outcomes, particularly regarding impairment. We aimed to develop guidelines for improved scientific reporting of observational neonatal infection studies, to increase comparability and to strengthen research in this area. This checklist, Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI), is an extension of the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement. STROBE-NI was developed following systematic reviews of published literature (1996-2015), compilation of more than 130 potential reporting recommendations, and circulation of a survey to relevant professionals worldwide, eliciting responses from 147 professionals from 37 countries. An international consensus meeting of 18 participants (with expertise in infectious diseases, neonatology, microbiology, epidemiology, and statistics) identified priority recommendations for reporting, additional to the STROBE statement. Implementation of these STROBE-NI recommendations, and linked checklist, aims to improve scientific reporting of neonatal infection studies, increasing data utility and allowing meta-analyses and pathogen-specific burden estimates to inform global policy and new interventions, including maternal vaccines.
C1 [Fitchett, Elizabeth J. A.; Seale, Anna C.; Cousens, Simon; Lawn, Joy E.] London Sch Hyg & Trop Med, MARCH Ctr, London, England.
   [Seale, Anna C.] UCL, Farr Inst Hlth Informat Res, London, England.
   [Vergnano, Stefania; Sharland, Michael; Heath, Paul T.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England.
   [Saha, Samir K.] Dhaka Shishu Hosp, Dept Microbiol, Child Hlth Res Fdn, Dhaka, Bangladesh.
   [Agarwal, Ramesh] All India Inst Med Sci, Dept Pediat, New Delhi, India.
   [Ayede, Adejumoke I.] Univ Ibadan, Coll Med, Dept Paediat, Ibadan, Nigeria.
   [Ayede, Adejumoke I.] Univ Coll Hosp, Ibadan, Nigeria.
   [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.
   [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada.
   [Black, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA.
   [Bojang, Kalifa] MRC, Gambia Unit, Banjul, Gambia.
   [Campbell, Harry] Univ Edinburgh, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland.
   [Darmstadt, Gary L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.
   [Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.
   [Madhi, Shabir A.] Univ Witwatersrand, DST NRF Vaccine Preventable Dis, Fac Hlth Sci, Johannesburg, South Africa.
   [Sobanjo-ter Meulen, Ajoke] Bill & Melinda Gates Fdn, Vaccines, Seattle, WA USA.
   [Modi, Neena] Royal Coll Paediat & Child Hlth, London, England.
   [Modi, Neena] Imperial Coll London, Sect Neonatal Med, Dept Med, London, England.
   [Patterson, Janna] Bill & Melinda Gates Fdn, Maternal Newborn & Child Hlth, Seattle, WA USA.
   [Qazi, Shamim] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland.
   [Schrag, Stephanie J.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA.
   [Stoll, Barbara J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.
   [Stoll, Barbara J.] Childrens Healthcare Atlanta, Atlanta, GA USA.
   [Wall, Stephen N.] Save Children, Saving Newborn Lives, Washington, DC USA.
   [Wammanda, Robinson D.] Ahmadu Bello Univ, Teaching Hosp, Dept Paediat, Zaria, Nigeria.
RP Lawn, JE (reprint author), London Sch Hyg & Trop Med, MARCH Ctr, London, England.
EM joy.lawn@lshtm.ac.uk
OI Bojang, Kalifa/0000-0001-7506-0938
FU Wellcome Trust; WHO; Bill & Melinda Gates Foundation
FX No specific funding was received for this work. Travel fellowships for
   experts attending the consensus meeting were provided by the Wellcome
   Trust, WHO, and the Bill & Melinda Gates Foundation through a grant to
   the Johns Hopkins Bloomberg School of Public Health. We thank the Royal
   Society of Medicine (Global Health Section) for hosting the expert
   consensus meeting and the members of the SPRING Group.
CR Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X
   Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8
   Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3
   Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204
   Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Carlin JB, 2008, LANCET, V371, P135
   Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9
   Chan GJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001502
   Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548
   Darmstadt GL, 2011, ARCH DIS CHILD, V96, P1140, DOI 10.1136/archdischild-2011-300591
   Darmstadt GL, 2012, J INFECT DIS, V127, P358
   Darmstadt GL, 2015, REMINGTON KLEINS INF, P24
   Diaz MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066183
   Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011
   Every Woman Every Child, 2015, GLOB STRAT WOM CHILD
   Farzin A, 2015, PEDIATR INFECT DIS J, V34, P706, DOI 10.1097/INF.0000000000000726
   Field N, 2014, LANCET INFECT DIS, V14, P341, DOI 10.1016/S1473-3099(13)70324-4
   Folgori L, 2013, ARCH DIS CHILD-FETAL, V98, pF518, DOI 10.1136/archdischild-2012-303149
   Hamer DH, 2015, PEDIATR INFECT DIS J, V34, pE1, DOI 10.1097/INF.0000000000000549
   Hassall O, 2008, VOX SANG, V94, P125, DOI 10.1111/j.1423-0410.2007.01012.x
   Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5
   Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183
   Howson C.P., 2012, BORN TOO SOON GLOBAL
   Kaiser Margaret M, 2006, Issues Compr Pediatr Nurs, V29, P45, DOI 10.1080/01460860500523764
   Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5
   Lawn JE, 2014, LANCET, V384, P931, DOI 10.1016/S0140-6736(14)61057-6
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Maine D, 2009, MONITORING EMERGENCY
   Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9
   McFetridge R, 2015, VACCINE, V33, P2793, DOI 10.1016/j.vaccine.2015.04.025
   Modi N, 2014, ARCH DIS CHILD, V99, P887, DOI 10.1136/archdischild-2014-306444
   Modjarrad K, 2016, VACCINE, V34, P190, DOI 10.1016/j.vaccine.2015.05.093
   Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992
   Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Ohlsson A, 2009, COCHRANE DB SYST REV, V3
   Oza S, 2014, LANCET GLOB HEALTH, V2, pE635, DOI 10.1016/S2214-109X(14)70309-2
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231
   Saint-Raymond A, 2010, LANCET, V376, P229, DOI 10.1016/S0140-6736(10)61134-8
   Schrag SJ, 2011, LANCET, V378, P11, DOI 10.1016/S0140-6736(10)61932-0
   SCHUCHAT A, 1990, J INFECT DIS, V162, P672
   Seale AC, 2015, CURR OPIN INFECT DIS, V28, P225, DOI 10.1097/QCO.0000000000000163
   Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7
   Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207
   Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0
   Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8
   Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755
   Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4
   Tshefu A, 2015, LANCET, V385, P1758, DOI 10.1016/S0140-6736(14)62285-6
   von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120
   [Anonymous], 2014, INT MAN CHILDH ILLN
   World Health Organization, 2015, STRAT END PREV MAT M
   World Health Organization, 2014, ANT RES GLOB REP SUR
   World Health Organization, 2014, EV NEWB ACT PLAN END
   You D., 2014, LEVELS TRENDS CHILD
NR 59
TC 3
Z9 3
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP E202
EP E213
DI 10.1016/S1473-3099(16)30082-2
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000001
PM 27633910
OA No
DA 2017-08-15
ER

PT J
AU Vandamme, E
   Wissuwe, M
   Rose, T
   Dieng, I
   Drame, KN
   Fofana, M
   Senthilkumar, K
   Venuprasad, R
   Jallow, D
   Segda, Z
   Suriyagoda, L
   Sirisena, D
   Kato, Y
   Saito, K
AF Vandamme, Elke
   Wissuwe, Matthias
   Rose, Terry
   Dieng, Ibnou
   Drame, Khady N.
   Fofana, Mamadou
   Senthilkumar, Kalimuthu
   Venuprasad, Ramaiah
   Jallow, Demba
   Segda, Zacharie
   Suriyagoda, Lalith
   Sirisena, Dinarathna
   Kato, Yoichiro
   Saito, Kazuki
TI Genotypic Variation in Grain P Loading across Diverse Rice Growing
   Environments and Implications for Field P Balances
SO FRONTIERS IN PLANT SCIENCE
LA English
DT Article
DE grain P concentration; P removal; P utilization efficiency; rice
   genotypes; P cycling
ID PHOSPHORUS EFFICIENCY; FARMING SYSTEMS; LOWLAND RICE; YIELD; CROPS;
   ACQUISITION; POTASSIUM; IMPROVE; SOIL
AB More than 60% of phosphorus (P) taken up by rice (Oryza spp.) is accumulated in the grains at harvest and hence exported from fields, leading to a continuous removal of P. If P removed from fields is not replaced by P inputs then soil P stocks decline, with consequences for subsequent crops. Breeding rice genotypes with a low concentration of P in the grains could be a strategy to reduce maintenance fertilizer needs and slow soil P depletion in low input systems. This study aimed to assess variation in grain P concentrations among rice genotypes across diverse environments and evaluate the implications for field P balances at various grain yield levels. Multi-location screening experiments were conducted at different sites across Africa and Asia and yield components and grain P concentrations were determined at harvest. Genotypic variation in grain P concentration was evaluated while considering differences in P supply and grain yield using cluster analysis to group environments and boundary line analysis to determine minimum grain P concentrations at various yield levels. Average grain P concentrations across genotypes varied almost 3-fold among environments, from 1.4 to 3.9 mg g(-1). Minimum grain P concentrations associated with grain yields of 150, 300, and 500 g m(-2) varied between 1.2 and 1.7, 1.3 and 1.8, and 1.7 and 2.2 mg g(-1) among genotypes respectively. Two genotypes, Santhi Sufaid and DJ123, were identified as potential donors for breeding for low grain P concentration. Improvements in P balances that could be achieved by exploiting this genotypic variation are in the range of less than 0.10 g P m(-2) (1 kg P ha(-1)) in low yielding systems, and 0.15-0.50 g P m(-2) (1.5-5.0 kg P ha(-1)) in higher yielding systems. Improved crop management and alternative breeding approaches may be required to achieve larger reductions in grain P concentrations in rice.
C1 [Vandamme, Elke; Drame, Khady N.; Senthilkumar, Kalimuthu] Africa Rice Ctr, Dar Es Salaam, Tanzania.
   [Wissuwe, Matthias] Japan Int Res Ctr Agr Sci, Crop Prod & Environm Div, Tsukuba, Ibaraki, Japan.
   [Rose, Terry] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.
   [Rose, Terry] Southern Cross Univ, Southern Cross GeoSci, Lismore, NSW, Australia.
   [Dieng, Ibnou] Africa Rice Ctr, Bouake, Cote Ivoire.
   [Fofana, Mamadou; Venuprasad, Ramaiah] Afica Rice Ctr, Ibadan, Nigeria.
   [Jallow, Demba] Natl Agr Res Inst, Brikama, Gambia.
   [Segda, Zacharie] CNRST INERA, Programme Riz & Riziculture, Bobo Dioulasso, Burkina Faso.
   [Suriyagoda, Lalith] Univ Peradeniya, Dept Crop Sci, Fac Agr, Peraaeniya, Sri Lanka.
   [Sirisena, Dinarathna] Rice Res & Dev Inst, Ibbagamuwa, Sri Lanka.
   [Kato, Yoichiro] Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines.
   [Saito, Kazuki] Africa Rice Ctr, Cotonou, Benin.
RP Vandamme, E (reprint author), Africa Rice Ctr, Dar Es Salaam, Tanzania.
EM e.vandamme@cgiar.org
RI Dieng, Ibnou/F-1356-2016
OI Dieng, Ibnou/0000-0002-1051-9143
CR BATES TE, 1971, SOIL SCI, V112, P116, DOI 10.1097/00010694-197108000-00005
   BATTEN GD, 1992, PLANT SOIL, V146, P163, DOI 10.1007/BF00012009
   Bi JG, 2013, PLANT SOIL, V369, P231, DOI 10.1007/s11104-012-1561-4
   Bryant RJ, 2005, CEREAL CHEM, V82, P517, DOI 10.1094/CC-82-0517
   Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009
   Daouia A, 2016, J R STAT SOC B, V78, P3, DOI 10.1111/rssb.12098
   Dobermann A, 1998, FIELD CROP RES, V56, P113, DOI 10.1016/S0378-4290(97)00124-X
   Dobermann A, 2000, NUTR DISORDERS NUTR
   Dorsch JA, 2003, PHYTOCHEMISTRY, V62, P691, DOI 10.1016/S0031-9422(02)00610-6
   Fairhurst TH, 2007, RICE PRACTICAL GUIDE
   Fixen P., 2015, MANAGING WATER FERTI, P8
   Henry A, 2010, FIELD CROP RES, V115, P67, DOI 10.1016/j.fcr.2009.10.004
   Inthapanya P, 2000, FIELD CROP RES, V65, P57, DOI 10.1016/S0378-4290(99)00070-2
   Janssen BH, 1998, FIELD CROP RES, V56, P197, DOI 10.1016/S0378-4290(97)00130-5
   Jeong K, 2017, PLANT BIOTECHNOL J, V15, P15, DOI 10.1111/pbi.12586
   Leiser WL, 2014, PLANT SOIL, V377, P383, DOI 10.1007/s11104-013-1978-4
   MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108
   McDonald GK, 2008, PLANT SOIL, V306, P49, DOI 10.1007/s11104-008-9555-y
   Mori A, 2016, J EXP BOT, V67, P1179, DOI 10.1093/jxb/erv557
   MURPHY J, 1962, ANAL CHIM ACTA, V26, P31
   NOVOZAMSKY I, 1983, COMMUN SOIL SCI PLAN, V14, P239, DOI 10.1080/00103628309367359
   Nziguheba G, 2016, NUTR CYCL AGROECOSYS, V104, P321, DOI 10.1007/s10705-015-9729-y
   Pariasca-Tanaka J, 2015, PLANT SOIL, V392, P253, DOI 10.1007/s11104-015-2460-2
   R Core Team, 2016, R LANG ENV STAT COMP
   Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012
   Rose TJ, 2016, PLANT SOIL, V401, P79, DOI 10.1007/s11104-015-2565-7
   Rose TJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00444
   Rose TJ, 2012, J PLANT NUTR SOIL SC, V175, P799, DOI 10.1002/jpln.201200140
   Rose TJ, 2012, ADV AGRON, V116, P185, DOI 10.1016/B978-0-12-394277-7.00005-1
   Rose TJ, 2010, FIELD CROP RES, V119, P154, DOI 10.1016/j.fcr.2010.07.004
   Saito K, 2015, CROP SCI, V55, P1223, DOI 10.2135/cropsci2014.07.0521
   SAS Institute Inc, 2012, SAS STAT 9 3 US GUID
   Senthilkumar K, 2014, RESOUR CONSERV RECY, V87, P97, DOI 10.1016/j.resconrec.2014.03.005
   Senthilkumar K, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004102
   Senthilkumar K, 2012, NUTR CYCL AGROECOSYS, V92, P145, DOI 10.1007/s10705-011-9478-5
   Shatar TM, 2004, J AGR SCI, V142, P553, DOI 10.1017/S0021859604004642
   Simpson RJ, 2011, PLANT SOIL, V349, P89, DOI 10.1007/s11104-011-0880-1
   Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53
   Somaweera KATN, 2016, PLANT SOIL, V401, P169, DOI 10.1007/s11104-015-2541-2
   THOMAS RL, 1967, AGRON J, V59, P240
   Vandamme E, 2016, NUTR CYCL AGROECOSYS, V104, P413, DOI 10.1007/s10705-015-9716-3
   Vandamme E, 2016, FIELD CROP RES, V186, P10, DOI 10.1016/j.fcr.2015.11.003
   Wang FM, 2016, J EXP BOT, V67, P1221, DOI 10.1093/jxb/erv517
   Wang XR, 2010, PLANT SCI, V179, P302, DOI 10.1016/j.plantsci.2010.06.007
   Wardyn BM, 2004, CROP SCI, V44, P753
   Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215
   Withers PJA, 2001, SOIL USE MANAGE, V17, P139, DOI 10.1079/SUM200181
   Wu HJ, 2016, J CLEAN PROD, V114, P45, DOI 10.1016/j.jclepro.2015.07.073
NR 48
TC 1
Z9 1
U1 4
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-462X
J9 FRONT PLANT SCI
JI Front. Plant Sci.
PD SEP 27
PY 2016
VL 7
AR 1435
DI 10.3389/fpls.2016.01435
PG 14
WC Plant Sciences
SC Plant Sciences
GA DX6ER
UT WOS:000384476700001
PM 27729916
OA gold
DA 2017-08-15
ER

PT J
AU Liu, J
   Platts-Mills, JA
   Juma, J
   Kabir, F
   Nkeze, J
   Okoi, C
   Operario, DJ
   Uddin, J
   Ahmed, S
   Alonso, PL
   Antonio, M
   Becker, SM
   Blackwelder, WC
   Breiman, RF
   Faruque, AG
   Fields, B
   Gratz, J
   Haque, R
   Hossain, A
   Hossain, MJ
   Jarju, S
   Qamar, F
   Iqbal, NT
   Kwambana, B
   Mandomando, I
   McMurry, TL
   Ochieng, C
   Ochieng, JB
   Ochieng, M
   Onyango, C
   Panchalingam, S
   Kalam, A
   Aziz, F
   Qureshi, S
   Ramamurthy, T
   Roberts, JH
   Saha, D
   Sow, SO
   Stroup, SE
   Sur, D
   Tamboura, B
   Taniuchi, M
   Tennant, SM
   Toema, D
   Wu, YK
   Zaidi, A
   Nataro, JP
   Kotloff, KL
   Levine, MM
   Houpt, ER
AF Liu, Jie
   Platts-Mills, James A.
   Juma, Jane
   Kabir, Furqan
   Nkeze, Joseph
   Okoi, Catherine
   Operario, Darwin J.
   Uddin, Jashim
   Ahmed, Shahnawaz
   Alonso, Pedro L.
   Antonio, Martin
   Becker, Stephen M.
   Blackwelder, William C.
   Breiman, Robert F.
   Faruque, Abu S. G.
   Fields, Barry
   Gratz, Jean
   Haque, Rashidul
   Hossain, Anowar
   Hossain, M. Jahangir
   Jarju, Sheikh
   Qamar, Farah
   Iqbal, Najeeha Talat
   Kwambana, Brenda
   Mandomando, Inacio
   McMurry, Timothy L.
   Ochieng, Caroline
   Ochieng, John B.
   Ochieng, Melvin
   Onyango, Clayton
   Panchalingam, Sandra
   Kalam, Adil
   Aziz, Fatima
   Qureshi, Shahida
   Ramamurthy, Thandavarayan
   Roberts, James H.
   Saha, Debasish
   Sow, Samba O.
   Stroup, Suzanne E.
   Sur, Dipika
   Tamboura, Boubou
   Taniuchi, Mami
   Tennant, Sharon M.
   Toema, Deanna
   Wu, Yukun
   Zaidi, Anita
   Nataro, James P.
   Kotloff, Karen L.
   Levine, Myron M.
   Houpt, Eric R.
TI Use of quantitative molecular diagnostic methods to identify causes of
   diarrhoea in children: a reanalysis of the GEMS case-control study
SO LANCET
LA English
DT Article
ID GLOBAL ENTERIC MULTICENTER; HELICOBACTER-PYLORI INFECTION;
   DEVELOPING-COUNTRIES; YOUNG-CHILDREN; ASYMPTOMATIC CHILDREN; SYSTEMATIC
   ANALYSIS; CHILDHOOD DIARRHEA; RAPID DETECTION; VIRAL LOAD; DISEASE
AB Background Diarrhoea is the second leading cause of mortality in children worldwide, but establishing the cause can be complicated by diverse diagnostic approaches and varying test characteristics. We used quantitative molecular diagnostic methods to reassess causes of diarrhoea in the Global Enteric Multicenter Study (GEMS).
   Methods GEMS was a study of moderate to severe diarrhoea in children younger than 5 years in Africa and Asia. We used quantitative real-time PCR (qPCR) to test for 32 enteropathogens in stool samples from cases and matched asymptomatic controls from GEMS, and compared pathogen-specific attributable incidences with those found with the original GEMS microbiological methods, including culture, EIA, and reverse-transcriptase PCR. We calculated revised pathogen-specific burdens of disease and assessed causes in individual children.
   Findings We analysed 5304 sample pairs. For most pathogens, incidence was greater with qPCR than with the original methods, particularly for adenovirus 40/41 (around five times), Shigella spp or enteroinvasive Escherichia coli (EIEC) and Campylobactor jejuni or C coli (around two times), and heat-stable enterotoxin-producing E coli ([ST-ETEC] around 1.5 times). The six most attributable pathogens became, in descending order, Shigella spp, rotavirus, adenovirus 40/41, ST-ETEC, Cryptosporidium spp, and Campylobacter spp. Pathogen-attributable diarrhoeal burden was 89.3% (95% CI 83.2-96.0) at the population level, compared with 51.5% (48.0-55.0) in the original GEMS analysis. The top six pathogens accounted for 77.8% (74.6-80.9) of all attributable diarrhoea. With use of model-derived quantitative cutoffs to assess individual diarrhoeal cases, 2254 (42.5%) of 5304 cases had one diarrhoea-associated pathogen detected and 2063 (38.9%) had two or more, with Shigella spp and rotavirus being the pathogens most strongly associated with diarrhoea in children with mixed infections.
   Interpretation A quantitative molecular diagnostic approach improved population-level and case-level characterisation of the causes of diarrhoea and indicated a high burden of disease associated with six pathogens, for which targeted treatment should be prioritised.
C1 [Liu, Jie; Platts-Mills, James A.; Operario, Darwin J.; Becker, Stephen M.; Gratz, Jean; Stroup, Suzanne E.; Taniuchi, Mami; Houpt, Eric R.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
   [McMurry, Timothy L.; Roberts, James H.] Univ Virginia, Publ Hlth Sci, Charlottesville, VA USA.
   [Nataro, James P.] Univ Virginia, Dept Pediat, Charlottesville, VA USA.
   [Okoi, Catherine; Antonio, Martin; Hossain, M. Jahangir; Jarju, Sheikh; Kwambana, Brenda; Saha, Debasish] MRC Unit, Banjul, Gambia.
   [Breiman, Robert F.; Fields, Barry; Onyango, Clayton] US Ctr Dis Control & Prevent, Kenya Off, Global Dis Detect Div, Nairobi, Kenya.
   [Juma, Jane; Ochieng, Caroline; Ochieng, John B.; Ochieng, Melvin] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya.
   [Uddin, Jashim; Ahmed, Shahnawaz; Faruque, Abu S. G.; Haque, Rashidul; Hossain, Anowar] ICDDR B, Dhaka, Bangladesh.
   [Kabir, Furqan; Qamar, Farah; Iqbal, Najeeha Talat; Kalam, Adil; Aziz, Fatima; Qureshi, Shahida; Zaidi, Anita] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.
   [Nkeze, Joseph; Blackwelder, William C.; Panchalingam, Sandra; Tennant, Sharon M.; Toema, Deanna; Wu, Yukun; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Nkeze, Joseph; Blackwelder, William C.; Panchalingam, Sandra; Tennant, Sharon M.; Toema, Deanna; Wu, Yukun; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA.
   [Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA.
   [Nkeze, Joseph; Blackwelder, William C.; Tennant, Sharon M.; Toema, Deanna; Wu, Yukun; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
   [Sow, Samba O.; Tamboura, Boubou] Ctr Dev Vaccins, Bamako, Mali.
   [Alonso, Pedro L.; Mandomando, Inacio] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Ramamurthy, Thandavarayan; Sur, Dipika] Natl Inst Cholera & Enter Dis, Kolkata, India.
   [Alonso, Pedro L.] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain.
RP Houpt, ER (reprint author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
EM erh6k@virginia.edu
FU Bill & Melinda Gates Foundation
FX Bill & Melinda Gates Foundation.
CR Barletta F, 2011, CLIN INFECT DIS, V53, P1223, DOI 10.1093/cid/cir730
   Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788
   BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904
   Buss SN, 2015, J CLIN MICROBIOL, V53, P915, DOI 10.1128/JCM.02674-14
   CLEMENS J, 1995, J INFECT DIS, V171, P1653
   Dung Tran Thi Ngoc, 2013, J Virol Methods, V187, P138, DOI 10.1016/j.jviromet.2012.09.021
   Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012
   Graham DY, 2004, GUT, V53, P1235, DOI 10.1136/gut.2003.037499
   Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514
   Harrington SM, 2015, J CLIN MICROBIOL, V53, P1639, DOI 10.1128/JCM.03480-14
   HUILAN S, 1991, B WORLD HEALTH ORGAN, V69, P549
   Isenbarger DW, 1998, AM J TROP MED HYG, V59, P796
   Kaplon J, 2015, J CLIN MICROBIOL, V53, P3670, DOI 10.1128/JCM.01984-15
   KOPLAN JP, 1980, LANCET, V2, P413
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   KOTLOFF KL, 1989, PEDIATRICS, V84, P219
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Lindsay B, 2013, J CLIN MICROBIOL, V51, P1740, DOI 10.1128/JCM.02713-12
   Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158199
   Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4
   Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468
   Mukhopadhya I, 2013, J MED VIROL, V85, P1661, DOI 10.1002/jmv.23641
   Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021
   Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5
   Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114
   Shmuely H, 2004, AM J GASTROENTEROL, V99, P2041, DOI 10.1111/j.1572-0241.2004.40120.x
   Spina A, 2015, CLIN MICROBIOL INFEC, V21, P719, DOI 10.1016/j.cmi.2015.04.007
   SULLIVAN PB, 1990, ARCH DIS CHILD, V65, P189
   Taniuchi M, 2013, J INFECT DIS, V208, P1794, DOI 10.1093/infdis/jit507
   von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353
   Vu Dinh Thiem, 2004, J Clin Microbiol, V42, P2031, DOI 10.1128/JCM.42.5.2031-2035.2004
   Duong VT, 2016, J CLIN MICROBIOL, V54, P1094, DOI 10.1128/JCM.03321-15
   WHO, 2005, TREATM DIARRH MAN PH, P44
   [Anonymous], 2015, LANCET, V386, P2145
   2015, LANCET, V385, P117, DOI DOI 10.1016/S0140-6736(14)61682-2
NR 38
TC 13
Z9 13
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD SEP 24
PY 2016
VL 388
IS 10051
BP 1291
EP 1301
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW5RH
UT WOS:000383704000032
PM 27673470
OA No
DA 2017-08-15
ER

PT J
AU Fernandes, S
   Sicuri, E
   Halimatou, D
   Akazili, J
   Boiang, K
   Chandramohan, D
   Coulibaly, S
   Diawara, SI
   Kayentao, K
   ter Kuile, F
   Magnussen, P
   Tagbor, H
   Williams, J
   Woukeu, A
   Cairns, M
   Greenwood, B
   Hanson, K
AF Fernandes, Silke
   Sicuri, Elisa
   Halimatou, Diawara
   Akazili, James
   Boiang, Kalifa
   Chandramohan, Daniel
   Coulibaly, Sheikh
   Diawara, Sory Ibrahim
   Kayentao, Kassoum
   ter Kuile, Feiko
   Magnussen, Pascal
   Tagbor, Harry
   Williams, John
   Woukeu, Arouna
   Cairns, Matthew
   Greenwood, Brian
   Hanson, Kara
TI Cost effectiveness of intermittent screening followed by treatment
   versus intermittent preventive treatment during pregnancy in West
   Africa: analysis and modelling of results from a non-inferiority trial
SO MALARIA JOURNAL
LA English
DT Article
ID SULFADOXINE-PYRIMETHAMINE; DIHYDROARTEMISININ-PIPERAQUINE;
   PLASMODIUM-FALCIPARUM; GLOBAL BURDEN; MALARIA; METAANALYSIS; RESISTANCE;
   EFFICACY; THERAPY; DISEASE
AB Background: Emergence of high-grade sulfadoxine-pyrimethamine (SP) resistance in parts of Africa has led to growing concerns about the efficacy of intermittent preventive treatment of malaria during pregnancy (IPTp) with SP. The incremental cost-effectiveness of intermittent screening and treatment (ISTp) with artemether-lumefantrine (AL) as an alternative strategy to IPTp-SP was estimated followed by a simulation of the effects on cost-effectiveness of decreasing efficacy of IPTp-SP due to SP resistance. The analysis was based on results from a multi-centre, non-inferiority trial conducted in West Africa.
   Methods: A decision tree model was analysed from a health provider perspective. Model parameters for all trial countries with appropriate ranges and distributions were used in a probabilistic sensitivity analysis. Simulations were performed in hypothetical cohorts of 1000 pregnant women who received either ISTp-AL or IPTp-SP. In addition a cost-consequences analysis was conducted. Trial estimates were used to calculate disability-adjusted-life-years (DALYs) for low birth weight and severe/moderate anaemia (both shown to be non-inferior for ISTp-AL) and clinical malaria (inferior for ISTp-AL). Cost estimates were obtained from observational studies, health facility costings and public procurement databases. Results were calculated as incremental cost per DALY averted. Finally, the cost-effectiveness changes with decreasing SP efficacy were explored by simulation.
   Results: Relative to IPTp-SP, delivering ISTp-AL to 1000 pregnant women cost US$ 4966.25 more (95 % CI US$ 3703.53; 6376.83) and led to a small excess of 28.36 DALYs (95 % CI -75.78; 134.18), with LBW contributing 81.3 % of this difference. The incremental cost-effectiveness ratio was -175.12 (95 % CI -1166.29; 1267.71) US$/DALY averted. Simulations show that cost-effectiveness of ISTp-AL increases as the efficacy of IPTp-SP decreases, though the specific threshold at which ISTp-AL becomes cost-effective depends on assumptions about the contribution of bed nets to malaria control, bed net coverage and the willingness-to-pay threshold used.
   Conclusions: At SP efficacy levels currently observed in the trial settings it would not be cost-effective to switch from IPTp-SP to ISTp-AL, mainly due to the substantially higher costs of ISTp-AL and limited difference in outcomes. The modelling results indicate thresholds below which IPT-SP efficacy must fall for ISTp-AL to become a cost-effective option for the prevention of malaria in pregnancy.
C1 [Fernandes, Silke; Chandramohan, Daniel; Woukeu, Arouna; Cairns, Matthew; Greenwood, Brian; Hanson, Kara] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Sicuri, Elisa] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Halimatou, Diawara; Diawara, Sory Ibrahim; Kayentao, Kassoum] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Dent, Dept Epidemiol Parasit Dis, Bamako, Mali.
   [Akazili, James; Williams, John] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Boiang, Kalifa] MRC Unit, Fajara, Gambia.
   [Coulibaly, Sheikh] Univ Ouagadougou, Fac Hlth Sci, Ouagadougou, Burkina Faso.
   [Kayentao, Kassoum; ter Kuile, Feiko] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Magnussen, Pascal] Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.
   [Magnussen, Pascal] Univ Copenhagen, Inst Vet Dis Biol, Copenhagen, Denmark.
   [Tagbor, Harry] Univ Hlth & Allied Sci, Sch Med, Ho, Ghana.
RP Fernandes, S (reprint author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM silke.fernandes@lshtm.ac.uk
FU Malaria in Pregnancy Consortium; Bill and Melinda Gates Foundation; UK
   Medical Research Council (MRC); UK Department for International
   Development (DFID); European Union
FX This work was funded by the Malaria in Pregnancy Consortium, which is
   funded through a grant by the Bill and Melinda Gates Foundation to the
   LSTM. MC was supported by a fellowship jointly funded by the UK Medical
   Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement, and part of
   the EDCTP2 programme supported by the European Union. The funding
   institution had no role in the model design and development, data
   collection, analysis and interpretation; or preparation, review or
   approval of the manuscript.
CR Brabin BJ, 2001, J NUTR, V131, p604S
   Briggs A, 2006, DECISION MODELLING H
   Coulibaly SO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-41
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4
   Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106
   Kakuru A, 2016, NEW ENGL J MED, V374, P928, DOI 10.1056/NEJMoa1509150
   Kalanda GC, 2006, TROP MED INT HEALTH, V11, P569, DOI 10.1111/j.1365-3156.2006.01608.x
   Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231
   Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292
   Mauskopf JA, 1998, PHARMACOECONOMICS, V13, P277, DOI 10.2165/00019053-199813030-00002
   Minja DT, 2013, EMERG INFECT DIS, V19, P9
   Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002
   Naidoo I, 2011, PARASITOLOGY, V138, P1469, DOI 10.1017/S0031182011000746
   Naidoo I, 2010, TRENDS PARASITOL, V26, P447, DOI 10.1016/j.pt.2010.05.001
   Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152
   Price RN, 2001, AM J TROP MED HYG, V65, P614
   Radeva-Petrova D, 2014, COCHRANE DB SYST REV, V10
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   Sicuri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013407
   Tagbor H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132247
   Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425
   ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603
   van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3
   van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
   WHO, 1996, INV HLTH RES DEV REP
   World Health Organization, CHOOS INT AR COST EF
   WHO, 2004, AFRMAL0401 WHO
   [Anonymous], 2012, WORLD EC OUTLOOK DAT
NR 32
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD SEP 23
PY 2016
VL 15
AR 493
DI 10.1186/s12936-016-1539-4
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DY1HS
UT WOS:000384846100002
PM 27663678
OA gold
DA 2017-08-15
ER

PT J
AU Idoko, OT
   Hampton, LM
   Mboizi, RB
   Agbla, SC
   Wallace, AS
   Harris, JB
   Sowe, D
   Ehlman, DC
   Kampmann, B
   Ota, MO
   Hyde, TB
AF Idoko, Olubukola T.
   Hampton, Lee M.
   Mboizi, Robert B.
   Agbla, Schadrac C.
   Wallace, Aaron S.
   Harris, Jennifer B.
   Sowe, Dawda
   Ehlman, Daniel C.
   Kampmann, Beate
   Ota, Martin O.
   Hyde, Terri B.
TI Acceptance of multiple injectable vaccines in a single immunization
   visit in The Gambia pre and post introduction of inactivated polio
   vaccine
SO VACCINE
LA English
DT Article
DE Acceptance; Multiple injectable vaccines; Single visit; Healthcare
   providers; Caregivers; The Gambia
ID PARENTAL ATTITUDES; INJECTIONS; PROVIDER
AB Background: As the World Health Organization (WHO) currently recommends that children be protected against 11 different pathogens, it is becoming increasingly necessary to administer multiple injectable vaccines during a single immunization visit. In this study we assess Gambian healthcare providers' and infant caregivers' attitudes and practices related to the administration of multiple injectable vaccines to a child at a single immunization visit before and after the 2015 introduction of inactivated polio vaccine (IPV). IPV introduction increased the number of injectable vaccines recommended for the 4-month immunization visit from two to three in The Gambia.
   Methods: We conducted a cross-sectional questionnaire-based survey before and after the introduction of IPV at 4 months of age in a representative sample of all health facilities providing immunizations in The Gambia. Healthcare providers who administer vaccines at the selected health facilities and caregivers who brought infants for their 4 month immunization visit were surveyed.
   Findings: Prior to IPV introduction, 9.9% of healthcare providers and 35.7% of infant caregivers expressed concern about a child receiving more than 2 injections in a single visit. Nevertheless, 98.8% and 90.9% of infants received all required vaccinations for the visit before and after IPV introduction, respectively. The only reason why vaccines were not received was vaccine stock-outs. Infant caregivers generally agreed that vaccinators could be trusted to provide accurate information regarding the number of vaccines that a child needed.
   Conclusion: Healthcare providers and infant caregivers in this resource limited setting accepted an increase in the number of injectable vaccines administered at a single visit even though some expressed concerns about the increase. Published by Elsevier Ltd.
C1 [Idoko, Olubukola T.; Mboizi, Robert B.; Agbla, Schadrac C.; Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
   [Hampton, Lee M.; Wallace, Aaron S.; Harris, Jennifer B.; Ehlman, Daniel C.; Hyde, Terri B.] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA.
   [Sowe, Dawda] Minist Hlth & Social Welf, Banjul, Gambia.
   [Kampmann, Beate] Imperial Coll London, Acad Dept Paediat, London, England.
   [Ota, Martin O.] WHO Reg Off Africa, Brazaville, Congo.
RP Idoko, OT (reprint author), MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
EM bukkyidoko@gmail.com
FU Centres for Disease Control by The medical Research Council Unit, The
   Gambia
FX Funds for the conduct of the study were received from the Centres for
   Disease Control by The medical Research Council Unit, The Gambia. The
   authors have no other conflicts of interest to declare.
CR Allred NJ, 2005, AM J PREV MED, V28, P221, DOI 10.1016/j.amepre.2004.10.014
   Bakhache P, 2013, EUR J PEDIATR, V172, P485, DOI 10.1007/s00431-012-1904-4
   Centers for Disease C. and Prevention, 2013, MMWR-MORBID MORTAL W, V62, P308
   Dawar M, 2002, CAN J PUBLIC HEALTH, V93, P281
   Dudley LD, 2015, ACCEPTABILITY 3 VACC
   EFRON B, 1981, ANN STAT, V9, P586, DOI 10.1214/aos/1176345462
   Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04
   Hasman A, 2014, LANCET GLOB HEALTH, V2, pE627, DOI 10.1016/S2214-109X(14)70324-9
   Healy CM, 2014, VACCINE, V32, P579, DOI 10.1016/j.vaccine.2013.11.076
   KOCH GG, 1975, INT STAT REV, V43, P59, DOI 10.2307/1402660
   Kolasa MS, 2001, AM J PREV MED, V21, P261, DOI 10.1016/S0749-3797(01)00371-3
   Kolasa MS, 2001, PUBLIC HEALTH REP, V116, P282
   Melman ST, 1999, ARCH PEDIAT ADOL MED, V153, P1289
   Okeibunor JC, 2015, VACCINE
   Prevots D R, 2000, MMWR Recomm Rep, V49, P1
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P261
   Tebbens RJD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1114-6
   Wallace AS, 2014, J INFECT DIS, V210, pS514, DOI 10.1093/infdis/jiu108
   Wallace AS, 2014, VACCINE, V32, P5301, DOI 10.1016/j.vaccine.2014.07.076
   World health Organization, 2016, WHO VACC PREV DIS MO
   WHO, 2015, DAT STAT GRAPHS
   World Health Organization, 2015, WHO REC ROUT IMM SUM
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P337
   [Anonymous], 1997, MMWR RECOMM REP, V46, P1
NR 24
TC 5
Z9 5
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD SEP 22
PY 2016
VL 34
IS 41
BP 5034
EP 5039
DI 10.1016/j.vaccine.2016.07.021
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DY1LY
UT WOS:000384857700027
PM 27570237
OA No
DA 2017-08-15
ER

PT J
AU Bassat, Q
   Lanaspa, M
   Machevo, S
   O'Callaghan-Gordo, C
   Madrid, L
   Nhampossa, T
   Acacio, S
   Roca, A
   Alonso, PL
AF Bassat, Quique
   Lanaspa, Miguel
   Machevo, Sonia
   O'Callaghan-Gordo, Cristina
   Madrid, Lola
   Nhampossa, Tacilta
   Acacio, Sozinho
   Roca, Anna
   Alonso, Pedro L.
TI Hypoxaemia in Mozambican children < 5 years of age admitted to hospital
   with clinical severe pneumonia: clinical features and performance of
   predictor models
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE infant; child; preschool; pneumonia; hypoxaemia; clinical
   decision-making; Mozambique
ID RESPIRATORY-TRACT INFECTION; PAPUA-NEW-GUINEA; CHILDHOOD PNEUMONIA;
   RURAL MOZAMBIQUE; DEVELOPING-COUNTRIES; CASE-MANAGEMENT; PULSE OXIMETRY;
   YOUNG-CHILDREN; ILL CHILDREN; PREVALENCE
AB OBJECTIVE To determine the prevalence of hypoxaemia among under-five children admitted to hospital with clinical severe pneumonia and to assess the performance to diagnose hypoxaemia of models based on clinical signs.
   METHODS We conducted a hospital-based survey in a district hospital from Southern Mozambique.
   RESULTS A total of 825 children were recruited after obtaining an informed consent. The prevalence of hypoxaemia on admission was 27.9%, and 19.8% of these children died (OR compared with non-hypoxaemic children 3.22, 95% CI 1.98-5.21, P < 0.001). The model with larger area under the ROC curve (AUC-ROC) to predict hypoxaemia included cyanosis or thoracoabdominal breathing or respiratory rate >= 70 breaths per minute. None of the models performed well when tested in different case scenarios of oxygen availability through mathematical modelling, with over 50% of hypoxaemic children not receiving oxygen even in favourable case scenarios.
   CONCLUSIONS Clinical signs alone or in combination are not suitable to diagnose hypoxaemia. The use of pulse oximeters should be strongly encouraged.
C1 [Bassat, Quique; Lanaspa, Miguel; O'Callaghan-Gordo, Cristina; Madrid, Lola; Alonso, Pedro L.] Univ Barcelona, Barcelona Ctr Int Hlth Res, ISGlobal, Barcelona, Spain.
   [Bassat, Quique; Lanaspa, Miguel; Machevo, Sonia; O'Callaghan-Gordo, Cristina; Madrid, Lola; Nhampossa, Tacilta; Acacio, Sozinho; Roca, Anna; Alonso, Pedro L.] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [O'Callaghan-Gordo, Cristina] Ctr Res Environm Epidemiol, Barcelona, Spain.
   [Nhampossa, Tacilta; Acacio, Sozinho] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique.
   [Roca, Anna] MRC Unit, Banjul, Gambia.
RP Lanaspa, M (reprint author), Inst Salud Global Barcelona, 132,5 2a, Barcelona 08036, Spain.
EM miguel.lanaspa@isglobal.org
OI Bassat, Quique/0000-0003-0875-7596
FU WHO; program Miguel Servet of the ISCIII; program Rio Hortega of the
   ISCIII
FX We are indebted to the children and mothers participating in the study.
   The work of the clinical officers, medical 'estagiarios', HIV
   counsellors, data managers, laboratory workers and laboratory
   coordinator was important for the successful collection of data. This
   work was supported by WHO. Quique Bassat has a fellowship from the
   program Miguel Servet of the ISCIII; Lola Madrid has a fellowship from
   the program Rio Hortega of the ISCIII.
CR Ayieko P, 2007, PEDIATR INFECT DIS J, V26, P432, DOI 10.1097/01.inf.0000260107.79355.7d
   Basnet Sudha, 2006, Indian Journal of Pediatrics, V73, P777, DOI 10.1007/BF02790384
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Chisti MJ, 2012, TROP MED INT HEALTH, V17, P106, DOI 10.1111/j.1365-3156.2011.02890.x
   Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051376
   de Armas Y, 2012, MED MYCOL, V50, P417, DOI 10.3109/13693786.2011.607474
   Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108
   Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2
   Duke Trevor, 2010, Papua New Guinea Medical Journal, V53, P126
   Floyd J, 2015, NATURE, V528, pS53, DOI 10.1038/nature16043
   Friaza V, 2010, POSTGRAD MED, V122, P24, DOI 10.3810/pgm.2010.11.2219
   Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512
   Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36
   Ibraheem R M, 2014, West Afr J Med, V33, P37
   Lanaspa M, 2015, CLIN MICROBIOL INFEC, V1018
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Lodha Rakesh, 2004, Indian Pediatr, V41, P129
   McCollum ED, 2013, T ROY SOC TROP MED H, V107, P285, DOI 10.1093/trstmh/trt017
   Mwaniki MK, 2009, B WORLD HEALTH ORGAN, V87, P263, DOI 10.2471/BLT.07.049148
   Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1
   O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe
   ONYANGO FE, 1993, BRIT MED J, V306, P612
   Orimadegun AE, 2013, T ROY SOC TROP MED H, V107, P699, DOI 10.1093/trstmh/trt082
   Rao YK, 2012, WORLD J PEDIATR, V8, P247, DOI 10.1007/s12519-012-0365-1
   REULAND DS, 1991, J PEDIATR-US, V119, P900, DOI 10.1016/S0022-3476(05)83040-9
   Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x
   Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060
   Ross PA, 2014, PEDIATRICS, V133, P22, DOI 10.1542/peds.2013-1760
   Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030
   Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d
   Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4
   Usen S, 1999, BRIT MED J, V318, P86
   Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x
   Weber MW, 1997, ARCH DIS CHILD, V76, P310
   World Health Organization, 2005, POCK BOOK HOSP CAR C
   World Health Organisation programme for the control of acute respiratory infections, 1990, AC RESP INF CHILDR C
   Rojas-Reyes MX, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005975.pub3
NR 37
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2016
VL 21
IS 9
BP 1147
EP 1156
DI 10.1111/tmi.12738
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EB1VS
UT WOS:000387144800010
PM 27310711
OA No
DA 2017-08-15
ER

PT J
AU Burr, SE
   Sillah, A
   Sanou, AS
   Wadagni, AC
   Hart, J
   Harding-Esch, EM
   Kanyi, S
   Bailey, RL
AF Burr, Sarah E.
   Sillah, Ansumana
   Sanou, Anselme S.
   Wadagni, Anita C.
   Hart, John
   Harding-Esch, Emma M.
   Kanyi, Sarjo
   Bailey, Robin L.
TI Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and
   Trichiasis in The Gambia: Has Elimination Been Reached?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID COMMUNITY; ETHIOPIA; TRIAL
AB Background
   The Gambia's National Eye Health Programme has made a concerted effort to reduce the prevalence of trachoma. The present study had two objectives. The first was to conduct surveillance following mass drug administrations to determine whether The Gambia has reached the World Health Organization's (WHO) criteria for trachoma elimination, namely a prevalence of trachomatous inflammation-follicular (TF) of less than 5% in children aged 1 to 9 years. The second was to determine the prevalence of trichiasis (TT) cases unknown to the programme and evaluate whether these meet the WHO criteria of less than 0.1% in the total population.
   Methodology/Principal Findings
   Three cross-sectional surveys were conducted between 2011 and 2013 to determine the prevalence of TF and TT in each of nine surveillance zones. Each zone was of similar size, with a population of 60,000 to 90,000, once urban settlements were excluded. Trachoma grading was carried out according to the WHO's simplified trachoma grading system. The prevalence of TF in children aged 1 to 9 years was less than 5% in each surveillance zone at each of the three surveys. The prevalence of TT cases varied by zone from 0 to 1.7% of adults greater than 14 years while the prevalence of TT cases unknown to the country's National Eye Health Programme was estimated at 0.15% total population.
   Conclusions/Significance
   The Gambia has reached the elimination threshold for TF in children. Further work is needed to bring the number of unknown TT cases below the elimination threshold.
C1 [Burr, Sarah E.; Hart, John; Harding-Esch, Emma M.; Bailey, Robin L.] London Sch Hyg & Trop Med, Dept Clin Res, London, England.
   [Burr, Sarah E.; Sanou, Anselme S.; Wadagni, Anita C.] MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Sillah, Ansumana; Kanyi, Sarjo] Minist Hlth & Social Welf, Natl Eye Hlth Programme, Kanifing, Gambia.
   [Sanou, Anselme S.; Wadagni, Anita C.] West Africa Hlth Org, Bobo Dioulasso, Burkina Faso.
   [Harding-Esch, Emma M.] Publ Hlth England, HIV STI Dept, London, England.
RP Burr, SE (reprint author), London Sch Hyg & Trop Med, Dept Clin Res, London, England.; Burr, SE (reprint author), MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.
EM Sarah.Burr@lshtm.ac.uk
FU International Trachoma Initiative; Sightsavers International
FX This study was funded by the International Trachoma Initiative and by
   Sightsavers International. The funders had no role in data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X
   Dolin PJ, 1998, BRIT J OPHTHALMOL, V82, P930, DOI 10.1136/bjo.82.8.930
   FAAL H, 1989, BRIT J OPHTHALMOL, V73, P82, DOI 10.1136/bjo.73.2.82
   The Gambia Bureau of Statistics, 2014, GAMB 2013 POP HOUS C, P1
   The Gambia Bureau of Statistics, 2006, ATL 2003 POP HOUS CE, P1
   Habtamu E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001014
   Harding-Esch EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002115
   Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V12, pe573
   [International Coalition for Trachoma Control (ICTC) Available], 2012, GLOB SCI M TRACH TRI, P1
   Martin DL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003555
   Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
   Quicke E, 2013, TROP MED INT HEALTH, V18, P1344, DOI 10.1111/tmi.12182
   Rajak SN, 2011, INVEST OPHTH VIS SCI, V52, P7974, DOI 10.1167/iovs.11-7880
   REACHER MH, 1990, BRIT J OPHTHALMOL, V74, P109, DOI 10.1136/bjo.74.2.109
   Solomon Anthony W, 2014, Community Eye Health, V27, P18
   Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0
   THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477
   World Health Organisation (WHO), TRACH STAT END BLIND
   World Health Organisation (WHO), 2010, 3 GLOB SCI M TRACH B, P1
   World Health Organisation (WHO), 2008, MAL RAP DIAGN TEST P, P1
   World Health Organisation (WHO), 1966, FUT APPR TRACH CONTR, P1
NR 21
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0004906
DI 10.1371/journal.pntd.0004906
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900010
PM 27643498
OA gold
DA 2017-08-15
ER

PT J
AU Deitz, KC
   Athrey, GA
   Jawara, M
   Overgaard, HJ
   Matias, A
   Slotman, MA
AF Deitz, Kevin C.
   Athrey, Giridhar A.
   Jawara, Musa
   Overgaard, Hans J.
   Matias, Abrahan
   Slotman, Michel A.
TI Genome-Wide Divergence in the West-African Malaria Vector Anopheles
   melas
SO G3-GENES GENOMES GENETICS
LA English
DT Article
DE Anopheles melas; Anopheles gambiae; malaria; population genomics;
   Pool-seq
ID GAMBIAE COMPLEX; EQUATORIAL-GUINEA; MOLECULAR-FORMS; ADAPTIVE
   INTROGRESSION; POPULATION-STRUCTURE; BIOKO ISLAND; ARABIENSIS; SEQUENCE;
   TRANSMISSION; DIFFERENTIATION
AB Anopheles melas is a member of the recently diverged An. gambiae species complex, a model for speciation studies, and is a locally important malaria vector along the West-African coast where it breeds in brackish water. A recent population genetic study of An. melas revealed species-level genetic differentiation between three population clusters. An. melas West extends from The Gambia to the village of Tiko, Cameroon. The other mainland cluster, An. melas South, extends from the southern Cameroonian village of Ipono to Angola. Bioko Island, Equatorial Guinea An. melas populations are genetically isolated from mainland populations. To examine how genetic differentiation between these An. melas forms is distributed across their genomes, we conducted a genome-wide analysis of genetic differentiation and selection using whole genome sequencing data of pooled individuals (Pool-seq) from a representative population of each cluster. The An. melas forms exhibit high levels of genetic differentiation throughout their genomes, including the presence of numerous fixed differences between clusters. Although the level of divergence between the clusters is on a par with that of other species within the An. gambiae complex, patterns of genome-wide divergence and diversity do not provide evidence for the presence of pre- and/or postmating isolating mechanisms in the form of speciation islands. These results are consistent with an allopatric divergence process with little or no introgression.
C1 [Deitz, Kevin C.; Slotman, Michel A.] Texas A&M Univ, Dept Entomol, 2475 TAMU,Heep Ctr Room 412, College Stn, TX 77843 USA.
   [Athrey, Giridhar A.] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA.
   [Jawara, Musa] MRC Unit, Fajara, Gambia.
   [Overgaard, Hans J.] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway.
   [Matias, Abrahan] Med Care Dev Int, Malabo, Equat Guinea.
RP Deitz, KC (reprint author), Texas A&M Univ, Dept Entomol, 2475 TAMU,Heep Ctr Room 412, College Stn, TX 77843 USA.
EM kcdeitz@tamu.edu
FU Bioko Island Malaria Control Project (BIMCP); Marathon Oil Corporation
   (Houston, TX); Government of Equatorial Guinea; National Institutes of
   Health/National Institute of Allergy and Infectious Diseases
   [R01AI085079, R21 AI115175]; Department of Entomology at Texas AM
   University
FX We thank Michael C. Fontaine (University of Groningen), Daniel E.
   Neafsey (Broad Institute of Massachusetts Institute of Technology and
   Harvard), and Nora J. Besansky (University of Notre Dame) for their
   helpful comments and feedback regarding this manuscript. Additionally,
   we thank the Anopheles Genome Consortium for data availability. We are
   grateful to Parfait H. Awono-Ambene, Christophe Antonio-Nkondjo, and
   Frederic Simard for assistance with collections in Ipono, Cameroon.
   Collections in Ballingho, The Gambia were supported by a research grant
   to M.A.S. by the Bioko Island Malaria Control Project (BIMCP). The BIMCP
   is funded by a consortium led by Marathon Oil Corporation (Houston, TX)
   and the Government of Equatorial Guinea. Collections on Bioko Island
   were conducted as part of the vector monitoring efforts under the BIMCP.
   We are grateful for the entomology staff of the BIMCP and the local
   volunteers for conducting these collections. Partial support of this
   work was provided by National Institutes of Health/National Institute of
   Allergy and Infectious Diseases grants R01AI085079 and R21 AI115175 to
   M.A.S. K.C.D. was partially supported by the J. H. Benedict, Sr.
   Memorial Graduate Student Scholarship and the Herb Dean '40 Endowed
   Scholarship, through the Department of Entomology at Texas A&M
   University during the term of this project.
CR Aboagye-Antwi F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005141
   Athrey G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003097
   BESANSKY NJ, 1994, P NATL ACAD SCI USA, V91, P6885, DOI 10.1073/pnas.91.15.6885
   Bogh C, 2007, AM J TROP MED HYG, V76, P875
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bryan J.H., 1987, Parassitologia (Rome), V29, P221
   BRYAN JH, 1983, ANN TROP MED PARASIT, V77, P1
   Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698
   Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182
   Cheng CD, 2012, GENETICS, V190, P1417, DOI 10.1534/genetics.111.137794
   Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248
   Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2
   Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227
   Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769
   Darum S. R., 2006, CONSERV GENET, V7, P783
   DAVIDSON G, 1962, NATURE, V196, P907, DOI 10.1038/196907a0
   Deitz KC, 2012, MOL ECOL, V21, P4498, DOI 10.1111/j.1365-294X.2012.05724.x
   della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x
   Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2
   Donnelly MJ, 2000, INSECT MOL BIOL, V9, P357, DOI 10.1046/j.1365-2583.2000.00197.x
   Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048
   Fabian DK, 2012, MOL ECOL, V21, P4748, DOI 10.1111/j.1365-294X.2012.05731.x
   Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x
   Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1
   Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524
   GELFAND H. M., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P508, DOI 10.1016/0035-9203(55)90023-7
   Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1
   Karlsen BO, 2013, MOL ECOL, V22, P5098, DOI 10.1111/mec.12454
   Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589
   Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925
   Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4
   Lanzaro G. C., 2013, DISTRIBUTION GENETIC, DOI [10.5772/56232, DOI 10.5772/56232]
   Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004
   Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110
   MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4
   Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149
   MARCHAND RP, 1984, NETH J ZOOL, V34, P367
   Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x
   Marsden CD, 2014, G3-GENES GENOM GENET, V4, P121, DOI 10.1534/g3.113.008326
   Mayr E., 1970, POPULATIONS SPECIES
   Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019
   Montague MJ, 2014, P NATL ACAD SCI USA, V111, P17230, DOI 10.1073/pnas.1410083111
   Moreno M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-137
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269
   Norris LC, 2015, P NATL ACAD SCI USA, V112, P815, DOI 10.1073/pnas.1418892112
   Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001
   OKEREKE TA, 1980, B ENTOMOL RES, V70, P391
   Overgaard HJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-253
   Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101
   Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184
   Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803
   Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103
   Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5
   Sharakhova MV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-459
   Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17
   Slotman M, 2005, EVOLUTION, V59, P1016
   Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275
   Slotman MA, 2005, AM J TROP MED HYG, V73, P326
   Smith HA, 2015, HEREDITY, V115, P471, DOI 10.1038/hdy.2015.39
   TAJIMA F, 1989, GENETICS, V123, P585
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Tripet F, 2005, J MED ENTOMOL, V42, P596, DOI 10.1603/0022-2585(2005)042[0596:EOSFIM]2.0.CO;2
   Turner T. L., 2005, PLOS BIOL, V9, pe285
   Weetman D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-345
   White BJ, 2007, AM J TROP MED HYG, V76, P334
   White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028
   White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x
   WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2
   Wilding CS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-320
NR 76
TC 1
Z9 1
U1 3
U2 5
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 2160-1836
J9 G3-GENES GENOM GENET
JI G3-Genes Genomes Genet.
PD SEP
PY 2016
VL 6
IS 9
BP 2867
EP 2879
DI 10.1534/g3.116.031906
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA DW9ZN
UT WOS:000384021400019
PM 27466271
OA gold
DA 2017-08-15
ER

PT J
AU Pekyi, D
   Ampromfi, AA
   Tinto, H
   Traore-Coulibaly, M
   Tahita, MC
   Valea, I
   Mwapasa, V
   Kalilani-Phiri, L
   Kalanda, G
   Madanitsa, M
   Ravinetto, R
   Mutabingwa, T
   Gbekor, P
   Tagbor, H
   Antwi, G
   Menten, J
   De Crop, M
   Claeys, Y
   Schurmans, C
   Van Overmeir, C
   Thriemer, K
   Van Geertruyden, JP
   D'Alessandro, U
   Nambozi, M
   Mulenga, M
   Hachizovu, S
   Kabuya, JBB
   Mulenga, J
AF Pekyi, Divine
   Ampromfi, Akua A.
   Tinto, Halidou
   Traore-Coulibaly, Maminata
   Tahita, Marc C.
   Valea, Innocent
   Mwapasa, Victor
   Kalilani-Phiri, Linda
   Kalanda, Gertrude
   Madanitsa, Mwayiwawo
   Ravinetto, Raffaella
   Mutabingwa, Theonest
   Gbekor, Prosper
   Tagbor, Harry
   Antwi, Gifty
   Menten, Joris
   De Crop, Maaike
   Claeys, Yves
   Schurmans, Celine
   Van Overmeir, Chantal
   Thriemer, Kamala
   Van Geertruyden, Jean-Pierre
   D'Alessandro, Umberto
   Nambozi, Michael
   Mulenga, Modest
   Hachizovu, Sebastian
   Kabuya, Jean-Bertin B.
   Mulenga, Joyce
CA PREGACT Study Grp
TI Four artemisinin-based treatments in African pregnant women with malaria
SO MALAWI MEDICAL JOURNAL
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE;
   ARTEMETHER-LUMEFANTRINE; NONPREGNANT WOMEN; CONTROLLED-TRIAL;
   CLINICAL-TRIALS; VIVAX MALARIA; COMBINATION; PHARMACOKINETICS;
   AMODIAQUINE
AB Background
   Information regarding the safety and efficacy of artemisinin combination treatments for malaria in pregnant women is limited, particularly among women who live in sub-Saharan Africa.
   Methods
   We conducted a multicenter, randomized, open-label trial of treatments for malaria in pregnant women in four African countries. A total of 3428 pregnant women in the second or third trimester who had falciparum malaria (at any parasite density and regardless of symptoms) were treated with artemether-lumefantrine, amodiaquine-artesunate, mefloquine-artesunate, or dihydroartemisinin-piperaquine. The primary end points were the polymerase-chain-reaction (PCR)-adjusted cure rates (i.e., cure of the original infection; new infections during follow-up were not considered to be treatment failures) at day 63 and safety outcomes.
   Results
   The PCR-adjusted cure rates in the per-protocol analysis were 94.8% in the artemether-lumefantrine group, 98.5% in the amodiaquine-artesunate group, 99.2% in the dihydroartemisinin-piperaquine group, and 96.8% in the mefloquine-artesunate group; the PCR-adjusted cure rates in the intention-to-treat analysis were 94.2%, 96.9%, 98.0%, and 95.5%, respectively. There was no significant difference among the amodiaquine-artesunate group, dihydroartemisinin-piperaquine group, and the mefloquine-artesunate group. The cure rate in the artemether-lumefantrine group was significantly lower than that in the other three groups, although the absolute difference was within the 5-percentage-point margin for equivalence. The unadjusted cure rates, used as a measure of the post-treatment prophylactic effect, were significantly lower in the artemether-lumefantrine group (52.5%) than in groups that received amodiaquine-artesunate (82.3%), dihydroartemisinin-piperaquine (86.9%), or mefloquine-artesunate (73.8%). No significant difference in the rate of serious adverse events and in birth outcomes was found among the treatment groups. Drug-related adverse events such as asthenia, poor appetite, dizziness, nausea, and vomiting occurred significantly more frequently in the mefloquine-artesunate group (50.6%) and the amodiaquine-artesunate group (48.5%) than in the dihydroartemisinin-piperaquine group (20.6%) and the artemether-lumefantrine group (11.5%) (P<0.001 for comparison among the four groups).
   Conclusions
   Artemether-lumefantrine was associated with the fewest adverse effects and with acceptable cure rates but provided the shortest post-treatment prophylaxis, whereas dihydroartemisinin-piperaquine had the best efficacy and an acceptable safety profile.
C1 [Pekyi, Divine; PREGACT Study Grp] Ctr Global Hlth Res, Kumasi, Ghana.
   [Tinto, Halidou; Traore-Coulibaly, Maminata; Tahita, Marc C.; Valea, Innocent] Clin Trial Unit Nanoro, Nanoro, Burkina Faso.
   [Mwapasa, Victor; Kalilani-Phiri, Linda; Kalanda, Gertrude; Madanitsa, Mwayiwawo] Univ Malawi, Coll Med, Blantyre, Malawi.
   [Ravinetto, Raffaella] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium.
   [Ravinetto, Raffaella; Menten, Joris; De Crop, Maaike; Claeys, Yves; Schurmans, Celine; Van Overmeir, Chantal; Thriemer, Kamala; D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [Mutabingwa, Theonest] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania.
   [Gbekor, Prosper] Juaben Govt Hosp, Juaben, Ghana.
   [Tagbor, Harry; Antwi, Gifty] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana.
   [Thriemer, Kamala] Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [Nambozi, Michael; Mulenga, Modest; Hachizovu, Sebastian; Kabuya, Jean-Bertin B.; Mulenga, Joyce] Trop Dis Res Ctr, Ndola, Zambia.
RP D'Alessandro, U (reprint author), Inst Trop Med, Antwerp, Belgium.; D'Alessandro, U (reprint author), MRC Unit, Fajara, Gambia.; D'Alessandro, U (reprint author), London Sch Hyg & Trop Med, London, England.
EM udalessandro@mrc.gm
FU European and Developing Countries Clinical Trials Partnership; Malaria
   in Pregnancy Consortium (Bill and Melinda Gates Foundation); Belgian
   Development Cooperation Agency; Liverpool School of Tropical Medicine;
   Medical Research Council UK; Netherlands Organization for Scientific
   Research; Sanofi-Aventis
FX Supported by the European and Developing Countries Clinical Trials
   Partnership, the Malaria in Pregnancy Consortium (which is funded
   through a grant from the Bill and Melinda Gates Foundation to the
   Liverpool School of Tropical Medicine), the Belgian Development
   Cooperation Agency, the Liverpool School of Tropical Medicine, the
   Medical Research Council UK, the Netherlands Organization for Scientific
   Research, and Sanofi-Aventis.
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Adam I, 2012, AM J TROP MED HYG, V87, P35, DOI 10.4269/ajtmh.2012.11-0410
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Clerk CA, 2008, J INFECT DIS, V198, P1202, DOI 10.1086/591944
   D'Alessandro U, 2009, EXPERT OPIN PHARMACO, V10, P1291, DOI 10.1517/14656560902942319
   Dmitrienko A, 2013, STAT MED, V32, P5172, DOI 10.1002/sim.5990
   Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Gonzalez R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-75
   Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07
   Gupta V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-19
   Hoglund RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-398
   Kloprogge F, 2013, CPT Pharmacometrics Syst Pharmacol, V2, pe83, DOI 10.1038/psp.2013.59
   Lutje V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-61
   Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141
   McGready R, 2011, BJOG-INT J OBSTET GY, V118, P123, DOI 10.1111/j.1471-0528.2010.02810.x
   McGready R, 2008, PLOS MED, V5, P1699, DOI 10.1371/journal.pmed.0050253
   Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5
   Orton LC, 2008, COCHRANE DB SYST REV, V4
   Rijken MJ, 2011, ANTIMICROB AGENTS CH, V55, P4338, DOI 10.1128/AAC.00154-11
   Tagbor H, 2006, LANCET, V368, P1349, DOI 10.1016/S0140-6736(06)69559-7
   Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI DOI 10.4084/MJHID.2013.010
   Valea I, 2014, J ANTIMICROB CHEMOTH, V69, P2499, DOI 10.1093/jac/dku154
   van Riemsdijk MM, 2004, BRIT J CLIN PHARMACO, V57, P506, DOI 10.1046/j.1365-2125.2003.02035.x
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   [Anonymous], 2008, METH TEHCN CLIN TRIA
   WHO, 2015, GUID TREATM MAL
   WorldWide Antimalarial Resistance Network (WWARN), 2012, CLIN MOD DAT MAN STA
NR 28
TC 0
Z9 0
U1 2
U2 3
PU MED COLL MALAWI
PI CHICHIRI
PA MALAWAI MEDICAL JOURNAL, PRIVATE BAG 360, CHICHIRI, BLANTYRE 3 00000,
   MALAWI
SN 1995-7262
EI 1995-7270
J9 MALAWI MED J
JI Malawi Med. J.
PD SEP
PY 2016
VL 28
IS 3
SI SI
BP 139
EP 149
DI 10.1056/NEJMoa1508606
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DZ1PR
UT WOS:000385610800015
PM 27895848
OA No
DA 2017-08-15
ER

PT J
AU Braithwaite, VS
   Freeman, R
   Greenwood, CL
   Summers, DM
   Nigdikar, S
   Lavy, CBD
   Offiah, AC
   Bishop, NJ
   Cashman, J
   Prentice, A
AF Braithwaite, V. S.
   Freeman, R.
   Greenwood, C. L.
   Summers, D. M.
   Nigdikar, S.
   Lavy, C. B. D.
   Offiah, A. C.
   Bishop, N. J.
   Cashman, J.
   Prentice, A.
TI The aetiology of rickets-like lower limb deformities in Malawian
   children (vol 27, pg 2367, 2016)
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Correction
C1 [Braithwaite, V. S.; Greenwood, C. L.; Nigdikar, S.; Prentice, A.] MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge, England.
   [Freeman, R.] Robert Jones Agnes Hunt NHS Fdn Trust, Dept Paediat Orthopaed, Oswestry, Shrops, England.
   [Summers, D. M.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge, England.
   [Lavy, C. B. D.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.
   [Offiah, A. C.; Bishop, N. J.] Univ Sheffield, Dept Oncol & Metab, Acad Unit Child Hlth, Sheffield, S Yorkshire, England.
   [Cashman, J.] Beit Cure Orthopaed Hosp, Blantyre, Malawi.
   [Prentice, A.] MRC Keneba, Keneba, Gambia.
RP Braithwaite, VS (reprint author), MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge, England.
EM vickie.braithwaite@mrc-hnr.cam.ac.uk
FU Medical Research Council [MC_U105960371]
CR Braithwaite VS, 2016, OSTEOPOROSIS INT, V27, P2367, DOI 10.1007/s00198-016-3541-7
NR 1
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD SEP
PY 2016
VL 27
IS 9
BP 2889
EP 2889
DI 10.1007/s00198-016-3680-x
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DZ2LD
UT WOS:000385672400030
PM 27349560
OA No
DA 2017-08-15
ER

PT J
AU Chegou, NN
   Sutherland, JS
   Malherbe, S
   Crampin, AC
   Corstjens, PLAM
   Geluk, A
   Mayanja-Kizza, H
   Loxton, AG
   van der Spuy, G
   Stanley, K
   Kotze, LA
   van der Vyver, M
   Rosenkrands, I
   Kidd, M
   van Helden, PD
   Dockrell, HM
   Ottenhoff, THM
   Kaufmann, SHE
   Walzl, G
AF Chegou, Novel N.
   Sutherland, Jayne S.
   Malherbe, Stephanus
   Crampin, Amelia C.
   Corstjens, Paul L. A. M.
   Geluk, Annemieke
   Mayanja-Kizza, Harriet
   Loxton, Andre G.
   van der Spuy, Gian
   Stanley, Kim
   Kotze, Leigh A.
   van der Vyver, Marieta
   Rosenkrands, Ida
   Kidd, Martin
   van Helden, Paul D.
   Dockrell, Hazel M.
   Ottenhoff, Tom H. M.
   Kaufmann, Stefan H. E.
   Walzl, Gerhard
CA AE-TBC Consortium
TI Diagnostic performance of a seven-marker serum protein biosignature for
   the diagnosis of active TB disease in African primary healthcare clinic
   attendees with signs and symptoms suggestive of TB
SO THORAX
LA English
DT Article
DE Tuberculosis
ID C-REACTIVE PROTEIN; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS;
   INFECTION; ASSAY; BLOOD; PROCALCITONIN; RESPONSES; FERRITIN; HIV
AB Background User-friendly, rapid, inexpensive yet accurate TB diagnostic tools are urgently needed at points of care in resource-limited settings. We investigated host biomarkers detected in serum samples obtained from adults with signs and symptoms suggestive of TB at primary healthcare clinics in five African countries (Malawi, Namibia, South Africa, The Gambia and Uganda), for the diagnosis of TB disease.
   Methods We prospectively enrolled individuals presenting with symptoms warranting investigation for pulmonary TB, prior to assessment for TB disease. We evaluated 22 host protein biomarkers in stored serum samples using a multiplex cytokine platform. Using a pre-established diagnostic algorithm comprising of laboratory, clinical and radiological findings, participants were classified as either definite TB, probable TB, questionable TB status or non-pulmonary TB.
   Results Of the 716 participants enrolled, 185 were definite and 29 were probable TB cases, 6 had questionable TB disease status, whereas 487 had no evidence of TB. A seven-marker biosignature of C reactive protein, transthyretin, IFN-, complement factor H, apolipoprotein-A1, inducible protein 10 and serum amyloid A identified on a training sample set (n=491), diagnosed TB disease in the test set (n=210) with sensitivity of 93.8% (95% CI 84.0% to 98.0%), specificity of 73.3% (95% CI 65.2% to 80.1%), and positive and negative predictive values of 60.6% (95% CI 50.3% to 70.1%) and 96.4% (95% CI 90.5% to 98.8%), respectively, regardless of HIV infection status or study site.
   Conclusions We have identified a seven-marker host serum protein biosignature for the diagnosis of TB disease irrespective of HIV infection status or ethnicity in Africa. These results hold promise for the development of a field-friendly point-of-care screening test for pulmonary TB.
C1 [Chegou, Novel N.; Malherbe, Stephanus; Loxton, Andre G.; van der Spuy, Gian; Stanley, Kim; Kotze, Leigh A.; van Helden, Paul D.; Walzl, Gerhard] Univ Stellenbosch, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, POB 241, ZA-8000 Cape Town, South Africa.
   [Chegou, Novel N.; Malherbe, Stephanus; Loxton, Andre G.; van der Spuy, Gian; Stanley, Kim; Kotze, Leigh A.; van Helden, Paul D.; Walzl, Gerhard] Univ Stellenbosch, SAMRC Ctr TB Res, POB 241, ZA-8000 Cape Town, South Africa.
   [Sutherland, Jayne S.] MRC Unit, Vaccines & Immun, Fajara, Gambia.
   [Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi.
   [Corstjens, Paul L. A. M.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.
   [Geluk, Annemieke; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.
   [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Kampala, Uganda.
   [van der Vyver, Marieta] Univ Namibia, Sch Med, Fac Hlth Sci, Windhoek, Namibia.
   [Rosenkrands, Ida] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark.
   [Kidd, Martin] Univ Stellenbosch, Ctr Stat Consultat, Dept Stat & Actuarial Sci, Cape Town, South Africa.
   [Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England.
   [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.
RP Chegou, NN (reprint author), Univ Stellenbosch, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, POB 241, ZA-8000 Cape Town, South Africa.; Chegou, NN (reprint author), Univ Stellenbosch, SAMRC Ctr TB Res, POB 241, ZA-8000 Cape Town, South Africa.
EM novel@sun.ac.za
OI Walzl, Gerhard/0000-0003-2487-125X; van der Spuy,
   Gian/0000-0002-9067-5903; Sutherland, Jayne/0000-0002-7083-4997
FU European and Developing Countries Clinical Trials Partnership (EDCTP),
   through the African European Tuberculosis Consortium (AE-TBC)
   [IP_2009_32040]
FX This work was supported by the European and Developing Countries
   Clinical Trials Partnership (EDCTP), grant number IP_2009_32040, through
   the African European Tuberculosis Consortium (AE-TBC,
   http://www.ae-tbc.eu), with GW as principal investigator.
CR Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2
   Baumann R, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/364758
   Baumann R, 2014, J INFECTION, V69, P581, DOI 10.1016/j.jinf.2014.05.014
   Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0
   Carroll MV, 2009, MOL IMMUNOL, V46, P3367, DOI 10.1016/j.molimm.2009.07.015
   Chegou NN, 2008, RESPIRATION, V76, P131, DOI 10.1159/000128575
   Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413
   Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226
   Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501
   Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10
   Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]
   Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21
   Claassens MM, 2013, INT J TUBERC LUNG D, V17, P603, DOI 10.5588/ijtld.12.0505
   Corstjens PLAM, 2008, CLIN BIOCHEM, V41, P440, DOI 10.1016/j.clinbiochem.2007.12.015
   Corstjens PLAM, 2007, ANN NY ACAD SCI, V1098, P437, DOI 10.1196/annals.1384.016
   Corstjens PLAM, 2016, CLIN BIOCHEM, V49, P22, DOI 10.1016/j.clinbiochem.2015.08.013
   DEBEER FC, 1984, THORAX, V39, P196, DOI 10.1136/thx.39.3.196
   Essone PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102584
   Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007
   Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135
   Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006
   Goletti D, 2005, CLIN DIAGN LAB IMMUN, V12, P1311, DOI 10.1128/CDLI.12.11.1311-1316.2005
   Hoeboer SH, 2015, CLIN MICROBIOL INFEC, V21, P474, DOI 10.1016/j.cmi.2014.12.026
   Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545
   Kotru M, 2004, ANN HEMATOL, V83, P95, DOI 10.1007/s00277-003-0788-9
   Luo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079940
   Marais BJ, 2007, PAEDIATR RESPIR REV, V8, P124, DOI 10.1016/j.prrv.2007.04.002
   Montecucco Fabrizio, 2015, Handb Exp Pharmacol, V224, P455, DOI 10.1007/978-3-319-09665-0_14
   Opolot JO, 2015, LUNG, V193, P13, DOI 10.1007/s00408-014-9680-8
   Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12
   Phalane KG, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/981984
   Schleicher GK, 2005, EUR RESPIR J, V25, P688, DOI 10.1183/09031936.05.00067604
   Singh Manpreet, 2014, Int J Crit Illn Inj Sci, V4, P233, DOI 10.4103/2229-5151.141437
   Statsoft, GEN DISCR AN GDA STA
   Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392
   Visser A, 2011, CLIN INFECT DIS, V52, P273, DOI 10.1093/cid/ciq126
   Wang C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-52
   World Health Organization, 2015, GLOB TUB REP
NR 40
TC 3
Z9 3
U1 1
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0040-6376
EI 1468-3296
J9 THORAX
JI Thorax
PD SEP
PY 2016
VL 71
IS 9
BP 785
EP 794
DI 10.1136/thoraxjnl-2015-207999
PG 10
WC Respiratory System
SC Respiratory System
GA DW3ME
UT WOS:000383544900005
PM 27146200
OA No
DA 2017-08-15
ER

PT J
AU Awoniyi, DO
   Teuchert, A
   Sutherland, JS
   Mayanja-Kizza, H
   Howe, R
   Mihret, A
   Loxton, AG
   Sheehama, J
   Kassa, D
   Crampin, AC
   Dockrell, HM
   Kidd, M
   Rosenkrands, I
   Geluk, A
   Ottenhoff, THM
   Corstjens, PLAM
   Chegou, NN
   Walzl, G
AF Awoniyi, Dolapo O.
   Teuchert, Andrea
   Sutherland, Jayne S.
   Mayanja-Kizza, Harriet
   Howe, Rawleigh
   Mihret, Adane
   Loxton, Andre G.
   Sheehama, Jacob
   Kassa, Desta
   Crampin, Amelia C.
   Dockrell, Hazel M.
   Kidd, Martin
   Rosenkrands, Ida
   Geluk, Annemieke
   Ottenhoff, Tom H. M.
   Corstjens, P. L. A. M.
   Chegou, Novel N.
   Walzl, Gerhard
CA AE-TBC Consortium
TI Evaluation of cytokine responses against novel Mtb antigens as
   diagnostic markers for TB disease
SO JOURNAL OF INFECTION
LA English
DT Article
DE Biosignature; Host markers; Antigen
ID MYCOBACTERIUM-TUBERCULOSIS INFECTION; C-REACTIVE PROTEIN; GAMMA
   INDUCIBLE PROTEIN-10; LATERAL FLOW ASSAY; INTERFERON-GAMMA; PULMONARY
   TUBERCULOSIS; MULTICENTER EVALUATION; ACTIVE TUBERCULOSIS; DORMANCY
   REGULON; DETERMINE IP-10
AB Objective: We investigated the accuracy of host markers detected in Mtb antigen-stimulated whole blood culture supernatant in the diagnosis of TB.
   Methods: Prospectively, blood from 322 individuals with presumed TB disease from six African sites was stimulated with four different Mtb antigens (Rv0081, Rv1284, ESAT-6/CFP-10, and Rv2034) in a 24 h whole blood stimulation assay (WBA). The concentrations of 42 host markers in the supernatants were measured using the Luminex multiplex platform. Diagnostic bio-signatures were investigated through the use of multivariate analysis techniques.
   Results: 17% of the participants were HIV infected, 106 had active TB disease and in 216 TB was excluded. Unstimulated concentrations of CRP, SAA, ferritin and IP-10 had better discriminating ability than markers from stimulated samples. Accuracy of marker combinations by general discriminant analysis (GDA) identified a six analyte model with 77% accuracy for TB cases and 84% for non TB cases, with a better performance in HIV uninfected patients.
   Conclusions: A biosignature of 6 cytokines obtained after stimulation with four Mtb antigens has moderate potential as a diagnostic tool for pulmonary TB disease individuals and stimulated marker expression had no added value to unstimulated marker performance. (C) 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Awoniyi, Dolapo O.; Teuchert, Andrea; Loxton, Andre G.; Chegou, Novel N.; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Biomed Sci, Div Mol Biol & Human Genet, POB 19063,Francie van Zijl Dr, ZA-7505 Cape Town, South Africa.
   [Sutherland, Jayne S.] MRC Unit, Fajara, Gambia.
   [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Kampala, Uganda.
   [Howe, Rawleigh; Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Sheehama, Jacob] Univ Namibia, Sch Med, Fac Hlth Sci, Windhoek, Namibia.
   [Kassa, Desta] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia.
   [Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi.
   [Crampin, Amelia C.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, London, England.
   [Kidd, Martin] Univ Stellenbosch, Ctr Stat Anal, Cape Town, South Africa.
   [Rosenkrands, Ida] Statens Serum Inst, Copenhagen, Denmark.
   [Geluk, Annemieke; Ottenhoff, Tom H. M.] Leiden Univ Med Ctr, Dept Infect Dis, Leiden, Netherlands.
   [Corstjens, P. L. A. M.] Leiden Univ Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.
RP Walzl, G (reprint author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Biomed Sci, Div Mol Biol & Human Genet, POB 19063,Francie van Zijl Dr, ZA-7505 Cape Town, South Africa.
EM gwalzl@sun.ac.za
OI Walzl, Gerhard/0000-0003-2487-125X; van der Spuy,
   Gian/0000-0002-9067-5903; Sutherland, Jayne/0000-0002-7083-4997
FU EDCTP [IP_2009_32040]
FX The African European Tuberculosis Consortium (AE-TBC, www.ae-tbc.eu) was
   funded by the EDCTP, grant number IP_2009_32040, Principal Investigator:
   Prof. Gerhard Walzl.
CR Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010
   Baumann R, 2014, J INFECTION, V69, P581, DOI 10.1016/j.jinf.2014.05.014
   Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x
   Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09
   Bobosha K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002845
   Chegou NN, 2016, THORAX
   Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413
   Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501
   Chegou NN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-10
   Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]
   Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21
   Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x
   Commandeur S, 2014, VACCINE, V32, P3580, DOI 10.1016/j.vaccine.2014.05.005
   Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602
   Corstjens PLAM, 2016, CLIN BIOCHEM, V49, P22, DOI 10.1016/j.clinbiochem.2015.08.013
   dos Anjos BL, 2010, CLIN CHEM LAB MED, V48, P493, DOI 10.1515/CCLM.2010.110
   Essone PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102584
   Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001
   Fujiwara H, 2011, J SURG ONCOL, V103, P62, DOI 10.1002/jso.21751
   Haider DG, 2006, CLIN EXP IMMUNOL, V146, P533, DOI 10.1111/j.1365-2249.2006.03224.x
   Honaker RW, 2008, INFECT IMMUN, V76, P2587, DOI 10.1128/IAI.01235-07
   Hong JY, 2012, INT J INFECT DIS, V16, pE855, DOI 10.1016/j.ijid.2012.07.013
   Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3
   Jacobs R, 2016, CYTOKINE, V81, P50, DOI 10.1016/j.cyto.2016.02.004
   Kabeer BSA, 2012, J INFECTION, V64, P573, DOI 10.1016/j.jinf.2012.02.013
   Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051
   Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538
   Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018
   Lin MY, 2008, BIOL CHEM, V389, P497, DOI 10.1515/BC.2008.057
   MAASILTA P, 1989, INFECTION, V17, P13, DOI 10.1007/BF01643491
   MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186
   Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002
   Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED
   Phalane KG, 2013, MEDIAT INFLAMM, V2013
   Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06
   Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508
   Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001
   Sauty A, 1999, J IMMUNOL, V162, P3549
   Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590
   Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810
   Sutherland JS, 2016, TUBERCULOSIS, V96, P31, DOI 10.1016/j.tube.2015.10.011
   Verweij KE, 2010, INT J TUBERC LUNG D, V14, P1127
   Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139
   Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18
NR 46
TC 2
Z9 2
U1 1
U2 6
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD SEP
PY 2016
VL 73
IS 3
BP 219
EP 230
DI 10.1016/j.jinf.2016.04.036
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA DW1CN
UT WOS:000383380500005
PM 27311746
OA No
DA 2017-08-15
ER

PT J
AU Wegmuller, R
   Bah, A
   Kendall, L
   Goheen, MM
   Mulwa, S
   Cerami, C
   Moretti, D
   Prentice, AM
AF Wegmuller, Rita
   Bah, Amat
   Kendall, Lindsay
   Goheen, Morgan M.
   Mulwa, Sarah
   Cerami, Carla
   Moretti, Diego
   Prentice, Andrew M.
TI Efficacy and safety of hepcidin-based screen-and-treat approaches using
   two different doses versus a standard universal approach of iron
   supplementation in young children in rural Gambia: a double-blind
   randomised controlled trial
SO BMC PEDIATRICS
LA English
DT Article
DE Hepcidin; Iron supplementation; Iron deficiency; Iron deficiency
   anaemia; Anaemia; Safety; Children; Gambia; Sub-Saharan Africa
ID AFRICAN CHILDREN; FORTIFICATION; MICRONUTRIENTS; INFANTS; GROWTH
AB Background: Iron deficiency prevalence rates frequently exceed 50 % in young children in low-income countries. The World Health Organization (WHO) recommended universal supplementation of young children where anaemia rates are >40 %. However, large randomized trials have revealed that provision of iron to young children caused serious adverse effects because iron powerfully promotes microbial growth. Hepcidin - the master regulator of iron metabolism that integrates signals of infection and iron deficiency - offers the possibility of new solutions to diagnose and combat global iron deficiency. We aim to evaluate a hepcidin-screening- based iron supplementation intervention using hepcidin cut-offs designed to indicate that an individual requires iron, is safe to receive it and will absorb it.
   Methods: The study is a proof-of-concept, three-arm, double blind, randomised controlled, prospective, parallel-group non-inferiority trial. Children will be randomised to receive, for a duration of 12 weeks, one of three multiple micronutrient powders (MNP) containing: A) 12 mg iron daily; B) 12 mg or 0 mg iron daily based on a weekly hepcidin screening indicating if iron can be given for the next seven days or not; C) 6 mg or 0 mg iron daily based on a weekly hepcidin screening indicating if iron can be given for the next seven days or not. The inclusion criteria are age 6-23 months, haemoglobin (Hb) concentration between 7 and 11 g/dL, z-scores for Height-for-Age, Weight-for-Age and Weight-for-Height > -3 SD and free of malaria. Hb concentration at 12 weeks will be used to test whether the screen-and-treat approaches are non-inferior to universal supplementation. Safety will be assessed using caregiver reports of infections, in vitro bacterial and P. falciparum growth assays and by determining the changes in the gut microbiota during the study period.
   Discussion: A screen-and-treat approach using hepcidin has the potential to make iron administration safer in areas with widespread infections. If this proof-of-concept study shows promising results the development of a point-of-care diagnostic test will be the next step.
C1 [Wegmuller, Rita; Bah, Amat; Prentice, Andrew M.] MRC Int Nutr Grp, MRC Unit Gambia, Keneba, Gambia.
   [Kendall, Lindsay; Mulwa, Sarah] MRC Unit Gambia, Fajara, Gambia.
   [Goheen, Morgan M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Cerami, Carla] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Moretti, Diego] ETH, Lab Human Nutr, Inst Food Nutr & Hlth, CH-8092 Zurich, Switzerland.
RP Wegmuller, R (reprint author), MRC Int Nutr Grp, MRC Unit Gambia, Keneba, Gambia.
EM rwegmuller@mrc.gm
RI Moretti, Diego/G-5212-2013
OI Moretti, Diego/0000-0002-7366-2182; Cerami, Carla/0000-0002-7634-0955
FU Bill & Melinda Gates Foundation
FX This research is undertaken with a research grant provided by the Bill &
   Melinda Gates Foundation. The funding agency had no role in the design
   and conduct of the study, and will not have any role in the collection,
   management, analyses or interpretation of the data nor in the
   preparation, review, or approval of the manuscript.
CR Clark MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5446
   Cross JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16670
   De-Regil LM, 2011, COCHRANE DB SYST REV, V9
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Fomon SJ, 2005, J NUTR, V135, P771
   Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   Lozoff B, 2013, J PEDIATR-US, V163, P1260, DOI 10.1016/j.jpeds.2013.05.015
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249
   Prentice AM, 2007, J NUTR, V137, P1334
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7
   Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125
   WHO, 2015, GLOB PREV AN 2011
   WHO, 2007, FOOD NUTR BULL, V28, pS621
   WHO, 2011, GUID US MULT MICR PO
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
   Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129
NR 20
TC 5
Z9 6
U1 4
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD SEP 1
PY 2016
VL 16
AR 149
DI 10.1186/s12887-016-0689-4
PG 9
WC Pediatrics
SC Pediatrics
GA DV6HZ
UT WOS:000383035800001
PM 27585745
OA gold
DA 2017-08-15
ER

PT J
AU Thera, MA
   Coulibaly, D
   Kone, AK
   Guindo, AB
   Traore, K
   Sall, AH
   Diarra, I
   Daou, M
   Traore, IM
   Tolo, Y
   Sissoko, M
   Niangaly, A
   Arama, C
   Baby, M
   Kouriba, B
   Sissoko, MS
   Sagara, I
   Toure, OB
   Dolo, A
   Diallo, DA
   Remarque, E
   Chilengi, R
   Noor, R
   Sesay, S
   Thomas, A
   Kocken, CH
   Faber, BW
   Imoukhuede, EB
   Leroy, O
   Doumbo, OK
AF Thera, Mahamadou A.
   Coulibaly, Drissa
   Kone, Abdoulaye K.
   Guindo, Ando B.
   Traore, Karim
   Sall, Abdourhamane H.
   Diarra, Issa
   Daou, Modibo
   Traore, Idrissa M.
   Tolo, Youssouf
   Sissoko, Mady
   Niangaly, Amadou
   Arama, Charles
   Baby, Mounirou
   Kouriba, Bourema
   Sissoko, Mahamadou S.
   Sagara, Issaka
   Toure, Ousmane B.
   Dolo, Amagana
   Diallo, Dapa A.
   Remarque, Edmond
   Chilengi, Roma
   Noor, Ramadhani
   Sesay, Sanie
   Thomas, Alan
   Kocken, Clemens H.
   Faber, Bart W.
   Imoukhuede, Egeruan Babatunde
   Leroy, Odile
   Doumbo, Ogobara K.
TI Phase 1 randomized controlled trial to evaluate the safety and
   immunogenicity of recombinant Pichia pastoris-expressed Plasmodium
   falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy
   Malian adults in Bandiagara
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Vaccine; Safety; Immunogenicity; Blood-stage; PfAMA1;
   Plasmodium falciparum antigen
ID BLOOD-STAGE MALARIA; VACCINE CANDIDATE; AMA1; IMMUNIZATION; DIVERSITY;
   RESPONSES; CHILDREN; EFFICACY; IMPACT; SITE
AB Background: The safety and immunogenicity of PfAMA1, adjuvanted with Alhydrogel (R) was assessed in malaria-experienced Malian adults. The malaria vaccine, PfAMA1-FVO [25-545] is a recombinant protein Pichia pastoris-expressed AMA-1 from Plasmodium falciparum FVO clone adsorbed to Alhydrogel (R), the control vaccine was tetanus toxoid produced from formaldehyde detoxified and purified tetanus toxin.
   Methods: A double blind randomized controlled phase 1 study enrolled and followed 40 healthy adults aged 18-55 years in Bandiagara, Mali, West Africa, a rural setting with intense seasonal transmission of P. falciparum malaria. Volunteers were randomized to receive either 50 mu g of malaria vaccine or the control vaccine. Three doses of vaccine were given on Days 0, 28 and 56, and participants were followed for 1 year. Solicited symptoms were assessed for seven days and unsolicited symptoms for 28 days after each vaccination. Serious adverse events were assessed throughout the study. The titres of anti-AMA-1 antibodies were measured by ELISA and P. falciparum growth inhibition assays were performed.
   Results: Commonest local solicited adverse events were the injection site pain and swelling more frequent in the PfAMA1 group. No vaccine related serious adverse events were reported. A significant 3.5-fold increase of anti-AMA-1 IgG antibodies was observed in malaria vaccine recipients four weeks after the third immunization compared to the control group.
   Conclusion: The PfAMA1 showed a good safety profile. Most adverse events reported were of mild to moderate intensity. In addition, the vaccine induced a significant though short-lived increase in the anti-AMA1 IgG titres.
C1 [Thera, Mahamadou A.; Coulibaly, Drissa; Kone, Abdoulaye K.; Guindo, Ando B.; Traore, Karim; Sall, Abdourhamane H.; Diarra, Issa; Daou, Modibo; Traore, Idrissa M.; Tolo, Youssouf; Sissoko, Mady; Niangaly, Amadou; Arama, Charles; Baby, Mounirou; Kouriba, Bourema; Sissoko, Mahamadou S.; Sagara, Issaka; Toure, Ousmane B.; Dolo, Amagana; Diallo, Dapa A.; Doumbo, Ogobara K.] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med & Dent, Bamako, Mali.
   [Noor, Ramadhani] African Malaria Network Trust AMANET, POB 33207, Dar Es Salaam, Tanzania.
   [Remarque, Edmond; Thomas, Alan; Kocken, Clemens H.; Faber, Bart W.] BPRC, POB 3306, NL-2280 GH Rijswijk, Netherlands.
   [Chilengi, Roma] CIDRZ, POB 34681, Lusaka 10101, Zambia.
   [Imoukhuede, Egeruan Babatunde; Leroy, Odile] European Vaccine Initiat, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.
   [Sesay, Sanie] MRC, POB 273, Banjul, Gambia.
RP Thera, MA (reprint author), Univ Sci Tech & Technol, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med & Dent, Bamako, Mali.
EM mthera@icermali.org
FU AMANET [002/2007]
FX The trial was funded by AMANET under the contract 002/2007 CLIN signed
   by all parties on 12 March 2007.
CR Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4
   Bergmann-Leitner ES, 2008, AM J TROP MED HYG, V78, P468
   Breman JG, 2009, J INFECT DIS, V200, P317, DOI 10.1086/600121
   Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003
   Coulibaly D, 2002, AM J TROP MED HYG, V67, P604
   Coulibaly D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-374
   Diallo DA, 2005, CLIN INFECT DIS, V41, P255, DOI 10.1086/430707
   Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045
   Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563
   Ellis RD, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-13
   Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055
   Giersing B, 2005, INFECT IMMUN, V73, P3963, DOI 10.1128/IAI.73.7.3963-3970.2005
   Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002
   Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-182
   Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391
   Laurens MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079323
   Lyke KE, 2004, VACCINE, V22, P3169, DOI 10.1016/j.vaccine.2004.01.054
   Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005
   Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940
   Ouattara A, 2013, J INFECT DIS, V207, P511, DOI 10.1093/infdis/jis709
   Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012
   Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08
   Remarque EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038898
   Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960
   Sagara I, 2009, VACCINE, V27, P7292, DOI 10.1016/j.vaccine.2009.10.087
   Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014
   Spring MD, 2009, PLOS ONE, V4, pe5254
   Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002
   Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093
   Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257
   Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465
   Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115
   World Health Organization, 2015, WORLD MAL REP 2015
NR 33
TC 0
Z9 0
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD AUG 30
PY 2016
VL 15
AR 442
DI 10.1186/s12936-016-1466-4
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU9KM
UT WOS:000382535900003
PM 27577237
OA gold
DA 2017-08-15
ER

PT J
AU Mbaye, A
   Dieye, B
   Ndiaye, YD
   Bei, AK
   Muna, A
   Deme, AB
   Yade, MS
   Diongue, K
   Gaye, A
   Ndiaye, IM
   Ndiaye, T
   Sy, M
   Diallo, MA
   Badiane, AS
   Ndiaye, M
   Seck, MC
   Sy, N
   Koita, O
   Krogstad, DJ
   Nwakanma, D
   Ndiaye, D
AF Mbaye, Aminata
   Dieye, Baba
   Ndiaye, Yaye D.
   Bei, Amy K.
   Muna, Affara
   Deme, Awa B.
   Yade, Mamadou S.
   Diongue, Khadim
   Gaye, Amy
   Ndiaye, Ibrahima M.
   Ndiaye, Tolla
   Sy, Mouhamad
   Diallo, Mamadou A.
   Badiane, Aida S.
   Ndiaye, Mouhamadou
   Seck, Mame C.
   Sy, Ngayo
   Koita, Ousmane
   Krogstad, Donald J.
   Nwakanma, Davis
   Ndiaye, Daouda
TI Selection of N86F184D1246 haplotype of Pfmrd1 gene by
   artemether-lumefantrine drug pressure on Plasmodium falciparum
   populations in Senegal
SO MALARIA JOURNAL
LA English
DT Article
DE Plasmodium falciparum; Haplotype; Artemether-lumefantrine; pfmdr1;
   Senegal
ID IN-VITRO; ANTIMALARIAL-DRUGS; WESTERN CAMBODIA; MALARIA; RESISTANCE;
   CHLOROQUINE; SUSCEPTIBILITY; AMODIAQUINE; PARASITES; POLYMORPHISMS
AB Background: The use of artemisinin as a monotherapy resulted in the emergence of artemisinin resistance in 2005 in Southeast Asia. Monitoring of artemisinin combination therapy (ACT) is critical in order to detect and prevent the spread of resistance in endemic areas. Ex vivo studies and genotyping of molecular markers of resistance can be used as part of this routine monitoring strategy. One gene that has been associated in some ACT partner drug resistance is the Plasmodium falciparum multidrug resistance protein 1 (pfmdr1) gene. The purpose of this study was to assess the drug susceptibility of P. falciparum populations from Thies, Senegal by ex vivo assay and typing molecular markers of resistance to drug components of ACT currently used for treatment.
   Methods: The ex vivo susceptibility of 170 P. falciparum isolates to chloroquine, amodiaquine, lumefantrine, artesunate, and artemether was determined using the DAPI ex vivo assay. The high resolution melting technique was used to genotype the pfmdr1 gene at codons 86, 184 and 1246.
   Results: A significant decrease in IC50 values was observed between 2012 and 2013: from 13.84 to 6.484 for amodiaquine, 173.4 to 113.2 for lumefantrine, and 39.72 to 18.29 for chloroquine, respectively. Increase of the wild haplotype NYD and the decrease of the mutant haplotype NFD (79 and 62.26 %) was also observed. A correlation was observed between the wild type allele Y184 in pfmdr1 and higher IC50 for all drugs, except amodiaquine.
   Conclusion: This study has shown an increase in sensitivity over the span of two transmission seasons, marked by an increase in the WT alleles at pfmdr1. Continuous the monitoring of the ACT used for treatment of uncomplicated malaria will be helpful.
C1 [Mbaye, Aminata; Dieye, Baba; Ndiaye, Yaye D.; Bei, Amy K.; Deme, Awa B.; Yade, Mamadou S.; Diongue, Khadim; Gaye, Amy; Ndiaye, Ibrahima M.; Ndiaye, Tolla; Sy, Mouhamad; Diallo, Mamadou A.; Badiane, Aida S.; Ndiaye, Mouhamadou; Seck, Mame C.; Sy, Ngayo; Ndiaye, Daouda] Cheikh Anta Diop Univ Dakar, Lab Parasitol Mycol HALD, POB 5005, Dakar, Senegal.
   [Bei, Amy K.; Ndiaye, Daouda] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Krogstad, Donald J.] Tulane Univ, New Orleans, LA 70118 USA.
   [Muna, Affara; Nwakanma, Davis] Malaria Res Ctr, Serrekunda, Gambia.
   [Koita, Ousmane] Univ Bamako, Bamako, Mali.
RP Mbaye, A (reprint author), Cheikh Anta Diop Univ Dakar, Lab Parasitol Mycol HALD, POB 5005, Dakar, Senegal.
EM aminatambaye155@gmail.com
OI DIALLO, Mamadou Alpha/0000-0001-6478-7875
FU International Centers of Excellence for Malaria Research, (ICEMR) West
   Africa [U19AI089696]
FX The work was supported by the International Centers of Excellence for
   Malaria Research, (ICEMR) West Africa (U19AI089696).
CR Achieng AO, 2015, INT J PARASITOL-DRUG, V5, P92, DOI 10.1016/j.ijpddr.2015.05.005
   Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Baliraine FN, 2011, J INFECT DIS, V204, P1120, DOI 10.1093/infdis/jir486
   Blount R E, 1967, Trans Am Clin Climatol Assoc, V78, P196
   BREWER TG, 1994, AM J TROP MED HYG, V51, P251
   Daniels R, 2012, ANTIMICROB AGENTS CH, V56, P2976, DOI 10.1128/AAC.05737-11
   Eyase FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064299
   Fall B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0589-3
   Fandeur T, 2011, LAB NATL REFERENCE S, P1
   Faye B, 2010, TROP MED INT HEALTH, V15, P608, DOI 10.1111/j.1365-3156.2010.02487.x
   Happi CT, 2009, ANTIMICROB AGENTS CH, V53, P888, DOI 10.1128/AAC.00968-08
   Huang X, 2012, CASE STUDIES MODERN
   Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06
   Jacqueline K, 2008, MOL BIOCHEM PARASIT, V157, P107
   Kavishe RA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-264
   KIHAMIA CM, 1982, LANCET, V2, P43
   Ly O, 2012, PARASITOL RES, V111, P1541, DOI 10.1007/s00436-012-2994-7
   Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106
   Menard D, 2013, M S-MED SCI, V29, P647, DOI 10.1051/medsci/2013296020
   Mouzin E, 2010, FOCUS SUR LE SENEGAL
   Ndiaye D, 2013, INT J PARASITOL-DRUG, V3, P135, DOI 10.1016/j.ijpddr.2013.07.001
   Ndiaye D, 2010, AM J TROP MED HYG, V82, P228, DOI 10.4269/ajtmh.2010.09-0470
   Ndiaye JL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-125
   Ndiaye M, 2012, AM J TROP MED HYG, V87, P640, DOI 10.4269/ajtmh.2012.11-0709
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   PNLP, 2013, DIR NAT PREV PRIS CH, P2013
   PNLP, 2010, PLAN STRAT NAT 2011
   PNLP, 2014, B EP ANN PAL SEN, P2014
   Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333
   Pradines B, 2010, REV FRANCOPHONE LAB, P422
   Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x
   Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738
   Sylla K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-598
   Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1
   Van Tyne D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-441
   WHO, 2014, STAT REP ART RES
   WHO, 2006, BRIEF MAL TREATM GUI
   World Health Organization, 2015, WORLD MALARIA REPORT
   WHO, 2010, GLOB REP ANT DRUG EF
   WHO, 2013, Q A ART RES
   Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4
   Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12
NR 44
TC 1
Z9 1
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD AUG 25
PY 2016
VL 15
AR 433
DI 10.1186/s12936-016-1490-4
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU9KI
UT WOS:000382535400001
PM 27562216
OA gold
DA 2017-08-15
ER

PT J
AU Battersby, AJ
   Khara, J
   Wright, VJ
   Levy, O
   Kampmann, B
AF Battersby, Anna J.
   Khara, Jasmeet
   Wright, Victoria J.
   Levy, Ofer
   Kampmann, Beate
TI Antimicrobial Proteins and Peptides in early Life: Ontogeny and
   Translational Opportunities
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE antimicrobial peptides; protein; peptide; infant; newborn; infection;
   innate; immunity
ID BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; BOVINE LACTOFERRIN
   SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; INVASIVE
   FUNGAL-INFECTIONS; BLOOD-STREAM INFECTIONS; HOST-DEFENSE PROTEINS;
   INNATE IMMUNITY; NECROTIZING ENTEROCOLITIS; NEWBORN-INFANTS; NEONATAL
   SEPSIS
AB While developing adaptive immune responses, young infants are especially vulnerable to serious infections, including sepsis, meningitis, and pneumonia. Antimicrobial proteins and peptides (APPs) are key effectors that function as broad-spectrum anti-infectives. This review seeks to summarize the clinically relevant functional qualities of APPs and the increasing clinical trial evidence for their use to combat serious infections in infancy. Levels of APPs are relatively low in early life, especially in infants born preterm or with low birth weight (LBW). There are several rationales for the potential clinical utility of APPs in the prevention and treatment of infections in infants: (a) APPs may be most helpful in those with reduced levels; (b) during sepsis microbial products signal via pattern recognition receptors causing potentially harmful inflammation that APPs may counteract; and (c) in the era of antibiotic resistance, development of new anti-infective strategies is essential. Evidence supports the potential clinical utility of exogenous APPs to reduce infection-related morbidity in infancy. Further studies should characterize the ontogeny of antimicrobial activity in mucosal and systemic compartments, and examine the efficacy of exogenous-APP formulations to inform translational development of APPs for infant groups.
C1 [Battersby, Anna J.; Khara, Jasmeet; Wright, Victoria J.; Kampmann, Beate] Imperial Coll London, Acad Paediat, London, England.
   [Battersby, Anna J.; Kampmann, Beate] Med Res Council MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
   [Khara, Jasmeet] Natl Univ Singapore, Dept Pharm, Singapore, Singapore.
   [Levy, Ofer] Boston Childrens Hosp, Div Infect Dis, Dept Med, Precis Vaccines Program, Boston, MA USA.
   [Levy, Ofer] Harvard Med Sch, Boston, MA USA.
RP Battersby, AJ (reprint author), Imperial Coll London, Acad Paediat, London, England.; Battersby, AJ (reprint author), Med Res Council MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
EM a.battersby@imperial.ac.uk
FU Wellcome Trust; Medical Research Council [MC_UP_A900/1122]; NIHR based
   at Imperial College Healthcare NHS Trust and Imperial College London;
   National University of Singapore; Great Ormond Street Hospital Charity
   [v1401]; Boston Children's Hospital Department of Medicine; NIH
   [1R01AI100135-01]
FX AB is supported by a Wellcome Trust clinical research training
   fellowship. BK is supported by funding from the Medical Research Council
   (MC_UP_A900/1122) and the NIHR based at Imperial College Healthcare NHS
   Trust and Imperial College London. JK is supported by the President's
   Graduate Fellowship from the National University of Singapore. VW is
   supported by Great Ormond Street Hospital Charity (v1401). OL laboratory
   is supported by a Boston Children's Hospital Department of Medicine
   award to the Precision Vaccines Program and by NIH Infant Immunity grant
   (1R01AI100135-01) and its Administrative Supplements.
CR Akin IM, 2014, AM J PERINAT, V31, P1111, DOI 10.1055/s-0034-1371704
   Akinbi HT, 2004, AM J OBSTET GYNECOL, V191, P2090, DOI 10.1016/j.ajog.2004.05.002
   Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651
   Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9
   Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9
   Barbeiro DF, 2013, MICROBES INFECT, V15, P342, DOI 10.1016/j.micinf.2013.01.001
   Baricelli J, 2015, J PEDIAT-BRAZIL, V91, P36, DOI 10.1016/j.jped.2014.05.006
   Battersby AJ, 2013, PEDIAT ALLERG IMM-UK, V24, P414, DOI 10.1111/pai.12079
   Bellm L, 2000, EXPERT OPIN INV DRUG, V9, P1731, DOI 10.1517/13543784.9.8.1731
   Biron CA, 2010, NAT IMMUNOL, V11, P1080, DOI 10.1038/ni1210-1080
   Blackburn RM, 2014, EPIDEMIOL INFECT, V142, P803, DOI 10.1017/S0950268813001520
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003
   Campeotto F, 2010, NEONATOLOGY, V98, P365, DOI 10.1159/000315872
   Canny G, 2002, P NATL ACAD SCI USA, V99, P3902, DOI 10.1073/pnas.052533799
   Cantey JB, 2015, CLIN PERINATOL, V42, P1, DOI 10.1016/j.clp.2014.10.002
   Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831
   Conlon J Michael, 2014, Pharmaceuticals (Basel), V7, P58, DOI 10.3390/ph7010058
   de Ferrer PAR, 2000, J AM COLL NUTR, V19, P370
   Desbois AP, 2010, J APPL MICROBIOL, V108, P723, DOI 10.1111/j.1365-2672.2009.04472.x
   Dorschner RA, 2003, PEDIATR RES, V53, P566, DOI 10.1203/01.PDR.0000057205.64451.B7
   Dosler S, 2013, PEPTIDES, V49, P53, DOI 10.1016/j.peptides.2013.08.008
   Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007
   Evans SE, 2011, BRIT J PHARMACOL, V163, P195, DOI 10.1111/j.1476-5381.2011.01237.x
   Faust K, 2014, ACTA PAEDIATR, V103, pE143, DOI 10.1111/apa.12544
   Fehervari Z., 2015, NAT IMMUNOL, V16, P906, DOI [10.1038/ni.3261, DOI 10.1038/NI.3261]
   Flamm RK, 2015, ANTIMICROB AGENTS CH, V59, P1756, DOI 10.1128/AAC.04773-14
   Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572
   Frew L, 2011, REPRODUCTION, V141, P725, DOI 10.1530/REP-10-0537
   Froy O, 2005, CELL MICROBIOL, V7, P1387, DOI 10.1111/j.1462-5822.2005.00590.x
   Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300
   Giroir BP, 2001, CRIT CARE MED, V29, pS130, DOI 10.1097/00003246-200107001-00039
   Guinan EC, 2011, SCI TRANSL MED, V3, P110, DOI DOI 10.1126/SCITRANSLMED.3003126
   Guntupalli K, 2013, CRIT CARE MED, V41, P706, DOI 10.1097/CCM.0b013e3182741551
   Haug BE, 2007, CURR MED CHEM, V14, P1, DOI 10.2174/092986707779313435
   Havelka AM, 2010, ACTA PAEDIATR, V99, P836, DOI 10.1111/j.1651-2227.2010.01726.x
   Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001
   Jenke ACW, 2012, PEDIATR RES, V72, P513, DOI 10.1038/pr.2012.110
   Jindal HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128532
   Kai-Larsen Y, 2007, PEDIATR RES, V61, P530, DOI 10.1203/pdr.0b013e318045be83
   Kai-Larsen Y, 2014, ACTA PAEDIATR, V103, P1000, DOI 10.1111/apa.12700
   Le CF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11886
   Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004
   Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4
   Levy O, 2000, BLOOD, V96, P2664
   Levy O, 2000, INFECT IMMUN, V68, P5120, DOI 10.1128/IAI.68.9.5120-5125.2000
   Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320
   Levy O, 1999, PEDIATRICS, V104, P1327, DOI 10.1542/peds.104.6.1327
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   Manzoni P, 2014, EARLY HUM DEV, V90, pS60, DOI 10.1016/S0378-3782(14)70020-9
   Manzoni P, 2012, PEDIATRICS, V129, P116, DOI 10.1542/peds.2011-0279
   Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403
   Marchant A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00077
   Marchini G, 2002, BRIT J DERMATOL, V147, P1127, DOI 10.1046/j.1365-2133.2002.05014.x
   Menard S, 2008, J EXP MED, V205, P183, DOI 10.1084/jem.20071022
   Minami J, 2016, BENEF MICROBES, V7, P53, DOI 10.3920/BM2015.0041
   Misawa Y, 2009, INT J HEMATOL, V90, P561, DOI 10.1007/s12185-009-0452-9
   Murakami M, 2005, PEDIATR RES, V57, P10, DOI 10.1203/01.PDR.0000148068.32201.50
   Murata M, 2013, J DAIRY SCI, V96, P4891, DOI 10.3168/jds.2013-6612
   Nathe KE, 2009, PEDIATR RES, V66, P191, DOI 10.1203/PDR.0b013e3181aa33d7
   Nelson A, 2009, PEDIATR RES, V66, P174, DOI 10.1203/PDR.0b013e3181a9d80c
   Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408
   Nupponen I, 2002, PEDIATR RES, V51, P670, DOI 10.1023/01.PDR.0000017477.64723.9D
   Ochoa TJ, 2015, PEDIATR INFECT DIS J, V34, P571, DOI 10.1097/INF.0000000000000593
   Olbrich P, 2013, PEDIATR CRIT CARE ME, V14, P796, DOI 10.1097/PCC.0b013e3182975e0f
   Pana ZD, 2015, EXPERT OPIN PHARMACO, V16, P693, DOI 10.1517/14656566.2015.1013936
   Pergialiotis V, 2016, INFLAMM RES, V65, P847, DOI 10.1007/s00011-016-0963-9
   Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301
   Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11
   Rogan MP, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-29
   Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520
   Salzman NH, 1998, PEDIATR RES, V44, P20, DOI 10.1203/00006450-199807000-00003
   Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002
   Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825
   Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/rccm.200110-020OC
   Scharf S, 2012, EXP LUNG RES, V38, P100, DOI 10.3109/01902148.2011.652802
   Selsted ME, 2007, CURR PHARM DESIGN, V13, P3061, DOI 10.2174/138161207782110363
   Sherman MP, 2013, CLIN PERINATOL, V40, P79, DOI 10.1016/j.clp.2012.12.006
   Singh VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062845
   Starner TD, 2005, J IMMUNOL, V174, P1608
   Strunk T, 2009, ARCH DIS CHILD-FETAL, V94, pF230, DOI 10.1136/adc.2008.143438
   Strunk T, 2011, J MATERN-FETAL NEO M, V24, P25, DOI 10.3109/14767058.2010.482605
   Tang ZR, 2016, ANIM SCI J, V87, P1258, DOI 10.1111/asj.12540
   Trend S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117038
   van der Velden WJFM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-44
   Vergnano S, 2005, ARCH DIS CHILD-FETAL, V90, P220, DOI 10.1136/adc.2002.022863
   Vincent JL, 2015, CRIT CARE MED, V43, P1832, DOI 10.1097/CCM.0000000000001090
   Vogel HJ, 2012, BIOCHEM CELL BIOL, V90, P233, DOI [10.1139/o2012-016, 10.1139/O2012-016]
   von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683
   Walker VP, 2008, J PEDIATR, V152, P777, DOI 10.1016/j.jpeds.2007.11.030
   Wardlaw T, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-82
   WHO, 2013, LEV TRENDS CHILDH MO
   Xie ZL, 2015, FASEB J, V29, P4324, DOI 10.1096/fj.15-274787
   Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603
   Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0
   Yost CC, 2009, BLOOD, V113, P6419, DOI 10.1182/blood-2008-07-171629
   Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147
NR 97
TC 3
Z9 3
U1 3
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 18
PY 2016
VL 7
AR 309
DI 10.3389/fimmu.2016.00309
PG 12
WC Immunology
SC Immunology
GA DT6LV
UT WOS:000381596600001
PM 27588020
OA gold
DA 2017-08-15
ER

PT J
AU O'Neill, S
   Dierickx, S
   Okebe, J
   Dabira, E
   Gryseels, C
   d'Alessandro, U
   Grietens, KP
AF O'Neill, Sarah
   Dierickx, Susan
   Okebe, Joseph
   Dabira, Edgard
   Gryseels, Charlotte
   d'Alessandro, Umberto
   Grietens, Koen Peeters
TI The Importance of Blood Is Infinite: Conceptions of Blood as Life Force,
   Rumours and Fear of Trial Participation in a Fulani Village in Rural
   Gambia
SO PLOS ONE
LA English
DT Article
ID SUB-SAHARAN AFRICA; MEDICAL-RESEARCH; CLINICAL-TRIAL; VACCINE TRIAL;
   VULNERABILITY; CHALLENGES; MALARIA; EXPERIENCES; COMMUNITY; CAMEROON
AB Background
   Clinical trials require high levels of participation and low drop-out rates to be successful. However, collecting blood samples from individuals recruited into clinical trials can be challenging when there is reticence about blood-taking. In addition to concerns regarding the feasibility of medical research, fears of 'blood-stealing' and 'blood-selling' have ethical implications related to cultural sensitivity and informed consent. This study explores anxieties around blood-taking during a malaria treatment trial in the Gambia.
   Methods
   This case study is based on ethnographic research in one theoretically selected village due to the high reticence to screening for the clinical trial 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' carried out in the Gambia between 2013 and 2014. Data collection tools included in-depth interviews, participant observation, informal conversations and group discussions.
   Results
   In total only 176 of 411 habitants (42%) in the village accepted having a bloodspot taken to screen for malaria. Although trial recruitment was initially high in the village, some families refused screening when rumours started spreading that the trial team was taking too much blood. Concerns about 'loss of blood' were equated to loss of strength and lack of good food to replenish bodily forces. Families in the study village were concerned about the weakness of their body while they had to harvest their crops at the time of recruitment for the trial.
   Conclusion
   A common recommendation to prevent and avoid rumours against public health interventions and trials is the provision of full and consistent information during the consent procedure, which is assumed to lead to more accurate knowledge of the purpose of the intervention and increased trial participation. However, even when information provision is continuous, the emergence of rumours can be related to times of uncertainty and perceptions of vulnerability, which are often a reflection of structural inequalities and diverging value orientations between communities and public health institutions.
C1 [O'Neill, Sarah; Dierickx, Susan; Gryseels, Charlotte; d'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium.
   [Dierickx, Susan; Gryseels, Charlotte] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.
   [Dierickx, Susan] Vrije Univ Brussels, RHEA, Ctr Expertise Gender Div & Intersect, Brussels, Belgium.
   [Okebe, Joseph; Dabira, Edgard; d'Alessandro, Umberto] Med Res Council Gambia, Fajara, Gambia.
   [Okebe, Joseph] Univ Antwerp, Antwerp, Belgium.
   [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.
   [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.
RP O'Neill, S (reprint author), Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium.
EM soneill@itg.be
FU Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust)
   [MR/K007203/1]; Institute of Social Cultural Anthropology at the
   University of Oxford, Oxford, UK
FX This work is part of the study 'Primaquine's gametocytocidal efficacy in
   malaria asymptomatic carriers treated with
   dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint
   Global Health Trials Scheme (DFID/MRC/Wellcome Trust). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.; We thank the MRCG social
   science fieldworkers Fatou Y Manneh, Hejinkey Darboe and Michelle Demba
   for their assistance with data collection during fieldwork as well as
   for the transcription and translation of recorded interviews and
   discussions. We also thank the Prinogam trial fieldwork coordinator
   Matar Ceesay and team for good co-operation and assistance with
   fieldwork arrangements. This work is part of the study 'Primaquine's
   gametocytocidal efficacy in malaria asymptomatic carriers treated with
   dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint
   Global Health Trials Scheme (DFID/MRC/Wellcome Trust). The main author
   thanks the Institute of Social Cultural Anthropology at the University
   of Oxford, Oxford, UK for the visiting fellowship.
CR Alwang J., 2001, SOCIAL PROTECTION DI
   Bannister-Tyrrell M, 2015, LANCET, V385, P420, DOI 10.1016/S0140-6736(14)62392-8
   Baxter P, 2008, QUALITATIVE REPORT, V13, P544, DOI DOI 10.2174/1874434600802010058
   Bernard R. H., 2006, RES METHODS ANTHR
   Brooks N, 2003, TYNDALL CTR CLIM CHA, V38, P20
   Cham M, 2000, MATERNAL MORTALITY G
   Chapman RR, 2006, MED ANTHROPOL Q, V20, P487, DOI 10.1525/maq.2006.20.4.487
   Clarke SE, 2003, TROP MED INT HEALTH, V8, P884, DOI 10.1046/j.1365-3156.2003.01095.x
   Comaroff J, 1999, AM ETHNOL, V26, P279, DOI 10.1525/ae.1999.26.2.279
   Comaroff J, 2000, PUBLIC CULTURE, V12, P291, DOI 10.1215/08992363-12-2-291
   Dal-Re R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001149
   Dierickx S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148627
   Emerson R.M., 2001, HDB ETHNOGRAPHY
   Fairhead J, 2006, SOC SCI MED, V63, P1109, DOI 10.1016/j.socscimed.2006.02.018
   Feldman-Savelsberg P, 2000, MED ANTHROPOL Q, V14, P159, DOI 10.1525/maq.2000.14.2.159
   Fischer F., 2000, CITIZENS EXPERTS ENV
   Geissler PW, 2006, TROP MED INT HEALTH, V11, P975, DOI 10.1111/j.1365-3156.2006.01682.x
   Geissler PW, 2008, SOC SCI MED, V67, P696, DOI [10.1016/j.socscimed.2008.02.004, 10.1016/.j.socscimed.2008.02.004]
   Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003
   Graboyes M, 2010, DEV WORLD BIOETH, V10, P34, DOI 10.1111/j.1471-8847.2009.00274.x
   Grietens KP, 2014, AM J TROP MED HYG, V91, P213, DOI 10.4269/ajtmh.13-0630
   Oaks L, 2003, CULTURE HLTH INEQUAL
   Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073
   Jones COH, 2004, AM J TROP MED HYG, V71, P156
   Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038
   Kamuya DM, 2013, DEV WORLD BIOETH, V13, P1, DOI 10.1111/dewb.12009
   Kathy Charmaz, 2014, CONSTRUCTING GROUNDE
   Katz J, 1996, JAMA-J AM MED ASSOC, V276, P1662, DOI 10.1001/jama.276.20.1662
   Khalil Susan S, 2007, BMC Med Ethics, V8, P9, DOI 10.1186/1472-6939-8-9
   Kingori P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-556
   Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2
   Leach Melissa, 2007, VACCINE ANXIETIES
   Leatherman T, 2005, ETHOS, V33, P46, DOI 10.1525/eth.2005.33.1.046
   Madiega PA, 2013, DEV WORLD BIOETH, V13, P21, DOI 10.1111/dewb.12019
   Lucia S, 2013, JRAI, P42
   Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-145
   National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (NCPHS), 1979, BELM REP ETH PRINC G
   Nichter M, 2003, RISK CULTURE AND HEALTH INEQUALITY: SHIFTING PERCEPTIONS OF DANGER AND BLAME, P13
   O'Neill S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0687-2
   Okebe J, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0597-1
   Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351
   Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800
   Wiseman V, 2008, SOC SCI MED, V67, P487, DOI 10.1016/j.socscimed.2008.04.007
   WMA General Assembly, 1964, WORLD MED ASS DECL H
   Yin R., 2003, DESIGN AND METHODS
   Zaidah Z, 2007, J KEMANUS, V9, P1, DOI [10.1177/ 15222302004003007, DOI 10.1177/15222302004003007]
   Zarowsky C, 2013, GLOB HEALTH PROMOT, V20, P3, DOI 10.1177/1757975912470062
NR 47
TC 0
Z9 0
U1 2
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2016
VL 11
IS 8
AR e0160464
DI 10.1371/journal.pone.0160464
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4SL
UT WOS:000381471100015
PM 27525652
OA gold
DA 2017-08-15
ER

PT J
AU Idoko, P
   Nkeng, G
   Anyawu, M
AF Idoko, Patrick
   Nkeng, Glenda
   Anyawu, Matthew
TI Reasons for current pregnancy amongst grand multiparous Gambian women -
   a cross sectional survey
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Grand multiparity; Reasons; Gambia; Contraception
ID COMPLICATIONS; AFRICA; RISK
AB Background: While grand multiparity is now relatively rare in the developed world it is still common in Sub Saharan Africa. Although significant resources have been committed to providing modern contraceptive methods in the Gambia, the total fertility rate is still high at 5.6. Determining the reasons grand multiparous women proffer for the current pregnancy may help in understanding this trend and tailoring appropriate messages to address any specific concerns.
   Method: A cross sectional survey of grand multiparous women was carried out at the Royal Victoria Teaching Hospital (now Edward Francis Small Teaching Hospital) to determine the reasons for the current pregnancy.
   Results: The prevalence of grand multiparity was 26.5 % while the average parity among the study population was 7.2 (sd 1.8). The most common reasons given for the current pregnancy were: the desire for another child (22.8 %), the pregnancy was unplanned - a "mistake" (18.4 %) and the need to replace a dead child (15.4 %).
   Conclusion: Grand multiparity is still very common in The Gambia. Additional efforts are required to target those with unplanned pregnancies. Improving child survival may also decrease the prevalence of grand multiparity.
C1 [Idoko, Patrick; Anyawu, Matthew] Edward Francis Small Teaching Hosp, Independence Dr, Banjul, Gambia.
   [Idoko, Patrick; Nkeng, Glenda; Anyawu, Matthew] Univ Gambia, Sch Med & Allied Hlth Sci, Independence Dr, Banjul, Gambia.
RP Idoko, P (reprint author), Edward Francis Small Teaching Hosp, Independence Dr, Banjul, Gambia.; Idoko, P (reprint author), Univ Gambia, Sch Med & Allied Hlth Sci, Independence Dr, Banjul, Gambia.
EM patidoko@gmail.com
CR Abasiattai Aniekan M, 2011, Niger J Med, V20, P345
   Adanu Richard M K, 2009, Afr J Reprod Health, V13, P123
   Al Jama FE, 2012, J REPROD MED, V57, P53
   Ali Fatheia Ahmed, 1996, Materia Medica Polona, V28, P87
   Anya SE, 2004, AM J TROP MED HYG, V70, P510
   Bugg GJ, 2002, BJOG-INT J OBSTET GY, V109, P249
   Eze JN, 2006, TROP J OBSTET GYNAEC, V23, P8
   Geidam AD, 2011, J OBSTET GYNAECOL, V31, P404, DOI 10.3109/01443615.2011.561383
   Gharoro EP, 2001, TROP J OBSTET GYNAEC, V18, P27
   Hoestermann CFL, 1996, TROP MED INT HEALTH, V1, P710
   Hoque M, 2008, IRAN J REPROD MED, V6, P25
   Kennedy KI, 1996, BAILLIERE CLIN OB GY, V10, P25, DOI 10.1016/S0950-3552(96)80060-5
   Kuti O, 2001, TROP J OBSTET GYNAEC, V18, P34
   Maymon E, 1998, EUR J OBSTET GYN R B, V81, P21, DOI 10.1016/S0301-2115(98)00152-3
   Mgaya AH, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-241
   Mutihir JT, 2005, J MED TROP, V7, P14
   Nasir SG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001687
   Obiechina NJA, 2008, TROP J MED RES, V12, P65
   Omole-Ohonsi A, 2011, NIGER J CLIN PRACT, V14, P6, DOI 10.4103/1119-3077.79231
   Rayamajhi R, 2006, Kathmandu Univ Med J (KUMJ), V4, P70
   Shechter Y, 2010, J MATERN-FETAL NEO M, V23, P1211, DOI 10.3109/14767051003615459
   Solomons B, 1934, LANCET, V2, P8
   World Health Organization, GAMB HLTH PROF
   Yasir R, 2010, MED CHANNEL, V16, P264
NR 24
TC 0
Z9 0
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 11
PY 2016
VL 16
AR 217
DI 10.1186/s12884-016-1016-7
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DT4UJ
UT WOS:000381476300003
PM 27514824
OA gold
DA 2017-08-15
ER

PT J
AU Parveen, S
   Islam, MS
   Begum, M
   Alam, MU
   Sazzad, HMS
   Sultana, R
   Rahman, M
   Gurley, ES
   Hossain, MJ
   Luby, SP
AF Parveen, Shahana
   Islam, M. Saiful
   Begum, Momtaz
   Alam, Mahbub-Ul
   Sazzad, Hossain M. S.
   Sultana, Rebeca
   Rahman, Mahmudur
   Gurley, Emily S.
   Hossain, M. Jahangir
   Luby, Stephen P.
TI It's not only what you say, it's also how you say it: communicating
   nipah virus prevention messages during an outbreak in Bangladesh
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Nipah virus; Outbreak; Prevention messages; Communication strategy;
   Anthropological approach; Contextual understanding; Bangladesh
ID TO-PERSON TRANSMISSION; HEALTH; INFECTION; ENCEPHALITIS; STRATEGIES;
   COMMUNITY; MODEL
AB Background: During a fatal Nipah virus (NiV) outbreak in Bangladesh, residents rejected biomedical explanations of NiV transmission and treatment and lost trust in the public healthcare system. Field anthropologists developed and communicated a prevention strategy to bridge the gap between the biomedical and local explanation of the outbreak.
   Methods: We explored residents' beliefs and perceptions about the illness and care-seeking practices and explained prevention messages following an interactive strategy with the aid of photos showed the types of contact that can lead to NiV transmission from bats to humans by drinking raw date palm sap and from person-to-person.
   Results: The residents initially believed that the outbreak was caused by supernatural forces and continued drinking raw date palm sap despite messages from local health authorities to stop. Participants in community meetings stated that the initial messages did not explain that bats were the source of this virus. After our intervention, participants responded that they now understood how NiV could be transmitted and would abstain from raw sap consumption and maintain safer behaviours while caring for patients.
   Conclusions: During outbreaks, one-way behaviour change communication without meaningful causal explanations is unlikely to be effective. Based on the cultural context, interactive communication strategies in lay language with supporting evidence can make biomedical prevention messages credible in affected communities, even among those who initially invoke supernatural causal explanations.
C1 [Parveen, Shahana; Islam, M. Saiful; Begum, Momtaz; Alam, Mahbub-Ul; Sazzad, Hossain M. S.; Sultana, Rebeca; Gurley, Emily S.; Hossain, M. Jahangir; Luby, Stephen P.] Icddr B, Div Infect Dis, Dhaka, Bangladesh.
   [Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh.
   [Hossain, M. Jahangir] Med Res Council Unit UK, Banjul, Gambia.
   [Luby, Stephen P.] Ctr Dis Control & Prevent CDC, Global Hlth Protect Div, Atlanta, GA USA.
   [Luby, Stephen P.] Stanford Univ, Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Parveen, Shahana] Icddr B, Div Infect Dis, Programme Emerging Infect, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh.
RP Parveen, S (reprint author), Icddr B, Div Infect Dis, Dhaka, Bangladesh.; Parveen, S (reprint author), Icddr B, Div Infect Dis, Programme Emerging Infect, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh.
EM shahana@icddrb.org
RI Gurley, Emily/B-7903-2010
OI Gurley, Emily/0000-0002-8648-9403; Luby, Stephen/0000-0001-5385-899X
FU U.S. Centers for Disease Control and Prevention (CDC) [5U01CI000628-01];
   Government of the People's Republic of Bangladesh
FX This study was supported by the U.S. Centers for Disease Control and
   Prevention (CDC) through cooperative award number 5U01CI000628-01 and by
   the Government of the People's Republic of Bangladesh. icddr,b
   acknowledges with gratitude the commitment of the CDC for its research
   efforts. icddr,b is also grateful to the Governments of Bangladesh,
   Canada, Sweden and the UK for providing core/unrestricted support.
CR Ahmed N U, 1993, Int Q Community Health Educ, V14, P283, DOI 10.2190/A4XQ-QFL6-CPVV-XJEJ
   Airhihenbuwa C., 1995, HLTH CULTURE W PARAD
   Division S., 2010, STAT YB BANGL REP HO
   Blum LS, 2009, AM J TROP MED HYG, V80, P96
   Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x
   Caprara A, 1998, TROP MED INT HEALTH, V3, P996, DOI 10.1046/j.1365-3156.1998.00341.x
   Carter Caroline A, 2007, Qual Manag Health Care, V16, P194
   CHAMBERS R, 1994, WORLD DEV, V22, P1253, DOI 10.1016/0305-750X(94)90003-5
   Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432
   Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8
   Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2
   Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2
   Doglus M., 1994, RISK BLAME ESSAYS CU
   Dutta M. J., 2008, COMMUNICATING HLTH C
   Dutta MJ, 2007, COMMUN THEOR, V17, P304, DOI 10.1111/j.1468-2885.2007.00297.x
   Jones J, 2011, J GLOB HLTH, V1, P1
   Good BJ., 1994, MED RATIONALITY EXPE
   Gordis L., 2004, EPIDEMIOLOGY
   Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128
   Gurley ES, 2013, INT J INFECT CONTROL, V9, P1
   Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567
   Havelka M, 2009, COLLEGIUM ANTROPOL, V33, P303
   Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242
   Homaira N, 2010, EPIDEMIOL INFECT, V138, P1630, DOI 10.1017/S0950268810000695
   Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147
   Hsu VP, 2004, EMERG INFECT DIS, V10, P2082
   icddrb, 2012, HLTH SCI B, V10, P16
   Islam MS, 2013, WHEN CULTURE IMPACTS HEALTH: GLOBAL LESSONS FOR EFFECTIVE HEALTH RESEARCH, P329, DOI 10.1016/B978-0-12-415921-1.00028-2
   Koss-Chioino JD, 2009, ANTHR PUBLIC HLTH BR, P221
   [Anonymous], 2013, CULTURE IMPACTS HLTH, DOI DOI 10.1016/B978-0-12-415921-1.00005-1
   Luby SP, 2006, EMERG INFECT DIS, V12, P1888
   Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951
   Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237
   Lupton Deborah, 1994, HEALTH COMMUN, V6, P55, DOI DOI 10.1207/S15327027HC0601_4
   Nahar N, 2010, ECOHEALTH, V7, P196, DOI 10.1007/s10393-010-0320-3
   Nzioka C, 1996, AIDS CARE, V8, P565, DOI 10.1080/09540129650125524
   Panter-Brick C, 2006, SOC SCI MED, V62, P2810, DOI 10.1016/j.socscimed.2005.10.009
   [Anonymous], 2013, CULTURE IMPACTS HLTH, DOI DOI 10.1016/B978-0-12-415921-1.00019-1
   Prior L, 2003, SOCIOL HEALTH ILL, V25, P41
   Quinn SC, 2008, HEALTH PROMOT PRACT, V9, p18S, DOI 10.1177/1524839908324022
   Reynolds B., 2002, CRISIS EMERGENCY RIS, P1
   Rheinlander T, 2010, SOC SCI MED, V71, P994, DOI 10.1016/j.socscimed.2010.06.014
   Rock M, 2009, SOC SCI MED, V68, P991, DOI 10.1016/j.socscimed.2008.12.047
   Rowel Randy, 2012, Health Promot Pract, V13, P124, DOI 10.1177/1524839910390312
   Ryan G. W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569
   Sazzad HMS, 2013, EMERG INFECT DIS, V19, P210, DOI 10.3201/eid1902.120971
   Singer MC, 2009, SOC SCI MED, V68, P996, DOI 10.1016/j.socscimed.2008.12.041
   Trostle James A., 2005, EPIDEMIOLOGY CULTURE
   Veil S, 2008, HEALTH PROMOT PRACT, V9, p26S, DOI 10.1177/1524839908322113
   Wray R., 2006, INT J MASS EMERG DIS, V24, P45
   Yob J M, 2001, Emerg Infect Dis, V7, P439
   [Anonymous], 2015, EMERGENCIES PREPARED
NR 52
TC 2
Z9 2
U1 5
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD AUG 5
PY 2016
VL 16
AR 726
DI 10.1186/s12889-016-3416-z
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS8BA
UT WOS:000381006400002
PM 27495927
OA gold
DA 2017-08-15
ER

PT J
AU Ikumapayi, UN
   Kanteh, A
   Manneh, J
   Lamin, M
   Mackenzie, GA
AF Ikumapayi, Usman Nurudeen
   Kanteh, Abdoulie
   Manneh, Jarra
   Lamin, Modou
   Mackenzie, Grant Austin
TI An outbreak of Serratia liquefaciens at a rural health center in The
   Gambia
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Healthcare-associated infection; outbreak; Serratia liquefaciens;
   antibiotic; Gambia
ID MARCESCENS SEPSIS; CONTAMINATION; UNIT; TRANSFUSION; INFECTIONS
AB Introduction: Healthcare-associated infections (HAIs) are better documented in developed than in developing countries. There are emerging reports regarding the high frequency of HAIs in developing countries. We aimed to report an outbreak of an HAI caused by Serratia liquefaciens at a rural health center in The Gambia.
   Methodology: Following an abrupt increase in the isolation of S. liquefaciens in clinical samples, laboratory and clinical consumables, as well as staff, were screened for contamination with S. liquefaciens. Conventional microbiological techniques and biochemical identification tests were used. A phenotypic typing was achieved using the Kirby-Bauer antibiotic susceptibility method. Strategies to control the outbreak were implemented.
   Results: A total of 794 samples were processed during the outbreak; 44 (6%) grew S. liquefaciens. Five (25%) of the 20 suspected contaminated materials (hospital consumables and equipment) screened yielded growth of the organism. The primary source of the outbreak was hospital consumables. Three (7%) of the 44 infected children died with no other known cause than S. liquefaciens infection. Ninety-nine percent similarity of the antibiogram phenotypic typing suggests the isolates were from the same clonal origin. The outbreak was successfully controlled after the removal and sterilization of the respective contaminated fluids and equipment.
   Conclusions: This HAI was caused by poor practice in the preparation of medications for nebulization and intravenous infusion, hygiene practices, and a lack of awareness among staff about infection control. We recommend further studies to delineate the role played by HAIs in the developing world.
C1 [Ikumapayi, Usman Nurudeen; Kanteh, Abdoulie; Manneh, Jarra; Lamin, Modou; Mackenzie, Grant Austin] MRC Unit, Dept Dis Control & Eliminat, Fajara, Gambia.
RP Ikumapayi, UN (reprint author), MRC Unit, Dept Dis Control & Eliminat, POB 273, Banjul, Gambia.
EM uikumapayi@mrc.gm
FU Medical Research Council Unit of The Gambia
FX We express our profound gratitude to Medical Research Council Unit of
   The Gambia for providing us infrastructure and funding to do this study.
CR Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4
   Arslan U, 2010, PEDIATR INT, V52, P208, DOI 10.1111/j.1442-200X.2009.02934.x
   Aydin S, 2001, TURK J VET ANIM SCI, V25, P643
   Boulton FE, 1998, TRANSFUSION MED, V8, P15
   Chuang Tzu-Yi, 2007, J Infect, V54, pe161, DOI 10.1016/j.jinf.2006.10.003
   Dubouix A, 2005, J HOSP INFECT, V60, P8, DOI 10.1016/j.jhin.2004.09.029
   DUNCAN KL, 1994, TRANSFUSION, V34, P738, DOI 10.1046/j.1537-2995.1994.34894353473.x
   European Centre for Ddisease Prevention and Control, 2010, ANN EP REP COMM DIS
   Engel HJ, 2009, EUR J CLIN MICROBIOL, V28, P821, DOI 10.1007/s10096-009-0707-7
   Engelhart S, 2003, J CLIN MICROBIOL, V41, P3986, DOI 10.1128/JCM.41.8.3986-3988.2003
   FITZGERALD P, 1984, AUST PAEDIATR J, V20, P205
   Grimont F., 2006, PROKARYOTES, V6, P219
   Grohskopf LA, 2001, NEW ENGL J MED, V344, P1491, DOI 10.1056/NEJM200105173442001
   Harnett SJ, 2001, J HOSP INFECT, V47, P301, DOI 10.1053/jhin.2001.0941
   Hurrell E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-146
   Kim JH, 2010, CLIN PEDIATR, V49, P1000, DOI 10.1177/0009922809351238
   Laupland KB, 2008, EUR J CLIN MICROBIOL, V27, P89, DOI 10.1007/s10096-007-0400-7
   Macias AE, 1999, AM J INFECT CONTROL, V27, P285, DOI 10.1053/ic.1999.v27.a92879
   Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11
   Morgan DJ, 2012, CRIT CARE MED, V40, P1045, DOI 10.1097/CCM.0b013e31823bc7c8
   Mossad SB, 2000, CLIN MICROBIOL INFEC, V6, P559, DOI 10.1046/j.1469-0691.2000.00164.x
   Naidu K, 2014, J TROP MED, V2014
   Nejad BS, 2011, B WORLD HEALTH ORGAN, V89, P757
   Samonis G, 2011, EUR J CLIN MICROBIOL, V30, P653, DOI 10.1007/s10096-010-1135-4
   SERRUYSSCHOUTENS E, 1984, EUR J CLIN MICROBIOL, V3, P316, DOI 10.1007/BF01977480
   Stock I, 2003, INT J ANTIMICROB AG, V22, P35, DOI 10.1016/S0924-8579(02)00163-2
   WALDERMANN F, 1987, HAUTARZT, V38, P36
   [Anonymous], 2009, WHO GUID HAND HYG HL
NR 28
TC 1
Z9 1
U1 2
U2 2
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD AUG
PY 2016
VL 10
IS 8
BP 791
EP 798
DI 10.3855/jidc.7184
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA EC8BR
UT WOS:000388365600003
PM 27580323
OA No
DA 2017-08-15
ER

PT J
AU Afolabi, MO
   Tiono, AB
   Adetifa, UJ
   Yaro, JB
   Drammeh, A
   Nebie, I
   Bliss, C
   Hodgson, SH
   Anagnostou, NA
   Sanou, GS
   Jagne, YJ
   Ouedraogo, O
   Tamara, C
   Ouedraogo, N
   Ouedraogo, M
   Njie-Jobe, J
   Diarra, A
   Duncan, CJA
   Cortese, R
   Nicosia, A
   Roberts, R
   Viebig, NK
   Leroy, O
   Lawrie, AM
   Flanagan, KL
   Kampman, B
   Bejon, P
   Imoukhuede, EB
   Ewer, KJ
   Hill, AVS
   Bojang, K
   Sirima, SB
AF Afolabi, Muhammed O.
   Tiono, Alfred B.
   Adetifa, Uche J.
   Yaro, Jean Baptiste
   Drammeh, Abdoulie
   Nebie, Issa
   Bliss, Carly
   Hodgson, Susanne H.
   Anagnostou, Nicholas A.
   Sanou, Guillaume S.
   Jagne, Ya Jankey
   Ouedraogo, Oumarou
   Tamara, Casimir
   Ouedraogo, Nicolas
   Ouedraogo, Mirielle
   Njie-Jobe, Jainaba
   Diarra, Amidou
   Duncan, Christopher J. A.
   Cortese, Riccardo
   Nicosia, Alfredo
   Roberts, Rachel
   Viebig, Nicola K.
   Leroy, Odile
   Lawrie, Alison M.
   Flanagan, Katie L.
   Kampman, Beate
   Bejon, Philip
   Imoukhuede, Egeruan B.
   Ewer, Katie J.
   Hill, Adrian V. S.
   Bojang, Kalifa
   Sirima, Sodiomon B.
TI Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African
   Children and Infants
SO MOLECULAR THERAPY
LA English
DT Article
ID RTS,S/AS01 MALARIA VACCINE; TRIAL; IMMUNIZATION; PHASE-3; GAMBIA
AB Malaria remains a significant global health burden and a vaccine would make a substantial contribution to malaria control. Chimpanzee Adenovirus 63 Modified Vaccinia Ankara Multiple epitope thrombospondin adhesion protein (ME-TRAP) and vaccination has shown significant efficacy against malaria sporozoite challenge in malaria-naive European volunteers and against malaria infection in Kenyan adults. Infants are the target age group for malaria vaccination; however, no studies have yet assessed T-cell responses in children and infants. We enrolled 138 Gambian and Burkinabe children in four different age-groups: 2-6 years old in The Gambia; 5-17 months old in Burkina Faso; 5-12 months old, and also 10 weeks old, in The Gambia; and evaluated the safety and immunogenicity of Chimpanzee Adenovirus 63 Modified Vaccinia Ankara ME-TRAP heterologous prime-boost immunization. The vaccines were well tolerated in all age groups with no vaccine-related serious adverse events. T-cell responses to vaccination peaked 7 days after boosting with-Modified Vaccinia Ankara, with T-cell responses highest in 10 week-old infants. Heterologous prime-boost immunization with Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara ME-TRAP was well tolerated in infants and children, inducing strong T-cell responses. We identify an approach that induces potent T-cell responses in infants, which may be useful for preventing other infectious diseases requiring cellular immunity.
C1 [Afolabi, Muhammed O.; Adetifa, Uche J.; Drammeh, Abdoulie; Jagne, Ya Jankey; Njie-Jobe, Jainaba; Flanagan, Katie L.; Kampman, Beate; Bojang, Kalifa] MRC Unit, Fajara, Gambia.
   [Tiono, Alfred B.; Yaro, Jean Baptiste; Nebie, Issa; Sanou, Guillaume S.; Ouedraogo, Oumarou; Tamara, Casimir; Ouedraogo, Nicolas; Ouedraogo, Mirielle; Diarra, Amidou; Sirima, Sodiomon B.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.
   [Bliss, Carly; Ewer, Katie J.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford, England.
   [Hodgson, Susanne H.; Anagnostou, Nicholas A.; Duncan, Christopher J. A.; Roberts, Rachel; Lawrie, Alison M.; Imoukhuede, Egeruan B.; Hill, Adrian V. S.] Churchill Hosp, Jenner Inst, Ctr Clin Vaccinol & Trop Med, Oxford, England.
   [Cortese, Riccardo] Keires AG, Baumleingasse, Basel, Switzerland.
   [Nicosia, Alfredo] ReiThera, Rome, Italy.
   [Nicosia, Alfredo] CEINGE, Naples, Italy.
   [Nicosia, Alfredo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.
   [Viebig, Nicola K.; Leroy, Odile] Univ Klinikum Heidelberg, European Vaccine Initiat, Heidelberg, Germany.
   [Flanagan, Katie L.] Monash Univ, Dept Immunol, Melbourne, Vic, Australia.
   [Bejon, Philip] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya.
RP Bojang, K (reprint author), MRC Unit, Dis Control & Eliminat Theme, Atlantic Rd,POB 273, Banjul, Gambia.
EM kbojang@mrc.gm
OI Bojang, Kalifa/0000-0001-7506-0938
FU European and Developing Countries Clinical Trials Partnership (EDCTP)
   [IP.2008.31100.001]; UK National Institute of Health Research (NIHR)
   through the NIHR Oxford Biomedical Research Centre [A91301]; Wellcome
   Trust [084113/Z/07/Z]; Medical Research Council; Swedish International
   Development Cooperation Agency (Sida); Irish Aid; UK Medical Research
   Council (MRC); UK Department for International Development (DFID) under
   MRC/DFID Concordat agreement; Wellcome Trust research training
   fellowship [097940/Z/11/Z];  [MC_UP_A900/1122]
FX For the study in The Gambia, the authors thank the Gambian National
   Malaria Control Program and staff of Sukuta Health Centre for their
   collaboration; Momodou Cox, Isatou Bah, Victor Kouassi, Pa Saidou Chaw,
   Ebrima Touray, Sarjo Sanneh, Lisa Fofana, Jarrai Barrow, Christiana
   Demba, Sally Savage, Omar Badjie for laboratory support; Maimuna Sowe,
   Haddy Kanyi for data management; Prof Ousman Nyan for local safety
   monitoring; Jenny Mueller and Vivat Thomas-Njie from the Clinical Trial
   Support Office; Dembo Kanteh, Mamkumba Sanneh from the Research Support
   Office. For the study in Burkina Faso, we thank Ceri McKenna (Appledown)
   for external monitoring. The authors also thank the members of the Data
   Safety Monitoring Board and all the study volunteers. Trials Partnership
   (EDCTP) and was performed by the Malaria Vectored Vaccines Consortium
   (MVVC), a four and a half year integrated project funded by the European
   and Developing Countries Clinical Trials Partnership (EDCTP, grant
   number IP.2008.31100.001). N.K.V. is an employee of the European Vaccine
   Initiative (EVI). EVI is the coordinator of the EDCTP funded MVVC
   project (grant number IP.2008.31100.001). The work was also supported by
   the UK National Institute of Health Research (NIHR) through the NIHR
   Oxford Biomedical Research Centre (http://www.oxfordbrc.org/) [A91301
   Adult Vaccine], The Wellcome Trust (http://www.wellcome.ac.uk/)
   (084113/Z/07/Z) and the Medical Research Council. Cofunding was also
   provided by the Swedish International Development Cooperation Agency
   (Sida) and Irish Aid. This research was supported by the UK Medical
   Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement and
   MC_UP_A900/1122 (M.O.A., A.D., Y.J., K.F., B.K., K.B.). S.H.H. holds a
   Wellcome Trust research training fellowship (097940/Z/11/Z). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. The following authors have
   declared that no conflict of interest exists: M.O.A., C.M.B., A.B.T.,
   AD, I.N., Y.J.J., J.U.A., J.N.J., S.H.H., N.A.A., C.J.D., R.R., N.K.V.,
   O.L., A.M.L. K.L.F., B.K., P.B., E.B.I., S.B.S., K.B., K.J.E. AVSH is a
   named inventor on patent applications on malaria vectored vaccines and
   immunization regimens. Authors from ReiThera are employees of and/or
   shareholders in ReiThera, which is developing vectored vaccines for
   malaria and other diseases.
CR Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287
   Antrobus RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048322
   Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029
   Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707
   Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248
   Borthwick Nicola J, 2015, Immun Inflamm Dis, V3, P82, DOI 10.1002/iid3.52
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423
   Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836
   Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745
   Kagina BMN, 2014, VACCINE, V32, P5908, DOI 10.1016/j.vaccine.2014.09.001
   Kimani D, 2014, MOL THER, V22, P1992, DOI 10.1038/mt.2014.109
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6
   Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726
   Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI [10.1586/erv.09.14, 10.1586/ERV.09.14]
   Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208
   Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185
   Tameris M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087340
   Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Tiono AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086936
   WHO, 2011, MAL DEATHS AR PROGR
NR 24
TC 6
Z9 6
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD AUG
PY 2016
VL 24
IS 8
BP 1470
EP 1477
DI 10.1038/mt.2016.83
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA DV9SD
UT WOS:000383280900018
PM 27109630
OA No
DA 2017-08-15
ER

PT J
AU Goncalves, A
   Makalo, P
   Joof, H
   Burr, S
   Ramadhani, A
   Massae, P
   Malisa, A
   Mtuy, T
   Derrick, T
   Last, AR
   Nabicassa, M
   Cassama, E
   Houghton, J
   Palmer, CD
   Pickering, H
   Burton, MJ
   Mabey, DCW
   Bailey, RL
   Goodier, MR
   Holland, MJ
   Roberts, CH
AF Goncalves, Adriana
   Makalo, Pateh
   Joof, Hassan
   Burr, Sarah
   Ramadhani, Athumani
   Massae, Patrick
   Malisa, Aiweda
   Mtuy, Tara
   Derrick, Tamsyn
   Last, Anna R.
   Nabicassa, Meno
   Cassama, Eunice
   Houghton, Joanna
   Palmer, Christine D.
   Pickering, Harry
   Burton, Matthew J.
   Mabey, David C. W.
   Bailey, Robin L.
   Goodier, Martin R.
   Holland, Martin J.
   Roberts, Chrissy H.
TI Differential frequency of NKG2C/KLRC2 deletion in distinct African
   populations and susceptibility to Trachoma: a new method for imputation
   of KLRC2 genotypes from SNP genotyping data
SO HUMAN GENETICS
LA English
DT Article
ID NATURAL-KILLER-CELLS; HUMAN CYTOMEGALOVIRUS-INFECTION; NKG2C(+) NK
   CELLS; GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION;
   CHLAMYDIA-TRACHOMATIS; HLA-E; DENDRITIC CELLS; GENE DELETION; RECEPTOR
AB NKG2C is an activating receptor that is preferentially expressed on natural killer (NK) cells. The gene encoding NKG2C (killer cell lectin-like receptor C2, KLRC2) is present at different copy numbers in the genomes of different individuals. Deletion at the NKG2C locus was investigated in a case-control study of 1522 individuals indigenous to East- and West-Africa and the association with the ocular Chlamydia trachomatis infection and its sequelae was explored. The frequency of homozygous KLRC2 deletion was 13.7 % in Gambians and 4.7 % in Tanzanians. A significantly higher frequency of the deletion allele was found in West-Africans from the Gambia and Guinea-Bissau (36.2 % p = 2.105 x 10(-8), 26.8 % p = 0.050; respectively) in comparison to East-African Tanzanians where the frequency of the deletion is comparable to other human populations (20.9 %). We found no evidence for an association between the numbers of KLRC2 gene copies and the clinical manifestations of trachoma (follicular trachoma or conjunctival scarring). A new method for imputation of KLRC2 genotypes from single nucleotide polymorphism (SNP) data in 2621 individuals from the Gambia further confirmed these results. Our data suggest that NKG2C does not play a major role in trachomatous disease. We found that the deletion allele is present at different frequencies in different populations but the reason behind these differences is currently not understood. The new method offers the potential to use SNP arrays from genome wide association studies to study the frequency of KLRC2 deletion in other populations and its association with other diseases.
C1 [Goncalves, Adriana; Burr, Sarah; Derrick, Tamsyn; Last, Anna R.; Houghton, Joanna; Palmer, Christine D.; Pickering, Harry; Mabey, David C. W.; Bailey, Robin L.; Holland, Martin J.; Roberts, Chrissy H.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England.
   [Makalo, Pateh; Joof, Hassan; Burr, Sarah; Holland, Martin J.] MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Ramadhani, Athumani; Massae, Patrick; Malisa, Aiweda; Mtuy, Tara; Derrick, Tamsyn; Burton, Matthew J.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania.
   [Mtuy, Tara; Burton, Matthew J.] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London, England.
   [Nabicassa, Meno; Cassama, Eunice] Minist Saude Publ, Programa Nacl Saude Visao, Bissau, Guinea Bissau.
   [Goodier, Martin R.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect Dis, London, England.
RP Roberts, CH (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England.
EM Chrissy.Roberts@lshtm.ac.uk
OI Burton, Matthew/0000-0003-1872-9169; Roberts, Chrissy
   h./0000-0003-1064-5980
CR Batista MD, 2013, EXP DERMATOL, V22, P64, DOI 10.1111/exd.12060
   Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545
   Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826
   Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762
   Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813
   Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869
   Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f
   Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258
   Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564
   Courtright P, 2004, EMERG INFECT DIS, V10, P2012
   Dawson CR, 1981, GUIDE TRACHOMA CONTR
   Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003
   Derrick T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1367-8
   Derrick T, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1308-9
   Derrick T, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/791847
   Djaoud Z, 2013, J IMMUNOL, V191, P2708, DOI 10.4049/jimmunol.1301138
   Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964
   Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995
   Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355
   Gall A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00010
   Goodier MR, 2014, BLOOD, V124, P2213, DOI 10.1182/blood-2014-05-576124
   Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682
   Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058
   Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997
   Hikami K, 2003, GENES IMMUN, V4, P160, DOI 10.1038/sj.gene.6363940
   Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695
   Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x
   Hollenbach JA, 2012, IMMUNOGENETICS, V64, P719, DOI 10.1007/s00251-012-0629-x
   Hook CE, 2005, FEMS IMMUNOL MED MIC, V45, P113, DOI 10.1016/j.femsim.2005.02.010
   Hook CE, 2004, CLIN EXP IMMUNOL, V138, P54, DOI 10.1111/j.1365-2249.2004.02596.x
   Horowitz A, 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3006702
   Hu VH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004734
   Hu VH, 2010, TROP MED INT HEALTH, V15, P673, DOI 10.1111/j.1365-3156.2010.02521.x
   Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734
   Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526
   Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199
   Levin AM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-72
   Li LX, 2015, HUM IMMUNOL, V76, P90, DOI 10.1016/j.humimm.2015.01.022
   Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7
   Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879
   Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066
   Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005
   Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108
   McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282
   Miyashita R, 2004, INT IMMUNOL, V16, P163, DOI 10.1093/intimm/dxh013
   Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897
   Moraru M, 2012, TISSUE ANTIGENS, V80, P184, DOI 10.1111/j.1399-0039.2012.01911.x
   Moraru M, 2012, J IMMUNOL, V188, P4412, DOI [10.4049/jimmunol.1103434, 10.4049/j.immunol.1103434]
   Morel E, 2010, J ALLERGY CLIN IMMUN, V125, P703, DOI 10.1016/j.jaci.2009.10.030
   Muntasell A, 2013, EUR J IMMUNOL, V43, P3268, DOI 10.1002/eji.201343773
   Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10
   Noyola DE, 2012, EUR J IMMUNOL, V42, P3256, DOI 10.1002/eji.201242752
   Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570
   Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370
   Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268
   Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936
   Rangel-Ramirez VV, 2014, INT J IMMUNOGENET, V41, P126, DOI 10.1111/iji.12104
   Roberts CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17447
   Roberts CH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002744
   Shekhar S, 2015, EUR J IMMUNOL, V45, P2810, DOI 10.1002/eji.201445390
   Thomas R, 2012, AIDS RES HUM RETROV, V28, P844, DOI [10.1089/AID.2011.0253, 10.1089/aid.2011.0253]
   Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257
   Tseng CTK, 1998, INFECT IMMUN, V66, P5867
   Vukcevic D, 2015, AM J HUM GENET, V97, P593, DOI 10.1016/j.ajhg.2015.09.005
   Wieten L, 2014, TISSUE ANTIGENS, V84, P523, DOI 10.1111/tan.12478
   Wolle MA, 2009, INVEST OPHTH VIS SCI, V50, P592, DOI 10.1167/iovs.08-2414
   Wright MN, 2015, RANGER FAST IMPLEMEN
   Zeng X, 2013, EXP DERMATOL, V22, P679, DOI 10.1111/exd.12233
   Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18
   [Anonymous], 2004, COMMUN EYE HLTH, V17, P68
NR 70
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD AUG
PY 2016
VL 135
IS 8
BP 939
EP 951
DI 10.1007/s00439-016-1694-2
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA DR7DR
UT WOS:000380060700010
PM 27312142
OA No
DA 2017-08-15
ER

PT J
AU Saso, A
   Kampmann, B
AF Saso, Anja
   Kampmann, Beate
TI Vaccination against respiratory syncytial virus in pregnancy: a suitable
   tool to combat global infant morbidity and mortality?
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID TRANSPLACENTAL ANTIBODY TRANSFER; MATERNAL INFLUENZA IMMUNIZATION;
   REGULATORY T-CELLS; RSV VACCINE; FUSION GLYCOPROTEIN; IMMUNE-RESPONSES;
   NEUTRALIZING ANTIBODIES; INACTIVATED VACCINE; PLACENTAL MALARIA;
   NEONATAL OUTCOMES
AB Respiratory syncytial virus (RSV) is the most important viral cause of pneumonia in early childhood (ie, younger than 2 years), responsible for high infant morbidity and mortality worldwide. It is widely accepted that an effective vaccine against RSV would have a major impact on child health globally. Despite the setbacks of the clinical trials in the 1960s, there has been a recent and significant revival of interest in vaccines against RSV, with several promising candidates undergoing evaluation. In this Review, we describe the epidemiological and immunological background to RSV infection and subsequently focus on the promising pipeline of RSV vaccine development. We discuss the potential for implementation of a safe and immunogenic RSV vaccine within the context of global health and with regards to a range of strategies, including vaccination of women during pregnancy, which is likely to emerge as a beneficial and feasible public health tool. This approach would provide interim protection to vulnerable, RSV-naive infants and other high risk groups, in which the burden of admission to hospital and death is greatest. Extending research and implementation from resource-rich to resource-poor settings is required to enhance our understanding of RSV immunity and inform vaccine development and delivery strategies for all settings. We summarise key outstanding issues for researchers and policy makers to understand the interplay of biological and non-biological factors affecting design and distribution of a successful RSV vaccine globally.
C1 [Saso, Anja; Kampmann, Beate] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London, England.
   [Kampmann, Beate] Imperial Coll London, Dept Paediat, Ctr Int Child Hlth, London, England.
   [Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Serekunda, Gambia.
RP Kampmann, B (reprint author), Imperial Coll Healthcare NHS Trust, Dept Paediat, Ctr Int Child Hlth, London W2 1NY, England.
EM b.kampmann@imperial.ac.uk
FU National Institute for Health Research Biomedical Research Centre based
   at Imperial College Healthcare NHS Trust and Imperial College London;
   Medical Research Council, UK [MC_UP_A900/1122]
FX BK acknowledges the support by the National Institute for Health
   Research Biomedical Research Centre based at Imperial College Healthcare
   NHS Trust and Imperial College London and the core support from the
   Medical Research Council, UK to the Vaccines & Immunity Theme at the
   Medical Research Centre Unit in The Gambia (MC_UP_A900/1122). We thank
   PATH for their kind permission to use the RSV vaccine snapshot in the
   appendix.
CR Ambrose CS, 2014, HUM VACC IMMUNOTHER, V10, P2785, DOI 10.4161/hv.32082
   Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106
   Anderson LJ, 2013, SEMIN IMMUNOL, V25, P160, DOI 10.1016/j.smim.2013.04.011
   Anderson R, 2010, FUTURE MICROBIOL, V5, P585, DOI [10.2217/fmb.10.22, 10.2217/FMB.10.22]
   Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011
   Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959
   Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917
   Bodeker B, 2014, BUNDESGESUNDHEITSBLA, V57, P1315, DOI 10.1007/s00103-014-2044-y
   Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303
   Bukreyev A, 2008, J VIROL, V82, P12191, DOI 10.1128/JVI.01604-08
   Byington CL, 2015, PEDIATRICS, V135, pE24, DOI 10.1542/peds.2014-2151
   Cade A, 2000, ARCH DIS CHILD, V82, P126, DOI 10.1136/adc.82.2.126
   Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13
   Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316
   Chu HY, 2014, CLIN INFECT DIS, V59, P560, DOI 10.1093/cid/ciu327
   Collins J, 2014, HUM VACC IMMUNOTHER, V10, P2922, DOI 10.4161/21645515.2014.971606
   Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020
   Crowe JE, 2001, CLIN INFECT DIS, V33, P1720, DOI 10.1086/322971
   De Halleux V, 2007, Rev Med Liege, V62, P299
   de Moraes-Pinto MI, 1998, ARCH DIS CHILD, V79, pF202
   deMoraesPinto I, 1997, BRIT J HOSP MED, V58, P317
   Diez-Domingo J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0544-x
   Donaldson B, 2015, VACCINE, V33, P5822, DOI 10.1016/j.vaccine.2015.08.093
   Durant LR, 2013, J VIROL, V87, P10946, DOI 10.1128/JVI.01295-13
   Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047
   Escobar GJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-97
   Falsey AR, 2006, J MED VIROL, V78, P1493, DOI 10.1002/jmv.20724
   Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839
   Fortner KB, 2012, OBSTET GYNECOL SURV, V67, P251, DOI 10.1097/OGX.0b013e3182524cee
   Glenn GM, 2016, J INFECT DIS, V213, P411, DOI 10.1093/infdis/jiv406
   GLEZEN WP, 1981, J PEDIATR-US, V98, P708
   The Global Vaccine Alliance, 2013, VACC INV STRAT 2013
   Graham BS, 2013, CURR TOP MICROBIOL, V372, P391, DOI 10.1007/978-3-642-38919-1_20
   Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x
   Green CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008748
   Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018
   Groothuis JR, 2011, ADV THER, V28, P91, DOI 10.1007/s12325-010-0100-z
   Guvenel AK, 2014, EXPERT REV VACCINES, V13, P333, DOI 10.1586/14760584.2014.878653
   Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877
   HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201
   HALL CB, 1991, J INFECT DIS, V163, P693
   Hartling L, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1714
   Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515
   Haynes LM, 2013, J INFECT DIS, V208, pS177, DOI 10.1093/infdis/jit512
   Heidema J, 2007, J IMMUNOL, V179, P8410
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Jorquera PA, 2013, EXPERT REV RESP MED, V7, P411, DOI 10.1586/17476348.2013.814409
   Kaaijk P, 2013, HUM VACC IMMUNOTHER, V9, P1263, DOI 10.4161/hv.24096
   Kawasaki Y, 2004, PEDIATR INT, V46, P126, DOI 10.1046/j.1442-200x.2004.01860.x
   Kay AW, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00289
   Khan AA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-322
   Khan AA, 2015, VACCINE, V33, P5103, DOI 10.1016/j.vaccine.2015.08.014
   Kim D, 2011, BLOOD, V117, P6143, DOI 10.1182/blood-2010-11-320317
   KIM HW, 1976, PEDIATR RES, V10, P75, DOI 10.1203/00006450-197601000-00015
   KIM HW, 1969, AM J EPIDEMIOL, V89, P422
   Kizito D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-619
   Lambach P, 2015, VACCINE, V33, P6493, DOI 10.1016/j.vaccine.2015.08.037
   Lambach P, 2015, VACCINE, V33, P6376, DOI 10.1016/j.vaccine.2015.08.036
   Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466
   Langley JM, 2009, VACCINE, V27, P5913, DOI 10.1016/j.vaccine.2009.07.038
   Le Saux N, 2003, PEDIATR INFECT DIS J, V22, P563, DOI 10.1097/00006454-200306000-00015
   Lindsey B, 2013, CURR OPIN INFECT DIS, V26, P248, DOI 10.1097/QCO.0b013e3283607a58
   Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08
   Loebbermann J, 2013, P NATL ACAD SCI USA, V110, P2987, DOI 10.1073/pnas.1217580110
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Magro M, 2010, J VIROL, V84, P7970, DOI 10.1128/JVI.00447-10
   Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143
   McFetridge R, 2015, VACCINE, V33, P2793, DOI 10.1016/j.vaccine.2015.04.025
   McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283
   Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456
   Moniz MH, 2014, HUM VACC IMMUNOTHER, V10, P2562, DOI 10.4161/21645515.2014.970901
   Moyes J, 2013, J INFECT DIS
   Munoz FM, 2015, VACCINE, V33, P6441, DOI 10.1016/j.vaccine.2015.07.112
   Munoz FM, 2015, CURR OPIN INFECT DIS, V28, P221, DOI 10.1097/QCO.0000000000000161
   Munoz FM, 2012, AM J OBSTET GYNECOL, V207, pS33, DOI 10.1016/j.ajog.2012.06.072
   Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9
   MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   NANDAPALAN N, 1986, J MED VIROL, V20, P79, DOI 10.1002/jmv.1890200110
   Ndibazza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050325
   Nelson CL, 2013, VACCINE, V31, P3756, DOI 10.1016/j.vaccine.2013.04.015
   Nyiro JU, 2015, VACCINE, V33, P1797, DOI 10.1016/j.vaccine.2015.02.039
   Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088
   Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257
   Okoko BJ, 2002, ANN TROP PAEDIATR, V22, P325, DOI 10.1179/027249302125001985
   Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808
   Olson MR, 2007, J IMMUNOL, V179, P5415
   Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005
   Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005
   Openshaw PJM, 2001, VACCINE, V20, pS27, DOI 10.1016/S0264-410X(01)00301-2
   Ortiz JR, 2012, VACCINE, V30, P7134, DOI 10.1016/j.vaccine.2012.09.034
   [Anonymous], 1998, PEDIATRICS, V102, P531
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   PATH, RSV VACC TECHN LANDS
   Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4
   Piedra PA, 2014, J INFECT DIS, V210, P1526, DOI 10.1093/infdis/jiu323
   Polack FP, 2015, VACCINE, V33, P6473, DOI 10.1016/j.vaccine.2015.06.119
   Poletti P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0283-x
   Regan AK, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0495-2
   Resch Bernhard, 2011, Open Microbiol J, V5, P135, DOI 10.2174/1874285801105010135
   Resch Bernhard, 2012, World J Clin Pediatr, V1, P8, DOI 10.5409/wjcp.v1.i3.8
   Resch Bernhard, 2014, Open Microbiol J, V8, P71, DOI 10.2174/1874285801408010071
   Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045
   Rudan I, 2013, J GLOB HEALTH, V3, P10401, DOI DOI 10.7189/J0GH.03.010401
   Rudraraju R, 2013, VIRUSES-BASEL, V5, P577, DOI 10.3390/v5020577
   Shaw CA, 2013, CURR OPIN VIROL, V3, P332, DOI 10.1016/j.coviro.2013.05.003
   Shinoff JJ, 2008, J INFECT DIS, V198, P1007, DOI 10.1086/591460
   Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.3.CO;2-C
   Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6
   Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582
   Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003
   Smith G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050852
   Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6
   Steinhoff MC, 2012, CAN MED ASSOC J, V184, P645, DOI 10.1503/cmaj.110754
   Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013
   Tregoning JS, 2008, J VIROL, V82, P4115, DOI 10.1128/JVI.02313-07
   Ventre K, 2007, COCHRANE DB SYST REV, V1
   Waris ME, 1996, J VIROL, V70, P2852
   World Health Organization, 2015, TECHN CONS MAT INFL
   Wiley KE, 2015, QUAL HEALTH RES, V25, P360, DOI 10.1177/1049732314551061
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
   [Anonymous], 2015, 21 FIG WORLD C GYN O
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P97
NR 123
TC 8
Z9 8
U1 8
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD AUG
PY 2016
VL 16
IS 8
BP E153
EP E163
DI 10.1016/S1473-3099(16)00119-5
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA DU4XH
UT WOS:000382215700002
PM 27317449
OA No
DA 2017-08-15
ER

PT J
AU Redmond, J
   Fulford, AJ
   Jarjou, L
   Zhou, B
   Prentice, A
   Schoenmakers, I
AF Redmond, Jean
   Fulford, Anthony J.
   Jarjou, Landing
   Zhou, Bo
   Prentice, Ann
   Schoenmakers, Inez
TI Diurnal Rhythms of Bone Turnover Markers in Three Ethnic Groups
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID PARATHYROID-HORMONE SECRETION; RURAL GAMBIAN WOMEN; CIRCADIAN-RHYTHM;
   VITAMIN-D; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; UNITED-KINGDOM;
   SERUM CORTISOL; HIP FRACTURE; BLACK-WOMEN
AB Context: Ethnic groups differ in fragility fracture risk and bone metabolism. Differences in diurnal rhythms (DRs) of bone turnover and PTH may play a role.
   Objective: Weinvestigated the DRs of plasma bone turnover markers (BTMs), PTH, and 1,25(OH)(2)D in three groups with pronounced differences in bone metabolism and plasma PTH.
   Participants: Healthy Gambian, Chinese, andwhite British adults (ages 60-75 years; 30 per country).
   Interventions: Observational study with sample collection every 4 hours for 24 hours.
   Main Outcomes: Levels of plasma C-terminal telopeptide of type I collagen, procollagen type-1 N-propeptide, N-mid osteocalcin, bone alkaline phosphatase, PTH, and 1,25-dihydroxyvitamin D were measured. DRs were analyzed with random-effects Fourier regression and cross-correlation and regression analyses to assess associations between DRs and fasting and 24-hour means of BTMs and PTH.
   Results: Concentrations of BTMs, PTH, and 1,25-dihydroxyvitamin D were higher in Gambians compared to other groups (P < .05). The DRs were significant for all variables and groups (P < .03) and were unimodal, with a nocturnal peak and a daytime nadir for BTMs, whereas PTH had two peaks. The DRs of BTMs and PTH were significantly cross-correlated for all groups (P < .05). There was a significant positive association between C-terminal telopeptide of type I collagen and PTH in the British and Gambian groups (P < .03), but not the Chinese group.
   Conclusions: Despite ethnic differences in plasma BTMs and PTH, DRs were similar. This indicates that alteration of rhythmicity and loss of coupling of bone resorption and formation associated with an elevated PTH in other studies may not uniformly occur across different populations and needs to be considered in the interpretation of PTH as a risk factor of increased bone loss.
C1 [Redmond, Jean; Prentice, Ann; Schoenmakers, Inez] Med Res Council MRC Human Nutr Res, Cambridge CB1 9NL, England.
   [Fulford, Anthony J.; Jarjou, Landing; Prentice, Ann] MRC Keneba, Banjul, Gambia.
   [Fulford, Anthony J.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1E 7HT, England.
   [Zhou, Bo] Shenyang Med Coll, Dept Publ Hlth, Shenyang 110034, Peoples R China.
RP Schoenmakers, I (reprint author), MRC Human Nutr Res, Nutr & Bone Hlth Grp, 120 Fulbourn Rd, Cambridge CB1 9NL, England.
EM Inez.Schoenmakers@mrc-hnr.cam.ac.uk
FU Medical Research Council (MRC); Department for International Development
   (DFID) under the MRC/DFID Concordat Agreement (MRC Unit Programs)
   [U105960371, U123261351]; Bone Research Society
FX This research was jointly funded by the Medical Research Council (MRC)
   and the Department for International Development (DFID) under the
   MRC/DFID Concordat Agreement (MRC Unit Programs U105960371 and
   U123261351). We thank the Bone Research Society for its support of J.R.
   for a research visit to Shenyang, China, through a Barbara Mawer Travel
   Fellowship.
CR ADEBAJO AO, 1991, AGE AGEING, V20, P435, DOI 10.1093/ageing/20.6.435
   Ahmad AM, 2003, BONE, V32, P170, DOI 10.1016/S8756-3282(02)00952-3
   Aloia JF, 1998, J LAB CLIN MED, V132, P383, DOI 10.1016/S0022-2143(98)90109-3
   Aspray TJ, 1996, J BONE MINER RES, V11, P1019
   Aspray TJ, 2005, BONE, V36, P710, DOI 10.1016/j.bone.2005.01.002
   BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995
   Bell NH, 2001, OSTEOPOROSIS INT, V12, P43, DOI 10.1007/s001980170156
   Bjarnason NH, 2002, BONE, V30, P307, DOI 10.1016/S8756-3282(01)00662-7
   Cosman F, 1997, J BONE MINER RES, V12, P958, DOI 10.1359/jbmr.1997.12.6.958
   EASTELL R, 1992, J CLIN ENDOCR METAB, V74, P487, DOI 10.1210/jc.74.3.487
   el-Hajj FG, 1997, J CLIN ENDOCR METAB, V82, P281
   Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3051, DOI 10.1210/jc.87.7.3051
   Fraser WD, 1998, OSTEOPOROSIS INT, V8, P121, DOI 10.1007/BF02672507
   Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x
   Fulford AJC, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-15
   Greenspan SL, 1997, CALCIFIED TISSUE INT, V60, P419
   GUNDBERG CM, 1985, J CLIN ENDOCR METAB, V60, P736
   Henriksen DB, 2003, J BONE MINER RES, V18, P2180, DOI 10.1359/jbmr.2003.18.12.2180
   Joseph F, 2007, J CLIN ENDOCR METAB, V92, P3230, DOI 10.1021/jc.2006-1832
   Josse AR, 2012, J CLIN ENDOCR METAB, V97, P251, DOI 10.1210/jc.2011-2165
   Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3
   KLEEREKOPER M, 1994, J BONE MINER RES, V9, P1267
   LEDGER GA, 1995, J CLIN ENDOCR METAB, V80, P3304, DOI 10.1210/jc.80.11.3304
   Maronde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011527
   Pedersen BJ, 1995, OSTEOPOROSIS INT, V5, P472, DOI 10.1007/BF01626611
   POSEN S, 1982, CLIN CHEM, V28, P153
   PRANK K, 1995, J CLIN INVEST, V95, P2910, DOI 10.1172/JCI117998
   Qvist P, 2002, BONE, V31, P57, DOI 10.1016/S8756-3282(02)00791-3
   Redmond J, 2015, OSTEOPOROSIS INT, V26, P1125, DOI 10.1007/s00198-014-2926-8
   Refinetti R, 2005, CIRCADIAN PHYSL
   Rejnmark L, 2002, EUR J ENDOCRINOL, V146, P635, DOI 10.1530/eje.0.1460635
   Schlemmer A, 1997, BONE, V21, P83, DOI 10.1016/S8756-3282(97)00039-2
   Schoenmakers I, 2010, J STEROID BIOCHEM, V121, P217, DOI 10.1016/j.jsbmb.2010.03.012
   Walsh JS, 2010, ARCH BIOCHEM BIOPHYS, V503, P11, DOI 10.1016/j.abb.2010.06.020
   Wichers M, 1999, CLIN CHEM, V45, P1858
   Yan L, 1999, BONE, V24, P151, DOI 10.1016/S8756-3282(98)00168-9
   Yan L, 2003, BONE, V33, P620, DOI 10.1016/S8756-3282(03)00216-3
   Yan LY, 2009, BONE, V45, P238, DOI 10.1016/j.bone.2009.04.237
   Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1539/JBMR.061114
NR 39
TC 0
Z9 0
U1 1
U2 2
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD AUG
PY 2016
VL 101
IS 8
BP 3222
EP 3230
DI 10.1210/jc.2016-1183
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DU0YF
UT WOS:000381930200032
PM 27294326
OA No
DA 2017-08-15
ER

PT J
AU Clarke, E
   Saidu, Y
   Adetifa, JU
   Adigweme, I
   Hydara, MB
   Bashorun, AO
   Moneke-Anyanwoke, N
   Umesi, A
   Roberts, E
   Cham, PM
   Okoye, ME
   Brown, KE
   Niedrig, M
   Chowdhury, PR
   Clemens, R
   Bandyopadhyay, AS
   Mueller, J
   Jeffries, DJ
   Kampmann, B
AF Clarke, Ed
   Saidu, Yauba
   Adetifa, Jane U.
   Adigweme, Ikechukwu
   Hydara, Mariama Badjie
   Bashorun, Adedapo O.
   Moneke-Anyanwoke, Ngozi
   Umesi, Ama
   Roberts, Elishia
   Cham, Pa Modou
   Okoye, Michael E.
   Brown, Kevin E.
   Niedrig, Matthias
   Chowdhury, Panchali Roy
   Clemens, Ralf
   Bandyopadhyay, Ananda S.
   Mueller, Jenny
   Jeffries, David J.
   Kampmann, Beate
TI Safety and immunogenicity of inactivated poliovirus vaccine when given
   with measles-rubella combined vaccine and yellow fever vaccine and when
   given via different administration routes: a phase 4, randomised,
   non-inferiority trial in The Gambia
SO LANCET GLOBAL HEALTH
LA English
DT Article
ID INFANTS; DEVICE; NEEDLE; CUBA
AB Background The introduction of the inactivated poliovirus vaccine (IPV) represents a crucial step in the polio eradication endgame. This trial examined the safety and immunogenicity of IPV given alongside the measles-rubella and yellow fever vaccines at 9 months and when given as a full or fractional dose using needle and syringe or disposable-syringe jet injector.
   Methods We did a phase 4, randomised, non-inferiority trial at three periurban government clinics in west Gambia. Infants aged 9-10 months who had already received oral poliovirus vaccine were randomly assigned to receive the IPV, measles-rubella, and yellow fever vaccines, singularly or in combination. Separately, IPV was given as a full intramuscular or fractional intradermal dose by needle and syringe or disposable-syringe jet injector at a second visit. The primary outcomes were seroprevalence rates for poliovirus 4-6 weeks post-vaccination and the rate of seroconversion between baseline and post-vaccination serum samples for measles, rubella, and yellow fever; and the post-vaccination antibody titres generated against each component of the vaccines. We did a per-protocol analysis with a non-inferiority margin of 10% for poliovirus seroprevalence and measles, rubella, and yellow fever seroconversion, and (1/3) log(2) for log(2)-transformed antibody titres. This trial is registered with ClinicalTrials.gov, number NCT01847872.
   Findings Between July 10, 2013, and May 8, 2014, we assessed 1662 infants for eligibility, of whom 1504 were enrolled into one of seven groups for vaccine interference and one of four groups for fractional dosing and alternative route of administration. The rubella and yellow fever antibody titres were reduced by co-administration but the seroconversion rates achieved non-inferiority in both cases (rubella, -4.5% [95% CI-9.5 to -0.1]; yellow fever, 1.2% [-2.9 to 5.5]). Measles and poliovirus responses were unaffected (measles, 6.8% [95% CI -1.4 to 14.9]; poliovirus serotype 1, 1.6% [-6.7 to 4.7]; serotype 2, 0.0% [-2.1 to 2.1]; serotype 3, 0.0% [-3.8 to 3.9]). Poliovirus seroprevalence was universally high (> 97%) after vaccination, but the antibody titres generated by fractional intradermal doses of IPV did not achieve non-inferiority compared with full dose. The number of infants who seroconverted or had a four-fold rise in titres was also lower by the intradermal route. There were no safety concerns.
   Interpretation The data support the future co-administration of IPV, measles-rubella, and yellow fever vaccines within the Expanded Programme on Immunization schedule at 9 months. The administration of single fractional intradermal doses of IPV by needle and syringe or disposable-syringe jet injector compromises the immunity generated, although it results in a high post-vaccination poliovirus seroprevalence. Copyright (C) Clarke et al. Open Access article distributed under the terms of CC BY.
C1 [Clarke, Ed; Saidu, Yauba; Adetifa, Jane U.; Adigweme, Ikechukwu; Hydara, Mariama Badjie; Bashorun, Adedapo O.; Moneke-Anyanwoke, Ngozi; Umesi, Ama; Roberts, Elishia; Cham, Pa Modou; Okoye, Michael E.; Mueller, Jenny; Jeffries, David J.; Kampmann, Beate] MRC Unit Gambia, Banjul, Gambia.
   [Kampmann, Beate] Imperial Coll, Dept Med, London, England.
   [Brown, Kevin E.] Publ Hlth England, Virus Reference Dept, Colindale, England.
   [Niedrig, Matthias; Chowdhury, Panchali Roy] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany.
   [Clemens, Ralf] Global Res Infect Dis, Rio De Janeiro, Brazil.
   [Clarke, Ed; Bandyopadhyay, Ananda S.] Bill & Melinda Gates Fdn, Seattle, WA USA.
RP Clarke, E (reprint author), MRC Unit Gambia, Vaccines & Immun Theme, POB 273, Banjul, Gambia.
EM eclarke@mrc.gm
OI Bandyopadhyay, Ananda/0000-0002-8395-2001
FU Bill & Melinda Gates Foundation
FX Bill & Melinda Gates Foundation.
CR Anand A, 2015, VACCINE, V33, P6816, DOI 10.1016/j.vaccine.2015.09.039
   Bandyopadhyay AS, 2015, FUTURE MICROBIOL, V10, P791, DOI [10.2217/fmb.15.19, 10.2217/FMB.15.19]
   Bottiger M, 1998, INT J EPIDEMIOL, V27, P916, DOI 10.1093/ije/27.5.916
   Cadorna-Carlos J, 2012, INT J INFECT DIS, V16, pE110, DOI 10.1016/j.ijid.2011.10.002
   Chowdhury PR, 2015, CLIN INFECT DIS, V61, pS586, DOI 10.1093/cid/civ603
   EMEA, 2005, EMEACPMPEWP215899
   Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6
   GPEI, 2013, POL ER ENDG STRAT PL
   Grassly NC, 2014, J INFECT DIS, V210, pS439, DOI 10.1093/infdis/jit601
   LHUILLIER M, 1989, J BIOL STAND, V17, P9, DOI 10.1016/0092-1157(89)90023-1
   Mascha EJ, 2012, ANESTH ANALG, V114, P1304, DOI 10.1213/ANE.0b013e3182504435
   Metcalf CJE, 2012, EPIDEMIOL INFECT, V140, P2290, DOI 10.1017/S0950268812000131
   Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383
   MORINIERE BJ, 1993, LANCET, V341, P1545, DOI 10.1016/0140-6736(93)90693-B
   Silva JRN, 2011, VACCINE, V29, P6327, DOI 10.1016/j.vaccine.2011.05.019
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Resik S, 2015, VACCINE, V33, P307, DOI 10.1016/j.vaccine.2014.11.025
   Resik S, 2013, NEW ENGL J MED, V368, P416, DOI 10.1056/NEJMoa1202541
   Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611
   Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103
   WHO, 2013, BACKGR PAP YELL FEV
   WHO, 2004, WHOEPIGEN9701
   World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P269
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P145
   WHO, 2004, WHO TECHN REP SER, V924, P35
NR 25
TC 3
Z9 3
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD AUG
PY 2016
VL 4
IS 8
BP E534
EP E547
DI 10.1016/S2214-109X(16)30075-4
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS3RI
UT WOS:000380700000018
PM 27364568
OA gold
DA 2017-08-15
ER

PT J
AU Lemoine, M
   Shimakawa, Y
   Njie, R
   Taal, M
   Ndow, G
   Chemin, I
   Ghosh, S
   Njai, HF
   Jeng, A
   Sow, A
   Toure-Kane, C
   Mboup, S
   Suso, P
   Tamba, S
   Jatta, A
   Sarr, L
   Kambi, A
   Stanger, W
   Nayagam, S
   Howell, J
   Mpabanzi, L
   Nyan, O
   Corrah, T
   Whittle, H
   Taylor-Robinson, SD
   D'Alessandro, U
   Mendy, M
   Thursz, MR
AF Lemoine, Maud
   Shimakawa, Yusuke
   Njie, Ramou
   Taal, Makie
   Ndow, Gibril
   Chemin, Isabelle
   Ghosh, Sumantra
   Njai, Harr F.
   Jeng, Adam
   Sow, Amina
   Toure-Kane, Coumba
   Mboup, Souleymane
   Suso, Penda
   Tamba, Saydiba
   Jatta, Abdullah
   Sarr, Louise
   Kambi, Aboubacar
   Stanger, William
   Nayagam, Shevanthi
   Howell, Jessica
   Mpabanzi, Liliane
   Nyan, Ousman
   Corrah, Tumani
   Whittle, Hilton
   Taylor-Robinson, Simon D.
   D'Alessandro, Umberto
   Mendy, Maimuna
   Thursz, Mark R.
CA PROLIFICA Investigators
TI Acceptability and feasibility of a screen-and-treat programme for
   hepatitis B virus infection in The Gambia: the Prevention of Liver
   Fibrosis and Cancer in Africa (PROLIFICA) study
SO LANCET GLOBAL HEALTH
LA English
DT Article
ID COMMUNITY-BASED SURVEY; SUB-SAHARAN AFRICA; INFANT VACCINATION;
   PREVALENCE; SETTINGS; CARE; EPIDEMIOLOGY; PROTECTION; ADHERENCE;
   CARRIAGE
AB Background Despite the introduction of immunisation for hepatitis B virus (HBV) in the 1990s, HBV-related morbidity and mortality remain high in sub-Saharan Africa. Identification and treatment of asymptomatic people with chronic HBV infection should reduce the disease burden. We therefore assessed the feasibility of a screen-and-treat programme for HBV infection in The Gambia, west Africa, and estimated the proportion of HBV-infected people who had significant liver disease in need of treatment.
   Methods Between Dec 7, 2011, and Jan 24, 2014, individuals living in randomly selected communities in western Gambia were offered hepatitis B surface antigen (HBsAg) screening via a point-of-care test. The test was also offered to potential blood donors attending the central hospital in the capital, Banjul. HBsAg-positive individuals were invited for a comprehensive liver assessment and were offered treatment according to international guidelines. We defined linkage to care as visiting the liver clinic at least once. Eligibility for treatment was judged in accordance with the 2012 European Association for the Study of the Liver guidelines.
   Findings HBsAg screening was accepted by 5980 (weighted estimate 68.9%, 95% CI 65.0-72.4) of 8170 adults from 27 rural and 27 urban communities and 5559 (81.4%, 80.4-82.3) of 6832 blood donors. HBsAg was detected in 495 (8.8%, 7.9-9.7) individuals in communities and 721 (13.0%, 12.1-13.9) blood donors. Prevalence was higher in men (239 [10.5%, 8.9-12.1] of 2328 men vs 256 [7.6%, 6.5-8.7] of 3652 women; p=0.004) and middle-aged participants. Linkage to care was high in the communities, with 402 (81.3%) of 495 HBsAg-positive individuals attending the clinic. However, only 300 (41.6%) of 721 HBsAg-positive people screened at the blood bank linked into care. Of those who attended the clinic, 18 (4.4%, 2.5-7.7) patients from the communities and 29 (9.7%, 6.8-13.6) from the blood bank were eligible for treatment. Male sex was strongly associated with treatment eligibility (odds ratio 4.35, 1.50-12.58; p=0.007).
   Interpretation HBV infection remains highly prevalent in The Gambia. The high coverage of community-based screening, good linkage into care, and the small proportion of HBsAg carriers who need treatment suggest that large-scale screening and treatment programmes are feasible in sub-Saharan Africa. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
C1 [Lemoine, Maud; Shimakawa, Yusuke; Ndow, Gibril; Njai, Harr F.; Jeng, Adam; Suso, Penda; Tamba, Saydiba; Jatta, Abdullah; Sarr, Louise; Kambi, Aboubacar; Corrah, Tumani; D'Alessandro, Umberto] MRC Labs, Gambia Unit, Fajara, Gambia.
   [Lemoine, Maud; Ndow, Gibril; Stanger, William; Nayagam, Shevanthi; Howell, Jessica; Taylor-Robinson, Simon D.; Thursz, Mark R.] Imperial Coll London, St Marys Hosp, Div Digest Dis, London W2 1NY, England.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.
   [Njie, Ramou; Mendy, Maimuna] IARC, Lyon, France.
   [Taal, Makie] Minist Hlth & Social Welf, Banjul, Gambia.
   [Chemin, Isabelle; Ghosh, Sumantra] Univ Lyon 1, Ctr Rech Cancerol, INSERM, CNRS,UMR5286,U1052, Lyon, France.
   [Sow, Amina; Toure-Kane, Coumba; Mboup, Souleymane] CHU Le Dantec, Dept Bacteriol & Virol, Dakar, Senegal.
   [Mpabanzi, Liliane] Maastricht Univ, Med Ctr, Dept Surg, NL-6200 MD Maastricht, Netherlands.
   [Mpabanzi, Liliane] Maastricht Univ, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands.
   [Mpabanzi, Liliane] UCL, Royal Free Hosp, Hepatopancreatobiliary & Liver Transplant Surg, London, England.
   [Nyan, Ousman] EFSTH, Banjul, Gambia.
   [Whittle, Hilton] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
RP Thursz, MR (reprint author), Imperial Coll London, St Marys Hosp, Div Digest Dis, London W2 1NY, England.
EM m.thursz@imperial.ac.uk
RI Chemin, Isabelle/I-3032-2016
FU European Commission (FP7)
FX European Commission (FP7).
CR Allain JP, 2009, TRANSFUSION, V49, P669, DOI 10.1111/j.1537-2995.2008.02055.x
   Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112
   Beckett GA, 2014, MMWR-MORBID MORTAL W, V63, P399
   Bottero J, 2013, J HEPATOL, V58, P473, DOI 10.1016/j.jhep.2012.11.016
   Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993
   Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317
   Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655
   DUSHEIKO GM, 1989, AM J EPIDEMIOL, V129, P138
   [Anonymous], 2012, J HEPATOL, V57, P167, DOI DOI 10.1016/J.JHEP.2012.02.010
   FERET E, 1987, AM J EPIDEMIOL, V125, P140
   Ghosh S, 2016, J VIRAL HEPATITIS, V23, P897, DOI 10.1111/jvh.12561
   Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x
   Kiire CF, 1996, GUT, V38, pS5, DOI 10.1136/gut.38.Suppl_2.S5
   Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027
   Koh C, 2013, HEPATOLOGY, V58, P2142, DOI 10.1002/hep.26578
   Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561
   Lemoine M, 2016, GUT, V65, P1369, DOI 10.1136/gutjnl-2015-309260
   Lemoine M, 2014, LIVER INT, V34, P12, DOI 10.1111/liv.12283
   Locarnini S, 2015, J HEPATOL, V62, pS76, DOI 10.1016/j.jhep.2015.01.018
   Marcellin P, 2016, DIGEST DIS SCI, V61, P3072, DOI 10.1007/s10620-015-4027-8
   Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Nayagam S, 2016, LANCET GLOB HEALTH, V4, pE568, DOI 10.1016/S2214-109X(16)30101-2
   Njai HF, 2015, J CLIN MICROBIOL, V53, P1156, DOI 10.1128/JCM.02980-14
   O'Leary MC, 2013, TRAVEL MED INFECT DI, V11, P301, DOI 10.1016/j.tmaid.2013.08.001
   Peto TJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-7
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892
   Thursz M, 2010, TROP MED INT HEALTH, V15, P2, DOI 10.1111/j.1365-3156.2009.02410.x
   van der Sande MAB, 2006, J INFECT DIS, V193, P1528
   WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4
   WHO, GLOB DAT BLOOD SAF
   World Health Organization, 2015, GUID PREV CAR TREATM
NR 33
TC 9
Z9 9
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD AUG
PY 2016
VL 4
IS 8
BP E559
EP E567
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS3RI
UT WOS:000380700000020
PM 27443781
OA gold
DA 2017-08-15
ER

PT J
AU Nayagam, S
   Conteh, L
   Sicuri, E
   Shimakawa, Y
   Suso, P
   Tamba, S
   Njie, R
   Njai, H
   Lemoine, M
   Hallett, TB
   Thursz, M
AF Nayagam, Shevanthi
   Conteh, Lesong
   Sicuri, Elisa
   Shimakawa, Yusuke
   Suso, Penda
   Tamba, Saydiba
   Njie, Ramou
   Njai, Harr
   Lemoine, Maud
   Hallett, Timothy B.
   Thursz, Mark
TI Cost-effectiveness of community-based screening and treatment for
   chronic hepatitis B in The Gambia: an economic modelling analysis
SO LANCET GLOBAL HEALTH
LA English
DT Article
ID TERM-FOLLOW-UP; TENOFOVIR DISOPROXIL FUMARATE; SUB-SAHARAN AFRICA;
   QUALITY-OF-LIFE; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY;
   VIRUS-INFECTION; DISEASE PROGRESSION; LIVER-CIRRHOSIS; E-ANTIGEN
AB Background Despite the high burden of hepatitis B virus (HBV) infection in sub-Saharan Africa, absence of widespread screening and poor access to treatment leads to most people remaining undiagnosed until later stages of disease when prognosis is poor and treatment options are limited. We examined the cost-effectiveness of community-based screening and early treatment with antiviral therapy for HBV in The Gambia.
   Methods In this economic evaluation, we combined a decision tree with a Markov state transition model to compare a screen and treat intervention consisting of adult community-based screening using a hepatitis B surface antigen (HBsAg) rapid test and subsequent HBV antiviral therapy versus current practice, in which there is an absence of publicly provided screening or treatment for HBV. We used data from the PROLIFICA study to parameterise epidemiological, primary screening, and cost information, and other model parameter inputs were obtained from a literature search. Outcome measures were cost per disability-adjusted life-year (DALY) averted; cost per life-year saved; and cost per quality-adjusted life-year (QALY) gained. We calculated the incremental cost-effectiveness ratios (ICERs) between current practice and the screen and treat intervention. Costs were assessed from a health provider perspective. Costs (expressed in 2013 US$) and health outcomes were discounted at 3% per year.
   Findings In The Gambia, where the prevalence of HBsAg is 8.8% in people older than 30 years, adult screening and treatment for HBV has an incremental cost-eff ectiveness ratio (ICER) of $540 per DALY averted, $645 per life-year saved, and $511 per QALY gained, compared with current practice. These ICERs are in line with willingness-to-pay levels of one times the country's gross domestic product per capita ($487) per DALY averted, and remain robust over a wide range of epidemiological and cost parameter inputs.
   Interpretation Adult community-based screening and treatment for HBV in The Gambia is likely to be a cost-effective intervention. Higher cost-eff ectiveness might be achievable with targeted facility-based screening, price reductions of drugs and diagnostics, and integration of HBV screening with other public health interventions.
C1 [Nayagam, Shevanthi; Lemoine, Maud; Thursz, Mark] Imperial Coll, St Marys Hosp, Div Digest Dis, London W2 1NY, England.
   [Nayagam, Shevanthi; Hallett, Timothy B.] Imperial Coll, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England.
   [Conteh, Lesong; Sicuri, Elisa] Imperial Coll, Hlth Econ Grp, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England.
   [Sicuri, Elisa] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Shimakawa, Yusuke; Tamba, Saydiba; Lemoine, Maud] MRC Labs, Gambia Unit, Fajara, Gambia.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.
   [Njie, Ramou] Int Agcy Res Canc, Lyon, France.
RP Nayagam, S (reprint author), Imperial Coll, St Marys Hosp, Div Digest Dis, London W2 1NY, England.
EM s.nayagam01@imperial.ac.uk
FU European Commission; Medical Research Council Laboratories; The Gambia
   Unit; local ministry of health and social welfare; national public
   health laboratories; UK Medical Research Council (MRC); UK Department
   for International Development (DFID); French Research Agency on HIV/AIDS
   and viral hepatitis (ANRS)
FX European Commission.; We thank the European Commission (FP7) for funding
   the programme; the Medical Research Council Laboratories, The Gambia
   Unit, the local ministry of health and social welfare, and the national
   public health laboratories for supporting the project; the PROLIFICA
   team; all the study participants; and Debbie Garside, the project
   manager of PROLIFICA. We acknowledge the support of the UK Medical
   Research Council (MRC) and the UK Department for International
   Development (DFID) who jointly fund (under the MRC/DFID Concordat
   agreement) the clinical research fellowship that supports SN. All
   authors acknowledge the support of the UK National Institute for Health
   Research (NIHR) Biomedical Research Centre (BRC) at Imperial College
   London for infrastructure support. We also thank the French Research
   Agency on HIV/AIDS and viral hepatitis (ANRS) for supporting ML's work
   within the PROLIFICA project.
CR BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J
   BEASLEY RP, 1981, LANCET, V2, P1129
   Berg T, 2015, J HEPATOL, V62, pS253
   Bill and Melinda Gates Foundation, 2014, METH EC EV PROJ MEEP
   Chang MH, 2000, J GASTROEN HEPATOL, V15, pE16, DOI 10.1046/j.1440-1746.2000.02096.x
   Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x
   Chen D-S., 1994, VIRAL HEPATITIS LIVE, P685
   Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042
   CHEN TJ, 1988, LIVER, V8, P10
   Chen YC, 2007, HEPATOL INT, V1, P267, DOI 10.1007/s12072-007-5001-0
   Chotiyaputta W, 2012, J VIRAL HEPATITIS, V19, P205, DOI 10.1111/j.1365-2893.2011.01494.x
   Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612
   Chu CM, 2009, AM J GASTROENTEROL, V104, P1693, DOI 10.1038/ajg.2009.187
   Chu CM, 2005, J HEPATOL, V43, P411, DOI 10.1016/j.jhep.2005.03.018
   Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040
   Cremin I, 2012, TROP MED INT HEALTH, V17, pe26, DOI 10.1111/j.1365-3156.2011.02937.x
   Dan YY, 2014, HEPATOL INT, V8, P382, DOI 10.1007/s12072-014-9549-1
   European Association for the Study of the Liver, 2009, J HEPATOL, V50, P227, DOI DOI 10.1016/J.JHEP.2008.10.001
   Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886
   FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294
   Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011
   Gigi E, 2007, J GASTROINTEST LIVER, V16, P19
   Hahne SJM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-181
   Hill Andrew, 2015, J Virus Erad, V1, P103
   Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638
   Hui AY, 2002, J CLIN GASTROENTEROL, V34, P569, DOI 10.1097/01.MCG.0000012446.01616.DA
   Huo TI, 2000, EUR J GASTROEN HEPAT, V12, P687, DOI 10.1097/00042737-200012060-00019
   Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5
   IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H
   Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260
   Kitrinos KM, 2014, HEPATOLOGY, V59, P434, DOI 10.1002/hep.26686
   Kobayashi M, 2006, J MED VIROL, V78, P459, DOI 10.1002/jmv.20562
   Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9
   Levy AR, 2008, VALUE HEALTH, V11, P527, DOI 10.1111/j.1524-4733.2007.00297.x
   LIAW YF, 1989, LIVER, V9, P235
   LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310
   LIAW YF, 1986, GASTROENTEROLOGY, V90, P263
   Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364
   LIN HH, 1989, LIVER, V9, P129
   Lin XM, 2005, J GASTROEN HEPATOL, V20, P833, DOI 10.1111/j.1400-1746.2005.03813.x
   LO KJ, 1982, J INFECT DIS, V146, P205
   Mahmood S, 2005, LIVER INT, V25, P220, DOI 10.1111/j.1478-3231.2005.01077.x
   Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206
   Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679
   MSF Access Campaign, 2014, UNT WEB ANT PRIC RED
   Nayagam S, LANCET INFE IN PRESS
   Njai HF, 2015, J CLIN MICROBIOL, V53, P1156, DOI 10.1128/JCM.02980-14
   OBATA H, 1980, INT J CANCER, V25, P741, DOI 10.1002/ijc.2910250609
   Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138
   Papatheodoridis GV, 2008, J VIRAL HEPATITIS, V15, P434, DOI 10.1111/j.1365-2893.2007.00957.x
   Papatheodoridis GV, 2015, J VIRAL HEPATITIS, V22, P120, DOI 10.1111/jvh.12283
   Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000
   Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892
   Shimakawa Y, 2015, LIVER INT, V35, P2318, DOI 10.1111/liv.12814
   Shivkumar S, 2012, AM J GASTROENTEROL, V107, P1306, DOI 10.1038/ajg.2012.141
   Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496
   Tong MJ, 2008, HEPATOLOGY, V48, P1070, DOI 10.1002/hep.22476
   Tong MJ, 2009, DIGEST DIS SCI, V54, P1337, DOI 10.1007/s10620-009-0747-y
   Toy M, 2012, EUR J HEALTH ECON, V13, P663, DOI 10.1007/s10198-012-0413-8
   Tsai JF, 1997, BRIT J CANCER, V76, P968, DOI 10.1038/bjc.1997.493
   Tseng TC, 2012, J INFECT DIS, V205, P54, DOI 10.1093/infdis/jir687
   [Anonymous], 2014, GAMB COUNTR PROF
   United Nations Department of Economic and Social Affairs, WORLD POP PROSP 2012
   Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303
   Whittle H, 2002, BRIT MED J, V325, P569, DOI 10.1136/bmj.325.7364.569
   World Health Organization, 2014, COST EFF STRAT PLANN
   WHO, HIV AIDS GLOB PRIC R
   World Health Organization, 2015, GUID PREV CAR TREATM
   World Health Organization, 2003, WHO GUID COST EFF AN
   World Health Organisation, 2011, WHO CHOICE UN COST E
   World Health Organization, 2013, GLOB POL REP PREV CO
   Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301
   [巫贵成 Wu Guicheng], 2002, [中华肝脏病杂志, Chinese Journal of Hepatology], V10, P46
   Xu B, 2003, J GASTROEN HEPATOL, V18, P1345, DOI 10.1046/j.1440-1746.2003.03187.x
   Zacharakis GH, 2005, J MED VIROL, V77, P173, DOI 10.1002/jmv.20434
NR 78
TC 8
Z9 9
U1 4
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD AUG
PY 2016
VL 4
IS 8
BP E568
EP E578
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS3RI
UT WOS:000380700000021
PM 27443782
OA gold
DA 2017-08-15
ER

PT J
AU Bradley, BD
   Light, JD
   Ebonyi, AO
   N'Jai, PC
   Ideh, RC
   Ebruke, BE
   Nyassi, E
   Peel, D
   Howie, SRC
AF Bradley, B. D.
   Light, J. D.
   Ebonyi, A. O.
   N'Jai, P. C.
   Ideh, R. C.
   Ebruke, B. E.
   Nyassi, E.
   Peel, D.
   Howie, S. R. C.
TI Implementation and 8-year follow-up of an uninterrupted oxygen supply
   system in a hospital in The Gambia
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE oxygen concentrators; oxygen cylinders; The Gambia; Africa; cost
   analysis
ID PAPUA-NEW-GUINEA; RESOURCE-LIMITED SETTINGS; CHILDHOOD PNEUMONIA;
   CONCENTRATORS; COUNTRIES; CARE
AB SETTING: A 42-bed hospital operated by the Medical Research Council (MRC) Unit in The Gambia.
   OBJECTIVE: To devise, test and evaluate a cost-efficient uninterrupted oxygen system in the MRC Hospital.
   DESIGN: Oxygen cylinders were replaced with oxygen concentrators as the primary source of oxygen. An uninterruptable power supply (UPS) ensured continuity of power. Hospital staff were trained on the use of the new system. Eight years post-installation, an analysis of concentrator maintenance needs and costs was conducted and user feedback obtained to assess the success of the system.
   RESULTS: The new system saved at least 51% of oxygen supply costs compared to cylinders, with savings likely to have been far greater due to cylinder leakages. Users SUMMARY indicated that the system is easier to use and more reliable, although technical support and staff training are still needed.
   CONCLUSION: Oxygen concentrators offer long-term cost savings and an improved user experience compared to cylinders; however, some technical support and maintenance are needed to upkeep the system. A UPS dedicated to oxygen concentrators is an appropriate solution for settings where power interruptions are frequent but short in duration. This approach can be a model for health systems in settings with similar infrastructure.
C1 [Bradley, B. D.] Univ Toronto, Ctr Global Engn, Toronto, ON, Canada.
   [Bradley, B. D.] Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.
   [Light, J. D.] Univ Toronto, Engn Sci, Toronto, ON, Canada.
   [Ebonyi, A. O.; N'Jai, P. C.; Ideh, R. C.; Ebruke, B. E.; Nyassi, E.; Howie, S. R. C.] Med Res Council Unit Gambia, Fajara, Gambia.
   [Peel, D.] Ashdown Consultants, Hartfield, England.
   [Howie, S. R. C.] Univ Auckland, Dept Pediat, Auckland, New Zealand.
   [Howie, S. R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
RP Bradley, BD (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.; Howie, SRC (reprint author), Univ Auckland, Dept Paediat, Child & Youth Hlth, Auckland City Hosp, Level 12,Support Bldg,Pk Rd, Auckland, New Zealand.
EM showie@mrc.gm
FU UK Medical Research Council, Swindon, UK
FX This work was funded by the UK Medical Research Council, Swindon, UK.
CR Belle J, 2010, J INFECT DEV COUNTR, V4, P419
   Bradley B., 2011, 2011 IEEE Global Humanitarian Technology Conference, DOI 10.1109/GHTC.2011.25
   [Anonymous], 2012, 7 IET APPR HEALTHC T
   Bradley B. D., 2012, 2012 IEEE Global Humanitarian Technology Conference (GHTC 2012), DOI 10.1109/GHTC.2012.53
   Bradley BD, 2015, HLTH TECHNOL, V4, P319
   Dobson M, 1996, LANCET, V347, P1597, DOI 10.1016/S0140-6736(96)91080-6
   DOBSON MB, 1991, ANAESTHESIA, V46, P217, DOI 10.1111/j.1365-2044.1991.tb09413.x
   Duke T, 2010, INT J TUBERC LUNG D, V14, P1362
   Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2
   Enarson PM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000137
   Enarson P, 2008, B WORLD HEALTH ORGAN, V86, P344, DOI 10.2471/BLT.07.048017
   Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103
   Hill SE, 2009, INT J TUBERC LUNG D, V13, P587
   Howie SRC, 2009, B WORLD HEALTH ORGAN, V87, P763, DOI 10.2471/BLT.08.058370
   Kingham TP, 2009, ARCH SURG-CHICAGO, V144, P122, DOI 10.1001/archsurg.2008.540
   La Vincente SF, 2011, INT J TUBERC LUNG D, V15, P693, DOI 10.5588/ijtld.10.0544
   Matai S, 2008, ANN TROP PAEDIATR, V28, P71, DOI 10.1179/146532808X270716
   Mokuolu OA, 2002, ANN TROP PAEDIATR, V22, P209, DOI 10.1179/027249302125001499
   [Anonymous], 2013, WORLD C MED PHYS BIO
   Peel D, 2013, ANAESTHESIA, V68, P706, DOI 10.1111/anae.12260
   Peel David, 2009, Journal of Clinical Engineering, V34, P205
   Perrelet A, 2004, INT J TUBERC LUNG D, V8, P1138
   [Anonymous], 2013, COUNTR STAT GAMB
NR 23
TC 1
Z9 1
U1 0
U2 4
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD AUG
PY 2016
VL 20
IS 8
BP 1130
EP 1134
DI 10.5588/ijtld.15.0889
PG 5
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA DS0PC
UT WOS:000380298200025
PM 27393551
OA No
DA 2017-08-15
ER

PT J
AU Lemoine, M
   Shimakawa, Y
   Nayagam, S
   Khalil, M
   Suso, P
   Lloyd, J
   Goldin, R
   Njai, HF
   Ndow, G
   Taal, M
   Cooke, G
   D'Alessandro, U
   Vray, M
   Mbaye, PS
   Njie, R
   Mallet, V
   Thursz, M
AF Lemoine, Maud
   Shimakawa, Yusuke
   Nayagam, Shevanthi
   Khalil, Mustapha
   Suso, Penda
   Lloyd, Jo
   Goldin, Robert
   Njai, Harr-Freeya
   Ndow, Gibril
   Taal, Makie
   Cooke, Graham
   D'Alessandro, Umberto
   Vray, Muriel
   Mbaye, Papa Saliou
   Njie, Ramou
   Mallet, Vincent
   Thursz, Mark
TI The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts
   significant liver fibrosis and cirrhosis in patients with chronic HBV
   infection in West Africa
SO GUT
LA English
DT Article
ID CHRONIC HEPATITIS-B; SIMPLE NONINVASIVE INDEX; TRANSIENT ELASTOGRAPHY;
   STIFFNESS MEASUREMENT; DIAGNOSTIC-ACCURACY; VIRAL-HEPATITIS; MARKER;
   AMINOTRANSFERASE; BIOMARKERS; FIBROTEST
AB Background Simple and inexpensive non-invasive fibrosis tests are highly needed but have been poorly studied in sub-Saharan Africa.
   Methods Using liver histology as a gold standard, we developed a novel index using routine laboratory tests to predict significant fibrosis in patients with chronic HBV infection in The Gambia, West Africa. We prospectively assessed the diagnostic accuracy of the novel index, Fibroscan, aspartate transaminase-to-platelet ratio index (APRI), and Fib-4 in Gambian patients with CHB (training set) and also in French and Senegalese CHB cohorts (validation sets).
   Results Of 135 consecutive treatment-naive patients with CHB who had liver biopsy, 39% had significant fibrosis (Metavir fibrosis stage >= F2) and 15% had cirrhosis (F4). In multivariable analysis, gamma-glutamyl transpeptidase (GGT) and platelet count were independent predictors of significant fibrosis. Consequently, GGT-to-platelet ratio (GPR) was developed. In The Gambia, the area under the receiver operating characteristic curve (AUROC) of the GPR was significantly higher than that of APRI and Fib-4 to predict >= F2, >= F3 and F4. In Senegal, the AUROC of GPR was significantly better than Fib-4 and APRI for >= F2 (0.73, 95% CI 0.59 to 0.86) and better than Fib-4 and Fibroscan for >= F3 (0.93, 0.87 to 0.99). In France, the AUROC of GPR to diagnose >= F2 (0.72, 95% CI 0.59 to 0.85) and F4 (0.87, 0.76 to 0.98) was equivalent to that of APRI and Fib-4.
   Conclusions The GPR is a more accurate routine laboratory marker than APRI and Fib-4 to stage liver fibrosis in patients with CHB in West Africa. The GPR represents a simple and inexpensive alternative to liver biopsy and Fibroscan in sub-Saharan Africa.
C1 [Lemoine, Maud; Nayagam, Shevanthi; Thursz, Mark] Imperial Coll London, St Marys Hosp, Dept Hepatol, London W2 1NY, England.
   [Lemoine, Maud; Shimakawa, Yusuke; Njai, Harr-Freeya; Ndow, Gibril; D'Alessandro, Umberto; Njie, Ramou] MRC, Gambia Unit, Liver Unit, Fajara, Gambia.
   [Shimakawa, Yusuke; Vray, Muriel] Inst Pasteur, Emerging Dis Epidemil Unit, Paris, France.
   [Khalil, Mustapha; Suso, Penda] Edward Francis Small Teaching Hosp, Dept Histopathol, Banjul, Gambia.
   [Lloyd, Jo; Goldin, Robert] Imperial Coll London, Ctr Pathol, London, England.
   [Taal, Makie] Minist Hlth & Social Welf, Banjul, Gambia.
   [Cooke, Graham] Imperial Coll London, St Marys Hosp, Dept Infect Dis, London, England.
   [Mbaye, Papa Saliou] Principal Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal.
   [Mallet, Vincent] Univ Paris 05, Inst Pasteur, Grp Hosp Cochin Port Royal, AP HP, Paris, France.
RP Lemoine, M (reprint author), Imperial Coll London, St Marys Hosp, Dept Hepatol, London W2 1NY, England.
EM m.lemoine@imperial.ac.uk
OI Nayagam, Amanda Shevanthi/0000-0002-8030-3380; Ndow,
   Gibril/0000-0001-5837-5110
FU European commission: EC FP7 [P34114]; ANRS (National Institute of
   Research on AIDS and Viral Hepatitis), France
FX The study in The Gambia is part of the PROLIFICA programme funded by the
   European commission: EC FP7, P34114. The study in Senegal was funded by
   the ANRS (National Institute of Research on AIDS and Viral Hepatitis),
   France.
CR Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022
   Bonnard P, 2010, AM J TROP MED HYG, V82, P454, DOI 10.4269/ajtmh.2010.09-0088
   Bossuyt PM, 2003, ANN INTERN MED, V138, P40
   Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993
   Cardoso AC, 2012, LIVER INT, V32, P612, DOI 10.1111/j.1478-3231.2011.02660.x
   Castera L, 2006, HEPATOLOGY, V43, P373, DOI 10.1002/hep.21019
   Castera L, 2011, ALIMENT PHARM THER, V33, P455, DOI 10.1111/j.1365-2036.2010.04547.x
   Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018
   Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017
   Chan HLY, 2009, J VIRAL HEPATITIS, V16, P36, DOI 10.1111/j.1365-2893.2008.01037.x
   CHOI BCK, 1992, J CLIN EPIDEMIOL, V45, P581, DOI 10.1016/0895-4356(92)90129-B
   Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x
   Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035
   Eminler AT, 2014, TURK J GASTROENTEROL, V25, P411, DOI 10.5152/tjg.2014.3693
   Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410
   Kim DY, 2009, DIGEST DIS SCI, V54, P1758, DOI 10.1007/s10620-008-0541-2
   Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561
   Lemoine M, 2013, J HEPATOL, P58
   Mallet V, 2009, ALIMENT PHARM THER, V29, P409, DOI 10.1111/j.1365-2036.2008.03895.x
   Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x
   Mbaye PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022291
   Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5
   Njai HF, 2015, J CLIN MICROBIOL, V53, P1156, DOI 10.1128/JCM.02980-14
   Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
   Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X
   Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001
   Shin WG, 2008, DIGEST LIVER DIS, V40, P267, DOI 10.1016/j.dld.2007.10.011
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Suthar AB, 2014, AIDS, V28, pS175, DOI 10.1097/QAD.0000000000000259
   Thursz M, 2012, NAT REV GASTRO HEPAT, V9, P492, DOI 10.1038/nrgastro.2012.155
   Vardar R, 2009, HEPATO-GASTROENTEROL, V56, P1459
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   World Health Organization, 2015, GUID PREV CAR TREATM
   Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506
NR 35
TC 24
Z9 26
U1 1
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD AUG
PY 2016
VL 65
IS 8
BP 1369
EP 1376
DI 10.1136/gutjnl-2015-309260
PG 8
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA DR2TL
UT WOS:000379756700017
PM 26109530
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU D'Alessandro, U
AF D'Alessandro, Umberto
CA PREGACT Study Grp
TI Artemisinin-Based Treatments in Pregnant Women with Malaria REPLY
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
RP D'Alessandro, U (reprint author), MRC Unit, Fajara, Gambia.
EM udalessandro@mrc.gm
CR Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004
   Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7
   [Anonymous], 2008, METH TECHN CLIN TRIA, P29
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 21
PY 2016
VL 375
IS 3
BP 283
EP 284
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0ZL
UT WOS:000380325400017
PM 27468067
OA No
DA 2017-08-15
ER

PT J
AU Bah, A
   Wegmuller, R
   Cerami, C
   Kendall, L
   Pasricha, SR
   Moore, SE
   Prentice, AM
AF Bah, Amat
   Wegmuller, Rita
   Cerami, Carla
   Kendall, Lindsay
   Pasricha, Sant-Rayn
   Moore, Sophie E.
   Prentice, Andrew M.
TI A double blind randomised controlled trial comparing standard dose of
   iron supplementation for pregnant women with two screen-and-treat
   approaches using hepcidin as a biomarker for ready and safe to receive
   iron
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Pregnancy; Hepcidin; Anaemia; UNIMMAP; Lower dose iron; Iron deficiency
ID SERUM HEPCIDIN; DEFICIENCY; COUNTRIES; MALARIA; ANEMIA
AB Background: Until recently, WHO recommended daily iron supplementation for all pregnant women (60 mg/d iron combined with 400ug/d folic acid) where anaemia rates exceeded 40 %. Recent studies indicate that this may pose a risk to pregnant women. Therefore, there is a need to explore screen-and-treat options to minimise iron exposure during pregnancy using an overall lower dosage of iron that would achieve equivalent results as being currently recommended by the WHO. However, there is a lack of agreement on how to best assess iron deficiency when infections are prevalent. Here, we test the use of hepcidin a peptide hormone and key regulator of iron metabolism, as a potential index for 'safe and ready to receive' iron.
   Design/Methods: This is a 3-arm randomised-controlled proof-of-concept trial. We will test the hypothesis that a screen-and-treat approach to iron supplementation using a pre-determined hepcidin cut-off value of <2.5 ng/ml will achieve similar efficacy in preventing iron deficiency and anaemia at a lower iron dose and hence will improve safety. A sample of 462 pregnant women in rural Gambia will be randomly assigned to receive: a) UNU/UNICEF/WHO international multiple micronutrient preparation (UNIMMAP) containing 60 mg/d iron (reference arm); b) UNIMMAP containing 60 mg/d iron but based on a weekly hepcidin screening indicating if iron can be given for the next 7 days or not; c) or UNIMMAP containing 30 mg/d iron as in (b) for 12 weeks in rural Gambia. The study will test if the screen-and-treat approach is non-inferior to the reference arm using the primary endpoint of haemoglobin levels at a non-inferiority margin of 0.5 g/dl. Secondary outcomes of adverse effects, compliance and the impact of iron supplementation on susceptibility to infections will also be assessed.
   Discussion: This trial is expected to contribute towards minimising the exposure of pregnant women to iron that may not be needed and therefore potentially harmful. If the evidence in this study shows that the overall lower dosage of iron is non-inferior to 60 mg/day iron, this may help decrease side-effects, improve compliance and increase safety. The potential for the use of hepcidin for a simple point-of-care (PoC) diagnostic for when it is most safe and effective to give iron may improve maternal health outcomes.
C1 [Bah, Amat; Wegmuller, Rita; Cerami, Carla; Kendall, Lindsay; Prentice, Andrew M.] MRC Unit Gambia, POB 273, Banjul, Gambia.
   [Bah, Amat; Wegmuller, Rita; Cerami, Carla; Prentice, Andrew M.] MRC Int Nutr Grp, POB 273, Banjul, Gambia.
   [Pasricha, Sant-Rayn] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.
   [Moore, Sophie E.] MRC Human Nutr Res, Elsie Widdowson Lab, 120 Fulbourn Rd, Cambridge CB1 9NL, England.
RP Bah, A (reprint author), MRC Unit Gambia, POB 273, Banjul, Gambia.; Bah, A (reprint author), MRC Int Nutr Grp, POB 273, Banjul, Gambia.
EM Amat.Bah@lshtm.ac.uk
OI Cerami, Carla/0000-0002-7634-0955
FU Bill and Melinda Gates Foundation; UK MRC; UK Department for
   International Development (DFID)
FX The trial will not be possible without the funding provided by the Bill
   and Melinda Gates Foundation to the MRC-ING. The trial is also supported
   by the UK MRC and the UK Department for International Development (DFID)
   under the MRC/DFID Concordant agreement. We appreciate the valuable
   contribution of Momodou W. Jallow and Ebrima Ceesay for analysing the
   blood samples for the determination of the hepcidin cut-off point used
   in this trial.
CR Anderson GJ, 2002, BIOCHEM SOC T, V30, P724
   Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337
   Bah A., 2001, NATIONWIDE SURVEY PR
   Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6
   Clark MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101041
   Cross JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16670
   de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331
   Fall CHD, 2009, FOOD NUTR BULL, V30, pS533
   Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X
   Ganz T, 2006, BBA-MOL CELL RES, V1763, P690, DOI 10.1016/j.bbamcr.2006.03.014
   Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467
   Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc9992
   Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641
   Kemna EHJM, 2008, HAEMATOL-HEMATOL J, V93, P90, DOI 10.3324/haematol.11705
   Kohgo Y, 2002, INT J HEMATOL, V76, P213, DOI 10.1007/BF02982790
   Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053
   Lynch S, 2011, AM J CLIN NUTR, V94, p673S, DOI 10.3945/ajcn.110.005959
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686
   Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960
   Pena-Rosas J, 2012, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858.CD004736.pub4, DOI 10.1002/14651858.CD004736.PUB4]
   Pena-Rosas JP, 2009, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD004736.PUB3, 10.1002/14651858.CD004736.pub3]
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   Reveiz L, 2011, COCHRANE DB SYST REV, V10
   Sangare L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087743
   Senga EL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-47
   Thomas C, 2011, CLIN CHEM LAB MED, V49, P207, DOI 10.1515/CCLM.2011.056
   Weinberg ED, 2009, MED HYPOTHESES, V73, P714, DOI 10.1016/j.mehy.2009.04.039
   WHO (World Health Organization), 2008, WORLDWIDE PREVALENCE
   World Health Organisation, 2002, WORLD HLTH REP RED R
   World Health Organization, 2012, GUID DAIL IR FOL AC
   [Anonymous], 2001, IR DEF AN ASS PREV C
   Young B, 2009, CLIN J AM SOC NEPHRO, V4, P1384, DOI 10.2215/CJN.02190309
   Ziaei S, 2007, BJOG-INT J OBSTET GY, V114, P684, DOI 10.1111/j.1471-0528.2007-01325.x
NR 34
TC 5
Z9 5
U1 1
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD JUL 13
PY 2016
VL 16
AR 157
DI 10.1186/s12884-016-0934-8
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DR0OH
UT WOS:000379606300002
PM 27411564
OA gold
DA 2017-08-15
ER

PT J
AU Naydenova, E
   Tsanas, A
   Howie, S
   Casals-Pascual, C
   De Vos, M
AF Naydenova, Elina
   Tsanas, Athanasios
   Howie, Stephen
   Casals-Pascual, Climent
   De Vos, Maarten
TI The power of data mining in diagnosis of childhood pneumonia
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE childhood pneumonia; machine learning; diagnostics
ID CASE-MANAGEMENT; CHILDREN; ETIOLOGY; HEALTH
AB Childhood pneumonia is the leading cause of death of children under the age of 5 years globally. Diagnostic information on the presence of infection, severity and aetiology (bacterial versus viral) is crucial for appropriate treatment. However, the derivation of such information requires advanced equipment (such as X-rays) and clinical expertise to correctly assess observational clinical signs (such as chest indrawing); both of these are often unavailable in resource constrained settings. In this study, these challenges were addressed through the development of a suite of data mining tools, facilitating automated diagnosis through quantifiable features. Findings were validated on a large dataset comprising 780 children diagnosed with pneumonia and 801 age-matched healthy controls. Pneumonia was identified via four quantifiable vital signs (98.2% sensitivity and 97.6% specificity). Moreover, it was shown that severity can be determined through a combination of three vital signs and two lung sounds (72.4% sensitivity and 82.2% specificity); addition of a conventional biomarker (C-reactive protein) further improved severity predictions (89.1% sensitivity and 81.3% specificity). Finally, we demonstrated that aetiology can be determined using three vital signs and a newly proposed biomarker (lipocalin-2) (81.8% sensitivity and 90.6% specificity). These results suggest that a suite of carefully designed machine learning tools can be used to support multi-faceted diagnosis of childhood pneumonia in resource-constrained settings, compensating for the shortage of expensive equipment and highly trained clinicians.
C1 [Naydenova, Elina; Tsanas, Athanasios; De Vos, Maarten] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England.
   [Howie, Stephen] MRC Unit, Child Survival Theme, Serrekunda, Gambia.
   [Casals-Pascual, Climent] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Oxford, England.
RP Naydenova, E (reprint author), Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England.
EM elina.naydenova@eng.ox.ac.uk
OI Casals-Pascual, Climent/0000-0002-0867-8954; Tsanas,
   Athanasios/0000-0002-0994-8100
FU EPSRC; RCUK Digital Economy Programme [EP/G036861/1]; Skoll Centre for
   Social Entrepreneurship at the University of Oxford; Wellcome Trust
   [098461/Z/12/Z]
FX E.N. acknowledges the support of the EPSRC and the RCUK Digital Economy
   Programme grant no EP/G036861/1 (Oxford Centre for Doctoral Training in
   Healthcare Innovation). The authors would like to thank the Skoll Centre
   for Social Entrepreneurship at the University of Oxford for supporting
   this study and the research vision behind the larger project. This study
   was also supported by the Wellcome Trust through a Centre grant no.
   098461/Z/12/Z, 'The University of Oxford Sleep and Circadian
   Neuroscience Institute (SCNi)'.
CR Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555
   Cardoso MRA, 2011, ARCH DIS CHILD, V96, P58, DOI 10.1136/adc.2010.189894
   Cooper GF, 2005, J BIOMED INFORM, V38, P347, DOI 10.1016/j.jbi.2005.02.005
   Cooper GF, 1997, ARTIF INTELL MED, V9, P107, DOI 10.1016/S0933-3657(96)00367-3
   CRAIN EF, 1991, PEDIATRICS, V88, P821
   DeLisle S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070944
   Hinton G., 2008, JMLR, V9, P2579
   Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014
   Ebell M., 2010, POINT OF CARE GUIDES, V82, P2
   Fleming S., 2010, THESIS
   Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512
   Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616
   HARARI M, 1991, LANCET, V338, P928, DOI 10.1016/0140-6736(91)91785-S
   Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325
   Huang HL, 2014, CLIN INFECT DIS, V58, P1707, DOI 10.1093/cid/ciu202
   Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66
   Lynch T, 2004, PEDIATRICS, V113, pE186, DOI 10.1542/peds.113.3.e186
   Marsh DR, 2008, B WORLD HEALTH ORGAN, V86, P381, DOI 10.2471/BLT.07.048462
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   Matsui T, 2010, J INFECTION, V60, P271, DOI 10.1016/j.jinf.2010.01.005
   Palafox M, 2000, ARCH DIS CHILD, V82, P41, DOI 10.1136/adc.82.1.41
   Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769
   Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065
   Sjostrand K, SPASM MATLAB TOOLBOX
   Sun GH, 2012, J INFECTION, V65, P591, DOI 10.1016/j.jinf.2012.10.010
   TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401
   Tsanas A., 2012, THESIS
   UNICEF and WHO, 2006, PNEUMONIA FORGOTTEN
   Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640
   WHO, 2013, POCK BOOK HOSP CAR C
   WHO/UNICEF, 2005, INT MAN CHILDH ILLN
   WHO/UNICEF, 2013, INT GLOB ACT PLAN PN
   Wu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089053
NR 33
TC 0
Z9 0
U1 4
U2 4
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUL
PY 2016
VL 13
IS 120
AR 20160266
DI 10.1098/rsif.2016.0266
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DU6VR
UT WOS:000382353200005
OA No
DA 2017-08-15
ER

PT J
AU Ofori-Anyinam, B
   Kanuteh, F
   Agbla, SC
   Adetifa, I
   Okoi, C
   Dolganov, G
   Schoolnik, G
   Secka, O
   Antonio, M
   de Jong, BC
   Gehre, F
AF Ofori-Anyinam, Boatema
   Kanuteh, Fatoumatta
   Agbla, Schadrac C.
   Adetifa, Ifedayo
   Okoi, Catherine
   Dolganov, Gregory
   Schoolnik, Gary
   Secka, Ousman
   Antonio, Martin
   de Jong, Bouke C.
   Gehre, Florian
TI Impact of the Mycobaterium africanum West Africa 2 Lineage on TB
   Diagnostics in West Africa: Decreased Sensitivity of Rapid
   Identification Tests in The Gambia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS COMPLEX; TIME; MPT64
AB Background
   MPT64 rapid speciation tests are increasingly being used in diagnosis of tuberculosis (TB). Mycobacterium africanum West Africa 2 (Maf 2) remains an important cause of TB in West Africa and causes one third of disease in The Gambia. Since the introduction of MPT64 antigen tests, a higher than expected rate of suspected non-tuberculous mycobacteria (NTM) was seen among AFB smear positive TB suspects, which led us to prospectively assess sensitivity of the MPT64 antigen test in our setting.
   Methodology/Principal Findings
   We compared the abundance of mRNA encoded by the mpt64 gene in sputa of patients with untreated pulmonary TB caused by Maf 2 and Mycobacterium tuberculosis (Mtb). Subsequently, prospectively collected sputum samples from presumptive TB patients were inoculated in the BACTEC MGIT 960 System. One hundred and seventy-three acid fast bacilli (AFB)-positive and blood agar negative MGIT cultures were included in the study. Cultures were tested on the day of MGIT positivity with the BD MGIT TBc Identification Test. A random set of positives and all negatives were additionally tested with the SD Bioline Ag MPT64 Rapid. MPT64 negative cultures were further incubated at 37 degrees C and retested until positive. Bacteria were spoligotyped and assigned to different lineages. Maf 2 isolates were 2.52-fold less likely to produce a positive test result and sensitivity ranged from 78.4% to 84.3% at the beginning and end of the recommended 10 day testing window, respectively. There was no significant difference between the tests. We further showed that the decreased rapid test sensitivity was attributable to variations in mycobacterial growth behavior and the smear grades of the patient.
   Conclusions/Significance
   In areas where Maf 2 is endemic MPT64 tests should be cautiously used and MPT64 negative results confirmed by a second technique, such as nucleic acid amplification tests, to avoid their misclassification as NTMs.
C1 [Ofori-Anyinam, Boatema; de Jong, Bouke C.; Gehre, Florian] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium.
   [Ofori-Anyinam, Boatema; Kanuteh, Fatoumatta; Agbla, Schadrac C.; Okoi, Catherine; Secka, Ousman; Antonio, Martin; de Jong, Bouke C.; Gehre, Florian] MRC Unit, Vaccines & Immun Theme, Serrekunda, Gambia.
   [Adetifa, Ifedayo] MRC Unit, Dis Control & Eliminat Theme, Serrekunda, Gambia.
   [Adetifa, Ifedayo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Dolganov, Gregory; Schoolnik, Gary] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA.
   [Antonio, Martin] Warwick Med Sch, Div Microbiol & Immun, Coventry, W Midlands, England.
   [Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [de Jong, Bouke C.] NYU, Div Infect Dis, New York, NY USA.
RP Gehre, F (reprint author), Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium.; Gehre, F (reprint author), MRC Unit, Vaccines & Immun Theme, Serrekunda, Gambia.
EM fgehre@mrc.gm
OI Antonio, Martin/0000-0002-4810-1308
FU European Research Council [311725]
FX FG, BCdJ and BOA were supported by a European Research Council Starting
   grant INTERRUPTB, no.: 311725. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170
   Basu I, 2015, INT J TUBERC LUNG D, V19, P1073, DOI 10.5588/ijtld.15.0032
   Bekmurzayeva A, 2013, TUBERCULOSIS, V93, P381, DOI 10.1016/j.tube.2013.03.003
   Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X
   de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977
   de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504
   de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x
   Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103
   Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1
   Gaillard T, 2011, DIAGN MICR INFEC DIS, V70, P154, DOI 10.1016/j.diagmicrobio.2010.12.011
   Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337
   Garcia B, 2014, ANAL BIOCHEM, V458, P11, DOI 10.1016/j.ab.2014.04.021
   Gehre F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002220
   Hirano K, 2004, J CLIN MICROBIOL, V42, P390, DOI 10.1128/JCM.42.1.390-392.2004
   Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907
   Lu PL, 2011, J CLIN MICROBIOL, V49, P2290, DOI 10.1128/JCM.00571-11
   Peres RL, 2009, INT J TUBERC LUNG D, V13, P1572
   Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010
   Sun JG, 1996, STAT MED, V15, P1387, DOI 10.1002/(SICI)1097-0258(19960715)15:13<1387::AID-SIM268>3.0.CO;2-R
   Vadwai V, 2012, DIAGN MICR INFEC DIS, V74, P282, DOI 10.1016/j.diagmicrobio.2012.06.018
   Viana-Niero C, 2001, J CLIN MICROBIOL, V39, P57, DOI 10.1128/JCM.39.1.57-65.2001
   Walter ND, 2015, J INFECT DIS
   Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039
   Yin XM, 2013, J INFECTION, V67, P369, DOI 10.1016/j.jinf.2013.06.009
   Yu MC, 2011, J CLIN MICROBIOL, V49, P802, DOI 10.1128/JCM.02243-10
NR 26
TC 1
Z9 1
U1 2
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2016
VL 10
IS 7
AR e0004801
DI 10.1371/journal.pntd.0004801
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DS8FC
UT WOS:000381017800020
PM 27387550
OA gold
DA 2017-08-15
ER

PT J
AU Talsma, EF
   Brouwer, ID
   Verhoef, H
   Mbera, GNK
   Demir, AY
   Boy, E
   Zimmermann, MB
   Melse-Boonstra, A
AF Talsma, Elise Francina
   Brouwer, Inge D.
   Verhoef, Hans
   Mbera, Gloria N. K.
   Demir, Ayse Y.
   Boy, Erick
   Zimmermann, Michael B.
   Melse-Boonstra, Alida
TI Concerns when serum retinol concentration is the primary biological
   indicator of vitamin A status in intervention studies Reply
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Letter
ID VARIABLES
C1 [Talsma, Elise Francina] Int Ctr Trop Agr CIAT, Cali, Colombia.
   [Brouwer, Inge D.; Melse-Boonstra, Alida] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.
   [Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands.
   [Verhoef, Hans] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London, England.
   [Verhoef, Hans] MRC Keneba, Keneba, Gambia.
   [Mbera, Gloria N. K.] Univ Nairobi, Dept Food Technol & Nutr, Appl Nutr Program, Nairobi, Kenya.
   [Demir, Ayse Y.] Meander Med Ctr, Clin Chem Lab, Amersfoort, Netherlands.
   [Boy, Erick] Int Food Policy Res Inst, HarvestPlus, Washington, DC USA.
   [Zimmermann, Michael B.] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Dept Hlth Sci & Technol, Human Nutr Lab, Zurich, Switzerland.
RP Talsma, EF (reprint author), Int Ctr Trop Agr CIAT, Cali, Colombia.
EM elisetalsma@gmail.com
CR Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080
   Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0
   OLSON JA, 1984, J NATL CANCER I, V73, P1439
   RAGLAND DR, 1992, EPIDEMIOLOGY, V3, P434, DOI 10.1097/00001648-199209000-00009
   SUTHUTVORAVOOT S, 1974, AM J CLIN NUTR, V27, P883
   van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080
NR 6
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JUL
PY 2016
VL 104
IS 1
BP 236
EP 237
DI 10.3945/ajcn.116.135715
PG 2
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DQ1RD
UT WOS:000378977200030
PM 27371096
OA No
DA 2017-08-15
ER

PT J
AU Braithwaite, VS
   Freeman, R
   Greenwood, CL
   Summers, DM
   Nigdikar, S
   Lavy, CBD
   Offiah, AC
   Bishop, NJ
   Cashman, J
   Prentice, A
AF Braithwaite, V. S.
   Freeman, R.
   Greenwood, C. L.
   Summers, D. M.
   Nigdikar, S.
   Lavy, C. B. D.
   Offiah, A. C.
   Bishop, N. J.
   Cashman, J.
   Prentice, A.
TI The aetiology of rickets-like lower limb deformities in Malawian
   children
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Article
DE Africa; Blount; Children; Genu valgum; Genu varum; Phosphate; Rickets
ID GAMBIAN CHILDREN; NUTRITIONAL RICKETS; NIGERIAN CHILDREN; BONE
   DEFORMITIES; BLOUNT DISEASE; CALCIUM; GROWTH; FGF23
AB Debilitating rickets-like lower limb deformities are common in children throughout the world, particularly in Malawi, Africa where the causes are unknown. We have identified that Blount disease and calcium deficiency rickets are the likely causes of these deformities and propose calcium supplementation as a potential treatment of Malawian rickets.
   Surgical correction of rickets-like lower limb deformities is the most common paediatric operation performed at Beit Cure Orthopaedic Hospital, Malawi. The aim of this study was to investigate the aetiology of these deformities.
   Children with a tibio-femoral angle of deformity > 20A degrees were enrolled (n = 42, 3.0-15.0 years). Anthropometric and early life and well-being data were collected. Early morning serum and urine samples were collected on the morning of the operation for markers of calcium and phosphate homeostasis. Knee radiographs were obtained, and the children were diagnosed with either Blount (BD, n = 22) or evidence of rickets disease (RD, n = 20). As BD is a mechanical rather than metabolic disease, BD were assumed to be biochemically representative of the local population and thus used as a local reference for RD.
   There were no differences in anthropometry or early life experiences between BD and RD. Parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, total alkaline phosphatase and urinary phosphate were significantly higher and serum phosphate, 25-hydroxyvitamin D (25OHD) and tubular maximal reabsorption of phosphate significantly lower in RD than BD. There was no difference in serum calcium, fibroblast growth factor 23 or markers of iron status between groups. All children had 25OHD > 25 nmol/L.
   Vitamin D deficiency is not implicated in the aetiology of RD or BD in Malawian children. The cause of RD in Malawi is likely to be dietary calcium deficiency leading to elevated PTH resulting in increased losses of phosphate from the bone and glomerular filtrate. The causes of BD remain unclear; there was no evidence in support of previously suggested risk factors such as being overweight or starting to walk early. Prior to surgical intervention, supplementation with calcium should be considered for children with RD.
C1 [Braithwaite, V. S.; Greenwood, C. L.; Nigdikar, S.; Prentice, A.] MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge, England.
   [Freeman, R.] Robert Jones Agnes Hunt NHS Fdn Trust, Dept Paediat Orthopaed, Oswestry, Shrops, England.
   [Summers, D. M.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England.
   [Lavy, C. B. D.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.
   [Offiah, A. C.; Bishop, N. J.] Univ Sheffield, Dept Oncol & Metab, Acad Unit Child Hlth, Sheffield, S Yorkshire, England.
   [Cashman, J.] Beit Cure Orthopaed Hosp, Blantyre, Malawi.
   [Prentice, A.] MRC Keneba, Keneba, Gambia.
RP Braithwaite, VS (reprint author), MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge, England.
EM vickie.braithwaite@mrc-hnr.cam.ac.uk
OI Braithwaite, Vickie/0000-0002-3366-2903; Summers,
   Dominic/0000-0003-3360-0726
FU Orthopaedic Research UK; MRC; Department for International Development
   (DFID) under the MRC/DFID Concordat agreement; MRC programme
   [U105960371, U123261351]
FX This research was funded by the Furlong Foundation (now known as
   Orthopaedic Research UK) and by the MRC and the Department for
   International Development (DFID) under the MRC/DFID Concordat agreement.
   MRC programme U105960371 and U123261351.
CR Bain BJ, 2001, PRACTICAL HAEMATOLOG, V9, P19
   Barth JH, 1996, ANN CLIN BIOCHEM, V33, P55
   BATHFIELD CA, 1978, CLIN ORTHOP RELAT R, P29
   Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8
   Braithwaite Vickie, 2012, Int J Pediatr Endocrinol, V2012, P27, DOI 10.1186/1687-9856-2012-27
   Braithwaite V, 2012, BONE, V50, P1351, DOI 10.1016/j.bone.2012.03.010
   Braithwaite V, 2012, BONE, V50, P218, DOI 10.1016/j.bone.2011.10.009
   CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038/325062a0
   Craviari T, 2008, J HEALTH POPUL NUTR, V26, P112
   Group RC, 2006, J HEALTH POPUL NUTR, V26, P112
   Grubb AO, 2001, ADV CLIN CHEM, V35, P72
   Jones HL, 2015, BONE, V77, P1, DOI 10.1016/j.bone.2015.04.011
   Kuh D, 2014, J BONE MINER RES, V29, P123, DOI 10.1002/jbmr.2008
   Mughal M Zulf, 2011, Curr Osteoporos Rep, V9, P291, DOI 10.1007/s11914-011-0081-0
   Oginni LM, 1996, J PEDIATR-US, V128, P692, DOI 10.1016/S0022-3476(96)80137-5
   Payne RB, 1998, ANN CLIN BIOCHEM, V35, P201
   PETTIFOR JM, 1978, J PEDIATR-US, V92, P320, DOI 10.1016/S0022-3476(78)80035-3
   Prentice A, 2008, BONE, V42, P788, DOI 10.1016/j.bone.2007.11.014
   Prentice A, 2013, J STEROID BIOCHEM, V136, P201, DOI 10.1016/j.jsbmb.2012.11.018
   Sabharwal S, 2009, J BONE JOINT SURG AM, V91A, P1758, DOI 10.2106/JBJS.H.01348
   Thacher TD, 2000, J TROP PEDIATRICS, V46, P132, DOI 10.1093/tropej/46.3.132
   Thacher TD, 2000, J PEDIATR-US, V137, P367, DOI 10.1067/mpd.2000.107527
   Thacher TD, 2010, NUTR REV, V68, P682, DOI 10.1111/j.1753-4887.2010.00338.x
   Wesselsky V, 2016, INT ORTHOP, V40, P653, DOI 10.1007/s00264-015-2911-7
NR 24
TC 2
Z9 2
U1 0
U2 3
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD JUL
PY 2016
VL 27
IS 7
BP 2367
EP 2372
DI 10.1007/s00198-016-3541-7
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DO8AQ
UT WOS:000378004800023
PM 27059923
OA No
DA 2017-08-15
ER

PT J
AU Rees, CP
   Hawkesworth, S
   Moore, SE
   Dondeh, BL
   Unger, SA
AF Rees, Claire P.
   Hawkesworth, Sophie
   Moore, Sophie E.
   Dondeh, Bai L.
   Unger, Stefan A.
TI Factors Affecting Access to Healthcare: An Observational Study of
   Children under 5 Years of Age Presenting to a Rural Gambian Primary
   Healthcare Centre
SO PLOS ONE
LA English
DT Article
ID TREATMENT-SEEKING BEHAVIOR; EFFECTIVE MALARIA TREATMENT; BURKINA-FASO;
   YOUNG-CHILDREN; DEVELOPING-COUNTRIES; SERVICES UTILIZATION; CHILDHOOD
   ILLNESSES; UNDER-5 CHILDREN; HOUSEHOLD SURVEY; FEBRILE ILLNESS
AB Main Objective
   Prompt access to primary healthcare before onset of severe illness is vital to improve morbidity and mortality rates. The Gambia has high rates of child mortality and research is needed to investigate contributing factors further. This study aimed to identify factors affecting access to primary healthcare for children <5 years (y) in rural Gambia focusing on delayed presentation and severe illness at presentation as indicators in a setting where primary healthcare is delivered free of charge.
   Methods
   Data were extracted from an electronic medical records system at a rural primary healthcare clinic in The Gambia for children (0-5y) between 2009 and 2012. First clinic attendances with malaria, lower respiratory tract infections (LRTI) and diarrhoeal disease, the main contributors to mortality in this setting, were identified and categorized as delayed/non-delayed and severe/non-severe representing our two main outcome measures. Potential explanatory variables, identified through a comprehensive literature review were obtained from an ongoing demographic surveillance system for this population. Variables associated with either delayed/non-delayed and/or with severe/non-severe presentations identified by univariate analysis (p<0.1) were assessed in multivariate models using logistic regression (p<0.05).
   Results
   Out of 6554 clinic attendances, 571 relevant attendances were identified. Delayed presentation was common (45% of all presentations) and there was a significantly reduced risk associated with being from villages with free regular access to transport (OR 0.502, 95% CI [0.310, 0.814], p = 0.005). Children from villages with free regular transport were also less likely to present with severe illness (OR 0.557, 95% CI[0.325, 0.954], p = 0.033).
   Conclusions
   Transport availability rather than distance to health clinic is an important barrier to accessing healthcare for children in The Gambia, and public health interventions should aim to reduce this barrier.
C1 [Rees, Claire P.] Barts & London Queen Marys Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England.
   [Hawkesworth, Sophie; Moore, Sophie E.; Dondeh, Bai L.; Unger, Stefan A.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England.
   [Hawkesworth, Sophie; Moore, Sophie E.; Dondeh, Bai L.; Unger, Stefan A.] MRC Unit Gambia, MRC Keneba, MRC Int Nutr Grp, Banjul, Gambia.
   [Moore, Sophie E.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England.
   [Unger, Stefan A.] Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland.
RP Unger, SA (reprint author), London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England.; Unger, SA (reprint author), MRC Unit Gambia, MRC Keneba, MRC Int Nutr Grp, Banjul, Gambia.; Unger, SA (reprint author), Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland.
EM sunger@staffmail.ed.ac.uk
OI Rees, Claire/0000-0001-5649-7835; Hawkesworth,
   Sophie/0000-0002-3554-242X
FU MRC International Nutrition Group [MC-A760-5QX00]
FX This work was supported by Grant MC-A760-5QX00, MRC International
   Nutrition Group, http://www.mrc.gm. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR AHONSI BA, 1995, J BIOSOC SCI, V27, P19
   Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x
   Akre M, 2010, PEDIATRICS, V125, pE763, DOI 10.1542/peds.2009-0338
   Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6
   Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729
   Burgert CR, 2011, TROP MED INT HEALTH, V16, P711, DOI 10.1111/j.1365-3156.2011.02752.x
   Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61
   BYASS P, 1994, INT J EPIDEMIOL, V23, P757, DOI 10.1093/ije/23.4.757
   Byass P, 2008, PAEDIATR PERINAT EP, V22, P569, DOI 10.1111/j.1365-3016.2008.00974.x
   Cashat-Cruz Miguel, 2005, Semin Pediatr Infect Dis, V16, P84, DOI 10.1053/j.spid.2005.12.005
   Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144
   Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-49
   Egdell P, 2008, EMERG MED J, V25, P745, DOI 10.1136/emj.2007.054965
   Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x
   FOSU GB, 1994, SOC SCI MED, V38, P1209, DOI 10.1016/0277-9536(94)90186-4
   Franckel A, 2009, J BIOSOC SCI, V41, P1, DOI 10.1017/S0021932008002885
   Getahun A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-320
   Gething PW, 2004, ACTA TROP, V91, P227, DOI 10.1016/j.actatropica.2004.05.002
   Gove S, 1999, ARCH DIS CHILD, V81, P473
   Hennig BJ, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv206
   Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317
   Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x
   Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2
   International TGBoSGal, 2014, GAMBIA DEMOGRAPHIC H
   Justesen A, 2000, INT J EPIDEMIOL, V29, P678, DOI 10.1093/ije/29.4.678
   Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099
   Kahabuka C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058789, DOI 10.1371/JOURNAL.PONE.0058789]
   Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93
   Kenny A, 2015, J GLOB HEALTH, V5, P48, DOI 10.7189/jogh.05.020401
   Khatib RA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-155
   Mackway-Jones KME, 2005, ADV PAEDIAT LIFE SUP
   Malaria RB, 2000, ABUJA DECLARATION PL
   Manongi R, 2014, TROP MED INT HEALTH, V19, P555, DOI 10.1111/tmi.12294
   MATERIA E, 1993, EUR J EPIDEMIOL, V9, P511
   Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796
   Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x
   Nasrin D, 2013, AM J TROP MED HYG, V89, P3, DOI 10.4269/ajtmh.12-0749
   O'Meara WP, 2009, TROP MED INT HEALTH, V14, P29, DOI 10.1111/j.1365-3156.2008.02194.x
   O'Reilly CE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001256
   Odu BP, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-1
   Parmar D, 2014, HEALTH POLICY PLANN, V29, P76, DOI 10.1093/heapol/czs136
   Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x
   Risk R, 2013, ARCH DIS CHILD, V98, P503, DOI 10.1136/archdischild-2012-302987
   Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x
   Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175
   Sartorius B, 1992, GEOSPAT HLTH, V5, P285, DOI DOI 10.4081/GH.2011.181
   Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194
   Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386
   Sodemann M, 2006, TROP MED INT HEALTH, V11, P1868, DOI 10.1111/j.1365-3156.2006.01744.x
   Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x
   Tipke M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-266
   UNITED NATIONS, 2012, MILL DEV GOALS REP
   UNICEF, 2007, GAMBIA MULTIPLE INDI
   UNICEF, 2011, PROM GEND EQ UN SUPP
   Ustrup M, 2014, J HEALTH POPUL NUTR, V32, P68
   VandenBroeck J, 1996, INT J EPIDEMIOL, V25, P998
   Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19
   WHO, 1978, INT  C PRIM HLTH CAR
   World Health Organization, 2005, POCK BOOK HOSP CAR C
   WHO, 2005, HDB IMCI INT MAN CHI
   WHO, 2007, ICD 10 COD
   Zoungrana A, 2014, ACTA TROP, V139, P109, DOI 10.1016/j.actatropica.2014.07.011
NR 64
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 23
PY 2016
VL 11
IS 6
AR e0157790
DI 10.1371/journal.pone.0157790
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP3JL
UT WOS:000378389200046
PM 27336164
OA gold
DA 2017-08-15
ER

PT J
AU Gichohi-Wainaina, WN
   Tanaka, T
   Towers, GW
   Verhoef, H
   Veenemans, J
   Talsma, EF
   Harryvan, J
   Boekschoten, MV
   Feskens, EJ
   Melse-Boonstra, A
AF Gichohi-Wainaina, Wanjiku N.
   Tanaka, Toshiko
   Towers, G. Wayne
   Verhoef, Hans
   Veenemans, Jacobien
   Talsma, Elise F.
   Harryvan, Jan
   Boekschoten, Mark V.
   Feskens, Edith J.
   Melse-Boonstra, Alida
TI Associations between Common Variants in Iron-Related Genes with
   Haematological Traits in Populations of African Ancestry
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; BLOOD-CELL TRAITS; DEFICIENCY ANEMIA; SERUM
   IRON; TRANSFERRIN SATURATION; HEMOGLOBIN LEVELS; TMPRSS6; AMERICANS;
   CHILDREN; FERRITIN
AB Background
   Large genome-wide association (GWA) studies of European ancestry individuals have identified multiple genetic variants influencing iron status. Studies on the generalizability of these associations to African ancestry populations have been limited. These studies are important given interethnic differences in iron status and the disproportionate burden of iron deficiency among African ancestry populations.
   Methods
   We tested the associations of 20 previously identified iron status-associated single nucleotide polymorphisms (SNPs) in 628 Kenyans, 609 Tanzanians, 608 South Africans and 228 African Americans. In each study, we examined the associations present between 20 SNPs with ferritin and haemoglobin, adjusting for age, sex and CRP levels.
   Results
   In the meta analysis including all 4 African ancestry cohorts, we replicated previously reported associations with lowered haemoglobin concentrations for rs2413450 (beta = -0.19, P = 0.02) and rs4820268 (beta = -0.16, P = 0.04) in TMPRSS6. An association with increased ferritin concentrations was also confirmed for rs1867504 in TF (beta = 1.04, P = <0.0001) in the meta analysis including the African cohorts only.
   Conclusions
   In all meta analyses, we only replicated 4 of the 20 single nucleotide polymorphisms reported to be associated with iron status in large GWA studies of European ancestry individuals. While there is now evidence for the associations of a number of genetic variants with iron status in both European and African ancestry populations, the considerable lack of concordance highlights the importance of continued ancestry-specific studies to elucidate the genetic underpinnings of iron status in ethnically diverse populations.
C1 [Gichohi-Wainaina, Wanjiku N.; Harryvan, Jan; Feskens, Edith J.; Melse-Boonstra, Alida] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.
   [Gichohi-Wainaina, Wanjiku N.] IITA, Dar Es Salaam, Tanzania.
   [Tanaka, Toshiko] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA.
   [Towers, G. Wayne] North West Univ, Ctr Excellence Nutr, Potchefstroom Campus, Potchefstroom, South Africa.
   [Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands.
   [Verhoef, Hans] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England.
   [Verhoef, Hans] Med Res Council Banjul, Banjul, Gambia.
   [Veenemans, Jacobien] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.
   [Veenemans, Jacobien] Admiraal De Ruyter Hosp, Dept Med Microbiol & Immunol, Goes, Netherlands.
   [Talsma, Elise F.] CIAT, HarvestPlus, Cali, Colombia.
   [Boekschoten, Mark V.] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands.
RP Gichohi-Wainaina, WN (reprint author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.; Gichohi-Wainaina, WN (reprint author), IITA, Dar Es Salaam, Tanzania.
EM wngichohi@gmail.com
FU European Union's Seventh Framework Programme [FP7] [211484]; Netherlands
   Organisation for Scientific Research (NWO)/WOTRO [W93-413, WAO93-441,
   WIZ93-465]; UNICEF; Cornelis Visser Foundation; Wageningen University
   (Interdisciplinary Research and Education Fund); South African Medical
   Research Council (Self-Initiated Research Grants), Cape Town, South
   Africa; Unilever R&D, Vlaardingen, The Netherlands; European Union (EU)
   [MC-IRSES-2008-230786]; Intramural Research Program of the NIH; National
   Institute on Aging
FX The Kenyan cohort research was conducted within the framework of INSTAPA
   Project, funded by the European Union's Seventh Framework Programme
   [FP7/2007-2013] under grant agreement nr 211484. The Tanzanian cohort
   research was supported through funding from the Netherlands Organisation
   for Scientific Research (NWO)/WOTRO [W93-413, WAO93-441, as well as
   WIZ93-465, UNICEF, Cornelis Visser Foundation and Wageningen University
   (Interdisciplinary Research and Education Fund). The PURE study was
   supported through grants provided by the South African Medical Research
   Council (Self-Initiated Research Grants), Cape Town, South Africa, with
   further support from a fellowship provided by Unilever R&D, Vlaardingen,
   The Netherlands, and from the European Union (EU) funded staff exchange
   European-South African Partnership in Nutrition Research program (grant
   MC-IRSES-2008-230786). The BLSA was supported through funding by the
   Intramural Research Program of the NIH, National Institute on Aging. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029
   An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028
   Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073
   Aslan D, 2007, ACTA HAEMATOL-BASEL, V118, P244, DOI 10.1159/000112726
   Atkinson SH, 2008, BLOOD, V112, P4276, DOI 10.1182/blood-2008-06-162008
   Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456
   Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011
   Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713
   Beutler E, 2000, BLOOD, V96, P4071
   Blanco-Rojo R, 2014, INT J MOL SCI, V15, P4077, DOI 10.3390/ijms15034077
   Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462
   Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087
   Coad J, 2011, CURR OPIN CLIN NUTR, V14, P625, DOI 10.1097/MCO.0b013e32834be6fd
   De Falco L, 2013, HAEMATOLOGICA, V98, P845, DOI 10.3324/haematol.2012.075515
   Ding KY, 2013, G3-GENES GENOM GENET, V3, P1061, DOI 10.1534/g3.113.006452
   Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121
   Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130
   Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355
   Galesloot TE, 2013, J MED GENET, V50, P593, DOI 10.1136/jmedgenet-2013-101673
   Gan W, 2012, AM J CLIN NUTR, V95, P626, DOI 10.3945/ajcn.111.025684
   Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466
   Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467
   GARN SM, 1981, AM J CLIN NUTR, V34, P1645
   Gomez F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a008524
   Gordon D, 2003, Pac Symp Biocomput, P490
   Jonker FAM, 2014, J INFECTION, V69, pS23, DOI 10.1016/j.jinf.2014.08.007
   Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011
   Lee PL, 2001, BRIT J HAEMATOL, V115, P329, DOI 10.1046/j.1365-2141.2001.03096.x
   Li J, 2015, HUM MOL GENET, V24, P572, DOI 10.1093/hmg/ddu454
   Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534
   Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1
   MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0
   McLaren CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038339
   McLaren CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017390
   Meynard D, 2014, BLOOD, V123, P168, DOI 10.1182/blood-2013-06-427757
   Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012
   Njajou OT, 2006, HUM HERED, V61, P222, DOI 10.1159/000094777
   Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148
   Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x
   Pfeiffer RM, 2003, GENET EPIDEMIOL, V25, P136, DOI 10.1002/gepi.10245
   Pichler I, 2011, HUM MOL GENET, V20, P1232, DOI 10.1093/hmg/ddq552
   Scherag A, 2003, HUM HERED, V56, P56, DOI 10.1159/000073733
   Shock N. W., 1984, NORMAL HUMAN AGING B
   Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467
   Talsma EFVH, 2015, BMC MED
   Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496
   Team RC, 2013, R LANG ENV STAT COMP
   Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438
   Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061
   Trenor CC, 2000, BLOOD, V96, P1113
   Trey JE, 1995, CRIT REV ONCOL HEMAT, V21, P1, DOI 10.1016/1040-8428(94)00141-3
   Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125
   [Geneva WHO Vitamin and Mineral Nutrition Information System], 2011, WHONMHNHDMNM111 VIT
   Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201
   Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862
   Whitfield JB, 2001, ALCOHOL CLIN EXP RES, V25, P1037, DOI 10.1111/j.1530-0277.2001.tb02314.x
   WHO (World Health Organization), 2008, WORLDWIDE PREVALENCE
   YIP R, 1984, AM J CLIN NUTR, V39, P427
   Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115
NR 59
TC 1
Z9 1
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 22
PY 2016
VL 11
IS 6
AR e0157996
DI 10.1371/journal.pone.0157996
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WX
UT WOS:000378212800065
PM 27332551
OA gold
DA 2017-08-15
ER

PT J
AU Busby, GBJ
   Band, G
   Le, QS
   Jallow, M
   Bougama, E
   Mangano, VD
   Amenga-Etego, LN
   Enimil, A
   Apinjoh, T
   Ndila, CM
   Manjurano, A
   Nyirongo, V
   Doumbo, O
   Rockett, KA
   Kwiatkowski, DP
   Spencer, CCA
AF Busby, George B. J.
   Band, Gavin
   Le, Quang Si
   Jallow, Muminatou
   Bougama, Edith
   Mangano, Valentina D.
   Amenga-Etego, Lucas N.
   Enimil, Anthony
   Apinjoh, Tobias
   Ndila, Carolyne M.
   Manjurano, Alphaxard
   Nyirongo, Vysaul
   Doumbo, Ogobara
   Rockett, Kirk A.
   Kwiatkowski, Domnic P.
   Spencer, Chris C. A.
CA Malaria Genomic Epidemiology Netwo
TI Admixture into and within sub-Saharan Africa
SO ELIFE
LA English
DT Article
ID BLOOD-GROUP LOCUS; GENETIC SIGNATURES; BANTU EXPANSION;
   POPULATION-STRUCTURE; LACTASE PERSISTENCE; LINGUISTIC EVIDENCE; REVEALS
   ADAPTATION; NATURAL-SELECTION; SOUTHERN AFRICA; HIGH-ALTITUDE
AB Similarity between two individuals in the combination of genetic markers along their chromosomes indicates shared ancestry and can be used to identify historical connections between different population groups due to admixture. We use a genome-wide, haplotype-based, analysis to characterise the structure of genetic diversity and gene-flow in a collection of 48 sub-Saharan African groups. We show that coastal populations experienced an influx of Eurasian haplotypes over the last 7000 years, and that Eastern and Southern Niger-Congo speaking groups share ancestry with Central West Africans as a result of recent population expansions. In fact, most subSaharan populations share ancestry with groups from outside of their current geographic region as a result of gene-flow within the last 4000 years. Our in-depth analysis provides insight into haplotype sharing across different ethno-linguistic groups and the recent movement of alleles into new environments, both of which are relevant to studies of genetic epidemiology.
C1 [Busby, George B. J.; Band, Gavin; Le, Quang Si; Rockett, Kirk A.; Kwiatkowski, Domnic P.; Spencer, Chris C. A.] Wellcome Trust Ctr Human Genet, Oxford, England.
   [Band, Gavin; Rockett, Kirk A.; Kwiatkowski, Domnic P.; Malaria Genomic Epidemiology Netwo] Wellcome Trust Sanger Inst, Cambridge, England.
   [Jallow, Muminatou] MRC Unit, Serrekunda, Gambia.
   [Jallow, Muminatou] Royal Victoria Teaching Hosp, Banjul, Gambia.
   [Bougama, Edith] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.
   [Mangano, Valentina D.] Univ Roma La Sapienza, Dipartimento Sanita Publ & Malattie Infett, Rome, Italy.
   [Amenga-Etego, Lucas N.] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Enimil, Anthony] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Apinjoh, Tobias] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon.
   [Ndila, Carolyne M.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.
   [Manjurano, Alphaxard] Kilimanjaro Christian Med Coll, Joint Malaria Programme, Moshi, Tanzania.
   [Manjurano, Alphaxard] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Nyirongo, Vysaul] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.
   [Doumbo, Ogobara] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali.
RP Busby, GBJ (reprint author), Wellcome Trust Ctr Human Genet, Oxford, England.
EM george@well.ox.ac.uk; spencer@well.ox.ac.uk
OI Oyola, Samuel O./0000-0002-6425-7345; Kivinen,
   Katja/0000-0002-1135-7625; Deloukas, Panos/0000-0001-9251-070X;
   Kwiatkowski, Dominic/0000-0002-5023-0176; Mead,
   Daniel/0000-0001-7717-4330; Manske, Magnus/0000-0001-5916-0947;
   Casals-Pascual, Climent/0000-0002-0867-8954; Auburn,
   Sarah/0000-0002-4638-536X; Busby, George/0000-0003-4148-6222
FU Wellcome Trust [084538, 090532, 098051, 077383, 097364, 090770];
   National Institute of Allergy and Infectious Diseases; Medical Research
   Council [G0600718, MR/M006212/1]; Foundation for the National Institutes
   of Health [566]
FX Wellcome Trust 084538 Carolyne M Ndila; National Institute of Allergy
   and Infectious Diseases Ogobara Doumba; Wellcome Trust 090532 Dominic P
   Kwiatkowski; Medical Research Council G0600718 Dominic P Kwiatkowski;
   Foundation for the National Institutes of Health 566 Dominic P
   Kwiatkowski; Wellcome Trust 098051 Dominic P Kwiatkowski; Wellcome Trust
   077383 Dominic P Kwiatkowski; Wellcome Trust 097364 Chris C.A. Spencer;
   Wellcome Trust 090770 Dominic P Kwiatkowski; Medical Research Council
   MR/M006212/1 Dominic P Kwiatkowski; The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR Allen J. de V., 1993, SWAHILI ORIGINS SWAH
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298
   Band G, 2015, NATURE, V526, P253, DOI 10.1038/nature15390
   Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509
   Barham L, 2008, 1 AFRICANS AFRICAN A, DOI [10.1017/CB09780511817830, DOI 10.1017/CB09780511817830]
   Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103
   Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3
   Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069
   Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051
   Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113
   Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116
   Blench R, 2010, GLOBAL ORIGINS DEV S
   Blench Roger, 2006, ARCHAEOLOGY LANGUAGE
   Bostoen K, 2007, J AFR HIST, V48, P173, DOI 10.1017/S002185370700254X
   Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107
   Busby GBJ, 2015, CURR BIOL, V25, P2518, DOI 10.1016/j.cub.2015.08.007
   Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258
   Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304
   Currie TE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0695
   de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318
   Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/nmeth.1785, 10.1038/NMETH.1785]
   Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208
   Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188
   Fraley C., 2012, MCLUST VERSION 4 R N
   Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319
   Gonzalez-Santos M, 2015, GENOME BIOL EVOL, V7, P2560, DOI 10.1093/gbe/evv164
   GREENBERG JH, 1972, J AFR HIST, V13, P189
   Grollemund R, 2015, P NATL ACAD SCI USA, V112, P13296, DOI 10.1073/pnas.1503793112
   Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035
   Guidemann T, 2014, CURRENT ISSUES LINGU, DOI [10.1075/cilt.330, DOI 10.1075/CILT.330]
   Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997
   Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879
   Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628
   Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16
   Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518
   Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397
   Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336
   Hodgson JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0930
   Hodgson JA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004393
   Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955
   HUDSON RR, 1992, GENETICS, V132, P583
   Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089
   Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632
   Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519
   Lavachery P, 2001, AFR ARCHAEOL REV, V18, P213, DOI DOI 10.1023/A:1013114008855
   Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453
   Leslie S, 2015, NATURE, V519, P309, DOI 10.1038/nature14230
   Li S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1448
   Li N, 2003, GENETICS, V165, P2213
   Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879
   Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330
   Macholdt E, 2015, AM J PHYS ANTHROPOL, V156, P661, DOI 10.1002/ajpa.22675
   Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337
   Marks SJ, 2015, MOL BIOL EVOL, V32, P29, DOI 10.1093/molbev/msu263
   Mitchell P., 2002, ARCHAEOLOGY SO AFRIC
   Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350
   Montinaro F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7596
   Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012
   Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331
   Nurse D, 2003, BANTU LANGUAGES ROUT
   Oliver RA, 1975, AFRICA IRON AGE C 50
   Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015
   Pakendorf B, 2011, LANG DYN CHANG, V1, P50, DOI 10.1163/221058211X570349
   Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037
   Petersen DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003309
   Patterson N, 2006, PLOS GENET, V2, DOI [10.1371/journal.pgen.0020190, DOI 10.1371/JOURNAL.PGEN.0020190]
   Pickrell JK, 2014, TRENDS GENET, V30, P377, DOI 10.1016/j.tig.2014.07.007
   Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111
   Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967
   Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140
   Pour NA, 2013, EUR J HUM GENET, V21, P423, DOI 10.1038/ejhg.2012.176
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555
   Ranciaro A, 2014, AM J HUM GENET, V94, P496, DOI 10.1016/j.ajhg.2014.02.009
   Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365
   Roberts J. M., 2007, NEW PENGUIN HIST WOR
   Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107
   Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546
   Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564
   Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721
   Smith Andrew B., 2005, AFRICAN HERDERS EMER
   Thompson L.M., 2001, HIST S AFRICA
   Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257
   Tofanelli S, 2009, MOL BIOL EVOL, V26, P2109, DOI 10.1093/molbev/msp120
   van Dorp L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005397
   VANSINA J, 1995, J AFR HIST, V36, P173
   Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229
   Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371
   Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606
NR 91
TC 4
Z9 4
U1 2
U2 6
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JUN 21
PY 2016
VL 5
AR e15266
DI 10.7554/eLife.15266
PG 44
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DQ7SK
UT WOS:000379407800001
OA gold
DA 2017-08-15
ER

PT J
AU Miyahara, R
   Jasseh, M
   Gomez, P
   Shimakawa, Y
   Greenwood, B
   Keita, K
   Ceesay, S
   D'Alessandro, U
   Roca, A
AF Miyahara, Reiko
   Jasseh, Momodou
   Gomez, Pierre
   Shimakawa, Yusuke
   Greenwood, Brian
   Keita, Karamba
   Ceesay, Samba
   D'Alessandro, Umberto
   Roca, Anna
TI Barriers to timely administration of birth dose vaccines in The Gambia,
   West Africa
SO VACCINE
LA English
DT Article
DE Vaccine; Birth dose; Hepatitis B; BCG; Polio; West Africa
ID DEMOGRAPHIC SURVEILLANCE SYSTEM; HEPATITIS-B; VACCINATION COVERAGE;
   RISK-FACTORS; CHILDHOOD IMMUNIZATION; INFANT IMMUNIZATION; CHILDREN;
   TIMELINESS; HEALTH; AGE
AB Objective: Although vaccine coverage in infants in sub-Saharan Africa is high, this is estimated at the age of 6-12 months. There is little information on the timely administration of birth dose vaccines. The objective of this study was to assess the timing of birth dose vaccines (hepatitis B, BCG and oral polio) and reasons for delayed administration in The Gambia.
   Methods: We used vaccination data from the Farafenni Health and Demographic Surveillance System (FHDSS) between 2004 and 2014. Coverage was calculated at birth (0-1 day), day 7, day 28, 6 months and 1 year of age. Logistic regression models were used to identify demographic and socio-economic variables associated with vaccination by day 7 in children born between 2011 and 2014.
   Results: Most of the 10,851 children had received the first dose of hepatitis B virus (HBV) vaccine by the age of 6 months (93.1%). Nevertheless, only 1.1% of them were vaccinated at birth, 5.4% by day 7, and 58.4% by day 28. Vaccination by day 7 was associated with living in urban areas (West rural: adjusted OR (AOR) = 6.13, 95%CI: 3.20-11.75, east rural: AOR=6.72, 95%CI: 3.66-12.33) and maternal education (senior-educations: AOR=2.43, 95%CI: 1.17-5.06); and inversely associated with distance to vaccination delivery points (>= km: AOR = 0.41, 95%Cl: 0.24-0.70), and Fula ethnicity (AOR=0.60, 95%CI: 0.40-0.91).
   Conclusion: Vaccine coverage in The Gambia is high but infants are usually vaccinated after the neonatal period. Interventions to ensure the implementation of national vaccination policies are urgently needed. (C) 2016 The Authors. Published by Elsevier Ltd.
C1 [Miyahara, Reiko; Jasseh, Momodou; Gomez, Pierre; D'Alessandro, Umberto; Roca, Anna] MRC, Banjul, Gambia.
   [Miyahara, Reiko] Nagasaki Univ, Grad Sch Biomed Sci, Inst Trop Med, Dept Clin Trop Med, Nagasaki 852, Japan.
   [Miyahara, Reiko] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.
   [Greenwood, Brian; D'Alessandro, Umberto; Roca, Anna] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Keita, Karamba; Ceesay, Samba] Minist Hlth, Banjul, Gambia.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
RP Roca, A (reprint author), Atlantic Rd,POB 273, Banjul, Gambia.
EM aroca@mrc.gm
FU MRC UK
FX The MRC Unit The Gambia core funding that supports the Farafenni HDSS
   comes from the MRC UK.
CR Africa Health Workforce Observatory, 2009, HUM RES HLTH COUNTR
   Akmatov MK, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.124651
   Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089
   Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432
   Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819
   Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2
   COLDITZ GA, 1995, PEDIATRICS, V96, P29
   de Waroux OL, 2013, INT HEALTH, V5, P139, DOI 10.1093/inthealth/iht006
   EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197
   Fadnes LT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-404
   Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093
   Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324
   Higgins J, 2014, SYSTEMATIC REV NONSP
   INSKIP HM, 1991, INT J EPIDEMIOL, V20, P764, DOI 10.1093/ije/20.3.764
   Jasseh M, 2015, INT J EPIDEMIOL, V44, P837, DOI 10.1093/ije/dyv049
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kuruvilla TA, 2009, INDIAN PEDIATR, V46, P1013
   Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332
   Lund N, 2015, CLIN INFECT DIS
   Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381
   Odutola A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1015-9
   Okwaraji YB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-476
   Payne S, 2014, HEALTH POLICY PLANN, V29, P193, DOI 10.1093/heapol/czt004
   Peto TJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-7
   Quattrochi J, 2015, TROP MED INT HEALTH, V20, P941, DOI 10.1111/tmi.12490
   Sadoh AE, 2008, PUBLIC HEALTH, V122, P1318, DOI 10.1016/j.puhe.2008.06.003
   Sadoh AE, 2014, AFR HEALTH SCI, V14, P377, DOI 10.4314/ahs.v14i2.13
   Sankoh O, 2014, INT J EPIDEMIOL, V43, P645, DOI 10.1093/ije/dyu101
   Schoeps A, 2013, VACCINE, V32, P96, DOI 10.1016/j.vaccine.2013.10.063
   Scott S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107280
   Shimakawa Y, 2013, J HEPATOL, V58, pS21
   Shimakawa Y, 2015, GUT
   Shimakawa Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-532
   Shimakawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069430
   Thysen SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1037
   World Health Organization Geneva, 2004, WKLY EPIDEMIOL REC, V79, P25
   WHO, 2016, HEP B
   World Health Organization, 2014, WHO POL STAT MULT VI
   World Health Organization, 2014, WKLY EPIDEMIOL REC, V9, P73
   World Health Organization, 2009, WKLY EPIDEMIOL REC, V28, P589
   World Health Organization, 2016, PRACT IMPR COV HEP B
   World Health Organization, 2015, WHO VACC PREV DIS MO
   [UNICEF WHO], 2015, EST NAT IMM COV
NR 43
TC 1
Z9 2
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 17
PY 2016
VL 34
IS 29
BP 3335
EP 3341
DI 10.1016/j.vaccine.2016.05.017
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DP7GU
UT WOS:000378668000002
PM 27195759
OA No
DA 2017-08-15
ER

PT J
AU Zak, DE
   Penn-Nicholson, A
   Scriba, TJ
   Thompson, E
   Suliman, S
   Amon, LM
   Mahomed, H
   Erasmus, M
   Whatney, W
   Hussey, GD
   Abrahams, D
   Kafaar, F
   Hawkridge, T
   Verver, S
   Hughes, EJ
   Ota, M
   Sutherland, J
   Howe, R
   Dockrell, HM
   Boom, WH
   Thiel, B
   Ottenhoff, THM
   Mayanja-Kizza, H
   Crampin, AC
   Downing, K
   Hatherill, M
   Valvo, J
   Shankar, S
   Parida, SK
   Kaufmann, SHE
   Walzl, G
   Aderem, A
   Hanekom, WA
AF Zak, Daniel E.
   Penn-Nicholson, Adam
   Scriba, Thomas J.
   Thompson, Ethan
   Suliman, Sara
   Amon, Lynn M.
   Mahomed, Hassan
   Erasmus, Mzwandile
   Whatney, Wendy
   Hussey, Gregory D.
   Abrahams, Deborah
   Kafaar, Fazlin
   Hawkridge, Tony
   Verver, Suzanne
   Hughes, E. Jane
   Ota, Martin
   Sutherland, Jayne
   Howe, Rawleigh
   Dockrell, Hazel M.
   Boom, W. Henry
   Thiel, Bonnie
   Ottenhoff, Tom H. M.
   Mayanja-Kizza, Harriet
   Crampin, Amelia C.
   Downing, Katrina
   Hatherill, Mark
   Valvo, Joe
   Shankar, Smitha
   Parida, Shreemanta K.
   Kaufmann, Stefan H. E.
   Walzl, Gerhard
   Aderem, Alan
   Hanekom, Willem A.
CA ACS Cohort Study Grp
   GC6-74 Cohort Study Grp
TI A blood RNA signature for tuberculosis disease risk: a prospective
   cohort study
SO LANCET
LA English
DT Article
ID GENE-EXPRESSION PROFILES; MYCOBACTERIUM-TUBERCULOSIS; CHILDHOOD
   TUBERCULOSIS; UNITED-STATES; DIAGNOSIS; AFRICA; REACTIVATION;
   BIOMARKERS; INFECTION
AB Background Identification of blood biomarkers that prospectively predict progression of Mycobacterium tuberculosis infection to tuberculosis disease might lead to interventions that combat the tuberculosis epidemic. We aimed to assess whether global gene expression measured in whole blood of healthy people allowed identification of prospective signatures of risk of active tuberculosis disease.
   Methods In this prospective cohort study, we followed up healthy, South African adolescents aged 12-18 years from the adolescent cohort study (ACS) who were infected with M tuberculosis for 2 years. We collected blood samples from study participants every 6 months and monitored the adolescents for progression to tuberculosis disease. A prospective signature of risk was derived from whole blood RNA sequencing data by comparing participants who developed active tuberculosis disease (progressors) with those who remained healthy (matched controls). After adaptation to multiplex quantitative real-time PCR (qRT-PCR), the signature was used to predict tuberculosis disease in untouched adolescent samples and in samples from independent cohorts of South African and Gambian adult progressors and controls. Participants of the independent cohorts were household contacts of adults with active pulmonary tuberculosis disease.
   Findings Between July 6, 2005, and April 23, 2007, we enrolled 6363 participants from the ACS study and 4466 from independent South African and Gambian cohorts. 46 progressors and 107 matched controls were identified in the ACS cohort. A 16 gene signature of risk was identified. The signature predicted tuberculosis progression with a sensitivity of 66.1% (95% CI 63.2-68.9) and a specificity of 80.6% (79.2-82.0) in the 12 months preceding tuberculosis diagnosis. The risk signature was validated in an untouched group of adolescents (p= 0.018 for RNA sequencing and p= 0.0095 for qRT-PCR) and in the independent South African and Gambian cohorts (p values < 0.0001 by qRT-PCR) with a sensitivity of 53.7% (42.6-64.3) and a specificity of 82.8% (76.7-86) in the 12 months preceding tuberculosis.
   Interpretation The whole blood tuberculosis risk signature prospectively identified people at risk of developing active tuberculosis, opening the possibility for targeted intervention to prevent the disease.
C1 [Zak, Daniel E.; Thompson, Ethan; Amon, Lynn M.; Valvo, Joe; Shankar, Smitha; Aderem, Alan] Ctr Infect Dis Res, Seattle, WA USA.
   [Penn-Nicholson, Adam; Scriba, Thomas J.; Suliman, Sara; Mahomed, Hassan; Erasmus, Mzwandile; Whatney, Wendy; Hussey, Gregory D.; Abrahams, Deborah; Kafaar, Fazlin; Hawkridge, Tony; Hughes, E. Jane; Downing, Katrina; Hatherill, Mark; Hanekom, Willem A.] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa.
   [Penn-Nicholson, Adam; Scriba, Thomas J.; Suliman, Sara; Mahomed, Hassan; Erasmus, Mzwandile; Whatney, Wendy; Hussey, Gregory D.; Abrahams, Deborah; Kafaar, Fazlin; Hawkridge, Tony; Hughes, E. Jane; Downing, Katrina; Hatherill, Mark; Hanekom, Willem A.] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa.
   [Verver, Suzanne] KNCV TB Fdn, The Hague, Netherlands.
   [Ota, Martin; Sutherland, Jayne] MRC Unit, Vaccines & Immun, Fajara, Gambia.
   [Howe, Rawleigh] Armauer Hansen Res Inst, Immunol Unit, Addis Ababa, Ethiopia.
   [Dockrell, Hazel M.; Crampin, Amelia C.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.
   [Boom, W. Henry; Thiel, Bonnie] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA.
   [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.
   [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Kampala, Uganda.
   [Mayanja-Kizza, Harriet] Makerere Univ, Dept Microbiol, Kampala, Uganda.
   [Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi.
   [Parida, Shreemanta K.; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.
   [Walzl, Gerhard] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa.
   [Walzl, Gerhard] Univ Stellenbosch, MRC Ctr TB Res, Div Mol Biol & Human Genet, ZA-7505 Tygerberg, South Africa.
RP Hanekom, WA (reprint author), Bill & Melinda Gates Fdn, Seattle, WA 98102 USA.
EM willem.hanekom@gatesfoundation.org
RI Joosten, Simone/E-4731-2011
OI Joloba, Moses/0000-0002-0334-9983; Walzl, Gerhard/0000-0003-2487-125X;
   van der Spuy, Gian/0000-0002-9067-5903; Sutherland,
   Jayne/0000-0002-7083-4997
FU Bill & Melinda Gates Foundation; National Institutes of Health; European
   Union; South African Medical Research Council; Aeras
FX Bill & Melinda Gates Foundation, the National Institutes of Health,
   Aeras, the European Union, and the South African Medical Research
   Council.
CR Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09
   Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630
   Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191
   Jonassen I, 2002, GENOME BIOL, V3
   Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131
   Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219
   Gray JW, 2004, CLIN BIOCHEM, V37, P450, DOI 10.1016/j.clinbiochem.2004.03.003
   Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC
   Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667
   Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230
   Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538
   Maertzdorf J., 2011, PLoS ONE, pe26938, DOI 10.1371/journal.pone.0026938
   Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51
   Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109
   Mahomed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059652
   Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694
   Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489
   Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   SADOH, 2014, NAT TUB MAN GUID
   Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246
   Shi P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-375
   Sloot R, 2015, EBIOMEDICINE, V2, P172, DOI 10.1016/j.ebiom.2014.12.001
   Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383
   Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631
   Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665
   Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257
   Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247
   Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Organization WH, 2014, GLOB TUB REP
   Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
NR 38
TC 53
Z9 53
U1 11
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 4
PY 2016
VL 387
IS 10035
BP 2312
EP 2322
DI 10.1016/S0140-6736(15)01316-1
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN3NN
UT WOS:000376969100034
PM 27017310
OA No
HC Y
HP Y
DA 2017-08-15
ER

PT J
AU Pinder, M
   Conteh, L
   Jeffries, D
   Jones, C
   Knudsen, J
   Kandeh, B
   Jawara, M
   Sicuri, E
   D'Alessandro, U
   Lindsay, SW
AF Pinder, Margaret
   Conteh, Lesong
   Jeffries, David
   Jones, Caroline
   Knudsen, Jakob
   Kandeh, Balla
   Jawara, Musa
   Sicuri, Elisa
   D'Alessandro, Umberto
   Lindsay, Steve W.
TI The RooPfs study to assess whether improved housing provides additional
   protection against clinical malaria over current best practice in The
   Gambia: study protocol for a randomized controlled study and ancillary
   studies
SO TRIALS
LA English
DT Article
DE Clinical malaria; Cost-effectiveness; Housing; Household randomized
   controlled trial; House screening; Insecticide-treated bed net;
   Long-lasting insecticidal nets; Malaria control
ID PLASMODIUM-FALCIPARUM; AFRICA; MOSQUITOS; BEDNETS; ENTRY; RISK
AB Background: In malaria-endemic areas, residents of modern houses have less malaria than those living in traditional houses. This study will determine if modern housing provides incremental protection against clinical malaria over the current best practice of long-lasting insecticidal nets (LLINs) and prompt treatment in The Gambia, determine the incremental cost-effectiveness of the interventions, and analyze the housing market in The Gambia.
   Methods/design: A two-armed, household, cluster-randomized, controlled study will be conducted to assess whether improved housing and LLINs combine to provide better protection against clinical malaria in children than LLINs alone in The Gambia. The unit of randomization will be the household, defined as a house and its occupants. A total of 800 households will be enrolled and will receive LLINs, and 400 will receive improved housing before clinical follow-up. One child aged 6 months to 13 years will be enrolled from each household and followed for clinical malaria using active case detection to estimate malaria incidence for two malaria transmission seasons. Episodes of clinical malaria will be the primary endpoint. Study children will be surveyed at the end of each transmission season to estimate the prevalence of Plasmodium falciparum infection, parasite density, and the prevalence of anemia. Exposure to malaria parasites will be assessed using light traps, followed by detection of Anopheles gambiae species and sporozoite infection. Ancillary economic and social science studies will undertake a cost-effectiveness analysis and use qualitative and participatory methods to explore the acceptability of the housing modifications and to design strategies for scaling-up housing interventions.
   Discussion: The study is the first of its kind to measure the efficacy of housing on reducing clinical malaria, assess the incremental cost-effectiveness of improved housing, and identify mechanisms for scaling up housing interventions. Trial findings will help inform policy makers on improved housing for malaria control in sub-Saharan Africa.
C1 [Pinder, Margaret; Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England.
   [Pinder, Margaret; Jeffries, David; Jawara, Musa; D'Alessandro, Umberto] Med Res Councils MRC Unit Gambia, Banjul, Gambia.
   [Conteh, Lesong; Sicuri, Elisa] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, Hlth Econ Grp, London, England.
   [Jones, Caroline] Univ Oxford, Kemri Wellcome Trust Res Programme, Ctr Trop Med & Global Hlth, Kilifi, Kenya.
   [Knudsen, Jakob] Sch Architecture, Copenhagen, Denmark.
   [Knudsen, Jakob] Sch Design, Copenhagen, Denmark.
   [Knudsen, Jakob] Sch Conservat KADK, Copenhagen, Denmark.
   [Kandeh, Balla] Natl Malaria Control Programme, Banjul, Gambia.
RP Lindsay, SW (reprint author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.
EM S.W.Lindsay@durham.ac.uk
OI Sicuri, Elisa/0000-0002-2499-2732
FU Global Health Trials - MRC-DfID-Wellcome Trust
FX This study is supported by the Global Health Trials funded by the
   MRC-DfID-Wellcome Trust. We are grateful to Sumitomo Chemicals for
   donating the nets for this trial.
CR Anderson L, 2014, 1 HAB HUM
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   BOYD MARK F., 1926, AMER JOUR TROP MED, V6, P157
   Brabin B, 1990, TROP DIS B, V87, P20
   BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173
   Byrd I, 1914, NEW ORLEANS MED SUR, V67, P1417
   Wang C, 1997, HEALTH EDUC BEHAV, V24, P369
   Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0
   Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X
   Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262
   Fenwick E, 2013, J EPIDEMIOL COMMUN H, V67, P835, DOI 10.1136/jech-2012-202124
   Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063
   Group WB, 2015, STOCKTAKING HOUSING
   Hackett LW, 1937, MALARIA EUROPE EC ST
   Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214
   Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0
   Kirby MJ, 2008, MALARIA J, V7, pe2
   LINDSAY SW, 1992, B ENTOMOL RES, V82, P49
   Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6
   Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915
   Mackenzie G, 2010, INT J INFECT DIS, V14, pE27, DOI 10.1016/j.ijid.2010.02.1548
   Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314
   Pinder M, 2015, LANCET, V385, P1436, DOI 10.1016/S0140-6736(14)61007-2
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   RBM, 2015, COMM FOLL RBM 28 BOA
   [UNDP RBM], 2013, MULT ACT FRAM MAL
   SCOTT JA, 1993, AM J TROP MED HYG, V49, P520
   SNOW RW, 1989, ANN TROP MED PARASIT, V83, P321
   Snow RW, 1998, J INFECT DIS, V177, P819
   Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1
   von Seidlein L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-200
   WHO, WHO OFFS PUBL, V66
   World Health Organization, 2015, WORLD MAL REP 2015
   WIRTZ RA, 1989, B WORLD HEALTH ORGAN, V67, P535
NR 34
TC 1
Z9 1
U1 1
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD JUN 3
PY 2016
VL 17
AR 275
DI 10.1186/s13063-016-1400-7
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN3LX
UT WOS:000376964800002
PM 27255167
OA gold
DA 2017-08-15
ER

PT J
AU Ekwochi, U
   Ndu, IK
   Osuorah, CDI
   Onah, KS
   Obuoha, E
   Odetunde, OI
   Nwokoye, I
   Obumneme-Anyim, NI
   Okeke, IB
   Amadi, OF
AF Ekwochi, Uchenna
   Ndu, Ikenna K.
   Osuorah, Chidiebere D. I.
   Onah, Kenechi S.
   Obuoha, Ejike
   Odetunde, Odutola I.
   Nwokoye, Ikenna
   Obumneme-Anyim, Nnenne I.
   Okeke, Ifeyinwa B.
   Amadi, Ogechukwu F.
TI Delays in healthcare delivery to sick neonates in Enugu South-East
   Nigeria: an analysis of causes and effects
SO JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE delays; Enugu; healthcare services; mortality; newborn
AB In most parts of the world, neonatal mortality rates have shown a slower decline when compared with under-5 mortality decline. A sick newborn can die within minutes if there is a delay in presentation, thus early diagnosis and treatment are essential for the survival of a critically ill newborn. This study investigated factors responsible for delays in healthcare services for the sick newborn and maternal socio-demographic variables that influence these delays in Enugu, South-East Nigeria.
   This was a community-based descriptive study. A total of 376 respondents were randomly selected from 4 of the 17 local government areas of Enugu State. Mothers and/or caregivers that were nursing or had nursed a child in the previous 2 years were enrolled. Self-reported data on delays encountered during healthcare for sick newborn were collected using pretested structured questionnaire. Chi-square and multivariate logistic regression were used to determine the association between causes of delays in newborn healthcare services, maternal socio-demographics and relationships with newborn mortality.
   Delays in reaching healthcare facilities accounted for the most common delays encountered by respondents, 78.0%, in this study, followed by delays at household level, 24.2% and delays at health facility level 16.0% (P = 0.000). Mothers with knowledge of a parts per thousand yen3 WHO recognized danger signs compared with those with a parts per thousand currency sign2 were significantly less likely to delay at household (level 1: 40.7 versus 59.3%) (P = 0.017) and reaching healthcare service (level 2: 19.9 versus 80.1%) (P = 0.028). Delays at health facility level (level 3) occurred more at tertiary health facilities (59.0%), secondary health facilities (39.1%) and primary healthcare facilities (19.7%) compared with private health facilities (13.5%) (P = 0.000).
   Delays in seeking healthcare at all levels especially those related to transporting the sick newborn to the hospital are a contributor to newborn mortality in Nigeria. Improving access to healthcare could potentially reduce mortality in the sick newborn.
C1 [Ekwochi, Uchenna; Ndu, Ikenna K.; Obuoha, Ejike; Okeke, Ifeyinwa B.; Amadi, Ogechukwu F.] Enugu State Univ Sci & Technol, Dept Paediat, Enugu, Enugu State, Nigeria.
   [Osuorah, Chidiebere D. I.] Med Res Council UK, Child Survival Unit, Gambia Unit, Fajara, Gambia.
   [Onah, Kenechi S.] Nnamdi Azikiwe Univ Teaching Hosp, Dept Paediat, Nnewi, Anambra State, Nigeria.
   [Odetunde, Odutola I.; Obumneme-Anyim, Nnenne I.] Univ Nigeria, Dept Paediat, Teaching Hosp, Enugu, Enugu State, Nigeria.
   [Nwokoye, Ikenna] Fed Teaching Hosp, Dept Paediat, Abakaliki, Ebonyi State, Nigeria.
RP Osuorah, CDI (reprint author), Med Res Council UK, Child Survival Unit, Gambia Unit, Fajara, Gambia.
EM chidi.osuorah@yahoo.com
CR Ekwochi U, 2014, J TROP PEDIATRICS, V60, P249, DOI 10.1093/tropej/fmt111
   Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009
   Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011
   Nigerian Population Commission, 1991, STAT LOC GOV DEM PRO
   OYEDEJI G A, 1985, Nigerian Journal of Paediatrics, V12, P111
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Uchenna E, 2015, ITAL J PEDIATR, V41, P18
   UNICEF WHO World Bank and UN Population Division, 2012, LEV TRENDS CHILD MOR
   Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x
   UNICEF WHO, 2012, CAR NEWB HOM TRAIN C
   WHO, 2005, WORLD HLTH REP 2005
NR 11
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1741-3842
EI 1741-3850
J9 J PUBLIC HEALTH-UK
JI J. Public Health
PD JUN
PY 2016
VL 38
IS 2
BP E171
EP E177
DI 10.1093/pubmed/fdv092
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DW2ZI
UT WOS:000383511000022
PM 26201350
OA No
DA 2017-08-15
ER

PT J
AU Bonwitt, J
   Kelly, A
   Ansumana, R
   Agbla, S
   Sahr, F
   Saez, A
   Borchert, M
   Kock, R
   Fichet-Calvet, E
AF Bonwitt, Jesse
   Kelly, Ann H.
   Ansumana, Rashid
   Agbla, Schadrac
   Sahr, Foday
   Saez, Almudena Mari
   Borchert, Matthias
   Kock, Richard
   Fichet-Calvet, Elisabeth
TI Rat-atouille: A Mixed Method Study to Characterize Rodent Hunting and
   Consumption in the Context of Lassa Fever
SO ECOHEALTH
LA English
DT Article
DE Lassa fever; human-rodent interaction; Mastomys natalensis; hunting;
   consumption; mixed method
ID SIERRA-LEONE; MASTOMYS-NATALENSIS; WEST-AFRICA; RISK-FACTORS; GUINEA;
   VIRUS; EPIDEMIOLOGY; PREVALENCE; DISEASES; BUSHMEAT
AB Lassa fever is a zoonotic hemorrhagic illness predominant in areas across Nigeria, Sierra Leone, Guinea, Liberia, and southern Mali. The reservoir of Lassa virus is the multimammate mouse (Mastomys natalensis), a highly commensal species in West Africa. Primary transmission to humans occurs through direct or indirect contact with rodent body fluids such as urine, feces, saliva, or blood. Our research draws together qualitative and quantitative methods to provide a fuller and more nuanced perspective on these varied points of human-animal contact. In this article, we focus on the hunting, preparation, and consumption of rodents as possible routes of exposure in Bo, Sierra Leone. We found that the consumption of rodents, including the reservoir species, is widespread and does not neatly tally against generational or gender lines. Further, we found that the reasons for rodent consumption are multifactorial, including taste preferences, food security, and opportunistic behavior. We argue that on certain topics, such as rodent consumption, establishing trust with communities, and using qualitative research methods, is key to investigate sensitive issues and situate them in their wider context. To conclude, we recommend ways to refine sensitization campaigns to account for these socio-cultural contexts.
C1 [Bonwitt, Jesse] Univ Durham, Dept Anthropol, Dawson Bldg,South Rd, Durham DH1 3LE, England.
   Univ Exeter, Dept Sociol Philosophy & Anthropol, Exeter, Devon, England.
   [Kelly, Ann H.] London Sch Hyg & Trop Med, London, England.
   [Ansumana, Rashid] Mercy Hosp Res Lab, Bo, Sierra Leone.
   [Agbla, Schadrac] MRC Unit, Fajara, Gambia.
   [Sahr, Foday] Univ Sierra Leone, Freetown, Sierra Leone.
   [Saez, Almudena Mari; Borchert, Matthias] Charite, Inst Trop Med & Int Hlth, Berlin, Germany.
   [Kock, Richard] Royal Vet Coll, Dept Pathol & Pathogen Biol, London, England.
   [Fichet-Calvet, Elisabeth] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany.
RP Bonwitt, J (reprint author), Univ Durham, Dept Anthropol, Dawson Bldg,South Rd, Durham DH1 3LE, England.
EM jesse.bonwitt@gmail.com
FU RVC [M2013 0002H]; UK ESRC [ES/M009203/]; German Research Foundation
   [DFG BO 3790/1-1, FI 1781/1-1]
FX Our thanks go to the Mercy Hospital Research Laboratory staff who were
   essential for the success of the project, as well to all the informants
   cited that gave their time for discussions. Our thanks also go to Clare
   Chandler (LSHTM) for her help in drafting the protocol. The research for
   this paper was conducted as part of the requirements for the degree of
   Master of Science in One Health (Infectious Diseases) at the London
   School of Hygiene and Tropical Medicine and the Royal Veterinary College
   (RVC) with funding from the RVC (Ethics No: M2013 0002H), the UK ESRC
   (ES/M009203/), and the German Research Foundation (DFG BO 3790/1-1 and
   FI 1781/1-1).
CR Akoua-Koffi C, 2006, Med Trop (Mars), V66, P465
   Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839
   Bausch DG, 2001, VECTOR-BORNE ZOONOT, V1, P269, DOI 10.1089/15303660160025903
   Bonner PC, 2007, AM J TROP MED HYG, V77, P169
   CIA, 2014, WORLD FACTB AFR SIER
   Davies G, 2007, CONSERV SCI PRACT, P15
   Dufour S, 2013, ETUDE CHASSE FILIERE
   Duplantier JM, 1992, MAMMALIA, DOI [10.1515/mamm-1990-0201, DOI 10.1515/MAMM-1990-0201]
   Fa JE, 2006, BIOL CONSERV, V129, P497, DOI 10.1016/j.biocon.2005.11.031
   Fairhead J., 1996, MISREADING AFRICAN L
   Fichet-Calvet E, 2007, VECTOR-BORNE ZOONOT, V7, P119, DOI 10.1089/vbz.2006.0520
   Fichet-Calvet E, 2014, ROLE OF ANIMALS IN EMERGING VIRAL DISEASES, P89, DOI 10.1016/B978-0-12-405191-1.00005-3
   Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388
   Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112
   Hewlett Barry, 2008, EBOLA CULTURE POLITI
   Inapogui A. P., 2007, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P47
   Kerneis S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000548
   Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003
   Kock R, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.739
   Lecompte E, 2006, EMERG INFECT DIS, V12, P1971
   LUKASHEVICH IS, 1993, J MED VIROL, V40, P210, DOI 10.1002/jmv.1890400308
   Mari-Saez A, 2014, EMBO MOL MED, DOI 10.15252/emmm.201404792
   McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75
   MCCORMICK JB, 1987, J INFECT DIS, V155, P445
   Merlin, 2002, LICK LASS FEV STRAT
   Merlin, 2002, LASS FEV KAP SURV RE
   MONATH TP, 1974, AM J TROP MED HYG, V23, P1140
   MONATH TP, 1974, SCIENCE, V185, P263, DOI 10.1126/science.185.4147.263
   MONATH TP, 1975, B WORLD HEALTH ORGAN, V52, P577
   Oxfam, 2012, COND SEM INT
   Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271
   Senior K, 2009, LANCET INFECT DIS, V9, P532
   Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748
   SSL, 2004, POP PROF SIERR LEON, V4
   Subramanian M, 2012, ECOHEALTH, V9, P471, DOI 10.1007/s10393-012-0807-1
   Taylor PJ, 2008, INTEGR ZOOL, V3, P38, DOI 10.1111/j.1749-4877.2008.00072.x
   terMeulen J, 1996, AM J TROP MED HYG, V55, P661
   WALKER DH, 1975, B WORLD HEALTH ORGAN, V52, P523
   WHO, 2008, WHOIVB0807 MLM EXP P
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   World Bank, 2014, WORLD DEV IND SIERR
NR 41
TC 4
Z9 4
U1 7
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD JUN
PY 2016
VL 13
IS 2
BP 234
EP 247
DI 10.1007/s10393-016-1098-8
PG 14
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA DU3VM
UT WOS:000382140300003
PM 26895631
OA No
DA 2017-08-15
ER

PT J
AU Howell, J
   Ladep, NG
   Nayagam, S
   Lemoine, M
   Garside, DA
   Crossey, MME
   Okeke, E
   Njie, R
   Ka, MM
   Taal, M
   Thursz, MR
   Taylor-Robinson, SD
AF Howell, J.
   Ladep, N. G.
   Nayagam, S.
   Lemoine, M.
   Garside, D. A.
   Crossey, M. M. E.
   Okeke, E.
   Njie, R.
   Ka, M. M.
   Taal, M.
   Thursz, M. R.
   Taylor-Robinson, S. D.
TI PROLIFICA: a story of West African clinical and research collaborations
   to target hepatitis B-related hepatocellular carcinoma in West Africa
SO QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID CANCER; VACCINATION; INFECTION; GAMBIA
C1 [Howell, J.; Ladep, N. G.; Nayagam, S.; Lemoine, M.; Garside, D. A.; Crossey, M. M. E.; Thursz, M. R.; Taylor-Robinson, S. D.] Imperial Coll London, Dept Med, St Marys Campus,South Wharf Rd, London W2 1NY, England.
   [Ladep, N. G.; Okeke, E.] Univ Jos, Dept Med, Teaching Hosp, Jos, Plateau State, Nigeria.
   [Nayagam, S.; Lemoine, M.; Njie, R.] MRC, Gambia Unit, Dept Viral Hepatitis, Atlantic Blvd, Fajara, Gambia.
   [Nayagam, S.; Ka, M. M.] Ctr Hosp Reg Thies, Dept Med, Thies, Senegal.
   [Nayagam, S.; Ka, M. M.] UFR Sci Sante Thies, Thies, Senegal.
   [Lemoine, M.; Taal, M.] Royal Victoria Teaching Hosp, Dept Med, Independence Dr, Banjul, Gambia.
RP Howell, J (reprint author), Imperial Coll London, Dept Med, St Marys Campus,South Wharf Rd, London W2 1NY, England.
EM j.howell@imperial.ac.uk
FU Medical Research Council [MR/L002086/1]
CR [Anonymous], 2012, J HEPATOL, V57, P167, DOI DOI 10.1016/J.JHEP.2012.02.010
   Ekra D, 2008, VACCINE, V26, P2753, DOI 10.1016/j.vaccine.2008.03.018
   [Anonymous], 2004, WKLY EPIDEMIOL REC, V79, P255
   Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410
   Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027
   Ladep NG, 2007, CLIN MED, V7, P439
   MacIntyre CR, 2001, J PAEDIATR CHILD H, V37, P215, DOI 10.1046/j.1440-1754.2001.00639.x
   Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029
   Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74
   Shariff MIF, 2010, J PROTEOME RES, V9, P1096, DOI 10.1021/pr901058t
   WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4
   WHITTLE HC, 1983, LANCET, V1, P1203
NR 13
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1460-2725
EI 1460-2393
J9 QJM-INT J MED
JI QJM-An Int. J. Med.
PD JUN
PY 2016
VL 109
IS 6
BP 373
EP 375
DI 10.1093/qjmed/hcv118
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR3UK
UT WOS:000379827900003
PM 26106184
OA No
DA 2017-08-15
ER

PT J
AU Roca, A
   Oluwalana, C
   Bojang, A
   Camara, B
   Kampmann, B
   Bailey, R
   Demba, A
   Bottomley, C
   D'Alessandro, U
AF Roca, A.
   Oluwalana, C.
   Bojang, A.
   Camara, B.
   Kampmann, B.
   Bailey, R.
   Demba, A.
   Bottomley, C.
   D'Alessandro, U.
TI Oral azithromycin given during labour decreases bacterial carriage in
   the mothers and their offspring: a double-blind randomized trial
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Azithromycin; bacterial carriage; neonatal sepsis; randomized clinical
   trial; sub-Saharan Africa
ID STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-PROPHYLAXIS; PREVENTION; TRACHOMA;
   RESISTANCE; CHILDREN; INFANTS; SEPSIS; GAMBIA
AB Bacterial sepsis remains a leading cause of death among neonates with Staphylococcus aureus, group B streptococcus (GBS) and Streptococcus pneumoniae identified as the most common causative pathogens in Africa. Asymptomatic bacterial colonization is an intermediate step towards sepsis. We conducted a phase III, double-blind, placebo-controlled randomized trial to determine the impact of giving one oral dose of azithromycin to Gambian women in labour on the nasopharyngeal carriage of S. aureus, GBS or S. pneumoniae in the newborn at day 6 postpartum. Study participants were recruited in a health facility in western Gambia. They were followed for 8 weeks and samples were collected during the first 4 weeks. Between April 2013 and April 2014 we recruited 829 women who delivered 843 babies, including 13 stillbirths. Sixteen babies died during the follow-up period. No maternal deaths were observed. No serious adverse events related to the intervention were reported. According to the intent-to-treat analysis, prevalence of nasopharyngeal carriage of the bacteria of interest in the newborns at day 6 was lower in the intervention arm (28.3% versus 65.1% prevalence ratio 0.43; 95% CI 0.36-0.52, p <0.001). At the same time-point, prevalence of any bacteria in the mother was also lower in the azithromycin group (nasopharynx, 9.3% versus 40.0%, p <0.001; breast milk, 7.9% versus 21.6%, p <0.001; and the vaginal tract, 13.2% versus 24.2%, p <0.001). Differences between arms lasted for at least 4 weeks. Oral azithromycin given to women in labour decreased the carriage of bacteria of interest in mothers and newborns and may lower the risk of neonatal sepsis. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Roca, A.; Oluwalana, C.; Bojang, A.; Camara, B.; Kampmann, B.; D'Alessandro, U.] Med Res Council Unit Gambia, Atlantic Rd,POB 273, Banjul, Gambia.
   [Roca, A.; Bailey, R.; Bottomley, C.; D'Alessandro, U.] London Sch Hyg & Trop Med, London, England.
   [Demba, A.] Minist Hlth & Social Welf, Banjul, Gambia.
   [D'Alessandro, U.] Inst Trop Med, Antwerp, Belgium.
RP Roca, A (reprint author), Med Res Council Unit Gambia, Atlantic Rd,POB 273, Banjul, Gambia.
EM aroca@mrc.gm
FU MRC UK; UK MRC; UK Department for International Development (DFID) under
   the MRC/DFID Concordat agreement [MR/J010391/1]; European Union
FX The MRC Unit in The Gambia receives core funding from the MRC UK. This
   trial was jointly funded by the UK MRC and the UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement
   (reference number MR/J010391/1) and is also part of the EDCTP2 programme
   supported by the European Union.
CR Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319
   Bottomley C, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-014-0022-3
   Burr SE, 2014, B WORLD HEALTH ORGAN, V92, P490, DOI 10.2471/BLT.13.133462
   Chatzakis E, 2011, EUR J CLIN MICROBIOL, V30, P1111, DOI 10.1007/s10096-011-1199-9
   Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8
   Di Renzo GC, 2015, J MATERN-FETAL NEO M, V28, P766, DOI 10.3109/14767058.2014.934804
   DREW RH, 1992, PHARMACOTHERAPY, V12, P161
   Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414
   Halsey NA, 1997, PEDIATRICS, V99, P489
   Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Leach AJ, 1997, CLIN INFECT DIS, V24, P356
   Nosten Francois, 2006, Curr Drug Saf, V1, P1, DOI 10.2174/157488606775252584
   Orton LC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004912.pub3
   Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266
   Roca A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0737-3
   Rudan Igor, 2011, J Glob Health, V1, P106
   Salman S, 2015, ANTIMICROB AGENTS CH
   Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056
   Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0
   Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d
   SUARA RO, 1994, J INFECT DIS, V170, P1316
   Unger HW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0258-3
   Unger HW, 2015, J CLIN MICROBIOL
   van den Broek NR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000191
   Waters Donald, 2011, J Glob Health, V1, P154
   Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769
NR 27
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2016
VL 22
IS 6
DI 10.1016/j.cmi.2016.03.005
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DQ5NM
UT WOS:000379252100022
OA No
DA 2017-08-15
ER

PT J
AU Adetifa, IMO
   Kendall, L
   Bashorun, A
   Linda, C
   Omoleke, S
   Jeffries, D
   Maane, R
   Dei Alorse, B
   Dei Alorse, W
   Okoi, CB
   Mlaga, KD
   Kinteh, MA
   Donkor, S
   de Jong, BC
   Antonio, M
   d'Alessandro, U
AF Adetifa, Ifedayo M. O.
   Kendall, Lindsay
   Bashorun, Adedapo
   Linda, Christopher
   Omoleke, Semeeh
   Jeffries, David
   Maane, Rahmatulai
   Dei Alorse, Beatrice
   Dei Alorse, William
   Okoi, Catherine Bi
   Mlaga, Kodjovi D.
   Kinteh, Ma Ansu
   Donkor, Simon
   de Jong, Bouke C.
   Antonio, Martin
   d'Alessandro, Umberto
TI A tuberculosis nationwide prevalence survey in Gambia, 2012
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID PROSPECTS
AB Objective To estimate the population prevalence of active pulmonary tuberculosis in Gambia.
   Methods Between December 2011 and January 2013, people aged 15 years participating in a nationwide, multistage cluster survey were screened for active pulmonary tuberculosis with chest radiography and for tuberculosis symptoms. For diagnostic confirmation, sputum samples were collected from those whose screening were positive and subjected to fluorescence microscopy and liquid tuberculosis cultures. Multiple imputation and inverse probability weighting were used to estimate tuberculosis prevalence.
   Findings Of 100678 people enumerated, 55832 were eligible to participate and 43100 (77.2%) of those participated. A majority of participants (42 942 99.6%) were successfully screened for symptoms and by chest X-ray. Only 5948 (13.8%) were eligible for sputum examination, yielding 43 bacteriologically confirmed, 28 definite smear-positive and six probable smear-positive tuberculosis cases. Chest X-ray identified more tuberculosis cases (58/69) than did symptoms alone (43/71). The estimated prevalence of smear-positive and bacteriologically confirmed pulmonary tuberculosis were 90 (95% confidence interval, CI: 53-127) and 212 (95% CI: 152-272) per 100 000 population, respectively. Tuberculosis prevalence was higher in males (333; 95% CI: 233-433) and in the 35-54 year age group (355; 95% CI: 219-490).
   Conclusion The burden of tuberculosis remains high in Gambia but lower than earlier estimates of 490 per 100 000 population in 2010. Less than half of all cases would have been identified based on smear microscopy results alone. Successful control efforts will require interventions targeting men, increased access to radiography and more accurate, rapid diagnostic tests.
C1 [Adetifa, Ifedayo M. O.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
   [Kendall, Lindsay; Bashorun, Adedapo; Linda, Christopher; Omoleke, Semeeh; Jeffries, David; Kinteh, Ma Ansu; Donkor, Simon; d'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat Theme, Banjul, Gambia.
   [Maane, Rahmatulai; Dei Alorse, Beatrice] MRC Unit, Clin Serv Dept, Banjul, Gambia.
   [Dei Alorse, William; Okoi, Catherine Bi; Mlaga, Kodjovi D.; Antonio, Martin] MRC Unit, Vaccinol Theme, Banjul, Gambia.
   [de Jong, Bouke C.] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
RP Adetifa, IMO (reprint author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
FU Medical Research Council [MC_UP_A900_1119, MC_U190081991,
   MC_UP_A900_1122]
CR [Anonymous], 2014, REP 1 NAT TUB PREV S
   Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10
   [Anonymous], 2007, GAMB ATL 2003 POP HO
   Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510
   Kapata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146392
   Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417
   Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797
   Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721
   Ottmani S, 2005, WHOHTMTUBERCULOSIS20
   Sterne JAC, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Stiles T, 2011, GOOD CLIN LAB PRACTI
   Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, 2011, TUB PREV SURV HDB
   [Anonymous], 2012, GAMB TUB PROF
   World Health Organization, 2015, GLOB TUB REP 2015
   World Health Organization, 2015, GLOB STRAT TARG TUB
   [Anonymous], 2008, WHOHTMTUBERCULOSIS20
   [Anonymous], 2010, GLOB PLAN STOP TUB 2
   [Anonymous], 2010, TUB PREV SURV HDB, P324
   World Health Organization, 2010, GLOB TUB CONTR 2010
NR 21
TC 1
Z9 1
U1 0
U2 1
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JUN
PY 2016
VL 94
IS 6
BP 433
EP 441
DI 10.2471/BLT.14.151670
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DO9HT
UT WOS:000378096800013
PM 27274595
OA No
DA 2017-08-15
ER

PT J
AU Mackenzie, GA
   Hill, PC
   Jeffries, DJ
   Hossain, I
   Uchendu, U
   Ameh, D
   Ndiaye, M
   Adeyemi, O
   Pathirana, J
   Olatunji, Y
   Abatan, B
   Muhammad, BS
   Fombah, AE
   Saha, D
   Plumb, I
   Akano, A
   Ebruke, B
   Ideh, RC
   Kuti, B
   Githua, P
   Olutunde, E
   Ofordile, O
   Green, E
   Usuf, E
   Badji, H
   Ikumapayi, UNA
   Manjang, A
   Salaudeen, R
   Nsekpong, ED
   Jarju, S
   Antonio, M
   Sambou, S
   Ceesay, L
   Lowe-Jallow, Y
   Jasseh, M
   Mulholland, K
   Knoll, M
   Levine, OS
   Howie, SR
   Adegbola, RA
   Greenwood, BM
   Corrah, T
AF Mackenzie, Grant A.
   Hill, Philip C.
   Jeffries, David J.
   Hossain, Ilias
   Uchendu, Uchendu
   Ameh, David
   Ndiaye, Malick
   Adeyemi, Oyedeji
   Pathirana, Jayani
   Olatunji, Yekini
   Abatan, Bade
   Muhammad, Bilquees S.
   Fombah, Augustin E.
   Saha, Debasish
   Plumb, Ian
   Akano, Aliu
   Ebruke, Bernard
   Ideh, Readon C.
   Kuti, Bankole
   Githua, Peter
   Olutunde, Emmanuel
   Ofordile, Ogochukwu
   Green, Edward
   Usuf, Effua
   Badji, Henry
   Ikumapayi, Usman N. A.
   Manjang, Ahmad
   Salaudeen, Rasheed
   Nsekpong, E. David
   Jarju, Sheikh
   Antonio, Martin
   Sambou, Sana
   Ceesay, Lamin
   Lowe-Jallow, Yamundow
   Jasseh, Momodou
   Mulholland, Kim
   Knoll, Maria
   Levine, Orin S.
   Howie, Stephen R.
   Adegbola, Richard A.
   Greenwood, Brian M.
   Corrah, Tumani
TI Effect of the introduction of pneumococcal conjugate vaccination on
   invasive pneumococcal disease in The Gambia: a population-based
   surveillance study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID OBSERVATIONAL COHORT; CHILDREN; PNEUMONIA; ENGLAND; AFRICA; IMPACT;
   WALES
AB Background Little information is available about the effect of pneumococcal conjugate vaccines (PCVs) in low-income countries. We measured the effect of these vaccines on invasive pneumococcal disease in The Gambia where the 7-valent vaccine (PCV7) was introduced in August, 2009, followed by the 13-valent vaccine (PCV13) in May, 2011.
   Methods We conducted population-based surveillance for invasive pneumococcal disease in individuals aged 2 months and older who were residents of the Basse Health and Demographic Surveillance System (BHDSS) in the Upper River Region, The Gambia, using standardised criteria to identify and investigate patients. Surveillance was done between May, 2008, and December, 2014. We compared the incidence of invasive pneumococcal disease between baseline (May 12, 2008 May 11, 2010) and after the introduction of PCV13 (Jan 1, 2013 Dec 31, 2014), adjusting for changes in case ascertainment over time.
   Findings We investigated 14650 patients, in whom we identified 320 cases of invasive pneumococcal disease. Compared with baseline, after the introduction of the PCV programme, the incidence of invasive pneumococcal disease decreased by 55% (95% CI 30-71) in the 2-23 months age group, from 253 to 113 per 100 000 population. This decrease was due to an 82% (95% CI 64-91) reduction in serotypes covered by the PCV13 vaccine. In the 2-4 years age group, the incidence of invasive pneumococcal disease decreased by 56% (95% CI 25-75), from 113 to 49 cases per 100 000, with a 68% (95% CI 39-83) reduction in PCV13 serotypes. The incidence of non-PCV13 serotypes in children aged 2-59 months increased by 47% (-21 to 275) from 28 to 41 per 100 000, with a broad range of serotypes. The incidence of non-pneumococcal bacteraemia varied little over time.
   Interpretation The Gambian PCV programme reduced the incidence of invasive pneumococcal disease in children aged 2-59 months by around 55%. Further surveillance is needed to ascertain the maximum effect of the vaccine in the 2-4 years and older age groups, and to monitor serotype replacement. Low-income and middle-income countries that introduce PCV13 can expect substantial reductions in invasive pneumococcal disease.
C1 [Mackenzie, Grant A.; Jeffries, David J.; Hossain, Ilias; Uchendu, Uchendu; Ameh, David; Ndiaye, Malick; Adeyemi, Oyedeji; Pathirana, Jayani; Olatunji, Yekini; Abatan, Bade; Muhammad, Bilquees S.; Fombah, Augustin E.; Saha, Debasish; Plumb, Ian; Ebruke, Bernard; Ideh, Readon C.; Kuti, Bankole; Githua, Peter; Olutunde, Emmanuel; Ofordile, Ogochukwu; Green, Edward; Usuf, Effua; Badji, Henry; Ikumapayi, Usman N. A.; Manjang, Ahmad; Salaudeen, Rasheed; Nsekpong, E. David; Jarju, Sheikh; Antonio, Martin; Jasseh, Momodou; Howie, Stephen R.; Corrah, Tumani] MRC, Gambia Unit, Atlantic Rd, Fajara, Gambia.
   [Mackenzie, Grant A.; Mulholland, Kim] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Mackenzie, Grant A.; Antonio, Martin; Mulholland, Kim; Greenwood, Brian M.] London Sch Hyg & Trop Med, London WC1, England.
   [Hill, Philip C.; Howie, Stephen R.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Akano, Aliu] Natl Hosp, Cent Area, Garki, Abuja, Nigeria.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
   [Sambou, Sana; Lowe-Jallow, Yamundow] Gambia Govt, Minist Hlth & Social Welf, Kotu, Gambia.
   [Knoll, Maria; Levine, Orin S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Howie, Stephen R.] Univ Auckland, Dept Paediat Child andYouth Hlth, Auckland 1, New Zealand.
   [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium.
RP Mackenzie, GA (reprint author), MRC Gambia Unit, Basse Field Stn, POB 273, Banjul, Gambia.
EM gmackenzie@mrc.gm
OI OLATUNJI, YEKINI/0000-0002-2347-5952
FU GAVI's Pneumococcal vaccines Accelerated Development and Introduction
   Plan (PneumoADIP); Bill & Melinda Gates Foundation; UK Medical Research
   Council
FX GAVI's Pneumococcal vaccines Accelerated Development and Introduction
   Plan (PneumoADIP), Bill & Melinda Gates Foundation, and the UK Medical
   Research Council.
CR ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008
   Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   de Kluyver R, 2014, COMMUN DIS INTELL, V38, pE266
   Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517
   Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4
   Harboe ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051460
   Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524
   Jokinen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120290
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1
   [Anonymous], 2015, 2014 NAT HIV SENT SU
   Moore CE, 2014, J INFECT DIS, V210, P1001, DOI 10.1093/infdis/jiu213
   Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3
   ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010
   Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593
   Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12
   Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032
   von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914
   Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7
   Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823
   World Health Organization, 2008, EST HIB PNEUM DEATHS
NR 22
TC 9
Z9 9
U1 3
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 703
EP 711
DI 10.1016/S1473-3099(16)00054-2
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500049
PM 26897105
OA No
DA 2017-08-15
ER

PT J
AU Foster-Nyarko, E
   Kwambana, B
   Aderonke, O
   Ceesay, F
   Jarju, S
   Bojang, A
   McLellan, J
   Jafali, J
   Kampmann, B
   Ota, MO
   Adetifa, I
   Antonio, M
AF Foster-Nyarko, Ebenezer
   Kwambana, Brenda
   Aderonke, Odutola
   Ceesay, Fatima
   Jarju, Sheikh
   Bojang, Abdoulie
   McLellan, Jessica
   Jafali, James
   Kampmann, Beate
   Ota, Martin O.
   Adetifa, Ifedayo
   Antonio, Martin
TI Associations between nasopharyngeal carriage of Group B Streptococcus
   and other respiratory pathogens during early infancy
SO BMC MICROBIOLOGY
LA English
DT Article
DE Nasopharyngeal; Group B streptococcus; Beta-haemolytic streptococci;
   Gambia
ID PNEUMOCOCCAL CONJUGATE VACCINE; MOLECULAR EPIDEMIOLOGY; NEONATAL
   INFECTIONS; HEALTHY-CHILDREN; PREGNANT-WOMEN; AGALACTIAE; RESISTANCE;
   COLONIZATION; MENINGITIS; DISEASE
AB Background: In West Africa, the carriage of Group B Streptococcus (GBS), among infants is poorly characterised. We investigated co-carriage of GBS with other respiratory pathogens in the infants' nasopharynx in The Gambia.
   Methods: We assessed the carriage, serotypes and antibiotic susceptibility of Beta-haemolytic Streptococci (BHS) groups A-G; along with the carriage of Streptococcus pneumoniae; Haemophilus influenzae; Staphylococcus aureus and Moraxella catarrhalis in 1200 two-month old infants.
   Results: The BHS prevalence was 20.0 % and GBS dominated (13.8 %), particularly serotypes V and II; serotype V being negatively associated with H. Influenzae carriage (OR 0.41 [95 % CI: 0.18-0.93], p = 0.033). Although co-colonization of GBS and other BHS was not seen, colonization with GBS was positively associated with S. aureus (OR 1.89 [95 % CI: 1.33-2.69], P < 0.001) and negatively associated with S. pneumoniae (OR 0.47 [95 % CI: 0.33-0.67], p < 0.001) and M. catarrhalis (OR 0.61 [95 % CI: 0.40-0.92], p = 0.017). >= 89 % of GBS isolates were susceptible to most antibiotics tested, except for tetracycline resistance, which was 89 %.
   Conclusion: This study provides baseline data on the carriage of GBS in two month old infants from West Africa. The dominant serotypes of GBS in this setting are serotypes V and II. This may be important for future GBS vaccine development for the West African sub-region.
C1 [Foster-Nyarko, Ebenezer; Kwambana, Brenda; Aderonke, Odutola; Ceesay, Fatima; Jarju, Sheikh; Bojang, Abdoulie; McLellan, Jessica; Jafali, James; Kampmann, Beate; Ota, Martin O.; Antonio, Martin] MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
   [Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Ota, Martin O.] WHO, Reg Off Afr, Brazzaville, Rep of Congo.
   [Adetifa, Ifedayo] MRC Unit, Disease Control & Eliminat Theme, Banjul, Gambia.
   [Adetifa, Ifedayo] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London WC1, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
RP Antonio, M (reprint author), MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.; Antonio, M (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.; Antonio, M (reprint author), Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
EM mantonio@mrc.gm
FU Medical Research Council Unit, The Gambia
FX Funding was provided by the Medical Research Council Unit, The Gambia.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81
   Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198
   Beigverdi R, 2014, ACTA MICROBIOL IMM H, V61, P425, DOI 10.1556/AMicr.61.2014.4.4
   Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275
   Berkovitch M, 2002, INT J PEDIATR OTORHI, V63, P19, DOI 10.1016/S0165-5876(01)00635-8
   Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Brigtsen AK, 2015, J MICROBIOL METH, V108, P31, DOI 10.1016/j.mimet.2014.11.001
   Brzychczy-Wloch M, 2014, MED PRIN PRACT, V23, P323, DOI 10.1159/000362368
   Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09
   Chauhan D, 2015, ANN INDIAN ACAD NEUR, V18, P71, DOI 10.4103/0972-2327.151049
   CLSI, 2011, M100S21 CLSI
   Collins DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082280
   Liebana-Martos MD, 2015, ENFERM INFEC MICR CL, V33, P84, DOI 10.1016/j.eimc.2014.02.023
   Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006
   Florindo C, 2011, J MED MICROBIOL, V60, P1276, DOI 10.1099/jmm.0.031674-0
   Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506
   Garland SM, 2011, J MED MICROBIOL, V60, P230, DOI 10.1099/jmm.0.022616-0
   Heath PT, 2005, EXPERT REV VACCINES, V4, P207, DOI 10.1586/14760584.4.2.207
   Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443
   Ikebe T, 2015, EPIDEMIOL INFECT, V143, P864, DOI 10.1017/S0950268814001265
   Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010
   Juncosa-Morros T, 2014, ENFERM INFEC MICR CL, V32, P574, DOI 10.1016/j.eimc.2013.09.012
   Ku LC, 2015, CLIN PERINATOL, V42, P29, DOI 10.1016/j.clp.2014.10.004
   Kuroda J, 2015, PEDIATR INT, V24, P12563
   Lancefield RC, 1933, J EXP MED, V57, P571, DOI 10.1084/jem.57.4.571
   Lee WT, 2015, J MICROBIOL IMMUNOL, V48, P510, DOI 10.1016/j.jmii.2014.03.002
   Lin HC, 2014, J MICROBIOL IMMUNOL, V11
   Milledge J, 2005, ANN TROP PAEDIATR, V25, P101, DOI 10.1179/146532805X45692
   Murphy TF, 2009, PEDIATR INFECT DIS J, V28, pS121, DOI 10.1097/INF.0b013e3181b6d7ec
   Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558
   Palmeiro JK, 2010, J CLIN MICROBIOL, V48, P4397, DOI 10.1128/JCM.00419-10
   Principi N, 1999, PEDIATR INFECT DIS J, V18, P517, DOI 10.1097/00006454-199906000-00008
   Shabayek S, 2014, J MED MICROBIOL, V63, P1324, DOI 10.1099/jmm.0.077057-0
   Spijkerman J, 2012, PLOS ONE, V7, P25
   SUARA RO, 1994, J INFECT DIS, V170, P1316
   [Anonymous], 2011, LAB METH DIAGN MEN C
   Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X
   Zhu Minli, 2015, Zhonghua Er Ke Za Zhi, V53, P51
NR 39
TC 0
Z9 0
U1 2
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD MAY 27
PY 2016
VL 16
AR 97
DI 10.1186/s12866-016-0714-7
PG 9
WC Microbiology
SC Microbiology
GA DN7NP
UT WOS:000377263700001
PM 27230066
OA gold
DA 2017-08-15
ER

PT J
AU Jones, KS
   Assar, S
   Prentice, A
   Schoenmakers, I
AF Jones, Kerry S.
   Assar, Shima
   Prentice, Ann
   Schoenmakers, Inez
TI Vitamin D expenditure is not altered in pregnancy and lactation despite
   changes in vitamin D metabolite concentrations
SO SCIENTIFIC REPORTS
LA English
DT Article
ID D-BINDING PROTEIN; GAMBIAN WOMEN; D DEFICIENCY; 25-HYDROXYVITAMIN D;
   CLINICAL POPULATIONS; CALCIUM; 1,25-DIHYDROXYVITAMIN-D; SUPPLEMENTATION;
   PLASMA; SERUM
AB Pregnancy and lactation are associated with changes in vitamin D and calcium metabolism but the impact of these changes on vitamin D expenditure is unknown. We measured plasma 25(OH)D-3 half-life with a stable-isotope tracer and investigated relationships with vitamin D metabolites in pregnant, lactating and 'non-pregnant, non-lactating' (NPNL) women. Vitamin D metabolites, vitamin D binding protein (DBP), PTH and 25(OH)D-3 half-life were measured in third-trimester pregnant women (n22) and repeated during lactation 12 weeks post-partum (n14) and twice in NPNL women (n23 and n10, respectively) in rural Gambia where calcium intakes are low with little seasonality in UVB-exposure. 25(OH)D-3 half-life was not significantly different between groups (mean(SD): 20.6(6.8), 22.6(7.7), 18.0(4.7) and 17.7(9.5) days in pregnant, lactating and NPNL women, respectively). Plasma 25(OH) D3, 1,25(OH)(2)D, and DBP were higher in pregnancy, and calculated free-25(OH)D-3 and PTH were lower (P < 0.05). In lactation, 25(OH)D-3 and 24,25(OH)(2)D-3 were lower compared to pregnant (P < 0.001, P = 0.02) and NPNL women (P = 0.04, P = 0.07). Significant associations were observed between half-life and 25(OH)D-3 (+ ve) in pregnancy, and in all groups between 25(OH)D-3 and free-25(OH)D-3 (+ ve) and PTH and 25(OH)D-3 (-ve) (P < 0.0001). These data suggest that adaptive changes in pregnancy and lactation occur that prevent pronounced changes in vitamin D expenditure.
C1 [Jones, Kerry S.; Assar, Shima; Prentice, Ann; Schoenmakers, Inez] MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.
   [Jones, Kerry S.; Prentice, Ann] MRC Keneba, MRC Unit, Banjul, Gambia.
RP Jones, KS (reprint author), MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.; Jones, KS (reprint author), MRC Keneba, MRC Unit, Banjul, Gambia.
EM kerry.jones@mrc-hnr.cam.ac.uk
FU Medical Research Council (MRC) [U105960371, U123261351, MCA760-5QX00];
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement [U105960371, U123261351, MCA760-5QX00]
FX We thank the participants and MRC staff in Keneba, in particular field
   and laboratory staff and midwives. We also thank Dr Sophie Moore (MRC
   HNR) as PI of the ENID trial and Ann Laidlaw, Janet Bennett and Shailja
   Nigdikar at MRC HNR who performed the biochemical analysis and Dr Gail
   Goldberg for advice on interpretation of dietary intake data. This
   research was jointly funded by the Medical Research Council (MRC)
   (programme codes U105960371, U123261351, MCA760-5QX00) and the
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement.
CR BIKLE DD, 1984, J CLIN INVEST, V74, P1966, DOI 10.1172/JCI111617
   Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807
   BROADUS AE, 1977, J CLIN INVEST, V60, P771, DOI 10.1172/JCI108831
   Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012
   CLEMENTS MR, 1992, CLIN ENDOCRINOL, V37, P17, DOI 10.1111/j.1365-2265.1992.tb02278.x
   CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038/325062a0
   CLEMENTS MR, 1988, J CLIN INVEST, V81, P1768, DOI 10.1172/JCI113518
   CROSS NA, 1995, AM J CLIN NUTR, V61, P514
   Davies M, 1997, J CLIN ENDOCR METAB, V82, P209, DOI 10.1210/jc.82.1.209
   Dawes M, 2001, BEST PRACT RES CL OB, V15, P819, DOI 10.1053/beog.2001.0231
   FAO/WHO/UNU, 2001, HUM EN REQ
   Fitt E, 2015, PUBLIC HEALTH NUTR, V18, P234, DOI 10.1017/S1368980014000342
   Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450
   Harvey NC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-13
   Hennig BJ, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv206
   Holt E, 2011, VITAMIN D, P725
   Horwitz MJ, 2005, J BONE MINER RES, V20, P1792, DOI 10.1359/JBMR.050602
   Institute of Medicine, 2011, DIETARY REFERENCE IN
   Jarjou LM, 2006, AM J CLIN NUTR, V83, P657
   Johnson W., 2016, MATERN CHILD HLTH
   Jones KS, 2015, OSTEOPOROSIS INT, V26, P1137, DOI 10.1007/s00198-014-2905-0
   Jones KS, 2014, J CLIN ENDOCR METAB, V99, P3373, DOI 10.1210/jc.2014-1714
   Jones KS, 2012, BRIT J NUTR, V107, P1128, DOI 10.1017/S0007114511004132
   KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950
   KENT GN, 1990, J BONE MINER RES, V5, P361
   Kirby BJ, 2013, J BONE MINER RES, V28, P1987, DOI 10.1002/jbmr.1925
   Kovacs CS, 2013, SEMIN FETAL NEONAT M, V18, P129, DOI 10.1016/j.siny.2013.01.005
   Kovacs CS, 2008, AM J CLIN NUTR, V88, p520S
   Luxwolda MF, 2013, EUR J NUTR, V52, P1115, DOI 10.1007/s00394-012-0421-6
   Mitchell M.N., 2012, INTERPRETING VISUALI
   Moller UK, 2012, EUR J CLIN NUTR, V66, P862, DOI 10.1038/ejcn.2012.18
   Moller UK, 2013, NUTRIENTS, V5, P3470, DOI 10.3390/nu5093470
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Nielson CM, 2016, NEW ENGL J MED, V374, P1695, DOI 10.1056/NEJMc1513502
   Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200
   Papapetrou PD, 2010, HORM-INT J ENDOCRINO, V9, P136
   POPPITT SD, 1993, AM J CLIN NUTR, V57, P353
   PRENTICE A, 1993, BRIT J NUTR, V69, P885, DOI 10.1079/BJN19930088
   Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249
   Prentice A, 2000, AM J CLIN NUTR, V71, P1312
   Prentice A., 2011, PEDIAT BONE, P223
   Prentice A, 2008, AM J CLIN NUTR S5, V88, P500
   PRENTICE AM, 1981, AM J CLIN NUTR, V34, P2790
   Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x
   Paul AA, 2007, FOOD COMPOSITION TAB
   (SACN) SACoN, 2015, VIT D HLTH IN PRESS
   Schoenmakers I, 2013, OSTEOPOROSIS INT, V24, P2301, DOI 10.1007/s00198-013-2280-2
   Schoenmakers I, 2010, J STEROID BIOCHEM, V121, P217, DOI 10.1016/j.jsbmb.2010.03.012
   Schoenmakers I, 2016, J STEROID BIOCHEM, V164, P156, DOI 10.1016/j.jsbmb.2015.11.004
   Schwartz JB, 2014, J STEROID BIOCHEM, V144, P156, DOI 10.1016/j.jsbmb.2013.11.006
   Schwartz JB, 2014, J CLIN ENDOCR METAB, V99, P1631, DOI 10.1210/jc.2013-3874
   Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108
   Tietz NW., 1990, CLIN GUIDE LAB TESTS
   VIETH R, 1987, J NUTR, V117, P914
   Wagner D, 2011, J STEROID BIOCHEM, V126, P72, DOI 10.1016/j.jsbmb.2011.05.003
   WHO, 2012, GUID VIT D SUPPL PRE
   Zhang JY, 2014, BRIT J NUTR, V112, P1081, DOI 10.1017/S0007114514001883
NR 57
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 25
PY 2016
VL 6
AR 26795
DI 10.1038/srep26795
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM6ZN
UT WOS:000376501700001
PM 27222109
OA gold
DA 2017-08-15
ER

PT J
AU Abdulla, S
   Achan, J
   Adam, I
   Alemayehu, BH
   Allan, R
   Allen, EN
   Anvikar, AR
   Arinaitwe, E
   Ashley, EA
   Asih, PBS
   Awab, GR
   Barnes, KI
   Bassat, Q
   Baudin, E
   Bjorkman, A
   Bompart, F
   Bonnet, M
   Borrmann, S
   Bousema, T
   Carrara, VI
   Cenci, F
   Checchi, F
   Cot, M
   Dahal, P
   D'Alessandro, U
   Deloron, P
   Djimde, A
   Dondorp, A
   Dorsey, G
   Doumbo, OK
   Drakeley, CJ
   Duparc, S
   Espie, E
   Faiz, A
   Falade, CO
   Fanello, C
   Faucher, JF
   Faye, B
   Filler, S
   Fofana, B
   Fogg, C
   Gansane, A
   Gaye, O
   Genton, B
   Gething, PW
   Gonzalez, R
   Grandesso, F
   Greenwood, B
   Grivoyannis, A
   Guerin, PJ
   Hamed, K
   Hatz, C
   Hay, SI
   Hodel, EM
   Humphreys, GS
   Hwang, J
   Janssens, B
   Jima, D
   Juma, E
   Kachur, SP
   Kager, P
   Kamya, MR
   Kapulu, M
   Karema, C
   Kayentao, K
   Kiechel, JR
   Kofoed, PE
   Lameyre, V
   Lee, SJ
   Lell, B
   Lima, N
   Marsh, K
   Martensson, A
   Massougbodji, A
   Mayxay, M
   McGready, R
   Menan, H
   Menendez, C
   Mens, P
   Meremikwu, M
   Mockenhaupt, FP
   Moreira, C
   Nabasumba, C
   Nambozi, M
   Ndiaye, JL
   Newton, PN
   Ngasala, BE
   Nosten, F
   Nsanzabana, C
   Offianan, AT
   Oguike, M
   Ogutu, BR
   Olliaro, P
   Omar, SA
   Osorio, L
   Owusu-Agyei, S
   Penali, LK
   Pene, M
   Peshu, J
   Piola, P
   Premji, Z
   Price, RN
   Ramharter, M
   Rombo, L
   Roper, C
   Rosenthal, PJ
   Sagara, I
   Sawa, P
   Schallig, HDFH
   Schramm, B
   Shekalaghe, SA
   Sibley, CH
   Sirima, S
   Smithuis, F
   Sow, D
   Staedke, SG
   Stepniewska, K
   Sutanto, I
   Sutherland, CJ
   Swarthout, TD
   Syafruddin, D
   Sylla, K
   Talisuna, AO
   Taylor, WR
   Temu, EA
   Ter Kuile, F
   Tinto, H
   Tjitra, E
   Ursing, J
   Valecha, N
   van den Broek, I
   van Herp, M
   van Vugt, M
   Ward, SA
   White, NJ
   Winstanley, PA
   Woodrow, CJ
   Yeka, A
   Zwang, J
AF Abdulla, Salim
   Achan, Jane
   Adam, Ishag
   Alemayehu, Bereket H.
   Allan, Richard
   Allen, Elizabeth N.
   Anvikar, Anupkumar R.
   Arinaitwe, Emmanuel
   Ashley, Elizabeth A.
   Asih, Puji Budi Setia
   Awab, Ghulam Rahim
   Barnes, Karen I.
   Bassat, Quique
   Baudin, Elisabeth
   Bjorkman, Anders
   Bompart, Francois
   Bonnet, Maryline
   Borrmann, Steffen
   Bousema, Teun
   Carrara, Verena I.
   Cenci, Fabio
   Checchi, Francesco
   Cot, Michel
   Dahal, Prabin
   D'Alessandro, Umberto
   Deloron, Philippe
   Djimde, Abdoulaye
   Dondorp, Arjen
   Dorsey, Grant
   Doumbo, Ogobara K.
   Drakeley, Chris J.
   Duparc, Stephan
   Espie, Emmanuelle
   Faiz, Abul
   Falade, Catherine O.
   Fanello, Caterina
   Faucher, Jean-Francois
   Faye, Babacar
   Filler, Scott
   Fofana, Bakary
   Fogg, Carole
   Gansane, Adama
   Gaye, Oumar
   Genton, Blaise
   Gething, Peter W.
   Gonzalez, Raquel
   Grandesso, Francesco
   Greenwood, Brian
   Grivoyannis, Anastasia
   Guerin, Philippe J.
   Hamed, Kamal
   Hatz, Christoph
   Hay, Simon I.
   Hodel, Eva Maria
   Humphreys, Georgina S.
   Hwang, Jimee
   Janssens, Bart
   Jima, Daddi
   Juma, Elizabeth
   Kachur, S. Patrick
   Kager, Piet
   Kamya, Moses R.
   Kapulu, Melissa
   Karema, Corine
   Kayentao, Kassoum
   Kiechel, Jean R.
   Kofoed, Poul-Erik
   Lameyre, Valerie
   Lee, Sue J.
   Lell, Bertrand
   Lima, Nines
   Marsh, Kevin
   Martensson, Andreas
   Massougbodji, Achille
   Mayxay, Mayfong
   McGready, Rose
   Menan, Herve
   Menendez, Clara
   Mens, Petra
   Meremikwu, Martin
   Mockenhaupt, Frank P.
   Moreira, Clarissa
   Nabasumba, Carolyn
   Nambozi, Michael
   Ndiaye, Jean-Louis
   Newton, Paul N.
   Ngasala, Billy E.
   Nosten, Francois
   Nsanzabana, Christian
   Offianan, Andre Toure
   Oguike, Mary
   Ogutu, Bernhards R.
   Olliaro, Piero
   Omar, Sabah A.
   Osorio, Lyda
   Owusu-Agyei, Seth
   Penali, Louis K.
   Pene, Mbaye
   Peshu, Judy
   Piola, Patrice
   Premji, Zul
   Price, Ric N.
   Ramharter, Michael
   Rombo, Lars
   Roper, Cally
   Rosenthal, Philip J.
   Sagara, Issaka
   Sawa, Patrick
   Schallig, Henk D. F. H.
   Schramm, Birgit
   Shekalaghe, Seif A.
   Sibley, Carol H.
   Sirima, Sodiomon
   Smithuis, Frank
   Sow, Doudou
   Staedke, Sarah G.
   Stepniewska, Kasia
   Sutanto, Inge
   Sutherland, Colin J.
   Swarthout, Todd D.
   Syafruddin, Din
   Sylla, Khadime
   Talisuna, Ambrose O.
   Taylor, Walter R.
   Temu, Emmanuel A.
   Ter Kuile, Feiko
   Tinto, Halidou
   Tjitra, Emiliana
   Ursing, Johan
   Valecha, Neena
   van den Broek, Ingrid
   van Herp, Michel
   van Vugt, Michele
   Ward, Stephen A.
   White, Nicholas J.
   Winstanley, Peter A.
   Woodrow, Charles J.
   Yeka, Adoke
   Zwang, Julien
CA WWARN Gametocyte Study Grp
TI Gametocyte carriage in uncomplicated Plasmodium falciparum malaria
   following treatment with artemisinin combination therapy: a systematic
   review and meta-analysis of individual patient data
SO BMC MEDICINE
LA English
DT Review
DE Malaria; Plasmodium falciparum; Drug resistance; Gametocyte
ID DIHYDROARTEMISININ-PIPERAQUINE; ARTEMETHER-LUMEFANTRINE;
   ARTESUNATE-MEFLOQUINE; ANTIMALARIAL-DRUGS; RANDOMIZED-TRIAL;
   RISK-FACTORS; TRANSMISSION; DYNAMICS; CHILDREN; RESISTANCE
AB Background: Gametocytes are responsible for transmission of malaria from human to mosquito. Artemisinin combination therapy (ACT) reduces post-treatment gametocyte carriage, dependent upon host, parasite and pharmacodynamic factors. The gametocytocidal properties of antimalarial drugs are important for malaria elimination efforts. An individual patient clinical data meta-analysis was undertaken to identify the determinants of gametocyte carriage and the comparative effects of four ACTs: artemether-lumefantrine (AL), artesunate/amodiaquine (AS-AQ), artesunate/mefloquine (AS-MQ), and dihydroartemisinin-piperaquine (DP).
   Methods: Factors associated with gametocytaemia prior to, and following, ACT treatment were identified in multivariable logistic or Cox regression analysis with random effects. All relevant studies were identified through a systematic review of PubMed. Risk of bias was evaluated based on study design, methodology, and missing data.
   Results: The systematic review identified 169 published and 9 unpublished studies, 126 of which were shared with the WorldWide Antimalarial Resistance Network (WWARN) and 121 trials including 48,840 patients were included in the analysis. Prevalence of gametocytaemia by microscopy at enrolment was 12.1 % (5887/48,589), and increased with decreasing age, decreasing asexual parasite density and decreasing haemoglobin concentration, and was higher in patients without fever at presentation. After ACT treatment, gametocytaemia appeared in 1.9 % (95 % CI, 1.7-2.1) of patients. The appearance of gametocytaemia was lowest after AS-MQ and AL and significantly higher after DP (adjusted hazard ratio (AHR), 2.03; 95 % CI, 1.24-3.12; P = 0.005 compared to AL) and AS-AQ fixed dose combination (FDC) (AHR, 4.01; 95 % CI, 2.40-6.72; P < 0.001 compared to AL). Among individuals who had gametocytaemia before treatment, gametocytaemia clearance was significantly faster with AS-MQ (AHR, 1.26; 95 % CI, 1.00-1.60; P = 0.054) and slower with DP (AHR, 0.74; 95 % CI, 0.63-0.88; P = 0.001) compared to AL. Both recrudescent (adjusted odds ratio (AOR), 9.05; 95 % CI, 3.74-21.90; P < 0.001) and new (AOR, 3.03; 95 % CI, 1.66-5.54; P < 0.001) infections with asexual-stage parasites were strongly associated with development of gametocytaemia after day 7.
   Conclusions: AS-MQ and AL are more effective than DP and AS-AQ FDC in preventing gametocytaemia shortly after treatment, suggesting that then on-artemisinin partner drug or the timing of artemisinin dosing are important determinants of post-treatment gametocyte dynamics.
C1 Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol 268, POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [WWARN Gametocyte Study Grp] Univ Oxford, CCVTM, WorldWide Antimalarial Resistance Network WWARN, Churchill Hosp,Ctr Trop Med & Global Hlth, Oxford OX3 7LE, England.
   [Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Achan, Jane] Uganda Malaria Surveillance Project, Kampala, Uganda.
   [Achan, Jane; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Adam, Ishag] Univ Khartoum, Fac Med, Khartoum, Sudan.
   [Alemayehu, Bereket H.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA.
   [Allan, Richard; Temu, Emmanuel A.] MENTOR Initiat, Crawley, England.
   [Allen, Elizabeth N.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.
   [Anvikar, Anupkumar R.] Natl Inst Malaria Res, New Delhi, India.
   [Arinaitwe, Emmanuel] Infect Dis Res Collaborat, Kampala, Uganda.
   [Ashley, Elizabeth A.; Carrara, Verena I.; McGready, Rose; Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand.
   [Ashley, Elizabeth A.; Lee, Sue J.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand.
   [Asih, Puji Budi Setia] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Awab, Ghulam Rahim; Carrara, Verena I.; Dondorp, Arjen; Fanello, Caterina; Woodrow, Charles J.] Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand.
   [Awab, Ghulam Rahim] Minist Publ Hlth, Kabul, Afghanistan.
   [Barnes, Karen I.; Dahal, Prabin; Guerin, Philippe J.; Humphreys, Georgina S.; Moreira, Clarissa; Nsanzabana, Christian; Price, Ric N.; Sibley, Carol H.; Stepniewska, Kasia] WWARN, Oxford, England.
   [Barnes, Karen I.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.
   [Bassat, Quique] Ctr Invest Saude Manhica, Manhica, Mozambique.
   [Bassat, Quique] Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona CRESIB, ISGlobal, Barcelona, Spain.
   [Baudin, Elisabeth; Checchi, Francesco; Espie, Emmanuelle; Grandesso, Francesco; Nabasumba, Carolyn; Schramm, Birgit] Epictr, Paris, France.
   [Bjorkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
   [Bompart, Francois; Lameyre, Valerie] Sanofi, Paris, France.
   [Bonnet, Maryline] Epictr, Mbarara, Uganda.
   [Bonnet, Maryline] Univ Montpellier, INSERM, U1175, Inst Rech Dev UMI233, Montelier, France.
   [Borrmann, Steffen; Kapulu, Melissa; Marsh, Kevin; Peshu, Judy] Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya.
   [Borrmann, Steffen; Lell, Bertrand] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Bousema, Teun] London Sch Hyg & Trop Med, Dept Infect & Immunity, London WC1, England.
   [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.
   [Cenci, Fabio] Sigma Tau Pharmaceut Co, Rome, Italy.
   [Cot, Michel] Univ Paris 05, Mother & Child Hlth Trop Res Unit, IRD, Paris, France.
   [Dahal, Prabin; Dondorp, Arjen; Guerin, Philippe J.; Humphreys, Georgina S.; Kapulu, Melissa; Lee, Sue J.; Marsh, Kevin; Mayxay, Mayfong; McGready, Rose; Moreira, Clarissa; Newton, Paul N.; Nosten, Francois; Nsanzabana, Christian; Ogutu, Bernhards R.; Price, Ric N.; Stepniewska, Kasia; White, Nicholas J.; Woodrow, Charles J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [D'Alessandro, Umberto; Roper, Cally] LSHTM, London, England.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Deloron, Philippe; Faucher, Jean-Francois] Mother & Child Faced Trop Infect Res Unit, Inst Rech Dev, Paris, France.
   [Deloron, Philippe] Univ Paris 05, PRES Paris Sorbonne Cite, Paris, France.
   [Djimde, Abdoulaye] Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali.
   [Dorsey, Grant; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Doumbo, Ogobara K.; Fofana, Bakary; Kayentao, Kassoum; Sagara, Issaka] Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali.
   [Drakeley, Chris J.] LSHTM, Dept Infect & Immunity, London, England.
   [Duparc, Stephan] Med Malaria Venture, Geneva, Switzerland.
   [Faiz, Abul] Dev Care Fdn, Dhaka, Bangladesh.
   [Falade, Catherine O.] Univ Ibadan, Coll Med, Dept Pharmacol & Therapeut, Ibadan, Nigeria.
   [Faucher, Jean-Francois] Univ Paris 05, Fac Pharm, Paris, France.
   [Faucher, Jean-Francois] Univ Besancon, Med Ctr, Dept Infect Dis, F-25030 Besancon, France.
   [Faye, Babacar; Pene, Mbaye] Univ Cheikh Anta Diop, Dept Med Parasitol, Fac Med, Dakar, Senegal.
   [Filler, Scott] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.
   [Fogg, Carole] Univ Portsmouth, Portsmouth, Hants, England.
   [Gansane, Adama] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.
   [Gaye, Oumar] Univ Cheikh Anta Diop, Fac Med, Dept Med Parasitol, Dakar, Senegal.
   [Genton, Blaise] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Genton, Blaise] Univ Hosp, Div Infect Dis, Lausanne, Switzerland.
   [Genton, Blaise] Univ Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland.
   [Gething, Peter W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, S Parks Rd, Oxford, England.
   [Gonzalez, Raquel] Univ Barcelona, Hosp Clin, Ctr Invest Saude Manhica Manhica Mozamb & ISGloba, Barcelona Ctr Int Hlth Res CRESIB, E-08007 Barcelona, Spain.
   [Greenwood, Brian] LSHTM, Dept Dis Control, London, England.
   [Grivoyannis, Anastasia] Univ Washington, Seattle, WA 98195 USA.
   [Hamed, Kamal] Novartis Pharmaceut, E Hanover, NJ USA.
   [Hatz, Christoph] Swiss Trop Inst, Dept Med, CH-4002 Basel, Switzerland.
   [Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Hodel, Eva Maria; Temu, Emmanuel A.] Swiss Trop Inst & Publ Hlth Inst, Basel, Switzerland.
   [Hodel, Eva Maria] Univ Liverpool, Liverpool Sch Trop Med, Clin Sci, Liverpool L3 5QA, Merseyside, England.
   [Hwang, Jimee; Kachur, S. Patrick] US Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Hwang, Jimee] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.
   [Janssens, Bart] Med Sans Frontieres Operat Ctr, Brussels, Belgium.
   [Jima, Daddi] Fed Minist Hlth, Addis Ababa, Ethiopia.
   [Juma, Elizabeth] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Kager, Piet] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda.
   [Karema, Corine] Minist Hlth, RBC, Malaria & Other Parasit Dis Div, Kigali, Rwanda.
   [Kiechel, Jean R.; Zwang, Julien] Drugs Neglected Dis Initiat DNDi, Geneva, Switzerland.
   [Kofoed, Poul-Erik] Projecto Saude Bandim, Bissau, Guinea Bissau.
   [Kofoed, Poul-Erik] IRS Univ So Denmark, Lillebaelt Hosp, Hlth Serv Res Unit, Vejle, Denmark.
   [Kofoed, Poul-Erik] Kolding Cty Hosp, Dept Paediat, Kolding, Denmark.
   [Lell, Bertrand; Ramharter, Michael] Ctr Rech Medicales Lambarene, Lambarene, Gabon.
   [Lima, Nines] Med Sans Frontieres Operat Ctr Barcelona Athens, Barcelona, Spain.
   [Martensson, Andreas] Upssala Univ, Int Maternal & Child Hlth, Dept Womens & Childrens Hlth, Uppsala, Sweden.
   [Massougbodji, Achille] Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin.
   [Mayxay, Mayfong] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit LOMWRU, Viangchan, Laos.
   [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos.
   [Menan, Herve] Univ Cocody, Fac Pharm, Dept Parasitol, Abidjan, Cote Ivoire.
   [Menendez, Clara] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, E-08007 Barcelona, Spain.
   [Menendez, Clara] CISM, Manhica Hlth Res Ctr, Manhica, Mozambique.
   [Mens, Petra; Schallig, Henk D. F. H.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.
   [Mens, Petra] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Div Infect Dis, NL-1012 WX Amsterdam, Netherlands.
   [Meremikwu, Martin] Univ Calabar, Dept Paediat, Calabar, Nigeria.
   [Meremikwu, Martin] Nigeria Inst Trop Dis Res & Prevent, Calabar, Nigeria.
   [Mockenhaupt, Frank P.] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.
   [Nabasumba, Carolyn] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda.
   [Nambozi, Michael] Trop Dis Res Ctr, Ndola, Zambia.
   [Ndiaye, Jean-Louis] Univ Cheikh Anta Diop, Fac Med, Parasitol & Mycol Lab, Dakar, Senegal.
   [Newton, Paul N.] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos.
   [Ngasala, Billy E.] Muhimbili Univ Hlth & Allied Sci, Dept Parasitol, Dar Es Salaam, Tanzania.
   [Ngasala, Billy E.] Karolinska Inst, Dept Med, Infect Dis Unit, Malaria Res, Stockholm, Sweden.
   [Offianan, Andre Toure] Inst Pasteur, Malariol Dept, Abidjan, Cote Ivoire.
   [Oguike, Mary; Sutherland, Colin J.] LSHTM, Dept Immunol & Infect, London, England.
   [Ogutu, Bernhards R.] US Army, Med Res Unit, Kenya Med Res Inst, Kisumu, Kenya.
   [Olliaro, Piero] UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.
   [Omar, Sabah A.] Int Ctr Insect Physiol & Ecol, Mbita Point, Kenya.
   [Osorio, Lyda] Univ Valle, Fac Salud, Cali, Colombia.
   [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana.
   [Penali, Louis K.] WWARN, Dakar, Senegal.
   [Piola, Patrice] Inst Pasteur Madagascar, Antananarivo, Madagascar.
   [Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.
   [Price, Ric N.] Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia.
   [Ramharter, Michael] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.
   [Ramharter, Michael] Univ Tubingen, Inst Tropenmed, Tubingen, Germany.
   [Rombo, Lars] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.
   [Sawa, Patrick] Int Ctr Insect Physiol & Ecol, Human Hlth Div, Mbita, Kenya.
   [Sibley, Carol H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Sirima, Sodiomon] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.
   [Smithuis, Frank] Myanmar Oxford Clin Res Unit, Yangon, Myanmar.
   [Smithuis, Frank] Med Act Myanmar, Yangon, Myanmar.
   [Sow, Doudou] Univ Cheikh Anta Diop, Fac Med, Serv Parasitol, Dakar, Senegal.
   [Staedke, Sarah G.] LSHTM, Dept Clin Res, London, England.
   [Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda.
   [Sutanto, Inge] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia.
   [Swarthout, Todd D.; van den Broek, Ingrid] Med Sans Frontieres, London, England.
   [Syafruddin, Din] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Sylla, Khadime] Univ Cheikh Anta Diop, Serv Parasitol Mycol Medicale, Dakar, Senegal.
   [Talisuna, Ambrose O.] Univ Oxford, KEMRI, Wellcome Trust Res Programme, Nairobi, Kenya.
   [Taylor, Walter R.] ETH, Dept Hlth Sci & Technol, Inst Biomech, Zurich, Switzerland.
   [Temu, Emmanuel A.] Univ Basel, Basel, Switzerland.
   [Ter Kuile, Feiko] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Ter Kuile, Feiko] Ctr Global Hlth Res, Kenya Med Res Inst KEMRI, Kisumu, Kenya.
   [Tinto, Halidou] Burkina Faso & Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.
   [Tjitra, Emiliana] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia.
   [Ursing, Johan] Indepth Network, Projecto Saude Bandim, Bissau, Guinea Bissau.
   [Ursing, Johan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
   [Valecha, Neena] Natl Inst Malaria Res, New Delhi, India.
   [van den Broek, Ingrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.
   [van Herp, Michel] Operat Ctr Brussels, Med Sans Frontieres, Brussels, Belgium.
   [van Vugt, Michele] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Div Infect Dis, NL-1012 WX Amsterdam, Netherlands.
   [Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.
   [Winstanley, Peter A.] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England.
   [Yeka, Adoke] Uganda Malaria Surveillance Project, Kampala, Uganda.
RP Stepniewska, K (reprint author), WWARN, Oxford, England.; Bousema, T (reprint author), London Sch Hyg & Trop Med, Dept Infect & Immunity, London WC1, England.; Bousema, T (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.; Stepniewska, K (reprint author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
EM teun.bousema@radboudumc.nl; kasia.stepniewska@wwarn.org
RI ; Bousema, Teun/N-3574-2014; Hay, Simon/F-8967-2015; Ward,
   Steve/G-6003-2015; Gonzalez, Raquel/J-3604-2017
OI Bassat, Quique/0000-0003-0875-7596; Hamed, Kamal/0000-0003-1896-9736;
   Osorio, Lyda/0000-0002-5121-4741; DELORON, Philippe/0000-0003-4705-2484;
   Cot, Michel/0000-0003-3014-4294; Gething, Peter/0000-0001-6759-5449;
   Hay, Simon/0000-0002-0611-7272; Ward, Steve/0000-0003-2331-3192;
   Gonzalez, Raquel/0000-0001-5487-801X; Dahal, Prabin/0000-0002-2158-846X;
   Kapulu, Melissa/0000-0003-0321-7128; ter Kuile,
   Feiko/0000-0003-3663-5617; Guerin, Philippe/0000-0002-6008-2963;
   Humphreys, Georgina/0000-0001-9947-0034; Price,
   Richard/0000-0003-2000-2874
FU Bill and Melinda Gates Foundation grant; European Research Council
   [ERC-2014-StG 639776]
FX We thank the patients and all the staff who participated in these
   clinical trials at all the sites and the WorldWide Antimalarial
   Resistance Network (WWARN) team for technical and administrative
   support. We would also like to thank Sigma-Tau for sharing data and
   Hasifa Bukirwa, Marco Corsi, Oumar Faye, Bouasy Hongvanthong, Anand
   Joshi, Maniphone Khanthavong Moussa Kone, Elfaith Malik, Ushma Mehta,
   Albert Same-Ekobo, Bhwana Sharma, and Roger CK Tine for their
   contributions to the studies used in the pooled analysis. WWARN is
   funded by a Bill and Melinda Gates Foundation grant. The funder did not
   participate in developing the protocol or writing the paper. Teun
   Bousema is supported by a fellowship from the European Research Council
   (ERC-2014-StG 639776).
CR Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108
   Akim NIJ, 2000, AM J TROP MED HYG, V63, P199
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645
   Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330
   Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bolscher JM, 2015, J ANTIMICROB CHEMOTH, V70, P1357, DOI 10.1093/jac/dkv003
   Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051
   Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10
   Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136
   Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551
   Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626
   Delves MJ, 2013, ANTIMICROB AGENTS CH, V57, P3268, DOI 10.1128/AAC.00325-13
   Dicko A, 2016, LANCET INFECT DIS
   Eziefula AC, 2014, LANCET INFECT DIS, V14, P130, DOI 10.1016/S1473-3099(13)70268-8
   Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/JOURNAL.PMED.1001119
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Griffin JT, 2010, PLOS MED, V7
   Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015
   Johnston GL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003434
   Joice R, 2014, SCI TRANSL MED, V6, DOI DOI 10.1126/SCITRANSLMED.3008882
   Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13
   Nacher M, 2002, J PARASITOL, V88, P97, DOI 10.1645/0022-3395(2002)088[0097:DHCHAS]2.0.CO;2
   Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8
   Okell LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6606
   Price R, 1999, AM J TROP MED HYG, V60, P1019
   Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9
   Price RN, 2001, AM J TROP MED HYG, V65, P614
   Reece SE, 2005, P ROY SOC B-BIOL SCI, V272, P511, DOI 10.1098/rspb.2004.2972
   ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429
   Sawa P, 2013, J INFECT DIS, V207, P1637, DOI 10.1093/infdis/jit077
   Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040
   Sowunmi A, 2004, PARASITOLOGY, V129, P255, DOI 10.1017/S0031182004005669
   Stepniewska K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-249
   Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092
   Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689
   Taylor WRJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-209
   Trager W, 1999, EXP PARASITOL, V91, P115, DOI 10.1006/expr.1998.4347
   White NJ, 2013, LANCET INFECT DIS, V13, P175, DOI 10.1016/S1473-3099(12)70198-6
   White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   World Health Organization, 2010, GUID TREATM MAL
   WHO, 2015, GUID TREATM MAL
   WorldWide Antimalarial Resistance Network, 2015, GAM CARR STUD GROUP
   WorldWide Antimalarial Resistance Network DPSG, 2013, PLOS MED, V10, DOI DOI 10.1371/J0URNAL.PMED.1001564
   Yeka A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002390
   Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358
NR 48
TC 0
Z9 0
U1 3
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD MAY 24
PY 2016
VL 14
AR 79
DI 10.1186/s12916-016-0621-7
PG 18
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM7YL
UT WOS:000376576000001
OA gold
DA 2017-08-15
ER

PT J
AU Strakova, A
   Leathlobhair, MN
   Wang, GD
   Yin, TT
   Airikkala-Otter, I
   Allen, JL
   Allum, KM
   Bansse-Issa, L
   Bisson, JL
   Domracheva, AC
   de Castro, KF
   Corrigan, AM
   Cran, HR
   Crawford, JT
   Cutter, SM
   Keenan, LD
   Donelan, EM
   Faramade, IA
   Reynoso, EF
   Fotopoulou, E
   Fruean, SN
   Gallardo-Arrieta, F
   Glebova, O
   Manrique, RFH
   Henriques, JJGP
   Ignatenko, N
   Koenig, D
   Lanza-Perea, M
   Lobetti, R
   Quintana, AML
   Losfelt, T
   Marino, G
   Martincorena, I
   Castaneda, SM
   Martinez-Lopez, MF
   Meyer, M
   Nakanwagi, B
   De Nardi, AB
   Neunzie, W
   Nixon, SJ
   Onsare, MM
   Ortega-Pacheco, A
   Peleteiro, MC
   Pye, RJ
   Reece, JF
   Gutierrez, JR
   Sadia, H
   Schmeling, SK
   Shamanova, O
   Ssuna, RK
   Steenland-Smith, AE
   Svitich, A
   Ngoka, IT
   Vitalaru, BA
   de Vos, AP
   de Vos, JP
   Walkinton, O
   Wedge, DC
   Wehrle-Martinez, AS
   van der Wel, MG
   Widdowson, SAE
   Murchison, EP
AF Strakova, Andrea
   Leathlobhair, Maire Ni
   Wang, Guo-Dong
   Yin, Ting-Ting
   Airikkala-Otter, Ilona
   Allen, Janice L.
   Allum, Karen M.
   Bansse-Issa, Leontine
   Bisson, Jocelyn L.
   Domracheva, Artemio Castillo
   de Castro, Karina F.
   Corrigan, Anne M.
   Cran, Hugh R.
   Crawford, Jane T.
   Cutter, Stephen M.
   Keenan, Laura Delgadillo
   Donelan, Edward M.
   Faramade, Ibikunle A.
   Reynoso, Erika Flores
   Fotopoulou, Eleni
   Fruean, Skye N.
   Gallardo-Arrieta, Fanny
   Glebova, Olga
   Haefelin Manrique, Rodrigo F.
   Henriques, Joaquim J. G. P.
   Ignatenko, Natalia
   Koenig, Debbie
   Lanza-Perea, Marta
   Lobetti, Remo
   Lopez Quintana, Adriana M.
   Losfelt, Thibault
   Marino, Gabriele
   Martincorena, Inigo
   Castaneda, Simon Martinez
   Martinez-Lopez, Mayra F.
   Meyer, Michael
   Nakanwagi, Berne
   De Nardi, Andrigo B.
   Neunzie, Winifred
   Nixon, Sally J.
   Onsare, Marsden M.
   Ortega-Pacheco, Antonio
   Peleteiro, Maria C.
   Pye, Ruth J.
   Reece, John F.
   Gutierrez, Jose Rojas
   Sadia, Haleema
   Schmeling, Sheila K.
   Shamanova, Olga
   Ssuna, Richard K.
   Steenland-Smith, Audrey E.
   Svitich, Alla
   Ngoka, Ismail Thoya
   Vitalaru, Bogdan A.
   de Vos, Anna P.
   de Vos, Johan P.
   Walkinton, Oliver
   Wedge, David C.
   Wehrle-Martinez, Alvaro S.
   van der Wel, Mirjam G.
   Widdowson, Sophie A. E.
   Murchison, Elizabeth P.
TI Mitochondrial genetic diversity, selection and recombination in a canine
   transmissible cancer
SO ELIFE
LA English
DT Article
ID INTEGRATIVE GENOMICS VIEWER; DNA RECOMBINATION; MUTATIONAL PROCESSES;
   MAXIMUM-LIKELIHOOD; MOSAIC STRUCTURE; VENEREAL TUMOR; NUCLEAR GENOME;
   DOMESTIC DOG; SEQUENCE; ORIGIN
AB Canine transmissible venereal tumour (CTVT) is a clonally transmissible cancer that originated approximately 11,000 years ago and affects dogs worldwide. Despite the clonal origin of the CTVT nuclear genome, CTVT mitochondrial genomes (mtDNAs) have been acquired by periodic capture from transient hosts. We sequenced 449 complete mtDNAs from a global population of CTVTs, and show that mtDNA horizontal transfer has occurred at least five times, delineating five tumour clades whose distributions track two millennia of dog global migration. Negative selection has operated to prevent accumulation of deleterious mutations in captured mtDNA, and recombination has caused occasional mtDNA re-assortment. These findings implicate functional mtDNA as a driver of CTVT global metastatic spread, further highlighting the important role of mtDNA in cancer evolution.
C1 [Strakova, Andrea; Leathlobhair, Maire Ni; Bisson, Jocelyn L.; Murchison, Elizabeth P.] Univ Cambridge, Dept Vet Med, Cambridge, England.
   [Wang, Guo-Dong; Yin, Ting-Ting] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.
   [Airikkala-Otter, Ilona] Int Training Ctr, Worldwide Vet Serv, Aruvankadu, India.
   [Allen, Janice L.; Cutter, Stephen M.; Donelan, Edward M.] Anim Management Rural & Remote Indigenous Commun, Darwin, NT, Australia.
   [Allum, Karen M.; Koenig, Debbie; Neunzie, Winifred] World Vets, Fargo, ND USA.
   [Bansse-Issa, Leontine; Steenland-Smith, Audrey E.] Stichting Dierenbescherming Suriname, Paramaribo, Surinam.
   [Domracheva, Artemio Castillo] Univ Panama, Corozal Vet Hosp, Panama City, Panama.
   [de Castro, Karina F.; De Nardi, Andrigo B.] Sao Paulo State Univ, Dept Clin & Vet Surg, Sao Paulo, Brazil.
   [Corrigan, Anne M.; Lanza-Perea, Marta] St Georges Univ, True Blue, Grenada.
   [Cran, Hugh R.] Nakuru Dist Vet Scheme Ltd, Nakuru, Kenya.
   [Crawford, Jane T.] Anim Med Ctr, Belize City, Belize.
   [Keenan, Laura Delgadillo] Vet Clin Sr Dogs, Guadalajara, Mexico.
   [Faramade, Ibikunle A.] Natl Inst Vet Res, Vom, Nigeria.
   [Reynoso, Erika Flores] Int Fund Anim Welf, Quintana Roo, Mexico.
   [Fotopoulou, Eleni] Intermunicipal Stray Anim Care Ctr, Perama, Greece.
   [Fruean, Skye N.] Anim Protect Soc Samoa, Apia, Samoa.
   [Gallardo-Arrieta, Fanny] Univ Zulia, Fac Vet Sci, Maracaibo, Venezuela.
   [Glebova, Olga] Vet Clin BIOCONTROL, Moscow, Russia.
   [Haefelin Manrique, Rodrigo F.] Vet Clin El Roble, Santiago, Chile.
   [Henriques, Joaquim J. G. P.] Ctr Vet Berna, OnevetGrp, Lisbon, Portugal.
   [Ignatenko, Natalia] Vet Clin Zoovetservis, Kiev, Ukraine.
   [Lobetti, Remo] Bryanston Vet Hosp, Bryanston, South Africa.
   [Lopez Quintana, Adriana M.] Vet Clin Lopez Quintana, Maldonado, Uruguay.
   [Losfelt, Thibault] Clin Vet Grand Fond, St Gilles Les Bains, France.
   [Marino, Gabriele] Univ Messina, Dept Vet Sci, Messina, Italy.
   [Martincorena, Inigo; Wedge, David C.] Wellcome Trust Sanger Inst, Hinxton, England.
   [Castaneda, Simon Martinez] Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Toluca, Mexico.
   [Martinez-Lopez, Mayra F.] Amer Univ, Sch Vet Med, Quito, Ecuador.
   [Meyer, Michael] Touray & Meyer Vet Clin, Serrekunda, Gambia.
   [Nakanwagi, Berne] Kampala Vet Surg, Kampala, Uganda.
   [Nixon, Sally J.; Pye, Ruth J.; Walkinton, Oliver] Vets Borders, The Rocks, Australia.
   [Onsare, Marsden M.] Aniworld Vet Clin, Kisumu, Kenya.
   [Ortega-Pacheco, Antonio] Autonomous Univ Yucatan, Fac Vet Med, Merida, Mexico.
   [Peleteiro, Maria C.] Univ Lisbon, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth, P-1699 Lisbon, Portugal.
   [Reece, John F.] Help Suffering, Jaipur, Rajasthan, India.
   [Gutierrez, Jose Rojas] Vet Clin Dr Jose Rojas, Los Andes, Chile.
   [Sadia, Haleema] Univ Vet & Anim Sci, Lahore, Pakistan.
   [Schmeling, Sheila K.] Corozal Vet Clin, Corozal Town, Belize.
   [Shamanova, Olga] Vet Clin Vetmaster, Ramenskoye, Russia.
   [Ssuna, Richard K.; Widdowson, Sophie A. E.] Lilongwe Soc Protect & Care Anim, Lilongwe, Malawi.
   [Svitich, Alla] State Hosp Vet Med, Dniprodzerzhynsk, Ukraine.
   [Ngoka, Ismail Thoya] Kenya Soc Protect & Care Anim, Nairobi, Kenya.
   [Vitalaru, Bogdan A.] Fac Vet Med, Dept Clin Sci, Bucharest, Romania.
   [de Vos, Anna P.] Ladybrand Anim Clin, Ladybrand, South Africa.
   [de Vos, Johan P.] Vet Oncol Referral Ctr Ottenhorst, Terneuzen, Netherlands.
   [Wehrle-Martinez, Alvaro S.] Natl Univ Asunc, Fac Vet Sci, San Lorenzo, Paraguay.
   [van der Wel, Mirjam G.] Anim Anti Cruelty League, Port Elizabeth, South Africa.
RP Murchison, EP (reprint author), Univ Cambridge, Dept Vet Med, Cambridge, England.
EM epm27@cam.ac.uk
OI Wedge, David/0000-0002-7572-3196
FU Wellcome Trust [102942/Z/13/A]; Leverhulme Trust; Royal Society
   [RG130615]
FX Wellcome Trust Investigator Award, 102942/Z/13/A Elizabeth P Murchison;
   Leverhulme Trust Philip Leverhulme Prize Elizabeth P Murchison; Royal
   Society Research Grant, RG130615 Elizabeth P Murchison
CR Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477
   Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743
   Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874
   COHEN D, 1972, BRIT J CANCER, V26, P413, DOI 10.1038/bjc.1972.54
   Coupland P, 2012, BIOTECHNIQUES, V53, P365, DOI 10.2144/000113962
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Decker B, 2015, GENOME RES, V25, P1646, DOI 10.1101/gr.190314.115
   Fregel R, 2015, MITOCHONDRION, V22, P75, DOI 10.1016/j.mito.2015.04.001
   Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hoarau G, 2002, MOL BIOL EVOL, V19, P2261
   Hordijk W, 2005, BIOINFORMATICS, V21, P4338, DOI 10.1093/bioinformatics/bti713
   Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062
   Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935
   Ju YS, 2015, GENOME RES, V25, P814, DOI 10.1101/gr.190470.115
   KATZIR N, 1987, ONCOGENE, V1, P445
   KATZIR N, 1985, P NATL ACAD SCI USA, V82, P1054, DOI 10.1073/pnas.82.4.1054
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Ladoukakis ED, 2001, MOL BIOL EVOL, V18, P1168
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338
   Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0
   Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562
   Martin D. P., 2015, VIRUS EVOL, V1, DOI [10.1093/ve/vev003, DOI 10.1093/VE/VEV003]
   Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806
   McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330
   Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167
   Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051
   Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024
   Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   R Development Core Team, 2013, LANG ENV STAT COMP
   Rebbeck CA, 2007, THESIS IMPERIAL COLL
   Rebbeck CA, 2011, SCIENCE, V331, P303, DOI 10.1126/science.1197696
   Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906
   Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31
   SMITH JM, 1992, J MOL EVOL, V34, P126
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stewart J.B., 2015, PLOS GENET, V11
   Strakova A, 2015, CURR OPIN GENET DEV, V30, P49, DOI 10.1016/j.gde.2015.03.005
   Strakova A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0168-9
   Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536
   Ujvari B, 2007, BIOL LETT-UK, V3, P189, DOI 10.1098/rsbl.2006.0587
   Verscheure S, 2015, GENETICA, V143, P453, DOI 10.1007/s10709-015-9844-3
   Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 57
TC 7
Z9 7
U1 6
U2 13
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD MAY 17
PY 2016
VL 5
AR e14552
DI 10.7554/eLife.14552
PG 25
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DN2VV
UT WOS:000376922000001
OA gold
DA 2017-08-15
ER

PT J
AU Nielson, CM
   Jones, KS
   Chun, RF
   Jacobs, JM
   Wang, Y
   Hewison, M
   Adams, JS
   Swanson, CM
   Lee, CG
   Vanderschueren, D
   Pauwels, S
   Prentice, A
   Smith, RD
   Shi, TJ
   Gao, YQ
   Schepmoes, AA
   Zmuda, JM
   Lapidus, J
   Cauley, JA
   Bouillon, R
   Schoenmakers, I
   Orwoll, ES
AF Nielson, Carrie M.
   Jones, Kerry S.
   Chun, Rene F.
   Jacobs, Jon M.
   Wang, Ying
   Hewison, Martin
   Adams, John S.
   Swanson, Christine M.
   Lee, Christine G.
   Vanderschueren, Dirk
   Pauwels, Steven
   Prentice, Ann
   Smith, Richard D.
   Shi, Tujin
   Gao, Yuqian
   Schepmoes, Athena A.
   Zmuda, Joseph M.
   Lapidus, Jodi
   Cauley, Jane A.
   Bouillon, Roger
   Schoenmakers, Inez
   Orwoll, Eric S.
CA Osteoporotic Fractures Men MrOS
TI Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on
   Racial-Genotypic Associations
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID BONE-MINERAL DENSITY; CLINICAL POPULATIONS; GENETIC-VARIANTS; D
   DEFICIENCY; HUMAN-SERUM; AFFINITY; METABOLITES; STATEMENT; AMERICANS;
   CALCIUM
AB Context: Total 25-hydroxyvitamin D (25OHD) is a marker of vitamin D status and is lower in African Americans than in whites. Whether this difference holds for free 25OHOD (f25OHD) is unclear, considering reported genetic-racial differences in vitamin D binding protein (DBP) used to calculate f25OHD.
   Objectives: Our objective was to assess racial-geographic differences in f25OHD and to understand inconsistencies in racial associations with DBP and calculated f25OHD.
   Design: This study used a cross-sectional design.
   Setting: The general community in the United States, United Kingdom, and The Gambia were included in this study.
   Participants: Men in Osteoporotic Fractures in Men and Medical Research Council studies (N = 1057) were included.
   Exposures: Total 25OHD concentration, race, and DBP (GC) genotype exposures were included.
   Outcome Measures: Directly measured f25OHD, DBP assessed by proteomics, monoclonal and polyclonal immunoassays, and calculated f25OHD were the outcome measures.
   Results: Total 25OHD correlated strongly with directly measured f25OHD (Spearman r = 0.84). Measured by monoclonal assay, mean DBP in African-ancestry subjects was approximately 50% lower than in whites, whereas DBP measured by polyclonal DBP antibodies or proteomic methods was not lower in African-ancestry. Calculated f25OHD (using polyclonal DBP assays) correlated strongly with directly measured f25OHD (r = 0.80-0.83). Free 25OHD, measured or calculated from polyclonal DBP assays, reflected total 25OHD concentration irrespective of race and was lower in African Americans than in US whites.
   Conclusions: Previously reported racial differences in DBP concentration are likely from monoclonal assay bias, as there was no racial difference in DBP concentration by other methods. This confirms the poor vitamin D status of many African-Americans and the utility of total 25OHD in assessing vitamin D in the general population.
C1 [Nielson, Carrie M.; Wang, Ying; Swanson, Christine M.; Orwoll, Eric S.] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97239 USA.
   [Nielson, Carrie M.; Lapidus, Jodi] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97239 USA.
   [Jones, Kerry S.; Prentice, Ann; Schoenmakers, Inez] MRC, Human Nutr Res, Cambridge CB1 9NL, England.
   [Chun, Rene F.] Univ Calif Los Angeles, Dept Orthoped, Los Angeles, CA 90095 USA.
   [Jacobs, Jon M.; Smith, Richard D.; Shi, Tujin; Gao, Yuqian; Schepmoes, Athena A.] Pacific NW Natl Lab, Richland, WA 99354 USA.
   [Hewison, Martin] Univ Birmingham, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.
   [Adams, John S.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA.
   [Swanson, Christine M.; Lee, Christine G.; Orwoll, Eric S.] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97239 USA.
   [Lee, Christine G.] Portland VA Med Ctr, Portland, OR 97239 USA.
   [Vanderschueren, Dirk] Katholieke Univ Leuven, Lab Diagnost Med, B-3000 Leuven, Belgium.
   [Vanderschueren, Dirk; Bouillon, Roger] Katholieke Univ Leuven, Lab Clin & Expt Endocrinol, B-3000 Leuven, Belgium.
   [Pauwels, Steven] Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Leuven, Belgium.
   [Pauwels, Steven] Univ Hosp Leuven, Dept Lab Med, B-3000 Leuven, Belgium.
   [Prentice, Ann] MRC Keneba, Keneba, Gambia.
   [Zmuda, Joseph M.; Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
RP Bouillon, R (reprint author), Katholieke Univ Leuven, Clin & Expt Endocrinol, O&NI Herestr 49,Box 902, B-3000 Leuven, Belgium.
EM roger.bouillon@med.kuleuven.be
RI Smith, Richard/J-3664-2012; Chun, Rene/A-9415-2010
OI Smith, Richard/0000-0002-2381-2349; Chun, Rene/0000-0002-0190-0807;
   Cauley, Jane A/0000-0003-0752-4408
FU National Institutes of Health (NIH); National Institute on Aging;
   National Institute of Arthritis and Musculoskeletal and Skin Diseases
   (NIAMS); National Center for Advancing Translational Sciences; NIH
   Roadmap for Medical Research [U01 AG027810, U01 AG042124, U01 AG042139,
   U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160,
   UL1 TR000128]; Medical Research Council [U105960371, U123261351,
   MC-A760-5QX00]; Department for International Development (DFID) under
   the MRC/DFID Concordat; Department of Energy [DE-AC05-76RL0 1830]; NIH
   [P41GM103493]
FX The Osteoporotic Fractures in Men (MrOS) Study is supported by National
   Institutes of Health (NIH) funding. The following institutes provide
   support: the National Institute on Aging, the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National
   Center for Advancing Translational Sciences, and NIH Roadmap for Medical
   Research under the following grant numbers: U01 AG027810, U01 AG042124,
   U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168,
   U01 AR066160, and UL1 TR000128. The research in the United Kingdom and
   The Gambia were funded by the Medical Research Council (program codes
   U105960371, U123261351, MC-A760-5QX00) and the Department for
   International Development (DFID) under the MRC/DFID Concordat agreement.
   Additionally, portions of the experimental work described herein were
   performed in the Environmental Molecular Sciences Laboratory, a national
   scientific user facility sponsored by the Department of Energy and
   located at Pacific Northwest National Laboratory, which is operated by
   Battelle Memorial Institute for the Department of Energy under Contract
   DE-AC05-76RL0 1830. Portions of this work were supported by NIH
   P41GM103493 (to R.D.S.). Free 25OHD assay provided by DIAsource
   ImmunoAssays SA (Belgium) and Future Diagnostics Solutions BV
   (Netherlands), an ELISA based on DIAsource patented monoclonal
   antibodies.
CR Aloia J, 2015, J CLIN ENDOCR METAB, V100, P3356, DOI 10.1210/JC.2015-2066
   ARNAUD J, 1993, HUM GENET, V92, P183
   Ashraf AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114689
   BARTALENA L, 1992, THYROID, V2, P237, DOI 10.1089/thy.1992.2.237
   Bhan I, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/561214
   Bhan I, 2012, KIDNEY INT, V82, P84, DOI 10.1038/ki.2012.19
   BIKLE DD, 1984, J CLIN INVEST, V74, P1966, DOI 10.1172/JCI111617
   BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172/JCI110072
   BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8
   BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225
   Bouillon R, 2014, NEW ENGL J MED, V370, P879, DOI 10.1056/NEJMc1315850#SA3
   BOUTIN B, 1989, J STEROID BIOCHEM, V32, P59, DOI 10.1016/0022-4731(89)90014-9
   Casetta B, 2010, EUR J MASS SPECTROM, V16, P81, DOI 10.1255/ejms.1024
   Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012
   Chun RF, 2012, PLOS ONE, V7
   Durazo-Arvizu RA, 2014, AM J CLIN NUTR, V100, P908, DOI 10.3945/ajcn.113.066605
   Fiscella K, 2010, ANN FAM MED, V8, P11, DOI 10.1370/afm.1035
   Hannan MT, 2008, J CLIN ENDOCR METAB, V93, P40, DOI 10.1210/jc.2007-1217
   Henderson CM, 2016, CLIN CHEM, V62, P179, DOI 10.1373/clinchem.2015.244541
   Heureux N, 2015, END ABSTR, V37
   Hollis BW, 2014, NEW ENGL J MED, V370, P879, DOI 10.1056/NEJMc1315850#SA4
   Institute of Medicine, 2011, DIETARY REFERENCE IN
   Jemielita TO, 2016, OSTEOPOROSIS INT, V27, P617, DOI 10.1007/s00198-015-3296-6
   Johnsen MS, 2014, SCAND J CLIN LAB INV, V74, P177, DOI 10.3109/00365513.2013.869701
   Jones KS, 2014, J CLIN ENDOCR METAB, V99, P3373, DOI 10.1210/jc.2014-1714
   KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950
   KAWAKAMI M, 1979, BIOCHEM J, V179, P413
   LeFevre ML, 2015, ANN INTERN MED, V162, P133, DOI 10.7326/M14-2450
   Looker A., 2008, AM J CLIN NUTR, V88, P1519, DOI DOI 10.3945/AJCN.2008.26182
   Murphy AB, 2014, CLIN CANCER RES, V20, P2289, DOI 10.1158/1078-0432.CCR-13-3085
   Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006
   Ponda MP, 2014, J CLIN ENDOCR METAB, V99, P2494, DOI 10.1210/jc.2014-1181
   Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357
   Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387
   Redmond J, 2014, P NUTR SOC, V73, P340, DOI 10.1017/S0029665114000068
   Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000
   Schwartz JB, 2014, J STEROID BIOCHEM, V144, P156, DOI 10.1016/j.jsbmb.2013.11.006
   Schwartz JB, 2014, J CLIN ENDOCR METAB, V99, P1631, DOI 10.1210/jc.2013-3874
   Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710
   Winters SJ, 2009, METABOLISM, V58, P438, DOI 10.1016/j.metabol.2008.10.017
NR 40
TC 24
Z9 24
U1 2
U2 4
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD MAY
PY 2016
VL 101
IS 5
BP 2226
EP 2234
DI 10.1210/jc.2016-1104
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DP9MG
UT WOS:000378819700041
PM 27007693
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Sow, SO
   Muhsen, K
   Nasrin, D
   Blackwelder, WC
   Wu, YK
   Farag, TH
   Panchalingam, S
   Sur, D
   Zaidi, AKM
   Faruque, ASG
   Saha, D
   Adegbola, R
   Alonso, PL
   Breiman, RF
   Bassat, Q
   Tamboura, B
   Sanogo, D
   Onwuchekwa, U
   Manna, B
   Ramamurthy, T
   Kanungo, S
   Ahmed, S
   Qureshi, S
   Quadri, F
   Hossain, A
   Das, SK
   Antonio, M
   Hossain, MJ
   Mandomando, I
   Nhampossa, T
   Acacio, S
   Omore, R
   Oundo, JO
   Ochieng, JB
   Mintz, ED
   O'Reilly, CE
   Berkeley, LY
   Livio, S
   Tennant, SM
   Sommerfelt, H
   Nataro, JP
   Ziv-Baran, T
   Robins-Browne, RM
   Mishcherkin, V
   Zhang, JX
   Liu, J
   Houpt, ER
   Kotloff, KL
   Levine, MM
AF Sow, Samba O.
   Muhsen, Khitam
   Nasrin, Dilruba
   Blackwelder, William C.
   Wu, Yukun
   Farag, Tamer H.
   Panchalingam, Sandra
   Sur, Dipika
   Zaidi, Anita K. M.
   Faruque, Abu S. G.
   Saha, Debasish
   Adegbola, Richard
   Alonso, Pedro L.
   Breiman, Robert F.
   Bassat, Quique
   Tamboura, Boubou
   Sanogo, Doh
   Onwuchekwa, Uma
   Manna, Byomkesh
   Ramamurthy, Thandavarayan
   Kanungo, Suman
   Ahmed, Shahnawaz
   Qureshi, Shahida
   Quadri, Farheen
   Hossain, Anowar
   Das, Sumon K.
   Antonio, Martin
   Hossain, M. Jahangir
   Mandomando, Inacio
   Nhampossa, Tacilta
   Acacio, Sozinho
   Omore, Richard
   Oundo, Joseph O.
   Ochieng, John B.
   Mintz, Eric D.
   O'Reilly, Ciara E.
   Berkeley, Lynette Y.
   Livio, Sofie
   Tennant, Sharon M.
   Sommerfelt, Halvor
   Nataro, James P.
   Ziv-Baran, Tomer
   Robins-Browne, Roy M.
   Mishcherkin, Vladimir
   Zhang, Jixian
   Liu, Jie
   Houpt, Eric R.
   Kotloff, Karen L.
   Levine, Myron M.
TI The Burden of Cryptosporidium Diarrheal Disease among Children < 24
   Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa
   and South Asia, Utilizing Data from the Global Enteric Multicenter Study
   (GEMS)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DEVELOPING-COUNTRIES; ANTIBODY-RESPONSES; PARVUM INFECTION;
   YOUNG-CHILDREN; GUINEA-BISSAU; WEST-AFRICA; COMMUNITY; INDIA;
   EPIDEMIOLOGY; INFANTS
AB Background
   The importance of Cryptosporidium as a pediatric enteropathogen in developing countries is recognized.
   Methods
   Data from the Global Enteric Multicenter Study (GEMS), a 3-year, 7-site, case-control study of moderate-to-severe diarrhea (MSD) and GEMS-1A (1-year study of MSD and less-severe diarrhea [LSD]) were analyzed. Stools from 12,110 MSD and 3,174 LSD cases among children aged <60 months and from 21,527 randomly-selected controls matched by age, sex and community were immunoassay-tested for Cryptosporidium. Species of a subset of Cryptosporidium-positive specimens were identified by PCR; GP60 sequencing identified anthroponotic C. parvum. Combined annual Cryptosporidium-attributable diarrhea incidences among children aged < 24 months for African and Asian GEMS sites were extrapolated to sub-Saharan Africa and South Asian regions to estimate region-wide MSD and LSD burdens. Attributable and excess mortality due to Cryptosporidium diarrhea were estimated.
   Findings
   Cryptosporidium was significantly associated with MSD and LSD below age 24 months. Among Cryptosporidium-positive MSD cases, C. hominis was detected in 77.8% (95% CI, 73.0%-81.9%) and C. parvum in 9.9%(95% CI, 7.1%-13.6%); 92% of C. parvum tested were anthroponotic genotypes. Annual Cryptosporidium-attributable MSD incidence was 3.48 (95% CI, 2.27-4.67) and 3.18 (95% CI, 1.85-4.52) per 100 child-years in African and Asian infants, respectively, and 1.41 (95% CI, 0.73-2.08) and 1.36 (95% CI, 0.66-2.05) per 100 child-years in toddlers. Corresponding Cryptosporidium-attributable LSD incidences per 100 child-years were 2.52 (95% CI, 0.33-5.01) and 4.88 (95% CI, 0.82-8.92) in infants and 4.04 (95% CI, 0.56-7.51) and 4.71 (95% CI, 0.24-9.18) in toddlers. We estimate 2.9 and 4.7 millio nCryptosporidium-attributable cases annually in children aged < 24 months in the sub-Saharan Africa and India/Pakistan/Bangladesh/Nepal/Afghanistan regions, respectively, and similar to 202,000 Cryptosporidium-attributable deaths (regions combined). similar to 59,000 excess deaths occurred among Cryptosporidium-attributable diarrhea cases over expected if cases had been Cryptosporidium-negative.
   Conclusions
   The enormous African/Asian Cryptosporidium disease burden warrants investments to develop vaccines, diagnostics and therapies.
C1 [Sow, Samba O.; Tamboura, Boubou; Sanogo, Doh; Onwuchekwa, Uma] Ctr Dev Vaccins, Bamako, Mali.
   [Muhsen, Khitam; Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun; Farag, Tamer H.; Panchalingam, Sandra; Berkeley, Lynette Y.; Livio, Sofie; Tennant, Sharon M.; Nataro, James P.; Mishcherkin, Vladimir; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun; Farag, Tamer H.; Berkeley, Lynette Y.; Livio, Sofie; Tennant, Sharon M.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
   [Wu, Yukun] Emergent Biosolut, Gaithersburg, MD USA.
   [Sur, Dipika; Ramamurthy, Thandavarayan; Kanungo, Suman] Natl Inst Cholera & Enter Dis, Kolkata, India.
   [Zaidi, Anita K. M.; Qureshi, Shahida; Quadri, Farheen] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.
   [Faruque, Abu S. G.; Ahmed, Shahnawaz; Hossain, Anowar; Das, Sumon K.] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.
   [Saha, Debasish; Adegbola, Richard; Antonio, Martin; Hossain, M. Jahangir] Med Res Council United Kingdom Unit, Fajara, Gambia.
   [Saha, Debasish; Adegbola, Richard] GSK Vaccines, Wavre, Belgium.
   [Alonso, Pedro L.; Bassat, Quique; Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Alonso, Pedro L.; Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho] Minist Saude, Inst Nacl Saude, Maputo, Mozambique.
   [Alonso, Pedro L.; Bassat, Quique] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Breiman, Robert F.] Kenya Off US Ctr Dis Control & Prevent, Global Dis Detect Div, Nairobi, Kenya.
   [Omore, Richard; Oundo, Joseph O.; Ochieng, John B.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Kisumu, Kenya.
   [Mintz, Eric D.; O'Reilly, Ciara E.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA.
   [Sommerfelt, Halvor] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway.
   [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway.
   [Muhsen, Khitam; Ziv-Baran, Tomer] Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Ramat Aviv, Israel.
   [Robins-Browne, Roy M.] Univ Melbourne, Murdoch Childrens Res Inst, Dept Microbiol & Immunol, Royal Childrens Hosp, Parkville, Vic, Australia.
   [Zhang, Jixian; Liu, Jie; Houpt, Eric R.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
   [Kotloff, Karen L.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA.
   [Farag, Tamer H.; Zaidi, Anita K. M.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Sur, Dipika; Ramamurthy, Thandavarayan] Translat Hlth Sci & Technol Inst, Faridabad, India.
   [Alonso, Pedro L.] WHO Global Malaria Programme, Geneva, Switzerland.
   [Breiman, Robert F.] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA.
   [Berkeley, Lynette Y.] US FDA, Silver Spring, MD USA.
   [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA.
RP Levine, MM (reprint author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.; Levine, MM (reprint author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
EM mlevine@medicine.umaryland.edu
RI Bassat, Quique/P-2341-2016
OI Bassat, Quique/0000-0003-0875-7596
FU Bill & Melinda Gates Foundation [38774, OPP1033572]
FX This work was supported by grants 38774 and OPP1033572 from the Bill &
   Melinda Gates Foundation to MML, URL of the funder's website:
   http://www.gatesfoundation.org/. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ajjampur SSR, 2010, AM J TROP MED HYG, V83, P1110, DOI [10.4269/ajtmh.2010.09-0644, 10.4269/ajtmh.2010.09.0644]
   Ajjampur SSR, 2007, J CLIN MICROBIOL, V45, P915, DOI 10.1128/JCM.01590-06
   Ajjampur SSR, 2010, J CLIN MICROBIOL, V48, P2075, DOI 10.1128/JCM.02509-09
   Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003
   Amadi B, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-195
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788
   Borad AJ, 2012, AM J TROP MED HYG, V86, P214, DOI 10.4269/ajtmh.2012.11-0273
   Chappell CL, 2002, CURR OPIN INFECT DIS, V15, P523
   Chappell CL, 1996, J INFECT DIS, V173, P232
   Checkley W, 1998, AM J EPIDEMIOL, V148, P497
   Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8
   Eibach D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003551
   Farag TH, 2012, CLIN INFECT DIS, V55, pS225, DOI 10.1093/cid/cis787
   Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10
   Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580
   Johansen OH, 2015, EPIDEMIOL INFECT, V143, P1702, DOI 10.1017/S095026881400243X
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   Kovacs SD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0728-4
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Lazarus RP, 2015, AM J TROP MED HYG, V93, P931, DOI 10.4269/ajtmh.15-0044
   Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761
   Liu J, 2014, LANCET INFECT DIS, V9, P10
   Liu L, 2015, LANCET, V385, P2461, DOI [10.1016/S0140-6736(15)61132-1, 10.1016/S0140-6736(15)60663-8]
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304
   McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639
   MOLBAK K, 1993, BRIT MED J, V307, P417
   Molbak K, 1997, AM J CLIN NUTR, V65, P149
   Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Nasrin D, 2013, AM J TROP MED HYG, V89, P3, DOI 10.4269/ajtmh.12-0749
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   NEWMAN RD, 1994, ANN INTERN MED, V120, P500
   Newman RD, 1999, J INFECT DIS, V180, P167, DOI 10.1086/314820
   Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Platts-Mills JA, 2015, LANCET GLOB HEALTH, P10
   Rolando RFR, 2012, MEM I OSWALDO CRUZ, V107, P476, DOI 10.1590/S0074-02762012000400006
   Robin G, 2001, AM J EPIDEMIOL, V153, P194, DOI 10.1093/aje/153.2.194
   Sarkar R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003042
   Sheoran A, 2012, J INFECT DIS, V205, P1019, DOI 10.1093/infdis/jir874
   SHEPHERD RC, 1988, J CLIN PATHOL, V41, P1104, DOI 10.1136/jcp.41.10.1104
   Shirley DAT, 2012, CURR OPIN INFECT DIS, V25, P555, DOI 10.1097/QCO.0b013e328357e569
   Snelling WJ, 2007, J INFECT DEV COUNTR, V1, P242
   United Nations, 2013, WORLD POP PROSP 2012
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   Wanyiri JW, 2014, AM J TROP MED HYG, V91, P319, DOI 10.4269/ajtmh.13-0254
   Widmer G, 2012, PARASITE IMMUNOL, V34, P61, DOI 10.1111/j.1365-3024.2011.01301.x
   Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090
   Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018
NR 53
TC 7
Z9 8
U1 3
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004729
DI 10.1371/journal.pntd.0004729
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300066
PM 27219054
OA gold
DA 2017-08-15
ER

PT J
AU Tientcheu, LD
   Haks, MC
   Agbla, SC
   Sutherland, JS
   Adetifa, IM
   Donkor, S
   Quinten, E
   Daramy, M
   Antonio, M
   Kampmann, B
   Ottenhoff, THM
   Dockrell, HM
   Ota, MO
AF Tientcheu, Leopold D.
   Haks, Marielle C.
   Agbla, Schadrac C.
   Sutherland, Jayne S.
   Adetifa, Ifedayo M.
   Donkor, Simon
   Quinten, Edwin
   Daramy, Mohammed
   Antonio, Martin
   Kampmann, Beate
   Ottenhoff, Tom H. M.
   Dockrell, Hazel M.
   Ota, Martin O.
TI Host Immune Responses Differ between M-africanum- and
   M-tuberculosis-Infected Patients following Standard Anti-tuberculosis
   Treatment
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; RESISTANT TUBERCULOSIS; DIRECTED
   THERAPIES; COMPLEX; EXPRESSION; LINEAGE; BLOOD; IDENTIFICATION;
   PROTECTION
AB Epidemiological differences exist between Mycobacterium africanum (Maf)- and Mycobacterium tuberculosis (Mtb)-infected patients, but to date, contributing host factors have not been characterised. We analysed clinical outcomes, as well as soluble markers and gene expression profiles in unstimulated, and ESAT6/CFP-10-, whole-Maf- and Mtb-stimulated blood samples of 26 Maf- and 49 Mtb-HIV-negative tuberculosis patients before, and after 2 and 6 months of anti-tuberculosis therapy. Before treatment, both groups had similar clinical parameters, but differed in few cytokines concentration and gene expression profiles. Following treatment the body mass index, skinfold thickness and chest X-ray scores showed greater improvement in the Mtb-compared to Maf-infected patients, after adjusting for age, sex and ethnicity (p = 0.02; 0.04 and 0.007, respectively). In addition, in unstimulated blood, IL-12p70, IL12A and TLR9 were significantly higher in Maf-infected patients, while IL-15, IL-8 and MIP-1 alpha were higher in Mtb-infected patients. Overnight stimulation with ESAT-6/CFP-10 induced significantly higher levels of IFN-gamma and TNF-alpha production, as well as gene expression of CCL4, IL1B and TLR4 in Mtb-compared to Maf-infected patients. Our study confirms differences in clinical features and immune genes expression and concentration of proteins associated with inflammatory processes between Mtb- and Maf-infected patients following anti-tuberculosis treatment These findings have public health implications for treatment regimens, and biomarkers for tuberculosis diagnosis and susceptibility.
C1 [Tientcheu, Leopold D.; Agbla, Schadrac C.; Sutherland, Jayne S.; Donkor, Simon; Daramy, Mohammed; Antonio, Martin; Kampmann, Beate; Ota, Martin O.] MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
   [Tientcheu, Leopold D.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England.
   [Tientcheu, Leopold D.] Univ Yaounde I, Dept Biochem, Fac Sci, Yaounde, Cameroon.
   [Haks, Marielle C.; Quinten, Edwin; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.
   [Agbla, Schadrac C.] London Sch Hyg & Trop Med, Dept Med Stat, Fac Epidemiol & Populat Hlth, London WC1, England.
   [Adetifa, Ifedayo M.] MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Adetifa, Ifedayo M.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England.
   [Antonio, Martin] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Fac Infect & Trop Dis, London WC1, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
   [Ota, Martin O.] World Hlth Org Reg Off Africa, Brazzaville, Rep Congo.
RP Tientcheu, LD (reprint author), MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.; Tientcheu, LD (reprint author), London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1, England.; Tientcheu, LD (reprint author), Univ Yaounde I, Dept Biochem, Fac Sci, Yaounde, Cameroon.
EM ltientcheu@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709; Sutherland,
   Jayne/0000-0002-7083-4997
FU MRC Unit, The Gambia; EC
FX The study was funded by the MRC Unit, The Gambia as a PhD fellowship
   awarded to LDT. Financial support for these studies was obtained from
   projects EC FP7 IDEA, EC FP7 ADITEC, EC FP7 NEWTBVAC and EC HOR2020
   TBVAC2020. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390
   Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317
   Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370
   Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1081/jem.20051782
   Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191
   Click ES, 2013, INT J TUBERC LUNG D, V17, P878, DOI 10.5588/ijtld.12.0732
   Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788
   Cliff JM, 2015, IMMUNOL REV, V264, P88, DOI 10.1111/imr.12269
   Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499
   Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012
   Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468
   de Jong BC, 2007, INT J TUBERC LUNG D, V11, P450
   de Jong BC, 2005, AIDS, V19, P1714, DOI 10.1097/01.aids.0000185991.54595.41
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x
   de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08
   Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656
   Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316
   Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010
   Gehre F, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004408
   Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000
   Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426
   Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275
   Gumbo T, 2013, NAT GENET, V45, P720, DOI 10.1038/ng.2675
   Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2
   Huang KH, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0071-5
   Jackson-Sillah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068121
   Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64
   Kaewseekhao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134168
   Kaneko Y, 2015, AM J RESP CRIT CARE, V191, P480, DOI 10.1164/rccm.201409-1590LE
   Kay MK, 2011, J CLIN MICROBIOL, V49, P618, DOI 10.1128/JCM.00807-10
   Khader SA, 2005, J IMMUNOL, V175, P788
   Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409
   Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000
   Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429
   Mensah GI, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-495
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817
   Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-125
   Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753
   Ning BF, 2014, HEPATOLOGY, V60, P1607, DOI 10.1002/hep.27177
   O'Sullivan DM, 2010, J MED MICROBIOL, V59, P1533, DOI 10.1099/jmm.0.019091-0
   Pareek M, 2013, THORAX, V68, P221, DOI 10.1136/thoraxjnl-2012-201824
   Reuter MA, 2010, J VIROL, V84, P8549, DOI 10.1128/JVI.02303-09
   Satti L, 2010, INT J TUBERC LUNG D, V14, P1354
   Shakoor S, 2010, INT J TUBERC LUNG D, V14, P1644
   SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989
   Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011
   Tientcheu LD, 2015, GENES IMMUN, V16, P347, DOI 10.1038/gene.2015.21
   Tientcheu LD, 2014, EUR J IMMUNOL, V44, P1387, DOI 10.1002/eji.201343956
   Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397
   Umemura M, 2001, J IMMUNOL, V167, P946
   Via LE, 2013, INFECT IMMUN, V81, P2909, DOI 10.1128/IAI.00632-13
   Wang J, 2015, BRAZ J INFECT DIS, V19, P125, DOI 10.1016/j.bjid.2014.10.008
   WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1
   World Health Organization, 2015, GLOBAL TUBERCULOSIS
   Winglee K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004332
   Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906
   Yu CC, 2010, J MICROBIOL IMMUNOL, V43, P285, DOI 10.1016/S1684-1182(10)60045-X
   Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5
   Zumla A, 2015, NAT REV DRUG DISCOV, V14, P511, DOI 10.1038/nrd4696
NR 60
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004701
DI 10.1371/journal.pntd.0004701
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300043
PM 27192147
OA gold
DA 2017-08-15
ER

PT J
AU Dolo, O
   Clack, A
   Gibson, H
   Lewis, N
   Southall, DP
AF Dolo, Obed
   Clack, Alice
   Gibson, Hannah
   Lewis, Naomi
   Southall, David P.
TI Training of midwives in advanced obstetrics in Liberia
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
AB Problem The shortage of doctors in Liberia limits the provision of comprehensive emergency obstetric and neonatal care.
   Approach In a pilot project, two midwives were trained in advanced obstetric procedures and in the team approach to the in-hospital provision of advanced maternity care. The training took two years and was led by a Liberian consultant obstetrician with support from international experts.
   Local setting The training took place in CB Dunbar Maternity Hospital. This rural hospital deals with approximately 2000 deliveries annually, many of which present complications. In February 2015 there were just 117 doctors available in Liberia.
   Relevant changes In the first 18 months of training, the trainees were involved with 236 caesarean sections, 35 manual evacuations of products of conception, 25 manual removals of placentas, 21 vaginal breech deliveries, 14 vacuum deliveries, four repairs of ruptured uteri, the management of four cases of shoulder dystocia, three hysterectomies, two laparotomies for ruptured ectopic pregnancies and numerous obstetric ultrasound examinations. The trainees also managed 41 cases of eclampsia or severe pre-eclampsia, 25 of major postpartum haemorrhage and 21 of shock. Although, initially they only assisted senior doctors, the trainees subsequently progressed from direct to indirect supervision and then to independent management.
   Lessons learnt To compensate for a shortage of doctors able to undertake comprehensive emergency obstetric and neonatal care, experienced midwives can be taught to undertake advanced obstetric care and procedures. Their team work with doctors can be particularly valuable in rural hospitals in resource-poor countries.
C1 [Dolo, Obed; Gibson, Hannah; Lewis, Naomi] CB Dunbar Matern Hosp, Gbanga, Liberia.
   [Clack, Alice] Brikama Major Hlth Ctr, Maternal & Childhlth Advocacy Int, Brikama, Gambia.
   [Southall, David P.] Maternal & Childhlth Advocacy Int, 1 Columba Court, Laide IV22 2NL, Scotland.
RP Southall, DP (reprint author), Maternal & Childhlth Advocacy Int, 1 Columba Court, Laide IV22 2NL, Scotland.
EM director@mcai.org.uk
FU United Kingdom's Department for International Development through the
   Tropical Health Education Trust; Maternal and Childhealth Advocacy
   International; Liberian office of WHO; Liberian office of United Nations
   Population Fund
FX This project was initially funded by the United Kingdom's Department for
   International Development through the Tropical Health Education Trust
   and subsequently by Maternal and Childhealth Advocacy International and
   the Liberian offices of WHO and the United Nations Population Fund.
CR International maternal & child health care, 2014, INT MAT CHILD HLTH C
   Liberia, 2015, STRENGTH EM CAR PREG
   [Anonymous], 2014, POCK BOOK HOSP CAR M
   [Anonymous], 2015, CURR ADV OBST TRAIN
   [Anonymous], 2015, REP LIB INV PLAN BUI
   Pal R, 2015, BACKGROUND PROGRAMME
   [Anonymous], 2010, BAS PRACT SKILLS OBS
   Tankwanchi ABS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001513
   United Nations Children's Fund, 2014, STAT WORLDS CHILDR 2
   United Nations Childrens Fund, 2012, STAT WORLDS CHILDR 2
   World Health Organization, 2013, MAN DIAGN ULTR, V2
   World Health Organization, 2003, SURG CAR DISTR HOSP
NR 12
TC 1
Z9 1
U1 0
U2 1
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD MAY
PY 2016
VL 94
IS 5
BP 383
EP 387
DI 10.2471/BLT.15.160473
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM6OR
UT WOS:000376472800023
PM 27147768
OA No
DA 2017-08-15
ER

PT J
AU Baker, KK
   O'Reilly, CE
   Levine, MM
   Kotloff, KL
   Nataro, JP
   Ayers, TL
   Farag, TH
   Nasrin, D
   Blackwelder, WC
   Wu, YK
   Alonso, PL
   Breiman, RF
   Omore, R
   Faruque, ASG
   Das, SK
   Ahmed, S
   Saha, D
   Sow, SO
   Sur, D
   Zaidi, AKM
   Quadri, F
   Mintz, ED
AF Baker, Kelly K.
   O'Reilly, Ciara E.
   Levine, Myron M.
   Kotloff, Karen L.
   Nataro, James P.
   Ayers, Tracy L.
   Farag, Tamer H.
   Nasrin, Dilruba
   Blackwelder, William C.
   Wu, Yukun
   Alonso, Pedro L.
   Breiman, Robert F.
   Omore, Richard
   Faruque, Abu S. G.
   Das, Sumon Kumar
   Ahmed, Shahnawaz
   Saha, Debasish
   Sow, Samba O.
   Sur, Dipika
   Zaidi, Anita K. M.
   Quadri, Fahreen
   Mintz, Eric D.
TI Sanitation and Hygiene-Specific Risk Factors for Moderate-to-Severe
   Diarrhea in Young Children in the Global Enteric Multicenter Study,
   2007-2011: Case-Control Study
SO PLOS MEDICINE
LA English
DT Article
ID DEVELOPING-COUNTRIES; SHARED SANITATION; KAMPALA SLUMS; SYSTEMATIC
   ANALYSIS; HOUSEHOLD LATRINES; CHOLERA OUTBREAK; GAMBIAN INFANTS;
   NATIONAL CAUSES; WATER; MORTALITY
AB Background
   Diarrheal disease is the second leading cause of disease in children less than 5 y of age. Poor water, sanitation, and hygiene conditions are the primary routes of exposure and infection. Sanitation and hygiene interventions are estimated to generate a 36% and 48% reduction in diarrheal risk in young children, respectively. Little is known about whether the number of households sharing a sanitation facility affects a child's risk of diarrhea. The objective of this study was to describe sanitation and hygiene access across the Global Enteric Multicenter Study (GEMS) sites in Africa and South Asia and to assess sanitation and hygiene exposures, including shared sanitation access, as risk factors for moderate-tosevere diarrhea (MSD) in children less than 5 y of age.
   Methods/Findings
   The GEMS matched case-control study was conducted between December 1, 2007, and March 3, 2011, at seven sites in Basse, The Gambia; Nyanza Province, Kenya; Bamako, Mali; Manhica, Mozambique; Mirzapur, Bangladesh; Kolkata, India; and Karachi, Pakistan. Data was collected for 8,592 case children aged < 5 y old experiencing MSD and for 12,390 asymptomatic age, gender, and neighborhood-matched controls. An MSD case was defined as a child with a diarrheal illness < 7 d duration comprising >= 3 loose stools in 24 h and >= 1 of the following: sunken eyes, skin tenting, dysentery, intravenous (IV) rehydration, or hospitalization. Site-specific conditional logistic regression models were used to explore the association between sanitation and hygiene exposures and MSD. Most households at six sites (> 93%) had access to a sanitation facility, while 70% of households in rural Kenya had access to a facility. Practicing open defecation was a risk factor for MSD in children < 5 y old in Kenya. Sharing sanitation facilities with 1-2 or >= 3 other households was a statistically significant risk factor for MSD in Kenya, Mali, Mozambique, and Pakistan. Among those with a designated handwashing area near the home, soap or ash were more frequently observed at control households and were significantly protective against MSD in Mozambique and India.
   Conclusions
   This study suggests that sharing a sanitation facility with just one to two other households can increase the risk of MSD in young children, compared to using a private facility. Interventions aimed at increasing access to private household sanitation facilities may reduce the burden of MSD in children. These findings support the current World Health Organization/United Nations Children's Emergency Fund (UNICEF) system that categorizes shared sanitation as unimproved.
C1 [Baker, Kelly K.; Levine, Myron M.; Kotloff, Karen L.; Nataro, James P.; Farag, Tamer H.; Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun] Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Med, Baltimore, MD 21201 USA.
   [Baker, Kelly K.] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA.
   [O'Reilly, Ciara E.; Ayers, Tracy L.; Mintz, Eric D.] US Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA.
   [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA.
   [Farag, Tamer H.; Zaidi, Anita K. M.; Quadri, Fahreen] Gates Fdn, Seattle, WA USA.
   [Wu, Yukun] Emergent BioSolut, Gaithersburg, MD USA.
   [Alonso, Pedro L.] Univ Barcelona, Ctr Recerca Salut Internac Barcelona, Hosp Clin CRESIB, Barcelona, Spain.
   [Alonso, Pedro L.] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Alonso, Pedro L.] World Hlth Org, Geneva, Switzerland.
   [Breiman, Robert F.] US Ctr Dis Control & Prevent, Nairobi, Kenya.
   [Breiman, Robert F.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA.
   [Omore, Richard] Ctr Dis Control & Prevent KEMRI CDC, Kenya Med Res Inst, Kisumu, Kenya.
   [Faruque, Abu S. G.; Das, Sumon Kumar; Ahmed, Shahnawaz] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.
   [Das, Sumon Kumar] Univ Queensland, Brisbane, Qld, Australia.
   [Saha, Debasish] Med Res Council United Kingdom, Fajara, Gambia.
   [Sow, Samba O.] Ctr Dev Vaccins, Bamako, Mali.
   [Sur, Dipika] Natl Inst Cholera & Enter Dis, Kolkata, India.
   [Sur, Dipika] India Publ Hlth Assoc, New Delhi, India.
   [Sur, Dipika] PATH India Off, New Delhi, India.
   [Zaidi, Anita K. M.] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.
RP Baker, KK (reprint author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Med, Baltimore, MD 21201 USA.; Baker, KK (reprint author), Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA.
EM kelly-k-baker@uiowa.edu
OI Baker, Kelly/0000-0002-3774-2628; Ayers, Tracy/0000-0003-4140-3263
FU Bill and Melinda Gates Foundation [38874]; US Agency for International
   Development; US Centers for Disease Control and Prevention
FX This work was supported by Grant #38874 from the Bill and Melinda Gates
   Foundation (http://www.gatesfoundation.org/) to MML, Principal
   Investigator. Salary support for CEO was provided by the US Agency for
   International Development (https://www.usaid.gov/) through an
   Inter-Agency Agreement with the US Centers for Disease Control and
   Prevention. THF, a current employee of the Bill & Melinda Gates
   Foundation, contributed as an author to the design and collection of
   data supporting the preparation of this manuscript while employed by the
   Center for Vaccine Development, University of Maryland Baltimore.
CR Azage M, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0090-z
   Baker KK, 2013, AM J TROP MED HYG, V89, P214, DOI 10.4269/ajtmh.12-0256
   Barreto ML, 2010, ENVIRON HEALTH PERSP, V118, P1637, DOI 10.1289/ehp.1002058
   Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6
   Biran A, 2011, TROP MED INT HEALTH, V16, P854, DOI 10.1111/j.1365-3156.2011.02764.x
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   Cairncross S, 1996, TROP MED INT HEALTH, V1, P27, DOI 10.1046/j.1365-3156.1996.d01-9.x
   Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035
   Campbell DI, 2003, J NUTR, V133, P1332
   Caruso BA, 2015, LANCET, V386, P650, DOI 10.1016/S0140-6736(15)61497-0
   Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099
   Cheng JJ, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-4
   Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE
   Clasen TF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007180.pub2
   Curtale F., 1998, Parassitologia (Rome), V40, P251
   CURTIS V, 1995, SOC SCI MED, V41, P383, DOI 10.1016/0277-9536(94)00341-P
   DANIELS DL, 1990, B WORLD HEALTH ORGAN, V68, P455
   Eisenberg JNS, 2012, ANNU REV PUBL HEALTH, V33, P239, DOI 10.1146/annurev-publhealth-031811-124530
   ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757
   ESREY SA, 1986, EPIDEMIOL REV, V8, P117
   Exley JLR, 2015, ENVIRON SCI TECHNOL, V49, P1086, DOI 10.1021/es503945x
   Ezeh OK, 2014, INT J ENV RES PUB HE, V11, P9256, DOI 10.3390/ijerph110909256
   Ezeh OK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-521
   Farag TH, 2012, CLIN INFECT DIS, V55, pS225, DOI 10.1093/cid/cis787
   Fewtrell L, 2005, WATER SCI TECHNOL, V52, P133
   Fuentes R, LOGISTIC ANAL DIARRH
   Fuller JA, 2014, AM J TROP MED HYG, V91, P173, DOI 10.4269/ajtmh.13-0503
   GOLDING J, 1994, PAEDIATR PERINAT EP, V8, P17, DOI 10.1111/j.1365-3016.1994.tb00489.x
   Heijnen M, 2015, AM J TROP MED HYG, V93, P263, DOI [10.4269/ajtmh.14-0812, 10.4269/apmh.14-0812]
   Heijnen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093300
   HO MS, 1989, LANCET, V2, P961
   Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   Kwiringira J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1180
   Kwiringira J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-624
   Lima Marilia de Carvalho, 2004, Sao Paulo Med J, V122, P117, DOI 10.1590/S1516-31802004000300008
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M
   McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7
   Miller-Petrie MK, 2016, AM J TROP MED HYG, V94, P456, DOI 10.4269/ajtmh.15-0423
   Nelson KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103886
   NETO UF, 1994, J AM COLL NUTR, V13, P51
   Rheingans R., 2012, ESTIMATING INEQUITIE
   Rheinlander T, 2015, B WORLD HEALTH ORGAN, V93, P509, DOI 10.2471/BLT.14.144980
   Rodgers AF, 2007, TROP MED INT HEALTH, V12, P772, DOI 10.1111/j.1365-3156.2007.01848.x
   Sasaki S, 2008, AM J TROP MED HYG, V79, P414
   Shultz A, 2009, AM J TROP MED HYG, V80, P640
   Sobel J, 2004, CLIN INFECT DIS, V38, P1545, DOI 10.1086/420822
   Spears D, EFFECTS RURAL SANITA
   Tumwebaze IK, 2013, INT J ENVIRON HEAL R, V23, P191, DOI 10.1080/09603123.2012.713095
   [Anonymous], 2010, JMP TECHN TASK FORC
   UNICEF WHO, PROGR SAN DRINK 2015
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   [Anonymous], 2015, BIOETH GNOWCCF GLOB
NR 55
TC 4
Z9 4
U1 11
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD MAY
PY 2016
VL 13
IS 5
AR e1002010
DI 10.1371/journal.pmed.1002010
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN2NK
UT WOS:000376900100002
PM 27138888
OA gold
DA 2017-08-15
ER

PT J
AU Coeck, N
   de Jong, BC
   Diels, M
   de Rijk, P
   Ardizzoni, E
   Van Deun, A
   Rigouts, L
AF Coeck, Nele
   de Jong, Bouke C.
   Diels, Maren
   de Rijk, Pim
   Ardizzoni, Elisa
   Van Deun, Armand
   Rigouts, Leen
TI Correlation of different phenotypic drug susceptibility testing methods
   for four fluoroquinolones in Mycobacterium tuberculosis
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID MULTIDRUG-RESISTANT TUBERCULOSIS; RESAZURIN MICROTITER ASSAY;
   MULTICENTER LABORATORY VALIDATION; MGIT 960 SYSTEM; RIFAMPIN RESISTANCE;
   2ND-LINE DRUGS; IN-VITRO; INEXPENSIVE METHOD; RAPID DETECTION; RPOB
   MUTATIONS
AB Molecular resistance testing fails to explain all fluoroquinolone resistance, with a continued need for a suitable rapid phenotypic drug susceptibility testing method.
   To evaluate the optimal method for phenotypic fluoroquinolone susceptibility testing.
   Using Lowenstein-Jensen medium, Middlebrook 7H11 agar, BACTEC-MGIT 960 and the resazurin microtitre plate assay, we determined susceptibility to fluoroquinolones in Mycobacterium tuberculosis and investigated cross-resistance between ofloxacin, levofloxacin, moxifloxacin and gatifloxacin. We compared MICs of all four fluoroquinolones for 91 strains on Lowenstein-Jensen (as the gold standard) with their MICs in resazurin plates, and with ofloxacin susceptibility at a single concentration in MGIT and on 7H11 agar, in addition to sequencing of the gyrAB genes.
   Applying a cut-off of 2 mg/L ofloxacin, 1 mg/L levofloxacin and 0.5 mg/L moxifloxacin and gatifloxacin in all methods, some discordance between solid medium and MGIT methods was observed, yet this tended to be explained by MICs around the cut-off. The high discordance between Lowenstein-Jensen (LJ) and resazurin plates suggests that the currently applied cut-offs for all fluoroquinolones in the resazurin method should decrease and minor changes in colour (from blue to purple) be considered as meaningful. High-level resistance in all assays to all drugs correlated well with the presence of gyrA mutations, in support of recent findings that fluoroquinolone resistance should be tested at different concentrations, as patients with lower levels of resistance may continue to benefit from high-dose fluoroquinolone-based therapy.
C1 [Coeck, Nele; de Jong, Bouke C.; Diels, Maren; de Rijk, Pim; Ardizzoni, Elisa; Van Deun, Armand; Rigouts, Leen] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
   [Coeck, Nele; Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.
   [de Jong, Bouke C.] NYU, Dept Med, Div Infect Dis, 550 1St Ave, New York, NY 10016 USA.
   [de Jong, Bouke C.] MRC Unit, Vaccinol Dept, Fajara, Gambia.
   [Ardizzoni, Elisa] Med Sans Frontieres, Paris, France.
RP Rigouts, L (reprint author), Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.; Rigouts, L (reprint author), Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.
EM lrigouts@itg.be
FU Damien Foundation (Belgium); Dehousse grant from the University of
   Antwerp (Belgium); European Research Council Starting grant INTERRUPTB
   [311725]
FX This study was supported by the Damien Foundation (Belgium). NC was
   funded by a Dehousse grant from the University of Antwerp (Belgium). BdJ
   and LR were funded by a European Research Council Starting grant
   INTERRUPTB (311725).
CR da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x
   Angeby KA, 2010, J ANTIMICROB CHEMOTH, V65, P946, DOI 10.1093/jac/dkq091
   Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.1.104-112.2006
   Aubry A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095083
   Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100
   Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866
   Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09
   CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
   Eilertson B, 2014, ANTIMICROB AGENTS CH, V58, P3270, DOI 10.1128/AAC.02066-13
   Escribano I, 2007, CHEMOTHERAPY, V53, P397, DOI 10.1159/000109769
   Folkvardsen DB, 2013, J CLIN MICROBIOL, V51, P1596, DOI 10.1128/JCM.00472-13
   Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410
   Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09
   Horne DJ, 2013, J CLIN MICROBIOL, V51, P393, DOI 10.1128/JCM.02724-12
   Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115
   JI BH, 1995, ANTIMICROB AGENTS CH, V39, P1341
   Jo KW, 2014, INT J TUBERC LUNG D, V18, P39, DOI 10.5588/ijtld.13.0307
   Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006
   Li J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.21
   Lu J, 2014, FEMS MICROBIOL LETT, V353, P40, DOI 10.1111/1574-6968.12401
   Malik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039754
   Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004
   Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003
   Martin A, 2011, J ANTIMICROB CHEMOTH, V66, P827, DOI 10.1093/jac/dkq527
   Mayer C, 2014, MICROBIOL SPECTR, V2, P1
   Merle CS, 2015, NEW ENGL J MED, V372, P1677
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817
   Mokrousov I, 2008, ANTIMICROB AGENTS CH, V52, P2937, DOI 10.1128/AAC.00036-08
   Nosova EY, 2013, J MED MICROBIOL, V62, P108, DOI 10.1099/jmm.0.046821-0
   Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002
   Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191
   Pholwat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057238
   Poissy J, 2010, ANTIMICROB AGENTS CH, V54, P4765, DOI 10.1128/AAC.00968-10
   Rigouts L, 2016, J ANTIMICROB CHEMOTH, V71, P314, DOI 10.1093/jac/dkv360
   Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12
   Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006
   Said HM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-369
   Singh M, 2011, INDIAN J MED RES, V133, P535
   Singh P, 2015, J ANTIBIOT, V68, P63, DOI 10.1038/ja.2014.95
   Somasundaram S, 2006, CHEMOTHERAPY, V52, P190, DOI 10.1159/000093486
   Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11
   Sulochana S, 2005, J CHEMOTHERAPY, V17, P169
   Umubyeyi AN, 2006, INT J TUBERC LUNG D, V10, P808
   Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC
   van Ingen J, 2010, J CLIN MICROBIOL, V48, P2749, DOI 10.1128/JCM.00652-10
   Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09
   World Health Organization, WHOHTMTB201408
   World Health Organization, 2001, WHOCDSTB2001288
   World Health Organization, 2011, WHOHTMTB20119
   World Health Organization, 2008, WHOHTMTB2008392
   Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476
   Yin XM, 2010, J INFECTION, V61, P150, DOI 10.1016/j.jinf.2010.05.001
   Zhao LL, 2012, J MICROBIOL METH, V91, P212, DOI 10.1016/j.mimet.2012.06.010
NR 54
TC 3
Z9 3
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD MAY
PY 2016
VL 71
IS 5
BP 1233
EP 1240
DI 10.1093/jac/dkv499
PG 8
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA DM4BT
UT WOS:000376291300014
PM 26851609
OA No
DA 2017-08-15
ER

PT J
AU Owolabi, O
   Agbla, S
   Owiafe, P
   Donkor, S
   Togun, T
   Sillah, AK
   Ota, MOC
   Sutherland, JS
AF Owolabi, Olumuyiwa
   Agbla, Schadrac
   Owiafe, Patrick
   Donkor, Simon
   Togun, Toyin
   Sillah, Abdou K.
   Ota, Martin O. C.
   Sutherland, Jayne S.
TI Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk
   of TB progression in Gambian adults
SO TUBERCULOSIS
LA English
DT Article
DE Tuberculosis; Incident cases; 25(OH) D; Vitamin D binding protein;
   Latent TB infection
ID D-RECEPTOR POLYMORPHISMS; PULMONARY TUBERCULOSIS RISK; D DEFICIENCY;
   AFRICA; GENE; MALNUTRITION; POPULATION; PREVALENCE; INFECTION; EUROPE
AB Background: Vitamin D is essential in the host defence against tuberculosis (TB) as an immune modulator. The aim of this study was to determine the level of 25-hydroxyvitamin D (25 (OH) D) from adult TB index cases before and after treatment and their exposed household contacts (HHC) in The Gambia.
   Methods: Serum from adult index TB cases and their TB-exposed household contacts (HHC) was analysed for 25(OH) D and Vitamin D binding protein (VDBP) concentrations. Tuberculin skin test (TST) status was used as a measure of Mycobacterium tuberculosis (Mtb) infectivity in the HHC. In addition, HHC who later progressed to active TB (incident cases) were assessed alongside non-progressors to determine the influence of 25 (OH) D levels on TB risk.
   Results: Eighty-three TB cases, 46 TST+ and 52 TST- HHC were analysed. Generally levels of 25(OH) D were considered insufficient in all subjects. However, median levels of 25(OH) D and VDBP were significantly higher in TB cases compared to both TST+ and TST- HHC at recruitment and were significantly reduced after TB therapy (p < 0.0001 for all). In addition, levels of serum 25(OH) D at recruitment were significantly higher in TB progressors compared to non-progressors (median (IQR): 25.0(20.8-29.2) in progressors and 20.3 (16.3-24.6) ng/ml in non-progressors; p = 0.007).
   Conclusion: In The Gambia, an equatorial country, 25(OH) D levels are higher in serum of TB progressors and those with active disease compared to latently infected and uninfected subjects. These results contrast to findings in non-equatorial countries. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Owolabi, Olumuyiwa; Agbla, Schadrac; Owiafe, Patrick; Donkor, Simon; Togun, Toyin; Sillah, Abdou K.; Ota, Martin O. C.; Sutherland, Jayne S.] Vaccines & Immun Theme, Med Res Council Unit, Atlantic Rd, Fajara, Gambia.
   [Owiafe, Patrick] Univ Hlth & Allied Sci, Dept Med Lab Sci, PMB 31, Ho, Volta Region, Ghana.
   [Ota, Martin O. C.] WHO, Reg Off, Brazzaville, Congo.
RP Owolabi, O (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM oowolabi@mrc.gm
OI Kwasi Owiafe, Patrick/0000-0002-4287-3577; Sutherland,
   Jayne/0000-0002-7083-4997
FU Medical Research Council (UK)
FX Medical Research Council (UK).
CR Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614
   Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462
   Braithwaite VS, 2015, BONE, V74, P166, DOI 10.1016/j.bone.2014.12.068
   Conesa-Botella A, 2012, INT J TUBERC LUNG D, V16, P1517, DOI 10.5588/ijtld.11.0146
   Coussens AK, 2014, SCIENTIFICA, V2014
   Daley P, 2015, LANCET INFECT DIS, V15, P528, DOI 10.1016/S1473-3099(15)70053-8
   Friis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081142
   GARBINSKI TADEUSZ, 1956, SCHWEIZ ZEITSCHR TUBERK, V13, P440
   Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268
   Harishankar M, 2014, INT IMMUNOPHARMACOL, V23, P148, DOI 10.1016/j.intimp.2014.08.021
   Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Hong JY, 2014, INT J TUBERC LUNG D, V18, P73, DOI 10.5588/ijtld.13.0536
   Hood MLH, 2013, EUR J CLIN NUTR, V67, P1122, DOI 10.1038/ejcn.2013.143
   Lalvani A, 2012, PATHOG GLOB HEALTH, V106, P378, DOI 10.1179/2047772412Z.00000000087
   Lewis SJ, 2005, INT J TUBERC LUNG D, V9, P1174
   Lips P, 2007, J STEROID BIOCHEM, V103, P620, DOI 10.1016/j.jsbmb.2006.12.076
   Malik ZA, 2003, J IMMUNOL, V170, P2811
   Martineau AR, 2007, J IMMUNOL, V178, P7190
   Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108
   Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333
   Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410
   Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607
   Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212
   Sutherland JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074080
   Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665
   van der Meer IM, 2011, OSTEOPOROSIS INT, V22, P1009, DOI 10.1007/s00198-010-1279-1
   van Lettow M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-61
   Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407
   Wejse C, 2007, AM J CLIN NUTR, V86, P1376
   Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6
   Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4
   [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P69
NR 34
TC 3
Z9 3
U1 0
U2 1
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD MAY
PY 2016
VL 98
BP 86
EP 91
DI 10.1016/j.tube.2016.02.007
PG 6
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA DL4DJ
UT WOS:000375583200012
PM 27156622
OA No
DA 2017-08-15
ER

PT J
AU Oduro, AR
   Maya, ET
   Akazili, J
   Baiden, F
   Koram, K
   Bojang, K
AF Oduro, Abraham Rexford
   Maya, Ernest Tei
   Akazili, James
   Baiden, Frank
   Koram, Kwadwo
   Bojang, Kalifa
TI Monitoring malaria using health facility based surveys: challenges and
   limitations
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Community; Health centre; Malaria; Surveys
ID PLASMODIUM-FALCIPARUM; SEEKING BEHAVIOR; WEST-AFRICA; GAMBIA;
   PREVALENCE; INFECTION; CHILDREN; IMPACT; TRIAL; CARE
AB Background: Health facility data are more readily accessible for operational planning and evaluation of disease control programmes. The importance, potential challenges and limitations of using facility based survey as an alternative tool for monitoring changes in local malaria epidemiology were examined.
   Methods: The study involved six areas within the administrative divisions of The Gambia. The areas were selected to reflect socioeconomic and malaria transmission intensities across the country. The study design involved an age stratified cross sectional surveys that were conducted during the wet season in 2008 and in the 2009 during the dry season. Participants were patients attending clinics in six health centres and the representative populations from the catchment communities of the health centres.
   Results: Overall participants' characteristics were mostly not comparable in the two methodological approaches in the different seasons and settings. More females than males were enrolled (55.8 vs. 44.2 %) in all the surveys. Malaria infection was higher in the surveys in health centres than in the communities (p < 0.0001) and also in males than in females (OR = 1.3; p < 0.001). Males were less likely than females to sleep under an insecticide treated net in the communities (OR = 1.6; 95 % CI 1.3, 1.9) and in the health centres (OR = 1.3; 95 % CI 1.1, 1.5). Representativeness of the ethnic groups was better in the health centre surveys than in the community surveys when compared to the 2003 national population census in The Gambia.
   Conclusion: Health facility based survey though a potential tool for monitoring changes in the local epidemiology of malaria will require continuous validation of the facility and participants sociodemograhic characteristics as these may change over time. The effects of health seeking practices on service utilization and health facility surveys as an approach will also need continuous review.
C1 [Oduro, Abraham Rexford; Akazili, James] Navrongo Hlth Res Ctr, POB 114, Navrongo, Ghana.
   [Oduro, Abraham Rexford; Maya, Ernest Tei] Univ Ghana, Sch Publ Hlth, POB LG 13, Legon, Ghana.
   [Oduro, Abraham Rexford; Baiden, Frank] Ghana Hlth Serv, Res & Dev Div, Accra, Ghana.
   [Koram, Kwadwo] Noguchi Mem Inst Med Res, POB LG 581, Legon, Ghana.
   [Bojang, Kalifa] Med Res Council Unit, POB 273, Banjul, Gambia.
RP Oduro, AR (reprint author), Navrongo Hlth Res Ctr, POB 114, Navrongo, Ghana.; Oduro, AR (reprint author), Univ Ghana, Sch Publ Hlth, POB LG 13, Legon, Ghana.; Oduro, AR (reprint author), Ghana Hlth Serv, Res & Dev Div, Accra, Ghana.
EM aroduro@yahoo.com
OI Bojang, Kalifa/0000-0001-7506-0938
FU Medical Research Council (UK)
FX We are thankful to all the study participants and field workers who
   participated in the study. We are also grateful to the community
   members, elders and the heads and staff of the health centres that
   participated in this study. We would like acknowledge the support of the
   study supervisors Professors David Conway, David Schellenberg and Brian
   Greenwood. This work was sponsored by a Medical Research Council (UK)
   PhD studentship for ARO, and supported by core funding to the Malaria
   Programme at the Medical Research Council Laboratories in The Gambia.
   The funders had no direct role in study design, data collection,
   analysis and the decision to publish.
CR Bertakis KD, 2000, J FAM PRACTICE, V49, P147
   Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Chandramohan D, 2001, INT J EPIDEMIOL, V30, P509, DOI 10.1093/ije/30.3.509
   Chilundo B, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-3
   Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133
   Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014
   GBoS, 2007, GAMB MULT IND CLUST
   [Anonymous], 2003, GAMB POP HOUS CENS 2
   GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q
   GREENWOOD BM, 1987, ANN TROP MED PARASIT, V81, P345
   Kasse Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-143
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   Oduro AR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-222
   Oduro AR, 2011, PLOS ONE, V6, P26305
   OJANUGA DN, 1992, SOC SCI MED, V35, P613
   Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99
   Remme JHF, 2001, AM J TROP MED HYG, V64, P76
   Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209
   Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274
   Shaikh BT, 2005, J PUBLIC HEALTH, V27, P49, DOI 10.1093/pubmed/fdh207
   Skarbinski J, 2008, TROP MED INT HEALTH, V13, P396, DOI 10.1111/j.1365-3156.2008.02014.x
   Thomson M, 1996, SOC SCI MED, V43, P101, DOI 10.1016/0277-9536(95)00346-0
   Roll Back Malaria MEASURE Evaluation USAID UNICEF World Health Organization MACEPA CDC. Guidelines for Core Population-Based Indicators, 2009, GUID COR POP BAS IND
   Woldu DO, 2015, WOMEN HEALTH, V55, P227, DOI 10.1080/03630242.2014.979968
NR 25
TC 0
Z9 0
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD APR 21
PY 2016
VL 16
AR 354
DI 10.1186/s12889-016-2858-7
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK0IS
UT WOS:000374597100006
PM 27102913
OA gold
DA 2017-08-15
ER

PT J
AU Darboe, A
   Lin, IF
   Kuo, HW
AF Darboe, Amadou
   Lin, I-Feng
   Kuo, Hsien-Wen
TI Effort-reward imbalance and self-rated health among Gambian healthcare
   professionals
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
DE ERI model; Healthcare workers; Sub-Saharan Africa; Gambia
ID MODEL; WORK; STRESS
AB Background: The effort-reward imbalance (ERI) model of work stress has been widely applied in investigating association between psychosocial factors at work and health. This study examined associations between perceived psychosocial work stress as measured by the ERI model and self-rated health (SRH) among nurses and environmental health officers (EHOs) working in secondary public healthcare facilities in the Gambia.
   Method: A cross-sectional study on a random sample of 287 health care professionals (201 nurses and 86 EHOs). A 22-item ERI questionnaire was used to collect data on the psychosocial factors defined by the ERI model. SRH was assessed using a single item measure.
   Results: The distribution of subjective health was not statistically different between nurses and EHOs. However, our study uncovered significant associations between perceived psychosocial work stress and subjective health. Specifically, we found that a perceived high effort-reward imbalance (ER-ratio > 1) is a significant risk factor for poor SRH, in both occupational groups. However, over-commitment was not significantly associated with poor SRH in the two groups. When efforts and rewards were considered as separate variables in the analysis, rewards were inversely associated with poor SRH in both groups.
   Conclusion: Because of the high perceived Effort-Reward Imbalance among healthcare professionals at secondary public healthcare facilities, it is necessary to modify working conditions through improvement of psychosocial work environment, such as reasonable allocation of resources to increase pay, incentives or other forms of rewards from government. Interventions that could mitigate and prevent stress at work are worth considering in future healthcare policies.
C1 [Darboe, Amadou] Minist Hlth & Social Welf, Banjul, Gambia.
   [Darboe, Amadou] Natl Yang Ming Univ, Inst Publ Hlth, Int Hlth Program, Taipei 112, Taiwan.
   [Lin, I-Feng] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.
   [Kuo, Hsien-Wen] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.
   [Kuo, Hsien-Wen] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.
RP Kuo, HW (reprint author), Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.; Kuo, HW (reprint author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.
EM hwkuo@ym.edu.tw
CR Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002
   Arial M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-121
   Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001
   Campbell J, 2013, UNIVERSAL TRUTH NO H
   CIAM, 2010, EFF INC HLTH SERV PR
   DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.0291.x
   Unit H., 2012, ANN HLTH SERV STAT R
   Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-198
   Kakunje A., 2011, ONLINE J HLTH ALLIED, V10
   Kinnunen U, 2008, J OCCUP HEALTH PSYCH, V13, P114, DOI 10.1037/1076-8998.13.2.114
   Kuper H, 2002, OCCUP ENVIRON MED, V59, P777, DOI 10.1136/oem.59.11.777
   Lau B., 2008, J OCCUP MED TOXICOL, V3, P1
   Li J, 2005, INT ARCH OCC ENV HEA, V78, P198, DOI 10.1007/s00420-004-0581-7
   McAuliffe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058415
   MOH, 2005, HUM RES HLTH UPD SIT
   Niedhammer I, 2004, SOC SCI MED, V58, P1531, DOI 10.1016/S0277-9536(03)00346-0
   Ojedokun O., 2010, IFE PSYCHOL, V18, P137
   Peltzer K, 2009, STRESS HEALTH, V25, P247, DOI 10.1002/smi.1244
   Pikhart H, 2001, J EPIDEMIOL COMMUN H, V55, P624, DOI 10.1136/jech.55.9.624
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4
   Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037//1076-8998.1.1.27
   Siegrist J., 2002, EFFORT REWARD IMBALA, P261
   Siegrist J., 2013, PSCYHOMETRIC PROPERT
   Siegrist J, 2008, SCAND J WORK ENV HEA, P163
   Subramanian SV, 2010, B WORLD HEALTH ORGAN, V88, P131, DOI 10.2471/BLT.09.067058
   Tanzman ES, 2001, NEW ENGL J MED, V345, P1916
   van Vegchel N, 2005, SOC SCI MED, V60, P1117, DOI 10.1016/j.socscimed.2004.06.043
   Van Vegchela N, 2002, J WORK ORG PSYCHOL, V11, P403
   Weyers S, 2006, SCAND J CARING SCI, V20, P26, DOI 10.1111/j.1471-6712.2006.00376.x
   WHO, 2006, WHOCDSWHOPESGCDPP200, P67
NR 31
TC 1
Z9 1
U1 2
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD APR 11
PY 2016
VL 16
AR 125
DI 10.1186/s12913-016-1347-0
PG 9
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA DI8RU
UT WOS:000373769700001
PM 27067122
OA gold
DA 2017-08-15
ER

PT J
AU Jaiteh, F
   Dierickx, S
   Gryseels, C
   O'Neill, S
   D'Alessandro, U
   Scott, S
   Balen, J
   Grietens, KP
AF Jaiteh, Fatou
   Dierickx, Susan
   Gryseels, Charlotte
   O'Neill, Sarah
   D'Alessandro, Umberto
   Scott, Susana
   Balen, Julie
   Grietens, Koen Peeters
TI 'Some anti-malarials are too strong for your body, they will harm
   you.'Socio-cultural factors influencing pregnant women's adherence to
   anti-malarial treatment in rural Gambia
SO MALARIA JOURNAL
LA English
DT Article
DE Adherence; Anti-malarials; Pregnancy; Rural Gambia
ID PLASMODIUM-VIVAX
AB Background: Despite declining prevalence of malaria in The Gambia, non-adherence to anti-malarial treatment still remains a challenge to control efforts. There is limited evidence on the socio-cultural factors that influence adherence to anti-malarial treatment in pregnancy. This study explored perceptions of malaria in pregnancy and their influence on adherence to anti-malarial treatment in a rural area of The Gambia.
   Methods: An exploratory ethnographic study was conducted ancillary to a cluster-randomized trial on scheduled screening and treatment of malaria in pregnancy at village level in the Upper River Region of The Gambia from June to August 2014. Qualitative data were collected through interviewing and participant observation. Analysis was concurrent to data collection and carried out using NVivo 10.
   Results: Although women had good bio-medical knowledge of malaria in pregnancy, adherence to anti-malarial treatment was generally perceived to be low. Pregnant women were perceived to discontinue the provided antimalarial treatment after one or 2 days mainly due to non-recognition of symptoms, perceived ineffectiveness of the anti-malarial treatment, the perceived risks of medication and advice received from mothers-in-law.
   Conclusion: Improving women's knowledge of malaria in pregnancy is not sufficient to assure adherence to antimalarial treatment. Addressing structural barriers such as unclear health workers' messages about medication dosage, illness recognition, side effects of the medication and the integration of relatives, especially the mothers-in-law, in community-based programmes are additionally required.
C1 [Jaiteh, Fatou] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England.
   [Jaiteh, Fatou; Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; D'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Jaiteh, Fatou; D'Alessandro, Umberto; Scott, Susana] MRC Unit, Fajara, Gambia.
   [Dierickx, Susan; Gryseels, Charlotte] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.
   [D'Alessandro, Umberto; Scott, Susana] London Sch Hyg & Trop Med, London WC1, England.
   [Balen, Julie] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan.
   [Grietens, Koen Peeters] PASS Int, Tessenderlo, Belgium.
RP Jaiteh, F (reprint author), Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England.; Jaiteh, F (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.; Jaiteh, F (reprint author), MRC Unit, Fajara, Gambia.
EM fjaiteh@mrc.gm
FU Demba Njie (COSMIC study nurse coordinator)
FX We like to express our sincere gratitude to Demba Njie (COSMIC study
   nurse coordinator) and Teeda Sonko (COSMIC study field nurse) for all
   their support given during the study period. We are also grateful to the
   community members of the Demba Kunda Kuta, Koto and Mandinka for their
   cooperation during the study period.
CR Andrew EVW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119077
   Banek K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-7
   Bernard H. R, 2006, RES METHODS ANTHR QU
   Boene H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086038
   Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Conteh L, 2007, TROP MED INT HEALTH, V12, P382, DOI 10.1111/j.1365-3156.2006.01806.x
   Grietens KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012013
   Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521
   Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343
   Hartman TK, 2010, ANN TROP PAEDIATR, V30, P271, DOI 10.1179/146532810X12858955921032
   Heggenhougen HK, 2003, BEHAV SOCIAL ASPECTS
   Manderson L, 1998, TROP MED INT HEALTH, V3, P1020, DOI 10.1046/j.1365-3156.1998.00334.x
   McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7
   The Ministry of Health and Social Affairs. The Government of The Gambia, 2012, NAT MAL STRAT PAP
   Hausmann Muela S, 2012, MALARIA REPORTS, V1, P17
   Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6
   Ndoyomugyenyi R, 1998, HLTH POLICY PLAN, V13, P94
   Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2
   Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452
   Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092
   Scott S, 2014, TRIALS, V28, P340
   Shanks GD, 2006, J POSTGRAD MED, V52, P277
   Spencer L., 2003, QUALITY QUALITATIVE
   Stark L, 2010, PRACTICAL GUIDE RES
   Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x
   Tagbor H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132247
   Tefler M, 2002, AFR J REPROD HEALTH, V6, P74
   Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003
   White N, 1998, ANN TROP MED PARASIT, V92, P367
   WHO, 2015, GUID TREATM MAL
   Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010
NR 32
TC 1
Z9 1
U1 1
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD APR 11
PY 2016
VL 15
AR 195
DI 10.1186/s12936-016-1255-0
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DI7EZ
UT WOS:000373663400001
PM 27068760
OA gold
DA 2017-08-15
ER

PT J
AU Sarr, I
   Jarju, S
   Kebbeh, N
   Sey, G
   Saidykhan, M
   Thomas, G
   Secka, F
   Antonio, M
   Bojang, K
AF Sarr, I.
   Jarju, S.
   Kebbeh, N.
   Sey, G.
   Saidykhan, M.
   Thomas, G.
   Secka, F.
   Antonio, M.
   Bojang, K.
TI The impact of pre-hospital antibiotics on blood culture yields in a low
   resource setting
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Sarr, I.] MRC, Banjul, Gambia.
   [Jarju, S.; Kebbeh, N.; Saidykhan, M.; Thomas, G.; Antonio, M.; Bojang, K.] MRC Gambia, Banjul, Gambia.
   [Sey, G.] MRC, Banjul, Gambia.
   [Secka, F.] Med & Res Council Unit, Banjul, Gambia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
SU 1
MA 41.008
BP 72
EP 73
DI 10.1016/j.ijid.2016.02.206
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DK4GZ
UT WOS:000374876700150
OA gold
DA 2017-08-15
ER

PT J
AU Oriero, EC
   Jacobs, J
   Van Geertruyden, JP
   Nwakanma, DC
   D'Alessandro, U
AF Oriero, E. C.
   Jacobs, J.
   Van Geertruyden, J. -P.
   Nwakanma, D. C.
   D'Alessandro, U.
TI Field evaluation of a novel loop mediated isothermal amplification
   (LAMP) assay for molecular diagnosis of asymtomatic malaria in a field
   setting in sub-Saharan Africa
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Oriero, E. C.; Nwakanma, D. C.; D'Alessandro, U.] MRC Unit, Banjul, Gambia.
   [Jacobs, J.] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium.
OI Van geertruyden, Jean-Pierre/0000-0001-5006-6364
NR 0
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
SU 1
MA 41.181
BP 155
EP 155
DI 10.1016/j.ijid.2016.02.373
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DK4GZ
UT WOS:000374876700317
OA gold
DA 2017-08-15
ER

PT J
AU Ward, KA
   Jarjou, L
   Prentice, A
AF Ward, K. A.
   Jarjou, L.
   Prentice, A.
TI MATERNAL CALCIUM SUPPLEMENTATION AND OFFSPRING GROWTH
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Meeting Abstract
CT WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and
   Musculoskeletal Diseases
CY APR 14-17, 2016
CL Malaga, SPAIN
SP WCO, IOF, ESCEO
C1 [Ward, K. A.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
   [Jarjou, L.] MRC Gambia Unit, Keneba, Gambia.
   [Prentice, A.] MRC Gambia Unit, MRC Human Nutr Res, Cambridge, England.
CR Goldberg, 2013, AM J CLIN NUTR, V98
   Jarjou, 2006, AM J CLIN NUTR, P83
   Ward, J BONE MINER RES, V30
NR 3
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD APR
PY 2016
VL 27
SU 1
MA P585
BP S327
EP S328
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DM6NH
UT WOS:000376469102105
OA No
DA 2017-08-15
ER

PT J
AU Williams, JE
   Cairns, M
   Njie, F
   Quaye, SL
   Awine, T
   Oduro, A
   Tagbor, H
   Bojang, K
   Magnussen, P
   ter Kuile, FO
   Woukeu, A
   Milligan, P
   Chandramohan, D
   Greenwood, B
AF Williams, John E.
   Cairns, Matthew
   Njie, Fanta
   Quaye, Stephen Laryea
   Awine, Timothy
   Oduro, Abraham
   Tagbor, Harry
   Bojang, Kalifa
   Magnussen, Pascal
   ter Kuile, Feiko O.
   Woukeu, Arouna
   Milligan, Paul
   Chandramohan, Daniel
   Greenwood, Brian
TI The Performance of a Rapid Diagnostic Test in Detecting Malaria
   Infection in Pregnant Women and the Impact of Missed Infections
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE malaria in pregnancy; rapid diagnostic test; intermittent screening and
   treatment; Ghana
ID INTERMITTENT PREVENTIVE TREATMENT; LOW-BIRTH-WEIGHT;
   PLASMODIUM-FALCIPARUM INFECTIONS; SULFADOXINE-PYRIMETHAMINE;
   SUBMICROSCOPIC MALARIA; DRUG-RESISTANCE; MATERNAL ANEMIA; METAANALYSIS;
   AFRICA; AREA
AB Background. Intermittent screening and treatment in pregnancy (ISTp) is a potential strategy for the control of malaria during pregnancy. However, the frequency and consequences of malaria infections missed by a rapid diagnostic test (RDT) for malaria are a concern.
   Methods. Primigravidae and secundigravidae who participated in the ISTp arm of a noninferiority trial in 4 West African countries were screened with an HRP2/pLDH RDT on enrollment and, in Ghana, at subsequent antenatal clinic (ANC) visits. Blood samples were examined subsequently by microscopy and by a polymerase chain reaction (PCR) assay.
   Results. The sensitivity of the RDT to detect peripheral blood infections confirmed by microscopy and/or PCR at enrollment ranged from 91% (95% confidence interval [CI], 88%, 94%) in Burkina Faso to 59% (95% CI, 48%, 70% in The Gambia. In Ghana, RDT sensitivity was 89% (95% CI, 85%, 92%), 83% (95% CI, 76%, 90%) and 77% (95% CI, 67%, 86%) at enrollment, second and third ANC visits respectively but only 49% (95% CI, 31%, 66%) at delivery. Screening at enrollment detected 56% of all infections detected throughout pregnancy. Seventy-five RDT negative PCR or microscopy positive infections were detected in 540 women; these were not associated with maternal anemia, placental malaria, or low birth weight.
   Conclusions. The sensitivity of an RDT to detect malaria in primigravidae and secundigravidae was high at enrollment in 3 of 4 countries and, in Ghana, at subsequent ANC visits. In Ghana, RDT negative malaria infections were not associated with adverse birth outcomes but missed infections were uncommon.
C1 [Williams, John E.; Quaye, Stephen Laryea; Awine, Timothy; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Cairns, Matthew; Woukeu, Arouna; Milligan, Paul; Chandramohan, Daniel; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.
   [Cairns, Matthew; Woukeu, Arouna; Milligan, Paul; Chandramohan, Daniel; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
   [Njie, Fanta; Bojang, Kalifa] Med Res Unit, Fajara, Gambia.
   [Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Dept Community Med, Kumasi, Ghana.
   [Magnussen, Pascal] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1168 Copenhagen, Denmark.
   [Magnussen, Pascal] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, DK-1168 Copenhagen, Denmark.
   [ter Kuile, Feiko O.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.
RP Greenwood, B (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
EM brian.greenwood@lshtm.ac.uk
RI Milligan, Paul/D-8985-2017
OI Milligan, Paul/0000-0003-3430-3395; ter Kuile, Feiko/0000-0003-3663-5617
FU European Developing Country Clinical Trials Programme
   [IP.2007.31080.003]; Malaria in Pregnancy Consortium through Bill &
   Melinda Gates Foundation; UK Medical Research Council (MRC); UK
   Department for International Development (DFID)
FX The study was funded by the European Developing Country Clinical Trials
   Programme (grant number IP.2007.31080.003) and by the Malaria in
   Pregnancy Consortium which is funded through a grant from the Bill &
   Melinda Gates Foundation to the Liverpool School of Tropical Medicine.
   M. C. is supported by a fellowship jointly funded the UK Medical
   Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement.
CR Adegnika AA, 2006, AM J TROP MED HYG, V75, P798
   Arinaitwe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073073
   Cohee LM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-274
   Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122
   Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4
   Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0
   Fried M, 2012, EXPERT REV ANTI-INFE, V10, P1177, DOI [10.1586/eri.12.98, 10.1586/ERI.12.98]
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Gutman J, 2013, J INFECT DIS, V208, P907, DOI 10.1093/infdis/jit276
   Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106
   Harrington WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056183
   Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376
   Kattenberg JH, 2012, TROP MED INT HEALTH, V5, P550
   Kyabayinze DJ, 2012, MALARIA J, V10, pe306
   Likwela JL, 2012, TROP MED INT HEALTH, V17, P322, DOI 10.1111/j.1365-3156.2011.02935.x
   Mankhambo L, 2002, J CLIN MICROBIOL, V40, P155, DOI 10.1128/JCM.40.1.155-158.2002
   Mayor A, 2012, CLIN INFECT DIS, V54, P1561, DOI 10.1093/cid/cis236
   McClure EM, 2013, INT J GYNECOL OBSTET, V121, P103, DOI 10.1016/j.ijgo.2012.12.014
   Minja DT, 2013, EMERG INFECT DIS, V9, P1446
   Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x
   Mohammed AH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-172
   Singh N, 2015, PATHOG GLOB HEALTH, V109, P30, DOI 10.1179/2047773215Y.0000000002
   Sridaran S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-247
   Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223
   Tagbor H, 2015, PLOS ONE, V10, P1371
   Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425
   World Health Organization (WHO), 2012, UPD WHO POL REC INT
NR 27
TC 8
Z9 8
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 1
PY 2016
VL 62
IS 7
BP 837
EP 844
DI 10.1093/cid/civ1198
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DJ5LD
UT WOS:000374248700005
PM 26721833
OA No
DA 2017-08-15
ER

PT J
AU Ahouidi, AD
   Amambua-Ngwa, A
   Awandare, GA
   Bei, AK
   Conway, DJ
   Diakite, M
   Duraisingh, MT
   Rayner, JC
   Zenonos, ZA
AF Ahouidi, Ambroise D.
   Amambua-Ngwa, Alfred
   Awandare, Gordon A.
   Bei, Amy K.
   Conway, David J.
   Diakite, Mahamadou
   Duraisingh, Manoj T.
   Rayner, Julian C.
   Zenonos, Zenon A.
TI Malaria Vaccine Development: Focusing Field Erythrocyte Invasion Studies
   on Phenotypic Diversity The West African Merozoite Invasion Network
   (WAMIN)
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID PLASMODIUM-FALCIPARUM MALARIA; LIGAND GENE-EXPRESSION; RED-BLOOD-CELL;
   ARTEMISININ RESISTANCE; PARASITE INVASION; RECEPTOR; POPULATIONS;
   GLYCOPHORIN; COMPLEMENT; MECHANISMS
AB Erythrocyte invasion by Plasmodium falciparum merozoites is an essential step for parasite survival and proliferation. Invasion is mediated by multiple ligands, which could be promising vaccine targets. The usage and sequence of these ligands differs between parasites, yet most studies of them have been carried out in only a few laboratory-adapted lines. To understand the true extent of natural variation in invasion phenotypes and prioritize vaccine candidates on a relevant evidence base, we need to develop and apply standardized assays to large numbers of field isolates. The West African Merozoite Invasion Network (WAMIN) has been formed to meet these goals, expand training in Plasmodium phenotyping, and perform large-scale field phenotyping studies in order to prioritize blood stage vaccine candidates.
C1 [Ahouidi, Ambroise D.; Bei, Amy K.] Cheikh Anta Diop Univ, Fac Med & Pharm, Le Dantec Hosp, Lab Bacteriol & Virol, Dakar, Senegal.
   [Amambua-Ngwa, Alfred] MRC Unit, Banjul, Gambia.
   [Awandare, Gordon A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana.
   [Awandare, Gordon A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana.
   [Bei, Amy K.; Duraisingh, Manoj T.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Conway, David J.] London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, Keppel St, London WC1, England.
   [Diakite, Mahamadou] Univ Bamako, Fac Med Pharm & Odontostomatol, Bamako, Mali.
   [Rayner, Julian C.; Zenonos, Zenon A.] Wellcome Trust Sanger Inst, Malaria Programme, Wellcome Genome Campus, Cambridge CB10 1SA, England.
RP Rayner, JC (reprint author), Wellcome Trust Sanger Inst, Malaria Programme, Wellcome Genome Campus, Cambridge CB10 1SA, England.
EM jr9@sanger.ac.uk
OI Rayner, Julian/0000-0002-9835-1014
FU National Institutes of Health (NIH) [R01AI102848]; Royal
   Society-Leverhulme Trust Africa [AA130127]; European Research Council
   (ERC) Advanced Award [AdG-2011-294428]; NIH [R01AI091787]; Wellcome
   Trust [098051]; Medical Research Council (MRC) Career Development Award;
   Cambridge-Africa
FX The WAMIN workshop was supported by a grant from Cambridge-Africa to
   J.C.R., A.K.B., and Prof. Souleymane Mboup. The authors wish to
   acknowledge Prof. Souleymane Mboup, Prof. Tandakha N. Dieye, Dr Selasi
   Dankwa, and Prof. Jose A. Stoute for their support and contribution to
   the success of the workshop. Investigators in WAMIN were supported by a
   National Institutes of Health (NIH) grant R01AI102848 to G.A.A., Royal
   Society-Leverhulme Trust Africa Awards jointly to G.A.A. and D.J.C.
   (AA130127), a European Research Council (ERC) Advanced Award to D.J.C.
   (AdG-2011-294428), an NIH grant R01AI091787 to M.T.D., the Wellcome
   Trust to J.C.R. (098051) and a Medical Research Council (MRC) Career
   Development Award to A.A-N.
CR AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72
   Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406
   Arley F, 2014, NATURE, V505, P50, DOI DOI 10.1038/NATURE12876
   Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Awandare GA, 2011, MOL BIOCHEM PARASIT, V177, P57, DOI 10.1016/j.molbiopara.2011.01.005
   Badiane AS, 2013, CLIN VACCINE IMMUNOL, V20, P1238, DOI 10.1128/CVI.00135-13
   Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019
   Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200
   Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003
   Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157
   Bel A.K., 2007, MOL BIOCHEM PARASIT, V153, P66
   Bel A.K., 2012, INT J PARASITOL, V42, P575
   Bowyer PW, 2015, INFECT IMMUN, V83, P2575, DOI 10.1128/IAI.03009-14
   Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012
   Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966
   Chotivanich K, 2000, J INFECT DIS, V182, P629, DOI 10.1086/315718
   Cortes A, 2008, TRENDS PARASITOL, V24, P517, DOI 10.1016/j.pt.2008.08.005
   Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006
   Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112
   Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606
   Deans AM, 2007, INFECT IMMUN, V75, P3014, DOI 10.1128/IAI.00249-07
   Douglas A.D., 2011, NAT COMMUN, V3, P601
   Duncan CJA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7728
   Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096
   Egan ES, 2015, SCIENCE, V348, P711, DOI 10.1126/science.aaa3526
   Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010
   Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007
   Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902
   Harvey KL, 2012, INT J PARASITOL, V42, P567, DOI 10.1016/j.ijpara.2012.02.011
   Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07
   Lantos PM, 2009, PARASITOLOGY, V136, P1, DOI 10.1017/S0031182008005167
   Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004
   Lopez-Perez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047913
   Mensah-Brown HE, 2015, J INFECT DIS, V212, P1288, DOI 10.1093/infdis/jiv207
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   MILLER LH, 1977, J EXP MED, V146, P277, DOI 10.1084/jem.146.1.277
   Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624
   MITCHELL GH, 1986, BLOOD, V67, P1519
   Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004
   Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528
   Niang M, 2014, CELL HOST MICROBE, V16, P81, DOI 10.1016/j.chom.2014.06.004
   Okoyeh JN, 1999, INFECT IMMUN, V67, P5784
   PASVOL G, 1983, CIBA F SYMP, V94, P174
   PASVOL G, 1982, LANCET, V2, P947
   Patel SD, 2013, J INFECT DIS, V208, P1679, DOI 10.1093/infdis/jit385
   Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003
   Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968
   Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110
   Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002
   Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107
   Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972
   Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670
   Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943
   Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216
NR 55
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD APR
PY 2016
VL 32
IS 4
BP 274
EP 283
DI 10.1016/j.pt.2015.11.009
PG 10
WC Parasitology
SC Parasitology
GA DK0NT
UT WOS:000374610200005
OA No
DA 2017-08-15
ER

PT J
AU Abu-Ghori, IK
   Bodrick, MME
   Hussain, R
   Rassool, GH
AF Abu-Ghori, Ibrahim K.
   Bodrick, Mustafa M. E.
   Hussain, Rafat
   Rassool, G. Hussein
TI Nurses' involvement in end-of-life care of patients after a do not
   resuscitate decision on general medical units in Saudi Arabia
SO INTENSIVE AND CRITICAL CARE NURSING
LA English
DT Article
DE Do-not-resuscitate; End-of-life care; Nurses involvement; Nurses' lived
   experience; Reflective journaling technique
ID INTENSIVE-CARE; EXPERIENCES; PEOPLE
AB Objectives: To describe the essence of the nurses' lived experience and explore the meaning of their involvement in end-of-life care after a do-not-resuscitate decision has been made.
   Research methodology/design: The research design embraced qualitative, exploratory and descriptive approaches utilising aspects of phenomenology. Purposive sampling of twenty-six registered nurses was used. Data was collected using the reflective journaling technique and were analysed using an integrated approach. Field notes were also used as a mean to enrich the description of the findings contextually.
   Setting: Medical units in Saudi Arabia.
   Results: Three main themes emerged: exhausted medical treatment, continuity of nursing care and cultural considerations in nursing care. Related sub-themes were also identified as an extension to the description of the main themes.
   Conclusion: The findings affirm that nurses working on medical units continue to maintain a constant level of care for patients and families after the do-not-resuscitate decision. Nurses found that caring for dying patients was a rewarding and worthwhile experience, albeit a challenging and demanding one. The findings suggest that improvement in end-of-life care would be best achieved by collaborative and interdisciplinary practices amongst the health care team members. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Abu-Ghori, Ibrahim K.] King Abdul Aziz Med City, Minist Natl Guard Hlth Affairs, Acute Med Unit, Riyadh, Saudi Arabia.
   [Bodrick, Mustafa M. E.] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.
   [Hussain, Rafat] Univ New England, Armidale, NSW, Australia.
   [Rassool, G. Hussein] Islamic Online Univ, Fac Psychol, Bansang, Gambia.
RP Rassool, GH (reprint author), Islamic Online Univ, Fac Psychol, Bansang, Gambia.
EM ghorii@ngha.med.sa; BodrickM@NGHA.MED.SA; rhussain@une.edu.au;
   husseinrassool@gmail.com
CR al-Shahri Mohammad Zafir, 2005, J Support Oncol, V3, P432
   Allen CH, 2008, NURSING MADE INCREDI, P46
   Badger JM, 2005, HEART LUNG, V34, P63, DOI 10.1016/j.hrtlng.2004.08.005
   Barnett M., 2006, J CLIN NURS, V20, P30
   Beckstrand RL, 2006, AM J CRIT CARE, V15, P38
   Blais KK, 2006, PROFESSIONAL NURSING
   Bolmsjo IA, 2008, AM J HOSP PALLIAT ME, V25, P328, DOI 10.1177/1049909108315910
   Borbasi S., 2005, AUSTR CRITICAL CARE, V18, P104, DOI 10.1016/S1036-7314(05)80011-6
   Bristowe K, 2015, PALLIATIVE MED, V29, P797, DOI 10.1177/0269216315578990
   Brown Anthony E, 2006, Palliat Support Care, V4, P81
   Calvin Amy O, 2007, J Neurosci Nurs, V39, P143
   Coffey A., 1996, MAKING SENSE QUALITA
   Coombs MA, 2012, INT J NURS STUD, V49, P519, DOI 10.1016/j.ijnurstu.2011.10.019
   Gibbins J, 2011, MED EDUC, V45, P389, DOI 10.1111/j.1365-2923.2010.03873.x
   Graham LW, 2005, INT J NURS PRACT, V11, P277
   Heland Melodie, 2006, Aust Crit Care, V19, P25, DOI 10.1016/S1036-7314(06)80020-2
   Hopkinson JB, 2003, J ADV NURS, V44, P525, DOI 10.1046/j.0309-2402.2003.02836.x
   Johns C., 2004, BECOMING REFLECTIVE
   KREFTING L, 1991, AM J OCCUP THER, V45, P214
   London MR, 2007, J NURS CARE QUAL, V22, P152
   Long-Sutehall T, 2001, INT J NURS STUD, V48, P1466
   McCann JA, 2007, END LIFE NURSES GUID
   McGrath Pam, 2006, Int J Nurs Pract, V12, P295, DOI 10.1111/j.1440-172X.2006.00585.x
   Patton MQ, 2002, QUALITATIVE RES EVAL
   Plack MM, 2005, J ALLIED HLTH, V34, P199
   Quinn F., 2007, QUINNS PRINCIPLES PR
   Rassool GH, 2000, J ADV NURS, V32, P1476, DOI 10.1046/j.1365-2648.2000.01614.x
   Richards L., 2007, READ ME 1 USERS GUID
   Rogers A, 2005, J RES NURS, V10, P153, DOI 10.1177/174498710501000208
   Ross HM, 2001, MEDSURG NURSING, V10, P83
   Ruth-Sahd LA, 2003, J NURS EDUC, V42, P488
   Schober M, 2004, COLLABORATIVE PRACTI
   Smeltzer S.C., 2010, BRUNNER SUDDARTHS TX
   Streubert HJ, 2010, QUALITATIVE RES NURS
   Taylor B., 2006, REFLECTIVE PRACTICE
   Tesch R., 1990, QUALITATIVE RES ANAL
   Thomas R, 2008, J HOSP PALLIAT NURS, V10, P142, DOI DOI 10.1097/01.NJH.0000306740.10636.64
   Thompson G, 2006, J ADV NURS, V53, P169, DOI 10.1111/j.1365-2648.2006.03712.x
   Touhy T, 2005, J GERONTOLOGICAL NUR, V31, P27
   Walker SE, 2006, J ATHL TRAINING, V41, P216
   Wallerstedt B, 2007, SCAND J CARING SCI, V21, P32, DOI 10.1111/j.1471-6712.2007.00430.x
   Weigal C, 2007, J HOSP PALLIAT NURS, V9, P86, DOI 10.1097/01.NJH.0000263530.37671.b8
NR 42
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0964-3397
EI 1532-4036
J9 INTENS CRIT CARE NUR
JI Intensive Crit. Care Nurs.
PD APR
PY 2016
VL 33
BP 21
EP 29
DI 10.1016/j.iccn.2015.10.007
PG 9
WC Nursing
SC Nursing
GA DG5MQ
UT WOS:000372122900005
PM 26685090
OA No
DA 2017-08-15
ER

PT J
AU Miyahara, R
   Jasseh, M
   Mackenzie, GA
   Bottomley, C
   Hossain, MJ
   Greenwood, BM
   D'Alessandro, U
   Roca, A
AF Miyahara, Reiko
   Jasseh, Momodou
   Mackenzie, Grant Austin
   Bottomley, Christian
   Hossain, M. Jahangir
   Greenwood, Brian M.
   D'Alessandro, Umberto
   Roca, Anna
TI The large contribution of twins to neonatal and post-neonatal mortality
   in The Gambia, a 5-year prospective study
SO BMC PEDIATRICS
LA English
DT Article
DE Twins; HDSS; Mortality; Risk factors; Neonatal; Post-neonatal
ID DEMOGRAPHIC SURVEILLANCE SYSTEM; PERINATAL-MORTALITY; UNDER-5 MORTALITY;
   CHILD-MORTALITY; SEX-DIFFERENCES; RISK-FACTORS; INFANT; HEALTH; BIRTH;
   NIGERIA
AB Background: A high twinning rate and an increased risk of mortality among twins contribute to the high burden of infant mortality in Africa. This study examined the contribution of twins to neonatal and post-neonatal mortality in The Gambia, and evaluated factors that contribute to the excess mortality among twins.
   Methods: We analysed data from the Basse Health and Demographic Surveillance System (BHDSS) collected from January 2009 to December 2013. Demographic and epidemiological variables were assessed for their association with mortality in different age groups.
   Results: We included 32,436 singletons and 1083 twins in the analysis (twining rate 16.7/1000 deliveries). Twins represented 11.8 % of all neonatal deaths and 7.8 % of post-neonatal deaths. Mortality among twins was higher than in singletons [ adjusted odds ratio (AOR) 4.33 (95 % CI: 3.09, 6.06) in the neonatal period and 2.61 (95 % CI: 1.85, 3.68) in the post-neonatal period]. Post-neonatal mortality among twins increased in girls (P for interaction = 0.064), being born during the dry season (P for interaction = 0.030) and lacking access to clean water (P for interaction = 0.042).
   Conclusion: Mortality among twins makes a significant contribution to the high burden of neonatal and post-neonatal mortality in The Gambia and preventive interventions targeting twins should be prioritized.
C1 [Miyahara, Reiko; Jasseh, Momodou; Mackenzie, Grant Austin; Hossain, M. Jahangir; D'Alessandro, Umberto; Roca, Anna] MRC, Banjul, Gambia.
   [Miyahara, Reiko] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan.
   [Mackenzie, Grant Austin] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England.
   [Bottomley, Christian; Greenwood, Brian M.; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Mackenzie, Grant Austin] Murdoch Children Res Inst, Melbourne, Vic, Australia.
   [Roca, Anna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.
RP Roca, A (reprint author), MRC, Banjul, Gambia.; Roca, A (reprint author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.
EM aroca@mrc.gm
FU MRC (UK); Global Alliance for Vaccines and Immunisation's PneumoADIP;
   Bill & Melinda Gates Foundation; GlaxoSmithKline
FX MRC Unit The Gambia core funding comes from the MRC (UK). Funding for
   the Basse HDSS has been provided by the Global Alliance for Vaccines and
   Immunisation's PneumoADIP, the Bill & Melinda Gates Foundation, and MRC
   (UK). RM has received the sponsorship from GlaxoSmithKline.
CR AABY P, 1995, EPIDEMIOLOGY, V6, P419, DOI 10.1097/00001648-199507000-00016
   Bjerregaard Andersen M, 2014, TROP MED INT HEALTH, V19, P1477
   ASINDI AA, 1993, J TROP PEDIATRICS, V39, P378
   Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265
   Bjerregaard-Andersen M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-140
   Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008
   Castelino J. M., 2013, TROP MED INT HEALTH, V19, P348
   Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786
   Collinson AC, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-18
   Schmalisch G, 2012, TWIN RES HUM GENET, V13, P88
   Eriksson A W, 2000, Twin Res, V3, P189, DOI 10.1375/136905200320565148
   Fellman J, 1999, Twin Res, V2, P22, DOI 10.1375/136905299320566077
   Gebremedhin S., 2014, TWIN RES HUM GENET, V18, P100
   Hardin J, 2009, TWIN RES HUM GENET, V12, P79, DOI 10.1375/twin.12.1.79
   Jaffar S, 1998, ANN TROP PAEDIATR, V18, P231
   Jasseh M, 2015, INT J EPIDEMIOL, V44, P837, DOI 10.1093/ije/dyv049
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Justesen A, 2000, INT J EPIDEMIOL, V29, P678, DOI 10.1093/ije/29.4.678
   Kalanda BF, 2006, EUR J CLIN NUTR, V60, P598, DOI 10.1038/sj.ejcn.1602356
   Khera R, 2014, ARCH DIS CHILD, V99, P369, DOI 10.1136/archdischild-2013-303889
   Mallard SR, 2014, J NUTR, V144, P1818, DOI 10.3945/jn.114.199547
   Matanda DJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-5
   MOTARJEMI Y, 1993, B WORLD HEALTH ORGAN, V71, P79
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Olusanya BO, 2011, J HEALTH POPUL NUTR, V29, P639
   Parker JD, 2001, PAEDIATR PERINAT EP, V15, P12
   Pongou R, 2012, DEMOGRAPHY, V50, P421
   Quattrochi J, 2015, TROP MED INT HEALTH, V20, P941, DOI 10.1111/tmi.12490
   Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134
   Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239
   Steen EE, 2014, J PERINAT MED, V42, P225, DOI 10.1515/jpm-2013-0147
   Uthman Olalekan A, 2008, BMC Pregnancy Childbirth, V8, P41, DOI 10.1186/1471-2393-8-41
   WALDRON I, 1983, SOC SCI MED, V17, P321, DOI 10.1016/0277-9536(83)90234-4
   Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9
NR 34
TC 3
Z9 3
U1 2
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD MAR 15
PY 2016
VL 16
AR 39
DI 10.1186/s12887-016-0573-2
PG 8
WC Pediatrics
SC Pediatrics
GA DH1JB
UT WOS:000372539100001
PM 26979832
OA gold
DA 2017-08-15
ER

PT J
AU Opondo, KO
   Weetman, D
   Jawara, M
   Diatta, M
   Fofana, A
   Crombe, F
   Mwesigwa, J
   D'Alessandro, U
   Donnelly, MJ
AF Opondo, Kevin Ochieng'
   Weetman, David
   Jawara, Musa
   Diatta, Mathurin
   Fofana, Amfaal
   Crombe, Florence
   Mwesigwa, Julia
   D'Alessandro, Umberto
   Donnelly, Martin James
TI Does insecticide resistance contribute to heterogeneities in malaria
   transmission in The Gambia?
SO MALARIA JOURNAL
LA English
DT Article
ID MOSQUITOS VECTORIAL CAPACITY; CROSS-SECTIONAL SURVEY; WESTERN
   BURKINA-FASO; TREATED BED NETS; ANOPHELES-GAMBIAE; PYRETHROID
   RESISTANCE; MOLECULAR-FORMS; KDR MUTATION; URBAN AGRICULTURE;
   COTE-DIVOIRE
AB Background: Malaria hotspots, areas with consistently higher than average transmission, may become increasingly common as malaria declines. This phenomenon, currently observed in The Gambia, may be caused by several factors, including some related to the local vectors, whose contribution is poorly understood.
   Methods: Using WHO susceptibility bioassays, insecticide resistance status was determined in vector populations sampled from six pairs of villages across The Gambia, each pair contained a low and high prevalence village.
   Results: Three vector species were observed (23.5 % Anopheles arabiensis, 31.2 % Anopheles gambiae, 43.3 % Anopheles coluzzii and 2.0 % An. coluzzii x An. gambiae hybrids). Even at a fine scale, significant differences in species composition were detected within village pairs. Resistance to both DDT and deltamethrin was more common in An. gambiae, most markedly in the eastern part of The Gambia and partly attributable to differing frequencies of resistance mutations. The Vgsc-1014F target site mutation was strongly associated with both DDT (OR = 256.7, (95 % CI 48.6-6374.3, p < 0.001) and deltamethrin survival (OR = 9.14, (95 % CI 4.24-21.4, p < 0.001). A second target site mutation, Vgsc-1575Y, which co-occurs with Vgsc-1014F, and a metabolic marker of resistance, Gste2-114T, conferred additional survival benefits to both insecticides. DDT resistance occurred significantly more frequently in villages with high malaria prevalence (p = 0.025) though this did not apply to deltamethrin resistance.
   Conclusion: Whilst causality of relationships requires further investigation, variation in vector species and insecticide resistance in The Gambia is associated with malaria endemicity; with a notably higher prevalence of infection and insecticide resistance in the east of the country. In areas with heterogeneous malaria transmission, the role of the vector should be investigated to guide malaria control interventions.
C1 [D'Alessandro, Umberto; Donnelly, Martin James] London Sch Hyg & Trop Med, London WC1, England.
   [Opondo, Kevin Ochieng'; Jawara, Musa; Diatta, Mathurin; Fofana, Amfaal; Mwesigwa, Julia; D'Alessandro, Umberto] MRC Unit, POB 273, Banjul, Gambia.
   [Opondo, Kevin Ochieng'; Weetman, David; Crombe, Florence; Donnelly, Martin James] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
RP Donnelly, MJ (reprint author), London Sch Hyg & Trop Med, London WC1, England.
EM Martin.Donnelly@lstmed.ac.uk
RI ; Weetman, David/M-1261-2014
OI Donnelly, Martin/0000-0001-5218-1497; Weetman, David/0000-0002-5820-1388
FU UK Medical Research Council (MRC); UK Department for International
   Development (DFID) under the MRC/DFID Concordat; European Union
FX This work is jointly funded by the UK Medical Research Council (MRC) and
   the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement and is also part of the EDCTP2 programme
   supported by the European Union.
CR Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154
   Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-155
   Bass C, 2010, PESTIC BIOCHEM PHYS, V96, P80, DOI 10.1016/j.pestbp.2009.09.004
   Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304
   Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456
   Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572
   Bryan J, 1986, PARASSITOLOGIA, V29, P221
   BRYAN JH, 1982, GENETICA, V59, P167, DOI 10.1007/BF00056539
   BURKOT TR, 1988, AM J TROP MED HYG, V39, P135
   BUSVINE JR, 1978, NATURE, V273, P604, DOI 10.1038/273604a0
   BUSVINE JR, 1969, B WORLD HEALTH ORGAN, V40, P731
   Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182
   Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319
   Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248
   Coetzee M., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P400
   Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005
   Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16
   Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2
   Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188
   DE ZULUETA J, 1959, Bull World Health Organ, V20, P797
   Diatta M, 1998, T ROY SOC TROP MED H, V92, P270, DOI 10.1016/S0035-9203(98)91005-7
   Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261
   Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262
   Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78
   GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71
   Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286
   Gillies MT, 1988, MALARIA PRINCIPLES P, V1, P453
   Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x
   GNMCP, 2011, MAL IND SURV
   Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x
   Henry MC, 2005, AM J TROP MED HYG, V73, P859
   Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x
   Jawara M, 2008, MALARIA J, V7, P9
   Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109
   Kleinschmidt I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0782-4
   Klinkenberg E, 2006, TROP MED INT HEALTH, V11, P578, DOI 10.1111/j.1365-3156.2006.01609.x
   Klinkenberg E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-151
   Kloke RG, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-16
   Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066
   Lindblade KA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0554-1
   LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P45, DOI 10.1016/0035-9203(93)90175-P
   Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x
   Macdonald G., 1953, Tropical Diseases Bulletin, V50, P871
   Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76
   Majambere S, 2008, AM J TROP MED HYG, V79, P19
   MARASCUILO LA, 1966, PSYCHOL BULL, V65, P280, DOI 10.1037/h0023189
   Mawejje HD, 2013, MED VET ENTOMOL, V27, P276, DOI 10.1111/j.1365-2915.2012.01055.x
   Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672
   Mitchell SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092662
   MoH, 2012, NAT HLTH POL 2012 20, P22
   MOLINEAUX L, 1979, B WORLD HEALTH ORGAN, V57, P265
   Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6
   N'Guessan R, 2007, EMERG INFECT DIS, V13, P199
   Ndiath MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097700
   Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
   Niang E. A, 2014, VARIABILITE GENETIQU
   Ochomo E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-310
   Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926
   Padonou GG, 2011, J PARASITOL VECTOR B, V3, P59
   Pinder M., 2014, LANCET, V385, P1436, DOI DOI 10.1016/S0140-6736(14)61007-2
   Pinder M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-147
   Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2
   Reimer LJ, 2005, INSECT MOL BIOL, V14, P683, DOI 10.1111/j.1365-2583.2005.00599.x
   SAMCP, 2001, KWAZ NAT MAL CRIS PR
   Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163
   Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74
   SCOTT JA, 1993, AM J TROP MED HYG, V49, P520
   SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C
   SNMCP, 2011, PROF ENT PAL SEN MIN
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Stump AD, 2004, AM J TROP MED HYG, V70, P591
   Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351
   Taylor C, 2001, GENETICS, V157, P743
   Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8
   THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6
   Tokponnon FT, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-76
   Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3
   Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199
   Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   World Health Organization:, 2007, MAL EL FIELD MAN LOW
   (WHO) World Health Organization, 2013, TEST PROC INS RES MO
   Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774
   Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318
NR 89
TC 1
Z9 1
U1 3
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD MAR 15
PY 2016
VL 15
AR 166
DI 10.1186/s12936-016-1203-z
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DG3JT
UT WOS:000371966200008
PM 26980461
OA gold
DA 2017-08-15
ER

PT J
AU Ebruke, C
   Dione, MM
   Walter, B
   Worwui, A
   Adegbola, RA
   Roca, A
   Antonio, M
AF Ebruke, Chinelo
   Dione, Michel M.
   Walter, Brigitte
   Worwui, Archibald
   Adegbola, Richard A.
   Roca, Anna
   Antonio, Martin
TI High genetic diversity of Staphylococcus aureus strains colonising the
   nasopharynx of Gambian villagers before widespread use of pneumococcal
   conjugate vaccines
SO BMC MICROBIOLOGY
LA English
DT Article
DE Staphylococcus aureus; Streptococcus pneumoniae; Colonization;
   Antibiotic resistance; Genotypes; The Gambia
ID STREPTOCOCCUS-PNEUMONIAE; NASAL CARRIAGE; MOLECULAR EPIDEMIOLOGY;
   POPULATION-STRUCTURE; GLOBAL DISTRIBUTION; HEALTHY-CHILDREN; YOUNG
   INFANTS; COLONIZATION; BACTEREMIA; AFRICA
AB Background: With the global efforts of reducing pneumococcal disease through widespread introduction of pneumococcal vaccines, concerns have emerged on the potential increase of morbidity and mortality from S. aureus disease. Little is known however, of the carriage rates of S. aureus or of its' relationship with carriage of S. pneumoniae in rural Africa, and West Africa in particular where very high rates of carriage of S. pneumoniae have been reported. This study aims to evaluate the prevalence, antibiotic susceptibility patterns and genotypes of S. aureus isolated from the nasopharynx of healthy individuals in rural Gambia before the introduction of routine use of pneumococcal conjugate vaccines in the country.
   Results: Overall prevalence of S. aureus nasopharyngeal carriage was 25.2 %. All S. aureus isolates tested were susceptible to methicillin. Resistant was observed for sulphamethoxazole-trimethoprim (15 %) and tetracycline (34.3 %). We found 59 different sequence types (ST), 35 of which were novel. The most prevalent sequence types were ST 15 (28 %) and ST 5 (4 %). Eighty two percent (494/600) of study individuals were S. pneumoniae carriers with S. pneumoniae carriage rates decreasing with increasing age groups. S. aureus carriage among pneumococcal carriers was slightly lower than among non-pneumococcal carriers (24.3 versus 29.3 %; p = 0.324). There were no associations of carriage between these two bacteria across the 4 age groups. However, analysis of pooled data children < 2 years and children 2 to < 5 years of age showed a statistically significant inverse association (24.1 and 50.0 % for S. aureus carriage among S. pneumoniae carriers and non-carriers respectively; p = 0.015).
   Conclusions: We report that nasopharyngeal carriage of S. aureus in rural Gambia is high in all age groups, with approximately 1 out of 4 individuals being carriers in the pre-pneumococcal vaccination era. There are indications that nasopharyngeal carriage of S. aureus could be inversely related to carriage of S. pneumoniae amongst younger children in The Gambian and that S. aureus clones in The Gambia show significant genetic diversity suggesting worldwide dissemination. Findings from this study provide a useful background for impact studies evaluating the introduction of pneumococcal vaccines or other interventions targeting the control of S. aureus infections and disease.
C1 [Ebruke, Chinelo; Dione, Michel M.; Walter, Brigitte; Worwui, Archibald; Antonio, Martin] MRC Unit, Vaccine & Immun Theme, Banjul, Gambia.
   [Roca, Anna] MRC Unit, Dis Control & Eliminat, Banjul, Gambia.
   [Ebruke, Chinelo; Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
RP Antonio, M (reprint author), MRC Unit, Vaccine & Immun Theme, Banjul, Gambia.; Antonio, M (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
EM mantonio@mrc.gm
FU Medical Research Council (UK)
FX The study was funded by the Medical Research Council (UK). We
   acknowledge the use of the core sequencing facility at MRC Unit, The
   Gambia and the S. aureus MLST database ((http://saureus.mlst.net).
CR Abdulgader SM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00348
   Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293
   Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X
   AMIR M, 1995, EUR J CLIN MICROBIOL, V14, P34, DOI 10.1007/BF02112615
   Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198
   Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5
   Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI
   Cohen R, 2007, CLIN INFECT DIS, V45, P1583, DOI 10.1086/523734
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Dolapo O, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-121
   Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096119
   Esposito S, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0723-9
   Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068024
   Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004
   Hamer DH, 2015, PEDIATR INFECT DIS J, V34, pE1, DOI 10.1097/INF.0000000000000549
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Hongsuwan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109324
   Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505
   Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175
   Mainous AG, 2006, ANN FAM MED, V4, P132, DOI 10.1370/afm.526
   Ngoa UA, 2012, ACTA TROP, V124, P42, DOI 10.1016/j.actatropica.2012.06.005
   Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008
   Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07
   Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062
   Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150
   Shiri T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-483
   Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92
   Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/ajic.2007.10.006
   Tristan A, 2007, EMERG INFECT DIS, V13, P594
   van der Loeff MFS, 2003, AIDS, V17, P1841, DOI 10.1097/01.aids.0000076303.76477.49
   van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229
   von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102
   Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769
NR 35
TC 3
Z9 3
U1 4
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD MAR 12
PY 2016
VL 16
AR 38
DI 10.1186/s12866-016-0661-3
PG 9
WC Microbiology
SC Microbiology
GA DG8DE
UT WOS:000372311800002
PM 26969294
OA gold
DA 2017-08-15
ER

PT J
AU Pekyi, D
   Ampromfi, AA
   Tinto, H
   Traore-Coulibaly, M
   Tahita, MC
   Valea, I
   Mwapasa, V
   Kalilani-Phiri, L
   Kalanda, G
   Madanitsa, M
   Ravinetto, R
   Mutabingwa, T
   Gbekor, P
   Tagbor, H
   Antwi, G
   Menten, J
   De Crop, M
   Claeys, Y
   Schurmans, C
   Van Overmeir, C
   Thriemer, K
   Van Geertruyden, JP
   D'Alessandro, U
   Nambozi, M
   Mulenga, M
   Hachizovu, S
   Kabuya, JBB
   Mulenga, J
AF Pekyi, D.
   Ampromfi, A. A.
   Tinto, H.
   Traore-Coulibaly, M.
   Tahita, M. C.
   Valea, I.
   Mwapasa, V.
   Kalilani-Phiri, L.
   Kalanda, G.
   Madanitsa, M.
   Ravinetto, R.
   Mutabingwa, T.
   Gbekor, P.
   Tagbor, H.
   Antwi, G.
   Menten, J.
   De Crop, M.
   Claeys, Y.
   Schurmans, C.
   Van Overmeir, C.
   Thriemer, K.
   Van Geertruyden, J. -P.
   D'Alessandro, U.
   Nambozi, M.
   Mulenga, M.
   Hachizovu, S.
   Kabuya, J. -B. B.
   Mulenga, J.
CA PREGACT Study Grp
TI Four Artemisinin-Based Treatments in African Pregnant Women with Malaria
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE;
   ARTEMETHER-LUMEFANTRINE; NONPREGNANT WOMEN; CONTROLLED-TRIAL;
   CLINICAL-TRIALS; VIVAX MALARIA; COMBINATION; PHARMACOKINETICS;
   AMODIAQUINE
AB BACKGROUND
   Information regarding the safety and efficacy of artemisinin combination treatments for malaria in pregnant women is limited, particularly among women who live in sub-Saharan Africa.
   METHODS
   We conducted a multicenter, randomized, open-label trial of treatments for malaria in pregnant women in four African countries. A total of 3428 pregnant women in the second or third trimester who had falciparum malaria (at any parasite density and regardless of symptoms) were treated with artemether-lumefantrine, amodiaquine-artesunate, mefloquine-artesunate, or dihydroartemisinin-piperaquine. The primary end points were the polymerase-chain-reaction (PCR)-adjusted cure rates (i.e., cure of the original infection; new infections during follow-up were not considered to be treatment failures) at day 63 and safety outcomes.
   RESULTS
   The PCR-adjusted cure rates in the per-protocol analysis were 94.8% in the artemether-lumefantrine group, 98.5% in the amodiaquine-artesunate group, 99.2% in the dihydroartemisinin-piperaquine group, and 96.8% in the mefloquine-artesunate group; the PCR-adjusted cure rates in the intention-to-treat analysis were 94.2%, 96.9%, 98.0%, and 95.5%, respectively. There was no significant difference among the amodiaquine-artesunate group, dihydroartemisinin-piperaquine group, and the mefloquine-artesunate group. The cure rate in the artemether-lumefantrine group was significantly lower than that in the other three groups, although the absolute difference was within the 5-percentage-point margin for equivalence. The unadjusted cure rates, used as a measure of the post-treatment prophylactic effect, were significantly lower in the artemether-lumefantrine group (52.5%) than in groups that received amodiaquine-artesunate (82.3%), dihydroartemisinin-piperaquine (86.9%), or mefloquine-artesunate (73.8%). No significant difference in the rate of serious adverse events and in birth outcomes was found among the treatment groups. Drug-related adverse events such as asthenia, poor appetite, dizziness, nausea, and vomiting occurred significantly more frequently in the mefloquine-artesunate group (50.6%) and the amodiaquine-artesunate group (48.5%) than in the dihydroartemisinin-piperaquine group (20.6%) and the artemether-lumefantrine group (11.5%) (P<0.001 for comparison among the four groups).
   CONCLUSIONS
   Artemether-lumefantrine was associated with the fewest adverse effects and with acceptable cure rates but provided the shortest post-treatment prophylaxis, whereas dihydroartemisinin-piperaquine had the best efficacy and an acceptable safety profile. (Funded by the European and Developing Countries Clinical Trials Partnership and others; ClinicalTrials.gov number, NCT00852423.)
C1 [D'Alessandro, U.] MRC Unit, Atlantic Blvd, Fajara, Gambia.
   [Pekyi, D.; Ampromfi, A. A.] Ctr Global Hlth Res, Kumasi, Ghana.
   [Tinto, H.; Antwi, G.] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana.
   [Gbekor, P.] Juaben Govt Hosp, Juaben, Ghana.
   [Tinto, H.; Traore-Coulibaly, M.; Tahita, M. C.; Valea, I.] Clin Trial Unit Nanoro, Nanoro, Burkina Faso.
   [Mwapasa, V.; Kalilani-Phiri, L.; Kalanda, G.; Madanitsa, M.] Coll Med, Blantyre, Malawi.
   [Ravinetto, R.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium.
   [Ravinetto, R.; Menten, J.; De Crop, M.; Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Thriemer, K.; D'Alessandro, U.] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Mutabingwa, T.] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania.
   [Thriemer, K.] Menzies Sch Hlth Res, Darwin, NT, Australia.
   [D'Alessandro, U.] London Sch Hyg & Trop Med, London, England.
   [Nambozi, M.; Mulenga, M.; Hachizovu, S.; Kabuya, J. -B. B.; Mulenga, J.] Trop Dis Res Ctr, Ndola, Zambia.
RP D'Alessandro, U (reprint author), MRC Unit, Atlantic Blvd, Fajara, Gambia.
EM udalessandro@mrc.gm
RI Van geertruyden, Jean-pierre/K-6425-2014
OI Van geertruyden, Jean-pierre/0000-0001-5006-6364
FU European and Developing Countries Clinical Trials Partnership
FX Funded by the European and Developing Countries Clinical Trials
   Partnership and others; ClinicalTrials.gov number, NCT00852423.
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Adam I, 2012, AM J TROP MED HYG, V87, P35, DOI 10.4269/ajtmh.2012.11-0410
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Clerk CA, 2008, J INFECT DIS, V198, P1202, DOI 10.1086/591944
   D'Alessandro U, 2009, EXPERT OPIN PHARMACO, V10, P1291, DOI 10.1517/14656560902942319
   Dmitrienko A, 2013, STAT MED, V32, P5172, DOI 10.1002/sim.5990
   Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Gonzalez R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-75
   Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07
   Gupta V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-19
   Hoglund RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-398
   Kloprogge F, 2013, CPT Pharmacometrics Syst Pharmacol, V2, pe83, DOI 10.1038/psp.2013.59
   Lutje V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-61
   Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141
   McGready R, 2011, BJOG-INT J OBSTET GY, V118, P123, DOI 10.1111/j.1471-0528.2010.02810.x
   McGready R, 2008, PLOS MED, V5, P1699, DOI 10.1371/journal.pmed.0050253
   Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5
   Orton LC, 2008, COCHRANE DB SYST REV, V4
   Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4
   Rijken MJ, 2011, ANTIMICROB AGENTS CH, V55, P4338, DOI 10.1128/AAC.00154-11
   Tagbor H, 2006, LANCET, V368, P1349, DOI 10.1016/S0140-6736(06)69559-7
   Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI DOI 10.4084/MJHID.2013.010
   Valea I, 2014, J ANTIMICROB CHEMOTH, V69, P2499, DOI 10.1093/jac/dku154
   van Riemsdijk MM, 2004, BRIT J CLIN PHARMACO, V57, P506, DOI 10.1046/j.1365-2125.2003.02035.x
   White N. J., 2013, LANCET, V383, P723
   WHO, 2008, METH TECHN CLIN TRIA
   WHO, 2015, GUID TREATM MAL
   WorldWide Antimalarial Resistance Network (WWARN), 2012, CLIN MOD DAT MAN STA
NR 29
TC 9
Z9 9
U1 1
U2 10
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 10
PY 2016
VL 374
IS 10
BP 913
EP 927
DI 10.1056/NEJMoa1508606
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF9DH
UT WOS:000371660000005
OA No
DA 2017-08-15
ER

PT J
AU Mendy, J
   Togun, T
   Owolabi, O
   Donkor, S
   Ota, MOC
   Sutherland, JS
AF Mendy, Joseph
   Togun, Toyin
   Owolabi, Olumuyiwa
   Donkor, Simon
   Ota, Martin O. C.
   Sutherland, Jayne S.
TI C-reactive protein, Neopterin and Beta(2) microglobulin levels pre and
   post TB treatment in The Gambia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Activation markers; TB therapy; Point of care tests
ID HIV-INFECTED PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; M-AFRICANUM;
   BETA(2)-MICROGLOBULIN; BETA-2-MICROGLOBULIN; INDIVIDUALS; THERAPY;
   MARKERS; STRAIN
AB Background: Tuberculosis is one of the leading causes of morbidity and mortality in developing countries. Analysis of the host immune response may help with generating point-of-care tests for personalised monitoring. Thus, the aim of this study was to assess the relationship between immune activation markers: C-reactive protein (CRP), Beta(2) microglobulin (B2M) and Neopterin, disease severity prior to treatment and response to therapy in adult pulmonary TB patients.
   Methods: HIV negative adult pulmonary TB index cases (n = 91) were recruited from the TB clinic at MRC, The Gambia. Plasma samples were collected at enrolment and at 2 and 6 months following TB treatment initiation. An enzyme linked immunosorbent assay (ELISA) was performed for evaluation of CRP, B2M and Neopterin levels and correlated with clinical and microbiological parameters including strain of infection. Disease severity was determined using Chest X-ray (CXR), Body Mass Index (BMI) and sputum smear grade.
   Results: Plasma levels of all three markers were highly elevated in patients at recruitment and declined significantly during TB therapy. No correlation with disease severity was seen at recruitment. CRP showed the most significant decrease by 2 months of treatment (p < 0.0001) whereas levels of B2M and Neopterin showed little change by 2 months but a significant decrease by 6 months of treatment (p = 0.0002 and p < 0.0001 respectively). At recruitment, B2M levels were significantly higher in subjects infected with Mycobacterium africanum (Maf) compared with those infected with Mycobacterium tuberculosis sensu stricto (Mtb) (p = 0.0075). In addition, while CRP and Neopterin showed a highly significant decline post-treatment regardless of strain (p < 0.0001 for all), B2M showed differential decline depending on strain (p = 0.0153 for Mtb and p = 0.0048 for Maf) and levels were still significantly higher at 6 months in Maf compared to Mtb infected subjects (p = 0.0051).
   Conclusion: Our findings suggest that activation markers, particularly CRP, may have a role in identifying good response to TB therapy regardless of the strain of infection and could be further developed as point-of-care tests. In addition, B2M levels may allow differentiation between Mtb and Maf-infected subjects.
C1 [Mendy, Joseph; Togun, Toyin; Owolabi, Olumuyiwa; Donkor, Simon; Ota, Martin O. C.; Sutherland, Jayne S.] Med Res Council MRC Unit, Vaccines & Immun Theme, Atlantic Rd, Fajara, Gambia.
   [Ota, Martin O. C.] WHO, Reg Off, Brazzaville, Congo.
   [Sutherland, Jayne S.] MRC Unit, POB 273, Banjul, Gambia.
RP Sutherland, JS (reprint author), Med Res Council MRC Unit, Vaccines & Immun Theme, Atlantic Rd, Fajara, Gambia.; Sutherland, JS (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM jsutherland@mrc.gm
FU Gambian National Tuberculosis and Leprosy Control Programme; MRC(UK)
FX We thank all study participants, MRC TB Clinic Staff, TBCC Field Staff,
   TB Diagnostic and Immunology Laboratories Staff, Research Support Office
   Staff, and The Gambian National Tuberculosis and Leprosy Control
   Programme for their support. This study was funded by MRC(UK).
CR Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44
   Clifford V, 2015, TUBERCULOSIS, V95, P217, DOI 10.1016/j.tube.2015.01.003
   Collazos J, 1999, SCAND J INFECT DIS, V31, P265
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   de Jong BC, 2007, INT J TUBERC LUNG D, V11, P450
   Donadio C, 2001, J PHARMACEUT BIOMED, V24, P835, DOI 10.1016/S0731-7085(00)00550-1
   Drain PK, 2014, INT J TUBERC LUNG D, V18, P20, DOI 10.5588/ijtld.13.0519
   Dzieciuchowicz L, 2012, FOOT ANKLE INT, V33, P832, DOI 10.3113/FAI.2012.0832
   Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023
   Immanuel C, 2005, INDIAN J MED RES, V121, P220
   Lawn SD, 2000, CLIN EXP IMMUNOL, V122, P79, DOI 10.1046/j.1365-2249.2000.01341.x
   Leung CC, 2015, EUR RESPIR J, V45, P738, DOI 10.1183/09031936.00114214
   Marcus SA, 2015, VACCINE, V33, P5633, DOI 10.1016/j.vaccine.2015.08.084
   [Anonymous], 2009, TUB NEW FAC OLD DIS
   MEYER KC, 1992, AM J RESP CELL MOL, V6, P639
   Romero-Sanchez MC, 2014, ANTIVIR RES, V111, P26, DOI 10.1016/j.antiviral.2014.08.011
   Shimoda T, 2015, ALLERGY ASTHMA PROC, V36, pE23, DOI 10.2500/aap.2015.36.3816
   Sreejit G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004446
   Tientcheu LD, 2015, GENES IMMUN, V16, P347, DOI 10.1038/gene.2015.21
   Tientcheu LD, 2014, EUR J IMMUNOL, V44, P1387, DOI 10.1002/eji.201343956
   Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397
   Turgut T, 2006, TOHOKU J EXP MED, V209, P321, DOI 10.1620/tjem.209.321
   [Anonymous], WHO GLOBAL TUBERCULO
NR 23
TC 2
Z9 2
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 8
PY 2016
VL 16
AR 115
DI 10.1186/s12879-016-1447-9
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DG0TJ
UT WOS:000371778300001
PM 26951717
OA gold
DA 2017-08-15
ER

PT J
AU Amato, R
   Miotto, O
   Woodrow, CJ
   Almagro-Garcia, J
   Sinha, I
   Campino, S
   Mead, D
   Drury, E
   Kekre, M
   Sanders, M
   Amambua-Ngwa, A
   Amaratunga, C
   Amenga-Etego, L
   Andrianaranjaka, V
   Apinjoh, T
   Ashley, E
   Auburn, S
   Awandare, GA
   Baraka, V
   Barry, A
   Boni, MF
   Borrmann, S
   Bousema, T
   Branch, O
   Bull, PC
   Chotivanich, K
   Conway, DJ
   Craig, A
   Day, NP
   Djimde, A
   Dolecek, C
   Dondorp, AM
   Drakeley, C
   Duffy, P
   Echeverry, DF
   Egwang, TG
   Fairhurst, RM
   Faiz, MA
   Fanello, CI
   Hien, TT
   Hodgson, A
   Imwong, M
   Ishengoma, D
   Lim, P
   Lon, C
   Marfurt, J
   Marsh, K
   Mayxay, M
   Michon, P
   Mobegi, V
   Mokuolu, OA
   Montgomery, J
   Mueller, I
   Kyaw, MP
   Newton, PN
   Nosten, F
   Noviyanti, R
   Nzila, A
   Ocholla, H
   Oduro, A
   Onyamboko, M
   Ouedraogo, JB
   Phyo, APP
   Plowe, C
   Price, RN
   Pukrittayakamee, S
   Randrianarivelojosia, M
   Ringwald, P
   Ruiz, L
   Saunders, D
   Shayo, A
   Siba, P
   Takala-Harrison, S
   Thanh, TNN
   Thathy, V
   Verra, F
   Wendler, J
   White, NJ
   Ye, H
   Cornelius, VJ
   Giacomantonio, R
   Muddyman, D
   Henrichs, C
   Malangone, C
   Jyothi, D
   Pearson, RD
   Rayner, JC
   McVean, G
   Rockett, KA
   Miles, A
   Vauterin, P
   Jeffery, B
   Manske, M
   Stalker, J
   Maclnnis, B
   Kwiatkowski, DP
AF Amato, Roberto
   Miotto, Olivo
   Woodrow, Charles J.
   Almagro-Garcia, Jacob
   Sinha, Ipsita
   Campino, Susana
   Mead, Daniel
   Drury, Eleanor
   Kekre, Mihir
   Sanders, Mandy
   Amambua-Ngwa, Alfred
   Amaratunga, Chanaki
   Amenga-Etego, Lucas
   Andrianaranjaka, Voahangy
   Apinjoh, Tobias
   Ashley, Elizabeth
   Auburn, Sarah
   Awandare, Gordon A.
   Baraka, Vito
   Barry, Alyssa
   Boni, Maciej F.
   Borrmann, Steffen
   Bousema, Teun
   Branch, Oralee
   Bull, Peter C.
   Chotivanich, Kesinee
   Conway, David J.
   Craig, Alister
   Day, Nicholas P.
   Djimde, Abdoulaye
   Dolecek, Christiane
   Dondorp, Arjen M.
   Drakeley, Chris
   Duffy, Patrick
   Echeverry, Diego F.
   Egwang, Thomas G.
   Fairhurst, Rick M.
   Faiz, Md. Abul
   Fanello, Caterina I.
   Tran Tinh Hien
   Hodgson, Abraham
   Imwong, Mallika
   Ishengoma, Deus
   Lim, Pharath
   Lon, Chanthap
   Marfurt, Jutta
   Marsh, Kevin
   Mayxay, Mayfong
   Michon, Pascal
   Mobegi, Victor
   Mokuolu, Olugbenga A.
   Montgomery, Jacqui
   Mueller, Ivo
   Kyaw, Myat Phone
   Newton, Paul N.
   Nosten, Francois
   Noviyanti, Rintis
   Nzila, Alexis
   Ocholla, Harold
   Oduro, Abraham
   Onyamboko, Marie
   Ouedraogo, Jean-Bosco
   Phyo, Aung Pyae P.
   Plowe, Christopher
   Price, Ric N.
   Pukrittayakamee, Sasithon
   Randrianarivelojosia, Milijaona
   Ringwald, Pascal
   Ruiz, Lastenia
   Saunders, David
   Shayo, Alex
   Siba, Peter
   Takala-Harrison, Shannon
   Thanh, Thuy-Nhien N.
   Thathy, Vandana
   Verra, Federica
   Wendler, Jason
   White, Nicholas J.
   Ye, Htut
   Cornelius, Victoria J.
   Giacomantonio, Rachel
   Muddyman, Dawn
   Henrichs, Christa
   Malangone, Cinzia
   Jyothi, Dushyanth
   Pearson, Richard D.
   Rayner, Julian C.
   McVean, Gilean
   Rockett, Kirk A.
   Miles, Alistair
   Vauterin, Paul
   Jeffery, Ben
   Manske, Magnus
   Stalker, Jim
   Maclnnis, Bronwyn
   Kwiatkowski, Dominic P.
CA MalariaGEN Plasmodium Falciparum C
TI Genomic epidemiology of artemisinin resistant malaria
SO ELIFE
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; MOLECULAR POPULATION-GENETICS; SOFT
   SELECTIVE SWEEPS; SUB-SAHARAN AFRICA; SUBSTITUTION MATRICES;
   DRUG-RESISTANCE; ADAPTATION; MUTATIONS; EVOLUTION; CAMBODIA
AB The current epidemic of artemisinin resistant Plasmodium falciparum in Southeast Asia is the result of a soft selective sweep involving at least 20 independent kelch13 mutations. In a large global survey, we find that kelchl3 mutations which cause resistance in Southeast Asia are present at low frequency in Africa. We show that African kelch13 mutations have originated locally, and that kelch13 shows a normal variation pattern relative to other genes in Africa, whereas in Southeast Asia there is a great excess of non-synonymous mutations, many of which cause radical amino-acid changes. Thus, kelch13 is not currently undergoing strong selection in Africa, despite a deep reservoir of variations that could potentially allow resistance to emerge rapidly. The practical implications are that public health surveillance for artemisinin resistance should not rely on kelchl3 data alone, and interventions to prevent resistance must account for local evolutionary conditions, shown by genomic epidemiology to differ greatly between geographical regions.
C1 [Amato, Roberto; Miotto, Olivo; Almagro-Garcia, Jacob; Campino, Susana; Mead, Daniel; Drury, Eleanor; Kekre, Mihir; Sanders, Mandy; Giacomantonio, Rachel; Muddyman, Dawn; Malangone, Cinzia; Jyothi, Dushyanth; Pearson, Richard D.; Rayner, Julian C.; Rockett, Kirk A.; Miles, Alistair; Manske, Magnus; Stalker, Jim; Maclnnis, Bronwyn; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England.
   [Amato, Roberto; Miotto, Olivo; Almagro-Garcia, Jacob; Wendler, Jason; Cornelius, Victoria J.; Giacomantonio, Rachel; Henrichs, Christa; Pearson, Richard D.; McVean, Gilean; Rockett, Kirk A.; Miles, Alistair; Vauterin, Paul; Jeffery, Ben; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Ctr Genom & Global Hlth, Oxford, England.
   [Miotto, Olivo; Woodrow, Charles J.; Sinha, Ipsita; Ashley, Elizabeth; Day, Nicholas P.; Dondorp, Arjen M.; Fanello, Caterina I.; Imwong, Mallika; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.
   [Woodrow, Charles J.; Boni, Maciej F.; Bull, Peter C.; Day, Nicholas P.; Dolecek, Christiane; Dondorp, Arjen M.; Tran Tinh Hien; Price, Ric N.; Thanh, Thuy-Nhien N.; White, Nicholas J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Amambua-Ngwa, Alfred; Conway, David J.; Mobegi, Victor] MRC Unit, Banjul, Gambia.
   [Amaratunga, Chanaki; Duffy, Patrick; Fairhurst, Rick M.; Lim, Pharath] NIAID, NIH, Rockville, MD USA.
   [Amenga-Etego, Lucas; Tran Tinh Hien; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Andrianaranjaka, Voahangy; Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Malaria Res Unit, Antananarivo, Madagascar.
   [Apinjoh, Tobias] Univ Buea, Buea, Cameroon.
   [Auburn, Sarah; Marfurt, Jutta; Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.
   [Auburn, Sarah; Marfurt, Jutta; Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia.
   [Awandare, Gordon A.] Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana.
   [Baraka, Vito; Ishengoma, Deus] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania.
   [Baraka, Vito] Univ Antwerp, Dept Epidemiol, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Barry, Alyssa] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Populat Hlth & Immun, Parkville, Vic 3050, Australia.
   [Barry, Alyssa; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Carlton, Vic 3053, Australia.
   [Boni, Maciej F.] Univ Oxford, Ho Chi Minh City, Vietnam.
   [Borrmann, Steffen; Bull, Peter C.; Marsh, Kevin; Thathy, Vandana] Wellcome Trust Collaborat Res Program, Kenya Med Res Inst, Kilifi, Kenya.
   [Borrmann, Steffen] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Bousema, Teun; Conway, David J.; Drakeley, Chris; Mobegi, Victor; Verra, Federica] London Sch Hyg & Trop Med, London WC1, England.
   [Branch, Oralee] NYU, Sch Med, New York, NY USA.
   [Chotivanich, Kesinee; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok, Thailand.
   [Craig, Alister] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Djimde, Abdoulaye] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali.
   [Dolecek, Christiane; Tran Tinh Hien; Thanh, Thuy-Nhien N.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Echeverry, Diego F.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
   [Echeverry, Diego F.] CIDEIM, Int Ctr Med Res & Training, Cali, Colombia.
   [Egwang, Thomas G.] Med Biotech Labs, Kampala, Uganda.
   [Faiz, Md. Abul] Malaria Res Grp, Dhaka, Bangladesh.
   [Faiz, Md. Abul] Dev Care Fdn, Dhaka, Bangladesh.
   [Lim, Pharath] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   [Lon, Chanthap; Saunders, David] Armed Forces Res Inst Med Sci, US Army Med Component, Dept Immunol & Med, Bangkok 10400, Thailand.
   [Mayxay, Mayfong; Newton, Paul N.] Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Vientiane, Lao PDR, England.
   [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Vientiane, Lao PDR, England.
   [Michon, Pascal] Divine Word Univ, Fac Med & Hlth Sci, Madang, Papua N Guinea.
   [Mokuolu, Olugbenga A.] Univ Ilorin, Dept Paediat & Child Hlth, Ilorin, Nigeria.
   [Montgomery, Jacqui] Penn State Univ, Dept Biol & Entomol, University Pk, PA 16802 USA.
   [Kyaw, Myat Phone; Ye, Htut] Minist Hlth, Dept Med Res Lower Myanmar, Yangon, Myanmar.
   [Nosten, Francois] Mahidol Univ, Mahido Oxford Trop Med Res Unit, Mae Sot, Thailand.
   [Nosten, Francois; Phyo, Aung Pyae P.] Shoklo Malaria Res Unit, Mae Sot, Thailand.
   [Noviyanti, Rintis] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Nzila, Alexis] King Fahd Univ Petr & Minerals, Dept Biol, Dhahran, Saudi Arabia.
   [Ocholla, Harold] Malawi Liverpool Wellcome Trust Clin Res Programm, Lilongwe, Malawi.
   [Onyamboko, Marie] Univ Kinshasa, Kinshasa, Zaire.
   [Ouedraogo, Jean-Bosco] Direct Regionale Ouest, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.
   [Phyo, Aung Pyae P.] Shoklo Malaria Res Unit, Bangkok, Thailand.
   [Plowe, Christopher; Takala-Harrison, Shannon] Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA.
   [Ringwald, Pascal] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland.
   [Ruiz, Lastenia] Univ Nacl Amazonia Peruana, Iquitos, Peru.
   [Shayo, Alex] Univ Dodoma, Dept Biotechnol & Bioinformat, Dodoma, Tanzania.
   [Siba, Peter] Papua New Guinea Inst Med Res, Madang, Papua N Guinea.
RP Amato, R; Miotto, O; Kwiatkowski, DP (reprint author), Wellcome Trust Sanger Inst, Cambridge, England.; Amato, R; Miotto, O; Kwiatkowski, DP (reprint author), Wellcome Trust Ctr Human Genet, Ctr Genom & Global Hlth, Oxford, England.; Miotto, O (reprint author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.
EM ra4@sanger.ac.uk; olivo@tropmedres.ac; dominic@sanger.ac.uk
RI ; Bousema, Teun/N-3574-2014
OI Auburn, Sarah/0000-0002-4638-536X; Conway, David/0000-0002-8711-3037;
   Thathy, Vandana/0000-0001-7797-8638; Miotto, Olivo/0000-0001-8060-6771;
   Baraka, Vito /0000-0001-9694-9293; Craig, Alister/0000-0003-0914-6164;
   Jyothi, Dushyanth/0000-0002-0448-5303; Rayner,
   Julian/0000-0002-9835-1014; Kwiatkowski, Dominic/0000-0002-5023-0176;
   Mead, Daniel/0000-0001-7717-4330; Price, Richard/0000-0003-2000-2874;
   Awandare, Gordon/0000-0002-8793-3641; Manske,
   Magnus/0000-0001-5916-0947; Pyae Phyo, Aung/0000-0002-0383-9624
FU Wellcome Trust [98051, 090532/Z/09/Z, 90770, 0892375/H/09/Z]; Medical
   Research Council [G0600718]; Bill and Melinda Gates Foundation
   [OPP1040463]; National Institute of Allergy and Infectious Diseases
FX Wellcome Trust WT Sanger Institute Core Funding, 98051 Roberto Amato
   Susana Campino Daniel Mead Eleanor Drury Mihir Kekre Mandy Sanders
   Victoria J Cornelius Rachel Giacomantonio Dawn Muddyman Cinzia Malangone
   Dushyanth Jyothi Richard D Pearson Julian C Rayner Kirk A Rockett
   Alistair Miles Heinrich M Manske Jim Stalker Bronwyn MacInnis Dominic P
   Kwiatkowski; Wellcome Trust WT Centre for Human Genetics Core Funding,
   090532/Z/09/Z Roberto Amato Jacob Almagro-Garcia Victoria J Cornelius
   Rachel Giacomantonio Christa Henrichs Richard D Pearson Gilean McVean
   Kirk A Rockett Alistair Miles Paul Vauterin Ben Jeffery Dominic P
   Kwiatkowski; Wellcome Trust WT Stategic Award, 90770 Roberto Amato Olivo
   Miotto Jacob Almagro-Garcia Susana Campino Daniel Mead Eleanor Drury
   Mihir Kekre Lucas Amenga-Etego Tobias Apinjoh Abdoulaye Djimde Deus
   Ishengoma Milijaona Randrianarivelojosia Victoria J Cornelius Rachel
   Giacomantonio Dawn Muddyman Christa Henrichs Cinzia Malangone Dushyanth
   Jyothi Richard D Pearson Kirk A Rockett Alistair Miles Paul Vauterin Ben
   Jeffery Heinrich M Manske Jim Stalker Bronwyn MacInnis Dominic P
   Kwiatkowski; Medical Research Council Centre for Genomics and Global
   Health, G0600718 Roberto Amato Olivo Miotto Jacob Almagro-Garcia Lucas
   Amenga-Etego Tobias Apinjoh Abdoulaye Djimde Deus Ishengoma Victoria J
   Cornelius Rachel Giacomantonio Dawn Muddyman Gilean McVean Kirk A
   Rockett Alistair Miles Paul Vauterin Ben Jeffery Heinrich M Manske Jim
   Stalker Bronwyn MacInnis Dominic P Kwiatkowski; Bill and Melinda Gates
   Foundation Grant OPP1040463 Roberto Amato Olivo Miotto Charles J Woodrow
   Ipsita Sinha Elizabeth Ashley Nicholas P Day Arjen M Dondorp Mallika
   Imwong Nicholas J White Dominic P Kwiatkowski; Wellcome Trust WT Mahidol
   University Oxford Tropical Medicine Research Programme, 0892375/H/09/Z
   Olivo Miotto Charles J Woodrow Ipsita Sinha Elizabeth Ashley Nicholas P
   Day Arjen M Dondorp Caterina I Fanello Mayfong Mayxay Paul N Newton
   Francois Nosten Nicholas J White; National Institute of Allergy and
   Infectious Diseases Intramural Research Program Chanaki Amaratunga Rick
   M Fairhurst Pharath Lim
CR Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6
   Arley F, 2014, NATURE, V505, P50, DOI DOI 10.1038/NATURE12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Brick K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-236
   Claessens A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004812
   Dogovski C, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002132
   Dondorp AM, 2013, TRENDS PARASITOL, V29, P359, DOI 10.1016/j.pt.2013.05.005
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793
   Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339
   Gardner KB, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-257
   Garud NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005004
   Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925
   GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639
   Hastings IM, 2003, TRENDS PARASITOL, V19, P70, DOI 10.1016/S1471-4922(02)00017-X
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947
   Jensen JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6281
   Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449
   Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608
   Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Manske HM, 2009, BIOINFORMATICS, V25, P2434, DOI 10.1093/bioinformatics/btp403
   Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174
   Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412
   Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003
   Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189
   Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624
   Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004
   Mok S, 2015, SCIENCE, V347, P431, DOI 10.1126/science.1260403
   Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335
   Nair Shalini, 2007, Mol Biol Evol, V24, P562
   Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108
   Pennings PS, 2006, MOL BIOL EVOL, V23, P1076, DOI 10.1093/molbev/msj117
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Prugnolle F, 2010, HEREDITY, V104, P371, DOI 10.1038/hdy.2009.127
   Salgueiro P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-163
   Saunders DL, 2014, NEW ENGL J MED, V371, P484, DOI 10.1056/NEJMc1403007
   Sibley CH, 2015, J INFECT DIS, V211, P667, DOI 10.1093/infdis/jiu469
   Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867
   Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491
   Tanabe K, 2010, CURR BIOL, V20, P1283, DOI 10.1016/j.cub.2010.05.053
   Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467
   Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355
   Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   World Health Organization, 2014, UPD ART RES SEPT 201
   Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4
NR 53
TC 3
Z9 4
U1 5
U2 22
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD MAR 4
PY 2016
VL 5
AR e08714
DI 10.7554/eLife.08714
PG 29
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DG2IH
UT WOS:000371890100001
OA gold
DA 2017-08-15
ER

PT J
AU Salman, S
   Davis, TME
   Page-Sharp, M
   Camara, B
   Oluwalana, C
   Bojang, A
   D'Alessandro, U
   Roca, A
AF Salman, Sam
   Davis, Timothy M. E.
   Page-Sharp, Madhu
   Camara, Bully
   Oluwalana, Claire
   Bojang, Abdoulie
   D'Alessandro, Umberto
   Roca, Anna
TI Pharmacokinetics of Transfer of Azithromycin into the Breast Milk of
   African Mothers
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID SEXUALLY-TRANSMITTED INFECTIONS; HYPERTROPHIC PYLORIC-STENOSIS;
   HEALTHY-VOLUNTEERS; PREGNANCY; PREVENTION; MALARIA; CELLS; BIRTH;
   MACROLIDES; OUTCOMES
AB Azithromycin (AZI) is used for its antibiotic and antimalarial properties in pregnancy. Reported estimates of AZI breast milk transfer, based on concentrations in mostly single samples from small numbers of women, have suggested that infant intake is safe. To better characterize infant intake and the associated potential benefits and risks, AZI was measured by liquid chromatography-mass spectrometry in four breast milk samples taken over 28 days postpartum from each of 20 Gambian women given 2 g AZI during labor. A population pharmacokinetic model utilizing published parameters for AZI disposition in pregnancy, the present breast milk concentrations, and increasing/decreasing sigmoid maximum-effect (E-max) functions adequately described temporal changes in the milk/plasma ratio. The median estimated absolute and relative cumulative infant doses were 4.5 mg/kg of body weight (95% prediction interval, 0.6 to 7.0 mg/kg) and 15.7% (95% prediction interval, 2.0 to 27.8%) of the maternal dose, respectively; the latter exceeded the recommended 10% safety limit. Although some infants with bacterial infections may benefit from AZI in breast milk, there is a risk of hypertrophic pyloric stenosis with a worst-case number needed to harm of 60 based on the present and available epidemiologic data.
C1 [Salman, Sam; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.
   [Page-Sharp, Madhu] Curtin Univ Technol, Sch Pharm, Perth, WA, Australia.
   [Page-Sharp, Madhu] Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.
   [Camara, Bully; Oluwalana, Claire; Bojang, Abdoulie; D'Alessandro, Umberto; Roca, Anna] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto; Roca, Anna] London Sch Hyg & Trop Med, London WC1, England.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
RP Davis, TME (reprint author), Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.
EM tim.davis@uwa.edu.au
OI Salman, Sam/0000-0002-8276-6784
FU Medical Research Council (MRC) [MR/J010391/1]; Department for
   International Development (DFID) [MR/J010391/1]; Department of Health |
   National Health and Medical Research Council (NHMRC) [1058260]
FX Medical Research Council (MRC) provided funding to Umberto D'Alessandro
   and Anna Roca under grant number MR/J010391/1. Department for
   International Development (DFID) provided funding to Umberto
   D'Alessandro and Anna Roca under grant number MR/J010391/1. Department
   of Health | National Health and Medical Research Council (NHMRC)
   provided funding to Timothy M. E. Davis under grant number 1058260.
CR Alcorn J, 2002, J PHARMACOL EXP THER, V303, P487, DOI 10.1124/jpet.102.038315
   Amsden GW, 2000, J CLIN PHARMACOL, V40, P1522
   Ballow CH, 1998, CLIN DRUG INVEST, V15, P159, DOI 10.2165/00044011-199815020-00009
   Beal S., 2009, NONMEM USERS GUIDES
   Bennett P. N., 1996, DRUGS HUMAN LACTATIO, P67, DOI 10.1016/B978-044481981-9/50024-2
   Bickler SW, 2008, PEDIATR SURG INT, V24, P251, DOI 10.1007/s00383-007-2095-3
   Chico RM, 2013, EXPERT REV ANTI-INFE, V11, P1303, DOI 10.1586/14787210.2013.851601
   Chico RM, 2011, EXPERT OPIN DRUG MET, V7, P1153, DOI 10.1517/17425255.2011.598506
   Cooper WO, 2002, ARCH PEDIAT ADOL MED, V156, P647
   Curatolo W, 2010, PHARM RES-DORDR, V27, P1361, DOI 10.1007/s11095-010-0126-6
   Davis TME, 2010, FUTURE MICROBIOL, V5, P1599, DOI [10.2217/fmb.10.113, 10.2217/FMB.10.113]
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Eberly MD, 2015, PEDIATRICS, V135, P483, DOI 10.1542/peds.2014-2026
   Evans KC, 2003, ARCH DIS CHILD, V88, pF380, DOI 10.1136/fn.88.5.F380
   FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73
   Goldstein LH, 2009, BREASTFEED MED, V4, P197, DOI 10.1089/bfm.2008.0135
   HO FCS, 1979, ACTA PAEDIATR SCAND, V68, P389, DOI 10.1111/j.1651-2227.1979.tb05025.x
   Ito S, 2003, ADV DRUG DELIVER REV, V55, P617, DOI 10.1016/S0169-409X(03)00034-6
   Kearns GL, 2000, J ALLERGY CLIN IMMUN, V106, pS128
   KELSEY JJ, 1994, AM J OBSTET GYNECOL, V170, P1375
   Kociszewska-Najman B, 2012, J MATERN-FETAL NEO M, V25, P1599, DOI 10.3109/14767058.2011.648239
   Lemay DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067531
   Lund M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1908
   Merchan LM, 2015, ANTIMICROB AGENTS CH, V59, P570, DOI 10.1128/AAC.03951-14
   Moore BR, 2015, ANTIMICROB AGENTS CH, V59, P4272, DOI 10.1128/AAC.00327-15
   Nair V, 2014, NEONATOLOGY, V106, P337, DOI 10.1159/000363493
   NEVILLE MC, 1991, AM J CLIN NUTR, V54, P81
   Riskin A, 2012, PEDIATR RES, V71, P220, DOI 10.1038/pr.2011.34
   Salman S, 2011, EUR J CLIN PHARMACOL, V67, P899, DOI 10.1007/s00228-011-1023-6
   Salman S, 2010, ANTIMICROB AGENTS CH, V54, P360, DOI 10.1128/AAC.00771-09
   Sutton AL, 2015, AM J OBSTET GYNECOL, V212
   Tanoshima R, 2014, BRIT J CLIN PHARMACO, V78, P918, DOI 10.1111/bcp.12409
   Tayman Cuneyt, 2011, J Pediatr Pharmacol Ther, V16, P170, DOI 10.5863/1551-6776-16.3.170
   Tiwari Tejpratap, 2005, Morbidity and Mortality Weekly Report, V54, P1
   Unger HW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0258-3
   Wildfeuer A, 1996, ANTIMICROB AGENTS CH, V40, P75
   Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x
NR 37
TC 1
Z9 1
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD MAR
PY 2016
VL 60
IS 3
BP 1592
EP 1599
DI 10.1128/AAC.02668-15
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA DM6VM
UT WOS:000376490800052
PM 26711756
OA No
DA 2017-08-15
ER

PT J
AU Gehre, F
   Kumar, S
   Kendall, L
   Ejo, M
   Secka, O
   Ofori-Anyinam, B
   Abatih, E
   Antonio, M
   Berkvens, D
   de Jong, BC
AF Gehre, Florian
   Kumar, Samrat
   Kendall, Lindsay
   Ejo, Mebrat
   Secka, Oumie
   Ofori-Anyinam, Boatema
   Abatih, Emmanuel
   Antonio, Martin
   Berkvens, Dirk
   de Jong, Bouke C.
TI A Mycobacterial Perspective on Tuberculosis in West Africa: Significant
   Geographical Variation of M. africanum and Other M. tuberculosis Complex
   Lineages
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; BURKINA-FASO; STRAINS;
   NIGERIA; TRANSMISSION; BACILLI; GAMBIA
AB Background
   Phylogenetically distinct Mycobacterium tuberculosis lineages differ in their phenotypes and pathogenicity. Consequently, understanding mycobacterial population structures phylogeographically is essential for design, interpretation and generalizability of clinical trials. Comprehensive efforts are lacking to date to establish the West African mycobacterial population structure on a sub-continental scale, which has diagnostic implications and can inform the design of clinical TB trials.
   Methodology/Principal Findings
   We collated novel and published genotyping (spoligotyping) data and classified spoligotypes into mycobacterial lineages/families using TBLineage and Spotclust, followed by phylogeographic analyses using statistics (logistic regression) and lineage axis plot analysis in GenGIS, in which a phylogenetic tree constructed in MIRU-VNTRplus was analysed. Combining spoligotyping data from 16 previously published studies with novel data from The Gambia, we obtained a total of 3580 isolates from 12 countries and identified 6 lineages comprising 32 families. By using stringent analytical tools we demonstrate for the first time a significant phylogeographic separation between western and eastern West Africa not only of the two M. africanum (West Africa 1 and 2) but also of several major M. tuberculosis sensu stricto families, such as LAM10 and Haarlem 3. Moreover, in a longitudinal logistic regression analysis for grouped data we showed that M. africanum West Africa 2 remains a persistent health concern.
   Conclusions/Significance
   Because of the geographical divide of the mycobacterial populations in West Africa, individual research findings from one country cannot be generalized across the whole region. The unequal geographical family distribution should be considered in placement and design of future clinical trials in West Africa.
C1 [Gehre, Florian; Ejo, Mebrat; Ofori-Anyinam, Boatema; de Jong, Bouke C.] Inst Trop Med, Mycobacterial Unit, Biomed Sci, B-2000 Antwerp, Belgium.
   [Gehre, Florian; Secka, Oumie; Ofori-Anyinam, Boatema; Antonio, Martin; de Jong, Bouke C.] Med Res Council MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
   [Kumar, Samrat; Abatih, Emmanuel; Berkvens, Dirk] Inst Trop Med, Biomed Sci, B-2000 Antwerp, Belgium.
   [Kendall, Lindsay] Med Res Council MRC Unit, Stat & Bioinformat Dept, Fajara, Gambia.
   [Ejo, Mebrat] Univ Gondar, Gondar, Ethiopia.
   [de Jong, Bouke C.] NYU, Div Infect Dis, Dept Med, New York, NY USA.
RP Gehre, F (reprint author), Inst Trop Med, Mycobacterial Unit, Biomed Sci, B-2000 Antwerp, Belgium.; Gehre, F (reprint author), Med Res Council MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
EM fgehre@mrc.gm
OI de Jong, Bouke/0000-0002-1017-4675; Ejo, Mebrat/0000-0001-8119-8394
FU European Research Council [311725]
FX FG, BCdJ, and BOA were supported by a European Research Council Starting
   grant INTERRUPTB (grant No.: 311725). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Affolabi D, 2009, EMERG INFECT DIS, V15, P1123, DOI 10.3201/eid1507.080697
   Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08
   Aminian M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S4
   Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189
   Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006
   Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815
   de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   Gehre F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110393
   Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000
   Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023
   Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06
   Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275
   Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601
   Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X
   Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103
   Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12
   Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409
   Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13
   Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753
   Niang MN, 1999, MICROBES INFECT, V1, P1189, DOI 10.1016/S1286-4579(99)00243-9
   Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363
   Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109
   Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011
   Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397
   UNDP, 2014, 2014 HUM DEV REP SUS
   Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003
   Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906
NR 28
TC 4
Z9 4
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2016
VL 10
IS 3
AR e0004408
DI 10.1371/journal.pntd.0004408
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DI1RF
UT WOS:000373272500009
PM 26964059
OA gold
DA 2017-08-15
ER

PT J
AU Lafond, KE
   Nair, H
   Rasooly, MH
   Valente, F
   Booy, R
   Rahman, M
   Kitsutani, P
   Yu, HJ
   Guzman, G
   Coulibaly, D
   Armero, J
   Jima, D
   Howie, SRC
   Ampofo, W
   Mena, R
   Chadha, M
   Sampurno, OD
   Emukule, GO
   Nurmatov, Z
   Corwin, A
   Heraud, JM
   Noyola, DE
   Cojocaru, R
   Nymadawa, P
   Barakat, A
   Adedeji, A
   von Horoch, M
   Olveda, R
   Nyatanyi, T
   Venter, M
   Mmbaga, V
   Chittaganpitch, M
   Nguyen, TH
   Theo, A
   Whaley, M
   Azziz-Baumgartner, E
   Bresee, J
   Campbell, H
   Widdowson, MA
AF Lafond, Kathryn E.
   Nair, Harish
   Rasooly, Mohammad Hafiz
   Valente, Fatima
   Booy, Robert
   Rahman, Mahmudur
   Kitsutani, Paul
   Yu, Hongjie
   Guzman, Guiselle
   Coulibaly, Daouda
   Armero, Julio
   Jima, Daddi
   Howie, Stephen R. C.
   Ampofo, William
   Mena, Ricardo
   Chadha, Mandeep
   Sampurno, Ondri Dwi
   Emukule, Gideon O.
   Nurmatov, Zuridin
   Corwin, Andrew
   Heraud, Jean Michel
   Noyola, Daniel E.
   Cojocaru, Radu
   Nymadawa, Pagbajabyn
   Barakat, Amal
   Adedeji, Adebayo
   von Horoch, Marta
   Olveda, Remigio
   Nyatanyi, Thierry
   Venter, Marietjie
   Mmbaga, Vida
   Chittaganpitch, Malinee
   Tran Hien Nguyen
   Theo, Andros
   Whaley, Melissa
   Azziz-Baumgartner, Eduardo
   Bresee, Joseph
   Campbell, Harry
   Widdowson, Marc-Alain
CA Global Resp Hospitalizations Influ
TI Global Role and Burden of Influenza in Pediatric Respiratory
   Hospitalizations, 1982-2012: A Systematic Analysis
SO PLOS MEDICINE
LA English
DT Article
ID LABORATORY-CONFIRMED INFLUENZA; SEASONAL INFLUENZA; YOUNG-CHILDREN;
   UNITED-STATES; VIRUS; INFECTIONS; PNEUMONIA; MORTALITY; COUNTRIES;
   AFRICA
C1 [Lafond, Kathryn E.; Kitsutani, Paul; Corwin, Andrew; Whaley, Melissa; Azziz-Baumgartner, Eduardo; Bresee, Joseph; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.
   [Lafond, Kathryn E.] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland.
   [Nair, Harish; Campbell, Harry] Univ Edinburgh, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland.
   [Nair, Harish] Publ Hlth Fdn India, New Delhi, India.
   [Rasooly, Mohammad Hafiz] Minist Publ Hlth, Afghanistan Natl Publ Hlth Inst, Kabul, Afghanistan.
   [Valente, Fatima] Minist Hlth, Natl Directorate Publ Hlth, Luanda, Angola.
   [Booy, Robert] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Westmead, NSW, Australia.
   [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh.
   [Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.
   [Guzman, Guiselle] Caja Costarricense Seguro Social, San Jose, Costa Rica.
   [Coulibaly, Daouda] Pasteur Inst Cote Ivoire, Abidjan, Cote Ivoire.
   [Armero, Julio] Minist Salud El Salvador, San Salvador, El Salvador.
   [Jima, Daddi] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.
   [Howie, Stephen R. C.] MRC Unit, Fajara, Gambia.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Ampofo, William] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana.
   [Mena, Ricardo] Minist Salud Publ & Asistencia Social, Guatemala City, Guatemala.
   [Chadha, Mandeep] Natl Inst Virol, Pune, Maharashtra, India.
   [Sampurno, Ondri Dwi] Natl Inst Hlth Res & Dev, Jakarta, Indonesia.
   [Emukule, Gideon O.] Ctr Dis Control & Prevent, Nairobi, Kenya.
   [Nurmatov, Zuridin] Minist Hlth, Bishkek, Kyrgyzstan.
   [Heraud, Jean Michel] Inst Pasteur Madagascar, Natl Influenza Ctr, Virol Unit, Antananarivo, Madagascar.
   [Noyola, Daniel E.] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico.
   [Cojocaru, Radu] Natl Ctr Publ Hlth, Kishinev, Moldova.
   [Nymadawa, Pagbajabyn] Natl Influenza Ctr, Ulaanbaatar, Mongol Peo Rep.
   [Barakat, Amal] Minist Sante, Natl Inst Hyg, Rabat, Morocco.
   [Adedeji, Adebayo] Fed Minist Hlth, Abuja, Nigeria.
   [von Horoch, Marta] Minist Salud Publ & Bienestar Social, Asuncion, Paraguay.
   [Olveda, Remigio] Res Inst Trop Med, Manila, Philippines.
   [Nyatanyi, Thierry] Minist Hlth, Kigali, Rwanda.
   [Venter, Marietjie] Natl Inst Communicable Dis, Johannesburg, South Africa.
   [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0001 Pretoria, South Africa.
   [Venter, Marietjie] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA.
   [Mmbaga, Vida] Minist Hlth, Dar Es Salaam, Tanzania.
   [Chittaganpitch, Malinee] Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand.
   [Tran Hien Nguyen] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam.
   [Theo, Andros] Univ Teaching Hosp, Virol Lab, Lusaka, Zambia.
RP Lafond, KE; Widdowson, MA (reprint author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.; Lafond, KE (reprint author), Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland.
EM gmj3@cdc.gov; zux5@cdc.gov
RI Nair, Harish/E-7431-2010; Venter, Marietjie/P-9604-2016
OI Nair, Harish/0000-0002-9432-9100; Venter, Marietjie/0000-0003-2696-824X;
   HERAUD, Jean-Michel/0000-0003-1107-0859
FU U.S. Centers for Disease Control and Prevention (CDC)
FX Funding for this study was provided entirely by the U.S. Centers for
   Disease Control and Prevention (CDC). The study was designed by the
   authors, and the results and conclusions do not necessarily reflect the
   official position of the CDC.
CR Ampofo K, 2008, PEDIATRICS, V122, P229, DOI 10.1542/peds.2007-3192
   Bender JM, 2010, PEDIATR INFECT DIS J, V29, P6, DOI 10.1097/INF.0b013e3181b4b950
   Chadha MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055918
   Cox CM, 2012, J INFECT DIS, V206, P1350, DOI 10.1093/infdis/jis517
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Dawood FS, 2010, PEDIATR INFECT DIS J, V29, P585, DOI 10.1097/INF.0b013e3181d411c5
   Gessner BD, 2013, VACCINE, V31, P3222, DOI 10.1016/j.vaccine.2013.05.017
   Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1
   Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d
   Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007
   LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1
   Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986
   Nzussouo NT, 2012, J INFECT DIS, V206, pS101, DOI 10.1093/infdis/jis572
   Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048
   Perdue ML, 2011, VACCINE, V29, pA48, DOI 10.1016/j.vaccine.2011.02.080
   Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869
   Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606
   Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361
   Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401
   Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x
   Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333
   United Nations, 2012, WORLD EC SIT PROSP 2
   United Nations Department of Economic and Social Affairs Population Division, 2013, STESASERA336 UN DEP
   Wells G, 2014, NEWCASTLE OTTAWA SCA
   World Health Organization, 2012, WHO INT GLOB EP SURV
   World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6
   Yu HJ, 2014, INFLUENZA OTHER RESP, V8, P53, DOI 10.1111/irv.12205
   Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211
   [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P201
NR 33
TC 8
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD MAR
PY 2016
VL 13
IS 3
AR e1001977
DI 10.1371/journal.pmed.1001977
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH8JN
UT WOS:000373039400010
PM 27011229
OA gold
DA 2017-08-15
ER

PT J
AU Le Doare, K
   Jarju, S
   Darboe, S
   Warburton, F
   Gorringe, A
   Heath, PT
   Kampmann, B
AF Le Doare, K.
   Jarju, S.
   Darboe, S.
   Warburton, F.
   Gorringe, A.
   Heath, P. T.
   Kampmann, B.
TI Risk factors for Group B Streptococcus colonisation and disease in
   Gambian women and their infants
SO JOURNAL OF INFECTION
LA English
DT Article
DE Neonatal infection; Group B Streptococcus; Vaccines; Immunity
ID NEONATAL COLONIZATION; ANTIMICROBIAL RESISTANCE; PREGNANT-WOMEN;
   CARRIAGE; CARE; MILK; EPIDEMIOLOGY; PREVALENCE; PREVENTION; PROTECTION
AB Objectives: To determine risk factors for GBS colonisation in Gambian mothers and in their infants from birth to day 60-89 of age.
   Methods: Swabs and breastmilk from mothers/infant pairs were collected and cultured on selective agar. Negative samples were analysed for GBS DNA via real-time PCR. Positive isolates were serotyped using multiplex PCR and gel-agarose electrophoresis.
   Results: Seven hundred and fifty women/infant pairs were recruited. 253 women (33.7%) were GBS-colonised at delivery. The predominant serotypes were: V (55%), II (16%), III (10%), Ia (8%) and Ib (8%). 186 infants were colonised (24.8%) at birth, 181 (24.1%) at 6 days and 96 at day 60-89 (14%). Infants born before 34 weeks of gestation and to women with rectovaginal and breastmilk colonisation at delivery had increased odds of GBS colonisation at birth. Season of birth was associated with increased odds of persistent infant GBS colonisation (dry season vs. wet season AOR 2.9; 95% CI 1.6-5.2).
   Conclusion: GBS colonisation is common in Gambian women at delivery and in their infants to day 60-89 and is dominated by serotype V. In addition to maternal colonisation, breastmilk and season of birth are important risk factors for infant GBS colonisation. Crown Copyright (C) 2015 Published by Elsevier Ltd on behalf of The British Infection Association.
C1 [Le Doare, K.; Kampmann, B.] Univ London Imperial Coll Sci Technol & Med, Norfolk Pl, London W2 1PG, England.
   [Le Doare, K.; Jarju, S.; Darboe, S.; Kampmann, B.] MRC Unit, Atlantic Rd, Fajara, Gambia.
   [Warburton, F.] Publ Hlth England, 61 Colindale Ave, London NW9 5EQ, England.
   [Le Doare, K.; Gorringe, A.] Publ Hlth England, Manor Farm Rd, Porton Down NW9 5EQ, England.
   [Le Doare, K.; Heath, P. T.] St Georges Univ London, Cranmer Terrace, London SW17 0RE, England.
RP Le Doare, K (reprint author), Univ London Imperial Coll Sci Technol & Med, Ctr Int Child Hlth, Norfolk Pl, London W2 1PG, England.
EM K.mehring-le-doare@ic.ac.uk; shjarju@mrc.gm; sdarboe@mrc.gm;
   Fiona.warburton@phe.gov.uk; Andrew-gorringe@phe.gov.uk;
   pheath@sgul.ac.uk; b.kampmann@ic.ac.uk
OI le doare, kirsty/0000-0002-5104-085X
FU Wellcome Trust Clinical Research Fellowship [WT104482MA]; Thrasher
   Research Fund [BK: 12250]; UK MRC [MC_UP_A900/1122, MC_UP_A900/115]; UK
   Medical Research Council (MRC); Department for International Development
   (DFID) under the MRC/DFID Concordat arrangement
FX This work was supported by a Wellcome Trust Clinical Research Fellowship
   to KLD (WT104482MA) and the Thrasher Research Fund (BK: 12250). BK is
   also supported by grants from the UK MRC (MC_UP_A900/1122,
   MC_UP_A900/115) and the UK Medical Research Council (MRC) and the
   Department for International Development (DFID) under the MRC/DFID
   Concordat arrangement.
CR Berardi A, 2014, ARCH DIS CHILD, V99, P395, DOI 10.1136/archdischild-2013-305291
   Berardi A, 2013, J PEDIATR-US, V163, P1099, DOI 10.1016/j.jpeds.2013.05.064
   Blumberg HM, 1996, J INFECT DIS, V173, P365
   Dagnew AF, 2012, CLIN INFECT DIS, V55, P91, DOI 10.1093/cid/cis395
   Diaz MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066183
   EASMON CSF, 1983, BRIT J OBSTET GYNAEC, V90, P241, DOI 10.1111/j.1471-0528.1983.tb08617.x
   Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6
   El Aila NA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-285
   Filleron A, 2014, Arch Dis Child Fetal Neonatal Ed, V99, pF41, DOI 10.1136/archdischild-2013-304362
   Hakansson S, 2008, ACTA OBSTET GYN SCAN, V87, P50, DOI 10.1080/00016340701802888
   Heath PT, 2011, EXPERT REV VACCINES, V10, P685, DOI [10.1586/erv.11.61, 10.1586/ERV.11.61]
   Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010
   Joachim A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-437
   Kadanali A, 2005, INT J CLIN PRACT, V59, P437, DOI 10.1111/j.1368-5031.2005.00395.x
   Kwatra G, 2015, CLIN MICROBIOL INFEC, V21, P568
   Kwatra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098778
   Kwatra G, 2013, J CLIN MICROBIOL, V51, P2515, DOI 10.1128/JCM.00251-13
   Le Doare K, 2014, VACCINE, V32, P3128, DOI 10.1016/j.vaccine.2014.04.020
   MacFarquhar JK, 2010, AM J INFECT CONTROL, V38, P283, DOI 10.1016/j.ajic.2009.08.011
   Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861
   Meehan M, 2014, EUR J CLIN MICROBIOL, V33, P1155, DOI 10.1007/s10096-014-2055-5
   Monari F, 2013, EARLY HUM DEV, V89, P1049, DOI 10.1016/j.earlhumdev.2013.08.010
   Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, P35
   Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18
   Okomo UA, 2015, PAEDIATR INT CHILD H, V35, P252, DOI 10.1179/2046905515Y.0000000036
   Schuchat A, 2000, NEW ENGL J MED, V343, P209, DOI 10.1056/NEJM200007203430310
   Shah D, 2014, PAEDIATR INT CHILD H, V34, P184, DOI 10.1179/2046905513Y.0000000112
   SUARA RO, 1994, J INFECT DIS, V170, P1316
   UNICEF, 2015, STATE WORLDS CHILDR
   Vanderhoeven JP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003920
   Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1
NR 31
TC 5
Z9 5
U1 2
U2 5
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD MAR
PY 2016
VL 72
IS 3
BP 283
EP 294
DI 10.1016/j.jinf.2015.12.014
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA DG2XW
UT WOS:000371935100002
PM 26763186
OA No
DA 2017-08-15
ER

PT J
AU Bojang, AL
   Mendy, FS
   Tientcheu, LD
   Otu, J
   Antonio, M
   Kampmann, B
   Agbla, S
   Sutherland, JS
AF Bojang, Adama L.
   Mendy, Francis S.
   Tientcheu, Leopold D.
   Otu, Jacob
   Antonio, Martin
   Kampmann, Beate
   Agbla, Schadrac
   Sutherland, Jayne S.
TI Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of
   pulmonary tuberculosis in The Gambia
SO JOURNAL OF INFECTION
LA English
DT Article
DE Tuberculosis; Diagnosis; TB-LAMP; GeneXpert; Sputum culture; Gambia;
   West Africa
ID BACTEC MGIT 960; MYCOBACTERIUM-TUBERCULOSIS; ASSAY
AB Background: Diagnosis of tuberculosis (TB) remains difficult, particularly in resource-limited settings. The development of nucleic acid-based tests for detection of Mycobacterium tuberculosis complex (MTBC) has significantly increased sensitivity compared to conventional smear microscopy and provides results within a matter of hours compared to weeks for the current gold-standard, liquid culture.
   Methods: In this study we performed side-by-side comparison of mycobacterial detection assays on sputum samples from 285 subjects presenting with symptoms suggestive of TB in The Gambia and a cross-sectional cohort of 156 confirmed TB patients with a median of 2 months of treatment. A novel assay, Loop-Mediated Amplification test for TB (TB-LAMP), was compared to smear microscopy, MGIT culture and GeneXpert MTB/RIF for all samples.
   Results: When culture was used as the reference standard, we found an overall sensitivity for TB-LAMP of 99% (95% CI: 94.5-99.8) and specificity of 94% (95% CI: 89.3-96.7). When latent class analysis was performed, TB-LAMP had 98.6% (95% CI: 95.9-100) sensitivity and 99% (95% CI: 98.2-100) specificity compared to 91.1% (95% CI: 86.1-96) sensitivity and 100% (95% CI: 98.2-100) specificity for MGIT culture. GeneXpert had the highest sensitivity 99.1% (95% CI: 97.1-100) but the lowest specificity 96% (95% CI: 92.6-98.3). Both TB-LAMP and GeneXpert showed high sensitivity and specificity regardless of age or strain of infection.
   Conclusion: Our findings show the diagnostic utility of both GeneXpert and TB-LAMP in The Gambia. Whilst TB-LAMP requires less infrastructure, it is unable to detect drug-resistant patterns and therefore would be most suitable as a screening test for new TB cases in peripheral health clinics. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Bojang, Adama L.; Mendy, Francis S.; Tientcheu, Leopold D.; Otu, Jacob; Antonio, Martin; Kampmann, Beate; Agbla, Schadrac; Sutherland, Jayne S.] MRC, Vaccines & Immun Theme, Fajara, Gambia.
RP Sutherland, JS (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM jsutherland@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709; Sutherland,
   Jayne/0000-0002-7083-4997
FU Foundation for Innovative Diagnostics (FIND)
FX The authors thank all study participants, TB diagnostic laboratory staff
   and TB clinic staff. This study was funded by the Foundation for
   Innovative Diagnostics (FIND) as part of a larger multi-site study.
CR Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8
   Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023
   Hanna BA, 1999, J CLIN MICROBIOL, V37, P748
   Kumar P, 2014, J INFECTION, V69, P607, DOI 10.1016/j.jinf.2014.08.017
   Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629
   Otu J, 2008, J INFECT DEV COUNTR, V2, P200
   Li Q, 2014, PLOS ONE, V9
   Pandey BD, 2008, J MED MICROBIOL, V57, P439, DOI 10.1099/jmm.0.47499-0
   Piatek Amy S, 2013, Glob Health Sci Pract, V1, P18, DOI 10.9745/GHSP-D-12-00004
   Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3
   Rabna P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127536
   Tientcheu LD, 2014, EUR J IMMUNOL, V44, P1387, DOI 10.1002/eji.201343956
   Togun TO, 2015, INT J TUBERC LUNG D, V19, P1091, DOI 10.5588/ijtld.15.0228
   Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120
   Whitelaw A, 2009, TUBERCULOSIS COMPREH, P164
   World Health Organization, WHO GLOB TUB REP 201
   [Anonymous], 2013, US LOOP MED IS AMPL
NR 17
TC 5
Z9 5
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD MAR
PY 2016
VL 72
IS 3
BP 332
EP 337
DI 10.1016/j.jinf.2015.11.011
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DG2XW
UT WOS:000371935100008
PM 26724771
OA No
DA 2017-08-15
ER

PT J
AU Prentice, AM
   Nabwera, H
   Unger, S
   Moores, SE
AF Prentice, Andrew M.
   Nabwera, Helen
   Unger, Stefan
   Moores, Sophie E.
TI Growth monitoring and the prognosis of mortality in low-income settings
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Editorial Material
C1 [Prentice, Andrew M.; Nabwera, Helen] Med Res Council MRC Unit, Banjul, Gambia.
   [Prentice, Andrew M.; Nabwera, Helen] Univ London London Sch Hyg & Trop Med, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
   [Unger, Stefan] Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland.
   [Moores, Sophie E.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England.
RP Prentice, AM (reprint author), Med Res Council MRC Unit, Banjul, Gambia.; Prentice, AM (reprint author), Univ London London Sch Hyg & Trop Med, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
EM andrew.prentice@lshtm.ac.uk
FU Medical Research Council [MCA760-5QX00, MC_UP_1005/1, MC_U123292701]
CR Beaton G, 1990, ACC SCN STATE OF THE
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Man WDC, 1998, TROP MED INT HEALTH, V3, P678
   Schwinger C, 2016, AM J CLIN NUTR, V103, P801, DOI 10.3945/ajcn.115.118679
   UNICEF, 2015, COMM CHILD SURV PROM
NR 5
TC 1
Z9 1
U1 0
U2 4
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAR
PY 2016
VL 103
IS 3
BP 681
EP 682
DI 10.3945/ajcn.115.130013
PG 2
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DF8ZO
UT WOS:000371650200001
PM 26888709
OA No
DA 2017-08-15
ER

PT J
AU Gruca, MA
   Moore, S
   Darboe, M
   Bernstein, R
AF Gruca, Margaret A.
   Moore, Sophie
   Darboe, Momodou
   Bernstein, Robin
TI Prenatal supplementation, breast milk composition, and infant growth in
   rural Gambia
SO AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
LA English
DT Meeting Abstract
CT 85th Annual Meeting of the
   American-Association-of-Physical-Anthropologists
CY APR 13-16, 2016
CL Atlanta, GA
SP Amer Assoc Phys Anthropologists
C1 [Gruca, Margaret A.; Bernstein, Robin] Univ Colorado Boulder, Anthropol, Boulder, CO USA.
   [Moore, Sophie] MRC Human Nutr Res, Boulder, CO USA.
   [Darboe, Momodou] MRC Keneba, Serrekunda, Gambia.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-9483
EI 1096-8644
J9 AM J PHYS ANTHROPOL
JI Am. J. Phys. Anthropol.
PD MAR
PY 2016
VL 159
SU 62
BP 163
EP 163
PG 1
WC Anthropology; Evolutionary Biology
SC Anthropology; Evolutionary Biology
GA DF3OW
UT WOS:000371255201218
OA No
DA 2017-08-15
ER

PT J
AU Koss, CA
   Natureeba, P
   Nyafwono, D
   Plenty, A
   Mwesigwa, J
   Nzarubara, B
   Clark, TD
   Ruel, TD
   Achan, J
   Charlebois, ED
   Cohan, D
   Kamya, MR
   Havlir, DV
   Young, SL
AF Koss, Catherine A.
   Natureeba, Paul
   Nyafwono, Dorcas
   Plenty, Albert
   Mwesigwa, Julia
   Nzarubara, Bridget
   Clark, Tamara D.
   Ruel, Theodore D.
   Achan, Jane
   Charlebois, Edwin D.
   Cohan, Deborah
   Kamya, Moses R.
   Havlir, Diane V.
   Young, Sera L.
TI Brief Report: Food Insufficiency Is Associated With Lack of Sustained
   Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan
   Women
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE nutrition; perinatal transmission; household hunger; virologic outcomes;
   pregnancy; food insecurity
ID COMBINATION ANTIRETROVIRAL THERAPY; TO-CHILD TRANSMISSION; NUTRIENT
   SUPPLEMENTS; TREATMENT OUTCOMES; RANDOMIZED-TRIAL; RURAL UGANDA;
   WEIGHT-LOSS; INSECURITY; EFAVIRENZ; LOPINAVIR/RITONAVIR
AB Food insecurity is associated with poor virologic outcomes, but this has not been studied during pregnancy and breastfeeding. We assessed sustained viral suppression from 8 weeks on antiretroviral therapy to 48 weeks postpartum among 171 pregnant and breastfeeding Ugandan women; 74.9% experienced food insufficiency. In multivariable analysis, food insufficiency [adjusted odds ratio (aOR) 0.38, 95% confidence interval (CI): 0.16 to 0.91], higher pretreatment HIV-1 RNA (aOR 0.55 per 10-fold increase, 95% CI: 0.37 to 0.82), and lopinavir/ritonavir versus efavirenz (aOR 0.49, 95% CI: 0.24 to 0.96) were associated with lower odds of sustained viral suppression. Interventions to address food security may improve virologic outcomes among HIV-infected women.
C1 [Koss, Catherine A.; Clark, Tamara D.; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV Infect Dis & Global Med, Box 0874, San Francisco, CA 94143 USA.
   [Koss, Catherine A.; Natureeba, Paul; Nyafwono, Dorcas; Plenty, Albert; Mwesigwa, Julia; Nzarubara, Bridget; Clark, Tamara D.; Ruel, Theodore D.; Achan, Jane; Charlebois, Edwin D.; Cohan, Deborah; Kamya, Moses R.; Havlir, Diane V.] Makerere Univ Univ Calif San Francisco Res Collab, Kampala, Uganda.
   [Plenty, Albert; Charlebois, Edwin D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA 94143 USA.
   [Mwesigwa, Julia; Achan, Jane] MRC Unit, Serrekunda, Gambia.
   [Ruel, Theodore D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.
   [Cohan, Deborah] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.
   [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.
   [Young, Sera L.] Cornell Univ, Program Int Nutr, Dept Populat Med & Diagnost Sci, Ithaca, NY USA.
RP Koss, CA (reprint author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV Infect Dis & Global Med, Box 0874, San Francisco, CA 94143 USA.
EM catherine.koss@ucsf.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development [P01 HD059454, K23 HD60459]; National Institute of Allergy
   and Infectious Diseases [T32 AI060530]; National Institute of Mental
   Health at the National Institutes of Health [K01 MH098902]; President's
   Emergency Plan For AIDS Relief; Office of the Global AIDS Coordinator;
   Office of AIDS Research; NIH
FX This work was supported by grants from the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development (P01 HD059454,
   D. V. H. and K23 HD60459, T. D. R.), the National Institute of Allergy
   and Infectious Diseases (T32 AI060530, D. V. H./C. A. K.), and the
   National Institute of Mental Health (K01 MH098902, S. L. Y.) at the
   National Institutes of Health. The nutritional substudy was supported by
   the President's Emergency Plan For AIDS Relief, the Office of the Global
   AIDS Coordinator, and the Office of AIDS Research.; AbbVie
   Pharmaceuticals donated lopinavir/ritonavir (Aluvia) for the parent
   study but had no role in study design, data accrual and analysis, or
   manuscript preparation. Gilead donates medications for participants in a
   separate NIH-funded study led by D. V. H. but provides no financial
   support. The other authors have no conflicts of interest to disclose.
CR Ades V, 2013, J TROP PEDIATRICS, V59, P441, DOI 10.1093/tropej/fmt044
   Anema A, 2014, AIDS BEHAV, V18, pS476, DOI 10.1007/s10461-013-0659-x
   Bartelink IH, 2015, PEDIATR INFECT DIS J, V34, pE63, DOI 10.1097/INF.0000000000000603
   Bartelink IH, 2014, J CLIN PHARMACOL, V54, P121, DOI 10.1002/jcph.167
   BRIEFEL RR, 1992, J NUTR EDUC, V24, pS24
   Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2
   Coates C, 2007, HOUSEHOLD FOOD INSEC
   Cohan D, 2015, AIDS, V29, P183, DOI 10.1097/QAD.0000000000000531
   Cohen CR, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0886-x
   Deitchler M., 2011, INTRO SIMPLE MEASURE
   Deitchler M, 2010, 360 FANTA2 FHI, P360
   FAO, 1996, ROM DECL WORLD FOOD
   Feldman MB, 2015, JAIDS-J ACQ IMM DEF, V69, P329, DOI 10.1097/QAI.0000000000000596
   Flax VL, 2012, J NUTR, V142, P1350, DOI 10.3945/jn.111.155598
   Gandhi M, 2013, JAIDS-J ACQ IMM DEF, V63, P578, DOI 10.1097/QAI.0b013e31829c48ad
   Grobler L, 2013, COCHRANE DB SYST REV, V2
   Institute of Medicine, 2006, DIETARY REFERENCE IN
   Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGN RE
   Ivers LC, 2014, CLIN INFECT DIS, V58, P1176, DOI 10.1093/cid/ciu028
   Ivers LC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-33
   Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573
   Jones AD, 2013, ADV NUTR, V4, P481, DOI 10.3945/an.113.004119
   Kalichman SC, 2015, INFECT DIS THER, V4, P79, DOI DOI 10.1007/S40121-015-0057-Y
   Kayira D, 2012, AM J CLIN NUTR, V95, P759, DOI 10.3945/ajcn.111.018812
   Koss CA, 2015, AIDS, V29, P825, DOI 10.1097/QAD.0000000000000619
   Koss CA, 2014, JAIDS-J ACQ IMM DEF, V67, P128, DOI 10.1097/QAI.0000000000000281
   Laraia BA, 2006, J NUTR, V136, P177
   McCoy SI, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1764-8
   Mehta S, 2008, AM J CLIN NUTR, V87, P1639
   Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679
   Nagata JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091403
   Natureeba P, 2014, J INFECT DIS, V210, P1938, DOI 10.1093/infdis/jiu346
   Ramlal RT, 2012, NUTR CLIN PRACT, V27, P416, DOI 10.1177/0884533611435991
   Siegfried N, 2012, COCHRANE DB SYST REV, V3
   UNAIDS, 2015, AIDS CHANG EV MDG 6
   Villamor E, 2005, JAIDS-J ACQ IMM DEF, V38, P622, DOI 10.1097/01.qai.0000143601.48986.47
   Villamor E, 2004, J NUTR, V134, P1424
   Wang EA, 2011, J GEN INTERN MED, V26, P1012, DOI 10.1007/s11606-011-1723-8
   Webb-Girard A, 2012, MATERN CHILD NUTR, V8, P199, DOI 10.1111/j.1740-8709.2010.00272.x
   Weiser S, 2011, AM J CLIN NUTR S, V2011, p1729S
   Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35
   Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37
   Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340
   Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2
   Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5
   [Anonymous], 2013, CONS GUID US ANT DRU
   World Food Programme, 2013, COMPR FOOD SEC VULN
   Young S, 2015, AIDS BEHAV, V19, P1535, DOI 10.1007/s10461-014-0947-0
   Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4
   Young S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041934
   Young SL, 2014, MATERN CHILD HLTH J, V18, P2044, DOI 10.1007/s10995-014-1450-y
NR 51
TC 5
Z9 5
U1 1
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD MAR 1
PY 2016
VL 71
IS 3
BP 310
EP 315
DI 10.1097/QAI.0000000000000860
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DF7FB
UT WOS:000371522100010
PM 26397935
OA No
DA 2017-08-15
ER

PT J
AU Cross, J
   Bradbury, R
   Fulford, A
   Jallow, A
   Wegmuller, R
   Prentice, A
   Cerami, C
AF Cross, James
   Bradbury, Richard
   Fulford, Anthony
   Jallow, Amadou
   Wegmuller, Rita
   Prentice, Andrew
   Cerami, Carla
TI SERUM FROM INDIVIDUALS GIVEN A SINGLE ORAL DOSE OF IRON SUPPLEMENTATION
   SUPPORTS INCREASED BACTERIAL GROWTH
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Meeting Abstract
C1 [Cerami, Carla] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Cross, James; Bradbury, Richard; Jallow, Amadou; Wegmuller, Rita] MRC Gambia, Serrekunda, Gambia.
   [Fulford, Anthony; Prentice, Andrew] London Sch Hyg & Trop Med, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
EI 1096-8652
J9 AM J HEMATOL
JI Am. J. Hematol.
PD MAR
PY 2016
VL 91
IS 3
MA 148
BP E171
EP E171
PG 1
WC Hematology
SC Hematology
GA DF2HI
UT WOS:000371162800154
OA No
DA 2017-08-15
ER

PT J
AU Goheen, M
   Darboe, B
   Danso, E
   Bah, M
   Affara, M
   Bah, A
   Wegmuller, R
   Prentice, A
   Cerami, C
AF Goheen, Morgan
   Darboe, Bakary
   Danso, Ebrima
   Bah, Mamadou
   Affara, Muna
   Bah, Amat
   Wegmuller, Rita
   Prentice, Andrew
   Cerami, Carla
TI IRON DEFICIENT RBCS FROM GAMBIAN CHILDREN AND PREGNANT WOMEN ARE
   RESISTANT TO FIELD ISOLATES OF FALCIPARUM MALARIA
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Meeting Abstract
C1 [Goheen, Morgan; Cerami, Carla] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Darboe, Bakary; Danso, Ebrima; Bah, Mamadou; Affara, Muna; Bah, Amat; Wegmuller, Rita] MRC Gambia, Serrekunda, Gambia.
   [Prentice, Andrew] London Sch Hyg & Trop Med, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
EI 1096-8652
J9 AM J HEMATOL
JI Am. J. Hematol.
PD MAR
PY 2016
VL 91
IS 3
MA 87
BP E107
EP E107
PG 1
WC Hematology
SC Hematology
GA DF2HI
UT WOS:000371162800093
OA No
DA 2017-08-15
ER

PT J
AU Cheeseman, IH
   Miller, B
   Tan, JC
   Tan, A
   Nair, S
   Nkhoma, SC
   De Donato, M
   Rodulfo, H
   Dondorp, A
   Branch, OH
   Mesia, LR
   Newton, P
   Mayxay, M
   Amambua-Ngwa, A
   Conway, DJ
   Nosten, F
   Ferdig, MT
   Anderson, TJC
AF Cheeseman, Ian H.
   Miller, Becky
   Tan, John C.
   Tan, Asako
   Nair, Shalini
   Nkhoma, Standwell C.
   De Donato, Marcos
   Rodulfo, Hectorina
   Dondorp, Arjen
   Branch, Oralee H.
   Ruiz Mesia, Lastenia
   Newton, Paul
   Mayxay, Mayfong
   Amambua-Ngwa, Alfred
   Conway, David J.
   Nosten, Francois
   Ferdig, Michael T.
   Anderson, Tim J. C.
TI Population Structure Shapes Copy Number Variation in Malaria Parasites
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE copy number variation; population genetics; parasitology
ID ANTIMALARIAL-DRUG RESISTANCE; PLASMODIUM-FALCIPARUM GENOME; ERYTHROCYTE
   INVASION; GENETIC DIVERSITY; DROSOPHILA-MELANOGASTER; ARTEMISININ
   RESISTANCE; MEFLOQUINE RESISTANCE; NATURAL-POPULATIONS; MEROZOITE
   PROTEINS; NUTRIENT-UPTAKE
AB If copy number variants (CNVs) are predominantly deleterious, we would expect them to be more efficiently purged from populations with a large effective population size (Ne) than from populations with a small Ne. Malaria parasites (Plasmodium falciparum) provide an excellent organism to examine this prediction, because this protozoan shows a broad spectrum of population structures within a single species, with large, stable, outbred populations in Africa, small unstable inbred populations in South America and with intermediate population characteristics in South East Asia. We characterized 122 single-clone parasites, without prior laboratory culture, from malaria-infected patients in seven countries in Africa, South East Asia and South America using a high-density single-nucleotide polymorphism/CNV microarray. We scored 134 high-confidence CNVs across the parasite exome, including 33 deletions and 102 amplifications, which ranged in size from <500 bp to 59 kb, as well as 10,107 flanking, biallelic single-nucleotide polymorphisms. Overall, CNVs were rare, small, and skewed toward low frequency variants, consistent with the deleterious model. Relative to African and South East Asian populations, CNVs were significantly more common in South America, showed significantly less skew in allele frequencies, and were significantly larger. On this background of low frequency CNV, we also identified several high-frequency CNVs under putative positive selection using an FST outlier analysis. These included known adaptive CNVs containing rh2b and pfmdr1, and several other CNVs (e.g., DNA helicase and three conserved proteins) that require further investigation. Our data are consistent with a significant impact of genetic structure on CNV burden in an important human pathogen.
C1 [Cheeseman, Ian H.; Nair, Shalini; Anderson, Tim J. C.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA.
   [Miller, Becky; Tan, John C.; Tan, Asako; Ferdig, Michael T.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Nkhoma, Standwell C.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.
   [De Donato, Marcos; Rodulfo, Hectorina] Univ De Oriente, IIBCAUDO, Genet Mol Lab, Cumana, Venezuela.
   [Dondorp, Arjen] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.
   [Dondorp, Arjen; Newton, Paul; Mayxay, Mayfong; Nosten, Francois] Univ Oxford, Churchill Hosp, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Branch, Oralee H.] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10003 USA.
   [Ruiz Mesia, Lastenia] Univ Nacl De La Amazonia Peruana, Lab Invest Prod Nat & Antiparasitaros, Iquitos, Peru.
   [Newton, Paul; Mayxay, Mayfong] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit LOMWRU, Viangchan, Laos.
   [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos.
   [Amambua-Ngwa, Alfred; Conway, David J.] MRC Unit, Banjul, Gambia.
   [Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England.
   [Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand.
RP Cheeseman, IH (reprint author), Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA.
EM ianc@txbiomed.org
OI cheeseman, ian/0000-0003-4426-4027; De Donato,
   Marcos/0000-0001-8860-6020; Conway, David/0000-0002-8711-3037
FU National Institutes for Health [R37AI048071, R01AI075145]; Cowles
   Fellowship; Research Facilities Improvement Program from the National
   Center for Research Resources of the National Institutes of Health [C06
   RR013556, RR017515]; National Center for Research Resources [S10
   RR029392]
FX Molecular work was funded by National Institutes for Health grants
   R37AI048071 and R01AI075145 (T.J.C.A.) and a Cowles Fellowship (I.H.C.).
   This investigation was conducted in facilities constructed with support
   from Research Facilities Improvement Program grant C06 RR013556 and
   RR017515 from the National Center for Research Resources of the National
   Institutes of Health. The AT&T Genomics Computing Center supercomputing
   facilities were supported by the AT&T Foundation and the National Center
   for Research Resources Grant Number S10 RR029392. We thank the Peruvian
   community members for participation. We thank patients and staff who
   contributed to data collection in Thailand (SMRU staff), Cambodia (Chea
   Nguon, Char Meng Chuor, and Duong Socheat), Laos (Maniphone Khanthavong,
   Odai Chanthongthip, Bongkot Soonthornsata, Tiengkham Pongvongsa, Samlane
   Phompida, and Bouasy Hongvanthong), and The Gambia (Michael Walther and
   Lamin Manneh), Richard Pinapati for assistance with data submission, and
   MalariaGen for generating the P. falciparum genome resequencing data.
CR Aaltonen J, 1999, ANN MED, V31, P111, DOI 10.3109/07853899708998786
   Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110
   Ahouidi AD, 2010, INFECT GENET EVOL, V10, P200, DOI 10.1016/j.meegid.2009.11.008
   Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699
   Aminoff M, 1999, NAT GENET, V21, P309
   Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562
   Anderson TJC, 2009, TRENDS PARASITOL, V25, P336, DOI 10.1016/j.pt.2009.04.005
   Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467
   Anderson TJC, 2005, MOL BIOL EVOL, V22, P2362, DOI 10.1093/molbev/msi235
   Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005
   Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837
   BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428
   Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670
   Brown KH, 2012, P NATL ACAD SCI USA, V109, P529, DOI 10.1073/pnas.1112163109
   Carret CK, 2005, MOL BIOCHEM PARASIT, V144, P177, DOI 10.1016/j.molbiopara.2005.08.010
   Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966
   Cheeseman IH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-353
   Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]
   Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516
   Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506
   COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143
   Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x
   Cridland JM, 2010, GENOME BIOL EVOL, V2, P83, DOI 10.1093/gbe/evq001
   Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21
   Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096
   Eastman RT, 2011, ANTIMICROB AGENTS CH, V55, P3908, DOI 10.1128/AAC.01793-10
   Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2
   Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078
   Flannery EL, 2013, J MED CHEM, V56, P7761, DOI 10.1021/jm400325j
   Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531
   Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Gazave E, 2011, GENOME RES, V21, P1626, DOI 10.1101/gr.117242.110
   Gonzales JM, 2008, PLOS BIOL, V6, P2016, DOI 10.1371/journal.pbio.0060238
   Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160
   Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8278.2004.00828.x
   Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375
   Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x
   Heinberg A, 2013, MOL MICROBIOL, V88, P702, DOI 10.1111/mmi.12162
   Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07
   Jiang HY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-398
   Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449
   Katju Vaishali, 2013, Frontiers in Genetics, V4, P273, DOI 10.3389/fgene.2013.00273
   KEMP DJ, 1992, MEM I OSWALDO CRUZ, V87, P85
   Kidgell Claire, 2006, PLoS Pathogens, V2, P562, DOI 10.1371/journal.ppat.0020057
   Kumpornsin K, 2014, MOL BIOL EVOL, V31, P1649, DOI 10.1093/molbev/msu140
   Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07
   Lantos PM, 2009, PARASITOLOGY, V136, P1, DOI 10.1017/S0031182008005167
   Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494
   Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026
   Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743
   Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644
   Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174
   Mayxay M, 2007, AM J TROP MED HYG, V77, P36
   Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003
   Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708
   Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335
   Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162
   Nair Shalini, 2007, Mol Biol Evol, V24, P562
   Nair S, 2010, MOL BIOCHEM PARASIT, V172, P145, DOI 10.1016/j.molbiopara.2010.03.015
   Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243
   Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026
   Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171
   Nery S, 2006, MOL BIOCHEM PARASIT, V149, P208, DOI 10.1016/j.molbiopara.2006.05.014
   Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002
   OHTA T, 1992, ANNU REV ECOL SYST, V23, P263
   Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186
   Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228
   Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08
   Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055
   Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097
   Ribacke U, 2007, MOL BIOCHEM PARASIT, V155, P33, DOI 10.1016/j.molbiopara.2007.05.005
   Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140
   Savukoski M, 1998, NAT GENET, V19, P286
   Sepulveda N, 2013, BMC GENOMICS, V14, P128
   Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371
   SHIRLEY MW, 1990, MOL BIOCHEM PARASIT, V40, P137, DOI 10.1016/0166-6851(90)90087-3
   Singh A, 2004, J BIOL CHEM, V279, P35236, DOI 10.1074/jbc.M404235200
   Sjodin P, 2012, METHODS MOL BIOL, V838, P209, DOI 10.1007/978-1-61779-507-7_10
   SMITH J M, 1974, Genetical Research, V23, P23
   Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7
   Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113
   Tan JC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r35
   Thaithong S, 2001, EXP PARASITOL, V98, P59, DOI 10.1006/expr.2001.4618
   Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x
   WHO, 2014, WHO EPIBRIEF, Vi-xiv, P1
NR 88
TC 6
Z9 6
U1 7
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD MAR
PY 2016
VL 33
IS 3
BP 603
EP 620
DI 10.1093/molbev/msv282
PG 18
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA DF3BU
UT WOS:000371219500002
PM 26613787
OA No
DA 2017-08-15
ER

PT J
AU Last, A
   Roberts, C
   Coll, F
   Burr, S
   Clarke, I
   Mabey, D
   Bailey, R
   Clark, T
   Thomson, N
   Holland, M
AF Last, Anna
   Roberts, Chrissy
   Coll, Francesc
   Burr, Sarah
   Clarke, Ian
   Mabey, David
   Bailey, Robin
   Clark, Taane
   Thomson, Nicholas
   Holland, Martin
TI Ocular chlamydial genomic variants and disease severity in trachoma: a
   cross-sectional population-based genome-wide association study
SO LANCET
LA English
DT Meeting Abstract
CT Spring Meeting on Clinician Scientists in Training
CY FEB 25, 2016
CL Royal Coll Phys, London, ENGLAND
HO Royal Coll Phys
C1 [Last, Anna; Roberts, Chrissy; Coll, Francesc; Mabey, David; Bailey, Robin; Clark, Taane; Holland, Martin] London Sch Hyg & Trop Med, London, England.
   [Burr, Sarah] MRC Unit, Fajara, Gambia.
   [Clarke, Ian] Univ Southampton, Southampton, Hants, England.
   [Thomson, Nicholas] Wellcome Trust Sanger Inst, Cambridge, England.
EM anna.last@lshtm.ac.uk
FU Wellcome Trust
FX Wellcome Trust.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 25
PY 2016
VL 387
SU 1
MA 67
BP 63
EP 63
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA ER0YK
UT WOS:000398515000061
OA No
DA 2017-08-15
ER

PT J
AU Usuf, E
   Mackenzie, G
   Sambou, S
   Atherly, D
   Suraratdecha, C
AF Usuf, Effua
   Mackenzie, Grant
   Sambou, Sana
   Atherly, Deborah
   Suraratdecha, Chutima
TI The economic burden of childhood pneumococcal diseases in The Gambia
SO COST EFFECTIVENESS AND RESOURCE ALLOCATION
LA English
DT Article
ID CONJUGATE VACCINATION; BACTERIAL-MENINGITIS; COST-EFFECTIVENESS;
   PNEUMONIA; COMMUNITY; MORTALITY; KENYA; RISK; CARE
AB Background: Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a societal perspective, the costs incurred by health providers and families of children with pneumococcal diseases.
   Methods: We recruited children less than 5 years of age with outpatient pneumonia, inpatient pneumonia, pneumococcal sepsis and bacterial meningitis at facilities in rural and urban Gambia. We collected provider costs, out of pocket costs and productivity loss for the families of children. For each disease diagnostic category, costs were collected before, during, and for 1 week after discharge from hospital or outpatient visit.
   Results: A total of 340 children were enrolled; 100 outpatient pneumonia, 175 inpatient pneumonia 36 pneumococcal sepsis, and 29 bacterial meningitis cases. The mean provider costs per patient for treating outpatient pneumonia, inpatient pneumonia, pneumococcal sepsis and meningitis were US$ 8, US$ 64, US$ 87 and US$ 124 respectively and the mean out of pocket costs per patient were US$ 6, US$ 31, US$ 44 and US$ 34 respectively. The economic burden of outpatient pneumonia, inpatient pneumonia, pneumococcal sepsis and meningitis increased to US$ 15, US$ 109, US$ 144 and US$ 170 respectively when family members' time loss from work was taken into account.
   Conclusion: The economic burden of pneumococcal disease in The Gambia is substantial, costs to families was approximately one-third to a half of the provider costs, and accounted for up to 30 % of total societal costs. The introduction of pneumococcal conjugate vaccine has the potential to significantly reduce this economic burden in this society.
C1 [Usuf, Effua; Mackenzie, Grant] MRC, Gambia Unit, POB 273, Banjul, Gambia.
   [Mackenzie, Grant] Murdoch Childrens Res Inst, Pneumococcal Grp, Parkville, Vic, Australia.
   [Mackenzie, Grant] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Sambou, Sana] Minist Hlth, Banjul, Gambia.
   [Atherly, Deborah; Suraratdecha, Chutima] PATH, Seattle, WA USA.
   [Suraratdecha, Chutima] US Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Usuf, E (reprint author), MRC, Gambia Unit, POB 273, Banjul, Gambia.
EM eusuf@mrc.gm
FU Bill & Melinda Gates Foundation; PATH; MRC (UK)
FX This study was funded by PATH, MRC (UK), and the Bill & Melinda Gates
   Foundation.
CR Alvis-Guzman N, 2013, VACCINE, V31, pC58, DOI 10.1016/j.vaccine.2013.05.035
   Ayieko Philip, 2009, Cost Eff Resour Alloc, V7, P3, DOI 10.1186/1478-7547-7-3
   Chola Lumbwe, 2009, Cost Eff Resour Alloc, V7, P16, DOI 10.1186/1478-7547-7-16
   Edmond K, 2010, PEDIAT INFECT DIS J
   Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7
   GREENWOOD BM, 1987, ANN TROP PAEDIATR, V7, P91
   Guinness L, 2002, AIDS, V16, P901, DOI 10.1097/00002030-200204120-00010
   Howie SRC, 2009, B WORLD HEALTH ORGAN, V87, P763, DOI 10.2471/BLT.08.058370
   Hussain H, 2006, INT J HEALTH PLAN M, V21, P229, DOI 10.1002/hpm.847
   Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   Madsen HO, 2009, TROP MED INT HEALTH, V14, P1315, DOI 10.1111/j.1365-3156.2009.02374.x
   Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Pritchard C, 2000, PRODUCTIVITY COSTS P
   Rozenbaum MH, 2015, VACCINE, V33, P3193, DOI 10.1016/j.vaccine.2015.05.001
   Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401
   Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0
   Touray MML, 2011, J PHARM HEALTH SERV, V2, P175, DOI 10.1111/j.1759-8893.2011.00057.x
   Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
   Usuf E, 2014, VACCINE, V32, P1975, DOI 10.1016/j.vaccine.2014.01.045
   [Anonymous], 2015, INT VACC ACC CTR IVA
NR 24
TC 1
Z9 1
U1 1
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1478-7547
J9 COST EFFECT RESOUR A
JI Cost Effect. Resour Alloc.
PD FEB 17
PY 2016
VL 14
AR 4
DI 10.1186/s12962-016-0053-4
PG 10
WC Health Policy & Services
SC Health Care Sciences & Services
GA EF0NW
UT WOS:000390023600001
PM 26893592
OA gold
DA 2017-08-15
ER

PT J
AU Manigart, O
   Trotter, C
   Findlow, H
   Assefa, A
   Mihret, W
   Demisse, TM
   Yeshitela, B
   Osei, I
   Hodgson, A
   Quaye, SL
   Sow, S
   Coulibaly, M
   Diallo, K
   Traore, A
   Collard, JM
   Boukary, RM
   Djermakoye, O
   Mahamane, AE
   Jusot, JF
   Sokhna, C
   Alavo, S
   Doucoure, S
   Ba, E
   Dieng, M
   Diallo, A
   Daugla, DM
   Omotara, B
   Chandramohan, D
   Hassan-King, M
   Nascimento, M
   Woukeu, A
   Borrow, R
   Stuart, JM
   Greenwood, B
AF Manigart, Olivier
   Trotter, Caroline
   Findlow, Helen
   Assefa, Abraham
   Mihret, Wude
   Demisse, Tesfaye Moti
   Yeshitela, Biruk
   Osei, Isaac
   Hodgson, Abraham
   Quaye, Stephen Laryea
   Sow, Samba
   Coulibaly, Mamadou
   Diallo, Kanny
   Traore, Awa
   Collard, Jean-Marc
   Boukary, Rahamatou Moustapha
   Djermakoye, Oumarou
   Mahamane, Ali Elhaji
   Jusot, Jean-Francois
   Sokhna, Cheikh
   Alavo, Serge
   Doucoure, Souleymane
   Ba, El Hadj
   Dieng, Marietou
   Diallo, Aldiouma
   Daugla, Doumagoum Moto
   Omotara, Babatunji
   Chandramohan, Daniel
   Hassan-King, Musa
   Nascimento, Maria
   Woukeu, Arouna
   Borrow, Ray
   Stuart, James M.
   Greenwood, Brian
TI A Seroepidemiological Study of Serogroup A Meningococcal Infection in
   the African Meningitis Belt
SO PLOS ONE
LA English
DT Article
ID A CAPSULAR POLYSACCHARIDE; NEISSERIA-MENINGITIDIS; MALARIA TRANSMISSION;
   SEROLOGICAL MARKERS; IMMUNE-RESPONSE; CHILDREN; ANTIBODY; VACCINE;
   IMMUNIZATION; CARRIAGE
AB The pattern of epidemic meningococcal disease in the African meningitis belt may be influenced by the background level of population immunity but this has been measured infrequently. A standardised enzyme-linked immunosorbent assay (ELISA) for measuring meningococcal serogroup A IgG antibodies was established at five centres within the meningitis belt. Antibody concentrations were then measured in 3930 individuals stratified by age and residence from six countries. Seroprevalence by age was used in a catalytic model to determine the force of infection. Meningococcal serogroup A IgG antibody concentrations were high in each country but showed heterogeneity across the meningitis belt. The geometric mean concentration (GMC) was highest in Ghana (9.09 mu g/mL [95% CI 8.29, 9.97]) and lowest in Ethiopia (1.43 mu g/mL [95% CI 1.31, 1.57]) on the margins of the belt. The force of infection was lowest in Ethiopia (lambda = 0.028). Variables associated with a concentration above the putative protective level of 2 mu g/mL were age, urban residence and a history of recent vaccination with a meningococcal vaccine. Prior to vaccination with the serogroup A meningococcal conjugate vaccine, meningococcal serogroup A IgG antibody concentrations were high across the African meningitis belt and yet the region remained susceptible to epidemics.
C1 [Manigart, Olivier; Chandramohan, Daniel; Hassan-King, Musa; Nascimento, Maria; Woukeu, Arouna; Stuart, James M.; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect Dis, London WC1, England.
   [Manigart, Olivier] MRC Unit, Fajara, Gambia.
   [Trotter, Caroline] Univ Cambridge, Dept Vet Med, Cambridge, England.
   [Findlow, Helen; Borrow, Ray] Publ Hlth England Vaccine Evaluat Unit, Manchester, Lancs, England.
   [Assefa, Abraham; Mihret, Wude; Demisse, Tesfaye Moti; Yeshitela, Biruk] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Osei, Isaac; Hodgson, Abraham; Quaye, Stephen Laryea] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Sow, Samba; Coulibaly, Mamadou; Diallo, Kanny; Traore, Awa] Ctr Vaccins Dev, Bamako, Mali.
   [Collard, Jean-Marc; Boukary, Rahamatou Moustapha; Djermakoye, Oumarou; Mahamane, Ali Elhaji; Jusot, Jean-Francois] Ctr Rech Med & Sanitaire CERMES, Niamey, Niger.
   [Sokhna, Cheikh; Alavo, Serge; Doucoure, Souleymane; Ba, El Hadj; Dieng, Marietou; Diallo, Aldiouma] Inst Rech Dev, Dakar, Senegal.
   [Daugla, Doumagoum Moto] CSSI, Ndjamena, Chad.
   [Omotara, Babatunji] Univ Maiduguri, Dept Community Med, Maiduguri, Nigeria.
RP Greenwood, B (reprint author), London Sch Hyg & Trop Med, Fac Infect Dis, London WC1, England.
EM brian.greenwood@lshtm.ac.uk
RI Aseffa, Abraham/J-3248-2016
OI Aseffa, Abraham/0000-0002-8028-1150; Trotter,
   Caroline/0000-0003-4000-2708
FU Wellcome Trust [086546/Z/08/Z]; Bill & Melinda Gates Foundation [51251]
FX This work was supported by Wellcome Trust (grant no. 086546/Z/08/Z),
   www.wellcome.ac.uk; Bill & Melinda Gates Foundation (grant no. 51251),
   www.gatesfoundation.org. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154
   CEESAY SJ, 1993, J INFECT DIS, V167, P1212
   Collard JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-576
   Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Ferraro CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101129
   Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065
   GOLD R, 1978, J INFECT DIS, V137, P112
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327
   Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2
   GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P340, DOI 10.1016/0035-9203(80)90095-4
   GRIFFISS JM, 1975, J IMMUNOL, V114, P1779
   GUIRGUIS N, 1985, J EXP MED, V162, P1837, DOI 10.1084/jem.162.6.1837
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MacLennan J, 1999, VACCINE, V17, P3086, DOI 10.1016/S0264-410X(99)00139-5
   MenAfriCar Consortium, 2015, J INFECT DIS
   MenAfriCar Consortium, 2013, TROP MED INT HEALTH, V19, P968
   Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623
   Norheim G, 2008, CLIN VACCINE IMMUNOL, V15, P863, DOI 10.1128/CVI.00252-07
   PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302
   ROBBINS JB, 1972, INFECT IMMUN, V6, P651
   ROBBINS JB, 1975, J ALLERGY CLIN IMMUN, V56, P141, DOI 10.1016/0091-6749(75)90119-0
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08
   Trotter CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055486
   Vann WF, 1976, INFECT IMMUN, V13, P9
   Wong J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-451
NR 27
TC 3
Z9 3
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2016
VL 11
IS 2
AR e0147928
DI 10.1371/journal.pone.0147928
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD6SI
UT WOS:000370054100012
PM 26872255
OA gold
DA 2017-08-15
ER

PT J
AU Dierickx, S
   Gryseels, C
   Mwesigwa, J
   O'Neill, S
   Bannister-Tyrell, M
   Ronse, M
   Jaiteh, F
   Gerrets, R
   D'Alessandro, U
   Grietens, KP
AF Dierickx, Susan
   Gryseels, Charlotte
   Mwesigwa, Julia
   O'Neill, Sarah
   Bannister-Tyrell, Melanie
   Ronse, Maya
   Jaiteh, Fatou
   Gerrets, Rene
   D'Alessandro, Umberto
   Grietens, Koen Peeters
TI Factors Associated with Non-Participation and Non-Adherence in Directly
   Observed Mass Drug Administration for Malaria in The Gambia
SO PLOS ONE
LA English
DT Article
ID HEALTH-CARE; ELIMINATION; TRANSMISSION; COMBINATION; UGANDA; TRIAL
AB Introduction
   The potential benefits of Mass Drug Administration (MDA) for malaria elimination are being considered in several malaria endemic countries where a decline in malaria transmission has been reported. For this strategy to work, it is important that a large proportion of the target population participates, requiring an in-depth understanding of factors that may affect participation and adherence to MDA programs.
   Methodology
   This social science study was ancillary to a one-round directly observed MDA campaign with dihydroartemisinin-piperaquine, carried out in 12 villages in rural Gambia between June and August 2014. The social science study employed a mixed-methods approach combining qualitative methods (participant observation and in-depth interviewing) and quantitative methods (structured follow-up interviews among non-participating and non-adhering community members).
   Results
   Of 3942 people registered in the study villages, 67.9% adhered to the three consecutive daily doses. For the remaining villagers, 12.6% did not attend the screening, 3.5% was not eligible and 16% did not adhere to the treatment schedule. The main barriers for non-participation and adherence were long and short-term mobility of individuals and specific subgroups, perceived adverse drug reactions and rumors, inconveniences related to the logistics of MDA (e.g. waiting times) and the perceived lack of information about MDA.
   Conclusion
   While, there was no fundamental resistance from the target communities, adherence was 67.9%. This shows the necessity of understanding local perceptions and barriers to increase its effectiveness. Moreover, certain of the constraining factors were socio-spatially clustered which might prove problematic since focal areas of residual malaria transmission may remain allowing malaria to spread to adjacent areas where transmission had been temporarily interrupted.
C1 [Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; Bannister-Tyrell, Melanie; Ronse, Maya; Jaiteh, Fatou; D'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Dierickx, Susan; Gryseels, Charlotte; Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.
   [Dierickx, Susan] Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect, Rhea, Brussels, Belgium.
   [Mwesigwa, Julia; Jaiteh, Fatou; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Grietens, Koen Peeters] PASS Int, Tessenderlo, Belgium.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan.
RP Dierickx, S (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.; Dierickx, S (reprint author), Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.; Dierickx, S (reprint author), Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect, Rhea, Brussels, Belgium.
EM susan.dierickx@vub.ac.be
FU UK Medical Research Council (MRC); UK Department for International
   Development (DFID) under the MRC/DFID; European Union
FX This award is jointly funded by the UK Medical Research Council (MRC)
   and the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement and is also part of the EDCTP2 programme
   supported by the European Union.
CR Amazigo U. V., 2002, Annals of Tropical Medicine and Parasitology, V96, pS41, DOI 10.1179/000349802125000646
   Bhullar N, 2010, PARASITE VECTOR, V3, P1
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Cassell JA, 2006, OXFORD J, P373
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4
   Crowell V, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-4
   De Martin S, 2001, TROP MED INT HEALTH, V6, P442, DOI 10.1046/j.1365-3156.2001.00723.x
   Dial NJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-47
   GARFIELD RM, 1986, SOC SCI MED, V22, P869, DOI 10.1016/0277-9536(86)90241-8
   Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003
   Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9
   Greenwood B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S2
   Gryseels C, 2015, AM J TROP MED HYG, V93, P810, DOI 10.4269/ajtmh.15-0259
   Katabarwa MN, 2001, ANN TROP MED PARASIT, V95, P275
   Kingori P, 2013, SOC SCI MED, V98, P361, DOI 10.1016/j.socscimed.2013.10.013
   Krentel A, 2012, HEALTH POLICY PLANN, V27, P384, DOI 10.1093/heapol/czr048
   Marshall MN, 1996, FAMILY PRACTICE
   Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6
   Nichter M, 2008, INTRODUCING ZINC DIA
   Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179
   Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3
   Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205
   Poirot E, 2013, MASS DRUG A IN PRESS
   Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x
   Shekalaghe SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-247
   Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108
   Toe LP, 2013, PLOS ONE, V8, P1
NR 28
TC 4
Z9 4
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 11
PY 2016
VL 11
IS 2
AR e0148627
DI 10.1371/journal.pone.0148627
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD6RE
UT WOS:000370050700023
PM 26866685
OA gold
DA 2017-08-15
ER

PT J
AU Derrick, T
   Last, AR
   Burr, SE
   Roberts, CH
   Nabicassa, M
   Cassama, E
   Bailey, RL
   Mabey, DCW
   Burton, MJ
   Holland, MJ
AF Derrick, Tamsyn
   Last, Anna R.
   Burr, Sarah E.
   Roberts, Chrissy H.
   Nabicassa, Meno
   Cassama, Eunice
   Bailey, Robin L.
   Mabey, David C. W.
   Burton, Matthew J.
   Holland, Martin J.
TI Inverse relationship between microRNA-155 and-184 expression with
   increasing conjunctival inflammation during ocular Chlamydia trachomatis
   infection
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Chlamydia trachomatis; Trachoma; MiRNA; Inflammation; RNAseq; MiR-155;
   MiR-184; Follicular trachoma
ID EPITHELIAL-CELLS; GENE-EXPRESSION; NONHUMAN-PRIMATES; ACTIVE TRACHOMA;
   MIR-200 FAMILY; SEED REGION; DISEASE; PLASMID; CANCER; GENERATION
AB Background: Trachoma, a preventable blinding eye disease, is initiated by ocular infection with Chlamydia trachomatis (Ct). We previously showed that microRNAs (miR) - 147b and miR-1285 were up-regulated in inflammatory trachomatous scarring. During the initial stage of disease, follicular trachoma with current Ct infection, the differential expression of miR has not yet been investigated.
   Methods: Conjunctival samples were collected from 163 children aged 1-9 years old living in a trachoma-endemic region of Guinea Bissau, West Africa. Small RNA sequencing (RNAseq) was carried out on samples from five children with follicular trachoma and current Ct infection and five children with healthy conjunctivae and no Ct infection. Small RNAseq was also carried out on human epithelial cell lines infected with ocular Ct strains A2497 and isogenic plasmid-free A2497 in vitro. Results were validated by quantitative PCR (qPCR) in 163 clinical samples.
   Results: Differential expression of RNAseq data identified 12 miR with changes in relative expression during follicular trachoma, of which 9 were confirmed as differentially expressed by qPCR (miR-155, miR-150, miR-142, miR-181b, miR-181a, miR-342, miR-132, miR-4728 and miR-184). MiR-155 and miR-184 expression had a direct relationship with the degree of clinical inflammation. MiR-155 was up-regulated (OR = 2.533 ((95 % CI = 1.291-4.971); P = 0.0069) and miR-184 was down-regulated (OR = 0.416 ((95 % CI = 0.300-0.578); P = 1.61*10(-7)) as the severity of clinical inflammation increased. Differential miR expression was not detected in HEp-2 or HCjE epithelial cells 48 h post infection with Ct in vitro. HCjE cells, a conjunctival epithelial cell line, had a markedly different miR background expression compared to HEp-2 cells.
   Conclusions: In follicular trachoma, expression of miR-155 and miR-184 is correlated with the severity of inflammation. This likely reflects host regulation of the immune response and a prolonged period of wound healing following the clearance of Ct. Prolonged healing may be associated with subsequent development of scarring trachoma.
C1 [Derrick, Tamsyn; Last, Anna R.; Burr, Sarah E.; Roberts, Chrissy H.; Bailey, Robin L.; Mabey, David C. W.; Burton, Matthew J.; Holland, Martin J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Burr, Sarah E.] Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Nabicassa, Meno; Cassama, Eunice] Minist Saude Publ, Programa Nacl Saude Visao, Bissau, Guinea Bissau.
RP Derrick, T (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
EM tamsyn.derrick@lshtm.ac.uk
OI Burton, Matthew/0000-0003-1872-9169; Roberts, Chrissy
   h./0000-0003-1064-5980
FU Wellcome Trust [079246/Z/06/Z, 097330/Z/11/Z]; Fight for Sight
FX This study was funded by grants from the Wellcome Trust (079246/Z/06/Z
   and 097330/Z/11/Z) and Fight for Sight in the form of a graduate
   studentship for TD (http://www.wellcome.ac.uk;
   http://www.fightforsight.org.uk). The funders had no part in the study
   design; in the collection, analysis and interpretation of data; in the
   writing of the report; and in the decision to submit the paper for
   publication.
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Bailey R, 1999, EPIDEMIOL INFECT, V123, P479, DOI 10.1017/S0950268899003076
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bertero T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044919
   BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248
   Buckner LR, 2013, CYTOKINE, V63, P151, DOI 10.1016/j.cyto.2013.04.022
   Buckner LR, 2011, J REPROD IMMUNOL, V92, P8, DOI 10.1016/j.jri.2011.08.002
   Burton MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003763
   Burton MJ, 2011, INVEST OPHTH VIS SCI, V52, P6012, DOI 10.1167/iovs.11-7326
   Bykhovskaya Y, 2013, OPHTHALMIC GENET, V36, P244
   Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08
   DAWSON C, 1966, AM J EPIDEMIOL, V84, P411
   Dawson CR, 1981, GUIDE TRACHOMA CONTR
   Derrick T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002117
   Gambhir M, MODELLING TRACHOMA I
   Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851
   Godard P, 2015, NUCLEIC ACIDS RES, V43, P3490, DOI 10.1093/nar/gkv249
   Grassly NC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000341
   Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722
   Gupta R, 2015, AM J REPROD IMMUNOL, V73, P126, DOI 10.1111/aji.12281
   Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107
   Hu VH, 2010, TROP MED INT HEALTH, V15, P673, DOI 10.1111/j.1365-3156.2010.02521.x
   Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014
   Igietseme JU, 2013, J INFECT DIS, V207, P1095, DOI 10.1093/infdis/jit009
   Iliff BW, 2012, INVEST OPHTH VIS SCI, V53, P348, DOI 10.1167/iovs.11-8783
   Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023
   Izar B, 2012, INT J MOL SCI, V13, P1173, DOI 10.3390/ijms13011173
   Jimenez V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003610
   JONES BR, 1962, ANN NY ACAD SCI, V98, P212, DOI 10.1111/j.1749-6632.1962.tb30546.x
   JONES HW, 1971, OBSTET GYNECOL, V38, P945
   Kari L, 2008, J INFECT DIS, V197, P449, DOI 10.1086/525285
   Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266
   Keenan JD, 2010, AM J TROP MED HYG, V82, P482, DOI 10.4269/ajtmh.2010.09-0315
   Kessler M, 2011, AM J PATHOL, V180, P186
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Last AR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002900
   Last AR, 2014, J CLIN MICROBIOL, V52, P324, DOI 10.1128/JCM.02618-13
   Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432
   Miyairi I, 2011, J INFECT DIS, V204, P654, DOI 10.1093/infdis/jir333
   O'Connell CM, 2007, J IMMUNOL, V179, P4027
   Olivares-Zavaleta N, 2014, J IMMUNOL, V192, P4648, DOI 10.4049/jimmunol.1400120
   Package T, 2015, PACKAGE PMCMR
   Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608
   Porcella SF, 2015, INFECT IMMUN, V83, P534, DOI 10.1128/IAI.02764-14
   Roberts CH, 2013, J CLIN MICROBIOL, V51, P2195, DOI 10.1128/JCM.00622-13
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484
   Ryan D, 2006, MOL VIS, V12, P1175
   Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6
   Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94
   Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227
   Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240
   Solomon AW, 2008, NEW ENGL J MED, V358, P1870, DOI 10.1056/NEJMc0706263
   Takahashi Y, 2015, FEBS LETT, V589, P1143, DOI 10.1016/j.febslet.2015.03.010
   Elimination G, 2014, RELEVE EPIDEMIOLOGIQ, V96, P421
   Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x
   Venables W. N., 2002, MODERN APPL STAT S
   Wenger SL, 2004, BIOSCIENCE REP, V24, P631, DOI 10.1007/s10540-005-2797-5
   [Anonymous], 2004, COMMUNITY EYE HLTH D, V17, P68
   [Anonymous], 1997, GLOB SCI M GEN UNPUB
   Wu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055044
   Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443
   Yang C, 2015, MBIO, V6
   Yeruva L., 2014, MBIO, V5
   Walker JM, 2013, LIFE SCI, V531, P375
   Yu HS, 1997, PHARMACEUT RES, V14, P757, DOI 10.1023/A:1012150405949
   Zhou Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0099-x
NR 69
TC 8
Z9 9
U1 1
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 3
PY 2016
VL 16
AR 60
DI 10.1186/s12879-016-1367-8
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA DC6YI
UT WOS:000369365100001
PM 26842862
OA gold
DA 2017-08-15
ER

PT J
AU Hazen, TH
   Donnenberg, MS
   Panchalingam, S
   Antonio, M
   Hossain, A
   Mandomando, I
   Ochieng, JB
   Ramamurthy, T
   Tamboura, B
   Qureshi, S
   Quadri, F
   Zaidi, A
   Kotloff, KL
   Levine, MM
   Barry, EM
   Kaper, JB
   Rasko, DA
   Nataro, JP
AF Hazen, Tracy H.
   Donnenberg, Michael S.
   Panchalingam, Sandra
   Antonio, Martin
   Hossain, Anowar
   Mandomando, Inacio
   Ochieng, John Benjamin
   Ramamurthy, Thandavarayan
   Tamboura, Boubou
   Qureshi, Shahida
   Quadri, Farheen
   Zaidi, Anita
   Kotloff, Karen L.
   Levine, Myron M.
   Barry, Eileen M.
   Kaper, James B.
   Rasko, David A.
   Nataro, James P.
TI Genomic diversity of EPEC associated with clinical presentations of
   differing severity
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; GLOBAL ENTERIC MULTICENTER; BLAST
   SCORE RATIO; PATHOGENICITY ISLAND; DEVELOPING-COUNTRIES; LOCALIZED
   ADHERENCE; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; DIARRHEAL DISEASE;
   YOUNG-CHILDREN
AB Enteropathogenic Escherichia coli (EPEC) are diarrhoeagenic E. coli, and are a significant cause of gastrointestinal illness among young children in developing countries. Typical EPEC are identified by the presence of the bundle-forming pilus encoded by a virulence plasmid, which has been linked to an increased severity of illness, while atypical EPEC lack this feature. Comparative genomics of 70 total EPEC from lethal (LI), non-lethal symptomatic (NSI) or asymptomatic (AI) cases of diarrhoeal illness in children enrolled in the Global Enteric Multicenter Study was used to investigate the genomic differences in EPEC isolates obtained from individuals with various clinical outcomes. A comparison of the genomes of isolates from different clinical outcomes identified genes that were significantly more prevalent in EPEC isolates of symptomatic and lethal outcomes than in EPEC isolates of asymptomatic outcomes. These EPEC isolates exhibited previously unappreciated phylogenomic diversity and combinations of virulence factors. These comparative results highlight the diversity of the pathogen, as well as the complexity of the EPEC virulence factor repertoire.
C1 [Hazen, Tracy H.; Rasko, David A.] Univ Maryland, Sch Med, Inst Genome Sci, 801 W Baltimore St,Room 600, Baltimore, MD 21201 USA.
   [Hazen, Tracy H.; Barry, Eileen M.; Kaper, James B.; Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St,HSF 1 Suite 380, Baltimore, MD 21201 USA.
   [Donnenberg, Michael S.; Barry, Eileen M.] Univ Maryland, Sch Med, Dept Med, Med Ctr, N3W42,22 S Greene St, Baltimore, MD 21201 USA.
   [Panchalingam, Sandra; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, 685 West Baltimore St,Room 480, Baltimore, MD 21201 USA.
   [Antonio, Martin] MRC Unit, Atlantic Blvd,POB 273, Banjul, Gambia.
   [Hossain, Anowar] ICDDR, GPO Box 128, Dhaka 1000, Bangladesh.
   [Mandomando, Inacio] Ctr Invest Saude, Rua 12,Vila Manhica,CP 1929, Maputo, Mozambique.
   [Ochieng, John Benjamin] Kenya Med Res Inst CDC, POB 54840-00200, Kisumu, Kenya.
   [Ramamurthy, Thandavarayan] Natl Inst Cholera & Enter Dis, P-33,CIT Rd, Kolkata 700010, India.
   [Tamboura, Boubou] Ctr Vaccine Dev Mali, Bamako, Mali.
   [Qureshi, Shahida; Quadri, Farheen; Zaidi, Anita] Aga Khan Univ, Stadium Rd,POB 3500, Karachi 74800, Pakistan.
   [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, POB 800386, Charlottesville, VA 22908 USA.
RP Rasko, DA (reprint author), Univ Maryland, Sch Med, Inst Genome Sci, 801 W Baltimore St,Room 600, Baltimore, MD 21201 USA.; Rasko, DA (reprint author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St,HSF 1 Suite 380, Baltimore, MD 21201 USA.; Donnenberg, MS (reprint author), Univ Maryland, Sch Med, Dept Med, Med Ctr, N3W42,22 S Greene St, Baltimore, MD 21201 USA.
EM mdonnenb@umaryland.edu; drasko@som.umaryland.edu
OI Antonio, Martin/0000-0002-4810-1308
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services NIH [U19
   AI090873]
FX This project was funded by federal funds from the National Institute of
   Allergy and Infectious Diseases, National Institutes of Health,
   Department of Health and Human Services NIH grant no. U19 AI090873.
CR Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665
   Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114
   Blank TE, 2000, INFECT IMMUN, V68, P7028, DOI 10.1128/IAI.68.12.7028-7038.2000
   Clements Abigail, 2012, Gut Microbes, V3, P71, DOI 10.4161/gmic.19182
   Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641
   Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101
   Donnenberg MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003791
   Donnenberg MS, 1997, GENE, V192, P33, DOI 10.1016/S0378-1119(96)00826-8
   DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x
   Galens K, 2011, STAND GENOMIC SCI, V4, P244, DOI 10.4056/sigs.1223234
   Hazen TH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00569
   Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110
   Heithoff DM, 1999, J BACTERIOL, V181, P799
   Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06
   MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142
   NATARO JP, 1985, INFECT IMMUN, V48, P378
   Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b
   Orvis J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/bioinformatics/btq167
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4
   Perna NT, 1998, INFECT IMMUN, V66, P3810
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2
   Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08
   Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5
   Sahl JW, 2014, PEERJ, V2, DOI 10.7717/peerj.332
   Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287
   Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Stone KD, 1996, MOL MICROBIOL, V20, P325, DOI 10.1111/j.1365-2958.1996.tb02620.x
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2
   Tauschek M, 2002, MOL MICROBIOL, V44, P1533, DOI 10.1046/j.1365-2958.2002.02968.x
   Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298
   Tennant SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-117
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344
NR 45
TC 8
Z9 8
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2016
VL 1
IS 2
AR 15014
DI 10.1038/NMICROBIOL.2015.14
PG 9
WC Microbiology
SC Microbiology
GA DW4HT
UT WOS:000383604500002
PM 27571975
OA No
DA 2017-08-15
ER

PT J
AU Ingle, DJ
   Tauschek, M
   Edwards, DJ
   Hocking, DM
   Pickard, DJ
   Azzopardi, KI
   Amarasena, T
   Bennett-Wood, V
   Pearson, JS
   Tamboura, B
   Antonio, M
   Ochieng, JB
   Oundo, J
   Mandomando, I
   Qureshi, S
   Ramamurthy, T
   Hossain, A
   Kotloff, KL
   Nataro, JP
   Dougan, G
   Levine, MM
   Robins-Browne, RM
   Holt, KE
AF Ingle, Danielle J.
   Tauschek, Marija
   Edwards, David J.
   Hocking, Dianna M.
   Pickard, Derek J.
   Azzopardi, Kristy I.
   Amarasena, Thakshila
   Bennett-Wood, Vicki
   Pearson, Jaclyn S.
   Tamboura, Boubou
   Antonio, Martin
   Ochieng, John B.
   Oundo, Joseph
   Mandomando, Inacio
   Qureshi, Shahida
   Ramamurthy, Thandavarayan
   Hossain, Anowar
   Kotloff, Karen L.
   Nataro, James P.
   Dougan, Gordon
   Levine, Myron M.
   Robins-Browne, Roy M.
   Holt, Kathryn E.
TI Evolution of atypical enteropathogenic E. coli by repeated acquisition
   of LEE pathogenicity island variants
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ESCHERICHIA-COLI; ENTEROCYTE EFFACEMENT; GENETICS ANALYSIS; LOCUS;
   SEQUENCE; IDENTIFICATION; CHILDREN; GENOME; INFECTION; ALIGNMENT
AB Atypical enteropathogenic Escherichia coli (aEPEC) is an umbrella term given to E. coli that possess a type III secretion system encoded in the locus of enterocyte effacement (LEE), but lack the virulence factors (stx, bfpA) that characterize enterohaemorrhagic E. coli and typical EPEC, respectively. The burden of disease caused by aEPEC has recently increased in industrialized and developing nations, yet the population structure and virulence profile of this emerging pathogen are poorly understood. Here, we generated whole-genome sequences of 185 aEPEC isolates collected during the Global Enteric Multicenter Study from seven study sites in Asia and Africa, and compared them with publicly available E. coli genomes. Phylogenomic analysis revealed ten distinct widely distributed aEPEC clones. Analysis of genetic variation in the LEE pathogenicity island identified 30 distinct LEE subtypes divided into three major lineages. Each LEE lineage demonstrated a preferred chromosomal insertion site and different complements of non-LEE encoded effector genes, indicating distinct patterns of evolution of these lineages. This study provides the first detailed genomic framework for aEPEC in the context of the EPEC pathotype and will facilitate further studies into the epidemiology and pathogenicity of EPEC by enabling the detection and tracking of specific clones and LEE variants.
C1 [Ingle, Danielle J.; Tauschek, Marija; Hocking, Dianna M.; Azzopardi, Kristy I.; Amarasena, Thakshila; Bennett-Wood, Vicki; Pearson, Jaclyn S.; Robins-Browne, Roy M.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3010, Australia.
   [Ingle, Danielle J.; Edwards, David J.; Holt, Kathryn E.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.
   [Ingle, Danielle J.; Edwards, David J.; Holt, Kathryn E.] Univ Melbourne, Ctr Syst Genom, Parkville, Vic 3010, Australia.
   [Pickard, Derek J.; Dougan, Gordon] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.
   [Tamboura, Boubou] Ctr Dev Vaccins Mali, Bamako, Mali.
   [Antonio, Martin] Med Res Council Unit United Kingdom, Fajara, Gambia.
   [Ochieng, John B.; Oundo, Joseph] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, Kisumu, Kenya.
   [Mandomando, Inacio] CISM, CP 1929, Maputo, Mozambique.
   [Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique.
   [Qureshi, Shahida] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi 74800, Pakistan.
   [Ramamurthy, Thandavarayan] Natl Inst Cholera & Enter Dis, Kolkata 700010, W Bengal, India.
   [Hossain, Anowar] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA.
   [Robins-Browne, Roy M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
RP Ingle, DJ; Robins-Browne, RM (reprint author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3010, Australia.; Ingle, DJ; Holt, KE (reprint author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.; Ingle, DJ; Holt, KE (reprint author), Univ Melbourne, Ctr Syst Genom, Parkville, Vic 3010, Australia.; Robins-Browne, RM (reprint author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.
EM ingled@student.unimelb.edu.au; r.browne@unimelb.edu.au;
   kholt@unimelb.edu.au
FU Australian NHMRC [1009296, 1067428, 1061409]; Wellcome Trust [098051];
   Bill & Melinda Gates Foundation [38874]; Victorian Life Sciences
   Computation Initiative [VR0082]
FX This work was funded by the Australian NHMRC (project grant nos. 1009296
   and 1067428 to R.M.R.-B., fellowship no. 1061409 to K.E.H.), the
   Wellcome Trust (grant no. 098051 to the Wellcome Trust Sanger Institute,
   WTSI), the Bill & Melinda Gates Foundation (grant ID no. 38874 to
   M.M.L.) and the Victorian Life Sciences Computation Initiative (grant
   no. VR0082). The authors thank the sequencing teams at the WTSI for
   genome sequencing.
CR Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983
   Bugarel M., 2011, BMC MICROBIOL, V11, P1
   Castillo A, 2005, P NATL ACAD SCI USA, V102, P1542, DOI 10.1073/pnas.0408633102
   Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI DOI 10.1007/978-3-540-35306-5_10
   Contreras CA, 2012, J MED MICROBIOL, V61, P1114, DOI 10.1099/jmm.0.045443-0
   Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13
   Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x
   Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006
   Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041
   Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256
   Donnenberg MS, 2013, TRENDS MICROBIOL, V21, P317, DOI 10.1016/j.tim.2013.05.003
   Dray S, 2007, J STAT SOFTW, V22, P1
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x
   Gartner JF, 2004, INFECT IMMUN, V72, P6722, DOI 10.1128/IAI.72.11.6722-6728.2004
   Gauthier A, 2003, J BIOL CHEM, V278, P25273, DOI 10.1074/jbc.R300012200
   Giogha C, 2014, CYTOKINE GROWTH F R, V25, P235, DOI 10.1016/j.cytogfr.2013.12.012
   Hazen T. H., 2013, P NATL ACAD SCI USA, P1
   Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379
   Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062
   Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Lacher DW, 2006, FEMS MICROBIOL LETT, V261, P80, DOI 10.1111/j.1574-6968.2006.00328.x
   Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Muller D, 2009, INFECT IMMUN, V77, P3501, DOI 10.1128/IAI.00090-09
   Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b
   Ogura Y, 2008, J BACTERIOL, V190, P6948, DOI 10.1128/JB.00625-08
   Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524
   Pommier T, 2009, BIOINFORMATICS, V25, P736, DOI 10.1093/bioinformatics/btp051
   Quail M, 2009, CURR PROTOC HUM GENE, V18, P1
   Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008
   Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508
   von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145
   Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 45
TC 11
Z9 11
U1 5
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2016
VL 1
IS 2
AR 15010
DI 10.1038/NMICROBIOL.2015.10
PG 9
WC Microbiology
SC Microbiology
GA DW4HT
UT WOS:000383604500001
PM 27571974
OA No
DA 2017-08-15
ER

PT J
AU Van Hong, N
   Delgado-Ratto, C
   Thanh, PV
   Van den Eede, P
   Guetens, P
   Binh, NTH
   Phuc, BQ
   Duong, TT
   Van Geertruyden, JP
   D'Alessandro, U
   Erhart, A
   Rosanas-Urgell, A
AF Nguyen Van Hong
   Delgado-Ratto, Christopher
   Pham Vinh Thanh
   Van den Eede, Peter
   Guetens, Pieter
   Nguyen Thi Huong Binh
   Bui Quang Phuc
   Tran Thanh Duong
   Van Geertruyden, Jean Pierre
   D'Alessandro, Umberto
   Erhart, Annette
   Rosanas-Urgell, Anna
TI Population Genetics of Plasmodium vivax in Four Rural Communities in
   Central Vietnam
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HUMAN MALARIA PARASITE; MICROSATELLITE DIVERSITY; FALCIPARUM
   POPULATIONS; TRANSMISSION DYNAMICS; INFECTION; AMAZONIA; ELIMINATION;
   PREVALENCE; COMPLEXITY; CLUSTERS
AB Background
   The burden of malaria in Vietnam has drastically reduced, prompting the National Malaria Control Program to officially engage in elimination efforts. Plasmodium vivax is becoming increasingly prevalent, remaining a major problem in the country's central and southern provinces. A better understanding of P. vivax genetic diversity and structure of local parasite populations will provide baseline data for the evaluation and improvement of current efforts for control and elimination. The aim of this study was to examine the population genetics and structure of P. vivax isolates from four communities in Tra Leng commune, Nam Tra My district in Quang Nam, Central Vietnam.
   Methodology/Principal Findings
   P. vivax mono infections collected from 234 individuals between April 2009 and December 2010 were successfully analyzed using a panel of 14 microsatellite markers. Isolates displayed moderate genetic diversity (He = 0.68), with no significant differences between study communities. Polyclonal infections were frequent (71.4%) with a mean multiplicity of infection of 1.91 isolates/person. Low but significant genetic differentiation (F-ST value from -0.05 to 0.18) was observed between the community across the river and the other communities. Strong linkage disequilibrium (I-A(S) = 0.113, p < 0.001) was detected across all communities, suggesting gene flow within and among them. Using multiple approaches, 101 haplotypes were grouped into two genetic clusters, while 60.4% of haplotypes were admixed.
   Conclusions/Significance
   In this area of Central Vietnam, where malaria transmission has decreased significantly over the past decade, there was moderate genetic diversity and high occurrence of polyclonal infections. Local human populations have frequent social and economic interactions that facilitate gene flow and inbreeding among parasite populations, while decreasing population structure. Findings provide important information on parasites populations circulating in the study area and are relevant to current malaria elimination efforts.
C1 [Nguyen Van Hong; Pham Vinh Thanh; Nguyen Thi Huong Binh; Bui Quang Phuc; Tran Thanh Duong] NIMPE, Hanoi, Vietnam.
   [Nguyen Van Hong; Van den Eede, Peter; Guetens, Pieter; D'Alessandro, Umberto; Erhart, Annette; Rosanas-Urgell, Anna] ITM, Antwerp, Belgium.
   [Nguyen Van Hong; Delgado-Ratto, Christopher] Univ Antwerp, Fac Med, Int Hlth Unit, Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
RP Rosanas-Urgell, A (reprint author), ITM, Antwerp, Belgium.
EM arosanas@itg.be
RI Rosanas-Urgell, Anna/D-3193-2015
OI Rosanas-Urgell, Anna/0000-0002-0432-5203; Delgado-Ratto,
   Christopher/0000-0003-2300-5181
FU FWO "Krediet aan Navorsers" [1.5.197.13N]; UBS Optimus Foundation
   [Opt1648]; Belgian Directorate-General for Development Cooperation
   (DGDC) within DGD-ITM Framework Agreement [3.2, 3.3]
FX This work was supported by FWO "Krediet aan Navorsers" (www.fwo.be,
   grant 1.5.197.13N), UBS Optimus Foundation (www.ubs.com/optimus, grant
   number Opt1648) and the Belgian Directorate-General for Development
   Cooperation (DGDC) within DGD-ITM Framework Agreement 3.2 and 3.3. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552
   Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14
   Barry AE, 2013, AM J TROP MED HYG, V88, P718, DOI 10.4269/ajtmh.12-0056
   Batista CL, 2015, PARASITOLOGY, V142, P374, DOI 10.1017/S0031182014001176
   Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412
   Christopher D, 2014, MALARIA J, V13, P8
   Earl Dent A, 2014, CONVERSATION GENET R, V4, P359
   Duong TT, 2015, MALARIA EPIDEMIOLOGI, V11, P21
   Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58
   Erhart E, 2004, AM J TROP MED HYG, V70, P110
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Fansisco AP, 2012, BMC BIOINFORMATICS, P13
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685
   Gluikart G, 1998, J HERED, V89, P238
   Goudet J, 1995, J HERED, V86, P485
   Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278
   Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588
   Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847
   Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048
   Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047
   Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010
   Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241
   Iwagami M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001592
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x
   Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022
   Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041
   LEVINSON G, 1987, MOL BIOL EVOL, V4, P203
   Meirmans P, RECODE DATA V 0 1
   Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x
   Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X
   Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613
   National Institute of Malarialogy Parasitology and Entomology, 2015, ANN REP NAT MAL CONT
   National Institute of Malarialogy Parasitology and Entomology, 2011, NAT STRAT MAL CONTR
   Noah A., 2004, MOL ECOLOGY NOTE, V4, P137
   Obaldia N, 2015, J INFECT DIS, V211, P1087, DOI 10.1093/infdis/jiu575
   Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029
   Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337
   Peakall R, 2012, BIOINFORMATICS, V10, P1093
   Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689
   Pham VT, 2015, MALARIA J, V14, P86, DOI [10.1186/s12936-015-0601-y, DOI 10.1186/S12936-015-0601-Y]
   Phuc BQ, 2011, NATL REPORT MALARIOL
   Quang Nam provincial Malaria Station, 2009, INTERNAL REPORT
   Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5
   SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384
   Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447
   Thanh PV, 2015, ANTIMICROB AGENTS CH, P00791
   Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x
   Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257
   Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458
   Van NV, 2015, SOME EPIDEMIOLOGICAL, P22
   Whilte NJ, 2011, MALARIA J, V10, P297, DOI [10.1186/1475-2875-10-297, DOI 10.1186/1475-2875-10-297]
   World Health Organization, 2012, MAL POL COMM M 11 13
   World Health Organization, 2010, GUID TREATM MAL
NR 55
TC 0
Z9 0
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2016
VL 10
IS 2
AR e0004434
DI 10.1371/journal.pntd.0004434
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1TH
UT WOS:000372567300047
OA gold
DA 2017-08-15
ER

PT J
AU Rigouts, L
   Coeck, N
   Gumusboga, M
   de Rijk, WB
   Aung, KJM
   Hossain, MA
   Fissette, K
   Rieder, HL
   Meehan, CJ
   de Jong, BC
   Van Deun, A
AF Rigouts, L.
   Coeck, N.
   Gumusboga, M.
   de Rijk, W. B.
   Aung, K. J. M.
   Hossain, M. A.
   Fissette, K.
   Rieder, H. L.
   Meehan, C. J.
   de Jong, B. C.
   Van Deun, A.
TI Specific gyrA gene mutations predict poor treatment outcome in MDR-TB
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID RESISTANT MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO ACTIVITY; FLUOROQUINOLONE
   RESISTANCE; DNA GYRASE; MOLECULAR CHARACTERIZATION; PYRAZINAMIDE
   RESISTANCE; QUINOLONE RESISTANCE; MOXIFLOXACIN; LEVOFLOXACIN;
   GATIFLOXACIN
AB Mutations in the gyrase genes cause fluoroquinolone resistance in Mycobacterium tuberculosis. However, the predictive value of these markers for clinical outcomes in patients with MDR-TB is unknown to date. The objective of this study was to determine molecular markers and breakpoints predicting second-line treatment outcomes in M. tuberculosis patients treated with fourth-generation fluoroquinolones.
   We analysed treatment outcome data in relation to the gyrA and gyrB sequences and MICs of ofloxacin, gatifloxacin and moxifloxacin for pretreatment M. tuberculosis isolates from 181 MDR-TB patients in Bangladesh whose isolates were susceptible to injectable drugs.
   The gyrA 90Val, 94Gly and 94Ala mutations were most frequent, with the highest resistance levels for 94Gly mutants. Increased pretreatment resistance levels (> 2 mg/L), related to specific mutations, were associated with lower cure percentages, with no cure in patients whose isolates were resistant to gatifloxacin at 4 mg/L. Any gyrA 94 mutation, except 94Ala, predicted a significantly lower proportion of cure compared with all other gyrA mutations taken together (all non-94 mutantsaEuroS+aEuroS94Ala) [ORaEuroS=aEuroS4.3 (95% CI 1.4-13.0)]. The difference in treatment outcome was not explained by resistance to the other drugs.
   Our study suggests that gyrA mutations at position 94, other than Ala, predict high-level resistance to gatifloxacin and moxifloxacin, as well as poor treatment outcome, in MDR-TB patients in whom an injectable agent is still effective.
C1 [Rigouts, L.; Coeck, N.; Gumusboga, M.; de Rijk, W. B.; Fissette, K.; Meehan, C. J.; de Jong, B. C.; Van Deun, A.] Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
   [Rigouts, L.; Coeck, N.] Univ Antwerp, Biomed Sci, B-2020 Antwerp, Belgium.
   [Aung, K. J. M.; Hossain, M. A.] Damien Fdn, Dhaka, Bangladesh.
   [Rieder, H. L.] Univ Zurich, Biostat & Prevent Inst, Dept Epidemiol, Zurich, Switzerland.
   [de Jong, B. C.] NYU, Dept Med, Div Infect Dis, 550 1St Ave, New York, NY 10016 USA.
   [de Jong, B. C.] MRC Unit, Vaccinol Dept, Fajara, Gambia.
   [Van Deun, A.] Int Union TB & Lung Dis, Paris, France.
RP Rigouts, L (reprint author), Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, B-2000 Antwerp, Belgium.; Rigouts, L (reprint author), Univ Antwerp, Biomed Sci, B-2020 Antwerp, Belgium.
EM lrigouts@itg.be
OI de Jong, Bouke/0000-0002-1017-4675
FU Damien Foundation Belgium; University of Antwerp (Belgium); European
   Research Council [311725]
FX Field work, consumables for laboratory analysis and a lab technician
   were generously financed by a grant from the Damien Foundation Belgium.
   N. C. was funded for this study by a Dehousse grant from the University
   of Antwerp (Belgium). B. C. d. J., C. J. M. and L. R. were funded by a
   European Research Council Starting grant INTERRUPTB (311725).
CR Ahmad Z, 2013, AM J RESP CRIT CARE, V188, P97, DOI 10.1164/rccm.201212-2328OC
   An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09
   Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100
   Bottger EC, 2011, CLIN MICROBIOL INFEC, V17, P1128, DOI 10.1111/j.1469-0691.2011.03551.x
   Cui ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-78
   Devasia R, 2012, J CLIN MICROBIOL, V50, P1390, DOI 10.1128/JCM.05286-11
   Diaz JCR, 2003, INT J ANTIMICROB AG, V21, P585, DOI 10.1016/S0924-8579(03)00048-7
   El Sahly HM, 2011, J CLIN MICROBIOL, V49, P2942, DOI 10.1128/JCM.00231-11
   Esterly JS, 2010, PHARMACOTHERAPY, V30, p479e
   Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712
   Hu Y, 2011, TUBERCULOSIS, V91, P238, DOI 10.1016/j.tube.2011.03.001
   Huang TS, 2005, J ANTIMICROB CHEMOTH, V56, P1058, DOI 10.1093/jac/dki353
   Jawahar MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067030
   Kam KM, 2006, MICROB DRUG RESIST, V12, P7, DOI 10.1089/mdr.2006.12.7
   Kim H, 2011, ANTIMICROB AGENTS CH, V55, P3661, DOI 10.1128/AAC.00042-11
   Lau RWT, 2011, ANTIMICROB AGENTS CH, V55, P608, DOI 10.1128/AAC.00920-10
   Lee Jinwoo, 2011, Korean Journal of Internal Medicine, V26, P153, DOI 10.3904/kjim.2011.26.2.153
   Li J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.21
   Malik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039754
   Matrat S, 2008, ANTIMICROB AGENTS CH, V52, P2909, DOI 10.1128/AAC.01380-07
   Merle CS, 2015, NEW ENGL J MED, V372, P1677
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817
   Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P69
   Mokrousov I, 2008, ANTIMICROB AGENTS CH, V52, P2937, DOI 10.1128/AAC.00036-08
   Nosova EY, 2013, J MED MICROBIOL, V62, P108, DOI 10.1099/jmm.0.046821-0
   Pantel A, 2012, ANTIMICROB AGENTS CH, V56, P1990, DOI 10.1128/AAC.06272-11
   Pantel A, 2011, ANTIMICROB AGENTS CH, V55, P4524, DOI 10.1128/AAC.00707-11
   Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191
   Peloquin CA, 2008, ANTIMICROB AGENTS CH, V52, P852, DOI 10.1128/AAC.01036-07
   Piton J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012245
   Poissy J, 2010, ANTIMICROB AGENTS CH, V54, P4765, DOI 10.1128/AAC.00968-10
   Ramirez-Busby SM, 2015, ANTIMICROB AGENTS CH, V59, P5267, DOI 10.1128/AAC.00204-15
   Rodriguez JP, 2003, INT J ANTIMICROB AG, V20, P464
   Singh M, 2009, INDIAN J MED RES, V129, P542
   Sulochana S, 2005, J CHEMOTHERAPY, V17, P169
   van Ingen J, 2010, J CLIN MICROBIOL, V48, P2749, DOI 10.1128/JCM.00652-10
   Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09
   Wang JY, 2007, J ANTIMICROB CHEMOTH, V59, P860, DOI 10.1093/jac/dkm061
   Whitfield MG, 2015, J CLIN MICROBIOL, V53, P3633, DOI 10.1128/JCM.01001-15
   World Health Organization, 2001, WHONHD011 UNICEF ICC, P1
   WHO, 2009, WHO GLOB DAT VIT A D, P1
   World Health Organization, 2008, WHO REP GLOB TOB EP, P1
   Xu P, 2009, ANTIMICROB AGENTS CH, V53, P3170, DOI 10.1128/AAC.00177-09
   Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476
NR 44
TC 19
Z9 19
U1 2
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD FEB
PY 2016
VL 71
IS 2
BP 314
EP 323
DI 10.1093/jac/dkv360
PG 10
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA DG9TV
UT WOS:000372427600006
PM 26604243
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Odutola, A
   Ota, MO
   Ogundare, EO
   Antonio, M
   Owiafe, P
   Worwui, A
   Greenwood, B
   Alderson, M
   Traskine, M
   Verlant, V
   Dobbelaere, K
   Borys, D
AF Odutola, A.
   Ota, M. O.
   Ogundare, E. O.
   Antonio, M.
   Owiafe, P.
   Worwui, A.
   Greenwood, B.
   Alderson, M.
   Traskine, M.
   Verlant, V.
   Dobbelaere, K.
   Borys, D.
TI Reactogenicity, safety and immunogenicity of a protein-based
   pneumococcal vaccine in Gambian children aged 2-4 years: A phase II
   randomized study
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article
DE pneumococcal protein; pneumococcal vaccine; Gambian children;
   immunogenicity; safety
ID NONTYPABLE HAEMOPHILUS-INFLUENZAE; D CONJUGATE VACCINE; ACUTE
   OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE;
   DETOXIFIED PNEUMOLYSIN; INVASIVE DISEASE; TRIAD PROTEINS; DOUBLE-BLIND;
   PROTECTION
AB Pneumococcal conjugate vaccines (PCVs) have been successful in preventing invasive pneumococcal disease but effectiveness has been challenged by replacement of vaccine serotypes with non-vaccine serotypes. Vaccines targeting common pneumococcal protein(s) found in most/all pneumococci may overcome this limitation. This phase II study assessed safety and immunogenicity of a new protein-based pneumococcal vaccine containing polysaccharide conjugates of 10 pneumococcal serotypes combined with pneumolysin toxoid(dPly) and pneumococcal histidine triad protein D(PhtD) (PHiD-CV/dPly/PhtD-30) in African children. 120 Gambian children (2-4years, not previously vaccinated against Streptococcus pneumoniae) randomized (1:1) received a single dose of PHiD-CV/dPly/PhtD-30 or PCV13. Adverse events occurring over 4 d post-vaccination were reported, and blood samples obtained pre- and 1-month post-vaccination. Serious adverse events were reported for 6 months post-vaccination. Solicited local and systemic adverse events were reported at similar frequency in each group. One child (PHiD-CV/dPly/PhtD-30 group) reported a grade 3 local reaction to vaccination. Haematological and biochemical parameters seemed similar pre- and 1-month post-vaccination in each group. High pre-vaccination Ply and PhtD antibody concentrations were observed in each group, but only increased in PHiD-CV/dPly/PhtD-30 vaccinees one month post-vaccination. One month post-vaccination, for each vaccine serotype 96.2% of PHiD-CV/dPly/PhtD-30 vaccinees had serotype-specific polysaccharide antibody concentrations 0.20 mu g/mL except serotypes 6B (80.8%) and 23F (65.4%), and 94.1% had OPA titres of 8 except serotypes 1 (51.9%), 5 (38.5%) and 6B (78.0%), within ranges seen in PCV13-vaccinated children. A single dose of PHiD-CV/dPly/PhtD-30 vaccine, administered to Gambian children aged 2-4 y not previously vaccinated with a pneumococcal vaccine, was well-tolerated and immunogenic.
C1 [Odutola, A.; Ota, M. O.; Ogundare, E. O.; Antonio, M.; Owiafe, P.; Worwui, A.] MRC Unit, Banjul, Gambia.
   [Greenwood, B.] London Sch Hyg & Trop Med, London WC1, England.
   [Alderson, M.] PATH, Seattle, WA USA.
   [Traskine, M.; Verlant, V.; Dobbelaere, K.; Borys, D.] GSK Vaccines, Wavre, Belgium.
RP Odutola, A (reprint author), MRC Unit, Banjul, Gambia.
EM aaodutola@mrc.gm
OI Kwasi Owiafe, Patrick/0000-0002-4287-3577
FU Medical Research Council (MRC) UK; PATH, Seattle, USA; GlaxoSmithKline
   Biologicals SA
FX The study was funded by Medical Research Council (MRC) UK, PATH,
   Seattle, USA and GlaxoSmithKline Biologicals SA. Synflorix is a
   trademark of the GSK group of companies.
CR Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001
   Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x
   Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94
   Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185
   Concepcion NF, 2001, CLIN DIAGN LAB IMMUN, V8, P266, DOI 10.1128/CDLI.8.2.266-272.2001
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Dagan R, 2010, J INFECT DIS, V201, P1570, DOI 10.1086/652006
   Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051
   Dicko A, 2013, HUM VACC IMMUNOTHER, V9, P382, DOI 10.4161/hv.22692
   Dicko A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-882
   Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602
   Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7
   Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506
   Garcia-Suarez MD, 2004, INFECT IMMUN, V72, P4534, DOI 10.1128/IAI.72.8.4534-4540.2004
   Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10
   Henckaerts I, 2006, CLIN VACCINE IMMUNOL, V13, P356, DOI 10.1128/CVI.13.3.356-360.2006
   Henckaerts I, 2007, VACCINE, V25, P2518, DOI 10.1016/j.vaccine.2006.09.029
   Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001
   Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001
   Leroux-Roels G, 2014, VACCINE, V32, P6838, DOI 10.1016/j.vaccine.2014.02.052
   Musher DM, 2001, J INFECT DIS, V183, P827, DOI 10.1086/318833
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Odusanya OO, 2014, HUM VACC IMMUNOTHER, V10, P757, DOI 10.4161/hv.27276
   Odutola AA, 2014, TROP MED INT HEALTH, V19, P275, DOI 10.1111/tmi.12245
   Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537
   Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6
   Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100
   Pauksens K, 2014, CLIN VACCINE IMMUNOL, V21, P651, DOI 10.1128/CVI.00807-13
   Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004
   Poolman JT, 2010, CLIN VACCINE IMMUNOL, V17, P134, DOI 10.1128/CVI.00289-09
   Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9
   Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822
   RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415
   Salha D, 2012, INFECT IMMUN, V80, P2212, DOI 10.1128/IAI.06348-11
   Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657
   Vesikari T, 2011, PEDIATR INFECT DIS J, V30, pE130, DOI 10.1097/INF.0b013e31821d1790
   Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8
   Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2
   [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893
NR 41
TC 7
Z9 7
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PD FEB 1
PY 2016
VL 12
IS 2
BP 393
EP 402
DI 10.1080/21645515.2015.1111496
PG 10
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA DG0HK
UT WOS:000371745700029
PM 26618243
OA No
DA 2017-08-15
ER

PT J
AU Cisneros-Montemayor, AM
   West, K
   Boiro, IS
   Vincent, ACJ
AF Cisneros-Montemayor, A. M.
   West, K.
   Boiro, I. S.
   Vincent, A. C. J.
TI An assessment of West African seahorses in fisheries catch and trade
SO JOURNAL OF FISH BIOLOGY
LA English
DT Article
DE CITES; Hippocampus algiricus; life history; morphometry
ID FAMILY SYNGNATHIDAE; LIFE-HISTORY; HIPPOCAMPUS; MANAGEMENT; POPULATION;
   CONSERVATION; PIPEFISHES; DYNAMICS; GULF
AB This study provides the first assessment of a heavily traded West African seahorse species, Hippocampus algiricus, and the first information on short-snouted seahorse Hippocampus hippocampus biology in Africa. A total of 219 seahorses were sampled from fisher catch in Senegal and The Gambia, with estimated height at reproductive activity for H. algiricus (161 mm) larger than mean +/- s.d. catch height (150 +/- 31 mm). Catch composition, height at reproductive activity and potential biases in fishery retention are discussed with regard to the current Convention on International Trade of Endangered Species (CITES) guidelines.
C1 [Cisneros-Montemayor, A. M.] Univ British Columbia, Fisheries Econ Res Unit, Fisheries Ctr, 2202 Main Mall, Vancouver, BC V6T 1Z4, Canada.
   [Cisneros-Montemayor, A. M.; West, K.; Vincent, A. C. J.] Univ British Columbia, Project Seahorse, Fisheries Ctr, 2202 Main Mall, Vancouver, BC V6T 1Z4, Canada.
   [Boiro, I. S.] Cent River Div, Banjul, Gambia.
RP Cisneros-Montemayor, AM (reprint author), Univ British Columbia, Fisheries Econ Res Unit, Fisheries Ctr, 2202 Main Mall, Vancouver, BC V6T 1Z4, Canada.; Cisneros-Montemayor, AM (reprint author), Univ British Columbia, Project Seahorse, Fisheries Ctr, 2202 Main Mall, Vancouver, BC V6T 1Z4, Canada.
EM a.cisneros@fisheries.ubc.ca
FU People's Trust for Endangered Species; Mohamed bin Zayed Species Fund;
   Erasmus Darwin Barlow Expedition award
FX This is a contribution from Project Seahorse. We gratefully acknowledge
   the many Senegalese and Gambian individuals who participated in this
   study, and particularly M. Abba Sonko and the staff of Senegal's
   Direction des Eaux, Forets, Chasse et de la Conservation des Sols for
   their assistance. We also thank J. Lawson, G. Bestbier, R. Pollom, L.
   Woodall and F. Otero for their assistance with sample identification and
   comments on the manuscript. This work was kindly funded by the People's
   Trust for Endangered Species, the Mohamed bin Zayed Species Fund and an
   Erasmus Darwin Barlow Expedition award. A.C.J.V. thanks Guylian
   Chocolates Belgium and an anonymous donor for their generous support
   through partnerships with Project Seahorse for marine conservation. This
   work was approved by the UBC Human Behavioural Research Ethics Board,
   Permit H13-00819, and animal ethics Certificate 5884-13 of the Canadian
   Council on Animal Care.
CR Afonso P, 1999, LIFE MAR SCI, V17A, P65
   Baum JK, 2003, FISH B-NOAA, V101, P721
   BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141
   Boisseau J., 1967, REGULATIONS HORMOLA
   Choo CK, 2003, J MAR BIOL ASSOC UK, V83, P271, DOI 10.1017/S0025315403007069h
   Evanson M., 2011, FISHERIES CTR RES RE, V19
   Foster S, 2016, AQUAT CONSERV, V26, P154, DOI 10.1002/aqc.2493
   Foster SJ, 2005, CONSERV BIOL, V19, P1044, DOI 10.1111/j.1523-1739.2005.00192.x
   Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.1095-8649.2004.00429.x
   Harasti D, 2012, J FISH BIOL, V81, P1297, DOI 10.1111/j.1095-8649.2012.03406.x
   Lawson JM, 2015, J FISH BIOL, V86, P1, DOI 10.1111/jfb.12527
   Loh T. L., 2014, ISEAHORE TRNDS TOOLK
   Lourie S. A., 2004, GUIDE IDENTIFICATIO
   Mallison CT, 2004, N AM J FISH MANAGE, V24, P880, DOI 10.1577/M03-043.1
   Mamonekene Victor, 2006, Bulletin of the Biological Society of Washington, V12, P285
   Martin-Smith KM, 2006, ORYX, V40, P141, DOI 10.1017/S003060530600010X
   Morgan SK, 2013, MAR FRESHWATER RES, V64, P185, DOI 10.1071/MF12171
   Naud MJ, 2009, BEHAV ECOL, V20, P160, DOI 10.1093/beheco/arn128
   Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860
   Schneider J.C., 2000, MANUAL FISHERIES SUR, P1
   STRAWN KIRK, 1958, COPEIA, V1958, P16, DOI 10.2307/1439534
   Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x
   VINCENT ACJ, 1994, BEHAVIOUR, V128, P153, DOI 10.1163/156853994X00091
   Vincent A. C. J., 2014, 3 MORE COUNTRIES REQ
   Vincent A. C. J., 2013, FISH FISH, V15, P563
   West K., 2012, INVESTIGATIONS SENGA
   Wilson AB, 2003, EVOLUTION, V57, P1374
   Wirtz P, 2007, ZOOTAXA, P1
   Woodall LC, 2011, J FISH BIOL, V78, P1738, DOI 10.1111/j.1095-8649.2011.02974.x
NR 29
TC 1
Z9 1
U1 2
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1112
EI 1095-8649
J9 J FISH BIOL
JI J. Fish Biol.
PD FEB
PY 2016
VL 88
IS 2
BP 751
EP 759
DI 10.1111/jfb.12818
PG 9
WC Fisheries; Marine & Freshwater Biology
SC Fisheries; Marine & Freshwater Biology
GA DE7WS
UT WOS:000370848200025
PM 26676971
OA No
DA 2017-08-15
ER

PT J
AU Steedman, MR
   Kampmann, B
   Schillings, E
   Al Kuwari, H
   Darzi, A
AF Steedman, Mark R.
   Kampmann, Beate
   Schillings, Egbert
   Al Kuwari, Hanan
   Darzi, Ara
TI Strategies To Boost Maternal Immunization To Achieve Further Gains In
   Improved Maternal And Newborn Health
SO HEALTH AFFAIRS
LA English
DT Article
ID GROUP-B STREPTOCOCCUS; INFLUENZA VACCINATION COVERAGE; PROTEIN CONJUGATE
   VACCINE; PREGNANT-WOMEN; UNITED-STATES; POLYSACCHARIDE VACCINE;
   ADVISORY-COMMITTEE; PERTUSSIS-VACCINE; DEVELOPMENT GOALS; NEONATAL
   TETANUS
AB Despite the indisputable successes of the United Nations Millennium Development Goals, which include goals on improving maternal health and reducing child mortality, millions of mothers and newborns still die tragically and unnecessarily each year. Many of these deaths result from vaccine-preventable diseases, since obstacles such as cost and accessibility have hampered efforts to deliver efficacious vaccines to those most in need. Additionally, many vaccines given to mothers and children under age five are not suitable for newborns, since their maturing immune systems do not respond optimally during the first few months of life. Maternal immunization-the process by which a pregnant woman's immune system is fortified against a particular disease and the protection is then transferred to her unborn child-has emerged as a strategy to prevent many unnecessary maternal and newborn deaths. We review vaccines that are already used for maternal immunization, analyze vaccines under development that could be used for maternal immunization strategies in the future, and recommend that policy makers use maternal immunization for improved maternal and newborn health.
C1 [Steedman, Mark R.; Schillings, Egbert; Al Kuwari, Hanan; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Pediat Infect & Immun, London SW7 2AZ, England.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Ctr Int Child Hlth, London SW7 2AZ, England.
   [Kampmann, Beate] MRC Unit, Vaccines & Immun Res, Serrekunda, Gambia.
   [Schillings, Egbert] Qatar Fdn, WISH, Doha, Qatar.
   [Al Kuwari, Hanan] Hamad Med Corp, Doha, Qatar.
   [Darzi, Ara] Qatar Fdn, WISH, Doha, Qatar.
RP Steedman, MR (reprint author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England.
EM m.steedman@imperial.ac.uk
FU Qatar Foundation
FX The authors acknowledge Qatar Foundation for funding the research in
   this article. The article follows from the Maternal and Newborn Health
   Policy Briefing from the World Innovation Summit for Health, an
   initiative of Qatar Foundation, in Doha, Qatar, February 18, 2015. The
   authors thank Jessica Prestt, Will Warburton, Sarah Henderson, and
   Gianluca Fontana for their comments and advice.
CR Bridges CB, 2013, MMWR SURVEILL SUM S1, V62, P9
   Acosta AM, 2015, PEDIATRICS, V135, P981, DOI [10.1542/peds.2014-3358, 10.1542/peds.2014-4118]
   AMSTEY MS, 1985, AM J OBSTET GYNECOL, V153, P607
   Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106
   BAKER CJ, 1988, NEW ENGL J MED, V319, P1180, DOI 10.1056/NEJM198811033191802
   Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0
   Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708
   Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151
   Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2
   Black S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005451
   Blanchard-Rohner G, 2011, VACCINE, V29, P7542, DOI 10.1016/j.vaccine.2011.08.013
   BURNEY LE, 1960, PUBLIC HEALTH REP, V75, P944, DOI 10.2307/4590965
   Centers for Disease Control and Prevention, PERT WHOOP COUGH SUR
   Chaithongwongwatthana S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004903.pub4
   Chu HY, 2014, CLIN INFECT DIS, V59, P560, DOI 10.1093/cid/ciu327
   Department of Health, 2012, PREGN WOM BE OFF WHO
   Ding H, 2014, MMWR-MORBID MORTAL W, V63, P816
   Dodd R, 2006, ANN TROP MED PARASIT, V100, P379, DOI 10.1179/136485906X97471
   Donaldson B, 2015, VACCINE, V33, P5822, DOI 10.1016/j.vaccine.2015.08.093
   Englund J, 1998, VACCINE, V16, P1456, DOI 10.1016/S0264-410X(98)00108-X
   ENGLUND JA, 1993, J INFECT DIS, V168, P647
   Englund JA, 2015, VACCINE, V33, P6372, DOI 10.1016/j.vaccine.2015.07.084
   Glezen WP, 1999, CLIN INFECT DIS, V28, P219, DOI 10.1086/515122
   Grohskopf LA, 2015, MMWR-MORBID MORTAL W, V64, P818
   Hamborsky J, 2015, EPIDEMIOLOGY PREVENT
   HOWIE PW, 1990, BRIT MED J, V300, P11
   Isbell M, SAVING LIVES PROTECT
   Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Jones C, 2013, BMJ OPEN, V3
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Kampmann B, 2015, PHILOS T R SOC LON B, V370
   Kennedy ED, 2012, AM J OBSTET GYNECOL, V207, pS9, DOI 10.1016/j.ajog.2012.06.069
   Khan Rownak, 2015, Int J Womens Health, V7, P171, DOI 10.2147/IJWH.S50539
   Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836
   Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S1
   LINDER N, 1994, CLIN PERINATOL, V21, P663
   Lindsey B, 2013, CURR OPIN INFECT DIS, V26, P248, DOI 10.1097/QCO.0b013e3283607a58
   Lu YL, 2015, NATURE, V520, P432, DOI 10.1038/520432a
   Madhi SA, 2013, VACCINE, V31, pD52, DOI 10.1016/j.vaccine.2013.02.029
   Meeting of the Strategic Advisory Group of Experts on Immunization, 2015, WKLY EPIDEMIOL REC, V90, P261
   Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033
   Mulholland K, 1996, JAMA-J AM MED ASSOC, V275, P1182
   Munoz FM, 2013, VACCINE, V31, pD46, DOI 10.1016/j.vaccine.2012.11.026
   ODempsey TJD, 1996, VACCINE, V14, P963, DOI 10.1016/0264-410X(96)00009-6
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P385
   Pierce M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3214
   Public Health England, 2014, VACC PERT WHOOP COUG
   PUCK JM, 1980, J INFECT DIS, V142, P844
   REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398
   Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6
   Roth K, 2013, MICROB PATHOGENESIS, V58, P45, DOI 10.1016/j.micpath.2012.11.001
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081
   Serdobova I, 2006, AM J PUBLIC HEALTH, V96, P1554, DOI 10.2105/AJPH.2005.074583
   SHAHID NS, 1995, LANCET, V346, P1252, DOI 10.1016/S0140-6736(95)91861-2
   STANFIELD JP, 1984, B WORLD HEALTH ORGAN, V62, P647
   SUMAYA CV, 1979, J INFECT DIS, V140, P141
   Swamy GK, 2015, VACCINE, V33, P6436, DOI 10.1016/j.vaccine.2015.08.035
   United Nations, 2015, MILL DEV GOALS REP 2
   World Health Organization, 2012, GLOB VACC SAF BLUEPR
   World Health Organization, 2015, GLOB VACC ACT PLAN 2
   World Health Organization, 2015, STRAT END PREV MAT M
   World Health Organization, 2015, MAT NEON TET MNT EL
   World Health Organization, 2014, EV NEWB ACT PLAN END
   World Health Organization, 2015, GLOB HLTH OBS DAT RE
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
   [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P131
   [Anonymous], 1993, WKLY EPIDEMIOL REC, V68, P277
   [Anonymous], 2005, WKLY EPIDEMIOL REC, V80, P277
NR 70
TC 0
Z9 0
U1 2
U2 2
PU PROJECT HOPE
PI BETHESDA
PA 7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA
SN 0278-2715
J9 HEALTH AFFAIR
JI Health Aff.
PD FEB
PY 2016
VL 35
IS 2
BP 309
EP 316
DI 10.1377/hlthaff.2015.1090
PG 8
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA DD1QU
UT WOS:000369697200020
PM 26858385
OA No
DA 2017-08-15
ER

PT J
AU Naylor, C
   Petri, WA
AF Naylor, Caitlin
   Petri, William A., Jr.
TI Leotin Regulation of Immune Responses
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE LUNG INJURY; LEPTIN RECEPTOR;
   T-CELLS; MALNOURISHED CHILDREN; ENTAMOEBA-HISTOLYTICA; CYTOKINE
   PRODUCTION; OBESE SUBJECTS; HOST-DEFENSE; TH17 CELLS
AB Leptin is a regulatory hormone with multiple roles in the immune system. We favor the concept that leptin signaling 'licenses' various immune cells to engage in immune responses and/or to differentiate. Leptin is an inflammatory molecule that is capable of activating both adaptive and innate immunity. It can also 'enhance' immune functions, including inflammatory cytokine production in macrophages, granulocyte chemotaxis, and increased T(h)17 proliferation. Leptin can also 'inhibit' cells; CD4(+) T cells are inhibited from differentiating into regulatory T cells in the presence of elevated leptin, while NK cells can exhibit impaired cytotoxicity under the same circumstances. Consequently, understanding the effect of leptin signaling is important to appreciate various aspects of immune dysregulation observed in malnutrition, obesity, and autoimmunity.
C1 [Naylor, Caitlin] MRC Unit, Atlantic Blvd, Serrekunda, Gambia.
   [Petri, William A., Jr.] Univ Virginia, Charlottesville, VA USA.
RP Naylor, C (reprint author), MRC Unit, Atlantic Blvd, Serrekunda, Gambia.
EM cnaylor@mrc.gm
FU NIH [AI 26649]
FX Work reported from the authors' laboratory was supported by NIH grant AI
   26649.
CR Al-Hassi HO, 2013, MUCOSAL IMMUNOL, V6, P751, DOI 10.1038/mi.2012.113
   Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404
   Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797
   Bartz S, 2014, J CLIN ENDOCR METAB, V99, P2128, DOI 10.1210/jc.2013-4018
   Behnes M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-217
   Bracho-Riquelme RL, 2011, CRIT CARE, V15, DOI 10.1186/cc10467
   Brotfain E, 2015, CLIN EXP IMMUNOL, V181, P156, DOI 10.1111/cei.12631
   Bruno A, 2005, J IMMUNOL, V174, P8090
   D'Avila H, 2008, INT IMMUNOPHARMACOL, V8, P1308, DOI 10.1016/j.intimp.2008.01.035
   Deng J, 2012, ARTHRITIS RHEUM-US, V64, P3564, DOI 10.1002/art.34637
   do Carmo LS, 2013, EXP BIOL MED, V238, P375, DOI 10.1177/1535370213477976
   dos Reis M, 2011, MOL BIOL EVOL, V28, P1755, DOI 10.1093/molbev/msq317
   Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294
   Dunn SL, 2005, MOL ENDOCRINOL, V19, P925, DOI 10.1210/me.2004-0353
   Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev
   Fazolini NPB, 2015, CELL CYCLE, V14, P2667, DOI 10.1080/15384101.2015.1041684
   Fernandez-Rejos B, 2011, MEDIAT INFLAMM, V2010
   Gil-Campos M, 2010, CLIN NUTR, V29, P54, DOI 10.1016/j.clnu.2009.06.007
   Gonzalez-Martinez H, 2008, J CLIN IMMUNOL, V28, P593, DOI 10.1007/s10875-008-9204-5
   Grotta MB, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-39
   Gruen ML, 2007, AM J PHYSIOL-CELL PH, V293, pC1481, DOI 10.1152/ajpcell.00062.2007
   Jaedicke KM, 2013, J LEUKOCYTE BIOL, V93, P561, DOI 10.1189/jlb.1211606
   Jahn J, 2015, OBESITY, V23, P2233, DOI 10.1002/oby.21229
   Kamp VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073170
   Kato H, 2011, INT ARCH ALLERGY IMM, V155, P335, DOI 10.1159/000321195
   Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x
   Korbonits M, 1997, CLIN ENDOCRINOL, V46, P751, DOI 10.1046/j.1365-2265.1997.1820979.x
   Kordonowy LL, 2012, AM J RESP CELL MOL, V47, P120, DOI 10.1165/rcmb.2011-0334OC
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Lamas B, 2013, J CELL PHYSIOL, V228, P1202, DOI 10.1002/jcp.24273
   Laue Tobias, 2015, BMC Obes, V2, P1, DOI 10.1186/s40608-014-0033-1
   Liu YY, 2012, J IMMUNOL, V188, P2070, DOI 10.4049/jimmunol.1102835
   Mackey-Lawrence NM, 2013, INFECT IMMUN, V81, P1460, DOI 10.1128/IAI.01383-12
   Mackintosh RM, 2001, OBES RES, V9, P462, DOI 10.1038/oby.2001.60
   Madan R, 2014, INFECT IMMUN, V82, P341, DOI 10.1128/IAI.00972-13
   Mancuso P, 2012, J IMMUNOL, V189, P867, DOI 10.4049/jimmunol.1200465
   Mancuso P, 2011, J IMMUNOL, V186, P1081, DOI 10.4049/jimmunol.1001470
   Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142
   Marie CS, 2012, INFECT IMMUN, V80, P1934, DOI 10.1128/IAI.06140-11
   Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200
   McNicholas S, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0580-6
   Montecucco F, 2006, ANN NY ACAD SCI, V1069, P463, DOI 10.1196/annals.1351.045
   Moraes-Vieira PMM, 2014, EUR J IMMUNOL, V44, P794, DOI 10.1002/eji.201343592
   Naylor C., 2014, MBLO, V5
   Palacio A, 2002, J CLIN ENDOCR METAB, V87, P3040, DOI 10.1210/jc.87.7.3040
   Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012
   Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024
   Reis BS, 2015, J IMMUNOL, V194, P5253, DOI 10.4049/jimmunol.1402996
   Rodriguez L, 2007, CLIN EXP IMMUNOL, V148, P478, DOI 10.1111/j.1365-2249.2007.03361.x
   Rodriguez L, 2005, CLIN DIAGN LAB IMMUN, V12, P502, DOI 10.1128/CDLI.12.4.502-507.2005
   Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158
   Siegl D., 2014, ANESTHESIOLOGY, P1
   Soliman AT, 2000, METABOLISM, V49, P819, DOI 10.1053/meta.2000.6745
   Suzukawa M., 2015, J IMMUNOL, V186, P5254
   Tsiotra PC, 2013, BIOMED RES INT, DOI 10.1155/2013/487081
   Ubags ND, 2014, CRIT CARE MED, V42, pE143, DOI 10.1097/CCM.0000000000000048
   Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang D., 2011, J BIOSCIENCE, V37, P91
   Wang S, 2013, CLIN EXP IMMUNOL, V171, P63, DOI 10.1111/j.1365-2249.2012.04670.x
   Wrann CD, 2012, AM J PHYSIOL-ENDOC M, V302, pE108, DOI 10.1152/ajpendo.00057.2011
   Yu YY, 2013, J IMMUNOL, V190, P3054, DOI 10.4049/jimmunol.1203275
   Zarkesh-Esfahani H, 2004, J IMMUNOL, V172, P1809
   Zhou Y., 2015, CELL METAB, V22, P1
NR 64
TC 19
Z9 19
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD FEB
PY 2016
VL 22
IS 2
BP 88
EP 98
DI 10.1016/j.molmed.2015.12.001
PG 11
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DD7GF
UT WOS:000370091000003
PM 26776093
OA No
DA 2017-08-15
ER

PT J
AU Maertzdorf, J
   McEwen, G
   Weiner, J
   Tian, S
   Lader, E
   Schriek, U
   Mayanja-Kizza, H
   Ota, M
   Kenneth, J
   Kaufmann, SHE
AF Maertzdorf, Jeroen
   McEwen, Gayle
   Weiner, January, III
   Tian, Song
   Lader, Eric
   Schriek, Ulrich
   Mayanja-Kizza, Harriet
   Ota, Martin
   Kenneth, John
   Kaufmann, Stefan H. E.
TI Concise gene signature for point-of-care classification of tuberculosis
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE disease classification; genomics; molecular diagnosis; real-time PCR;
   tuberculosis
ID DIAGNOSTICS; EXPRESSION; RESISTANCE; LANDSCAPE
AB There is an urgent need for new tools to combat the ongoing tuberculosis (TB) pandemic. Gene expression profiles based on blood signatures have proved useful in identifying genes that enable classification of TB patients, but have thus far been complex. Using real-time PCR analysis, we evaluated the expression profiles from a large panel of genes in TB patients and healthy individuals in an Indian cohort. Classification models were built and validated for their capacity to discriminate samples from TB patients and controls within this cohort and on external independent gene expression datasets. A combination of only four genes distinguished TB patients from healthy individuals in both cross-validations and on separate validation datasets with very high accuracy. An external validation on two distinct cohorts using a real-time PCR setting confirmed the predictive power of this 4-gene tool reaching sensitivity scores of 88% with a specificity of around 75%. Moreover, this gene signature demonstrated good classification power in HIV+ populations and also between TB and several other pulmonary diseases. Here we present proof of concept that our 4-gene signature and the top classifier genes from our models provide excellent candidates for the development of molecular point-of-care TB diagnosis in endemic areas.
C1 [Maertzdorf, Jeroen; McEwen, Gayle; Weiner, January, III; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Berlin, Germany.
   [Tian, Song; Lader, Eric] Qiagen, Frederick, MD USA.
   [Schriek, Ulrich] Qiagen GmbH, Hilden, Germany.
   [Mayanja-Kizza, Harriet] Makerere Univ, Kampala, Uganda.
   [Ota, Martin] MRC, Banjul, Gambia.
   [Kenneth, John] St Johns Res Inst, Bangalore, Karnataka, India.
RP Maertzdorf, J; Kaufmann, SHE (reprint author), Max Planck Inst Infect Biol, Berlin, Germany.
EM maertzdorf@mpiib-berlin.mpg.de; kaufmann@mpiib-berlin.mpg.de
FU Qiagen; Norwegian Agency for Development Cooperation (NORAD)
FX We thank all study participants and clinical and technical staff for
   providing and processing the samples. We would also like to acknowledge
   all other collaborators from Qiagen's bioinformatics team in Frederick,
   MD, for analyzing the data and M.L. Grossman for copyediting this
   manuscript. This work was supported by Qiagen and by the Norwegian
   Agency for Development Cooperation (NORAD).
CR Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106
   Babu Kalpana, 2013, J Ophthalmic Inflamm Infect, V3, P53, DOI 10.1186/1869-5760-3-53
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630
   Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8
   Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642
   Dawany N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089925
   Fu SJ, 2011, APPL BIOCHEM BIOTECH, V163, P845, DOI 10.1007/s12010-010-9088-8
   Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933
   Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538
   Lee SH, 2008, LAB CHIP, V8, P2121, DOI 10.1039/b811131f
   Liaw A, 2002, R NEWS, V2002, P18, DOI DOI 10.1016/J.MEMSCI.2010.02.036
   Maertzdorf J., 2011, PLoS ONE, pe26938, DOI 10.1371/journal.pone.0026938
   Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51
   Maertzdorf J, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018531
   Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109
   Maurin M, 2012, EXPERT REV MOL DIAGN, V12, P731, DOI [10.1586/erm.12.53, 10.1586/ERM.12.53]
   Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078
   Norbis L, 2013, NEW MICROBIOL, V36, P111
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803
   Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Satproedprai N, 2015, GENES IMMUN, V16, P253, DOI 10.1038/gene.2015.4
   Scrivens M, 2005, BRIT J PHARMACOL, V146, P435, DOI 10.1038/sj.bjp.0706322
   Song HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053325
   Weiner J, 2013, ANN NY ACAD SCI, V1283, P22, DOI 10.1111/j.1749-6632.2012.06802.x
   World Health Organization, 2015, GLOB TUB REP 2015
NR 29
TC 7
Z9 7
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD FEB
PY 2016
VL 8
IS 2
BP 86
EP 95
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DD2BR
UT WOS:000369727900005
PM 26682570
OA gold
DA 2017-08-15
ER

PT J
AU Lukianova-Hleb, E
   Bezek, S
   Szigeti, R
   Khodarev, A
   Kelley, T
   Hurrell, A
   Berba, M
   Kumar, N
   D'Alessandro, U
   Lapotko, D
AF Lukianova-Hleb, Ekaterina
   Bezek, Sarah
   Szigeti, Reka
   Khodarev, Alexander
   Kelley, Thomas
   Hurrell, Andrew
   Berba, Michail
   Kumar, Nirbhay
   D'Alessandro, Umberto
   Lapotko, Dmitri
TI Transdermal Diagnosis of Malaria Using Vapor Nanobubbles Response
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Lukianova-Hleb, Ekaterina; Lapotko, Dmitri] Rice Univ, 6100 Main St,MS-140, Houston, TX 77005 USA.
   [Bezek, Sarah; Szigeti, Reka] Baylor Coll Med, Houston, TX 77030 USA.
   [Bezek, Sarah; Szigeti, Reka] Ben Taub Gen Hosp, Harris Hlth Syst, Houston, TX 77030 USA.
   [Khodarev, Alexander] X Instruments LLC, Fremont, CA USA.
   [Kelley, Thomas; Hurrell, Andrew] Precis Acoust Ltd, Dorchester, Dorset, England.
   [Berba, Michail] Standa UAB, Vilnius, Lithuania.
   [Kumar, Nirbhay] Tulane Univ, New Orleans, LA 70118 USA.
   [D'Alessandro, Umberto] MRC, Banjul, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
RP Lapotko, D (reprint author), Rice Univ, 6100 Main St,MS-140, Houston, TX 77005 USA.
EM dl5@rice.edu
CR Lukianova-Hleb E, 2015, EMERG INFECT DIS, V21, P1122, DOI 10.3201/eid2107.150089
   Lukianova-Hleb EY, 2014, P NATL ACAD SCI USA, V111, P900, DOI 10.1073/pnas.1316253111
   Rebelo M, 2016, EMERG INFECT DIS, V22, P343, DOI 10.3201/eid2202.151203
   Rebelo M, 2012, ACTA TROP, V123, P58, DOI 10.1016/j.actatropica.2012.03.005
NR 4
TC 0
Z9 0
U1 1
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2016
VL 22
IS 2
BP 344
EP 344
DI 10.3201/eid2202.151829
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DC1HX
UT WOS:000368968500038
PM 26814719
OA gold
DA 2017-08-15
ER

PT J
AU Holder, B
   Jones, T
   Shimizu, VS
   Rice, TF
   Donaldson, B
   Bouqueau, M
   Forbes, K
   Kampmann, B
AF Holder, Beth
   Jones, Tessa
   Shimizu, Vanessa Sancho
   Rice, Thomas F.
   Donaldson, Beverly
   Bouqueau, Marielle
   Forbes, Karen
   Kampmann, Beate
TI Macrophage Exosomes Induce Placental Inflammatory Cytokines: A Novel
   Mode of Maternal-Placental Messaging
SO TRAFFIC
LA English
DT Article
DE cytokines; endocytosis; exosomes; extracellular vesicles; immunology;
   macrophage; microvesicles; placenta; pregnancy; reproductive;
   trophoblast
ID CELL-DERIVED EXOSOMES; IN-VIVO; DENDRITIC CELLS; T-CELLS; SECRETION;
   RESPONSES; SYNCYTIOTROPHOBLAST; ACTIVATION; PREGNANCY; BLOOD
AB During pregnancy, the placenta forms the interface between mother and fetus. Highly controlled regulation of trans-placental trafficking is therefore essential for the healthy development of the growing fetus. Extracellular vesicle-mediated transfer of protein and nucleic acids from the human placenta into the maternal circulation is well documented; the possibility that this trafficking is bi-directional has not yet been explored but could affect placental function and impact on the fetus. We hypothesized that the ability of the placenta to respond to maternal inflammatory signals is mediated by the interaction of maternal immune cell exosomes with placental trophoblast. Utilizing the BeWo cell line and whole placental explants, we demonstrated that the human placenta internalizes macrophage-derived exosomes in a time- and dose-dependent manner. This uptake was via clathrin-dependent endocytosis. Furthermore, macrophage exosomes induced release of proinflammatory cytokines by the placenta. Taken together, our data demonstrates that exosomes are actively transported into the human placenta and that exosomes from activated immune cells modulate placental cytokine production. This represents a novel mechanism by which immune cells can signal to the placental unit, potentially facilitating responses to maternal inflammation and infection, and thereby preventing harm to the fetus.
C1 [Holder, Beth; Jones, Tessa; Shimizu, Vanessa Sancho; Rice, Thomas F.; Donaldson, Beverly; Bouqueau, Marielle; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Med, Sect Paediat, London, England.
   [Shimizu, Vanessa Sancho] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Infect Dis, Virol, London, England.
   [Forbes, Karen] Univ Leeds, Leeds Inst Cardiovasc & Metab Med LICAMM, Div Reprod & Early Dev, Leeds, W Yorkshire, England.
   [Forbes, Karen] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.
   [Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
RP Holder, B (reprint author), Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Med, Sect Paediat, London, England.
EM b.holder@imperial.ac.uk
OI Forbes, Karen/0000-0002-3745-1337
FU Newlife Foundation; NIHR Imperial Biomedical Research Centre; MRC
   [MR/K007602/1]
FX The authors would like to thank Prof. Sharon Tooze at the London
   Research Institute, Cancer Research UK, for advice with endocytosis
   experiments. We would also like to thank Ms. Sandra Okala for technical
   assistance with NTA, Dr. Malte Paulsen for technical assistance with
   flow cytometry, and Ms. Bayarchimeg Mashbat for assistance with ELISAs.
   Microscopy was performed in the Facility for Imaging by Light Microscopy
   (FILM) at Imperial College London. Flow cytometry was performed at
   Imperial College NHLI St. Mary's, FACS Facility. All patient samples
   were collected under the MatImms research study (REC 13/LO/1712). The
   work was funded by a start-up grant from the Newlife Foundation, and the
   NIHR Imperial Biomedical Research Centre. B. H. and B. K. are supported
   by the MRC (MR/K007602/1). None of the authors have any conflicts of
   interest to declare.
CR Abrahams VM, 2004, J IMMUNOL, V173, P4286
   Abrahams VM, 2004, MOL HUM REPROD, V10, P55, DOI 10.1093/molehr/gah006
   Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449
   Bechi N, 2010, ENVIRON HEALTH PERSP, V118, P427, DOI 10.1289/ehp.0900882
   Benyo DF, 1997, J CLIN ENDOCR METAB, V82, P1582, DOI 10.1210/jc.82.5.1582
   Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152
   Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200
   Bowen JM, 2002, PLACENTA, V23, P257, DOI 10.1053/plac.2001.0782
   Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806
   de la Torre E, 2009, J IMMUNOL, V182, P3735, DOI 10.4049/jimmunol.0800764
   Denison FC, 1998, HUM REPROD, V13, P3560, DOI 10.1093/humrep/13.12.3560
   Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108
   Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2
   Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088
   Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x
   Germain SJ, 2007, J IMMUNOL, V178, P5949
   Giri PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002461
   Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009
   Holder BS, 2012, IMMUNOLOGY, V136, P184, DOI 10.1111/j.1365-2567.2012.03568.x
   Holder BS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097014
   Holmlund U, 2002, IMMUNOLOGY, V107, P145, DOI 10.1046/j.1365-2567.2002.01491.x
   Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100
   Koh YQ, 2014, EUR J OBSTET GYN R B, V175, P129, DOI 10.1016/j.ejogrb.2013.12.032
   Lambot N, 2006, BIOL REPROD, V75, P90, DOI 10.1095/biolreprod.105.050021
   Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406
   Lyden TW, 2002, PLACENTA, V23, P640, DOI 10.1053/plac.2002.0847
   Ma YH, 2006, AM J REPROD IMMUNOL, V55, P12, DOI 10.1111/j.1600-0897.2005.00347.x
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011
   Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824
   Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13
   Qu Y, 2007, J IMMUNOL, V179, P1913
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   Redline RW, 2006, SEMIN FETAL NEONAT M, V11, P296, DOI 10.1016/j.siny.2006.02.011
   Singh PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018564
   Skokos D, 2001, J IMMUNOL, V166, P868
   Skokos D, 2003, J IMMUNOL, V170, P3037
   Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245
   Taylor DD, 2006, J IMMUNOL, V176, P1534
   Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599
   Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004
   Vargas A, 2014, FASEB J, V28, P3703, DOI 10.1096/fj.13-239053
   Witwer KW, 2013, J EXTRACELL VESICLES, V2, P1, DOI [10.3402/jev.v2i0.20360, DOI 10.3402/JEV.V2I0.20360]
NR 43
TC 7
Z9 7
U1 4
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD FEB
PY 2016
VL 17
IS 2
BP 168
EP 178
DI 10.1111/tra.12352
PG 11
WC Cell Biology
SC Cell Biology
GA DC1YN
UT WOS:000369014500006
PM 26602702
OA No
DA 2017-08-15
ER

PT J
AU Braithwaite, VS
   Prentice, A
   Darboe, MK
   Prentice, AM
   Moore, SE
AF Braithwaite, V. S.
   Prentice, A.
   Darboe, M. K.
   Prentice, A. M.
   Moore, S. E.
TI The effects of maternal iron deficiency on infant fibroblast growth
   factor-23 and mineral metabolism
SO BONE
LA English
DT Article
DE Iron status in pregnancy; FGF23; Phosphate; Bone health; Africa; Early
   life
ID GAMBIAN CHILDREN; FGF23; RICKETS; MICE; PREGNANCY
AB Fibroblast growth factor-23 (FGF23), a phosphate(Phos)-regulating hormone, is abnormally elevated in hypophosphataemic syndromes and an elevated FGF23 is a predictor of mortality in kidney disease. Recent findings suggest iron deficiency as a potential mediator of FGF23 expression and murine studies have shown in utero effects of maternal iron deficiency on offspring FGF23 and phosphate metabolism.
   Our aim was to investigate the impact of maternal iron status on infant FGF23 and mineral metabolites over the first 2 years of life. Infants born to mothers with normal (NI n = 25,) and low (LI n = 25) iron status during pregnancy, from a mother-infant trial (ISRCTN49285450) in rural Gambia, West Africa, had blood and plasma samples analysed at 12, 24, 52, 78 and 104 weeks (wk) of age.
   Circulating intact-FGF23 (I-FGF23), Phos, total alkaline phosphatase (TALP) and haemoglobin (Hb) decreased and estimated glomerular filtration rate increased over time [all P <= 0.0001)]. C-terminal-FGF23 (C-FGF23) and TALP were significantly higher in LI compared with NI, from 52 wk for C-FGF23 [Beta coefficient (SE) 18.1 (0.04) %, P = 0.04] and from 24 wk for TALP [44.7 (29.6) U/L, P = 0.04]. Infant Hb was the strongest negative predictor of C-FGF23 concentration [-21% (4%) RU/mL, P <= 0.0001], Phos was the strongest positive predictor of I-FGF23 [32.0(3.9) pg/mI, P <= 0.0001] and I-FGF23 did not predict C-FGF23 over time [-0.5% (0.5%), P = 0.3].
   In conclusion, this study suggests that poor maternal iron status is associated with a higher infant C-FGF23 and TALP but similar I-FGF23 concentrations in infants and young children. These findings further highlight the likely public health importance of preventing iron deficiency during pregnancy. Whether or not children who are born to iron deficient mothers have persistently high concentrations of these metabolites and are more likely to be at risk of impaired bone development and pre-disposed to rickets requires further research. (c) 2015 The Authors. Published by Elsevier Inc.
C1 [Braithwaite, V. S.; Prentice, A.; Moore, S. E.] MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.
   [Braithwaite, V. S.; Prentice, A.; Darboe, M. K.; Prentice, A. M.; Moore, S. E.] MRC Unit, Serrekunda, Gambia.
   [Darboe, M. K.; Prentice, A. M.; Moore, S. E.] Univ London London Sch Hyg & Trop Med, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
RP Braithwaite, VS (reprint author), MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.
EM vickie.braithwaite@mrc-hnr.cam.ac.uk
OI Braithwaite, Vickie/0000-0002-3366-2903
FU MRC; Department for International Development (DFID) under the MRC/DFID
   Concordat agreement [U105960371, U123261351, MC-A760-5QX00]
FX This research was jointly funded by the MRC and the Department for
   International Development (DFID) under the MRC/DFID Concordat agreement:
   programme numbers U105960371, U123261351 and MC-A760-5QX00.
CR Barth JH, 1996, ANN CLIN BIOCHEM, V33, P55
   Bergwitz C, 2012, ADV EXP MED BIOL, V728, P41, DOI 10.1007/978-1-4614-0887-1_3
   Berndt TJ, 2007, PFLUG ARCH EUR J PHY, V454, P615, DOI 10.1007/s00424-007-0231-5
   Bozentowicz-Wikarek M, 2015, CLIN BIOCHEM, V48, P431, DOI 10.1016/j.clinbiochem.2014.12.027
   Braithwaite VS, 2015, BONE, V74, P166, DOI 10.1016/j.bone.2014.12.068
   Braithwaite V, 2014, ENDOCR CONNECT, V3, P1, DOI 10.1530/EC-13-0070
   Braithwaite Vickie, 2012, Int J Pediatr Endocrinol, V2012, P27, DOI 10.1186/1687-9856-2012-27
   Braithwaite V, 2012, BONE, V50, P1351, DOI 10.1016/j.bone.2012.03.010
   Braithwaite V, 2012, BONE, V50, P218, DOI 10.1016/j.bone.2011.10.009
   Clinkenbeard EL, 2014, J BONE MINER RES, V29, P361, DOI 10.1002/jbmr.2049
   Drake KA, 2009, PEDIATR RES, V66, P619, DOI 10.1203/PDR.0b013e3181be79c2
   Elsammak M., 2011, ERJ, V38, P3581
   Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108
   Fatani T, 2015, J PEDIATR ENDOCR MET, V28, P825, DOI 10.1515/jpem-2014-0186
   Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107
   Spiegel HE, 2001, ADV CLIN CHEM, P72, DOI 10.1016/S0065-2423(01)35015-1
   Imel E.A., 2011, J CLIN ENDOCRINOL ME, V96
   Khosravi A, 2007, J CLIN ENDOCR METAB, V92, P2374, DOI 10.1210/jc.2006-2865
   Kirby BJ, 2013, J BONE MINER RES, V28, P1987, DOI 10.1002/jbmr.1925
   KOVAR I, 1982, LANCET, V1, P308
   Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768
   Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43
   Lozoff B, 2006, NUTR REV, V64, pS72
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   The National Nutrition Agency (NaNA) The Medical Research Council The Gambia, 2001, NAT SURV PREV VIT A
   Ohata Y, 2014, J BONE MINER RES, V29, P1627, DOI 10.1002/jbmr.2186
   Prentice AM, 2013, WORLD REV NUTR DIET, V106, P90, DOI 10.1159/000342563
   Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x
   Prentice A, 2008, BONE, V42, P788, DOI 10.1016/j.bone.2007.11.014
   Punnonen K, 1997, BLOOD, V89, P1052
   WHO, 2011, HAEM CONC DIAGN AN A
   World Health Organization (WHO), 2011, WHO ANTHR PERS COMP
   Wolf M, 2010, CLIN J AM SOC NEPHRO, V5, P1727, DOI 10.2215/CJN.07410810
   Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294
NR 34
TC 2
Z9 2
U1 2
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD FEB
PY 2016
VL 83
BP 1
EP 8
DI 10.1016/j.bone.2015.10.003
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DB5RJ
UT WOS:000368571000001
PM 26453792
OA No
DA 2017-08-15
ER

PT J
AU Shimakawa, Y
   Njai, HF
   Takahashi, K
   Berg, L
   Ndow, G
   Jeng-Barry, A
   Ceesay, A
   Tamba, S
   Opoku, E
   Taal, M
   Akbar, SMF
   Arai, M
   D'Alessandro, U
   Taylor-Robinson, SD
   Njie, R
   Mishiro, S
   Thursz, MR
   Lemoine, M
AF Shimakawa, Y.
   Njai, H. F.
   Takahashi, K.
   Berg, L.
   Ndow, G.
   Jeng-Barry, A.
   Ceesay, A.
   Tamba, S.
   Opoku, E.
   Taal, M.
   Akbar, S. M. F.
   Arai, M.
   D'Alessandro, U.
   Taylor-Robinson, S. D.
   Njie, R.
   Mishiro, S.
   Thursz, M. R.
   Lemoine, M.
TI Hepatitis E virus infection and acute-on-chronic liver failure in West
   Africa: a case-control study from The Gambia
SO ALIMENTARY PHARMACOLOGY & THERAPEUTICS
LA English
DT Article
ID ASIAN-PACIFIC ASSOCIATION; IMMUNOGLOBULIN-A; CONSENSUS RECOMMENDATIONS;
   FULMINANT-HEPATITIS; HEV INFECTION; GENOTYPE 3; PREVALENCE; JAPAN;
   ANTIBODIES; PIGS
AB Background
   In sub-Saharan Africa, it is unknown whether hepatitis E virus (HEV) infection is a common precipitating event of acute-on-chronic liver failure (ACLF).
   Aims
   To estimate the prevalence of HEV infection in general population and assess whether HEV is a common trigger of ACLF in cirrhotic patients in The Gambia, West Africa.
   Methods
   We first conducted an HEV sero-survey in healthy volunteers. We then tested cirrhotic patients with ACLF (cases) and compensated cirrhosis (controls) for anti-HEV IgG as a marker of exposure to HEV, and anti-HEV IgA and HEV RNA as a marker of recent infection. We also described the characteristics and survival of the ACLF cases and controls.
   Results
   In the healthy volunteers (n = 204), 13.7% (95% CI: 9.6-19.2) were positive for anti-HEV IgG, and none had positive HEV viraemia. After adjusting for age and sex, the following were associated with positive anti-HEV IgG: being a Christian, a farmer, drinking water from wells, handling pigs and eating pork. In 40 cases (median age: 45 years, 72.5% male) and 71 controls (39 years, 74.6% male), >= 70% were infected with hepatitis B virus. Although hepatitis B flare and sepsis were important precipitating events of ACLF, none had marker of acute HEV. ACLF cases had high (70.0%) 28-day mortality.
   Conclusions
   Hepatitis E virus infection is endemic in The Gambia, where both faecal-oral route (contaminated water) and zoonotic transmission (pigs/pork meat) may be important. However, acute HEV was not a common cause of acute-on-chronic liver failure in The Gambia.
C1 [Shimakawa, Y.; Njai, H. F.; Berg, L.; Ndow, G.; Jeng-Barry, A.; Ceesay, A.; Tamba, S.; Opoku, E.; D'Alessandro, U.; Njie, R.; Lemoine, M.] MRC, Unit Gambia, Banjul, Gambia.
   [Shimakawa, Y.] Inst Pasteur, Unite Epidemiol Malad Emergentes, F-75015 Paris, France.
   [Takahashi, K.; Akbar, S. M. F.; Arai, M.; Mishiro, S.] Toshiba Gen Hosp, Dept Med Sci, Tokyo, Japan.
   [Berg, L.; Ndow, G.; Opoku, E.; Taylor-Robinson, S. D.; Thursz, M. R.; Lemoine, M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Hepatol Unit, London, England.
   [Taal, M.] Minist Hlth & Social Welf, Banjul, Gambia.
   [Njie, R.] MRC Unit, Gambia Hepatitis Intervent Study, IARC, Banjul, Gambia.
RP Shimakawa, Y (reprint author), Inst Pasteur, Unite Epidemiol Malad Emergentes, 25-28 Rue Dr Roux, F-75015 Paris, France.
EM yusuke.shimakawa@gmail.com; m.lemoine@imperial.ac.uk
OI Ndow, Gibril/0000-0001-5837-5110
FU European Commission [265994]; MRC Unit The Gambia; Gambia Government;
   International Agency for Research on Cancer (IARC); NIHR Biomedical
   Facility at the Imperial College London; Asia-Africa-Oceania Hepatitis
   Experts Linkage Promotion (AAO-HELP) project - Viral Hepatitis Research
   Foundation of Japan
FX The PROLIFICA study was funded by the European Commission's Seventh
   Framework Program (grant 265994). The study was also supported by the
   MRC Unit The Gambia, the Gambia Government, International Agency for
   Research on Cancer (IARC), NIHR Biomedical Facility at the Imperial
   College London and the Asia-Africa-Oceania Hepatitis Experts Linkage
   Promotion (AAO-HELP) project which was funded by the Viral Hepatitis
   Research Foundation of Japan.
CR Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016
   Adjei AA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-336
   Aggarwal R., 2010, THE GLOBAL PREVALENC
   Aggarwal R, 2013, NAT REV GASTRO HEPAT, V10, P24, DOI 10.1038/nrgastro.2012.187
   Andersson MI, 2015, J CLIN VIROL, V70, P23, DOI 10.1016/j.jcv.2015.06.081
   Attia K, 2008, WORLD J GASTROENTERO, V14, P286, DOI 10.3748/wjg.14.286
   Blasco-Perrin H, 2015, ALIMENT PHARM THER, V42, P574, DOI 10.1111/apt.13309
   COURSAGET P, 1995, SCAND J INFECT DIS, V27, P9, DOI 10.3109/00365549509018964
   Coursaget P, 1998, AM J TROP MED HYG, V58, P330
   de Paula VS, 2013, EMERG INFECT DIS, V19, P666, DOI 10.3201/eid1904.121634
   Elkady A, 2007, J GASTROENTEROL, V42, P911, DOI 10.1007/s00535-007-2109-x
   Fix AD, 2000, AM J TROP MED HYG, V62, P519
   GBD, 2013, LANCET, V385, P1990
   Hamid SS, 2002, HEPATOLOGY, V36, P474, DOI 10.1053/jhep.2002.34856
   Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P276, DOI 10.1128/CVI.00312-06
   Iino S, 2005, JPN J MED PHARM SCI, V53, P461
   Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037
   Junaid Surajudeen A, 2014, Virology (Auckl), V5, P15, DOI 10.4137/VRT.S15422
   Kaba M, 2010, INFECT GENET EVOL, V10, P154, DOI 10.1016/j.meegid.2009.09.011
   Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7
   KAMEL MA, 1995, J MED VIROL, V47, P399, DOI 10.1002/jmv.1890470417
   Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308
   Kmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111
   Kumar Arvind, 2004, Indian J Gastroenterol, V23, P59
   Kumar Ashish, 2013, J Clin Exp Hepatol, V3, P225, DOI 10.1016/j.jceh.2013.08.013
   Labrique AB, 2009, AM J TROP MED HYG, V81, P875, DOI 10.4269/ajtmh.2009.09-0352
   Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561
   Lemoine M, 2016, GUT, V65, P1369, DOI 10.1136/gutjnl-2015-309260
   Mitsui T, 2004, J MED VIROL, V74, P563, DOI 10.1002/jmv.20215
   Mizuo H, 2002, J CLIN MICROBIOL, V40, P3209, DOI 10.1128/JCM.40.9.3209-3218.2002
   Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042
   Njai HF, 2015, J CLIN MICROBIOL, V53, P1156, DOI 10.1128/JCM.02980-14
   Peto TJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-7
   Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505
   Sarin SK, 2014, HEPATOL INT, V8, P453, DOI 10.1007/s12072-014-9580-2
   Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x
   Sehonou J, 2010, MED TROP-MARSEILLE, V70, P375
   Shi Y, 2015, HEPATOLOGY, V62, P232, DOI 10.1002/hep.27795
   Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892
   Shimakawa Y, 2015, LIVER INT, V35, P2318, DOI 10.1111/liv.12814
   Shimakawa Y, 2015, PALLIATIVE MED, V29, P184, DOI 10.1177/0269216314547103
   Shrestha A, 2015, EMERG INFECT DIS, V21, P711, DOI 10.3201/eid2104.141512
   Takahashi K, 2003, INTERVIROLOGY, V46, P308, DOI 10.1159/000073210
   Takahashi K, 2009, EMERG INFECT DIS, V15, P704, DOI 10.3201/eid1505.081100
   Takahashi M, 2005, J CLIN MICROBIOL, V43, P49, DOI 10.1128/JCM.43.1.49-56.2005
   Temmam S, 2013, AM J TROP MED HYG, V88, P329, DOI 10.4269/ajtmh.2012.12-0615
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P185
   WHO, 2012, WKLY EPIDEMIOL REC, V87, P261
   Zaki ME, 2011, LIVER INT, V31, P1001, DOI 10.1111/j.1478-3231.2011.02521.x
   Zhang SJ, 2009, DIGEST DIS SCI, V54, P2512, DOI 10.1007/s10620-008-0657-4
   Zhang XH, 2010, HEPATOL INT, V4, P615, DOI 10.1007/s12072-010-9204-4
NR 51
TC 2
Z9 2
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-2813
EI 1365-2036
J9 ALIMENT PHARM THER
JI Aliment. Pharmacol. Ther.
PD FEB
PY 2016
VL 43
IS 3
BP 375
EP 384
DI 10.1111/apt.13484
PG 10
WC Gastroenterology & Hepatology; Pharmacology & Pharmacy
SC Gastroenterology & Hepatology; Pharmacology & Pharmacy
GA DB0HN
UT WOS:000368189300006
PM 26623967
OA No
DA 2017-08-15
ER

PT J
AU Brabin, BJ
   Gies, S
   Owens, S
   Claeys, Y
   D'Alessandro, U
   Tinto, H
   Brabin, L
AF Brabin, Bernard J.
   Gies, Sabine
   Owens, Stephen
   Claeys, Yves
   D'Alessandro, Umberto
   Tinto, Halidou
   Brabin, Loretta
TI Perspectives on the design and methodology of periconceptional nutrient
   supplementation trials
SO TRIALS
LA English
DT Review
DE Periconceptional; Pregnancy; Placenta; Iron; Folic acid; Micronutrients;
   Adherence
ID NEURAL-TUBE DEFECTS; FOLIC-ACID SUPPLEMENTATION; RANDOMIZED
   CONTROLLED-TRIAL; MULTIPLE-MICRONUTRIENT SUPPLEMENTATION;
   FOR-GESTATIONAL-AGE; MOTHER-CHILD COHORT; LOW-BIRTH-WEIGHT;
   FETAL-GROWTH; 1ST TRIMESTER; IRON STATUS
AB Periconceptional supplementation could extend the period over which maternal and fetal nutrition is improved, but there are many challenges facing early-life intervention studies. Periconceptional trials differ from pregnancy supplementation trials, not only because of the very early or pre-gestational timing of nutrient exposure but also because they generate subsidiary information on participants who remain non-pregnant. The methodological challenges are more complex although, if well designed, they provide opportunities to evaluate concurrent hypotheses related to the health of non-pregnant women, especially nulliparous adolescents. This review examines the framework of published and ongoing randomised trial designs. Four cohorts typically arise from the periconceptional trial design - two of which are non-pregnant and two are pregnant - and this structure provides assessment options related to pre-pregnant, maternal, pregnancy and fetal outcomes. Conceptually the initial decision for single or micronutrient intervention is central - as is the choice of dosage and content - in order to establish a comparative framework across trials, improve standardisation, and facilitate interpretation of mechanistic hypotheses. Other trial features considered in the review include: measurement options for baseline and outcome assessments; adherence to long-term supplementation; sample size considerations in relation to duration of nutrient supplementation; cohort size for non-pregnant and pregnant cohorts as the latter is influenced by parity selection; integrating qualitative studies and data management issues. Emphasis is given to low resource settings where high infection rates and the possibility of nutrient-infection interactions may require appropriate safety monitoring. The focus is on pragmatic issues that may help investigators planning a periconceptional trial.
C1 [Brabin, Bernard J.] Univ Liverpool Liverpool Sch Trop Med, Clin Div, Liverpool L35QA, Merseyside, England.
   [Brabin, Bernard J.] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [Gies, Sabine] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Owens, Stephen] Northumbria Healthcare NHS Fdn Trust, North Shields NE29 8NH, England.
   [Claeys, Yves] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] Med Res Council Unit MRC, Fajara, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Tinto, Halidou] Clin Res Unit Nanoro URCN IRSS, Nanoro, Burkina Faso.
   [Brabin, Loretta] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England.
RP Brabin, BJ (reprint author), Univ Liverpool Liverpool Sch Trop Med, Clin Div, Liverpool L35QA, Merseyside, England.; Brabin, BJ (reprint author), Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM b.j.brabin@liverpool.ac.uk
FU National Institutes of Child Health and Development/Gates Foundation;
   NIH Office of Dietary Supplements (NICHD) [NIH-1U01HD061234-01A1]
FX We wish to acknowledge the financial support of the National Institutes
   of Child Health and Development/Gates Foundation, and the NIH Office of
   Dietary Supplements for support for the periconceptional trial 'Malaria
   risk prior to and during early pregnancy in nulliparous women receiving
   long-term weekly iron and folic acid supplementation (WIFS): a
   non-inferiority randomised controlled trial' (PALUFER) (NICHD grant
   number NIH-1U01HD061234-01A1). We are grateful to Raffaella Ravinetto
   and Celine Schurmans of the Clinical Trials Unit, Institute of Tropical
   Medicine, Antwerp and Isidore Traore for their efforts on trial
   monitoring activities.
CR Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027
   Allen LH, 2009, FOOD NUTR BULL, V30, pS527
   Azzi S, 2014, EPIGENETICS-US, V9, P338, DOI 10.4161/epi.27387
   Bazer FW, 2012, ANN NY ACAD SCI, V1271, P88, DOI 10.1111/j.1749-6632.2012.06741.x
   Beard JL, 2000, AM J CLIN NUTR, V71, p1288S
   Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108
   Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001
   Berti C, 2011, CLIN NUTR, V30, P689, DOI 10.1016/j.clnu.2011.08.004
   Bhutta ZA, 2012, PAEDIATR PERINAT EP, V26, P27, DOI 10.1111/j.1365-3016.2012.01313.x
   Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019
   Brabin BJ, 2003, TRENDS PARASITOL, V19, P39, DOI 10.1016/S1471-4922(02)00004-1
   Brabin L, 2013, NUTR REV, V71, P528, DOI 10.1111/nure.12049
   Brik M, 2011, EUR J OBSTET GYN R B, V155, P14, DOI 10.1016/j.ejogrb.2010.11.001
   Buhling KJ, 2013, CURR OPIN OBSTET GYN, V25, P173, DOI 10.1097/GCO.0b013e3283609138
   Caselli G., 2006, DEMOGRAPHY ANAL SYNT
   Catalano PM, 1998, DIABETES CARE, V21, pB85
   Catov JM, 2011, AM J CLIN NUTR, V94, P906, DOI 10.3945/ajcn.111.012393
   Cetin I, 2010, HUM REPROD UPDATE, V16, P80, DOI 10.1093/humupd/dmp025
   Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006
   Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012
   Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006
   CHAOUKI ML, 1994, EUR J ENDOCRINOL, V130, P547
   Chappell LC, 1999, LANCET, V354, P810
   Chow SC, 2003, DESIGN ANAL CLIN TRI
   Cogswell ME, 2003, AM J CLIN NUTR, V78, P773
   Compaore A, 2014, MATERN CHILD HLTH J, V18, P1976, DOI 10.1007/s10995-014-1443-x
   Conde-Agudelo A, 2013, BJOG-INT J OBSTET GY, V120, P681, DOI 10.1111/1471-0528.12172
   Conde-Agudelo A, 2011, BJOG-INT J OBSTET GY, V118, P1042, DOI 10.1111/j.1471-0528.2011.02923.x
   Connor KL, 2009, REPROD SCI, V16, P1201, DOI 10.1177/1933719109345162
   Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708
   Cross JC, 2006, NUTR REV, V64, p[S12, S72]
   Cupedo T, 2005, EUR J IMMUNOL, V35, P383, DOI 10.1002/eji.200425763
   CZEIZEL AE, 1992, ARCH GYNECOL OBSTET, V251, P181, DOI 10.1007/BF02718384
   CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602
   De-Regil LM, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007950.pub2, DOI 10.1002/14651858.CD007950.PUB2]]
   Carmel R, 2001, HOMOCYSTEINE HLTH DI
   Fowden AL, 2014, PLACENTA
   Gambling L, 2003, J NUTR, V133, P1554
   Garland SM, 2002, J REPROD IMMUNOL, V57, P169, DOI 10.1016/S0165-0378(02)00018-9
   Godfrey KM, 2000, AM J CLIN NUTR, V71, P1344
   GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206
   Groenen PMW, 2004, J NUTR, V134, P1516
   Gulati R, 2009, EUR J CLIN NUTR, V63, P970, DOI 10.1038/ejcn.2009.11
   Haider BA, 2011, BMC PUBLIC HLTH S3, V13, pS19
   Hambidge KM, 2014, BMC PREGNANCY CHILDB, V14, P11
   Hartwig IRV, 2013, HUM REPROD, V28, P77, DOI 10.1093/humrep/des367
   Heerman WJ, 2014, ACAD PEDIATR, V14, P463, DOI 10.1016/j.acap.2014.05.005
   Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1
   Hodgetts VA, 2015, BJOG-INT J OBSTET GY, V122, P478, DOI 10.1111/1471-0528.13202
   Imdad A, 2011, BMC PUBLIC HEALTH, V11, pS17, DOI DOI 10.1186/1471-2458-11-S3-S17
   Jackson AA, 2000, ADV EXP MED BIOL, V478, P41
   Jonker FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042670
   Kadyrov M, 1998, LANCET, V352, P1747
   Kalanda BF, 2006, ACTA OBSTET GYN SCAN, V85, P33, DOI 10.1080/00016340500334869
   Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382
   Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073
   Khambalia AZ, 2009, AM J CLIN NUTR, V90, P1295, DOI 10.3945/ajcn.2009.28350
   Khong T Yee, 2004, Semin Neonatol, V9, P255, DOI 10.1016/j.siny.2003.11.010
   KIRKE PN, 1992, ARCH DIS CHILD, V67, P1442
   Korevaar TIM, 2014, J CLIN ENDOCR METAB, V99, pE1627, DOI 10.1210/jc.2014-1884
   Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2
   Kuchinke W, 2006, METHOD INFORM MED, V45, P441
   Kweider N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047055
   Langley-Evans SC, 2009, J ANAT, V215, P36, DOI 10.1111/j.1469-7580.2008.00977.x
   LAURENCE KM, 1981, BRIT MED J, V282, P1509
   Lawlor DA, 2006, ANN EPIDEMIOL, V16, P19, DOI 10.1016/j.annepidem.2005.04.006
   Lawlor DA, 2012, NAT REV ENDOCRINOL, V11, P679
   Lawlor DA, 2013, INT J EPIDEMIOL, V42, P7, DOI 10.1093/ije/dys209
   LONNERDAL B, 1986, J NUTR, V116, P499
   Lynch SR, 2000, J NUTR, V130, p448S
   Magnusardottir AR, 2009, ACTA OBSTET GYN SCAN, V88, P91, DOI 10.1080/00016340802616914
   Maitre L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-110
   McArdle HJ, 2014, P NUTR SOC, V73, P9, DOI 10.1017/S0029665113003637
   McArdle HJ, 1999, BRIT MED BULL, V55, P499, DOI 10.1258/0007142991902574
   MCPARTLIN J, 1993, LANCET, V341, P148, DOI 10.1016/0140-6736(93)90007-4
   Mihaila C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017483
   MILLER HC, 1989, YALE J BIOL MED, V62, P241
   Mistry HD, 2015, FREE RADICAL BIO MED, V78, P147, DOI 10.1016/j.freeradbiomed.2014.10.580
   Morken NH, 2006, AM J OBSTET GYNECOL, V195, P154, DOI 10.1016/j.ajog.2006.01.019
   Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050
   Nguyen PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-898
   Owens S, 2015, AM J CLIN NUTR, V102, P1450, DOI 10.3945/ajcn.113.072413
   Payne PRO, 2010, APPL CLIN INFORM, V12, P177
   Pena-Rosas J, 2012, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858.CD004736.pub4, DOI 10.1002/14651858.CD004736.PUB4]
   Viteri FE, 2012, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD009997
   Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061
   PHAROAH POD, 1971, LANCET, V1, P308
   Poston LN, 2011, AM J CLIN NUTR, V94, P1980, DOI DOI 10.3945/AJCN.110.001156
   Raiten D, 2009, CONSIDERATIONS SAFE
   Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P153, DOI 10.1111/j.1365-3016.2012.01276.x
   Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x
   Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006
   Ronnenberg AG, 2004, J NUTR, V134, P2586
   Ronsmans C, 2009, FOOD NUTR BULL, V30, pS547
   Shrier I, 2014, CLIN TRIALS, V11, P28, DOI 10.1177/1740774513504151
   Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011
   Davey Smith G, 2009, ADV EXP MED BIOL, V646, P1, DOI DOI 10.1007/978-1-4020-9173-5_1
   SMITHELLS RW, 1980, LANCET, V1, P339
   Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a
   Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x
   Strickland KC, 2013, CLIN CHEM LAB MED, V51, P607, DOI 10.1515/cclm-2012-0561
   Swali A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023189
   Tang RB, 2015, HYPERTENS PREGNANCY, V34, P181, DOI 10.3109/10641955.2014.988353
   Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854
   Thomas IM, 2000, INDIAN J MED RES, V112, P206
   Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002
   Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994
   van Rheenen P, 2013, PAEDIATR INT CHILD H, V33, P57, DOI 10.1179/2046905513Y.0000000059
   VERGEL RG, 1990, PRENATAL DIAG, V10, P149, DOI 10.1002/pd.1970100303
   Vickers AJ, 2001, BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123
   WALD N, 1991, LANCET, V338, P131
   Wang XD, 2014, BLOOD, V124, P946, DOI 10.1182/blood-2013-11-539718
   Wang YF, 2013, BIOMED ENVIRON SCI, V26, P23, DOI 10.3967/0895-3988.2013.01.003
   West KP, 2014, JAMA-J AM MED ASSOC, V312, P2649, DOI 10.1001/jama.2014.16819
   West KP, 1999, BRIT MED J, V318, P570
   Wortelboer EJ, 2011, ULTRASOUND OBST GYN, V38, P383, DOI 10.1002/uog.9029
   Wu GY, 2012, PAEDIATR PERINAT EP, V26, P4, DOI 10.1111/j.1365-3016.2012.01291.x
   Zheng XY, 2015, PAEDIATR PERINAT EP, V29, P299, DOI 10.1111/ppe.12192
   Zhou SJ, 2013, AM J CLIN NUTR, V98, P1241, DOI 10.3945/ajcn.113.065854
NR 119
TC 0
Z9 0
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD JAN 30
PY 2016
VL 17
AR 58
DI 10.1186/s13063-015-1124-0
PG 24
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DC3SN
UT WOS:000369139200001
PM 26833080
OA gold
DA 2017-08-15
ER

PT J
AU Williams, J
   Njie, F
   Cairns, M
   Bojang, K
   Coulibaly, SO
   Kayentao, K
   Abubakar, I
   Akor, F
   Mohammed, K
   Bationo, R
   Dabira, E
   Soulama, A
   Djimde, M
   Guirou, E
   Awine, T
   Quaye, SL
   Ordi, J
   Doumbo, O
   Hodgson, A
   Oduro, A
   Magnussen, P
   ter Kuile, FO
   Woukeu, A
   Milligan, P
   Tagbor, H
   Greenwood, B
   Chandramohan, D
AF Williams, John
   Njie, Fanta
   Cairns, Matthew
   Bojang, Kalifa
   Coulibaly, Sheick Oumar
   Kayentao, Kassoum
   Abubakar, Ismaela
   Akor, Francis
   Mohammed, Khalifa
   Bationo, Richard
   Dabira, Edgar
   Soulama, Alamissa
   Djimde, Moussa
   Guirou, Etienne
   Awine, Timothy
   Quaye, Stephen L.
   Ordi, Jaume
   Doumbo, Ogobara
   Hodgson, Abraham
   Oduro, Abraham
   Magnussen, Pascal
   ter Kuile, Feiko O.
   Woukeu, Arouna
   Milligan, Paul
   Tagbor, Harry
   Greenwood, Brian
   Chandramohan, Daniel
TI Non-falciparum malaria infections in pregnant women in West Africa
SO MALARIA JOURNAL
LA English
DT Article
DE Non falciparum malaria; Pregnancy; Africa
ID PLASMODIUM-VIVAX MALARIA; OVALE; EPIDEMIOLOGY; BURDEN
AB Background: Non-Plasmodium falciparum malaria infections are found in many parts of sub-Saharan Africa but little is known about their importance in pregnancy.
   Methods: Blood samples were collected at first antenatal clinic attendance from 2526 women enrolled in a trial of intermittent screening and treatment of malaria in pregnancy (ISTp) versus intermittent preventive treatment (IPTp) conducted in Burkina Faso, The Gambia, Ghana and Mali. DNA was extracted from blood spots and tested for P. falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale using a nested PCR test. Risk factors for a non-falciparum malaria infection were investigated and the influence of these infections on the outcome of pregnancy was determined.
   Results: P. falciparum infection was detected frequently (overall prevalence by PCR: 38.8 %, [95 % CI 37.0, 40.8]), with a prevalence ranging from 10.8 % in The Gambia to 56.1 % in Ghana. Non-falciparum malaria infections were found only rarely (overall prevalence 1.39 % [95 % CI 1.00, 1.92]), ranging from 0.17 % in the Gambia to 3.81 % in Mali. Ten non-falciparum mono-infections and 25 mixed falciparum and non-falciparum infections were found. P. malariae was the most frequent non-falciparum infection identified; P. vivax was detected only in Mali. Only four of the non-falciparum mono-infections were detected by microscopy or rapid diagnostic test. Recruitment during the late rainy season and low socio-economic status were associated with an increased risk of non-falciparum malaria as well as falciparum malaria. The outcome of pregnancy did not differ between women with a non-falciparum malaria infection and those who were not infected with malaria at first ANC attendance.
   Conclusions: Non-falciparum infections were infrequent in the populations studied, rarely detected when present as a mono-infection and unlikely to have had an important impact on the outcome of pregnancy in the communities studied due to the small number of women infected with non-falciparum parasites.
C1 [Williams, John; Awine, Timothy; Quaye, Stephen L.; Hodgson, Abraham; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Njie, Fanta; Bojang, Kalifa; Akor, Francis; Mohammed, Khalifa] MRC Unit, Fajara, Gambia.
   [Cairns, Matthew; Abubakar, Ismaela; Woukeu, Arouna; Milligan, Paul; Greenwood, Brian; Chandramohan, Daniel] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Bationo, Richard; Dabira, Edgar; Soulama, Alamissa] Univ Ouagadougou, Fac Hlth Sci, Ouagadougou, Burkina Faso.
   [Kayentao, Kassoum; Djimde, Moussa; Guirou, Etienne; Doumbo, Ogobara] Univ Sci Tech & Technol, Fac Med & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali.
   [Ordi, Jaume] Univ Barcelona, Hosp Clin, Dept Pathol, JSGlobal,Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Magnussen, Pascal] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.
   [Magnussen, Pascal] Univ Copenhagen, Inst Vet Dis Biol, Copenhagen, Denmark.
   [ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana.
RP Chandramohan, D (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM daniel.chandramohan@lshtm.ac.uk
RI Milligan, Paul/D-8985-2017
OI Milligan, Paul/0000-0003-3430-3395; ter Kuile,
   Feiko/0000-0003-3663-5617; Guirou, Etienne A./0000-0002-8576-328X
FU Ministries of Health; European Developing Country Clinical Trials
   Programme [IP.2007.31080.003]; Malaria in Pregnancy Consortium through
   Bill and Melinda Gates Foundation; UK Medical Research Council (MRC); UK
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement
FX We thank the women who participated in the trial, the many field,
   laboratory and data management staff at each of the trial sites who
   contributed to its successful outcome and the Ministries of Health which
   supported this study. We thank Manuela Claite for her administrative
   support for the trial. We also thank members of the Data Safety and
   Monitoring Board (Prof. GAT Targett [chair]; Dr. GA Quansah-Asare, Prof.
   F Little, Prof. O Nyan, Dr. C Ouedraogo and Prof. S Sow). Raouf Osseni
   and Adama Gansane were the trial's clinical monitors. High quality
   placental histology slides were prepared by the staff of the Department
   of Pathology, Korle Bu Hospital, Accra, Ghana. We thank Professors Steve
   Meshnik, Steve Taylor and Colin Sutherland for assistance with the PCR
   assays and Dr Maria Ruperez for helpful comments on the paper. The study
   was funded by the European Developing Country Clinical Trials Programme
   (Grant Number IP.2007.31080.003) and by the Malaria in Pregnancy
   Consortium which is funded through a grant from the Bill and Melinda
   Gates Foundation to the Liverpool School of Tropical Medicine. MC is
   supported by a fellowship jointly funded the UK Medical Research Council
   (MRC) and the UK Department for International Development (DFID) under
   the MRC/DFID Concordat agreement.
CR Bernabeu M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-405
   Brutus L, 2013, EMERG INFECT DIS, V19, P1605, DOI 10.3201/eid1910.130308
   Coldren RL, 2007, AM J TROP MED HYG, V77, P992
   Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Dhorda M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019801
   Doderer-Lang C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-240
   Fru-Cho J, 2014, MALARIA J, V13, P179
   Mockenhaupt Frank P., 2001, American Journal of Tropical Medicine and Hygiene, V64, P6
   Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878
   Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2
   Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2
   Rodriguez-Morales AJ, 2006, AM J TROP MED HYG, V74, P755
   Roucher C, 2014, PLOS ONE, V10
   Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567
   Souza RM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002071
   Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240
   Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223
   Tagbor H, 2015, PLOS ONE, V10, pe137
   ter Kuile FO, 2008, CLIN INFECT DIS, V46, P1382, DOI 10.1086/586744
   Walker-Abbey A, 2005, AM J TROP MED HYG, V72, P229
   Williams JE, 2015, CLIN INFECT IN PRESS
NR 22
TC 4
Z9 4
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JAN 29
PY 2016
VL 15
AR 53
DI 10.1186/s12936-016-1092-1
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DC0VW
UT WOS:000368937000004
PM 26823277
OA gold
DA 2017-08-15
ER

PT J
AU Le Doare, K
   Taylor, S
   Allen, L
   Gorringe, A
   Heath, PT
   Kampmann, B
   Hesseling, AC
   Jones, CE
AF Le Doare, Kirsty
   Taylor, Stephen
   Allen, Lauren
   Gorringe, Andrew
   Heath, Paul T.
   Kampmann, Beate
   Hesseling, Anneke C.
   Jones, Christine E.
TI Placental transfer of anti-group B Streptococcus immunoglobulin G
   antibody subclasses from HIV-infected and uninfected women to their
   uninfected infants
SO AIDS
LA English
DT Article
DE antibody; group B Streptococcus; HIV
ID IMMUNODEFICIENCY-VIRUS-INFECTION; IGG SUBCLASS; CONJUGATE VACCINE;
   HYPERGAMMAGLOBULINEMIA; POLYSACCHARIDE; TRANSPORT
AB Objectives:Placental antibody transfer is impaired in the context of HIV infection, which may render HIV-exposed, uninfected infants vulnerable to group B Streptococcus (GBS) disease. The GBS antibody response predominately consists of immunoglobulin G2 (IgG2) antibody. Thus we determined whether concentration and placental transfer of anti-GBS antibody subclasses was altered in HIV-infected compared with HIV-uninfected mothers.
   Design:A retrospective analysis of anti-GBS antibody subclasses in 38 HIV-infected and 33 HIV-uninfected mothers and their uninfected infants.
   Methods:Sera were analysed using a novel flow cytometric assay that quantified binding of IgG1, IgG2, IgG3 and IgG4 to serotype (ST)Ia, STIII and STV GBS bacteria.
   Results:IgG2 binding to GBS STIa and V was lower in HIV-infected women compared with HIV-uninfected women. Moreover, IgG2 binding to GBS STIa was also lower in HIV-exposed, uninfected infants compared with unexposed infants. However, there were no statistically significant differences in the transplacental transfer ratio of IgG2 for any GBS serotype. The transplacental transfer of total IgG was reduced for GBS STIII and V and IgG1 subclass for STIII; placental transfer of all other subclasses was comparable in HIV-affected and HIV-unaffected pregnancies.
   Conclusion:Anti-GBS IgG2 placental transfer is not affected by HIV infection. This is important for functional antibody against the capsular polysaccharide of GBS and provides confidence that maternal GBS vaccination may result in functional activity in HIV-infected and uninfected women. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Le Doare, Kirsty; Kampmann, Beate; Jones, Christine E.] Univ London Imperial Coll Sci Technol & Med, Ctr Int Child Hlth, London, England.
   [Le Doare, Kirsty; Kampmann, Beate; Jones, Christine E.] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London, England.
   [Le Doare, Kirsty; Heath, Paul T.; Jones, Christine E.] Univ London, Inst Infect & Immun St Georges, Paediat Infect Dis Res Grp, London, England.
   [Le Doare, Kirsty; Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
   [Taylor, Stephen; Allen, Lauren; Gorringe, Andrew] Publ Hlth England, Salisbury, Wilts, England.
   [Hesseling, Anneke C.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Pediat & Child Hlth, Cape Town, South Africa.
   [Jones, Christine E.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.
RP Le Doare, K (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Ctr Int Child Hlth, Norfolk Pl, London W2 1PG, England.
EM k.mehring-le-doare@imperial.ac.uk
FU Wellcome Trust Clinical Research Training Fellowship [KLD2013]; Thomas
   Watt Eden Fellowship (Royal College of Physicians) [01012013];
   Gilead/BHIVA Registrar Award; MRC [MR/K007602/1, MC_UP_A900/1122];
   European Society for Pediatric Infectious Diseases; Thrasher Research
   Fund
FX Funding: K.L.D. is supported by a Wellcome Trust Clinical Research
   Training Fellowship (KLD2013) The Thomas Watt Eden Fellowship (Royal
   College of Physicians Grant Number 01012013); and the Gilead/BHIVA
   Registrar Award. B.K. is supported by the MRC (MR/K007602/1,
   MC_UP_A900/1122). C.J. was supported by the European Society for
   Pediatric Infectious Diseases and the Thrasher Research Fund.
CR BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404
   BAKER CJ, 1980, AM J OBSTET GYNECOL, V137, P39
   Bamford A, 2015, CLIN EXP IMMUNOL, V181, P110, DOI 10.1111/cei.12618
   Bamford A, 2014, AIDS, V28, P2033, DOI 10.1097/QAD.0000000000000385
   BOYER KM, 1984, J PEDIATR-US, V104, P618, DOI 10.1016/S0022-3476(84)80564-8
   deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077
   EINHORN MS, 1987, J PEDIATR-US, V111, P783, DOI 10.1016/S0022-3476(87)80268-8
   Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183
   FERRANTE A, 1990, PEDIATR INFECT DIS J, V9, pS16
   GIVNER LB, 1987, J INFECT DIS, V155, P532
   Hosmalin A, 2006, J LEUKOCYTE BIOL, V80, P984, DOI 10.1189/jlb.0306154
   Jones CE, 2014, AIDS IN PRESS
   Jones CE, 2015, AIDS, V29, P155, DOI 10.1097/QAD.0000000000000536
   KAWANO Y, 1994, J IMMUNOL, V153, P4948
   Kwatra G, 2015, CLIN MICROBIOL INFEC, V21, pe13, DOI DOI 10.1016/J.CMI.2015.01.030
   Kwatra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098778
   Le Doare K, 2015, VACCINE, V33, P621, DOI 10.1016/j.vaccine.2014.12.025
   Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756
   Madzivhandila M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017861
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59
   REIMER CB, 1988, MONOGR ALLERGY, V23, P83
   Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
   WEISS PJ, 1995, J INFECT DIS, V171, P1217
NR 24
TC 5
Z9 5
U1 2
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JAN 28
PY 2016
VL 30
IS 3
BP 471
EP 475
DI 10.1097/QAD.0000000000000923
PG 5
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA DC6CD
UT WOS:000369306500002
PM 26760235
OA No
DA 2017-08-15
ER

PT J
AU Ashu, EE
   Jarju, S
   Dione, M
   Mackenzie, G
   Ikumapayi, UN
   Manjang, A
   Azuine, R
   Antonio, M
AF Ashu, Eta E.
   Jarju, Sheikh
   Dione, Michel
   Mackenzie, Grant
   Ikumapayi, Usman N.
   Manjang, Ahmed
   Azuine, Romuladus
   Antonio, Martin
TI Population structure, epidemiology and antibiotic resistance patterns of
   Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine
   introduction in Eastern Gambia
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE S. pneumoniae; Serotype 5; ST 3404; Population Structure; The Gambia;
   PCV-13
ID INVASIVE PNEUMOCOCCAL DISEASE; SEQUENTIAL MULTIPLEX PCR; RISK-FACTORS;
   WEST-AFRICA; CHILDREN; GENOME; MENINGITIS; CARRIAGE
AB Background: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive pneumococcal disease (IPD) in The Gambia. We anticipate that introduction of the 13-valent pneumococcal conjugate vaccine (PCV-13) into routine vaccination in The Gambia will reduce serotype 5 IPD. However, the emergence of new clones that have altered their genetic repertoire through capsular switching or genetic recombination after vaccination with PCV-13 poses a threat to this public health effort. In order to monitor for potential genetic changes post-PCV-13 vaccination, we established the baseline population structure, epidemiology, and antibiotic resistance patterns of serotype 5 before the introduction of PCV-13.
   Methods: Fifty-five invasive S. pneumoniae serotype 5 isolates were recovered from January 2009 to August 2011 in a population-based study in the Upper River Region of The Gambia. Serotyping was done by latex agglutination and confirmed by serotype-specific Polymerase Chain Reaction (PCR). Genotyping was undertaken using Multilocus Sequence Typing (MLST). Antimicrobial sensitivity was done using disc diffusion. Contingency table analyses were conducted using Pearson's Chi(2) and Fisher's exact test. Clustering was performed using Bionumerics version 6.5.
   Results: MLST resolved S. pneumoniae serotype 5 isolates into 3 sequence types (ST), namely ST 289(6/55), ST 3339(19/55) and ST 3404(30/55). ST 289 was identified as the major clonal complex. ST 3339, the prevalent genotype in 2009 [84.6 % (11/13)], was replaced by ST 3404 [70.4 % (19/27)] in 2010 as the dominant ST. Interestingly, ST 3404 showed lower resistance to tetracycline and oxacillin (P < 0.001), an empirical surrogate to penicillin in The Gambia.
   Conclusions: There has been an emergence of ST 3404 in The Gambia prior to the introduction of PCV-13. Our findings provide important background data for future assessment of the impact of PCV-13 into routine immunization in developing countries, such as The Gambia.
C1 [Ashu, Eta E.] McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.
   [Ashu, Eta E.; Jarju, Sheikh; Dione, Michel; Mackenzie, Grant; Ikumapayi, Usman N.; Manjang, Ahmed; Antonio, Martin] MRC Unit, POB 273, Fajara, Gambia.
   [Manjang, Ahmed] King Fahad Med City, Central 11525, Saudi Arabia.
   [Azuine, Romuladus] Ctr Global Hlth & Hlth Policy, Global Hlth & Educ Projects, POB 234, Riverdale, MD 20738 USA.
RP Ashu, EE (reprint author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.; Ashu, EE (reprint author), MRC Unit, POB 273, Fajara, Gambia.
EM ashuebasi@yahoo.com
CR Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415
   Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x
   Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81
   Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198
   Antonio M, 2009, J MED MICROBIOL, V58, P296, DOI 10.1099/jmm.0.006031-0
   Arason VA, 1996, BRIT MED J, V313, P387
   Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869
   Diekema DJ, 2000, EMERG INFECT DIS, V6, P552
   Donkor ES, 2011, MBIO, V2, DOI 10.1128/mBio.00040-11
   Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390
   Enright MC, 1999, MOL BIOL EVOL, V16, P1687
   Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152
   Jette LP, 1999, J CLIN MICROBIOL, V37, P1178
   Klugman KP, 2001, CLIN INFECT DIS, V33, P489, DOI 10.1086/322736
   Manninen R, 1998, J ANTIMICROB CHEMOTH, V41, P19, DOI 10.1093/jac/41.1.19
   Melander E, 1998, EUR J CLIN MICROBIOL, V17, P834, DOI 10.1007/s100960050202
   Molesworth AM, 2002, LANCET, V359, P81, DOI 10.1016/S0140-6736(02)07304-X
   Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1
   Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06
   Ouml;rtqvist A, 2005, SEMIN RESP CRIT CARE, V26, P563, DOI 10.1055/s-2005-925523
   Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006
   Pillai DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-642
   Pradier C, 1997, EUR J CLIN MICROBIOL, V16, P644, DOI 10.1007/BF01708553
   Roper DI, 2000, P NATL ACAD SCI USA, V97, P8921, DOI 10.1073/pnas.150116497
   Ryan KJ, 2004, MED MICROBIOLOGY INT, P273
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006
   Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217
   Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006
   van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4
NR 30
TC 0
Z9 0
U1 1
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 28
PY 2016
VL 16
AR 33
DI 10.1186/s12879-016-1370-0
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DC6XT
UT WOS:000369363600001
PM 26822883
OA gold
DA 2017-08-15
ER

PT J
AU Ekwochi, U
   Osuorah, CDI
   Ndu, IK
   Ifediora, C
   Asinobi, IN
   Eke, CB
AF Ekwochi, Uchenna
   Osuorah, Chidiebere D. I.
   Ndu, Ikenna K.
   Ifediora, Christian
   Asinobi, Isaac Nwabueze
   Eke, Christopher Bismark
TI Food taboos and myths in South Eastern Nigeria: The belief and practice
   of mothers in the region
SO JOURNAL OF ETHNOBIOLOGY AND ETHNOMEDICINE
LA English
DT Article
DE Food taboos; Pregnancy; Under-two years; Enugu
ID CHILDREN
AB Background: Poor nutritional practices especially in pregnancy and early childhood can result in dire consequences in the growth and development of a child.
   Methods: This study using purposive sampling enrolled 149 women who had carried at least one pregnancy to term in Enugu south east Nigeria. Logistic regression analysis was used to assess association between avoidance of certain food in pregnancy and selected socio-demographic factors.
   Results: Approximately 37 % of respondents avoided some foods in pregnancy due to food taboos and no relationship was seen between this avoidance of food and maternal educational attainment, parity (number of obstetrics deliveries) and occupation. Snail and grass-cutter meat were the commonly avoided food in pregnancy while egg were commonly avoided in children under-two years old. Some respondent believed eating snail and grass-cutter meat makes a child sluggish and labour difficult respectively while starting egg early for a child could predispose them to stealing later in life.
   Conclusion: Discussion about food taboos during antenatal care visits and during community education can help reduce the traditional belief about certain food in pregnancy and early childhood.
C1 [Ekwochi, Uchenna; Ndu, Ikenna K.; Asinobi, Isaac Nwabueze] Enugu State Univ Sci & Technol, Dept Paediat, Enugu, Enugu State, Nigeria.
   [Osuorah, Chidiebere D. I.] Med Res Council UK, Gambia Unit, Child Survival Unit, Fajara, Gambia.
   [Ifediora, Christian] Griffiths Univ, Sch Med, Gold Coast, Australia.
   [Eke, Christopher Bismark] Univ Nigeria, Dept Paediat, Coll Med, Nsukka, Enugu State, Nigeria.
RP Osuorah, CDI (reprint author), Med Res Council UK, Gambia Unit, Child Survival Unit, Fajara, Gambia.
EM chidi.osuorah@yahoo.com
OI Ifediora, Chris/0000-0002-9194-1740
CR Abubakar A, 2011, RURAL REMOTE HEALTH, V11
   Arzoaquoi S. K., 2014, COMMON FOOD TABOOS B
   Ashworth A, 1998, EUR J CLIN NUTR, V52, pS34
   Baker D. J., 1998, MOTHERS BABIES HLTH
   Barfield T., 1997, DICT ANTHR
   Poston FE, EFFECT FOOD TABOO PR
   Bentley GR, 1999, SOC SCI MED, V48, P149, DOI 10.1016/S0277-9536(98)00330-X
   Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1016/S0033-3549(04)50253-4
   Betancourt J. R., 2002, CULTURAL COMPETENCE, V576
   Cobbinah JR, 2008, SNAIL FARMING PRODUC
   Colding J., 1997, ECOLOGY SOC, V1, P1
   Richard A, 1994, ONE MANS FOOD IS SOM
   Fagbuaro O, 2006, J Zhejiang Univ Sci B, V7, P686, DOI 10.1631/jzus.2006.B0686
   Fikentscher W, 2004, MODES THOUGHT STUDY
   Ihara E., 2004, CULTURAL COMPETENCE
   JORI F, 1995, BIODIVERS CONSERV, V4, P257, DOI 10.1007/BF00055972
   Maduforo AN, 2010, J RES NATL DEV, V8, P1
   Nigerian Population Commission, STAT LOC GOV DEM PRO
   Ninuk T., 2005, SOC SCI MED, V61, P199, DOI DOI 10.1016/J.SOCSCIMED.2004.11.043
   OGBEIDE O, 1974, AM J CLIN NUTR, V27, P213
   Olusanya O, 1985, W AFR J MED, V4, P205
   Oni O. A., 2012, African Journal of Reproductive Health, V16, P67
   Garcia AP, 2013, J ANTHR, V2013, DOI [10.1155/2013/873612, DOI 10.1155/2013/873612]
   Santos-Torres MI, 2003, J HEALTH POPUL NUTR, V21, P142
   United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH
   UNICEF, 1990, STRAT IMPR NUTR CHIL
   World Health Organization, 2010, CHILD GROWTH STAND I
   Zepro Nejimu Biza, 2015, SCI J PUBLIC HLTH, V3, P410
NR 28
TC 2
Z9 2
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-4269
J9 J ETHNOBIOL ETHNOMED
JI J. Ethnobiol. Ethnomed.
PD JAN 27
PY 2016
VL 12
AR 7
DI 10.1186/s13002-016-0079-x
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DB7ZI
UT WOS:000368735800001
PM 26818243
OA gold
DA 2017-08-15
ER

PT J
AU Okebe, J
   Mwesigwa, J
   Agbla, SC
   Sanya-Isijola, F
   Abubakar, I
   D'Alessandro, U
   Jaye, A
   Bojang, K
AF Okebe, Joseph
   Mwesigwa, Julia
   Agbla, Schadrac C.
   Sanya-Isijola, Frank
   Abubakar, Ismaela
   D'Alessandro, Umberto
   Jaye, Assan
   Bojang, Kalifa
TI Seasonal variation in haematological and biochemical reference values
   for healthy young children in The Gambia
SO BMC PEDIATRICS
LA English
DT Article
DE Reference values; Seasonality; Malaria; Haematological; Biochemical;
   Children
ID GROWTH STANDARDS; WEST-AFRICA; DISEASES; MALARIA
AB Background: Haematological and biochemistry reference values for children are important for interpreting clinical and research results however, differences in demography and environment poses a challenge when comparing results. The study defines reference intervals for haematological and biochemistry parameters and examines the effect of seasonality in malaria transmission.
   Methods: Blood samples collected from clinically healthy children, aged 12-59 months, in two surveys during the dry and wet season in the Upper River region of The Gambia were processed and the data analysed to generate reference intervals based on the 2.5(th) and 97.5(th) percentiles of the data.
   Results: Analysis was based on data from 1141 children with median age of 32 months. The mean values for the total white cell count and differentials; lymphocyte, monocyte and neutrophil decreased with increasing age, were lower in males and higher in the wet season survey. However, platelet values declined with age (p < 0.0001). There was no evidence of effect of gender on mean values of AST, ALT, lymphocytes, monocytes, platelets and haemoglobin.
   Conclusion: Mean estimates for haematological and biochemistry reference intervals are affected by age and seasonality in the first five years of life. This consistency is important for harmonisation of reference values for clinical care and interpretation of trial results.
C1 [Okebe, Joseph; Mwesigwa, Julia; Agbla, Schadrac C.; Sanya-Isijola, Frank; Abubakar, Ismaela; D'Alessandro, Umberto; Jaye, Assan; Bojang, Kalifa] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
RP Okebe, J (reprint author), MRC Unit, Fajara, Gambia.
EM jokebe@mrc.gm
OI Bojang, Kalifa/0000-0001-7506-0938
FU European and Developing Countries Clinical Trial Partnership (EDCPT)
   grant
FX This study was funded by the European and Developing Countries Clinical
   Trial Partnership (EDCPT) grant to West African Network of Excellence
   for TB, AIDS and Malaria (WANETAM) consortium. The funders did not have
   any input on the study design of preparation of the manuscript.
CR Adetifa IMO, 2009, INT J LAB HEMATOL, V31, P615, DOI 10.1111/j.1751-553X.2008.01087.x
   Akingbola T S, 2006, J Obstet Gynaecol, V26, P763
   BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133
   Buchanan AM, 2010, TROP MED INT HEALTH, V15, P1011, DOI 10.1111/j.1365-3156.2010.02585.x
   Buseri FI, 2010, PATHOLOGY LAB MED IN, V2, P65
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39
   Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   de Onis M, 2015, WORLD REV NUTR DIET, V113, P278, DOI 10.1159/000360352
   Dosoo DK, 2014, AM J TROP MED HYG, V90, P767, DOI 10.4269/ajtmh.13-0098
   Sasse Edward A, 2000, C28A2 NCCLS
   Horn PS, 2002, CLIN CHEM, V48, P1802
   Kueviakoe I. M., 2011, ISRN HEMATOL, V2011
   Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568
   Man WDC, 1998, TROP MED INT HEALTH, V3, P678
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   Odutola AA, 2014, TROP MED INT HEALTH, V19, P275, DOI 10.1111/tmi.12245
   Palacpac NMQ, 2014, INT J ENV RES PUB HE, V11, P4870, DOI 10.3390/ijerph110504870
   Quattrochi J, 2015, TROP MED INT HEALTH, V20, P941, DOI 10.1111/tmi.12490
   Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861
   Robins EB, 2007, AM J HEMATOL, V82, P611, DOI 10.1002/ajh.20848
   Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274
   SOLBERG HE, 1983, J CLIN CHEM CLIN BIO, V21, P749
   Stasinopoulos DM, 2007, J STAT SOFTW, V23, P7
NR 25
TC 1
Z9 1
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD JAN 11
PY 2016
VL 16
AR 5
DI 10.1186/s12887-016-0545-6
PG 8
WC Pediatrics
SC Pediatrics
GA DA5WC
UT WOS:000367872300003
PM 26754650
OA gold
DA 2017-08-15
ER

PT J
AU Shah, SS
   Rockett, KA
   Jallow, M
   Sisay-Joof, F
   Bojang, KA
   Pinder, M
   Jeffreys, A
   Craik, R
   Hubbart, C
   Wellems, TE
   Kwiatkowski, DP
AF Shah, Shivang S.
   Rockett, Kirk A.
   Jallow, Muminatou
   Sisay-Joof, Fatou
   Bojang, Kalifa A.
   Pinder, Margaret
   Jeffreys, Anna
   Craik, Rachel
   Hubbart, Christina
   Wellems, Thomas E.
   Kwiatkowski, Dominic P.
CA MalariaGEN Consortium
TI Heterogeneous alleles comprising G6PD deficiency trait in West Africa
   exert contrasting effects on two major clinical presentations of severe
   malaria
SO MALARIA JOURNAL
LA English
DT Article
DE G6PD deficiency; malaria
ID SICKLE-CELL TRAIT; PLASMODIUM-FALCIPARUM MALARIA;
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; X-CHROMOSOME; HUMAN
   GENOME; RESISTANCE; DEHYDROGENASE; ASSOCIATION; PROTECTION; ERYTHROCYTES
AB Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency exhibits considerable allelic heterogeneity which manifests with variable biochemical and clinical penetrance. It has long been thought that G6PD deficiency confers partial protection against severe malaria, however prior genetic association studies have disagreed with regard to the strength and specificity of a protective effect, which might reflect differences in the host genetic background, environmental influences, or in the specific clinical phenotypes considered.
   Methods: A case-control association study of severe malaria was conducted in The Gambia, a region in West Africa where there is considerable allelic heterogeneity underlying expression of G6PD deficiency trait, evaluating the three major nonsynonymous polymorphisms known to be associated with enzyme deficiency (A968G, T542A, and C202T) in a cohort of 3836 controls and 2379 severe malaria cases.
   Results: Each deficiency allele exhibited a similar trend toward protection against severe malaria overall (15-26 % reduced risk); however, in stratifying severe malaria to two of its constituent clinical subphenotypes, severe malarial anaemia (SMA) and cerebral malaria (CM), the three deficiency alleles exhibited trends of opposing effect, with risk conferred to SMA and protection with respect to CM. To assess the overall effect of G6PD deficiency trait, deficiency alleles found across all three loci were pooled. G6PD deficiency trait was found to be significantly associated with protection from severe malaria overall (OR 0.83 [0.75-0.92], P = 0.0006), but this was limited to CM (OR 0.73 [0.61-0.87], P = 0.0005), with a trend toward increased risk for SMA, especially in fully-deficient individuals (OR 1.43 [0.99-2.08], P = 0.056). Sex-stratified testing largely comported with these results, with evidence suggesting that protection by G6PD deficiency trait is conferred to both males and females, though susceptibility to SMA may be restricted to fully-deficient male hemizygotes.
   Conclusions: In a part of Africa where multiple alleles contribute to expression of G6PD deficiency trait, these findings clarify and extend previous work done in populations where a single variant predominates, and taken together suggest a causal role for G6PD deficiency trait itself with respect to severe malaria, with opposing effects seen on two major clinical subphenotypes.
C1 [Shah, Shivang S.; Rockett, Kirk A.; Jeffreys, Anna; Craik, Rachel; Hubbart, Christina; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Jallow, Muminatou; Sisay-Joof, Fatou; Bojang, Kalifa A.; Pinder, Margaret] MRC Labs, Banjul, Fajara, Gambia.
   [Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England.
   [Shah, Shivang S.; Wellems, Thomas E.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA.
RP Shah, SS (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
EM ssshah03@gmail.com
OI Kwiatkowski, Dominic/0000-0002-5023-0176
FU Wellcome Trust [077383/Z/05/Z, 090770/Z/09/Z, 075491/Z/04,
   090532/Z/09/Z]; Foundation for the National Institutes of Health as part
   of the Bill and Melinda Gates Grand Challenges in Global Health
   Initiative [566]; Medical Research Council [G0600718, G19/9]; Wellcome
   Trust Sanger Institute [077012/Z/05/Z]; Intramural Research Program of
   the National Institute of Allergy and Infectious Diseases at the
   National Institutes of Health; Medical Scientist Training Program at the
   NIH
FX We thank the all participants and communities in The Gambia who made
   this study possible and the healthcare workers who assisted with this
   work. MalariaGEN is supported by the Wellcome Trust (077383/Z/05/Z) and
   by the Foundation for the National Institutes of Health (566) as part of
   the Bill and Melinda Gates Grand Challenges in Global Health Initiative.
   The Resource Centre for Genomic Epidemiology of Malaria is supported by
   the Wellcome Trust (090770/Z/09/Z). Support was also provided by the
   Medical Research Council (G0600718). Dominic Kwiatkowski receives
   support from the Medical Research Council (G19/9). The Wellcome Trust
   also provides core awards to The Wellcome Trust Centre for Human
   Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger
   Institute (077012/Z/05/Z). This study was also supported by the
   Intramural Research Program of the National Institute of Allergy and
   Infectious Diseases at the National Institutes of Health, and Shivang
   Shah is also supported by the Medical Scientist Training Program at the
   NIH.
CR Agudelo-Florez P, 2004, AM J HEMATOL, V75, P151, DOI 10.1002/ajh.10477
   ALLISON AC, 1954, BRIT MED J, V1, P290
   ALLISON AC, 1961, BRIT MED J, V1, P1346
   Araujo CD, 2006, HAEMATOLOGICA, V91, P262
   BEUTLER E, 1991, HUM GENET, V87, P462
   BEUTLER E, 1989, BLOOD, V74, P2550
   Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3
   BEUTLER E, 1955, BRIT MED J, V1, P1189
   Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490
   BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9
   BIENZLE U, 1972, LANCET, V1, P107
   Cappadoro M, 1998, BLOOD, V92, P2527
   Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2
   CARLSON J, 1994, BLOOD, V84, P3909
   Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105
   Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8
   Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007
   FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994
   FRIEDMAN MJ, 1979, NATURE, V280, P245, DOI 10.1038/280245a0
   GALL JC, 1965, AM J HUM GENET, V17, P359
   GILLES HM, 1967, LANCET, V1, P138
   Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066
   Haldane J, 1949, P 8 INT C GEN, P267
   Jallow M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045645
   Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246
   KRUATRACHUE M, 1962, LANCET, V2, P1183
   Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519
   Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200
   Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545
   Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849
   LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839
   Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journa;.pmed.0020340
   Manjurano A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004960
   MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102
   MARTIN SK, 1979, LANCET, V1, P524
   Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002
   May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x
   May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220
   Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23
   Network MGE, 2014, NAT GENET, V46, P1197
   Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005
   PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   R Development Core Team, 2008, R LANG ENV STAT COMP
   ROTH EF, 1983, P NATL ACAD SCI-BIOL, V80, P298, DOI 10.1073/pnas.80.1.298
   RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0
   Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140
   Shah SS, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0093-6
   Shah SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00299
   Sirugo G, 2014, AM J TROP MED HYG, V90, P856, DOI 10.4269/ajtmh.13-0622
   SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202
   Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573
   Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128
   Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744
NR 54
TC 5
Z9 5
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JAN 7
PY 2016
VL 15
DI 10.1186/s12936-015-1045-0
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DA8MQ
UT WOS:000368059400001
PM 26738565
OA gold
DA 2017-08-15
ER

PT J
AU Omotosho, OF
   Ologbenla, DK
   Nnaocha, CI
AF Omotosho, Oyejide Felix
   Ologbenla, Derin K.
   Nnaocha, Cajetan I.
BE Uslu, F
TI NATIONHOOD AND THE QUEST FOR NATIONAL DEVELOPMENT: THE GAMBIA'S
   EXPERIENCE UNDER THE SECOND REPUBLIC, 1994-2015
SO SOCIOINT16: 3RD INTERNATIONAL CONFERENCE ON SOCIAL SCIENCES AND
   HUMANITIES
LA English
DT Proceedings Paper
CT 3rd International Conference on Social Sciences and Humanities
   (SOCIOINT)
CY MAY 23-25, 2016
CL Istanbul, TURKEY
DE Nation; Nationhood; National Development; The Gambia; Second Republic
   and Independence
AB The Gambia and other nations of the world are today in the tasks of nation-building, by harnessing their human, material and ecological resources and channeling them towards increased production for higher outcome and satisfactory basic needs' requirements, the very essence of development.
   This paper examines the Gambia's nationhood from 1965, when it attained independence and all efforts of national development by the two regimes so far both in first and second republics. The paper looks at the various policy-thrusts of the governments and how such have been effective to achieving sustainable development goals, through socio-economic programs and other drives that have complimented the efforts of the state to realize sustainable growth, particularly, those ones applied and actualized by the Yahya jammeh administration, 1994-2015.
   To this effect, the strategies and approaches that the latter has employed in the formulation, execution and realization of policies and plans for his visionary objectives are explored so as to decipher the basic inductive and deductive facts for objective analysis and generalized conclusions. A number of suggested standard measures are raised for the administration to tap into in furtherance of efforts to industrialize the state and make it a destination for future investors and visitors and a happy home for all Gambians and non-Gambians alike.
   This research is of the view that, although, this onerous task was begun in the first republic, but, with policies that were conservatively-constructed, placing the country to be too dependent on the outside and making it to lack rigorous development strives, thereby lagging in innovation and self-reliance and rendering the populace poor and non-vibrant. The paper argues that, with the coming of the second republic and a reversal of policy-thrust with a pragmatic approach, the economy began to be bouncing and responding to modern innovation, giving life to its citizenry and generating more vibrant, self-sustaining and reliant opportunities for them to contribute to nation-building. The paper opines that, not until this development occurred and the economy had been well-positioned under the new government, that, the Gambia began to experience genuine sustainable growth that is future guaranteeing, dependable and assuring.
C1 [Omotosho, Oyejide Felix; Nnaocha, Cajetan I.] Univ Gambia, Brikama, Gambia.
   [Ologbenla, Derin K.] Univ Lagos, Akoka, Yaba, Nigeria.
RP Omotosho, OF (reprint author), Univ Gambia, Brikama, Gambia.
EM ofomotosho@utg.edu.gm; dologbenla@unilag.edu.ng; cnnaocha@utg.edu.gm
CR Akinboye, 2007, SYSTEMCTIC APPROACH, P85
   Anifowoshe, 2005, ELEMENTS POLITICS IR, P85
   Appadorai, 1975, SUBSTANCE POLITICS, P14
   Barker, 1928, STUDY POLITICAL SCI
   Economic Commission For Africa, 2011, NAT STRAT SUST DEV A
   [Anonymous], 2012, ACT SOC COMP EC EFF
   Garner R., INTRO POLITICS
   Heywood, 2007, POLITICS PALGRAVE FD, P110
   Heywood, 2004, POLITICAL THEORY INT
   Holsti K.J., 1983, INT POLITICS FRAMEWO, P29
   Irobi, 2013, ETHNICITY NATION BUI
   Jagne, 2015, GAMBIA TAIWAN RELATI
   Laski, 1967, GRAMMAR POLITICS
   Laski, 1952, GRAMMAR POLITICS
   Maclver, 1966, MODERN STATE
   Nnaocha, 2012, NAT STAT BUILD COL G, P1
   Omotosho, 2016, THESIS
   Omotosho, 2014, ETHNICITY NATION BUI, P3
   Omotosho, 2015, NATIONHOOD QUEST NAT
   Omotosho, 2014, ELECT PROCESS GAMBIA, P4
   Renan E., 2011, QUE ST CWQ UN NAT C
   Roskin, 1994, POLITICAL SCI INTRO
   Weekend Observer, 2014, UTG LECT OM O FEL CO, V22, P6
   [Anonymous], 2015, THE VOICE NEWSPAPER, V8
   [Anonymous], 2014, BBC NEWS AFRICA
NR 25
TC 0
Z9 0
U1 0
U2 0
PU INT ORGANIZATION CENTER ACAD RESEARCH
PI ISTANBUL
PA YUNUS EMRE CAD AKASYA SK NO 22, UGUR MUMCU, ISTANBUL, KARTAL 00000,
   TURKEY
BN 978-605-64453-7-8
PY 2016
BP 472
EP 481
PG 10
WC Humanities, Multidisciplinary; Social Sciences, Interdisciplinary
SC Arts & Humanities - Other Topics; Social Sciences - Other Topics
GA BH4BB
UT WOS:000400168100059
OA No
DA 2017-08-15
ER

PT J
AU Omotosho, OF
   Ologbenla, DK
   Omotosho, OOA
AF Omotosho, Oyejide Felix
   Ologbenla, Derin K.
   Omotosho, Oluwatobiloba-Oyejide Alex
BE Uslu, F
TI THE PEOPLE OF ONDO KINGDOM AND THEIR CULTURE: A HISTORICAL SURVEY AND
   POLITICAL UNDERPINNING
SO SOCIOINT16: 3RD INTERNATIONAL CONFERENCE ON SOCIAL SCIENCES AND
   HUMANITIES
LA English
DT Proceedings Paper
CT 3rd International Conference on Social Sciences and Humanities
   (SOCIOINT)
CY MAY 23-25, 2016
CL Istanbul, TURKEY
DE Ondo People; Yoruba Tribe; Dialect; Culture
AB In every given nation, particularly in Africa, where tribal affiliations are strong, different groupings as tribes exist with their peculiar languages and dialects, and also the totality of the culture that singularly unifies and identifies them as a people. However, with the advent of colonialism, some of these tribes were scattered about and could not be found together on one location again but now mixed up there and then with different dialects and histories. The Yoruba tribe of the Western part of Nigeria is no exemption to this experience and historical distortions. The tribe comprises of different sub-groups that make it up as a people which are again strategically positioned in their respective locations in the region, up to the Republic of Benin, Togo and Ghana as history had it. Among these sub-groups are the Ondo indigenes in Ondo kingdom and the people of Ile-Oluji town-ship, who were believed to have been born by their parents as twins but were escaped out of their abode in Ile-Ife or Oyo, where twins were believed to be forbidden to be borne, by then, and if born, shouldn't be spared but slaughtered unto the gods, lest they caused misfortune to the community. They journeyed far through the forests and settled in their present locations in Ondo State South-West Nigeria, though, not without some nasty experiences and horror. As agriculturalist Ondo indigenes are, so, they are very creative, industrious, hardworking, highly educated and highly influential in the public sector. They have a rich history and culture that stands amongst the best in Yoruba land as they are believed to be the direct descendants of Oduduwa (the Yoruba Progenitor), whose own father was said to have migrated from Mecca to the present day Ile- Ife in Osun state of western Nigeria. The significance of this research is to examine the origin and etymological root of the people of Ondo Kingdom in Ondo State with a view to knowing more about them and their culture, most especially, how they came to be influential on the political landscape of their state and Nigeria as a nation. The paper employs the descriptive and analytical methodological approach in surveying this historical past, with a focus on circumstances surrounding how they came to be established as a kingdom in their present abode and how they formed a political organization akin to modern governmental practice under the paramount ruler ship of the 'Osemawe'. The paper re-appraises the distortions of facts about the people's history and descent by trying to seek the consensus reached on these, centuries ago and how scholars too attempted to juxtapose on this very argument. The paper argues that the Ondo people of Ondo-dialect speaking sub-group are genuinely aboriginal descendants of Lamurudu, the father of Oduduwa, whose settlement history and culture are empirically verifiable and not strictly mere folklores or legend, except for non-availability of proper records as at 1510, some six centuries ago.
C1 [Omotosho, Oyejide Felix; Omotosho, Oluwatobiloba-Oyejide Alex] Univ Gambia, Brikama, Gambia.
   [Ologbenla, Derin K.] Univ Lagos, Akoka, Yaba, Nigeria.
RP Omotosho, OF (reprint author), Univ Gambia, Brikama, Gambia.
EM ofomotosho@utg.edu.gm; dologbenla@unilag.edu.ng; omotoshoalex@yahoo.com
CR Abimbola W., 1977, STUDY YORUBA LIT AN
   Ajulo E. B., 2000, MEANING DIS EQUIVAL
   Babalola S. A., 1966, CONTENT FORM YORUBA
   Bascom W. R., 1965, J AM FOLKLORE, VLXXVII
   Clarke K. W., 1963, INTRO FOLKLORE
   Crowther S. A, 1852, GRAMMAR VOCABULARY Y
   Eades J. S, 1980, THE YORUBA TODAY
   Johnson Samuel, 1921, HIST YORUBAS EARLIES
   Lloyd P.C., 1962, YORUBA LAND LAW
   Olupona J. K, 1991, STOCKHOLM STUDIES CO, V28, P195
   Omotosho O. F., 2016, ARTICLE ALREADY ACCE
   [Anonymous], 1991, ARTICLE J RELIG AFRI, V22, P279, DOI 10:1163/157006692X00266
NR 12
TC 0
Z9 0
U1 0
U2 0
PU INT ORGANIZATION CENTER ACAD RESEARCH
PI ISTANBUL
PA YUNUS EMRE CAD AKASYA SK NO 22, UGUR MUMCU, ISTANBUL, KARTAL 00000,
   TURKEY
BN 978-605-64453-7-8
PY 2016
BP 482
EP 488
PG 7
WC Humanities, Multidisciplinary; Social Sciences, Interdisciplinary
SC Arts & Humanities - Other Topics; Social Sciences - Other Topics
GA BH4BB
UT WOS:000400168100060
OA No
DA 2017-08-15
ER

PT J
AU Unger, HW
   Cates, JE
   Gutman, J
   Briand, V
   Fievet, N
   Valea, I
   Tinto, H
   d'Alessandro, U
   Landis, SH
   Adu-Afarwuah, S
   Dewey, KG
   Ter Kuile, F
   Dellicour, S
   Ouma, P
   Slutsker, L
   Terlouw, DJ
   Kariuki, S
   Ayisi, J
   Nahlen, B
   Desai, M
   Madanitsa, M
   Kalilani-Phiri, L
   Ashorn, P
   Maleta, K
   Mueller, I
   Stanisic, D
   Schmiegelow, C
   Lusingu, J
   Westreich, D
   van Eijk, AM
   Meshnick, S
   Rogerson, S
AF Unger, Holger W.
   Cates, Jordan E.
   Gutman, Julie
   Briand, Valerie
   Fievet, Nadine
   Valea, Innocent
   Tinto, Halidou
   d'Alessandro, Umberto
   Landis, Sarah H.
   Adu-Afarwuah, Seth
   Dewey, Kathryn G.
   Ter Kuile, Feiko
   Dellicour, Stephanie
   Ouma, Peter
   Slutsker, Laurence
   Terlouw, Dianne J.
   Kariuki, Simon
   Ayisi, John
   Nahlen, Bernard
   Desai, Meghna
   Madanitsa, Mwayi
   Kalilani-Phiri, Linda
   Ashorn, Per
   Maleta, Kenneth
   Mueller, Ivo
   Stanisic, Danielle
   Schmiegelow, Christentze
   Lusingu, John
   Westreich, Daniel
   van Eijk, Anna Maria
   Meshnick, Steven
   Rogerson, Stephen
TI Maternal Malaria and Malnutrition (M3) initiative, a pooled birth cohort
   of 13 pregnancy studies in Africa and the Western Pacific
SO BMJ OPEN
LA English
DT Article
ID PAPUA-NEW-GUINEA; INTERMITTENT PREVENTIVE TREATMENT; RANDOMIZED
   CONTROLLED-TRIAL; PARTICIPANT DATA METAANALYSIS; MIDDLE-INCOME
   COUNTRIES; SULFADOXINE-PYRIMETHAMINE; BURKINA-FASO; FETAL-GROWTH;
   RISK-FACTORS; BLOOD-FLOW
AB Purpose: The Maternal Malaria and Malnutrition (M3) initiative has pooled together 13 studies with the hope of improving understanding of malaria-nutrition interactions during pregnancy and to foster collaboration between nutritionists and malariologists.
   Participants: Data were pooled on 14 635 singleton, live birth pregnancies from women who had participated in 1 of 13 pregnancy studies. The 13 studies cover 8 countries in Africa and Papua New Guinea in the Western Pacific conducted from 1996 to 2015.
   Findings to date: Data are available at the time of antenatal enrolment of women into their respective parent study and at delivery. The data set comprises essential data such as malaria infection status, anthropometric assessments of maternal nutritional status, presence of anaemia and birth weight, as well as additional variables such gestational age at delivery for a subset of women. Participating studies are described in detail with regard to setting and primary outcome measures, and summarised data are available from each contributing cohort.
   Future plans: This pooled birth cohort is the largest pregnancy data set to date to permit a more definite evaluation of the impact of plausible interactions between poor nutritional status and malaria infection in pregnant women on fetal growth and gestational length. Given the current comparative lack of large pregnancy cohorts in malaria-endemic settings, compilation of suitable pregnancy cohorts is likely to provide adequate statistical power to assess malaria-nutrition interactions, and could point towards settings where such interactions are most relevant. The M3 cohort may thus help to identify pregnant women at high risk of adverse outcomes who may benefit from tailored intensive antenatal care including nutritional supplements and alternative or intensified malaria prevention regimens, and the settings in which these interventions would be most effective.
C1 [Unger, Holger W.] Royal Edinburgh Infirm, Dept Obstet & Gynaecol, Edinburgh, Midlothian, Scotland.
   [Unger, Holger W.; Rogerson, Stephen] Univ Melbourne, Doherty Inst, Dept Med, Parkville, Vic, Australia.
   [Cates, Jordan E.; Westreich, Daniel; Meshnick, Steven] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.
   [Gutman, Julie; Slutsker, Laurence; Desai, Meghna] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA USA.
   [Briand, Valerie; Fievet, Nadine] IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France.
   [Briand, Valerie; Fievet, Nadine] Univ Paris 05, Fa Pharm, COMUE Sorbonne Paris Cite, Paris, France.
   [Valea, Innocent; Tinto, Halidou] Inst Rech Sci Sante DRO, Unite Rech Clin Nanoro, Bobo Dioulasso, Burkina Faso.
   [Valea, Innocent; Tinto, Halidou] Ctr Muraz, Dept Rech Clin, Bobo Dioulasso, Burkina Faso.
   [d'Alessandro, Umberto] MRC Unit, Serrekunda, Gambia.
   [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England.
   [d'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium.
   [Landis, Sarah H.] GlaxoSmithKline, Worldwide Epidemiol, Uxbridge, Middx, England.
   [Adu-Afarwuah, Seth] Univ Ghana, Dept Nutr & Food Sci, Legon, Accra, Ghana.
   [Dewey, Kathryn G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
   [Ter Kuile, Feiko; Dellicour, Stephanie; Kalilani-Phiri, Linda; van Eijk, Anna Maria] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.
   [Ouma, Peter; Kariuki, Simon; Ayisi, John] Ctr Global Hlth Res, Kenya Med Res Inst KEMRI, Kisumu, Kenya.
   [Terlouw, Dianne J.] Malawi Liverpool Wellcome Trust Clin Res Programm, Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Nahlen, Bernard] Presidents Malaria Initiat, Washington, DC USA.
   [Madanitsa, Mwayi; Kalilani-Phiri, Linda; Maleta, Kenneth] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi.
   [Ashorn, Per] Tampere Ctr Child Hlth Res, Tampere, Finland.
   [Ashorn, Per] Univ Tampere, Dept Pediat, Tampere, Finland.
   [Ashorn, Per] Tampere Univ Hosp, Tampere, Finland.
   [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.
   [Stanisic, Danielle] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.
   [Schmiegelow, Christentze; Lusingu, John] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Fac Hlth Sci, Copenhagen, Denmark.
   [Lusingu, John] Tanga Ctr, Inst Med Res, Tanga, Tanzania.
RP Rogerson, S (reprint author), Univ Melbourne, Doherty Inst, Dept Med, Parkville, Vic, Australia.
EM hwunger@doctors.org.uk; sroger@unimelb.edu.au
OI Cates, Jordan/0000-0003-4300-7416; shmiegelow,
   christentze/0000-0002-9360-9741; Fievet, Nadine/0000-0003-2272-9794
FU European Union; STOPPAM [200889]; Nutrition Third World; Belgium
   Ministry of Development; Flemish Interuniversity Council; French
   Ministry of Development; Department of Epidemiology, University of North
   Carolina Chapel Hill; UNC Gillings School of Global Public Health; Bill
   & Melinda Gates Foundation; Malaria in Pregnancy (MiP) Consortium; Bill
   & Melinda Gates Foundation [46099]; US Centers for Disease Control and
   Prevention (CDC), Division of Parasitic Diseases and Malaria; CDC; US
   Agency for International Development; Royal Netherlands Embassy
   (Nairobi, Kenya); US Agency for International Development
   [AOT0483-PH1-2171, HRN-A-00-04-00010-02]; Netherlands Foundation for the
   Advancement of Tropical Research; European and Developing Countries
   Clinical Trials Partnership (EDCTP); Academy of Finland [79787, 207010];
   Foundation for Pediatric Research in Finland; Medical Research Fund of
   Tampere University Hospital; MiP Consortium through Bill & Melinda Gates
   Foundation [46099]; Pregvax Consortium through EU FP7-HEALTH [PREGVAX
   201588]; Spanish Government (EUROSALUD); Pfizer [WS394663]; AusAID;
   National Health and Medical Research Council of Australia; Australian
   Research Council; Wellcome Trust; Veterans Affairs Research Service;
   NHMRC Infrastructure for Research Institutes; Victorian State
   Government; National Institute of Allergy and Infectious Diseases at the
   National Institutes of Health [5 T32 AI070114]
FX The STOPPAM project, 'Strategies To Prevent Pregnancy Associated
   Malaria' was supported by the European Union's Seventh Framework
   Programme (EU FP7); STOPPAM contract number: 200889. STOPPAM I (Benin)
   and STOPPAM II (Tanzania). The FSP/MISAME study (Burkina Faso) was
   funded by Nutrition Third World, The Belgium Ministry of Development,
   Flemish Interuniversity Council, and French Ministry of Development. The
   ECHO study (Democratic Republic of the Congo) was funded by the
   Department of Epidemiology, University of North Carolina Chapel Hill,
   UNC Gillings School of Global Public Health. The iLiNS-DYAD (Ghana)
   trial was funded by a grant to the University of California, Davis from
   the Bill & Melinda Gates Foundation. EMEP was partly supported by the
   Malaria in Pregnancy (MiP) Consortium, which is funded through a grant
   from the Bill & Melinda Gates Foundation to the Liverpool School of
   Tropical Medicine, UK (46099) and partly by the US Centers for Disease
   Control and Prevention (CDC), Division of Parasitic Diseases and Malaria
   through a cooperative agreement with Kenya Medical Research Institute
   (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya. The
   IPTp-MON study (Kenya) was supported by the CDC. The ITN project (Kenya)
   was funded by the US Agency for International Development. The Special
   Health Support Fund from the Royal Netherlands Embassy (Nairobi, Kenya)
   provided additional support for the study of the impact of ITN in
   pregnancy. The Kisumu study (Kenya) was funded by US Agency for
   International Development (grant numbers AOT0483-PH1-2171 and
   HRN-A-00-04-00010-02) and the Netherlands Foundation for the Advancement
   of Tropical Research. The STOPMIP study (Kenya) was funded by the
   Malaria in Pregnancy (MiP) Consortium, which is funded through a grant
   from the Bill & Melinda Gates Foundation to the Liverpool School of
   Tropical Medicine, UK. The ISTp study (Malawi) was funded by the
   European and Developing Countries Clinical Trials Partnership (EDCTP).
   The LAIS study was supported by grants from the Academy of Finland
   (grant numbers 79787 and 207010), the Foundation for Pediatric Research
   in Finland, and the Medical Research Fund of Tampere University
   Hospital. Azithromycin and its placebo were provided free of charge by
   Pfizer (New York, New York, USA), which also provided funding for the
   PCR testing of the sexually transmitted infections. The IPTp study
   (Papua New Guinea (PNG)) was funded by the MiP Consortium, through a
   grant from the Bill & Melinda Gates Foundation (46099); the Pregvax
   Consortium, through a grant from the EU FP7-2007-HEALTH (PREGVAX 201588)
   and the Spanish Government (EUROSALUD 2008 Programme); and Pfizer,
   through an investigator-initiated research grant (WS394663). The Sek
   study (PNG) was supported by AusAID (grant to PNG Institute of Medical
   Research (IMR)), the National Health and Medical Research Council of
   Australia; Australian Research Council; Wellcome Trust; and Veterans
   Affairs Research Service. The Walter and Eliza Hall Institute is
   supported by the NHMRC Infrastructure for Research Institutes Support
   Scheme and Victorian State Government Operational Infrastructure
   Support. JEC was funded by the National Institute of Allergy and
   Infectious Diseases at the National Institutes of Health (Pre-doctoral
   Training in Infectious Disease Epidemiology grant #5 T32 AI070114).
CR Adu-Afarwuah S, 2015, AM J CLIN NUTR, V101, P835, DOI 10.3945/ajcn.114.091546
   Ahern J, 2009, AM J EPIDEMIOL, V169, P1140, DOI 10.1093/aje/kwp015
   Anchang-Kimbi JK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-126
   Andersen LT, 2003, PUBLIC HEALTH NUTR, V6, P131, DOI 10.1079/PHN2002367
   Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049
   BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A
   Huynh BT, 2015, CLIN INFECT DIS, V60, P598, DOI 10.1093/cid/ciu848
   Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Branca F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4173
   Burki TK, 2013, LANCET, V382, P587
   Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122
   Dellicour S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0950-6
   Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221
   Desai M, 2016, CLIN INFECT DIS, V62, P323, DOI 10.1093/cid/civ881
   Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4
   Gonzalez R, 2012, EXPERT REV ANTI-INFE, V10, P153, DOI [10.1586/eri.11.167, 10.1586/ERI.11.167]
   Griffin JB, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-319
   Hanson MA, 2015, INT J GYNECOL OBSTET, V131, pS213, DOI 10.1016/S0020-7292(15)30023-0
   Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253
   International Food Policy Research Institute, 2014, GLOB NUTR REP 2014 A
   Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8
   Kapil Umesh, 2009, Indian J Community Med, V34, P85, DOI 10.4103/0970-0218.51221
   Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231
   Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374
   Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915
   Lisonkova S, 2015, EPIDEMIOLOGY, V26, P436, DOI 10.1097/EDE.0000000000000268
   Luntamo M, 2013, TROP MED INT HEALTH, V18, P386, DOI 10.1111/tmi.12074
   Luntamo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041123
   Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264
   Madanitsa M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002124
   McClure EM, 2014, INT J GYNECOL OBSTET, V126, P78, DOI 10.1016/j.ijgo.2014.01.016
   Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2
   Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269
   Resche-Rigon M, 2013, STAT MED, V32, P4890, DOI 10.1002/sim.5894
   Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x
   Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017
   Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794
   Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906
   Siddique J, 2015, STAT MED, V34, P3399, DOI 10.1002/sim.6562
   Stanisic DI, 2015, T ROY SOC TROP MED H, V109, P313, DOI 10.1093/trstmh/trv019
   Tang A, 2013, 360FANTA FHI
   Taubman SL, 2009, INT J EPIDEMIOL, V38, P1599, DOI 10.1093/ije/dyp192
   ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50
   Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007
   Unger HW, 2016, MATERN CHILD NUTR, V12, P699, DOI 10.1111/mcn.12215
   Unger HW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0258-3
   Unger HW, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0511-6
   Valea I, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-71
   Valea I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-324
   van Eijk AM, 2007, TROP MED INT HEALTH, V12, P342, DOI 10.1111/j.1365-3156.2006.01787.x
   Ververs MT, 2013, PLOS CURR, V5
   Westreich D, 2014, AM J EPIDEMIOL, V179, P797, DOI 10.1093/aje/kwt328
   WHO, WHO GLOB STRAT WOM C
   WHO, WHO INF NOT REC SEL
   Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119
   [Anonymous], 2007, LANCET INFECT DIS, V7, P79
NR 57
TC 0
Z9 0
U1 5
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PY 2016
VL 6
IS 12
AR e012697
DI 10.1136/bmjopen-2016-012697
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG8JS
UT WOS:000391303600152
PM 28003287
OA gold
DA 2017-08-15
ER

PT J
AU McCollum, ED
   Park, DE
   Watson, N
   Buck, WC
   Bunthi, C
   Devendra, A
   Ebruke, BE
   Elhilali, M
   Emmanouilidou, D
   Garcia-Prats, AJ
   Githinji, LN
   Hossain, ML
   Moore, DP
   Mudau, A
   Mulindwa, JM
   Olson, D
   Awori, JO
   Vandepitte, WP
   Verwey, C
   West, JE
   O'Brien, KL
   Feikin, D
   Hammitt, L
AF McCollum, E. D.
   Park, D. E.
   Watson, N.
   Buck, W. C.
   Bunthi, C.
   Devendra, A.
   Ebruke, B. E.
   Elhilali, M.
   Emmanouilidou, D.
   Garcia-Prats, A. J.
   Githinji, L. N.
   Hossain, M. L.
   Moore, D. P.
   Mudau, A.
   Mulindwa, J. M.
   Olson, D.
   Awori, J. Otieno
   Vandepitte, W. P.
   Verwey, C.
   West, J. E.
   O'Brien, K. L.
   Feikin, D.
   Hammitt, L.
TI The Characteristics And Reliability Of Pediatric Digital Lung Sound
   Examinations In Six African And Asian Countries Participating In The
   Pneumonia Etiology Research For Child Health (perch) Project
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT International Conference of the American-Thoracic-Society (ATS)
CY MAY 13-18, 2016
CL San Francisco, CA
SP Amer Thorac Soc
C1 [McCollum, E. D.] Johns Hopkins Sch Med, Baltimore, MD USA.
   [Park, D. E.; O'Brien, K. L.; Hammitt, L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Watson, N.] EMMES Corp, Rockville, MD USA.
   [Buck, W. C.] Univ Calif Los Angeles, Maputo, CA, Mozambique.
   [Bunthi, C.] Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth US, Nonthaburi, Thailand.
   [Devendra, A.] Natl Hlth Serv Highland, Inverness, Scotland.
   [Ebruke, B. E.] MRC, Basse, Gambia.
   [Elhilali, M.; Emmanouilidou, D.; West, J. E.] Johns Hopkins Univ, Baltimore, MD USA.
   [Garcia-Prats, A. J.] Univ Stellenbosch, Tygerberg, South Africa.
   [Githinji, L. N.] Univ Cape Town, Cape Town, South Africa.
   [Hossain, M. L.] Icddr b, Dhaka, Bangladesh.
   [Moore, D. P.; Mudau, A.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Soweto, Bangladesh.
   [Mulindwa, J. M.] Univ Teaching Hosp, Lusaka, Zambia.
   [Olson, D.] Univ Colorado, Aurora, CO USA.
   [Awori, J. Otieno] Kenya Med Res Inst Wellcome Trust Res Programme, Kilifi, Kenya.
   [Vandepitte, W. P.] Child Hlth Rangsit Univ, Queen Sirikit Natl Inst, Bangkok, Thailand.
   [Verwey, C.] Univ Witwatersrand, Johannesburg, South Africa.
   [Feikin, D.] Ctr Dis Control & Prevent, Atlanta, GA USA.
EM emccoll3@jhmi.edu
RI GITHINJI, LEAH/M-2352-2017
OI GITHINJI, LEAH/0000-0003-0480-0868
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2016
VL 193
MA A3043
PG 2
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA EG0VE
UT WOS:000390749602291
OA No
DA 2017-08-15
ER

PT S
AU Sanyang, ML
   Kaban, A
AF Sanyang, Momodou L.
   Kaban, Ata
BE Handl, J
   Hart, E
   Lewis, PR
   LopezIbanez, M
   Ochoa, G
   Paechter, B
TI REMEDA: Random Embedding EDA for Optimising Functions with Intrinsic
   Dimension
SO PARALLEL PROBLEM SOLVING FROM NATURE - PPSN XIV
SE Lecture Notes in Computer Science
LA English
DT Proceedings Paper
CT 14th International Conference on Parallel Problem Solving from Nature
   (PPSN)
CY SEP 17-21, 2016
CL Edinburgh, ENGLAND
SP Edinburgh Napier Univ, Edinburgh Napier Univ, Sch Comp
DE Estimation of distribution algorithm; Black-box optimization; Intrinsic
   dimension
ID DISTRIBUTION ALGORITHMS; OPTIMIZATION
AB It has been observed that in many real-world large scale problems only few variables have a major impact on the function value: While there are many inputs to the function, there are just few degrees of freedom. We refer to such functions as having a low intrinsic dimension. In this paper we devise an Estimation of Distribution Algorithm (EDA) for continuous optimisation that exploits intrinsic dimension without knowing the influential subspace of the input space, or its dimension, by employing the idea of random embedding. While the idea is applicable to any optimiser, EDA is known to be remarkably successful in low dimensional problems but prone to the curse of dimensionality in larger problems because its model building step requires large population sizes. Our method, Random Embedding in Estimation of Distribution Algorithm (REMEDA) remedies this weakness and is able to optimise very large dimensional problems as long as their intrinsic dimension is low.
C1 [Sanyang, Momodou L.; Kaban, Ata] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England.
   [Sanyang, Momodou L.] Univ Gambia, Sch Informat Technolgy & Commun, Brikama Campus,POB 3530, Serekunda, Gambia.
RP Sanyang, ML (reprint author), Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England.; Sanyang, ML (reprint author), Univ Gambia, Sch Informat Technolgy & Commun, Brikama Campus,POB 3530, Serekunda, Gambia.
EM M.L.Sanyang@cs.bham.ac.uk; A.Kaban@cs.bham.ac.uk
CR Bergstra J, 2012, J MACH LEARN RES, V13, P281
   Bosman P., 2009, P GEN EV COMP C GECC, P389, DOI 10.1145/1569901.1569956
   Constantine PG, 2014, SIAM J SCI COMPUT, V36, pA1500, DOI 10.1137/130916138
   Band Johnson W, 2001, HDB GEOMETRY BANACH, V1, P317, DOI 10.1016/S1874-5849(01)80010-3
   Dong WS, 2008, INFORM SCIENCES, V178, P3000, DOI 10.1016/j.ins.2008.01.021
   Dong WS, 2013, IEEE T EVOLUT COMPUT, V17, P797, DOI 10.1109/TEVC.2013.2247404
   Hansen N., 2006, STUDIES FUZZINESS SO, V192
   Hutter F., 2009, THESIS
   Kaban A., 2015, EVOL COMPUT
   Ros R, 2008, LECT NOTES COMPUT SC, V5199, P296, DOI 10.1007/978-3-540-87700-4_30
   Sanyang M.L., 2015, IEEE C EV COMP CEC, P2074
   Sanyang ML, 2014, LECT NOTES COMPUT SC, V8669, P449, DOI 10.1007/978-3-319-10840-7_54
   Tang K., 2008, IEEE WORLD C COMP IN
   Wang Z., 2013, IJCAI
   Weicker K., 1999, P C EV COMP, V3
   Yang Z., 2010, PARALLEL PROBLEM SOL, V11, P300
NR 16
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INT PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0302-9743
BN 978-3-319-45823-6; 978-3-319-45822-9
J9 LECT NOTES COMPUT SC
PY 2016
VL 9921
BP 859
EP 868
DI 10.1007/978-3-319-45823-6_80
PG 10
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods
SC Computer Science
GA BG3KE
UT WOS:000387962100080
OA No
DA 2017-08-15
ER

PT S
AU Hladik, J
   Jadama, LM
AF Hladik, Jakub
   Jadama, Langsajo Mustafa
BE Minas, M
TI Multicultural Competence of Helping Profession Students: Cross-cultural
   Comparison between Europe and Africa
SO FUTURE ACADEMY MULTIDISCIPLINARY CONFERENCE ICEEPSY & CPSYC & ICPSIRS &
   BE-CI
SE Procedia Social and Behavioral Sciences
LA English
DT Proceedings Paper
CT Future Academy Multidisciplinary Conference ICEEPSY / CPSYC / icPSIRS /
   BE-ci
CY OCT 13-17, 2015
CL Istanbul, TURKEY
DE Multicultural competence; university students; cross-cultural comparison
ID SENSITIVITY
AB The research study is focused on the multicultural competence of helping profession students. We were interested in a cross-cultural comparison between Czech (European) and Gambian (African) students. The main purpose was to discover the level of multicultural competence of Czech and Gambian helping profession students; to discover potential differences in multicultural components between these two groups; to discover if there is an interactive effect of the variable state and university on multicultural competence. The sample consisted of 516 helping profession students from Czech and Gambian universities. The research tool was the Multicultural Competence Scale of Helping Profession Students (MCSHPS). MCSHPS is a 20 item questionnaire containing five factors: multicultural knowledge, multicultural activity, multicultural awareness, understanding of terms and multicultural communication skills. MCSHPS shows the general level and the level of the five factors of multicultural competence. There are differences in the general level of multicultural competence between the Czech and the Gambian students. Czech students have a higher value of multicultural competence than Gambian students. The analysis of the multicultural competence components shows that we can find more important differences among universities rather than between states. The two-way ANOVA shows a significant interactive effect of the state and university on multicultural competence. Although we found significant differences in the general level of multicultural competence between Czech and Gambian students, we consider the differences among universities as more important. The university factor (R squared = 10 %) proved more important than the state factor (R squared = 1%). The effect of the university (e.g. teaching methods, motivation, teacher's character etc.) is stronger than cultural determination. (C) 2016 The Authors Published by Elseiver Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Hladik, Jakub] Tomas Bata Univ Zlin, Fac Humanities, Nam TG Masaryka 5555, Zlin 76001, Czech Republic.
   [Jadama, Langsajo Mustafa] Univ Gambia, Sch Educ, Brikama Campus,POB 3530, Kombo Cent, Gambia.
RP Hladik, J (reprint author), Tomas Bata Univ Zlin, Fac Humanities, Nam TG Masaryka 5555, Zlin 76001, Czech Republic.
EM hladik@fhs.utb.cz
RI Hladik, Jakub/E-8323-2012
CR BENNETT MJ, 1986, INT J INTERCULT REL, V10, P179, DOI 10.1016/0147-1767(86)90005-2
   CHIU LH, 1972, INT J PSYCHOL, V7, P235, DOI 10.1080/00207597208246604
   Deardorff D. K., 2009, SAGE HDB INTERCULTUR
   Deardorff D. K., 2006, J STUD INT EDUC, V10, P241, DOI DOI 10.1177/1028315306287002
   Fantini A., 2007, EXPLORING ASSESSING
   Gamst G., 2011, HDB MULTICULTURAL ME
   Hladik J., 2014, MULTIKULTURNI KOMPET
   Hladik J., 2014, ASIAN SOC SCI, V10, P162
   Hladik J., 2011, PEDAGOGIKA, V61, P53
   Knutson TJ, 2003, INT J INTERCULT REL, V27, P63, DOI 10.1016/S0147-1767(02)00060-3
   Kohls L.R., 1994, DEV INTERCULTURAL AW
   Manak J., 2006, SKOLNI VZDELAVANI ZA
   Marsh HW, 2003, AM PSYCHOL, V58, P364, DOI 10.1037/0003-006X.58.5.364
   Martincova J, 2015, PROCD SOC BEHV, V171, P1255, DOI 10.1016/j.sbspro.2015.01.239
   Oudenhoven Van J. P., 2002, INT J INTERCULTURAL, V26, P672
   Padila A. M., 2008, HDB MULTICULTURAL AS
   Pope RL, 1997, J COLL STUDENT DEV, V38, P266
   Purdie N, 1996, J EDUC PSYCHOL, V88, P87, DOI 10.1037/0022-0663.88.1.87
   Skalkova J., 2007, ORBIS SCHOLAE, V2, P7
   Spitzberg BH, 2009, SAGE HDB INTERCULTUR
   SUE DW, 1982, COUNS PSYCHOL, V10, P45, DOI 10.1177/0011000082102008
   Sue S, 2009, ANNU REV PSYCHOL, V60, P525, DOI 10.1146/annurev.psych.60.110707.163651
   The World Bank, 2014, GDP PER CAP CZECH RE
   The World Bank, 2014, GDP PER CAP GAMB
NR 24
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-0428
J9 PROCD SOC BEHV
PY 2016
VL 217
BP 669
EP 678
DI 10.1016/j.sbspro.2016.02.117
PG 10
WC Education & Educational Research
SC Education & Educational Research
GA BG2MP
UT WOS:000387478700084
OA No
DA 2017-08-15
ER

PT J
AU Graham, WJ
   Morrison, E
   Dancer, S
   Afsana, K
   Aulakh, A
   Campbell, OMR
   Cross, S
   Ellis, R
   Enkubahiri, S
   Fekad, B
   Gon, G
   Idoko, P
   Moore, J
   Saxena, D
   Velleman, Y
   Woodd, S
AF Graham, Wendy J.
   Morrison, Emma
   Dancer, Stephanie
   Afsana, Kaosar
   Aulakh, Alex
   Campbell, Oona M. R.
   Cross, Suzanne
   Ellis, Ryan
   Enkubahiri, Siyoum
   Fekad, Bazezew
   Gon, Giorgia
   Idoko, Patrick
   Moore, Jolene
   Saxena, Deepak
   Velleman, Yael
   Woodd, Susannah
TI What are the threats from antimicrobial resistance for maternity units
   in low- and middle- income countries?
SO GLOBAL HEALTH ACTION
LA English
DT Editorial Material
ID ANTIBIOTICS
C1 [Graham, Wendy J.; Campbell, Oona M. R.; Gon, Giorgia; Woodd, Susannah] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Morrison, Emma; Cross, Suzanne; Ellis, Ryan] Soapbox Collaborat, Aberdeen, Scotland.
   [Dancer, Stephanie] NHS Lanarkshire, Edinburgh, Midlothian, Scotland.
   [Dancer, Stephanie] Edinburgh Napier Univ, Edinburgh, Midlothian, Scotland.
   [Afsana, Kaosar] BRAC, Dhaka Div, Hlth Nutr & Populat Programme, Dhaka, Bangladesh.
   [Aulakh, Alex] London North West Healthcare Trust, Northwick Pk Hosp, London, England.
   [Enkubahiri, Siyoum; Fekad, Bazezew] Felege Hiwot Referral Hosp, Bahir Dar, Ethiopia.
   [Idoko, Patrick] Univ Gambia, Sch Med & Allied Hlth Sci, Banjul, Gambia.
   [Moore, Jolene] Univ Aberdeen, Inst Educ Med & Dent Sci, Aberdeen, Scotland.
   [Saxena, Deepak] Indian Inst Publ Hlth, Gandhinagar, India.
   [Velleman, Yael] WaterAid, London, England.
RP Graham, WJ (reprint author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, IDE EPH, Keppel St, London WC1E 7HT, England.
EM Wendy.Graham@lshtm.ac.uk
CR Afsana K, 2014, CLEAN DELIVERY SITUA
   Campbell OM, 2016, LANCET, V388, P36
   Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11
   Dancer S. J., 2013, Healthcare Infection, V18, P51, DOI 10.1071/HI12042
   Dancer SJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1931
   Godlee F, 2009, BMJ-BRIT MED J, V339, pb4346
   Gastmeier P, 2010, INT J MED MICROBIOL, V300, P342, DOI 10.1016/j.ijmm.2010.04.007
   Gon G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160572
   Graham WJ, 2015, BJOG-INT J OBSTET GY, V122, P156, DOI 10.1111/1471-0528.13189
   Graham W, 2016, LANCET, V388, P7
   Institute of Medicine, 2001, CROSSING QUALITY CHA
   Koblinsky M, 2016, LANCET, V388, P77
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7
   LOUDON I, 1992, BRIT MED J, V305, P1557
   Miller S, 2016, LANCET, V388, P19
   Review on Antimicrobial Resistance, 2016, INF PREV CONTR SURV
   Roca A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.03.005
   Sheldon T, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4192
   Temmerman M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4414
   United Nations, 2014, ROAD DIGN 2030 END P
   Velleman Y, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001771
   WaterAid, 2016, IMPR QUAL HEALTHC RE
   World Health Organization, 2015, GLOB ACT PLAN ANT RE
   World Health Organization, 2014, ANT RES GLOB REP SUR
   WHO, 2015, WAT SAN HYG HLTH CAR
NR 25
TC 0
Z9 0
U1 1
U2 1
PU CO-ACTION PUBLISHING
PI JARFALLA
PA RIPVAGEN 7, JARFALLA, SE-175 64, SWEDEN
SN 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PY 2016
VL 9
AR 33381
DI 10.3402/gha.v9.33381
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EA3SD
UT WOS:000386524000001
PM 27640424
OA gold
DA 2017-08-15
ER

PT J
AU Nargis, N
   Manneh, Y
   Krubally, B
   Jobe, B
   Ouma, AEO
   Tcha-Kondor, N
   Blecher, EH
AF Nargis, Nigar
   Manneh, Yahya
   Krubally, Bakary
   Jobe, Baboucarr
   Ouma, Ahmed E. Ogwell
   Tcha-Kondor, Noureiny
   Blecher, Evan H.
TI How effective has tobacco tax increase been in the Gambia? A case study
   of tobacco control
SO BMJ OPEN
LA English
DT Article
ID EXCISE TAXES; CIGARETTES; STRATEGY; PRICES; MARKET; POLICY
AB Objectives: The objective of the present study was to evaluate how effective tobacco tax increase has been in increasing price of tobacco products and reducing tobacco consumption in the Gambia. In addition, it tests the hypothesis that tobacco tax revenue grows while tobacco consumption decreases as a result of tax and price increase.
   Setting: The study is designed at the macroeconomic level to examine the import of tobacco products and revenue collected from tobacco taxation in a low-income setting.
   Participants: The participants of this study are the government officials employed in the Ministry of Finance and Economic Affairs (MoFEA), the Gambia and the Gambia Revenue Authority, who are in charge of planning and implementing the tobacco tax policy in the Gambia.
   Interventions: The study includes 2 consecutive interventions in tobacco tax policy in the Gambia. The first intervention was moving the tax base for the uniform specific excise tax on cigarettes from weight to pack of cigarettes in 2013. The second intervention involved increasing the excise and the environmental tax on tobacco products in 2014.
   Primary and secondary outcome measures: The primary outcome measures were the cost, insurance and freight value and the price of tobacco products. The secondary outcome measures included the import of tobacco products and tobacco tax revenue.
   Results: In 2013-2014, the Gambia MoFEA raised the specific excise rate, which increased price, reduced consumption and generated significantly more government revenue from tobacco products. This is a clear evidence of the win-win outcome of raising tobacco tax. In addition, the Gambia has set the example of harmonising tax rates between tobacco products that reduces the substitution between tobacco products.
   Conclusions: The Gambia presents the best practice in tobacco taxation. There is need for documenting more country-specific evidence on the win-win outcome of raising tobacco tax.
C1 [Nargis, Nigar] Amer Canc Soc, Atlanta, GA 30329 USA.
   [Manneh, Yahya] Gambia Revenue Author, Banjul, Gambia.
   [Krubally, Bakary; Jobe, Baboucarr] Minist Finance & Econ Affairs, Banjul, Gambia.
   [Ouma, Ahmed E. Ogwell; Tcha-Kondor, Noureiny] WHO, Brazzaville, Rep Congo.
   [Blecher, Evan H.] WHO, Geneva, Switzerland.
RP Nargis, N (reprint author), Amer Canc Soc, Atlanta, GA 30329 USA.
EM nigar.nargis@cancer.org
FU WHO
FX The study was conducted with financial support from the WHO.
CR Blecher EH, 2008, ANAL CIGRETTE AFFORD
   Blecher E, 2010, TOB CONTROL, V19, P325, DOI 10.1136/tc.2009.030155
   Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417
   Curti D, 2015, TOB CONTROL, V24, P17, DOI 10.1136/tobaccocontrol-2014-051890
   Gilmore AB, 2013, ADDICTION, V108, P1317, DOI 10.1111/add.12159
   HARRIS JE, 1987, TAX POLICY EC, V1, P87
   IARC, 2011, EFF TAX PRIC POL TOV, V14
   Marsh L, 2016, TOB CONTROL, V25, P458, DOI 10.1136/tobaccocontrol-2015-052259
   Ohsfeldt RL, 1997, HEALTH ECON, V6, P525, DOI 10.1002/(SICI)1099-1050(199709)6:5<525::AID-HEC300>3.0.CO;2-Y
   Ohsfeldt RL, 1998, 6486 NBER
   Oshfeldt RL, 1994, TOB CONTROL, V3, P316
   Pigou A. C., 1920, EC WELFARE
   Saloojee Y, 2011, INT DEV RES CTR, P227
   Tauras JA, 2006, REV IND ORGAN, V28, P253, DOI 10.1007/s11151-006-0016-6
   Tsai YW, 2005, HEALTH ECON, V14, P627, DOI 10.1002/hec.972
   Warner KE, 2000, TOB CONTROL, V9, P78, DOI 10.1136/tc.9.1.78
   [Anonymous], WHO REP GLOB TOB EP
   WHO, WHO TECHN MAN TOB AD
   WHO, FCTC GUID IMPL ART
   World Bank, WORLD DEV IND DAT 20
   Young D, 2006, TOB CONTROL, V15, P76, DOI 10.1136/tc.2005.013268
NR 21
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PY 2016
VL 6
IS 8
AR e010413
DI 10.1136/bmjopen-2015-010413
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU6PI
UT WOS:000382336700105
PM 27566626
OA gold
DA 2017-08-15
ER

PT J
AU Perl, D
   Leddin, D
   Bizos, D
   Veitch, A
   N'Dow, J
   Bush-Goddard, S
   Njie, R
   Lemoine, M
   Anderson, ST
   Igoe, J
   Anandasabapathy, S
   Shah, B
AF Perl, Daniel
   Leddin, Desmond
   Bizos, Damon
   Veitch, Andrew
   N'Dow, James
   Bush-Goddard, Stephanie
   Njie, Ramou
   Lemoine, Maud
   Anderson, Suzanne T.
   Igoe, John
   Anandasabapathy, Sharmila
   Shah, Brijen
TI Endoscopic capacity in West Africa
SO AFRICAN HEALTH SCIENCES
LA English
DT Article
DE Endoscopic capacity; endoscopic demand; West Africa; training course
ID DEVELOPING-COUNTRIES; DELAYED ENDOSCOPY; GASTROENTEROLOGY; MORTALITY;
   HEALTH
AB Background: Levels of endoscopic demand and capacity in West Africa are unclear.
   Objectives: This paper aims to: 1. describe the current labor and endoscopic capacity, 2. quantify the impact of a mixed-methods endoscopy course on healthcare professionals in West Africa, and 3. quantify the types of diagnoses encountered.
   Methods: In a three-day course, healthcare professionals were surveyed on endoscopic resources and capacity and were taught through active observation of live cases, case discussion, simulator experience and didactics. Before and after didactics, multiple-choice exams as well as questionnaires were administered to assess for course efficacy. Also, a case series of 23 patients needing upper GI endoscopy was done.
   Results: In surveying physicians, less than half had resources to perform an EGD and none could perform an ERCP, while waiting time for emergency endoscopy in urban populations was at least one day. In assessing improvement in medical knowledge among participants after didactics, objective data paired with subjective responses was more useful than either alone. Of 23 patients who received endoscopy, 7 required endoscopic intervention with 6 having gastric or esophageal varices.
   Currently the endoscopic capacity in West Africa is not sufficient. A formal GI course with simulation and didactics improves gastrointestinal knowledge amongst participants.
C1 [Perl, Daniel; Anandasabapathy, Sharmila; Shah, Brijen] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY 10029 USA.
   [Leddin, Desmond; Igoe, John] Dalhousie Univ, Gastroenterol, Halifax, NS, Canada.
   [Bizos, Damon] Univ Witwatersrand, Dept Surg, Johannesburg, South Africa.
   [Veitch, Andrew] New Cross Hosp, Gastroenterol, Wolverhampton, England.
   [N'Dow, James] Univ Aberdeen, Urol Surg, Aberdeen, Scotland.
   [Anderson, Suzanne T.] MRC Unit, Clin Serv Dept, Serrekunda, Gambia.
   [Njie, Ramou; Lemoine, Maud] MRC Unit, Hepatol, Serrekunda, Gambia.
RP Perl, D (reprint author), Annenberg Bldg,Box 1069,1468 Madison Ave, New York, NY 10029 USA.
EM perld@med.umich.edu
FU Karl Storz Endoscopy-America Inc
FX Karl Storz Endoscopy-America Inc funded some equipment and technical
   support as well as some travel expenses.
CR Africa Partners Medical, 2009, OLMST OUTR
   Asombang AW, 2013, WORLD J GASTROENTERO, V19, P3996, DOI 10.3748/wjg.v19.i25.3996
   Chen PH, 2012, J HEPATOL, V57, P1207, DOI 10.1016/j.jhep.2012.07.038
   Chuks Nwokediuko Sylvester, 2011, CHALLENGES GASTROINT, DOI [10.5772/22471, DOI 10.5772/22471]
   Fried M, 2008, J EVAL CLIN PRACT, V14, P874, DOI 10.1111/j.1365-2753.2008.01044.x
   Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1
   Hsu YC, 2009, J GASTROEN HEPATOL, V24, P1294, DOI 10.1111/j.1440-1746.2009.05903.x
   Olokoba A.B. LBO, 2008, RES J MED SCI, V2, P212
   Mandeville KL, 2009, WORLD J GASTROENTERO, V15, P2839, DOI 10.3748/wjg.15.2839
   Moayyedi P, 2007, AM J GASTROENTEROL, V102, P478, DOI 10.1111/j.1572-0241.2006.00973.x
   Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027
   Nwokediuko Sylvester Chuks, 2012, Ann Gastroenterol, V25, P52
   World Health Organization, 2013, WORLD HLTH STAT
   Wilhelm TJ, 2012, ENDOSCOPY, V44, P174, DOI 10.1055/s-0031-1291446
   [Anonymous], 2014, PHYS COUNTRIES
   [Anonymous], 2011, WORLD HLTH RANKINGS
NR 16
TC 1
Z9 1
U1 1
U2 3
PU MAKERERE UNIV, FAC MED
PI KAMPALA
PA PO BOX 7072, KAMPALA, 00000, UGANDA
SN 1680-6905
EI 1729-0503
J9 AFR HEALTH SCI
JI Afr. Health Sci.
PY 2016
VL 16
IS 1
BP 329
EP 338
DI 10.4314/ahs.v16i1.44
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP9WE
UT WOS:000378847700044
PM 27358650
OA No
DA 2017-08-15
ER

PT J
AU Novelli, M
   Morgan, N
   Mitchell, G
   Ivanov, K
AF Novelli, Marina
   Morgan, Nigel
   Mitchell, Geri
   Ivanov, Konstantin
TI Travel philanthropy and sustainable development: the case of the
   Plymouth-Banjul Challenge
SO JOURNAL OF SUSTAINABLE TOURISM
LA English
DT Article
DE aid; charity; social entrepreneurship; social justice; travel
   philanthropy; The Gambia
ID VOLUNTEER TOURISM; CORPORATE PHILANTHROPY; AID EFFECTIVENESS;
   EXPERIENCES
AB Travel philanthropy is an evolving phenomenon. It owes its origins to rising frustrations with conventional aid and traditional philanthropic giving and is seen as development assistance enabling resources to flow directly from the tourism industry into community development and conservation initiatives. Philanthropists have long sought to achieve social transformation, and travel philanthropy in all its forms has evolved through the democratization of charity, as a kind of "doing good" through "giving back" whilst travelling. This paper evaluates values, practices and impacts of traditional, modern and post-modern philanthropy. Drawing upon evidence emerging from a longitudinal study, which involved the retrospective evaluation of personal diary entries, participant observations and semi-structured interviews about the transcontinental Plymouth-Banjul (car) Challenge (PBC), it exemplifies how an initiative can evolve across all three philanthropic approaches. It further debates critical understandings of the problematic travel philanthropy concept and its role in stimulating sustainable development in sub-Saharan Africa.
C1 [Novelli, Marina; Ivanov, Konstantin] Univ Brighton, Sch Sport & Serv Management, Eastbourne, England.
   [Morgan, Nigel] Univ Surrey, Sch Hospital & Tourism Management, Guildford, Surrey, England.
   [Mitchell, Geri] Sandele Ecoretreat & Learning Ctr, Kartong, Gambia.
RP Novelli, M (reprint author), Univ Brighton, Sch Sport & Serv Management, Eastbourne, England.
EM M.Novelli@brighton.ac.uk
RI liang, lemmy/G-5232-2017
OI Morgan, Nigel/0000-0002-4804-4972
CR Abernethy D., 2011, TRAVELERS PHILANTHRO, P179
   Adam T, 2004, PHILAN NONPROFIT S, P1
   Ashley C., 2006, Development Southern Africa, V23, P265, DOI 10.1080/03768350600707553
   Azarya V., 2004, CURR SOCIOL, V52, P949, DOI 10.1177/0011392104046617
   Bailin MA, 2003, NONPROF VOLUNT SEC Q, V32, P635, DOI 10.1177/0899764003257464
   Beck U., 2005, POWER GLOBAL AGE
   Beebe J., 2001, RAPID ASSESSMENT PRO
   Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927
   Bornstein D., 2010, SOCIAL ENTREPRENEURS
   Bornstein E, 2009, CULT ANTHROPOL, V24, P622, DOI 10.1111/j.1548-1360.2009.01042.x
   Bourguignon F, 2007, AM ECON REV, V97, P316, DOI 10.1257/aer.97.2.316
   Brainard L., 2008, BURDEN BENEFIT IMPER, P13
   Brantlinger P., 2008, BURDEN BENEFIT IMPER, P13
   Brendon P., 1991, T COOK 150 YEARS POP
   Brohman J, 1996, ANN TOURISM RES, V23, P48, DOI 10.1016/0160-7383(95)00043-7
   Brown D. R., 1998, Journal of International Development, V10, P55, DOI 10.1002/(SICI)1099-1328(199801)10:1<55::AID-JID452>3.0.CO;2-W
   Zamagni S., 2013, HDB EC RECIPROCITY S
   Burkemann S., 2001, DEV UPDATE, V3, P151
   Butcher J., 2003, MORALISATION TOURISM
   Butcher J., 2015, VOLUNTEER TOURISM LI
   Carlisle S, 2013, TOURISM MANAGE, V35, P59, DOI 10.1016/j.tourman.2012.05.010
   Carnegie A., 1993, THE GOSPEL OF WEALTH
   Caton K., 2012, ANN TOURISM RES, V4, P1906
   Coghlan A., 2011, CAUTHE 2011 NAT C TO
   Coghlan A, 2009, ANN LEIS RES, V12, P377, DOI 10.1080/11745398.2009.9686830
   Collier P, 2007, BOTTOM BILLION WHY P
   Dees J.G., 2008, GLOBAL DEV 2 0 CAN P, P120
   De La Mare T., 2014, FOOTLOOSE PHILANTHRO
   De Lorenzo M., 2007, ENTREPRENEURIAL PHIL
   Desai RM, 2008, SURVIVAL, V50, P155, DOI 10.1080/00396330802328982
   Doucouliagos H, 2009, J ECON SURV, V23, P433, DOI 10.1111/j.1467-6419.2008.00568.x
   Dreier P., 2002, SOC POLICY, V33, P27
   Easterly W, 2006, WHITE MANS BURDEN WH
   Easterly W, 2007, AM ECON REV, V97, P328, DOI 10.1257/aer.97.2.328
   Edwards M, 2009, WRR VERKENN, P237
   Eikenberry AM, 2006, NONPROF VOLUNT SEC Q, V35, P517, DOI 10.1177/0899764006287482
   Frumkin P, 2000, SOCIETY, V37, P40, DOI 10.1007/s12115-000-1021-2
   Frumkin P., 2006, STRATEGIC GIVING ART
   Goldberg A.D., 2002, FDN NEWS COMMENTARY, V43, P17
   Goodwin H., 2009, ADV TRAVEL PHILANTHR
   Guttentag DA, 2009, INT J TOUR RES, V11, P537, DOI 10.1002/jtr.727
   Handy C., 2007, NEW PHILANTHROPISTS
   deCourcy Hero P., 2001, NEW DIRECTION PHILAN, V32, P47
   Higgins-Desbiolles F, 2008, J SUSTAIN TOUR, V16, P345, DOI 10.2167/jost749.0
   Higgins-Desbiolles F, 2006, TOURISM MANAGE, V27, P1192, DOI 10.1016/j.tourman.2005.05.020
   Honey M., 2011, TRAVELERS PHILANTHRO, P3
   Katz SN, 2005, P AM PHILOS SOC, V149, P123
   Korf B, 2007, GEOFORUM, V38, P366, DOI 10.1016/j.geoforum.2006.09.005
   Lyons K, 2008, JOURNEYS OF DISCOVERY IN VOLUNTEER TOURISM: INTERNATIONAL CASE STUDY PERSPECTIVES, P147
   Maathai W., 2011, TRAVELERS PHILANTHRO, P1
   Macy P., 2011, TRAVELERS PHILANTHRO, P177
   Mahrouse G, 2011, ACME, V10, P372
   McAlister D. T., 2002, EUR J MARKETING, V36, P689, DOI DOI 10.1108/03090560210422952
   McCully G., 2000, FDN NEWS COMMENTARY, V41, P20
   McGehee NG, 2014, J SUSTAIN TOUR, V22, P847, DOI 10.1080/09669582.2014.907299
   Micklewright J., 2005, NEW SOURCES DEV FINA, P90
   Micklewright J, 2009, J SOC POLICY, V38, P317, DOI 10.1017/S0047279408002869
   Monroe Kristen Renwick, 1996, HEART ALTRUISM PERCE
   Mostafanezhad M, 2013, TOURISM GEOGR, V15, P318, DOI 10.1080/14616688.2012.675579
   Mustonen P., 2006, J TOUR CULT CHANGE, V3, P166
   Mustonen P, 2007, ANATOLIA, V18, P97, DOI 10.1080/13032917.2007.9687038
   Nelson J., 2008, GLOBAL DEV 2 0 CAN P, P149
   Nevarez L, 2000, URBAN AFF REV, V36, P197, DOI 10.1177/10780870022184831
   Novelli M., 2016, TOURISM DEV SUB SAHA
   Novelli M., 2015, CONVERSATION    0727
   Novelli M, 2012, ANN TOURISM RES, V39, P1446, DOI 10.1016/j.annals.2012.03.003
   Ostrander SA, 2007, NONPROF VOLUNT SEC Q, V36, P356, DOI 10.1177/0899764007300386
   Patton MQ, 2002, QUALITATIVE RES EVAL
   Payton Robert L., 1988, PHILANTHROPY VOLUNTA
   Perrini F, 2006, NEW SOCIAL ENTREPREN
   Plewes B., 2008, GLOBAL PHILANTHROPY
   Porter ME, 2002, HARVARD BUS REV, V80, P56
   Prahalad CK, 2002, HARVARD BUS REV, V80, P48
   Prahalad C. K., 2010, FORTUNE BOTTOM PYRAM
   Pritchard A, 2011, ANN TOURISM RES, V38, P941, DOI 10.1016/j.annals.2011.01.004
   Reis T.K., 2001, NEW DIRECTIONS PHILA, V32, P109
   Saiia D.H., 2003, BUS SOC, V42, P169, DOI DOI 10.1177/0007650303042002002
   Salamon L. M., 1992, AM NONPROFIT SECTOR
   Schervish PG, 2007, NONPROF VOLUNT SEC Q, V36, P373, DOI 10.1177/0899764007302596
   Scheyvens R., 2007, Current Issues in Tourism, V10, P231, DOI 10.2167/cit318.0
   SEALANDER J., 1997, PRIVATE WEALTH PUBLI
   Seglow J., 2004, ETHICS ALTRUISM, P1
   Simpson K., 2004, Journal of International Development, V16, P681, DOI 10.1002/jid.1120
   Sin HL, 2010, GEOFORUM, V41, P983, DOI 10.1016/j.geoforum.2010.08.007
   Smith M., 2003, ETHICS TOURISM DEV
   Spalding M.J., 2011, TRAVELERS PHILANTHRO, P19
   Stephenson ML, 2014, TOURISM MANAGE, V40, P155, DOI 10.1016/j.tourman.2013.05.002
   Sulek M, 2010, NONPROF VOLUNT SEC Q, V39, P385, DOI 10.1177/0899764009333050
   Sulek M, 2010, NONPROF VOLUNT SEC Q, V39, P193, DOI 10.1177/0899764009333052
   Sundberg M., 2006, FINANC DEV, V43, P1
   Sutcliffe B., 1999, CRITICAL DEV THEORY, P135
   Tetzschner H., 2003, INNOVATION SOCIAL EN
   Tiffin C., 2008, BURDEN BENEFIT IMPER, P1
   Valente M, 2010, CALIF MANAGE REV, V52, P52
   Wagner L., 2002, INT J NONPROFIT VOLU, V7, P342
   Wearing S., 2001, VOLUNTEER TOURISM EX
   Wearing S, 2013, TOURISM MANAGE, V38, P120, DOI 10.1016/j.tourman.2013.03.002
   Western D.J., 2011, TRAVELERS PHILANTHRO, P13
NR 98
TC 0
Z9 0
U1 6
U2 14
PU CHANNEL VIEW PUBLICATIONS
PI CLEVEDON
PA FRANKFURT LODGE, CLEVEDON HALL, VICTORIA ROAD, CLEVEDON, BS21 7HH,
   ENGLAND
SN 0966-9582
EI 1747-7646
J9 J SUSTAIN TOUR
JI J. Sustain. Tour.
PY 2016
VL 24
IS 6
BP 824
EP 845
DI 10.1080/09669582.2015.1088858
PG 22
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Hospitality, Leisure, Sport &
   Tourism
SC Science & Technology - Other Topics; Social Sciences - Other Topics
GA DL8CX
UT WOS:000375868400002
OA No
DA 2017-08-15
ER

PT S
AU Begus, K
   Lloyd-Fox, S
   Halliday, D
   Papademetriou, M
   Darboe, MK
   Prentice, AM
   Moore, SE
   Elwell, CE
AF Begus, K.
   Lloyd-Fox, S.
   Halliday, D.
   Papademetriou, M.
   Darboe, M. K.
   Prentice, A. M.
   Moore, S. E.
   Elwell, C. E.
BE Elwell, CE
   Leung, TS
   Harrison, DK
TI Using fNIRS to Study Working Memory of Infants in Rural Africa
SO OXYGEN TRANSPORT TO TISSUE XXXVII
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 42nd Annual Meeting of
   International-Society-on-Oxygen-Transport-to-Tissue
CY JUN 28-JUL 03, 2014
CL Univ Coll London, Manchester, ENGLAND
SP Hitachi High Tech, Hamamatsu Photon, NanoBlood LLC, Seahorse Bioscience, Baker Ruskinn, Gowerlabs, Moor Instruments, Swiss Innovat Concepts AG Secret Training, Oxford Optron
HO Univ Coll London
DE fNIRS; Working memory; Nutrition; Infants
ID NEAR-INFRARED SPECTROSCOPY; IRON-DEFICIENCY; BRAIN
AB A pilot study was conducted to assess the feasibility of using fNIRS as an alternative to behavioral assessments of cognitive development with infants in rural Africa. We report preliminary results of a study looking at working memory in 12-16-month-olds and discuss the benefits and shortcomings for the potential future use of fNIRS to investigate the effects of nutritional insults and interventions in global health studies.
C1 [Begus, K.; Lloyd-Fox, S.] Univ London, Birkbeck Coll, Ctr Brain & Cognit Dev, London, England.
   [Lloyd-Fox, S.; Halliday, D.; Papademetriou, M.] Univ London, Dept Med Phys & Bioengn, London, England.
   [Darboe, M. K.; Prentice, A. M.; Moore, S. E.] Keneba Field Stn, MRC Int Nutr Grp, Keneba, Gambia.
   [Prentice, A. M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England.
   [Moore, S. E.] MRC Human Nutr Res, Cambridge, England.
   [Elwell, C. E.] UCL, Dept Med Phys & Biomed Engn, London, England.
RP Begus, K (reprint author), Univ London, Birkbeck Coll, Ctr Brain & Cognit Dev, London, England.
EM k.begus@bbk.ac.uk
FU Medical Research Council [MC_U123292701, MC_UP_1005/1, G0400120]
CR Algarin C, 2013, DEV MED CHILD NEUROL, V55, P453, DOI 10.1111/dmcn.12118
   Baird AA, 2002, NEUROIMAGE, V16, P1120, DOI 10.1006/nimg.2002.1170
   Beard J, 2003, J NUTR, V133, p1468S
   Coutts LV, 2012, CEPHALALGIA, V32, P621, DOI 10.1177/0333102412444474
   Elwell C., 1995, PRACTICAL USERS GUID
   Everdell NL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038567
   Gladstone MJ, 2007, ARCH DIS CHILD, V93, P23
   Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003
   Lloyd-Fox S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3026
   Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008
   Lloyd-Fox S, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025006
   Lloyd-Fox S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04740
   Lloyd-Fox S, 2009, CHILD DEV, V80, P986, DOI 10.1111/j.1467-8624.2009.01312.x
   Lukowski AF, 2010, NUTR NEUROSCI, V13, P54, DOI 10.1179/147683010X12611460763689
   Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
NR 16
TC 1
Z9 1
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0065-2598
BN 978-1-4939-3023-4; 978-1-4939-3022-7
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2016
VL 876
BP 273
EP 279
DI 10.1007/978-1-4939-3023-4_34
PG 7
WC Medicine, Research & Experimental; Physiology
SC Research & Experimental Medicine; Physiology
GA BE6CG
UT WOS:000373880600035
PM 26782222
OA No
DA 2017-08-15
ER

PT J
AU Neuberger, A
   Okebe, J
   Yahav, D
   Paul, M
AF Neuberger, Ami
   Okebe, Joseph
   Yahav, Dafna
   Paul, Mical
TI Oral iron supplements for children in malaria-endemic areas
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Endemic Diseases; Anemia, Iron-Deficiency [etiology; prevention &
   control] Antimalarials [administration & dosage]; Dietary Supplements
   [adverse effects]; Folic Acid [adverse effects]; Iron [administration &
   dosage; adverse effects]; Malaria [chemically induced; complications];
   Parasitemia [chemically induced; complications]; Randomized Controlled
   Trials as Topic; Adolescent; Child; Child; Preschool; Humans
ID PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIALS;
   PAPUA-NEW-GUINEA; ROUTINE PROPHYLACTIC SUPPLEMENTATION; WEEKLY
   MICRONUTRIENT SUPPLEMENTATION; INTERMITTENT PREVENTIVE TREATMENT;
   ZANZIBARI PRESCHOOL-CHILDREN; FOLIC-ACID SUPPLEMENTATION; PRIMARY-SCHOOL
   CHILDREN; RURAL GAMBIAN CHILDREN
AB Background
   Iron-deficiency anaemia is common during childhood. Iron administration has been claimed to increase the risk of malaria.
   Objectives
   To evaluate the effects and safety of iron supplementation, with or without folic acid, in children living in areas with hyperendemic or holoendemic malaria transmission.
   Search methods
   We searched the Cochrane Infectious Diseases Group Specialized Register; the Cochrane Central Register of Controlled Trials (CENTRAL), published in the Cochrane Library, MEDLINE (up to August 2015) and LILACS (up to February 2015). We also checked the metaRegister of Controlled Trials (mRCT) and World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) up to February 2015. We contacted the primary investigators of all included trials, ongoing trials, and those awaiting assessment to ask for unpublished data and further trials. We scanned references of included trials, pertinent reviews, and previous meta-analyses for additional references.
   Selection criteria
   We included individually randomized controlled trials (RCTs) and cluster RCTs conducted in hyperendemic and holoendemic malaria regions or that reported on any malaria-related outcomes that included children younger than 18 years of age. We included trials that compared orally administered iron, iron with folic acid, and iron with antimalarial treatment versus placebo or no treatment. We included trials of iron supplementation or fortification interventions if they provided at least 80% of the Recommended Dietary Allowance (RDA) for prevention of anaemia by age. Antihelminthics could be administered to either group, and micronutrients had to be administered equally to both groups.
   Data collection and analysis
   The primary outcomes were clinical malaria, severe malaria, and death from any cause. We assessed the risk of bias in included trials with domain-based evaluation and assessed the quality of the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. We performed a fixed-effect meta-analysis for all outcomes and random-effects meta-analysis for hematological outcomes, and adjusted analyses for cluster RCTs. We based the subgroup analyses for anaemia at baseline, age, and malaria prevention or management services on trial-level data.
   Main results
   Thirty-five trials (31,955 children) met the inclusion criteria. Overall, iron does not cause an excess of clinical malaria (risk ratio (RR) 0.93, 95% confidence intervals (CI) 0.87 to 1.00; 14 trials, 7168 children, high quality evidence). Iron probably does not cause an excess of clinical malaria in both populations where anaemia is common and those in which anaemia is uncommon. In areas where there are prevention and management services for malaria, iron (with or without folic acid) may reduce clinical malaria (RR 0.91, 95% CI 0.84 to 0.97; seven trials, 5586 participants, low quality evidence), while in areas where such services are unavailable, iron (with or without folic acid) may increase the incidence of malaria, although the lower CIs indicate no difference (RR 1.16, 95% CI 1.02 to 1.31; nine trials, 19,086 participants, low quality evidence). Iron supplementation does not cause an excess of severe malaria (RR 0.90, 95% CI 0.81 to 0.98; 6 trials, 3421 children, high quality evidence). We did not observe any differences for deaths (control event rate 1%, low quality evidence). Iron and antimalarial treatment reduced clinical malaria (RR 0.54, 95% CI 0.43 to 0.67; three trials, 728 children, high quality evidence). Overall, iron resulted in fewer anaemic children at follow up, and the end average change in haemoglobin from base line was higher with iron.
   Authors' conclusions
   Iron treatment does not increase the risk of clinical malaria when regular malaria prevention or management services are provided. Where resources are limited, iron can be administered without screening for anaemia or for iron deficiency, as long asmalaria prevention or management services are provided efficiently.
C1 [Neuberger, Ami] Rambam Hlth Care Campus, Div Infect Dis, Tel Aviv, Israel.
   [Neuberger, Ami] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Tel Aviv, Israel.
   [Okebe, Joseph] MRC Unit, Banjul, Gambia.
   [Yahav, Dafna] Beilinson Med Ctr, Dept Med E, Rabin Med Ctr, Petah Tiqwa, Israel.
   [Paul, Mical] Rambam Hlth Care Campus, Div Infect Dis, Ha Aliya 8 St, IL-33705 Haifa, Israel.
RP Paul, M (reprint author), Rambam Hlth Care Campus, Div Infect Dis, Ha Aliya 8 St, IL-33705 Haifa, Israel.
EM paulm@post.tau.ac.il
FU Liverpool School of Tropical Medicine, UK; Department of Nutrition for
   Health and Development, World Health Organization, Switzerland;
   Department for International Development, UK
FX Internal sources; Liverpool School of Tropical Medicine, UK.; External
   sources; Department of Nutrition for Health and Development, World
   Health Organization, Switzerland.; Department for International
   Development, UK.
CR Abdelrazik N, 2007, INDIAN J PEDIATR, V74, P739, DOI 10.1007/s12098-007-0130-y
   Adam Z., 1997, THESIS LONDON SCH TR
   Adu-Afarwuah S, 2008, AM J CLIN NUTR, V87, P929
   Ahmed F, 2001, AM J CLIN NUTR, V74, P108
   AKENZUA GI, 1985, J TROP PEDIATRICS, V31, P59
   AngelesAgdeppa I, 1997, AM J CLIN NUTR, V66, P177
   Asibey-Berko E, 2007, East Afr Med J, V84, P473
   Ayoya MA, 2009, J NUTR, V139, P1972, DOI 10.3945/jn.109.106625
   Baird JK, 1997, LANCET, V350, P1855, DOI 10.1016/S0140-6736(05)63676-8
   BATES CJ, 1987, T ROY SOC TROP MED H, V81, P286, DOI 10.1016/0035-9203(87)90244-6
   BATES CJ, 1994, BRIT J NUTR, V72, P601, DOI 10.1079/BJN19940062
   Beard JL, 2001, J NUTR, V131, p568S
   Beasley NMR, 2000, TROP MED INT HEALTH, V5, P794, DOI 10.1046/j.1365-3156.2000.00641.x
   Beck HP, 1999, T ROY SOC TROP MED H, V93, pS41
   BENDERGOTZE C, 1980, FORTSCHR MED, V98, P590
   Berger J, 2006, EUR J CLIN NUTR, V60, P443, DOI 10.1038/sj.ejcn.1602336
   BERGER J, 1992, NUTR RES, V12, P39, DOI 10.1016/S0271-5317(05)80408-7
   Berger J, 2000, EUR J CLIN NUTR, V54, P29, DOI 10.1038/sj.ejcn.1600888
   Bhandari N, 2001, BRIT J NUTR, V85, pS131
   BOIVIN MJ, 1993, J PEDIATR PSYCHOL, V18, P249, DOI 10.1093/jpepsy/18.2.249
   Bojang KA, 1997, T ROY SOC TROP MED H, V91, P557, DOI 10.1016/S0035-9203(97)90025-0
   BRADFIELD RB, 1968, AM J CLIN NUTR, V21, P57
   BRADFIELD RB, 1968, AM J CLIN NUTR, V21, P68
   Breman JG, 2001, AM J TROP MED HYG, V64, P1
   Browne E, 2005, 4 MIM MAL C YAOUND C
   BRUNSER O, 1993, EUR J CLIN NUTR, V47, P317
   Carol Lefebvre, 2011, COCHRANE HDB SYSTEMA
   Carter JY, 2005, AM J TROP MED HYG, V73, P166
   Chandramohan D, 2005, BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727
   CHIPPAUX JP, 1991, B SOC PATHOL EXOT, V84, P54
   Chilenje Infant Growth Nutrition and Infection (CIGNIS) Study Team, 2010, PLOS ONE, V5
   Cusick SE, 2005, AM J CLIN NUTR, V82, P406
   Darboe MK, 2007, LANCET, V369, P2088, DOI 10.1016/S0140-6736(07)60981-7
   Desai MR, 2004, J NUTR, V134, P1167
   Desai MR, 2003, J INFECT DIS, V187, P658, DOI 10.1086/367986
   Dijkhuizen MA, 2001, J NUTR, V131, P2860
   Diouf S, 2002, ARCH PEDIATRIE, V9, P102, DOI 10.1016/S0929-693X(01)00704-7
   Dossa RAM, 2001, J NUTR, V131, P2874
   Dossa RAM, 2001, EUR J CLIN NUTR, V55, P223, DOI 10.1038/sj.ejcn.1601126
   Ekvall H, 2000, TROP MED INT HEALTH, V5, P696, DOI 10.1046/j.1365-3156.2000.00626.x
   Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002
   Esan MO, 2013, CLIN INFECT DIS, V57, P1626, DOI 10.1093/cid/cit528
   Fahmida U, 2007, ASIA PAC J CLIN NUTR, V16, P301
   FUERTH JH, 1972, J PEDIATR-US, V80, P974, DOI 10.1016/S0022-3476(72)80010-6
   Gara SN, 2010, AM J TROP MED HYG, V83, P843, DOI 10.4269/ajtmh.2010.10-0170
   Gebreselassie H., 1996, THESIS MCGILL U QUEB
   Gera T, 2002, BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142
   Gera T, 2002, BMJ-BRIT MED J, V325, P1142
   Gera T, 2007, J PEDIATR GASTR NUTR, V44, P468, DOI 10.1097/01.mpg.0000243440.85452.38
   Gewa CA, 2009, BRIT J NUTR, V101, P1378, DOI [10.1017/S0007114508066804, 10.1017/50007114508066804]
   Giovannini M, 2006, J PEDIATR GASTR NUTR, V42, P306, DOI 10.1097/01.mpg.0000189363.07040.4b
   Glinz D, 2015, AM J CLIN NUTR, V101, P462, DOI 10.3945/ajcn.114.090175
   Gomber S, 1998, INDIAN J MED RES, V107, P269
   Grantham-McGregor S, 2001, J NUTR, V131, p649S
   GREISEN G, 1986, ACTA PAEDIATR SCAND, V75, P662, DOI 10.1111/j.1651-2227.1986.tb10268.x
   Gulliford MC, 1999, AM J EPIDEMIOL, V149, P876
   Hall A, 2002, PUBLIC HEALTH NUTR, V5, P413, DOI 10.1079/PHN2001327
   HARVEY PWJ, 1989, AM J TROP MED HYG, V40, P12
   HATHIRAT P, 1992, BRIT J NUTR, V68, P245, DOI 10.1079/BJN19920081
   Hay SI, 2004, REPORT AGREEMENT PER
   Hess SY, 2002, AM J CLIN NUTR, V75, P743
   HEYWOOD A, 1989, AM J CLIN NUTR, V50, P630
   Higgins Jpt GS, 2011, COCHRANE HDB SYSTEMA
   Honig AS, 1978, INFANT BEHAV DEV, V1, P168, DOI 10.1016/S0163-6383(78)80027-7
   Hop LT, 2005, J NUTR, V135, p660S
   Le HT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-32
   Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261
   International Nutritional Anemia Consultative Group (INACG), 1999, INACG CONS STAT SAF
   Isager H, 1974, Scand J Haematol Suppl, V21, P1
   JACOBI H, 1972, Medizinische Welt, V23, P228
   Joint FAO/WHOExpert Consultation on Human Vitamin Mineral Requirements. Iron, 2005, VIT MIN REQ HUM NUTR, P246
   Kaiser R, 2006, DISASTERS, V30, P199, DOI 10.1111/j.0361-3666.2006.00315.x
   Kanani SJ, 2000, J NUTR, V130, p452S
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Kazembe PN, 1995, AM J TROPICAL MED S2, V53, P91
   Kleinschmidt H, 1985, MUNCHEN MED WOCHEN, V107, P1835
   Kochan I, 1973, Curr Top Microbiol Immunol, V60, P1
   Kordas K, 2005, J PEDIATR-US, V147, P632, DOI 10.1016/j.jpeds.2005.06.037
   Kurz KM, 1985, THESIS CORNELL U ITH
   LATHAM MC, 1990, NUTRITION, V6, P159
   LAWLESS JW, 1994, J NUTR, V124, P645
   le Cessie S, 2002, ARCH DIS CHILD, V86, P182, DOI 10.1136/fn.86.3.F182
   Le Huong Thi, 2007, Br J Nutr, V97, P955
   Leenstra T, 2009, EUR J CLIN NUTR, V63, P173, DOI 10.1038/sj.ejcn.1602919
   Lima Ana C V M S, 2006, J Pediatr (Rio J), V82, P452, DOI 10.1590/S0021-75572006000800010
   Liu X N, 1996, Biomed Environ Sci, V9, P341
   Liu Xu-Nian, 1995, Food and Nutrition Bulletin, V16, P139
   Low M, 2013, CAN MED ASSOC J, V185, pE791, DOI 10.1503/cmaj.130628
   LOZOFF B, 1987, PEDIATRICS, V79, P981
   Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7
   LOZOFF B, 1982, J PEDIATR-US, V100, P351, DOI 10.1016/S0022-3476(82)80428-9
   Lynch S, 2011, AM J CLIN NUTR, V93, P1188, DOI 10.3945/ajcn.111.015214
   Mamiro P R, 2001, Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet, V66, P291
   Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0
   Mburu ASW, 2008, J NUTR, V138, P613
   Mebrahtu T, 2004, J NUTR, V134, P3037
   Mei ZG, 2005, J NUTR, V135, P1974
   Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9
   Menendez C, 2004, AM J TROP MED HYG, V71, P434
   Menendez C, 2002, PEDIATR INFECT DIS J, V21, P249, DOI 10.1097/00006454-200203000-00016
   Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3
   Meremikwu MM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003756.pub2
   Metz J, 2007, FOOD NUTR BULL, V28, pS540
   Migasena P, 1972, Southeast Asian J Trop Med Public Health, V3, P255
   Mitra AK, 1997, J NUTR, V127, P1451
   Mosha TCE, 2014, TANZANIA J HLTH RES, V16, P2
   Mozaffari-Khosravi H, 2010, BIOL TRACE ELEM RES, V135, P22, DOI 10.1007/s12011-009-8480-0
   Mulenga M, 2006, AM J TROP MED HYG, V74, P986
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   MURRAY MJ, 1978, BRIT MED J, V2, P1113
   Mwanakasale V, 2009, MALAWI MED J, V21, P12
   Mwanri L, 2000, J NUTR, V130, P2691
   Nchito M, 2004, T ROY SOC TROP MED H, V98, P218, DOI 10.1016/S0035-9203(03)00045-2
   Ngnie-Teta I, 2007, FOOD NUTR BULL, V28, P76
   Nguyen Xuan Ninh, 2002, Sante, V12, P31
   The Nordic Cochrane Centre The Cochrane Collaboration, 2014, REV MAN REVMAN VERS
   Nwanyanwu OC, 1996, ANN TROP MED PARASIT, V90, P589
   Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331
   Ojukwu JU, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub2
   Ojukwu JU, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589
   Okebe JU, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub3
   Olney DK, 2006, J NUTR, V136, P2427
   Olsen A, 2006, ANN TROP MED PARASIT, V100, P251, DOI 10.1179/136485906X91486
   OPPENHEIMER SJ, 1987, T ROY SOC TROP MED H, V81, P322, DOI 10.1016/0035-9203(87)90253-7
   OPPENHEIMER SJ, 1986, T ROY SOC TROP MED H, V80, P603, DOI 10.1016/0035-9203(86)90154-9
   Oppenheimer SJ, 2001, J NUTR, V131, p616S
   OPPENHEIMER SJ, 1984, LANCET, V1, P389
   OPPENHEIMER SJ, 1986, T ROY SOC TROP MED H, V80, P596, DOI 10.1016/0035-9203(86)90153-7
   Oppenheimer Stephen, 2012, Paediatr Int Child Health, V32 Suppl 2, pS21, DOI 10.1179/2046904712Z.00000000075
   OSKI FA, 1983, PEDIATRICS, V71, P877
   OSKI FA, 1978, J PEDIATR-US, V92, P21, DOI 10.1016/S0022-3476(78)80063-8
   Ouedraogo HZ, 2010, PUBLIC HEALTH NUTR, V13, P1923, DOI 10.1017/S1368980010000911
   Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522
   PEREIRA SM, 1978, BRIT J NUTR, V39, P493, DOI 10.1079/BJN19780065
   POLLITT E, 1989, AM J CLIN NUTR, V50, P687
   POLLITT E, 1993, ANNU REV NUTR, V13, P521, DOI 10.1146/annurev.nutr.13.1.521
   POWERS HJ, 1983, HUM NUTR-CLIN NUTR, V37, P413
   Rahimy MC, 2007, PEDIATR BLOOD CANCER, V48, P544, DOI 10.1002/pbc.21103
   Rahman MM, 1999, J NUTR, V129, P1319
   Ramakrishnan U, 2004, J NUTR, V134, P2592
   Rice AL, IRON SUPPLEMENTATION
   Richard SA, 2006, AM J TROP MED HYG, V75, P126
   Rico JA, 2006, PEDIATRICS, V117, pE518, DOI 10.1542/peds.2005-1172
   Rohner F, 2010, J NUTR, V140, P635, DOI 10.3945/jn.109.114256
   Roschnik N, 2004, TROP MED INT HEALTH, V9, P904, DOI 10.1111/j.1365-3156.2004.01279.x
   Roschnik N., 2003, IMPACT WEEKLY SCH BA
   Roth DE, 2010, EVID BASED CHILD HLT, V5, P1186, DOI DOI 10.1002/EBCH.505
   Sachdev HPS, 2006, PUBLIC HEALTH NUTR, V9, P904, DOI 10.1017/PHN2005918
   Sachdev HPS, 2005, PUBLIC HEALTH NUTR, V8, P117, DOI 10.1079/PHN2004677
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8
   Schellenberg D, 2004, AM J TROP MED HYG, V71, P428
   Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2
   Schneider D, 1996, B SOC PATHOL EXOT, V88, P260
   Schumann K, 2009, EUR J CLIN NUTR, V63, P355, DOI 10.1038/sj.ejcn.1602930
   SCHULTINK W, 1995, AM J CLIN NUTR, V61, P111
   SESHADRI S, 1982, BRIT J NUTR, V48, P233, DOI 10.1079/BJN19820109
   Sharma A, 2000, Indian Pediatr, V37, P261
   Siegel E, 2004, THESIS J HOPKINS U
   SINGLA PN, 1982, J TROP PEDIATRICS, V28, P77
   SMITH AW, 1989, ANN TROP PAEDIATR, V9, P17
   SMITH AW, 1989, ANN TROP PAEDIATR, V9, P6
   Smuts CM, 2005, J NUTR, V135, p631S
   Stoltzfus Rebecca, 2010, Int J Epidemiol, V39, P34, DOI 10.1093/ije/dyp368
   Stoltzfus RJ, 2011, J NUTR, V141, p756S, DOI 10.3945/jn.110.128793
   Stoltzfus RJ, 2004, J NUTR, V134, P348
   Stoltzfus RJ, 2001, BRIT MED J, V323, P1389, DOI 10.1136/bmj.323.7326.1389
   Stoltzfus RJ, 1997, NUTR REV, V55, P223
   Stoltzfus RJ, 2004, COMP QUANTIFICATION, V1
   Stoltzfus RJ, 1998, GUIDELINES USE IRON
   Suchdev PS, 2010, J NUTR, V140, P875, DOI 10.3945/jn.109.118638
   Sungthong R, 2002, J NUTR, V132, P418
   Tee ES, 1999, AM J CLIN NUTR, V69, P1249
   Terlouw DJ, 2004, AM J CLIN NUTR, V79, P466
   Thompson J, 2013, PEDIATRICS, V131, P739, DOI 10.1542/peds.2012-2256
   Thu BD, 1999, AM J CLIN NUTR, V69, P80
   Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284
   Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4
   Tomashek KM, 2001, AM J TROP MED HYG, V64, P164
   Troesch B, 2011, J NUTR, V141, P237, DOI 10.3945/jn.110.129247
   United Nations, MILL DEV GOALS
   United Nations Children's Fund (UNICEF), 1998, STAT WORLDS CHILDR 1
   Untoro J, 2005, J NUTR, V135, p639S
   Institute of Medicine (US), 1998, DIET REF INT
   vandenHombergh J, 1996, J TROP PEDIATRICS, V42, P220, DOI 10.1093/tropej/42.4.220
   vanHensbroek MB, 1995, T ROY SOC TROP MED H, V89, P672, DOI 10.1016/0035-9203(95)90438-7
   VAUGHAN JP, 1977, TROP GEOGR MED, V29, P369
   Verhoef H, 2002, BLOOD, V100, P3489, DOI 10.1182/blood-2001-12-0228
   Verhoef H, 2002, LANCET, V360, P908, DOI 10.1016/S0140-6736(02)11027-0
   WALTER T, 1986, AM J CLIN NUTR, V44, P877
   WALTER T, 1989, PEDIATRICS, V84, P7
   WALTER T, 1989, AM J CLIN NUTR, V50, P655
   Wang B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001444.pub2
   Wegmuller R, 2006, J NUTR, V136, P1814
   WHO, 2011, WHONMHNHDMNM112
   World Health Organization Malaria Control Unit, AFR MAL REP 2003
   WHO, 2011, WHONMHNHDMNM111
   WHO, 2007, FOOD NUTR BULL, V28, pS621
   World Health Organization/Centers for Disease Control and Prevention, 2004, ASS IR STAT POP 2004
   World Health Organization, WORLDW PREV AN REP 1
   WHO, 2011, US MULT MICR POWD HO
   WORLD HEALTH ORGANIZATION, GUID TREATM MAL
   WHO, WORLD MALARIA REPORT
   Wijaya-Erhardt M, 2007, AM J CLIN NUTR, V86, P1680
   Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615
   Zimmermann MB, IRON FORTIFICATION P
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
   Zlotkin S, 2003, B WORLD HEALTH ORGAN, V81, P108
   Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129
   [Anonymous], 2006, PRESCRIRE INT, V15, P233
NR 210
TC 2
Z9 2
U1 5
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2016
IS 2
AR CD006589
DI 10.1002/14651858.CD006589.pub4
PG 132
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI1VP
UT WOS:000373285000027
OA No
DA 2017-08-15
ER

PT J
AU Delgado-Ratto, C
   Gamboa, D
   Soto-Calle, VE
   Van den Eede, P
   Torres, E
   Sanchez-Martinez, L
   Contreras-Mancilla, J
   Rosanas-Urgell, A
   Ferrucci, HR
   Llanos-Cuentas, A
   Erhart, A
   Van Geertruyden, JP
   D'Alessandro, U
AF Delgado-Ratto, Christopher
   Gamboa, Dionicia
   Soto-Calle, Veronica E.
   Van den Eede, Peter
   Torres, Eliana
   Sanchez-Martinez, Luis
   Contreras-Mancilla, Juan
   Rosanas-Urgell, Anna
   Ferrucci, Hugo Rodriguez
   Llanos-Cuentas, Alejandro
   Erhart, Annette
   Van Geertruyden, Jean-Pierre
   D'Alessandro, Umberto
TI Population Genetics of Plasmodium vivax in the Peruvian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ALLELE FREQUENCY DATA; TRANSMISSION DYNAMICS; MALARIA CONTROL;
   MICROSATELLITE DIVERSITY; RURAL AMAZONIA; FALCIPARUM; INFECTIONS;
   GENOMICS; CLUSTERS; PROGRAM
AB Background
   Characterizing the parasite dynamics and population structure provides useful information to understand the dynamic of transmission and to better target control interventions. Despite considerable efforts for its control, vivax malaria remains a major health problem in Peru. In this study, we have explored the population genetics of Plasmodium vivax isolates from Iquitos, the main city in the Peruvian Amazon, and 25 neighbouring peri-urban as well as rural villages along the Iquitos-Nauta Road.
   Methodology/Results
   From April to December 2008, 292 P. vivax isolates were collected and successfully genotyped using 14 neutral microsatellites. Analysis of the molecular data revealed a similar proportion of monoclonal and polyclonal infections in urban areas, while in rural areas monoclonal infections were predominant (p = 0.002). Multiplicity of infection was higher in urban (MOI = 1.5-2) compared to rural areas (MOI = 1) (p = 0.003). The level of genetic diversity was similar in all areas (He = 0.66-0.76, p = 0.32) though genetic differentiation between areas was substantial (PHIPT = 0.17, p<0.0001). Principal coordinate analysis showed a marked differentiation between parasites from urban and rural areas. Linkage disequilibrium was detected in all the areas (I-A(S) = 0.08-0.49, for all p<0.0001). Gene flow among the areas was stablished through Bayesian analysis of migration models. Recent bottleneck events were detected in 4 areas and a recent parasite expansion in one of the isolated areas. In total, 87 unique haplotypes grouped in 2 or 3 genetic clusters described a sub-structured parasite population.
   Conclusion/Significance
   Our study shows a sub-structured parasite population with clonal propagation, with most of its components recently affected by bottleneck events. Iquitos city is the main source of parasite spreading for all the peripheral study areas. The routes of transmission and gene flow and the reduction of the parasite population described are important from the public health perspective as well for the formulation of future control policies.
C1 [Delgado-Ratto, Christopher; Van Geertruyden, Jean-Pierre] Univ Antwerp, Epidemiol Global Hlth Inst, B-2020 Antwerp, Belgium.
   [Gamboa, Dionicia; Soto-Calle, Veronica E.; Torres, Eliana; Sanchez-Martinez, Luis; Contreras-Mancilla, Juan; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru.
   [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru.
   [Rosanas-Urgell, Anna; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Ferrucci, Hugo Rodriguez] Minist Hlth, Loreto, Peru.
   [D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
RP Delgado-Ratto, C (reprint author), Univ Antwerp, Epidemiol Global Hlth Inst, B-2020 Antwerp, Belgium.
EM chris.delgadoratto@uantwerp.be
RI Rosanas-Urgell, Anna/D-3193-2015
OI Rosanas-Urgell, Anna/0000-0002-0432-5203; Delgado-Ratto,
   Christopher/0000-0003-2300-5181; Contreras Mancilla, Juan
   Jose/0000-0003-0447-0926
FU Directorate General for Development Cooperation (DGCD) of the Belgian
   Government [95501, 95502]
FX The sample collection was funded by the Directorate General for
   Development Cooperation (DGCD) of the Belgian Government (framework
   agreement 2 and 3; project 95501 and 95502 respectively):
   http://diplomatie.belgium.be/en/policy/development_cooperation/. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x
   Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552
   Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14
   Barry AE, 2015, PATHOG GLOB HEALTH, V109, P142, DOI 10.1179/2047773215Y.0000000012
   Batista CL, 2014, PARASITOLOGY, P1
   Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803
   Beerli P., 2009, USE MIGRATE WHY ARE
   Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532
   Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27
   Carlton JM, 2013, ADV PARASIT, V81, P203, DOI 10.1016/B978-0-12-407826-0.00005-9
   Chapilliquen F, 2015, SITUACION EPIDEMIOLO
   Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412
   Cornuet JM, 1996, GENETICS, V144, P2001
   Cristescu R, 2009, CONSERV GENET, V11, P1043
   Delgado-Ratto C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-8
   Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7
   Erhart A, 2014, 63 ANN M AM SOC TROP, P291
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685
   Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87
   Gething PW, 2012, PLOS NEGLECT TROP D, V6, pe1814, DOI [10.1371/journal.pntd.0001814, DOI 10.1371/J0URNAL.PNTD.0001814]
   Goudet J, 1995, J HERED, V86, P485
   Graf PCF, 2012, MALAR RES TREAT, V2012, DOI DOI 10.1155/2012/936067
   Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303
   Guarda JA, 1999, EMERG INFECT DIS, V5, P209
   Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278
   Gutierrez S, 2003, MANUAL PROCEDIMIENTO, P7
   Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847
   Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95
   Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x
   Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022
   Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872
   Kosek M, 2012, AM J TROP MED HYG, V86, P580, DOI 10.4269/ajtmh.2012.11-0627
   Mateo Lizarbe S, 2013, REEMERGENCIA MALARIA
   Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x
   Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x
   McCollum AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-67
   Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047
   Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x
   Menegon M, 2014, INFECT GENET EVOL, V27, P244, DOI 10.1016/j.meegid.2014.07.029
   ORAS-CONHU, 2009, COMP LECC APR PROYEC
   Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029
   Orjuela-Sanchez P, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-65
   Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337
   Peakall R, 2012, BIOINFORMATICS
   PEAKALL R.E., 2006, MOL ECOL NOTES, V6, P288, DOI DOI 10.1111/J.1471-8286.2005.01155.X
   Piry S, 1999, BOTTLENECK COMPUTER
   PLOWE CV, 1995, AM J TROP MED HYG, V52, P565
   Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x
   Roshanravan B, 2003, AM J TROP MED HYG, V69, P45
   Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5
   SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384
   Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447
   Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132
   Thanapongpichat S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-275
   Tibayrenc M, 2014, ADV PARASIT, V84, P253, DOI 10.1016/B978-0-12-800099-1.00005-3
   Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257
   Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151
   Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458
   Volkman SK, 2012, NAT REV GENET, V13, P315, DOI 10.1038/nrg3187
   Volkman SK, 2012, ACTA TROP, V121, P324, DOI 10.1016/j.actatropica.2011.12.002
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
NR 65
TC 4
Z9 4
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2016
VL 10
IS 1
AR e0004376
DI 10.1371/journal.pntd.0004376
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1SR
UT WOS:000372565700070
PM 26766548
OA gold
DA 2017-08-15
ER

PT J
AU Oyelakin, O
   Traore, M
   Mbaye, EB
   Konte, A
   Cisse, L
   Faye, AN
   Faye, O
   Mbaye, M
   Kital, K
   Seye, G
   Coly, A
   Tine, A
   Delattre, F
AF Oyelakin, Oladele
   Traore, Moumouny
   Mbaye, El Hadji Babacar
   Konte, Abdourahmane
   Cisse, Lamine
   Faye, Abdoulaye N.
   Faye, Ousman
   Mbaye, Moussa
   Kital, Khemesse
   Seye, Gaye
   Coly, Atanasse
   Tine, Alphonse
   Delattre, Francois
TI Spectrofluorometric Determination of Putrescine Using Orthophthaladehyde
   as a Fluorophore: A Novel Method
SO JOURNAL OF AOAC INTERNATIONAL
LA English
DT Article
ID BIOGENIC-AMINES; POLYAMINE ANALOGS; CHEESE-MAKING; CANCER-CELLS; FOODS
AB This paper concerns spectrofluorometric analysis of putrescine using orthophthaladehyde as a fluorophore in aqueous alkaline medium. Wavelengths of excitation and emission in acid, neutral, and alkaline media were different. There is a maximum intensity of fluorescence in alkaline medium 24 h after complexation compared with other media. Putrescine and orthophthaladehyde are used at an equimolar ratio, and the product is kinetically stable in alkaline medium. Calibration curves obtained gave limits of detection and quantification of 39 and 65 ng/mL, respectively. The correlation coefficient obtained in alkaline medium was 0.992 at pH 12. Results obtained largely showed a good reproducibility of our method.
C1 [Oyelakin, Oladele] Univ Gambia, Sch Arts & Sci, Div Phys & Nat Sci, Kunda, Gambia.
   [Traore, Moumouny; Mbaye, El Hadji Babacar; Konte, Abdourahmane; Cisse, Lamine; Faye, Abdoulaye N.; Faye, Ousman; Mbaye, Moussa; Kital, Khemesse; Seye, Gaye; Coly, Atanasse; Tine, Alphonse] Univ Cheikh Anta Diop, Fac Sci & Tech, Dept Chim, Lab Photochim & Analyse, Dakar, Senegal.
   [Delattre, Francois] Univ Littorale Cote Opale, Unite Chim Environm & Interact Vivant, BP 59140, Dunkerque, France.
RP Oyelakin, O (reprint author), Univ Gambia, Sch Arts & Sci, Div Phys & Nat Sci, Kunda, Gambia.
EM ooyelakin@utg.edu.gm
FU University of The Gambia
FX This work was financed partly by the University of The Gambia. This is
   highly appreciated. Thanks go to Muhammadou M.O. Kah, Omar Jah, Pierre
   Gomez, Isatou Drammeh, Mariam Jobe, Sainabou Jobe, and Ebrima Tunkara
   for their contributions.
CR ANTILA P, 1983, KIELER MILCHW FORSCH, V35, P373
   Bardocz A., 1995, TRENDS FOOD SCI TECH, V6, P341
   Bergeron RJ, 2000, J MED CHEM, V43, P224, DOI 10.1021/jm990375z
   Cinquina AL, 2004, J CHROMATOGR A, V1032, P73, DOI 10.1016/j.chroma.2004.01.013
   den Brinker CA, 2003, AUST J EXP AGR, V43, P113, DOI 10.1071/EA01147
   Gennaro MC, 2003, FOOD CHEM, V82, P545, DOI 10.1016/S0308-8146(03)00009-8
   Kuhn D.M., 1982, NUTR TOXICOLOGY
   LOVENBERG W, 1974, J AGR FOOD CHEM, V22, P23, DOI 10.1021/jf60191a032
   McCloskey DE, 2000, CLIN CANCER RES, V6, P17
   Moret S, 2005, FOOD CHEM, V89, P355, DOI 10.1016/j.foodchem.2004.02.050
   MORET S, 1992, J CHROMATOGR, V591, P175, DOI 10.1016/0021-9673(92)80235-M
   Nairn LM, 2000, J CELL PHYSIOL, V182, P209, DOI 10.1002/(SICI)1097-4652(200002)182:2<209::AID-JCP9>3.0.CO;2-8
   TENBRINK B, 1990, INT J FOOD MICROBIOL, V11, P73, DOI 10.1016/0168-1605(90)90040-C
NR 13
TC 1
Z9 1
U1 0
U2 0
PU AOAC INT
PI GAITHERSBURG
PA 481 N FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 USA
SN 1060-3271
EI 1944-7922
J9 J AOAC INT
JI J. AOAC Int.
PD JAN-FEB
PY 2016
VL 99
IS 1
BP 170
EP 173
DI 10.5740/jaoacint.15-0212
PG 4
WC Chemistry, Analytical; Food Science & Technology
SC Chemistry; Food Science & Technology
GA DG3EX
UT WOS:000371953400020
PM 26856313
OA No
DA 2017-08-15
ER

PT J
AU Raiten, DJ
   Neufeld, LM
   De-Regil, LM
   Pasricha, SR
   Darnton-Hill, I
   Hurrell, R
   Murray-Kolb, LE
   Nair, KM
   Wefwafwa, T
   Kupka, R
   Phall, MC
   Ashour, FAS
AF Raiten, Daniel J.
   Neufeld, Lynnette M.
   De-Regil, Luz-Maria
   Pasricha, Sant-Rayn
   Darnton-Hill, Ian
   Hurrell, Richard
   Murray-Kolb, Laura E.
   Nair, K. Madhavan
   Wefwafwa, Terry
   Kupka, Roland
   Phall, Modou Cheyassin
   Ashour, Fayrouz A. Sakr
TI Integration to Implementation and the Micronutrient Forum: A Coordinated
   Approach for Global Nutrition. Case Study Application: Safety and
   Effectiveness of Iron Interventions
SO ADVANCES IN NUTRITION
LA English
DT Review
DE anemias; international nutrition; interventions; iron; public health
ID RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; YOUNG-CHILDREN;
   GAMBIAN CHILDREN; AFRICAN CHILDREN; STABLE-ISOTOPE; COTE-DIVOIRE;
   ANEMIA; FORTIFICATION; MALARIA
AB Paramount among the challenges to our ability to address the role of food and nutrition in health promotion and disease prevention is how to design and implement context-specific interventions and guidance. The Integration to Effective Implementation (I-to-I) concept is intended to address the complexities of the global health context through engagement of the continuum of stakeholders involved in the food and nutrition enterprise. The 2014 Micronutrient Forum (MNF) Global Conference held in Addis Ababa, Ethiopia, in June 2014 offered the opportunity to apply the I-to-I approach with the use of current concerns about the safety and effectiveness of interventions to prevent and treat iron deficiency (ID) as a case study. ID is associated with a range of adverse outcomes, especially in pregnant and nonpregnant women, infants, and primary school-age children. Strategies to combat ID include iron supplementation, multiple micronutrient powders, and food-based interventions to enhance dietary iron intake. Recent reports indicate potential increased adverse risks when iron is provided in areas with high infection burdens (e.g., malaria). This paradox has weakened iron intervention programs. Furthermore, the selection and interpretation of available biomarkers for assessing iron nutrition have been found to be compromised by the inflammatory process. These issues highlight the need for a comprehensive approach that considers basic biology, assessment, interventions, and howthese can be translated into appropriate programs and policies. The application of the I-to-I with the use of the MNF offered an opportunity to explore how that might be achieved.
C1 [Raiten, Daniel J.; Ashour, Fayrouz A. Sakr] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bldg 10, Bethesda, MD 20892 USA.
   [Neufeld, Lynnette M.] Global Alliance Improved Nutr, Geneva, Switzerland.
   [De-Regil, Luz-Maria] Micronutrient Initiat, Ottawa, ON, Canada.
   [Pasricha, Sant-Rayn] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England.
   [Darnton-Hill, Ian] Univ Sydney, Fac Med, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia.
   [Hurrell, Richard] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland.
   [Murray-Kolb, Laura E.] Penn State Univ, Nut Sci, State Coll, PA USA.
   [Nair, K. Madhavan] Indian Council Med Res, Natl Inst Nutr, Dept Biophys, Jamai Osmania Po, Hyderabad 500007, Andhra Pradesh, India.
   [Wefwafwa, Terry] Minist Hlth, Div Nutr, Nairobi, Kenya.
   [Kupka, Roland] UNICEF, New York, NY USA.
   [Phall, Modou Cheyassin] Natl Nutr Agcy, Banjul, Gambia.
RP Raiten, DJ (reprint author), NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bldg 10, Bethesda, MD 20892 USA.
EM raitend@mail.nih.gov
FU The Iron and Malaria Project - Bill and Melinda Gates Foundation; Eunice
   Kennedy Shriver National Institute of Child Health and Human Development
FX Supported by the parent grant The Iron and Malaria Project, funded by
   the Bill and Melinda Gates Foundation and the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development. This is a free
   access article, distributed under terms
   (http://www.nutrition.org/publications/guidelines-and-policies/license/)
   that permit unrestricted noncommercial use, distribution, and
   reproduction in any medium, provided the original work is properly
   cited.
CR Andang'o PEA, 2007, LANCET, V369, P1799, DOI 10.1016/S0140-6736(07)60817-4
   Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957
   Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014
   BATES CJ, 1987, T ROY SOC TROP MED H, V81, P286, DOI 10.1016/0035-9203(87)90244-6
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Blanton CA, 2013, BRIT J NUTR, V109, P906, DOI 10.1017/S0007114512002620
   Brittenham GM, 2014, AM J CLIN NUTR, V100, P813, DOI 10.3945/ajcn.113.081505
   Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051
   Christian P, 2010, JAMA-J AM MED ASSOC, V304, P2716, DOI 10.1001/jama.2010.1861
   De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008959.pub2
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Duffy LC, 2015, J NUTR, V145, p1123S, DOI 10.3945/jn.114.194936
   Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013
   Glinz D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-397
   Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4
   Habicht JP, 2014, ADV NUTR, V5, P27, DOI 10.3945/an.113.004689
   Harding KB, 2012, ADV NUTR, V3, P551, DOI 10.3945/an.111.000760
   Hurrell R, 2010, FOOD NUTR BULL, V31, pS7
   Iron and Malaria Technical Working Group, 2009, CONS SAF EFF US IR I
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   Johnston JL, 2014, ADV NUTR, V5, P418, DOI 10.3945/an.113.005553
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108
   Lozoff B, 2013, J PEDIATR-US, V163, P1260, DOI 10.1016/j.jpeds.2013.05.015
   Lozoff B, 2012, ARCH PEDIAT ADOL MED, V166, P208, DOI 10.1001/archpediatrics.2011.197
   Martorell R, 2015, AM J CLIN NUTR, V101, P210, DOI 10.3945/ajcn.114.097709
   McMichael T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1359
   Murray-Kolb LE, 2007, AM J CLIN NUTR, V85, P778
   Murray-Kolb LE, 2009, AM J CLIN NUTR, V89, P946
   Nguyen PH, 2015, EUR J CLIN NUTR, V69, P107, DOI 10.1038/ejcn.2014.181
   Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x
   Ojukwu JU, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub2
   OPPENHEIMER SJ, 1986, T ROY SOC TROP MED H, V80, P603, DOI 10.1016/0035-9203(86)90154-9
   Oppenheimer SJ, 2001, J NUTR, V131, p616S
   Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249
   Pasricha SR, 2014, BLOOD, V123, P611, DOI 10.1182/blood-2013-12-543405
   Pasricha SR, 2013, LANCET GLOB HEALTH, V1, pE77, DOI 10.1016/S2214-109X(13)70046-9
   Pena-Rosas JP, 2012, J NUTR, V142, p197S, DOI 10.3945/jn.111.138834
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   Raiten DJ, 2015, J NUTR, V145, p1039S, DOI 10.3945/jn.114.194571
   Raiten DJ., 2011, AM J CLIN NUTR, V94, p1697S, DOI DOI 10.3945/AJCN.111.019109
   Salam RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S22
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   SMITH AW, 1989, ANN TROP PAEDIATR, V9, P17
   Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7
   [Anonymous], 2013, SCAL UP NUTR
   van Ommen B, 2004, NUTRITION, V20, P4, DOI 10.1016/j.nut.2003.09.003
   van Ommen B, 2008, GENES NUTR, V3, P51, DOI 10.1007/s12263-008-0084-3
   Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2
   Wegmuller R, 2006, J NUTR, V136, P1814
   WHO, 2012, PRIOR ASS VIT A IR S
   WHO, 2011, HAEM CONC DIAGN AN A
   WHO, 2009, WEEKL IR FOL AC SUPP
   WHO, 2012, DAIL IR FOL AC SUPPL
   WHO, 2007, FOOD NUTR BULL, V28, pS621
   WHO, 2012, INT IR FOL AC SUPPL
   World Health Organization, 2011, SER FERR CONC ASS IR
   World Health Organization, 2011, US MULT MICR POWD HO
   WHO, 2002, WORLD HLTH REP
   [Anonymous], 2011, INT IR SUPPL PRESCH
   WHO, 2009, INT APPR NUTR CAR HI
   World Health Organization, 2011, INT IR FOL AC SUPPL
   WHO UNICEF, 2006, IR SUPPL YOUNG CHILD
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
   Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129
   [Anonymous], THOUSAND DAYS
   [Anonymous], MICRONUTRIENT FORUM
   [Anonymous], PEPFAR
NR 69
TC 1
Z9 1
U1 3
U2 9
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 2161-8313
EI 2156-5376
J9 ADV NUTR
JI Adv. Nutr.
PD JAN
PY 2016
VL 7
IS 1
BP 135
EP 148
DI 10.3945/an.115.008581
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DC3HX
UT WOS:000369111500013
PM 26773021
OA No
DA 2017-08-15
ER

PT J
AU Kremsner, PG
   Adegnika, AA
   Hounkpatin, AB
   Zinsou, JF
   Taylor, TE
   Chimalizeni, Y
   Liomba, A
   Kombila, M
   Bouyou-Akotet, MK
   Mboumba, DPM
   Agbenyega, T
   Ansong, D
   Sylverken, J
   Ogutu, BR
   Otieno, GA
   Wangwe, A
   Bojang, KA
   Okomo, U
   Sanya-Isijola, F
   Newton, CR
   Njuguna, P
   Kazungu, M
   Kerb, R
   Geditz, M
   Schwab, M
   Velavan, TP
   Nguetse, C
   Kohler, C
   Issifou, S
   Bolte, S
   Engleitner, T
   Mordmuller, B
   Krishna, S
AF Kremsner, Peter G.
   Adegnika, Akim A.
   Hounkpatin, Aurore B.
   Zinsou, Jeannot F.
   Taylor, Terrie E.
   Chimalizeni, Yamikani
   Liomba, Alice
   Kombila, Maryvonne
   Bouyou-Akotet, Marielle K.
   Mboumba, Denise P. Mawili
   Agbenyega, Tsiri
   Ansong, Daniel
   Sylverken, Justice
   Ogutu, Bernhards R.
   Otieno, Godfrey A.
   Wangwe, Anne
   Bojang, Kalifa A.
   Okomo, Uduak
   Sanya-Isijola, Frank
   Newton, Charles R.
   Njuguna, Patricia
   Kazungu, Michael
   Kerb, Reinhold
   Geditz, Mirjam
   Schwab, Matthias
   Velavan, Thirumalaisamy P.
   Nguetse, Christian
   Koehler, Carsten
   Issifou, Saadou
   Bolte, Stefanie
   Engleitner, Thomas
   Mordmueller, Benjamin
   Krishna, Sanjeev
TI Intramuscular Artesunate for Severe Malaria in African Children: A
   Multicenter Randomized Controlled Trial
SO PLOS MEDICINE
LA English
DT Article
ID SEVERE FALCIPARUM-MALARIA; SEVERE IMPORTED MALARIA; INTRAVENOUS
   ARTESUNATE; DELAYED HEMOLYSIS; POPULATION PHARMACOKINETICS;
   PLASMODIUM-FALCIPARUM; CLINICAL EFFICACY; QUININE; BIOAVAILABILITY;
   ARTEMETHER
AB Background
   Current artesunate (ARS) regimens for severe malaria are complex. Once daily intramuscular (i.m.) injection for 3 d would be simpler and more appropriate for remote health facilities than the current WHO-recommended regimen of five intravenous (i.v.) or i.m. injections over 4 d. We compared both a three-dose i.m. and a three-dose i.v. parenteral ARS regimen with the standard five-dose regimen using a non-inferiority design (with non-inferiority margins of 10%).
   Methods and Findings
   This randomized controlled trial included children (0.5-10 y) with severe malaria at seven sites in five African countries to assess whether the efficacy of simplified three-dose regimens is non-inferior to a five-dose regimen. We randomly allocated 1,047 children to receive a total dose of 12 mg/kg ARS as either a control regimen of five i.m. injections of 2.4 mg/kg (at 0, 12, 24, 48, and 72 h) (n = 348) or three injections of 4 mg/kg (at 0, 24, and 48 h) either i.m. (n = 348) or i.v. (n = 351), both of which were the intervention arms. The primary endpoint was the proportion of children with >= 99% reduction in parasitemia at 24 h from admission values, measured by microscopists who were blinded to the group allocations. Primary analysis was performed on the per-protocol population, which was 96% of the intention-to-treat population. Secondary analyses included an analysis of host and parasite genotypes as risks for prolongation of parasite clearance kinetics, measured every 6 h, and a Kaplan-Meier analysis to compare parasite clearance kinetics between treatment groups. A post hoc analysis was performed for delayed anemia, defined as hemoglobin <= 7g/dl 7 d or more after admission.
   The per-protocol population was 1,002 children (five-dose i.m.: n = 331; three-dose i.m.: n = 338; three-dose i.v.: n = 333); 139 participants were lost to follow-up. In the three-dose i.m. arm, 265/338 (78%) children had a >= 99% reduction in parasitemia at 24 h compared to 263/331 (79%) receiving the five-dose i.m. regimen, showing non-inferiority of the simplified three-dose regimen to the conventional five-dose regimen (95% CI -7, 5; p = 0.02). In the three-dose i.v. arm, 246/333 (74%) children had >= 99% reduction in parasitemia at 24 h; hence, non-inferiority of this regimen to the five-dose control regimen was not shown (95% CI -12, 1; p = 0.24). Delayed parasite clearance was associated with the (N86Y)Pfmdr1 genotype. In a post hoc analysis, 192/885 (22%) children developed delayed anemia, an adverse event associated with increased leukocyte counts. There was no observed difference in delayed anemia between treatment arms.
   A potential limitation of the study is its open-label design, although the primary outcome measures were assessed in a blinded manner.
   Conclusions
   A simplified three-dose i.m. regimen for severe malaria in African children is non-inferior to the more complex WHO-recommended regimen. Parenteral ARS is associated with a risk of delayed anemia in African children.
C1 [Kremsner, Peter G.; Adegnika, Akim A.; Hounkpatin, Aurore B.; Zinsou, Jeannot F.; Velavan, Thirumalaisamy P.; Nguetse, Christian; Koehler, Carsten; Issifou, Saadou; Bolte, Stefanie; Engleitner, Thomas; Mordmueller, Benjamin; Krishna, Sanjeev] Univ Tubingen, Inst Tropenmed, Tubingen, Germany.
   [Kremsner, Peter G.; Adegnika, Akim A.; Hounkpatin, Aurore B.; Zinsou, Jeannot F.; Issifou, Saadou; Mordmueller, Benjamin; Krishna, Sanjeev] Hop Albert Schweitzer, Ctr Rech Med Lambarene, Lambarene, Gabon.
   [Taylor, Terrie E.; Chimalizeni, Yamikani; Liomba, Alice] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi.
   [Kombila, Maryvonne; Bouyou-Akotet, Marielle K.; Mboumba, Denise P. Mawili] Univ Sci Sante, Fac Med, Dept Parasitol Mycol, Libreville, Gabon.
   [Agbenyega, Tsiri; Ansong, Daniel; Sylverken, Justice] Univ Sci & Technol, Sch Med Sci, Dept Physiol, Kumasi, Ghana.
   [Agbenyega, Tsiri; Ansong, Daniel; Sylverken, Justice] Komfo Anokye Teaching Hosp, Dept Child Hlth, Kumasi, Ghana.
   [Agbenyega, Tsiri; Ansong, Daniel; Sylverken, Justice] Komfo Anokye Teaching Hosp, Dept Med, Kumasi, Ghana.
   [Ogutu, Bernhards R.; Otieno, Godfrey A.; Wangwe, Anne] Kenya Govt Med Res Ctr, Clin Res Ctr, Kisumu, Kenya.
   [Bojang, Kalifa A.; Okomo, Uduak; Sanya-Isijola, Frank] MRC Labs, Fajara, Gambia.
   [Newton, Charles R.; Njuguna, Patricia; Kazungu, Michael] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.
   [Kerb, Reinhold; Geditz, Mirjam; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.
   [Kerb, Reinhold; Geditz, Mirjam] Univ Tubingen, Tubingen, Germany.
   [Schwab, Matthias] Univ Klinikum tUBINGEN, Klin Pharmakol Abt, Tubingen, Germany.
   [Krishna, Sanjeev] St Georges Univ London, Inst Infect & Immun, London, England.
RP Kremsner, PG; Krishna, S (reprint author), Univ Tubingen, Inst Tropenmed, Tubingen, Germany.; Kremsner, PG; Krishna, S (reprint author), Hop Albert Schweitzer, Ctr Rech Med Lambarene, Lambarene, Gabon.; Krishna, S (reprint author), St Georges Univ London, Inst Infect & Immun, London, England.
EM peter.kremsner@uni-tuebingen.de; s.krishna@sgul.ac.uk
RI Mordmuller, Benjamin/A-5749-2010
OI Mordmuller, Benjamin/0000-0001-9101-2768; Bojang,
   Kalifa/0000-0001-7506-0938
FU European and Developing Countries Clinical Trials Partnership
   [CT.2004.31070.001]; Federal Ministry of Education and Research (BMBF)
   [01KA1011]; Central African Network on Tuberculosis, HIV/AIDS and
   Malaria; CANTAM, German Center for Infection Research (DZIF), Deutsche
   Forschungsgemeinschaft (DFG) [KE 1629/1-1]; Robert Bosch Stiftung
   (Stuttgart, Germany)
FX The study was funded by European and Developing Countries Clinical
   Trials Partnership (http://www.edctp.org; CT.2004.31070.001) and Federal
   Ministry of Education and Research (http://www.bmbf.de/en/; BMBF grant
   01KA1011). Additional support was received by Central African Network on
   Tuberculosis, HIV/AIDS and Malaria;
   http://www.cantam.org/content/about-cantam; CANTAM, German Center for
   Infection Research (http://www.dzif.de/en/; DZIF), Deutsche
   Forschungsgemeinschaft (DFG; http://www.dfg.degrant; KE 1629/1-1) and
   Robert Bosch Stiftung (Stuttgart, Germany). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Angus BJ, 2002, ANTIMICROB AGENTS CH, V46, P778, DOI 10.1128/AAC.46.3.778-782.2002
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
   Bethell D, 2010, CLIN INFECT DIS, V51, pE105, DOI 10.1086/657402
   Briggs M, 2013, MMWR-MORBID MORTAL W, V62, P5
   Bustamante C, 2012, J INFECT DIS, V206, P324, DOI 10.1093/infdis/jis359
   Tunes da SG, 2009, BIOL BLOOD MARROW TR, V15, P120, DOI 10.1016/j.bbmt.2008.10.004
   Dondorp AM, 2012, J INFECT DIS, V206, P618, DOI 10.1093/infdis/jis389
   Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1
   FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208
   Geditz MCK, 2014, ANAL BIOANAL CHEM, V406, P4299, DOI 10.1007/s00216-014-7820-x
   Helbok R, 2009, J INFECT DIS, V200, P1834, DOI 10.1086/648409
   Hendriksen ICE, 2013, CLIN PHARMACOL THER, V93, P443, DOI 10.1038/clpt.2013.26
   Jaureguiberry S, 2014, BLOOD, V124, P167, DOI 10.1182/blood-2014-02-555953
   Karunajeewa HA, 2006, ANTIMICROB AGENTS CH, V50, P968, DOI 10.1128/AAC.50.3.968-974.2006
   Kreeftmeijer-Vegter AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-102
   Kremsner PG, 2012, J INFECT DIS, V206, P621, DOI 10.1093/infdis/jis391
   Kremsner PG, 2012, J INFECT DIS, V205, P312, DOI 10.1093/infdis/jir724
   Kremsner PG, 2009, J INFECT DIS, V199, P142, DOI 10.1086/595295
   Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P1803, DOI 10.1128/AAC.45.6.1803-1809.2001
   Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P509, DOI 10.1128/AAC.45.2.509-516.2001
   Nealon C, 2002, ANTIMICROB AGENTS CH, V46, P3933, DOI 10.1128/AAC.46.12.3933-3939.2002
   Parpia S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-44
   Planche T, 2001, AM J TROP MED HYG, V65, P599
   Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6
   Rolling T, 2014, J INFECT DIS, V209, P1921, DOI 10.1093/infdis/jit841
   Rolling T, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-241
   Rolling T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-169
   Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021
   Van TD, 2013, MALARIA J, V12, P441
   Wellek S., 2010, TESTING STAT HYPOTHE
   WHITE NJ, 1983, AM J TROP MED HYG, V32, P1
   World Health Organization, MAN SEV MAL PRACT HD
   WHO, 2015, GUID TREATM MAL
NR 35
TC 10
Z9 10
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2016
VL 13
IS 1
AR e1001938
DI 10.1371/journal.pmed.1001938
PG 22
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC7AL
UT WOS:000369370600007
PM 26757276
OA gold
DA 2017-08-15
ER

PT J
AU Corstjens, PLAM
   Fat, EMTK
   de Dood, CJ
   van der Ploeg-van Schip, JJV
   Franken, KLMC
   Chegou, NN
   Sutherland, JS
   Howe, R
   Mihret, A
   Kassa, D
   van der Vyver, M
   Sheehama, J
   Simukonda, F
   Mayanja-Kizza, H
   Ottenhoff, THM
   Walzl, G
   Geluk, A
AF Corstjens, Paul L. A. M.
   Fat, Elisa M. Tjon Kon
   de Dood, Claudia J.
   van der Ploeg-van Schip, Jolien J.
   Franken, Kees L. M. C.
   Chegou, Novel N.
   Sutherland, Jayne S.
   Howe, Rawleigh
   Mihret, Adane
   Kassa, Desta
   van der Vyver, Marieta
   Sheehama, Jacob
   Simukonda, Felanji
   Mayanja-Kizza, Harriet
   Ottenhoff, Tom H. M.
   Walzl, Gerhard
   Geluk, Annemieke
CA AE-TBC Consortium
TI Multi-center evaluation of a user-friendly lateral flow assay to
   determine IP-10 and CCL4 levels in blood of TB and non-TB cases in
   Africa
SO CLINICAL BIOCHEMISTRY
LA English
DT Article
DE CCL4; Chemokine; Diagnosis, field-friendly, lateral flow; IP-10;
   Up-converting phosphor,UCP; Tuberculosis
ID CIRCULATING ANODIC ANTIGEN; PULMONARY INFECTION; TUBERCULOSIS;
   DIAGNOSIS; BIOMARKERS; CELLS; SCHISTOSOMIASIS; TECHNOLOGY; DETECT
AB Objective: Multi-center evaluation of a user-friendly lateral flow test for detection of IP-10 and CCL4 levels in Mycobacterium tuberculosis (Mtb) antigen-stimulated whole blood samples from tuberculosis (TB) suspects.
   Design and methods: A quantitative lateral flow (LF)-based assay platform was applied to detect chemokines IP-10 and CCL4. Chemokine quantitation was achieved using interference-free, fluorescent up converting phosphor (UCP) labels. The new assays allowed worldwide shipping and storage without requiring a cold chain and were tested at seven institutes (including Ethiopia, Malawi, The Gambia, South Africa, Uganda and Namibia) employing portable lightweight readers for detection of the UCP label. At each site, clinical samples, confirmed TB and non-TB (i.e. other respiratory diseases (ORD)) cases, were collected and analyzed simultaneously with quality control (QC) human IP-10 or CCL4 standards.
   Results: Performance of the UCP-LF assay in Africa using QC standards indicated high robustness allowing quantitative detection between 100 and 100,000 pg/mL. The optimized assays allowed successful determination of chemokine levels using 1 mu L. whole blood sample from the locally recruited subjects with TB or ORD.
   Conclusion: This African multi-center trial further demonstrated the applicability of the low-tech and robust UCP-LF platform as a convenient quantitative assay for chemokine detection in whole blood. Ambient shipping and storage of all assay reagents and the availability of lightweight standalone readers were acknowledged as essential requirement for test implementation in particular in remote and resource-limited settings. (C) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
C1 [Corstjens, Paul L. A. M.; Fat, Elisa M. Tjon Kon; de Dood, Claudia J.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, POB 9600, NL-2300 RC Leiden, Netherlands.
   [van der Ploeg-van Schip, Jolien J.; Franken, Kees L. M. C.; Ottenhoff, Tom H. M.; Geluk, Annemieke] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands.
   [Chegou, Novel N.; Walzl, Gerhard] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci, Cape Town, South Africa.
   [Chegou, Novel N.; Walzl, Gerhard] Univ Stellenbosch, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci, Cape Town, South Africa.
   [Sutherland, Jayne S.] MRC Unit, Vaccines & Immun, Banjul, Gambia.
   [Howe, Rawleigh; Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Kassa, Desta] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia.
   [van der Vyver, Marieta; Sheehama, Jacob] Univ Namibia, Windhoek, Namibia.
   [Simukonda, Felanji] Karonga Prevent Study, Lilongwe, Malawi.
   [Mayanja-Kizza, Harriet] Makerere Univ CWRU, Dept Med, Kampala, Uganda.
RP Corstjens, PLAM (reprint author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, POB 9600, NL-2300 RC Leiden, Netherlands.
EM P.Corstjens@LUMC.NL
OI Mayanja-Kizza, Harriet/0000-0002-9297-6208; Walzl,
   Gerhard/0000-0003-2487-125X; van der Spuy, Gian/0000-0002-9067-5903;
   Sutherland, Jayne/0000-0002-7083-4997
FU European and Developing Countries Clinical Trials Partnership (EDCTP)
   [IP_2009_32040]; Q.M. Gastmann-Wichers-Foundation
FX This study was supported by the European and Developing Countries
   Clinical Trials Partnership (EDCTP), grant no. IP_2009_32040 for the
   African European Tuberculosis Consortium (AE-TBC) with coordinator
   Gerhard Walzl from Stellenbosch University, South Africa and the Q.M.
   Gastmann-Wichers-Foundation.
CR Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010
   Bobosha K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002845
   Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847
   Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501
   Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21
   Commandeur S, 2014, VACCINE, V32, P3580, DOI 10.1016/j.vaccine.2014.05.005
   Commandeur S, 2013, J IMMUNOL, V190, P1659, DOI 10.4049/jimmunol.1201593
   Corstjens P, 2001, CLIN CHEM, V47, P1885
   Corstjens P. L. A. M., 2005, IEE Proceedings Nanobiotechnology, V152, P64, DOI 10.1049/ip-nbt:20045014
   Corstjens P.L.A.M., 2010, United States patent application US, Patent No. [7,858,396 B2, 7858396]
   Corstjens PLAM, 2008, CLIN BIOCHEM, V41, P440, DOI 10.1016/j.clinbiochem.2007.12.015
   Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07
   Corstjens PLAM, 2014, PARASITOLOGY, V141, P1841, DOI 10.1017/S0031182014000626
   Corstjens PLAM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002944
   Corstjens PLAM, 2011, CLIN BIOCHEM, V44, P1241, DOI 10.1016/j.clinbiochem.2011.06.983
   Downs JA, 2012, AM J TROP MED HYG, V87, P868, DOI 10.4269/ajtmh.2012.12-0395
   Essone PN, 2014, RESPIRATION, V88, P251, DOI 10.1159/000365816
   Essone PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102584
   Tjon Kon Fat E.M., 2012, METHOD CELL BIOL, V112, P203
   Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162
   Geluk A, 2012, J IMMUNOL, V188, P4782, DOI 10.4049/jimmunol.1103452
   Hur YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079742
   Malamud D, 2005, Adv Dent Res, V18, P12
   Mokkapati VK, 2007, ANN NY ACAD SCI, V1098, P476, DOI 10.1196/annals.1384.021
   Ota MOC, 2014, EUR RESPIR J, V44, P254, DOI 10.1183/09031936.00209913
   Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002
   Phalane KG, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/981984
   Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001
   Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19
   Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693
   Tanke HJ, 2014, PROC SPIE, V8947, DOI 10.1117/12.2036906
   van Dam GJ, 2013, EXP PARASITOL, V135, P274, DOI 10.1016/j.exppara.2013.06.017
   Weiner J, 2014, J INTERN MED, V275, P467, DOI 10.1111/joim.12212
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Ye XC, 2010, P NATL ACAD SCI USA, V107, P22430, DOI 10.1073/pnas.1008958107
   Zijlmans HJMAA, 1999, ANAL BIOCHEM, V267, P30, DOI 10.1006/abio.1998.2965
   Zarling DA, 1997, United States Patent Patent, Patent No. [5,674,698, 5674698]
NR 37
TC 15
Z9 15
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-9120
EI 1873-2933
J9 CLIN BIOCHEM
JI Clin. Biochem.
PD JAN
PY 2016
VL 49
IS 1-2
BP 22
EP 31
DI 10.1016/j.clinbiochem.2015.08.013
PG 10
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA DB8FN
UT WOS:000368752700006
PM 26285074
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Talsma, EF
   Brouwer, ID
   Verhoef, H
   Mbera, GNK
   Mwangi, AM
   Demir, AY
   Maziya-Dixon, B
   Boy, E
   Zimmermann, MB
   Melse-Boonstra, A
AF Talsma, Elise F.
   Brouwer, Inge D.
   Verhoef, Hans
   Mbera, Gloria N. K.
   Mwangi, Alice M.
   Demir, Ayse Y.
   Maziya-Dixon, Busie
   Boy, Erick
   Zimmermann, Michael B.
   Melse-Boonstra, Alida
TI Biofortified yellow cassava and vitamin A status of Kenyan children: a
   randomized controlled trial
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE biofortification; efficacy; food-based approach; nutrition-sensitive
   intervention; vitamin A
ID BETA-CAROTENE SUPPLEMENTATION; FLESHED SWEET-POTATO; RETINOL; WOMEN;
   BIOAVAILABILITY; BIOCONVERSION; METAANALYSIS; DEFICIENCY; PROVITAMIN;
   CONVERSION
AB Background: Whereas conventional white cassava roots are devoid of provitamin A, biofortified yellow varieties are naturally rich in beta-carotene, the primary provitamin A carotenoid.
   Objective: We assessed the effect of consuming yellow cassava on serum retinol concentration in Kenyan schoolchildren with marginal vitamin A status.
   Design: We randomly allocated 342 children aged 5-13 y to receive daily, 6 d/wk, for 18.5 wk 1) white cassava and placebo supplement (control group), 2) provitamin A-rich cassava (mean content: 1460 mu g beta-carotene/d) and placebo supplement (yellow cassava group), and 3) white cassava and beta-carotene supplement (1053 mu g/d; beta-carotene supplement group). The primary outcome was serum retinol concentration; prespecified secondary outcomes were hemoglobin concentration and serum concentrations of beta-carotene, retinol-binding protein, and prealbumin. Groups were compared by using ANCOVA, adjusting for inflammation, baseline serum concentrations of retinol and beta-carotene, and stratified design.
   Results: The baseline prevalence of serum retinol concentration <0.7 mu mol/L and inflammation was 27% and 24%, respectively. For children in the control, yellow cassava, and beta-carotene supplement groups, the mean daily intake of cassava was 378, 371, and 378 g, respectively, and the total daily supply of provitamin A and vitamin A from diet and supplements was equivalent to 22, 220, and 175 mu g retinol, respectively. Both yellow cassava and beta-carotene supplementation increased serum retinol concentration by 0.04 mu mol/L (95% CI: 0.00, 0.07 mu mol/L); correspondingly, serum beta-carotene concentration increased by 524% (448%, 608%) and 166% (134%, 202%). We found no effect on hemoglobin concentration or serum concentrations of retinol-binding protein and prealbumin.
   Conclusions: In our study population, consumption of yellow cassava led to modest gains in serum retinol concentration and a large increase in beta-carotene concentration. It can be an efficacious, new approach to improve vitamin A status.
C1 [Talsma, Elise F.; Brouwer, Inge D.; Melse-Boonstra, Alida] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.
   [Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands.
   [Verhoef, Hans] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England.
   [Verhoef, Hans] MRC Keneba, Keneba, Gambia.
   [Mbera, Gloria N. K.; Mwangi, Alice M.] Univ Nairobi, Dept Food Technol & Nutr, Appl Nutr Program, Nairobi, Kenya.
   [Demir, Ayse Y.] Meander Med Ctr, Clin Chem Lab, Amersfoort, Netherlands.
   [Maziya-Dixon, Busie] Int Inst Trop Agr, Ibadan, Nigeria.
   [Boy, Erick] HarvestPlus, Int Food Policy Res Inst, Washington, DC USA.
   [Zimmermann, Michael B.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Inst Food Nutr & Hlth, Human Nutr Lab, Zurich, Switzerland.
RP Talsma, EF (reprint author), HarvestPlus, Ctr Trop Agr, Cali, Colombia.
EM elise.talsma@gmail.com
RI Zimmermann, Michael/C-3062-2016; Brouwer, Inge/K-8455-2013
FU European Union's Seventh Framework Programme [211484]; HarvestPlus;
   Capsugel (Bornem, Belgium); Laboratory&Allied (Nairobi, Kenya); DSM
   Nutritional Products/Sight and Life (Basel, Switzerland); Laboratorium
   Medisan (Heerenveen, Netherlands)
FX Supported by the European Union's Seventh Framework Programme
   (FP7/2007-2013) under grant agreement 211484, conducted within the
   framework of INSTAPA Project. HarvestPlus provided financial support for
   biochemical analyses and supplies. Capsugel (Bornem, Belgium),
   Laboratory&Allied (Nairobi, Kenya), DSM Nutritional Products/Sight and
   Life (Basel, Switzerland), and Laboratorium Medisan (Heerenveen,
   Netherlands) provided financial and technical support in producing
   supplements. This is a free access article, distributed under terms
   (http://www.nutrition.org/publications/guidelines-and-policies/license/)
   that permit unrestricted noncommercial use, distribution, and
   reproduction in any medium, provided the original work is properly
   cited.
CR Beckman Coulter, 2012, ACC IMM SYST STFR RE
   Biesalski HK, 2007, VITAM HORM, V75, P117, DOI 10.1016/S0083-6729(06)75005-1
   Borel P, 2012, MOL NUTR FOOD RES, V56, P228, DOI 10.1002/mnfr.201100322
   Bouis HE, 2011, FOOD NUTR BULL, V32, pS31
   CARLIER C, 1993, BRIT MED J, V307, P1106
   Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19
   Chavez AL, 2007, J SCI FOOD AGR, V87, P388, DOI 10.1002/jsfa.2704
   Chavez AL, 2005, EUPHYTICA, V143, P125, DOI 10.1007/s10681-005-3057-2
   Christian P, 1998, J NUTR, V128, P1458
   Christian P, 1998, AM J CLIN NUTR, V68, P435
   de Benoist B, 2007, FOOD NUTR BULL, V28, pS480
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27
   de Pee S, 1998, AM J CLIN NUTR, V68, P1058
   Dijkhuizen MA, 2004, AM J CLIN NUTR, V80, P1299
   Fukuda W. M. G., 2010, SELECTED MORPHOLOGIC
   Hillocks RJ, 2002, CASSAVA BIOL PRODUCT
   Jamil KM, 2012, J NUTR, V142, P1896, DOI 10.3945/jn.112.164830
   Khan NC, 2007, AM J CLIN NUTR, V85, P1112
   Kleinbaum D. G., 2007, APPL REGRESSION ANAL
   Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962
   Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756
   Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094
   OLSON JA, 1984, J NATL CANCER I, V73, P1439
   Olson JA, 1994, PURE APPL CHEM, V66, P117
   Palmer AC, 2012, PUBLIC HEALTH NUTR, V15, P1201, DOI 10.1017/S1368980012000560
   Saltzman A, 2013, GLOB FOOD SECUR-AGR, V2, P9, DOI 10.1016/j.gfs.2012.12.003
   Sommer A, 2002, J NUTR, V132, p2845S
   Sun X, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c117
   Talsma EF, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0256-5
   Talsma EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073433
   Thurnham DI, 2007, J SCI FOOD AGR, V87, P13, DOI 10.1002/jsfa.2647
   Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4
   United Nations System Standing Committee on Nutrition, 2010, 6 UN SYST STAND COMM
   van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080
   von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629
   West CE, 1998, INT J VITAM NUTR RES, V68, P371
   West KP, 1999, BRIT MED J, V318, P570
   World Health Organization, 2011, SER RET CONC DET PRE
   WHO/UNICEF/UNU, 2001, WHONHD013 WHOUNICEFU
NR 39
TC 12
Z9 12
U1 2
U2 18
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JAN
PY 2016
VL 103
IS 1
BP 258
EP 267
DI 10.3945/ajcn.114.100164
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DA5VA
UT WOS:000367869500030
PM 26675768
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Sutherland, JS
   Mendy, J
   Gindeh, A
   Walzl, G
   Togun, T
   Owolabi, O
   Donkor, S
   Ota, MO
   Fat, ETK
   Ottenhoff, THM
   Geluk, A
   Corstjens, PLAM
AF Sutherland, Jayne S.
   Mendy, Joseph
   Gindeh, Awa
   Walzl, Gerhard
   Togun, Toyin
   Owolabi, Olumuyiwa
   Donkor, Simon
   Ota, Martin O.
   Fat, Elisa Tjon Kon
   Ottenhoff, Tom H. M.
   Geluk, Annemieke
   Corstjens, Paul L. A. M.
TI Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural
   effusions and whole blood for TB diagnosis
SO TUBERCULOSIS
LA English
DT Article
DE UCP-LF; Tuberculosis; Pleural TB; Pulmonary TB; IP10; CCL4
ID INDUCIBLE PROTEIN 10; INTERFERON-GAMMA; TUBERCULOSIS INFECTION; LATENT
   TUBERCULOSIS; IMMUNE-RESPONSES; HIV-INFECTION; CHILDREN; ANTIGEN;
   SCHISTOSOMIASIS; BIOMARKER
AB One of the key problems in combating TB is the lack of fast and accurate diagnostic tests that are affordable and easy to use in resource-limited settings. We have used a field-friendly up-converting phosphor (UCP) reporter technology in a lateral flow (LF) based test for the diagnosis of respiratory infections. In this study we analysed samples obtained from patients presenting with symptoms suggestive of TB but prior to confirmation by microbiology in The Gambia. Following clinical and microbiological evaluation they were classified as either having TB or other respiratory disorder (ORD). Analysis of blood was performed for those with pulmonary TB and pleural fluid for those with pleural TB. UCP-LF test for detection and quantitation of IP-10 and CCL4 were used being the two chemokine markers that have been shown to increase in active TB disease. UCP-LF test accurately determined concentrations of both markers as compared to ELISA and multiplex cytokine array. However, only IP-10 could discriminate between TB and ORD, and this was significantly enhanced by analysing the site of infection (pleural fluid), which showed 92% correct classification. Future work will assess the use of multiple markers to increase diagnostic accuracy. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Sutherland, Jayne S.; Mendy, Joseph; Gindeh, Awa; Togun, Toyin; Owolabi, Olumuyiwa; Donkor, Simon; Ota, Martin O.] MRC Unit, Vaccines & Immun, Koldo, Gambia.
   [Walzl, Gerhard] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa.
   [Walzl, Gerhard] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,Dept Biomed Sci, ZA-7505 Tygerberg, South Africa.
   [Fat, Elisa Tjon Kon; Ottenhoff, Tom H. M.; Geluk, Annemieke] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RA Leiden, Netherlands.
   [Corstjens, Paul L. A. M.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RA Leiden, Netherlands.
RP Sutherland, JS (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM jsutherland@mrc.gm
OI Walzl, Gerhard/0000-0003-2487-125X; Sutherland,
   Jayne/0000-0002-7083-4997
FU EDCTP [IP_2009_32040]
FX This study was part of the AE-TBC trial (PI, Gerhard Walzl) funded by
   EDCTP (grant no. IP_2009_32040).
CR Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010
   Alsleben N, 2012, SCAND J INFECT DIS, V44, P256, DOI 10.3109/00365548.2011.632644
   Batz H-G, 2011, LAB FREE TB DIAGNOST
   Bobosha K, 2014, PLOS NEGLECT TROP D, V8
   Bobosha K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002773
   Broadhurst MJ, 2015, LANCET, V386, P867, DOI 10.1016/S0140-6736(15)61042-X
   Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21
   Corstjens PLAM, 2014, PARASITOLOGY, V141, P1841, DOI 10.1017/S0031182014000626
   Corstjens PLAM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002944
   Corstjens PLAM, 2011, CLIN BIOCHEM, V44, P1241, DOI 10.1016/j.clinbiochem.2011.06.983
   Corstjens PL, 2015, CLIN BIOCH
   Giang DC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0814-2
   Downs JA, 2012, AM J TROP MED HYG, V87, P868, DOI 10.4269/ajtmh.2012.12-0395
   DRISCOLL KE, 1994, EXP LUNG RES, V20, P473, DOI 10.3109/01902149409031733
   Eibach D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-188
   Geluk A, 2014, J CLIN IMMUNOL, V34, P245, DOI 10.1007/s10875-013-9979-x
   Hur YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079742
   Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104
   Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407
   Ota MOC, 2014, EUR RESPIR J, V44, P254, DOI 10.1183/09031936.00209913
   Petrucci R, 2008, PEDIATR INFECT DIS J, V27, P1073, DOI 10.1097/INF.0b013e31817d05a3
   Phalane KG, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/981984
   Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789
   Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051
   Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002
   Sutherland JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030324
   Tincati C., 2012, CELLS, V1, P99
   van Dam GJ, 2013, EXP PARASITOL, V135, P274, DOI 10.1016/j.exppara.2013.06.017
   Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901
   World Health Organization, 2014, GLOB TUB REP 2014
   [Anonymous], 2011, TUBERCULOSIS IGRA TB
NR 31
TC 3
Z9 3
U1 1
U2 12
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD JAN
PY 2016
VL 96
BP 31
EP 36
DI 10.1016/j.tube.2015.10.011
PG 6
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA DA9OI
UT WOS:000368138500005
PM 26786652
OA No
DA 2017-08-15
ER

PT J
AU Togun, TO
   Egere, U
   Gomez, MP
   Sillah, AK
   Daramy, M
   Tientcheu, LD
   Sutherland, JS
   Hill, PC
   Kampmann, B
AF Togun, Toyin O.
   Egere, Uzochukwu
   Gomez, Marie P.
   Sillah, Abdou K.
   Daramy, Mohammed
   Tientcheu, Leopold D.
   Sutherland, Jayne S.
   Hill, Philip C.
   Kampmann, Beate
TI No added value of interferon-gamma release to a prediction model for
   childhood tuberculosis
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; HOUSEHOLD CONTACTS;
   SKIN-TEST; CHILDREN; INFECTION; DIAGNOSIS; ASSAYS; ANTIGENS;
   EPIDEMIOLOGY
AB The predictive value of a combination of clinical and radiological features with interferon-. release assay (IGRA) for diagnosis of active tuberculosis (TB) disease among TB-exposed children is unknown.
   150 symptomatic HIV-negative children (aged 3 months to 14 years), prospectively recruited through active contact tracing, were included. Backward stepwise logistic regression and bootstrapping techniques were used for the development and internal validation of a clinical prediction model for active TB disease. Model discrimination and incremental value of a positive IGRA test were assessed by area under the receiver operating characteristic curve (AUC).
   35 (23%) children were diagnosed with active TB disease and started on treatment and 115 (77%) had other respiratory tract infections. A final parsimonious clinical model, comprising age < 5 years (adjusted (a) OR 4.8, 95% CI 2.0-11.5) and lymphadenopathy on clinical examination (aOR 4.9, 95% CI 1.8-13.0) discriminated active TB disease from other disease with an AUC of 0.70 (95% CI 0.61-0.80). A positive IGRA result did not improve the discriminatory ability of the clinical model (c-statistic 0.72 versus 0.70; p=0.644).
   A clinical algorithm, including age < 5 years and lymphadenopathy classified 70% of active TB disease among symptomatic TB-exposed children. IGRA does not add any discriminatory value to this prediction model.
C1 [Togun, Toyin O.; Egere, Uzochukwu; Gomez, Marie P.; Sillah, Abdou K.; Daramy, Mohammed; Tientcheu, Leopold D.; Sutherland, Jayne S.; Kampmann, Beate] Med Res Council MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
   [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Hill, Philip C.] Univ Otago, Sch Med, Dept Prevent & Social Med, Otago Int Hlth Res Network, Dunedin, New Zealand.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London, England.
RP Togun, TO (reprint author), Med Res Council MRC Unit, Vaccines & Immun Theme, Atlantic Rd,POB 273, Banjul, Gambia.
EM ttogun@mrc.gm
FU UK the Medical Research Council (MRC); UK Department for International
   Development (DFID) under the MRC/DFID concordat agreement (Childhood TB
   Research Programme) [MR/K011944/1]; World Health Organization STOP
   TB/TBReach Wave 2 grant [T9-370-114GAM]; FundRef
FX This work was supported by UK the Medical Research Council (MRC) and the
   UK Department for International Development (DFID) under the MRC/DFID
   concordat agreement (Childhood TB Research Programme grant reference
   number MR/K011944/1 to B. Kampmann) and the World Health Organization
   STOP TB/TBReach Wave 2 grant (reference number T9-370-114GAM). The
   funders had no involvement in the study design, collection, analysis and
   interpretation of the data nor in writing and submission of the report.
   Funding information for this article has been deposited with FundRef.
CR Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da
   Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09
   Critselis E, 2012, J PEDIATR-US, V161, P632, DOI 10.1016/j.jpeds.2012.04.007
   Gambian National Leprosy and Tuberculosis Control Programme, 2012, GAMB NAT LEPR TUB CO
   Graham SM, 2014, LANCET, V383, P1605, DOI 10.1016/S0140-6736(14)60420-7
   Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008
   Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227
   Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095
   Kassa D, 2012, CLIN VACCINE IMMUNOL, V19, P1907, DOI 10.1128/CVI.00482-12
   Lewinsohn DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003407
   Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915
   Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519
   Marais BJ, 2005, ARCH DIS CHILD, V90, P1166, DOI 10.1136/adc.2004.060640
   Marais BJ, 2005, ARCH DIS CHILD, V90, P1162, DOI 10.1136/adc.2004.070797
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278
   Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246
   Moons KGM, 1999, EPIDEMIOLOGY, V10, P276, DOI 10.1097/00001648-199905000-00015
   Moons KGM, 2002, J EPIDEMIOL COMMUN H, V56, P337, DOI 10.1136/jech.56.5.337
   Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636
   Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8
   Pai M, 2008, ANN INTERN MED, V149, P177
   Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049
   Pollock L, 2013, ARCH DIS CHILDHOOD-E, V98, P99, DOI 10.1136/archdischild-2013-303641
   Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9
   SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004
   Sutherland JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074080
   United Nations Programme on HIV/AIDS (UNAIDS), GLOB REP UNAIDS REP
   World Health Organization, 2007, WHO CHILD GROWTH STA
   World Health Organization, DEF REP FRAM TUB 201
   WHO, GLOB TUB REP 2014
NR 30
TC 1
Z9 1
U1 0
U2 0
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD JAN
PY 2016
VL 47
IS 1
BP 223
EP 232
DI 10.1183/13993003.00890-2015
PG 10
WC Respiratory System
SC Respiratory System
GA CZ9VA
UT WOS:000367443900028
PM 26493802
OA No
DA 2017-08-15
ER

PT J
AU Shimakawa, Y
   Toure-Kane, C
   Mendy, M
   Thursz, M
   Lemoine, M
AF Shimakawa, Yusuke
   Toure-Kane, Coumba
   Mendy, Maimuna
   Thursz, Mark
   Lemoine, Maud
TI Mother-to-child transmission of hepatitis B in sub-Saharan Africa
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Shimakawa, Yusuke; Lemoine, Maud] Med Res Council MRC Unit, Banjul, Gambia.
   [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, F-75015 Paris, France.
   [Toure-Kane, Coumba] CHU Aristide Dantec, Lab Bacteriol Virol, Dakar, Senegal.
   [Mendy, Maimuna] Int Agcy Res Canc, F-69372 Lyon, France.
   [Thursz, Mark; Lemoine, Maud] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, London, England.
RP Shimakawa, Y (reprint author), Med Res Council MRC Unit, Banjul, Gambia.
EM yusuke.shimakawa@gmail.com
CR Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313
   Howell J, 2014, J VIRAL HEPATITIS, V21, P381, DOI 10.1111/jvh.12263
   Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892
   Thio CL, 2015, LANCET INFECT DIS, V15, P981, DOI 10.1016/S1473-3099(15)00158-9
   WHO, 2009, WKLY EPIDEMIOL REC, V84, P405
NR 5
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2016
VL 16
IS 1
BP 19
EP 20
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA CY8NG
UT WOS:000366664900019
PM 26738828
OA No
DA 2017-08-15
ER

PT J
AU Sester, M
   Kampmann, B
AF Sester, Martina
   Kampmann, Beate
TI What defines latent infection with Mycobacterium tuberculosis in
   patients with autoimmune diseases?
SO THORAX
LA English
DT Editorial Material
ID TBNET CONSENSUS STATEMENT; IMMUNOCOMPROMISED PATIENTS; RISK
C1 [Sester, Martina] Univ Saarland, Dept Transplant & Infect Immunol, Homburg, Germany.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London W2 1PG, England.
   [Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Serrekunda, Gambia.
RP Kampmann, B (reprint author), Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, 2nd Floor Wright Fleming Bldg,St Marys Campus, London W2 1PG, England.
EM b.kampmann@imperial.ac.uk
FU Department of Health [SRF-2009-02-07]
CR Bumbacea D, 2012, EUR RESPIR J, V40, P990, DOI 10.1183/09031936.00000712
   Chee CBE, 2013, RESPIROLOGY, V18, P205, DOI 10.1111/resp.12002
   Lange C, 2015, J ACQ IMMUN DEF SYND, DOI [10.1097/QAI.0000000000000834, DOI 10.1097/QAI.0000000000000834]
   Scholman T, 2015, AM J TRANSPLANT, V15, P2616, DOI 10.1111/ajt.13330
   Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC
   Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510
   World Health Organization, 2014, GUID MAN LAT TUB INF
   World Health Organization, 2014, TUB EL ACT FRAM LOW
   Wong SH, THORAX, V71, P64
NR 9
TC 0
Z9 0
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0040-6376
EI 1468-3296
J9 THORAX
JI Thorax
PD JAN
PY 2016
VL 71
IS 1
BP 3
EP 4
DI 10.1136/thoraxjnl-2015-207991
PG 2
WC Respiratory System
SC Respiratory System
GA CY8TV
UT WOS:000366682100002
PM 26678433
OA No
DA 2017-08-15
ER

PT J
AU Roca, A
   Bojang, A
   Bottomley, C
   Gladstone, RA
   Adetifa, JU
   Egere, U
   Burr, S
   Antonio, M
   Bentley, S
   Kampmann, B
   Oluwalana, C
   Idoko, O
   Cox, I
   Kwambana-Adams, BA
   Jarju, S
   Foster-Nyarko, E
   Greenwood, B
AF Roca, Anna
   Bojang, Abdoulie
   Bottomley, Christian
   Gladstone, Rebecca A.
   Adetifa, Jane U.
   Egere, Uzochukwu
   Burr, Sarah
   Antonio, Martin
   Bentley, Stephen
   Kampmann, Beate
   Oluwalana, Claire
   Idoko, Olubukola
   Cox, Isatou
   Kwambana-Adams, Brenda A.
   Jarju, Sheikh
   Foster-Nyarko, Ebenezer
   Greenwood, Brian
CA Pneumo13 Study Grp
TI Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with
   PCV13 in the Expanded Programme of Immunization in The Gambia
SO VACCINE
LA English
DT Article
DE PCV7; PCV13; Vaccine-type; Non-typable; Epidemiology; Expanded Programme
   of Immunization; Africa
ID CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; SEROTYPE REPLACEMENT;
   DISEASE; CHILDREN; EPIDEMIOLOGY; 13-VALENT; EVOLUTION; YOUNGER; DECLINE
AB Introduction: In 2011, two years after the introduction of 7-valent Pneumococcal conjugate vaccine (PCV7), the Gambian immunization programme replaced PVC7 with PCV13 (13-valent). Our objective was to assess the additional impact of PCV13 on prevalence of pneumococcal nasopharyngeal carriage.
   Methods: We recruited healthy Gambian infants who had received three PCV doses. Nasopharyngeal swabs were collected from infants and their mothers during two cross-sectional surveys (CSS) conducted in infants vaccinated with PCV7 (CSS1) and vaccinated with PCV13 (CSS2). Pneumococci were isolated and serotyped following standardized methods. Whole genome sequencing was performed on non-typable pneumococcus isolated in CSS1 and CSS2.
   Results: 339 and 350 infants and their mothers were recruited in CSS1 and CSS2, respectively. Overall prevalence of pneumococcal carriage was 85.4% in infants. Among infants, prevalence of vaccine type (VT) carriage was lower in CSS2 [9.4% versus 4.9% (p = 0.025) for PCV7-VT; 33.3% versus 18.3% (p < 0.001) for PCV13-VT and 23.9% versus 13.7% (p = 0.001) for the 6 additional serotypes included in PCV13]. At CSS2, there was a decrease of serotypes 6A (from 15.3% to 5.7%, p < 0.001) and 19F (from 5.6% to 1.7%, p = 0.007), and an increase of non-typable pneumococci (0.3-6.0%, p < 0.001), most of which (82.4%) were from typable serotype backgrounds that had lost the ability to express a capsule. Prevalence of overall and VT carriage in mothers was similar in CSS1 and CSS2.
   Conclusions: Replacing PCV7 for PCV13 rapidly decreased prevalence of VT carriage among vaccinated Gambian infants. An indirect effect in mothers was not observed yet. Vaccine-driven selection pressure may have been responsible for the increase of non-typable isolates. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Roca, Anna; Bojang, Abdoulie; Adetifa, Jane U.; Egere, Uzochukwu; Burr, Sarah; Antonio, Martin; Kampmann, Beate; Oluwalana, Claire; Idoko, Olubukola; Cox, Isatou; Kwambana-Adams, Brenda A.; Jarju, Sheikh; Foster-Nyarko, Ebenezer] MRC Unit, Fajara, Gambia.
   [Roca, Anna; Bottomley, Christian; Burr, Sarah; Greenwood, Brian] London Sch Hyg & Trop Med, London WC1, England.
   [Gladstone, Rebecca A.; Bentley, Stephen] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge, England.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England.
RP Roca, A (reprint author), MRC Unit, POB 273, Fajara, Gambia.
EM aroca@mrc.gm
RI Gladstone, Rebecca/J-8821-2017
OI Gladstone, Rebecca/0000-0002-7993-3051; Kampmann,
   Beate/0000-0002-6546-4709
FU Pfizer [WS2021038]; MRC UK
FX This study was funded by an investigator-initiated proposal supported by
   Pfizer (WS2021038). Pfizer played no part in the design of the study,
   writing or decision to publish this manuscript. The MRC Unit The Gambia
   receives core funding from the MRC UK.
CR Ben-Shimol S, 2015, HUM VACCIN IMMUNOTHE
   Bottomley C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0786
   Burr SE, 2014, B WORLD HEALTH ORGAN, V92, P490, DOI 10.2471/BLT.13.133462
   Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185
   Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895
   Croucher NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005095
   Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08
   Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525
   Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428
   Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849
   Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15
   Gladstone RA, 2015, VACCINE, V33, P2015, DOI 10.1016/j.vaccine.2015.03.012
   Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005
   Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102
   Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443
   Hilty M, 2014, GENOME BIOL EVOL, V6, P3281, DOI 10.1093/gbe/evu263
   Hsieh YC, 2009, VACCINE, V27, P5513, DOI 10.1016/j.vaccine.2009.06.091
   Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348
   Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043
   O'Brien Katherine L, 2003, Pediatr Infect Dis J, V22, pe1, DOI 10.1097/01.inf.0000049347.42983.77
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593
   Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554
   Roca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072198
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   Sahni V, 2012, CAN J PUBLIC HEALTH, V103, P29
   Scott S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107280
   Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   van Gils EJM, 2010, JAMA-J AM MED ASSOC, V304, P1099, DOI 10.1001/jama.2010.1290
   Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823
   Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zuccotti G, 2014, VACCINE, V32, P527, DOI 10.1016/j.vaccine.2013.12.003
NR 37
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD DEC 16
PY 2015
VL 33
IS 51
BP 7144
EP 7151
DI 10.1016/j.vaccine.2015.11.012
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA CZ0FD
UT WOS:000366779600004
PM 26592141
OA No
DA 2017-08-15
ER

PT J
AU Boone, P
   Camara, A
   Eble, A
   Elbourne, D
   Fernandes, S
   Frost, C
   Jayanty, C
   Lenin, M
   Silva, AF
AF Boone, Peter
   Camara, Alpha
   Eble, Alex
   Elbourne, Diana
   Fernandes, Samory
   Frost, Chris
   Jayanty, Chitra
   Lenin, Maitri
   Silva, Ana Filipa
TI Remedial after-school support classes offered in rural Gambia (The SCORE
   trial): study protocol for a cluster randomized controlled trial
SO TRIALS
LA English
DT Article
DE Primary education; Development; Para-teachers; West Africa
ID EDUCATION
AB Background: Low education levels are endemic in much of the developing world, particularly in rural areas where traditional government-provided public services often have difficulty reaching beneficiaries. Providing trained para-teachers to teach regular after-school remedial education classes has been shown to improve literacy and numeracy in children of primary school age residing in such areas in India. This trial investigates whether such an intervention can also be effective in a West African setting with similarly low learning levels and difficult geographic access.
   Methods/Design: Design: cluster-randomized controlled trial. Clusters: villages or groups of villages with 15-300 households and at least 15 eligible children in the Lower River and North Bank Regions of The Gambia.
   Participants: children born between 1 September 2007 and 31 August 2009 planning to enter the first grade, for the first time, in the 2015-2016 school year in eligible villages. We anticipate enrolling approximately 150 clusters of villages with approximately 6000 children as participants. Intervention: a program providing remedial after-school lessons, focusing on literacy and numeracy, 5 to 6 days a week for 3 years to eligible children, based on the intervention evaluated in the Support To Rural India's Public Education System (STRIPES) trial (PLoS ONE 8(7):e65775).
   Control: both the intervention and control groups will receive small bundles of useful materials during annual data collection as recompense for their time. If the education intervention is shown to be cost-effective at raising learning levels, it is expected that the control group villages will receive the intervention for several years after the trial results are available.
   Outcomes: the primary outcome of the trial is a composite mathematics and language test score. Secondary outcomes include school attendance, enrollment, performance on nationally administered exams, parents' spending on education, spillover learning to siblings and family members, and school-related time use of parents and children. Subgroup analyses of the primary outcome will also be carried out based on ethnic group, gender, distance from the main highway, parents' education level, and school type. The trial will run by independent research and implementation teams and supervised by a Trial Steering Committee.
   Discussion: Along with the overall impact of the intervention, we will conduct a cost-effectiveness analysis. There are no major ethical issues for this study.
C1 [Boone, Peter; Camara, Alpha; Fernandes, Samory; Jayanty, Chitra; Lenin, Maitri; Silva, Ana Filipa] Effect Intervent, London, England.
   [Eble, Alex] Brown Univ, Banjul, Gambia.
   [Eble, Alex] Effect Intervent, Banjul, Gambia.
   [Elbourne, Diana; Frost, Chris] London Sch Hyg & Trop Med, Providence, RI USA.
RP Eble, A (reprint author), Brown Univ, Banjul, Gambia.
EM alexander_eble@brown.edu
FU Effective Intervention
FX Funding for this study comes from Effective Intervention.
CR Banerjee AV, 2007, Q J ECON, V122, P1235, DOI 10.1162/qjec.122.3.1235
   Barro RJ, 2001, AM EC REV, V91
   Boone P, 2013, NATL BUREAU EC RES
   Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058
   CIA World Factbook, 2014, WORLD FACTB 2014
   Kremer M, 2009, ANNU REV ECON, V1, P513, DOI 10.1146/annurev.economics.050708.143323
   Lakshminarayana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065775
   Malik K., 2013, HUMAN DEV REPORT 201
   Manski C., 2013, PUBLIC POLICY UNCERT
   Muralidharan Karthik, 2013, INDIA POLICY FORUM, P1
   Murnane RJ, 2014, IMPROVING ED OUTCOME
   Pratham, 2013, 2013 ANN STAT ED REP
   Pritchett L., 2013, REBIRTH ED SCH AINT
   PSACHAROPOULOS G, 1994, WORLD DEV, V22, P1325, DOI 10.1016/0305-750X(94)90007-8
   Regional Directorates of Education Lower Bank Region and North River Region Government of The Gambia, 2013, AC DAT 2013 2014 AC
   Sen A, 1999, DEV FREEDOM
   UNESCO Institute for Statistics, 2011, SUBS AFR REG REP
   McEwan PJ, 2013, IMPROVING LEARNING P
NR 18
TC 0
Z9 0
U1 1
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD DEC 16
PY 2015
VL 16
AR 574
DI 10.1186/s13063-015-1081-7
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CY7CA
UT WOS:000366564400001
PM 26671345
OA gold
DA 2017-08-15
ER

PT J
AU Forouzanfar, MH
   Alexander, L
   Anderson, HR
   Bachman, VF
   Biryukov, S
   Brauer, M
   Burnett, R
   Casey, D
   Coates, MM
   Cohen, A
   Delwiche, K
   Estep, K
   Frostad, JJ
   Astha, KC
   Kyu, HH
   Moradi-Lakeh, M
   Ng, M
   Slepak, EL
   Thomas, BA
   Wagner, J
   Aasvang, GM
   Abbafati, C
   Ozgoren, AA
   Abd-Allah, F
   Abera, SF
   Aboyans, V
   Abraham, B
   Abraham, JP
   Abubakar, I
   Abu-Rmeileh, NME
   Aburto, TC
   Achoki, T
   Adelekan, A
   Adofo, K
   Adou, AK
   Adsuar, JC
   Afshin, A
   Agardh, EE
   Al Khabouri, MJ
   Al Lami, FH
   Alam, SS
   Alasfoor, D
   Albittar, MI
   Alegretti, MA
   Aleman, AV
   Alemu, ZA
   Alfonso-Cristancho, R
   Alhabib, S
   Ali, R
   Ali, MK
   Alla, F
   Allebeck, P
   Allen, PJ
   Alsharif, U
   Alvarez, E
   Alvis-Guzman, N
   Amankwaa, AA
   Amare, AT
   Ameh, EA
   Ameli, O
   Amini, H
   Ammar, W
   Anderson, BO
   Antonio, CAT
   Anwari, P
   Cunningham, SA
   Arnlov, J
   Arsenijevic, VSA
   Artaman, A
   Asghar, RJ
   Assadi, R
   Atkins, LS
   Atkinson, C
   Avila, MA
   Awuah, B
   Badawi, A
   Bahit, MC
   Bakfalouni, T
   Balakrishnan, K
   Balalla, S
   Balu, RK
   Banerjee, A
   Barber, RM
   Barker-Collo, SL
   Barquera, S
   Barregard, L
   Barrero, LH
   Barrientos-Gutierrez, T
   Basto-Abreu, AC
   Basu, A
   Basu, S
   Basulaiman, MO
   Ruvalcaba, CB
   Beardsley, J
   Bedi, N
   Bekele, T
   Bell, ML
   Benjet, C
   Bennett, DA
   Benzian, H
   Bernabe, E
   Beyene, TJ
   Bhala, N
   Bhalla, A
   Bhutta, ZQA
   Bikbov, B
   Bin Abdulhak, AA
   Blore, JD
   Blyth, FM
   Bohensky, MA
   Basara, BB
   Borges, G
   Bornstein, NM
   Bose, D
   Boufous, S
   Bourne, RR
   Brainin, M
   Brazinova, A
   Breitborde, NJ
   Brenner, H
   Briggs, ADM
   Broday, DM
   Brooks, PM
   Bruce, NG
   Brugha, TS
   Brunekreef, B
   Buchbinder, R
   Bui, LN
   Bukhman, G
   Bulloch, AG
   Burch, M
   Burney, PGJ
   Campos-Nonato, IR
   Campuzano, JC
   Cantoral, AJ
   Caravanos, J
   Cardenas, R
   Cardis, E
   Carpenter, DO
   Caso, V
   Castaneda-Orjuela, CA
   Castro, RE
   Catala-Lopez, F
   Cavalleri, F
   Ccedil;avlin, A
   Chadha, VK
   Chang, JC
   Charlson, FJ
   Chen, HL
   Chen, WQ
   Chen, ZM
   Chiang, PP
   Chimed-Ochir, O
   Chowdhury, R
   Christophi, CA
   Chuang, TW
   Chugh, SS
   Cirillo, M
   Classen, TKD
   Colistro, V
   Colomar, M
   Colquhoun, SM
   Contreras, AG
   Cooper, C
   Cooperrider, K
   Cooper, LT
   Coresh, J
   Courville, KJ
   Criqui, MH
   Cuevas-Nasu, L
   Damsere-Derry, J
   Danawi, H
   Dandona, L
   Dandona, R
   Dargan, PI
   Davis, A
   Davitoiu, DV
   Dayama, A
   de Castro, EF
   De la Cruz-Gongora, V
   De Leo, D
   de Lima, G
   Degenhardt, L
   del Pozo-Cruz, B
   Dellavalle, RP
   Deribe, K
   Derrett, S
   Jarlais, DCD
   Dessalegn, M
   deVeber, GA
   Devries, KM
   Dharmaratne, SD
   Dherani, MK
   Dicker, D
   Ding, EL
   Dokova, K
   Dorsey, ER
   Driscoll, TR
   Duan, L
   Durrani, AM
   Ebel, BE
   Ellenbogen, RG
   Elshrek, YM
   Endres, M
   Ermakov, SP
   Erskine, HE
   Eshrati, B
   Esteghamati, A
   Fahimi, S
   Faraon, EJA
   Farzadfar, F
   Fay, DFJ
   Feigin, VL
   Feigl, AB
   Fereshtehnejad, SM
   Ferrari, AJ
   Ferri, CP
   Flaxman, AD
   Fleming, TD
   Foigt, N
   Foreman, KJ
   Paleo, UF
   Franklin, RC
   Gabbe, B
   Gaffikin, L
   Gakidou, E
   Gamkrelidze, A
   Gankpe, FG
   Gansevoort, RT
   Garcia-Guerra, FA
   Gasana, E
   Geleijnse, JM
   Gessner, BD
   Gething, P
   Gibney, KB
   Gillum, RF
   Ginawi, IAM
   Giroud, M
   Giussani, G
   Goenka, S
   Goginashvili, K
   Dantes, HG
   Gona, P
   de Cosio, TG
   Gonzalez-Castell, D
   Gotay, CC
   Goto, A
   Gouda, HN
   Guerrant, RL
   Gugnani, HC
   Guillemin, F
   Gunnell, D
   Gupta, R
   Gupta, R
   Gutierrez, RA
   Hafezi-Nejad, N
   Hagan, H
   Hagstromer, M
   Halasa, YA
   Hamadeh, RR
   Hammami, M
   Hankey, GJ
   Hao, YT
   Harb, HL
   Haregu, TN
   Haro, JM
   Havmoeller, R
   Hay, SI
   Hedayati, MT
   Heredia-Pi, IB
   Hernandez, L
   Heuton, KR
   Heydarpour, P
   Hijar, M
   Hoek, HW
   Man, HJH
   Hornberger, JC
   Hosgood, HD
   Hoy, DG
   Hsairi, M
   Hu, GQ
   Hu, H
   Huang, C
   Huang, JJ
   Hubbell, BJ
   Huiart, L
   Husseini, A
   Iannarone, ML
   Iburg, KM
   Idrisov, BT
   Ikeda, N
   Innos, K
   Inoue, M
   Islami, F
   Ismayilova, S
   Jacobsen, KH
   Jansen, HA
   Jarvis, DL
   Jassal, SK
   Jauregui, A
   Jayaraman, S
   Jeemon, P
   Jensen, PN
   Jha, V
   Jiang, F
   Jiang, GH
   Jiang, Y
   Jonas, JB
   Juel, K
   Kan, HD
   Roseline, SSK
   Karam, NE
   Karch, A
   Karema, CK
   Karthikeyan, G
   Kaul, A
   Kawakami, N
   Kazi, DS
   Kemp, AH
   Kengne, AP
   Keren, A
   Khader, YS
   Khalifa, SEAH
   Khan, EA
   Khang, YH
   Khatibzadeh, S
   Khonelidze, I
   Kieling, C
   Kim, D
   Kim, S
   Kim, Y
   Kimokoti, RW
   Kinfu, Y
   Kinge, JM
   Kissela, BM
   Kivipelto, M
   Knibbs, LD
   Knudsen, AK
   Kokubo, Y
   Kose, MR
   Kosen, S
   Kraemer, A
   Kravchenko, M
   Krishnaswami, S
   Kromhout, H
   Ku, T
   Defo, BK
   Bicer, BK
   Kuipers, EJ
   Kulkarni, C
   Kulkarni, VS
   Kumar, GA
   Kwan, GF
   Lai, T
   Balaji, AL
   Lalloo, R
   Lallukka, T
   Lam, H
   Lan, Q
   Lansingh, VC
   Larson, HJ
   Larsson, A
   Laryea, DO
   Lavados, PM
   Lawrynowicz, AE
   Leasher, JL
   Lee, JT
   Leigh, J
   Leung, R
   Levi, M
   Li, Y
   Li, Y
   Liang, J
   Liang, XF
   Lim, SS
   Lindsay, MP
   Lipshultz, SE
   Liu, SW
   Liu, Y
   Lloyd, BK
   Logroscino, G
   London, SJ
   Lopez, N
   Lortet-Tieulent, J
   Lotufo, PA
   Lozano, R
   Lunevicius, R
   Ma, JX
   Ma, S
   Machado, VMP
   MacIntyre, MF
   Magis-Rodriguez, C
   Mahdi, AA
   Majdan, M
   Malekzadeh, R
   Mangalam, S
   Mapoma, CC
   Marape, M
   Marcenes, W
   Margolis, DJ
   Margono, C
   Marks, GB
   Martin, RV
   Marzan, MB
   Mashal, MT
   Masiye, F
   Mason-Jones, AJ
   Matsushita, K
   Matzopoulos, R
   Mayosi, BM
   Mazorodze, TT
   Mckay, AC
   Mckee, M
   McLain, A
   Meaney, PA
   Medina, C
   Mehndiratta, MM
   Mejia-Rodriguez, F
   Mekonnen, W
   Melaku, YA
   Meltzer, M
   Memish, ZA
   Mendoza, W
   Mensah, GA
   Meretoja, A
   Mhimbira, FA
   Micha, R
   Miller, TR
   Mills, EJ
   Misganaw, A
   Mishra, S
   Ibrahim, NM
   Mohammad, KA
   Mokdad, AH
   Mola, GL
   Monasta, L
   Hernandez, JCM
   Montico, M
   Moore, AR
   Morawska, L
   Mori, R
   Moschandreas, J
   Moturi, WN
   Arian, DM
   Mueller, UO
   Mukaigawara, M
   Mullany, EC
   Murthy, KS
   Naghavi, M
   Nahas, Z
   Naheed, A
   Naidoo, KS
   Naldi, L
   Nand, D
   Nangia, V
   Narayan, KMV
   Nash, D
   Neal, B
   Nejjari, C
   Neupane, SP
   Newton, CR
   Ngalesoni, FN
   Ngirabega, JD
   Nguyen, G
   Nguyen, NT
   Nieuwenhuijsen, MJ
   Nisar, MI
   Nogueira, JR
   Nolla, JM
   Nolte, S
   Norheim, OF
   Norman, RE
   Norrving, B
   Nyakarahuka, L
   Oh, IH
   Ohkubo, T
   Olusanya, BO
   Omer, SB
   Opio, JN
   Orozco, R
   Pagcatipunan, RS
   Pain, AW
   Pandian, JD
   Panelo, CIA
   Papachristou, C
   Park, EK
   Parry, CD
   Caicedo, AJP
   Patten, SB
   Paul, VK
   Pavlin, BI
   Pearce, N
   Pedraza, LS
   Pedroza, A
   Stokic, LP
   Pekericli, A
   Pereira, DM
   Perez-Padilla, R
   Perez-Ruiz, F
   Perico, N
   Perry, SAL
   Pervaiz, A
   Pesudovs, K
   Peterson, CB
   Petzold, M
   Phillips, MR
   Phua, HP
   Plass, D
   Poenaru, D
   Polanczyk, GV
   Polinder, S
   Pond, CD
   Pope, CA
   Pope, D
   Popova, S
   Pourmalek, F
   Powles, J
   Prabhakaran, D
   Prasad, NM
   Qato, DM
   Quezada, AD
   Quistberg, DAA
   Racape L
   Rafay, A
   Rahimi, K
   Rahimi-Movaghar, V
   Rahman, SU
   Raju, M
   Rakovac, I
   Rana, SM
   Rao, M
   Razavi, H
   Reddy, KS
   Refaat, AH
   Rehm, J
   Remuzzi, G
   Ribeiro, AL
   Riccio, PM
   Richardson, L
   Riederer, A
   Robinson, M
   Roca, A
   Rodriguez, A
   Rojas-Rueda, D
   Romieu, I
   Ronfani, L
   Room, R
   Roy, N
   Ruhago, GM
   Rushton, L
   Sabin, N
   Sacco, RL
   Saha, S
   Sahathevan, R
   Sahraian, MA
   Salomon, JA
   Salvo, D
   Sampson, UK
   Sanabria, JR
   Sanchez, LM
   Sanchez-Pimienta, TG
   Sanchez-Riera, L
   Sandar, L
   Santos, IS
   Sapkota, A
   Satpathy, M
   Saunders, JE
   Sawhney, M
   Saylan, MI
   Scarborough, P
   Schmidt, JC
   Schneider, IJC
   Schottker, B
   Schwebel, DC
   Scott, JG
   Seedat, S
   Sepanlou, SG
   Serdar, B
   Servan-Mori, EE
   Shaddick, G
   Shahraz, S
   Levy, TS
   Shangguan, S
   She, J
   Sheikhbahaei, S
   Shibuya, K
   Shin, HH
   Shinohara, Y
   Shiri, R
   Shishani, K
   Shiue, I
   Sigfusdottir, ID
   Silberberg, DH
   Simard, EP
   Sindi, S
   Singh, A
   Singh, GM
   Singh, JA
   Skirbekk, V
   Sliwa, K
   Soljak, M
   Soneji, S
   Soreide, K
   Soshnikov, S
   Sposato, LA
   Sreeramareddy, CT
   Stapelberg, NJC
   Stathopoulou, V
   Steckling, N
   Stein, DJ
   Stein, MB
   Stephens, N
   Stockl, H
   Straif, K
   Stroumpoulis, K
   Sturua, L
   Sunguya, BF
   Swaminathan, S
   Swaroop, M
   Sykes, BL
   Tabb, KM
   Takahashi, K
   Talongwa, RT
   Tandon, N
   Tanne, D
   Tanner, M
   Tavakkoli, M
   Ao, BJT
   Teixeira, CM
   Rojo, MMT
   Terkawi, AS
   Texcalac-Sangrador, JL
   Thackway, SV
   Thomson, B
   Thorne-Lyman, AL
   Thrift, AG
   Thurston, GD
   Tillmann, T
   Tobollik, M
   Tonelli, M
   Topouzis, F
   Towbin, JRA
   Toyoshima, H
   Traebert, JE
   Tran, BX
   Trasande, L
   Trillini, M
   Trujillo, U
   Dimbuene, ZT
   Tsilimbaris, M
   Tuzcu, EM
   Uchendu, US
   Ukwaja, KN
   Uzun, SB
   van de Vijver, S
   Van Dingenen, R
   Van Gool, CH
   Van Os, J
   Varakin, YY
   Vasankari, TJ
   Vasconcelos, AMN
   Vavilala, MS
   Veerman, LJ
   Velasquez-Melendez, G
   Venketasubramanian, N
   Vijayakumar, L
   Villalpando, S
   Violante, FS
   Vlassov, VV
   Vollset, SE
   Wagner, GR
   Waller, SG
   Wallin, MT
   Wan, X
   Wang, HD
   Wang, JL
   Wang, LH
   Wang, WZ
   Wang, YP
   Warouw, TS
   Watts, CH
   Weichenthal, S
   Weiderpass, E
   Weintraub, RG
   Werdecker, A
   Wessells, KR
   Westerman, R
   Whiteford, HA
   Wilkinson, JD
   Williams, HC
   Williams, TN
   Woldeyohannes, SM
   Wolfe, CDA
   Wong, JQ
   Woolf, AD
   Wright, JL
   Wurtz, B
   Xu, G
   Yan, LJL
   Yang, GH
   Yano, Y
   Ye, PP
   Yenesew, M
   Yentur, GK
   Yip, P
   Yonemoto, N
   Yoon, SJ
   Younis, MZ
   Younoussi, Z
   Yu, CH
   Zaki, ME
   Zhao, Y
   Zheng, YF
   Zhou, MG
   Zhu, J
   Zhu, SK
   Zou, XN
   Zunt, JR
   Lopez, AD
   Vos, T
   Murray, CJ
AF Forouzanfar, Mohammad H.
   Alexander, Lily
   Anderson, H. Ross
   Bachman, Victoria F.
   Biryukov, Stan
   Brauer, Michael
   Burnett, Richard
   Casey, Daniel
   Coates, Matthew M.
   Cohen, Aaron
   Delwiche, Kristen
   Estep, Kara
   Frostad, Joseph J.
   Astha, K. C.
   Kyu, Hmwe H.
   Moradi-Lakeh, Maziar
   Ng, Marie
   Slepak, Erica Leigh
   Thomas, Bernadette A.
   Wagner, Joseph
   Aasvang, Gunn Marit
   Abbafati, Cristiana
   Ozgoren, Ayse Abbasoglu
   Abd-Allah, Foad
   Abera, Semaw F.
   Aboyans, Victor
   Abraham, Biju
   Abraham, Jerry Puthenpurakal
   Abubakar, Ibrahim
   Abu-Rmeileh, Niveen M. E.
   Aburto, Tania C.
   Achoki, Tom
   Adelekan, Ademola
   Adofo, Koranteng
   Adou, Arsene K.
   Adsuar, Jose C.
   Afshin, Ashkan
   Agardh, Emilie E.
   Al Khabouri, Mazin J.
   Al Lami, Faris H.
   Alam, Sayed Saidul
   Alasfoor, Deena
   Albittar, Mohammed I.
   Alegretti, Miguel A.
   Aleman, Alicia V.
   Alemu, Zewdie A.
   Alfonso-Cristancho, Rafael
   Alhabib, Samia
   Ali, Raghib
   Ali, Mohammed K.
   Alla, Francois
   Allebeck, Peter
   Allen, Peter J.
   Alsharif, Ubai
   Alvarez, Elena
   Alvis-Guzman, Nelson
   Amankwaa, Adansi A.
   Amare, Azmeraw T.
   Ameh, Emmanuel A.
   Ameli, Omid
   Amini, Heresh
   Ammar, Walid
   Anderson, Benjamin O.
   Antonio, Carl Abelardo T.
   Anwari, Palwasha
   Cunningham, Solveig Argeseanu
   Arnlov, Johan
   Arsenijevic, Valentina S. Arsic
   Artaman, Al
   Asghar, Rana J.
   Assadi, Reza
   Atkins, Lydia S.
   Atkinson, Charles
   Avila, Marco A.
   Awuah, Baffour
   Badawi, Alaa
   Bahit, Maria C.
   Bakfalouni, Talal
   Balakrishnan, Kalpana
   Balalla, Shivanthi
   Balu, Ravi Kumar
   Banerjee, Amitava
   Barber, Ryan M.
   Barker-Collo, Suzanne L.
   Barquera, Simon
   Barregard, Lars
   Barrero, Lope H.
   Barrientos-Gutierrez, Tonatiuh
   Basto-Abreu, Ana C.
   Basu, Arindam
   Basu, Sanjay
   Basulaiman, Mohammed O.
   Ruvalcaba, Carolina Batis
   Beardsley, Justin
   Bedi, Neeraj
   Bekele, Tolesa
   Bell, Michelle L.
   Benjet, Corina
   Bennett, Derrick A.
   Benzian, Habib
   Bernabe, Eduardo
   Beyene, Tariku J.
   Bhala, Neeraj
   Bhalla, Ashish
   Bhutta, Zulfi Qar A.
   Bikbov, Boris
   Bin Abdulhak, Aref A.
   Blore, Jed D.
   Blyth, Fiona M.
   Bohensky, Megan A.
   Basara, Berrak Bora
   Borges, Guilherme
   Bornstein, Natan M.
   Bose, Dipan
   Boufous, Soufiane
   Bourne, Rupert R.
   Brainin, Michael
   Brazinova, Alexandra
   Breitborde, Nicholas J.
   Brenner, Hermann
   Briggs, Adam D. M.
   Broday, David M.
   Brooks, Peter M.
   Bruce, Nigel G.
   Brugha, Traolach S.
   Brunekreef, Bert
   Buchbinder, Rachelle
   Bui, Linh N.
   Bukhman, Gene
   Bulloch, Andrew G.
   Burch, Michael
   Burney, Peter G. J.
   Campos-Nonato, Ismael R.
   Campuzano, Julio C.
   Cantoral, Alejandra J.
   Caravanos, Jack
   Cardenas, Rosario
   Cardis, Elisabeth
   Carpenter, David O.
   Caso, Valeria
   Castaneda-Orjuela, Carlos A.
   Castro, Ruben E.
   Catala-Lopez, Ferran
   Cavalleri, Fiorella
   Cavlin, Alanur
   Chadha, Vineet K.
   Chang, Jung-chen
   Charlson, Fiona J.
   Chen, Honglei
   Chen, Wanqing
   Chen, Zhengming
   Chiang, Peggy P.
   Chimed-Ochir, Odgerel
   Chowdhury, Rajiv
   Christophi, Costas A.
   Chuang, Ting-Wu
   Chugh, Sumeet S.
   Cirillo, Massimo
   Classen, Thomas K. D.
   Colistro, Valentina
   Colomar, Mercedes
   Colquhoun, Samantha M.
   Contreras, Alejandra G.
   Cooper, Cyrus
   Cooperrider, Kimberly
   Cooper, Leslie T.
   Coresh, Josef
   Courville, Karen J.
   Criqui, Michael H.
   Cuevas-Nasu, Lucia
   Damsere-Derry, James
   Danawi, Hadi
   Dandona, Lalit
   Dandona, Rakhi
   Dargan, Paul I.
   Davis, Adrian
   Davitoiu, Dragos V.
   Dayama, Anand
   de Castro, E. Filipa
   De la Cruz-Gongora, Vanessa
   De Leo, Diego
   de Lima, Graca
   Degenhardt, Louisa
   del Pozo-Cruz, Borja
   Dellavalle, Robert P.
   Deribe, Kebede
   Derrett, Sarah
   Jarlais, Don C. Des
   Dessalegn, Muluken
   deVeber, Gabrielle A.
   Devries, Karen M.
   Dharmaratne, Samath D.
   Dherani, Mukesh K.
   Dicker, Daniel
   Ding, Eric L.
   Dokova, Klara
   Dorsey, E. Ray
   Driscoll, Tim R.
   Duan, Leilei
   Durrani, Adnan M.
   Ebel, Beth E.
   Ellenbogen, Richard G.
   Elshrek, Yousef M.
   Endres, Matthias
   Ermakov, Sergey P.
   Erskine, Holly E.
   Eshrati, Babak
   Esteghamati, Alireza
   Fahimi, Saman
   Faraon, Emerito Jose A.
   Farzadfar, Farshad
   Fay, Derek F. J.
   Feigin, Valery L.
   Feigl, Andrea B.
   Fereshtehnejad, Seyed-Mohammad
   Ferrari, Alize J.
   Ferri, Cleusa P.
   Flaxman, Abraham D.
   Fleming, Thomas D.
   Foigt, Nataliya
   Foreman, Kyle J.
   Paleo, Urbano Fra
   Franklin, Richard C.
   Gabbe, Belinda
   Gaffikin, Lynne
   Gakidou, Emmanuela
   Gamkrelidze, Amiran
   Gankpe, Fortune G.
   Gansevoort, Ron T.
   Garcia-Guerra, Francisco A.
   Gasana, Evariste
   Geleijnse, Johanna M.
   Gessner, Bradford D.
   Gething, Pete
   Gibney, Katherine B.
   Gillum, Richard F.
   Ginawi, Ibrahim A. M.
   Giroud, Maurice
   Giussani, Giorgia
   Goenka, Shifalika
   Goginashvili, Ketevan
   Dantes, Hector Gomez
   Gona, Philimon
   de Cosio, Teresita Gonzalez
   Gonzalez-Castell, Dinorah
   Gotay, Carolyn C.
   Goto, Atsushi
   Gouda, Hebe N.
   Guerrant, Richard L.
   Gugnani, Harish C.
   Guillemin, Francis
   Gunnell, David
   Gupta, Rahul
   Gupta, Rajeev
   Gutierrez, Reyna A.
   Hafezi-Nejad, Nima
   Hagan, Holly
   Hagstromer, Maria
   Halasa, Yara A.
   Hamadeh, Randah R.
   Hammami, Mouhanad
   Hankey, Graeme J.
   Hao, Yuantao
   Harb, Hilda L.
   Haregu, Tilahun Nigatu
   Haro, Josep Maria
   Havmoeller, Rasmus
   Hay, Simon I.
   Hedayati, Mohammad T.
   Heredia-Pi, Ileana B.
   Hernandez, Lucia
   Heuton, Kyle R.
   Heydarpour, Pouria
   Hijar, Martha
   Hoek, Hans W.
   Man, Howard J. Hoff
   Hornberger, John C.
   Hosgood, H. Dean
   Hoy, Damian G.
   Hsairi, Mohamed
   Hu, Guoqing
   Hu, Howard
   Huang, Cheng
   Huang, John J.
   Hubbell, Bryan J.
   Huiart, Laetitia
   Husseini, Abdullatif
   Iannarone, Marissa L.
   Iburg, Kim M.
   Idrisov, Bulat T.
   Ikeda, Nayu
   Innos, Kaire
   Inoue, Manami
   Islami, Farhad
   Ismayilova, Samaya
   Jacobsen, Kathryn H.
   Jansen, Henrica A.
   Jarvis, Deborah L.
   Jassal, Simerjot K.
   Jauregui, Alejandra
   Jayaraman, Sudha
   Jeemon, Panniyammakal
   Jensen, Paul N.
   Jha, Vivekanand
   Jiang, Fan
   Jiang, Guohong
   Jiang, Ying
   Jonas, Jost B.
   Juel, Knud
   Kan, Haidong
   Roseline, Sidibe S. Kany
   Karam, Nadim E.
   Karch, Andre
   Karema, Corine K.
   Karthikeyan, Ganesan
   Kaul, Anil
   Kawakami, Norito
   Kazi, Dhruv S.
   Kemp, Andrew H.
   Kengne, Andre P.
   Keren, Andre
   Khader, Yousef S.
   Khalifa, Shams Eldin Ali Hassan
   Khan, Ejaz A.
   Khang, Young-Ho
   Khatibzadeh, Shahab
   Khonelidze, Irma
   Kieling, Christian
   Kim, Daniel
   Kim, Sungroul
   Kim, Yunjin
   Kimokoti, Ruth W.
   Kinfu, Yohannes
   Kinge, Jonas M.
   Kissela, Brett M.
   Kivipelto, Miia
   Knibbs, Luke D.
   Knudsen, Ann Kristin
   Kokubo, Yoshihiro
   Kose, M. Rifat
   Kosen, Soewarta
   Kraemer, Alexander
   Kravchenko, Michael
   Krishnaswami, Sanjay
   Kromhout, Hans
   Ku, Tiffany
   Defo, Barthelemy Kuate
   Bicer, Burcu Kucuk
   Kuipers, Ernst J.
   Kulkarni, Chanda
   Kulkarni, Veena S.
   Kumar, G. Anil
   Kwan, Gene F.
   Lai, Taavi
   Balaji, Arjun Lakshmana
   Lalloo, Ratilal
   Lallukka, Tea
   Lam, Hilton
   Lan, Qing
   Lansingh, Van C.
   Larson, Heidi J.
   Larsson, Anders
   Laryea, Dennis O.
   Lavados, Pablo M.
   Lawrynowicz, Alicia E.
   Leasher, Janet L.
   Lee, Jong-Tae
   Leigh, James
   Leung, Ricky
   Levi, Miriam
   Li, Yichong
   Li, Yongmei
   Liang, Juan
   Liang, Xiaofeng
   Lim, Stephen S.
   Lindsay, M. Patrice
   Lipshultz, Steven E.
   Liu, Shiwei
   Liu, Yang
   Lloyd, Belinda K.
   Logroscino, Giancarlo
   London, Stephanie J.
   Lopez, Nancy
   Lortet-Tieulent, Joannie
   Lotufo, Paulo A.
   Lozano, Rafael
   Lunevicius, Raimundas
   Ma, Jixiang
   Ma, Stefan
   Machado, Vasco M. P.
   MacIntyre, Michael F.
   Magis-Rodriguez, Carlos
   Mahdi, Abbas A.
   Majdan, Marek
   Malekzadeh, Reza
   Mangalam, Srikanth
   Mapoma, Christopher C.
   Marape, Marape
   Marcenes, Wagner
   Margolis, David J.
   Margono, Christopher
   Marks, Guy B.
   Martin, Randall V.
   Marzan, Melvin B.
   Mashal, Mohammad T.
   Masiye, Felix
   Mason-Jones, Amanda J.
   Matsushita, Kunihiro
   Matzopoulos, Richard
   Mayosi, Bongani M.
   Mazorodze, Tasara T.
   Mckay, Abigail C.
   Mckee, Martin
   McLain, Abigail
   Meaney, Peter A.
   Medina, Catalina
   Mehndiratta, Man Mohan
   Mejia-Rodriguez, Fabiola
   Mekonnen, Wubegzier
   Melaku, Yohannes A.
   Meltzer, Michele
   Memish, Ziad A.
   Mendoza, Walter
   Mensah, George A.
   Meretoja, Atte
   Mhimbira, Francis Apolinary
   Micha, Renata
   Miller, Ted R.
   Mills, Edward J.
   Misganaw, Awoke
   Mishra, Santosh
   Ibrahim, Norlinah Mohamed
   Mohammad, Karzan A.
   Mokdad, Ali H.
   Mola, Glen L.
   Monasta, Lorenzo
   Hernandez, Julio C. Montaez
   Montico, Marcella
   Moore, Ami R.
   Morawska, Lidia
   Mori, Rintaro
   Moschandreas, Joanna
   Moturi, Wilkister N.
   Arian, Dariush Mozaff
   Mueller, Ulrich O.
   Mukaigawara, Mitsuru
   Mullany, Erin C.
   Murthy, Kinnari S.
   Naghavi, Mohsen
   Nahas, Ziad
   Naheed, Aliya
   Naidoo, Kovin S.
   Naldi, Luigi
   Nand, Devina
   Nangia, Vinay
   Narayan, K. M. Venkat
   Nash, Denis
   Neal, Bruce
   Nejjari, Chakib
   Neupane, Sudan P.
   Newton, Charles R.
   Ngalesoni, Frida N.
   Ngirabega, Jean de Dieu
   Nguyen, Grant
   Nguyen, Nhung T.
   Nieuwenhuijsen, Mark J.
   Nisar, Muhammad I.
   Nogueira, Jose R.
   Nolla, Joan M.
   Nolte, Sandra
   Norheim, Ole F.
   Norman, Rosana E.
   Norrving, Bo
   Nyakarahuka, Luke
   Oh, In-Hwan
   Ohkubo, Takayoshi
   Olusanya, Bolajoko O.
   Omer, Saad B.
   Opio, John Nelson
   Orozco, Ricardo
   Pagcatipunan, Rodolfo S., Jr.
   Pain, Amanda W.
   Pandian, Jeyaraj D.
   Panelo, Carlo Irwin A.
   Papachristou, Christina
   Park, Eun-Kee
   Parry, Charles D.
   Caicedo, Angel J. Paternina
   Patten, Scott B.
   Paul, Vinod K.
   Pavlin, Boris I.
   Pearce, Neil
   Pedraza, Lilia S.
   Pedroza, Andrea
   Stokic, Ljiljana Pejin
   Pekericli, Ayfer
   Pereira, David M.
   Perez-Padilla, Rogelio
   Perez-Ruiz, Fernando
   Perico, Norberto
   Perry, Samuel A. L.
   Pervaiz, Aslam
   Pesudovs, Konrad
   Peterson, Carrie B.
   Petzold, Max
   Phillips, Michael R.
   Phua, Hwee Pin
   Plass, Dietrich
   Poenaru, Dan
   Polanczyk, Guilherme V.
   Polinder, Suzanne
   Pond, Constance D.
   Pope, C. Arden
   Pope, Daniel
   Popova, Svetlana
   Pourmalek, Farshad
   Powles, John
   Prabhakaran, Dorairaj
   Prasad, Noela M.
   Qato, Dima M.
   Quezada, Amado D.
   Quistberg, D. Alex A.
   Racape, Lionel
   Rafay, Anwar
   Rahimi, Kazem
   Rahimi-Movaghar, Vafa
   Rahman, Sajjad Ur
   Raju, Murugesan
   Rakovac, Ivo
   Rana, Saleem M.
   Rao, Mayuree
   Razavi, Homie
   Reddy, K. Srinath
   Refaat, Amany H.
   Rehm, Juergen
   Remuzzi, Giuseppe
   Ribeiro, Antonio L.
   Riccio, Patricia M.
   Richardson, Lee
   Riederer, Anne
   Robinson, Margaret
   Roca, Anna
   Rodriguez, Alina
   Rojas-Rueda, David
   Romieu, Isabelle
   Ronfani, Luca
   Room, Robin
   Roy, Nobhojit
   Ruhago, George M.
   Rushton, Lesley
   Sabin, Nsanzimana
   Sacco, Ralph L.
   Saha, Sukanta
   Sahathevan, Ramesh
   Sahraian, Mohammad Ali
   Salomon, Joshua A.
   Salvo, Deborah
   Sampson, Uchechukwu K.
   Sanabria, Juan R.
   Sanchez, Luz Maria
   Sanchez-Pimienta, Tania G.
   Sanchez-Riera, Lidia
   Sandar, Logan
   Santos, Itamar S.
   Sapkota, Amir
   Satpathy, Maheswar
   Saunders, James E.
   Sawhney, Monika
   Saylan, Mete I.
   Scarborough, Peter
   Schmidt, Juergen C.
   Schneider, Ione J. C.
   Schoettker, Ben
   Schwebel, David C.
   Scott, James G.
   Seedat, Soraya
   Sepanlou, Sadaf G.
   Serdar, Berrin
   Servan-Mori, Edson E.
   Shaddick, Gavin
   Shahraz, Saeid
   Levy, Teresa Shamah
   Shangguan, Siyi
   She, Jun
   Sheikhbahaei, Sara
   Shibuya, Kenji
   Shin, Hwashin H.
   Shinohara, Yukito
   Shiri, Rahman
   Shishani, Kawkab
   Shiue, Ivy
   Sigfusdottir, Inga D.
   Silberberg, Donald H.
   Simard, Edgar P.
   Sindi, Shireen
   Singh, Abhishek
   Singh, Gitanjali M.
   Singh, Jasvinder A.
   Skirbekk, Vegard
   Sliwa, Karen
   Soljak, Michael
   Soneji, Samir
   Soreide, Kjetil
   Soshnikov, Sergey
   Sposato, Luciano A.
   Sreeramareddy, Chandrashekhar T.
   Stapelberg, Nicolas J. C.
   Stathopoulou, Vasiliki
   Steckling, Nadine
   Stein, Dan J.
   Stein, Murray B.
   Stephens, Natalie
   Stoeckl, Heidi
   Straif, Kurt
   Stroumpoulis, Konstantinos
   Sturua, Lela
   Sunguya, Bruno F.
   Swaminathan, Soumya
   Swaroop, Mamta
   Sykes, Bryan L.
   Tabb, Karen M.
   Takahashi, Ken
   Talongwa, Roberto T.
   Tandon, Nikhil
   Tanne, David
   Tanner, Marcel
   Tavakkoli, Mohammad
   Ao, Braden J. Te
   Teixeira, Carolina M.
   Rojo, Martha M. Tellez
   Terkawi, Abdullah S.
   Texcalac-Sangrador, Jose Luis
   Thackway, Sarah V.
   Thomson, Blake
   Thorne-Lyman, Andrew L.
   Thrift, Amanda G.
   Thurston, George D.
   Tillmann, Taavi
   Tobollik, Myriam
   Tonelli, Marcello
   Topouzis, Fotis
   Towbin, Jeff Rey A.
   Toyoshima, Hideaki
   Traebert, Jeff Erson
   Tran, Bach X.
   Trasande, Leonardo
   Trillini, Matias
   Trujillo, Ulises
   Dimbuene, Zacharie Tsala
   Tsilimbaris, Miltiadis
   Tuzcu, Emin Murat
   Uchendu, Uche S.
   Ukwaja, Kingsley N.
   Uzun, Selen B.
   van de Vijver, Steven
   Van Dingenen, Rita
   Van Gool, Coen H.
   Van Os, Jim
   Varakin, Yuri Y.
   Vasankari, Tommi J.
   Vasconcelos, Ana Maria N.
   Vavilala, Monica S.
   Veerman, Lennert J.
   Velasquez-Melendez, Gustavo
   Venketasubramanian, N.
   Vijayakumar, Lakshmi
   Villalpando, Salvador
   Violante, Francesco S.
   Vlassov, Vasiliy Victorovich
   Vollset, Stein Emil
   Wagner, Gregory R.
   Waller, Stephen G.
   Wallin, Mitchell T.
   Wan, Xia
   Wang, Haidong
   Wang, JianLi
   Wang, Linhong
   Wang, Wenzhi
   Wang, Yanping
   Warouw, Tati S.
   Watts, Charlotte H.
   Weichenthal, Scott
   Weiderpass, Elisabete
   Weintraub, Robert G.
   Werdecker, Andrea
   Wessells, K. Ryan
   Westerman, Ronny
   Whiteford, Harvey A.
   Wilkinson, James D.
   Williams, Hywel C.
   Williams, Thomas N.
   Woldeyohannes, Solomon M.
   Wolfe, Charles D. A.
   Wong, John Q.
   Woolf, Anthony D.
   Wright, Jonathan L.
   Wurtz, Brittany
   Xu, Gelin
   Yan, Lijing L.
   Yang, Gonghuan
   Yano, Yuichiro
   Ye, Pengpeng
   Yenesew, Muluken
   Yentuer, Goekalp K.
   Yip, Paul
   Yonemoto, Naohiro
   Yoon, Seok-Jun
   Younis, Mustafa Z.
   Younoussi, Zourkaleini
   Yu, Chuanhua
   Zaki, Maysaa E.
   Zhao, Yong
   Zheng, Yingfeng
   Zhou, Maigeng
   Zhu, Jun
   Zhu, Shankuan
   Zou, Xiaonong
   Zunt, Joseph R.
   Lopez, Alan D.
   Vos, Theo
   Murray, Christopher J.
CA GBD 2013 Risk Factors
TI Global, regional, and national comparative risk assessment of 79
   behavioural, environmental and occupational, and metabolic risks or
   clusters of risks in 188 countries, 1990-2013: a systematic analysis for
   the Global Burden of Disease Study 2013
SO LANCET
LA English
DT Article
ID BODY-MASS INDEX; CORONARY-HEART-DISEASE; CAUSE-SPECIFIC MORTALITY; FINE
   PARTICULATE MATTER; OUTDOOR AIR-POLLUTION; MALE BRITISH DOCTORS;
   ALL-CAUSE MORTALITY; LONG-TERM EXPOSURE; BLOOD-PRESSURE; TOBACCO SMOKING
AB Background The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) is the first of a series of annual updates of the GBD. Risk factor quantification, particularly of modifiable risk factors, can help to identify emerging threats to population health and opportunities for prevention. The GBD 2013 provides a timely opportunity to update the comparative risk assessment with new data for exposure, relative risks, and evidence on the appropriate counterfactual risk distribution.
   Methods Attributable deaths, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) have been estimated for 79 risks or clusters of risks using the GBD 2010 methods. Risk-outcome pairs meeting explicit evidence criteria were assessed for 188 countries for the period 1990-2013 by age and sex using three inputs: risk exposure, relative risks, and the theoretical minimum risk exposure level (TMREL). Risks are organised into a hierarchy with blocks of behavioural, environmental and occupational, and metabolic risks at the first level of the hierarchy. The next level in the hierarchy includes nine clusters of related risks and two individual risks, with more detail provided at levels 3 and 4 of the hierarchy. Compared with GBD 2010, six new risk factors have been added: handwashing practices, occupational exposure to trichloroethylene, childhood wasting, childhood stunting, unsafe sex, and low glomerular filtration rate. For most risks, data for exposure were synthesised with a Bayesian meta-regression method, DisMod-MR 2.0, or spatial-temporal Gaussian process regression. Relative risks were based on meta-regressions of published cohort and intervention studies. Attributable burden for clusters of risks and all risks combined took into account evidence on the mediation of some risks such as high body-mass index (BMI) through other risks such as high systolic blood pressure and high cholesterol.
   Findings All risks combined account for 57.2% (95% uncertainty interval [UI] 55.8-58.5) of deaths and 41.6% (40.1-43.0) of DALYs. Risks quantified account for 87.9% (86.5-89.3) of cardiovascular disease DALYs, ranging to a low of 0% for neonatal disorders and neglected tropical diseases and malaria. In terms of global DALYs in 2013, six risks or clusters of risks each caused more than 5% of DALYs: dietary risks accounting for 11.3 million deaths and 241.4 million DALYs, high systolic blood pressure for 10.4 million deaths and 208.1 million DALYs, child and maternal malnutrition for 1.7 million deaths and 176.9 million DALYs, tobacco smoke for 6.1 million deaths and 143.5 million DALYs, air pollution for 5.5 million deaths and 141.5 million DALYs, and high BMI for 4.4 million deaths and 134.0 million DALYs. Risk factor patterns vary across regions and countries and with time. In sub-Saharan Africa, the leading risk factors are child and maternal malnutrition, unsafe sex, and unsafe water, sanitation, and handwashing. In women, in nearly all countries in the Americas, north Africa, and the Middle East, and in many other high-income countries, high BMI is the leading risk factor, with high systolic blood pressure as the leading risk in most of Central and Eastern Europe and south and east Asia. For men, high systolic blood pressure or tobacco use are the leading risks in nearly all high-income countries, in north Africa and the Middle East, Europe, and Asia. For men and women, unsafe sex is the leading risk in a corridor from Kenya to South Africa.
   Interpretation Behavioural, environmental and occupational, and metabolic risks can explain half of global mortality and more than one-third of global DALYs providing many opportunities for prevention. Of the larger risks, the attributable burden of high BMI has increased in the past 23 years. In view of the prominence of behavioural risk factors, behavioural and social science research on interventions for these risks should be strengthened. Many prevention and primary care policy options are available now to act on key risks.
C1 [Forouzanfar, Mohammad H.; Alexander, Lily; Bachman, Victoria F.; Biryukov, Stan; Brauer, Michael; Casey, Daniel; Coates, Matthew M.; Cohen, Aaron; Delwiche, Kristen; Estep, Kara; Frostad, Joseph J.; Kyu, Hmwe H.; Moradi-Lakeh, Maziar; Ng, Marie; Slepak, Erica Leigh; Thomas, Bernadette A.; Wagner, Joseph; Achoki, Tom; Atkinson, Charles; Barber, Ryan M.; Cooperrider, Kimberly; Dandona, Lalit; Dicker, Daniel; Flaxman, Abraham D.; Fleming, Thomas D.; Foreman, Kyle J.; Gakidou, Emmanuela; Hay, Simon I.; Heuton, Kyle R.; Iannarone, Marissa L.; Ku, Tiffany; Larson, Heidi J.; Lim, Stephen S.; Lozano, Rafael; MacIntyre, Michael F.; Margono, Christopher; McLain, Abigail; Mokdad, Ali H.; Mullany, Erin C.; Naghavi, Mohsen; Nguyen, Grant; Pain, Amanda W.; Richardson, Lee; Robinson, Margaret; Sandar, Logan; Stephens, Natalie; Thomson, Blake; Wan, Xia; Wurtz, Brittany; Lopez, Alan D.; Vos, Theo; Murray, Christopher J.] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Ebel, Beth E.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.
   [Ellenbogen, Richard G.] Univ Washington, Harborview UW Med, Seattle, WA 98195 USA.
   [Wright, Jonathan L.] Univ Washington, Sch Med, Seattle, WA 98195 USA.
   [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Jensen, Paul N.; Quistberg, D. Alex A.; Riederer, Anne; Vavilala, Monica S.; Zunt, Joseph R.] Univ Washington, Seattle, WA 98195 USA.
   [Anderson, H. Ross] Univ London, St Georges, London, England.
   [Pourmalek, Farshad] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.
   [Brauer, Michael; Gotay, Carolyn C.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   [Burnett, Richard; Shin, Hwashin H.; Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada.
   [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA.
   [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Dept Community Med, Tehran, Iran.
   [Knudsen, Ann Kristin] Norwegian Inst Publ Hlth, Dept Hlth Registries, Oslo, Norway.
   [Aasvang, Gunn Marit; Kinge, Jonas M.; Skirbekk, Vegard; Vollset, Stein Emil] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Abbafati, Cristiana] Univ Roma La Sapienza, I-00185 Rome, Italy.
   [Ozgoren, Ayse Abbasoglu; Cavlin, Alanur] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey.
   [Bicer, Burcu Kucuk] Hacettepe Univ, Inst Publ Hlth, Ankara, Turkey.
   [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt.
   [Abera, Semaw F.] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.
   [Melaku, Yohannes A.] Mekelle Univ, Mekelle, Ethiopia.
   [Abera, Semaw F.] Kilte Awlaelo Hlth & Demog Surveillance Site, Mekelle, Ethiopia.
   [Aboyans, Victor] Dupuytren Univ Hosp, Limoges, France.
   [Abraham, Biju] Govt Coll Munnar, Munnar, India.
   [Abraham, Jerry Puthenpurakal] Univ So Calif, Calif Hosp, Family Med Residency Program, Los Angeles, CA USA.
   [Abraham, Jerry Puthenpurakal] Harvard Univ, Inst Global Hlth, Boston, MA 02115 USA.
   [Thorne-Lyman, Andrew L.] Harvard Univ, Dept Nutr, Boston, MA 02115 USA.
   [Ding, Eric L.; Fahimi, Saman; Khatibzadeh, Shahab; Wagner, Gregory R.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Bukhman, Gene] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Campos-Nonato, Ismael R.; Feigl, Andrea B.; Salomon, Joshua A.] Harvard Univ, Boston, MA 02115 USA.
   [Benzian, Habib] UCL, Dept Epidemiol & Publ Hlth, London, England.
   [Abubakar, Ibrahim] UCL, London, England.
   [Abu-Rmeileh, Niveen M. E.] Birzeit Univ, Inst Community & Publ Hlth, Ramallah, Pakistan.
   [Aburto, Tania C.; Avila, Marco A.; Barquera, Simon; Barrientos-Gutierrez, Tonatiuh; Campos-Nonato, Ismael R.; Campuzano, Julio C.; Cantoral, Alejandra J.; Contreras, Alejandra G.; Cuevas-Nasu, Lucia; De la Cruz-Gongora, Vanessa; Garcia-Guerra, Francisco A.; Dantes, Hector Gomez; de Cosio, Teresita Gonzalez; Gonzalez-Castell, Dinorah; Heredia-Pi, Ileana B.; Hernandez, Lucia; Jauregui, Alejandra; Lozano, Rafael; Medina, Catalina; Mejia-Rodriguez, Fabiola; Hernandez, Julio C. Montaez; Pedraza, Lilia S.; Pedroza, Andrea; Quezada, Amado D.; Salvo, Deborah; Sanchez, Luz Maria; Sanchez-Pimienta, Tania G.; Servan-Mori, Edson E.; Levy, Teresa Shamah; Rojo, Martha M. Tellez; Villalpando, Salvador] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogbo, Nigeria.
   [Adofo, Koranteng] Kwame Nkrumah Univ Sci, Kumasi, Ghana.
   [Adou, Arsene K.] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire.
   [Adsuar, Jose C.; Paleo, Urbano Fra] Univ Extremadura, Caceres, Spain.
   [Afshin, Ashkan; Micha, Renata; Arian, Dariush Mozaff] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA USA.
   [Shahraz, Saeid; Shangguan, Siyi] Tufts Univ, Tufts Med Ctr, Boston, MA USA.
   [Agardh, Emilie E.] Inst Publ Hlth Sci, Stockholm, Sweden.
   [Al Khabouri, Mazin J.] Minist Hlth, Muscat, Oman.
   [Al Lami, Faris H.] Baghdad Coll Med, Baghdad, Iraq.
   [Alam, Sayed Saidul; Naheed, Aliya] icddr b, Dhaka, Bangladesh.
   [Alasfoor, Deena] Minist Hlth, Al Khuwair, Oman.
   [Albittar, Mohammed I.] Independent, Damascus, Syria.
   [Alegretti, Miguel A.] Univ Republica, Dept Prevent & Social Med, Montevideo, Uruguay.
   [Cavalleri, Fiorella] Univ Republica, Fac Med, Montevideo, Uruguay.
   [Alemu, Zewdie A.] Debre Markos Univ, Addis Ababa, Ethiopia.
   [Alhabib, Samia] King Abdullah Bin Abdulaziz Univ Hosp, Riyadh, Saudi Arabia.
   [Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.
   [Gething, Pete] Univ Oxford, Dept Zool, Oxford, England.
   [Ali, Raghib; Bennett, Derrick A.; Briggs, Adam D. M.; Hay, Simon I.; Rahimi, Kazem; Scarborough, Peter] Univ Oxford, Oxford, England.
   [Singh, Gitanjali M.] Tufts Univ, Boston, MA USA.
   [Aleman, Alicia V.; Colistro, Valentina] Univ Republica, Montevideo, Uruguay.
   [Simard, Edgar P.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA.
   [Ali, Mohammed K.; Cunningham, Solveig Argeseanu; Liu, Yang; Narayan, K. M. Venkat; Omer, Saad B.] Emory Univ, Atlanta, GA USA.
   [Alla, Francois; Guillemin, Francis] Univ Lorraine, Nancy, France.
   [Allebeck, Peter; Roy, Nobhojit] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.
   [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.
   [Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden.
   [Allen, Peter J.] Minist Hlth, Belmopan, Belize.
   [Alsharif, Ubai; Endres, Matthias; Nolte, Sandra; Papachristou, Christina] Charite, Berlin, Germany.
   [Alvarez, Elena] Govt, Madrid, Spain.
   [Alvis-Guzman, Nelson; Caicedo, Angel J. Paternina] Univ Cartagena, Cartagena De Indias, Colombia.
   [Amankwaa, Adansi A.] Albany State Univ, Albany, GA 31705 USA.
   [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.
   [Hoek, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.
   [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.
   [Yenesew, Muluken] Bahir Dar Univ, Bahir Dar, Ethiopia.
   [Ameh, Emmanuel A.] Ahmadu Bello Univ, Zaria, Nigeria.
   [Ameli, Omid] Boston Univ, Boston, MA USA.
   [Amini, Heresh] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Iran.
   [Amini, Heresh] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Amini, Heresh] Univ Basel, Basel, Switzerland.
   [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon.
   [Faraon, Emerito Jose A.] Univ Philippines Manila, Coll Publ Hlth, Manila, Philippines.
   [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Manila, Philippines.
   [Panelo, Carlo Irwin A.] Univ Philippines Manila, Manila, Philippines.
   [Arnlov, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden.
   [Larsson, Anders] Uppsala Univ, Uppsala, Sweden.
   [Arnlov, Johan] Dalarna Univ, Falun, Sweden.
   [Arsenijevic, Valentina S. Arsic] Univ Belgrade, Inst Microbiol & Immunol, Sch Med, Belgrade, Serbia.
   [Arsenijevic, Valentina S. Arsic] Univ Childrens Hosp Belgrade, Belgrade, Serbia.
   [Asghar, Rana J.] South Asian Publ Hlth Forum, Islamabad, Pakistan.
   [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran.
   [Atkins, Lydia S.] Minist Hlth, Wellness Human Serv & Gender Relat, St Lucia, Qld, Australia.
   [Awuah, Baffour; Laryea, Dennis O.] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada.
   [Bahit, Maria C.] INECO Neurociencias, Rosario, Argentina.
   [Bakfalouni, Talal] Minist Hlth, Damascus, Syria.
   [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India.
   [Balalla, Shivanthi; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.
   [Ao, Braden J. Te] Auckland Univ Technol, Auckland, New Zealand.
   [Balu, Ravi Kumar; Dandona, Lalit; Dandona, Rakhi; Goenka, Shifalika; Kumar, G. Anil; Murthy, Kinnari S.; Reddy, K. Srinath] Publ Hlth Fdn India, Delhi, India.
   [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England.
   [Barker-Collo, Suzanne L.] Univ Auckland, Sch Psychol, Auckland, New Zealand.
   [del Pozo-Cruz, Borja] Univ Auckland, Auckland, New Zealand.
   [Barregard, Lars] Univ Gothenburg, Dept Occupat & Environm Hlth, Gothenburg, Sweden.
   [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia.
   [Basto-Abreu, Ana C.; Ruvalcaba, Carolina Batis; de Castro, E. Filipa; Lopez, Nancy; Texcalac-Sangrador, Jose Luis] Natl Inst Publ Hlth, Mexico City, DF, Mexico.
   [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Christchurch, New Zealand.
   [Gaffikin, Lynne] Stanford Univ, Sch Med, Stanford, CA USA.
   [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA.
   [Basulaiman, Mohammed O.; Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia.
   [Beardsley, Justin] Univ Oxford, Ho Hi Minh City, Vietnam.
   [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia.
   [Bekele, Tolesa] Madawalabu Univ, Bale Robe, Ethiopia.
   [Bell, Michelle L.] Yale Univ, New Haven, CT USA.
   [Benjet, Corina; Borges, Guilherme; Gutierrez, Reyna A.; Orozco, Ricardo] Natl Inst Psychiat Ramon Fuente Muniz, Mexico City, DF, Mexico.
   [Benzian, Habib] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY 10003 USA.
   [Trasande, Leonardo] NYU, Sch Med, New York, NY USA.
   [Hagan, Holly] NYU, New York, NY 10003 USA.
   [Bernabe, Eduardo; Wolfe, Charles D. A.] Kings Coll London, London, England.
   [Beyene, Tariku J.] Addis Ababa Univ, Debre Zeyit, Ethiopia.
   [Bhala, Neeraj] Queen Elizabeth Hosp, Birmingham, W Midlands, England.
   [Bhala, Neeraj] Univ Otago, Capital & Coast District Hlth Board, Wellington, New Zealand.
   [Derrett, Sarah] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Wellington, New Zealand.
   [Bhalla, Ashish; Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh, India.
   [Bhutta, Zulfi Qar A.] Aga Khan Univ, Med Ctr, Karachi, Pakistan.
   [Nisar, Muhammad I.] Aga Khan Univ, Karachi, Pakistan.
   [Bikbov, Boris] AI Evdokimov Moscow State Univ Med & Dent, Moscow, Russia.
   [Bikbov, Boris] Acad VI Shumakov Fed Res Ctr Transplantol & Artif, Moscow, Russia.
   [Bin Abdulhak, Aref A.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA.
   [Vijayakumar, Lakshmi] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia.
   [Chiang, Peggy P.] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia.
   [Blore, Jed D.; Brooks, Peter M.; Colquhoun, Samantha M.; Balaji, Arjun Lakshmana; Weintraub, Robert G.; Lopez, Alan D.] Univ Melbourne, Melbourne, Vic, Australia.
   [Blyth, Fiona M.] Univ Sydney, Concord, NSW, Australia.
   [Meretoja, Atte] Univ Melbourne, Dept Florey, Parkville, Vic, Australia.
   [Meretoja, Atte] Univ Melbourne, Dept Med, Parkville, Vic, Australia.
   [Bohensky, Megan A.] Univ Melbourne, Parkville, Vic, Australia.
   [Basara, Berrak Bora; Yentuer, Goekalp K.] Minist Hlth, Gen Directorate Hlth Res, Ankara, Turkey.
   [Kose, M. Rifat; Pekericli, Ayfer; Uzun, Selen B.] Minist Hlth, Ankara, Turkey.
   [Bornstein, Natan M.] Tel Aviv Saurasky Med Ctr, Tel Aviv, Israel.
   [Bose, Dipan] World Bank, Washington, DC USA.
   [Boufous, Soufiane] Univ New S Wales, Transport & Rd Safety, Sydney, NSW, Australia.
   [Degenhardt, Louisa] Univ New S Wales, Sydney, NSW, Australia.
   [Bourne, Rupert R.] Anglia Ruskin Univ, Cambridge, England.
   [Brainin, Michael] Danube Univ Krems, Krems, Austria.
   [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Trnava, Slovakia.
   [Breitborde, Nicholas J.] Ohio State Univ, Columbus, OH USA.
   [Breitborde, Nicholas J.] Univ Arizona, Tucson, AZ USA.
   [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
   [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany.
   [Broday, David M.] Technion, Haifa, Israel.
   [Lunevicius, Raimundas] Univ Liverpool, Sch Med, Liverpool, Merseyside, England.
   [Bruce, Nigel G.; Dherani, Mukesh K.; Pope, Daniel] Univ Liverpool, Liverpool, Merseyside, England.
   [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England.
   [Brunekreef, Bert; Kromhout, Hans] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.
   [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia.
   [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.
   [Gabbe, Belinda; Gibney, Katherine B.; Thrift, Amanda G.] Monash Univ, Melbourne, Vic, Australia.
   [Bui, Linh N.; Nguyen, Nhung T.] Hanoi Sch Publ Hlth, Hanoi, Vietnam.
   [Bulloch, Andrew G.; Patten, Scott B.; Tonelli, Marcello; Wang, JianLi] Univ Calgary, Calgary, AB, Canada.
   [Burch, Michael] Great Ormond St Hosp Sick Children, London, England.
   [Burney, Peter G. J.; Foreman, Kyle J.; Jarvis, Deborah L.; Rodriguez, Alina; Rushton, Lesley; Soljak, Michael; Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, London, England.
   [Caravanos, Jack; Nash, Denis] CUNY, Sch Publ Hlth, New York, NY USA.
   [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico.
   [Cardis, Elisabeth; Nieuwenhuijsen, Mark J.; Rojas-Rueda, David] Ctr Res Environm Epidemiol, Barcelona, Spain.
   [Carpenter, David O.; Leung, Ricky] SUNY Albany, Rensselaer, NY USA.
   [Caso, Valeria] Univ Perugia, Stroke Unit, Perugia, Italy.
   [Castaneda-Orjuela, Carlos A.] Colombian Natl Hlth Observ, Inst Nacl Salud, Bogota, Colombia.
   [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Dept Publ Hlth, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia.
   [Castro, Ruben E.] Univ Diego Portales, Santiago, Chile.
   [Catala-Lopez, Ferran] Spanish Med & Healthcare Prod Agcy, Minist Hlth, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain.
   [Catala-Lopez, Ferran] Univ Valencia, Dept Med, CIBERSAM, Valencia, Spain.
   [Chadha, Vineet K.] Natl TB Inst, Bangalore, Karnataka, India.
   [Chang, Jung-chen] Natl Taiwan Univ, Taipei, Taiwan.
   [Scott, James G.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.
   [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.
   [Knibbs, Luke D.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
   [Charlson, Fiona J.; Erskine, Holly E.; Ferrari, Alize J.; Gouda, Hebe N.; Veerman, Lennert J.; Whiteford, Harvey A.] Univ Queensland, Brisbane, Qld, Australia.
   [Chen, Wanqing; Zou, Xiaonong] Chinese Acad Med Sci, Canc Inst, Beijing, Peoples R China.
   [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing, Peoples R China.
   [Chen, Honglei; London, Stephanie J.] NIEHS, Div Intramural Res, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC USA.
   [Jiang, Ying] Univ Occupat & Environm Hlth, Dept Hlth Dev, Kitakyushu, Fukuoka 807, Japan.
   [Takahashi, Ken] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan.
   [Chimed-Ochir, Odgerel] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan.
   [Chowdhury, Rajiv; Powles, John] Univ Cambridge, Cambridge, England.
   [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus.
   [Chuang, Ting-Wu] Taipei Med Univ, Taipei, Taiwan.
   [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Los Angeles, CA USA.
   [Cirillo, Massimo] Univ Salerno, Baronissi, Italy.
   [Classen, Thomas K. D.] Univ Bielefeld, Dept Environm & Hlth, Bielefeld, Germany.
   [Kraemer, Alexander; Tobollik, Myriam] Univ Bielefeld, Sch Publ Hlth, Bielefeld, Germany.
   [Colomar, Mercedes] UNICEM, Montevideo, Uruguay.
   [Colquhoun, Samantha M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
   [Cooper, Leslie T.] Mayo Clin, Rochester, MN USA.
   [Coresh, Josef; Matsushita, Kunihiro] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
   [Tran, Bach X.] Johns Hopkins Univ, Baltimore, MD 21218 USA.
   [Courville, Karen J.] Hosp Dr Gustavo N Collado, Chitre, Panama.
   [Criqui, Michael H.; Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana.
   [Danawi, Hadi; Refaat, Amany H.] Walden Univ, Minneapolis, MN USA.
   [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England.
   [Davis, Adrian; Fay, Derek F. J.; Schmidt, Juergen C.] Publ Hlth England, London, England.
   [Davitoiu, Dragos V.] Univ Med & Pharm Bucharest, Bucharest, Romania.
   [Dayama, Anand] Jacobi Med Ctr, Dept Surg, Atlanta, GA USA.
   [De Leo, Diego] Griffith Univ, Brisbane, Qld, Australia.
   [de Lima, Graca] Local Hlth Unit Matosinhos, Matosinhos, Portugal.
   [de Lima, Graca; Machado, Vasco M. P.] Northern Reg Hlth Adm, Dept Publ Hlth, Oporto, Portugal.
   [Nogueira, Jose R.; Teixeira, Carolina M.] Northern Reg Hlth Adm, Oporto, Portugal.
   [Dellavalle, Robert P.] Eastern Colorado Healthcare Syst, US Dept Vet Affairs, Denver, CO USA.
   [Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England.
   [Deribe, Kebede] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia.
   [Mekonnen, Wubegzier] Univ Addis Ababa, Addis Ababa, Ethiopia.
   [Derrett, Sarah] Massey Univ, Coll Hlth, Sch Publ Hlth, Palmerston North, New Zealand.
   [Jarlais, Don C. Des] Mt Sinai Beth Israel, New York, NY USA.
   [Jarlais, Don C. Des] Icahn Sch Med Mt Sinai, New York, NY USA.
   [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia.
   [deVeber, Gabrielle A.] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada.
   [Lindsay, M. Patrice] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Hu, Howard] Univ Toronto, Toronto, ON M5S 1A1, Canada.
   [Devries, Karen M.; Larson, Heidi J.; Mckee, Martin; Pearce, Neil; Stoeckl, Heidi; Tillmann, Taavi; Watts, Charlotte H.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka.
   [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria.
   [Dorsey, E. Ray] Univ Rochester, Med Ctr, Rochester, NY USA.
   [Driscoll, Tim R.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.
   [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia.
   [Leigh, James] Univ Sydney, Sydney, NSW 2006, Australia.
   [Duan, Leilei; Li, Yichong; Liu, Shiwei; Ma, Jixiang; Wang, Linhong; Ye, Pengpeng; Zhou, Maigeng] Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China.
   [Durrani, Adnan M.] Natl Inst Hlth, Montgomery Village, MD USA.
   [Elshrek, Yousef M.] Univ Tripoli, Fac Agr, Dept Food Sci, Tripoli, Libya.
   [Ermakov, Sergey P.] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia.
   [Ermakov, Sergey P.; Soshnikov, Sergey] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia.
   [Liang, Xiaofeng] China CDC, Beijing, Peoples R China.
   [Eshrati, Babak] Arak Univ Med Sci & Hlth Affairs, Arak, Iran.
   [Farzadfar, Farshad] Univ Tehran Med Sci, NonCommunicable Dis Res Ctr, Tehran, Iran.
   [Heydarpour, Pouria; Sahraian, Mohammad Ali] Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Neurosci Inst, Tehran, Iran.
   [Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Ferri, Cleusa P.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine.
   [Franklin, Richard C.] James Cook Univ, Townsville, Qld, Australia.
   [Gamkrelidze, Amiran; Khonelidze, Irma; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Rep of Georgia.
   [Gankpe, Fortune G.] Leras Afrique, Cotonou, Benin.
   [Gankpe, Fortune G.] CHU Hassan II, Fes, Morocco.
   [Gasana, Evariste] Rwanda Biomed Ctr, TB & Other Respir Dis Div, Kigali, Rwanda.
   [Sabin, Nsanzimana] Rwanda Biomed Ctr, Kigali, Rwanda.
   [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.
   [Gessner, Bradford D.] Agence Med Prevent, Paris, France.
   [Gibney, Katherine B.] Melbourne Hlth, Parkville, Vic, Australia.
   [Gillum, Richard F.] Howard Univ, Washington, DC USA.
   [Ginawi, Ibrahim A. M.] Univ Hail, Coll Med, Hailsham, E Sussex, England.
   [Giroud, Maurice] Univ Hosp Dijon, Dijon, France.
   [Giussani, Giorgia] IRCCS Mario Negri Inst Pharmacol Res, Milan, Italy.
   [Goginashvili, Ketevan] Minist Labour Hlth & Social Affairs, Tbilisi, Rep of Georgia.
   [Esteghamati, Alireza; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Tehran, Iran.
   [Gona, Philimon] Univ Massachusetts Boston, Boston, MA USA.
   [Goto, Atsushi] Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan.
   [Guerrant, Richard L.] Univ Virginia, Sch Med, Charlottesville, VA USA.
   [Terkawi, Abdullah S.] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA.
   [Gugnani, Harish C.] St James Sch Med, Kralendijk, Netherlands.
   [Gunnell, David] Univ Bristol, Bristol, Avon, England.
   [Gupta, Rahul] West Virginia Bur Publ Hlth, Charleston, WV USA.
   [Gupta, Rajeev] Fortis Escorts Hosp, Jaipur, Rajasthan, India.
   [Hagstromer, Maria] Karolinska Inst, Huddinge, Sweden.
   [Halasa, Yara A.; Idrisov, Bulat T.] Brandeis Univ, Waltham, MA USA.
   [Hamadeh, Randah R.] Arabian Gulf Univ, Manama, Bahrain.
   [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA.
   [Hankey, Graeme J.] Univ Western Australia, Perth, WA, Australia.
   [Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Zheng, Yingfeng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China.
   [Haregu, Tilahun Nigatu; van de Vijver, Steven] African Populat & Hlth Res Ctr, Nairobi, Kenya.
   [Haro, Josep Maria] CIBERSAM, Parc Sanitari St Joan de Deu, Sant Boi De Llobregat, Spain.
   [Haro, Josep Maria] Univ Barcelona, Barcelona, Spain.
   [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran.
   [Hijar, Martha] Fdn Entornos AC, Cuernavaca, Morelos, Mexico.
   [Hoek, Hans W.] Columbia Univ, Dept Epidemiol, New York, NY USA.
   [Man, Howard J. Hoff] Natl Inst Deafness & Other Commun Disorders, Epidemiol & Stat Program, NIH, Bethesda, MD USA.
   [Mensah, George A.] NIH, Ctr Translat Res & Implementat Sci, Bethesda, MD USA.
   [Sampson, Uchechukwu K.] NIH, NHLBI, Bethesda, MD USA.
   [Hornberger, John C.] Cedar Associates, Menlo Pk, CA USA.
   [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY USA.
   [Hsairi, Mohamed] Natl Inst Publ Hlth, Tunis, Tunisia.
   [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia.
   [Hu, Guoqing] Cent S Univ, Changsha, Peoples R China.
   [Huang, Cheng] George Washington Univ, Washington, DC USA.
   [Hubbell, Bryan J.] US EPA, Res Triangle Pk, NC USA.
   [Huiart, Laetitia; Racape, Lionel] CHU La Reunion, Saint Denis, France.
   [Husseini, Abdullatif] Qatar Univ, Doha, Qatar.
   [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark.
   [Ikeda, Nayu] Natl Inst Hlth Nutr, Tokyo, Japan.
   [Innos, Kaire] Natl Inst Hlth Dev, Tallinn, Estonia.
   [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan.
   [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan.
   [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan.
   [Islami, Farhad] Amer Canc Soc, New York, NY USA.
   [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA USA.
   [Jansen, Henrica A.] UNFPA Asia & Pacific Reg Off, Bangkok, Thailand.
   [Jassal, Simerjot K.] Univ Calif San Diego, San Diego, CA USA.
   [Jayaraman, Sudha] Virginia Commonwealth Univ, Richmond, VA USA.
   [Jeemon, Panniyammakal; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India.
   [Jiang, Fan] Shanghai Childrens Med Ctr, Tianjin, Peoples R China.
   [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China.
   [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China.
   [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.
   [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark.
   [She, Jun] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China.
   [Kan, Haidong] Fudan Univ, Shanghai, Peoples R China.
   [Roseline, Sidibe S. Kany] MARIKANI, Bamako, Mali.
   [Karam, Nadim E.] Univ Balamand, Beirut, Lebanon.
   [Karch, Andre] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany.
   [Karch, Andre] German Ctr Infect Res, Hannover Braunschweig Site, Braunschweig, Germany.
   [Karema, Corine K.] Minist Hlth, Malaria & Other Parasit Dis Div, Kigali City, Rwanda.
   [Karthikeyan, Ganesan; Paul, Vinod K.; Satpathy, Maheswar; Tandon, Nikhil] All India Inst Med Sci, New Delhi, India.
   [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA.
   [Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA USA.
   [Kemp, Andrew H.; Lotufo, Paulo A.; Polanczyk, Guilherme V.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Kemp, Andrew H.] Univ Sydney, Camperdown, NSW, Australia.
   [Kengne, Andre P.; Matzopoulos, Richard; Parry, Charles D.] South African Med Res Council, Cape Town, South Africa.
   [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa.
   [Matzopoulos, Richard] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa.
   [Kengne, Andre P.; Mayosi, Bongani M.; Stein, Dan J.] Univ Cape Town, Cape Town, South Africa.
   [Keren, Andre] Hadassah Kerem Univ Hosp, Cardiol, Jerusalem, Israel.
   [Khader, Yousef S.] Jordan Univ Sci & Technol, Irbid, Jordan.
   [Khalifa, Shams Eldin Ali Hassan] Supreme Council Hlth, Doha, Qatar.
   [Khan, Ejaz A.] Hlth Serv Acad, Islamabad, Pakistan.
   [Khan, Ejaz A.] Expanded Programme Immunizat, Islamabad, Pakistan.
   [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea.
   [Kieling, Christian] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Kim, Daniel] Northeastern Univ, Boston, MA USA.
   [Kim, Sungroul] Soonchunhyang Univ, Seoul, South Korea.
   [Kim, Yunjin] Southern Univ Coll, Johor Baharu, Malaysia.
   [Kimokoti, Ruth W.] Simmons Coll, Boston, MA USA.
   [Kinfu, Yohannes] Univ Canberra, Canberra, ACT, Australia.
   [Kissela, Brett M.] Univ Cincinnati, Cincinnati, OH USA.
   [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan.
   [Kosen, Soewarta] Minist Hlth Indonesia, NIHRD, Ctr Community Empowerment Hlth Policy & Human, Jakarta, Indonesia.
   [Warouw, Tati S.] Minist Hlth Indonesia, NIHRD, Jakarta, Indonesia.
   [Kravchenko, Michael] Res Ctr Neurol, Moscow, Russia.
   [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR USA.
   [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada.
   [Kuipers, Ernst J.] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands.
   [Kulkarni, Chanda] Rajrajeswari Med Coll & Hosp, Bangalore, Karnataka, India.
   [Kulkarni, Veena S.] Arkansas State Univ, State Univ, AR USA.
   [Kwan, Gene F.] Boston Med Ctr, Boston, MA USA.
   [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia.
   [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Gold Coast, Qld, Australia.
   [Lalloo, Ratilal] Univ Adelaide, Sch Dent, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia.
   [Lallukka, Tea] Finnish Inst Occupat Hlth, Disabil Prevent Res Ctr, Helsinki, Finland.
   [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland.
   [Lallukka, Tea] Univ Helsinki, Fac Med, Helsinki, Finland.
   [Lam, Hilton] NIH, Inst Hlth Policy & Dev Studies, Manila, Philippines.
   [Lan, Qing] NCI, Rockville, MD USA.
   [Lansingh, Van C.] Help Me See Inc, New York, NY USA.
   [Lansingh, Van C.] Inst Mexicano Oftalmol, Queretaro, Mexico.
   [Lavados, Pablo M.] Univ Desarrollo, Serv Neurol, Clin Alemana, Santiago, Chile.
   [Lawrynowicz, Alicia E.] Inst Nacl Epidemiol Dr Juan H Jara, Mar Del Plata, Buenos Aires, Argentina.
   [Leasher, Janet L.] Nova SE Univ, Coll Optometry, Ft Lauderdale, FL USA.
   [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea.
   [Levi, Miriam] Tuscany Reg Ctr Occupat Injuries & Dis, Florence, Italy.
   [Li, Yichong] Anolinx LLC, Salt Lake City, UT USA.
   [Liang, Juan; Wang, Yanping; Zhu, Jun] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu, Peoples R China.
   [Lindsay, M. Patrice] Heart & Stroke Fdn Canada, Ottawa, ON, Canada.
   [Lipshultz, Steven E.] Wayne State Univ, Detroit, MI USA.
   [Lloyd, Belinda K.] Monash Univ, Eastern Hlth Clin Sch, Fitzroy, Vic, Australia.
   [Lloyd, Belinda K.; Room, Robin] Eastern Hlth, Turning Point Alcohol & Drug Ctr, Fitzroy, Vic, Australia.
   [Logroscino, Giancarlo] Univ Bari, Bari, Italy.
   [Lortet-Tieulent, Joannie] Amer Canc Soc, Atlanta, GA USA.
   [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England.
   [Ma, Stefan; Phua, Hwee Pin] Minist Hlth Singapore, Singapore, Singapore.
   [Ma, Stefan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Magis-Rodriguez, Carlos] Secretaria Salud Mexico, Ctr Nacl Prevenc & Control VIH SIDA, Mexico City, DF, Mexico.
   [Mahdi, Abbas A.] King Georges Med Univ, Lucknow, Uttar Pradesh, India.
   [Malekzadeh, Reza] Shariati Hosp, Digest Dis Reseach Inst, Tehran, Iran.
   [Malekzadeh, Reza] Shiraz Univ Med Sci, Shiraz, Iran.
   [Mangalam, Srikanth] Tech Stand & Safety Author, Toronto, ON, Canada.
   [Masiye, Felix] Univ Zambia, Lusaka, Zambia.
   [Marape, Marape] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana.
   [Marcenes, Wagner] Queen Mary Univ London, London, England.
   [Meaney, Peter A.] Univ Penn, Pereleman Sch Med, Philadelphia, PA USA.
   [Martin, Randall V.] Dalhousie Univ, Halifax, NS, Canada.
   [Marzan, Melvin B.] Univ East Ramon Magsaysay Memorial, Med Ctr, Quezon City, Philippines.
   [Mashal, Mohammad T.] Minist Publ Hlth, Kabul, Afghanistan.
   [Mason-Jones, Amanda J.] Univ York, York, N Yorkshire, England.
   [Mazorodze, Tasara T.] Automot Ind Dev Ctr Eastern Cape, Port Elizabeth, South Africa.
   [Mckay, Abigail C.] EmergentCorp, Belize City, Belize.
   [Meaney, Peter A.] Childrens Hosp Philadelphia, Philadelphia, PA USA.
   [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, New Delhi, India.
   [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA USA.
   [Mendoza, Walter] United Nations Populat Fund, Lima, Peru.
   [Meretoja, Atte] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland.
   [Mhimbira, Francis Apolinary] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA.
   [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth, Perth, WA, Australia.
   [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada.
   [Margolis, David J.; Silberberg, Donald H.] Univ Penn, Philadelphia, PA USA.
   [Mishra, Santosh] SNDT Womens Univ, Populat Educ Resource Ctr, Dept Continuing & Adult Educ & Extens, Bombay, Maharashtra, India.
   [Ibrahim, Norlinah Mohamed] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Bandar Tun Razak, Malaysia.
   [Mohammad, Karzan A.] Univ Salahaddin, Erbil, Iraq.
   [Mola, Glen L.] Univ Papua New Guinea, Boroko, Papua N Guinea.
   [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] Inst Maternal & Child Hlth, IRCCS Burlo Garofolo, Trieste, Italy.
   [Moore, Ami R.] Univ N Texas, Denton, TX USA.
   [Morawska, Lidia] Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld, Australia.
   [Norman, Rosana E.] Queensland Univ Technol, Inst Hlth Biomed Innovat, Brisbane, Qld, Australia.
   [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan.
   [Tsilimbaris, Miltiadis] Univ Crete, Dept Med, Iraklion, Greece.
   [Moschandreas, Joanna] Univ Crete, Iraklion, Greece.
   [Moturi, Wilkister N.] Egerton Univ, Egerton, Kenya.
   [Werdecker, Andrea] Competence Ctr Mortal Follow Up German Natl Cohor, Heidelberg, Germany.
   [Mueller, Ulrich O.; Westerman, Ronny] Fed Inst Populat Res, Wiesbaden, Germany.
   [Mukaigawara, Mitsuru] Okinawa Chubu Hosp, Okinawa, Japan.
   [Nahas, Ziad] Amer Univ Beirut, Med Ctr, Beirut, Lebanon.
   [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, South Africa.
   [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy.
   [Nand, Devina] Minist Hlth Fiji, Suva, Fiji.
   [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India.
   [Neal, Bruce] George Inst Global Hlth, Sydney, NSW, Australia.
   [Nejjari, Chakib] Fac Med, Fes, Morocco.
   [Neupane, Sudan P.] Univ Oslo, Oslo, Norway.
   [Ngalesoni, Frida N.] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania.
   [Ngirabega, Jean de Dieu] East African Community Hlth Res Commiss, Kigali, Rwanda.
   [Nolla, Joan M.] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain.
   [Nolte, Sandra] Deakin Univ, Melbourne, Vic, Australia.
   [Vollset, Stein Emil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Norheim, Ole F.] Univ Bergen, Bergen, Norway.
   [Norrving, Bo] Lund Univ, Dept Clin Sci, Lund, Sweden.
   [Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda.
   [Oh, In-Hwan] Kyung Hee Univ, Seoul, South Korea.
   [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo, Japan.
   [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Ikoyi, Nigeria.
   [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Lira, Uganda.
   [Pagcatipunan, Rodolfo S., Jr.] United Lab Inc, Mandaluyong City, Philippines.
   [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India.
   [Park, Eun-Kee] Kosin Univ, Coll Med, Busan, South Korea.
   [Stein, Dan J.] South African Med Res Council, Unit Anxiety & Stress Disorders, Cape Town, South Africa.
   [Parry, Charles D.] South African Med Res Council, Cape Town, South Africa.
   [Parry, Charles D.; Seedat, Soraya] Univ Stellenbosch, Cape Town, South Africa.
   [Stokic, Ljiljana Pejin] Econ Inst, Belgrade, Serbia.
   [Pereira, David M.] Univ Porto, REQUIMTE, Fac Farm, Dept Quim,Lab Farmacognosia, Oporto, Portugal.
   [Perez-Padilla, Rogelio] Natl Inst Resp Dis, Mexico City, DF, Mexico.
   [Perez-Ruiz, Fernando] Hosp Univ Cruces, OSI EE Cruces, Baracaldo, Spain.
   [Perez-Ruiz, Fernando] Biocruces Hlth Res Inst, Baracaldo, Spain.
   [Perico, Norberto; Remuzzi, Giuseppe; Trillini, Matias] IRCCS Mario Negri Inst Pharmacol Res, Bergamo, Italy.
   [Perry, Samuel A. L.] Washington State Dept Hlth, Kent, WA USA.
   [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Pakistan.
   [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA, Australia.
   [Peterson, Carrie B.] Aalborg Univ, Aalborg Esst, Denmark.
   [Petzold, Max] Hlth Metr Unit, Gothenburg, Sweden.
   [Petzold, Max] Univ Witwatersrand, Johannesburg, South Africa.
   [Phillips, Michael R.] Emory Univ, Atlanta, GA USA.
   [Plass, Dietrich] Fed Environm Agcy, Sect Exposure Assessment & Environm Hlth Indicato, Berlin, Germany.
   [Poenaru, Dan] McGill Univ, Montreal Childrens Hosp, Montreal, PQ, Canada.
   [Poenaru, Dan] MyungSung Med Coll, Addis Ababa, Ethiopia.
   [Pond, Constance D.] Univ Newcastle, Callaghan, NSW 2308, Australia.
   [Pope, C. Arden] Brigham Young Univ, Provo, UT USA.
   [Popova, Svetlana; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Prasad, Noela M.] Fred Hollows Fdn, Sydney, NSW, Australia.
   [Qato, Dima M.] Univ Illinois, Coll Pharm, Chicago, IL USA.
   [Rafay, Anwar; Rana, Saleem M.] Contech Int Hlth Consultants, Lahore, Pakistan.
   [Rafay, Anwar; Rana, Saleem M.] Contech Sch Publ Hlth, Lahore, Pakistan.
   [Rahman, Sajjad Ur] Hamad Med Corp, Doha, Qatar.
   [Raju, Murugesan] Univ Missouri, Columbia, MO USA.
   [Rakovac, Ivo] WHO Reg Off Europe, Copenhagen, Denmark.
   [Rao, Mayuree] Brown Univ, Warren Alpert Med Sch, Providence, RI USA.
   [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA.
   [Refaat, Amany H.] Suez Canal Univ, Ismailia, Egypt.
   [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Escola Enfermagem, Belo Horizonte, MG, Brazil.
   [Riccio, Patricia M.; Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada.
   [Riederer, Anne] George Washington Univ, Washington, DC USA.
   [Roca, Anna] MRC Unit, Fajara, Gambia.
   [Rodriguez, Alina] Mid Sweden Univ, Stersund, Sweden.
   [Romieu, Isabelle; Straif, Kurt] WHO, IARC, Lyon, France.
   [Roy, Nobhojit] HBNI Univ, BARC Hosp, Bombay, Maharashtra, India.
   [Ruhago, George M.; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.
   [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Miami, FL USA.
   [Saha, Sukanta] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.
   [Sahathevan, Ramesh] Univ Kebangsaan Malaysia, Med Ctr, Kuala Lumpur, Malaysia.
   [Sahathevan, Ramesh] Calvary Healthcare Bruce, Canberra, ACT, Australia.
   [Sanabria, Juan R.] Case Western Reserve Univ, Cleveland, OH USA.
   [Sanabria, Juan R.] RFU Chicago Med Sch, Canc Treatment Ctr Amer, N Chicago, IL USA.
   [Sanchez-Riera, Lidia] Univ Zurich, Ctr Ageing & Mobil, Zurich, Switzerland.
   [Sanchez-Riera, Lidia] City Hosp Waid, Zurich, Switzerland.
   [Sapkota, Amir] Univ Maryland, Sch Publ Hlth, College Pk, MD USA.
   [Saunders, James E.] Dartmouth Coll, Dartmouth Hitchcock Med Ctr, Lebanon, NH USA.
   [Soneji, Samir] Dartmouth Coll, Lebanon, NH USA.
   [Sawhney, Monika] Marshall Univ, Huntington, WV USA.
   [Saylan, Mete I.] Novartis Turkey, Istanbul, Turkey.
   [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA.
   [Serdar, Berrin] Univ Colorado, Aurora, CO USA.
   [Shaddick, Gavin] Univ Bath, Bath BA2 7AY, Avon, England.
   [Shangguan, Siyi] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA.
   [Shinohara, Yukito] Tachikawa Hosp, Tokyo, Japan.
   [Shiri, Rahman] Univ Tampere, Sch Hlth Sci, Tampere, Finland.
   [Shishani, Kawkab] Washington State Univ, Spokane, WA USA.
   [Shiue, Ivy] Northumbria Univ, Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Shiue, Ivy] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland.
   [Sigfusdottir, Inga D.] Reykjavik Univ, Reykjavik, Iceland.
   [Singh, Abhishek] Int Inst Populat Sci, Bombay, Maharashtra, India.
   [Soreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway.
   [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Kajang, Cheras, Malaysia.
   [Stapelberg, Nicolas J. C.] Griffith Univ, Southport, Qld, Australia.
   [Stathopoulou, Vasiliki] Attikon Univ Hosp, Athens, Greece.
   [Steckling, Nadine] Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.
   [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, Athens, Greece.
   [Stroumpoulis, Konstantinos] Ctr Hosp Publ Cotentin, Cherbourg, France.
   [Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India.
   [Swaroop, Mamta; Yano, Yuichiro] Northwestern Univ, Chicago, IL USA.
   [Sykes, Bryan L.] Univ Calif Irvine, Irvine, CA USA.
   [Tabb, Karen M.] Univ Illinois, Champaign, IL USA.
   [Talongwa, Roberto T.] Minist Hlth, MINSANTE, Yaounde, Cameroon.
   [Tanne, David] Chaim Sheba Med Ctr, Tel Hashomer, Israel.
   [Tanne, David] Tel Aviv Univ, Tel Hashomer, Israel.
   [Tavakkoli, Mohammad] Westchester Med Ctr, Valhalla, NY USA.
   [Terkawi, Abdullah S.] Outcomes Res Consortium, Cleveland, OH USA.
   [Terkawi, Abdullah S.] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia.
   [Thackway, Sarah V.] New South Wales Hlth, Sydney, NSW, Australia.
   [Thurston, George D.] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA.
   [Topouzis, Fotis] Aristotle Univ Thessaloniki, Thessaloniki, Greece.
   [Towbin, Jeff Rey A.] Bonheur Childrens Hosp, Memphis, TN USA.
   [Towbin, Jeff Rey A.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN USA.
   [Toyoshima, Hideaki] Anjo Kosei Hosp, Hlth Care Ctr, Anjo City, Japan.
   [Traebert, Jeff Erson] Univ Southern Santa Catarina, Palhoca, Brazil.
   [Tran, Bach X.] Hanoi Med Univ, Hanoi, Vietnam.
   [Trujillo, Ulises] Serv Canario Salud, Tenerife, Spain.
   [Dimbuene, Zacharie Tsala] Univ Kinshasa, Fac Econ & Management, Dept Populat Sci & Dev, Kinshasa, Zaire.
   [Tuzcu, Emin Murat] Cleveland Clin, Cleveland, OH USA.
   [Uchendu, Uche S.] Dept Vet Affairs, Washington, DC USA.
   [Ukwaja, Kingsley N.] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria.
   [Van Dingenen, Rita] European Commiss, Joint Res Ctr, Ispra, Italy.
   [Van Gool, Coen H.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.
   [Van Os, Jim] Maastricht Univ, Med Ctr, Maastricht, Netherlands.
   [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland.
   [Vasconcelos, Ana Maria N.] Univ Brasilia, Brasilia, DF, Brazil.
   [Vijayakumar, Lakshmi] VHS SNEHA, Madras, Tamil Nadu, India.
   [Violante, Francesco S.] Univ Bologna, Bologna, Italy.
   [Vlassov, Vasiliy Victorovich] Higher Sch Econ, Moscow, Russia.
   [Wagner, Gregory R.] Natl Inst Occupat Safety & Hlth, Washington, DC USA.
   [Waller, Stephen G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA.
   [Wallin, Mitchell T.] Georgetown Univ, Dept Neurol, Arlington, VA USA.
   [Wallin, Mitchell T.] VA Med Ctr, Washington, DC USA.
   [Wang, Wenzhi] Beijing Neurosurg Inst, Beijing, Peoples R China.
   [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Wessells, K. Ryan] Univ Calif Davis, Davis, CA USA.
   [Westerman, Ronny] German Natl Cohort Consortium, Heidelberg, Germany.
   [Wilkinson, James D.] Wayne State Univ, Detroit, MI USA.
   [Williams, Hywel C.] Univ Nottingham, Nottingham, England.
   [Woldeyohannes, Solomon M.] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.
   [Wong, John Q.] Manila Univ, Ateneo Sch Med & Publ Hlth, Pasig, Philippines.
   [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, Cornwall, England.
   [Xu, Gelin] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing, Peoples R China.
   [Yan, Lijing L.] Duke Kunshan Univ, Kunshan, Peoples R China.
   [Yang, Gonghuan] Peking Union Med Coll, Beijing, Peoples R China.
   [Yano, Yuichiro] Jichi Med Sch, Tochigi, Japan.
   [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.
   [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan.
   [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA.
   [Younoussi, Zourkaleini] Univ Niamey, Niamey, Niger.
   [Yu, Chuanhua] Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Peoples R China.
   [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan, Peoples R China.
   [Zaki, Maysaa E.] Mansoura Fac Med, Mansoura, Egypt.
   [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China.
   [Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Hangzhou, Peoples R China.
RP Murray, CJ (reprint author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
EM cjlm@uw.edu
RI Kravchenko, Michael/B-2596-2012; Nolte, Sandra/B-7498-2008; Stein,
   Dan/A-1752-2008; Tonelli, Marcello/B-3028-2009; Lalloo,
   Ratilal/O-5624-2014; Tillmann, Taavi/R-6026-2016; Salomon,
   Joshua/D-3898-2009; Beyene, Tariku Jibat/A-6875-2017; Varakin,
   Yuriy/C-8634-2012; Majdan, Marek/K-5017-2012; Cardis,
   Elisabeth/C-3904-2017; Nieuwenhuijsen, Mark/C-3914-2017; Alsharif,
   Ubai/C-6527-2017; Ferri, Cleusa/B-2922-2010; Devries, Karen/K-1083-2016;
   Jacobsen, Kathryn/B-5857-2008; LOGROSCINO, GIANCARLO/K-5148-2016; wang,
   YA XING/K-9671-2016; Ribeiro, Antonio/C-2707-2009; Hay,
   Simon/F-8967-2015; Naldi, Luigi/K-6343-2016; Thrift, Amanda/I-6251-2012;
   Weiderpass, Elisabete/M-4029-2016; Dokova, Klara/N-2448-2016; Montico,
   Marcella/B-5290-2013; Parry, Charles/A-2906-2009; Brenner,
   Hermann/B-4627-2017; Santos, Itamar/K-7055-2012; Scott,
   James/D-5900-2012; eshrati, babak/M-1152-2017; Amini,
   Heresh/B-3076-2010; Lotufo, Paulo/A-9843-2008; Karch, Andre/D-6973-2017;
   Hedayati, Mohammad T./E-2304-2017; Franklin, Richard/H-1731-2012;
   Giussani, Giorgia/E-8057-2017; Ermakov, Sergey/G-1709-2016; Pereira,
   David/M-9286-2013; PACELLA, ROSANA/F-2774-2010; Kuate Defo,
   Barthelemy/I-4818-2017; Newton, 21/B-7578-2014; Satpathy,
   Maheswar/J-3135-2017; Rakovac, Ivo/A-7678-2013; Banerjee,
   Amitava/D-4381-2014; Charlson, Fiona/F-5290-2011; Patten,
   Scott/B-4434-2011; Fra.Paleo, Urbano/B-8088-2016; Monasta,
   Lorenzo/B-1388-2012; Sepanlou, Sadaf/H-9343-2016; Haro, Josep
   Maria/D-1423-2011; Degenhardt, Louisa/D-4515-2012; Martin,
   Randall/C-1205-2014; Hankey, Graeme /H-4968-2014; Kaul, Anil/B-2075-2016
OI Kravchenko, Michael/0000-0001-5187-5518; Nolte,
   Sandra/0000-0001-6185-9423; Stein, Dan/0000-0001-7218-7810; Tonelli,
   Marcello/0000-0002-0846-3187; Lalloo, Ratilal/0000-0001-5822-1269;
   Tillmann, Taavi/0000-0002-8428-3719; Salomon,
   Joshua/0000-0003-3929-5515; Beyene, Tariku Jibat/0000-0002-7474-1966;
   Majdan, Marek/0000-0001-8037-742X; Nieuwenhuijsen,
   Mark/0000-0001-9461-7981; Alsharif, Ubai/0000-0002-4024-3950; Quezada,
   Amado David/0000-0003-3258-8198; Heydarpour, Pouria/0000-0001-5644-7555;
   Goenka, Shifalika/0000-0001-6993-2883; Olusanya,
   Bolajoko/0000-0002-3826-0583; Perez-Ruiz, Fernando/0000-0002-5268-1894;
   Kissela, Brett/0000-0002-9773-4013; Broday, David/0000-0002-6525-3979;
   Norheim, Ole F./0000-0002-5748-5956; Castaneda-Orjuela,
   Carlos/0000-0002-8735-6223; Aburto, Tania/0000-0002-6932-9344; Derrett,
   Sarah/0000-0003-2867-0498; London, Stephanie/0000-0003-4911-5290; Ferri,
   Cleusa/0000-0002-1815-7685; Devries, Karen/0000-0001-8935-2181;
   Jacobsen, Kathryn/0000-0002-4198-6246; LOGROSCINO,
   GIANCARLO/0000-0003-0423-3242; wang, YA XING/0000-0003-2749-7793;
   Ribeiro, Antonio/0000-0002-2740-0042; Hay, Simon/0000-0002-0611-7272;
   Naldi, Luigi/0000-0002-3160-2835; Thrift, Amanda/0000-0001-8533-4170;
   Weiderpass, Elisabete/0000-0003-2237-0128; Montico,
   Marcella/0000-0003-0377-8232; Parry, Charles/0000-0001-9787-2785; Sindi,
   Shireen/0000-0002-3786-0552; Gething, Peter/0000-0001-6759-5449;
   Husseini, Abdullatif/0000-0001-8767-5956; Benjet,
   Corina/0000-0002-4569-6094; Neupane, Sudan Prasad/0000-0002-7389-4178;
   Kemp, Andrew/0000-0003-1146-3791; Erskine, Holly/0000-0003-3119-9211;
   Aboyans, Victor/0000-0002-0322-9818; Gouda, Hebe/0000-0002-5709-4509;
   Chen, Honglei/0000-0003-3446-7779; Xu, Gelin/0000-0002-6194-0341; Goto,
   Atsushi/0000-0003-0669-654X; Soshnikov, Sergey/0000-0002-6983-7066;
   assadi, reza/0000-0002-5016-2994; Vlassov, Vasiliy/0000-0001-5203-549X;
   Soreide, Kjetil/0000-0001-7594-4354; Villalpando,
   Salvador/0000-0001-6429-3816; Giussani, Giorgia/0000-0003-2460-3095;
   Leung, Ricky/0000-0002-2852-6771; Kieling,
   Christian/0000-0001-7691-4149; Hu, Howard/0000-0002-3676-2707;
   Balakrishnan, Kalpana/0000-0002-5905-1801; Mhimbira,
   Francis/0000-0001-8989-6832; Heredia-Pi, Ileana
   Beatriz/0000-0002-9998-9239; Brenner, Hermann/0000-0002-6129-1572;
   Santos, Itamar/0000-0003-3212-8466; Scott, James/0000-0002-0744-0688;
   Stockl, Heidi/0000-0002-0907-8483; Vlassov,
   Valentin/0000-0003-2845-2992; Davis, Adrian/0000-0001-7134-7528;
   Leasher, Janet/0000-0002-8779-5162; Amini, Heresh/0000-0002-4825-1322;
   Lotufo, Paulo/0000-0002-4856-8450; Karch, Andre/0000-0003-3014-8543;
   Hedayati, Mohammad T./0000-0001-6415-4648; Franklin,
   Richard/0000-0003-1864-4552; Ermakov, Sergey/0000-0003-1072-1162;
   Pereira, David/0000-0003-0384-7592; PACELLA, ROSANA/0000-0002-9742-1957;
   Kuate Defo, Barthelemy/0000-0002-6589-0564; Newton,
   21/0000-0002-6999-5507; Satpathy, Maheswar/0000-0003-3521-4781; Rakovac,
   Ivo/0000-0003-3462-2636; Banerjee, Amitava/0000-0001-8741-3411;
   Charlson, Fiona/0000-0003-2876-5040; Patten, Scott/0000-0001-9871-4041;
   Fra.Paleo, Urbano/0000-0001-6192-7684; Monasta,
   Lorenzo/0000-0001-7774-548X; Sepanlou, Sadaf/0000-0002-3669-5129; Haro,
   Josep Maria/0000-0002-3984-277X; Degenhardt, Louisa/0000-0002-8513-2218;
   Martin, Randall/0000-0003-2632-8402; Hankey, Graeme
   /0000-0002-6044-7328; Ukwaja, Kingsley N./0000-0002-1974-8735; Miller,
   Ted/0000-0002-0958-2639; Khang, Young-Ho/0000-0002-9585-8266; Batis,
   Carolina/0000-0002-2823-6651; Nisar, Muhammad Imran/0000-0002-2378-4720;
   Paternina-Caicedo, Angel/0000-0002-6332-5174; Salvo,
   Deborah/0000-0002-9726-0882; Prabhakaran, Dorairaj/0000-0002-3172-834X;
   Kromhout, Hans/0000-0002-4233-1890; Roy MD, PhD,
   Nobhojit/0000-0003-2022-7416; Hoek, Hans/0000-0001-6353-5465;
   Sreeramareddy, Chandrashekhar/0000-0002-5693-7631; Ding,
   Eric/0000-0002-5881-8097; Juel, Knud/0000-0002-4134-1173; Borges,
   Guilherme/0000-0002-3269-0507; Bernabe, Eduardo/0000-0002-1858-3713;
   Neal, Bruce/0000-0002-0490-7465; Moradi-Lakeh,
   Maziar/0000-0001-7381-5305; Gabbe, Belinda/0000-0001-7096-7688;
   Farzadfar, Farshad/0000-0001-8288-4046; Tsilimbaris,
   Miltiadis/0000-0002-0130-1150; Catala-Lopez, Ferran/0000-0002-3833-9312
FU Bill AMP; Melinda Gates Foundation
FX Funding Bill & Melinda Gates Foundation.
CR Abrams DI, 2014, J CLIN ONCOL, V32, P2290, DOI 10.1200/JCO.2014.56.6299
   Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901
   Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672
   Arnold C, 2014, ENVIRON HEALTH PERSP, V122, pA111, DOI 10.1289/ehp.122-A111
   Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5
   Bagnardi V, 2008, J EPIDEMIOL COMMUN H, V62, P615, DOI 10.1136/jech.2007.065607
   Banks E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0281-z
   Batuman V, 2014, NEW ENGL J MED, V371, P2134, DOI 10.1056/NEJMc1412113#SA2
   Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8
   Bloomberg Philanthropies, 2011, ACC WORLDW MOV RED T
   Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987
   Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752
   Brumback BA, 2000, BIOSTATISTICS, V1, P203, DOI 10.1093/biostatistics/1.2.203
   Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049
   Carey IM, 2013, AM J RESP CRIT CARE, V187, P1226, DOI 10.1164/rccm.201210-1758OC
   Chafe ZA, 2014, ENVIRON HEALTH PERSP, V122, P1314, DOI 10.1289/ehp.1206340
   Chan M, 2012, LANCET, V380, P2054, DOI 10.1016/S0140-6736(12)62135-7
   Clasen T, 2014, TROP MED INT HEALTH, V19, P884, DOI 10.1111/tmi.12330
   Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240
   Cook RJ, 2001, BIOMETRICS, V57, P671, DOI 10.1111/j.0006-341X.2001.00671.x
   Crouse DL, 2012, ENVIRON HEALTH PERSP, V120, P708, DOI 10.1289/ehp.1104049
   DOLL R, 1994, BRIT MED J, V309, P901
   Doll R, 2004, BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE
   Dye C, 2013, NATURE, V502, pS13, DOI 10.1038/502S13a
   Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303
   Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935
   Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339
   Global Burden of Disease Study, 2013, LANCET, V386, P743, DOI DOI 10.1016/S0140-6736(15)60692-4
   Guasch-Ferre M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-164
   Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141
   Hawkes S, 2013, LANCET, V381, P1783, DOI 10.1016/S0140-6736(13)60253-6
   He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144
   He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325
   Hebert JR, 2014, ADV NUTR, V5, P447, DOI 10.3945/an.114.006189
   Hystad P, 2013, EPIDEMIOLOGY, V24, P762, DOI 10.1097/EDE.0b013e3182949ae7
   Institute of Medicine of the National Academies, 2013, SOD INT POP ASEV
   Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698
   Jackson CL, 2014, AM J CLIN NUTR, V100, P408
   Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429
   Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098
   Kim JY, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62162-X
   Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274
   Lewington S, 2002, LANCET, V360, P1903
   Li N, 2007, J HYPERTENS, V25, P2011
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC
   Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X
   Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692
   Masters RK, 2013, AM J PUBLIC HEALTH, V103, P1895, DOI 10.2105/AJPH.2013.301379
   Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325
   Mente A, 2014, CAN J CARDIOL, V30, P507, DOI 10.1016/j.cjca.2014.02.003
   Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Navas-Acien A, 2008, EPIDEMIOLOGY, V19, P496, DOI 10.1097/EDE.0b013e31816a2400
   Naveedullah, 2013, BIOMED RES INT, DOI 10.1155/2013/590306
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889
   Olofin I, 2013, PLOS ONE, V8
   Patel SR, 2012, SLEEP, V35, P97, DOI 10.5665/sleep.1594
   PETO R, 1992, LANCET, V339, P1268
   Pope CA, 2015, J AIR WASTE MANAGE, V65, P516, DOI 10.1080/10962247.2014.993004
   Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639
   Preston SH, 2013, EPIDEMIOLOGY, V24, P158, DOI 10.1097/EDE.0b013e3182770217
   Preston S., 1980, POPULATION EC CHANGE, P289
   Rehm J, 2013, INT J ALCOHOL DRUG R, V2, P1
   Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3
   Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X
   Rhodes HG, MEAS RISKS CAUS PREM
   Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671
   Rouhani MH, 2014, OBES REV, V15, P740, DOI 10.1111/obr.12172
   Saint-Jacques N, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-44
   Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356
   Stokes A, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-6
   Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2
   Vander Hoorn S, 2004, COMP QUANTIFICATION
   Villeneuve PJ, 1999, CANCER CAUSE CONTROL, V10, P355, DOI 10.1023/A:1008958103865
   Watts C, 2012, LANCET, V380, P2060, DOI 10.1016/S0140-6736(12)62121-7
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   World Health Organization, 2008, MPOWER POL PACK REV
   Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331
   Zhao XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110131
NR 86
TC 359
Z9 380
U1 166
U2 426
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD DEC 5
PY 2015
VL 386
IS 10010
BP 2287
EP 2323
DI 10.1016/S0140-6736(15)00128-2
PG 37
WC Medicine, General & Internal
SC General & Internal Medicine
GA CX8ZB
UT WOS:000365993200031
OA No
HC Y
HP Y
DA 2017-08-15
ER

PT J
AU Tinto, H
   Sevene, E
   Dellicour, S
   Calip, GS
   d'Alessandro, U
   Macete, E
   Nakanabo-Diallo, S
   Kazienga, A
   Valea, I
   Sorgho, H
   Vala, A
   Augusto, O
   Ruperez, M
   Menendez, C
   Ouma, P
   Desai, M
   Ter Kuile, F
   Stergachis, A
AF Tinto, Halidou
   Sevene, Esperanca
   Dellicour, Stephanie
   Calip, Gregory S.
   d'Alessandro, Umberto
   Macete, Eusebio
   Nakanabo-Diallo, Seydou
   Kazienga, Adama
   Valea, Innocent
   Sorgho, Hermann
   Vala, Anifa
   Augusto, Orvalho
   Ruperez, Maria
   Menendez, Clara
   Ouma, Peter
   Desai, Meghna
   Ter Kuile, Feiko
   Stergachis, Andy
TI Assessment of the safety of antimalarial drug use during early pregnancy
   (ASAP): protocol for a multicenter prospective cohort study in Burkina
   Faso, Kenya and Mozambique
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Pregnancy; Malaria; ACTs
ID DEMOGRAPHIC SURVEILLANCE SYSTEM; PLASMODIUM-FALCIPARUM MALARIA;
   RANDOMIZED CONTROLLED-TRIAL; ARTEMETHER-LUMEFANTRINE; DEVELOPMENTAL
   TOXICITY; COMBINED ARTESUNATE; WESTERN KENYA; WOMEN; PHARMACOKINETICS;
   PROFILE
AB Background: A major unresolved safety concern for malaria case management is the use of artemisinin combination therapies (ACTs) in the first trimester of pregnancy. There is a need for human data to inform policy makers and treatment guidelines on the safety of artemisinin combination therapies (ACT) when used during early pregnancy.
   Methods: The overall goal of this paper is to describe the methods and implementation of a study aimed at developing surveillance systems for identifying exposures to antimalarials during early pregnancy and for monitoring pregnancy outcomes using health and demographic surveillance platforms. This was a multi-center prospective observational cohort study involving women at health and demographic surveillance sites in three countries in Africa: Burkina Faso, Kenya and Mozambique [(ClinicalTrials.gov Identifier: NCT01232530)]. The study was designed to identify pregnant women with artemisinin exposure in the first trimester and compare them to: 1) pregnant women without malaria, 2) pregnant women treated for malaria, but exposed to other antimalarials, and 3) pregnant women with malaria and treated with artemisinins in the 2nd or 3rd trimesters from the same settings. Pregnant women were recruited through community-based surveys and attendance at health facilities, including antenatal care clinics and followed until delivery. Data from the three sites will be pooled for analysis at the end of the study. Results are forthcoming.
   Discussion: Despite few limitations, the methods described here are relevant to the development of sustainable pharmacovigilance systems for drugs used by pregnant women in the tropics using health and demographic surveillance sites to prospectively ascertain drug safety in early pregnancy.
C1 [Tinto, Halidou; Nakanabo-Diallo, Seydou; Kazienga, Adama; Valea, Innocent; Sorgho, Hermann] IRSS, Clin Res Unit Nanoro, Bobo Dioulasso, Burkina Faso.
   [Sevene, Esperanca; Augusto, Orvalho] Eduardo Mondlane Univ, Maputo, Mozambique.
   [Sevene, Esperanca; Macete, Eusebio; Vala, Anifa; Augusto, Orvalho; Ruperez, Maria; Menendez, Clara] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Dellicour, Stephanie; Ter Kuile, Feiko] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Calip, Gregory S.] Univ Washington, Sch Publ Hlth, Dept Pharm & Global Hlth, Seattle, WA 98195 USA.
   [d'Alessandro, Umberto; Stergachis, Andy] MRC, Fajara, Gambia.
   [Ouma, Peter] Kenya Med Res Inst Ctr Global Hlth Res, Kisumu, Kenya.
   [Desai, Meghna] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Desai, Meghna] Ctr Dis Control & Prevent, Nairobi, Kenya.
   [Ruperez, Maria; Menendez, Clara] Inst Salud Global Barcelona, Barcelona, Spain.
RP Tinto, H (reprint author), IRSS, Clin Res Unit Nanoro, Bobo Dioulasso, Burkina Faso.
EM tintohalidou@yahoo.fr; hsorgho@hotmail.com
OI ter Kuile, Feiko/0000-0003-3663-5617; Calip, Gregory/0000-0002-7744-3518
FU Bill & Melinda Gates Foundation through the Malaria in Pregnancy
   Consortium
FX We wish to thank all study participants and the study field staffs in
   the three countries. This study was made possible thanks to the
   financial support of the Bill & Melinda Gates Foundation through the
   Malaria in Pregnancy Consortium. We acknowledge the assistance of Laura
   Sangare, Robert Nathan, and Gillian Levine of the University of
   Washington during the early phases of the study for their contributions
   to study planning and operations. The authors also thank the following
   individuals who contributed in various ways to the protocol: G. Aol, M.
   Oneko, G. Bigogo, S. Kariuki, F. Odhiambo and J. Vulule from KEMRI-CDC
   Research and Public Health Collaboration; D. Burton, R.F. Breiman, M.
   Hamel, L. Slutsker, D. Feikin and KF. Laserson from CDC, Atlanta, USA;
   J. Pandit from the Kenyan Pharmacy and Poison Board; P Alonso from
   ISGLOBAL, Barcelona, Spain. KEMRI/CDC Research and Public Health
   Collaboration, the Clinical Research Unit of Nanoro and Manhica Health
   Research Center are members of the INDEPTH Network.
CR Adam I, 2009, ANN TROP MED PARASIT, V103, P205, DOI 10.1179/136485909X398285
   Boareto AC, 2013, HUM EXP TOXICOL, V32, P930, DOI 10.1177/0960327113475678
   Boareto AC, 2012, REPROD TOXICOL, V34, P658, DOI 10.1016/j.reprotox.2012.10.004
   Clark RL, 2011, BIRTH DEFECTS RES B, V92, P52, DOI [10.1002/bdrb.20282, 10.1002/hdrb.20282]
   Dellicour S, 2008, PLOS MED, V5, P1310, DOI 10.1371/journal.pmed.0050187
   Dellicour S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-15
   Dellicour S, 2013, DRUG SAFETY, V36, P505, DOI 10.1007/s40264-013-0059-1
   Derra K, 2012, INT J EPIDEMIOL, V41, P1293, DOI 10.1093/ije/dys159
   Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374
   Finaurini S, 2012, TOXICOLOGY, V300, P57, DOI 10.1016/j.tox.2012.05.024
   Li QG, 2009, BIRTH DEFECTS RES B, V86, P385, DOI 10.1002/bdrb.20207
   Lin AE, 1999, AM J MED GENET, V84, P102, DOI 10.1002/(SICI)1096-8628(19990521)84:2<102::AID-AJMG4>3.0.CO;2-G
   Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141
   Manyando C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-249
   McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5
   McGready R, 2008, PLOS MED, V5, P1699, DOI 10.1371/journal.pmed.0050253
   McGready R, 2012, BRIT J CLIN PHARMACO, V73, P467, DOI 10.1111/j.1365-2125.2011.04103.x
   Mongelli M, 1996, AM J OBSTET GYNECOL, V174, P278, DOI 10.1016/S0002-9378(96)70408-8
   Muehlenbachs A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-150
   Neilson JP, 2000, COCHRANE DB SYST REV, V2
   NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104
   Nosten Francois, 2006, Curr Drug Saf, V1, P1, DOI 10.2174/157488606775252584
   Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108
   Ouma P, 2007, TROP MED INT HEALTH, V12, P1515, DOI 10.1111/j.1365-3156.2007.01960.x
   Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092
   Rulisa S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-225
   Sacarlal J, 2008, VACCINE, V26, P174, DOI 10.1016/j.vaccine.2007.11.003
   Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148
   Sangare LR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-152
   Sasidharan K, 2009, ARCH DIS CHILD-FETAL, V94, pF39, DOI 10.1136/adc.2007.122564
   Seffah JD, 2009, CLIN OBSTET GYNECOL, V52, P250, DOI 10.1097/GRF.0b013e3181a4c2d5
   Tarning J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-293
   Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-113
   Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7
   White LJ, 2012, J R SOC INTERFACE, V9, P503, DOI 10.1098/rsif.2011.0376
   White NJ, 2008, PLOS MED, V5, P843, DOI 10.1371/journal.pmed.0050133
   White TEK, 2008, BIRTH DEFECTS RES B, V83, P407, DOI 10.1002/bdrb.20157
   Yartey JE, 2006, INT J GYNECOL OBSTET, V94, P364, DOI 10.1016/j.ijgo.2006.04.026
NR 38
TC 2
Z9 2
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD DEC 4
PY 2015
VL 12
AR 112
DI 10.1186/s12978-015-0101-0
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CZ3VG
UT WOS:000367031500001
PM 26637464
OA gold
DA 2017-08-15
ER

PT J
AU Thanh, PV
   Hong, NV
   Van, NV
   Louisa, M
   Baird, K
   Xa, NX
   Grietens, KP
   Hung, LX
   Duong, TT
   Rosanas-Urgell, A
   Speybroeck, N
   D'Alessandro, U
   Erhart, A
AF Pham Vinh Thanh
   Nguyen Van Hong
   Nguyen Van Van
   Louisa, Melva
   Baird, Kevin
   Nguyen Xuan Xa
   Grietens, Koen Peeters
   Le Xuan Hung
   Tran Thanh Duong
   Rosanas-Urgell, Anna
   Speybroeck, Niko
   D'Alessandro, Umberto
   Erhart, Annette
TI Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID FALCIPARUM-MALARIA; PARASITE CLEARANCE; FOREST MALARIA; IN-VIVO;
   ARTEMISININ; PRIMAQUINE; EPIDEMIOLOGY; TRANSMISSION; INFECTION; SOUTHERN
AB Plasmodium vivax resistance to chloroquine (CQ) is currently reported in almost all countries where P. vivax is endemic. In Vietnam, despite a first report on P. vivax resistance to chloroquine published in the early 2000s, P. vivax was still considered sensitive to CQ. Between May 2009 and December 2011, a 2-year cohort study was conducted in central Vietnam to assess the recommended radical cure regimen based on a 10-day course of primaquine (0.5 mg/kg/day) together with 3 days of CQ (25 mg/kg). Here we report the results of the first 28-day follow-up estimating the cumulative risk of P. vivax recurrences together with the corresponding CQ blood concentrations, among other endpoints. Out of 260 recruited P. vivax patients, 240 completed treatment and were followed up to day 28 according to the WHO guidelines. Eight patients (3.45%) had a recurrent P. vivax infection, at day 14 (n = 2), day 21 (n = 1), and day 28 (n = 5). Chloroquine blood concentrations, available for 3/8 recurrent infections (days 14, 21, and 28), were above the MIC (>100 ng/ml whole blood) in all of these cases. Fever and parasitemia (both sexual and asexual stages) were cleared by day 3. Anemia was common at day 0 (35.8%), especially in children under 10 years (50%), and hemoglobin (Hb) recovery at day 28 was substantial among anemic patients (median change from day 0 to 28, + 1.7 g/dl; interquartile range [IQR], +0.7 to +3.2). This report, based on CQ blood levels measured at the time of recurrences, confirms for the first time P. vivax CQ resistance in central Vietnam and calls for further studies using standardized protocols for accurately monitoring the extent and evolution of P. vivax resistance to chloroquine in Vietnam. These results, together with the mounting evidence of artemisinin resistance in central Vietnam, further highlight the increasing threat of antimalarial drug resistance to malaria elimination in Vietnam.
C1 [Pham Vinh Thanh; Nguyen Van Hong; Nguyen Xuan Xa; Le Xuan Hung; Tran Thanh Duong] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
   [Nguyen Van Van] Prov Malaria Stn, Tam Ky City, Quang Nam Provi, Vietnam.
   [Louisa, Melva] Univ Indonesia, Fac Med, Dept Pharmacol, Jakarta, Indonesia.
   [Baird, Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [Grietens, Koen Peeters; Rosanas-Urgell, Anna; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Speybroeck, Niko] Catholic Univ Louvain, B-1200 Brussels, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Thanh, PV (reprint author), Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
EM phamvinht@gmail.com
RI Rosanas-Urgell, Anna/D-3193-2015
OI Rosanas-Urgell, Anna/0000-0002-0432-5203; Louisa,
   Melva/0000-0002-9451-0380
FU UBS Optimus Foundation; Framework Agreement project (FA3) of the Belgium
   Cooperation (DGCD)
FX This study was funded by the UBS Optimus Foundation and the Framework
   Agreement project (FA3) of the Belgium Cooperation (DGCD).
CR Ahlm C, 1996, J TRAVEL MED, V3, P124, DOI 10.1111/j.1708-8305.1996.tb00719.x
   Alecrim M das G, 1999, Rev Soc Bras Med Trop, V32, P67
   Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09
   Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004
   BAIRD JK, 1995, J INFECT DIS, V171, P1678
   Baird JK, 1997, AM J TROP MED HYG, V56, P621
   BAIRD JK, 1991, AM J TROP MED HYG, V44, P547
   BEUTLER E, 1994, BLOOD, V84, P3613
   Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697
   Cheomung A, 2011, J PHARMACEUT BIOMED, V55, P1031, DOI 10.1016/j.jpba.2011.03.001
   Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575
   Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58
   Erhart A, 2004, TROP MED INT HEALTH, V9, P1081, DOI 10.1111/j.1365-3156.2004.01310.x
   Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339
   Garg M, 1995, T ROY SOC TROP MED H, V89, P656, DOI 10.1016/0035-9203(95)90432-8
   Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774
   HemoCue, 2014, HEMOCUE HB 301 OP MA
   Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047
   Hue Nguyen Thi, 2009, Malar J, V8, P152, DOI 10.1186/1475-2875-8-152
   Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241
   Marlar Than, 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene, V89, P307
   Matsuoka H, 2007, ACTA MED OKAYAMA, V61, P213
   Ministry of Health National Malaria Control and Elimination Programme, 2011, NAT STRAT MAL CONTR
   MURPHY GS, 1993, LANCET, V341, P96, DOI 10.1016/0140-6736(93)92568-E
   Myat P, 1993, T R SOC TROP MED HYG, V87, P687
   National Institute of Malariology Parasitology and Entomology, REV ANT DRUG EFF LAS
   Ngo T, 2003, AM J TROP MED HYG, V68, P350
   Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010
   Peeters Grietens K, 2010, MALARIA J, V9, P23
   Thanh PV, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0601-y
   Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x
   Phillips EJ, 1996, CLIN INFECT DIS, V23, P1171
   Phuc Bui Q., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P959
   Price RN, 2007, AM J TROP MED HYG, V77, P79
   Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2
   PUKRITTAYAKAMEE S, 1994, J INFECT DIS, V169, P932
   RIECKMANN KH, 1989, LANCET, V2, P1183
   Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544
   SCHUURKAMP GJ, 1992, T ROY SOC TROP MED H, V86, P121, DOI 10.1016/0035-9203(92)90531-G
   SCHUURKAMP GJ, 1989, T ROY SOC TROP MED H, V83, P607, DOI 10.1016/0035-9203(89)90370-2
   Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x
   Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09
   Singh RK, 2000, T ROY SOC TROP MED H, V94, P327, DOI 10.1016/S0035-9203(00)90305-5
   Soto J, 2001, AM J TROP MED HYG, V65, P90
   Taylor WRJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-209
   Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003
   Taylor WRJ, 2000, AM J TROP MED HYG, V62, P693
   Thanh NV, 2001, T ROY SOC TROP MED H, V95, P513, DOI 10.1016/S0035-9203(01)90023-9
   Thriemer K, 2014, ANTIMICROB AGENTS CH, V58, P7049, DOI 10.1128/AAC.02746-14
   Tien NT., 2007, INT C ITM NIMPE, P71
   Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373
   WHO, 2014, STAT REP ART RES
   WHO, 2009, METH SURV ANT DRUG E
   WHO, 2014, WORLD MALARIA REPORT, P162
   [Anonymous], 2001, IR DEF AN ASS PREV C
   WHO, 2015, GUID TREATM MAL
NR 56
TC 2
Z9 2
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD DEC
PY 2015
VL 59
IS 12
BP 7411
EP 7419
DI 10.1128/AAC.00791-15
PG 9
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA DB2KO
UT WOS:000368337300031
PM 26392501
OA No
DA 2017-08-15
ER

PT J
AU Seddon, JA
   Kampmann, B
AF Seddon, James A.
   Kampmann, Beate
TI HIV and tuberculosis in children: biology meets epidemiology
SO LANCET HIV
LA English
DT Editorial Material
C1 [Seddon, James A.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London, England.
   [Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.
RP Seddon, JA (reprint author), Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London, England.
EM james.seddon@imperial.ac.uk
OI Kampmann, Beate/0000-0002-6546-4709; Seddon, James/0000-0002-2296-2302
FU Department of Health [SRF-2009-02-07]; Medical Research Council
   [MC_EX_MR/K011944/1, MC_UP_A900_1122]
CR Bamford A, 2015, HIV MED, DOI [10.1111/hiv.12217, DOI 10.1111/HIV.12217]
   European Centre for Disease Prevention and Control, EXP OP PUBL HLTH NEE
   Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d
   National Institute for Health and Clinical Excellence, TUB UPD DRAFT GUID C
   Public Health England, COLL TUB STRAT ENGL
   Public Health England, TUB ENGL 2015 REP
   Roy RB, 2012, CURR OPIN INFECT DIS, V25, P250, DOI 10.1097/QCO.0b013e3283529af9
   Turkova A, 2015, LANCET HIV
   Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5
NR 9
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-3018
J9 LANCET HIV
JI Lancet HIV
PD DEC
PY 2015
VL 2
IS 12
BP E506
EP E507
DI 10.1016/S2352-3018(15)00209-X
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DB1IZ
UT WOS:000368263200004
PM 26614962
OA No
DA 2017-08-15
ER

PT J
AU Owens, S
   Gulati, R
   Fulford, AJ
   Sosseh, F
   Denison, FC
   Brabin, BJ
   Prentice, AM
AF Owens, Stephen
   Gulati, Ruchi
   Fulford, Anthony J.
   Sosseh, Fatou
   Denison, Fiona C.
   Brabin, Bernard J.
   Prentice, Andrew M.
TI Periconceptional multiple-micronutrient supplementation and placental
   function in rural Gambian women: a double-blind, randomized,
   placebo-controlled trial
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE periconceptional; micronutrients; pregnancy; placenta; Africa; birth
   weight; fetal growth
ID GESTATIONAL-AGE; EARLY-PREGNANCY; BIRTH-WEIGHT; FETAL; PREECLAMPSIA;
   PRETERM; GROWTH; RISK; IMPLANTATION; MECHANISMS
AB Background: Maternal micronutrient deficiencies are commonly associated with clinical indicators of placental dysfunction.
   Objective: We tested the hypothesis that periconceptional multiple-micronutrient supplementation (MMS) affects placental function.
   Design: We conducted a double-blind, randomized, placebo-controlled trial of MMS in 17- to 45-y-old Gambian women who were menstruating regularly and within the previous 3 mo. Eligible subjects were prerandomly assigned to supplementation with the UNICEF/WHO/United Nations University multiple micronutrient preparation (UNIMMAP) or placebo on recruitment and until they reached their first antenatal checkup or for 1 y if they failed to conceive. Primary outcome measures were midgestational indexes of utero-placental vascular-endothelial function [ratio of plasminogen-activator inhibitor (PAI) 1 to PAI-2 and mean uterine-artery resistance index (UtARI)] and placental active transport capacity at delivery [fetal to maternal measles antibody (MMA) ratio].
   Results: We recruited 1156 women who yielded 415 pregnancies, of which 376 met all of the inclusion criteria. With adjustment for gestational age at sampling, there were no differences in PAI-1 to PAI-2 or MMA ratios between trial arms, but there was a 0.02-unit reduction in UtARI between 18 and 32 wk of gestation (95% CI: -0.03, -0.00; P = 0.040) in women taking UNIMMAP.
   Conclusions: Placental vascular function was modifiable by periconceptional micronutrient supplementation. However, the effect was small and supplementation did not further affect other variables of placental function.
C1 [Owens, Stephen] Northumbria Healthcare NHS Fdn Trust, Childrens Unit, North Shields, England.
   [Owens, Stephen; Gulati, Ruchi; Fulford, Anthony J.; Sosseh, Fatou; Prentice, Andrew M.] London Sch Hyg & Trop Med, Med Res Council MRC Int Nutr Grp, London WC1, England.
   [Owens, Stephen; Gulati, Ruchi; Fulford, Anthony J.; Sosseh, Fatou; Prentice, Andrew M.] MRC Keneba, Fajara, Gambia.
   [Denison, Fiona C.] Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.
   [Brabin, Bernard J.] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England.
RP Owens, S (reprint author), Northumbria Healthcare NHS Fdn Trust, Childrens Unit, North Shields, England.
EM stephen.owens@ncl.ac.uk
FU UK Medical Research Council [MC-A760-5QX00]; UK Department for
   International Development (DFID)
FX Supported by the UK Medical Research Council (MC-A760-5QX00) and the UK
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement.
CR BATES CJ, 1994, EUR J CLIN NUTR, V48, P660
   BreathnachMd FM, 2012, SEMIN PERINATOL, V36, P175, DOI 10.1053/j.semperi.2012.02.002
   Catov JM, 2011, AM J CLIN NUTR, V94, P906, DOI 10.3945/ajcn.111.012393
   Cetin I, 2010, HUM REPROD UPDATE, V16, P80, DOI 10.1093/humupd/dmp025
   Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012
   Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006
   Chappell LC, 1999, LANCET, V354, P810
   Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813
   Chudleigh P, 2004, OBSTET ULTRASOUND WH
   Cole-Ceesay R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-21
   Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708
   Cross JC, 2006, NUTR REV, V64, pS12, DOI 10.1301/nr.may.S12-S18
   ESTELLES A, 1989, BLOOD, V74, P1332
   Gulati R, 2009, EUR J CLIN NUTR, V63, P970, DOI 10.1038/ejcn.2009.11
   Haider BA, 2012, COCHRANE DB SYST REV, V4
   Khong T Yee, 2004, Semin Neonatol, V9, P255, DOI 10.1016/j.siny.2003.11.010
   Khulan B, 2012, HUM MOL GENET, V21, P2086, DOI 10.1093/hmg/dds026
   Medical Research Council, 1998, MRC GUID GOOD CLIN P
   Myatt L, 2012, OBSTET GYNECOL, V120, P815, DOI 10.1097/AOG.0b013e31826af7fb
   Nafee TM, 2008, BJOG-INT J OBSTET GY, V115, P158, DOI 10.1111/j.1471-0528.2007.01528.x
   Owens S, 2006, ARCH DIS CHILD, V91, P507, DOI 10.1136/adc.2005.085274
   Ramakrishnan U, 1999, NUTR RES, V19, P103, DOI 10.1016/S0271-5317(98)00178-X
   Ramakrishnan U, 2002, NUTR REV, V60, pS46, DOI 10.1301/00296640260130731
   Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x
   Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134
   Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x
   Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006
   Sciscione AC, 2009, AM J OBSTET GYNECOL, V201, P121, DOI 10.1016/j.ajog.2009.03.027
   Shaw GM, 1997, J PEDIATR-US, V130, P1013, DOI 10.1016/S0022-3476(97)70303-2
   Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083
   Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x
   Taylor RAM, 2010, ANN TROP PAEDIATR, V30, P197, DOI 10.1179/146532810X12786388978526
   THURNHAM DI, 1988, CLIN CHEM, V34, P377
   Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002
   Torheim L.E., 2010, J NUTR, V140, P2051
   UNICEF, 1999, WHO UN U WORKSH
   van der Loeff MFS, 2003, AIDS, V17, P1841, DOI 10.1097/01.aids.0000076303.76477.49
   WHEELER T, 1994, LANCET, V343, P511, DOI 10.1016/S0140-6736(94)91461-3
   Wu GY, 2012, PAEDIATR PERINAT EP, V26, P4, DOI 10.1111/j.1365-3016.2012.01291.x
   Yajnik CS, 2012, REV ENDOCR METAB DIS, V13, P121, DOI 10.1007/s11154-012-9214-8
NR 40
TC 3
Z9 3
U1 0
U2 4
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD DEC
PY 2015
VL 102
IS 6
BP 1450
EP 1459
DI 10.3945/ajcn.113.072413
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CX5BY
UT WOS:000365717300019
PM 26561613
OA No
DA 2017-08-15
ER

PT J
AU Warren, WC
   Jasinska, AJ
   Garcia-Perez, R
   Svarda, H
   Tomlinson, C
   Rocchi, M
   Archidiacono, N
   Capozzi, O
   Minx, P
   Montague, MJ
   Kyung, K
   Hillier, LW
   Kremitzki, M
   Graves, T
   Chiang, C
   Hughes, J
   Tran, N
   Huang, Y
   Ramensky, V
   Choi, OW
   Jung, YJ
   Schmitt, CA
   Juretic, N
   Wasserscheid, J
   Turner, TR
   Wiseman, RW
   Tuscher, JJ
   Kar, JA
   Schmitz, JE
   Zahn, R
   O'Connor, DH
   Redmond, E
   Nisbett, A
   Jacquelin, B
   Muller-Trutwin, MC
   Brenchley, JM
   Dione, M
   Antonio, M
   Schroth, GP
   Kaplan, JR
   Jorgensen, MJ
   Thomas, GWC
   Hahn, MW
   Raney, BJ
   Aken, B
   Nag, R
   Schmitz, J
   Churakov, G
   No, A
   Stanyon, R
   Webb, D
   Thibaud-Nissen, F
   Nordborg, M
   Marques-Bonet, T
   Dewar, K
   Weinstock, GM
   Wilson, RK
   Freimer, NB
AF Warren, Wesley C.
   Jasinska, Anna J.
   Garcia-Perez, Raquel
   Svarda, Hannes
   Tomlinson, Chad
   Rocchi, Mariano
   Archidiacono, Nicoletta
   Capozzi, Oronzo
   Minx, Patrick
   Montague, Michael J.
   Kyung, Kim
   Hillier, LaDeana W.
   Kremitzki, Milinn
   Graves, Tina
   Chiang, Colby
   Hughes, Jennifer
   Tran, Nam
   Huang, Yu
   Ramensky, Vasily
   Choi, Oi-wa
   Jung, Yoon J.
   Schmitt, Christopher A.
   Juretic, Nikoleta
   Wasserscheid, Jessica
   Turner, Trudy R.
   Wiseman, Roger W.
   Tuscher, Jennifer J.
   Kar, Julie A.
   Schmitz, Joern E.
   Zahn, Roland
   O'Connor, David H.
   Redmond, Eugene
   Nisbett, Alex
   Jacquelin, Beatrice
   Mueller-Trutwin, Michaela C.
   Brenchley, Jason M.
   Dione, Michel
   Antonio, Martin
   Schroth, Gary P.
   Kaplan, Jay R.
   Jorgensen, Matthew J.
   Thomas, Gregg W. C.
   Hahn, Matthew W.
   Raney, Brian J.
   Aken, Bronwen
   Nag, Rishi
   Schmitz, Juergen
   Churakov, Gennady
   Noll, Angela
   Stanyon, Roscoe
   Webb, David
   Thibaud-Nissen, Francoise
   Nordborg, Magnus
   Marques-Bonet, Tomas
   Dewar, Ken
   Weinstock, George M.
   Wilson, Richard K.
   Freimer, Nelson B.
TI The genome of the vervet (Chlorocebus aethiops sabaeus)
SO GENOME RESEARCH
LA English
DT Article
ID AFRICAN-GREEN MONKEYS; MAJOR HISTOCOMPATIBILITY COMPLEX; SIMIAN
   IMMUNODEFICIENCY VIRUS; COPY NUMBER VARIATION; GENETIC DIVERSITY;
   ANALYSIS TOOLKIT; PRIMATE; MACAQUE; EVOLUTIONARY; MAP
AB We describe a genome reference of the African green monkey or vervet (Chlorocebus aethiops). This member of the Old World monkey (OWM) superfamily is uniquely valuable for genetic investigations of simian immunodeficiency virus (Sly), for which it is the most abundant natural host species, and of a wide range of health-related phenotypes assessed in Caribbean vervets (C. a. sabaeus), whose numbers have expanded dramatically since Europeans introduced small numbers of their ancestors from West Africa during the colonial era. We use the reference to characterize the genomic relationship between vervets and other primates, the intra-generic phylogeny of vervet subspecies, and genome-wide structural variations of a pedigreed C.a. sabaeuspopulation. Through comparative analyses with human and rhesus macaque, we characterize at high resolution the unique chromosomal fission events that differentiate the vervets and their close relatives from most other catarrhine primates, in whom karyotype is highly conserved. We also provide a summary of transposable elements and contrast these with the rhesus macaque and human. Analysis of sequenced genomes representing each of the main vervet subspecies supports previously hypothesized relationships between these populations, which range across most of sub-Saharan Africa, while uncovering high levels of genetic diversity within each. Sequence-based analyses of major histocompatibility complex alFig polymorphisms reveal extremely low diversity in Caribbean C.a. sabaeusvervets, compared to vervets from putatively ancestral West African regions. In the C.a. sabaeus research population, we discover the first structural variations that are, in some cases, predicted to have a deleterious effect; future studies will determine the phenotypic impact of these variations.
C1 [Warren, Wesley C.; Tomlinson, Chad; Minx, Patrick; Montague, Michael J.; Kyung, Kim; Hillier, LaDeana W.; Kremitzki, Milinn; Graves, Tina; Chiang, Colby; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA.
   [Jasinska, Anna J.; Tran, Nam; Huang, Yu; Ramensky, Vasily; Choi, Oi-wa; Jung, Yoon J.; Schmitt, Christopher A.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.
   [Jasinska, Anna J.] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland.
   [Garcia-Perez, Raquel; Marques-Bonet, Tomas] UPF CSIC, Inst Biol Evolut, ICREA, Barcelona 08003, Spain.
   [Garcia-Perez, Raquel; Marques-Bonet, Tomas] PRBB PCB, CNAG, Barcelona 08003, Spain.
   [Svarda, Hannes; Nordborg, Magnus] Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, A-1030 Vienna, Austria.
   [Rocchi, Mariano; Archidiacono, Nicoletta; Capozzi, Oronzo] Univ Bari, Dept Biol, I-70126 Bari, Italy.
   [Hughes, Jennifer] Whitehead Inst, Cambridge, MA 02142 USA.
   [Juretic, Nikoleta; Wasserscheid, Jessica; Dewar, Ken] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada.
   [Turner, Trudy R.] Univ Wisconsin, Dept Anthropol, Madison, WI 53705 USA.
   [Turner, Trudy R.] Univ Orange Free State, Fac Nat & Agr Sci, Dept Genet, ZA-9300 Bloemfontein, South Africa.
   [Wiseman, Roger W.; Tuscher, Jennifer J.; Kar, Julie A.; O'Connor, David H.] Univ Wisconsin, Dept Lab Med & Pathol, Madison, WI 53705 USA.
   [Schmitz, Joern E.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.
   [Zahn, Roland] Crucell Holland BV, NL-2333 CN Leiden, Netherlands.
   [Jacquelin, Beatrice; Mueller-Trutwin, Michaela C.] Inst Pasteur, Unite Regulat Infect Retrovirales, F-75015 Paris, France.
   [Brenchley, Jason M.] NIAID, NIH, Bethesda, MD 20892 USA.
   [Dione, Michel; Antonio, Martin] MRC, Fajara, Gambia.
   [Schroth, Gary P.] Illumina Inc, San Diego, CA 92722 USA.
   [Kaplan, Jay R.; Jorgensen, Matthew J.] Wake Forest Sch Med, Ctr Comparat Med Res, Winston Salem, NC 27157 USA.
   [Thomas, Gregg W. C.; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.
   [Raney, Brian J.] Univ Calif Santa Cruz, Santa Cruz, CA 95060 USA.
   [Aken, Bronwen; Nag, Rishi] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England.
   [Schmitz, Juergen; Churakov, Gennady; Noll, Angela] Univ Munster, Inst Expt Pathol ZMBE, D-48149 Munster, Germany.
   [Churakov, Gennady] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany.
   [Stanyon, Roscoe] Univ Florence, Dept Biol, I-50122 Florence, Italy.
   [Webb, David; Thibaud-Nissen, Francoise] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.
   [Weinstock, George M.] Jackson Lab Genom Med, Farmington, CT 06001 USA.
RP Warren, WC (reprint author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA.
EM wwarren@genome.wustl.edu
RI ; Schmitt, Christopher/F-7251-2013; Ramensky, Vasily/H-4318-2017
OI Svardal, Hannes/0000-0001-7866-7313; Hahn, Matthew/0000-0002-5731-8808;
   Schmitt, Christopher/0000-0003-2143-9226; JACQUELIN,
   Beatrice/0000-0002-1896-5092; Chiang, Colby/0000-0002-4113-6065;
   archidiacono, nicoletta/0000-0002-1439-9521; Rocchi,
   Mariano/0000-0002-9451-5616; Aken, Bronwen/0000-0002-3032-4095;
   Marques-Bonet, Tomas/0000-0002-5597-3075; Nag, Rishi/0000-0001-6399-3773
FU NIH-NHGRI [5U54HG00307907]; NIH [RR019963/OD010965, R01RR016300,
   R01OD010980]; French National Agency for Research on AIDS and Viral
   Hepatitis (ANRS); Ministero della Universita e della Ricerca; Genome
   Canada; Genome Quebec; Wellcome Trust [WT095908]; European Molecular
   Biology Laboratory; ICREA
FX Funding to R.K.W. was provided by NIH-NHGRI grant 5U54HG00307907.
   Support for the Vervet Research Colony was provided by NIH grant
   RR019963/OD010965 to J.R.K. Funding to N.B.F. was provided by NIH grants
   R01RR016300 and R01OD010980. The French National Agency for Research on
   AIDS and Viral Hepatitis (ANRS) provided funding to M.C.M.-T. Funding to
   M.R. and R.S. was provided by the Ministero della Universita e della
   Ricerca. Funding to K.D. was provided by Genome Canada and Genome
   Quebec. B.A. and R.N. acknowledge support from the Wellcome Trust (grant
   number WT095908) and the European Molecular Biology Laboratory. We thank
   the following organizations for providing sampling permits and
   permissions: Ethiopian Wildlife Conservation Authority; Zambia Wildlife
   Authority; Wildlife Division, Forestry Commission, Republic of Ghana;
   and Gambia Department of Parks and Wildlife Management. We thank Dr.
   James L. Blanchard and Dr. Ivona Pandrea for vervet samples used to
   characterize MHC. We thank Josh McMichael and Josh Peck for figure
   assistance. We thank Joanne Nelson and Barbara Gillam for data
   submission. We thank the members of the library production group led by
   Catrina Fronick and sequencing led by Matt Cordes. We also thank the
   Medical Research Council Unit (MRC), The Gambia for their assistance, as
   well as all the veterinarians who worked with us to safely obtain
   samples.
CR Aamink A, 2014, IMMUNOGENETICS, V66, P353
   Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110
   Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437
   Alkuraya FS, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0173-z
   ALLAN JS, 1991, J VIROL, V65, P2816
   Antonacci F, 2014, NAT GENET, V46, P1293, DOI 10.1038/ng.3120
   Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Bonhomme M, 2008, MOL ECOL, V17, P1009, DOI 10.1111/j.1365-294X.2007.03645.x
   Cagliani R, 2010, HUM MOL GENET, V19, P4705, DOI 10.1093/hmg/ddq401
   Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679
   Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909
   Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504
   Elsworth JD, 2015, J COMP NEUROL, V523, P1248, DOI 10.1002/cne.23735
   Finelli P, 1999, MAMM GENOME, V10, P713, DOI 10.1007/s003359901077
   Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196
   FOMSGAARD A, 1990, J MED PRIMATOL, V19, P295
   FUKASAWA M, 1988, NATURE, V333, P457, DOI 10.1038/333457a0
   Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130
   Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247
   Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108
   Gokcumen O, 2013, P NATL ACAD SCI USA, V110, P15764, DOI 10.1073/pnas.1305904110
   Goldstein S, 2000, J VIROL, V74, P11744, DOI 10.1128/JVI.74.24.11744-11753.2000
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018
   Han MV, 2013, MOL BIOL EVOL, V30, P1987, DOI 10.1093/molbev/mst100
   Harris RS, 2007, THESIS
   Hill WCO, 1966, PRIMATES COMP ANATOM, VVI
   HIRSCH VM, 1993, VIROLOGY, V197, P426, DOI 10.1006/viro.1993.1606
   HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0
   Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843
   Jasinska AJ, 2007, MAMM GENOME, V18, P347, DOI 10.1007/s00335-007-9026-4
   Jasinska AJ, 2013, ILAR J, V54, P122, DOI 10.1093/ilar/ilt049
   Jasinska AJ, 2012, HUM MOL GENET, V21, P3307, DOI 10.1093/hmg/dds160
   Jdo JW, 1991, P NATL ACAD SCI USA, V88, P9051
   JIN MJ, 1994, EMBO J, V13, P2935
   Johnston JJ, 2015, AM J HUM GENET, V96, P913, DOI 10.1016/j.ajhg.2015.04.013
   Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20
   Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1
   Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]
   Kingdon J., 1984, E AFRICAN MAMMALS AT
   Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Long J. L., 2003, INTRO MAMMALS WORLD
   Ma DZ, 2014, J VIROL, V88, P5687, DOI 10.1128/JVI.03606-13
   Ma DZ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003011
   Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Pasquau F, 2005, EUR J CLIN MICROBIOL, V24, P411, DOI 10.1007/s10096-005-1342-6
   Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342
   Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023
   Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228
   Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114
   Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795
   Ruiz-Herrera A, 2005, AM J PRIMATOL, V65, P73, DOI 10.1002/ajp.20098
   Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015
   Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706
   Service SK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004147
   Stanyon R, 2012, CYTOGENET GENOME RES, V137, P273, DOI 10.1159/000339381
   Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113
   Ventura M, 2004, GENOME RES, V14, P1696, DOI 10.1101/gr.2608804
   Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615
   Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439
   Watanabe A, 2007, GENOMICS, V89, P402, DOI 10.1016/j.ygeno.2006.11.002
   Wiseman RW, 2013, ILAR J, V54, P196, DOI 10.1093/ilar/ilt036
   Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992
   Yao GH, 2012, BIOINFORMATICS, V28, P13, DOI 10.1093/bioinformatics/btr588
   Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871
   Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20
NR 71
TC 6
Z9 6
U1 2
U2 16
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD DEC
PY 2015
VL 25
IS 12
BP 1921
EP 1933
DI 10.1101/gr.192922.115
PG 13
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA CX6RZ
UT WOS:000365830400014
PM 26377836
OA No
DA 2017-08-15
ER

PT J
AU Heggum, C
   Vallejos, JJG
   Njie, OB
   Adegboye, AO
AF Heggum, Claus
   Vallejos, Jorge J. Guerrero
   Njie, O. B.
   Adegboye, A. O.
TI Application of the moving window approach in the verification of the
   performance of food safety management systems
SO FOOD CONTROL
LA English
DT Article
DE Microbiological criteria; Moving window; Verification; Food safety
   management system
AB In a food business, microbiological testing is one of several methods of verifying the performance and acceptability of the entire food safety management system. Demonstrating compliance with microbiological criteria applicable for end products through the moving window approach is a practical and cost-effective approach for well-managed food safety management systems based on Hazard Analysis and Critical Control Points (HACCP).
   This article discusses the moving windows approach and provides an example of how the approach can be used by a food business operator to verify compliance over time with a microbiological criterion applicable to end products manufactured within a HACCP-based food safety management system.
   The approach consists of sampling a defined number of analytical units at a specified frequency over a defined time period. Compliance with the microbiological criteria is demonstrated when (i) the specified absolute maximum level of acceptability (M) is not exceeded in any sample and (ii) any specified maximum frequency (c) of all samples taken during the specified period (window) do not exceed a marginally acceptable level (m). Corrective action is triggered by exceeding either c or M, which, depending on the type of organism, includes action on the operation or design of the food safety management system and may include actions on affected lots such as withdrawal/recall. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Heggum, Claus] Danish Agr & Food Council, DK-8200 Aarhus N, Denmark.
   [Vallejos, Jorge J. Guerrero] Minist Salud & Deportes, Unidad Nutr, La Paz, Bolivia.
   [Njie, O. B.] Minist Hlth & Social Welf, Food Stand Qual & Hyg Enforcement, Banjul, Gambia.
   [Adegboye, A. O.] Natl Agcy Food & Drug Adm & Control, Lagos, Nigeria.
RP Heggum, C (reprint author), Danish Agr & Food Council, 13 Agro Food Pk, DK-8200 Aarhus N, Denmark.
EM chg@lf.dk
CR Codex Alimentarius Commission CAC, 2003, 11969 CACRCP
   CAC (Codex Alimentarius Commission), 2013, 21 CACGL
   Jarvis B, 2007, LETT APPL MICROBIOL, V45, P592, DOI 10.1111/j.1472-765X.2007.02237.x
NR 3
TC 0
Z9 1
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-7135
EI 1873-7129
J9 FOOD CONTROL
JI Food Control
PD DEC
PY 2015
VL 58
SI SI
BP 17
EP 22
DI 10.1016/j.foodcont.2015.02.024
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA CW5TI
UT WOS:000365059100004
OA No
DA 2017-08-15
ER

PT J
AU Roberts, CH
   Franklin, CS
   Makalo, P
   Joof, H
   Sarr, I
   Mahdi, OS
   Sillah, A
   Bah, M
   Payne, F
   Jeffreys, AE
   Bottomley, WZ
   Natividad, A
   Molina-Gonzalez, S
   Burr, SE
   Preston, M
   Kwiatkowski, D
   Rockett, KA
   Clark, TG
   Burton, MJ
   Mabey, DCW
   Bailey, R
   Barroso, I
   Holland, MJ
AF Roberts, Chrissy H.
   Franklin, Christopher S.
   Makalo, Pateh
   Joof, Hassan
   Sarr, Isatou
   Mahdi, Olaimatu S.
   Sillah, Ansumana
   Bah, Momodou
   Payne, Felicity
   Jeffreys, Anna E.
   Bottomley, William
   Natividad, Angels
   Molina-Gonzalez, Sandra
   Burr, Sarah E.
   Preston, Mark
   Kwiatkowski, Dominic
   Rockett, Kirk A.
   Clark, Taane G.
   Burton, Matthew J.
   Mabey, David C. W.
   Bailey, Robin
   Barroso, Ines
   Holland, Martin J.
TI Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis
   intracellular infection: a genome wide association study
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SCARRING TRACHOMA; ENDEMIC POPULATION; GENETIC-VARIATION; RISK;
   SUSCEPTIBILITY; SEQUELAE; POLYMORPHISMS; EXPRESSION; GAMBIANS; DISEASE
AB Chlamydia trachomatis causes both trachoma and sexually transmitted infections. These diseases have similar pathology and potentially similar genetic predisposing factors. We aimed to identify polymorphisms and pathways associated with pathological sequelae of ocular Chlamydia trachomatis infections in The Gambia. We report a discovery phase genome-wide association study (GWAS) of scarring trachoma (1090 cases, 1531 controls) that identified 27 SNPs with strong, but not genome-wide significant, association with disease (5 x 10(-6) > P > 5 x 10(-8)). The most strongly associated SNP (rs111513399, P = 5.38 x 10(-7)) fell within a gene (PREX2) with homology to factors known to facilitate chlamydial entry to the host cell. Pathway analysis of GWAS data was significantly enriched for mitotic cell cycle processes (P = 0.001), the immune response (P = 0.00001) and for multiple cell surface receptor signalling pathways. New analyses of published transcriptome data sets from Gambia, Tanzania and Ethiopia also revealed that the same cell cycle and immune response pathways were enriched at the transcriptional level in various disease states. Although unconfirmed, the data suggest that genetic associations with chlamydial scarring disease may be focussed on processes relating to the immune response, the host cell cycle and cell surface receptor signalling.
C1 [Roberts, Chrissy H.; Natividad, Angels; Molina-Gonzalez, Sandra; Burr, Sarah E.; Preston, Mark; Clark, Taane G.; Mabey, David C. W.; Bailey, Robin; Holland, Martin J.] London Sch Hyg & Trop Med, London WC1, England.
   [Franklin, Christopher S.; Payne, Felicity; Bottomley, William; Kwiatkowski, Dominic; Barroso, Ines] Wellcome Trust Sanger Inst, Hinxton, England.
   [Makalo, Pateh; Joof, Hassan; Sarr, Isatou; Mahdi, Olaimatu S.; Burr, Sarah E.] MRC Unit, Fajara, Gambia.
   [Sillah, Ansumana] Natl Eye Care Programme, Gambian Minist Hlth, Banjul, Gambia.
   [Bah, Momodou] Sightsavers Int, Banjul, Gambia.
   [Burton, Matthew J.] Int Ctr Eye Hlth, London, England.
   [Jeffreys, Anna E.; Kwiatkowski, Dominic; Rockett, Kirk A.] Wellcome Trust Ctr Human Genet, Oxford, England.
   [Barroso, Ines] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge, England.
   [Barroso, Ines] NIHR, Cambridge Biomed Res Ctr, Cambridge, England.
RP Roberts, CH (reprint author), London Sch Hyg & Trop Med, London WC1, England.
EM chrissy.roberts@lshtm.ac.uk
OI Burton, Matthew/0000-0003-1872-9169; Kwiatkowski,
   Dominic/0000-0002-5023-0176; Roberts, Chrissy h./0000-0003-1064-5980;
   Payne, Felicity/0000-0003-4228-581X
FU Wellcome Trust [WT098051, GR079246MA, WT093368MA]; Medical Research
   Council [G0600718]; Wellcome Trust Centre for Human Genetics
   [075491/Z/04, 090532/Z/09/Z]; Wellcome Trust Sanger Institute
   [077012/Z/05/Z]; MRC Unit, the Gambia; Medical Research Council UK
   [MR/K000551/1, MR/M01360X/1]; Wellcome Trust Institutional Strategic
   Support Fund [105609/Z/14/Z]
FX We are grateful to the participants who volunteered to take part in this
   study. We wish to thank Emma Harding Esch, Nkoyo Faal, Ousman Jallow,
   Richard Bowman, Alison Campbell, Nadine Mozzato-Chamay and David Conway
   for their various contributions, support and advice. We also thank the
   Wellcome Trust Sanger Institute sample management and genotyping
   facilities. This work was funded by programme grants from the Wellcome
   Trust (WT098051, GR079246MA and WT093368MA), by the Medical Research
   Council (G0600718 award to DK) and by core funds of the Wellcome Trust
   Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z), the Wellcome
   Trust Sanger Institute (077012/Z/05/Z) and the MRC Unit, the Gambia. TGC
   is funded by the Medical Research Council UK (MR/K000551/1,
   MR/M01360X/1). ChR is funded by the Wellcome Trust Institutional
   Strategic Support Fund (105609/Z/14/Z).
CR Abbas M, 2009, INVEST OPHTH VIS SCI, V50, P1734, DOI 10.1167/iovs.08-2053
   ALRAJHI AA, 1993, OPHTHALMOLOGY, V100, P1293
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Atik B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003600
   Balsara ZR, 2006, INFECT IMMUN, V74, P5602, DOI 10.1128/IAI.00266-06
   Braun R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002101
   Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x
   Burton MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003763
   Chen QR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065982
   Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101
   Conway DJ, 1997, INFECT IMMUN, V65, P1003
   Conway DJ, 1996, J INFECT DIS, V174, P643
   Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397
   Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/nmeth.1785, 10.1038/NMETH.1785]
   Derrick T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002117
   Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569
   Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386
   Gonzalez E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6201
   Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2
   Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997
   Guzey M, 2000, OPHTHALMOLOGICA, V214, P277, DOI 10.1159/000027504
   Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395
   Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011
   Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354
   Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529
   Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020
   Hu VH, 2011, OPHTHALMOLOGY, V118, P2138, DOI 10.1016/j.ophtha.2011.04.014
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388
   Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002
   Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548
   Knowlton AE, 2011, TRAFFIC, V12, P854, DOI 10.1111/j.1600-0854.2011.01204.x
   Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014
   Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863
   Mozzato-Chamay N, 2000, J INFECT DIS, V182, P1545, DOI 10.1086/315891
   Natividad A, 2007, GENES IMMUN, V8, P288, DOI 10.1038/sj.gene.6364384
   Natividad A, 2005, GENES IMMUN, V6, P332, DOI 10.1038/sj.gene.6364182
   Natividad A, 2008, HUM MOL GENET, V17, P323, DOI 10.1093/hmg/ddm310
   Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40
   Natividad A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-138
   O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234
   Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roberts CH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002744
   Rowley J., 2008, GLOB INC PREV SEL CU
   Siegl C, 2014, CELL REP, V9, P918, DOI 10.1016/j.celrep.2014.10.004
   Southam L, 2011, EUR J HUM GENET, V19, P610, DOI 10.1038/ejhg.2010.242
   Stare D, 2011, OPHTHAL EPIDEMIOL, V18, P20, DOI 10.3109/09286586.2010.545500
   Su Y., 2014, P 13 INT S HUM CHLAM, V261
   Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443
   Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731
   Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177
   Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639
   Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334
   WEST SK, 1991, ARCH OPHTHALMOL-CHIC, V109, P855
   White AG, 1997, BRIT J OPHTHALMOL, V81, P431, DOI 10.1136/bjo.81.6.431
   Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029
   Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144
   Ye Z, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00125
   Kermani B. G, 2006, Patent, Patent No. [US7035740, 7035740]
NR 62
TC 3
Z9 3
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 30
PY 2015
VL 5
AR 17447
DI 10.1038/srep17447
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CX0WV
UT WOS:000365419000001
PM 26616738
OA gold
DA 2017-08-15
ER

PT J
AU Fryer, HR
   Van Tienen, C
   Van Der Loeff, MS
   Aaby, P
   Da Silva, ZJ
   Whittle, H
   Rowland-Jones, SL
   de Silva, TI
AF Fryer, Helen R.
   Van Tienen, Carla
   Van Der Loeff, Maarten Schim
   Aaby, Peter
   Da Silva, Zacarias J.
   Whittle, Hilton
   Rowland-Jones, Sarah L.
   de Silva, Thushan I.
TI Predicting the extinction of HIV-2 in rural Guinea-Bissau
SO AIDS
LA English
DT Article
DE age; epidemiology; extinction; HIV-2; incidence; mathematical model;
   prevalence
ID IMMUNODEFICIENCY-VIRUS TYPE-2; PLASMA VIRAL LOAD; WEST-AFRICA;
   ANTIRETROVIRAL THERAPY; COMPETITIVE-EXCLUSION; DUAL INFECTIONS;
   TRANSMISSION; MORTALITY; POPULATION; PREVALENCE
AB Objective:This article predicts the future epidemiology of HIV-2 in Caio, a rural region of Guinea Bissau; and investigates whether HIV-2, which has halved in prevalence between 1990 and 2007 and is now almost absent in young adults in Caio, can persist as an infection of the elderly.Design:A mathematical model of the spread of HIV-2 was tailored to the epidemic in Caio, a village in Guinea-Bissau.Methods:An age-stratified difference equation model of HIV-2 transmission was fitted to age-stratified HIV-2 incidence and prevalence data from surveys conducted in Caio in 1990, 1997 and 2007. A stochastic version of the same model was used to make projections.Results:HIV-2 infection is predicted to continue to rapidly decline in Caio such that new infections will cease and prevalence will reach low levels (e.g. below 0.1%) within a few decades. HIV-2 is not predicted to persist in the elderly.Conclusion:HIV-2 is predicted go extinct in Caio during the second half of this century.
C1 [Fryer, Helen R.] Univ Oxford, Dept Zool, Oxford Martin Sch, Inst Emerging Infect, Oxford, England.
   [Rowland-Jones, Sarah L.] John Radcliffe Hosp, Weatherall Inst Mol Med, Nuffield Dept Med, Oxford OX3 9DU, England.
   [Van Tienen, Carla; Whittle, Hilton; de Silva, Thushan I.] Med Res Council Labs UK, Fajara, Gambia.
   [de Silva, Thushan I.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England.
   [Van Tienen, Carla] Erasmus MC, Med Microbiol & Infect Dis, Rotterdam, Netherlands.
   [Van Der Loeff, Maarten Schim] Hlth Serv Amsterdam GGD, Amsterdam, Netherlands.
   [Van Der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
   [Van Der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands.
   [Aaby, Peter; Da Silva, Zacarias J.] Projecto Saude Bandim, Bissau, Guinea Bissau.
   [Whittle, Hilton] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
RP Fryer, HR (reprint author), Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
EM helen.fryer@zoo.ox.ac.uk
RI van Tienen, Carla/A-1119-2012
FU Oxford Martin School, University of Oxford
FX H.F. is funded by The Oxford Martin School, University of Oxford.
CR Aaby P, 1996, AIDS, V10, P1585
   Alabi AS, 2003, AIDS, V17, P1513, DOI 10.1097/01.aids.0000060410.18106.46
   Anderson RM, 1996, AIDS, V10, P1663
   ANDERSON RM, 1992, PHILOS T ROY SOC B, V336, P135, DOI 10.1098/rstb.1992.0052
   Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9
   BLYTHE SP, 1989, MATH BIOSCI, V96, P221, DOI 10.1016/0025-5564(89)90060-6
   da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d
   de Silva TI, 2013, AIDS, V27, P125, DOI 10.1097/QAD.0b013e32835ab12c
   de Silva Thushan I., 2010, HIV Therapy, V4, P305, DOI 10.2217/HIV.10.26
   de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003
   GAO F, 1994, J VIROL, V68, P7433
   Glasser J, 2012, MATH BIOSCI, V235, P1, DOI 10.1016/j.mbs.2011.10.001
   Gottlieb GS, 2006, AIDS, V20, P895, DOI 10.1097/01.aids.0000218554.59531.80
   Heitzinger K, 2012, INT J STD AIDS, V23, P710, DOI 10.1258/ijsa.2012.011219
   Hogsborg M, 1990, SEXUAL RELATIONS USE
   Holmgren B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-85
   Ibe S, 2010, JAIDS-J ACQ IMM DEF, V54, P241, DOI 10.1097/QAI.0b013e3181dc98c1
   Jensen ML, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000101
   Kanki PJ, 1994, REPROD BIOL, V8, pS85
   Koblavi-Deme S, 2004, AIDS, V18, P413, DOI 10.1097/01.aids.0000104327.15729.cb
   Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100
   Mansson F, 2009, AIDS, V23, P1575, DOI 10.1097/QAD.0b013e32832cedfb
   O'Donovan D, 2000, AIDS, V14, P441, DOI 10.1097/00002030-200003100-00019
   Pepin J, 2006, AIDS, V20, P1303
   Peterson I, 2011, AIDS, V25, P2167, DOI 10.1097/QAD.0b013e32834c4adb
   POULSEN AG, 1989, LANCET, V1, P827
   Poulsen AG, 2000, SCAND J INFECT DIS, V32, P169
   POULSEN AG, 1992, J ACQ IMMUN DEF SYND, V5, P25
   Prince PD, 2014, AIDS, V28, P549, DOI 10.1097/01.SPC.0000432532.87841.78
   Schmidt WP, 2008, EPIDEMIOL INFECT, V136, P551, DOI 10.1017/S0950268807008758
   Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24
   van der Loeff MFS, 2006, INT J EPIDEMIOL, V35, P1322, DOI 10.1093/ije/dy1037
   van der Loeff MFS, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-46
   van der Loeff MFS, 1999, AIDS, V13, pS69
   van der Loeff MFS, 2001, AIDS, V15, P2303, DOI 10.1097/00002030-200111230-00012
   van Tienen C, 2010, JAIDS-J ACQ IMM DEF, V53, P640, DOI 10.1097/QAI.0b013e3181bf1a25
   Watts C, 2010, SEX TRANSM INFECT, V86, P85, DOI 10.1136/sti.2010.044602
   WILKINS A, 1993, AIDS, V7, P1119, DOI 10.1097/00002030-199308000-00015
NR 38
TC 1
Z9 1
U1 3
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD NOV 28
PY 2015
VL 29
IS 18
BP 2479
EP 2486
DI 10.1097/QAD.0000000000000844
PG 8
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA DB4NO
UT WOS:000368490100002
PM 26485121
OA No
DA 2017-08-15
ER

PT J
AU Cross, JH
   Bradbury, RS
   Fulford, AJ
   Jallow, AT
   Wegmuller, R
   Prentice, AM
   Cerami, C
AF Cross, James H.
   Bradbury, Richard S.
   Fulford, Anthony J.
   Jallow, Amadou T.
   Wegmueller, Rita
   Prentice, Andrew M.
   Cerami, Carla
TI Oral iron acutely elevates bacterial growth in human serum
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; AFRICAN CHILDREN; DEFICIENCY ANEMIA;
   YOUNG-CHILDREN; SUPPLEMENTATION; HEPCIDIN; MALARIA; FORTIFICATION;
   TRANSFERRIN; INFECTIONS
AB Iron deficiency is the most common nutrient deficiency worldwide and routine supplementation is standard policy for pregnant mothers and children in most low-income countries. However, iron lies at the center of host-pathogen competition for nutritional resources and recent trials of iron administration in African and Asian children have resulted in significant excesses of serious adverse events including hospitalizations and deaths. Increased rates of malaria, respiratory infections, severe diarrhea and febrile illnesses of unknown origin have all been reported, but the mechanisms are unclear. We here investigated the ex vivo growth characteristics of exemplar sentinel bacteria in adult sera collected before and 4 h after oral supplementation with 2 mg/kg iron as ferrous sulfate. Escherichia coli, Yersinia enterocolitica and Salmonella enterica serovar Typhimurium (all gram-negative bacteria) and Staphylococcus epidermidis (gram-positive) showed markedly elevated growth in serum collected after iron supplementation. Growth rates were very strongly correlated with transferrin saturation (p < 0.0001 in all cases). Growth of Staphylococcus aureus, which preferentially scavenges heme iron, was unaffected. These data suggest that even modest oral supplements with highly soluble (non-physiological) iron, as typically used in low-income settings, could promote bacteremia by accelerating early phase bacterial growth prior to the induction of immune defenses.
C1 [Cross, James H.; Bradbury, Richard S.; Fulford, Anthony J.; Jallow, Amadou T.; Wegmueller, Rita; Prentice, Andrew M.] MRC Keneba, MRC Unit, Serrekunda, Gambia.
   [Bradbury, Richard S.] Cent Queensland Univ, Sch Med & Appl Sci, North Rockhampton, Qld, Australia.
   [Fulford, Anthony J.; Prentice, Andrew M.] Univ London London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1E 7HT, England.
   [Cerami, Carla] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.
RP Cerami, C (reprint author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.
EM ccerami@unc.edu
OI Cerami, Carla/0000-0002-7634-0955
FU UK Medical Research Council (MRC) [MCA760-5QX00]; UK Department for
   International Development (DFID) under MRC/DFID Concordat agreement;
   National Institutes of Health; National Institute of Child Health and
   Human Development [U01 HD061234 05S2]
FX The authors would like to acknowledge Bakary Darboe, Pierre Coulin,
   Karamo Camara, Ebrima Sise, Morgan Goheen, Daniel Gardner, Abdoulie Faal
   and all of the lab staff at the MRC-ING Keneba lab for their endless
   help, support and enthusiasm during this project. In addition, we would
   like to thank all of the blood donors who participated in the study.
   Funding: This work was supported by MCA760-5QX00 to the MRC
   International Nutrition Group by the UK Medical Research Council (MRC)
   and the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement, and by the National Institutes of Health
   and the National Institute of Child Health and Human Development (U01
   HD061234 05S2 to CC).
CR BARRY DMJ, 1977, PEDIATRICS, V60, P908
   Black MM, 2011, NUTR REV, V69, pS64, DOI 10.1111/j.1753-4887.2011.00435.x
   Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1
   BULLEN JJ, 1968, IMMUNOLOGY, V15, P581
   Dostal A, 2014, BRIT J NUTR, V112, P547, DOI 10.1017/S0007114514001160
   Dostal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093549
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Esan MO, 2013, CLIN INFECT DIS, V57, P1626, DOI 10.1093/cid/cit528
   Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720
   Jonker FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042670
   KOCHAN I, 1969, J INFECT DIS, V119, P11
   Kortman GAM, 2015, EUR J IMMUNOL, V45, P2553, DOI 10.1002/eji.201545642
   Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968
   Manno D, 2011, EUR J CLIN NUTR, V65, P1163, DOI 10.1038/ejcn.2011.103
   Miller JL, 2013, COLD SPRING HARB PER, V3
   MURRAY MJ, 1978, BRIT MED J, V2, P1113
   Nappi C, 2009, ACTA OBSTET GYN SCAN, V88, P1031, DOI 10.1080/00016340903117994
   Okebe JU, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub3
   Oppenheimer SJ, 2001, J NUTR, V131, p616S
   Pena-Rosas J, 2012, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858.CD004736.pub4, DOI 10.1002/14651858.CD004736.PUB4]
   Pereira DIA, 2014, NANOMED-NANOTECHNOL, V10, P1877, DOI 10.1016/j.nano.2014.06.012
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   [Report of a WHO scientific group Nutritional anaemias], 1968, WHO TECH REP SER, V405, P5
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Schumann K, 2012, ANN NUTR METAB, V60, P98, DOI 10.1159/000336177
   Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930
   Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7
   Spottiswoode N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00125
   Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125
   Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
   Zlotkin S, 2013, JAMA-J AM MED ASSOC, V310, P938, DOI 10.1001/jama.2013.277129
NR 32
TC 8
Z9 8
U1 2
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 23
PY 2015
VL 5
AR 16670
DI 10.1038/srep16670
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CW6CN
UT WOS:000365085200001
PM 26593732
OA gold
DA 2017-08-15
ER

PT J
AU Grietens, KP
   Gryseels, C
   Dierickx, S
   Bannister-Tyrrell, M
   Trienekens, S
   Uk, S
   Phoeuk, P
   Suon, S
   Set, S
   Gerrets, R
   Hoibak, S
   Ribera, JM
   Hausmann-Muela, S
   Tho, S
   Durnez, L
   Sluydts, V
   d'Alessandro, U
   Coosemans, M
   Erhart, A
AF Grietens, Koen Peeters
   Gryseels, Charlotte
   Dierickx, Susan
   Bannister-Tyrrell, Melanie
   Trienekens, Suzan
   Uk, Sambunny
   Phoeuk, Pisen
   Suon, Sokha
   Set, Srun
   Gerrets, Rene
   Hoibak, Sarah
   Ribera, Joan Muela
   Hausmann-Muela, Susanna
   Tho, Sochantha
   Durnez, Lies
   Sluydts, Vincent
   d'Alessandro, Umberto
   Coosemans, Marc
   Erhart, Annette
TI Characterizing Types of Human Mobility to Inform Differential and
   Targeted Malaria Elimination Strategies in Northeast Cambodia
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TRANSMISSION; TRIAL; EPIDEMIOLOGY; CHALLENGES; REPELLENT; MOVEMENT;
   VECTORS; AFRICA; IMPACT; FIELD
AB Human population movements currently challenge malaria elimination in low transmission foci in the Greater Mekong Subregion. Using a mixed-methods design, combining ethnography (n = 410 interviews), malariometric data (n = 4996) and population surveys (n = 824 indigenous populations; n = 704 Khmer migrants) malaria vulnerability among different types of mobile populations was researched in the remote province of Ratanakiri, Cambodia. Different structural types of human mobility were identified, showing differential risk and vulnerability. Among local indigenous populations, access to malaria testing and treatment through the VMW-system and LLIN coverage was high but control strategies failed to account for forest farmers' prolonged stays at forest farms/fields (61% during rainy season), increasing their exposure (p = 0.002). The Khmer migrants, with low acquired immunity, active on plantations and mines, represented a fundamentally different group not reached by LLIN-distribution campaigns since they were largely unregistered (79%) and unaware of the local VMW-system (95%) due to poor social integration. Khmer migrants therefore require control strategies including active detection, registration and immediate access to malaria prevention and control tools from which they are currently excluded. In conclusion, different types of mobility require different malaria elimination strategies. Targeting mobility without an in-depth understanding of malaria risk in each group challenges further progress towards elimination.
C1 [Grietens, Koen Peeters; Gryseels, Charlotte; Dierickx, Susan; Bannister-Tyrrell, Melanie; d'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan.
   [Grietens, Koen Peeters; Ribera, Joan Muela; Hausmann-Muela, Susanna] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.
   [Trienekens, Suzan; Durnez, Lies; Sluydts, Vincent; Coosemans, Marc; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Uk, Sambunny; Phoeuk, Pisen; Suon, Sokha; Set, Srun; Tho, Sochantha] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   [Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.
   [Hoibak, Sarah] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.
   [d'Alessandro, Umberto] MRC, Fajara, Gambia.
   [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
RP Grietens, KP (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
EM kpeeters@itg.be
FU Bill and Melinda Gates foundation [OPP1032354]; Institute of Tropical
   Medicine (ITM), Antwerp, Belgium; National Center for Parasitology,
   Entomology and Malaria Control (CNM), Phnom Penh, Cambodia
FX We are most grateful to all community members in the study region for
   their time and their confidence in our research. We also sincerely thank
   the staff of the provincial health department in Ratanakiri. This work
   was partly funded by the Bill and Melinda Gates foundation under the
   Global Health Grant number OPP1032354, and the Belgian Cooperation
   within the Framework Agreement III between the Institute of Tropical
   Medicine (ITM), Antwerp, Belgium and the National Center for
   Parasitology, Entomology and Malaria Control (CNM), Phnom Penh,
   Cambodia.
CR Bernard H. R., 2011, RES METHODS ANTHR QU
   Bousema T., 2012, PLOS MED, V9, DOI 10.1371/journal.pmed
   Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405
   Carpenter C. C., 1991, MALARIA OBSTACLES OP
   Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4
   Cui LW, 2012, ACTA TROP, V121, P240, DOI 10.1016/j.actatropica.2011.04.006
   Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016
   Deressa W., 2006, ETHIOPIAN J HLTH DEV, V20
   Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925
   Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329
   Erhart A, 2004, AM J TROP MED HYG, V70, P110
   Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991
   Xuan XN, 2010, MALARIA J, V9, P1
   Gryseels C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0689-0
   Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343
   Heggenhougen H., 2007, BEHAV SOCIAL ASPECTS
   Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55
   Hu Hong, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P191
   Hui L., 1997, SE ASIAN J TROP MED, V28, P456
   Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-146
   Kimani EW, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-63
   Martens P, 2000, EMERG INFECT DIS, V6, P103
   Muller GC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-210
   Pindolia DK, 2013, MALARIA J, V12, P12, DOI DOI 10.1186/1475-2875-12-397
   Pongvongsa T, 2012, VIETNAM MALAR J, V11, P262, DOI DOI 10.1186/1475-2875-11-262
   PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259
   PROTHERO RM, 1963, B WORLD HEALTH ORGAN, V28, P615
   Schelling E, 2007, EMERG INFECT DIS, V13, P373
   Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387
   Smith C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-307
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Syafruddin D, 2014, AM J TROP MED HYG, V91, P1079, DOI 10.4269/ajtmh.13-0735
   Teddlie C., 2009, FDN MIXED METHODS RE
   Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369
   Todrys KW, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-17
   Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   WESSEN AF, 1972, AM J TROP MED HYG, V21, P658
   Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446
NR 39
TC 6
Z9 6
U1 4
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 23
PY 2015
VL 5
AR 16837
DI 10.1038/srep16837
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CW6DP
UT WOS:000365088000001
OA gold
DA 2017-08-15
ER

PT J
AU Roca, A
   Oluwalana, C
   Camara, B
   Bojang, A
   Burr, S
   Davis, TME
   Bailey, R
   Kampmann, B
   Mueller, J
   Bottomley, C
   D'Alessandro, U
AF Roca, Anna
   Oluwalana, Claire
   Camara, Bully
   Bojang, Abdoulie
   Burr, Sarah
   Davis, Timothy M. E.
   Bailey, Robin
   Kampmann, Beate
   Mueller, Jenny
   Bottomley, Christian
   D'Alessandro, Umberto
TI Prevention of bacterial infections in the newborn by pre-delivery
   administration of azithromycin: Study protocol of a randomized efficacy
   trial
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Bacterial colonization; Neonatal sepsis; Azithromycin; Randomized
   clinical trial; Sub-Saharan Africa
ID PLACEBO-CONTROLLED TRIAL; STREPTOCOCCUS-PNEUMONIAE; RISK-FACTORS;
   CARRIAGE; TRACHOMA; INFANTS; TRANSMISSION; MORTALITY; CHILDREN; ADVERSE
AB Background: Neonatal deaths, estimated at approximately 4 million annually, now account for almost 40 % of global mortality in children aged under-five. Bacterial sepsis is a leading cause of neonatal mortality. Assuming the mother is the main source for bacterial transmission to newborns, the primary objective of the trial is to determine the impact of one oral dose of azithromycin, given to women in labour, on the newborn's bacterial carriage in the nasopharynx. Secondary objectives include the impact of the intervention on bacterial colonization in the baby and the mother during the first month of life.
   Methods/design: This is a Phase III, double -blind, placebo controlled randomized clinical trial in which 830 women in labour were randomized to either a single dose of 2 g oral azithromycin or placebo (ratio 1: 1). The trial included pregnant women in labour aged 18 to 45 years attending study health centres in the Western Gambia. A post-natal check of the mother and baby was conducted at the health centre by study clinicians before discharge and 8-10 days after delivery. Home follow up visits were conducted daily during the first week and then weekly until week 8 after delivery. Vaginal swabs and breast milk samples were collected from the mothers, and the pathogens Streptococcus pneumoniae, Group B Streptococcus (GBS) and Staphylococcus aureus were isolated from the study samples. For bacterial isolates, susceptibility pattern to azithromycin was determined using disk diffusion and E-test. Eye swabs were collected from newborns with eye discharge during the follow up period, and Chlamydial infection was assessed using molecular methods.
   Discussion: This is a proof-of-concept study to assess the impact of antibiotic preventive treatment of women during labour on bacterial infections in the newborn. If the trial confirms this hypothesis, the next step will be to assess the impact of this intervention on neonatal sepsis. The proposed intervention should be easily implementable in developing countries.
C1 [Roca, Anna; Oluwalana, Claire; Camara, Bully; Bojang, Abdoulie; Kampmann, Beate; Mueller, Jenny; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Roca, Anna; Burr, Sarah; Bailey, Robin; Bottomley, Christian; D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.
RP Roca, A (reprint author), MRC Unit, Fajara, Gambia.
EM aroca@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709
FU MRC UK; UK MRC; UK Department for International Development (DFID) under
   the MRC/DFID Concordat agreement [MR/J010391/1]
FX The MRC Unit in The Gambia receives core funding from the MRC UK. This
   trial is jointly funded by the UK MRC and the UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement
   (reference number MR/J010391/1).
CR Ballard HO, 2011, PEDIATR PULM, V46, P111, DOI 10.1002/ppul.21352
   Bottomley C, 2013, IMPACT CHIL IN PRESS
   Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168
   Burr SE, 2014, B WORLD HEALTH ORGAN, V92, P490, DOI 10.2471/BLT.13.133462
   Chang AB, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-94
   Chatzakis E, 2011, EUR J CLIN MICROBIOL, V30, P1111, DOI 10.1007/s10096-011-1199-9
   Chico RM, 2013, EXPERT REV ANTI-INFE, V11, P1303, DOI 10.1586/14787210.2013.851601
   DREW RH, 1992, PHARMACOTHERAPY, V12, P161
   Friedman DS, 2004, INFECT CONT HOSP EP, V25, P967, DOI 10.1086/502328
   Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414
   Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861
   Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kalilani L, 2007, PLOS ONE, V2, pe1166
   KELSEY JJ, 1994, AM J OBSTET GYNECOL, V170, P1375
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   Leach AJ, 1997, CLIN INFECT DIS, V24, P356
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264
   Neal AH, 1997, PEDIATRICS, V99, P489
   Nosten Francois, 2006, Curr Drug Saf, V1, P1, DOI 10.2174/157488606775252584
   O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI 10.1097/00006454-200302000-00009
   Onalo R, 2011, Niger Postgrad Med J, V18, P20
   Orton LC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004912.pub3
   Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266
   Roberts CH, 2013, J CLIN MICROBIOL, V51, P2195, DOI 10.1128/JCM.00622-13
   Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554
   Rudan Igor, 2011, J Glob Health, V1, P106
   Salman S, 2010, ANTIMICROB AGENTS CH, V54, P360, DOI 10.1128/AAC.00771-09
   Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056
   Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a
   Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0
   Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d
   SUARA RO, 1994, J INFECT DIS, V170, P1316
   Tramper-Stranders GA, 2007, J ANTIMICROB CHEMOTH, V60, P665, DOI 10.1093/jac/dkm235
   Waters Donald, 2011, J Glob Health, V1, P154
NR 36
TC 2
Z9 2
U1 1
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD NOV 19
PY 2015
VL 15
AR 302
DI 10.1186/s12884-015-0737-3
PG 13
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CW8QL
UT WOS:000365264200002
PM 26585192
OA gold
DA 2017-08-15
ER

PT J
AU Neafsey, DE
   Juraska, M
   Bedford, T
   Benkeser, D
   Valim, C
   Griggs, A
   Lievens, M
   Abdulla, S
   Adjei, S
   Agbenyega, T
   Agnandji, ST
   Aide, P
   Anderson, S
   Ansong, D
   Aponte, JJ
   Asante, KP
   Bejon, P
   Birkett, AJ
   Bruls, M
   Connolly, KM
   D'Alessandro, U
   Dobano, C
   Gesase, S
   Greenwood, B
   Grimsby, J
   Tinto, H
   Hamel, MJ
   Hoffman, I
   Kamthunzi, P
   Kariuki, S
   Kremsner, PG
   Leach, A
   Lell, B
   Lennon, NJ
   Lusingu, J
   Marsh, K
   Martinson, F
   Molel, JT
   Moss, EL
   Njuguna, P
   Ockenhouse, CF
   Ogutu, BR
   Otieno, W
   Otieno, L
   Otieno, K
   Owusu-Agyei, S
   Park, DJ
   Pelle, K
   Robbins, D
   Russ, C
   Ryan, EM
   Sacarlal, J
   Sogoloff, B
   Sorgho, H
   Tanner, M
   Theander, T
   Valea, I
   Volkman, SK
   Yu, Q
   Lapierre, D
   Birren, BW
   Gilbert, PB
   Wirth, DF
AF Neafsey, D. E.
   Juraska, M.
   Bedford, T.
   Benkeser, D.
   Valim, C.
   Griggs, A.
   Lievens, M.
   Abdulla, S.
   Adjei, S.
   Agbenyega, T.
   Agnandji, S. T.
   Aide, P.
   Anderson, S.
   Ansong, D.
   Aponte, J. J.
   Asante, K. P.
   Bejon, P.
   Birkett, A. J.
   Bruls, M.
   Connolly, K. M.
   D'Alessandro, U.
   Dobano, C.
   Gesase, S.
   Greenwood, B.
   Grimsby, J.
   Tinto, H.
   Hamel, M. J.
   Hoffman, I.
   Kamthunzi, P.
   Kariuki, S.
   Kremsner, P. G.
   Leach, A.
   Lell, B.
   Lennon, N. J.
   Lusingu, J.
   Marsh, K.
   Martinson, F.
   Molel, J. T.
   Moss, E. L.
   Njuguna, P.
   Ockenhouse, C. F.
   Ogutu, B. Ragama
   Otieno, W.
   Otieno, L.
   Otieno, K.
   Owusu-Agyei, S.
   Park, D. J.
   Pelle, K.
   Robbins, D.
   Russ, C.
   Ryan, E. M.
   Sacarlal, J.
   Sogoloff, B.
   Sorgho, H.
   Tanner, M.
   Theander, T.
   Valea, I.
   Volkman, S. K.
   Yu, Q.
   Lapierre, D.
   Birren, B. W.
   Gilbert, P. B.
   Wirth, D. F.
TI Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria
   Vaccine
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID FALCIPARUM CIRCUMSPOROZOITE PROTEIN; PLASMODIUM-FALCIPARUM; AFRICAN
   CHILDREN; EXPANDED-PROGRAM; COMPETING RISKS; PHASE-3 TRIAL; ENDEMIC
   AREA; DOUBLE-BLIND; SAFETY; INFECTION
AB BACKGROUND
   The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium falciparum and has partial protective efficacy against clinical and severe malaria disease in infants and children. We investigated whether the vaccine efficacy was specific to certain parasite genotypes at the circumsporozoite protein locus.
   METHODS
   We used polymerase chain reaction-based next-generation sequencing of DNA extracted from samples from 4985 participants to survey circumsporozoite protein polymorphisms. We evaluated the effect that polymorphic positions and haplotypic regions within the circumsporozoite protein had on vaccine efficacy against first episodes of clinical malaria within 1 year after vaccination.
   RESULTS
   In the per-protocol group of 4577 RTS, S/AS01-vaccinated participants and 2335 control-vaccinated participants who were 5 to 17 months of age, the 1-year cumulative vaccine efficacy was 50.3% (95% confidence interval [CI], 34.6 to 62.3) against clinical malaria in which parasites matched the vaccine in the entire circumsporozoite protein C-terminal (139 infections), as compared with 33.4% (95% CI, 29.3 to 37.2) against mismatched malaria (1951 infections) (P = 0.04 for differential vaccine efficacy). The vaccine efficacy based on the hazard ratio was 62.7% (95% CI, 51.6 to 71.3) against matched infections versus 54.2% (95% CI, 49.9 to 58.1) against mismatched infections (P = 0.06). In the group of infants 6 to 12 weeks of age, there was no evidence of differential allele-specific vaccine efficacy.
   CONCLUSIONS
   These results suggest that among children 5 to 17 months of age, the RTS, S vaccine has greater activity against malaria parasites with the matched circumsporozoite protein allele than against mismatched malaria. The overall vaccine efficacy in this age category will depend on the proportion of matched alleles in the local parasite population; in this trial, less than 10% of parasites had matched alleles. (Funded by the National Institutes of Health and others.)
C1 [Neafsey, D. E.; Valim, C.; Griggs, A.; Anderson, S.; Connolly, K. M.; Grimsby, J.; Lennon, N. J.; Moss, E. L.; Park, D. J.; Pelle, K.; Robbins, D.; Russ, C.; Ryan, E. M.; Sogoloff, B.; Volkman, S. K.; Yu, Q.; Birren, B. W.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA.
   [Valim, C.; Pelle, K.; Volkman, S. K.; Wirth, D. F.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Volkman, S. K.] Simmons Coll Sch Nursing & Hlth Sci, Boston, MA USA.
   [Juraska, M.; Bedford, T.; Benkeser, D.; Valim, C.; Gilbert, P. B.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA.
   [Benkeser, D.; Gilbert, P. B.] Univ Washington, Seattle, WA 98195 USA.
   [Lievens, M.; Bruls, M.; Leach, A.; Lapierre, D.] GlaxoSmithKline Vaccines, Rixensart, Belgium.
   [Abdulla, S.; Molel, J. T.] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Gesase, S.; Lusingu, J.] Natl Inst Med Res, Korogwe, Tanzania.
   [Adjei, S.; Agbenyega, T.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana.
   [Asante, K. P.; Greenwood, B.; Owusu-Agyei, S.] Kintampo Hlth Res Ctr, Kintampo, Ghana.
   [Agnandji, S. T.; Ansong, D.; Kremsner, P. G.; Lell, B.] Albert Schweitzer Hosp, Lambarene, Gabon.
   [Agnandji, S. T.; Kremsner, P. G.; Lell, B.] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Aide, P.; Aponte, J. J.; Dobano, C.; Sacarlal, J.] Ctr Invest Saude Manhica, Manhica, Mozambique.
   [Aide, P.; Aponte, J. J.; Dobano, C.] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain.
   [Birkett, A. J.; Ockenhouse, C. F.] PATH Malaria Vaccine Initiat, Washington, DC USA.
   [D'Alessandro, U.] MRC Unit, Banjul, Gambia.
   [Greenwood, B.] London Sch Hyg & Trop Med, London, England.
   [Tinto, H.; Sorgho, H.; Valea, I.] Inst Rech Sci Sante, Nanoro, Burkina Faso.
   [Hamel, M. J.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA.
   [Hoffman, I.] Univ N Carolina, Chapel Hill, NC USA.
   [Kamthunzi, P.; Martinson, F.] UNC Project, Lilongwe, Malawi.
   [Bejon, P.; Marsh, K.; Njuguna, P.] Kenya Med Res Inst KEMRI, Wellcome Trust Res Program, Kilifi, Kenya.
   [Kariuki, S.; Otieno, K.] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya.
   [Ogutu, B. Ragama; Otieno, W.; Otieno, L.; Pelle, K.] KEMRI Walter Reed Project, Kombewa, Kenya.
   [Tanner, M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Theander, T.] Univ Copenhagen, Copenhagen, Denmark.
RP Wirth, DF (reprint author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.
EM pgilbert@fredhutch.org; dfwirth@hsph.harvard.edu
RI Dobano, Carlota/N-4119-2014; Theander, Thor/F-6714-2015
OI Dobano, Carlota/0000-0002-6751-4060; Theander, Thor/0000-0002-3509-7514;
   ANSONG, Daniel/0000-0003-1328-9117
FU National Institutes of Health
FX Funded by the National Institutes of Health and others.
CR Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773
   Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190
   Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287
   Aide P, 2011, VACCINE, V29, P6059, DOI 10.1016/j.vaccine.2011.03.041
   Alloueche A, 2003, AM J TROP MED HYG, V68, P97
   Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1
   Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6
   Aragam NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062427
   Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1
   Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329
   Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   CALLE JMC, 1992, J IMMUNOL, V149, P2695
   Campo JJ, 2015, MOL CELL PROTEOMICS, V14, P519, DOI 10.1074/mcp.M114.044677
   Edlefsen PT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003973
   Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005
   ESPOSITO F, 1988, T ROY SOC TROP MED H, V82, P827, DOI 10.1016/0035-9203(88)90007-7
   Follmann D, 2003, BIOMETRICS, V59, P420, DOI 10.1111/1541-0420.00049
   Gandhi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101783
   Gandhi K, 2012, AM J TROP MED HYG, V86, P775, DOI 10.4269/ajtmh.2012.11-0478
   Gilbert PB, 2000, STAT MED, V19, P3065
   GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199
   Hall BF, 2009, J INFECT DIS, V200, P1639, DOI 10.1086/646611
   HOLM S, 1979, SCAND J STAT, V6, P65
   Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120
   Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074
   LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613
   Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009
   RTS, 2015, LANCET, V386, P31, DOI DOI 10.1016/S0140-6736(15)60721-8
   [Anonymous], 2014, PLOS MED, V11
   Sun PF, 2003, J IMMUNOL, V171, P6961
   Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093
   Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115
   van der Laan M, 2007, INT J BIOSTAT, V3, DOI DOI 10.2202/1557-4679.1022
   Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849
   Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
NR 39
TC 38
Z9 38
U1 4
U2 17
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD NOV 19
PY 2015
VL 373
IS 21
BP 2025
EP 2037
DI 10.1056/NEJMoa1505819
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA CW4JN
UT WOS:000364957700008
PM 26488565
OA No
DA 2017-08-15
ER

PT J
AU Basta, NE
   Borrow, R
   Berthe, A
   Onwuchekwa, U
   Dembele, ATE
   Almond, R
   Frankland, S
   Patel, S
   Wood, D
   Nascimento, M
   Manigart, O
   Trotter, CL
   Greenwood, B
   Sow, SO
AF Basta, Nicole E.
   Borrow, Ray
   Berthe, Abdoulaye
   Onwuchekwa, Uma
   Dembele, Awa Traore Eps
   Almond, Rachael
   Frankland, Sarah
   Patel, Sima
   Wood, Daniel
   Nascimento, Maria
   Manigart, Olivier
   Trotter, Caroline L.
   Greenwood, Brian
   Sow, Samba O.
TI Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE meningococcal vaccines; tetanus; conjugate; seroprevalence; Africa
ID MENINGOCOCCAL CONJUGATE VACCINE; MENINGITIS; CARRIAGE
AB Background. In 2010, mass vaccination with a then-new meningococcal A polysaccharide-tetanus toxoid protein conjugate vaccine (PsA-TT, or MenAfriVac) was undertaken in 1-to 29-year-olds in Bamako, Mali. Whether vaccination with PsA-TT effectively boosts tetanus immunity in a population with heterogeneous baseline tetanus immunity is not known. We assessed the impact of PsA-TT on tetanus toxoid (TT) immunity by quantifying ageand sex-specific immunity prior to and 2 years after introduction.
   Methods. Using a household-based, age-stratified design, we randomly selected participants for a prevaccination serological survey in 2010 and a postvaccination survey in 2012. TT immunoglobulin G (IgG) antibodies were quantified and geometric mean concentrations (GMCs) pre- and postvaccination among all age groups targeted for vaccination were compared. The probability of TT IgG levels a parts per thousand yen0.1 IU/mL (indicating short-term protection) and a parts per thousand yen1.0 IU/mL (indicating long-term protection) by age and sex was determined using logistic regression models.
   Results. Analysis of 793 prevaccination and 800 postvaccination sera indicated that while GMCs were low pre-PsA-TT, significantly higher GMCs in all age-sex strata were observed 2 years after PsA-TT introduction. The percentage with short-term immunity increased from 57.1% to 88.4% (31.3-point increase; 95% confidence interval [CI], 26.6-36.0;, P < .0001) and with long-term immunity increased from 20.0% to 58.5% (38.5-point increase; 95% CI, 33.7-43.3; P < .0001) pre- and postvaccination.
   Conclusions. Significantly higher TT immunity was observed among vaccine-targeted age groups up to 2 years after Mali's PsA-TT mass vaccination campaign. Our results, combined with evidence from clinical trials, strongly suggest that conjugate vaccines containing TT such as PsA-TT should be considered bivalent vaccines because of their ability to boost tetanus immunity.
C1 [Basta, Nicole E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.
   [Basta, Nicole E.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Borrow, Ray; Almond, Rachael; Frankland, Sarah; Patel, Sima; Wood, Daniel] Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England.
   [Berthe, Abdoulaye; Onwuchekwa, Uma; Dembele, Awa Traore Eps; Sow, Samba O.] Minist Sante, Ctr Dev Vaccins, Bamako, Mali.
   [Nascimento, Maria; Manigart, Olivier; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Manigart, Olivier] MRC Unit, Fajara, Gambia.
   [Trotter, Caroline L.] Univ Cambridge, Dis Dynam Unit, Dept Vet Med, Cambridge CB2 1TN, England.
RP Basta, NE (reprint author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, West Bank Off Bldg,1300 S 2nd St,Ste 300, Minneapolis, MN 55454 USA.
EM nebasta@umn.edu
OI Trotter, Caroline/0000-0003-4000-2708
FU US National Institutes of Health Early Independence Award from the
   Office of the Director and the National Institute of Dental and
   Craniofacial Research [1DP5OD009162]; RAPIDD program of the Science and
   Technology Directorate of the Department of Homeland Security and the
   Fogarty International Center; Bill & Melinda Gates Foundation [51251];
   Wellcome Trust [086546]
FX This work was supported by the US National Institutes of Health Early
   Independence Award from the Office of the Director and the National
   Institute of Dental and Craniofacial Research (1DP5OD009162 to N. E.
   B.); the RAPIDD program of the Science and Technology Directorate of the
   Department of Homeland Security and the Fogarty International Center (to
   N. E. B.); the Bill & Melinda Gates Foundation (51251 to B. G.); and the
   Wellcome Trust (086546 to B. G.). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of funding agencies.
CR Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125
   Basta NE, 2015, CLIN INFECT DIS, V61, pS547, DOI 10.1093/cid/civ602
   Borrow R, 2007, MODULE 3 TETANUS UPD
   Borrow R, 2015, CLIN INFECT DIS, V61, pS570, DOI 10.1093/cid/civ512
   Centers for Disease Control and Prevention (CDC, 2013, MMWR-MORBID MORTAL W, V62, P858
   Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8
   Frasch CE, 2012, HUM VACC IMMUNOTHER, V8, P715, DOI 10.4161/hv.19619
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Maiden MCJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0147
   Organisation mondiale de la sante, 2011, PROGR EL VACC EV CAM
   Owusu-Darko S, 2012, REV OBSTET GYNECOL, V5, P151
   Pichichero ME, 2013, HUM VACC IMMUNOTHER, V9, P2505, DOI 10.4161/hv.26109
   Pickering JW, 2002, CLIN DIAGN LAB IMMUN, V9, P872, DOI 10.1128/CDLI.9.4.872-876.2002
   Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Strategic Advisory Group of Experts on Immunization World Health Organization, 2014, 2014 ASS REP GLOB VA
   United Nation's Children's Fund, EL MAT NEON TET
   [Anonymous], SUMM WHO POS PAP REC
   World Health Organization, MALI WHO UNICEF EST
   World Health Organization, IMM VACC BIOL DAT ST
   World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P198
NR 21
TC 4
Z9 4
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2015
VL 61
SU 5
BP S578
EP S585
DI 10.1093/cid/civ513
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW7FF
UT WOS:000365162700029
PM 26553691
OA No
DA 2017-08-15
ER

PT J
AU Diallo, A
   Sow, SO
   Idoko, OT
   Hirve, S
   Findlow, H
   Preziosi, MP
   Elie, C
   Kulkarni, PS
   Parulekar, V
   Diarra, B
   Haidara, FC
   Diallo, F
   Tapia, M
   Akinsola, AK
   Adegbola, RA
   Bavdekar, A
   Juvekar, S
   Chaumont, J
   Martellet, L
   Marchetti, E
   LaForce, MF
   Plikaytis, BD
   Enwere, GC
   Tang, YX
   Borrow, R
   Carlone, G
   Viviani, S
AF Diallo, Aldiouma
   Sow, Samba O.
   Idoko, Olubukola T.
   Hirve, Siddhivinayak
   Findlow, Helen
   Preziosi, Marie-Pierre
   Elie, Cheryl
   Kulkarni, Prasad S.
   Parulekar, Varsha
   Diarra, Bou
   Haidara, Fadima Cheick
   Diallo, Fatoumata
   Tapia, Milagritos
   Akinsola, Adebayo K.
   Adegbola, Richard A.
   Bavdekar, Ashish
   Juvekar, Sanjay
   Chaumont, Julie
   Martellet, Lionel
   Marchetti, Elisa
   LaForce, Marc F.
   Plikaytis, Brian D.
   Enwere, Godwin C.
   Tang, Yuxiao
   Borrow, Ray
   Carlone, George
   Viviani, Simonetta
TI Antibody Persistence at 1 and 4 Years Following a Single Dose of
   MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects
   Aged 2-29 Years
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE MenA conjugate vaccine; antibody persistence; African meningitis belt;
   India
ID MENINGOCOCCAL CONJUGATE VACCINE; A CAPSULAR POLYSACCHARIDE;
   NEISSERIA-MENINGITIDIS; EPIDEMIC MENINGITIS; AFRICA; IMMUNOGENICITY;
   SAFETY; SEROGROUP; PROJECT
AB Background. Mass vaccination campaigns of the population aged 1-29 years with 1 dose of group A meningococcal (MenA) conjugate vaccine (PsA-TT, MenAfriVac) in African meningitis belt countries has resulted in the near-disappearance of MenA. The vaccine was tested in clinical trials in Africa and in India and found to be safe and highly immunogenic compared with the group A component of the licensed quadrivalent polysaccharide vaccine (PsACWY). Antibody persistence in Africa and in India was investigated.
   Methods. A total of 900 subjects aged 2-29 years were followed up for 4 years in Senegal, Mali, and The Gambia (study A). A total of 340 subjects aged 2-10 years were followed up for 1 year in India (study B). In study A, subjects were randomized in a 2:1 ratio, and in study B a 1:1 ratio to receive either PsA-TT or PsACWY. Immunogenicity was evaluated by measuring MenA serum bactericidal antibody (SBA) with rabbit complement and by a group A-specific immunoglobulin G (IgG) enzyme-linked immunosorbent assay.
   Results. In both studies, substantial SBA decay was observed at 6 months postvaccination in both vaccine groups, although more marked in the PsACWY group. At 1 year and 4 years (only for study A) postvaccination, SBA titers were relatively sustained in the PsA-TT group, whereas a slight increasing trend, more pronounced among the youngest, was observed in the participants aged < 18 years in the PsACWY groups. The SBA titers were significantly higher in the PsA-TT group than in the PsACWY group at any time point, and the majority of subjects in the PsA-TT group had SBA titers a parts per thousand yen128 and group A-specific IgG concentrations a parts per thousand yen2 A mu g/mL at any point in time in both the African and Indian study populations.
   Conclusions. Four years after vaccination with a single dose of PsA-TT vaccine in Africa, most subjects are considered protected from MenA disease.
   Clinical Trials Registration. PsA-TT-003 (ISRCTN87739946); PsA-TT-003a (ISRCTN46335400).
C1 [Diallo, Aldiouma; Diarra, Bou] Inst Rech Dev, Niakhar, Senegal.
   [Sow, Samba O.; Haidara, Fadima Cheick; Diallo, Fatoumata] Minist Sante, Ctr Dev Vaccins, Bamako, Mali.
   [Idoko, Olubukola T.; Akinsola, Adebayo K.] MRC Labs, Basse, Gambia.
   [Hirve, Siddhivinayak; Bavdekar, Ashish; Juvekar, Sanjay] Shirdi Sai Baba Hosp, Vadu King Edward Mem Hosp & Res Ctr, Pune, Maharashtra, India.
   [Findlow, Helen; Borrow, Ray] Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England.
   [Preziosi, Marie-Pierre; Chaumont, Julie; Martellet, Lionel; Marchetti, Elisa; LaForce, Marc F.; Enwere, Godwin C.; Viviani, Simonetta] PATH, Meningitis Vaccine Project, Ferney Voltaire, France.
   [Preziosi, Marie-Pierre] WHO, Meningitis Vaccine Project, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.
   [Elie, Cheryl; Plikaytis, Brian D.; Carlone, George] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Kulkarni, Prasad S.; LaForce, Marc F.] Serum Inst India Ltd, Pune, Maharashtra, India.
   [Parulekar, Varsha] DiagnoSearch Life Sci, Bombay, Maharashtra, India.
   [Tapia, Milagritos] Univ Maryland, Sch Med, Dept Pediat, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium.
   [Tang, Yuxiao] PATH, Meningitis Vaccine Project, Seattle, WA USA.
   [Adegbola, Richard A.] MRC, Serrekunda, Gambia.
RP Viviani, S (reprint author), Via Gramsci,12 Loc Strove, I-53035 Siena, Italy.
EM sviviani@hotmail.com
FU Meningitis Vaccine Project (PATH) from Bill & Melinda Gates Foundation
   (BMGF)
FX These studies were funded by the Meningitis Vaccine Project (PATH)
   through a grant from the Bill & Melinda Gates Foundation (BMGF).
CR Altmann D, 2013, VACCINE, V31, P1453
   Balmer Paul, 2004, Expert Rev Vaccines, V3, P77, DOI 10.1586/14760584.3.1.77
   Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051
   CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154
   Daugla DM, 2014, LANCET, V383, P30
   Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073
   Frasch CE, 2012, HUM VACC IMMUNOTHER, V8, P715, DOI 10.4161/hv.19619
   Greenwood B, 2006, TROP MED INT HEALTH, V11, P773, DOI 10.1111/j.1365-3156.2006.01639.x
   GUIRGUIS N, 1985, J EXP MED, V162, P1837, DOI 10.1084/jem.162.6.1837
   Hirve S, 2012, VACCINE, V30, P6456, DOI 10.1016/j.vaccine.2012.08.004
   Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0
   Kristiansen PA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0663-4
   Kshirsagar N, 2007, VACCINE, V25, pA101, DOI 10.1016/j.vaccine.2007.04.050
   LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049
   LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062
   Lapeyssonnie L., 1963, B WHO              S, V28, P3
   MAKELA PH, 1975, LANCET, V2, P883
   Marchetti E, 2012, VACCINE, V30, P6859, DOI 10.1016/j.vaccine.2012.09.008
   Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156
   Meningitis Vaccine Project, WORLD MEN
   PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302
   ROBBINS JB, 1972, INFECT IMMUN, V6, P651
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   VANN WF, 1976, INFECT IMMUN, V13, P1654
   World Health Organization, MEN
NR 25
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2015
VL 61
SU 5
BP S521
EP S530
DI 10.1093/cid/civ518
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW7FF
UT WOS:000365162700022
PM 26553684
OA No
DA 2017-08-15
ER

PT J
AU Holme, D
   Findlow, H
   Sow, SO
   Idoko, OT
   Preziosi, MP
   Carlone, G
   Plikaytis, BD
   Borrow, R
AF Holme, Daniel
   Findlow, Helen
   Sow, Samba O.
   Idoko, Olubukola T.
   Preziosi, Marie-Pierre
   Carlone, George
   Plikaytis, Brian D.
   Borrow, Ray
TI Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in
   African Children Aged 12-23 Months Following Meningococcal Vaccination
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE meningococcal; vaccination; IgG subclass; Neisseria meningitidis
ID C CONJUGATE VACCINATION; MEMORY B-CELLS; IMMUNOGLOBULIN-G IGG;
   SEROGROUP-C; POLYSACCHARIDE VACCINE; IMMUNOLOGICAL HYPORESPONSIVENESS;
   PNEUMOCOCCAL CONJUGATE; ANTIBODY PERSISTENCE; UNITED-KINGDOM;
   YOUNG-CHILDREN
AB Background. A group A meningococcal conjugate vaccine, PsA-TT, was licensed in 2010 and was previously studied in a phase 2 clinical trial to evaluate its safety and immunogenicity in African children 12-23 months of age.
   Methods. Subjects received either PsA-TT; meningococcal group A, C, W, Y polysaccharide vaccine (PsACWY); or Haemophilus influenzae type b conjugate vaccine (Hib-TT). Forty weeks following primary vaccination, the 3 groups were further randomized to receive either PsA-TT, one-fifth dose of PsACWY, or Hib-TT. Group A-specific immunoglobulin G (IgG) subclass response was characterized using an enzyme-linked immunosorbent assay.
   Results. The predominant IgG subclass response, regardless of vaccine, was IgG1. One month following primary vaccination, the geometric mean concentrations (GMCs) of IgG1 and IgG2 in the PsA-TT group were 21.73 A mu g/mL and 6.27 A mu g/mL, whereas in the PsACWY group the mean GMCs were 2.01 A mu g/mL and 0.97 A mu g/mL, respectively (P < .0001). Group A-specific IgG1 and IgG2 GMCs remained greater in the PsA-TT group than in the PsACWY group 40 weeks following primary vaccination (P < .0001). One week following revaccination, those given 2 doses of PsA-TT had the greatest IgG1 and IgG2 GMCs of 125.23 A mu g/mL and 36.12 A mu g/mL, respectively (P = .0008), and demonstrated a significant increase in IgG1:IgG2 mean ratio, indicative of the T-cell-dependent response associated with conjugate vaccines.
   Conclusions. Vaccination of African children aged 12-24 months with either PsA-TT or PsACWY elicited a predominantly IgG1 response. The IgG1:IgG2 mean ratio decreased following successive vaccination with PsACWY, indicating a shift toward IgG2, suggestive of the T-cell-independent immune response commonly associated with polysaccharide antigens.
   Clinical Trials Registration. SRCTN78147026.
C1 [Holme, Daniel; Findlow, Helen; Borrow, Ray] Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester M13 9WZ, Lancs, England.
   [Sow, Samba O.] Minist Sante, Ctr Dev Vaccins, Bamako, Mali.
   [Idoko, Olubukola T.] MRC Unit, Basse, Gambia.
   [Preziosi, Marie-Pierre] PATH, Meningitis Vaccine Project, Ferney Voltaire, France.
   [Preziosi, Marie-Pierre] WHO, Meningitis Vaccine Project, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.
   [Carlone, George; Plikaytis, Brian D.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Findlow, H (reprint author), Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester Med Microbiol Partnership, POB 209,Clin Sci Bldg, Manchester M13 9WZ, Lancs, England.
EM helen.findlow@phe.gov.uk
FU Meningitis Vaccine Project; World Health Organization; Bill & Melinda
   Gates Foundation
FX This work was funded by the Meningitis Vaccine Project, a partnership
   between PATH and the World Health Organization
   (http://www.meningvax.org/), supported by a grant from the Bill &
   Melinda Gates Foundation.
CR ARTENSTEIN MS, 1971, B WORLD HEALTH ORGAN, V45, P291
   Baxendale HE, 2010, VACCINE, V28, P4763, DOI 10.1016/j.vaccine.2010.04.103
   Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324
   Borrow R, 2001, J INFECT DIS, V184, P377, DOI 10.1086/322024
   Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001
   Borrow R, 2006, EXPERT REV VACCINES, V5, P851, DOI 10.1586/14760584.5.6.851
   Borrow R, 2011, EXPERT REV VACCINES, V10, P1621, DOI [10.1586/erv.11.142, 10.1586/ERV.11.142]
   BREDIUS RGM, 1992, INFECT IMMUN, V60, P4838
   de Voer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023497
   de Voer RM, 2009, VACCINE, V27, P6974, DOI 10.1016/j.vaccine.2009.09.082
   Findlow H, 2006, CLIN VACCINE IMMUNOL, V13, P507, DOI 10.1128/CVI.13.4.507-510.2006
   Findlow H, 2004, THESIS, P231
   Findlow H, 2011, CLIN VACCINE IMMUNOL, V18, P1492, DOI 10.1128/CVI.05020-11
   GOLD R, 1975, J CLIN INVEST, V56, P1536, DOI 10.1172/JCI108235
   Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2
   Hutchins WA, 1999, J INFECT DIS, V179, P1433, DOI 10.1086/314750
   Joseph H, 2004, CLIN DIAGN LAB IMMUN, V11, P1, DOI 10.1128/CDLI.11.1.1-5.2004
   Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282
   Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907
   Kshirsagar N, 2007, VACCINE, V25, pA101, DOI 10.1016/j.vaccine.2007.04.050
   LaForce FM, 2012, HLTH AFF, V30, P1049
   Lakshman R, 2002, VACCINE, V20, P3778, DOI 10.1016/S0264-410X(02)00318-3
   LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1
   Lottenbach KR, 1999, INFECT IMMUN, V67, P4935
   MacLennan J, 1999, VACCINE, V17, P3086, DOI 10.1016/S0264-410X(99)00139-5
   MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279
   OBrien KL, 1996, PEDIATR INFECT DIS J, V15, P425, DOI 10.1097/00006454-199605000-00009
   OXELIUS VA, 1979, ACTA PAEDIATR SCAND, V68, P23, DOI 10.1111/j.1651-2227.1979.tb04424.x
   Richmond P, 2000, J INFECT DIS, V181, P761, DOI 10.1086/315284
   Rijkers G, 1998, VACCINE, V16, P1396, DOI 10.1016/S0264-410X(98)00098-X
   SANDERS LAM, 1995, INFECT IMMUN, V63, P73
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   TWUMASI PA, 1995, J INFECT DIS, V171, P632
   Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346
   Wuorimaa T, 2001, J INFECT DIS, V184, P1211, DOI 10.1086/323648
NR 35
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2015
VL 61
SU 5
BP S563
EP S569
DI 10.1093/cid/civ505
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW7FF
UT WOS:000365162700027
PM 26553689
OA No
DA 2017-08-15
ER

PT J
AU Idoko, OT
   Diallo, A
   Sow, SO
   Hodgson, A
   Akinsola, A
   Diarra, B
   Haidara, FC
   Ansah, PO
   Kampmann, B
   Bouma, E
   Preziosi, MP
   Enwere, GC
AF Idoko, Olubukola T.
   Diallo, Aldiouma
   Sow, Samba O.
   Hodgson, Abraham
   Akinsola, Adebayo
   Diarra, Bou
   Haidara, Fadima Cheick
   Ansah, Patrick Odum
   Kampmann, Beate
   Bouma, Enricke
   Preziosi, Marie-Pierre
   Enwere, Godwin C.
TI Community Perspectives Associated With the African PsA-TT (MenAfriVac)
   Vaccine Trials
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE community perspective; Africa; MenAfriVac; vaccine trial
ID INFORMED-CONSENT
AB Background. The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub-Saharan Africa and, to that end, worked to develop a group A meningococcal conjugate vaccine, PsA-TT.
   Methods. Experiences in 4 clinical trial sites are described. Culturally sensitive collaborative strategies were adopted to manage acceptable communication methods, peculiarities with the consent process, participant medical issues, community care, and death.
   Results. The clinical trials were completed successfully through community acceptance and active community collaboration. The trials also strengthened the capacities in the participating communities, and actively worked to resolve community problems.
   Conclusions. The understanding and integration of sociocultural realities of communities were major assets in the conduct and acceptance of these trials. MVP succeeded in these sites and provided a sound example for future clinical studies in Africa.
   Clinical Trials Registration. ISRTCN78147026 (PsA-TT 002); ISRCTN87739946 (PsA-TT 003); ISRCTN82484612 (PsA-TT 004); PACTR ATMR2010030001913177 (PsA-TT 006); and PACTR201110000328305 (PsA-TT 007).
C1 [Idoko, Olubukola T.; Akinsola, Adebayo; Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Basse, Gambia.
   [Diallo, Aldiouma; Diarra, Bou] Inst Rech Dev, Niakhar, Senegal.
   [Sow, Samba O.; Haidara, Fadima Cheick] Minist Sante, Ctr Dev Vaccins, Bamako, Mali.
   [Hodgson, Abraham; Ansah, Patrick Odum] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Bouma, Enricke; Preziosi, Marie-Pierre; Enwere, Godwin C.] PATH, Meningitis Vaccine Project, Ferney Voltaire, France.
   [Preziosi, Marie-Pierre] WHO, Dept Immunizat Vaccines & Biol, Meningitis Vaccine Project, CH-1211 Geneva, Switzerland.
RP Idoko, OT (reprint author), MRC Unit, Vaccines & Immun Theme, Basse, Gambia.
EM oidoko@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709
FU Meningitis Vaccine Project from Bill & Melinda Gates Foundation
FX This article appears as part of the supplement "The Meningitis Vaccine
   Project: The Development, Licensure, Introduction, and Impact of a New
   Group A Meningococcal Conjugate Vaccine for Africa," sponsored by the
   Meningitis Vaccine Project through a grant from the Bill & Melinda Gates
   Foundation.
CR Berlier M, 2015, CLIN INFECT DIS, V61, pS451, DOI 10.1093/cid/civ493
   Diallo A, 2003, J INT BIOETHIQUE, V14
   Diallo A, 2015, CLIN INFECT DIS, V61, pS521, DOI 10.1093/cid/civ518
   Enquete Demographique et de Sante du Mali (EDSM-V), 2012, RAPP PREL MORT INF J, V32
   Enwere GC, 2015, CLIN INFECT DIS, V61, pS501, DOI 10.1093/cid/civ509
   International Conference on Harmonisation (ICH), 1996, EFF GUID GOOD CLIN P
   Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Killawi A, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-9
   Martellet L, 2015, CLIN INFECT DIS, V61, pS422, DOI 10.1093/cid/civ598
   Novac A, 2014, PRIM CARE COMPANION, P16
   Nunez-Wallace KR, 2010, INTELLECT DEV DISAB, V48, P175, DOI 10.1352/1944-7558-48.3.175
   Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   Tapia MD, 2015, CLIN INFECT DIS, V61, pS514, DOI 10.1093/cid/civ672
   Tapia MD, 2015, CLIN INFECT DIS, V61, pS507, DOI 10.1093/cid/civ626
NR 16
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2015
VL 61
SU 5
BP S416
EP S421
DI 10.1093/cid/civ596
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW7FF
UT WOS:000365162700007
PM 26553669
OA No
DA 2017-08-15
ER

PT J
AU Martellet, L
   Sow, SO
   Diallo, A
   Hodgson, A
   Kampmann, B
   Hirve, S
   Tapia, M
   Haidara, FC
   Ndiaye, A
   Diarra, B
   Ansah, PO
   Akinsola, A
   Idoko, OT
   Adegbola, RA
   Bavdekar, A
   Juvekar, S
   Viviani, S
   Enwere, GC
   Marchetti, E
   Chaumont, J
   Makadi, MF
   Pallardy, F
   Kulkarni, PS
   Preziosi, MP
   LaForce, FM
AF Martellet, Lionel
   Sow, Samba O.
   Diallo, Aldiouma
   Hodgson, Abraham
   Kampmann, Beate
   Hirve, Siddhivinayak
   Tapia, Milagritos
   Haidara, Fadima Cheick
   Ndiaye, Assane
   Diarra, Bou
   Ansah, Patrick Odum
   Akinsola, Adebayo
   Idoko, Olubukola T.
   Adegbola, Richard A.
   Bavdekar, Ashish
   Juvekar, Sanjay
   Viviani, Simonetta
   Enwere, Godwin C.
   Marchetti, Elisa
   Chaumont, Julie
   Makadi, Marie-Francoise
   Pallardy, Flore
   Kulkarni, Prasad S.
   Preziosi, Marie-Pierre
   LaForce, F. Marc
TI Ethical Challenges and Lessons Learned During the Clinical Development
   of a Group A Meningococcal Conjugate Vaccine
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE informed consent; ethics; subject protection; ethics committees;
   developing countries
ID SETTINGS; CARE; CONSENT; TRIALS
AB Background. The group A meningococcal vaccine (PsA-TT) clinical development plan included clinical trials in India and in the West African region between 2005 and 2013. During this period, the Meningitis Vaccine Project (MVP) accumulated substantial experience in the ethical conduct of research to the highest standards.
   Methods. Because of the public-private nature of the sponsorship of these trials and the extensive international collaboration with partners from a diverse setting of countries, the ethical review process was complex and required strategic, timely, and attentive communication to ensure the smooth review and approval for the clinical studies. Investigators and their site teams fostered strong community relationships prior to, during, and after the studies to ensure the involvement and the ownership of the research by the participating populations. As the clinical work proceeded, investigators and sponsors responded to specific questions of informed consent, pregnancy testing, healthcare, disease prevention, and posttrial access.
   Results. Key factors that led to success included (1) constant dialogue between partners to explore and answer all ethical questions; (2) alertness and preparedness for emerging ethical questions during the research and in the context of evolving international ethics standards; and (3) care to assure that approaches were acceptable in the diverse community contexts.
   Conclusions. Many of the ethical issues encountered during the PsA-TT clinical development are familiar to groups conducting field trials in different cultural settings. The successful approaches used by the MVP clinical team offer useful examples of how these problems were resolved.
   Clinical Trials Registration. ISRCTN17662153 (PsA-TT-001); ISRTCN78147026 (PsA-TT-002); ISRCTN87739946 (PsA-TT-003); ISRCTN46335400 (PsA-TT-003a); ISRCTN82484612 (PsA-TT-004); CTRI/2009/091/000368 (PsA-TT-005); PACTR ATMR2010030001913177 (PsA-TT-006); PACTR201110000328305 (PsA-TT-007).
C1 [Martellet, Lionel; Viviani, Simonetta; Enwere, Godwin C.; Marchetti, Elisa; Chaumont, Julie; Makadi, Marie-Francoise; Pallardy, Flore; Preziosi, Marie-Pierre; LaForce, F. Marc] PATH, Meningitis Vaccine Project, Ferney Voltaire, France.
   [Sow, Samba O.; Haidara, Fadima Cheick] Ctr Dev Vaccins, Bamako, Mali.
   [Diallo, Aldiouma; Ndiaye, Assane; Diarra, Bou] Inst Rech & Dev, Niakhar, Senegal.
   [Hodgson, Abraham; Ansah, Patrick Odum] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Kampmann, Beate; Akinsola, Adebayo; Idoko, Olubukola T.] MRC Unit, Vaccines & Immun Theme, Basse, Gambia.
   [Hirve, Siddhivinayak; Bavdekar, Ashish; Juvekar, Sanjay] Vadu King Edward Mem Hosp Res Ctr, Shirdi Sai Baba Hosp, Pune, Maharashtra, India.
   [Tapia, Milagritos] Univ Maryland, Sch Med, Ctr Vaccine Dev, Dept Pediat, Baltimore, MD 21201 USA.
   [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium.
   [Kulkarni, Prasad S.; LaForce, F. Marc] Serum Inst India Ltd, Pune, Maharashtra, India.
   [Preziosi, Marie-Pierre] WHO, Dept Immunizat Vaccines & Biol, Meningitis Vaccine Project, CH-1211 Geneva, Switzerland.
   [Adegbola, Richard A.] MRC Unit, Serrekunda, Gambia.
RP Martellet, L (reprint author), PATH, Meningitis Vaccine Project, Geneva, Switzerland.
EM lmartellet@path.org
OI Kampmann, Beate/0000-0002-6546-4709
FU Bill & Melinda Gates Foundation
FX This work was supported by the Bill & Melinda Gates Foundation.
CR Alfano Sandra L., 2013, Yale Journal of Biology and Medicine, V86, P315
   Bhutta ZA, 2004, B WORLD HEALTH ORGAN, V82, P771
   [Anonymous], 2002, INT ETH GUID BIOM RE
   Council for International Organizations of Medical Sciences (CIOMS), 2009, INT ETH GUID EP STUD
   International Conference on Harmonisation (ICH), 1996, EFF GUID GOOD CLIN P
   Idoko OT, 2015, CLIN INFECT DIS, V61, pS416, DOI 10.1093/cid/civ596
   Joint United Nations Programme on HIV/AIDS, 2004, ETH CONS HIV PREV VA
   Lahey Timothy, 2013, Handb Clin Neurol, V118, P301, DOI 10.1016/B978-0-444-53501-6.00025-1
   Laman M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-29
   Mamotte N, 2010, BMC MED ETHICS
   Marchetti E, 2012, VACCINE, V30, P6859, DOI 10.1016/j.vaccine.2012.09.008
   Merritt MW, 2011, KENNEDY INST ETHIC J, V21, P311
   Rajaraman D, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-3
   Tarantola D, 2007, VACCINE, V25, P4863, DOI 10.1016/j.vaccine.2007.03.022
   Yauba S, 2013, J CLIN RES BIOETH, V4, P1
NR 15
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2015
VL 61
SU 5
BP S422
EP S427
DI 10.1093/cid/civ598
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW7FF
UT WOS:000365162700008
PM 26553670
OA No
DA 2017-08-15
ER

PT J
AU Price, GA
   Hollander, AM
   Plikaytis, BD
   Mocca, BT
   Carlone, G
   Findlow, H
   Borrow, R
   Sow, SO
   Diallo, A
   Idoko, OT
   Enwere, GC
   Elie, C
   Preziosi, MP
   Kulkarni, PS
   Bash, MC
AF Price, Gregory A.
   Hollander, Aimee M.
   Plikaytis, Brian D.
   Mocca, Brian T.
   Carlone, George
   Findlow, Helen
   Borrow, Ray
   Sow, Samba O.
   Diallo, Aldiouma
   Idoko, Olubukola T.
   Enwere, Godwin C.
   Elie, Cheryl
   Preziosi, Marie-Pierre
   Kulkarni, Prasad S.
   Bash, Margaret C.
TI Human Complement Bactericidal Responses to a Group A Meningococcal
   Conjugate Vaccine in Africans and Comparison to Responses Measured by 2
   Other Group A Immunoassays
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE MenAfriVac; bactericidal activity; assay development; Neisseria
   meningitidis; clinical trials
ID NEISSERIA-MENINGITIDIS SEROGROUP; POLYSACCHARIDE VACCINE; ANTIBODY
   PERSISTENCE; HUMAN IMMUNITY; SERUM; SAFETY; IMMUNOGENICITY; CARRIAGE;
   DISEASE; EPIDEMIC
AB Background. PsA-TT (MenAfriVac) is a conjugated polysaccharide vaccine developed to eliminate group A meningococcal disease in Africa. Vaccination of African study participants with 1 dose of PsA-TT led to the production of anti-A polysaccharide antibodies and increased serum bactericidal activity measured using rabbit complement (rSBA). Bactericidal responses measured with human complement (hSBA) are presented here.
   Methods. Sera collected before and at 28 days and 1 year after vaccination with either PsA-TT or quadrivalent polysaccharide vaccine (PsACWY) from a random, age-distributed 360-subject subset of the Meningitis Vaccine Project study of PsA-TT in Africans aged 2-29 years were tested for hSBA. Geometric mean titer, fold-rise, and threshold analyses were compared between vaccine groups and age groups. hSBA, rSBA, and immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) results were compared and assay correlation and agreement determined.
   Results. hSBA responses to PsA-TT were substantially higher than those to PsACWY at 28 days and 1 year following immunization, similar to previously reported rSBA and IgG results. The hSBA and IgG ELISA results identified differences between age groups that were not evident by rSBA. The rSBA data indicated sustained high titers 1 year after immunization, whereas hSBA GMTs at 1 year approached 4 in young children.
   Conclusions. The high level of protection following PsA-TT immunization campaigns is consistent with the strong hSBA immune responses observed here. Future implementation decisions will likely depend on immunologic data and their long-term correlation with disease and carriage prevention. Expanded immunologic and epidemiologic surveillance may improve the interpretation of differences between these immunoassays.
C1 [Price, Gregory A.; Hollander, Aimee M.; Mocca, Brian T.; Bash, Margaret C.] US FDA, Lab Bacterial Polysaccharides, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.
   [Plikaytis, Brian D.; Carlone, George; Elie, Cheryl] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Findlow, Helen; Borrow, Ray] Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England.
   [Sow, Samba O.] Minist Sante, Ctr Dev Vaccins, Bamako, Mali.
   [Diallo, Aldiouma] Inst Rech Dev, Niakhar, Senegal.
   [Idoko, Olubukola T.] MRC Unit, Vaccines & Immun Theme, Basse, Gambia.
   [Enwere, Godwin C.; Preziosi, Marie-Pierre] PATH, Meningitis Vaccine Project, Ferney Voltaire, France.
   [Preziosi, Marie-Pierre] WHO, Meningitis Vaccine Project, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.
   [Kulkarni, Prasad S.] Serum Inst India Ltd, Pune, Maharashtra, India.
RP Bash, MC (reprint author), US FDA, Lab Bacterial Polysaccharides, DBPAP, CBER, 10903 New Hampshire Ave,Bld 52 Rm 5212, Silver Spring, MD 20993 USA.
EM margaret.bash@fda.hhs.gov
FU Meningitis Vaccine Project from Bill & Melinda Gates Foundation
FX This article appears as part of the supplement "The Meningitis Vaccine
   Project: The Development, Licensure, Introduction, and Impact of a New
   Group A Meningococcal Conjugate Vaccine for Africa," sponsored by the
   Meningitis Vaccine Project through a grant from the Bill & Melinda Gates
   Foundation.
CR Amir J, 2005, VACCINE, V23, P977, DOI 10.1016/j.vaccine.2004.07.042
   Bash MC, 2014, CLIN VACCINE IMMUNOL, V21, P755, DOI 10.1128/CVI.00812-13
   Borja-Tabora C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-116
   Borrow R, 2006, HDB MENINGOCOCCAL DI, P323
   CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154
   Daugla D, 2013, LANCET, V383, P40, DOI DOI 10.1016/S0140-6736(13)61612-8
   Dellicour S, 2007, TROP MED INT HEALTH, V12, P1409, DOI 10.1111/j.1365-3156.2007.01929.x
   Djingarey MH, 2015, CLIN INFECT DIS, V61, pS434, DOI 10.1093/cid/civ551
   Findlow H, 2013, ADV THER, V30, P431, DOI 10.1007/s12325-013-0032-5
   Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065
   Gill CJ, 2011, VACCINE, V30, P29, DOI 10.1016/j.vaccine.2011.10.068
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327
   Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08
   HASSANKING MKA, 1988, J INFECTION, V16, P55, DOI 10.1016/S0163-4453(88)96117-8
   Hirve S, 2012, VACCINE, V30, P6456, DOI 10.1016/j.vaccine.2012.08.004
   HOLDER PK, 1995, CLIN DIAGN LAB IMMUN, V2, P132
   Ismail AA, 2004, PEDIATR INFECT DIS J, V23, P748, DOI 10.1097/01.inf.0000135659.52662.a2
   Kristiansen PA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0663-4
   Kshirsagar N, 2007, VACCINE, V25, pA101, DOI 10.1016/j.vaccine.2007.04.050
   LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049
   LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1
   Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101
   MAKELA PH, 1975, LANCET, V2, P883
   Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156
   Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7
   Norheim G, 2007, CLIN VACCINE IMMUNOL, V14, P451, DOI 10.1128/CVI.00008-07
   PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302
   PINNER RW, 1992, J INFECT DIS, V166, P359
   Santos GF, 2001, CLIN DIAGN LAB IMMUN, V8, P616, DOI 10.1128/CDLI.8.3.616-623.2001
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8
   Trotter CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055486
   Vesikari T, 2012, HUM VACC IMMUNOTHER, V8, P1892, DOI 10.4161/hv.22166
   WHO, 1976, WHO TECHN REP SER, P1
   ZOLLINGER WD, 1983, INFECT IMMUN, V40, P257
NR 36
TC 1
Z9 1
U1 1
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2015
VL 61
SU 5
BP S554
EP S562
DI 10.1093/cid/civ504
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW7FF
UT WOS:000365162700026
PM 26553688
OA No
DA 2017-08-15
ER

PT J
AU Tapia, MD
   Findlow, H
   Idoko, OT
   Preziosi, MP
   Kulkarni, PS
   Enwere, GC
   Elie, C
   Parulekar, V
   Sow, SO
   Haidara, FC
   Diallo, F
   Doumbia, M
   Akinsola, AK
   Adegbola, RA
   Kampmann, B
   Chaumont, J
   Martellet, L
   Marchetti, E
   Viviani, S
   Tang, YX
   Plikaytis, BD
   LaForce, FM
   Carlone, G
   Borrow, R
AF Tapia, Milagritos D.
   Findlow, Helen
   Idoko, Olubukola T.
   Preziosi, Marie-Pierre
   Kulkarni, Prasad S.
   Enwere, Godwin C.
   Elie, Cheryl
   Parulekar, Varsha
   Sow, Samba O.
   Haidara, Fadima Cheick
   Diallo, Fatoumata
   Doumbia, Moussa
   Akinsola, Adebayo K.
   Adegbola, Richard A.
   Kampmann, Beate
   Chaumont, Julie
   Martellet, Lionel
   Marchetti, Elisa
   Viviani, Simonetta
   Tang, Yuxiao
   Plikaytis, Brian D.
   LaForce, F. Marc
   Carlone, George
   Borrow, Ray
TI Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in
   African Children Vaccinated at 12-23 Months of Age
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE MenAfriVac; group A meningococcal conjugate vaccine; antibody
   persistence; African meningitis belt
ID MENINGOCOCCAL CONJUGATE VACCINE; NEISSERIA-MENINGITIDIS SEROGROUP;
   IMMUNOLOGICAL MEMORY; UNITED-KINGDOM
AB Background. Following mass vaccination campaigns in the African meningitis belt with group A meningococcal conjugate vaccine, MenAfriVac (PsA-TT), disease due to group A meningococci has nearly disappeared. Antibody persistence in healthy African toddlers was investigated.
   Methods. African children vaccinated at 12-23 months of age with PsA-TT were followed for evaluation of antibody persistence up to 5 years after primary vaccination. Antibody persistence was evaluated by measuring group A serum bactericidal antibody (SBA) with rabbit complement and by a group A-specific IgG enzyme-linked immunosorbent assay (ELISA).
   Results. Group A antibodies measured by SBA and ELISA were shown to decline in the year following vaccination and plateaued at levels significantly above baseline for up to 5 years following primary vaccination.
   Conclusions. A single dose of PsA-TT induces long-term sustained levels of group A meningococcal antibodies for up to 5 years after vaccination.
   Clinical Trials Registration. ISRTCN78147026.
C1 [Tapia, Milagritos D.] Univ Maryland, Ctr Vaccine Dev, Sch Med, Dept Pediat, Baltimore, MD 21201 USA.
   [Findlow, Helen; Borrow, Ray] Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England.
   [Idoko, Olubukola T.; Akinsola, Adebayo K.; Adegbola, Richard A.; Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Basse, Gambia.
   [Preziosi, Marie-Pierre; Enwere, Godwin C.; Chaumont, Julie; Martellet, Lionel; Marchetti, Elisa; Viviani, Simonetta; LaForce, F. Marc] PATH, Meningitis Vaccine Project, Ferney Voltaire, France.
   [Preziosi, Marie-Pierre] WHO, Meningitis Vaccine Project, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.
   [Kulkarni, Prasad S.; LaForce, F. Marc] Serum Inst India Ltd, Pune, Maharashtra, India.
   [Elie, Cheryl; Plikaytis, Brian D.; Carlone, George] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Parulekar, Varsha] DiagnoSearch Life Sci, Bombay, Maharashtra, India.
   [Sow, Samba O.; Haidara, Fadima Cheick; Diallo, Fatoumata] Minist Sante, Ctr Dev Vaccins, Bamako, Mali.
   [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium.
   [Tang, Yuxiao] PATH, Meningitis Vaccine Project, Seattle, WA USA.
RP Tapia, MD (reprint author), Univ Maryland, Ctr Vaccine Dev, Sch Med, 685 W Baltimore St,Rm 480, Baltimore, MD 21201 USA.
EM mtapia@medicine.umaryland.edu
OI Kampmann, Beate/0000-0002-6546-4709
FU Meningitis Vaccine Project (PATH) from Bill & Melinda Gates Foundation
FX This work was supported by the Meningitis Vaccine Project (PATH), with a
   grant from the Bill & Melinda Gates Foundation.
CR Auckland C, 2006, J INFECT DIS, V194, P1745, DOI 10.1086/509619
   Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324
   Borrow R, 2000, EPIDEMIOL INFECT, V124, P427, DOI 10.1017/S0950268899003787
   Borrow R, 2006, EXPERT REV VACCINES, V5, P851, DOI 10.1586/14760584.5.6.851
   Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09
   CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154
   Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8
   Diallo A, CLIN INFECT DIS S5, V61, pS521
   Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073
   Frasch CE, 2012, HUM VACC IMMUNOTHER, V8, P715, DOI 10.4161/hv.19619
   HOLDER PK, 1995, CLIN DIAGN LAB IMMUN, V2, P132
   Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0
   Klein NP, 2013, PEDIATR INFECT DIS J, V32, P760, DOI 10.1097/INF.0b013e31828693c5
   LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049
   LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062
   Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   Spoulou VI, 2007, VACCINE, V25, P7012, DOI 10.1016/j.vaccine.2007.07.024
   Vesikari T, 2012, HUM VACC IMMUNOTHER, V8, P1892, DOI 10.4161/hv.22166
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P123
   WHO, 2010, IMM BAS IMM SER MOD
NR 21
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2015
VL 61
SU 5
BP S514
EP S520
DI 10.1093/cid/civ672
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW7FF
UT WOS:000365162700021
PM 26553683
OA No
DA 2017-08-15
ER

PT J
AU Waitt, CJ
   Banda, P
   Glennie, S
   Kampmann, B
   Squire, SB
   Pirmohamed, M
   Heyderman, RS
AF Waitt, Catriona John
   Banda, Peter
   Glennie, Sarah
   Kampmann, Beate
   Squire, S. Bertel
   Pirmohamed, Munir
   Heyderman, Robert Simon
TI Monocyte unresponsiveness and impaired IL1 beta, TNF alpha and IL7
   production are associated with a poor outcome in Malawian adults with
   pulmonary tuberculosis
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis; Innate immunity; Cytokines; Monocytes; Africa; Clinical
   outcome
ID HLA-DR EXPRESSION; IMMUNE-RESPONSES; POLYMICROBIAL SEPSIS; WHOLE-BLOOD;
   DEACTIVATION; INFECTIONS; MORTALITY; CYTOKINES; ANTIGENS; CELLS
AB Background: Early death during TB treatment is associated with depressed TNF alpha response to antigenic stimulation and propensity to superadded bacterial infection. Hypothesising the role of monocyte unresponsiveness, we further compared the immunological profile between patients who died or suffered a life-threatening deterioration ('poor outcome') during the intensive phase of TB treatment with patients who had an uneventful clinical course ('good outcome') who had been recruited as part of a larger prospective cohort study of Malawian TB patients.
   Methods: Using Luminex, IL1 beta, IL2, IL4, IL5, IL6, IL7, IL8, IL10, IL12, IL13, IL17, GCSF, GMCSF, MCP1, MIP1b, IFN gamma and TNF alpha were measured in whole blood assay supernatants (stimulated with Mycobacterium tuberculosis H37Rv and LPS) and serum from 44 Malawian adult TB patients (22 of each outcome) immediately prior to commencing treatment, after 7 days and on day 56 of TB treatment. Monocyte surface expression of CD14, CD16, TLR2, TLR4, CD86 and HLADR, and intracellular TNF alpha were measured by flow cytometry as was intracellular TNF alpha response to purified TLR ligands.
   Results: Lower TB antigen-induced IL1 beta (p = 0.006), TNF alpha (p = 0.02) and IL7 (p = 0.009) were produced in the poor outcome group. TNF alpha was produced by 'classical' CD14(hi)CD16(lo) monocytes, with no correlation between this response and expression of monocyte surface markers. Response to TB antigens correlated with responses to the purified TLR 2, 3 and 4 ligands.
   Conclusions: Dysregulated monocyte cytokine production was identified in TB patients with poor outcome. Lower TNF alpha responses to H37Rv paralleled lower responses to a panel of TLR ligands, suggesting an underlying perturbation in common TLR signalling pathways. Future work should explore the role of TLR polymorphisms in immune response and clinical outcome in TB patients.
C1 [Waitt, Catriona John; Glennie, Sarah; Heyderman, Robert Simon] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi.
   [Waitt, Catriona John; Pirmohamed, Munir] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3GL, Merseyside, England.
   [Banda, Peter] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi.
   [Glennie, Sarah] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, London, England.
   [Kampmann, Beate] MRC Unit, Serrekunda, Gambia.
   [Squire, S. Bertel; Heyderman, Robert Simon] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
RP Waitt, CJ (reprint author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Clin Res Programme, POB 30096, Blantyre, Malawi.
EM cwaitt@liv.ac.uk
FU Wellcome Trust Training Fellowship [076210/Z/04/Z]
FX Catriona Waitt was funded by Wellcome Trust Training Fellowship
   076210/Z/04/Z. We also wish to thank the nurses and TB officers at Queen
   Elizabeth Central Hospital, Malawi, who assisted with patient
   recruitment. These data were presented as conference proceedings at
   Federation of Infection Societies/Healthcare Infection Society
   Conference, Liverpool, November 2012
CR Asadullah K, 1995, Eur J Emerg Med, V2, P184, DOI 10.1097/00063110-199512000-00003
   Belge KU, 2002, J IMMUNOL, V168, P3536
   Condos R, 1998, AM J RESP CRIT CARE, V157, P729
   Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678
   FINGERLE G, 1993, BLOOD, V82, P3170
   Kibiki GS, 2007, CLIN EXP IMMUNOL, V148, P254, DOI 10.1111/j.1365-2249.2007.03330.x
   Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039
   Layoun A, 2012, AM J PATHOL, V180, P2340, DOI 10.1016/j.ajpath.2012.01.046
   Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004
   Manjuck J, 2000, J LAB CLIN MED, V135, P153, DOI 10.1067/mlc.2000.104306
   MendezSamperio P, 1997, CLIN DIAGN LAB IMMUN, V4, P138
   MendezSamperio P, 1996, CLIN EXP IMMUNOL, V104, P374, DOI 10.1046/j.1365-2249.1996.06695.x
   Mikacenic C, 2013, GENES IMMUN, V14, P52, DOI 10.1038/gene.2012.53
   Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8
   Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC
   Nolan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006600
   Perry SE, 2003, INTENS CARE MED, V29, P1245, DOI 10.1007/s00134-003-1686-2
   Pinto LA, 2005, VACCINE, V23, P3555, DOI 10.1016/j.vaccine.2005.01.146
   Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265
   Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016
   Silva D, 2013, ACTA TROP, V127, P75, DOI 10.1016/j.actatropica.2013.04.002
   Smith SG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-35
   VANDEUREN M, 1994, J INFECT DIS, V169, P157
   Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727
   Waitt CJ, 2011, J INFECT DIS, V204, P358, DOI 10.1093/infdis/jir265
   Wolk K, 2007, CRIT CARE MED, V35, P458, DOI 10.1097/01.CCM.0000254724.54515.2F
NR 26
TC 3
Z9 3
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 13
PY 2015
VL 15
AR 513
DI 10.1186/s12879-015-1274-4
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA CW8ZA
UT WOS:000365286800001
PM 26567164
OA gold
DA 2017-08-15
ER

PT J
AU Kombe, F
   Abdoulaye, T
   Gebru, GT
   Addei, S
   Zandoh, C
   Bangha, MW
   Tei, TA
   Oduor, C
   Ondeng'e, K
   Kamuya, KD
   Ikamba, D
   Kivaya, E
   Kombe, F
   Mumba, N
   Kinyanju, S
   Marsh, V
   Molyneux, S
   Ndaa, S
   Tsory, E
   Pedro, EN
   Mngomezulu, TN
   Zomboko, AS
   Mrema, SE
   Dibba, SM
   Kizza, M
   Mehta, A
AF Kombe, Francis
   Abdoulaye, Traore
   Gebru, Gelila Tesfaye
   Addei, Sheila
   Zandoh, Charles
   Bangha, Martin Wultoff
   Tei, Titus Annoi
   Oduor, Clement
   Ondeng'e, Ken
   Kamuya, Kisumu Dorcas
   Ikamba, Dorothy
   Kivaya, Esther
   Kombe, Francis
   Mumba, Noni
   Kinyanju, Sam
   Marsh, Vicki
   Molyneux, Sassy
   Ndaa, Siti
   Tsory, Emmanuel
   Pedro, Elpidia Narciso
   Mngomezulu, Thobeka Noxoliso
   Zomboko, Amri Shamte
   Mrema, Sigilbert Erasmus
   Dibba, Sheikh Mafuji
   Kizza, Moses
   Mehta, Ashwin
CA Int Workshop Kenya Role Frontline
TI Enhancing quality and integrity in biomedical research in Africa: an
   international call for greater focus, investment and standardisation in
   capacity strengthening for frontline staff
SO BMC MEDICAL ETHICS
LA English
DT Article
DE Africa; Continuing professional development (CPD); Fieldworkers; Health
   Research Ethics
ID GLOBAL HEALTH RESEARCH; ETHICAL DILEMMAS; WESTERN KENYA; EXPERIENCES;
   CHALLENGES; BIOETHICS; IDENTITY; WORKERS; TRIAL
AB The integrity of biomedical research depends heavily on the quality of research data collected. In turn, data quality depends on processes of data collection, a task undertaken by frontline research staff in many research programmes in Africa and elsewhere. These frontline research staff often have additional responsibilities including translating and communicating research in local languages, seeking informed consent for study participation and maintaining supportive relationships between research institutions and study participants and wider communities. The level of skills that fieldworkers need to undertake these responsibilities clearly affects the quality of data collected, the ethics of research 'on the ground' and the short and long term acceptability of research. We organised an international workshop in Kenya in July 2014 to discuss the role of frontline staff in scientific research. A total of 25 field managers from 9 African countries and the UK met for 2.5 days to discuss the relationship between data quality and institutional performance management systems and how they affect career progression and supportive supervision policies of research frontline staff.
   From this workshop, and supporting an expanding literature on the role of fieldworkers in international health research, participants agreed that fieldworkers' roles present them with practical and ethical challenges that their routine training does not adequately prepare them for. We argue that the common and complex challenges facing fieldworkers should in part be addressed through increased investment and collaborative agreements across types of research institutions in Africa. We call for standardization of core elements of training for this critically important cadre of research staff who perform similar roles and encounter similar challenges in many African settings. Although many valuable training elements are offered in institutions, there is a need to develop broader, more grounded and innovative strategies to address complex realities for fieldworkers, and support the integrity and ethics of health research in these settings.
C1 [Abdoulaye, Traore] Natl Ctr Res & Training Malaria, Ouagadougou, Burkina Faso.
   [Gebru, Gelila Tesfaye] Armauer Hansen Res Inst AHRI, Accra, Ghana.
   [Addei, Sheila] Dodowa Hlth Res Ctr, Accra, Ghana.
   [Zandoh, Charles] Kintampo Hlth Res Ctr, Accra, Ghana.
   [Bangha, Martin Wultoff] INDEPTH Network, Accra, Ghana.
   [Oduor, Clement] African Populat & Hlth Res Ctr, Nairobi, Kenya.
   [Ondeng'e, Ken] KEMRI Ctr Global Hlth Res, Nairobi, Kenya.
   [Kamuya, Kisumu Dorcas; Ikamba, Dorothy; Kivaya, Esther; Kombe, Francis; Mumba, Noni; Kinyanju, Sam; Marsh, Vicki; Molyneux, Sassy; Ndaa, Siti; Tsory, Emmanuel] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.
   [Kamuya, Kisumu Dorcas; Ikamba, Dorothy; Kivaya, Esther; Kombe, Francis; Mumba, Noni; Kinyanju, Sam; Marsh, Vicki; Molyneux, Sassy; Ndaa, Siti; Tsory, Emmanuel] PATH Kenya, Nairobi, Kenya.
   [Pedro, Elpidia Narciso] CISM, Maputo, Mozambique.
   [Mngomezulu, Thobeka Noxoliso] Africa Ctr Hlth & Populat Studies, Pretoria, South Africa.
   [Zomboko, Amri Shamte; Mrema, Sigilbert Erasmus] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Dibba, Sheikh Mafuji] MRC, Banjul, Gambia.
   [Kizza, Moses] MRC UVRI Uganda Res Unit AIDS, Kampala, Uganda.
   [Mehta, Ashwin] UK Med Res Council, London, England.
RP Kombe, F (reprint author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.
EM Fkombe@kemri-wellcome.org
FU Global Health Bioethics Network-UK (Wellcome Trust) [OXF-GHB02]; KEMRI
   Wellcome Trust Research Programme Capacity Building Strategic Award
   (Wellcome Trust) [084538]
FX This project was funded by Global Health Bioethics Network-UK (Wellcome
   Trust grant no. OXF-GHB02) and KEMRI Wellcome Trust Research Programme
   Capacity Building Strategic Award (Wellcome Trust grant no 084538). The
   funders did not influence the design or conduct of the workshop, the
   findings or the decision to publish.
CR ABELSON PH, 1992, SCIENCE, V256, P1257, DOI 10.1126/science.256.5061.1257
   Alexander LB, 2008, AM J EVAL, V29, P73, DOI 10.1177/1098214007313023
   Angwenyi V, 2013, DEV WORLD BIOETH, V13, P38, DOI 10.1111/dewb.12015
   Benatar SR, 2010, J MED ETHICS, V36, P194, DOI 10.1136/jme.2009.032672
   Chantler T, 2013, DEV WORLD BIOETH, V13, P30, DOI 10.1111/dewb.12023
   De Vries R, 2006, J EMPIR RES HUM RES, V1, P43, DOI 10.1525/jer.2006.1.1.43
   Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709
   Kamuya DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126671
   Kamuya DM, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-90
   Kamuya DM, 2013, DEV WORLD BIOETH, V13, P1, DOI 10.1111/dewb.12009
   Kingori P, 2013, SOC SCI MED, V98, P361, DOI 10.1016/j.socscimed.2013.10.013
   Kingori P, 2013, SOC SCI MED, V98, P260, DOI 10.1016/j.socscimed.2013.10.036
   Kombe F, 2014, DEV WORLD BIOETH, V3, P158
   Lairumbi Geoffrey M, 2012, Philos Ethics Humanit Med, V7, P7, DOI 10.1186/1747-5341-7-7
   Lairumbi GM, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-22
   Madiega PA, 2013, DEV WORLD BIOETH, V13, P21, DOI 10.1111/dewb.12019
   Molyneux S, 2013, DEV WORLD BIOETH, V13, pii
   Molyneux S, 2010, AM J BIOETHICS, V10, P24, DOI 10.1080/15265161003708623
   Mosavel M, 2011, SOC SCI MED, V73, P145, DOI 10.1016/j.socscimed.2011.04.029
   Simon C, 2008, CAMB Q HEALTHC ETHIC, V17, P195, DOI 10.1017/S0963180108080225
   Simon C, 2011, DEV WORLD BIOETH, V11, P82, DOI 10.1111/j.1471-8847.2011.00297.x
   Uthman OA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006340
NR 22
TC 0
Z9 0
U1 3
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6939
J9 BMC MED ETHICS
JI BMC Med. Ethics
PD NOV 13
PY 2015
VL 16
AR 77
DI 10.1186/s12910-015-0071-3
PG 5
WC Ethics; Medical Ethics; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Biomedical Social
   Sciences
GA CW1GB
UT WOS:000364736500001
OA gold
DA 2017-08-15
ER

PT J
AU Coscolla, M
   Copin, R
   Sutherland, J
   Gehre, F
   de Jong, B
   Owolabi, O
   Mbayo, G
   Giardina, F
   Ernst, JD
   Gagneux, S
AF Coscolla, Mireia
   Copin, Richard
   Sutherland, Jayne
   Gehre, Florian
   de Jong, Bouke
   Owolabi, Olumuiya
   Mbayo, Georgetta
   Giardina, Federica
   Ernst, Joel D.
   Gagneux, Sebastien
TI M. tuberculosis T Cell Epitope Analysis Reveals Paucity of Antigenic
   Variation and Identifies Rare Variable TB Antigens
SO CELL HOST & MICROBE
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; YOUNG-CHILDREN; HEPATITIS-C; CLASS-I;
   EVOLUTION; DIVERSITY; IMMUNITY; HIV; PATHOGENS; BACTERIAL
AB Pathogens that evade adaptive immunity typically exhibit antigenic variation. By contrast, it appears that although the chronic human tuberculosis (TB)-causing pathogen Mycobacterium tuberculosis needs to counter host T cell responses, its T cell epitopes are hyperconserved. Here we present an extensive analysis of the T cell epitopes of M. tuberculosis. We combined population genomics with experimental immunology to determine the number and identity of T cell epitope sequence variants in 216 phylogenetically diverse strains of M. tuberculosis. Antigen conservation is indeed a hallmark of M. tuberculosis. However, our analysis revealed a set of seven variable antigens that were immunogenic in subjects with active TB. These findings suggest that M. tuberculosis uses mechanisms other than antigenic variation to evade T cells. T cell epitopes that exhibit sequence variation may not be subject to the same evasion mechanisms, and hence vaccines that include such variable epitopes may be more efficacious.
C1 [Coscolla, Mireia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
   [Coscolla, Mireia; Giardina, Federica; Gagneux, Sebastien] Univ Basel, CH-4003 Basel, Switzerland.
   [Copin, Richard; Ernst, Joel D.] NYU, Div Infect Dis, Dept Med, Sch Med, New York, NY 10016 USA.
   [Sutherland, Jayne; Gehre, Florian; de Jong, Bouke; Owolabi, Olumuiya; Mbayo, Georgetta] MRC Unit, TB Immunol Lab, Vaccinol Theme, Fajara, Gambia.
   [de Jong, Bouke] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Giardina, Federica] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.
RP Ernst, JD (reprint author), NYU, Div Infect Dis, Dept Med, Sch Med, New York, NY 10016 USA.
EM joel.ernst@med.nyu.edu; sebastien.gagneux@unibas.ch
RI de Jong, Bouke/A-3636-2013; Coscolla, Mireia/L-5893-2017
OI de Jong, Bouke/0000-0002-1017-4675; Coscolla,
   Mireia/0000-0003-0752-0538; Gagneux, Sebastien/0000-0001-7783-9048;
   Ernst, Joel/0000-0001-9951-6207; Sutherland, Jayne/0000-0002-7083-4997
FU National Institutes of Health [R01 AI090928, HHSN266200700022C]; Swiss
   National Science Foundation [PP00P3_150750]; Potts Memorial Foundation;
   Belgian American Educational Foundation
FX This work was supported by the National Institutes of Health (R01
   AI090928 and HHSN266200700022C) and the Swiss National Science
   Foundation (PP00P3_150750). R.C. was supported by the Potts Memorial
   Foundation and the Belgian American Educational Foundation. Calculations
   were performed at sciCORE (http://scicore.unibas.ch/) scientific
   computing core facility at University of Basel.
CR Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006
   Arlehamn CSL, 2015, P NATL ACAD SCI USA, V112, pE147, DOI 10.1073/pnas.1416537112
   Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130
   Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x
   Black GF, 2001, INT J TUBERC LUNG D, V5, P664
   Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09
   Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012
   Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x
   Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591
   Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264
   Cole ST, 1998, NATURE, V393, P537
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590
   Copin R, 2014, MBIO, V5, DOI 10.1128/mBio.00960-13
   CORRADIN G, 1979, J EXP MED, V149, P436, DOI 10.1084/jem.149.2.436
   Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012
   DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081
   de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016
   Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145
   Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904
   Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602
   Ernst JD, 2008, TUBERCULOSIS, V88, P366, DOI 10.1016/j.tube.2007.11.002
   Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259
   Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339
   Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925
   Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1
   Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021
   Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576
   Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110
   HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004
   Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311
   Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z
   Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260
   Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746
   Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10
   Lancioni C, 2012, AM J RESP CRIT CARE, V185, P206, DOI 10.1164/rccm.201107-1355OC
   Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008
   Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09
   Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330
   Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396
   Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005
   Mugnier MR, 2015, SCIENCE, V347, P1470, DOI 10.1126/science.aaa4502
   Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9
   North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635
   Palmer GH, 2009, CELL MICROBIOL, V11, P1697, DOI 10.1111/j.1462-5822.2009.01366.x
   Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458
   Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991
   Reid TB, 2014, INFECT IMMUN, V82, P4959, DOI 10.1128/IAI.02236-14
   Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V
   Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008
   Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017
   Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517
   Tientcheu LD, 2014, EUR J IMMUNOL, V44, P1387, DOI 10.1002/eji.201343956
   Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656
   Organization WH, 2014, GLOB TUB REP
   Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569
NR 58
TC 18
Z9 18
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 11
PY 2015
VL 18
IS 5
BP 538
EP 548
DI 10.1016/j.chom.2015.10.008
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA CW6NA
UT WOS:000365113100007
PM 26607161
OA No
DA 2017-08-15
ER

PT J
AU Oriero, EC
   van Geertruyden, JP
   Nwakanma, DC
   D'Alessandro, U
   Jacobs, J
AF Oriero, Eniyou Cheryll
   van Geertruyden, Jean-Pierre
   Nwakanma, Davis C.
   D'Alessandro, Umberto
   Jacobs, Jan
TI Novel techniques and future directions in molecular diagnosis of malaria
   in resource-limited settings
SO EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
LA English
DT Review
DE hemozoin detection; isothermal amplification; lamp; malaria; molecular
   diagnosis; nucleic acid amplification tests; nalfia; polymerase chain
   reaction; POC tests
ID MEDIATED ISOTHERMAL AMPLIFICATION; REAL-TIME PCR; PLASMODIUM-FALCIPARUM;
   TESTS; INFECTIONS; PARASITES; BLOOD; LAMP; DNA; ELIMINATION
AB Despite being preventable and treatable, malaria remains a global health concern with approximately 1.2 billion people at high risk of being infected, 90% of whom are in the resource-limited settings of sub-Saharan Africa. The continued decline in malaria cases globally has rekindled the possibility of elimination in certain regions. As humans constitute the main reservoir of malaria, prompt and accurate diagnosis by microscopy or rapid diagnostic tests is part not only of effective disease management but also of control measures. However, for malaria elimination, more sensitive diagnostic tools are needed to detect asymptomatic and sub-microscopic infections that contribute to transmission. Molecular techniques, which involve amplification of nucleic acids, are being developed and modified to suit this purpose. This report provides a summary of the nucleic acid amplification tests that are currently available for diagnosis of malaria, with current improvements and adaptations for use in resource-limited settings.
C1 [Oriero, Eniyou Cheryll; Nwakanma, Davis C.; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Oriero, Eniyou Cheryll; van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Oriero, Eniyou Cheryll; D'Alessandro, Umberto; Jacobs, Jan] Inst Trop Med, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.
RP Oriero, EC (reprint author), MRC Unit, Fajara, Gambia.
EM eoriero@mrc.gm
RI Van geertruyden, Jean-pierre/K-6425-2014
OI Van geertruyden, Jean-pierre/0000-0001-5006-6364
CR Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001
   Berry A, 2005, Med Trop (Mars), V65, P176
   Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364
   Buates S, 2010, PARASITOL INT, V59, P414, DOI 10.1016/j.parint.2010.05.008
   Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626
   Cnops L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-67
   Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y
   Fischbach J, 2015, BIOTECHNIQUES, V58, P189, DOI 10.2144/000114275
   Garrett NL, 2014, PHYS CHEM CHEM PHYS
   Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271
   Gosling RD, 2011, CLIN MICROBIOL INFEC, V17, P1617, DOI 10.1111/j.1469-0691.2011.03660.x
   Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26
   Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06
   Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184
   Juul S, 2012, ACS NANO, V6, P10676, DOI 10.1021/nn3038594
   Kersting S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-99
   Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665
   LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738
   Lee WG, 2010, ADV DRUG DELIVER REV, V62, P449, DOI 10.1016/j.addr.2009.11.016
   Li Y, 2013, J MOL DIAGN, V15, P634, DOI 10.1016/j.jmoldx.2013.05.005
   Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189
   Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733
   Lukianova-Hleb E, 2015, EMERG INFECT DIS, V21, P1122, DOI 10.3201/eid2107.150089
   malERA, 2011, PLOS MED, V8
   Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152
   Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7
   Mens PF, 2012, MALARIA J, V11, P279
   Mixson-Hayden Tonya, 2010, BMC Res Notes, V3, P88, DOI 10.1186/1756-0500-3-88
   Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002
   Orban A, 2014, PLOS ONE, P9
   Oriero CE, 2015, CLIN MICROBIOL INFEC, V21
   Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343
   Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Peng WK, 2014, NAT MED, V20, P1069, DOI 10.1038/nm.3622
   Poschl B, 2010, AM J TROP MED HYG, V83, P56, DOI 10.4269/ajtmh.2010.09-0630
   Polley SD, 2015, MALARIA J, V14, P45
   Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10
   Poon LLM, 2006, CLIN CHEM, V52, P303
   Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004
   Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072
   Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467
   Tan JJL, 2014, PLOS NEGLECTED TROPI, P8
   Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2010, WORLD MALARIA REPORT 2010, P1
   WHO, 2012, MAL POL ADV COMM M P
   WHO, 2014, POL BRIEF MAL DIAGN
   World Health Organization, 2009, MAL MICR QUAL ASS MA
   WHO, 2014, MAL DIAGN LANDSC
   Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361
NR 53
TC 2
Z9 2
U1 5
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1473-7159
EI 1744-8352
J9 EXPERT REV MOL DIAGN
JI Expert Rev. Mol. Diagn.
PD NOV 2
PY 2015
VL 15
IS 11
BP 1419
EP 1426
DI 10.1586/14737159.2015.1090878
PG 8
WC Pathology
SC Pathology
GA CV9TX
UT WOS:000364630800001
PM 26413727
OA No
DA 2017-08-15
ER

PT J
AU Andreas, NJ
   Kampmann, B
   Le-Doare, KM
AF Andreas, Nicholas J.
   Kampmann, Beate
   Le-Doare, Kirsty Mehring
TI Human breast milk: A review on its composition and bioactivity
SO EARLY HUMAN DEVELOPMENT
LA English
DT Review
DE Human milk; Child nutrition science; Neonate; Immunity
ID FATTY-ACID-COMPOSITION; B STREPTOCOCCAL INFECTION; MATURE HUMAN-MILK;
   FED INFANTS; HUMAN COLOSTRUM; MONOCLONAL-ANTIBODIES; MATERNAL
   IMMUNIZATION; LIPID-COMPOSITION; ESCHERICHIA-COLI; IMMUNE-RESPONSES
AB Breast milk is the perfect nutrition for infants, a result of millions of years of evolution, finely attuning it to the requirements of the infant Breast milk contains many complex proteins, lipids and carbohydrates, the concentrations of which alter dramatically over a single feed, as well as over lactation, to reflect the infant's needs. In addition to providing a source of nutrition for infants, breast milk contains a myriad of biologically active components. These molecules possess diverse roles, both guiding the development of the infants immune system and intestinal microbiota.
   Orchestrating the development of the microbiota are the human milk oligosaccharides, the synthesis of which are determined by the maternal genotype. In this review, we discuss the composition of breast milk and the factors that affect it during the course of breast feeding.
   Understanding the components of breast milk and their functions will allow for the improvement of clinical practices, infant feeding and our understanding of immune responses to infection and vaccination in infants. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Andreas, Nicholas J.; Kampmann, Beate; Le-Doare, Kirsty Mehring] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Paediat, Ctr Int Child Hlth, London W2 1NY, England.
   [Le-Doare, Kirsty Mehring] Wellcome Trust Ctr Global Hlth Res, London, England.
   [Kampmann, Beate; Le-Doare, Kirsty Mehring] Gambia Vaccines & Immun Theme, MRC Unit, Fajara, Gambia.
RP Andreas, NJ (reprint author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Paediat, Praed St, London W2 1NY, England.
EM n.andreas11@imperial.ac.uk; b.kampmann@imperial.ac.uk;
   k.mehring-le-doare@imperial.ac.uk
OI Andreas, Nicholas/0000-0002-7224-0420; Kampmann,
   Beate/0000-0002-6546-4709
FU Imperial College Biomedical Research Centre; Wellcome Trust
FX We acknowledge the support of the Imperial College Biomedical Research
   Centre and the Wellcome Trust for our work. Also, we would like to
   acknowledge Jessica Birt, Amadou Faal, Asmaa Al-Khalidi, and Mustapha
   Jaiteh.
CR Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0
   ANDERSSON B, 1986, J INFECT DIS, V153, P232
   Andreas NJ, 2015, ELECTROPHORESIS, V36, P2269, DOI 10.1002/elps.201500011
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Bezirtzoglou E, 2011, ANAEROBE, V17, P478, DOI 10.1016/j.anaerobe.2011.03.009
   Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001
   Brenna JT, 2007, AM J CLIN NUTR, V85, P1457
   BUTTE NF, 1984, AM J CLIN NUTR, V39, P296
   Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652
   COPPA GV, 1993, PEDIATRICS, V91, P637
   Coppa GV, 1999, ACTA PAEDIATR, V88, P89, DOI 10.1080/080352599750029808
   CRAVIOTO A, 1991, J INFECT DIS, V163, P1247
   CRUZ JR, 1988, ACTA PAEDIATR SCAND, V77, P658, DOI 10.1111/j.1651-2227.1988.tb10726.x
   Dewey KG FD, 1986, HUMAN LACTATION 2 MA
   Dickinson EC, 1998, SURGERY, V124, P284, DOI 10.1016/S0039-6060(98)70132-1
   Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018
   Donovan SM, 2014, FEBS LETT, V588, P4112, DOI 10.1016/j.febslet.2014.07.008
   Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213
   Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x
   FlidelRimon O, 1997, J PEDIATR-US, V131, P748, DOI 10.1016/S0022-3476(97)70105-7
   Fujita M, 2012, AM J PHYS ANTHROPOL, V149, P52, DOI 10.1002/ajpa.22092
   German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322
   German JB, 2008, NESTLE NUTR WORKSHOP, V62, P18
   Goldman AS, 2000, J NUTR, V130, P426
   GRAY BM, 1988, PEDIATR RES, V24, P68, DOI 10.1203/00006450-198807000-00017
   Gutierrez-Castrellon P, 2007, BRIT J NUTR, V98, pS64, DOI 10.1017/S000711450783296X
   Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7
   HEIMAN HS, 1989, PEDIATR RES, V26, P629, DOI 10.1203/00006450-198912000-00023
   Holt C, 1996, NETH MILK DAIRY J, V50, P85
   Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442
   HYTTEN FE, 1954, BRIT MED J, V1, P175
   Innis SM, 2014, AM J CLIN NUTR, V99, p734S, DOI 10.3945/ajcn.113.072595
   INNIS SM, 1993, AM J CLIN NUTR, V57, P382
   INNIS SM, 1992, J PEDIATR-US, V120, pS56, DOI 10.1016/S0022-3476(05)81237-5
   INSULL W, 1959, J CLIN INVEST, V38, P443, DOI 10.1172/JCI103819
   ISAACS CE, 1995, J NUTR BIOCHEM, V6, P362, DOI 10.1016/0955-2863(95)00048-5
   JACKSON DA, 1988, BRIT J NUTR, V59, P349, DOI 10.1079/BJN19880044
   JATSYK GV, 1985, ACTA PAEDIATR SCAND, V74, P246, DOI 10.1111/j.1651-2227.1985.tb10958.x
   JENNESS R, 1979, SEMIN PERINATOL, V3, P225
   Jensen R. G., 1995, HDB MILK COMPOSITION
   KADER MMA, 1972, J BIOSOC SCI, V4, P403
   Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731
   KOLETZKO B, 1992, J PEDIATR-US, V120, pS62, DOI 10.1016/S0022-3476(05)81238-7
   Koletzko B, 2001, EARLY HUM DEV, V65, pS3, DOI 10.1016/S0378-3782(01)00204-3
   KOLETZKO B, 1988, AM J CLIN NUTR, V47, P954
   KRAKAUER R, 1975, AM J GASTROENTEROL, V64, P319
   Kuntz S, 2009, BRIT J NUTR, V101, P1306, DOI 10.1017/S0007114508079622
   Labeta MO, 2000, J EXP MED, V191, P1807, DOI 10.1084/jem.191.10.1807
   LAGERGARD T, 1992, EUR J PEDIATR, V151, P98, DOI 10.1007/BF01958951
   LARYEA MD, 1995, INT J FOOD SCI NUTR, V46, P205, DOI 10.3109/09637489509012550
   Lawrence RA, 2005, BREASTFEEDING GUIDE
   Lawrence RM, 2004, CLIN PERINATOL, V31, P501, DOI 10.1016/j.clp.2004.03.019
   Le Doare K, 2014, VACCINE, V32, P3128, DOI 10.1016/j.vaccine.2014.04.020
   LeBouder E, 2006, J IMMUNOL, V176, P3742
   Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075
   Lewis ZT, 2015, MICROBIOME, V3, P13
   LONNERDAL B, 1987, J NUTR, V117, P1385
   Lonnerdal B, 2004, ADV EXP MED BIOL, V554, P11
   LONNERDAL B, 1976, AM J CLIN NUTR, V29, P1134
   Lonnerdal Bo, 2003, Am J Clin Nutr, V77, p1537S
   Lopez C, 2011, COLLOID SURFACE B, V83, P29, DOI 10.1016/j.colsurfb.2010.10.039
   MARTIN JC, 1993, LIPIDS, V28, P637, DOI 10.1007/BF02536059
   Michaelsen K F, 1997, Acta Paediatr Suppl, V420, P1
   MICHAELSEN KF, 1990, J PEDIATR GASTR NUTR, V11, P229, DOI 10.1097/00005176-199008000-00013
   Michalski MC, 2005, J DAIRY SCI, V88, P1927
   Molinari CE, 2012, J PROTEOME RES, V11, P1696, DOI 10.1021/pr2008797
   Morrow AL, 2004, ADV EXP MED BIOL, V554, P443
   Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054
   Neville M. C., 1983, LACTATION PHYSL NUTR
   Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18
   Novak EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE807, DOI 10.1152/ajpendo.00225.2011
   OKADA M, 1991, LIFE SCI, V48, P1151, DOI 10.1016/0024-3205(91)90452-H
   Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638
   Pereira CL, 2012, HETEROCYCLES, V84, P637, DOI 10.3987/COM-11-S(P)37
   Pratico G, 2014, NAT PROD RES, V28, P95, DOI 10.1080/14786419.2013.843180
   PRENTICE A, 1989, J PEDIATR GASTR NUTR, V8, P486, DOI 10.1097/00005176-198905000-00011
   PRITCHARD DG, 1992, INFECT IMMUN, V60, P1598
   Saint L, 1984, BR J NUTR, V52, P87
   SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220
   Shahid NS, 2002, VACCINE, V20, P2404, DOI 10.1016/S0264-410X(02)00061-0
   Singhal A, 2008, AM J CLIN NUTR, V87, P1785
   STEPHENS S, 1984, ACTA PAEDIATR SCAND, V73, P426, DOI 10.1111/j.1651-2227.1984.tb09950.x
   Svanborg Eden, 1979, LANCET
   Tanaka K, 2013, BRAIN DEV-JPN, V35, P45, DOI 10.1016/j.braindev.2012.03.004
   Thurl S, 1997, GLYCOCONJUGATE J, V14, P795, DOI 10.1023/A:1018529703106
   UAUY R, 1994, J NUTR, V124, pS1436
   Villasenor A, 2014, ANAL CHEM, V86, P8245, DOI 10.1021/ac501853d
   VUKAVIC T, 1984, J PEDIATR GASTR NUTR, V3, P700, DOI 10.1097/00005176-198411000-00011
   WALTERSPIEL JN, 1994, PEDIATRICS, V93, P28
   Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05
   Weaver LTWN, 1991, PEDIAT ALLERGY IMMUN, V2, P2
   Weisman L E, 1991, Adv Exp Med Biol, V310, P345
   WILKINSON HW, 1975, INFECT IMMUN, V11, P845
   Zou XQ, 2012, J AGR FOOD CHEM, V60, P7158, DOI 10.1021/jf3013597
   [Anonymous], 2011, SURG GEN CALL ACTION
NR 95
TC 31
Z9 31
U1 14
U2 105
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-3782
EI 1872-6232
J9 EARLY HUM DEV
JI Early Hum. Dev.
PD NOV
PY 2015
VL 91
IS 11
BP 629
EP 635
DI 10.1016/j.earlhumdev.2015.08.013
PG 7
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA CW3IK
UT WOS:000364885400004
PM 26375355
OA No
DA 2017-08-15
ER

PT J
AU Elliott, TOJP
   Owolabi, O
   Donkor, S
   Kampmann, B
   Hill, PC
   Ottenhoff, THM
   Haks, MC
   Kaufmann, SHE
   Maertzdorf, J
   Sutherland, JS
AF Elliott, Thomas O. J. P.
   Owolabi, Olumuyiwa
   Donkor, Simon
   Kampmann, Beate
   Hill, Philip C.
   Ottenhoff, Tom H. M.
   Haks, Marielle C.
   Kaufmann, Stefan H. E.
   Maertzdorf, Jeroen
   Sutherland, Jayne S.
TI Dysregulation of Apoptosis Is a Risk Factor for Tuberculosis Disease
   Progression
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE active tuberculosis disease; apoptosis; Bcl2; flow cytometry; latent
   tuberculosis infection; microarray; RT-MLPA; tuberculosis progressors;
   tuberculosis
ID PROGRAMMED CELL-DEATH; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; PULMONARY
   TUBERCULOSIS; ACTIVE TUBERCULOSIS; GRANULOMA-FORMATION; HOST
   MACROPHAGES; INFECTION; IMMUNITY; NECROSIS
AB Background. A major barrier to effective tuberculosis control is our limited understanding of risk factors for tuberculosis disease progression. This study examined the role of apoptosis in immunity to tuberculosis.
   Methods. Cell subsets from tuberculosis cases and tuberculin skin test-positive (TST+) and TST-negative (TST-) household contacts (HHCs) were analyzed for expression of annexin-V and propidium iodide by flow cytometry. RNA microarrays were used to determine differences in apoptotic gene expression levels and multiplex ligation-dependent probe amplification was used to analyze gene expression in HHCs who progressed to active tuberculosis.
   Results. T cells from TST+HHC exhibited higher levels of apoptosis than tuberculosis cases; however, tuberculosis cases had a higher proportion of late apoptotic cells within the CD3(+)PD-1(+) subset. Tuberculosis cases had reduced levels of antiapoptotic genes compared to HHCs with a significant reduction in BCL2 associated with disease progression at least 1 year prior to progression.
   Conclusions. While T cells are clearly able to mount a robust immune response to Mycobacterium tuberculosis, there are increased levels of apoptosis seen in effector T cells from tuberculosis patients. Dysregulation of several apoptotic genes suggest that apoptosis is a major functional pathway that could be targeted for future host-directed therapeutics.
C1 [Elliott, Thomas O. J. P.; Owolabi, Olumuyiwa; Donkor, Simon; Kampmann, Beate; Hill, Philip C.; Sutherland, Jayne S.] MRC Unit, Vaccines & Immun, Fajara, Gambia.
   [Elliott, Thomas O. J. P.] Univ Manchester, Manchester M13 9PL, Lancs, England.
   [Hill, Philip C.] Univ Otago, Fac Med, Dept Prevent & Social Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Ottenhoff, Tom H. M.; Haks, Marielle C.] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RA Leiden, Netherlands.
   [Kaufmann, Stefan H. E.; Maertzdorf, Jeroen] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.
RP Sutherland, JS (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM jsutherland@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709; Sutherland,
   Jayne/0000-0002-7083-4997
FU Medical Research Council UK; Bill and Melinda Gates Foundation: Grand
   Challenges in Global Health [37772]; EC FP7 ADITEC (Advanced
   Immunization Technologies) grant [HEALTH.2011.1.4-4 280873]
FX This work was supported by Medical Research Council UK intramural
   funding; the Bill and Melinda Gates Foundation: Grand Challenges in
   Global Health grant no. 37772; and EC FP7 ADITEC (Advanced Immunization
   Technologies) grant no. HEALTH.2011.1.4-4 280873. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856
   Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006
   Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636
   Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387
   Butler RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047573
   Chen MJ, 2006, J IMMUNOL, V176, P3707
   Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x
   Day CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094949
   Diez J, 2010, CELL DEATH DIFFER, V17, P735, DOI 10.1038/cdd.2009.215
   Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904
   Dorhoi A, 2014, SEMIN IMMUNOL, V26, P533, DOI 10.1016/j.smim.2014.10.002
   Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009
   Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178
   Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098
   Haanen C, 1996, EUR J OBSTET GYN R B, V64, P129, DOI 10.1016/0301-2115(95)02261-9
   Hirsch CS, 2005, J CLIN IMMUNOL, V25, P353, DOI 10.1007/s10875-005-4841-4
   Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686
   Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64
   Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558
   Kremer L, 1997, EUR J IMMUNOL, V27, P2450, DOI 10.1002/eji.1830270945
   Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263
   Kyrylkova Kateryna, 2012, Methods Mol Biol, V887, P41, DOI 10.1007/978-1-61779-860-3_5
   Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61
   Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1
   Li BQ, 1998, J IMMUNOL, V161, P1558
   Maertzdorf J., 2011, PLoS ONE, pe26938, DOI 10.1371/journal.pone.0026938
   McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001
   Oddo M, 1998, J IMMUNOL, V160, P5448
   ORME IM, 1983, J EXP MED, V158, P74, DOI 10.1084/jem.158.1.74
   Pena FJ, 2003, THERIOGENOLOGY, V60, P677, DOI 10.1016/S0093-691X(03)00081-5
   Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180
   Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7
   Qiu ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00216
   Roach DR, 2002, J IMMUNOL, V168, P4620
   Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277
   Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784
   Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906
   Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031
   Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206
   Sly LM, 2003, J IMMUNOL, V170, P430
   Sutherland JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025230
   Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693
   Tousif S, 2014, J BIOL CHEM, V289, P30190, DOI 10.1074/jbc.C114.598946
   Vermes I, 1995, ANNEXIN 5, V184, P39, DOI DOI 10.1016/0022-1759(95)00072-I)
   Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960
   Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001
   Yang SJ, 2015, CELL PHYSIOL BIOCHEM, V35, P1276, DOI 10.1159/000373950
   Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237
NR 50
TC 5
Z9 5
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 1
PY 2015
VL 212
IS 9
BP 1469
EP 1479
DI 10.1093/infdis/jiv238
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CW1QX
UT WOS:000364767500016
PM 25895988
OA No
DA 2017-08-15
ER

PT J
AU Lindsay, B
   Saha, D
   Sanogo, D
   Das, SK
   Omore, R
   Farag, TH
   Nasrin, D
   Li, S
   Panchalingam, S
   Levine, MM
   Kotloff, K
   Nataro, JP
   Magder, L
   Hungerford, L
   Faruque, ASG
   Oundo, J
   Hossain, MA
   Adeyemi, M
   Stine, OC
AF Lindsay, Brianna
   Saha, Debasish
   Sanogo, Doh
   Das, Sumon Kumar
   Omore, Richard
   Farag, Tamer H.
   Nasrin, Dilruba
   Li, Shan
   Panchalingam, Sandra
   Levine, Myron M.
   Kotloff, Karen
   Nataro, James P.
   Magder, Laurence
   Hungerford, Laura
   Faruque, A. S. G.
   Oundo, Joseph
   Hossain, M. Anowar
   Adeyemi, Mitchell
   Stine, Oscar Colin
TI Association between Shigella Infection and Diarrhea Varies Based on
   Location and Age of Children
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID GLOBAL ENTERIC MULTICENTER; POLYMERASE-CHAIN-REACTION; LOW-INCOME
   COUNTRIES; ESCHERICHIA-COLI; BANGLADESHI CHILDREN; YOUNG-CHILDREN;
   ETIOLOGY; INFANTS; DISEASE; BURDEN
AB Molecular identification of the invasion plasmid antigen-H (ipaH) gene has been established as a useful detection mechanism for Shigella spp. The Global Enteric Multicenter Study (GEMS) identified the etiology and burden of moderate-to-severe diarrhea (MSD) in sub-Saharan Africa and south Asia using a case control study and traditional culture techniques. Here, we used quantitative polymerase chain reaction (qPCR) to identify Shigella spp. in 2,611 stool specimens from GEMS and compared these results to those using culture. Demographic and nutritional characteristics were assessed as possible risk factors. The qPCR identified more cases of shigellosis than culture; however, the distribution of demographic characteristics was similar by both methods. In regression models adjusting for Shigella quantity, age, and site, children who were exclusively breast-fed had significantly lower odds of MSD compared with children who were not breast-fed (odds ratio [OR] = 0.47, 95% confidence interval (CI) = 0.28-0.81). The association between Shigella quantity and MSD increased with age, with a peak in children of 24-35 months of age (OR = 8.2, 95% Cl = 4.3-15.7) and the relationship between Shigella quantity and disease was greatest in Bangladesh (OR = 13.2, 95% CI = 7.3-23.8). This study found that qPCR identified more cases of Shigella and age, site, and breast-feeding status were significant risk factors for MSD.
C1 [Lindsay, Brianna; Farag, Tamer H.; Nasrin, Dilruba; Li, Shan; Panchalingam, Sandra; Levine, Myron M.; Kotloff, Karen; Magder, Laurence; Hungerford, Laura; Stine, Oscar Colin] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   [Saha, Debasish; Adeyemi, Mitchell] MRC Unit, Basse, Gambia.
   [Sanogo, Doh] Ctr Dev Vaccins Mali, Bamako, Mali.
   [Das, Sumon Kumar; Hossain, M. Anowar] Icddr B, Mirzapur, Bangladesh.
   [Nataro, James P.] Univ Virginia, Sch Med, Charlottesville, VA USA.
   [Omore, Richard; Oundo, Joseph] US Ctr Dis Control & Prevent, Kenya Med Res Inst Res Stn, Kisumu, Kenya.
   [Faruque, A. S. G.] Ctr Nutr & Food Secur, Dhaka 1212, Bangladesh.
RP Stine, OC (reprint author), Univ Maryland, Sch Med, 660 West Redwood St Howard Hall Room 585, Baltimore, MD 21201 USA.
EM brlindsay@gmail.com; Debasish.x.Saha@GSK.com; anogodoh@yahoo.fr;
   sumon@icddrb.org; romore@ke.cdc.gov; tamer.farag@gatesfoundation.org;
   dnasrin@medicine.umaryland.edu; slil@epi.umaryland.edu;
   spanchal@medicine.umaryland.edu; mlevinc@medicine.umaryland.edu;
   kkotloff@medicine.umaryland.edu; jpn2r@hscmail.mcc.virginia.edu;
   Imagder@epi.umaryland.edu; lhungerf@epi.umaryland.edu;
   gfaruque@icddrb.org; joseph.oundo@usamru-k.org; anowar@icddrb.org;
   adeyemimitchell@yahoo.com; ostin001@umaryland.edu
FU Bill & Melinda Gates Foundation [BMGF 38874, BMGF OPP42917, BMGF
   OPP1016839]
FX This research was funded by Bill & Melinda Gates Foundation awards: BMGF
   38874 to Myron M. Levine, Karen Kotloff, and James P. Nataro, BMGF
   OPP42917 to James P. Natal. and and Oscar Colin Stine, BMGF OPP1016839
   to James P. Nataro and Oscar Colin Stine.
CR Ahmed F, 1997, AM J TROP MED HYG, V56, P258
   AHMED F, 1992, PEDIATRICS, V90, P406
   Barletta F, 2013, J CLIN MICROBIOL, V51, P2822, DOI 10.1128/JCM.01397-13
   Barletta F, 2011, CLIN INFECT DIS, V53, P1223, DOI 10.1093/cid/cir730
   CLEMENS JD, 1986, AM J EPIDEMIOL, V123, P710
   Dutta S, 2001, J MED MICROBIOL, V50, P667
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   Lindsay B, 2015, EMERG INFECT DIS, V21, P242, DOI [10.3201/eid2101.140795, 10.3201/eid2102.140795]
   Lindsay B, 2013, J CLIN MICROBIOL, V51, P3263, DOI 10.1128/JCM.01342-13
   Lindsay B, 2013, J CLIN MICROBIOL, V51, P1740, DOI 10.1128/JCM.02713-12
   Lindsay B, 2011, EMERG INFECT DIS, V17, P606, DOI [10.3201/eid1704.100939, 10.3201/eid1704100939]
   Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Ricci Karen A, 2006, Nature, V444 Suppl 1, P29
   Samosornsuk S, 2007, THAMMASAT INT J SCI, V12, P52
   Taniuchi M, 2013, J INFECT DIS, V208, P1794, DOI 10.1093/infdis/jit507
   Taniuchi M, 2012, DIAGN MICR INFEC DIS, V73, P121, DOI 10.1016/j.diagmicrobio.2012.03.008
   UNAIDS, 2014, HIV PREV AG 15 49
   von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353
   Vu Dinh Thiem, 2004, J Clin Microbiol, V42, P2031, DOI 10.1128/JCM.42.5.2031-2035.2004
NR 21
TC 5
Z9 6
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2015
VL 93
IS 5
BP 918
EP 924
DI 10.4269/ajtmh.14-0319
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CV7FJ
UT WOS:000364437500007
PM 26324734
OA No
DA 2017-08-15
ER

PT J
AU Lanaspa, M
   O'Callaghan-Gordo, C
   Machevo, S
   Madrid, L
   Nhampossa, T
   Acacio, S
   de la Horra, C
   Friaza, V
   Campano, E
   Alonso, PL
   Calderon, EJ
   Roca, A
   Bassat, Q
AF Lanaspa, M.
   O'Callaghan-Gordo, C.
   Machevo, S.
   Madrid, L.
   Nhampossa, T.
   Acacio, S.
   de la Horra, C.
   Friaza, V.
   Campano, E.
   Alonso, P. L.
   Calderon, E. J.
   Roca, A.
   Bassat, Q.
TI High prevalence of Pneumocystis jirovecii pneumonia among Mozambican
   children < 5 years of age admitted to hospital with clinical severe
   pneumonia
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Child preschool; developing countries; infant; Pneumocystis jirovecii;
   pneumonia
ID HUMAN-IMMUNODEFICIENCY-VIRUS; SOUTH-AFRICAN CHILDREN; RURAL MOZAMBIQUE;
   CARINII-PNEUMONIA; INFECTION; EPIDEMIOLOGY; DIAGNOSIS; ETIOLOGY;
   MALARIA; RISK
AB We aimed to describe Pneumocystis jirovecii pneumonia (PCP) prevalence and features in children from sub-Saharan Africa and to investigate PCP-associated risk factors. During 2006-2007 we used molecular methods to test children younger than 5 years old admitted with severe pneumonia to a hospital in southern Mozambique for Pneumocystis infection. We recruited 834 children. PCP prevalence was 6.8% and HIV prevalence was 25.7%. The in-hospital and delayed mortality were significantly higher among children with PCP (20.8% vs. 10.2%, p 0.021, and 11.5% vs. 3.6%, p 0.044, respectively). Clinical features were mostly overlapping between the two groups. Independent risk factors for PCP were age less than a year (odds ratio (OR) 6.34, 95% confidence interval (CI) 1.86-21.65), HIV infection (OR 2.99, 95% CI 1.16-7.70), grunting (OR 2.64, 95% CI 1.04-6.73) and digital clubbing (OR 10.75, 95% CI 1.21-95.56). PCP is a common and life-threatening cause of severe pneumonia in Mozambican children. Mother-to-child HIV transmission prevention should be strengthened. Better diagnostic tools are needed. Clinical Microbiology and Infection (C) 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Lanaspa, M.; O'Callaghan-Gordo, C.; Madrid, L.; Alonso, P. L.; Bassat, Q.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Lanaspa, M.; O'Callaghan-Gordo, C.; Machevo, S.; Madrid, L.; Nhampossa, T.; Acacio, S.; Alonso, P. L.; Roca, A.; Bassat, Q.] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [O'Callaghan-Gordo, C.] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.
   [Roca, A.] MRC Unit, Banjul, Gambia.
   [Nhampossa, T.; Acacio, S.] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique.
   [de la Horra, C.; Friaza, V.; Campano, E.; Calderon, E. J.] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, CIBER Epidemiol & Salud Publ, Seville, Spain.
   [de la Horra, C.; Friaza, V.; Campano, E.; Calderon, E. J.] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain.
RP Calderon, EJ (reprint author), Inst Biomed Sevilla, Campus Hosp Univ Virgen del Rocio, Seville 41013, Spain.
EM sandube@cica.es
RI IBIS, EPIDEMIOLOGIA/O-8791-2015; Bassat, Quique/P-2341-2016
OI Bassat, Quique/0000-0003-0875-7596; Friaza, Vicente/0000-0002-2900-4334;
   Calderon, Enrique/0000-0002-3166-5086
FU World Health Organization [WHO-C6-181-489]; program Miguel Servet of the
   ISCIII (Plan Nacional de I+D+I) [CP11/00269]; program Rio Hortega of the
   ISCIII [CM13/00260]
FX This work was supported by the World Health Organization
   (WHO-C6-181-489). QB has a fellowship from the program Miguel Servet of
   the ISCIII (Plan Nacional de I+D+I 2008-2011, grant CP11/00269). LM has
   a fellowship from the program Rio Hortega of the ISCIII (CM13/00260).
   All authors report no conflicts of interest relevant to this article.
CR Bakeera-Kitaka S, 2004, ANN TROP PAEDIATR, V24, P227, DOI 10.1179/027249304225019046
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   de Armas Y, 2012, MED MYCOL, V50, P417, DOI 10.3109/13693786.2011.607474
   Durand-Joly I, 2005, FEMS IMMUNOL MED MIC, V45, P405, DOI 10.1016/j.femsim.2005.06.006
   Fei MW, 2009, SCAND J INFECT DIS, V41, P672, DOI 10.1080/00365540903051633
   Friaza V, 2010, POSTGRAD MED, V122, P24, DOI 10.3810/pgm.2010.11.2219
   Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7
   Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36
   Heffelfinger JD, 2009, PLOS ONE, V4
   Huang L, 2011, PARASITE, V18, P3
   Jones LL, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-5
   Lowe DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069969
   Madhi SA, 2002, CLIN INFECT DIS, V35, P1120, DOI 10.1086/343049
   Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934
   Morris A, 2004, EMERG INFECT DIS, V10, P1713
   Morrow Brenda M, 2014, BMC Res Notes, V7, P26, DOI 10.1186/1756-0500-7-26
   Morrow BM, 2010, PEDIATR INFECT DIS J, V29, P535, DOI 10.1097/INF.0b013e3181ce871e
   O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe
   Rabie H, 2007, J TROP PEDIATRICS, V53, P270, DOI 10.1093/tropej/fmm036
   Regional Office for Europe, 2009, HIV AIDS SURV EUR 20
   Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x
   Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013
   Siberry George K, 2013, Pediatr Infect Dis J, V32 Suppl 2, pi, DOI 10.1097/01.inf.0000437856.09540.11
   Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030
   Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d
   Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x
   World Health Organization, 2005, POCK BOOK HOSP CAR C
   Zar HJ, 2001, ACTA PAEDIATR, V90, P119
NR 28
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD NOV
PY 2015
VL 21
IS 11
DI 10.1016/j.cmi.2015.07.011
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA CV8XY
UT WOS:000364572800018
PM 26231980
OA No
DA 2017-08-15
ER

PT J
AU Zumla, A
   Maeurer, M
   Chakaya, J
   Hoelscher, M
   Ntoumi, F
   Rustomjee, R
   Vilaplana, C
   Yeboah-Manu, D
   Rasolofo, V
   Munderi, P
   Singh, N
   Aklillu, E
   Padayatchi, N
   Macete, E
   Kapata, N
   Mulenga, M
   Kibiki, G
   Mfinanga, S
   Nyirenda, T
   Mboko, L
   Garcia-Basteiro, AL
   Rakotosamimanana, N
   Bates, M
   Mwaba, P
   Reither, K
   Gagneux, S
   Edwards, S
   Mfinanga, E
   Abdulla, S
   Cardona, PJ
   Russell, JBW
   Gant, V
   Noursadeghi, M
   Elkington, P
   Bonnet, M
   Menendez, C
   Dieye, TN
   Diarra, B
   Maiga, A
   Aseffa, A
   Parida, S
   Wejse, C
   Petersen, E
   Kaleebu, P
   Oliver, M
   Craig, G
   Corrah, T
   Tientcheu, L
   Antonio, M
   McHugh, TD
   Sheikh, A
   Ippolito, G
   Ramjee, G
   Kaufmann, SHE
   Churchyard, G
   Steyn, AJC
   Grobusch, MP
   Sanne, I
   Martinson, N
   Mandansein, R
   Wilkinson, RJ
   Wallis, RS
   Mayosi, B
   Schito, M
AF Zumla, Alimuddin
   Maeurer, Markus
   Chakaya, Jeremiah
   Hoelscher, Michael
   Ntoumi, Francine
   Rustomjee, Roxana
   Vilaplana, Cristina
   Yeboah-Manu, Dorothy
   Rasolofo, Voahangy
   Munderi, Paula
   Singh, Nalini
   Aklillu, Eleni
   Padayatchi, Nesri
   Macete, Eusebio
   Kapata, Nathan
   Mulenga, Modest
   Kibiki, Gibson
   Mfinanga, Sayoki
   Nyirenda, Thomas
   Mboko, Leonard
   Garcia-Basteiro, Alberto L.
   Rakotosamimanana, Niaina
   Bates, Matthew
   Mwaba, Peter
   Reither, Klaus
   Gagneux, Sebastien
   Edwards, Sarah
   Mfinanga, Elirehema
   Abdulla, Salim
   Cardona, Pere-Joan
   Russell, James B. W.
   Gant, Vanya
   Noursadeghi, Mahdad
   Elkington, Paul
   Bonnet, Maryline
   Menendez, Clara
   Dieye, Tandakha N.
   Diarra, Bassirou
   Maiga, Almoustapha
   Aseffa, Abraham
   Parida, Shreemanta
   Wejse, Christian
   Petersen, Eskild
   Kaleebu, Pontiano
   Oliver, Matt
   Craig, Gill
   Corrah, Tumena
   Tientcheu, Leopold
   Antonio, Martin
   McHugh, Timothy D.
   Sheikh, Aziz
   Ippolito, Giuseppe
   Ramjee, Gita
   Kaufmann, Stefan H. E.
   Churchyard, Gavin
   Steyn, Adrie J. C.
   Grobusch, Martin P.
   Sanne, Ian
   Martinson, Neil
   Mandansein, Rajhmun
   Wilkinson, Robert J.
   Wallis, Robert S.
   Mayosi, Bongani
   Schito, Marco
CA Host-Directed Therapies Network HD
TI Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis:
   Learning From the Pasteur-Bechamp Debates
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE host-directed therapy; tuberculosis; treatment; multi-drug resistant
   tuberculosis; repurposed drugs
ID SUB-SAHARAN AFRICA; DEVELOPING-COUNTRIES; PULMONARY TUBERCULOSIS;
   ADJUNCT THERAPIES; MOXIFLOXACIN; REGIMENS; TRIALS; DRUGS; OPPORTUNITIES;
   PARTNERSHIPS
AB Tuberculosis remains a global emergency causing an estimated 1.5 million deaths annually. For several decades the major focus of tuberculosis treatment has been on antibiotic development targeting Mycobacterium tuberculosis. The lengthy tuberculosis treatment duration and poor treatment outcomes associated with multi-drug resistant tuberculosis (MDR-TB) are of major concern. The sparse new tuberculosis drug pipeline and widespread emergence of MDR-TB signal an urgent need for more innovative interventions to improve treatment outcomes. Building on the historical Pasteur-Bechamp debates on the role of the "microbe" vs the "host internal milieu" in disease causation, we make the case for parallel investments into host-directed therapies (HDTs). A range of potential HDTs are now available which require evaluation in randomized controlled clinical trials as adjunct therapies for shortening the duration of tuberculosis therapy and improving treatment outcomes for drug-susceptible tuberculosis and MDR-TB. Funder initiatives that may enable further research into HDTs are described.
C1 [Zumla, Alimuddin; McHugh, Timothy D.] UCL, Ctr Clin Microbiol, Div Infect Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, London, England.
   [Maeurer, Markus] Karolinska Inst, Dept Lab Med, Therapeut Immunol, Stockholm, Sweden.
   [Maeurer, Markus] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden.
   [Zumla, Alimuddin; Edwards, Sarah] NIHR Biomed Res Ctr, London, England.
   [Chakaya, Jeremiah] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Mboko, Leonard] Univ Munich, Med Ctr, Div Infect Dis & Trop Med, Marchioninistr 15, D-81377 Munich, Germany.
   [Hoelscher, Michael] DZIF German Ctr Infect Res, Munich, Germany.
   [Ntoumi, Francine] Fdn Congolaise Rech Med, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Rustomjee, Roxana] MRC, Cape Town, South Africa.
   [Vilaplana, Cristina; Cardona, Pere-Joan] Unitat TB Expt Fundacio Inst Invest Ciencies Salu, Labs Recerca Can Ruti Campus, Barcelona, Spain.
   [Yeboah-Manu, Dorothy] Univ Ghana, Bacteriol Dept, Noguchi Memorial Inst Med Res, Legon, Ghana.
   [Rasolofo, Voahangy; Rakotosamimanana, Niaina] Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar.
   [Munderi, Paula] Uganda Virus Res Inst, HIV Care Res Program, MRC Res Unit, Entebbe, Uganda.
   [Singh, Nalini] Inkosi Albert Luthuli Cent Hosp, Durban, South Africa.
   [Singh, Nalini] King DinuZulu Hosp, Durban, South Africa.
   [Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden.
   [Padayatchi, Nesri] Ctr AIDS Prevent Res South Africa CAPRISA, SAMRC CAPRISA HIV TB Pathogenesis & Treatment Res, Durban, South Africa.
   [Macete, Eusebio; Garcia-Basteiro, Alberto L.] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Kapata, Nathan; Bates, Matthew; Mwaba, Peter] Univ Teaching Hosp, UNZA UCLMS Res & Training Project, Lusaka, Zambia.
   [Kapata, Nathan] Minist Hlth, Lusaka, Zambia.
   [Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia.
   [Kibiki, Gibson] Kilimanjaro Clin Res Inst KCRI, Kilimanjaro, Tanzania.
   [Mfinanga, Sayoki] Natl Inst Med Res NIMR, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania.
   [Nyirenda, Thomas] EDCTP, Cape Town, South Africa.
   [Mboko, Leonard] Mbeya Med Res Ctr, Mbeya, Tanzania.
   [Garcia-Basteiro, Alberto L.] Univ Barcelona, Hosp Clin, IS Global, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Reither, Klaus; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Edwards, Sarah] Univ Coll London Hosp NHS Trust, NIHR BRC, Eth & Governance, London, England.
   [Mfinanga, Elirehema] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Russell, James B. W.] Univ Sierra Leone, Coll Med & Allied Hlth Sci, Connaught Hosp, Dept Internal Med, Freetown, Sierra Leone.
   [Gant, Vanya; Noursadeghi, Mahdad] Univ Coll London Hosp NHS Fdn Trust, Dept Microbiol, London, England.
   [Elkington, Paul] Univ Southampton, Resp Med Dept, Southampton, Hants, England.
   [Bonnet, Maryline] IRD, Epictr, Paris, France.
   [Menendez, Clara] Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain.
   [Dieye, Tandakha N.] Le Dantec Hosp, Immunol Unit, Lab Bacteriol Virol, Labs Natl Blood Transfus Ctr, Dakar, Senegal.
   [Diarra, Bassirou; Maiga, Almoustapha] Univ STT, SEREFO HIV TB Res & Training CenteHIV TB Res Trai, FMOS, Bamako, Mali.
   [Aseffa, Abraham] AHRI, Addis Ababa, Ethiopia.
   [Wejse, Christian; Petersen, Eskild] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark.
   [Kaleebu, Pontiano] Uganda Med Res Council, Kampala, Uganda.
   [Oliver, Matt] Results UK, London, England.
   [Craig, Gill] City Univ London, Sch Hlth Sci, London EC1V 0HB, England.
   [Corrah, Tumena] Northwick Pk Hosp & Clin Res Ctr, Dept Infect & Trop Dis, London, England.
   [Tientcheu, Leopold; Antonio, Martin] MRC, Banjul, Gambia.
   [Sheikh, Aziz] Univ Edinburgh, Ctr Med Informat, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.
   [Ippolito, Giuseppe] Natl Inst Infect Dis Lazzar Spallanzani, Rome, Italy.
   [Ramjee, Gita] MRC, HIV Prevent Res Unit, Durban, South Africa.
   [Kaufmann, Stefan H. E.] Max Planck Inst Infekt Biol, Dept Immunol, D-10117 Berlin, Germany.
   [Churchyard, Gavin; Wallis, Robert S.] Aurum Inst, Johannesburg, South Africa.
   [Steyn, Adrie J. C.] Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, K RITH Tower Bldg, Durban, South Africa.
   [Grobusch, Martin P.] Univ Amsterdam, Dept Infect & Trop Dis, Amsterdam, Netherlands.
   [Sanne, Ian] Univ Witwatersrand, Right Care, Johannesburg, South Africa.
   [Martinson, Neil] Publ Hlth Res Unit, Soweto, South Africa.
   [Singh, Nalini; Mandansein, Rajhmun] Univ KwaZulu Natal, Inkosi Albert Luthuli Cent Hosp, Dept Cardiothorac Surg, Durban, South Africa.
   [Singh, Nalini; Mandansein, Rajhmun] King DinuZulu Hosp, Durban, South Africa.
   [Wilkinson, Robert J.] Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa.
   [Wilkinson, Robert J.] Francis Crick Inst Mill Hill Lab, London, England.
   [Mayosi, Bongani] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa.
   [Mayosi, Bongani] Univ Cape Town, ZA-7925 Cape Town, South Africa.
   [Schito, Marco] Crit Path Inst, Crit Path TB Drug Regimens, Tucson, AZ USA.
   [Maeurer, Markus; Parida, Shreemanta] Karolinska Inst, Dept Lab Med, Therapeut Immunol, Stockholm, Sweden.
   [Maeurer, Markus; Parida, Shreemanta] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Therapeut Immunol, Stockholm, Sweden.
RP Maeurer, M (reprint author), Karolinska Inst, Dept Lab Med, Therapeut Immunol, Stockholm, Sweden.
EM a.i.zumla@gmail.com; markus.maeurer@ki.se; chakaya.jm@gmail.com;
   hoelscher@lrz.uni-muenchen.de; fntoumi@fcrm-congo.com;
   Roxana.Rustomjee@mrc.ac.za; cvilaplana@gmail.com;
   dyeboah-manu@noguchi.ug.edu.gh; vrasolof@pasteur.mg;
   Paula.Munderi@mrcuganda.org; Nalini.Singh@kznhealth.gov.za;
   Eleni.Aklillu@ki.se; nesri.padayatchi@caprisa.org;
   Eusebio.Macete@manhica.net; nkapata@gmail.com; mulengam@tdrc.org;
   g.kibiki@kcri.ac.tz; gsmfinanga@yahoo.com; nyirenda@edctp.org;
   lmaboko@nimr-mmrc.org; alberto.garcia-basteiro@manhica.net;
   niaina@pasteur.mg; matthew.bates@ucl.ac.uk; pbmwaba2000@gmail.com;
   klaus.reither@unibas.ch; sebastien.gagneux@unibas.ch;
   sarah.edwards@ucl.ac.uk; emfinanga@ihi.or.tz; salim.abdulla@gmail.com;
   pjcardona@igtp.cat; jamesbwrussell@gmail.com; vanya.gant@uclh.nhs.uk;
   m.noursadeghi@ucl.ac.uk; P.Elkington@soton.ac.uk;
   maryline.bonnet@ird.fr; MENENDEZ@clinic.ub.es; tndieye@yahoo.co.uk;
   bdiarra@icermali.org; adjimde@icermali.org; aseffaa@gmail.com;
   shreemanta.parida@gmail.com; wejse@dadlnet.dk; eskildp@dadlnet.dk;
   pontiano.kaleebu@mrcuganda.org; oliver@results.org.uk;
   Gill.Craig.1@city.ac.uk; tcorrah@gmail.com; ltientcheu@mrc.gm;
   mantonio@mrc.gm; t.mchugh@ucl.ac.uk; Aziz.Sheikh@ed.ac.uk;
   giuseppe.ippolito@inmi.it; Gita.Ramjee@mrc.ac.za;
   kaufmann@mpiib-berlin.mpg.de; GChurchyard@auruminstitute.org;
   asteyn@uab.edu; m.p.grobusch@amc.uva.nl; isanne@witshealth.co.za;
   Martinson@phru.co.za; RajhmunMad@ialch.co.za;
   robert.wilkinson@uct.ac.za; rwallis@auruminsitute.or;
   bongani.mayosi@uct.ac.za; mschito@c-path.org
RI Wejse, Christian/C-8468-2014; Vilaplana, Cristina/K-7216-2012; Ippolito,
   Giuseppe/J-7207-2017
OI Wejse, Christian/0000-0002-2534-2942; Zumla,
   Alimuddin/0000-0002-5111-5735; Vilaplana, Cristina/0000-0002-2808-7270;
   Wilkinson, Robert/0000-0002-2753-1800; Aklillu,
   Eleni/0000-0002-9788-0790; Steyn, Adrie JC/0000-0001-9177-8827; Cardona,
   Pere-Joan/0000-0001-5623-7873; Ippolito, Giuseppe/0000-0002-1076-2979;
   Elkington, Paul/0000-0003-0390-0613
FU Wellcome Trust [104803]
CR Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7
   Bento CF, 2015, DNA CELL BIOL, V34, P228, DOI 10.1089/dna.2014.2745
   Costello A, 2000, BRIT MED J, V321, P827, DOI 10.1136/bmj.321.7264.827
   Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006
   Dawson R, 2015, LANCET, V385, P1738, DOI 10.1016/S0140-6736(14)62002-X
   Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712
   Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426
   Grange J, 1999, J ROY SOC MED, V92, P105
   Grange JM, 2002, J R SOC PROMO HEALTH, V122, P78, DOI 10.1177/146642400212200206
   Grange JM, 2001, INT J TUBERC LUNG D, V5, P208
   Hamilton CD, 2015, CLIN INFECT DIS, V61, pS155, DOI 10.1093/cid/civ611
   Herbert N, 2014, LANCET, V383, P1016, DOI 10.1016/S0140-6736(14)60422-0
   James D G, 1982, Trans Med Soc Lond, V99-100, P131
   Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210
   Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5
   Kilale A M, 2008, Tanzan J Health Res, V10, P89
   McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817
   Migliori GB, 2014, EUR RESPIR J, V44, P1412, DOI 10.1183/09031936.00132114
   Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312
   Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859
   Parida SK, 2015, INT J INFECT DIS, V32, P32, DOI 10.1016/j.ijid.2015.01.016
   Shuchman M, 2014, NAT MED, V20, P12, DOI 10.1038/nm0114-12
   Tobin DM, 2015, COLD SPRING HARB PER, V1, P417
   Tucker TJ, 2008, SCIENCE, V320, P1016, DOI 10.1126/science.1156720
   Uhlin M, 2012, J INFECT DIS, V205, pS325, DOI 10.1093/infdis/jis197
   Ukwaja Kingsley Nnanna, 2013, Pan Afr Med J, V16, P11, DOI 10.11604/pamj.2013.16.11.680
   Uplekar M, 2014, WHOS NEW END TB STRA
   Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813
   World Health Organization, 2014, GLOB TUB REP 2014
   World Health Organization, 2014, TUB EL ACT FRAM LOW
   Zumla A, 2001, Lancet Infect Dis, V1, P199, DOI 10.1016/S1473-3099(01)00096-2
   Zumla A, 2002, J ROY SOC MED, V95, P275, DOI 10.1258/jrsm.95.6.275
   Zumla A, 2010, TROP MED INT HEALTH, V15, P489, DOI 10.1111/j.1365-3156.2010.02479.x
   Zumla A, 2009, LANCET INFECT DIS, V9, P197, DOI 10.1016/S1473-3099(09)70045-3
   Zumla A, 2015, INT J INFECT DIS, V32, P46, DOI 10.1016/j.ijid.2014.12.039
   Zumla A, 2015, LANCET RESP MED, V3, P220, DOI 10.1016/S2213-2600(15)00063-6
   Zumla A, 2015, LANCET INFECT DIS, V15, P11, DOI 10.1016/S1473-3099(14)71034-5
   Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858
   Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x
   Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1
NR 41
TC 10
Z9 10
U1 1
U2 16
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2015
VL 61
IS 9
BP 1432
EP 1438
DI 10.1093/cid/civ631
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CT6XI
UT WOS:000362956000012
PM 26219693
OA No
DA 2017-08-15
ER

PT J
AU Kwambana-Adams, B
   Darboe, S
   Nabwera, H
   Foster-Nyarko, E
   Ikumapayi, UN
   Secka, O
   Betts, M
   Bradbury, R
   Wegmuller, R
   Lawal, B
   Saha, D
   Hossain, MJ
   Prentice, AM
   Kampmann, B
   Anderson, S
   Dalessandro, U
   Antonio, M
AF Kwambana-Adams, Brenda
   Darboe, Saffiatou
   Nabwera, Helen
   Foster-Nyarko, Ebenezer
   Ikumapayi, Usman N.
   Secka, Ousman
   Betts, Modupeh
   Bradbury, Richard
   Wegmueller, Rita
   Lawal, Bolarinde
   Saha, Debasish
   Hossain, M. Jahangir
   Prentice, Andrew M.
   Kampmann, Beate
   Anderson, Suzanne
   Dalessandro, Umberto
   Antonio, Martin
TI Salmonella Infections in The Gambia, 2005-2015
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Salmonella enterica serovar Typhi; nontyphoidal Salmonella enterica;
   multidrug resistance; invasive Salmonella disease
ID NON-TYPHOIDAL SALMONELLA; AGED 2-29 MONTHS; GLOBAL BURDEN; CHILDREN;
   BACTEREMIA; MENINGITIS; AFRICA; DISEASE; ADULTS; EPIDEMIOLOGY
AB Background. There are large data gaps in the epidemiology of diseases caused by Salmonella enterica in West Africa. Regional surveillance of Salmonella infections is necessary, especially with the emergence and spread of multidrug-resistant clones.
   Methods. Data on Salmonella isolated from various clinical specimens from patients from across The Gambia were collected and analyzed retrospectively from 2005 to April 2015. Antibiotic sensitivity testing of Salmonella isolates was performed by disk diffusion method. Serotyping and serogrouping of Salmonella isolates was performed using standard microbiology techniques.
   Results. Two hundred three Salmonella isolates were isolated from 190 patients: 52% (106/203) from blood and 39% (79/203) from stool specimens. Salmonella was also isolated from urine, aspirates, cerebrospinal fluid, wounds, and abscesses. The prevalence of Salmonella in blood cultures was 0.8% (106/13 905). Of the serotyped salmonellae, 14% (21/152) were Salmonella enterica serovar Typhi, whereas 86% (131/152) were serovars other than Typhi (non-typhoidal Salmonella). Of the 102 typed NTS isolates, 40% (41) were Salmonella enterica serovar Typhimurium, 10% (10) were Salmonella enterica serovar Enteritidis, and 3% (3) were Salmonella enterica serovar Arizonae. Overall, 70% (142/203) of the salmonellae were pansusceptible. Multidrug resistance was found in 4% (9/203) of the isolates, 3 of which were Salmonella Enteritidis.
   Conclusions. Salmonellae are associated with a wide spectrum of invasive and noninvasive infections across all ages in The Gambia. There is evidence of multidrug resistance in salmonellae that warrants vigilant monitoring and surveillance.
C1 [Kwambana-Adams, Brenda; Darboe, Saffiatou; Nabwera, Helen; Foster-Nyarko, Ebenezer; Ikumapayi, Usman N.; Secka, Ousman; Betts, Modupeh; Wegmueller, Rita; Lawal, Bolarinde; Saha, Debasish; Hossain, M. Jahangir; Prentice, Andrew M.; Kampmann, Beate; Anderson, Suzanne; Dalessandro, Umberto; Antonio, Martin] MRC Unit, Fajara, Gambia.
   [Nabwera, Helen; Wegmueller, Rita; Prentice, Andrew M.] MRC Unit, Int Nutr Grp, Banjul, Gambia.
   [Bradbury, Richard] Cent Queensland Univ, Sch Med & Appl Sci, North Rockhampton, Australia.
   [Dalessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Dalessandro, Umberto; Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Coventry, W Midlands, England.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
RP Antonio, M (reprint author), MRC Unit, Vaccines & Immun Theme, Post Off Box 273, Banjul, Gambia.
EM mantonio@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709
FU MRC (UK) funds
FX This work was supported by MRC (UK) funds.
CR Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5
   Chacha Flora, 2015, BMC Res Notes, V8, P64, DOI 10.1186/s13104-015-1030-2
   Clinical and Laboratory Standards Institute, PERF STAND ANT SUS S
   Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
   Crump JA, 2014, T ROY SOC TROP MED H, V108, P673, DOI 10.1093/trstmh/tru152
   Enwere G, 1998, ANN TROP PAEDIATR, V18, P275
   Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5
   Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2
   Galanis E, 2006, EMERG INFECT DIS, V12, P381
   GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z
   Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009
   Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146
   Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980
   Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2
   Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0
   Kariuki S, 2005, INT J ANTIMICROB AG, V25, P38, DOI 10.1016/j.ijantimicag.2004.08.015
   Kariuki Samuel, 2015, Vaccine, V33 Suppl 3, pC21, DOI 10.1016/j.vaccine.2015.03.102
   Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Labi AK, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0697-7
   Laupland KB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-95
   Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733
   Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103
   Molyneux EM, 2009, ANN TROP PAEDIATR, V29, P13, DOI 10.1179/146532809X401980
   Molyneux EM, 2000, ANN TROP PAEDIATR, V20, P41, DOI 10.1080/02724930092057
   Okomo U. A., 2011, International Journal of Pediatrics, V2011, P825123, DOI 10.1155/2011/825123
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d
   Teckie G, 2015, INT J INFECT DIS, V30, P38, DOI 10.1016/j.ijid.2014.10.006
NR 29
TC 3
Z9 4
U1 2
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2015
VL 61
SU 4
BP S354
EP S362
DI 10.1093/cid/civ781
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CT6WZ
UT WOS:000362955100016
PM 26449952
OA No
DA 2017-08-15
ER

PT J
AU van den Hoogen, LL
   Griffin, JT
   Cook, J
   Sepulveda, N
   Corran, P
   Conway, DJ
   Milligan, P
   Affara, M
   Allen, SJ
   Proietti, C
   Ceesay, SJ
   Targett, GA
   D'Alessandro, U
   Greenwood, B
   Riley, EM
   Drakeley, C
AF van den Hoogen, Lotus L.
   Griffin, Jamie T.
   Cook, Jackie
   Sepulveda, Nuno
   Corran, Patrick
   Conway, David J.
   Milligan, Paul
   Affara, Muna
   Allen, Stephen J.
   Proietti, Carla
   Ceesay, Serign J.
   Targett, Geoffrey A.
   D'Alessandro, Umberto
   Greenwood, Brian
   Riley, Eleanor M.
   Drakeley, Chris
TI Serology describes a profile of declining malaria transmission in
   Farafenni, The Gambia
SO MALARIA JOURNAL
LA English
DT Article
DE Plasmodium falciparum; Malaria; Transmission; Serology; MSP-1(19)
ID PLASMODIUM-FALCIPARUM; INTENSITY; PREVALENCE; ANTIBODIES; CARRIAGE;
   PATTERNS; EXPOSURE; CHILDREN; MARKERS; PROTEIN
AB Background: Malaria morbidity and mortality has declined in recent years in a number of settings. The ability to describe changes in malaria transmission associated with these declines is important in terms of assessing the potential effects of control interventions, and for monitoring and evaluation purposes.
   Methods: Data from five cross-sectional surveys conducted in Farafenni and surrounding villages on the north bank of River Gambia between 1988 and 2011 were compiled. Antibody responses to MSP-1(19) were measured in samples from all surveys, data were normalized and expressed as seroprevalence and seroconversion rates (SCR) using different mathematical models.
   Results: Results showed declines in serological metrics with seroprevalence in children aged one to 5 years dropping from 19 % (95 % CI 15-23 %) in 1988 to 1 % (0-2 %) in 2011 (p value for trend in proportions < 0.001) and the SCR dropping from 0.069 year(-1) (0.059-0.080) to 0.022 year(-1) (0.017-0.028; p = 0.004). The serological data were consistent with previously described drops in both parasite prevalence in children aged 1-5 years (62 %, 57-66 %, in 1988 to 2 %, 0-4 %, in 2011; p < 0.001), and all-cause under five mortality rates (37 per 1000 person-years, 34-41, in 1990 to 17, 15-19, in 2006; p = 0.059).
   Conclusions: This analysis shows accurate reconstruction of historical malaria transmission patterns in the Farafenni area using anti-malarial antibody responses. Demonstrating congruence between serological measures, and conventional clinical and parasitological measures suggests broader utility for serology in monitoring and evaluation of malaria transmission.
C1 [van den Hoogen, Lotus L.; Cook, Jackie; Sepulveda, Nuno; Corran, Patrick; Conway, David J.; Milligan, Paul; Targett, Geoffrey A.; D'Alessandro, Umberto; Greenwood, Brian; Riley, Eleanor M.; Drakeley, Chris] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England.
   [Griffin, Jamie T.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
   [Sepulveda, Nuno] Univ Lisbon, Fac Ciencias, Ctr Stat & Applicat, P-17491016 Lisbon, Portugal.
   [Affara, Muna; Ceesay, Serign J.; D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara 220, Gambia.
   [Allen, Stephen J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.
   [Proietti, Carla] QIMR Berghofer Med Res Inst, Infect Dis Programme, Brisbane, Qld 4029, Australia.
RP van den Hoogen, LL (reprint author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.
EM lotus.vandenhoogen@lshtm.ac.uk
RI Riley, Eleanor/C-8960-2013; Milligan, Paul/D-8985-2017
OI Riley, Eleanor/0000-0003-3447-3570; Milligan, Paul/0000-0003-3430-3395;
   Sepulveda, Nuno/0000-0002-8542-1706; Conway, David/0000-0002-8711-3037
FU World Health Organization/TDR; UK MRC; Wellcome Trust [091924]; Fundacao
   para a Ciencia e Tecnologia (Portugal) [Pest-OE/MAT/UI0006/2011]
FX We thank all those who contributed to the field surveys including the
   Medical Research Council (MRC), the staff and the residents of Farafenni
   area. Furthermore, we would like to thank Jonathan Gillig for
   serological data analyses. The 1988 survey was funded by the World
   Health Organization/TDR and UK MRC. CD and NS are funded by the Wellcome
   Trust Grant Number 091924. NS also acknowledges partial funding from
   Fundacao para a Ciencia e Tecnologia (Portugal) through the project
   Pest-OE/MAT/UI0006/2011.
CR Bosomprah S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-12
   Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2015, EMERG INFECT DIS, V21, P1114, DOI 10.3201/eid2107.142036
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86
   Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137
   Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169
   Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023
   Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195
   Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004
   Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Griffin J., 2015, REVCAT STATA MODULE
   Ismaili J, 2007, THESIS LONDON SCH HY
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111
   Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0
   Lulat A A, 1993, THESIS LONDON SCH HY
   Ndugwa RP, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-15
   Oduro AR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-222
   Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926
   Ord R, 2007, J INFECT DIS, V196, P1613, DOI 10.1086/522154
   RILEY EM, 1990, T ROY SOC TROP MED H, V84, P648, DOI 10.1016/0035-9203(90)90133-Y
   RILEY EM, 1991, EUR J IMMUNOL, V21, P1019, DOI 10.1002/eji.1830210424
   Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274
   Sepulveda N, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0661-z
   Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107
   Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083
   Stresman GH, 2014, AM J TROP MED HYG, V91, P1101, DOI 10.4269/ajtmh.14-0355
   Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1
   Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X
   White MT, 2014, J INFECT DIS, V201, P1115
   WHO, 2014, GAMB COUNTR PROF
   Wong J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-451
NR 35
TC 10
Z9 10
U1 1
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD OCT 22
PY 2015
VL 14
AR 416
DI 10.1186/s12936-015-0939-1
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CU1PF
UT WOS:000363293100002
PM 26492873
OA gold
DA 2017-08-15
ER

PT J
AU Graham, SM
   Cuevas, LE
   Jean-Philippe, P
   Browning, R
   Casenghi, M
   Detjen, AK
   Gnanashanmugam, D
   Hesseling, AC
   Kampmann, B
   Mandalakas, A
   Marais, BJ
   Schito, M
   Spiegel, HML
   Starke, JR
   Worrell, C
   Zar, HJ
AF Graham, Stephen M.
   Cuevas, Luis E.
   Jean-Philippe, Patrick
   Browning, Renee
   Casenghi, Martina
   Detjen, Anne K.
   Gnanashanmugam, Devasena
   Hesseling, Anneke C.
   Kampmann, Beate
   Mandalakas, Anna
   Marais, Ben J.
   Schito, Marco
   Spiegel, Hans M. L.
   Starke, Jeffrey R.
   Worrell, Carol
   Zar, Heather J.
TI Clinical Case Definitions for Classification of Intrathoracic
   Tuberculosis in Children: An Update
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE childhood tuberculosis; tuberculosis classification; tuberculosis case
   definitions; tuberculosis diagnosis
ID XPERT MTB/RIF ASSAY; PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS;
   STOOL SAMPLES; DIAGNOSIS; METAANALYSIS; CONSENSUS; ACCURACY; BURDEN;
   TIME
AB Consensus case definitions for childhood tuberculosis have been proposed by an international expert panel, aiming to standardize the reporting of cases in research focusing on the diagnosis of intrathoracic tuberculosis in children. These definitions are intended for tuberculosis diagnostic evaluation studies of symptomatic children with clinical suspicion of intrathoracic tuberculosis, and were not intended to predefine inclusion criteria into such studies. Feedback from researchers suggested that further clarification was required and that these case definitions could be further improved. Particular concerns were the perceived complexity and overlap of some case definitions, as well as the potential exclusion of children with acute onset of symptoms or less severe disease. The updated case definitions proposed here incorporate a number of key changes that aim to reduce complexity and improve research performance, while maintaining the original focus on symptomatic children suspected of having intrathoracic tuberculosis. The changes proposed should enhance harmonized classification for intrathoracic tuberculosis disease in children across studies, resulting in greater comparability and the much-needed ability to pool study results.
C1 [Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia.
   [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia.
   [Graham, Stephen M.; Detjen, Anne K.] Int Union TB & Lung Dis, Paris, France.
   [Graham, Stephen M.] Burnet Inst, Melbourne, Vic, Australia.
   [Cuevas, Luis E.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.
   [Jean-Philippe, Patrick; Schito, Marco; Spiegel, Hans M. L.] Henry M Jackson Fdn, Rockville, MD USA.
   [Browning, Renee; Gnanashanmugam, Devasena] NIAID, Div AIDS, NIH, Rockville, MD 20852 USA.
   [Casenghi, Martina] Med Sans Frontieres, Geneva, Switzerland.
   [Hesseling, Anneke C.] Univ Stellenbosch, Dept Pediat & Child Hlth, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Cape Town, South Africa.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England.
   [Kampmann, Beate] MRC Unit, Vaccinol Theme, Serrekunda, Gambia.
   [Mandalakas, Anna; Starke, Jeffrey R.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Marais, Ben J.] Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia.
   [Marais, Ben J.] Sydney Emerging Infect Dis & Biosecur Inst, Westmead, NSW, Australia.
   [Marais, Ben J.] Childrens Hosp, Westmead, NSW, Australia.
   [Marais, Ben J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Worrell, Carol] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Rockville, MD USA.
   [Zar, Heather J.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, MRC Unit Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa.
RP Graham, SM (reprint author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.
EM steve.graham@rch.org.au
OI Kampmann, Beate/0000-0002-6546-4709; Cuevas, Luis E./0000-0002-6581-0587
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health [HHSN272200800014C]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health (contract number
   HHSN272200800014C).
CR Belard S, 2014, SAMJ S AFR MED J, V104, P181, DOI [10.7196/SAMJ.7984, 10.7196/samj.7984]
   Beneri C, 2015, INT J TUBER IN PRESS
   Breuninger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106381
   Buck WC, 2013, INT J TUBERC LUNG D, V17, P1389, DOI 10.5588/ijtld.13.0030
   Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879
   Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8
   Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1
   Engelbrecht AL, 2006, J INFECTION, V53, P364, DOI 10.1016/j.jinf.2005.12.025
   Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812
   Graham SM, 2014, LANCET, V383, P1605, DOI 10.1016/S0140-6736(14)60420-7
   Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008
   Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012
   Holm LL, 2013, J INFECT DIS, V207, P870, DOI 10.1093/infdis/jis768
   Jaganath D, 2013, CLIN INFECT DIS, V57, P1685, DOI 10.1093/cid/cit645
   Jaganath D, 2012, J INFECT DIS, V206, P1809, DOI 10.1093/infdis/jis608
   Kaguthi G, 2014, INTERDISC PERSPECT I, V2014
   Li N, 2013, AIDS, V27, P1273, DOI 10.1097/QAD.0b013e32835ecb24
   Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392
   Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9
   Moore DP, 2010, PEDIATR INFECT DIS J, V29, P1099, DOI 10.1097/INF.0b013e3181eaefff
   Mpofu N, 2014, PEDIATR INFECT DIS J, V33, P1226, DOI 10.1097/INF.0000000000000523
   Nicol MP, 2013, CLIN INFECT DIS, V57, pE18, DOI 10.1093/cid/cit230
   Nicol MP, 2011, PAEDIATR RESPIR REV, V12, P16, DOI 10.1016/j.prrv.2010.09.008
   Oliwa JN, 2015, LANCET RESP MED, V3, P235, DOI 10.1016/S2213-2600(15)00028-4
   Schumacher SG, 2015, INT J TUBERC LUNG D, V19, P2, DOI 10.5588/ijtld.14.0850
   Swingler GH, 2005, ARCH DIS CHILD, V90, P1153, DOI 10.1136/adc.2004.062315
   Walters E, 2012, PEDIATR INFECT DIS J, V31, P1316, DOI 10.1097/INF.0b013e318266c21c
   World Health Organization, 2011, INT ROADM TUB RES WO
   World Health Organization, 2014, GLOB TUB REP 2014
   World Health Organization, 2014, GUID NAT TUB PROGR M
   World Health Organization, POL UPD XPERT MTB RI
   World Health Organization, 2013, ROADM CHILDH TUB ZER
   Wiseman CA, 2015, INT J TUBERC LUNG D, V19, P446, DOI 10.5588/ijtld.14.0585
   Zar HJ, 2015, CLIN INFECT DIS, V61, pS173, DOI 10.1093/cid/civ622
   Zar HJ, 2010, EXPERT REV ANTI-INFE, V8, P277, DOI [10.1586/eri.10.9, 10.1586/ERI.10.9]
NR 35
TC 9
Z9 9
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2015
VL 61
SU 3
BP S179
EP S187
DI 10.1093/cid/civ581
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CT6WG
UT WOS:000362952900012
PM 26409281
OA No
DA 2017-08-15
ER

PT J
AU Seddon, JA
   McKenna, L
   Shah, T
   Kampmann, B
AF Seddon, James A.
   McKenna, Lindsay
   Shah, Tejshri
   Kampmann, Beate
TI Recent Developments and Future Opportunities in the Treatment of
   Tuberculosis in Children
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE tuberculosis; children; resistant; treatment; prevention
ID MULTIDRUG-RESISTANT TUBERCULOSIS; HIV-INFECTED CHILDREN; PULMONARY
   TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PREVENTING TUBERCULOSIS;
   LATENT TUBERCULOSIS; TREATMENT OUTCOMES; MENINGITIS; MANAGEMENT;
   PHARMACOKINETICS
AB Tuberculosis in children accounts for a significant proportion of the overall burden of disease, and yet for many years research into pediatric treatment has been neglected. Recently, there have been major developments in our understanding of pediatric tuberculosis, and a large number of studies are under way or planned. New drugs and regimens are being evaluated, and older drugs are being repurposed. Shorter regimens with potentially fewer side effects are being assessed for the treatment and prevention of both drug-susceptible and drug-resistant tuberculosis. It may be possible to tailor treatment so that children with less severe disease are given shorter regimens, and weekly dosing is under investigation for preventive therapy and for the continuation phase of treatment. The interaction with human immunodeficiency virus and the management of tuberculosis meningitis are also likely to be better understood. Exciting times lie ahead for pediatric tuberculosis, but much work remains to be done.
C1 [Seddon, James A.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London W2 1NY, England.
   [Seddon, James A.; Shah, Tejshri; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, NHS Healthcare Trust, Dept Paediat Infect Dis, London W2 1NY, England.
   [McKenna, Lindsay] Treatment Act Grp, New York, NY USA.
   [Kampmann, Beate] MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
RP Seddon, JA (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat Infect Dis, Norfolk Pl, London W2 1NY, England.
EM james.seddon@imperial.ac.uk
OI Kampmann, Beate/0000-0002-6546-4709; Seddon, James/0000-0002-2296-2302
FU National Institute for Health Research Biomedical Research Centre at
   Imperial College Healthcare National Health Service Trust and Imperial
   College London
FX This work was supported by the National Institute for Health Research
   Biomedical Research Centre based at Imperial College Healthcare National
   Health Service Trust and Imperial College London.
CR Adler-Shohet FC, 2014, PEDIATR INFECT DIS J, V33, P664, DOI 10.1097/INF.0000000000000260
   Alsaad N, 2014, EUR RESPIR J, V43, P884, DOI 10.1183/09031936.00113713
   Attamna A, 2009, THORAX, V64, P271, DOI 10.1136/thx.2008.100974
   Bamrah S, 2014, INT J TUBERC LUNG D, V18, P912, DOI 10.5588/ijtld.13.0028
   Burkhardt JE, 1997, CLIN INFECT DIS, V25, P1196, DOI 10.1086/516119
   Burman WJ, 2008, PLOS MED, V5, P1168, DOI 10.1371/journal.pmed.0050176
   Centers for Disease Control and Prevention (CDC), 2013, MMWR RECOMM REP, V62, P1
   Centers for Disease Control A Georgia USA, 1992, MMWR-MORBID MORTAL W, P61
   ClinicalTrials.gov, 2011, EV SAF EFF SHORTC RI
   ClinicalTrials.gov, EV STAND TREATM REG
   ClinicalTrials.gov, STUD ASS REL BIOAV T
   ClinicalTrials.gov, PHARM SAF TRIAL DET
   Collective IP, INN PK PD APPR OPT T
   Diacon AH, 2007, ANTIMICROB AGENTS CH, V51, P2994, DOI 10.1128/AAC.01474-06
   Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427
   Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1
   Donald PR, 2011, TUBERCULOSIS, V91, P196, DOI 10.1016/j.tube.2011.02.004
   Donald PR, 2010, TUBERCULOSIS, V90, P279, DOI 10.1016/j.tube.2010.07.002
   Donald PR, 1998, INT J TUBERC LUNG D, V2, P704
   Dooley KE, 2013, J INFECT DIS, V207, P1352, DOI 10.1093/infdis/jis460
   Dooley KE, 2012, CLIN INFECT DIS, V55, P572, DOI 10.1093/cid/cis487
   Esposito S, 2014, EUR RESPIR J, V44, P811, DOI 10.1183/09031936.00060414
   Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6
   European Centre for Disease Prevention and Control, 2012, MAN CONT MDR TB XDR
   Fraser A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005435.pub2
   Frydenberg AR, 2009, TROP MED INT HEALTH, V14, P1329, DOI 10.1111/j.1365-3156.2009.02375.x
   Furin J, 2013, INT J TUBERC LUNG D, V17, P1239, DOI 10.5588/ijtld.13.0196
   Garcia-Prats AJ, 2014, TUBERCULOSIS, V94, P93, DOI 10.1016/j.tube.2013.10.003
   Garie KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026452
   Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426
   Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433
   Hallbauer U. M., 2011, Southern African Journal of Epidemiology & Infection, V26, P161
   Heemskerk D, 2011, TRIALS, V2, P12
   INGHAM B, 1977, TOXICOL LETT, V1, P21, DOI 10.1016/0378-4274(77)90016-9
   Iseman M D, 2002, Eur Respir J Suppl, V36, p87s
   ISRCTN Registry, SHINE STUD SHORT TRE
   Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1
   Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210
   Kam KM, 2006, MICROB DRUG RESIST, V12, P7, DOI 10.1089/mdr.2006.12.7
   Kroger A, 2008, TROP MED INT HEALTH, V13, P594, DOI 10.1111/j.1365-3156.2008.02045.x
   Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964
   Liwa AC, 2013, J TROP PEDIATRICS, V59, P90, DOI 10.1093/tropej/fms053
   Marais BJ, 2006, ARCH DIS CHILD, V91, P762, DOI 10.1136/adc.2006.097220
   Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO
   Marx GE, 2011, TUBERC RES TREAT, V2011, DOI DOI 10.1155/2011/798764
   McIlleron H, 2011, ANTIVIR THER, V16, P417, DOI 10.3851/IMP1757
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817
   Misra UK, 2010, J NEUROL SCI, V293, P12, DOI 10.1016/j.jns.2010.03.025
   Nachman S, 2015, LANCET INFECT DIS, V15, P711, DOI 10.1016/S1473-3099(15)00007-9
   National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T
   Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003
   National Institutes of Health, HOST DIR TB THER NEW
   Noel GJ, 2007, PEDIATR INFECT DIS J, V26, P879, DOI 10.1097/INF.0b013e3180cbd382
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6
   Prasad K, 2008, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858
   Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257
   Ren Y, 2009, JAIDS-J ACQ IMM DEF, V50, P439, DOI 10.1097/QAI.0b013e31819c33a3
   Rodriguez JC, 2001, INT J ANTIMICROB AG, V17, P229, DOI 10.1016/S0924-8579(00)00337-X
   Ruslami R, 2013, LANCET INFECT DIS, V13, P27, DOI 10.1016/S1473-3099(12)70264-5
   Schaaf HS, 2014, CURR OPIN INFECT DIS, V27, P211, DOI 10.1097/QCO.0000000000000062
   Schaaf HS, 2011, PAEDIATR RESPIR REV, V12, P31, DOI 10.1016/j.prrv.2010.09.010
   Schoeman JF, 2006, J CHILD NEUROL, V21, P301, DOI 10.2310/7010.2006.00071
   Schoeman JF, 2004, J CHILD NEUROL, V19, P250, DOI 10.1177/088307380401900402
   Schoeman JF, 2011, J CHILD NEUROL, V26, P956, DOI 10.1177/0883073811398132
   Schoeman JF, 2010, J CHILD NEUROL, V25, P822, DOI 10.1177/0883073809350507
   Seddon James A, 2013, J Pediatric Infect Dis Soc, V2, P100, DOI 10.1093/jpids/pit012
   Seddon JA, 2014, THORAX, V69, P471, DOI 10.1136/thoraxjnl-2013-203900
   Seddon JA, 2013, CLIN INFECT DIS, V57, P1676, DOI 10.1093/cid/cit655
   Seddon JA, 2013, J INFECTION, V66, P320, DOI 10.1016/j.jinf.2012.09.002
   Seddon JA, 2012, AM J RESP CRIT CARE, V186, P953, DOI 10.1164/rccm.201206-1001CI
   Seddon JA, 2012, LANCET INFECT DIS, V12, P469, DOI 10.1016/S1473-3099(11)70366-8
   The Sentinel Project for Pediatric Drug-Resistant Tuberculosis, 2012, MAN MULT RES TUB CHI
   Shah I, 2014, J CLIN NEUROSCI, V21, P761, DOI 10.1016/j.jocn.2013.07.021
   Skripconoka V, 2013, EUR RESPIR J, V41, P1393, DOI 10.1183/09031936.00125812
   Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875
   TB Alliance, 2012, TB ALL REC GRANT UNI
   Thee S, 2014, ANTIMICROB AGENTS CH, V58, P2948, DOI 10.1128/AAC.02755-13
   Thee S, 2011, ANTIMICROB AGENTS CH, V55, P5560, DOI 10.1128/AAC.05429-11
   Thee S, 2011, ANTIMICROB AGENTS CH, V55, P4594, DOI 10.1128/AAC.00379-11
   Thee S, 2011, INT J TUBERC LUNG D, V15, P1191, DOI 10.5588/ijtld.10.0707
   Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6
   Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023
   Treatment Action Group, 2014 REP TUB RES FUN
   van der Werf MJ, 2012, INT J TUBERC LUNG D, V16, P288, DOI 10.5588/ijtld.11.0437
   van der Werf MJ, 2012, INT J TUBERC LUNG D, V16, P426, DOI 10.5588/ijtld.11.0605
   Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC
   van Toorn R, 2014, PEDIATR INFECT DIS J, V33, P248, DOI 10.1097/INF.0000000000000065
   van Well Gijs T J, 2009, Pediatrics, V123, pe1, DOI 10.1542/peds.2008-1353
   Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158
   Walters E, 2013, PEDIATR INFECT DIS J, V32, P361, DOI 10.1097/INF.0b013e318279c800
   Weiner Marc, 2014, J Pediatric Infect Dis Soc, V3, P132, DOI 10.1093/jpids/pit077
   World Health Organization, 2008, WHOHTMTB2008402
   World Health Organization, 2006, WHOHTMTB2006365
   World Health Organization, 2014, GUID NAT TUB PROGR M
   World Health Organization, WHOHTMTB20136
   World Health Organization, 2010, WHOHTMTB201013
   Alvarez-Uria G., 2012, ANT THER HIV INF INF, V1, pe14
   Wiseman CA, 2012, PEDIATR INFECT DIS J, V31, P347, DOI 10.1097/INF.0b013e318243e27b
   Working Group on New TB Drugs, DRUG PIP
   Yee CL, 2002, PEDIATR INFECT DIS J, V21, P525, DOI 10.1097/01.inf.0000015367.34699.b0
   Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001
   Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1
NR 102
TC 1
Z9 1
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2015
VL 61
SU 3
BP S188
EP S199
DI 10.1093/cid/civ582
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CT6WG
UT WOS:000362952900013
PM 26409282
OA No
DA 2017-08-15
ER

PT J
AU Adetifa, IMO
   Muhammad, AK
   Jeffries, D
   Donkor, S
   Borgdorff, MW
   Corrah, T
   D'Alessandro, U
AF Adetifa, Ifedayo M. O.
   Muhammad, Abdul Khalie
   Jeffries, David
   Donkor, Simon
   Borgdorff, Martien W.
   Corrah, Tumani
   D'Alessandro, Umberto
TI A Tuberculin Skin Test Survey and the Annual Risk of Mycobacterium
   tuberculosis Infection in Gambian School Children
SO PLOS ONE
LA English
DT Article
ID HIGH-PREVALENCE COUNTRIES; GAMMA RELEASE ASSAYS; METHODOLOGICAL ISSUES;
   HIV EPIDEMIC; SENSITIVITY; POPULATION; GUIDELINES; DIAGNOSIS; TANZANIA;
   AFRICA
AB Background
   A Tuberculin skin test (TST) survey was conducted to assess the prevalence of latent TB Infection (LTBI) and to estimate the annual risk of M. tuberculosis infection (ARTI) in Gambian school children. The results are expected to contribute to understanding of Tuberculosis epidemiology in The Gambia.
   Methods
   This was a nationwide, multi-cluster survey in children aged 6-11 years. Districts, 20 of 37, were selected by probability proportional to size and schools by simple random sampling. All TST were performed using the Mantoux method. Height and weight measurements were obtained for all participants. We calculated prevalence of LTBI using cut-off points of 10mm, the mirror and mixture modelling methods.
   Results
   TST readings were completed 13,386 children with median age of 9 years (interquartile range [IQR] 8-10 years). Mixture analysis yielded a cut-off point of 12 mm, and LTBI prevalence of 6.9% [95% CI 6.47-7.37] and the ARTI was 0.75%[95% CI 0.60-0.91]. LTBI was associated gender and urban residence (p < 0.01). Nutritional status was not associated with non-reactive TST or sizes of TST indurations. ARTI did not differ significantly by age, gender, BCG vaccination or residence.
   Conclusions
   This estimates for LTBI prevalence and ARTI were low but this survey provides updated data. Malnutrition did not affect estimates of LTBI and ARTI. Given the low ARTI in this survey and the overlapping distribution of indurations with mixture modelling, further surveys may require complementary tests such as interferon gamma release assays or novel diagnostic tools.
C1 [Adetifa, Ifedayo M. O.; Muhammad, Abdul Khalie; Jeffries, David; Donkor, Simon; Corrah, Tumani; D'Alessandro, Umberto] Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Banjul, Gambia.
   [Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
RP Adetifa, IMO (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM Ifedayo.Adetifa@lshtm.ac.uk
FU Global Fund to fight against AIDS, Tuberculosis and Malaria through
   grant GMD-T-MRC; Medical Research Council Unit-The Gambia
FX This project was funded by Global Fund to fight against AIDS,
   Tuberculosis and Malaria through grant GMD-T-MRC, and the Medical
   Research Council Unit-The Gambia. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Addo KK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-35
   Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122
   Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da
   Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6
   Arnadottir T, 2001, INT J TUBERC LUNG D, V5, P391
   Bleiker MA, 1976, SKIN SENSITIVITY HUM
   Chadha VK, 2000, IND J TUB, V47
   Corrah PT, 1994, STUDIES TUBERCULOSIS
   DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Egwaga SA, 2006, AIDS, V20, P915, DOI 10.1097/01.aids.0000218557.44284.83
   Eilers P H C, 2004, Int J Tuberc Lung Dis, V8, P232
   ELLIOTT A, 1985, ANN TROP PAEDIATR, V5, P185
   Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962
   Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133
   Gambia Bureau of Statistics [GBoS], GAMB 2013 POP HOUS C
   Gninafon M, 2011, INT J TUBERC LUNG D, V15, P61
   Hossain S, 2013, INT J TUBERC LUNG D, V17, P1267, DOI 10.5588/ijtld.13.0114
   HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968
   Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x
   Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC
   Minime-Lingoupou F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1829-8
   National Leprosy and Tuberculosis Control Programme Ministry of Health and Social Welfare, 2007, NAT GUID MAN TUB 200
   Rieder HL, 2011, INT J TUBERC LUNG D, V15, P662, DOI 10.5588/ijtld.10.0433
   Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1
   RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9
   ROELSGAARD E., 1964, BULL WORLD HEALTH ORGAN, V30, P459
   Royston P., 1991, STATA TECHNICAL B, V3, P23
   Styblo K, 2001, INT J TUBERC LUNG D, V5, P103
   [Anonymous], 2014 HUM DEV REP
   UNAIDS, 2013, GAMB HIV AIDS EST
   Wangchuk LZ, 2013, INT J TUBERC LUNG D, V17, P468, DOI 10.5588/ijtld.12.0668
   World Health Organization, GROWTH REF 5 19 YEAR
   World Health Organization, 2007, ASS TUB PREV POP BAS
   World Health Organization United Nations Children's Fund, IMM SUMM
   WHO Tuberculosis Research Office, 1955, B WORLD HEALTH ORGAN, V12, P169
NR 36
TC 1
Z9 1
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 14
PY 2015
VL 10
IS 10
AR e0139354
DI 10.1371/journal.pone.0139354
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CU0CK
UT WOS:000363183100046
PM 26465745
OA gold
DA 2017-08-15
ER

PT J
AU Oriero, EC
   Okebe, J
   Jacobs, J
   Van Geertruyden, JP
   Nwakanma, D
   D'Alessandro, U
AF Oriero, Eniyou C.
   Okebe, Joseph
   Jacobs, Jan
   Van Geertruyden, Jean-Pierre
   Nwakanma, Davis
   D'Alessandro, Umberto
TI Diagnostic performance of a novel loop-mediated isothermal amplification
   (LAMP) assay targeting the apicoplast genome for malaria diagnosis in a
   field setting in sub-Saharan Africa
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria diagnosis; LAMP; RDT; Microscopy; PCR; Field-based;
   Resource-limited settings
ID DRIED BLOOD SPOTS; INFECTIONS; PARASITE; KIT; TRANSMISSION; PREVALENCE;
   CARRIERS; SAMPLES; GAMBIA
AB Background: New diagnostic tools to detect reliably and rapidly asymptomatic and low-density malaria infections are needed as their treatment could interrupt transmission. Isothermal amplification techniques are being explored for field diagnosis of malaria. In this study, a novel molecular tool (loop-mediated isothermal amplification-LAMP) targeting the apicoplast genome of Plasmodium falciparum was evaluated for the detection of asymptomatic malaria-infected individuals in a rural setting in The Gambia.
   Methods: A blood was collected from 341 subjects (median age 9 years, range 1-68 years) screened for malaria. On site, a rapid diagnostic test (RDT, SD Bioline Malaria Antigen P.f) was performed, thick blood films (TBF) slides for microscopy were prepared and dry blood spots (DBS) were collected on Whatman (R) 903 Specimen collection paper. The TBF and DBS were transported to the field laboratory where microscopy and LAMP testing were performed. The latter was done on DNA extracted from the DBS using a crude (methanol/heating) extraction method. A laboratory-based PCR amplification was done on all the samples using DNA extracted with the Qiagen kit and its results were taken as reference for all the other tests.
   Results: Plasmodium falciparum malaria prevalence was 37 % (127/341) as detected by LAMP, 30 % (104/341) by microscopy and 37 % (126/341) by RDT. Compared to the reference PCR method, sensitivity was 92 % for LAMP, 78 % for microscopy, and 76 % for RDT; specificity was 97 % for LAMP, 99 % for microscopy, and 88 % for RDT. Area under the receiver operating characteristic (ROC) curve in comparison with the reference standard was 0.94 for LAMP, 0.88 for microscopy and 0.81 for RDT. Turn-around time for the entire LAMP assay was approximately 3 h and 30 min for an average of 27 +/- 9.5 samples collected per day, compared to a minimum of 10 samples an hour per operator by RDT and over 8 h by microscopy.
   Conclusion: The LAMP assay could produce reliable results the same day of the screening. It could detect a higher proportion of low density malaria infections than the other methods tested and may be used for large campaigns of systematic screening and treatment.
C1 [Oriero, Eniyou C.; Okebe, Joseph; Nwakanma, Davis; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia.
   [Oriero, Eniyou C.; Okebe, Joseph; Jacobs, Jan; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Oriero, Eniyou C.; Okebe, Joseph; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.
   [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Oriero, EC (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM eoriero@mrc.gm
FU UK Medical Research Council (MRC); UK Department for International
   Development (DFID) under the MRC/DFID
FX We would like to thank all the study participants who made this study
   possible. We acknowledge the entire field and laboratory staff of the
   PRINOGAM Trial, as well as David Jefferies for statistical support. This
   study has been jointly funded by The UK Medical Research Council (MRC)
   and the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement.
CR Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364
   Canier L, 2015, AM J TROP MED HYG, V92, P573, DOI 10.4269/ajtmh.14-0614
   Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149
   Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06
   Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]
   Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184
   Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10
   Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]
   malERA, 2011, PLOS MED, V8
   Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7
   McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x
   Okebe J, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0597-1
   Oriero CE, 2015, CLIN MICROBIOL INFEC, V21
   Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183
   Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10
   Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274
   Sattabongkot J, 2014, J CLIN MICROBIOL, V52, P1471, DOI 10.1128/JCM.03313-13
   Sirichaisinthop J, 2011, AM J TROP MED HYG, V85, P594, DOI 10.4269/ajtmh.2011.10-0676
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8
   Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108
   Vallejo AF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003453
NR 22
TC 3
Z9 3
U1 2
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD OCT 9
PY 2015
VL 14
AR 396
DI 10.1186/s12936-015-0926-6
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CT2KO
UT WOS:000362630600003
PM 26450599
OA gold
DA 2017-08-15
ER

PT J
AU Band, G
   Rockett, KA
   Spencer, CCA
   Kwiatkowski, DP
   Band, G
   Le, QS
   Clarke, GM
   Kivinen, K
   Leffler, EM
   Rockett, KA
   Kwiatkowski, DP
   Spencer, CCA
   Rockett, KA
   Spencer, CCA
   Cornelius, V
   Conway, DJ
   Williams, TN
   Taylor, T
   Kwiatkowski, DP
   Conway, DJ
   Bojang, KA
   Doumbo, O
   Thera, MA
   Modiano, D
   Sirima, SB
   Wilson, MD
   Koram, KA
   Agbenyega, T
   Achidi, E
   Williams, TN
   Marsh, K
   Reyburn, H
   Drakeley, C
   Riley, E
   Taylor, T
   Molyneux, M
   Jallow, M
   Bojang, KA
   Conway, DJ
   Pinder, M
   Doumbo, O
   Thera, MA
   Toure, OB
   Konate, S
   Sissoko, S
   Bougouma, EC
   Mangano, VD
   Modiano, D
   Sirima, SB
   Amenga-Etego, LN
   Ghansah, AK
   Hodgson, AVO
   Koram, KA
   Wilson, MD
   Agbenyega, T
   Ansong, D
   Enimil, A
   Evans, J
   Achidi, E
   Apinjoh, TO
   Macharia, A
   Marsh, K
   Ndila, CM
   Newton, C
   Peshu, N
   Uyoga, S
   Williams, TN
   Drakeley, C
   Manjurano, A
   Reyburn, H
   Riley, E
   Kachala, D
   Molyneux, M
   Nyirongo, V
   Taylor, T
   Rockett, KA
   Kivinen, K
   Mead, D
   Drury, E
   Auburn, S
   Campino, SG
   MacInnis, B
   Stalker, J
   Gray, E
   Hubbart, C
   Jeffreys, AE
   Rowlands, K
   Mendy, A
   Craik, R
   Fitzpatrick, K
   Molloy, S
   Hart, L
   Hutton, R
   Kerasidou, A
   Johnson, KJ
   Cornelius, V
AF Band, Gavin
   Rockett, Kirk A.
   Spencer, Chris C. A.
   Kwiatkowski, Dominic P.
   Band, Gavin
   Le, Quang Si
   Clarke, Geraldine M.
   Kivinen, Katja
   Leffler, Ellen M.
   Rockett, Kirk A.
   Kwiatkowski, Dominic P.
   Spencer, Chris C. A.
   Rockett, Kirk A.
   Spencer, Chris C. A.
   Cornelius, Victoria
   Conway, David J.
   Williams, Thomas N.
   Taylor, Terrie
   Kwiatkowski, Dominic P.
   Conway, David J.
   Bojang, Kalifa A.
   Doumbo, Ogobara
   Thera, Mahamadou A.
   Modiano, David
   Sirima, Sodiomon B.
   Wilson, Michael D.
   Koram, Kwadwo A.
   Agbenyega, Tsiri
   Achidi, Eric
   Williams, Thomas N.
   Marsh, Kevin
   Reyburn, Hugh
   Drakeley, Chris
   Riley, Eleanor
   Taylor, Terrie
   Molyneux, Malcolm
   Jallow, Muminatou
   Bojang, Kalifa A.
   Conway, David J.
   Pinder, Margaret
   Doumbo, Ogobara
   Thera, Mahamadou A.
   Toure, Ousmane B.
   Konate, Salimata
   Sissoko, Sibiri
   Bougouma, Edith C.
   Mangano, Valentina D.
   Modiano, David
   Sirima, Sodiomon B.
   Amenga-Etego, Lucas N.
   Ghansah, Anita K.
   Hodgson, Abraham V. O.
   Koram, Kwadwo A.
   Wilson, Michael D.
   Agbenyega, Tsiri
   Ansong, Daniel
   Enimil, Anthony
   Evans, Jennifer
   Achidi, Eric
   Apinjoh, Tobias O.
   Macharia, Alexander
   Marsh, Kevin
   Ndila, Carolyne M.
   Newton, Charles
   Peshu, Norbert
   Uyoga, Sophie
   Williams, Thomas N.
   Drakeley, Chris
   Manjurano, Alphaxard
   Reyburn, Hugh
   Riley, Eleanor
   Kachala, David
   Molyneux, Malcolm
   Nyirongo, Vysaul
   Taylor, Terrie
   Rockett, Kirk A.
   Kivinen, Katja
   Mead, Daniel
   Drury, Eleanor
   Auburn, Sarah
   Campino, Susana G.
   MacInnis, Bronwyn
   Stalker, Jim
   Gray, Emma
   Hubbart, Christina
   Jeffreys, Anna E.
   Rowlands, Kate
   Mendy, Alieu
   Craik, Rachel
   Fitzpatrick, Kathryn
   Molloy, Sile
   Hart, Lee
   Hutton, Robert
   Kerasidou, Angeliki
   Johnson, Kimberly J.
   Cornelius, Victoria
CA Malaria Genomic Epidemiology
TI A novel locus of resistance to severe malaria in a region of ancient
   balancing selection
SO NATURE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; HUMAN X-CHROMOSOME; PLASMODIUM-FALCIPARUM;
   NATURAL-SELECTION; POPULATION-STRUCTURE; GENE; ORIGIN; SUSCEPTIBILITY;
   POLYMORPHISMS; GLYCOPHORINS
AB The high prevalence of sickle haemoglobin in Africa shows that malaria has been a major force for human evolutionary selection, but surprisingly few other polymorphisms have been proven to confer resistance to malaria in large epidemiological studies(1-3). To address this problem, we conducted a multi-centre genome-wide association study (GWAS) of life-threatening Plasmodium falciparum infection (severe malaria) in over 11,000 African children, with replication data in a further 14,000 individuals. Here we report a novel malaria resistance locus close to a cluster of genes encoding glycophorins that are receptors for erythrocyte invasion by P. falciparum. We identify a haplotype at this locus that provides 33% protection against severe malaria (odds ratio = 0.67, 95% confidence interval = 0.60-0.76, P value = 9.5 x 10(-11)) and is linked to polymorphisms that have previously been shown to have features of ancient balancing selection, on the basis of haplotype sharing between humans and chimpanzees(4). Taken together with previous observations on the malaria-protective role of blood group O-1-3,O-5, these data reveal that two of the strongest GWAS signals for severe malaria lie in or close to genes encoding the glycosylated surface coat of the erythrocyte cell membrane, both within regions of the genome where it appears that evolution has maintained diversity for millions of years. These findings provide new insights into the host-parasite interactions that are critical in determining the outcome of malaria infection.
C1 [Band, Gavin; Rockett, Kirk A.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.; Band, Gavin; Le, Quang Si; Clarke, Geraldine M.; Leffler, Ellen M.; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Spencer, Chris C. A.; Rockett, Kirk A.; Spencer, Chris C. A.; Cornelius, Victoria; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Auburn, Sarah; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Mendy, Alieu; Craik, Rachel; Fitzpatrick, Kathryn; Molloy, Sile; Hart, Lee; Hutton, Robert; Kerasidou, Angeliki; Johnson, Kimberly J.; Cornelius, Victoria] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.
   [Rockett, Kirk A.; Kivinen, Katja; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Kivinen, Katja; Mead, Daniel; Drury, Eleanor; Campino, Susana G.; MacInnis, Bronwyn; Stalker, Jim; Gray, Emma] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Conway, David J.; Conway, David J.; Bojang, Kalifa A.; Jallow, Muminatou; Bojang, Kalifa A.; Conway, David J.; Pinder, Margaret] MRC Unit, Fajara, Gambia.
   [Conway, David J.; Conway, David J.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England.
   [Williams, Thomas N.; Williams, Thomas N.; Marsh, Kevin; Macharia, Alexander; Marsh, Kevin; Ndila, Carolyne M.; Newton, Charles; Peshu, Norbert; Uyoga, Sophie; Williams, Thomas N.] KEMRI Wellcome Trust Res Programme CGMRC, Kilifi, Kenya.
   [Williams, Thomas N.; Williams, Thomas N.; Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, London SW7 2AZ, England.
   [Taylor, Terrie; Taylor, Terrie; Taylor, Terrie] Queen Elizabeth Cent Hosp, Coll Med, Blantyre Malaria Project, Chichiri, Malawi.
   [Taylor, Terrie; Taylor, Terrie; Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA.
   [Doumbo, Ogobara; Thera, Mahamadou A.; Doumbo, Ogobara; Thera, Mahamadou A.; Toure, Ousmane B.; Konate, Salimata; Sissoko, Sibiri] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali.
   [Modiano, David; Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, I-00185 Rome, Italy.
   [Sirima, Sodiomon B.; Bougouma, Edith C.; Sirima, Sodiomon B.] CNRFP, Ouagadougou, Burkina Faso.
   [Wilson, Michael D.; Koram, Kwadwo A.; Ghansah, Anita K.; Koram, Kwadwo A.; Wilson, Michael D.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Accra, Ghana.
   [Agbenyega, Tsiri; Agbenyega, Tsiri; Ansong, Daniel; Enimil, Anthony; Mendy, Alieu] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Agbenyega, Tsiri; Ansong, Daniel] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana.
   [Achidi, Eric; Achidi, Eric] Univ Buea, Dept Med Lab Sci, Buea, South West Regi, Cameroon.
   [Reyburn, Hugh; Drakeley, Chris; Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania.
   [Reyburn, Hugh; Drakeley, Chris; Riley, Eleanor; Drakeley, Chris; Manjurano, Alphaxard; Reyburn, Hugh; Riley, Eleanor] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.
   [Molyneux, Malcolm; Kachala, David; Molyneux, Malcolm; Nyirongo, Vysaul] Queen Elizabeth Cent Hosp, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.
   [Jallow, Muminatou] Royal Victoria Teaching Hosp, Banjul, Gambia.
   [Amenga-Etego, Lucas N.; Hodgson, Abraham V. O.] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Evans, Jennifer] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20324 Hamburg, Germany.
   [Evans, Jennifer] KNUST, Sch Med Sci, Kumasi Ctr Collaborat Res, Kumasi, Ghana.
   [Apinjoh, Tobias O.] Univ Buea, Dept Biochem & Mol Biol, Buea, South West Regi, Cameroon.
   [Kerasidou, Angeliki] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford OX3 7LF, England.
RP Band, G (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.
RI Newton, 21/B-7578-2014
OI Newton, 21/0000-0002-6999-5507; Mangano, Valentina
   D/0000-0002-2021-6162; ANSONG, Daniel/0000-0003-1328-9117; Kivinen,
   Katja/0000-0002-1135-7625; Leffler, Ellen/0000-0002-1614-9366;
   Kwiatkowski, Dominic/0000-0002-5023-0176; Mead,
   Daniel/0000-0001-7717-4330; Auburn, Sarah/0000-0002-4638-536X; Conway,
   David/0000-0002-8711-3037
FU Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 075491/Z/04,
   090532/Z/09/Z, 077012/Z/05/Z, 098051, 076934/Z/05/Z, 091758/Z/10/Z,
   084538]; Bill & Melinda Gates Foundation through the Foundations of the
   National Institutes of Health (NIH) as part of the Grand Challenges in
   Global Health Initiative [566]; Medical Research Council (MRC)
   [G0600718, G0600230]; Wellcome Trust Biomedical ethics Enhancement Award
   [087285]; Strategic Award [096527]; MRC [G19/9, G9901439]; Wellcome
   Trust Career Development Fellowship [097364/Z/11/Z]; National Institute
   of Allergy and Infectious Diseases (NIAID) [N01AI85346, U19AI065683];
   Fogarty International Centre, NIH [D43TW001589]; Mali-NIAID/NIH
   International Center for Excellence in Research at the University of
   Sciences, Techniques, and Technology of Bamako; European Community's
   Seventh Framework Programme (FP7) [242095-EVIMalaR]; Central African
   Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM) - European and
   Developing Countries Clinical Trials Partnership (EDCTP)
FX The Malaria Genomic Epidemiology Network Project is supported by the
   Wellcome Trust (WT077383/Z/05/Z) and the Bill & Melinda Gates Foundation
   through the Foundations of the National Institutes of Health (NIH; 566)
   as part of the Grand Challenges in Global Health Initiative. The
   Resource Centre for Genomic Epidemiology of Malaria is supported by the
   Wellcome Trust (090770/Z/09/Z). This research was supported by the
   Medical Research Council (MRC; G0600718; G0600230), the Wellcome Trust
   Biomedical ethics Enhancement Award (087285) and Strategic Award
   (096527). D.P.K. receives support from the MRC (G19/9). C.C.A.S. was
   supported by a Wellcome Trust Career Development Fellowship
   (097364/Z/11/Z). The Wellcome Trust also provides core awards to The
   Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z)
   and the Wellcome Trust Sanger Institute (077012/Z/05/Z and 098051). The
   Mali MRTC-BMP group is supported by a contract (N01AI85346) and a
   cooperative agreement (U19AI065683) from the National Institute of
   Allergy and Infectious Diseases (NIAID) and by a grant (D43TW001589)
   from the Fogarty International Centre, NIH to University of Maryland and
   University of Bamako and the Mali-NIAID/NIH International Center for
   Excellence in Research at the University of Sciences, Techniques, and
   Technology of Bamako. E.A. received partial funding from the European
   Community's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no. 242095-EVIMalaR and the Central African Network for
   Tuberculosis, HIV/AIDS and Malaria (CANTAM) funded by the European and
   Developing Countries Clinical Trials Partnership (EDCTP). T.N.W. is
   funded by Senior Fellowships from the Wellcome Trust (076934/Z/05/Z and
   091758/Z/10/Z) and through the European Community's Seventh Framework
   Programme (FP7/2007-2013) under grant agreement no. 242095-EVIMalaR. The
   KEMRI-Wellcome Trust Programme is funded through core support from the
   Wellcome Trust. C.M.N. is supported through a strategic award to the
   KEMRI-Wellcome Trust Programme by the Wellcome Trust (084538).
   Tanzania/Kilimanjaro Christian Medical College Joint Malaria Programme,
   Moshi, Tanzania received funding from MRC grant number G9901439. We
   acknowledge the work of B. Poudiougou and A. Niangaly for their help in
   collecting clinical data and biological samples for the Bamako study. We
   thank L. Jostins and M. Pirinen for advice on statistical analyses.
CR Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307
   Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509
   Baum J, 2002, MOL BIOL EVOL, V19, P223
   Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599
   Binks RH, 2001, MOL BIOCHEM PARASIT, V114, P63, DOI 10.1016/S0166-6851(01)00240-7
   BLUMENFELD OO, 1995, HUM MUTAT, V6, P199, DOI 10.1002/humu.1380060302
   Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440
   Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307
   Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331
   Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386
   Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173
   Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997
   Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466
   Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354
   Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529
   Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388
   Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449
   Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734
   Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103
   Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]
   Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005
   Lanzillotti R, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-100
   Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191
   Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070
   Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442
   Manjurano A, 2015, J INFECT DIS, V212, P1129, DOI 10.1093/infdis/jiv192
   Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174
   Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106
   Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754
   Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586
   Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106
   Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107
   Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440
   Segurel L, 2012, P NATL ACAD SCI USA, V109, P18493, DOI 10.1073/pnas.1210603109
   SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226
   Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639
   Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311
   Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123
   Teo Yik Ying, 2012, Methods Mol Biol, V850, P525, DOI 10.1007/978-1-61779-555-8_29
   Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731
   Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334
   Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359
   Wang HY, 2003, MOL BIOL EVOL, V20, P1795, DOI 10.1093/molbev/msg185
   Wellcome Trust Case Control C., 2012, NAT GENET, V44, P1294, DOI DOI 10.1038/NG.2435
   Wellcome Trust Case Control Consortium, 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911
   Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229
   World Health Organization, 2000, T R SOC TROP MED S1, V94, pS1, DOI DOI 10.1016/S0035-9203(00)90300-6
   Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693
NR 52
TC 21
Z9 21
U1 8
U2 32
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD OCT 8
PY 2015
VL 526
IS 7572
BP 253
EP +
DI 10.1038/nature15390
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS9GV
UT WOS:000362399000047
OA No
DA 2017-08-15
ER

PT J
AU Altshuler, DM
   Durbin, RM
   Abecasis, GR
   Bentley, DR
   Chakravarti, A
   Clark, AG
   Donnelly, P
   Eichler, EE
   Flicek, P
   Gabriel, SB
   Gibbs, RA
   Green, ED
   Hurles, ME
   Knoppers, BM
   Korbel, JO
   Lander, ES
   Lee, C
   Lehrach, H
   Mardis, ER
   Marth, GT
   McVean, GA
   Nickerson, DA
   Schmidt, JP
   Sherry, ST
   Wang, J
   Wilson, RK
   Gibbs, RA
   Boerwinkle, E
   Doddapaneni, H
   Han, Y
   Korchina, V
   Kovar, C
   Lee, S
   Muzny, D
   Reid, JG
   Zhu, YM
   Wang, J
   Chang, YQ
   Feng, Q
   Fang, XD
   Guo, XS
   Jian, M
   Jiang, H
   Jin, X
   Lan, TM
   Li, GQ
   Li, JX
   Li, YR
   Liu, SM
   Liu, X
   Lu, Y
   Ma, XD
   Tang, MF
   Wang, B
   Wang, GB
   Wu, HL
   Wu, RH
   Xu, X
   Yin, Y
   Zhang, DD
   Zhang, WW
   Zhao, J
   Zhao, MR
   Zheng, XL
   Lander, ES
   Altshuler, DM
   Gabriel, SB
   Gupta, N
   Gharani, N
   Toji, LH
   Gerry, NP
   Resch, AM
   Flicek, P
   Barker, J
   Clarke, L
   Gil, L
   Hunt, SE
   Kelman, G
   Kulesha, E
   Leinonen, R
   McLaren, WM
   Radhakrishnan, R
   Roa, A
   Smirnov, D
   Smith, RE
   Streeter, I
   Thormann, A
   Toneva, I
   Vaughan, B
   Zheng-Bradley, X
   Bentley, DR
   Grocock, R
   Humphray, S
   James, T
   Kingsbury, Z
   Lehrach, H
   Sudbrak, R
   Albrecht, MW
   Amstislavskiy, VS
   Borodina, TA
   Lienhard, M
   Mertes, F
   Sultan, M
   Timmermann, B
   Yaspo, ML
   Mardis, ER
   Wilson, RK
   Fulton, L
   Fulton, R
   Sherry, ST
   Ananiev, V
   Belaia, Z
   Beloslyudtsev, D
   Bouk, N
   Chen, C
   Church, D
   Cohen, R
   Cook, C
   Garner, J
   Hefferon, T
   Kimelman, M
   Liu, CL
   Lopez, J
   Meric, P
   O'Sullivan, C
   Ostapchuk, Y
   Phan, L
   Ponomarov, S
   Schneider, V
   Shekhtman, E
   Sirotkin, K
   Slotta, D
   Zhang, H
   McVean, GA
   Durbin, RM
   Balasubramaniam, S
   Burton, J
   Danecek, P
   Keane, TM
   Kolb-Kokocinski, A
   McCarthy, S
   Stalker, J
   Quail, M
   Schmidt, JP
   Davies, CJ
   Gollub, J
   Webster, T
   Wong, B
   Zhan, YP
   Auton, A
   Campbell, CL
   Kong, Y
   Marcketta, A
   Gibbs, RA
   Yu, FL
   Antunes, L
   Bainbridge, M
   Muzny, D
   Sabo, A
   Huang, ZY
   Wang, J
   Coin, LJM
   Fang, L
   Guo, XS
   Jin, X
   Li, GQ
   Li, QB
   Li, YR
   Li, ZY
   Lin, HX
   Liu, BH
   Luo, RB
   Shao, HJ
   Xie, YL
   Ye, C
   Yu, C
   Zhang, F
   Zheng, HC
   Zhu, HM
   Alkan, C
   Dal, E
   Kahveci, F
   Marth, GT
   Garrison, EP
   Kural, D
   Lee, WP
   Leong, WF
   Stromberg, M
   Ward, AN
   Wu, JT
   Zhang, MY
   Daly, MJ
   DePristo, MA
   Handsaker, RE
   Altshuler, DM
   Banks, E
   Bhatia, G
   del Angel, G
   Gabriel, SB
   Genovese, G
   Gupta, N
   Li, H
   Kashin, S
   Lander, ES
   McCarroll, SA
   Nemesh, JC
   Poplin, RE
   Yoon, SC
   Lihm, J
   Makarov, V
   Clark, AG
   Gottipati, S
   Keinan, A
   Rodriguez-Flores, JL
   Korbel, JO
   Rausch, T
   Fritz, MH
   Stuetz, AM
   Flicek, P
   Beal, K
   Clarke, L
   Datta, A
   Herrero, J
   McLaren, WM
   Ritchie, GRS
   Smith, RE
   Zerbino, D
   Zheng-Bradley, X
   Sabeti, PC
   Shlyakhter, I
   Schaffner, SF
   Vitti, J
   Cooper, DN
   Ball, EV
   Stenson, PD
   Bentley, DR
   Barnes, B
   Bauer, M
   Cheetham, RK
   Cox, A
   Eberle, M
   Humphray, S
   Kahn, S
   Murray, L
   Peden, J
   Shaw, R
   Kenny, EE
   Batzer, MA
   Konkel, MK
   Walker, JA
   MacArthur, DG
   Lek, M
   Sudbrak, R
   Amstislavskiy, VS
   Herwig, R
   Mardis, ER
   Ding, L
   Koboldt, DC
   Larson, D
   Ye, K
   Gravel, S
   Swaroop, A
   Chew, E
   Lappalainen, T
   Erlich, Y
   Gymrek, M
   Willems, TF
   Simpson, JT
   Shriver, MD
   Rosenfeld, JA
   Bustamante, CD
   Montgomery, SB
   De La Vega, FM
   Byrnes, JK
   Carroll, AW
   DeGorter, MK
   Lacroute, P
   Maples, BK
   Martin, AR
   Moreno-Estrada, A
   Shringarpure, SS
   Zakharia, F
   Halperin, E
   Baran, Y
   Lee, C
   Cerveira, E
   Hwang, J
   Malhotra, A
   Plewczynski, D
   Radew, K
   Romanovitch, M
   Zhang, CS
   Hyland, FCL
   Craig, DW
   Christoforides, A
   Homer, N
   Izatt, T
   Kurdoglu, AA
   Sinari, SA
   Squire, K
   Sherry, ST
   Xiao, CL
   Sebat, J
   Antaki, D
   Gujral, M
   Noor, A
   Ye, K
   Burchard, EG
   Hernandez, RD
   Gignoux, CR
   Haussler, D
   Katzman, SJ
   Kent, WJ
   Howie, B
   Ruiz-Linares, A
   Dermitzakis, ET
   Devine, SE
   Goncalo, RA
   Kang, HM
   Kidd, JM
   Blackwell, T
   Caron, S
   Chen, W
   Emery, S
   Fritsche, L
   Fuchsberger, C
   Jun, G
   Li, BS
   Lyons, R
   Scheller, C
   Sidore, C
   Song, SY
   Sliwerska, E
   Taliun, D
   Tan, A
   Welch, R
   Wing, MK
   Zhan, XW
   Awadalla, P
   Hodgkinson, A
   Li, Y
   Shi, XH
   Quitadamo, A
   Lunter, G
   McVean, GA
   Marchini, JL
   Myers, S
   Churchhouse, C
   Delaneau, O
   Gupta-Hinch, A
   Kretzschmar, W
   Iqbal, Z
   Mathieson, I
   Menelaou, A
   Rimmer, A
   Xifara, DK
   Oleksyk, TK
   Fu, YX
   Liu, XM
   Xiong, MM
   Jorde, L
   Witherspoon, D
   Xing, JC
   Eichler, EE
   Browning, BL
   Browning, SR
   Hormozdiari, F
   Sudmant, PH
   Khurana, E
   Durbin, RM
   Hurles, ME
   Tyler-Smith, C
   Albers, CA
   Ayub, Q
   Balasubramaniam, S
   Chen, Y
   Colonna, V
   Danecek, P
   Jostins, L
   Keane, TM
   McCarthy, S
   Walter, K
   Xue, YL
   Gerstein, MB
   Abyzov, A
   Balasubramanian, S
   Chen, JM
   Clarke, D
   Fu, Y
   Harmanci, AO
   Jin, M
   Lee, D
   Liu, J
   Mu, XJ
   Zhang, J
   Zhang, Y
   Li, YR
   Luo, RB
   Zhu, HM
   Alkan, C
   Dal, E
   Kahveci, F
   Marth, GT
   Garrison, EP
   Kural, D
   Lee, WP
   Ward, AN
   Wu, JT
   Zhang, MY
   McCarroll, SA
   Handsaker, RE
   Altshuler, DM
   Banks, E
   Del Angel, G
   Genovese, G
   Hartl, C
   Li, H
   Kashin, S
   Nemesh, JC
   Shakir, K
   Yoon, SC
   Lihm, J
   Makarov, V
   Degenhardt, J
   Korbel, JO
   Fritz, MH
   Meiers, S
   Raeder, B
   Rausch, T
   Stuetz, AM
   Flicek, P
   Casale, FP
   Clarke, L
   Smith, RE
   Stegle, O
   Zheng-Bradley, X
   Bentley, DR
   Barnes, B
   Cheetham, RK
   Eberle, M
   Humphray, S
   Kahn, S
   Murray, L
   Shaw, R
   Lameijer, EW
   Batzer, MA
   Konkel, MK
   Walker, JA
   Ding, L
   Hall, I
   Ye, K
   Lacroute, P
   Lee, C
   Cerveira, E
   Malhotra, A
   Hwang, J
   Plewczynski, D
   Radew, K
   Romanovitch, M
   Zhang, CS
   Craig, DW
   Homer, N
   Church, D
   Xiao, CL
   Sebat, J
   Antaki, D
   Bafna, V
   Michaelson, J
   Ye, K
   Devine, SE
   Gardner, EJ
   Abecasis, GR
   Kidd, JM
   Mills, RE
   Dayama, G
   Emery, S
   Jun, G
   Shi, XH
   Quitadamo, A
   Lunter, G
   McVean, GA
   Chen, K
   Fan, X
   Chong, ZC
   Chen, TH
   Witherspoon, D
   Xing, JC
   Eichler, EE
   Chaisson, MJ
   Hormozdiari, F
   Huddleston, J
   Malig, M
   Nelson, BJ
   Sudmant, PH
   Parrish, NF
   Khurana, E
   Hurles, ME
   Ben Blackburne,
   Lindsay, SJ
   Ning, ZM
   Walter, K
   Zhang, YJ
   Gerstein, MB
   Abyzov, A
   Chen, JM
   Clarke, D
   Lam, H
   Mu, XJ
   Sisu, C
   Zhang, J
   Zhang, Y
   Gibbs, RA
   Yu, FL
   Bainbridge, M
   Challis, D
   Evani, US
   Kovar, C
   Lu, J
   Muzny, D
   Nagaswamy, U
   Reid, JG
   Sabo, A
   Yu, J
   Guo, XS
   Li, WS
   Li, YR
   Wu, RH
   Marth, GT
   Garrison, EP
   Leong, WF
   Ward, AN
   del Angel, G
   DePristo, MA
   Gabriel, SB
   Gupta, N
   Hartl, C
   Poplin, RE
   Clark, AG
   Rodriguez-Flores, JL
   Flicek, P
   Clarke, L
   Smith, RE
   Zheng-Bradley, X
   MacArthur, DG
   Mardis, ER
   Fulton, R
   Koboldt, DC
   Gravel, S
   Bustamante, CD
   Craig, DW
   Christoforides, A
   Homer, N
   Izatt, T
   Sherry, ST
   Xiao, CL
   Dermitzakis, ET
   Abecasis, GR
   Kang, HM
   McVean, GA
   Gerstein, MB
   Balasubramanian, S
   Habegger, L
   Yu, HY
   Flicek, P
   Clarke, L
   Cunningham, F
   Dunham, I
   Zerbino, D
   Zheng-Bradley, X
   Lage, K
   Jespersen, JB
   Horn, H
   Montgomery, SB
   DeGorter, MK
   Khurana, E
   Tyler-Smith, C
   Chen, Y
   Colonna, V
   Xue, YL
   Gerstein, MB
   Balasubramanian, S
   Fu, Y
   Kim, D
   Auton, A
   Marcketta, A
   Desalle, R
   Narechania, A
   Sayres, MAW
   Garrison, EP
   Handsaker, RE
   Kashin, S
   McCarroll, SA
   Rodriguez-Flores, JL
   Flicek, P
   Clarke, L
   Zheng-Bradley, X
   Erlich, Y
   Gymrek, M
   Willems, TF
   Bustamante, CD
   Mendez, FL
   Poznik, GD
   Underhill, PA
   Lee, C
   Cerveira, E
   Malhotra, A
   Romanovitch, M
   Zhang, CS
   Abecasis, GR
   Coin, L
   Shao, HJ
   Mittelman, D
   Tyler-Smith, C
   Ayub, Q
   Banerjee, R
   Cerezo, M
   Chen, Y
   Fitzgerald, T
   Louzada, S
   Massaia, A
   McCarthy, S
   Ritchie, GR
   Xue, YL
   Yang, FT
   Gibbs, RA
   Kovar, C
   Kalra, D
   Hale, W
   Muzny, D
   Reid, JG
   Wang, J
   Dan, X
   Guo, XS
   Li, GQ
   Li, YR
   Ye, C
   Zheng, XL
   Altshuler, DM
   Flicek, P
   Clarke, L
   Zheng-Bradley, X
   Bentley, DR
   Cox, A
   Humphray, S
   Kahn, S
   Sudbrak, R
   Albrecht, MW
   Lienhard, M
   Larson, D
   Craig, DW
   Izatt, T
   Kurdoglu, AA
   Sherry, ST
   Xiao, CL
   Haussler, D
   Abecasis, GR
   McVean, GA
   Durbin, RM
   Balasubramaniam, S
   Keane, TM
   McCarthy, S
   Stalker, J
   Chakravarti, A
   Knoppers, BM
   Abecasis, GR
   Barnes, KC
   Beiswanger, C
   Burchard, EG
   Bustamante, CD
   Cai, HY
   Cao, HZ
   Durbin, RM
   Gerry, NP
   Gharani, N
   Gibbs, RA
   Gignoux, CR
   Gravel, S
   Henn, B
   Jones, D
   Jorde, L
   Kaye, JS
   Keinan, A
   Kent, A
   Kerasidou, A
   Li, YR
   Mathias, R
   McVean, GA
   Moreno-Estrada, A
   Ossorio, PN
   Parker, M
   Resch, AM
   Rotimi, CN
   Royal, CD
   Sandoval, K
   Su, YY
   Sudbrak, R
   Tian, ZM
   Tishkoff, S
   Toji, LH
   Tyler-Smith, C
   Via, M
   Wang, YH
   Yang, HM
   Yang, L
   Zhu, JY
   Bodmer, W
   Bedoya, G
   Ruiz-Linares, A
   Cai, ZM
   Gao, Y
   Chu, JY
   Peltonen, L
   Garcia-Montero, A
   Orfao, A
   Dutil, J
   Martinez-Cruzado, JC
   Oleksyk, TK
   Barnes, KC
   Mathias, RA
   Hennis, A
   Watson, H
   McKenzie, C
   Qadri, F
   LaRocque, R
   Sabeti, PC
   Zhu, JY
   Deng, XY
   Sabeti, PC
   Asogun, D
   Folarin, O
   Happi, C
   Omoniwa, O
   Stremlau, M
   Tariyal, R
   Jallow, M
   Joof, FS
   Corrah, T
   Rockett, K
   Kwiatkowski, D
   Kooner, J
   Hien, TT
   Dunstan, SJ
   Hang, NT
   Fonnie, R
   Garry, R
   Kanneh, L
   Moses, L
   Sabeti, PC
   Schieffelin, J
   Grant, DS
   Gallo, C
   Poletti, G
   Saleheen, D
   Rasheed, A
   Brook, LD
   Felsenfeld, A
   McEwen, JE
   Vaydylevich, Y
   Green, ED
   Duncanson, A
   Dunn, M
   Schloss, JA
   Wang, J
   Yang, HM
   Auton, A
   Brooks, LD
   Durbin, RM
   Garrison, EP
   Kang, HM
   Korbel, JO
   Marchini, JL
   McCarthy, S
   McVean, GA
   Abecasis, GR
AF Altshuler, David M.
   Durbin, Richard M.
   Abecasis, Goncalo R.
   Bentley, David R.
   Chakravarti, Aravinda
   Clark, Andrew G.
   Donnelly, Peter
   Eichler, Evan E.
   Flicek, Paul
   Gabriel, Stacey B.
   Gibbs, Richard A.
   Green, Eric D.
   Hurles, Matthew E.
   Knoppers, Bartha M.
   Korbel, Jan O.
   Lander, Eric S.
   Lee, Charles
   Lehrach, Hans
   Mardis, Elaine R.
   Marth, Gabor T.
   McVean, Gil A.
   Nickerson, Deborah A.
   Schmidt, Jeanette P.
   Sherry, Stephen T.
   Wang, Jun
   Wilson, Richard K.
   Gibbs, Richard A.
   Boerwinkle, Eric
   Doddapaneni, Harsha
   Han, Yi
   Korchina, Viktoriya
   Kovar, Christie
   Lee, Sandra
   Muzny, Donna
   Reid, Jeffrey G.
   Zhu, Yiming
   Wang, Jun
   Chang, Yuqi
   Feng, Qiang
   Fang, Xiaodong
   Guo, Xiaosen
   Jian, Min
   Jiang, Hui
   Jin, Xin
   Lan, Tianming
   Li, Guoqing
   Li, Jingxiang
   Li, Yingrui
   Liu, Shengmao
   Liu, Xiao
   Lu, Yao
   Ma, Xuedi
   Tang, Meifang
   Wang, Bo
   Wang, Guangbiao
   Wu, Honglong
   Wu, Renhua
   Xu, Xun
   Yin, Ye
   Zhang, Dandan
   Zhang, Wenwei
   Zhao, Jiao
   Zhao, Meiru
   Zheng, Xiaole
   Lander, Eric S.
   Altshuler, David M.
   Gabriel, Stacey B.
   Gupta, Namrata
   Gharani, Neda
   Toji, Lorraine H.
   Gerry, Norman P.
   Resch, Alissa M.
   Flicek, Paul
   Barker, Jonathan
   Clarke, Laura
   Gil, Laurent
   Hunt, Sarah E.
   Kelman, Gavin
   Kulesha, Eugene
   Leinonen, Rasko
   McLaren, William M.
   Radhakrishnan, Rajesh
   Roa, Asier
   Smirnov, Dmitriy
   Smith, Richard E.
   Streeter, Ian
   Thormann, Anja
   Toneva, Iliana
   Vaughan, Brendan
   Zheng-Bradley, Xiangqun
   Bentley, David R.
   Grocock, Russell
   Humphray, Sean
   James, Terena
   Kingsbury, Zoya
   Lehrach, Hans
   Sudbrak, Ralf
   Albrecht, Marcus W.
   Amstislavskiy, Vyacheslav S.
   Borodina, Tatiana A.
   Lienhard, Matthias
   Mertes, Florian
   Sultan, Marc
   Timmermann, Bernd
   Yaspo, Marie-Laure
   Mardis, Elaine R.
   Wilson, Richard K.
   Fulton, Lucinda
   Fulton, Robert
   Sherry, Stephen T.
   Ananiev, Victor
   Belaia, Zinaida
   Beloslyudtsev, Dimitriy
   Bouk, Nathan
   Chen, Chao
   Church, Deanna
   Cohen, Robert
   Cook, Charles
   Garner, John
   Hefferon, Timothy
   Kimelman, Mikhail
   Liu, Chunlei
   Lopez, John
   Meric, Peter
   O'Sullivan, Chris
   Ostapchuk, Yuri
   Phan, Lon
   Ponomarov, Sergiy
   Schneider, Valerie
   Shekhtman, Eugene
   Sirotkin, Karl
   Slotta, Douglas
   Zhang, Hua
   McVean, Gil A.
   Durbin, Richard M.
   Balasubramaniam, Senduran
   Burton, John
   Danecek, Petr
   Keane, Thomas M.
   Kolb-Kokocinski, Anja
   McCarthy, Shane
   Stalker, James
   Quail, Michael
   Schmidt, Jeanette P.
   Davies, Christopher J.
   Gollub, Jeremy
   Webster, Teresa
   Wong, Brant
   Zhan, Yiping
   Auton, Adam
   Campbell, Christopher L.
   Kong, Yu
   Marcketta, Anthony
   Gibbs, Richard A.
   Yu, Fuli
   Antunes, Lilian
   Bainbridge, Matthew
   Muzny, Donna
   Sabo, Aniko
   Huang, Zhuoyi
   Wang, Jun
   Coin, Lachlan J. M.
   Fang, Lin
   Guo, Xiaosen
   Jin, Xin
   Li, Guoqing
   Li, Qibin
   Li, Yingrui
   Li, Zhenyu
   Lin, Haoxiang
   Liu, Binghang
   Luo, Ruibang
   Shao, Haojing
   Xie, Yinlong
   Ye, Chen
   Yu, Chang
   Zhang, Fan
   Zheng, Hancheng
   Zhu, Hongmei
   Alkan, Can
   Dal, Elif
   Kahveci, Fatma
   Marth, Gabor T.
   Garrison, Erik P.
   Kural, Deniz
   Lee, Wan-Ping
   Leong, Wen Fung
   Stromberg, Michael
   Ward, Alistair N.
   Wu, Jiantao
   Zhang, Mengyao
   Daly, Mark J.
   DePristo, Mark A.
   Handsaker, Robert E.
   Altshuler, David M.
   Banks, Eric
   Bhatia, Gaurav
   del Angel, Guillermo
   Gabriel, Stacey B.
   Genovese, Giulio
   Gupta, Namrata
   Li, Heng
   Kashin, Seva
   Lander, Eric S.
   McCarroll, Steven A.
   Nemesh, James C.
   Poplin, Ryan E.
   Yoon, Seungtai C.
   Lihm, Jayon
   Makarov, Vladimir
   Clark, Andrew G.
   Gottipati, Srikanth
   Keinan, Alon
   Rodriguez-Flores, Juan L.
   Korbel, Jan O.
   Rausch, Tobias
   Fritz, Markus H.
   Stuetz, Adrian M.
   Flicek, Paul
   Beal, Kathryn
   Clarke, Laura
   Datta, Avik
   Herrero, Javier
   McLaren, William M.
   Ritchie, Graham R. S.
   Smith, Richard E.
   Zerbino, Daniel
   Zheng-Bradley, Xiangqun
   Sabeti, Pardis C.
   Shlyakhter, Ilya
   Schaffner, Stephen F.
   Vitti, Joseph
   Cooper, David N.
   Ball, Edward V.
   Stenson, Peter D.
   Bentley, David R.
   Barnes, Bret
   Bauer, Markus
   Cheetham, R. Keira
   Cox, Anthony
   Eberle, Michael
   Humphray, Sean
   Kahn, Scott
   Murray, Lisa
   Peden, John
   Shaw, Richard
   Kenny, Eimear E.
   Batzer, Mark A.
   Konkel, Miriam K.
   Walker, Jerilyn A.
   MacArthur, Daniel G.
   Lek, Monkol
   Sudbrak, Ralf
   Amstislavskiy, Vyacheslav S.
   Herwig, Ralf
   Mardis, Elaine R.
   Ding, Li
   Koboldt, Daniel C.
   Larson, David
   Ye, Kai
   Gravel, Simon
   Swaroop, Anand
   Chew, Emily
   Lappalainen, Tuuli
   Erlich, Yaniv
   Gymrek, Melissa
   Willems, Thomas Frederick
   Simpson, Jared T.
   Shriver, Mark D.
   Rosenfeld, Jeffrey A.
   Bustamante, Carlos D.
   Montgomery, Stephen B.
   De La Vega, Francisco M.
   Byrnes, Jake K.
   Carroll, Andrew W.
   DeGorter, Marianne K.
   Lacroute, Phil
   Maples, Brian K.
   Martin, Alicia R.
   Moreno-Estrada, Andres
   Shringarpure, Suyash S.
   Zakharia, Fouad
   Halperin, Eran
   Baran, Yael
   Lee, Charles
   Cerveira, Eliza
   Hwang, Jaeho
   Malhotra, Ankit
   Plewczynski, Dariusz
   Radew, Kamen
   Romanovitch, Mallory
   Zhang, Chengsheng
   Hyland, Fiona C. L.
   Craig, David W.
   Christoforides, Alexis
   Homer, Nils
   Izatt, Tyler
   Kurdoglu, Ahmet A.
   Sinari, Shripad A.
   Squire, Kevin
   Sherry, Stephen T.
   Xiao, Chunlin
   Sebat, Jonathan
   Antaki, Danny
   Gujral, Madhusudan
   Noor, Amina
   Ye, Kenny
   Burchard, Esteban G.
   Hernandez, Ryan D.
   Gignoux, Christopher R.
   Haussler, David
   Katzman, Sol J.
   Kent, W. James
   Howie, Bryan
   Ruiz-Linares, Andres
   Dermitzakis, Emmanouil T.
   Devine, Scott E.
   Goncalo, R. Abecasis
   Kang, Hyun Min
   Kidd, Jeffrey M.
   Blackwell, Tom
   Caron, Sean
   Chen, Wei
   Emery, Sarah
   Fritsche, Lars
   Fuchsberger, Christian
   Jun, Goo
   Li, Bingshan
   Lyons, Robert
   Scheller, Chris
   Sidore, Carlo
   Song, Shiya
   Sliwerska, Elzbieta
   Taliun, Daniel
   Tan, Adrian
   Welch, Ryan
   Wing, Mary Kate
   Zhan, Xiaowei
   Awadalla, Philip
   Hodgkinson, Alan
   Li, Yun
   Shi, Xinghua
   Quitadamo, Andrew
   Lunter, Gerton
   McVean, Gil A.
   Marchini, Jonathan L.
   Myers, Simon
   Churchhouse, Claire
   Delaneau, Olivier
   Gupta-Hinch, Anjali
   Kretzschmar, Warren
   Iqbal, Zamin
   Mathieson, Iain
   Menelaou, Androniki
   Rimmer, Andy
   Xifara, Dionysia K.
   Oleksyk, Taras K.
   Fu, Yunxin
   Liu, Xiaoming
   Xiong, Momiao
   Jorde, Lynn
   Witherspoon, David
   Xing, Jinchuan
   Eichler, Evan E.
   Browning, Brian L.
   Browning, Sharon R.
   Hormozdiari, Fereydoun
   Sudmant, Peter H.
   Khurana, Ekta
   Durbin, Richard M.
   Hurles, Matthew E.
   Tyler-Smith, Chris
   Albers, Cornelis A.
   Ayub, Qasim
   Balasubramaniam, Senduran
   Chen, Yuan
   Colonna, Vincenza
   Danecek, Petr
   Jostins, Luke
   Keane, Thomas M.
   McCarthy, Shane
   Walter, Klaudia
   Xue, Yali
   Gerstein, Mark B.
   Abyzov, Alexej
   Balasubramanian, Suganthi
   Chen, Jieming
   Clarke, Declan
   Fu, Yao
   Harmanci, Arif O.
   Jin, Mike
   Lee, Donghoon
   Liu, Jeremy
   Mu, Xinmeng Jasmine
   Zhang, Jing
   Zhang, Yan
   Li, Yingrui
   Luo, Ruibang
   Zhu, Hongmei
   Alkan, Can
   Dal, Elif
   Kahveci, Fatma
   Marth, Gabor T.
   Garrison, Erik P.
   Kural, Deniz
   Lee, Wan-Ping
   Ward, Alistair N.
   Wu, Jiantao
   Zhang, Mengyao
   McCarroll, Steven A.
   Handsaker, Robert E.
   Altshuler, David M.
   Banks, Eric
   Del Angel, Guillermo
   Genovese, Giulio
   Hartl, Chris
   Li, Heng
   Kashin, Seva
   Nemesh, James C.
   Shakir, Khalid
   Yoon, Seungtai C.
   Lihm, Jayon
   Makarov, Vladimir
   Degenhardt, Jeremiah
   Korbel, Jan O.
   Fritz, Markus H.
   Meiers, Sascha
   Raeder, Benjamin
   Rausch, Tobias
   Stuetz, Adrian M.
   Flicek, Paul
   Casale, Francesco Paolo
   Clarke, Laura
   Smith, Richard E.
   Stegle, Oliver
   Zheng-Bradley, Xiangqun
   Bentley, David R.
   Barnes, Bret
   Cheetham, R. Keira
   Eberle, Michael
   Humphray, Sean
   Kahn, Scott
   Murray, Lisa
   Shaw, Richard
   Lameijer, Eric-Wubbo
   Batzer, Mark A.
   Konkel, Miriam K.
   Walker, Jerilyn A.
   Ding, Li
   Hall, Ira
   Ye, Kai
   Lacroute, Phil
   Lee, Charles
   Cerveira, Eliza
   Malhotra, Ankit
   Hwang, Jaeho
   Plewczynski, Dariusz
   Radew, Kamen
   Romanovitch, Mallory
   Zhang, Chengsheng
   Craig, David W.
   Homer, Nils
   Church, Deanna
   Xiao, Chunlin
   Sebat, Jonathan
   Antaki, Danny
   Bafna, Vineet
   Michaelson, Jacob
   Ye, Kenny
   Devine, Scott E.
   Gardner, Eugene J.
   Abecasis, Goncalo R.
   Kidd, Jeffrey M.
   Mills, Ryan E.
   Dayama, Gargi
   Emery, Sarah
   Jun, Goo
   Shi, Xinghua
   Quitadamo, Andrew
   Lunter, Gerton
   McVean, Gil A.
   Chen, Ken
   Fan, Xian
   Chong, Zechen
   Chen, Tenghui
   Witherspoon, David
   Xing, Jinchuan
   Eichler, Evan E.
   Chaisson, Mark J.
   Hormozdiari, Fereydoun
   Huddleston, John
   Malig, Maika
   Nelson, Bradley J.
   Sudmant, Peter H.
   Parrish, Nicholas F.
   Khurana, Ekta
   Hurles, Matthew E.
   Blackburne, Ben
   Lindsay, Sarah J.
   Ning, Zemin
   Walter, Klaudia
   Zhang, Yujun
   Gerstein, Mark B.
   Abyzov, Alexej
   Chen, Jieming
   Clarke, Declan
   Lam, Hugo
   Mu, Xinmeng Jasmine
   Sisu, Cristina
   Zhang, Jing
   Zhang, Yan
   Gibbs, Richard A.
   Yu, Fuli
   Bainbridge, Matthew
   Challis, Danny
   Evani, Uday S.
   Kovar, Christie
   Lu, James
   Muzny, Donna
   Nagaswamy, Uma
   Reid, Jeffrey G.
   Sabo, Aniko
   Yu, Jin
   Guo, Xiaosen
   Li, Wangshen
   Li, Yingrui
   Wu, Renhua
   Marth, Gabor T.
   Garrison, Erik P.
   Leong, Wen Fung
   Ward, Alistair N.
   del Angel, Guillermo
   DePristo, Mark A.
   Gabriel, Stacey B.
   Gupta, Namrata
   Hartl, Chris
   Poplin, Ryan E.
   Clark, Andrew G.
   Rodriguez-Flores, Juan L.
   Flicek, Paul
   Clarke, Laura
   Smith, Richard E.
   Zheng-Bradley, Xiangqun
   MacArthur, Daniel G.
   Mardis, Elaine R.
   Fulton, Robert
   Koboldt, Daniel C.
   Gravel, Simon
   Bustamante, Carlos D.
   Craig, David W.
   Christoforides, Alexis
   Homer, Nils
   Izatt, Tyler
   Sherry, Stephen T.
   Xiao, Chunlin
   Dermitzakis, Emmanouil T.
   Abecasis, Gonalo R.
   Kang, Hyun Min
   McVean, Gil A.
   Gerstein, Mark B.
   Balasubramanian, Suganthi
   Habegger, Lukas
   Yu, Haiyuan
   Flicek, Paul
   Clarke, Laura
   Cunningham, Fiona
   Dunham, Ian
   Zerbino, Daniel
   Zheng-Bradley, Xiangqun
   Lage, Kasper
   Jespersen, Jakob Berg
   Horn, Heiko
   Montgomery, Stephen B.
   DeGorter, Marianne K.
   Khurana, Ekta
   Tyler-Smith, Chris
   Chen, Yuan
   Colonna, Vincenza
   Xue, Yali
   Gerstein, Mark B.
   Balasubramanian, Suganthi
   Fu, Yao
   Kim, Donghoon
   Auton, Adam
   Marcketta, Anthony
   Desalle, Rob
   Narechania, Apurva
   Sayres, Melissa A. Wilson
   Garrison, Erik P.
   Handsaker, Robert E.
   Kashin, Seva
   McCarroll, Steven A.
   Rodriguez-Flores, Juan L.
   Flicek, Paul
   Clarke, Laura
   Zheng-Bradley, Xiangqun
   Erlich, Yaniv
   Gymrek, Melissa
   Willems, Thomas Frederick
   Bustamante, Carlos D.
   Mendez, Fernando L.
   Poznik, G. David
   Underhill, Peter A.
   Lee, Charles
   Cerveira, Eliza
   Malhotra, Ankit
   Romanovitch, Mallory
   Zhang, Chengsheng
   Abecasis, Goncalo R.
   Coin, Lachlan
   Shao, Haojing
   Mittelman, David
   Tyler-Smith, Chris
   Ayub, Qasim
   Banerjee, Ruby
   Cerezo, Maria
   Chen, Yuan
   Fitzgerald, ThomasW.
   Louzada, Sandra
   Massaia, Andrea
   McCarthy, Shane
   Ritchie, Graham R.
   Xue, Yali
   Yang, Fengtang
   Gibbs, Richard A.
   Kovar, Christie
   Kalra, Divya
   Hale, Walker
   Muzny, Donna
   Reid, Jeffrey G.
   Wang, Jun
   Dan, Xu
   Guo, Xiaosen
   Li, Guoqing
   Li, Yingrui
   Ye, Chen
   Zheng, Xiaole
   Altshuler, David M.
   Flicek, Paul
   Clarke, Laura
   Zheng-Bradley, Xiangqun
   Bentley, David R.
   Cox, Anthony
   Humphray, Sean
   Kahn, Scott
   Sudbrak, Ralf
   Albrecht, Marcus W.
   Lienhard, Matthias
   Larson, David
   Craig, David W.
   Izatt, Tyler
   Kurdoglu, Ahmet A.
   Sherry, Stephen T.
   Xiao, Chunlin
   Haussler, David
   Abecasis, Goncalo R.
   McVean, Gil A.
   Durbin, Richard M.
   Balasubramaniam, Senduran
   Keane, Thomas M.
   McCarthy, Shane
   Stalker, James
   Chakravarti, Aravinda
   Knoppers, Bartha M.
   Abecasis, Goncalo R.
   Barnes, Kathleen C.
   Beiswanger, Christine
   Burchard, Esteban G.
   Bustamante, Carlos D.
   Cai, Hongyu
   Cao, Hongzhi
   Durbin, Richard M.
   Gerry, Norman P.
   Gharani, Neda
   Gibbs, Richard A.
   Gignoux, Christopher R.
   Gravel, Simon
   Henn, Brenna
   Jones, Danielle
   Jorde, Lynn
   Kaye, Jane S.
   Keinan, Alon
   Kent, Alastair
   Kerasidou, Angeliki
   Li, Yingrui
   Mathias, Rasika
   McVean, Gil A.
   Moreno-Estrada, Andres
   Ossorio, Pilar N.
   Parker, Michael
   Resch, Alissa M.
   Rotimi, Charles N.
   Royal, Charmaine D.
   Sandoval, Karla
   Su, Yeyang
   Sudbrak, Ralf
   Tian, Zhongming
   Tishkoff, Sarah
   Toji, Lorraine H.
   Tyler-Smith, Chris
   Via, Marc
   Wang, Yuhong
   Yang, Huanming
   Yang, Ling
   Zhu, Jiayong
   Bodmer, Walter
   Bedoya, Gabriel
   Ruiz-Linares, Andres
   Cai, Zhiming
   Gao, Yang
   Chu, Jiayou
   Peltonen, Leena
   Garcia-Montero, Andres
   Orfao, Alberto
   Dutil, Julie
   Martinez-Cruzado, Juan C.
   Oleksyk, Taras K.
   Barnes, Kathleen C.
   Mathias, Rasika A.
   Hennis, Anselm
   Watson, Harold
   McKenzie, Colin
   Qadri, Firdausi
   LaRocque, Regina
   Sabeti, Pardis C.
   Zhu, Jiayong
   Deng, Xiaoyan
   Sabeti, Pardis C.
   Asogun, Danny
   Folarin, Onikepe
   Happi, Christian
   Omoniwa, Omonwunmi
   Stremlau, Matt
   Tariyal, Ridhi
   Jallow, Muminatou
   Joof, Fatoumatta Sisay
   Corrah, Tumani
   Rockett, Kirk
   Kwiatkowski, Dominic
   Kooner, Jaspal
   Tran Tinh Hien
   Dunstan, Sarah J.
   Nguyen Thuy Hang
   Fonnie, Richard
   Garry, Robert
   Kanneh, Lansana
   Moses, Lina
   Sabeti, Pardis C.
   Schieffelin, John
   Grant, Donald S.
   Gallo, Carla
   Poletti, Giovanni
   Saleheen, Danish
   Rasheed, Asif
   Brook, Lisa D.
   Felsenfeld, Adaml.
   McEwen, Jean E.
   Vaydylevich, Yekaterina
   Green, Eric D.
   Duncanson, Audrey
   Dunn, Michael
   Schloss, Jeffery A.
   Wang, Jun
   Yang, Huanming
   Auton, Adam
   Brooks, Lisa D.
   Durbin, Richard M.
   Garrison, Erik P.
   Kang, Hyun Min
   Korbel, Jan O.
   Marchini, Jonathan L.
   McCarthy, Shane
   McVean, Gil A.
   Abecasis, Goncalo R.
CA Genomes Project Consortium
TI A global reference for human genetic variation
SO NATURE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; COMPLEMENT FACTOR-H; MACULAR DEGENERATION;
   POPULATION HISTORY; BAYES FACTORS; MUTATION; DISEASE; VARIANT;
   SUSCEPTIBILITY; INDIVIDUALS
AB The 1000 Genomes Project set out to provide a comprehensive description of common human genetic variation by applying whole-genome sequencing to a diverse set of individuals from multiple populations. Here we report completion of the project, having reconstructed the genomes of 2,504 individuals from 26 populations using a combination of low-coverage whole-genome sequencing, deep exome sequencing, and dense microarray genotyping. We characterized a broad spectrum of genetic variation, in total over 88 million variants (84.7 million single nucleotide polymorphisms (SNPs), 3.6 million short insertions/deletions (indels), and 60,000 structural variants), all phased onto high-quality haplotypes. This resource includes >99% of SNP variants with a frequency of >1% for a variety of ancestries. We describe the distribution of genetic variation across the global sample, and discuss the implications for common disease studies.
C1 [Auton, Adam; Campbell, Christopher L.; Kong, Yu; Marcketta, Anthony; Auton, Adam; Marcketta, Anthony; Auton, Adam] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.
   [Abecasis, Goncalo R.; Goncalo, R. Abecasis; Kang, Hyun Min; Blackwell, Tom; Caron, Sean; Fritsche, Lars; Fuchsberger, Christian; Jun, Goo; Scheller, Chris; Sidore, Carlo; Taliun, Daniel; Tan, Adrian; Welch, Ryan; Wing, Mary Kate; Jun, Goo; Abecasis, Gonalo R.] Univ Michigan, Ctr Stat Genet, Biostat, Ann Arbor, MI 48109 USA.
   [Altshuler, David M.] Vertex Pharmaceut, Boston, MA 02210 USA.
   [Durbin, Richard M.; Hurles, Matthew E.; Balasubramaniam, Senduran; Burton, John; Danecek, Petr; Keane, Thomas M.; Kolb-Kokocinski, Anja; McCarthy, Shane; Stalker, James; Quail, Michael; Garrison, Erik P.; Tyler-Smith, Chris; Ayub, Qasim; Chen, Yuan; Colonna, Vincenza; Walter, Klaudia; Xue, Yali; Garrison, Erik P.; Blackburne, Ben; Lindsay, Sarah J.; Ning, Zemin; Zhang, Yujun; Banerjee, Ruby; Cerezo, Maria; Fitzgerald, ThomasW.; Louzada, Sandra; Massaia, Andrea; Ritchie, Graham R.; Yang, Fengtang] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Bentley, David R.; Grocock, Russell; Humphray, Sean; James, Terena; Kingsbury, Zoya; Bauer, Markus; Cheetham, R. Keira; Cox, Anthony; Eberle, Michael; Murray, Lisa; Peden, John; Shaw, Richard] Illumina United Kingdom, Saffron Walden CB10 1XL, Essex, England.
   [Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.
   [Clark, Andrew G.; Clark, Andrew G.; Keinan, Alon; Degenhardt, Jeremiah] Cornell Univ, Ctr Comparat & Populat Genom, Ithaca, NY 14850 USA.
   [Donnelly, Peter; McVean, Gil A.; McVean, Gil A.; Lunter, Gerton; Marchini, Jonathan L.; Myers, Simon; Gupta-Hinch, Anjali; Kretzschmar, Warren; Iqbal, Zamin; Mathieson, Iain; Xifara, Dionysia K.; Jostins, Luke; Jallow, Muminatou; Joof, Fatoumatta Sisay; Corrah, Tumani; Rockett, Kirk; Kwiatkowski, Dominic] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.
   [Donnelly, Peter; McVean, Gil A.; Marchini, Jonathan L.; Myers, Simon; Churchhouse, Claire; Delaneau, Olivier; Menelaou, Androniki; Xifara, Dionysia K.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England.
   [Eichler, Evan E.; Nickerson, Deborah A.; Hormozdiari, Fereydoun; Sudmant, Peter H.; Chaisson, Mark J.; Huddleston, John; Malig, Maika; Nelson, Bradley J.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.
   [Eichler, Evan E.; Huddleston, John] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.
   [Flicek, Paul; Korbel, Jan O.; Barker, Jonathan; Clarke, Laura; Gil, Laurent; Hunt, Sarah E.; Kelman, Gavin; Kulesha, Eugene; Leinonen, Rasko; McLaren, William M.; Radhakrishnan, Rajesh; Roa, Asier; Smirnov, Dmitriy; Smith, Richard E.; Streeter, Ian; Thormann, Anja; Toneva, Iliana; Vaughan, Brendan; Zheng-Bradley, Xiangqun; Beal, Kathryn; Datta, Avik; Ritchie, Graham R. S.; Zerbino, Daniel; Casale, Francesco Paolo; Stegle, Oliver; Cunningham, Fiona; Dunham, Ian] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England.
   [Gabriel, Stacey B.; Lander, Eric S.; Gupta, Namrata; Daly, Mark J.; Handsaker, Robert E.; Banks, Eric; Bhatia, Gaurav; del Angel, Guillermo; Genovese, Giulio; Li, Heng; Kashin, Seva; McCarroll, Steven A.; Nemesh, James C.; Poplin, Ryan E.; Sabeti, Pardis C.; Shlyakhter, Ilya; Schaffner, Stephen F.; Vitti, Joseph; Gymrek, Melissa; Mu, Xinmeng Jasmine; Hartl, Chris; Shakir, Khalid; Poplin, Ryan E.; Lage, Kasper; Jespersen, Jakob Berg; Horn, Heiko; Stremlau, Matt; Tariyal, Ridhi] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Gibbs, Richard A.; Boerwinkle, Eric; Doddapaneni, Harsha; Han, Yi; Korchina, Viktoriya; Kovar, Christie; Lee, Sandra; Muzny, Donna; Reid, Jeffrey G.; Zhu, Yiming; Yu, Fuli; Antunes, Lilian; Bainbridge, Matthew; Sabo, Aniko; Huang, Zhuoyi; Challis, Danny; Evani, Uday S.; Lu, James; Nagaswamy, Uma; Yu, Jin; Kalra, Divya; Hale, Walker] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Green, Eric D.; Green, Eric D.] NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA.
   [Knoppers, Bartha M.] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada.
   [Rausch, Tobias; Stuetz, Adrian M.; Meiers, Sascha; Raeder, Benjamin] European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany.
   [Lee, Charles; Cerveira, Eliza; Hwang, Jaeho; Malhotra, Ankit; Plewczynski, Dariusz; Radew, Kamen; Romanovitch, Mallory; Zhang, Chengsheng] Jackson Lab Genom Med, Farmington, CT 06032 USA.
   [Lee, Charles] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea.
   [Lehrach, Hans; Amstislavskiy, Vyacheslav S.; Lienhard, Matthias; Mertes, Florian; Sultan, Marc; Timmermann, Bernd; Yaspo, Marie-Laure; Herwig, Ralf] Max Planck Inst Mol Genet, D-14195 Berlin, Germany.
   [Lehrach, Hans] Dahlem Ctr Genome Res & Med Syst Biol, D-14195 Berlin, Germany.
   [Mardis, Elaine R.; Wilson, Richard K.; Mardis, Elaine R.; Fulton, Lucinda; Fulton, Robert; Ding, Li; Koboldt, Daniel C.; Larson, David; Ye, Kai; Hall, Ira] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA.
   [Marth, Gabor T.; Ward, Alistair N.; Wu, Jiantao; Zhang, Mengyao; Leong, Wen Fung] Univ Utah, Sch Med, USTAR Ctr Genet Discovery, Salt Lake City, UT 84112 USA.
   [Marth, Gabor T.; Ward, Alistair N.; Wu, Jiantao; Zhang, Mengyao; Leong, Wen Fung] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA.
   [Schmidt, Jeanette P.; Davies, Christopher J.; Gollub, Jeremy; Webster, Teresa; Wong, Brant; Zhan, Yiping] Affymetrix, Santa Clara, CA 95051 USA.
   [Sherry, Stephen T.; Ananiev, Victor; Belaia, Zinaida; Beloslyudtsev, Dimitriy; Bouk, Nathan; Chen, Chao; Cohen, Robert; Cook, Charles; Garner, John; Hefferon, Timothy; Kimelman, Mikhail; Liu, Chunlei; Lopez, John; Meric, Peter; Ostapchuk, Yuri; Phan, Lon; Ponomarov, Sergiy; Schneider, Valerie; Shekhtman, Eugene; Sirotkin, Karl; Slotta, Douglas; Zhang, Hua; Xiao, Chunlin] US Natl Inst Hlth, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA.
   [Wang, Jun; Chang, Yuqi; Feng, Qiang; Fang, Xiaodong; Guo, Xiaosen; Jian, Min; Jiang, Hui; Jin, Xin; Lan, Tianming; Li, Guoqing; Li, Jingxiang; Li, Yingrui; Liu, Shengmao; Liu, Xiao; Lu, Yao; Ma, Xuedi; Tang, Meifang; Wang, Bo; Wang, Guangbiao; Wu, Honglong; Wu, Renhua; Xu, Xun; Yin, Ye; Zhang, Dandan; Zhang, Wenwei; Zhao, Jiao; Zhao, Meiru; Zheng, Xiaole; Coin, Lachlan J. M.; Fang, Lin; Guo, Xiaosen; Li, Qibin; Li, Zhenyu; Lin, Haoxiang; Liu, Binghang; Luo, Ruibang; Shao, Haojing; Xie, Yinlong; Ye, Chen; Yu, Chang; Zhang, Fan; Zheng, Hancheng; Zhu, Hongmei; Moreno-Estrada, Andres; Li, Wangshen; Dan, Xu; Cai, Hongyu; Cao, Hongzhi; Su, Yeyang; Tian, Zhongming; Wang, Yuhong; Yang, Huanming; Yang, Ling; Zhu, Jiayong; Cai, Zhiming; Yang, Huanming] BGI Shenzhen, Shenzhen 518083, Peoples R China.
   [Feng, Qiang; Fang, Xiaodong; Jian, Min; Jiang, Hui; Liu, Xiao; Fang, Lin; Cao, Hongzhi] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark.
   King Abdulaziz Univ, Princess Jawhara Albrahim Ctr Excellence Res Here, Jeddah 80205, Saudi Arabia.
   Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China.
   Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.
   Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China.
   [Gharani, Neda; Toji, Lorraine H.; Gerry, Norman P.; Resch, Alissa M.; Beiswanger, Christine] Coriell Inst Med Res, Camden, NJ 08103 USA.
   [Sudbrak, Ralf] Maastricht Univ, UNU MERIT, European Ctr Publ Heath Genom, NL-6200 MD Maastricht, Netherlands.
   [Albrecht, Marcus W.; Borodina, Tatiana A.] Alacris Theranost, D-14195 Berlin, Germany.
   [Church, Deanna] Personalis, Menlo Pk, CA 94025 USA.
   [O'Sullivan, Chris] NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA.
   [Alkan, Can; Dal, Elif; Kahveci, Fatma] Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey.
   [Kural, Deniz; Lee, Wan-Ping] Seven Bridges Genom, Cambridge, MA 02142 USA.
   [Leong, Wen Fung] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.
   [Stromberg, Michael; Wu, Jiantao; Barnes, Bret; Kahn, Scott] Illumina, San Diego, CA 92122 USA.
   [Zhang, Mengyao; Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02142 USA.
   [DePristo, Mark A.] SynapDx, Lexington, MA 02421 USA.
   [Yoon, Seungtai C.; Lihm, Jayon] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.
   [Makarov, Vladimir] Mt Sinai Sch Med, Seaver Autism Ctr, New York, NY 10029 USA.
   [Makarov, Vladimir] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.
   [Gottipati, Srikanth; Yu, Haiyuan; Jones, Danielle] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.
   [Rodriguez-Flores, Juan L.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10044 USA.
   [Rausch, Tobias; Fritz, Markus H.] European Mol Biol Lab, Genom Core Facil, D-69117 Heidelberg, Germany.
   [Herrero, Javier] UCL, UCL Canc Inst, Bill Lyons Informat Ctr, London WC1E 6DD, England.
   [Shlyakhter, Ilya; Schaffner, Stephen F.; Stremlau, Matt; Tariyal, Ridhi] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA.
   [Shlyakhter, Ilya; Schaffner, Stephen F.; Stremlau, Matt; Tariyal, Ridhi] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
   [Vitti, Joseph] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
   [Cooper, David N.; Ball, Edward V.; Stenson, Peter D.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales.
   [Kenny, Eimear E.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
   [Batzer, Mark A.; Konkel, Miriam K.; Walker, Jerilyn A.] Louisiana State Univ, Dept Sci Biol, Baton Rouge, LA 70803 USA.
   [MacArthur, Daniel G.; Lek, Monkol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.
   [Gravel, Simon] McGill Univ, Montreal, PQ H3A 0G1, Canada.
   [Gravel, Simon] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada.
   [Swaroop, Anand; Chew, Emily] NEI, NIH, Bethesda, MD 20892 USA.
   [Lappalainen, Tuuli; Erlich, Yaniv] New York Genome Ctr, New York, NY 10013 USA.
   [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.
   [Erlich, Yaniv] Columbia Univ, Fu Fdn Sch Engn, Dept Comp Sci, New York, NY USA.
   Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Gen Hosp, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Boston, MA 02114 USA.
   [Willems, Thomas Frederick] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.
   [Simpson, Jared T.; Awadalla, Philip] Ontario Inst Canc Res, MaRS Ctr, Toronto, ON M5G 0A3, Canada.
   [Shriver, Mark D.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.
   [Rosenfeld, Jeffrey A.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.
   [Montgomery, Stephen B.; DeGorter, Marianne K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA.
   [Montgomery, Stephen B.; DeGorter, Marianne K.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.
   [Byrnes, Jake K.] Ancestry Com, San Francisco, CA 94107 USA.
   [Carroll, Andrew W.] DNAnexus, Mountain View, CA 94040 USA.
   [Moreno-Estrada, Andres] CINVESTAV, Lab Nacl Genom Biodiversidad LANGEBIO, Guanajuato 36821, Mexico.
   [Halperin, Eran; Baran, Yael] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.
   [Halperin, Eran] Tel Aviv Univ, Dept Microbiol, IL-69978 Tel Aviv, Israel.
   [Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA.
   [Hyland, Fiona C. L.] Thermo Fisher Sci, San Francisco, CA 94080 USA.
   [Craig, David W.; Christoforides, Alexis; Izatt, Tyler; Kurdoglu, Ahmet A.; Sinari, Shripad A.] Translat Genom Res Inst, Phoenix, AZ 85004 USA.
   [Homer, Nils] Life Technol, Beverly, MA 01915 USA.
   [Squire, Kevin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA.
   [Sebat, Jonathan; Antaki, Danny; Gujral, Madhusudan; Noor, Amina; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.
   [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Ye, Kenny] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA.
   [Burchard, Esteban G.; Hernandez, Ryan D.; Gignoux, Christopher R.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94158 USA.
   [Burchard, Esteban G.; Hernandez, Ryan D.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco, CA 94158 USA.
   [Hernandez, Ryan D.] Univ Calif San Francisco, Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA.
   [Hernandez, Ryan D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA.
   [Haussler, David; Katzman, Sol J.; Kent, W. James] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.
   [Haussler, David] Howard Hughes Med Inst, Santa Cruz, CA 95064 USA.
   [Howie, Bryan] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.
   [Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England.
   [Dermitzakis, Emmanouil T.; Delaneau, Olivier; Rimmer, Andy] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.
   [Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland.
   [Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland.
   [Devine, Scott E.; Gardner, Eugene J.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.
   [Kidd, Jeffrey M.; Song, Shiya; Mills, Ryan E.; Dayama, Gargi] Univ Michigan, Dept Computat Med & Bioinfomat, Ann Arbor, MI 48109 USA.
   [Emery, Sarah; Sliwerska, Elzbieta; Mills, Ryan E.; Dayama, Gargi] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.
   [Chen, Wei] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA.
   [Jun, Goo; Fu, Yunxin; Liu, Xiaoming; Xiong, Momiao; Jun, Goo] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.
   [Li, Bingshan; Parrish, Nicholas F.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA.
   [Lyons, Robert] Univ Michigan, Sequencing Core, Ann Arbor, MI 48109 USA.
   [Sidore, Carlo] CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy.
   [Sidore, Carlo] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy.
   [Zhan, Xiaowei] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Awadalla, Philip; Hodgkinson, Alan] Univ Montreal, St Justine Hosp, Res Ctr, Dept Pediat, Montreal, PQ H3T 1C5, Canada.
   [Li, Yun] Univ Chapel Hill, Dept Comp Sci, Dept Biostat, Dept Genet, Chapel Hill, NC 27599 USA.
   [Shi, Xinghua; Quitadamo, Andrew] Univ N Carolina, Coll Comp & Informat, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.
   [Menelaou, Androniki] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands.
   [Oleksyk, Taras K.; Martinez-Cruzado, Juan C.] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00680 USA.
   [Jorde, Lynn; Witherspoon, David] Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA.
   [Xing, Jinchuan] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.
   [Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.
   [Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Khurana, Ekta] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.
   [Albers, Cornelis A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands.
   [Albers, Cornelis A.] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, NL-6525 GA Nijmegen, Netherlands.
   [Albers, Cornelis A.] Radboud Univ Nijmegen, Fac Sci, RIMLS, Dept Mol Dev Biol, NL-6500 HB Nijmegen, Netherlands.
   [Colonna, Vincenza] CNR, Inst Genet & Biophys, I-80125 Naples, Italy.
   [Gerstein, Mark B.; Chen, Jieming; Fu, Yao; Harmanci, Arif O.; Lee, Donghoon; Mu, Xinmeng Jasmine; Zhang, Jing; Zhang, Yan; Sisu, Cristina; Habegger, Lukas] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA.
   Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA.
   [Balasubramanian, Suganthi; Jin, Mike; Liu, Jeremy; Zhang, Jing; Kim, Donghoon] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.
   [Abyzov, Alexej] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.
   [Clarke, Declan] Yale Univ, Dept Chem, New Haven, CT 06520 USA.
   [Lameijer, Eric-Wubbo] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Mol Epidemiol Sect, NL-2333 ZA Leiden, Netherlands.
   [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci, La Jolla, CA 92093 USA.
   [Michaelson, Jacob] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA.
   [Chen, Ken; Fan, Xian; Chong, Zechen; Chen, Tenghui] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77230 USA.
   [Lam, Hugo] Roche Sequencing, Bina Technol, Redwood City, CA 94065 USA.
   [Lage, Kasper; Jespersen, Jakob Berg; Horn, Heiko] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.
   [Jespersen, Jakob Berg] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.
   [Desalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.
   [Narechania, Apurva] Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA.
   [Sayres, Melissa A. Wilson] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.
   [Poznik, G. David] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA.
   [Coin, Lachlan; Shao, Haojing] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.
   [Mittelman, David] Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.
   [Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA.
   [Henn, Brenna] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.
   [Kaye, Jane S.] Univ Oxford, Lawand Emerging Technol, Ctr Hlth, Oxford OX3 7LF, England.
   [Kent, Alastair] Genet Alliance, London N1 3QP, England.
   [Kerasidou, Angeliki; Parker, Michael] Univ Oxford, Ethox Ctr, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England.
   [Mathias, Rasika; Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.
   [Ossorio, Pilar N.] Univ Wisconsin, Morgridge Inst Res, Dept Med Hist & Bioeth, Madison, WI 53706 USA.
   [Ossorio, Pilar N.] Univ Wisconsin, Sch Law, Madison, WI 53706 USA.
   [Rotimi, Charles N.] NHGRI, US Natl Inst Hlth, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA.
   [Royal, Charmaine D.] Duke Univ, Dept African & African Amer Studies, Durham, NC 27708 USA.
   [Tishkoff, Sarah] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.
   [Via, Marc] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona 08035, Spain.
   [Via, Marc] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona 08035, Spain.
   [Bodmer, Walter] Univ Oxford, John Radcliffe Hosp, Canc & Immunogenet Lab, Oxford OX3 9DS, England.
   [Bedoya, Gabriel] Univ Antioquia, Inst Biol, Lab Mol Genet, Medellin, Colombia.
   [Gao, Yang] Peking Univ, Shenzhen Hosp, Shenzhen 518036, Peoples R China.
   [Chu, Jiayou] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China.
   [Chu, Jiayou] Peking Union Med Coll, Kunming 650118, Peoples R China.
   [Garcia-Montero, Andres; Orfao, Alberto] Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Ctr Invest Canc IBMCC CSIC USAL, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain.
   [Garcia-Montero, Andres; Orfao, Alberto] Univ Salamanca, Natl DNA Bank Carlos 3, Salamanca 37007, Spain.
   [Dutil, Julie] Ponce Hlth Sci Univ, Ponce Res Inst, Ponce, PR 00716 USA.
   [Hennis, Anselm] Univ W Indies, Res Inst Trop Med, Chron Dis Res Ctr, Mona, Jamaica.
   [Hennis, Anselm; Watson, Harold] Univ W Indies, Fac Med Sci, Mona, Jamaica.
   [McKenzie, Colin] Univ W Indies, Res Inst Trop Med, Trop Metab Res Unit, Mona, Jamaica.
   [Qadri, Firdausi; LaRocque, Regina] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Deng, Xiaoyan] Xishuangbanna Hlth Sch, Xishuangbanna 666100, Peoples R China.
   [Asogun, Danny] Irrua Specialist Teaching Hosp, Edo, Edo State, Nigeria.
   [Folarin, Onikepe; Happi, Christian; Omoniwa, Omonwunmi] Redeemers Univ, Ede, Ogun State, Nigeria.
   [Happi, Christian; Omoniwa, Omonwunmi] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Jallow, Muminatou; Joof, Fatoumatta Sisay; Corrah, Tumani; Rockett, Kirk; Kwiatkowski, Dominic] MRC Unit, Banjul, Gambia.
   [Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, NHLI, Hammersmith Hosp, London SW7 2AZ, England.
   [Tran Tinh Hien; Dunstan, Sarah J.; Nguyen Thuy Hang] Univ Oxford, Clin Res Unit, Ctr Trop Med, Ho Chi Minh City, Vietnam.
   [Dunstan, Sarah J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia.
   [Fonnie, Richard; Kanneh, Lansana; Grant, Donald S.] Kenema Govt Hosp, Minist Hlth & Sanitat, Kenema, Sierra Leone.
   [Garry, Robert; Moses, Lina; Schieffelin, John; Grant, Donald S.] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA.
   [Gallo, Carla; Poletti, Giovanni] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Invest & Desarrollo, Lima, Peru.
   [Saleheen, Danish; Rasheed, Asif] Ctr Noncommunicable Dis, Karachi, Pakistan.
   [Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   [Brook, Lisa D.; Felsenfeld, Adaml.; McEwen, Jean E.; Vaydylevich, Yekaterina; Schloss, Jeffery A.; Brooks, Lisa D.] NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA.
   [Duncanson, Audrey; Dunn, Michael] Wellcome Trust Res Labs, London NW1 2BE, England.
   [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310008, Zhejiang, Peoples R China.
RP Auton, A (reprint author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.
EM goncalo@umich.edu; adam.auton@gmail.com
RI ; Colonna, Vincenza/H-2021-2014; Wang, Jun/B-9503-2016; Myers,
   Simon/A-6792-2015; Zhang, Jing/K-4498-2017; Jun, Goo/F-1941-2017; Alkan,
   Can/D-2982-2009; Schaffner, Stephen/D-1189-2011; Ye, Kai/B-3640-2012;
   Wang, Jun/C-8434-2016; Browning, Sharon/B-1530-2008; Lunter,
   Gerton/H-4939-2016; Browning, Brian/A-1178-2010; Li, Heng/D-9344-2011;
   Coin, Lachlan/A-9001-2014; Mu, Xinmeng/P-2562-2016; Mills,
   Ryan/A-1979-2011; Kahveci, Fatma/E-1621-2017
OI Chen, Tenghui/0000-0003-0683-8974; Ayub, Qasim/0000-0003-3291-0917;
   Mendez, Fernando/0000-0002-0879-3813; Colonna,
   Vincenza/0000-0002-3966-0474; Cerezo Fernandez,
   Maria/0000-0003-3073-1130; Herrero, Javier/0000-0001-7313-717X; Clarke,
   Laura/0000-0002-5989-6898; McLaren, William/0000-0001-6218-1116; Dunham,
   Ian/0000-0003-2525-5598; Zerbino, Daniel/0000-0001-5350-3056; Dunstan,
   Sarah/0000-0001-7873-933X; Kwiatkowski, Dominic/0000-0002-5023-0176;
   Raeder, Benjamin/0000-0002-9494-8884; Flicek, Paul/0000-0002-3897-7955;
   Ning, Zemin/0000-0003-4359-776X; Martin, Alicia/0000-0003-0241-3522;
   Cooper, David N./0000-0002-8943-8484; Bafna, Vineet/0000-0002-5810-6241;
   Keinan, Alon/0000-0002-9760-1122; Shriver, Mark/0000-0003-0006-0479;
   Kulesha, Eugene/0000-0002-4285-6232; McCarthy,
   Shane/0000-0002-2715-4187; Sudmant, Peter/0000-0002-9573-8248; Chen,
   Jieming/0000-0003-3767-9486; Iqbal, Zamin/0000-0001-8466-7547;
   Radhakrishnan, Rajesh/0000-0001-7170-699X; Keane,
   Thomas/0000-0001-7532-6898; Swaroop, Anand/0000-0002-1975-1141; Via,
   Marc/0000-0002-9966-9921; Hunt, Sarah/0000-0002-8350-1235; Horn,
   Heiko/0000-0003-4898-0557; Sebat, Jonathan/0000-0002-9087-526X; Zheng
   Bradley, Xiangqun/0000-0002-9324-2708; Gil, Laurent/0000-0002-9475-4502;
   Gerstein, Mark/0000-0002-9746-3719; Rodriguez-Flores, Juan
   L/0000-0002-0394-8062; Lindsay, Sarah/0000-0002-0965-3070; Wang,
   Jun/0000-0002-2113-5874; Myers, Simon/0000-0002-2585-9626; Lunter,
   Gerton/0000-0002-3798-2058; Parrish, Nicholas/0000-0002-6971-8016;
   Lappalainen, Tuuli/0000-0002-7746-8109; Sisu,
   Cristina/0000-0001-9371-0797; Datta, Avik/0000-0002-1411-8638;
   Fitzgerald, Tomas/0000-0002-2370-8496; Vaughan,
   Brendan/0000-0002-2199-1267; /0000-0002-6086-3903; Garner,
   John/0000-0003-0853-0279; Meiers, Sascha/0000-0003-2609-0000; Thormann,
   Anja/0000-0001-8858-5506; Kretzschmar, Warren/0000-0002-2575-0807;
   Fuchsberger, Christian/0000-0002-5918-8947; Stegle,
   Oliver/0000-0002-8818-7193; Abyzov, Alexej/0000-0001-5405-6729;
   Leinonen, Rasko/0000-0002-2639-7187; Jun, Goo/0000-0003-0891-0204;
   Alkan, Can/0000-0002-5443-0706; Wang, Jun/0000-0002-8540-8931; Browning,
   Sharon/0000-0001-7251-9715; Browning, Brian/0000-0001-6454-6633; Li,
   Heng/0000-0003-4874-2874; Coin, Lachlan/0000-0002-4300-455X; Mu,
   Xinmeng/0000-0002-8079-0828; Mills, Ryan/0000-0003-3425-6998; Kahveci,
   Fatma/0000-0003-3096-1753
FU Wellcome Trust [090532/Z/09/Z, 095552/Z/11/Z, WT098051, WT095908,
   WT109497, WT086084/Z/08/Z, WT100956/Z/13/Z, WT097307, WT0855322/Z/08/Z,
   WT090770/Z/09/Z, 089276/Z.09/Z]; Medical Research Council UK [G0801823];
   UK Biotechnology and Biological Sciences Research Council [BB/I02593X/1,
   BB/I021213/1]; British Heart Foundation; Monument Trust; European
   Molecular Biology Laboratory; European Research Council [617306];
   Chinese 863 Program [2012AA02A201]; National Basic Research program of
   China 973 program [2011CB809201, 2011CB809202, 2011CB809203]; Natural
   Science Foundation of China [31161130357]; Shenzhen Municipal Government
   of China [ZYC201105170397A]; Canadian Institutes of Health Research
   [136855]; Canada Research Chair; Le Fonds de Recherche du Quebec-Sante
   (FRQS); Genome Quebec; Ontario Ministry of Research and Innovation -
   Ontario Institute for Cancer Research Investigator Award; Quebec
   Ministry of Economic Development, Innovation, and Exports
   [PSR-SIIRI-195]; German Federal Ministry of Education and Research
   (BMBF) [0315428A, 01GS08201]; Max Planck Society; BMBF-EPITREAT
   [0316190A]; German Research Foundation (Deutsche Forschungsgemeinschaft)
   [KO4037/1-1]; Beatriu de Pinos Program [2006 BP-A 10144, 2009 BP-B
   00274]; Spanish National Institute for Health Research [PRB2
   IPT13/0001-ISCIII-SGEFI/FEDER]; Ewha Womans University; Japan Society
   for the Promotion of Science [PE13075]; Louis Jeantet Foundation; Marie
   Curie Actions Career Integration grant [303772]; Swiss National Science
   Foundation [31003A_130342]; NCCR "Frontiers in Genetics"; University of
   Geneva; US National Institutes of Health National Center for
   Biotechnology Information; Harvard Medical School Eleanor and Miles
   Shore Fellowship; Lundbeck Foundation [R170-2014-1039]; NIJ
   [2014-DN-BX-K089]; Mary Beryl Patch Turnbull Scholar Program; NSF
   Graduate Research Fellowship [DGE-1147470]; Simons Foundation SFARI
   [SF51]; Sloan Foundation;  [U54HG3067];  [U54HG3273];  [U01HG5211]; 
   [U54HG3079];  [R01HG2898];  [R01HG2385];  [RC2HG5552];  [U01HG6513]; 
   [U01HG5214];  [U01HG5715];  [U01HG5718];  [U01HG5728];  [U41HG7635]; 
   [U41HG7497];  [R01HG4960];  [R01HG5701];  [R01HG5214];  [R01HG6855]; 
   [R01HG7068];  [R01HG7644];  [DP2OD6514];  [DP5OD9154];  [R01CA166661]; 
   [R01CA172652];  [P01GM99568];  [R01GM59290];  [R01GM104390]; 
   [T32GM7790];  [R01HL87699];  [R01HL104608];  [T32HL94284]; 
   [HHSN268201100040C];  [HHSN272201000025C]
FX We thank the many people who were generous with contributing their
   samples to the project: the African Caribbean in Barbados; Bengali in
   Bangladesh; British in England and Scotland; Chinese Dai in
   Xishuangbanna, China; Colombians in Medellin, Colombia; Esan in Nigeria;
   Finnish in Finland; Gambian in Western Division - Mandinka; Gujarati
   Indians in Houston, Texas, USA; Han Chinese in Beijing, China; Iberian
   populations in Spain; Indian Telugu in the UK; Japanese in Tokyo, Japan;
   Kinh in Ho Chi Minh City, Vietnam; Luhya in Webuye, Kenya; Mende in
   Sierra Leone; people with African ancestry in the southwest USA; people
   with Mexican ancestry in Los Angeles, California, USA; Peruvians in
   Lima, Peru; Puerto Ricans in Puerto Rico; Punjabi in Lahore, Pakistan;
   southern Han Chinese; Sri Lankan Tamil in the UK; Toscani in Italia;
   Utah residents (CEPH) with northern and western European ancestry; and
   Yoruba in Ibadan, Nigeria. Many thanks to the people who contributed to
   this project: P. Maul, T. Maul, and C. Foster; Z. Chong, X. Fan, W.
   Zhou, and T. Chen; N. Sengamalay, S. Ott, L. Sadzewicz, J. Liu, and L.
   Tallon; L. Merson; O. Folarin, D. Asogun, O. Ikpwonmosa, E. Philomena,
   G. Akpede, S. Okhobgenin, and O. Omoniwa; the staff of the Institute of
   Lassa Fever Research and Control (ILFRC), Irrua Specialist Teaching
   Hospital, Irrua, Edo State, Nigeria; A. Schlattl and T. Zichner; S.
   Lewis, E. Appelbaum, and L. Fulton; A. Yurovsky and I. Padioleau; N.
   Kaelin and F. Laplace; E. Drury and H. Arbery; A. Naranjo, M. Victoria
   Parra, and C. Duque; S. Dokel, B. Lenz, and S. Schrinner; S. Bumpstead;
   and C. Fletcher-Hoppe. Funding for this work was from the Wellcome Trust
   Core Award 090532/Z/09/Z and Senior Investigator Award 095552/Z/11/Z (P.
   D.), and grants WT098051 (R.D.), WT095908 and WT109497 (P. F.),
   WT086084/Z/08/Z and WT100956/Z/13/Z (G. M.), WT097307 (W.K.),
   WT0855322/Z/08/Z (R.L.), WT090770/Z/09/Z (D.K.), the Wellcome Trust
   Major Overseas program in Vietnam grant 089276/Z.09/Z (S. D.), the
   Medical Research Council UK grant G0801823 (J. L. M.), the UK
   Biotechnology and Biological Sciences Research Council grants
   BB/I02593X/1 (G. M.) and BB/I021213/1 (A.R.L.), the British Heart
   Foundation (C. A. A.), the Monument Trust (J. H.), the European
   Molecular Biology Laboratory (P. F.), the European Research Council
   grant 617306 (J. L. M.), the Chinese 863 Program 2012AA02A201, the
   National Basic Research program of China 973 program no. 2011CB809201,
   2011CB809202 and 2011CB809203, Natural Science Foundation of China
   31161130357, the Shenzhen Municipal Government of China grant
   ZYC201105170397A (J. W.), the Canadian Institutes of Health Research
   Operating grant 136855 and Canada Research Chair (S. G.), Banting
   Postdoctoral Fellowship from the Canadian Institutes of Health Research
   (M.K.D.), a Le Fonds de Recherche du Quebec-Sante (FRQS) research
   fellowship (A. H.), Genome Quebec (P. A.), the Ontario Ministry of
   Research and Innovation - Ontario Institute for Cancer Research
   Investigator Award (P. A., J. S.), the Quebec Ministry of Economic
   Development, Innovation, and Exports grant PSR-SIIRI-195 (P. A.), the
   German Federal Ministry of Education and Research (BMBF) grants 0315428A
   and 01GS08201 (R.H.), the Max Planck Society (H. L., G. M., R.S.),
   BMBF-EPITREAT grant 0316190A (R.H., M. L.), the German Research
   Foundation (Deutsche Forschungsgemeinschaft) Emmy Noether Grant
   KO4037/1-1 (J.O.K.), the Beatriu de Pinos Program grants 2006 BP-A 10144
   and 2009 BP-B 00274 (M.V.; ), the Spanish National Institute for Health
   Research grant PRB2 IPT13/0001-ISCIII-SGEFI/FEDER (A. O.), Ewha Womans
   University (C. L.), the Japan Society for the Promotion of Science
   Fellowship number PE13075 (N. P.), the Louis Jeantet Foundation (E. T.
   D.), the Marie Curie Actions Career Integration grant 303772 (C. A.),
   the Swiss National Science Foundation 31003A_130342 and NCCR "Frontiers
   in Genetics" (E. T. D.), the University of Geneva (E. T. D., T. L., G.
   M.), the US National Institutes of Health National Center for
   Biotechnology Information (S. S.) and grants U54HG3067 (E. S. L.),
   U54HG3273 and U01HG5211 (R.A.G.), U54HG3079 (R.K.W., E.R.M.), R01HG2898
   (S. E. D.), R01HG2385 (E. E. E.), RC2HG5552 and U01HG6513 (G. T. M.,
   G.R.A.), U01HG5214 (A. C.), U01HG5715 (C. D. B.), U01HG5718 (M. G.),
   U01HG5728 (Y.X.F.), U41HG7635 (R.K.W., E. E. E., P. H. S.), U41HG7497
   (C. L., M. A. B., K.C., L. D., E. E. E., M. G., J.O.K., G. T. M., S. A.
   M., R.E.M., J. L. S., K.Y.), R01HG4960 and R01HG5701 (B. L. B.),
   R01HG5214 (G. A.), R01HG6855 (S. M.), R01HG7068 (R.E.M.), R01HG7644
   (R.D.H.), DP2OD6514(P. S.), DP5OD9154 (J.K.), R01CA166661 (S. E. D.),
   R01CA172652 (K.C.), P01GM99568 (S.R.B.), R01GM59290 (L. B. J., M. A.
   B.), R01GM104390 (L. B. J., M.Y.Y.), T32GM7790 (C. D. B., A.R.M.),
   P01GM99568 (S.R.B.), R01HL87699 and R01HL104608 (K.C.B.), T32HL94284
   (J.L.R.F.), and contracts HHSN268201100040C (A.M.R.) and
   HHSN272201000025C (P. S.), Harvard Medical School Eleanor and Miles
   Shore Fellowship (K.L.), Lundbeck Foundation Grant R170-2014-1039
   (K.L.), NIJ Grant 2014-DN-BX-K089 (Y.E.), the Mary Beryl Patch Turnbull
   Scholar Program (K.C. B.), NSF Graduate Research Fellowship DGE-1147470
   (G. D. P.), the Simons Foundation SFARI award SF51 (M. W.), and a Sloan
   Foundation Fellowship (R.D. H.). E. E. E. is an investigator of the
   Howard Hughes Medical Institute.
CR Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907
   Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107
   Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934
   Do R, 2015, NAT GENET, V47, P126, DOI 10.1038/ng.3186
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x
   Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170
   Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750
   Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247
   Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878
   Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354
   Jung H, 2013, NAT BIOTECHNOL, V31, P787, DOI 10.1038/nbt.2681
   Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557
   Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435
   Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926
   Menelaou A, 2013, BIOINFORMATICS, V29, P84, DOI 10.1093/bioinformatics/bts632
   Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425
   O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234
   Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353
   Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706
   Sidore C, 2015, NATURE GENET
   Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896
   Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639
   Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998
   UK10K Consortium, 2015, NATURE
   Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793
   Wakefield J, 2012, INT J EPIDEMIOL, V41, P286, DOI 10.1093/ije/dyr241
   Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359
   Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015
   Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618
   Mathieson I., 2014, PLOS GENET, V10
   Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371
NR 37
TC 308
Z9 311
U1 45
U2 183
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD OCT 1
PY 2015
VL 526
IS 7571
BP 68
EP +
DI 10.1038/nature15393
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS5CY
UT WOS:000362095100036
OA No
HC Y
HP Y
DA 2017-08-15
ER

PT J
AU Gryseels, C
   Grietens, KP
   Dierickx, S
   Xuan, XN
   Uk, S
   Bannister-Tyrrell, M
   Trienekens, S
   Ribera, JM
   Hausmann-Muela, S
   Gerrets, R
   D'Alessandro, U
   Sochantha, T
   Coosemans, M
   Erhart, A
AF Gryseels, Charlotte
   Grietens, Koen Peeters
   Dierickx, Susan
   Xuan, Xa Nguyen
   Uk, Sambunny
   Bannister-Tyrrell, Melanie
   Trienekens, Suzan
   Ribera, Joan Muela
   Hausmann-Muela, Susanna
   Gerrets, Rene
   D'Alessandro, Umberto
   Sochantha, Tho
   Coosemans, Marc
   Erhart, Annette
TI High Mobility and Low Use of Malaria Preventive Measures among the Jarai
   Male Youth along the Cambodia-Vietnam Border
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID SOUTHEAST-ASIA; FOREST MALARIA; RISK-FACTORS; RANDOMIZED TRIAL; TREATED
   HAMMOCK; VECTOR CONTROL; NET COVERAGE; TRANSMISSION; EPIDEMIOLOGY;
   ELIMINATION
AB Malaria control along the Vietnam Cambodia border presents a challenge for both countries' malaria elimination targets as the region is forested, inhabited by ethnic minority populations, and potentially characterized by early and outdoor malaria transmission. A mixed methods study assessed the vulnerability to malaria among the Jarai population living on both sides of the border in the provinces of Ratanakiri (Cambodia) and Gia Lai (Vietnam). A qualitative study generated preliminary hypotheses that were quantified in two surveys, one targeting youth (N = 498) and the other household leaders (N = 449). Jarai male youth, especially in Cambodia, had lower uptake of preventive measures (57.4%) and more often stayed overnight in the deep forest (35.8%) compared with the female youth and the adult population. Among male youth, a high-risk subgroup was identified that regularly slept at friends' homes or outdoors, who had fewer bed nets (32.5%) that were torn more often (77.8%). The vulnerability of Jarai youth to malaria could be attributed to the transitional character of youth itself, implying less fixed sleeping arrangements in nonpermanent spaces or non-bed sites. Additional tools such as long-lasting hammock nets could be suitable as they are in line with current practices.
C1 Inst Trop Med, B-2000 Antwerp, Belgium.
   Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.
   Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.
   Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan.
   Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
   Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   MRC Unit, Fajara, Gambia.
   London Sch Hyg & Trop Med, London WC1, England.
   Univ Antwerp, B-2020 Antwerp, Belgium.
RP Gryseels, C (reprint author), Inst Trop Med, Med Anthropol Unit, Natl Str 155, B-2000 Antwerp, Belgium.
EM cgryseels@itg.be
FU Belgian Co-operation (Directorate General for Development Cooperation)
FX This study was conducted in the framework of the Institutional
   Collaboration between the National Centre for Malaria Control (CNM)
   Cambodia and the Institute of Tropical Medicine, Belgium, supported by
   the Belgian Co-operation (Directorate General for Development
   Cooperation).
CR AAA, COD ETH AM ANTHR ASS
   Abe T, 2009, SE ASIAN J TROP MED, V40, P18
   Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456
   Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2
   Coosemans M, 2006, P INT C HUBS HARB DE, P551
   Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4
   Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016
   Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674
   Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925
   Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329
   Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58
   Erhart A, 2004, AM J TROP MED HYG, V70, P110
   Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286
   Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3
   Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294
   Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991
   Xuan XN, 2010, MALARIA J, V9, P1
   Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343
   Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2
   Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176
   Kar NP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-265
   Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330
   Konradsen F, 2003, AM J TROP MED HYG, V68, P177
   LeVine R.A., 2008, ANTHR CHILD DEV
   Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x
   Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57
   Magris M, 2007, TROP MED INT HEALTH, V12, P392, DOI 10.1111/j.1365-3156.2006.01801.x
   Morrow M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-85
   Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2
   Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948
   Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26
   Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205
   Pongvongsa T, 2012, VIETNAM MALAR J, V11, P262, DOI DOI 10.1186/1475-2875-11-262
   Prothero RM, 1999, SINGAPORE J TROP GEO, V20, P76, DOI 10.1111/1467-9493.00044
   Sanh NH, 2008, AM J TROP MED HYG, V79, P652
   Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387
   Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x
   Somboon Pradya, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P3
   Tashakkori A., 1998, APPL SOCIAL RES METH, V46
   Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369
   Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28
   Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175
   Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x
   Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x
   Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373
   WHO, 2008, MAL GREAT MEK SUBR
   Zimmerman R H, 1997, Rev Panam Salud Publica, V2, P18, DOI 10.1590/S1020-49891997000700004
NR 49
TC 6
Z9 6
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
BP 810
EP 818
DI 10.4269/ajtmh.15-0259
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CS8BX
UT WOS:000362311800026
PM 26283747
OA No
DA 2017-08-15
ER

PT J
AU Shimakawa, Y
   Lemoine, M
   Bottomley, C
   Njai, HF
   Ndow, G
   Jatta, A
   Tamba, S
   Bojang, L
   Taal, M
   Nyan, O
   D'Alessandro, U
   Njie, R
   Thursz, M
   Hall, AJ
AF Shimakawa, Yusuke
   Lemoine, Maud
   Bottomley, Christian
   Njai, Harr Freeya
   Ndow, Gibril
   Jatta, Abdoulie
   Tamba, Saydiba
   Bojang, Lamin
   Taal, Makie
   Nyan, Ousman
   D'Alessandro, Umberto
   Njie, Ramou
   Thursz, Mark
   Hall, Andrew J.
TI Birth order and risk of hepatocellular carcinoma in chronic carriers of
   hepatitis B virus: a case-control study in The Gambia
SO LIVER INTERNATIONAL
LA English
DT Article
DE Africa; birth order; carcinoma; hepatocellular; Hepatitis B; infectious
   disease transmission; vertical
ID WEST-AFRICA; FOLLOW-UP; INFECTION; TRANSMISSION; BIAS; CANCER; AGE;
   ASSOCIATION; PREVALENCE; LYMPHOMA
AB Background & AimsEarly age at infection with Hepatitis B virus (HBV) increases the risk of chronic infection. Moreover, early HBV infection may further independently increase the risk of hepatocellular carcinoma (HCC) beyond its effect on chronicity.
   MethodsThe distribution of birth order, a proxy for mode and timing of HBV transmission, was compared in The Gambia between hepatitis B surface antigen (HBsAg)-positive HCC cases recruited from hospitals (n=72) and two HBsAg-positive control groups without HCC: population-based controls from a community HBV screening (n=392) and hospital-based controls (n=63).
   ResultsHCC risk decreased with increasing birth order in the population-based case-control analysis. Using first birth order as the reference, the odds ratios were 0.52 (95% CI: 0.20-1.36), 0.52 (0.17-1.56), 0.57 (0.16-2.05) and 0.14 (0.03-0.64) for second, third, fourth and greater than fourth birth order respectively (P=0.01). A similar inverse association was observed in the hospital-based case-control comparison (P=0.04).
   ConclusionsCompared to controls, HCC cases had earlier birth order, a proxy for young maternal age and maternal HBV viraemia at birth. This finding suggests that in chronic HBV carriers perinatal mother-to-infant transmission may increase HCC risk more than horizontal transmission. Providing HBV vaccine within 24h of birth to interrupt perinatal transmission might reduce the incidence of HCC in The Gambia.
C1 [Shimakawa, Yusuke; Lemoine, Maud; Njai, Harr Freeya; Ndow, Gibril; Jatta, Abdoulie; Tamba, Saydiba; Bojang, Lamin; D'Alessandro, Umberto; Njie, Ramou] MRC Unit, Banjul, Gambia.
   [Shimakawa, Yusuke; Bottomley, Christian; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   [Shimakawa, Yusuke] Inst Pasteur, Emerging Dis Epidemiol Unit, F-75724 Paris, France.
   [Lemoine, Maud; Thursz, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, London, England.
   [Ndow, Gibril; Njie, Ramou] IARC, MRC Unit, Gambia Hepatitis Intervent Study, Banjul, Gambia.
   [Taal, Makie] Minist Hlth & Social Welf, Banjul, Gambia.
   [Nyan, Ousman] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [Hall, Andrew J.] IARC, Lyon, France.
RP Shimakawa, Y (reprint author), Inst Pasteur, Emerging Dis Epidemiol Unit, 25-28 Rue Dr Roux, F-75724 Paris, France.
EM yusuke.shimakawa@pasteur.fr
OI Ndow, Gibril/0000-0001-5837-5110
FU European Commission [265994]
FX This work was supported by the European Commission's Seventh Framework
   Programme (grant 265994, PROLIFICA).
CR Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730
   Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933
   Cai Ru-lin, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P22
   Cao Yan-yan, 2005, Fudan Xuebao (Yixuekexueban), V32, P447
   Cardwell CR, 2011, INT J EPIDEMIOL, V40, P363, DOI 10.1093/ije/dyq207
   CHANG MH, 1989, CANCER-AM CANCER SOC, V64, P2377, DOI 10.1002/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8
   CHOTARD J, 1992, J INFECT DIS, V166, P764
   CIA, WORLD FACT BOOK MOTH
   Dumpis U, 2001, J HEPATOL, V35, P99, DOI 10.1016/S0168-8278(01)00064-2
   Elefsiniotis LS, 2007, EUR J OBSTET GYN R B, V132, P200, DOI 10.1016/j.ejogrb.2006.08.015
   Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008
   Grulich AE, 2010, AM J EPIDEMIOL, V172, P621, DOI 10.1093/aje/kwq167
   Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030
   HALDANE JBS, 1948, ANN EUGENIC, V14, P117
   HALL AJ, 1989, LANCET, V1, P1057
   HARE EH, 1969, BRIT J PSYCHIAT, V115, P647, DOI 10.1192/bjp.115.523.647
   Howell J, 2014, J VIRAL HEPATITIS, V21, P381, DOI 10.1111/jvh.12263
   HSIEH CC, 1992, AM J EPIDEMIOL, V136, P1115
   HYAMS KC, 1995, CLIN INFECT DIS, V20, P992
   Kuper H, 2000, EPIDEMIOLOGY, V11, P680, DOI 10.1097/00001648-200011000-00011
   LAROUZE B, 1976, LANCET, V2, P534
   Law GR, 2002, BRIT J CANCER, V86, P350, DOI 10.1038/sj/bjc/6600092
   MacMahon B, 1960, EPIDEMIOLOGIC METHOD
   MAYANS MV, 1990, LANCET, V336, P1107
   Mendy ME, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-49
   Mensahl FK, 2007, AM J EPIDEMIOL, V166, P717, DOI 10.1093/aje/kwm131
   Modin B, 2002, SOC SCI MED, V54, P1051, DOI 10.1016/S0277-9536(01)00080-6
   MUNOZ N, 1989, INT J CANCER, V44, P981, DOI 10.1002/ijc.2910440606
   PRICE JS, 1969, BRIT J PSYCHIAT, V115, P633, DOI 10.1192/bjp.115.523.633
   RYDER RW, 1992, AM J EPIDEMIOL, V136, P1122
   Shimakawa Y, 2013, J HEPATOL, V58, pS21
   Shimakawa Y, 2015, PALLIATIVE MED, V29, P184, DOI 10.1177/0269216314547103
   Shimakawa Yusuke, 2014, Trop Med Health, V42, P59, DOI 10.2149/tmh.2014-S08
   Shimakawa Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-532
   Shimakawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069430
   Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646
   Song SF, 2009, CHINESE J PUBLIC HLT, V25, P1326
   WHITTLE H, 1990, J INFECT DIS, V161, P1112
   WHITTLE HC, 1983, LANCET, V1, P1203
   WHO, 2009, WKLY EPIDEMIOL REC, V84, P405
NR 40
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD OCT
PY 2015
VL 35
IS 10
BP 2318
EP 2326
DI 10.1111/liv.12814
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CS6PC
UT WOS:000362201800014
PM 25728498
OA No
DA 2017-08-15
ER

PT J
AU Abdulla, S
   Ashley, EA
   Bassat, Q
   Bethell, D
   Bjorkman, A
   Borrmann, S
   D'Alessandro, U
   Dahal, P
   Day, NP
   Diakite, M
   Djimde, AA
   Dondorp, AM
   Duong, S
   Edstein, MD
   Fairhurst, RM
   Faiz, MA
   Falade, C
   Flegg, JA
   Fogg, C
   Gonzalez, R
   Greenwood, B
   Guerin, PJ
   Guthmann, JP
   Hamed, K
   Hien, TT
   Htut, Y
   Juma, E
   Lim, P
   Martensson, A
   Mayxay, M
   Mokuolu, OA
   Moreira, C
   Newton, P
   Noedl, H
   Nosten, F
   Ogutu, BR
   Onyamboko, MA
   Owusu-Agyei, S
   Phyo, AP
   Premji, Z
   Price, RN
   Pukrittayakamee, S
   Ramharter, M
   Sagara, I
   Se, Y
   Suon, S
   Stepniewska, K
   Ward, SA
   White, NJ
   Winstanley, PA
AF Abdulla, Salim
   Ashley, Elizabeth A.
   Bassat, Quique
   Bethell, Delia
   Bjorkman, Anders
   Borrmann, Steffen
   D'Alessandro, Umberto
   Dahal, Prabin
   Day, Nicholas P.
   Diakite, Mahamadou
   Djimde, Abdoulaye A.
   Dondorp, Arjen M.
   Duong, Socheat
   Edstein, Michael D.
   Fairhurst, Rick M.
   Faiz, M. Abul
   Falade, Catherine
   Flegg, Jennifer A.
   Fogg, Carole
   Gonzalez, Raquel
   Greenwood, Brian
   Guerin, Philippe J.
   Guthmann, Jean-Paul
   Hamed, Kamal
   Tran Tinh Hien
   Htut, Ye
   Juma, Elizabeth
   Lim, Pharath
   Martensson, Andreas
   Mayxay, Mayfong
   Mokuolu, Olugbenga A.
   Moreira, Clarissa
   Newton, Paul
   Noedl, Harald
   Nosten, Francois
   Ogutu, Bernhards R.
   Onyamboko, Marie A.
   Owusu-Agyei, Seth
   Phyo, Aung Pyae
   Premji, Zul
   Price, Ric N.
   Pukrittayakamee, Sasithon
   Ramharter, Michael
   Sagara, Issaka
   Se, Youry
   Suon, Seila
   Stepniewska, Kasia
   Ward, Stephen A.
   White, Nicholas J.
   Winstanley, Peter A.
CA WWARN Parasite Clearance Study Grp
TI Baseline data of parasite clearance in patients with falciparum malaria
   treated with an artemisinin derivative: an individual patient data
   meta-analysis
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Parasite clearance; Artemisinin resistance; Drug resistance;
   Plasmodium falciparum
ID RESISTANT PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED
   MALARIA; WESTERN CAMBODIA; ORAL ARTESUNATE; AFRICAN INFANTS;
   SOUTHEAST-ASIA; NO EVIDENCE; CHILDREN; EFFICACY
AB Background: Artemisinin resistance in Plasmodium falciparum manifests as slow parasite clearance but this measure is also influenced by host immunity, initial parasite biomass and partner drug efficacy. This study collated data from clinical trials of artemisinin derivatives in falciparum malaria with frequent parasite counts to provide reference parasite clearance estimates stratified by location, treatment and time, to examine host factors affecting parasite clearance, and to assess the relationships between parasite clearance and risk of recrudescence during follow-up.
   Methods: Data from 24 studies, conducted from 1996 to 2013, with frequent parasite counts were pooled. Parasite clearance half-life (PC1/2) was estimated using the WWARN Parasite Clearance Estimator. Random effects regression models accounting for study and site heterogeneity were used to explore factors affecting PC1/2 and risk of recrudescence within areas with reported delayed parasite clearance (western Cambodia, western Thailand after 2000, southern Vietnam, southern Myanmar) and in all other areas where parasite populations are artemisinin sensitive.
   Results: PC1/2 was estimated in 6975 patients, 3288 of whom also had treatment outcomes evaluate d during 28-63 days follow-up, with 93 (2.8 %) PCR-confirmed recrudescences. In areas with artemisinin-sensitive parasites, the median PC1/2 following three-day artesunate treatment (4 mg/kg/day) ranged from 1.8 to 3.0 h and the proportion of patients with PC1/2 > 5 h from 0 to 10 %. Artesunate doses of 4 mg/kg/day decreased PC1/2 by 8.1 % (95 % CI 3.2-12.6) compared to 2 mg/kg/day, except in populations with delayed parasite clearance. PC1/2 was longer in children and in patients with fever or anaemia at enrolment. Long PC1/2 (HR = 2.91, 95 % CI 1.95-4.34 for twofold increase, p < 0.001) and high initial parasitaemia (HR = 2.23, 95 % CI 1.44-3.45 for tenfold increase, p < 0.001) were associated independently with an increased risk of recrudescence. In western Cambodia, the region with the highest prevalence of artemisinin resistance, there was no evidence for increasing PC1/2 since 2007.
   Conclusions: Several factors affect PC1/2. As substantial heterogeneity in parasite clearance exists between locations, early detection of artemisinin resistance requires reference PC1/2 data. Studies with frequent parasite count measurements to characterize PC1/2 should be encouraged. In western Cambodia, where PC1/2 values are longest, there is no evidence for recent emergence of higher levels of artemisinin resistance.
C1 [Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Ashley, Elizabeth A.; Dahal, Prabin; Day, Nicholas P.; Dondorp, Arjen M.; Guerin, Philippe J.; Tran Tinh Hien; Mayxay, Mayfong; Moreira, Clarissa; Newton, Paul; Nosten, Francois; Onyamboko, Marie A.; Price, Ric N.; Stepniewska, Kasia; White, Nicholas J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Ashley, Elizabeth A.; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit MORU, Fac Trop Med, Bangkok 10700, Thailand.
   [Bassat, Quique] Univ Barcelona, Ctr Invest Saude Manhica Manhica Mozamb & ISGloba, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain.
   [Bethell, Delia] AFRIMS, Dept Immunol & Med, Bangkok, Thailand.
   [Bjorkman, Anders] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Malaria Res, Stockholm, Sweden.
   [Borrmann, Steffen] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.
   [Borrmann, Steffen] Univ Magdeburg, Sch Med, D-39106 Magdeburg, Germany.
   [D'Alessandro, Umberto] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Dahal, Prabin; Guerin, Philippe J.; Moreira, Clarissa; Price, Ric N.; Stepniewska, Kasia] WorldWide Antimalarial Resistance Network WWARN, Oxford, England.
   [Diakite, Mahamadou] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali.
   [Duong, Socheat] Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   [Fairhurst, Rick M.; Lim, Pharath] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.
   [Faiz, M. Abul] Malaria Res Grp MRG & Dev Care Fdn, Dhaka, Bangladesh.
   [Falade, Catherine] Univ Ibadan, Coll Med, Ibadan, Nigeria.
   [Flegg, Jennifer A.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia.
   [Fogg, Carole] Univ Portsmouth, Portsmouth, Hants, England.
   [Gonzalez, Raquel] Ctr Invest Saude Manhica Manhica Mozamb, Barcelona, Spain.
   [Gonzalez, Raquel] CRESIB, Barcelona, Spain.
   [Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Guthmann, Jean-Paul] Epicentre, Paris, France.
   [Hamed, Kamal] Novartis Pharmaceut, E Hanover, NJ USA.
   [Tran Tinh Hien] OUCRU, Wellcome Trust Major Overseas Programme MOP, Ho Chi Minh City, Vietnam.
   [Htut, Ye] Dept Med Res, Lower Myanmar, Yangon, Myanmar.
   [Juma, Elizabeth] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Lim, Pharath] US & Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   [Martensson, Andreas] Karolinska Inst, Dept Microbiol Cell & Tumour Biol, Dept Publ Hlth Sci, Malaria Res, Stockholm, Sweden.
   [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden.
   [Mayxay, Mayfong; Newton, Paul] Mahosot Hosp, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit LOMWRU, Viangchan, Laos.
   [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos.
   [Mokuolu, Olugbenga A.] Univ Ilorin, Dept Paediat & Child Hlth, Ilorin, Nigeria.
   [Noedl, Harald] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.
   [Nosten, Francois; Phyo, Aung Pyae] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok 10700, Thailand.
   [Ogutu, Bernhards R.] Kenya Govt Med Res Ctr, US Army Med Res Unit, Kisumu, Kenya.
   [Onyamboko, Marie A.] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO.
   [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana.
   [Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.
   [Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.
   [Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia.
   [Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand.
   [Ramharter, Michael] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.
   [Ramharter, Michael] Univ Tubingen, Inst Tropenmed, Tubingen, Germany.
   [Ramharter, Michael] Ctr Rech Med Lambarene, Lambarene, Gabon.
   [Sagara, Issaka] Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali.
   [Se, Youry] AFRIMS, Phnom Penh, Cambodia.
   [Suon, Seila] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
   [Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.
   [Winstanley, Peter A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
RP Abdulla, S (reprint author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
EM sabdulla@ihi.or.tz; liz@tropmedres.ac; quique.bassat@isglobal.org;
   deliabethell@btinternet.com; anders.bjorkman@ki.se;
   sborrmann@kilifi.kemri-wellcome.org; udalessandro@mrc.gm;
   prabin.dahal@wwarn.org; nickd@tropmedres.ac; mdiakite@icermali.org;
   adjimde@icermali.org; arjen@tropmedres.ac; d_socheat@yahoo.com;
   Mike.Edstein@defence.gov.au; rfairhurst@niaid.nih.gov;
   drmafaiz@gmail.com; lillyfunke@yahoo.com; jennifer.flegg@monash.edu;
   carole.fogg@port.ac.uk; raquel.gonzalez@cresib.cat;
   brian.greenwood@lshtm.ac.uk; philippe.guerin@wwarn.org;
   jp.guthmann@invs.sante.fr; kamal.hamed@novartis.com; hientt@oucru.org;
   dr.y.htut@gmail.com; jumaelizabeth@yahoo.com; limp@niaid.nih.gov;
   andreas.martensson@ki.se; mayfong@tropmedres.ac; oamokuolu@yahoo.com;
   clarissa.moreira@wwarn.org; paul@tropmedres.ac;
   harald.noedl@meduniwien.ac.at; francois@tropmedres.ac;
   bernhards.ogutu@usamru-k.org; akatshimarie@yahoo.fr;
   owusu-agyei@kintampo-hrc.org; aungpyaephyo@shoklo-unit.com;
   zulpremji688@gmail.com; ric.price@wwarn.org; yon@tropmedres.ac;
   michael.ramharter@meduniwien.ac.at; isagara@mrtcbko.org;
   suon_seila012@yahoo.com; kasia.stepniewska@wwarn.org;
   saward@liverpool.ac.uk; nickwdt@tropmedres.ac;
   P.Winstanley@warwick.ac.uk
RI Ward, Steve/G-6003-2015
OI Ward, Steve/0000-0003-2331-3192; Price, Richard/0000-0003-2000-2874;
   Flegg, Jennifer/0000-0002-8809-726X; Dahal, Prabin/0000-0002-2158-846X;
   Guerin, Philippe/0000-0002-6008-2963; Bassat, Quique/0000-0003-0875-7596
FU Bill and Melinda Gates Foundation; NIAID, NIH
FX We thank the patients and staff who participated in the clinical trials
   at all sites. WWARN is funded by a Bill and Melinda Gates Foundation
   grant. The funder did not participate in developing the protocol or
   writing the paper. This study was supported in part by the Intramural
   Research Program of the NIAID, NIH. All clinical studies were approved
   by the respective ethics committees or institutional review boards of
   each collaborative entity and host country of conduct. All subjects
   provided informed consent before study participation, and parents or
   legal guardians provided informed consent on behalf of their children.
   Disclaimer: The opinions expressed are those of the authors and do not
   necessarily reflect those of the Australian Defence Organisation or any
   extant policy.
CR Abdulla S, 2008, LANCET, V372, P1819, DOI 10.1016/S0140-6736(08)61492-0
   Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Bethell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019283
   Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005
   Bouyou-Akotet MK, 2010, WIEN KLIN WOCHENSCHR, V122, P173, DOI 10.1007/s00508-010-1317-1
   Chotivanich K, 2014, ANTIMICROB AGENTS CH, V58, P3157, DOI 10.1128/AAC.01924-13
   Das D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-125
   Das Debashish, 2013, Clin Infect Dis, V56, pe48, DOI 10.1093/cid/cis958
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013
   Flegg JA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-411
   Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339
   Fogg C, 2008, T ROY SOC TROP MED H, V102, P25, DOI 10.1016/j.trstmh.2007.09.014
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599
   Hietala SF, 2010, ANTIMICROB AGENTS CH, V54, P4780, DOI 10.1128/AAC.00252-10
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   KWIATKOWSKI D, 1989, CLIN EXP IMMUNOL, V77, P361
   Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689
   Lee SJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-149
   Lefevre G, 2001, AM J TROP MED HYG, V64, P247
   Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082
   Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058
   Mayxay M, 2012, AM J TROP MED HYG, V86, P403, DOI 10.4269/ajtmh.2012.11-0497
   Muhindo MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-32
   Thanh NX, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-217
   Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239
   Starzengruber P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052236
   Suputtamongkol Y, 2001, BRIT J CLIN PHARMACO, V52, P655, DOI 10.1046/j.1365-2125.2001.01458.x
   Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110
   Tran T H, 1996, N Engl J Med, V335, P76
   Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355
   Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999
   Vugt M V, 1999, Am J Trop Med Hyg, V60, P936
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2009, METH SURV ANT DRUG E
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, P312
   Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4
NR 45
TC 0
Z9 0
U1 1
U2 27
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD SEP 22
PY 2015
VL 14
AR 359
DI 10.1186/s12936-015-0874-1
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CR6AW
UT WOS:000361426500001
OA gold
DA 2017-08-15
ER

PT J
AU Huang, HW
   Chen, YS
   Chen, JYF
   Lu, PL
   Lin, YC
   Chen, BC
   Chou, LC
   Wang, CF
   Su, HJ
   Huang, YC
   Shi, YY
   Chen, HL
   Sanno-Duanda, B
   Huang, TS
   Lin, KH
   Tyan, YC
   Chu, PY
AF Huang, Hui-Wen
   Chen, Yao-Shen
   Chen, Jeff Yi-Fu
   Lu, Po-Liang
   Lin, Yung-Cheng
   Chen, Bao-Chen
   Chou, Li-Chiu
   Wang, Chu-Feng
   Su, Hui-Ju
   Huang, Yi-Chien
   Shi, Yong-Ying
   Chen, Hsiu-Lin
   Sanno-Duanda, Bintou
   Huang, Tsi-Shu
   Lin, Kuei-Hsiang
   Tyan, Yu-Chang
   Chu, Pei-Yu
TI Phylodynamic reconstruction of the spatiotemporal transmission and
   demographic history of coxsackievirus B2
SO BMC BIOINFORMATICS
LA English
DT Article
DE Coxsackievirus B2; Phylodynamic; Spatiotemporal transmission;
   Demographic history; Molecular epidemiology
ID HUMAN-ENTEROVIRUS-B; FREQUENT RECOMBINATION; EVOLUTIONARY DYNAMICS;
   PHYLOGENETIC ANALYSIS; T-COFFEE; SURVEILLANCE; IDENTIFICATION;
   EPIDEMIOLOGY; VARIABILITY; INFECTIONS
AB Background: Studies regarding coxsackievirus (CV) tend to focus on epidemic outbreaks, an imbalanced topology is considered to be an indication of acute infection with partial cross-immunity. In enteroviruses, a clear understanding of the characteristics of tree topology, transmission, and its demographic dynamics in viral succession and circulation are essential for identifying prevalence trends in endemic pathogens such as coxsackievirus B2 (CV-B2). This study applied a novel Bayesian evolutionary approach to elucidate the phylodynamic characteristics of CV-B2. A dataset containing 51 VP1 sequences and a dataset containing 34 partial 3D(pol) sequencing were analyzed, where each dataset included Taiwan sequences isolated during 1988-2013.
   Results: Four and five genotypes were determined based on the 846-nucleotide VP1 and 441-nucleotide 3D(pol) (6641-7087) regions, respectively, with spatiotemporally structured topologies in both trees. Some strains with tree discordance indicated the occurrence of recombination in the region between the VP1 and 3D(pol) genes. The similarities of VP1 and 3D(pol) gene were 80.0 %-96.8 % and 74.7 %-91.9 %, respectively. Analyses of population dynamics using VP1 dataset indicated that the endemic CV-B2 has a small effective population size. The balance indices, high similarity, and low evolutionary rate in the VP1 region indicated mild herd immunity selection in the major capsid region.
   Conclusions: Phylodynamic analysis can reveal demographic trends and herd immunity in endemic pathogens.
C1 [Huang, Hui-Wen] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan.
   [Huang, Hui-Wen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.
   [Huang, Hui-Wen] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.
   [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Div Infect Dis, Kaohsiung, Taiwan.
   [Chen, Yao-Shen; Chen, Bao-Chen; Huang, Tsi-Shu] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Div Microbiol, Kaohsiung, Taiwan.
   [Chen, Yao-Shen] Natl Yang Ming Med Univ, Dept Internal Med, Taipei, Taiwan.
   [Chen, Jeff Yi-Fu] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan.
   [Lu, Po-Liang; Lin, Kuei-Hsiang] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan.
   [Lu, Po-Liang; Chou, Li-Chiu; Wang, Chu-Feng; Su, Hui-Ju; Chu, Pei-Yu] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.
   [Lin, Yung-Cheng] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan.
   [Huang, Yi-Chien; Shi, Yong-Ying; Sanno-Duanda, Bintou; Chu, Pei-Yu] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung, Taiwan.
   [Chen, Hsiu-Lin] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.
   [Chen, Hsiu-Lin] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan.
   [Sanno-Duanda, Bintou] Edward Francis Small Teaching Hosp, Dept Lab Med, Banjul, Gambia.
   [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan.
   [Tyan, Yu-Chang] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.
RP Chu, PY (reprint author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.
EM peiyuchu@kmu.edu.tw
FU Ministry of Science and Technology, Taiwan, Republic of China [MOST
   103-2320-B037-024, 104-2320-B037-018]; Kaohsiung Medical University
   (KMU) [KMU-O104003]; NSYSU-KMU JOINT RESEARCH PROJECT [NSYSUKMU
   104-P032]
FX The findings of this study are also based in part on biological
   materials from the Taiwan Centers for Disease Control, Taiwan (CDC-TW).
   However, the interpretations of data and the conclusions contained
   herein do not represent those of the CDC-TW. This study was funded by a
   grant from the Ministry of Science and Technology, Taiwan, Republic of
   China (URL: http://www.most.gov.tw/; under grant nos. MOST
   103-2320-B037-024 and 104-2320-B037-018), and by grants from Kaohsiung
   Medical University (KMU) and NSYSU-KMU JOINT RESEARCH PROJECT (URL:
   http://english2.kmu.edu.tw/front/bin/ home.phtml; grant nos. KMU-O104003
   and NSYSUKMU 104-P032, respectively). The funders had no role in the
   study design, data collection and analysis, decision to publish, or
   manuscript preparation. The authors have no competing interests in the
   publication of this study.
CR Antona D, 2007, EUR J CLIN MICROBIOL, V26, P403, DOI 10.1007/s10096-007-0306-4
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Butan C, 2014, J VIROL, V88, P1758, DOI 10.1128/JVI.01949-13
   Chu PY, 2011, INFECT GENET EVOL, V11, P1426, DOI 10.1016/j.meegid.2011.05.010
   Chu PY, 2010, INFECT GENET EVOL, V10, P777, DOI 10.1016/j.meegid.2010.04.004
   Di Tommaso Paolo, 2011, Nucleic Acids Res, V39, pW13, DOI 10.1093/nar/gkr245
   Di Tommaso P, 2010, BIOINFORMATICS, V26, P1903, DOI 10.1093/bioinformatics/btq304
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-68
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Henquell C, 2013, J VIROL, V87, P12249, DOI 10.1128/JVI.02075-13
   Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10
   Hyeon JY, 2013, EMERG INFECT DIS, V19, P1268, DOI [10.3201/eid.1908.130496, 10.3201/eid1908.130496]
   Khetsuriani Nino, 2006, MMWR Surveill Summ, V55, P1
   Kim H, 2013, J MED VIROL, V85, P110, DOI 10.1002/jmv.23359
   Knipe D. M., 2001, FIELDS VIROLOGY, P723
   Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0
   Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021
   Morand S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01774
   Morimoto K, 2008, ONCOGENE, V27, P264, DOI 10.1038/sj.onc.1210645
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Oberste MS, 2008, CURR TOP MICROBIOL, V323, P33
   Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004
   Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0
   Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288
   Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170
   Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320
   Roth B, 2007, J MED VIROL, V79, P956, DOI 10.1002/jmv.20917
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Sojka M, 2011, EUROSURVEILLANCE, V16, P16
   Tavare S., 1986, LECTURES MATH LIFE S, V17, P57
   Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0
   Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947
   Wikswo ME, 2009, CLIN INFECT DIS, V49, pE44, DOI 10.1086/605090
   Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157
NR 39
TC 2
Z9 2
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD SEP 21
PY 2015
VL 16
AR 302
DI 10.1186/s12859-015-0738-2
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA CR7HZ
UT WOS:000361521000001
PM 26390997
OA gold
DA 2017-08-15
ER

PT J
AU Tahita, MC
   Tinto, H
   Erhart, A
   Kazienga, A
   Fitzhenry, R
   VanOvermeir, C
   Rosanas-Urgell, A
   Ouedraogo, JB
   Guiguemde, RT
   Van Geertruyden, JP
   D'Alessandro, U
AF Tahita, Marc C.
   Tinto, Halidou
   Erhart, Annette
   Kazienga, Adama
   Fitzhenry, Robert
   VanOvermeir, Chantal
   Rosanas-Urgell, Anna
   Ouedraogo, Jean-Bosco
   Guiguemde, Robert T.
   Van Geertruyden, Jean-Pierre
   D'Alessandro, Umberto
TI Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural
   Burkina Faso Five Years after the Introduction of Intermittent
   Preventive Treatment with Sulfadoxine-Pyrimethamine
SO PLOS ONE
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; DIHYDROPTEROATE SYNTHASE GENE;
   DIHYDROFOLATE-REDUCTASE; DRUG-RESISTANCE; POINT MUTATIONS; SYNTHETASE;
   EFFICACY; POLICY; LINE; AREA
AB Background
   The emergence and spread of drug resistance represents one of the biggest challenges for malaria control in endemic regions. Sulfadoxine-pyrimethamine (SP) is currently deployed as intermittent preventive treatment in pregnancy (IPTp) to prevent the adverse effects of malaria on the mother and her offspring. Nevertheless, its efficacy is threatened by SP resistance which can be estimated by the prevalence of dihydropteroate synthase (dhps) and dihydrofolate reductase (dhfr) mutations. This was measured among pregnant women in the health district of Nanoro, Burkina Faso.
   Methods
   From June to December 2010, two hundred and fifty six pregnant women in the second and third trimester, attending antenatal care with microscopically confirmed malaria infection were invited to participate, regardless of malaria symptoms. A blood sample was collected on filter paper and analyzed by PCR-RFLP for the alleles 51, 59, 108, 164 in the pfdhfr gene and 437, 540 in the pfdhps gene.
   Results
   The genes were successfully genotyped in all but one sample (99.6%; 255/256) for dhfr and in 90.2% (231/256) for dhps. The dhfr C59R and S108N mutations were the most common, with a prevalence of 61.2%(156/255) and 55.7%(142/255), respectively; 12.2%(31/255) samples had also the dhfr N51I mutation while the I164L mutation was absent. The dhps A437G mutation was found in 34.2%(79/231) isolates, but none of them carried the codon K540E. The prevalence of the dhfr double mutations NRNI and the triple mutations IRNI was 35.7% (91/255) and 11.4% (29/255), respectively.
   Conclusion
   Though the mutations in the pfdhfr and pfdhps genes were relatively common, the prevalence of the triple pfdhfr mutation was very low, indicating that SP as IPTp is still efficacious in Burkina Faso.
C1 [Tahita, Marc C.; Tinto, Halidou; Ouedraogo, Jean-Bosco] IRSS, DRO, Bobo Dioulasso, Burkina Faso.
   [Tahita, Marc C.; Tinto, Halidou; Kazienga, Adama; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.] IRSS CRUN, Clin Res Unit Nanoro, Nanoro, Burkina Faso.
   [Tahita, Marc C.; Tinto, Halidou; Guiguemde, Robert T.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso.
   [Tahita, Marc C.; Erhart, Annette; Fitzhenry, Robert; VanOvermeir, Chantal; Rosanas-Urgell, Anna; D'Alessandro, Umberto] Inst Trop Med, Malariol Unit, B-2000 Antwerp, Belgium.
   [Tahita, Marc C.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Guiguemde, Robert T.] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [D'Alessandro, Umberto] MRC Unit, Banjul, Gambia.
RP Tahita, MC (reprint author), IRSS, DRO, Bobo Dioulasso, Burkina Faso.
EM marctahita@yahoo.fr
RI Rosanas-Urgell, Anna/D-3193-2015
OI Rosanas-Urgell, Anna/0000-0002-0432-5203
CR Artimovich E, 2015, J INFECT DIS, V212, P694, DOI 10.1093/infdis/jiv078
   Aziken ME, 2011, INT J GYNECOL OBSTET, V112, P30, DOI 10.1016/j.ijgo.2010.07.027
   Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08
   Basco LK, 1998, AM J TROP MED HYG, V58, P374
   BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x
   Coulibaly SO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-41
   COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109
   Cuzin-Ouattara N, 1999, T ROY SOC TROP MED H, V93, P473, DOI 10.1016/S0035-9203(99)90343-7
   Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274
   FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014
   Geiger C, 2014, TROP MED INT HEALTH, V19, P690, DOI 10.1111/tmi.12305
   Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4
   Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376
   Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400
   Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566
   Maiga OM, 2011, CLIN INFECT DIS, V53, P215, DOI 10.1093/cid/cir374
   Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000
   Omar SA, 2001, T ROY SOC TROP MED H, V95, P315, DOI 10.1016/S0035-9203(01)90250-0
   Pearce RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000055
   PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018
   Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x
   PLOWE CV, 1995, AM J TROP MED HYG, V52, P565
   Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE
   Plowe CV, 1997, J INFECT DIS, V176, P1590
   Programme National de Lutte contre le Paludisme (PNLP), 2010, DIR NAT PRIS CHARG P
   Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2
   Sicuri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013407
   Tahita MC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-464
   Tinto H, 2007, AM J TROP MED HYG, V76, P608
   Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-113
   TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149
   Vinayak S, 2010, PLOS PATHOG
   Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X
   White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003
   Zhou ZY, 2008, ANTIMICROB AGENTS CH, V52, P739, DOI 10.1128/AAC.00975-07
NR 35
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 14
PY 2015
VL 10
IS 9
AR e0137440
DI 10.1371/journal.pone.0137440
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR8KS
UT WOS:000361601100073
PM 26368675
OA gold
DA 2017-08-15
ER

PT J
AU Rosas-Aguirre, A
   Speybroeck, N
   Llanos-Cuentas, A
   Rosanas-Urgell, A
   Carrasco-Escobar, G
   Rodriguez, H
   Gamboa, D
   Contreras-Mancilla, J
   Alava, F
   Soares, IS
   Remarque, E
   D'Alessandro, U
   Erhart, A
AF Rosas-Aguirre, Angel
   Speybroeck, Niko
   Llanos-Cuentas, Alejandro
   Rosanas-Urgell, Anna
   Carrasco-Escobar, Gabriel
   Rodriguez, Hugo
   Gamboa, Dionicia
   Contreras-Mancilla, Juan
   Alava, Freddy
   Soares, Irene S.
   Remarque, Edmond
   D'Alessandro, Umberto
   Erhart, Annette
TI Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid
   Assessment through a Parasitological and Serological Survey
SO PLOS ONE
LA English
DT Article
ID PLASMODIUM-VIVAX-MALARIA; FALCIPARUM; ELIMINATION; COMMUNITIES;
   PREVALENCE; ENDEMICITY; STRATEGIES; PATTERNS; IQUITOS; AMERICA
AB Background
   With low and markedly seasonal malaria transmission, increasingly sensitive tools for better stratifying the risk of infection and targeting control interventions are needed. A cross-sectional survey to characterize the current malaria transmission patterns, identify hotspots, and detect recent changes using parasitological and serological measures was conducted in three sites of the Peruvian Amazon.
   Material and Methods
   After full census of the study population, 651 participants were interviewed, clinically examined and had a blood sample taken for the detection of malaria parasites (microscopy and PCR) and antibodies against P. vivax (PvMSP1(19), PvAMA1) and P. falciparum (PfGLURP, PfAMA1) antigens by ELISA. Risk factors for malaria infection (positive PCR) and malaria exposure (seropositivity) were assessed by multivariate survey logistic regression models. Age-specific seroprevalence was analyzed using a reversible catalytic conversion model based on maximum likelihood for generating seroconversion rates (SCR, lambda). SaTScan was used to detect spatial clusters of serology-positive individuals within each site.
   Results
   The overall parasite prevalence by PCR was low, i.e. 3.9% for P. vivax and 6.7% for P. falciparum, while the seroprevalence was substantially higher, 33.6% for P. vivax and 22.0% for P. falciparum, with major differences between study sites. Age and location (site) were significantly associated with P. vivax exposure; while location, age and outdoor occupation were associated with P. falciparum exposure. P. falciparum seroprevalence curves showed a stable transmission throughout time, while for P. vivax transmission was better described by a model with two SCRs. The spatial analysis identified well-defined clusters of P. falciparum seropositive individuals in two sites, while it detected only a very small cluster of P. vivax exposure.
   Conclusion
   The use of a single parasitological and serological malaria survey has proven to be an efficient and accurate method to characterize the species specific heterogeneity in malaria transmission at micro-geographical level as well as to identify recent changes in transmission.
C1 [Rosas-Aguirre, Angel; Llanos-Cuentas, Alejandro; Carrasco-Escobar, Gabriel; Gamboa, Dionicia; Contreras-Mancilla, Juan] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru.
   [Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.
   [Rosas-Aguirre, Angel; Rosanas-Urgell, Anna; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Rodriguez, Hugo; Alava, Freddy] Iquitos, Reg Salud Loreto, Loreto 160, Peru.
   [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima 31, Peru.
   [Soares, Irene S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508900 Sao Paulo, Brazil.
   [Remarque, Edmond] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands.
   [D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara 220, Gambia.
   [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Rosas-Aguirre, A (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru.
EM angelrosasa@gmail.com
RI Rosas Aguirre, Angel/A-5054-2016; Rosanas-Urgell, Anna/D-3193-2015;
   Soares, Irene/C-5974-2012
OI Rosas Aguirre, Angel/0000-0002-3271-7028; Rosanas-Urgell,
   Anna/0000-0002-0432-5203; Contreras Mancilla, Juan
   Jose/0000-0003-0447-0926; Carrasco-Escobar, Gabriel/0000-0002-6945-0419
FU Directorate General for Development Cooperation (DGCD) of the Belgian
   Government
FX The study was funded by the Directorate General for Development
   Cooperation (DGCD) of the Belgian Government within the Third Framework
   Agreement of the Institutional Collaboration between the Institute of
   Tropical Medicine "Alexander von Humboldt" - Universidad Peruana
   Cayetano Heredia, Lima and the Institute of Tropical Medicine in
   Antwerp, Belgium (FA3-II project, 2011-2013)). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008
   Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684
   Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109
   Bautista CT, 2006, AM J TROP MED HYG, V75, P1216
   Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456
   Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732
   Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27
   Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003
   Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86
   Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137
   Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169
   Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   Cunha MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113357
   da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001
   DiCiccio TJ, 1996, STAT SCI, V11, P189
   Dolo A, 2005, AM J TROP MED HYG, V72, P243
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8
   Elliott SR, 2014, F1000PRIME REP, V6, DOI 10.12703/P6-100
   Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055
   Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6
   Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294
   Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303
   Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3
   Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352
   Instituto Nacional de Estadistica e Informatica, 2014, AN EST AMB 2013
   Kulldorff M., 2010, SATSCAN SOFTWARE SPA
   Kulldorff M., 2011, SATSCAN USER GUIDE V
   Maheu-Giroux M, 2010, ACTA TROP, V115, P112, DOI 10.1016/j.actatropica.2010.02.011
   Maki S, 2001, ENVIRON CONSERV, V28, P199
   Mendis K, 2001, AM J TROP MED HYG, V64, P97
   Ministerio de Salud del Peru, 2013, BOL EPIDEMIOL, V22, P1088
   Muench H., 1959, CATALYTIC MODELS EPI
   Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179
   Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601
   Organismo Andino de Salud-PAMAFRO, 2009, COMP LECC APR
   Parekh FK, 2007, AM J TROP MED HYG, V77, P451
   Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178
   PLOWE CV, 1995, AM J TROP MED HYG, V52, P565
   QGIS developer team, 2014, QGIS US GUID REL 2 6
   Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547
   Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39
   Rodriguesa MHC, 2005, INT J PARASITOL, V35, P185, DOI 10.1016/j.ijpara.2004.11.003
   Rosas-Aguirre A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-339
   Rosas-Aguirre Angel, 2011, Rev Peru Med Exp Salud Publica, V28, P228, DOI 10.1590/s1726-46342011000200009
   Rosas-Aguirre Angel, 2010, Rev Peru Med Exp Salud Publica, V27, P540, DOI 10.1590/s1726-46342010000400008
   Roshanravan B, 2003, AM J TROP MED HYG, V69, P45
   Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5
   Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189
   Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083
   Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467
   Supargiyono S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-444
   THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30
   Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X
   Vinetz JM, 2002, AM J TROP MED HYG, V66, P639
   Vittor AY, 2006, AM J TROP MED HYG, V74, P3
   Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005
NR 60
TC 9
Z9 9
U1 3
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 10
PY 2015
VL 10
IS 9
AR e0137458
DI 10.1371/journal.pone.0137458
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ9WL
UT WOS:000360965800049
PM 26356311
OA gold
DA 2017-08-15
ER

PT J
AU Chhibber, AV
   Hill, PC
   Jafali, J
   Jasseh, M
   Hossain, MI
   Ndiaye, M
   Pathirana, JC
   Greenwood, B
   Mackenzie, GA
AF Chhibber, Aakash Varun
   Hill, Philip C.
   Jafali, James
   Jasseh, Momodou
   Hossain, Mohammad Ilias
   Ndiaye, Malick
   Pathirana, Jayani C.
   Greenwood, Brian
   Mackenzie, Grant A.
TI Child Mortality after Discharge from a Health Facility following
   Suspected Pneumonia, Meningitis or Septicaemia in Rural Gambia: A Cohort
   Study
SO PLOS ONE
LA English
DT Article
ID MANAGEMENT; INFECTION; COMMUNITY; AFRICA
AB Objective
   To measure mortality and its risk factors among children discharged from a health centre in rural Gambia.
   Methods
   We conducted a cohort study between 12 May 2008 and 11 May 2012. Children aged 2-59 months, admitted with suspected pneumonia, sepsis, or meningitis after presenting to primary and secondary care facilities, were followed for 180 days after discharge. We developed models associating post-discharge mortality with clinical syndrome on admission and clinical risk factors.
   Findings
   One hundred and five of 3755 (2.8%) children died, 80% within 3 months of discharge. Among children aged 2-11 and 12-59 months, there were 30 and 29 deaths per 1000 children per 180 days respectively, compared to 11 and 5 respectively in the resident population. Children with suspected pneumonia unaccompanied by clinically severe malnutrition (CSM) had the lowest risk of post-discharge mortality. Mortality increased in children with suspected meningitis or septicaemia without CSM (hazard ratio [HR] 2.6 and 2.2 respectively). The risk of mortality greatly increased with CSM on admission: CSM with suspected pneumonia (HR 8.1; 95% confidence interval (CI) 4.4 to 15), suspected sepsis (HR 18.4; 95% CI 11.3 to 30), or suspected meningitis (HR 13.7; 95% CI 4.2 to 45). Independent associations with mortality were: mid-upper arm circumference (MUAC) of 11.5-13.0 cm compared to > 13.0 cm (HR 7.2; 95% CI 3.0 to 17.0), MUAC 10.5-11.4 cm (HR 24; 95% CI 9.4 to 62), and MUAC <10.5 cm (HR 44; 95% CI 18 to 108), neck stiffness (HR 10.4; 95% CI 3.1 to 34.8), non-medical discharge (HR 4.7; 95% CI 2.0 to 10.9), dry season discharge (HR 2.0; 95% CI 1.2 to 3.3), while greater haemoglobin (HR 0.82; 0.73 to 0.91), axillary temperature (HR 0.71; 95% CI 0.58 to 0.87), and oxygen saturation (HR 0.96; 95% CI 0.93 to 0.99) were associated with reduced mortality.
   Conclusion
   Gambian children experience increased mortality after discharge from primary and secondary care. Interventions should target both moderately and severely malnourished children.
C1 [Chhibber, Aakash Varun; Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Jafali, James; Jasseh, Momodou; Hossain, Mohammad Ilias; Ndiaye, Malick; Pathirana, Jayani C.; Mackenzie, Grant A.] Med Res Council UK, Gambia Unit, Fajara, Gambia.
   [Greenwood, Brian; Mackenzie, Grant A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Mackenzie, Grant A.] Murdoch Childrens Res Inst, Infect & Immun Theme, Melbourne, Vic, Australia.
RP Mackenzie, GA (reprint author), Med Res Council UK, Gambia Unit, Fajara, Gambia.
EM gmackenzie@mrc.gm
FU Global Alliance for Vaccines and Immunisation's PneumoADIP; Bill &
   Melinda Gates Foundation; MRC (UK); University of Otago
FX Global Alliance for Vaccines and Immunisation's PneumoADIP
   (http://www.gavi.org/), Bill & Melinda Gates Foundation
   (http://www.gatesfoundation.org/, MRC (UK) (http://www.mrc.ac.uk/), and
   the University of Otago (http://www.otago.ac.nz/) funded the work. The
   funding bodies did not influence the design or implementation of the
   study or the decision to publish, and the authors alone are responsible
   for the content of this paper.
CR Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x
   Burkart KA, 2014, T ROY SOC TROP MED H, V108, P393, DOI 10.1093/trstmh/tru055
   Chang RKR, 2006, AM HEART J, V152, P386, DOI 10.1016/j.ahj.2005.12.016
   Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107663
   Cooper S, 2004, INTENS CARE MED, V30, P113, DOI 10.1007/s00134-003-2074-7
   Garenne M, 2013, PUBLIC HEALTH NUTR, V16, P1533, DOI 10.1017/S136898001200448X
   Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7
   HANLON P, 1987, ANN TROP PAEDIATR, V7, P238
   Lally KP, 2008, PEDIATRICS, V121, P627
   Liu L., 2012, LANCET, V379, P2151, DOI DOI 10.1016/S0140-6736(12)60560-1
   Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P725, DOI 10.2471/BLT.11.089235
   National AIDS Control Programme, 2012, HIV SENT SURV REP 20
   ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009
   Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903
   ROY SK, 1983, BRIT MED J, V287, P1097
   Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522
   Snow RW, 2000, TROP MED INT HEALTH, V5, P377, DOI 10.1046/j.1365-3156.2000.00568.x
   UNICEF, 2012, ACC PROGR CHILD SURV
   United Nations Children's Fund - UNICEF, COMM CHILD SURV PROM
   Veirum JE, 2007, ACTA PAEDIATR, V96, P1832, DOI 10.1111/j.1651-2227.2007.00562.x
   Villamor E, 2005, INT J EPIDEMIOL, V34, P61
   West TE, 1999, B WORLD HEALTH ORGAN, V77, P144
   Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698
NR 25
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2015
VL 10
IS 9
AR e0137095
DI 10.1371/journal.pone.0137095
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ9KG
UT WOS:000360932800061
PM 26353110
OA gold
DA 2017-08-15
ER

PT J
AU Mwangi, MN
   Roth, JM
   Smit, MR
   Trijsburg, L
   Mwangi, AM
   Demir, AY
   Wielders, JPM
   Mens, PF
   Verweij, JJ
   Cox, SE
   Prentice, AM
   Brouwer, ID
   Savelkoul, HFJ
   Andang'o, PEA
   Verhoef, H
AF Mwangi, Martin N.
   Roth, Johanna M.
   Smit, Menno R.
   Trijsburg, Laura
   Mwangi, Alice M.
   Demir, Ayse Y.
   Wielders, Jos P. M.
   Mens, Petra F.
   Verweij, Jaco J.
   Cox, Sharon E.
   Prentice, Andrew M.
   Brouwer, Inge D.
   Savelkoul, Huub F. J.
   Andang'o, Pauline E. A.
   Verhoef, Hans
TI Effect of Daily Antenatal Iron Supplementation on Plasmodium Infection
   in Kenyan Women A Randomized Clinical Trial
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID BIRTH-WEIGHT; PREGNANCY; MALARIA; METAANALYSIS; GESTATION; ANEMIA;
   MEDICATION; FALCIPARUM; MORTALITY; GROWTH
AB IMPORTANCE Anemia affects most pregnant African women and is predominantly due to iron deficiency, but antenatal iron supplementation has uncertain health benefits and can increase the malaria burden.
   OBJECTIVE To measure the effect of antenatal iron supplementation on maternal Plasmodium infection risk, maternal iron status, and neonatal outcomes.
   DESIGN, SETTING, AND PARTICIPANTS Randomized placebo-controlled trial conducted October 2011 through April 2013 in a malaria endemic area among 470 rural Kenyan women aged 15 to 45 years with singleton pregnancies, gestational age of 13 to 23 weeks, and hemoglobin concentration of 9 g/dL or greater. All women received 5.7 mg iron/day through flour fortification during intervention, and usual intermittent preventive treatment against malaria was given.
   INTERVENTIONS Supervised daily supplementation with 60 mg of elemental iron (as ferrous fumarate, n = 237 women) or placebo (n = 233) from randomization until 1 month postpartum.
   MAIN OUTCOMES AND MEASURES Primary outcome was maternal Plasmodium infection at birth. Predefined secondary outcomes were birth weight and gestational age at delivery, intrauterine growth, and maternal and infant iron status at 1 month after birth.
   RESULTS Among the 470 participating women, 40 women (22 iron, 18 placebo) were lost to follow-up or excluded at birth; 12 mothers were lost to follow-up postpartum (5 iron, 7 placebo). At baseline, 190 of 318 women (59.7%) were iron-deficient. In intention-to-treat analysis, comparison of women who received iron vs placebo, respectively, yielded the following results at birth: Plasmodium infection risk: 50.9% vs 52.1% (crude difference, -1.2%, 95% CI, -11.8% to 9.5%; P = .83); birth weight: 3202 g vs 3053 g (crude difference, 150 g, 95% CI, 56 to 244; P = .002); birth-weight-for-gestational-age z score: 0.52 vs 0.31 (crude difference, 0.21, 95% CI, -0.11 to 0.52; P = .20); and at 1 month after birth: maternal hemoglobin concentration: 12.89 g/dL vs 11.99 g/dL (crude difference, 0.90 g/dL, 95% CI, 0.61 to 1.19; P < .001); geometric mean maternal plasma ferritin concentration: 32.1 mu g/L vs 14.4 mu g/L (crude difference, 123.4%, 95% CI, 85.5% to 169.1%; P < .001); geometric mean neonatal plasma ferritin concentration: 163.0 mu g/L vs 138.7 mu g/L (crude difference, 17.5%, 95% CI, 2.4% to 34.8%; P = .02). Serious adverse events were reported for 9 and 12 women who received iron and placebo, respectively. There was no evidence that intervention effects on Plasmodium infection risk were modified by intermittent preventive treatment use.
   CONCLUSIONS AND RELEVANCE Among rural Kenyan women with singleton pregnancies, administration of daily iron supplementation, compared with administration of placebo, resulted in no significant differences in overall maternal Plasmodium infection risk. Iron supplementation led to increased birth weight.
C1 [Mwangi, Martin N.; Roth, Johanna M.; Smit, Menno R.; Trijsburg, Laura; Savelkoul, Huub F. J.; Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AH Wageningen, Netherlands.
   [Mwangi, Martin N.; Andang'o, Pauline E. A.] Maseno Univ, Sch Publ Hlth & Community Dev, Maseno, Kenya.
   [Roth, Johanna M.; Mens, Petra F.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.
   [Mwangi, Alice M.] Univ Nairobi, Appl Nutr Programme, Nairobi, Kenya.
   [Demir, Ayse Y.; Wielders, Jos P. M.] Meander Med Ctr, Clin Chem Lab, Amersfoort, Netherlands.
   [Verweij, Jaco J.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.
   [Cox, Sharon E.; Prentice, Andrew M.; Verhoef, Hans] London Sch Hyg & Trop Med, MRC Int Nutr Programme, London, England.
   [Cox, Sharon E.; Prentice, Andrew M.; Verhoef, Hans] MRC, MRC Int Nutr Programme, Keneba, Gambia.
   [Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, NL-6700 AH Wageningen, Netherlands.
RP Mwangi, MN (reprint author), Wageningen Univ, Cell Biol & Immunol Grp, POB 338, NL-6700 AH Wageningen, Netherlands.
EM mart.mwangi@gmail.com
RI Verhoef, Hans/L-3024-2015; Brouwer, Inge/K-8455-2013
OI Verhoef, Hans/0000-0002-9346-9689; Cox, Sharon/0000-0002-9908-2936;
   Mwangi, Martin N./0000-0002-8358-4448
FU INSTAPA project - European Union [211484]
FX This work was supported by the INSTAPA project, which received funding
   from the European Union's Seventh Framework Programme (FP7/2007-2013)
   under grant agreement 211484. Fortitech and Swiss Precision Diagnostics
   donated fortification premix and urine pregnancy tests, respectively.
   Laboratory and Allied, Nairobi, prepared supplemental capsules (without
   financial compensation).
CR Beaton GH, 2000, AM J CLIN NUTR S, V72, P265
   BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x
   Clark MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5446
   Cogswell ME, 2003, AM J CLIN NUTR, V78, P773
   Cottrell G, 2006, ACTA TROP, V98, P255, DOI 10.1016/j.actatropica.2006.05.009
   CRAMER JA, 1989, JAMA-J AM MED ASSOC, V261, P3273, DOI 10.1001/jama.261.22.3273
   McLean E, 2008, WORLDWIDE PREVALENCE
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X
   Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443
   Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231
   Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20
   Mason J. B., 2001, MICRONUTRIENT REPORT
   McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1841
   MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7
   Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4
   Ministry of Public Health and Sanitation and Ministry of Medical Services, 2010, NAT GUID DIAGN TREAT
   [Anonymous], 2008, KEN NAT TECHN GUID M
   Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002
   OLIVIERI NF, 1991, ARCH DIS CHILD, V66, P1399
   Oppenheimer SJ, 2001, J NUTR, V131, p616S
   Othoro C, 2006, CLIN VACCINE IMMUNOL, V13, P568, DOI 10.1128/CVI.13.5.568-574.2006
   Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3
   Pena-Rosas J, 2012, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858.CD004736.pub4, DOI 10.1002/14651858.CD004736.PUB4]
   Prentice AM, 2012, ADV NUTR, V3, P583, DOI 10.3945/an.111.001230
   Preziosi P, 1997, AM J CLIN NUTR, V66, P1178
   Puma M. J., 2009, 20090049 NCEE US DEP
   Sangare L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087743
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Scholl TO, 2011, NUTR REV, V69, pS23, DOI 10.1111/j.1753-4887.2011.00429.x
   United Nations Children's Fund World Health Organization, 2004, LOW BIRTHW COUNTR RE
   US Institute of Medicine, 2001, DIET REF INT VIT A V
   Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125
   Vucic V, 2013, NUTR REV, V71, P386, DOI 10.1111/nure.12037
   [Anonymous], 1958, IR DEF AN REP STUD G
   [Anonymous], GUID DAIL IR FOL AC
   Zeng LX, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2001
NR 37
TC 10
Z9 10
U1 0
U2 10
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD SEP 8
PY 2015
VL 314
IS 10
BP 1009
EP 1020
DI 10.1001/jama.2015.9496
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA CQ8FA
UT WOS:000360840700013
PM 26348751
OA No
DA 2017-08-15
ER

PT J
AU Abdulla, S
   Adam, I
   Adjei, GO
   Adjuik, MA
   Alemayehu, B
   Allan, R
   Arinaitwe, E
   Ashley, EA
   Ba, MS
   Barennes, H
   Barnes, KI
   Bassat, Q
   Baudin, E
   Berens-Riha, N
   Bjorkman, A
   Bompart, F
   Bonnet, M
   Borrmann, S
   Bousema, T
   Brasseur, P
   Bukirwa, H
   Checchi, F
   Dahal, P
   D'Alessandro, U
   Desai, M
   Dicko, A
   Djimde, AA
   Dorsey, G
   Doumbo, OK
   Drakeley, CJ
   Duparc, S
   Eshetu, T
   Espie, E
   Etard, JF
   Faiz, AM
   Falade, CO
   Fanello, CI
   Faucher, JF
   Faye, B
   Faye, O
   Filler, S
   Flegg, JA
   Fofana, B
   Fogg, C
   Gadalla, NB
   Gaye, O
   Genton, B
   Gething, PW
   Gil, JP
   Gonzalez, R
   Grandesso, F
   Greenhouse, B
   Greenwood, B
   Grivoyannis, A
   Guerin, PJ
   Guthmann, JP
   Hamed, K
   Hamour, S
   Hay, SI
   Hodel, EM
   Humphreys, GS
   Hwang, J
   Ibrahim, ML
   Jima, D
   Jones, JJ
   Jullien, V
   Juma, E
   Kachur, PS
   Kager, PA
   Kamugisha, E
   Kamya, MR
   Karema, C
   Kayentao, K
   Kiechel, JR
   Kironde, F
   Kofoed, PE
   Kremsner, PG
   Krishna, S
   Lameyre, V
   Lell, B
   Lima, A
   Makanga, M
   Malik, EM
   Marsh, K
   Martensson, A
   Massougbodji, A
   Menan, H
   Menard, D
   Menendez, C
   Mens, PF
   Meremikwu, M
   Moreira, C
   Nabasumba, C
   Nambozi, M
   Ndiaye, JL
   Ngasala, BE
   Nikiema, F
   Nsanzabana, C
   Ntoumi, F
   Oguike, M
   Ogutu, BR
   Olliaro, P
   Omar, SA
   Ouedraogo, JB
   Owusu-Agyei, S
   Penali, LK
   Pene, M
   Peshu, J
   Piola, P
   Plowe, CV
   Premji, Z
   Price, RN
   Randrianarivelojosia, M
   Rombo, L
   Roper, C
   Rosenthal, PJ
   Sagara, I
   Same-Ekobo, A
   Sawa, P
   Schallig, HDFH
   Schramm, B
   Seck, A
   Shekalaghe, SA
   Sibley, CH
   Sinou, V
   Sirima, SB
   Som, FA
   Sow, D
   Staedke, SG
   Stepniewska, K
   Sutherland, CJ
   Swarthout, TD
   Sylla, K
   Talisuna, AO
   Taylor, WRJ
   Temu, EA
   Thwing, JI
   Tine, RCK
   Tinto, H
   Tommasini, S
   Toure, OA
   Ursing, J
   Vaillant, MT
   Valentini, G
   Van den Broek, I
   Van Vugt, M
   Ward, SA
   Winstanley, PA
   Yavo, W
   Yeka, A
   Zolia, YM
   Zongo, I
AF Abdulla, Salim
   Adam, Ishag
   Adjei, George O.
   Adjuik, Martin A.
   Alemayehu, Bereket
   Allan, Richard
   Arinaitwe, Emmanuel
   Ashley, Elizabeth A.
   Ba, Mamadou S.
   Barennes, Hubert
   Barnes, Karen I.
   Bassat, Quique
   Baudin, Elisabeth
   Berens-Riha, Nicole
   Bjoerkman, Anders
   Bompart, Francois
   Bonnet, Maryline
   Borrmann, Steffen
   Bousema, Teun
   Brasseur, Philippe
   Bukirwa, Hasifa
   Checchi, Francesco
   Dahal, Prabin
   D'Alessandro, Umberto
   Desai, Meghna
   Dicko, Alassane
   Djimde, Abdoulaye A.
   Dorsey, Grant
   Doumbo, Ogobara K.
   Drakeley, Chris J.
   Duparc, Stephan
   Eshetu, Teferi
   Espie, Emmanuelle
   Etard, Jean-Francois
   Faiz, Abul M.
   Falade, Catherine O.
   Fanello, Caterina I.
   Faucher, Jean-Francois
   Faye, Babacar
   Faye, Oumar
   Filler, Scott
   Flegg, Jennifer A.
   Fofana, Bakary
   Fogg, Carole
   Gadalla, Nahla B.
   Gaye, Oumar
   Genton, Blaise
   Gething, Peter W.
   Gil, Jose P.
   Gonzalez, Raquel
   Grandesso, Francesco
   Greenhouse, Bryan
   Greenwood, Brian
   Grivoyannis, Anastasia
   Guerin, Philippe J.
   Guthmann, Jean-Paul
   Hamed, Kamal
   Hamour, Sally
   Hay, Simon I.
   Hodel, Eva Maria
   Humphreys, Georgina S.
   Hwang, Jimee
   Ibrahim, Maman L.
   Jima, Daddi
   Jones, Joel J.
   Jullien, Vincent
   Juma, Elizabeth
   Kachur, Patrick S.
   Kager, Piet A.
   Kamugisha, Erasmus
   Kamya, Moses R.
   Karema, Corine
   Kayentao, Kassoum
   Kiechel, Jean-Rene
   Kironde, Fred
   Kofoed, Poul-Erik
   Kremsner, Peter G.
   Krishna, Sanjeev
   Lameyre, Valerie
   Lell, Bertrand
   Lima, Angeles
   Makanga, Michael
   Malik, ElFatih M.
   Marsh, Kevin
   Martensson, Andreas
   Massougbodji, Achille
   Menan, Herve
   Menard, Didier
   Menendez, Clara
   Mens, Petra F.
   Meremikwu, Martin
   Moreira, Clarissa
   Nabasumba, Carolyn
   Nambozi, Michael
   Ndiaye, Jean-Louis
   Ngasala, Billy E.
   Nikiema, Frederic
   Nsanzabana, Christian
   Ntoumi, Francine
   Oguike, Mary
   Ogutu, Bernhards R.
   Olliaro, Piero
   Omar, Sabah A.
   Ouedraogo, Jean-Bosco
   Owusu-Agyei, Seth
   Penali, Louis K.
   Pene, Mbaye
   Peshu, Judy
   Piola, Patrice
   Plowe, Christopher V.
   Premji, Zul
   Price, Ric N.
   Randrianarivelojosia, Milijaona
   Rombo, Lars
   Roper, Cally
   Rosenthal, Philip J.
   Sagara, Issaka
   Same-Ekobo, Albert
   Sawa, Patrick
   Schallig, Henk D. F. H.
   Schramm, Birgit
   Seck, Amadou
   Shekalaghe, Seif A.
   Sibley, Carol H.
   Sinou, Vronique
   Sirima, Sodiomon B.
   Som, Fabrice A.
   Sow, Doudou
   Staedke, Sarah G.
   Stepniewska, Kasia
   Sutherland, Colin J.
   Swarthout, Todd D.
   Sylla, Khadime
   Talisuna, Ambrose O.
   Taylor, Walter R. J.
   Temu, Emmanuel A.
   Thwing, Julie I.
   Tine, Roger C. K.
   Tinto, Halidou
   Tommasini, Silva
   Toure, Offianan A.
   Ursing, Johan
   Vaillant, Michel T.
   Valentini, Giovanni
   Van den Broek, Ingrid
   Van Vugt, Michele
   Ward, Stephen A.
   Winstanley, Peter A.
   Yavo, William
   Yeka, Adoke
   Zolia, Yah M.
   Zongo, Issaka
CA WWARN Artemisinin Based
TI Clinical determinants of early parasitological response to ACTs in
   African patients with uncomplicated falciparum malaria: a literature
   review and meta-analysis of individual patient data
SO BMC MEDICINE
LA English
DT Review
ID RESISTANT PLASMODIUM-FALCIPARUM; PARASITE CLEARANCE;
   ARTEMETHER-LUMEFANTRINE; ARTEMISININ RESISTANCE; COMBINATION THERAPY;
   IN-VIVO; EFFICACY; ARTESUNATE; CHILDREN; CAMBODIA
AB Background: Artemisinin-resistant Plasmodium falciparum has emerged in the Greater Mekong sub-region and poses a major global public health threat. Slow parasite clearance is a key clinical manifestation of reduced susceptibility to artemisinin. This study was designed to establish the baseline values for clearance in patients from Sub-Saharan African countries with uncomplicated malaria treated with artemisinin-based combination therapies (ACTs).
   Methods: A literature review in PubMed was conducted in March 2013 to identify all prospective clinical trials (uncontrolled trials, controlled trials and randomized controlled trials), including ACTs conducted in Sub-Saharan Africa, between 1960 and 2012. Individual patient data from these studies were shared with the WorldWide Antimalarial Resistance Network (WWARN) and pooled using an a priori statistical analytical plan. Factors affecting early parasitological response were investigated using logistic regression with study sites fitted as a random effect. The risk of bias in included studies was evaluated based on study design, methodology and missing data.
   Results: In total, 29,493 patients from 84 clinical trials were included in the analysis, treated with artemether-lumefantrine (n = 13,664), artesunate-amodiaquine (n = 11,337) and dihydroartemisinin-piperaquine (n = 4,492). The overall parasite clearance rate was rapid. The parasite positivity rate (PPR) decreased from 59.7 % (95 % CI: 54.5-64.9) on day 1 to 6.7 % (95 % CI: 4.8-8.7) on day 2 and 0.9 % (95 % CI: 0.5-1.2) on day 3. The 95th percentile of observed day 3 PPR was 5.3 %. Independent risk factors predictive of day 3 positivity were: high baseline parasitaemia (adjusted odds ratio (AOR) = 1.16 (95 % CI: 1.08-1.25); per 2-fold increase in parasite density, P <0.001); fever (>37.5 degrees C) (AOR = 1.50 (95 % CI: 1.06-2.13), P = 0.022); severe anaemia (AOR = 2.04 (95 % CI: 1.21-3.44), P = 0.008); areas of low/moderate transmission setting (AOR = 2.71 (95 % CI: 1.38-5.36), P = 0.004); and treatment with the loose formulation of artesunate-amodiaquine (AOR = 2.27 (95 % CI: 1.14-4.51), P = 0.020, compared to dihydroartemisinin-piperaquine).
   Conclusions: The three ACTs assessed in this analysis continue to achieve rapid early parasitological clearance across the sites assessed in Sub-Saharan Africa. A threshold of 5 % day 3 parasite positivity from a minimum sample size of 50 patients provides a more sensitive benchmark in Sub-Saharan Africa compared to the current recommended threshold of 10 % to trigger further investigation of artemisinin susceptibility.
C1 [Abdulla, Salim; Shekalaghe, Seif A.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Adam, Ishag] Univ Khartoum, Fac Med, Khartoum, Sudan.
   [Adjei, George O.] Univ Ghana, Sch Med, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana.
   [Adjuik, Martin A.] INDEPTH Network Secretariat, Accra, Ghana.
   [Alemayehu, Bereket] Int Ctr AIDS Care & Treatment Programs, Addis Ababa, Ethiopia.
   [Allan, Richard; Baudin, Elisabeth; Temu, Emmanuel A.] MENTOR Initiat, Crawley, England.
   [Arinaitwe, Emmanuel; Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda.
   [Ashley, Elizabeth A.; Checchi, Francesco; Espie, Emmanuelle; Etard, Jean-Francois; Grandesso, Francesco; Nabasumba, Carolyn; Schramm, Birgit] Epictr, Paris, France.
   [Ba, Mamadou S.; Faye, Babacar; Faye, Oumar; Gaye, Oumar; Ndiaye, Jean-Louis; Pene, Mbaye; Sow, Doudou; Sylla, Khadime; Tine, Roger C. K.] Univ Cheikh Anta Diop, Dept Parasitol & Mycol, Fac Med, Dakar, Senegal.
   [Barennes, Hubert; Ouedraogo, Jean-Bosco; Tinto, Halidou] Ctr Muraz, Bobo Dioulasso, Burkina Faso.
   [Barennes, Hubert] French Foreign Affairs, Biarritz, France.
   [Barnes, Karen I.] WorldWide Antimalarial Resistance Network WWARN, Cape Town, South Africa.
   [Barnes, Karen I.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.
   [Bassat, Quique; Gonzalez, Raquel; Menendez, Clara] Ctr Invest Saude Manhica, Manhica, Mozambique.
   [Bassat, Quique; Eshetu, Teferi; Gonzalez, Raquel; Menendez, Clara] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Hosp Clin, Barcelona, Spain.
   [Berens-Riha, Nicole] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.
   [Berens-Riha, Nicole] LMU, German Ctr Infect Res DZIF, Munich, Germany.
   [Bjoerkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden.
   [Bompart, Francois; Lameyre, Valerie] Sanofi Aventis, Direct Acces Med Access Med, Gentilly, France.
   [Bonnet, Maryline] Epictr, Geneva, Switzerland.
   [Borrmann, Steffen; Marsh, Kevin; Peshu, Judy] Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya.
   [Borrmann, Steffen; Kremsner, Peter G.; Lell, Bertrand; Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Borrmann, Steffen; Drakeley, Chris J.] German Ctr Infect Res, Tubingen, Germany.
   [Bousema, Teun; Gadalla, Nahla B.; Oguike, Mary; Sutherland, Colin J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Infect & Immun, London WC1, England.
   [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Njimegen, Netherlands.
   [Brasseur, Philippe] IRD, Dakar, Senegal.
   [Bukirwa, Hasifa; Yeka, Adoke] Uganda Malaria Surveillance Project, Kampala, Uganda.
   [Dahal, Prabin; Flegg, Jennifer A.; Guerin, Philippe J.; Humphreys, Georgina S.; Moreira, Clarissa; Nsanzabana, Christian; Price, Ric N.; Sibley, Carol H.; Stepniewska, Kasia] WorldWide Antimalarial Resistance Network WWARN, Oxford, England.
   [Dahal, Prabin; Guerin, Philippe J.; Humphreys, Georgina S.; Marsh, Kevin; Moreira, Clarissa; Nsanzabana, Christian; Olliaro, Piero; Price, Ric N.; Stepniewska, Kasia] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [D'Alessandro, Umberto] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England.
   [Desai, Meghna; Hwang, Jimee; Kachur, Patrick S.; Thwing, Julie I.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA.
   [Dicko, Alassane; Djimde, Abdoulaye A.; Doumbo, Ogobara K.; Fofana, Bakary; Kayentao, Kassoum; Sagara, Issaka] Univ Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali.
   [Dicko, Alassane] Univ Bamako, Fac Med Pharm & Dent, Dept Publ Hlth, Bamako, Mali.
   [Dorsey, Grant; Greenhouse, Bryan; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Duparc, Stephan] Med Malaria Venture, Geneva, Switzerland.
   [Eshetu, Teferi] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.
   [Etard, Jean-Francois] IRD, Montpellier, France.
   [Faiz, Abul M.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand.
   [Falade, Catherine O.] Univ Ibadan, Coll Med, Dept Pharmacol & Therapeut, Ibadan, Nigeria.
   [Fanello, Caterina I.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand.
   [Faucher, Jean-Francois] IRD, Mother & Child Hlth Trop Res Unit, Paris, France.
   [Faucher, Jean-Francois] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France.
   [Faucher, Jean-Francois] Univ Besancon, Med Ctr, Dept Infect Dis, F-25030 Besancon, France.
   [Filler, Scott] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.
   [Flegg, Jennifer A.] Monash Univ, Sch Math Sci, Melbourne, Vic 3004, Australia.
   [Flegg, Jennifer A.] Monash Univ, Monash Acad Cross & Interdisciplinary Math Applic, Melbourne, Vic 3004, Australia.
   [Fogg, Carole] Univ Portsmouth, Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.
   [Gadalla, Nahla B.] Natl Res Ctr, Res Inst Trop Med, Dept Epidemiol, Khartoum, Sudan.
   [Gadalla, Nahla B.] NIAID, Rockville, MD USA.
   [Genton, Blaise; Hodel, Eva Maria; Temu, Emmanuel A.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Genton, Blaise] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland.
   [Genton, Blaise] Univ Lausanne Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland.
   [Gething, Peter W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England.
   [Gil, Jose P.] Karolinska Inst, Pharmacogenet Sect, Drug Resistance Unit, Dept Physiol & Pharmacol, Stockholm, Sweden.
   [Gil, Jose P.] Univ Lisbon, Fac Sci, Biosyst & Integrat Sci Inst BioISI, P-1699 Lisbon, Portugal.
   [Gil, Jose P.] SUNY Binghamton, Harpur Coll Arts & Sci, Binghamton, NY USA.
   [Grivoyannis, Anastasia] Univ Washington, Div Emergency Med, Seattle, WA 98195 USA.
   [Guthmann, Jean-Paul] Inst Veille Sanit, Dept Malad Infect, St Maurice, France.
   [Hamed, Kamal] Novartis Pharmaceut, E Hanover, NJ USA.
   [Hamour, Sally] Royal Free Hosp, UCL Ctr Nephrol, London NW3 2QG, England.
   [Hay, Simon I.; Lima, Angeles] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Hay, Simon I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Hodel, Eva Maria] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.
   [Hwang, Jimee] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.
   [Ibrahim, Maman L.] Ctr Rech Med & Sanit, Niamey, Niger.
   [Jima, Daddi] Fed Minist Hlth, Addis Ababa, Ethiopia.
   [Jones, Joel J.; Zolia, Yah M.] Minist Hlth & Social Welf, Natl Malaria Control Programme, Monrovia, Liberia.
   [Jullien, Vincent] Univ Paris 05, AP HP, Paris, France.
   [Juma, Elizabeth] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Kager, Piet A.; Mens, Petra F.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands.
   [Kamugisha, Erasmus] Catholic Univ Hlth & Allied Sci, Mwanza, Tanzania.
   [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda.
   [Karema, Corine] Minist Hlth, Malaria & Other Parasit Dis Div RBC, Kigali, Rwanda.
   [Kiechel, Jean-Rene] Drugs Neglected Dis initiat, Geneva, Switzerland.
   [Kironde, Fred] Makerere Univ, Dept Biochem, Kampala, Uganda.
   [Kofoed, Poul-Erik; Ursing, Johan] Projecto Saude Bandim, Bissau, Guinea Bissau.
   [Kofoed, Poul-Erik] Kolding Cty Hosp, Dept Paediat, Kolding, Denmark.
   [Kremsner, Peter G.; Lell, Bertrand] Ctr Rech Med Lambarene, Lambarene, Gabon.
   [Krishna, Sanjeev] Univ London, Inst Infect & Immun, London, England.
   Operat Ctr Barcelona Athens, Med Sans Frontieres, Barcelona, Spain.
   [Makanga, Michael] European & Dev Countries Clin Trials Partnership, Cape Town, South Africa.
   [Malik, ElFatih M.] Fed Minist Hlth, Khartoum, Sudan.
   [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden.
   [Massougbodji, Achille] Univ Abomey Calavi, FSS, CERPAGE, Cotonou, Benin.
   [Menan, Herve] Univ Cocody, Fac Pharm, Dept Parasitol, Abidjan, Cote Ivoire.
   [Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.
   [Mens, Petra F.; Schallig, Henk D. F. H.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.
   [Meremikwu, Martin] Univ Calabar, Dept Paediat, Calabar, Nigeria.
   [Meremikwu, Martin] Inst Trop Dis Res & Prevent, Calabar, Nigeria.
   [Nabasumba, Carolyn] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda.
   [Nambozi, Michael] Trop Dis Res Ctr, Ndola, Zambia.
   [Ngasala, Billy E.; Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Dept Parasitol, Dar Es Salaam, Tanzania.
   [Ngasala, Billy E.; Ursing, Johan] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Malaria Res, Stockholm, Sweden.
   [Nikiema, Frederic; Ouedraogo, Jean-Bosco; Som, Fabrice A.; Tinto, Halidou; Zongo, Issaka] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.
   [Ntoumi, Francine] Univ Marien Ngouabi, FCRM, Fac Sci Sante, Brazzaville, Congo.
   [Ogutu, Bernhards R.] United States Army Med Res Unit, Kenya Med Res Inst, Kisumu, Kenya.
   [Olliaro, Piero; Taylor, Walter R. J.] UNICEF UNDP World Bank WHO Special Programme Res, Geneva, Switzerland.
   [Omar, Sabah A.] Kenya Govt Med Res Ctr, Ctr Biotechnol Res & Dev, Nairobi, Kenya.
   [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana.
   [Penali, Louis K.; Seck, Amadou] WorldWide Antimalarial Resistance Network WWARN W, Dakar, Senegal.
   [Piola, Patrice] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.
   [Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Price, Ric N.] Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia.
   [Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Malaria Res Unit, Antananarivo, Madagascar.
   [Rombo, Lars] Karolinska Inst, Karolinska Univ Hosp, Infect Dis Unit, Malaria Res Lab,Dept Med, Stockholm, Sweden.
   [Rombo, Lars] Malarsjukhuset, Dept Infect Dis, S-63188 Eskilstuna, Sweden.
   [Rombo, Lars] Clin Res Ctr, Uppsala, Sweden.
   [Roper, Cally] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1, England.
   [Same-Ekobo, Albert] Ctr Hosp Univ Yaounde, Fac Med & Sci Biomed, Yaounde, Cameroon.
   [Sawa, Patrick] Int Ctr Insect Physiol & Ecol, Human Hlth Div, Mbita, Kenya.
   [Shekalaghe, Seif A.] Kilimanjaro Christian Med Ctr, Kilimanjaro Clin Med Res Inst, Moshi, Tanzania.
   [Sibley, Carol H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Sinou, Vronique] Aix Marseille Univ, Fac Pharm, UMR MD3, Marseille, France.
   [Sirima, Sodiomon B.] CNRFP, Ouagadougou, Burkina Faso.
   [Staedke, Sarah G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England.
   [Swarthout, Todd D.; Van den Broek, Ingrid] Med Sans Frontieres, London, England.
   [Talisuna, Ambrose O.] East Africa Reg Ctr, WorldWide Antimalarial Resistance Network WWARN, Nairobi, Kenya.
   [Talisuna, Ambrose O.] Univ Oxford, KEMRI, Wellcome Trust Res Programme, Nairobi, Kenya.
   [Taylor, Walter R. J.] Hop Cantonal Univ Geneva, Serv Med Int & Humanitaire, Geneva, Switzerland.
   [Temu, Emmanuel A.] Univ Basel, Basel, Switzerland.
   [Tommasini, Silva; Valentini, Giovanni] Sigma Tau Ind Farmaceut Riunite SpA, Rome, Italy.
   [Toure, Offianan A.] Inst Pasteur Cote Ivoire, Malariol Dept, Abidjan, Cote Ivoire.
   [Vaillant, Michel T.] CRP Sante, Ctr Hlth Studies, Methodol & Stat Unit, Luxembourg, Luxembourg.
   [Vaillant, Michel T.] Univ Bordeaux 2, Unite Bases Therapeut Inflammat & Infect 3677, F-33076 Bordeaux, France.
   [Van den Broek, Ingrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.
   [Van Vugt, Michele] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Div Infect Dis, NL-1012 WX Amsterdam, Netherlands.
   [Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.
   [Winstanley, Peter A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
   [Yavo, William] Univ Cocody, Fac Pharmaceut & Biol Sci, Dept Parasitol & Mycol, Abidjan, Cote Ivoire.
   [Yavo, William] Natl Inst Publ Hlth, Malaria Res & Control Ctr, Abidjan, Cote Ivoire.
RP Abdulla, S (reprint author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med WorldWide Antimalarial Res, Oxford, England.
RI ; Roper, Cally/K-2989-2013; Bousema, Teun/N-3574-2014; Ward,
   Steve/G-6003-2015; Hay, Simon/F-8967-2015
OI Humphreys, Georgina/0000-0001-9947-0034; SOME, Anyirekun
   Fabrice/0000-0002-1530-1493; Price, Richard/0000-0003-2000-2874; Menard,
   Didier/0000-0003-1357-4495; Bassat, Quique/0000-0003-0875-7596; Hamed,
   Kamal/0000-0003-1896-9736; Flegg, Jennifer/0000-0002-8809-726X; Dahal,
   Prabin/0000-0002-2158-846X; Sutherland, Colin/0000-0003-1592-6407;
   Gething, Peter/0000-0001-6759-5449; Guerin,
   Philippe/0000-0002-6008-2963; Roper, Cally/0000-0002-6545-309X; Ward,
   Steve/0000-0003-2331-3192; Hay, Simon/0000-0002-0611-7272; GADALLA,
   NAHLA/0000-0002-6177-6705
FU Bill & Melinda Gates Foundation
FX WWARN is funded by a Bill & Melinda Gates Foundation grant. The funder
   did not participate in the study protocol development or the writing of
   the paper.
CR Anstey NM, 2015, LANCET INFECT DIS, V15, P692, DOI 10.1016/S1473-3099(15)70024-1
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005
   Conrad MD, 2014, PLOS ONE, P9
   Das D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-125
   Db R, 1987, MULTIPLE IMPUTATION
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Elliott I, 2014, TROP MED INT HEALTH, V19, P754, DOI 10.1111/tmi.12309
   Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000
   Fairhurst RM, 2012, AM J TROP MED HYG, V87, P231, DOI 10.4269/ajtmh.2012.12-0025
   Flegg JA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-411
   Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339
   Fleiss JL, 2003, STAT METHODS RATES P
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Greenhouse B, 2009, J INFECT DIS, V199, P758, DOI 10.1086/596741
   Kamau E, 2014, J INFECT DIS, V211, P1352
   Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689
   Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12
   Lee SJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-149
   Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082
   Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058
   Matangila JR, 2014, PLOS ONE, V9
   Menard D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-55
   Muhindo MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-32
   Murphy SC, 2013, AM J TROP MED HYG, V89, P824, DOI 10.4269/ajtmh.12-0675
   Ndiaye JL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-125
   Ndiaye JLA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-16
   Ndour PA, 2015, J INFECT DIS, V211, P290, DOI 10.1093/infdis/jiu427
   NEWTON PN, 2015, BMJ-BRIT MED J, V25, P350
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Price RN, 2013, J INFECT DIS, V207, P1627, DOI 10.1093/infdis/jit079
   Price RN, 2001, AM J TROP MED HYG, V65, P614
   Smith T, 1999, Trans R Soc Trop Med Hyg, V93 Suppl 1, P35, DOI 10.1016/S0035-9203(99)90325-5
   Snow RW, 1998, BRIT MED BULL, V54, P293
   Sowunmi A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-53
   Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301
   Tabernero P, 2014, MALARIA J, V13, p139v
   Tahar R, 2014, J INFECT DIS, V21
   Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491
   Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467
   Special Programme for Research and Training in Tropical Diseases (TDR)/World Health Organization (WHO), 2015, METH MAN MICR DET ID
   Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0
   White LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001823
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278
   White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002
   White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2014, STAT REP ART RES
   WHO, 2011, HAEM CONC DIAGN AN A
   World Health Organization, 2010, GUID TREATM MAL
   Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4
   WorldWide Antimalarial Resistance Network (WWARN), TRACK RES
   WorldWide Antimalarial Resistance Network (WWARN), WWARN CLIN TRIALS PU
   WorldWide Antimalarial Resistance Network (WWARN), 2012, CLIN MOD DAT MAN STA
   WorldWide Antimalarial Resistance Network (WWARN), 2012, STAT AN PLAN ART COM
   WorldWide Antimalarial Resistance Network (WWARN) Parasite Clearance Study Group, 2015, MALARIA J IN PRESS
NR 59
TC 0
Z9 0
U1 2
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD SEP 7
PY 2015
VL 13
AR 212
DI 10.1186/s12916-015-0445-x
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA CQ7SO
UT WOS:000360804700001
OA gold
DA 2017-08-15
ER

PT J
AU Bah, E
   Carrieri, MP
   Sam, O
   Rajaraman, S
AF Bah, Ebrima
   Carrieri, Maria P.
   Sam, Omar
   Rajaraman, Swaminathan
TI 20-Years of Lung Cancer Incidence and Baseline Survival Rates in the
   Gambia, West Africa
SO JOURNAL OF THORACIC ONCOLOGY
LA English
DT Meeting Abstract
DE survival; Incidence; Gambia; Cancer
C1 [Bah, Ebrima] Minist Hlth & Social Welf, Directorate Publ Hlth Res, Serekunda, Gambia.
   [Carrieri, Maria P.] Univ Aix Marseille, Ird, Marseille, France.
   [Sam, Omar] WHO, Bobodulaso, Burkina Faso.
   [Rajaraman, Swaminathan] Canc Inst Wia, Madras, Tamil Nadu, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1556-0864
EI 1556-1380
J9 J THORAC ONCOL
JI J. Thorac. Oncol.
PD SEP
PY 2015
VL 10
IS 9
SU 2
MA PUB074
BP S781
EP S781
PG 1
WC Oncology; Respiratory System
SC Oncology; Respiratory System
GA DE1CX
UT WOS:000370365103631
OA No
DA 2017-08-15
ER

PT J
AU Chertow, JH
   Alkaitis, MS
   Nardone, G
   Ikeda, AK
   Cunnington, AJ
   Okebe, J
   Ebonyi, AO
   Njie, M
   Correa, S
   Jayasooriya, S
   Casals-Pascual, C
   Billker, O
   Conway, DJ
   Walther, M
   Ackerman, H
AF Chertow, Jessica H.
   Alkaitis, Matthew S.
   Nardone, Glenn
   Ikeda, Allison K.
   Cunnington, Aubrey J.
   Okebe, Joseph
   Ebonyi, Augustine O.
   Njie, Madi
   Correa, Simon
   Jayasooriya, Shamanthi
   Casals-Pascual, Climent
   Billker, Oliver
   Conway, David J.
   Walther, Michael
   Ackerman, Hans
TI Plasmodium Infection Is Associated with Impaired Hepatic
   Dimethylarginine Dimethylaminohydrolase Activity and Disruption of
   Nitric Oxide Synthase Inhibitor/Substrate Homeostasis
SO PLOS PATHOGENS
LA English
DT Article
ID SEVERE FALCIPARUM-MALARIA; ASYMMETRIC DIMETHYLARGININE; CEREBRAL
   MALARIA; ENDOGENOUS INHIBITOR; PARASITE SEQUESTRATION;
   CLINICAL-FEATURES; MALAWIAN CHILDREN; DEPENDENT PATHWAY; AFRICAN
   CHILDREN; ARGININE
AB Inhibition of nitric oxide (NO) signaling may contribute to pathological activation of the vascular endothelium during severe malaria infection. Dimethylarginine dimethylaminohydrolase (DDAH) regulates endothelial NO synthesis by maintaining homeostasis between asymmetric dimethylarginine (ADMA), an endogenous NO synthase (NOS) inhibitor, and arginine, the NOS substrate. We carried out a community-based case-control study of Gambian children to determine whether ADMA and arginine homeostasis is disrupted during severe or uncomplicated malaria infections. Circulating plasma levels of ADMA and arginine were determined at initial presentation and 28 days later. Plasma ADMA/arginine ratios were elevated in children with acute severe malaria compared to 28-day follow-up values and compared to children with uncomplicated malaria or healthy children (p<0.0001 for each comparison). To test the hypothesis that DDAH1 is inactivated during Plasmodium infection, we examined DDAH1 in a mouse model of severe malaria. Plasmodium berghei ANKA infection inactivated hepatic DDAH1 via a post-transcriptional mechanism as evidenced by stable mRNA transcript number, decreased DDAH1 protein concentration, decreased enzyme activity, elevated tissue ADMA, elevated ADMA/arginine ratio in plasma, and decreased whole blood nitrite concentration. Loss of hepatic DDAH1 activity and disruption of ADMA/arginine homeostasis may contribute to severe malaria pathogenesis by inhibiting NO synthesis.
C1 [Chertow, Jessica H.; Alkaitis, Matthew S.; Ikeda, Allison K.; Ackerman, Hans] NIAID, Lab Malaria & Vector Res, Div Intramural Res, NIH, Rockville, MD 20852 USA.
   [Alkaitis, Matthew S.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Headington Oxford, England.
   [Nardone, Glenn] NIAID, Res Technol Branch, Div Intramural Res, NIH, Rockville, MD USA.
   [Cunnington, Aubrey J.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London, England.
   [Okebe, Joseph; Ebonyi, Augustine O.; Njie, Madi; Correa, Simon; Jayasooriya, Shamanthi; Conway, David J.; Walther, Michael] MRC Unit, Fajara, Gambia.
   [Casals-Pascual, Climent] Wellcome Trust Ctr Human Genet, Oxford, England.
   [Billker, Oliver] Wellcome Trust Sanger Inst, Hinxton Cambridge, England.
   [Conway, David J.] London Sch Hyg & Trop Med, London WC1, England.
RP Chertow, JH (reprint author), NIAID, Lab Malaria & Vector Res, Div Intramural Res, NIH, Rockville, MD 20852 USA.
EM hans.ackerman@nih.gov
OI Cunnington, Aubrey/0000-0002-1305-3529; Casals-Pascual,
   Climent/0000-0002-0867-8954; Billker, Oliver/0000-0003-1716-168X;
   Conway, David/0000-0002-8711-3037
FU NIAID Division of Intramural Research; Wellcome Trust [WT098051]
FX Funding to support patient enrollment and sample collection was provided
   by the MRC Unit, The Gambia. Biochemical analyses of clinical samples
   and animal model experiments were funded by the NIAID Division of
   Intramural Research and the Wellcome Trust (grant WT098051). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59
   Achan V, 2005, VASC MED, V10, P7, DOI 10.1191/1358863x05vm580oa
   Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557
   Billecke SS, 2006, AM J PHYSIOL-HEART C, V291, pH1788, DOI 10.1152/ajpheart.00066.2006
   BLUMBERG BS, 1963, JAMA-J AM MED ASSOC, V184, P1021
   Boger RH, 2000, J AM COLL CARDIOL, V36, P2287, DOI 10.1016/S0735-1097(00)01013-5
   BOGLE RG, 1995, AM J PHYSIOL-CELL PH, V269, pC750
   Brenner T, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/210454
   Cabrales P, 2011, J INFECT DIS, V203, P1454, DOI 10.1093/infdis/jir058
   Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200
   Chan JR, 2000, ARTERIOSCL THROM VAS, V20, P1040
   Chen MF, 2008, CYTOKINE, V43, P149, DOI 10.1016/j.cyto.2008.05.001
   Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106
   Cunnington AJ, 2013, J INFECTION, V67, P220, DOI 10.1016/j.jinf.2013.04.013
   Davids M, 2012, AM J PHYSIOL-HEART C, V302, pH1762, DOI 10.1152/ajpheart.01205.2011
   Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260
   Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E
   DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074
   Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255
   Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762
   Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204
   Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1
   Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016
   Dowsett L, 2015, CIRCULATION, V131, P2217, DOI 10.1161/CIRCULATIONAHA.114.015064
   FARACI FM, 1995, AM J PHYSIOL-HEART C, V269, pH1522
   Fiedler LR, 2009, BIOCHEM SOC T, V37, P1243, DOI 10.1042/BST0371243
   Fiedler LR, 2009, ARTERIOSCL THROM VAS, V29, P2117, DOI 10.1161/ATVBAHA.109.194035
   Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499
   Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x
   Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120
   Hu TH, 2006, J BIOL CHEM, V281, P39831, DOI 10.1074/jbc.M606779200
   Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912
   Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7
   Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388
   Jiang DJ, 2009, ATHEROSCLEROSIS, V205, P554, DOI 10.1016/j.atherosclerosis.2008.12.024
   Jiang JL, 2007, BIOCHEM CELL BIOL, V85, P66, DOI 10.1139/O06-146
   KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751
   Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1
   Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4
   Konishi H, 2007, J AM COLL CARDIOL, V49, P1099, DOI 10.1016/j.jacc.2006.10.068
   KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5
   LEE HW, 1977, BIOCHEMISTRY-US, V16, P78, DOI 10.1021/bi00620a013
   Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543
   Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209
   Luo ZM, 2010, HYPERTENSION, V56, P498, DOI 10.1161/HYPERTENSIONAHA.110.152959
   Masuda H, 1999, BRIT J PHARMACOL, V126, P211, DOI 10.1038/sj.bjp.0702298
   [Anonymous], 2005, GUIDELINES FOR THE M
   MOLYNEUX ME, 1989, AM J TROP MED HYG, V40, P470
   Mookerjee RP, 2007, LIVER TRANSPLANT, V13, P400, DOI 10.1002/lt.21053
   Murray CJL, 2010, LANCET, V379, P413, DOI [10.1016/S0140-6736(12)60034-8, DOI 10.1016/S0140-6736(12)60034-8]
   Nijveldt RJ, 2003, CLIN NUTR, V22, P17, DOI 10.1054/clnu.2002.0612
   Nijveldt RJ, 2004, JPEN-PARENTER ENTER, V28, P382, DOI 10.1177/0148607104028006382
   O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053
   Planche T, 2003, CLIN INFECT DIS, V37, P890, DOI 10.1086/377536
   Rubach MP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004655
   Serghides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027714
   Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X
   Seydel KB, 2006, J INFECT DIS, V194, P208, DOI 10.1086/505078
   Siroen MPC, 2005, HEPATOLOGY, V41, P559, DOI 10.1002/hep.20579
   Siroen MPC, 2004, LIVER TRANSPLANT, V10, P1524, DOI 10.1002/lt.20286
   Smith CL, 2005, PLOS MED, V2, P1031, DOI 10.1371/journal.pmed.0020264
   Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986
   TAYLOR TE, 1993, Q J MED, V86, P99
   Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002
   VALLANCE P, 1992, LANCET, V339, P572
   WALLER D, 1995, CLIN INFECT DIS, V21, P577
   Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364
   Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915
   Wang J, 2006, CELL MOL LIFE SCI, V63, P2838, DOI 10.1007/s00018-006-6271-8
   Weinberg JB, 2014, J INFECT DIS
   Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE210, DOI 10.1097/PCC.0b013e318238b5cd
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212
   Wojciak-Stothard B, 2009, MOL BIOL CELL, V20, P33, DOI 10.1091/mbc.E08-04-0395
   Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819
   Yeo TW, 2013, J INFECT DIS, V207, P528, DOI 10.1093/infdis/jis692
   Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868
   Zhang GG, 2008, VASC PHARMACOL, V48, P115, DOI 10.1016/j.vph.2008.01.004
   Zhang P, 2013, J NANOMATER, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0055941
   Zhang Q, 2011, THROMB RES, V128, P42, DOI 10.1016/j.thromres.2011.02.013
NR 80
TC 7
Z9 7
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD SEP
PY 2015
VL 11
IS 9
AR e1005119
DI 10.1371/journal.ppat.1005119
PG 20
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA CS7NH
UT WOS:000362269800009
PM 26407009
OA gold
DA 2017-08-15
ER

PT J
AU Thanh, PV
   Hong, NV
   Van, NV
   Louisa, M
   Baird, K
   Tinh, TT
   Xa, NX
   Grietens, KP
   Hung, LX
   Duong, TT
   Rosanas-Urgell, A
   Speybroeck, N
   D'Alessandro, U
   Erhart, A
AF Thanh, P. V.
   Hong, N. V.
   Van, N. V.
   Louisa, M.
   Baird, K.
   Tinh, T. T.
   Xa, N. X.
   Grietens, K. Peeters
   Hung, L. X.
   Duong, T. T.
   Rosanas-Urgell, A.
   Speybroeck, N.
   D'Alessandro, U.
   Erhart, A.
TI Confirmed Plasmodium vivax resistance to chloroquine in Central Vietnam
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Thanh, P. V.; Hong, N. V.; Tinh, T. T.; Xa, N. X.; Hung, L. X.; Duong, T. T.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
   [Thanh, P. V.; Hong, N. V.; Grietens, K. Peeters; Rosanas-Urgell, A.; D'Alessandro, U.; Erhart, A.] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Thanh, P. V.; Speybroeck, N.] Catholic Univ Louvain, B-1200 Brussels, Belgium.
   [Hong, N. V.] Univ Antwerp, B-2020 Antwerp, Belgium.
   [Van, N. V.] Prov Malaria Stn, Tam Ky, Vietnam.
   [Louisa, M.] Univ Indonesia, Pharmacol, Jakarta, Indonesia.
   [Baird, K.] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [D'Alessandro, U.] London Sch Hyg & Trop Med, London WC1, England.
   [D'Alessandro, U.] MRC, Gambia Unit, Fajara, Gambia.
RI Rosanas-Urgell, Anna/D-3193-2015
OI Rosanas-Urgell, Anna/0000-0002-0432-5203
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
BP 14
EP 14
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758800032
OA No
DA 2017-08-15
ER

PT J
AU Coscolla, M
   Copin, R
   Sutherland, J
   Giardina, F
   Gehre, F
   Mbayo, G
   Isatou, T
   de Jong, B
   Ernst, J
   Gagneux, S
AF Coscolla, M.
   Copin, R.
   Sutherland, J.
   Giardina, F.
   Gehre, F.
   Mbayo, G.
   Isatou, T.
   de Jong, B.
   Ernst, J.
   Gagneux, S.
TI Identification of potential tuberculosis vaccine antigens by integrating
   population genomics and immunology
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Coscolla, M.; Giardina, F.; Gagneux, S.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Coscolla, M.; Gagneux, S.] Univ Basel, Basel, Switzerland.
   [Copin, R.; Ernst, J.] NYU, New York, NY USA.
   [Sutherland, J.; Gehre, F.; Mbayo, G.; Isatou, T.] MRC, Banjul, Gambia.
   [de Jong, B.] Inst Trop Med, B-2000 Antwerp, Belgium.
OI Gagneux, Sebastien/0000-0001-7783-9048
NR 0
TC 0
Z9 0
U1 1
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
BP 23
EP 23
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758800055
OA No
DA 2017-08-15
ER

PT J
AU Verhoef, H
AF Verhoef, H.
TI New insights into the role of iron in the etiology and pathogenesis of
   malaria, severe anaemia and invasive bacteraemia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Verhoef, H.] Univ London London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1E 7HT, England.
   [Verhoef, H.] MRC, Keneba, Gambia.
   [Verhoef, H.] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands.
RI Verhoef, Hans/L-3024-2015
OI Verhoef, Hans/0000-0002-9346-9689
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
BP 78
EP 78
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758800190
OA No
DA 2017-08-15
ER

PT J
AU Balen, J
   Masunaga, Y
   Jaiteh, F
   d'Alessandro, U
AF Balen, J.
   Masunaga, Y.
   Jaiteh, F.
   d'Alessandro, U.
TI Pandemic preparedness, disease surveillance and health systems in West
   Africa: the case of The Gambia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Balen, J.; Masunaga, Y.] Univ Sheffield, Sheffield, S Yorkshire, England.
   [Jaiteh, F.; d'Alessandro, U.] MRC, Gambia Unit, Fajara, Gambia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
BP 126
EP 126
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758800307
OA No
DA 2017-08-15
ER

PT J
AU Tahita, MC
   Tinto, H
   Yarga, S
   Kazienga, A
   Coulibaly, MT
   Valea, I
   VanOvermeir, C
   Rosanas-Urgell, A
   Ouedraogo, JB
   Guiguemde, RT
   Van Geertruyden, JP
   Erhart, A
   D'Alessandro, U
AF Tahita, M. C.
   Tinto, H.
   Yarga, S.
   Kazienga, A.
   Coulibaly, M. Traore
   Valea, I.
   VanOvermeir, C.
   Rosanas-Urgell, A.
   Ouedraogo, J. -B.
   Guiguemde, R. T.
   Van Geertruyden, J. -P.
   Erhart, A.
   D'Alessandro, U.
TI Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum
   isolates from pregnant women in an area of highly seasonal transmission
   in Burkina Faso
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Tahita, M. C.; Tinto, H.; Coulibaly, M. Traore; Ouedraogo, J. -B.] Direct Reg Ouest IRSS DRO, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.
   [Tahita, M. C.; Tinto, H.; Kazienga, A.; Coulibaly, M. Traore; Valea, I.; Ouedraogo, J. -B.; Guiguemde, R. T.] Clin Res Unit Nanoro IRSS CRUN, Nanoro, Burkina Faso.
   [Tahita, M. C.; Tinto, H.; VanOvermeir, C.; Rosanas-Urgell, A.; Erhart, A.; D'Alessandro, U.] Inst Trop Med ITM, Malariol Unit, Antwerp, Belgium.
   [Tahita, M. C.; Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Yarga, S.; Valea, I.; Guiguemde, R. T.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso.
   [Guiguemde, R. T.] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso.
   [D'Alessandro, U.] MRC Unit, Fajara, Gambia.
   [D'Alessandro, U.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RI Rosanas-Urgell, Anna/D-3193-2015
OI Rosanas-Urgell, Anna/0000-0002-0432-5203
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS1.040
BP 186
EP 187
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758801040
OA No
DA 2017-08-15
ER

PT J
AU O'Neill, S
   Dierickx, S
   Okebe, J
   Dabira, E
   Gryseels, C
   d'Alessandro, U
   Grietens, KP
AF O'Neill, S.
   Dierickx, S.
   Okebe, J.
   Dabira, E.
   Gryseels, C.
   d'Alessandro, U.
   Grietens, K. Peeters
TI 'The importance of blood is infinite': conceptions of blood as life
   force and fear of trial participation in a Fulani village in the Gambia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [O'Neill, S.; Dierickx, S.; Gryseels, C.; Grietens, K. Peeters] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Okebe, J.; Dabira, E.; d'Alessandro, U.] MRC, Gambia Unit, Fajara, Gambia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS2.153
BP 360
EP 360
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758802138
OA No
DA 2017-08-15
ER

PT J
AU Jaiteh, F
   Dierickx, S
   O'Neill, S
   Alessandro, UD
   Balen, J
   Grietens, KP
AF Jaiteh, F.
   Dierickx, S.
   O'Neill, S.
   Alessandro, U. D'
   Balen, J.
   Grietens, K. P.
TI Socio-cultural factors influencing pregnant women's adherence to
   anti-malarial treatment in rural Gambia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Jaiteh, F.; Alessandro, U. D'] MRC, Gambia Unit, Banjul, Gambia.
   [Dierickx, S.; O'Neill, S.; Grietens, K. P.] Insitute Trop Med Antwerp, Med Anthropol Unit, Antwerp, Belgium.
   [Alessandro, U. D'] London Sch Hyg & Trop Med, London WC1, England.
   [Balen, J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.
   [Grietens, K. P.] Nagasaki Univ, Sch Hlth Dev, Nagasaki 852, Japan.
   [Grietens, K. P.] Partners Appl Social Sci PASS Int, Antwerp, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS2.159
BP 362
EP 362
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758802142
OA No
DA 2017-08-15
ER

PT J
AU Njunju, M
   Manyando, C
   Mwakazanga, D
   Champo, D
   Chongwe, G
   Mwewa, D
   Mulenga, M
   Claeys, Y
   Schurmans, C
   Van Overmeir, C
   Menten, J
   Thriemer, K
   Erhart, A
   Ravinetto, R
   D'Alessandro, U
   Van Geertruyden, JP
AF Njunju, M.
   Manyando, C.
   Mwakazanga, D.
   Champo, D.
   Chongwe, G.
   Mwewa, D.
   Mulenga, M.
   Claeys, Y.
   Schurmans, C.
   Van Overmeir, C.
   Menten, J.
   Thriemer, K.
   Erhart, A.
   Ravinetto, R.
   D'Alessandro, U.
   Van Geertruyden, J. P.
TI Effectiveness and safety of cotrimoxazole and sulfadoxine-pyrimethamine
   in preventing malaria infection during pregnancy in HIV negative
   pregnant women in Zambia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Njunju, M.] Copperbelt Univ, Sch Med, Basic Sci, Kitwe, Zambia.
   [Manyando, C.; Mwakazanga, D.; Champo, D.] Trop Dis Res Ctr, Publ Hlth, Ndola, Zambia.
   [Chongwe, G.] Univ Zambia, Publ Hlth, Lusaka, Zambia.
   [Mwewa, D.] Nchelenge Dist Hlth Off, Nchelenge, Nchelenge, Zambia.
   [Mulenga, M.] Trop Dis Res Ctr, Ndola, Zambia.
   [Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Menten, J.; Thriemer, K.; Erhart, A.; Ravinetto, R.; D'Alessandro, U.] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Thriemer, K.] Menzies Sch Publ Hlth Res, Brisbane, Qld, Australia.
   [Erhart, A.; D'Alessandro, U.] MRC, Fajara, Gambia.
   [Ravinetto, R.] Katholieke Univ Leuven, Pharmaceut & Pharmacol Sci, Leuven, Belgium.
   [Van Geertruyden, J. P.] Univ Antwerp, Int Hlth, B-2020 Antwerp, Belgium.
RI Van geertruyden, Jean-pierre/K-6425-2014
OI Van geertruyden, Jean-pierre/0000-0001-5006-6364
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
MA PS2.175
BP 368
EP 368
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758802158
OA No
DA 2017-08-15
ER

PT J
AU Togun, TO
   Egere, U
   Sillah, AK
   Ayorinde, A
   Mendy, F
   Tientcheu, L
   Otu, J
   Antonio, M
   Sutherland, J
   Hill, PC
   Kampmann, B
AF Togun, T. O.
   Egere, U.
   Sillah, A. K.
   Ayorinde, A.
   Mendy, F.
   Tientcheu, L.
   Otu, J.
   Antonio, M.
   Sutherland, J.
   Hill, P. C.
   Kampmann, B.
TI Contribution of Xpert (R) MTB/RIF to the diagnosis of pulmonary
   tuberculosis among TB-exposed children in The Gambia
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE accuracy; Xpert (R) MTB/RIF; child contacts
ID INTRATHORACIC TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PEDIATRIC
   TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; ASSAY; SPECIMENS; ACCURACY;
   THERAPY
AB SETTING: Greater Banjul Area, The Gambia.
   OBJECTIVE: To conduct a pragmatic evaluation of the Xpert (R) MTB/RIF assay in the diagnosis of tuberculosis (TB) among child contacts.
   DESIGN: In this prospective study, one induced sputum sample was obtained from TB contacts aged <15 years and tested using fluorescent microscopy, culture and Xpert. The diagnostic accuracy of the microbiological tests was evaluated against culture and 'all TB diagnosis and treatment' as separate reference standards.
   RESULTS: Using culture as a reference standard, Xpert was positive for Mycobacterium tuberculosis in 6/14 culture-positive and 6/473 culture-negative children, giving a sensitivity and specificity of respectively 42.9% (95%CI 17.7-71.1) and 98.7% (95%CI 97.2-99.5). With 'all TB diagnosis and treatment' as a composite reference standard, combined Xpert and culture tests were positive for M. tuberculosis in 20/62 children with TB disease (32.3%, 95%CI 20.9-45.3), which was comparable to the yield from microscopy, culture and Xpert combined (33.9%, 95%CI 22.3-47.0), but significantly higher than individual yields from each test.
   CONCLUSION: The sensitivity of Xpert is low in actively traced child contacts, but a combination of Xpert and mycobacterial culture has incremental benefits for the bacteriological confirmation of TB disease.
C1 [Togun, T. O.; Egere, U.; Sillah, A. K.; Ayorinde, A.; Mendy, F.; Tientcheu, L.; Otu, J.; Antonio, M.; Sutherland, J.; Kampmann, B.] MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
   [Hill, P. C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Hill, P. C.] Univ Otago, Sch Med, Otago Int Hlth Res Network, Dept Prevent & Social Med, Dunedin, New Zealand.
   [Kampmann, B.] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London, England.
RP Togun, TO (reprint author), Med Res Council Unit Gambia, Atlantic Rd,POB 273, Banjul, Gambia.
EM ttogun@mrc.gm
FU UK Medical Research Council; UK Department for International Development
   (DFID, London, UK) [MR/K011944/1]; WHO STOP TB/TB Reach Wave 2 Grant (TB
   Reach Grant) [T9-370-114GAM]
FX The work was supported by the UK Medical Research Council and the UK
   Department for International Development (DFID, London, UK) under the
   MRC/DFID Concordat agreement (Childhood TB Research Programme Grant
   reference number MR/K011944/1 to BK) and the WHO STOP TB/TB Reach Wave 2
   Grant (TB Reach Grant reference number T9-370-114GAM).
CR Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390
   Lopez Avalos GG, 2012, J TROP MED, DOI [10.1155/2012/818219, DOI 10.1155/2012/818219]
   Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8
   Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093776
   Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879
   Detjen A K, 2015, LANCET RESP MED 0323
   Edwards DJ, 2007, INT J TUBERC LUNG D, V11, P263
   EDWARDS K, 1987, PAPUA NEW GUINEA MED, V30, P169
   Gambian National Leprosy and Tuberculosis Control Programme, 2012, NAT GUID MAN TUB
   Gotuzzo E, 2011, LANCET INFECT DIS, V11, P802, DOI [10.1016/S1473-3099(11)70187-6, 10.1016/S1473-3099(11)70182-6]
   Graham SM, 2013, CLIN INFECT DIS, V57, P1693, DOI 10.1093/cid/cit647
   Kent PT, 1985, PUBLIC HLTH MYCOBACT
   Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652
   Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8
   Nhu Nguyen Thi Quynh, 2013, BMC Infect Dis, V13, P31, DOI 10.1186/1471-2334-13-31
   Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0
   Nicol MP, 2005, CLIN INFECT DIS, V40, P1301, DOI 10.1086/429245
   Pang Y, 2014, PEDIATR INFECT DIS J, V33, P1047, DOI 10.1097/INF.0000000000000403
   Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190
   Rutherford ME, 2012, TROP MED INT HEALTH, V17, P1264, DOI 10.1111/j.1365-3156.2012.03053.x
   SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004
   Sekadde MP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-133
   Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC
   Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, UNAIDSJC25021E
   Van Rie A, 2013, LANCET GLOB HEALTH, V1, pE60, DOI 10.1016/S2214-109X(13)70049-4
   World Health Organization, 2013, WHOHTMTB20132
   World Health Organization, 2014, WHOHTMTB201316
   World Health Organization, 2014, WHOHTMTB201408
   World Health Organization, 2010, ROADM ROLL OUT XPERT
   World Health Organization, 2012, ZER TB DEATHS CHILDR
   World Health Organization, 2007, CHILD GROWTH STAND L
   Zar HJ, 2013, LANCET GLOB HEALTH, V1, pE97, DOI 10.1016/S2214-109X(13)70036-6
   Zar HJ, 2012, CLIN INFECT DIS, V55, P1088, DOI 10.1093/cid/cis598
NR 33
TC 3
Z9 3
U1 0
U2 1
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD SEP
PY 2015
VL 19
IS 9
BP 1091
EP 1097
DI 10.5588/ijtld.15.0228
PG 7
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA CP5AT
UT WOS:000359894400018
PM 26260831
OA No
DA 2017-08-15
ER

PT J
AU Odutola, A
   Afolabi, MO
   Ogundare, EO
   Lowe-Jallow, YN
   Worwul, A
   Okebe, J
   Ota, MO
AF Odutola, Aderonke
   Afolabi, Muhammed O.
   Ogundare, Ezra O.
   Lowe-Jallow, Yamu Ndow
   Worwul, Archibald
   Okebe, Joseph
   Ota, Martin O.
TI Risk factors for delay in age-appropriate vaccinations among Gambian
   children
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
DE Timeliness; Vaccination; Protection; Vaccine preventable diseases;
   Children
ID CHILDHOOD VACCINATIONS; VACCINE UPTAKE; TIMELINESS; IMMUNIZATION;
   COVERAGE; EFFICACY; NAIROBI
AB Background: Vaccination has been shown to reduce mortality and morbidity due to vaccine-preventable diseases. However, these diseases are still responsible for majority of childhood deaths worldwide especially in the developing countries. This may be due to low vaccine coverage or delay in receipt of age-appropriate vaccines. We studied the timeliness of routine vaccinations among children aged 12-59 months attending infant welfare clinics in semi-urban areas of The Gambia, a country with high vaccine coverage.
   Methods: A cross-sectional survey was conducted in four health centres in the Western Region of the Gambia. Vaccination dates were obtained from health cards and timeliness assessed based on the recommended age ranges for BCG (birth-8 weeks), Diphtheria-Pertussis-Tetanus (6 weeks-4 months; 10 weeks-5 months; 14 weeks-6 months) and measles vaccines (38 weeks-12 months). Risk factors for delay in age-appropriate vaccinations were determined using logistic regression. Analysis was limited to BCG, third dose of Diphtheria-Pertussis -Tetanus (DPT3) and measles vaccines.
   Results: Vaccination records of 1154 children were studied. Overall, 63.3 % (95 % CI 60.6-66.1 %) of the children had a delay in the recommended time to receiving at least one of the studied vaccines. The proportion of children with delayed vaccinations increased from BCG [5.8 % (95 % CI 4.5-7.0 %)] to DPT3 [60.4 % (95 % CI 57.9 %-63.0 %)] but was comparatively low for the measles vaccine [10.8 % (95 % CI 9.1 %-12.5 %)]. Mothers of affected children gave reasons for the delay, and their profile correlated with type of occupation, place of birth and mode of transportation to the health facilities.
   Conclusion: Despite high vaccination coverage reported in The Gambia, a significant proportion of the children's vaccines were delayed for reasons related to health services as well as profile of mothers. These findings are likely to obtain in several countries and should be addressed by programme managers in order to improve and optimize the impact of the immunization coverage rates.
C1 [Odutola, Aderonke; Afolabi, Muhammed O.; Ogundare, Ezra O.; Worwul, Archibald; Okebe, Joseph; Ota, Martin O.] MRC Unit, Banjul, Fajara, Gambia.
   [Lowe-Jallow, Yamu Ndow] Minist Hlth & Social Welf, Banjul, Gambia.
   [Ota, Martin O.] WHO, Reg Off Africa, Brazzaville, Rep Congo.
RP Odutola, A (reprint author), MRC Unit, POB 273, Banjul, Fajara, Gambia.
EM aaodutola@mrc.gm
OI Afolabi, Muhammed/0000-0002-9967-6419
FU World Health Organization [001]
CR Akmatov MK, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.124651
   Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432
   Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   CUTTS FT, 1989, INT J EPIDEMIOL, V18, P427, DOI 10.1093/ije/18.2.427
   de Waroux OL, 2013, INT HEALTH, V5, P139, DOI 10.1093/inthealth/iht006
   Department of Central Statictics TG, 2005, 2003 POP CENS
   Ettarh Remare R, 2012, Trop Med Health, V40, P59, DOI 10.2149/tmh.2012-09s
   Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093
   Global routine vaccination coverage, 2012, WKLY EPIDEMIOL REC, V87, P432
   Hambidge SJ, 2014, PEDIATRICS
   Heininger U, 2006, EUR J PEDIATR, V165, P124, DOI 10.1007/s00431-005-0014-y
   HULL HF, 1983, LANCET, V1, P972
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kalan R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005130
   Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6
   Luman ET, 2005, JAMA-J AM MED ASSOC, V293, P1204, DOI 10.1001/jama.293.10.1204
   Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6
   Odusanya O, 2000, NIGERIA J NIG INF CO, V3, P9
   Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381
   Onyiriuka A. N., 2005, Journal of Medicine and Biomedical Research, V4, P71
   Payne S, 2014, HEALTH POLICY PLANN, V29, P193, DOI 10.1093/heapol/czt004
   Sadoh AE, 2009, J HEALTH POPUL NUTR, V27, P391
   Scott S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107280
   Suarez-Castaneda E, 2014, VACCINE, V32, P437, DOI 10.1016/j.vaccine.2013.11.072
   Takum T, 2011, J TROP PEDIATRICS, V57, P251, DOI 10.1093/tropej/fmq086
   UNICEF, 1993, STAT WORLDS CHILDR 1
   [Anonymous], 2009, DIARRH WHY CHILDR AR
   WHO U World Bank, 2009, STAT WORLDS VACC IMM
NR 29
TC 3
Z9 3
U1 1
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD AUG 28
PY 2015
VL 15
AR 346
DI 10.1186/s12913-015-1015-9
PG 9
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA CP7YS
UT WOS:000360106700001
PM 26315547
OA gold
DA 2017-08-15
ER

PT J
AU Vos, T
   Barber, RM
   Bell, B
   Bertozzi-Villa, A
   Biryukov, S
   Bolliger, I
   Charlson, F
   Davis, A
   Degenhardt, L
   Dicker, D
   Duan, L
   Erskine, H
   Feigin, VL
   Ferrari, AJ
   Fitzmaurice, C
   Fleming, T
   Graetz, N
   Guinovart, C
   Haagsma, J
   Hansen, GM
   Hanson, SW
   Heuton, KR
   Higashi, H
   Kassebaum, N
   Kyu, H
   Laurie, E
   Liang, XF
   Lofgren, K
   Lozano, R
   MacIntyre, MF
   Moradi-Lakeh, M
   Naghavi, M
   Nguyen, G
   Odell, S
   Ortblad, K
   Roberts, DA
   Roth, GA
   Sandar, L
   Serina, PT
   Stanaway, JD
   Steiner, C
   Thomas, B
   Vollset, SE
   Whiteford, H
   Wolock, TM
   Ye, PP
   Zhou, MG
   Avila, MA
   Aasvang, GM
   Abbafati, C
   Ozgoren, AA
   Abd-Allah, F
   Aziz, MIA
   Abera, SF
   Aboyans, V
   Abraham, JP
   Abraham, B
   Abubakar, I
   Abu-Raddad, LJ
   Abu-Rmeileh, NME
   Aburto, TC
   Achoki, T
   Ackerman, IN
   Adelekan, A
   Ademi, Z
   Adou, AK
   Adsuar, JC
   Arnlov, J
   Agardh, EE
   Al Khabouri, MJ
   Alam, SS
   Alasfoor, D
   Albittar, MI
   Alegretti, MA
   Aleman, AV
   Alemu, ZA
   Alfonso-Cristancho, R
   Alhabib, S
   Ali, R
   Alla, F
   Allebeck, P
   Allen, PJ
   AlMazroa, MA
   Alsharif, U
   Alvarez, E
   Alvis-Guzman, N
   Ameli, O
   Amini, H
   Ammar, W
   Anderson, BO
   Anderson, HR
   Antonio, CAT
   Anwari, P
   Apfel, H
   Arsenijevic, VSA
   Artaman, A
   Asghar, RJ
   Assadi, R
   Atkins, LS
   Atkinson, C
   Badawi, A
   Bahit, MC
   Bakfalouni, T
   Balakrishnan, K
   Balalla, S
   Banerjee, A
   Barker-Collo, SL
   Barquera, S
   Barregard, L
   Barrero, LH
   Basu, S
   Basu, A
   Baxter, A
   Beardsley, J
   Bedi, N
   Beghi, E
   Bekele, T
   Bell, ML
   Benjet, C
   Bennett, DA
   Bensenor, IM
   Benzian, H
   Bernabe, E
   Beyene, TJ
   Bhala, N
   Bhalla, A
   Bhutta, ZQ
   Bienhoff, K
   Bikbov, B
   Bin Abdulhak, A
   Blore, JD
   Blyth, FM
   Bohensky, MA
   Basara, BB
   Borges, G
   Bornstein, NM
   Bose, D
   Boufous, S
   Bourne, RR
   Boyers, LN
   Brainin, M
   Brauer, M
   Brayne, CEG
   Brazinova, A
   Breitborde, NJK
   Brenner, H
   Briggs, ADM
   Brooks, PM
   Brown, J
   Brugha, TS
   Buchbinder, R
   Buckle, GC
   Bukhman, G
   Bulloch, AG
   Burch, M
   Burnett, R
   Cardenas, R
   Cabral, NL
   Nonato, IRC
   Campuzano, JC
   Carapetis, JR
   Carpenter, DO
   Caso, V
   Castaneda-Orjuela, CA
   Catala-Lopez, F
   Chadha, VK
   Chang, JC
   Chen, HL
   Chen, WQ
   Chiang, PP
   Chimed-Ochir, O
   Chowdhury, R
   Christensen, H
   Christophi, CA
   Chugh, SS
   Cirillo, M
   Coggeshall, M
   Cohen, A
   Colistro, V
   Colquhoun, SM
   Contreras, AG
   Cooper, LT
   Cooper, C
   Cooperrider, K
   Coresh, J
   Cortinovis, M
   Criqui, MH
   Crump, JA
   Cuevas-Nasu, L
   Dandona, R
   Dandona, L
   Dansereau, E
   Dantes, HG
   Dargan, PI
   Davey, G
   Davitoiu, DV
   Dayama, A
   De la Cruz-Gongora, V
   de la Vega, SF
   De Leo, D
   del Pozo-Cruz, B
   Dellavalle, RP
   Deribe, K
   Derrett, S
   Des Jarlais, DC
   Dessalegn, M
   de Veber, GA
   Dharmaratne, SD
   Diaz-Torne, C
   Ding, EL
   Dokova, K
   Dorsey, ER
   Driscoll, TR
   Duber, H
   Durrani, AM
   Edmond, KM
   Ellenbogen, RG
   Endres, M
   Ermakov, SP
   Eshrati, B
   Esteghamati, A
   Estep, K
   Fahimi, S
   Farzadfar, F
   Fay, DFJ
   Felson, DT
   Fereshtehnejad, SM
   Fernandes, JG
   Ferri, CP
   Flaxman, A
   Foigt, N
   Foreman, KJ
   Fowkes, FGR
   Franklin, RC
   Furst, T
   Futran, ND
   Gabbe, BJ
   Gankpe, FG
   Garcia-Guerra, FA
   Geleijnse, JM
   Gessner, BD
   Gibney, KB
   Gillum, RF
   Ginawi, IA
   Giroud, M
   Giussani, G
   Goenka, S
   Goginashvili, K
   Gona, P
   de Cosio, TG
   Gosselin, RA
   Gotay, CC
   Goto, A
   Gouda, HN
   Guerrant, RL
   Gugnani, HC
   Gunnell, D
   Gupta, R
   Gupta, R
   Gutierrez, RA
   Hafezi-Nejad, N
   Hagan, H
   Halasa, Y
   Hamadeh, RR
   Hamavid, H
   Hammami, M
   Hankey, GJ
   Hao, YT
   Harb, HL
   Haro, JM
   Havmoeller, R
   Hay, RJ
   Hay, S
   Hedayati, MT
   Pi, IBH
   Heydarpour, P
   Hijar, M
   Hoek, HW
   Hoffman, HJ
   Hornberger, JC
   Hosgood, HD
   Hossain, M
   Hotez, PJ
   Hoy, DG
   Hsairi, M
   Hu, H
   Hu, GQ
   Huang, JJ
   Huang, C
   Huiart, L
   Husseini, A
   Iannarone, M
   Iburg, KM
   Innos, K
   Inoue, M
   Jacobsen, KH
   Jassal, SK
   Jeemon, P
   Jensen, PN
   Jha, V
   Jiang, G
   Jiang, Y
   Jonas, JB
   Joseph, J
   Juel, K
   Kan, HD
   Karch, A
   Karimkhani, C
   Karthikeyan, G
   Katz, R
   Kaul, A
   Kawakami, N
   Kazi, DS
   Kemp, AH
   Kengne, AP
   Khader, YS
   Khalifa, SEAH
   Khan, EA
   Khan, G
   Khang, YH
   Khonelidze, I
   Kieling, C
   Kim, D
   Kim, S
   Kimokoti, RW
   Kinfu, Y
   Kinge, JM
   Kissela, BM
   Kivipelto, M
   Knibbs, L
   Knudsen, AK
   Kokubo, Y
   Kosen, S
   Kramer, A
   Kravchenko, M
   Krishnamurthi, RV
   Krishnaswami, S
   Defo, BK
   Bicer, BK
   Kuipers, EJ
   Kulkarni, VS
   Kumar, K
   Kumar, GA
   Kwan, GF
   Lai, T
   Lalloo, R
   Lam, H
   Lan, Q
   Lansingh, VC
   Larson, H
   Larsson, A
   Lawrynowicz, AEB
   Leasher, JL
   Lee, JT
   Leigh, J
   Leung, R
   Levi, M
   Li, B
   Li, YC
   Li, YM
   Liang, J
   Lim, S
   Lin, HH
   Lind, M
   Lindsay, MP
   Lipshultz, SE
   Liu, SW
   Lloyd, BK
   Ohno, SL
   Logroscino, G
   Looker, KJ
   Lopez, AD
   Lopez-Olmedo, N
   Lortet-Tieulent, J
   Lotufo, PA
   Low, N
   Lucas, RM
   Lunevicius, R
   Lyons, RA
   Ma, JX
   Ma, S
   Mackay, MT
   Majdan, M
   Malekzadeh, R
   Mapoma, CC
   Marcenes, W
   March, LM
   Margono, C
   Marks, GB
   Marzan, MB
   Masci, JR
   Mason-Jones, AJ
   Matzopoulos, RG
   Mayosi, BM
   Mazorodze, TT
   McGill, NW
   McGrath, JJ
   McKee, M
   McLain, A
   McMahon, BJ
   Meaney, PA
   Mehndiratta, MM
   Mejia-Rodriguez, F
   Mekonnen, W
   Melaku, YA
   Meltzer, M
   Memish, ZA
   Mensah, G
   Meretoja, A
   Mhimbira, FA
   Micha, R
   Miller, TR
   Mills, EJ
   Mitchell, PB
   Mock, CN
   Moffitt, TE
   Ibrahim, NM
   Mohammad, KA
   Mokdad, AH
   Mola, GL
   Monasta, L
   Montico, M
   Montine, TJ
   Moore, AR
   Moran, AE
   Morawska, L
   Mori, R
   Moschandreas, J
   Moturi, WN
   Moyer, M
   Mozaffarian, D
   Mueller, UO
   Mukaigawara, M
   Murdoch, ME
   Murray, J
   Murthy, KS
   Naghavi, P
   Nahas, Z
   Naheed, A
   Naidoo, KS
   Naldi, L
   Nand, D
   Nangia, V
   Narayan, KMV
   Nash, D
   Nejjari, C
   Neupane, SP
   Newman, LM
   Newton, CR
   Ng, M
   Ngalesoni, FN
   Nhung, NT
   Nisar, MI
   Nolte, S
   Norheim, OF
   Norman, RE
   Norrving, B
   Nyakarahuka, L
   Oh, IH
   Ohkubo, T
   Omer, SB
   Opio, JN
   Ortiz, A
   Pandian, JD
   Panelo, CIA
   Papachristou, C
   Park, EK
   Parry, CD
   Caicedo, AJP
   Patten, SB
   Paul, VK
   Pavlin, BI
   Pearce, N
   Pedraza, LS
   Pellegrini, CA
   Pereira, DM
   Perez-Ruiz, FP
   Perico, N
   Pervaiz, A
   Pesudovs, K
   Peterson, CB
   Petzold, M
   Phillips, MR
   Phillips, D
   Phillips, B
   Piel, FB
   Plass, D
   Poenaru, D
   Polanczyk, GV
   Polinder, S
   Pope, CA
   Popova, S
   Poulton, RG
   Pourmalek, F
   Prabhakaran, D
   Prasad, NM
   Qato, D
   Quistberg, DA
   Rafay, A
   Rahimi, K
   Rahimi-Movaghar, V
   Rahman, SU
   Raju, M
   Rakovac, I
   Rana, SM
   Razavi, H
   Refaat, A
   Rehm, J
   Remuzzi, G
   Resnikoff, S
   Ribeiro, AL
   Riccio, PM
   Richardson, L
   Richardus, JH
   Riederer, AM
   Robinson, M
   Roca, A
   Rodriguez, A
   Rojas-Rueda, D
   Ronfani, L
   Rothenbacher, D
   Roy, N
   Ruhago, GM
   Sabin, N
   Sacco, RL
   Ksoreide, K
   Saha, S
   Sahathevan, R
   Sahraian, MA
   Sampson, U
   Sanabria, JR
   Sanchez-Riera, L
   Santos, IS
   Satpathy, M
   Saunders, JE
   Sawhney, M
   Saylan, MI
   Scarborough, P
   Schoettker, B
   Schneider, IJ
   Schwebel, DC
   Scott, JG
   Seedat, S
   Sepanlou, SG
   Serdar, B
   Servan-Mori, EE
   Shackelford, K
   Shaheen, A
   Shahraz, S
   Levy, TS
   Shangguan, S
   She, J
   Sheikhbahaei, S
   Shepard, DS
   Shi, PL
   Shibuya, K
   Shinohara, Y
   Shiri, R
   Shishani, K
   Shiue, I
   Shrime, MG
   Sigfusdottir, ID
   Silberberg, DH
   Simard, EP
   Sindi, S
   Singh, JA
   Singh, L
   Skirbekk, V
   Sliwa, K
   Soljak, M
   Soneji, S
   Soshnikov, SS
   Speyer, P
   Sposato, LA
   Sreeramareddy, CT
   Stoeckl, H
   Stathopoulou, VK
   Steckling, N
   Stein, MB
   Stein, DJ
   Steiner, TJ
   Stewart, A
   Stork, E
   Stovner, LJ
   Stroumpoulis, K
   Sturua, L
   Sunguya, BF
   Swaroop, M
   Sykes, BL
   Tabb, KM
   Takahashi, K
   Tan, F
   Tandon, N
   Tanne, D
   Tanner, M
   Tavakkoli, M
   Taylor, HR
   Ao, BJT
   Temesgen, AM
   Ten Have, M
   Tenkorang, EY
   Terkawi, AS
   Theadom, AM
   Thomas, E
   Thorne-Lyman, AL
   Thrift, AG
   Tleyjeh, IM
   Tonelli, M
   Topouzis, F
   Towbin, JA
   Toyoshima, H
   Traebert, J
   Tran, BX
   Trasande, L
   Trillini, M
   Truelsen, T
   Trujillo, U
   Tsilimbaris, M
   Tuzcu, EM
   Ukwaja, KN
   Undurraga, EA
   Uzun, SB
   van Brakel, WH
   de Vijver, SV
   Van Dingenen, R
   van Gool, CH
   Varakin, YY
   Vasankari, TJ
   Vavilala, MS
   Veerman, LJ
   Velasquez-Melendez, G
   Venketasubramanian, N
   Vijayakumar, L
   Villalpando, S
   Violante, FS
   Vlassov, VV
   Waller, S
   Wallin, MT
   Wan, X
   Wang, LH
   Wang, JL
   Wang, YP
   Warouw, TS
   Weichenthal, S
   Weiderpass, E
   Weintraub, RG
   Werdecker, A
   Wessells, KRR
   Westerman, R
   Wilkinson, JD
   Williams, HC
   Williams, TN
   Woldeyohannes, SM
   Wolfe, CDA
   Wong, JQ
   Wong, HD
   Woolf, AD
   Wright, JL
   Wurtz, B
   Xu, GL
   Yang, GH
   Yano, Y
   Yenesew, MA
   Yentur, GK
   Yip, P
   Yonemoto, N
   Yoon, SJ
   Younis, M
   Yu, CH
   Kim, KY
   Zaki, MES
   Zhang, Y
   Zhao, Z
   Zhao, Y
   Zhu, J
   Zonies, D
   Zunt, JR
   Salomon, JA
   Murray, CJL
AF Vos, Theo
   Barber, Ryan M.
   Bell, Brad
   Bertozzi-Villa, Amelia
   Biryukov, Stan
   Bolliger, Ian
   Charlson, Fiona
   Davis, Adrian
   Degenhardt, Louisa
   Dicker, Daniel
   Duan, Leilei
   Erskine, Holly
   Feigin, Valery L.
   Ferrari, Alize J.
   Fitzmaurice, Christina
   Fleming, Thomas
   Graetz, Nicholas
   Guinovart, Caterina
   Haagsma, Juanita
   Hansen, Gillian M.
   Hanson, Sarah Wulf
   Heuton, Kyle R.
   Higashi, Hideki
   Kassebaum, Nicholas
   Kyu, Hmwe
   Laurie, Evan
   Liang, Xiofeng
   Lofgren, Katherine
   Lozano, Rafael
   MacIntyre, Michael F.
   Moradi-Lakeh, Maziar
   Naghavi, Mohsen
   Nguyen, Grant
   Odell, Shaun
   Ortblad, Katrina
   Roberts, David Allen
   Roth, Gregory A.
   Sandar, Logan
   Serina, Peter T.
   Stanaway, Jeffrey D.
   Steiner, Caitlyn
   Thomas, Bernadette
   Vollset, Stein Emil
   Whiteford, Harvey
   Wolock, Timothy M.
   Ye, Pengpeng
   Zhou, Maigeng
   Avila, Marco A.
   Aasvang, Gunn Marit
   Abbafati, Cristiana
   Ozgoren, Ayse Abbasoglu
   Abd-Allah, Foad
   Aziz, Muna I. Abdel
   Abera, Semaw F.
   Aboyans, Victor
   Abraham, Jerry P.
   Abraham, Biju
   Abubakar, Ibrahim
   Abu-Raddad, Laith J.
   Abu-Rmeileh, Niveen M. E.
   Aburto, Tania C.
   Achoki, Tom
   Ackerman, Ilana N.
   Adelekan, Ademola
   Ademi, Zanfina
   Adou, Arsene K.
   Adsuar, Josef C.
   Arnlov, Johan
   Agardh, Emilie E.
   Al Khabouri, Mazin J.
   Alam, Sayed Saidul
   Alasfoor, Deena
   Albittar, Mohammed I.
   Alegretti, Miguel A.
   Aleman, Alicia V.
   Alemu, Zewdie A.
   Alfonso-Cristancho, Rafael
   Alhabib, Samia
   Ali, Raghib
   Alla, Francois
   Allebeck, Peter
   Allen, Peter J.
   AlMazroa, Mohammad AbdulAziz
   Alsharif, Ubai
   Alvarez, Elena
   Alvis-Guzman, Nelson
   Ameli, Omid
   Amini, Heresh
   Ammar, Walid
   Anderson, Benjamin O.
   Anderson, H. Ross
   Antonio, Carl Abelardo T.
   Anwari, Palwasha
   Apfel, Henry
   Arsenijevic, Valentain S. Arsic
   Artaman, Al
   Asghar, Rana J.
   Assadi, Reza
   Atkins, Lydia S.
   Atkinson, Charles
   Badawi, Alaa
   Bahit, Maria C.
   Bakfalouni, Talal
   Balakrishnan, Kalpana
   Balalla, Shivanthi
   Banerjee, Amitava
   Barker-Collo, Suzanne L.
   Barquera, Simon
   Barregard, Lars
   Barrero, Lope H.
   Basu, Sanjay
   Basu, Arindam
   Baxter, Amanda
   Beardsley, Justin
   Bedi, Neeraj
   Beghi, Ettore
   Bekele, Tolesa
   Bell, Michelle L.
   Benjet, Corina
   Bennett, Derrick A.
   Bensenor, Isabela M.
   Benzian, Habib
   Bernabe, Eduardo
   Beyene, Tariku J.
   Bhala, Neeraj
   Bhalla, Ashish
   Bhutta, Zulfi Qar
   Bienhoff, Kelly
   Bikbov, Boris
   Bin Abdulhak, Aref
   Blore, Jed D.
   Blyth, Fiona M.
   Bohensky, Megan A.
   Basara, Berrak Bora
   Borges, Guilherme
   Bornstein, Natan M.
   Bose, Dipan
   Boufous, Soufiane
   Bourne, Rupert R.
   Boyers, Lindsay N.
   Brainin, Michael
   Brauer, Michael
   Brayne, Carol E. G.
   Brazinova, Alexandra
   Breitborde, Nicholas J. K.
   Brenner, Hermann
   Briggs, Adam D. M.
   Brooks, Peter M.
   Brown, Jonathan
   Brugha, Traolach S.
   Buchbinder, Rachelle
   Buckle, Geoffrey C.
   Bukhman, Gene
   Bulloch, Andrew G.
   Burch, Michael
   Burnett, Richard
   Cardenas, Rosario
   Cabral, Norberto L.
   Nonato, Ismael R. Campos
   Campuzano, Julio C.
   Carapetis, Jonathan R.
   Carpenter, David O.
   Caso, Valeria
   Castaneda-Orjuela, Carlos A.
   Catala-Lopez, Ferran
   Chadha, Vineet K.
   Chang, Jung-Chen
   Chen, Honglei
   Chen, Wanqing
   Chiang, Peggy P.
   Chimed-Ochir, Odgerel
   Chowdhury, Rajiv
   Christensen, Hanne
   Christophi, Costas A.
   Chugh, Sumeet S.
   Cirillo, Massimo
   Coggeshall, Megan
   Cohen, Aaron
   Colistro, Valentina
   Colquhoun, Samantha M.
   Contreras, Alejandra G.
   Cooper, Leslie T.
   Cooper, Cyrus
   Cooperrider, Kimberly
   Coresh, Josef
   Cortinovis, Monica
   Criqui, Michael H.
   Crump, John A.
   Cuevas-Nasu, Lucia
   Dandona, Rakhi
   Dandona, Lalit
   Dansereau, Emily
   Dantes, Hector G.
   Dargan, Paul I.
   Davey, Gail
   Davitoiu, Dragos V.
   Dayama, Anand
   De la Cruz-Gongora, Vanessa
   de la Vega, Shelley F.
   De Leo, Diego
   del Pozo-Cruz, Borja
   Dellavalle, Robert P.
   Deribe, Kebede
   Derrett, Sarah
   Des Jarlais, Don C.
   Dessalegn, Muluken
   de Veber, Gabrielle A.
   Dharmaratne, Samath D.
   Diaz-Torne, Cesar
   Ding, Eric L.
   Dokova, Klara
   Dorsey, E. R.
   Driscoll, Tim R.
   Duber, Herbert
   Durrani, Adnan M.
   Edmond, Karen M.
   Ellenbogen, Richard G.
   Endres, Matthias
   Ermakov, Sergey P.
   Eshrati, Babak
   Esteghamati, Alireza
   Estep, Kara
   Fahimi, Saman
   Farzadfar, Farshad
   Fay, Derek F. J.
   Felson, David T.
   Fereshtehnejad, Seyed-Mohammad
   Fernandes, Jefferson G.
   Ferri, Cluesa P.
   Flaxman, Abraham
   Foigt, Nataliya
   Foreman, Kyle J.
   Fowkes, F. Gerry R.
   Franklin, Richard C.
   Furst, Thomas
   Futran, Neal D.
   Gabbe, Belinda J.
   Gankpe, Fortune G.
   Garcia-Guerra, Francisco A.
   Geleijnse, Johanna M.
   Gessner, Bradford D.
   Gibney, Katherine B.
   Gillum, Richard F.
   Ginawi, Ibrahim A.
   Giroud, Maurice
   Giussani, Giorgia
   Goenka, Shifalika
   Goginashvili, Ketevan
   Gona, Philimon
   de Cosio, Teresita Gonzalez
   Gosselin, Richard A.
   Gotay, Carolyn C.
   Goto, Atsushi
   Gouda, Hebe N.
   Guerrant, Richard L.
   Gugnani, Harish C.
   Gunnell, David
   Gupta, Rajeev
   Gupta, Rahul
   Gutierrez, Reyna A.
   Hafezi-Nejad, Nima
   Hagan, Holly
   Halasa, Yara
   Hamadeh, Randah R.
   Hamavid, Hannah
   Hammami, Mouhanad
   Hankey, Graeme J.
   Hao, Yuantao
   Harb, Hilda L.
   Haro, Josep Maria
   Havmoeller, Rasmus
   Hay, Roderick J.
   Hay, Simon
   Hedayati, Mohammad T.
   Pi, Ileana B. Heredia
   Heydarpour, Pouria
   Hijar, Martha
   Hoek, Hans W.
   Hoffman, Howard J.
   Hornberger, John C.
   Hosgood, H. Dean
   Hossain, Mazeda
   Hotez, Peter J.
   Hoy, Damian G.
   Hsairi, Mohamed
   Hu, Howard
   Hu, Guoqing
   Huang, John J.
   Huang, Cheng
   Huiart, Laetitia
   Husseini, Abdullatif
   Iannarone, Marissa
   Iburg, Kim M.
   Innos, Kaire
   Inoue, Manami
   Jacobsen, Kathryn H.
   Jassal, Simerjot K.
   Jeemon, Panniyammakal
   Jensen, Paul N.
   Jha, Vivekanand
   Jiang, Guohong
   Jiang, Ying
   Jonas, Jost B.
   Joseph, Jonathan
   Juel, Knud
   Kan, Haidong
   Karch, Andre
   Karimkhani, Chante
   Karthikeyan, Ganesan
   Katz, Ronit
   Kaul, Anil
   Kawakami, Norito
   Kazi, Dhruv S.
   Kemp, Andrew H.
   Kengne, Andre P.
   Khader, Yousef S.
   Khalifa, Shams Eldin A. H.
   Khan, Ejaz A.
   Khan, Gulfaraz
   Khang, Young-Ho
   Khonelidze, Irma
   Kieling, Christian
   Kim, Daniel
   Kim, Sungroul
   Kimokoti, Ruth W.
   Kinfu, Yohannes
   Kinge, Jonas M.
   Kissela, Brett M.
   Kivipelto, Miia
   Knibbs, Luke
   Knudsen, Ann Kristin
   Kokubo, Yoshihiro
   Kosen, Soewarta
   Kramer, Alexander
   Kravchenko, Michael
   Krishnamurthi, Rita V.
   Krishnaswami, Sanjay
   Defo, Barthelemy Kuate
   Bicer, Burcu Kucuk
   Kuipers, Ernst J.
   Kulkarni, Veena S.
   Kumar, Kaushalendra
   Kumar, G. Anil
   Kwan, Gene F.
   Lai, Taavi
   Lalloo, Ratilal
   Lam, Hilton
   Lan, Qing
   Lansingh, Van C.
   Larson, Heidi
   Larsson, Anders
   Lawrynowicz, Alicia E. B.
   Leasher, Janet L.
   Lee, Jong-Tae
   Leigh, James
   Leung, Ricky
   Levi, Miriam
   Li, Bin
   Li, Yichong
   Li, Yongmei
   Liang, Juan
   Lim, Stephen
   Lin, Hsien-Ho
   Lind, Margaret
   Lindsay, M. Patrice
   Lipshultz, Steven E.
   Liu, Shiwei
   Lloyd, Belinda K.
   Ohno, Summer Lockett
   Logroscino, Giancarlo
   Looker, Katharine J.
   Lopez, Alan D.
   Lopez-Olmedo, Nancy
   Lortet-Tieulent, Joannie
   Lotufo, Paulo A.
   Low, Nicola
   Lucas, Robyn M.
   Lunevicius, Raimundas
   Lyons, Ronan A.
   Ma, Jixiang
   Ma, Stefan
   Mackay, Mark T.
   Majdan, Marek
   Malekzadeh, Reza
   Mapoma, Christopher C.
   Marcenes, Wagner
   March, Lyn M.
   Margono, Chris
   Marks, Guy B.
   Marzan, Melvin B.
   Masci, Joseph R.
   Mason-Jones, Amanda J.
   Matzopoulos, Richard G.
   Mayosi, Bongani M.
   Mazorodze, Tasara T.
   McGill, Neil W.
   McGrath, John J.
   McKee, Martin
   McLain, Abby
   McMahon, Brian J.
   Meaney, Peter A.
   Mehndiratta, Man Mohan
   Mejia-Rodriguez, Fabiola
   Mekonnen, Wubegzier
   Melaku, Yohannes A.
   Meltzer, Michele
   Memish, Ziad A.
   Mensah, George
   Meretoja, Atte
   Mhimbira, Francis A.
   Micha, Renata
   Miller, Ted R.
   Mills, Edward J.
   Mitchell, Philip B.
   Mock, Charles N.
   Moffitt, Terrie E.
   Ibrahim, Norlinah Mohamed
   Mohammad, Karzan A.
   Mokdad, Ali H.
   Mola, Glen L.
   Monasta, Lorenzo
   Montico, Marcella
   Montine, Thomas J.
   Moore, Ami R.
   Moran, Andrew E.
   Morawska, Lidia
   Mori, Rintaro
   Moschandreas, Joanna
   Moturi, Wilkister N.
   Moyer, Madeline
   Mozaffarian, Dariush
   Mueller, Ulrich O.
   Mukaigawara, Mitsuru
   Murdoch, Michele E.
   Murray, Joseph
   Murthy, Kinnari S.
   Naghavi, Paria
   Nahas, Ziad
   Naheed, Aliya
   Naidoo, Kovin S.
   Naldi, Luigi
   Nand, Devina
   Nangia, Vinay
   Narayan, K. M. Venkat
   Nash, Denis
   Nejjari, Chakib
   Neupane, Sudan P.
   Newman, Lori M.
   Newton, Charles R.
   Ng, Marie
   Ngalesoni, Frida N.
   Nhung, Nguyen T.
   Nisar, Muhammad I.
   Nolte, Sandra
   Norheim, Ole F.
   Norman, Rosana E.
   Norrving, Bo
   Nyakarahuka, Luke
   Oh, In Hwan
   Ohkubo, Takayoshi
   Omer, Saad B.
   Opio, John Nelson
   Ortiz, Alberto
   Pandian, Jeyaraj D.
   Panelo, Carlo Irwin A.
   Papachristou, Christina
   Park, Eun-Kee
   Parry, Charles D.
   Caicedo, Angel J. Paternina
   Patten, Scott B.
   Paul, Vinod K.
   Pavlin, Boris I.
   Pearce, Neil
   Pedraza, Lilia S.
   Pellegrini, Carlos A.
   Pereira, David M.
   Perez-Ruiz, Fernando P.
   Perico, Norberto
   Pervaiz, Aslam
   Pesudovs, Konrad
   Peterson, Carrie B.
   Petzold, Max
   Phillips, Michael R.
   Phillips, David
   Phillips, Bryan
   Piel, Frederic B.
   Plass, Dietrich
   Poenaru, Dan
   Polanczyk, Guilherme V.
   Polinder, Suzanne
   Pope, C. A., III
   Popova, Svetlana
   Poulton, Richie G.
   Pourmalek, Farshad
   Prabhakaran, Dorairaj
   Prasad, Noela M.
   Qato, Dima
   Quistberg, D. A.
   Rafay, Anwar
   Rahimi, Kazem
   Rahimi-Movaghar, Vafa
   Rahman, Sajjad Ur
   Raju, Murugesan
   Rakovac, Ivo
   Rana, Saleem M.
   Razavi, Homie
   Refaat, Amany
   Rehm, Jurgen
   Remuzzi, Giuseppe
   Resnikoff, Serge
   Ribeiro, Antonio L.
   Riccio, Patricia M.
   Richardson, Lee
   Richardus, Jan Hendrik
   Riederer, Anne M.
   Robinson, Margot
   Roca, Anna
   Rodriguez, Alina
   Rojas-Rueda, David
   Ronfani, Luca
   Rothenbacher, Dietrich
   Roy, Nobhojit
   Ruhago, George M.
   Sabin, Nsanzimana
   Sacco, Ralph L.
   Ksoreide, Kjetil
   Saha, Sukanta
   Sahathevan, Ramesh
   Sahraian, Mohammad Ali
   Sampson, Uchechukwu
   Sanabria, Juan R.
   Sanchez-Riera, Lidia
   Santos, Itamar S.
   Satpathy, Maheswar
   Saunders, James E.
   Sawhney, Monika
   Saylan, Mete I.
   Scarborough, Peter
   Schoettker, Ben
   Schneider, Ione J. C.
   Schwebel, David C.
   Scott, James G.
   Seedat, Soraya
   Sepanlou, Sadaf G.
   Serdar, Berrin
   Servan-Mori, Edson E.
   Shackelford, Katya
   Shaheen, Amira
   Shahraz, Saeid
   Levy, Teresa Shamah
   Shangguan, Siyi
   She, Jun
   Sheikhbahaei, Sara
   Shepard, Donald S.
   Shi, Peilin
   Shibuya, Kenji
   Shinohara, Yukito
   Shiri, Rahman
   Shishani, Kawkab
   Shiue, Ivy
   Shrime, Mark G.
   Sigfusdottir, Inga D.
   Silberberg, Donald H.
   Simard, Edgar P.
   Sindi, Shireen
   Singh, Jasvinder A.
   Singh, Lavanya
   Skirbekk, Vegard
   Sliwa, Karen
   Soljak, Michael
   Soneji, Samir
   Soshnikov, Sergey S.
   Speyer, Peter
   Sposato, Luciano A.
   Sreeramareddy, Chandrashekhar T.
   Stoeckl, Heidi
   Stathopoulou, Vasiliki Kalliopi
   Steckling, Nadine
   Stein, Murray B.
   Stein, Dan J.
   Steiner, Timothy J.
   Stewart, Andrea
   Stork, Eden
   Stovner, Lars J.
   Stroumpoulis, Konstantinos
   Sturua, Lela
   Sunguya, Bruno F.
   Swaroop, Mamta
   Sykes, Bryan L.
   Tabb, Karen M.
   Takahashi, Ken
   Tan, Feng
   Tandon, Nikhil
   Tanne, David
   Tanner, Marcel
   Tavakkoli, Mohammad
   Taylor, Hugh R.
   Ao, Braden J. Te
   Temesgen, Awoke Misganaw
   Ten Have, Margreet
   Tenkorang, Eric Yeboah
   Terkawi, Abdullah Sulieman
   Theadom, Alice M.
   Thomas, Elissa
   Thorne-Lyman, Andrew L.
   Thrift, Amanda G.
   Tleyjeh, Imad M.
   Tonelli, Marcello
   Topouzis, Fotis
   Towbin, Jeffrey A.
   Toyoshima, Hideaki
   Traebert, Jefferson
   Tran, Bach X.
   Trasande, Leonardo
   Trillini, Matias
   Truelsen, Thomas
   Trujillo, Ulises
   Tsilimbaris, Miltiadis
   Tuzcu, Emin M.
   Ukwaja, Kingsley N.
   Undurraga, Eduardo A.
   Uzun, Selen B.
   van Brakel, Wim H.
   de Vijver, Steven van
   Van Dingenen, Rita
   van Gool, Coen H.
   Varakin, Yuri Y.
   Vasankari, Tommi J.
   Vavilala, Monica S.
   Veerman, Lennert J.
   Velasquez-Melendez, Gustavo
   Venketasubramanian, Narayanaswamy
   Vijayakumar, Lakshmi
   Villalpando, Salvador
   Violante, Francesco S.
   Vlassov, Vasiliy V.
   Waller, Stephen
   Wallin, Mitchell T.
   Wan, Xia
   Wang, Linhong
   Wang, JianLi
   Wang, Yanping
   Warouw, Tati S.
   Weichenthal, Scott
   Weiderpass, Elisabete
   Weintraub, Robert G.
   Werdecker, Andrea
   Wessells, K. Ryan R.
   Westerman, Ronny
   Wilkinson, James D.
   Williams, Hywel C.
   Williams, Thomas N.
   Woldeyohannes, Solomon M.
   Wolfe, Charles D. A.
   Wong, John Q.
   Wong, Haidong
   Woolf, Anthony D.
   Wright, Jonathan L.
   Wurtz, Brittany
   Xu, Gelin
   Yang, Gonghuan
   Yano, Yuichiro
   Yenesew, Muluken A.
   Yentur, Gokalp K.
   Yip, Paul
   Yonemoto, Naohiro
   Yoon, Seok-Jun
   Younis, Mustafa
   Yu, Chuanhua
   Kim, Kim Yun
   Zaki, Maysaa El Sayed
   Zhang, Yong
   Zhao, Zheng
   Zhao, Yong
   Zhu, Jun
   Zonies, David
   Zunt, Joseph R.
   Salomon, Joshua A.
   Murray, Christopher J. L.
CA Global Burden Dis Study
TI Global, regional, and national incidence, prevalence, and years lived
   with disability for 301 acute and chronic diseases and injuries in 188
   countries, 1990-2013: a systematic analysis for the Global Burden of
   Disease Study 2013
SO LANCET
LA English
DT Article
ID ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ALCOHOL DEPENDENCE; CUTANEOUS
   LEISHMANIASIS; MENTAL-DISORDERS; CONDUCT DISORDER; HEALTH OUTCOMES;
   IRON-DEFICIENCY; OTITIS-MEDIA; WEIGHTS; EPIDEMIOLOGY
AB Background Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013), we estimated these quantities for acute and chronic diseases and injuries for 188 countries between 1990 and 2013.
   Methods Estimates were calculated for disease and injury incidence, prevalence, and YLDs using GBD 2010 methods with some important refinements. Results for incidence of acute disorders and prevalence of chronic disorders are new additions to the analysis. Key improvements include expansion to the cause and sequelae list, updated systematic reviews, use of detailed injury codes, improvements to the Bayesian meta-regression method (DisMod-MR), and use of severity splits for various causes. An index of data representativeness, showing data availability, was calculated for each cause and impairment during three periods globally and at the country level for 2013. In total, 35 620 distinct sources of data were used and documented to calculated estimates for 301 diseases and injuries and 2337 sequelae. The comorbidity simulation provides estimates for the number of sequelae, concurrently, by individuals by country, year, age, and sex. Disability weights were updated with the addition of new population-based survey data from four countries.
   Findings Disease and injury were highly prevalent; only a small fraction of individuals had no sequelae. Comorbidity rose substantially with age and in absolute terms from 1990 to 2013. Incidence of acute sequelae were predominantly infectious diseases and short-term injuries, with over 2 billion cases of upper respiratory infections and diarrhoeal disease episodes in 2013, with the notable exception of tooth pain due to permanent caries with more than 200 million incident cases in 2013. Conversely, leading chronic sequelae were largely attributable to non-communicable diseases, with prevalence estimates for asymptomatic permanent caries and tension-type headache of 2.4 billion and 1.6 billion, respectively. The distribution of the number of sequelae in populations varied widely across regions, with an expected relation between age and disease prevalence. YLDs for both sexes increased from 537.6 million in 1990 to 764.8 million in 2013 due to population growth and ageing, whereas the age-standardised rate decreased little from 114.87 per 1000 people to 110.31 per 1000 people between 1990 and 2013. Leading causes of YLDs included low back pain and major depressive disorder among the top ten causes of YLDs in every country. YLD rates per person, by major cause groups, indicated the main drivers of increases were due to musculoskeletal, mental, and substance use disorders, neurological disorders, and chronic respiratory diseases; however HIV/AIDS was a notable driver of increasing YLDs in sub-Saharan Africa. Also, the proportion of disability-adjusted life years due to YLDs increased globally from 21.1% in 1990 to 31.2% in 2013.
   Interpretation Ageing of the world's population is leading to a substantial increase in the numbers of individuals with sequelae of diseases and injuries. Rates of YLDs are declining much more slowly than mortality rates. The non-fatal dimensions of disease and injury will require more and more attention from health systems. The transition to non-fatal outcomes as the dominant source of burden of disease is occurring rapidly outside of sub-Saharan Africa. Our results can guide future health initiatives through examination of epidemiological trends and a better understanding of variation across countries.
C1 [Vos, Theo; Barber, Ryan M.; Bell, Brad; Bertozzi-Villa, Amelia; Biryukov, Stan; Bolliger, Ian; Dicker, Daniel; Fitzmaurice, Christina; Fleming, Thomas; Graetz, Nicholas; Haagsma, Juanita; Hansen, Gillian M.; Hanson, Sarah Wulf; Heuton, Kyle R.; Higashi, Hideki; Kyu, Hmwe; Laurie, Evan; Lofgren, Katherine; Lozano, Rafael; MacIntyre, Michael F.; Moradi-Lakeh, Maziar; Naghavi, Mohsen; Nguyen, Grant; Odell, Shaun; Ortblad, Katrina; Roberts, David Allen; Roth, Gregory A.; Sandar, Logan; Serina, Peter T.; Stanaway, Jeffrey D.; Steiner, Caitlyn; Thomas, Bernadette; Vollset, Stein Emil; Wolock, Timothy M.; Achoki, Tom; Apfel, Henry; Atkinson, Charles; Bienhoff, Kelly; Blore, Jed D.; Brown, Jonathan; Coggeshall, Megan; Cohen, Aaron; Cooperrider, Kimberly; Dandona, Lalit; Dansereau, Emily; Duber, Herbert; Estep, Kara; Flaxman, Abraham; Foreman, Kyle J.; Hamavid, Hannah; Iannarone, Marissa; Joseph, Jonathan; Lim, Stephen; Lind, Margaret; Ohno, Summer Lockett; Lopez, Alan D.; Margono, Chris; McLain, Abby; Mokdad, Ali H.; Moyer, Madeline; Naghavi, Paria; Phillips, David; Phillips, Bryan; Richardson, Lee; Robinson, Margot; Shackelford, Katya; Singh, Lavanya; Speyer, Peter; Stewart, Andrea; Stork, Eden; Thomas, Elissa; Wong, Haidong; Wurtz, Brittany; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Ellenbogen, Richard G.] Harborview Hosp, Seattle, WA USA.
   [Ellenbogen, Richard G.] Childrens Hosp, Dept Med, Seattle, WA USA.
   [Kassebaum, Nicholas] Childrens Hosp, Seattle, WA USA.
   [Katz, Ronit] Kidney Res Inst, Seattle, WA USA.
   [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Futran, Neal D.; Jensen, Paul N.; Mock, Charles N.; Montine, Thomas J.; Pellegrini, Carlos A.; Quistberg, D. A.; Riederer, Anne M.; Vavilala, Monica S.; Zunt, Joseph R.] Univ Washington, Sch Med, Seattle, WA USA.
   [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.
   [Scott, James G.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.
   [Charlson, Fiona; Erskine, Holly; Ferrari, Alize J.; Whiteford, Harvey; Gouda, Hebe N.; Knibbs, Luke; McGrath, John J.; Norman, Rosana E.; Veerman, Lennert J.] Publ Hlth England, London, England.
   [Boufous, Soufiane] Univ New S Wales, Transport & Rd Safety TARS Res, Sydney, NSW, Australia.
   [Degenhardt, Louisa; Mitchell, Philip B.; Satpathy, Maheswar] Univ New S Wales, Sydney, NSW, Australia.
   [Duan, Leilei; Liang, Xiofeng; Ye, Pengpeng; Zhou, Maigeng; Li, Yichong; Liu, Shiwei; Ma, Jixiang; Wang, Linhong] Chinese Ctr Dis Control, Natl Centers Chron & Noncommunible Dis Control &, Beijing, Peoples R China.
   [Feigin, Valery L.; Balalla, Shivanthi] Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.
   [Krishnamurthi, Rita V.; Ao, Braden J. Te; Theadom, Alice M.] Auckland Univ Technol, Auckland, New Zealand.
   [Guinovart, Caterina] PATH, Seattle, WA USA.
   [Lozano, Rafael; Avila, Marco A.; Aburto, Tania C.; Barquera, Simon; Nonato, Ismael R. Campos; Campuzano, Julio C.; Contreras, Alejandra G.; Cuevas-Nasu, Lucia; Dantes, Hector G.; De la Cruz-Gongora, Vanessa; Garcia-Guerra, Francisco A.; de Cosio, Teresita Gonzalez; Pi, Ileana B. Heredia; Lopez-Olmedo, Nancy; Mejia-Rodriguez, Fabiola; Pedraza, Lilia S.; Servan-Mori, Edson E.; Levy, Teresa Shamah; Villalpando, Salvador] Natl Inst Publ Hlth, Mexico City, DF, Mexico.
   [Aasvang, Gunn Marit; Kinge, Jonas M.; Knudsen, Ann Kristin; Skirbekk, Vegard] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Abbafati, Cristiana] Univ Roma La Sapienza, I-00185 Rome, Italy.
   [Ozgoren, Ayse Abbasoglu] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey.
   [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt.
   [Aziz, Muna I. Abdel] Inst Publ Hlth, Khartoum, Sudan.
   [Abera, Semaw F.; Melaku, Yohannes A.] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia.
   [Aboyans, Victor] Dupuytren Univ Hosp, Limoges, France.
   [Abraham, Biju] Oslo & Akershus Univ Coll Appl Sci HiOA, Oslo, Norway.
   [Abraham, Jerry P.] Univ Texas Sch Med, San Antonio, TX USA.
   [Benzian, Habib] UCL, Dept Epidemiol & Publ Hlth, London, England.
   [Abubakar, Ibrahim] UCL, London, England.
   [Abu-Raddad, Laith J.] Weill Cornell Med Coll Qatar, Doha, Qatar.
   [Abu-Rmeileh, Niveen M. E.] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel.
   [Chiang, Peggy P.] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia.
   [Colquhoun, Samantha M.] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia.
   [Taylor, Hugh R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.
   [Ackerman, Ilana N.; Ademi, Zanfina; Bohensky, Megan A.; Brooks, Peter M.; Lopez, Alan D.; Meretoja, Atte; Weintraub, Robert G.] Univ Melbourne, Melbourne, Vic, Australia.
   [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogbo, Nigeria.
   [Adou, Arsene K.] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire.
   [Adsuar, Josef C.] Univ Extremadura, Caceres, Spain.
   [Agardh, Emilie E.] Inst Publ Hlth Sci, Stockholm, Sweden.
   [Al Khabouri, Mazin J.; Alasfoor, Deena] Minist Hlth, Muskat, Oman.
   [Alam, Sayed Saidul; Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.
   [Alegretti, Miguel A.] Univ Republica, Fac Med, Dept Med Prevent & Social, Montevideo, Uruguay.
   [Aleman, Alicia V.] Univ Republica, Sch Med, Montevideo, Uruguay.
   [Colistro, Valentina] Univ Republica, Dept Med, Montevideo, Uruguay.
   [Alemu, Zewdie A.] Debre Markos Univ, Debre Markos, Amhara, Ethiopia.
   [Alhabib, Samia] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   [Ali, Raghib; Bennett, Derrick A.; Briggs, Adam D. M.; Hay, Simon; Piel, Frederic B.; Rahimi, Kazem; Scarborough, Peter] Univ Oxford, Oxford, England.
   [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France.
   [Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.
   [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.
   [Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden.
   [Allen, Peter J.] Minist Hlth, Belmopan, Belize.
   [AlMazroa, Mohammad AbdulAziz] Saudi Minist Hlth, Riyadh, Saudi Arabia.
   [Alsharif, Ubai; Endres, Matthias; Nolte, Sandra; Papachristou, Christina] Charite, D-13353 Berlin, Germany.
   [Alvarez, Elena] Govt Spain, Madrid, Spain.
   [Alvis-Guzman, Nelson; Caicedo, Angel J. Paternina] Univ Cartagena, Cartagena De Indias, Colombia.
   [Sreeramareddy, Chandrashekhar T.] Univ Groningen, Univ Med Ctr Groningen, Coll Med & Hlth Sci, Dept Epidemiol, Groningen, Netherlands.
   [Yenesew, Muluken A.] Bahir Dar Univ, Bahir Dar, Ethiopia.
   [Ameli, Omid; Felson, David T.] Boston Univ, Boston, MA 02215 USA.
   [Amini, Heresh] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Kurdistan, Iran.
   [Amini, Heresh; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Amini, Heresh] Univ Basel, Basel, Switzerland.
   [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon.
   [Anderson, H. Ross; Marcenes, Wagner] Univ London, London, England.
   [Antonio, Carl Abelardo T.; Panelo, Carlo Irwin A.] Univ Philippines, Coll Publ Hlth, Manila, Philippines.
   [Anwari, Palwasha] United Nations Populat Fund, Kabul, Afghanistan.
   [Arnlov, Johan; Larsson, Anders] Uppsala Univ, Uppsala, Norway.
   [Arsenijevic, Valentain S. Arsic] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia.
   [Artaman, Al] Evidera Inc, Lexington, KY USA.
   [Asghar, Rana J.] South Asian Publ Hlth Forum, Islamabad, Pakistan.
   [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran.
   [Atkins, Lydia S.] Minist Hlth, Wellness Human Serv & Gender Relat, St Lucia, Qld, Australia.
   [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada.
   [Bahit, Maria C.] INECO Neurociencias, Rosario, Santa Fe, Argentina.
   [Bakfalouni, Talal] Minist Hlth, Damascus, Syria.
   [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India.
   [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England.
   [Barker-Collo, Suzanne L.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand.
   [del Pozo-Cruz, Borja] Univ Auckland, Auckland 1, New Zealand.
   [Barregard, Lars] Univ Gothenburg, Dept Occupat & Environm Hlth, Gothenburg, Sweden.
   [Petzold, Max] Univ Gothenburg, Hlth Metr Sahlgrenska Acad, Gothenburg, Sweden.
   [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia.
   [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Christchurch 1, New Zealand.
   [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA.
   [Beardsley, Justin] Univ Oxford, Ho Hi Minh City, Vietnam.
   [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia.
   [Beghi, Ettore; Remuzzi, Giuseppe] Mario Negri, Milan, Italy.
   [Ronfani, Luca] Burlo Garofolo, Trieste, Italy.
   IRCCS Ist Ric Farmacol, Milan, Italy.
   [Bekele, Tolesa; Cortinovis, Monica; Giussani, Giorgia; Monasta, Lorenzo; Montico, Marcella; Perico, Norberto; Trillini, Matias] Madawalabu Univ, Bale Robe, Ethiopia.
   [Bell, Brad; Huang, John J.] Yale Univ, New Haven, CT USA.
   [Benjet, Corina; Borges, Guilherme; Gutierrez, Reyna A.] Natl Inst Psychiat Ramon Fuente Muniz, Mexico City, DF, Mexico.
   [Bensenor, Isabela M.] Univ Sao Paulo, Univ Hosp, Sao Paulo, Brazil.
   [Kemp, Andrew H.; Lotufo, Paulo A.; Polanczyk, Guilherme V.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Bernabe, Eduardo; Wolfe, Charles D. A.] Kings Coll London, London WC2R 2LS, England.
   [Beyene, Tariku J.; Deribe, Kebede] Univ Addis Ababa, Addis Ababa, Ethiopia.
   [Bhalla, Ashish] Wellington Hosp, Wellington, New Zealand.
   [Bhalla, Ashish] Postgrad Inst Med Educ & Res, Chandigarh, UT, India.
   [Bhutta, Zulfi Qar] Aga Khan Univ, Med Ctr, Karachi, Pakistan.
   [Nisar, Muhammad I.] Aga Khan Univ, Karachi, Pakistan.
   [Bikbov, Boris] I Evdokimov Moscow State Univ Med & Dent, Moscow, Russia.
   [Bin Abdulhak, Aref] Univ Missouri, Kansas City, KS USA.
   [Driscoll, Tim R.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.
   [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.
   [Uzun, Selen B.] Minist Hlth, Ankara, Turkey.
   [Basara, Berrak Bora] Gen Directorate Hlth Res, Ankara, Turkey.
   [Bornstein, Natan M.] Tel Aviv Saurasky Med Ctr, Tel Aviv, Israel.
   [Bose, Dipan] World Bank, Washington, DC 20433 USA.
   [Bourne, Rupert R.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England.
   [Boyers, Lindsay N.] Georgetown Univ, Sch Med, Washington, DC USA.
   [Wallin, Mitchell T.] Georgetown Univ, Dept Neurol, Washington, DC USA.
   [Brainin, Michael] Danube Univ Krems, Krems An Der Donau, Austria.
   [Brauer, Michael; Gotay, Carolyn C.; Pourmalek, Farshad] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   [Brayne, Carol E. G.] Cambridge Inst Publ Hlth, Cambridge, England.
   [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Trnava, Slovakia.
   [Breitborde, Nicholas J. K.] Univ Arizona, Tucson, AZ USA.
   [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
   [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany.
   [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England.
   [Buchbinder, Rachelle] Monash Univ, Melbourne, Vic 3004, Australia.
   [Buchbinder, Rachelle] Cabrini Inst, Melbourne, Vic, Australia.
   [Buckle, Geoffrey C.; Gona, Philimon] Univ Massachusetts, Sch Med, Worcester, MA USA.
   [Bukhman, Gene] Harvard Univ, Sch Med, Cambridge, MA 02138 USA.
   [Ding, Eric L.; Fahimi, Saman; Shangguan, Siyi] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA.
   [Shrime, Mark G.; Salomon, Joshua A.] Harvard Univ, Cambridge, MA 02138 USA.
   [Bulloch, Andrew G.; Patten, Scott B.; Wang, JianLi] Univ Calgary, Calgary, AB, Canada.
   [Burch, Michael; Burnett, Richard] Great Ormond St Hosp Sick Children, London WC1N 3JH, England.
   [Cabral, Norberto L.] Univ Joinville, Joinville, Brazil.
   [Carapetis, Jonathan R.] Telethon Inst Child Hlth Res, Perth, Australia.
   [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico.
   [Carpenter, David O.] SUNY Albany, Albany, NY 12222 USA.
   [Caso, Valeria] Univ Perugia, Stroke Unit, I-06100 Perugia, Italy.
   [Castaneda-Orjuela, Carlos A.] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia.
   [Catala-Lopez, Ferran] Minist Hlth, Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain.
   [Chadha, Vineet K.] Natl TB Inst, Bangalore, Karnataka, India.
   [Lin, Hsien-Ho] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.
   [Chang, Jung-Chen] Natl Taiwan Univ, Taipei 10764, Taiwan.
   [Chen, Wanqing] Chinese Acad Med Sci, Inst Canc, Beijing 100021, Peoples R China.
   [Chen, Honglei] NIEHS, Div Intramural Res, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA.
   [Jiang, Ying; Takahashi, Ken] Univ Occupat & Environm Hlth, Dept Hlth Dev, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan.
   [Chimed-Ochir, Odgerel; Jiang, Ying; Takahashi, Ken] Univ Occupat & Environm Hlth, Dept Environm, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan.
   [Chowdhury, Rajiv; Murray, Joseph] Univ Cambridge, Cambridge, England.
   [Christensen, Hanne] Bispebjerg Hosp, Copenhagen, Denmark.
   [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus.
   [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
   [Cirillo, Massimo] Univ Salerno, I-84100 Salerno, Italy.
   [Cohen, Aaron] Hlth Eff ects Inst, Boston, MA USA.
   [Cooper, Leslie T.; Tleyjeh, Imad M.] Mayo Clin, Rochester, MN USA.
   [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
   [Coresh, Josef; Tran, Bach X.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Jassal, Simerjot K.] VA San Diego, San Diego, CA USA.
   [Stein, Murray B.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Crump, John A.] Univ Otago, Dunedin Sch Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Poulton, Richie G.] Univ Otago, Dunedin, New Zealand.
   [Goenka, Shifalika] Indian Inst Publ Hlth, Delhi, India.
   [Dandona, Rakhi; Kumar, G. Anil; Murthy, Kinnari S.] Publ Hlth Fdn India, Delhi, India.
   [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England.
   [Davey, Gail] Brighton & Sussex Med Sch, Brighton, E Sussex, England.
   [Davitoiu, Dragos V.] Univ Med & Pharm Bucharest, Bucharest, Romania.
   [Dayama, Anand] Jacobi Med Ctr, Dept Surg, New York, NY USA.
   [de la Vega, Shelley F.] Natl Inst Hlth, Inst Aging, Manila, Philippines.
   [Lam, Hilton] Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines.
   [De Leo, Diego] Griffith Univ, Nathan, Qld 4111, Australia.
   [Dellavalle, Robert P.] Eastern Colorado Healthcare Syst, Dept Vet Aff, Denver, CO USA.
   [Derrett, Sarah] Massey Univ, Palmerston North, New Zealand.
   [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA.
   [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia.
   [de Veber, Gabrielle A.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.
   [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka.
   [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain.
   [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria.
   [Dorsey, E. R.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA.
   [Hoffman, Howard J.] NIDCD, Bethesda, MD USA.
   [Durrani, Adnan M.] NIH, Bethesda, MD 20892 USA.
   [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia.
   [Edmond, Karen M.] Univ Western Australia, Crawley, WA, Australia.
   [Ermakov, Sergey P.] Russian Acad Sci, Inst Social & Econ Studies Populat, Chernogolovka 142432, Russia.
   [Eshrati, Babak] Arak Univ Med Sci & Hlth Aff airs, Arak, Markazi, Iran.
   [Esteghamati, Alireza; Farzadfar, Farshad; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Endocrine & Metab Res Inst, Noncommun Dis Res Ctr, Tehran, Iran.
   [Malekzadeh, Reza; Sepanlou, Sadaf G.] Digest Dis Res Ctr, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Sahraian, Mohammad Ali] MS Res Ctr, Tehran, Iran.
   [Heydarpour, Pouria] Univ Tehran Med Sci, Tehran, Iran.
   [Fernandes, Jefferson G.] German Hosp Oswaldo Cruz, Inst Educ & Sci, Sao Paulo, Brazil.
   [Ferri, Cluesa P.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Foigt, Nataliya] Ukraine Acad Med Sci, Inst Gerontol, UA-252655 Kiev, Ukraine.
   [Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland.
   [Franklin, Richard C.] James Cook Univ, Townsville, Qld 4811, Australia.
   [Furst, Thomas] Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London, England.
   [Furst, Thomas] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.
   [Rodriguez, Alina; Soljak, Michael] Univ London Imperial Coll Sci Technol & Med, London, England.
   [Lloyd, Belinda K.] Monash Univ, Eastern Hlth Clin Sch, Malvern East, Vic, Australia.
   [Gabbe, Belinda J.; Gibney, Katherine B.; Thrift, Amanda G.] Monash Univ, Malvern East, Vic, Australia.
   [Gankpe, Fortune G.] Clin Cooperat Parakou, Parakou, Borgou, Benin.
   [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.
   [Gessner, Bradford D.] Agence Med Prevent, Paris, France.
   [Gillum, Richard F.] Howard Univ, Washington, DC 20059 USA.
   [Ginawi, Ibrahim A.] Univ Hail, Coll Med, Hail, Saudi Arabia.
   [Giroud, Maurice] Univ Hosp Dijon, Dijon, France.
   [Goginashvili, Ketevan] Minist Labour Hlth & Social Aff airs, Tbilisi, Rep of Georgia.
   [Gosselin, Richard A.; Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Goto, Atsushi] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan.
   [Guerrant, Richard L.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA.
   [Gugnani, Harish C.] St James Sch Med, Willemstad, Neth Antilles.
   [Gunnell, David; Looker, Katharine J.] Univ Bristol, Bristol, Avon, England.
   [Gupta, Rahul] Fortis Escorts Hosp, Delhi, India.
   [Gupta, Rajeev] Kanawha Charleston Hlth Dept, Charleston, WV USA.
   [Hagan, Holly; Trasande, Leonardo] NYU, Sch Med, New York, NY USA.
   [Halasa, Yara; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA.
   [Hamadeh, Randah R.] Arabian Gulf Univ, Manama, Bahrain.
   [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Wayne, MI USA.
   [Zhao, Yong] Sun Yae Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Haro, Josep Maria] Univ Barcelona, CIBERSAM, Parc Sanitari St Joan de Deu, Barcelona, Spain.
   [Hay, Roderick J.] Int Fdn Dermatol, London, England.
   [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran.
   [Hijar, Martha] Fdn Entornos AC, Cuernavaca, Morelos, Mexico.
   [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands.
   [Hornberger, John C.] Cedar Associates, Menlo Pk, CA USA.
   [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA.
   [Hossain, Mazeda; Larson, Heidi; McKee, Martin; Pearce, Neil; Stoeckl, Heidi] London Sch Hyg & Trop Med, London WC1, England.
   [Hotez, Peter J.] Baylor Coll Med, Waco, TX USA.
   [Hsairi, Mohamed] Minist Hlth, Natl Inst Publ Hlth, Tunis, Tunisia.
   [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia.
   [Hu, Guoqing] Cent S Univ, Changsha, Hunan, Peoples R China.
   [Hu, Howard] Univ Toronto, Toronto, ON, Canada.
   [Huiart, Laetitia] George Washington Univ, Washington, DC USA.
   [Huiart, Laetitia] Ctr Hosp Univ La Reunion, Stanford, CA USA.
   [Husseini, Abdullatif] Qatar Univ, Publ Hlth Program, Doha, Qatar.
   [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark.
   [Innos, Kaire] Natl Inst Hlth Dev, Tallinn, Estonia.
   [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan.
   [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan.
   [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA.
   [Jeemon, Panniyammakal; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India.
   [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh 160012, India.
   [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China.
   [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany.
   [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark.
   [She, Jun] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China.
   [Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China.
   [Karch, Andre] Holtz Ctr Infect Res, Braunschweig, Germany.
   [Karch, Andre] German Ctr Infect Res DZIF, Hannover, Germany.
   [Karimkhani, Chante] Columbia Univ, Coll Phys & Surg, New York, NY USA.
   [Moran, Andrew E.] Columbia Univ, New York, NY USA.
   [Karthikeyan, Ganesan; Paul, Vinod K.; Tandon, Nikhil] All India Inst Med Sci, New Delhi, India.
   [Kaul, Anil] Oklahoma State Univ, Stillwater, OK 74078 USA.
   [Kengne, Andre P.] South African Med Res Council, Cape Town, South Africa.
   [Khader, Yousef S.] Jordan Univ Sci & Technol, Irbid, Jordan.
   [Khalifa, Shams Eldin A. H.] Supreme Council Hlth, Doha, Qatar.
   [Khan, Ejaz A.] Hlth Serv Acad, Islamabad, Punjab, Pakistan.
   [Khan, Gulfaraz] UAE Univ, Abu Dhabi, U Arab Emirates.
   [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea.
   [Khonelidze, Irma; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Rep of Georgia.
   [Kieling, Christian] Univ Fed Rio Grande do Sul, Curitiba, Parana, Brazil.
   [Kim, Daniel] Northeastern Univ, Boston, MA 02115 USA.
   [Kim, Sungroul] Soonchunhyang Univ, Asan, South Korea.
   [Kimokoti, Ruth W.] Simmons Coll, Boston, MA 02115 USA.
   [Kinfu, Yohannes] Univ Canberra, Canberra, ACT 2601, Australia.
   [Kissela, Brett M.] Univ Cincinnati, Cincinnati, OH USA.
   [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan.
   [Kosen, Soewarta] MoH Indonesia, NIHRD, Ctr Community Empowerment Hlth Policy & Human, Jakarta, Indonesia.
   [Warouw, Tati S.] MoH Indonesia, NIHRD, Jakarta, Indonesia.
   [Kramer, Alexander] Univ Bielefeld, Sch Publ Hlth, D-33615 Bielefeld, Germany.
   [Plass, Dietrich] Univ Bielefeld, Dept Publ Hlth Med, D-33615 Bielefeld, Germany.
   [Kravchenko, Michael] Res Ctr Neurol, Moscow, Russia.
   [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada.
   [Bicer, Burcu Kucuk] Hacettepe Univ, Ankara, Turkey.
   [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Kuipers, Ernst J.; Richardus, Jan Hendrik] Erasmus MC, Univ Med Ctr, Rotterdam, Netherlands.
   [Kulkarni, Veena S.] Arkansas State Univ, Jonesboro, AR USA.
   [Kumar, Kaushalendra] Int Inst Populat Sci, Mimbai, India.
   [Kwan, Gene F.] Boston Med Ctr, Boston, MA USA.
   [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia.
   [Lalloo, Ratilal] Univ Adelaide, Sch Dent, ARCPOH, Gold Coast, Qld, Australia.
   [Lan, Qing] NCI, Rockville, MD USA.
   [Lansingh, Van C.] IAPB & Vis 2020 LA, Weston, FL USA.
   [Lawrynowicz, Alicia E. B.] Inst Nacl Epidemiol Dr Juan H Jara, Buenos Aires, DF, Argentina.
   [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA.
   [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea.
   [Leung, Ricky] SUNY Albany, Albany, NY 12222 USA.
   [Levi, Miriam] Tuscany Reg Ctr Occupat Injuries & Dis, Florence, Italy.
   [Li, Yichong] Genentech Inc, San Francisco, CA 94080 USA.
   [Zhang, Yong] Jinan Cent Hosp, Dept Gerontol, Jinan, Shandong, Peoples R China.
   [Liang, Juan] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China.
   [Lindsay, M. Patrice] Heart & Stroke Fdn Canada, Ottawa, ON, Canada.
   [Lipshultz, Steven E.] Wayne State Univ, Detroit, MI USA.
   [Lloyd, Belinda K.] Eastern Hlth, Turning Point Alcohol & Drug Ctr, Fitzroy, Vic, Australia.
   [Logroscino, Giancarlo] Univ Bari, Bari, Italy.
   [Lortet-Tieulent, Joannie] Amer Canc Soc, Atlanta, GA 30329 USA.
   [Low, Nicola] Univ Bern, CH-3012 Bern, Switzerland.
   [Lucas, Robyn M.] Australian Natl Univ, Canberra, ACT, Australia.
   [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England.
   [Lyons, Ronan A.] Swansea Univ, Swansea, W Glam, Wales.
   [Ma, Stefan; Zhao, Zheng] Minist Hlth Singapore, Singapore, Singapore.
   [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Mackay, Mark T.] Royal Childrens Hosp Melbourne, Melbourne, Vic, Australia.
   [Mapoma, Christopher C.] Univ Zambia, Lusaka, Zambia.
   [Marzan, Melvin B.] Univ East Ramon Magsaysay Med Ctr, Quezon City, Philippines.
   [Masci, Joseph R.] Elmhurst Hosp Ctr, Mt Sinai Serv, Elmhurst, NY USA.
   [Mason-Jones, Amanda J.] Univ York, York YO10 5DD, N Yorkshire, England.
   [Matzopoulos, Richard G.; Parry, Charles D.] MRC, Cape Town, Western Cape, South Africa.
   [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa.
   [Mayosi, Bongani M.; Stein, Dan J.] Univ Cape Town, ZA-7925 Cape Town, South Africa.
   [Mazorodze, Tasara T.] AIDC EC, Port Elizabeth, Eastern Cape, South Africa.
   [McGill, Neil W.] Royal Prince Alfred Hosp, Sydney, NSW, Australia.
   [McMahon, Brian J.] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA.
   [Meaney, Peter A.] Univ Penn, Pereleman Sch Med, Philadelphia, PA 19104 USA.
   [Silberberg, Donald H.] Univ Penn, Philadelphia, PA 19104 USA.
   [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, Delhi, India.
   [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA.
   [Mensah, George] NIH, Bethesda, MD 20892 USA.
   [Mhimbira, Francis A.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Micha, Renata; Mozaffarian, Dariush] Friedman Sch Nutr Sci & Policy, Medford, MA USA.
   [Shi, Peilin] Tufts Univ, Medford, MA 02155 USA.
   [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA.
   [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia.
   [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada.
   [Moffitt, Terrie E.] Duke Univ, Durham, NC USA.
   [Ibrahim, Norlinah Mohamed] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Kuala Lumpur, Malaysia.
   [Mohammad, Karzan A.] Univ Salahaddin, Erbil, Iraq.
   [Mola, Glen L.] Univ Papua New Guinea, Port Moresby, Papua N Guinea.
   [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA.
   [Morawska, Lidia] Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld 4001, Australia.
   [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan.
   [Moschandreas, Joanna; Tsilimbaris, Miltiadis] Univ Crete, Dept Med, Iraklion, Greece.
   [Moturi, Wilkister N.] Egerton Univ, Egerton, Rift Valley, Kenya.
   [Mueller, Ulrich O.] Univ Marburg, Marburg, Germany.
   [Mukaigawara, Mitsuru] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan.
   [Murdoch, Michele E.] West Hertfordshire Hosp NHS Trust, Hempstead, Herts, England.
   [Nahas, Ziad] Amer Univ Beirut, Med Ctr, Beirut, Lebanon.
   [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa.
   [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy.
   [Nand, Devina] Minist Hlth Fiji, Suva, Fiji.
   [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India.
   [Simard, Edgar P.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Narayan, K. M. Venkat; Omer, Saad B.; Phillips, Michael R.] Emory Univ, Atlanta, GA 30322 USA.
   [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA.
   [Nejjari, Chakib] Fac Med, Fes, Morocco.
   [Neupane, Sudan P.] Univ Oslo, Norwegian Ctr Addict Res SERAF, Oslo, Norway.
   [Rakovac, Ivo] WHO Reg Off Europe, Copenhagen, Denmark.
   [Newman, Lori M.] WHO, CH-1211 Geneva, Switzerland.
   [Newton, Charles R.] KEMRI Wellcome Trust, Kilifi, Kenya.
   [Ngalesoni, Frida N.] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania.
   [Nhung, Nguyen T.] Hanoi Sch Publ Hlth, Hanoi, Vietnam.
   [Norheim, Ole F.] Univ Bergen, Bergen, Norway.
   [Norrving, Bo] Lund Univ, Fac Med, Dept Clin Sci, Lund, Sweden.
   [Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda.
   [Oh, In Hwan] Kyung Hee Univ, Seoul, South Korea.
   [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Itabashi Ku, Tokyo 173, Japan.
   [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Northern Uganda, Uganda.
   [Ortiz, Alberto] Fdn Jimenez Diaz, IIS, E-28040 Madrid, Spain.
   [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India.
   [Park, Eun-Kee] Kosin Univ, Coll Med, Busan, South Korea.
   [Pereira, David M.] Univ Porto, Fac Farm, REQUIMTE Lab Farmacognosia, Dept Quam, P-4100 Oporto, Portugal.
   [Perez-Ruiz, Fernando P.] Hosp Univ Cruces, Baracaldo, Bizkaia, Spain.
   [Perez-Ruiz, Fernando P.] Biocruces Hlth Res Inst, Baracaldo, Bizkaia, Spain.
   [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Pakistan.
   [Pesudovs, Konrad] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia.
   [Peterson, Carrie B.] Aalborg Univ, Aalborg, Denmark.
   [Petzold, Max] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.
   [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China.
   [Poenaru, Dan] McMaster Univ, Hamilton, ON, Canada.
   [Pope, C. A., III] Brigham Young Univ, Provo, UT 84602 USA.
   [Popova, Svetlana; Rehm, Jurgen] Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Prasad, Noela M.] Fred Hollows Fdn, Sydney, NSW, Australia.
   [Qato, Dima] Univ Illinois, Coll Pharm, Chicago, IL USA.
   [Rafay, Anwar] Contech Int, Lahore, Pakistan.
   [Rahman, Sajjad Ur] Hamad Med Corp, Doha, Qatar.
   [Raju, Murugesan] Univ Missouri, Columbia, MO USA.
   [Rana, Saleem M.] Univ Punjab, Dept Publ Hlth, Lahore, Pakistan.
   [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA.
   [Refaat, Amany] Walden Univ, Minneapolis, MN USA.
   [Resnikoff, Serge] Int Hlth & Dev, Zurich, Switzerland.
   [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Escola Enfermagem, Belo Horizonte, MG, Brazil.
   [Riccio, Patricia M.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada.
   [Roca, Anna] MRC Unit, Fajara, Gambia.
   [Rojas-Rueda, David] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.
   [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.
   [Roy, Nobhojit] BARC Hosp, Mumbai, Maharashtra, India.
   [Ruhago, George M.; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.
   [Sabin, Nsanzimana] Rwanda Biomed Ctr, Kigali, Rwanda.
   [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Saha, Sukanta] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia.
   [Sahathevan, Ramesh] Univ Kebangsaan Malaysia, Med Ctr, Bangi 43600, Selangor, Malaysia.
   [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN 37235 USA.
   [Sanabria, Juan R.] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Sanchez-Riera, Lidia] Mafraq Hosp SEHA, Abu Dhabi, U Arab Emirates.
   [Saunders, James E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA.
   [Sawhney, Monika] Marshall Univ, Huntington, WV USA.
   [Saylan, Mete I.] Novartis, Istanbul, Turkey.
   [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA.
   [Seedat, Soraya] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa.
   [Serdar, Berrin] Univ Colorado, Boulder, CO 80309 USA.
   [Shaheen, Amira] An Najah Univ, Nablus, Israel.
   [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan.
   [Shinohara, Yukito] Tachikawa Hosp, Tokyo, Japan.
   [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland.
   [Shishani, Kawkab] Washington State Univ, Pullman, WA 99164 USA.
   [Shiue, Ivy] Heriot Watt Univ, Edinburgh, Midlothian, Scotland.
   [Sigfusdottir, Inga D.] Reykjavik Univ, Reykjavik, Iceland.
   [Soneji, Samir] Dartmouth Coll, Hanover, NH USA.
   [Ksoreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway.
   [Soshnikov, Sergey S.] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia.
   [Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada.
   [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Selangor, Malaysia.
   [Stathopoulou, Vasiliki Kalliopi] Ctr Hosp Nord Deux Sevres, Bressuire, France.
   [Steckling, Nadine] Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.
   [Stovner, Lars J.] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway.
   [Steiner, Timothy J.] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway.
   [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, KEELPNO, Ctr Dis Control, Athens, Greece.
   [Swaroop, Mamta] Northwestern Univ, Evanston, IL USA.
   [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc & Sociol, Irvine, CA USA.
   [Tabb, Karen M.] Univ Illinois, Urbana, IL 61801 USA.
   [Tan, Feng] China CDC, Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China.
   [Tanne, David] Chaim Sheba Med Ctr, Tel Aviv, Israel.
   [Tanne, David] Tel Aviv Univ, IL-69978 Tel Aviv, Israel.
   [Tavakkoli, Mohammad] Westchester Cty Med Ctr, Valhalla, NY 10595 USA.
   [Temesgen, Awoke Misganaw] Jhpiego, Addis Ababa, Ethiopia.
   [Ten Have, Margreet] Netherlands Inst Mental Hlth & Addict, Utrecht, Netherlands.
   [Tenkorang, Eric Yeboah] Mem Univ Newfoundland, St John, NF, Canada.
   [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia.
   [Tleyjeh, Imad M.] King Fahad Med City, Coll Med, Riyadh, Saudi Arabia.
   [Thorne-Lyman, Andrew L.] Saudi Arabial WorldFish, George Town, Malaysia.
   [Tonelli, Marcello] Univ Alberta, Edmonton, AB, Canada.
   [Topouzis, Fotis] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece.
   [Towbin, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.
   [Toyoshima, Hideaki] Anjo Kosei Hosp, Hlth Care Ctr, Anjo City, Aichi, Japan.
   [Traebert, Jefferson] Univ Southern Santa Catarina, Palhoca, SC, Brazil.
   [Truelsen, Thomas] Copenhagen Univ Hosp Herlev, Dept Neurol, Copenhagen, Denmark.
   [Trujillo, Ulises] Serv Canario Salud, Tenerife, Spain.
   [Tuzcu, Emin M.] Cleveland Clin, Cleveland, OH 44106 USA.
   [Ukwaja, Kingsley N.] Fed Teaching Hosp Abakaliki, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria.
   [van Brakel, Wim H.] Netherlands Leprosy Relief, Delft, Netherlands.
   [de Vijver, Steven van] African Populat & Hlth Res Ctr, Nairobi, Kenya.
   [Van Dingenen, Rita] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy.
   [van Gool, Coen H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.
   [Varakin, Yuri Y.] Res Ctr Neurol, Moscow, Russia.
   [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland.
   [Venketasubramanian, Narayanaswamy] Raffles Hosp, Ctr Neurosci, Singapore, Singapore.
   [Vijayakumar, Lakshmi] Voluntary Hlth Serv, Sneha, India.
   [Violante, Francesco S.] Univ Bologna, Bologna, Italy.
   [Vlassov, Vasiliy V.] Higher Sch Econ, Moscow, Russia.
   [Waller, Stephen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Wallin, Mitchell T.] VA Med Ctr, Washington, DC USA.
   [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.
   [Wang, Yanping] Natl Off Maternal & Childs Hlth Surveillance, Chengdu, Peoples R China.
   [Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada.
   [Werdecker, Andrea] Inst Med Sociol & Social Med, Berlin, Germany.
   [Wessells, K. Ryan R.] Univ Calif Davis, Davis, CA 95616 USA.
   [Westerman, Ronny] Univ Marburg, Hessen, Germany.
   [Wilkinson, James D.] Univ Miami, Miami, FL USA.
   [Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, London, England.
   [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England.
   [Woldeyohannes, Solomon M.] Univ Gondar, Inst Publ Hlth, Amhara, Ethiopia.
   [Wong, John Q.] Ateneo Sch Med & Publ Hlth, Manila, Philippines.
   [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, Cornwall, England.
   [Xu, Gelin; Yang, Gonghuan] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.
   [Yano, Yuichiro] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.
   [Yentur, Gokalp K.] Gen Directorate Hlth Res, Ankara, Turkey.
   [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.
   [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan.
   [Younis, Mustafa] Jackson State Univ, Jackson, MS USA.
   [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Hubei, Peoples R China.
   [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Hubei, Peoples R China.
   [Kim, Kim Yun] TCM Med TK SDN BHD TCM, Nusajaya, Johor Bahru, Malaysia.
   [Zaki, Maysaa El Sayed] Mansoura Sch Med, Mansoura, Egypt.
   [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China.
   [Zhu, Jun] Natl Off MCH Surveillance China, Beijing, Peoples R China.
   [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany.
RP Vos, T (reprint author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
EM tvos@uw.edu
RI Franklin, Richard/H-1731-2012; Giussani, Giorgia/E-8057-2017; Ermakov,
   Sergey/G-1709-2016; Pereira, David/M-9286-2013; PACELLA,
   ROSANA/F-2774-2010; Satpathy, Maheswar/J-3135-2017; Brenner,
   Hermann/B-4627-2017; Scott, James/D-5900-2012; eshrati,
   babak/M-1152-2017; Stein, Dan/A-1752-2008; Tonelli,
   Marcello/B-3028-2009; Lalloo, Ratilal/O-5624-2014; Mohammadi,
   Alireza/R-9202-2016; Salomon, Joshua/D-3898-2009; Beyene, Tariku
   Jibat/A-6875-2017; Santos, Itamar/K-7055-2012; Varakin,
   Yuriy/C-8634-2012; Majdan, Marek/K-5017-2012; Alsharif,
   Ubai/C-6527-2017; Amini, Heresh/B-3076-2010; Lotufo, Paulo/A-9843-2008;
   Karch, Andre/D-6973-2017; Monasta, Lorenzo/B-1388-2012; Sepanlou,
   Sadaf/H-9343-2016; Bolliger, Ian/C-4207-2016; LOGROSCINO,
   GIANCARLO/K-5148-2016; wang, YA XING/K-9671-2016; Naldi,
   Luigi/K-6343-2016; Thrift, Amanda/I-6251-2012; Weiderpass,
   Elisabete/M-4029-2016; Dokova, Klara/N-2448-2016; Montico,
   Marcella/B-5290-2013; Kravchenko, Michael/B-2596-2012; Jacobsen,
   Kathryn/B-5857-2008; Nolte, Sandra/B-7498-2008; Haro, Josep
   Maria/D-1423-2011; Degenhardt, Louisa/D-4515-2012; Kaul,
   Anil/B-2075-2016; Patten, Scott/B-4434-2011; Ribeiro,
   Antonio/C-2707-2009; Ronfani, Luca/B-6668-2013; Rakovac,
   Ivo/A-7678-2013; Hankey, Graeme /H-4968-2014; Moffitt,
   Terrie/D-5295-2011; Whiteford, Harvey/A-4840-2009; Ferri,
   Cleusa/B-2922-2010; Rahimi, Kazem/Q-1279-2015; Adsuar, Jose
   C/C-6558-2008; Undurraga, Eduardo/I-3739-2014
OI Franklin, Richard/0000-0003-1864-4552; Ermakov,
   Sergey/0000-0003-1072-1162; Pereira, David/0000-0003-0384-7592; PACELLA,
   ROSANA/0000-0002-9742-1957; Satpathy, Maheswar/0000-0003-3521-4781;
   Brenner, Hermann/0000-0002-6129-1572; Scott, James/0000-0002-0744-0688;
   Rodriguez, Alina/0000-0003-1209-8802; Bikbov, Boris/0000-0002-1925-7506;
   Higashi, Hideki/0000-0002-5534-0905; Vlassov,
   Valentin/0000-0003-2845-2992; Stein, Dan/0000-0001-7218-7810; Tonelli,
   Marcello/0000-0002-0846-3187; Lalloo, Ratilal/0000-0001-5822-1269;
   Mohammadi, Alireza/0000-0002-1004-5339; Salomon,
   Joshua/0000-0003-3929-5515; Beyene, Tariku Jibat/0000-0002-7474-1966;
   Santos, Itamar/0000-0003-3212-8466; Majdan, Marek/0000-0001-8037-742X;
   Alsharif, Ubai/0000-0002-4024-3950; Amini, Heresh/0000-0002-4825-1322;
   Lotufo, Paulo/0000-0002-4856-8450; Karch, Andre/0000-0003-3014-8543;
   Monasta, Lorenzo/0000-0001-7774-548X; Sepanlou,
   Sadaf/0000-0002-3669-5129; Bolliger, Ian/0000-0001-8055-297X;
   LOGROSCINO, GIANCARLO/0000-0003-0423-3242; wang, YA
   XING/0000-0003-2749-7793; Naldi, Luigi/0000-0002-3160-2835; Thrift,
   Amanda/0000-0001-8533-4170; Weiderpass, Elisabete/0000-0003-2237-0128;
   Montico, Marcella/0000-0003-0377-8232; Kravchenko,
   Michael/0000-0001-5187-5518; Jacobsen, Kathryn/0000-0002-4198-6246;
   Nolte, Sandra/0000-0001-6185-9423; Haro, Josep
   Maria/0000-0002-3984-277X; Degenhardt, Louisa/0000-0002-8513-2218;
   Patten, Scott/0000-0001-9871-4041; Ribeiro, Antonio/0000-0002-2740-0042;
   Ronfani, Luca/0000-0001-5710-3914; Rakovac, Ivo/0000-0003-3462-2636;
   Hankey, Graeme /0000-0002-6044-7328; Moffitt,
   Terrie/0000-0002-8589-6760; Whiteford, Harvey/0000-0003-4667-6623;
   Ferri, Cleusa/0000-0002-1815-7685; Rahimi, Kazem/0000-0002-4807-4610;
   Adsuar, Jose C/0000-0001-7203-3168; Buckle,
   Geoffrey/0000-0001-7721-0397; Moradi-Lakeh, Maziar/0000-0001-7381-5305;
   Gabbe, Belinda/0000-0001-7096-7688; Farzadfar,
   Farshad/0000-0001-8288-4046; Tsilimbaris, Miltiadis/0000-0002-0130-1150;
   Catala-Lopez, Ferran/0000-0002-3833-9312; Hoek,
   Hans/0000-0001-6353-5465; Sreeramareddy,
   Chandrashekhar/0000-0002-5693-7631; Ding, Eric/0000-0002-5881-8097;
   Kuate Defo, Barthelemy/0000-0002-6589-0564; Juel,
   Knud/0000-0002-4134-1173; Borges, Guilherme/0000-0002-3269-0507;
   Bernabe, Eduardo/0000-0002-1858-3713; Tabb Dina,
   Karen/0000-0002-4722-9502; Ukwaja, Kingsley N./0000-0002-1974-8735;
   Miller, Ted/0000-0002-0958-2639; Ortiz Arduan,
   Alberto/0000-0002-9805-9523; Khang, Young-Ho/0000-0002-9585-8266; Nisar,
   Muhammad Imran/0000-0002-2378-4720; Newton, Charles/0000-0002-6999-5507;
   Prabhakaran, Dorairaj/0000-0002-3172-834X; Roy MD, PhD,
   Nobhojit/0000-0003-2022-7416; Derrett, Sarah/0000-0003-2867-0498;
   Heydarpour, Pouria/0000-0001-5644-7555; Goenka,
   Shifalika/0000-0001-6993-2883; Hedayati, Mohammad
   T./0000-0001-6415-4648; Gouda, Hebe/0000-0002-5709-4509; Chen,
   Honglei/0000-0003-3446-7779; Perez-Ruiz, Fernando/0000-0002-5268-1894;
   Kissela, Brett/0000-0002-9773-4013; Norheim, Ole F./0000-0002-5748-5956;
   Castaneda-Orjuela, Carlos/0000-0002-8735-6223; Aburto,
   Tania/0000-0002-6932-9344; Kieling, Christian/0000-0001-7691-4149;
   Sindi, Shireen/0000-0002-3786-0552; Husseini,
   Abdullatif/0000-0001-8767-5956; Benjet, Corina/0000-0002-4569-6094;
   Neupane, Sudan Prasad/0000-0002-7389-4178; Deribe,
   Kebede/0000-0002-8526-6996; Taylor, Hugh/0000-0002-9437-784X; Kemp,
   Andrew/0000-0003-1146-3791; Charlson, Fiona/0000-0003-2876-5040;
   Erskine, Holly/0000-0003-3119-9211; Aboyans, Victor/0000-0002-0322-9818;
   Goto, Atsushi/0000-0003-0669-654X; Soshnikov,
   Sergey/0000-0002-6983-7066; assadi, reza/0000-0002-5016-2994; Mitchell,
   Philip/0000-0002-7954-5235; Parry, Charles/0000-0001-9787-2785; Vlassov,
   Vasiliy/0000-0001-5203-549X; Villalpando, Salvador/0000-0001-6429-3816;
   Quistberg, Alex/0000-0001-9730-2686; Giussani,
   Giorgia/0000-0003-2460-3095; Leung, Ricky/0000-0002-2852-6771; Liu,
   Zhi-Hong/0000-0001-6093-0726; Theadom, Alice/0000-0003-0351-6216;
   Mhimbira, Francis/0000-0001-8989-6832; Heredia-Pi, Ileana
   Beatriz/0000-0002-9998-9239; Xu, Gelin/0000-0002-6194-0341; Hu,
   Howard/0000-0002-3676-2707; Gibney, Katherine/0000-0001-5851-5339;
   Naghavi, Paria/0000-0002-8908-7952; Davis, Adrian/0000-0001-7134-7528;
   Banerjee, Amitava/0000-0001-8741-3411; Hotez, Peter/0000-0001-8770-1042;
   Pourmalek, Farshad/0000-0002-2134-0771; Undurraga,
   Eduardo/0000-0002-4425-1253; Balakrishnan, Kalpana/0000-0002-5905-1801
FU Lundbeck and Auckland University of Technology University; Bill &
   Melinda Gates Foundation; Ministry of Health, Labour and Welfare of
   Japan; Australian National health and Medical Research Council (NHMRC)
   [1041742]; Japan Society of Clinical Pharmacology and Therapeutics;
   National Heart Foundation, Australia; Wellcome Trust [091758, 095066,
   089963/Z/09/Z, 099876]; Health Protection Scotland; National Institute
   for Health Research (NIHR) Health Protection Research Unit (HPRU) in
   Evaluation of Interventions, and Sexual Health 24; WHO; University of
   Illinois, Lemann Institute for Brazilian Studies Faculty Research Grant;
   NIHR Oxford BRC; NIHR; CIBERSAM; Instituto de Salud Carlos III; Spanish
   Ministry of Economy and Competitiveness, Madrid, Spain; Qatar National
   Research Fund [NPRP 04-924-3-251]; joint US National Institutes of
   Health-National Science Foundation Ecology and Evolution of Infectious
   Disease program [R01 TW009237]; UK Biotechnology and Biological Sciences
   Research Council (BBSRC) [BB/J010367/1]; UK BBSRC Zoonoses in Emerging
   Livestock Systems awards [BB/L017679, BB/L018926, BB/L018845];
   Queensland Department of Health; VIROPHARMA; EISAI; UCB-Pharma;
   GlaxoSmithKline; Italian Drug Agency; Italian Ministry of Health;
   Sanofi-Aventis; American ALS Association; Wellcome Trust; NIHR
   Biomedical Research Centre at Guy's and St Thomas' National Health
   Service Foundation Trust and King's College London - NIHR; Abbott;
   ABMRF; Astrazeneca; Biocodex; Eli-Lilly; Jazz Pharmaceuticals; Johnson
   Johnson; Lundbeck; National Responsible Gambling Foundation; Novartis;
   Orion; Pfizer; Pharmacia; Roche; Servier; Solvay; Sumitomo; Sun; Takeda;
   Tikvah; Wyeth; Medical Research Council of South Africa; Eunice Kennedy
   Shriver National Institute of Child Health and Human Development of the
   National Institutes of Health [5T32HD057822]; Public Health Foundation
   of India; consortium of UK universities; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo
   a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Farr Institute at
   CIPHER; Arthritis Research UK; British Heart Foundation; Cancer Research
   UK; Economic and Social Research Council; Engineering and Physical
   Sciences Research Council; Medical Research Council; National Institute
   of Health Research; National Institute for Social Care and Health
   Research (Welsh Assembly Government); Chief Scientist Office (Scottish
   Government Health Directorates); MRC [MR/K006525/1]; Savient; Regeneron;
   Allergan; American College of Rheumatology's Guidelines Subcommittee of
   the Quality of Care Committee; Veterans Affairs Rheumatology Field
   Advisory Committee; National Health and Medical Research of Australia;
   NIH, the National Institute of Environmental Health Sciences; Brien
   Holden Vision Institute; Victorian Articles 56 Government; Korean Health
   Technology research and development project, Ministry of Health and
   Welfare, North Korea [HI13C0729]; NIH; Commonwealth Government of
   Australia; Institute of Bone and Joint Research; Crucell; Merck; Sanofi
   Pasteur; NIH [R01 DA 003574]; Oklahoma Center for the Advancement of
   Science and Technology; NIHR Career Development Fellowship; Wellcome
   Trust Training Fellowship [099876]; South African Medical Research
   Council
FX Bill & Melinda Gates Foundation.; This study was funded by the Bill &
   Melinda Gates Foundation. VF and RK were partly supported by the
   unrestricted educational grant from Lundbeck and Auckland University of
   Technology University. RM received funding from Ministry of Health,
   Labour and Welfare of Japan. LD is supported by an Australian National
   health and Medical Research Council (NHMRC) Principal Research
   Fellowship (#1041742). Work by NY was supported by funding from the
   Japan Society of Clinical Pharmacology and Therapeutics. YK would like
   to thank the National Heart Foundation, Australia, for extending a
   special grant to the University of Canberra that enabled him to
   participate in the GBD 2013 study and more broadly engage in research on
   cardiovascular conditions in Australia. TW would like to acknowledge the
   Wellcome Trust, through whom he is supported through a Senior Research
   Fellowship number 091758. During the study, KJL received funding from
   Health Protection Scotland, the National Institute for Health Research
   (NIHR) Health Protection Research Unit (HPRU) in Evaluation of
   Interventions, and Sexual Health 24. KJL received funding from WHO to
   conduct the review of HSV.2 seroprevalence data that informed this
   study. GR's contribution to this paper has been on behalf of the
   International Society of Nephrology (ISN), as a follow-up of the
   activities of the GBD 2010 Genitourinary Diseases Expert Group. KTD
   would like to acknowledge the following funding source of institutional
   support: University of Illinois, Lemann Institute for Brazilian Studies
   Faculty Research Grant. KR is supported by the NIHR Oxford BRC and an
   NIHR Career Development Fellowship. FC-L would like to thank funding
   support by Spanish Ministry of Economy and Competitiveness, Madrid,
   Spain, Instituto de Salud Carlos III, Spanish Ministry of Economy and
   Competitiveness, Madrid, Spain. LJAR would like to acknowledge the
   support of Qatar National Research Fund (NPRP 04-924-3-251) who provided
   the main funding for generating the data provided to the GBD-IHME
   effort. MBS is a member of the board of directors of the Anxiety and
   Depression Association of America (a non-profit professional and
   consumer organization). He has in the past 24 months been a consultant
   for companies that either market or are conducting research involving
   antidepressant or antianxiety medications: Janssen, Pfizer, and Tonix
   Pharmaceuticals. JAC is supported by the joint US National Institutes of
   Health-National Science Foundation Ecology and Evolution of Infectious
   Disease program (R01 TW009237) and the UK Biotechnology and Biological
   Sciences Research Council (BBSRC) (BB/J010367/1), and by UK BBSRC
   Zoonoses in Emerging Livestock Systems awards BB/L017679, BB/L018926,
   and BB/L018845. HW, AF, FC, and HE are affiliated with the Queensland
   Centre for Mental Health Research, which receives funding from the
   Queensland Department of Health. EB has received money for board
   membership by VIROPHARMA and EISAI; funding for travel and speaker
   honoraria from UCB-Pharma and GlaxoSmithKline and funding for
   educational presentations from GlaxoSmithKline; grants for research
   activities from the Italian Drug Agency, Italian Ministry of Health,
   Sanofi-Aventis, and the American ALS Association. ML would like to
   acknowledge the institutional support received from CeRIMP, Centro
   Regionale Infortuni e Malattie Professionali Regione Toscana (via
   S.Salvi, 12 - 50135 Firenze - Italy). AB would like to acknowledge
   funding from the Wellcome Trust.; CW was supported by the NIHR
   Biomedical Research Centre at Guy's and St Thomas' National Health
   Service Foundation Trust and King's College London, funded by the NIHR.
   DS has received research grants or consultancy honoraria from Abbott,
   ABMRF, Astrazeneca, Biocodex, Eli-Lilly, GlaxoSmithKline, Jazz
   Pharmaceuticals, Johnson & Johnson, Lundbeck, National Responsible
   Gambling Foundation, Novartis, Orion, Pfizer, Pharmacia, Roche, Servier,
   Solvay, Sumitomo, Sun, Takeda, Tikvah, and Wyeth. DS would like to
   acknowledge support by the Medical Research Council of South Africa. DAQ
   was supported by the Eunice Kennedy Shriver National Institute of Child
   Health and Human Development of the National Institutes of Health under
   award number 5T32HD057822. The content of this report is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. PJ is supported by
   a career development fellowship from the Wellcome Trust, Public Health
   Foundation of India and a consortium of UK universities. CK receives
   research grants from Brazilian public funding agencies Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de
   Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). He has also
   received authorship royalties from publishers Artmed and Manole. RAL is
   partly funded through the Farr Institute at CIPHER. The Farr Institute
   at CIPHER is supported by a ten-funder consortium: Arthritis Research
   UK, the British Heart Foundation, Cancer Research UK, the Economic and
   Social Research Council, the Engineering and Physical Sciences Research
   Council, the Medical Research Council, the National Institute of Health
   Research, the National Institute for Social Care and Health Research
   (Welsh Assembly Government), the Chief Scientist Office (Scottish
   Government Health Directorates), the Wellcome Trust, (MRC Grant No:
   MR/K006525/1). JAS has received research grants from Takeda and Savient
   and consultant fees from Savient, Takeda, Regeneron and Allergan. JAS is
   a member of the executive of OMERACT, an organisation that develops
   outcome measures in rheumatology and receives arms-length funding from
   36 companies; a member of the American College of Rheumatology's
   Guidelines Subcommittee of the Quality of Care Committee; and a member
   of the Veterans Affairs Rheumatology Field Advisory Committee. SIH is
   funded by a Wellcome Trust Grant (#095066). JM is funded as a Research
   Career Development Fellow from the Wellcome Trust (#089963/Z/09/Z). RL
   is supported by a National Health and Medical Research of Australia
   Fellowship. KK thanks the Director of International Institute for
   Population Sciences (IIPS) for giving KK the opportunity to do PhD at
   the IIPS, during which KK got the chance to become a GBD Study 2013
   collaborator. HC is supported by the Intramural Research Program of the
   NIH, the National Institute of Environmental Health Sciences. The GBD
   Vision Loss Expert Group received additional funding from Brien Holden
   Vision Institute. NP has an honorary position with the University of
   Melbourne, through the Centre for Eye Research Australia (CERA), and is
   employed by the Fred Hollows Foundation (FHF). Access to information on
   population-based prevalence studies from the countries they support work
   in was primarily as a result of her work at FHF, and the review of the
   manuscript and revisions suggested were a part of her position at CERA.;
   CERA receives Operational Infrastructure CERA receives Operational
   Infrastructure Support funding from the Victorian Articles 56
   Government. I-HO and S-JY's work was funded by a grant of the Korean
   Health Technology research and development project, Ministry of Health
   and Welfare, North Korea (grant number HI13C0729). SS is supported by
   grants from the NIH and employed by NRF and has honoraria from
   pharmaceutical companies. KD is supported by a Wellcome Trust Fellowship
   in Public Health and Tropical Medicine (grant number 099876). LM would
   like to acknowledge the Commonwealth Government of Australia and the
   Institute of Bone and Joint Research as funders of this work as all the
   original data collection for musculoskeletal was funded by these
   sources. BDG works for Agence de Medecine Preventive which receives
   grant specific support from Crucell, GlaxoSmithKline, Merck, Novartis,
   and Sanofi Pasteur. None of these sources contributed to the current
   work. MGS previously served as a consultant for Ellicon. DCDJ was
   supported by NIH grant R01 DA 003574. LJA-R would like to acknowledge
   the Qatar National Research Fund (NPRP 04-924-3-251) who provided the
   main funding for generating the data he provided to the GBD-IHME effort.
   The GBD Genitourinary Diseases Expert Group's activities with the GBD
   2013 have been made on behalf of the International Society of
   Nephrology. AK would like to acknowledge funding support from Oklahoma
   Center for the Advancement of Science and Technology. KR is supported by
   the NIHR Oxford BRC and an NIHR Career Development Fellowship. KD is
   supported by a Wellcome Trust Training Fellowship (grant number 099876).
   KS would like to acknowledge funding from the South African Medical
   Research Council. IR and WHO staff acknowledge that the authors alone
   are responsible for the views expressed in this article and they do not
   necessarily represent the views, decisions or policies of the
   institutions with which they are affiliated.
CR Agency for Healthcare Research and Quality, US MED EXP PAN SURV
   [Anonymous], 2014, HTLH CAR EXP ARTHR O
   Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526
   Aregawi M, 2009, WORLD MAL REP 2009
   Baltussen R, 2004, J NUTR, V134, P2678
   Baxter AJ, 2014, PSYCHOL MED, V45, P1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bishop YMM, 1975, DISCRETE MULTIVARIAT
   Bittles A H, 2013, J R Coll Physicians Edinb, V43, P7, DOI 10.4997/JRCPE.2013.102
   Gabbe BJ, 2013, PLOS MED, DOI 10.1136/injuryprev-2013-040936
   Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010
   Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203
   Bluestone CD, 1998, INT J PEDIATR OTORHI, V42, P207, DOI 10.1016/S0165-5876(97)00147-X
   Boyers LN, 2014, JAMA OPHTHALMOL, DOI 10.1001/jamaophthalmol.2014.3527
   Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477
   Casey GJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002146
   Centers for Disease Control and Prevention ( CDC), 2013, US S CAR TRAUM BRAIN
   Charlson FJ, 2013, J AFFECT DISORDERS, V151, P111, DOI 10.1016/j.jad.2013.05.060
   Cheng HG, 2015, ADDICTION, V110, P761, DOI 10.1111/add.12876
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763
   Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627
   Degenhardt L, 2013, PLOS ONE, V8
   Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551
   Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5
   Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032
   Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937
   Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631
   Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7
   Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186
   Erskine HE, 2013, J CHILD PSYCHOL PSYC, V54, P1263, DOI 10.1111/jcpp.12144
   Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4
   Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
   Flaxman A, 2014, INTEGRATED METAREGRE
   Forero R, 1999, BRIT MED J, V319, P344
   Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2
   Franke CR, 2002, T ROY SOC TROP MED H, V96, P236, DOI 10.1016/S0035-9203(02)90087-8
   GBD 2010 Country Collaboration, 2013, LANCET, V381, P965
   Haagsma JA, 2013, J DEPRESS ANXIETY, V14, P1242
   Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4
   Hansen AM, 2006, J PSYCHOSOM RES, V60, P63, DOI 10.1016/j.jpsychores.2005.06.078
   HART DJ, 1993, J RHEUMATOL, V20, P331
   Higashi H, 2014, ARCH DIS CHILD
   Hillberg T, 2011, TRAUMA VIOLENCE ABUS, V12, P38, DOI 10.1177/1524838010386812
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865
   Hoy D, 2014, BEST PRACT RES CL RH, V28, P377, DOI 10.1016/j.berh.2014.07.006
   Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431
   Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428
   Hser YI, 2014, ADDICTION, V109, P1334, DOI 10.1111/add.12597
   Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS GEN EV
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Kates Erica Hyman, 2007, Pediatr Rev, V28, P33, DOI 10.1542/pir.28-1-33
   Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI [10.1016/S2214-109X(13)70089-5, 10.1016/S0140-6736(13)61953-4]
   [Anonymous], 2013, J DENT RES, DOI DOI 10.1016/S0140-6736(13)61953-4
   Leonardi M, 2013, NEUROL SCI, V34, pS117, DOI 10.1007/s10072-013-1387-8
   [Anonymous], 2013, NEUROL SCI S
   Llyod LS., 2003, BEST PRACTICES DENGU
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mathers Colin D, 2006, Popul Health Metr, V4, P4, DOI 10.1186/1478-7954-4-4
   [Anonymous], 2013, J AM COLL CARDIOL S, DOI DOI 10.1161/CIRCULATIONAHA.113.004042
   Minja BM, 1996, INT J PEDIATR OTORHI, V37, P29, DOI 10.1016/0165-5876(96)01363-8
   Moran A, 2013, PROG CARDIOVASC DIS, V56, P234, DOI 10.1016/j.pcad.2013.09.019
   Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Nord E, 2013, HEALTH POLICY, V111, P99, DOI 10.1016/j.healthpol.2013.03.019
   Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349
   Pearson K., 1904, MATH CONTRIBUTIONS T
   Pullan RL, 2015, PARASITE VECTOR, V7, P37
   Pederson H, 2015, JAMA OTOLARYNGOL, V141, P67, DOI 10.1001/jamaoto.2014.2700
   Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743
   Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9
   Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733
   Rastogi T, 2002, GLOBAL BURDEN IRON D
   Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8
   Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8
   Risal A, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-51
   Salomon JA, 2013, LANCET GLOB IN PRESS
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   Salomon JA, 2010, B WORLD HEALTH ORGAN, V88, P879, DOI 10.2471/BLT.10.084301
   Sankaranarayanan R, 2011, IARC SCI PUBLICATION, V162
   Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089
   Schomerus G, 2011, DRUG ALCOHOL DEPEN, V114, P12, DOI 10.1016/j.drugalcdep.2010.08.013
   Smith E, 2014, ANN RHEUM DIS, V73, P1470, DOI 10.1136/annrheumdis-2013-204647
   Smith E, 2014, ANN RHEUM DIS, V73, P1462, DOI 10.1136/annrheumdis-2013-204680
   [Anonymous], 2013, GLOB CARDIOL SCI PRA
   Statistics Norway, 2006, NORW SURV LIV COND 2
   Statistics Norway, 2004, NORW SURV LIV COND 2
   Statistics Norway, 2009, NORW SURV LIV COND 2
   Statistics Norway, 2013, NORW SURV LIV COND 2
   Stovner LJ, 2014, ACTA NEUROL SCAND, V129, P1, DOI 10.1111/ane.12229
   Sustainable Development, 2014, PROP SUST DEV GOALS
   Taylor HR, 2013, LANCET, V381, P23, DOI 10.1016/S0140-6736(12)62081-9
   Bethesda MD, 2014, US SEER CANC STAT RE
   van Baal Pieter H M, 2006, Popul Health Metr, V4, P1, DOI 10.1186/1478-7954-4-1
   van Loey NE, 2012, J TRAUMA ACUTE CARE, V72, P513, DOI 10.1097/TA.0b013e3182199072
   Voigt K, 1111, B WORLD HEALTH ORGAN, V92, P226
   Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
   Yu SC, 2014, BIOMED ENVIRON SCI, V27, P45, DOI 10.3967/bes2014.013
NR 102
TC 775
Z9 793
U1 99
U2 434
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 22
PY 2015
VL 386
IS 9995
BP 743
EP 800
DI 10.1016/S0140-6736(15)60692-4
PG 58
WC Medicine, General & Internal
SC General & Internal Medicine
GA CQ0LR
UT WOS:000360287900025
OA No
HC Y
HP Y
DA 2017-08-15
ER

PT J
AU Olaosebikan, R
   Ernest, K
   Bojang, K
   Mokuolu, O
   Rehman, AM
   Affara, M
   Nwakanma, D
   Kiechel, JR
   Ogunkunle, T
   Olagunju, T
   Murtala, R
   Omefe, P
   Lambe, T
   Bello, S
   Ibrahim, O
   Olorunsola, B
   Ojuawo, A
   Greenwood, B
   Milligan, P
AF Olaosebikan, Rasaq
   Ernest, Kolade
   Bojang, Kalifa
   Mokuolu, Olugbenga
   Rehman, Andrea M.
   Affara, Muna
   Nwakanma, Davis
   Kiechel, Jean-Rene
   Ogunkunle, Taofik
   Olagunju, Tope
   Murtala, Rukayat
   Omefe, Peter
   Lambe, Tosin
   Bello, Surajudeen
   Ibrahim, Olayinka
   Olorunsola, Benedict
   Ojuawo, Ayotade
   Greenwood, Brian
   Milligan, Paul
TI A Randomized Trial to Compare the Safety, Tolerability, and
   Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria
   in Nigerian Patients With Sickle Cell Disease
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE sickle cell disease; malaria; chemoprevention; intermittent preventive
   treatment; prophylaxis; mefloquine-artesunate; proguanil
ID PLASMODIUM-FALCIPARUM MALARIA; ARTESUNATE-MEFLOQUINE;
   SULFADOXINE-PYRIMETHAMINE; OPEN-LABEL; CHILDREN; CHEMOPROPHYLAXIS;
   ANEMIA; COMBINATION; MANAGEMENT; RESISTANCE
AB Background. Malaria prophylaxis is recommended for persons with sickle cell disease (SCD), but the value of this has been questioned. The aim of this study was to find out whether intermittent preventive treatment (IPT) with a fixed-dose combination of mefloquine-artesunate (MQAS) or sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) was more effective than daily proguanil for malaria prevention in subjects with SCD.
   Methods. Patients with SCD were randomized to receive daily treatment with proguanil or IPT with either MQAS or SPAQ once every 2 months at routine clinic visits. Patients were followed up for 14 months.
   Findings. A total of 270 patients with SCD were studied, with 90 in each group. Adherence to the IPT regimens was excellent, but 57% of patients took <75% of their daily doses of proguanil. IPT was well tolerated; the most common side effects were vomiting and abdominal pain. Protective efficacy against malaria, compared with daily proguanil, was 61% (95% confidence interval, 3%-84%) for MQAS and 36% (40%-70%) for SPAQ. There were fewer outpatient illness episodes in children who received IPT than those who received proguanil.
   Conclusions. IPT with MQAS administered to patients with SCD during routine clinic visits was well tolerated and more effective in preventing malaria than daily prophylaxis with proguanil.
   Clinical Trials Registration. NCT01319448 and ISRCTN46158146.
C1 [Olaosebikan, Rasaq; Ernest, Kolade; Mokuolu, Olugbenga; Ogunkunle, Taofik; Olagunju, Tope; Murtala, Rukayat; Omefe, Peter; Lambe, Tosin; Bello, Surajudeen; Ibrahim, Olayinka; Olorunsola, Benedict; Ojuawo, Ayotade] Univ Ilorin, Teaching Hosp, Ilorin, Kwara, Nigeria.
   [Olaosebikan, Rasaq; Bojang, Kalifa; Affara, Muna; Nwakanma, Davis] MRC Unit, Banjul, Gambia.
   [Olaosebikan, Rasaq] Univ Nebraska Med Ctr, Omaha, NE USA.
   [Kiechel, Jean-Rene] Drugs Neglected Dis Initiat, Geneva, Switzerland.
   [Rehman, Andrea M.; Greenwood, Brian; Milligan, Paul] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Olaosebikan, R (reprint author), Univ Ilorin, Teaching Hosp, Dept Paediat & Child Hlth, PMB 1459, Ilorin, Kwara, Nigeria.
EM laoshrsk@yahoo.com
RI Milligan, Paul/D-8985-2017
OI Milligan, Paul/0000-0003-3430-3395; Ogunkunle,
   Taofik/0000-0002-7243-7741; Rehman, Andrea/0000-0001-9967-5822
FU Wellcome Trust [086153/Z/08/Z]
FX This work was supported by the Wellcome Trust as part of a Master's
   Training Fellowship in Public Health and Tropical Medicine
   (086153/Z/08/Z).
CR Abdel-Muhsin AA, 2003, PARASITOLOGY, V126, P391, DOI 10.1017/S0031182003003020
   Agomo PU, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-172
   Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9
   Ambe JP, 2001, TROP DOCT, V31, P26
   Ashley EA, 2006, TROP MED INT HEALTH, V11, P1653, DOI 10.1111/j.1365-3156.2006.01724.x
   Awodu Omolade Augustina, 2008, Turk J Haematol, V25, P8
   Cairns M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009467
   Diop S, 2011, ANN HEMATOL, V90, P23, DOI 10.1007/s00277-010-1040-z
   Edington G, 1976, PATHOLOGY TROPICS, P432
   Eke FU, 2003, CURR THER RES CLIN E, V64, P616, DOI [10.1016/j.curtheres.2003.09.003, 10.1016/S0011-393X(03)00161-9]
   Food and Drug Administration, MEFL HYDR DRUG SAF C
   Frey SG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-291
   Galadanci N, 2014, INT HEALTH, V6, P23, DOI 10.1093/inthealth/iht022
   Gonsalez R, 2014, MALARIA J, V13, P75
   Happi CT, 2005, ACTA TROP, V95, P183, DOI 10.1016/j.actatropica.2005.06.015
   Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528
   Nakibuuka V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-237
   National Population Commission (NPC) [Nigeria] National Malaria Control Programme (NMCP) [Nigeria] and ICF International, 2012, NIG MAL IND SURV 201
   Nwokolo C, 2001, CLIN DRUG INVEST, V21, P537, DOI 10.2165/00044011-200121080-00002
   Oniyangi O, 2003, COCHRANE DB SYST REV
   Plowe C, 1995, AM J TROP MED HYG, V52, P1590
   Schlagenhauf P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-292
   SHAPIRO BS, 1995, PAIN, V61, P139, DOI 10.1016/0304-3959(94)00164-A
   WARLEY MA, 1965, BRIT MED J, V2, P86
   Wells S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-68
   WHO, 2012, SEAS MAL CHEM SULF P
   Williams TN, 2011, TRENDS PARASITOL, V27, P315, DOI 10.1016/j.pt.2011.02.004
NR 27
TC 3
Z9 3
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2015
VL 212
IS 4
BP 617
EP 625
DI 10.1093/infdis/jiv093
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CP1ZW
UT WOS:000359677600014
PM 25701866
OA No
DA 2017-08-15
ER

PT J
AU Mwesigwa, J
   Okebe, J
   Affara, M
   Di Tanna, GL
   Nwakanma, D
   Janha, O
   Opondo, K
   Grietens, KP
   Achan, J
   D'Alessandro, U
AF Mwesigwa, Julia
   Okebe, Joseph
   Affara, Muna
   Di Tanna, Gian Luca
   Nwakanma, Davis
   Janha, Omar
   Opondo, Kevin
   Grietens, Koen Peeters
   Achan, Jane
   D'Alessandro, Umberto
TI On-going malaria transmission in The Gambia despite high coverage of
   control interventions: a nationwide cross-sectional survey
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria transmission; Asymptomatic parasitaemia; Heterogeneity; The
   Gambia
ID PLASMODIUM-FALCIPARUM; CHILDREN; PARASITEMIA; PREVALENCE; INFECTION;
   CARRIAGE; TANZANIA; INDEXES; FIELD
AB Background: As indicators of burden of malaria have substantially decreased in The Gambia, reaching a pre-elimination status may be attainable. Achieving this goal requires in-depth understanding of the current burden of Plasmodium falciparum infection.
   Methods: A nationwide cross-sectional survey was conducted in 2012 to determine the prevalence of P. falciparum infection, and to describe its heterogeneity and associated risk factors. Finger-prick blood samples were collected for microscopy, species-specific PCR and haemoglobin measurement.
   Results: A total of 9,094 participants were included and median age was 11.9 years (IQR 5, 28). Overall prevalence of P. falciparum was 16.01 % with marked heterogeneity between sites (4.32-36.75 %) and within villages in each site (1.63-49.13 %). Across all sites, 51.17 % (745/1,456) of infections were asymptomatic and 35.61 % (448/1,258) were sub-microscopic. The odds of P. falciparum infection were higher in older children; 5-15 years (OR = 1.90; 95 % CI 1.60-2.26), adults (OR = 1.48; 95 % CI 1.24-1.78) and participants with moderate anaemia (OR = 1.62; 95 % CI 1.32-1.99).
   Conclusions: The current malaria control interventions are not sufficient to interrupt transmission in The Gambia as malaria prevalence is still relatively high in the eastern part of the country. New interventions aiming at interrupting transmission are needed and should be urgently evaluated.
C1 [Mwesigwa, Julia; Okebe, Joseph; Affara, Muna; Nwakanma, Davis; Janha, Omar; Opondo, Kevin; Achan, Jane; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia.
   [Di Tanna, Gian Luca; D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Grietens, Koen Peeters; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan.
   [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.
RP D'Alessandro, U (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM udalessandro@mrc.gm
FU Gambia Ministry of Health and Social Welfare; National Malaria Control
   Programme; Medical Research Council (MRC), UK; Department for
   International Development (DFID), UK, under the MRC/DFID Concordat
   Agreement [MC_EX_MR/J002364/1]
FX The study team is grateful to the village leaders and study participants
   who gave tremendous support and willingly allowed us to collect the data
   and samples. We are grateful to Mr Archibald Worwui for his support on
   the data management. The tireless effort of our field teams (assistants
   and nurses) is greatly appreciated. We acknowledge the tremendous
   support received from The Gambia Ministry of Health and Social Welfare
   and National Malaria Control Programme.; This work is funded Medical
   Research Council (MRC), UK and the Department for International
   Development (DFID), UK, under the MRC/DFID Concordat Agreement. Grant
   number MC_EX_MR/J002364/1.
CR Bartlett J, 2014, STAT METHODS MED RES, V24, P462
   Betson M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-187
   Bogh C, 2007, AM J TROP MED HYG, V76, P875
   Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18
   Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10
   Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI DOI 10.1177/0962280206074463
   Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405
   Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39
   Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939
   DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0
   Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669
   Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255
   Geiger C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-27
   Gudo ES, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-244
   Kimbi HK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-193
   Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358
   Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004
   Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529
   Manirakiza P, 2003, ARCH ENVIRON CON TOX, V44, P171, DOI 10.1007/s00244-002-2006-5
   Manjurano A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-370
   Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   Oduro AR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-222
   Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926
   Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252
   Quinones ML, 1997, MED VET ENTOMOL, V11, P71, DOI 10.1111/j.1365-2915.1997.tb00292.x
   Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189
   Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467
   Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108
   Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351
   WHO, 2011, WORLD MALARIA REPORT 2011, P1
   WHO, 2009, WHONMHNHDMNM111
NR 35
TC 11
Z9 11
U1 2
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD AUG 14
PY 2015
VL 14
AR 314
DI 10.1186/s12936-015-0829-6
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CO7KZ
UT WOS:000359339300001
PM 26268225
OA gold
DA 2017-08-15
ER

PT J
AU Tagbor, H
   Cairns, M
   Bojang, K
   Coulibaly, SO
   Kayentao, K
   Williams, J
   Abubakar, I
   Akor, F
   Mohammed, K
   Bationo, R
   Dabira, E
   Soulama, A
   Djimde, M
   Guirou, E
   Awine, T
   Quaye, S
   Njie, F
   Ordi, J
   Doumbo, O
   Hodgson, A
   Oduro, A
   Meshnick, S
   Taylor, S
   Magnussen, P
   ter Kuile, F
   Woukeu, A
   Milligan, P
   Chandramohan, D
   Greenwood, B
AF Tagbor, Harry
   Cairns, Matthew
   Bojang, Kalifa
   Coulibaly, Sheick Oumar
   Kayentao, Kassoum
   Williams, John
   Abubakar, Ismaela
   Akor, Francis
   Mohammed, Khalifa
   Bationo, Richard
   Dabira, Edgar
   Soulama, Alamissa
   Djimde, Moussa
   Guirou, Etienne
   Awine, Timothy
   Quaye, Stephen
   Njie, Fanta
   Ordi, Jaume
   Doumbo, Ogobara
   Hodgson, Abraham
   Oduro, Abraham
   Meshnick, Steven
   Taylor, Steve
   Magnussen, Pascal
   ter Kuile, Feiko
   Woukeu, Arouna
   Milligan, Paul
   Chandramohan, Daniel
   Greenwood, Brian
TI A Non-Inferiority, Individually Randomized Trial of Intermittent
   Screening and Treatment versus Intermittent Preventive Treatment in the
   Control of Malaria in Pregnancy
SO PLOS ONE
LA English
DT Article
ID SULFADOXINE-PYRIMETHAMINE RESISTANCE; LOW-BIRTH-WEIGHT; DRUG-RESISTANCE;
   METAANALYSIS; AFRICA; THERAPY
AB Background
   The efficacy of intermittent preventive treatment for malaria with sulfadoxine-pyrimethamine (IPTp-SP) in pregnancy is threatened in parts of Africa by the emergence and spread of resistance to SP. Intermittent screening with a rapid diagnostic test (RDT) and treatment of positive women (ISTp) is an alternative approach.
   Methods and Findings
   An open, individually randomized, non-inferiority trial of IPTp-SP versus ISTp was conducted in 5,354 primi- or secundigravidae in four West African countries with a low prevalence of resistance to SP (The Gambia, Mali, Burkina Faso and Ghana). Women in the IPTp-SP group received SP on two or three occasions whilst women in the ISTp group were screened two or three times with a RDT and treated if positive for malaria with artemether-lumefantrine (AL). ISTp-AL was non-inferior to IPTp-SP in preventing low birth weight (LBW), anemia and placental malaria, the primary trial endpoints. The prevalence of LBW was 15.1% and 15.6% in the IPTp-SP and ISTp-AL groups respectively (OR = 1.03 [95% CI: 0.88, 1.22]). The mean hemoglobin concentration at the last clinic attendance before delivery was 10.97g/dL and 10.94g/dL in the IPTp-SP and ISTp-AL groups respectively (mean difference: -0.03 g/dL [95% CI: -0.13, +0.06]). Active malaria infection of the placenta was found in 24.5% and in 24.2% of women in the IPTp-SP and ISTp-AL groups respectively (OR = 0.95 [95% CI 0.81, 1.12]). More women in the ISTp-AL than in the IPTp-SP group presented with malaria parasitemia between routine antenatal clinics (310 vs 182 episodes, rate difference: 49.4 per 1,000 pregnancies [95% CI 30.5, 68.3], but the number of hospital admissions for malaria was similar in the two groups.
   Conclusions
   Despite low levels of resistance to SP in the study areas, ISTp-AL performed as well as IPTp-SP. In the absence of an effective alternative medication to SP for IPTp, ISTp-AL is a potential alternative to IPTp in areas where SP resistance is high. It may also have a role in areas where malaria transmission is low and for the prevention of malaria in HIV positive women receiving cotrimoxazole prophylaxis in whom SP is contraindicated.
C1 [Tagbor, Harry; Cairns, Matthew; Woukeu, Arouna; Milligan, Paul; Chandramohan, Daniel; Greenwood, Brian] London Sch Hyg & Trop Med, London, England.
   [Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana.
   [Bojang, Kalifa; Abubakar, Ismaela; Akor, Francis; Mohammed, Khalifa; Njie, Fanta] MRC Unit, Fajara, Gambia.
   [Coulibaly, Sheick Oumar; Bationo, Richard; Dabira, Edgar; Soulama, Alamissa] Univ Ouagadougou, Fac Hlth Sci, Ouagadougou, Burkina Faso.
   [Kayentao, Kassoum; Djimde, Moussa; Guirou, Etienne; Doumbo, Ogobara] Univ Sci Tech & Technol, Fac Med & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali.
   [Williams, John; Awine, Timothy; Quaye, Stephen; Hodgson, Abraham; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Ordi, Jaume] Univ Barcelona, Hosp Clin Barcelona, Dept Pathol, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Meshnick, Steven] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   [Taylor, Steve] Duke Univ, Med Ctr, Durham, NC USA.
   [Magnussen, Pascal] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.
   [Magnussen, Pascal] Univ Copenhagen, Inst Vet Dis Biol, Copenhagen, Denmark.
   [ter Kuile, Feiko] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
RP Greenwood, B (reprint author), London Sch Hyg & Trop Med, London, England.
EM brian.greenwood@lshtm.ac.uk
RI Milligan, Paul/D-8985-2017
OI Milligan, Paul/0000-0003-3430-3395; Akor, Francis/0000-0002-5181-8609;
   ter Kuile, Feiko/0000-0003-3663-5617; Guirou, Etienne
   A./0000-0002-8576-328X
FU European Developing Country Clinical Trials Programme
   [IP.2007.31080.003]; Malaria in Pregnancy Consortium through Bill &
   Melinda Gates Foundation; UK Medical Research Council (MRC) under
   MRC/DFID Concordat agreement; UK Department for International
   Development (DFID) under MRC/DFID Concordat agreement
FX The study was funded by the European Developing Country Clinical Trials
   Programme (grant number IP.2007.31080.003) and by the Malaria in
   Pregnancy Consortium which is funded through a grant from the Bill &
   Melinda Gates Foundation to the Liverpool School of Tropical Medicine.
   MC is supported by a fellowship jointly funded by the UK Medical
   Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement. No funding
   bodies had any role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Arinaitwe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073073
   Coulibaly SO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-41
   Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Gutman J, 2013, J INFECT DIS, V208, P907, DOI 10.1093/infdis/jit276
   Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106
   Harrington WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056183
   Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376
   Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231
   Landis SH, 2009, ULTRASOUND OBST GYN, V34, P379, DOI 10.1002/uog.6357
   Likwela JL, 2012, TROP MED INT HEALTH, V17, P322, DOI 10.1111/j.1365-3156.2011.02935.x
   McClure EM, 2013, INT J GYNECOL OBSTET, V121, P103, DOI 10.1016/j.ijgo.2012.12.014
   Minja DTR, 2013, EMERG INFECT DIS, V19, P1446, DOI 10.3201/eid1909.130133
   Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002
   Naidoo I, 2010, TRENDS PARASITOL, V26, P447, DOI 10.1016/j.pt.2010.05.001
   Paintain LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024035
   Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152
   Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106
   Siqueira AL, 2008, STAT MED, V27, P353, DOI 10.1002/sim.2975
   Sridaran S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-247
   Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223
   Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425
   Taylor SM, 2013, J INFECT DIS, V208, P1998, DOI 10.1093/infdis/jit392
   ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603
   van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3
   World Health Organization (WHO), 2012, UPD WHO POL REC INT
   Xu Y, 2010, AM J EPIDEMIOL, V172, P334, DOI 10.1093/aje/kwq099
NR 27
TC 11
Z9 11
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 10
PY 2015
VL 10
IS 8
AR e0132247
DI 10.1371/journal.pone.0132247
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO7PJ
UT WOS:000359352600002
PM 26258474
OA gold
DA 2017-08-15
ER

PT J
AU Tavakoli, H
   Cessay, IB
   Cole, WPO
AF Tavakoli, Heidi
   Cessay, Ismaila B.
   Cole, Winston Percy Onipede
TI Substantial but Uneven Achievement: Selected Success When Stars Align.
   Public Financial Management Reforms in Sierra Leone
SO INTERNATIONAL PEACEKEEPING
LA English
DT Article
AB In the decade following the end of the civil war, the Government of Sierra Leone made substantial progress in strengthening public financial management. Improvements were achieved across all aspects of the budget cycle and were particularly notable with regard to budget execution functions. The main factors that appear to have contributed to these improvements are a strong starting position at the beginning of the cease-fire; political appetite for public financial management reforms; a cadre of motivated and professional local technical advisers; and considerable international support co-ordinated through budget support operations.
C1 [Tavakoli, Heidi] Bill & Melinda Gates Fdn, Washington, DC 20005 USA.
   [Tavakoli, Heidi] ODI, London, England.
   [Tavakoli, Heidi] Oxford Policy Management, Oxford, England.
   [Tavakoli, Heidi] Minist Educ, Windhoek, Namibia.
   [Cessay, Ismaila B.; Cole, Winston Percy Onipede] ACCA, London, England.
   [Cessay, Ismaila B.] CIMA, London, England.
   [Cessay, Ismaila B.] Gambia Natl Investment Board, Banjul, Gambia.
   [Cessay, Ismaila B.] Gambia Telecommun Co Ltd, Banjul, Gambia.
   [Cessay, Ismaila B.] EU, Mission, Maastricht, Netherlands.
   [Cessay, Ismaila B.] Cent Fiscal Author Timor Leste Auspices United Na, Treasury, Maastricht, Netherlands.
   [Cessay, Ismaila B.] Cent Fiscal Author Timor Leste Auspices United Na, Maastricht, Netherlands.
   [Cole, Winston Percy Onipede] Barclays Bank Sierra Leone, Little Rock, AR USA.
   [Cole, Winston Percy Onipede] Govt Sierra Leone, Minist Finance, Accountant Gen Dept, Unit, Little Rock, AR USA.
   [Cole, Winston Percy Onipede] World Bank Assisted Inst Reform & Capac Project, Implementing PFM Reform Component, Washington, DC USA.
RP Tavakoli, H (reprint author), Bill & Melinda Gates Fdn, Washington, DC 20005 USA.
EM heiditavakoli1@gmail.com
CR Matthew Andrews, 2010, FACULTY RES WORKING
   Collier P., 2007, ACCOUNTABILITY PROVI
   de Renzio Paolo, 2010, EVALUATION DONOR SUP
   GoSL, 2013, SIERR LEON PUBL FIN
   GoSL, 2010, 2010 REV PROGR ASS F
   GoSL, 2010, REP SIERR L IN PRESS
   GoSL, 2010, REV GOV BUD IN PRESS
   GoSL (Government of Sierra Leone), 2007, REP SIERR L IN PRESS
   IDD and Associates, 2006, JOINT EV GEN BUDG SU
   IMF, 2012, SIERR LEON PUBL FIN
   IMF, 2004, REB FISC I POSTC COU
   IMF, 2012, SIERR LEON DET IMPL
   IMF, 2009, SIERR LEON SEL ISS S
   Ingram S., 2010, STATE BUILDING KEY C
   Lawson A., 2012, EVALUATION PUBLIC FI
   Lawson A., 2007, DFID MULTIDONOR BUDG
   Morgan P., 2009, PARALLEL IM IN PRESS
   Pretorius C., 2008, REV PUBLIC FINANCIAL
   Tavakoli H., 2012, PUBLIC FINANCIAL MAN
   Thomson B., 2007, SIERRA LEONE REFORM, P26
   World Bank, 2009, PROP GRANT AM SDR2 7
   World Bank, 2010, PUBL EXP RE IN PRESS
   World Bank, 2012, 69964 WORLD BANK
   World Bank, 2002, REP SIERR LEON COUNT
   World Bank, 2008, POL EC PUBL FIN MAN
NR 25
TC 0
Z9 0
U1 2
U2 2
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1353-3312
EI 1743-906X
J9 INT PEACEKEEPING
JI Int. Peacekeeping
PD AUG 8
PY 2015
VL 22
IS 4
SI SI
BP 337
EP 353
DI 10.1080/13533312.2015.1059286
PG 17
WC International Relations
SC International Relations
GA CQ1PL
UT WOS:000360370000004
OA No
DA 2017-08-15
ER

PT J
AU Grosso, AL
   Lei, EL
   Ketende, SC
   Peitzmeier, S
   Mason, K
   Ceesay, N
   Diouf, D
   Drame, FM
   Loum, J
   Papworth, E
   Baral, S
AF Grosso, Ashley L.
   Lei, Esther L.
   Ketende, Sosthenes C.
   Peitzmeier, Sarah
   Mason, Krystal
   Ceesay, Nuha
   Diouf, Daouda
   Drame, Fatou Maria
   Loum, Jaegan
   Papworth, Erin
   Baral, Stefan
TI Correlates of condom use among female sex workers in The Gambia: results
   of a cross-sectional survey
SO PEERJ
LA English
DT Article
DE Condoms; Female sex workers; The Gambia
ID SEXUALLY-TRANSMITTED DISEASES; HIV TRANSMISSION; REGULAR PARTNERS;
   HIGH-RISK; CLIENTS; INTERVENTIONS; DETERMINANTS; AFRICA; BENIN;
   PREVALENCE
AB Objectives. This study examined correlates of condom use among 248 female sex workers (FSW) in The Gambia.
   Methods. Between July and August 2011, FSW in The Gambia who were older than 16 years of age, the age of consent in The Gambia, were recruited for the study using venue-based sampling and snowball sampling, beginning with seeds who were established clients with the Network of AIDS Services Organizations. To be eligible, FSW must have reported selling sex for money, favors, or goods in the past 12 months. Bivariate and multivariate logistic regressions were used to determine associations and the relative odds of the independent variables with condom use. Four different condom use dependent variables were used: consistent condom use in the past six months during vaginal or anal sex with all clients and partners; consistent condom use in the past month during vaginal sex with new clients; consistent condom use in the past month during vaginal sex with nonpaying partners (including boyfriends, husbands, or casual sexual partners); and condom use at last vaginal or anal sex with a nonpaying partner.
   Results. Many FSW (67.34%, n = 167) reported it was not at all difficult to negotiate condom use with clients in all applicable situations, and these FSW were more likely to report consistent condom use with all clients and partners in the past 6 months (aOR 3.47, 95% CI [1.70-7.07]) compared to those perceiving any difficulty in condom negotiation. In addition, FSW were more likely to report using condoms in the past month with new clients (aOR 8.04, 95% CI [2.11-30.65]) and in the past month with nonpaying partners (aOR 2.93, 95% CI [1.09-7.89]) if they had been tested for HIV in the past year. Women who bought all their condoms were less likely than those who received all of their condoms for free (aOR 0.38, 95% CI [0.15-0.97]) to have used a condom at last vaginal or anal sex with a nonpaying partner.
   Conclusions. HIV and sexually transmitted infection (STI) prevention interventions for FSW should aim to improve condom negotiation self-efficacy since women who report less difficulty negotiating condom use are more likely to use condoms with clients. Interventions should also be aimed at structural issues such as increasing access to free condoms and HIV testing since these were positively associated with condom use among FSW.
C1 [Grosso, Ashley L.; Lei, Esther L.; Ketende, Sosthenes C.; Peitzmeier, Sarah; Mason, Krystal; Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Ceesay, Nuha] UNAIDS Gambia, Banjul, Gambia.
   [Diouf, Daouda] Enda Sante, Dakar, Senegal.
   [Drame, Fatou Maria] Gaston Berger Univ, Sch Social Sci, Dept Geog, St Louis, Senegal.
   [Loum, Jaegan] Network AIDS Serv Org, Banjul, Gambia.
   [Papworth, Erin] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Dakar, Senegal.
RP Grosso, AL (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Baltimore, MD 21205 USA.
EM agrosso@jhu.edu
OI Grosso, Ashley/0000-0001-5759-7125
FU National AIDS Secretariat and Action Aid-The Gambia; UNAIDS; Enda Sante
   of Senegal; Johns Hopkins Bloomberg School of Public Health
FX This research was funded by the National AIDS Secretariat and Action
   Aid-The Gambia, UNAIDS, Enda Sante of Senegal and the Johns Hopkins
   Bloomberg School of Public Health. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adu-Oppong A, 2007, AIDS EDUC PREV, V19, P160, DOI 10.1521/aeap.2007.19.2.160
   Agha S, 2004, CULT HEALTH SEX, V6, P283, DOI 10.1080/13691050410001680474
   Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019
   Alfonsi G. A., 2005, CURRENT WOMENS HLTH, V1, P151, DOI DOI 10.2174/1573-404054064584
   Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482
   Barrington C, 2009, SOC SCI MED, V68, P2037, DOI 10.1016/j.socscimed.2009.03.009
   Fonner VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087527
   Jallow C., 2011, GAMBIA 2000 BEHAV SU
   Kayembe PK, 2008, SEX TRANSM INFECT, V84, P202, DOI 10.1136/sti.2007.028324
   Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9
   Lowndes CM, 2007, SEX TRANSM INFECT, V83, P577, DOI 10.1136/sti.2007.027441
   Lowndes CM, 2000, AIDS, V14, P2523, DOI 10.1097/00002030-200011100-00015
   Lowndes CMA, 2008, WORLD BANK GLOBAL HI
   Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103
   Ntumbanzondo M, 2006, AIDS CARE, V18, P777, DOI 10.1080/09540120500412824
   Oladosu M, 2001, 39 POP SERV INT
   Papworth E, 2015, JAIDS-J ACQ IMM DEF, V68, pS154, DOI 10.1097/QAI.0000000000000454
   Papworth Erin, 2013, J Int AIDS Soc, V16 Suppl 3, P18751, DOI 10.7448/IAS.16.4.18751
   Peitzmeier S, 2013, INT J STD AIDS, V25, P244, DOI DOI 10.1177/0956462413498858
   PICKERING H, 1993, AIDS, V7, P1093, DOI 10.1097/00002030-199308000-00011
   Schwartz S, 2015, J ACQ IMMUN DEF SYND, V68, P91
   Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187
   Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090
   Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234
   Stadler J, 2006, CULT HEALTH SEX, V8, P451, DOI 10.1080/13691050600872107
   Umar U S, 2001, Afr J Med Med Sci, V30, P285
   UNAIDS, 2011, GAMB HIV AIDS EST
   Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277
   Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007
   Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077
   Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x
   Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151
NR 32
TC 1
Z9 2
U1 2
U2 6
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD AUG 6
PY 2015
VL 3
AR e1076
DI 10.7717/peerj.1076
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ8GK
UT WOS:000360844500002
PM 26290781
OA gold
DA 2017-08-15
ER

PT J
AU Hernandez-Vargas, H
   Castelino, J
   Silver, MJ
   Dominguez-Salas, P
   Cros, MP
   Durand, G
   Le Calvez-Kelm, F
   Prentice, AM
   Wild, CP
   Moore, SE
   Hennig, BJ
   Herceg, Z
   Gong, YY
   Routledge, MN
AF Hernandez-Vargas, Hector
   Castelino, Jovita
   Silver, Matt J.
   Dominguez-Salas, Paula
   Cros, Marie-Pierre
   Durand, Geoffroy
   Le Calvez-Kelm, Florence
   Prentice, Andrew M.
   Wild, Christopher P.
   Moore, Sophie E.
   Hennig, Branwen J.
   Herceg, Zdenko
   Gong, Yun Yun
   Routledge, Michael N.
TI Exposure to aflatoxin B-1 in utero is associated with DNA methylation in
   white blood cells of infants in The Gambia
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE Aflatoxin; DNA methylation; in utero exposure
ID HEPATOCELLULAR-CARCINOMA; EPIGENETIC EPIDEMIOLOGY; CORD BLOOD; CANCER;
   GROWTH; ARRAY; HYPERMETHYLATION; MECHANISMS; POPULATION; NUTRITION
AB Background: Exposure to environmental toxins during embryonic development may lead to epigenetic changes that influence disease risk in later life. Aflatoxin is a contaminant of staple foods in sub-Saharan Africa, is a known human liver carcinogen and has been associated with stunting in infants.
   Methods: We have measured aflatoxin exposure in 115 pregnant women in The Gambia and examined the DNA methylation status of white blood cells from their infants at 2-8 months old (mean 3.6 +/- 0.9). Aflatoxin exposure in women was assessed using an ELISA method to measure aflatoxin albumin (AF-alb) adducts in plasma taken at 1-16 weeks of pregnancy. Genome-wide DNA methylation of infant white blood cells was measured using the Illumina Infinium HumanMethylation450beadchip.
   Results: AF-alb levels ranged from 3.9 to 458.4 pg/mg albumin. We found that aflatoxin exposure in the mothers was associated to DNA methylation in their infants for 71 CpG sites (false discovery rate<0.05), with an average effect size of 1.7% change in methylation. Aflatoxin-associated differential methylation was observed in growth factor genes such as FGF12 and IGF1, and immune-related genes such as CCL28, TLR2 and TGFBI. Moreover, one aflatoxin-associated methylation region (corresponding to the miR-4520b locus) was identified.
   Conclusions: This study shows that maternal exposure to aflatoxin during the early stages of pregnancy is associated with differential DNA methylation patterns of infants, including in genes related to growth and immune function. This reinforces the need for interventions to reduce aflatoxin exposure, especially during critical periods of fetal and infant development.
C1 [Hernandez-Vargas, Hector; Cros, Marie-Pierre; Herceg, Zdenko] IARC, Epigenet Grp, Lyon, France.
   [Castelino, Jovita; Routledge, Michael N.] Univ Leeds, Sch Med, LICAMM, Leeds LS2 9JT, W Yorkshire, England.
   [Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Moore, Sophie E.; Hennig, Branwen J.] LSHTM, MRC Int Nutr Grp, London, England.
   [Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Moore, Sophie E.; Hennig, Branwen J.; Routledge, Michael N.] MRC Keneba, MRC Unit, Serrekunda, Gambia.
   [Durand, Geoffroy; Le Calvez-Kelm, Florence] IARC, Genet Canc Susceptibil Grp, Lyon, France.
   [Wild, Christopher P.] IARC, Lyon, France.
   [Moore, Sophie E.] MRC Human Nutr Res, Cambridge, England.
   [Gong, Yun Yun] Queens Univ Belfast, UK Inst Global Food Secur, Belfast, Antrim, North Ireland.
RP Routledge, MN (reprint author), Univ Leeds, LICAMM, LIGHT Bldg, Leeds LS2 9JT, W Yorkshire, England.
EM medmnr@leeds.ac.uk
RI Gong, Yun/L-7094-2016
OI Gong, Yun/0000-0003-4927-5526; Silver, Matt/0000-0002-3852-9677
FU UK Medical Research Council (MRC) [MC-A760-5QX00]; UK Department for
   International Development (DFID) under the MRC/DFID Concordat; Wellcome
   Trust [WT086369MA]; International Agency for Research on Cancer; Bill
   and Melinda Gates Foundation [OPP1061062]; National Institute of
   Environmental Health Sciences [ES06052]
FX Sample collection in The Gambia was supported by core funding
   MC-A760-5QX00 to the International Nutrition Group by the UK Medical
   Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement and by a
   Wellcome Trust grant (WT086369MA). Y.Y.G., M.N.R. and J.M.C. were
   supported by a grant from the International Agency for Research on
   Cancer. Z.H. and the Epigenetics Group at IARC is supported by a Grand
   Challenges Exploration Grant from the Bill and Melinda Gates Foundation
   (Grant Number: OPP1061062). Y.Y.G. and C.P.W. were also supported by the
   National Institute of Environmental Health Sciences (grant ES06052).
CR Accomando WP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r50
   Barker DJP, 2004, J AM COLL NUTR, V23, p588S
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Broberg K, 2014, J DEV ORIG HLTH DIS, V5, P288, DOI 10.1017/S2040174414000221
   Castelino JM, 2015, MOL NUTR FOOD RES, V59, P574, DOI 10.1002/mnfr.201300619
   Castelino JM, 2014, TROP MED INT HEALTH, V19, P348, DOI 10.1111/tmi.12250
   Chapot B, 1991, TECHNIQUES DIAGNOSTI
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470
   Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8
   Costanzo P, 2015, FOOD CHEM TOXICOL, V76, P77, DOI 10.1016/j.fct.2014.11.025
   De Prins S, 2013, ENVIRON INT, V59, P418, DOI 10.1016/j.envint.2013.07.007
   Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746
   Du P, 2010, BMC BIOINFORMATICS, V11, P587, DOI DOI 10.1186/1471-2105-11-587
   Feng Y, 2012, HEPATO-GASTROENTEROL, V59, P1883, DOI 10.5754/hge11731
   Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102
   Gong YY, 2004, ENVIRON HEALTH PERSP, V112, P1334, DOI 10.1289/ehp.6954
   Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20
   Gong YY, 2008, MYCOTOXINS DETECTION
   Harper KN, 2013, CANCER EPIDEM BIOMAR, V22, P1052, DOI 10.1158/1055-9965.EPI-13-0114
   Herbstman JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072824
   Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262
   Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86
   The International Agency for Research on Cancer (IARC), 2002, IARC MONOGR EVAL CAR, V82, P1
   Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31
   Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238
   Jiang Y, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/790309
   Kippler M, 2013, EPIGENETICS-US, V8, P494, DOI 10.4161/epi.24401
   Koestler DC, 2013, ENVIRON HEALTH PERSP, V121, P971, DOI 10.1289/ehp.1205925
   Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034
   Maccani JZJ, 2013, EPIGENOMICS-UK, V5, P619, DOI 10.2217/epi.13.63
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293
   Routledge MN, 2011, WOODHEAD PUBL FOOD S, P225
   Rossi A, 2016, APPL GENET MOL BIOL, V2, DOI DOI 10.2202/1544-6115.1027
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   Turner PC, 2007, INT J EPIDEMIOL, V36, P1119, DOI 10.1093/ije/dym122
   Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705
   Wu HC, 2013, EPIGENETICS-US, V8, P962, DOI 10.4161/epi.25696
   Zhang FF, 2012, EPIGENETICS-US, V7, P606, DOI 10.4161/epi.20236
   Zhang YJ, 2005, CANCER LETT, V221, P135, DOI 10.1016/j.canlet.2004.08.028
NR 44
TC 14
Z9 14
U1 3
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD AUG
PY 2015
VL 44
IS 4
BP 1238
EP 1248
DI 10.1093/ije/dyv027
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CT8JK
UT WOS:000363061500022
PM 25855716
OA No
DA 2017-08-15
ER

PT J
AU Okomo, UA
   Dibbasey, T
   Kassama, K
   Lawn, JE
   Zaman, SMA
   Kampmann, B
   Howie, SRC
   Bojang, K
AF Okomo, Uduak A.
   Dibbasey, Tida
   Kassama, Kalipha
   Lawn, Joy E.
   Zaman, Syed M. A.
   Kampmann, Beate
   Howie, Stephen R. C.
   Bojang, Kalifa
TI Neonatal admissions, quality of care and outcome: 4 years of inpatient
   audit data from The Gambia's teaching hospital
SO PAEDIATRICS AND INTERNATIONAL CHILD HEALTH
LA English
DT Article
DE Neonate; Newborn; Mortality; Infection; Audit; Quality of care;
   Antimicrobial
ID PRETERM BIRTH; HEALTH; MORBIDITY; MORTALITY; SURVIVAL; DEATHS;
   COMPLICATIONS; HYPOTHERMIA; PRIORITIES; UNIVERSITY
AB Background: National facility-based neonatal mortality audits are an important source of data to identify areas for improvement of service delivery and outcome of care.
   Objectives: To examine admissions to the neonatal unit, Edward Francis Small Teaching Hospital, Banjul, The Gambia and make recommendations for programme action to reduce mortality through improvements in the quality of care, particularly with respect to suspected neonatal infections.
   Methods: Case notes were reviewed for all neonates admitted to the neonatal unit during a 5-year period (1 January 2009 to 31 December 2013) to assess outcome and quality of care. Data for 2009 were subsequently excluded because of the low proportion of records retrieved.
   Results: Of the 4944 admissions between 1 January 2010 and 31 December 2013, 1734 infants (35%) died, with 57% of all deaths occurring within the first 48 hours of admission. There were 1267 early neonatal deaths (deaths occurring during the first 7 days of life), 67% of which occurred during the first 48 hours of life. Independent predictors of neonatal death in the multivariable analysis were; maternal lack of antenatal care, non-teaching hospital delivery, admission weight <1500g, abnormal blood glucose concentration (<2.6 mmol/L or >6.9 mmol/L) and hypothermia (axillary temperature <36.5 degrees C). Forty-eight per cent of newborns had point-of-admission hypothermia. Possible severe bacterial infection (pSBI) accounted for 44% (2166/4944) of admissions, prematurity/low birthweight for 27% (1340/4944) and intra-partum-related conditions for 20%. Only 5% (104/2166) of pSBI cases had at least one supportive investigation; 41 had a chest radiograph, 26 had a blood culture and 43 had a lumbar puncture. Although 94% of the newborns received intravenous antibiotics, 55% of those who did lacked clinical evidence of pSBI and had no diagnostic work-up.
   Conclusion: Priority areas for action include infection prevention and improved diagnosis and management. There is also scope to reduce hypothermia with feasible interventions particularly targeting preterm infants. Improved patient records and audit data with linked action and accountability are interventions which could prevent such deaths of newborns in The Gambia and other developing countries.
C1 [Okomo, Uduak A.; Zaman, Syed M. A.; Kampmann, Beate; Howie, Stephen R. C.; Bojang, Kalifa] MRC Unit, Banjul, Gambia.
   [Okomo, Uduak A.; Lawn, Joy E.; Zaman, Syed M. A.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
   [Okomo, Uduak A.; Dibbasey, Tida; Kassama, Kalipha; Bojang, Kalifa] Edward Francis Small Teaching Hosp, Dept Paediat, Banjul, Gambia.
   [Lawn, Joy E.] Univ London London Sch Hyg & Trop Med, Maternal Reprod & Child Hlth Ctr, London WC1E 7HT, England.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England.
   [Howie, Stephen R. C.] Univ Auckland, Sch Med, Dept Paediat, Auckland, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Sch Prevent & Social Med, Ctr Int Hlth, Dunedin, New Zealand.
RP Okomo, UA (reprint author), MRC Unit, Atlantic Blvd,POB 273, Banjul, Gambia.
EM uokomo@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709; Bojang, Kalifa/0000-0001-7506-0938
FU UK Medical Research Council (MRC) [MC_UP_A900_1118]
FX This work was supported by the UK Medical Research Council (MRC) [Budget
   support for Edward Francis Small Teaching Hospital/University of The
   Gambia platform number MC_UP_A900_1118 to KB]. The funder had no
   involvement in the study design, collection, analysis and interpretation
   of the data, nor in the writing and submission of the report.
CR Adebami O, 2005, INT J PEDIAT NEONATO, V5, P1
   BAPM, 2010, SERV STAND HOSP PROV
   BATES CJ, 1994, EUR J CLIN NUTR, V48, P660
   Blencowe H, 2009, J TROP PEDIATRICS, V55, P244, DOI 10.1093/tropej/fmn116
   BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133
   Carlin JB, 2008, LANCET, V371, P135
   CHRISTENSSON K, 1995, J TROP PEDIATRICS, V41, P210
   Cisse C T, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P46
   Clark RH, 2006, PEDIATRICS, V117, P67, DOI 10.1542/peds.2005-0179
   Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1512/peds.2005-2677
   Ekwochi U, 2014, NIGER J CLIN PRACT, V17, P346, DOI 10.4103/1119-3077.130238
   Enweronu-Laryea CC, 2008, J PERINATOL, V28, P561, DOI 10.1038/jp.2008.61
   Gambia Bureau of Statistics, 2013, GAMB DEM HLTH SURV 2
   Gambia Bureau of Statistics, 2011, GAMB MULT IND CLUST
   Harris J, 2001, INFECT DIS FETUS NEW, P1371
   Hatherill M, 2003, INTENS CARE MED, V29, P1547, DOI 10.1007/s00134-003-1888-7
   Jallow A, 2007, THESIS U OSLO OSLO
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Koueta Fla, 2007, Sante, V17, P187, DOI 10.1684/san.2007.0090
   Lawn J, 2006, PARTNERSHIP MATERNAL
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   Lawn JE, 2013, REPROD HLTH S1, V10, P6, DOI DOI 10.1186/1742-4755-10-S1-S6
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7
   Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3
   Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031
   Liu L, 2014, LANCET, V385, P430, DOI DOI 10.1016/S0140-6736(14)61698-6
   Lunze K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-24
   Mbaruku G, 2009, INT J GYNECOL OBSTET, V106, P85, DOI 10.1016/j.ijgo.2009.04.008
   Mbwele B, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-182
   McQuide PA, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-64
   Ministry of Health and Social Welfare Banjul The Gambia, 2012, HLTH IS WEALTH NAT H
   Mukhtar-Yola M, 2007, TROP DOCT, V37, P130, DOI 10.1258/004947507781524683
   Mullany LC, 2010, SEMIN PERINATOL, V34, P426, DOI 10.1053/j.semperi.2010.09.007
   Musau P, 2008, East Afr Med J, V85, P232
   Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029
   Nagalo Kisito, 2013, Pan Afr Med J, V14, P153, DOI 10.11604/pamj.2013.14.153.2022
   Omoigberale AI, 2010, NIGER J CLIN PRACT, V13, P321
   Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790
   Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134
   Riley LE, 2012, GUIDELINES PERINATAL
   Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7
   Sola A, 2008, J PERINATOL, V28, pS28, DOI 10.1038/jp.2008.47
   Tripathi N, 2012, CLIN PERINATOL, V39, P61, DOI 10.1016/j.clp.2011.12.003
   Udo JJ, 2008, NIGER J CLIN PRACT, V11, P285
   [Anonymous], LEV TRENDS CHILD MOR
   UNAIDS, 2013, EP FACT SHEET HIV AI
   UNAIDS National AIDS Secretariat, 2012, COUNTR PROGR REP GAM
   UNFPA- United Nations Population Fund, 2011, STAT WORLDS MIDW REP
   Fundo das Nacoes Unidas para a Infancia (UNICEF), 2013, COMM CHILD SURV PROM
   UNICEF and World health Organization, 2014, FULF HLTH AG WOM CHI
   UNICEF UNFPA World Health Organization World Bank, 2010, PACK INT FAM PLANN S
   Vieira Anna Luiza P., 2007, Rev. paul. pediatr., V25, P240, DOI 10.1590/S0103-05822007000300008
   Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x
   World Health Organization, 2011, AB DECL 10 YEARS
   World Health Organization, 2010, APPL WSIN METH PRACT
   World Health Organization, 2014, EB13614 WHO
   World Health Organization, 2014, TRENDS MAT MORT 1990
   World Health Organization, 1997, THERM PROT NEWB PRAC
   World Health Organization, 2014, EV NEWB ACT PLAN END
   Yoshida S, 2014, LANCET, V384, pE27, DOI 10.1016/S0140-6736(14)60263-4
   Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X
NR 61
TC 4
Z9 4
U1 0
U2 0
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 2046-9047
EI 2046-9055
J9 PAEDIATR INT CHILD H
JI Paediatr. Int. Child Health
PD AUG
PY 2015
VL 35
IS 3
BP 252
EP 264
DI 10.1179/2046905515Y.0000000036
PG 13
WC Pediatrics
SC Pediatrics
GA CT1BW
UT WOS:000362533300010
PM 26052891
OA No
DA 2017-08-15
ER

PT J
AU Wilson, AL
   Boelaert, M
   Kleinschmidt, I
   Pinder, M
   Scott, TW
   Tusting, LS
   Lindsay, SW
AF Wilson, Anne L.
   Boelaert, Marleen
   Kleinschmidt, Immo
   Pinder, Margaret
   Scott, Thomas W.
   Tusting, Lucy S.
   Lindsay, Steve W.
TI Evidence-based vector control? Improving the quality of vector control
   trials
SO TRENDS IN PARASITOLOGY
LA English
DT Review
DE vector-borne disease; vector control; Phase III trials; research
   design/standards
ID LASTING INSECTICIDAL NETS; CLUSTER-RANDOMIZED-TRIALS; TREATED BED NETS;
   PLASMODIUM-FALCIPARUM INFECTIONS; DAR-ES-SALAAM; MALARIA CONTROL;
   AEDES-AEGYPTI; VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS;
   IMPREGNATED BEDNETS
AB Vector-borne diseases (VBDs) such as malaria, dengue, and leishmaniasis cause a high level of morbidity and mortality. Although vector control tools can play a major role in controlling and eliminating these diseases, in many cases the evidence base for assessing the efficacy of vector control interventions is limited or not available. Studies assessing the efficacy of vector control interventions are often poorly conducted, which limits the return on investment of research funding. Here we outline the principal design features of Phase Ill vector control field studies, highlight major failings and strengths of published studies, and provide guidance on improving the design and conduct of vector control studies. We hope that this critical assessment will increase the impetus for more carefully considered and rigorous design of vector control studies.
C1 [Wilson, Anne L.; Pinder, Margaret; Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.
   [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Kleinschmidt, Immo] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
   [Pinder, Margaret] MRC Unit, Banjul, Gambia.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Scott, Thomas W.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Tusting, Lucy S.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.
RP Lindsay, SW (reprint author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.
EM s.w.lindsay@durham.ac.uk
OI Tusting, Lucy/0000-0002-6897-8625
FU Bill & Melinda Gates Foundation [OPP1053338]; Research and Policy for
   Infectious Disease Dynamics (RAPIDD) programme of the Science and
   Technology Directorate, US Department of Homeland Security, Fogarty
   International Center (US National Institutes of Health)
FX This work was supported by a grant from the Bill & Melinda Gates
   Foundation (OPP1053338: S.W.L., A.L.W.) and the Research and Policy for
   Infectious Disease Dynamics (RAPIDD) programme of the Science and
   Technology Directorate, US Department of Homeland Security, Fogarty
   International Center (US National Institutes of Health; T.W.S., S.W.L.).
CR Alten B, 2003, J VECTOR ECOL, V28, P53
   Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-500
   BANG YH, 1975, E AFR MED J, V52, P578
   Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31
   Bogh C, 1998, MED VET ENTOMOL, V12, P52, DOI 10.1046/j.1365-2915.1998.00091.x
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002
   Campbell MK, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5661
   Chen-Hussey V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070664
   Cook T. D., 1979, QUASIEXPERIMENTATION
   Corbett M.S., 2013, RES SYNTH METHODS, V5, P79
   D'Souza BJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-28
   Deressa W, 2014, PARASITE VECTOR, V7, P1
   Dutta P, 2011, T ROY SOC TROP MED H, V105, P327, DOI 10.1016/j.trstmh.2011.02.008
   Elnaiem DA, 1999, MED VET ENTOMOL, V13, P310, DOI 10.1046/j.1365-2915.1999.00191.x
   Dora Feliciangeli M., 2003, T R SOC TROP MED HYG, V97, P641
   Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20
   Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632
   Focks DA, 1997, AM J TROP MED HYG, V56, P159
   Focks DA, 2000, AM J TROP MED HYG, V62, P11
   Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684
   Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45
   Hawley WA, 2003, AM J TROP MED HYG, V68, P121
   Hayes RJ, 2009, INTERD STAT, P3
   Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319
   Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8
   IYENGAR M O, 1959, Trop Geogr Med, V11, P287
   Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54
   KARCH S, 1992, J AM MOSQUITO CONTR, V8, P376
   Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0
   Kirkwood B. R., 2003, ESSENTIAL MED STAT
   Kroeger A, 2006, BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Kroeger A, 1997, AM J TROP MED HYG, V56, P580
   Le Prince JAA, 1916, MOSQUITO CONTROL PAN
   LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P45, DOI 10.1016/0035-9203(93)90175-P
   Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6
   Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875
   Majambere S, 2010, AM J TROP MED HYG, V82, P176, DOI 10.4269/ajtmh.2010.09-0373
   Matthews G.A., 2010, ASP APPL BIOL, V99, P165
   McGready R, 2001, T ROY SOC TROP MED H, V95, P137, DOI 10.1016/S0035-9203(01)90137-3
   Moore SJ, 2007, TROP MED INT HEALTH, V12, P532, DOI 10.1111/j.1365-3156.2006.01811.x
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Nguyen HT, 1996, DENGUE B, V20, P87
   Noazin S, 2013, T ROY SOC TROP MED H, V107, P444, DOI 10.1093/trstmh/trt036
   Petticrew M, 2003, J EPIDEMIOL COMMUN H, V57, P527, DOI 10.1136/jech.57.7.527
   Picado A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003597
   Picado A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6760
   Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587
   Pinder M., 2014, LANCET, V385, P1436, DOI DOI 10.1016/S0140-6736(14)61007-2
   Porta M., 2014, DICT EPIDEMIOLOGY
   Quinones ML, 1998, T ROY SOC TROP MED H, V92, P373, DOI 10.1016/S0035-9203(98)91053-7
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Sama W, 2006, T ROY SOC TROP MED H, V100, P811, DOI 10.1016/j.trstmh.2005.11.001
   Sama W, 2004, AM J TROP MED HYG, V70, P625
   Sandoval-Ruiz CA, 2014, SALUD PUBLICA MEXICO, V56, P213
   Sangoro O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-324
   Schofield CJ, 1999, ADV PARASIT, V42, P1, DOI 10.1016/S0065-308X(08)60147-5
   Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251
   Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9
   Scott TW, 2008, VECTOR BORNE DIS UND, P132
   Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87
   Soper F., 1943, ANOPHELES GAMBIAE BR
   Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779
   Tan AWA, 2012, SE ASIAN J TROP MED, V43, P296
   Torr SJ, 2005, TRENDS PARASITOL, V21, P537, DOI 10.1016/j.pt.2005.08.021
   Tsunoda T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-6
   Tusting LS, 2013, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD008923.PUB2
   Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X
   Varnell SP, 2001, EVALUATION REV, V25, P440
   VITTAL M, 1984, Indian Journal of Medical Sciences, V38, P201
   Vontas J, 2014, TRENDS PARASITOL, V30, P191, DOI 10.1016/j.pt.2014.02.005
   Walshe DP, 2013, COCHRANE DB SYST REV, V12
   WEBBER RH, 1979, T ROY SOC TROP MED H, V73, P722, DOI 10.1016/0035-9203(79)90031-2
   Weerasooriya MV, 1996, T ROY SOC TROP MED H, V90, P103, DOI 10.1016/S0035-9203(96)90101-7
   West PA, 2014, PLOS MED, V11
   WHO, 2013, WHO TECH REP SER, V984, P1
   WHO, 2010, WHO TECH REP SER, V949, P1
   WHO, 2013, IND RES SPRAYING OP
   World Health Organization, 2009, DENG GUID DIAGN TREA
   WHO, 2011, UN ACC MAL DIAGN TES
   WHO, 2013, LARV SOURC MAN SUPPL
   World Health Organization, 2012, HDB INT VECT MAN
   [Anonymous], 2002, WHO TECHN REP SER, V905
   Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
NR 93
TC 10
Z9 10
U1 3
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD AUG
PY 2015
VL 31
IS 8
BP 380
EP 390
DI 10.1016/j.pt.2015.04.015
PG 11
WC Parasitology
SC Parasitology
GA CP4TY
UT WOS:000359876700010
PM 25999026
OA No
DA 2017-08-15
ER

PT J
AU Jallow, S
   Leligdowicz, A
   Kramer, HB
   Onyango, C
   Cotten, M
   Wright, C
   Whittle, HC
   McMichael, A
   Dong, T
   Kessler, BM
   Rowland-Jones, SL
AF Jallow, Sabelle
   Leligdowicz, Aleksandra
   Kramer, Holger B.
   Onyango, Clayton
   Cotten, Matthew
   Wright, Cynthia
   Whittle, Hilton C.
   McMichael, Andrew
   Dong, Tao
   Kessler, Benedikt M.
   Rowland-Jones, Sarah L.
TI The presence of prolines in the flanking region of an immunodominant
   HIV-2 gag epitope influences the quality and quantity of the epitope
   generated
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE Antigen processing; CTL epitopes; HIV-2; Gag p26; DRFYKSLRA
ID CYTOTOXIC T-LYMPHOCYTES; CLASS-I MOLECULES; IMMUNODEFICIENCY-VIRUS
   TYPE-1; VIRAL LOAD; ANTIGEN PRESENTATION; WEST-AFRICA; CELL RESPONSES;
   CTL EPITOPE; INFECTION; PEPTIDES
AB Both the recognition of HIV-infected cells and the immunogenicity of candidate CTL vaccines depend on the presentation of a peptide epitope at the cell surface, which in turn depends on intracellular antigen processing. Differential antigen processing maybe responsible for the differences in both the quality and the quantity of epitopes produced, influencing the immunodominance hierarchy of viral epitopes. Previously, we showed that the magnitude of the HIV-2 gag-specific T-cell response is inversely correlated with plasma viral load, particularly when responses are directed against an epitope, (165)DRFYKSLRA(173), within the highly conserved Major Homology Region of gag-p26. We also showed that the presence of three proline residues, at positions 119, 159 and 178 of gag-p26, was significantly correlated with low viral load. Since this proline motif was also associated with stronger gag-specific CTL responses, we investigated the impact of these prolines on proteasomal processing of the protective 165DRFYKSLRA173 epitope. Our data demonstrate that the 165DRFYKSLRA173 epitope is most efficiently processed from precursors that contain two flanking proline residues, found naturally in low viral-load patients. Superior antigen processing and enhanced presentation may account for the link between infection with HIV-2 encoding the "PPP-gag" sequence and both strong gag-specific CTL responses as well as lower viral load.
C1 [Jallow, Sabelle; McMichael, Andrew; Dong, Tao] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DU, England.
   [Leligdowicz, Aleksandra] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5S 1A1, Canada.
   [Kramer, Holger B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Onyango, Clayton; Whittle, Hilton C.] MRC Unit, Fajara, Gambia.
   [Cotten, Matthew] Wellcome Trust Sanger Inst, Cambridge, England.
   [Wright, Cynthia; Kessler, Benedikt M.; Rowland-Jones, Sarah L.] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Oxford, England.
RP Jallow, S (reprint author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DU, England.
EM sabellejallow@yahoo.com
OI Leligdowicz, Aleksandra/0000-0001-6055-4644; Kramer,
   Holger/0000-0002-6400-0945; Kessler, Benedikt/0000-0002-8160-2446
FU Medical Research Council [G0801751]; Wellcome Trust OXION initiative;
   John Fell OUP Research Award; Biomedical Research Centre (NIHR), Oxford,
   UK
FX S.J, S.R-J, and this project were funded by the Medical Research Council
   strategic grant (G0801751). H.B.K. is supported by the Wellcome Trust
   OXION initiative. B.M.K. is supported by a John Fell OUP Research Award
   and by the Biomedical Research Centre (NIHR), Oxford, UK. We would like
   to acknowledge the Caio cohort members and staff and also the
   Computational Biology Research Group, Nuffield Department of Clinical
   Medicine, Oxford, for maintenance of the MASCOT server. S.J. generated
   the data, analyzed and wrote the manuscript; AL generated and analyzed
   data; H.B.K. setup, optimized mass spectrometry and generated data, C.O.
   generated and analyzed data; C.W. contributed to optimizing the mass
   spectrometry; M.C., H.C.W., A.M., T.D., and B.M.K. contributed to
   editing of the manuscript, supervision of lab work, and study design;
   S.R.J. designed the study, supervised the work, and contributed to
   editing of the manuscript.
CR Ariyoshi K, 1996, J INFECT DIS, V173, P245
   Ariyoshi K, 2000, AIDS, V14, P339, DOI 10.1097/00002030-200003100-00006
   Balbach J., 2000, MECH PROTEIN FOLDING, P212
   Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a
   Berry N, 2002, AIDS RES HUM RETROV, V18, P1167, DOI 10.1089/08892220260387904
   BROMME D, 1986, ARCH BIOCHEM BIOPHYS, V244, P439, DOI 10.1016/0003-9861(86)90611-9
   Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2
   Choppin J, 2001, J IMMUNOL, V166, P6164
   Cohen WM, 2002, J VIROL, V76, P10219, DOI 10.1128/JVI.76.20.10219-10225.2002
   Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929
   de Silva TI, 2013, BLOOD, V121, P4330, DOI 10.1182/blood-2012-12-472787
   DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y
   Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982
   Eisenlohr LC, 2007, NAT REV IMMUNOL, V7, P403, DOI 10.1038/nri2077
   EISENLOHR LC, 1992, J EXP MED, V175, P481, DOI 10.1084/jem.175.2.481
   Esbjornsson J, 2012, NEW ENGL J MED, V367, P224, DOI 10.1056/NEJMoa1113244
   Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001
   Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691
   Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0
   Harrer T, 1996, J IMMUNOL, V156, P2616
   Kay BK, 2000, FASEB J, V14, P231
   Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363
   Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572
   Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JC132047
   Leligdowicz A, 2007, J CLIN INVEST, V117, P3067, DOI 10.1172/JCI32380
   Lucchiari-Hartz M, 2003, P NATL ACAD SCI USA, V100, P7755, DOI 10.1073/pnas.1232228100
   MAMMANO F, 1994, J VIROL, V68, P4927
   Markert Y, 2003, PROTEIN ENG, V16, P1041, DOI 10.1093/protein/gzg136
   Martinez-Steele E, 2007, AIDS, V21, P317, DOI 10.1097/QAD.0b013e328011d7ab
   Milicic A, 2005, J IMMUNOL, V175, P4618
   Mo AXY, 2000, J IMMUNOL, V164, P4003
   Nahnsen S, 2013, MOL CELL PROTEOMICS, V12, P549, DOI 10.1074/mcp.R112.025163
   Onyango CO, 2010, VACCINE, V28, pB60, DOI 10.1016/j.vaccine.2009.08.060
   Popper SJ, 2000, J VIROL, V74, P1554, DOI 10.1128/JVI.74.3.1554-1557.2000
   Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010
   Poulsen AG, 1997, LANCET, V349, P911, DOI 10.1016/S0140-6736(96)04402-9
   Ranasinghe SRF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001341
   Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739
   ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591
   Saveanu L, 2002, MOL IMMUNOL, V39, P203, DOI 10.1016/S0161-5890(02)00102-5
   Saxova P, 2003, INT IMMUNOL, V15, P781, DOI 10.1093/intimm/dxg084
   Seifert U, 2004, J CLIN INVEST, V114, P250, DOI 10.1172/JCI200420985
   Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800
   THOMPSON RC, 1973, BIOCHEMISTRY-US, V12, P51, DOI 10.1021/bi00725a010
   Wagner R, 1999, J IMMUNOL, V162, P3727
   Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200
   YellenShaw AJ, 1997, J IMMUNOL, V158, P1727
   York IA, 2006, J IMMUNOL, V177, P1434
NR 48
TC 2
Z9 2
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD AUG
PY 2015
VL 45
IS 8
BP 2232
EP 2242
DI 10.1002/eji.201545451
PG 11
WC Immunology
SC Immunology
GA CP1YQ
UT WOS:000359674200009
PM 26018465
OA No
DA 2017-08-15
ER

PT J
AU Torrea, G
   Coeck, N
   Desmaretz, C
   Van De Parre, T
   Van Poucke, T
   Lounis, N
   de Jong, BC
   Rigouts, L
AF Torrea, Gabriela
   Coeck, Nele
   Desmaretz, Christel
   Van De Parre, Tim
   Van Poucke, Tijs
   Lounis, Nacer
   de Jong, Bouke C.
   Rigouts, Leen
TI Bedaquiline susceptibility testing of Mycobacterium tuberculosis in an
   automated liquid culture system
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE multidrug resistance; epidemiological cut-offs; drug susceptibility
   testing; MGIT960
ID ATP SYNTHASE; CROSS-RESISTANCE; IN-VITRO; CLOFAZIMINE
AB Objectives: The objective of this study was to evaluate the performance of the BACTEC MGIT960 system to test the susceptibility to bedaquiline for Mycobacterium tuberculosis complex.
   Methods: We determined the quality control (QC) range of bedaquiline using the M. tuberculosis H37Rv reference strain and the epidemiological cut-off (ECOFF) in MGIT960 and on Middlebrook 7H11 agar (M7H11) using 47 strains from bedaquiline treatment-naive patients. The accuracy of MGIT960 was evaluated versus M7H11 using 74 'probably susceptible to bedaquiline' and 18 'probably resistant to bedaquiline' strains. Repeatability and reproducibility of MGIT960 were assessed using five strains showing different resistance levels.
   Results: The QC range for the H37Rv strain was between 0.125 and 0.50 mg/L. The WT MIC distribution ranged from <= 0.03 to 1.00 mg/L in MGIT960 and from <= 0.008 to 0.25 mg/L on M7H11 with suggested ECOFFs of 1.00 and 0.25 mg/L, respectively. Applying these ECOFFs, the probably susceptible and probably resistant strains were distinguishable by both methods, albeit with only a 2-fold increased MIC for one of the resistant strains compared with the ECOFF. Intermethod agreement to classify the isolates was excellent (100%). All replicates in the repeatability and reproducibility experiments fell within the normal range.
   Conclusions: The MGIT960 system proved to be highly stable, reproducible and accurate relative to the M7H11 agar method for determining the bedaquiline MIC. The small margin between the suggested ECOFF and the lowest MIC for the mutant strains risks making both methods prone to discordant results. Further validation in clinical settings linked to treatment outcome data is needed.
C1 [Torrea, Gabriela; Coeck, Nele; Desmaretz, Christel; de Jong, Bouke C.; Rigouts, Leen] Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
   [Van De Parre, Tim; Van Poucke, Tijs] Inst Trop Med, Qual Dept, B-2000 Antwerp, Belgium.
   [Lounis, Nacer] Janssen Infect Dis, Clin Virol Dept, Beerse, Belgium.
   [de Jong, Bouke C.] NYU, Dept Med, Div Infect Dis, New York, NY 10016 USA.
   [de Jong, Bouke C.] MRC Unit, Vaccinol Dept, Fajara, Gambia.
   [Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.
RP Torrea, G (reprint author), Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
EM gtorrea@itg.be
RI de Jong, Bouke/A-3636-2013
OI de Jong, Bouke/0000-0002-1017-4675
FU INTERRUPTB [311725]; 'Agentschap voor Innovatie door Wetenschap en
   Technologie' ('Innovation by Science and Technology') [IWT 130308]
FX This work was supported by 'INTERRUPTB' (grant number 311725) and
   'Agentschap voor Innovatie door Wetenschap en Technologie' ('Innovation
   by Science and Technology') (grant number IWT 130308). The consumables
   were provided by ITM, Belgium.
CR Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753
   Andries K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102135
   Anti-Infective Drugs Advisory Committee, ANT DRUGS ADV COMM M
   CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
   Clinical Laboratory Standards Institute, 2011, M24A2 CLSI
   Clinical and Laboratory Standards Institute, 2008, DEV IN VITR SUSC TES
   European Committee for Antimicrobial Susceptibility Testing (EUCAST), 2013, SETT BREAKP NEW ANT
   EUCAST, 2015, DEF CLIN BREAKP EP C
   [Anonymous], SIRT BED PROD INS
   Hartkoorn RC, 2014, ANTIMICROB AGENTS CH, V58, P2979, DOI 10.1128/AAC.00037-14
   Huitric E, 2007, ANTIMICROB AGENTS CH, V51, P4202, DOI 10.1128/AAC.00181-07
   Jureen P, 2010, J CLIN MICROBIOL, V48, P1853, DOI 10.1128/JCM.00240-10
   Kahlmeter G, 2006, CLIN MICROBIOL INFEC, V12, P501, DOI 10.1111/j.1469-0691.2006.01454.x
   Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x
   Lounis N, 2014, 45 WORLD C LUNG HLTH, pS186
   Salfinger M, 2015, EUR RESPIR J, V45, P317, DOI 10.1183/09031936.00199814
   Schon T, 2009, J ANTIMICROB CHEMOTH, V64, P786, DOI 10.1093/jac/dkp262
   Sohn H, 2008, INT J ANTIMICROB AG, V31, P567, DOI 10.1016/j.ijantimicag.2008.01.016
   Somoskovi A, 2015, EUR RESPIR J, V45, P554, DOI [10.1183/09031936.00142914, 10]
   Sturegard E, 2015, CLIN MICROBIOL INFEC, V21
   World Health Organization, US BED TREATM MULT R
   WHO, GLOB TUB REP 2014
   Wiid J, 1999, ANTIMICROB AGENTS CH, V43, P975
NR 25
TC 14
Z9 15
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD AUG
PY 2015
VL 70
IS 8
BP 2300
EP 2305
DI 10.1093/jac/dkv117
PG 6
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA CP2RB
UT WOS:000359723600020
PM 25977401
OA No
DA 2017-08-15
ER

PT J
AU Silver, MJ
   Corbin, KD
   Hellenthal, G
   da Costa, KA
   Dominguez-Salas, P
   Moore, SE
   Owen, J
   Prentice, AM
   Hennig, BJ
   Zeisel, SH
AF Silver, Matt J.
   Corbin, Karen D.
   Hellenthal, Garrett
   da Costa, Kerry-Ann
   Dominguez-Salas, Paula
   Moore, Sophie E.
   Owen, Jennifer
   Prentice, Andrew M.
   Hennig, Branwen J.
   Zeisel, Steven H.
TI Evidence for negative selection of gene variants that increase
   dependence on dietary choline in a Gambian cohort
SO FASEB JOURNAL
LA English
DT Article
DE diet and selection; adequate intake levels;
   phosphatidylethanolamine-N-methyltransferase; choline dehydrogenase;
   methylenetetrahydrofolate dehydrogenase
ID NEURAL-TUBE DEFECTS; HUMAN-POPULATIONS; DNA METHYLATION; HUMAN GENOME;
   RAT-LIVER; BETAINE; FOLATE; RISK; POLYMORPHISMS; REQUIREMENT
AB Choline is an essential nutrient, and the amount needed in the diet is modulated by several factors. Given geographical differences in dietary choline intake and disparate frequencies of single-nucleotide polymorphisms (SNPs) in choline metabolism genes between ethnic groups, we tested the hypothesis that 3 SNPs that increase dependence on dietary choline would be under negative selection pressure in settings where choline intake is low: choline dehydrogenase (CHDH) rs12676, methylenetetrahydrofolate reductase 1 (MTHFD1) rs2236225, and phosphatidylethanolamine-N-methyltransferase (PEMT) rs12325817. Evidence of negative selection was assessed in 2 populations: one in The Gambia, West Africa, where there is historic evidence of a choline-poor diet, and the other in the United States, with a comparatively choline-rich diet. We used 2 independent methods, and confirmation of our hypothesis was sought via a comparison with SNP data from the Maasai, an East African population with a genetic background similar to that of Gambians but with a traditional diet that is higher in choline. Our results show that frequencies of SNPs known to increase dependence on dietary choline are significantly reduced in the low-choline setting of The Gambia. Our findings suggest that adequate intake levels of choline may have to be reevaluated in different ethnic groups and highlight a possible approach for identifying novel functional SNPs under the influence of dietary selective pressure.
C1 [Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Hennig, Branwen J.] Univ London London Sch Hyg & Trop Med, Med Res Council, Int Nutr Grp, London WC1E 7HT, England.
   [Silver, Matt J.; Dominguez-Salas, Paula; Prentice, Andrew M.; Hennig, Branwen J.] MRC Unit, Banjul, Gambia.
   [Corbin, Karen D.; Owen, Jennifer; Zeisel, Steven H.] Inst Nutr Res, Kannapolis, NC 28081 USA.
   [Corbin, Karen D.; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA.
   [Hellenthal, Garrett] UCL, Genet Inst, London WC1E 6BT, England.
   [da Costa, Kerry-Ann] Toxicol Serv Inc, Chapel Hill, NC USA.
   [Moore, Sophie E.] Med Res Council Human Nutr Res, Maternal & Child Nutr Grp, Cambridge, England.
RP Zeisel, SH (reprint author), Inst Nutr Res, 500 Laureate Way, Kannapolis, NC 28081 USA.
EM steven_zeisel@unc.edu
OI Silver, Matt/0000-0002-3852-9677
FU Wellcome Trust Grant [WT086369MA]; U.K. Medical Research Council
   [MC-A760-5QX00]; United Kingdom Department for the International
   Development (DFID) under MRC/DFID Concordat agreement; Bill and Melinda
   Gates Foundation; U.S. National Institutes of Health National Institute
   of Diabetes and Digestive and Kidney Diseases [DK56350]; Wellcome Trust
   [098386/Z/12/Z]; Royal Society [098386/Z/12/Z]
FX The authors thank the women from Kiang West, The Gambia, for their
   participation; their laboratory technicians, field assistants, nurses,
   data entry clerks, and other staff at MRC Keneba, The Gambia, and A. J.
   Fulford, Ph.D., for support in data management; Joseph Galanko, Ph.D.,
   for assistance with data organization; the research subjects in the
   North Carolina clinical cohorts for participating; Leslie Fischer for
   clinical study management; and Catherine Walker for a critical reading
   of the manuscript. The Gambian studies that provided data for the
   analyses were supported by Wellcome Trust Grant WT086369MA (to B.J.H.),
   U.K. Medical Research Council core funding Grant MC-A760-5QX00 to the
   International Nutrition Group, and the United Kingdom Department for the
   International Development (DFID) under the MRC/DFID Concordat agreement.
   Work completed by Dr. Zeisel's research team was supported by grants
   from the Bill and Melinda Gates Foundation and Grant DK56350 from the
   U.S. National Institutes of Health National Institute of Diabetes and
   Digestive and Kidney Diseases. G.H. is jointly funded by Grant
   098386/Z/12/Z from the Wellcome Trust and by a Sir Henry Dale Fellowship
   from the Royal Society. B.J.H. and S.H.Z. share senior authorship of
   this article.
CR Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766
   Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286
   Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298
   Babbitt CC, 2011, P ROY SOC B-BIOL SCI, V278, P961, DOI 10.1098/rspb.2010.2433
   BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146
   Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x
   Buchman AL, 2009, GASTROENTEROLOGY, V137, pS119, DOI 10.1053/j.gastro.2009.08.010
   Carroll N, 2009, HUM GENET, V125, P247, DOI 10.1007/s00439-008-0616-3
   Cho E, 2006, AM J CLIN NUTR, V83, P905
   Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097
   Corbin KD, 2012, PROG MOL BIOL TRANSL, V108, P159, DOI 10.1016/B978-0-12-398397-8.00007-1
   Cordain L, 2005, AM J CLIN NUTR, V81, P341
   da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06.5734.com
   da Costa KA, 2014, FASEB J, V28, P2970, DOI 10.1096/fj.14-249557
   Dalmeijer GW, 2008, EUR J CLIN NUTR, V62, P386, DOI 10.1038/sj.ejcn.1602725
   Detopoulou P, 2008, AM J CLIN NUTR, V87, P424
   Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746
   Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462
   Dyson LK, 2000, FOOD REV, V21, P2
   Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69
   Fay JC, 2000, GENETICS, V155, P1405
   Field MS, 2013, J NUTR, V143, P41, DOI 10.3945/jn.112.169821
   Fischer LM, 2007, AM J CLIN NUTR, V85, P1275
   Fischer LM, 2010, AM J CLIN NUTR, V92, P1113, DOI [10.3945/ajcn.2010.30064, 10.3945/ajen.2010.30064]
   Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459
   Gillespie J., 2004, POPULATION GENETICS
   Horne DW, 2003, J NUTR, V133, P476
   Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529
   Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013
   HUDSON GJ, 1995, BRIT J NUTR, V73, P551, DOI 10.1079/BJN19950058
   Food and Nutrition Board, 1998, DIET REF INT FOL THI, P390
   Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491
   Ivanov A, 2009, J AM DIET ASSOC, V109, P313, DOI 10.1016/j.jada.2008.10.046
   Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388
   Johnson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036047
   Knoll N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-141
   Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102
   Spigelski D, 2009, INDIGENOUS PEOPLES, P231
   Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833
   MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0
   Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107
   Moore SE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-107
   Murphy P. K., 1981, OXFORD S FODO COOKER, P290
   Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187
   Park M, 2000, TRAVELS INTERIOR DIS
   Patin E, 2008, TRENDS ECOL EVOL, V23, P56, DOI 10.1016/j.tree.2007.11.002
   Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123
   POMFRET EA, 1990, J NUTR BIOCHEM, V1, P533, DOI 10.1016/0955-2863(90)90039-N
   Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922
   RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366
   Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140
   Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097
   Schlebusch CM, 2013, EUR J HUM GENET, V21, P550, DOI 10.1038/ejhg.2012.199
   Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187
   Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049
   TAJIMA F, 1989, GENETICS, V123, P585
   United States Department of Agriculture Agricultural Research Service USDA-ARS., 2013, USDA NAT NUTR DAT ST
   Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072
   Wagh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044751
   Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806
   Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100
   Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003
   Weichselbaum E., 2009, 6 I FODO RES
   Yonemori KM, 2013, J NUTR, V143, P894, DOI 10.3945/jn.112.171132
   Zeisel Steven H, 2013, Int J Womens Health, V5, P193, DOI 10.2147/IJWH.S36610
   Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x
   Zeng FF, 2014, BRIT J CANCER, V110, P808, DOI 10.1038/bjc.2013.686
   Zhang CX, 2013, CANCER SCI, V104, P250, DOI 10.1111/cas.12064
NR 68
TC 3
Z9 3
U1 2
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD AUG
PY 2015
VL 29
IS 8
BP 3426
EP 3435
DI 10.1096/fj.15-271056
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CN9VA
UT WOS:000358796900029
PM 25921832
OA No
DA 2017-08-15
ER

PT J
AU Zumla, A
   Maeurer, M
   Chakaya, J
   Hoelscher, M
   Ntoumi, F
   Rustomjee, R
   Vilaplana, C
   Yeboah-Manu, D
   Rasolofo, V
   Munderi, P
   Singh, N
   Aklillu, E
   Padayatchi, N
   Macete, E
   Kapata, N
   Mulenga, M
   Kibiki, G
   Mfinanga, S
   Nyirenda, T
   Maboko, L
   Garcia-Basteiro, A
   Rakotosamimanana, N
   Bates, M
   Mwaba, P
   Reither, K
   Gagneux, S
   Edwards, S
   Mfinanga, E
   Abdulla, S
   Cardona, PJ
   Russell, JBW
   Gant, V
   Noursadeghi, M
   Elkington, P
   Bonnet, M
   Menendez, C
   Dieye, TN
   Diarra, B
   Maiga, A
   Aseffa, A
   Parida, S
   Wejse, C
   Petersen, E
   Kaleebu, P
   Oliver, M
   Craig, G
   Corrah, T
   Tientcheu, L
   Antonio, M
   Rao, M
   McHugh, TD
   Sheikh, A
   Ippolito, G
   Ramjee, G
   Kaufmann, SHE
   Churchyard, G
   Steyn, A
   Grobusch, M
   Sanne, I
   Martinson, N
   Madansein, R
   Wilkinson, RJ
   Mayosi, B
   Schito, M
   Wallis, RS
AF Zumla, Alimuddin
   Maeurer, Markus
   Chakaya, Jeremiah
   Hoelscher, Michael
   Ntoumi, Francine
   Rustomjee, Roxana
   Vilaplana, Cristina
   Yeboah-Manu, Dorothy
   Rasolofo, Voahangy
   Munderi, Paula
   Singh, Nalini
   Aklillu, Eleni
   Padayatchi, Nesri
   Macete, Eusebio
   Kapata, Nathan
   Mulenga, Modest
   Kibiki, Gibson
   Mfinanga, Sayoki
   Nyirenda, Thomas
   Maboko, Leonard
   Garcia-Basteiro, Alberto
   Rakotosamimanana, Niaina
   Bates, Matthew
   Mwaba, Peter
   Reither, Klaus
   Gagneux, Sebastien
   Edwards, Sarah
   Mfinanga, Elirehema
   Abdulla, Salim
   Cardona, Pere-Joan
   Russell, James B. W.
   Gant, Vanya
   Noursadeghi, Mahdad
   Elkington, Paul
   Bonnet, Maryline
   Menendez, Clara
   Dieye, Tandakha N.
   Diarra, Bassirou
   Maiga, Almoustapha
   Aseffa, Abraham
   Parida, Shreemanta
   Wejse, Christian
   Petersen, Eskild
   Kaleebu, Pontiano
   Oliver, Matt
   Craig, Gill
   Corrah, Tumena
   Tientcheu, Leopold
   Antonio, Martin
   Rao, Martin
   McHugh, Timothy D.
   Sheikh, Aziz
   Ippolito, Giuseppe
   Ramjee, Gita
   Kaufmann, Stefan H. E.
   Churchyard, Gavin
   Steyn, Andrie
   Grobusch, Martin
   Sanne, Ian
   Martinson, Neil
   Madansein, Rajhmun
   Wilkinson, Robert J.
   Mayosi, Bongani
   Schito, Marco
   Wallis, Robert S.
CA Host-Directed Therapies Network
TI Towards host-directed therapies for tuberculosis
SO NATURE REVIEWS DRUG DISCOVERY
LA English
DT Editorial Material
ID TREATMENT REGIMENS; DRUGS
C1 [Zumla, Alimuddin; Noursadeghi, Mahdad; McHugh, Timothy D.] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin; Noursadeghi, Mahdad; McHugh, Timothy D.] UCL Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London NW3 2PF, England.
   [Maeurer, Markus; Parida, Shreemanta; Rao, Martin] Karolinska Inst, Dept Lab Med, Therapeut Immunol, SE-14186 Stockholm, Sweden.
   [Maeurer, Markus; Parida, Shreemanta; Rao, Martin] Karolinska Hosp, Ctr Allogene Stem Cell Transplantat, SE-14186 Stockholm, Sweden.
   [Chakaya, Jeremiah] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Hoelscher, Michael] Univ Munich, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.
   [Hoelscher, Michael] DZIF German Ctr Infect Res, Munich, Germany.
   [Ntoumi, Francine] Fdn Congolaise Rech Med, Brazzaville, Congo.
   [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Rustomjee, Roxana] MRC, Cape Town, South Africa.
   [Vilaplana, Cristina; Cardona, Pere-Joan] Fundacio Inst Invest Ciencies Salut Germans Trias, Unitat TB Expt, Edifici Labos Rec Can Ruti Campus, Barcelona, Spain.
   [Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Bacteriol Dept, Legon, Ghana.
   [Rasolofo, Voahangy; Rakotosamimanana, Niaina] Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar.
   [Munderi, Paula; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, Res Unit AIDS, Entebbe, Uganda.
   [Singh, Nalini] Inkosi Albert Luthuli Cent Hosp, Durban, South Africa.
   [Singh, Nalini; Madansein, Rajhmun] King DinuZulu Hosp, Durban, South Africa.
   [Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden.
   [Padayatchi, Nesri] Ctr AIDS Prevent Res South Africa CAPRISA, SAMRC CAPRISA HIV TB Pathogenesis & Treatment Res, Durban, South Africa.
   [Macete, Eusebio; Garcia-Basteiro, Alberto] Ctr Invest Saude Manhica, Maputo, Mozambique.
   [Kapata, Nathan; Bates, Matthew; Mwaba, Peter] Univ Teaching Hosp, UNZA UCLMS Res & Training Project, Lusaka, Zambia.
   [Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia.
   [Kibiki, Gibson] Kilimanjaro Clin Res Inst KCRI, Kilimanjaro, Tanzania.
   [Mfinanga, Elirehema] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania.
   [Nyirenda, Thomas] Eur Developing Countries Clin Trials Partnership, Cape Town, South Africa.
   [Maboko, Leonard] Mbeya Med Res Ctr, Mbeya, Tanzania.
   [Reither, Klaus; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Edwards, Sarah] Univ Coll London Hosp NHS Trust, NIHR BRC, Eth & Governance, London, England.
   [Mfinanga, Elirehema] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Russell, James B. W.] Univ Sierra Leone, Connaught Hosp, Coll Med & Allied Hlth Sci, Dept Internal Med, Freetown, Sierra Leone.
   [Zumla, Alimuddin; Gant, Vanya; Noursadeghi, Mahdad] Univ Coll London Hosp NHS Fdn, Dept Microbiol, London, England.
   [Elkington, Paul] Univ Southampton, Dept Resp Med, Southampton, Hants, England.
   [Bonnet, Maryline] IRD, Epicentre, Paris, France.
   [Menendez, Clara] Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain.
   [Menendez, Clara] Immunol Unit Lab Bacteriol Virol, Le Dantec, Senegal.
   [Dieye, Tandakha N.] Labs Natl Blood Transfus Ctr, Dakar, Senegal.
   [Diarra, Bassirou; Maiga, Almoustapha] Univ STT, FMOS, SEREFO HIV TB Res & Training CenteHIV TB Res Trai, Bamako, Mali.
   [Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Wejse, Christian; Petersen, Eskild] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark.
   [Oliver, Matt] Results UK, London, England.
   [Craig, Gill] City Univ London, Sch Hlth Sci, London EC1V 0HB, England.
   [Corrah, Tumena] Northwick Pk Hosp & Clin Res Ctr, Dept Infect & Trop Dis, London, England.
   [Tientcheu, Leopold; Antonio, Martin] MRC, Banjul, Gambia.
   [Sheikh, Aziz] Univ Edinburgh, Ctr Med Informat, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.
   [Ippolito, Giuseppe] Natl Inst Infect Dis Lazzar Spallanzani, Rome, Italy.
   [Ramjee, Gita] MRC, HIV Prevent Res Unit, Durban, South Africa.
   [Kaufmann, Stefan H. E.] Max Planck Inst, Berlin, Germany.
   [Churchyard, Gavin; Wallis, Robert S.] Aurum Inst, Johannesburg, South Africa.
   [Steyn, Andrie] Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB, K-RITH Tower Bldg, Durban, South Africa.
   [Grobusch, Martin] Univ Amsterdam, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands.
   [Sanne, Ian] Univ Witwatersrand, Right Care, Johannesburg, South Africa.
   [Martinson, Neil] Publ Hlth Res Unit, Soweto, South Africa.
   [Madansein, Rajhmun] Univ KwaZulu Natal, Dept Cardiothorac Surg, Inkosi Albert Luthuli Cent Hosp, Durban, South Africa.
   [Wilkinson, Robert J.] Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa.
   [Wilkinson, Robert J.] Francis Crick Inst Mill Hill Lab, London, England.
   [Mayosi, Bongani] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa.
   [Mayosi, Bongani] Univ Cape Town, ZA-7925 Cape Town, South Africa.
   [Schito, Marco] Crit Path Inst, Crit Path TB Drug Regimens, Tucson, AZ USA.
RP Zumla, A (reprint author), UCL, Div Infect & Immun, London, England.
EM a.zumla@ucl.ac.uk; Markus.Maeurer@ki.se
RI ; Wejse, Christian/C-8468-2014; Vilaplana, Cristina/K-7216-2012;
   Ippolito, Giuseppe/J-7207-2017
OI Steyn, Adrie JC/0000-0001-9177-8827; Wejse,
   Christian/0000-0002-2534-2942; Aseffa, Abraham/0000-0002-8028-1150;
   Cardona, Pere-Joan/0000-0001-5623-7873; Gagneux,
   Sebastien/0000-0001-7783-9048; Vilaplana, Cristina/0000-0002-2808-7270;
   Rao, Martin/0000-0002-0579-1097; Zumla, Alimuddin/0000-0002-5111-5735;
   Aklillu, Eleni/0000-0002-9788-0790; Wilkinson,
   Robert/0000-0002-2753-1800; Ippolito, Giuseppe/0000-0002-1076-2979;
   Elkington, Paul/0000-0003-0390-0613
FU Wellcome Trust [104803]
CR Bento CF, 2015, DNA CELL BIOL, V34, P228, DOI 10.1089/dna.2014.2745
   Stanley SA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003946
   Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813
   Zumla A, 2015, LANCET RESP MED, V3, P220, DOI 10.1016/S2213-2600(15)00063-6
   Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001
NR 5
TC 35
Z9 35
U1 2
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1776
EI 1474-1784
J9 NAT REV DRUG DISCOV
JI Nat. Rev. Drug Discov.
PD AUG
PY 2015
VL 14
IS 8
BP 511
EP +
DI 10.1038/nrd4696
PG 2
WC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
GA CO3BX
UT WOS:000359032700001
PM 26184493
OA No
DA 2017-08-15
ER

PT J
AU Jones, HL
   Jammeh, L
   Owens, S
   Fulford, AJ
   Moore, SE
   Pettifor, JM
   Prentice, A
AF Jones, Helen L.
   Jammeh, Lamin
   Owens, Stephen
   Fulford, Anthony J.
   Moore, Sophie E.
   Pettifor, John M.
   Prentice, Ann
TI Prevalence of rickets-like bone deformities in rural Gambian children
SO BONE
LA English
DT Article
DE Africa; Calcium; Deformity; Rickets
ID VITAMIN-D DEFICIENCY; NUTRITIONAL RICKETS; CALCIUM SUPPLEMENTATION;
   NIGERIAN CHILDREN; WORLD
AB The aim of this study was to estimate the burden of childhood rickets-like bone deformity in a rural region of West Africa where rickets has been reported in association with a low calcium intake. A population-based survey of children aged 0.5-17.9 years living in the province of West Kiang, The Gambia was conducted in 2007. 6221 children, 92% of those recorded in a recent census, were screened for physical signs of rickets by a trained survey team with clinical referral of suspected cases. Several objective measures were tested as potential screening tools. The prevalence of bone deformity in children <18.0 years was 33%. The prevalence was greater in males (M = 43%, F = 23%, p < 0.001) and in children <5.0 years (5.7%, M = 8.3%, F = 2.9%). Knock-knee was more common (58%) than bow-leg (31%) or windswept deformity (9%). Of the 196 examined clinically, 36 were confirmed to have a deformity outside normal variation (47% knock-knee, 53% bow-leg), resulting in more conservative prevalence estimates of bone deformity: 0.6% for children <18.0 years (M = 0.9%, F = 0.2%), 1.5% for children <5.0 years (M = 2.3%, F = 0.6%). Three of these children (9% of those with clinically-confirmed deformity, 0.05% of those screened) had active rickets on X-ray at the time of medical examination. This emphasises the difficulties in comparing prevalence estimates of rickets-like bone deformities from population surveys and clinic-based studies. Interpopliteal distance showed promise as an objective screening measure for bow-leg deformity. In conclusion, this population survey in a rural region of West Africa with a low calcium diet has demonstrated a significant burden of rickets-like bone deformity, whether based on physical signs under survey conditions or after clinical examination, especially in boys <5.0 years. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Jones, Helen L.; Prentice, Ann] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge CBI 9NL, England.
   [Jones, Helen L.; Jammeh, Lamin; Owens, Stephen; Fulford, Anthony J.; Moore, Sophie E.; Prentice, Ann] MRC Keneba, Keneba, Gambia.
   [Fulford, Anthony J.; Moore, Sophie E.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Pettifor, John M.] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, MRC Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.
RP Prentice, A (reprint author), MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge CBI 9NL, England.
EM ann.prentice@mrc-hnr.cam.ac.uk
OI Pettifor, John/0000-0003-1155-0334
FU Medical Research Council (MRC) [U105960371, U123261351]; MRC; Department
   for International Development (DFID) under the MRC/DFID Concordat
   agreement
FX We wish to thank Dr Ahamefula Ebirim, Dr Landing Jarjou, Mr Yankuba Sawo
   and the survey, medical, transport and IT teams at MRC Keneba, The
   Gambia and others who contributed to this work. The work was conducted
   under Medical Research Council (MRC) programmes U105960371 and
   U123261351 and was jointly funded by the MRC and the Department for
   International Development (DFID) under the MRC/DFID Concordat agreement.
   The funding bodies had no involvement in the study design, the writing
   of the report or the decision to publish.
CR Braithwaite V, 2013, BONE, V53, P216, DOI 10.1016/j.bone.2012.12.003
   Braithwaite Vickie, 2012, Int J Pediatr Endocrinol, V2012, P27, DOI 10.1186/1687-9856-2012-27
   Braithwaite V, 2012, BONE, V50, P1351, DOI 10.1016/j.bone.2012.03.010
   Dibba B, 2000, AM J CLIN NUTR, V71, P544
   FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17
   ICDDRB, 2009, HLTH SCI B, V7, P7
   LANGENSKIOLD A, 1989, CLIN ORTHOP RELAT R, P195
   Pettifor JM, 2012, PEDIATRIC BONE: BIOLOGY & DISEASES, 2ND EDITION, P625, DOI 10.1016/B978-0-12-382040-2.10023-1
   Pfitzner MA, 1998, J PEDIATR-US, V133, P740, DOI 10.1016/S0022-3476(98)70143-X
   Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x
   Prentice A, 2008, BONE, V42, P788, DOI 10.1016/j.bone.2007.11.014
   Prentice A, 2013, J STEROID BIOCHEM, V136, P201, DOI 10.1016/j.jsbmb.2012.11.018
   Strand MA, 2007, PEDIATR INT, V49, P202, DOI 10.1111/j.1442-200X.2007.02343.x
   Thacher TD, 2006, ANN TROP PAEDIATR, V26, P1, DOI 10.1179/146532806X90556
   Thacher TD, 2000, J TROP PEDIATRICS, V46, P132, DOI 10.1093/tropej/46.3.132
   Thacher TD, 2002, ANN TROP PAEDIATR, V22, P229, DOI 10.1179/027249302125001525
   Thacher TD, 2012, BONE, V50, P1074, DOI 10.1016/j.bone.2012.02.010
NR 17
TC 4
Z9 4
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD AUG
PY 2015
VL 77
BP 1
EP 5
DI 10.1016/j.bone.2015.04.011
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CJ7ZB
UT WOS:000355717800001
PM 25871880
OA No
DA 2017-08-15
ER

PT J
AU Ke, GM
   Ho, CH
   Chiang, MJ
   Sanno-Duanda, B
   Chung, CS
   Lin, MY
   Shi, YY
   Yang, MH
   Tyan, YC
   Liao, PC
   Chu, PY
AF Ke, Guan-Ming
   Ho, Chin-Hsiang
   Chiang, Meng-Jung
   Sanno-Duanda, Bintou
   Chung, Cheng-Shu
   Lin, Maw-Yeong
   Shi, Yong-Ying
   Yang, Ming-Hui
   Tyan, Yu-Chang
   Liao, Pao-Chi
   Chu, Pei-Yu
TI Phylodynamic analysis of the canine distemper virus hemagglutinin gene
SO BMC VETERINARY RESEARCH
LA English
DT Article
DE Canine distemper virus; hemagglutinin (H) gene; Spatiotemporal dynamics;
   Demographic dynamics; Taiwan
ID NATURALLY INFECTED-DOGS; DOMESTIC DOGS; H PROTEIN;
   GEOGRAPHICAL-DISTRIBUTION; PHYLOGENETIC ANALYSES; ACTIVATION MOLECULE;
   MEASLES VIRUSES; SOUTH-AMERICA; RNA VIRUSES; RECOMBINATION
AB Background: Canine distemper (CD) is one of the most contagious and lethal viral diseases in dogs. Despite the widespread use of vaccines, the prevalence of the CD virus (CDV) has increased at an alarming rate in recent years. In this phylodynamic study, we investigated the spatiotemporal modes of dispersal, viral demographic trends, and effectiveness of vaccines for CDV. A total of 188 full-length CDV hemagglutinin (H) gene sequences dataset were subjected to recombination analysis, including seven from modified live vaccine (MLV) strains and 12 from Taiwan specimens. After excluding the MLV strains and potential recombinant strains, alignments of 176 of 188 previous CDV strains were further used to analyze phylodynamic characteristics, and evidence of selection, and co-evolution.
   Results: The CDV genotype consisted of MLV-associated genotypes such as America-1 and Rockborn-like strains, which were characterized by long terminal branches and no distinct geographical patterns among lineages. In contrast, wild-type isolates clustered into lineages with a spatiotemporal structure and short terminal branches. Co-circulation and extensive diversification were simultaneously observed. The sequence variation signature was shaped by both geographic diversity and host tropism. Codon 506 was identified as a multi-epistatic interacting in the H protein.
   Conclusions: The topological signature revealed in this study suggests different epidemic scenarios. For example, a ladder-like backbone is a hallmark of directional selection, and cladogenesis at long terminal branches indicates the emergence of a surviving lineage. The stable effective viral population of CDV indicate the effectiveness of vaccines currently used to control the virus.
C1 [Ke, Guan-Ming; Chiang, Meng-Jung] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Grad Inst Anim Vaccine Technol, Neipu, Pingtung, Taiwan.
   [Ho, Chin-Hsiang; Chung, Cheng-Shu; Lin, Maw-Yeong] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Neipu, Pingtung, Taiwan.
   [Chiang, Meng-Jung] Country Year Ltd Co, Taoyuan, Taiwan.
   [Sanno-Duanda, Bintou; Shi, Yong-Ying; Chu, Pei-Yu] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.
   [Sanno-Duanda, Bintou] Edward Francis Small Teaching Hosp, Dept Lab Med, Banjul, Gambia.
   [Yang, Ming-Hui] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.
   [Yang, Ming-Hui; Tyan, Yu-Chang] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung, Taiwan.
   [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan.
   [Liao, Pao-Chi] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.
   [Chu, Pei-Yu] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.
RP Chu, PY (reprint author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.
EM peiyuchu@kmu.edu.tw
FU Ministry of Science and Technology [MOST 103-2320-B037-024, MOST
   104-2320-B037-018]; National Sun Yat-Sen University (Joint Research
   Project) [NSYSUKMU 104-P032]; Kaohsiung Medical University (Aim for the
   Top 500 Universities) [KMU-O104003]
FX The authors gratefully acknowledge S. Sheldon MT (ASCP) of Oklahoma
   University Medical Center Edmond (USA) for contributing to fruitful
   discussions of this research. This Taiwan study was supported by grants
   from the Ministry of Science and Technology (grant nos. MOST
   103-2320-B037-024 and MOST 104-2320-B037-018), National Sun Yat-Sen
   University (Joint Research Project grant no. NSYSUKMU 104-P032), and
   Kaohsiung Medical University (Aim for the Top 500 Universities grant no.
   KMU-O104003). The funders had no role in study design, data collection
   and analysis, decision to publish, or manuscript preparation.
CR Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493
   Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Bellini WJ, 1998, EMERG INFECT DIS, V4, P29
   Bi ZW, 2015, ARCH VIROL, V160, P523, DOI 10.1007/s00705-014-2293-y
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Blixenkrone-Moller M, 1993, APMIS Suppl, V36, P1
   BLIXENKRONEMOLLER M, 1992, ARCH VIROL, V123, P279, DOI 10.1007/BF01317264
   Bolt G, 1997, J GEN VIROL, V78, P367
   Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020
   Chare Elizabeth R., 2003, Journal of General Virology, V84, P2691, DOI 10.1099/vir.0.19277-0
   Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441
   Denzin N, 2013, VET MICROBIOL, V162, P214, DOI 10.1016/j.vetmic.2012.08.031
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Gemma T, 1996, J VET MED SCI, V58, P791
   Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799
   Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a
   Han GZ, 2008, VIRUS RES, V136, P198, DOI 10.1016/j.virusres.2008.04.022
   Han GZ, 2011, VIRUSES-BASEL, V3, P1358, DOI 10.3390/v3081358
   Hashimoto M, 2001, ARCH VIROL, V146, P149, DOI 10.1007/s007050170198
   Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752
   Hsu Z, 2011, ANIMAL HLTH REPORT, V6, P11
   Iwatsuki K, 1997, J GEN VIROL, V78, P373
   Iwatsuki K, 2000, VET MICROBIOL, V71, P281, DOI 10.1016/S0378-1135(99)00172-8
   Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3
   Kosakovsky PSL, 2005, MOL BIOL EVOL, V22, P1208, DOI DOI 10.1093/M0LBEV/MSI105
   Lan NT, 2005, VET MICROBIOL, V110, P197, DOI 10.1016/j.vetmic.2005.07.016
   Lee MS, 2010, VET J, V183, P184, DOI 10.1016/j.tvjl.2008.10.001
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Liang CT, 2007, J COMP PATHOL, V136, P57, DOI 10.1016/j.jcpa.2006.11.002
   Lole KS, 1999, J VIROL, V73, P152
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Masse N, 2004, J VIROL, V78, P9051, DOI 10.1128/JVI.78.17.9051-9063.2004
   Mateo M, 2013, J VIROL, V87, P9208, DOI 10.1128/JVI.01210-13
   McCarthy AJ, 2007, P R SOC B, V274, P3165, DOI 10.1098/rspb.2007.0884
   Mochizuki M, 1999, J CLIN MICROBIOL, V37, P2936
   Murphy F. A., 1999, VET VIROLOGY
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Noyce RS, 2013, VIROLOGY, V436, P210, DOI 10.1016/j.virol.2012.11.011
   Ohishi K, 2014, J WILDLIFE DIS, V50, P596, DOI 10.7589/2013-09-228
   Panzera Y, 2012, VIRUS RES, V163, P401, DOI 10.1016/j.virusres.2011.10.008
   Pardo IDR, 2005, J CLIN MICROBIOL, V43, P5009, DOI 10.1128/JCM.43.40.5009-5017.2005
   Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x
   Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320
   Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231
   RIMA BK, 1995, J GEN VIROL, V76, P1173, DOI 10.1099/0022-1317-76-5-1173
   ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8
   ROTA JS, 1994, VIRUS RES, V31, P317, DOI 10.1016/0168-1702(94)90025-6
   Santibanez S, 2005, J GEN VIROL, V86, P365, DOI 10.1099/vir.0.80467-0
   Sarute N, 2014, VIRUS GENES, V48, P474, DOI 10.1007/s11262-014-1054-z
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   TAMURA K, 1992, MOL BIOL EVOL, V9, P678
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Trebbien R, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085598, 10]
   Uema M, 2005, VIRUS RES, V109, P59, DOI 10.1016/j.virusres.2004.10.008
   Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947
   von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001
   von Messling V, 2005, J VIROL, V79, P5857, DOI 10.1128/JVI.79.9.5857-5862.2005
   Wilson SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099265
   Zhao JJ, 2010, VET MICROBIOL, V140, P34, DOI 10.1016/j.vetmic.2009.07.010
   Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10
NR 62
TC 6
Z9 6
U1 2
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-6148
J9 BMC VET RES
JI BMC Vet. Res.
PD JUL 25
PY 2015
VL 11
AR 164
DI 10.1186/s12917-015-0491-9
PG 15
WC Veterinary Sciences
SC Veterinary Sciences
GA CN4NA
UT WOS:000358405700002
PM 26205391
OA gold
DA 2017-08-15
ER

PT J
AU Grosso, A
   Stahlman, S
   Mothopeng, T
   Taruberekera, N
   Ouedraogo, G
   Ky-Zerbo, O
   Pitche, V
   Anato, S
   Sithole, B
   Mabuza, X
   Ceesay, N
   Diouf, D
   Trapence, G
   Umar, E
   Baral, S
AF Grosso, Ashley
   Stahlman, Shauna
   Mothopeng, Tampose
   Taruberekera, Noah
   Ouedraogo, Gautier
   Ky-Zerbo, Odette
   Pitche, Vincent
   Anato, Simplice
   Sithole, Bhekie
   Mabuza, Xolile
   Ceesay, Nuha
   Diouf, Daouda
   Trapence, Gift
   Umar, Eric
   Baral, Stefan
TI Ethical considerations for inclusion of men who have sex with men under
   the age of 18 in epidemiological research: evidence from six sub-Saharan
   African countries
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Meeting Abstract
C1 [Grosso, Ashley; Stahlman, Shauna; Baral, Stefan] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD USA.
   [Mothopeng, Tampose] Matrix Support Grp, Maseru, Lesotho.
   [Taruberekera, Noah] Populat Serv Int, Johannesburg, South Africa.
   [Ouedraogo, Gautier] Inst Rech Sci Sante, Ouagadougou, Burkina Faso.
   [Ky-Zerbo, Odette] Programme Appui Monde Associatif & Communautaire, Ouagadougou, Burkina Faso.
   [Pitche, Vincent] Conseil Natl Lutte SIDA Togo, Lome, Togo.
   [Anato, Simplice] Arc Ciel, Lome, Togo.
   [Sithole, Bhekie] Univ Stellenbosch, Dept Hlth Sci, ZA-7600 Stellenbosch, South Africa.
   [Mabuza, Xolile] Rock Hope, Manzini, Swaziland.
   [Ceesay, Nuha] UNAIDS, Banjul, Gambia.
   [Diouf, Daouda] Enda Sante, Dakar, Senegal.
   [Trapence, Gift] Ctr Dev People, Blantyre, Malawi.
   [Umar, Eric] Malawi Coll Med, Blantyre, Malawi.
EM grossoas@gmail.com
OI Grosso, Ashley/0000-0001-5759-7125
NR 0
TC 0
Z9 0
U1 1
U2 1
PU INT AIDS SOCIETY
PI GENEVA
PA AVENUE DE FRANCE 23, GENEVA, 1202, SWITZERLAND
SN 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD JUL
PY 2015
VL 18
SU 4
MA TUAC0304
DI 10.7448/IAS.18.5.20376
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CN8FS
UT WOS:000358675700085
OA gold
DA 2017-08-15
ER

PT J
AU Simpson, S
   deSilva, T
   Yindom, LM
   Leligdowicz, A
   Vincent, T
   Rowland-Jones, S
AF Simpson, Shmona
   deSilva, Thushan
   Yindom, Louis-Marie
   Leligdowicz, Alexandra
   Vincent, Timothy
   Rowland-Jones, Sarah
TI Polymorphisms in TRIM22 are associated with HIV-2 acquisition and
   disease progression
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Meeting Abstract
C1 [Simpson, Shmona; deSilva, Thushan; Yindom, Louis-Marie; Leligdowicz, Alexandra; Rowland-Jones, Sarah] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Vincent, Timothy] MRC Unit, Serrekunda, Gambia.
EM shmona.simpson@trinity.ox.ac.uk
NR 0
TC 0
Z9 0
U1 0
U2 2
PU INT AIDS SOCIETY
PI GENEVA
PA AVENUE DE FRANCE 23, GENEVA, 1202, SWITZERLAND
SN 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD JUL
PY 2015
VL 18
SU 4
MA TUPDA0105
DI 10.7448/IAS.18.5.20443
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CN8FS
UT WOS:000358675700162
OA gold
DA 2017-08-15
ER

PT J
AU Tientcheu, LD
   Maertzdorf, J
   Weiner, J
   Adetifa, IM
   Mollenkopf, HJ
   Sutherland, JS
   Donkor, S
   Kampmann, B
   Kaufmann, SHE
   Dockrell, HM
   Ota, MO
AF Tientcheu, L. D.
   Maertzdorf, J.
   Weiner, J.
   Adetifa, I. M.
   Mollenkopf, H-J
   Sutherland, J. S.
   Donkor, S.
   Kampmann, B.
   Kaufmann, S. H. E.
   Dockrell, H. M.
   Ota, M. O.
TI Differential transcriptomic and metabolic profiles of M-africanum- and
   M-tuberculosis-infected patients after, but not before, drug treatment
SO GENES AND IMMUNITY
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; RESISTANT TUBERCULOSIS;
   IMMUNE-RESPONSE; COMPLEX; LINEAGE; COMMON; LIVER; IDENTIFICATION;
   ASSOCIATION
AB The epidemiology of Mycobacterium tuberculosis (Mtb) and M. africanum (Maf) suggests differences in their virulence, but the host immune profile to better understand the pathogenesis of tuberculosis (TB) have not been studied. We compared the transcriptomic and metabolic profiles between Mtb- and Maf-infected TB cases to identify host biomarkers associated with lineages-specific pathogenesis and response to anti-TB chemotherapy. Venous blood samples from Mtb- and Maf-infected patients obtained before and after anti-TB treatment were analyzed for cell composition, gene expression and metabolic profiles. Prior to treatment, similar transcriptomic profiles were seen in Maf- and Mtb-infected patients. In contrast, post treatment, over 1600 genes related to immune responses and metabolic diseases were differentially expressed between the groups. Notably, the upstream regulator hepatocyte nuclear factor 4-alpha (HNF4 alpha), which regulated 15% of these genes, was markedly enriched. Serum metabolic profiles were similar in both group pre-treatment, but the decline in pro-inflammatory metabolites post treatment were most pronounced in Mtb-infected patients. Together, the differences in both peripheral blood transcriptomic and serum metabolic profiles between Maf- and Mtb-infected patients observed over the treatment period, might be indicative of intrinsic host factors related to susceptibility to TB and/or differential efficacy of the standard anti-TB treatment on the two lineages.
C1 [Tientcheu, L. D.; Sutherland, J. S.; Donkor, S.; Kampmann, B.; Ota, M. O.] Vaccinol Theme, Med Res Council Unit, Banjul 273, Gambia.
   [Tientcheu, L. D.; Dockrell, H. M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England.
   [Tientcheu, L. D.] Univ Yaounde I, Fac Sci, Dept Biochem, Yaounde, Cameroon.
   [Maertzdorf, J.; Weiner, J.; Mollenkopf, H-J; Kaufmann, S. H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.
   [Adetifa, I. M.] Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Ota, M. O.] WHO, Reg Off Afr, Brazzaville, Congo.
RP Tientcheu, LD (reprint author), Vaccinol Theme, Med Res Council Unit, Atlantic Rd Fajara, Banjul 273, Gambia.
EM ltientcheu@mrc.gm; maertzdorf@mpiib-berlin.mpg.de;
   kaufmann@mpiib-berlin.mpg.de
RI Kaufmann, Stefan HE/I-5454-2014
OI Kaufmann, Stefan HE/0000-0001-9866-8268; Dockrell,
   Hazel/0000-0003-1869-9107; Kampmann, Beate/0000-0002-6546-4709;
   Sutherland, Jayne/0000-0002-7083-4997
FU MRC Unit; Gambia as a PhD fellowship; European Commission Advanced
   Immunization Technologies (ADITEC) [FP7-HEALTH-2011-280873]; Max Planck
   Institute for Infection Biology in Berlin, Germany
FX We thank the Gambian National Leprosy and Tuberculosis Programme for
   their continuing collaboration. We are also grateful to study
   participants, field workers, especially K Kanyi and O Ceesay for
   performing sample collection, MRC TB clinical staff and P Camara for
   obtaining consent and enrolling participants, TB immunology and TB
   diagnostic laboratory staff, and M Antonio, P Owiafe, A Bojang, J Mendy,
   M Daramy, J Otu and F Mendy for laboratory assistance. We also thank T
   Togun for clinical examination of study patients and ML Grossman for
   editorial support. Finally, we thank Metabolon Inc. for generating the
   metabolic profiles. The study was funded by the MRC Unit, The Gambia as
   a PhD fellowship awarded to LDT, the European Commission Advanced
   Immunization Technologies (ADITEC) Grant FP7-HEALTH-2011-280873, and the
   Max Planck Institute for Infection Biology in Berlin, Germany.
CR Ammons MC, 2013, BIOFOULING, V29, P443, DOI 10.1080/08927014.2013.773317
   Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657
   Babeu JP, 2014, WORLD J GASTROENTERO, V20, P22, DOI 10.3748/wjg.v20.i1.22
   Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191
   Blumenthal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037314
   Bold TD, 2012, J INFECT DIS, V205, P984, DOI 10.1093/infdis/jir883
   Click ES, 2013, INT J TUBERC LUNG D, V17, P878, DOI 10.5588/ijtld.12.0732
   Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499
   Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590
   Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468
   Crestani M, 2004, BIOCHEM SOC T, V32, P92, DOI 10.1042/BST0320092
   de Jong BC, 2007, INT J TUBERC LUNG D, V11, P450
   de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x
   de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08
   Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656
   Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316
   Gehre F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002220
   Gumbo T, 2013, NAT GENET, V45, P720, DOI 10.1038/ng.2675
   Han M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095954
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010
   Jafar-Mohammadi B, 2011, DIABETOLOGIA, V54, P111, DOI 10.1007/s00125-010-1916-4
   Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64
   Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538
   Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288
   Liaw A, 2002, R NEWS, V2002, P18, DOI DOI 10.1016/J.MEMSCI.2010.02.036
   Maertzdorf J., 2011, PLoS ONE, pe26938, DOI 10.1371/journal.pone.0026938
   Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51
   Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109
   Mohlke Karen L, 2005, Curr Diab Rep, V5, P149, DOI 10.1007/s11892-005-0043-y
   Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004
   Pareek M, 2013, THORAX, V68, P221, DOI 10.1136/thoraxjnl-2012-201824
   Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307
   Renko M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-45
   Restrepo BI, 2014, DIABETES RES CLIN PR, V106, P191, DOI 10.1016/j.diabres.2014.06.011
   Sedlmayr P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00230
   Smyth GK, 2005, STAT BIOL HEALTH, P397
   Suzuki Y, 2012, CLIN VACCINE IMMUNOL, V19, P436, DOI 10.1128/CVI.05402-11
   Tientcheu LD, 2014, EUR J IMMUNOL, V44, P1387, DOI 10.1002/eji.201343956
   Varahram M, 2014, MEDITERR J HEMATOL I, V6
   Via LE, 2013, INFECT IMMUN, V81, P2909, DOI 10.1128/IAI.00632-13
   Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594
   Weiner J, 2013, ANN NY ACAD SCI, V1283, P22, DOI 10.1111/j.1749-6632.2012.06802.x
   Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221
   Yin SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084633
NR 49
TC 9
Z9 9
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-4879
EI 1476-5470
J9 GENES IMMUN
JI Genes Immun.
PD JUL-AUG
PY 2015
VL 16
IS 5
BP 347
EP 355
DI 10.1038/gene.2015.21
PG 9
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA CN4CC
UT WOS:000358375500007
PM 26043170
OA No
DA 2017-08-15
ER

PT J
AU Bojang, A
   Jafali, J
   Egere, UE
   Hill, PC
   Antonio, M
   Jeffries, D
   Greenwood, BM
   Roca, A
AF Bojang, Abdoulie
   Jafali, James
   Egere, Uzochukwu E.
   Hill, Phillip C.
   Antonio, Martin
   Jeffries, David
   Greenwood, Brian M.
   Roca, Anna
TI Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia
   Determined within the Context of a Cluster Randomized Pneumococcal
   Vaccine Trial
SO PLOS ONE
LA English
DT Article
ID STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROTYPE REPLACEMENT;
   INFANT VACCINATION; CLINICAL-FEATURES; AFRICAN CHILDREN;
   INVASIVE-DISEASE; KILIFI DISTRICT; WEST-AFRICA; EPIDEMIOLOGY
AB Background
   We conducted an ancillary study among individuals who had participated in a PCV-7 trial in rural Gambia, to determine the influence of season on the prevalence of pneumococcal carriage.
   Methods
   636 individuals above 30 months of age were followed from 4 to 20 months after vaccination with PCV-7 or meningococcal-conjugate-vaccine. Nasopharyngeal swabs were collected periodically between November 2006 and June 2008. Overall, 4,495 NPS were collected.
   Results
   Prevalence of pneumococcal nasopharyngeal carriage in the study subjects (median age 11 years) was 55.0%; this prevalence decreased linearly with increasing age (p = 0.001). Prevalence of carriage was significantly higher during the dry than the rainy season for any pneumococcal carriage [57.6% versus 47.8% (p<0.001)], pneumococcal vaccine serotype carriage [10.3% versus 6.5% (p< 0.001)] and non-vaccine serotype carriage [49.7% versus 42.7% (p<0.001)]. Differences remained significant in the adjusted analysis.
   Conclusions
   In areas of Africa with marked variation in rainfall, seasonality of pneumococcal carriage needs to be considered when interpreting carriage data.
C1 [Bojang, Abdoulie; Jafali, James; Egere, Uzochukwu E.; Hill, Phillip C.; Antonio, Martin; Jeffries, David; Roca, Anna] MRC Unit, Fajara, Gambia.
   [Hill, Phillip C.] Ctr Int Hlth, Sch Med, Dunedin, New Zealand.
   [Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
RP Roca, A (reprint author), MRC Unit, Fajara, Gambia.
EM aroca@mrc.gm
FU Medical Research Council Unit, The Gambia
FX This work was supported by the Medical Research Council Unit, The
   Gambia. Study vaccines were donated by Wyeth Lederle Vaccines (Pfizer).
CR Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c
   Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Bottomley C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0786
   BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133
   Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624
   Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168
   Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195
   Egere U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049143
   Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x
   Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5
   Gounder PP, 2013, J INFECT DIS
   Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2
   Greenwood B, 1999, PHILOS T ROY SOC B, V354, P777, DOI 10.1098/rstb.1999.0430
   Greenwood B, 2006, CLIN INFECT DIS, V43, P701, DOI 10.1086/506943
   Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100
   Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443
   Isaacman DJ, 2007, VACCINE, V25, P2420, DOI 10.1016/j.vaccine.2006.09.011
   Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010
   Kanungo R, 2000, INDIAN J MED RES, V112, P100
   Mehtala J, 2013, EPIDEMIOLOGY, V24, P522, DOI 10.1097/EDE.0b013e318294be89
   Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1
   Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI 10.1097/00006454-200302000-00009
   ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010
   ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y
   Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558
   Olaleye BO, 1998, T ROY SOC TROP MED H, V92, P300, DOI 10.1016/S0035-9203(98)91021-5
   REDD SC, 1992, LANCET, V340, P1140, DOI 10.1016/0140-6736(92)93160-O
   Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   Rozenbaum MH, 2011, EXPERT REV VACCINES, V10, P187, DOI [10.1586/erv.10.163, 10.1586/ERV.10.163]
   Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]
   Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498
   TUGWELL P, 1976, Q J MED, V45, P583
   van der Linden M, 2012, VACCINE, V30, P5880, DOI 10.1016/j.vaccine.2012.06.068
   van Hoek AJ, 2014, CLIN INFECT DIS, V58, P195, DOI 10.1093/cid/cit726
   Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562
   Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721
   Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8
NR 43
TC 0
Z9 0
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2015
VL 10
IS 7
AR e0129649
DI 10.1371/journal.pone.0129649
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1CG
UT WOS:000358153000030
PM 26132206
OA gold
DA 2017-08-15
ER

PT J
AU Ejo, M
   Gehre, F
   Barry, MD
   Sow, O
   Bah, NM
   Camara, M
   Bah, B
   Uwizeye, C
   Nduwamahoro, E
   Fissette, K
   De Rijk, P
   Merle, C
   Olliaro, P
   Burgos, M
   Lienhardt, C
   Rigouts, L
   de Jong, BC
AF Ejo, Mebrat
   Gehre, Florian
   Barry, Mamadou Dian
   Sow, Oumou
   Bah, Nene Mamata
   Camara, Mory
   Bah, Boubacar
   Uwizeye, Cecile
   Nduwamahoro, Elie
   Fissette, Kristina
   De Rijk, Pim
   Merle, Corinne
   Olliaro, Piero
   Burgos, Marcos
   Lienhardt, Christian
   Rigouts, Leen
   de Jong, Bouke C.
TI First insights into circulating Mycobacterium tuberculosis complex
   lineages and drug resistance in Guinea
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Genotypes; Guinea; Resistance; Spoligotyping; Tuberculosis
ID GENETIC DIVERSITY; PULMONARY TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY;
   TREATMENT OUTCOMES; CONTROLLED-TRIAL; LESSONS LEARNT; STRAINS; AFRICA;
   SPOLIGOTYPES; GATIFLOXACIN
AB In this study we assessed first-line anti-tuberculosis drug resistance and the genotypic distribution of Mycobacterium tuberculosis complex (MTBC) isolates that had been collected from consecutive new tuberculosis patients enrolled in two clinical trials conducted in Guinea between 2005 and 2010. Among the total 359 MTBC strains that were analyzed in this study, 22.8% were resistant to at least one of the first line anti-tuberculosis drugs, including 2.5% multidrug resistance and 17.5% isoniazid resistance, with or without other drugs. In addition, further characterization of isolates from a subset of the two trials (n = 184) revealed a total of 80 different spoligotype patterns, 29 "orphan" and 51 shared patterns. We identified the six major MTBC lineages of human relevance, with predominance of the Euro-American lineage. In total, 132 (71.7%) of the strains were genotypically clustered, and further analysis (using the DESTUS model) suggesting significantly faster spread of LAM10_CAM family (p = 0.00016). In conclusion, our findings provide a first insight into drug resistance and the population structure of the MTBC in Guinea, with relevance for public health scientists in tuberculosis control programs. (C) 2015 Published by Elsevier B.V.
C1 [Ejo, Mebrat; Gehre, Florian; Uwizeye, Cecile; Nduwamahoro, Elie; Fissette, Kristina; De Rijk, Pim; Rigouts, Leen; de Jong, Bouke C.] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Ejo, Mebrat] Univ Gondar, Gondar, Ethiopia.
   [Gehre, Florian; de Jong, Bouke C.] MRC, Fajara, Gambia.
   [Barry, Mamadou Dian; Sow, Oumou; Bah, Nene Mamata; Camara, Mory] Reference Lab Mycobacteria, Conakry, Guinea.
   [Sow, Oumou; Bah, Boubacar] Natl Univ Hosp IgnaceDeen, Conakry, Guinea.
   [Merle, Corinne] London Sch Hyg & Trop Med, London WC1, England.
   [Merle, Corinne; Olliaro, Piero] WHO Special Programme Res & Training Trop Dis TRD, UNICEF, UNDP, World Bank, Geneva, Switzerland.
   [Olliaro, Piero] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England.
   [Burgos, Marcos] Univ New Mexico, Dept Internal Med, Div Infect Dis, Albuquerque, NM 87131 USA.
   [Lienhardt, Christian] Int Union TB & Lung Dis, Clin Trial Div, Paris, France.
   [Lienhardt, Christian] World Hlth Org, Geneva, Switzerland.
   [Rigouts, Leen] Univ Antwerp, B-2020 Antwerp, Belgium.
   [de Jong, Bouke C.] NYU, New York, NY USA.
RP Gehre, F (reprint author), Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Natl Str 155, B-2000 Antwerp, Belgium.
EM fgehre@itg.be
RI de Jong, Bouke/A-3636-2013
OI de Jong, Bouke/0000-0002-1017-4675; Ejo, Mebrat/0000-0001-8119-8394
FU European Research Council (ERC) starting grant "INTERRUPTB" [311725]
FX We would like to acknowledge the staff members of the Mycobacteriology
   Laboratory in Guinea-Conakry and of the Mycobacteriology Unit, Institute
   of Tropical Medicine, Belgium. We are grateful to the VLIR-UOS
   scholarship program and the staffs of the Interuniversity Program of
   Molecular Biology (IPMB) (Vrije University Brussel, Katholic University
   of Leuven, and Antwerp University). The study was partially funded by
   European Research Council (ERC) starting grant "INTERRUPTB", Grant
   agreement No.: 311725.
CR Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390
   Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317
   Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189
   Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017
   Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10
   CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
   Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689
   Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9
   Coscolla M., 2015, J INFECT DIS
   Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012
   Dale JW, 2001, INT J TUBERC LUNG D, V5, P216
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x
   de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08
   Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004
   Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256
   Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1
   Gagneux Sebastien, 2006, PLoS Pathogens, V2, P603, DOI 10.1371/journal.ppat.0020061
   Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000
   Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06
   Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601
   Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103
   Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907
   Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748
   Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797
   Lienhardt C, 2011, JAMA-J AM MED ASSOC, V305, P1415, DOI 10.1001/jama.2011.436
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817
   Merle CSC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-61
   Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004
   Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003
   Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363
   Sergeev R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003815
   Stucki D., 2014, J INFECT DIS
   Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253
   Tanaka MM, 2006, P NATL ACAD SCI USA, V103, P15266, DOI 10.1073/pnas.0603130103
   Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434
   Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397
   WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1
   [Anonymous], 2014, COMP HDB WHO GUID PR
   World Health Organization, 2009, GUID SURV DRUG RES T
   WHO, 2008, 4 WHO
   World Health Organization, 2014, GLOB TUB REP 2014, P1
   Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906
NR 46
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2015
VL 33
BP 314
EP 319
DI 10.1016/j.meegid.2015.05.022
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA CM1JX
UT WOS:000357438300044
PM 26004194
OA No
DA 2017-08-15
ER

PT J
AU Ceesay, SJ
   Koivogui, L
   Nahum, A
   Taal, MA
   Okebe, J
   Affara, M
   Kaman, LE
   Bohissou, F
   Agbowai, C
   Tolno, BG
   Amambua-Ngwa, A
   Bangoura, N
   Ahounou, D
   Muhammad, AK
   Duparc, S
   Hamed, K
   Ubben, D
   Bojang, K
   Achan, J
   D'Alessandro, U
AF Ceesay, Serign J.
   Koivogui, Lamine
   Nahum, Alain
   Taal, Makie Abdoulie
   Okebe, Joseph
   Affara, Muna
   Kaman, Lama Eugene
   Bohissou, Francis
   Agbowai, Carine
   Tolno, Benoit Gniouma
   Amambua-Ngwa, Alfred
   Bangoura, Nfaly
   Ahounou, Daniel
   Muhammad, Abdul Khalie
   Duparc, Stephan
   Hamed, Kamal
   Ubben, David
   Bojang, Kalifa
   Achan, Jane
   D'Alessandro, Umberto
TI Malaria Prevalence among Young Infants in Different Transmission
   Settings, Africa
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; RETROSPECTIVE SURVEILLANCE; NEONATAL
   MALARIA; AGE; EPIDEMIOLOGY; PARASITEMIA; PREGNANCY; EXPOSURE; CHILDREN;
   RECORDS
AB The prevalence and consequences of malaria among infants are not well characterized and may be underestimated. A better understanding of the risk for malaria in early infancy is critical for drug development and informed decision making. In a cross-sectional survey in Guinea, The Gambia, and Benin, countries with different malaria transmission intensities, the overall prevalence of malaria among infants <= 6 months of age was 11.8% (Guinea, 21.7%; The Gambia, 3.7%; and Benin, 10.2%). Seroprevalence ranged from 5.7% in The Gambia to 41.6% in Guinea. Mean parasite densities in infants were significantly lower than those in children 1-9 years of age in The Gambia (p<0.0001) and Benin (p = 0.0021). Malaria in infants was significantly associated with fever or recent history of fever (p = 0.007) and anemia (p = 0.001). Targeted preventive interventions, adequate drug formulations, and treatment guidelines are needed to address the sizeable prevalence of malaria among young infants in malaria-endemic countries.
C1 [Ceesay, Serign J.; Okebe, Joseph; Affara, Muna; Amambua-Ngwa, Alfred; Muhammad, Abdul Khalie; Bojang, Kalifa; Achan, Jane; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Koivogui, Lamine; Kaman, Lama Eugene; Tolno, Benoit Gniouma] Inst Natl Sante Publ, Conakry, Guinea.
   [Nahum, Alain; Bohissou, Francis; Agbowai, Carine; Ahounou, Daniel] Ctr Rech Entomol Cotonou, Cotonou, Benin.
   [Taal, Makie Abdoulie] Natl Publ Hlth Lab, Kotu, Gambia.
   [Bangoura, Nfaly] Prefectoral Sante Faranah, Faranah, Guinea.
   [Duparc, Stephan; Ubben, David] Med Malaria Venture, Geneva, Switzerland.
   [Hamed, Kamal] Novartis Pharmaceut, E Hanover, NJ USA.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
RP D'Alessandro, U (reprint author), MRC, POB 273, Banjul, Gambia.
EM Udalessandro@mrc.gm
OI Bojang, Kalifa/0000-0001-7506-0938; Hamed, Kamal/0000-0003-1896-9736
FU Medicines for Malaria Venture; Novartis Pharma AG
FX This study was funded by Medicines for Malaria Venture and Novartis
   Pharma AG.
CR Afolabi BM, 2001, AM J TROP MED HYG, V65, P822
   Alao MJ, 2013, J TROP PEDIATRICS, V59, P154, DOI 10.1093/tropej/fms069
   BIGGAR RJ, 1980, AM J TROP MED HYG, V29, P720
   Brabin B., 1990, TROP DIS B, V87, P1
   Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195
   Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4
   D'Alessandro U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-400
   Dinko B, 2013, INT J PARASITOL-DRUG, V3, P45, DOI 10.1016/j.ijpddr.2013.01.001
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Hashemzadeh A, CONGENITAL MALARIA N
   Ibhanesebhor SE, 1995, J TROP PEDIATRICS, V41, P330
   King CL, 2002, J IMMUNOL, V168, P356
   Klouwenberg PMCK, 2005, ACTA TROP, V95, P81, DOI 10.1016/j.actatropica.2005.05.003
   Larru B, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-310
   Lindsay S, 2000, LANCET, V355, P1972, DOI 10.1016/S0140-6736(00)02334-5
   Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151
   MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517
   MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740
   Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07
   Mwaniki MK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-313
   Nankabirwa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021862
   Nweneka CV, 2004, J TROP PEDIATRICS, V50, P114, DOI 10.1093/tropej/50.2.114
   Olupot-Olupot P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-117
   PASVOL G, 1977, NATURE, V270, P171, DOI 10.1038/270171a0
   Pedro R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-307
   Rowley CF, 2014, CLIN INFECT DIS, V58, P407, DOI 10.1093/cid/cit733
   Sehgal V M, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P105, DOI 10.1016/0035-9203(89)90616-0
   Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189
   Snow RW, 1999, PARASITOL TODAY, V15, P99, DOI 10.1016/S0169-4758(99)01395-2
   Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083
   Verhulst NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028991
   WORLD HEALTH ORGANIZATION, GUID TREATM MAL
   [Anonymous], 1988, BULL WORLD HEALTH OR, V66, P575
NR 33
TC 5
Z9 5
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2015
VL 21
IS 7
BP 1114
EP 1121
DI 10.3201/eid2107.142036
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CL5KF
UT WOS:000356998100003
PM 26079062
OA gold
DA 2017-08-15
ER

PT J
AU Lukianova-Hleb, E
   Bezek, S
   Szigeti, R
   Khodarev, A
   Kelley, T
   Hurrell, A
   Berba, M
   Kumar, N
   D'Alessandro, U
   Lapotko, D
AF Lukianova-Hleb, Ekaterina
   Bezek, Sarah
   Szigeti, Reka
   Khodarev, Alexander
   Kelley, Thomas
   Hurrell, Andrew
   Berba, Michail
   Kumar, Nirbhay
   D'Alessandro, Umberto
   Lapotko, Dmitri
TI Transdermal Diagnosis of Malaria Using Vapor Nanobubbles
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SCATTERING PROPERTIES; MICROSCOPY; PARASITE; SPECTROSCOPY; ELIMINATION;
   TESTS
AB A fast, precise, noninvasive, high-throughput, and simple approach for detecting malaria in humans and mosquitoes is not possible with current techniques that depend on blood sampling, reagents, facilities, tedious procedures, and trained personnel. We designed a device for rapid (20-second) noninvasive diagnosis of Plasmodium falciparum infection in a malaria patient without drawing blood or using any reagent. This method uses transdermal optical excitation and acoustic detection of vapor nanobubbles around intraparasite hemozoin. The same device also identified individual malaria parasite-infected Anopheles mosquitoes in a few seconds and can be realized as a low-cost universal tool for clinical and field diagnoses.
C1 [Lukianova-Hleb, Ekaterina] Rice Univ, Houston, TX 77005 USA.
   [Bezek, Sarah; Szigeti, Reka] Baylor Coll Med, Houston, TX 77030 USA.
   [Bezek, Sarah; Szigeti, Reka] Ben Taub Gen Hosp, Houston, TX 77030 USA.
   [Khodarev, Alexander] X Instruments LLC, Fremont, CA USA.
   [Kelley, Thomas; Hurrell, Andrew] Precis Acoust Ltd, Dorchester, Dorset, England.
   [Berba, Michail] Standa UAB, Vilnius, Lithuania.
   [Kumar, Nirbhay] Tulane Univ, New Orleans, LA 70118 USA.
   [D'Alessandro, Umberto] MRC, Banjul, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
RP Lapotko, D (reprint author), Rice Univ, 6100 Main St,MS 140, Houston, TX 77005 USA.
EM DL5@rice.edu
FU National Institutes of Health grants [AI47089, AI101427]
FX Studies in the laboratory of N.K. are supported by National Institutes
   of Health grants (AI47089 and AI101427). The patent application for the
   method described has been filed by Rice University.
CR ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297
   BALASUBRAMANIAN D, 1984, SCIENCE, V223, P828, DOI 10.1126/science.6695185
   BEIER JC, 1990, J MED ENTOMOL, V27, P377
   Butykai A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01431
   Custer JR, 2010, PROC SPIE, V7564, DOI 10.1117/12.841399
   Delahunt C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-147
   Demirev PA, 2002, ANAL CHEM, V74, P3262, DOI 10.1021/ac025621k
   Egan TJ, 2008, J INORG BIOCHEM, V102, P1288, DOI 10.1016/j.jinorgbio.2007.12.004
   Horning MP, 2014, LAB CHIP, V14, P2040, DOI 10.1039/c4lc00293h
   Lapotko D, 2009, OPT EXPRESS, V17, P2538, DOI 10.1364/OE.17.002538
   Laser Institute of America, 2007, ANSI Z136 1 2007
   Lee JY, 2012, IEEE J SEL TOP QUANT, V18, P1130, DOI 10.1109/JSTQE.2011.2164239
   Lukianova-Hleb EY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772958
   Lukianova-Hleb EY, 2014, P NATL ACAD SCI USA, V111, P900, DOI 10.1073/pnas.1316253111
   *MALERA CONS GROUP, 2011, PLOS MED, V0008
   McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x
   Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522
   Newman DM, 2008, BIOPHYS J, V95, P994, DOI 10.1529/biophysj.107.128140
   Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5
   Orban A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096981
   Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343
   Peng WK, 2014, NAT MED, V20, P1069, DOI 10.1038/nm.3622
   Samson EB, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/6/065302
   Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467
   Sullivan D., 2014, BIOPOLYM ONLINE, V9
   Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219
   Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210
   Webster GT, 2009, ANAL CHEM, V81, P2516, DOI 10.1021/ac802291a
   WHO, WORLD MALARIA REPORT
   Wilson BK, 2011, OPT EXPRESS, V19, P12190, DOI 10.1364/OE.19.012190
   Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119
   Wood BR, 2009, ANALYST, V134, P1119, DOI 10.1039/b822603b
   Zonios G, 2001, J INVEST DERMATOL, V117, P1452, DOI 10.1046/j.0022-202x.2001.01577.x
NR 33
TC 6
Z9 6
U1 0
U2 18
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2015
VL 21
IS 7
BP 1122
EP 1127
DI 10.3201/eid2107.150089
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CL5KF
UT WOS:000356998100004
PM 26079141
OA gold
DA 2017-08-15
ER

PT J
AU Hong, NV
   Amambua-Ngwa, A
   Tuan, NQ
   Cuong, DD
   Giang, NTH
   Dung, NV
   Tinh, TT
   Tien, NV
   Phuc, BQ
   Duong, IT
   Rosanas-Urgell, A
   Van Geertruyden, JP
   D'Alessandro, U
   Erhart, A
AF Nguyen Van Hong
   Amambua-Ngwa, Alfred
   Nguyen Quang Tuan
   Do Duy Cuong
   Nguyen Thi Huong Giang
   Nguyen Van Dung
   Ta Thi Tinh
   Nguyen Van Tien
   Bui Quang Phuc
   Iran Thanh Duong
   Rosanas-Urgell, Anna
   Van Geertruyden, Jean-Pierre
   D'Alessandro, Umberto
   Erhart, Annette
TI Severe Malaria Not Responsive to Artemisinin Derivatives in Man
   Returning from Angola to Vietnam Response
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Nguyen Van Hong; Ta Thi Tinh; Bui Quang Phuc; Iran Thanh Duong] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
   [Amambua-Ngwa, Alfred; D'Alessandro, Umberto] Med Res Unit, Fajara, Gambia.
   [Nguyen Quang Tuan; Do Duy Cuong; Nguyen Thi Huong Giang; Nguyen Van Dung; Nguyen Van Tien] Bach Mai Hosp, Hanoi, Vietnam.
   [Rosanas-Urgell, Anna; Erhart, Annette] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Van Geertruyden, Jean-Pierre] Univ Antwerp, Antwerp, Belgium.
RP Erhart, A (reprint author), Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium.
EM aerhart@itg.be
RI Rosanas-Urgell, Anna/D-3193-2015; Van geertruyden,
   Jean-pierre/K-6425-2014
OI Rosanas-Urgell, Anna/0000-0002-0432-5203; Van geertruyden,
   Jean-pierre/0000-0001-5006-6364
CR Chotivanich K, 2002, J INFECT DIS, V185, P1538, DOI 10.1086/340213
   National Institute of Malariology Parasitology and Entomology (NIMPE), 2015, NIMPE ANN REP NAT MA
   National Institute of Malariology Parasitology and Entomology (NIMPE), 2013, NIMPE ANN REP NAT MA
   Ringwald P, 2015, EMERG INFECT DIS, V21, P1264, DOI 10.3201/eid2107.141448
   Van Hong Nguyen, 2014, Emerg Infect Dis, V20, P1199, DOI 10.3201/eid2007.140155
NR 5
TC 0
Z9 0
U1 2
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2015
VL 21
IS 7
BP 1265
EP 1265
DI 10.3201/eid2107.150402
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CL5KF
UT WOS:000356998100036
OA gold
DA 2017-08-15
ER

PT J
AU Bamford, A
   Hart, M
   Lyall, H
   Goldblatt, D
   Kelleher, P
   Kampmann, B
AF Bamford, A.
   Hart, M.
   Lyall, H.
   Goldblatt, D.
   Kelleher, P.
   Kampmann, B.
TI The influence of paediatric HIV infection on circulating B cell subsets
   and CXCR5(+) T helper cells
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE B cell; follicular T helper; HIV; memory; paediatric
ID ANTIRETROVIRAL THERAPY; ANTIBODY-RESPONSES; IMMUNE-SYSTEM; CHILDREN;
   MEMORY
AB Antiretroviral therapy (ART) only partially restores HIV-induced alterations in lymphocyte populations. We assessed B and T cell phenotypes in a cohort of children from a single centre in the United Kingdom with perinatally acquired HIV compared to healthy controls. The majority of HIV infected children (44 of 56) were on fully suppressive combination ART. Children with perinatally acquired HIV had significantly lower memory B and CD4(+)CD45RO(+)CXCR5(+) [follicular T helper cell (Tfh)-like] T cell percentages. Detectable viraemia was associated with higher CD21(-) (activated and exhausted/tissue-like memory) B cells. A greater proportion of life spent on suppressive ART was associated with higher memory B cell percentages. These results suggest that early and sustained suppressive ART may preserve B and T cell phenotypes in perinatally acquired HIV and limit deficits in humoral immunity. A lower proportion of circulating Tfh-like cells in HIV infected children appears to be independent of HIV treatment history and ongoing HIV viraemia and warrants further investigation.
C1 [Bamford, A.; Kampmann, B.] UCL, Div Infect Dis, Paediat Sect, London, England.
   [Hart, M.; Kelleher, P.] UCL, Imperial Coll, Div Infect Dis, Immunol Sect, London, England.
   [Lyall, H.] UCL, Imperial Coll Healthcare NHS Trust, Dept Paediat Infect Dis, London, England.
   [Goldblatt, D.] UCL, Inst Child Hlth, Immunobiol Unit, London, England.
   [Kampmann, B.] Gambia Vaccinol Theme, MRC Unit, Fajara, Gambia.
RP Bamford, A (reprint author), Univ London Imperial Coll Sci Technol & Med, 2nd Floor Wright Fleming Bldg,St Marys Campus, London W2 1NY, England.
EM a.bamford@imperial.ac.uk
RI Goldblatt, David/C-5972-2008
OI Goldblatt, David/0000-0002-0769-5242; Kampmann,
   Beate/0000-0002-6546-4709
FU Imperial College Academic Health Science Centre; Medicines for Children
   Research Network; North West London Comprehensive Local Research
   Network; National Institute of Health Research (NIHR) [RTF/08/01/009];
   European Society for Pediatric Infectious Diseases (ESPID); NIHR
   [NIHR/SRF-2009-02-07]; Medical Research Council/DFID [MR/K007602/1];
   Engineering and Physical Sciences Research Council; Westminster Medical
   Research Trust; St Stephen's AIDS Trust
FX We are thankful to study participants and their families. We also thank
   Deborah Ridout for statistical support and Jo Dodge, the family clinic
   team and Amy Brewer and Farhana Abdulla (research nurses) for help with
   recruitment. We acknowledge the support of Imperial College Academic
   Health Science Centre, Medicines for Children Research Network and North
   West London Comprehensive Local Research Network. This work was
   supported by the National Institute of Health Research (NIHR) (grant
   number RTF/08/01/009) to A. B. and a European Society for Pediatric
   Infectious Diseases (ESPID) small grant award to A. B. B. K. is
   supported by funding from NIHR (grant number NIHR/SRF-2009-02-07) and
   the Medical Research Council/DFID (grant number MR/K007602/1). P. K.'s
   laboratory is supported by the Engineering and Physical Sciences
   Research Council, the Westminster Medical Research Trust and St
   Stephen's AIDS Trust.
CR Bamford A, 2015, HIV MED, DOI [10.1111/hiv.12217, DOI 10.1111/HIV.12217]
   Bamford A, 2014, AIDS, V28, P2033, DOI 10.1097/QAD.0000000000000385
   Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853
   Cagigi A, 2013, CLIN EXP IMMUNOL, V174, P274, DOI 10.1111/cei.12173
   Cagigi A, 2014, PEDIATR INFECT DIS J, V33, pE126, DOI 10.1097/INF.0000000000000144
   Cagigi A, 2014, J ALLERGY CLIN IMMUN, V133, P592, DOI 10.1016/j.jaci.2013.10.003
   Cotugno N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/805151
   Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109
   Debock I, 2013, J IMMUNOL, V191, P1231, DOI 10.4049/jimmunol.1203288
   He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007
   Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316
   Jacobsen MC, 2008, J INFECT DIS, V198, P481, DOI 10.1086/590215
   Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031
   Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067
   Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524
   Petrovas C, 2014, CURR OPIN HIV AIDS, V9, P235, DOI 10.1097/COH.0000000000000053
   Picat MQ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001542
   Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277
   Rainwater-Lovett K, 2014, JAIDS-J ACQ IMM DEF, V65, P505, DOI 10.1097/QAI.0000000000000074
   Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136
   Shi YH, 2003, CLIN IMMUNOL, V108, P128, DOI 10.1016/S1521-6616(03)00092-5
   Weinberg A, 2008, AIDS, V22, P2267, DOI 10.1097/QAD.0b013e3283189bb3
NR 22
TC 4
Z9 4
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD JUL
PY 2015
VL 181
IS 1
BP 110
EP 117
DI 10.1111/cei.12618
PG 8
WC Immunology
SC Immunology
GA CJ9TA
UT WOS:000355844500010
PM 25737039
OA No
DA 2017-08-15
ER

PT J
AU Usuf, E
   Badji, H
   Bojang, A
   Jarju, S
   Ikumapayi, UN
   Antonio, M
   Mackenzie, G
   Bottomley, C
AF Usuf, Effua
   Badji, Henry
   Bojang, Abdoulie
   Jarju, Sheikh
   Ikumapayi, Usman Nurudeen
   Antonio, Martin
   Mackenzie, Grant
   Bottomley, Christian
TI Pneumococcal carriage in rural Gambia prior to the introduction of
   pneumococcal conjugate vaccine: a population-based survey
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE pneumococcal; nasopharyngeal carriage; Gambia
ID STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE;
   HAEMOPHILUS-INFLUENZAE; SEROTYPE REPLACEMENT; CONTROLLED-TRIAL;
   CHILDREN; DISEASE; IMPACT; ADULTS
AB OBJECTIVE To evaluate pneumococcal colonisation before and after the introduction of pneumococcal conjugate vaccine (PCV) in eastern Gambia.
   METHODS Population-based cross-sectional survey of pneumococcal carriage between May and August 2009 before the introduction of PCV into the Expanded Program on Immunization. Nasopharyngeal swabs were collected from all household members, but in selected households, only children aged 6-10 years were swabbed. This age group participated in an earlier trial of a nine-valent PCV between 2000 and 2004.
   RESULTS The prevalence of nasopharyngeal pneumococcal carriage in 2933 individuals was 72.0% in underfives (N = 515), 41.6% in children aged 5-17 (N = 1508) and 13.0% in adults >= 18 (N = 910) years. The age-specific prevalence of serotypes included in PCV7, PCV10 and PCV13 was 24.7%, 26.6% and 46.8% among children <5 years of age; 8.5%, 9.2% and 17.7% among children 5-17 years; and 2.5%, 3.3% and 5.5% among adults >= 18 years. The most common serotypes were 6A (13.1%), 23F (7.6%), 3 (7.3%), 19F (7.1%) and 34 (4.6%). There was no difference in the overall carriage of pneumococci between vaccinated and unvaccinated children 8 years after the primary vaccination with three doses of PCV (48.3% vs. 41.1%).
   CONCLUSION Before the introduction of PCV, serotypes included in PCV13 accounted for about half the pneumococcal serotypes in nasopharyngeal carriage. Thus, the potential impact of PCV13 on pneumococcal disease in the Gambia is substantial.
C1 [Usuf, Effua; Badji, Henry; Bojang, Abdoulie; Jarju, Sheikh; Ikumapayi, Usman Nurudeen; Antonio, Martin; Mackenzie, Grant] MRC Unit, Fajara, Gambia.
   [Antonio, Martin] Univ Warwick, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
   [Antonio, Martin; Mackenzie, Grant] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Mackenzie, Grant] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Bottomley, Christian] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1, England.
RP Usuf, E (reprint author), MRC Gambia Unit, Atlantic Blvd,POB 273, Fajara, Gambia.
EM effuau@gmail.com
FU MRC PhD studentship; MRC (UK); Global Alliance for Vaccines and
   Immunisation
FX We sincerely thank theMRC Fajara Laboratories for serotyping the
   isolates. We appreciate the support of the entire pneumococcal
   surveillance team in Basse and many thanks to the villagers of URR. We
   thank Sir Andrew Hall and Prof Richard Adegbola who contributed to the
   design, analysis and earlier drafts of the manuscript. This work was
   funded from an MRC PhD studentship to EU, MRC (UK), and the Global
   Alliance for Vaccines and Immunisation.
CR Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548
   Akinsola AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031050
   AUSTRIAN R, 1976, MT SINAI J MED, V43, P699
   Ba F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0627-8
   Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494
   Bottomley C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0786
   Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Dayie NTKD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-490
   Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517
   Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935
   Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4
   Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443
   Liu L, 2015, LANCET, V385, P430, DOI DOI 10.1016/S0140-6736(14)61698-6
   LloydEvans N, 1996, PEDIATR INFECT DIS J, V15, P866, DOI 10.1097/00006454-199610000-00007
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304
   Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009
   Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1
   O'Brien Katherine L, 2003, Pediatr Infect Dis J, V22, pe1, DOI 10.1097/01.inf.0000049347.42983.77
   Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7
   ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010
   ONEILL KP, 1989, BRIT MED J, V298, P1061
   Pilishvili T, 2010, PEDIATRICS, V126, pE9, DOI 10.1542/peds.2009-2150
   Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   Russell FM, 2010, CLIN VACCINE IMMUNOL, V17, P1970, DOI 10.1128/CVI.00117-10
   Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730
   Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]
   Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784
   Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001
   van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975
   Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8
   Wenger JD, 2010, PEDIATR INFECT DIS J, V29, P251, DOI 10.1097/INF.0b013e3181bdbed5
NR 36
TC 2
Z9 2
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JUL
PY 2015
VL 20
IS 7
BP 871
EP 879
DI 10.1111/tmi.12505
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CJ7FY
UT WOS:000355661200005
PM 25778937
OA No
DA 2017-08-15
ER

PT J
AU Quattrochi, J
   Jasseh, M
   Mackenzie, G
   Castro, MC
AF Quattrochi, John
   Jasseh, Momodou
   Mackenzie, Grant
   Castro, Marcia C.
TI Spatial analysis of under-5 mortality and potential risk factors in the
   Basse Health and Demographic Surveillance System, the Gambia
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE child mortality; spatial analysis; risk factors; demographic
   surveillance; Cox proportional hazards models; The Gambia
ID CHILD-MORTALITY; DEVELOPING-COUNTRIES; TEMPORAL TRENDS; SOUTH-AFRICA;
   POOR; CARE; DETERMINANTS; SURVIVAL; EQUITY; MODEL
AB OBJECTIVES To describe the spatial pattern in under-5 mortality rates in the Basse Health and Demographic Surveillance System (BHDSS) and to test for associations between under-5 deaths and biodemographic and socio-economic risk factors.
   METHODS Using data on child survival from 2007 to 2011 in the BHDSS, we mapped under-5 mortality by km(2). We tested for spatial clustering of high or low death rates using Kulldorff's spatial scan statistic. Associations between child death and a variety of biodemographic and socio-economic factors were assessed with Cox proportional hazards models, and deviance residuals from the best-fitting model were tested for spatial clustering.
   RESULTS The overall death rate among children under 5 was 0.0195 deaths per child-year. We found two spatial clusters of high death rates and one spatial cluster of low death rates; children in the two high clusters died at a rate of 0.0264 and 0.0292 deaths per child-year, while in the low cluster, the rate was 0.0144 deaths per child-year. We also found that children born to Fula mothers experienced, on average, a higher hazard of death, whereas children born in the households in the upper two quintiles of asset ownership experienced, on average, a lower hazard of death. After accounting for the spatial distribution of biodemographic and socio-economic characteristics, we found no residual spatial pattern in child mortality risk.
   CONCLUSION This study demonstrates that significant inequality in under-5 death rates can occur within a relatively small area (1100 km 2). Risks of under-5 mortality were associated with mother's ethnicity and household wealth. If high mortality clusters persist, then equity concerns may require additional public health efforts in those areas.
C1 [Quattrochi, John; Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Jasseh, Momodou; Mackenzie, Grant] MRC, Fajara, Gambia.
RP Quattrochi, J (reprint author), Dept Global Hlth & Populat, 665 Huntington Ave,Bldg 1,Room 1104, Boston, MA 02115 USA.
EM john.Quattrochi@mail.harvard.edu
FU Harvard University Presidential Scholarship; NIH Infectious Disease and
   Biodefense traineeship [T32 AI007535]
FX We would like to thank the many dedicated staff of the Medical Research
   Council Unit, The Gambia and the Basse Health and Demographic
   Surveillance System for the years of work without which this study would
   not have been possible. JQ also acknowledges the support of a Harvard
   University Presidential Scholarship and an NIH Infectious Disease and
   Biodefense traineeship (T32 AI007535, PI: George Seage).
CR Adams AM, 2002, SOC SCI MED, V54, P165, DOI 10.1016/S0277-9536(01)00017-X
   Adjuik M, 2010, GLOBAL HEALTH ACTION, V3, P15, DOI 10.3402/gha.v3i0.5233
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Alam N, 2010, GLOBAL HEALTH ACTION, V3, P64, DOI 10.3402/gha.v3i0.5252
   Awini E, 2010, TROP MED INT HEALTH, V15, P520, DOI 10.1111/j.1365-3156.2010.02492.x
   Byass P, 2010, GLOBAL HEALTH ACTION, V3, P26, DOI 10.3402/gha.v3i0.5244
   Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66
   Chalasani S, 2013, POPULATION STUDIES, V68, P1
   Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57
   COX DR, 1972, J R STAT SOC B, V34, P187
   Fazzio I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-683
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292
   GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515
   Hanifi SMA, 2010, GLOBAL HEALTH ACTION, V3, P70, DOI 10.3402/gha.v3i0.5274
   Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190
   Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kanjala C, 2010, GLOBAL HEALTH ACTION, V3, P59, DOI 10.3402/gha.v3i0.5236
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995
   Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58
   Lutambi AM, 2010, GLOBAL HEALTH ACTION, V3, P32, DOI 10.3402/gha.v3i0.5254
   Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2
   Moisi JC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-142
   Moser KA, 2005, BRIT MED J, V331, P1180, DOI 10.1136/bmj.38659.588125.79
   Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954
   Nettey OEA, 2010, GLOBAL HEALTH ACTION, V3, P8, DOI 10.3402/gha.v3i0.5258
   Ombok M, 2010, TROP MED INT HEALTH, V15, P423, DOI 10.1111/j.1365-3156.2010.02467.x
   [Anonymous], 2010, GLOBAL HEALTH ACT S1
   Sankoh O, 2013, LANCET GLOB HEALTH, V1, pE69, DOI 10.1016/S2214-109X(13)70034-2
   Sartorius B, 2011, GEOSPATIAL HEALTH, V5, P285
   Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386
   Shabani J, 2010, GLOBAL HEALTH ACTION, V3, P42, DOI 10.3402/gha.v3i0.5264
   Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7
   Wagstaff A, 2004, AM J PUBLIC HEALTH, V94, P726, DOI 10.2105/AJPH.94.5.726
   World Health Organization UNICEF, 2013, PROGR SAN DRINK WAT
NR 36
TC 6
Z9 6
U1 1
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JUL
PY 2015
VL 20
IS 7
BP 941
EP 951
DI 10.1111/tmi.12490
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CJ7FY
UT WOS:000355661200013
PM 25728631
OA No
DA 2017-08-15
ER

PT J
AU Gichohi-Wainaina, WN
   Melse-Boonstra, A
   Feskens, EJ
   Demir, AY
   Veenemans, J
   Verhoef, H
AF Gichohi-Wainaina, Wanjiku N.
   Melse-Boonstra, Alida
   Feskens, Edith J.
   Demir, Ayse Y.
   Veenemans, Jacobien
   Verhoef, Hans
TI Tumour necrosis factor allele variants and their association with the
   occurrence and severity of malaria in African children: a longitudinal
   study
SO MALARIA JOURNAL
LA English
DT Article
DE Tumour necrosis factor; Malaria; Plasmodium infection
ID PLASMODIUM-FALCIPARUM MALARIA; TNF-ALPHA PROMOTER; CEREBRAL MALARIA;
   LINKAGE DISEQUILIBRIUM; RHEUMATOID-ARTHRITIS; DIABETES-MELLITUS;
   POLYMORPHISMS; GENE; DISEASE; HLA
AB Background: Tumour necrosis factor (TNF) is central to the immune response to Plasmodium infection. Its plasma concentration is influenced by allele variants in the promoter region of TNF. The study's objectives were to assess TNF allele variants (TNF-1031, TNF-308): (1) modulation of malaria rates in young Tanzanian children; (2) modulation of the severity of malaria as indicated by haemoglobin concentrations at the time of presentation with febrile episodes; and (3) the association between Plasmodium infection and haemoglobin concentration in symptomless parasite carriers.
   Methods: Data from a placebo-controlled trial in which 612 Tanzanian children aged 6-60 months with height-forage z-score in the range -3 SD to 1.5 SD was utilised. Those with Plasmodium infection at baseline were treated with artemether-lumefantrine. An episode of malaria was predefined as current Plasmodium infection with an inflammatory response (axillary temperature >= 37.5 degrees C or whole blood C-reactive protein concentration >= 8 mg/L) in children reported sick. Linkage disequilibrium (LD) pattern assessment as well as haplotype analysis was conducted using HAPLOVIEW. Cox regression models used in the primary analysis accounted for multiple episodes per child.
   Results: Genotyping of 94.9% (581/612) children for TNF-1031 (TNF-1031T>C); allele frequency was 0.39. Corresponding values for rs1800629 (TNF(-308)G>A) were 95.4% (584/612) and 0.17. Compared to the wild type genotype (TT), malaria rates were increased in the TNF-1031CC genotype (hazard ratio, HR [95% CI]: 1.41 [1.01-1.97] and 1.31 [0.97-1.76] for crude analysis and adjusting for pre-specified baseline factors, respectively) but decreased in those with the TNF(-308)AA genotype (corresponding HR: 0.13 [0.02-0.63] and 0.16 [0.04-0.67]). These associations were weaker when analysing first episodes of malaria (P value-0.59 and 0.38, respectively). No evidence that allele variants of TNF-1031 and TNF-308 affected haemoglobin concentration at first episode of malaria, or that they modified the association between Plasmodium infection and haemoglobin concentrations at baseline was observed.
   Conclusion: In this cohort of Tanzanian children, the TNF-1031CC genotype was associated with increased rates of malarial episodes, whereas the TNF(-308)AA genotype was associated with decreased rates.
C1 [Gichohi-Wainaina, Wanjiku N.; Melse-Boonstra, Alida; Feskens, Edith J.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.
   [Demir, Ayse Y.] Meander Med Ctr, Clin Chem Lab, Amersfoort, Netherlands.
   [Veenemans, Jacobien] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.
   [Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands.
   [Verhoef, Hans] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England.
   [Verhoef, Hans] MRC, Keneba, Gambia.
RP Gichohi-Wainaina, WN (reprint author), Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.
EM wngichohi@gmail.com
RI Verhoef, Hans/L-3024-2015
OI Verhoef, Hans/0000-0002-9346-9689; Feskens, Edith/0000-0001-5819-2488
CR Ackerman H, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r24
   Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029
   Altman GDM, 2000, STAT CONFIDENCE
   Atkinson SH, 2008, BLOOD, V112, P4276, DOI 10.1182/blood-2008-06-162008
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055
   BRINKMAN BMN, 1995, HUM GENET, V96, P493
   BRINKMAN BMN, 1994, HUM IMMUNOL, V41, P259, DOI 10.1016/0198-8859(94)90044-2
   Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31
   Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320
   DALFONSO S, 1994, IMMUNOGENETICS, V39, P150
   Daniele G, 2014, ACTA DIABETOL, V51, P123, DOI 10.1007/s00592-013-0543-1
   DEVRIES RRP, 1994, NETH J MED, V45, P302
   Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007
   Ellman R, 1998, ANN TROP MED PARASIT, V92, P741
   Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x
   Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010
   HALL JM, 1995, BLOOD, V86, P2829
   HAMANN A, 1995, BIOCHEM BIOPH RES CO, V211, P833, DOI 10.1006/bbrc.1995.1887
   Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x
   Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407
   Lyke KE, 2011, TISSUE ANTIGENS, V77, P562, DOI 10.1111/j.1399-0039.2011.01661.x
   McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533
   MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0
   Meyer CG, 2002, TISSUE ANTIGENS, V59, P287, DOI 10.1034/j.1399-0039.2002.590406.x
   Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53
   Newton J, 2003, ARTHRITIS RHEUM, V48, P90, DOI 10.1002/art.10719
   Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X
   Osafo-Addo AD, 2008, AM J TROP MED HYG, V78, P251
   Prentice AM, 2012, ADV NUTR, V3, P583, DOI 10.3945/an.111.001230
   Randall LM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-302
   Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590
   Sinha S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-13
   Stirnadel HA, 1999, TROP MED INT HEALTH, V4, P187, DOI 10.1046/j.1365-3156.1999.43381.x
   Thompson EA, 1997, AM J HUM GENET, V60, P197
   TOMLINSON IPM, 1995, TRENDS GENET, V11, P493, DOI 10.1016/S0168-9525(00)89159-3
   Ubalee R, 2001, TISSUE ANTIGENS, V58, P407, DOI 10.1034/j.1399-0039.2001.580610.x
   Uglialoro AM, 1998, TISSUE ANTIGENS, V52, P359, DOI 10.1111/j.1399-0039.1998.tb03056.x
   Veenemans J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041630
   Veenemans J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001125
   Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26
   Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x
   WILSON A, 1992, J ROY SOC MED, V85, P1
   Yamazaki A, 2011, HUM IMMUNOL, V72, P881, DOI 10.1016/j.humimm.2011.06.007
NR 44
TC 2
Z9 2
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JUN 20
PY 2015
VL 14
AR 249
DI 10.1186/s12936-015-0767-3
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CK9VP
UT WOS:000356587900001
PM 26088606
OA gold
DA 2017-08-15
ER

PT J
AU Tahita, MC
   Tinto, H
   Yarga, S
   Kazienga, A
   Coulibaly, MT
   Valea, I
   Van Overmeir, C
   Rosanas-Urgell, A
   Ouedraogo, JB
   Guiguemde, RT
   van Geertruyden, JP
   Erhart, A
   D'Alessandro, U
AF Tahita, Marc C.
   Tinto, Halidou
   Yarga, Sibiri
   Kazienga, Adama
   Coulibaly, Maminata Traore
   Valea, Innocent
   Van Overmeir, Chantal
   Rosanas-Urgell, Anna
   Ouedraogo, Jean-Bosco
   Guiguemde, Robert T.
   van Geertruyden, Jean-Pierre
   Erhart, Annette
   D'Alessandro, Umberto
TI Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum
   isolates from pregnant women in an area of highly seasonal transmission
   in Burkina Faso
SO MALARIA JOURNAL
LA English
DT Article
ID ARTEMISININ-RESISTANT MALARIA; IN-VITRO SUSCEPTIBILITY;
   DIHYDROARTEMISININ-PIPERAQUINE; ARTEMETHER-LUMEFANTRINE;
   SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE USE; COMBINATION; MALAWI;
   ARTESUNATE; QINGHAOSU
AB Background: Ex vivo assays are usually carried out on parasite isolates collected from patients with uncomplicated Plasmodium falciparum malaria, from which pregnant women are usually excluded as they are often asymptomatic and with relatively low parasite densities. Nevertheless, P. falciparum parasites infecting pregnant women selectively sequester in the placenta and may have a different drug sensitivity profile compared to those infecting other patients. The drug sensitivity profile of P. falciparum isolates from infected pregnant women recruited in a treatment efficacy trial conducted in Burkina Faso was determined in an ex vivo study.
   Methods: The study was conducted between October 2010 and December 2012. Plasmodium falciparum isolates were collected before treatment and at the time of any recurrent infection whose parasite density was at least 100/mu l. A histidine-rich protein-2 assay was used to assess their susceptibility to a panel of seven anti-malarial drugs. The concentration of anti-malarial drug inhibiting 50% of the parasite maturation to schizonts (IC50) for each drug was determined with the IC Estimator version 1.2.
   Results: The prevalence of resistant isolates was 23.5% for chloroquine, 9.2% for mefloquine, 8.0% for monodesethylamodiaquine, and 4.4% for quinine. Dihydroartemisinin, mefloquine, lumefantrine, and monodesethylamodiaquine had the lowest mean IC50 ranging between 1.1 and 1.5 nM respectively. The geometric mean IC50 of the tested drugs did not differ between chloroquine-sensitive and resistant parasites, with the exception of quinine, for which the IC50 was higher for chloroquine-resistant isolates. The pairwise comparison between the IC50 of the tested drugs showed a positive and significant correlation between dihydroartemisinin and both mefloquine and chloroquine, between chloroquine and lumefantrine and between monodesethylamodiaquine and mefloquine.
   Conclusion: These ex vivo results suggest that treatment with the currently available artemisinin-based combinations is efficacious for the treatment of malaria in pregnancy in Burkina Faso.
C1 [Tahita, Marc C.; Tinto, Halidou; Coulibaly, Maminata Traore; Ouedraogo, Jean-Bosco] IRSS DRO, Bobo Dioulasso, Burkina Faso.
   [Tahita, Marc C.; Tinto, Halidou; Kazienga, Adama; Coulibaly, Maminata Traore; Valea, Innocent; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.] IRSS, CRUN, Nanoro, Burkina Faso.
   [Tinto, Halidou; Yarga, Sibiri; Valea, Innocent; Guiguemde, Robert T.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso.
   [Tahita, Marc C.; Van Overmeir, Chantal; Rosanas-Urgell, Anna; Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med, Malariol Unit, B-2000 Antwerp, Belgium.
   [Guiguemde, Robert T.] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso.
   [Tahita, Marc C.; van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
RP Tahita, MC (reprint author), IRSS DRO, Bobo Dioulasso, Burkina Faso.
EM marctahita@yahoo.fr
FU Bill and Melinda Gates Foundation (BMGF); Malaria in Pregnancy (MiP)
   Consortium; EDCTP
FX This publication is supported by the Malaria in Pregnancy (MiP)
   Consortium, which is funded through a grant from EDCTP and co-funding
   from Bill and Melinda Gates Foundation (BMGF).
CR Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c
   Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27
   Basco LK, 2007, AM J TROP MED HYG, V76, P20
   Basco LK, 1994, ANN TROP MED PARASIT, V88, P131
   Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871
   Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019
   Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Fall B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-310
   Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502
   Frosch AEP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-116
   Gansane A, 2009, Bull Soc Pathol Exot, V102, P31, DOI 10.3185/pathexo3235
   HIEN TT, 1993, LANCET, V341, P603
   Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419
   Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032
   Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09
   Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5
   Noedl H, 2007, ANTIMICROB AGENTS CH, V51, P651, DOI 10.1128/AAC.01023-06
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231
   Nosten F, 2007, AM J TROP MED HYG, V77, P181
   Nunes MC, 2007, PARASITOLOGY, V134, P1863, DOI 10.1017/S0031182007000133
   Parzy D, 1997, AM J TROP MED HYG, V57, P646
   Pascual A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-189
   Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x
   Quashie NB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-450
   Ringwald P, 1999, AM J TROP MED HYG, V61, P187
   Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09
   Steketee RW, 1996, AM J TROP MED HYG, V55, P33
   Tahita MC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-464
   Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491
   Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-207
   Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7
   White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165
   White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8
   World Health Organization, 2010, GUID TREATM MAL, P13
   WHO, 2011, CONT MAL MULT RES CA
   WHO, 2014, MAL STAT REP ART RES
   Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601
   Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985
NR 40
TC 0
Z9 0
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JUN 20
PY 2015
VL 14
AR 251
DI 10.1186/s12936-015-0769-1
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CK9VQ
UT WOS:000356588000001
PM 26088768
OA gold
DA 2017-08-15
ER

PT J
AU Grassly, NC
   Kang, G
   Kannpmann, B
AF Grassly, Nicholas C.
   Kang, Gagandeep
   Kannpmann, Beate
TI Biological challenges to effective vaccines in the developing world
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Editorial Material
DE infectious disease; vaccine; immunology; vaccinology; immunization
ID ORAL POLIOVIRUS VACCINE; ROTAVIRUS VACCINE; SYSTEMS VACCINOLOGY;
   IMMUNE-RESPONSE; PROTECTION; IMMUNOGENICITY; ELIMINATION; INFECTIONS;
   FAILURE; INFANTS
AB The reason for holding a meeting to discuss biological challenges to vaccines is simple: not all vaccines work equally well in all settings. This special issue reviews the performance of vaccines in challenging environments, summarizes current thinking on the reasons why vaccines underperform and considers what approaches are necessary to understand the heterogeneity in responses and to improve vaccine immunogenicity and efficacy.
C1 [Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Infect Dis Epidemiol, London W2 1PG, England.
   [Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Med, London W2 1PG, England.
   [Grassly, Nicholas C.; Kang, Gagandeep] Christian Med Coll & Hosp, Div Gastrointestinal Sci, Wellcome Trust Res Lab, Vellore 632004, Tamil Nadu, India.
   [Kannpmann, Beate] The Gambia, MRC Unit, Vaccinol Theme, Fajara, Gambia.
RP Grassly, NC (reprint author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Infect Dis Epidemiol, London W2 1PG, England.
EM n.grassly@imperial.ac.uk
OI Grassly, Nicholas/0000-0001-6067-4507; Kang,
   Gagandeep/0000-0002-3656-564X; Kampmann, Beate/0000-0002-6546-4709
CR Amenyogbe N., 2015, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, V370, P20140340, DOI 10.1098/rstb.2014.0340
   Appaiahgari MB, 2014, VACCINE, V32, P651, DOI 10.1016/j.vaccine.2013.12.017
   Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6
   Barocchi MA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0150
   Borrow R., 2006, IMMUNOLOGICAL BASIS
   Chandran A, 2008, VACCINES, V5th, P157
   Czerkinsky C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0142
   Edwards KM, 2008, VACCINES, P467
   Gilmartin AA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0143
   Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388
   JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263
   Kampmann B, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0148
   Kollmann TR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00081
   Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797
   Majumder PP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0142
   Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790
   Mast E, 2008, VACCINES, P205
   Mawa PA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0137
   MCBEAN AM, 1988, AM J EPIDEMIOL, V128, P615
   McElhaney JE, 2009, VACCINE, V27, P2418, DOI 10.1016/j.vaccine.2009.01.136
   Mentzer AJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0341
   Monath TCM, 2008, VACCINES, P959
   Mwanza-Lisulo M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0145
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051
   Parker EPK, 2014, J INFECT DIS, V210, P853, DOI 10.1093/infdis/jiu182
   Patel M, 2013, J INFECT DIS, V208, P284, DOI 10.1093/infdis/jit166
   PATRIARCA PA, 1991, REV INFECT DIS, V13, P926
   Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048
   POLAND GA, 1994, ARCH INTERN MED, V154, P1815, DOI 10.1001/archinte.154.16.1815
   Praharaj I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0144
   Prendergast AJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0141
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312
   Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021
   Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0
   United Nations, 2013, WORLD POP PROSP 2012
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   Verhasselt V, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0139
   Vitek CR, 2008, VACCINES, P139
   Wassilak SGF, 2008, VACCINES, P805
   World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P129
   World Health Organization, 2009, STAT WORLDS VACC IMM
   WHO/UNICEF, 2014, EST NAT IMM COV 2013
   Wilson CB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0152
NR 47
TC 0
Z9 0
U1 1
U2 4
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD JUN 19
PY 2015
VL 370
IS 1671
AR 20140138
DI 10.1098/rstb.2014.0138
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA CJ6AQ
UT WOS:000355575800001
OA No
DA 2017-08-15
ER

PT J
AU Kampmann, B
   Jones, CE
AF Kampmann, Beate
   Jones, Christine E.
TI Factors influencing innate immunity and vaccine responses in infancy
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Review
DE immune ontogeny; vaccine responses; maternal immunization; BCG vaccine
ID CALMETTE-GUERIN VACCINATION; MATERNAL IMMUNIZATION; INFECTIOUS-DISEASES;
   CYTOKINE RESPONSES; ANTIBODY-RESPONSES; NEWBORN-INFANTS; NEONATAL
   DEATHS; BCG VACCINATION; BIRTH; AGE
AB Despite significant progress in reducing the burden of mortality in children under the age of five, reducing mortality in newborns remains a major challenge. Infection plays a significant role in infant deaths and interventions such as early vaccination or antenatal immunization could make a significant contribution to prevention of such deaths. In the last few years, we have gained new insights into immune ontogeny and are now beginning to understand the impact of vaccines, nutrition and environmental factors on 'training' of the immune response in early life. This review article sets out to explain why vaccine responses can be heterogeneous between populations and individuals by providing examples chosen to illustrate the impact of host, pathogen and environmental factors on shaping the immune 'interactome' in young children.
C1 [Kampmann, Beate] Gambia, MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London, England.
   [Jones, Christine E.] Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England.
RP Kampmann, B (reprint author), Gambia, MRC Unit, Vaccines & Immun Theme, Atlantic Rd, Fajara, Gambia.
EM bkampmann@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709
FU MRC [MR/K007602/1, MR/K011944/1, MC_UP_A900/1122]; Biomedical Research
   Centre at Imperial College, London
FX B.K. is supported by a Program grant from the MRC (MR/K007602/1,
   MR/K011944/1, MC_UP_A900/1122) and the Biomedical Research Centre at
   Imperial College, London.
CR Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3
   Burl S, 2011, PLOS ONE, V6
   Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552
   Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926
   Dabrera G, 2015, CLIN INFECT DIS, V60, P333, DOI 10.1093/cid/ciu821
   Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047
   Freyne B, 2015, T ROY SOC TROP MED H, V109, P52, DOI 10.1093/trstmh/tru197
   Hartgers FC, 2008, INFECT IMMUN, V76, P5149, DOI 10.1128/IAI.01579-07
   Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303
   Houghteling PD, 2015, J PEDIATR GASTR NUTR, V60, P294, DOI 10.1097/MPG.0000000000000597
   Hur YG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-184
   Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13
   Jones C, 2014, VACCINE, V32, P996, DOI 10.1016/j.vaccine.2013.11.104
   Jones C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002473
   Jones CE, 2015, AIDS, V29, P155, DOI 10.1097/QAD.0000000000000536
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401.6407.2004
   Khan Rownak, 2015, Int J Womens Health, V7, P171, DOI 10.2147/IJWH.S50539
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Kollmann TR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00081
   Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481
   Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075
   Lindsey B, 2012, PATHOG GLOB HEALTH, V106, P137, DOI 10.1179/204777312X13462106637684
   Lindsey B, 2013, CURR OPIN INFECT DIS, V26, P248, DOI 10.1097/QCO.0b013e3283607a58
   Lisciandro JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036793
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Lutwama F, 2014, J INFECT DIS, V209, P887, DOI 10.1093/infdis/jit570
   Marchant A, 2006, J INFECT DIS, V193, P1598, DOI 10.1086/503775
   Mentzer AJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0341
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Netea MG, 2014, SEMIN IMMUNOL, V26, P512, DOI 10.1016/j.smim.2014.09.006
   Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051
   Ota MOC, 2002, J IMMUNOL, V168, P919
   Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045
   Shey MS, 2014, J IMMUNOL, V192, P4833, DOI 10.4049/jimmunol.1400062
   Smolen KK, 2014, J IMMUNOL, V193, P3003, DOI 10.4049/jimmunol.1400895
   Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3
   Waters Donald, 2011, J Glob Health, V1, P154
NR 40
TC 1
Z9 1
U1 3
U2 11
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD JUN 19
PY 2015
VL 370
IS 1671
AR 20140148
DI 10.1098/rstb.2014.0148
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA CJ6AQ
UT WOS:000355575800012
OA No
DA 2017-08-15
ER

PT J
AU Prentice, S
   Jallow, MW
   Prentice, AM
AF Prentice, Sarah
   Jallow, Mornodou W.
   Prentice, Andrew M.
CA MRC-Int Nutr Grp
TI The effect of BCG on iron metabolism in the early neonatal period: A
   controlled trial in Gambian neonates
SO VACCINE
LA English
DT Article
DE BCG; Iron; Hepcidin; Heterologous effects; Neonate
ID GUINEA-BISSAU; ROUTINE VACCINATIONS; RANDOMIZED-TRIAL; CHILDREN;
   HEPCIDIN; WEIGHT; BIRTH; SURVIVAL; INFANTS
AB Bacillus Calmette-Guerin (BCG) vaccination has been reported to protect neonates from non-tuberculous pathogens, but no biological mechanism to explain such effects is known. We hypothesised that BCG produces broad-spectrum anti-microbial protection via a hepcidin-mediated hypoferraemia, limiting iron availability for pathogens.
   To test this we conducted a trial in 120 Gambian neonates comparing iron status in the first 5-days of life after allocation to: (1) All routine vaccinations at birth (BCG/Oral Polio Vaccine (OPV)/Hepatitis B Vaccine (HBV)); (2) BCG delayed until after the study period (at day 5); and (3) All routine vaccinations delayed until after the study period.
   Vaccine regime at birth did not significantly impact on any measured parameter of iron metabolism. However, the ability to detect an effect of BCG on iron metabolism may have been limited by short follow-up time and high activation of the inflammatory-iron axis in the study population. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Prentice, Sarah] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England.
   [Jallow, Mornodou W.; Prentice, Andrew M.; MRC-Int Nutr Grp] MRC Keneba, MRC Int Nutr Grp, Serrekunda, Gambia.
RP Prentice, S (reprint author), Univ London London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.
EM sarah.prentice@lshtm.ac.uk; mwjallow@mrc.gm; Andrew.prentice@lshtm.ac.uk
FU UK Medical Research Council [MCA760-5QX00]; UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement
FX We thank Drs Sophie Moore and Rita Wegmuller for guidance and
   institutional support; our midwife, Mrs Fatou Sosseh, and nurses Mr
   Simon Jarju and Mr Edrissa Sinjanka; the laboratory team, especially Mr
   Ebrima Sise; and the datateam led by Mr Bai Lamin Dondeh and Mr Bakary
   Sonko. The study was funded through core support (MCA760-5QX00) to the
   MRC International Nutrition Group by the UK Medical Research Council and
   the UK Department for International Development (DFID) under the
   MRC/DFID Concordat agreement.
CR Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240
   Atkinson S, 2000, TUBERCLE LUNG DIS, V80, P197, DOI 10.1054/tuld.2000.0247
   BARRY DMJ, 1977, PEDIATRICS, V60, P908
   Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289
   Cangemi G, 2013, EUR J HAEMATOL, V90, P323, DOI 10.1111/ejh.12081
   Collard KJ, 2009, PEDIATRICS, V123, P1208, DOI 10.1542/peds.2008-1047
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Guida C, 2015, BLOOD, V125, P2265, DOI 10.1182/blood-2014-08-595256
   Hosick P, 2013, PEDIATR EXERC SCI, V25, P238
   Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109
   KOCHAN I, 1969, J BACTERIOL, V100, P64
   Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435
   Marchini G, 2000, ACTA PAEDIATR, V89, P1082, DOI 10.1080/713794557
   Mu XJ, 2011, FISH SHELLFISH IMMUN, V31, P1162, DOI 10.1016/j.fsi.2011.10.011
   Paiva AD, 2007, REV SAUDE PUBL, V41, P321, DOI 10.1590/S0034-89102007000300001
   Rodrigues A, 2006, VACCINE, V24, P4737, DOI 10.1016/j.vaccine.2006.03.033
   Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh393
   Stensballe LG, 2005, VACCINE, V23, P1251, DOI 10.1016/j.vaccine.2004.09.006
   Veirum JE, 2005, VACCINE, V23, P1197, DOI 10.1016/j.vaccine.2004.02.053
   WIEDEMANN G, 1993, EUR J CLIN CHEM CLIN, V31, P453
NR 20
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 12
PY 2015
VL 33
IS 26
BP 2963
EP 2967
DI 10.1016/j.vaccine.2015.04.087
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA CL7FU
UT WOS:000357138700002
PM 25959747
OA No
DA 2017-08-15
ER

PT J
AU Silver, MJ
   Kessler, NJ
   Hennig, BJ
   Dominguez-Salas, P
   Laritsky, E
   Baker, MS
   Coarfa, C
   Hernandez-Vargas, H
   Castelino, JM
   Routledge, MN
   Gong, YY
   Herceg, Z
   Lee, YS
   Lee, K
   Moore, SE
   Fulford, AJ
   Prentice, AM
   Waterland, RA
AF Silver, Matt J.
   Kessler, Noah J.
   Hennig, Branwen J.
   Dominguez-Salas, Paula
   Laritsky, Eleonora
   Baker, Maria S.
   Coarfa, Cristian
   Hernandez-Vargas, Hector
   Castelino, Jovita M.
   Routledge, Michael N.
   Gong, Yun Yun
   Herceg, Zdenko
   Lee, Yong Sun
   Lee, Kwanbok
   Moore, Sophie E.
   Fulford, Anthony J.
   Prentice, Andrew M.
   Waterland, Robert A.
TI Independent genomewide screens identify the tumor suppressor VTRNA2-1 as
   a human epiallele responsive to periconceptional environment
SO GENOME BIOLOGY
LA English
DT Article
ID EPIGENOME-WIDE ASSOCIATION; DNA METHYLATION ARRAY; EPIGENETIC
   EPIDEMIOLOGY; METASTABLE EPIALLELES; TRANSPOSABLE ELEMENTS; GENE;
   ILLUMINA; CANCER; MECHANISMS; DISEASES
AB Background: Interindividual epigenetic variation that occurs systemically must be established prior to gastrulation in the very early embryo and, because it is systemic, can be assessed in easily biopsiable tissues. We employ two independent genome-wide approaches to search for such variants.
   Results: First, we screen for metastable epialleles by performing genomewide bisulfite sequencing in peripheral blood lymphocyte (PBL) and hair follicle DNA from two Caucasian adults. Second, we conduct a genomewide screen for genomic regions at which PBL DNA methylation is affected by season of conception in rural Gambia. Remarkably, both approaches identify the genomically imprinted VTRNA2-1 as a top environmentally responsive epiallele. We demonstrate systemic and stochastic interindividual variation in DNA methylation at the VTRNA2-1 differentially methylated region in healthy Caucasian and Asian adults and show, in rural Gambians, that periconceptional environment affects offspring VTRNA2-1 epigenotype, which is stable over at least 10 years. This unbiased screen also identifies over 100 additional candidate metastable epialleles, and shows that these are associated with cis genomic features including transposable elements.
   Conclusions: The non-coding VTRNA2-1 transcript (also called nc886) is a putative tumor suppressor and modulator of innate immunity. Thus, these data indicating environmentally induced loss of imprinting at VTRNA2-1 constitute a plausible causal pathway linking early embryonic environment, epigenetic alteration, and human disease. More broadly, the list of candidate metastable epialleles provides a resource for future studies of epigenetic variation and human disease.
C1 [Silver, Matt J.; Hennig, Branwen J.; Moore, Sophie E.; Fulford, Anthony J.; Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1E 7HT, England.
   [Silver, Matt J.; Hennig, Branwen J.; Moore, Sophie E.; Fulford, Anthony J.; Prentice, Andrew M.] MRC Keneba, MRC Unit, Banjul, Gambia.
   [Kessler, Noah J.; Laritsky, Eleonora; Baker, Maria S.; Waterland, Robert A.] USDA ARS, Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA.
   [Dominguez-Salas, Paula] Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, Hatfield AL9 7TA, Herts, England.
   [Dominguez-Salas, Paula] Int Livestock Res Inst, Nairobi 00100, Kenya.
   [Coarfa, Cristian] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA.
   [Hernandez-Vargas, Hector; Herceg, Zdenko] IARC, Epigenet Grp, F-69372 Lyon 08, France.
   [Castelino, Jovita M.; Routledge, Michael N.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.
   [Gong, Yun Yun] Queens Univ Belfast, Inst Global Food Secur, Belfast BT9 5AG, Antrim, North Ireland.
   [Lee, Yong Sun; Lee, Kwanbok] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Moore, Sophie E.] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge CB1 9NL, England.
   [Waterland, Robert A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
RP Prentice, AM (reprint author), London Sch Hyg & Trop Med, MRC, Int Nutr Grp, Keppel St, London WC1E 7HT, England.
EM Andrew.Prentice@lshtm.ac.uk; waterland@bcm.edu
RI Gong, Yun/L-7094-2016
OI Gong, Yun/0000-0003-4927-5526; Silver, Matt/0000-0002-3852-9677
FU NIH/National Institute of Diabetes and Digestive and Kidney Diseases
   [1R01DK081557]; USDA [CRIS 6250-51000-055]; Wellcome Trust [WT086369MA];
   International Nutrition Group by the UK Medical Research Council (MRC)
   [MCA760-5QX00]; UK Department for International Development (DFID) under
   the MRC/DFID Concordat agreement; IARC; Grand Challenges Exploration
   grant from the Bill and Melinda Gates Foundation
FX We thank Adam Gillum (Baylor College of Medicine) for assistance with
   the figures, Dr Yongtao Guan (Baylor College of Medicine) for help with
   the analysis of the LCL methylation data, and Dr Florence Le Calvez-Kelm
   and Mr Geoffroy Durand from the Genetic Cancer Susceptibility group
   (IARC, Lyon) for performing the HM450 beadchip assays. RAW was supported
   by grants from NIH/National Institute of Diabetes and Digestive and
   Kidney Diseases (1R01DK081557) and the USDA (CRIS 6250-51000-055). The
   Gambian study was supported by a Wellcome Trust grant WT086369MA (to
   BJH), and core funding MCA760-5QX00 to the International Nutrition Group
   by the UK Medical Research Council (MRC) and the UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement.
   Our thanks go to the study participants in The Gambia and staff at MRC
   Keneba, The Gambia. MNR, JMC and YYG were supported by a grant from
   IARC. HHV and ZH were supported by a Grand Challenges Exploration grant
   from the Bill and Melinda Gates Foundation.
CR Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153
   Amarasekera M, 2014, FASEB J, V28, P4068, DOI 10.1096/fj.13-249029
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Cao JZ, 2013, CANCER RES, V73, P3326, DOI 10.1158/0008-5472.CAN-12-3055
   Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540
   Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746
   Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462
   Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587
   Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142
   Gemma C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r43
   Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102
   Harris RA, 2013, EPIGENETICS-US, V8, P157, DOI 10.4161/epi.23438
   Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31
   Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238
   Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045
   Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167
   Kunde-Ramamoorthy G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1325
   Lee HS, 2014, ONCOTARGET, V5, P3472
   Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111
   Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825
   Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014
   Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61
   Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0
   Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008
   Michels KB, 2013, NAT METHODS, V10, P949, DOI 10.1038/nmeth.2632
   Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245
   Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088
   Ng JWY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-246
   Oakes CC, 2014, CANCER DISCOV, V4, P348, DOI 10.1158/2159-8290.CD-13-0349
   Paliwal A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003622
   Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000
   Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9
   Roessler Jessica, 2012, BMC Res Notes, V5, P210, DOI 10.1186/1756-0500-5-210
   Romanelli V, 2014, EPIGENETICS-US, V9, P783, DOI 10.4161/epi.28323
   Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312
   Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   Treppendahl MB, 2012, BLOOD, V119, P206, DOI 10.1182/blood-2011-06-362541
   Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003
   Waterland RA, 1999, AM J CLIN NUTR, V69, P179
   Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705
   Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230
   Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252
   Zhang X, 2014, HUM MOL GENET, V23, P5893, DOI 10.1093/hmg/ddu313
NR 46
TC 30
Z9 30
U1 1
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PD JUN 11
PY 2015
VL 16
AR 118
DI 10.1186/s13059-015-0660-y
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA CK0OF
UT WOS:000355903800001
PM 26062908
OA gold
DA 2017-08-15
ER

PT J
AU Chu, PY
   Tyan, YC
   Chen, YS
   Chen, HL
   Lu, PL
   Chen, YH
   Chen, BC
   Huang, TS
   Wang, CF
   Su, HJ
   Shi, YY
   Sanno-Duanda, B
   Lin, KH
   Motomura, K
AF Chu, Pei-Yu
   Tyan, Yu-Chang
   Chen, Yao-Shen
   Chen, Hsiu-Lin
   Lu, Po-Liang
   Chen, Yu-Hsien
   Chen, Bao-Chen
   Huang, Tsi-Shu
   Wang, Chu-Feng
   Su, Hui-Ju
   Shi, Yong-Ying
   Sanno-Duanda, Bintou
   Lin, Kuei-Hsiang
   Motomura, Kazushi
TI Transmission and Demographic Dynamics of Coxsackievirus B1
SO PLOS ONE
LA English
DT Article
ID HUMAN ENTEROVIRUS 71; EVOLUTIONARY GENETICS; RECOMBINATION EVENTS;
   INFECTION; VP1; IDENTIFICATION; EPIDEMIOLOGY; ASSOCIATION; EMERGENCE;
   BOOTSTRAP
AB The infectious activity of coxsackievirus B1 (CV-B1) in Taiwan was high from 2008 to 2010, following an alarming increase in severe neonate disease in the United States (US). To examine the relationship between CV-B1 strains isolated in Taiwan and those from other parts of the world, we performed a phylodynamic study using VP1 and partial 3D(pol) (414 nt) sequences from 22 strains of CV-B1 isolated in Taiwan (1989-2010) and compared them to sequences from strains isolated worldwide. Phylogenetic trees were constructed by neighbor-joining, maximum likelihood, and Bayesian Monte Carlo Markov Chain methods. Four genotypes (GI-IV) in the VP1 region of CV-B1 and three genotypes (GA-C) in the 3D(pol) region of enterovirus B were identified and had high support values. The phylogenetic analysis indicates that the GI and GIII strains in VP1 were geographically distributed in Taiwan (1993-1994) and in India (2007-2009). On the other hand, the GII and GIV strains appear to have a wider spatiotemporal distribution and ladder-like topology A stair-like phylogeny was observed in the VP1 region indicating that the phylogeny of the virus may be affected by different selection pressures in the specified regions. Further, most of the GI and GII strains in the VP1 tree were clustered together in GA in the 3D tree, while the GIV strains diverged into GB and GC. Taken together, these data provide important insights into the population dynamics of CV-B1 and indicate that incongruencies in specific gene regions may contribute to spatiotemporal patterns of epidemicity for this virus.
C1 [Chu, Pei-Yu; Chen, Yu-Hsien; Shi, Yong-Ying; Sanno-Duanda, Bintou] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung 804, Taiwan.
   [Chu, Pei-Yu; Lu, Po-Liang; Wang, Chu-Feng; Su, Hui-Ju] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 807, Taiwan.
   [Tyan, Yu-Chang] Kaohsiung Med Univ Hosp, Dept Med Imaging & Radiol Sci, Kaohsiung 807, Taiwan.
   [Tyan, Yu-Chang] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 807, Taiwan.
   [Tyan, Yu-Chang] Kaohsiung Med Univ, Joint Res Ctr, Natl Sun Yat Sen Univ, Kaohsiung 804, Taiwan.
   [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 804, Taiwan.
   [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Div Infect Dis, Kaohsiung, Taiwan.
   [Chen, Yao-Shen; Chen, Bao-Chen; Huang, Tsi-Shu] Kaohsiung Vet Gen Hosp, Div Microbiol, Dept Pathol & Lab Med, Kaohsiung, Taiwan.
   [Chen, Yao-Shen] Natl Yang Ming Med Univ, Dept Internal Med, Taipei, Taiwan.
   [Chen, Hsiu-Lin] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung 807, Taiwan.
   [Chen, Hsiu-Lin] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung 804, Taiwan.
   [Lu, Po-Liang; Lin, Kuei-Hsiang] Kaohsiung Med Univ, Coll Med, Dept Lab Med, Sch Med, Kaohsiung 804, Taiwan.
   [Sanno-Duanda, Bintou] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [Motomura, Kazushi] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.
   [Motomura, Kazushi] Osaka Univ, Thailand Japan Res Collaborat Ctr Emerging & Re E, Microbial Dis Res Inst, Nonthaburi, Thailand.
RP Chu, PY (reprint author), Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung 804, Taiwan.
EM peiyuchu@kmu.edu.tw; kmotomura@biken.osaka-u.ac.jp
OI Chen, Hsiu-Lin/0000-0002-0565-4631
FU Ministry of Science and Technology, Taiwan, Republic of China (MOST)
   [MOST103-2320-B-037-024]
FX This study was funded by grants from the Ministry of Science and
   Technology, Taiwan, Republic of China (MOST, url:
   http://www.most.gov.tw/) to PYC under grant no. MOST103-2320-B-037-024.
   The funders had no role in the study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   authors have no competing interests in the publication of this study.
CR Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5
   Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028
   Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   Chu PY, 2011, INFECT GENET EVOL, V11, P1426, DOI 10.1016/j.meegid.2011.05.010
   Chu PY, 2009, J CLIN VIROL, V45, P16, DOI 10.1016/j.jcv.2009.02.012
   Coyne KP, 2012, J VIROL, V86, P11356, DOI 10.1128/JVI.00701-12
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   DRUYTSVOETS E, 1993, J INFECTION, V27, P311, DOI 10.1016/0163-4453(93)92329-U
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Hampl V, 2001, INT J SYST EVOL MICR, V51, P731
   Hovi T, 1998, CLIN DIAGN VIROL, V9, P89, DOI 10.1016/S0928-0197(97)10018-6
   Ke GM, 1988, VIRUS GENES, V42, P178, DOI [10.1007/s11262-010-0565-5, DOI 10.1007/S11262-010-0565-5]
   Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010
   Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1
   Kim H, 2013, J MED VIROL, V85, P110, DOI 10.1002/jmv.23359
   Laitinen OH, 2014, DIABETES, V63, P446, DOI 10.2337/db13-0619
   Lee HC, 2005, TAIWAN EPIDEMIOLOGY, P96
   Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lin TY, 2003, PEDIATR INFECT DIS J, V22, P889, DOI 10.1097/01.inf.0000091294.63706.f3
   Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0
   Lole KS, 1999, J VIROL, V73, P152
   Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0
   Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Mascola L., 2008, Morbidity and Mortality Weekly Report, V57, P553
   Mirand A, 2007, J GEN VIROL, V88, P166, DOI 10.1099/vir.0.82146-0
   Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004
   Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0
   Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288
   Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170
   Oikarinen S, 2014, DIABETES, V63, P655, DOI 10.2337/db13-0620
   Oprisan G, 2002, J GEN VIROL, V83, P2193
   Quinn KK, 2007, GENOME ANNOUNCEMENTS, V2, DOI DOI 10.1128/GENOMEA.00574-14
   RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8
   TAM PE, 1991, J VIROL, V65, P6654
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tavare S., 1986, LECTURES MATH LIFE S, V17, P57
   Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09
   Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006
   Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947
   Wang SM, 1998, J INFECTION, V37, P270, DOI 10.1016/S0163-4453(98)92076-X
   Wikswo ME, 2009, CLIN INFECT DIS, V49, pE44, DOI 10.1086/605090
   Worobey M, 1999, J GEN VIROL, V80, P2535
   Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157
NR 48
TC 3
Z9 4
U1 2
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2015
VL 10
IS 6
AR e0129272
DI 10.1371/journal.pone.0129272
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK1GM
UT WOS:000355955300106
PM 26053872
OA gold
DA 2017-08-15
ER

PT J
AU Jasseh, M
   Gomez, P
   Greenwood, BM
   Howie, SRC
   Scott, S
   Snell, PC
   Bojang, K
   Cham, M
   Corrah, T
   D'Alessandro, U
AF Jasseh, Momodou
   Gomez, Pierre
   Greenwood, Brian M.
   Howie, Stephen R. C.
   Scott, Susana
   Snell, Paul C.
   Bojang, Kalifa
   Cham, Mamady
   Corrah, Tumani
   D'Alessandro, Umberto
TI Health & Demographic Surveillance System Profile: Farafenni Health and
   Demographic Surveillance System in The Gambia
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
ID RESISTANT PLASMODIUM-FALCIPARUM; TRADITIONAL BIRTH ATTENDANTS; CARE
   PROGRAM; MALARIA CHEMOPROPHYLAXIS; RURAL GAMBIA;
   CHLOROQUINE/SULPHADOXINE-PYRIMETHAMINE; MATERNAL MORTALITY; WEST-AFRICA;
   CHILDREN; MORBIDITY
AB The Farafenni Health and Demographic Surveillance System (Farafenni HDSS) is located 170km from the coast in a rural area of The Gambia, north of the River Gambia. It was set up in 1981 by the UK Medical Research Council Laboratories to generate demographic and health information required for the evaluation of a village-based, primary health care programme in 40 villages. Regular updates of demographic events and residency status have subsequently been conducted every 4 months. The surveillance area was extended in 2002 to include Farafenni Town and surrounding villages to support randomized, controlled trials. With over three decades of prospective surveillance, and through specific scientific investigations, the platform (population approximate to 50 000) has generated data on: morbidity and mortality due to malaria in children and during pregnancy; non-communicable disease among adults; reproductive health; and levels and trends in childhood and maternal mortality. Other information routinely collected includes causes of death through verbal autopsy, and household socioeconomic indicators. The current portfolio of the platform includes tracking Millennium Development Goal 4 (MDG4) attainments in rural Gambia and cause-of-death determination.
C1 [Jasseh, Momodou; Gomez, Pierre; Howie, Stephen R. C.; Scott, Susana; Bojang, Kalifa; Corrah, Tumani; D'Alessandro, Umberto] MRC, Gambia Unit, Banjul, Gambia.
   [Jasseh, Momodou] INDEPTH Network, Accra, Ghana.
   [Greenwood, Brian M.; Scott, Susana; Snell, Paul C.; D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland 1, New Zealand.
   [Howie, Stephen R. C.] Univ Otago, Dept Prevent & Social Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Cham, Mamady] AFPRC Gen Hosp, Farafenni, Gambia.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
RP Jasseh, M (reprint author), MRC, Gambia Unit, Atlantic Blvd,POB 273, Banjul, Gambia.
EM mjasseh@mrc.gm
OI Bojang, Kalifa/0000-0001-7506-0938
FU UK Medical Research Council (MRC)
FX The UK Medical Research Council (MRC) has provided core financial
   support for the maintenance of the Farafenni HDSS since its inception in
   1981. The INDEPTH Network settled the Open Access publication charges
   for this article.
CR ALLEN SJ, 1990, T ROY SOC TROP MED H, V84, P218, DOI 10.1016/0035-9203(90)90261-C
   ALLEN SJ, 1990, T ROY SOC TROP MED H, V84, P666, DOI 10.1016/0035-9203(90)90136-3
   Bledsoe C, 1998, POPUL DEV REV, V24, P15, DOI 10.2307/2808121
   BLEDSOE CH, 1994, POPUL DEV REV, V20, P81, DOI 10.2307/2137631
   BRADLEY AK, 1986, LANCET, V2, P204
   Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014
   Government of The Gambia, 1993, MAN MAT CHILD HLTH S
   GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567
   GREENWOOD AM, 1990, J TROP MED HYG, V93, P58
   GREENWOOD AM, 1994, T ROY SOC TROP MED H, V88, P311, DOI 10.1016/0035-9203(94)90094-9
   GREENWOOD AM, 1987, B WORLD HEALTH ORGAN, V65, P635
   GREENWOOD AM, 1992, T ROY SOC TROP MED H, V86, P483, DOI 10.1016/0035-9203(92)90078-Q
   GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P182, DOI 10.1016/0035-9203(89)90635-4
   GREENWOOD BM, 1988, LANCET, V1, P1121
   GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2
   GREENWOOD BM, 1990, J TROP MED HYG, V93, P87
   GREENWOOD BM, 1987, ANN TROP PAEDIATR, V7, P91
   Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015
   Hill AG, 1998, LANCET, V352, P1909, DOI 10.1016/S0140-6736(05)60400-X
   Hill AG, 2000, TROP MED INT HEALTH, V5, P107, DOI 10.1046/j.1365-3156.2000.00528.x
   Jasseh M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25598
   Jasseh M, 2011, TROP MED INT HEALTH, V16, P1314, DOI 10.1111/j.1365-3156.2011.02809.x
   Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0
   Mbaye A, 2006, TROP MED INT HEALTH, V11, P992, DOI 10.1111/j.1365-3156.2006.01649.x
   MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7
   MENENDEZ C, 1994, J TROP MED HYG, V97, P244
   MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L
   MENON A, 1991, J TROP MED HYG, V94, P268
   Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033
   Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111
   Payne S, 2014, HEALTH POLICY PLANN, V29, P193, DOI 10.1093/heapol/czt004
   Phillips JF, 2000, DEMOGR RES, V2, P40
   Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570
   STEPHENS J, 1989, METHOD INFORM MED, V28, P155
   Walraven G, 2000, B WORLD HEALTH ORGAN, V78, P603
   Walraven G, 2001, LANCET, V357, P1161, DOI 10.1016/S0140-6736(00)04333-6
NR 39
TC 3
Z9 3
U1 2
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD JUN
PY 2015
VL 44
IS 3
BP 837
EP 847
DI 10.1093/ije/dyv049
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CP2JB
UT WOS:000359702200018
PM 25948661
OA No
DA 2017-08-15
ER

PT J
AU Barletta, F
   Otero, L
   de Jong, BC
   Iwamoto, T
   Arikawa, K
   Van der Stuyft, P
   Niemann, S
   Merker, M
   Uwizeye, C
   Seas, C
   Rigouts, L
AF Barletta, Francesca
   Otero, Larissa
   de Jong, Bouke C.
   Iwamoto, Tomotada
   Arikawa, Kentaro
   Van der Stuyft, Patrick
   Niemann, Stefan
   Merker, Matthias
   Uwizeye, Cecile
   Seas, Carlos
   Rigouts, Leen
TI Predominant Mycobacterium tuberculosis Families and High Rates of Recent
   Transmission among New Cases Are Not Associated with Primary Multidrug
   Resistance in Lima, Peru
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID MOLECULAR EPIDEMIOLOGY; POPULATION-STRUCTURE; GENETIC DIVERSITY;
   RISK-FACTORS; STRAINS; COMPLEX; INFECTION; DIAGNOSIS; BACTERIA; GEORGIA
AB Sputum samples from new tuberculosis (TB) cases were collected over 2 years as part of a prospective study in the northeastern part of Lima, Peru. To measure the contribution of recent transmission to the high rates of multidrug resistance (MDR) in this area, Mycobacterium tuberculosis complex (MTBc) isolates were tested for drug susceptibility to first-line drugs and were genotyped by spoligotyping and 15-locus mycobacterial interspersed repetitive-unit (MIRU-15)-variable-number tandem repeat (VNTR) analysis. MDR was found in 6.8% of 844 isolates, of which 593 (70.3%) were identified as belonging to a known MTBc lineage, whereas 198 isolates (23.5%) could not be assigned to these lineages and 12 (1.4%) represented mixed infections. Lineage 4 accounted for 54.9% (n = 463) of the isolates, most of which belonged to the Haarlem family (n = 279). MIRU-15 analysis grouped 551/791 isolates (69.7%) in 102 clusters, with sizes ranging from 2 to 46 strains. The overall high clustering rate suggests a high level of recent transmission in this population, especially among younger patients (odds ratio [OR], 1.6; P = 0.01). Haarlem strains were more prone to cluster, compared to the other families taken together (OR, 2.0; P<0.0001), while Beijing (OR, 0.6; P = 0.006) and LAM (OR, 0.7; P = 0.07) strains clustered less. Whereas streptomycin-resistant strains were more commonly found in clusters (OR, 1.8; P = 0.03), clustering rates did not differ between MDR and non-MDR strains (OR, 1.8; P = 0.1). Furthermore, only 16/51 MDR strains clustered with other MDR strains, suggesting that patients with primary MDR infections acquired the infections mostly from index cases outside the study population, such as retreated cases.
C1 [Barletta, Francesca; Otero, Larissa; Seas, Carlos] Cayetano Heredia Univ, Inst Trop Med Alexander von Humboldt, Lima, Peru.
   [de Jong, Bouke C.] MRC Unit, Serekunda, Gambia.
   [de Jong, Bouke C.] NYU, New York, NY USA.
   [de Jong, Bouke C.; Uwizeye, Cecile; Rigouts, Leen] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium.
   [Iwamoto, Tomotada; Arikawa, Kentaro] Kobe Inst Hlth, Kobe, Hyogo, Japan.
   [Van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Sect, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Van der Stuyft, Patrick] Univ Ghent, B-9000 Ghent, Belgium.
   [Niemann, Stefan; Merker, Matthias] Res Ctr Borstel, Mol Mycobacteriol, Borstel, Germany.
   [Niemann, Stefan; Merker, Matthias] German Ctr Infect, Borstel, Germany.
   [Rigouts, Leen] Univ Antwerp, B-2020 Antwerp, Belgium.
RP Barletta, F (reprint author), Cayetano Heredia Univ, Inst Trop Med Alexander von Humboldt, Lima, Peru.
EM francescabarletta@yahoo.es
RI Niemann, Stefan/C-9327-2011; Merker, Matthias/P-7399-2015; de Jong,
   Bouke/A-3636-2013
OI Merker, Matthias/0000-0003-1386-2331; de Jong,
   Bouke/0000-0002-1017-4675; Iwamoto, Tomotada/0000-0002-2650-0308
FU Belgian Directorate-General for Development Cooperation; Health Science
   Research grant from the Ministry of Health, Labor, and Welfare of Japan
   [H26-SHINKO-IPPAN-011]; MEXT/JSPS KAKENHI grant [24590845]
FX This study was funded by the Belgian Directorate-General for Development
   Cooperation through an institutional collaboration between the Institute
   of Tropical Medicine (Antwerp, Belgium) and the Institute of Tropical
   Medicine Alexander von Humboldt (Lima, Peru), by Health Science Research
   grant H26-SHINKO-IPPAN-011 from the Ministry of Health, Labor, and
   Welfare of Japan, and by MEXT/JSPS KAKENHI grant 24590845.
CR Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122
   Affolabi D, 2009, EMERG INFECT DIS, V15, P1123, DOI 10.3201/eid1507.080697
   Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05
   Asencios Luis, 2009, Rev. perú. med. exp. salud publica, V26, P278
   BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673
   Barletta F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-397
   Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159
   Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6
   Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957
   Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   Caceres O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112789
   Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75
   Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006
   Cohen T, 2011, EMERG INFECT DIS, V17, P969, DOI [10.3201/eid/1706.101471, 10.3201/eid1706.101471]
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815
   DAVID HL, 1970, APPL MICROBIOL, V20, P810
   Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994
   Garcia de Viedma D, 2011, ENFERM INFECC MIC S1, V29, pS8
   Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103
   Gilks CF, 1997, AIDS, V11, P911, DOI 10.1097/00002030-199707000-00011
   Glynn JR, 2002, EMERG INFECT DIS, V8, P843
   Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517
   Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441
   Health Communication Partnership, 2004, ROL COMM PER FIGHT T
   Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC
   Instituto Nacional de Estadistica e Informatica, 2007, CENSOS NACIONALES 20
   Instituto Nacional de Estadistica e Informatica, 2012, EST PROYECC POBL SEX
   Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907
   Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI [10.2217/fmb.10.165, 10.2217/FMB.10.165]
   Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05
   Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028
   Ministerio de Salud, 2010, ESTR SAN NAC PREV CO
   Ministerio de Salud, 2013, INF OP MINSA OTR I
   Ministerio de Salud, 2010, DIR SAL 4 LIM EST PL
   Ministerio de Salud, 2011, AN SIT SAL 2011 DIR
   Ministerio de Salud, 2006, ESTRATEGIA SANITARIA
   Mulenga C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-177
   Niemann S, 2000, J CLIN MICROBIOL, V38, P2563
   Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10
   Otero L, 2015, TROP MED INT HEALTH, V20, P322, DOI 10.1111/tmi.12430
   Paranjothy S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1184
   Perizzolo PF, 2012, TUBERCULOSIS, V92, P56, DOI 10.1016/j.tube.2011.09.008
   Ricaldi JN, 2008, TROP DOCT, V38, P97, DOI 10.1258/td.2007.070024
   Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387
   Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004
   Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99
   Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873
   Sirgel Frederick A, 2009, Methods Mol Biol, V465, P173, DOI 10.1007/978-1-59745-207-6_11
   SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402
   Supply P, 2005, U629 INSERM I BIOL
   Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06
   SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5
   Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002
   Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131
   Velasquez GE, 2011, EMERG INFECT DIS, V17, P432, DOI 10.3201/eid1703.101553
   Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021
   Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, 2011, WHO HTM TB 2011 16
   World Health Organization, 2014, WHOHTMTB201408
   World Health Organization, 2013, WHOHTMTB201311
   Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160
NR 66
TC 5
Z9 5
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JUN
PY 2015
VL 53
IS 6
BP 1854
EP 1863
DI 10.1128/JCM.03585-14
PG 10
WC Microbiology
SC Microbiology
GA CN2WZ
UT WOS:000358284600011
PM 25809979
OA No
DA 2017-08-15
ER

PT J
AU Bowyer, PW
   Stewart, LB
   Aspeling-Jones, H
   Mensah-Brown, HE
   Ahouidi, AD
   Amambua-Ngwa, A
   Awandare, GA
   Conway, DJ
AF Bowyer, Paul W.
   Stewart, Lindsay B.
   Aspeling-Jones, Harvey
   Mensah-Brown, Henrietta E.
   Ahouidi, Ambroise D.
   Amambua-Ngwa, Alfred
   Awandare, Gordon A.
   Conway, David J.
TI Variation in Plasmodium falciparum Erythrocyte Invasion Phenotypes and
   Merozoite Ligand Gene Expression across Different Populations in Areas
   of Malaria Endemicity
SO INFECTION AND IMMUNITY
LA English
DT Article
ID RECEPTOR HETEROGENEITY; FUNCTIONAL-ANALYSIS; GLYCOPHORIN-B; PROTEIN;
   PARASITES; PATHWAYS; INFECTION; PROFILES; ANTIGENS; DEFINES
AB Plasmodium falciparum merozoites use diverse alternative erythrocyte receptors for invasion and variably express cognate ligands encoded by the erythrocyte binding antigen (eba) and reticulocyte binding-like homologue (Rh) gene families. Previous analyses conducted on parasites from single populations in areas of endemicity revealed a wide spectrum of invasion phenotypes and expression profiles, although comparisons across studies have been limited by the use of different protocols. For direct comparisons within and among populations, clinical isolates from three different West African sites of endemicity (in Ghana, Guinea, and Senegal) were cryopreserved and cultured ex vivo after thawing in a single laboratory to assay invasion of target erythrocytes pretreated with enzymes affecting receptor subsets. Complete invasion assay data from 67 isolates showed no differences among the populations in the broad range of phenotypes measured by neuraminidase treatment (overall mean, 40.6% inhibition) or trypsin treatment (overall mean, 83.3% inhibition). The effects of chymotrypsin treatment (overall mean, 79.2% inhibition) showed heterogeneity across populations (Kruskall-Wallis P = 0.023), although the full phenotypic range was seen in each. Schizont-stage transcript data for a panel of 8 invasion ligand genes (eba175, eba140, eba181, Rh1, Rh2a, Rh2b, Rh4, and Rh5) were obtained for 37 isolates, showing similar ranges of variation in each population except that eba175 levels tended to be higher in parasites from Ghana than in those from Senegal (whereas levels of eba181 and Rh2b were lower in parasites from Ghana). The broad diversity in invasion phenotypes and gene expression seen within each local population, with minimal differences among them, is consistent with a hypothesis of immune selection maintaining parasite variation.
C1 [Bowyer, Paul W.; Stewart, Lindsay B.; Aspeling-Jones, Harvey; Conway, David J.] London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London WC1, England.
   [Mensah-Brown, Henrietta E.; Awandare, Gordon A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Ghana.
   [Ahouidi, Ambroise D.] Univ Cheikh Anta Diop, Le Dantec Hosp, Dakar, Senegal.
   [Amambua-Ngwa, Alfred] MRC Unit, Banjul, Gambia.
RP Conway, DJ (reprint author), London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London WC1, England.
EM david.conway@lshtm.ac.uk
OI /0000-0002-4046-9191; Awandare, Gordon/0000-0002-8793-3641; Conway,
   David/0000-0002-8711-3037
FU ERC Advanced Award [AdG-2011-294428]; Leverhulme-Royal Society Africa
   Award [AA110050]
FX This study was funded by an ERC Advanced Award (grant AdG-2011-294428 to
   D.J.C.) and a Leverhulme-Royal Society Africa Award (grant AA110050 to
   G.A.A. and D.J.C.).
CR Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x
   Awandare GA, 2011, MOL BIOCHEM PARASIT, V177, P57, DOI 10.1016/j.molbiopara.2011.01.005
   Balu B, 2011, EUKARYOT CELL, V10, P1257, DOI 10.1128/EC.05099-11
   Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003
   Bei AK, 2007, MOL BIOCHEM PARASIT, V153, P66, DOI 10.1016/j.molbiopara.2007.01.007
   Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006
   Blair PL, 2002, NUCLEIC ACIDS RES, V30, P2224, DOI 10.1093/nar/30.10.2224
   Comeaux CA, 2011, MOL MICROBIOL, V80, P378, DOI 10.1111/j.1365-2958.2011.07572.x
   Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137
   Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606
   Deans AM, 2007, INFECT IMMUN, V75, P3014, DOI 10.1128/IAI.00249-07
   Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200
   Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902
   HADLEY TJ, 1987, J CLIN INVEST, V80, P1190, DOI 10.1172/JCI113178
   Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07
   Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107
   Lantos PM, 2009, PARASITOLOGY, V136, P1, DOI 10.1017/S0031182008005167
   Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517
   Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004
   Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10
   Lopez-Perez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047913
   Maier A, 2003, EUR J RADIOL, V47, P87, DOI 10.1016/S0720-048X(03)00160-8
   Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106
   Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624
   MITCHELL GH, 1986, BLOOD, V67, P1519
   Mobegi VA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-223
   Nery S, 2006, MOL BIOCHEM PARASIT, V149, P208, DOI 10.1016/j.molbiopara.2006.05.014
   Okoyeh JN, 1999, INFECT IMMUN, V67, P5784
   Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220
   Persson KEM, 2013, J IMMUNOL, V191, P785, DOI 10.4049/jimmunol.1300444
   Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571
   Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111
   SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226
   Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002
   Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107
   Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972
   Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x
   Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943
NR 40
TC 3
Z9 3
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD JUN
PY 2015
VL 83
IS 6
BP 2575
EP 2582
DI 10.1128/IAI.03009-14
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CK5DS
UT WOS:000356243000034
PM 25870227
OA No
DA 2017-08-15
ER

PT J
AU Minchella, PA
   Armitage, AE
   Darboe, B
   Jallow, MW
   Drakesmith, H
   Jaye, A
   Prentice, AM
   McDermid, JM
AF Minchella, Peter A.
   Armitage, Andrew E.
   Darboe, Bakary
   Jallow, Momodou W.
   Drakesmith, Hal
   Jaye, Assan
   Prentice, Andrew M.
   McDermid, Joann M.
TI Elevated Hepcidin Is Part of a Complex Relation That Links Mortality
   with Iron Homeostasis and Anemia in Men and Women with HIV Infection
SO JOURNAL OF NUTRITION
LA English
DT Article
DE Africa; cohort; ferritin; hemoglobin; HIV-2; inflammation; nutrition;
   survival; transferrin receptor; transferrin
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INDEPENDENT PREDICTOR; DISEASE;
   TRANSFERRIN; DEFICIENCY; SERUM; TUBERCULOSIS; INFLAMMATION; PREVALENCE;
   EXPRESSION
AB Background: Early and chronic inflammation is a hallmark of HIV infection, and inflammation is known to increase hepcidin expression. Consequently, hepcidin may be a key determinant of the iron homeostasis and anemia associated with poorer HIV prognoses.
   Objective: The objective of this study was to understand how hepcidin is related to anemia, iron homeostasis, and inflammation at HIV diagnosis and to investigate associations between hepcidin and all-cause mortality in HIV infection.
   Methods: In a retrospective cohort, baseline plasma hepcidin was measured by competitive enzyme immunoassay within 3 mo of HIV diagnosis in 196 antiretroviral-naive Gambians. Iron homeostasis [hemoglobin, plasma transferrin, ferritin, iron, soluble transferrin receptor (sTfR)] and inflammation [alpha(1)-antichymotrypsin (ACT)] from the same plasma sample were available, as were absolute CD4 cell counts, age, gender, body mass index (BMI), and HIV type,
   Results: Anemia was common across the spectrum of immunosuppression [CD4 cell counts (prevalence of anemia): >500 cells/mu L (68%), 200-500 cells/mu L (73%), and <200 cells/mu L (89%); P = 0.032] and in men (81%) and women (76%). Increasing hepcidin was associated with iron homeostasis biomarkers (higher ferritin and lower transferrin, hemoglobin, and sTfR), inflammation (higher ACT), and key health indicators (lower CD4 or BM I, advancing age, and male gender; P<0.001 except for hemoglobin, P = 0.021). Elevated hepcidin was associated with greater all-cause mortality in a dose-dependent manner [intermediate vs. lowest tertile: unadjusted HR (95% CI), 1.95 (1.22, 3.10); upper vs. lowest tertile: 3.02 (1.91, 4.78)]. Principal components analysis identified 2 patterns composed of hepcidin-ferritin-transferrin, with or without ACT, and iron-sTfR-hemoglobin that may distinguish inflammation and erythropoiesis iron functions.
   Conclusions: Elevated hepcidin is independently associated with greater mortality in men and women with HIV infection, and hepcidin is also part of a complex relation linking iron homeostasis, anemia, and HIV. Understanding the mechanisms and role of hepcidin modulation may further guide evidence-based interventions needed to counter detrimental iron homeostasis and anemia in HIV infection.
C1 [Minchella, Peter A.; McDermid, Joann M.] Cornell Univ, Dept Nutr Sci, Ithaca, NY 14850 USA.
   [Armitage, Andrew E.; Drakesmith, Hal] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.
   [Darboe, Bakary; Jallow, Momodou W.; Jaye, Assan] Med Res Council Unit UK, Fajara, Gambia.
   [Prentice, Andrew M.] Univ London London Sch Hyg & Trop Med, Dept Nutr, Int Nutr Grp, London WC1E 7HT, England.
   [Prentice, Andrew M.] Univ London London Sch Hyg & Trop Med, Publ Hlth Intervent Unit, London WC1E 7HT, England.
   Univ Virginia, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.
RP McDermid, JM (reprint author), Cornell Univ, Dept Nutr Sci, Ithaca, NY 14850 USA.
EM jmm585@cornell.edu
FU National Science Foundation [NSF 12-599]
FX PAM is supported in part by the National Science Foundation Graduate
   Research Fellowship Program under grant NSF 12-599, the hepcidin
   analysis was supported in part by the Medical Research Council
   (MC-A760-5QX00). This is an open access article distributed under the
   CC-BY license (http://creativecommons.org/licenses/by/3.0/).
CR Ahmed I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-867
   Allen J, 1998, CLIN CHEM, V44, P35
   Atkinson SH, 2014, BLOOD, V123, P3221, DOI 10.1182/blood-2013-10-533000
   Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359
   Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010
   Bregman DB, 2013, AM J HEMATOL, V88, P97, DOI 10.1002/ajh.23354
   Cheng PP, 2012, EUR J CLIN INVEST, V42, P517, DOI 10.1111/j.1365-2362.2011.02608.x
   de Benoist Bruno, 2008, Food Nutr Bull, V29, pS238
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Dudkowiak R, 2013, ADV CLIN EXP MED, V22, P585
   Fields-Gardner CTC, 1997, CLIN GUID NUTR HIV A
   Fung E, 2013, HAEMATOLOGICA, V98, P1667, DOI 10.3324/haematol.2013.084624
   Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014
   Jaspers A, 2014, HAEMATOLOGICA, V99, pE35, DOI 10.3324/haematol.2013.100032
   Johannessen A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-190
   Jonker FAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078964
   Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Khumalo H, 1998, CLIN CHEM, V44, P40
   Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001
   Li XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015831
   May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6
   McDermid JM, 2007, JAIDS-J ACQ IMM DEF, V46, P498
   McDermid JM, 2009, AM J CLIN NUTR, V90, P225, DOI 10.3945/ajcn.2009.27709
   Merlini G, 2010, CLIN CHEM LAB MED, V48, P1567, DOI 10.1515/CCLM.2010.314
   MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401
   Minchella PA, 2014, INT J TUBERC LUNG D, V18, P1337, DOI 10.5588/ijtld.14.0143
   Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945
   Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010
   Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29
   O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2
   Pardanani A, 2013, AM J HEMATOL, V88, P312, DOI 10.1002/ajh.23406
   Pasricha SR, 2014, SCI TRANSL MED, V6
   Porta M, 2008, DICT EPIDEMIOLOGY
   Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219
   Ruchala P, 2014, TRENDS PHARMACOL SCI, V35, P155, DOI 10.1016/j.tips.2014.01.004
   Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034
   Sullivan PS, 1998, BLOOD, V91, P301
   Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4
   van Asbeck BS, 2001, J CLIN VIROL, V20, P141, DOI 10.1016/S1386-6532(00)00122-0
   van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03
   Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809
   World Health Organization (WHO) Centers for Disease Control and Prevention, 2007, ASS IR STAT POP
   WHO/UNICEF/UNU, 2001, IR DEF AN ASS PREV C
   Wisaksana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079904
   Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104
NR 46
TC 7
Z9 7
U1 1
U2 4
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JUN
PY 2015
VL 145
IS 6
BP 1194
EP 1201
DI 10.3945/jn.114.203158
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CJ6ZI
UT WOS:000355643300007
PM 25904736
OA No
DA 2017-08-15
ER

PT J
AU Anstey, NM
   Price, RN
   Davis, TME
   Karunajeewa, HA
   Mueller, I
   Karunajeewa, HA
   D'Alessandro, U
   Massougbodji, A
   Nikiema, F
   Ouedraogo, JB
   Tinto, H
   Zongo, I
   Ouedraogo, JB
   Tinto, H
   Same-Ekobo, A
   Kone, M
   Menan, H
   Toure, AO
   Yavo, W
   Yavo, W
   Kofoed, PE
   Alemayehu, BH
   Jima, D
   Baudin, E
   Espie, E
   Nabasumba, C
   Pinoges, L
   Schramm, B
   Cot, M
   Deloron, P
   Faucher, JF
   Cot, M
   Deloron, P
   Faucher, JF
   Faucher, JF
   Guthmann, JP
   Lell, B
   Borrmann, S
   Lell, B
   Adjei, GO
   Kofoed, PE
   Ursing, J
   Tjitra, E
   Borrmann, S
   Marsh, K
   Peshu, J
   Juma, E
   Ogutu, BR
   Omar, SA
   Sawa, P
   Talisuna, AO
   Talisuna, AO
   Khanthavong, M
   Mayxay, M
   Newton, PN
   Mayxay, M
   Piola, P
   Djimde, AA
   Doumbo, OK
   Fofana, B
   Sagara, I
   Bassat, Q
   Gonzalez, R
   Menendez, C
   Smithuis, F
   Smithuis, F
   Bousema, T
   Kager, PA
   Mens, PF
   Mens, PF
   Schallig, HDFH
   Van den Broek, I
   Van Vugt, M
   Ibrahim, ML
   Falade, CO
   Meremikwu, M
   Meremikwu, M
   Gil, JP
   Karema, C
   Ba, MS
   Faye, B
   Faye, O
   Gaye, O
   Ndiaye, JL
   Pene, M
   Sow, D
   Sylla, K
   Tine, RCK
   Penali, LK
   Barnes, KI
   Workman, LJ
   Barnes, KI
   Workman, LJ
   Bassat, Q
   Gonzalez, R
   Menendez, C
   Mueller, I
   Lima, A
   Adam, I
   Gadalla, NB
   Malik, EFM
   Bjorkman, A
   Gil, JP
   Martensson, A
   Ngasala, BE
   Ursing, J
   Rombo, L
   Rombo, L
   Rombo, L
   Aliu, P
   Duparc, S
   Filler, S
   Genton, B
   Genton, B
   Hodel, EM
   Olliaro, P
   Abdulla, S
   Kamugisha, E
   Ngasala, BE
   Premji, Z
   Shekalaghe, SA
   Shekalaghe, SA
   Ashley, EA
   Carrara, VI
   McGready, R
   Nosten, F
   Ashley, EA
   Faiz, AM
   Lee, SJ
   White, NJ
   Carrara, VI
   Dondorp, AM
   Smith, JJ
   D'Alessandro, U
   Tarning, J
   Achan, J
   Bukirwa, H
   Yeka, A
   Arinaitwe, E
   Staedke, SG
   Kamya, MR
   Kironde, F
   Nabasumba, C
   Bousema, T
   Drakeley, CJ
   Gadalla, NB
   Oguike, M
   Sutherland, CJ
   Checchi, F
   Dahal, P
   Flegg, JA
   Guerin, PJ
   Moreira, C
   Newton, PN
   Nsanzabana, C
   Price, RN
   Sibley, CH
   Stepniewska, K
   Tarning, J
   Dahal, P
   Dondorp, AM
   Flegg, JA
   Guerin, PJ
   Lee, SJ
   Marsh, K
   McGready, R
   Moreira, C
   Newton, PN
   Nosten, F
   Nsanzabana, C
   Olliaro, P
   Price, RN
   Tarning, J
   White, NJ
   Gething, PW
   Hay, SI
   Greenwood, B
   Hodel, EM
   Ward, SA
   Staedke, SG
   Van den Broek, I
   Winstanley, PA
   Dorsey, G
   Greenhouse, B
   Rosenthal, PJ
   Gadalla, NB
   Gil, JP
   Grivoyannis, A
   Hamed, K
   Hwang, J
   Kachur, PS
   Hwang, J
   Sibley, CH
   Nambozi, M
AF Anstey, N. M.
   Price, R. N.
   Davis, T. M. E.
   Karunajeewa, H. A.
   Mueller, I.
   Karunajeewa, H. A.
   D'Alessandro, U.
   Massougbodji, A.
   Nikiema, F.
   Ouedraogo, J-B
   Tinto, H.
   Zongo, I.
   Ouedraogo, J-B
   Tinto, H.
   Same-Ekobo, A.
   Kone, M.
   Menan, H.
   Toure, A. O.
   Yavo, W.
   Yavo, W.
   Kofoed, P-E
   Alemayehu, B. H.
   Jima, D.
   Baudin, E.
   Espie, E.
   Nabasumba, C.
   Pinoges, L.
   Schramm, B.
   Cot, M.
   Deloron, P.
   Faucher, J-F
   Cot, M.
   Deloron, P.
   Faucher, J-F
   Faucher, J-F
   Guthmann, J-P
   Lell, B.
   Borrmann, S.
   Lell, B.
   Adjei, G. O.
   Kofoed, P-E
   Ursing, J.
   Tjitra, E.
   Borrmann, S.
   Marsh, K.
   Peshu, J.
   Juma, E.
   Ogutu, B. R.
   Omar, S. A.
   Sawa, P.
   Talisuna, A. O.
   Talisuna, A. O.
   Khanthavong, M.
   Mayxay, M.
   Newton, P. N.
   Mayxay, M.
   Piola, P.
   Djimde, A. A.
   Doumbo, O. K.
   Fofana, B.
   Sagara, I.
   Bassat, Q.
   Gonzalez, R.
   Menendez, C.
   Smithuis, F.
   Smithuis, F.
   Bousema, T.
   Kager, P. A.
   Mens, P. F.
   Mens, P. F.
   Schallig, H. D. F. H.
   Van den Broek, I.
   Van Vugt, M.
   Ibrahim, M. L.
   Falade, C. O.
   Meremikwu, M.
   Meremikwu, M.
   Gil, J. P.
   Karema, C.
   Ba, M. S.
   Faye, B.
   Faye, O.
   Gaye, O.
   Ndiaye, J-L
   Pene, M.
   Sow, D.
   Sylla, K.
   Tine, R. C. K.
   Penali, L. K.
   Barnes, K. I.
   Workman, L. J.
   Barnes, K. I.
   Workman, L. J.
   Bassat, Q.
   Gonzalez, R.
   Menendez, C.
   Mueller, I.
   Lima, A.
   Adam, I.
   Gadalla, N. B.
   Malik, E. F. M.
   Bjorkman, A.
   Gil, J. P.
   Martensson, A.
   Ngasala, B. E.
   Ursing, J.
   Rombo, L.
   Rombo, L.
   Rombo, L.
   Aliu, P.
   Duparc, S.
   Filler, S.
   Genton, B.
   Genton, B.
   Hodel, E. M.
   Olliaro, P.
   Abdulla, S.
   Kamugisha, E.
   Ngasala, B. E.
   Premji, Z.
   Shekalaghe, S. A.
   Shekalaghe, S. A.
   Ashley, E. A.
   Carrara, V. I.
   McGready, R.
   Nosten, F.
   Ashley, E. A.
   Faiz, A. M.
   Lee, S. J.
   White, N. J.
   Carrara, V. I.
   Dondorp, A. M.
   Smith, J. J.
   D'Alessandro, U.
   Tarning, J.
   Achan, J.
   Bukirwa, H.
   Yeka, A.
   Arinaitwe, E.
   Staedke, S. G.
   Kamya, M. R.
   Kironde, F.
   Nabasumba, C.
   Bousema, T.
   Drakeley, C. J.
   Gadalla, N. B.
   Oguike, M.
   Sutherland, C. J.
   Checchi, F.
   Dahal, P.
   Flegg, J. A.
   Guerin, P. J.
   Moreira, C.
   Newton, P. N.
   Nsanzabana, C.
   Price, R. N.
   Sibley, C. H.
   Stepniewska, K.
   Tarning, J.
   Dahal, P.
   Dondorp, A. M.
   Flegg, J. A.
   Guerin, P. J.
   Lee, S. J.
   Marsh, K.
   McGready, R.
   Moreira, C.
   Newton, P. N.
   Nosten, F.
   Nsanzabana, C.
   Olliaro, P.
   Price, R. N.
   Tarning, J.
   White, N. J.
   Gething, P. W.
   Hay, S. I.
   Greenwood, B.
   Hodel, E. M.
   Ward, S. A.
   Staedke, S. G.
   Van den Broek, I.
   Winstanley, P. A.
   Dorsey, G.
   Greenhouse, B.
   Rosenthal, P. J.
   Gadalla, N. B.
   Gil, J. P.
   Grivoyannis, A.
   Hamed, K.
   Hwang, J.
   Kachur, P. S.
   Hwang, J.
   Sibley, C. H.
   Nambozi, M.
CA Worldwide Antimalarial Resistance
TI The effect of dose on the antimalarial efficacy of
   artemether-lumefantrine: a systematic review and pooled analysis of
   individual patient data
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID PLASMODIUM-FALCIPARUM MALARIA; POPULATION PHARMACOKINETICS;
   UNCOMPLICATED MALARIA; AFRICAN INFANTS; CHILDREN; SAFETY;
   PHARMACODYNAMICS; CHLOROQUINE; ARTESUNATE; RESISTANCE
AB Background Artemether-lumefantrine is the most widely used artemisinin-based combination therapy for malaria, although treatment failures occur in some regions. We investigated the effect of dosing strategy on efficacy in a pooled analysis from trials done in a wide range of malaria-endemic settings.
   Methods We searched PubMed for clinical trials that enrolled and treated patients with artemether-lumefantrine and were published from 1960 to December, 2012. We merged individual patient data from these trials by use of standardised methods. The primary endpoint was the PCR-adjusted risk of Plasmodium falciparum recrudescence by day 28. Secondary endpoints consisted of the PCR-adjusted risk of P falciparum recurrence by day 42, PCR-unadjusted risk of P falciparum recurrence by day 42, early parasite clearance, and gametocyte carriage. Risk factors for PCR-adjusted recrudescence were identified using Cox's regression model with frailty shared across the study sites.
   Findings We included 61 studies done between January, 1998, and December, 2012, and included 14 327 patients in our analyses. The PCR-adjusted therapeutic efficacy was 97.6% (95% CI 97.4-97.9) at day 28 and 96.0% (95.6-96.5) at day 42. After controlling for age and parasitaemia, patients prescribed a higher dose of artemether had a lower risk of having parasitaemia on day 1 (adjusted odds ratio [OR] 0.92, 95% CI 0.86-0.99 for every 1 mg/kg increase in daily artemether dose; p=0.024), but not on day 2 (p=0.69) or day 3 (0.087). In Asia, children weighing 10-15 kg who received a total lumefantrine dose less than 60 mg/kg had the lowest PCR-adjusted efficacy (91.7%, 95% CI 86.5-96.9). In Africa, the risk of treatment failure was greatest in malnourished children aged 1-3 years (PCR-adjusted efficacy 94.3%, 95% CI 92.3-96.3). A higher artemether dose was associated with a lower gametocyte presence within 14 days of treatment (adjusted OR 0.92, 95% CI 0.85-0.99; p=0.037 for every 1 mg/kg increase in total artemether dose).
   Interpretation The recommended dose of artemether-lumefantrine provides reliable efficacy in most patients with uncomplicated malaria. However, therapeutic efficacy was lowest in young children from Asia and young underweight children from Africa; a higher dose regimen should be assessed in these groups.
C1 [Anstey, N. M.; Price, R. N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.
   [Anstey, N. M.] Charles Darwin Univ, Darwin, NT 0909, Australia.
   [Davis, T. M. E.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia.
   [Karunajeewa, H. A.; Mueller, I.] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Melbourne, Vic, Australia.
   Western Hlth, Div Med, Melbourne, Vic, Australia.
   [D'Alessandro, U.] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium.
   [Massougbodji, A.] Univ dAbomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin.
   [Nikiema, F.; Ouedraogo, J-B; Tinto, H.] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso.
   Ctr Muraz, Bobo Dioulasso, Burkina Faso.
   [Same-Ekobo, A.] Univ Yaounde, Ctr Hosp, Fac Med & Sci Biomed, Yaounde, Cameroon.
   [Kone, M.; Menan, H.; Yavo, W.] Univ Cocody, Fac Pharm, Dept Parasitol & Mycol, Abidjan, Cote Ivoire.
   [Toure, A. O.] Inst Pasteur Cote Ivoire, Malariol Dept, Abidjan, Cote Ivoire.
   [Yavo, W.] Natl Inst Publ Hlth, Malaria Res & Control Ctr, Abidjan, Cote Ivoire.
   [Kofoed, P-E] Kolding Cty Hosp, Dept Paediat, Kolding, Denmark.
   [Alemayehu, B. H.] Int Ctr AIDS Care & Treatment Programs, Addis Ababa, Ethiopia.
   [Jima, D.] Fed Minist Hlth, Addis Ababa, Ethiopia.
   [Baudin, E.; Espie, E.; Nabasumba, C.; Pinoges, L.; Schramm, B.] Epictr, Paris, France.
   [Cot, M.; Deloron, P.; Faucher, J-F] Inst Rech Dev, Mother & Child Hlth Trop Res Unit, Paris, France.
   [Cot, M.; Deloron, P.; Faucher, J-F] Univ Paris 05, Sorbonne Paris Cite, PRES, Paris, France.
   [Faucher, J-F] Univ Besancon, Med Ctr, Dept Infect Dis, F-25030 Besancon, France.
   [Guthmann, J-P] Inst Veille Sanit, Dept Malad Infect, St Maurice, France.
   [Lell, B.] Ctr Rech Med Lambarene, Lambarene, Gabon.
   [Lell, B.; Borrmann, S.] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Adjei, G. O.] Univ Ghana, Sch Med, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana.
   [Kofoed, P-E] Projecto Saude Bandim, Bissau, Guinea Bissau.
   [Tjitra, E.] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia.
   [Borrmann, S.; Marsh, K.; Peshu, J.] Kenya Govt Med Res Ctr, Kilifi, Kenya.
   [Borrmann, S.; Marsh, K.; Peshu, J.] Wellcome Trust Res Programme, Kilifi, Kenya.
   [Juma, E.] Kenya Govt Med Res Ctr, Nairobi, Kenya.
   [Ogutu, B. R.] Kenya Govt Med Res Ctr, Kisumu, Kenya.
   [Ogutu, B. R.] US Army Med Res Unit, Kisumu, Kenya.
   [Omar, S. A.; Sawa, P.] Int Ctr Insect Physiol & Ecol, Human Hlth Div, Mbita Point, Kenya.
   [Talisuna, A. O.] WWARN East Africa Reg Ctr, Nairobi, Kenya.
   [Talisuna, A. O.] Univ Oxford, KEMRI, Oxford OX3 7LJ, England.
   [Talisuna, A. O.] Wellcome Trust Res Programme, Nairobi, Kenya.
   [Khanthavong, M.] Ctr Malariol Parasitol & Entomol, Viangchan, Laos.
   [Mayxay, M.; Newton, P. N.] Oxford Univ Trop Med Res Collaborat, Mahosot Hosp, Wellcome Trust Mahosot Hosp, Viangchan, Laos.
   [Mayxay, M.] Natl Univ Laos, Fac Med Sci, Viangchan, Laos.
   [Piola, P.] Inst Pasteur Madagascar, Antananarivo, Madagascar.
   [Djimde, A. A.; Doumbo, O. K.; Fofana, B.; Sagara, I.] Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali.
   [Bassat, Q.; Gonzalez, R.; Menendez, C.] Ctr Invest Saude Manhica, Manhica, Mozambique.
   [Smithuis, F.] Myanmar Oxford Clin Res Unit, Yangon, Myanmar.
   [Smithuis, F.] Myanmar & Med Act Myanmar, Yangon, Myanmar.
   [Bousema, T.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Njimegen, Netherlands.
   [Kager, P. A.; Mens, P. F.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINEMA, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands.
   [Mens, P. F.; Schallig, H. D. F. H.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.
   [Van den Broek, I.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.
   [Van Vugt, M.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Div Infect Dis, NL-1012 WX Amsterdam, Netherlands.
   [Ibrahim, M. L.] Ctr Rech Med & Sanit, Niamey, Niger.
   [Falade, C. O.] Univ Ibadan, Coll Med, Ibadan, Nigeria.
   [Meremikwu, M.] Univ Calabar, Dept Paediat, Calabar, Nigeria.
   Inst Trop Dis Res & Prevent, Calabar, Nigeria.
   [Gil, J. P.] Univ Lisbon, Fac Ciencias, Ctr Biodivers Funct & Integrat Genom, Drug Resistance & Pharmacogenet, P-1699 Lisbon, Portugal.
   [Karema, C.] Minist Hlth, Malaria & Other Parasit Dis Div RBC, Kigali, Rwanda.
   [Ba, M. S.; Faye, B.; Faye, O.; Gaye, O.; Ndiaye, J-L; Pene, M.; Sow, D.; Sylla, K.; Tine, R. C. K.] Univ Cheikh Anta Diop, Fac Med, Dept Parasitol & Mycol, Dakar, Senegal.
   [Penali, L. K.] WWARN West Africa Reg Ctr, Dakar, Senegal.
   [Barnes, K. I.; Workman, L. J.] WWARN, Pharmacol Module, Cape Town, South Africa.
   [Barnes, K. I.; Workman, L. J.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.
   [Bassat, Q.; Gonzalez, R.; Menendez, C.] Ctr Recerca Salut Int Barcelona, Barcelona, Spain.
   [Lima, A.] Medecins Sans Frontieres Operat Ctr Barcelona Ath, Barcelona, Spain.
   [Adam, I.] Univ Khartoum, Fac Med, Khartoum, Sudan.
   [Gadalla, N. B.] Natl Res Ctr, Res Inst Trop Med, Dept Epidemiol, Khartoum, Sudan.
   [Malik, E. F. M.] Fed Minist Hlth, Khartoum, Sudan.
   [Bjorkman, A.] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden.
   [Gil, J. P.] Karolinska Inst, Dept Physiol & Pharmacol, Drug Resistance Unit, Pharmacogenet Sect, Stockholm, Sweden.
   [Ursing, J.; Martensson, A.; Ngasala, B. E.] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Malaria Res, Stockholm, Sweden.
   [Martensson, A.] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden.
   [Rombo, L.] Karolinska Univ Hosp, Dept Med, Malaria Res Lab, Infect Dis Unit, Stockholm, Sweden.
   [Rombo, L.] Dept Infect Dis, Eskilstuna, Sweden.
   [Rombo, L.] Sormland Cty Council, Clin Res Ctr, Sormland, Sweden.
   [Aliu, P.] Novartis Pharma AG, Basel, Switzerland.
   [Duparc, S.] Med Malaria Venture, Geneva, Switzerland.
   [Filler, S.] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.
   [Genton, B.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Genton, B.] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland.
   [Genton, B.] Univ Lausanne Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland.
   [Hodel, E. M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Olliaro, P.] UNDP, UNICEF, World Bank, Geneva, Switzerland.
   [Olliaro, P.] WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland.
   [Abdulla, S.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Kamugisha, E.] Catholic Univ Hlth & Allied Sci, Mwanza, Tanzania.
   [Ngasala, B. E.; Premji, Z.] Muhimbili Univ Hlth & Allied Sci, Dept Parasitol, Dar Es Salaam, Tanzania.
   [Shekalaghe, S. A.] Kilimanjaro Christian Med Ctr, Kilimanjaro Clin Med Res Inst, Moshi, Tanzania.
   [Shekalaghe, S. A.] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Ashley, E. A.; Carrara, V. I.; McGready, R.; Nosten, F.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand.
   [Ashley, E. A.; Faiz, A. M.; Lee, S. J.; White, N. J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand.
   [Carrara, V. I.; Dondorp, A. M.] Mahidol Univ, Mahidol Oxford Univ Res Unit, Bangkok, Thailand.
   [Smith, J. J.] WWARN Asia Reg Ctr, Bangkok, Thailand.
   MRC Unit, Fajara, Gambia.
   [Tarning, J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.
   [Achan, J.; Bukirwa, H.; Yeka, A.] Uganda Malaria Surveillance Project, Kampala, Uganda.
   [Arinaitwe, E.; Staedke, S. G.] Infect Dis Res Collaborat, Kampala, Uganda.
   [Kamya, M. R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda.
   [Kironde, F.] Makerere Univ, Dept Biochem, Kampala, Uganda.
   [Nabasumba, C.] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda.
   [Bousema, T.; Gadalla, N. B.; Drakeley, C. J.; Oguike, M.; Sutherland, C. J.] London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1, England.
   [Checchi, F.] Save Children, Humanitarian Dept, London, England.
   [Newton, P. N.; Tarning, J.; Dahal, P.; Flegg, J. A.; Guerin, P. J.; Moreira, C.; Nsanzabana, C.; Sibley, C. H.; Stepniewska, K.] Worldwide Antimalarial Resistance Network, Oxford, England.
   [Marsh, K.; Newton, P. N.; Olliaro, P.; McGready, R.; Nosten, F.; Lee, S. J.; White, N. J.; Dondorp, A. M.; Tarning, J.; Dahal, P.; Flegg, J. A.; Guerin, P. J.; Moreira, C.; Nsanzabana, C.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Gething, P. W.; Hay, S. I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England.
   [Greenwood, B.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.
   [Hodel, E. M.; Ward, S. A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.
   [Staedke, S. G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England.
   [Van den Broek, I.] Medecins Sans Frontieres, London, England.
   [Winstanley, P. A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
   [Dorsey, G.; Greenhouse, B.; Rosenthal, P. J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Gadalla, N. B.] NIAID, Rockville, MD USA.
   [Gil, J. P.] SUNY Binghamton, Harpur Coll Arts & Sci, Binghamton, NY USA.
   [Grivoyannis, A.] Univ Washington, Div Emergency Med, Seattle, WA 98195 USA.
   [Hamed, K.] Novartis, E Hanover, NJ USA.
   [Hwang, J.; Kachur, P. S.] US Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Hwang, J.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.
   [Sibley, C. H.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   [Nambozi, M.] Trop Dis Res Ctr, Ndola, Zambia.
RP Price, RN (reprint author), Univ Oxford, Ctr Trop Med & Global Hlth, Worldwide Antimalarial Resistance Network, S Parks Rd, Oxford OX3 7LJ, England.
EM ric.price@wwarn.org; christian.nsanzabana@wwarn.org
RI Hodel, Eva Maria/E-1258-2014; Bousema, Teun/N-3574-2014; Ward,
   Steve/G-6003-2015; Hay, Simon/F-8967-2015; Gonzalez, Raquel/J-3604-2017
OI Hodel, Eva Maria/0000-0001-5821-1685; Flegg,
   Jennifer/0000-0002-8809-726X; Ward, Steve/0000-0003-2331-3192; Hay,
   Simon/0000-0002-0611-7272; Gonzalez, Raquel/0000-0001-5487-801X;
   GADALLA, NAHLA/0000-0002-6177-6705; Dahal, Prabin/0000-0002-2158-846X;
   Price, Richard/0000-0003-2000-2874; Gething, Peter/0000-0001-6759-5449;
   Guerin, Philippe/0000-0002-6008-2963; Nosten,
   Francois/0000-0002-7951-0745; McGready, Rose/0000-0003-1621-3257;
   Bassat, Quique/0000-0003-0875-7596; Hamed, Kamal/0000-0003-1896-9736;
   DELORON, Philippe/0000-0003-4705-2484; Cot, Michel/0000-0003-3014-4294
FU Bill & Melinda Gates Foundation
FX Bill & Melinda Gates Foundation.
CR Abdulla S, 2008, LANCET, V372, P1819, DOI 10.1016/S0140-6736(08)61492-0
   Ashley EA, 2007, TROP MED INT HEALTH, V12, P201, DOI 10.1111/j.1365-3165.2006.01785.x
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000
   Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599
   Hatz C, 1998, TROP MED INT HEALTH, V3, P498, DOI 10.1046/j.1365-3156.1998.00250.x
   Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46
   Jiao Xiuquing, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P476
   Kshirsagar NA, 2000, AM J TROP MED HYG, V62, P402
   Levin ML, 1953, NEW ENGL J MED, V9, P531
   MMV, 2013, COART DISP 200 MILL
   Nacher M, 2004, T ROY SOC TROP MED H, V98, P322, DOI 10.1016/j.trstmh.2003.10.005
   Oshikoya KA, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-50
   Price R, 1998, T ROY SOC TROP MED H, V92, P207, DOI 10.1016/S0035-9203(98)90750-7
   Salman S, 2011, ANTIMICROB AGENTS CH, V55, P5306, DOI 10.1128/AAC.05136-11
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239
   Song JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-231
   Tarning J, 2012, CLIN PHARMACOL THER, V91, P497, DOI 10.1038/clpt.2011.254
   Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031
   Verret WJ, 2011, ANTIMICROB AGENTS CH, V55, P2629, DOI 10.1128/AAC.01727-10
   Vugt M V, 1999, Am J Trop Med Hyg, V60, P936
   White N, 1999, PHILOS T ROY SOC B, V354, P739, DOI 10.1098/rstb.1999.0426
   White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002
   White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5
   White NJ, 2008, MALARIA J S1, V7, pS8, DOI DOI 10.1186/1475-2875-7-S1-S8
   WHO, WORLD MAL REP 2013
   WHO, 2006, WHO CHILD GROWTH STA
   WWARN, 2012, STAT AN PLAN AL DOS
   WorldWide Antimalarial Resistance Network (WWARN), 2012, CLIN MOD DAT MAN STA
   Worldwide Antimalarial Resistance Network (WWARN) DP Study Group, 2013, PLOS MED, V10
NR 32
TC 20
Z9 20
U1 4
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2015
VL 15
IS 6
BP 692
EP 702
DI 10.1016/S1473-3099(15)70024-1
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA CI3HI
UT WOS:000354638000034
PM 25788162
OA No
DA 2017-08-15
ER

PT J
AU Meyer, CT
   Bauer, IK
   Antonio, M
   Adeyemi, M
   Saha, D
   Oundo, JO
   Ochieng, JB
   Omore, R
   Stine, OC
   Wang, D
   Holtz, LR
AF Meyer, Caroline T.
   Bauer, Irma K.
   Antonio, Martin
   Adeyemi, Mitchell
   Saha, Debasish
   Oundo, Joseph O.
   Ochieng, John B.
   Omore, Richard
   Stine, O. Colin
   Wang, David
   Holtz, Lori R.
TI Prevalence of classic, MLB-clade and VA-clade Astroviruses in Kenya and
   The Gambia
SO VIROLOGY JOURNAL
LA English
DT Article
DE Astrovirus; MLB; VA; Diarrhea; Gastroenteritis
ID DEVELOPING-COUNTRIES; DIARRHEAL DISEASE; CHILD-MORTALITY; HUMAN FECES;
   INFECTION; GASTROENTERITIS; DIVERSITY; EVOLUTION; ETIOLOGY; TRENDS
AB Background: Infectious diarrhea leads to significant mortality in children, with 40 % of these deaths occurring in Africa. Classic human astroviruses are a well-established etiology of diarrhea. In recent years, seven novel astroviruses have been discovered (MLB1, MLB2, MLB3, VA1/HMO-C, VA2/HMO-B, VA3/HMO-A, VA4); however, there have been few studies on their prevalence or potential association with diarrhea.
   Methods: To investigate the prevalence and diversity of these classic and recently described astroviruses in a pediatric population, a case-control study was performed. Nine hundred and forty nine stools were previously collected from cases of moderate-to-severe diarrhea and matched controls of patients less than 5 years of age in Kenya and The Gambia. RT-PCR screening was performed using pan-astrovirus primers.
   Results: Astroviruses were present in 9.9 % of all stool samples. MLB3 was the most common astrovirus with a prevalence of 2.6 %. Two subtypes of MLB3 were detected that varied based on location in Africa. In this case-control study, Astrovirus MLB1 was associated with diarrhea in Kenya, whereas Astrovirus MLB3 was associated with the control state in The Gambia. Classic human astrovirus was not associated with diarrhea in this study. Unexpectedly, astroviruses with high similarity to Canine Astrovirus and Avian Nephritis Virus 1 and 2 were also found in one case of diarrhea and two control stools respectively.
   Conclusions: Astroviruses including novel MLB- and VA-clade members are commonly found in pediatric stools in Kenya and The Gambia. The most recently discovered astrovirus, MLB3, was the most prevalent and was found more commonly in control stools in The Gambia, while astrovirus MLB1 was associated with diarrhea in Kenya. Furthermore, a distinct subtype of MLB3 was noted, as well as 3 unanticipated avian or canine astroviruses in the human stool samples. As a result of a broadly reactive PCR screen for astroviruses, new insight was gained regarding the epidemiology of astroviruses in Africa, where a large proportion of diarrheal morbidity and mortality occur.
C1 [Meyer, Caroline T.; Bauer, Irma K.; Wang, David; Holtz, Lori R.] Washington Univ, Sch Med, St Louis, MO 63130 USA.
   [Antonio, Martin; Adeyemi, Mitchell; Saha, Debasish] MRC Unit, Banjul, Gambia.
   [Saha, Debasish] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Oundo, Joseph O.; Ochieng, John B.; Omore, Richard] Ctr Dis Control & Prevent, Kenya Med Res Inst, Kisumu, Kenya.
   [Stine, O. Colin] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
RP Holtz, LR (reprint author), Washington Univ, Sch Med, St Louis, MO 63130 USA.
EM Holtz_L@kids.wustl.edu
FU National Institutes of Health Pediatric Gastroenterology Research
   Training Program from the NIDDK [5T32DK077653]; National Institutes of
   Health/National Center for Research Resources Washington University-ICTS
   [KL2 RR024994]; NIH [U54 AI057160]; Children's Discovery Institute
   [MD-FR-2013-292]; Bill & Melinda Gates Foundation [OPP1016839];
   Burroughs Welcome Fund
FX This study was supported in part by the National Institutes of Health
   Pediatric Gastroenterology Research Training Program (5T32DK077653) from
   the NIDDK, National Institutes of Health/National Center for Research
   Resources Washington University-ICTS (KL2 RR024994), NIH grant U54
   AI057160 to the Midwest Regional Center of Excellence for Biodefense and
   Emerging Infectious Disease Research, Children's Discovery Institute
   (MD-FR-2013-292), and the Bill & Melinda Gates Foundation (OPP1016839).
   D.W. holds an Investigators in the Pathogenesis of Infectious Disease
   award from the Burroughs Welcome Fund.
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   Ahmed SF, 2011, EMERG INFECT DIS, V17, P2391, DOI 10.3201/eid1712.110909
   Allos BM, 2001, CLIN INFECT DIS, V32, P1201
   Banyai K, 2010, EMERG INFECT DIS, V16, P169, DOI [10.3201/eid1601.091563, 10.3201/eid1601.091120]
   Basu G, 2003, East Afr Med J, V80, P652
   Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI [10.4269/ajtmh.2010.10-0367, 10.4269/ajtmh.2010.10.0367]
   Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14
   Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054
   Brown JR, 2015, CLIN INFECT DIS, V60, P881, DOI 10.1093/cid/ciu940
   Burbelo PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022576
   Cunliffe NA, 2002, J MED VIROL, V67, P563, DOI 10.1002/jmv.10139
   De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024
   Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011
   Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161
   Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09
   Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117
   Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213
   GLASS RI, 1983, J INFECT DIS, V148, P292
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hien Bui Thi Thu, 2007, J Med Microbiol, V56, P1086, DOI 10.1099/jmm.0.47093-0
   Holtz LR, 2014, VIROLOGY, V468, P556, DOI 10.1016/j.virol.2014.09.012
   Holtz LR, 2014, CLIN VACCINE IMMUNOL, V21, P908, DOI 10.1128/CVI.00100-14
   Holtz LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028647
   Holtz LR, 2011, EMERG INFECT DIS, V17, P2050, DOI 10.3201/eid1711.110496
   Imada T, 2000, J VIROL, V74, P8487, DOI 10.1128/JVI.74.18.8487-8493.2000
   Jiang HB, 2013, VIROLOGY, V436, P8, DOI 10.1016/j.virol.2012.09.040
   Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0
   Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960
   Kiulia NM, 2007, J TROP PEDIATRICS, V53, P206, DOI 10.1093/tropej/fml093
   KONKEL ME, 1990, INFECT IMMUN, V58, P1101
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Marx FE, 1998, S AFR J EPIDEMIOL IN, V13, P5
   Mason J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059663
   Matsumoto T, 2013, GENOME ANNOUNC, V1
   Medici MC, 2014, EMERG INFECT DIS, V20, P169, DOI 10.3201/eid2001.131259
   Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Pantin-Jackwood MJ, 2011, ARCH VIROL, V156, P235, DOI 10.1007/s00705-010-0849-z
   Pennap G, 2002, J TROP PEDIATRICS, V48, P98, DOI 10.1093/tropej/48.2.98
   Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005
   Phan TG, 2014, J CLIN VIROL, V60, P161, DOI 10.1016/j.jcv.2014.03.024
   Platts-Mills JA, 2014, AM J TROP MED HYG, V90, P133, DOI 10.4269/ajtmh.13-0439
   Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536
   Wang YX, 2013, EMERG INFECT DIS, V19, P1333, DOI 10.3201/eid1908.121863
   Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003
   Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470
NR 47
TC 11
Z9 11
U1 1
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD MAY 15
PY 2015
VL 12
AR 78
DI 10.1186/s12985-015-0299-z
PG 7
WC Virology
SC Virology
GA CK1OX
UT WOS:000355977700002
PM 25975198
OA gold
DA 2017-08-15
ER

PT J
AU Rosas-Aguirre, A
   Erhart, A
   Llanos-Cuentas, A
   Branch, O
   Berkvens, D
   Abatih, E
   Lambert, P
   Frasso, G
   Rodriguez, H
   Gamboa, D
   Sihuincha, M
   Rosanas-Urgell, A
   D'Alessandro, U
   Speybroeck, N
AF Rosas-Aguirre, Angel
   Erhart, Annette
   Llanos-Cuentas, Alejandro
   Branch, Oralee
   Berkvens, Dirk
   Abatih, Emmanuel
   Lambert, Philippe
   Frasso, Gianluca
   Rodriguez, Hugo
   Gamboa, Dionicia
   Sihuincha, Moises
   Rosanas-Urgell, Anna
   D'Alessandro, Umberto
   Speybroeck, Niko
TI Modelling the potential of focal screening and treatment as elimination
   strategy for Plasmodium falciparum malaria in the Peruvian Amazon Region
SO PARASITES & VECTORS
LA English
DT Article
DE Malaria; Plasmodium falciparum; Focal Screening and Treatment (FSAT);
   Modelling; Elimination; Peru
ID ASYMPTOMATIC CARRIERS; VIVAX-MALARIA; TRANSMISSION; INFECTION;
   COMMUNITY; PARASITEMIA; BRAZIL; RISK; POPULATIONS; MOSQUITOS
AB Background: Focal screening and treatment (FSAT) of malaria infections has recently been introduced in Peru to overcome the inherent limitations of passive case detection (PCD) and further decrease the malaria burden. Here, we used a relatively straightforward mathematical model to assess the potential of FSAT as elimination strategy for Plasmodium falciparum malaria in the Peruvian Amazon Region.
   Methods: A baseline model was developed to simulate a scenario with seasonal malaria transmission and the effect of PCD and treatment of symptomatic infections on the P. falciparum malaria transmission in a low endemic area of the Peruvian Amazon. The model was then adjusted to simulate intervention scenarios for predicting the long term additional impact of FSAT on P. falciparum malaria prevalence and incidence. Model parameterization was done using data from a cohort study in a rural Amazonian community as well as published transmission parameters from previous studies in similar areas. The effect of FSAT timing and frequency, using either microscopy or a supposed field PCR, was assessed on both predicted incidence and prevalence rates.
   Results: The intervention model indicated that the addition of FSAT to PCD significantly reduced the predicted P. falciparum incidence and prevalence. The strongest reduction was observed when three consecutive FSAT were implemented at the beginning of the low transmission season, and if malaria diagnosis was done with PCR. Repeated interventions for consecutive years (10 years with microscopy or 5 years with PCR), would allow reaching near to zero incidence and prevalence rates.
   Conclusions: The addition of FSAT interventions to PCD may enable to reach P. falciparum elimination levels in low endemic areas of the Amazon Region, yet the progression rates to those levels may vary substantially according to the operational criteria used for the intervention.
C1 [Rosas-Aguirre, Angel; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru.
   [Rosas-Aguirre, Angel; Erhart, Annette; Berkvens, Dirk; Abatih, Emmanuel; Rosanas-Urgell, Anna] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Rosas-Aguirre, Angel; Lambert, Philippe; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.
   [Branch, Oralee] NYU, Dept Med Parasitol, New York, NY 10012 USA.
   [Lambert, Philippe; Frasso, Gianluca] Univ Liege, Inst Sci Humaines & Sociales, B-4000 Liege, Belgium.
   [Rodriguez, Hugo] Reg Salud Loreto, Iquitos 160, Loreto, Peru.
   [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima 31, Peru.
   [Sihuincha, Moises] Univ Nacl Amazonia Peruana, Fac Med, Iquitos 160, Loreto, Peru.
   [D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara 220, Gambia.
   [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Rosas-Aguirre, A (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru.
EM angelrosasa@gmail.com
RI Rosas Aguirre, Angel/A-5054-2016
OI Rosas Aguirre, Angel/0000-0002-3271-7028
FU Institute of Tropical Medicine "Alexander von Humboldt" - Universidad
   Peruana Cayetano Heredia, Lima; Institute of Tropical Medicine in
   Antwerp, Belgium (FA3-II project); National Institute of Allergy and
   Infectious Diseases-National Institutes of Health (NIAID-NIH) [R01
   AI64831]
FX The study was funded by the Directorate General for Development
   Cooperation (DGCD) of the Belgian Government within the Third Framework
   Agreement of the Institutional Collaboration between the Institute of
   Tropical Medicine "Alexander von Humboldt" - Universidad Peruana
   Cayetano Heredia, Lima and the Institute of Tropical Medicine in
   Antwerp, Belgium (FA3-II project, 2011-2013)). Data of a cohort study in
   a rural community of the Peruvian Amazon were collected as part of the
   Malaria Immunology and Genetics project (MIGIA) which was funded by
   National Institute of Allergy and Infectious Diseases-National
   Institutes of Health (NIAID-NIH, R01 AI64831).
CR Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2
   Anderson RM, 1991, INFECT DIS HUMANS DY
   Babiker HA, 1998, AM J TROP MED HYG, V59, P582
   Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109
   Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27
   Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626
   Clark EH, 2012, INFECT IMMUN, V80, P1583, DOI 10.1128/IAI.05961-11
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010
   da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341
   da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001
   Freeman J, 1999, AM J TROP MED HYG, V60, P774
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   Griffin JT, 2010, PLOS MED, V7
   HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132
   Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177
   Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184
   Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797
   Kern SE, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-210
   Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229
   Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452
   Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004
   malERA Consultative Group on Drugs, 2011, PLOS MED, V8
   *MALERA CONS GROUP, 2011, PLOS MED, V0008
   Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202
   Cucunuba ZM, 2013, T ROY SOC TROP MED H, V107, P129, DOI 10.1093/trstmh/trs021
   Ministerio de Salud del Peru, 2013, BOL EPIDEMIOL, V22, P1088
   Moiroux N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-71
   Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X
   Nawaz H, 2001, AM J TROP MED HYG, V65, P252
   Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781
   Parekh FK, 2007, AM J TROP MED HYG, V77, P451
   Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178
   Rosas-Aguirre Angel, 2011, Rev Peru Med Exp Salud Publica, V28, P228, DOI 10.1590/s1726-46342011000200009
   Roshanravan B, 2003, AM J TROP MED HYG, V69, P45
   Soetaert K, 2011, JNAIAM, V6, P51
   Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467
   Suarez-Mutis Martha C., 2007, Revista do Instituto de Medicina Tropical de Sao Paulo, V49, P159, DOI 10.1590/S0036-46652007000300005
   Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396
   Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132
   Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09
   Tiono AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-79
   Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204
   Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257
   Vinetz JM, 2002, AM J TROP MED HYG, V66, P639
   World Health Organization, 2012, DIS SURV MAL EL
   World Health Organization, 2009, MAL LIGHT MICR CREAT
   Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-226
NR 48
TC 2
Z9 2
U1 1
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 7
PY 2015
VL 8
AR 261
DI 10.1186/s13071-015-0868-4
PG 12
WC Parasitology
SC Parasitology
GA CH7TA
UT WOS:000354238300002
PM 25948081
OA gold
DA 2017-08-15
ER

PT J
AU Mousson, CI
   Tinel, C
   Kamar, N
   del Bello, A
   Laurent, C
   Janbon, B
AF Mousson, Christiane I.
   Tinel, Claire
   Kamar, Nassim
   del Bello, Arnaud
   Laurent, Charlotte
   Janbon, Benedicte
TI EARLY RECURRENCE OF ISOLATED RENAL MICROPOLYANGIITIS DURING THE FIRST
   THREE MONTHS OF KIDNEY TRANSPLANTATION
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Meeting Abstract
CT 52nd Congress of the
   European-Renal-Association-European-Dialysis-and-Transplant-Assocation
CY MAY 28-31, 2015
CL London, ENGLAND
SP European Renal Assoc, European Dialysis & Transplant Assoc
C1 [Mousson, Christiane I.; Tinel, Claire] Univ Hosp, Nephrol, Dijon, France.
   [Kamar, Nassim] Univ Hosp, Organ Transplantat, Dijon, France.
   [del Bello, Arnaud] Univ Hosp, Organ Transplantat, Toulouse, Gambia.
   [Laurent, Charlotte] Univ Hosp, Nephrol, Rouen, France.
   [Janbon, Benedicte] Univ Hosp, Nephrol, Grenoble, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
EI 1460-2385
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD MAY
PY 2015
VL 30
SU 3
MA SP830
DI 10.1093/ndt/gfv202.56
PG 1
WC Transplantation; Urology & Nephrology
SC Transplantation; Urology & Nephrology
GA CR3FD
UT WOS:000361215103095
OA No
DA 2017-08-15
ER

PT J
AU Afolabi, MO
   McGrath, N
   D'Alessandro, U
   Kampmann, B
   Imoukhuede, EB
   Ravinetto, RM
   Alexander, N
   Larson, HJ
   Chandramohan, D
   Bojang, K
AF Afolabi, Muhammed Olanrewaju
   McGrath, Nuala
   D'Alessandro, Umberto
   Kampmann, Beate
   Imoukhuede, Egeruan B.
   Ravinetto, Raffaella M.
   Alexander, Neal
   Larson, Heidi J.
   Chandramohan, Daniel
   Bojang, Kalifa
TI A multimedia consent tool for research participants in the Gambia: a
   randomized controlled trial
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID INFORMED-CONSENT; CLINICAL-TRIALS; INTERVENTION; MALARIA; WORLD
AB Objective To assess the effectiveness of a multimedia informed consent tool for adults participating in a clinical trial in the Gambia.
   Methods Adults eligible for inclusion in a malaria treatment trial (n = 311) were randomized to receive information needed for informed consent using either a multimedia tool (intervention arm) or a standard procedure (control arm). A computerized, audio questionnaire was used to assess participants' comprehension of informed consent. This was done immediately after consent had been obtained (at day 0) and at subsequent follow-up visits (days 7, 14,21 and 28). The acceptability and ease of use of the multimedia tool were assessed in focus groups.
   Findings On day 0, the median comprehension score in the intervention arm was 64% compared with 40% in the control arm (P=0.042). The difference remained significant at all follow-up visits. Poorer comprehension was independently associated with female sex (odds ratio, OR: 0.29; 95% confidence interval, CI: 0.12-0.70) and residing in Jahaly rather than Basse province (OR: 0.33; 95% CI: 0.13-0.82). There was no significant independent association with educational level. The risk that a participant's comprehension score would drop to half of the initial value was lower in the intervention arm (hazard ratio 0.22, 95% CI: 0.16-0.31). Overall, 70% (42/60) of focus group participants from the intervention arm found the multimedia tool clear and easy to understand.
   Conclusion A multimedia informed consent tool significantly improved comprehension and retention of consent information by research participants with low levels of literacy.
C1 [Afolabi, Muhammed Olanrewaju; D'Alessandro, Umberto; Kampmann, Beate; Bojang, Kalifa] MRC Unit, Banjul, Gambia.
   [McGrath, Nuala] Univ Southampton, Southampton, Hants, England.
   [Imoukhuede, Egeruan B.] Univ Oxford, Jenner Inst, Oxford, England.
   [Ravinetto, Raffaella M.] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Alexander, Neal; Larson, Heidi J.; Chandramohan, Daniel] London Sch Hyg & Trop Med, London WC1, England.
RP Afolabi, MO (reprint author), MRC Unit, Atlantic Rd,POB 273, Banjul, Gambia.
EM mafolabi@mrc.gm
OI Afolabi, Muhammed/0000-0002-9967-6419; Kampmann,
   Beate/0000-0002-6546-4709; Bojang, Kalifa/0000-0001-7506-0938
FU European and Developing Countries Clinical Trials Partnership
   [IP.2008.31100.001]; Wellcome Trust [WT083495MA]; United Kingdom Medical
   Research Council; Department for International Development
   [MR/K012126/1]
FX The study was supported by a grant (IP.2008.31100.001) from the European
   and Developing Countries Clinical Trials Partnership. Nuala McGrath was
   supported by a Wellcome Trust Fellowship (grant WT083495MA) and Neal
   Alexander received support from the United Kingdom Medical Research
   Council and Department for International Development (MR/K012126/1).
CR Afolabi MO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004817
   Afolabi MO, 2014, TROP MED INT HEALTH, V19, P625, DOI 10.1111/tmi.12288
   Afolabi MO, 2014, AM J TROP MED HYG, V90, P908, DOI 10.4269/ajtmh.13-0615
   Afolabi Muhammed Olanrewaju, 2014, J Clin Res Bioeth, V5, P178
   Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209
   Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474
   Castelnuovo Barbara, 2014, J Clin Res Bioeth, V5, P165
   ClinicalTrials.gov, 2015, PRIM GAM EFF MAL AS
   Dhai A, 2010, J MED ETHICS, V36, P238, DOI 10.1136/jme.2009.033407
   Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593
   Hoffman SL, 2010, HUM VACCINES, V6, P97
   Hutchison C, 2007, BRIT J CANCER, V97, P705, DOI 10.1038/sj.bjc.6603943
   Hutchison C, 2007, EUR J CANCER CARE, V16, P187, DOI 10.1111/j.1365-2354.2006.00732.x
   Hutchison C, 2007, EUR J CANCER CARE, P195
   Minnies Deon, 2008, BMC Med Ethics, V9, P15, DOI 10.1186/1472-6939-9-15
   Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28
   Saidu Y., 2013, Journal of Clinical Research and Bioethics, V4, P1000141
   Wirshing DA, 2005, AM J PSYCHIAT, V162, P186, DOI 10.1176/appi.ajp.162.1.186
   [Anonymous], 2015, LIT RAT AD TOT PEOPL
   World Medical Association, 2013, WORLD MED J, V59, P199
NR 20
TC 3
Z9 3
U1 0
U2 3
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD MAY
PY 2015
VL 93
IS 5
BP 320
EP 328
DI 10.2471/BLT.14.146159
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CL0OB
UT WOS:000356640900014
PM 26229203
OA No
DA 2017-08-15
ER

PT J
AU Burton, MJ
   Rajak, SN
   Hu, VH
   Ramadhani, A
   Habtamu, E
   Massae, P
   Tadesse, Z
   Callahan, K
   Emerson, PM
   Khaw, PT
   Jeffries, D
   Mabey, DCW
   Bailey, RL
   Weiss, HA
   Holland, MJ
AF Burton, Matthew J.
   Rajak, Saul N.
   Hu, Victor H.
   Ramadhani, Athumani
   Habtamu, Esmael
   Massae, Patrick
   Tadesse, Zerihun
   Callahan, Kelly
   Emerson, Paul M.
   Khaw, Peng T.
   Jeffries, David
   Mabey, David C. W.
   Bailey, Robin L.
   Weiss, Helen A.
   Holland, Martin J.
TI Pathogenesis of Progressive Scarring Trachoma in Ethiopia and Tanzania
   and Its Implications for Disease Control: Two Cohort Studies
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TISSUE GROWTH-FACTOR; INCREASED CONJUNCTIVAL EXPRESSION; VIVO CONFOCAL
   MICROSCOPY; CHLAMYDIA-TRACHOMATIS; BACTERIAL-INFECTION; QUANTITATIVE
   PCR; IMMUNE-RESPONSES; NATURAL-HISTORY; FOLLOW-UP; COMMUNITY
AB Background
   Trachoma causes blindness through a conjunctival scarring process initiated by ocular Chlamydia trachomatis infection; however, the rates, drivers and pathophysiological determinants are poorly understood. We investigated progressive scarring and its relationship to conjunctival infection, inflammation and transcript levels of cytokines and fibrogenic factors.
   Methodology/Principal Findings
   We recruited two cohorts, one each in Ethiopia and Tanzania, of individuals with established trachomatous conjunctival scarring. They were followed six-monthly for two years, with clinical examinations and conjunctival swab sample collection. Progressive scarring cases were identified by comparing baseline and two-year photographs, and compared to individuals without progression. Samples were tested for C. trachomatis by PCR and transcript levels of S100A7, IL1B, IL13, IL17A, CXCL5, CTGF, SPARCL1, CEACAM5, MMP7, MMP9 and CD83 were estimated by quantitative RT-PCR. Progressive scarring was found in 135/585 (23.1%) of Ethiopian participants and 173/577 (30.0%) of Tanzanian participants. There was a strong relationship between progressive scarring and increasing inflammatory episodes (Ethiopia: OR 5.93, 95% CI 3.31-10.6, p<0.0001. Tanzania: OR 5.76, 95% CI 2.60-12.7, p<0.0001). No episodes of C. trachomatis infection were detected in the Ethiopian cohort and only 5 episodes in the Tanzanian cohort. Clinical inflammation, but not scarring progression, was associated with increased expression of S100A7, IL1B, IL17A, CXCL5, CTGF, CEACAM5, MMP7, CD83 and reduced SPARCL1.
   Conclusions/Significance
   Scarring progressed in the absence of detectable C. trachomatis, which raises uncertainty about the primary drivers of late-stage trachoma. Chronic conjunctival inflammation appears to be central and is associated with enriched expression of pro-inflammatory factors and altered expression of extracellular matrix regulators. Host determinants of scarring progression appear more complex and subtle than the features of inflammation. Overall this indicates a potential role for anti-inflammatory interventions to interrupt progression and the need for trichiasis disease surveillance and surgery long after chlamydial infection has been controlled at community level.
C1 [Burton, Matthew J.; Rajak, Saul N.; Hu, Victor H.; Ramadhani, Athumani; Habtamu, Esmael; Mabey, David C. W.; Bailey, Robin L.; Holland, Martin J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Burton, Matthew J.; Khaw, Peng T.] Moorfields Eye Hosp, Biomed Res Ctr, NIHR, London, England.
   [Burton, Matthew J.; Khaw, Peng T.] UCL, Inst Ophthalmol, London, England.
   [Burton, Matthew J.; Hu, Victor H.; Ramadhani, Athumani; Massae, Patrick] Kilimanjaro Christian Med Ctr, Dept Ophthalmol, Moshi, Tanzania.
   [Habtamu, Esmael; Tadesse, Zerihun] Carter Ctr, Addis Ababa, Ethiopia.
   [Callahan, Kelly] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA.
   [Emerson, Paul M.] Int Trachoma Initiat, Atlanta, GA USA.
   [Jeffries, David] Med Res Council MRC Labs, Fajara, Gambia.
   [Weiss, Helen A.] London Sch Hyg & Trop Med, Med Res Council MRC Trop Epidemiol Grp, London WC1, England.
RP Burton, MJ (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
EM matthew.burton@lshtm.ac.uk
OI Mabey, David/0000-0002-0031-8276; Burton, Matthew/0000-0003-1872-9169
FU Wellcome Trust [080741/Z/06/Z, 098481/Z/12/Z]
FX This research was funded by the Wellcome Trust (Reference numbers:
   080741/Z/06/Z and 098481/Z/12/Z). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abraham D, 2008, RHEUMATOLOGY, V47, pV8, DOI 10.1093/rheumatology/ken278
   Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Berhane Y, 2006, NATIONAL SURVEY ON B
   Biebesheimer JB, 2009, OPHTHALMOLOGY, V116, P2047, DOI 10.1016/j.ophtha.2009.04.041
   Bowman RJC, 2001, OPHTHALMOLOGY, V108, P2219, DOI 10.1016/S0161-6420(01)00645-5
   Burton MJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001985
   Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11
   Burton MJ, 2011, INFECT IMMUN, V79, P499, DOI 10.1128/IAI.00888-10
   Burton MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000835
   Burton MJ, 2005, BRIT J OPHTHALMOL, V89, P1282, DOI 10.1136/bjo.2004.062489
   Burton MJ, 2003, INVEST OPHTH VIS SCI, V44, P4215, DOI 10.1167/iovs.03-0107
   Cevallos V, 2012, INVEST OPHTH VIS SCI, V53, P5208, DOI 10.1167/iovs.12-9984
   Chaurasia SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081544
   Dawson CR, 1981, GUIDE TO TRACHOMA CO
   Dawson CR, 1990, CHLAMYDIAL INFECT, P271
   Dendooven A, 2011, BIOMARKERS, V16, P289, DOI 10.3109/1354750X.2011.561366
   EL-ASRAR A M A, 1989, British Journal of Ophthalmology, V73, P276, DOI 10.1136/bjo.73.4.276
   Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836
   Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142
   Grassly NC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000341
   Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x
   Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686
   Hu VH, 2013, BRIT J OPHTHALMOL, V97, P1333, DOI 10.1136/bjophthalmol-2013-303126
   Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020
   Hu VH, 2012, INFECT IMMUN, V80, P121, DOI 10.1128/IAI.05965-11
   Hu VH, 2011, OPHTHALMOLOGY, V118, P2138, DOI 10.1016/j.ophtha.2011.04.014
   Hu VH, 2011, INVEST OPHTH VIS SCI, V52, P2181, DOI 10.1167/iovs.10-5829
   Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC
   Keenan JD, 2010, AM J TROP MED HYG, V82, P482, DOI 10.4269/ajtmh.2010.09-0315
   Klaile E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-85
   Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K
   Munoz B, 1997, TROP MED INT HEALTH, V2, P1030, DOI 10.1046/j.1365-3156.1997.d01-186.x
   Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005
   Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10
   Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316
   Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687
   Rajak SN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001136
   Rajak SN, 2012, SURV OPHTHALMOL
   Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086
   Solomon AW, 2008, NEW ENGL J MED, V358, P1870, DOI 10.1056/NEJMc0706263
   Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8
   Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929
   West S K, 2001, Ophthalmic Epidemiol, V8, P137, DOI 10.1076/opep.8.2.137.4158
   Wolle MA, 2009, OPHTHALMOLOGY, V116, P243, DOI 10.1016/j.ophtha.2008.09.011
   Wolle MA, 2009, INVEST OPHTH VIS SCI, V50, P592, DOI 10.1167/iovs.08-2414
   Zhou Y, 2014, THE CONJUNCTIVAL MIC
   [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P421
NR 50
TC 11
Z9 11
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2015
VL 9
IS 5
AR UNSP e0003763
DI 10.1371/journal.pntd.0003763
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CJ2HA
UT WOS:000355303600030
PM 25970613
OA gold
DA 2017-08-15
ER

PT J
AU Donnenberg, MS
   Hazen, TH
   Farag, TH
   Panchalingam, S
   Antonio, M
   Hossain, A
   Mandomando, I
   Ochieng, JB
   Ramamurthy, T
   Tamboura, B
   Zaidi, A
   Levine, MM
   Kotloff, K
   Rasko, DA
   Nataro, JP
AF Donnenberg, Michael S.
   Hazen, Tracy H.
   Farag, Tamer H.
   Panchalingam, Sandra
   Antonio, Martin
   Hossain, Anowar
   Mandomando, Inacio
   Ochieng, John Benjamin
   Ramamurthy, Thandavarayan
   Tamboura, Boubou
   Zaidi, Anita
   Levine, Myron M.
   Kotloff, Karen
   Rasko, David A.
   Nataro, James P.
TI Bacterial Factors Associated with Lethal Outcome of Enteropathogenic
   Escherichia coli Infection: Genomic Case-Control Studies
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DIARRHEAL DISEASE; CHILDREN; INFANTS; EPEC
AB Background
   Typical enteropathogenic Escherichia coli (tEPEC) strains were associated with mortality in the Global Enteric Multicenter Study (GEMS). Genetic differences in tEPEC strains could underlie some of the variability in clinical outcome.
   Methods
   We produced draft genome sequences of all available tEPEC strains from GEMS lethal infections (LIs) and of closely matched EPEC strains from GEMS subjects with non-lethal symptomatic infections (NSIs) and asymptomatic infections (AIs) to identify gene clusters (potential protein encoding sequences sharing >= 90% nucleotide sequence identity) associated with lethality.
   Results
   Among 14,412 gene clusters identified, the presence or absence of 392 was associated with clinical outcome. As expected, more gene clusters were associated with LI versus AI than LI versus NSI. The gene clusters more prevalent in strains from LI than those from NSI and AI included those encoding proteins involved in O-antigen biogenesis, while clusters encoding type 3 secretion effectors EspJ and OspB were among those more prevalent in strains from non-lethal infections. One gene cluster encoding a variant of an NleG ubiquitin ligase was associated with LI versus AI, while two other nleG clusters had the opposite association. Similar associations were found for two nleG gene clusters in an additional, larger sample of NSI and AI GEMS strains.
   Conclusions
   Particular genes are associated with lethal tEPEC infections. Further study of these factors holds potential to unravel the mechanisms underlying severe disease and to prevent adverse outcomes.
C1 [Donnenberg, Michael S.; Farag, Tamer H.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
   [Hazen, Tracy H.; Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA.
   [Panchalingam, Sandra; Levine, Myron M.; Kotloff, Karen] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Antonio, Martin] MRC, Fajara, Gambia.
   [Hossain, Anowar] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh.
   [Mandomando, Inacio] Ctr Invest Saude Manh, Maputo, Mozambique.
   [Ochieng, John Benjamin] Kenya Govt Med Res Ctr, Ctr Dis Control, Kisumu, Kenya.
   [Ramamurthy, Thandavarayan] Natl Inst Cholera & Enter Dis, Kolkata, India.
   [Tamboura, Boubou] Ctr Vaccine Dev, Bamako, Mali.
   [Zaidi, Anita] Aga Khan Univ, Karachi, Pakistan.
   [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA.
RP Donnenberg, MS (reprint author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
EM mdonnenb@umaryland.edu; drasko@som.umaryland.edu
OI David, Rasko/0000-0002-7337-7154
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health [U19AI090873]
FX MSD, THH and DAR were funded to conduct the research reported in this
   study by the National Institute of Allergy and Infectious Diseases
   (www.niaid.nih.gov) of the National Institutes of Health through award
   U19AI090873. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Afset JE, 2006, J CLIN MICROBIOL, V44, P3703, DOI 10.1128/JCM.00429-06
   BEGAUD E, 1993, AM J TROP MED HYG, V48, P26
   BRAY J, 1945, J PATHOL BACTERIOL, V57, P239, DOI 10.1002/path.1700570210
   Clements A, 2013, ESCHERICHIA COLI: PATHOTYPES AND PRINCIPLES OF PATHOGENESIS, 2ND EDITION, P451, DOI 10.1016/B978-0-12-397048-0.00015-2
   CRAVIOTO A, 1988, EPIDEMIOL INFECT, V101, P123
   Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Gertz EM, 2006, BMC BIOL, V4, P41, DOI DOI 10.1186/1741-7007-4-41
   GILES C, 1948, J HYG-CAMBRIDGE, V46, P1
   GILES C, 1949, ARCH DIS CHILD, V24, P45
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   GOMES TAT, 1991, J INFECT DIS, V164, P331
   Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110
   Kaper JB, 1996, REV MICROBIOL, V27, P130
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49
   McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996
   MOON HW, 1983, INFECT IMMUN, V41, P1340
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08
   ROBINSBROWNE RM, 1980, ARCH DIS CHILD, V55, P923
   Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287
   Tacket CO, 2000, INFECT IMMUN, V68, P3689, DOI 10.1128/IAI.68.6.3689-3695.2000
   Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344
   Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508
   ULSHEN MH, 1980, NEW ENGL J MED, V302, P99, DOI 10.1056/NEJM198001103020207
   Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620
   Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960
   WU SX, 1992, ACTA PAEDIATR, V81, P217, DOI 10.1111/j.1651-2227.1992.tb12207.x
NR 29
TC 5
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2015
VL 9
IS 5
AR e0003791
DI 10.1371/journal.pntd.0003791
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CJ2HA
UT WOS:000355303600052
PM 25978422
OA gold
DA 2017-08-15
ER

PT J
AU Bradbury, RS
   Barbe, B
   Jacobs, J
   Jallow, AT
   Camara, KC
   Colley, M
   Wegmuller, R
   Jassey, B
   Cham, Y
   Baldeh, I
   Prentice, A
AF Bradbury, Richard S.
   Barbe, Barbara
   Jacobs, Jan
   Jallow, Amadou T.
   Camara, Karamo C.
   Colley, Musa
   Wegmueller, Rita
   Jassey, Babucarr
   Cham, Yorro
   Baldeh, Ignatius
   Prentice, Andrew
TI Enteric pathogens of food sellers in rural Gambia with incidental
   finding of Myxobolus species (Protozoa: Myxozoa)
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Africa; Food sellers; Gambia; Myxozoa; Parasitology; Salmonella
ID NON-TYPHOIDAL SALMONELLA; AGED 2-29 MONTHS; STOOL SAMPLES; CHILDREN;
   AFRICA; IDENTIFICATION; ALBENDAZOLE; MEBENDAZOLE; INFECTIONS; TRICHURIS
AB Background: Ongoing surveillance of enteric pathogens of public health significance among casual food sellers is undertaken in many resource-limited countries. We report the results of a survey in Kiang West province, The Gambia, and provide an exemplar methodology for such surveys in resource-limited laboratories.
   Methods: Unpreserved, unrefrigerated stool samples were subjected to Salmonella, Shigella and agar plate culture for rhabditoid nematodes. Direct microscopy, formalin-ethyl acetate concentration and iron-hematoxylin staining was performed later, following preservation.
   Results: Of 128 specimens received, no Shigella spp. was recovered, while four serovars of non-typhoidal Salmonella enterica, including Chandans, were isolated. Pathogenic parasitic infections were Necator americanus 10/128 (7.8%), Strongyloides stercoralis 3/128 (2.8%), Blastocystis species 45/128 (35.1%), Entamoeba histolytica complex 19/128 (14.8%) and Giardia intestinalis 4/128 (3.1%). A single case each of Hymenolepis diminuta and S. mansoni infection were detected. In one participant, myxozoan spores identical to those of Myxobolus species were found.
   Conclusions: Rare parasitoses and serovars of Salmonella enterica may occur relatively commonly in rural Africa. This paper describes intestinal pathogens found in a cohort of food sellers in such a setting. Furthermore, it describes two parasites rarely recovered from humans and demonstrates the need for methods other than microscopy to detect S. stercoralis infections.
C1 [Bradbury, Richard S.; Jallow, Amadou T.; Camara, Karamo C.; Colley, Musa; Wegmueller, Rita; Prentice, Andrew] MRC Gambia, MRC Keneba, Keneba, Gambia.
   [Barbe, Barbara; Jacobs, Jan] Institserovarute Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium.
   [Jassey, Babucarr; Cham, Yorro; Baldeh, Ignatius] Minist Hlth & Social Welf, Banjul, Gambia.
   [Prentice, Andrew] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England.
RP Bradbury, RS (reprint author), Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia.
EM r.bradbury@cqu.edu.au
FU UK Medical Research Council [MRC] [MC-A760-5QX00]; UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement
   [MC-A760-5QX00]
FX This work was supported by joint funding from the UK Medical Research
   Council [MRC, grant number MC-A760-5QX00] and the UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement.
CR ALBONICO M, 1994, T ROY SOC TROP MED H, V88, P585, DOI 10.1016/0035-9203(94)90174-0
   Belding D., 1965, TXB PARASITOLOGY, V3rd
   Boreham RE, 1998, J CLIN MICROBIOL, V36, P3728
   Bradbury RS, 2014, J CLIN MICROBIOL, V52, P699, DOI 10.1128/JCM.02738-13
   Bradbury RS, 2010, ANN AUSTRALAS COLL T, V11, P24
   Brockmann SO, 2004, J FOOD PROTECT, V67, P178
   Bundy DAP, 1991, HUMAN PARASITIC DIS, V4
   Capita R, 2003, INT J FOOD MICROBIOL, V81, P169, DOI 10.1016/S0168-1605(02)00195-2
   Dione MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001148
   Dolabella SS, 2012, ANN HEPATOL, V11, P107
   Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5
   FALADE S, 1976, Journal of Wildlife Diseases, V12, P464
   Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2
   Galanis E, 2006, EMERG INFECT DIS, V12, P381
   Garcia LS., 2007, DIAGNOSTIC MED PARAS
   Ghadage Dnyaneshwari, 2003, Indian J Pathol Microbiol, V46, P268
   Goldsmid JM, 1982, CRC HDB SERIES ZOO C, V2
   Hessen Eman M., 2004, Journal of the Egyptian Society of Parasitology, V34, P925
   Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2
   HINSHAW WR, 1948, J BACTERIOL, V55, P870
   HOLZER BR, 1987, EUR J CLIN PHARMACOL, V32, P635, DOI 10.1007/BF02456002
   Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0
   Kapoor L, 2006, INDIAN J MED RES, V123, P691
   Kawai T, 2012, CLIN INFECT DIS, V54, P1046, DOI 10.1093/cid/cir1040
   Kidanemariam A, 2010, J S AFR VET ASSOC, V81, P37
   KOGA K, 1990, J TROP MED HYG, V93, P183
   Kumar Y, 2001, T R SOC TROP MED HYG, V103, P390
   Madden RH, 2007, LETT APPL MICROBIOL, V44, P115, DOI 10.1111/j.1472-765X.2006.02064.x
   McClelland RS, 1997, J CLIN MICROBIOL, V35, P2815
   MCGREGOR IA, 1952, T ROY SOC TROP MED H, V46, P403, DOI 10.1016/0035-9203(52)90058-8
   Moncada LI, 2001, J CLIN MICROBIOL, V39, P1938, DOI 10.1128/JCM.39.5.1938-1940.2001
   Muley V A, 2004, Indian J Med Microbiol, V22, P51
   Nayak R, 2003, BRIT POULTRY SCI, V44, P192, DOI [10.1080/0007166031000088370, 10.1080/00071660301959]
   Outbreak Investigation Group, 2005, EUROSURVEILLANCE, V10
   Phoba MF, 2014, EUR J CLIN MICROBIOL, V33, P79, DOI 10.1007/s10096-013-1931-8
   Royer TL, 2012, EMERG INFECT DIS, V18, P1543, DOI 10.3201/eid1809.120122
   Shilangale RP, 2012, VET ITAL, V48, P125
   Sillah F, 2013, NUTRITION, V29, P1368, DOI 10.1016/j.nut.2013.05.014
   Speare R., 1989, STRONGYLOIDIASIS MAJ
   Taylor J, 2012, J FOOD PROTECT, V75, P738, DOI 10.4315/0362-028X.JFP-11-408
   Veitch M, 2012, GUIDELINES INVESTIGA
   WILLIAMS AW, 1950, J PATHOL BACTERIOL, V62, P43, DOI 10.1002/path.1700620106
NR 42
TC 0
Z9 0
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY
PY 2015
VL 109
IS 5
BP 334
EP 339
DI 10.1093/trstmh/trv020
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CJ1YB
UT WOS:000355279900007
PM 25758855
OA No
DA 2017-08-15
ER

PT J
AU Minchella, PA
   Donkor, S
   McDermid, JM
   Sutherland, JS
AF Minchella, Peter A.
   Donkor, Simon
   McDermid, Joann M.
   Sutherland, Jayne S.
TI Iron homeostasis and progression to pulmonary tuberculosis disease among
   household contacts
SO TUBERCULOSIS
LA English
DT Article
DE Africa; Ferritin; Hepcidin; Hemoglobin; Transferrin; TB
ID MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; INCIDENT TUBERCULOSIS;
   RETROSPECTIVE COHORT; XPERT MTB/RIF; MACROPHAGES; DIAGNOSIS; INFECTION;
   SURVIVAL; GROWTH
AB Early identification of individuals at risk for progressing to active tuberculosis (TB) disease may limit new transmission and improve clinical outcomes. Evidence indicates altered iron homeostasis may identify those at greater risk of disease progression in HIV co-infection. We aimed to investigate iron homeostasis biomarkers as risk factors for progression to TB. Archived plasma samples were analyzed from household contacts of pulmonary TB index cases in The Gambia. Contacts were classified as asymptomatic nonprogressors (n = 17) or TB-progressors (n = 10), which included two HIV-infected participants. Iron homeostasis (hemoglobin, ferritin, hepcidin, soluble transferrin receptor, transferrin) was assessed in all contacts at study recruitment. Plasma was collected a median of 910 days prior to TB diagnosis. Low transferrin around the time of known exposure to infectious TB was a disease progression risk factor among all TB-progressors (Poisson incidence rate ratio: 0.55; 95% CI: 0.35e0.89). Iron homeostasis also differed between early and delayed TB-progressors, with higher ferritin and hepcidin concentrations observed among early TB-progressors (mean ferritin 50.2 vs. 26.2 ng/ml; P = 0.027; mean hepcidin 37.7 vs. 5.6 ng/ml; P = 0.036). Iron homeostasis is associated with progression to TB among household contacts. Further studies are needed to elucidate mechanisms and determine the clinical utility of monitoring iron homeostasis biomarkers. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Minchella, Peter A.; McDermid, Joann M.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Donkor, Simon; Sutherland, Jayne S.] MRC Unit, Vaccinol Theme, Fajara, Gambia.
RP McDermid, JM (reprint author), Cornell Univ, Div Nutr Sci, 310 Savage Hall, Ithaca, NY 14853 USA.
EM jmm585@cornell.edu
OI Sutherland, Jayne/0000-0002-7083-4997
FU International Life Sciences Institute North America Future Leaders
   Award; Sigma Xi Grants-in-Aid of Research Program [G20130315164088];
   National Science Foundation Graduate Research Fellowship Program [NSF
   12-599]
FX This work was supported by International Life Sciences Institute North
   America Future Leaders Award [to JMM], Sigma Xi Grants-in-Aid of
   Research Program [Grant No. G20130315164088 to PAM] and the National
   Science Foundation Graduate Research Fellowship Program [Grant No. NSF
   12-599 to PAM]. Study sponsors were not involved in the study design,
   data collection, analysis, interpretation, writing of the manuscript or
   in the decision to submit the manuscript for publication.
CR Banerjee S, 2011, INFECT GENET EVOL, V11, P825, DOI 10.1016/j.meegid.2011.02.016
   Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1186/518040
   Cheng SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067516
   de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504
   de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010
   De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252
   Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC
   Fatima R, 2014, INT J TUBERC LUNG D, V18, P1099, DOI 10.5588/ijtld.14.0001
   Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203
   Gibson R., 2005, PRINCIPLES NUTR ASSE
   Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x
   Gordeuk VR, 1996, BLOOD, V87, P3470
   Greenaway C, 2002, AM J RESP CRIT CARE, V165, P927, DOI 10.1164/rccm.2107040
   Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227
   Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156
   Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X
   Kasvosve I, 2000, CLIN CHEM, V46, P1535
   Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0
   Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2
   Lorent N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092754
   Lui G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092077
   Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908
   McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48
   Minchella PA, 2014, INT J TUBERC LUNG D, V18, P1337, DOI 10.5588/ijtld.14.0143
   Pandey SD, 2014, J BACTERIOL, V196, P1853, DOI 10.1128/JB.01483-13
   Qin ZZ, 2015, EUR RESPIR J, V45, P549, DOI 10.1183/09031936.00147714
   Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250
   Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11
   Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x
   Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91
   Sutherland JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025230
   Wagner D, 2005, J IMMUNOL, V174, P1491
   World Health Organization (WHO) Centers for Disease Control and Prevention, 2007, ASS IR STAT POP
   World Health Organization, 2014, GLOB TUB REP 2014
   Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 36
TC 2
Z9 2
U1 1
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD MAY
PY 2015
VL 95
IS 3
BP 288
EP 293
DI 10.1016/j.tube.2015.02.042
PG 6
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA CH6DK
UT WOS:000354126100008
PM 25764944
OA No
DA 2017-08-15
ER

PT J
AU Mackenzie, GA
   Ikumapayi, UNA
   Scott, S
   Idoko, O
   Odutola, A
   Ndiaye, M
   Sahito, SM
   Osuorah, CD
   Manjang, A
   Jarju, S
   Bojang, A
   Roca, A
   Secka, O
   Zaman, A
   Ceesay, L
   Lowe-Jallow, Y
   Sambou, S
   Jasseh, M
   Antonio, M
   Greenwood, B
   Kampmann, B
   Mulholland, K
   Corrah, T
   Howie, SRC
AF Mackenzie, Grant A.
   Ikumapayi, Usman N. A.
   Scott, Susana
   Idoko, Olubukola
   Odutola, Aderonke
   Ndiaye, Malick
   Sahito, Shah M.
   Osuorah, Chidiebereh D.
   Manjang, Ahmed
   Jarju, Sheikh
   Bojang, Abdoulie
   Roca, Anna
   Secka, Ousman
   Zaman, Akram
   Ceesay, Lamin
   Lowe-Jallow, Yamundow
   Sambou, Sana
   Jasseh, Momodou
   Antonio, Martin
   Greenwood, Brian
   Kampmann, Beate
   Mulholland, Kim
   Corrah, Tumani
   Howie, Stephen R. C.
TI Increased Disease due to Haemophilus influenzae Type b Population-based
   Surveillance in Eastern Gambia, 2008-2013
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE Haemophilus influenza; conjugate Haemophilus influenzae type b vaccine;
   surveillance; incidence
ID CONJUGATE VACCINE INTRODUCTION; CHILDHOOD IMMUNIZATION; ROUTINE
   IMMUNIZATION; UNITED-KINGDOM; CHILDREN; IMPACT; SEROTYPE; MENINGITIS;
   PROTECTION; PNEUMONIA
AB Background: In 1997, The Gambia became the first African country to introduce conjugate Haemophilus influenzae type b (Hib) vaccine with good disease control through to 2010.
   Methods: Culture-based surveillance for invasive bacterial disease in eastern Gambia, specifically the Basse Health and Demographic Surveillance System (BHDSS) area, was conducted from 12 May 2008 and in Fuladu West district from 12 September 2011 until 31 December 2013. In 2011, Hib serology was measured in 5-34-year-olds.
   Results: In all, 16,735 of 17,932 (93%) eligible patients were investigated. We detected 57 cases of invasive H. influenzae disease; 24 (42%) were type b. No cases of Hib disease were detected in the BHDSS area in 2008-2009; 1 was detected in 2010, 2 in 2011, 4 in 2012 and 7 in 2013. In 2013, the incidence of Hib disease in those aged 2-11 and 2-59 months in the BHDSS area was 88 [95% confidence interval (CI): 29-207] and 22 (95% CI: 9-45) cases per 105 person-years, respectively. In 2013, disease incidence in Fuladu West among those aged 0-59 months was 26 (95% CI: 7-67) cases per 105 person-years. Nine of 24 Hib cases were vaccine failures (2 HIV positive) and 9 were too young to have been vaccinated. The proportion of children aged 5-6 years (n = 223) with anti-Hib IgG >= 1.0 mu g/mL was 67%; the antibody nadir was in 9-14-year-olds (n = 58) with 55% above threshold.
   Conclusions: Hib disease in eastern Gambia has increased in recent years. Surveillance in developing countries should remain alert to detect such changes.
C1 [Mackenzie, Grant A.; Ikumapayi, Usman N. A.; Scott, Susana; Idoko, Olubukola; Odutola, Aderonke; Ndiaye, Malick; Sahito, Shah M.; Osuorah, Chidiebereh D.; Manjang, Ahmed; Jarju, Sheikh; Bojang, Abdoulie; Roca, Anna; Secka, Ousman; Zaman, Akram; Ceesay, Lamin; Jasseh, Momodou; Antonio, Martin; Kampmann, Beate; Corrah, Tumani; Howie, Stephen R. C.] MRC, Gambia Unit, Banjul, Gambia.
   [Mackenzie, Grant A.; Mulholland, Kim] Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Lowe-Jallow, Yamundow; Sambou, Sana] Gambia Govt, Minist Hlth & Social Welf, Banjul, Gambia.
   [Greenwood, Brian; Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England.
   Univ Otago, Dunedin, New Zealand.
RP Mackenzie, GA (reprint author), MRC, Gambia Unit, Basse Field Stn, POB 273, Banjul, Gambia.
EM gmackenzie@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709
FU Bill & Melinda Gates Foundation [OPP 1020327]; Global Alliance for
   Vaccines and Immunisation's PneumoADIP; MRC; UK's Medical Research
   Council
FX This work was supported by the Bill & Melinda Gates Foundation (grant
   OPP 1020327) and the Global Alliance for Vaccines and Immunisation's
   PneumoADIP. The MRC provides core financial support for infrastructure
   and scientific platforms at MRC, The Gambia Unit. The funders had no
   role in analysis or interpretation of data. All authors were responsible
   for the final decision to submit the manuscript for publication. Sources
   of support: Global Alliance for Vaccines and Immunisation's PneumoADIP,
   the Bill & Melinda Gates Foundation and the UK's Medical Research
   Council.
CR Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8
   ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008
   Bar-On ES, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005530.pub2
   Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671
   Daza P, 2006, VACCINE, V24, P6232, DOI 10.1016/j.vaccine.2006.05.076
   Adegbola RA, 1996, ANN TROP PAEDIATR, V16, P103
   Fernandez J, 2000, J INFECT DIS, V182, P1553, DOI 10.1086/315870
   Heath PT, 2000, JAMA-J AM MED ASSOC, V284, P2334, DOI 10.1001/jama.284.18.2334
   Howie SRC, 2013, CLIN INFECT DIS, V57, P1527, DOI 10.1093/cid/cit598
   Khowaja AR, 2013, J PEDIATR-US, V163, pS79, DOI 10.1016/j.jpeds.2013.03.034
   Ladhani S, 2010, CLIN MICROBIOL INFEC, V16, P948, DOI 10.1111/j.1469-0691.2009.02945.x
   Lee EH, 2008, REV PANAM SALUD PUBL, V24, P161, DOI 10.1590/S1020-49892008000900002
   Lee EHJ, 2008, TROP MED INT HEALTH, V13, P495, DOI 10.1111/j.1365-3156.2008.02027.x
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   National AIDS Control Programme, 2012, REP GAMB HIV SENT SU
   Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558
   Oh SY, 2008, J INFECT DIS, V197, P1275, DOI 10.1086/586716
   Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X
   Scott S, 2013, J PEDIATR-US, V163, pS8, DOI 10.1016/j.jpeds.2013.03.024
   Sigauque B, 2013, J PEDIATR-US, V163, pS19, DOI 10.1016/j.jpeds.2013.03.026
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   Sow SO, 2009, AM J TROP MED HYG, V80, P1033
   Sultana NK, 2013, J PEDIATR-US, V163, pS73, DOI 10.1016/j.jpeds.2013.03.033
   Trotter C L, 2003, Commun Dis Public Health, V6, P55
   Ulanova M, 2014, LANCET INFECT DIS, V14, P70, DOI 10.1016/S1473-3099(13)70170-1
   von Gottberg A, 2012, VACCINE, V30, P565, DOI 10.1016/j.vaccine.2011.11.066
   Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4
   Watt JP, 2013, HAEMOPHILUS INFLUENZ
   World Health Organisation, 2011, WHO MAN LAB METH DIA
NR 29
TC 3
Z9 3
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD MAY
PY 2015
VL 34
IS 5
BP E107
EP E112
DI 10.1097/INF.0000000000000645
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA CG5PH
UT WOS:000353344500002
PM 25879650
OA No
DA 2017-08-15
ER

PT J
AU Braithwaite, VS
   Jones, KS
   Schoenmakers, I
   Silver, M
   Prentice, A
   Hennig, BJ
AF Braithwaite, V. S.
   Jones, K. S.
   Schoenmakers, I.
   Silver, M.
   Prentice, A.
   Hennig, B. J.
TI Vitamin D binding protein genotype is associated with plasma 25OHD
   concentration in West African children
SO BONE
LA English
DT Article
DE Vitamin D; Africa; DBP; Gc genotype; 25OHD
ID GENOME-WIDE ASSOCIATION; BONE-MINERAL ACCRETION; GAMBIAN CHILDREN;
   BIRTH-WEIGHT; AFFINITY; GROWTH; SERUM; SUPPLEMENTATION; CELLS; WOMEN
AB Vitamin D is well known for its role in promoting skeletal health. Vitamin D status is determined conventionally by circulating 25-dihydroxyvitamin D (25OHD) concentration. There is evidence indicating that circulating 25OHD concentratiodis affected by variation in Cc, the gene encoding the vitamin D binding protein (DBP). The composite genotype of two single nucleotide polymorphisms (rs7041 and rs4588) results in different DBP isotypes (Gc1f, Gc1s and Gc2). The protein configurational differences among DBP isotypes affect DBP substrate binding affinity.
   The aims of this study were to determine 1) Gc variant frequencies in a population from an isolated rural region of The Gambia, West Africa (n = 3129) with year-round opportunity for cutaneous vitamin D synthesis and 2) the effects of Gc variants on 25OHD concentration (n = 237) in a genetically representative sub-group of children (mean (SD) age: 11.9 (4.8) years).
   The distribution of Cc variants was Gc1f: 0.86, Gc1s: 0.11 and Gc2: 0.03. The mean (SD) concentration of 25OHD was 59.6 (12.9) nmol/L and was significantly higher in those homozygous for Gc1f compared to other Cc variants (60.7 (13.1) vs. 56.6 (12.1) nmol/L, P = 0.03). Plasma 25OHD and 1,25(OH)(2)D concentration was significantly associated with parathyroid hormone in Gc1f-1f but not in the other Cc variants combined. This study demonstrates that different Cc variants are associated with different 25OHD concentrations in a rural Gambian population. Gc1f-1f, thought to have the highest affinity for 25OHD, had the highest 25OHD concentration compared with lower affinity Cc variants.
   The considerable difference in Gc1f frequency observed in Gambians compared with other non-West African populations and associated differences in plasma 25OHD concentration, may have implications for the way in which vitamin D status should be interpreted across different ancestral groups. (c) 2015 The Authors. Published by Elsevier Inc.
C1 [Braithwaite, V. S.; Jones, K. S.; Schoenmakers, I.; Prentice, A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge CB1 9NL, England.
   [Silver, M.; Hennig, B. J.] Univ London London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1E 7HT, England.
   [Silver, M.; Hennig, B. J.] MRC Unit, Serrekunda, Gambia.
   [Prentice, A.] MRC Keneba, Keneba, Gambia.
RP Braithwaite, VS (reprint author), Elsie Widdowson Lab, MRC Human Nutr Res, Fulbourn Rd, Cambridge CB1 9NL, England.
EM vickie.braithwaite@mrc-hnr.cam.ac.uk
OI Silver, Matt/0000-0002-3852-9677; Braithwaite,
   Vickie/0000-0002-3366-2903; Jones, Kerry/0000-0002-7380-9797
FU MRC [U105960371, U123261351, MC-A760-5QX00]; Department for
   International Development (DFID) under the MRC/DFID Concordat
FX This research was jointly funded by the MRC & the Department for
   International Development (DFID) under the MRC/DFID Concordat agreement.
   MRC programmes: U105960371, U123261351 & MC-A760-5QX00
CR Adams JS, 2013, BONE RES, V1, DOI 10.4248/BR201301002
   ARNAUD J, 1993, HUM GENET, V92, P183
   BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954
   BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8
   Bouillon R., 2011, VITAMIN D, P57
   BOUTIN B, 1989, J STEROID BIOCHEM, V32, P59, DOI 10.1016/0022-4731(89)90014-9
   Braithwaite V, 2012, BONE, V50, P1351, DOI 10.1016/j.bone.2012.03.010
   Braithwaite V, 2012, BONE, V50, P218, DOI 10.1016/j.bone.2011.10.009
   Chun RF, 2013, J STEROID BIOCH M PA, V144PA, P132, DOI DOI 10.1016/J.JSBMB.2013.09.012
   Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F
   COOKE NE, 1986, HUM GENET, V73, P225, DOI 10.1007/BF00401232
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Hawkesworth S, 2008, J NUTR, V138, P2468, DOI 10.3945/jn.108.098665
   HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P169
   Jarjou LM, 2006, AM J CLIN NUTR, V83, P657
   Jones KS, 2014, J CLIN ENDOCR METAB, V99, P3373, DOI 10.1210/jc.2014-1714
   Jones KS, 2012, BRIT J NUTR, V107, P1128, DOI 10.1017/S0007114511004132
   KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950
   Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Moy KA, 2014, AM J CLIN NUTR, V99, P1424, DOI 10.3945/ajcn.113.080309
   Prentice A, 2009, ACTA PAEDIATR, V98, P1360, DOI 10.1111/j.1651-2227.2009.01352.x
   SANGER JM, 1990, P NATL ACAD SCI USA, V87, P5474, DOI 10.1073/pnas.87.14.5474
   Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0
   Yamamoto N, 1996, J IMMUNOL, V157, P1744
NR 25
TC 5
Z9 6
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD MAY
PY 2015
VL 74
BP 166
EP 170
DI 10.1016/j.bone.2014.12.068
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CD6HE
UT WOS:000351189400021
PM 25652210
OA No
DA 2017-08-15
ER

PT J
AU Ebruke, C
   Roca, A
   Egere, U
   Darboe, O
   Hill, PC
   Greenwood, B
   Wren, B
   Adegbola, RA
   Antonio, M
AF Ebruke, Chinelo
   Roca, Anna
   Egere, Uzochukwu
   Darboe, Ousainou
   Hill, Philip C.
   Greenwood, Brian
   Wren, BrendanW.
   Adegbola, Richard A.
   Antonio, Martin
TI Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae
   serotype 1 genotypes in healthy Gambians before and after the 7-valent
   pneumococcal conjugate vaccine
SO PEERJ
LA English
DT Article
DE Invasive pneumococcal disease; Nasopharyngeal Swab; Streptococcus
   pneumoniae serotype 1; Nasopharyngeal carriage; 7-valent pneumococcal
   conjugate vaccine; Gambia; Multilocus Sequence Typing; Sequence type;
   ST217 hyper virulent clonal complex; Molecular epidemiology
ID INVASIVE DISEASE; MENINGITIS; CHILDREN; COLONIZATION; OUTBREAK;
   EPIDEMIC; ERA
AB Streptococcus pneumoniae serotype 1 is one of the leading causes of invasive pneumococcal disease. However, this invasive serotype is hardly found in nasopharyngeal asymptomatic carriage and therefore large epidemiological studies are needed to assess the dynamics of serotype 1 infection. Within the context of a large cluster randomized trial conducted in rural Gambia to assess the impact of PCV-7 vaccination on nasopharyngeal carriage, we present an ancillary analysis describing the prevalence of nasopharyngeal carriage of pneumococcal serotype 1 and temporal changes of its more frequent genotypes. Nasopharyngeal swabs (NPS) were collected before PCV-7 vaccination (December 2003-May 2004) and up to 30 months after PCV-7 vaccination. The post-vaccination time was divided in three periods to ensure an equal distribution of the number of samples: (1) July 2006-March 2007, (2) April 2007-March 2008 and (3) April 2008-Feb 2009. S. pneumoniae serotype 1 were genotyped by MLST. Serotype 1 was recovered from 87 (0.71%) of 12,319 NPS samples collected. In the pre-vaccination period, prevalence of serotype 1 was 0.47% in both study arms. In the post-vaccination periods, prevalence in the fully vaccinated villages ranged between 0.08% in period 1 and 0.165% in period 2, while prevalence in partly vaccinated villages was between 0.17% in period 3 and 1.34% in period 2. Overall, four different genotypes were obtained, with ST3081 the most prevalent (60.71%), followed by ST618 (29.76%). ST3081 was found only in post-vaccination period 2 and 3, while ST618 had disappeared in post-vaccination period 3. Distribution of these major genotypes was similar in both study arms. Emergence of ST3081 and concomitant disappearance of ST618 may suggest a change in the molecular epidemiology of pneumococcal serotype 1 in this region. This change is not likely to be associated with the introduction of PCV-7 which lacks serotype 1, as it was observed simultaneously in both study arms. Future population-based epidemiological studies will provide further evidence of substantive changes in the pneumococcal serotype 1 epidemiology and the likely mechanisms.
C1 [Ebruke, Chinelo; Roca, Anna; Egere, Uzochukwu; Darboe, Ousainou; Adegbola, Richard A.; Antonio, Martin] MRC Unit, Vaccinol Theme, Banjul, Gambia.
   [Ebruke, Chinelo; Greenwood, Brian; Wren, BrendanW.; Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand.
   [Adegbola, Richard A.] GlaxoSmithKline Biol Wavre, Wavre, Belgium.
   [Antonio, Martin] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
RP Antonio, M (reprint author), MRC Unit, Vaccinol Theme, Banjul, Gambia.
EM mantonio@mrc.gm
FU Medical Research Council [MC_U190085849, MR/K012053/1]
CR Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x
   Ahern JW, 2009, SOUTH MED J, V102, P1189, DOI 10.1097/SMJ.0b013e3181b9b137
   Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198
   Baker CI, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-38
   Balicer RD, 2010, VACCINE, V28, P5591, DOI 10.1016/j.vaccine.2010.06.031
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003
   Chiou A. C., 2008, Journal of Medical Microbiology, V57, P839, DOI 10.1099/jmm.0.47612-0
   Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22
   Gleich S, 2000, INFECT CONT HOSP EP, V21, P711, DOI 10.1086/501717
   Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83
   Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338
   Laval CB, 2006, CLIN MICROBIOL INFEC, V12, P50, DOI 10.1111/j.1469-0691.2005.01304.x
   Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009
   Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966
   Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0
   Nunes S, 2008, CLIN MICROBIOL INFEC, V14, P82, DOI 10.1111/j.1469-0691.2007.01871.x
   O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833
   Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107
   Smith-Vaughan H, 2009, CLIN VACCINE IMMUNOL, V16, P218, DOI 10.1128/CVI.00283-08
   Williams TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026742
   Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940
NR 26
TC 1
Z9 1
U1 0
U2 5
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD APR 30
PY 2015
VL 3
AR e903
DI 10.7717/peerj.903
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH2FH
UT WOS:000353840600001
PM 25945306
OA gold
DA 2017-08-15
ER

PT J
AU Sagnon, N
   Pinder, M
   Tchicaya, EFS
   Tiono, AB
   Faragher, B
   Ranson, H
   Lindsay, SW
AF Sagnon, N'Fale
   Pinder, Margaret
   Tchicaya, Emile F. S.
   Tiono, Alfred B.
   Faragher, Brian
   Ranson, Hilary
   Lindsay, Steve W.
TI To assess whether addition of pyriproxyfen to long-lasting insecticidal
   mosquito nets increases their durability compared to standard
   long-lasting insecticidal mosquito nets: study protocol for a randomised
   controlled trial
SO TRIALS
LA English
DT Article
DE Net durability; Insecticide resistance management; Malaria control;
   Insecticide-treated bed net; Pyrethroid; Pyriproxyfen; Insect juvenile
   hormone mimic; Clinical malaria; Entomological inoculation rate;
   Randomised controlled trial
ID ANOPHELES-GAMBIAE; BURKINA-FASO; MALARIA; VECTORS
AB Background: The effectiveness of pyrethroid-treated bednets for malaria control in sub-Saharan Africa is under threat because of high levels of resistance to pyrethroid insecticides in the vectors. Here we assess the durability of polyethylene nets with a novel combination of permethrin, a pyrethroid, with pyriproxyfen, an insect juvenile mimic (PPF-LLIN), in comparison with a typical permethrin-treated long-lasting insecticidal net (LLIN).
   Methods: This is a cluster randomised controlled trial of net durability in Burkina Faso, with clustering at the level of the compound and includes entomological outcome measurements. Half the compounds in each village will be randomly allocated PPF-LLIN and half the LLIN. All sleeping places in a compound will be provided with one type of net. We will distribute the nets at the start of the first transmission season and follow net use at the start and end of each transmission season for 3 years. In one village, bio-efficacy and chemical content will be recorded immediately after net distribution and then at 6, 12, 18, 24, 30 and 36 months. In the other village net survivorship and fabric integrity will be recorded immediately after distribution, and then at 6, 12, 18, 24, 30 and 36 months. Routine measurements of indoor temperature and relative humidity will be made in both villages during the study. Residents will be followed for possible side effects of the PPF-LLIN by surveillance of known asthmatic subjects during the first month post-distribution and pregnancy outcomes will be monitored from antenatal clinic records.
   Discussion: The protocol is novel on two accounts. Firstly, it is the first to describe the procedure for measuring net durability following recent World Health Organisation (WHO) guidelines. Meeting the minimum requirements set in the guidelines is essential before a new type of net can be recommended by WHO's Pesticide Evaluation Scheme (WHOPES). Secondly, it describes methods to monitor the persistence of an active ingredient that reduces vector fertility and fecundity. If the PPF-LLIN is both effective and persistent it will provide an alternative vector control strategy where pyrethroid-resistant vectors are present.
C1 [Sagnon, N'Fale; Tiono, Alfred B.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.
   [Pinder, Margaret; Lindsay, Steve W.] Univ Durham, Sch Biol Sci & Biomed, Durham, England.
   [Pinder, Margaret] Med Res Council Unit Gambia, Banjul, Gambia.
   [Tchicaya, Emile F. S.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire.
   [Faragher, Brian; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
RP Lindsay, SW (reprint author), Univ Durham, Sch Biol Sci & Biomed, Durham, England.
EM S.W.Lindsay@durham.ac.uk
OI Ranson, Hilary/0000-0003-2332-8247
FU European Union Seventh Framework Programme FP7 [265660]; AvecNet
FX The study is supported by the European Union Seventh Framework Programme
   FP7/2007-2013 under grant agreement number 265660, AvecNet. We are
   grateful to the Sumitomo Chemical Company Limited who will donate the
   nets for this trial.
CR Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232
   Dabire KR, 2012, INSECTICIDES PEST EN
   Fornadel C, 2013, MIM S 15 DURB
   Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144
   Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319
   Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2
   Mbare M, 2014, PARASITE VECTOR, V7, P280
   Mbare O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-94
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Tiono AB, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0606-4
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2006, PEST THEIR APPL CONT
   WHO, 2006, WHO SPEC EV PUBL HLT
   WHO, 2012, GLOB PLAN INS RES MA
   WHO, 2013, GUID LAB FIELD TEST
   World Health Organization, 2008, PYR DRINK WAT US VEC
   WHO, 2011, GUID MON DUR LONG LA
   WHO, 2013, MAL POL ADV COMM M 1, P34
NR 20
TC 3
Z9 3
U1 1
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD APR 28
PY 2015
VL 16
AR 195
DI 10.1186/s13063-015-0700-7
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CH4QO
UT WOS:000354018200001
PM 25927378
OA gold
DA 2017-08-15
ER

PT J
AU O'Neill, S
   Gryseels, C
   Dierickx, S
   Mwesigwa, J
   Okebe, J
   d'Alessandro, U
   Grietens, KP
AF O'Neill, Sarah
   Gryseels, Charlotte
   Dierickx, Susan
   Mwesigwa, Julia
   Okebe, Joseph
   d'Alessandro, Umberto
   Grietens, Koen Peeters
TI Foul wind, spirits and witchcraft: illness conceptions and
   health-seeking behaviour for malaria in the Gambia
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Symptom interpretation; Health-seeking behaviour; Treatment
   seeking behaviour; Elimination; Disease categories; Folk illnesses
ID WEST-AFRICA; PREVENTION; DETERMINANTS; ELIMINATION; TANZANIA; PRINCIPE
AB Background: As the disease burden in the Gambia has reduced considerably over the last decade, heterogeneity in malaria transmission has become more marked, with infected but asymptomatic individuals maintaining the reservoir. The identification, timely diagnosis and treatment of malaria-infected individuals are crucial to further reduce or eliminate the human parasite reservoir. This ethnographic study focused on the relationship between local beliefs of the cause of malaria and treatment itineraries of suspected cases.
   Methods: An ethnographic qualitative study was conducted in twelve rural communities in the Upper River Region and the Central River Region in the Gambia. The data collection methods included in-depth interviews, participant observation, informal conversations, and focus group discussions.
   Results: While at first glance, the majority of people seek biomedical treatment for 'malaria', there are several constraints to seeking treatment at health centres. Certain folk illnesses, such as Jontinooje and Kajeje, translated and interpreted as 'malaria' by healthcare professionals, are often not considered to be malaria by local populations but rather as self-limiting febrile illnesses - consequently not leading to seeking care in the biomedical sector. Furthermore, respondents reported delaying treatment at a health centre while seeking financial resources, and consequently relying on herbal treatments. In addition, when malaria cases present symptoms, such as convulsions, hallucinations and/or loss of consciousness, the illness is often interpreted as having a supernatural aetiology, leading to diagnosis and treatment by traditional healers.
   Conclusion: Although malaria diagnostics and treatment-seeking in the biomedical sector has been reported to be relatively high in the Gambia compared to other sub-Saharan African countries, local symptom interpretation and illness conceptions can delay or stop people from seeking timely biomedical treatment, which may contribute to maintaining a parasite reservoir of undiagnosed and untreated malaria patients.
C1 [O'Neill, Sarah; Gryseels, Charlotte; Dierickx, Susan; d'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Mwesigwa, Julia; Okebe, Joseph; d'Alessandro, Umberto] MRC, Fajara, Gambia.
   [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [Okebe, Joseph] Univ Antwerp, Fac Med Sci, B-2020 Antwerp, Belgium.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan.
   [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.
   [O'Neill, Sarah] Univ Oxford, Sch Anthropol, Oxford, England.
RP O'Neill, S (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
EM soneill@itg.be
FU Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust)
   [MR/K007203/1]
FX We are grateful to the MRC fieldworkers Fatou Y Manneh, Hejinkey Darboe,
   Michelle Demba, Dullo Baldeh, Bintou Jarju and Kebba Jassey for their
   assisting with data collection during fieldwork as well as for
   transcription and translation of recorded interviews and discussions. We
   would also like to thank them for re-reading early versions of the
   results and clarification of and discussions on local disease
   categories. This work is part of the study 'Primaquine's gametocytocidal
   efficacy in malaria asymptomatic carriers treated with
   dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint
   Global Health Trials Scheme (DFID/MRC/Wellcome Trust).
CR Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x
   Bernard H. R, 2006, RES METHODS ANTHR QU
   Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309
   Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364
   Ceesay SJ, 2012, ACTA TROP, V121, P166, DOI 10.1016/j.actatropica.2011.11.005
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Ceesay SJ, 2008, LANCET, V372, P1545
   CIAM, 2011, CIAM PUBL HLTH RES D
   Clarke SE, 2003, TROP MED INT HEALTH, V8, P884, DOI 10.1046/j.1365-3156.2003.01095.x
   Culture W, 1986, POETICS POLITICS ETH
   Dilley RM, 2005, ISLAMIC CASTE KNOWLE
   Dugas Marylene, 2009, Anthropol Med, V16, P307, DOI 10.1080/13648470903183487
   FASSIN D., 1992, POUVOIR MALADIE AFRI
   Hames C., 2008, CAH ETUD AFR, VXLVIII, P81
   KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5
   Kuczynski L, 2008, CAH ETUD AFR, V89, P237
   Leach Melissa, 2007, VACCINE ANXIETIES GL
   Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26
   Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]
   Madge C, 1998, HEALTH PLACE, V4, P293, DOI 10.1016/S1353-8292(98)00033-1
   Makemba AM, 1996, TROP MED INT HEALTH, V1, P305
   Muela S H, 1998, Anthropol Med, V5, P43, DOI 10.1080/13648470.1998.9964548
   Muela SH, 2002, SOC SCI MED, V55, P403
   Hausmann Muela S, 2012, MALARIA REPORTS, V2, pe3
   MWENESI H, 1995, SOC SCI MED, V40, P1271, DOI 10.1016/0277-9536(94)00250-W
   Mwenesi H, 1993, THESIS U LONDON
   O'Neill S, 2013, THESIS
   Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14
   Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108
   Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351
   Tarimo DS, 1998, E AFR MED J, V75, P93
   Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO TDR, 1997, INT C MAL AFR 6 9 JA
   WHO AFRO, 1998, WORK GROUP M SOC SCI
   WHO, 2008, WHO PHARM NEWSLETTER, P6
   Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010
   Wiseman V, 2006, TROP MED INT HEALTH, V11, P419, DOI 10.1111/j.1365-3156.2006.01586.x
   Wiseman V, 2008, SOC SCI MED, V67, P487, DOI 10.1016/j.socscimed.2008.04.007
   [Anonymous], 1997, INT C MAL AFR 6 9 JA
NR 40
TC 5
Z9 5
U1 3
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD APR 24
PY 2015
VL 14
AR 167
DI 10.1186/s12936-015-0687-2
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CG5IV
UT WOS:000353325600001
PM 25908392
OA gold
DA 2017-08-15
ER

PT J
AU Idoko, P
   Ogbe, E
   Jallow, O
   Ocheke, A
AF Idoko, Patrick
   Ogbe, Emmanuel
   Jallow, Oley
   Ocheke, Amaka
TI Burden of intimate partner violence in The Gambia - a cross sectional
   study of pregnant women
SO Reproductive Health
LA English
DT Article
DE Intimate partner violence; Pregnancy; The Gambia
ID DOMESTIC VIOLENCE; BIRTH OUTCOMES; PREVALENCE; ABUSE; ALCOHOL; NIGERIA
AB Background: Intimate partner violence is an important public health problem that cuts across geographic and cultural barriers. Intimate partner violence refers to the range of sexually, psychologically and physically coercive acts used against women by current or former male intimate partners. The frequency and severity of violence varies greatly but the main goal is usually to control the victims through fear and intimidation. About 80% of Gambian women believe it is acceptable for a man to beat his wife thus encouraging the perpetuation of violence against women. The objective was to ascertain the burden of intimate partner violence amongst pregnant women in Gambia.
   Methods: A cross sectional survey was carried out at Edward Francis Small Teaching Hospital, Banjul, The Gambia, on antenatal clinic attendees between October and December 2012, using a pre-tested structured interviewer administered questionnaire. All pregnant women were informed about the study at the antenatal booking clinic. Of the 161 pregnant women informed, 136 (84.5%) consented to take part and were recruited in the study. Descriptive analysis was done using the Epi info statistical software. Any pregnant woman booking for the first time during the period of the study was eligible to be recruited into the study.
   Results: Majority of enrolled participants (61.8%) reported intimate partner violence. Verbal forms of intimate partner violence were the commonest forms, with 12% requiring medical care on account of intimate partner violence and 3% prevented from seeking healthcare as a result of such violence.
   Conclusion: Intimate partner violence is common in The Gambia, West Africa and is a threat to women's health.
C1 [Idoko, Patrick; Jallow, Oley] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [Ogbe, Emmanuel] Dalhatu Araf Specialist Hosp, Lafia, Nigeria.
   [Ocheke, Amaka] Univ Jos, Teaching Hosp, Jos, Nigeria.
RP Idoko, P (reprint author), Edward Francis Small Teaching Hosp, Banjul, Gambia.
EM patidoko@gmail.com
CR American Congress of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V119, P412, DOI DOI 10.1097/AOG.0B013E318249FF74
   BERENSON AB, 1994, AM J OBSTET GYNECOL, V170, P1760
   Boy A, 2004, INT J FERTIL WOMEN M, V49, P159
   Brecklin LR, 2002, J FAM VIOLENCE, V17, P185, DOI 10.1023/A:1016070427112
   Campbell Doris Williams, 2002, Online J Issues Nurs, V7, P5
   Chambliss LR, 2008, CLIN OBSTET GYNECOL, V51, P385, DOI 10.1097/GRF.0b013e31816f29ce
   Cokkinides VE, 1999, OBSTET GYNECOL, V93, P661, DOI 10.1016/S0029-7844(98)00486-4
   Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5
   DOMINO JV, 1987, HEADACHE, V27, P310, DOI 10.1111/j.1526-4610.1987.hed2706310.x
   Fawole AO, 2008, AUST NZ J OBSTET GYN, V48, P405, DOI 10.1111/j.1479-828X.2008.00868.x
   Garcia-Moreno C., 2005, WHO MULTICOUNTRY STU
   Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915
   Heisev L, 1999, POPULATION REPORTS L, V11
   HILLARD PJA, 1985, OBSTET GYNECOL, V66, P185
   Jasinski Jana L, 2004, Trauma Violence Abuse, V5, P47, DOI 10.1177/1524838003259322
   Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218
   Kaye D, 2002, Cent Afr J Med, V48, P64
   Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521
   Leonard KE, 1999, J STUD ALCOHOL, V60, P537
   Leone JM, 2010, J WOMENS HEALTH, V19, P1501, DOI 10.1089/jwh.2009.1716
   Mbokota M, 2003, SAMJ S AFR MED J, V93, P455
   Olagbuji B, 2010, INT J GYNECOL OBSTET, V108, P101, DOI 10.1016/j.ijgo.2009.09.024
   Smith P H, 1995, Womens Health, V1, P273
   Testa M, 2003, J INTERPERS VIOLENCE, V18, P735, DOI 10.1177/0886260503253232
   Townsend L, 2010, AIDS BEHAV, V15, P132
   United Nations Economic Commission for Africa, VIOL WOM AFR SIT AN
   Weinbaum Z, 2001, AM J PREV MED, V21, P313, DOI 10.1016/S0749-3797(01)00363-4
   World Health Organization, 1997, WHOFRHWHD978
   World Health Organization, WHO PATH RES VIOL WO
NR 29
TC 2
Z9 2
U1 0
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD APR 21
PY 2015
VL 12
AR 34
DI 10.1186/s12978-015-0023-x
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CG4NM
UT WOS:000353263100001
PM 25895955
OA gold
DA 2017-08-15
ER

PT J
AU Kamau, E
   Campino, S
   Amenga-Etego, L
   Drury, E
   Ishengoma, D
   Johnson, K
   Mumba, D
   Kekre, M
   Yavo, W
   Mead, D
   Bouyou-Akotet, M
   Apinjoh, T
   Golassa, L
   Randrianarivelojosia, M
   Andagalu, B
   Maiga-Ascofare, O
   Amambua-Ngwa, A
   Tindana, P
   Ghansah, A
   MacInnis, B
   Kwiatkowski, D
   Djimde, AA
AF Kamau, Edwin
   Campino, Susana
   Amenga-Etego, Lucas
   Drury, Eleanor
   Ishengoma, Deus
   Johnson, Kimberly
   Mumba, Dieudonne
   Kekre, Mihir
   Yavo, William
   Mead, Daniel
   Bouyou-Akotet, Marielle
   Apinjoh, Tobias
   Golassa, Lemu
   Randrianarivelojosia, Milijaona
   Andagalu, Ben
   Maiga-Ascofare, Oumou
   Amambua-Ngwa, Alfred
   Tindana, Paulina
   Ghansah, Anita
   MacInnis, Bronwyn
   Kwiatkowski, Dominic
   Djimde, Abdoulaye A.
TI K13-Propeller Polymorphisms in Plasmodium falciparum Parasites From
   Sub-Saharan Africa
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE K13-propeller; artemisinin resistance; sub-Saharan Africa
ID ARTEMISININ RESISTANCE; MALARIA; CLEARANCE; CAMBODIA
AB Mutations in the Plasmodium falciparum K13-propeller domain have recently been shown to be important determinants of artemisinin resistance in Southeast Asia. This study investigated the prevalence of K13-propeller polymorphisms across sub-Saharan Africa. A total of 1212 P. falciparum samples collected from 12 countries were sequenced. None of the K13-propeller mutations previously reported in Southeast Asia were found, but 22 unique mutations were detected, of which 7 were nonsynonymous. Allele frequencies ranged between 1% and 3%. Three mutations were observed in >1 country, and the A578S was present in parasites from 5 countries. This study provides the baseline prevalence of K13-propeller mutations in sub-Saharan Africa.
C1 [Kamau, Edwin; Andagalu, Ben] KEMRI US Army Med Res Unit Kenya, Kisumu, Kenya.
   [Campino, Susana; Drury, Eleanor; Kekre, Mihir; Mead, Daniel; MacInnis, Bronwyn; Kwiatkowski, Dominic; Djimde, Abdoulaye A.] Wellcome Trust Sanger Inst, Hinxton, England.
   [Johnson, Kimberly; Kwiatkowski, Dominic] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England.
   [Amenga-Etego, Lucas; Tindana, Paulina] Univ Ghana, Navrongo Hlth Res Ctr, Legon, Ghana.
   [Ghansah, Anita] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana.
   [Ishengoma, Deus] Natl Inst Med Res, Tanga, Tanzania.
   [Mumba, Dieudonne] Univ Kinshasa, Fac Med, Ecole Sante Publ, Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Yavo, William] Natl Inst Publ Hlth, Malaria Res & Control Ctr, Abidjan, Cote Ivoire.
   [Bouyou-Akotet, Marielle] Univ Sci Sante, Fac Med, Dept Parasitol & Mycol, Libreville, Gabon.
   [Apinjoh, Tobias] Univ Buea, Buea, Cameroon.
   [Golassa, Lemu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.
   [Golassa, Lemu] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Antananarivo, Madagascar.
   [Maiga-Ascofare, Oumou] Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali.
   [Amambua-Ngwa, Alfred] MRC, Gambia Unit, Serekunda, Gambia.
   [Maiga-Ascofare, Oumou] Benhard Nocht Inst Trop Med, Hamburg, Germany.
RP Djimde, AA (reprint author), Univ Sci Tech & Technol Bamako, Fac Pharm MRTC DEAP, Point G, Bamako 1805, Mali.
EM adjimde@icermali.org
OI Kwiatkowski, Dominic/0000-0002-5023-0176; Mead,
   Daniel/0000-0001-7717-4330
FU Medical Research Council UK [G0600718]; Wellcome Trust [098051]
FX This work was supported by the Medical Research Council UK (grant
   G0600718) and the Wellcome Trust (grant 098051).
CR Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966
   Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Ghansah A, 2014, SCIENCE, V345, P1297, DOI 10.1126/science.1259423
   Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058
   Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Plowe CV, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-121
   Roper C, 2014, LANCET INFECT DIS, V14, P668, DOI 10.1016/S1473-3099(14)70826-6
   Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110
   Taylor SM, 2015, J INFECT DIS, V211, P1680
   Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4
NR 14
TC 50
Z9 52
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 15
PY 2015
VL 211
IS 8
BP 1352
EP 1355
DI 10.1093/infdis/jiu608
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CI4LP
UT WOS:000354720900020
PM 25367300
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Agyepong, I
   Corrah, T
   Guo, Y
   Hollingsworth, B
   Klag, M
   Longfield, K
   Souza, MDM
   Piot, P
   Rao, JVRP
   Rottingen, JA
   Smith, P
   Sprenger, M
   Sutton, T
   Curran, S
   Ng, ESW
AF Agyepong, Irene
   Corrah, Tumani
   Guo, Yan
   Hollingsworth, Bruce
   Klag, Michael
   Longfield, Kim
   de Fatima Marinho de Souza, Maria
   Piot, Peter
   Rao, J. V. R. Prasada
   Rottingen, John-Arne
   Smith, Peter
   Sprenger, Marc
   Sutton, Trevor
   Curran, Sarah
   Ng, Edmond SW
CA Independent Advisory Comm Globa
TI Making sense of health estimates
SO LANCET
LA English
DT Editorial Material
ID MORTALITY; SYSTEMS; DISEASE; AFRICA; EBOLA
C1 [Agyepong, Irene] Univ Ghana, Sch Publ Hlth, Accra, Ghana.
   [Corrah, Tumani] MRC Unit, Banjul, Gambia.
   [Guo, Yan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China.
   [Hollingsworth, Bruce] Univ Lancaster, Div Hlth Res, Lancaster LA1 4YW, England.
   [Klag, Michael] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
   [Longfield, Kim] Populat Serv Int, Washington, DC USA.
   [de Fatima Marinho de Souza, Maria] Minist Hlth, Brasilia, DF, Brazil.
   [Piot, Peter; Smith, Peter; Curran, Sarah; Ng, Edmond SW] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Rao, J. V. R. Prasada] UNAIDS, Bangalore, Karnataka, India.
   [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Sprenger, Marc] European Ctr Dis Prevent & Control, Stockholm, Sweden.
   [Sutton, Trevor] Australian Bur Stat, Canberra, ACT, Australia.
RP Smith, P (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM peter.piot@lshtm.ac.uk
OI Hollingsworth, Bruce/0000-0002-4314-6523
CR Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288
   Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006
   Horton R, 2014, LANCET, V383, P1792
   Kassebaum NJ, 2014, LANCET, V384, P2209, DOI 10.1016/S0140-6736(14)62421-1
   Kovacs SD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0728-4
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Murray CJL, 2013, LANCET, V382, P9, DOI 10.1016/S0140-6736(13)60225-1
   Piot P, 2014, LANCET INFECT DIS, V14, P1034, DOI 10.1016/S1473-3099(14)70956-9
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29
   UNAIDS, 2014, THE GAP REP
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   World Health Organization, 2014, TRENDS MAT MORT 1990
   Ye Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-741
NR 13
TC 4
Z9 4
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 11
PY 2015
VL 385
IS 9976
BP 1377
EP 1379
DI 10.1016/S0140-6736(15)60024-1
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA CF7EU
UT WOS:000352719800010
PM 25796458
OA No
DA 2017-08-15
ER

PT J
AU Pinder, M
   Jawara, M
   Jarju, LBS
   Salami, K
   Jeffries, D
   Adiamoh, M
   Bojang, K
   Correa, S
   Kandeh, B
   Kaur, H
   Conway, DJ
   D'Alessandro, U
   Lindsay, SW
AF Pinder, Margaret
   Jawara, Musa
   Jarju, Lamin B. S.
   Salami, Kolawole
   Jeffries, David
   Adiamoh, Majidah
   Bojang, Kalifa
   Correa, Simon
   Kandeh, Balla
   Kaur, Harparkash
   Conway, David J.
   D'Alessandro, Umberto
   Lindsay, Steve W.
TI Efficacy of indoor residual spraying with
   dichlorodiphenyltrichloroethane against malaria in Gambian communities
   with high usage of long-lasting insecticidal mosquito nets: a
   cluster-randomised controlled trial
SO LANCET
LA English
DT Article
ID VECTOR-CONTROL INTERVENTIONS; TREATED NETS; RESISTANCE; AFRICA;
   COMBINATION; POWER; AREA
AB Background Although many malaria control programmes in sub-Saharan Africa use indoor residual spraying with long-lasting insecticidal nets (LLINs), the two studies assessing the benefit of the combination of these two interventions gave conflicting results. We aimed to assess whether the addition of indoor residual spraying to LLINs provided a significantly different level of protection against clinical malaria in children or against house entry by vector mosquitoes.
   Methods In this two-arm cluster, randomised, controlled efficacy trial we randomly allocated clusters of Gambian villages using a computerised algorithm to LLINs alone (n=35) or indoor residual spraying with dichlorodiphenyltrichloroethane plus LLINs (n=35). In each cluster, 65-213 children, aged 6 months to 14 years, were surveyed at the start of the 2010 transmission season and followed in 2010 and 2011 by passive case detection for clinical malaria. Exposure to parasite transmission was assessed by collection of vector mosquitoes with both light and exit traps indoors. Primary endpoints were the incidence of clinical malaria assessed by passive case detection and number of Anopheles gambiae sensu lato mosquitoes collected per light trap per night. Intervention teams had no role in data collection and the data collection teams were not informed of the spray status of villages. The trial is registered at the ISRCTN registry, number ISRCTN01738840.
   Findings LLIN coverage in 2011 was 3510 (93%) of 3777 children in the indoor residual spraying plus LLIN group and 3622 (95.5%) of 3791 in the LLIN group. In 2010, 7845 children were enrolled, 7829 completed passive case detection, and 7697 (98%) had complete clinical and covariate data. In 2011, 7009 children remained in the study, 648 more were enrolled, 7657 completed passive case detection, and 7545 (98.5%) had complete data. Indoor residual spraying coverage per cluster was more than 80% for both years in the indoor residual spraying plus LLIN group. Incidence of clinical malaria was 0.047 per child-month at risk in the LLIN group and 0.044 per child-month at risk in the indoor residual spraying plus LLIN group in 2010, and 0.032 per child-month at risk in the LLIN group and 0.034 per child-month at risk in the indoor residual spraying plus LLIN group in 2011. The incident rate ratio was 1.08 (95% CI 0.80-1.46) controlling for confounders and cluster by mixed-effect negative binomial regression on all malaria attacks for both years. No significant difference was recorded in the density of vector mosquitoes caught in light traps in houses over the two transmission seasons; the mean number of A gambiae sensu lato mosquitoes per trap per night was 6.7 (4.0-10.1) in the LLIN group and 4.5 (2.4-7.4) in the indoor residual spraying plus LLIN group (p=0.281 in the random-effects linear regression model).
   Interpretation We identified no significant difference in clinical malaria or vector density between study groups. In this area with high LLIN coverage, moderate seasonal transmission, and susceptible vectors, indoor residual spraying did not provide additional benefit.
C1 [Pinder, Margaret; Jawara, Musa; Salami, Kolawole; Jeffries, David; Adiamoh, Majidah; Bojang, Kalifa; Correa, Simon; Conway, David J.; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia.
   [Jarju, Lamin B. S.; Kandeh, Balla] Natl Malaria Control Programme, Banjul, Gambia.
   [Pinder, Margaret; Kaur, Harparkash; Conway, David J.; Lindsay, Steve W.] London Sch Hyg & Trop Med, London WC1, England.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Pinder, Margaret; Lindsay, Steve W.] Univ Durham, Durham, England.
RP Lindsay, SW (reprint author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.
EM s.w.lindsay@durham.ac.uk
OI Bojang, Kalifa/0000-0001-7506-0938; Conway, David/0000-0002-8711-3037
FU UK Medical Research Council
FX UK Medical Research Council.
CR Bennett S, 2002, INT J EPIDEMIOL, V31, P839, DOI 10.1093/ije/31.4.839
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179
   Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6
   Fullman N, 2013, MALARIA J, V12, pe62
   Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x
   GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q
   Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324
   Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684
   Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319
   Kilian A, 2013, MALARIA J, V12, pe259
   Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519
   Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2
   Lengeler C, 1996, NET GAIN NEW METHOD
   Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503
   LINDSAY SW, 1995, MED VET ENTOMOL, V9, P50, DOI 10.1111/j.1365-2915.1995.tb00116.x
   Okumu FO, 2013, PARASITE VECTOR, V6, pe17
   Okumu FO, 2013, PARASITE VECTOR, V6, pe46
   Okumu FO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-208
   O'Meara W, 2010, LANCET INFECT DIS, V10, P505
   Pampana E, 1969, TXB MALARIA ERADICAT
   Pinder M, 2011, TRIALS, V12, pe147
   Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2
   Quinones ML, 1998, T ROY SOC TROP MED H, V92, P373, DOI 10.1016/S0035-9203(98)91053-7
   ROBERTS DR, 1994, AM J TROP MED HYG, V50, P21
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117
   SMITH A, 1969, B ENTOMOL RES, V59, P33
   Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351
   Thomas CJ, 2013, PLOS ONE, V8, pe7
   Todd J, 2003, INT J EPIDEMIOL, V32, P755, DOI 10.1093/ije/dyg150
   Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105
   West PA, 2014, PLOS MED, V11
   White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2006, PEST THEIR APPL CONT
   World Health Organization, 2006, GUID TEST MOSQ AD IN
   WHO, 2007, MAN IND RES SPRAYING
   Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537
   Zhou G, 2013, MALARIA J, V12, pe256
NR 40
TC 14
Z9 15
U1 2
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 11
PY 2015
VL 385
IS 9976
BP 1436
EP 1446
DI 10.1016/S0140-6736(14)61007-2
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA CF7EU
UT WOS:000352719800032
PM 25498847
OA No
DA 2017-08-15
ER

PT J
AU Shimakawa, Y
   Lemoine, M
   Bottomley, C
   Njai, HF
   Ndow, G
   Wegmuller, R
   Moore, SE
   D'Alessandro, U
   Whittle, H
   Mendy, M
   Thursz, M
   Njie, R
AF Shimakawa, Y.
   Lemoine, M.
   Bottomley, C.
   Njai, H. Freeya
   Ndow, G.
   Wegmuller, R.
   Moore, S. E.
   D'Alessandro, U.
   Whittle, H.
   Mendy, M.
   Thursz, M.
   Njie, R.
TI NATURAL HISTORY OF CHRONIC HEPATITIS B INFECTION IN THE GAMBIA, WEST
   AFRICA: A LONGITUDINAL POPULATION-BASED STUDY
SO JOURNAL OF HEPATOLOGY
LA English
DT Meeting Abstract
CT 50th International Liver Congress of the
   European-Association-for-the-Study-of-the-Liver
CY APR 22-26, 2015
CL Vienna, AUSTRIA
SP European Assoc Study Liver
C1 [Shimakawa, Y.; Lemoine, M.; Njai, H. Freeya; Ndow, G.; D'Alessandro, U.; Njie, R.] MRC Unit, Banjul, Gambia.
   [Shimakawa, Y.; Bottomley, C.; D'Alessandro, U.; Whittle, H.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.
   [Shimakawa, Y.] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.
   [Lemoine, M.; Thursz, M.] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, London, England.
   [Wegmuller, R.; Moore, S. E.] MRC Keneba, MRC Int Nutr Grp, West Kiang, Gambia.
   [Moore, S. E.] MRC Human Nutr Res, Cambridge, England.
   [Mendy, M.; Njie, R.] Int Agcy Res Canc, F-69372 Lyon, France.
EM yusuke.shimakawa@pasteur.fr
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD APR
PY 2015
VL 62
SU 2
MA P0598
BP S540
EP S541
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CT5EJ
UT WOS:000362830600315
OA No
DA 2017-08-15
ER

PT J
AU Cerami, C
   Cross, J
   Bradbury, R
   Fulford, A
   Jallow, A
   Prentice, A
AF Cerami, Carla
   Cross, James
   Bradbury, Richard
   Fulford, Anthony
   Jallow, Amadou
   Prentice, Andrew
TI Increased bacterial growth in serum from iron supplemented individuals
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY MAR 28-APR 01, 2015
CL Boston, MA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, ASIP, ASN, ASPET
C1 [Cerami, Carla] Univ N Carolina, Epidemiol, Chapel Hill, NC USA.
   [Cross, James; Bradbury, Richard; Jallow, Amadou] Med Res Council Gambia, Int Nutr Grp, MRC, Keneba, Gambia.
   [Fulford, Anthony; Prentice, Andrew] London Sch Hyg & Trop Med, Int Nutr Grp, MRC, London WC1, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2015
VL 29
SU 1
MA 757.8
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CS0BT
UT WOS:000361722702338
OA No
DA 2017-08-15
ER

PT J
AU Lloyd-Fox, S
   Halliday, D
   Begus, K
   Darboe, M
   Prentice, A
   Moore, S
   Elwell, C
AF Lloyd-Fox, Sarah
   Halliday, Drew
   Begus, Katarina
   Darboe, Momodue
   Prentice, Andrew
   Moore, Sophie
   Elwell, Clare
TI Measuring Brain Function in Newborns in Rural Gambia
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY MAR 28-APR 01, 2015
CL Boston, MA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, ASIP, ASN, ASPET
C1 [Lloyd-Fox, Sarah; Begus, Katarina] Univ London, Ctr Brain & Cognit Dev Birkbeck, London, England.
   [Lloyd-Fox, Sarah; Halliday, Drew; Elwell, Clare] UCL, Med Phys & Bioengn, London WC1E 6BT, England.
   [Darboe, Momodue; Prentice, Andrew; Moore, Sophie] Keneba MRC Unit, Int Nutr Grp, Serrekunda, Gambia.
   [Prentice, Andrew] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Moore, Sophie] Univ Cambridge, MRC Human Nutr Res, Cambridge, England.
NR 0
TC 1
Z9 1
U1 1
U2 3
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2015
VL 29
SU 1
MA 899.5
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CS0BT
UT WOS:000361722705302
OA No
DA 2017-08-15
ER

PT J
AU Lloyd-Fox, S
   Halliday, D
   Begus, K
   Vellekoop, P
   Maris, H
   Sanyang, L
   Drammeh, S
   Darboe, M
   Prentice, A
   Moore, S
   Elwell, C
AF Lloyd-Fox, Sarah
   Halliday, Drew
   Begus, Katarina
   Vellekoop, Perijne
   Maris, Helen
   Sanyang, Lamin
   Drammeh, Saikou
   Darboe, Momodue
   Prentice, Andrew
   Moore, Sophie
   Elwell, Clare
TI Cognitive Development in Rural Gambia: Relating Behavior and Growth from
   6-24 Months of Age
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Lloyd-Fox, Sarah; Begus, Katarina; Maris, Helen] Univ London, Ctr Brain & Cognit Dev Birkbeck, London, England.
   [Lloyd-Fox, Sarah; Halliday, Drew; Elwell, Clare] UCL, Med Phys & Bioengn, London WC1E 6BT, England.
   [Vellekoop, Perijne; Sanyang, Lamin; Drammeh, Saikou; Darboe, Momodue; Prentice, Andrew; Moore, Sophie] Keneba MRC Unit, Int Nutr Grp, Keneba, Gambia.
   [Vellekoop, Perijne; Prentice, Andrew] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Moore, Sophie] Univ Cambridge, MRC Human Nutr Res, Cambridge CB2 1TN, England.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2015
VL 29
SU 1
MA 28.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CR6PV
UT WOS:000361470501216
OA No
DA 2017-08-15
ER

PT J
AU Nabwera, H
   Bernstein, R
   Jallow, A
   Jallow, M
   Liberatore, J
   Prentice, A
AF Nabwera, Helen
   Bernstein, Robin
   Jallow, Amadou
   Jallow, Momodou
   Liberatore, Jennifer
   Prentice, Andrew
TI Evaluating Growth Regulating Hormones in Rural Gambian Children
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Nabwera, Helen; Jallow, Amadou; Jallow, Momodou; Prentice, Andrew] The Gambia, Med Res Council Unit, Nutr, Banjul, Gambia.
   [Nabwera, Helen; Prentice, Andrew] London Sch Hyg & Trop Med, Populat Hlth, London WC1, England.
   [Bernstein, Robin; Liberatore, Jennifer] Univ Colorado, Anthropol, Boulder, CO 80309 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2015
VL 29
SU 1
MA 579.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CR6PV
UT WOS:000361470504340
OA No
DA 2017-08-15
ER

PT J
AU Harding-Esch, E
   Jofre-Bonet, M
   Dhanjal, JK
   Burr, S
   Edwards, T
   Holland, M
   Sillah, A
   West, S
   Lietman, T
   Keenan, J
   Mabey, D
   Bailey, R
AF Harding-Esch, Emma
   Jofre-Bonet, Mireia
   Dhanjal, Jaskiran K.
   Burr, Sarah
   Edwards, Tansy
   Holland, Martin
   Sillah, Ansumana
   West, Sheila
   Lietman, Tom
   Keenan, Jeremy
   Mabey, David
   Bailey, Robin
TI Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to
   Mass Drug Administration for Trachoma in The Gambia: Application of
   Results from the PRET Study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AZITHROMYCIN; ELIMINATION; PROGRAMS; TANZANIA; TRIAL; ANTIBIOTICS;
   PREVALENCE; STRATEGIES; SPECIMENS; DISEASE
AB Background
   Mass drug administration (MDA) treatment of active trachoma with antibiotic is recommended to be initiated in any district where the prevalence of trachoma inflammation, follicular (TF) is >= 10% in children aged 1-9 years, and then to continue for at least three annual rounds before resurvey. In The Gambia the PRET study found that discontinuing MDA based on testing a sample of children for ocular Chlamydia trachomatis(Ct) infection after one MDA round had similar effects to continuing MDA for three rounds. Moreover, one round of MDA reduced disease below the 5% TF threshold. We compared the costs of examining a sample of children for TF, and of testing them for Ct, with those of MDA rounds.
   Methods
   The implementation unit in PRET The Gambia was a census enumeration area (EA) of 600-800 people. Personnel, fuel, equipment, consumables, data entry and supervision costs were collected for census and treatment of a sample of EAs and for the examination, sampling and testing for Ct infection of 100 individuals within them. Programme costs and resource savings from testing and treatment strategies were inferred for the 102 EAs in the study area, and compared.
   Results
   Census costs were $103.24 per EA plus initial costs of $108.79. MDA with donated azithromycin cost $227.23 per EA. The mean cost of examining and testing 100 children was $796.90 per EA, with Ct testing kits costing $4.80 per result. A strategy of testing each EA for infection is more expensive than two annual rounds of MDA unless the kit cost is less than $1.38 per result. However stopping or deciding not to initiate treatment in the study area based on testing a sample of EAs for Ct infection (or examining children in a sample of EAs) creates savings relative to further unnecessary treatments.
   Conclusion
   Resources may be saved by using tests for chlamydial infection or clinical examination to determine that initial or subsequent rounds of MDA for trachoma are unnecessary.
C1 [Harding-Esch, Emma; Edwards, Tansy; Holland, Martin; Mabey, David; Bailey, Robin] London Sch Hyg & Trop Med, London WC1, England.
   [Harding-Esch, Emma] Publ Hlth England, HIV STI Dept, London, England.
   [Jofre-Bonet, Mireia] City Univ London, Dept Econ, London EC1V 0HB, England.
   [Dhanjal, Jaskiran K.] Abacus Int, Bicester, Oxon, England.
   [Burr, Sarah] MRC Labs, Fajara, Gambia.
   [Sillah, Ansumana] Natl Eye Hlth Programme, Banjul, Gambia.
   [West, Sheila] Johns Hopkins Univ, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21218 USA.
   [Lietman, Tom; Keenan, Jeremy] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.
RP Harding-Esch, E (reprint author), London Sch Hyg & Trop Med, London WC1, England.
EM Robin.Bailey@lshtm.ac.uk
OI Mabey, David/0000-0002-0031-8276
FU Bill and Melinda Gates Foundation [48027]
FX This study was supported by the Bill and Melinda Gates Foundation
   www.gatesfoundation.org grant 48027. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baltussen RMRM, 2005, OPHTHAL EPIDEMIOL, V12, P91, DOI 10.1080/09286580490932761
   BENNETT S, 1991, World Health Statistics Quarterly, V44, P98
   Blake IM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000862
   Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007
   Burton M, 2001, 6 M GLOB ALL EL TRAC
   Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X
   Chen CQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000979
   Chidambaram JD, 2005, LANCET INFECT DIS, V5, P194, DOI 10.1016/S1473-3099(05)70032-3
   Dize L, 2013, DIAGN MICR INFEC DIS, V77, P289, DOI 10.1016/j.diagmicrobio.2013.08.005
   Drummond MF, 2005, METHODS EC EVALUATIO
   Frick KD, 2003, AM J TROP MED HYG, V69, P1
   Frick KD, 2001, B WORLD HEALTH ORGAN, V79, P201
   Harding-Esch EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002115
   Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861
   Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573
   Kolaczinski JH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001362
   Kumaresan JA, 2003, AM J TROP MED HYG, V69, P24
   Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494
   Peeling RW, 1998, SEX TRANSM INFECT, V74, P66
   Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844
   Schemann JF, 2007, ACTA TROP, V101, P40, DOI 10.1016/j.actatropica.2006.12.003
   Sillah A, 2006, DEP STATE HLTH SOCIA
   Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979
   Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8
   Stare D, 2011, OPHTHAL EPIDEMIOL, V18, P20, DOI 10.3109/09286586.2010.545500
   THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477
   WHO, 2006, TRACH CONTR GUID PRO
   WHO, 2011, 3 GLOB SCI M TRACH B
NR 28
TC 5
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2015
VL 9
IS 4
AR e0003670
DI 10.1371/journal.pntd.0003670
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CI7VF
UT WOS:000354972200030
PM 25901349
OA gold
DA 2017-08-15
ER

PT J
AU Imwong, M
   Woodrow, CJ
   Hendriksen, ICE
   Veenemans, J
   Verhoef, H
   Faiz, MA
   Mohanty, S
   Mishra, S
   Mtove, G
   Gesase, S
   Seni, A
   Chhaganlal, KD
   Day, NPJ
   Dondorp, AM
   White, NJ
AF Imwong, Mallika
   Woodrow, Charles J.
   Hendriksen, Ilse C. E.
   Veenemans, Jacobien
   Verhoef, Hans
   Faiz, M. Abul
   Mohanty, Sanjib
   Mishra, Saroj
   Mtove, George
   Gesase, Samwel
   Seni, Amir
   Chhaganlal, Kajal D.
   Day, Nicholas P. J.
   Dondorp, Arjen M.
   White, Nicholas J.
TI Plasma Concentration of Parasite DNA as a Measure of Disease Severity in
   Falciparum Malaria
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Plasmodium falciparum; malaria; severe disease; plasma DNA; diagnostic
   accuracy
ID REAL-TIME PCR; PLASMODIUM-FALCIPARUM; PFHRP2 CONCENTRATION; MALAWIAN
   CHILDREN; CEREBRAL MALARIA; BLOOD; ASSAY; RETINOPATHY; CLEARANCE;
   DIAGNOSIS
AB In malaria-endemic areas, Plasmodium falciparum parasitemia is common in apparently healthy children and severe malaria is commonly misdiagnosed in patients with incidental parasitemia. We assessed whether the plasma Plasmodium falciparum DNA concentration is a useful datum for distinguishing uncomplicated from severe malaria in African children and Asian adults. P. falciparum DNA concentrations were measured by real-time polymerase chain reaction (PCR) in 224 African children (111 with uncomplicated malaria and 113 with severe malaria) and 211 Asian adults (100 with uncomplicated malaria and 111 with severe malaria) presenting with acute falciparum malaria. The diagnostic accuracy of plasma P. falciparum DNA concentrations in identifying severe malaria was 0.834 for children and 0.788 for adults, similar to that of plasma P. falciparum HRP2 levels and substantially superior to that of parasite densities (P < .0001). The diagnostic accuracy of plasma P. falciparum DNA concentrations plus plasma P. falciparum HRP2 concentrations was significantly greater than that of plasma P. falciparum HRP2 concentrations alone (0.904 for children [P = .004] and 0.847 for adults [P = .003]). Quantitative real-time PCR measurement of parasite DNA in plasma is a useful method for diagnosing severe falciparum malaria on fresh or archived plasma samples.
C1 [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok 10400, Thailand.
   [Woodrow, Charles J.; Hendriksen, Ilse C. E.; Day, Nicholas P. J.; Dondorp, Arjen M.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand.
   [Woodrow, Charles J.; Hendriksen, Ilse C. E.; Day, Nicholas P. J.; Dondorp, Arjen M.; White, Nicholas J.] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford OX1 2JD, England.
   [Verhoef, Hans] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London, England.
   [Veenemans, Jacobien; Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands.
   [Veenemans, Jacobien] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.
   [Verhoef, Hans] MRC Keneba, Keneba, Gambia.
   [Faiz, M. Abul] Dev Care Fdn, Dhaka, Bangladesh.
   [Mohanty, Sanjib; Mishra, Saroj] Ispat Hosp, Dept Med, Rourkela, India.
   [Mtove, George] Amani Ctr, Natl Inst Med Res, Muheza, Tanzania.
   [Gesase, Samwel] Natl Inst Med Res, Korogwe Res Lab, Tanga, Tanzania.
   [Seni, Amir; Chhaganlal, Kajal D.] Catholic Univ Mozamb, Hosp Cent Beira, Beira, Mozambique.
   [Chhaganlal, Kajal D.] Catholic Univ Mozamb, Fac Hlth Sci, Beira, Mozambique.
RP Imwong, M (reprint author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.
EM noi@tropmedres.ac
RI Verhoef, Hans/L-3024-2015
OI Verhoef, Hans/0000-0002-9346-9689
FU Wellcome Trust as part of the Wellcome Trust Mahidol University Oxford
   Tropical Medicine Research Programme
FX The work was supported by the Wellcome Trust as part of the Wellcome
   Trust Mahidol University Oxford Tropical Medicine Research Programme.
CR Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593
   Beare NAV, 2006, AM J TROP MED HYG, V75, P790
   Bharti AR, 2009, AM J TROP MED HYG, V81, P754, DOI 10.4269/ajtmh.2009.09-0274
   Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61
   Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1
   Gal S, 2001, ANN NY ACAD SCI, V945, P234
   Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Gauthier VJ, 1996, J IMMUNOL, V156, P1151
   Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675
   Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297
   Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700
   Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11
   Lamikanra AA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-201
   Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205
   Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118
   Mercereau-Puijalon O, 2002, INT J PARASITOL, V32, P1323, DOI 10.1016/S0020-7519(02)00111-X
   Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8
   Ramutton T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-276
   Seydel KB, 2012, J INFECT DIS, V206, P309, DOI 10.1093/infdis/jis371
   Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986
   Tran T H, 1996, N Engl J Med, V335, P76
NR 22
TC 7
Z9 7
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 1
PY 2015
VL 211
IS 7
BP 1128
EP 1133
DI 10.1093/infdis/jiu590
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CI4DQ
UT WOS:000354697500014
PM 25344520
OA No
DA 2017-08-15
ER

PT J
AU Roca, A
   Afolabi, MO
   Saidu, Y
   Kampmann, B
AF Roca, Anna
   Afolabi, Muhammed O.
   Saidu, Yauba
   Kampmann, Beate
TI Ebola: A holistic approach is required to achieve effective management
   and control
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Article
DE Ebola virus disease; viral hemorrhagic fever; containment; holistic;
   West Africa
ID HEMORRHAGIC-FEVER; VIRUS DISEASE; WEST-AFRICA; INFECTED PATIENTS;
   OUTBREAK; TRIALS; TRANSMISSION; RESPONSES; DYNAMICS; UGANDA
AB The current Ebola outbreak in West Africa has already caused substantial mortality and dire human and economic consequences. It continues to represent an alarming public health threat in the region and beyond and jeopardizes the provision of health care and other services in the affected countries. The scale of the epidemic has accelerated research efforts for diagnostics, treatment, and prevention galvanized through increased availability of funding. Our knowledge relating to the virus, disease pathogenesis, risk factors, dynamics of transmission, and epidemic control is increasing, and sociocultural factors have emerged as critical determinants for the success and failure of control efforts. However, there is a long way to go. In this review we summarize the current knowledge, examine the sociocultural context in West Africa, and outline priority areas for future research.
C1 [Roca, Anna; Afolabi, Muhammed O.; Saidu, Yauba; Kampmann, Beate] MRC, Med Res Unit, Fajara, Gambia.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.
RP Kampmann, B (reprint author), Med Res Unit, Vaccinol Theme, Atlantic Rd, Fajara, Gambia.
EM bkampmann@mrc.gm
OI Afolabi, Muhammed/0000-0002-9967-6419; Kampmann,
   Beate/0000-0002-6546-4709
FU Medical Research Council Unit Core; Wellcome Trust; Bill & Melinda Gates
   Foundation; European Respiratory Society; European & Developing
   Countries Clinical Trial Partnership
FX B. Kampmann has received research support from the Medical Research
   Council Unit Core, the Wellcome Trust, and the Bill & Melinda Gates
   Foundation and has received payment for development of educational
   presentations from the European Respiratory Society. A. Roca has
   received travel support from the World Health Organization. M. Afolabi
   has received research support from the European & Developing Countries
   Clinical Trial Partnership. Y. Saidu declares no relevant conflicts of
   interest.
CR Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7
   Ascenzi P, 2008, MOL ASPECTS MED, V29, P151, DOI 10.1016/j.mam.2007.09.005
   Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249
   Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109
   Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227
   Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015
   Bray M, EPIDEMIOLOGY PATHOGE
   Breman JG, 2014, NEW ENGL J MED, V371, P1663, DOI 10.1056/NEJMp1410540
   Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858
   Brown Celia A, 2006, BMC Med Res Methodol, V6, P54, DOI 10.1186/1471-2288-6-54
   Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
   Burki TK, 2011, LANCET, V378, P389
   Camacho A, 2014, EPIDEMICS-NETH, V9, P70, DOI 10.1016/j.epidem.2014.09.003
   Centers for Disease Control and Prevention, TRANSM EB EB VIR DIS
   Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859
   Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0
   Clark DV, 2012, VIRUSES-BASEL, V4, P1668, DOI 10.3390/v4091668
   Dowell SF, 1999, J INFECT DIS, V179, pS87
   Edwards SJL, 2013, AM J BIOETHICS, V13, P3, DOI 10.1080/15265161.2013.813597
   Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471
   Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494
   Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8
   FISHERHOCH SP, 1985, J INFECT DIS, V152, P887
   Food and Agricultural Organisation, BATS BUSHM IMPL GLOB
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Geisbert TW, 2000, LAB INVEST, V80, P171
   Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gonzalez JP, 2000, MICROBES INFECT, V2, P39, DOI 10.1016/S1286-4579(00)00287-2
   Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3
   Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001
   Heffernan RT, 2005, J INFECT DIS, V191, P964, DOI 10.1086/427994
   Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242
   Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007
   Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166
   Kinsman J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-15
   Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299
   Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2
   Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI 10.1056/NEJMoa1410863
   Lefebvre A, 2014, MED MALADIES INFECT, V44, P412, DOI 10.1016/j.medmal.2014.08.005
   Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217
   Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167
   Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099
   Modrof J, 2001, VIROLOGY, V287, P171, DOI 10.1006/viro.2001.1027
   Nanbo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01206
   Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099
   Nossiter A, FEAR EBOLA BREEDS TE
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   Omaswa F, LANCET GLOBAL HLTH
   Painter W, 2012, ANTIMICROB AGENTS CH, V56, P2726, DOI 10.1128/AAC.05983-11
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Prewitt KC., WHY LIBERIANS RAIDED
   Reith C, 2013, NEW ENGL J MED, V369, P1061, DOI 10.1056/NEJMsb1300760
   Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5
   The Rockefeller Foundation, LESS PREV EB OUTBR I
   Saijo M, 2006, CLIN VACCINE IMMUNOL, V13, P444, DOI 10.1128/CVI.13.4.444-451.2006
   Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004
   SANCHEZ A, 1987, VIROLOGY, V157, P414, DOI 10.1016/0042-6822(87)90283-2
   Sanchez A, 2007, FIELDS VIROLOGY, V1, P1409
   Sanchez A, 2007, J INFECT DIS, V196, pS329, DOI 10.1086/520588
   Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680
   Schopper D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000115
   Schulte-Herbruggen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072807
   Shaw D, 2014, LANCET, V384, P1667, DOI 10.1016/S0140-6736(14)61735-9
   Skolnik R, 2008, GLOBAL HLTH, V101, P120
   Sobarzo A, 2013, J INFECT DIS, V208, P299, DOI 10.1093/infdis/jit162
   Takada A, 2001, TRENDS MICROBIOL, V9, P506, DOI 10.1016/S0966-842X(01)02201-6
   Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004
   Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283
   WHO, WHAT DO WE KNOW TRAM
   World Health Organization (WHO), 2007, EV BUS STRENGTH HLTH
   World Health Organisation, UNPR NUM MED STAFF I
   WHO Ebola Response Team, 2014, N ENGL J MED, V371, P1481
   Wolf T, 2015, LANCET, V385, P1428, DOI 10.1016/S0140-6736(14)62384-9
   1978, B WHO, V56, P247
NR 79
TC 9
Z9 10
U1 2
U2 43
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
EI 1097-6825
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD APR
PY 2015
VL 135
IS 4
BP 856
EP 867
DI 10.1016/j.jaci.2015.02.015
PG 12
WC Allergy; Immunology
SC Allergy; Immunology
GA CF0MQ
UT WOS:000352238600002
PM 25843598
OA No
DA 2017-08-15
ER

PT J
AU Watson, G
   Jallow, B
   Le Doare, K
   Pushparajah, K
   Anderson, ST
AF Watson, Gabriella
   Jallow, Bintou
   Le Doare, Kirsty
   Pushparajah, Kuberan
   Anderson, Suzanne T.
TI Acute rheumatic fever and rheumatic heart disease in resource-limited
   settings
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Review
ID A STREPTOCOCCAL DISEASES; GLOBAL BURDEN; HEALTH; ECHOCARDIOGRAPHY;
   DIAGNOSIS
AB Poststreptococcal complications, such as acute rheumatic fever (ARF) and rheumatic heart disease (RHD), are common in resource-limited settings, with RHD recognised as the most common cause of paediatric heart disease worldwide. Managing these conditions in resource-limited settings can be challenging. We review the investigation and treatment options for ARF and RHD and, most importantly, prevention methods in an African setting.
C1 [Watson, Gabriella; Jallow, Bintou; Le Doare, Kirsty; Anderson, Suzanne T.] MRC, Gambia Unit, Fajara, Gambia.
   [Le Doare, Kirsty] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Global Hlth Res, London, England.
   [Pushparajah, Kuberan] Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Dept Congenital Heart Dis, London, England.
RP Watson, G (reprint author), MRC, Gambia Unit, POB 273, Fajara, Gambia.
EM gw@gabriellawatson.com
CR Beaton A, 2015, EUR HEART J CARDIOVA
   Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312
   Carapetis JR, 2007, NEW ENGL J MED, V357, P439, DOI 10.1056/NEJMp078039
   Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
   Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2
   Coleman R, 2006, SOC PSYCH PSYCH EPID, V41, P720, DOI 10.1007/s00127-006-0085-8
   Dale JB, 2013, VACCINE, V31, pB216, DOI 10.1016/j.vaccine.2012.09.045
   Finucane Kirsten, 2013, Glob Heart, V8, P213, DOI 10.1016/j.gheart.2013.08.010
   Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085
   Marijon E, 2009, CIRCULATION, V120, P663, DOI 10.1161/CIRCULATIONAHA.109.849190
   Mirabel M, 2015, CIRC-CARDIOVASC IMAG, V8, P1
   Parks T, 2012, CURR OPIN INFECT DIS, V25, P145, DOI 10.1097/QCO.0b013e3283511d27
   Passali D, 2007, Acta Otorhinolaryngol Ital, V27, P27
   Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280
   Remenyi Bo, 2013, World J Pediatr Congenit Heart Surg, V4, P155, DOI 10.1177/2150135112474024
   Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7
   Remond MGW, 2012, HEART LUNG CIRC, V21, P632, DOI 10.1016/j.hlc.2012.05.006
   RHDAustralia (ARF/RHD writing group) National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand, 2012, QUICK REF GUID
   Robertson Katharine A, 2005, BMC Cardiovasc Disord, V5, P11, DOI 10.1186/1471-2261-5-11
   Steer AC, 2013, PEDIATR INFECT DIS J, V32, P180, DOI 10.1097/INF.0b013e318281da11
   Swain JD, 2014, LANCET GLOB HEALTH, V2, P141
   Turina MI, 2002, EUR J CARDIO-THORAC, V22, P857, DOI 10.1016/S1010-7940(02)00731-5
   WHO, 2001, RHEUM FEV RHEUM HEAR
   WHO, 2005, DISC PAP CHILD HLTH
   WHO, 2004, WORLD HLTH REP 2004
NR 25
TC 4
Z9 4
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD APR
PY 2015
VL 100
IS 4
BP 370
EP 375
DI 10.1136/archdischild-2014-307938
PG 6
WC Pediatrics
SC Pediatrics
GA CD6PE
UT WOS:000351210600016
PM 25784737
OA No
DA 2017-08-15
ER

PT J
AU Njai, HF
   Shimakawa, Y
   Sanneh, B
   Ferguson, L
   Ndow, G
   Mendy, M
   Sow, A
   Lo, G
   Toure-Kane, C
   Tanaka, J
   Taal, M
   D'alessandro, U
   Njie, R
   Thursz, M
   Lemoine, M
AF Njai, Harr Freeya
   Shimakawa, Yusuke
   Sanneh, Bakary
   Ferguson, Lynne
   Ndow, Gibril
   Mendy, Maimuna
   Sow, Amina
   Lo, Gora
   Toure-Kane, Coumba
   Tanaka, Junko
   Taal, Makie
   D'alessandro, Umberto
   Njie, Ramou
   Thursz, Mark
   Lemoine, Maud
TI Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis
   B Surface Antigen in Field and Laboratory Settings in the Gambia,
   Western Africa
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; DIAGNOSTIC-ACCURACY; LIVER FIBROSIS; C
   VIRUS; INFECTION; PERFORMANCE; ASSAYS; HBSAG; HIV; METAANALYSIS
AB Hepatitis B virus (HBV) infection is a leading cause of death in sub-Saharan Africa (SSA). Point-of-care tests for hepatitis B surface antigen (HBsAg) could be an ideal tool for a large-scale HBV screening/treatment program in SSA. Using data from the PROLIFICA (Prevention of Liver Fibrosis and Cancer in Africa) program, we conducted a cross-sectional study to assess the diagnostic accuracy of three point-of-care tests (Determine, Vikia, and Espline) for the detection of HBsAg in the field or a laboratory setting in the Gambia. In the field, we used finger-prick whole blood for the Determine and Vikia tests and dried blood spots for the reference standard test (AxSYM HBsAg enzyme-linked immunosorbent assay [ELISA]). In the laboratory we used serum for the Determine, Espline, and reference test (Architect chemiluminescent microparticle immunoassay). Of 773 participants recruited at the community and 227 known chronic HBV carriers (1,000 subjects in total), 293 were positive for HBsAg. The sensitivity and specificity of the Determine test were 88.5% and 100% in the field and 95.3% and 93.3% in the laboratory setting, respectively. The sensitivity and specificity were 90.0% and 99.8% for the Vikia test (in the field) and 93.9% and 94.7% for the Espline test (in the laboratory). There was no evidence that one kit was better than another. Most of the patients with false-negative results (18/19) were classified as inactive chronic carriers. In summary, the three point-of-care tests had acceptable ranges of diagnostic accuracy. These tests may represent accurate, rapid, and inexpensive alternatives to serology testing for the screening of HBV infection at field level in SSA.
C1 [Njai, Harr Freeya; Shimakawa, Yusuke; Ferguson, Lynne; Ndow, Gibril; D'alessandro, Umberto; Njie, Ramou; Lemoine, Maud] MRC Unit, Banjul, Gambia.
   [Shimakawa, Yusuke; Tanaka, Junko] Hiroshima Univ, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan.
   [Sanneh, Bakary; Taal, Makie] Natl Publ Hlth Lab, Banjul, Gambia.
   [Mendy, Maimuna; Njie, Ramou] Int Agcy Res Canc, Lab Serv & Biobank Grp, F-69372 Lyon, France.
   [Sow, Amina; Lo, Gora; Toure-Kane, Coumba] Univ Cheikh Anta Diop, CHU Le Dantec, Lab Bacteriol Virol, Dakar, Senegal.
   [Thursz, Mark; Lemoine, Maud] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, Div Med, London, England.
RP Lemoine, M (reprint author), MRC Unit, Banjul, Gambia.
EM m.lemoine@imperial.ac.uk
OI Ndow, Gibril/0000-0001-5837-5110; Sow, Amina/0000-0001-6081-4506
FU Medical Research Council Laboratories in the Gambia,; Ministry of Health
   and Social Welfare; European commission (EC FP7) [P34114]
FX We thank the Medical Research Council Laboratories in the Gambia, the
   local Ministry of Health and Social Welfare for supporting the project,
   all the study participants, and the PROLIFICA team, in particular,
   Ignatius Baldeh, Famara Bojang, Amie Ceesay, Mavis Foster-Nyarko, Debbo
   Jallow, Abdoulie Jatta, Adam Jeng, Sheriff Kolley, Yamundow Jallow
   Samba, Alagie Sanneh, Demba Sonko, Penda Suso, and Saydiba Tamba. We
   also thank Debbie Garside, the project manager of the PROLIFICA
   project.; This study is part of the PROLIFICA program funded by the
   European commission (EC FP7, P34114).
CR Akanmu A S, 2006, Afr J Med Med Sci, V35, P5
   Bossuyt PM, 2003, ANN INTERN MED, V138, P40
   Bottero J, 2013, J HEPATOL, V58, P473, DOI 10.1016/j.jhep.2012.11.016
   Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008
   Davies J, 2010, T ROY SOC TROP MED H, V104, P162, DOI 10.1016/j.trstmh.2009.10.010
   FARGHALY AM, 1990, FARMACO, V45, P431
   Franzeck FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058468
   Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09
   Hoffmann C. J., 2012, International Journal of STD & AIDS, V23, pe10, DOI 10.1258/ijsa.2009.009340
   Honge BL, 2014, HIV MED, V15, P571, DOI 10.1111/hiv.12158
   Hwang SH, 2008, KOR J LAB MED, V28, P160, DOI 10.3343/kjlm.2008.28.2.160
   Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410
   Kania D, 2013, CLIN MICROBIOL INFEC, V19, pE533, DOI 10.1111/1469-0691.12292
   Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561
   Lien TX, 2000, AM J TROP MED HYG, V62, P301
   Lin YH, 2008, J CLIN MICROBIOL, V46, P3319, DOI 10.1128/JCM.00498-08
   Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x
   Mvere D, 1996, B WORLD HEALTH ORGAN, V74, P19
   Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004
   Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
   Palmer CJ, 1999, 39 INT C ANT AG CHEM
   Papatheodoridis G, 2012, J HEPATOL, V57, P167
   Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X
   Randrianirina F, 2008, J VIROL METHODS, V151, P294, DOI 10.1016/j.jviromet.2008.03.019
   Scheiblauer H, 2010, VOX SANG, V98, P403, DOI 10.1111/j.1423-0410.2009.01272.x
   Shibahara K, 1997, JPN J MED PHARM SCI, V38, P343
   Shivkumar S, 2012, AM J GASTROENTEROL, V107, P1306, DOI 10.1038/ajg.2012.141
   Thursz M, 2012, NAT REV GASTRO HEPAT, V9, P492, DOI 10.1038/nrgastro.2012.155
   Thursz M, 2010, TROP MED INT HEALTH, V15, P2, DOI 10.1111/j.1365-3156.2009.02410.x
   Villar LM, 2011, J MED VIROL, V83, P1522, DOI 10.1002/jmv.22138
   WHITTLE H, 1990, J INFECT DIS, V161, P1112
   WHITTLE HC, 1983, LANCET, V1, P1203
   World Health Organization, 2014, CALL ACT SCAL GLOB H
NR 33
TC 19
Z9 19
U1 2
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD APR
PY 2015
VL 53
IS 4
BP 1156
EP 1163
DI 10.1128/JCM.02980-14
PG 8
WC Microbiology
SC Microbiology
GA CD8QA
UT WOS:000351359500016
PM 25631805
OA No
DA 2017-08-15
ER

PT J
AU Scott, S
   van der Sande, M
   Faye-Joof, T
   Mendy, M
   Sanneh, B
   Jallow, FB
   de Melker, H
   van der Klis, F
   van Gageldonk, P
   Mooi, F
   Kampmann, B
AF Scott, Susana
   van der Sande, Marianne
   Faye-Joof, Tisbeh
   Mendy, Maimuna
   Sanneh, Bakary
   Jallow, Fatou Barry
   de Melker, Hester
   van der Klis, Fiona
   van Gageldonk, Pieter
   Mooi, Frits
   Kampmann, Beate
TI Seroprevalence of Pertussis in The Gambia Evidence for Continued
   Circulation of Bordetella pertussis Despite High Vaccination Rates
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE pertussis; whooping cough; seroprevalence; sub-Saharan Africa; vaccine
ID WHOLE-CELL; IGG ANTIBODIES; INFECTION; DISEASE; EPIDEMIOLOGY; INFANTS;
   TOXIN; AGE; SPECIFICITY; SENSITIVITY
AB Background: Bordetella pertussis can cause severe respiratory disease and death in children. In recent years, large outbreaks have occurred in high-income countries; however, little is known about pertussis incidence in sub-Saharan Africa.
   Methods: We evaluated antibody responses to pertussis toxin (Ptx) from individuals aged between 2 and 90 years in rural Gambia. IgG-Ptx was measured using luminex xMAP technology. IgG-Ptx geometric mean concentrations (GMC) and their 95% confidence intervals were calculated. The proportion seropositive (>20 EU/mL or >= 62.5 EU/mL) and GMCs were compared by age, sex, ethnic group, vaccination status, birth order and number of siblings per household using logistic and linear regression.
   Results: 76.3% had anti-Ptx levels <20 EU/mL, 17.5% had concentrations between 20 and 62.5 EU/mL, 4.4% had concentrations between 62.5 and 125 EU/mL and 1.8% had concentrations >= 125 EU/mL. The overall Ptx antibody GMC was 6.4 EU/mL (95% confidence interval: 5.8-6.9). Higher antibody concentrations were observed in older populations with evidence for an increase in infection risk with increasing age (1.9% yearly increase, 95% confidence interval: 1.3-2.5). No child under 6 years of age had GMC above 62.5 EU/mL but 29.5% had concentrations between 20 and 62.5 EU/mL.
   Conclusions: These data provide evidence that B. pertussis is being transmitted within this population despite high vaccination coverage. Re-infection may occur implying that immunity from childhood vaccination may not be lifelong. In the absence of data on actual clinical cases of pertussis, seroprevalence studies remain valuable tools to assess the transmission dynamics of B. pertussis.
C1 [Scott, Susana; Faye-Joof, Tisbeh; Sanneh, Bakary; Jallow, Fatou Barry; Kampmann, Beate] Med Res Council MRC Unit, Fajara, Gambia.
   [Scott, Susana] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   [van der Sande, Marianne; de Melker, Hester; van der Klis, Fiona; van Gageldonk, Pieter; Mooi, Frits] Ctr Infect Dis Control CIb, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.
   [van der Sande, Marianne] Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Mendy, Maimuna] Int Agcy Res Canc, F-69372 Lyon, France.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England.
RP Scott, S (reprint author), MRC, Dis Control Eliminat Theme, POB 273, Banjul, Gambia.
EM sscott@mrc.gm
OI Kampmann, Beate/0000-0002-6546-4709
FU UK Medical Research Council/Dutch Centre for Infectious Disease Control
FX The study was funded by UK Medical Research Council/Dutch Centre for
   Infectious Disease Control.
CR Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77
   de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281
   de Greeff SC, 2012, CLIN VACCINE IMMUNOL, V19, P1452, DOI 10.1128/CVI.00229-12
   de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183
   de Melker HE, 2000, J CLIN MICROBIOL, V38, P800
   European Centre for Disease Prevention and Control, 2014, EXT QUAL ASS SCH BOR
   Gaayeb L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048684
   Galanis E, 2006, CAN MED ASSOC J, V174, P451, DOI 10.1503/cmaj.050379
   Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x
   Hallander HO, 2005, VACCINE, V23, P5359, DOI 10.1016/j.vaccine.2005.06.009
   Higgins SC, 2006, J IMMUNOL, V177, P7980
   Jusot V, 2014, J TROP PEDIATRICS, V60, P223, DOI 10.1093/tropej/fmu001
   Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee
   Liko J, 2013, NEW ENGL J MED, V368, P581, DOI 10.1056/NEJMc1212006
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Mahon BP, 2000, J INFECT DIS, V181, P2087, DOI 10.1086/315527
   Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029
   Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071
   Preziosi MP, 2002, AM J EPIDEMIOL, V155, P891, DOI 10.1093/aje/155.10.891
   Scott S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107280
   Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364
   Simondon F, 1997, VACCINE, V15, P1606, DOI 10.1016/S0264-410X(97)00100-X
   Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968
   van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018
   Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833
   Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110
   Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010
   [Anonymous], 2010, WKLY EPIDEMIOL REC, V40, P385
NR 30
TC 12
Z9 12
U1 3
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD APR
PY 2015
VL 34
IS 4
BP 333
EP 338
DI 10.1097/INF.0000000000000576
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA CD3UN
UT WOS:000351007900004
PM 25764094
OA No
DA 2017-08-15
ER

PT J
AU Mwangome, MK
   Fegan, G
   Prentice, AM
   Berkley, JA
AF Mwangome, Martha K.
   Fegan, Gregory
   Prentice, Andrew M.
   Berkley, James A.
TI Maternal perception of malnutrition among infants using verbal and
   pictorial methods in Kenya
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Mothers; Undernutrition; Mid-upper arm circumference; Weight-for-age;
   Infants
ID LINEAR GROWTH-RETARDATION; WEIGHT STATUS; CHILD UNDERNUTRITION;
   PRESCHOOL-CHILDREN; BLOOD-PRESSURE; OVERWEIGHT; MOTHERS; HEALTH;
   PREDICTORS; COUNTRIES
AB Objective: To compare mothers' perceptions of their own infants' nutritional status with anthropometric indicators of undernutrition.
   Design: A qualitative study and cross-sectional quantitative survey. The qualitative study involved developing tools to assess mother's perception. Two methods of verbal description and a pictorial scale were developed. The quantitative survey involved measuring maternal perception and comparing it with the anthropometric measures of weight-for-age Z-score (WAZ) and mid-upper arm circumference-for-age Z-score (MUACZ).
   Setting: A rural community setting in Kenya.
   Subjects: Seventy-four infants aged between 4 and 6 months, and their mothers, living in rural Kenya were enrolled.
   Results: Using verbal description, the positive and negative likelihood ratios were 3.57 (95 % CI 1.44, 9.98) and 0.69 (95% CI 0.50, 0.96) respectively for MUACZ < -2; and 4.60 (95% CI 1.60, 13.3) and 0.67 (95% CI 0.49, 0.92) respectively for WAZ < -2. Using the pictorial scale, the positive and negative likelihood ratios were 8.30 (95% CI 1.91, 36.3) and 0.69 (95% CI 0.52, 0.93) respectively for MUACZ < -2; and 4.31 (95% CI 1.22, 15.0) and 0.78 (95% CI 0.61, 1.00) respectively for WAZ < -2.
   Conclusions: In a rural community, mothers better identify undernutrition in their infants using a pictorial scale than verbal description. However, neither can replace formal anthropometric assessment. Objective anthropometric tools should be validated for identification of severe acute malnutrition among infants aged less than 6 months.
C1 [Mwangome, Martha K.; Fegan, Gregory; Berkley, James A.] KEMRI Wellcome Trust Res Programme, Kilifi 80108, Kenya.
   [Mwangome, Martha K.; Prentice, Andrew M.] Univ London, London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England.
   [Fegan, Gregory; Berkley, James A.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England.
   [Prentice, Andrew M.] MRC Keneba, Med Res Council Labs, Serekunda, Gambia.
RP Mwangome, MK (reprint author), KEMRI Wellcome Trust Res Programme, POB 230, Kilifi 80108, Kenya.
EM mmwangome@kemri-wellcome.org
OI Berkley, James/0000-0002-1236-849X; Fegan, Greg/0000-0002-2663-2765
FU KEMRI through the Wellcome Trust [084538, 083576]
FX This work was supported by KEMRI through the strategic award (084538)
   and personal fellowship (083576) from the Wellcome Trust and is
   published with the permission of the Director, KEMRI.
CR Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x
   Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105
   Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380
   Bejon P, 2008, AM J CLIN NUTR, V88, P1626, DOI 10.3945/ajcn.2008.26510
   Bernal H, 1997, NURS RES, V46, P179, DOI 10.1097/00006199-199705000-00009
   BERTRAND WE, 1983, INT J EPIDEMIOL, V12, P205, DOI 10.1093/ije/12.2.205
   Black R, 2008, LANCET, V317, P243, DOI DOI 10.1016/S0140-6736(07)61690-0
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Briend A, 2011, MATERN CHILD NUTR, V8, P130
   Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910
   Gaskin PS, 2000, EUR J CLIN NUTR, V54, P563, DOI 10.1038/sj.ejcn.1601057
   Genovesi S, 2005, ACTA PAEDIATR, V94, P747, DOI 10.1080/08035250510028894
   Grantham-McGregor S, 2005, PUBLIC HEALTH NUTR, V8, P1191, DOI 10.1079/PHN2005805
   Hackie M, 2007, PUBLIC HEALTH NURS, V24, P538, DOI 10.1111/j.1525-1446.2007.00666.x
   He M, 2007, CAN FAM PHYSICIAN, V53, P1493
   Hirschler V, 2006, PEDIATR DIABETES, V7, P201, DOI 10.1111/j.1399-5448.2006.00183.x
   Houts PS, 2006, PATIENT EDUC COUNS, V64, P393, DOI 10.1016/j.pec.2006.06.023
   Jeffery AN, 2005, BRIT MED J, V330, P23, DOI 10.1136/bmj.38315.451539.F7
   Kenya National Bureau of Statistics & ICF MACRO, 2009, KENY DEM HLTH SURV 2
   Kerac M, 2011, ARCH DIS CHILD, V96, P1008, DOI 10.1136/adc.2010.191882
   Mamun AA, 2008, INT J OBESITY, V32, P48, DOI 10.1038/sj.ijo.0803757
   Manios Y, 2009, PUBLIC HEALTH NUTR, V12, P1099, DOI 10.1017/S1368980008004412
   Maynard LM, 2003, PEDIATRICS, V111, P1226
   McOyoo EO, 2010, HLTH NUTR LIV SURV G
   Mwangome MK, 2012, B WORLD HEALTH ORGAN, V90, P887, DOI 10.2471/BLT.12.109009
   Mwangome MK, 2012, TROP MED INT HEALTH, V7, P622
   Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9
   ROY SK, 1993, HEALTH POLICY PLANN, V8, P143, DOI 10.1093/heapol/8.2.143
   United Nations, 1986, SUMM PROC WEIGH MEAS
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
   Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   Walker SP, 2001, J EPIDEMIOL COMMUN H, V55, P394, DOI 10.1136/jech.55.6.394
   WHO, 2006, WHO CHILD GROWTH STA
   Zonana-Nacach A, 2010, GAC MED MEX, V146, P165
NR 35
TC 3
Z9 3
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD APR
PY 2015
VL 18
IS 5
BP 869
EP 876
DI 10.1017/S1368980014001074
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA CC4EP
UT WOS:000350303900013
PM 24866925
OA No
DA 2017-08-15
ER

PT J
AU Adjuik, MA
   Allan, R
   Anvikar, AR
   Ashley, EA
   Ba, MS
   Barennes, H
   Barnes, KI
   Bassat, Q
   Baudin, E
   Bjoorkman, A
   Bompart, F
   Bonnet, M
   Borrmann, S
   Brasseur, P
   Bukirwa, H
   Checchi, F
   Cot, M
   Dahal, P
   D'Alessandro, U
   Deloron, P
   Desai, M
   Diap, G
   Djimde, AA
   Dorsey, G
   Doumbo, OK
   Espiee, E
   Etard, JF
   Fanello, CI
   Faucher, JF
   Faye, B
   Flegg, JA
   Gaye, O
   Gething, PW
   Gonzalez, R
   Grandesso, F
   Guerin, PJ
   Guthmann, JP
   Hamour, S
   Hasugian, AR
   Hay, SI
   Humphreys, GS
   Jullien, V
   Juma, E
   Kamya, MR
   Karema, C
   Kiechel, JR
   Kremsner, PG
   Krishna, S
   Lameyre, V
   Ibrahim, LM
   Lee, SJ
   Lell, B
   Martensson, A
   Massougbodji, A
   Menan, H
   Menard, D
   Menendez, C
   Meremikwu, M
   Moreira, C
   Nabasumba, C
   Nambozi, M
   Ndiaye, JL
   Nikiema, F
   Nsanzabana, C
   Ntoumi, F
   Ogutu, BR
   Olliaro, P
   Osorio, L
   Ouedraogo, JB
   Penali, LK
   Pene, M
   Pinoges, L
   Piola, P
   Price, RN
   Roper, C
   Rosenthal, PJ
   Rwagacondo, CE
   Same-Ekobo, A
   Schramm, B
   Seck, A
   Sharma, B
   Sibley, CH
   Sinou, V
   Sirima, SB
   Smith, JJ
   Smithuis, F
   Some, FA
   Sow, D
   Staedke, SG
   Stepniewska, K
   Swarthout, TD
   Sylla, K
   Talisuna, AO
   Tarning, J
   Taylor, WRJ
   Temu, EA
   Thwing, JI
   Tjitra, E
   Tine, RCK
   Tinto, H
   Vaillant, MT
   Valecha, N
   Van den Broek, I
   White, NJ
   Yeka, A
   Zongo, I
AF Adjuik, Martin A.
   Allan, Richard
   Anvikar, Anupkumar R.
   Ashley, Elizabeth A.
   Ba, Mamadou S.
   Barennes, Hubert
   Barnes, Karen I.
   Bassat, Quique
   Baudin, Elisabeth
   Bjorkman, Anders
   Bompart, Francois
   Bonnet, Maryline
   Borrmann, Steffen
   Brasseur, Philippe
   Bukirwa, Hasifa
   Checchi, Francesco
   Cot, Michel
   Dahal, Prabin
   D'Alessandro, Umberto
   Deloron, Philippe
   Desai, Meghna
   Diap, Graciela
   Djimde, Abdoulaye A.
   Dorsey, Grant
   Doumbo, Ogobara K.
   Espie, Emmanuelle
   Etard, Jean-Francois
   Fanello, Caterina I.
   Faucher, Jean-Francois
   Faye, Babacar
   Flegg, Jennifer A.
   Gaye, Oumar
   Gething, Peter W.
   Gonzalez, Raquel
   Grandesso, Francesco
   Guerin, Philippe J.
   Guthmann, Jean-Paul
   Hamour, Sally
   Hasugian, Armedy Ronny
   Hay, Simon I.
   Humphreys, Georgina S.
   Jullien, Vincent
   Juma, Elizabeth
   Kamya, Moses R.
   Karema, Corine
   Kiechel, Jean R.
   Kremsner, Peter G.
   Krishna, Sanjeev
   Lameyre, Valerie
   Ibrahim, Laminou M.
   Lee, Sue J.
   Lell, Bertrand
   Martensson, Andreas
   Massougbodji, Achille
   Menan, Herve
   Menard, Didier
   Menendez, Clara
   Meremikwu, Martin
   Moreira, Clarissa
   Nabasumba, Carolyn
   Nambozi, Michael
   Ndiaye, Jean-Louis
   Nikiema, Frederic
   Nsanzabana, Christian
   Ntoumi, Francine
   Ogutu, Bernhards R.
   Olliaro, Piero
   Osorio, Lyda
   Ouedraogo, Jean-Bosco
   Penali, Louis K.
   Pene, Mbaye
   Pinoges, Loretxu
   Piola, Patrice
   Price, Ric N.
   Roper, Cally
   Rosenthal, Philip J.
   Rwagacondo, Claude Emile
   Same-Ekobo, Albert
   Schramm, Birgit
   Seck, Amadou
   Sharma, Bhawna
   Sibley, Carol Hopkins
   Sinou, Veronique
   Sirima, Sodiomon B.
   Smith, Jeffery J.
   Smithuis, Frank
   Some, Fabrice A.
   Sow, Doudou
   Staedke, Sarah G.
   Stepniewska, Kasia
   Swarthout, Todd D.
   Sylla, Khadime
   Talisuna, Ambrose O.
   Tarning, Joel
   Taylor, Walter R. J.
   Temu, Emmanuel A.
   Thwing, Julie I.
   Tjitra, Emiliana
   Tine, Roger C. K.
   Tinto, Halidou
   Vaillant, Michel T.
   Valecha, Neena
   Van den Broek, Ingrid
   White, Nicholas J.
   Yeka, Adoke
   Zongo, Issaka
CA WorldWide Antimalarial Resistance
TI The effect of dosing strategies on the therapeutic efficacy of
   artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of
   individual patient data
SO BMC Medicine
LA English
DT Article
DE Malaria; Plasmodium falciparum; Drug resistance; Artesunate;
   Amodiaquine; Dosing; Efficacy
ID PLASMODIUM-FALCIPARUM MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE;
   CHLOROQUINE-RESISTANCE TRANSPORTER; FIXED-DOSE COMBINATION;
   ARTEMISININ-BASED COMBINATIONS; ANTIMALARIAL-DRUG RESISTANCE;
   MULTICENTER CLINICAL-TRIALS; NON-INFERIORITY TRIAL;
   ARTEMETHER-LUMEFANTRINE; IN-VIVO
AB Background: Artesunate-amodiaquine (AS-AQ) is one of the most widely used artemisinin-based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria in Africa. We investigated the impact of different dosing strategies on the efficacy of this combination for the treatment of falciparum malaria.
   Methods: Individual patient data from AS-AQ clinical trials were pooled using the WorldWide Antimalarial Resistance Network (WWARN) standardised methodology. Risk factors for treatment failure were identified using a Cox regression model with shared frailty across study sites.
   Results: Forty-three studies representing 9,106 treatments from 1999-2012 were included in the analysis; 4,138 (45.4%) treatments were with a fixed dose combination with an AQ target dose of 30 mg/kg (FDC), 1,293 (14.2%) with a non-fixed dose combination with an AQ target dose of 25 mg/kg (loose NFDC-25), 2,418 (26.6%) with a non-fixed dose combination with an AQ target dose of 30 mg/kg (loose NFDC-30), and the remaining 1,257 (13.8%) with a co-blistered non-fixed dose combination with an AQ target dose of 30 mg/kg (co-blistered NFDC). The median dose of AQ administered was 32.1 mg/kg [IQR: 25.9-38.2], the highest dose being administered to patients treated with co-blistered NFDC (median = 35.3 mg/kg [IQR: 30.6-43.7]) and the lowest to those treated with loose NFDC-25 (median = 25.0 mg/kg [IQR: 22.7-25.0]). Patients treated with FDC received a median dose of 32.4 mg/kg [IQR: 27-39.0]. After adjusting for reinfections, the corrected antimalarial efficacy on day 28 after treatment was similar for co-blistered NFDC (97.9% [95% confidence interval (CI): 97.0-98.8%]) and FDC (98.1% [95% CI: 97.6%-98.5%]; P = 0.799), but significantly lower for the loose NFDC-25 (93.4% [95% CI: 91.9%-94.9%]), and loose NFDC-30 (95.0% [95% CI: 94.1%-95.9%]) (P < 0.001 for all comparisons). After controlling for age, AQ dose, baseline parasitemia and region; treatment with loose NFDC-25 was associated with a 3.5-fold greater risk of recrudescence by day 28 (adjusted hazard ratio, AHR = 3.51 [95% CI: 2.02-6.12], P < 0.001) compared to FDC, and treatment with loose NFDC-30 was associated with a higher risk of recrudescence at only three sites.
   Conclusions: There was substantial variation in the total dose of amodiaquine administered in different AS-AQ combination regimens. Fixed dose AS-AQ combinations ensure optimal dosing and provide higher antimalarial treatment efficacy than the loose individual tablets in all age categories.
C1 [Adjuik, Martin A.] INDEPTH NETWORK Secretariat, Accra, Ghana.
   [Allan, Richard] MENTOR Initiat, Crawley, England.
   [Anvikar, Anupkumar R.; Valecha, Neena] Natl Inst Malaria Res, New Delhi, India.
   [Ashley, Elizabeth A.; Baudin, Elisabeth; Checchi, Francesco; Guthmann, Jean-Paul; Pinoges, Loretxu] Epictr, Paris, France.
   [Ba, Mamadou S.; Faye, Babacar; Ndiaye, Jean-Louis; Pene, Mbaye; Sow, Doudou; Tine, Roger C. K.] Univ Cheikh Anta Diop, Fac Med, Dept Parasitol, Dakar, Senegal.
   [Barennes, Hubert] Ctr Muraz, Unite Epidemiol Intervent, Bobo Dioulasso, Burkina Faso.
   [Barennes, Hubert] French Foreign Affairs, Biarritz, France.
   [Barnes, Karen I.; Yeka, Adoke] WWARN, Pharmacol Module, Cape Town, South Africa.
   [Barnes, Karen I.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.
   [Bassat, Quique; Gonzalez, Raquel; Menendez, Clara] Ctr Invest Saude Manhica, Manhica, Mozambique.
   [Bassat, Quique; Gonzalez, Raquel; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
   [Bjorkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
   [Bompart, Francois] Direct AccEs Med Access Med, Gentilly, France.
   [Bonnet, Maryline] Epictr, Geneva, Switzerland.
   [Borrmann, Steffen] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Borrmann, Steffen] German Ctr Infect Res, Tubingen, Germany.
   [Brasseur, Philippe] IRD, Dakar, Senegal.
   [Bukirwa, Hasifa; Yeka, Adoke] Uganda Malaria Surveillance Project, Kampala, Uganda.
   [Cot, Michel; Deloron, Philippe] IRD, Mother & Child Hlth Trop Res Unit, Paris, France.
   [Cot, Michel; Deloron, Philippe] Univ Paris 05, Sorbonne Paris Cite, PRES, Paris, France.
   [Dahal, Prabin; Flegg, Jennifer A.; Guerin, Philippe J.; Humphreys, Georgina S.; Moreira, Clarissa; Nsanzabana, Christian; Sibley, Carol Hopkins; Stepniewska, Kasia] WWARN, Oxford, England.
   [Dahal, Prabin; Fanello, Caterina I.; Guerin, Philippe J.; Humphreys, Georgina S.; Lee, Sue J.; Moreira, Clarissa; Nsanzabana, Christian; Olliaro, Piero; Price, Ric N.; Tarning, Joel; White, Nicholas J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Desai, Meghna; Thwing, Julie I.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.
   [Diap, Graciela; Kiechel, Jean R.] Drugs Neglected Dis initiat, Geneva, Switzerland.
   [Djimde, Abdoulaye A.] Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali.
   [Dorsey, Grant; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Espie, Emmanuelle] Inst Pasteur, Dakar, Senegal.
   [Etard, Jean-Francois] IRD, Montpellier, France.
   [Fanello, Caterina I.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok 10700, Thailand.
   [Faucher, Jean-Francois] Basancon Univ, Med Ctr, Dept Infect Dis, Besancon, France.
   [Flegg, Jennifer A.] Monash Univ, Sch Math Sci, Melbourne, Vic 3004, Australia.
   [Flegg, Jennifer A.] Monash Univ, Monash Acad Cross & Interdisciplinary Math Applic, Melbourne, Vic 3004, Australia.
   [Gething, Peter W.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England.
   [Hamour, Sally] Royal Free Hosp, UCL Ctr Nephrol, London NW3 2QG, England.
   [Hasugian, Armedy Ronny; Tjitra, Emiliana] Nat Inst Hlth Res & Dev, Minist Hlth, Jakarta, Indonesia.
   [Jullien, Vincent] Univ Paris 05, Assistance Publ Hop Paris, Paris, France.
   [Juma, Elizabeth] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya.
   [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda.
   [Karema, Corine] Minist Hlth, Malaria & Other Parasit Dis Div RBC, Kigali, Rwanda.
   [Kremsner, Peter G.; Lell, Bertrand] Ctr Rech Med Lambarene, Lambarene, Gabon.
   [Kremsner, Peter G.; Lell, Bertrand; Ntoumi, Francine] Univ Tubingen, Inst Tropenmed, Tubingen, Germany.
   [Krishna, Sanjeev] Univ London, Inst Infect & Immun St Georges, London, England.
   [Ibrahim, Laminou M.] Ctr Rech Med & Sanitaire, Niamey, Niger.
   [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, S-75105 Uppsala, Sweden.
   [Massougbodji, Achille] Univ Abomey Calavi, FSS, CERPAGE, Cotonou, Benin.
   [Menan, Herve] Univ Cocody, Fac Pharm, Dept Parasitol, Abidjan, Cote Ivoire.
   [Menard, Didier] Inst Pasteur Cambodge, Unite Epidemiol Mol Paludisme, Phnom Penh, Cambodia.
   [Meremikwu, Martin] Univ Calabar, Dept Paediat, Calabar, Nigeria.
   [Meremikwu, Martin] Inst Trop Dis Res & Prevent, Calabar, Nigeria.
   [Nabasumba, Carolyn] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda.
   [Nambozi, Michael] Trop Dis Res Ctr, Ndola, Zambia.
   [Nikiema, Frederic; Ouedraogo, Jean-Bosco; Tinto, Halidou; Zongo, Issaka] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.
   [Ntoumi, Francine] Univ Marien Ngouabi, Fac Sci Sante, FCRM, Brazzaville, Congo.
   [Ogutu, Bernhards R.] Kenya Govt Med Res Ctr, United States Army Med Res Unit, Kisumu, Kenya.
   [Olliaro, Piero; Taylor, Walter R. J.] UNDP, UNICEF, World Bank WHO Special Programme, Res & Training Trop Dis TDR, Geneva, Switzerland.
   [Osorio, Lyda] Int Ctr Med Res & Training CIDEIM, Cali, Colombia.
   [Ouedraogo, Jean-Bosco; Tinto, Halidou] Ctr Muraz, Bobo Dioulasso, Burkina Faso.
   [Penali, Louis K.; Seck, Amadou] WWARN, West Africa Reg Ctr, Dakar, Senegal.
   [Piola, Patrice] Inst Pasteur Madagascar, Antananarivo, Madagascar.
   [Price, Ric N.] Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia.
   [Roper, Cally] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1, England.
   [Rwagacondo, Claude Emile] UNICEF WCARO, RBM Focal Point, Dakar, Senegal.
   [Same-Ekobo, Albert] Univ Yaounde, Ctr Hosp, Yaounde, Cameroon.
   [Sharma, Bhawna] Drugs Neglected Dis initiat, New Delhi, India.
   [Sibley, Carol Hopkins] Univ Washington, Dept Gen Sci, Seattle, WA 98195 USA.
   [Sinou, Veronique] Aix Marseille Univ, Fac Pharm, UMR MD3, Marseille, France.
   [Sirima, Sodiomon B.] CNRFP, Ouagadougou, Burkina Faso.
   [Smith, Jeffery J.; Tarning, Joel] WWARN, Asia Reg Ctr, Bangkok, Thailand.
   [Smith, Jeffery J.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Smithuis, Frank] Med Sans Frontieres Holland, Yangon, Myanmar.
   [Smithuis, Frank] Med Act Myanmar, Yangon, Myanmar.
   [Staedke, Sarah G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England.
   [Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda.
   [Swarthout, Todd D.] Med Sans Frontieres, London, England.
   [Talisuna, Ambrose O.] WWARN, East Africa Reg Ctr, Nairobi, Kenya.
   [Talisuna, Ambrose O.] Univ Oxford, KEMRI, Wellcome Trust Res Programme, Nairobi, Kenya.
   [Taylor, Walter R. J.] Hop Univ Geneva, Serv Med Int & Humanitaire, Geneva, Switzerland.
   [Temu, Emmanuel A.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Temu, Emmanuel A.] Univ Basel, Basel, Switzerland.
   [Vaillant, Michel T.] CRP Sante, Ctr Hlth Studies, Methodol & Stat Unit, Luxembourg, Luxembourg.
   [Vaillant, Michel T.] Univ Victor Segalen Bordeaux 2, Bases Therapeut Inflammat & Infect, Unite 3677, Bordeaux, France.
   [Van den Broek, Ingrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.
   [Yeka, Adoke] Makerere Univ, Sch Publ Hlth, Kampala, Uganda.
RP Guerin, PJ (reprint author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
EM philippe.guerin@wwarn.org; christian.nsanzabana@wwarn.org
RI ; Roper, Cally/K-2989-2013; Hay, Simon/F-8967-2015; Gonzalez,
   Raquel/J-3604-2017
OI Osorio, Lyda/0000-0002-5121-4741; DELORON, Philippe/0000-0003-4705-2484;
   Cot, Michel/0000-0003-3014-4294; Roper, Cally/0000-0002-6545-309X; Hay,
   Simon/0000-0002-0611-7272; Price, Richard/0000-0003-2000-2874; Gething,
   Peter/0000-0001-6759-5449; Guerin, Philippe/0000-0002-6008-2963;
   Humphreys, Georgina/0000-0001-9947-0034; Menard,
   Didier/0000-0003-1357-4495; Gonzalez, Raquel/0000-0001-5487-801X; Flegg,
   Jennifer/0000-0002-8809-726X; Dahal, Prabin/0000-0002-2158-846X;
   Krishna, Sanjeev/0000-0003-0066-0634; Bassat, Quique/0000-0003-0875-7596
FU Bill and Melinda Gates Foundation
FX WWARN is funded by a Bill and Melinda Gates Foundation grant. The funder
   did not participate in the study protocol development and the writing of
   the paper.
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4
   Alifrangis M, 2006, J INFECT DIS, V193, P1738, DOI 10.1086/504269
   Anvikar AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-97
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Barennes H, 2004, TROP MED INT HEALTH, V9, P438, DOI 10.1111/j.1365-3156.2004.01224.x
   Beshir K, 2010, ANTIMICROB AGENTS CH, V54, P3714, DOI 10.1128/AAC.00358-10
   Bonnet M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-54
   Bonnet M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-192
   Brasseur P, 2009, TROP MED INT HEALTH, V14, P79, DOI 10.1111/j.1365-3156.2008.02190.x
   Bukirwa H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004966.pub2
   Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007
   Connor J, 2004, B WORLD HEALTH ORGAN, V82, P935
   Danquah I, 2010, ACTA TROP, V114, P63, DOI 10.1016/j.actatropica.2009.12.008
   De la Hoz RF, 2012, REV SOC BRAS MED TRO, V45, P732
   Dittrich S, 2005, TROP MED INT HEALTH, V10, P1267, DOI 10.1111/j.1365-3156.2005.01514.x
   Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210
   Echeverry DF, 2007, AM J TROP MED HYG, V77, P1034
   Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002
   Elliott I, 2014, TROP MED INT HEALTH, V19, P754, DOI 10.1111/tmi.12309
   Espie E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-174
   Eyase FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064299
   Faucher JF, 2009, J INFECT DIS, V200, P57, DOI 10.1086/599378
   Faye B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-433
   Faye B, 2010, TROP MED INT HEALTH, V15, P608, DOI 10.1111/j.1365-3156.2010.02487.x
   Gasasira AF, 2008, CLIN INFECT DIS, V46, P985, DOI 10.1086/529192
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599
   Grandesso F, 2006, TROP MED INT HEALTH, V11, P1017, DOI 10.1111/j.1365-3156.2006.01655.x
   Guthmann JP, 2006, AM J TROP MED HYG, V75, P143
   Guthmann JP, 2005, T ROY SOC TROP MED H, V99, P485, DOI 10.1016/j.trstmh.2004.11.010
   Hamour S, 2005, T ROY SOC TROP MED H, V99, P548, DOI 10.1016/j.trstmh.2004.10.003
   Happi CT, 2006, AM J TROP MED HYG, V75, P155
   Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677
   HATTON CSR, 1986, LANCET, V1, P411
   Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005
   Jullien V, 2010, ANTIMICROB AGENTS CH, V54, P2611, DOI 10.1128/AAC.01496-09
   Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001
   Kayentao K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-5
   LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531
   Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460
   Menard D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-55
   Munda M, 2014, PHARM STAT, V13, P145, DOI 10.1002/pst.1612
   Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3
   Nacher M, 2004, T ROY SOC TROP MED H, V98, P322, DOI 10.1016/j.trstmh.2003.10.005
   Ndiaye JL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-125
   Ndiaye JLA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-237
   Ndounga M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-53
   Thanh NX, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-217
   Nsobya SL, 2007, ANTIMICROB AGENTS CH, V51, P3023, DOI 10.1128/AAC.00012.07
   Ochong EO, 2003, AM J TROP MED HYG, V69, P184
   Osorio L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-25
   Price R, 1998, T ROY SOC TROP MED H, V92, P207, DOI 10.1016/S0035-9203(98)90750-7
   Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349
   Rwagacondo CE, 2004, TROP MED INT HEALTH, V9, P1091, DOI 10.1111/j.1365-3156.2004.01316.x
   Sa JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-374
   Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106
   Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649
   Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-251
   Sinclair D, 2009, COCHRANE DB SYST REV, V3
   Sinou V, 2009, EUR J DRUG METAB PH, V34, P133
   Sirima SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-48
   Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0
   Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3
   Swarthout TD, 2006, TROP MED INT HEALTH, V11, P1503, DOI 10.1111/j.1365-3156.2006.01710.x
   Taylor WRJ, 2006, B WORLD HEALTH ORGAN, V84, P956
   Thanh NX, 2009, TROP MED INT HEALTH, V14, P504, DOI 10.1111/j.1365-3156.2009.02269.x
   Thwing JI, 2009, TROP MED INT HEALTH, V14, P294, DOI 10.1111/j.1365-3156.2009.02222.x
   van den Broek I, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-113
   White N, 1999, PHILOS T ROY SOC B, V354, P739, DOI 10.1098/rstb.1999.0426
   White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8
   WHO, 2014, WORLD MAL REP 2014, P242
   WWARN, 2012, WWARN STAT AN PLAN A
   WorldWide Antimalarial Resistance Network (WWARN), 2012, CLIN MOD DAT MAN STA
   WWARN AL Study Group TWARNA Dose Impact S Group, 2015, LANCET INFE IN PRESS
   Worldwide Antimalarial Resistance Network (WWARN) DP Study Group, 2013, PLOS MED, V10
   Yeka Adoke, 2005, PLoS Med, V2, pe190
   Zwang J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-203
NR 78
TC 3
Z9 3
U1 1
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD MAR 31
PY 2015
VL 13
AR 66
DI 10.1186/s12916-015-0301-z
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA CG8CY
UT WOS:000353536000001
OA gold
DA 2017-08-15
ER

PT J
AU Kimhofer, T
   Fye, H
   Taylor-Robinson, S
   Thursz, M
   Holmes, E
AF Kimhofer, T.
   Fye, H.
   Taylor-Robinson, S.
   Thursz, M.
   Holmes, E.
TI Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a
   comprehensive review
SO BRITISH JOURNAL OF CANCER
LA English
DT Review
ID GAS CHROMATOGRAPHY/MASS SPECTROMETRY; GAMMA-CARBOXY PROTHROMBIN; CHRONIC
   LIVER-DISEASES; HEPATITIS-C VIRUS; MASS-SPECTROMETRY; SERUM MARKERS;
   HUMAN PLASMA; FUCOSYLATED GLYCOPROTEINS; POTENTIAL BIOMARKER; TISSUE
   METABOLOMICS
AB Hepatocellular carcinoma (HCC) ranks third in overall global cancer-related mortality. Symptomatic presentation often means advanced disease where potentially curative treatment options become very limited. Numerous international guidelines propose the routine monitoring of those with the highest risk factors for the condition in order to diagnose potential tumourigenesis early. To aid this, the fields of metabonomic-and proteomic-based biomarker discovery have applied advanced tools to identify early changes in protein and metabolite expression in HCC patients vs controls. With robust validation, it is anticipated that from these candidates will rise a high-performance non-invasive test able to diagnose early HCC and related conditions. This review gathers the numerous markers proposed by studies using mass spectrometry and proton nuclear magnetic resonance spectroscopy and evaluates areas of consistency as well as discordance.
C1 [Kimhofer, T.; Holmes, E.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, London SW7 2AZ, England.
   [Fye, H.] Gambia Labs, MRC Unit UK, Fajara, Gambia.
   [Taylor-Robinson, S.; Thursz, M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Diabet Endocrinol & Metab, Liver Unit, London W2 1NY, England.
RP Fye, H (reprint author), Gambia Labs, MRC Unit UK, POB 273,Atlantic Blvd, Fajara, Gambia.
EM hfye@mrc.gm
CR Ahn YH, 2012, J PROTEOMICS, V75, P5507, DOI 10.1016/j.jprot.2012.06.027
   Ahn YH, 2012, ANALYST, V137, P691, DOI 10.1039/c1an15775b
   Ang IL, 2006, J PROTEOME RES, V5, P2691, DOI 10.1021/pr060109r
   Baniasadi H, 2013, ELECTROPHORESIS, V34, P2910, DOI 10.1002/elps.201300029
   Baptissart M, 2013, BIOCHIMIE, V95, P504, DOI 10.1016/j.biochi.2012.06.022
   Bellinghieri G, 2003, AM J KIDNEY DIS, V41, pS116, DOI 10.1053/ajkd.2003.50099
   Bertino G, 2011, MINERVA MED, V102, P363
   Bertino G, 2014, BIOMED RES INT, DOI 10.1155/2014/203693
   Bertino G, 2012, SEMIN ONCOL, V39, P410, DOI 10.1053/j.seminoncol.2012.05.001
   Bertino G, 2010, DRUG NEWS PERSPECT, V23, P498, DOI 10.1358/dnp.2010.23.8.1444236
   Bessa SSE, 2010, ARCH MED RES, V41, P541, DOI 10.1016/j.arcmed.2010.10.007
   Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350
   Biondi A, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S7
   Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010
   Bouatra S, 2013, PLOS ONE, V4, P8, DOI [DOI 10.1371/J0URNAL.P0NE.0073076, DOI 10.1371/JOURNAL.PONE.0073076]
   Boyle P, 2008, WORLD CANC REPORT 20
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Calabrese V, 2006, J NUTR BIOCHEM, V17, P73, DOI 10.1016/j.jnutbio.2005.03.027
   Cave MC, 2008, NUTR CLIN PRACT, V23, P16, DOI 10.1177/011542650802300116
   Chen F, 2011, ANAL BIOANAL CHEM, V401, P1899, DOI 10.1007/s00216-011-5245-3
   Chen J, 2009, ANAL CHIM ACTA, V650, P3, DOI 10.1016/j.aca.2009.03.039
   Chen SL, 2013, ELECTROPHORESIS, V34, P2848, DOI 10.1002/elps.201200629
   Chen SL, 2013, ANAL CHEM, V85, P8326, DOI 10.1021/ac4016787
   Chen T, 2011, MOL CELL PROTEOMICS, V10, pM110, DOI [DOI 10.1074/mcp.A110.004945, DOI 10.1074/MCP.A110.004945]
   Chen Y, 2012, METABOLOMICS, V8, P845, DOI 10.1007/s11306-011-0379-z
   Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x
   Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c
   De Leon M Ponz, 1978, GUT, V19, P32, DOI 10.1136/gut.19.1.32
   DODSON WL, 1989, J AM COLL NUTR, V8, P133
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer, 2012, J HEPATOL, V56, P908, DOI DOI 10.1016/J.JHEP.2011.12.001
   Feng JT, 2005, PROTEOMICS, V5, P4581, DOI 10.1002/pmic.200401309
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Flanagan JL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-30
   Fye HKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068381
   Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159
   Ganti S, 2012, INT J CANCER, V130, P2791, DOI 10.1002/ijc.26274
   Gao HC, 2009, CANCER SCI, V100, P782, DOI 10.1111/j.1349-7006.2009.01086.x
   Giannini EG, 2012, HEPATOLOGY, V56, P1371, DOI 10.1002/hep.25814
   He QY, 2008, J CELL BIOCHEM, V103, P740, DOI 10.1002/jcb.21443
   Heuberger W, 1998, EUR J CLIN PHARMACOL, V54, P503, DOI 10.1007/s002280050504
   Hoi PM, 2006, BRIT J PHARMACOL, V147, P560, DOI 10.1038/sj.bjp.0706643
   Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4
   Hsieh SY, 2011, J PROTEOME RES, V10, P4715, DOI 10.1021/pr200519q
   Huang Q, 2013, CANCER RES, V73, P4992, DOI 10.1158/0008-5472.CAN-13-0308
   Ishihara T, 2011, J PROTEOMICS, V74, P2159, DOI 10.1016/j.jprot.2011.06.010
   Kang XN, 2010, J CANCER RES CLIN, V136, P1151, DOI 10.1007/s00432-010-0762-6
   Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Krahenbuhl S, 1996, LIFE SCI, V59, P1579, DOI 10.1016/0024-3205(96)00343-8
   LARUSSO NF, 1978, AM J DIG DIS, V23, P385, DOI 10.1007/BF01072919
   Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141
   Lee IN, 2006, PROTEOMICS, V6, P2865, DOI 10.1002/pmic.200500488
   Lee JY, 2011, MOL CELL PROTEOMICS, V10
   Linkous AG, 2010, J NATL CANCER I, V102, P1398, DOI 10.1093/jnci/djq290
   Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933
   Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047
   Lu Y, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-115
   Malaguarnera Giulia, 2014, Hepatobiliary Surg Nutr, V3, P407, DOI 10.3978/j.issn.2304-3881.2014.07.04
   Malaguarnera M, 2012, CURR OPIN GASTROEN, V28, P166, DOI 10.1097/MOG.0b013e3283505a3b
   Martinez-Gonzalez D, 2004, NEUROSCI LETT, V364, P1, DOI 10.1016/j.neulet.2004.03.080
   Masuzaki R, 2012, SEMIN ONCOL, V39, P434, DOI 10.1053/j.seminoncol.2012.05.009
   Matos JM, 2009, J SURG RES, V155, P237, DOI 10.1016/j.jss.2008.06.008
   Mederacke I, 2012, PROMOTION HEPATOCELL
   Michitaka K, 2010, HEPATOL RES, V40, P393, DOI 10.1111/j.1872-034X.2009.00614.x
   Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020
   Morita Y, 2013, J HEPATOL, V59, P292, DOI 10.1016/j.jhep.2013.02.030
   Na K, 2009, PROTEOMICS, V9, P3989, DOI 10.1002/pmic.200900105
   Nahon P, 2012, CLIN CANCER RES, V18, P6714, DOI 10.1158/1078-0432.CCR-12-1099
   NEALE G, 1971, GUT, V12, P145, DOI 10.1136/gut.12.2.145
   Nesvizhskii Alexey I, 2007, Methods Mol Biol, V367, P87
   Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010
   Paradis V, 2005, HEPATOLOGY, V41, P40, DOI 10.1002/hep.20505
   Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885
   Regimbeau Jean M, 2004, Liver Transpl, V10, pS69, DOI 10.1002/lt.20033
   Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013
   Saito Y, 2010, ONCOL REP, V23, P1325, DOI 10.3892/or_00000767
   Shang SF, 2012, HEPATOLOGY, V55, P483, DOI 10.1002/hep.24703
   Shariff MIF, 2011, J PROTEOME RES, V10, P1828, DOI 10.1021/pr101096f
   Shariff MIF, 2010, J PROTEOME RES, V9, P1096, DOI 10.1021/pr901058t
   Shen YF, 2004, ANAL CHEM, V76, P1134, DOI 10.1021/ac034869m
   Steel LF, 2003, PROTEOMICS, V3, P601, DOI 10.1002/pmic.200300399
   Sun S, 2010, J PROTEOME RES, V9, P1923, DOI 10.1021/pr901085z
   Sun YY, 2010, INT J MOL SCI, V11, P1423, DOI 10.3390/ijms11041423
   Sun YL, 2008, J PROTEOME RES, V7, P3847, DOI 10.1021/pr800153s
   Taylor LA, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-17
   Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619
   Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001
   Wang BH, 2012, J PROTEOME RES, V11, P1217, DOI 10.1021/pr2009252
   Ward DG, 2006, BRIT J CANCER, V95, P1379, DOI 10.1038/sj.bjc.6603429
   Wei Siwei, 2012, Metabolites, V2, P701, DOI 10.3390/metabo2040701
   Wu H, 2009, ANAL CHIM ACTA, V648, P98, DOI 10.1016/j.aca.2009.06.033
   Wu WY, 2012, J INVEST SURG, V25, P37, DOI 10.3109/08941939.2011.603816
   Xiao JF, 2012, J PROTEOME RES, V11, P5914, DOI 10.1021/pr300673x
   Xue RY, 2008, RAPID COMMUN MASS SP, V22, P3061, DOI 10.1002/rcm.3708
   Yang MH, 2007, ANAL BIOANAL CHEM, V388, P637, DOI 10.1007/s00216-007-1263-6
   Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h
   Yin PY, 2009, MOL BIOSYST, V5, P868, DOI 10.1039/b820224a
   Zhang AH, 2013, CLIN CHIM ACTA, V418, P86, DOI 10.1016/j.cca.2012.12.024
   Zhao Y, 2010, J PROTEOME RES, V9, P3319, DOI 10.1021/pr9011969
   Zhou LN, 2012, J PROTEOME RES, V11, P5433, DOI 10.1021/pr300683a
   Zhou LN, 2012, ANAL BIOANAL CHEM, V403, P203, DOI 10.1007/s00216-012-5782-4
NR 102
TC 20
Z9 22
U1 0
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0007-0920
EI 1532-1827
J9 BRIT J CANCER
JI Br. J. Cancer
PD MAR 31
PY 2015
VL 112
IS 7
BP 1141
EP 1156
DI 10.1038/bjc.2015.38
PG 16
WC Oncology
SC Oncology
GA CE9DZ
UT WOS:000352145300001
PM 25826224
OA No
DA 2017-08-15
ER

PT J
AU Tiono, AB
   Pinder, M
   N'Fale, S
   Faragher, B
   Smith, T
   Silkey, M
   Ranson, H
   Lindsay, SW
AF Tiono, Alfred B.
   Pinder, Margaret
   N'Fale, Sagnon
   Faragher, Brian
   Smith, Tom
   Silkey, Mariabeth
   Ranson, Hilary
   Lindsay, Steve W.
TI The AvecNet Trial to assess whether addition of pyriproxyfen, an insect
   juvenile hormone mimic, to long-lasting insecticidal mosquito nets
   provides additional protection against clinical malaria over current
   best practice in an area with pyrethroid-resistant vectors in rural
   Burkina Faso: study protocol for a randomised controlled trial
SO TRIALS
LA English
DT Article
DE Insecticide resistance management; Malaria control; Insecticide-treated
   bed net; Pyrethroid; Pyriproxyfen; Insect juvenile hormone mimic;
   Clinical malaria; Entomological inoculation rate; Cluster randomized
   controlled trial
ID ANOPHELES-GAMBIAE COMPLEX; TREATED BED NETS; WEST-AFRICA; UNTREATED
   BEDNETS; POTENTIAL USE; SAMPLE-SIZE; MORBIDITY; MORTALITY;
   IDENTIFICATION; CULICIDAE
AB Background: Recent reductions in malaria in sub-Saharan Africa have been associated with increased coverage with long-lasting insecticidal nets (LLINs). Pyrethroids are currently the only insecticide class used for treating nets, and the rapid increase in resistance to pyrethroids in vector mosquitoes may jeopardise future vector control. Nets containing a novel combination of permethrin, a pyrethroid, and pyriproxyfen, an insect juvenile hormone mimic, (PPF-LLIN) may enhance malaria control, as well as reducing the spread of pyrethroid-resistant mosquitoes. This trial will determine whether PPF-LLINs provide incremental protection against malaria over current best practice of LLINs and prompt treatment in an area with pyrethroid-resistant vectors.
   Methods: A 2 armed cluster-randomised controlled trial will be conducted in Burkina Faso to assess whether PPF-LLIN (containing 2% permethrin and 1% pyriproxyfen w/w) provide better protection against clinical malaria in children than 2% permethrin-treated LLINs. Study subjects will be recruited and provided with LLINs at the start of the study. The LLINs will be exchanged for PPF-LLIN by cluster in a step-wedge fashion so 3 months before the end of the 2 year trial all participants will have a PPF-LLIN. The primary endpoint will be clinical malaria incidence measured by passive case detection in a cohort of children, aged 6 months to 5 years. Anaemia and parasite prevalence will also be measured in children during cross-sectional surveys. Exposure to malaria parasites will be assessed using light traps followed by identification of common vector species and their sporozoite infection rates. Safety evaluation will include recording of adverse events and pregnancy outcomes. The main endpoint analysis will include adjusting for distance between village clusters with different types of nets, as the impact of PPF-LLIN is likely to increase as larger areas are dominated by PPF-LLIN, reducing the spill over of mosquitoes from villages with LLINs.
   Discussion: The step-wedge design is to measure the impact of an incrementally delivered environmental intervention where we expect the degree of control to be improved as more people use PPF-LLIN over a larger area. Trial findings will help inform policy makers on the effectiveness of PPF-LLIN nets for malaria control in areas of pyrethroid resistance.
C1 [Tiono, Alfred B.; N'Fale, Sagnon] CNRFP, Ouagadougou, Burkina Faso.
   [Pinder, Margaret; Lindsay, Steve W.] Univ Durham, Sch Biol Sci & Biomed, Durham, England.
   [Pinder, Margaret] Med Res Council Unit Gambia, Banjul, Gambia.
   [Faragher, Brian; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Smith, Tom; Silkey, Mariabeth] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
RP Lindsay, SW (reprint author), Univ Durham, Sch Biol Sci & Biomed, Durham, England.
EM S.W.Lindsay@durham.ac.uk
RI Smith, Thomas/B-5569-2015
OI Smith, Thomas/0000-0002-3650-9381
FU European Union [265660]
FX The study is supported by the European Union Seventh Framework Programme
   FP7/2007-2013 under grant agreement no 265660, AvecNet. We are grateful
   to Sumitomo Chemical who will donate the nets for this trial.
CR ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P13, DOI 10.1016/0035-9203(93)90170-U
   Bass C, 2007, MALARIA J, V6, pe111
   BAUDON D, 1985, T ROY SOC TROP MED H, V79, P283, DOI 10.1016/0035-9203(85)90361-X
   Brabin B, 1990, TROP DIS B, V87, P20
   BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173
   Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X
   COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0
   Dabire K, 2012, INSECT PEST ENG
   EDOZIEN JC, 1962, LANCET, V2, P951
   Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dy1129
   Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x
   Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144
   Hatakoshi M, 1987, PARASITE VECTOR, V38, P271
   Hawley WA, 2003, AM J TROP MED HYG, V68, P121
   Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319
   Itoh Takaaki, 1994, Tropical Medicine, V36, P243
   Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109
   Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x
   Konate AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023391
   Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127
   Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2
   LINDSAY SW, 1989, MED VET ENTOMOL, V3, P253, DOI 10.1111/j.1365-2915.1989.tb00225.x
   Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915
   Mbare M, 2014, PARASITE VECTOR, V7, P280
   McGREGOR I. A., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P170, DOI 10.1016/0035-9203(63)90058-0
   Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085
   Ngufor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083897
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006
   Pinder M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-147
   Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2
   SCOTT JA, 1993, AM J TROP MED HYG, V49, P520
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Smith PG, 1996, FIELD TRIALS HLTH IN
   SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206
   SNOW RW, 1988, T ROY SOC TROP MED H, V82, P212, DOI 10.1016/0035-9203(88)90414-2
   Snow RW, 1998, J INFECT DIS, V177, P819
   Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2006, PEST THEIR APPL CONT
   (WHO) World Health Organization, 2013, TEST PROC INS RES MO
   WIRTZ RA, 1989, B WORLD HEALTH ORGAN, V67, P535
   Yapabandara AMGM, 2002, ACTA TROP, V81, P211, DOI 10.1016/S0001-706X(01)00208-X
   Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x
NR 46
TC 4
Z9 4
U1 1
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD MAR 25
PY 2015
VL 16
AR 113
DI 10.1186/s13063-015-0606-4
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CE4TP
UT WOS:000351823400001
PM 25873089
OA gold
DA 2017-08-15
ER

PT J
AU Ekwochi, U
   Ndu, IK
   Osuorah, CDI
   Amadi, OF
   Okeke, IB
   Obuoha, E
   Onah, KS
   Nwokoye, I
   Odetunde, OI
   Obumneme-Anyim, NI
AF Ekwochi, Uchenna
   Ndu, Ikenna K.
   Osuorah, Chidiebere D. I.
   Amadi, Ogechukwu F.
   Okeke, Ifeyinwa B.
   Obuoha, Ejike
   Onah, Kenechi S.
   Nwokoye, Ikenna
   Odetunde, Odutola I.
   Obumneme-Anyim, Nnenne I.
TI Knowledge of danger signs in newborns and health seeking practices of
   mothers and care givers in Enugu state, South-East Nigeria
SO ITALIAN JOURNAL OF PEDIATRICS
LA English
DT Article
AB Background: According to UNICEF, 40% of all under-5 deaths occur within the first month of life and half of these within the first few days of life. Many of these deaths are related to late recognition of neonatal illness, delays in decision to seek care at household level and subsequent late intervention at healthcare facilities. Knowledge of mothers about the danger signs in newborn is imperative to reduce these delays and preventable deaths.
   Aim: This study aimed to assess the perception of mothers and/or care givers of danger signs in newborns and their knowledge of the WHO recognized danger. A secondary aim was to explore the socio-demographic factors of mothers that influence knowledge of the WHO recognized danger signs and the health seeking behaviors of these mothers and/or care-givers.
   Methods: This was a community based descriptive and analytical study which used a multistage sampling technique to select 376 mothers and/or care-givers from four communities in 4 of the 17 Local Government Areas (LGA) of Enugu State. Logistic regression and chi-square was used in testing associations between variables.
   Results: Knowledge of more than three of the nine WHO recognized danger sign was poor (0.0-30.3%). Majority of the mothers had knowledge of one (i.e. fever) WHO recognized danger sign (95.2%). Knowledge of the WHO signs was not significantly associated with maternal socio-demographic variables considered in this study. Healthcare seeking behaviour was significantly determined by knowledge of at least one WHO recognized danger sign (OR 4.6 CI 1.1-18.7, P = 0.032). Cough, diarrhea and the excessive crying were the most perceived and experienced non-WHO recognized dangers signs among respondents.
   Conclusion: There is urgent need to strengthen the teaching and training of expectant mothers across all maternal socio-demographic variables on these danger signs and the most appropriate measures to take when they occur.
C1 [Ekwochi, Uchenna; Ndu, Ikenna K.; Amadi, Ogechukwu F.; Okeke, Ifeyinwa B.; Obuoha, Ejike] Enugu State Univ Sci & Technol, Dept Paediat, Enugu, Enugu State, Nigeria.
   [Osuorah, Chidiebere D. I.] Med Res Council UK, Gambia Unit, Child Survival Unit, Fajara, Gambia.
   [Onah, Kenechi S.] Nnamdi Azikiwe Univ Teaching Hosp, Dept Paediat, Nnewi, Anambra State, Nigeria.
   [Nwokoye, Ikenna] Fed Teaching Hosp, Dept Paediat, Abakaliki, Ebonyi State, Nigeria.
   [Odetunde, Odutola I.; Obumneme-Anyim, Nnenne I.] Univ Nigeria Teaching Hosp, Dept Paediat, Ituku Ozara, Enugu State, Nigeria.
RP Osuorah, CDI (reprint author), Med Res Council UK, Gambia Unit, Child Survival Unit, Fajara, Gambia.
EM chidi.osuorah@yahoo.com
CR Awasthi S, 2006, B WORLD HEALTH ORGAN, V84, P819, DOI 10.2471/BLT.05.029207
   Baqui AH, 2003, TINAL REPORT FORMATI
   Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441
   Dongre AR, 2009, INDIAN J PEDIATR, V76, P691, DOI 10.1007/s12098-009-0106-1
   Dutta A, 2007, RECENT ADV DIAGNOSIS, P78
   Enugu State Government Official Website, AB EN
   Newborn Care, 2012, NNF TEACHING AIDS
   Nigerian Population Commission, 2010, STAT LOC GOV DEM PRO
   OYEDEJI G A, 1985, Nigerian Journal of Paediatrics, V12, P111
   Sandes J. M., 2014, PLOS ONE, V9, P1
   Shally A, 2006, B WORLD HEALTH ORGAN, V84, P819
   United Nation Children Fund (UNICEF), 2013, DAT MON SIT CHILDR W
   United Nations Children's Fund UNICEF, 2004, REG OFF S AS SURV CH, P11
   [Anonymous], 2012, UN INT GROUP REP 201
   Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x
   World Health Organization, 1999, CHILD HLTH RES PROJ
   UNICEF WHO, 2012, CAR NEWB HOM TRAIN C
NR 17
TC 2
Z9 2
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1720-8424
EI 1824-7288
J9 ITAL J PEDIATR
JI Ital. J. Pediatr.
PD MAR 21
PY 2015
VL 41
AR 18
DI 10.1186/s13052-015-0127-5
PG 7
WC Pediatrics
SC Pediatrics
GA CE3LE
UT WOS:000351727000001
PM 25888409
OA gold
DA 2017-08-15
ER

PT J
AU Zengin, A
   Prentice, A
   Ward, KA
AF Zengin, Ayse
   Prentice, Ann
   Ward, Kate Anna
TI Ethnic differences in bone health
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE ethnic groups; bone; muscle; pQCT; DXA; fracture; skeletal; bone mineral
   density
ID RURAL GAMBIAN WOMEN; SOUTH-ASIAN ORIGIN; REPUBLIC-OF-CHINA; MINERAL
   DENSITY; HIP FRACTURE; OLDER MEN; OSTEOPOROTIC FRACTURES;
   BODY-COMPOSITION; RACE/ETHNIC DIFFERENCES; POSTMENOPAUSAL WOMEN
AB There are differences in bone health between ethnic groups in both men and in women. Variations in body size and composition are likely to contribute to reported differences. Most studies report ethnic differences in areal bone mineral density (aBMD), which do not consistently parallel ethnic patterns in fracture rates. This suggests that other parameters beside aBMD should be considered when determining fracture risk between and within populations, including other aspects of bone strength: bone structure and microarchitecture, as well as muscle strength (mass, force generation, anatomy) and fat mass. We review what is known about differences in bone-densitometry-derived outcomes between ethnic groups and the extent to which they account for the differences in fracture risk. Studies are included that were published primarily between 1994 and 2014. A "one size fits all approach" should definitely not be used to understand better ethnic differences in fracture risk.
C1 [Zengin, Ayse; Prentice, Ann; Ward, Kate Anna] Med Res Council Human Nutr Res, Cambridge, England.
   [Prentice, Ann] MRC, Keneba, Gambia.
RP Ward, KA (reprint author), Med Res Council Human Nutr Res, Cambridge, England.; Ward, KA (reprint author), MRC Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.
EM kate.ward@mrc-hnr.cam.ac.uk
OI Zengin, Ayse/0000-0001-6428-6165
FU Medical Research Council (MRC) [0105960371, 0123261351]; Department for
   International Development (DFID)
FX This research is funded by the Medical Research Council (MRC) (program
   codes 0105960371, 0123261351) and the Department for International
   Development (DFID) under the MRC/DFID Concordat agreement.
CR Aspray TJ, 1996, J BONE MINER RES, V11, P1019
   ASPRAY TJ, 1995, BONE, V17, P261, DOI 10.1016/8756-3282(95)00216-Z
   Baker JF, 2013, BONE, V53, P34, DOI 10.1016/j.bone.2012.11.035
   Ballane G, 2014, J BONE MINER RES, V29, P1745, DOI 10.1002/jbmr.2218
   Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007
   Bouxsein ML, 2011, J BONE MINER RES, V26, P1389, DOI 10.1002/jbmr.442
   Cauley JA, 2014, NAT REV ENDOCRINOL, V10, P338, DOI 10.1038/nrendo.2014.51
   Chantler S, 2012, OSTEOPOROSIS INT, V23, P533, DOI 10.1007/s00198-011-1570-9
   Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013
   COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184
   Danielson ME, 2013, J BONE MINER RES, V28, P771, DOI 10.1002/jbmr.1781
   Darling AL, 2013, BONE, V55, P36, DOI 10.1016/j.bone.2013.03.006
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   Dibba B, 1999, ANN HUM BIOL, V26, P229
   Duboeuf F, 1997, J BONE MINER RES, V12, P1895, DOI 10.1359/jbmr.1997.12.11.1895
   Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3057, DOI 10.1210/jc.87.7.3057
   FROST HM, 1987, ANAT REC, V219, P1, DOI 10.1002/ar.1092190104
   Heo M, 2012, AM J CLIN NUTR, V95, P594, DOI 10.3945/ajcn.111.025171
   Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190
   Jeffrey M., 2012, 8 INT WORKSH MUSC NE
   Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3
   Khan UI, 2012, METABOLISM, V61, P1261, DOI 10.1016/j.metabol.2012.02.005
   Lau EMC, 2001, OSTEOPOROSIS INT, V12, P239, DOI 10.1007/s001980170135
   Liu XS, 2011, J BONE MINER RES, V26, P1783, DOI 10.1002/jbmr.378
   Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093
   Malan NT, 2013, CLIN EXP HYPERTENS, V35, P228, DOI 10.3109/10641963.2012.721839
   Marshall D, 1996, BRIT MED J, V312, P1254
   Marshall LM, 2008, J BONE MINER RES, V23, P121, DOI 10.1359/JBMR.070908
   MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785
   Mehta G, 2004, QJM-INT J MED, V97, P95, DOI 10.1093/qjmed/hch017
   Miljkovic I, 2009, J CLIN ENDOCR METAB, V94, P2735, DOI 10.1210/jc.2008-2541
   Nam HS, 2010, OSTEOPOROSIS INT, V21, P2115, DOI 10.1007/s00198-010-1188-3
   Nam HS, 2013, J BONE MINER METAB, V31, P190, DOI 10.1007/s00774-012-0402-0
   Nelson DA, 2011, OSTEOPOROSIS INT, V22, P1377, DOI 10.1007/s00198-010-1349-4
   Orimo H, 2007, ARCH OSTEOPOROS, V4, P71, DOI 10.1007/s11657-009-0031-y
   Premaor MO, 2010, J BONE MINER RES, V25, P292, DOI 10.1359/jbmr.091004
   PRENTICE A, 1991, BONE MINER, V12, P201, DOI 10.1016/0169-6009(91)90033-V
   Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590
   PRENTICE A, 1994, AM J CLIN NUTR, V60, P837
   Prentice A, 2012, BONE GROWTH AFRICAN
   Putman MS, 2013, J BONE MINER RES, V28, P2177, DOI 10.1002/jbmr.1953
   Pye S, 2013, BON RES SOC BRIT ORT
   Rittweger J, 2004, J AM GERIATR SOC, V52, P128, DOI 10.1111/j.1532-5415.2004.52022.x
   Roy D, 2005, OSTEOPOROSIS INT, V16, P1254, DOI 10.1007/s00198-005-1837-0
   Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221
   SCHNITZLER CM, 1990, BONE MINER, V10, P183, DOI 10.1016/0169-6009(90)90261-D
   Shin MH, 2014, OSTEOPOROSIS INT, V25, P837, DOI 10.1007/s00198-013-2503-6
   SOLOMON L, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P2
   Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343
   Tsang SWY, 2009, OSTEOPOROSIS INT, V20, P1939, DOI 10.1007/s00198-009-0906-1
   Walker MD, 2011, J BONE MINER RES, V26, P1392, DOI 10.1002/jbmr.352
   Wang Q, 2009, OSTEOPOROSIS INT, V20, P1151, DOI 10.1007/s00198-008-0768-y
   Ward K, 2010, OSTEOPOROSIS INT, V21, pS443, DOI [10.1007/s00198-010-1388-x, DOI 10.1007/S00198-010-1388-X]
   Ward KA, 2007, BONE, V41, P117, DOI 10.1016/j.bone.2007.03.013
   Ward K, 2012, P NUTR SOC, V71, P27, DOI 10.1017/S0029665111003375
   Yan L, 1999, BONE, V24, P151, DOI 10.1016/S8756-3282(98)00168-9
   Yan L, 2004, BONE, V34, P584, DOI 10.1016/j.bone.2003.12.005
   Zebaze RMD, 2003, OSTEOPOROSIS INT, V14, P301, DOI 10.1007/s00198-002-1356-1
NR 58
TC 5
Z9 5
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD MAR 17
PY 2015
VL 6
AR 24
DI 10.3389/fendo.2015.00024
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DP3OH
UT WOS:000378403900001
PM 25852642
OA gold
DA 2017-08-15
ER

PT J
AU Afolabi, MO
AF Afolabi, Muhammed O.
TI Situating the Trovan Trial With the Use of Experimental Ebola Therapies
   Is Like Comparing an Apple With an Orange
SO JOURNAL OF BIOETHICAL INQUIRY
LA English
DT Letter
C1 MRC Unit, Banjul, Gambia.
RP Afolabi, MO (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM mafolabi@mrc.gm
OI Afolabi, Muhammed/0000-0002-9967-6419
CR Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7
   Folayan M, 2014, LANCET, V384, P1843, DOI 10.1016/S0140-6736(14)61605-6
   Hossain MJ, 2013, EMERG INFECT DIS, V19, P1507, DOI [10.3201/eid1909.130077, 10.3204/eid1909.130077]
   Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166
   Lenzer J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5268
   Lenzer Jeanne, 2006, BMJ, V332, P1233, DOI 10.1136/bmj.332.7552.1233-a
   Maurice J, 2014, LANCET, V384, pE45, DOI 10.1016/S0140-6736(14)61411-2
   Omonzejele PF, 2014, J BIOETHIC INQ, V11, P417, DOI 10.1007/s11673-014-9587-3
   Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5
   WHO, 2014, POT EB THER VACC
NR 10
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1176-7529
EI 1872-4353
J9 J BIOETHIC INQ
JI J. Bioethical Inq.
PD MAR
PY 2015
VL 12
IS 1
BP 19
EP 20
DI 10.1007/s11673-015-9619-7
PG 2
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA CF9QF
UT WOS:000352899700005
PM 25652573
OA No
DA 2017-08-15
ER

PT J
AU Rebollo, MP
   Sambou, SM
   Thomas, B
   Biritwum, NK
   Jaye, MC
   Kelly-Hope, L
   Escalada, AG
   Molyneux, DH
   Bockarie, MJ
AF Rebollo, Maria P.
   Sambou, Sana Malang
   Thomas, Brent
   Biritwum, Nana-Kwadwo
   Jaye, Momodou C.
   Kelly-Hope, Louise
   Gonzalez Escalada, Alba
   Molyneux, David H.
   Bockarie, Moses J.
TI Elimination of Lymphatic Filariasis in The Gambia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ANOPHELES-TRANSMITTED FILARIASIS; WUCHERERIA-BANCROFTI INFECTION;
   FACTORS AFFECTING TRANSMISSION; LASTING INSECTICIDAL NETS; DEFINE
   END-POINTS; PAPUA-NEW-GUINEA; VECTOR CONTROL; WEST-AFRICA; MULTICENTER
   EVALUATION; MALARIA CONTROL
AB Background
   The prevalence of Wuchereria bancrofti, which causes lymphatic filariasis (LF) in The Gambia was among the highest in Africa in the 1950s. However, surveys conducted in 1975 and 1976 revealed a dramatic decline in LF endemicity in the absence of mass drug administration (MDA). The decline in prevalence was partly attributed to a significant reduction in mosquito density through the widespread use of insecticidal nets. Based on findings elsewhere that vector control alone can interrupt LF, we asked the question in 2013 whether the rapid scale up in the use of insecticidal nets in The Gambia had interrupted LF transmission.
   Methodology/Principal Finding
   We present here the results of three independently designed filariasis surveys conducted over a period of 17 years (1997-2013), and involving over 6000 subjects in 21 districts across all administrative divisions in The Gambia. An immunochromatographic (ICT) test was used to detectW. bancrofti antigen during all three surveys. In 2001, tests performed on stored samples collected between 1997 and 2000, in three divisions, failed to show positive individuals from two divisions that were previously highly endemic for LF, suggesting a decline towards extinction in some areas. Results of the second survey conducted in 2003 showed that LF was no longer endemic in 16 of 21 districts surveyed. The 2013 survey used a WHO recommended LF transmission verification tool involving 3180 6-7 year-olds attending 60 schools across the country. We demonstrated that transmission of W. bancrofti has been interrupted in all 21 districts.
   Conclusions
   We conclude that LF transmission may have been interrupted in The Gambia through the extensive use of insecticidal nets for malaria control for decades. The growing evidence for the impact of malaria vector control activities on parasite transmission has been endorsed by WHO through a position statement in 2011 on integrated vector management to control malaria and LF.
C1 [Rebollo, Maria P.; Thomas, Brent; Kelly-Hope, Louise; Molyneux, David H.; Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.
   [Sambou, Sana Malang; Jaye, Momodou C.] Minist Hlth & Social Welf, Banjul, Gambia.
   [Biritwum, Nana-Kwadwo] Ghana Hlth Serv, Accra, Ghana.
   [Gonzalez Escalada, Alba] Rey Juan Carlos Univ, Madrid, Spain.
RP Rebollo, MP (reprint author), Task Force Global Hlth, Neglected Trop Dis Support Ctr, Decatur, GA 30030 USA.
EM moses.bockarie@lstmed.ac.uk
FU Centre for Neglected Tropical Diseases, Liverpool School of Tropical
   Medicine through (PO) from the Department for International Development
   (DFID) [40021437]
FX This study was supported by the Centre for Neglected Tropical Diseases,
   Liverpool School of Tropical Medicine, through funding (PO# 40021437)
   from the Department for International Development (DFID) awarded to MJB.
   The funders of this study had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Amazigo U, 2008, ANN TROP MED PARASIT, V102, P19, DOI 10.1179/136485908X337436
   BAIN O, 1972, Annales de Parasitologie Humaine et Comparee, V47, P399
   BAIN O, 1971, Annales de Parasitologie Humaine et Comparee, V46, P613
   Barnish G, 1993, Parassitologia, V35 Suppl, P1
   Bockarie MJ, 2009, ANNU REV ENTOMOL, V54, P469, DOI 10.1146/annurev.ento.54.110807.090626
   Brengues J, 1978, Med Trop (Mars), V38, P691
   Brengues J, 1975, 79 ORSTOM
   BRYAN JH, 1988, T ROY SOC TROP MED H, V82, P128, DOI 10.1016/0035-9203(88)90286-6
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Chu BK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002584
   DALESSANDRO U, 1994, B WORLD HEALTH ORGAN, V72, P391
   de Souza DK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-259
   Eigege A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002508
   Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328
   Gambhir M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-22
   Gass K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001479
   GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q
   Hawking F, 1977, Trop Dis Bull, V74, P649
   HAWKING F, 1957, Bull World Health Organ, V16, P581
   Kelly-Hope LA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-39
   KNIGHT R, 1980, ANN TROP MED PARASIT, V74, P63
   Koroma JB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002273
   Koroma JB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-10
   Lindsay SW, 2000, T ROY SOC TROP MED H, V94, P37, DOI 10.1016/S0035-9203(00)90431-0
   Mc GI, 1952, T ROY SOC TROP MED H, V46, P403
   MCFADZEAN JA, 1954, T ROY SOC TROP MED H, V48, P267, DOI 10.1016/0035-9203(54)90075-9
   MCGREGOR IA, 1952, BRIT MED J, V2, P908
   MCGREGOR IA, 1956, BRIT MED J, V1, P331
   Michael E, 1997, PARASITOL TODAY, V13, P472, DOI 10.1016/S0169-4758(97)01151-4
   Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1
   Molyneux DH, 2004, TRENDS PARASITOL, V20, P347, DOI 10.1016/j.pt.2004.06.004
   Njenga SM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-90
   Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2
   Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x
   Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491
   Pichon G, 2002, ANN TROP MED PARASIT, V96, pS143, DOI 10.1179/000349802125002509
   PICHON G, 1974, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V12, P199
   Reimer LJ, 2013, NEW ENGL J MED, V369, P745, DOI 10.1056/NEJMoa1207594
   Richards FO, 2013, AM J TROP MED HYG, V89, P578, DOI 10.4269/ajtmh.12-0775
   Schuetz A, 2000, AM J TROP MED HYG, V62, P502
   Snow LC, 2006, MED VET ENTOMOL, V20, P261, DOI 10.1111/j.1365-2915.2006.00629.x
   SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U
   Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7
   Tisch DJ, 2008, AM J TROP MED HYG, V78, P289
   van den Berg H, 2013, LANCET INFECT DIS, V13, P89, DOI 10.1016/S1473-3099(12)70148-2
   WADA Y, 1995, TROP MED PARASITOL, V46, P27
   WEBBER R H, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P430
   WEBBER RH, 1991, J TROP MED HYG, V94, P241
   WEBBER RH, 1979, T ROY SOC TROP MED H, V73, P722, DOI 10.1016/0035-9203(79)90031-2
   WEBBER RH, 1977, T ROY SOC TROP MED H, V71, P396, DOI 10.1016/0035-9203(77)90037-2
   WHO, 2013, RELEVE EPIDEMIOLOGIQ, V88, P389
   WHO, 2010, RELEVE EPIDEMIOLOGIQ, V86, P377
   World Health Organization, 2012, WHOHTMNTD20121
   World Health Organization, 2000, WHOCDSCPECEE20009
   WHO, 2011, RELEVE EPIDEMIOLOGIQ, V86, P121
   WHO, 2011, WHOHTMNTDPCT20114
   WHO, 2010, WHOHTMNTDPCT20106
   [Anonymous], 2014, LANCET, V383, P1269
NR 58
TC 11
Z9 11
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2015
VL 9
IS 3
AR e0003642
DI 10.1371/journal.pntd.0003642
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CE9YK
UT WOS:000352199400095
PM 25785587
OA gold
DA 2017-08-15
ER

PT J
AU Jayasooriya, S
   de Silva, TI
   Njie-jobe, J
   Sanyang, C
   Leese, AM
   Bell, AI
   McAulay, KA
   Yanchun, P
   Long, HM
   Dong, T
   Whittle, HC
   Rickinson, AB
   Rowland-Jones, SL
   Hislop, AD
   Flanagan, KL
AF Jayasooriya, Shamanthi
   de Silva, Thushan I.
   Njie-jobe, Jainaba
   Sanyang, Chilel
   Leese, Alison M.
   Bell, Andrew I.
   McAulay, Karen A.
   Yanchun, Peng
   Long, Heather M.
   Dong, Tao
   Whittle, Hilton C.
   Rickinson, Alan B.
   Rowland-Jones, Sarah L.
   Hislop, Andrew D.
   Flanagan, Katie L.
TI Early Virological and Immunological Events in Asymptomatic Epstein-Barr
   Virus Infection in African Children
SO PLOS PATHOGENS
LA English
DT Article
ID CD8(+) T-CELLS; PRIMARY IMMUNE-RESPONSE; PRIMARY EBV INFECTION;
   NATURAL-KILLER-CELLS; UNIVERSITY-STUDENTS; VIRAL-INFECTION; IN-VIVO;
   MONONUCLEOSIS; INFANTS; MALARIA
AB Epstein-Barr virus (EBV) infection often occurs in early childhood and is asymptomatic. However, if delayed until adolescence, primary infection may manifest as acute infectious mononucleosis (AIM), a febrile illness characterised by global CD8+ T-cell lymphocytosis, much of it reflecting a huge expansion of activated EBV-specific CD8+ T-cells. While the events of AIM have been intensely studied, little is known about how these relate to asymptomatic primary infection. Here Gambian children (14-18 months old, an age at which many acquire the virus) were followed for the ensuing six months, monitoring circulating EBV loads, antibody status against virus capsid antigen (VCA) and both total and virus-specific CD8+ T-cell numbers. Many children were IgG anti-VCA-positive and, though no longer IgM-positive, still retained high virus loads comparable to AIM patients and had detectable EBV-specific T-cells, some still expressing activation markers. Virus loads and the frequency/activation status of specific T-cells decreased over time, consistent with resolution of a relatively recent primary infection. Six children with similarly high EBV loads were IgM anti-VCA-positive, indicating very recent infection. In three of these donors with HLA types allowing MHC-tetramer analysis, highly activated EBV-specific T-cells were detectable in the blood with one individual epitope response reaching 15% of all CD8+ T-cells. That response was culled and the cells lost activation markers over time, just as seen in AIM. However, unlike AIM, these events occurred without marked expansion of total CD8+ numbers. Thus asymptomatic EBV infection in children elicits a virus-specific CD8+ T-cell response that can control the infection without over-expansion; conversely, in AIM it appears the CD8 over-expansion, rather than virus load per se, is the cause of disease symptoms.
C1 [Jayasooriya, Shamanthi; de Silva, Thushan I.; Njie-jobe, Jainaba; Sanyang, Chilel; Whittle, Hilton C.; Flanagan, Katie L.] MRC Labs, Fajara, Gambia.
   [Jayasooriya, Shamanthi; Leese, Alison M.; Bell, Andrew I.; Long, Heather M.; Rickinson, Alan B.; Hislop, Andrew D.] Univ Birmingham, Sch Canc Sci, Edgbaston, England.
   [de Silva, Thushan I.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England.
   [de Silva, Thushan I.; Yanchun, Peng; Dong, Tao] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.
   [McAulay, Karen A.] Univ Glasgow, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Whittle, Hilton C.] London Sch Hyg & Trop Med, London WC1, England.
   [Rowland-Jones, Sarah L.] Univ Oxford, Nuffied Dept Med, Headington, England.
   [Flanagan, Katie L.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia.
RP Jayasooriya, S (reprint author), MRC Labs, Fajara, Gambia.
EM a.d.hislop@bham.ac.uk
OI Bell, Andrew/0000-0001-9520-4417
FU Medical Research Council (MRC), The Gambia; MRC [G9901294]; MRC
FX This work was funded by the Medical Research Council (MRC), The Gambia,
   a MRC programme grant awarded to the University of Birmingham, G9901294
   and SJ was a recipient of an MRC studentship. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646
   Balfour HH, 2005, J INFECT DIS, V192, P1505
   BIGGAR RJ, 1978, INT J CANCER, V22, P244, DOI 10.1002/ijc.2910220305
   Callan MFC, 2000, J CLIN INVEST, V106, P1251, DOI 10.1172/JCI10590
   Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395
   Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906
   Catalina MD, 2001, J IMMUNOL, V167, P4450
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Chattopadhyay PK, 2013, J VIROL, V87, P1779, DOI 10.1128/JVI.02158-12
   Chijioke O, 2013, CELL REP, V5, P1489, DOI 10.1016/j.celrep.2013.11.041
   Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JC125078
   Condon LM, 2014, CLIN INFECT DIS
   Crawford DH, 2006, CLIN INFECT DIS, V43, P276, DOI 10.1086/505400
   De Martino M, 1998, PEDIATR RES, V43, P752, DOI 10.1203/00006450-199806000-00007
   Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004
   Dunne PJ, 2002, BLOOD, V100, P933, DOI 10.1182/blood-2002-01-0160
   FLEISHER G, 1979, J INFECT DIS, V139, P553
   Helminen M, 1999, J INFECT DIS, V180, P496, DOI 10.1086/314883
   HENLE G, 1966, J BACTERIOL, V91, P1248
   Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810
   Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692
   Hislop AD, 2001, J IMMUNOL, V167, P2019
   Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553
   Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141
   Holder B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014013
   HORWITZ CA, 1981, BLOOD, V57, P933
   Hwang AE, 2012, EPIDEMIOL INFECT, V140, P2089, DOI 10.1017/S0950268811002457
   Junying Jia, 2003, Virology, V306, P236, DOI 10.1016/S0042-6822(02)00027-2
   Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014
   Long HM, 2013, J EXP MED, V210, P933, DOI 10.1084/jem.20121437
   Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456
   McAulay KA, 2007, J CLIN INVEST, V117, P3042, DOI 10.1172/JCI32377
   Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910
   Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373
   Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401
   Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872
   Rostgaard K, 2014, CLIN INFECT DIS, V58, P1684, DOI 10.1093/cid/ciu204
   Silins SL, 2001, BLOOD, V98, P3739, DOI 10.1182/blood.V98.13.3739
   Slyker JA, 2013, J INFECT DIS, V207, P1798, DOI 10.1093/infdis/jit093
   Steven NM, 1996, J EXP MED, V184, P1801, DOI 10.1084/jem.184.5.1801
   Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605
   SUMAYA CV, 1975, J INFECT DIS, V131, P403
   TAMAKI H, 1995, J INFECT DIS, V172, P739
   TAMARU Y, 1993, BLOOD, V82, P521
   Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820
   Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x
   Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741
   YAO QY, 1985, INT J CANCER, V35, P35, DOI 10.1002/ijc.2910350107
NR 49
TC 8
Z9 8
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAR
PY 2015
VL 11
IS 3
AR e1004746
DI 10.1371/journal.ppat.1004746
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA CE9ZI
UT WOS:000352201900060
PM 25816224
OA gold
DA 2017-08-15
ER

PT J
AU Ndiaye, BP
   Thienemann, F
   Ota, M
   Landry, BS
   Camara, M
   Dieye, S
   Dieye, TN
   Esmail, H
   Goliath, R
   Huygen, K
   January, V
   Ndiaye, I
   Oni, T
   Raine, M
   Romano, M
   Satti, I
   Sutton, S
   Thiam, A
   Wilkinson, KA
   Mboup, S
   Wilkinson, RJ
   McShane, H
AF Ndiaye, Birahim Pierre
   Thienemann, Friedrich
   Ota, Martin
   Landry, Bernard S.
   Camara, Makhtar
   Dieye, Shy
   Dieye, Tandakha Ndiaye
   Esmail, Hanif
   Goliath, Rene
   Huygen, Kris
   January, Vanessa
   Ndiaye, Ibrahima
   Oni, Tolu
   Raine, Michael
   Romano, Marta
   Satti, Iman
   Sutton, Sharon
   Thiam, Aminata
   Wilkinson, Katalin A.
   Mboup, Souleymane
   Wilkinson, Robert J.
   McShane, Helen
CA MVA85A Trial Investigators
TI Safety, immunogenicity, and efficacy of the candidate tuberculosis
   vaccine MVA85A in healthy adults infected with HIV-1: a randomised,
   placebo-controlled, phase 2 trial
SO LANCET RESPIRATORY MEDICINE
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; VIRUS ANKARA;
   SOUTH-AFRICA; DOUBLE-BLIND; BCG VACCINE; METAANALYSIS; PREVENTION;
   MENINGITIS; AG85A
AB Background HIV-1 infection is associated with increased risk of tuberculosis and a safe and effective vaccine would assist control measures. We assessed the safety, immunogenicity, and efficacy of a candidate tuberculosis vaccine, modified vaccinia virus Ankara expressing antigen 85A (MVA85A), in adults infected with HIV-1.
   Methods We did a randomised, double-blind, placebo-controlled, phase 2 trial of MVA85A in adults infected with HIV-1, at two clinical sites, in Cape Town, South Africa and Dakar, Senegal. Eligible participants were aged 18-50 years, had no evidence of active tuberculosis, and had baseline CD4 counts greater than 350 cells per mu L if they had never received antiretroviral therapy or greater than 300 cells per mu L (and with undetectable viral load before randomisation) if they were receiving antiretroviral therapy; participants with latent tuberculosis infection were eligible if they had completed at least 5 months of isoniazid preventive therapy, unless they had completed treatment for tuberculosis disease within 3 years before randomisation. Participants were randomly assigned (1:1) in blocks of four by randomly generated sequence to receive two intradermal injections of either MVA85A or placebo. Randomisation was stratified by antiretroviral therapy status and study site. Participants, nurses, investigators, and laboratory staff were masked to group allocation. The second (booster) injection of MVA85A or placebo was given 6-12 months after the first vaccination. The primary study outcome was safety in all vaccinated participants (the safety analysis population). Safety was assessed throughout the trial as defined in the protocol. Secondary outcomes were immunogenicity and vaccine efficacy against Mycobacterium tuberculosis infection and disease, assessed in the per-protocol population. Immunogenicity was assessed in a subset of participants at day 7 and day 28 after the first and second vaccination, and M tuberculosis infection and disease were assessed at the end of the study. The trial is registered with ClinicalTrials.gov, number NCT01151189.
   Findings Between Aug 4, 2011, and April 24, 2013, 650 participants were enrolled and randomly assigned; 649 were included in the safety analysis (324 in the MVA85A group and 325 in the placebo group) and 645 in the per-protocol analysis (320 and 325). 513 (71%) participants had CD4 counts greater than 300 cells per mu L and were receiving antiretroviral therapy; 136 (21%) had CD4 counts above 350 cells per mu L and had never received antiretroviral therapy. 277 (43%) had received isoniazid prophylaxis before enrolment. Solicited adverse events were more frequent in participants who received MVA85A (288 [89%]) than in those given placebo (235 [72%]). 34 serious adverse events were reported, 17 (5%) in each group. MVA85A induced a significant increase in antigen 85A-specific T-cell response, which peaked 7 days after both vaccinations and was primarily monofunctional. The number of participants with negative QuantiFERON-TB Gold In-Tube findings at baseline who converted to positive by the end of the study was 38 (20%) of 186 in the MVA85A group and 40 (23%) of 173 in the placebo group, for a vaccine efficacy of 11-7% (95% CI -41.3 to 44.9). In the per-protocol population, six (2%) cases of tuberculosis disease occurred in the MVA85A group and nine (3%) occurred in the placebo group, for a vaccine efficacy of 32.8% (95% CI -111.5 to 80.3).
   Interpretation MVA85A was well tolerated and immunogenic in adults infected with HIV-1. However, we detected no efficacy against M tuberculosis infection or disease, although the study was underpowered to detect an effect against disease. Potential reasons for the absence of detectable efficacy in this trial include insufficient induction of a vaccine-induced immune response or the wrong type of vaccine-induced immune response, or both. Copyright (C) Ndiaye et al. Open Access article distributed under the terms of CC BY.
C1 [Ndiaye, Birahim Pierre; Camara, Makhtar; Dieye, Shy; Dieye, Tandakha Ndiaye; Ndiaye, Ibrahima; Mboup, Souleymane] Ctr Hosp Univ Le Dantec, Lab Bacteriol Virol, Dakar, Senegal.
   [Thienemann, Friedrich; Esmail, Hanif; Goliath, Rene; January, Vanessa; Oni, Tolu; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.
   [Oni, Tolu] Univ Cape Town, Div Publ Hlth Med, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.
   [Thienemann, Friedrich; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa.
   [Ota, Martin] MRC Unit, Fajara, Gambia.
   [Landry, Bernard S.; Raine, Michael; Sutton, Sharon] Aeras, Rockville, MD USA.
   [Huygen, Kris; Romano, Marta] Sci Inst Publ Hlth WIV ISP, Serv Immunol, Brussels, Belgium.
   [Thiam, Aminata] Ctr Hosp Univ Fann, Ctr Traitement Ambulatoire, Dakar, Senegal.
   [Satti, Iman; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England.
   [Esmail, Hanif; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.
   [Wilkinson, Katalin A.; Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England.
RP McShane, H (reprint author), Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England.
EM helen.mcshane@ndm.ox.ac.uk; helen.mcshane@ndm.ox.ac.uk
OI Esmail, Hanif/0000-0002-4278-9316; Wilkinson,
   Robert/0000-0002-2753-1800; Huygen, Kris/0000-0001-7808-0512
FU European & Developing Countries Clinical Trials Partnership
   [IP.07.32080.002]; Aeras, Bill & Melinda Gates Foundation; Wellcome
   Trust [095780, 084323, 088316]; Oxford-Emergent Tuberculosis Consortium
FX The study was funded by the European & Developing Countries Clinical
   Trials Partnership (IP.07.32080.002), Aeras, Bill & Melinda Gates
   Foundation, the Wellcome Trust (095780,084323, and 088316), and the
   Oxford-Emergent Tuberculosis Consortium. Quintiles (Bloemfontein, South
   Africa) were used for the statistical analysis, and Aeras paid for this
   service. The appendix includes a complete list of acknowledgments. We
   dedicate this study to the memory of Robyn Louw.
CR Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698
   Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742
   Falzon Dennis, 2013, Lancet Respir Med, V1, pe9, DOI 10.1016/S2213-2600(12)70056-5
   Gartner T, 2007, IMMUNOL LETT, V111, P26, DOI 10.1016/j.imlet.2007.04.010
   Goonetilleke NP, 2003, J IMMUNOL, V171, P1602
   Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010
   Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185
   Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14
   Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790
   McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128
   McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003
   Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223
   Rangaka MX, 2012, EUR RESPIR J, V39, P163, DOI 10.1183/09031936.00058911
   Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8
   RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154
   Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC
   Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X
   Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754
   Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4
   Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3
   Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264
   von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b
   Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09
   Walker NF, 2013, FUTURE VIROL, V8, P57, DOI 10.2217/FVL.12.123
   Organization WH, 2014, GLOB TUB REP
   Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005
NR 27
TC 34
Z9 35
U1 2
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-2600
J9 LANCET RESP MED
JI Lancet Resp. Med.
PD MAR
PY 2015
VL 3
IS 3
BP 190
EP 200
DI 10.1016/S2213-2600(15)00037-5
PG 11
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA CE0FN
UT WOS:000351480000015
PM 25726088
OA No
DA 2017-08-15
ER

PT J
AU Howell, J
   Ladep, NG
   Lemoine, M
   Nayagam, S
   Toure, PS
   Diop, MM
   Daveiga, JA
   Sall, AS
   Lo, G
   Crossey, MME
   Thursz, MR
   Taylor-Robinson, SD
   Ka, MM
AF Howell, Jessica
   Ladep, Nimzing G.
   Lemoine, Maud
   Nayagam, Shevanthi
   Toure, Papa Souleymane
   Diop, Magatte Madoky
   Daveiga, Joao Armindo
   Sall, Amina Sow
   Lo, Gora
   Crossey, Mary M. E.
   Thursz, Mark R.
   Taylor-Robinson, Simon D.
   Ka, Mamadou Mourtalla
TI Prevention of Liver Fibrosis and Cancer in Africa: The PROLIFICA project
   - a collaborative study of hepatitis B-related liver disease in West
   Africa
SO SAMJ SOUTH AFRICAN MEDICAL JOURNAL
LA English
DT Editorial Material
ID HEPATOCELLULAR-CARCINOMA; MANAGEMENT; INFECTION
C1 [Howell, Jessica; Ladep, Nimzing G.; Lemoine, Maud; Nayagam, Shevanthi; Crossey, Mary M. E.; Thursz, Mark R.; Taylor-Robinson, Simon D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.
   [Howell, Jessica] Macfarlane Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.
   [Howell, Jessica] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia.
   [Ladep, Nimzing G.] Jos Univ Teaching Hosp, Dept Med, Jos, Plateau State, Nigeria.
   [Lemoine, Maud] MRC, Gambia Unit, Fajara, Gambia.
   [Toure, Papa Souleymane; Diop, Magatte Madoky; Daveiga, Joao Armindo; Ka, Mamadou Mourtalla] Thies Univ, UFR Sante, Thies, Senegal.
   [Sall, Amina Sow; Lo, Gora] Le Dantec Hosp, Lab Bacteriol Virol, Dakar, Senegal.
RP Howell, J (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.
EM j.howell@imperial.ac.uk
OI Nayagam, Amanda Shevanthi/0000-0002-8030-3380
FU Medical Research Council [MR/L002086/1]
CR European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer, 2011, J HEPATOL, V56, P908
   Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027
   Ladep NG, 2014, HEPATOLOGY, V60, P1291, DOI 10.1002/hep.27264
   Lemoine M, 2014, ALIMENT PHARM THER, V39, P188, DOI 10.1111/apt.12561
   Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364
   Lopez PM, 2006, ALIMENT PHARM THERAP, V23, P1535, DOI 10.1111/j.1365-2036.2006.02932.x
   Papatheodoridis G, 2012, J HEPATOL, V57, P167
   Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74
   Robotin MC, 2010, BMC HLTH SERE RES, V10, P215
   Sheriff MI, 2010, J PROTEOME RES, V9, P1096
   Shimakawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069430
   WHO, GLOB POL REP PREV CO
NR 13
TC 0
Z9 1
U1 0
U2 1
PU SA MEDICAL ASSOC
PI PRETORIA
PA BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3,
   PRETORIA, 0002, SOUTH AFRICA
SN 0256-9574
EI 2078-5135
J9 SAMJ S AFR MED J
JI SAMJ S. Afr. Med. J.
PD MAR
PY 2015
VL 105
IS 3
BP 185
EP +
DI 10.7196/SAMJ.8880
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA CD8IA
UT WOS:000351337200014
PM 26294822
OA gold
DA 2017-08-15
ER

PT J
AU Okebe, J
   Bousema, T
   Affara, M
   DiTanna, G
   Eziefula, AC
   Jawara, M
   Nwakanma, D
   Amambua-Ngwa, A
   Van Geertruyden, JP
   Drakeley, C
   D'Alessandro, U
AF Okebe, Joseph
   Bousema, Teun
   Affara, Muna
   DiTanna, GianLuca
   Eziefula, Alice C.
   Jawara, Musa
   Nwakanma, Davis
   Amambua-Ngwa, Alfred
   Van Geertruyden, Jean-Pierre
   Drakeley, Chris
   D'Alessandro, Umberto
TI The gametocytocidal efficacy of primaquine in malaria asymptomatic
   carriers treated with dihydroartemisinin-piperaquine in The Gambia
   (PRINOGAM): study protocol for a randomised controlled trial
SO TRIALS
LA English
DT Article
DE Malaria; Plasmodium falciparum; Asymptomatic infection; Gametocyte;
   Primaquine; Safety; Efficacy; Elimination
ID PLASMODIUM-FALCIPARUM-GAMETOCYTES; SINGLE-DOSE PRIMAQUINE; TRANSMISSION;
   CHILDREN; TANZANIA; ARTEMISININ; POPULATIONS; DEFICIENCY; HEMOLYSIS;
   TIME
AB Background: Finding efficacious tools to decrease and interrupt malaria transmission is essential to sustain the gains in malaria control and contain the emergence of artemisinin resistance. Primaquine is effective against Plasmodium falciparum gametocytes and recommended for treatment campaigns in (pre-) elimination settings. Safety concerns preclude its use in endemic African countries with variable proportions of glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals. The efficacy of the current recommended dose needs to be evaluated, particularly in individuals with an asymptomatic malaria infection.
   Methods/design: This is a four-arm, open label, randomized controlled trial that aims to determine and compare the effect of three different single doses of primaquine combined with dihydroartemisinin-piperaquine, an artemisinin-based combination therapy, on gametocyte carriage in asymptomatic, malaria infected, G6PD-normal individuals. Approximately 1,200 participants are enrolled and followed for 42 days, with the primary endpoint being the prevalence of Plasmodium falciparum gametocyte carriage at day 7 of follow-up determined by quantitative nucleic acid sequence based amplification assay. Direct membrane feeding experiments to determine infectiousness to mosquitoes are conducted as a biological secondary endpoint.
   Discussion: Sub-Saharan Africa, with a relatively high but poorly characterized G6PD prevalence, could potentially benefit from the use of primaquine to further reduce or interrupt malaria transmission. However, G6PD screening may not be feasible given the cost and difficulties in interpreting test results in terms of risk of haemolysis. Because the haemolytic effect of primaquine is dose-dependent, determining the minimal gametocytocidal and transmission-blocking dose of primaquine is extremely important to help address public health concerns over its safety and validate the efficacy of lower than recommended dosages. By including infectiousness to mosquitoes, the trial provides complementary evidence for the potential of the drug to interrupt transmission to mosquitoes.
C1 [Okebe, Joseph; Affara, Muna; Jawara, Musa; Nwakanma, Davis; Amambua-Ngwa, Alfred; D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.
   [Bousema, Teun; Eziefula, Alice C.; Drakeley, Chris] London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1, England.
   [DiTanna, GianLuca] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England.
   [Van Geertruyden, Jean-Pierre] Univ Antwerp, Fac Med & Hlth Sci, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, London WC1, England.
   [D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
RP Okebe, J (reprint author), MRC Unit, Dis Control & Eliminat Theme, Fajara, Gambia.
EM jokebe@mrc.gm
RI Bousema, Teun/N-3574-2014; Van geertruyden, Jean-pierre/K-6425-2014
OI Van geertruyden, Jean-pierre/0000-0001-5006-6364
FU Bill & Melinda Gates Foundation (AFIRM) [OPP1034789]; Global Health
   Trials Scheme by the Medical Research Council (UK); Department for
   International Development (DFID); Wellcome Trust
FX The authors acknowledge Mathurin Diatta and Abdoulaye Gaye for setting
   up the membrane feeding experiments, Drs Edgard Dabira and Frank
   Sanya-Isijola for drafting the standard operating procedures and
   supervising the field teams, and Henry Badji for supervising laboratory
   activities. CD and TB are supported by a grant from the Bill & Melinda
   Gates Foundation (AFIRM, grant number OPP1034789). The trial is jointly
   funded under the Global Health Trials Scheme by the Medical Research
   Council (UK), the Department for International Development (DFID) and
   the Wellcome Trust. The funders have no role in the trial design or the
   preparation of the protocol or manuscript.
CR Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364
   Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626
   Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7
   Drakeley CJ, 2000, ANN TROP MED PARASIT, V94, P399
   Dunyo S, 2006, PLOS CLIN TRIALS, V1, P20
   El-Sayed B, 2007, PLOS ONE, V2, pe1311
   Eziefula AC, 2014, ANTIMICROB AGENTS CH, V58, P4971, DOI 10.1128/AAC.02889-14
   Eziefula AC, 2014, LANCET INFECT DIS, V14, P130, DOI 10.1016/S1473-3099(13)70268-8
   Gosling RD, 2011, CLIN MICROBIOL INFEC, V17, P1617, DOI 10.1111/j.1469-0691.2011.03660.x
   Graves PM, 2012, COCHRANE DB SYST REV, V9
   Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339
   Kast K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-438
   Lawpoolsri S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-159
   Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]
   The maIERA Consultative Group on Drugs, 2011, PLOS MED, V8, DOI DOI 10.1371/JOURNAL.PMED.1000402
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   Okebe J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-148
   Ouedraogo A. L., 2013, MALARIA WORLD J, V4
   Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626
   Pinder M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-147
   Shekalaghe S, 2007, PLOS ONE, V2, pe1023
   Shekalaghe SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-247
   Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09
   Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57
   White NJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-418
   White NJ, 2008, MALARIA J S1, V7, pS8, DOI DOI 10.1186/1475-2875-7-S1-S8
   World Health Organization, 2010, GUID TREATM MAL
   World Health Organization, 2008, MAL MICR QUAL ASS MA, V1
   [Anonymous], 2011, PLOS MED, V8
NR 32
TC 6
Z9 6
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD MAR 1
PY 2015
VL 16
AR 70
DI 10.1186/s13063-015-0597-1
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CC8BL
UT WOS:000350592900002
PM 25887344
OA gold
DA 2017-08-15
ER

PT J
AU Gaye, A
   Bousema, T
   Libasse, G
   Ndiath, MO
   Konate, L
   Jawara, M
   Faye, O
   Sokhna, C
AF Gaye, Abdoulaye
   Bousema, Teun
   Libasse, Gadiaga
   Ndiath, Mamadou O.
   Konate, Lassana
   Jawara, Musa
   Faye, Ousmane
   Sokhna, Cheikh
TI Infectiousness of the Human Population to Anopheles arabiensis by Direct
   Skin Feeding in an Area Hypoendemic for Malaria in Senegal
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; AFRICAN VILLAGE; TRANSMISSION;
   INFECTIVITY; MOSQUITOS; RESERVOIR; GAMBIAE; GAMETOCYTES; ASSAY
AB Direct skin feeding experiments are sensitive assays to determine human infectiousness to mosquitoes but are rarely used in malaria epidemiological surveys. We determined the infectiousness of inhabitants of a malaria hypoendemic area in Senegal. Gametocyte prevalence by microscopy was 13.5% (26 of 192). Of all individuals who were gametocyte positive, 44.4% (11 of 25) infected >= 1 Anopheles arabiensis mosquito and 10.8% (54 of 500) of mosquitoes became infected. Of all individuals who were gametocyte negative by microscopy, 4.3% (7 of 162) infected 1 mosquito and 0.4% (12 of 3240) of mosquitoes became infected. The 18.2% (12 of 66) of all mosquito infections was a result of submicroscopic gametocyte carriage and two individuals without asexual parasites or gametocytes by microscopy were infectious to mosquitoes. When infectivity and local demography was taken into account, children 5-14 years of age contributed 50.8% of the human infectious reservoir for malaria. Adults and submicroscopic gametocyte carriers may contribute considerably to onward malaria transmission in our setting.
C1 [Sokhna, Cheikh] Campus UCAD IRD, UMR 198, Unite Rech Malad Infect & Trop Emergentes, Dakar, Senegal.
   [Bousema, Teun] Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands.
   [Bousema, Teun] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.
   [Libasse, Gadiaga] Programme Natl Lutte Paludisme, Dakar, Senegal.
   [Ndiath, Mamadou O.] Inst Pasteur, Bangui, Cent Afr Republ.
   [Konate, Lassana; Faye, Ousmane] Univ Cheikh Anta Diop Dakar, Dept Biol Anim, Dakar, Senegal.
   [Gaye, Abdoulaye; Jawara, Musa] MRC Unit, Banjul, Fajara, Gambia.
   Atlantic Blvd Fajara, Fajara, Gambia.
RP Gaye, A (reprint author), MRC Unit, Atlantic Blvd,POB 273, Banjul, Basse, Gambia.
EM layegaye@gmail.com; Teun.Bousema@lshtm.ac.uk; lgadius@gmail.com;
   ousmane.ndiath@gmail.com; konatela@yahoo.fr; jawaramusa@mrc.gm;
   jogomaye@yahoo.fr; cheikh.sokhna@ird.fr
RI Bousema, Teun/N-3574-2014
FU Institute of Research for Development (IRD)
FX This work was supported by the Institute of Research for Development
   (IRD).
CR Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5
   Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8
   BOUDIN C, 1993, AM J TROP MED HYG, V48, P700
   Boudin C, 1998, Med Trop (Mars), V58, P69
   Bousema T, 2013, TRENDS PARASITOL, V29, P53, DOI 10.1016/j.pt.2012.11.004
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10
   Chardome Janssen PS, 1952, ANN SOC BELG MED TR, V32, P209
   Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626
   Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002
   Diallo M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-248
   Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7
   GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531
   Gething PW, 2011, MALARIA J, DOI 10.1186/1475-2875
   GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y
   GRAVES PM, 1988, PARASITOLOGY, V96, P251
   Hay SI, 2010, PLOS MED, V7
   Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004
   Macdonald G., 1957, EPIDEMIOLOGY CONTROL
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   MUIRHEADTHOMSON RC, 1957, AM J TROP MED HYG, V6, P971
   MUIRHEADTHOMSON RC, 1954, T ROY SOC TROP MED H, V48, P208, DOI 10.1016/0035-9203(54)90067-X
   Murray JC, 2012, LANCET, V379, P413
   Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241
   Pethleart A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-34
   Pichon G, 2000, PARASITOLOGY, V121, P115, DOI 10.1017/S0031182099006277
   Robert V, 1998, TROP MED INT HEALTH, V3, P667
   Schneider P, 2007, AM J TROP MED HYG, V76, P470
   Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419
   Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3
   Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X
NR 31
TC 8
Z9 8
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAR
PY 2015
VL 92
IS 3
BP 648
EP 652
DI 10.4269/ajtmh.14-0402
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CC7EB
UT WOS:000350529400039
PM 25624409
OA No
DA 2017-08-15
ER

PT J
AU Taylor, SM
   Parobek, CM
   DeConti, DK
   Kayentao, K
   Coulibaly, SO
   Greenwood, BM
   Tagbor, H
   Williams, J
   Bojang, K
   Njie, F
   Desai, M
   Kariuki, S
   Gutman, J
   Mathanga, DP
   Martensson, A
   Ngasala, B
   Conrad, MD
   Rosenthal, PJ
   Tshefu, AK
   Moormann, AM
   Vulule, JM
   Doumbo, OK
   ter Kuile, FO
   Meshnick, SR
   Bailey, JA
   Juliano, JJ
AF Taylor, Steve M.
   Parobek, Christian M.
   DeConti, Derrick K.
   Kayentao, Kassoum
   Coulibaly, Sheick Oumar
   Greenwood, Brian M.
   Tagbor, Harry
   Williams, John
   Bojang, Kalifa
   Njie, Fanta
   Desai, Meghna
   Kariuki, Simon
   Gutman, Julie
   Mathanga, Don P.
   Martensson, Andreas
   Ngasala, Billy
   Conrad, Melissa D.
   Rosenthal, Philip J.
   Tshefu, Antoinette K.
   Moormann, Ann M.
   Vulule, John M.
   Doumbo, Ogobara K.
   ter Kuile, Feiko O.
   Meshnick, Steven R.
   Bailey, Jeffrey A.
   Juliano, Jonathan J.
TI Absence of Putative Artemisinin Resistance Mutations Among Plasmodium
   falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE falciparum malaria; artemisinin resistance; drug resistance; molecular
   epidemiology
ID DRUG-RESISTANCE; MALARIA; ARTESUNATE; CLEARANCE; DIVERSITY; CHILDREN;
   MARKER; TOOL
AB Plasmodium falciparum parasites that are resistant to artemisinins have been detected in Southeast Asia. Resistance is associated with several polymorphisms in the parasite's K13-propeller gene. The molecular epidemiology of these artemisinin resistance genotypes in African parasite populations is unknown. We developed an assay to quantify rare polymorphisms in parasite populations that uses a pooled deep-sequencing approach to score allele frequencies, validated it by evaluating mixtures of laboratory parasite strains, and then used it to screen P. falciparum parasites from >1100 African infections collected since 2002 from 14 sites across sub-Saharan Africa. We found no mutations in African parasite populations that are associated with artemisinin resistance in Southeast Asian parasites. However, we observed 15 coding mutations, including 12 novel mutations, and limited allele sharing between parasite populations, consistent with a large reservoir of naturally occurring K13-propeller variation. Although polymorphisms associated with artemisinin resistance in P. falciparum in Southeast Asia are not prevalent in sub-Saharan Africa, numerous K13-propeller coding polymorphisms circulate in Africa. Although their distributions do not support a widespread selective sweep for an artemisinin-resistant phenotype, the impact of these mutations on artemisinin susceptibility is unknown and will require further characterization. Rapid, scalable molecular surveillance offers a useful adjunct in tracking and containing artemisinin resistance.
C1 [Taylor, Steve M.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA.
   [Taylor, Steve M.] Duke Univ, Med Ctr, Duke Global Hlth Inst, Durham, NC USA.
   [Taylor, Steve M.; Meshnick, Steven R.] Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA.
   [Parobek, Christian M.; Juliano, Jonathan J.] Univ N Carolina, Curriculum Genet & Mol Biol, Sch Med, Chapel Hill, NC USA.
   [Juliano, Jonathan J.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA.
   [DeConti, Derrick K.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA USA.
   [Moormann, Ann M.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA.
   [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Div Transfus Med, Worcester, MA USA.
   [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA.
   [Desai, Meghna; Gutman, Julie] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA.
   [Conrad, Melissa D.; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Kayentao, Kassoum; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Bamako, Mali.
   [Kayentao, Kassoum; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.
   [Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Coulibaly, Sheick Oumar] Univ Ouagadougou, Fac Hlth Sci, Ouagadougou, Burkina Faso.
   [Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana.
   [Williams, John] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Bojang, Kalifa; Njie, Fanta] MRC Labs, Banjul, Gambia.
   [Desai, Meghna] CDC Kenya, Kisumu, Kenya.
   [Kariuki, Simon] CDC, KEMRI, Kisumu, Kenya.
   [Vulule, John M.; ter Kuile, Feiko O.] KEMRI, Ctr Global Hlth Res, Kisumu, Kenya.
   [Mathanga, Don P.] Univ Malawi, Coll Med, Malaria Alert Ctr, Blantyre, Malawi.
   [Mathanga, Don P.] Coll Med, Dept Community Hlth, Lilongwe, Malawi.
   [Martensson, Andreas] Karolinska Inst, Dept Med Solna, Malaria Res, Stockholm, Sweden.
   [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth, Stockholm, Sweden.
   [Ngasala, Billy] Muhumbili Univ Hlth & Allied Sci, Dept Parasitol, Dar Es Salaam, Tanzania.
   [Tshefu, Antoinette K.] Univ Kinshasa, Fac Med, Ecole Sante Publ, Kinshasa, DEM REP CONGO.
RP Juliano, JJ (reprint author), Div Infect Dis, CB 7030, Chapel Hill, NC 27599 USA.
EM jjuliano@med.unc.edu
OI ter Kuile, Feiko/0000-0003-3663-5617; Bojang,
   Kalifa/0000-0001-7506-0938; Parobek, Christian/0000-0002-4511-3493
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health (NIH) [K08AI10092, R01AI089819, R56AI097909,
   U19AI089674]; NIH [KL2RR031981, T32GM0088719]; Malaria in Pregnancy
   Consortium - Bill and Melinda Gates Foundation [46099]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health (NIH; grants
   K08AI100924 [to S. M. T.], R01AI089819 [to J. J. J.], R56AI097909 [to S.
   R. M.], and U19AI089674), the NIH (KL2RR031981 to J. A. B. and training
   grant T32GM0088719 to C. M. P.), and the Malaria in Pregnancy
   Consortium, which is funded through a grant from the Bill and Melinda
   Gates Foundation to the Liverpool School of Tropical Medicine (grant
   46099 to F. O. t. K.). Additional sources of funding for the original
   clinical studies are specified in Supplementary Table 1.
CR Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329
   Consortium M, 2014, P FALC COMM PROJ
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210
   Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239
   Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925
   Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282
   Lon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093138
   Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082
   Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058
   NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Pearce RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000055
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269
   Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Taylor SM, 2013, J INFECT DIS, V208, P1998, DOI 10.1093/infdis/jit392
   Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771
   Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153
   Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830
   White NJ, 2014, LANCET, V383, P1439, DOI 10.1016/S0140-6736(14)60656-5
   WHO, 2011, WORLD MALARIA REPORT 2011, P1
   World Health Organization (WHO), 2011, GLOB PLAN ART RES CO
   Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813
   [Anonymous], 2011, PLOS MED, V8
NR 31
TC 83
Z9 85
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 1
PY 2015
VL 211
IS 5
BP 680
EP 688
DI 10.1093/infdis/jiu467
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CC3CL
UT WOS:000350222000003
PM 25180240
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Redmond, J
   Palla, L
   Yan, L
   Jarjou, L
   Prentice, A
   Schoenmakers, I
AF Redmond, J.
   Palla, L.
   Yan, L.
   Jarjou, L. M. A.
   Prentice, A.
   Schoenmakers, I.
TI Ethnic differences in urinary calcium and phosphate excretion between
   Gambian and British older adults
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Article
DE Bone; Calcium; Diet; Ethnicity; Kidney; Phosphate
ID HIP FRACTURE INCIDENCE; BONE-MINERAL CONTENT; PARATHYROID-HORMONE;
   RACIAL-DIFFERENCES; WHITE WOMEN; OSTEOPOROSIS; TURNOVER; PERIMENOPAUSAL;
   REABSORPTION; POPULATIONS
AB Ethnic differences in renal calcium and phosphate excretion exist, which may depend on differences in their dietary intakes and regulatory factors. We report highly significant differences in urinary calcium and phosphate excretion between white British and Gambian adults after statistical adjustment for mineral intakes, indicating an independent effect of ethnicity.
   Introduction Populations vary in their risk of age-related osteoporosis. There are racial or ethnic differences in the metabolism of the bone-forming minerals calcium (Ca) and phosphate (P), with a lower renal Ca and P excretion in African-Americans compared to white counterparts, even at similar intakes and rates of absorption. Also, Africans in The Gambia have a lower Ca excretion compared to white British subjects, groups known to differ in their dietary Ca intake. Here, we report on differences in urinary Ca and P excretion between Gambian and white British adults while allowing for known predictors, including dietary intakes.
   Methods Participants were healthy white British (n = 60) and Gambian (n = 61) men and women aged 60-75 years. Fasting blood and 2-h urine samples were collected. Markers of Ca and P metabolism were analysed. Dietary intake was assessed with country-specific methods.
   Results White British older adults had higher creatinine-corrected urinary Ca and P excretion (uCa/uCr, uP/uCr) and lower tubular maximum of Ca and P compared to Gambian counterparts. The predictors of urinary Ca and P differed between groups. Multiple regression analysis showed that dietary Ca and Ca/P were predictors of uCa/uCr and uP/uCr, respectively. Ethnicity remained a significant predictor of uCa/uCr and uP/uCr after adjustment for diet and other factors.
   Conclusion Gambian older adults have higher renal Ca conservation than British counterparts. Dietary mineral intakes were predictors of the differences in urinary Ca and P excretion, but ethnicity remained a highly significant predictor after statistical adjustment. This suggests that ethnicity has an independent effect on renal Ca and P handling.
C1 [Redmond, J.; Palla, L.; Yan, L.; Prentice, A.; Schoenmakers, I.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge CB1 9NL, England.
   [Jarjou, L. M. A.; Prentice, A.] Med Res Council Keneba, Keneba, Gambia.
RP Schoenmakers, I (reprint author), Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge CB1 9NL, England.
EM inez.schoenmakers@mrc-hnr.cam.ac.uk
RI Palla, Luigi/Q-4950-2016
OI Palla, Luigi/0000-0001-6944-1750
FU Medical Research Council (MRC); Department for International Development
   (DFID) under the MRC/DFID (MRC Unit Programmes) [U105960371, U123261351]
FX This research was jointly funded by the Medical Research Council (MRC)
   and the Department for International Development (DFID) under the
   MRC/DFID Concordat agreement (MRC Unit Programmes U105960371 and
   U123261351). JR received a Ph.D. studentship from the MRC. We wish to
   thank Janet Bennett, Ann Laidlaw and Shailja Nigdikar, MRC Human
   Nutrition Research, for the laboratory analyses. We wish to also thank
   the participants of our research studies and the members of staff at MRC
   Human Nutrition Research and MRC Keneba for their assistance with
   conducting the studies.
CR ADEBAJO AO, 1991, AGE AGEING, V20, P435, DOI 10.1093/ageing/20.6.435
   Agency FS, 2002, MCCANCE WIDD COMP FO
   Aspray TJ, 1996, J BONE MINER RES, V11, P1019
   Aspray TJ, 2005, BONE, V36, P710, DOI 10.1016/j.bone.2005.01.002
   Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X
   Barth JH, 2000, ANN CLIN BIOCHEM, V37, P79, DOI 10.1258/0004563001901371
   BELL NH, 1993, J BONE MINER RES, V8, P1111
   BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995
   Berg K, 2005, AM J HUM GENET, V77, P519
   Blackwood AM, 2001, J HUM HYPERTENS, V15, P229, DOI 10.1038/sj.jhh.1001171
   Braun M, 2007, AM J CLIN NUTR, V85, P1657
   Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507
   Charlton KE, 2005, EUR J CARDIOV PREV R, V12, P355, DOI 10.1097/01.hjr.0000170265.22938.d1
   Christakos Sylvia, 2014, Bonekey Rep, V3, P496, DOI 10.1038/bonekey.2013.230
   Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F
   DAWSONHUGHES B, 1993, J BONE MINER RES, V8, P779
   DAWSONHUGHES B, 1995, J CLIN ENDOCR METAB, V80, P3068, DOI 10.1210/jc.80.10.3068
   Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2
   Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765
   Finkelstein JS, 2002, J CLIN ENDOCR METAB, V87, P3051, DOI 10.1210/jc.87.7.3051
   Greenspan SL, 1997, CALCIFIED TISSUE INT, V60, P419
   Gutierrez OM, 2010, NEPHROL DIAL TRANSPL, V25, P3970, DOI 10.1093/ndt/gfq316
   Hans DB, 2011, J CLIN DENSITOM, V14, P171, DOI 10.1016/j.jocd.2011.05.007
   Heaney RP, 2006, NUTR HLTH, P145
   Jarjou LM, 2006, AM J CLIN NUTR, V83, P657
   KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950
   Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3
   KENT GN, 1987, CLIN CHIM ACTA, V166, P155, DOI 10.1016/0009-8981(87)90417-7
   MALM OLE J., 1958, SCAND JOUR CLIN AND LAB INVERT, V10, P1
   Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429
   Megyesi MS, 2011, OSTEOPOROSIS INT, V22, P1669, DOI 10.1007/s00198-010-1503-z
   MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098
   Olds LC, 2011, HUM GENET, V129, P111, DOI 10.1007/s00439-010-0898-0
   PAYNE RB, 1979, J CLIN PATHOL, V32, P56, DOI 10.1136/jcp.32.1.56
   PEACOCK M, 1968, BRIT MED J, V2, P729
   PRENTICE A, 1993, BRIT J NUTR, V69, P885, DOI 10.1079/BJN19930088
   PRENTICE A, 1991, BONE MINER, V12, P201, DOI 10.1016/0169-6009(91)90033-V
   Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590
   Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x
   Paul AA, 2007, FOOD COMPOSITION TAB
   ROSS PD, 1991, AM J EPIDEMIOL, V133, P801
   SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V53, pS27, DOI 10.1007/BF01673398
   Schoenmakers I, 2013, OSTEOPOROSIS INT, V24, P2301, DOI 10.1007/s00198-013-2280-2
   Signorello LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028623
   Taylor EN, 2007, J AM SOC NEPHROL, V18, P654, DOI 10.1681/ASN.2006080854
   Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404
   Trumble W, 2002, OXFORD ENGLISH DICT
   Tsang SWY, 2009, OSTEOPOROSIS INT, V20, P1939, DOI 10.1007/s00198-009-0906-1
   Walker MD, 2008, J NUTR, V138, p1256S
   Yan LY, 2009, BONE, V45, P238, DOI 10.1016/j.bone.2009.04.237
NR 50
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD MAR
PY 2015
VL 26
IS 3
BP 1125
EP 1135
DI 10.1007/s00198-014-2926-8
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CC2ZP
UT WOS:000350214100030
PM 25311107
OA No
DA 2017-08-15
ER

PT J
AU Jones, KS
   Assar, S
   Vanderschueren, D
   Bouillon, R
   Prentice, A
   Schoenmakers, I
AF Jones, K. S.
   Assar, S.
   Vanderschueren, D.
   Bouillon, R.
   Prentice, A.
   Schoenmakers, I.
TI Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The
   Gambia and the UK
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Article
DE 24,25(OH)(2)D; Gambia; Half-life; Vitamin D binding protein; Vitamin D
   metabolism
ID D-BINDING PROTEIN; VITAMIN-D DEFICIENCY; 25-HYDROXYVITAMIN D;
   MASS-SPECTROMETRY; SERUM; 1,25-DIHYDROXYVITAMIN-D; MECHANISM;
   QUANTIFICATION; METABOLISM; HEALTH
AB Predictors of 25(OH)D-3 half-life were factors associated with vitamin D metabolism, but were different between people in The Gambia and the UK. Country was the strongest predictor of plasma 25(OH)D concentration, probably as a marker of UVB exposure. 25(OH)D-3 half-life may be applied as a tool to investigate vitamin D expenditure.
   Introduction The aim of this study was to investigate predictors of 25(OH)D-3 half-life and plasma 25(OH)D concentration.
   Methods Plasma half-life of an oral tracer dose of deuterated-25(OH)D-3 was measured in healthy men aged 24-39 years, resident in The Gambia, West Africa (n = 18) and in the UK during the winter (n = 18), countries that differ in calcium intake and vitamin D status. Plasma and urinary markers of vitamin D, calcium, phosphate and bone metabolism, nutrient intakes and anthropometry were measured.
   Results Normally distributed data are presented as mean (SD) and non-normal data as geometric mean (95 % CI). Gambian compared to UK men had higher plasma concentrations of 25(OH)D (69 (13) vs. 29 (11) nmol/L; P < 0.0001); 1,25(OH)(2)D (181 (165, 197) vs. 120 (109, 132) pmol/L; P < 0.01); and parathyroid hormone (PTH) (50 (42, 60) vs. 33 (27, 39); P < 0.0001). There was no difference in 25(OH)D-3 half-life (14.7 (3.5) days vs. 15.6 (2.5) days) between countries (P = 0.2). In multivariate analyses, 25(OH)D, 1,25(OH)(2)D, vitamin D binding protein and albumin-adjusted calcium (Ca-alb) explained 79 % of variance in 25(OH)D-3 half-life in Gambians, but no significant predictors were found in UK participants. For the countries combined, Ca-alb, PTH and plasma phosphate explained 39 % of half-life variability. 1,25(OH)(2)D, weight, PTH and country explained 81 % of variability in 25(OH)D concentration; however, country alone explained 74 %.
   Conclusion Factors known to affect 25(OH)D metabolism predict 25(OH)D-3 half-life, but these differed between countries. Country predicted 25(OH)D, probably as a proxy measure for UVB exposure and vitamin D supply. This study supports the use of 25(OH)D half-life to investigate vitamin D metabolism.
C1 [Jones, K. S.; Assar, S.; Prentice, A.; Schoenmakers, I.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge CB1 9NL, England.
   [Vanderschueren, D.; Bouillon, R.] Katholieke Univ Leuven, Dept Clin & Expt Med, Leuven, Belgium.
   [Jones, K. S.; Prentice, A.] Med Res Council Keneba, Banjul, Gambia.
   [Vanderschueren, D.; Bouillon, R.] Univ Hosp, Dept Endocrinol, Leuven, Belgium.
RP Jones, KS (reprint author), Med Res Council Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.
EM kerry.jones@mrc-hnr.cam.ac.uk
FU Medical Research Council (MRC) [U105960371, U123261351, MC-A760-5QX00];
   Department for International Development (DFID) under the MRC/DFID
FX This research is jointly funded by the Medical Research Council (MRC)
   (programme codes U105960371, U123261351, MC-A760-5QX00) and the
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement.
CR Abboud M, 2013, ENDOCRINOLOGY, V154, P3022, DOI 10.1210/en.2012-2245
   Anderson PH, 2010, J STEROID BIOCHEM, V121, P288, DOI 10.1016/j.jsbmb.2010.03.022
   BATCHELOR AJ, 1982, GUT, V23, P1068, DOI 10.1136/gut.23.12.1068
   BATCHELOR AJ, 1983, BRIT J NUTR, V49, P213, DOI 10.1079/BJN19830027
   BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8
   BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225
   Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004
   Braithwaite V, 2014, ENDOCR CONNECT, V3, P1, DOI 10.1530/EC-13-0070
   Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157
   Casetta B, 2010, EUR J MASS SPECTROM, V16, P81, DOI 10.1255/ejms.1024
   Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012
   CLEMENTS MR, 1992, CLIN ENDOCRINOL, V37, P17, DOI 10.1111/j.1365-2265.1992.tb02278.x
   CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038/325062a0
   CLEMENTS MR, 1987, CLIN SCI, V73, P659
   Davies M, 1997, J CLIN ENDOCR METAB, V82, P209, DOI 10.1210/jc.82.1.209
   Fitt E, 2015, PUBLIC HEALTH NUTR, V18, P234, DOI 10.1017/S1368980014000342
   Gravesen E, 2014, CALCIFIED TISSUE INT, V95, P46, DOI 10.1007/s00223-014-9861-8
   GRAY RW, 1974, J CLIN ENDOCR METAB, V39, P1045
   Haddock L, 1985, P R Health Sci J, V4, P47
   IOM (Institute of Medicine), 2011, DIET REF INT CALC VI
   Jones KS, 2014, J CLIN ENDOCR METAB, V99, P3373, DOI 10.1210/jc.2014-1714
   Jones KS, 2012, BRIT J NUTR, V107, P1128, DOI 10.1017/S0007114511004132
   MAWER EB, 1971, CLIN SCI, V40, P39
   Moller UK, 2013, NUTRIENTS, V5, P3470, DOI 10.3390/nu5093470
   Prentice A, 2008, AM J CLIN NUTR, V88, p500S
   Paul AA, 2007, FOOD COMPOSITION TAB
   Schoenmakers I, 2013, OSTEOPOROSIS INT, V24, P2301, DOI 10.1007/s00198-013-2280-2
   Schoenmakers I, 2010, J STEROID BIOCHEM, V121, P217, DOI 10.1016/j.jsbmb.2010.03.012
   SMITH JE, 1971, J CLIN INVEST, V50, P2159, DOI 10.1172/JCI106710
   Vanderschueren D, 2013, J CLIN ENDOCR METAB, V98, P995, DOI 10.1210/jc.2012-2772
   VICCHIO D, 1993, BIOL MASS SPECTROM, V22, P53, DOI 10.1002/bms.1200220107
   Wagner D, 2011, J STEROID BIOCHEM, V126, P72, DOI 10.1016/j.jsbmb.2011.05.003
   Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079
NR 33
TC 7
Z9 7
U1 0
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD MAR
PY 2015
VL 26
IS 3
BP 1137
EP 1146
DI 10.1007/s00198-014-2905-0
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CC2ZP
UT WOS:000350214100031
PM 25278297
OA No
DA 2017-08-15
ER

PT J
AU Minchella, PA
   Donkor, S
   Owolabi, O
   Sutherland, JS
   McDermid, JM
AF Minchella, Peter A.
   Donkor, Simon
   Owolabi, Olumuyiwa
   Sutherland, Jayne S.
   McDermid, Joann M.
TI Complex Anemia in Tuberculosis: The Need to Consider Causes and Timing
   When Designing Interventions
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE hepcidin; hemoglobin; iron; tuberculosis; inflammation
ID IRON-DEFICIENCY ANEMIA; PULMONARY TUBERCULOSIS; CHRONIC DISEASE;
   RISK-FACTORS; INCIDENT TUBERCULOSIS; RETROSPECTIVE COHORT;
   PRESCHOOL-CHILDREN; CONTROLLED-TRIAL; INFECTION; SUPPLEMENTATION
AB Background. Anemia is common in tuberculosis, and multiple etiologies necessitate targeted interventions. The proportion of iron-responsive anemia due to iron deficiency compared with iron-unresponsive anemia due to impaired iron absorption/redistribution from tuberculosis-associated immune activation or inflammation is unknown. This impedes selection of safe and effective treatment and appropriate intervention timing.
   Methods. Baseline hemoglobin, ferritin, hepcidin, soluble transferrin receptor (sTfR), and transferrin were measured in 45 patients with confirmed pulmonary tuberculosis (cases), 47 tuberculin skin test (TST)-positive controls, and 39 TST-negative controls in The Gambia. Tuberculosis cases were additionally followed 2 and 6 months after tuberculosis treatment initiation. Mutually exclusive anemia categories based on iron biomarker concentrations were iron deficiency anemia (IDA), anemia of inflammation (AI), and multifactorial anemia (IDA+AI).
   Results. Anemia was more frequent in tuberculosis cases (67%) than in TST-positive (36%) or TST-negative (21%) controls. AI was the predominant anemia at tuberculosis diagnosis, declining from 36% to 8% after 6 months of treatment; however, a corresponding reduction was not evident for anemia with iron-responsive components (IDA, IDA+AI). Iron biomarkers discriminated between active tuberculosis and TST-positive or TST-negative controls, as well as between active untreated and treated tuberculosis. This was most noticeable for hepcidin, which decreased from a median of 84.0 ng/mL at diagnosis to 9.7 ng/mL after 2 months (P < .001).
   Conclusions. Tuberculosis chemotherapy is associated with significant reductions in AI, but IDA and IDA+AI remain unresolved. Iron-based interventions are needed for IDA and IDA+AI, and monitoring of iron biomarkers reveals a window for intervention opening as early as 2 months into tuberculosis treatment.
C1 [Minchella, Peter A.; McDermid, Joann M.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Donkor, Simon; Owolabi, Olumuyiwa; Sutherland, Jayne S.] MRC Unit, Fajara, Gambia.
RP McDermid, JM (reprint author), Cornell Univ, Div Nutr Sci, 310 Savage Hall, Ithaca, NY 14853 USA.
EM jmm585@cornell.edu
OI Sutherland, Jayne/0000-0002-7083-4997
FU International Life Sciences Institute North America Future Leaders
   Award; Sigma Xi [G20130315164088]; National Science Foundation Graduate
   Research Fellowship Program [NSF 12-599]
FX This work was supported by the International Life Sciences Institute
   North America Future Leaders Award (to J. M. M.), Sigma Xi Grants-in-Aid
   of Research (grant number G20130315164088 to P. A. M.) and the National
   Science Foundation Graduate Research Fellowship Program (grant number
   NSF 12-599 to P. A. M.).
CR Bal D, 2015, INDIAN J PEDIATR, V82, P253, DOI 10.1007/s12098-014-1483-7
   Bregman DB, 2013, AM J HEMATOL, V88, P97, DOI 10.1002/ajh.23354
   Davis SL, 2012, BLOOD REV, V26, P65, DOI 10.1016/j.blre.2011.10.003
   Esan MO, 2013, CLIN INFECT DIS, V57, P1626, DOI 10.1093/cid/cit528
   Fagan RP, 2009, J INFECT DIS, V199, P652, DOI 10.1086/596659
   Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287
   Karyadi E, 2000, J NUTR, V130, P2953
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Lee SW, 2006, J KOREAN MED SCI, V21, P1028
   Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC
   Lynch SR, 2011, J NUTR, V141, p763S, DOI 10.3945/jn.110.130609
   McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48
   Minchella PA, 2014, INT J TUBERC LUNG D, V18, P1337, DOI 10.5588/ijtld.14.0143
   Nagu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091229
   Nissenson AR, 2003, ARCH INTERN MED, V163, P1400, DOI 10.1001/archinte.163.12.1400
   Sahiratmadja E, 2007, BRIT J NUTR, V98, P684, DOI 10.1017/S0007114507742691
   Savy M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011075
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Scholz BD, 1997, BRIT J NUTR, V77, P47
   Shah S, 2001, J NUTR, V131, P2843
   Shimazaki T, 2013, INT J TUBERC LUNG D, V17, P1420, DOI 10.5588/ijtld.12.0848
   Skikne BS, 2011, AM J HEMATOL, V86, P923, DOI 10.1002/ajh.22108
   Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034
   Stoltzfus RJ, 2004, J NUTR, V134, P348
   van Lettow M, 2005, EUR J CLIN NUTR, V59, P526, DOI 10.1038/sj.ejcn.1602116
   WALTER T, 1993, PEDIATRICS, V91, P976
   Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809
   Weiss G, 2002, BLOOD REV, V16, P87, DOI 10.1054/blre.2002.0193
   World Health Organization (WHO) Centers for Disease Control and Prevention, 2007, ASS IR STAT POP
   World Health Organization, 2012, TUB TB TREATM SUCC 1
   World Health Organization, 2010, WHO TREATM TUB GUID
   Bruno de B., 2008, WORLDW PREV AN 1993
   Wintrobe M. M., 2009, WINTROBES CLIN HEMAT
   Wisaksana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079904
NR 35
TC 10
Z9 11
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2015
VL 60
IS 5
BP 764
EP 772
DI 10.1093/cid/ciu945
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CB6VY
UT WOS:000349766100015
PM 25428413
OA No
DA 2017-08-15
ER

PT J
AU Thanh, PV
   Van Hong, N
   Van Van, N
   Van Malderen, C
   Obsomer, V
   Rosanas-Urgell, A
   Grietens, KP
   Xa, NX
   Bancone, G
   Chowwiwat, N
   Duong, TT
   D'Alessandro, U
   Speybroeck, N
   Erhart, A
AF Pham Vinh Thanh
   Nguyen Van Hong
   Nguyen Van Van
   Van Malderen, Carine
   Obsomer, Valerie
   Rosanas-Urgell, Anna
   Grietens, Koen Peeters
   Nguyen Xuan Xa
   Bancone, Germana
   Chowwiwat, Nongnud
   Tran Thanh Duong
   D'Alessandro, Umberto
   Speybroeck, Niko
   Erhart, Annette
TI Epidemiology of forest malaria in Central Vietnam: the hidden parasite
   reservoir
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Sub-patent infections; Elimination; Central Vietnam
ID PLASMODIUM-VIVAX; INFECTIONS; TRANSMISSION; GAMETOCYTEMIA; BEHAVIOR
AB Background: After successfully reducing the malaria burden to pre-elimination levels over the past two decades, the national malaria programme in Vietnam has recently switched from control to elimination. However, in forested areas of Central Vietnam malaria elimination is likely to be jeopardized by the high occurrence of asymptomatic and submicroscopic infections as shown by previous reports. This paper presents the results of a malaria survey carried out in a remote forested area of Central Vietnam where we evaluated malaria prevalence and risk factors for infection.
   Methods: After a full census (four study villages = 1,810 inhabitants), the study population was screened for malaria infections by standard microscopy and, if needed, treated according to national guidelines. An additional blood sample on filter paper was also taken in a random sample of the population for later polymerase chain reaction (PCR) and more accurate estimation of the actual burden of malaria infections. The risk factor analysis for malaria infections was done using survey multivariate logistic regression as well as the classification and regression tree method (CART).
   Results: A total of 1,450 individuals were screened. Malaria prevalence by microscopy was 7.8% (ranging from 3.9 to 10.9% across villages) mostly Plasmodium falciparum (81.4%) or Plasmodium vivax (17.7%) mono-infections; a large majority (69.9%) was asymptomatic. By PCR, the prevalence was estimated at 22.6% (ranging from 16.4 to 42.5%) with a higher proportion of P. vivax mono-infections (43.2%). The proportion of sub-patent infections increased with increasing age and with decreasing prevalence across villages. The main risk factors were young age, village, house structure, and absence of bed net.
   Conclusion: This study confirmed that in Central Vietnam a substantial part of the human malaria reservoir is hidden. Additional studies are urgently needed to assess the contribution of this hidden reservoir to the maintenance of malaria transmission. Such evidence will be crucial for guiding elimination strategies.
C1 [Pham Vinh Thanh; Nguyen Van Hong; Nguyen Xuan Xa; Tran Thanh Duong] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
   [Nguyen Van Van] Prov Malaria Stn, Tam Ky City, Quang Nam Provi, Vietnam.
   [Van Malderen, Carine; Speybroeck, Niko] Catholic Univ Louvain, B-1200 Brussels, Belgium.
   [Obsomer, Valerie] Catholic Univ Louvain, Louvain La Neuve, Belgium.
   [Rosanas-Urgell, Anna; Grietens, Koen Peeters; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med Prince Leopold ITM, Antwerp, Belgium.
   [Bancone, Germana; Chowwiwat, Nongnud] Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand.
   [D'Alessandro, Umberto] Med Res Council Unit MRC Unit, Fajara, Gambia.
RP Thanh, PV (reprint author), Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
EM phamvinht@gmail.com
OI Bancone, Germana/0000-0003-4550-0431
FU UBS Optimus Foundation; Belgium Cooperation (DGCD) [FA3]
FX We would like to thank the M'nong and Ca Dong communities in Tra Leng
   and Tra Don communes for their contribution to the present study, as
   well as the local authorities for their strong and continuous support.
   The study was funded by the UBS Optimus Foundation and the Framework
   Agreement project (FA3) of the Belgium Cooperation (DGCD).
CR Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456
   Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626
   Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58
   Garmin, ETREX HC SER PERS NA
   Garros C, 2008, MALARIA J, V7, DOI [10.1186/1475-2875-7-11, 10.1186/147-2875-7-11]
   Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3
   HemoCue, ACC POC AN SCREEN PI
   Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047
   McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1
   McKenzie FE, 2006, J PARASITOL, V92, P1281, DOI 10.1645/GE-911R.1
   Ministry of Health. National Malaria Control Program. National Institute of Malariology Parasitology and Entomology (NIMPE), 2011, INTERNAL REPORT
   Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206
   Modiano D., 1995, Parassitologia (Rome), V37, P255
   National Institute of Malarialogy Parasitology and Entomology, 2013, INTERNAL REPORT
   Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010
   Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241
   Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781
   Peeters Grietens K, 2010, MALARIA J, V9, P23
   Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498
   Pukrittayakamee S, 2008, AM J TROP MED HYG, V79, P378
   Speybroeck N, 2012, INT J PUBLIC HEALTH, V57, P243, DOI 10.1007/s00038-011-0315-z
   Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369
   Thang Ngo Duc, 2009, Malar J, V8, P3, DOI 10.1186/1475-2875-8-3
   Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28
   Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   WALSH PS, 1991, BIOTECHNIQUES, V10, P506
   WHO, 2014, STAT REP ART RES
   Xu JW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-417
NR 31
TC 9
Z9 9
U1 1
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD FEB 19
PY 2015
VL 14
AR 86
DI 10.1186/s12936-015-0601-y
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CC8GB
UT WOS:000350605000001
PM 25880664
OA gold
DA 2017-08-15
ER

PT J
AU Almaguer-Mederos, LE
   Sarr, L
   Abascal, JV
   Aguilera-Rodriquez, R
   Martin, MA
   Khalil, MIA
   Al-Jafari, MA
   Lopez, LD
   Volpini, V
   Nyan, O
AF Almaguer-Mederos, Luis E.
   Sarr, Louise
   Vega Abascal, Jorge
   Aguilera-Rodriquez, Raul
   Martin, Maydelis Avila
   Khalil, M. I. A.
   Al-Jafari, Muhammed Ammar
   de Jorge Lopez, Laura
   Volpini, Victor
   Nyan, Ousman
TI Spinocerebellar ataxia type 2 in The Gambia: A case report
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
ID CLINICAL-FEATURES; GENETIC-ANALYSIS; SCA2
C1 [Almaguer-Mederos, Luis E.; Vega Abascal, Jorge; Martin, Maydelis Avila; Nyan, Ousman] Sch Med & Allied Hlth Sci, Banjul, Gambia.
   [Almaguer-Mederos, Luis E.; Aguilera-Rodriquez, Raul] Ctr Invest & Rehabil Hereditary Ataxias CIRAH, Holguin, Cuba.
   [Sarr, Louise; Vega Abascal, Jorge; Khalil, M. I. A.; Al-Jafari, Muhammed Ammar] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [de Jorge Lopez, Laura; Volpini, Victor] Bellvitge Idibell Hosp Duran I Reynals, Inst Invest Biomed, Barcelona, Spain.
RP Almaguer-Mederos, LE (reprint author), Sch Med & Allied Hlth Sci, Banjul, Gambia.
EM luisalmaguer1976@yahoo.com
CR Abdel-Aleem A, 2008, J NEUROL, V255, P413, DOI 10.1007/s00415-008-0690-4
   Almaguer-Mederos LE, 2010, CLIN GENET, V78, P169, DOI 10.1111/j.1399-0004.2009.01358.x
   Biyer A, 2003, J NEUROL SCI, V216, P47
   Charles P, 2007, NEUROLOGY, V69, P1970, DOI 10.1212/01.wnl.0000269323.21969.db
   Chin-Song L, 2004, ARCH NEUROL-CHICAGO, V61, P35
   Montes-Brown J, 2011, REV MEX NEUROCI, V12
   Mutesa L, 2008, J TROP PEDIATRICS, V54, P350, DOI 10.1093/tropej/fmn034
   Rub U, 2013, PROG NEUROBIOL, V104, P38, DOI 10.1016/j.pneurobio.2013.01.001
   Smith DC, 2012, SAMJ S AFR MED J, V102, P683, DOI 10.7196/SAMJ.5521
   Traore M, 2011, EUR J NEUROL, V18, P1269, DOI 10.1111/j.1468-1331.2011.03376.x
NR 10
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD FEB 15
PY 2015
VL 349
IS 1-2
BP 269
EP 271
DI 10.1016/j.jns.2015.01.027
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA CC6YZ
UT WOS:000350516200053
PM 25649479
OA No
DA 2017-08-15
ER

PT J
AU Talsma, EF
   Verhoef, H
   Brouwer, ID
   Mburu-de Wagt, AS
   Hulshof, PJM
   Melse-Boonstra, A
AF Talsma, Elise F.
   Verhoef, Hans
   Brouwer, Inge D.
   Mburu-de Wagt, Anne S.
   Hulshof, Paul J. M.
   Melse-Boonstra, Alida
TI Proxy markers of serum retinol concentration, used alone and in
   combination, to assess population vitamin A status in Kenyan children: a
   cross-sectional study
SO BMC MEDICINE
LA English
DT Article
DE Vitamin A deficiency; Discriminant analysis; ROC curve; Sensitivity and
   specificity; Predictive value of tests; Retinol; Retinol binding
   protein; Transthyretin; Inflammation; Diagnosis
ID BINDING-PROTEIN; TRANSTHYRETIN; DEFICIENCY; INDICATORS
AB Background: Serum retinol concentration determined by high-performance liquid chromatography (HPLC) is recommended by the World Health Organization to assess population vitamin A status. This assay is expensive, technically demanding and rarely available in developing countries. Our objective was a) to assess the diagnostic performance of proxy markers in detecting vitamin A deficiency and b) to derive decision rules based on these markers to estimate vitamin A deficiency prevalence.
   Methods: A survey was conducted in 15 rural primary schools in Eastern Province, Kenya, with 375 children aged 6 to 12 years (25 randomly selected per school). Serum retinol concentration <0.70 mu mol/L by HPLC was used to define vitamin A deficiency. Proxy markers for vitamin A deficiency were serum concentrations of retinol binding protein (RBP), transthyretin, retinol measured by fluorometry and RBP: transthyretin molar ratio.
   Results: The prevalence of vitamin A deficiency (HPLC) was 18%. Transthyretin and RBP showed the best diagnostic performance individually, with area-under-the-curve (AUC) values of 0.96 and 0.93. When combined, and with C-reactive protein added, the AUC increased to 0.98. A simple decision rule {(-15.277 x [RBP, mu mol/L(-7.013 x [Transthyretin, mu mol/L(+0.367 x [C-reactive protein, mg/L(+24.714) >0.496} yielded prevalence estimates of vitamin A deficiency that is unbiased by diagnostic error.
   Conclusions: The combination of transthyretin, RBP and C-reactive protein concentrations could eventually replace retinol concentration by HPLC in resource-poor settings as the preferred method to assess the population burden of vitamin A deficiency.
C1 [Talsma, Elise F.; Brouwer, Inge D.; Mburu-de Wagt, Anne S.; Hulshof, Paul J. M.; Melse-Boonstra, Alida] Wageningen Univ, Div Human Nutr, NL-6700 EV Wageningen, Netherlands.
   [Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 EV Wageningen, Netherlands.
   [Verhoef, Hans] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England.
   [Verhoef, Hans] MRC, Keneba, Gambia.
RP Talsma, EF (reprint author), Wageningen Univ, Div Human Nutr, POB 8129, NL-6700 EV Wageningen, Netherlands.
EM Elise.talsma@gmail.com
RI Verhoef, Hans/L-3024-2015; Brouwer, Inge/K-8455-2013
OI Verhoef, Hans/0000-0002-9346-9689; 
FU European Union [211484]
FX This research was conducted within the framework of the INSTAPA Project,
   funded by the European Union's Seventh Framework Programme
   [Fp7/2007-2013] under grant agreement number 211484. Harvest Plus
   provided financial support for biochemical analyses and supplies. Sight
   & Life provided the iCheck<SUP>tm</SUP> FLUORO machine. The funders had
   no role in the design or interpretation of the study.
CR Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001
   CHEN BH, 1986, CLIN CHEM, V32, P1231
   Craft NE, 2001, J NUTR, V131, p1626S
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27
   de Pee S, 2002, J NUTR, V132, p2895S
   Engle-Stone R, 2011, J NUTR, V141, P2233, DOI 10.3945/jn.111.145805
   FUTTERMAN S, 1975, INVEST OPHTH VISUAL, V14, P125
   INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431
   Weinman ARM, 2007, NUTRITION, V23, P454, DOI 10.1016/j.nut.2007.04.003
   MONACO HL, 1994, J MOL BIOL, V244, P110, DOI 10.1006/jmbi.1994.1708
   RONNE H, 1983, J CELL BIOL, V96, P907, DOI 10.1083/jcb.96.3.907
   Rosales FJ, 1998, J NUTR, V128, P1681
   Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777
   Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4
   Verhoef H, 2005, AM J CLIN NUTR, V81, P835
   World Health Organization, 2011, WHONMHNHDMNM113
   WHO, 1996, WHONUT9610
NR 17
TC 2
Z9 2
U1 2
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD FEB 11
PY 2015
VL 13
AR 30
DI 10.1186/s12916-014-0256-5
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA CB1VT
UT WOS:000349416800001
PM 25856672
OA gold
DA 2017-08-15
ER

PT J
AU Shimakawa, Y
   Takao, Y
   Anderson, ST
   Taal, M
   Yamaguchi, T
   Giana, L
   Ndow, G
   Sarr, L
   Kambi, A
   Njai, HF
   Bottomley, C
   Nyan, O
   Sabally, S
   D'Alessandro, U
   Taylor-Robinson, SD
   Thursz, M
   Lemoine, M
   Njie, R
AF Shimakawa, Yusuke
   Takao, Yuki
   Anderson, Suzanne T.
   Taal, Makie
   Yamaguchi, Takashi
   Giana, Lamin
   Ndow, Gibril
   Sarr, Louise
   Kambi, Abubacarr
   Njai, Harr Freeya
   Bottomley, Christian
   Nyan, Ousman
   Sabally, Saihou
   D'Alessandro, Umberto
   Taylor-Robinson, Simon D.
   Thursz, Mark
   Lemoine, Maud
   Njie, Ramou
TI The prevalence and burden of symptoms in patients with chronic liver
   diseases in The Gambia, West Africa
SO PALLIATIVE MEDICINE
LA English
DT Letter
C1 [Shimakawa, Yusuke; Anderson, Suzanne T.; Ndow, Gibril; Sarr, Louise; Kambi, Abubacarr; Njai, Harr Freeya; D'Alessandro, Umberto; Lemoine, Maud; Njie, Ramou] Med Res Council MRC Unit, Banjul, Gambia.
   [Shimakawa, Yusuke; Bottomley, Christian; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   [Takao, Yuki; Taylor-Robinson, Simon D.; Thursz, Mark; Lemoine, Maud] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1NY, England.
   [Taal, Makie] Amer Int Univ, Banjul, Gambia.
   [Yamaguchi, Takashi] Kobe Univ, Dept Palliat Med, Grad Sch Med, Kobe, Hyogo 657, Japan.
   [Giana, Lamin; Ndow, Gibril; Njie, Ramou] MRC Unit, Gambia Hepatitis Intervent Study, IARC, Banjul, Gambia.
   [Sarr, Louise; Kambi, Abubacarr; Nyan, Ousman] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [Sabally, Saihou] Brikama Hlth Ctr, Hands Care, Brikama, Gambia.
RP Lemoine, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Norfolk Pl, London W2 1NY, England.
EM m.lemoine@imperial.ac.uk
RI D'Alessandro, Umberto/D-3457-2015
OI D'Alessandro, Umberto/0000-0001-6341-5009; Ndow,
   Gibril/0000-0001-5837-5110
FU Medical Research Council [MC_UP_A900_1119, MC_UP_A900_1120,
   MR/K012126/1]; Wellcome Trust [100693]
CR Harding R, 2013, LANCET ONCOL, V14, pE183, DOI 10.1016/S1470-2045(12)70396-0
   Ladep NG, 2014, HEPATOLOGY, V60, P1291, DOI 10.1002/hep.27264
   Powell RA, 2007, J PAIN SYMPTOM MANAG, V33, P229, DOI 10.1016/j.jpainsymman.2006.10.008
NR 3
TC 5
Z9 5
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0269-2163
EI 1477-030X
J9 PALLIATIVE MED
JI Palliat. Med.
PD FEB
PY 2015
VL 29
IS 2
BP 184
EP 185
DI 10.1177/0269216314547103
PG 2
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; Medicine, General & Internal
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; General & Internal Medicine
GA CA7NJ
UT WOS:000349103800012
PM 25193933
OA No
DA 2017-08-15
ER

PT J
AU Lindsay, B
   Oundo, J
   Hossain, MA
   Antonio, M
   Tamboura, B
   Walker, AW
   Paulson, JN
   Parkhill, J
   Omore, R
   Faruque, ASG
   Das, SK
   Ikumapayi, UN
   Adeyemi, M
   Sanogo, D
   Saha, D
   Sow, S
   Farag, TH
   Nasrin, D
   Li, S
   Panchalingam, S
   Levine, MM
   Kotloff, K
   Magder, LS
   Hungerford, L
   Sommerfelt, H
   Pop, M
   Nataro, JP
   Stine, OC
AF Lindsay, Brianna
   Oundo, Joe
   Hossain, M. Anowar
   Antonio, Martin
   Tamboura, Boubou
   Walker, Alan W.
   Paulson, Joseph N.
   Parkhill, Julian
   Omore, Richard
   Faruque, Abu S. G.
   Das, Suman Kumar
   Ikumapayi, Usman N.
   Adeyemi, Mitchell
   Sanogo, Doh
   Saha, Debasish
   Sow, Samba
   Farag, Tamer H.
   Nasrin, Dilruba
   Li, Shan
   Panchalingam, Sandra
   Levine, Myron M.
   Kotloff, Karen
   Magder, Laurence S.
   Hungerford, Laura
   Sommerfelt, Halvor
   Pop, Mihai
   Nataro, James P.
   Stine, O. Colin
TI Microbiota That Affect Risk for Shigellosis in Children in Low-Income
   Countries
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID GLOBAL ENTERIC MULTICENTER; DIARRHEAL DISEASE; YOUNG-CHILDREN;
   PATHOGENS; INFANTS; BURDEN; GEMS; CASE/CONTROL; ETIOLOGY; MATCHES
AB Pathogens in the gastrointestinal tract exist within a vast population of microbes. We examined associations between pathogens and composition of gut microbiota as they relate to Shigella spp./enteroinvasive Escherichia coli infection. We analyzed 3,035 stool specimens (1,735 nondiarrheal and 1,300 moderate-to-severe diarrheal) from the Global Enteric Multicenter Study for 9 enteropathogens. Diarrheal specimens had a higher number of enteropathogens (diarrheal mean 1.4, nondiarrheal mean 0.95; p<0.0001). Rotavirus showed a negative association with Shigella spp. in cases of diarrhea (odds ratio 0.31, 95% Cl 0.17-0.55) and had a large combined effect on moderate-to-severe diarrhea (odds ratio 29, 95% CI 3.8-220). In 4 Lactobacillus taxa identified by 16S rRNA gene sequencing, the association between pathogen and disease was decreased, which is consistent with the possibility that Lactobacillus spp. are protective against Shigella spp. induced diarrhea. Bacterial diversity of gut microbiota was associated with diarrhea status, not high levels of the Shigella spp. ipaH gene.
C1 [Lindsay, Brianna; Faruque, Abu S. G.; Nasrin, Dilruba; Li, Shan; Panchalingam, Sandra; Levine, Myron M.; Kotloff, Karen; Magder, Laurence S.; Hungerford, Laura; Stine, O. Colin] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
   [Oundo, Joe; Omore, Richard] Kenya Govt Med Res Ctr, Res Stn, Ctr Dis Control & Prevent, Kisumu, Kenya.
   [Hossain, M. Anowar; Faruque, Abu S. G.; Das, Suman Kumar] Int Ctr Diarrheal Dis Res, Mirzapur, Bangladesh.
   [Antonio, Martin; Ikumapayi, Usman N.; Adeyemi, Mitchell; Saha, Debasish] MRC, Basse, Gambia.
   [Tamboura, Boubou; Sanogo, Doh; Sow, Samba] Ctr Dev Vaccins Mali, Bamako, Mali.
   [Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Hinxton, Cambs, England.
   [Paulson, Joseph N.; Pop, Mihai] Univ Maryland, College Pk, MD 20742 USA.
   [Das, Suman Kumar] Univ Queensland, Brisbane, Qld, Australia.
   [Sommerfelt, Halvor] Univ Bergen, Bergen, Norway.
   [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Bergen, Norway.
   [Nataro, James P.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
RP Lindsay, B (reprint author), Univ Maryland, Sch Med, 660 W Redwood St,Howard Hall,Rm 585, Baltimore, MD 21201 USA.
EM brlindsay@gmail.com
RI Parkhill, Julian/G-4703-2011; Pop, Mihai/A-7987-2013
OI Parkhill, Julian/0000-0002-7069-5958; Pop, Mihai/0000-0001-9617-5304;
   Walker, Alan/0000-0001-5099-8495
FU Bill and Melinda Gates Foundation [BMGF 38874, BMGF OPP42917, BMGF
   OPP1016839]; National Institutes of Health [U19 090873]; US National
   Science Foundation [DGE0750616]
FX This study was supported by the Bill and Melinda Gates Foundation
   (awards BMGF 38874 to M.M.L., K.K., and J.P.N.; BMGF OPP42917 to J.P.N.
   and O.C.S.; and BMGF OPP1016839 to J.P.N. and O.C.S.); the National
   Institutes of Health (grant U19 090873 to James Kaper); and the US
   National Science Foundation (Graduate Research Fellowship DGE0750616 to
   J.N.P.).
CR Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x
   Bhavnani D, 2012, AM J EPIDEMIOL, V176, P387, DOI 10.1093/aje/kws220
   Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038
   Ghodsi M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-271
   Guandalini S, 2008, J CLIN GASTROENTEROL, V42, pS53, DOI 10.1097/MCG.0b013e3181674087
   Hansson L, 2008, STAT METHODS MED RES, V17, P595, DOI 10.1177/0962280207082348
   HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012
   Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   Kwambana BA, 2014, PEDIATR INFECT DIS J, V33, pS69, DOI 10.1097/INF.0000000000000087
   Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761
   Lindsay B, 2013, J CLIN MICROBIOL, V51, P3263, DOI 10.1128/JCM.01342-13
   Lindsay B, 2013, J CLIN MICROBIOL, V51, P1740, DOI 10.1128/JCM.02713-12
   Lindsay B, 2011, EMERG INFECT DIS, V17, P606, DOI [10.3201/eid1704.100939, 10.3201/eid1704100939]
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   LYNN HS, 1992, BIOMETRICS, V48, P397, DOI 10.2307/2532299
   Oksanen J., 2013, VEGAN COMMUNITY ECOL
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Platts-Mills JA, 2013, MUCOSAL IMMUNOL, V6, P876, DOI 10.1038/mi.2013.50
   Platts-Mills JA, 2014, AM J TROP MED HYG, V90, P133, DOI 10.4269/ajtmh.13-0439
   Pop M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r76
   Rothman KJ, 2012, EPIDEMIOLOGY INTRO
   Sinha A, 2013, CLIN MICROBIOL INFEC, V19, P173, DOI 10.1111/j.1469-0691.2011.03746.x
   Srikanth CV, 2008, INTERDISCIP PERSPECT, V2008, DOI [10.1155/2008/626827, DOI 10.1155/2008/626827]
   Taniuchi M, 2013, J INFECT DIS, V208, P1794, DOI 10.1093/infdis/jit507
   Vu Dinh Thiem, 2004, J Clin Microbiol, V42, P2031, DOI 10.1128/JCM.42.5.2031-2035.2004
   Walker CLF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029151
   Yun JH, 2005, ARCH PHARM RES, V28, P660
   Zou GY, 2008, AM J EPIDEMIOL, V168, P212, DOI 10.1093/aje/kwn104
NR 30
TC 5
Z9 5
U1 1
U2 13
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2015
VL 21
IS 2
BP 242
EP 250
DI 10.3201/eid2102.140795
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AZ8WC
UT WOS:000348491400007
PM 25625766
OA gold
DA 2017-08-15
ER

PT J
AU Bannister-Tyrrell, M
   Gryseels, C
   Delamou, A
   D'Alessandro, U
   van Griensven, J
   Grietens, KP
AF Bannister-Tyrrell, Melanie
   Gryseels, Charlotte
   Delamou, Alexandre
   D'Alessandro, Umberto
   van Griensven, Johan
   Grietens, Koen Peeters
CA Ebola Tx Trial Platform
TI Blood as medicine: social meanings of blood and the success of Ebola
   trials
SO LANCET
LA English
DT Letter
C1 [Bannister-Tyrrell, Melanie; Gryseels, Charlotte; Grietens, Koen Peeters] Inst Trop Med, Unit Med Anthropol, B-2000 Antwerp, Belgium.
   [Delamou, Alexandre] Ctr Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan.
   [Grietens, Koen Peeters] Partners Appl Social Sci Int, Tessenderlo, Belgium.
RP Grietens, KP (reprint author), Inst Trop Med, Unit Med Anthropol, B-2000 Antwerp, Belgium.
EM kpeeters@itg.be
RI D'Alessandro, Umberto/D-3457-2015
OI D'Alessandro, Umberto/0000-0001-6341-5009
FU Medical Research Council [MC_UP_A900_1119]
CR DIALLO J., 1951, BULL SOC PATH EXOT, V44, P93
   Grietens KP, 2014, AM J TROP MED HYG, V91, P213, DOI 10.4269/ajtmh.13-0630
   Mohammadi D, 2014, LANCET, V384, P1833, DOI 10.1016/S0140-6736(14)62043-2
   Moore H. L., 2001, MAGICAL INTERPRETATI
   White L., 2000, SPEAKING VAMPIRES RU
NR 5
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 31
PY 2015
VL 385
IS 9966
BP 420
EP 420
DI 10.1016/S0140-6736(14)62392-8
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA AZ9CT
UT WOS:000348509900025
PM 25608754
OA No
DA 2017-08-15
ER

PT J
AU Le Doare, K
   Allen, L
   Kampmann, B
   Heath, PT
   Taylor, S
   Hesseling, AC
   Gorringe, A
   Jones, CE
AF Le Doare, Kirsty
   Allen, Lauren
   Kampmann, Beate
   Heath, Paul Trafford
   Taylor, Stephen
   Hesseling, Anneke C.
   Gorringe, Andrew
   Jones, Christine Elizabeth
TI Anti-Group B Streptococcus antibody in infants born to mothers with
   human immunodeficiency virus (HIV) infection
SO VACCINE
LA English
DT Article
DE Antibody; Group B Streptococcus; HIV-exposed-uninfected infants; HIV;
   Immunity
ID UNINFECTED INFANTS; MATERNAL ANTIBODY; IMMUNE-RESPONSE; SOUTH-AFRICA;
   DISEASE; MORBIDITY; MORTALITY; NEWBORNS; VACCINE; POLYSACCHARIDES
AB Background: HIV-exposed uninfected infants have increased infection risk and mortality compared to HIV-unexposed infants. HIV-exposed infants may be at increased risk of invasive GBS disease due to reduced maternal antibody against GBS.
   Methods: We quantified antibodies that bind to the surface of whole Group B Streptococcus (GBS) of serotypes Ia, lb, II, III and V using novel flow cytometry assays in South African HIV-infected and noninfected mothers and their uninfected infants. Antibody-mediated complement Cb3/iC3b deposition onto GBS of these serotypes was also quantified by a novel flow cytometry assay.
   Results: Geometric mean concentration (GMC) of both surface-binding anti-GBS antibody and antibody-mediated complement deposition onto GBS were reduced in HIV-infected women (n = 46) compared to HIV-uninfected women (n=58) for ST1a (surface-binding: 19.3 vs 293; p=0.003; complement deposition: 2.9 vs 5.3 SU/mL; p=0.003), STIb (24.9 vs 47.6; p=0.003; 2.6 vs 4.9 SU/mL; p=0.003), STII (19.8 vs 50.0; p=0.001; 3.1 vs 6.2 SU/mL; p=0.001), STIII (27.8 vs 60.1; p=0.001; 2.8 vs 5.3 SU/mL; p=0.001) and STV (121.9 vs 185.6 SU/mL; p<0.001) and in their infants for STIa (complement deposition 9.4 vs 27.0 SU/mL; p=0.02), STIb (13.4 vs 24.5 SU/mL; p=0.02), STII (14.6 vs 42.7 SU/mL; p=0.03), STIII (26.6 vs 62.7 SU/mL; p=0.03) and STV (90.4 vs 165.8 SU/mL; p=0.04). Median transplacental transfer of antibody from HIV-infected women to their infants was reduced compared to HIV-uninfected women for GBS serotypes 11 (0.42 [IQR 0.22-0.59] vs 1.0 SU/mL [0.42-1.66]; p<0.001), III (0.54 [0.34-1.03] vs 0.95 SU/mL [0.42-3.05],p=0.05) and V (0.51 [0.28-0.79] vs 0.75 SU/mL [0.26-2.9],p=0.04). The differences between infants remained significant at 16 weeks of age.
   Conclusions: Maternal HIV infection was associated with lower anti-GBS surface binding antibody concentration and antibody-mediated C3b/iC3b deposition onto GBS bacteria of serotypes Ia, lb, II, III and V. This may render these infants more susceptible to early and late onset GBS disease. Crown Copyright (C) 2014 Published by Elsevier Ltd.
C1 [Le Doare, Kirsty; Kampmann, Beate; Jones, Christine Elizabeth] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, Wellcome Trust Imperial Ctr Global Hlth Res, London W2 1NY, England.
   [Le Doare, Kirsty; Heath, Paul Trafford; Jones, Christine Elizabeth] Univ London, Paediat Infect Dis Res Grp, London SW17 0RE, England.
   [Allen, Lauren; Taylor, Stephen; Gorringe, Andrew] Publ Hlth England, Salisbury SP4 0JG, Wilts, England.
   [Kampmann, Beate] MRC, Fajara, Gambia.
   [Hesseling, Anneke C.; Jones, Christine Elizabeth] Univ Stellenbosch, Dept Pediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa.
RP Le Doare, K (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Wellcome Trust Imperial Ctr Global Hlth Res, Norfolk Pl, London W2 1PG, England.
EM k.mehring-le-doare@imperial.ac.uk
OI le doare, kirsty/0000-0002-5104-085X; Jones,
   Christine/0000-0003-1523-2368; Kampmann, Beate/0000-0002-6546-4709
FU Medical Research Council [MC_UP_A900_1122, MC_EX_MR/K011944/1]; Wellcome
   Trust [KLD2013]
CR Baker CJ, 2014, J INFECT DIS, V209, P781, DOI 10.1093/infdis/jit549
   Baker CJ, 2004, J INFECT DIS, V189, P1103, DOI 10.1086/382193
   BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404
   Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807
   Brookes C, 2013, J IMMUNOL METHODS, V391, P39, DOI 10.1016/j.jim.2013.02.007
   Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926
   Clerici M, 2000, BLOOD, V96, P3866
   Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845
   Groome MJ, 2013, INVASIVE GROUP B STR, pOP2
   Edwards MS, 2012, VACCINE, V30, P4123, DOI 10.1016/j.vaccine.2012.04.048
   Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183
   Frigati L, 2013, RETROSPECTIVE REV GR, pOP1
   Gray KJ, 2007, EMERG INFECT DIS, V13, P223
   Gray KJ, 2011, EMERG INFECT DIS, V17, P1932, DOI 10.3201/eid1710.102008
   Gupta A, 2014, VACCINE, V32, P1466, DOI 10.1016/j.vaccine.2014.01.033
   HALL MA, 1992, INFECT IMMUN, V60, P5030
   Healy CM, 2004, J INFECT DIS, V190, P335, DOI 10.1086/421033
   Hygino J, 2008, CLIN IMMUNOL, V127, P340, DOI 10.1016/j.clim.2008.01.020
   Jones CE, 2014, AIDS IN PRESS
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Kaspar DL, 1996, J CLIN INVEST, V98, P2308, DOI 10.1172/JCI119042
   Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e
   Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029
   Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009
   Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756
   Madzivhandila M, 2013, J MED MICROBIOL, V62, P249, DOI 10.1099/jmm.0.052951-0
   Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c
   Mayer E, 2013, HIVEXPOSED UNINFECTE, pOP4
   McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9
   Mussi-Pinhata MM, 2007, PEDIATRICS, V119, pE694, DOI 10.1542/peds.2006-1856
   Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7
   Quan V, 2013, PAEDIAT INVASIVE GRO, pOP3
   Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0
   Simani OE, 2013, AIDS, V27, P1583, DOI 10.1097/QAD.0b013e32835fae26
   Suara RO, 1998, J NATL MED ASSOC, V90, P109
   UNAIDS, 2010, GLOB REP UNAIDS REP
NR 36
TC 11
Z9 11
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JAN 25
PY 2015
VL 33
IS 5
BP 621
EP 627
DI 10.1016/j.vaccine.2014.12.025
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA CB3BR
UT WOS:000349503700007
PM 25543061
OA No
DA 2017-08-15
ER

PT J
AU Santolamazza, F
   Caputo, B
   Nwakanma, DC
   Fanello, C
   Petrarca, V
   Conway, DJ
   Weetman, D
   Pinto, J
   Mancini, E
   della Torre, A
AF Santolamazza, Federica
   Caputo, Beniamino
   Nwakanma, Davis C.
   Fanello, Caterina
   Petrarca, Vincenzo
   Conway, David J.
   Weetman, David
   Pinto, Joao
   Mancini, Emiliano
   della Torre, Alessandra
TI Remarkable diversity of intron-1 of the para voltage-gated sodium
   channel gene in an Anopheles gambiae/Anopheles coluzzii hybrid zone
SO MALARIA JOURNAL
LA English
DT Article
DE Mosquito; Malaria; Hybridization
ID KNOCKDOWN RESISTANCE MUTATIONS; GAMBIAE MOLECULAR-FORMS; GENOMIC
   ISLANDS; MALARIA VECTOR; S FORMS; ECOLOGICAL SPECIATION; INCIPIENT
   SPECIATION; STATISTICAL-METHOD; DNA POLYMORPHISM; FLOW
AB Background: Genomic differentiation between Anopheles gambiae and Anopheles coluzzii - the major malaria vectors in sub-Saharan Africa - is localized into large "islands" toward the centromeres of chromosome-X and the two autosomes. Linkage disequilibrium between these genomic islands was first detected between species-specific polymorphisms within ribosomal DNA genes (IGS-rDNA) on the X-chromosome and a single variant at position 702 of intron 1 (Int-1(702)) of the para Voltage-Gated Sodium Channel (VGSC) gene on chromosome arm 2 L. Intron-1 sequence data from West and Central Africa revealed two clearly distinct and species-specific haplogroups, each characterized by very low polymorphism, which has been attributed to a selective sweep. The aim of this study was to analyse Int-1 sequence diversity in A. gambiae and A. coluzzii populations from the Far-West of their range, in order to assess whether this selective-sweep signature could persist in a zone of high interspecific hybridization.
   Methods: A 531 bp region of VGSC Int-1 was sequenced in 21 A. coluzzii, 31 A. gambiae, and 12 hybrids from The Gambia and Guinea Bissau, located within the Far-West geographical region, and in 53 A. gambiae s.l. samples from the rest of the range.
   Results: Far-West samples exhibit dramatic Int-1 polymorphism, far higher within each country than observed throughout the rest of the species range. Moreover, patterning of haplotypes within A. coluzzii confirms previous evidence of a macro-geographic subdivision into a West and a Central African genetic cluster, and reveals a possible genetic distinction of A. coluzzii populations from the Far-West.
   Conclusions: The results suggest a relaxation of selective pressures acting across the VGSC gene region in the hybrid zone. Genetic differentiation in the Far-West could be attributable to a founder effect within A. coluzzii, with subsequent extensive gene flow with secondarily-colonizing A. gambiae, potentially yielding a novel insight on the dynamic processes impacting genetic divergence of these key malaria vectors.
C1 [Santolamazza, Federica; Caputo, Beniamino; Mancini, Emiliano; della Torre, Alessandra] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dipartimento Sanita Pubbl & Malattie Infett, I-00185 Rome, Italy.
   [Nwakanma, Davis C.; Conway, David J.] MRC Unit, Banjul, Gambia.
   [Fanello, Caterina] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England.
   [Petrarca, Vincenzo] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dipartimento Biol & Biotecnol, I-00185 Rome, Italy.
   [Weetman, David] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England.
   [Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal.
   [Mancini, Emiliano] Univ Rome Tre, Dipartimento Sci, I-00146 Rome, Italy.
RP Mancini, E (reprint author), Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dipartimento Sanita Pubbl & Malattie Infett, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM emiliano.mancini@uniroma1.it
RI Caputo, Beniamino/I-2880-2015; Pinto, Joao/C-2208-2012; Weetman,
   David/M-1261-2014
OI Caputo, Beniamino/0000-0002-5650-8773; Pinto, Joao/0000-0001-8572-7708;
   Weetman, David/0000-0002-5820-1388; Conway, David/0000-0002-8711-3037
FU European Union [228421]; MIUR-FIRB "Futuro in Ricerca" grant
   [RBFR106NTE]; CIRM ISS - Italian Malaria Network; Universita di Roma
   SAPIENZA
FX We are grateful to all scientists and entomology teams who contributed
   to mosquito samples, with particular reference to L. Iyikirenga
   (National Malaria Control Programme-TRAC Plus, Ministry of Health,
   Kigali, Rwanda), T.G.T. Jaenson (Medical Entomology Unit, Department of
   Systematic Biology, Uppsala University, Uppsala, Sweden) and K. Palsson
   (KTH Royal Institute of Technology, Stockholm, Sweden). This work was
   supported by European Union's INFRAVEC project (grant agreement no.
   228421 under FP7 program) to AdT and JP, Ricerca Scientifica 2012 grant
   by Universita di Roma SAPIENZA to AdT and MIUR-FIRB "Futuro in Ricerca
   2010" grant to BC (Grant No RBFR106NTE) and by CIRM ISS - Italian
   Malaria Network.
CR Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102
   Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415
   Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248
   Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x
   Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2
   Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769
   Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143
   Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796
   della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x
   della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170
   Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47
   Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x
   Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009
   Feder JL, 2010, EVOLUTION, V64, P1729, DOI 10.1111/j.1558-5646.2010.00943.x
   FU YX, 1993, GENETICS, V133, P693
   Gentile G, 2004, INSECT MOL BIOL, V13, P371, DOI 10.1111/j.0962-1075.2004.00494.x
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755
   Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16
   Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105
   Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036
   Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718
   Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075
   Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243
   Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x
   Santolamazza F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-215
   Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163
   Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74
   SCOTT JA, 1993, AM J TROP MED HYG, V49, P520
   Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x
   Staden R, 2000, Methods Mol Biol, V132, P115
   Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501
   TAJIMA F, 1989, GENETICS, V123, P585
   Turner TL, 2010, MOL ECOL, V19, P848, DOI 10.1111/j.1365-294X.2010.04532.x
   Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285
   Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x
   Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199
   Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x
   White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x
NR 44
TC 2
Z9 2
U1 1
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JAN 21
PY 2015
VL 14
AR 9
DI 10.1186/s12936-014-0522-1
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CA4LK
UT WOS:000348875400001
PM 25604888
OA gold
DA 2017-08-15
ER

PT J
AU Nambozi, M
   Mulenga, M
   Halidou, T
   Tagbor, H
   Mwapasa, V
   Phiri, LK
   Kalanda, G
   Valea, I
   Traore, M
   Mwakazanga, D
   Claeys, Y
   Schurmans, C
   De Crop, M
   Menten, J
   Ravinetto, R
   Thriemer, K
   Van Geertruyden, JP
   Mutabingwa, T
   D'Alessandro, U
AF Nambozi, Michael
   Mulenga, Modest
   Halidou, Tinto
   Tagbor, Harry
   Mwapasa, Victor
   Phiri, Linda Kalilani
   Kalanda, Gertrude
   Valea, Innocent
   Traore, Maminata
   Mwakazanga, David
   Claeys, Yves
   Schurmans, Celine
   De Crop, Maaike
   Menten, Joris
   Ravinetto, Raffaella
   Thriemer, Kamala
   Van Geertruyden, Jean-Pierre
   Mutabingwa, Theonest
   D'Alessandro, Umberto
CA Pregact Grp
TI Safe and efficacious artemisinin-based combination treatments for
   African pregnant women with malaria: a multicentre randomized control
   trial
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Artemisinin-based therapy; Malaria in pregnancy; Pregnant women;
   Malaria; Sub-Saharan
ID FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; NONPREGNANT WOMEN;
   PHARMACOKINETICS; INFECTION; ANTIMALARIAL; HIV-1; ARTESUNATE; MORTALITY;
   ADULTS
AB Background: Asymptomatic and symptomatic malaria during pregnancy has consequences for both mother and her offspring. Unfortunately, there is insufficient information on the safety and efficacy of most antimalarials in pregnancy. Indeed, clinical trials assessing antimalarial treatments systematically exclude pregnancy for fear of teratogenicity and embryotoxicity. The little available information originates from South East Asia while in sub-Saharan Africa such information is still limited and needs to be provided.
   Design: A Phase 3, non-inferiority, multicentre, randomized, open-label clinical trial on safety and efficacy of 4 ACT when administered during pregnancy was carried out in 4 African countries: Burkina Faso, Ghana, Malawi and Zambia. This is a four arm trial using a balanced incomplete block design. Pregnant women diagnosed with malaria are randomised to receive either amodiaquine-artesunate (AQ-AS), dihydroartemisinin-piperaquine (DHA-PQ), artemether-lumefantrine (AL), or mefloquine-artesunate (MQAS). They are actively followed up until day 63 post-treatment and then monthly until 4-6 weeks post-delivery. The offspring is visited at the time of the first birthday. The primary endpoint is treatment failure (PCR adjusted) at day 63 and safety profiles. Secondary endpoints included PCR unadjusted treatment failure up to day 63, gametocyte carriage, Hb changes, placenta malaria, mean birth weight and low birth weight. The primary statistical analysis will use the combined data from all 4 centres, with adjustment for any centre effects, using an additive model for the response rates. This will allow the assessment of all 6 possible pair-wise treatment comparisons using all available data.
   Discussion: The strength of this trial is the involvement of several African countries, increasing the generalisability of the results. In addition, it assesses most ACTs currently available, determining their relative `-value-' compared to others. The balanced incomplete block design was chosen because using all 4-arms in each site would have increased complexity in terms of implementation. Excluding HIV-positive pregnant women on antiretroviral drugs may be seen as a limitation because of the possible interactions between antiretroviral and antimalarial treatments. Nevertheless, the results of this trial will provide the evidence base for the formulation of malaria treatment policy for pregnant women in sub-Saharan Africa.
C1 [Nambozi, Michael; Mulenga, Modest] Trop Dis Res Ctr, Dept Clin Sci, Ndola, Zambia.
   [Halidou, Tinto; Valea, Innocent; Traore, Maminata] Clin Res Unit, Nanoro, Burkina Faso.
   [Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana.
   [Mwapasa, Victor; Phiri, Linda Kalilani; Kalanda, Gertrude] Univ Malawi, Coll Med, Zomba, Malawi.
   [Claeys, Yves; Schurmans, Celine; De Crop, Maaike; Menten, Joris; Ravinetto, Raffaella; Thriemer, Kamala; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Thriemer, Kamala] Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Nambozi, Michael; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Mutabingwa, Theonest] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania.
   [D'Alessandro, Umberto] MRC Unit, Serrekunda, Gambia.
   [D'Alessandro, Umberto] Pharmaceut & Pharmacol Sci Dept, Leuven, Ku, Belgium.
RP D'Alessandro, U (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.
EM udalessandro@mrc.gm
RI D'Alessandro, Umberto/D-3457-2015; Van geertruyden,
   Jean-pierre/K-6425-2014
OI D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden,
   Jean-pierre/0000-0001-5006-6364; Thriemer, Kamala/0000-0001-7536-7497
FU EDCTP; Bill and Melinda Gates foundation (BMGF) - USA;
   Directorate-General for Development Cooperation (DGDC) - Belgium; London
   School of Hygiene and Tropical Medicine (LSHTM) - United Kingdom;
   Netherlands-African Partnership for Capacity Development and Clinical
   interventions Against Poverty-related diseases (NACCAP) - Netherlands;
   Medical Research Council (MRC) - UK
FX The research was funded by EDCTP and Co-funding from Bill and Melinda
   Gates foundation (BMGF) - USA, Directorate-General for Development
   Cooperation (DGDC) - Belgium, London School of Hygiene and Tropical
   Medicine (LSHTM) - United Kingdom, Netherlands-African Partnership for
   Capacity Development and Clinical interventions Against Poverty-related
   diseases (NACCAP) - Netherlands, and Medical Research Council (MRC) -
   UK. The authors declare that they have no competing interests.
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Adjuik M, 2004, LANCET, V363, P9
   ATZORI C, 1993, ANN TROP MED PARASIT, V87, P585
   Barnes KI, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-122
   BLOLAND PB, 1995, AIDS, V9, P721, DOI 10.1097/00002030-199507000-00009
   Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8
   Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141
   McGready R, 2012, BRIT J CLIN PHARMACO, V73, P467, DOI 10.1111/j.1365-2125.2011.04103.x
   Noedl H, 2004, AM J TROP MED HYG, V71, P711
   Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC-49.8.3575-3577.2005
   Nosten F, 2007, AM J TROP MED HYG, V77, P181
   Nosten Francois, 2006, Curr Drug Saf, V1, P1, DOI 10.2174/157488606775252584
   Poespoprodjo JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084976
   Rijken MJ, 2011, ANTIMICROB AGENTS CH, V55, P5500, DOI 10.1128/AAC.05067-11
   Rijken MJ, 2011, ANTIMICROB AGENTS CH, V55, P4338, DOI 10.1128/AAC.00154-11
   Shulman CE, 2003, T ROY SOC TROP MED H, V97, P30, DOI 10.1016/S0035-9203(03)90012-5
   Steketee RW, 1996, AM J TROP MED HYG, V55, P42
   Unekel CJ, 2009, T ROY SOC TROP MED H, V103, P761, DOI 10.1016/j.trstmh.2008.06.017
   Valea I, 2014, J ANTIMICROB CHEMOTH, V69, P2499, DOI 10.1093/jac/dku154
   Van Geertruyden JP, 2006, JAIDS-J ACQ IMM DEF, V43, P363
   Verhoeff FH, 1999, TROP MED INT HEALTH, V4, P5, DOI 10.1046/j.1365-3156.1999.00349.x
   Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7
   Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6
   WHO, 2009, METH SURV ANT DURG E
   World Health Organization, 2010, GUID TREATM MAL WORL
   Wilby KJ, 2011, CLIN PHARMACOKINET, V50, P705, DOI 10.2165/11594550-000000000-00000
NR 26
TC 6
Z9 6
U1 2
U2 16
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD JAN 15
PY 2015
VL 12
AR 5
DI 10.1186/1742-4755-12-5
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CB2VJ
UT WOS:000349486100001
PM 25592254
OA gold
DA 2017-08-15
ER

PT J
AU Gurdasani, D
   Carstensen, T
   Tekola-Ayele, F
   Pagani, L
   Tachmazidou, I
   Hatzikotoulas, K
   Karthikeyan, S
   Iles, L
   Pollard, MO
   Choudhury, A
   Ritchie, GS
   Xue, YL
   Asimit, J
   Nsubuga, RN
   Young, EH
   Pomilla, C
   Kivinen, K
   Rockett, K
   Kamali, A
   Doumatey, AP
   Asiki, G
   Seeley, J
   Sisay-Joof, F
   Jallow, M
   Tollman, S
   Mekonnen, E
   Ekong, R
   Oljira, T
   Bradman, N
   Bojang, K
   Ramsay, M
   Adeyemo, A
   Bekele, E
   Motala, A
   Norris, SA
   Pirie, F
   Kaleebu, P
   Kwiatkowski, D
   Tyler-Smith, C
   Rotimi, C
   Zeggini, E
   Sandhu, MS
AF Gurdasani, Deepti
   Carstensen, Tommy
   Tekola-Ayele, Fasil
   Pagani, Luca
   Tachmazidou, Ioanna
   Hatzikotoulas, Konstantinos
   Karthikeyan, Savita
   Iles, Louise
   Pollard, Martin O.
   Choudhury, Ananyo
   Ritchie, GrahamR. S.
   Xue, Yali
   Asimit, Jennifer
   Nsubuga, Rebecca N.
   Young, Elizabeth H.
   Pomilla, Cristina
   Kivinen, Katja
   Rockett, Kirk
   Kamali, Anatoli
   Doumatey, Ayo P.
   Asiki, Gershim
   Seeley, Janet
   Sisay-Joof, Fatoumatta
   Jallow, Muminatou
   Tollman, Stephen
   Mekonnen, Ephrem
   Ekong, Rosemary
   Oljira, Tamiru
   Bradman, Neil
   Bojang, Kalifa
   Ramsay, Michele
   Adeyemo, Adebowale
   Bekele, Endashaw
   Motala, Ayesha
   Norris, Shane A.
   Pirie, Fraser
   Kaleebu, Pontiano
   Kwiatkowski, Dominic
   Tyler-Smith, Chris
   Rotimi, Charles
   Zeggini, Eleftheria
   Sandhu, Manjinder S.
TI The African Genome Variation Project shapes medical genetics in Africa
SO NATURE
LA English
DT Article
ID POPULATION-GENETICS; WIDE ASSOCIATION; MALARIA; SELECTION; HYPERTENSION;
   HISTORY; SUSCEPTIBILITY; REVEALS; DIVERSITY; EVOLUTION
AB Given the importance of Africa to studies of human origins and disease susceptibility, detailed characterization of African genetic diversity is needed. The African Genome Variation Project provides a resource with which to design, implement and interpret genomic studies in sub-Saharan Africa and worldwide. The African Genome Variation Project represents dense genotypes from 1,481 individuals and whole-genome sequences from 320 individuals across sub-Saharan Africa. Using this resource, we find novel evidence of complex, regionally distinct hunter-gatherer and Eurasian admixture across sub-Saharan Africa. We identify new loci under selection, including loci related to malaria susceptibility and hypertension. We show that modern imputation panels (sets of reference genotypes from which unobserved or missing genotypes in study sets can be inferred) can identify association signals at highly differentiated loci across populations in sub-Saharan Africa. Using whole-genome sequencing, we demonstrate further improvements in imputation accuracy, strengthening the case for large-scale sequencing efforts of diverse African haplotypes. Finally, we present an efficient genotype array design capturing common genetic variation in Africa.
C1 [Gurdasani, Deepti; Carstensen, Tommy; Pagani, Luca; Tachmazidou, Ioanna; Hatzikotoulas, Konstantinos; Karthikeyan, Savita; Iles, Louise; Pollard, Martin O.; Ritchie, GrahamR. S.; Xue, Yali; Asimit, Jennifer; Young, Elizabeth H.; Pomilla, Cristina; Kivinen, Katja; Adeyemo, Adebowale; Kwiatkowski, Dominic; Tyler-Smith, Chris; Zeggini, Eleftheria; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Gurdasani, Deepti; Carstensen, Tommy; Karthikeyan, Savita; Iles, Louise; Young, Elizabeth H.; Pomilla, Cristina; Sandhu, Manjinder S.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.
   [Tekola-Ayele, Fasil; Doumatey, Ayo P.; Adeyemo, Adebowale; Rotimi, Charles] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20891 USA.
   [Pagani, Luca] Univ Bologna, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy.
   [Iles, Louise] Univ York, Dept Archaeol, York YO1 7EP, N Yorkshire, England.
   [Choudhury, Ananyo; Ramsay, Michele] Univ Witwatersrand, SBIMB, Johannesburg, Gauteng, South Africa.
   [Ritchie, GrahamR. S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England.
   [Nsubuga, Rebecca N.; Kamali, Anatoli; Asiki, Gershim; Seeley, Janet; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, Entebbe, Uganda.
   [Rockett, Kirk; Kwiatkowski, Dominic] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.
   [Sisay-Joof, Fatoumatta; Jallow, Muminatou; Bojang, Kalifa] MRC Unit, Banjul, Gambia.
   [Tollman, Stephen] MRC, Sch Publ Hlth, Wits Rural Publ Hlth & Hlth Transit Unit, Johannesburg, Gauteng, South Africa.
   [Tollman, Stephen] INDEPTH Network, Accra, Ghana.
   [Mekonnen, Ephrem] Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia.
   [Ekong, Rosemary] UCL, Dept Genet Evolut & Environm, London, England.
   [Oljira, Tamiru] Univ Haramaya, Dept Biol, Dire Dawa, Ethiopia.
   [Bradman, Neil] Henry Stewart Grp, London WC1A 2HN, England.
   [Ramsay, Michele] Natl Hlth Lab Serv, Div Human Genet, ZA-2000 Johannesburg, South Africa.
   [Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, ZA-2000 Johannesburg, South Africa.
   [Bekele, Endashaw] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.
   [Motala, Ayesha; Pirie, Fraser] Univ KwaZulu Natal, Dept Endocrinol & Diabet, ZA-4013 Durban, South Africa.
   [Norris, Shane A.] Univ Witwatersrand, Dept Paediat, Johannesburg, Gauteng, South Africa.
RP Sandhu, MS (reprint author), Wellcome Trust Sanger Inst, Genome Campus, Cambridge CB10 1SA, England.
EM dg11@sanger.ac.uk; cts@sanger.ac.uk; rotimic@mail.nih.gov;
   eleftheria@sanger.ac.uk; ms23@sanger.ac.uk
RI ; Pollard, Martin/G-7205-2012; Pagani, Luca/G-8511-2017
OI Tekola-Ayele, Fasil/0000-0003-4194-9370; Pollard,
   Martin/0000-0001-8738-0920; Pagani, Luca/0000-0002-6639-524X; Seeley,
   Janet/0000-0002-0583-5272; Asimit, Jennifer/0000-0002-4857-2249;
   Adeyemo, Adebowale/0000-0002-3105-3231; Zeggini,
   Eleftheria/0000-0003-4238-659X; Kivinen, Katja/0000-0002-1135-7625;
   Kwiatkowski, Dominic/0000-0002-5023-0176
FU Wellcome Trust [WT077383/Z/05/Z]; Wellcome Trust Sanger Institute
   [WT098051]; Bill and Melinda Gates Foundation; Foundation for the
   National Institutes of Health [566]; UK Medical Research Council
   [G0901213-92157, G0801566, G0600718, MR/K013491/1]; South African Sugar
   Association; Servier South Africa; Victor Daitz Foundation; National
   Institute on Minority Health and Health Disparities; National Institute
   of Diabetes and Digestive and Kidney Diseases (NIDDK); National Human
   Genome Research Institute (NHGRI); Intramural Research Program of the
   Center for Research on Genomics and Global Health (CRGGH) [Z01HG200362];
   MRC Centre for Genomics and Global Health; Cambridge Commonwealth
   Scholarship
FX This project was funded in part by the Wellcome Trust (grant number
   WT077383/Z/05/Z), The Wellcome Trust Sanger Institute (grant number
   WT098051), the Bill and Melinda Gates Foundation, the Foundation for the
   National Institutes of Health (grant number 566), and the UK Medical
   Research Council (grant numbers G0901213-92157, G0801566, G0600718 and
   MR/K013491/1). We also acknowledge the National Institute for Health
   Research Cambridge Biomedical Research Centre and the Wellcome Trust
   Cambridge Centre for Global Health Research. We are very grateful to J.
   Pickrell for sharing human origins data and MALDER code, and for useful
   input on interpretations of these analyses. We also thank E. Garrison
   for his suggestions on using Genome in a bottle sets
   (ftp://ftp-trace.ncbi.nih.gov/giab/ftp/data/NA12878/variant_calls/NIST/R
   EADME.NIST.v2.18.txt) for validation of whole-genome sequencing data. We
   also thank the African Partnership for Chronic Disease Research
   (APCDR)for providing a network to support this study as well as a
   repository for deposition of curated data. Sample collections from South
   Africa were funded by The South African Sugar Association, Servier South
   Africa and The Victor Daitz Foundation. The Kenyan samples were
   collected by D. Ngare of Moi University, Eldoret, Kenya, as part of the
   Africa America Diabetes Mellitus (AADM) study and the International
   HapMap project (D. Ngare, who is now deceased, was a great supporter of
   genomics in Africa,as exemplified by his leadership in engaging the
   Luhya and Maasai communities for the HapMap project). The Igbo samples
   were collected by J. Oli of the University of Nigeria, Enugu, Nigeria.
   The Ga-Adangbe samples were collected by the laboratories of A. Amoah of
   the University of Ghana, Accra, Ghana, and J. Acheampong of the
   University of Science and Technology, Kumasi, Ghana. Support for the
   AADM study is provided by the National Institute on Minority Health and
   Health Disparities, the National Institute of Diabetes and Digestive and
   Kidney Diseases (NIDDK) and the National Human Genome Research Institute
   (NHGRI). The Gambian samples were collected by M. Jallow and colleagues
   at the MRC Unit, The Gambia and form part of the MalariaGEN Consortial
   Resource. This research was supported in part by the Intramural Research
   Program of the Center for Research on Genomics and Global Health (CRGGH;
   grant number Z01HG200362) and by the MRC Centre for Genomics and Global
   Health. D.G. was funded by the Cambridge Commonwealth Scholarship. We
   thank the 1000 Genomes Project for sharing genotype data that were
   analysed as part of this project. We also thank all study participants
   who contributed to this study.
CR Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299
   Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509
   Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550
   Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110
   The Bradshaw Foundation, 2014, OR PREH ROCK ART ART
   Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x
   Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056
   de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318
   Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867
   Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119
   Fumagalli M, 2010, MOL BIOL EVOL, V27, P2555, DOI 10.1093/molbev/msq141
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Graffe CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-15
   Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16
   Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86
   Jacobs T, 2002, J IMMUNOL, V169, P2323
   Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388
   Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641
   Ko WY, 2013, AM J HUM GENET, V93, P54, DOI 10.1016/j.ajhg.2013.05.014
   Kosoy R, 2011, GENES IMMUN, V12, P582, DOI 10.1038/gene.2011.33
   Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989
   Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07
   Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384
   Lopes MF, 1999, EUR J IMMUNOL, V29, P81, DOI 10.1002/(SICI)1521-4141(199901)29:01<81::AID-IMMU81>3.0.CO;2-Y
   Machado P, 2010, BRIT J HAEMATOL, V149, P775, DOI 10.1111/j.1365-2141.2010.08165.x
   Martins GA, 2001, IMMUNOLOGY, V103, P122, DOI 10.1046/j.1365-2567.2001.01216.x
   Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10
   Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203
   Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015
   Panda AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049420
   Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283
   Patin E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4163
   Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037
   Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111
   Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886
   Ribeiro CMS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013012
   Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546
   Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721
   Sereno P.C., 2008, PIOS ONE, V3, P2995, DOI DOI 10.1371/J0URNAL.P0NE.0002995
   Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11
   Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429
   Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109
   Tilman L.-E., 2007, ATLAS CULTURAL ENV C
   Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257
   Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072
   Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227
   Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082
   Zhang GC, 2012, INFECT IMMUN, V80, P2316, DOI 10.1128/IAI.00261-12
NR 50
TC 88
Z9 88
U1 5
U2 45
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JAN 15
PY 2015
VL 517
IS 7534
BP 327
EP U397
DI 10.1038/nature13997
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AY8NK
UT WOS:000347810300037
PM 25470054
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Jones, CE
   Hesseling, AC
   Tena-Coki, NG
   Scriba, TJ
   Chegou, NN
   Kidd, M
   Wilkinson, RJ
   Kampmann, B
AF Jones, Christine E.
   Hesseling, Anneke C.
   Tena-Coki, Nontobeko G.
   Scriba, Thomas J.
   Chegou, Novel N.
   Kidd, Martin
   Wilkinson, Robert J.
   Kampmann, Beate
TI The impact of HIV exposure and maternal Mycobacterium tuberculosis
   infection on infant immune responses to bacille Calmette-Guerin
   vaccination
SO AIDS
LA English
DT Article
DE bacille Calmette-Guerin; HIV infection; HIV-exposed; immunogenicity;
   Mycobacterium tuberculosis infection; uninfected infants; vaccination
ID ACTIVE ANTIRETROVIRAL THERAPY; UNINFECTED INFANTS; CORD BLOOD;
   HIV-1-INFECTED MOTHERS; LYMPHOCYTE SUBSETS; CYTOKINE RESPONSES;
   INTERFERON-GAMMA; T-LYMPHOCYTES; IN-UTERO; CHILDREN
AB Objective: The objective of this study is to assess the effect of maternal HIV and Mycobacterium tuberculosis (Mtb) infection on cellular responses to bacille CalmetteGue Guerin (BCG) immunization.
   Design: A mother-infant cohort study.
   Methods: Samples were collected from mother-infant pairs at delivery. Infants were BCG-vaccinated at 6 weeks of age and a repeat blood sample was collected from infants at 16 weeks of age. BCG-specific T-cell proliferation and intracellular cytokine expression were measured by flow cytometry. Secreted cytokines and chemokines in cell culture supernatants were analysed using a Multiplex assay.
   Results: One hundred and nine (47 HIV-exposed and 62 HIV-unexposed) mother infants pairs were recruited after delivery and followed longitudinally. At birth, proportions of mycobacteria-specific proliferating T cells were not associated with either in-utero HIV exposure or maternal Mtb sensitization. However, in-utero HIV exposure affected infant-specific T-cell subsets [tumour necrosis factor-alpha (TNF-alpha) single positive proliferating CD4(+) T cells and interferon-gamma (IFN-gamma), TNF-alpha dual positive CD4(+) T cells]. Levels of TNF-a protein in cell culture supernatants were also significantly higher in HIV-exposed infants born to Mtb-sensitized mothers. In the presence of maternal Mtb sensitization, frequencies of maternal and newborn BCG specific proliferating CD4(+) T cells were positively correlated. Following BCG vaccination, there was no demonstrable effect of HIV exposure or maternal Mtb infection on infant BCG-specific T-cell proliferative responses or concentrations of secreted cytokines and chemokines.
   Conclusion: Effects of maternal HIV and Mtb infection on infant immune profiles at birth are transient only, and HIV-exposed, noninfected infants have the same potential to respond to and be protected by BCG vaccination as HIV-unexposed infants. (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Jones, Christine E.; Tena-Coki, Nontobeko G.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Pediat, London, England.
   [Jones, Christine E.; Tena-Coki, Nontobeko G.; Kampmann, Beate] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.
   [Jones, Christine E.] Univ London, Paediat Infect Dis Res Grp, London SW17 0RE, England.
   [Hesseling, Anneke C.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Pediat & Child Hlth, Fac Hlth Sci, ZA-7600 Stellenbosch, South Africa.
   [Scriba, Thomas J.] Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.
   [Chegou, Novel N.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7600 Stellenbosch, South Africa.
   [Chegou, Novel N.] Univ Stellenbosch, MRC Ctr TB Res, Div Mol Biol & Human Genet, Dept Biomed Sci,Fac Med & Hlth Sci, ZA-7600 Stellenbosch, South Africa.
   [Kidd, Martin] Univ Stellenbosch, Div Stat & Actuarial Sci, Fac Sci, ZA-7600 Stellenbosch, South Africa.
   [Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England.
   [Wilkinson, Robert J.] Univ Cape Town, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.
   [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England.
   [Kampmann, Beate] MRC Unit, Vaccinol Theme, Banjul, Gambia.
RP Jones, CE (reprint author), Univ London, Paediat Infect Dis Res Grp, Mail Point J2C,Level 2,Jenner Wing, London SW17 0RE, England.
EM cjones@sgul.ac.uk
OI Kampmann, Beate/0000-0002-6546-4709; Wilkinson,
   Robert/0000-0002-2753-1800
FU European Society for Pediatric Infectious Diseases; Thrasher Research
   Foundation; British Society of Infection; Wellcome Trust [GR 077273,
   084323, 088316]; Medical Research Council [MR/K007602/1, MR/K011944/1,
   MC_UP_A900/115, U1175.02.0002.00014]; National Institute for Health
   Research, UK; European Union [FP7-PEOPLE-2011-IRSES, FP7
   HEALTH-F3-2012-305578]; EDCTP [IP.07.32080.002]
FX This work was supported by the European Society for Pediatric Infectious
   Diseases (C.E.J.), the Thrasher Research Foundation (C.E.J.), British
   Society of Infection (C.E.J.). B.K. receives support from the Wellcome
   Trust (GR 077273), Medical Research Council (MR/K007602/1; MR/K011944/1;
   MC_UP_A900/115) and the National Institute for Health Research, UK.
   R.J.W. receives support from the Wellcome Trust (084323, 088316),
   Medical Research Council (U1175.02.0002.00014), European Union
   (FP7-PEOPLE-2011-IRSES and FP7 HEALTH-F3-2012-305578) and from EDCTP
   (IP.07.32080.002).
CR Adegnika AA, 2008, J INFECT DIS, V198, P928, DOI 10.1086/591057
   Borges-Almeida E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-38
   Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a
   Chougnet C, 2000, J INFECT DIS, V181, P1590, DOI 10.1086/315458
   City of Cape Town Department of Health, CIT HLTH HIV AIDS ST
   Clerici M, 2000, BLOOD, V96, P3866
   Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083
   Cotton MF, 2008, INT J TUBERC LUNG D, V12, P225
   Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3
   Economides A, 1998, CLIN DIAGN LAB IMMUN, V5, P230
   Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047
   Elrefaei M, 2004, J IMMUNOL, V173, P2184
   Embree J, 2001, PEDIATR INFECT DIS J, V20, P397, DOI 10.1097/00006454-200104000-00006
   Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183
   Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401.6407.2004
   Kemp K, 2001, J INTERF CYTOK RES, V21, P503, DOI 10.1089/10799900152434376
   Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e
   Kuhn L, 2001, PEDIATR RES, V50, P412, DOI 10.1203/00006450-200109000-00018
   Madhi SA, 2011, NEW ENGL J MED, V365, P21, DOI 10.1056/NEJMoa1011214
   Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340
   Malhotra I, 1999, J IMMUNOL, V162, P6843
   Mansoor N, 2009, J INFECT DIS, V199, P982, DOI 10.1086/597304
   Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c
   Mazzola TN, 2011, AIDS, V25, P2079, DOI 10.1097/QAD.0b013e32834bba0a
   McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9
   Miles DJC, 2010, IMMUNOLOGY, V129, P446, DOI 10.1111/j.1365-2567.2009.03186.x
   Nakiyingi JS, 2003, AIDS, V17, P1827, DOI 10.1097/01.aids.0000076274.54156.41
   Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7
   Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398
   Ono E, 2008, BRAZ J MED BIOL RES, V41, P700, DOI 10.1590/S0100-879X2008000800011
   Otieno RO, 2006, AIDS, V20, P275, DOI 10.1097/01.aids.0000200533.56490.b7
   Puissant-Lubrano B, 2009, VACCINE, V27, P3576, DOI 10.1016/j.vaccine.2009.03.050
   Rahman MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009699
   Resino S, 2006, JAIDS-J ACQ IMM DEF, V42, P269, DOI 10.1097/01.qai.0000222287.90201.d7
   Rich KC, 1997, CLIN DIAGN LAB IMMUN, V4, P358
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Schramm DB, 2007, CLIN VACCINE IMMUNOL, V14, P348, DOI 10.1128/CVI.00464-06
   Schramm DB, 2006, JAIDS-J ACQ IMM DEF, V42, P545, DOI 10.1097/01.qai.0000225009.30698.ce
   Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847
   Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007
   Torre P, 2012, PEDIATR INFECT DIS J, V31, P835, DOI 10.1097/INF.0b013e31825b9524
   Van Rie A, 2006, CLIN VACCINE IMMUNOL, V13, P246, DOI 10.1128/CVI.13.2.246-252.2006
   van den Biggelaar AHJ, 2009, J ALLERGY CLIN IMMUN, V124
   Velilla PA, 2008, CLIN IMMUNOL, V126, P243, DOI 10.1016/j.clim.2007.11.004
   Weir RE, 2006, CLIN EXP IMMUNOL, V146, P390, DOI 10.1111/j.1365-2249.2006.03222.x
   WHO, 2007, WKLY EPIDEMIOL REC, V82, P193
NR 49
TC 9
Z9 9
U1 2
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JAN 14
PY 2015
VL 29
IS 2
BP 155
EP 165
DI 10.1097/QAD.0000000000000536
PG 11
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA AX8HE
UT WOS:000347149900003
PM 25535752
OA No
DA 2017-08-15
ER

PT J
AU Cohan, D
   Natureeba, P
   Koss, CA
   Plenty, A
   Luwedde, F
   Mwesigwa, J
   Ades, V
   Charlebois, ED
   Gandhi, M
   Clark, TD
   Nzarubara, B
   Achan, J
   Ruel, T
   Kamya, MR
   Havlir, DV
AF Cohan, Deborah
   Natureeba, Paul
   Koss, Catherine A.
   Plenty, Albert
   Luwedde, Flavia
   Mwesigwa, Julia
   Ades, Veronica
   Charlebois, Edwin D.
   Gandhi, Monica
   Clark, Tamara D.
   Nzarubara, Bridget
   Achan, Jane
   Ruel, Theodore
   Kamya, Moses R.
   Havlir, Diane V.
TI Efficacy and safety of lopinavir/ritonavir versus efavirenz-based
   antiretroviral therapy in HIV-infected pregnant Ugandan women
SO AIDS
LA English
DT Article
DE breastfeeding; efavirenz; lopinavir/ritonavir; pregnancy; prevention of
   mother-to-child transmission of HIV
ID RANDOMIZED CONTROLLED-TRIAL; TO-CHILD TRANSMISSION; LOPINAVIR-RITONAVIR;
   PREVENTION; REGIMENS; HAIR; METAANALYSIS; OUTCOMES; PHARMACOKINETICS;
   EXPOSURE
AB Objective: Combination antiretroviral therapy (ART) is now the global standard for HIV-infected pregnant and breastfeeding women at all CD4(+) cell counts. We compared the efficacy and safety of an efavirenz versus lopinavir/ritonavir regimen for HIV infected pregnant women initiating ART in rural Uganda.
   Design: Randomized clinical trial.
   Methods: We performed a planned secondary analysis comparing viral load suppression (HIV-1 RNA <= 400 copies/ml), safety, and HIV transmission to infants in a trial designed to test the hypothesis that lopinavir/ritonavir versus efavirenz-based ART would reduce placental malaria (PROMOTE, ClinicalTrials.gov, NCT00993031). HIV-infected, ART naive pregnant women at 12-28 weeks gestation and any CD4(+) cell count were randomized. ART was provided and participants were counseled to breastfeed for 1 year postpartum.
   Results: The median age of the 389 study participants was 29 years; median CD4(+) cell count was 370 cells/mu l. At delivery, virologic suppression was 97.6% in the efavirenz arm and 86.0% in the lopinavir/ ritonavir arm (P< 0.001). At 48 weeks postpartum, 91.0% of women on efavirenz and 88.4% on lopinavir/ ritonavir had viral suppression (P = 0.49). Grade 1 or 2 gastrointestinal adverse events were higher among women on lopinavir/ ritonavir versus efavirenz. Only two infants acquired HIV (both in the lopinavir/ritonavir arm), and HIV-free infant survival was similar between study arms: 92.9% (lopinavir/ ritonavir) versus 97.2% (efavirenz) (P = 0.10).
   Conclusion: Virologic suppression at delivery was higher with an efavirenz versus lopinavir/ ritonavir-based regimen. However, women in both arms achieved high levels of virologic suppression through 1 year postpartum and the risk of transmission to infants was low. (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Cohan, Deborah] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.
   [Natureeba, Paul; Luwedde, Flavia; Mwesigwa, Julia; Nzarubara, Bridget] Makerere Univ Univ Calif San Francisco Res Collab, Kampala, Uganda.
   [Koss, Catherine A.; Gandhi, Monica; Clark, Tamara D.; Havlir, Diane V.] Univ Calif San Francisco, Div HIV AIDS, San Francisco Gen Hosp, San Francisco, CA 94143 USA.
   [Plenty, Albert; Charlebois, Edwin D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.
   [Ades, Veronica] NYU, Dept Obstet & Gynecol, New York, NY 10016 USA.
   [Achan, Jane] MRC Unit, Serrekunda, Gambia.
   [Ruel, Theodore] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.
   [Kamya, Moses R.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda.
RP Havlir, DV (reprint author), Univ Calif San Francisco, Div HIV AIDS, San Francisco Gen Hosp, Box 0874, San Francisco, CA 94143 USA.
EM dhavlir@php.ucsf.edu
OI Ades, Veronica/0000-0002-9163-7511
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development [P01 HD059454, K23 HD60459]; National Institute of Allergy
   and Infectious Diseases (NIAID) at the National Institutes of Health
   [T32 AI060530]; NIAID [R01 AI098472]; NIH
FX This work was supported by grants from the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development (P01 HD059454,
   D.V.H. and K23 HD60459, T.R.) and the National Institute of Allergy and
   Infectious Diseases (NIAID, T32 AI060530, D.V.H./C.A.K.) at the National
   Institutes of Health. A grant from NIAID supported the hair analyses
   (R01 AI098472, M.G.). AbbVie Pharmaceuticals donated lopinavir/ritonavir
   (Aluvia) for the parent trial. Gilead donates medications for
   participants in a separate NIH-funded study led by D.V.H. but provides
   no financial support.
CR Bartelink IH, 2014, J CLIN PHARMACOL, V54, P121, DOI 10.1002/jcph.167
   Best BM, 2010, JAIDS-J ACQ IMM DEF, V54, P381, DOI 10.1097/QAI.0b013e3181d6c9ed
   Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622
   Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486
   Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553
   Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243
   Ford N, 2011, AIDS, V25, P2301, DOI 10.1097/QAD.0b013e32834cdb71
   Ford N, 2010, AIDS, V24, P1461, DOI 10.1097/QAD.0b013e32833a2a14
   Gandhi M, 2013, JAIDS-J ACQ IMM DEF, V63, P578, DOI 10.1097/QAI.0b013e31829c48ad
   Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131
   Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9
   Huang Y, 2008, RAPID COMMUN MASS SP, V22, P3401, DOI 10.1002/rcm.3750
   Jamieson DJ, 2012, LANCET, V379, P2449, DOI 10.1016/S0140-6736(12)60321-3
   Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff
   Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252
   Koss CA, 2014, JAIDS-J ACQ IMM DEF, V67, P128, DOI 10.1097/QAI.0000000000000281
   Lorenzi P, 1998, AIDS, V12, pF241, DOI 10.1097/00002030-199818000-00002
   Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7
   Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f
   Natureeba P, 2014, J INFECT DIS, V210, P1938, DOI 10.1093/infdis/jiu346
   Newell ML, 2013, CURR OPIN HIV AIDS, V8, P503
   Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, REC US ANT DRUGS PRE
   Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718
   Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609
   Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736
   Simon A, 2011, JAMA-J AM MED ASSOC, V306, P70, DOI 10.1001/jama.2011.915
   Stek AM, 2006, AIDS, V20, P1931, DOI 10.1097/01.aids.0000247114.43714.90
   Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015
   van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc
   [Anonymous], 2013, CONS GUID US ANT DRU
   World Health Organization, 2007, WHO CAS DEN HIV SURV
   [Anonymous], 2004, DIVISION AIDS TABLES
NR 32
TC 9
Z9 9
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD JAN 14
PY 2015
VL 29
IS 2
BP 183
EP 191
DI 10.1097/QAD.0000000000000531
PG 9
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA AX8HE
UT WOS:000347149900006
PM 25426808
OA No
DA 2017-08-15
ER

PT J
AU Naghavi, M
   Wang, HD
   Lozano, R
   Davis, A
   Liang, XF
   Zhou, MG
   Vollset, SE
   Ozgoren, AA
   Abdalla, S
   Abd-Allah, F
   Aziz, MIA
   Abera, SF
   Aboyans, V
   Abraham, B
   Abraham, JP
   Abuabara, KE
   Abubakar, I
   Abu-Raddad, LJ
   Abu-Rmeileh, NME
   Achoki, T
   Adelekan, A
   Ademi, ZN
   Adofo, K
   Adou, AK
   Adsuar, JC
   Aernlov, J
   Agardh, EE
   Akena, D
   Al Khabouri, MJ
   Alasfoor, D
   Albittar, M
   Alegretti, MA
   Aleman, AV
   Alemu, ZA
   Alfonso-Cristancho, R
   Alhabib, S
   Ali, MK
   Ali, R
   Alla, F
   Al Lami, F
   Allebeck, P
   AlMazroa, MA
   Salman, RAS
   Alsharif, U
   Alvarez, E
   Alviz-Guzman, N
   Amankwaa, AA
   Amare, AT
   Ameli, O
   Amini, H
   Ammar, W
   Anderson, HR
   Anderson, BO
   Antonio, CAT
   Anwari, P
   Apfel, H
   Cunningham, SA
   Arsenijevic, VSA
   Al Artaman
   Asad, MM
   Asghar, RJ
   Assadi, R
   Atkins, LS
   Atkinson, C
   Badawi, A
   Bahit, MC
   Bakfalouni, T
   Balakrishnan, K
   Balalla, S
   Banerjee, A
   Barber, RM
   Barker-Collo, SL
   Barquera, S
   Barregard, L
   Barrero, LH
   Barrientos-Gutierrez, T
   Basu, A
   Basu, S
   Basulaiman, MO
   Beardsley, J
   Bedi, N
   Beghi, E
   Bekele, T
   Bell, ML
   Benjet, C
   Bennett, DA
   Bensenor, IM
   Benzian, H
   Bertozzi-Villa, A
   Beyene, TJ
   Bhala, N
   Bhalla, A
   Bhutta, ZA
   Bikbov, B
   Bin Abdulhak, A
   Biryukov, S
   Blore, JD
   Blyth, FM
   Bohensky, MA
   Borges, G
   Bose, D
   Boufous, S
   Bourne, RR
   Boyers, LN
   Brainin, M
   Brauer, M
   Brayne, CEG
   Brazinova, A
   Breitborde, N
   Brenner, H
   Briggs, ADM
   Brown, JC
   Brugha, TS
   Buckle, GC
   Bui, LN
   Bukhman, G
   Burch, M
   Nonato, IRC
   Carabin, H
   Cardenas, R
   Carapetis, J
   Carpenter, DO
   Caso, V
   Castaneda-Orjuela, CA
   Castro, RE
   Catala-Lopez, F
   Cavalleri, F
   Chang, JC
   Charlson, FC
   Che, X
   Chen, HL
   Chen, YY
   Chen, JS
   Chen, ZM
   Chiang, PPC
   Chimed-Ochir, O
   Chowdhury, R
   Christensen, H
   Christophi, CA
   Chuang, TW
   Chugh, SS
   Cirillo, M
   Coates, MM
   Coffeng, LE
   Coggeshall, MS
   Cohen, A
   Colistro, V
   Colquhoun, SM
   Colomar, M
   Cooper, LT
   Cooper, C
   Coppola, LM
   Cortinovis, M
   Courville, K
   Cowie, BC
   Criqui, MH
   Crump, JA
   Cuevas-Nasu, L
   Leite, IDC
   Dabhadkar, KC
   Dandona, L
   Dandona, R
   Dansereau, E
   Dargan, PI
   Dayama, A
   De la Cruz-Gongora, V
   de la Vega, SF
   De Leo, D
   Degenhardt, L
   del Pozo-Cruz, B
   Dellavalle, RP
   Deribe, K
   Jarlais, DCD
   Dessalegn, M
   deVeber, GA
   Dharmaratne, SD
   Dherani, M
   Diaz-Ortega, JL
   Diaz-Torne, C
   Dicker, D
   Ding, EL
   Dokova, K
   Dorsey, ER
   Driscoll, TR
   Duan, LL
   Duber, HC
   Durrani, AM
   Ebel, BE
   Edmond, KM
   Ellenbogen, RG
   Elshrek, Y
   Ermakov, SP
   Erskine, HE
   Eshrati, B
   Esteghamati, A
   Estep, K
   Furst, T
   Fahimi, S
   Fahrion, AS
   Faraon, EJA
   Farzadfar, F
   Fay, DFJ
   Feigl, AB
   Feigin, VL
   Felicio, MM
   Fereshtehnejad, SM
   Fernandes, JG
   Ferrari, AJ
   Fleming, TD
   Foigt, N
   Foreman, K
   Forouzanfar, MH
   Fowkes, FGR
   Paleo, UF
   Franklin, RC
   Futran, ND
   Gaffikin, L
   Gambashidze, K
   Gankpe, FG
   Garcia-Guerra, FA
   Garcia, AC
   Geleijnse, JM
   Gessner, BD
   Gibney, KB
   Gillum, RF
   Gilmour, S
   Abdelmageem, I
   Ginawi, M
   Giroud, M
   Glaser, EL
   Goenka, S
   Dantes, HG
   Gona, P
   Gonzalez-Medina, D
   Guinovart, C
   Gupta, R
   Gupta, R
   Gosselin, RA
   Gotay, CC
   Goto, A
   Gowda, HN
   Graetz, N
   Greenwell, KF
   Gugnani, HC
   Gunnell, D
   Gutierrez, RA
   Haagsma, J
   Hafezi-Nejad, N
   Hagan, H
   Hagstromer, M
   Halasa, YA
   Hamadeh, RR
   Hamavid, H
   Hammami, M
   Hancock, J
   Hankey, GJ
   Hansen, GM
   Harb, HL
   Harewood, H
   Haro, JM
   Havmoeller, R
   Hay, RJ
   Hay, SI
   Hedayati, MT
   Pi, IBH
   Heuton, KR
   Heydarpour, P
   Higashi, H
   Hijar, M
   Hoek, HW
   Hoffman, HJ
   Hornberger, JC
   Hosgood, HD
   Hossain, M
   Hotez, PJ
   Hoy, DG
   Hsairi, M
   Hu, GQ
   Huang, JJ
   Huffman, MD
   Hughes, AJ
   Husseini, A
   Huynh, C
   Iannarone, M
   Iburg, KM
   Idrisov, BT
   Ikeda, N
   Innos, K
   Inoue, M
   Islami, F
   Ismayilova, S
   Jacobsen, KH
   Jassal, S
   Jayaraman, SP
   Jensen, PN
   Jha, V
   Jiang, GH
   Jiang, Y
   Jonas, JB
   Joseph, J
   Juel, K
   Kabagambe, EK
   Kan, HD
   Karch, A
   Karimkhani, C
   Karthikeyan, G
   Kassebaum, N
   Kaul, A
   Kawakami, N
   Kazanjan, K
   Kazi, DS
   Kemp, AH
   Kengne, AP
   Keren, A
   Kereselidze, M
   Khader, YS
   Khalifa, SEAH
   Khan, EA
   Khan, G
   Khang, YH
   Kieling, C
   Kinfu, Y
   Kinge, JM
   Kim, D
   Kim, S
   Kivipelto, M
   Knibbs, L
   Knudsen, AK
   Kokubo, Y
   Kosen, S
   Kotagal, M
   Kravchenko, MA
   Krishnaswami, S
   Krueger, H
   Defo, BK
   Kuipers, EJ
   Bicer, BK
   Kulkarni, C
   Kulkarni, VS
   Kumar, K
   Kumar, RB
   Kwan, GF
   Kyu, H
   Lai, T
   Balaji, AL
   Lalloo, R
   Lallukka, T
   Lam, H
   Lan, Q
   Lansingh, VC
   Larson, HJ
   Larsson, A
   Lavados, PM
   Lawrynowicz, AEB
   Leasher, JL
   Lee, JT
   Leigh, J
   Leinsalu, M
   Leung, R
   Levitz, C
   Li, B
   Li, YC
   Li, YM
   Liddell, C
   Lim, SS
   de Lima, GMF
   Lind, ML
   Lipshultz, SE
   Liu, SW
   Liu, Y
   Lloyd, BK
   Lofgren, KT
   Logroscino, G
   London, SJ
   Lortet-Tieulent, J
   Lotufo, PA
   Lucas, RM
   Lunevicius, R
   Lyons, RA
   Ma, S
   Machado, VMP
   MacIntyre, MF
   Mackay, MT
   MacLachlan, JH
   Magis-Rodriguez, C
   Mahdi, AA
   Majdan, M
   Malekzadeh, R
   Mangalam, S
   Mapoma, CC
   Marape, M
   Marcenes, W
   Margono, C
   Marks, GB
   Marzan, MB
   Masci, JR
   Mashal, MTQ
   Masiye, F
   Mason-Jones, AJ
   Matzopolous, R
   Mayosi, BM
   Mazorodze, TT
   McGrath, JJ
   Mckay, AC
   Mckee, M
   McLain, A
   Meaney, PA
   Mehndiratta, MM
   Mejia-Rodriguez, F
   Melaku, YA
   Meltzer, M
   Memish, ZA
   Mendoza, W
   Mensah, GA
   Meretoja, A
   Mhimbira, FA
   Miller, TR
   Mills, EJ
   Misganaw, A
   Mishra, SK
   Mock, CN
   Moffitt, TE
   Ibrahim, NM
   Mohammad, KA
   Mokdad, AH
   Mola, GL
   Monasta, L
   Monis, JD
   Hernandez, JCM
   Montico, M
   Montine, TJ
   Mooney, MD
   Moore, AR
   Moradi-Lakeh, M
   Moran, AE
   Mori, R
   Moschandreas, J
   Moturi, WN
   Moyer, ML
   Mozaffarian, D
   Mueller, UO
   Mukaigawara, M
   Mullany, EC
   Murray, J
   Mustapha, A
   Naghavi, P
   Naheed, A
   Naidoo, KS
   Naldi, L
   Nand, D
   Nangia, V
   Narayan, KMV
   Nash, D
   Nasher, J
   Nejjari, C
   Nelson, RG
   Neuhouser, M
   Neupane, SP
   Newcomb, PA
   Newman, L
   Newton, CR
   Ng, M
   Ngalesoni, FN
   Nguyen, G
   Nguyen, NTT
   Nisar, MI
   Nolte, S
   Norheim, OF
   Norman, RE
   Norrving, B
   Nyakarahuka, L
   Odell, S
   O'Donnell, M
   Ohkubo, T
   Ohno, SL
   Olusanya, BO
   Omer, SB
   Opio, JN
   Orisakwe, OE
   Ortblad, KF
   Ortiz, A
   Otayza, MLK
   Pain, AW
   Pandian, JD
   Panelo, CI
   Panniyammakal, J
   Papachristou, C
   Caicedo, AJP
   Patten, SB
   Patton, GC
   Paul, VK
   Pavlin, B
   Pearce, N
   Pellegrini, CA
   Pereira, DM
   Peresson, SC
   Perez-Padilla, R
   Perez-Ruiz, FP
   Perico, N
   Pervaiz, A
   Pesudovs, K
   Peterson, CB
   Petzold, M
   Phillips, BK
   Phillips, DE
   Phillips, MR
   Plass, D
   Piel, FB
   Poenaru, D
   Polinder, S
   Popova, S
   Poulton, RG
   Pourmalek, F
   Prabhakaran, D
   Qato, D
   Quezada, AD
   Quistberg, DA
   Rabito, F
   Rafay, A
   Rahimi, K
   Rahimi-Movaghar, V
   Rahman, SUR
   Raju, M
   Rakovac, I
   Rana, SM
   Refaat, A
   Remuzzi, G
   Ribeiro, AL
   Ricci, S
   Riccio, PM
   Richardson, L
   Richardus, JH
   Roberts, B
   Roberts, DA
   Robinson, M
   Roca, A
   Rodriguez, A
   Rojas-Rueda, D
   Ronfani, L
   Room, R
   Roth, GA
   Rothenbacher, D
   Rothstein, DH
   Rowley, JT
   Roy, N
   Ruhago, GM
   Rushton, L
   Sambandam, S
   Soreide, K
   Saeedi, MY
   Saha, S
   Sahathevan, R
   Sahraian, MA
   Sahle, BW
   Salomon, JA
   Salvo, D
   Samonte, GMJ
   Sampson, U
   Sanabria, JR
   Sandar, L
   Santos, IS
   Satpathy, M
   Sawhney, M
   Saylan, M
   Scarborough, P
   Schottker, B
   Schmidt, JC
   Schneider, IJC
   Schumacher, AE
   Schwebel, DC
   Scott, JG
   Sepanlou, SG
   Servan-Mori, EE
   Shackelford, K
   Shaheen, A
   Shahraz, S
   Shakh-Nazarova, M
   Shangguan, S
   She, J
   Sheikhbahaei, S
   Shepard, DS
   Shibuya, K
   Shinohara, Y
   Shishani, K
   Shiue, I
   Shivakoti, R
   Shrime, MG
   Sigfusdottir, ID
   Silberberg, DH
   Silva, AP
   Simard, EP
   Sindi, S
   Singh, JA
   Singh, L
   Sioson, E
   Skirbekk, V
   Sliwa, K
   So, S
   Soljak, M
   Soneji, S
   Soshnikov, SS
   Sposato, LA
   Sreeramareddy, CT
   Stanaway, JRD
   Stathopoulou, VK
   Steenland, K
   Stein, C
   Steiner, C
   Stevens, A
   Stoeckl, H
   Straif, K
   Stroumpoulis, K
   Sturua, L
   Sunguya, BF
   Swaminathan, S
   Swaroop, M
   Sykes, BL
   Tabb, KM
   Takahashi, K
   Talongwa, RT
   Tan, F
   Tanne, D
   Tanner, M
   Tavakkoli, M
   Ao, BT
   Teixeira, CM
   Templin, T
   Tenkorang, EY
   Terkawi, AS
   Thomas, BA
   Thorne-Lyman, AL
   Thrift, AG
   Thurston, GD
   Tillmann, T
   Tirschwell, DL
   Tleyjeh, IM
   Tonelli, M
   Topouzis, F
   Towbin, JA
   Toyoshima, H
   Traebert, J
   Tran, BX
   Truelsen, T
   Trujillo, U
   Trillini, M
   Dimbuene, ZT
   Tsilimbaris, M
   Tuzcu, EM
   Ubeda, C
   Uchendu, US
   Ukwaja, KN
   Undurraga, EA
   Vallely, AJ
   van de Vijver, S
   van Gool, CH
   Varakin, YY
   Vasankari, TJ
   Vasconcelos, AMN
   Vavilala, MS
   Venketasubramanian, N
   Vijayakumar, L
   Villalpando, S
   Violante, FS
   Vlassov, VV
   Wagner, GR
   Waller, SG
   Wang, JL
   Wang, L
   Wang, XR
   Wang, YP
   Warouw, TS
   Weichenthal, S
   Weiderpass, E
   Weintraub, RG
   Wenzhi, W
   Werdecker, A
   Wessells, KRR
   Westerman, R
   Whiteford, HA
   Wilkinson, JD
   Williams, TN
   Woldeyohannes, SM
   Wolfe, CDA
   Wolock, TM
   Woolf, AD
   Wong, JQ
   Wright, JL
   Wulf, S
   Wurtz, B
   Xu, GL
   Yang, YC
   Yano, Y
   Yatsuya, H
   Yip, P
   Yonemoto, N
   Yoon, SJ
   Younis, M
   Yu, CH
   Jin, KY
   Zaki, MES
   Zamakhshary, MF
   Zeeb, H
   Zhang, Y
   Zhao, Y
   Zheng, YF
   Zhu, J
   Zhu, S
   Zonies, D
   Zou, XN
   Zunt, JR
   Vos, T
   Lopez, AD
   Murray, CJL
AF Naghavi, Mohsen
   Wang, Haidong
   Lozano, Rafael
   Davis, Adrian
   Liang, Xiaofeng
   Zhou, Maigeng
   Vollset, Stein Emil
   Ozgoren, Ayse Abbasoglu
   Abdalla, Safa
   Abd-Allah, Foad
   Aziz, Muna I. Abdel
   Abera, Semaw Ferede
   Aboyans, Victor
   Abraham, Biju
   Abraham, Jerry P.
   Abuabara, Katrina E.
   Abubakar, Ibrahim
   Abu-Raddad, Laith J.
   Abu-Rmeileh, Niveen M. E.
   Achoki, Tom
   Adelekan, Ademola
   Ademi, Zanfi Na
   Adofo, Koranteng
   Adou, Arsene Kouablan
   Adsuar, Jose C.
   Aernlov, Johan
   Agardh, Emilie Elisabet
   Akena, Dickens
   Al Khabouri, Mazin J.
   Alasfoor, Deena
   Albittar, Mohammed
   Alegretti, Miguel Angel
   Aleman, Alicia V.
   Alemu, Zewdie Aderaw
   Alfonso-Cristancho, Rafael
   Alhabib, Samia
   Ali, Mohammed K.
   Ali, Raghib
   Alla, Francois
   Al Lami, Faris
   Allebeck, Peter
   AlMazroa, Mohammad A.
   Salman, Rustam Al-Shahi
   Alsharif, Ubai
   Alvarez, Elena
   Alviz-Guzman, Nelson
   Amankwaa, Adansi A.
   Amare, Azmeraw T.
   Ameli, Omid
   Amini, Hassan
   Ammar, Walid
   Anderson, H. Ross
   Anderson, Benjamin O.
   Antonio, Carl Abelardo T.
   Anwari, Palwasha
   Apfel, Henry
   Cunningham, Solveig Argeseanu
   Arsenijevic, Valentina S. Arsic
   Al Artaman
   Asad, Majed Masoud
   Asghar, Rana J.
   Assadi, Reza
   Atkins, Lydia S.
   Atkinson, Charles
   Badawi, Alaa
   Bahit, Maria C.
   Bakfalouni, Talal
   Balakrishnan, Kalpana
   Balalla, Shivanthi
   Banerjee, Amitava
   Barber, Ryan M.
   Barker-Collo, Suzanne L.
   Barquera, Simon
   Barregard, Lars
   Barrero, Lope H.
   Barrientos-Gutierrez, Tonatiuh
   Basu, Arindam
   Basu, Sanjay
   Basulaiman, Mohammed Omar
   Beardsley, Justin
   Bedi, Neeraj
   Beghi, Ettore
   Bekele, Tolesa
   Bell, Michelle L.
   Benjet, Corina
   Bennett, Derrick A.
   Bensenor, Isabela M.
   Benzian, Habib
   Bertozzi-Villa, Amelia
   Beyene, Tariku Jibat
   Bhala, Neeraj
   Bhalla, Ashish
   Bhutta, Zulfiqar A.
   Bikbov, Boris
   Bin Abdulhak, Aref
   Biryukov, Stan
   Blore, Jed D.
   Blyth, Fiona M.
   Bohensky, Megan A.
   Borges, Guilherme
   Bose, Dipan
   Boufous, Soufiane
   Bourne, Rupert R.
   Boyers, Lindsay N.
   Brainin, Michael
   Brauer, Michael
   Brayne, Carol E. G.
   Brazinova, Alexandra
   Breitborde, Nicholas
   Brenner, Hermann
   Briggs, Adam D. M.
   Brown, Jonathan C.
   Brugha, Traolach S.
   Buckle, Geoffrey C.
   Bui, Linh Ngoc
   Bukhman, Gene
   Burch, Michael
   Nonato, Ismael Ricardo Campos
   Carabin, Helesne
   Cardenas, Rosario
   Carapetis, Jonathan
   Carpenter, David O.
   Caso, Valeria
   Castaneda-Orjuela, Carlos A.
   Castro, Ruben Estanislao
   Catala-Lopez, Ferrn
   Cavalleri, Fiorella
   Chang, Jung-Chen
   Charlson, Fiona C.
   Che, Xuan
   Chen, Honglei
   Chen, Yingyao
   Chen, Jian Sheng
   Chen, Zhengming
   Chiang, Peggy Pei-Chia
   Chimed-Ochir, Odgerel
   Chowdhury, Rajiv
   Christensen, Hanne
   Christophi, Costas A.
   Chuang, Ting-Wu
   Chugh, Sumeet S.
   Cirillo, Massimo
   Coates, Matthew M.
   Coffeng, Luc Edgar
   Coggeshall, Megan S.
   Cohen, Aaron
   Colistro, Valentina
   Colquhoun, Samantha M.
   Colomar, Mercedes
   Cooper, Leslie Trumbull
   Cooper, Cyrus
   Coppola, Luis M.
   Cortinovis, Monica
   Courville, Karen
   Cowie, Benjamin C.
   Criqui, Michael H.
   Crump, John A.
   Cuevas-Nasu, Lucia
   Leite, Iuri da Costa
   Dabhadkar, Kaustubh C.
   Dandona, Lalit
   Dandona, Rakhi
   Dansereau, Emily
   Dargan, Paul I.
   Dayama, Anand
   De la Cruz-Gongora, Vanessa
   de la Vega, Shelley F.
   De Leo, Diego
   Degenhardt, Louisa
   del Pozo-Cruz, Borja
   Dellavalle, Robert P.
   Deribe, Kebede
   Jarlais, Don C. Des
   Dessalegn, Muluken
   deVeber, Gabrielle A.
   Dharmaratne, Samath D.
   Dherani, Mukesh
   Diaz-Ortega, Jose-Luis
   Diaz-Torne, Cesar
   Dicker, Daniel
   Ding, Eric L.
   Dokova, Klara
   Dorsey, E. Ray
   Driscoll, Tim R.
   Duan, Leilei
   Duber, Herbert C.
   Durrani, Adnan M.
   Ebel, Beth E.
   Edmond, Karen M.
   Ellenbogen, Richard G.
   Elshrek, Yousef
   Ermakov, Sergey Petrovich
   Erskine, Holly E.
   Eshrati, Babak
   Esteghamati, Alireza
   Estep, Kara
   Fuerst, Thomas
   Fahimi, Saman
   Fahrion, Anna S.
   Faraon, Emerito Jose A.
   Farzadfar, Farshad
   Fay, Derek F. J.
   Feigl, Andrea B.
   Feigin, Valery L.
   Felicio, Manuela Mendonca
   Fereshtehnejad, Seyed-Mohammad
   Fernandes, Jefferson G.
   Ferrari, Alize J.
   Fleming, Thomas D.
   Foigt, Nataliya
   Foreman, Kyle
   Forouzanfar, Mohammad H.
   Fowkes, F. Gerry R.
   Fra Paleo, Urbano
   Franklin, Richard C.
   Futran, Neal D.
   Gaffikin, Lynne
   Gambashidze, Ketevan
   Gankpe, Fortune Gbetoho
   Garcia-Guerra, Francisco Armando
   Garcia, Ana Cristina
   Geleijnse, Johanna M.
   Gessner, Bradford D.
   Gibney, Katherine B.
   Gillum, Richard F.
   Gilmour, Stuart
   Abdelmageem, Ibrahim
   Ginawi, Mohamed
   Giroud, Maurice
   Glaser, Elizabeth L.
   Goenka, Shifalika
   Dantes, Hector Gomez
   Gona, Philimon
   Gonzalez-Medina, Diego
   Guinovart, Caterina
   Gupta, Rahul
   Gupta, Rajeev
   Gosselin, Richard A.
   Gotay, Carolyn C.
   Goto, Atsushi
   Gowda, Hube N.
   Graetz, Nicholas
   Greenwell, K. Fern
   Gugnani, Harish Chander
   Gunnell, David
   Gutierrez, Reyna A.
   Haagsma, Juanita
   Hafezi-Nejad, Nima
   Hagan, Holly
   Hagstromer, Maria
   Halasa, Yara A.
   Hamadeh, Randah Ribhi
   Hamavid, Hannah
   Hammami, Mouhanad
   Hancock, Jamie
   Hankey, Graeme J.
   Hansen, Gillian M.
   Harb, Hilda L.
   Harewood, Heather
   Haro, Josep Maria
   Havmoeller, Rasmus
   Hay, Roderick J.
   Hay, Simon I.
   Hedayati, Mohammad T.
   Pi, Ileana B. Heredia
   Heuton, Kyle R.
   Heydarpour, Pouria
   Higashi, Hideki
   Hijar, Martha
   Hoek, Hans W.
   Hoffman, Howard J.
   Hornberger, John C.
   Hosgood, H. Dean
   Hossain, Mazeda
   Hotez, Peter J.
   Hoy, Damian G.
   Hsairi, Mohamed
   Hu, Guoqing
   Huang, John J.
   Huffman, Mark D.
   Hughes, Andrew J.
   Husseini, Abdullatif
   Huynh, Chantal
   Iannarone, Marissa
   Iburg, Kim M.
   Idrisov, Bulat T.
   Ikeda, Nayu
   Innos, Kaire
   Inoue, Manami
   Islami, Farhad
   Ismayilova, Samaya
   Jacobsen, Kathryn H.
   Jassal, Simerjot
   Jayaraman, Sudha P.
   Jensen, Paul N.
   Jha, Vivekanand
   Jiang, Guohong
   Jiang, Ying
   Jonas, Jost B.
   Joseph, Jonathan
   Juel, Knud
   Kabagambe, Edmond Kato
   Kan, Haidong
   Karch, Andre
   Karimkhani, Chante
   Karthikeyan, Ganesan
   Kassebaum, Nicholas
   Kaul, Anil
   Kawakami, Norito
   Kazanjan, Konstantin
   Kazi, Dhruv S.
   Kemp, Andrew H.
   Kengne, Andre Pascal
   Keren, Andre
   Kereselidze, Maia
   Khader, Yousef Saleh
   Khalifa, Shams Eldin Ali Hassan
   Khan, Ejaz Ahmed
   Khan, Gulfaraz
   Khang, Young-Ho
   Kieling, Christian
   Kinfu, Yohannes
   Kinge, Jonas M.
   Kim, Daniel
   Kim, Sungroul
   Kivipelto, Miia
   Knibbs, Luke
   Knudsen, Ann Kristin
   Kokubo, Yoshihiro
   Kosen, Sowarta
   Kotagal, Meera
   Kravchenko, Michael A.
   Krishnaswami, Sanjay
   Krueger, Hans
   Defo, Barthelemy Kuate
   Kuipers, Ernst J.
   Bicer, Burcu Kucuk
   Kulkarni, Chanda
   Kulkarni, Veena S.
   Kumar, Kaushalendra
   Kumar, Ravi B.
   Kwan, Gene F.
   Kyu, Hmwe
   Lai, Taavi
   Balaji, Arjun Lakshmana
   Lalloo, Ratilal
   Lallukka, Tea
   Lam, Hilton
   Lan, Qing
   Lansingh, Van C.
   Larson, Heidi J.
   Larsson, Anders
   Lavados, Pablo M.
   Lawrynowicz, Alicia E. B.
   Leasher, Janet L.
   Lee, Jong-Tae
   Leigh, James
   Leinsalu, Mall
   Leung, Ricky
   Levitz, Carly
   Li, Bin
   Li, Yichong
   Li, Yongmei
   Liddell, Chelsea
   Lim, Stephen S.
   de Lima, Graca Maria Ferreira
   Lind, Maggie L.
   Lipshultz, Steven E.
   Liu, Shiwei
   Liu, Yang
   Lloyd, Belinda K.
   Lofgren, Katherine T.
   Logroscino, Giancarlo
   London, Stephanie J.
   Lortet-Tieulent, Joannie
   Lotufo, Paulo A.
   Lucas, Robyn M.
   Lunevicius, Raimundas
   Lyons, Ronan Anthony
   Ma, Stefan
   Machado, Vasco Manuel Pedro
   MacIntyre, Michael F.
   Mackay, Mark T.
   MacLachlan, Jennifer H.
   Magis-Rodriguez, Carlos
   Mahdi, Abbas A.
   Majdan, Marek
   Malekzadeh, Reza
   Mangalam, Srikanth
   Mapoma, Christopher Chabila
   Marape, Marape
   Marcenes, Wagner
   Margono, Christopher
   Marks, Guy B.
   Marzan, Melvin Barrientos
   Masci, Joseph R.
   Mashal, Mohammad Taufi Q.
   Masiye, Felix
   Mason-Jones, Amanda J.
   Matzopolous, Richard
   Mayosi, Bongani M.
   Mazorodze, Tasara T.
   McGrath, John J.
   Mckay, Abigail C.
   Mckee, Martin
   McLain, Abigail
   Meaney, Peter A.
   Mehndiratta, Man Mohan
   Mejia-Rodriguez, Fabiola
   Melaku, Yohannes Adama
   Meltzer, Michele
   Memish, Ziad A.
   Mendoza, Walter
   Mensah, George A.
   Meretoja, Atte
   Mhimbira, Francis A.
   Miller, Ted R.
   Mills, Edward J.
   Misganaw, Awoke
   Mishra, Santosh K.
   Mock, Charles N.
   Moffitt, Terrie E.
   Ibrahim, Norlinah Mohamed
   Mohammad, Karzan Abdulmuhsin
   Mokdad, Ali H.
   Mola, Glen Liddell
   Monasta, Lorenzo
   Monis, Jonathan de la Cruz
   Hernandez, Julio C. Montaez
   Montico, Marcella
   Montine, Thomas J.
   Mooney, Meghan D.
   Moore, Ami R.
   Moradi-Lakeh, Maziar
   Moran, Andrew E.
   Mori, Rintaro
   Moschandreas, Joanna
   Moturi, Wilkister Nyaora
   Moyer, Madeline L.
   Mozaffarian, Dariush
   Mueller, Ulrich O.
   Mukaigawara, Mitsuru
   Mullany, Erin C.
   Murray, Joseph
   Mustapha, Adetoun
   Naghavi, Paria
   Naheed, Aliya
   Naidoo, Kovin S.
   Naldi, Luigi
   Nand, Devina
   Nangia, Vinay
   Narayan, K. M. Venkat
   Nash, Denis
   Nasher, Jamal
   Nejjari, Chakib
   Nelson, Robert G.
   Neuhouser, Marian
   Neupane, Sudan Prasad
   Newcomb, Polly A.
   Newman, Lori
   Newton, Charles R.
   Ng, Marie
   Ngalesoni, Frida Namnyak
   Nguyen, Grant
   Nhung Thi Trang Nguyen
   Nisar, Muhammad Imran
   Nolte, Sandra
   Norheim, Ole F.
   Norman, Rosana E.
   Norrving, Bo
   Nyakarahuka, Luke
   Odell, Shaun
   O'Donnell, Martin
   Ohkubo, Takayoshi
   Ohno, Summer Lockett
   Olusanya, Bolajoko O.
   Omer, Saad B.
   Opio, John Nelson
   Orisakwe, Orish Ebere
   Ortblad, Katrina F.
   Ortiz, Alberto
   Otayza, Maria Lourdes K.
   Pain, Amanda W.
   Pandian, Jeyaraj D.
   Panelo, Carlo Irwin
   Panniyammakal, Jeemon
   Papachristou, Christina
   Paternina Caicedo, Angel J.
   Patten, Scott B.
   Patton, George C.
   Paul, Vinod K.
   Pavlin, Boris
   Pearce, Neil
   Pellegrini, Carlos A.
   Pereira, David M.
   Peresson, Sophie C.
   Perez-Padilla, Rogelio
   Perez-Ruiz, Fernando P.
   Perico, Norberto
   Pervaiz, Aslam
   Pesudovs, Konrad
   Peterson, Carrie B.
   Petzold, Max
   Phillips, Bryan K.
   Phillips, David E.
   Phillips, Michael R.
   Plass, Dietrich
   Piel, Frederic Bernard
   Poenaru, Dan
   Polinder, Suzanne
   Popova, Svetlana
   Poulton, Richie G.
   Pourmalek, Farshad
   Prabhakaran, Dorairaj
   Qato, Dima
   Quezada, Amado D.
   Quistberg, D. Alex
   Rabito, Felicia
   Rafay, Anwar
   Rahimi, Kazem
   Rahimi-Movaghar, Vafa
   Rahman, Sajjad U. R.
   Raju, Murugesan
   Rakovac, Ivo
   Rana, Saleem M.
   Refaat, Amany
   Remuzzi, Giuseppe
   Ribeiro, Antonio L.
   Ricci, Stefano
   Riccio, Patricia M.
   Richardson, Lee
   Richardus, Jan Hendrik
   Roberts, Bayard
   Roberts, D. Allen
   Robinson, Margaret
   Roca, Anna
   Rodriguez, Alina
   Rojas-Rueda, David
   Ronfani, Luca
   Room, Robin
   Roth, Gregory A.
   Rothenbacher, Dietrich
   Rothstein, David H.
   Rowley, Jane Tf
   Roy, Nobhojit
   Ruhago, George M.
   Rushton, Lesley
   Sambandam, Sankar
   Soreide, Kjetil
   Saeedi, Mohammad Yahya
   Saha, Sukanta
   Sahathevan, Ramesh
   Sahraian, Mohammad Ali
   Sahle, Berhe Weldearegawi
   Salomon, Joshua A.
   Salvo, Deborah
   Samonte, Genesis May J.
   Sampson, Uchechukwu
   Sanabria, Juan Ramon
   Sandar, Logan
   Santos, Itamar S.
   Satpathy, Maheswar
   Sawhney, Monika
   Saylan, Mete
   Scarborough, Peter
   Schoettker, Ben
   Schmidt, Juergen C.
   Schneider, Ione J. C.
   Schumacher, Austin E.
   Schwebel, David C.
   Scott, James G.
   Sepanlou, Sadaf G.
   Servan-Mori, Edson E.
   Shackelford, Katya
   Shaheen, Amira
   Shahraz, Saeid
   Shakh-Nazarova, Marina
   Shangguan, Siyi
   She, Jun
   Sheikhbahaei, Sara
   Shepard, Donald S.
   Shibuya, Kenji
   Shinohara, Yukito
   Shishani, Kawkab
   Shiue, Ivy
   Shivakoti, Rupak
   Shrime, Mark G.
   Sigfusdottir, Inga Dora
   Silberberg, Donald H.
   Silva, Andrea P.
   Simard, Edgar P.
   Sindi, Shireen
   Singh, Jasvinder A.
   Singh, Lavanya
   Sioson, Edgar
   Skirbekk, Vegard
   Sliwa, Karen
   So, Samuel
   Soljak, Michael
   Soneji, Samir
   Soshnikov, Sergey S.
   Sposato, Luciano A.
   Sreeramareddy, Chandrashekhar T.
   Stanaway, Jeff Rey D.
   Stathopoulou, Vasiliki Kalliopi
   Steenland, Kyle
   Stein, Claudia
   Steiner, Caitlyn
   Stevens, Antony
   Stoeckl, Heidi
   Straif, Kurt
   Stroumpoulis, Konstantinos
   Sturua, Lela
   Sunguya, Bruno F.
   Swaminathan, Soumya
   Swaroop, Mamta
   Sykes, Bryan L.
   Tabb, Karen M.
   Takahashi, Ken
   Talongwa, Roberto Tchio
   Tan, Feng
   Tanne, David
   Tanner, Marcel
   Tavakkoli, Mohammad
   Ao, Braden Te
   Teixeira, Carolina Maria
   Templin, Tara
   Tenkorang, Eric Yeboah
   Terkawi, Abdullah Sulieman
   Thomas, Bernadette A.
   Thorne-Lyman, Andrew L.
   Thrift, Amanda G.
   Thurston, George D.
   Tillmann, Taavi
   Tirschwell, David L.
   Tleyjeh, Imad M.
   Tonelli, Marcello
   Topouzis, Fotis
   Towbin, Jeffrey A.
   Toyoshima, Hideaki
   Traebert, Jefferson
   Tran, Bach X.
   Truelsen, Thomas
   Trujillo, Ulises
   Trillini, Matias
   Dimbuene, Zacharie Tsala
   Tsilimbaris, Miltiadis
   Tuzcu, E. Murat
   Ubeda, Clotilde
   Uchendu, Uche S.
   Ukwaja, Kingsley N.
   Undurraga, Eduardo A.
   Vallely, Andrew J.
   van de Vijver, Steven
   van Gool, Coen H.
   Varakin, Yuri Y.
   Vasankari, Tommi J.
   Vasconcelos, Ana Maria Nogales
   Vavilala, Monica S.
   Venketasubramanian, N.
   Vijayakumar, Lakshmi
   Villalpando, Salvador
   Violante, Francesco S.
   Vlassov, Vasiliy Victorovich
   Wagner, Gregory R.
   Waller, Stephen G.
   Wang, JianLi
   Wang, Linhong
   Wang, XiaoRong
   Wang, Yanping
   Warouw, Tati Suryati
   Weichenthal, Scott
   Weiderpass, Elisabete
   Weintraub, Robert G.
   Wenzhi, Wang
   Werdecker, Andrea
   Wessells, K. Ryan R.
   Westerman, Ronny
   Whiteford, Harvey A.
   Wilkinson, James D.
   Williams, Thomas Neil
   Woldeyohannes, Solomon Meseret
   Wolfe, Charles D. A.
   Wolock, Timothy M.
   Woolf, Anthony D.
   Wong, John Q.
   Wright, Jonathan L.
   Wulf, Sarah
   Wurtz, Brittany
   Xu, Gelin
   Yang, Yang C.
   Yano, Yuichiro
   Yatsuya, Hiroshi
   Yip, Paul
   Yonemoto, Naohiro
   Yoon, Seok-Jun
   Younis, Mustafa
   Yu, Chuanhua
   Jin, Kim Yun
   Zaki, Maysaa El Sayed
   Zamakhshary, Mohammed Fouad
   Zeeb, Hajo
   Zhang, Yong
   Zhao, Yong
   Zheng, Yingfeng
   Zhu, Jun
   Zhu, Shankuan
   Zonies, David
   Zou, Xiao Nong
   Zunt, Joseph R.
   Vos, Theo
   Lopez, Alan D.
   Murray, Christopher J. L.
CA GBD Mortal 2013 Causes Death Colla
TI Global, regional, and national age-sex specific all-cause and
   cause-specific mortality for 240 causes of death, 1990-2013: a
   systematic analysis for the Global Burden of Disease Study 2013
SO LANCET
LA English
DT Article
ID INFLUENZAE TYPE-B; PNEUMOCOCCAL CONJUGATE VACCINE;
   PLACEBO-CONTROLLED-TRIAL; 187 COUNTRIES; RISK-FACTORS; ENTERIC
   MULTICENTER; CHILDREN YOUNGER; CHILDHOOD PNEUMONIA; INTEGRATED APPROACH;
   POPULATION HEALTH
AB Background Up-to-date evidence on levels and trends for age-sex-specifi c all-cause and cause-specifi c mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990, and 2013. We used the results to assess whether there is epidemiological convergence across countries.
   Methods We estimated age-sex-specifi c all-cause mortality using the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data. We generally estimated cause of death as in the GBD 2010. Key improvements included the addition of more recent vital registration data for 72 countries, an updated verbal autopsy literature review, two new and detailed data systems for China, and more detail for Mexico, UK, Turkey, and Russia. We improved statistical models for garbage code redistribution. We used six different modelling strategies across the 240 causes; cause of death ensemble modelling (CODEm) was the dominant strategy for causes with sufficient information. Trends for Alzheimer's disease and other dementias were informed by meta-regression of prevalence studies. For pathogen-specifi c causes of diarrhoea and lower respiratory infections we used a counterfactual approach. We computed two measures of convergence (inequality) across countries: the average relative difference across all pairs of countries (Gini coefficient) and the average absolute difference across countries. To summarise broad findings, we used multiple decrement life-tables to decompose probabilities of death from birth to exact age 15 years, from exact age 15 years to exact age 50 years, and from exact age 50 years to exact age 75 years, and life expectancy at birth into major causes. For all quantities reported, we computed 95% uncertainty intervals (UIs). We constrained cause-specific fractions within each age-sex-country-year group to sum to all-cause mortality based on draws from the uncertainty distributions.
   Findings Global life expectancy for both sexes increased from 65.3 years (UI 65.0-65.6) in 1990, to 71.5 years (UI 71.0-71.9) in 2013, while the number of deaths increased from 47.5 million (UI 46.8-48.2) to 54.9 million (UI 53.6-56.3) over the same interval. Global progress masked variation by age and sex: for children, average absolute diff erences between countries decreased but relative diff erences increased. For women aged 25-39 years and older than 75 years and for men aged 20-49 years and 65 years and older, both absolute and relative diff erences increased. Decomposition of global and regional life expectancy showed the prominent role of reductions in age-standardised death rates for cardiovascular diseases and cancers in high-income regions, and reductions in child deaths from diarrhoea, lower respiratory infections, and neonatal causes in low-income regions. HIV/AIDS reduced life expectancy in southern sub-Saharan Africa. For most communicable causes of death both numbers of deaths and age-standardised death rates fell whereas for most non-communicable causes, demographic shifts have increased numbers of deaths but decreased age-standardised death rates. Global deaths from injury increased by 10.7%, from 4.3 million deaths in 1990 to 4.8 million in 2013; but age-standardised rates declined over the same period by 21%. For some causes of more than 100 000 deaths per year in 2013, age-standardised death rates increased between 1990 and 2013, including HIV/AIDS, pancreatic cancer, atrial fibrillation and flutter, drug use disorders, diabetes, chronic kidney disease, and sickle-cell anaemias. Diarrhoeal diseases, lower respiratory infections, neonatal causes, and malaria are still in the top five causes of death in children younger than 5 years. The most important pathogens are rotavirus for diarrhoea and pneumococcus for lower respiratory infections. Country-specific probabilities of death over three phases of life were substantially varied between and within regions.
   Interpretation For most countries, the general pattern of reductions in age-sex specifi c mortality has been associated with a progressive shift towards a larger share of the remaining deaths caused by non-communicable disease and injuries. Assessing epidemiological convergence across countries depends on whether an absolute or relative measure of inequality is used. Nevertheless, age-standardised death rates for seven substantial causes are increasing, suggesting the potential for reversals in some countries. Important gaps exist in the empirical data for cause of death estimates for some countries; for example, no national data for India are available for the past decade.
C1 [Naghavi, Mohsen; Wang, Haidong; Lozano, Rafael; Vollset, Stein Emil; Achoki, Tom; Apfel, Henry; Atkinson, Charles; Barber, Ryan M.; Bertozzi-Villa, Amelia; Biryukov, Stan; Brown, Jonathan C.; Catala-Lopez, Ferrn; Coates, Matthew M.; Coffeng, Luc Edgar; Coggeshall, Megan S.; Dandona, Lalit; Dansereau, Emily; Dicker, Daniel; Duber, Herbert C.; Estep, Kara; Fleming, Thomas D.; Forouzanfar, Mohammad H.; Gonzalez-Medina, Diego; Graetz, Nicholas; Haagsma, Juanita; Hamavid, Hannah; Hancock, Jamie; Hansen, Gillian M.; Heuton, Kyle R.; Higashi, Hideki; Huynh, Chantal; Iannarone, Marissa; Joseph, Jonathan; Kassebaum, Nicholas; Kyu, Hmwe; Levitz, Carly; Liddell, Chelsea; Lind, Maggie L.; Lofgren, Katherine T.; MacIntyre, Michael F.; Margono, Christopher; McLain, Abigail; Mokdad, Ali H.; Mooney, Meghan D.; Moradi-Lakeh, Maziar; Moyer, Madeline L.; Mullany, Erin C.; Naghavi, Paria; Ng, Marie; Nguyen, Grant; Odell, Shaun; Ohno, Summer Lockett; Ortblad, Katrina F.; Pain, Amanda W.; Phillips, Bryan K.; Phillips, David E.; Richardson, Lee; Roberts, D. Allen; Robinson, Margaret; Roth, Gregory A.; Sandar, Logan; Schumacher, Austin E.; Shackelford, Katya; Singh, Lavanya; Sioson, Edgar; Stanaway, Jeff Rey D.; Steiner, Caitlyn; Stevens, Antony; Templin, Tara; Thomas, Bernadette A.; Wolock, Timothy M.; Wulf, Sarah; Wurtz, Brittany; Vos, Theo; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, Seattle, WA USA.
   [Ellenbogen, Richard G.; Wright, Jonathan L.] Univ Washington, Sch Med, Seattle, WA USA.
   [Kassebaum, Nicholas] Childrens Hosp, Seattle, WA USA.
   [Tirschwell, David L.] Dept Neurol, Seattle, WA USA.
   [Ebel, Beth E.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA.
   [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Futran, Neal D.; Jensen, Paul N.; Kotagal, Meera; Mock, Charles N.; Montine, Thomas J.; Pellegrini, Carlos A.; Quistberg, D. Alex; Vavilala, Monica S.; Zunt, Joseph R.] Univ Washington, Seattle, WA 98195 USA.
   [Lozano, Rafael; Barquera, Simon; Barrientos-Gutierrez, Tonatiuh; Nonato, Ismael Ricardo Campos; Cuevas-Nasu, Lucia; De la Cruz-Gongora, Vanessa; Diaz-Ortega, Jose-Luis; Garcia-Guerra, Francisco Armando; Dantes, Hector Gomez; Pi, Ileana B. Heredia; Mejia-Rodriguez, Fabiola; Hernandez, Julio C. Montaez; Perez-Padilla, Rogelio; Quezada, Amado D.; Salvo, Deborah; Servan-Mori, Edson E.; Villalpando, Salvador] Natl Inst Publ Hlth Mexico, Mexico City, DF, Mexico.
   [Davis, Adrian; Fay, Derek F. J.; Schmidt, Juergen C.] Publ Hlth England, London, England.
   [Zhou, Maigeng; Duan, Leilei; Li, Yichong; Liu, Shiwei; Wang, Linhong] Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China.
   [Tan, Feng] Natl Inst Occupat Hlth & Control, Beijing, Peoples R China.
   [Liang, Xiaofeng] China Ctr Dis Control Prevent, Beijing, Peoples R China.
   [Vollset, Stein Emil; Kinge, Jonas M.; Knudsen, Ann Kristin; Skirbekk, Vegard] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Vollset, Stein Emil; Norheim, Ole F.] Univ Bergen, Bergen, Norway.
   [Ozgoren, Ayse Abbasoglu; Bicer, Burcu Kucuk] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey.
   [Abdalla, Safa] Sudanese Publ Hlth Consultancy Grp, Solihull, W Midlands, England.
   [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt.
   [Aziz, Muna I. Abdel] Inst Publ Hlth, Khartoum, Sudan.
   [Abera, Semaw Ferede] Coll Hlth Sci, Sch Publ Hlth, Mekelle, Tigray, Ethiopia.
   [Melaku, Yohannes Adama; Sahle, Berhe Weldearegawi] Mekelle Univ, Mekelle, Tigray, Ethiopia.
   [Aboyans, Victor] Dupuytren Univ Hosp, Limoges, France.
   [Abraham, Biju] Oslo & Akershus Univ, Coll Appl Sci HiOA, Oslo, Norway.
   [Abraham, Jerry P.] Univ Texas San Antonio, Sch Med, San Antonio, TX USA.
   [Abuabara, Katrina E.; Silberberg, Donald H.] Univ Penn, Philadelphia, PA 19104 USA.
   [Benzian, Habib] Dept Epidemiol & Publ Hlth, London, England.
   [Benzian, Habib] UCL, London, England.
   [Abu-Raddad, Laith J.] Weill Cornell Med Coll Qatar, Doha, Qatar.
   [Abu-Rmeileh, Niveen M. E.] Birzeit Univ, Inst Community & Publ Hlth, Ramallah, W Bank, Israel.
   [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogbp, Nigeria.
   [Chiang, Peggy Pei-Chia] Beneral Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia.
   [Colquhoun, Samantha M.] Ctr Int Child Hlth, Melbourne, Vic, Australia.
   [Ademi, Zanfi Na; Blore, Jed D.; Bohensky, Megan A.; Catala-Lopez, Ferrn; Balaji, Arjun Lakshmana; Patton, George C.; Weintraub, Robert G.] Univ Melbourne, Melbourne, Vic, Australia.
   [Adofo, Koranteng] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ashanti, Ghana.
   [Adou, Arsene Kouablan] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire.
   [Adsuar, Jose C.; Fra Paleo, Urbano] Univ Extremadura, Caceres, Spain.
   [Aernlov, Johan; Larsson, Anders] Uppsala Univ, Uppsala, Sweden.
   [Agardh, Emilie Elisabet] Inst Publ Hlth Sci, Stockholm, Sweden.
   [Akena, Dickens; Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda.
   [Al Khabouri, Mazin J.; Alasfoor, Deena] Minist Hlth, Muscat, Oman.
   [Al Lami, Faris] Baghdad Coll Med, Baghdad, Iraq.
   [Albittar, Mohammed] Independent, Damascus, Syria.
   Grp Invest Ciencias Salud & Neurociencias CISNEUR, Cartagena De Indias, Bolivar, Colombia.
   [Alegretti, Miguel Angel; Aleman, Alicia V.; Cavalleri, Fiorella; Colistro, Valentina] Univ Republica, Fac Med, Dept Prevent & Social Med, Montevideo, Uruguay.
   [Alemu, Zewdie Aderaw] Debre Markos Univ, Debre Markos, Amhara, Ethiopia.
   [Alhabib, Samia] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   [Simard, Edgar P.; Steenland, Kyle] Rollins Sch Publ Hlth, Atlanta, GA USA.
   [Ali, Mohammed K.; Cunningham, Solveig Argeseanu; Dabhadkar, Kaustubh C.; Liu, Yang; Narayan, K. M. Venkat; Omer, Saad B.; Phillips, Michael R.] Emory Univ, Atlanta, GA 30322 USA.
   [Ali, Raghib; Bennett, Derrick A.; Briggs, Adam D. M.; Chen, Zhengming; Hay, Simon I.; Piel, Frederic Bernard; Rahimi, Kazem; Scarborough, Peter] Univ Oxford, Oxford, England.
   [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France.
   [Allebeck, Peter] Dept Publ Hlth Sci, Stockholm, Sweden.
   [Fereshtehnejad, Seyed-Mohammad] Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.
   [Kivipelto, Miia] Aging Res Ctr, Stockholm, Sweden.
   [Weiderpass, Elisabete] Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Hagstromer, Maria; Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden.
   [AlMazroa, Mohammad A.; Basulaiman, Mohammed Omar; Memish, Ziad A.; Saeedi, Mohammad Yahya] Saudi Minist Hlth, Riyadh, Saudi Arabia.
   [Salman, Rustam Al-Shahi; Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland.
   [Alsharif, Ubai; Nolte, Sandra; Papachristou, Christina] Charite, D-13353 Berlin, Germany.
   [Alvarez, Elena] Government, Madrid, Spain.
   [Alviz-Guzman, Nelson; Paternina Caicedo, Angel J.] Univ Cartagena, Cartagena De Indias, Colombia.
   [Amankwaa, Adansi A.] Albany State Univ, Albany, GA 31705 USA.
   [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.
   [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.
   [Ameli, Omid] Boston Univ, Boston, MA 02215 USA.
   [Amini, Hassan] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Kurdistan, Iran.
   [Amini, Hassan] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.
   [Tanner, Marcel] Univ Basel, Basel, Switzerland.
   [Ammar, Walid] Minist Publ Hlth, Beirut, Lebanon.
   [Anderson, H. Ross] St Georges Univ London, London, England.
   [Antonio, Carl Abelardo T.; Faraon, Emerito Jose A.; Panelo, Carlo Irwin] Univ Philippines Manila, Coll Publ Hlth, Manila, Philippines.
   [Anwari, Palwasha] UNFPA, Kabul, Afghanistan.
   [Arsenijevic, Valentina S. Arsic] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia.
   [Al Artaman] Evidera Inc, Lexington, MA USA.
   [Asad, Majed Masoud] Minist Hlth, Amman, Jordan.
   [Asghar, Rana J.] South Asian Publ Hlth Forum, Islamabad, Pakistan.
   [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Khorasan Razavi, Iran.
   [Atkins, Lydia S.] Minist Hlth Wellness Human Serv & Gender Relat, Castries, St Lucia.
   [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada.
   [Bahit, Maria C.] INECO Neurociencias, Santa Fe, NM USA.
   [Bakfalouni, Talal] Minist Hlth, Damascus, Syria.
   [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India.
   [Balalla, Shivanthi; Feigin, Valery L.] Natl Inst Stroke & Appl Neurosciences, Auckland, New Zealand.
   [Barker-Collo, Suzanne L.] Sch Psychol, Auckland, New Zealand.
   [del Pozo-Cruz, Borja] Univ Auckland, Auckland 1, New Zealand.
   [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England.
   [Barregard, Lars] Univ Gothenburg, Dept Environm & Occupat Hlth, Gothenburg, Sweden.
   [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia.
   [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Canterbury, New Zealand.
   [So, Samuel] Asian Liver Ctr, Palo Alto, CA USA.
   [Gaffikin, Lynne] Stanford Univ, Med Ctr, Sch Med, Stanford, CA 94305 USA.
   [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA.
   [Beardsley, Justin] Univ Oxford, Ho Hi Minh City, Vietnam.
   [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia.
   [Beghi, Ettore; Cortinovis, Monica; Perico, Norberto; Remuzzi, Giuseppe; Trillini, Matias] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy.
   [Bekele, Tolesa] Madawalabu Univ, Bale Goba, Oromia, Ethiopia.
   [Bell, Michelle L.; Huang, John J.] Yale Univ, New Haven, CT USA.
   [Benjet, Corina; Gutierrez, Reyna A.] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico.
   [Bensenor, Isabela M.; Kemp, Andrew H.] Univ Hosp, Sao Paulo, Brazil.
   [Lotufo, Paulo A.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Beyene, Tariku Jibat; Deribe, Kebede] Univ Addis Ababa, Debre Zeit, Ethiopia.
   [Bhala, Neeraj] Wellington Hosp, Wellington, New Zealand.
   [Bhalla, Ashish] Postgrad Inst Med Educ & Res, Chandigarh 160012, UT, India.
   [Bhutta, Zulfiqar A.] Med Ctr, Karachi, Pakistan.
   [Nisar, Muhammad Imran] Aga Khan Univ, Karachi, Pakistan.
   [Bikbov, Boris] I Evdokimov Moscow State Univ Med & Dent, Moscow, Russia.
   [Bin Abdulhak, Aref] Univ Missouri, Kansas City, MO 64110 USA.
   [Marks, Guy B.] Woolcock Inst Med Res, Sydney, NSW, Australia.
   [Driscoll, Tim R.] Sydney Sch Publ Hlth, Sydney, NSW, Australia.
   [Blyth, Fiona M.; Leigh, James] Univ Sydney, Sydney, NSW 2006, Australia.
   [Borges, Guilherme] Inst Nacl Psiquiatria, Mexico City, DF, Mexico.
   [Bose, Dipan] World Bank, Washington, DC 20433 USA.
   [Boufous, Soufiane] Transport & Rd Safety TARS Res, Sydney, NSW, Australia.
   [Vallely, Andrew J.] Kirby Inst, Sydney, NSW, Australia.
   [Degenhardt, Louisa; Satpathy, Maheswar] Univ New S Wales, Sydney, NSW, Australia.
   [Bourne, Rupert R.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England.
   [Boyers, Lindsay N.] Georgetown Univ, Sch Med, Washington, DC USA.
   [Brainin, Michael] Danube Univ Krems, Krems, Austria.
   [Krueger, Hans] Sch Populat & Publ Hlth, Vancouver, BC, Canada.
   [Brauer, Michael; Gotay, Carolyn C.; Pourmalek, Farshad] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   [Brayne, Carol E. G.] Cambridge Inst Publ Hlth, Cambridge, England.
   [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Trnava, Slovakia.
   [Breitborde, Nicholas] Univ Arizona, Tucson, AZ USA.
   [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany.
   [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England.
   [Buckle, Geoffrey C.; Gona, Philimon] Univ Massachusetts, Sch Med, Worcester, MA USA.
   [Bui, Linh Ngoc; Nhung Thi Trang Nguyen] Hanoi Sch Publ Hlth, Hanoi, Vietnam.
   [Bukhman, Gene] Harvard Univ, Sch Med, Cambridge, MA 02138 USA.
   [Ding, Eric L.; Fahimi, Saman; Shangguan, Siyi] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA.
   [Feigl, Andrea B.; Salomon, Joshua A.; Shrime, Mark G.] Harvard Univ, Cambridge, MA 02138 USA.
   [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England.
   [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico.
   [Carabin, Helesne] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA.
   [Carapetis, Jonathan] Telethon Inst Child Hlth Res, Subiaco, WA, Australia.
   [Carpenter, David O.] Univ Albany, Rensselaer, NY USA.
   [Caso, Valeria] Univ Perugia, Stroke Unit, I-06100 Perugia, Italy.
   [Castaneda-Orjuela, Carlos A.] Colombian Natl Hlth Observ, Inst Nacl Salud, Bogota, Colombia.
   [Castro, Ruben Estanislao] Univ Diego Portales, Santiago, Chile.
   [Catala-Lopez, Ferrn] Minist Hlth, Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain.
   [Chang, Jung-Chen] Natl Taiwan Univ, Taipei 10764, Taiwan.
   [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.
   [Scott, James G.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia.
   [Charlson, Fiona C.; Erskine, Holly E.; Ferrari, Alize J.; Knibbs, Luke; McGrath, John J.; Norman, Rosana E.; Whiteford, Harvey A.] Univ Queensland, Brisbane, Qld, Australia.
   [Che, Xuan] NIH, Bethesda, MD 20892 USA.
   [She, Jun] Zhongshan Hosp, Shanghai, Peoples R China.
   [Chen, Yingyao; Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China.
   [Chen, Zhengming] CTSU, Nuffield Dept Populat Hlth, Oxford, England.
   [Chen, Honglei; London, Stephanie J.] NIEHS, Div Intramural Res, NIH, Dept Hlth & Human Serv,RTP,NC USA, Res Triangle Pk, NC 27709 USA.
   [Chen, Jian Sheng] Inst Bone & Joint Res, St Laonards, NSW, Australia.
   [Chimed-Ochir, Odgerel] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan.
   [Chowdhury, Rajiv; Murray, Christopher J. L.] Univ Cambridge, Cambridge, England.
   [Christensen, Hanne] Bispebjerg Hosp, Copenhagen, Denmark.
   [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus.
   [Chang, Jung-Chen] Taipei Med Univ, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan.
   [Chuang, Ting-Wu] Taipei Med Univ, Ctr Int Trop Med, Coll Med, Taipei, Taiwan.
   [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
   [Cirillo, Massimo] Univ Salerno, I-84081 Baronissi, SA, Italy.
   [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA.
   [Colomar, Mercedes] UNICEM, Montevideo, Uruguay.
   [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.
   [Cooper, Cyrus; Tleyjeh, Imad M.] Mayo Clin, Rochester, MN USA.
   [Coppola, Luis M.] Hosp Municipal Ramon Santamarina, Buenos Aires, DF, Argentina.
   [Cowie, Benjamin C.; MacLachlan, Jennifer H.] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia.
   [Criqui, Michael H.; Jassal, Simerjot] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Crump, John A.] Dunedin Sch Med, Ctr Int Hlth, Dunedin, Otago, New Zealand.
   [Poulton, Richie G.] Univ Otago, Dunedin, Otago, New Zealand.
   [Leite, Iuri da Costa] Natl Sch Publ Hlth ENSP Fiocruz, Rio De Janeiro, Brazil.
   [Dandona, Lalit; Dandona, Rakhi; Goenka, Shifalika] Publ Hlth Fdn India, New Delhi, India.
   [Dandona, Rakhi; Goenka, Shifalika] Indian Inst Publ Hlth, New Delhi, India.
   [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England.
   [Dayama, Anand] Jacobi Med Ctr, Dept Surg, Atlanta, GA USA.
   [de la Vega, Shelley F.] Univ Philippines, Inst Aging, Manila, Philippines.
   [Lam, Hilton] Univ Philippines, Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines.
   [De Leo, Diego] Griffith Univ, Brisbane, Qld 4111, Australia.
   [Uchendu, Uche S.] US Dept Vet Affairs, Washington, DC USA.
   [Dellavalle, Robert P.] Eastern Colorado Healthcare Syst, Denver, CO USA.
   [Jarlais, Don C. Des] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA.
   [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia.
   [deVeber, Gabrielle A.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.
   [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka.
   [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
   [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain.
   [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria.
   [Dorsey, E. Ray] Univ Rochester, Med Ctr, Rochester, NY 14642 USA.
   [Durrani, Adnan M.] NIH, Montgomery, MD USA.
   [Hankey, Graeme J.] Sch Med & Pharmacol, Perth, WA, Australia.
   [Kabagambe, Edmond Kato] Univ Western Australia, Perth, WA 6009, Australia.
   [Elshrek, Yousef] Univ Tripoli, Fac Agr, Dept Food Sci, Tripoli, Libya.
   [Ermakov, Sergey Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia.
   [Eshrati, Babak] Arak Univ Med Sci & Hlth Affairs, Arak, Markazi, Iran.
   [Esteghamati, Alireza; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Endocrinol & Metab Res Ctr, Tehran, Iran.
   [Farzadfar, Farshad] Noncommunicable Dis Reesearch Ctr, Tehran, Iran.
   [Malekzadeh, Reza; Sepanlou, Sadaf G.] Digest Dis Res Ctr, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Sahraian, Mohammad Ali] Res Ctr, Tehran, Iran.
   [Moradi-Lakeh, Maziar] Dept Community Med, Tehran, Iran.
   [Heydarpour, Pouria] Univ Tehran Med Sci, Tehran, Iran.
   [Fuerst, Thomas] Ctr Hlth Policy, London, England.
   [Fuerst, Thomas] Dept Infect Dis Epidemiol, London, England.
   [Mustapha, Adetoun] MRC PHE Ctr Hlth & Environm, London, England.
   [Foreman, Kyle; Rodriguez, Alina; Rushton, Lesley; Soljak, Michael; Williams, Thomas Neil] Univ London Imperial Coll Sci Technol & Med, London, England.
   [Vollset, Stein Emil] Div Informat Evidence Res & Innovat, Copenhagen, Denmark.
   [Fahrion, Anna S.; Rakovac, Ivo] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark.
   [Newman, Lori] WHO, CH-1211 Geneva, Switzerland.
   [Teixeira, Carolina Maria] ARS Norte, Oporto, Portugal.
   [Felicio, Manuela Mendonca; de Lima, Graca Maria Ferreira; Machado, Vasco Manuel Pedro] IP Dept Saude Publ, Oporto, Portugal.
   [Fernandes, Jefferson G.] German Hosp Oswaldo Cruz, Inst Educ & Sci, Sao Paulo, Brazil.
   [Foigt, Nataliya] Ukraine Acad Med Sci, Inst Gerontol, UA-252655 Kiev, Ukraine.
   [Franklin, Richard C.] James Cook Univ, Townsville, Qld 4811, Australia.
   [Gambashidze, Ketevan; Kazanjan, Konstantin; Kereselidze, Maia; Shakh-Nazarova, Marina; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Rep of Georgia.
   [Gankpe, Fortune Gbetoho] Clin Cooperat Parakou, Parakou, Borgou, Benin.
   [Garcia, Ana Cristina] Publ Hlth Unit Primary Hlth Care Grp Almada Seixa, Almada, Setubal, Portugal.
   [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.
   [Gessner, Bradford D.] Agence Med Prevent, Paris, France.
   [Lloyd, Belinda K.] Eastern Hlth Clin Sch, Melbourne, Vic, Australia.
   [Gibney, Katherine B.; Thrift, Amanda G.] Monash Univ, Melbourne, Vic 3004, Australia.
   [Gillum, Richard F.] Howard Univ, Washington, DC 20059 USA.
   [Inoue, Manami] Grad Sch Med, Tokyo, Japan.
   [Kawakami, Norito] Sch Publ Hlth, Tokyo, Japan.
   [Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Tokyo, Japan.
   [Ginawi, Mohamed] Univ Hail, Coll Med, Hail, Saudi Arabia.
   [Giroud, Maurice] Univ Hosp Dijon, Dijon France, Region Of Burgo, France.
   [Glaser, Elizabeth L.; Halasa, Yara A.; Idrisov, Bulat T.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA.
   [Gosselin, Richard A.; Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Goto, Atsushi] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan.
   [Gugnani, Harish Chander] St James Sch Med, Kralendijk, Bonaire, Netherlands.
   [Guinovart, Caterina] PATH, Seattle, WA USA.
   [Gunnell, David] Univ Bristol, Bristol, Avon, England.
   [Gupta, Rahul] Fortis Escorts Hosp, Jaipur, Rajasthan, India.
   [Gupta, Rajeev] Kanawha Charleston Hlth Dept, Charleston, WV USA.
   [Thurston, George D.] NYU, Nelson Inst Environm Med, Tuxedo Pk, NY USA.
   [Hagan, Holly] NYU, New York, NY USA.
   [Hamadeh, Randah Ribhi] Arabian Gulf Univ, Manama, Bahrain.
   [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA.
   [Harewood, Heather] Eunice Gibson Polyclin, Bridgetown, St Michael, Barbados.
   [Haro, Josep Maria] Univ Barcelona, CIBERSAM, Barcelona, Spain.
   [Hay, Roderick J.] Int Fdn Dermatol, London, England.
   [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran.
   [Hijar, Martha] Fdn Entornos AC, Cuernavaca, Morelos, Mexico.
   [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands.
   [Hoffman, Howard J.] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA.
   [Hornberger, John C.] Cedar Associates, Menlo Pk, CA USA.
   [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA.
   [Hossain, Mazeda; Larson, Heidi J.; Mckee, Martin; Pearce, Neil; Roberts, Bayard; Stoeckl, Heidi; Tillmann, Taavi] London Sch Hyg & Trop Med, London WC1, England.
   [Hotez, Peter J.] Baylor Coll Med, Houston, TX 77030 USA.
   [Hoy, Damian G.] Secretariat Pacific Commun, Publ Hlth Div, Herston, Qld, Australia.
   [Hsairi, Mohamed] Natl Inst Publ Hlth MOH, Tunis, Tunisia.
   [Hu, Guoqing] Univ Toronto, Toronto, ON, Canada.
   [Hu, Guoqing] Cent S Univ, Changsha, Hunan, Peoples R China.
   [Huffman, Mark D.] Feinberg Sch Med, Chicago, IL USA.
   [Swaroop, Mamta] Northwestern Univ, Chicago, IL 60611 USA.
   [Husseini, Abdullatif] Qatar Univ, Publ Hlth Program, Birzeit, Ramallah, Israel.
   [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark.
   [Ikeda, Nayu] Natl Inst Hlth & Nutr, Bunkyo Ku, Tokyo 162, Japan.
   [Innos, Kaire; Leinsalu, Mall] Natl Inst Hlth Dev, Tallinn, Estonia.
   [Islami, Farhad] Amer Canc Soc, New York, NY USA.
   [Ismayilova, Samaya] Self Employed, Baku, Azerbaijan.
   [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA.
   [Jassal, Simerjot] VA San Diego, San Diego, CA USA.
   [Jayaraman, Sudha P.] Virginia Commonwealth Univ, Richmond, VA USA.
   [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh 160012, India.
   [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China.
   [Jiang, Ying] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Hlth Dev, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan.
   [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.
   [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark.
   [Kabagambe, Edmond Kato; Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN 37235 USA.
   Univ Balamand, Beirut, Lebanon.
   [Karch, Andre] Helmholtz Ctr Infect Res, Braunschweig, Germany.
   [Karch, Andre] German Ctr Infect Res DZIF, Braunschweig, Germany.
   [Karimkhani, Chante] Columbia Univ, Coll Phys & Surg, New York, NY USA.
   [Moran, Andrew E.] Columbia Univ, New York, NY USA.
   [Karthikeyan, Ganesan; Paul, Vinod K.] All India Inst Med Sci, New Delhi, India.
   [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA.
   [Kengne, Andre Pascal; Matzopolous, Richard] South African Med Res Council, Cape Town, Western Cape, South Africa.
   [Keren, Andre] Hadassah Kerem Univ Hosp, Jerusalem, Israel.
   [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Irbid, Jordan.
   [Khalifa, Shams Eldin Ali Hassan] Supreme Council Hlth, Doha, Qatar.
   [Khan, Ejaz Ahmed] Hlth Serv Acad, Islamabad, Punjab, Pakistan.
   [Khan, Gulfaraz] UAE Univ, Abu Dhabi, U Arab Emirates.
   [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea.
   [Kieling, Christian] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Kim, Daniel] Northeastern Univ, Boston, MA 02115 USA.
   [Kim, Sungroul] Soonchunhyang Univ, Asan, South Korea.
   [Kinfu, Yohannes] Univ Canberra, Canberra, ACT 2601, Australia.
   [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan.
   [Kosen, Sowarta] Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia.
   [Warouw, Tati Suryati] NIHRD, Jakarta, Special Provinc, Indonesia.
   [Kravchenko, Michael A.; Varakin, Yuri Y.] Res Ctr Neurol, Moscow, Russia.
   [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada.
   [Polinder, Suzanne] Dept Publ Hlth, Rotterdam, Netherlands.
   [Kuipers, Ernst J.; Richardus, Jan Hendrik] Erasmus MC Univ Med Ctr, Rotterdam, Netherlands.
   [Kulkarni, Chanda] Rajrajeshwari Med Coll & Hosp, Bangalore, Karnataka, India.
   [Kulkarni, Veena S.] Arkansas State Univ, State Univ, AR 72467 USA.
   [Kumar, Kaushalendra] Int Inst Populat Sci, Bombay, Maharashtra, India.
   [Kwan, Gene F.] Boston Med Ctr, Boston, MA USA.
   [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia.
   [Lalloo, Ratilal] Australian Res Ctr Populat Oral Hlth, Gold Coast, Qld, Australia.
   [Lalloo, Ratilal] Univ Adelaide, Sch Dent, Gold Coast, Qld, Australia.
   [Lallukka, Tea] Finnish Inst Occupat Hlth, Helsinki, Finland.
   [Lallukka, Tea] Univ Helsinki, Fac Med, Hjelt Inst, FIN-00014 Helsinki, Finland.
   [Lan, Qing] NCI, Rockville, MD USA.
   [Lansingh, Van C.] IAPB & Vis 2020 LA, Weston, FL USA.
   [Lavados, Pablo M.] Univ Desarrollo, Serv Neurol Clin Alemana, Santiago, RM, Chile.
   [Lawrynowicz, Alicia E. B.; Silva, Andrea P.; Ubeda, Clotilde] Inst Nacl Epidemiol Dr Juan H Jara, Buenos Aires, DF, Argentina.
   [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA.
   [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea.
   [Leung, Ricky] SUNY Albany, Rensselaer, NY USA.
   [Zhang, Yong] Dept Gerontol, Jinan, Shandong, Peoples R China.
   [Li, Bin] Jinan Cent Hosp, Jinan, Shandong, Peoples R China.
   [Li, Yichong] Genentech Inc, San Francisco, CA USA.
   [Lipshultz, Steven E.] Wayne State Univ, Miami, FL USA.
   [Lloyd, Belinda K.; Room, Robin] Eastern Hlth, Turning Point Alcohol & Drug Ctr, Fitzroy, Vic, Australia.
   [Logroscino, Giancarlo] Univ Bari, Bari, Italy.
   Australian Natl Univ, Canberra, ACT, Australia.
   [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England.
   [Lyons, Ronan Anthony] Swansea Univ, swauni, Swansea, W Glam, Wales.
   [Ma, Stefan] Minist Hlth Singapore, Singapore, Singapore.
   [Mackay, Mark T.] Royal Childrens Hosp, Melbourne, Vic, Australia.
   [Magis-Rodriguez, Carlos] Ctr Prevenc & Control VIH SIDA, Mexico City, DF, Mexico.
   [Mahdi, Abbas A.] King Georges Med Univ, Lucknow, Uttar Pradesh, India.
   [Mangalam, Srikanth] Tech Stand & Safety Author, Toronto, ON, Canada.
   [Mapoma, Christopher Chabila; Masiye, Felix] Univ Zambia, Lusaka, Zambia.
   [Marape, Marape] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana.
   [Marcenes, Wagner] Univ London, London, England.
   [Marzan, Melvin Barrientos] Univ East Ramon Magsaysay, Med Ctr, Quezon City, Metro Manila, Philippines.
   [Masci, Joseph R.] Elmhurst Hosp Ctr, Mt Sinai Serv, Elmhurst, NY USA.
   [Mashal, Mohammad Taufi Q.] Minist Publ Hlth, Kabul, Afghanistan.
   [Mason-Jones, Amanda J.] Univ York, York YO10 5DD, N Yorkshire, England.
   [Sliwa, Karen] Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, Cape Town, Western Cape, South Africa.
   [Mayosi, Bongani M.] Univ Cape Town, Cape Town, Western Cape, South Africa.
   [Mazorodze, Tasara T.] AIDC EC, Port Elizabeth, Eastern Cape, South Africa.
   [Mckay, Abigail C.] EmergentCorp, Belize City, Belize District, Belize.
   [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, Delhi, India.
   [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA.
   [Mendoza, Walter] UNFPA, Lima, Peru.
   [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bethesda, MD 20892 USA.
   [Mhimbira, Francis A.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
   [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA.
   [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia.
   [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada.
   [Mishra, Santosh K.] SNDT Womens Univ, Populat Educ Resource Ctr, Dept Continuing & Adult Educ & Extens, Bombay, Maharashtra, India.
   [Moffitt, Terrie E.] Duke Univ, Durham, NC USA.
   [Ibrahim, Norlinah Mohamed] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Kuala Lumpur, Malaysia.
   [Mohammad, Karzan Abdulmuhsin] Univ Salahaddin, Erbil, Iraq.
   [Mola, Glen Liddell] Univ Papua New Guinea, Port Moresby, NCD, Papua N Guinea.
   [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] Inst Maternal & Child Health IRCCS Burlo Garofolo, Trieste, Italy.
   [Monis, Jonathan de la Cruz] Bur Int Hlth Cooperat, Manila, Philippines.
   [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA.
   [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan.
   [Tsilimbaris, Miltiadis] Dept Med, Iraklion, Greece.
   [Moschandreas, Joanna] Univ Crete, Iraklion, NE, Greece.
   [Moturi, Wilkister Nyaora] Egerton Univ, Egerton, Rift Valley, Kenya.
   [Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
   [Mueller, Ulrich O.] Univ Marburg, Marburg, Germany.
   [Mukaigawara, Mitsuru] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan.
   [Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh.
   [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, KwaZulu Natal, South Africa.
   [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy.
   [Nand, Devina] Minist Hlth Fiji, Suva, Fiji.
   [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India.
   [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA.
   [Nasher, Jamal] Minist Publ Hlth & Populat, Sanaa, Yemen.
   [Nejjari, Chakib] Fac Med, Fes, Morocco.
   [Nelson, Robert G.] Natl Inst Diabet & Digest & Kidney Dis, Phoenix, AZ USA.
   [Neuhouser, Marian; Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA.
   [Neupane, Sudan Prasad] Univ Oslo, Norwegian Ctr Addict Res SERAF, N-0316 Oslo, Norway.
   [Ngalesoni, Frida Namnyak] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania.
   [Norrving, Bo] Lund Univ, Fac Med, Dept Clin Sci, Lund, Sweden.
   [O'Donnell, Martin] Natl Univ Ireland Galway, Galway, Ireland.
   [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo 173, Japan.
   [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria.
   [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Northern Uganda, Uganda.
   [Orisakwe, Orish Ebere] Univ Port Harcourt, Fac Pharm, Toxicol Unit, Port Harcourt, Rivers State, Nigeria.
   [Ortiz, Alberto] IIS Fdn Jimenez Diaz, Madrid, Spain.
   [Otayza, Maria Lourdes K.] Mariano Marcos Mem Hosp, City Of Batac, Ilocos Norte, Philippines.
   [Otayza, Maria Lourdes K.] Med Ctr, City Of Batac, Ilocos Norte, Philippines.
   [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India.
   [Panniyammakal, Jeemon] Ctr Chron Dis Control, Delhi, India.
   [Patten, Scott B.; Wang, JianLi] Univ Calgary, Calgary, AB, Canada.
   [Pavlin, Boris] Independent Researcher, Waigani, NCD, Papua N Guinea.
   [Pereira, David M.] Univ Porto, REQUIMTE, Fac Farm, Dept Quim,Lab Farmacognosia, P-4100 Oporto, Portugal.
   [Peresson, Sophie C.] Int Diabet Federat, Brussels, Belgium.
   [Perez-Ruiz, Fernando P.] Hosp Univ Cruces, Baracaldo, Spain.
   [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Punjab, Pakistan.
   [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia.
   [Peterson, Carrie B.] Aalborg Univ, Aalborg, Denmark.
   [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden.
   [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China.
   [Plass, Dietrich] Fed Environm Agcy, Exposure Assessment & Environm Hlth Indicators, Bielefeld, North Rhine Wes, Germany.
   [Poenaru, Dan] McMaster Univ, Hamilton, ON, Canada.
   [Popova, Svetlana] Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Prabhakaran, Dorairaj] Ctr Chron Dis Control, Delhi, India.
   [Qato, Dima] Univ Illinois, Coll Pharm, Chicago, IL USA.
   [Tabb, Karen M.] Univ Illinois, Chicago, IL USA.
   [Rabito, Felicia] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA.
   [Rafay, Anwar] Contech Intl, Lahore, Punjab, Pakistan.
   [Rahman, Sajjad U. R.] Hamad Med Corp, Doha, Qatar.
   [Raju, Murugesan] Univ Missouri, Columbia, MS USA.
   [Rana, Saleem M.] Univ Punjab, Dept Publ Hlth, Lahore, Punjab, Pakistan.
   [Refaat, Amany] Walden Univ, Minneapolis, MN USA.
   [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.
   [Ricci, Stefano] UO Neurol USL Umbria 1, Perugia, Italy.
   [Riccio, Patricia M.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada.
   [Roca, Anna] MRC Unit, Fajara, Gambia.
   [Rojas-Rueda, David] Ctr Res Environm Epidemiol CREAL, Barcelona, Catalonia, Spain.
   [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.
   [Rothstein, David H.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA.
   [Roy, Nobhojit] BARC Hosp, Bombay, Maharashtra, India.
   [Ruhago, George M.; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.
   Rwanda Biomed Ctr, Kigali, Rwanda.
   [Soreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway.
   [Saha, Sukanta] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.
   [Sahathevan, Ramesh] UKM Med Ctr, Kuala Lumpur, Malaysia.
   [Samonte, Genesis May J.] Natl Epidemiol Ctr, HIV AIDS & STI Surveillance & Strateg Informat Un, Dept Hlth, Manila, National Capita, Philippines.
   [Sanabria, Juan Ramon] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Sawhney, Monika] Marshall Univ, Huntington, WV USA.
   [Saylan, Mete] Novartis, Istanbul, Turkey.
   [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Baden Wurttembe, Switzerland.
   [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA.
   [Shaheen, Amira] An Najah Univ, Nablus, Palestine, Israel.
   [Shinohara, Yukito] Tachikawa Hosp, Tokyo, Japan.
   [Shishani, Kawkab] Washington State Univ, Spokane, WA USA.
   [Shiue, Ivy] Heriot Watt Univ, Edinburgh, Midlothian, Scotland.
   [Shivakoti, Rupak] Ctr Clin Global Hlth Educ, Baltimore, MD USA.
   [Tran, Bach X.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland.
   [Soneji, Samir] Dartmouth Coll, Lebanon, NH 03756 USA.
   [Soshnikov, Sergey S.] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia.
   [Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada.
   [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Kajang, Selangor, Malaysia.
   [Stathopoulou, Vasiliki Kalliopi] Ctr Hosp Nord Deux Sevres, Bressuire, France.
   [Straif, Kurt] IARC WHO, Lyon, France.
   [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, KEELPNO, Ctr Dis Control, Athens, Greece.
   [Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India.
   [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc & Sociol, Irvine, CA USA.
   [Takahashi, Ken] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan.
   [Talongwa, Roberto Tchio] Minist Hlth MINSANTE, Yaounde, Cameroon.
   [Tanne, David] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel.
   [Tanne, David] Tel Aviv Univ, Tel Hashomer, Israel.
   [Tavakkoli, Mohammad] Westchester Med Ctr, Valhalla, NY USA.
   [Ao, Braden Te] Auckland Univ Technol, Auckland, New Zealand.
   Jhpiego, Addis Ababa, Ethiopia.
   [Tenkorang, Eric Yeboah] Mem Univ Newfoundland, St John, NF, Canada.
   [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA.
   [Terkawi, Abdullah Sulieman; Tleyjeh, Imad M.] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia.
   [Thorne-Lyman, Andrew L.] WorldFish, New York, NY USA.
   [Tleyjeh, Imad M.] Alfasial Univ, Coll Med, Riyadh, Saudi Arabia.
   [Tonelli, Marcello] Univ Alberta, Edmonton, AB, Canada.
   [Topouzis, Fotis] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece.
   [Towbin, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.
   [Toyoshima, Hideaki] Hlth Care Ctr Anjo Kosei Hosp, Anjo, Aichi, Japan.
   [Traebert, Jefferson] Univ Southern Santa Catarina, Palhoca, SC, Brazil.
   [Truelsen, Thomas] Univ Copenhagen, Herlev Hosp, Dept Neurol, Copenhagen, Denmark.
   [Trujillo, Ulises] Serv Canario Salud, Tenerife, Spain.
   [Dimbuene, Zacharie Tsala] Univ Kinshasa, Fac Econ & Management, Dept Populat Sci & Dev, Kinshasa, Zaire.
   [Ukwaja, Kingsley N.] Fed Teaching Hosp Abakaliki, Dept Internal Med, Abakailiki, Ebonyi State, Nigeria.
   [van de Vijver, Steven] African Populat & Hlth Res Ctr, Nairobi, Kenya.
   [van Gool, Coen H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.
   [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland.
   [Vasconcelos, Ana Maria Nogales] Univ Brasilia, Brasilia, DF, Brazil.
   [Venketasubramanian, N.] Raffles Hosp, Ctr Neurosci, Singapore, Singapore.
   [Vijayakumar, Lakshmi] Voluntary Hlth Serv, Madras, Tamil Nadu, India.
   [Violante, Francesco S.] Univ Bologna, Bologna, Italy.
   [Vlassov, Vasiliy Victorovich] Higher Sch Econ, Moscow, Russia.
   [Wagner, Gregory R.] Natl Inst Occupat Safety & Hlth, Washington, DC USA.
   [Waller, Stephen G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Wang, Yanping; Zhu, Jun] Natl Off Maternal & Childs Hlth Surveillance, Chengdu, Peoples R China.
   [Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada.
   [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Wenzhi, Wang] Beijing Neurosurg Inst, Beijing, Peoples R China.
   [Werdecker, Andrea] Inst Med Sociol & Social Med, Marburg, Hessen, Germany.
   [Wessells, K. Ryan R.] Univ Calif Davis, Davis, CA 95616 USA.
   [Wilkinson, James D.] Univ Miami, Miami, FL USA.
   [Woldeyohannes, Solomon Meseret] Univ Gondar, Inst Publ Hlth, Gondar, Amhara, Ethiopia.
   [Wong, John Q.] Ateneo Sch Med & Publ Hlth, Pasig, Metro Manila, Philippines.
   [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, Cornwall, England.
   [Xu, Gelin] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.
   [Yang, Yang C.] Univ N Carolina, Chapel Hill, NC USA.
   [Yano, Yuichiro] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.
   [Yatsuya, Hiroshi] Fujita Hlth Univ, Toyoake, Aichi, Japan.
   [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.
   [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Tokyo, Japan.
   [Younis, Mustafa] Jackson State Univ, Jackson, MS USA.
   [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Global Hlth Inst, Dept Epidemiol & Biostat, Wuhan 430072, Hubei, Peoples R China.
   [Jin, Kim Yun] TCM Med TK SDN BHD, Nusajaya, Johor Bahru, Malaysia.
   [Zaki, Maysaa El Sayed] Mansoura Fac Med, Mansoura, Egypt.
   [Zamakhshary, Mohammed Fouad] Minist Planning & Training, Riyadh, Saudi Arabia.
   [Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.
   [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China.
   [Zheng, Yingfeng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.
   [Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.
   [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, NY USA.
   [Zou, Xiao Nong] Chinese Acad Med Sci, Canc Inst Hosp, Beijing 100730, Peoples R China.
RP Murray, CJL (reprint author), 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
EM cjlm@uw.edu
RI Dokova, Klara/N-2448-2016; Montico, Marcella/B-5290-2013; Jacobsen,
   Kathryn/B-5857-2008; Lalloo, Ratilal/O-5624-2014; Tillmann,
   Taavi/R-6026-2016; Soshnikov, Sergey/R-7352-2016; Salomon,
   Joshua/D-3898-2009; Beyene, Tariku Jibat/A-6875-2017; Santos,
   Itamar/K-7055-2012; Patton, George/B-5246-2013; Varakin,
   Yuriy/C-8634-2012; Alsharif, Ubai/C-6527-2017; Amini,
   Heresh/B-3076-2010; Whiteford, Harvey/A-4840-2009; Charlson,
   Fiona/F-5290-2011; Ronfani, Luca/B-6668-2013; LOGROSCINO,
   GIANCARLO/K-5148-2016; Moffitt, Terrie/D-5295-2011; McGrath,
   John/G-5493-2010; Hankey, Graeme /H-4968-2014; wang, YA
   XING/K-9671-2016; Naldi, Luigi/K-6343-2016; Thrift, Amanda/I-6251-2012;
   Weiderpass, Elisabete/M-4029-2016; Tonelli, Marcello/B-3028-2009;
   Rahimi, Kazem/Q-1279-2015; Haro, Josep Maria/D-1423-2011; Degenhardt,
   Louisa/D-4515-2012; Kaul, Anil/B-2075-2016; Carabin, Helene/B-7600-2016;
   Patten, Scott/B-4434-2011; Monasta, Lorenzo/B-1388-2012; Sepanlou,
   Sadaf/H-9343-2016; Kravchenko, Michael/B-2596-2012; Rakovac,
   Ivo/A-7678-2013; Ribeiro, Antonio/C-2707-2009; Tanne, David/F-2560-2010;
   Adsuar, Jose C/C-6558-2008; Majdan, Marek/K-5017-2012; Castro,
   Ruben/J-1948-2015; Nolte, Sandra/B-7498-2008; CSTFA,
   ResearcherID/P-1067-2014; Research ID, CTBCC /O-3564-2014; Ameli,
   Omid/G-1583-2013; Undurraga, Eduardo/I-3739-2014; Lavados,
   Pablo/E-9918-2016; Brenner, Hermann/B-4627-2017; Scott,
   James/D-5900-2012; eshrati, babak/M-1152-2017; Lotufo,
   Paulo/A-9843-2008; Karch, Andre/D-6973-2017; Hedayati, Mohammad
   T./E-2304-2017; Franklin, Richard/H-1731-2012; Ermakov,
   Sergey/G-1709-2016; Pereira, David/M-9286-2013; PACELLA,
   ROSANA/F-2774-2010; Kuate Defo, Barthelemy/I-4818-2017; Hay,
   Simon/F-8967-2015; Newton, 21/B-7578-2014; Satpathy,
   Maheswar/J-3135-2017
OI Montico, Marcella/0000-0003-0377-8232; Jacobsen,
   Kathryn/0000-0002-4198-6246; Lalloo, Ratilal/0000-0001-5822-1269;
   Tillmann, Taavi/0000-0002-8428-3719; Soshnikov,
   Sergey/0000-0002-6983-7066; Salomon, Joshua/0000-0003-3929-5515; Beyene,
   Tariku Jibat/0000-0002-7474-1966; Santos, Itamar/0000-0003-3212-8466;
   Patton, George/0000-0001-5039-8326; Alsharif, Ubai/0000-0002-4024-3950;
   Amini, Heresh/0000-0002-4825-1322; Paternina-Caicedo,
   Angel/0000-0002-6332-5174; Prabhakaran, Dorairaj/0000-0002-3172-834X;
   Roy MD, PhD, Nobhojit/0000-0003-2022-7416; Ding,
   Eric/0000-0002-5881-8097; Juel, Knud/0000-0002-4134-1173; Meretoja,
   Atte/0000-0001-6433-1931; Moradi-Lakeh, Maziar/0000-0001-7381-5305;
   Whiteford, Harvey/0000-0003-4667-6623; Charlson,
   Fiona/0000-0003-2876-5040; Ronfani, Luca/0000-0001-5710-3914;
   LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Moffitt,
   Terrie/0000-0002-8589-6760; McGrath, John/0000-0002-4792-6068; Hankey,
   Graeme /0000-0002-6044-7328; wang, YA XING/0000-0003-2749-7793; Naldi,
   Luigi/0000-0002-3160-2835; Thrift, Amanda/0000-0001-8533-4170;
   Weiderpass, Elisabete/0000-0003-2237-0128; Goenka,
   Shifalika/0000-0001-6993-2883; Tabb Dina, Karen/0000-0002-4722-9502;
   Olusanya, Bolajoko/0000-0002-3826-0583; Schottker,
   Ben/0000-0002-1217-4521; Ukwaja, Kingsley N./0000-0002-1974-8735; Ortiz
   Arduan, Alberto/0000-0002-9805-9523; Khang,
   Young-Ho/0000-0002-9585-8266; Cowie, Benjamin/0000-0002-7087-5895;
   Nisar, Muhammad Imran/0000-0002-2378-4720; Chen,
   Honglei/0000-0003-3446-7779; Perez-Ruiz, Fernando/0000-0002-5268-1894;
   Norheim, Ole F./0000-0002-5748-5956; Wessells, K.
   Ryan/0000-0002-5485-7144; London, Stephanie/0000-0003-4911-5290;
   Heydarpour, Pouria/0000-0001-5644-7555; Sindi,
   Shireen/0000-0002-3786-0552; Husseini, Abdullatif/0000-0001-8767-5956;
   Benjet, Corina/0000-0002-4569-6094; Al-Shahi Salman,
   Rustam/0000-0002-2108-9222; Deribe, Kebede/0000-0002-8526-6996; Kemp,
   Andrew/0000-0003-1146-3791; Erskine, Holly/0000-0003-3119-9211; Aboyans,
   Victor/0000-0002-0322-9818; Brauer, Michael/0000-0002-9103-9343; Glaser,
   Elizabeth/0000-0002-1918-057X; Tonelli, Marcello/0000-0002-0846-3187;
   Rahimi, Kazem/0000-0002-4807-4610; Haro, Josep
   Maria/0000-0002-3984-277X; Degenhardt, Louisa/0000-0002-8513-2218;
   Patten, Scott/0000-0001-9871-4041; Monasta, Lorenzo/0000-0001-7774-548X;
   Sepanlou, Sadaf/0000-0002-3669-5129; Kravchenko,
   Michael/0000-0001-5187-5518; Rakovac, Ivo/0000-0003-3462-2636; Ribeiro,
   Antonio/0000-0002-2740-0042; Tanne, David/0000-0002-6699-2220; Adsuar,
   Jose C/0000-0001-7203-3168; Majdan, Marek/0000-0001-8037-742X; Nolte,
   Sandra/0000-0001-6185-9423; Ameli, Omid/0000-0001-7878-0551; Higashi,
   Hideki/0000-0002-5534-0905; Vallely, Andrew/0000-0003-1558-4822; Xu,
   Gelin/0000-0002-6194-0341; Goto, Atsushi/0000-0003-0669-654X; Soreide,
   Kjetil/0000-0001-7594-4354; Quistberg, Alex/0000-0001-9730-2686;
   Kieling, Christian/0000-0001-7691-4149; Catala-Lopez,
   Ferran/0000-0002-3833-9312; Liu, Zhi-Hong/0000-0001-6093-0726;
   Undurraga, Eduardo/0000-0002-4425-1253; Balakrishnan,
   Kalpana/0000-0002-5905-1801; O'Donnell, Martin/0000-0002-7347-7761;
   O'donnell, Colm/0000-0002-8004-450X; Rodriguez,
   Alina/0000-0003-1209-8802; Mhimbira, Francis/0000-0001-8989-6832;
   Lavados, Pablo/0000-0002-9118-9093; Naghavi, Paria/0000-0002-8908-7952;
   Davis, Adrian/0000-0001-7134-7528; Banerjee,
   Amitava/0000-0001-8741-3411; Hotez, Peter/0000-0001-8770-1042; Abubakar,
   Ibrahim/0000-0002-0370-1430; Pourmalek, Farshad/0000-0002-2134-0771;
   Brenner, Hermann/0000-0002-6129-1572; Scott, James/0000-0002-0744-0688;
   Bohensky, Megan/0000-0001-8370-1408; Khan, Ejaz/0000-0002-7072-8035;
   Hagstromer, Maria/0000-0002-4607-8677; Bikbov,
   Boris/0000-0002-1925-7506; MacLachlan, Jennifer/0000-0002-7654-4536;
   Gibney, Katherine/0000-0001-5851-5339; Stockl,
   Heidi/0000-0002-0907-8483; Kwan, Gene/0000-0002-0929-6800; Piel,
   Frederic B./0000-0001-8131-7728; Lotufo, Paulo/0000-0002-4856-8450;
   Karch, Andre/0000-0003-3014-8543; Hedayati, Mohammad
   T./0000-0001-6415-4648; Franklin, Richard/0000-0003-1864-4552; Ermakov,
   Sergey/0000-0003-1072-1162; Pereira, David/0000-0003-0384-7592; PACELLA,
   ROSANA/0000-0002-9742-1957; Kuate Defo, Barthelemy/0000-0002-6589-0564;
   Hay, Simon/0000-0002-0611-7272; Newton, 21/0000-0002-6999-5507;
   Satpathy, Maheswar/0000-0003-3521-4781
FU British Heart Foundation [RG/08/014/24067]; Department of Health
   [CDF-2013-06-012, RP-PG-0407-10184]; Medical Research Council
   [MR/L003120/1, G9806489, MC_U137686851, MC_U147585819, MC_UP_A620_1014,
   MC_UU_12011/1, MR/K006525/1]; NCATS NIH HHS [KL2 TR001088]; NIA NIH HHS
   [P30 AG017253]; NIEHS NIH HHS [P30 ES000260]; Wellcome Trust [089276,
   089963, 099876]
CR Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8
   Ahmad OB, 2001, AGE STANDARDIZATION
   AIWH, 2004, FIELD B RHEUM HEART
   Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X
   Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5
   Baqui AH, 2007, PEDIATR INFECT DIS J, V26, P565, DOI 10.1097/INF.0b013e31806166a0
   Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323
   Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/01.inf.0000027926.99356.4c
   Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788
   Bloom DE, 2007, P NATL ACAD SCI USA, V104, P16044, DOI 10.1073/pnas.0702012104
   Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236
   Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7
   Clark R, 2011, SOC SCI MED, V72, P617, DOI 10.1016/j.socscimed.2010.12.008
   CRED, EM DAT OFDA CRED INT
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Das S, 2007, J Commun Dis, V39, P37
   Department for International Development. UKAID, 2011, ZER INF UKS POS PAP
   Dhama Kuldeep, 2012, Pak J Biol Sci, V15, P1001, DOI 10.3923/pjbs.2012.1001.1009
   Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7
   Flaxman A, 2014, INTEGRATED METAREGRE
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1
   Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2
   Forouzanfar MH, 2014, ARCH IRAN MED, V17, P304, DOI 0141705/AIM.004
   Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3
   Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2
   Gessner BD, 2008, VACCINE, V26, pB3, DOI 10.1016/j.vaccine.2008.04.013
   Gini C., 1912, VARIABILITA MUTABILI
   Gompertz B., 1825, PHILOS T ROY SOC LON, V115, P513, DOI DOI 10.1098/RSTL.1825.0026
   Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6
   Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165
   Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357
   Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508
   Hill K, 2013, ADOLESCENT MORTALITY
   Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS GEN EV
   Institute for Health Metrics and Evaluation, 2013, GBD 2013 PROT GLOB B
   International Agency for Research on Cancer, GLOBOCAN 2012 EST CA
   The International Institute For Strategic Studies, ARM CONFL DAT
   James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4
   Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1
   Kalantri SP, 2006, NATL MED J INDIA, V19, P315
   KANNISTO V., 1994, DEV OLDEST OLD MORTA
   Ki-moon B, 2011, SECRETARY GEN MESSAG
   Klugman KP, 2011, PHILOS T R SOC B, V366, P2790, DOI 10.1098/rstb.2011.0032
   Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060
   Kotila SM, 2011, CLIN MICROBIOL INFEC, V17, P888, DOI 10.1111/j.1469-0691.2010.03384.x
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Laishram S, 2012, INDIAN J GASTROENTER, V31, P3, DOI 10.1007/s12664-012-0161-9
   Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102
   Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Levine OS, 1999, PEDIATR INFECT DIS J, V18, P1060, DOI 10.1097/00006454-199912000-00006
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lozano R, 2013, SALUD PUBLICA MEXICO, V55, P580
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af
   Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692
   Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6
   Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202
   Mueller Yolanda, 2011, Confl Health, V5, P3, DOI 10.1186/1752-1505-5-3
   Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5
   Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI [10.1001/jama.2013.13805, 10.1111/jvh.12173]
   Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6
   Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262
   Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777
   Musher DM, 2004, NEW ENGL J MED, V351, P2417, DOI 10.1056/NEJMra041837
   Naghavi M, 2014, ARCH IRAN MED, V17, P321, DOI 0141705/AIM.005
   Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   NASH TE, 1987, J INFECT DIS, V156, P974
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   North AB, 2003, CANC INCIDENCE 5 CON, VX
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260
   Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67
   Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8
   Preston SH, 2000, DEMOGRAPHY MEASURING
   Quah DT, 1996, ECON J, V106, P1045, DOI 10.2307/2235377
   Raheel U, 2011, J INFECT DEV COUNTR, V5, P239
   Ravallion M, 2012, AM ECON REV, V102, P504, DOI 10.1257/aer.102.1.504
   RENDTORFF RC, 1954, AM J HYG, V59, P209
   Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x
   South Africa Info Reporter, 2012, S AFR HIV AIDS BATTL
   Sahloul Z, 2014, LANCET, V383, P407, DOI 10.1016/S0140-6736(13)62558-1
   Sala-I-Martin X, 2006, Q J ECON, V121, P351, DOI 10.1162/qjec.2006.121.2.351
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0
   Shahraz S, 2014, ARCH IRAN MED, V17, P336, DOI 0141705/AIM.006
   Sigauque B, 2013, J PEDIATR-US, V163, pS19, DOI 10.1016/j.jpeds.2013.03.026
   Simonsen L, 2011, BIRKHAUSER ADV INFEC, P27, DOI 10.1007/978-3-0346-0279-2_2
   Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7
   Stop TB Partnership, 2012, NO MOR CRYING NO MOR
   Treatment Action Group (TAG), 2012, THE ZERO DECLARATION
   United Nations, WORLD POP AG 2013
   United Nations Department of Economic and Social Affairs, WORLD POP PROSP 2012
   UNAIDS, 2013, METH UND HIV EST
   UNAIDS, 2010, 2011 2015 STRAT GETT
   Fundo das Nacoes Unidas para a Infancia (UNICEF), 2013, COMM CHILD SURV PROM
   United States Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. National Mortality Followback Survey, 2000, NAT MORT FOLL SURV 1
   USAID, 2012, CHILD SURV CALL ACT
   USAID, 2013, GLOB HLTH PROGR PROG
   Ng M, 2014, DEMOGRAPHIC RES SPEC, V311, P183, DOI DOI 10.4054/DEMRES.2004.S2.2
   Vangen S, 2005, TIDSSKR NOR LAEGEFOR, V134, P836
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
   Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4
   Wheldon MC, 2013, J AM STAT ASSOC, V108, P96, DOI 10.1080/01621459.2012.737729
   WHO, 2013, ROADM CHILDH TUB
   WHO, 2013, 2 M GEN SWITZ
   WHO, 2012, POS HLTH POST 2015 W
   WHO, INT STAT CLASS DIS R
   Wilson C, 2001, POPUL DEV REV, V27, P155, DOI 10.1111/j.1728-4457.2001.00155.x
   The World We Want, 2013, HLTH POST 2015 AG RE
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1
   Yoder J, 2010, GIARDIASIS SURVEILLA
   ZELLNER A, 1962, J AM STAT ASSOC, V57, P348, DOI 10.2307/2281644
NR 122
TC 1197
Z9 1256
U1 178
U2 859
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 10
PY 2015
VL 385
IS 9963
BP 117
EP 171
DI 10.1016/S0140-6736(14)61682-2
PG 55
WC Medicine, General & Internal
SC General & Internal Medicine
GA AY7BI
UT WOS:000347715900024
PM 25530442
OA No
HC Y
HP N
DA 2017-08-15
ER

PT J
AU Sanyang, ML
   Kaban, A
AF Sanyang, Momodou L.
   Kaban, Ata
GP IEEE
TI Heavy tails with Parameter Adaptation in Random Projection based
   continuous EDA
SO 2015 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC)
SE IEEE Congress on Evolutionary Computation
LA English
DT Proceedings Paper
CT IEEE Congress on Evolutionary Computation (CEC)
CY MAY 25-28, 2015
CL Sendai, JAPAN
SP IEEE
ID DISTRIBUTION ALGORITHMS; OPTIMIZATION
AB In this paper, we present a new variant of EDA for high dimensional continuous optimisation, which extends a recently proposed random projections (RP) ensemble based approach by employing heavy tailed random matrices. In particular, we use random matrices with i.i.d. t-distributed entries. The use of t-distributions may look surprising in the context of random projections, however we show that the resulting ensemble covariance is enlarged when the degree of freedom parameter is lowered. Based on this observation, we develop an adaptive scheme to adjust this parameter during evolution, and this results in a flexible means of balancing exploration and exploitation of the search process. A comprehensive set of experiments on high dimensional benchmark functions demonstrate the usefulness of our approach.
C1 [Sanyang, Momodou L.; Kaban, Ata] Univ Birmingham, Sch Comp Sci, Edgbaston B15 2TT, England.
   [Sanyang, Momodou L.] Univ Gambia, Sch Informat Technol & Commun, Serekunda, Gambia.
RP Sanyang, ML (reprint author), Univ Birmingham, Sch Comp Sci, Edgbaston B15 2TT, England.
EM M.L.Sanyang@cs.bham.ac.uk; A.Kaban@cs.bham.ac.uk
CR Abramowitz M., 1964, HDB MATH FUNCIONS FO, V55
   Armananzas R, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-6
   Bosman P., 1999, TECHNICAL REPORT
   Chen WX, 2010, LECT NOTES COMPUT SC, V6239, P300, DOI 10.1007/978-3-642-15871-1_31
   DeBonet JS, 1997, ADV NEUR IN, V9, P424
   Dong WS, 2008, INFORM SCIENCES, V178, P3000, DOI 10.1016/j.ins.2008.01.021
   Dong WS, 2013, IEEE T EVOLUT COMPUT, V17, P797, DOI 10.1109/TEVC.2013.2247404
   Eiben AE, 1999, IEEE T EVOLUT COMPUT, V3, P124, DOI 10.1109/4235.771166
   Hansen N., 2006, NEW EVOLUTIONARY COM
   Hansen N, 2010, GECCO-2010 COMPANION PUBLICATION: PROCEEDINGS OF THE 12TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1689
   Kaban A., 2014, 17 INT C ART INT STA, V33, P448
   Kaban A, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P383
   Kern Stefan, 2004, Natural Computing, V3, P77, DOI 10.1023/B:NACO.0000023416.59689.4e
   Kramer O., 2008, THESIS
   Larranaga P, 2001, ESTIMATION DISTRIBUT
   Paul T.K., 2002, P 9 MPS S EV COMP IP, V9, P99
   Petersen K.B., 2005, VERSION OCTOBER 3, P53
   Ros R, 2008, LECT NOTES COMPUT SC, V5199, P296, DOI 10.1007/978-3-540-87700-4_30
   Sanyang M.L., 2014, P IEEE INT C DAT MIN, P653
   Suganthan P.N., 2005, PROBLEM DEFINITIONS
   Tang K., CEC2010 SPEC SESS
   Weicker K., 1999, P C EV COMP, V3, P1627
   Wong YY, 2003, SOFT COMPUT, V7, P506, DOI 10.1007/S00500-002-0235-1
   Yang ZY, 2008, IEEE C EVOL COMPUTAT, P1663, DOI 10.1109/CEC.2008.4631014
   Yuan B., 2005, P GEN EV COMP C GECC, P719, DOI 10.1145/1068009.1068129
NR 25
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-7492-4
J9 IEEE C EVOL COMPUTAT
PY 2015
BP 2074
EP 2081
PG 8
WC Computer Science, Artificial Intelligence
SC Computer Science
GA BF1YE
UT WOS:000380444802014
OA No
DA 2017-08-15
ER

PT S
AU Prentice, AM
AF Prentice, Andrew M.
BE Bhutta, ZA
   Makrides, M
   Prentice, AM
TI Nutrition Challenges and Issues of Relevance to Adolescents in Low-and
   Middle-Income Countries
SO HEALTH AND NUTRITION IN ADOLESCENTS AND YOUNG WOMEN: PREPARING FOR THE
   NEXT GENERATION
SE Nestle Nutrition Institute Workshop Series
LA English
DT Proceedings Paper
CT 80th Nestle-Nutrition-Institute Workshop on Health and Nutrition in
   Adolescents and Young Women - Preparing for the Next Generation
CY NOV 26-29, 2013
CL Bali, INDONESIA
SP Nestle Nutr Inst
ID LACTATION PERFORMANCE; MATERNAL GROWTH; BIRTH-WEIGHT; PREGNANCY;
   CHILDREN; HEIGHT; AGE
AB Adolescence represents a key period in human development during which children metamorphose into sexually active adults capable of reproduction. This transition period is associated with incremental nutritional needs that must be met in order to optimize their parenting capacity, and hence the health of future generations. The key nutritional issues can be listed as follows: (a) adolescence provides a fresh opportunity for stunted children to cross centiles and catch up with international peers; (b) this opportunity may be lost if pubertal growth is prematurely terminated by a pregnancy; (c) competition for nutrients between the adolescent growth drive and an adolescent pregnancy can have sequelae for both the mother and her child; (d) the onset of menstruation in girls makes them more vulnerable to anemia and merits special control programs; (e) adolescent mothers may have less than ideal micronutrient status which could affect the epigenome of their offspring with long-term and intergenerational consequences. The best way to avoid these nutritional hazards is to avoid adolescent pregnancies. (C) 2015 Nestec Ltd., Vevey/S. Karger AG, Basel
C1 [Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
   [Prentice, Andrew M.] MRC Keneba, Keneba, Gambia.
RP Prentice, AM (reprint author), London Sch Hyg & Trop Med, MRC Int Nutr Grp, Keppel St, London WC1E 7HT, England.
EM Andrew.Prentice@lshtm.ac.uk
CR Christiansen CS, 2013, J PREGNANCY, V2013, DOI [DOI 10.1155/2013/257546, 10.1155/2013/257546]
   DUGDALE AE, 1975, NATURE, V256, P725, DOI 10.1038/256725a0
   Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X
   HEDIGER ML, 1990, AM J CLIN NUTR, V52, P793
   Karlberg J, 1989, Acta Paediatr Scand Suppl, V350, P70
   LAURENCE KM, 1981, BRIT MED J, V282, P1509
   McCarthy HD, 2014, PEDIATR OBES, V9, P249, DOI 10.1111/j.2047-6310.2013.00168.x
   Perry R L, 1996, J Matern Fetal Med, V5, P333
   PRENTICE AM, 1994, EUR J CLIN NUTR, V48, pS78
   Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332
   Prentice A, 2012, AM J CLIN NUTR, V96, P1042, DOI 10.3945/ajcn.112.037481
   FAO/WHO/UNU Expert Consultation, 2007, WHO TECH REP SER, V935
   SCHOLL TO, 1990, AM J CLIN NUTR, V51, P790
   SCHOLL TO, 1994, AM J CLIN NUTR, V60, P183
   Sinclair K D, 2007, Soc Reprod Fertil Suppl, V64, P425
   Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998
   Tanner J. M., 1990, FETUS MAN PHYS GROWT
   Teilmann G, 2006, PEDIATRICS, V118, pE391, DOI 10.1542/peds.2005-2939
   UNFPA, 2013, STAT WORLD POP 2013
   UNICEF, 2011, AD GIRLS AN CONTR PR
   Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252
   WHITEHEAD RG, 1978, LANCET, V2, P178
   [United Nations University Food and Agriculture Organization of the United Nations World Health Organization], 2004, HUM EN REQ
   WHO/FAO, 2005, VIT MIN REQ HUM NUTR
NR 24
TC 0
Z9 0
U1 4
U2 4
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 1664-2147
BN 978-3-318-02672-6; 978-3-318-02671-9
J9 NESTLE NUTR WORKS SE
PY 2015
VL 80
BP 49
EP 59
DI 10.1159/000360252
PG 11
WC Nutrition & Dietetics; Pediatrics
SC Nutrition & Dietetics; Pediatrics
GA BG3GZ
UT WOS:000387943700004
OA No
DA 2017-08-15
ER

PT J
AU Mwangi, MN
   Roth, JM
   Mwangi, AM
   Savelkoul, HFJ
   Hider, RC
   Mens, PF
   Schallig, HDFH
   Demir, AY
   Andang'o, PEA
   Verhoef, H
AF Mwangi, Martin N.
   Roth, Johanna M.
   Mwangi, Alice M.
   Savelkoul, Huub F. J.
   Hider, Robert C.
   Mens, Petra F.
   Schallig, Henk D. F. H.
   Demir, Ayse Y.
   Andang'o, Pauline E. A.
   Verhoef, Hans
TI Antenatal iron supplementation and serum non-transferrin bound iron in
   Kenyan women: a randomized placebo-controlled trial
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Meeting Abstract
DE Non-transferrin bound iron; malaria; Plasmodium; pregnancy; Kenya
C1 [Mwangi, Martin N.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands.
   [Roth, Johanna M.; Mens, Petra F.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.
   [Mwangi, Alice M.] Univ Nairobi, Appl Nutr Programme, Nairobi, Kenya.
   [Savelkoul, Huub F. J.; Verhoef, Hans] Wageningen Univ, Cell Biol & Immunol Grp, NL-6700 AP Wageningen, Netherlands.
   [Hider, Robert C.] Kings Coll London, Div Pharmaceut Sci, London WC2R 2LS, England.
   [Schallig, Henk D. F. H.] Meander Med Ctr, Clin Chem Lab, Parasitol Unit, Amersfoort, Netherlands.
   [Demir, Ayse Y.] Meander Med Ctr, Clin Chem Lab, Lab Med, Amersfoort, Netherlands.
   [Andang'o, Pauline E. A.] Maseno Univ, Sch Publ Hlth & Community Dev, Dept Nutr & Hlth, Maseno, Kenya.
   [Verhoef, Hans] London Sch Hyg & Trop Med, MRC Int Nutr Grp 8, London, England.
   [Verhoef, Hans] MRC Keneba, Serrekunda, Gambia.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2015
VL 67
SU 1
MA 149/309
BP 341
EP 341
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA DK5VM
UT WOS:000374988801318
OA No
DA 2017-08-15
ER

PT J
AU Tsai, MH
   Lin, KH
   Lin, KT
   Hung, CM
   Cheng, HS
   Tyan, YC
   Huang, HW
   Bintou, SD
   Yang, MH
   Yuan, SS
   Chu, PY
AF Tsai, Mei-Hua
   Lin, Kuei-Hsiang
   Lin, Kuan-Tsou
   Hung, Chi-Ming
   Cheng, Hung-Shiang
   Tyan, Yu-Chang
   Huang, Hui-Wen
   Bintou Sanno-Duanda
   Yang, Ming-Hui
   Yuan, Shyng-Shiou
   Chu, Pei-Yu
TI Predictors for Early Identification of Hepatitis C Virus Infection
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID CHRONIC LIVER-DISEASE; LOW PLATELET COUNT; HEPATOCELLULAR-CARCINOMA;
   SERUM THROMBOPOIETIN; SOUTHERN TAIWAN; BLOOD PLATELETS; B-VIRUS;
   THROMBOCYTOPENIA; MORTALITY; PREVALENCE
AB Hepatitis C virus (HCV) infection can cause permanent liver damage and hepatocellular carcinoma, and deaths related to HCV deaths have recently increased. Chronic HCV infection is often undiagnosed such that the virus remains infective and transmissible. Identifying HCV infection early is essential for limiting its spread, but distinguishing individuals who require further HCV tests is very challenging. Besides identifying high-risk populations, an optimal subset of indices for routine examination is needed to identify HCV screening candidates. Therefore, this study analyzed data from 312 randomly chosen blood donors, including 144 anti-HCV-positive donors and 168 anti-HCV-negative donors. The HCV viral load in each sample was measured by real-time polymerase chain reaction method. Receiver operating characteristic curves were used to find the optimal cell blood counts and thrombopoietin measurements for screening purposes. Correlations with values for key indices and viral load were also determined. Strong predictors of HCV infection were found by using receiver operating characteristics curves to analyze the optimal subsets among red blood cells, monocytes, platelet counts, platelet large cell ratios, and mean corpuscular hemoglobin concentrations. Sensitivity, specificity, and area under the receiver operator characteristic curve (P < 0.0001) were 75.6%, 78.5%, and 0.859, respectively.
C1 [Tsai, Mei-Hua; Lin, Kuan-Tsou; Hung, Chi-Ming] Taiwan Blood Serv Fdn, Kaohsiung Blood Ctr, Kaohsiung 811, Taiwan.
   [Tsai, Mei-Hua; Bintou Sanno-Duanda; Chu, Pei-Yu] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung 807, Taiwan.
   [Lin, Kuei-Hsiang] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Clin Lab, Kaohsiung 807, Taiwan.
   [Cheng, Hung-Shiang] Cishan Hosp, Minist Hlth & Welfare, Kaohsiung 842, Taiwan.
   [Tyan, Yu-Chang] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Imaging & Radiol Sci, Kaohsiung 807, Taiwan.
   [Tyan, Yu-Chang; Yang, Ming-Hui; Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 807, Taiwan.
   [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 804, Taiwan.
   [Huang, Hui-Wen] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Anesthesiol, Kaohsiung 833, Taiwan.
   [Huang, Hui-Wen] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan.
   [Bintou Sanno-Duanda] Edward Francis Small Teaching Hosp, Banjul, Gambia.
   [Yang, Ming-Hui; Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan.
   [Yuan, Shyng-Shiou] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung 807, Taiwan.
   [Yuan, Shyng-Shiou] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung 807, Taiwan.
   [Chu, Pei-Yu] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 807, Taiwan.
RP Chu, PY (reprint author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung 807, Taiwan.
EM peiyuchu@kmu.edu.tw
FU Taiwan Blood Services Foundation [97-01-KS]; Kaohsiung Medical
   University [KMU-M110018, KMU-O104003]; Aim for the Top Journal
   [KMU-DT103010]; Ministry of Health and Welfare [MOHW103-TD-B-111-05];
   National Science Council, Taiwan [NSC-102-2320-B-037-017]
FX The authors gratefully acknowledge Dr. Ren-Chin Jang for his dedication
   and commitment to this collaborative study. The Statistical Analysis
   Laboratory, Department of Medical Research, Kaohsiung Medical University
   Hospital, Kaohsiung Medical University, is greatly appreciated for
   helpful suggestions and guidance throughout the paper revision process.
   This study was funded by the Taiwan Blood Services Foundation
   (97-01-KS), Kaohsiung Medical University (KMU-M110018, Aim for the Top
   500 Universities Grant KMU-O104003, and Aim for the Top Journal Grant
   KMU-DT103010), Ministry of Health and Welfare (MOHW103-TD-B-111-05), and
   the National Science Council, Taiwan (NSC-102-2320-B-037-017). This
   study was approved by the Ethics Committee of the Taiwan Blood Services
   Foundation.
CR Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009
   BIK T, 1982, BLOOD, V59, P482
   Chen CH, 2007, J FORMOS MED ASSOC, V106, P148
   CHERNESKY MA, 1973, J GEN VIROL, V21, P205, DOI 10.1099/0022-1317-21-2-205
   Chiavetta JA, 2003, CAN MED ASSOC J, V169, P767
   Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26
   Cowie BC, 2013, ANTIVIR THER, V18, P953, DOI 10.3851/IMP2654
   Crapnell K, 2000, BLOOD, V95, P487
   Dai CY, 2010, J HEPATOL, V52, P160, DOI 10.1016/j.jhep.2009.11.017
   El Barbary MA, 2010, ANGIOLOGY, V61, P304, DOI 10.1177/0003319709343178
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Flaujac C, 2010, CELL MOL LIFE SCI, V67, P545, DOI 10.1007/s00018-009-0209-x
   Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074
   Giannini E, 2003, AM J GASTROENTEROL, V98, P2516, DOI 10.1016/S0002-9270(03)01698-8
   Gu JZ, 2008, STAT MED, V27, P5407, DOI 10.1002/sim.3366
   Hamaia S, 2001, BLOOD, V98, P2293, DOI 10.1182/blood.V98.8.2293
   Hobisch-Hagen P, 2000, EUR J HAEMATOL, V64, P157, DOI 10.1034/j.1600-0609.2000.90102.x
   KAHANE S, 1981, CLIN EXP IMMUNOL, V44, P49
   KARMEN A, 1955, J CLIN INVEST, V34, P126, DOI 10.1172/JCI103055
   Kauf Teresa L, 2012, BMC Res Notes, V5, P142, DOI 10.1186/1756-0500-5-142
   Kawasaki T, 1999, AM J GASTROENTEROL, V94, P1918
   Kitchens Craig S, 2009, Hematology Am Soc Hematol Educ Program, P240, DOI 10.1182/asheducation-2009.1.240
   Lee CM, 2006, T ROY SOC TROP MED H, V100, P767, DOI 10.1016/j.trstmh.2005.10.008
   Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385
   Li X, 1999, J VIRAL HEPATITIS, V6, P107, DOI 10.1046/j.1365-2893.1999.00140.x
   Martell M, 1999, J CLIN MICROBIOL, V37, P327
   McCombs J, 2014, JAMA INTERN MED, V174, P204, DOI 10.1001/jamainternmed.2013.12505
   MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884
   Muhlberger Nikolai, 2009, BMC Public Health, V9, P34, DOI 10.1186/1471-2458-9-34
   Nelson KE, 2012, J INFECT DIS, V206, P461, DOI 10.1093/infdis/jis394
   Puoti C, 2002, J HEPATOL, V37, P117, DOI 10.1016/S0168-8278(02)00101-0
   Scaradavou A, 2002, BLOOD REV, V16, P73, DOI 10.1054/bire.2001.0188
   SCOTT S, 1978, BLOOD, V52, P47
   Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806
   Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1
   Sun CA, 1999, J MED VIROL, V59, P290, DOI 10.1002/(SICI)1096-9071(199911)59:3<290::AID-JMV5>3.0.CO;2-R
   TERADA H, 1966, BLOOD-J HEMATOL, V28, P213
   Trepo C, 2014, LIVER INT, V34, P29, DOI 10.1111/liv.12409
   Tsai MC, 2007, J GASTROEN HEPATOL, V22, P92, DOI 10.1111/j.1440-1746.2006.04489.x
   Wang CS, 2004, CLIN INFECT DIS, V39, P790, DOI 10.1086/423384
   Wang JH, 1999, T ROY SOC TROP MED H, V93, P253, DOI 10.1016/S0035-9203(99)90012-3
   WANG SG, 1995, VIROLOGY, V213, P254, DOI 10.1006/viro.1995.1567
   Ward John W, 2013, Top Antivir Med, V21, P15
   WINIARSKI J, 1990, ARCH DIS CHILD, V65, P137
   Wu FB, 2008, J MED MICROBIOL, V57, P947, DOI 10.1099/jmm.0.47835-0
   Zahn A, 2006, J GEN VIROL, V87, P2243, DOI 10.1099/vir.0.81826-0
NR 46
TC 1
Z9 1
U1 0
U2 0
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2015
AR 429290
DI 10.1155/2015/429290
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA CQ6QD
UT WOS:000360728100001
OA gold
DA 2017-08-15
ER

PT J
AU Odey, F
   Okomo, U
   Oyo-Ita, A
AF Odey, Friday
   Okomo, Uduak
   Oyo-Ita, Angela
TI Vaccines for preventing invasive salmonella infections in people with
   sickle cell disease
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Anemia, Sickle Cell [complications]; Salmonella Infections [prevention &
   control]; Salmonella Vaccines [administration & dosage]; Humans
ID TYPHOID-FEVER; OSTEOMYELITIS; METAANALYSIS; SEPTICEMIA; MORTALITY;
   ANEMIA
AB Background
   Salmonella infections are a common bacterial cause of invasive disease in people with sickle cell disease especially children, and are associated with high morbidity and mortality rates. Although available in some centres, people with sickle cell anaemia are not routinely immunized with salmonella vaccines. This is an update of a previously published Cochrane Review.
   Objectives
   To determine whether routine administration of salmonella vaccines to people with sickle cell disease reduces the morbidity and mortality associated with infection.
   Search methods
   We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.
   We also conducted a search of the LILACS database.
   Date of most recent searches: 05 May 2015.
   Selection criteria
   We planned to select all randomized controlled trials that compared the use of either the inactivated vaccine or an oral attenuated vaccine with a placebo among people with sickle cell disease. Equally, studies that compared the efficacy of one vaccine type over another were to be selected for the review.
   Data collection and analysis
   No trials of salmonella vaccines in people with sickle cell disease were found.
   Main results
   There is an absence of randomized controlled trial evidence relating to the scope of this review.
   Authors' conclusions
   It is expected that salmonella vaccines may be useful in people with sickle cell disease, especially in resource-poor settings where the majority of those who suffer from the condition are found. Unfortunately, there are no randomized controlled trials on the efficacy and safety of the different types of salmonella vaccines in people with sickle cell disease. We conclude that there is a need for a well-designed, adequately-powered, randomized controlled trial to assess the benefits and risks of the different types of salmonella vaccines as a means of improving survival and decreasing mortality from salmonella infections in people with sickle cell disease.
C1 [Odey, Friday] Univ Calabar, Teaching Hosp, Dept Paediat, Calabar 540261, Cross River Sta, Nigeria.
   [Okomo, Uduak] Med Res Council UK, Viral Dis Programme, Fajara, Gambia.
   [Oyo-Ita, Angela] Univ Calabar, Teaching Hosp, Dept Community Hlth, Calabar 540261, Cross River Sta, Nigeria.
RP Odey, F (reprint author), Univ Calabar, Teaching Hosp, Dept Paediat, PMB 1115, Calabar 540261, Cross River Sta, Nigeria.
EM awhobe@yahoo.com
FU Nigeria branch of the South African Cochrane Centre; Institute of
   Tropical Diseases Research and Prevention, University of Calabar
   Teaching Hospital, Nigeria; Effective Health Care Alliance Programme -
   DFID, UK; National Institute for Health Research, UK; National Institute
   for Health Research, via Cochrane Infrastructure funding
FX Internal sources; Nigeria branch of the South African Cochrane Centre
   and Institute of Tropical Diseases Research and Prevention, University
   of Calabar Teaching Hospital, Nigeria.; External sources; Effective
   Health Care Alliance Programme (supported by DFID), UK.; National
   Institute for Health Research, UK.; This systematic review was supported
   by the National Institute for Health Research, via Cochrane
   Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic
   Disorders Group.
CR ADEYOKUNNU AA, 1980, ARCH DIS CHILD, V55, P175
   Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9
   Ashcroft M T, 1967, Lancet, V2, P1056
   BENNETT OM, 1990, J BONE JOINT SURG BR, V72, P494
   BENNISH ML, 1995, INFECT DIS CLIN PRAC, V4, P114, DOI 10.1097/00019048-199503000-00011
   Burnett MW, 1998, PEDIATRICS, V101, P297
   Cates C, 2003, VIS RX
   CONSTANT.A, 1973, AM J DIS CHILD, V125, P663
   Center for Disease Control, 1990, MMWR-MORBID MORTAL W, V39, P1
   Davies EG, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003885.pub2, DOI 10.1002/14651858.CD003885.PUB2]
   Davies SC, 1997, BRIT MED J, V315, P656
   DeRoeck D, 2004, UPDATE POLICY ISSUES
   EBONG WW, 1986, ANN RHEUM DIS, V45, P911, DOI 10.1136/ard.45.11.911
   Egger M, 1997, BRIT MED J, V315, P629
   Elbashier AM, 2003, ANN SAUDI MED, V23, P358
   Engels EA, 1998, BRIT MED J, V316, P110
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins Jpt GS, 2011, COCHRANE HDB SYSTEMA
   Magnus SA, 1999, ARCH DIS CHILD, V80, P537
   The Nordic Cochrane Centre The Cochrane Collaboration, 2014, REV MAN REVMAN 5 3
   Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818
   Odey F, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006975.pub2
   OVERTURF GD, 1977, AM J DIS CHILD, V131, P784
   Serjeant GR, 1994, RECENT ADV PAEDIAT, V12, P141
   Tarr PE, 1999, AM J TROP MED HYG, V61, P163
   VICHINSKY E, 1988, PEDIATRICS, V81, P749
   WHO, 2008, WKLY EPIDEMIOL REC, V83, P49
   Wierenga KJJ, 2001, ARCH DIS CHILD, V84, P156, DOI 10.1136/adc.84.2.156
   Wright J, 1997, J PEDIATR-US, V130, P394, DOI 10.1016/S0022-3476(97)70201-4
   Yugoslav Typhoid Commission, 1964, B WORLD HEALTH ORGAN, V30, P623
NR 30
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2015
IS 6
AR CD006975
DI 10.1002/14651858.CD006975.pub3
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA CM3TE
UT WOS:000357606400031
PM 26043710
OA No
DA 2017-08-15
ER

PT J
AU Okomo, U
   Meremikwu, MM
AF Okomo, Uduak
   Meremikwu, Martin M.
TI Fluid replacement therapy for acute episodes of pain in people with
   sickle cell disease
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Fluid Therapy; Acute Pain [etiology; therapy]; Anemia, Sickle Cell
   [complications; therapy]; Pain Management [methods]; Humans
ID CRISIS; ANEMIA; MANAGEMENT; HYPOSTHENURIA; PREVENTION; KETOROLAC;
   EMERGENCY; CHILDREN; TRIAL
AB Background
   Treating vaso-occlusive painful crises in people with sickle cell disease is complex and requires multiple interventions. Extra fluids are routinely given as adjunct treatment, regardless of the individual's state of hydration with the aim of slowing or stopping the sickling process and thereby alleviating pain. This is an update of a previously published Cochrane Review.
   Objectives
   To determine the optimal route, quantity and type of fluid replacement for people with sickle cell disease with acute painful crises.
   Search methods
   We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises of references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.
   We also conducted searches of Embase (November 2007), LILACS and www.ClinicalTrials.gov (05 January 2010).
   Date of most recent search of the Group's Haemoglobinopathies Trials Register: 24 September 2014.
   Selection criteria
   Randomised and quasi-randomised controlled trials that compared the administration of supplemental fluids adjunctive to analgesics by any route in people with any type of sickle cell disease during an acute painful episode, under medical supervision (inpatient, day care or community).
   Data collection and analysis
   No relevant trials have yet been identified.
   Main results
   Sixteen trials were identified by the searches, all of which were not eligible for inclusion in the review.
   Authors' conclusions
   Treating vaso-occlusive crises is complex and requires multiple interventions. Extra fluids, generally oral or intravenous, are routinely administered during acute painful episodes to people with sickle cell disease regardless of the individual's state of hydration. Reports of their use during these acute painful episodes do not state the efficacy of any single route, type or quantity of fluid compared to another. However, there are no randomised controlled trials that have assessed the safety and efficacy of different routes, types or quantities of fluid. This systematic review identifies the need for a multicentre randomised controlled trial assessing the efficacy and possible adverse effects of different routes, types and quantities of fluid administered to people with sickle cell disease during acute painful episodes.
C1 [Okomo, Uduak] Med Res Council UK, Viral Dis Programme, Fajara, Gambia.
   [Meremikwu, Martin M.] Univ Calabar, Teaching Hosp, Dept Paediat, Calabar, Nigeria.
RP Okomo, U (reprint author), Med Res Council UK, Viral Dis Programme, Atlantic Blvd,POB 273, Fajara, Gambia.
EM uokomo@mrc.gm
FU Institute of Tropical Diseases Research and Prevention, University of
   Calabar Teaching Hospital, Calabar, Nigeria; Effective Health Care
   Alliance Programme (DFID), UK; National Institute for Health Research,
   UK; National Institute for Health Research
FX Internal sources; Institute of Tropical Diseases Research and
   Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.;
   External sources; Effective Health Care Alliance Programme (supported by
   DFID), UK.; National Institute for Health Research, UK.; This systematic
   review was supported by the National Institute for Health Research, via
   Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and
   Genetic Disorders Group.
CR Adams S, 1996, Prof Care Mother Child, V6, P34
   Adekile AD, 1999, PAEDIAT CHILD HLTH T, P200
   ALLON M, 1990, ARCH INTERN MED, V150, P501, DOI 10.1001/archinte.150.3.501
   Alvim RC, 2005, ACTA HAEMATOL-BASEL, V113, P228, DOI 10.1159/000084675
   Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008
   Ballas SK, 2007, HEMATOL-AM SOC HEMAT, V1, P97
   Beiter JL, 2001, ARCH PEDIAT ADOL MED, V155, P496
   Brugnara C, 1995, Curr Opin Hematol, V2, P132
   CHARACHE S, 1983, AM J HEMATOL, V15, P315, DOI 10.1002/ajh.2830150402
   CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001
   CHARACHE S, 1981, BLOOD, V58, P892
   de Araujo J T, 1994, Rev Hosp Clin Fac Med Sao Paulo, V49, P13
   Gruber C, 1982, LANCET, V2, P229
   GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501
   GONZALEZ ER, 1991, ARCH INTERN MED, V151, P1373, DOI 10.1001/archinte.151.7.1373
   GONZALEZ ER, 1988, ANN EMERG MED, V17, P788, DOI 10.1016/S0196-0644(88)80554-7
   Guy R, 1971, CLIN RES, V21, P420
   GUY RB, 1973, AM J MED SCI, V266, P267, DOI 10.1097/00000441-197310000-00005
   Hardwick WE, 1999, PEDIATR EMERG CARE, V15, P179, DOI 10.1097/00006565-199906000-00004
   HATCH FE, 1965, ARCH INTERN MED, V116, P10
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Terry AL, DIPYRIDAMOLE MAGNESI
   KEITEL HG, 1956, J CLIN INVEST, V35, P998, DOI 10.1172/JCI103360
   KONTESSIS P, 1992, NEPHRON, V61, P10
   Lane PA, 2001, INPATIENT MANAGEMENT
   Lane PA, 2001, CURRENT PEDIAT DIAGN, P756
   Marti-Carvajal AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006786.pub2
   NALBANDIAN RM, 1971, AM J MED SCI, V261, P309, DOI 10.1097/00000441-197106000-00002
   Okomo U, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005406.pub2
   Okomo U, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005406.pub3
   Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099
   OSKI FA, 1965, J AMER MED ASSOC, V191, P43
   PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103
   Rhodes RS, 1974, JAMA-J AM MED ASSOC, V228, P1129
   ROSA RM, 1980, NEW ENGL J MED, V303, P1138, DOI 10.1056/NEJM198011133032002
   Saborio P, 1999, J AM SOC NEPHROL, V10, P187
   Serjeant GR, 1992, SICKLE CELL DIS
   Sickle Cell Information Center, 2005, SICKL CELL INF CLIN
   Steinberg MH, 2006, TRENDS PHARMACOL SCI, V27, P204, DOI 10.1016/j.tips.2006.02.007
   Steinberg MH, 1999, NEW ENGL J MED, V340, P1021
   VANEPS LWS, 1967, CLIN CHIM ACTA, V17, P449, DOI 10.1016/0009-8981(67)90222-7
NR 41
TC 3
Z9 3
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2015
IS 3
AR CD005406
DI 10.1002/14651858.CD005406.pub4
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA CF5PI
UT WOS:000352608900014
PM 25764071
OA No
DA 2017-08-15
ER

PT J
AU Oriero, EC
   Jacobs, J
   Van Geertruyden, JP
   Nwakanma, D
   D'Alessandro, U
AF Oriero, Eniyou C.
   Jacobs, Jan
   Van Geertruyden, Jean-Pierre
   Nwakanma, Davis
   D'Alessandro, Umberto
TI Molecular-based isothermal tests for field diagnosis of malaria and
   their potential contribution to malaria elimination
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Review
DE malaria elimination; isothermal amplification; PCR; tHDA; LAMP; NASBA;
   SDA; RPA
ID STRAND DISPLACEMENT AMPLIFICATION; SEQUENCE-BASED AMPLIFICATION;
   NUCLEIC-ACID AMPLIFICATION; HELICASE-DEPENDENT AMPLIFICATION; REAL-TIME
   PCR; PLASMODIUM-FALCIPARUM GAMETOCYTES; DISPOSABLE DETECTION DEVICE;
   LINKED-IMMUNOSORBENT-ASSAY; RESOURCE-LIMITED SETTINGS;
   MYCOBACTERIUM-TUBERCULOSIS
AB In countries where malaria transmission has decreased substantially, thanks to the scale-up of control interventions, malaria elimination may be feasible. Nevertheless, this goal requires new strategies such as the active detection and treatment of infected individuals. As the detection threshold for the currently used diagnostic methods is 100 parasites/mu L, most low-density, asymptomatic infections able to maintain transmission cannot be detected. Identifying them by molecular methods such as PCR is a possible option but the field deployment of these tests is problematic. Isothermal amplification of nucleic acids (at a constant temperature) offers the opportunity of addressing some of the challenges related to the field deployment of molecular diagnostic methods. One of the novel isothermal amplification methods for which a substantial amount of work has been done is the loop-mediated isothermal amplification (LAMP) assay. The present review describes LAMP and several other isothermal nucleic acid amplification methods, such as thermophilic helicase-dependent amplification, strand displacement amplification, recombinase polymerase amplification and nucleic acid sequence-based amplification, and explores their potential use as high-throughput, field-based molecular tests for malaria diagnosis.
C1 [Oriero, Eniyou C.; Nwakanma, Davis; D'Alessandro, Umberto] MRC, Banjul, Gambia.
   [Oriero, Eniyou C.; Jacobs, Jan; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Oriero, Eniyou C.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
RP Oriero, EC (reprint author), MRC, Banjul, Gambia.
EM eoriero@mrc.gm
RI D'Alessandro, Umberto/D-3457-2015; Van geertruyden,
   Jean-pierre/K-6425-2014
OI D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden,
   Jean-pierre/0000-0001-5006-6364
FU Medical Research Council [MC_UP_A900_1117, MC_UP_A900_1119]
CR Abd el-Galil Khaled H, 2005, Appl Environ Microbiol, V71, P7113, DOI 10.1128/AEM.71.11.7113-7116.2005
   Abdul-Ghani R, 2012, ACTA TROP, V122, P233, DOI 10.1016/j.actatropica.2012.02.004
   Ahram Biosystems, PALM PCR
   Al-Soud Waleed Abu, 2001, Journal of Clinical Microbiology, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001
   An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200
   Andresen D, 2009, EXPERT REV MOL DIAGN, V9, P645, DOI [10.1586/erm.09.46, 10.1586/ERM.09.46]
   Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a
   Bachmann LH, 2010, J CLIN MICROBIOL, V48, P1827, DOI 10.1128/JCM.02398-09
   Bearinger JP, 2011, IEEE T BIO-MED ENG, V58, P805, DOI 10.1109/TBME.2010.2089054
   bigtec Labs, TRUEPR MAG TRUEL UN
   BioFire, R A P I D BIODETECTI
   Boonma P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-124
   Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136
   Buates S, 2010, PARASITOL INT, V59, P414, DOI 10.1016/j.parint.2010.05.008
   Chan EL, 2000, ARCH PATHOL LAB MED, V124, P1649
   Chang CC, 2012, SENSORS-BASEL, V12, P8319, DOI 10.3390/s120608319
   Chen JH, 2010, ACTA TROP, V113, P61, DOI 10.1016/j.actatropica.2009.09.007
   Chow WHA, 2008, J MOL DIAGN, V10, P452, DOI 10.2353/jmoldx.2008.080008
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685
   Cosentino LA, 2003, J CLIN MICROBIOL, V41, P3592, DOI 10.1128/JCM.41.8.3592-3596.2003
   Dineva MA, 2007, ANALYST, V132, P1193, DOI 10.1039/b705672a
   Down JA, 1996, J CLIN MICROBIOL, V34, P860
   Eiken Chemical Co. Ltd, PRINC LAMP METH VER
   Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006
   Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08
   FORMOSA T, 1986, J BIOL CHEM, V261, P6107
   Fuehrer HP, 2011, J CLIN MICROBIOL, V49, P1628, DOI 10.1128/JCM.01792-10
   Ge B, 2002, MOL CELL PROBE, V16, P85, DOI 10.1006/mcpr.2001.0389
   Gill P, 2008, DIAGN MICR INFEC DIS, V62, P119, DOI 10.1016/j.diagmicrobio.2008.05.003
   Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204
   Gill P, 2007, DIAGN MICR INFEC DIS, V59, P243, DOI 10.1016/j.diagmicrobio.2007.05.005
   Gill P, 2006, BIOCHEM BIOPH RES CO, V347, P1151, DOI 10.1016/j.bbrc.2006.07.039
   Goldmeyer J, 2008, J CLIN MICROBIOL, V46, P1534, DOI 10.1128/JCM.02234-07
   Goldmeyer J, 2007, J MOL DIAGN, V9, P639, DOI 10.2353/jmoldx.2007.070012
   Gonzalez IJ, 2012, MALAR J S1, V11, pO30
   GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874
   Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06
   Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]
   HARRIS LD, 1988, BIOCHEMISTRY-US, V27, P6954, DOI 10.1021/bi00418a042
   Henning L, 1999, ACTA TROP, V72, P149, DOI 10.1016/S0001-706X(98)00090-4
   Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184
   Iseki H, 2010, J CLIN MICROBIOL, V48, P2509, DOI 10.1128/JCM.00331-10
   Jiang T, 2011, J CLIN MICROBIOL, V49, P870, DOI 10.1128/JCM.02045-10
   Jordan JA, 2012, J CLIN VIROL, V54, P11, DOI 10.1016/j.jcv.2012.01.004
   Karami A, 2011, J GLOB INFECT DIS, V3, P293
   Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805
   KIEVITS T, 1991, J VIROL METHODS, V35, P273, DOI 10.1016/0166-0934(91)90069-C
   Kim HJ, 2011, J CLIN VIROL, V50, P26, DOI 10.1016/j.jcv.2010.09.006
   Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665
   Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694
   LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738
   Lau YL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-197
   Li Y, 2013, J MOL DIAGN, V15, P634, DOI 10.1016/j.jmoldx.2013.05.005
   Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]
   Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898
   Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733
   Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841
   Maeda H, 2005, FEMS IMMUNOL MED MIC, V43, P233, DOI 10.1016/j.femsim.2004.08.005
   *MALERA CONS GROUP, 2011, PLOS MED, V0008
   *MALERA CONS GROUP, 2011, PLOS MED, V0008
   Mazzarelli G, 2003, J CLIN MICROBIOL, V41, P1779, DOI 10.1128/JCM.41.4.1779-1782.2003
   Mens PF, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-80
   Mens PF, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-279
   Misawa Yoshiki, 2007, Journal of Infection and Chemotherapy, V13, P134, DOI 10.1007/s10156-007-0516-9
   Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007
   Monis PT, 2006, INFECT GENET EVOL, V6, P2, DOI 10.1016/j.meegid.2005.08.004
   Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Mugasa CM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-13
   Mugasa CM, 2009, J CLIN MICROBIOL, V47, P630, DOI 10.1128/JCM.01430-08
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Nwakanma D, 2008, INT J PARASITOL, V38, P219, DOI 10.1016/j.ijpara.2007.07.003
   Nycz CM, 1998, ANAL BIOCHEM, V259, P226, DOI 10.1006/abio.1998.2641
   OKAZAKI T, 1964, J BIOL CHEM, V239, P259
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Parida MM, 2008, J BIOSCIENCES, V33, P617, DOI 10.1007/s12038-008-0079-7
   Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593
   Paris DH, 2007, AM J TROP MED HYG, V77, P972
   Pasternack R, 1997, J CLIN MICROBIOL, V35, P676
   Patel JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054986
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Poschl B, 2010, AM J TROP MED HYG, V83, P56, DOI 10.4269/ajtmh.2010.09-0630
   Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183
   Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10
   Poon LLM, 2006, CLIN CHEM, V52, P303
   Prithiviraj J, 2012, BIOCHEM BIOPH RES CO, V420, P738, DOI 10.1016/j.bbrc.2012.03.055
   Pyrc K, 2011, J VIROL METHODS, V175, P133, DOI 10.1016/j.jviromet.2011.04.024
   Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004
   Ryan C, 2007, SEX TRANSM INFECT, V83, P175, DOI 10.1136/sti.2006.021816
   Schallig HDFH, 2003, EUR J CLIN MICROBIOL, V22, P555, DOI 10.1007/s10096-003-0985-4
   Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005
   Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072
   Shen F, 2011, ANAL CHEM, V83, P3533, DOI 10.1021/ac200247e
   SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100
   Sirichaisinthop J, 2011, AM J TROP MED HYG, V85, P594, DOI 10.4269/ajtmh.2011.10-0676
   Smits HL, 1997, J MICROBIOL METH, V28, P65, DOI 10.1016/S0167-7012(96)00966-9
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
   SPARGO CA, 1993, MOL CELL PROBE, V7, P395, DOI 10.1006/mcpr.1993.1058
   Spargo CA, 1996, MOL CELL PROBE, V10, P247, DOI 10.1006/mcpr.1996.0034
   Sultan DM, 2009, KOREAN J PARASITOL, V47, P227, DOI 10.3347/kjp.2009.47.3.227
   Tai JH, 2003, J VIROL METHODS, V110, P119, DOI 10.1016/S0166-0934(03)00108-3
   Tang W, 2010, J INFECT DIS, V201, pS46, DOI 10.1086/650388
   Tatibana BT, 2009, J CLIN LAB ANAL, V23, P139, DOI 10.1002/jcla.20304
   Taylor BJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-244
   Thekisoe OMM, 2010, AM J TROP MED HYG, V82, P855, DOI 10.4269/ajtmh.2010.09-0533
   Tong YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-50
   TwistDX, REC POL AMPL BREAKTH
   Uemori T, 2007, J BIOCHEM, V142, P283, DOI 10.1093/jb/mvm137
   van der Pol B, 2001, J CLIN MICROBIOL, V39, P1008, DOI 10.1128/JCM.39.3.1008-1016.2001
   Van Dyck E, 2001, J CLIN MICROBIOL, V39, P1751, DOI 10.1128/JCM.39.5.1751-1756.2001
   Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100
   Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200
   Visca P, 2004, CLIN MICROBIOL INFEC, V10, P332, DOI 10.1111/j.1198-743X.2004.00818.x
   WALKER GT, 1993, PCR METH APPL, V3, P1
   WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691
   WALKER GT, 1994, NUCLEIC ACIDS RES, V22, P2670, DOI 10.1093/nar/22.13.2670
   Wang C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-164
   WHO, 2012, T3 TEST TREAT TRACK
   World Health Organization, 2012, DIS SURV MAL CONTR
   Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119
   Xia JF, 2011, DIAGN MICR INFEC DIS, V71, P244, DOI 10.1016/j.diagmicrobio.2011.07.014
   Yamamura M, 2009, JPN J INFECT DIS, V62, P20
   Yamazaki W, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-163
   YONESAKI T, 1985, EUR J BIOCHEM, V148, P127, DOI 10.1111/j.1432-1033.1985.tb08816.x
   Yulong Zhao, 2010, Mol Cell Probes, V24, P396, DOI 10.1016/j.mcp.2010.09.001
   Zhang Z, 2010, J MOL DIAGN, V12, P152, DOI 10.2353/jmoldx.2010.090070
NR 129
TC 15
Z9 15
U1 8
U2 32
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD JAN
PY 2015
VL 70
IS 1
BP 2
EP 13
DI 10.1093/jac/dku343
PG 12
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA CC2YJ
UT WOS:000350210800002
PM 25223973
OA No
DA 2017-08-15
ER

PT J
AU Jensen, KJ
   Ndure, J
   Plebanski, M
   Flanagan, KL
AF Jensen, Kristoffer J.
   Ndure, Jorjoh
   Plebanski, Magdalena
   Flanagan, Katie L.
TI Heterologous and sex differential effects of administering vitamin A
   supplementation with vaccines
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Review
DE All-cause mortality; BCG vaccine; DTP vaccine; Measles vaccine; Sex;
   Vitamin A
ID RANDOMIZED CONTROLLED-TRIAL; GUINEA-BISSAU; CHILDHOOD MORTALITY;
   INFANT-MORTALITY; CYTOKINE PRODUCTION; MEASLES-VACCINE; DOUBLE-BLIND;
   WEST-AFRICA; BCG VACCINE; BIRTH
AB WHO recommends high-dose vitamin A supplementation (VAS) to children from 6 months to 5 years of age in low-income countries, in order to prevent and treat vitamin A deficiency-associated morbidity and mortality. The current policy does not discriminate this recommendation either by sex or vaccination status of the child. There is accumulating evidence that the effects of VAS on morbidity, mortality and immunological parameters depend on concomitant vaccination status. Moreover, these interactions may manifest differently in males and females. Certain vaccines administered through the Expanded Program on Immunization have been shown to alter all-cause mortality from infections other than the vaccine-targeted disease. This review summarizes the evidence from observational studies and randomized-controlled trials of the effects of VAS on these so-called heterologous or non-specific effects of vaccines, with a focus on sex differences. In general, VAS seems to enhance the heterologous effects of vaccines, particularly for diphtheria-tetanus-pertussis and live measles vaccines, where some studies, although not unanimously, show a stronger interaction between VAS and vaccination in females. We suggest that vaccination status and sex should be considered when evaluating the effects of VAS in early life.
C1 [Jensen, Kristoffer J.] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen S, Denmark.
   [Jensen, Kristoffer J.] Projecto Saude Bandim, Indepth Network, Bissau, Guinea Bissau.
   [Ndure, Jorjoh] MRC Labs, Fajara, Gambia.
   [Plebanski, Magdalena; Flanagan, Katie L.] Monash Univ, Dept Immunol, Vaccine & Infect Dis Lab, Prahran, Vic 3004, Australia.
RP Flanagan, KL (reprint author), Monash Univ, Dept Immunol, Vaccine & Infect Dis Lab, 89 Commercial Rd, Prahran, Vic 3004, Australia.
EM katie.flanagan@dhhs.tas.gov.au
OI Jensen, Kristoffer Jarlov/0000-0001-9687-5706
FU European Research Council [ERC-2009-StG-243149]; Christine Stabell Benn;
   Danish National Research Council Foundation [DNRF108]; European
   Developing Countries Clinical Trials Partnership [CT.2006.33111.002];
   NHRMC
FX KJ was supported by a European Research Council Starting Grant
   [ERC-2009-StG-243149] to Dr Christine Stabell Benn and by a Danish
   National Research Council Foundation grant [DNRF108] to CVIVA. JN is
   supported by a capacity building grant from the European Developing
   Countries Clinical Trials Partnership [CT.2006.33111.002]. MP is the
   recipient of a NHRMC Senior Research Fellowship.
CR Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000707
   Aaby P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6495
   Beaton GH, 1993, 13 U TOR
   Benn CS, 2014, VACCINE, V32, P5468, DOI 10.1016/j.vaccine.2014.07.090
   Benn CS, 2014, J NUTR, V144, P1474, DOI 10.3945/jn.114.192674
   Benn CS, 2009, AM J CLIN NUTR, V90, P629, DOI 10.3945/ajcn.2009.27477
   Benn CS, 2008, VACCINE, V26, P4111, DOI 10.1016/j.vaccine.2008.04.021
   Benn CS, 2008, BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE
   Benn CS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1101
   Benn Christine Stabell, 2008, PLoS One, V3, pe4056, DOI 10.1371/journal.pone.0004056
   Benn CS, 2009, VACCINE, V27, P2891, DOI 10.1016/j.vaccine.2009.02.080
   Benn CS, 2009, INT J EPIDEMIOL, V38, P304, DOI 10.1093/ije/dyn195
   Benn CS, 2005, BRIT MED J, V331, P1428, DOI 10.1136/bmj.38670.639340.55
   Benn CS, 1997, LANCET, V350, P101, DOI 10.1016/S0140-6736(96)12019-5
   Benn CS, 2003, INT J EPIDEMIOL, V32, P822, DOI 10.1093/ije/dyg208
   Benn CS, 2002, LANCET, V359, P1313, DOI 10.1016/S0140-6736(02)08274-0
   Benn CS, 2000, ANN TROP PAEDIATR, V20, P259
   DAULAIRE NMP, 1992, BRIT MED J, V304, P207
   Dibley MJ, 1996, J NUTR, V126, P434
   Diness BR, 2007, AM J CLIN NUTR, V86, P1152
   Diness BR, 2011, BRIT J NUTR, V105, P1819, DOI 10.1017/S0007114510005532
   Diness BR, 2010, J INFECT DIS, V202, pS243, DOI 10.1086/653569
   Fisker AB, 2014, PEDIATRICS, V134, pE739, DOI 10.1542/peds.2014-0550
   Fisker AB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000448
   Fisker AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023265
   Flanagan KL, 2013, CLIN INFECT DIS, V57, P283, DOI 10.1093/cid/cit209
   Flanagan KL, 2014, T ROY SOC TROP MED H, V108, P385, DOI 10.1093/trstmh/tru079
   Flanagan KL, 2011, VACCINE, V29, P2349, DOI 10.1016/j.vaccine.2011.01.071
   Gogia S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007480.pub2
   Group NSA, 2012, TRIALS, V13, P22
   Haider BA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006980.pub2
   HERRERA MG, 1992, LANCET, V340, P267, DOI 10.1016/0140-6736(92)92357-L
   Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1
   Imdad A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008524.pub2
   Jensen KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097536
   Jorgensen MJ, 2013, BRIT J NUTR, V109, P467, DOI 10.1017/S0007114512001304
   Jorgensen MJ, 2012, BRIT J NUTR, V107, P615, DOI 10.1017/S0007114511003515
   Kirkwood B, 2010, LANCET, V376, P1643, DOI [10.1016/S0140-6736(10)61895-8, 10.1016/S0140-6236(10)61895-8]
   Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448
   Mahalanabis D, 2004, AM J CLIN NUTR, V79, P430
   Malaba LC, 2005, AM J CLIN NUTR, V81, P454
   Martines J, 1998, LANCET, V352, P1257
   McDonald SLR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-92
   Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378
   Rahman MM, 1997, AM J CLIN NUTR, V65, P144
   Rahmathullah L, 2003, BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254
   RAMAKRISHNAN U, 1995, AM J CLIN NUTR, V61, P1295
   ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q
   Roth AE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c671
   Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312
   SOMMER A, 1986, LANCET, V1, P1169
   SOMMER A, 1987, Indian Journal of Pediatrics, V54, P461, DOI 10.1007/BF02749034
   WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6
   WEST KP, 1995, AM J CLIN NUTR, V62, P143
   WHO, 2009, GLOB PREV VIT A DEF
   World Health Organization, 2014, WKLY EPIDEMIOL REC, V89, P221
   World Health Organization, 2011, GUID NEON VIT A SUPP
   World Health Organization, 2011, GUID VIT A SUPPL INF
   Yakymenko D, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-77
NR 59
TC 2
Z9 2
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JAN
PY 2015
VL 109
IS 1
BP 36
EP 45
DI 10.1093/trstmh/tru184
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CC1LO
UT WOS:000350102400007
PM 25477326
OA No
DA 2017-08-15
ER

PT J
AU Baraka, V
   Tinto, H
   Valea, I
   Fitzhenry, R
   Delgado-Ratto, C
   Mbonye, MK
   Van Overmeir, C
   Rosanas-Urgell, A
   Van Geertruyden, JP
   D'Alessandro, U
   Erhart, A
AF Baraka, Vito
   Tinto, Halidou
   Valea, Innocent
   Fitzhenry, Robert
   Delgado-Ratto, Christopher
   Mbonye, Martin K.
   Van Overmeir, Chantal
   Rosanas-Urgell, Anna
   Van Geertruyden, Jean-Pierre
   D'Alessandro, Umberto
   Erhart, Annette
TI In Vivo Selection of Plasmodium falciparum Pfcrt and Pfmdr1 Variants by
   Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina
   Faso
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID TREATING UNCOMPLICATED MALARIA; CHLOROQUINE-RESISTANCE; MOLECULAR
   MARKERS; POLYMORPHISMS; DRUG; UGANDA; VITRO; PARASITES; CHILDREN;
   ALLELES
AB Plasmodium falciparum Pfcrt-76 and Pfmdr1-86 gene polymorphisms were determined during a clinical trial in Burkina Faso comparing the efficacies of dihydroartemisinin-piperaquine (DHA-PPQ) and artemether-lumefantrine (AL). Significant selection of Pfcrt-K76 was observed after exposure to AL and DHA-PPQ, as well as selection of Pfmdr1-N86 after AL but not DHA-PPQ treatment, suggesting reverse selection on the Pfcrt gene by PPQ. These results support the rational use of DHA-PPQ in settings where chloroquine (CQ) resistance is high.
C1 [Baraka, Vito] Tanga Med Res Ctr, Natl Inst Med Res, Tanga, Tanzania.
   [Baraka, Vito; Delgado-Ratto, Christopher; Mbonye, Martin K.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [Tinto, Halidou; Valea, Innocent] Ctr Muraz, Bobo Dioulasso, Burkina Faso.
   [Fitzhenry, Robert; Van Overmeir, Chantal; Rosanas-Urgell, Anna; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, Malariol Unit, B-2000 Antwerp, Belgium.
   [Mbonye, Martin K.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.
   [D'Alessandro, Umberto] MRC, Banjul, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
RP Baraka, V (reprint author), Tanga Med Res Ctr, Natl Inst Med Res, Tanga, Tanzania.
EM vitobaraka@gmail.com
RI D'Alessandro, Umberto/D-3457-2015; Van geertruyden,
   Jean-pierre/K-6425-2014
OI D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden,
   Jean-pierre/0000-0001-5006-6364; Delgado-Ratto,
   Christopher/0000-0003-2300-5181; Baraka, Vito /0000-0001-9694-9293
FU Sigma Tau Industrie Farmaceutiche Riunite, Pomezia, Rome, Italy;
   VLIR-UOS, Belgium; Medicine for Malaria Venture
FX The multicentric clinical trial was sponsored by Sigma Tau Industrie
   Farmaceutiche Riunite, Pomezia, Rome, Italy. This study was supported by
   a grant from VLIR-UOS, Belgium, and the Medicine for Malaria Venture.
CR Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871
   Briolant S, 2010, ANTIMICROB AGENTS CH, V54, P3537, DOI 10.1128/AAC.00183-10
   Conrad MD, 2014, J INFECT DIS, V210, P344, DOI 10.1093/infdis/jiu141
   Danquah I, 2010, ACTA TROP, V114, P63, DOI 10.1016/j.actatropica.2009.12.008
   Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004
   Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403
   Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Eastman RT, 2011, ANTIMICROB AGENTS CH, V55, P3908, DOI 10.1128/AAC.01793-10
   Ministry of Health of Burkina Faso, 2005, APPL NOV POL TRAIT P, V0932
   Muangnoicharoen S, 2009, ANTIMICROB AGENTS CH, V53, P1362, DOI 10.1128/AAC.01656-08
   Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09
   PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897
   Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997
   Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738
   Some AF, 2014, ANTIMICROB AGENTS CH, V58, P3660, DOI 10.1128/AAC.02406-14
   Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09
   Tinto H, 2008, TROP MED INT HEALTH, V13, P238, DOI 10.1111/j.1365-3156.2007.01995.x
   Tinto H, 2003, INFECT GENET EVOL, V3, P287, DOI 10.1016/j.meegid.2003.08.002
   WHO, 2014, STAT REP ART RES
   WHO, 2014, COUNTR ANT DRUG POL
   WHO, 2003, WHOHTMRBM20035
   World Health Organization, 2010, GUID TREATM MAL
   Yeka A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002390
NR 26
TC 7
Z9 7
U1 2
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JAN
PY 2015
VL 59
IS 1
BP 734
EP 737
DI 10.1128/AAC.03647-14
PG 4
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA CA0LO
UT WOS:000348609500101
PM 25403659
OA No
DA 2017-08-15
ER

PT J
AU Zumla, A
   Makanga, M
   Nyirenda, T
   Beattie, P
   Olesen, OF
   Breugelmans, JG
   Aklillu, E
   Corrah, T
   Mgone, C
AF Zumla, Alimuddin
   Makanga, Michael
   Nyirenda, Thomas
   Beattie, Pauline
   Olesen, Ole F.
   Breugelmans, J. Gabrielle
   Aklillu, Eleni
   Corrah, Tumani
   Mgone, Charles
TI Genesis of EDCTP2
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID TRUE PARTNERSHIP; TRIALS
C1 [Zumla, Alimuddin] UCL, London, England.
   [Zumla, Alimuddin] Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England.
   [Makanga, Michael; Nyirenda, Thomas; Beattie, Pauline; Olesen, Ole F.; Breugelmans, J. Gabrielle; Mgone, Charles] European & Developing Countries Clin Trials Partn, NL-2593 The Hague, Netherlands.
   [Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden.
   [Corrah, Tumani] MRC, Banjul, Gambia.
RP Zumla, A (reprint author), UCL, London, England.
EM mgone@edctp.org
OI Zumla, Alimuddin/0000-0002-5111-5735; Aklillu, Eleni/0000-0002-9788-0790
CR Binka F, 2005, TROP MED INT HEALTH, V10, P207, DOI 10.1111/j.1365-3156.2004.01373.x
   ECA, 2003, AB DECL HIV AIDS TUB
   EDCTP, 2014, LAUNCH 2 EDCTP PROGR
   EDCTP, 2013, EDCTP ANN REP 2013
   The European Parliament and the Council of the European Union, 2014, OFFICIAL J EUROPEA L, V169, P38
   The European Parliament and the Council of the European Union, 2014, OFFICIAL J EUROPEA L, V169, P1
   Kitua A Y, 2009, Tanzan J Health Res, V11, P51
   Matee MI, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-249
   Mgone C, 2008, CURR OPIN HIV AIDS, V3, P521, DOI 10.1097/COH.0b013e3283025e3d
   Mgone CS, 2009, TROP MED INT HEALTH, V14, P1327, DOI 10.1111/j.1365-3156.2009.02391.x
   Mgone CS, 2012, TROP MED INT HLTH
   Olliaro Piero, 2004, J HIV Ther, V9, P53
   The PLoS Medicine Editors, 2004, PLOS MED, V1, pe71
   The Lancet, 2007, LANCET, V370, P362
   The Lancet, 2005, LANCET, V366, P2
   Zumla A, 2010, TROP MED INT HEALTH, V15, P489, DOI 10.1111/j.1365-3156.2010.02479.x
NR 16
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2015
VL 15
IS 1
BP 11
EP 13
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA AY9GD
UT WOS:000347857900008
PM 25477021
OA No
DA 2017-08-15
ER

PT J
AU Melendez, J
   van Ginneken, B
   Maduskar, P
   Philipsen, RHHM
   Reither, K
   Breuninger, M
   Adetifa, IMO
   Maane, R
   Ayles, H
   Sanchez, CI
AF Melendez, Jaime
   van Ginneken, Bram
   Maduskar, Pragnya
   Philipsen, Rick H. H. M.
   Reither, Klaus
   Breuninger, Marianne
   Adetifa, Ifedayo M. O.
   Maane, Rahmatulai
   Ayles, Helen
   Sanchez, Clara I.
TI A Novel Multiple-Instance Learning-Based Approach to Computer-Aided
   Detection of Tuberculosis on Chest X-Rays
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Article
DE Chest radiography; computer-aided detection (CAD); multiple-instance
   learning (MIL); tuberculosis
ID TEXTURE CLASSIFICATION; RADIOGRAPHS; FRAMEWORK; DIAGNOSIS; FUSION
AB To reach performance levels comparable to human experts, computer-aided detection (CAD) systems are typically optimized following a supervised learning approach that relies on large training databases comprising manually annotated lesions. However, manually outlining those lesions constitutes a difficult and time-consuming process that renders detailedly annotated data difficult to obtain. In this paper, we investigate an alternative approach, namely multiple-instance learning (MIL), that does not require detailed information for optimization. We have applied MIL to a CAD system for tuberculosis detection. Only the case condition (normal or abnormal) was required during training. Based upon the well-known miSVM technique, we propose an improved algorithm that overcomes miSVM's drawbacks related to positive instance underestimation and costly iteration. To show the advantages of our MIL-based approach as compared with a traditional supervised one, experiments with three X-ray databases were conducted. The area under the receiver operating characteristic curve was utilized as a performance measure. With the first database, for which training lesion annotations were available, our MIL-based method was comparable to the supervised system (0.86 versus 0.88). When evaluating the remaining databases, given their large difference with the previous image set, the most appealing strategy was to retrain the CAD systems. However, since only the case condition was available, only the MIL-based system could be retrained. This scenario, which is common in real-world applications, demonstrates the better adaptation capabilities of the proposed approach. After retraining, our MIL-based system significantly outperformed the supervised one (0.86 versus 0.79 and 0.91 versus 0.85, p < 0.0001 and p = 0.0002, respectively).
C1 [Melendez, Jaime; van Ginneken, Bram; Maduskar, Pragnya; Philipsen, Rick H. H. M.; Sanchez, Clara I.] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, NL-6525 GA Nijmegen, Netherlands.
   [Reither, Klaus; Breuninger, Marianne] Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland.
   [Reither, Klaus] Ifakara Hlth Inst, Bagamoyo, Tanzania.
   [Breuninger, Marianne] Univ Freiburg, D-79085 Freiburg, Germany.
   [Adetifa, Ifedayo M. O.; Maane, Rahmatulai] MRC Unit, Serrekunda 81657, Gambia.
   [Ayles, Helen] Univ Zambia, Sch Med, Zambia AIDS Related TB Project ZAM BART, Lusaka 260211, Zambia.
   [Ayles, Helen] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England.
RP Melendez, J (reprint author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, NL-6525 GA Nijmegen, Netherlands.
EM jaime.melendezrodriguez@radboudumc.nl
RI Sanchez Gutierrez, Clara Isabel/N-3580-2014; Sanchez Gutierrez, Clara
   Isabel/B-3800-2014; van Ginneken, Bram/A-3728-2012
OI Sanchez Gutierrez, Clara Isabel/0000-0001-9787-8319; Ayles,
   Helen/0000-0003-4108-2842; van Ginneken, Bram/0000-0003-2028-8972
CR Andrews S., 2003, P ADV NEUR INF PROC, V15, P561
   Balabanova Y, 2005, BRIT MED J, V331, P379, DOI 10.1136/bmj.331.7513.379
   Bi J., 2007, P IEEE COMP SOC C CO, P1
   Chapelle O, 2006, SEMISUPERVISED LEARN
   Chen YX, 2006, IEEE T PATTERN ANAL, V28, P1931, DOI 10.1109/TPAMI.2006.248
   Chen YX, 2004, J MACH LEARN RES, V5, P913
   Chih-Chung Chang, 2011, ACM Transactions on Intelligent Systems and Technology, V2, DOI 10.1145/1961189.1961199
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
   Dawson R, 2010, INT J TUBERC LUNG D, V14, P52
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Dietterich TG, 1997, ARTIF INTELL, V89, P31, DOI 10.1016/S0004-3702(96)00034-3
   Dundar MM, 2008, IEEE T BIO-MED ENG, V55, P1015, DOI 10.1109/TBME.2007.909544
   Fu ZY, 2011, IEEE T PATTERN ANAL, V33, P958, DOI 10.1109/TPAMI.2010.155
   Hogeweg L., 2011, ANN M RAD SOC N AM
   Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650
   Hogeweg L. E., 2013, THESIS RADBOUD U NIJ
   Jaeger S, 2014, IEEE T MED IMAGING, V33, P233, DOI 10.1109/TMI.2013.2284099
   Jaeger Stefan, 2013, Quant Imaging Med Surg, V3, P89, DOI 10.3978/j.issn.2223-4292.2013.04.03
   Janney P, 2010, IET IMAGE PROCESS, V4, P158, DOI 10.1049/iet-ipr.2008.0229
   Koeslag A., 2001, P PRASA
   Koppaka R, 2004, TOMANS TUBERCULOSIS, P51
   Lesniak JM, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5295
   Lesniak J, 2011, PROC SPIE, V7963, DOI 10.1117/12.878140
   Li WJ, 2010, IEEE T KNOWL DATA EN, V22, P76, DOI 10.1109/TKDE.2009.58
   Loog M, 2004, INT C PATT RECOG, P644, DOI 10.1109/ICPR.2004.1334244
   Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325
   Maron O, 1998, ADV NEUR IN, V10, P570
   Melendez J., 2014, P SPIE MED IMAG
   Muyoyeta M., 2014, PLOS ONE, V9
   Noor N. M., 2010, P IECBES, P47
   Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623
   Piccazzo Riccardo, 2014, J Rheumatol Suppl, V91, P32, DOI 10.3899/jrheum.140100
   Platt J., 1999, P ADV LARG MARG CLAS, V1, P61
   Quellec G, 2012, MED IMAGE ANAL, V16, P1228, DOI 10.1016/j.media.2012.06.003
   Rahmani R, 2008, IEEE T PATTERN ANAL, V30, P1902, DOI 10.1109/TPAMI.2008.112
   Rijal M., 2012, P IEEE EMBS BHI, P341
   Sakurada S., 2012, BMC INFECT DIS, V12
   Shen R, 2010, IEEE T BIO-MED ENG, V57, P2646, DOI 10.1109/TBME.2010.2057509
   Sun L, 2012, IEEE T BIO-MED ENG, V59, P3348, DOI 10.1109/TBME.2012.2213597
   Tan JH, 2012, J MED SYST, V36, P2751, DOI 10.1007/s10916-011-9751-9
   Vacha P, 2011, PATTERN RECOGN LETT, V32, P771, DOI 10.1016/j.patrec.2011.01.002
   van Ginneken B, 2006, MED IMAGE ANAL, V10, P19, DOI 10.1016/j.media.2005.02.002
   Wang D, 2006, LECT NOTES COMPUT SC, V4212, P473
   Wang J., 2000, P 17 INT C MACH LEAR, P1119
   Wang SJ, 2012, IEEE T MED IMAGING, V31, P1141, DOI 10.1109/TMI.2012.2187304
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Wu DJ, 2009, PROC CVPR IEEE, P1359, DOI 10.1109/CVPRW.2009.5206778
   Zhang Q, 2002, ADV NEUR IN, V14, P1073
   Zhou Z. - H., 2007, P 24 INT C MACH LEAR, P1167, DOI 10.1145/1273496.1273643
   Zhu X, 2009, SYNTHESIS LECT ARTIF, V3, P1, DOI DOI 10.2200/S00196ED1V01Y200906AIM006
NR 50
TC 6
Z9 6
U1 1
U2 9
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0278-0062
EI 1558-254X
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD JAN
PY 2015
VL 34
IS 1
BP 179
EP 192
DI 10.1109/TMI.2014.2350539
PG 14
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA AX5OJ
UT WOS:000346975900018
PM 25163057
OA No
DA 2017-08-15
ER

PT J
AU Clarke, E
   Desselberger, U
AF Clarke, E.
   Desselberger, U.
TI Correlates of protection against human rotavirus disease and the factors
   influencing protection in low-income settings
SO MUCOSAL IMMUNOLOGY
LA English
DT Review
ID 1ST 2 YEARS; MEMORY B-CELLS; SECRETORY IGA ANTIBODIES;
   PLACEBO-CONTROLLED TRIAL; ORAL POLIOVIRUS VACCINE; BLOOD GROUP ANTIGENS;
   DAY-CARE-CENTERS; AFRICAN INFANTS; IMMUNE-RESPONSE; DENDRITIC CELLS
AB Rotaviruses (RV) are the leading cause of gastroenteritis in infants and children worldwide and are associated with high mortality predominately in low-income settings. The virus is classified into G and P serotypes and further into P genotypes based on differences in the surface-exposed proteins VP7 and VP4, respectively. Infection results in a variable level of protection from subsequent reinfection and disease. This protection is predominantly homotypic in some settings, whereas broader heterotypic protection is reported in other cohorts. Two antigenically distinct oral RV vaccines are licensed and are being rolled out widely, including in resource-poor setting, with funding provided by the GAVI alliance. First is a monovalent vaccine derived from a live-attenuated human RV strain, whereas the second is a pentavalent bovine-human reassortment vaccine. Both vaccines are highly efficacious in high-income settings, but greatly reduced levels of protection are reported in low-income countries. Here, the current challenges facing mucosal immunologists and vaccinologists aiming to define immunological correlates and to understand the variable levels of protection conferred by these vaccines in humans is considered. Such understanding is critical to maximize the public health impact of the current vaccines and also to the development of the next generation of RV vaccines, which are needed.
C1 [Clarke, E.] MRC Unit, Banjul, Gambia.
   [Desselberger, U.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.
RP Clarke, E (reprint author), MRC Unit, Banjul, Gambia.
EM eclarke@mrc.gm
FU Medical Research Council [MC_UP_A900_1115]
CR ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x
   Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012
   Aiyegbo M.S., 2013, PLOS ONE, V8
   Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692
   Angel J, 2012, CURR OPIN VIROL, V2, P419, DOI 10.1016/j.coviro.2012.05.003
   ARIAS CF, 1994, CLIN DIAGN LAB IMMUN, V1, P89
   Armah GE, 2012, VACCINE, V30, pA86, DOI 10.1016/j.vaccine.2011.10.006
   Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6
   Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Asensi MT, 2006, J PEDIATR GASTR NUTR, V42, P560, DOI 10.1097/01.mpg.0000221892.59371.b3
   Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189
   Babji S, 2012, CURR OPIN VIROL, V2, P443, DOI 10.1016/j.coviro.2012.05.005
   Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101
   Banerjee I, 2007, J INFECT DIS, V195, P625, DOI 10.1086/510853
   Barreto A, 2010, VIRAL IMMUNOL, V23, P595, DOI 10.1089/vim.2009.0113
   Belkaid Y, 2013, TRENDS IMMUNOL, V34, P299, DOI 10.1016/j.it.2013.03.003
   BERNSTEIN DI, 1986, J MED VIROL, V20, P297, DOI 10.1002/jmv.1890200402
   BERNSTEIN DI, 1991, J INFECT DIS, V164, P277
   BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203
   Blutt SE, 2007, CURR OPIN GASTROEN, V23, P39, DOI 10.1097/MOG.0b013e328011829d
   Blutt SE, 2007, PLOS MED, V4, P660, DOI 10.1371/journal.pmed.0040102
   Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9
   BRUSSOW H, 1993, J CLIN MICROBIOL, V31, P593
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104
   BURNS JW, 1995, VIROLOGY, V207, P143, DOI 10.1006/viro.1995.1060
   Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee
   Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E
   Chan J, 2011, VACCINE, V29, P1242, DOI 10.1016/j.vaccine.2010.11.087
   CHIBA S, 1986, LANCET, V2, P417
   Chinen T, 2012, IMMUNOL REV, V245, P45, DOI 10.1111/j.1600-065X.2011.01083.x
   Ciarlet M, 2008, PEDIATR INFECT DIS J, V27, P874, DOI 10.1097/INF.0b013e3181782780
   Clark HF, 2004, J CLIN MICROBIOL, V42, P1434, DOI 10.1128/JCM.42.4.1434-1438.2004
   CLEMENS J, 1993, PEDIATRICS, V92, P680
   Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837
   Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843
   COULSON BS, 1992, J CLIN MICROBIOL, V30, P1678
   Cunliffe NA, 2012, VACCINE, V30, pA36, DOI 10.1016/j.vaccine.2011.09.120
   DAS M, 1993, VIROLOGY, V194, P374, DOI 10.1006/viro.1993.1271
   De Franco MT, 2013, PAEDIATR INT CHILD H, V33, P102, DOI 10.1179/2046905513Y.0000000057
   Desselberger U, 2011, J INFECT DIS, V203, P188, DOI 10.1093/infdis/jiq031
   Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245
   Estes M, 2007, FIELDS VIROLOGY, V2, P1917
   Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314
   Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397
   Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60
   Fischer TK, 2002, J INFECT DIS, V186, P593, DOI 10.1086/342294
   Franco MA, 1999, J INFECT DIS, V179, pS466, DOI 10.1086/314805
   Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048
   Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499
   Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261
   GRIMWOOD K, 1988, J CLIN MICROBIOL, V26, P732
   HAFFEJEE IE, 1991, REV INFECT DIS, V13, P957
   Herrera D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097087
   Herrera D, 2013, HUM VACC IMMUNOTHER, V9, P2409, DOI 10.4161/hv.25610
   HJELT K, 1985, J PEDIATR GASTR NUTR, V4, P414, DOI 10.1097/00005176-198506000-00016
   HJELT K, 1985, J PEDIATR GASTR NUTR, V4, P60, DOI 10.1097/00005176-198502000-00012
   HJELT K, 1987, J MED VIROL, V21, P39, DOI 10.1002/jmv.1890210106
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Hu LY, 2012, NATURE, V485, P256, DOI 10.1038/nature10996
   Huang PW, 2012, J VIROL, V86, P4833, DOI 10.1128/JVI.05507-11
   Huber S, 2012, EUR J IMMUNOL, V42, P2238, DOI 10.1002/eji.201242619
   Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8
   Imbert-Marcille B-M, 2013, J INFECT DIS, V209, P1227
   Ishida S, 1996, J CLIN MICROBIOL, V34, P1694
   Jaimes MC, 2002, J VIROL, V76, P4741, DOI 10.1128/JVI.76.10.4741-4749.2002
   JAYASHREE S, 1988, SCAND J INFECT DIS, V20, P249, DOI 10.3109/00365548809032447
   JAYASHREE S, 1988, J MED VIROL, V26, P333, DOI 10.1002/jmv.1890260313
   Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2
   Kamada N, 2013, J IMMUNOL, V190, P1389, DOI 10.4049/jimmunol.1203100
   Kavanagh O, 2013, J VIROL METHODS, V189, P228, DOI 10.1016/j.jviromet.2012.11.003
   Kawamura N, 2011, VACCINE, V29, P6335, DOI 10.1016/j.vaccine.2011.05.017
   Kindler E, 2013, INFECT GENET EVOL, V14, P58, DOI 10.1016/j.meegid.2012.11.015
   Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007
   Lau YL, 2013, VACCINE, V31, P2253, DOI 10.1016/j.vaccine.2013.03.001
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838
   Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3
   Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078113
   Liu Y, 2012, J VIROL, V86, P9899, DOI 10.1128/JVI.00979-12
   Lopman BA, 2012, CURR OPIN VIROL, V2, P434, DOI 10.1016/j.coviro.2012.05.002
   Lopman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041720
   Lundell AC, 2012, J IMMUNOL, V188, P4315, DOI 10.4049/jimmunol.1103223
   LUNN PG, 1992, CLIN CHIM ACTA, V205, P151, DOI 10.1016/S0009-8981(05)80011-7
   LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M
   Madhi SA, 2012, VACCINE, V30, pA44, DOI 10.1016/j.vaccine.2011.08.080
   Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797
   Mast TC, 2011, PEDIATR INFECT DIS J, V30, pE209, DOI 10.1097/INF.0b013e31822a8527
   MATSON DO, 1993, J INFECT DIS, V167, P577
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a
   Mesa MC, 2010, VIROLOGY, V399, P77, DOI 10.1016/j.virol.2009.12.016
   Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d
   Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea
   Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742
   Muhsen K, 2010, HUM VACCINES, V6, P450
   Narang A, 2009, HUM VACCINES, V5, P414
   Narvaez CF, 2012, J VIROL, V86, P10829, DOI 10.1128/JVI.01466-12
   Narvaez CF, 2010, J VIROL, V84, P4543, DOI 10.1128/JVI.02550-09
   NETO UF, 1994, J AM COLL NUTR, V13, P51
   Nowrouzian F, 2003, PEDIATR RES, V54, P8, DOI 10.1203/01.PDR.0000069843.20655.EE
   ORYAN ML, 1994, J INFECT DIS, V169, P504
   ORYAN ML, 1994, PEDIATR INFECT DIS J, V13, P890, DOI 10.1097/00006454-199410000-00009
   Parashar UD, 2003, EMERG INFECT DIS, V9, P565
   Parashar UD, 2003, B WORLD HEALTH ORGAN, V81, P236
   Parashar U, 2013, EXPERT REV VACCINES, V12, P113, DOI [10.1586/erv.12.148, 10.1586/ERV.12.148]
   Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025
   Parra M, 2014, VIROLOGY, V452, P191, DOI 10.1016/j.virol.2014.01.014
   Patel M, 2013, J INFECT DIS, V208, P284, DOI 10.1093/infdis/jit166
   Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756
   PATH, 2014, EXPL NEW NONR ROT VA
   Paulke-Korinek M, 2010, PEDIATR INFECT DIS J, V29, P319, DOI 10.1097/INF.0b013e3181c18434
   Phua KB, 2009, VACCINE, V27, P5936, DOI 10.1016/j.vaccine.2009.07.098
   Pitzer VE, 2011, P NATL ACAD SCI USA, V108, P19353, DOI 10.1073/pnas.1110507108
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Ramachandran M, 1998, CLIN DIAGN LAB IMMUN, V5, P527
   Ramani S, 2008, PEDIATR INFECT DIS J, V27, P719, DOI [10.1097/INF.0b013e3181715170, 10.1097/INF.0b0136181715170]
   Ramani S, 2013, J VIROL, V87, P7255, DOI 10.1128/JVI.03518-12
   Ramani S, 2009, J CLIN VIROL, V45, P237, DOI 10.1016/j.jcv.2009.05.003
   Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364
   Rodriguez LS, 2012, CELL IMMUNOL, V272, P154, DOI 10.1016/j.cellimm.2011.10.017
   Rojas OL, 2003, VIROLOGY, V314, P671, DOI 10.1016/S0042-6822(03)00507-5
   Rojas OL, 2007, VIRAL IMMUNOL, V20, P300, DOI 10.1089/vim.2006.0105
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Santos SMR, 2013, J PEDIAT-BRAZIL, V89, P510, DOI 10.1016/j.jped.2013.02.017
   Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769
   Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322
   Shin S, 2012, VACCINE, V30, pA106, DOI 10.1016/j.vaccine.2011.11.091
   Sow SO, 2012, VACCINE, V30, pA71, DOI 10.1016/j.vaccine.2011.11.094
   Staat MA, 2011, PEDIATRICS, V128, pE267, DOI 10.1542/peds.2010-3722
   STANFIELD JP, 1965, LANCET, V2, P519
   Steele AD, 2010, J INFECT DIS, V202, pS93, DOI 10.1086/653550
   Steele AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-213
   Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003
   SVENSSON L, 1987, J GEN VIROL, V68, P1993, DOI 10.1099/0022-1317-68-7-1993
   SVENSSON L, 1987, J GEN VIROL, V68, P643, DOI 10.1099/0022-1317-68-3-643
   Tapia MD, 2012, VACCINE, V30, pA79, DOI 10.1016/j.vaccine.2012.01.022
   Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5
   Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002
   Thouvenin E, 2001, J MOL BIOL, V307, P161, DOI 10.1006/jmbi.2000.4479
   Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555
   Tregnaghi MW, 2011, PEDIATR INFECT DIS J, V30, pE103, DOI 10.1097/INF.0b013e3182138278
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622
   Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404
   Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619
   Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9
   Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664
   Vesikari T, 2007, INT J INFECT DIS, V11, pS29, DOI 10.1016/S1201-9712(07)60019-8
   Vesikari T, 2010, PEDIATR INFECT DIS J, V29, P957, DOI 10.1097/INF.0b013e3181e28e6e
   Vethanayagam RR, 2004, J INFECT DIS, V189, P2282, DOI 10.1086/420889
   Wang YH, 2007, J VIROL, V81, P3904, DOI 10.1128/JVI.01887-06
   Ward RL, 1996, J CLIN MICROBIOL, V34, P983
   WARD RL, 1986, J INFECT DIS, V154, P871
   Ward RL, 1997, J INFECT DIS, V176, P570
   WARD RL, 1992, J INFECT DIS, V166, P1251
   Wei J, 2009, VIRAL IMMUNOL, V22, P189, DOI 10.1089/vim.2008.0091
   Weitkamp JH, 2006, HUM IMMUNOL, V67, P33, DOI 10.1016/j.humimm.2006.02.024
   Weitkamp JH, 2005, J IMMUNOL, V174, P3454
   Weitkamp JH, 2003, J IMMUNOL, V171, P4680
   White LJ, 2008, J R SOC INTERFACE, V5, P1481, DOI 10.1098/rsif.2008.0115
   World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P533
   Yen C, 2011, J INFECT DIS, V204, P783, DOI 10.1093/infdis/jir390
   Yuan LJ, 2004, VIROLOGY, V330, P92, DOI 10.1016/j.virol.2004.09.021
   Yuan LJ, 2000, J VIROL, V74, P8843, DOI 10.1128/JVI.74.19.8843-8853.2000
   Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6
   [Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P49
NR 173
TC 21
Z9 21
U1 3
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1933-0219
EI 1935-3456
J9 MUCOSAL IMMUNOL
JI Mucosal Immunol.
PD JAN
PY 2015
VL 8
IS 1
BP 1
EP 17
DI 10.1038/mi.2014.114
PG 17
WC Immunology
SC Immunology
GA AW5TB
UT WOS:000346335600001
PM 25465100
OA No
DA 2017-08-15
ER

PT J
AU Ravinetto, RM
   Afolabi, MO
   Okebe, J
   Van Nuil, JI
   Lutumba, P
   Mavoko, HM
   Nahum, A
   Tinto, H
   Addissie, A
   D'Alessandro, U
   Grietens, KP
AF Ravinetto, Raffaella M.
   Afolabi, Muhammed O.
   Okebe, Joseph
   Van Nuil, Jennifer Ilo
   Lutumba, Pascal
   Mavoko, Hypolite Muhindo
   Nahum, Alain
   Tinto, Halidou
   Addissie, Adamu
   D'Alessandro, Umberto
   Grietens, Koen Peeters
TI Participation in medical research as a resource-seeking strategy in
   socio-economically vulnerable communities: call for research and action
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE research ethics; clinical trials; informed consent; developing
   countries; vulnerable populations; equity; health inequalities; ethique
   de la recherche; essais cliniques; consentement eclaire; pays en
   developpement; populations vulnerables; equite; inegalites dans la
   sante; etica de la investigacion; ensayos clinicos; consentimiento
   informado; paises en vias de desarrollo; poblaciones vulnerables;
   equidad; inequidades en salud
ID CONSENT; MALARIA
AB The freedom to consent to participate in medical research is a complex subject, particularly in socio-economically vulnerable communities, where numerous factors may limit the efficacy of the informed consent process. Informal consultation among members of the Switching the Poles Clinical Research Network coming from various sub-Saharan African countries, that is Burkina Faso, The Gambia, Rwanda, Ethiopia, the Democratic Republic of Congo (DRC) and Benin, seems to support the hypothesis that in socio-economical vulnerable communities with inadequate access to health care, the decision to participate in research is often taken irrespectively of the contents of the informed consent interview, and it is largely driven by the opportunity to access free or better quality care and other indirect benefits. Populations' vulnerability due to poverty and/or social exclusion should obviously not lead to exclusion from medical research, which is most often crucially needed to address their health problems. Nonetheless, to reduce the possibility of exploitation, there is the need to further investigate the complex links between socio-economical vulnerability, access to health care and individual freedom to decide on participation in medical research. This needs bringing together clinical researchers, social scientists and bioethicists in transdisciplinary collaborative research efforts that require the collective input from researchers, research sponsors and funders.
   La liberte de consentir a participer a la recherche medicale est un sujet complexe, en particulier dans les communautes socioeconomiquement vulnerables, oU de nombreux facteurs peuvent limiter l'efficacite du processus de consentement eclaire. Une consultation informelle parmi les membres du Reseau Switching the Poles Clinical Research' en provenance de divers pays d'Afrique subsaharienne, a savoir le Burkina-Faso, la Gambie, le Rwanda, l'Ethiopie, la Republique democratique du Congo et le Benin, semble appuyer l'hypothese que dans les communautes socioeconomiquement vulnerables avec un acces inadequat aux soins de sante, la decision de participer a la recherche est souvent prise independamment du contenu de l'interview de consentement eclaire, et elle est en grande partie motivee par l'opportunite d'acceder a des soins de qualite gratuits ou meilleurs et d'autres avantages indirects. La vulnerabilite des populations due a la pauvrete et/ou l'exclusion sociale ne devrait evidemment pas conduire a leur exclusion de la recherche medicale, qui le plus souvent est crucialement necessaire pour repondre a leurs problemes de sante. Neanmoins, afin de reduire la possibilite d'exploitation, il est necessaire d'investiguer plus en details les liens complexes entre la vulnerabilite socioeconomique, l'acces aux soins de sante et la liberte individuelle a decider de la participation a la recherche medicale. Cela doit reunir les agents de la recherche clinique, des sciences sociales et de la bioethique dans des efforts de recherche en collaboration transdisciplinaire qui necessitent l'apport collectif des chercheurs, des sponsors de la recherche et des bailleurs de fonds.
   La libertad de dar consentimiento para participar en proyectos de investigacion medica es un tema complejo, particularmente en comunidades socioeconomicamente vulnerables, en donde numerosos factores pueden limitar la eficacia del procedimiento del consentimiento informado. Una consulta informal a miembros de la red de investigacion Switching the Poles Clinical Research Network, pertenecientes a varios paises del africa subsahariana (Burkina Faso, Gambia, Ruanda, Etiopia, la Republica Democratica del Congo y Benin), parece apoyar la hipotesis de que en comunidades socioeconomicamente vulnerables con una acceso inadecuado a cuidados sanitarios, la decision de participar en investigacion a menudo se toma independientemente del contenido de la entrevista para el consentimiento informado, y en gran parte se debe a la oportunidad de tener acceso a cuidados sanitarios gratuitos o mejores, asi como a otros beneficios indirectos. La vulnerabilidad de la poblacion debido a la pobreza y/o exclusion social obviamente no deberia llevar a la exclusion de investigaciones medicas, las cuales a menudo son cruciales para abordar sus problemas sanitarios. Sin embargo, con el fin de reducir la posibilidad de explotacion, es necesario investigar mas a fondo el nexo complejo entre la vulnerabilidad socioeconomica, el acceso a cuidados sanitarios y la libertad individual para decidir participar en investigacion medica. Ello requiere un esfuerzo conjunto de los investigadores clinicos, sociales y expertos en bioetica mediante trabajos de colaboracion transdisciplinar con la aportacion colectiva de los investigadores, patrocinadores y financiadores de la investigacion.
C1 [Ravinetto, Raffaella M.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.
   [Ravinetto, Raffaella M.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium.
   [Afolabi, Muhammed O.; Okebe, Joseph; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Afolabi, Muhammed O.; Okebe, Joseph; D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England.
   [Van Nuil, Jennifer Ilo] Rinda Ubuzima, Kigali, Rwanda.
   [Van Nuil, Jennifer Ilo] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.
   [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Lutumba, Pascal; Mavoko, Hypolite Muhindo] Univ Kinshasa, Kinshasa, DEM REP CONGO.
   [Nahum, Alain] CREC, Cotonou, Benin.
   [Tinto, Halidou] Ctr Muraz, Inst Rech Sci Sante, Clin Res Unit Nanoro, Bobo Dioulasso, Burkina Faso.
   [Addissie, Adamu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia.
   [D'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan.
   [Grietens, Koen Peeters] Partners Appl Social Sci Int, Tessenderlo, Belgium.
RP Ravinetto, RM (reprint author), Inst Trop Med, Dept Clin Sci, Natl Str 155, B-2000 Antwerp, Belgium.
EM rravinetto@itg.be
RI D'Alessandro, Umberto/D-3457-2015
OI D'Alessandro, Umberto/0000-0001-6341-5009; Afolabi,
   Muhammed/0000-0002-9967-6419
FU Belgian Directorate-General for Development Cooperation (DGD); Institute
   of Tropical Medicine, Antwerp (Belgium)
FX This Switching the Poles Clinical Research Network is funded by the
   Belgian Directorate-General for Development Cooperation (DGD) under the
   Framework Agreement 3 (FA3) with the Institute of Tropical Medicine,
   Antwerp (Belgium).
CR Afolabi MO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004817
   Afolabi MO, 2014, AM J TROP MED HYG, V90, P908, DOI 10.4269/ajtmh.13-0615
   Afolabi Muhammed Olanrewaju, 2014, J Clin Res Bioeth, V5, P178
   Bull S, 2012, J EMPIR RES HUM RES, V7, P37, DOI 10.1525/jer.2012.7.1.37
   Chaisson LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022696
   Peeters Grietens K, 2014, AM J TROP MED HYG, V90, P630
   Muhindo M, 2013, TRIALS, V14, P307
   Nahum A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-170
   Ravinetto RM, 2013, MED RES SOCIOECONOMI
   Saidu Y., 2013, Journal of Clinical Research and Bioethics, V4, P1000141
   Tekola F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000482
   Tinto H, 2013, AM J TROP MED HYG, V88, P608, DOI 10.4269/ajtmh.12-0330
   Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800
   Vreeman R, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-23
NR 14
TC 4
Z9 4
U1 5
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JAN
PY 2015
VL 20
IS 1
BP 63
EP 66
DI 10.1111/tmi.12396
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AW0GX
UT WOS:000345970400008
PM 25302444
OA No
DA 2017-08-15
ER

PT J
AU Buchwald, UK
   Adetifa, IMO
   Bottomley, C
   Owiafe, PK
   Donkor, S
   Bojang, AL
   Sutherland, JS
AF Buchwald, Ulrike K.
   Adetifa, Ifedayo M. O.
   Bottomley, Christian
   Owiafe, Patrick K.
   Donkor, Simon
   Bojang, Adama L.
   Sutherland, Jayne S.
TI Broad Adaptive Immune Responses to M. tuberculosis Antigens Precede TST
   Conversion in Tuberculosis Exposed Household Contacts in a TB-Endemic
   Setting
SO PLOS ONE
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; INTERFERON-GAMMA; ACTIVE
   TUBERCULOSIS; GENE-EXPRESSION; INFECTION; CELLS; ASSAY; DISEASE; MEMORY
AB Background: The identification of Mycobacterium-tuberculosis (Mtb) infected individuals remains a challenge due to an insufficient understanding of immune responses detected with the current diagnostic tests for latent tuberculosis i.e. the tuberculin skin test (TST) or IFN-gamma release assays (IGRAs) and an inability to distinguish infection stages with current immunologic assays. Further classification based on markers other than IFN-gamma may help to define markers of early Mtb infection.
   Methods: We assessed the TST status of Mtb-exposed household contacts at baseline and at 6 months. Contacts were classified into those with initial positive TST (TST+); those with baseline negative TST but TST conversion at 6 months (TST converters, TSTC) and those with persistently negative TST (PTST-). We assessed their short-and long-term immune responses to PPD and ESAT-6/CFP-10 (EC) via IFN-gamma ELISPOT and a multiplex cytokine array in relation to TST status and compared them to those of TB cases to identify immune profiles associated with a spectrum of infection stages.
   Results: After 1 and 6 days stimulation with EC, 12 cytokines (IFN-gamma, IL-2, IP-10, TNF-alpha, IL-13, IL-17, IL-10, GMCSF, MIP-1 beta, MCP-3, IL-2RA and IL-1A) were not different in TSTC compared to TST+ suggesting that robust adaptive Mtb-specific immune responses precede TST conversion. Stratifying contacts by baseline IFN-gamma ELISPOT to EC in combination with TST results revealed that IP-10 and IL-17 were highest in the group of TST converters with positive baseline ELISPOT, suggesting they might be markers for recent infection.
   Conclusion: We describe a detailed analysis of Mtb-specific biomarker profiles in exposed household contacts in a TB endemic area that provides insights into the dynamic immune responses to Mtb infection and may help to identify biomarkers for 'at-risk' populations beyond TST and IGRA.
C1 [Buchwald, Ulrike K.; Adetifa, Ifedayo M. O.; Owiafe, Patrick K.; Donkor, Simon; Bojang, Adama L.; Sutherland, Jayne S.] MRC Unit, Banjul, Gambia.
   [Bottomley, Christian] London Sch Hyg & Trop Med, Med Res Council Trop Epidemiol Grp, London WC1, England.
RP Buchwald, UK (reprint author), MRC Unit, Banjul, Gambia.
EM ubuchwald@som.umaryland.edu; jsutherland@mrc.gm
OI Kwasi Owiafe, Patrick/0000-0002-4287-3577; Sutherland,
   Jayne/0000-0002-7083-4997
FU Infectious Diseases Society of America (IDSA) Education and Research
   Foundation (ERF); National Foundation for Infectious Diseases (NFID)
   Merle A. Sande/Pfizer Fellowship Award in International Infectious
   Diseases; Bill & Melinda Gates Foundation [6-74]; Medical Research
   Council Unit, The Gambia
FX UKB was supported by the 2008 Infectious Diseases Society of America
   (IDSA) Education and Research Foundation (ERF) and the National
   Foundation for Infectious Diseases (NFID) Merle A. Sande/Pfizer
   Fellowship Award in International Infectious Diseases while a fellow in
   Infectious Diseases at New York University. This project was funded by
   the Bill & Melinda Gates Foundation (Grand Challenges for Global Health
   6-74) and the Medical Research Council Unit, The Gambia. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Altet-Gomez N, 2011, EUR RESPIR J, V37, P1166, DOI 10.1183/09031936.00022710
   Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236
   Biselli R, 2009, CLIN MICROBIOL INFEC
   Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182
   Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07
   Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007
   Dheda K, 2008, THORAX, V63, P566, DOI 10.1136/thx.2007.092205
   Felber A, 2013, TUBERCULOSIS, V93, P647, DOI 10.1016/j.tube.2013.07.006
   Gallant CJ, 2010, CHEST, V137, P1071, DOI 10.1378/chest.09-1852
   Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001
   Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427
   Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002
   Govender L, 2010, VACCINE, V29, P51, DOI 10.1016/j.vaccine.2010.10.022
   Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030
   Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362
   Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192
   Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X
   Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667
   Hur YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079742
   Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444
   Jacobsen M, 2007, J MOL MED-JMM, V85, P613, DOI 10.1007/s00109-007-0157-6
   Jepson A, 2001, INFECT IMMUN, V69, P3989, DOI 10.1128/IAI.69.6.3989-3994.2001
   Lalvani Ajit, 1998, Proceedings of the National Academy of Sciences of the United States of America, V95, P270, DOI 10.1073/pnas.95.1.270
   Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07
   Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553
   Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC
   Marin ND, 2013, TUBERCULOSIS, V93, P155, DOI 10.1016/j.tube.2012.12.002
   Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-257
   Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230
   Perreau M, 2013, EUR J IMMUNOL, V43, P939, DOI 10.1002/eji.201243090
   Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004
   Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180
   Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19
   Salaman MR, 2013, TUBERCULOSIS, V93, P688, DOI 10.1016/j.tube.2013.08.007
   Scriba TJ, 2008, J IMMUNOL, V180, P1962
   Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365
   Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693
   Tao L, 2013, AM J TROP MED HYG, V89, P169, DOI 10.4269/ajtmh.12-0670
   van Brummelen SE, 2010, CLIN VACCINE IMMUNOL, V17, P937, DOI 10.1128/CVI.00005-10
   Winstone N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/eji.200839167
   Wong HL, 2008, CANCER EPIDEM BIOMAR, V17, P3450, DOI 10.1158/1055-9965.EPI-08-0311
NR 41
TC 2
Z9 3
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 30
PY 2014
VL 9
IS 12
AR e116268
DI 10.1371/journal.pone.0116268
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX6YH
UT WOS:000347063500071
PM 25549338
OA gold
DA 2017-08-15
ER

PT J
AU Oyebola, MK
   Idowu, ET
   Nyang, H
   Olukosi, YA
   Otubanjo, OA
   Nwakanma, DC
   Awolola, ST
   Amambua-Ngwa, A
AF Oyebola, Muyiwa K.
   Idowu, Emmanuel T.
   Nyang, Haddy
   Olukosi, Yetunde A.
   Otubanjo, Olubunmi A.
   Nwakanma, Davis C.
   Awolola, Samson T.
   Amambua-Ngwa, Alfred
TI Microsatellite markers reveal low levels of population sub-structuring
   of Plasmodium falciparum in southwestern Nigeria
SO MALARIA JOURNAL
LA English
DT Article
DE Genetic diversity; Plasmodium falciparum; Linkage disequilibrium;
   Population structure; Genetic differentiation
ID SOUTH-WESTERN NIGERIA; GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM;
   ANOPHELES-GAMBIAE; MALARIA; REGION; HAPLOTYPES; RECOMBINATION;
   POLYMORPHISM; INFECTIONS
AB Background: Genetic diversity studies provide evidence of Plasmodium falciparum differentiation that could affect fitness and adaptation to drugs and target antigens for vaccine development. This study describes the genetic structure of P. falciparum populations in urban and rural sites from southwestern Nigeria.
   Methodology: Ten neutral microsatellite loci were genotyped in 196 P. falciparum infections from three localities: Aramoko-Ekiti, a rural community; Lekki, an urban location and Badagry, a peri-urban border settlement. Analysis was performed on the genetic diversity, linkage disequilibrium, population structure and inter-population differentiation.
   Results: Allelic diversity values were similar across all populations, with mean expected heterozygosity (H-E) values between 0.65 and 0.79. No matching multilocus haplotypes were found and analysis of multilocus LD showed no significant index of association. Genetic differentiation between populations was low (Phi PT = 0.017).
   Conclusion: The absence of detectable population structure of P. falciparum in southwestern Nigeria is evident in the lack of significant differentiation between populations separated by about 200 km. This implies that a fairly uniform malaria control strategy may be effective over a wide geographic range in this highly endemic region. However, more wide-scale survey across the country will be required to inform malaria control in this large and densely populated endemic region.
C1 [Oyebola, Muyiwa K.; Idowu, Emmanuel T.; Otubanjo, Olubunmi A.] Univ Lagos, Fac Sci, Lagos, Nigeria.
   [Oyebola, Muyiwa K.; Olukosi, Yetunde A.; Awolola, Samson T.] Nigerian Inst Med Res, Malaria Res Grp, Lagos, Nigeria.
   [Nyang, Haddy; Nwakanma, Davis C.; Amambua-Ngwa, Alfred] MRC, Gambia Unit, Fajara, Gambia.
RP Amambua-Ngwa, A (reprint author), MRC, Gambia Unit, Fajara, Gambia.
EM angwa@mrc.gm
FU Medical Research Council [MC_EX_MR/K02440X/1]
CR Agyeman-Budu A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-22
   Al-Hamidhi S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-244
   Amodu OK, 2005, ACTA TROP, V95, P248, DOI 10.1016/j.actatropica.2005.05.011
   Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467
   Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338
   Awolola TS, 2002, ANN TROP MED PARASIT, V96, P849, DOI 10.1179/000349802125002581
   Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x
   Bogreau H, 2006, AM J TROP MED HYG, V74, P953
   Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242
   Conway DJ, 2001, MOL BIOCHEM PARASIT, V115, P145, DOI 10.1016/S0166-6851(01)00278-X
   dalla Martha RC, 2007, MEM I O CRUZ, V102, P293
   Escalante AA, 1998, GENETICS, V149, P189
   EXCOFFIER L, 1992, GENETICS, V131, P479
   Gourdon DM, 1997, MICROBIOLOGY, V143, P2039
   Haubold B, 1998, GENETICS, V150, P1341
   HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x
   HUGHES AL, 1992, MOL BIOL EVOL, V9, P381
   Iwagami M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-96
   Jaenisch T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-32
   Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449
   Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601
   Mobegi VA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-223
   National Population Commission (NPC) [Nigeria] National Malaria Control Programme (NMCP) [Nigeria] and ICF International, 2012, NIG MAL IND SURV 201
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   Okwa O O, 2009, Ann Afr Med, V8, P1
   Olasehinde GI, 2012, AFR HEALTH SCI, V12, P355, DOI 10.4314/ahs.v12i3.17
   Omole M. K., 2010, African Journal of Biomedical Research, V13, P1
   Onyabe DY, 2003, T ROY SOC TROP MED H, V97, P605, DOI 10.1016/S0035-9203(03)80045-7
   Oyebola Muyiwa K., 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS87, DOI 10.12980/APJTB.4.2014C1301
   Oyedeji S. I., 2013, Journal of Experimental and Clinical Medicine, V5, P143
   PEAKALL R.E., 2006, MOL ECOL NOTES, V6, P288, DOI DOI 10.1111/J.1471-8286.2005.01155.X
   Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336
   SOUZA V, 1992, P NATL ACAD SCI USA, V89, P8389, DOI 10.1073/pnas.89.17.8389
   Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351
   Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218
   Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813
NR 36
TC 5
Z9 6
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD DEC 13
PY 2014
VL 13
AR 493
DI 10.1186/1475-2875-13-493
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AY4TX
UT WOS:000347571900003
PM 25496185
OA gold
DA 2017-08-15
ER

PT J
AU Gehre, F
   Ejo, M
   Fissette, K
   de Rijk, P
   Uwizeye, C
   Nduwamahoro, E
   Goovaerts, O
   Affolabi, D
   Gninafon, M
   Lingoupou, FM
   Barry, MD
   Sow, O
   Merle, C
   Olliaro, P
   Ba, F
   Sarr, M
   Piubello, A
   Noeske, J
   Antonio, M
   Rigouts, L
   de Jong, BC
AF Gehre, Florian
   Ejo, Mebrat
   Fissette, Kristina
   de Rijk, Pim
   Uwizeye, Cecile
   Nduwamahoro, Elie
   Goovaerts, Odin
   Affolabi, Dissou
   Gninafon, Martin
   Lingoupou, Fanny M.
   Barry, Mamadou Dian
   Sow, Oumou
   Merle, Corinne
   Olliaro, Piero
   Ba, Fatoumata
   Sarr, Marie
   Piubello, Alberto
   Noeske, Juergen
   Antonio, Martin
   Rigouts, Leen
   de Jong, Bouke C.
TI Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West
   and Central Africa
SO PLOS ONE
LA English
DT Article
ID TUBERCULOSIS COMPLEX; GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY;
   STRAINS; TRANSMISSION; LINEAGE; GAMBIA
AB In this study, we retrospectively analysed a total of 605 clinical isolates from six West or Central African countries (Benin, Cameroon, Central African Republic, Guinea-Conakry, Niger and Senegal). Besides spoligotyping to assign isolates to ancient and modern mycobacterial lineages, we conducted phenotypic drug-susceptibility-testing for each isolate for the four first-line drugs. We showed that phylogenetically modern Mycobacterium tuberculosis strains are more likely associated with drug resistance than ancient strains and predict that the currently ongoing replacement of the endemic ancient by a modern mycobacterial population in West/Central Africa might result in increased drug resistance in the sub-region.
C1 [Gehre, Florian; Ejo, Mebrat; Fissette, Kristina; de Rijk, Pim; Uwizeye, Cecile; Nduwamahoro, Elie; Goovaerts, Odin; Rigouts, Leen; de Jong, Bouke C.] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Gehre, Florian; Antonio, Martin] MRC, Gambia Unit, Fajara, Gambia.
   [Affolabi, Dissou; Gninafon, Martin] Lab Reference Mycobacteries, Cotonou, Benin.
   [Lingoupou, Fanny M.] Inst Pasteur, Lab Mycobacteries, Bangui, Cent Afr Republ.
   [Barry, Mamadou Dian; Sow, Oumou] Lab Reference Mycobacteries, Conakry, Guinea.
   [Merle, Corinne] London Sch Hyg & Trop Med, London WC1, England.
   [Olliaro, Piero] WHO, Special Programme Res & Training Trop Dis TDR, UNICEF, UNDP,World Bank, CH-1211 Geneva, Switzerland.
   [Ba, Fatoumata] Lab Reference Mycobacteries, Dakar, Senegal.
   [Sarr, Marie] Natl TB Programme, Dakar, Senegal.
   [Piubello, Alberto] Damien Fdn, Niamey, Niger.
   [de Jong, Bouke C.] NYU, New York, NY USA.
RP Gehre, F (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.
EM fgehre@itg.be
RI de Jong, Bouke/A-3636-2013
OI de Jong, Bouke/0000-0002-1017-4675; Ejo, Mebrat/0000-0001-8119-8394
FU European Research Council (ERC) Starting grant "INTERRUPTB'' [311725];
   European and Developing Countries Clinical Trial Partnership (EDCTP)
   grant "Towards strengthening of the West African Node of Excellence for
   TB, AIDS and malaria: WANETAM plus'' [MSI 2010_10800]; UNICEF/UNDP/World
   Bank/WHO Special Programme for Research and Training in Tropical
   Diseases (TDR)
FX The study was partially funded by a European Research Council (ERC)
   Starting grant "INTERRUPTB'', grant agreement no.: 311725, and a
   European and Developing Countries Clinical Trial Partnership (EDCTP)
   grant "Towards strengthening of the West African Node of Excellence for
   TB, AIDS and malaria: WANETAM plus'', project code: MSI 2010_10800.
   Parts of this study were supported by a grant of the UNICEF/UNDP/World
   Bank/WHO Special Programme for Research and Training in Tropical
   Diseases (TDR). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008
   Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299
   CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217
   Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744
   Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815
   de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004
   Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000
   Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023
   Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601
   Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907
   Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12
   Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409
   Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363
   Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010
   Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011
   Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397
   World Health Organization, 2013, WHO REP GLOB TUB REP
   WHO, 2008, STOP TB DEP POL GUID
   Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906
   Yoshiyama T, 2004, INT J TUBERC LUNG D, V8, P31
NR 23
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 10
PY 2014
VL 9
IS 12
AR e110393
DI 10.1371/journal.pone.0110393
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AW9YP
UT WOS:000346611400003
PM 25493429
OA gold
DA 2017-08-15
ER

PT J
AU Miranda, CR
AF Miranda, Carlos R.
TI The Grandchildren of Solano Lopez: Frontier and Nation in Paraguay,
   1904-1936.
SO AMERICAN HISTORICAL REVIEW
LA English
DT Book Review
C1 [Miranda, Carlos R.] Euclid Univ, EUCLID, Banjul, Gambia.
RP Miranda, CR (reprint author), Euclid Univ, EUCLID, Banjul, Gambia.
CR CHESTERTON BM, 2013, GRANDCHILDREN S LOPE
NR 1
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-8762
EI 1937-5239
J9 AM HIST REV
JI Am. Hist. Rev.
PD DEC
PY 2014
VL 119
IS 5
BP 1750
EP 1751
DI 10.1093/ahr/119.5.1750a
PG 4
WC History
SC History
GA AW6ZC
UT WOS:000346413100136
OA No
DA 2017-08-15
ER

PT J
AU Idoko, OT
   Owolabi, OA
   Owiafe, PK
   Moris, P
   Odutola, A
   Bollaerts, A
   Ogundare, E
   Jongert, E
   Demoitie, MA
   Ofori-Anyinam, O
   Ota, MO
AF Idoko, Olubukola T.
   Owolabi, Olumuyiwa A.
   Owiafe, Patrick K.
   Moris, Philippe
   Odutola, Aderonke
   Bollaerts, Anne
   Ogundare, Ezra
   Jongert, Erik
   Demoitie, Marie-Ange
   Ofori-Anyinam, Opokua
   Ota, Martin O.
TI Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine
   when given as a booster to BCG in Gambian infants: An open-label
   randomized controlled trial
SO TUBERCULOSIS
LA English
DT Article
DE Tuberculosis vaccine; Co-administration; M72; AS01; EPI
ID BACILLUS-CALMETTE-GUERIN; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS;
   IMMUNE-RESPONSES; WHOLE-BLOOD; PROTECTIVE IMMUNITY; ADJUVANT SYSTEMS;
   FLOW-CYTOMETRY; HUMAN NEWBORNS; TNF-ALPHA
AB We evaluated the candidate tuberculosis vaccine M72/AS01 in Bacille-Calmette-Guerin (BCG)-vaccinated infants after or concomitantly with Expanded-Programme-on-Immunization (EPI) vaccines.
   Methods: In a Phase-II study in The Gambia (NCT01098474), 2 cohorts of 150 BCG-vaccinated infants each were randomized 1 : 1 : 1. The 'Outside-EPI' cohort received one or two M72/AS01 doses, or meningitis vaccine, 1-2 months after primary EPI vaccination. The 'Within-EPI' cohort received one or two M72/AS01 doses concomitantly with the third or last two doses of their primary EPI-regimen, respectively, or EPI vaccines alone. Safety, M72-specific humoral (ELISA) and cell-mediated (whole-blood ICS) responses, and humoral responses to EPI vaccines were assessed.
   Results: M72/AS01 was acceptably tolerated with no vaccine-related serious adverse events reported. Seropositivity/seroprotection rates against EPI antigens in the Within-EPI cohort were comparable between groups, irrespective of M72/AS01 co-administration. Up to one year post M72/AS01 vaccination, M72-specific humoral and CD4(+) T-cell responses were higher after 2 doses versus 1 dose in both cohorts (p < 0.0001), and comparable between cohorts after either 1 or 2 doses (p > 0.05).
   Conclusion: M72/AS01 given to infants after or concomitantly with EPI vaccines had an acceptable safety profile. Our results suggest no interference of immunogenicity profiles occurred following coadministration of M72/AS01 and EPI vaccines. Two M72/AS01 doses elicited higher immune responses than one dose. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Idoko, Olubukola T.; Owolabi, Olumuyiwa A.; Owiafe, Patrick K.; Odutola, Aderonke; Ogundare, Ezra; Ota, Martin O.] MRC Unit, Banjul, Gambia.
   [Moris, Philippe; Bollaerts, Anne; Jongert, Erik; Demoitie, Marie-Ange; Ofori-Anyinam, Opokua] GlaxoSmithKline Vaccines, BE-1330 Rixensart, Belgium.
   [Ota, Martin O.] WHO, Reg Off Africa, Brazzaville, Rep Congo.
RP Idoko, OT (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM oidoko@mrc.gm; oowolabi@mrc.gm; powiafe@mrc.gm; philippe.moris@gsk.com;
   aaodutola@mrc.gm; anne.g.bollaerts@gsk.com; tundeyogundare@yahoo.com;
   erik.x.jongert@gsk.com; marie-ange.demoitie@gsk.com;
   opokua.ofori-anyinam@gsk.com; otama@who.int
OI Kwasi Owiafe, Patrick/0000-0002-4287-3577
FU Medical Research Council [MC_U190071468, MC_UP_A900_1122]
CR Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930
   Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190
   Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211
   Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8
   Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002
   COLDITZ GA, 1995, PEDIATRICS, V96, P29
   Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592
   Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC
   Deenadayalan Anbarasu, 2013, BMC Res Notes, V6, P120, DOI 10.1186/1756-0500-6-120
   DEGROOTE D, 1992, CYTOKINE, V4, P239, DOI 10.1016/1043-4666(92)90062-V
   Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, pE35, DOI 10.1097/INF.0b013e3181daf921
   Dillon DC, 1999, INFECT IMMUN, V67, P2941
   Fine PEM, 1996, LANCET, V348, P17
   FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9
   Flanagan KL, 2010, EXPERT REV VACCINES, V9, P665, DOI [10.1586/erv.10.41, 10.1586/ERV.10.41]
   Forbes EK, 2008, J IMMUNOL, V181, P4955
   Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6-5-723
   Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]
   Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035
   Leung CC, 2001, INT J TUBERC LUNG D, V5, P717
   Levy O, 2004, J IMMUNOL, V173, P4627
   Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592
   Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13
   Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.111/j.1365.2249.2005.02799.x
   Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012
   Montoya J, 2013, J CLIN IMMUNOL, V33, P1360, DOI 10.1007/s10875-013-9949-3
   Ota MOC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002461
   Ota MOC, 2002, J IMMUNOL, V168, P919
   Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0
   SEPULVEDA RL, 1992, TUBERCLE LUNG DIS, V73, P372, DOI 10.1016/0962-8479(92)90043-J
   Skeiky YAW, 2004, J IMMUNOL, V172, P7618
   Skeiky YAW, 1999, INFECT IMMUN, V67, P3998
   Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941
   Suni MA, 1998, J IMMUNOL METHODS, V212, P89, DOI 10.1016/S0022-1759(98)00004-0
   Vanden Driessche K., 2013, CLIN DEV IMMUNOL, V2013
   World Health Organization, 1997, WHO GLOB DAT CHILD G
   World Health Organization, 2013, WHOHTMTB2013111289, P1
   World Health Organization, 1995, GLOB TUB PROGR GLOB, P229
NR 38
TC 11
Z9 11
U1 0
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD DEC
PY 2014
VL 94
IS 6
BP 564
EP 578
DI 10.1016/j.tube.2014.07.001
PG 15
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA AW0KB
UT WOS:000345979900006
PM 25305000
OA No
DA 2017-08-15
ER

PT J
AU Goodier, MR
   White, MJ
   Darboe, A
   Nielsen, CM
   Goncalves, A
   Bottomley, C
   Moore, SE
   Riley, EM
AF Goodier, M. R.
   White, M. J.
   Darboe, A.
   Nielsen, C. M.
   Goncalves, A.
   Bottomley, C.
   Moore, S. E.
   Riley, E. M.
TI Age-related natural killer cell differentiation in a population with
   near universal human cytomegalovirus infection: impact of NK receptor
   gene deletions
SO IMMUNOLOGY
LA English
DT Meeting Abstract
C1 [Goodier, M. R.; White, M. J.; Darboe, A.; Nielsen, C. M.; Riley, E. M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.
   [Darboe, A.; Moore, S. E.] MRC Int Nutr Grp, MRC Unit, MRC Keneba, Keneba, Gambia.
   [Goncalves, A.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.
   [Bottomley, C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   [Moore, S. E.] MRC Human Nutr Res, Cambridge, England.
RI Riley, Eleanor/C-8960-2013
OI Riley, Eleanor/0000-0003-3447-3570
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2014
VL 143
SU 2
SI SI
MA 352
BP 56
EP 56
PG 1
WC Immunology
SC Immunology
GA AU6GT
UT WOS:000345702600129
OA No
DA 2017-08-15
ER

PT J
AU Goncalves, A
   Derrick, T
   Burr, SE
   Joof, H
   Makalo, P
   Goodier, MR
   Molina, S
   Roberts, CH
   Holland, MJ
AF Goncalves, A.
   Derrick, T.
   Burr, S. E.
   Joof, H.
   Makalo, P.
   Goodier, M. R.
   Molina, S.
   Roberts, C. H.
   Holland, M. J.
TI Maturation, subtypes and function of natural killer cells in Gambians
   with scarring Trachoma
SO IMMUNOLOGY
LA English
DT Meeting Abstract
C1 [Goncalves, A.; Derrick, T.; Molina, S.; Roberts, C. H.; Holland, M. J.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.
   [Burr, S. E.; Joof, H.; Makalo, P.] MRC Unit, Fajara, Gambia.
   [Goodier, M. R.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2014
VL 143
SU 2
SI SI
MA 360
BP 158
EP 158
PG 1
WC Immunology
SC Immunology
GA AU6GT
UT WOS:000345702600478
OA No
DA 2017-08-15
ER

PT J
AU Roberts, CH
   Franklin, C
   Molina-Gonzelez, S
   Payne, F
   Burr, SE
   Natividad, A
   Sillah, A
   Joof, H
   Makalo, P
   Faal, N
   Sarr, I
   Aryee, E
   Burton, MJ
   Clark, T
   Rockett, K
   Kwiatkowski, D
   Mabey, DC
   Bailey, RL
   Barroso, I
   Holland, MJ
AF Roberts, C. H.
   Franklin, C.
   Molina-Gonzelez, S.
   Payne, F.
   Burr, S. E.
   Natividad, A.
   Sillah, A.
   Joof, H.
   Makalo, P.
   Faal, N.
   Sarr, I.
   Aryee, E.
   Burton, M. J.
   Clark, T.
   Rockett, K.
   Kwiatkowski, D.
   Mabey, D. C.
   Bailey, R. L.
   Barroso, I.
   Holland, M. J.
TI Pathway-level analysis of a genome wide association scan coupled with
   transcriptome analysis reveals common repetitive signatures of innate
   defence and cell cycle interruption in trachoma
SO IMMUNOLOGY
LA English
DT Meeting Abstract
C1 [Roberts, C. H.; Molina-Gonzelez, S.; Burr, S. E.; Natividad, A.; Burton, M. J.; Mabey, D. C.; Bailey, R. L.; Holland, M. J.] LSHTM, Dept Clin Res, London, England.
   [Franklin, C.; Payne, F.; Barroso, I.] Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge, England.
   [Joof, H.; Makalo, P.; Faal, N.; Sarr, I.; Aryee, E.] MRC UNIT, Fajara, Gambia.
   [Sillah, A.] Minist Hlth, Natl Eye Hlth Programme, Banjul, Gambia.
   [Clark, T.] LSHTM, Dept Pathogen Mol Biol, London, England.
   [Rockett, K.; Kwiatkowski, D.] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Oxford, England.
   Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2014
VL 143
SU 2
SI SI
MA 440
BP 161
EP 161
PG 1
WC Immunology
SC Immunology
GA AU6GT
UT WOS:000345702600491
OA No
DA 2017-08-15
ER

PT J
AU Thriemer, K
   Hong, NV
   Rosanas-Urgell, A
   Phuc, BQ
   Ha, DM
   Pockele, E
   Guetens, P
   Van, NV
   Duong, TT
   Amambua-Ngwa, A
   D'Alessandro, U
   Erhart, A
AF Thriemer, Kamala
   Nguyen Van Hong
   Rosanas-Urgell, Anna
   Bui Quang Phuc
   Do Manh Ha
   Pockele, Evi
   Guetens, Pieter
   Nguyen Van Van
   Tran Thanh Duong
   Amambua-Ngwa, Alfred
   D'Alessandro, Umberto
   Erhart, Annette
TI Delayed Parasite Clearance after Treatment with
   Dihydroartemisinin-Piperaquine in Plasmodium falciparum Malaria Patients
   in Central Vietnam
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID ARTEMISININ-RESISTANT MALARIA; WESTERN CAMBODIA; IN-VITRO; COMBINATION
   THERAPY; SOUTHEAST-ASIA; SUSCEPTIBILITY; TRANSMISSION
AB Reduced susceptibility of Plasmodium falciparum toward artemisinin derivatives has been reported from the Thai-Cambodian and Thai-Myanmar borders. Following increasing reports from central Vietnam of delayed parasite clearance after treatment with dihydroartemisinin-piperaquine (DHA-PPQ), the current first-line treatment, we carried out a study on the efficacy of this treatment. Between September 2012 and February 2013, we conducted a 42-day in vivo and in vitro efficacy study in Quang Nam Province. Treatment was directly observed, and blood samples were collected twice daily until parasite clearance. In addition, genotyping, quantitative PCR (qPCR), and in vitro sensitivity testing of isolates was performed. The primary endpoints were parasite clearance rate and time. The secondary endpoints included PCR-corrected and uncorrected cure rates, qPCR clearance profiles, in vitro sensitivity results (for chloroquine, dihydroartemisinin, and piperaquine), and genotyping for mutations in the Kelch 13 propeller domain. Out of 672 screened patients, 95 were recruited and 89 available for primary endpoint analyses. The median parasite clearance time (PCT) was 61.7 h (interquartile range [IQR], 47.6 to 83.2 h), and the median parasite clearance rate had a slope half-life of 6.2 h (IQR, 4.4 to 7.5 h). The PCR-corrected efficacy rates were estimated at 100% at day 28 and 97.7% (95% confidence interval, 91.2% to 99.4%) at day 42. At day 3, the P. falciparum prevalence by qPCR was 2.5 times higher than that by microscopy. The 50% inhibitory concentrations (IC(50)s) of isolates with delayed clearance times (>= 72 h) were significantly higher than those with normal clearance times for all three drugs. Delayed parasite clearance (PCT, >= 72 h) was significantly higher among day 0 samples carrying the 543 mutant allele (47.8%) than those carrying the wild-type allele (1.8%; P = 0.048). In central Vietnam, the efficacy of DHA-PPQ is still satisfactory, but the parasite clearance time and rate are indicative of emerging artemisinin resistance.
C1 [Thriemer, Kamala; Nguyen Van Hong; Rosanas-Urgell, Anna; Pockele, Evi; Guetens, Pieter; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, B-2000 Antwerp, Belgium.
   [Nguyen Van Hong; Bui Quang Phuc; Do Manh Ha; Tran Thanh Duong] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.
   [Nguyen Van Van] Ctr Malaria & Goitre Control Quang Nam Prov, Phan Thiet, Vietnam.
   [Amambua-Ngwa, Alfred; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
RP Thriemer, K (reprint author), Menzies Sch Hlth Res, Darwin, NT, Australia.
EM k.leythriemer@gmail.com
RI D'Alessandro, Umberto/D-3457-2015
OI D'Alessandro, Umberto/0000-0001-6341-5009; Thriemer,
   Kamala/0000-0001-7536-7497
FU Belgian Directorate-General for Development Cooperation (DGDC) within
   DGD-ITM
FX This work was supported by the Belgian Directorate-General for
   Development Cooperation (DGDC) within DGD-ITM Framework Agreement 3.
CR Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Beshir KB, 2013, J INFECT DIS, V208, P2017, DOI 10.1093/infdis/jit431
   Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051
   Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966
   Chotivanich K, 2014, ANTIMICROB AGENTS CH, V58, P3157, DOI 10.1128/AAC.01924-13
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339
   Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/JOURNAL.PMED.1001119
   Giao PT, 2004, TROP MED INT HEALTH, V9, P209, DOI 10.1046/j.1365-3156.2003.01180.x
   Ministry of Health Vietnam, 2007, GUID MAL DIAGN TREAT
   Ministry of Health Vietnam, 2012, GUID MAL DIAGN TREAT
   Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120
   Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011
   Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231
   Parker D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-290
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9
   Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361
   Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110
   Thanh NV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-181
   Tran TH, 2012, MALARIA J, V11, P355, DOI DOI 10.1186/1475-2875-11-355
   Tran Tinh Hien, 2004, Lancet (North American Edition), V363, P18
   WHO, 2009, METH SURV ANT DRUG E
   WHO, 2008, METH TECHN CLIN TRIA
   World Health Organization, 2013, EM RESP ART RES GREA
   WHO, 2007, FIELD APPL IN VITR A
   World Health Organization, 2012, UPD ART RES APR 2012
   Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4
   Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12
   Woodrow CJ, 2013, ANTIMICROB AGENTS CH, V57, P3121, DOI 10.1128/AAC.02350-12
NR 32
TC 28
Z9 29
U1 2
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD DEC
PY 2014
VL 58
IS 12
BP 7049
EP 7055
DI 10.1128/AAC.02746-14
PG 7
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA AT9AW
UT WOS:000345221000004
PM 25224002
OA No
DA 2017-08-15
ER

PT J
AU Zaman, SMA
   Cox, J
   Enwere, GC
   Bottomley, C
   Greenwood, BM
   Cutts, FT
AF Zaman, S. M. A.
   Cox, J.
   Enwere, G. C.
   Bottomley, C.
   Greenwood, B. M.
   Cutts, F. T.
TI The effect of distance on observed mortality, childhood pneumonia and
   vaccine efficacy in rural Gambia
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Access to healthcare facilities; all-cause mortality; distance;
   pneumococcal conjugate vaccine; pneumonia; vaccine efficacy
ID PNEUMOCOCCAL CONJUGATE VACCINE; HEALTH-CARE FACILITIES; STANDARDIZED
   INTERPRETATION; CHEST RADIOGRAPHS; BURKINA-FASO; CHILDREN;
   ACCESSIBILITY; INFECTION; SURVIVAL; TANZANIA
AB We investigated whether straight-line distance from residential compounds to healthcare facilities influenced mortality, the incidence of pneumonia and vaccine efficacy against pneumonia in rural Gambia. Clinical surveillance for pneumonia was conducted on 6938 children living in the catchment areas of the two largest healthcare facilities. Deaths were monitored by three-monthly home visits. Children living > 5 km from the two largest healthcare facilities had a 2.78 [95% confidence interval (CI) 1.74-4.43] times higher risk of all-cause mortality compared to children living within 2 km of these facilities. The observed rate of clinical and radiological pneumonia was lower in children living > 5 km from these facilities compared to those living within 2 km [rate ratios 0.65 (95% CI 0.57-0.73) and 0.74 (95% CI 0.55-0.98), respectively]. There was no association between distance and estimated pneumococcal vaccine efficacy. Geographical access to healthcare services is an important determinant of survival and pneumonia in children in rural Gambia.
C1 [Zaman, S. M. A.; Enwere, G. C.; Cutts, F. T.] MRC Unit, Banjul, Gambia.
   [Cox, J.; Greenwood, B. M.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.
   [Bottomley, C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, MRC, Trop Epidemiol Grp, London WC1, England.
RP Zaman, SMA (reprint author), MRC Unit, Atlantic Rd,POB 273, Banjul, Gambia.
EM azaman@mrc.gm
FU Johns Hopkins University; Boards of the Global Alliance for Vaccines and
   Immunizations; Vaccine Fund; National Institute of Allergy and
   Infectious Diseases at the USA National Institutes of Health
   [N01-AI-25477]; WHO [V23/181/127]; Children's Vaccine Program at PATH;
   US Agency for International Development
FX We thank all staff of Basse Field Station, Medical Research Council
   Unit, The Gambia for their assistance and all the study children and
   their families for their participation. This analysis was supported by
   the Johns Hopkins University with funds provided by the Boards of the
   Global Alliance for Vaccines and Immunizations and the Vaccine Fund. The
   PVT was funded by grants from the National Institute of Allergy and
   Infectious Diseases at the USA National Institutes of Health through
   contract N01-AI-25477; WHO through contract V23/181/127; the Children's
   Vaccine Program at PATH; and US Agency for International Development.
CR Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38
   Becher H, 2004, B WORLD HEALTH ORGAN, V82, P265
   Blanford JI, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-24
   Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
   Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6
   Ewing VL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-32
   Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7
   Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f
   Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099
   Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93
   Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060
   ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y
   RAHAMAN MM, 1982, AM J PUBLIC HEALTH, V72, P1124, DOI 10.2105/AJPH.72.10.1124
   Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194
   Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386
   Tanser F, 2006, J EPIDEMIOL COMMUN H, V60, P846, DOI 10.1136/jech.2005.043265
   VandenBroeck J, 1996, INT J EPIDEMIOL, V25, P998
   Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562
NR 18
TC 3
Z9 3
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD DEC
PY 2014
VL 142
IS 12
BP 2491
EP 2500
DI 10.1017/S0950268814000314
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AT4OY
UT WOS:000344920800004
PM 24565180
OA No
DA 2017-08-15
ER

PT J
AU Kombe, F
   Anunobi, EN
   Tshifugula, NP
   Wassenaar, D
   Njadingwe, D
   Mwalukore, S
   Chinyama, J
   Randrianasolo, B
   Akindeh, P
   Dlamini, PS
   Ramiandrisoa, FN
   Ranaivo, N
AF Kombe, Francis
   Anunobi, Eucharia Nkechinyere
   Tshifugula, Nyanyukweni Pandeni
   Wassenaar, Douglas
   Njadingwe, Dimpho
   Mwalukore, Salim
   Chinyama, Jonathan
   Randrianasolo, Bodo
   Akindeh, Perpetua
   Dlamini, Priscilla S.
   Ramiandrisoa, Felasoa Noroseheno
   Ranaivo, Naina
TI PROMOTING RESEARCH INTEGRITY IN AFRICA: AN AFRICAN VOICE OF CONCERN ON
   RESEARCH MISCONDUCT AND THE WAY FORWARD
SO DEVELOPING WORLD BIOETHICS
LA English
DT Article
DE scientific research misconduct; ethics review committees; research
   ethics; Africa
ID HIGH-DOSE CHEMOTHERAPY; PROTECTING COMMUNITIES; BREAST-CANCER;
   SCIENTIFIC MISCONDUCT; SINGAPORE STATEMENT; MEDICAL LITERATURE; ETHICS;
   TRIAL; RISK; RETRACTIONS
AB African researchers and their collaborators have been making significant contributions to useful research findings and discoveries in Africa. Despite evidence of scientific misconduct even in heavily regulated research environments, there is little documented information that supports prevalence of research misconduct in Africa. Available literature on research misconduct has focused on the developed world, where credible research integrity systems are already in place. Public attention to research misconduct has lately increased, calling for attention to weaknesses in current research policies and regulatory frameworks. Africa needs policies, structural and governance systems that promote responsible conduct of research. To begin to offset this relative lack of documented evidence of research misconduct, contributors working in various research institutions from nine African countries agreed to share their experiences to highlight problems and explore the need to identify strategies to promote research integrity in the African continent. The experiences shared include anecdotal but reliable accounts of previously undocumented research misconduct, including some normal misbehavior' of frontline staff in those countries. Two broad approaches to foster greater research integrity are proposed including promotion of institutional and individual capacity building to instil a culture of responsible research conduct in existing and upcoming research scientist and developing deterrent and corrective policies to minimize research misconduct and other questionable research practices. By sharing these experiences and through the strategies proposed, the authors hope to limit the level of research misconduct and promote research integrity in Africa.
C1 [Kombe, Francis] KWTRP, Kilifi, Kenya.
   [Anunobi, Eucharia Nkechinyere] Univ Alabama UAB, Sch Nursing, Birmingham, AL USA.
   [Anunobi, Eucharia Nkechinyere] Asokoro Dist Hosp, Abuja, Nigeria.
   [Anunobi, Eucharia Nkechinyere] MRC, Serrekunda, Gambia.
   [Anunobi, Eucharia Nkechinyere] MRC, Serrekunda, Gambia.
   [Anunobi, Eucharia Nkechinyere] Univ Ilorin, Teaching Hosp, Ilorin, Nigeria.
   [Tshifugula, Nyanyukweni Pandeni] Univ Namibia UNAM, Sch Nursing & Publ Hlth, Windhoek, Namibia.
   [Wassenaar, Douglas] African Res Training Initiat SARETI, Pretoria, South Africa.
   [Wassenaar, Douglas] Univ KwaZulu Natal, Durban, South Africa.
   [Wassenaar, Douglas] UKZN Biomed Res Eth Comm, Durban, South Africa.
   [Wassenaar, Douglas] Human Sci Res Council, Res Eth Comm, Pretoria, South Africa.
   [Njadingwe, Dimpho] Univ Botswana UB, Sch Med, Gaborone, Botswana.
   [Mwalukore, Salim] KEMRI Welcome Trust Res Programme, Kilifi, Kenya.
   [Mwalukore, Salim] Inst Review Comm, Boulder, CO USA.
   [Mwalukore, Salim] Sci Coordinating Comm, Denver, CO USA.
   [Mwalukore, Salim] Consent & Commun Comm, Washington, DC USA.
   [Randrianasolo, Bodo; Ramiandrisoa, Felasoa Noroseheno] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Randrianasolo, Bodo; Ramiandrisoa, Felasoa Noroseheno] Inst Natl Sante Publ & Commun Madagascar, Congo, Ghana.
   [Dlamini, Priscilla S.] Inst Res Tradit Med Med & Indig Enous Food & Frui, Tehran, Iran.
RP Kombe, F (reprint author), Kemri Wellcome Trust HSSR, POB 230, Kilifi 80108, Kenya.
EM fkombe@kemri-wellcome.org
FU US NIH Fogarty International Center [5 R25 TW001599-11]; EDCTP
   [CB.2008.41302.002]; US NIH Fogarty MEPI [1R24TW008863-1]
FX The authors would like to thank Elliot Makhathini and Dumisa Sofika for
   their encouragements during the initial discussions where the original
   idea of writing this paper was born. Vicky Marsh and Sassy Molyneux are
   thanked for useful comments. The SARETI forum in which the ideas for
   this paper originated was partially supported by a grant from the US NIH
   Fogarty International Center Grant number 5 R25 TW001599-11, with
   additional participants supported by EDCTP and US NIH Fogarty MEPI
   (1R24TW008863-1) funding. Some contributors were supported by EDCTP
   grant number CB.2008.41302.002 PI: Prof D R Wassenaar.
CR Ahmad K, 2001, LANCET, V357, P129, DOI 10.1016/S0140-6736(05)71168-5
   Alberti KGMM, 2000, BRIT MED J, V320, P1157, DOI 10.1136/bmj.320.7243.1157
   Cleaton-Jones P, 2000, LANCET, V355, P1011, DOI 10.1016/S0140-6736(00)90003-5
   De Vries R, 2006, J EMPIR RES HUM RES, V1, P43, DOI 10.1525/jer.2006.1.1.43
   Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709
   Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271
   Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068
   Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738
   HACKETT EJ, 1993, ACAD MED, V68, pS72
   IAC and IAP, RESP COND GLOB RES E
   IAC and IAP, RESP COND GLOB RES E
   Ijsselmuiden C, 2012, DEV WORLD BIOETH, V12, P74, DOI 10.1111/j.1471-8847.2012.00325.x
   [Anonymous], 2007, S AFR SUND TIM
   International ethical guidelines for biomedical research involving human subjects, 2002, B MED ETHICS, P17
   Jegede AS, 2009, DEV WORLD BIOETH, V9, P81, DOI 10.1111/j.1471-8847.2008.00238.x
   Kamuya D., DEV WORLD E IN PRESS
   Kornfeld DS, 2012, ACAD MED, V87, P877, DOI 10.1097/ACM.0b013e318257ee6a
   Legemaate Johan, 1994, Eur J Health Law, V1, P161, DOI 10.1163/157180994X00268
   Lenzer Jeanne, 2006, BMJ, V332, P1233, DOI 10.1136/bmj.332.7552.1233-a
   Macklin R, 2003, BIOETHICS, V17, P472, DOI 10.1111/1467-8519.00362
   Marusic A, 2010, CROAT MED J, V51, P381, DOI 10.3325/cmj.2010.51.381
   Molyneux S., 2008, SOC SCI MED, V67, P685
   Newman A, 2006, J MED ETHICS, V32, P420, DOI 10.1136/jme.2005.012757
   Okonta P., 2012, DEV WORLD BIOETH
   Pozzi Andrea, WHAT CAN WE LEARN OR
   Presidential Commission for the Study of Bioethical Issues, PRES OB ASKS BIOETH
   [Anonymous], MAPP AFR RES ETH REV
   Resnik DB, 2011, ACCOUNT RES, V18, P71, DOI 10.1080/08989621.2011.557296
   Schneider Benjamin, 2005, Dev World Bioeth, V5, P92, DOI 10.1111/j.1471-8847.2005.00104.x
   Steen RG, 2012, J MED ETHICS, V38, P228, DOI 10.1136/medethics-2011-100184
   Steen RG, 2011, J MED ETHICS, V37, P688, DOI 10.1136/jme.2011.043133
   Steen RG, 2011, J MED ETHICS, V37, P249, DOI 10.1136/jme.2010.040923
   Steen RG, 2011, J MED ETHICS, V37, P113, DOI 10.1136/jme.2010.038125
   True G., 2011, PLOS ONE, V6, P3
   True G, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.2.3
   Universities UK, 2012, CONC SUPP RES INT
   U.S. Department of Health & Human Services, OFF HUM RES PROT OHR
   US Department of Health and Human Services, OFF RES INT
   Vasconcelos SMR, 2012, EMBO REP, V13, P404, DOI 10.1038/embor.2012.51
   Weijer C, 1999, NAT GENET, V23, P275, DOI 10.1038/15455
   Weijer C, 2000, SCIENCE, V289, P1142, DOI 10.1126/science.289.5482.1142
   Weijer C, 1999, CAMB Q HEALTHC ETHIC, V8, P501
   Weiss RB, 2000, LANCET, V355, P999, DOI 10.1016/S0140-6736(00)90024-2
   Weiss RB, 2001, J CLIN ONCOL, V19, P2771
   World Health Organization, 2005, HDB GOOD CLIN RES PR
   Willyard C, 2007, NAT MED, V13, P763, DOI 10.1038//nm0707-763
   [Anonymous], 2012, LANCET, V380, P1445
   [Anonymous], 2002, FED POL RES MISC
NR 48
TC 1
Z9 1
U1 2
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1471-8731
EI 1471-8847
J9 DEV WORLD BIOETH
JI Dev. World Bioeth.
PD DEC
PY 2014
VL 14
IS 3
BP 158
EP 166
DI 10.1111/dewb.12024
PG 9
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA AS9AA
UT WOS:000344534700008
PM 23594261
OA No
DA 2017-08-15
ER

PT J
AU Sanneh, ES
   Hu, AH
   Hsu, CW
   Njie, M
AF Sanneh, Edward Saja
   Hu, Allen H.
   Hsu, Chia-Wei
   Njie, Momodou
TI Prioritization of climate change adaptation approaches in the Gambia
SO MITIGATION AND ADAPTATION STRATEGIES FOR GLOBAL CHANGE
LA English
DT Article
DE Climate change adaptation; Fuzzy analytic hierarchy process; Gambia;
   Global warming; Prioritization
ID FUZZY AHP; ADAPTIVE CAPACITY; VULNERABILITY; RISK; MITIGATION;
   SELECTION; STRATEGY; IMPACTS; SYSTEMS; AFRICA
AB Adaptation to climate change has been recognized as very important in developing countries that face the greatest threats from global warming. In proposing various adaptation approaches, the United Nations Intergovernmental Panel on Climate Change required nations to prepare adaptation plans of action. However, the areas of priority in climate change adaptation have not been considered. This study has developed a new prioritization methodology for climate change adaptation in developing countries. Five categories and 25 approaches in climate change adaptation were adopted through a thorough and detailed analysis of pertinent literature related to the National Adaptation Program of Action (NAPA) in the Gambia. A fuzzy analytic hierarchy process-based questionnaire survey was designed and presented to 12 experts chosen from the committee members of the Gambia's NAPA. The survey was made to determine the relative importance of the strategies for climate change adaptation. The results indicate that the five most important adaptation categories are health (0.223), forestry (0.213), water (0.210), food (0.181), and energy (0.174), with health as the number one priority in climate change adaptation. Further findings show that the prioritization order of the adaptation approaches to climate change in the Gambia is as follows: "Health education," "public sensitization," "water supply infrastructure development," "microfinance," and "infrastructure and technology enhancement.".
C1 [Sanneh, Edward Saja; Hu, Allen H.] Natl Taipei Univ Technol, Inst Environm Engn & Management, Taipei 106, Taiwan.
   [Hsu, Chia-Wei] Tungnan Univ, Dept Ecotourism, New Taipei City 22202, Taiwan.
   [Njie, Momodou] Blue Gold Solut, Banjul, Gambia.
RP Hu, AH (reprint author), Natl Taipei Univ Technol, Inst Environm Engn & Management, Taipei 106, Taiwan.
EM allenhu@ntut.edu.tw
FU government of the Gambia
FX The authors would like to thank the government of the Gambia for the
   support of this study and profoundly acknowledge the efforts of the
   Gambia NAPA committee members for their collaboration and accomplishing
   the survey questionnaires.
CR Adams WM, 1997, GEOGR J, V163, P150, DOI 10.2307/3060178
   Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006
   African Development Bank (AfDB), 2003, POV CLIM CHANG RED V
   Badri MA, 2001, INT J PROD ECON, V72, P27, DOI 10.1016/S0925-5273(00)00077-3
   Bojang L, 2005, COUNTRY STUDY ASSESS, P21
   Boko M., 2007, CLIMATE CHANGE 2007, P433
   Bozdag CE, 2003, COMPUT IND, V51, P13, DOI 10.1016/S0166-3615(03)00029-0
   BUCKLEY JJ, 1985, FUZZY SET SYST, V17, P233, DOI 10.1016/0165-0114(85)90090-9
   Burch S, 2007, CLIM POLICY, V7, P304
   Buyukozkan G, 2004, INT J GEN SYST, V33, P259, DOI 10.1080/03081070310001633581
   Callaway JM, 2004, GLOBAL ENVIRON CHANG, V14, P273, DOI 10.1016/j.gloenvcha.2004.04.002
   CAMPBELL L, 1999, HIST LINGUISTICS INT
   Chan FTS, 2007, OMEGA-INT J MANAGE S, V35, P417, DOI 10.1016/j.omega.2005.08.004
   Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432
   Chen MF, 2008, APPL SOFT COMPUT, V8, P110, DOI 10.1016/j.asoc.2006.11.007
   Chiou H.-K., 2001, INT J FUZZY SYST, V3, P466
   Cole A, 2005, VULNERABILITY ADAPTA, P36
   Conceicao P, 2011, AFR DEV REV, V23, P439, DOI 10.1111/j.1467-8268.2011.00298.x
   Conisbee M., 2003, ENV REFUGEES CASE RE
   Eakin H, 2005, WORLD DEV, V33, P1923, DOI 10.1016/j.worlddev.2005.06.005
   Food and Agriculture Organisation (FAO), 2007, 2001 STAT FOOD INS W
   Goklany I. M., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P755, DOI 10.1007/s11027-007-9098-1
   Guranko EN, 2003, FIN RISKS NAT DIS C
   International Institute for Environment and Development (IIED), 2007, CRIT LIST 100 NAT VU
   Intergovernmental Panel on Climate Change (IPCC), 1995, 2 ASS SYNTH SCI TECH, P27
   Houghton J. T., 2001, SUMM POL CLIM CHANG, P17
   Parry E. M.L., 2007, CONTRIBUTION WORKING, P976
   Jaiteh M., 2006, GAMBIA ATLAS 2003 PO
   Kahraman C, 2004, INT J PROD ECON, V87, P171, DOI 10.1016/S0925-5273(03)00099-9
   Klein RJT, 2005, ENVIRON SCI POLICY, V8, P579, DOI 10.1016/j.envsci.2005.06.010
   Kurttila M., 2000, Forest Policy and Economics, V1, P41, DOI 10.1016/S1389-9341(99)00004-0
   Kwong CK, 2003, IIE TRANS, V35, P619, DOI 10.1080/07408170390214482
   Laukkonen J, 2009, HABITAT INT, V33, P287, DOI 10.1016/j.habitatint.2008.10.003
   Martens P, 2009, CURR OPIN SUST, V1, P14, DOI 10.1016/j.cosust.2009.07.010
   McCarthy JJ, 2001, CHANGE, V2, P28
   Melkas E, 2002, REV EUROPEAN COMMUNI, V11, P115, DOI DOI 10.1111/1467-9388.T01-1-00311
   MON DL, 1994, FUZZY SET SYST, V62, P127, DOI 10.1016/0165-0114(94)90052-3
   National Adaption Programme of Action (NAPA), 2007, GAMB NAT AD PROGR AC
   Njie M, 2002, 2 ASSESSMENT CLIMATE, P71
   Oxfam, 2012, DEV IMPL EFF AD MEAS
   Pamo ET, 1998, J ARID ENVIRON, V39, P179, DOI 10.1006/jare.1998.0400
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Reid PC, 2009, ADV MAR BIOL, V56, P1, DOI 10.1016/S0065-2881(09)56001-4
   Roach R., 2005, DRIED DROWNED OUT VO
   Roshan GR, 2010, INT J ENVIRON SCI TE, V7, P571, DOI 10.1007/BF03326166
   Saaty T. L., 1978, Fuzzy Sets and Systems, V1, P57, DOI 10.1016/0165-0114(78)90032-5
   Sahel Invest International, 2005, NAT EN POL SIT AN GA
   Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008
   Speranza CI, 2008, GLOBAL ENVIRON CHANG, V18, P220, DOI 10.1016/j.gloenvcha.2007.05.001
   Stringer LC, 2009, ENVIRON SCI POLICY, V12, P748, DOI 10.1016/j.envsci.2009.04.002
   Thomalla F, 2006, DISASTERS, V30, P39, DOI 10.1111/j.1467-9523.2006.00305.x
   Twomlow S, 2008, PHYS CHEM EARTH, V33, P780, DOI 10.1016/j.pce.2008.06.048
   Food and Agricultural Organization (FAO), 2010, CLIM CHANG THREAT AF
   United Nations Human Development Report, 2006, WAT RIGHTS WRONGS YO
   UNDP, 2007, HUMAN DEV REPORT 200
   UNFCCC, 2007, CLIM CHANG IMP VULN, P68
   United Nations Framework Convention on Climate Change (UNFCCC), 2010, LEAST DEV COUNTR POR
   Urama KC, 2010, IMPACTS CLIMATE CHAN
   Walter J, 2002, NEW EC FDN LONDON UK
   Wong S., 2009, LESSONS PARTICIPATOR, P99
   Wu HY, 2009, EXPERT SYST APPL, V36, P10135, DOI 10.1016/j.eswa.2009.01.005
   ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90036-5
NR 62
TC 0
Z9 0
U1 6
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1381-2386
EI 1573-1596
J9 MITIG ADAPT STRAT GL
JI Mitig. Adapt. Strateg. Glob. Chang.
PD DEC
PY 2014
VL 19
IS 8
BP 1163
EP 1178
DI 10.1007/s11027-013-9465-z
PG 16
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AT2YQ
UT WOS:000344801000003
OA No
DA 2017-08-15
ER

PT J
AU Sonko, ST
   Jaiteh, M
   Jafali, J
   Jarju, LBS
   D'Alessandro, U
   Camara, A
   Komma-Bah, M
   Saho, A
AF Sonko, Sheriff T.
   Jaiteh, Malanding
   Jafali, James
   Jarju, Lamin B. S.
   D'Alessandro, Umberto
   Camara, Abu
   Komma-Bah, Musu
   Saho, Alieu
TI Does socio-economic status explain the differentials in malaria parasite
   prevalence? Evidence from The Gambia
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; The Gambia; Poorest; Poverty; Socio-economic status
ID RISK-FACTORS; CHILDREN; TANZANIA; POVERTY; TRANSMISSION; ETHIOPIA; INDIA
AB Background: Malaria is commonly associated with poverty. Macro-level estimates show strong links between malaria and poverty, and increasing evidence suggests that the causal link between malaria and poverty runs in both directions. However, micro-level (household and population) analyses on the linkages between malaria and poverty have often produced mixed results.
   Methods: The Gambia Malaria Indicator Survey (MIS) 2010/11 was carried out between November 2010 and January 2011. Laboratory-confirmed malaria and wealth quintiles were used to assess the association of socio-economic status and malaria infection in children and the general population. Simple and multiple logistic regressions and survey data analysis procedures, including linearized standard errors to account for cluster sampling and unequal selection probabilities were applied.
   Results: Children (six to 59 months) from the second, third, fourth and richest quintiles were significantly less likely to have malaria compared to children from the poorest quintiles. Children (five to 14 years) from the fourth and richest quintiles were also significantly less likely to have malaria compared to those from the poorest quintiles. The malaria burden has shifted from the under-five children (six to 59 months) to children aged five to 14 years. Malaria prevalence was significantly higher in the Central River Region compared to the Upper River Region; and males bear the malaria brunt more than females. Children (six to 59 months) and children (five to 14 years) living in houses with poor walls, floors, roofs and windows were significant associated with higher prevalence of malaria. However, in the general population, only poor wall housing materials were associated with higher prevalence of malaria.
   Conclusions: Investments in strategies that address socio-economic disparities and improvements in the quality of housing could, in the long term, significantly reduce the malaria burden in the poorest communities.
C1 [Sonko, Sheriff T.; Jarju, Lamin B. S.] Natl Malaria Control Programme, Kanifing, Gambia.
   [Jaiteh, Malanding] Columbia Univ, Ctr Int Earth Sci Informat Network, New York, NY USA.
   [Jafali, James; D'Alessandro, Umberto] MRC Labs, Banjul, Gambia.
   [Camara, Abu] Islamic Dev Bank, Jeddah, Saudi Arabia.
   [Komma-Bah, Musu; Saho, Alieu] Gambia Bur Stat, Kanifing, Gambia.
RP Sonko, ST (reprint author), Natl Malaria Control Programme, Plot 17, Kanifing, Gambia.
EM stsonko@outlook.com
RI D'Alessandro, Umberto/D-3457-2015
OI D'Alessandro, Umberto/0000-0001-6341-5009
CR Ayele DG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-31
   Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195
   Boadu K, 2006, CANADIAN STUDIES POP, V33, P271
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456
   CHESTRAD, 2000, MAL POV HLTH
   Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X
   De Beaudrap P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-132
   de Castro MC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-161
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292
   Filmer D, 2002, WORLD BANK POLICY RE
   Gahutu JB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-134
   Gallup J., 2000, 52 HARV U CTR INT DE
   Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3
   Goodman C, 2003, EC MALARIA ITS CONTR, P24
   Government of The Gambia, 2014, GAMB 2013 POP HOUS C
   Government of The Gambia, 2006, 2003 POP HOUS CENS
   Government of The Gambia, 2012, GAMB MAL IND SURV
   Government of The Gambia, 2010, INT HOUS SURV INC EX
   Government of The Gambia, 2007, GAMB MULT IND CLUST
   Government of The Gambia, 2012, GAMB MULT IND CLUST
   Government of The Gambia, 2005, INT HOUS SURV INC EX
   Gwatkin DR, 2000, BURDEN DIS GLOBAL PO
   Hiscox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062769
   Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x
   Imbahale SS, 2012, J TROP MED, V2012
   Jarju LBS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-170
   Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0
   Macro ORC, 2005, GUID SAMPL MAL IND S
   Ministry of Health and Social Welfare, 2013, NAT MAL STRAT PLAN 2
   Ministry of Health and Social Welfare, 2013, NAT MAL POL 2014 202
   Onwujekwe O, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-45
   Ricci F., 2012, MEDITERR J HEMATOL I, V4
   Sachs J, 2002, NATURE, V415, P68
   Sharma VP, 2003, CURR SCI INDIA, V84, P513
   Sintasath DM, 2005, AM J TROP MED HYG, V72, P682
   Somi MF, 2008, TROP MED INT HEALTH, V13, P354, DOI 10.1111/j.1365-3156.2008.02009.x
   Somi MF, 2007, AM J TROP MED HYG, V77, P1020
   Teklehaimanot A, 2008, ANN NY ACAD SCI, V1136, P32, DOI 10.1196/annals.1425.037
   Temu EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031409
   Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X
   Verma V, 2010, J APPL STAT, V38, P1549
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
   Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98
   Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x
   Worrall E, 2003, BACKGR SEM ENS MAL C
   Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5
NR 48
TC 6
Z9 6
U1 1
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD NOV 21
PY 2014
VL 13
AR 449
DI 10.1186/1475-2875-13-449
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AW2BM
UT WOS:000346093200001
PM 25416303
OA gold
DA 2017-08-15
ER

PT J
AU Burr, SE
   Hart, J
   Edwards, T
   Harding-Esch, EM
   Holland, MJ
   Mabey, DCW
   Sillah, A
   Bailey, RL
AF Burr, Sarah E.
   Hart, John
   Edwards, Tansy
   Harding-Esch, Emma M.
   Holland, Martin J.
   Mabey, David C. W.
   Sillah, Ansumana
   Bailey, Robin L.
TI Anthropometric indices of Gambian children after one or three annual
   rounds of mass drug administration with azithromycin for trachoma
   control
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Mass drug administration; Azithromycin; Trachoma control; Anthropometry
ID RANDOMIZED CONTROLLED-TRIAL; RURAL MALAWIAN CHILDREN;
   DEVELOPING-COUNTRIES; YOUNG-CHILDREN; RISK-FACTORS; TRICHURIS-TRICHIURA;
   CHILDHOOD MORTALITY; INFANT GROWTH; INFECTION; IMPACT
AB Background: Mass drug administration (MDA) with azithromycin, carried out for the control of blinding trachoma, has been linked to reduced mortality in children. While the mechanism behind this reduction is unclear, it may be due, in part, to improved nutritional status via a potential reduction in the community burden of infectious disease. To determine whether MDA with azithromycin improves anthropometric indices at the community level, we measured the heights and weights of children aged 1 to 4 years in communities where one (single MDA arm) or three annual rounds (annual MDA arm) of azithromycin had been distributed.
   Methods: Data collection took place three years after treatment in the single MDA arm and one year after the final round of treatment in the annual MDA arm. Mean height-for-age, weight-for-age and weight-for-height z scores were compared between treatment arms.
   Results: No significant differences in mean height-for-age, weight-for-age or weight-for-height z scores were found between the annual MDA and single MDA arms, nor was there a significant reduction in prevalence of stunting, wasting or underweight between arms.
   Conclusions: Our data do not provide evidence that community MDA with azithromycin improved anthropometric outcomes of children in The Gambia. This may suggest reductions in mortality associated with azithromycin MDA are due to a mechanism other than improved nutritional status.
C1 [Burr, Sarah E.; Hart, John; Harding-Esch, Emma M.; Holland, Martin J.; Mabey, David C. W.; Bailey, Robin L.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.
   [Burr, Sarah E.] MRC Unit, Fajara, Banjul, Gambia.
   [Edwards, Tansy] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, MRC Trop Epidemiol Grp, London WC1, England.
   [Harding-Esch, Emma M.] Publ Hlth England, HIV STI Dept, London, England.
   [Sillah, Ansumana] Minist Hlth, Natl Eye Hlth Programme, Kanifing, Gambia.
RP Burr, SE (reprint author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.
EM Sarah.Burr@lshtm.ac.uk
OI Mabey, David/0000-0002-0031-8276
FU Bill and Melinda Gates Foundation [48027, OPP1066930]; Wellcome Trust
   [079246/Z/06/Z]; MRC; DFID [G0700837]
FX The PRET trial (www.clinicaltrials.gov: NCT00792922) was funded by the
   Bill and Melinda Gates Foundation (grant number 48027). SEB receives
   salary funding from the Bill and Melinda Gates Foundation (grant number
   OPP1066930). MJH receives salary funding from the Wellcome Trust (grant
   number 079246/Z/06/Z). TE receives salary support from MRC and DFID
   (grant number G0700837).
CR AABY P, 1995, BRIT MED J, V311, P481
   Amza A, 2013, AM J TROP MED HYG, V88, P138, DOI 10.4269/ajtmh.2012.12-0284
   Amza A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001586
   Basilion EV, 2002, T ROY SOC TROP MED H, V96, P691, DOI 10.1016/S0035-9203(02)90353-6
   Coles CL, 2012, PEDIATR INFECT DIS J, V31, P341, DOI 10.1097/INF.0b013e31824155c9
   Coles CL, 2011, AM J TROP MED HYG, V85, P691, DOI 10.4269/ajtmh.2011.11-0046
   ECCLES MP, 1989, ARCH DIS CHILD, V64, P1559
   Edwards T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003098
   Giamarellos-Bourboulis EJ, 2008, INT J ANTIMICROB AG, V31, P12, DOI 10.1016/j.ijantimicag.2007.08.001
   Goto R, 2009, BRIT J NUTR, V101, P1509, DOI 10.1017/S0007114508083554
   Gough EK, 2013, BMJ-BRIT MED J, V348, pg2267
   Guerrant RL, 2012, CLIN INFECT DIS, V54, P1674, DOI 10.1093/cid/cis241
   Harding-Esch EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002115
   Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861
   Haug S, 2010, CLIN INFECT DIS, V51, P571, DOI 10.1086/655697
   Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8
   Keenan JD, 2011, CLIN INFECT DIS, V52, P883, DOI 10.1093/cid/cir069
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Lunn PG, 2000, P NUTR SOC, V59, P147, DOI 10.1017/S0029665100000173
   NOKES C, 1992, PARASITOLOGY, V104, P539
   Panter-Brick C, 2009, BRIT J NUTR, V101, P558, DOI 10.1017/S000711450802744X
   Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266
   Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174
   Roth A, 2006, EXPERT REV VACCINES, V5, P277, DOI 10.1586/14760584-5.2.277
   ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134
   ROWLAND MGM, 1977, BRIT J NUTR, V37, P441, DOI 10.1079/BJN19770047
   Ryan KN, 2014, CLIN GASTROENTEROL H
   SOMMER A, 1986, LANCET, V1, P1169
   Stare D, 2011, OPHTHAL EPIDEMIOL, V18, P20, DOI 10.3109/09286586.2010.545500
   STEPHENSON LS, 1989, AM J TROP MED HYG, V41, P78
   Udan I, 2013, J GLOB HLTH, V3
   Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519
   Weisz A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-25
   Weisz AJ, 2012, J PEDIATR GASTR NUTR, V55, P747, DOI 10.1097/MPG.0b013e3182650a4d
   Whitty CJM, 1999, PEDIATR INFECT DIS J, V18, P955, DOI 10.1097/00006454-199911000-00003
   WHO, 1999, WHOPBDGET993
   WHO, 1995, WHOTRS854
   WHO, 1997, WHOPBLGET971
   World Health Organization, WHO VACC PREV DIS MO
   WHO, 2006, TRACH CONTR GUID PRO
NR 40
TC 0
Z9 0
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD NOV 18
PY 2014
VL 14
AR 1176
DI 10.1186/1471-2458-14-1176
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AX3TY
UT WOS:000346862700001
PM 25407464
OA gold
DA 2017-08-15
ER

PT J
AU Zhou, Y
   Holland, MJ
   Makalo, P
   Joof, H
   Roberts, CH
   Mabey, DCW
   Bailey, RL
   Burton, MJ
   Weinstock, GM
   Burr, SE
AF Zhou, Yanjiao
   Holland, Martin J.
   Makalo, Pateh
   Joof, Hassan
   Roberts, Chrissy H.
   Mabey, David C. W.
   Bailey, Robin L.
   Burton, Matthew J.
   Weinstock, George M.
   Burr, Sarah E.
TI The conjunctival microbiome in health and trachomatous disease: a case
   control study
SO GENOME MEDICINE
LA English
DT Article
ID BACTERIAL-INFECTION; ACTIVE TRACHOMA; DIVERSITY; GAMBIA; ASSOCIATION;
   TRICHIASIS; PATHOGENS; CARRIAGE; SURFACE; SEX
AB Background: Trachoma, caused by Chlamydia trachomatis, remains the world's leading infectious cause of blindness. Repeated ocular infection during childhood leads to scarring of the conjunctiva, in-turning of the eyelashes ( trichiasis) and corneal opacity in later life. There is a growing body of evidence to suggest non-chlamydial bacteria are associated with clinical signs of trachoma, independent of C. trachomatis infection.
   Methods: We used deep sequencing of the V1-V3 region of the bacterial 16S rRNA gene to characterize the microbiome of the conjunctiva of 220 residents of The Gambia, 105 with healthy conjunctivae and 115 with clinical signs of trachoma in the absence of detectable C. trachomatis infection. Deep sequencing was carried out using the Roche-454 platform. Sequence data were processed and analyzed through a pipeline developed by the Human Microbiome Project.
   Results: The microbiome of healthy participants was influenced by age and season of sample collection with increased richness and diversity seen in younger participants and in samples collected during the dry season. Decreased diversity and an increased abundance of Corynebacterium and Streptococcus were seen in participants with conjunctival scarring compared to normal controls. Abundance of Corynebacterium was higher still in adults with scarring and trichiasis compared to adults with scarring only.
   Conclusions: Our results indicate that changes in the conjunctival microbiome occur in trachomatous disease; whether these are a cause or a consequence is yet unknown.
C1 [Zhou, Yanjiao; Weinstock, George M.] Washington Univ, Genome Inst, St Louis, MO 63108 USA.
   [Zhou, Yanjiao] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63130 USA.
   [Holland, Martin J.; Roberts, Chrissy H.; Mabey, David C. W.; Bailey, Robin L.; Burton, Matthew J.; Burr, Sarah E.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England.
   [Makalo, Pateh; Joof, Hassan; Burr, Sarah E.] MRC Unit, Fajara, Gambia.
   [Weinstock, George M.] Jackson Lab Genom Med, Farmington, CT 06030 USA.
RP Burr, SE (reprint author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England.
EM Sarah.Burr@lshtm.ac.uk
OI Mabey, David/0000-0002-0031-8276; Burton, Matthew/0000-0003-1872-9169;
   Roberts, Chrissy h./0000-0003-1064-5980
FU Wellcome Trust, London, UK [079246/Z/06/Z, GR079246MA]; National
   Institutes of Health, Bethesda, MD, USA [U54HG004968]; Bill and Melinda
   Gates Foundation; Wellcome Trust
FX We are grateful to the participants of this study. We also thank Omar
   Manneh and Omar Camara for their assistance in the field. This study was
   funded by the Wellcome Trust, London, UK, grant numbers 079246/Z/06/Z
   and GR079246MA and the National Institutes of Health, Bethesda, MD, USA,
   grant number U54HG004968. SEB receives salary funding from the Bill and
   Melinda Gates Foundation. MJH, ChR and MJB receive salary funding from
   the Wellcome Trust. The funders played no role in the design,
   collection, analysis and interpretation of the data, in the writing of
   the manuscript and in the decision to send the manuscript for
   publication.
CR Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x
   Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30
   Boyton RJ, 2013, CLIN EXP IMMUNOL, V171, P117, DOI 10.1111/cei.12003
   Burr SE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002347
   Burton MJ, 2007, INVEST OPHTH VIS SCI, V48, P4440, DOI 10.1167/iovs.07-0315
   Burton MJ, 2011, INVEST OPHTH VIS SCI, V52, P6012, DOI 10.1167/iovs.11-7326
   Burton MJ, 2005, BRIT J OPHTHALMOL, V89, P575, DOI 10.1136/bjo.2004.055996
   Cevallos V, 2012, INVEST OPHTH VIS SCI, V53, P5208, DOI 10.1167/iovs.12-9984
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Cox MJ, 2013, HUM MOL GENET, V22, pR88, DOI 10.1093/hmg/ddt398
   Daroy MLG, 2011, CLIN MICROBIOL INFEC, V17, P776, DOI 10.1111/j.1469-0691.2010.03369.x
   Dawson CR, 1981, GUIDE TRACHOMA CONTR
   Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10
   Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939
   Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105
   Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110
   Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Holland MJ, 2010, INVEST OPHTH VIS SCI, V51, P3893, DOI 10.1167/iovs.09-5054
   Hospodsky D, 2014, MICROBIOL-SGM, V160, P1144, DOI 10.1099/mic.0.075390-0
   Hu VH, 2011, INVEST OPHTH VIS SCI, V52, P2181, DOI 10.1167/iovs.10-5829
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Oksanen J., 2011, VEGAN COMMUNITY ECOL
   Scales BS, 2013, J PATHOL, V229, P323, DOI 10.1002/path.4118
   Turovskiy Y, 2011, J APPL MICROBIOL, V110, P1105, DOI 10.1111/j.1365-2672.2011.04977.x
   Venables WN, 2003, MODERN APPL STAT S
   White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352
   Willcox MDP, 2013, EXP EYE RES, V117, P99, DOI 10.1016/j.exer.2013.06.003
   Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2
NR 29
TC 14
Z9 14
U1 2
U2 16
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-994X
J9 GENOME MED
JI Genome Med.
PD NOV 15
PY 2014
VL 6
AR 99
DI 10.1186/s13073-014-0099-x
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA AY1HZ
UT WOS:000347345800001
PM 25484919
OA gold
DA 2017-08-15
ER

PT J
AU Noulin, F
   Manesia, JK
   Rosanas-Urgell, A
   Erhart, A
   Borlon, C
   Van Den Abbeele, J
   d'Alessandro, U
   Verfaillie, CM
AF Noulin, Florian
   Manesia, Javed Karim
   Rosanas-Urgell, Anna
   Erhart, Annette
   Borlon, Celine
   Van Den Abbeele, Jan
   d'Alessandro, Umberto
   Verfaillie, Catherine M.
TI Hematopoietic Stem/Progenitor Cell Sources to Generate Reticulocytes for
   Plasmodium vivax Culture
SO PLOS ONE
LA English
DT Article
ID RED-BLOOD-CELLS; IN-VITRO CULTURE; STEM-CELLS; BONE-MARROW; CORD-BLOOD;
   PERIPHERAL-BLOOD; MALARIA; INFECTION; INVASION
AB The predilection of Plasmodium vivax (P. vivax) for reticulocytes is a major obstacle for its establishment in a long-term culture system, as this requires a continuous supply of large quantities of reticulocytes, representing only 1-2% of circulating red blood cells. We here compared the production of reticulocytes using an established in vitro culture system from three different sources of hematopoietic stem/ progenitor cells (HSPC), i.e. umbilical cord blood (UCB), bone marrow (BM) and adult peripheral blood (PB). Compared to CD34(+)-enriched populations of PB and BM, CD34(+)-enriched populations of UCB produced the highest amount of reticulocytes that could be invaded by P. vivax. In addition, when CD34(+)-enriched cells were first expanded, a further extensive increase in reticulocytes was seen for UCB, to a lesser degree BM but not PB. As invasion by P. vivax was significantly better in reticulocytes generated in vitro, we also suggest that P. vivax may have a preference for invading immature reticulocytes, which should be confirmed in future studies.
C1 [Noulin, Florian; Rosanas-Urgell, Anna; Erhart, Annette; Borlon, Celine] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium.
   [Manesia, Javed Karim; Verfaillie, Catherine M.] Stem Cell Inst, Dept Dev & regenerat, Leuven, Belgium.
   [Van Den Abbeele, Jan] Inst Trop Med, Unit Vet Protozool, B-2000 Antwerp, Belgium.
   [d'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
RP Noulin, F (reprint author), Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium.
EM flo_noulin@hotmail.com
RI D'Alessandro, Umberto/D-3457-2015; noulin, florian/J-3809-2013
OI D'Alessandro, Umberto/0000-0001-6341-5009; noulin,
   florian/0000-0001-7430-8073
FU ITM Secondary Research Funding (SOFI-B)
FX The funding was provided by ITM Secondary Research Funding (SOFI-B),
   http://www.itg.be/itgtool_v2/Projecten/Project.asp?PNr=755023. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR BENDER JG, 1994, CLIN IMMUNOL IMMUNOP, V70, P10, DOI 10.1006/clin.1994.1003
   Borlon C, 2012, INT J PARASITOL, V42, P155, DOI 10.1016/j.ijpara.2011.10.011
   Douay L, 2007, TRANSFUS MED REV, V21, P91, DOI 10.1016/j.tmrv.2006.11.004
   Fernandez-Becerra C, 2013, MEM I OSWALDO CRUZ, V108, P801, DOI 10.1590/0074-0276108062013019
   Furuya T, 2014, PARASITOL INT, V63, P278, DOI 10.1016/j.parint.2013.11.011
   Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047
   Golenda CF, 1997, P NATL ACAD SCI USA, V94, P6786, DOI 10.1073/pnas.94.13.6786
   Martin-Jaular L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-434
   Moreno-Perez DA, 2013, BIOL CELL, V105, P251, DOI 10.1111/boc.201200093
   Noulin F, 2013, TRENDS PARASITOL, V29, P286, DOI 10.1016/j.pt.2013.03.012
   Noulin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040798
   Panichakul Tasanee, 2007, Int J Parasitol, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009
   PATERAKIS GS, 1993, ACTA HAEMATOL-BASEL, V90, P182
   Price RN, 2007, AM J TROP MED HYG, V77, P79
   Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748
   Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037
NR 16
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 13
PY 2014
VL 9
IS 11
AR e112496
DI 10.1371/journal.pone.0112496
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AY6YT
UT WOS:000347709300061
PM 25393299
OA gold
DA 2017-08-15
ER

PT J
AU Okell, LC
   Cairns, M
   Griffin, JT
   Ferguson, NM
   Tarning, J
   Jagoe, G
   Hugo, P
   Baker, M
   D'Alessandro, U
   Bousema, T
   Ubben, D
   Ghani, AC
AF Okell, Lucy C.
   Cairns, Matthew
   Griffin, Jamie T.
   Ferguson, Neil M.
   Tarning, Joel
   Jagoe, George
   Hugo, Pierre
   Baker, Mark
   D'Alessandro, Umberto
   Bousema, Teun
   Ubben, David
   Ghani, Azra C.
TI Contrasting benefits of different artemisinin combination therapies as
   first-line malaria treatments using model-based cost-effectiveness
   analysis
SO NATURE COMMUNICATIONS
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; ARTEMETHER-LUMEFANTRINE;
   DIHYDROARTEMISININ-PIPERAQUINE; POPULATION PHARMACOKINETICS;
   UNCOMPLICATED MALARIA; AFRICAN CHILDREN; RANDOMIZED-TRIALS;
   TRANSMISSION; CAMBODIA; PHARMACODYNAMICS
AB There are currently several recommended drug regimens for uncomplicated falciparum malaria in Africa. Each has different properties that determine its impact on disease burden. Two major antimalarial policy options are artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DHA-PQP). Clinical trial data show that DHA-PQP provides longer protection against reinfection, while AL is better at reducing patient infectiousness. Here we incorporate pharmacokinetic-pharmacodynamic factors, transmission-reducing effects and cost into a mathematical model and simulate malaria transmission and treatment in Africa, using geographically explicit data on transmission intensity and seasonality, population density, treatment access and outpatient costs. DHA-PQP has a modestly higher estimated impact than AL in 64% of the population at risk. Given current higher cost estimates for DHA-PQP, there is a slightly greater cost per case averted, except in areas with high, seasonally varying transmission where the impact is particularly large. We find that a locally optimized treatment policy can be highly cost effective for reducing clinical malaria burden.
C1 [Okell, Lucy C.; Griffin, Jamie T.; Ferguson, Neil M.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London W2 1PG, England.
   [Cairns, Matthew] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1E 7HT, England.
   [Tarning, Joel] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7LJ, England.
   [Tarning, Joel] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 73170, Thailand.
   [Jagoe, George; Hugo, Pierre; Baker, Mark; Ubben, David] Med Malaria Venture, CH-1215 Geneva 15, Switzerland.
   [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, Dept Publ Hlth, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Banjul Fajara, Gambia.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.
   [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 GA Nijmegen, Netherlands.
RP Okell, LC (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London W2 1PG, England.
EM l.okell@imperial.ac.uk
RI Ghani, Azra/B-8560-2009; D'Alessandro, Umberto/D-3457-2015; Bousema,
   Teun/N-3574-2014; Ferguson, Neil/B-8578-2008
OI D'Alessandro, Umberto/0000-0001-6341-5009; Ferguson,
   Neil/0000-0002-1154-8093; Okell, Lucy/0000-0001-7202-6873
FU UK Medical Research Council (MRC); UK Department for International
   Development (DFID) under the MRC/DFID Concordat; MRC fellowship;
   Wellcome Trust; Bill and Melinda Gates Foundation; MRC; Bill and Melinda
   Gates Foundation (AFIRM) [OPP1034789]; European FP7 project REDMAL
   [242079]
FX We thank Sigma-Tau Pharmaceuticals Inc. and Issaka Zongo for access to
   the clinical trial data, Patrick Sawa for human-to-mosquito transmission
   data, Chris Drakeley for age-weight data from Tanzania and Lesong Conteh
   for advice on cost-effectiveness analysis. This analysis was funded by
   the Medicines for Malaria Venture. Three of the authors are affiliated
   to the funder Medicines for Malaria Venture and were involved in
   conceiving the study, the decision to publish and commenting on the
   manuscript. The following funding bodies had no role in study design,
   data collection and analysis, decision to publish or preparation of the
   manuscript. L.C.O. and M.C. are funded by joint fellowships from the UK
   Medical Research Council (MRC) and the UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement. J.T.G. is
   funded by a MRC fellowship. J.T. is part of the Mahidol-Oxford Tropical
   Medicine Research Unit, supported by the Wellcome Trust. A.C.G. and
   N.M.F. acknowledge grant funding from the Bill and Melinda Gates
   Foundation and Centre support from the MRC. T. B. is supported by grants
   from the Bill and Melinda Gates Foundation (AFIRM, grant number
   OPP1034789) and the European FP7 project REDMAL (#242079).
CR Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNAL.PMED.1001119
   Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108
   Amaratunga C, 2013, 62 ANN M S 44 ART RE
   Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI 10.1111/j.1365-3165.2006.01784.x
   Basco LK, 1998, ANTIMICROB AGENTS CH, V42, P2347
   Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871
   Bigira V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001689
   Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136
   Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879
   Cairns M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018947
   Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5
   Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045
   Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012223
   Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313
   De Beaudrap P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-132
   Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x
   Djimde AA, 2011, ANTIMICROB AGENTS CH, V55, P3994, DOI 10.1128/AAC.01115-10
   Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020
   Edejer T, 2003, MAKING CHOICES HLTH
   Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000
   Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136
   Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324
   Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036
   Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048
   Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6
   KUMAR N, 1990, PARASITOL RES, V76, P214, DOI 10.1007/BF00930817
   Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12
   LENGELER C, 2004, COCHRANE DATABASE SY, DOI 10.1002/14651858.CD000363
   Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498
   malERA Consultative Group on Drugs, 2011, PLOS MED, V8
   Management Sciences for Health, INT DRUG PRIC IND GU
   MEASURE DHS, DEM HLTH SURV
   Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109
   Oak Ridge National Laboratory, 2011, LANDSCAN HIGH RES GL
   Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179
   Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125
   Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226
   Pfeil J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095681
   Sawa P, 2013, J INFECT DIS, V207, P1637, DOI 10.1093/infdis/jit077
   Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2
   Smith DL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-217
   Song JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-231
   Tarning J, 2012, CLIN PHARMACOL THER, V91, P497, DOI 10.1038/clpt.2011.254
   Tarning J, 2012, ANTIMICROB AGENTS CH, V56, P1997, DOI 10.1128/AAC.05756-11
   Tarning J, 2009, ANTIMICROB AGENTS CH, V53, P3837, DOI 10.1128/AAC.00195-09
   Tran Tinh Hien, 2004, Lancet (North American Edition), V363, P18
   United Nations, 2010, WORLD POP PROSP 2010
   van Pelt-Koops JC, 2012, ANTIMICROB AGENTS CH, V56, P3544, DOI 10.1128/AAC.06377-11
   Wanzira H, 2014, CLIN INFECT DIS, V59, P509, DOI 10.1093/cid/ciu353
   White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337
   White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
   [Anonymous], 2010, WHO GUID TREATM MAL
   WHO-CHOICE, COUNTR SPEC UN COSTS
   Worldwide Antimalarial Resistance Network (WWARN) DP Study Group, 2013, PLOS MED, V10
   Zambia Ministry of Health, 2006, ZAMB MAL IND SURV 20
   Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985
NR 60
TC 20
Z9 20
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV
PY 2014
VL 5
AR 5606
DI 10.1038/ncomms6606
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AW1XR
UT WOS:000346082500001
PM 25425081
OA gold
DA 2017-08-15
ER

PT J
AU Kimani, D
   Jagne, YJ
   Cox, M
   Kimani, E
   Bliss, CM
   Gitau, E
   Ogwang, C
   Afolabi, MO
   Bowyer, G
   Collins, KA
   Edwards, N
   Hodgson, SH
   Duncan, CJA
   Spencer, AJ
   Knight, MG
   Drammeh, A
   Anagnostou, NA
   Berrie, E
   Moyle, S
   Gilbert, SC
   Soipei, P
   Okebe, J
   Colloca, S
   Cortese, R
   Viebig, NK
   Roberts, R
   Lawrie, AM
   Nicosia, A
   Imoukhuede, EB
   Bejon, P
   Chilengi, R
   Bojang, K
   Flanagan, KL
   Hill, AVS
   Urban, BC
   Ewer, KJ
AF Kimani, Domtila
   Jagne, Ya Jankey
   Cox, Momodou
   Kimani, Eva
   Bliss, Carly M.
   Gitau, Evelyn
   Ogwang, Caroline
   Afolabi, Muhannmed O.
   Bowyer, Georgina
   Collins, Katharine A.
   Edwards, Nick
   Hodgson, Susanne H.
   Duncan, Christopher J. A.
   Spencer, Alexandra J.
   Knight, Miguel G.
   Drammeh, Abdoulie
   Anagnostou, Nicholas A.
   Berrie, Eleanor
   Moyle, Sarah
   Gilbert, Sarah C.
   Soipei, Peninah
   Okebe, Joseph
   Colloca, Stefano
   Cortese, Riccardo
   Viebig, Nicola K.
   Roberts, Rachel
   Lawrie, Alison M.
   Nicosia, Alfredo
   Imoukhuede, Egeruan B.
   Bejon, Philip
   Chilengi, Roma
   Bojang, Kalifa
   Flanagan, Katie L.
   Hill, Adrian V. S.
   Urban, Britta C.
   Ewer, Katie J.
TI Translating the Immunogenicity of Prime-boost Immunization With ChAd63
   and MVA ME-TRAP From Malaria Naive to Malaria-endemic Populations
SO MOLECULAR THERAPY
LA English
DT Article
ID VACCINIA VIRUS ANKARA; T-CELL IMMUNITY; PLASMODIUM-FALCIPARUM;
   PROTECTIVE IMMUNITY; CLINICAL MALARIA; MEMORY; ADENOVIRUS; TRIAL;
   INFECTIONS; SAFETY
AB To induce a deployable level of efficacy, a successful malaria vaccine would likely benefit from both potent cellular and humoral immunity. These requirements are met by a heterologous prime-boost immunization strategy employing a chimpanzee adenovirus vector followed by modified vaccinia Ankara (MVA), both encoding the pre-erythrocytic malaria antigen ME-thronnbospondin-related adhesive protein (TRAP), with high immunogenicity and significant efficacy in UK adults. We undertook two phase 1b open-label studies in adults in Kenya and The Gambia in areas of similar seasonal malaria transmission dynamics and have previously reported safety and basic immunogenicity data. We now report flow cytonnetry and additional interferon (IFN)-gamma enzyme-linked immunospot (ELISPOT) data characterizing pre-existing and induced cellular immunity as well as anti-TRAP IgG responses. T-cell responses induced by vaccination averaged 1,254 spot-forming cells (SFC) per million peripheral blood mononuclear cells (PBMC) across both trials and flow cytometry revealed cytokine production from both CD4(+) and CD8(+) T cells with the frequency of CD8(+) IFN-gamma-secreting monofunctional T cells (previously shown to associate with vaccine efficacy) particularly high in Kenyan adults. Immunization with ChAd63 and MVA ME-TRAP induced strong cellular and humoral immune responses in adults living in two malaria-endemic regions of Africa. This prime-boost approach targeting the pre-erythrocytic stage of the malaria life-cycle is now being assessed for efficacy in a target population.
C1 [Kimani, Domtila; Kimani, Eva; Gitau, Evelyn; Ogwang, Caroline; Knight, Miguel G.; Soipei, Peninah; Bejon, Philip; Chilengi, Roma; Urban, Britta C.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.
   [Jagne, Ya Jankey; Cox, Momodou; Afolabi, Muhannmed O.; Drammeh, Abdoulie; Okebe, Joseph; Bojang, Kalifa; Flanagan, Katie L.] MRC Unit, Fajara, Gambia.
   [Bliss, Carly M.; Bowyer, Georgina; Collins, Katharine A.; Edwards, Nick; Spencer, Alexandra J.; Gilbert, Sarah C.; Hill, Adrian V. S.; Ewer, Katie J.] Univ Oxford, Jenner Inst Labs, Oxford, England.
   [Hodgson, Susanne H.; Duncan, Christopher J. A.; Anagnostou, Nicholas A.; Roberts, Rachel; Lawrie, Alison M.; Hill, Adrian V. S.] Churchill Hosp, Centre Clin Vaccinol & Trop Med, Jenner Inst, Oxford OX3 7LJ, England.
   [Berrie, Eleanor; Moyle, Sarah] Univ Oxford, Churchill Hosp, Clin Biomfg Facil, Oxford, England.
   [Colloca, Stefano; Cortese, Riccardo; Nicosia, Alfredo] Okairos AG, Rome, Italy.
   [Cortese, Riccardo; Nicosia, Alfredo] CEINGE, Naples, Italy.
   [Viebig, Nicola K.; Imoukhuede, Egeruan B.] Univ Klinikum Heidelberg, European Vaccine Initiat, Heidelberg, Germany.
   [Nicosia, Alfredo] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy.
   [Flanagan, Katie L.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia.
   [Urban, Britta C.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
RP Ewer, KJ (reprint author), Univ Oxford, Jenner Inst Labs, Old Rd Campus Res Bldg, Oxford, England.
EM katie.ewer@ndm.ox.ac.uk
RI Ewer, Katie/B-4328-2011
OI Ewer, Katie/0000-0001-9827-9836; OGWANG, CAROLINE/0000-0003-2689-9459;
   Gitau, Evelyn /0000-0002-5270-7492; Bowyer,
   Georgina/0000-0002-2058-4045; Afolabi, Muhammed/0000-0002-9967-6419;
   Garcia Knight, Miguel Antonio/0000-0001-9556-3719; Urban,
   Britta/0000-0002-4197-8393; Collins, Katharine/0000-0002-7080-2215;
   Spencer, Alexandra/0000-0001-7958-6961
FU European and Developing Countries Clinical Trials Partnership (EDCTP);
   Malaria Vectored Vaccines Consortium (MVVC); European and Developing
   Countries Clinical Trials Partnership (EDCTP) [IP.2008.31100.001]; MVVC
   project [1R2008.31100.001]; UK National Institute of Health Research
   through the Oxford Biomedical Research Centre [A91301]; Wellcome Trust
   [084113/Z/07/Z]; Medical Research Council;  [097940/Z/11/Z]
FX For the study in The Gambia, we thank the Gambian National Malaria
   Control Programme and staff of Sukuta Health Centre for their
   collaboration; J Adetifa and the Sukuta field team; E Touray, S Sanneh,
   M Sambou, and O Badjie for field work; J Jobe, F Darboe, and lsatou Bah
   for laboratory assistance; O Nyan for safety monitoring; J Suso for
   clinical trial support; M Sowe and H Kanyi for help with data management
   and C McKenna for study monitoring. For the study in Kenya, we thank V
   Mwatemo for clinical assistance, REA Vipingo Plantations Ltd for use of
   facilities, C McKenna for study monitoring, M Otieno for data
   management, A Etyang' for safety monitoring, and E Pembe and A Mbaru for
   field work. We thank the members of both Data Safety Monitoring Boards
   and all the study volunteers. We thank W Ripley Ballou of GSK for
   reviewing the manuscript. This study is published with the permission of
   the Director of the Kenyan Medical Research Institute. This work was
   supported by an award from the European and Developing Countries
   Clinical Trials Partnership (EDCTP) and was performed by the Malaria
   Vectored Vaccines Consortium (MVVC), a four and a half year integrated
   project funded by the European and Developing Countries Clinical Trials
   Partnership (EDCTP, grant number IP.2008.31100.001). N.I.V. is an
   employee of the European Vaccine Initiative (EVI). E.V.I. is the
   coordinator of the EDCTP funded MVVC project (grant number
   1R2008.31100.001). E.V.I. supports salaries of the MWC project in kind.
   The work was also supported by the UK National Institute of Health
   Research through the Oxford Biomedical Research Centre
   (http://www.oxfordbrc.org/) [A91301 Adult Vaccine], the Wellcome Trust
   (http://www.wellcome.ac.uk/) (084113/Z/07/Z) and the Medical Research
   Council. S.H.H. holds a Wellcome Trust research training fellowship
   (097940/Z/11/Z). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. A.V.S.H. is a named inventor on patent applications on
   malaria vectored vaccines and immunization regimens. Authors from
   Okairas are employees of and/or shareholders in Okairos, which is
   developing vectored vaccines for malaria and other diseases.
CR Bejon P, 2007, J IMMUNOL, V179, P4193
   Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029
   Bejon P, 2006, EUR J IMMUNOL, V36, P2264, DOI 10.1002/eji.200636187
   Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110
   Birkett AJ, 2013, VACCINE, V31, pB233, DOI 10.1016/j.vaccine.2013.02.040
   de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004
   Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548
   Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836
   GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q
   Imoukhuede EB, 2006, VACCINE, V24, P6526, DOI 10.1016/j.vaccine.2006.06.022
   Imoukhuede EB, 2007, AM J TROP MED HYG, V76, P486
   Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007
   Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120
   Malaria Vaccine Funders Group, 2013, MAL VACC TECHN ROADM
   McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881
   Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033
   Moorthy VS, 2003, J INFECT DIS, V188, P1239, DOI 10.1086/378515
   Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006
   Ndungu FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052870
   Nebie I, 2014, CLIN VACCINE IMMUNOL, V21, P901, DOI 10.1128/CVI.00723-13
   Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0
   O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850
   Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726
   Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009
   Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302
   Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212
   Robson KJH, 1998, AM J TROP MED HYG, V58, P81
   RTS S Clinical Trials Partnership, 2012, N ENGL J MED, V367, P2284
   Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902
   Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998
   Schmidt NW, 2009, VACCINE, V27, P6103, DOI 10.1016/j.vaccine.2009.08.025
   Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176
   Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102
   Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247
   Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889
   White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
NR 38
TC 19
Z9 20
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD NOV
PY 2014
VL 22
IS 11
BP 1992
EP 2003
DI 10.1038/mt.2014.109
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA AS7IJ
UT WOS:000344429800016
PM 24930599
OA No
DA 2017-08-15
ER

PT J
AU Rockett, KA
   Clarke, GM
   Fitzpatrick, K
   Hubbart, C
   Jeffreys, AE
   Rowlands, K
   Craik, R
   Jallow, M
   Conway, DJ
   Bojang, KA
   Pinder, M
   Usen, S
   Sisay-Joof, F
   Sirugo, G
   Toure, O
   Thera, MA
   Konate, S
   Sissoko, S
   Niangaly, A
   Poudiougou, B
   Mangano, VD
   Bougouma, EC
   Sirima, SB
   Modiano, D
   Amenga-Etego, LN
   Ghansah, A
   Koram, KA
   Wilson, MD
   Enimil, A
   Evans, J
   Amodu, O
   Olaniyan, S
   Apinjoh, T
   Mugri, R
   Ndi, A
   Ndila, CM
   Uyoga, S
   Macharia, A
   Peshu, N
   Williams, TN
   Manjurano, A
   Riley, E
   Drakeley, C
   Reyburn, H
   Nyirongo, V
   Kachala, D
   Molyneux, M
   Dunstan, SJ
   Phu, NH
   Quyen, NTN
   Thai, CQ
   Hien, TT
   Manning, L
   Laman, M
   Siba, P
   Karunajeewa, H
   Allen, S
   Allen, A
   Davis, TME
   Michon, P
   Mueller, I
   Green, A
   Molloy, S
   Johnson, KJ
   Kerasidou, A
   Cornelius, V
   Hart, L
   Vanderwal, A
   SanJoaquin, M
   Band, G
   Le, SQ
   Pirinen, M
   Sepulveda, N
   Spencer, CCA
   Clark, TG
   Agbenyega, T
   Achidi, E
   Doumbo, O
   Farrar, J
   Marsh, K
   Taylor, T
   Kwiatkowski, DP
AF Rockett, Kirk A.
   Clarke, Geraldine M.
   Fitzpatrick, Kathryn
   Hubbart, Christina
   Jeffreys, Anna E.
   Rowlands, Kate
   Craik, Rachel
   Jallow, Muminatou
   Conway, David J.
   Bojang, Kalifa A.
   Pinder, Margaret
   Usen, Stanley
   Sisay-Joof, Fatoumatta
   Sirugo, Giorgio
   Toure, Ousmane
   Thera, Mahamadou A.
   Konate, Salimata
   Sissoko, Sibiry
   Niangaly, Amadou
   Poudiougou, Belco
   Mangano, Valentina D.
   Bougouma, Edith C.
   Sirima, Sodiomon B.
   Modiano, David
   Amenga-Etego, Lucas N.
   Ghansah, Anita
   Koram, Kwadwo A.
   Wilson, Michael D.
   Enimil, Anthony
   Evans, Jennifer
   Amodu, Olukemi
   Olaniyan, Subulade
   Apinjoh, Tobias
   Mugri, Regina
   Ndi, Andre
   Ndila, Carolyne M.
   Uyoga, Sophie
   Macharia, Alexander
   Peshu, Norbert
   Williams, Thomas N.
   Manjurano, Alphaxard
   Riley, Eleanor
   Drakeley, Chris
   Reyburn, Hugh
   Nyirongo, Vysaul
   Kachala, David
   Molyneux, Malcolm
   Dunstan, Sarah J.
   Nguyen Hoan Phu
   Nguyen Thi Ngoc Quyen
   Cao Quang Thai
   Tran Tinh Hien
   Manning, Laurens
   Laman, Moses
   Siba, Peter
   Karunajeewa, Harin
   Allen, Steve
   Allen, Angela
   Davis, Timothy M. E.
   Michon, Pascal
   Mueller, Ivo
   Green, Angie
   Molloy, Sile
   Johnson, Kimberly J.
   Kerasidou, Angeliki
   Cornelius, Victoria
   Hart, Lee
   Vanderwal, Aaron
   SanJoaquin, Miguel
   Band, Gavin
   Le, Si Quang
   Pirinen, Matti
   Sepulveda, Nuno
   Spencer, Chris C. A.
   Clark, Taane G.
   Agbenyega, Tsiri
   Achidi, Eric
   Doumbo, Ogobara
   Farrar, Jeremy
   Marsh, Kevin
   Taylor, Terrie
   Kwiatkowski, Dominic P.
CA Malaria Genomic Epidemiology Netwo
TI Reappraisal of known malaria resistance loci in a large multicenter
   study
SO NATURE GENETICS
LA English
DT Article
ID PLASMODIUM-FALCIPARUM MALARIA; GENOME-WIDE ASSOCIATION; BLOOD-GROUP
   SYSTEM; SICKLE-CELL TRAIT; G6PD DEFICIENCY; NATURAL-SELECTION; AFRICAN
   CHILDREN; VIVAX; VARIANT; SUSCEPTIBILITY
AB Many human genetic associations with resistance to malaria have been reported, but few have been reliably replicated. We collected data on 11,890 cases of severe malaria due to Plasmodium falciparum and 17,441 controls from 12 locations in Africa, Asia and Oceania. We tested 55 SNPs in 27 loci previously reported to associate with severe malaria. There was evidence of association at P < 1 x 10(-4) with the HBB, ABO, ATP2B4, G6PD and CD40LG loci, but previously reported associations at 22 other loci did not replicate in the multicenter analysis. The large sample size made it possible to identify authentic genetic effects that are heterogeneous across populations or phenotypes, with a striking example being the main African form of G6PD deficiency, which reduced the risk of cerebral malaria but increased the risk of severe malarial anemia. The finding that G6PD deficiency has opposing effects on different fatal complications of P. falciparum infection indicates that the evolutionary origins of this common human genetic disorder are more complex than previously supposed.
C1 [Rockett, Kirk A.; Clarke, Geraldine M.; Fitzpatrick, Kathryn; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Craik, Rachel; Green, Angie; Molloy, Sile; Johnson, Kimberly J.; Kerasidou, Angeliki; Cornelius, Victoria; Hart, Lee; Vanderwal, Aaron; SanJoaquin, Miguel; Band, Gavin; Le, Si Quang; Pirinen, Matti; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Rockett, Kirk A.; Clarke, Geraldine M.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England.
   [Rockett, Kirk A.; Clarke, Geraldine M.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England.
   [Jallow, Muminatou; Conway, David J.; Bojang, Kalifa A.; Pinder, Margaret; Usen, Stanley; Sisay-Joof, Fatoumatta; Sirugo, Giorgio] MRC Unit, Serrekunda, Gambia.
   [Jallow, Muminatou] Royal Victoria Teaching Hosp, Banjul, Gambia.
   [Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England.
   [Toure, Ousmane; Thera, Mahamadou A.; Konate, Salimata; Sissoko, Sibiry; Niangaly, Amadou; Poudiougou, Belco; Doumbo, Ogobara] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali.
   [Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, Dipartimento Sanita Publ & Malattie Infett, I-00185 Rome, Italy.
   [Bougouma, Edith C.; Sirima, Sodiomon B.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.
   [Amenga-Etego, Lucas N.] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Ghansah, Anita; Koram, Kwadwo A.; Wilson, Michael D.] Noguchi Mem Inst Med Res, Accra, Ghana.
   [Enimil, Anthony; Agbenyega, Tsiri] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Evans, Jennifer] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany.
   [Evans, Jennifer] Kumasi Ctr Collaborat Res, Kumasi, Ghana.
   [Amodu, Olukemi; Olaniyan, Subulade] Univ Ibadan, Coll Med, Inst Child Hlth, Ibadan, Nigeria.
   [Apinjoh, Tobias] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon.
   [Mugri, Regina; Ndi, Andre; Achidi, Eric] Univ Buea, Dept Med Lab Sci, Buea, Cameroon.
   [Ndila, Carolyne M.; Uyoga, Sophie; Macharia, Alexander; Peshu, Norbert; Williams, Thomas N.; Marsh, Kevin] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.
   [Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Fac Med, London, England.
   [Manjurano, Alphaxard; Drakeley, Chris; Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania.
   [Manjurano, Alphaxard; Riley, Eleanor; Drakeley, Chris; Reyburn, Hugh] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.
   [Nyirongo, Vysaul] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi.
   [Kachala, David; Dunstan, Sarah J.; Nguyen Hoan Phu; Nguyen Thi Ngoc Quyen; Cao Quang Thai; Tran Tinh Hien; Farrar, Jeremy] Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Molyneux, Malcolm; Dunstan, Sarah J.; Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England.
   [Dunstan, Sarah J.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia.
   [Nguyen Hoan Phu; Cao Quang Thai; Tran Tinh Hien] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Manning, Laurens; Laman, Moses; Siba, Peter; Michon, Pascal; Mueller, Ivo] Papua New Guinea Inst Med Res, Garoka, Papua N Guinea.
   [Manning, Laurens; Karunajeewa, Harin; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp Unit, Sch Med & Pharmacol, Fremantle, WA, Australia.
   [Allen, Steve] Swansea Univ, Coll Med, Swansea, W Glam, Wales.
   [Allen, Angela] Univ Oxford, Weatherall Inst Mol Med, Oxford, England.
   [Michon, Pascal] Divine Word Univ, Fac Hlth Sci, Madang, Papua N Guinea.
   [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.
   [Mueller, Ivo] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Kerasidou, Angeliki] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England.
   [Sepulveda, Nuno; Clark, Taane G.] London Sch Hyg & Trop Med, London WC1, England.
   [Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana.
   [Taylor, Terrie] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi.
RP Rockett, KA (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
EM kirk.rockett@well.ox.ac.uk; dominic.kwiatkowski@well.ox.ac.uk
RI Riley, Eleanor/C-8960-2013; Manning, Laurens/H-5360-2014; Le,
   Quang/A-4861-2012
OI Riley, Eleanor/0000-0003-3447-3570; Manning,
   Laurens/0000-0003-4334-5351; Davis, Timothy/0000-0003-0749-7411; Farrar,
   Jeremy/0000-0002-2700-623X; Mangano, Valentina D/0000-0002-2021-6162;
   Le, Quang/0000-0002-3715-210X; Laman, Moses/0000-0003-0964-805X; Amodu,
   Olukemi/0000-0003-1477-4229; Dunstan, Sarah/0000-0001-7873-933X;
   Kwiatkowski, Dominic/0000-0002-5023-0176; Sepulveda,
   Nuno/0000-0002-8542-1706; Pirinen, Matti/0000-0002-1664-1350; Conway,
   David/0000-0002-8711-3037
FU Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 090532/Z/09/Z,
   098051/Z/05/Z, 076934/Z/05/Z, 091758/Z/10/Z]; Bill and Melinda Gates
   Foundation through The Foundation for the National Institutes of Health
   (FNIH, USA), Grand Challenges in Global Health Initiative [566];
   Interagency Committee on Disability Research (ICDR) grant from the
   National Institute of Allergy and Infectious Diseases/US National
   Institutes of Health (NIAID/NIH); University of Bamako (USTTB);
   Mali-NIAID/NIH International Centers for Excellence in Research (ICER)
   at USTTB; BioMalPar European Network of Excellence
   [LSHP-CT-2004-503578]; European Community's Seventh Framework Programme
   [242095-EVIMalaR]; Central African Network for Tuberculosis, HIV/AIDS
   and Malaria (CANTAM); European and Developing Countries Clinical Trials
   Partnership (EDCTP); Fogarty Foundation Scholarship; NHMRC
FX The MalariaGEN Project is supported by the Wellcome Trust
   (WT077383/Z/05/Z) and the Bill and Melinda Gates Foundation through The
   Foundation for the National Institutes of Health (FNIH, USA) (566) as
   part of the Grand Challenges in Global Health Initiative. The Resource
   Centre for Genomic Epidemiology of Malaria is supported by the Wellcome
   Trust (090770/Z/09/Z). This research was supported-by the UK Medical
   Research Council (G0600718 and G0600230) and by the Wellcome Trust
   Biomedical Ethics Enhancement Award (087285) and Strategic Award
   (096527). D.P.K. receives support from the UK Medical Research Council
   (G19/9). C.C.A.S. was supported by a Wellcome Trust Career Development
   Fellowship (097364/Z/11/Z). The Wellcome Trust also provides core awards
   to the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z) and the
   Wellcome Trust Sanger Institute (098051/Z/05/Z). The Malaria Research
   and Training Center-Bandiagara Malaria Project (MRTC-BMP) in Mali group
   is supported by an Interagency Committee on Disability Research (ICDR)
   grant from the National Institute of Allergy and Infectious Diseases/US
   National Institutes of Health (NIAID/NIH) to the University of Maryland
   and the University of Bamako (USTTB) and by the Mali-NIAID/NIH
   International Centers for Excellence in Research (ICER) at USTTB.
   Contributions from Nigeria to CP1 were supported financially by a grant
   within the BioMalPar European Network of Excellence
   (LSHP-CT-2004-503578). E.A. received partial funding from the European
   Community's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement 242095-EVIMalaR and the Central African Network for
   Tuberculosis, HIV/AIDS and Malaria (CANTAM) funded by the European and
   Developing Countries Clinical Trials Partnership (EDCTP). T.N.W. is
   funded by Senior Fellowship awards from the Wellcome Trust
   (076934/Z/05/Z and 091758/Z/10/Z) and through the European Community's
   Seventh Framework Programme (FP7/2007-2013) under grant agreement
   242095-EVIMalaR. The Kenya Medical Research Institute (KEMRI)-Wellcome
   Trust Programme is funded through core support from the Wellcome Trust.
   This paper is published with the permission of the director of KEMRI.
   C.M.N. is supported through a strategic award to the KEMRI-Wellcome
   Trust Programme from the Wellcome Trust (084538). The Joint Malaria
   Programme, Kilimanjaro Christian Medical Centre in Tanzania received
   funding from a UK MRC grant (G9901439). We would like to thank all the
   Vietnamese individuals who agreed to provide samples for this study. We
   acknowledge the work of the clinical staff from the Hospital of Tropical
   Diseases, HCMC and Phuoc Long and Dong Xoai District Hospitals in Binh
   Phuoc province, Vietnam, who initially diagnosed and studied the
   individuals with severe malaria. We would like to thank N.T. Hieu and
   his staff from Hung Vuong Obstetric Hospital for the collection of the
   cord blood controls. The clinical component of this study was funded
   through the Wellcome Trust Major Overseas Program in Vietnam
   (089276/Z/09/Z). L.M. was supported through Basser (Royal Australasian
   College of Physicians) and National Health and Medical Research Council
   (NHMRC) scholarships. M.L. was supported through a Fogarty Foundation
   Scholarship. T.M.E.D. was supported through an NHMRC practitioner
   fellowship.
CR ALLISON AC, 1954, BRIT MED J, V1, P290
   ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x
   Atkinson SH, 2014, BLOOD, V123, P2008, DOI 10.1182/blood-2013-10-533489
   Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509
   BIENZLE U, 1972, LANCET, V1, P107
   Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397
   Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727
   Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2
   Chokshi DA, 2007, PLOS MED, V4, P636, DOI 10.1371/journal.pmed.0040095
   Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8
   Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602
   Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631
   Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331
   Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774
   Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68
   Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628
   Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16
   HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951
   Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002
   Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7
   Jallow M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045645
   Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632
   Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519
   Liu WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4346
   Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849
   Luzzatto L, 2012, HEREDITY, V108, P456, DOI 10.1038/hdy.2011.90
   MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102
   Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9
   MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602
   Ogasawara K, 1996, BLOOD, V88, P2732
   Parker M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000143
   Price RN, 2007, AM J TROP MED HYG, V77, P79
   Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461
   Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104
   RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0
   Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.636877
   Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2
   STEINBERG MH, 1978, BRIT J HAEMATOL, V40, P533, DOI 10.1111/j.1365-2141.1978.tb05829.x
   Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021
   Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109
   Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731
   Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334
   Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573
   Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x
   Weatherall DJ, 2002, PEDIATR CLIN N AM, V49, P1149, DOI 10.1016/S0031-3955(02)00087-1
   World Health Organization, 2010, GUID TREATM MAL
   World Health Organization, 2000, T R SOC TROP MED S1, V94, pS1, DOI DOI 10.1016/S0035-9203(00)90300-6
   Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660
   YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0
NR 49
TC 42
Z9 42
U1 1
U2 26
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD NOV
PY 2014
VL 46
IS 11
BP 1197
EP 1204
DI 10.1038/ng.3107
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA AS2TI
UT WOS:000344131900010
OA No
DA 2017-08-15
ER

PT J
AU Holtz, LR
   Cao, S
   Zhao, GY
   Bauer, IK
   Denno, DM
   Klein, EJ
   Antonio, M
   Stine, OC
   Snelling, TL
   Kirkwood, CD
   Wang, D
AF Holtz, Lori R.
   Cao, Song
   Zhao, Guoyan
   Bauer, Irma K.
   Denno, Donna M.
   Klein, Eileen J.
   Antonio, Martin
   Stine, O. Cohn
   Snelling, Thomas L.
   Kirkwood, Carl D.
   Wang, David
TI Geographic variation in the eukaryotic virome of human diarrhea
SO VIROLOGY
LA English
DT Article
DE Diarrhea; Virome; Metagenomics
ID GLOBAL ENTERIC MULTICENTER; WEST-AFRICAN CHILDREN; HUMAN GUT VIROME;
   RT-PCR ASSAY; DEVELOPING-COUNTRIES; HUMAN ADENOVIRUSES; FECAL SPECIMENS;
   YOUNG-CHILDREN; STOOL SAMPLES; VIRUSES
AB Little is known about the population of eukaryotic viruses in the human gut ("virome") or the potential role it may play in disease. We used a metagenomic approach to define and compare the eukaryotic viromes in pediatric diarrhea cohorts from two locations (Melbourne and Northern Territory, Australia). We detected viruses known to cause diarrhea, non-pathogenic enteric viruses, viruses not associated with an enteric reservoir, viruses of plants, and novel viruses. Viromes from Northern Territory children contained more viral families per sample than viromes from Melbourne, which could be attributed largely to an increased number of sequences from the families Adenoviridae and Picornaviridae (genus enterovirus). qRT-PCR/PCR confirmed the increased prevalence of adenoviruses and enteroviruses. Testing of additional diarrhea cohorts by qRT-PCR/PCR demonstrated statistically different prevalences in different geographic sites. These findings raise the question of whether the virome plays a role in enteric diseases and conditions that vary with geography. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Holtz, Lori R.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
   [Cao, Song; Zhao, Guoyan; Wang, David] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Bauer, Irma K.; Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Denno, Donna M.; Klein, Eileen J.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA.
   [Denno, Donna M.] Washington Univ, Dept Global Hlth, St Louis, MO USA.
   [Antonio, Martin] MRC Unit, Banjul, Gambia.
   [Stine, O. Cohn] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
   [Snelling, Thomas L.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.
   [Snelling, Thomas L.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia.
   [Kirkwood, Carl D.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Enter Virus Res Grp, Parkville, Vic, Australia.
RP Wang, D (reprint author), Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.
EM Holtz_l@kids.wustl.edu; scao@path.wustl.edu; GZhao@pathology.wustl.edu;
   Bauer_l@kids.wustl.edu; ddenno@u.washington.edu;
   eileen.klein@seattlechildrens.org; mantonio@mrc.gm;
   ostin001@umaryland.edu; tsnelling@ichr.uwa.edu.au;
   carl.kirkwood@mcri.edu.au; davewang@wustl.edu
OI Holtz, Lori/0000-0002-5591-7794
FU National Institutes of Health [U54 AI057160]; US Department of
   Agriculture [0202238]; Bill & Melinda Gates Foundation [OPP1016839];
   Children's Discovery Institute [MD-FR-2013-292]; Morphology and Biobank
   Cores of the Washington University School of Medicine Digestive Diseases
   Research Core Center [P30DK052574]; National Institutes of
   Health-National Center for Advancing Translational Sciences [UL1
   TR000448, KL2 TR000450]; Burroughs Wellcome Fund; National Health and
   Medical Research Council, Australia [607347]
FX This work was funded in part by National Institutes of Health [Grant U54
   AI057160] to the Midwest Regional Center of Excellence for Biodefense
   and Emerging Infectious Disease Research, US Department of Agriculture
   [Grant 0202238], Bill & Melinda Gates Foundation [OPP1016839],
   Children's Discovery Institute (MD-FR-2013-292), the Morphology and
   Biobank Cores of the Washington University School of Medicine Digestive
   Diseases Research Core Center [P30DK052574], and National Institutes of
   Health-National Center for Advancing Translational Sciences [UL1
   TR000448 sub award KL2 TR000450 to L.R.H.]. D.W. holds an Investigator
   in the Pathogenesis of Infectious Disease Award from the Burroughs
   Wellcome Fund. C.D.K. is supported by a Career Development Award
   fellowship from the National Health and Medical Research Council,
   Australia (607347).
CR Berciaud S, 2012, J CLIN VIROL, V54, P302, DOI 10.1016/j.jcv.2012.04.009
   Braun LoRanee E, 2012, J Pediatric Infect Dis Soc, V1, P136, DOI 10.1093/jpids/pis005
   Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006
   Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E
   Cantalupo P.G., 2011, MBIO, V2, DOI [10.1128/mBio.00180-11.Print2011, DOI 10.1128/MBIO.00180-11.PRINT2011]
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Denno DM, 2012, CLIN INFECT DIS, V55, P897, DOI 10.1093/cid/cis553
   Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011
   Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213
   Gracey Michael, 2009, Lancet, V374, P65, DOI 10.1016/S0140-6736(09)60914-4
   Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024
   HONIG EI, 1956, J EXP MED, V103, P247, DOI 10.1084/jem.103.2.247
   Hsieh YC, 2014, VACCINE, V32, P1199, DOI 10.1016/j.vaccine.2013.08.041
   Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   LINDENBAUM J, 1968, AM J CLIN NUTR, V21, P1023
   LINDENBAUM J, 1971, ANN INTERN MED, V74, P218
   Magwalivha M, 2010, J MED VIROL, V82, P77, DOI 10.1002/jmv.21673
   Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647
   Menzies IS, 1999, GUT, V44, P483
   Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110
   Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111
   Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219
   Ng Terry Fei Fan, 2012, J Virol, V86, P12161, DOI 10.1128/JVI.00869-12
   Okamoto H, 1998, J MED VIROL, V56, P128
   OTATUME S, 1975, JPN J MICROBIOL, V19, P201
   Pallansch MA, 2007, FIELDS VIROLOGY, V1, P839
   Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12
   RAO CD, 1995, VIROLOGY, V207, P327, DOI 10.1006/viro.1995.1087
   Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199
   Risku M, 2010, J CLIN VIROL, V48, P27, DOI 10.1016/j.jcv.2010.02.013
   Rolfe KJ, 2007, J CLIN VIROL, V39, P318, DOI 10.1016/j.jcv.2007.05.005
   Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x
   RUBEN AR, 1995, MED J AUSTRALIA, V162, P400
   Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059
   Smits SL, 2014, EMERG INFECT DIS, V20, P1218, DOI 10.3201/eid2007.140190
   Frank St D.N., 2007, P NATL ACAD SCI USA, V104, P13780
   STRACHAN DP, 1989, BRIT MED J, V299, P1259
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09
   Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001
   Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08
   Vijgen Leen, 2008, V454, P3, DOI 10.1007/978-1-59745-181-9_1
   Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002
   Wootton SH, 2006, PEDIATR INFECT DIS J, V25, P1194, DOI 10.1097/01.inf.0000245097.95543.11
   Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003
   Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470
NR 53
TC 12
Z9 12
U1 2
U2 19
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD NOV
PY 2014
VL 468
BP 556
EP 564
DI 10.1016/j.virol.2014.09.012
PG 9
WC Virology
SC Virology
GA AS7KF
UT WOS:000344434400058
PM 25262473
OA No
DA 2017-08-15
ER

PT J
AU Lemoine, M
   Serfaty, L
   Cervera, P
   Capeau, J
   Ratziu, V
AF Lemoine, Maud
   Serfaty, Lawrence
   Cervera, Pascale
   Capeau, Jacqueline
   Ratziu, Vlad
TI Hepatic molecular effects of rosiglitazone in human non-alcoholic
   steatohepatitis suggest long-term pro-inflammatory damage
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE fibrosis; inflammation; non-alcoholic fatty liver disease; non-alcoholic
   steatohepatitis; peroxisome proliferator-activated receptor-gamma;
   rosiglitazone
ID ACTIVATED RECEPTOR-ALPHA; FATTY LIVER-DISEASE; PPAR-GAMMA;
   INSULIN-RESISTANCE; STELLATE CELLS; EXPRESSION; PIOGLITAZONE; TRIAL;
   STEATOSIS; PLACEBO
AB AimGlitazones are agonists of peroxisome proliferator-activated receptor- (PPAR-) and have been proposed for the treatment of non-alcoholic steatohepatitis (NASH). However, efficacy results are conflicting and hepatic molecular changes induced by glitazones are mostly unknown. The aim of this study was to analyze the hepatic inflammatory and fibrogenic molecular effects of rosiglitazone in NASH patients.
   MethodsHepatic expression of PPAR- and several inflammatory/immune and fibrogenic genes were studied before and after a 12-month treatment with rosiglitazone or placebo in 25 patients with NASH from the Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial.
   ResultsTreatment with rosiglitazone induced hepatic PPAR- expression but increased the expression of several pro-inflammatory genes such as SOCS3 and TLR4. There was a significant reduction in mRNA and protein levels of -smooth muscle actin, compatible with previously documented antifibrotic actions of rosiglitazone on stellate cells. However, there was no change in type 1 collagen and transforming growth factor- expression thus suggesting an offset of the antifibrogenic actions by long-term pro-inflammatory changes.
   ConclusionIn NASH patients, hepatic PPAR- induction by rosiglitazone was associated with increased hepatic expression of pro-inflammatory genes which may explain the lack of long-term histological benefit shown in human studies with this drug. It is unclear whether these results are a class effect of PPAR- agonists or a specific effect of rosiglitazone.
C1 [Lemoine, Maud; Serfaty, Lawrence] Hop St Antoine, APHP, Dept Hepatol, F-75571 Paris, France.
   [Lemoine, Maud; Serfaty, Lawrence; Cervera, Pascale; Capeau, Jacqueline; Ratziu, Vlad] INSERM, UMR S 938, Paris, France.
   [Lemoine, Maud; Serfaty, Lawrence; Cervera, Pascale; Capeau, Jacqueline; Ratziu, Vlad] Univ Paris 06, Paris, France.
   [Cervera, Pascale] Hop St Antoine, APHP, Anatomopathol Dept, F-75571 Paris, France.
   [Capeau, Jacqueline] Hop Tenon, APHP, Serv Biochim & Hormonol, F-75970 Paris, France.
   [Ratziu, Vlad] Hop La Pitie Salpetriere, APHP, Dept Hepatogastroenterol, Paris, France.
RP Lemoine, M (reprint author), MRC, Gambia Unit, Liver Unit, Atlantic Rd,Fajara POB 273, Serrekunda, Gambia.
EM mlemoine@mrc.gm
FU GlaxoSmithKline Pharmaceuticals
FX The FLIRT study was an investigator initiated trial and GlaxoSmithKline
   Pharmaceuticals had no direct or indirect involvement in the design of
   the trial, data collection or preparation or submission of the article.
   GlaxoSmithKline Pharmaceuticals provided rosiglitazone for the Fatty
   Liver Improvement with Rosiglitazone Therapy (FLIRT) trial and partly
   funded the FLIRT trial but not the following study. None of the authors
   has a personal conflict of interest with the manufacturers of any of the
   marketed glitazones. V. R. is a consultant to Astellas, Axcan, Gilead,
   Genentech, Intercept and Sanofi-Aventis.
CR Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326
   Boettcher E, 2012, ALIMENT PHARM THER, V35, P66, DOI 10.1111/j.1365-2036.2011.04912.x
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016
   Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779
   Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002
   Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666
   Garcia-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687
   Guo L, 2006, MOL DIVERS, V10, P349, DOI 10.1007/s11030-006-9038-0
   Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941
   Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199
   Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kon K, 2002, BIOCHEM BIOPH RES CO, V291, P55, DOI 10.1006/bbrc.2002.6385
   Lemoine M, 2006, AIDS, V20, P387, DOI 10.1097/01.aids.0000206503.01536.11
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mahady SE, 2011, J HEPATOL, V55, P1383, DOI 10.1016/j.jhep.2011.03.016
   Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365
   Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623
   Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078
   Ratziu V, 2010, HEPATOLOGY, V52, P2206, DOI 10.1002/hep.24042
   Ratziu V, 2010, HEPATOLOGY, V51, P445, DOI 10.1002/hep.23270
   Rogue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018816
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929
   Serfaty L, 2008, DIABETES METAB, V34, P634, DOI 10.1016/S1262-3636(08)74597-X
   STAELS B, 1995, J CLIN INVEST, V95, P705, DOI 10.1172/JCI117717
   Torres DM, 2011, HEPATOLOGY, V54, P1631, DOI 10.1002/hep.24558
   Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088
NR 32
TC 4
Z9 4
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD NOV
PY 2014
VL 44
IS 12
BP 1241
EP 1247
DI 10.1111/hepr.12244
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA AS2ZR
UT WOS:000344145500010
OA No
DA 2017-08-15
ER

PT J
AU Lange, C
   Kampmann, B
AF Lange, Christoph
   Kampmann, Beate
TI Preventive chemotherapy for contacts of MDR-TB: is the proof in the
   pudding?
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Editorial Material
ID MULTIDRUG-RESISTANT TUBERCULOSIS; MANAGEMENT
C1 [Lange, Christoph] German Ctr Infect Res TB Unit, Res Ctr, Div Clin Infect Dis, Borstel, Germany.
   [Lange, Christoph] Med Univ Lubeck, Dept Int Hlth Infect Dis, D-23538 Lubeck, Germany.
   [Lange, Christoph] Univ Namibia, Sch Med, Dept Internal Med, Windhoek, Namibia.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England.
   [Kampmann, Beate] MRC Unit, Fajara, Gambia.
RP Lange, C (reprint author), German Ctr Infect Res TB Unit, Res Ctr, Div Clin Infect Dis, Borstel, Germany.
EM clange@fz-borstel.de
OI Kampmann, Beate/0000-0002-6546-4709
FU Department of Health [SRF-2009-02-07]; Medical Research Council
   [MC_EX_MR/K011944/1, MC_UP_A900_1122]
CR Garcia-Prats AJ, 2014, INT J TUBERC LUNG D, V18, P1292, DOI 10.5588/ijtld.13.0872
   Jones CE, 2011, LANCET, V377, P1404, DOI 10.1016/S0140-6736(11)60570-9
   Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313
   Muller B, 2011, INT J TUBERC LUNG D, V15, P344
   Williams B, 2013, PEDIATR INFECT DIS J, V32, P926, DOI 10.1097/INF.0b013e31829157e9
NR 5
TC 0
Z9 0
U1 0
U2 2
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD NOV
PY 2014
VL 18
IS 11
BP 1262
EP 1263
DI 10.5588/ijtld.14.0705
PG 2
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA AR4AK
UT WOS:000343530200002
PM 25299855
OA No
DA 2017-08-15
ER

PT J
AU Minchella, PA
   Armitage, AE
   Darboe, B
   Jallow, MW
   Drakesmith, H
   Jaye, A
   Prentice, AM
   McDermid, JM
AF Minchella, P. A.
   Armitage, A. E.
   Darboe, B.
   Jallow, M. W.
   Drakesmith, H.
   Jaye, A.
   Prentice, A. M.
   McDermid, J. M.
TI Elevated hepcidin at HIV diagnosis is associated with incident
   tuberculosis in a retrospective cohort study
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE Africa; biomarker; iron; nutrition; inflammation
ID MYCOBACTERIUM-TUBERCULOSIS; MACROPHAGES; INFECTION
AB Hepcidin inhibits ferroportin-mediated iron efflux, leading to intracellular macrophage iron retention, possibly favoring Mycobacterium tuberculosis iron acquisition and tuberculosis (TB) pathogenesis. Plasma hepcidin was measured at human immunodeficiency virus (HIV) diagnosis in a retrospective HIV-prevalent, antiretroviral-naive African cohort to investigate the association with incident pulmonary and/or extra-pulmonary TB. One hundred ninety-six participants were followed between 5 August 1992 and 1 June 2002, with 32 incident TB cases identified. Greater hepcidin was associated with significantly increased likelihood of TB after a median time to TB of 6 months. Elucidation of iron-related causal mechanisms and time-sensitive biomarkers that identify individual changes in TB risk are needed.
C1 [Minchella, P. A.; McDermid, J. M.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Armitage, A. E.; Drakesmith, H.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.
   [Darboe, B.; Jallow, M. W.; Jaye, A.] Med Res Council Unit UK, Fajara, Gambia.
   [Prentice, A. M.] London Sch Hyg & Trop Med, Dept Nutr, Int Nutr Grp, London WC1, England.
   [Prentice, A. M.] London Sch Hyg & Trop Med, Publ Hlth Intervent Unit, London WC1, England.
RP McDermid, JM (reprint author), Cornell Univ, Div Nutr Sci, 310 Savage Hall, Ithaca, NY 14853 USA.
EM jmm585@cornell.edu
FU National Science Foundation Graduate Research Fellowship Program [NSF
   12-599]; Cornell University Unrestricted Funds (Ithaca, NY, USA); UK
   Medical Research Council (London, UK) [MC-A760-5QX00]
FX This work was supported in part by the National Science Foundation
   Graduate Research Fellowship Program under Grant No. NSF 12-599, Cornell
   University Unrestricted Funds (Ithaca, NY, USA) and the UK Medical
   Research Council (MC-A760-5QX00) (London, UK).
CR De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Fung E, 2013, HAEMATOLOGICA, V98, P1667, DOI 10.3324/haematol.2013.084624
   McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48
   Ryndak MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094939
   Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216
   Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034
   van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03
   Wagner D, 2005, J IMMUNOL, V174, P1491
   Wisaksana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079904
NR 10
TC 7
Z9 7
U1 1
U2 1
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD NOV
PY 2014
VL 18
IS 11
BP 1337
EP 1339
DI 10.5588/ijtld.14.0143
PG 3
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA AR4AK
UT WOS:000343530200014
PM 25299867
OA No
DA 2017-08-15
ER

PT J
AU Okebe, J
   Affara, M
   Correa, S
   Muhammad, AK
   Nwakanma, D
   Drakeley, C
   D'Alessandro, U
AF Okebe, Joseph
   Affara, Muna
   Correa, Simon
   Muhammad, Abdul Khalie
   Nwakanma, Davis
   Drakeley, Chris
   D'Alessandro, Umberto
TI School-Based Countrywide Seroprevalence Survey Reveals Spatial
   Heterogeneity in Malaria Transmission in the Gambia
SO PLOS ONE
LA English
DT Article
ID INTERVENTIONS; PREVALENCE
AB Background: As the geographical distribution of malaria transmission becomes progressively clustered, identifying residual pockets of transmission is important for research and for targeting interventions. Malarial antibody-based surveillance is increasingly recognised as a valuable complement to classic methods for the detection of infection foci especially at low transmission levels. The study presents serological evidence for transmission heterogeneity among school children in The Gambia measured during the dry, non-transmission season.
   Methods: Healthy primary school children were randomly selected from 30 schools across the country and screened for malaria infection (microscopy) and antimalarial antibodies (MSP119). Antibody distribution was modelled using 2-component finite mixture model with cut-off for positivity from pooled sera set at 2-standard deviation from the mean of the first component. Factors associated with a positive serological status were identified in a univariate model and then combined in a multilevel mixed-effects logistic regression model, simultaneously adjusting for variations between individuals and school.
   Results: A total of 4140 children, 1897 (46%) boys, were enrolled with mean age of 10.2 years (SD 2.6, range 4-20 years). Microscopy results available for 3640 (87.9%) children showed that 1.9% (69) were positive for Plasmodium falciparum infections, most of them (97.1%, 67/69) asymptomatic. The overall seroprevalence was 12.7% (527/4140) with values for the schools ranging from 0.6% to 43.8%. Age (OR 1.12, 95% CI 1.07-1.16,) and parasite carriage (OR 3.36, 95% CI 1.95-5.79) were strongly associated with seropositivity.
   Conclusion: Serological responses to malaria parasites could identify individuals who were or had been infected, and clusters of residual transmission. Field-adapted antibody tests able to guide mass screening and treatment campaigns would be extremely useful.
C1 [Okebe, Joseph; Affara, Muna; Correa, Simon; Muhammad, Abdul Khalie; Nwakanma, Davis; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.
   [D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England.
   [D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.
RP Okebe, J (reprint author), MRC Unit, Fajara, Gambia.
EM jokebe@mrc.gm
RI D'Alessandro, Umberto/D-3457-2015
OI D'Alessandro, Umberto/0000-0001-6341-5009
FU Medical Research Council United Kingdom
FX The study is funded by a grant from the Medical Research Council United
   Kingdom to UDA. The funders had not role in the design, data collection,
   analysis, decision and where to publish the results of the study.
CR Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711
   Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304
   Bogh C, 2007, AM J TROP MED HYG, V76, P875
   Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0
   Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401
   Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2
   Gambia, CIA WORLD FACTBOOK
   Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137
   Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023
   Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Elissa N, RELATIONSHIP ENTOMOL
   Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3
   malERA, 2011, PLOS MED, V8
   Messina JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-161
   Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221
   Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274
   Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265
   Supargiyono S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-444
   Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108
   The malEra Consultative Group on Monitoring Evaluation and Surveillance, 2011, PLOS MED, V8
   Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X
   WHO, 2010, WORLD MALARIA REPORT 2010, P1
NR 25
TC 6
Z9 6
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 22
PY 2014
VL 9
IS 10
AR e110926
DI 10.1371/journal.pone.0110926
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR6DY
UT WOS:000343674800089
PM 25338083
OA gold
DA 2017-08-15
ER

PT J
AU Takem, EN
   Roca, A
   Cunnington, A
AF Takem, Ebako Ndip
   Roca, Anna
   Cunnington, Aubrey
TI The association between malaria and non-typhoid Salmonella bacteraemia
   in children in sub-Saharan Africa: a literature review
SO MALARIA JOURNAL
LA English
DT Review
DE Malaria; Non-typhoid Salmonella; Children; Epidemiology; Pathogenesis
ID NON-TYPHOIDAL SALMONELLA; PLASMODIUM-FALCIPARUM MALARIA; INVASIVE
   BACTERIAL COINFECTION; SEROVAR TYPHIMURIUM INFECTION; SPECTRUM
   BETA-LACTAMASES; BLOOD-STREAM INFECTIONS; SICKLE-CELL DISEASE; AGED 2-29
   MONTHS; ANTIMICROBIAL RESISTANCE; MALAWIAN CHILDREN
AB Plasmodium falciparum malaria and non-typhoid Salmonella (NTS) bacteraemia are both major causes of morbidity and mortality in children in sub-Saharan Africa. Co-infections are expected to occur because of their overlapping geographical distribution, but accumulating evidence indicates that malaria is a risk factor for NTS bacteraemia. A literature review was undertaken to provide an overview of the evidence available for this association, the epidemiology of malaria-NTS co-infection (including the highest risk groups), the underlying mechanisms, and the clinical consequences of this association, in children in sub-Saharan Africa. The burden of malaria-NTS co-infection is highest in young children (especially those less than three years old). Malaria is one of the risk factors for NTS bacteraemia in children, and the risk is higher with severe malaria, especially severe malarial anaemia. There is insufficient evidence to determine whether asymptomatic parasitaemia is a risk factor for NTS bacteraemia. Many mechanisms have been proposed to explain how malaria causes susceptibility to NTS, ranging from macrophage dysfunction to increased gut permeability, but the most consistent evidence is that malarial haemolysis creates conditions which favour bacterial growth, by increasing iron availability and by impairing neutrophil function. Few discriminatory clinical features have been described for those with malaria and NTS co-infection, except for a higher risk of anaemia compared to those with either infection alone. Children with malaria and NTS bacteraemia co-infection have higher case fatality rates compared to those with malaria alone, and similar to those with bacteraemia alone. Antimicrobial resistance is becoming widespread in invasive NTS serotypes, making empirical treatment problematic, and increasing the need for prevention measures. Observational studies indicate that interventions to reduce malaria transmission might also have a substantial impact on decreasing the incidence of NTS bacteraemia.
C1 [Takem, Ebako Ndip] Minist Hlth, Buea, Cameroon.
   [Roca, Anna] MRC Unit, Banjul, Gambia.
   [Cunnington, Aubrey] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London W2 1PG, England.
RP Takem, EN (reprint author), Minist Hlth, BP 281, Buea, Cameroon.
EM ebako.takem@lshtm.ac.uk
OI Cunnington, Aubrey/0000-0002-1305-3529
FU Medical Research Council [G0701427, MR/L006529/1]
CR Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X
   Akinyemi KO, 2007, J HEALTH POPUL NUTR, V25, P351
   ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E
   Archibald LK, 2003, J INFECT DIS, V188, P202, DOI 10.1086/376507
   Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160
   Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0
   Bairwa M, 2012, HUM VACC IMMUNOTHER, V8, P819, DOI 10.4161/hv.20145
   Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004
   Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x
   BENNETT IL, 1959, ANNU REV MED, V10, P1, DOI 10.1146/annurev.me.10.020159.000245
   Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X
   Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275
   Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299
   Bhattacharya SK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-176
   Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309
   Biggs HM, 2014, CLIN INFECT DIS, V58, P638, DOI 10.1093/cid/cit798
   BLASER MJ, 1982, AM J EPIDEMIOL, V116, P266
   Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005
   Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43
   Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089
   Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff
   Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437
   Broz Petr, 2012, Gut Microbes, V3, P62, DOI 10.4161/gmic.19141
   Cardinale E, 2005, J APPL MICROBIOL, V99, P968, DOI 10.1111/j.1365-2672.2005.02618.x
   Chau JY, 2013, INFECT IMMUN, V81, P3515, DOI 10.1128/IAI.00380-13
   Cheesbrough JS, 1997, PEDIATR INFECT DIS J, V16, P277, DOI 10.1097/00006454-199703000-00005
   Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31
   Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x
   Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541
   Cunnington AJ, 2013, TRENDS PARASITOL, V29, P585, DOI 10.1016/j.pt.2013.10.004
   Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028
   Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601
   Cunnington AJ, 2010, EXPERT REV VACCINES, V9, P409, DOI [10.1586/erv.10.16, 10.1586/ERV.10.16]
   de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933
   Dione MM, 2012, J INFECT DEV COUNTR, V6, P436
   Dione MM, 2011, J INFECT DEV COUNTR, V5, P765
   Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x
   DUGGAN MB, 1975, ARCH DIS CHILD, V50, P67
   EBONG WW, 1986, ANN RHEUM DIS, V45, P911, DOI 10.1136/ard.45.11.911
   Edwards MD, 2012, MOL CELL PROBE, V26, P151, DOI 10.1016/j.mcp.2012.04.003
   Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5
   Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hcho93
   Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2
   Feasey NA, 2010, EMERG INFECT DIS, V16, P1448, DOI 10.3201/eid1609.100125
   French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010
   GIANNELLA RA, 1972, GUT, V13, P251, DOI 10.1136/gut.13.4.251
   Giglioli G, 1929, J HYG-CAMBRIDGE, V29, P273
   Gomez-Perez GP, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-335
   Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107
   Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009
   Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146
   Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080
   Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600
   Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7
   Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d
   Gross U, 2011, EMERG INFECT DIS, V17, P1879, DOI [10.3201/eid1710.110327, 10.3201/edi1710.110327]
   Haddock R L, 1986, J Diarrhoeal Dis Res, V4, P229
   Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913
   Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675
   Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2
   Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x
   Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0
   KAPPAS A, 1988, PEDIATRICS, V81, P485
   Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0
   Kariuki S, 2005, INT J ANTIMICROB AG, V25, P38, DOI 10.1016/j.ijantimicag.2004.08.015
   Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101
   KAYE D, 1963, J IMMUNOL, V91, P65
   KAYE D, 1965, P SOC EXP BIOL MED, V120, P810
   KAYE D, 1963, J IMMUNOL, V91, P518
   Keddy KH, 2009, J INFECT DEV COUNTR, V3, P585
   Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109
   Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882
   Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x
   Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069
   Lunguya O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002103
   MABEY DCW, 1987, J INFECT DIS, V155, P1319
   Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568
   MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021
   MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998
   MacLennan CA, 2013, CLIN VACCINE IMMUNOL, V20, P1487, DOI 10.1128/CVI.00465-13
   MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346
   Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500
   Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103
   Mandell GL, 2000, PRINCIPLES PRACTICE
   Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x
   Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237
   Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034
   Mtove G, 2011, MALARIA J, V10, P320, DOI DOI 10.1186/1475-2875-10-320
   Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244
   Nadjm B, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1350
   Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005
   Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002
   Niehaus AJ, 2011, FOODBORNE PATHOG DIS, V8, P693, DOI 10.1089/fpd.2010.0749
   Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193
   ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009
   Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423
   Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032
   Onyango D, 2008, J INFECT DEV COUNTR, V2, P106, DOI 10.3855/T2.2.106
   Oundo JO, 2000, T ROY SOC TROP MED H, V94, P212, DOI 10.1016/S0035-9203(00)90280-3
   Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586
   Phoba MF, 2013, EUR J CLIN MICROBIOL, V33, P79
   Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09
   Schwarz NG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-319
   Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X
   Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d
   Simon R, 2011, INFECT IMMUN, V79, P4240, DOI 10.1128/IAI.05484-11
   Tabu C, 2012, PLOS ONE, V7
   Taramelli D, 2000, LAB INVEST, V80, P1781, DOI 10.1038/labinvest.3780189
   Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11
   van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234
   Vandenberg O, 2010, PEDIATR INFECT DIS J, V29, P504, DOI 10.1097/INF.0b013e3181cd615a
   Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010
   Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10
   WHO, 2013, BOOK WORLD MAL REP 2
   WHO, 2012, BOOK WORLD MAL REP 2
   Wilairatana P, 1997, CLIN INFECT DIS, V24, P430
   Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X
   Wright J, 1997, J PEDIATR-US, V130, P394, DOI 10.1016/S0022-3476(97)70201-4
NR 118
TC 21
Z9 22
U1 1
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD OCT 13
PY 2014
VL 13
AR 400
DI 10.1186/1475-2875-13-400
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AS2PE
UT WOS:000344121200001
PM 25311375
OA gold
DA 2017-08-15
ER

PT J
AU Secka, O
   Moodley, Y
   Antonio, M
   Berg, DE
   Tapgun, M
   Walton, R
   Worwui, A
   Thomas, V
   Corrah, T
   Thomas, JE
   Adegbola, RA
AF Secka, Ousman
   Moodley, Yoshan
   Antonio, Martin
   Berg, Douglas E.
   Tapgun, Mary
   Walton, Robert
   Worwui, Archibald
   Thomas, Vivat
   Corrah, Tumani
   Thomas, Julian E.
   Adegbola, Richard A.
TI Population Genetic Analyses of Helicobacter pylori Isolates from Gambian
   Adults and Children
SO PLOS ONE
LA English
DT Article
ID INFECTION; STRAINS; DIVERSITY; AFRICAN; RECOMBINATION; COLONIZATION;
   TRANSMISSION; ASSOCIATION; PREVALENCE; DISEASE
AB The gastric pathogen Helicobacter pylori is one of the most genetically diverse of bacterial species. Much of its diversity stems from frequent mutation and recombination, preferential transmission within families and local communities, and selection during persistent gastric mucosal infection. MLST of seven housekeeping genes had identified multiple distinct H. pylori populations, including three from Africa: hpNEAfrica, hpAfrica1 and hpAfrica2, which consists of three subpopulations (hspWAfrica, hspCAfrica and hspSAfrica). Most detailed H. pylori population analyses have used strains from non-African countries, despite Africa's high importance in the emergence and evolution of humans and their pathogens. Our concatenated sequences from seven H. pylori housekeeping genes from 44 Gambian patients (MLST) identified 42 distinct sequence types (or haplotypes), and no clustering with age or disease. STRUCTURE analysis of the sequence data indicated that Gambian H. pylori strains belong to the hspWAfrica subpopulation of hpAfrica1, in accord with Gambia's West African location. Despite Gambia's history of invasion and colonisation by Europeans and North Africans during the last millennium, no traces of Ancestral Europe1 (AE1) population carried by those people were found. Instead, admixture of 17% from Ancestral Europe2 (AE2) was detected in Gambian strains; this population predominates in Nilo-Saharan speakers of North-East Africa, and might have been derived from admixture of hpNEAfrica strains these people carried when they migrated across the Sahara during the Holocene humid period 6,000-9,000 years ago. Alternatively, shared AE2 ancestry might have resulted from shared ancestral polymorphisms already present in the common ancestor of sister populations hpAfrica1 and hpNEAfrica.
C1 [Secka, Ousman; Antonio, Martin; Worwui, Archibald] MRC Unit, Fajara, Gambia.
   [Moodley, Yoshan] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria.
   [Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Berg, Douglas E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Tapgun, Mary; Walton, Robert; Thomas, Vivat; Corrah, Tumani] MRC Unit, Clin Serv Dept, Fajara, Gambia.
   [Thomas, Julian E.] Royal Victoria Infirm, Great North Childrens Hosp, Dept Paediat Gastroenterol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Adegbola, Richard A.] MRC Unit, Bacterial Dis Programme, Fajara, Gambia.
RP Secka, O (reprint author), MRC Unit, Fajara, Gambia.
EM osecka@mrc.gm
FU MRC unit, The Gambia; US National Institutes of Health (NIH)
   [RO3-AI061308, R21-AI078237, R21-AI088337]
FX This study was funded by MRC unit, The Gambia and US National Institutes
   of Health (NIH) grants RO3-AI061308, R21-AI078237 and R21-AI088337. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x
   Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0
   Alm RA, 1999, J MOL MED-JMM, V77, P834, DOI 10.1007/s001099900067
   Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344
   Blaser MJ, 1998, BRIT MED J, V316, P1507
   Breurec S, 2011, PLOS ONE, V6
   Campbell DI, 2001, HELICOBACTER, V6, P263, DOI 10.1046/j.1083-4389.2001.00047.x
   Chong VH, 2008, SINGAP MED J, V49, P42
   Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073
   Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384
   Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857
   Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08
   Isaacson G, 2005, J PATHOL, V205, P255
   Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698
   Jemilohun Abiodun Christopher, 2010, Pan Afr Med J, V6, P18
   Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230
   Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x
   Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562
   Linz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087355
   McNulty SL, 2004, J CLIN MICROBIOL, V42, P5658, DOI 10.1128/JCM.42.12.5658-5663.2004
   Moodley Y., 2012, PLOS PATHOG, V8
   Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083
   Nell S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003775
   Passaro DJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e87
   Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804
   Raymond J, 2004, EMERG INFECT DIS, V10, P1816
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180
   Secka O, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-5
   Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619
   Thomas JE, 2004, ARCH DIS CHILD, V89, P1149, DOI 10.1136/adc.2002.015313
   Thomas JE, 1999, PEDIATR RES, V45, P218, DOI 10.1203/00006450-199902000-00010
   Vakil N, 2008, ALIMENT PHARM THER, V28, P1304, DOI 10.1111/j.1365-2036.2008.03846.x
   Weyermann M, 2009, AM J GASTROENTEROL, V104, P182, DOI 10.1038/ajg.2008.61
NR 34
TC 1
Z9 1
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2014
VL 9
IS 10
AR e109466
DI 10.1371/journal.pone.0109466
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ9WZ
UT WOS:000343210300052
PM 25310300
OA gold
DA 2017-08-15
ER

PT J
AU Njuguna, IN
   Ambler, G
   Reilly, M
   Ondondo, B
   Kanyugo, M
   Lohman-Payne, B
   Gichuhi, C
   Borthwick, N
   Black, A
   Mehedi, SR
   Sun, JY
   Maleche-Obimbo, E
   Chohan, B
   John-Stewart, GC
   Jaoko, W
   Hanke, T
AF Njuguna, Irene N.
   Ambler, Gwen
   Reilly, Marie
   Ondondo, Beatrice
   Kanyugo, Mercy
   Lohman-Payne, Barbara
   Gichuhi, Christine
   Borthwick, Nicola
   Black, Antony
   Mehedi, Shams-Rony
   Sun, Jiyu
   Maleche-Obimbo, Elizabeth
   Chohan, Bhavna
   John-Stewart, Grace C.
   Jaoko, Walter
   Hanke, Tomas
TI PedVacc 002: A phase I/II randomized clinical trial of MVAHIVA vaccine
   administered to infants born to human immunodeficiency virus type
   1-positive mothers in Nairobi
SO VACCINE
LA English
DT Article
DE Modified vaccinia virus Ankara (MVA); Infant vaccine trial in Africa;
   Exposed-uninfected infants; HIV-1; Pediatric HIV-1 vaccines; KEPI
   vaccines; EPI vaccines
ID AMNIOTIC-FLUID ACCUMULATION; MATERNAL-FETAL TRANSFER; TO-CHILD
   TRANSMISSION; HIV-1 VACCINE; HIV-1-INFECTED WOMEN; RECOMBINANT BCG;
   PREGNANT-WOMEN; CELL INDUCTION; NEWBORNS; IMMUNITY
AB Background: A safe, effective vaccine for breastfeeding infants born to HIV-1-positive mothers could complement antiretroviral therapy (ART) for prevention of mother-to-child transmission of HIV-1. To date, only a few HIV-1 vaccine candidates have been tested in infants.
   Trial design: A phase I/II randomized controlled trial PedVacc 002 was conducted to determine the safety and immunogenicity of a single, low dose of MVA.HIVA vaccine delivered intramuscularly to healthy 20-week-old infants born to HIV-1-positive mothers in Nairobi, Kenya.
   Methods: Pregnant HIV-1-positive women in the 2nd/3rd trimester of gestation were enrolled, provided with ART and self-selected their infant-feeding modality. Infants received nevirapine and cotrimoxazole prophylaxis. At 20 weeks of age, eligible HIV-1-negative infants were randomized to vaccine versus no-treatment arms and followed to 48 weeks of age for assessments of vaccine safety, HIV-1-specific T-cell responses and antibodies to routine childhood vaccines.
   Results: Between February and November 2010, 182 mothers were screened, 104 were eligible and followed on ART during pregnancy/postpartum, of whom 73 had eligible infants at 20 weeks postpartum. Thirty-six infants were randomized to vaccine and 37 to no treatment. Eighty-four percent of infants breastfed, and retention at 48 weeks was 99%. Adverse events were rare and similar between the two arms. HIV-1-specific T-cell frequencies in interferon-gamma ELISPOT assay were transiently higher in the MVA.HIVA arm (p = 0.002), but not above the threshold for a positive assay. Protective antibody levels were adequate and similar between arms for all routine childhood vaccines except HBV, where 71% of MVA.HIVA subjects compared to 92% of control subjects were protected (p = 0.05).
   Conclusions: This trial tested for the first time an MVA-vectored candidate HIV-1 vaccine in HIV-1-exposed infants in Africa, demonstrating trial feasibility and vaccine safety, low immunogenicity, and compatibility with routine childhood vaccinations. These results are reassuring for use of the MVA vector in more potent prime-boost regimens. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
C1 [Njuguna, Irene N.; Kanyugo, Mercy; Lohman-Payne, Barbara; Maleche-Obimbo, Elizabeth; Chohan, Bhavna] Univ Nairobi, Dept Pediat & Child Hlth, Nairobi 00202, Kenya.
   [Ambler, Gwen] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.
   [Reilly, Marie; Sun, Jiyu] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.
   [Ondondo, Beatrice; Borthwick, Nicola; Black, Antony; Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England.
   [Gichuhi, Christine] Univ Nairobi, Dept Clin Med & Therapeut, Nairobi 00202, Kenya.
   [Mehedi, Shams-Rony] MRC Unit, Stat & Data Management Dept, Fajara, Gambia.
   [John-Stewart, Grace C.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA.
   [John-Stewart, Grace C.] Univ Washington, Dept Med, Seattle, WA 98104 USA.
   [John-Stewart, Grace C.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA.
   [John-Stewart, Grace C.] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.
   [Jaoko, Walter] Univ Nairobi, KAVI Inst Clin Res, Nairobi 00202, Kenya.
   [Hanke, Tomas] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England.
RP Hanke, T (reprint author), Univ Oxford, Jenner Inst, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.
EM tomas.hanke@ndm.ox.ac.uk
FU European and Developing Countries Clinical Trials Partnership (EDCTP)
   [CT.2006.33111.002]; Bill and Melinda Gates Foundation; Medical Research
   Council UK; Swedish International Development Cooperation Agency (SIDA);
   NIAID of the National Institutes of Health [P30A1027757]; NCI of the
   National Institutes of Health [P30A1027757]; NIMH of the National
   Institutes of Health [P30A1027757]; NIDA of the National Institutes of
   Health [P30A1027757]; NICHD of the National Institutes of Health
   [P30A1027757]; NHLBI of the National Institutes of Health [P30A1027757];
   NIA of the National Institutes of Health [P30A1027757]
FX The work was supported by European and Developing Countries Clinical
   Trials Partnership (EDCTP; CT.2006.33111.002) with co-funding from Bill
   and Melinda Gates Foundation, Medical Research Council UK and Swedish
   International Development Cooperation Agency (SIDA). Research reported
   in this publication was also supported in part by NIAID, NCI, NIMH,
   NIDA, NICHD, NHLBI, NIA of the National Institutes of Health under award
   number P30A1027757.
CR Abramczuk BM, 2011, CLIN VACCINE IMMUNOL, V18, P1406, DOI 10.1128/CVI.05065-11
   Afolabi MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078289
   Bae Woong Hwan, 2008, AIDS, V22, P1633, DOI 10.1097/QAD.0b013e328307a029
   Bedri TA, 2008, LANCET, V372, P300
   Borkowsky W, 2000, J INFECT DIS, V181, P890, DOI 10.1086/315298
   Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248
   Chappuy H, 2004, ANTIMICROB AGENTS CH, V48, P4332, DOI 10.1128/AAC.48.11.4332-4336.2004
   Chappuy H, 2004, AM J OBSTET GYNECOL, V191, P558, DOI 10.1016/j.ajog.2004.01.034
   Clerici M, 2000, BLOOD, V96, P3866
   Cunningham CK, 2001, CLIN INFECT DIS, V32, P801, DOI 10.1086/319215
   Cunningham CK, 2008, CURR OPIN HIV AIDS, V3, P151, DOI 10.1097/COH.0b013e3282f50c0f
   Eggers M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-347
   Gomez CE, 2013, EXPERT REV VACCINES, V12, P1395, DOI 10.1586/14760584.2013.845531
   Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836
   Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567
   Feiterna-Sperling C, 2007, JAIDS-J ACQ IMM DEF, V45, P43, DOI 10.1097/QAI.0b013e318042d5e3
   Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626
   Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0
   Hanke T, 2014, EXPERT OPIN BIOL TH, V14, P601, DOI 10.1517/14712598.2014.885946
   Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962
   Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067
   Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07
   Johnson DC, 2005, J INFECT DIS, V192, P2129, DOI 10.1086/498163
   Jones SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072794
   Kidzeru EB, 2014, AIDS
   Kintu K, 2013, JAIDS-J ACQ IMM DEF, V63, P1, DOI 10.1097/QAI.0b013e31827f1c2d
   Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984
   Luzuriaga Katherine, 2002, AIDS Reviews, V4, P21
   McFarland EJ, 2001, J INFECT DIS, V184, P1331, DOI 10.1086/323994
   McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45
   McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264
   McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128
   Miyamoto M, 2010, J TROP PEDIATRICS, V56, P427, DOI 10.1093/tropej/fmq024
   Mo HM, 1998, AIDS RES HUM RETROV, V14, P607, DOI 10.1089/aid.1998.14.607
   Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398
   Njuguna I., 2014, Retrovirology: Research and Treatment, V6, P1
   Ota MOC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002461
   Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645
   Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003
   Rosario M, 2010, J VIROL, V84, P7815, DOI 10.1128/JVI.00726-10
   Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09
   Saubi N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.17
   Saubi N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/516219
   Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195
   Shapiro RL, 2005, J INFECT DIS, V192, P720, DOI 10.1086/432483
   Sheehy SH, 2013, MOL THER, V20, P2355
   Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4
   Thaithumyanon Pimolrat, 2002, Journal of the Medical Association of Thailand, V85, P277
   van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018
NR 49
TC 4
Z9 5
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD OCT 7
PY 2014
VL 32
IS 44
BP 5801
EP 5808
DI 10.1016/j.vaccine.2014.08.034
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA AR5QI
UT WOS:000343638300006
PM 25173484
OA No
DA 2017-08-15
ER

PT J
AU Goodier, MR
   White, MJ
   Darboe, A
   Nielsen, CM
   Goncalves, A
   Bottomley, C
   Moore, SE
   Riley, EM
AF Goodier, Martin R.
   White, Matthew J.
   Darboe, Alansana
   Nielsen, Carolyn M.
   Goncalves, Adriana
   Bottomley, Christian
   Moore, Sophie E.
   Riley, Eleanor M.
TI Rapid NK cell differentiation in a population with near-universal human
   cytomegalovirus infection is attenuated by NKG2C deletions
SO BLOOD
LA English
DT Article
ID NATURAL-KILLER-CELLS; MHC CLASS-I; CORD BLOOD TRANSPLANTATION;
   EPSTEIN-BARR-VIRUS; T-CELL; HLA-E; RECEPTOR REPERTOIRE; GENE DELETION;
   CUTTING EDGE; SUBSET
AB Natural killer (NK) cells differentiate and mature during the human life course; human cytomegalovirus (HCMV) infection is a known driver of this process. We have explored human NK cell phenotypic and functional maturation in a rural African (Gambian) population with a high prevalence of HCMV. The effect of age on the frequency, absolute number, phenotype, and functional capacity of NK cells was monitored in 191 individuals aged from 1 to 49 years. Increasing frequencies of NK cells with age were associated with increased proportions of CD56(dim) cells expressing the differentiation marker CD57 and expansion of the NKG2C(+) subset. Frequencies of NK cells responding to exogenous cytokines declined with age in line with a decreased proportion of CD57(-) cells. These changes coincided with a highly significant drop in anti-HCMV IgG titers by the age of 10 years, suggesting that HCMV infection is brought under control as NK cells differentiate (or vice versa). Deletion at the NKG2Clocus was associated with a gene dose-dependent reduction in proportions of CD94(+) and CD57(+) NK cells. Importantly, anti-HCMV IgG titers were significantly elevated in NKG2C(-/-) children, suggesting that lack of expression of NKG2C may be associated with altered control of HCMV in childhood.
C1 [Goodier, Martin R.; White, Matthew J.; Darboe, Alansana; Nielsen, Carolyn M.; Riley, Eleanor M.] Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1E 7HT, England.
   [Darboe, Alansana; Moore, Sophie E.] MRC Unit, Med Res Council Keneba, Med Res Council Int Nutr Grp, Serrekunda, Gambia.
   [Goncalves, Adriana] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England.
   [Bottomley, Christian] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
   [Moore, Sophie E.] Med Res Council Human Nutr Res, Cambridge, England.
RP Riley, EM (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM eleanor.riley@lshtm.ac.uk
RI Riley, Eleanor/C-8960-2013
OI Riley, Eleanor/0000-0003-3447-3570
FU UK Medical Research Council [G1000808]
FX We would like to thank Professors Andy Hall and Andrew Prentice for
   facilitating the initiation of this project; Kerry Jones for logistical
   and technical support; Medical Research Council fieldworkers Sulayman
   Bah, Wally Kamara, and Lamin Jatta for recruiting subjects; Bai Lamin
   Dondeh for database management; the staff of the Medical Research
   Council International Nutrition Group and Medical Research Council
   Gambia (Keneba) for their support; and the villagers of Keneba, Manduar,
   and Kantong Kunda for participating in the study. We also thank
   Professor Beate Kampmann and colleagues (Medical Research Council
   Gambia, Fajara) for advice and access to laboratory facilities. This
   study was funded by the UK Medical Research Council (G1000808).
CR Almeida-Oliveira A, 2011, HUM IMMUNOL, V72, P319, DOI 10.1016/j.humimm.2011.01.009
   Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190
   Bengner M, 2014, AGE, V36, P571, DOI 10.1007/s11357-013-9587-y
   Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545
   Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826
   Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762
   Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675
   Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681
   Campos C, 2014, EXP GERONTOL, V54, P130, DOI 10.1016/j.exger.2014.01.008
   Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9
   Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002
   Della Chiesa M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00458
   Della Chiesa M, 2014, J IMMUNOL, V192, P1471, DOI 10.4049/jimmunol.1302053
   Della Chiesa M, 2013, IMMUNOL LETT, V155, P11, DOI 10.1016/j.imlet.2013.09.020
   Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003
   Fiegler N, 2013, BLOOD, V122, P684, DOI 10.1182/blood-2013-02-482513
   Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964
   Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995
   Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837
   Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682
   Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058
   Hayhoe RPG, 2010, HUM IMMUNOL, V71, P676, DOI 10.1016/j.humimm.2010.03.014
   Hazeldine J, 2013, AGEING RES REV, V12, P1069, DOI 10.1016/j.arr.2013.04.003
   Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211
   Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702
   Horowitz A, 2010, J IMMUNOL, V185, P2808, DOI 10.4049/jimmunol.1000844
   Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286
   Koch S, 2008, IMMUN AGEING, V5, DOI 10.1186/1742-4933-5-6
   Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526
   Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x
   Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108
   Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301
   Luetke-Eversloh M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00499
   Lutz CT, 2011, J IMMUNOL, V186, P4590, DOI 10.4049/jimmunol.1002732
   Lutz CT, 2005, MECH AGEING DEV, V126, P722, DOI 10.1016/j.mad.2005.01.004
   Mela CM, 2007, J INFECT DIS, V195, P158, DOI 10.1086/509811
   Mela CM, 2007, J INFECT DIS, V195, P159, DOI 10.1086/509811
   Miyashita R, 2004, INT IMMUNOL, V16, P163, DOI 10.1093/intimm/dxh013
   Monsivais-Urenda A, 2010, EUR J IMMUNOL, V40, P1418, DOI 10.1002/eji.200939898
   Muntasell A, 2013, EUR J IMMUNOL, V43, P3268, DOI 10.1002/eji.201343773
   Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422
   Nogusa S, 2012, J GERONTOL A-BIOL, V67, P947, DOI 10.1093/gerona/gls079
   Noyola DE, 2012, EUR J IMMUNOL, V42, P3256, DOI 10.1002/eji.201242752
   Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370
   Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268
   Prod'homme V, 2007, J IMMUNOL, V178, P4473
   Prod'homme V, 2012, J IMMUNOL, V188, P2794, DOI 10.4049/jimmunol.1102068
   Rangel-Ramirez VV, 2014, INT J IMMUNOGENET, V41, P126, DOI 10.1111/iji.12104
   Saghafian-Hedengren S, 2013, J VIROL, V87, P13446, DOI 10.1128/JVI.02382-13
   Saghafian-Hedengren S, 2009, J IMMUNOL, V182, P2511, DOI 10.4049/jimmunol.0801699
   Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x
   Tanaka J, 2009, HUM IMMUNOL, V70, P701, DOI 10.1016/j.humimm.2009.06.002
   Ulbrecht M, 2000, J IMMUNOL, V164, P5019
   White MJ, 2014, IMMUNOLOGY, V142, P140, DOI 10.1111/imm.12239
   Wu ZG, 2013, J VIROL, V87, P7717, DOI 10.1128/JVI.01096-13
   Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005
   Zeng X, 2013, EXP DERMATOL, V22, P679, DOI 10.1111/exd.12233
NR 57
TC 30
Z9 31
U1 0
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD OCT 2
PY 2014
VL 124
IS 14
BP 2213
EP 2222
DI 10.1182/blood-2014-05-576124
PG 10
WC Hematology
SC Hematology
GA AQ4KC
UT WOS:000342763900014
PM 25150297
OA No
DA 2017-08-15
ER

PT J
AU White, MT
   Griffin, JT
   Akpogheneta, O
   Conway, DJ
   Koram, KA
   Riley, EM
   Ghani, AC
AF White, Michael T.
   Griffin, Jamie T.
   Akpogheneta, Onome
   Conway, David J.
   Koram, Kwadwo A.
   Riley, Eleanor M.
   Ghani, Azra C.
TI Dynamics of the Antibody Response to Plasmodium falciparum Infection in
   African Children
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE malaria; antibody; immunity; model; Plasmodium falciparum
ID RTS,S/AS01 MALARIA VACCINE; MEMORY B-CELLS; PHASE-3 TRIAL; EXPOSURE;
   IMMUNITY; INFANTS; ANTIGENS; TRANSMISSION; DURATION; AGE
AB Background. Acquired immune responses to malaria have widely been perceived to be short-lived, with previously immune individuals losing immunity when they move from malaria-endemic areas. However long-lived Plasmodium falciparum-specific antibody responses lasting for an individual's lifetime are frequently observed.
   Methods. We fit mathematical models of the dynamics of antibody titers to P. falciparum antigens from longitudinal cohort studies of African children to estimate the half-lives of circulating immunoglobulin G (IgG) antibodies and IgG antibody-secreting cells (ASCs).
   Results. Comparison of antibody responses in the younger Ghanaian cohort and the older Gambian cohort suggests that young children are less able to generate the long-lived ASCs necessary to maintain the circulating antibodies that may provide protection against reinfection. Antibody responses in African children can be described by a model 15 including both short-lived ASCs (half-life range, 2-10 days), which are responsible for boosting antibody titers following infection, and long-lived ASCs (half-life range, 3-9 years), which are responsible for maintaining sustained humoral responses.
   Conclusions. The rapid decay of antibodies following exposure to malaria and the maintenance of sustained antibody responses can be explained in terms of populations of short-lived and long-lived ASCs.
C1 [White, Michael T.; Griffin, Jamie T.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
   [Akpogheneta, Onome; Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England.
   [Riley, Eleanor M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England.
   [Akpogheneta, Onome; Conway, David J.] MRC Labs, Fajara, Gambia.
   [Koram, Kwadwo A.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana.
RP White, MT (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.
EM m.white08@imperial.ac.uk
RI Ghani, Azra/B-8560-2009; Riley, Eleanor/C-8960-2013
OI Riley, Eleanor/0000-0003-3447-3570; Conway, David/0000-0002-8711-3037
FU Bill and Melinda Gates Foundation; United Kingdom Medical Research
   Council; Wellcome Trust [040328]; UK Medical Research Council
FX This work was supported by the Bill and Melinda Gates Foundation (grant
   to M. T. W. and support to A. C. G.), the United Kingdom Medical
   Research Council (fellowship to J. T. G. and support to A. C. G.), and
   the Wellcome Trust (grant 040328 for sample and data collection in
   Ghana). Sample and data collection in The Gambia was funded by the UK
   Medical Research Council.
CR Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71
   Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287
   Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x
   Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07
   Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071
   Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023
   DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z
   Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Franks S, 2001, J INFECT DIS, V183, P796, DOI 10.1086/318834
   Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560
   Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82
   Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Migot F, 1995, CLIN EXP IMMUNOL, V102, P529
   Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055756
   Nduati EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015007
   Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109
   Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690
   Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564
   Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000
   Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x
   Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5
   Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0
   Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x
   Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905
   Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x
   Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006
   WALDMANN TA, 1969, NEW ENGL J MED, V281, P1170
   Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912
   Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770
NR 31
TC 25
Z9 25
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD OCT 1
PY 2014
VL 210
IS 7
BP 1115
EP 1122
DI 10.1093/infdis/jiu219
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AT0ED
UT WOS:000344609100016
PM 24719471
OA No
DA 2017-08-15
ER

PT J
AU Livio, S
   Strockbine, NA
   Panchalingam, S
   Tennant, SM
   Barry, EM
   Marohn, ME
   Antonio, M
   Hossain, A
   Mandomando, I
   Ochieng, JB
   Oundo, JO
   Qureshi, S
   Ramamurthy, T
   Tamboura, B
   Adegbola, RA
   Hossain, MJ
   Saha, D
   Sen, S
   Faruque, AS
   Alonso, PL
   Breiman, RF
   Zaidi, AKM
   Sur, D
   Sow, SO
   Berkeley, LY
   O'Reilly, CE
   Mintz, ED
   Biswas, K
   Cohen, D
   Farag, TH
   Nasrin, D
   Wu, YK
   Blackwelder, WC
   Kotloff, KL
   Nataro, JP
   Levine, MM
AF Livio, Sofie
   Strockbine, Nancy A.
   Panchalingam, Sandra
   Tennant, Sharon M.
   Barry, Eileen M.
   Marohn, Mark E.
   Antonio, Martin
   Hossain, Anowar
   Mandomando, Inacio
   Ochieng, John B.
   Oundo, Joseph O.
   Qureshi, Shahida
   Ramamurthy, Thandavarayan
   Tamboura, Boubou
   Adegbola, Richard A.
   Hossain, Mohammed Jahangir
   Saha, Debasish
   Sen, Sunil
   Faruque, Abu Syed Golam
   Alonso, Pedro L.
   Breiman, Robert F.
   Zaidi, Anita K. M.
   Sur, Dipika
   Sow, Samba O.
   Berkeley, Lynette Y.
   O'Reilly, Ciara E.
   Mintz, Eric D.
   Biswas, Kousick
   Cohen, Dani
   Farag, Tamer H.
   Nasrin, Dilruba
   Wu, Yukun
   Blackwelder, William C.
   Kotloff, Karen L.
   Nataro, James P.
   Levine, Myron M.
TI Shigella Isolates From the Global Enteric Multicenter Study Inform
   Vaccine Development
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE serotyping; Shigella; shigellosis; vaccines
ID SHIGA BACILLUS DYSENTERY; FLEXNERI 2A; DIARRHEAL DISEASE; ORAL
   IMMUNIZATION; DEVELOPING-COUNTRIES; ENTEROTOXIN GENES; SERUM ANTIBODIES;
   YOUNG-CHILDREN; O-ANTIGEN; IN-VITRO
AB Background. Shigella, a major diarrheal disease pathogen worldwide, is the target of vaccine development. The Global Enteric Multicenter Study (GEMS) investigated burden and etiology of moderate-to-severe diarrheal disease in children aged <60 months and matched controls without diarrhea during 3 years at 4 sites in Africa and 3 in Asia. Shigella was 1 of the 4 most common pathogens across sites and age strata. GEMS Shigella serotypes are reviewed to guide vaccine development.
   Methods. Subjects' stool specimens/rectal swabs were transported to site laboratories in transport media and plated onto xylose lysine desoxycholate and MacConkey agar. Suspect Shigella colonies were identified by biochemical tests and agglutination with antisera. Shigella isolates were shipped to the GEMS Reference Laboratory (Baltimore, MD) for confirmation and serotyping of S. flexneri; one-third of isolates were sent to the Centers for Disease Control and Prevention for quality control.
   Results. Shigella dysenteriae and S. boydii accounted for 5.0% and 5.4%, respectively, of 1130 Shigella case isolates; S. flexneri comprised 65.9% and S. sonnei 23.7%. Five serotypes/subserotypes comprised 89.4% of S. flexneri, including S. flexneri 2a, S. flexneri 6, S. flexneri 3a, S. flexneri 2b, and S. flexneri 1b.
   Conclusions. A broad-spectrum Shigella vaccine must protect against S. sonnei and 15 S. flexneri serotypes/subserotypes. A quadrivalent vaccine with O antigens from S. sonnei, S. flexneri 2a, S. flexneri 3a, and S. flexneri 6 can provide broad direct coverage against these most common serotypes and indirect coverage against all but 1 (rare) remaining subserotype through shared S. flexneri group antigens.
C1 [Livio, Sofie; Panchalingam, Sandra; Tennant, Sharon M.; Barry, Eileen M.; Marohn, Mark E.; Sen, Sunil; Berkeley, Lynette Y.; Farag, Tamer H.; Nasrin, Dilruba; Wu, Yukun; Blackwelder, William C.; Kotloff, Karen L.; Nataro, James P.; Levine, Myron M.] Univ Maryland Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Strockbine, Nancy A.] Ctr Dis Control & Prevent, Escherichia & Shigella Reference Unit, Enter Dis Lab Branch, Atlanta, GA USA.
   [Strockbine, Nancy A.; O'Reilly, Ciara E.; Mintz, Eric D.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA.
   [Antonio, Martin; Adegbola, Richard A.; Hossain, Mohammed Jahangir; Saha, Debasish] Med Res Council Unit United Kingdom, Fajara, Gambia.
   [Hossain, Anowar; Faruque, Abu Syed Golam] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh.
   [Mandomando, Inacio; Alonso, Pedro L.] Ctr Invest Saude Manhica, Manhica, Mozambique.
   [Mandomando, Inacio; Breiman, Robert F.] Univ Barcelona, Hosp Clinic, Ctr Recerca Salut Int Barcelona, E-08007 Barcelona, Spain.
   [Ochieng, John B.; Oundo, Joseph O.; Breiman, Robert F.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Kisumu, Kenya.
   [Qureshi, Shahida; Zaidi, Anita K. M.] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.
   [Ramamurthy, Thandavarayan; Sur, Dipika] Natl Inst Cholera & Enter Dis, Kolkata, India.
   [Tamboura, Boubou; Sow, Samba O.] Ctr Dev Vaccins Mali, Bamako, Mali.
   [Breiman, Robert F.] US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Nairobi, Kenya.
   [Sur, Dipika] PATH, New Delhi, India.
   [Berkeley, Lynette Y.] US FDA, Rockville, MD 20857 USA.
   [Biswas, Kousick] US Dept Vet Affairs, Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA.
   [Cohen, Dani] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Ramat Aviv, Israel.
RP Levine, MM (reprint author), Univ Maryland Sch Med, Ctr Vaccine Dev, 685 West Baltimore St, Baltimore, MD 21201 USA.
EM mlevine@medicine.umaryland.edu
FU Bill & Melinda Gates Foundation [38774]
FX This work was supported by grant 38774 from the Bill & Melinda Gates
   Foundation to M. M. L.
CR Al-Hasani K, 2001, MICROB PATHOGENESIS, V30, P1, DOI 10.1006/mpat.2000.0404
   Barry EM, 2013, NAT REV GASTRO HEPAT, V10, P245, DOI 10.1038/nrgastro.2013.12
   Birmingham ME, 1997, B WORLD HEALTH ORGAN, V75, P45
   COHEN D, 1988, J INFECT DIS, V157, P1068
   COHEN D, 1991, J CLIN MICROBIOL, V29, P386
   Cohen D, 1997, LANCET, V349, P155, DOI 10.1016/S0140-6736(96)06255-1
   Coster TS, 1999, INFECT IMMUN, V67, P3437
   DUPONT HL, 1972, J INFECT DIS, V125, P12
   EBRIGHT JR, 1984, AM J TROP MED HYG, V33, P1192
   Farag TH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002280
   Farag TH, 2012, CLIN INFECT DIS, V55, pS225, DOI 10.1093/cid/cis787
   FASANO A, 1995, J CLIN INVEST, V95, P2853, DOI 10.1172/JCI117991
   Fasano A, 1997, GUT, V40, P505
   FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614
   FORMAL SB, 1991, J INFECT DIS, V164, P533
   Foster RA, 2011, CARBOHYD RES, V346, P872, DOI 10.1016/j.carres.2011.02.013
   GANGAROSA EJ, 1970, J INFECT DIS, V122, P181
   HERRINGTON DA, 1990, VACCINE, V8, P353, DOI 10.1016/0264-410X(90)90094-3
   HYAMS KC, 1991, NEW ENGL J MED, V325, P1423, DOI 10.1056/NEJM199111143252006
   Hyma KE, 2005, J BACTERIOL, V187, P619, DOI 10.1128/JB.187.2.619-628.2005
   Kotloff KL, 2007, HUM VACCINES, V3, P268
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7
   Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680
   Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662
   Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039
   Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761
   Lindsay B, 2013, J CLIN MICROBIOL, V51, P1740, DOI 10.1128/JCM.02713-12
   Martin S, 2012, B WORLD HEALTH ORGAN, V90, P714, DOI 10.2471/BLT.12.112433
   Martinez-Becerra FJ, 2012, INFECT IMMUN, V80, P1222, DOI 10.1128/IAI.06174-11
   MEL D, 1971, B WORLD HEALTH ORGAN, V45, P457
   MEL DM, 1965, B WORLD HEALTH ORGAN, V32, P647
   MEL DM, 1974, ACTA MICROBIOL HUNG, V21, P109
   MEL DM, 1968, B WORLD HEALTH ORGAN, V39, P375
   MORRIS GK, 1970, APPL MICROBIOL, V19, P434
   Noriega FR, 1999, INFECT IMMUN, V67, P782
   NORIEGA FR, 1995, J INFECT DIS, V172, P1408
   Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754
   Passwell JH, 2010, VACCINE, V28, P2231, DOI 10.1016/j.vaccine.2009.12.050
   RAHAMAN M M, 1975, Journal of Infectious Diseases, V132, P15
   Roy S, 2006, TROP MED INT HEALTH, V11, P1694, DOI 10.1111/j.1365-3156.2006.01723.x
   Samandari T, 2000, J IMMUNOL, V164, P2221
   Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501
   VandeVerg LL, 1996, VACCINE, V14, P1062, DOI 10.1016/0264-410X(96)00006-0
   von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353
NR 46
TC 54
Z9 55
U1 1
U2 17
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 1
PY 2014
VL 59
IS 7
BP 933
EP 941
DI 10.1093/cid/ciu468
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AR2JY
UT WOS:000343411900005
PM 24958238
OA No
DA 2017-08-15
ER

PT J
AU Lin, CY
   Chen, TC
   Lu, PL
   Chen, HJ
   Bojang, KS
   Chen, YH
AF Lin, Chun-Yu
   Chen, Tun-Chieh
   Lu, Po-Liang
   Chen, Hui-Juan
   Bojang, Kebba S.
   Chen, Yen-Hsu
TI Lower initial central venous pressure in septic patients from long-term
   care facilities than in those from the community
SO JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
LA English
DT Article
DE Central venous pressure; Long-term care; Resuscitation; Sepsis
ID SURVIVING SEPSIS CAMPAIGN; GUIDELINES; MANAGEMENT; SHOCK; RESIDENTS;
   THERAPY; UNITS
AB Background/purpose: The cornerstone of emergency management of severe sepsis and septic shock is early (within 6 hours) goal-directed therapy, including maintenance of central venous pressure (CVP) at 8-12 mmHg. It is unclear whether there is a difference in initial (baseline) CVP between septic patients who are referred from the community and those who come from long-term care facilities (LTCFs) in Taiwan. We designed this study to investigate the difference in hemodynamic parameters between these two groups.
   Materials and methods: Every patient with severe sepsis or septic shock who had a central venous catheter inserted via the internal jugular or subclavian vein at Kaohsiung Medical University Hospital between April 2007 and October 2007 was enrolled. CVP was measured immediately at the emergency department. Patient demographics, including residence, were retrospectively recorded and analyzed.
   Results: There were 166 evaluable patients; 125 (75.3%) came from the community and 41 (24.7%) from LTCFs. There were no significant differences in age, sex, initial body temperature, heart rate, blood pressure, or leukocyte count between the two groups. However, patients who were referred from LTCFs had a significantly lower initial CVP than those from the community (5.0 +/- 4.5 mmHg vs. 7.0 +/- 4.8 mmHg, p = 0.023). The difference was more significant between mechanically ventilated patients from LTCFs and those from the community (5.0 +/- 3.0 mmHg vs. 8.1 +/- 5.6 mmHg, p = 0.006).
   Conclusion: Severely septic patients referred from LTCFs may require more aggressive fluid resuscitation within the first 6 hours of the diagnostic criteria met at the emergency department to achieve the CVP target of early goal-directed therapy. Copyright (C) 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Lin, Chun-Yu; Chen, Tun-Chieh; Lu, Po-Liang; Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.
   [Lin, Chun-Yu; Chen, Tun-Chieh; Lu, Po-Liang; Bojang, Kebba S.; Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.
   [Chen, Hui-Juan] Kaohsiung Med Univ Hosp, Dept Emergency Med, Kaohsiung 807, Taiwan.
   [Bojang, Kebba S.] Royal Victoria Teaching Hosp, Dept Emergency Med, Banjul, Gambia.
RP Chen, YH (reprint author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, 100 Tz You 1st Rd, Kaohsiung 807, Taiwan.
EM infchen@gmail.com
RI Chen, Tun-Chieh/J-2877-2013
OI Chen, Tun-Chieh/0000-0002-9258-0692
FU Kaohsiung Medical University Hospital [KMUH99-9M39]
FX This study was supported in part by a grant from the Kaohsiung Medical
   University Hospital Grant (KMUH99-9M39).
CR Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207
   BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644
   Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15
   BROOKS S, 1994, ARCH INTERN MED, V154, P902, DOI 10.1001/archinte.154.8.902
   Carpenter CR, 2009, J EMERG MED, V37, P319, DOI 10.1016/j.jemermed.2009.03.016
   Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2
   Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4
   High KP, 2009, CLIN INFECT DIS, V48, P149, DOI 10.1086/595683
   High KP, 2005, CLIN INFECT DIS, V40, P114, DOI 10.1086/426082
   Huang CC, 2008, INT J GERONTOL, V2, P133, DOI 10.1016/S1873-9598(08)70052-8
   Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331
   Mehr DR, 2001, J FAM PRACTICE, V50, P931
   Pope JV, 2010, ANN EMERG MED, V55, P40, DOI 10.1016/j.annemergmed.2009.08.014
   Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307
   Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632
   Vincent JL, 1998, CRIT CARE MED, V26, P1793
   Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A
   Ytrebo LM, 2011, CRIT CARE MED, V39, P396, DOI 10.1097/CCM.0b013e318205c375
NR 18
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1684-1182
EI 1995-9133
J9 J MICROBIOL IMMUNOL
JI J. Microbiol. Immunol. Infect.
PD OCT
PY 2014
VL 47
IS 5
BP 422
EP 428
DI 10.1016/j.jmii.2013.04.006
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AR7YE
UT WOS:000343792000011
PM 23751764
OA No
DA 2017-08-15
ER

PT J
AU Ladep, NG
   Dona, AC
   Lewis, MR
   Crossey, MME
   Lemoine, M
   Okeke, E
   Shimakawa, Y
   Duguru, M
   Njai, HF
   Fye, HKS
   Taal, M
   Chetwood, J
   Kasstan, B
   Khan, SA
   Garside, DA
   Wijeyesekera, A
   Thillainayagam, AV
   Banwat, E
   Thursz, MR
   Nicholson, JK
   Njie, R
   Holmes, E
   Taylor-Robinson, SD
AF Ladep, Nimzing G.
   Dona, Anthony C.
   Lewis, Matthew R.
   Crossey, Mary M. E.
   Lemoine, Maud
   Okeke, Edith
   Shimakawa, Yusuke
   Duguru, Mary
   Njai, Harr F.
   Fye, Haddy K. S.
   Taal, Makie
   Chetwood, John
   Kasstan, Ben
   Khan, Shahid A.
   Garside, Deborah A.
   Wijeyesekera, Anisha
   Thillainayagam, Andrew V.
   Banwat, Edmund
   Thursz, Mark R.
   Nicholson, Jeremy K.
   Njie, Ramou
   Holmes, Elaine
   Taylor-Robinson, Simon D.
TI Discovery and Validation of Urinary Metabotypes for the Diagnosis of
   Hepatocellular Carcinoma in West Africans
SO HEPATOLOGY
LA English
DT Article
ID MASS-SPECTROMETRY; CHROMATOGRAPHY/MASS SPECTROMETRY; NMR-SPECTROSCOPY;
   CANCER; LIVER; IDENTIFICATION; EPIDEMIOLOGY; BIOMARKERS; PROTEIN; PLASMA
AB There is no clinically applicable biomarker for surveillance of hepatocellular carcinoma (HCC), because the sensitivity of serum alpha-fetoprotein (AFP) is too low for this purpose. Here, we determined the diagnostic performance of a panel of urinary metabolites of HCC patients from West Africa. Urine samples were collected from Nigerian and Gambian patients recruited on the case-control platform of the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) program. Urinary proton nuclear magnetic resonance (H-1-NMR) spectroscopy was used to metabolically phenotype 290 subjects: 63 with HCC; 32 with cirrhosis (Cir); 107 with noncirrhotic liver disease (DC); and 88 normal control (NC) healthy volunteers. Urine samples from a further cohort of 463 subjects (141 HCC, 56 Cir, 178 DC, and 88 NC) were analyzed, the results of which validated the initial cohort. The urinary metabotype of patients with HCC was distinct from those with Cir, DC, and NC with areas under the receiver operating characteristic (AUROC) curves of 0.86 (0.78-0.94), 0.93 (0.89-0.97), and 0.89 (0.80-0.98) in the training set and 0.81 (0.73-0.89), 0.96 (0.94-0.99), and 0.90 (0.85-0.96), respectively, in the validation cohort. A urinary metabolite panel, comprising inosine, indole-3-acetate, galactose, and an N-acetylated amino acid (NAA), showed a high sensitivity (86.9% [75.8-94.2]) and specificity (90.3% [74.2-98.0]) in the discrimination of HCC from cirrhosis, a finding that was corroborated in a validation cohort (AUROC: urinary panel=0.72; AFP=0.58). Metabolites that were significantly increased in urine of HCC patients, and which correlated with clinical stage of HCC, were NAA, dimethylglycine, 1-methylnicotinamide, methionine, acetylcarnitine, 2-oxoglutarate, choline, and creatine. Conclusion: The urinary metabotyping of this West African cohort identified and validated a metabolite panel that diagnostically outperforms serum AFP. (Hepatology 2014;60:1291-1301)
C1 [Ladep, Nimzing G.; Crossey, Mary M. E.; Lemoine, Maud; Chetwood, John; Kasstan, Ben; Khan, Shahid A.; Garside, Deborah A.; Thillainayagam, Andrew V.; Thursz, Mark R.; Taylor-Robinson, Simon D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1NY, England.
   [Dona, Anthony C.; Lewis, Matthew R.; Crossey, Mary M. E.; Wijeyesekera, Anisha; Nicholson, Jeremy K.; Holmes, Elaine] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Computat & Syst Med, London W2 1NY, England.
   [Lemoine, Maud; Shimakawa, Yusuke; Njai, Harr F.; Fye, Haddy K. S.; Njie, Ramou] MRC, Gambia Unit, Fajara, Gambia.
   [Okeke, Edith; Duguru, Mary; Banwat, Edmund] Jos Univ Teaching Hosp, Dept Med, Jos, Plateau State, Nigeria.
   [Taal, Makie] Royal Victoria Teaching Hosp, Banjul, Gambia.
RP Ladep, NG (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Med, St Marys Campus,South Wharf Rd, London W2 1NY, England.
EM n.ladep@imperial.ac.uk
RI Dona, Anthony/E-5968-2016
OI Dona, Anthony/0000-0001-6403-6721; Nicholson,
   Jeremy/0000-0002-8123-8349; Wijeyesekera, Anisha/0000-0001-6151-5065
FU European Union; Trustees of the London Clinic, London, UK; British
   Medical Research Council ICIC scheme; Halley Stewart Foundation,
   Cambridge, United Kingdom
FX This study was funded by the European Union Framework 7 programme
   (PROLIFICA: Prevention of Fibrosis and Liver Cancer in Africa). N.G.L.
   was supported by a fellowship from the Trustees of the London Clinic,
   London, UK and by the British Medical Research Council ICIC scheme. M.
   M. E. C. was supported by a fellowship (Halley Stewart Foundation,
   Cambridge, United Kingdom).
CR Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376
   Bell JD, 1998, NMR BIOMED, V11, P354, DOI 10.1002/(SICI)1099-1492(1998110)11:7<354::AID-NBM515>3.0.CO;2-N
   Bollard ME, 2005, TOXICOL APPL PHARM, V204, P135, DOI 10.1016/j.taap.2004.06.031
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Cao HC, 2011, ANAL CHIM ACTA, V691, P68, DOI 10.1016/j.aca.2011.02.038
   Chen F, 2011, ANAL BIOANAL CHEM, V401, P1899, DOI 10.1007/s00216-011-5245-3
   Chen T, 2011, MOL CELL PROTEOMICS, V10, pM110, DOI [DOI 10.1074/mcp.A110.004945, DOI 10.1074/MCP.A110.004945]
   Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x
   Costello LC, 2012, CANCER METAST REV, V31, P123, DOI 10.1007/s10555-011-9334-8
   Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023
   Dong XY, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-45
   El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
   Ferenci P, 2010, J GASTROINTEST LIVER, V19, P311
   Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162
   Heinzmann SS, 2012, J PROTEOME RES, V11, P643, DOI 10.1021/pr2005764
   Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0
   Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122
   Macuks R, 2012, ASIAN PAC J CANCER P, V13, P4695, DOI 10.7314/APJCP.2012.13.9.4695
   Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P3964, DOI 10.4161/cc.22137
   Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708
   NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004
   Pahor M, 2009, J NUTR HEALTH AGING, V13, P724, DOI 10.1007/s12603-009-0204-9
   Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74
   Polanski Malu, 2007, Biomark Insights, V1, P1
   Shariff MIF, 2011, J PROTEOME RES, V10, P1828, DOI 10.1021/pr101096f
   Shariff MIF, 2010, J PROTEOME RES, V9, P1096, DOI 10.1021/pr901058t
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Wu H, 2009, ANAL CHIM ACTA, V648, P98, DOI 10.1016/j.aca.2009.06.033
   Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h
   Ye GZ, 2012, J PROTEOME RES, V11, P4361, DOI 10.1021/pr300502v
   Yin PY, 2009, MOL BIOSYST, V5, P868, DOI 10.1039/b820224a
   Zhang AH, 2013, CLIN CHIM ACTA, V418, P86, DOI 10.1016/j.cca.2012.12.024
   Zhou LN, 2012, ANAL BIOANAL CHEM, V403, P203, DOI 10.1007/s00216-012-5782-4
   [Anonymous], 2012, J HEPATOL, V56, P908
NR 37
TC 17
Z9 17
U1 4
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2014
VL 60
IS 4
BP 1291
EP 1301
DI 10.1002/hep.27264
PG 11
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA AQ3AW
UT WOS:000342662100021
PM 24923488
OA No
DA 2017-08-15
ER

PT J
AU Ma, DZ
   Jasinska, AJ
   Wijewardana, V
   Schmitt, C
   Turner, T
   Antonio, M
   Pandrea, I
   Freimer, N
   Apetrei, C
AF Ma, Dongzhu
   Jasinska, Anna J.
   Wijewardana, Viskam
   Schmitt, Christopher
   Turner, Trudy
   Antonio, Martin
   Pandrea, Ivona
   Freimer, Nelson
   Apetrei, Cristian
TI FACTORS ASSOCIATED WITH SIV TRANSMISSION IN THE WILD IN A NATURAL HOST
   OF SIV
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Ma, Dongzhu; Jasinska, Anna J.; Wijewardana, Viskam; Schmitt, Christopher; Turner, Trudy; Antonio, Martin; Pandrea, Ivona; Freimer, Nelson; Apetrei, Cristian] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Ma, Dongzhu; Jasinska, Anna J.; Wijewardana, Viskam; Schmitt, Christopher; Turner, Trudy; Antonio, Martin; Pandrea, Ivona; Freimer, Nelson; Apetrei, Cristian] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.
   [Ma, Dongzhu; Jasinska, Anna J.; Wijewardana, Viskam; Schmitt, Christopher; Turner, Trudy; Antonio, Martin; Pandrea, Ivona; Freimer, Nelson; Apetrei, Cristian] Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA.
   [Ma, Dongzhu; Jasinska, Anna J.; Wijewardana, Viskam; Schmitt, Christopher; Turner, Trudy; Antonio, Martin; Pandrea, Ivona; Freimer, Nelson; Apetrei, Cristian] MRC Unit, Banjul, Gambia.
RI Schmitt, Christopher/F-7251-2013
OI Schmitt, Christopher/0000-0003-2143-9226
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2014
VL 43
IS 5
MA 15
BP 385
EP 385
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA AQ3EZ
UT WOS:000342673700028
OA No
DA 2017-08-15
ER

PT J
AU Jasinska, AJ
   Ma, DZ
   Tran, N
   Huang, Y
   Schmitt, C
   Choi, OW
   DeYoung, J
   Jung, Y
   Coppola, G
   Turner, T
   Grobler, P
   Antonio, M
   Dione, M
   Wasserscheid, J
   Dewar, K
   Warren, W
   Pandrea, I
   Apetrei, C
   Freimer, NB
AF Jasinska, Anna J.
   Ma, Dongzhu
   Nam Tran
   Huang, Yu
   Schmitt, Christopher
   Choi, Oi-wa
   DeYoung, Joseph
   Jung, Yoon
   Coppola, Giovanni
   Turner, Trudy
   Grobler, Paul
   Antonio, Martin
   Dione, Michel
   Wasserscheid, Jessica
   Dewar, Ken
   Warren, Wesley
   Pandrea, Ivona
   Apetrei, Cristian
   Freimer, Nelson B.
TI GENOMIC REGULATION OF NATURAL RESISTANCE TO SIV INFECTION IN WILD AGM
   POPULATIONS IN AFRICA
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Jasinska, Anna J.; Nam Tran; Huang, Yu; Schmitt, Christopher; Choi, Oi-wa; DeYoung, Joseph; Jung, Yoon; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.
   [Ma, Dongzhu; Pandrea, Ivona; Apetrei, Cristian] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.
   [Turner, Trudy] Univ Wisconsin, Milwaukee, WI 53201 USA.
   [Turner, Trudy; Grobler, Paul] Univ Orange Free State, Fac Nat & Agr Sci, Dept Genet, Bloemfontein, South Africa.
   [Antonio, Martin; Dione, Michel] MRC Unit, Banjul, Gambia.
   [Wasserscheid, Jessica; Dewar, Ken] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada.
   [Warren, Wesley] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA.
RI Schmitt, Christopher/F-7251-2013
OI Schmitt, Christopher/0000-0003-2143-9226
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2014
VL 43
IS 5
MA 32
BP 392
EP 392
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA AQ3EZ
UT WOS:000342673700045
OA No
DA 2017-08-15
ER

PT J
AU Koss, CA
   Natureeba, P
   Plenty, A
   Luwedde, F
   Mwesigwa, J
   Ades, V
   Charlebois, ED
   Clark, TD
   Achan, J
   Ruel, T
   Nzarubara, B
   Kamya, MR
   Havlir, DV
   Cohan, D
AF Koss, Catherine A.
   Natureeba, Paul
   Plenty, Albert
   Luwedde, Flavia
   Mwesigwa, Julia
   Ades, Veronica
   Charlebois, Edwin D.
   Clark, Tamara D.
   Achan, Jane
   Ruel, Theodore
   Nzarubara, Bridget
   Kamya, Moses R.
   Havlir, Diane V.
   Cohan, Deborah
TI Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women
   Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral
   Therapy
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE antiretroviral therapy, highly active; HIV; nutrition during pregnancy;
   premature birth; prevention of mother-to-child transmission; protease
   inhibitors
ID TO-CHILD TRANSMISSION; PREMATURE DELIVERY; HIV-1-INFECTED WOMEN;
   MALARIA; PROTEASE; WEIGHT; OUTCOMES; DRUGS; PROPHYLAXIS; PREVENTION
AB Background: Protease inhibitor-based antiretroviral therapy (ART) has been associated with preterm birth in some studies. We examined risk factors for preterm birth among women randomized to lopinavir/ritonavir (LPV/r)- or efavirenz (EFV)-based ART.
   Methods: This was a planned secondary analysis of the PROMOTE-Pregnant Women and Infants Study, an open-label, randomized controlled trial comparing the risk of placental malaria among HIV-infected, ART-naive pregnant Ugandan women assigned to initiate LPV/r- or EFV-based ART at 12-28 weeks gestation. Gestational age was determined based on last menstrual period and ultrasound biometry. All women received bednets and trimethoprim-sulfamethoxazole. Stillbirths, spontaneous abortions, and multiple gestations were excluded from the primary analysis. Potential risk factors for preterm birth (, 37 weeks gestation) were evaluated by univariate and multivariate logistic regression.
   Results: Three hundred fifty-six women were included in this analysis. At enrollment, median gestational age was 21 weeks and median CD4 cell count was 368 cells per cubic millimeter. 14.7% of deliveries in the EFV arm and 16.2% in the LPV/r arm were preterm. Preterm birth was associated with gestational weight gain below 0.1 kg/week versus 0.1 kg/week or more [odds ratio (OR) = 2.49; 95% confidence interval (CI): 1.38 to 4.47; P = 0.003]. Neither ART regimen of LPV/r versus EFV (OR = 1.12; 95% CI: 0.63 to 2.00; P = 0.69) nor placental malaria (OR = 0.74; 95% CI: 0.38 to 1.44; P = 0.37) was associated with preterm birth.
   Conclusions: LPV/r was not associated with an increased risk of preterm birth compared with EFV. However, interventions are needed to address modifiable risk factors for preterm birth, such as nutritional status (ClinicalTrials. gov, NCT00993031).
C1 [Koss, Catherine A.; Clark, Tamara D.; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, Dept Med, San Francisco, CA 94110 USA.
   [Koss, Catherine A.; Natureeba, Paul; Plenty, Albert; Luwedde, Flavia; Mwesigwa, Julia; Ades, Veronica; Charlebois, Edwin D.; Clark, Tamara D.; Achan, Jane; Ruel, Theodore; Nzarubara, Bridget; Kamya, Moses R.; Havlir, Diane V.; Cohan, Deborah] Univ Calif, Makerere Univ, San Francisco Res Collaborat, Kampala, Uganda.
   [Plenty, Albert; Charlebois, Edwin D.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94110 USA.
   [Ades, Veronica] NYU, Dept Obstet & Gynecol, New York, NY 10016 USA.
   [Achan, Jane] MRC Unit, Banjul, Gambia.
   [Ruel, Theodore] Univ Calif San Francisco, Dept Pediat, Div Infect Dis, San Francisco, CA 94110 USA.
   [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.
   [Cohan, Deborah] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94110 USA.
RP Koss, CA (reprint author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, Box 0874, San Francisco, CA 94110 USA.
EM catherine.koss@ucsf.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development [P01 HD059454]; National Institute of Allergy and Infectious
   Diseases at the National Institutes of Health [T32 AI060530]; NIH
FX Supported by a grant from the Eunice Kennedy Shriver National Institute
   of Child Health and Human Development (P01 HD059454, D.V.H.) and a
   training grant from the National Institute of Allergy and Infectious
   Diseases (T32 AI060530, D.V.H./C.A.K.) at the National Institutes of
   Health. AbbVie Pharmaceuticals donated lopinavir/ritonavir (Aluvia) for
   the parent trial. Gilead donates medications for participants in a
   separate NIH-funded study led by D.V.H. but provides no financial
   support. All other authors have no conflicts of interest to disclose.
CR Aebi C, 2000, AIDS, V14, P2913
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Boer K, 2007, BJOG-INT J OBSTET GY, V114, P148, DOI 10.1111/j.1471-0528.2006.01183.x
   Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553
   Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045
   Dembo EG, 2008, CLIN VACCINE IMMUNOL, V15, P617, DOI 10.1128/CVI.00378-07
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Fiore S, 2006, J REPROD IMMUNOL, V70, P143, DOI 10.1016/j.jri.2005.12.001
   Grosch-Woerner I, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00520.x
   Hutcheon JA, 2012, PAEDIATR PERINAT EP, V26, P109, DOI 10.1111/j.1365-3016.2011.01254.x
   Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGN RE
   Kourtis AP, 2007, AIDS, V21, P607, DOI 10.1097/QAD.0b013e32802ef2f6
   Lopez M, 2012, AIDS, V26, P37, DOI 10.1097/QAD.0b013e32834db300
   Lorenzi P, 1998, AIDS, V12, pF241, DOI 10.1097/00002030-199818000-00002
   Martin F, 2007, J INFECT DIS, V196, P558, DOI 10.1086/519848
   Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7
   Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X
   Natureeba P, 2013, PROTEASE INHIBITORS
   Newman PM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-254
   Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232
   Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307
   Ravizza M, 2007, J INFECT DIS, V195, P913, DOI 10.1086/507045
   Ravizza M, 2007, J INFECT DIS, V195, P6
   Rudin C, 2011, HIV MED, V12, P228, DOI 10.1111/j.1468-1293.2010.00876.x
   Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3
   Schulte J, 2007, PEDIATRICS, V119, pE900, DOI 10.1542/peds.2006-1123
   Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736
   Short CES, 2014, HIV MED, V15, P233, DOI 10.1111/hiv.12083
   Sibiude J, 2012, CLIN INFECT DIS, V54, P1348, DOI 10.1093/cid/cis198
   Steketee RW, 2001, AM J TROP MED HYG, V64, P28
   Szyld EG, 2006, AIDS, V20, P2345, DOI 10.1097/01.aids.0000253362.01696.9d
   Thorne C, 2004, AIDS, V18, P2337
   Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b
   Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159
   Tuomala RK, 2005, JAIDS-J ACQ IMM DEF, V38, P449, DOI 10.1097/01.qai.0000139398.38236.4d
   van den Broek NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090128
   Walter J, 2006, J INFECT DIS, V194, P1510, DOI 10.1086/508996
   Watts DH, 2013, J INFECT DIS, V207, P612, DOI 10.1093/infdis/jis728
   [Anonymous], 2013, CONS GUID US ANT DRU
   March of Dimes, 2012, BORN TOO SOON GLOB A
   Young S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041934
NR 41
TC 9
Z9 9
U1 1
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD OCT 1
PY 2014
VL 67
IS 2
BP 128
EP 135
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AP4NT
UT WOS:000342055000010
PM 25072616
OA No
DA 2017-08-15
ER

PT J
AU Doughty, EL
   Sergeant, MJ
   Adetifa, I
   Antonio, M
   Pallen, MJ
AF Doughty, Emma L.
   Sergeant, Martin J.
   Adetifa, Ifedayo
   Antonio, Martin
   Pallen, Mark J.
TI Culture-independent detection and characterisation of Mycobacterium
   tuberculosis and M. africanum in sputum samples using shotgun
   metagenomics on a benchtop sequencer
SO PEERJ
LA English
DT Article
DE Tuberculosis; Sputum; Diagnosis; Metagenomics; Mycobacterium
   tuberculosis
ID MULTIDRUG-RESISTANT TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPIN
   RESISTANCE; MIXED INFECTION; SOUTH-AFRICA; STRAIN; DIAGNOSIS; COMPLEX;
   OUTBREAK; DRUG
AB Tuberculosis remains a major global health problem. Laboratory diagnostic methods that allow effective, early detection of cases are central to management of tuberculosis in the individual patient and in the community. Since the 1880s, laboratory diagnosis of tuberculosis has relied primarily on microscopy and culture. However, microscopy fails to provide species- or lineage-level identification and culture-based workflows for diagnosis of tuberculosis remain complex, expensive, slow, technically demanding and poorly able to handle mixed infections. We therefore explored the potential of shotgun metagenomics, sequencing of DNA from samples without culture or target-specific amplification or capture, to detect and characterise strains from the Mycobacterium tuberculosis complex in smear-positive sputum samples obtained from The Gambia in West Africa. Eight smear-and culture-positive sputum samples were investigated using a differential-lysis protocol followed by a kit-based DNA extraction method, with sequencing performed on a benchtop sequencing instrument, the Illumina MiSeq. The number of sequence reads in each sputum-derived metagenome ranged from 989,442 to 2,818,238. The proportion of reads in each metagenome mapping against the human genome ranged from 20% to 99%. We were able to detect sequences from the M. tuberculosis complex in all eight samples, with coverage of the H37Rv reference genome ranging from 0.002X to 0.7X. By analysing the distribution of large sequence polymorphisms (deletions and the locations of the insertion element IS6110) and single nucleotide polymorphisms (SNPs), we were able to assign seven of eight metagenome-derived genomes to a species and lineage within the M. tuberculosis complex. Two metagenome-derived mycobacterial genomes were assigned to M. africanum, a species largely confined to West Africa; the others that could be assigned belonged to lineages T, H or LAM within the clade of "modern" M. tuberculosis strains. We have provided proof of principle that shotgun metagenomics can be used to detect and characterise M. tuberculosis sequences from sputum samples without culture or target-specific amplification or capture, using an accessible benchtop-sequencing platform, the Illumina MiSeq, and relatively simple DNA extraction, sequencing and bioinformatics protocols. In our hands, sputum metagenomics does not yet deliver sufficient depth of coverage to allow sequence-based sensitivity testing; it remains to be determined whether improvements in DNA extraction protocols alone can deliver this or whether culture, capture or amplification steps will be required. Nonetheless, we can foresee a tipping point when a unified automated metagenomics-based workflow might start to compete with the plethora of methods currently in use in the diagnostic microbiology laboratory.
C1 [Doughty, Emma L.; Sergeant, Martin J.; Antonio, Martin; Pallen, Mark J.] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
   [Adetifa, Ifedayo; Antonio, Martin] MRC Unit, Fajara, Gambia.
RP Pallen, MJ (reprint author), Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry CV4 7AL, W Midlands, England.
EM m.pallen@warwick.ac.uk
OI Pallen, Mark/0000-0003-1807-3657
FU Warwick Medical School; MRC Unit, The Gambia
FX Support for Emma Doughty's PhD studentship and research costs was
   provided by Warwick Medical School and MRC Unit, The Gambia. Support for
   Martin Sergeant's salary was provided by Warwick Medical School. The
   Enhanced Case Finding project was funded and sponsored by the MRC Unit,
   The Gambia. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allix-Beguec C, 2010, EUR RESPIR J, V35, P692, DOI 10.1183/09031936.00137309
   Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253
   Bouwman AS, 2012, P NATL ACAD SCI USA, V109, P18511, DOI 10.1073/pnas.1209444109
   Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299
   Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295
   Cohen T, 2011, J CLIN MICROBIOL, V49, P385, DOI 10.1128/JCM.01378-10
   Cole ST, 1998, NATURE, V393, P537
   Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97
   Coll F, 2014, TUBERCULOSIS, V94, P346, DOI 10.1016/j.tube.2014.02.005
   Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590
   Cubillos-Ruiz A, 2010, J CLIN MICROBIOL, V48, P3614, DOI 10.1128/JCM.00157-10
   de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744
   de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x
   de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08
   Drobniewski F, 2012, INT J TUBERC LUNG D, V16, P860, DOI 10.5588/ijtld.12.0180
   Ehrlich P, 1882, DEUT MED WOCHENSCHR, V9, P246
   Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016
   Feuerriegel S, 2013, J ANTIMICROB CHEMOTH, V68, P1439, DOI 10.1093/jac/dkt042
   Feuerriegel S, 2011, ANTIMICROB AGENTS CH, V55, P5718, DOI 10.1128/AAC.05500-11
   Fischer N, 2014, EMERG INFECT DIS, V20, P1072, DOI 10.3201/eid2006.131526
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176
   Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111
   Gutierrez MC, 2009, GENOME DYNAM, V6, P198, DOI 10.1159/000235772
   Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09
   Hingley-Wilson SM, 2013, EMERG INFECT DIS, V19, P1138, DOI [10.3201/1907.130313, 10.3201/eid1907.130313]
   Jagielski T, 2014, BIOMED RES INT, DOI 10.1155/2014/645802
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907
   Kay GL, 2014, MBIO, V5, DOI 10.1128/mBio.01337-14
   Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701
   Kent PT, 1985, PUBLIC HLTH MYCOBACT
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Koch R., 1882, BERL KLIN WOCHENSCHR, V19, P221
   Koser CU, 2014, TRENDS GENET, V30, P401, DOI 10.1016/j.tig.2014.07.003
   Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305
   Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824
   Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lanzas F, 2013, J CLIN MICROBIOL, V51, P3277, DOI 10.1128/JCM.01122-13
   Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009
   Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231
   Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850
   Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198
   Lysholm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030875
   Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036902
   Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538
   Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025
   Pallen MJ, 2014, PARASITOLOGY, V141, P1856, DOI 10.1017/S0031182014000134
   Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P364
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387
   Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286
   Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004
   SHAW JB, 1954, AM REV TUBERC PULM, V69, P724
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Sweeney FP, 2006, LETT APPL MICROBIOL, V43, P364, DOI 10.1111/j.1472-765X.2005.01983.x
   Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3
   Wang CS, 2008, J FORMOS MED ASSOC, V107, P13, DOI 10.1016/S0929-6646(08)60003-0
   Wang JY, 2011, CLIN MICROBIOL INFEC, V17, P1239, DOI 10.1111/j.1469-0691.2010.03401.x
   Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, 2011, WHOHTMTB20114
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Zetola NM, 2014, J CLIN MICROBIOL, V52, P2422, DOI 10.1128/JCM.02489-13
NR 63
TC 36
Z9 36
U1 3
U2 32
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD SEP 23
PY 2014
VL 2
AR e585
DI 10.7717/peerj.585
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AY5OI
UT WOS:000347621300005
PM 25279265
OA gold
DA 2017-08-15
ER

PT J
AU Scott, S
   Odutola, A
   Mackenzie, G
   Fulford, T
   Afolabi, MO
   Jallow, YL
   Jasseh, M
   Jeffries, D
   Dondeh, BL
   Howie, SRC
   D'Alessandro, U
AF Scott, Susana
   Odutola, Aderonke
   Mackenzie, Grant
   Fulford, Tony
   Afolabi, Muhammed O.
   Jallow, Yamundow Lowe
   Jasseh, Momodou
   Jeffries, David
   Dondeh, Bai Lamin
   Howie, Stephen R. C.
   D'Alessandro, Umberto
TI Coverage and Timing of Children's Vaccination: An Evaluation of the
   Expanded Programme on Immunisation in The Gambia
SO PLOS ONE
LA English
DT Article
ID INFLUENZAE TYPE-B; DISEASE
AB Objective: To evaluate the coverage and timeliness of the Expanded Programme on Immunisation (EPI) in The Gambia.
   Methods: Vaccination data were obtained between January 2005 and December 2012 from the Farafenni Health and Demographic Surveillance System (FHDSS), the Basse Health and Demographic Surveillance System (BHDSS), the Kiang West Demographic surveillance system (KWDSS), a cluster survey in the more urban Western Health Region (WR) and a cross sectional study in four clinics in the semi-urban Greater Banjul area of WR. Kaplan-Meier survival function was used to estimate the proportion vaccinated by age and to assess timeliness to vaccination.
   Findings: BCG vaccine uptake was over 95% in all regions. Coverage of DPT1 ranged from 93.2% in BHDSS to 99.8% in the WR. Coverage decreased with increasing number of DPT doses; DPT3 coverage ranged from 81.7% in BHDSS to 99.0% in WR. Measles vaccination coverage ranged from 83.3% in BHDSS to 97.0% in WR. DPT4 booster coverage was low and ranged from 43.9% in the WR to 82.8% in KWDSS. Across all regions, delaying on previous vaccinations increased the likelihood of being delayed for the subsequent vaccination.
   Conclusions: The Gambia health system achieves high vaccine coverage in the first year of life. However, there continues to be a delay to vaccination which may impact on the introduction of new vaccines. Examples of effectively functioning EPI programmes such as The Gambia one may well be important models for other low income countries struggling to achieve high routine vaccination coverage.
C1 [Scott, Susana; Odutola, Aderonke; Mackenzie, Grant; Fulford, Tony; Afolabi, Muhammed O.; Jasseh, Momodou; Jeffries, David; Dondeh, Bai Lamin; Howie, Stephen R. C.; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Scott, Susana; Fulford, Tony] London Sch Hyg & Trop Med, London WC1, England.
   [Jallow, Yamundow Lowe] Minist Hlth & Social Welf Govt Gambia, Banjul, Gambia.
RP Scott, S (reprint author), MRC Unit, Fajara, Gambia.
EM sscott@mrc.gm
RI ; D'Alessandro, Umberto/D-3457-2015
OI Afolabi, Muhammed/0000-0002-9967-6419; D'Alessandro,
   Umberto/0000-0001-6341-5009
FU UK Medical Research Council (MRC)
FX This study was funded by the UK Medical Research Council (MRC). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript
CR Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8
   Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432
   Chauke-Moagi BE, 2012, VACCINE, V30, pC3, DOI 10.1016/j.vaccine.2012.05.086
   Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2
   Clements CJ, 2008, VACCINE, V26, P1926, DOI 10.1016/j.vaccine.2008.02.032
   Dayan GH, 2006, AM J EPIDEMIOL, V163, P561, DOI 10.1093/aje/kwj074
   Fadnes LT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-404
   Gambia GoT, 2007, GAMB MULT IND CLUST
   Howie SRC, 2013, CLIN INFECT DIS, V57, P1527, DOI 10.1093/cid/cit598
   Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753
   Laubereau B, 2002, EPIDEMIOL INFECT, V128, P185, DOI 10.1017/S0950268801006550
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161
   Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029
   Medical Research Council, 2004, PROF FAR DSS GAMB
   MRC International Nutrition Group, W KIANG DEM SURV SYS
   Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132
   Patel MM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001330
   Payne S, 2014, HEALTH POLICY PLANN, V29, P193, DOI 10.1093/heapol/czt004
   World Health Organization Department of Immunization Vaccines and Biologicals, 2005, WHOIVB0423
   WHO/EPI JB, 2006, GAMB NAT EXP PROGR I
   [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P432
   [Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P49
   [Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P221
   [Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P2
NR 26
TC 10
Z9 11
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 18
PY 2014
VL 9
IS 9
AR e107280
DI 10.1371/journal.pone.0107280
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ6KR
UT WOS:000342921200023
PM 25232830
OA gold
DA 2017-08-15
ER

PT J
AU Parker, EPK
   Kampmann, B
   Kang, G
   Grassly, NC
AF Parker, Edward P. K.
   Kampmann, Beate
   Kang, Gagandeep
   Grassly, Nicholas C.
TI Influence of Enteric Infections on Response to Oral Poliovirus Vaccine:
   A Systematic Review and Meta-analysis
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE diarrhea; enterovirus; immunogenicity; interference; oral poliovirus
   vaccine
ID DEVELOPING-COUNTRIES; ANTIBODY-RESPONSE; IMMUNOGENICITY; POPULATION;
   CHILDREN; DIARRHEA; INFANTS; VIRUS; LIVE; IMMUNIZATION
AB Background. The impaired immunogenicity of oral poliovirus vaccine (OPV) in low-income countries has been apparent since the early field trials of this vaccine. Infection with enteropathogens at the time of vaccination may contribute to this phenomenon. However, the relative influence of these infections on OPV performance remains uncertain.
   Methods. We conducted a systematic review to examine the impact of concurrent enteric infections on OPV response. Using random-effects models, we assessed the effects of nonpolio enteroviruses (NPEVs) and diarrhea on the odds of seroconversion and/or vaccine virus shedding.
   Results. We identified 25 trials in which OPV outcomes were compared according to the presence or absence of enteric infections, the majority of which (n = 17) reported only on NPEVs. Concurrent NPEVs significantly reduced the odds of per-dose seroconversion for type 1 poliovirus (odds ratio [OR] 0.44, 95% confidence interval 0.23-0.84), but not type 2 (OR 0.53 [0.19-1.46]) or type 3 (OR 0.56 [0.27-1.12]). A similar reduction, significant for type 1 poliovirus (OR 0.50 [0.28-0.89]), was observed in the odds of vaccine virus shedding among NPEV-infected individuals. Concurrent diarrhea significantly inhibited per-dose seroconversion overall (OR 0.61 [0.38-0.87]).
   Conclusions. Our findings are consistent with an inhibitory effect of concurrent enteric infections on OPV response.
C1 [Parker, Edward P. K.; Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.
   [Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London W2 1PG, England.
   [Kampmann, Beate] MRC Unit, Fajara, Gambia.
   [Kang, Gagandeep] Christian Med Coll & Hosp, Div Gastrointestinal Sci, Vellore, Tamil Nadu, India.
RP Parker, EPK (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Sch Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.
EM e.parker12@imperial.ac.uk
OI Grassly, Nicholas/0000-0001-6067-4507; Kang,
   Gagandeep/0000-0002-3656-564X
FU UK Medical Research Council
FX This work was supported by funding from the UK Medical Research Council
   (E. P. K. P.).
CR Benyesh-Melnick M, 1959, SCI PUBLICATION PAN, V44, P272
   Cheung MWL, 2014, PSYCHOL METHODS, V19, P211, DOI 10.1037/a0032968
   CIRNE MD, 1995, J INFECT DIS, V171, P1097
   DARDANONI L., 1962, RIV IST SIEROTER AP ITAL, V37, P428
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DOMOK I, 1961, Br Med J, V1, P1410
   DROZDOV SG, 1961, ACTA VIROL, V5, P210
   Egger M, 1997, BRIT MED J, V315, P629
   FADEN H, 1992, AM J DIS CHILD, V146, P1320
   Fang-Cho K, 1960, ORAL LIVE POLIOVIRUS, P261
   Global Polio Eradication Initiative, POL ER ENDG STRAT PL
   INGRAM VG, 1962, PEDIATRICS, V29, P174
   Japan Live Poliovaccine Research Commission, 1966, JPN J MED SCI BIOL, V19, P277
   Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412
   JOHN TJ, 1975, AM J EPIDEMIOL, V102, P422
   KOK PW, 1992, B WORLD HEALTH ORGAN, V70, P93
   Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   LEE LH, 1965, B WORLD HEALTH ORGAN, V32, P657
   Levine S, 1960, SCI PUBLICATION PAN, V50, P270
   Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797
   Mahmoud A A, 1976, Gaz Egypt Paediatr Assoc, V24, P82
   Maldonado YA, 1997, J INFECT DIS, V175, P545
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   MONACI V., 1965, ANN SCLAVO, V7, P341
   Myaux JA, 1996, PEDIATR INFECT DIS J, V15, P204, DOI 10.1097/00006454-199603000-00006
   NARDI G., 1966, ANN SCLAVO, V8, P700
   PATRIARCA PA, 1991, REV INFECT DIS, V13, P926
   PAUL JR, 1962, B WORLD HEALTH ORGAN, V26, P311
   Paul JR, 1960, SCI PUBL PAN AM HLTH, V50, P174
   PLOTKIN S A, 1960, Bull World Health Organ, V22, P215
   Posey DL, 1997, J INFECT DIS, V175, pS258
   R Development Core Team, 2010, R LANG ENV STAT COMP
   RAMOS-ALVAREZ M, 1961, Bol Med Hosp Infant Mex, V18, P13
   Ramos-Alvarez M, 1967, SCI PUBLICATION PAN, V148, P213
   SABIN AB, 1960, JAMA-J AM MED ASSOC, V173, P1521
   SABIN AB, 1961, AM J DIS CHILD, V101, P546
   Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769
   Spano C, 1965, Riv Ist Sieroter Ital, V40, P169
   SUAREHAWARATANA P, 1992, J INFECT DIS, V165, P1042
   Sureau P, 1966, ARCH I PASTEUR ALGER, V44, P23
   Swartz T A, 1972, Adv Exp Med Biol, V31, P237
   SWARTZ TA, 1972, J HYG-CAMBRIDGE, V70, P719
   Takatsu T, 1962, SHONIKA SHINRYO, V25, P1316
   Triki H, 1997, VACCINE, V15, P1123, DOI 10.1016/S0264-410X(97)00001-7
   Urasawa S, 1964, Sapporo Igaku Zasshi, V26, P8
   Urasawa S, 1964, Sapporo Igaku Zasshi, V25, P247
   Voroshilova MK, 1960, ORAL LIVE POLIOVIRUS, P560
   The World Bank, COUNTR LEND GROUPS
NR 49
TC 16
Z9 17
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 15
PY 2014
VL 210
IS 6
BP 853
EP 864
DI 10.1093/infdis/jiu182
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AT0DW
UT WOS:000344608300004
PM 24688069
OA No
DA 2017-08-15
ER

PT J
AU Ghansah, A
   Amenga-Etego, L
   Amambua-Ngwa, A
   Andagalu, B
   Apinjoh, T
   Bouyou-Akotet, M
   Cornelius, V
   Golassa, L
   Andrianaranjaka, VH
   Ishengoma, D
   Johnson, K
   Kamau, E
   Maiga-Ascofare, O
   Mumba, D
   Tindana, P
   Tshefu-Kitoto, A
   Randrianarivelojosia, M
   William, Y
   Kwiatkowski, DP
   Djimde, AA
AF Ghansah, Anita
   Amenga-Etego, Lucas
   Amambua-Ngwa, Alfred
   Andagalu, Ben
   Apinjoh, Tobias
   Bouyou-Akotet, Marielle
   Cornelius, Victoria
   Golassa, Lemu
   Andrianaranjaka, Voahangy Hanitriniaina
   Ishengoma, Deus
   Johnson, Kimberly
   Kamau, Edwin
   Maiga-Ascofare, Oumou
   Mumba, Dieudonne
   Tindana, Paulina
   Tshefu-Kitoto, Antoinette
   Randrianarivelojosia, Milijaona
   William, Yavo
   Kwiatkowski, Dominic P.
   Djimde, Abdoulaye A.
TI Monitoring parasite diversity for malaria elimination in sub-Saharan
   Africa
SO SCIENCE
LA English
DT Editorial Material
ID ARTEMISININ RESISTANCE; PLASMODIUM-FALCIPARUM
AB The African continent continues to bear the greatest burden of malaria and the greatest diversity of parasites, mosquito vectors, and human victims. The evolutionary plasticity of malaria parasites and their vectors is a major obstacle to eliminating the disease. Of current concern is the recently reported emergence of resistance to the front-line drug, artemisinin, in South-East Asia in Plasmodium falciparum, which calls for preemptive surveillance of the African parasite population for genetic markers of emerging drug resistance. Here we describe the Plasmodium Diversity Network Africa (PDNA), which has been established across 11 countries in sub-Saharan Africa to ensure that African scientists are enabled to work together and to play a key role in the global effort for tracking and responding to this public health threat.
C1 [Ghansah, Anita] Noguchi Mem Inst Med Res, Accra, Ghana.
   [Amenga-Etego, Lucas; Tindana, Paulina] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Amambua-Ngwa, Alfred] MRC, Gambia Unit, Banjul, Gambia.
   [Andagalu, Ben; Kamau, Edwin] KEMRI US Army Med Res Unit Kenya, Nairobi, Kenya.
   [Apinjoh, Tobias] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon.
   [Bouyou-Akotet, Marielle] Univ Sci Sante, Fac Med, Dept Parasitol Mycol, Libreville, Gabon.
   [Cornelius, Victoria; Johnson, Kimberly; Kwiatkowski, Dominic P.] Univ Oxford, MRC Ctr Genom & Global Hlth, Oxford, England.
   [Golassa, Lemu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.
   [Golassa, Lemu] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Andrianaranjaka, Voahangy Hanitriniaina; Randrianarivelojosia, Milijaona] Inst Pasteur Madagascar, Malaria Res Unit, Antananarivo, Madagascar.
   [Ishengoma, Deus] Natl Inst Med Res, Tanga, Tanzania.
   [Mumba, Dieudonne; Tshefu-Kitoto, Antoinette] Univ Kinshasa, Fac Med, Ecole Sante Publ, Inst Natl Rech Biomed, Kinshasa, Zaire.
   [Maiga-Ascofare, Oumou; Djimde, Abdoulaye A.] Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, MRTC, Bamako, Mali.
   [Maiga-Ascofare, Oumou] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
   [William, Yavo] Natl Inst Publ Hlth, Malaria Res & Control Ctr, Abidjan, Cote Ivoire.
   [Kwiatkowski, Dominic P.; Djimde, Abdoulaye A.] Wellcome Trust Sanger Inst, Hinxton, Herts, England.
RP Djimde, AA (reprint author), Univ Sci Tech & Technol Bamako, Fac Pharm, Dept Epidemiol Parasit Dis, MRTC, Bamako, Mali.
EM adjimde@icermali.org
OI Kwiatkowski, Dominic/0000-0002-5023-0176
FU Medical Research Council [G0600718, MC_EX_MR/K02440X/1]; Wellcome Trust
   [090532, 090770]
CR Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Fairhurst RM, 2012, AM J TROP MED HYG, V87, P231, DOI 10.4269/ajtmh.2012.12-0025
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632
   Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
NR 7
TC 15
Z9 15
U1 0
U2 16
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD SEP 12
PY 2014
VL 345
IS 6202
BP 1297
EP 1298
DI 10.1126/science.1259423
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO6TG
UT WOS:000341483800051
PM 25214619
OA No
DA 2017-08-15
ER

PT J
AU Ndure, J
   Flanagan, KL
AF Ndure, Jorjoh
   Flanagan, Katie L.
TI Targeting regulatory T cells to improve vaccine immunogenicity in early
   life
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE regulatory T cells; vaccines; infants; neonates; immunogenicity; immune
   modulation; adjuvants
ID HEPATITIS-C-VIRUS; ANTI-CD25 MONOCLONAL-ANTIBODY; IMMUNOLOGICAL
   SELF-TOLERANCE; CALMETTE-GUERIN VACCINATION; NEONATAL DENDRITIC CELLS;
   CORD BLOOD; IMMUNE-RESPONSES; MATERNAL ANTIBODY; THERAPEUTIC
   VACCINATION; SUPPRESSIVE FUNCTION
AB Human newborns and infants are bombarded with multiple pathogens on leaving the sterile intra-uterine environment, and yet have suboptimal innate immunity and limited immunological memory, thus leading to increased susceptibility to infections in early life. They are thus the target age group for a host of vaccines against common bacterial and viral pathogens. They are also the target group for many vaccines in development, including those against tuberculosis (TB), malaria, and HIV infection. However, neonatal and infant responses too many vaccines are suboptimal, and in the case of the polysaccharide vaccines, it has been necessary to develop the alternative conjugated formulations in order to induce immunity in early life. lmmunoregulatory factors are an intrinsic component of natural immunity necessary to dampen or control immune responses, with the caveat that they may also decrease immunity to infections or lead to chronic infection. This review explores the key immunoregulatory factors at play in early life, with a particular emphasis on regulatory T cells (Tregs). It goes on to explore the role that Tregs play in limiting vaccine immunogenicity, and describes animal and human studies in which Tregs have been depleted in order to enhance vaccine responses. A deeper understanding of the role that Tregs play in limiting or controlling vaccine-induced immunity would provide strategies to improve vaccine immunogenicity in this critical age group. New adjuvants and drugs are being developed that can transiently suppress Treg function, and their use as part of human vaccination strategies against infections is becoming a real prospect for the future.
C1 [Ndure, Jorjoh] MRC Labs, Infant Immunol Grp, Fajara, Gambia.
   [Flanagan, Katie L.] Monash Univ, Dept Immunol, Vaccine & Infect Dis Lab, Melbourne, Vic 3004, Australia.
RP Flanagan, KL (reprint author), Monash Univ, Dept Immunol, Vaccine & Infect Dis Lab, Level 2,AMREP Bldg,89 Commercial Rd, Melbourne, Vic 3004, Australia.
EM katie.flanagan@dhhs.tas.gov.au
FU Medical Research Council [MC_UP_A900_1115]
CR Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554
   Abel S, 2012, J IMMUNOL, V188, P5467, DOI 10.4049/jimmunol.1102223
   Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394
   Afolabi MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078289
   Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862
   ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4
   Andersson PO, 2002, BRIT J HAEMATOL, V116, P862, DOI 10.1046/j.0007-1048.2002.03345.x
   Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   Barbon CM, 2010, CELL IMMUNOL, V262, P150, DOI 10.1016/j.cellimm.2010.02.007
   Bayry Jagadeesh, 2014, Indian Journal of Virology, V25, P18, DOI 10.1007/s13337-013-0187-3
   Bejon P., 2007, PLOS ONE, V2, pe707, DOI [10.1371/journal.pone.0000707, DOI 10.1371/J0URNAL.P0NE.0000707]
   Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381
   Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   Belkaid Y, 2008, CELL HOST MICROBE, V3, P341, DOI 10.1016/j.chom.2008.05.011
   Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189
   Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723
   Bennett CL, 2001, CURR OPIN PEDIATR, V13, P533, DOI 10.1097/00008480-200112000-00007
   BJORKHOLM B, 1995, PEDIATR INFECT DIS J, V14, P846, DOI 10.1097/00006454-199510000-00005
   Burl S, 2011, PLOS ONE, V6
   Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552
   BURSTYN DG, 1983, INFECT IMMUN, V41, P1150
   Carr R, 2000, BRIT J HAEMATOL, V110, P18, DOI 10.1046/j.1365-2141.2000.01992.x
   Chang KM, 2007, HEPATOL RES, V37, pS327, DOI 10.1111/j.1872-034X.2007.00220.x
   CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605
   Ciubotariu R, 1998, J IMMUNOL, V161, P5193
   CLAESSON BA, 1989, J PEDIATR-US, V114, P97, DOI 10.1016/S0022-3476(89)80611-0
   Clemente A, 2011, CELL MICROBIOL, V13, P1328, DOI 10.1111/j.1462-5822.2011.01622.x
   Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306
   Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/ERI.10.158, 10.1586/eri.10.158]
   Cusick MF, 2013, FUTURE VIROL, V8, P695, DOI 10.2217/FVL.13.49
   Cusick MF, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/806061
   Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760
   DAUM RS, 1991, J INFECT DIS, V164, P1154
   de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274
   De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216
   Dietze KK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003798
   Dowling DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058164
   Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324
   ENGLUND JA, 1995, PEDIATRICS, V96, P580
   Fabien S, 2014, BIOMED RES INT, DOI 10.1155/2014/290878
   Fan HH, 2012, IMMUNOLOGY, V136, P218, DOI 10.1111/j.1365-2567.2012.03573.x
   Filaci G, 2004, HUM IMMUNOL, V65, P142, DOI 10.1016/j.bumimm.2003.12.001
   Flanagan KL, 2010, EUR J IMMUNOL, V40, P1062, DOI 10.1002/eji.200939638
   Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
   Fujimaki W, 2008, CLIN DEV IMMUNOL, V2008, DOI [10.1155/2008/305859, DOI 10.1155/2008/305859]
   Gaardbo JC, 2014, JAIDS-J ACQ IMM DEF, V66, P349, DOI 10.1097/QAI.0000000000000173
   Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179
   Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010
   Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527
   Ghazal P, 2013, CURR OPIN INFECT DIS, V26, P213, DOI 10.1097/QCO.0b013e32835fb8bf
   Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467
   Goebel J, 2000, TRANSPL IMMUNOL, V8, P153, DOI 10.1016/S0966-3274(00)00021-6
   Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272
   Gregori S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00030
   Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872
   GRIFFIOEN AW, 1993, CLIN IMMUNOL IMMUNOP, V69, P1, DOI 10.1006/clin.1993.1142
   Groux H, 1997, NATURE, V389, P737
   Guilmot A, 2011, J INNATE IMMUN, V3, P280, DOI 10.1159/000323934
   Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]
   HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715
   Higashitani K, 2013, J GASTROENTEROL, V48, P660, DOI 10.1007/s00535-012-0667-z
   Ho PY, 2010, J LEUKOCYTE BIOL, V88, P1073, DOI 10.1189/jlb.0809582
   Horenstein AL, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26246
   Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490
   Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063
   Jepsen MPG, 2013, J INFECT DIS, V208, P479, DOI 10.1093/infdis/jit185
   Jones C, 2014, VACCINE, V32, P996, DOI 10.1016/j.vaccine.2013.11.104
   Kaleebu P, 2014, JAIDS-J ACQ IMM DEF, V65, P268, DOI 10.1097/01.qai.0000435600.65845.31
   KANEGANE H, 1991, INT IMMUNOL, V3, P1349, DOI 10.1093/intimm/3.12.1349
   Kanra G, 2000, TURKISH J PEDIATR, V42, P105
   Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043
   Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422
   Keenan BP, 2014, GASTROENTEROLOGY, V146, P1784, DOI 10.1053/j.gastro.2014.02.055
   Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736
   Kohm AP, 2006, J IMMUNOL, V176, P3301
   Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014
   Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481
   Koukouikila-Koussounda F, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-9
   Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020
   Lacan G, 2013, J NEUROSCI RES, V91, P1292, DOI 10.1002/jnr.23253
   Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10
   Langrish CL, 2002, CLIN EXP IMMUNOL, V128, P118, DOI 10.1046/j.1365-2249.2002.01817.x
   Laurens MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079323
   Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912
   Levings MK, 2000, J ALLERGY CLIN IMMUN, V106, pS109
   Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075
   Levy O, 2006, J IMMUNOL, V177, P1956
   Levy O, 2014, NEONATOLOGY, V105, P136, DOI 10.1159/000356035
   Lin SJ, 2014, IMMUNOL RES, V60, P105, DOI 10.1007/s12026-014-8488-1
   Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772
   Liu Y, 2014, J MOL CELL BIOL, V6, P81, DOI 10.1093/jmcb/mjt026
   Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105
   Lu W, 2012, CELL REP, V2, P1736, DOI 10.1016/j.celrep.2012.11.016
   Luciano AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095867
   Ly Ngoc P, 2009, Clin Mol Allergy, V7, P8, DOI 10.1186/1476-7961-7-8
   Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852
   MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340
   Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423
   Marchant A, 1999, J IMMUNOL, V163, P2249
   Mattarollo SR, 2013, IMMUNOL CELL BIOL, V91, P105, DOI 10.1038/icb.2012.58
   Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913
   Mayer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029355
   Mills KHG, 2004, SEMIN IMMUNOL, V16, P107, DOI 10.1016/j.smim.2003.12.006
   Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402
   Mitchell DA, 2011, BLOOD, V118, P3003, DOI 10.1182/blood-2011-02-334565
   Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019
   Moore AC, 2005, J IMMUNOL, V175, P7264
   Moorman JP, 2012, J IMMUNOL, V189, P755, DOI 10.4049/jimmunol.1200162
   Mwacharo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008434
   Nettenstrom L, 2013, J IMMUNOL METHODS, V387, P81, DOI 10.1016/j.jim.2012.09.014
   Ngamphaiboon J, 1998, ASIAN PAC J ALLERGY, V16, P49
   Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407
   Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726
   Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564
   Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI [10.1016/S1473-3099(10)70262-0, 10.1016/51473-3099(10)70262-0]
   Patton DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017359
   Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492
   Perez-Machado MA, 2003, EUR J IMMUNOL, V33, P2307, DOI 10.1002/eji.200323308
   Perret R, 2013, CANCER RES, V73, P6597, DOI 10.1158/0008-5472.CAN-13-0875
   Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042
   Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d
   Raskovalova T, 2005, J IMMUNOL, V175, P4383
   Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330
   Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x
   Roncarolo MG, 2006, IMMUNOL REV, V212, P28
   Rts S. C. T. P., 2012, NEW ENGL J MED, V367, P2284, DOI [10.1056/NEJMoa1208394, DOI 10.1056/NEJMOA1208394]
   Saison J, 2014, CLIN EXP IMMUNOL, V176, P401, DOI 10.1111/cei.12278
   Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9
   SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
   Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385
   Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x
   Santner-Nanan B, 2008, INT IMMUNOL, V20, P375, DOI 10.1093/intimm/dxm151
   Scalzo-Inguanti K, 2011, EUR J IMMUNOL, V41, P1298, DOI 10.1002/eji.201040726
   Schmetterer KG, 2012, FASEB J, V26, P2253, DOI 10.1096/fj.11-193672
   Scholzen A, 2010, TRENDS PARASITOL, V26, P16, DOI 10.1016/j.pt.2009.10.004
   Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543
   Serana F., 2014, OPEN AIDS J, V8, P1, DOI [10.2174/1874613601408010001, DOI 10.2174/1874613601408010001]
   Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468
   Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.3.CO;2-C
   Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6
   Simone R, 2008, J LEUKOCYTE BIOL, V84, P1454, DOI 10.1189/jlb.0907627
   Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004
   Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002
   Suzuki M, 2012, J IMMUNOL, V189, P2118, DOI 10.4049/jimmunol.1200122
   Suzuki M, 2008, HUM IMMUNOL, V69, P781, DOI 10.1016/j.humimm.2008.08.283
   Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012
   Tan CR, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-148
   Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027
   Tosello V, 2008, CLIN IMMUNOL, V126, P291, DOI 10.1016/j.clim.2007.11.008
   Uss E, 2006, J IMMUNOL, V177, P2775
   Vieira PL, 2004, J IMMUNOL, V172, P5986
   Voo KS, 2013, J IMMUNOL, V191, P3641, DOI 10.4049/jimmunol.1202752
   Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006
   Walther B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-6
   Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006
   Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364
   Wammes LJ, 2013, J INFECT DIS, V207, P1590, DOI 10.1093/infdis/jit058
   Wang WH, 2013, CHINESE MED J-PEKING, V126, P2054, DOI 10.3760/cma.j.issn.0366-6999.20121253
   Wing JB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00178
   Wing K, 2005, IMMUNOLOGY, V115, P516, DOI 10.1111/j.1365-2567.2005.02186.x
   Wing K, 2002, IMMUNOLOGY, V106, P190, DOI 10.1046/j.1365-2567.2002.01412.x
   Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002
   Wu JJ, 2010, PARASITOL INT, V59, P232, DOI 10.1016/j.parint.2010.02.007
   Yeung LTF, 2001, HEPATOLOGY, V34, P223, DOI 10.1053/jhep.2001.25885
   Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x
NR 166
TC 19
Z9 19
U1 2
U2 16
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 11
PY 2014
VL 5
AR UNSP 477
DI 10.3389/fmicb.2014.00477
PG 12
WC Microbiology
SC Microbiology
GA AP2RR
UT WOS:000341922500001
PM 25309517
OA gold
DA 2017-08-15
ER

PT J
AU Abubakar, I
   Sridhar, S
   Eisenhut, M
   Roy, A
   Harris, RJ
   Rodrigues, LC
   Mangtani, P
   Adetifa, I
   Lalvani, A
AF Abubakar, I.
   Sridhar, S.
   Eisenhut, M.
   Roy, A.
   Harris, R. J.
   Rodrigues, L. C.
   Mangtani, P.
   Adetifa, I.
   Lalvani, A.
TI BCG VACCINATION AND TB IN CHILDREN Authors' reply to Turner and
   colleagues
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Letter
ID MYCOBACTERIUM-TUBERCULOSIS INFECTION; CALMETTE-GUERIN VACCINATION;
   PROTECTION; METAANALYSIS
C1 [Abubakar, I.] UCL, Ctr Infect Dis Epidemiol, London, England.
   [Abubakar, I.] UCL, MRC Clin Trials Unit, London, England.
   [Sridhar, S.; Lalvani, A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, TB Res Ctr, Resp Infect Sect, London, England.
   [Eisenhut, M.] NHS Fdn Trust, Luton & Dunstable Univ Hosp, Luton, Beds, England.
   [Roy, A.; Harris, R. J.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London, England.
   [Rodrigues, L. C.; Mangtani, P.] London Sch Hyg & Trop Med, London WC1, England.
   [Adetifa, I.] MRC, Fajara, Gambia.
RP Abubakar, I (reprint author), UCL, Ctr Infect Dis Epidemiol, London, England.
EM i.abubakar@ucl.ac.uk
CR Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370
   Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI [10.1164/rccm.201003-0334OC, 10.1164/rrcm.201003-0334OC]
   Lalvani A, 2013, THORAX, V68, P1092, DOI 10.1136/thoraxjnl-2013-203456
   Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790
   Parascandola M, 2001, J EPIDEMIOL COMMUN H, V55, P905, DOI 10.1136/jech.55.12.905
   Pulickal AS, 2007, INDIAN PEDIATR, V44, P344
   Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643
   Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4
   Turner R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5436
NR 9
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 10
PY 2014
VL 349
AR g5441
DI 10.1136/bmj.g5441
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA AO9QO
UT WOS:000341691200006
PM 25209583
OA No
DA 2017-08-15
ER

PT J
AU Martins, C
   Garly, ML
   Bale, C
   Rodrigues, A
   Njie-Jobe, J
   Benn, CS
   Whittle, H
   Aaby, P
AF Martins, Cesario
   Garly, May-Lill
   Bale, Carlitos
   Rodrigues, Amabelia
   Njie-Jobe, Jainaba
   Benn, Christine S.
   Whittle, Hilton
   Aaby, Peter
TI Measles Virus Antibody Responses in Children Randomly Assigned to
   Receive Standard-Titer Edmonston-Zagreb Measles Vaccine at 4.5 and 9
   Months of Age, 9 Months of Age, or 9 and 18 Months of Age
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE antibody response; early measles vaccination; Edmonston-Zagreb measles
   vaccine; non-specific effects of vaccines; two-dose measles vaccination
ID DIPHTHERIA-TETANUS-PERTUSSIS; FEMALE-MALE MORTALITY; GUINEA-BISSAU;
   UNVACCINATED CHILDREN; TRIAL; IMMUNIZATION; INHIBITION; STRATEGIES;
   INFANTS
AB The World Health Organization recommends administration of measles vaccine (MV) at age 9 months in low-income countries. We tested the measles virus antibody response at 4.5, 9, 18, and 24 months of age for children randomly assigned to receive standard-titer Edmonston-Zagreb MV at 4.5 and 9 months, at 9 months, or at 9 and 18 months of age. At 4.5 months of age, 75% had nonprotective measles virus antibody levels. Following receipt of MV at 4.5 months of age, 77% (316/408) had protective antibody levels at 9 months of age; after a second dose at 9 months of age, 97% (326/337) had protective levels at 24 months of age. In addition, the response at both 9 and 24 months of age was inversely correlated with the antibody level at receipt of the first dose of MV, and the second dose of MV, received at 9 months of age, provided a significant boost in antibody level to children who had low antibody levels. In the group of 318 children who received MV at 9 months of age, with or without a second dose at 18 months of age, 99% (314) had protective levels at 24 months of age. The geometric mean titer at 24 months of age was significantly lower in the group that received MV at 4.5 and 9 months of age than in the group that received MV at 9 months of age (P = .0001). In conclusion, an early 2-dose MV schedule was associated with protective measles virus antibody levels at 24 months of age in nearly all children.
C1 [Martins, Cesario; Garly, May-Lill; Bale, Carlitos; Rodrigues, Amabelia; Benn, Christine S.; Aaby, Peter] Bandim Hlth Project, Indepth Network, Bissau, Guinea Bissau.
   [Benn, Christine S.; Aaby, Peter] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines, Copenhagen, Denmark.
   [Njie-Jobe, Jainaba; Whittle, Hilton] MRC Labs, Fajara, Gambia.
RP Martins, C (reprint author), Bandim Hlth Project, Apartado 861, Bissau, Guinea Bissau.
EM c.martins@bandim.org
FU Danish Council for Development Research, Ministry of Foreign Affairs,
   Denmark [104.Dan.8.f.]; European Union FP7 Programme (OPTIMUNIZE)
   [261375]; ERC [ERC-2009-StG-243149]; Novo Nordisk Foundation; Danish
   National Research Foundation
FX This work was supported by the Danish Council for Development Research,
   Ministry of Foreign Affairs, Denmark (grant 104.Dan.8.f.); the European
   Union FP7 Programme (OPTIMUNIZE; grant 261375 to C. M.); an ERC Starting
   Grant (ERC-2009-StG-243149 to C. S. B.); the Novo Nordisk Foundation
   (professorship grant to P. A.); and the Danish National Research
   Foundation (to the Research Center for Vitamins and Vaccines).
CR Aaby P, 2006, VACCINE, V24, P4701, DOI 10.1016/j.vaccine.2006.03.038
   AABY P, 1995, BRIT MED J, V311, P481
   Aaby P, 2003, PEDIATR INFECT DIS J, V22, P798, DOI 10.1097/01.inf.0000083821.33187.b5
   Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3
   Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01
   Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000761
   Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000707
   Aaby P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6495
   Aaby P, 2009, LANCET, V373, P1428, DOI 10.1016/S0140-6736(09)60823-0
   Benn CS, 2012, PEDIATR INFECT DIS J, V31, P1095, DOI 10.1097/INF.0b013e318263135e
   da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d
   deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224
   Expanded Programme on Immunization, 1992, WKLY EPIDEMIOL REC, V67, P357
   Garly ML, 1999, INT J EPIDEMIOL, V28, P347, DOI 10.1093/ije/28.2.347
   Garly ML, 2001, VACCINE, V19, P1951, DOI 10.1016/S0264-410X(00)00431-X
   George K, 1998, TROP MED INT HEALTH, V3, P751, DOI 10.1046/j.1365-3156.1998.00295.x
   KHANUM S, 1987, LANCET, V1, P150
   Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199
   MARKOWITZ LE, 1987, PEDIATR INFECT DIS J, V6, P809, DOI 10.1097/00006454-198709000-00001
   Martins C, 2013, VACCINE, V31, P5766, DOI 10.1016/j.vaccine.2013.08.044
   Martins C, 2009, VACCINE, V27, P5220, DOI 10.1016/j.vaccine.2009.06.076
   Martins CL, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a661
   NORRBY E, 1962, P SOC EXP BIOL MED, V111, P814
   ROSENTHAL SR, 1993, B WORLD HEALTH ORGAN, V71, P421
   Sabin AB, 1984, JAMA, V249, P2651
   SAMB B, 1995, PEDIATR INFECT DIS J, V14, P203, DOI 10.1097/00006454-199503000-00007
   Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.3.CO;2-C
   Whittle H, 1990, LANCET, V336, P1048
   Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5
NR 29
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2014
VL 210
IS 5
BP 693
EP 700
DI 10.1093/infdis/jiu117
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AT0DQ
UT WOS:000344607800004
PM 24688075
OA No
DA 2017-08-15
ER

PT J
AU Howie, SRC
   Morris, GAJ
   Tokarz, R
   Ebruke, BE
   Machuka, EM
   Ideh, RC
   Chimah, O
   Secka, O
   Townend, J
   Dione, M
   Oluwalana, C
   Njie, M
   Jallow, M
   Hill, PC
   Antonio, M
   Greenwood, B
   Briese, T
   Mulholland, K
   Corrah, T
   Lipkin, WI
   Adegbola, RA
AF Howie, Stephen R. C.
   Morris, Gerard A. J.
   Tokarz, Rafal
   Ebruke, Bernard E.
   Machuka, Eunice M.
   Ideh, Readon C.
   Chimah, Osaretin
   Secka, Ousman
   Townend, John
   Dione, Michel
   Oluwalana, Claire
   Njie, Malick
   Jallow, Mariatou
   Hill, Philip C.
   Antonio, Martin
   Greenwood, Brian
   Briese, Thomas
   Mulholland, Kim
   Corrah, Tumani
   Lipkin, W. Ian
   Adegbola, Richard A.
TI Etiology of Severe Childhood Pneumonia in The Gambia, West Africa,
   Determined by Conventional and Molecular Microbiological Analyses of
   Lung and Pleural Aspirate Samples
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE etiology; pneumonia; children; Gambia; lung aspirate
ID STREPTOCOCCUS-PNEUMONIAE; CHILDREN; PCR; DIAGNOSIS; DISEASE
AB Molecular analyses of lung aspirates from Gambian children with severe pneumonia detected pathogens more frequently than did culture and showed a predominance of bacteria, principally Streptococcus pneumoniae, >75% being of serotypes covered by current pneumococcal conjugate vaccines. Multiple pathogens were detected frequently, notably Haemophilus influenzae (mostly nontypeable) together with S. pneumoniae.
C1 [Howie, Stephen R. C.; Morris, Gerard A. J.; Ebruke, Bernard E.; Machuka, Eunice M.; Ideh, Readon C.; Chimah, Osaretin; Secka, Ousman; Townend, John; Dione, Michel; Oluwalana, Claire; Antonio, Martin; Corrah, Tumani; Adegbola, Richard A.] MRC Unit, Fajara, Gambia.
   [Tokarz, Rafal; Briese, Thomas; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY USA.
   [Njie, Malick; Jallow, Mariatou] Minist Hlth & Social Welf, Banjul, Gambia.
   [Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand.
   [Greenwood, Brian; Mulholland, Kim] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium.
RP Howie, SRC (reprint author), MRC Unit, POB 273, Banjul, Gambia.
EM showie@mrc.gm
FU MRC; Bill & Melinda Gates Foundation
FX This work was supported by the MRC and the Bill & Melinda Gates
   Foundation.
CR ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008
   Briese T, 2005, EMERG INFECT DIS, V11, P310
   Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003
   Carrol ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021042
   Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005
   Enright MC, 1998, MICROBIOL-UK, V144, P3049
   Ideh R, 2010, INT J TUBERC LUNG D, V15, P729
   Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003
   Morris GAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001773
   Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09
   Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257
   Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769
   Scott JAG, 1999, CHEST, V116, P1716, DOI 10.1378/chest.116.6.1716
   SHANN F, 1984, LANCET, V2, P537
   Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10
   Tokarz R, 2013, J CLIN MICROBIOL, V51, P995, DOI 10.1128/JCM.02974-12
   Tokarz R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-288
NR 19
TC 15
Z9 15
U1 1
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 1
PY 2014
VL 59
IS 5
BP 682
EP 685
DI 10.1093/cid/ciu384
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AQ6KQ
UT WOS:000342921100017
PM 24867789
OA No
DA 2017-08-15
ER

PT J
AU Valea, I
   Tinto, H
   Coulibaly, MT
   Toe, LC
   Lindegardh, N
   Tarning, J
   Van Geertruyden, JP
   D'Alessandro, U
   Davies, GR
   Ward, SA
AF Valea, Innocent
   Tinto, Halidou
   Coulibaly, Maminata Traore
   Toe, Laeticia C.
   Lindegardh, Niklas
   Tarning, Joel
   Van Geertruyden, Jean-Pierre
   D'Alessandro, Umberto
   Davies, Geraint R.
   Ward, Stephen A.
TI Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant
   and non-pregnant women with uncomplicated Plasmodium falciparum
   infection in Burkina Faso
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE PK; antimalarials; pregnancy
ID POPULATION PHARMACOKINETICS; ARTEMETHER-LUMEFANTRINE; MALARIA;
   DIHYDROARTEMISININ; BURDEN; EFFICACY; EPIDEMIOLOGY; CHLOROQUINE;
   COMBINATION; PROPHYLAXIS
AB Objectives: Mefloquine/artesunate has recently been developed as a fixed-dose combination, providing a promising rescue/alternative treatment for malaria during pregnancy. However, limited data are available on the effect of pregnancy on its pharmacokinetic properties. This study was conducted to assess the pharmacokinetic properties of mefloquine/carboxymefloquine and artesunate/dihydroartemisinin in pregnant and non-pregnant women with uncomplicated malaria.
   Methods: Twenty-four women in their second and third trimesters of pregnancy and 24 paired non-pregnant women were enrolled. All patients were treated for uncomplicated Plasmodium falciparum malaria with a standard fixed-dose combination of oral mefloquine and artesunate one daily over 3 days. Frequent blood samples were collected before treatment and at scheduled times post-dose for the drug measurements and pharmacokinetic analyses. The study was registered at www.clinicaltrials.gov (identifier: NCT00701961).
   Results: The total median exposure to mefloquine and dihydroartemisinin was not significantly different between the pregnant and non-pregnant women (P > 0.05). There was a trend of higher exposure to mefloquine in the pregnant women, but this difference did not reach statistical significance (656700 versus 542400 hxng/mL; P = 0.059). However, the total exposure to carboxymefloquine was 49% lower during pregnancy (735600 versus 1499000 hxng/mL; P < 0.001) and the total drug exposure to artesunate was 42% higher during pregnancy (89.0 versus 62.9 hxng/mL; P = 0.039) compared with non-pregnant controls.
   Conclusions: The plasma levels of mefloquine and dihydroartemisinin appeared to be similar in both pregnant and non-pregnant women, but there were significant differences in carboxymefloquine and artesunate exposure. The data presented here do not warrant a dose adjustment in pregnant patients, but an extensive analysis of the data could provide a better understanding of these findings.
C1 [Valea, Innocent; Tinto, Halidou; Toe, Laeticia C.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso.
   [Valea, Innocent; Coulibaly, Maminata Traore] Inst Rech Sci Sante, Unite Rech Clin Nanoro, Nanoro, Burkina Faso.
   [Tinto, Halidou; Coulibaly, Maminata Traore] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso.
   [Lindegardh, Niklas; Tarning, Joel] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.
   [Lindegardh, Niklas; Tarning, Joel] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England.
   [Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.
   [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, Dept Parasitol, Unit Epidemiol & Control Parasit Dis, B-2000 Antwerp, Belgium.
   [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia.
   [Davies, Geraint R.] Univ Liverpool, Inst Global Hlth, Liverpool L69 3BX, Merseyside, England.
   [Davies, Geraint R.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.
   [Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
RP Valea, I (reprint author), Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso.
EM innocentvalea@yahoo.fr
RI Van geertruyden, Jean-pierre/K-6425-2014; D'Alessandro,
   Umberto/D-3457-2015
OI Van geertruyden, Jean-pierre/0000-0001-5006-6364; D'Alessandro,
   Umberto/0000-0001-6341-5009; Ward, Steve/0000-0003-2331-3192
FU Malaria in Pregnancy (MiP) Consortium, through Bill & Melinda Gates
   Foundation; Wellcome Trust of Great Britain
FX This publication is supported and endorsed by the Malaria in Pregnancy
   (MiP) Consortium, which is funded through a grant from the Bill &
   Melinda Gates Foundation to the Liverpool School of Tropical Medicine.
   The Mahidol-Oxford Tropical Medicine Research Unit is supported by the
   Wellcome Trust of Great Britain.
CR BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005
   Briand V, 2008, J INFECT DIS, V198, P594, DOI 10.1086/590114
   Bukirwa H, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004531.pub2
   Dawes M, 2001, BEST PRACT RES CL OB, V15, P819, DOI 10.1053/beog.2001.0231
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Diourte Y, 2005, AM J TROP MED HYG, V52, P475
   Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013
   Guyatt HL, 2001, AM J TROP MED HYG, V64, P36
   Hanpithakpong W, 2008, J CHROMATOGR B, V876, P61, DOI 10.1016/j.jchromb.2008.10.018
   KARBWANG J, 1994, B WORLD HEALTH ORGAN, V72, P83
   Kayentao K, 2007, ACTA TROP, V102, P106, DOI 10.1016/j.actatropica.2007.04.005
   Lagerberg RE, 2008, J MIDWIFERY WOM HEAL, V53, P209, DOI 10.1016/j.jmwh.2008.02.012
   McGready R, 2006, EUR J CLIN PHARMACOL, V62, P1021, DOI 10.1007/s00228-006-0199-7
   McGready R, 2012, BRIT J CLIN PHARMACO, V73, P467, DOI 10.1111/j.1365-2125.2011.04103.x
   Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5
   Morris CA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-114
   Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3
   Na BK, 1994, T R SOC TROP MED HYG, V88, P321
   NOSTEN F, 1990, BRIT J CLIN PHARMACO, V30, P79
   Nosten F, 2007, AM J TROP MED HYG, V77, P181
   Onyamboko MA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-49
   Schlagenhauf P, 2012, CLIN INFECT DIS, V54, pe124, DOI 10.1093/cid/cis215
   Steketee RW, 1996, AM J TROP MED HYG, V55, P24
   Steketee RW, 2001, AM J TROP MED HYG, V64, P28
   Tagbor H, 2008, TROP MED INT HEALTH, V13, P1016, DOI 10.1111/j.1365-3156.2008.02111.x
   Tarning J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-293
   Tarning J, 2012, ANTIMICROB AGENTS CH, V56, P1997, DOI 10.1128/AAC.05756-11
   Tarning J, 2009, ANTIMICROB AGENTS CH, V53, P3837, DOI 10.1128/AAC.00195-09
   World Health Organization, 2010, GUID TREATM MAL
   WHO, 2007, METH TECHN CLIN TRIA
   Wilby KJ, 2011, CLIN PHARMACOKINET, V50, P705, DOI 10.2165/11594550-000000000-00000
   Ye X Y, 1992, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V10, P120
NR 32
TC 7
Z9 7
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD SEP
PY 2014
VL 69
IS 9
BP 2499
EP 2507
DI 10.1093/jac/dku154
PG 9
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA AR1DL
UT WOS:000343322200026
PM 24891429
OA No
DA 2017-08-15
ER

PT J
AU Ozor, FU
AF Ozor, Frederick U.
TI Research governance and scientific knowledge production in The Gambia
SO SOUTH AFRICAN JOURNAL OF SCIENCE
LA English
DT Article
DE research; governance; scientific; performance; practices
ID PUBLIC MANAGEMENT; CREATIVITY; MATTER
AB Public research institutions and scientists are principal actors in the production and transfer of scientific knowledge, technologies and innovations for application in industry as well for social and economic development. Based on the relevance of science and technology actors, the aim of this study was to identify and explain factors in research governance that influence scientific knowledge production and to contribute to empirical discussions on the impact levels of different governance models and structures. These discussions appear limited and mixed in the literature, although still are ongoing. No previous study has examined the possible contribution of the scientific committee model of research governance to scientific performance at the individual level of the scientist. In this context, this study contributes to these discussions, firstly, by suggesting that scientific committee structures with significant research steering autonomy could contribute not only directly to scientific output but also indirectly through moderating effects on research practices. Secondly, it is argued that autonomous scientific committee structures tend to play a better steering role than do management-centric models and structures of research governance.
C1 [Ozor, Frederick U.] Univ Gambia, Humanities & Social Sci Dept, Serekunda, Gambia.
RP Ozor, FU (reprint author), Ebonyi State Univ, Dept Publ Adm, Abakiliki, Nigeria.
EM f_oz_or@hotmail.com
CR Amabile TM, 1998, HARVARD BUS REV, V76, P76
   Amabile TM, 1996, ACAD MANAGE J, V39, P1154, DOI 10.2307/256995
   Armstrong J. S., 1997, SCI ENG ETHICS, V3, P63, DOI DOI 10.1007/S11948-997-0017-3
   Babchuk WA, 2011, US CHINA ED REV, V3, P383
   Braun D, 1999, NEW MANAGERIALISM GO, P934
   Butler L., 2007, SCI PUBL POLICY, V34, P565, DOI DOI 10.3152/030234207X254404
   Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x
   Creswell J., 2007, QUALITATIVE INQUIRY
   D'Souza C, 2006, SOC SCI MED, V62, P2072, DOI 10.1016/j.socscimed.2005.08.022
   Dewett D, 2004, SCIENTOMETRICS, V60, P249
   Educational Research Network for West and Central Africa (ERNWACA), 2007, STUD EXT WHICH SOC P
   Veltri G, 2009, TRENDS R D POLICIES
   Gillies D., 2008, SHOULD RES BE ORG
   Glaser B., 1967, DISCOVERY GROUNDED T
   Glaser B. G., 2002, INT J QUAL METH, V1, P23
   Glaser B., 2004, FORUM QUALITATIVE SO, V5
   GOTG, 2006, ED SECT STRAT PLAN 2
   Goulding C., 2002, GROUNDED THEORY PRAC
   Hayati Z, 2009, SCIENTOMETRICS, V80, P625, DOI 10.1007/s11192-009-2094-3
   Horta H, 2011, SCI PUBL POLICY, V38, P449, DOI 10.3152/030234211X12960315267813
   Ivankova NV, 2009, QUALITATIVE RESEARCH IN APPLIED LINGUISTICS: A PRACTICAL INTRODUCTION, P135
   Johnson R.B., 2004, ED RES, V33, P14, DOI DOI 10.3102/0013189X033007014
   Jones Robert, 2007, Qualitative Research in Organizations and Management, V2, P84, DOI 10.1108/17465640710778502
   Kirigia JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-135
   Lacetera N, 2004, ADV STRATEG MANAGE, P21
   Moed H. F., 2007, SCI PUBL POLICY, V34, P575, DOI [10.3152/030234207X255179, DOI 10.3152/030234207X255179]
   Mudambi R, 2007, J PROD INNOVAT MANAG, V24, P442, DOI 10.1111/j.1540-5885.2007.00262.x
   Osterloh M, 2009, 2797 CESIFO
   Ozor FU, 2013, THESIS ST CLEMENTS U
   Schimank U, 2005, MINERVA, V43, P361, DOI 10.1007/s11024-005-2472-9
   Schimank U, 2007, GOVERNANCE SCHULE PO, P231
   Schubert T, 2009, RES POLICY, V38, P1225, DOI 10.1016/j.respol.2009.06.007
   Song J, 2003, MANAGE SCI, V49, P351, DOI 10.1287/mnsc.49.4.351.14429
   Stokols D, 2005, AM J PREV MED, V28, P202, DOI 10.1016/j.amepre.2004.10.016
   University of Melbourne, 2011, MELB RES
   Villani C, 2010, ANZMAC 2010 DOING MO
   Weingart P, 2005, SCIENTOMETRICS, V62, P117, DOI 10.1007/s11192-005-0007-7
NR 37
TC 0
Z9 0
U1 0
U2 4
PU ACAD SCIENCE SOUTH AFRICA A S S AF
PI LYNWOOD RIDGE
PA PO BOX 72135, LYNWOOD RIDGE 0040, SOUTH AFRICA
SN 0038-2353
EI 1996-7489
J9 S AFR J SCI
JI S. Afr. J. Sci.
PD SEP-OCT
PY 2014
VL 110
IS 9-10
BP 17
EP 25
AR 2013-0185
DI 10.1590/sajs.2014/20130185
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ9BA
UT WOS:000343134100005
OA gold
DA 2017-08-15
ER

PT J
AU Caputo, B
   Nwakanma, D
   Caputo, FP
   Jawara, M
   Oriero, EC
   Hamid-Adiamoh, M
   Dia, I
   Konate, L
   Petrarca, V
   Pinto, J
   Conway, DJ
   Della Torre, A
AF Caputo, B.
   Nwakanma, D.
   Caputo, F. P.
   Jawara, M.
   Oriero, E. C.
   Hamid-Adiamoh, M.
   Dia, I.
   Konate, L.
   Petrarca, V.
   Pinto, J.
   Conway, D. J.
   Della Torre, A.
TI Prominent intraspecific genetic divergence within Anopheles gambiae
   sibling species triggered by habitat discontinuities across a riverine
   landscape
SO MOLECULAR ECOLOGY
LA English
DT Article
DE genetics; landscape; molecular evolution; mosquitoes; parasitology;
   population genetics-empirical; speciation
ID MOLECULAR-FORMS; MALARIA VECTOR; POPULATION-STRUCTURE; INCIPIENT
   SPECIATION; WEST-AFRICA; S FORMS; DIFFERENTIATION MEASURE; HELICONIUS
   BUTTERFLIES; ECOLOGICAL SPECIATION; PLASMODIUM-FALCIPARUM
AB The Anopheles gambiae complex of mosquitoes includes malaria vectors at different stages of speciation, whose study enables a better understanding of how adaptation to divergent environmental conditions leads to evolution of reproductive isolation. We investigated the population genetic structure of closely related sympatric taxa that have recently been proposed as separate species (An. coluzzii and An. gambiae), sampled from diverse habitats along the Gambia river in West Africa. We characterized putatively neutral microsatellite loci as well as chromosomal inversion polymorphisms known to be associated with ecological adaptation. The results revealed strong ecologically associated population subdivisions within both species. Microsatellite loci on chromosome-3L revealed clear differentiation between coastal and inland populations, which in An. coluzzii is reinforced by a unusual inversion polymorphism pattern, supporting the hypothesis of genetic divergence driven by adaptation to the coastal habitat. A strong reduction of gene flow was observed between An. gambiae populations west and east of an extensively rice-cultivated region apparently colonized exclusively by An. coluzzii. Notably, this 'intraspecific' differentiation is higher than that observed between the two species and involves also the centromeric region of chromosome-X which has previously been considered a marker of speciation within this complex, possibly suggesting that the two populations may be at an advanced stage of differentiation triggered by human-made habitat fragmentation. These results confirm ongoing ecological speciation within these most important Afro-tropical malaria vectors and raise new questions on the possible effect of this process in malaria transmission.
C1 [Caputo, B.; Caputo, F. P.; Della Torre, A.] Univ Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Sanita Pubbl & Malattie Infett, I-00185 Rome, Italy.
   [Nwakanma, D.; Jawara, M.; Oriero, E. C.; Hamid-Adiamoh, M.; Conway, D. J.] MRC Unit, Banjul, Gambia.
   [Dia, I.] Inst Pasteur, Dakar, Senegal.
   [Konate, L.] Univ Dakar, Dakar, Senegal.
   [Petrarca, V.] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, Dipartimento Biol & Biotecnol, I-00185 Rome, Italy.
   [Pinto, J.] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, Inst Higiene & Med Trop, P-1349008 Lisbon, Portugal.
RP Caputo, B (reprint author), Univ Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Sanita Pubbl & Malattie Infett, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM beniamino.caputo@uniroma1.it
RI ; Caputo, Beniamino/I-2880-2015; Pinto, Joao/C-2208-2012
OI Conway, David/0000-0002-8711-3037; Caputo,
   Beniamino/0000-0002-5650-8773; Pinto, Joao/0000-0001-8572-7708
FU UK Medical Research Council (MRC); MIUR-FIRB [RBFR106NTE]; Universita di
   Roma SAPIENZA
FX This piece of work originates from the seeds of inspiration that Mario
   Coluzzi planted in each of us. We are grateful to Emiliano Mancini,
   David Weetman and the two anonymous reviewers for comments and
   suggestions to improve the manuscript. This work was supported by UK
   Medical Research Council (MRC) funding for the Malaria Research
   Programme of the MRC Gambia Unit, MIUR-FIRB 'Futuro in Ricerca 2010'
   Grant to BC (Grant No RBFR106NTE), and by Ricerca Scientifica 2012 Grant
   by Universita di Roma SAPIENZA to AdT.
CR Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323
   Ashburner M, 1986, GENETICS BIOL DROSOP, V3
   Ayala D, 2011, MOL BIOL EVOL, V28, P745, DOI 10.1093/molbev/msq248
   Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102
   Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237
   Bogh C, 2003, B ENTOMOL RES, V93, P279, DOI 10.1079/BER2003239
   Boissiere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054820
   BRYAN JH, 1982, GENETICA, V59, P167, DOI 10.1007/BF00056539
   Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182
   Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415
   Cassone BJ, 2014, MOL ECOL, V23, P2242, DOI 10.1111/mec.12733
   Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x
   Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2
   COLUZZI M, 1985, B ZOOL, V52, P45
   Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769
   COLUZZI M, 1977, NATURE, V266, P832, DOI 10.1038/266832a0
   COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1
   Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143
   COLUZZI M, 1973, MOSQ NEWS, V33, P249
   Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154
   DAVIDSON G, 1964, B WORLD HEALTH ORGAN, V31, P625
   DAVIDSON G, 1962, B WORLD HEALTH ORGAN, V27, P303
   della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x
   della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006
   Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5
   Donnelly MJ, 1999, HEREDITY, V83, P408, DOI 10.1038/sj.hdy.6885930
   Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353
   Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106
   Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923
   Fryxell RTT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-133
   Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111
   Gimonneau G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-65
   Gimonneau G, 2010, BEHAV ECOL, V21, P1087, DOI 10.1093/beheco/arq114
   Goudet J, 2001, FSTAT PROGRAM ESTIMA
   Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x
   HOLM S, 1979, SCAND J STAT, V6, P65
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13
   Kalinowski ST, 2008, COMPUTER PROGRAM EVA
   Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647
   Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1
   Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110
   Lee Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057887
   Lee Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-75
   Legendre L, 1983, NUMERICAL ECOLOGY
   Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613
   Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024
   Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003
   Li ZM, 2011, THEOR APPL GENET, V123, P21, DOI 10.1007/s00122-011-1563-2
   Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105
   Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x
   Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113
   Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x
   Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x
   Michel AP, 2005, MOL ECOL, V14, P4235, DOI 10.1111/j.1365-294X.2005.02754.x
   Mousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895
   Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198
   Ndiath MO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-269
   Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018
   Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036
   Nei M., 1987, MOL EVOLUTIONARY GEN
   Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011
   Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718
   Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2
   PETRARCA V, 1983, Parassitologia (Rome), V25, P29
   Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075
   Pombi Marco, 2008, BMC Evol Biol, V8, P309, DOI 10.1186/1471-2148-8-309
   Pritchard JK, 2000, GENETICS, V155, P945
   Quantum GIS, 2011, QUANTUM GIS GEOGRAPH
   Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095
   Robert V., 1991, Le paludisme en Afrique de l'ouest: etudes entomologiques et epidemiologiques en zone rizicole et en milieu urbain., P17
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x
   Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163
   Shafer ABA, 2013, ECOL LETT, V16, P940, DOI 10.1111/ele.12120
   Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x
   Stump AD, 2005, GENETICS, V169, P1509, DOI 10.1534/genctics.104.035303
   Torre A. della, 1997, The molecular biology of insect disease vectors: a methods manual., P329
   Toure Y. T., 1998, Parassitologia (Rome), V40, P477
   TOURE YT, 1994, GENETICA, V94, P213, DOI 10.1007/BF01443435
   Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285
   Wang R, 1999, PARASITOL TODAY, V15, P33, DOI 10.1016/S0169-4758(98)01360-X
   Wang-Sattler R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001249
   Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x
   White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108
   Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2
   Wood SA, 2013, BIOMES ECOSYSTEMS EN, P584
   Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888
   Zheng LB, 1996, GENETICS, V143, P941
NR 93
TC 5
Z9 5
U1 3
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1083
EI 1365-294X
J9 MOL ECOL
JI Mol. Ecol.
PD SEP
PY 2014
VL 23
IS 18
BP 4574
EP 4589
DI 10.1111/mec.12866
PG 16
WC Biochemistry & Molecular Biology; Ecology; Evolutionary Biology
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology;
   Evolutionary Biology
GA AQ4DU
UT WOS:000342743400013
PM 25040079
OA No
DA 2017-08-15
ER

PT J
AU Ward, KA
   Cole, TJ
   Laskey, MA
   Ceesay, M
   Mendy, MB
   Sawo, Y
   Prentice, A
AF Ward, K. A. y
   Cole, T. J.
   Laskey, M. A.
   Ceesay, M.
   Mendy, M. B.
   Sawo, Y.
   Prentice, A.
TI The Effect of Prepubertal Calcium Carbonate Supplementation on Skeletal
   Development in Gambian Boys-A 12-Year Follow-Up Study
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID BONE-MINERAL DENSITY; ADOLESCENT GIRLS; CONTROLLED-TRIAL; MASS;
   CHILDREN; ACCRETION; INTERVENTION; GROWTH; DIET; DISCONTINUATION
AB Context: Calcium intake during growth is essential for future bone health but varies widely between individuals and populations. The impact on bone of increasing calcium intake is unknown in a population where low calcium intake, stunting, and delayed puberty are common.
   Objective: To determine the effect of prepubertal calcium supplementation on mean age at peak velocity for bone growth and mineral accrual.
   Design and Setting: Prospective follow-up of boys in rural Gambia, West Africa, who had participated in a double-blind, randomized, placebo-controlled trial of calcium supplementation.
   Participants: Eighty boys, initially aged 8.0-11.9 years, were followed up for 12 years.
   Interventions: Subjects received 1 year of calcium carbonate supplementation (1000 mg daily, 5 d/wk).
   Main Outcome Measures: Dual-energy x-ray absorptiometry measurements were carried out for whole body (WB), lumbar spine, and total hip bone mineral content, bone area (BA), and WB lean mass. Super imposition by translation and rotation models was made to assess bone growth.
   Results: Age at peak velocity was consistently earlier in the calcium group compared to the placebo group, for WB bone mineral content (mean, -6.2 [SE, 3.1]; P = .05), WB BA (mean, -7.0 [SE, 3.2] mo; P = .03), lumbar spine and total hip BA. By young adulthood, supplementation did not change the amount of bone accrued (mineral or size) or the rate of bone growth.
   Conclusions: Twelve months of prepubertal calcium carbonate supplementation in boys with a low calcium diet advanced the adolescent growth spurt but had no lasting effect on bone mineral or bone size. There is a need for caution when applying international recommendations to different populations.
C1 [Ward, K. A. y; Laskey, M. A.; Prentice, A.] Med Res Council Human Nutr Res, Cambridge CB1 9NL, England.
   [Cole, T. J.] UCL, Populat Policy & Practice Programme, Inst Child Hlth, London WC1N 1EH, England.
   [Ceesay, M.; Mendy, M. B.; Sawo, Y.; Prentice, A.] MRC, Keneba, Gambia.
RP Ward, KA (reprint author), MRC Human Nutr Res, Elsie Widdowson Lab, 120 Fulbourn Rd, Cambridge CB1 9NL, England.
EM kate.ward@mrc-hnr.cam.ac.uk
RI Cole, Tim/B-7883-2008
OI Cole, Tim/0000-0001-5711-8200
FU Medical Research Council (MRC); Department for International Development
   (DFID) under the MRC/DFID Concordat agreement program [U105960371,
   U123261351, MR/J004839/1]
FX This research is jointly funded by the Medical Research Council (MRC)
   and the Department for International Development (DFID) under the
   MRC/DFID Concordat agreement program no. U105960371, U123261351, and
   MR/J004839/1.
CR Bailey DA, 2000, J BONE MINER RES, V15, P2245, DOI 10.1359/jbmr.2000.15.11.2245
   Baxter-Jones ADG, 2011, J BONE MINER RES, V26, P1729, DOI 10.1002/jbmr.412
   Binkley T, 2004, BONE, V35, P1383, DOI 10.1016/j.bone.2004.08.012
   Bonjour JP, 2001, LANCET, V358, P1208, DOI 10.1016/S0140-6736(01)06342-5
   Cadogan J, 1997, BRIT MED J, V315, P1255
   Chevalley T, 2005, J CLIN ENDOCR METAB, V90, P3342, DOI 10.1210/jc.2004-1455
   Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115
   Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F
   Crabtree NJ, 2005, OSTEOPOROSIS INT, V16, P2157, DOI 10.1007/s00198-005-2021-2
   Dibba B, 2002, AM J CLIN NUTR, V76, P681
   Dibba B, 2000, AM J CLIN NUTR, V71, P544
   Eastell R, 2002, CALCIFIED TISSUE INT, V70, P400, DOI 10.1007/s00223-001-0047-9
   Ginty F, 2004, NUTR ASPECTS OSTEOPO, P45, DOI 10.1016/B978-012141704-8/50043-X
   HEANEY RP, 1994, J BONE MINER RES, V9, P1515
   Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020
   Institute of Medicine, 2010, DIETARY REFERENCE IN
   JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204
   Lambert HL, 2008, AM J CLIN NUTR, V87, P455
   Laskey MA, 2010, J CLIN DENSITOM, V13, P247, DOI 10.1016/j.jocd.2010.05.005
   MATKOVIC V, 1990, AM J CLIN NUTR, V52, P878
   MATKOVIC V, 1994, J CLIN INVEST, V93, P799, DOI 10.1172/JCI117034
   Matkovic Velimir, 2005, American Journal of Clinical Nutrition, V81, P175
   Prentice A, 2005, J CLIN ENDOCR METAB, V90, P3153, DOI 10.1210/jc.2004-2114
   Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590
   PRENTICE A, 1994, AM J CLIN NUTR, V60, P837
   Prentice A, 2012, AM J CLIN NUTR, V96, P1042, DOI 10.3945/ajcn.112.037481
   Rauch F, 2004, BONE, V34, P771, DOI 10.1016/j.bone.2004.01.022
   Rayco-Solon P, 2004, TROP MED INT HEALTH, V9, P1151, DOI 10.1111/j.1365-3156.2004.01325.x
   Remer T, 2002, LANCET, V359, P2037, DOI 10.1016/S0140-6736(02)08800-1
   Seeman E, 1999, NUTR BONE DEV, P245
   [Anonymous], 1998, NAT STAND PEOPL REP, P1
   Umaretiya PJ, 2013, BONE, V55, P64, DOI 10.1016/j.bone.2013.03.017
   Winzenberg T, 2006, BRIT MED J, V333, P775, DOI 10.1136/bmj.38950.561400.55
   Zhu K, 2006, AM J CLIN NUTR, V83, P714
   Zhu K, 2005, AM J CLIN NUTR, V81, P1168
NR 35
TC 5
Z9 5
U1 0
U2 4
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD SEP
PY 2014
VL 99
IS 9
BP 3169
EP 3176
DI 10.1210/jc.2014-1150
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AP8PQ
UT WOS:000342341400053
PM 24762110
OA No
DA 2017-08-15
ER

PT J
AU Jones, KS
   Assar, S
   Harnpanich, D
   Bouillon, R
   Lambrechts, D
   Prentice, A
   Schoenmakers, I
AF Jones, K. S.
   Assar, S.
   Harnpanich, D.
   Bouillon, R.
   Lambrechts, D.
   Prentice, A.
   Schoenmakers, I.
TI 25(OH)D-2 Half-Life Is Shorter Than 25(OH)D-3 Half-Life and Is
   Influenced by DBP Concentration and Genotype
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID D-BINDING PROTEIN; VITAMIN-D DEFICIENCY; SERUM 25-HYDROXYVITAMIN D;
   PLASMA-CONCENTRATIONS; D-2; CHOLECALCIFEROL; ERGOCALCIFEROL; MECHANISM;
   WOMEN; SUPPLEMENTATION
AB Context: There is uncertainty over the equivalence of vitamins D-2 and D-3 to maintain plasma 25-hydroxyvitamin D (25(OH)D).
   Objective: The objective of the study was to compare the plasma half-lives of 25(OH)D-2 and 25(OH)D-3 in two distinct populations with different dietary calcium intake and 25(OH)D status.
   Participants: Healthy men (aged 24 and 39 y), resident in The Gambia (n = 18) or the United Kingdom (n = 18) participated in the study.
   Interventions: The intervention included an oral tracer dose of deuterated-25(OH)D-2 and deuterated-25(OH)D-3 (both 40 nmol). Blood samples were collected over 33 days.
   Main Outcome Measures: 25(OH)D-2 and 25(OH)D-3 plasma half-lives, concentrations of 25(OH)D, and vitamin D binding protein (DBP) and DBP genotypes were measured.
   Results: 25(OH)D-2 half-life [mean (SD)] [13.9 (2.6) d] was shorter than 25(OH)D-3 half-life [15.1 (3.1) d; P = .001] for countries combined, and in Gambians [12.8 (2.3) d vs 14.7 (3.5) d; P < .001], but not in the United Kingdom [15.1 (2.4) d vs 15.6 (2.5) d; P = .3]. 25(OH)D concentration was 69 (13) and 29 (11) nmol/L (P < .0001), and the DBP concentration was 259 (33) and 269 (23) mg/L (P = .4) in The Gambia and United Kingdom, respectively. Half-lives were positively associated with plasma DBP concentration for countries combined [25(OH)D-2 half-life: regression coefficient (SE) 0.03 (0.01) d per 1 mg/L DBP, P = .03; 25(OH)D-3 half-life: 0.04 (0.02) d, P = .02] and in Gambians[25(OH)D-2 half-life: 0.04 (0.01) d; P = .02; 25(OH)D-3 half-life: 0.06 (0.02) d, P = .01] but not in UK participants. The DBP concentration x country interactions were not significant. DBP Gc1f/1f homozygotes had shorter 25(OH)D-2 half-lives compared with other combined genotypes (P = .007) after correction for country.
   Conclusions: 25(OH)D-2 half-life was shorter than 25(OH)D-3 half-life, and half-lives were affected by DBP concentration and genotype. The stable isotope 25(OH)D half-life measurements provide a novel tool to investigate vitamin D metabolism and vitamin D expenditure and aid in the assessment of vitamin D requirements.
C1 [Jones, K. S.; Assar, S.; Harnpanich, D.; Prentice, A.; Schoenmakers, I.] Med Res Council Human Nutr Res, Cambridge CB1 9NL, England.
   [Jones, K. S.; Prentice, A.] Med Res Council Keneba, Keneba, Gambia.
   [Bouillon, R.] Katholieke Univ Leuven, Clin & Lab Expt Med & Endocrinol, B-3000 Leuven, Belgium.
   [Lambrechts, D.] Katholieke Univ Leuven, Lab Translat Genet, B-3000 Leuven, Belgium.
   [Lambrechts, D.] Katholieke Univ Leuven, Vesalius Res Ctr, VIB, B-3000 Leuven, Belgium.
RP Jones, KS (reprint author), Med Res Council Human Nutr Res, Elsie Widdowson Lab, Fulbourn Rd, Cambridge CB1 9NL, England.
EM kerry.jones@mrc-hnr.cam.ac.uk
OI Jones, Kerry/0000-0002-7380-9797
FU Medical Research Council [U105960371, U123261351, MC-A760-5QX00];
   Department for International Development under the Medical Research
   Council/Department for International Development Concordat agreement
FX This work was jointly supported by the Medical Research Council (Program
   Grants U105960371, U123261351, and MC-A760-5QX00) and the Department for
   International Development under the Medical Research Council/Department
   for International Development Concordat agreement.
CR Abboud M, 2013, ENDOCRINOLOGY, V154, P3022, DOI 10.1210/en.2012-2245
   Anderson PH, 2010, J STEROID BIOCHEM, V121, P288, DOI 10.1016/j.jsbmb.2010.03.022
   Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360
   Biancuzzo RM, 2010, AM J CLIN NUTR, V91, P1621, DOI 10.3945/ajcn.2009.27972
   Binkley N, 2011, J CLIN ENDOCR METAB, V96, P981, DOI 10.1210/jc.2010-0015
   BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172/JCI110072
   BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8
   BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225
   Bouillon R., 2011, VITAMIN D, P57
   Casetta B, 2010, EUR J MASS SPECTROM, V16, P81, DOI 10.1255/ejms.1024
   Chun RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030773
   Chun RF, 2014, J STEROID BIOCHEM, DOI [10.1016/j/jsbmb.2013.09.12, DOI 10.1016/J/JSBMB.2013.09.12]
   CLEMENTS MR, 1992, CLIN ENDOCRINOL, V37, P17, DOI 10.1111/j.1365-2265.1992.tb02278.x
   CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038/325062a0
   Demetriou ETW, 2012, ENDOCR PRACT, V18, P399, DOI 10.4158/EP11268.OR
   Ding SJ, 2010, ANAL BIOANAL CHEM, V398, P779, DOI 10.1007/s00216-010-3993-0
   Duplessis CA, 2005, AVIAT SPACE ENVIR MD, V76, P569
   Fisk CM, 2012, J NUTR, V142, P1286, DOI 10.3945/jn.111.156166
   Glendenning P, 2009, BONE, V45, P870, DOI 10.1016/j.bone.2009.07.015
   Hatse S, 2012, CARCINOGENESIS, V33, P1319, DOI 10.1093/carcin/bgs187
   Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230
   Holick MF, 2008, J CLIN ENDOCR METAB, V93, P677, DOI 10.1210/jc.2007-2308
   HOLLIS BW, 1984, J STEROID BIOCHEM, V21, P81, DOI 10.1016/0022-4731(84)90063-3
   Institute of Medicine, 2011, DIETARY REFERENCE IN
   Jones KS, 2012, BRIT J NUTR, V107, P1128, DOI 10.1017/S0007114511004132
   KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950
   Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5
   LAWSON DEM, 1986, CLIN CHIM ACTA, V157, P175, DOI 10.1016/0009-8981(86)90223-8
   Pietras SM, 2009, ARCH INTERN MED, V169, P1806, DOI 10.1001/archinternmed.2009.361
   Porter Travis R., 2013, Frontiers in Genetics, V4, P234, DOI 10.3389/fgene.2013.00234
   Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357
   Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387
   Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x
   Romagnoli E, 2008, J CLIN ENDOCR METAB, V93, P3015, DOI 10.1210/jc.2008-0350
   Schoenmakers I, 2010, J STEROID BIOCHEM, V121, P217, DOI 10.1016/j.jsbmb.2010.03.012
   Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445
   Thacher TD, 2009, J CLIN ENDOCR METAB, V94, P3314, DOI 10.1210/jc.2009-0018
   Toutain PL, 2004, J VET PHARMACOL THER, V27, P427, DOI 10.1111/j.1365-2885.2004.00600.x
   Trang HM, 1998, AM J CLIN NUTR, V68, P854
   Wagner D, 2011, J STEROID BIOCHEM, V126, P72, DOI 10.1016/j.jsbmb.2011.05.003
NR 40
TC 39
Z9 40
U1 1
U2 12
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD SEP
PY 2014
VL 99
IS 9
BP 3373
EP 3381
DI 10.1210/jc.2014-1714
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AP8PQ
UT WOS:000342341400078
PM 24885631
OA No
DA 2017-08-15
ER

PT J
AU Bamford, A
   Kelleher, P
   Lyall, H
   Haston, M
   Zancolli, M
   Goldblatt, D
   Kampmann, B
AF Bamford, Alasdair
   Kelleher, Peter
   Lyall, Hermione
   Haston, Mitch
   Zancolli, Marta
   Goldblatt, David
   Kampmann, Beate
TI Serological response to 13-valent pneumococcal conjugate vaccine in
   children and adolescents with perinatally acquired HIV infection
SO AIDS
LA English
DT Article
DE HIV; paediatrics; pneumococcal vaccines; serology; vaccination
ID MEMORY B-CELLS; IMMUNODEFICIENCY-VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL
   THERAPY; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; IMMUNOLOGICAL
   MEMORY; AFRICAN CHILDREN; IMMUNOGENICITY; DISEASE; SEROTYPE
AB Background: Children with perinatally acquired HIV (paHIV) remain at an increased risk of pneumococcal infection despite highly active antiretroviral therapy (HAART). Beyond infancy, responses to pneumococcal conjugate vaccine (PCV) remain underinvestigated. There are currently no published data on serological response to 13-valent PCV (PCV13) in the HIV-infected populations.
   Methods: We measured pneumococcal serotype-specific IgG in 48 paHIV-infected child patients (CP), 27 young adult healthy controls (AHC) and 30 child healthy controls (CHC). Opsonophagocytic assay (OPA) titres for three PCV13-exclusive serotypes were measured in a subset of children. Serotype-specific IgG was repeated 1 and 6 months following PCV13 vaccination of CP and AHC groups. OPA titres for four serotypes were measured at the 1-month time-point.
   Results: The majority of CP, CHC and AHC had serotype-specific IgG above 0.35 mu g/ml at baseline, although OPA activity was undetectable for two of the three serotypes studied. Baseline IgG concentrations were significantly lower in CP than AHC for a proportion of serotypes and were strongly predictive of responses to vaccine. After adjusting for baseline, postvaccination IgG concentrations were comparable, although responses to some serotypes were impaired for CP. OPA correlated well with IgG after vaccination. Detectable HIV viral load was associated with significantly lower IgG concentration and OPA titre.
   Conclusion: Children with paHIV mount a robust serological response to PCV13 for most but not all vaccine serotypes. Viral load suppression with HAART and higher baseline IgG concentration are associated with higher postvaccination antibody levels. This has implications for HAART treatment and vaccination practices. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
C1 [Bamford, Alasdair; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Paediat Sect, London W2 1NY, England.
   [Kelleher, Peter] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Immunol Sect, London W2 1NY, England.
   [Lyall, Hermione] Imperial Coll Healthcare NHS Trust, Dept Paediat Infect Dis, London, England.
   [Haston, Mitch; Zancolli, Marta; Goldblatt, David] UCL, Immunobiol Sect, Inst Child Hlth, London WC1E 6BT, England.
   [Kampmann, Beate] Vaccinol Theme, MRC Unit, Fajara, Gambia.
RP Bamford, A (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Paediat, 2nd Floor,Wright Fleming Bldg,St Marys Campus, London W2 1NY, England.
EM a.bamford@nhs.net
RI Goldblatt, David/C-5972-2008
OI Goldblatt, David/0000-0002-0769-5242
FU National Institute of Health Research (NIHR) [RTF/08/01/009]; European
   Society for Pediatric Infectious Diseases (ESPID); NIHR
   [NIHR/SRF-2009-02-07]; Medical Research Council [MR/K007602/1]; Wellcome
   Trust; Westminster Medical Research Trust; St Stephen's AIDS Trust;
   Imperial College Academic Health Science Centre; Medicines for Children
   Research Network; North West London Comprehensive Local Research Network
FX We are grateful to study participants and their families. We also thank
   Lyndsey Ashton, Polly Burbidge, Lucy Roalfe, Marina Johnson and Tom Hall
   for laboratory work; Deborah Ridout for statistical support; Jo Dodge,
   The Family Clinic team; and Amy Brewer and Farhana Abdulla (research
   nurses), for help with recruitment. We acknowledge the support of the
   Imperial College Academic Health Science Centre, Medicines for Children
   Research Network and North West London Comprehensive Local Research
   Network and also Paul Balmer and Pfizer for providing PCV13 for the
   study free of charge.; This work was supported by the National Institute
   of Health Research (NIHR) (grant number RTF/08/01/009 to A. B.) and a
   European Society for Pediatric Infectious Diseases (ESPID) Small Grant
   Award to A. B. B. K. is supported by funding from NIHR (grant number
   NIHR/SRF-2009-02-07) and The Medical Research Council (grant number
   MR/K007602/1). P. K. laboratory is supported by the Wellcome Trust, the
   Westminster Medical Research Trust and St Stephen's AIDS Trust and his
   research group performs contract and/or collaborative research for/with
   Pfizer and Roche.
CR Abzug MJ, 2006, PEDIATR INFECT DIS J, V25, P920, DOI 10.1097/01.inf.0000237830.33228.c3
   Abzug MJ, 2013, VACCINE, V31, P4782, DOI 10.1016/j.vaccine.2013.08.002
   Auranen K, 2013, VACCINE, V32, P153, DOI 10.1016/j.vaccine.2013.08.061
   Balmer P, 2007, CLIN VACCINE IMMUNOL, V14, P1442, DOI 10.1128/CVI.00264-07
   Bocchini JA, 2010, PEDIATRICS, V126, P186, DOI 10.1542/peds.2010-1280
   Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd
   Collins IJ, 2014, CURR OPIN HIV AIDS, V9, P87, DOI 10.1097/COH.0000000000000027
   D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7
   Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC
   French N, 2010, NEW ENGL J MED, V362, P812, DOI 10.1056/NEJMoa0903029
   Fry AM, 2003, J INFECT DIS, V188, P643, DOI 10.1086/377289
   Ghosh S, 2009, PEDIATR RES, V66, P185, DOI 10.1203/PDR.0b013e3181aa057d
   Hart M, 2007, J IMMUNOL, V178, P8212
   Costa Ide C, 2008, REV SAUDE PUBL, V42, P844
   Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316
   Jacobsen MC, 2008, J INFECT DIS, V198, P481, DOI 10.1086/590215
   Johannesson TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042307
   Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013
   Kamboj KK, 2003, J INFECT DIS, V187, P1629, DOI 10.1086/374785
   King JC, 1996, PEDIATR INFECT DIS J, V15, P192, DOI 10.1097/00006454-199603000-00003
   Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060
   Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004
   Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019
   Madhi SA, 2009, J INFECT DIS, V199, P1168, DOI 10.1086/597388
   Menson EN, 2012, HIV MED, V13, P333, DOI 10.1111/j.1468-1293.2011.00982.x
   Mitchell R, 2013, EXPERT OPIN BIOL TH, V13, P1451, DOI 10.1517/14712598.2013.824419
   Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524
   Nunes Marta C, 2012, Hum Vaccin Immunother, V8, P161, DOI 10.4161/hv.18432
   Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929
   Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106
   Rozenbaum MH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6879
   Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119
   Soininen A, 2001, J INFECT DIS, V184, P569, DOI 10.1086/322794
   Spoulou VI, 2005, VACCINE, V23, P5289, DOI 10.1016/j.vaccine.2005.06.002
   Sutcliffe CG, 2010, LANCET INFECT DIS, V10, P630, DOI 10.1016/S1473-3099(10)70116-X
   Tarrago D, 2005, CLIN DIAGN LAB IMMUN, V12, P165, DOI 10.1128/CDLI.12.1.165-170.2005
   Thanee C, 2011, VACCINE, V29, P5886, DOI 10.1016/j.vaccine.2011.06.072
   Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89
   Tobin NH, 2013, IMMUNOL REV, V254, P143, DOI 10.1111/imr.12074
   Van Grevenynghe J, 2011, J CLIN INVEST, V121, P3877, DOI 10.1172/JCI59211
   [Anonymous], 2013, CONS GUID US ANT DRU
NR 41
TC 15
Z9 15
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-9370
EI 1473-5571
J9 AIDS
JI Aids
PD SEP
PY 2014
VL 28
IS 14
BP 2033
EP 2043
DI 10.1097/QAD.0000000000000385
PG 11
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA AO1NM
UT WOS:000341079800004
PM 25222526
OA No
DA 2017-08-15
ER

EF